PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	RP	EM	RI	OI	FU	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	D2	EA	PG	WC	SC	GA	UT	PM	OA	HC	HP	DA
J	Maxwell, WL; Bartlett, E; Morgan, H				Maxwell, William L.; Bartlett, Emma; Morgan, Hanna			Wallerian Degeneration in the Optic Nerve Stretch-Injury Model of Traumatic Brain Injury: A Stereological Analysis	JOURNAL OF NEUROTRAUMA			English	Article						central myelinated nerve fibers; secondary axotomy; stretch-injury; Wallerian degeneration	NONDISRUPTIVE AXONAL INJURY; WHITE-MATTER; CYTOSKELETAL CHANGES; LONGITUDINAL CHANGES; DIFFUSION-TENSOR; SPINAL-CORD; RAT; REGENERATION; FIBERS; MYELIN	Patients with chronic traumatic encephalopathy (CTE) show loss of central white matter, central gray matter, and cortical gray matter with increasing post-traumatic survival. The majority of experimental studies using animals have, however, discussed only the ultrastructural pathophysiology of injured central white matter leading to secondary axotomy and the formation of axonal terminal bulbs. Using the stretch-injured optic nerve model in adult guinea pigs, the present study provides novel quantitative data concerning Wallerian degeneration of disconnected axonal fragments following secondary axotomy out to 12 weeks after injury to an optic nerve. The time course of Wallerian degeneration at the level of an individual nerve fiber is comparable to that reported in earlier studies over 48h to two weeks after secondary axotomy. But only a relatively small proportion of nerve fibers within the optic tract degenerate via Wallerian degeneration during the first two weeks. Rather, examples of each of the three stages of Wallerian degenerationacute axonal degeneration, latency of the distal axonal segment, and granular fragmentationoccur within the optic tract across the entire experimental survival of 12 weeks used in the present study. This data suggests that some nerve fibers initiate Wallerian degeneration days and weeks after the initial time of mechanical injury to an optic nerve. The number of intact nerve fibers continues to fall over at least three months after injury in the stretch-injury model of traumatic axonal injury. It is suggested that these novel findings relate to the mechanism(s) whereby central white matter volume decreases over months and years in CTE patients.	[Maxwell, William L.; Bartlett, Emma; Morgan, Hanna] Univ Glasgow, Dept Anat, Glasgow G12 8QQ, Lanark, Scotland	Maxwell, WL (corresponding author), Univ Glasgow, Dept Anat, Glasgow G12 8QQ, Lanark, Scotland.	maxwellwilliam90@gmail.com					Araki T, 2004, SCIENCE, V305, P1010, DOI 10.1126/science.1098014; BAUR PS, 1977, J MICROSC-OXFORD, V109, P315, DOI 10.1111/j.1365-2818.1977.tb01145.x; Bendlin BB, 2008, NEUROIMAGE, V42, P503, DOI 10.1016/j.neuroimage.2008.04.254; Biiki A., 1999, J NEUROPATHOL EXP NE, V58, P365; Bramlett HM, 2002, ACTA NEUROPATHOL, V103, P607, DOI 10.1007/s00401-001-0510-8; Buki A, 1999, J NEUROTRAUM, V16, P511, DOI 10.1089/neu.1999.16.511; Buss A, 2004, BRAIN, V127, P34, DOI 10.1093/brain/awh001; CHAUDHRY V, 1992, MUSCLE NERVE, V15, P687, DOI 10.1002/mus.880150610; Cohen BA, 2007, AM J NEURORADIOL, V28, P907; Dinkel J, 2014, AM J NEURORADIOL, V35, P23, DOI 10.3174/ajnr.A3616; FRAHER JP, 1972, J ANAT, V112, P99; GENNARELLI TA, 1989, J NEUROSURG, V71, P244, DOI 10.3171/jns.1989.71.2.0244; GEORGE R, 1994, EXP NEUROL, V129, P225, DOI 10.1006/exnr.1994.1164; GILLIATT RW, 1972, J NEUROL NEUROSUR PS, V35, P335, DOI 10.1136/jnnp.35.3.335; GLASS JD, 1994, J NEUROCHEM, V62, P2472, DOI 10.1046/j.1471-4159.1994.62062472.x; GRIFFIN JW, 1993, PERIPHERAL NEUROPATH, P361; GUNDERSEN HJG, 1988, APMIS, V96, P379, DOI 10.1111/j.1699-0463.1988.tb05320.x; Jafari SS, 1998, J NEUROTRAUM, V15, P955, DOI 10.1089/neu.1998.15.955; Jafari SS, 1997, J NEUROCYTOL, V26, P207, DOI 10.1023/A:1018588114648; JEFFERY G, 1981, EXP BRAIN RES, V44, P34; Kampfl A, 1996, J NEUROCHEM, V67, P1575; Kerschensteiner M, 2005, NAT MED, V11, P572, DOI 10.1038/nm1229; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; KREUTZBERG GW, 1971, ACTA NEUROPATHOL, V17, P220, DOI 10.1007/BF00685055; Leuissen I., 2014, CORTEX, V51, P67; LUBINSKA L, 1977, BRAIN RES, V130, P47, DOI 10.1016/0006-8993(77)90841-1; Ma M, 2013, NEUROBIOL DIS, V56, P34, DOI 10.1016/j.nbd.2013.03.009; Maxwell W.L., 2015, BRAIN INJURY PRINCIP, P15; Maxwell WL, 2013, BRAIN SCI, V3, P1374, DOI 10.3390/brainsci3031374; Maxwell WL, 2010, BRAIN, V133, P139, DOI 10.1093/brain/awp264; Maxwell WL, 1997, J NEUROTRAUM, V14, P603, DOI 10.1089/neu.1997.14.603; Maxwell WL, 2003, J NEUROTRAUM, V20, P151, DOI 10.1089/08977150360547071; Moldovan M, 2009, BRAIN, V132, P511, DOI 10.1093/brain/awn332; MORGAN JE, 1987, NEUROSCIENCE, V20, P519, DOI 10.1016/0306-4522(87)90108-4; Narciso MS, 2001, AN ACAD BRAS CIENC, V73, P231, DOI 10.1590/S0001-37652001000200008; Neveu MM, 2007, EYE, V21, P1264, DOI 10.1038/sj.eye.6702839; Payne SC, 2012, INVEST OPHTH VIS SCI, V53, P6093, DOI 10.1167/iovs.12-10080; Pettus EH, 1996, BRAIN RES, V722, P1, DOI 10.1016/0006-8993(96)00113-8; RICHARDSON PM, 1982, J NEUROCYTOL, V11, P949, DOI 10.1007/BF01148310; Rodriguez-Paez AC, 2005, ACTA NEUROPATHOL, V109, P603, DOI 10.1007/s00401-005-1010-z; Saatman K.E., HDB NEUROCHEMISTRY M; Saggu SK, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-97; Sulaiman AM, 2011, J NEUROTRAUM, V28, P383, DOI 10.1089/neu.2010.1707; Tomaiuolo F, 2005, J NEUROTRAUM, V22, P76, DOI 10.1089/neu.2005.22.76; Trivedi MA, 2007, J NEUROTRAUM, V24, P766, DOI 10.1089/neu.2006.0205; TSAO JW, 1994, EUR J NEUROSCI, V6, P516, DOI 10.1111/j.1460-9568.1994.tb00295.x; Wang JT, 2012, J CELL BIOL, V196, P7, DOI 10.1083/jcb.201108111; Wang JQ, 2011, J NEUROTRAUM, V28, P1185, DOI 10.1089/neu.2011.1756; Warner MA, 2010, J NEUROTRAUM, V27, P2121, DOI 10.1089/neu.2010.1429; Warner MA, 2010, ARCH NEUROL-CHICAGO, V67, P1336, DOI 10.1001/archneurol.2010.149; WAXMAN SG, 1992, BRAIN RES, V574, P105, DOI 10.1016/0006-8993(92)90806-K; WEGNER JE, 1976, BIOL GUINEA PIG	52	17	20	0	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUN 1	2015	32	11					780	790		10.1089/neu.2014.3369			11	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	CV0YU	WOS:000363980700003	25333317				2021-06-18	
J	Carr, D; Lindstrom, AC; Jareborg, A; Champion, S; Waddell, N; Miller, D; Teagle, M; Horsfall, I; Kieser, J				Carr, Debra; Lindstrom, Anne-Christine; Jareborg, Andreas; Champion, Stephen; Waddell, Neil; Miller, David; Teagle, Michael; Horsfall, Ian; Kieser, Jules			Development of a skull/brain model for military wound ballistics studies	INTERNATIONAL JOURNAL OF LEGAL MEDICINE			English	Article						Helmet; High velocity; Bullet; Rifle; Penetrating	EQUESTRIAN INJURIES; HEAD; GUNSHOTS; SKULL	Reports on penetrating ballistic head injuries in the literature are dominated by case studies of suicides; the penetrating ammunition usually being .22 rimfire or shotgun. The dominating cause of injuries in modern warfare is fragmentation and hence, this is the primary threat that military helmets protect the brain from. When helmets are perforated, this is usually by bullets. In combat, 20 % of penetrating injuries occur to the head and its wounding accounts for 50 % of combat deaths. A number of head simulants are described in the academic literature, in ballistic test methods for helmets (including measurement of behind helmet blunt trauma, BHBT) and in the 'open' and 'closed' government literature of several nations. The majority of these models are not anatomically correct and are not assessed with high-velocity rifle ammunition. In this article, an anatomically correct 'skull' (manufactured from polyurethane) and 'brain' (manufactured from 10 %, by mass, gelatine) model for use in military wound ballistic studies is described. Filling the cranium completely with gelatine resulted in a similar 'skull' fracture pattern as an anatomically correct 'brain' combined with a representation of cerebrospinal fluid. In particular, posterior cranial fossa and occipital fractures and brain ejection were observed. This pattern of injury compared favourably to reported case studies of actual incidents in the literature.	[Carr, Debra; Miller, David; Teagle, Michael; Horsfall, Ian] Cranfield Univ, Def Acad United Kingdom, Impact & Armour Grp, Ctr Def Engn Cranfield Def & Secur, Shrivenham SN6 8LA, Wilts, England; [Lindstrom, Anne-Christine; Jareborg, Andreas; Waddell, Neil; Kieser, Jules] Univ Otago, Sir John Walsh Res Inst, Dunedin, New Zealand; [Champion, Stephen] Cranfield Univ, Def Acad United Kingdom, Weap & Vehicle Syst Grp, Ctr Def Engn Cranfield Def & Secur, Shrivenham SN6 8LA, Wilts, England	Carr, D (corresponding author), Cranfield Univ, Def Acad United Kingdom, Impact & Armour Grp, Ctr Def Engn Cranfield Def & Secur, Shrivenham SN6 8LA, Wilts, England.	d.j.carr@cranfield.ac.uk	Champion, Stephen/N-4249-2015; Carr, Debra/K-6845-2013	Champion, Stephen/0000-0002-7818-8096; Horsfall, Ian/0000-0002-2108-1087; Waddell, John/0000-0001-8889-4632; Carr, Debra/0000-0002-9476-2166	Royal Swedish Academy of Sciences; Impact and Armour Group at Cranfield University	A-CL acknowledges an equipment grant from the Royal Swedish Academy of Sciences. Miss E. Girvan (Otago Centre for Electron Microscopy) assisted with the EDS analysis. This work was internally funded by The Impact and Armour Group at Cranfield University.	BARBER TW, 1970, ACTA NEUROL SCAND, V46, P85, DOI 10.1111/j.1600-0404.1970.tb05606.x; Baxter D, 2012, NEUROSURGERY, V30, P116; Betz P, 1997, FORENSIC SCI INT, V86, P155, DOI 10.1016/S0379-0738(97)02121-X; BOND GR, 1995, PEDIATRICS, V95, P487; Breeze J, 2011, J TRAUMA, V71, P108, DOI 10.1097/TA.0b013e318203304a; CAREY ME, 1987, MIL MED, V152, P6; Chitnavis JP, 1996, INJURY, V27, P103, DOI 10.1016/0020-1383(95)00176-X; Eskridge SL, 2012, INJURY, V43, P1678, DOI 10.1016/j.injury.2012.05.027; Hardman JM, 2002, NEUROIMAG CLIN N AM, V12, P175, DOI 10.1016/S1052-5149(02)00009-6; Hejna P, 2011, INT J LEGAL MED, V125, P587, DOI 10.1007/s00414-011-0553-x; Jones SJ, 2004, BRIT J SPORT MED, V38, P159, DOI 10.1136/bjsm.2002.002584; Jussila J, 2004, FORENSIC SCI INT, V141, P91, DOI 10.1016/j.forsciint.2003.11.036; KARGER B, 1995, INT J LEGAL MED, V108, P53, DOI 10.1007/BF01369905; Kieser DC, 2013, INT J LEGAL MED, V127, P951, DOI 10.1007/s00414-013-0874-z; Lewis EA, 2006, PERS ARM SYST S 2006, P18; LIESKE K, 1991, INT J LEGAL MED, V104, P235, DOI 10.1007/BF01369813; Lim J, 2003, ANZ J SURG, V73, P567, DOI 10.1046/j.1445-2197.2003.02707.x; Mabbott A, 2013, INT S BALL FREIB GER; Macnab AJ, 2002, INJURY PREV, V8, P324, DOI 10.1136/ip.8.4.324; McCrory P, 2002, BRIT J SPORT MED, V36, P314, DOI 10.1136/bjsm.36.5.314; Rennick SL, 2005, J FORENSIC SCI, V50, P1016; Schyma C, 2012, INT J LEGAL MED, V126, P607, DOI 10.1007/s00414-012-0704-8; Siu TLT, 2004, J CLIN NEUROSCI, V11, P236, DOI 10.1016/j.jocn.2003.08.003; SPALDING TJW, 1991, BRIT J SURG, V78, P1102, DOI 10.1002/bjs.1800780921; Sturdivan LM, 1981, MATH MODEL PROBABILI; Thali MJ, 2002, FORENSIC SCI INT, V125, P178, DOI 10.1016/S0379-0738(01)00637-5; WATKINS FP, 1988, J TRAUMA, V28, pS40, DOI 10.1097/00005373-198801001-00011	27	17	17	1	35	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0937-9827	1437-1596		INT J LEGAL MED	Int. J. Legal Med.	MAY	2015	129	3					505	510		10.1007/s00414-014-1073-2			6	Medicine, Legal	Legal Medicine	CG4DO	WOS:000353233200015	25194710				2021-06-18	
J	Godbolt, AK; Stenberg, M; Lindgren, M; Ulfarsson, T; Lannsjo, M; Stalnacke, BM; Borg, J; DeBoussard, CN				Godbolt, Alison K.; Stenberg, Maud; Lindgren, Marie; Ulfarsson, Trandur; Lannsjo, Marianne; Stalnacke, Britt-Marie; Borg, Jorgen; DeBoussard, Catharina Nygren			Associations Between Care Pathways and Outcome 1 Year After Severe Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						health facility planning; outcome; rehabilitation; severe traumatic brain injury	REACTION LEVEL SCALE; GLASGOW COMA SCALE; INPATIENT REHABILITATION; PARIS-TBI; GUIDELINES; ADMISSIONS; COHORT; RLS85	Objective: To assess associations between real-world care pathways for working-age patients in the first year after severe traumatic brain injury and outcomes at 1 year. Setting and Design: Prospective, observational study with recruitment from 6 neurosurgical centers in Sweden and Iceland. Follow-up to 1 year, independently of care pathways, by rehabilitation physicians and paramedical professionals. Participants: Patients with severe traumatic brain injury, lowest (nonsedated) Glasgow Coma Scale score 3 to 8 during the first 24 hours and requiring neurosurgical intensive care, age 18 to 65 years, and alive 3 weeks after injury. Main Measures: Length of stay in intensive care, time between intensive care discharge and rehabilitation admission, outcome at 1 year (Glasgow Outcome Scale Extended score), acute markers of injury severity, preexisting medical conditions, and post-acute complications. Logistic regression analyses were performed. Results: A multivariate model found variables significantly associated with outcome (odds ratio for good outcome [confidence interval], P value) to be as follows: length of stay in intensive care (0.92 [0.87-0.98], 0.014), time between intensive care discharge and admission to inpatient rehabilitation (0.97 [0.94-0.99], 0.017), and post-acute complications (0.058 [0.006-0.60], 0.017). Conclusions: Delays in rehabilitation admission were negatively associated with outcome. Measures to ensure timely rehabilitation admission may improve outcome. Further research is needed to evaluate possible causation.	[Godbolt, Alison K.; Borg, Jorgen; DeBoussard, Catharina Nygren] Karolinska Inst, Dept Clin Sci, SE-18288 Stockholm, Sweden; [Godbolt, Alison K.; Borg, Jorgen; DeBoussard, Catharina Nygren] Danderyd Hosp, Univ Dept Rehabil Med Stockholm, Stockholm, Sweden; [Stenberg, Maud; Stalnacke, Britt-Marie] Umea Univ, Dept Community Med & Rehabil, Rehabil Med, Umea, Sweden; [Lindgren, Marie] Cty Council, Dept Clin Rehabil Med, Linkoping, Sweden; [Ulfarsson, Trandur] Sahlgrens Univ Hosp, Dept Rehabil Med, Gothenburg, Sweden; [Lannsjo, Marianne] Uppsala Univ, Dept Neurosci, Uppsala, Sweden; [Lannsjo, Marianne] Gavle & Sandviken Hosp, Dept Rehabil Med, Sandviken, Sweden; [Godbolt, Alison K.] Univ Hosptial Uppsala, Dept Rehabil Med, Uppsala, Sweden; [Godbolt, Alison K.] Uppsala Univ, Uppsala, Sweden	Godbolt, AK (corresponding author), Karolinska Inst, Dept Clin Sci, Hus 39,Plan 3, SE-18288 Stockholm, Sweden.	alison.godbolt@ki.se		Borg, Jorgen/0000-0002-2372-7478; Godbolt, Alison/0000-0003-4511-6181			Andelic N, 2012, J NEUROTRAUM, V29, P66, DOI 10.1089/neu.2011.1811; Chen HW, 2010, PM&R, V2, pS306, DOI 10.1016/j.pmrj.2010.10.006; Craig P., 2008, DEV EVALUATING COMPL; Engberg AW, 2006, ACTA NEUROL SCAND, V113, P178, DOI 10.1111/j.1600-0404.2005.00570.x; Grande PO, 2011, J NEUROSURG ANESTH, V23, P358, DOI 10.1097/01.ana.0000405612.20356.84; Hoffman JM, 2012, ARCH PHYS MED REHAB, V93, P1305, DOI 10.1016/j.apmr.2012.04.030; Jourdan C, 2013, BRAIN INJURY, V27, P1000, DOI 10.3109/02699052.2013.794971; Jourdan C, 2013, NEUROREHAB NEURAL RE, V27, P35, DOI 10.1177/1545968312440744; Katz DI, 2009, PROG BRAIN RES, V177, P73, DOI 10.1016/S0079-6123(09)17707-5; Krakau K, 2007, NUTRITION, V23, P308, DOI 10.1016/j.nut.2007.01.010; Levin HS, 2001, J NEUROTRAUM, V18, P575, DOI 10.1089/089771501750291819; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Olivecrona M, 2013, J CLIN NEUROSCI, V20, P996, DOI 10.1016/j.jocn.2012.09.015; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Polinder S, 2005, J TRAUMA, V59, P1283, DOI 10.1097/01.ta.0000195998.11304.5b; Socialstyrelsen, REH PERS TRAUM HJARN; STARMARK JE, 1988, J NEUROSURG, V69, P699, DOI 10.3171/jns.1988.69.5.0699; STARMARK JE, 1988, ACTA NEUROCHIR, V91, P12, DOI 10.1007/BF01400521; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; TESSERIS J, 1991, ACTA NEUROCHIR, V110, P65, DOI 10.1007/BF01402050; Turner-Stokes L, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004170.pub2; Turner-Stokes L, 2008, J REHABIL MED, V40, P691, DOI 10.2340/16501977-0265; Walther SM, 2003, INTENS CARE MED, V29, P933, DOI 10.1007/s00134-003-1757-4; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573	24	17	17	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAY-JUN	2015	30	3					E41	E51		10.1097/HTR.0000000000000050			11	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	CH8PJ	WOS:000354298100005	24901323				2021-06-18	
J	Alali, AS; Vavrek, D; Barber, J; Dikmen, S; Nathens, AB; Temkin, NR				Alali, Aziz S.; Vavrek, Darcy; Barber, Jason; Dikmen, Sureyya; Nathens, Avery B.; Temkin, Nancy R.			Comparative Study of Outcome Measures and Analysis Methods for Traumatic Brain Injury Trials	JOURNAL OF NEUROTRAUMA			English	Article						research design; outcome measures; traumatic brain injury; Glasgow Outcome Scale; statistical data analysis	SEVERE HEAD-INJURY; CLINICAL-TRIALS; SCALE; MODERATE; VALIDITY; IMPACT; DESIGN; ODDS	Batteries of functional and cognitive measures have been proposed as alternatives to the Extended Glasgow Outcome Scale (GOSE) as the primary outcome for traumatic brain injury (TBI) trials. We evaluated several approaches to analyzing GOSE and a battery of four functional and cognitive measures. Using data from a randomized trial, we created a "super" dataset of 16,550 subjects from patients with complete data (n=331) and then simulated multiple treatment effects across multiple outcome measures. Patients were sampled with replacement (bootstrapping) to generate 10,000 samples for each treatment effect (n=400 patients/group). The percentage of samples where the null hypothesis was rejected estimates the power. All analytic techniques had appropriate rates of type I error (<= 5%). Accounting for baseline prognosis either by using sliding dichotomy for GOSE or using regression-based methods substantially increased the power over the corresponding analysis without accounting for prognosis. Analyzing GOSE using multivariate proportional odds regression or analyzing the four-outcome battery with regression-based adjustments had the highest power, assuming equal treatment effect across all components. Analyzing GOSE using a fixed dichotomy provided the lowest power for both unadjusted and regression-adjusted analyses. We assumed an equal treatment effect for all measures. This may not be true in an actual clinical trial. Accounting for baseline prognosis is critical to attaining high power in Phase III TBI trials. The choice of primary outcome for future trials should be guided by power, the domain of brain function that an intervention is likely to impact, and the feasibility of collecting outcome data.	[Alali, Aziz S.; Nathens, Avery B.] Univ Toronto, Inst Hlth Policy, Toronto, ON, Canada; [Nathens, Avery B.] Univ Toronto, Dept Surg, Toronto, ON, Canada; [Alali, Aziz S.] Sunnybrook Hlth Sci Ctr, Sunnybrook Res Inst, Toronto, ON M4N 3M5, Canada; [Alali, Aziz S.] Univ Ottawa, Div Neurosurg, Ottawa, ON, Canada; [Vavrek, Darcy] Univ Western States, Ctr Outcome Studies, Portland, OR USA; [Temkin, Nancy R.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Barber, Jason; Dikmen, Sureyya; Temkin, Nancy R.] Univ Washington, Dept Neurol Surg, Seattle, WA 98195 USA; [Dikmen, Sureyya; Temkin, Nancy R.] Univ Washington, Dept Rehabil Med, Seattle, WA 98195 USA	Temkin, NR (corresponding author), Univ Washington, Dept Neurol Surg & Biostat, Box 359924, Seattle, WA 98104 USA.	temkin@uw.edu			Canada Research Chair Program in Systems of Trauma Care; DoDUnited States Department of Defense [W81XWH-08-2-0159]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 NS19643]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS019643] Funding Source: NIH RePORTER	This work was supported in part by a Canada Research Chair Program in Systems of Trauma Care (to A.B.N.) and by DoD grant W81XWH-08-2-0159 (to N.T). Clinical trial data were collected under NIH grant R01 NS19643.	Agresti A, 2010, ANAL ORDINAL CATEGOR, V2nd; Bagiella E, 2010, J HEAD TRAUMA REHAB, V25, P375, DOI 10.1097/HTR.0b013e3181d27fe3; Beers SR, 2012, J NEUROTRAUM, V29, P1126, DOI 10.1089/neu.2011.2272; Bell KR, 2005, ARCH PHYS MED REHAB, V86, P851, DOI 10.1016/j.apmr.2004.09.015; BRANT R, 1990, BIOMETRICS, V46, P1171, DOI 10.2307/2532457; BROOKS DN, 1986, J NEUROL NEUROSUR PS, V49, P549, DOI 10.1136/jnnp.49.5.549; BUSCHKE H, 1973, J VERB LEARN VERB BE, V12, P543, DOI 10.1016/S0022-5371(73)80034-9; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; Clifton GL, 2011, LANCET NEUROL, V10, P131, DOI 10.1016/S1474-4422(10)70300-8; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80; Edwards P, 2005, LANCET, V365, P1957; Efron B., 1998, INTRO BOOTSTRAP; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Finkelstein EA., 2006, INCIDENCE EC BURDEN; Freemantle N, 2003, JAMA-J AM MED ASSOC, V289, P2554, DOI 10.1001/jama.289.19.2554; Grimes DA, 2008, OBSTET GYNECOL, V111, P423, DOI 10.1097/01.AOG.0000297304.32187.5d; Haynes R. B., 2006, CLIN EPIDEMIOLOGY DO; Jennings D. A., 2005, COMP ANAL STRATEGIES; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Levin HS, 2001, J NEUROTRAUM, V18, P575, DOI 10.1089/089771501750291819; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Lezak M.D., 2004, NEUROPSYCHOLOGICAL A, Vfourth; Maas AIR, 2006, LANCET NEUROL, V5, P38, DOI 10.1016/S1474-4422(05)70253-2; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Maas AIR, 2013, LANCET NEUROL, V12, P1200, DOI 10.1016/S1474-4422(13)70234-5; Maas AIR, 2012, J NEUROTRAUM, V29, P32, DOI 10.1089/neu.2010.1599; MARLER JR, 1995, NEW ENGL J MED, V333, P1581, DOI 10.1056/nejm199512143332401; McHugh GS, 2010, CLIN TRIALS, V7, P44, DOI 10.1177/1740774509356580; Moher D, 2010, BMJ-BRIT MED J, V340, DOI [10.1016/j.jclinepi.2010.03.004, 10.1136/bmj.c869]; Montori VM, 2005, BMJ-BRIT MED J, V330, P594, DOI 10.1136/bmj.330.7491.594; Murray GD, 2005, J NEUROTRAUM, V22, P511, DOI 10.1089/neu.2005.22.511; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Park E, 2008, CAN MED ASSOC J, V178, P1163, DOI 10.1503/cmaj.080282; Ragnarsson KT, 2006, J HEAD TRAUMA REHAB, V21, P379, DOI 10.1097/00001199-200609000-00002; Roozenbeek B, 2011, CRIT CARE, V15, DOI 10.1186/cc10240; Stanley K, 2007, CIRCULATION, V115, P1164, DOI 10.1161/CIRCULATIONAHA.105.594945; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; Temkin NR, 2007, LANCET NEUROL, V6, P29, DOI 10.1016/S1474-4422(06)70630-5; Wechsler D., 1997, WAIS 3 ADM SCORING M; Weir J, 2012, J NEUROTRAUM, V29, P53, DOI 10.1089/neu.2011.2137; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wolfson D., 1993, HALSTEAD REITAN NEUR; Zafonte RD, 2012, JAMA-J AM MED ASSOC, V308, P1993, DOI 10.1001/jama.2012.13256	46	17	17	0	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR 15	2015	32	8					581	589		10.1089/neu.2014.3495			9	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	CF2BS	WOS:000352352900008	25317951	Green Published			2021-06-18	
J	Arbour, C; Khoury, S; Lavigne, GJ; Gagnon, K; Poirier, G; Montplaisir, JY; Carrier, J; Gosselin, N				Arbour, Caroline; Khoury, Samar; Lavigne, Gilles J.; Gagnon, Katia; Poirier, Gaetan; Montplaisir, Jacques Y.; Carrier, Julie; Gosselin, Nadia			Are NREM sleep characteristics associated to subjective sleep complaints after mild traumatic brain injury?	SLEEP MEDICINE			English	Article						Brain injury; Electroencephalography; Sleep; Slow oscillations; Sleep spindles	SLOW-WAVE ACTIVITY; EEG ACTIVITY; QUALITY INDEX; SPINDLES; DISTURBANCE; FREQUENCY; INSOMNIA; AGE	Introduction: Sleep complaints are common after mild traumatic brain injury (mTBI). While recent findings suggest that sleep macro-architecture is preserved in mTBI, features of non-rapid eye movement (NREM) sleep micro-architecture including electroencephalography (EEG) spectral power, slow waves (SW), and sleep spindles could be affected. This study aimed to compare NREM sleep in mTBI and healthy controls, and explore whether NREM sleep characteristics correlate with sleep complaints in these groups. Methods: Thirty-four mTBI participants (mean age: 34.2 +/- 11.9 yrs; post-injury delay: 10.5 +/- 10.4 weeks) and 29 age-matched controls (mean age: 32.4 +/- 8.2 yrs) were recruited for two consecutive nights of polysomnographic (PSG) recording. Spectral power was computed and SW and spindles were automatically detected in three derivations (F3, C3, O1) for the first three sleep cycles. Subjective sleep quality was assessed with the Pittsburgh Sleep Quality Index (PSQI). Results: mTBI participants reported significant poorer sleep quality than controls on the PSQI and showed significant increases in beta power during NREM sleep at the occipital derivation only. Conversely, no group differences were found in SW and spindle characteristics. Interestingly, changes in NREM sleep characteristics were not associated with mTBI estimation of sleep quality. Conclusions: Compared to controls, mTBI were found to have enhanced NREM beta power. However, these changes were not found to be associated with the subjective evaluation of sleep. While increases in beta bands during NREM sleep may be attributable to the occurrence of a brain injury, they could also be related to the presence of pain and anxiety as suggested in one prior study. Crown Copyright (C) 2014 Published by Elsevier B.V. All rights reserved.	[Arbour, Caroline; Khoury, Samar; Lavigne, Gilles J.; Gagnon, Katia; Poirier, Gaetan; Montplaisir, Jacques Y.; Carrier, Julie; Gosselin, Nadia] Hop Sacre Coeur, Ctr Adv Res Sleep Med, Montreal, PQ H4J 1C5, Canada; [Arbour, Caroline; Carrier, Julie; Gosselin, Nadia] Univ Montreal, Dept Psychol, Montreal, PQ H3C 3J7, Canada; [Khoury, Samar] Univ Montreal, Dept Physiol, Montreal, PQ H3C 3J7, Canada; [Lavigne, Gilles J.] Univ Montreal, Fac Med Dent, Montreal, PQ H3C 3J7, Canada; [Gagnon, Katia] Univ Quebec, Dept Psychol, Montreal, PQ H3C 3P8, Canada; [Montplaisir, Jacques Y.] Univ Montreal, Dept Psychiat, Montreal, PQ H3C 3J7, Canada	Gosselin, N (corresponding author), Hop Sacre Coeur, Ctr Adv Res Sleep Med, 5400 Boul Gouin Ouest, Montreal, PQ H4J 1C5, Canada.	nadia.gosselin@umontreal.ca		Carrier, Julie/0000-0001-5311-2370	Canadian Institutes of Health Research (CIHR)Canadian Institutes of Health Research (CIHR); Fonds de Recherche du Quebec - Sante (FRQ-S); FRQS's Quebec Pain Research Network; Research Centre of the study setting; Canada Research Chair on Pain, Sleep, and Traumatic Injuries; Canada Research Chair on Sleep Medicine	The authors would like to thank Dr Jean-Francois Giguere for his work in the confirmation of participants' mTBI diagnosis. This research was partially supported by the Canadian Institutes of Health Research (CIHR) and by the Fonds de Recherche du Quebec - Sante (FRQ-S) - both for Dr Gosselin. Part of this study was also funded by the FRQS's Quebec Pain Research Network and the Research Centre of the study setting. Dr. Lavigne holds a Canada Research Chair on Pain, Sleep, and Traumatic Injuries. Dr Montplaisir holds a Canada Research Chair on Sleep Medicine.	AESCHBACH D, 1993, J SLEEP RES, V2, P70, DOI 10.1111/j.1365-2869.1993.tb00065.x; American Academy of Sleep Medicine (AASM), 2005, INT CLASS SLEEP DIS, V2nd; Anderer P, 2001, NEUROSCIENCE, V103, P581, DOI 10.1016/S0306-4522(01)00028-8; [Anonymous], 1974, Electroencephalogr Clin Neurophysiol, V37, P538; Armitage R, 2007, SLEEP, V30, P657, DOI 10.1093/sleep/30.5.657; Backhaus J, 2002, J PSYCHOSOM RES, V53, P737, DOI 10.1016/S0022-3999(02)00330-6; Bader K, 2013, J CLIN NEUROPHYSIOL, V30, P188, DOI 10.1097/WNP.0b013e3182767c4a; Baker FC, 2012, J SLEEP RES, V21, P535, DOI 10.1111/j.1365-2869.2012.01007.x; BECK AT, 1988, CLIN PSYCHOL REV, V8, P77, DOI 10.1016/0272-7358(88)90050-5; Beck AT., 1996, BECK DEPRESSION INVE, V2; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Carrier J, 2011, EUR J NEUROSCI, V33, P758, DOI 10.1111/j.1460-9568.2010.07543.x; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Castellanos NP, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00090; Cohen B.H., 2008, EXPLAINING PSYCHOL S; Csercsa R, 2010, BRAIN, V133, P2814, DOI 10.1093/brain/awq169; De Gennaro L, 2003, SLEEP MED REV, V7, P423, DOI 10.1053/smrv.2002.0252; Gosselin N, 2009, SLEEP MED, V10, P35, DOI 10.1016/j.sleep.2007.11.023; Kempf J, 2010, J NEUROL NEUROSUR PS, V81, P1402, DOI 10.1136/jnnp.2009.201913; Khoury S, 2013, J NEUROTRAUM, V30, P633, DOI 10.1089/neu.2012.2519; Landolt HP, 1996, BRAIN RES, V738, P205, DOI 10.1016/S0006-8993(96)00770-6; Marshall L, 2006, NATURE, V444, P610, DOI 10.1038/nature05278; Martin N, 2013, NEUROBIOL AGING, V34, P468, DOI 10.1016/j.neurobiolaging.2012.05.020; Massimini M, 2004, J NEUROSCI, V24, P6862, DOI 10.1523/JNEUROSCI.1318-04.2004; Murphy M, 2009, P NATL ACAD SCI USA, V106, P1608, DOI 10.1073/pnas.0807933106; Ouellet MC, 2006, J HEAD TRAUMA REHAB, V21, P199, DOI 10.1097/00001199-200605000-00001; Rao V, 2011, J NEUROPSYCH CLIN N, V23, P201, DOI 10.1176/appi.neuropsych.23.2.201; Rechtschaffen A, 1968, MANUAL STANDARDIZED; Riemann D, 2010, SLEEP MED REV, V14, P19, DOI 10.1016/j.smrv.2009.04.002; Rioult-Pedotti MS, 2000, SCIENCE, V290, P533, DOI 10.1126/science.290.5491.533; Siapas AG, 1998, NEURON, V21, P1123, DOI 10.1016/S0896-6273(00)80629-7; Spiegelhalder K, 2012, BIOL PSYCHOL, V91, P329, DOI 10.1016/j.biopsycho.2012.08.009; Steriade M, 2006, NEUROSCIENCE, V137, P1087, DOI 10.1016/j.neuroscience.2005.10.029; Tsuno N, 2002, J SLEEP RES, V11, P43, DOI 10.1046/j.1365-2869.2002.00288.x; Urakami Y, 2012, CLIN EEG NEUROSCI, V43, P39, DOI 10.1177/1550059411428718	35	17	18	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	1389-9457	1878-5506		SLEEP MED	Sleep Med.	APR	2015	16	4					534	539		10.1016/j.sleep.2014.12.002			6	Clinical Neurology	Neurosciences & Neurology	CF6TM	WOS:000352689200015	25747335				2021-06-18	
J	Pastor, PN; Reuben, CA; Kobau, R; Helmers, SL; Lukacs, S				Pastor, Patricia N.; Reuben, Cynthia A.; Kobau, Rosemarie; Helmers, Sandra L.; Lukacs, Susan			Functional difficulties and school limitations of children with epilepsy: Findings from the 2009-2010 National Survey of Children with Special-Health Care Needs	DISABILITY AND HEALTH JOURNAL			English	Article						Epilepsy; Disability; Comorbid conditions	CHILDHOOD EPILEPSY; SEIZURE; PSYCHOPATHOLOGY; PERFORMANCE; PREVALENCE; DISABILITY; DISORDERS; PROGNOSIS; EDUCATION; BEHAVIOR	Background: Epilepsy is a common serious neurologic disorder in children. However, most studies of children's functional difficulties and school limitations have used samples from tertiary care or other clinical settings. Objective: To compare functional difficulties and school limitations of a national sample of US children with special health care needs (CSHCN) with and without epilepsy. Methods: Data from the 2009-2010 National Survey of CSHCN for 31,897 children aged 6-17 years with and without epilepsy were analyzed for CSHCN in two groups: 1) CSHCN with selected comorbid conditions (intellectual disability, cerebral palsy, autism, or traumatic brain injury) and 2) CSHCN without these conditions. Functional difficulties and school limitations, adjusted for the effect of sociodemographic characteristics, were examined by epilepsy and comorbid conditions. Results: Three percent of CSHCN had epilepsy. Among CSHCN with epilepsy 53% had comorbid conditions. Overall CSHCN with epilepsy, both with and without comorbid conditions, had more functional difficulties than CSHCN without epilepsy. For example, after adjustment for sociodemographic characteristics a higher percentage of children with epilepsy, compared to children without epilepsy, had difficulty with communication (with conditions: 53% vs. 37%, without conditions: 13% vs. 5%). Results for school limitations were similar. After adjustment, a higher percentage of children with epilepsy, compared to children without epilepsy, missed 11 + school days in the past year (with conditions: 36% vs. 18%, without conditions: 21% vs. 15%). Conclusion: CSHCN with epilepsy, compared to CSHCN without epilepsy, were more likely to have functional difficulties and limitations in school attendance regardless of comorbid conditions. Published by Elsevier Inc.	[Pastor, Patricia N.; Reuben, Cynthia A.; Lukacs, Susan] Ctr Dis Control & Prevent, Natl Ctr Hlth Stat, Hyattsville, MD 20782 USA; [Kobau, Rosemarie] Ctr Dis Control & Prevent, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA USA; [Helmers, Sandra L.] Emory Univ, Sch Med, Atlanta, GA USA	Pastor, PN (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Hlth Stat, 3311 Toledo Rd, Hyattsville, MD 20782 USA.	php3@cdc.gov					Austin JK, 2011, EPILEPSY BEHAV, V21, P373, DOI 10.1016/j.yebeh.2011.05.028; Bailet LL, 2000, EPILEPSIA, V41, P426, DOI 10.1111/j.1528-1157.2000.tb00184.x; Berg AT, 2008, EPILEPSIA, V49, P608, DOI 10.1111/j.1528-1167.2007.01461.x; Berg AT, 2011, J CHILD NEUROL, V26, P540, DOI 10.1177/0883073810384869; Berg AT, 2005, DEV MED CHILD NEUROL, V47, P749, DOI 10.1017/S001216220500157X; Berg AT, 2004, PEDIATRICS, V114, P645, DOI 10.1542/peds.2003-1151-L; Besag FMC, 2006, EPILEPSIA, V47, P119, DOI 10.1111/j.1528-1167.2006.00709.x; Bethell CD, 2002, AMBUL PEDIATR, V2, P38, DOI 10.1367/1539-4409(2002)002<0038:ICWSHC>2.0.CO;2; BOYLE CA, 1994, PEDIATRICS, V93, P399; Bramlett MD, VITAL HEALTH STAT FO, V1; Centers for Disease Control and Prevention National Center for Health Statistics State and Area Integrated Telephone Survey, 2011, 2009 2010 NATIONAL S; Dunn DW, 2009, DEV MED CHILD NEUROL, V51, P364, DOI 10.1111/j.1469-8749.2008.03172.x; Elger CE, 2004, LANCET NEUROL, V3, P663, DOI 10.1016/S1474-4422(04)00906-8; ELLENBERG JH, 1984, ANN NEUROL, V15, P127, DOI 10.1002/ana.410150204; Ellis N, 2000, SEIZURE-EUR J EPILEP, V9, P22, DOI 10.1053/seiz.1999.0353; Fastenau PS, 2008, J LEARN DISABIL-US, V41, P195, DOI 10.1177/0022219408317548; Gabis L, 2005, EPILEPSY BEHAV, V7, P652, DOI 10.1016/j.yebeh.2005.08.008; GOULDEN KJ, 1991, EPILEPSIA, V32, P690, DOI 10.1111/j.1528-1157.1991.tb04711.x; Hermann BP, 2008, EPILEPSIA, V49, P1847, DOI 10.1111/j.1528-1167.2008.01735.x; Hesdorffer DC, 2013, EPILEPSIA, V54, P207, DOI 10.1111/epi.12056; IOM (Institute of Medicine), 2012, EPILEPSY ACROSS THE; Jones JE, 2008, PEDIATR REV, V29, pE9, DOI 10.1542/pir.29-2-e9; Matson JL, 1999, J INTELL DISABIL RES, V43, P531, DOI 10.1046/j.1365-2788.1999.00247.x; McPherson M, 1998, PEDIATRICS, V102, P137, DOI 10.1542/peds.102.1.137; MURPHY CC, 1995, EPILEPSIA, V36, P866, DOI 10.1111/j.1528-1157.1995.tb01629.x; Perou R, 2013, MMWR-MORBID MORTAL W, V62, P1; Piccinelli P, 2008, DEV MED CHILD NEUROL, V50, P353, DOI [10.1111/j.1469-8749.2008.02040.x, 10.1111/j.1469-8749.2007.02040.x]; Reilly C, 2013, CHILD ADOL MENT H-UK, V18, P65, DOI 10.1111/j.1475-3588.2012.00648.x; Research Triangle Institute, 2012, SUDAAN LANGUAGE MANU; Rodenburg R, 2005, J PEDIATR PSYCHOL, V30, P453, DOI 10.1093/jpepsy/jsi071; Russ SA, 2012, PEDIATRICS, V129, P256, DOI 10.1542/peds.2010-1371; Shinnar S, 2002, J CHILD NEUROL, V17, pS4, DOI 10.1177/08830738020170010201; Sogawa Y, 2010, EPILEPSIA, V51, P2432, DOI 10.1111/j.1528-1167.2010.02724.x; Stevanovic D, 2012, EPILEPSY BEHAV, V25, P141, DOI 10.1016/j.yebeh.2012.07.017; Zafeiriou DI, 1999, J CHILD NEUROL, V14, P289, DOI 10.1177/088307389901400504	35	17	17	0	14	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1936-6574	1876-7583		DISABIL HEALTH J	Disabil. Health J.	APR	2015	8	2					231	239		10.1016/j.dhjo.2014.09.002			9	Health Care Sciences & Services; Health Policy & Services; Public, Environmental & Occupational Health; Rehabilitation	Health Care Sciences & Services; Public, Environmental & Occupational Health; Rehabilitation	CD7YY	WOS:000351313400011	25312691				2021-06-18	
J	Wasserman, EB; Shah, MN; Jones, CMC; Cushman, JT; Caterino, JM; Bazarian, JJ; Gillespie, SM; Cheng, JD; Dozier, A				Wasserman, Erin B.; Shah, Manish N.; Jones, Courtney M. C.; Cushman, Jeremy T.; Caterino, Jeffrey M.; Bazarian, Jeffrey J.; Gillespie, Suzanne M.; Cheng, Julius D.; Dozier, Ann			IDENTIFICATION OF A NEUROLOGIC SCALE THAT OPTIMIZES EMS DETECTION OF OLDER ADULT TRAUMATIC BRAIN INJURY PATIENTS WHO REQUIRE TRANSPORT TO A TRAUMA CENTER	PREHOSPITAL EMERGENCY CARE			English	Article						brain injuries; triage; emergency medical services; geriatrics	GLASGOW COMA SCALE; SIMPLIFIED MOTOR SCORE; EMERGENCY-DEPARTMENT; PREDICTING SURVIVAL; UNITED-STATES; OUTCOME SCALE; HEAD-INJURY; NOS-TBI; MORTALITY; DEMENTIA	Objective. We sought to identify a scale or components of a scale that optimize detection of older adult traumatic brain injury (TBI) patients who require transport to a trauma center, regardless of mechanism. Methods. We assembled a consensus panel consisting of nine experts in geriatric emergency medicine, prehospital medicine, trauma surgery, geriatric medicine, and TBI, as well as prehospital providers, to evaluate the existing scales used to identify TBI. We reviewed the relevant literature and solicited group feedback to create a list of candidate scales and criteria for evaluation. Using the nominal group technique, scales were evaluated by the expert panel through an iterative process until consensus was achieved. Results. We identified 15 scales for evaluation. The panel's criteria for rating the scales included ease of administration, prehospital familiarity with scale components, feasibility of use with older adults, time to administer, and strength of evidence for their performance in the prehospital setting. After review and discussion of aggregated ratings, the panel identified the Simplified Motor Scale, GCS-Motor Component, and AVPU (alert, voice, pain, unresponsive) as the strongest scales, but determined that none meet all EMS provider and patient needs due to poor usability and lack of supportive evidence. The panel proposed that a dichotomized decision scheme that includes domains of the top-rated scales - level of alertness (alert vs. not alert) and motor function (obeys commands vs. does not obey) - may be more effective in identifying older adult TBI patients who require transport to a trauma center in the prehospital setting. Conclusions. Existing scales to identify TBI are inadequate to detect older adult TBI patients who require transport to a trauma center. A new algorithm, derived from elements of previously established scales, has the potential to guide prehospital providers in improving the triage of older adult TBI patients, but needs further evaluation prior to use.	[Wasserman, Erin B.; Shah, Manish N.; Jones, Courtney M. C.; Cushman, Jeremy T.; Bazarian, Jeffrey J.] Univ Rochester, Sch Med & Dent, Dept Emergency Med, Rochester, NY USA; [Wasserman, Erin B.; Shah, Manish N.; Jones, Courtney M. C.; Bazarian, Jeffrey J.; Dozier, Ann] Univ Rochester, Sch Med & Dent, Dept Publ Hlth Sci, Rochester, NY USA; [Shah, Manish N.; Gillespie, Suzanne M.] Univ Rochester, Sch Med & Dent, Div Geriatr Aging, Rochester, NY USA; [Caterino, Jeffrey M.] Ohio State Univ, Dept Emergency Med, Columbus, OH 43210 USA; [Caterino, Jeffrey M.] Ohio State Univ, Dept Internal Med, Columbus, OH 43210 USA; [Cheng, Julius D.] Univ Rochester, Sch Med & Dent, Dept Surg, Rochester, NY USA	Shah, MN (corresponding author), 265 Crittenden Blvd,Box 655C, Rochester, NY 14642 USA.	manish.shah@rochester.edu		Shah, Manish/0000-0001-6331-1074; Cushman, Jeremy/0000-0003-4767-3731; Wasserman, Erin/0000-0001-5957-5878	NATIONAL CENTER FOR INJURY PREVENTION AND CONTROLUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [U01CE002175] Funding Source: NIH RePORTER; NCIPC CDC HHS [U01 CE002175] Funding Source: Medline		Al-Salamah MA, 2004, ACAD EMERG MED, V11, P834, DOI 10.1197/j.aem.2004.03.008; American College of Surgeons CoT, 1997, ADV TRAUM LIF SUPP M; Battistella FD, 1998, J TRAUMA, V44, P618, DOI 10.1097/00005373-199804000-00010; BAXT WG, 1987, J TRAUMA, V27, P365, DOI 10.1097/00005373-198704000-00004; Bazarian JJ, 2003, BRAIN INJURY, V17, P553, DOI 10.1080/0269905031000070260; Borg J, 2004, J REHABIL MED, V36, P61, DOI 10.1080/16501960410023822; Boustani M, 2003, ANN INTERN MED, V138, P927, DOI 10.7326/0003-4819-138-11-200306030-00015; Cabana MD, 1999, JAMA-J AM MED ASSOC, V282, P1458, DOI 10.1001/jama.282.15.1458; Caterino JM, 2012, EMERG MED J, V29, P492, DOI 10.1136/emj.2010.110437; Caterino JM, 2011, ACAD EMERG MED, V18, P1014, DOI 10.1111/j.1553-2712.2011.01164.x; Chambers J, 1996, J TRAUMA, V41, P976, DOI 10.1097/00005373-199612000-00006; CHESNUT RM, 1994, NEUROSURGERY, V34, P840, DOI 10.1227/00006123-199405000-00008; Clesham K, 2008, EMERG MED J, V25, P691, DOI 10.1136/emj.2007.054924; Coronado VG, 2005, J HEAD TRAUMA REHAB, V20, P215, DOI 10.1097/00001199-200505000-00005; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Dams-O'Connor K, 2013, J NEUROTRAUM, V30, P2001, DOI 10.1089/neu.2013.3047; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Gill M, 2005, ANN EMERG MED, V45, P37, DOI 10.1016/j.annemergmed.2004.07.429; Gill M, 2007, ANN EMERG MED, V49, P403, DOI 10.1016/j.annemergmed.2006.03.031; Gill M, 2006, ACAD EMERG MED, V13, P968, DOI 10.1197/j.aem.2006.05.019; Graham JE, 1997, LANCET, V349, P1793, DOI 10.1016/S0140-6736(97)01007-6; Haukoos JS, 2007, ANN EMERG MED, V50, P18, DOI 10.1016/j.annemergmed.2006.10.004; Healey C, 2003, J TRAUMA, V54, P671, DOI 10.1097/01.TA.0000058130.30490.5D; Hoyt DBR., 2008, TRAUMA, V6th ed., P57; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Jagoda AS, 2008, ANN EMERG MED, V52, P714, DOI 10.1016/j.annemergmed.2008.08.021; Jiang JY, 2002, J NEUROTRAUM, V19, P869, DOI 10.1089/08977150260190456; JONES J, 1995, BRIT MED J, V311, P376, DOI 10.1136/bmj.311.7001.376; Kerby JD, 2007, J TRAUMA, V63, P1026, DOI 10.1097/TA.0b013e318157d9e8; Levine SD, 2006, J EMERG MED, V31, P1, DOI 10.1016/j.jemermed.2005.08.007; Lloyd-Jones G, 1999, MED EDUC, V33, P8; MacKenzie EJ, 2006, NEW ENGL J MED, V354, P366, DOI 10.1056/NEJMsa052049; Mamelak AN, 1996, J TRAUMA, V41, P91, DOI 10.1097/00005373-199607000-00014; Management of Concussion/mTBI Working Group, 2009, J Rehabil Res Dev, V46, pCP1; Mc Dowell I., 2006, MEASURING HLTH GUIDE, V3rd; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M., 1997, STANDARDIZED ASSESSM; McNarry AF, 2004, ANAESTHESIA, V59, P34, DOI 10.1111/j.1365-2044.2004.03526.x; Meldon SW, 2002, J TRAUMA, V52, P79, DOI 10.1097/00005373-200201000-00014; MEREDITH W, 1995, J TRAUMA, V38, P129, DOI 10.1097/00005373-199501000-00030; Mosenthal AC, 2002, J TRAUMA, V52, P907, DOI 10.1097/00005373-200205000-00015; Mulholland SA, 2005, INJURY, V36, P1298, DOI 10.1016/j.injury.2005.07.010; Nell V, 2000, ARCH PHYS MED REHAB, V81, P614, DOI 10.1053/mr.2000.3877; NHS National institute for Health and Clinical Excellence, 2007, HEAD INJ TRIAG ASS I; Olsson T, 2003, ACAD EMERG MED, V10, P1040, DOI 10.1197/S1069-6563(03)00342-7; Plassman BL, 2007, NEUROEPIDEMIOLOGY, V29, P125, DOI 10.1159/000109998; Price Timothy G, 2005, Prehosp Emerg Care, V9, P322, DOI 10.1080/10903120590962012; Reynolds FD, 2003, J TRAUMA, V54, P492, DOI 10.1097/01.TA.0000051601.60556.FC; RHEE KJ, 1987, AM J EMERG MED, V5, P278, DOI 10.1016/0735-6757(87)90350-0; Ross SE, 1998, J TRAUMA, V45, P42, DOI 10.1097/00005373-199807000-00008; Roush WR, 1994, PRINCIPLES EMS SYSTE; Sasser SM, 2012, GUIDELINES FIELD TRI; Schreiber MA, 2002, ARCH SURG-CHICAGO, V137, P285, DOI 10.1001/archsurg.137.3.285; Servadei F, 1998, J TRAUMA, V44, P868, DOI 10.1097/00005373-199805000-00021; Signorini DF, 1999, J NEUROL NEUROSUR PS, V66, P20, DOI 10.1136/jnnp.66.1.20; Sporer KA, 2012, EMERG MED J; Stiell IG, 2007, ACAD EMERG MED, V14, P955, DOI 10.1197/j.aem.2007.06.039; Susman M, 2002, J TRAUMA, V53, P219, DOI 10.1097/00005373-200208000-00004; Thompson DO, 2011, ANN EMERG MED, V58, P417, DOI 10.1016/j.annemergmed.2011.05.033; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; Wilde EA, 2010, J NEUROTRAUM, V27, P975, DOI 10.1089/neu.2009.1193; Wilde EA, 2010, J NEUROTRAUM, V27, P983, DOI 10.1089/neu.2009.1194; Winchell RJ, 1997, ARCH SURG-CHICAGO, V132, P592; WINKLER J V, 1984, Journal of Emergency Medicine, V2, P1, DOI 10.1016/0736-4679(84)90038-6	64	17	17	0	10	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1090-3127	1545-0066		PREHOSP EMERG CARE	Prehosp. Emerg. Care	APR-JUN	2015	19	2					202	212		10.3109/10903127.2014.959225			11	Emergency Medicine; Public, Environmental & Occupational Health	Emergency Medicine; Public, Environmental & Occupational Health	CE6LS	WOS:000351948500004	25290953	Green Accepted			2021-06-18	
J	Freeman, A; Adams, M; Ashworth, F				Freeman, Anita; Adams, Malcolm; Ashworth, Fiona			An exploration of the experience of self in the social world for men following traumatic brain injury	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Self-conscious emotions; Self-identity; Neuropsychological rehabilitation; Traumatic brain injury	IDENTITY; PEOPLE; SHAME; CONSTRUCTION; DEPRESSION; HEALTH; ANGER	This study explores the lived experience of male survivors of traumatic brain injury (TBI) in relation to perceived changes in their personal and social identity. The aim was to provide an understanding of the individuals' sense of self and sources of emotional distress and growth following injury. Semi-structured interviews were conducted with nine male survivors of TBI (aged 22-59 years). These men were 17 months to 21 years post-injury and were recruited through a UK holistic neuropsychological rehabilitation centre. Transcripts of their accounts were analysed using thematic analysis. Identified dominant themes related to the men's described experience of changes in self relating to their social world, were titled: "abnormality", "hidden", "the old-me-new-me" and "others treat me differently". In response to these emotional experiences the themes of "self-criticism", "need to be as others want me to be" and "withdrawal" emerged. The identified themes are considered alongside the alternative narrative of "positive growth" in relation to current understanding of identity and "self-conscious" emotions. Future research and clinical implications are suggested.	[Freeman, Anita] South London & Maudsley NHS Fdn Trust, London, England; [Adams, Malcolm] Univ E Anglia, Norwich NR4 7TJ, Norfolk, England; [Ashworth, Fiona] Anglia Ruskin Univ, Cambridge, England	Freeman, A (corresponding author), Maudsley Hosp & Inst Psychiat, CASCAID, Community Link Centre, Ground Floor,Douglas Bennett House, London SE5 8AZ, England.	anitafreeman@nhs.net			Oliver Zangwill Centre, Cambridge	The authors gratefully acknowledge the support of the Oliver Zangwill Centre, Cambridge and extend our gratitude to the men who participated in this study. Anita Freeman would also like to thank Prof Malcolm Adams' family for consenting to his authorship following his sad death in 2013 whilst this article was being written.	Antaki C., 2003, DISCOURSE ANAL ONLIN, V1; Ashworth F., 2011, BRAIN IMPAIR, V4, P3272; Baumeister R. F., 1998, HDB SOCIAL PSYCHOL, V4, P680, DOI DOI 10.1002/PITS.20162; Blinder BJ, 2007, PSYCHIAT ANN, V37, P276; Braun V., 2006, QUALITATIVE RES PSYC, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706qp063oa]; Burr Vivienne, 1995, INTRO SOCIAL CONSTRU; Cantor JB, 2005, J HEAD TRAUMA REHAB, V20, P527, DOI 10.1097/00001199-200511000-00005; Carroll E, 2011, NEUROPSYCHOL REHABIL, V21, P289, DOI 10.1080/09602011.2011.555972; Chamberlain DJ, 2006, J ADV NURS, V54, P407, DOI 10.1111/j.1365-2648.2006.03840.x; Chiovitti RF, 2003, J ADV NURS, V44, P427, DOI 10.1046/j.0309-2402.2003.02822.x; Cloute K, 2008, NEUROPSYCHOL REHABIL, V18, P651, DOI 10.1080/09602010701306989; Colantonio A, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-102; Conneeley A. L., 2003, BRIT J OCCUPATIONAL, V66, P440; Coyne IT, 1997, J ADV NURS, V26, P623, DOI 10.1046/j.1365-2648.1997.t01-25-00999.x; DENZIN R, 1989, RES ACT THEORETICAL; Douglas J., 2012, SOCIAL CURE IDENTITY; Douglas JM, 2013, BRAIN INJURY, V27, P60, DOI 10.3109/02699052.2012.722254; Evans J. J., 2006, OL ZANGW CTR 10 ANN; Gilbert P, 2000, PERS INDIV DIFFER, V29, P757, DOI 10.1016/S0191-8869(99)00230-5; GILBERT P, 1994, BRIT J CLIN PSYCHOL, V33, P295, DOI 10.1111/j.2044-8260.1994.tb01125.x; Gilbert P., 2007, PSYCHOTHERAPY COUNSE; Gilbert P, 2006, CLIN PSYCHOL PSYCHOT, V13, P353, DOI 10.1002/cpp.507; Gracey F., 2012, SOCIAL CURE IDENTITY; Gracey F, 2008, NEUROPSYCHOL REHABIL, V18, P627, DOI 10.1080/09602010802041238; Haslam C, 2008, NEUROPSYCHOL REHABIL, V18, P671, DOI 10.1080/09602010701643449; Haslam SA, 2009, APPL PSYCHOL-INT REV, V58, P1, DOI 10.1111/j.1464-0597.2008.00379.x; Hefferon K, 2009, BRIT J HEALTH PSYCH, V14, P343, DOI 10.1348/135910708X332936; Jetten J., 2012, SOCIAL CURE IDENTITY; Jobson L, 2009, CLIN PSYCHOL REV, V29, P368, DOI 10.1016/j.cpr.2009.03.002; Jones J. A., 2011, DISABILITY REHABILIT, V33, P17; Jones J. M., 2010, PSYCHOL HEALTH, V1, P1; Karlovits T, 1999, BRAIN INJURY, V13, P845; LEDOUX JE, 1995, ANNU REV PSYCHOL, V46, P209, DOI 10.1146/annurev.ps.46.020195.001233; Levack WMM, 2010, DISABIL REHABIL, V32, P986, DOI 10.3109/09638281003775394; Lewis M., 1993, HDB EMOTIONS, P353; Mason J., 2002, QUALITATIVE RES; Morgan A., 2000, WHAT IS NARRATIVE TH; MORTON MV, 1995, BRAIN INJURY, V9, P81, DOI 10.3109/02699059509004574; Muenchberger H, 2008, BRAIN INJURY, V22, P979, DOI 10.1080/02699050802530532; Mukherjee D, 2003, WOMEN THER, V26, P3, DOI 10.1300/J015v26n01_01; Neidenthal P. M., 2006, PSYCHOL EMOTION INTE; Nochi M, 1998, QUAL HEALTH RES, V8, P665, DOI 10.1177/104973239800800507; Nochi M, 2000, SOC SCI MED, V51, P1795, DOI 10.1016/S0277-9536(00)00111-8; Ownsworth TL, 1998, BRAIN INJURY, V12, P735, DOI 10.1080/026990598122133; Paterson B, 2002, QUAL HEALTH RES, V12, P399, DOI 10.1177/104973202129119973; Postmes T., 2006, INDIVIDUALITY GROUP; Power M., 2008, COGNITION EMOTION OR, V2nd ed.; Riley GA, 2004, BRAIN INJURY, V18, P871, DOI 10.1080/02699050410001671829; Riley GA, 2010, NEUROPSYCHOL REHABIL, V20, P869, DOI 10.1080/09602011.2010.503041; SANDELOWSKI M, 1995, RES NURS HEALTH, V18, P179, DOI 10.1002/nur.4770180211; Silverman D., 2001, INTERPRETING QUALITA; Slavich GM, 2010, NEUROSCI BIOBEHAV R, V35, P39, DOI 10.1016/j.neubiorev.2010.01.003; Strauss A., 1998, BASICS QUALITATIVE R; Tajfel, 1986, PSYCHOL INTERGROUP R, P2; Tajfel H., 1979, SOCIAL PSYCHOL INTER, P33, DOI DOI 10.1016/S0065-2601(05)37005-5; Tangney J. P., 2002, SHAME GUILT; TANGNEY JP, 1992, J PERS SOC PSYCHOL, V62, P669, DOI 10.1037/0022-3514.62.4.669; Turner J., 1987, REDISCOVERING SOCIAL; TURNER JC, 1994, PERS SOC PSYCHOL B, V20, P454, DOI 10.1177/0146167294205002; Vickery CD, 2005, BRAIN INJURY, V19, P657, DOI 10.1080/02699050400005218; Vogenthaler D R, 1987, Brain Inj, V1, P113; Williams W. H., 2003, NEUROPSYCHOL REHABIL, V8, P43; Wilson BA, 2009, NEUROPSYCHOLOGICAL REHABILITATION: THEORY, MODELS, THERAPY AND OUTCOME, P1, DOI 10.1017/CBO9780511581083; Wright JC, 1996, BRIT J CLIN PSYCHOL, V35, P399, DOI 10.1111/j.2044-8260.1996.tb01194.x; Yardley L, 2000, PSYCHOL HEALTH, V15, P215, DOI 10.1080/08870440008400302; Yeates GN, 2008, NEUROPSYCHOL REHABIL, V18, P566, DOI 10.1080/09602010802151532; Ylvisaker M, 2008, NEUROPSYCHOL REHABIL, V18, P713, DOI 10.1080/09602010802201832	67	17	18	0	32	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.	MAR 4	2015	25	2					189	215		10.1080/09602011.2014.917686			27	Neurosciences; Psychology	Neurosciences & Neurology; Psychology	AZ6BY	WOS:000348304600002	24848538				2021-06-18	
J	Albrecht, JS; Liu, XG; Smith, GS; Baumgarten, M; Rattinger, GB; Gambert, SR; Langenberg, P; Zuckerman, IH				Albrecht, Jennifer S.; Liu, Xinggang; Smith, Gordon S.; Baumgarten, Mona; Rattinger, Gail B.; Gambert, Steven R.; Langenberg, Patricia; Zuckerman, Ilene H.			Stroke Incidence Following Traumatic Brain Injury in Older Adults	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						hemorrhagic stroke; ischemic stroke; older adults; traumatic brain injury	LONG-TERM DISABILITY; UNITED-STATES; MULTICENTER; POPULATION; MORTALITY; RISK	Objective: Following traumatic brain injury (TBI), older adults are at an increased risk of hemorrhagic and thromboembolic events, but it is unclear whether the increased risk continues after hospital discharge. We estimated incidence rates of hemorrhagic and ischemic stroke following hospital discharge for TBI among adults 65 years or older and compared them with pre-TBI rates. Participants: A total of 16 936 Medicare beneficiaries 65 years or older with a diagnosis of TBI in any position on an inpatient claim between June 1, 2006, and December 31, 2009, who survived to hospital discharge. Design: Retrospective analysis of a random 5% sample of Medicare claims data. Main Measures: Hemorrhagic stroke was defined as ICD-9 (International Classification of Diseases, Ninth Revision) codes 430.xx-432.xx. Ischemic stroke was defined as ICD-9 codes 433.xx-435.xx, 437.0x, and 437.1x. Results: There was a 6-fold increase in the rate of hemorrhagic stroke following TBI compared with the pre-TBI period (adjusted rate ratio, 6.5; 95% confidence interval, 5.3-7.8), controlling for age and sex. A smaller increase in the rate of ischemic stroke was observed (adjusted rate ratio, 1.3; 95% CI, 1.2-1.4). Conclusion: Future studies should investigate causes of increased stroke risk post-TBI as well as effective treatment options to reduce stroke risk and improve outcomes post-TBI among older adults.	[Albrecht, Jennifer S.; Liu, Xinggang; Zuckerman, Ilene H.] Univ Maryland, Sch Pharm, Dept Pharmaceut Hlth Serv Res, Baltimore, MD 21201 USA; [Smith, Gordon S.; Baumgarten, Mona; Langenberg, Patricia; Zuckerman, Ilene H.] Univ Maryland, Sch Med, Dept Epidemiol & Publ Hlth, Baltimore, MD 21201 USA; [Gambert, Steven R.] Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA; [Smith, Gordon S.] Univ Maryland, Natl Study Ctr Trauma & Emergency Med Serv, Shock Trauma & Anesthesiol Res STAR Organized Res, Baltimore, MD 21201 USA; [Rattinger, Gail B.] Fairleigh Dickinson Univ, Sch Pharm, Pharm Practice Div, Florham Pk, NJ USA	Zuckerman, IH (corresponding author), IMPAQ Int LLC, 10420 Little Patuxent Pkwy,Suite 300, Columbia, MD 21044 USA.	izuckerman@impaqint.com		Smith, Gordon/0000-0002-2911-3071; Albrecht, Jennifer/0000-0003-4838-2274	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R21 AG042768-01, T32AG000262-14]; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R21AG042768, T32AG000262] Funding Source: NIH RePORTER	This work was supported by National Institutes of Health grant R21 AG042768-01 (Dr Zuckerman, PI). Dr Albrecht is supported by National Institutes of Health grant T32AG000262-14 (Magaziner, PI).	Burke JF, 2013, NEUROLOGY, V81, P33, DOI 10.1212/WNL.0b013e318297eecf; Chen YH, 2011, STROKE, V42, P2733, DOI 10.1161/STROKEAHA.111.620112; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Gubler KD, 1997, ARCH SURG-CHICAGO, V132, P1010; Harvey LA, 2012, INJURY, V43, P1821, DOI 10.1016/j.injury.2012.07.188; Knudson MM, 2004, ANN SURG, V240, P490, DOI 10.1097/01.sla.0000137138.40116.6c; Livingston DH, 2005, J TRAUMA, V59, P1298, DOI 10.1097/01.ta.0000196002.03681.18; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Moretti L, 2012, LANCET NEUROL, V11, P1103, DOI 10.1016/S1474-4422(12)70226-0; Mosenthal AC, 2002, J TRAUMA, V52, P907, DOI 10.1097/00005373-200205000-00015; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Subaiya S, 2012, BMC EMERG MED, V12, DOI 10.1186/1471-227X-12-17; Susman M, 2002, J TRAUMA, V53, P219, DOI 10.1097/00005373-200208000-00004; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; Thompson HJ, 2012, J NEUROTRAUM, V29, P1864, DOI 10.1089/neu.2011.2284; Utomo WK, 2009, INJURY, V40, P973, DOI 10.1016/j.injury.2009.05.034; Yeh CC, 2013, J NEUROL NEUROSUR PS, V84, P441, DOI 10.1136/jnnp-2012-302547; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac	19	17	17	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAR-APR	2015	30	2					E62	E67		10.1097/HTR.0000000000000035			6	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	CF1MG	WOS:000352309300007	24816156	Green Accepted			2021-06-18	
J	Keller, MW; Han, PP; Galarneau, MR; Gaball, CW				Keller, Matthew W.; Han, Peggy P.; Galarneau, Michael R.; Gaball, Curtis W.			Characteristics of Maxillofacial Injuries and Safety of In-Theater Facial Fracture Repair in Severe Combat Trauma	MILITARY MEDICINE			English	Article							OPERATION-IRAQI-FREEDOM; FRONTAL-SINUS FRACTURES; ENDURING FREEDOM; NECK TRAUMA; AFGHANISTAN; CASUALTIES; WAR; BATTLEFIELD; EXPERIENCE; PERSONNEL	The study objectives were to characterize maxillofacial injuries and assess the safety of in-theater facial fracture repair in U.S. military personnel with severe combat trauma from Iraq and Afghanistan. We performed a retrospective chart review of the Expeditionary Medical Encounter Database from 2004 to 2010. 1,345 military personnel with combat-related maxillofacial injuries were identified. Injury severity was quantified with the Abbreviated Injury Scale and Injury Severity Score. Service members with maxillofacial injury and severe combat trauma (Injury Severity Score 3 16) were included. The distribution of facial fractures, types, and outcomes of surgical repairs, incidence of traumatic brain injury, concomitant head and neck injuries, burn rate/severity, and rates of Acinetobacter baumannii colonization and surgical site infection were analyzed. The prevalence of maxillofacial injury in the Expeditionary Medical Encounter Database was 22.7%. The most common mechanism of injury was improvised explosive device (65.7%). Midface trauma and facial burns were common. Approximately 64% of the study sample sustained traumatic brain injury. Overall, 45.6% (109/239) had at least one facial bone fracture. Of those with facial fractures, 64.2% (n = 70) underwent surgical repair. None of the service members who underwent in-theater facial fracture repair developed A. baumannii facial wound infection or implant extrusion.	[Keller, Matthew W.; Gaball, Curtis W.] Naval Med Ctr San Diego, Dept Otolaryngol Head & Neck Surg, San Diego, CA 92134 USA; [Han, Peggy P.; Galarneau, Michael R.] Naval Hlth Res Ctr, Med Modeling Simulat & Mission Support Dept, San Diego, CA 92106 USA	Keller, MW (corresponding author), Naval Med Ctr San Diego, Dept Otolaryngol Head & Neck Surg, San Diego, CA 92134 USA.				U.S. Navy Bureau of Medicine and Surgery under the Wounded, III; Injured/Psychological Health/Traumatic Brain Injury Program [60808]	Dr. Matthew Keller had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. Mary Clouser critically revised the article for important intellectual content (Medical Modeling, Simulation, and Mission Support Department, Naval Health Research Center) and Amber Dougherty (Medical Modeling, Simulation, and Mission Support Department, Naval Health Research Center) performed scientific and technical editorial reviews of the article. This work was supported by the U.S. Navy Bureau of Medicine and Surgery under the Wounded, III, and Injured/Psychological Health/Traumatic Brain Injury Program under work unit no. 60808.	AC Hart, 2008, ICD 9 CM PROFESSIONA; Ansell M J, 2010, J R Army Med Corps, V156, P106; BAKER SP, 1976, J TRAUMA, V16, P882, DOI 10.1097/00005373-197611000-00006; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; BEEBE GW, 1952, BATTLE CASUALTIES, P165; Breeze J, 2013, J ROY ARMY MED CORPS, V159, P59, DOI 10.1136/jramc-2013-000014; Breeze J, 2012, INJURY, V43, P1856, DOI 10.1016/j.injury.2011.07.001; Breeze J, 2012, J ROY ARMY MED CORPS, V158, P79, DOI 10.1136/jramc-158-02-02; Breeze J, 2010, J R Army Med Corps, V156, P137; Breeze J, 2011, J TRAUMA, V71, P108, DOI 10.1097/TA.0b013e318203304a; Brennan J, 2006, OTOLARYNG HEAD NECK, V134, P100, DOI 10.1016/j.otohns.2005.10.008; Brennan J, 2013, LARYNGOSCOPE, V123, P2411, DOI 10.1002/lary.24096; Brennan J, 2011, OTOLARYNG HEAD NECK, V144, P180, DOI 10.1177/0194599810391628; Centers for Disease Control and Prevention (CDC), 2004, MMWR MORB MORTAL WKL, V53, P1063; Chambers LW, 2006, J TRAUMA, V60, P1155, DOI 10.1097/01.ta.0000220340.91356.7e; Chan RK, 2012, J TRAUMA ACUTE CARE, V73, pS453, DOI 10.1097/TA.0b013e3182754868; Chen KT, 2006, PLAST RECONSTR SURG, V118, P457, DOI 10.1097/01.prs.0000227738.42077.2d; Davis KA, 2005, EMERG INFECT DIS, V11, P1218, DOI 10.3201/1108.050103; DOBSON JE, 1989, BRIT J ORAL MAX SURG, V27, P441, DOI 10.1016/S0266-4356(89)80001-4; Feldt BA, 2013, OTOLARYNG HEAD NECK, V148, P403, DOI 10.1177/0194599812472874; Galarneau MR, 2006, MIL MED, V171, P691, DOI 10.7205/MILMED.171.8.691; Gennarelli TA, 2005, ABBREVIATED INJURY S; Goldberg MS, 2010, MIL MED, V175, P220, DOI 10.7205/MILMED-D-09-00130; HARDAWAY RM, 1978, J TRAUMA, V18, P635, DOI 10.1097/00005373-197809000-00004; Hart AC, 2008, INT CLASSIFICATION D, V1; Hospenthal DR, 2011, J TRAUMA, V71, pS52, DOI 10.1097/TA.0b013e31822118fb; Levin L, 2008, J ORAL MAXIL SURG, V66, P1630, DOI 10.1016/j.joms.2007.11.028; Lew TA, 2010, J ORAL MAXIL SURG, V68, P3, DOI 10.1016/j.joms.2009.06.006; Lopez MA, 2007, ARCH FACIAL PLAST S, V9, P400, DOI 10.1001/archfaci.9.6.400; Mabry RL, 2000, J TRAUMA, V49, P515, DOI 10.1097/00005373-200009000-00021; Nessen S. C., 2008, WAR SURG AFGHANISTAN; Owens BD, 2008, J TRAUMA, V64, P295, DOI 10.1097/TA.0b013e318163b875; Reister F, 2008, BATTLE CASUALITES ME; Salinas NL, 2011, OTOLARYNG HEAD NECK, V144, P703, DOI 10.1177/0194599811400575; Salinas NL, 2010, J CRANIOFAC SURG, V21, P967, DOI 10.1097/SCS.0b013e3181e17ab5; Sheppard FR, 2010, AM J SURG, V200, P489, DOI 10.1016/j.amjsurg.2010.03.001; Sise MJ, 2006, J TRAUMA, V60, P1162; Strong EB, 2006, OTOLARYNG HEAD NECK, V135, P774, DOI 10.1016/j.otohns.2006.03.043; Wade AL, 2007, J TRAUMA, V63, P836, DOI 10.1097/01.ta.0000251453.54663.66; WALLIS A, 1988, LARYNGOSCOPE, V98, P593; Zapor MJ, 2005, CURR OPIN INFECT DIS, V18, P395, DOI 10.1097/01.qco.0000182102.50430.2c	41	17	17	1	5	ASSOC MILITARY SURG US	BETHESDA	9320 OLD GEORGETOWN RD, BETHESDA, MD 20814 USA	0026-4075	1930-613X		MIL MED	Milit. Med.	MAR	2015	180	3					315	320		10.7205/MILMED-D-14-00345			6	Medicine, General & Internal	General & Internal Medicine	CD3OI	WOS:000350987700018	25735023				2021-06-18	
J	Li, JY; Li, N; Jiang, Y				Li Junyi; Li Na; Jiang Yan			Mesenchymal Stem Cells Secrete Brain-Derived Neurotrophic Factor and Promote Retinal Ganglion Cell Survival After Traumatic Optic Neuropathy	JOURNAL OF CRANIOFACIAL SURGERY			English	Article						Mesenchymal stem cells; brain-derived neurotrophic factor; retinal ganglion cells; traumatic optic neuropathy	OLFACTORY ENSHEATHING CELLS; NEURITE REGENERATION; INJURY; DEATH; BDNF	Objective: The study aimed to investigate whether intravitreal injection of mesenchymal stem cells (MSCs) cultivated in vitro could increase the number of survived retinal ganglion cells (RGCs) after traumatic optic neuropathy and sought to identify potential mechanisms underlying such growth. Methods: The right eye of 24 cats in the MSC transplantation group accepted intravitreal injection of MSCs, and the other 24 cats in the phosphate buffer (PBS) control group received isotonic saline after traumatic optic neuropathy. The RGCs' survival rate in separated retinal and brain-derived neurotrophic factor (BDNF) expression were observed by Dil labeling and Enzyme-Linked Immuno Sorbent Assay (ELISA), respectively, at 3, 7, 14, and 28 days after transplantation. Results: Quantitative analysis showed that RGCs were significantly attenuated at 3, 7, 14, and 28 days after transplantation in both areas of the retina (peripheral, P-7d = 0.0011, P-14d < 0.001, P-28d < 0.001; central, P-3d = 0.0437, P-7d = 0.0067, P-14d < 0.001, P-28d < 0.001). Mean density of RGCs in the MSC transplantation group was significantly higher than that of the PBS control group after 14 days of treatment (P < 0.001). The homogenates BDNF (hBDNF) in the MSC transplantation group was obviously higher than that in the PBS control group at 14 and 28 days (P < 0.05). Conclusions: The MSCs transplanted into the retina of cats can slow down RGC apoptosis and steadily express BDNF. The MSC-mediated neuroprotection after optic nerve injury may be related to BNDF.	[Li Junyi; Li Na; Jiang Yan] Qingdao Univ, Coll Med, Affiliated Hosp, Dept Otolaryngol Head & Neck Surg, Qingdao 266071, Shangdong, Peoples R China	Li, N (corresponding author), 16 South Jiangsu St, Qingdao 266003, Shandong, Peoples R China.	dr_lient@126.com			Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81170895]; Natural Science Foundation of Shandong Province, ChinaNatural Science Foundation of Shandong Province [ZR2009CM053]	Supported by the Natural Science Foundation of China (81170895) and Natural Science Foundation of Shandong Province, China (ZR2009CM053).	Bonnet D, 2004, BRAIN RES, V1007, P142, DOI 10.1016/j.brainres.2004.02.023; Chaudhary P, 1999, MOL BRAIN RES, V67, P36, DOI 10.1016/S0169-328X(99)00032-7; Chong NHV, 1999, BRIT J OPHTHALMOL, V83, P120, DOI 10.1136/bjo.83.1.120; Dezawa Mari, 2002, Anatomical Science International, V77, P12, DOI 10.1046/j.0022-7722.2002.00012.x; Fang MR, 2011, ANAT REC, V294, P24, DOI 10.1002/ar.21281; Gass P, 2010, INT J NEUROPSYCHOPH, V13, P1, DOI 10.1017/S1461145709991039; Gavrilova N, 2010, INVEST OPHTH VIS SCI, V51, P2051; Griesbach GS, 2009, J NEUROSCI RES, V87, P795, DOI 10.1002/jnr.21893; Iacono E, 2012, VET RES COMMUN, V36, P107, DOI 10.1007/s11259-012-9520-3; Jiang Yan, 2007, Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, V42, P520; Johnson TV, 2010, INVEST OPHTH VIS SCI, V51, P2051, DOI 10.1167/iovs.09-4509; Koda M, 2005, NEUROREPORT, V16, P1763, DOI 10.1097/01.wnr.0000183329.05994.d7; Le Blanc K, 2003, SCAND J IMMUNOL, V57, P11, DOI 10.1046/j.1365-3083.2003.01176.x; Levkovitch-Verbin H, 2000, INVEST OPHTH VIS SCI, V41, P4169; Li N, 2009, GRAEF ARCH CLIN EXP, V247, P503, DOI 10.1007/s00417-008-1009-y; Li Y, 2003, J NEUROSCI, V23, P7783; Li Y, 2007, GLIA, V55, P312, DOI 10.1002/glia.20458; Lin Jianhua, 2010, Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, V24, P982; Martin DR, 2002, EXP HEMATOL, V30, P879, DOI 10.1016/S0301-472X(02)00864-0; Martin KRG, 2003, INVEST OPHTH VIS SCI, V44, P4357, DOI 10.1167/iovs.02-1332; Maysinger D, 1996, EXP NEUROL, V138, P177, DOI 10.1006/exnr.1996.0056; Mead B., 2013, Society for Neuroscience Abstract Viewer and Itinerary Planner, V43; Park K, 2004, J NEUROSCI, V24, P10806, DOI 10.1523/JNEUROSCI.3532-04.2004; Petruska JC, 2010, EUR J NEUROSCI, V32, P997, DOI 10.1111/j.1460-9568.2010.07392.x; Quimby JM, 2011, J FELINE MED SURG, V13, P418, DOI 10.1016/j.jfms.2011.01.005; Takano M, 2002, EXP EYE RES, V74, P319, DOI 10.1006/exer.2001.1118; Tang JM, 2006, EUR J CARDIO-THORAC, V30, P353, DOI 10.1016/j.ejcts.2006.02.070; Weber AJ, 2010, INVEST OPHTH VIS SCI, V51, P327, DOI 10.1167/iovs.09-3740; Wu JJ, 2010, NEUROCHEM RES, V35, P495, DOI 10.1007/s11064-009-0086-6	29	17	20	0	10	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1049-2275	1536-3732		J CRANIOFAC SURG	J. Craniofac. Surg.	MAR	2015	26	2					548	552		10.1097/SCS.0000000000001348			5	Surgery	Surgery	CD2FX	WOS:000350891600102	25723663				2021-06-18	
J	Schiehser, DM; Delano-Wood, L; Jak, AJ; Matthews, SC; Simmons, AN; Jacobson, MW; Filoteo, JV; Bondi, MW; Orff, HJ; Liu, L				Schiehser, Dawn M.; Delano-Wood, Lisa; Jak, Amy J.; Matthews, Scott C.; Simmons, Alan N.; Jacobson, Mark W.; Filoteo, J. Vincent; Bondi, Mark W.; Orff, Henry J.; Liu, Lin			Validation of the Modified Fatigue Impact Scale in Mild to Moderate Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						assessment; fatigue; Modified Fatigue Impact Scale; traumatic brain injury; validity	RELIABILITY	Objective: To evaluate the validity of the Modified Fatigue Impact Scale (MFIS) in veterans with a history of mild to moderate traumatic brain injury (TBI). Participants: Veterans (N = 106) with mild (92%) or moderate (8%) TBI. Setting: Veterans Administration Health System. Procedure: Factor structure, internal consistency, convergent validity, sensitivity, and specificity of the MFIS were examined. Results: Principal component analysis identified 2 viable MFIS factors: a Cognitive subscale and a Physical/Activities subscale. Item analysis revealed high internal consistency of the MFIS Total scale and subscale items. Strong convergent validity of the MFIS scales was established with 2 Beck Depression Inventory II fatigue items. Receiver operating characteristic curve analysis revealed good to excellent accuracy of the MFIS in classifying fatigued versus nonfatigued individuals. Conclusion: The MFIS is a valid multidimensional measure that can be used to evaluate the impact of fatigue on cognitive and physical functioning in individuals with mild to moderate TBI. The psychometric properties of the MFIS make it useful for evaluating fatigue and provide the potential for improving research on fatigue in this population.	[Schiehser, Dawn M.; Delano-Wood, Lisa; Jak, Amy J.; Matthews, Scott C.; Jacobson, Mark W.; Filoteo, J. Vincent; Bondi, Mark W.; Liu, Lin] VASDHS, San Diego, CA USA; [Schiehser, Dawn M.; Delano-Wood, Lisa; Jak, Amy J.; Matthews, Scott C.; Simmons, Alan N.; Jacobson, Mark W.; Filoteo, J. Vincent; Bondi, Mark W.; Orff, Henry J.] Univ Calif San Diego, Sch Med, Dept Psychiat, La Jolla, CA 92093 USA; [Liu, Lin] Univ Calif San Diego, Sch Med, Dept Family & Prevent Med, La Jolla, CA 92093 USA; [Delano-Wood, Lisa; Matthews, Scott C.; Simmons, Alan N.; Bondi, Mark W.; Orff, Henry J.] VASDHS, Ctr Excellence Stress & Mental Hlth, San Diego, CA USA	Schiehser, DM (corresponding author), Vet Affairs San Diego Healthcare Syst 151B, 3350 La Jolla Village Dr, San Diego, CA 92161 USA.	dschiehser@ucsd.edu	Simmons, Alan N/A-9815-2008	Simmons, Alan N/0000-0003-3963-2112	VA Career Development Awards; VA Merit AwardUS Department of Veterans Affairs	This study was supported by VA Career Development Awards (to D.M.S., L.D.W., and S.C.M.) and a VA Merit Award (to A.N.S.). The authors thank Russell Kim, Elisa Lanni, Norman Luc, Amber Gregory, Candice Colon, Ryan O'Connell, and Elena Kosheleva for their help with data collection and compilation. The authors also thank the patients, staff, and volunteers associated with the Veterans Affairs San Diego Healthcare System for their involvement in this study.	Ashman TA, 2008, J HEAD TRAUMA REHAB, V23, P33, DOI 10.1097/01.HTR.0000308719.70288.22; Beck A., 1996, MANUAL BDI 2; Borgaro SR, 2004, BRAIN INJURY, V18, P685, DOI 10.1080/02699050310001646080; Cantor JB, 2008, J HEAD TRAUMA REHAB, V23, P41, DOI 10.1097/01.HTR.0000308720.70288.af; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd; Department of Veterans Affairs Department of Defense, 2009, VA DOD CLIN PRACT GU, P112; Dittner AJ, 2004, J PSYCHOSOM RES, V56, P157, DOI 10.1016/S0022-3999(03)00371-4; FISK JD, 1994, CLIN INFECT DIS, V18, pS79, DOI 10.1093/clinids/18.Supplement_1.S79; Hair J.F, 1998, MULTIVARIATE DATA AN; Juengst S, 2013, ARCH PHYS MED REHAB, V94, P74, DOI 10.1016/j.apmr.2012.07.025; Kos D, 2005, MULT SCLER, V11, P76, DOI 10.1191/1352458505ms1117oa; KRUPP LB, 1989, ARCH NEUROL-CHICAGO, V46, P1121, DOI 10.1001/archneur.1989.00520460115022; LaChapelle DL, 1998, BRAIN INJURY, V12, P649, DOI 10.1080/026990598122214; LEE KA, 1991, PSYCHIAT RES, V36, P291, DOI 10.1016/0165-1781(91)90027-M; Multiple Sclerosis Council for Clinical Practice Guidelines, 1998, FAT MULT SCLER EV BA; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; Ouellet MC, 2006, J HEAD TRAUMA REHAB, V21, P199, DOI 10.1097/00001199-200605000-00001; Ponsford JL, 2012, J HEAD TRAUMA REHAB, V27, P224, DOI 10.1097/HTR.0b013e31824ee1a8; Schiehser DM, 2013, PARKINSONISM RELAT D, V19, P335, DOI 10.1016/j.parkreldis.2012.11.013; Stulemeijer M, 2006, J NEUROL, V253, P1041, DOI 10.1007/s00415-006-0156-5; van der Naalt J, 1999, J NEUROL NEUROSUR PS, V66, P207, DOI 10.1136/jnnp.66.2.207; Whitehead L, 2009, J PAIN SYMPTOM MANAG, V37, P107, DOI 10.1016/j.jpainsymman.2007.08.019; Ziino C, 2005, J INT NEUROPSYCH SOC, V11, P416, DOI 10.1017/S1355617705050472	23	17	17	0	9	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAR-APR	2015	30	2					116	121		10.1097/HTR.0000000000000019			6	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	CF1MG	WOS:000352309300014	24413076				2021-06-18	
J	Zemek, R; Eady, K; Moreau, K; Farion, KJ; Solomon, B; Weiser, M; Dematteo, C				Zemek, Roger; Eady, Kaylee; Moreau, Katherine; Farion, Ken J.; Solomon, Beverly; Weiser, Margaret; Dematteo, Carol			Canadian pediatric emergency physician knowledge of concussion diagnosis and initial management	CANADIAN JOURNAL OF EMERGENCY MEDICINE			English	Article						Concussion; Pediatric; Adolescent; Practice Variation; Guidelines	TRAUMATIC BRAIN-INJURY; SPORT-RELATED CONCUSSION; POSTCONCUSSIVE SYMPTOMS; HEAD-INJURY; PERSISTENT SYMPTOMS; UNITED-STATES; CHILDREN; GUIDELINES; PLAYERS; IDENTIFICATION	Introduction: The diagnosis of concussion is a critical step in the appropriate management of patients following minor head trauma. The authors hypothesized that wide practice variation exists among pediatric emergency medicine physicians in the application of physical and cognitive rest recommendations following an acute concussion. Methods: The authors developed a 35-item questionnaire incorporating case vignettes to examine pediatric emergency physician knowledge of concussion diagnosis, understanding of initial management using return-to-play/school/work guidelines, use of existing concussion protocols, and perceived barriers to protocol use. Using a modified Dillman technique, the authors distributed an online survey to members of Pediatric Emergency Research Canada, a national association of pediatric emergency physicians. Results: Of 176 potential participants, 115 (65%) responded to the questionnaire, 89% (95% confidence interval [CI]: 0.81, 0.93) of whom reported having diagnosed 20 or more concussions annually. Although 90% (95% CI: 0.83, 0.94) of respondents adequately diagnosed concussion, only 64% (95% CI: 0.54, 0.72) correctly applied graduated return-to-play guidelines. Cognitive rest recommendations were also frequently limited: 40% (95% CI: 0.31, 0.49) did not recommend school absence, 30% (95% CI: 0.22, 0.39) did not recommend schoolwork reduction, and 35% (95% CI: 0.27, 0.45) did not recommend limiting screen time. Eighty percent (95% CI: 0.72, 0.87) of respondents reported having used guidelines frequently or always to guide clinical decisions regarding concussion. Conclusion: Despite a proficiency in the diagnosis of concussion, pediatric emergency physicians exhibit wide variation in recommending the graduated return to play and cognitive rest following concussion.	[Zemek, Roger; Farion, Ken J.] Univ Ottawa, Childrens Hosp Eastern Ontario, Dept Pediat, Ottawa, ON K1N 6N5, Canada; [Zemek, Roger; Farion, Ken J.] Univ Ottawa, Childrens Hosp Eastern Ontario, Dept Emergency Med, Ottawa, ON K1N 6N5, Canada; [Eady, Kaylee; Moreau, Katherine] Univ Ottawa, Childrens Hosp Eastern Ontario, Clin Res Unit, Ottawa, ON K1N 6N5, Canada; [Solomon, Beverly] Holland Bloorview Kids Rehabil Hosp, Toronto, ON, Canada; [Weiser, Margaret] Univ Western Ontario, Parkwood Hosp, Dept Psychol, Acquired Brain Injury Program, London, ON, Canada; [Dematteo, Carol] McMaster Univ, CanChild Ctr Childhood Disabil Res, Sch Rehabil Sci, Hamilton, ON, Canada	Zemek, R (corresponding author), Childrens Hosp Eastern Ontario, 401 Smyth Rd, Ottawa, ON K1H 8L1, Canada.	rzemek@cheo.on.ca	Zemek, Roger/H-1039-2018; Meijer, Anna/K-5118-2016				Ayr LK, 2009, J INT NEUROPSYCH SOC, V15, P19, DOI 10.1017/S1355617708090188; Babikian T, 2011, J INT NEUROPSYCH SOC, V17, P886, DOI 10.1017/S1355617711000907; Bazarian JJ, 2001, CLIN PEDIATR, V40, P207, DOI 10.1177/000992280104000405; Boggild M, 2012, CAN J NEUROL SCI, V39, P361, DOI 10.1017/S0317167100013524; Burns KEA, 2008, CAN MED ASSOC J, V179, P245, DOI 10.1503/cmaj.080372; Canadian Medical Association (CMA), 2011, HEAD INJ SPORT; Carroll L J, 2011, CONCUSSION CRISIS AN; Centers for Disease Control (CDC) Atlanta, HEADS TOOLK PHYS; DeMatteo CA, 2010, PEDIATRICS, V125, P327, DOI 10.1542/peds.2008-2720; Dillman D.A., 2000, MAIL INTERNET SURVEY; Forsyth R, 2012, CAN MED ASSOC J, V184, P1257, DOI 10.1503/cmaj.111045; Gaetz M, 2000, BRAIN INJURY, V14, P1077; Ganesalingam K, 2008, J PEDIATR PSYCHOL, V33, P621, DOI 10.1093/jpepsy/jsm133; Giebel S, 2011, J EMERG MED, V41, P649, DOI 10.1016/j.jemermed.2011.03.021; Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P1337; Gioia GA, 2008, J HEAD TRAUMA REHAB, V23, P230, DOI 10.1097/01.HTR.0000327255.38881.ca; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; GRONWALL D, 1975, LANCET, V2, P995; Guskiewicz KM, 2013, BRIT J SPORT MED, V47, P289, DOI 10.1136/bjsports-2013-092225; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Hill CA, 2006, WESTERN J NURS RES, V28, P322, DOI 10.1177/0193945905284723; IBM, 2012, SPSS SOFTW; Inc Ci, 2012, FLUIDSURVEYS; Kashluba S, 2008, CLIN NEUROPSYCHOL, V22, P195, DOI 10.1080/13854040701263655; Korinthenberg R, 2004, BRAIN DEV-JPN, V26, P113, DOI 10.1016/S0387-7604(03)00110-4; Lebrun CM, 2013, BRIT J SPORT MED, V47, P54, DOI 10.1136/bjsports-2012-091480; Marchie A, 2003, CAN MED ASSOC J, V169, P124; Marshall S, 2012, CAN FAM PHYSICIAN, V58, P257; Matser EJT, 1999, JAMA-J AM MED ASSOC, V282, P971, DOI 10.1001/jama.282.10.971; McCrea M, 2013, BRIT J SPORT MED, V47, P272, DOI 10.1136/bjsports-2013-092145; McCrory P, 2013, BRIT J SPORT MED, V47, P268, DOI 10.1136/bjsports-2013-092247; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McLeod TCV, 2007, CLIN J SPORT MED, V17, P140; Meehan WP, 2010, J PEDIATR-US, V157, P889, DOI 10.1016/j.jpeds.2010.06.040; Meehan WP, 2009, PEDIATRICS, V123, P114, DOI 10.1542/peds.2008-0309; Naunheim RS, 2008, J HEAD TRAUMA REHAB, V23, P116, DOI 10.1097/01.HTR.0000314530.30401.70; Ponsford J, 1999, J HEAD TRAUMA REHAB, V14, P360, DOI 10.1097/00001199-199908000-00005; Provvidenza C, 2013, BRIT J SPORT MED, V47, P332, DOI 10.1136/bjsports-2012-092099; Purcell LK, 2012, PAED CHILD HEALT-CAN, V17, P36; Ryu WHA, 2009, CAN J NEUROL SCI, V36, P429, DOI 10.1017/S0317167100007745; Scorza KA, 2012, AM FAM PHYSICIAN, V85, P123; Swaine BR, 2007, PEDIATRICS, V119, P749, DOI 10.1542/peds.2006-1186; Sye G, 2006, BRIT J SPORT MED, V40, P1003, DOI 10.1136/bjsm.2005.020511; Taylor HG, 2010, NEUROPSYCHOLOGY, V24, P148, DOI 10.1037/a0018112; Yeates KO, 2012, ARCH PEDIAT ADOL MED, V166, P615, DOI 10.1001/archpediatrics.2011.1082; Yeates KO, 1999, J HEAD TRAUMA REHAB, V14, P337, DOI 10.1097/00001199-199908000-00003; Zemek R, 2014, PAED CHILD HEALT-CAN, V19, P474, DOI 10.1093/pch/19.9.475; Zonfrillo MR, 2012, PEDIATRICS, V130, P1120, DOI 10.1542/peds.2012-1431	49	17	18	0	10	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1481-8035	1481-8043		CAN J EMERG MED	Can. J. Emerg. Med.	MAR	2015	17	2					115	122		10.1017/cem.2014.38			8	Emergency Medicine	Emergency Medicine	CE8LY	WOS:000352095100003	25927255	Bronze			2021-06-18	
J	Perera, CJ; Duffy, SS; Lees, JG; Kim, CF; Cameron, B; Apostolopoulos, V; Moalem-Taylor, G				Perera, Chamini J.; Duffy, Samuel S.; Lees, Justin G.; Kim, Cristina F.; Cameron, Barbara; Apostolopoulos, Vasso; Moalem-Taylor, Gila			Active immunization with myelin-derived altered peptide ligand reduces mechanical pain hypersensitivity following peripheral nerve injury	JOURNAL OF NEUROINFLAMMATION			English	Article						Neuropathic pain; Myelin basic protein; Altered peptide ligand; Mechanical allodynia; Pro-inflammatory cytokines; Anti-inflammatory cytokines; M1 and M2 macrophages	PROINFLAMMATORY CYTOKINE EXPRESSION; TRAUMATIC BRAIN-INJURY; BASIC-PROTEIN EPITOPE; DORSAL-ROOT GANGLIA; REGULATORY T-CELLS; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; RAT SCIATIC-NERVE; NEUROPATHIC PAIN; SPINAL-CORD; IMMUNE-RESPONSES	Background: T cells have been implicated in neuropathic pain that is caused by peripheral nerve injury. Immunogenic myelin basic protein (MBP) peptides have been shown to initiate mechanical allodynia in a T cell-dependent manner. Antagonistic altered peptide ligands (APLs) are peptides with substitutions in amino acid residues at T cell receptor contact sites and can inhibit T cell function and modulate inflammatory responses. In the present study, we studied the effects of immunization with MBP-derived APL on pain behavior and neuroinflammation in an animal model of peripheral nerve injury. Methods: Lewis rats were immunized subcutaneously at the base of the tail with either a weakly encephalitogenic peptide of MBP (cyclo-MBP87-99) or APL (cyclo-(87-99)[A(91),A(96)]MBP87-99) in complete Freund's adjuvant (CFA) or CFA only (control), following chronic constriction injury (CCI) of the left sciatic nerve. Pain hypersensitivity was tested by measurements of paw withdrawal threshold to mechanical stimuli, regulatory T cells in spleen and lymph nodes were analyzed by flow cytometry, and immune cell infiltration into the nervous system was assessed by immunohistochemistry (days 10 and 30 post-CCI). Cytokines were measured in serum and nervous tissue of nerve-injured rats (day 10 post-CCI). Results: Rats immunized with the APL cyclo-(87-99)[A(91),A(96)]MBP87-99 had significantly reduced mechanical pain hypersensitivity in the ipsilateral hindpaw compared to cyclo-MBP87-99-treated and control rats. This was associated with significantly decreased infiltration of T cells and ED1+ macrophages in the injured nerve of APL-treated animals. The percentage of anti-inflammatory (M2) macrophages was significantly upregulated in the APL-treated rats on day 30 post-CCI. Compared to the control rats, microglial activation in the ipsilateral lumbar spinal cord was significantly increased in the MBP-treated rats, but was not altered in the rats immunized with the MBP-derived APL. In addition, immunization with the APL significantly increased splenic regulatory T cells. Several cytokines were significantly altered after CCI, but no significant difference was observed between the APL-treated and control rats. Conclusions: These results suggest that immune deviation by active immunization with a non-encephalitogenic MBP-derived APL mediates an analgesic effect in animals with peripheral nerve injury. Thus, T cell immunomodulation warrants further investigation as a possible therapeutic strategy for the treatment of peripheral neuropathic pain.	[Perera, Chamini J.; Duffy, Samuel S.; Lees, Justin G.; Kim, Cristina F.; Moalem-Taylor, Gila] Univ New S Wales, Sch Med Sci, Sydney, NSW 2052, Australia; [Cameron, Barbara] Univ New S Wales, Sch Med Sci, Ctr Infect & Inflammat Res, Sydney, NSW 2052, Australia; [Apostolopoulos, Vasso] Victoria Univ, Coll Hlth & Biomed, Ctr Chron Dis Prevent & Management, Melbourne, Vic 8001, Australia	Moalem-Taylor, G (corresponding author), Univ New S Wales, Sch Med Sci, Sydney, NSW 2052, Australia.	gila@unsw.edu.au	Apostolopoulos, Vasso/Q-4525-2019; Moalem-Taylor, Gila/C-3116-2008	Moalem-Taylor, Gila/0000-0003-3828-9527; Lees, Justin/0000-0002-0874-2856; Apostolopoulos, Vasso/0000-0001-6788-2771	National Health and Medical Research Council of AustraliaNational Health and Medical Research Council of AustraliaUK Research & Innovation (UKRI)Medical Research Council UK (MRC)	This study was supported by a grant from the National Health and Medical Research Council of Australia to Gila Moalem-Taylor. We would like to thank Ms Shima Zahrooni for technical assistance in immunohistochemistry and acknowledge the assistance of Mr Christopher Brownlee and the BRIL Flow Cytometry Facility at the University of New South Wales, Australia.	Austin PJ, 2012, PAIN, V153, P1916, DOI 10.1016/j.pain.2012.06.005; Austin PJ, 2010, J NEUROIMMUNOL, V229, P26, DOI 10.1016/j.jneuroim.2010.08.013; Barclay J, 2007, PAIN, V130, P225, DOI 10.1016/j.pain.2006.11.017; BENNETT GJ, 1988, PAIN, V33, P87, DOI 10.1016/0304-3959(88)90209-6; Bileviciute-Ljungar I, 2001, NEUROSCI LETT, V311, P157, DOI 10.1016/S0304-3940(01)02154-1; Cao L, 2008, EUR J IMMUNOL, V38, P448, DOI 10.1002/eji.200737485; Cao XF, 2007, IMMUNITY, V27, P635, DOI 10.1016/j.immuni.2007.08.014; Clark AK, 2007, EUR J PAIN, V11, P223, DOI 10.1016/j.ejpain.2006.02.003; Colburn RW, 1997, J NEUROIMMUNOL, V79, P163, DOI 10.1016/S0165-5728(97)00119-7; Costigan M, 2009, J NEUROSCI, V29, P14415, DOI 10.1523/JNEUROSCI.4569-09.2009; Cui JG, 2000, PAIN, V88, P239, DOI 10.1016/S0304-3959(00)00331-6; Draleau Ks, 2014, J Pain Relief, VSuppl 3, P003; Dworkin RH, 2003, ARCH NEUROL-CHICAGO, V60, P1524, DOI 10.1001/archneur.60.11.1524; Gao YJ, 2010, PHARMACOL THERAPEUT, V126, P56, DOI 10.1016/j.pharmthera.2010.01.002; Gaur A, 1997, J NEUROIMMUNOL, V74, P149, DOI 10.1016/S0165-5728(96)00220-2; Gillen C, 1998, J NEUROSCI RES, V51, P489, DOI 10.1002/(SICI)1097-4547(19980215)51:4<489::AID-JNR8>3.3.CO;2-5; GIULIAN D, 1986, J EXP MED, V164, P594, DOI 10.1084/jem.164.2.594; GOULD KE, 1993, J NEUROIMMUNOL, V46, P193, DOI 10.1016/0165-5728(93)90249-X; Gritsch S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6472; Hauben E, 2001, J CLIN INVEST, V108, P591, DOI 10.1172/JCI12837; HOPKINS SJ, 1995, TRENDS NEUROSCI, V18, P83; Hsieh CL, 2013, EUR J IMMUNOL, V43, P2010, DOI 10.1002/eji.201243084; Hu P, 2002, NEUROSCIENCE, V112, P23, DOI 10.1016/S0306-4522(02)00065-9; Hu P, 2007, BRAIN BEHAV IMMUN, V21, P599, DOI 10.1016/j.bbi.2006.10.013; Ibarra A, 2013, NEUROSCI LETT, V554, P59, DOI 10.1016/j.neulet.2013.08.048; Kalergis AM, 2000, J IMMUNOL, V165, P280, DOI 10.4049/jimmunol.165.1.280; KARIN N, 1994, J EXP MED, V180, P2227, DOI 10.1084/jem.180.6.2227; Katsara M, 2008, EXPERT OPIN BIOL TH, V8, P1873, DOI 10.1517/14712590802494501 ; Katsara M, 2008, MOL IMMUNOL, V45, P3661, DOI 10.1016/j.molimm.2008.04.024; Katsara M, 2009, IMMUNOLOGY, V128, P521, DOI 10.1111/j.1365-2567.2009.03137.x; Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009; Kim CF, 2011, BRAIN RES, V1405, P95, DOI 10.1016/j.brainres.2011.06.022; Kleinschnitz C, 2005, MOL BRAIN RES, V136, P23, DOI 10.1016/j.molbrainres.2004.12.015; Kobayashi H, 2008, MOL CELL NEUROSCI, V39, P619, DOI 10.1016/j.mcn.2008.08.008; Koltzenburg M, 1999, TRENDS NEUROSCI, V22, P122, DOI 10.1016/S0166-2236(98)01302-2; Ledeboer A, 2005, PAIN, V115, P71, DOI 10.1016/j.pain.2005.02.009; Ledeboer A, 2007, BRAIN BEHAV IMMUN, V21, P686, DOI 10.1016/j.bbi.2006.10.012; Lewitus GM, 2009, BIOL PSYCHIAT, V65, P283, DOI 10.1016/j.biopsych.2008.07.014; Liu HQ, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-119; Liu LJ, 2006, J NEUROPHYSIOL, V95, P1478, DOI 10.1152/jn.00509.2005; Liu T, 2000, PAIN, V86, P25, DOI 10.1016/S0304-3959(99)00306-1; Mantzourani ED, 2006, J MED CHEM, V49, P6683, DOI 10.1021/jm060040z; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Martinon S, 2007, EUR J NEUROSCI, V26, P403, DOI 10.1111/j.1460-9568.2007.05650.x; Matsoukas J, 2005, J MED CHEM, V48, P1470, DOI 10.1021/jm040849g; McGuirk P, 2002, TRENDS IMMUNOL, V23, P450, DOI 10.1016/S1471-4906(02)02288-3; Mert T, 2009, N-S ARCH PHARMACOL, V379, P445, DOI 10.1007/s00210-008-0387-3; Mika J, 2008, PAIN, V138, P587, DOI 10.1016/j.pain.2008.02.015; Mika J, 2009, EUR J PHARMACOL, V623, P65, DOI 10.1016/j.ejphar.2009.09.030; Moalem G, 2004, NEUROSCIENCE, V129, P767, DOI 10.1016/j.neuroscience.2004.08.035; Moalem-Taylor G, 2007, BRAIN BEHAV IMMUN, V21, P699, DOI 10.1016/j.bbi.2006.07.007; Moalem-Taylor G, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-1; Myers RR, 2006, DRUG DISCOV TODAY, V11, P8, DOI 10.1016/S1359-6446(05)03637-8; Nicholson LB, 1997, P NATL ACAD SCI USA, V94, P9279, DOI 10.1073/pnas.94.17.9279; NICHOLSON LB, 1995, IMMUNITY, V3, P397, DOI 10.1016/1074-7613(95)90169-8; Okamoto K, 2001, EXP NEUROL, V169, P386, DOI 10.1006/exnr.2001.7677; Parkitny L, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/890706; Qin HW, 2012, P NATL ACAD SCI USA, V109, P5004, DOI 10.1073/pnas.1117218109; Raghavendra V, 2004, EUR J NEUROSCI, V20, P467, DOI 10.1111/j.1460-9568.2004.03514.x; Reeve AJ, 2000, EUR J PAIN-LONDON, V4, P247, DOI 10.1053/eujp.2000.0177; Shechter R, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000113; SLOANLANCASTER J, 1994, CELL, V79, P913, DOI 10.1016/0092-8674(94)90080-9; Sung CS, 2004, BRAIN RES, V1015, P145, DOI 10.1016/j.brainres.2004.04.068; Tian DH, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00168; Turtzo LC, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-82; von Herrath MG, 2003, NAT REV IMMUNOL, V3, P223, DOI 10.1038/nri1029; Wang GH, 2013, J CEREBR BLOOD F MET, V33, P1864, DOI 10.1038/jcbfm.2013.146; Weber MS, 2007, NAT MED, V13, P935, DOI 10.1038/nm1620; Wolf G, 2006, PAIN, V120, P315, DOI 10.1016/j.pain.2005.11.011; Ydens E, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-176; Young DA, 2000, J IMMUNOL, V164, P3563, DOI 10.4049/jimmunol.164.7.3563; Zhang RX, 2008, PAIN, V135, P232, DOI 10.1016/j.pain.2007.05.023; Zhang XW, 2014, J NEUROSCI, V34, P3013, DOI 10.1523/JNEUROSCI.3681-13.2014; Zheng FY, 2011, NEUROSCIENCE, V176, P447, DOI 10.1016/j.neuroscience.2010.12.052	74	17	17	0	9	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1742-2094			J NEUROINFLAMM	J. Neuroinflamm.	FEB 13	2015	12								28	10.1186/s12974-015-0253-4			19	Immunology; Neurosciences	Immunology; Neurosciences & Neurology	CC5GE	WOS:000350386300001	25885812	DOAJ Gold, Green Published, Green Accepted			2021-06-18	
J	Massaro, AM; Doerfler, S; Nawalinski, K; Michel, B; Driscoll, N; Ju, C; Patel, H; Quattrone, F; Frangos, S; Maloney-Wilensky, E; Grady, MS; Stein, SC; Kasner, SE; Kumar, MA				Massaro, Allie M.; Doerfler, Sean; Nawalinski, Kelsey; Michel, Bernard; Driscoll, Nicolette; Ju, Connie; Patel, Hiren; Quattrone, Francis; Frangos, Suzanne; Maloney-Wilensky, Eileen; Grady, Michael Sean; Stein, Sherman C.; Kasner, Scott E.; Kumar, Monisha A.			Thromboelastography Defines Late Hypercoagulability After TBI: A Pilot Study	NEUROCRITICAL CARE			English	Article						Traumatic brain injury; Head trauma; Thromboelastography; TEG; Coagulopathy; Hypercoagulability	TRAUMATIC BRAIN-INJURY; ADMISSION RAPID THROMBELASTOGRAPHY; PROTEIN-C PATHWAY; VENOUS THROMBOEMBOLISM; NEUROSURGICAL PATIENTS; HEAD-INJURIES; 1602 EPISODES; DATA-BANK; COAGULOPATHY; COAGULATION	Traumatic brain injury (TBI) is associated with a hypercoagulable state, the mechanism and duration of which remain unclear. We sought to determine whether thromboelastography (TEG) analysis could identify the hypercoagulable state after TBI, as defined by elevations in maximal amplitude (MA), thrombus generation (TG), G value (G), and alpha angle (alpha A). Patients with moderate-severe TBI, defined primarily as a GCS < 12, admitted between 1/2012 and 8/2013 were eligible for enrolment in this prospective cohort study. TEG profiles were obtained between 0-24 h (T1), 24-48 h (T2), 48-72 h (T3), 72-96 h (T4), and 96-120 h (T5) after admission. Early TEG was defined as 0-48 h, and late TEG was defined as > 48 h. Twenty five patients (80 % men) and 7 age- and sex-matched control subjects were studied. Median age was 38 years (range 18-85). Early MA was [63.6 mm (60.5, 67.4)] versus late MA [69.9 mm (65.2,73.9); p = 0.02], early TG was [763.3 mm/min (712.8, 816.2)] versus late TG [835.9 mm/min (791.2,888.3); p = 0.02], and early G was [8.8 d/cm(2) (7.7,10.4)] versus late G [11.6 d/cm(2) (9.4,14.1); p = 0.02]. Study patients had higher MA (p = 0.02), TG (p = 0.03), and G (p = 0.02) values at T5 compared to controls. There was a linear increase per day of MA by 2.6 mm (p = 0.001), TG 31.9 mm/min (p a parts per thousand currency sign 0.001), and G value by 1.3 d/cm(2) (p a parts per thousand currency sign 0.001) when clustered by pairs in regression analysis. Lower MA values trended toward home discharge (p = 0.08). The data suggest a progressive and delayed hypercoagulable state observed days after initial TBI. The hypercoagulable state may reflect excess platelet activity.	[Massaro, Allie M.; Kasner, Scott E.; Kumar, Monisha A.] Perelman Sch Med, Dept Neurol, Philadelphia, PA 19104 USA; [Massaro, Allie M.; Doerfler, Sean; Nawalinski, Kelsey; Michel, Bernard; Driscoll, Nicolette; Ju, Connie; Patel, Hiren; Quattrone, Francis; Frangos, Suzanne; Maloney-Wilensky, Eileen; Grady, Michael Sean; Stein, Sherman C.; Kasner, Scott E.; Kumar, Monisha A.] Hosp Univ Penn, Philadelphia, PA 19104 USA; [Doerfler, Sean; Nawalinski, Kelsey; Michel, Bernard; Driscoll, Nicolette; Ju, Connie; Patel, Hiren; Quattrone, Francis; Frangos, Suzanne; Maloney-Wilensky, Eileen; Grady, Michael Sean; Stein, Sherman C.; Kumar, Monisha A.] Perelman Sch Med, Dept Neurosurg, Philadelphia, PA 19104 USA; [Kumar, Monisha A.] Perelman Sch Med, Dept Anesthesiol & Crit Care, Philadelphia, PA 19104 USA	Massaro, AM (corresponding author), Perelman Sch Med, Dept Neurol, 3 West Gates Bldg,3400 Spruce St, Philadelphia, PA 19104 USA.	allie.massaro@gmail.com	Driscoll, Nicolette/AAR-3699-2021	Driscoll, Nicolette/0000-0001-8364-460X	Haemonetics; WL Gore; AstraZenecaAstraZeneca; GlaxoSmithKlineGlaxoSmithKline; Acorda; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA	Dr. Kumar has received research support from Haemonetics. Dr. Kasner has received grants from WL Gore, AstraZeneca, GlaxoSmithKline, and Acorda. He acts as a consultant for Merck, Novartis, Medtronic, and Boehringer Ingelheim. Dr. Grady has received Grant funding from the NIH. For the remaining authors, none were declared.	Abrahams JM, 2002, SURG NEUROL, V58, P5, DOI 10.1016/S0090-3019(02)00777-2; [Anonymous], 1971, JAMA, V215, P277; Branco BC, 2014, SHOCK, V41, P200, DOI 10.1097/SHK.0000000000000109; Brohi K, 2007, CURR OPIN CRIT CARE, V13, P680, DOI 10.1097/MCC.0b013e3282f1e78f; Brohi K, 2007, ANN SURG, V245, P812, DOI 10.1097/01.sla.0000256862.79374.31; Cohan MJ, 2007, J TRAUMA, V63, P1254, DOI 10.1097/TA.0b013e318156ee4c; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Cotton BA, 2012, J TRAUMA ACUTE CARE, V72, P1470, DOI 10.1097/TA.0b013e31824d56ad; GEERTS WH, 1994, NEW ENGL J MED, V331, P1601, DOI 10.1056/NEJM199412153312401; Gonzalez E, 2010, SEMIN THROMB HEMOST, V36, P723, DOI 10.1055/s-0030-1265289; Gonzalez E, 2010, J SURG RES, V163, P96, DOI 10.1016/j.jss.2010.03.058; GRAHAM DI, 1971, LANCET, V1, P265; GRAHAM DI, 1978, J NEUROL SCI, V39, P213, DOI 10.1016/0022-510X(78)90124-7; Gurbel PA, 2005, J AM COLL CARDIOL, V46, P1820, DOI 10.1016/j.jacc.2005.07.041; Haemonetics TBMC, 2008, BAS CLIN TRAIN; Harhangi BS, 2008, ACTA NEUROCHIR, V150, P165, DOI 10.1007/s00701-007-1475-8; Holcomb JB, 2012, ANN SURG, V256, P476, DOI 10.1097/SLA.0b013e3182658180; Kashuk JL, 2012, TRANSFUSION, V52, P23, DOI 10.1111/j.1537-2995.2011.03264.x; Kashuk JL, 2009, SURGERY, V146, P764, DOI 10.1016/j.surg.2009.06.054; Knudson MM, 2004, ANN SURG, V240, P490, DOI 10.1097/01.sla.0000137138.40116.6c; Kunio NR, 2012, AM J SURG, V203, P584, DOI 10.1016/j.amjsurg.2011.12.011; Laroche M, 2012, NEUROSURGERY, V70, P1334, DOI 10.1227/NEU.0b013e31824d179b; Lustenberger T, 2013, THROMB RES, V131, pE26, DOI 10.1016/j.thromres.2012.11.005; Lustenberger T, 2010, INJURY, V41, P924, DOI 10.1016/j.injury.2010.04.019; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Maegele M, 2013, TRANSFUSION, V53, p28S, DOI 10.1111/trf.12033; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; McCrath DJ, 2005, ANESTH ANALG, V100, P1576, DOI 10.1213/01.ANE.0000155290.86795.12; Nielsen VG, 2008, THROMB RES, V122, P145, DOI 10.1016/j.thromres.2007.09.003; Phelan HA, 2012, J NEUROTRAUM, V29, P1821, DOI 10.1089/neu.2012.2459; Reiff DA, 2009, J TRAUMA, V66, P1436, DOI 10.1097/TA.0b013e31817fdf1c; Rivard GE, 2005, J THROMB HAEMOST, V3, P2039, DOI 10.1111/j.1538-7836.2005.01513.x; Rogers FB, 2001, SURGERY, V130, P1, DOI 10.1067/msy.2001.114558; Schrieber M, 2007, J TRAUMA, V63, P1261; Shackford SR, 2004, ANN SURG, V240, P496; SHACKFORD SR, 1993, ARCH SURG-CHICAGO, V128, P571, DOI 10.1001/archsurg.1993.01420170107016; Sorensen B, 2003, J THROMB HAEMOST, V1, P551, DOI 10.1046/j.1538-7836.2003.00075.x; Stein SC, 2004, NEUROCRIT CARE, V1, P479, DOI 10.1385/NCC:1:4:479; Stein SC, 2004, NEUROSURGERY, V54, P687, DOI 10.1227/01.NEU.0000108641.98845.88; STEIN SC, 1993, NEUROSURGERY, V32, P25, DOI 10.1227/00006123-199301000-00004; Talving P, 2009, J TRAUMA, V66, P55, DOI 10.1097/TA.0b013e318190c3c0; Wafaisade A, 2010, NEUROCRIT CARE, V12, P211, DOI 10.1007/s12028-009-9281-1; Wegner J, 2010, SEMIN THROMB HEMOST, V36, P699, DOI 10.1055/s-0030-1265286; Windelov NA, 2011, BLOOD COAGUL FIBRIN, V22, P416, DOI 10.1097/MBC.0b013e3283464f53	44	17	18	0	3	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	FEB	2015	22	1					45	51		10.1007/s12028-014-0051-3			7	Critical Care Medicine; Clinical Neurology	General & Internal Medicine; Neurosciences & Neurology	CA3FH	WOS:000348791300007	25127903				2021-06-18	
J	Odijk, M; van der Wouden, EJ; Olthuis, W; Ferrari, MD; Tolner, EA; van den Maagdenberg, AMJM; van den Berg, A				Odijk, M.; van der Wouden, E. J.; Olthuis, W.; Ferrari, M. D.; Tolner, E. A.; van den Maagdenberg, A. M. J. M.; van den Berg, A.			Microfabricated solid-state ion-selective electrode probe for measuring potassium in the living rodent brain: Compatibility with DC-EEG recordings to study spreading depression	SENSORS AND ACTUATORS B-CHEMICAL			English	Article						Neuroprobe; Ion selective electrode; Spreading depression; Microfabrication	ELECTROCHEMICAL DEPOSITION; POTENTIAL STABILITY; CONDUCTING POLYMERS; BULK OPTODES; SENSORS; OXYGEN; POLY(3,4-ETHYLENEDIOXYTHIOPHENE); MIGRAINE; TRANSDUCERS; MEMBRANES	There is considerable need in neuroscience research to reliably measure concentrations of extracellular ions in the living brain as the dynamics of ion levels increasingly is considered to play a key role in the pathophysiology of many brain disorders. Unfortunately, most probes currently used for direct measurement of extracellular ion concentrations in living brain tissue in experimental animals have considerable limitations. They are custom-made glass capillary ion-selective microelectrodes that are fragile, timeconsuming to prepare, and can practically only be used to measure at one depth and one location in the brain. We here present the design and fabrication of a novel type of miniaturized probe that can simultaneously measure, in the brain of a living animal, multiple parameters relevant to the neurological phenomenon of spreading depression (SD) at multiple depths and locations. SD is characterized by a slowly propagating wave of initial neuronal and glial cell depolarization that is followed by depression of activity. SD is accompanied by a massive redistribution of ions, including K+, between intracellular and extracellular compartments and is considered important in brain diseases such as stroke, traumatic brain injury, and migraine with aura. This work focuses on the functionalization of fabricated probes for measuring changes in extracellular K+ concentration (and its associated changes in neuronal activity) using an ion-selective potentiometric sensor. We show that the choice of conductive polymer and the method of electro-deposition is critical to obtain low cross-sensitivity for pH and O-2. The sensor's response to IC is approximately linear between 2 and 40 mM with a voltage-response of 39 mV/log[K+]. Proof-of-principle in vivo brain recordings were performed in the cortex of a wild-type mouse during induction of cortical SD. We reliably measured the theoretically expected rise and fall of brain tissue K+ levels during a locally induced cortical SD. We envisage that our probe can be of great use to reliably measure K+, without being affected by pH or O-2 changes, in the living brain and be widely applicable in neuroscience research. (C) 2014 Elsevier B.V All rights reserved.	[Odijk, M.; van der Wouden, E. J.; Olthuis, W.; van den Berg, A.] Univ Twente, MESA Inst Nanotechnol, NL-7500 AE Enschede, Netherlands; [Ferrari, M. D.; Tolner, E. A.; van den Maagdenberg, A. M. J. M.] Leiden Univ, Med Ctr, Dept Neurol, NL-2300 RA Leiden, Netherlands; [van den Maagdenberg, A. M. J. M.] Leiden Univ, Med Ctr, Dept Human Genet, NL-2300 RA Leiden, Netherlands	Odijk, M (corresponding author), Univ Twente, MESA Inst Nanotechnol, NL-7500 AE Enschede, Netherlands.	m.odijk@utwente.nl	Tolner, Else/J-9201-2015; van den Maagdenberg, Arn M.J.M./AAE-9052-2019; Olthuis, Wouter/AAA-7585-2021; van den Berg, Albert/B-4648-2013; Odijk, Mathieu/I-5880-2012	Olthuis, Wouter/0000-0002-7018-1383; van den Berg, Albert/0000-0001-9019-933X; Odijk, Mathieu/0000-0002-4467-9604	NWONetherlands Organization for Scientific Research (NWO); EU-funded Marie Curie Career Integration [294233]; Marie Curie IAPP Program BRAINPATH [612360]; FP7 Project EUROHEADPAIN	The authors would like to thank Lennart de Vreede for assistance during probe fabrication and Sandra van Heiningen for assistance during the in vivo mouse experiment. This work is funded by the NWO Spinoza prizes received by A. van den Berg and M.D. Ferrari, the EU-funded Marie Curie Career Integration Grant (no. 294233; E.A. Tolner), Marie Curie IAPP Program BRAINPATH (no. 612360; E.A. Tolner & A.M.J.M. van den Maagdenberg), and FP7 Project EUROHEADPAIN (no. 602633; M.D. Ferrari 82 A.MJ.M. van den Maagdenberg).	Bakker E, 1997, CHEM REV, V97, P3083, DOI 10.1021/cr940394a; Bobacka J, 1999, ANAL CHEM, V71, P4932, DOI 10.1021/ac990497z; Bobacka J, 2006, ELECTROANAL, V18, P7, DOI 10.1002/elan.200503384; Bobacka J, 2000, J ELECTROANAL CHEM, V489, P17, DOI 10.1016/S0022-0728(00)00206-0; Bobacka J, 2008, CHEM REV, V108, P329, DOI 10.1021/cr068100w; Boulton A A, 1990, NEUROPHYSIOLOGICAL T; Buhlmann P, 1998, CHEM REV, V98, P1593, DOI 10.1021/cr970113+; CHAN ADC, 1992, ANAL CHEM, V64, P2512, DOI 10.1021/ac00045a010; Cui XY, 2003, SENSOR ACTUAT B-CHEM, V89, P92, DOI 10.1016/S0925-4005(02)00448-3; Eikermann-Haerter K, 2009, J CLIN INVEST, V119, P99, DOI 10.1172/JCI36059; Faridbod F, 2008, SENSORS-BASEL, V8, P2331, DOI 10.3390/s8042331; Hajj-Hassan M, 2008, SENSORS-BASEL, V8, P7636, DOI 10.3390/s8127636; Han JH, 2001, ANALYST, V126, P2040, DOI 10.1039/b105585m; Lauritzen M, 2011, J CEREBR BLOOD F MET, V31, P17, DOI 10.1038/jcbfm.2010.191; Lian XY, 2004, BRAIN RES, V1012, P177, DOI 10.1016/j.brainres.2004.04.011; LIMEZAWA Y, 1995, PURE APPL CHEM, V67, P507; Michalska A, 2006, ANAL BIOANAL CHEM, V384, P391, DOI 10.1007/s00216-005-0132-4; Mikhel'son KN, 2008, RUSS J GEN CHEM+, V78, P2445, DOI 10.1134/S1070363208120268; Mustain WE, 2007, J ELECTROCHEM SOC, V154, pA668, DOI 10.1149/1.2735915; O'Neill RD, 2004, BIOSENS BIOELECTRON, V19, P1521, DOI 10.1016/j.bios.2003.12.004; Pandey PC, 1998, SENSOR ACTUAT B-CHEM, V46, P61, DOI 10.1016/S0925-4005(97)00332-8; Pawlowski P, 2011, TALANTA, V84, P814, DOI 10.1016/j.talanta.2011.02.018; Piilgaard H, 2009, J CEREBR BLOOD F MET, V29, P1517, DOI 10.1038/jcbfm.2009.73; Pijanowska DG, 2004, SENSOR ACTUAT B-CHEM, V103, P350, DOI 10.1016/j.snb.2004.04.108; Schuhmann W, 1997, BIOSENS BIOELECTRON, V12, P1157, DOI 10.1016/S0956-5663(97)00086-9; SOMJEN GG, 1984, BRAIN RES, V311, P186, DOI 10.1016/0006-8993(84)91416-1; Somjen GG, 2001, PHYSIOL REV, V81, P1065; van de Ven RCG, 2007, ARCH NEUROL-CHICAGO, V64, P643, DOI 10.1001/archneur.64.5.643; Vazquez M, 2002, SENSOR ACTUAT B-CHEM, V82, P7, DOI 10.1016/S0925-4005(01)00983-2; Veder JP, 2011, ANALYST, V136, P3252, DOI 10.1039/c1an15267j; Yuzawa I, 2012, J CEREBR BLOOD F MET, V32, P376, DOI 10.1038/jcbfm.2011.148; Zachara JE, 2004, SENSOR ACTUAT B-CHEM, V101, P207, DOI 10.1016/j.snb.2004.02.052; Zwickl T, 1998, ANAL SCI, V14, P57, DOI 10.2116/analsci.14.57	33	17	17	3	94	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0925-4005			SENSOR ACTUAT B-CHEM	Sens. Actuator B-Chem.	FEB	2015	207		B		SI		945	953		10.1016/j.snb.2014.06.138			9	Chemistry, Analytical; Electrochemistry; Instruments & Instrumentation	Chemistry; Electrochemistry; Instruments & Instrumentation	AU9EU	WOS:000345895400009					2021-06-18	
J	Salga, M; Jourdan, C; Durand, MC; Hangard, C; Denormandie, P; Carlier, RY; Genet, F				Salga, Marjorie; Jourdan, Claire; Durand, Marie-Christine; Hangard, Chloe; Denormandie, Philippe; Carlier, Robert-Yves; Genet, Francois			Sciatic nerve compression by neurogenic heterotopic ossification: use of CT to determine surgical indications	SKELETAL RADIOLOGY			English	Article						Heterotopic ossification; Sciatic nerve compression; CT; Electroneuromyography; Traumatic brain injury; Spinal cord injury	POSTERIOR FRACTURE-DISLOCATION; TRAUMATIC BRAIN; INJURED PATIENT; ULNAR NERVE; HIP; ENTRAPMENT; MANAGEMENT; PALSY; BONE	To describe the characteristics of neurogenic heterotopic ossification (NHO) based on clinical tests, electroneuromyography (ENMG) and CT in a database of patients with lesions of the central nervous system who required sciatic nerve neurolysis along with posterior hip NHO resection, and to determine the respective roles of ENMG and CT in the management of posterior hip NHOs in patients who are unable to communicate or express pain. The consistency of the ENMG results with clinical findings, CT results and macroscopic signs of lesions was retrospectively assessed after sciatic nerve neurolysis and ablation of 55 posterior hip NHOs. Sciatic nerve neurolysis was necessary in 55 cases (47.4 %; 55 out of 116). CT showed contact of the NHO with the nerve in all cases: 5 in contact with no deflection, 3 in contact with deflection, 21 moulded into a gutter and 26 entrapped in the NHO. There were clinical signs of sciatic nerve lesion in 21.8 % of cases (12 out of 55). ENMG showed signs of sciatic nerve lesions in only 55.6 % (10 out of 18), only 4 of whom presented with clinical signs of a nerve lesion. No significant relationship was found between clinical symptoms and ENMG findings of sciatic nerve compression (n = 13, p = 0.77). Nerve compression by NHO is likely an underdiagnosed condition, particularly in patients who are unable to communicate. Diagnosis of sciatic compression by NHO should be based on regular clinical examinations and CT. ENMG is not sufficiently sensitive to be used alone for surgical decision-making.	[Salga, Marjorie; Jourdan, Claire; Genet, Francois] Hop Raymond Poincare, APHP, Dept Phys Med & Rehabil, CIC IT 805, F-92380 Garches, France; [Jourdan, Claire] Univ Versailles St Quentin Yvelines, EA4047, Versailles, France; [Durand, Marie-Christine] Hop Raymond Poincare, APHP, Dept Neurophysiol, CIC IT 805, F-92380 Garches, France; [Durand, Marie-Christine; Denormandie, Philippe; Genet, Francois] Univ Versailles St Quentin Yvelines, EA 4497, GRCTH, Versailles, France; [Hangard, Chloe; Carlier, Robert-Yves] Hop Raymond Poincare, APHP, Dept Med Imaging, CIC IT 805, F-92380 Garches, France; [Denormandie, Philippe] Hop Raymond Poincare, APHP, Dept Orthopaed Surg, CIC IT 805, F-92380 Garches, France; [Genet, Francois] Hop Instruct Armees Percy, Mil Med Serv, Dept Phys Med & Rehabil, F-92140 Clamart, France	Genet, F (corresponding author), Hop Raymond Poincare, APHP, Dept Phys Med & Rehabil, CIC IT 805, 104 Bd Raymond Poincare, F-92380 Garches, France.	francois.genet@rpc.aphp.fr					Abayev B, 2005, NEUROLOGIST, V11, P184, DOI 10.1097/01.nrl.0000160557.86676.63; Aubut JAL, 2011, NEUROREHABILITATION, V28, P151, DOI 10.3233/NRE-2011-0643; Baird Evan O, 2009, J Orthop Surg Res, V4, P12, DOI 10.1186/1749-799X-4-12; BROOKE MM, 1991, ARCH PHYS MED REHAB, V72, P425; Carlier RY, 2005, J BONE JOINT SURG BR, V87B, P301, DOI 10.1302/0301-620X.87B3.14737; Chua H. C., 1997, SMJ, V38, P447; De Jonghe B, 2008, NEUROL CLIN, V26, P507, DOI 10.1016/j.ncl.2008.03.001; Della Santa D R, 1990, Ann Chir Main Memb Super, V9, P38, DOI 10.1016/S0753-9053(05)80435-1; DERIAN PS, 1974, SOUTH MED J, V67, P209, DOI 10.1097/00007611-197402000-00020; Fikry T, 2004, Chir Main, V23, P109, DOI 10.1016/j.main.2004.02.008; Gallucci GL, 2003, J SHOULDER ELB SURG, V12, P637, DOI 10.1016/S1058-2746(03)00043-0; Genet F, 2012, J HEAD TRAUMA REHAB, V27, P443, DOI 10.1097/HTR.0b013e31822b54ba; Genet F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016632; Hamdi MF, 2010, NEUROCHIRURGIE, V56, P340, DOI 10.1016/j.neuchi.2010.05.003; Humphreys DB, 2007, J NEUROSURG, V107, P314, DOI 10.3171/JNS-07/08/0314; Keenan MAE, 2004, J HEAD TRAUMA REHAB, V19, P143, DOI 10.1097/00001199-200403000-00006; KLEIMAN SG, 1971, J BONE JOINT SURG AM, VA 53, P781, DOI 10.2106/00004623-197153040-00019; Kline DG, 1998, J NEUROSURG, V89, P13, DOI 10.3171/jns.1998.89.1.0013; Manidakis N, 2009, J BONE JOINT SURG BR, V91B, P253, DOI 10.1302/0301-620X.91B2.21183; ORZEL JA, 1985, J NUCL MED, V26, P125; REINSTEIN L, 1983, ARCH PHYS MED REHAB, V64, P65; Safaz I, 2008, AM J PHYS MED REHAB, V87, P65, DOI 10.1097/PHM.0b013e31815b5b4d; Teasell RW, 2010, SPINAL CORD, V48, P512, DOI 10.1038/sc.2009.175; THAKKAR DH, 1981, INJURY, V13, P207, DOI 10.1016/0020-1383(81)90240-0; Topuz K, 2011, BRIT J NEUROSURG, V25, P509, DOI 10.3109/02688697.2011.566380; WAINAPEL SF, 1985, ARCH PHYS MED REHAB, V66, P512	26	17	18	0	5	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-2348	1432-2161		SKELETAL RADIOL	Skeletal Radiol.	FEB	2015	44	2					233	240		10.1007/s00256-014-2003-6			8	Orthopedics; Radiology, Nuclear Medicine & Medical Imaging	Orthopedics; Radiology, Nuclear Medicine & Medical Imaging	AX4LQ	WOS:000346904500009	25218150				2021-06-18	
J	Young, LA; Rule, GT; Bocchieri, RT; Burns, JM				Young, Lee Ann; Rule, Gregory T.; Bocchieri, Robert T.; Burns, Jennie M.			Biophysical Mechanisms of Traumatic Brain Injuries	SEMINARS IN NEUROLOGY			English	Article						traumatic brain injury; blunt trauma; blast; ballistic; physics; acceleration; diffuse axonal injury	HEAD; MILD; CONCUSSION; FOOTBALL; BLUNT; RISK; EPIDEMIOLOGY; BIOMECHANICS; RESPONSES	Despite years of effort to prevent traumatic brain injuries (TBIs), the occurrence of TBI in the United States alone has reached epidemic proportions. When an external force is applied to the head, it is converted into stresses that must be absorbed into the brain or redirected by a helmet or other protective equipment. Complex interactions of the head, neck, and jaw kinematics result in strains in the brain. Even relatively mild mechanical trauma to these tissues can initiate a neurochemical cascade that leads to TBI. Civilians and warfighters can experience head injuries in both combat and noncombat situations from a variety of threats, including ballistic and blunt impact, acceleration, and blast. It is critical to understand the physics created by these threats to develop meaningful improvements to clinical care, injury prevention, and mitigation. Here the authors review the current state of understanding of the complex loading conditions that lead to TBI and characterize how these loads are transmitted through soft tissue, the skull and into the brain, resulting in TBI. In addition, gaps in knowledge and injury thresholds are reviewed, as these must be addressed to better design strategies that reduce TBI incidence and severity.	[Young, Lee Ann] Appl Res Associates Inc, Phys Secur & Appl Sci Sect, Dallas, TX 75240 USA; [Rule, Gregory T.; Burns, Jennie M.] Appl Res Associates Inc, Phys Secur & Appl Sci Sect, San Antonio, TX USA; [Bocchieri, Robert T.] Appl Res Associates Inc, Silicon Valley Off, Los Altos, CA USA	Young, LA (corresponding author), Appl Res Associates Inc, Phys Secur & Appl Sci Sect, 13915 Preston Valley Pl, Dallas, TX 75240 USA.	lyoung@ara.com					Adams J H, 1983, Acta Neurochir Suppl (Wien), V32, P15; Adams J H, 1981, Acta Neuropathol Suppl, V7, P26; Bowen I., 1968, DASA2113; Cernak I, 1996, J TRAUMA, V40, pS100, DOI 10.1097/00005373-199603001-00023; Chafi MS, 2010, ANN BIOMED ENG, V38, P490, DOI 10.1007/s10439-009-9813-z; Chen Y, 2011, BRAIN INJURY, V25, P641, DOI 10.3109/02699052.2011.580313; Committee on Review of Test Protocols Used by the DoD to Test Combat Helmets. Board on Army Science and Technology; Division on Engineering and Physical Sciences; National Research Council Review of Department of Defense Test Protocols for Combat Helmets, 2014, TEST PROT BACKF DEF; Courtney AC, 2009, MED HYPOTHESES, V72, P76, DOI 10.1016/j.mehy.2008.08.015; Dagro A.M., 2013, PRELIMINARY INVESTIG; Department of Energy, 1980, MAN PRED BLAST FRAG; Duma SM, 2005, CLIN J SPORT MED, V15, P3, DOI 10.1097/00042752-200501000-00002; Elder GA, 2010, PSYCHIAT CLIN N AM, V33, P757, DOI 10.1016/j.psc.2010.08.001; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Gennarelli TA, 1979, P 23 STAPP CAR CRASH; Goeller J, 2013, CAVITATION POSSIBLE; Gorske T., 2014, PENNS PSYCH ASS ANN; Greenwald RM, 2008, NEUROSURGERY, V62, P789, DOI 10.1227/01.neu.0000318162.67472.ad; GURDJIAN ES, 1975, SURG GYNECOL OBSTET, V140, P845; Gurdjian ES., 1973, HEAD INJURY ANTIQUIT; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; HARDY WN, 1994, INT J IMPACT ENG, V15, P561, DOI 10.1016/0734-743X(94)80034-7; Hutchinson J, 1998, APPL MATH COMPUT, V96, P1, DOI 10.1016/S0096-3003(97)10106-0; King AI, 2000, ANNU REV BIOMED ENG, V2, P55, DOI 10.1146/annurev.bioeng.2.1.55; King AI, 2003, INT RES COUNC BIOM I; KRAUS JF, 1994, SEMIN NEUROL, V14, P1, DOI 10.1055/s-2008-1041052; KRAUS JF, 1988, J TRAUMA, V28, P1637, DOI 10.1097/00005373-198812000-00004; Lemonick DM, 2011, AM J CLIN MED, V8, P134; Levine B, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00009; LISSNER HR, 1960, SURG GYNECOL OBSTET, V111, P329; Lockhart P, 2011, J TRAUMA, V70, pE29, DOI 10.1097/TA.0b013e3181de3f4b; Long J, 2013, COMBINED EFFECTS PRI; MacPherson D, 2005, BULL PEN MOD DYN INC; McIntire BJ, 2005, 200512 USAARL; Moss WC, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.108702; Needham CE, 2010, SHOCK WAVE HIGH PRES, P1, DOI 10.1007/978-3-642-05288-0; Needham CE, FRONT NEURO IN PRESS; Nyein M, 2008, 26 ARM SCI C DEC 1 4; OMMAYA AK, 1994, INT J IMPACT ENG, V15, P535, DOI 10.1016/0734-743X(94)80033-6; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; Panzer MB, 2014, EXP NEUROL, V261, P120, DOI 10.1016/j.expneurol.2014.07.002; Panzer MB, 2012, NAT NEUR SOC ANN M J; Pellman EJ, 2003, NEUROSURGERY, V53, P1328, DOI 10.1227/01.NEU.0000093499.20604.21; Post A, 2012, TRAUMA, V14, P327, DOI 10.1177/1460408612446573; Prasad P, 1982, POSITION US DELEGATI; Przekwas A, 2011, ASME 2011 INT MECH E; Rafaels K, 2011, J NEUROTRAUM, V28, P2319, DOI 10.1089/neu.2009.1207; Rafaels KA, 2012, J TRAUMA ACUTE CARE, V73, P895, DOI 10.1097/TA.0b013e31825a760e; Raymond DE, 2008, ASME SUMM BIOENG C J; Shridharani Jay K, 2012, Front Neurol, V3, P70, DOI 10.3389/fneur.2012.00070; Slobonik BA, 1980, SPH 4 HELMET DAMAGE; Taylor PA, 2014, BRAIN INJURY, V28, P879, DOI 10.3109/02699052.2014.888478; Taylor PA, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3118765; Theeler BJ, 2010, HEADACHE, V50, P1262, DOI 10.1111/j.1526-4610.2010.01700.x; U.S. National Academies of Science Committee on Gulf War and Health: Brain Injury in Veterans and Long Term Health Outcomes, 2008, MULT PERS TRAUM BRAI; Versace J., 1971, P15 STAPP CAR CRASH; Wood G, 2013, INT RES COUNC BIOM I; Yoganandan N, 2005, SOLID MECH APPL, V124, P173; Yoganandan N, 1997, J TRAUMA, V42, P266, DOI 10.1097/00005373-199702000-00014; Yu AW, 2012, BIOM ENG SOC ANN M O; Zhang L, 2001, Stapp Car Crash J, V45, P369; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446; Zhou C, 1995, 39 STAPP CAR CRASH C, P121; Zhu F, 2013, INT J NUMER METH BIO, V29, P392, DOI 10.1002/cnm.2518	63	17	17	1	32	THIEME MEDICAL PUBL INC	NEW YORK	333 SEVENTH AVE, NEW YORK, NY 10001 USA	0271-8235	1098-9021		SEMIN NEUROL	Semin. Neurol.	FEB	2015	35	1					5	11		10.1055/s-0035-1544242			7	Clinical Neurology	Neurosciences & Neurology	CC4AP	WOS:000350293300003	25714862				2021-06-18	
J	Lauro, C; Catalano, M; Di Paolo, E; Chece, G; de Costanzo, I; Trettel, F; Limatola, C				Lauro, Clotilde; Catalano, Myriam; Di Paolo, Eleonora; Chece, Giuseppina; de Costanzo, Ida; Trettel, Flavia; Limatola, Cristina			Fractalkine/CX3CL1 engages different neuroprotective responses upon selective glutamate receptor overactivation	FRONTIERS IN CELLULAR NEUROSCIENCE			English	Article						CX3CL1; NMDA; A(2A)R; D-serine; neuroprotection; excitotoxicity	METHYL-D-ASPARTATE; RAT HIPPOCAMPAL-NEURONS; CORTICAL CELL-CULTURE; NMDA RECEPTORS; D-SERINE; MOLECULAR-MECHANISMS; ADENOSINE RECEPTORS; NR2 SUBUNITS; BRAIN; EXPRESSION	Neuronal death induced by overactivation of N-methyl-d-aspartate receptors (NMDARs) is implicated in the pathophysiology of many neurodegenerative diseases such as stroke, epilepsy and traumatic brain injury. This toxic effect is mainly mediated by NR2B-containing extrasynaptic NMDARs, while NR2A-containing synaptic NMDARs contribute to cell survival, suggesting the possibility of therapeutic approaches targeting specific receptor subunits. We report that fractalkine/CX3CL1 protects hippocampal neurons from NMDA-induced cell death with a mechanism requiring the adenosine receptors type 2(A) (A(2A)R). This is different from CX3CL1-induced protection from glutamate (Glu)-induced cell death, that fully depends on A(1)R and requires in part A(3)R. We show that CX3CL1 neuroprotection against NMDA excitotoxicity involves D-serine, a co-agonist of NR2A/NMDAR, resulting in cyclic AMP-dependent transcription factor cyclic-AMP response element-binding protein (CREB) phosphorylation.	[Lauro, Clotilde; Catalano, Myriam; Chece, Giuseppina; de Costanzo, Ida; Trettel, Flavia; Limatola, Cristina] Univ Roma La Sapienza, Ist Pasteur Fdn Cenci Bolognetti, Dept Physiol & Pharmacol, I-00185 Rome, Italy; [Catalano, Myriam; Limatola, Cristina] Ist Ricovero & Cura Carattere Sci Neuro Med, Pozzilli, Italy; [Di Paolo, Eleonora] Univ Milan, Dept Biosci, Milan, Italy	Lauro, C (corresponding author), Univ Roma La Sapienza, Ist Pasteur Fdn Cenci Bolognetti, Dept Physiol & Pharmacol, Piazzale Aldo Moro 5, I-00185 Rome, Italy.	clotilde.lauro@uniroma1.it	Lauro, Clotilde/Q-6110-2016	DI PAOLO, ELEONORA/0000-0003-4798-6631; trettel, flavia/0000-0002-7983-2955; Catalano, Myriam/0000-0003-4638-9202	Associazione Italiana Ricerca sul Cancro (AIRC) Investigator GrantFondazione AIRC per la ricerca sul cancro [IG12774]	We thanks Prof. Bertil B. Fredholm for critical reading and suggestions and for providing us A<INF>1</INF>R<SUP>-/-</SUP>, A<INF>2A</INF>R<SUP>-/-</SUP> and A<INF>3</INF>R<SUP>-/-</SUP> mice. This work was supported by Associazione Italiana Ricerca sul Cancro (AIRC) Investigator Grant IG12774.	Blondeau N, 2001, J NEUROSCI, V21, P4668, DOI 10.1523/JNEUROSCI.21-13-04668.2001; BONFOCO E, 1995, P NATL ACAD SCI USA, V92, P7162, DOI 10.1073/pnas.92.16.7162; Chen JF, 1999, J NEUROSCI, V19, P9192, DOI 10.1523/jneurosci.19-21-09192.1999; Chen M, 2008, STROKE, V39, P3042, DOI 10.1161/STROKEAHA.108.521898; CHOI DW, 1988, J NEUROSCI, V8, P185; CHOI DW, 1987, J NEUROSCI, V7, P369; Deiva K, 2004, EUR J NEUROSCI, V20, P3222, DOI 10.1111/j.1460-9568.2004.03800.x; Ghasemi M, 2014, NEUROSCI BIOBEHAV R, V47, P336, DOI 10.1016/j.neubiorev.2014.08.017; Grabb MC, 1999, J NEUROSCI, V19, P1657; Hardingham GE, 2006, BIOCHEM SOC T, V34, P936, DOI 10.1042/BST0340936; Hardingham GE, 2002, NAT NEUROSCI, V5, P405, DOI 10.1038/nn835; Hardingham GE, 2001, NAT NEUROSCI, V4, P261, DOI 10.1038/85109; Hardingham GE, 2001, NAT NEUROSCI, V4, P565, DOI 10.1038/88380; Hardingham GE, 2010, NAT REV NEUROSCI, V11, P682, DOI 10.1038/nrn2911; Hetman M, 2006, CURR TOP MED CHEM, V6, P787, DOI 10.2174/156802606777057553; Hetman M, 2000, ACTA NEUROBIOL EXP, V60, P531; IKEDA K, 1992, FEBS LETT, V313, P34, DOI 10.1016/0014-5793(92)81178-O; Ikonomidou C, 2002, LANCET NEUROL, V1, P383, DOI 10.1016/S1474-4422(02)00164-3; Jacobson KA, 2006, NAT REV DRUG DISCOV, V5, P247, DOI 10.1038/nrd1983; Jiang XY, 2005, J NEUROCHEM, V94, P713, DOI 10.1111/j.1471-4159.2005.03200.x; Johansson B, 2001, P NATL ACAD SCI USA, V98, P9407, DOI 10.1073/pnas.161292398; JOHNSON JW, 1987, NATURE, V325, P529, DOI 10.1038/325529a0; Koles L, 2001, NEUROCHEM RES, V26, P925, DOI 10.1023/A:1012380416876; KUTSUWADA T, 1992, NATURE, V358, P36, DOI 10.1038/358036a0; Laurie DJ, 1997, MOL BRAIN RES, V51, P23, DOI 10.1016/S0169-328X(97)00206-4; Lauro C, 2008, J IMMUNOL, V180, P7590, DOI 10.4049/jimmunol.180.11.7590; Lauro C, 2010, NEUROPSYCHOPHARMACOL, V35, P1550, DOI 10.1038/npp.2010.26; Lee B, 2005, J NEUROSCI, V25, P1137, DOI 10.1523/JNEUROSCI.4288-04.2005; Li X, 2014, CNS NEUROSCI THER, V20, P951, DOI 10.1111/cns.12308; Limatola C, 2005, J NEUROIMMUNOL, V166, P19, DOI 10.1016/j.jneuroim.2005.03.023; Liu XQ, 2009, ACTA PHARMACOL SIN, V30, P1071, DOI 10.1038/aps.2009.105; Madry C, 2007, MOL PHARMACOL, V72, P1535, DOI 10.1124/mol.107.040071; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Martire A, 2010, NEUROBIOL DIS, V37, P99, DOI 10.1016/j.nbd.2009.09.012; MATSUI T, 1995, J NEUROCHEM, V65, P454; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; MONYER H, 1992, SCIENCE, V256, P1217, DOI 10.1126/science.256.5060.1217; Navon H, 2012, J MOL NEUROSCI, V46, P100, DOI 10.1007/s12031-011-9532-4; Nicotera P, 1999, BIOCHEM SOC SYMP, V66, P69, DOI 10.1042/bss0660069; Papadia S, 2005, J NEUROSCI, V25, P4279, DOI 10.1523/JNEUROSCI.5019-04.2005; Papouin T, 2012, CELL, V150, P633, DOI 10.1016/j.cell.2012.06.029; Pizzorusso T, 2000, J NEUROSCI, V20, P2809; Rosito M, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00193; Salvatore CA, 2000, J BIOL CHEM, V275, P4429, DOI 10.1074/jbc.275.6.4429; Sattler R, 2000, J MOL MED, V78, P3, DOI 10.1007/s001090000077; Sattler R, 2001, MOL NEUROBIOL, V24, P107, DOI 10.1385/MN:24:1-3:107; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Scianni M, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-108; Shimazaki K, 1998, NEUROREPORT, V9, P1875, DOI 10.1097/00001756-199806010-00038; Soriano FX, 2006, J NEUROSCI, V26, P4509, DOI 10.1523/JNEUROSCI.0455-06.2006; Stocca G, 1998, J PHYSIOL-LONDON, V507, P13, DOI 10.1111/j.1469-7793.1998.013bu.x; Tebano MT, 2005, J NEUROCHEM, V95, P1188, DOI 10.1111/j.1471-4159.2005.03455.x; Thomas CG, 2006, J NEUROPHYSIOL, V95, P1727, DOI 10.1152/jn.00771.2005; Tovar KR, 1999, J NEUROSCI, V19, P4180; TYMIANSKI M, 1993, J NEUROSCI, V13, P2085; VOLONTE C, 1994, CYTOMETRY, V17, P274, DOI 10.1002/cyto.990170311; Wang YB, 2013, J NEUROSCI, V33, P18880, DOI 10.1523/JNEUROSCI.3293-13.2013; Yang ZJ, 2013, J CEREBR BLOOD F MET, V33, P1612, DOI 10.1038/jcbfm.2013.117; Zhou Q, 2013, NEUROPHARMACOLOGY, V74, P69, DOI 10.1016/j.neuropharm.2013.03.030	59	17	17	0	10	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1662-5102			FRONT CELL NEUROSCI	Front. Cell. Neurosci.	JAN 21	2015	8								472	10.3389/fncel.2014.00472			8	Neurosciences	Neurosciences & Neurology	CA7CG	WOS:000349074300001	25653593	DOAJ Gold, Green Published			2021-06-18	
J	Duff, MC; Stuck, S				Duff, Melissa C.; Stuck, Sarah			Paediatric concussion: Knowledge and practices of school speech-language pathologists	BRAIN INJURY			English	Article						Assessment; concussion; management; mild traumatic brain injury; speech language pathology	TRAUMATIC BRAIN-INJURY; CLOSED-HEAD-INJURY; SEX-DIFFERENCES; EPIDEMIOLOGY; LONG; AGE	Primary objective: To characterize paediatric concussion knowledge and the management practices of school-based speech-language pathologists (SLPs) in the US to establish a baseline upon which changes in SLP training, knowledge and best practices can be measured. Research design: A survey was developed to assess current knowledge and management of paediatric concussion allowing for comparison to previous and future surveys on SLP knowledge and practice in other areas of brain injury. Methods and procedures: One thousand surveys were distributed to school-based SLPs from 10 states. Two hundred and eighty SLPs from Minnesota, Wisconsin, New York, Massachusetts, Georgia, Florida, Texas, Tennessee, California and Arizona responded to the survey. Main outcomes and results: Compared to previous survey results, SLPs from the current sample indicate an increase in general brain injury training, but confidence in providing clinical services to brain-injured students remains low. SLPs have a mix of accurate and inaccurate concussion knowledge and uncertainty about their role in concussion management. Conclusions: Findings suggest that increasing communication with other school personnel about concussion, increased training in paediatric TBI and concussion improved access to appropriate assessments tools and implementation of long-term concussion management will improve service delivery to school-aged children with concussion.	[Duff, Melissa C.; Stuck, Sarah] Univ Iowa, Dept Commun Sci & Disorders, Iowa City, IA 52242 USA; [Duff, Melissa C.] Univ Iowa, Dept Neurol, Div Cognit Neurosci, Iowa City, IA 52242 USA	Duff, MC (corresponding author), Univ Iowa, Dept Commun Sci & Disorders, 250 Hawkins Dr, Iowa City, IA 52242 USA.	melissa-duff@uiowa.edu					American Speech-Language Hearing Association, 2010, 2010 SCH SURV REP SU; American Speech-Language-Hearing Association, 2005, ROL SPEECH LANG PATH; American Speech-Language-Hearing Association, 2007, SCOP PRACT SPEECH LA; Anderson V A, 1997, J Int Neuropsychol Soc, V3, P568; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Binder LM, 2006, J CLIN EXPT NEUROPSY, V8, P323; Blosser JL, 1991, J HEAD TRAUMA REHAB, V6, P73; Broshek DK, 2005, J NEUROSURG, V102, P856, DOI 10.3171/jns.2005.102.5.0856; Collins Michael W, 2002, Curr Sports Med Rep, V1, P12; Collins MW, 2002, NEUROSURGERY, V51, P1175, DOI 10.1097/00006123-200211000-00011; Duff M. C., 2009, ASHA LEADER; Duff MC, 2002, BRAIN INJURY, V16, P773, DOI 10.1080/02699050210128870; Duff MC, 2003, AM SPEECH LANG HEAR; Echenmend R, 2006, SPORTS NEUROPSYCHOLO; Fjordak BS, 2011, PROTECTING STUDENT A; Frank EM, 1997, J CHILDRENS COMMUNIC, V18, P49, DOI 10.1177/152574019701800206; Gamino JF, 2009, TOP LANG DISORD, V24, P1; Haarauer-Krupa J., 2012, SCH TBI SERVICE PROV; HUGENHOLTZ H, 1988, NEUROSURGERY, V22, P853, DOI 10.1227/00006123-198805000-00006; Hux K, 1996, INTERV SCH CLIN, V31, P158, DOI 10.1177/105345129603100305; Hux K, 1996, LANG SPEECH HEAR SER, V27, P171, DOI 10.1044/0161-1461.2702.171; Iverson GL, 2006, BRIT J SPORT MED, V40, P72, DOI 10.1136/bjsm.2005.020651; Kay T, 2006, MINOR HEAD INJURY IN; Kirkwood MW, 2006, PEDIATRICS, V117, P1359, DOI 10.1542/peds.2005-0994; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Levin HS, 2001, NEUROPSYCHOLOGIA, V39, P122, DOI 10.1016/S0028-3932(00)00111-1; Lovell M.R., 2004, TRAUMATIC BRAIN INJU; McCrea M, 2008, TRAUMATIC BRAIN INJU; McCrory P, 2009, J CLIN NEUROSCI, V16, P755, DOI 10.1016/j.jocn.2009.02.002; McCrory Paul, 2005, Clin J Sport Med, V15, P48; McGrane SA, 2000, BRAIN INJURY, V14, P975; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Russell N, 1993, LANG SPEECH HEAR SER, V24, P67; Salvatore AP, 2011, J MED SPEECH-LANG PA, V19, P1; SEGALOWITZ SJ, 1995, J LEARN DISABIL, V28, P309, DOI 10.1177/002221949502800507; SLAGLE DA, 1990, INT J PSYCHIAT MED, V20, P1, DOI 10.2190/BE6W-DCY1-V71N-N7J7; Thurman DJ, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199804000-00003; Todis B., 2007, BRAIN INJURY PROFESS, V3, P33; Tsushima WT, 2009, BRAIN INJURY, V23, P809, DOI 10.1080/02699050903200530; Turkstra L, 2005, J MED SPEECH-LANG PA, V13, pIX; Turkstra LS, 1999, LANG SPEECH HEAR SER, V30, P132, DOI 10.1044/0161-1461.3002.132; Webb C, 1996, BRAIN INJURY, V10, P303, DOI 10.1080/026990596124476; Ylvisaker M, 1998, TRAUMATIC BRAIN INJU, P222	43	17	17	0	15	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2015	29	1					64	77		10.3109/02699052.2014.965747			14	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	AW1WC	WOS:000346078000009	25313854				2021-06-18	
J	Lei, J; Gao, GY; Mao, Q; Feng, JF; Wang, L; You, WD; Jiang, JY				Lei, Jin; Gao, Guoyi; Mao, Qing; Feng, Junfeng; Wang, Lei; You, Wendong; Jiang, Jiyao		LTH-Trial Collaborators	Rationale, methodology, and implementation of a nationwide multicenter randomized controlled trial of long-term mild hypothermia for severe traumatic brain injury (the LTH-1 trial)	CONTEMPORARY CLINICAL TRIALS			English	Article						Long-term mild hypothermia; Severe traumatic brain injury; Multicenter randomized trial; Efficacy; Safety	THERAPEUTIC HYPOTHERMIA; INTRACRANIAL HYPERTENSION; MODERATE HYPOTHERMIA; HEAD-INJURY; PREVENTION; GUIDELINES; ADULT	Background: Traumatic brain injury (TB!) is a major public health problem recently, however, no intervention showing convincing efficacy. Therapeutic hypothermia with a relatively long duration (more than 48 h), as a promising treatment measure, might improve the patient outcome following severe TBI. Methods/design: The LTH-1 trial is a prospective, nationwide multicenter, randomized, controlled clinical trial to examine the efficacy and safety of long-term mild hypothermia in adult patients after severe traumatic brain injury. A total of 300 consecutive patients will be recruited from 15 large neurosurgical centers in China. The eligible patient will be randomized to receive either long-term mild hypothermia (34-35 degrees C) for 5 days, or normothermia (36-37 degrees C). Additionally, a standardized management protocol will be used in all patients. The primary end point is the neurological outcome 6 months post-injury on the Glasgow Outcome Scale. The secondary outcomes include GOS score at one month post-injury, mortality during six months after injury, length of ICU and hospital stay, intracranial pressure control and Glasgow Coma Scale score during the hospital stay and frequency of complications during the six-month follow-up period. Discussion: Long-term hypothermia is recommended by most recent studies and its efficacy urgently needs to be established in randomized controlled settings. The LTH-1 trial, together with other ongoing studies, will present more evidence for optimal use of hypothermia in severe TB! patients. (C) 2014 Elsevier Inc. All rights reserved.	Shanghai Inst Head Trauma, Shanghai, Peoples R China; [Jiang, Jiyao] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Neurosurg, Shanghai 200127, Peoples R China	Jiang, JY (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Neurosurg, 1630 Dongfang Rd, Shanghai 200127, Peoples R China.	doctorjinlei@l63.com; guoyigao@gmail.com; maoq@netease.com; fengifmail@l63.com; dIdtshwl@l26.com; smiles1949@l63.com; jiyaojiangrenji@126.com			National Key Basic Research ProjectNational Basic Research Program of China [2012CB518100]; National Natural Scientific grants [81271381]; Program for Shanghai Outstanding Medical Academic Leader [2014529]	This work was supported by grants from the National Key Basic Research Project (No. 2012CB518100), National Natural Scientific grants (No. 81271381) and Program for Shanghai Outstanding Medical Academic Leader (No. 2014529).	Abelson-Mitchell N, 2008, J CLIN NURS, V17, P46, DOI 10.1111/j.1365-2702.2007.01941.x; Adelson PD, 2005, NEUROSURGERY, V56, P740, DOI 10.1227/01.NEU.0000156471.50726.26; Andrews PJD, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-8; Auer RN, 2001, ANN NY ACAD SCI, V939, P271; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; Clifton GL, 2011, LANCET NEUROL, V10, P131, DOI 10.1016/S1474-4422(10)70300-8; Faul M, 2010, TRAUMATIC BRAIN INJU, P2; Fay T, 1943, RES PUBL ASSOC RES N, V24, P611; Jiang JY, 2009, J NEUROTRAUM, V26, P399, DOI 10.1089/neu.2008.0525; Jiang JY, 2000, J NEUROSURG, V93, P546, DOI 10.3171/jns.2000.93.4.0546; Jiang JY, 2006, J CEREBR BLOOD F MET, V26, P771, DOI 10.1038/sj.jcbfm.9600253; Kramer C, 2012, NEUROLOGIST, V18, P173, DOI 10.1097/NRL.0b013e318253f8ef; Lei J, 2013, J NEUROTRAUM, V30, P529, DOI 10.1089/neu.2012.2548; LUERSSEN TG, 1988, J NEUROSURG, V68, P409, DOI 10.3171/jns.1988.68.3.0409; Maas A, 2011, LANCET NEUROL, V10, P111, DOI 10.1016/S1474-4422(10)70312-4; Maas AIR, 2010, NEUROTHERAPEUTICS, V7, P115, DOI 10.1016/j.nurt.2009.10.022; Marion D, 2009, J NEUROTRAUM, V26, P455, DOI 10.1089/neu.2008.0582; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; Moore EM, 2011, INJURY, V42, P843, DOI 10.1016/j.injury.2011.03.027; Nolan JP, 2005, RESUSCITATION, V67, pS39, DOI 10.1016/j.resuscitation.2005.10.009; Polderman KH, 2008, LANCET, V371, P1955, DOI 10.1016/S0140-6736(08)60837-5; Polderman KH, 2011, LANCET NEUROL, V10, P404, DOI 10.1016/S1474-4422(11)70084-9; Shankaran S, 2005, NEW ENGL J MED, V353, P1574, DOI 10.1056/NEJMcps050929; Shann F, 2003, LANCET, V362, P1950, DOI 10.1016/S0140-6736(03)15083-0; Shiozaki T, 2003, J NEUROSURG, V99, P47, DOI 10.3171/jns.2003.99.1.0047; Stocchetti N, 2007, J NEUROTRAUM, V24, P1339, DOI 10.1089/neu.2007.0300; TEASDALE G, 1974, LANCET, V2, P81; Ueda Y, 2003, J NEUROSURG, V99, P899, DOI 10.3171/jns.2003.99.5.0899; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; World Medical Association. World Medical Association Declaration of Helsinki, 2011, B WORLD HEALTH ORGAN, V79, P373; Zweifler Richard M, 2003, J Stroke Cerebrovasc Dis, V12, P237, DOI 10.1016/j.jstrokecerebrovasdis.2003.09.006	31	17	18	0	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1551-7144	1559-2030		CONTEMP CLIN TRIALS	Contemp. Clin. Trials	JAN	2015	40						9	14		10.1016/j.cct.2014.11.008			6	Medicine, Research & Experimental; Pharmacology & Pharmacy	Research & Experimental Medicine; Pharmacology & Pharmacy	CB6IZ	WOS:000349732000002	25460339				2021-06-18	
J	Ma, JH; Liu, N; Yi, B; Zhang, XC; Gao, BB; Zhang, YS; Xu, RX; Li, X; Dai, YW				Ma, Jianhua; Liu, Ning; Yi, Bo; Zhang, Xiaochong; Gao, Bing Bing; Zhang, Yesen; Xu, Ruxiang; Li, Xin; Dai, Yiwu			Transplanted hUCB-MSCs migrated to the damaged area by SDF-1/CXCR4 signaling to promote functional recovery after traumatic brain injury in rats	NEUROLOGICAL RESEARCH			English	Article						hUCB-MSCs; Traumatic brain injury; SDF-1/CXCR4	MESENCHYMAL STEM-CELLS; THERAPY	Transplanted human umbilical cord mesenchymal stem cells (hUC-MSCs) have exhibited considerable therapeutic potential for traumatic brain injury (TBI). However, how hUC-MSCs migrating to the injury region and the mechanism of hUC-MSCs promoting functional recovery after TBI are still unclear. In this study, we investigated whether stromal cell-derived factor-1 (SDF-1) was involved in the hUC-MSCs migration and the possible mechanisms that might be involved in the beneficial effect on functional recovery. In vitro experiments demonstrated that SDF-1 induces a concentration-dependent migration of hUC-MSCs. Furthermore, pre-treatment with the CXCR4-specific antagonist AMD3100 significantly prevented the migration of hUC-MSCs in vitro. We found that the expression of SDF-1 increased significantly around the damaged area. Transplanted hUC-MSCs were localized to regions where SDF-1 was highly expressed. Additionally, our results showed that hUC-MSCs-treated animals showed significantly improved functional recovery compared with controls. In hUC-MSCs-transplanted group, terminal deoxynucleotidyl transferase-mediated dUTP nick end-labeling (TUNEL)-positive cells were decreased and BrdU-positive cells were significantly increased compared with control group, more of BrdU-positive cells co-localized with GFAP. These suggest that SDF-1 plays an important role in the migration of hUC-MSCs to the damaged area and hUC-MSCs are beneficial for functional recovery after TBI.	[Ma, Jianhua; Li, Xin] Peoples Hosp Feicheng Shandong Prov, Feicheng, Peoples R China; [Liu, Ning; Zhang, Yesen; Xu, Ruxiang; Dai, Yiwu] Gen Hosp Beijing Mil Reg, Affiliated Bayi Brain Hosp, Beijing 100700, Peoples R China; [Yi, Bo; Gao, Bing Bing] Anhui Med Univ, Clin Coll Gen Hosp Beijing Mil Reg, Hefei, Peoples R China; [Zhang, Xiaochong] Hebei Med Univ, Hosp 4, Shijiazhuang 050000, Peoples R China	Dai, YW (corresponding author), Gen Hosp Beijing Mil Reg, Affiliated Bayi Brain Hosp, Nan Men Cang 5, Beijing 100700, Peoples R China.	majh1206@126.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81271391]	This work was supported by the National Natural Science Foundation of China (81271391).	Broxmeyer HE, 2005, J EXP MED, V201, P1307, DOI 10.1084/jem.20041385; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Itoh T, 2012, J NEURAL TRANSM, V119, P877, DOI 10.1007/s00702-011-0764-9; Keilhoff G, 2006, CELL MOL NEUROBIOL, V26, P1235, DOI 10.1007/s10571-006-9029-9; Kuhn HG, 1996, J NEUROSCI, V16, P2027; Li QM, 2013, FITOTERAPIA, V86, P29, DOI 10.1016/j.fitote.2013.01.015; Li SH, 2012, BRAIN RES, V1444, P76, DOI 10.1016/j.brainres.2011.12.055; Li Y, 2002, NEUROLOGY, V59, P514, DOI 10.1212/WNL.59.4.514; Lim JY, 2011, STEM CELL RES THER, V2, DOI 10.1186/scrt79; LOIS C, 1994, SCIENCE, V264, P1145, DOI 10.1126/science.8178174; Mao WF, 2014, INT J NEUROSCI, V124, P281, DOI 10.3109/00207454.2013.838236; McKay R, 1997, SCIENCE, V276, P66, DOI 10.1126/science.276.5309.66; Shi W, 2012, BIOMATERIALS, V33, P3119, DOI 10.1016/j.biomaterials.2012.01.009; Shukla D, 2010, J NEUROSCI RURAL PRA, V1, P82, DOI 10.4103/0976-3147.71723; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Tong YH, 2011, PHYTOMEDICINE, V18, P443, DOI 10.1016/j.phymed.2010.10.009; Valentin G, 2007, CURR BIOL, V17, P1026, DOI 10.1016/j.cub.2007.05.020; Wang Y, 2008, BRAIN RES, V1195, P104, DOI 10.1016/j.brainres.2007.11.068; Yu J, 2010, J CARDIOVASC PHARM, V55, P496, DOI 10.1097/FJC.0b013e3181d7a384; Zendedel A, 2012, BRAIN RES, V1473, P214, DOI 10.1016/j.brainres.2012.07.037	20	17	18	3	19	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0161-6412	1743-1328		NEUROL RES	Neurol. Res.	JAN	2015	37	1					50	56		10.1179/1743132814Y.0000000399			7	Clinical Neurology; Neurosciences	Neurosciences & Neurology	AT9DQ	WOS:000345228600008	24919714				2021-06-18	
J	Matschke, J; Buttner, A; Bergmann, M; Hagel, C; Puschel, K; Glatzel, M				Matschke, Jakob; Buettner, Andreas; Bergmann, Markus; Hagel, Christian; Pueschel, Klaus; Glatzel, Markus			Encephalopathy and death in infants with abusive head trauma is due to hypoxic-ischemic injury following local brain trauma to vital brainstem centers	INTERNATIONAL JOURNAL OF LEGAL MEDICINE			English	Article						Abusive head trauma; Non-accidental head injury; Shaken baby syndrome; Child abuse; Diffuse axonal injury; Neuropathology	DIFFUSE AXONAL INJURY; SHAKEN-BABY SYNDROME; PRECURSOR PROTEIN IMMUNOHISTOCHEMISTRY; CENTRAL-NERVOUS-SYSTEM; YOUNG-CHILDREN; BETA-APP; NONACCIDENTAL INJURY; FORENSIC PRACTICE; ONDINES CURSE; NEUROPATHOLOGY	Infants with abusive head trauma (AHT) have diffuse brain damage with potentially fatal brain swelling. The pathogenesis of the brain damage remains unclear. We hypothesize that brain damage in AHT is due to hypoxic-ischemic injury with hypoxic-ischemic encephalopathy (HIE) rather than primary traumatic brain injury (TBI) with traumatic diffuse axonal injury (tDAI). We studied brain tissue of AHT victims. Primary outcome measure was the presence of primary traumatic versus hypoxic-ischemic brain injury. The diagnosis of tDAI followed a standardized semiquantitative diagnostic approach yielding a 4-tiered grading scheme (definite, possible, improbable, and none). In addition, results of quantitative immunohistochemical analysis in a subgroup of AHT victims with instant death were compared with matched SIDS controls. In our cohort of 50 AHT victims, none had definite tDAI (no tDAI in 30, tDAI possible in 2, and tDAI improbable in 18). Instead, all AHT victims showed morphological findings indicative of HIE. Furthermore, the subgroup with instant death showed significantly higher counts of damaged axons with accumulation of amyloid precursor protein (APP) in the brainstem adjacent to the central pattern generator of respiratory activity (CPG) (odds ratio adjusted for age, sex, brain weight, and APP-count in other regions = 3.1; 95 % confidence interval = 1.2 to 7.7; p = 0.015). AHT victims in our cohort do not have diffuse TBI or tDAI. Instead, our findings indicate that the encephalopathy in AHT is the due to hypoxic-ischemic injury probably as the result of respiratory arrest due to local damage to parts of the CPG in the brainstem.	[Matschke, Jakob] Univ Med Ctr Hamburg Eppendorf, Forens Neuropathol Unit, D-20246 Hamburg, Germany; [Matschke, Jakob; Hagel, Christian; Glatzel, Markus] Univ Med Ctr Hamburg Eppendorf, Inst Neuropathol, D-20246 Hamburg, Germany; [Buettner, Andreas] Univ Rostock, Fac Med, Inst Legal Med, D-18055 Rostock, Germany; [Bergmann, Markus] Klinikum Bremen Mitte, Inst Clin Neuropathol, Bremen, Germany; [Pueschel, Klaus] Univ Med Ctr Hamburg Eppendorf, Inst Legal Med, D-20246 Hamburg, Germany	Matschke, J (corresponding author), Univ Med Ctr Hamburg Eppendorf, Forens Neuropathol Unit, D-20246 Hamburg, Germany.	matschke@uke.de	Glatzel, Markus/G-3356-2011; Glatzel, Markus/V-8844-2019; Buttner, Andreas/I-5974-2014; Matschke, Jakob/F-6641-2013	Glatzel, Markus/0000-0002-7720-8817; Glatzel, Markus/0000-0002-7720-8817; Buttner, Andreas/0000-0002-6676-4957; Matschke, Jakob/0000-0001-6080-0198			ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Adamsbaum C, 2010, PEDIATRICS, V126, P546, DOI 10.1542/peds.2009-3647; Barnes Patrick D, 2007, Top Magn Reson Imaging, V18, P53, DOI 10.1097/RMR.0b013e3180d0a455; Barnes PD, 2010, SEMIN PEDIATR NEUROL, V17, P7, DOI 10.1016/j.spen.2010.01.005; Bell E, 2011, CHILD ABUSE NEGLECT, V35, P74, DOI 10.1016/j.chiabu.2010.11.001; Biron D, 2005, CHILD ABUSE NEGLECT, V29, P1347, DOI 10.1016/j.chiabu.2005.05.003; Bitsch A, 2000, BRAIN, V123, P1174, DOI 10.1093/brain/123.6.1174; Bittigau P, 2004, EXP TOXICOL PATHOL, V56, P83, DOI 10.1016/j.etp.2004.04.006; Brennan LK, 2009, J NEUROS-PEDIATR, V3, P232, DOI 10.3171/2008.11.PEDS0835; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; CAFFEY J, 1972, AM J DIS CHILD, V124, P161, DOI 10.1001/archpedi.1972.02110140011001; CALDER IM, 1984, J CLIN PATHOL, V37, P1095, DOI 10.1136/jcp.37.10.1095; Case Mary E., 2007, Legal Medicine, V9, P83, DOI 10.1016/j.legalmed.2006.11.017; Case ME, 2001, AM J FOREN MED PATH, V22, P112, DOI 10.1097/00000433-200106000-00002; Chen XH, 2009, BRAIN PATHOL, V19, P214, DOI 10.1111/j.1750-3639.2008.00176.x; Chiesa A, 2009, PEDIATR CLIN N AM, V56, P317, DOI 10.1016/j.pcl.2009.02.001; Choudhary AK, 2012, RADIOLOGY, V262, P216, DOI 10.1148/radiol.11102390; Christian CW, 2009, PEDIATRICS, V123, P1409, DOI 10.1542/peds.2009-0408; Dolinak D, 2006, ARCH PATHOL LAB MED, V130, P712; Duhaime AC, 1998, NEW ENGL J MED, V338, P1822, DOI 10.1056/NEJM199806183382507; Engel S, 2000, ACTA NEUROPATHOL, V100, P313, DOI 10.1007/s004019900172; Esernio-Jenssen D, 2011, PEDIATRICS, V127, P649, DOI 10.1542/peds.2010-1770; Garcia AJ, 2011, PROG BRAIN RES, V188, P31, DOI 10.1016/B978-0-444-53825-3.00008-5; Geddes JF, 2000, NEUROPATH APPL NEURO, V26, P105, DOI 10.1046/j.1365-2990.2000.026002105.x; Geddes JF, 1997, NEUROPATH APPL NEURO, V23, P339, DOI 10.1046/j.1365-2990.1997.4498044.x; Geddes JF, 2001, BRAIN, V124, P1299, DOI 10.1093/brain/124.7.1299; Geddes JF, 2001, BRAIN, V124, P1290, DOI 10.1093/brain/124.7.1290; GENTLEMAN SM, 1993, NEUROSCI LETT, V160, P139, DOI 10.1016/0304-3940(93)90398-5; Gleckman AM, 1999, ARCH PATHOL LAB MED, V123, P146; Graham DI, 2004, FORENSIC SCI INT, V146, P89, DOI 10.1016/S0379-0738(03)00274-3; HADLEY MN, 1989, NEUROSURGERY, V24, P536, DOI 10.1227/00006123-198904000-00008; Hart BL, 1996, AM J FOREN MED PATH, V17, P217, DOI 10.1097/00000433-199609000-00008; Itabashi HH., 2007, FORENSIC NEUROPATHOL; Johnson DL, 1995, PEDIATR NEUROSURG, V23, P305, DOI 10.1159/000120976; Johnson MW, 2011, J FORENSIC SCI, V56, P1198, DOI 10.1111/j.1556-4029.2011.01814.x; Kaya SS, 1999, BRAIN RES, V818, P23, DOI 10.1016/S0006-8993(98)01204-9; Keenan H.T., 2010, CHILD ABUSE NEGLECT, P35; KEMPE CH, 1962, JAMA-J AM MED ASSOC, V181, P17, DOI 10.1001/jama.1962.03050270019004; Kinney Hannah C, 2009, Dev Psychobiol, V51, P223, DOI 10.1002/dev.20367; Kinney HC, 2009, NEW ENGL J MED, V361, P795, DOI 10.1056/NEJMra0803836; Kinney H, 2009, ACTA NEUROPATHOL, V117, P247, DOI 10.1007/s00401-009-0490-7; Krous HF, 2004, PEDIATRICS, V114, P234, DOI 10.1542/peds.114.1.234; Kuhn J, 2005, ACTA NEUROPATHOL, V110, P579, DOI 10.1007/s00401-005-1090-9; Leestma JE, 2009, FORENSIC NEUROPATHOL; LINDENBERG R, 1969, ARCH PATHOL, V87, P298; Loane DJ, 2014, J NEUROPATH EXP NEUR, V73, P14, DOI 10.1097/NEN.0000000000000021; Loane DJ, 2010, NEUROTHERAPEUTICS, V7, P366, DOI 10.1016/j.nurt.2010.07.002; Matschke J, 2008, RECHTSMEDIZIN, V18, P29, DOI 10.1007/s00194-007-0487-2; Matschke J, 2008, RECHTSMEDIZIN, V18, P36, DOI 10.1007/s00194-007-0488-1; Matschke J, 2008, RECHTSMEDIZIN, V18, P7, DOI 10.1007/s00194-007-0490-7; Matschke J, 2007, AM J FOREN MED PATH, V28, P141, DOI 10.1097/01.paf.0000257396.79742.e9; Matschke J, 2009, PEDIATRICS, V124, P1587, DOI 10.1542/peds.2008-3734; Matschke J, 2009, INT J LEGAL MED, V123, P189, DOI 10.1007/s00414-008-0293-8; Medana IM, 2002, AM J PATHOL, V160, P655, DOI 10.1016/S0002-9440(10)64885-7; Mellen NM, 2012, CURR OPIN NEUROBIOL, V22, P676, DOI 10.1016/j.conb.2012.01.001; Mendoza M, 2013, NEUROLOGY, V80, pE13, DOI 10.1212/WNL.0b013e31827b9096; Napieralski JA, 1999, MOL BRAIN RES, V71, P78, DOI 10.1016/S0169-328X(99)00155-2; Newell KL, 1999, J NEUROPATH EXP NEUR, V58, P1263, DOI 10.1097/00005072-199912000-00007; Oehmichen M, 1999, INT J LEGAL MED, V112, P261, DOI 10.1007/s004140050246; Oehmichen M, 1998, FORENSIC SCI INT, V95, P67, DOI 10.1016/S0379-0738(98)00075-9; Oehmichen M, 2006, FORENSIC NEUROPATHOL; Oehmichen M, 2008, ACTA NEUROPATHOL, V116, P317, DOI 10.1007/s00401-008-0356-4; Oehmichen M, 2009, ACTA NEUROPATHOL, V117, P267, DOI 10.1007/s00401-008-0459-y; Ramirez JM, 1996, CURR OPIN NEUROBIOL, V6, P817, DOI 10.1016/S0959-4388(96)80033-X; Reichard RR, 2005, NEUROPATH APPL NEURO, V31, P304, DOI 10.1111/j.1365-2990.2005.00645.x; Reichard RR, 2003, J NEUROTRAUM, V20, P347, DOI 10.1089/089771503765172309; Richerson GB, 2012, MED PHYSL CELLULAR M, P725; Shannon P, 1998, ACTA NEUROPATHOL, V95, P625, DOI 10.1007/s004010050849; Sieswerda-Hoogendoorn T, 2012, EUR J PEDIATR, V171, P415, DOI 10.1007/s00431-011-1598-z; Smith C, 2003, NEUROPATH APPL NEURO, V29, P496, DOI 10.1046/j.1365-2990.2003.00488.x; Smith DH, 2003, NEUROMOL MED, V4, P59, DOI 10.1385/NMM:4:1-2:59; Smith JC, 2009, PHILOS T R SOC B, V364, P2577, DOI 10.1098/rstb.2009.0081; Smith Lisa H, 2003, Semin Pediatr Neurol, V10, P235, DOI 10.1016/S1071-9091(03)00076-7; Springer JE, 2002, J BIOCHEM MOL BIOL, V35, P94; Squier W, 2011, FORENSIC SCI INT, V212, pE31, DOI 10.1016/j.forsciint.2011.04.027; Squier W, 2011, ACTA NEUROPATHOL, V122, P519, DOI 10.1007/s00401-011-0875-2; Stadelmann C, 2000, CELL TISSUE RES, V301, P19, DOI 10.1007/s004410000203; Streit WJ, 1996, NEUROTOXICOLOGY, V17, P671; Uryu K, 2002, J NEUROSCI, V22, P446, DOI 10.1523/JNEUROSCI.22-02-00446.2002; Uryu K, 2007, EXP NEUROL, V208, P185, DOI 10.1016/j.expneurol.2007.06.018; VOWLES GH, 1987, J CLIN PATHOL, V40, P185, DOI 10.1136/jcp.40.2.185; Yam PS, 1997, BRAIN RES, V760, P150, DOI 10.1016/S0006-8993(97)00290-4	82	17	17	0	13	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0937-9827	1437-1596		INT J LEGAL MED	Int. J. Legal Med.	JAN	2015	129	1					105	114		10.1007/s00414-014-1060-7			10	Medicine, Legal	Legal Medicine	AX8IS	WOS:000347153900013	25107298				2021-06-18	
J	Mikell, CB; Banks, GP; Frey, HP; Youngerman, BE; Nelp, TB; Karas, PJ; Chan, AK; Voss, HU; Connolly, ES; Claassen, J				Mikell, Charles B.; Banks, Garrett P.; Frey, Hans-Peter; Youngerman, Brett E.; Nelp, Taylor B.; Karas, Patrick J.; Chan, Andrew K.; Voss, Henning U.; Connolly, E. Sander; Claassen, Jan			Frontal Networks Associated With Command Following After Hemorrhagic Stroke	STROKE			English	Article						coma; intracerebral hemorrhage; subarachnoid hemorrhage	DEFAULT-MODE NETWORK; ANTERIOR CINGULATE CORTEX; TRAUMATIC BRAIN-INJURY; FUNCTIONAL CONNECTIVITY; RESTING-STATE; INTRACEREBRAL HEMORRHAGE; SUBARACHNOID HEMORRHAGE; COGNITIVE CONTROL; CONSCIOUSNESS; COMA	Background and Purpose-Level of consciousness is frequently assessed by command-following ability in the clinical setting. However, it is unclear what brain circuits are needed to follow commands. We sought to determine what networks differentiate command following from noncommand following patients after hemorrhagic stroke. Methods-Structural MRI, resting-state functional MRI, and electroencephalography were performed on 25 awake and unresponsive patients with acute intracerebral and subarachnoid hemorrhage. Structural injury was assessed via volumetric T1-weighted MRI analysis. Functional connectivity differences were analyzed against a template of standard resting-state networks. The default mode network (DMN) and the task-positive network were investigated using seed-based functional connectivity. Networks were interrogated by pairwise coherence of electroencephalograph leads in regions of interest defined by functional MRI. Results-Functional imaging of unresponsive patients identified significant differences in 6 of 16 standard resting-state networks. Significant voxels were found in premotor cortex, dorsal anterior cingulate gyrus, and supplementary motor area. Direct interrogation of the DMN and task-positive network revealed loss of connectivity between the DMN and the orbitofrontal cortex and new connections between the task-positive network and DMN. Coherence between electrodes corresponding to right executive network and visual networks was also decreased in unresponsive patients. Conclusions-Resting-state functional MRI and electroencephalography coherence data support a model in which multiple, chiefly frontal networks are required for command following. Loss of DMN anticorrelation with task-positive network may reflect a loss of inhibitory control of the DMN by motor-executive regions. Frontal networks should thus be a target for future investigations into the mechanism of responsiveness in the intensive care unit environment.	[Mikell, Charles B.; Banks, Garrett P.; Youngerman, Brett E.; Nelp, Taylor B.; Karas, Patrick J.; Chan, Andrew K.; Connolly, E. Sander] Columbia Univ, Med Ctr, Dept Neurol Surg, New York, NY 10032 USA; [Voss, Henning U.] Cornell Univ, Weill Cornell Med Coll, Dept Radiol, New York, NY 10021 USA; [Frey, Hans-Peter; Claassen, Jan] Columbia Univ, Med Ctr, Dept Neurol, Div Neurocrit Care, New York, NY 10032 USA	Mikell, CB (corresponding author), Columbia Univ, Med Ctr, Dept Neurol Surg, 710 W 168th St, New York, NY 10032 USA.	cbm2104@columbia.edu	Claassen, Jan/AAA-5451-2020; Voss, Henning/C-2194-2009	Voss, Henning/0000-0003-2811-2074; Youngerman, Brett/0000-0002-4792-3190; Frey, Hans-Peter/0000-0002-1026-008X			Bakker AM, 2007, STROKE, V38, P2496, DOI 10.1161/STROKEAHA.107.484220; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Biswal BB, 2010, P NATL ACAD SCI USA, V107, P4734, DOI 10.1073/pnas.0911855107; Bollimunta A, 2011, J NEUROSCI, V31, P4935, DOI 10.1523/JNEUROSCI.5580-10.2011; Boly M, 2009, HUM BRAIN MAPP, V30, P2393, DOI 10.1002/hbm.20672; Bonnelle V, 2011, J NEUROSCI, V31, P13442, DOI 10.1523/JNEUROSCI.1163-11.2011; Boveroux P, 2010, ANESTHESIOLOGY, V113, P1038, DOI 10.1097/ALN.0b013e3181f697f5; Brefel-Courbon C, 2007, ANN NEUROL, V62, P102, DOI 10.1002/ana.21110; Brown EN, 2010, NEW ENGL J MED, V363, P2638, DOI 10.1056/NEJMra0808281; Bruno MA, 2012, J NEUROL, V259, P1087, DOI 10.1007/s00415-011-6303-7; Cauda F, 2009, J NEUROL NEUROSUR PS, V80, P429, DOI 10.1136/jnnp.2007.142349; Cavanagh JF, 2014, TRENDS COGN SCI, V18, P414, DOI 10.1016/j.tics.2014.04.012; Chatelle C, 2014, NEUROREHAB NEURAL RE, V28, P149, DOI 10.1177/1545968313503220; Chen AC, 2013, P NATL ACAD SCI USA, V110, P19944, DOI 10.1073/pnas.1311772110; CHESNUT RM, 1993, ACTA NEUROCHIR, P121; Christoff K, 2009, P NATL ACAD SCI USA, V106, P8719, DOI 10.1073/pnas.0900234106; Claassen J, 2002, STROKE, V33, P1225, DOI 10.1161/01.STR.0000015624.29071.1F; Claassen J, 2004, NEUROLOGY, V62, P1743, DOI 10.1212/01.WNL.0000125184.88797.62; Connolly ES, 2012, STROKE, V43, P1711, DOI 10.1161/STR.0b013e3182587839; Corbetta M, 2002, J COGNITIVE NEUROSCI, V14, P508, DOI 10.1162/089892902317362029; Cravo AM, 2013, J NEUROSCI, V33, P4002, DOI 10.1523/JNEUROSCI.4675-12.2013; Crone JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026373; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; Dehaene S, 2011, NEURON, V70, P200, DOI 10.1016/j.neuron.2011.03.018; Edlow BL, 2012, J NEUROPATH EXP NEUR, V71, P531, DOI 10.1097/NEN.0b013e3182588293; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fugate JE, 2010, ANN NEUROL, V68, P907, DOI 10.1002/ana.22133; Gerloff C, 1997, BRAIN, V120, P1587, DOI 10.1093/brain/120.9.1587; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Grote S, 2011, J NEUROTRAUM, V28, P527, DOI 10.1089/neu.2010.1433; Hemphill JC, 2001, STROKE, V32, P891, DOI 10.1161/01.STR.32.4.891; Hermans G, 2008, CRIT CARE, V12, DOI 10.1186/cc7100; Larson-Prior LJ, 2009, P NATL ACAD SCI USA, V106, P4489, DOI 10.1073/pnas.0900924106; Lingsma HF, 2010, LANCET NEUROL, V9, P543, DOI 10.1016/S1474-4422(10)70065-X; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; Massimini M, 2005, SCIENCE, V309, P2228, DOI 10.1126/science.1117256; Meindl T, 2010, HUM BRAIN MAPP, V31, P237, DOI 10.1002/hbm.20860; Mennes M, 2010, NEUROIMAGE, V50, P1690, DOI 10.1016/j.neuroimage.2010.01.002; Mizuhara H, 2007, NEUROIMAGE, V36, P232, DOI 10.1016/j.neuroimage.2007.02.026; Molaee-Ardekani B, 2007, P ANN INT IEEE EMBS, P1294, DOI 10.1109/IEMBS.2007.4352534; Moreno DR, 2010, NEUROLOGY, V75, P1871, DOI 10.1212/WNL.0b013e3181feb259; Morgenstern LB, 2010, STROKE, V41, P2108, DOI 10.1161/STR.0b013e3181ec611b; Nagaratnam N, 2004, J CLIN NEUROSCI, V11, P25, DOI 10.1016/j.jocn.2003.04.002; Norton L, 2012, NEUROLOGY, V78, P175, DOI 10.1212/WNL.0b013e31823fcd61; Parvizi J, 2003, BRAIN, V126, P1524, DOI 10.1093/brain/awg166; Purdon PL, 2013, P NATL ACAD SCI USA, V110, pE1142, DOI 10.1073/pnas.1221180110; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; RIMEL RW, 1982, NEUROSURGERY, V11, P344, DOI 10.1227/00006123-198209000-00002; Schiff ND, 2007, NATURE, V448, P600, DOI 10.1038/nature06041; Schnakers C, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-35; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Shenhav A, 2013, NEURON, V79, P217, DOI 10.1016/j.neuron.2013.07.007; Sherrington C, 1906, INTEGRATIVE ACTION N; Shirer WR, 2012, CEREB CORTEX, V22, P158, DOI 10.1093/cercor/bhr099; Smith E, 2005, BMJ-BRIT MED J, V330, P406, DOI 10.1136/bmj.330.7488.406; Soddu A, 2012, HUM BRAIN MAPP, V33, P778, DOI 10.1002/hbm.21249; Sridharan D, 2008, P NATL ACAD SCI USA, V105, P12569, DOI 10.1073/pnas.0800005105; TEASDALE G, 1974, LANCET, V2, P81; Vanhaudenhuyse A, 2010, BRAIN, V133, P161, DOI 10.1093/brain/awp313; Vinck M, 2010, NEUROIMAGE, V51, P112, DOI 10.1016/j.neuroimage.2010.01.073; Yan CG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005743; Yang H, 2007, NEUROIMAGE, V36, P144, DOI 10.1016/j.neuroimage.2007.01.054	63	17	18	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0039-2499	1524-4628		STROKE	Stroke	JAN	2015	46	1					49	+		10.1161/STROKEAHA.114.007645			16	Clinical Neurology; Peripheral Vascular Disease	Neurosciences & Neurology; Cardiovascular System & Cardiology	AX1XB	WOS:000346735800023	25492905	Bronze			2021-06-18	
J	Sandry, J; DeLuca, J; Chiaravalloti, N				Sandry, Joshua; DeLuca, John; Chiaravalloti, Nancy			Working memory capacity links cognitive reserve with long-term memory in moderate to severe TBI: a translational approach	JOURNAL OF NEUROLOGY			English	Article						Brain injuries; Cognitive reserve; Memory Disorders; Cognition; Rehabilitation; Working memory	TRAUMATIC BRAIN-INJURY; INTELLECTUAL ENRICHMENT; MULTIPLE-SCLEROSIS; REHABILITATION; MAINTENANCE; SPEED	Traumatic brain injury (TBI) can have devastating negative consequences on an individuals' ability to remember information; however, there is variability among memory impairment resulting from TBI. Some individuals exhibit long-term memory (LTM) impairment while others do not. This variability has been explained, at least in part, by the theory of cognitive reserve (CR). The theory suggests that individuals who have spent significant time engaged in intellectually enriching activities (higher CR) are better able to withstand LTM impairment despite neurological injury. The cognitive mechanisms that underlie this relationship are not well-specified. Recent evidence suggests that working memory (WM) capacity may be one mediating variable that can help explain how/why cognitive reserve (CR) protects against LTM impairment. The present research tested this hypothesis in a sample of fifty moderate to severe TBI patients. Specific neuropsychological tests were administered to estimate CR, LTM and WM. The results were congruent with a recent theoretical model that implicates WM capacity as a mediating variable in the relationship between CR and LTM (Sobel's Z = 2.62, p = 0.009). These data corroborate recent findings in an alternate neurological population and suggest that WM is an underlying mechanism of CR. Additional research is necessary to establish whether (1) WM is an important individual difference variable to include in memory rehabilitation trials and (2) to determine whether rehabilitation and treatment strategies that specifically target WM may also lead to complimentary improvements on diagnostic tests of delayed LTM in TBI and other memory impaired populations.	[Sandry, Joshua; DeLuca, John; Chiaravalloti, Nancy] Kessler Fdn, W Orange, NJ 07052 USA; [Sandry, Joshua; DeLuca, John; Chiaravalloti, Nancy] Rutgers New Jersey Med Sch, Dept Phys Med & Rehabil, Newark, NJ USA; [DeLuca, John] Rutgers New Jersey Med Sch, Dept Neurol & Neurosci, Newark, NJ USA	Sandry, J (corresponding author), Kessler Fdn, 300 Execut Dr,Suite 70, W Orange, NJ 07052 USA.	jsandry@kesslerfoundation.org		Chiaravalloti, Nancy/0000-0003-2943-7567	Northern NJ TBI Model Systems grant; US Department of Education-National Institute on Disability and Rehabilitation Research grant [H133P090009];  [H133A070037]	The authors wish to thank Dr. James F. Sumowski for helpful comments on an early draft of this manuscript. Study supported Northern NJ TBI Model Systems grant H133A070037 to NC. The contents of this article were also developed under the US Department of Education-National Institute on Disability and Rehabilitation Research grant H133P090009. However, the contents do not necessarily represent the policy of the Department of Education, and you should not assume endorsement by the Federal Government.	Akerlund E, 2013, BRAIN INJURY, V27, P1649, DOI 10.3109/02699052.2013.830195; Au J, 2015, PSYCHON B REV, V22, P366, DOI 10.3758/s13423-014-0699-x; Baddeley A., 1974, PSYCHOL LEARN MOTIV, P47, DOI [10.1016/s0079-7421(08)60452-1, DOI 10.1016/S0079-7421(08)60452-1]; Barulli D, 2013, TRENDS COGN SCI, V17, P502, DOI 10.1016/j.tics.2013.08.012; Berrigan LI, 2013, J INT NEUROPSYCH SOC, V19, P938, DOI 10.1017/S1355617713000696; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Constantinidou F, 2014, J INT NEUROPSYCH SOC, V20, P822, DOI 10.1017/S1355617714000678; Conway ARA, 2003, TRENDS COGN SCI, V7, P547, DOI 10.1016/j.tics.2003.10.005; Conway ARA, 2002, INTELLIGENCE, V30, P163, DOI 10.1016/S0160-2896(01)00096-4; Cowan N, 2005, PSYCHOLOGY; Cowan N, 2008, PROG BRAIN RES, V169, P323, DOI 10.1016/S0079-6123(07)00020-9; DeLuca J, 2004, J CLIN EXP NEUROPSYC, V26, P550, DOI 10.1080/13803390490496641; GRIGSBY J, 1994, J NEUROL, V241, P125; Harrison TL, 2013, PSYCHOL SCI; Hindle JV, 2014, PARKINSONISM RELAT D, V20, P1, DOI 10.1016/j.parkreldis.2013.08.010; Hoofien D, 2001, BRAIN INJURY, V15, P189; Levi Y, 2013, J INT NEUROPSYCH SOC, V19, P664, DOI 10.1017/S1355617713000192; McDowell S, 1997, NEUROPSYCHOLOGIA, V35, P1341, DOI 10.1016/S0028-3932(97)00082-1; McKinlay W, 1999, REHABILITATION ADULT, V3, P74; Melby-Lervag M, 2013, DEV PSYCHOL, V49, P270, DOI 10.1037/a0028228; Nunnari D, 2014, NEUROL SCI, P1; Oberauer K, 2009, PSYCHOL LEARN MOTIV, V51, P45, DOI 10.1016/S0079-7421(09)51002-X; Preacher KJ, 2007, MULTIVAR BEHAV RES, V42, P185, DOI 10.1080/00273170701341316; Richter KM, 2015, NEUROREHAB NEURAL RE, V29, P33, DOI 10.1177/1545968314527352; Robertson IH, 1999, CURR OPIN NEUROL, V12, P703, DOI 10.1097/00019052-199912000-00008; Sandry J, 2014, J INT NEUROPSYCH SOC, V20, P868, DOI 10.1017/S1355617714000630; Serino A, 2007, BRAIN INJURY, V21, P11, DOI 10.1080/02699050601151811; Shipstead Z, 2012, J APPL RES MEM COGN, V1, P185, DOI 10.1016/j.jarmac.2012.06.003; Shipstead Z, 2012, PSYCHOL BULL, V138, P628, DOI 10.1037/a0027473; Steffener J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091196; Stern Y, 2002, J INT NEUROPSYCH SOC, V8, P448, DOI 10.1017/S1355617702813248; Stern Y, 2012, LANCET NEUROL, V11, P1006, DOI 10.1016/S1474-4422(12)70191-6; Stern Y, 2009, NEUROPSYCHOLOGIA, V47, P2015, DOI 10.1016/j.neuropsychologia.2009.03.004; Sumowski JF, 2013, ARCH PHYS MED REHAB, V94, P2562, DOI 10.1016/j.apmr.2013.07.023; Sumowski JF, 2013, MULT SCLER J, V19, P1122, DOI 10.1177/1352458513498834; Sumowski JF, 2010, NEUROLOGY, V74, P1942, DOI 10.1212/WNL.0b013e3181e396be; Trafimow D, 2006, GENET SOC GEN PSYCH, V132, P215, DOI 10.3200/MONO.132.3.215-240; Trafimow D, 2011, J GEN PSYCHOL, V138, P201, DOI 10.1080/00221309.2011.584584; Unsworth N, 2007, PSYCHOL REV, V114, P104, DOI 10.1037/0033-295X.114.1.104; Unsworth N, 2014, COGNITIVE PSYCHOL, V71, P1, DOI 10.1016/j.cogpsych.2014.01.003; VANZOMEREN AH, 1985, J NEUROL NEUROSUR PS, V48, P21, DOI 10.1136/jnnp.48.1.21; Velikonja D, 2014, J HEAD TRAUMA REHAB, V29, P369, DOI 10.1097/HTR.0000000000000069; von Bastian CC, 2013, PSYCHOL RES, DOI [10.1007/s00426-013-0524-6, DOI 10.1007/S00426-013-0524-6]; Westerberg H, 2007, BRAIN INJURY, V21, P21, DOI 10.1080/02699050601148726	44	17	17	0	10	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0340-5354	1432-1459		J NEUROL	J. Neurol.	JAN	2015	262	1					59	64		10.1007/s00415-014-7523-4			6	Clinical Neurology	Neurosciences & Neurology	AZ4TM	WOS:000348216000007	25287019				2021-06-18	
J	Shapi'i, A; Zin, NAM; Elaklouk, AM				Shapi'i, Azrulhizam; Zin, Nor Azan Mat; Elaklouk, Ahmed Mohammed			A Game System for Cognitive Rehabilitation	BIOMED RESEARCH INTERNATIONAL			English	Article							BENEFITS	Brain injury such as traumatic brain injury (TBI) and stroke is the major cause of long-term disabilities in many countries. The increasing rate of brain damaged victims and the heterogeneity of impairments decrease rehabilitation effectiveness and competence resulting in higher cost of rehabilitation treatment. On the other hand, traditional rehabilitation exercises are boring, thus leading patients to neglect the prescribed exercises required for recovery. Therefore, we propose game-based approach to address these problems. This paper presents a rehabilitation gaming system (RGS) for cognitive rehabilitation. The RGS is developed based on a proposed conceptual framework which has also been presented in this paper.	[Shapi'i, Azrulhizam; Zin, Nor Azan Mat; Elaklouk, Ahmed Mohammed] UKM, Fac Informat Sci & Technol, Bangi 43600, Selangor, Malaysia	Shapi'i, A (corresponding author), UKM, Fac Informat Sci & Technol, Bangi 43600, Selangor, Malaysia.	azrul@ftsm.ukm.my	SHAPII, AZRULHIZAM/ABD-8856-2020; Zin, Nor Azan Mat/AAE-3363-2019	SHAPII, AZRULHIZAM/0000-0003-4274-5011; MatZin, Nor Azan/0000-0002-7274-7248			Alankus G, 2010, CHI2010: PROCEEDINGS OF THE 28TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, VOLS 1-4, P2113; Belchior P. D. C., 2007, THESIS U FLORIDA; Burdea GC, 2003, METHOD INFORM MED, V42, P519; Burke W., 2010, P 8 INT C DIS VIRT R; Doidge N, 2007, BRAIN CHANGES ITSELF; Elaklouk A., 2012, P 5 ANN INT C COMP G; Elaklouk A.M., 2012, GSTF J COMPUTING JOC, V2, P25; Elaklouk AM, 2013, LECT NOTES COMPUT SC, V8237, P218, DOI 10.1007/978-3-319-02958-0_21; Garris R., 2002, Simulation & Gaming, V33, P441, DOI 10.1177/1046878102238607; Karlsson P., 2010, P ARATA 2010 NAT C H; Koenig S., 2012, THESIS U CANTERBURY; Lopresti EF, 2008, IEEE ENG MED BIOL, V27, P29, DOI 10.1109/EMB.2007.907396; Maclean N, 2002, STROKE, V33, P444, DOI 10.1161/hs0202.102367; Mattheiss E., 2009, LERNEN DIGITALEN ZEI, P77; Panic A. S., 2010, THESIS DELFT U TECHN; Perry J. C., 2010, HDB RES IMPROVING LE, P683; Rosenbaum Peter, 2004, Semin Pediatr Neurol, V11, P5, DOI 10.1016/j.spen.2004.01.002; Scherer MJ, 2005, REHABIL PSYCHOL, V50, P132, DOI 10.1037/0090-5550.50.2.132; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Tam S., 2010, THESIS WASHINGTON U; Torrente J, 2012, LECT NOTES COMPUT SC, V7666, P603, DOI 10.1007/978-3-642-34478-7_73; Tsaousides T, 2009, MT SINAI J MED, V76, P173, DOI 10.1002/msj.20099	22	17	17	0	9	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	2314-6133	2314-6141		BIOMED RES INT	Biomed Res. Int.		2015	2015								493562	10.1155/2015/493562			7	Biotechnology & Applied Microbiology; Medicine, Research & Experimental	Biotechnology & Applied Microbiology; Research & Experimental Medicine	CD8VB	WOS:000351373400001	25815320	DOAJ Gold, Green Published			2021-06-18	
J	Yen, HC; Chen, TW; Yang, TC; Wei, HJ; Hsu, JC; Lin, CL				Yen, H. -C.; Chen, T. -W.; Yang, T-C.; Wei, H. -J.; Hsu, J. -C.; Lin, C. -L.			Levels of F-2-isoprostanes, F-4-neuroprostanes, and total nitrate/nitrite in plasma and cerebrospinal fluid of patients with traumatic brain injury	FREE RADICAL RESEARCH			English	Article						head injury; lipid peroxidation; sedative; outcome; nitric oxide	NITRIC-OXIDE; OXIDATIVE STRESS; LIPID-PEROXIDATION; HEAD-INJURY; SUBARACHNOID HEMORRHAGE; DOCOSAHEXAENOIC ACID; INTRALIPID INFUSION; MASS-SPECTROMETRY; PRACTICAL SCALE; IN-VIVO	Several events occurring during the secondary damage of traumatic brain injury (TBI) can cause oxidative stress. F-2-isoprostanes (F-2-IsoPs) and F-4-neuroprostanes (F-4-NPs) are specific lipid peroxidation markers generated from arachidonic acid and docosahexaenoic acid, respectively. In this study, we evaluated oxidative stress in patients with moderate and severe TBI. Since sedatives are routinely used to treat TBI patients and propofol has been considered an antioxidant, TBI patients were randomly treated with propofol or midazolam for 72 h postoperation. We postoperatively collected cerebrospinal fluid (CSF) and plasma from 15 TBI patients for 6-10 d and a single specimen of CSF or plasma from 11 controls. Compared with the controls, the TBI patients exhibited elevated levels of F-2-IsoPs and F-4-NPs in CSF throughout the postsurgery period regardless of the sedative used. Compared with the group of patients who received midazolam, those who received propofol exhibited markedly augmented levels of plasma F-2-IsoPs, which were associated with higher F-4-NPs levels and lower total nitrate/nitrite levels in CSF early in the postsurgery period. Furthermore, the higher CSF F-2-IsoPs levels correlated with 6-month and 12-month worse outcomes, which were graded according to the Glasgow Outcome Scale. The results demonstrate enhanced oxidative damage in the brain of TBI patients and the association of higher CSF levels of F-2-IsoPs with a poor outcome. Moreover, propofol treatment might promote lipid peroxidation in the circulation, despite possibly suppressing nitric oxide or peroxynitrite levels in CSF, because of the increased loading of the lipid components from the propofol infusion.	[Yen, H. -C.; Chen, T. -W.; Wei, H. -J.] Chang Gung Univ, Grad Inst, Coll Med, Taoyuan, Taiwan; [Yen, H. -C.; Chen, T. -W.; Wei, H. -J.] Chang Gung Univ, Dept Med Biotechnol & Lab Sci, Coll Med, Taoyuan, Taiwan; [Yang, T-C.; Lin, C. -L.] Chang Gung Mem Hosp, Dept Neurosurg, Taoyuan, Taiwan; [Yang, T-C.; Hsu, J. -C.; Lin, C. -L.] Chang Gung Univ, Taoyuan, Taiwan; [Hsu, J. -C.] Chang Gung Mem Hosp, Dept Anesthesiol, Taoyuan, Taiwan	Hsu, JC; Lin, CL (corresponding author), Chang Gung Mem Hosp, 5 Fu Shin St, Taoyuan 333, Taiwan.	hsujcs@cgmh.org.tw; 3480@adm.cgmh.org.tw		Lin, Chih-Lung/0000-0003-0649-4243	Ministry of Science and Technology, TaiwanMinistry of Science and Technology, Taiwan [NSC 98-2314-B-182A-041-MY2, NSC 97-2320-B-182-012-MY3, NSC 95-2314-B-182-050-MY2]; Chang Gung Memorial Hospital, TaiwanChang Gung Memorial Hospital [CMRPD1B0341]	This work was supported by grants (NSC 98-2314-B-182A-041-MY2 to Chih-Lung Lin, NSC 97-2320-B-182-012-MY3 to Hsiu-Chuan Yen, and NSC 95-2314-B-182-050-MY2 to Jee-Ching Hsu) from Ministry of Science and Technology (formerly known as National Science Council), Taiwan; and a grant from Chang Gung Memorial Hospital, Taiwan (CMRPD1B0341) to H.-C. Yen.	Arneson KO, 2007, METHOD ENZYMOL, V433, P127, DOI 10.1016/S0076-6879(07)33007-3; Ballester M, 2011, EUR J ANAESTH, V28, P874, DOI 10.1097/EJA.0b013e32834bea2a; Base S, 2011, PROSTAG LEUKOTR ESS, V84, P123, DOI 10.1016/j.plefa.2010.11.006; Basu S, 2001, RESUSCITATION, V50, P341, DOI 10.1016/S0300-9572(01)00351-3; Bayir H, 2004, J NEUROTRAUM, V21, P1, DOI 10.1089/089771504772695896; Bayir H, 2002, PEDIATR RES, V51, P571, DOI 10.1203/00006450-200205000-00005; Belik J, 2010, FREE RADICAL BIO MED, V48, P177, DOI 10.1016/j.freeradbiomed.2009.10.043; Chang EF, 2005, J CEREBR BLOOD F MET, V25, P1401, DOI 10.1038/sj.jcbfm.9600147; Chen TW, 2009, FREE RADICAL BIO MED, V47, pS108; Cherian L, 2004, BRAIN PATHOL, V14, P195, DOI 10.1111/j.1750-3639.2004.tb00053.x; Corcoran TB, 2011, ANTIOXID REDOX SIGN, V15, P2663, DOI 10.1089/ars.2011.4125; Cornelius C, 2013, ANTIOXID REDOX SIGN, V19, P836, DOI 10.1089/ars.2012.4981; Florian JP, 2010, EXP PHYSIOL, V95, P486, DOI 10.1113/expphysiol.2009.050997; Florian JP, 2010, CLIN SCI, V118, P61, DOI 10.1042/CS20090063; HELBOCK HJ, 1993, PEDIATRICS, V91, P83; Hlatky R, 2003, J CEREBR BLOOD F MET, V23, P582, DOI 10.1097/01.WCB.0000059586.71206.F3; Hsieh YP, 2009, FREE RADICAL BIO MED, V47, P814, DOI 10.1016/j.freeradbiomed.2009.06.026; JENNETT B, 1975, LANCET, V1, P480; Kandasamy R, 2013, INT J NEUROSCI, V123, P385, DOI 10.3109/00207454.2012.761983; Kasprzak HA, 2001, J NEUROTRAUM, V18, P793, DOI 10.1089/089771501316919157; Kessler U, 2005, PEDIATR SURG INT, V21, P197, DOI 10.1007/s00383-004-1319-z; Kirsch M, 2003, ARCH BIOCHEM BIOPHYS, V418, P133, DOI 10.1016/j.abb.2003.07.002; Kohnen SL, 2003, NITRIC OXIDE-BIOL CH, V8, P170, DOI 10.1016/S1089-8603(03)00013-2; Krogh-Madsen R, 2008, AM J PHYSIOL-ENDOC M, V294, pE371, DOI 10.1152/ajpendo.00507.2007; Lin CL, 2006, FREE RADICAL BIO MED, V40, P1466, DOI 10.1016/j.freeradbiomed.2005.12.019; Liu W, 2009, FREE RADICAL BIO MED, V47, P1101, DOI 10.1016/j.freeradbiomed.2009.07.028; Liu YC, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-8; Ma L, 2013, BRAZ J MED BIOL RES, V46, P299, DOI 10.1590/1414-431X20122379; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Marik PE, 2004, CURR PHARM DESIGN, V10, P3639, DOI 10.2174/1381612043382846; Milne GL, 2007, METHOD ENZYMOL, V433, P113, DOI 10.1016/S0076-6879(07)33006-1; Milne GL, 2013, FREE RADICAL BIO MED, V59, P36, DOI 10.1016/j.freeradbiomed.2012.09.030; Montuschi P, 2007, CURR MED CHEM, V14, P703, DOI 10.2174/092986707780059607; Morrow JD, 2006, CURR PHARM DESIGN, V12, P895, DOI 10.2174/138161206776055985; Mouithys-Mickalad A, 1998, BIOCHEM BIOPH RES CO, V249, P833, DOI 10.1006/bbrc.1998.9235; Nayak C, 2008, NEUROL RES, V30, P461, DOI 10.1179/016164107X251790; Nayak C, 2007, CLIN CHEM LAB MED, V45, P629, DOI 10.1515/CCLM.2007.123; O'Connell KM, 2013, BIOL RES NURS, V15, P253, DOI 10.1177/1099800411431823; Ozturk E, 2008, PROG NEURO-PSYCHOPH, V32, P81, DOI 10.1016/j.pnpbp.2007.07.016; Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006; Paolin A, 2002, NEUROSURGERY, V51, P949, DOI 10.1227/01.NEU.0000027881.33381.3F; Peng M, 2014, INFLAMM RES, V63, P411, DOI 10.1007/s00011-014-0713-9; Prasertsom W, 1996, ARCH DIS CHILD-FETAL, V74, pF95, DOI 10.1136/fn.74.2.F95; Roberts DJ, 2012, DRUGS, V72, P1881, DOI 10.2165/11636220-000000000-00000; Roberts LJ, 2004, CHEM PHYS LIPIDS, V128, P173, DOI 10.1016/j.chemphyslip.2003.09.016; Roberts LJ, 1998, J BIOL CHEM, V273, P13605, DOI 10.1074/jbc.273.22.13605; Roberts LJ, 2000, FREE RADICAL BIO MED, V28, P505, DOI 10.1016/S0891-5849(99)00264-6; Robertson CL, 2004, J BIOENERG BIOMEMBR, V36, P363, DOI 10.1023/B:JOBB.0000041769.06954.e4; Seifman MA, 2008, J CEREBR BLOOD F MET, V28, P684, DOI 10.1038/sj.jcbfm.9600603; Shiva S, 2013, REDOX BIOL, V1, P40, DOI 10.1016/j.redox.2012.11.005; Silvers KM, 2001, ACTA PAEDIATR, V90, P242, DOI 10.1080/080352501300067433; Stafforini DM, 2006, J BIOL CHEM, V281, P4616, DOI 10.1074/jbc.M507340200; TEASDALE G, 1974, LANCET, V2, P81; Tisdall MM, 2013, NEUROCRIT CARE, V19, P65, DOI 10.1007/s12028-011-9633-5; Urwin SC, 2004, DRUG SAFETY, V27, P107, DOI 10.2165/00002018-200427020-00003; Uzan M, 2001, SURG NEUROL, V56, P350, DOI 10.1016/S0090-3019(01)00633-4; Varma S, 2003, J NEUROTRAUM, V20, P781, DOI 10.1089/089771503767870005; Vasileiou I, 2009, EUR J PHARMACOL, V605, P1, DOI 10.1016/j.ejphar.2009.01.007; Weber JT, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00060; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Yen HC, 2015, FREE RADICAL RES, V49, P861, DOI 10.3109/10715762.2015.1014812; Yen HC, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/810915	62	17	17	0	4	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1071-5762	1029-2470		FREE RADICAL RES	Free Radic. Res.		2015	49	12					1419	1430		10.3109/10715762.2015.1080363			12	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	DD4KW	WOS:000369892800002	26271312				2021-06-18	
J	Pavlova, MA; Weber, S; Simoes, E; Sokolov, AN				Pavlova, Marina A.; Weber, Susanna; Simoes, Elisabeth; Sokolov, Alexander N.			Gender Stereotype Susceptibility	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; SEX-DIFFERENCES; DIAGNOSIS THREAT; TEST-PERFORMANCE; MENTAL ROTATION; COGNITIVE PERFORMANCE; MATH; WOMEN; IMPACT; AGE	Gender affects performance on a variety of cognitive tasks, and this impact may stem from socio-cultural factors such as gender stereotyping. Here we systematically manipulated gender stereotype messages on a social cognition task on which no initial gender gap has been documented. The outcome reveals: (i) Stereotyping affects both females and males, with a more pronounced impact on females. Yet an explicit negative message for males elicits a striking paradoxical deterioration in performance of females. (ii) Irrespective of gender and directness of message, valence of stereotype message affects performance: negative messages have stronger influence than positive ones. (iii) Directness of stereotype message differentially impacts performance of females and males: females tend to be stronger affected by implicit than explicit negative messages, whereas in males this relationship is opposite. The data are discussed in the light of neural networks underlying gender stereotyping. The findings provide novel insights into the sources of gender related fluctuations in cognition and behavior.	[Pavlova, Marina A.] Univ Tubingen, Dept Biomed Magnet Resonance, Sch Med, Tubingen, Germany; [Weber, Susanna] Univ Zurich, Dept Econ, Zurich, Switzerland; [Simoes, Elisabeth; Sokolov, Alexander N.] Univ Tubingen, Univ Hosp, Ctr Womens Hlth, Tubingen, Germany	Pavlova, MA (corresponding author), Univ Tubingen, Dept Biomed Magnet Resonance, Sch Med, Tubingen, Germany.	marina.pavlova@uni-tuebingen.de		Pavlova, Marina/0000-0001-8239-3589	Deutsche Forschungsgemeinschaft (DFG)German Research Foundation (DFG); Open Access Publishing Fund of Eberhard Karls University of Tubingen	We are grateful to the students of the University of Tubingen for participation and assistance with testing, Dr. Christel Bidet-Ildei, Dr. Arseny A. Sokolov, and Samuel Kruger for assistance and valuable comments, Franziska Hosl for administrative assistance, and Bernd Kardatzki for technical support. The authors acknowledge support toward open access publishing by Deutsche Forschungsgemeinschaft (DFG) and Open Access Publishing Fund of Eberhard Karls University of Tubingen.	Abrams D, 2006, PSYCHOL AGING, V21, P691, DOI 10.1037/0882-7974.21.4.691; Alaerts K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020989; Anderson LC, 2013, NEUROIMAGE, V83, P751, DOI 10.1016/j.neuroimage.2013.07.040; Aronson J, 1999, J EXP SOC PSYCHOL, V35, P29, DOI 10.1006/jesp.1998.1371; BARONCOHEN S, 1986, BRIT J DEV PSYCHOL, V4, P113, DOI 10.1111/j.2044-835X.1986.tb01003.x; Blaine H, 2013, J NEUROTRAUM, V30, P1405, DOI 10.1089/neu.2013.2865; Brownlow S, 2008, PERCEPT MOTOR SKILL, V107, P307, DOI 10.2466/PMS.107.1.307-316; Cadinu M, 2005, PSYCHOL SCI, V16, P572, DOI 10.1111/j.0956-7976.2005.01577.x; Cadinu M, 2003, EUR J SOC PSYCHOL, V33, P267, DOI 10.1002/ejsp.145; Cahill L, 2006, NAT REV NEUROSCI, V7, P477, DOI 10.1038/nrn1909; Cattaneo Z, 2011, NEUROIMAGE, V56, P1839, DOI 10.1016/j.neuroimage.2011.02.037; Chalabaev A, 2008, J SPORT EXERCISE PSY, V30, P143, DOI 10.1123/jsep.30.2.143; Cvencek D, 2014, J EXP CHILD PSYCHOL, V117, P73, DOI 10.1016/j.jecp.2013.07.018; Dunst B, 2013, PERS INDIV DIFFER, V55, P744, DOI 10.1016/j.paid.2013.06.007; Ford TE, 2004, PERS SOC PSYCHOL B, V30, P643, DOI 10.1177/0146167203262851; Good C, 2012, J PERS SOC PSYCHOL, V102, P700, DOI 10.1037/a0026659; Gustafsson E, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2713; Halim ML, 2013, BRIT J DEV PSYCHOL, V31, P128, DOI 10.1111/j.2044-835X.2012.02084.x; Hamilton Colin, 2008, COGNITION SEX DIFFER; Hartley BL, 2013, CHILD DEV, V84, P1716, DOI 10.1111/cdev.12079; Hausmann M, 2009, PSYCHONEUROENDOCRINO, V34, P389, DOI 10.1016/j.psyneuen.2008.09.019; Hess TM, 2004, PSYCHOL AGING, V19, P495, DOI 10.1037/0882-7974.19.3.495; Hess TM, 2003, J GERONTOL B-PSYCHOL, V58, pP3, DOI 10.1093/geronb/58.1.P3; Johns M, 2005, PSYCHOL SCI, V16, P175, DOI 10.1111/j.0956-7976.2005.00799.x; Kana RK, 2012, SOC COGN AFFECT NEUR, V7, P446, DOI 10.1093/scan/nsr022; Kit KA, 2008, NEUROPSYCHOL REV, V18, P132, DOI 10.1007/s11065-008-9059-9; Kit KA, 2014, J INT NEUROPSYCH SOC, V20, P157, DOI 10.1017/S1355617713001264; Kray LJ, 2001, J PERS SOC PSYCHOL, V80, P942, DOI 10.1037/0022-3514.80.6.942; Krendl AC, 2008, PSYCHOL SCI, V19, P168, DOI 10.1111/j.1467-9280.2008.02063.x; Kret ME, 2012, NEUROPSYCHOLOGIA, V50, P1211, DOI 10.1016/j.neuropsychologia.2011.12.022; Kret ME, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00003; Kruger S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081716; Leyens JP, 2000, PERS SOC PSYCHOL B, V26, P1189, DOI 10.1177/0146167200262002; Lippa RA, 2010, ARCH SEX BEHAV, V39, P990, DOI 10.1007/s10508-008-9460-8; Milne E, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-12-j0001.2001; Nguyen HHD, 2008, J APPL PSYCHOL, V93, P1314, DOI 10.1037/a0012702; Pavawalla SP, 2013, J INT NEUROPSYCH SOC, V19, P305, DOI 10.1017/S135561771200135X; Pavlova M, 2008, J COGNITIVE NEUROSCI, V20, P494, DOI 10.1162/jocn.2008.20034; Pavlova M, 2010, NEUROIMAGE, V50, P1327, DOI 10.1016/j.neuroimage.2009.12.096; Pavlova MA, 2015, CEREB CORTEX, V25, P3468, DOI 10.1093/cercor/bhu175; Pavlova MA, 2012, CEREB CORTEX, V22, P981, DOI 10.1093/cercor/bhr156; Pavlova MA, 2010, BRAIN RES, V1311, P81, DOI 10.1016/j.brainres.2009.11.046; Quadflieg S, 2009, J COGNITIVE NEUROSCI, V21, P1560, DOI 10.1162/jocn.2009.21091; Reuben E, 2014, P NATL ACAD SCI USA, V111, P4403, DOI 10.1073/pnas.1314788111; Rydell RJ, 2014, PERS SOC PSYCHOL B, V40, P377, DOI 10.1177/0146167213513475; Schmader T, 2002, J EXP SOC PSYCHOL, V38, P194, DOI 10.1006/jesp.2001.1500; Schmader T, 2008, PSYCHOL REV, V115, P336, DOI 10.1037/0033-295X.115.2.336; Seibt B, 2004, J PERS SOC PSYCHOL, V87, P38, DOI 10.1037/0022-3514.87.1.38; Shih M, 2002, J PERS SOC PSYCHOL, V83, P638, DOI 10.1037//0022-3514.83.3.638; Simoes E, 2013, GEBURTSH FRAUENHEILK, V73, P239, DOI 10.1055/s-0032-1328303; Sokolov AA, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00016; STEELE CM, 1995, J PERS SOC PSYCHOL, V69, P797, DOI 10.1037/0022-3514.69.5.797; Stone J, 1999, J PERS SOC PSYCHOL, V77, P1213, DOI 10.1037/0022-3514.77.6.1213; Suhr JA, 2005, J INT NEUROPSYCH SOC, V11, P23, DOI 10.1017/S1355617705050010; Suhr JA, 2002, J CLIN EXP NEUROPSYC, V24, P448, DOI 10.1076/jcen.24.4.448.1039; Vollm BA, 2006, NEUROIMAGE, V29, P90, DOI 10.1016/j.neuroimage.2005.07.022; Wechsler D, 1997, WECHSLER INTELLIGENZ; Wheeler SC, 2001, PSYCHOL BULL, V127, P797, DOI 10.1037//0033-2909.127.6.797; Wolbers T, 2010, TRENDS COGN SCI, V14, P138, DOI 10.1016/j.tics.2010.01.001; Wolf C, 2009, PSYCHOL RES, V74, P429; Wraga M, 2007, SOC COGN AFFECT NEUR, V2, P12, DOI 10.1093/scan/nsl041; Wraga M, 2006, PSYCHON B REV, V13, P813, DOI 10.3758/BF03194002; Yeung NCJ, 2008, ACCIDENT ANAL PREV, V40, P667, DOI 10.1016/j.aap.2007.09.003	63	17	17	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2014	9	12							e114802	10.1371/journal.pone.0114802			13	Multidisciplinary Sciences	Science & Technology - Other Topics	AX9IA	WOS:000347215600028	25517903	DOAJ Gold, Green Published			2021-06-18	
J	Andre-Obadia, N; Sauleau, P; Cheliout-Heraut, F; Convers, P; Debs, R; Eisermann, M; Gavaret, M; Isnard, J; Jung, J; Kaminska, A; Kubis, N; Lemesle, M; Maillard, L; Mazzola, L; Michel, V; Montavont, A; N'Guyen, S; Navarro, V; Parain, D; Perin, B; Rosenberg, SD; Sediri, H; Soufflet, C; Szurhaj, W; Taussig, D; Touzery-de Villepin, A; Vercueil, L; Lamblin, MD				Andre-Obadia, N.; Sauleau, P.; Cheliout-Heraut, F.; Convers, P.; Debs, R.; Eisermann, M.; Gavaret, M.; Isnard, J.; Jung, J.; Kaminska, A.; Kubis, N.; Lemesle, M.; Maillard, L.; Mazzola, L.; Michel, V.; Montavont, A.; N'Guyen, S.; Navarro, V.; Parain, D.; Perin, B.; Rosenberg, S. D.; Sediri, H.; Soufflet, C.; Szurhaj, W.; Taussig, D.; Touzery-de Villepin, A.; Vercueil, L.; Lamblin, M. D.			French Guidelines on electroencephalogram	NEUROPHYSIOLOGIE CLINIQUE-CLINICAL NEUROPHYSIOLOGY			French	Article						Guidelines; Electroencephalogram; Electroencephalography; Adult; Child; Neonatal care; Intensive care unit; Brain death; Epilepsy; Telemedicine; High-resolution electroencephalogram; Magnetoencephalogram; Video-EEG; Ambulatory EEG; Sleep-deprived EEG	INTENSIVE-CARE-UNIT; NONCONVULSIVE STATUS EPILEPTICUS; TERM VIDEO-EEG; TRAUMATIC BRAIN-INJURY; PSYCHOGENIC NONEPILEPTIC SEIZURES; NMDA-RECEPTOR ENCEPHALITIS; CRITICALLY-ILL PATIENTS; SLEEP-DEPRIVED EEG; QUALITY-STANDARDS-SUBCOMMITTEE; ANTIEPILEPTIC DRUG-WITHDRAWAL	Electroencephalography allows the functional analysis of electrical brain cortical activity and is the gold standard for analyzing electrophysiological processes involved in epilepsy but also in several other dysfunctions of the central nervous system. Morphological imaging yields complementary data, yet it cannot replace the essential functional analysis tool that is EEG. Furthermore, EEG has the great advantage of being non-invasive, easy to perform and allows control tests when follow-up is necessary, even at the patient's bedside. Faced with the advances in knowledge, techniques and indications, the Societe de Neurophysiologie Clinique de Longue Francaise (SNCLF) and the Ligue Francaise Contre l'Epilepsie (LFCE) found it necessary to provide an update on EEG recommendations. This article will review the methodology applied to this work, refine the various topics detailed in the following chapters. It will go over the summary of recommendations for each of these chapters and underline proposals for writing an EEG report. Some questions could not be answered by the review of the literature; in those cases, an expert advice was given by the working and reading groups in addition to the guidelines. (C) 2014 Elsevier Masson SAS. All rights reserved.	[Andre-Obadia, N.; Isnard, J.; Jung, J.; Montavont, A.] Hosp Civils Lyon, Hop Neurol P Wertheimer, Serv Neurophysiol & Epileptol, F-69677 Bron, France; [Mazzola, L.] Univ Lyon 1, CRNL, Equipe NeuroPain, Inserm U 1028, F-69677 Bron, France; [Sauleau, P.] Univ Rennes 1, Fac Med, EA Comportement & Noyaux Gris Cent 4712, F-35043 Rennes, France; [Sauleau, P.] CHU Rennes 2, Unite Explorat Fonct Neurol, F-35033 Rennes 9, France; [Cheliout-Heraut, F.] UVSQ, CHU Garches, Serv Physiol Explorat Fonct, F-92380 Garches, France; [Convers, P.] CHU St Etienne, Hop Nord, Serv Neurol, F-42055 St Etienne 2, France; [Convers, P.] UCB Lyon 1, UJM St Etienne, Inserm U1028, F-42055 St Etienne 2, France; [Debs, R.] CHU Toulouse, Serv Neurol, TSA 40031, F-31059 Toulouse 9, France; [Eisermann, M.; Kaminska, A.; Soufflet, C.] Hop Necker Enfants Malad, AP HP, Serv Explorat Fonct Neurol, F-75015 Paris, France; [Eisermann, M.; Kaminska, A.; Soufflet, C.] INSERM, U1129, Paris, France; [Eisermann, M.; Kaminska, A.; Soufflet, C.] Univ Paris 05, CEA, F-91191 Gif Sur Yvette, France; [Gavaret, M.] Hop La Timone, AP HM, Serv Neurophysiol Clin, F-13385 Marseille, France; [Gavaret, M.] Inst Neurosci Syst, Inserm UMR 1106, F-13385 Marseille 05, France; [Gavaret, M.] Aix Marseille Univ, Fac Med, F-13385 Marseille 5, France; [Jung, J.] CRNL, Equipe Brain Dynam & Cognit, Inserm U 1028, F-69677 Bron, France; [Jung, J.] Univ Lyon 1, F-69677 Bron, France; [Kubis, N.] Univ Paris Diderot, Sorbonne Paris Cite, Hop Lariboisiere, AP HP,Serv Physiol Clin Explorat Fonct, F-75010 Paris, France; [Kubis, N.] Hop Lariboisiere, Unite Inserm965 Paris 7, F-75475 Paris 10, France; [Lemesle, M.] CHU Dijon, Serv Neurophysiol Clin, F-21079 Dijon, France; [Maillard, L.] CHU Nancy, Serv Neurol, F-54000 Nancy, France; [Maillard, L.] CNRS, CRAN, UMR 7039, F-54506 Vandoeuvre Les Nancy, France; [Maillard, L.] Univ Lorraine, Fac Med, F-54505 Vandoeuvre Les Nancy, France; [Mazzola, L.] Hop Nord St Etienne, Serv Neurol, Unite Neurophysiol Clin, F-42055 St Etienne 2, France; [Michel, V.] CHU Bordeaux, EFSN, F-33076 Bordeaux, France; [Michel, V.] Univ Bordeaux, CNRS, IMN, UMR 3493, F-33076 Bordeaux, France; [Montavont, A.] HFME, Serv Epilepsie Sommeil & Explorat Fonct Neuropedi, F-69677 Bron, France; [N'Guyen, S.] CHU Angers, Unite Neurol Pediat, F-49100 Angers, France; [N'Guyen, S.] Univ Angers, LUNAM, LARIS EA 7315, F-49016 Angers, France; [Navarro, V.] Hop La Pitie Salpetriere, AP HP, Unite Epilepsie, F-75013 Paris, France; [Navarro, V.] Hop La Pitie Salpetriere, AP HP, Dept Clin Neurophysiol, F-75013 Paris, France; [Navarro, V.] Univ Paris 06, Ctr Rech, Inst Cerveau & Moelle Epiniere, CNRS,UMR 7225,Inserm UMR S975, F-75651 Paris 13, France; [Parain, D.] CHU Charles Nicolle, Serv Neurophysiol Clin, F-76031 Rouen, France; [Perin, B.] CHU Amiens, Serv Neurol, Serv Explorat Fonct Syst Nerveux, F-80054 Amiens 1, France; [Rosenberg, S. D.] CHU Clermont Ferrand, Hop Gabriel Montpied, Serv Neurol & Neurophysiol Clin, F-63000 Clermont Ferrand, France; [Rosenberg, S. D.] Univ Auvergne, IGCNC, EA 7282, UMR ISIT 6284, F-63001 Clermont Ferrand, France; [Sediri, H.; Lamblin, M. D.] CHRU, Hop Roger Salengro, Serv Neurophysiol clin, F-59037 Lille, France; [Szurhaj, W.] Univ Henri Warembourg, Fac Med, F-59045 Lille, France; [Taussig, D.] Fdn Adolphe De Rothschild, Serv Neurochirurg Pediat, F-75019 Paris, France; [Touzery-de Villepin, A.] Hop Arnaud De Villeneuve, Unite Neurophysiol Clin Enfant, F-34295 Montpellier, France; [Vercueil, L.] CHU Grenoble, EFSN, F-38043 Grenoble 09, France; [Vercueil, L.] Grenoble Inst Neurosciences, Unite Inserm U836 9, F-38043 Grenoble 09, France	Andre-Obadia, N (corresponding author), Hosp Civils Lyon, Hop Neurol P Wertheimer, Serv Neurophysiol & Epileptol, 59 Blvd Pinel, F-69677 Bron, France.	nathalie.obadia-andre@chu-lyon.fr	Sauleau, Paul/ABC-4459-2020; VERCUEIL, Laurent/AAN-2941-2021; Gavaret, Martine/AAT-1334-2020	VERCUEIL, Laurent/0000-0003-3323-0091; Gavaret, Martine/0000-0002-5790-2254; Kubis, Nathalie/0000-0002-9637-3682; Convers, Philippe/0000-0003-4672-5819; Szurhaj, William/0000-0003-4112-3691; Andre-Obadia, Nathalie/0000-0002-0940-7224; Navarro, Vincent/0000-0003-0077-8114; Kaminska, Anna/0000-0003-3805-6651			Abend NS, 2011, NEUROLOGY, V76, P1071, DOI 10.1212/WNL.0b013e318211c19e; Abend NS, 2009, NEUROLOGY, V72, P1931, DOI 10.1212/WNL.0b013e3181a82687; Abend NS, 2013, LANCET NEUROL, V12, P1170, DOI 10.1016/S1474-4422(13)70246-1; Abend NS, 2013, NEUROLOGY, V81, P383, DOI 10.1212/WNL.0b013e31829c5cfe; Abend NS, 2011, J PEDIATR-US, V159, P479, DOI 10.1016/j.jpeds.2011.02.004; Absalom AR, 2009, CRIT CARE, V13, DOI 10.1186/cc7776; Abubakr A, 2005, EPILEPSY BEHAV, V7, P447, DOI 10.1016/j.yebeh.2005.06.012; Abubakr A, 2005, EPILEPSY BEHAV, V6, P433, DOI 10.1016/j.yebeh.2005.01.003; Abubakr A, 2010, J CLIN NEUROSCI, V17, P1503, DOI 10.1016/j.jocn.2009.12.037; Ahmad S A Bazir, 2011, Pract Neurol, V11, P355, DOI 10.1136/practneurol-2011-000084; Airoldi L, 1999, J CLIN NEUROPHYSIOL, V16, P456, DOI 10.1097/00004691-199909000-00007; Alsaadi TM, 2004, SEIZURE-EUR J EPILEP, V13, P32, DOI 10.1016/S1059-1311(03)00072-4; Alvarez V, 2013, CRIT CARE, V17, DOI 10.1186/cc12879; Alving J, 2009, SEIZURE-EUR J EPILEP, V18, P470, DOI 10.1016/j.seizure.2009.04.005; Amantini A, 2012, MINERVA ANESTESIOL, V78, P1067; American Academy of Pediatrics Subcommittee on Febrile Seizures, 2011, PEDIATRICS, P389; American Clinical Neurophysiology Society, 2006, Am J Electroneurodiagnostic Technol, V46, P211; American Clinical Neurophysiology Society, 2006, Am J Electroneurodiagnostic Technol, V46, P205; American Clinical Neurophysiology Society, 2006, Am J Electroneurodiagnostic Technol, V46, P198; American Electroencephalographic Society, 1994, J CLIN NEUROPHYSIOL, V11, P30; American Electroencephalographic Society, 1994, J CLIN NEUROPHYSIOL, V11, P14; Angeleri F, 1975, SLEEP 1974, P196; ANNEGERS JF, 1980, NEUROLOGY, V30, P683, DOI 10.1212/WNL.30.7.683; ANNEGERS JF, 1986, EPILEPSIA, V27, P43, DOI 10.1111/j.1528-1157.1986.tb03499.x; [Anonymous], 1994, J Clin Neurophysiol, V11, P111; [Anonymous], 1994, J Clin Neurophysiol, V11, P2; [Anonymous], 2004, C CONS; [Anonymous], 1998, TOURS NEUROPHYSIOLOG, P103; Appleton RE, 2012, ARCH DIS CHILD, V97, P1073, DOI 10.1136/archdischild-2012-302822; Arain AM, 2011, EPILEPSY BEHAV, V21, P364, DOI 10.1016/j.yebeh.2011.06.003; Arain AM, 2009, J CLIN NEUROPHYSIOL, V26, P17, DOI 10.1097/WNP.0b013e3181969032; Arango JI, 2012, CHILD NERV SYST, V28, P1925, DOI 10.1007/s00381-012-1863-0; Arciniegas DB, 2011, INT J PSYCHOPHYSIOL, V82, P41, DOI 10.1016/j.ijpsycho.2011.03.004; Armelisasso C, 2004, CLIN EEG NEUROSCI, V35, P97, DOI 10.1177/155005940403500209; Arndt DH, 2013, EPILEPSIA, V54, P1780, DOI 10.1111/epi.12369; Arya R, 2013, EPILEPSIA, V54, P828, DOI 10.1111/epi.12073; Asano E, 2005, EPILEPSY RES, V66, P129, DOI 10.1016/j.eplepsyres.2005.07.012; Ashwal S, 1997, CLIN PERINATOL, V24, P859; Ashwal S, 2004, NEUROLOGY, V62, P851, DOI 10.1212/01.WNL.0000117981.35364.1B; Atkinson M, 2012, SEIZURE-EUR J EPILEP, V21, P124, DOI 10.1016/j.seizure.2011.10.004; Attarian H, 2003, NEUROLOGY, V61, P402, DOI 10.1212/01.WNL.0000073138.94582.7E; Badawy RAB, 2011, CLIN NEUROPHYSIOL, V122, P1086, DOI 10.1016/j.clinph.2010.10.048; Bagic AI, 2011, J CLIN NEUROPHYSIOL, V28; Bagic AI, 2011, J CLIN NEUROPHYSIOL, V28, P348, DOI 10.1097/WNP.0b013e3182272fed; Baheti NN, 2011, EPILEPSY RES, V97, P12, DOI 10.1016/j.eplepsyres.2011.06.014; Bancaud J, 1969, Rev Otoneuroophtalmol, V41, P299; Bancaud J., 1965, STEREOENCEPHALOGRAPH; Barber PA, 2000, ACTA NEUROL SCAND, V101, P53, DOI 10.1034/j.1600-0404.2000.00006.x; Barkley GL, 2004, CLIN NEUROPHYSIOL, V115, P1001, DOI 10.1016/j.clinph.2003.12.011; Bartolomei F, 2004, REV NEUROL-FRANCE, V160, pS81; Battaglia A, 1999, AM J MED GENET, V82, P60, DOI 10.1002/(SICI)1096-8628(19990101)82:1<60::AID-AJMG12>3.3.CO;2-W; Bauer G, 2005, ELECTROENCEPHALOGRAP, P701; Baumgartner C, 2004, CLIN NEUROPHYSIOL, V115, P1010, DOI 10.1016/j.clinph.2003.12.010; BAZIL CW, 1994, EPILEPSIA, V35, P768, DOI 10.1111/j.1528-1157.1994.tb02509.x; Beghi E, 2013, EPILEPSIA, V54, P2, DOI 10.1111/epi.12305; Benbadis SR, 2009, NEUROLOGY, V73, P843, DOI 10.1212/WNL.0b013e3181b78425; Benbadis Selim R, 2007, Pract Neurol, V7, P323, DOI 10.1136/jnnp.2007.124370; Benbadis SR, 2004, EPILEPSIA, V45, P1150, DOI 10.1111/j.0013-9580.2004.14504.x; Berg AT, 2012, EPILEPSY BEHAV, V23, P193, DOI 10.1016/j.yebeh.2012.01.015; Berg AT, 1996, EPILEPSIA, V37, P24, DOI 10.1111/j.1528-1157.1996.tb00507.x; BERG AT, 1991, NEUROLOGY, V41, P965, DOI 10.1212/WNL.41.7.965; Berg AT, 2001, NEUROLOGY, V56, P1445, DOI 10.1212/WNL.56.11.1445; BERGONZI P, 1972, Rivista di Neurologia, V42, P506; Bernier GP, 1987, COMMENTARY INTRACRAN, P323; Bhatia M, 1996, J Assoc Physicians India, V44, P393; BICKFORD RG, 1955, J CLIN INVEST, V34, P790, DOI 10.1172/JCI103134; Billard C, 2010, ARCH PEDIATRIE, V17, P350, DOI 10.1016/j.arcped.2010.01.012; Binnie C, 2005, TECHNIQUES CLIN NEUR, P267; Binnie CD, 1999, CLIN NEUROPHYSIOL, V110, P1671, DOI 10.1016/S1388-2457(99)00125-X; Bleck Thomas P, 2012, Continuum (Minneap Minn), V18, P560, DOI 10.1212/01.CON.0000415428.61277.90; BLUME WT, 1991, ANN NEUROL, V29, P638, DOI 10.1002/ana.410290611; Blume WT, 1996, ADV NEUROL, V70, P309; Bonanni L, 2008, BRAIN, V131, P690, DOI 10.1093/brain/awm322; Bonkowsky JL, 2009, J CHILD NEUROL, V24, P709, DOI 10.1177/0883073808329532; BOON P, 1994, EUR NEUROL, V34, P33, DOI 10.1159/000119507; BORA I, 1995, J NEUROL, V242, P157, DOI 10.1007/BF00936889; BORTONE E, 1994, ELECTROEN CLIN NEURO, V90, P323, DOI 10.1016/0013-4694(94)90048-5; Bottaro FJ, 2007, EPILEPSIA, V48, P966, DOI 10.1111/j.1528-1167.2007.01033.x; Bouet R, 2012, NEUROIMAGE, V59, P3955, DOI 10.1016/j.neuroimage.2011.10.052; Boulanger JM, 2006, CAN J NEUROL SCI, V33, P175, DOI 10.1017/S0317167100004935; Boulard G, 2005, Ann Fr Anesth Reanim, V24, P836, DOI 10.1016/j.annfar.2005.05.020; Bourez-Swart MD, 2009, CLIN NEUROPHYSIOL, V120, P1916, DOI 10.1016/j.clinph.2009.08.015; Brand DA, 2005, PEDIATRICS, V115, P885, DOI 10.1542/peds.2004-0847; Breen P, 2010, BMC MED INFORM DECIS, V10, DOI 10.1186/1472-6947-10-49; Bricolo A, 1990, HDB CLIN NEUROLOGY, P193; BRIDGERS SL, 1985, NEUROLOGY, V35, P1767, DOI 10.1212/WNL.35.12.1767; BRIDGERS SL, 1985, NEUROLOGY, V35, P166, DOI 10.1212/WNL.35.2.166; Briel RCG, 1999, J NEUROL NEUROSUR PS, V66, P401, DOI 10.1136/jnnp.66.3.401; Brodbeck V, 2011, BRAIN, V134, P2887, DOI 10.1093/brain/awr243; Bruce DA, 2000, CHILD NERV SYST, V16, P724, DOI 10.1007/s003810000336; BUCHNER H, 1990, EUR NEUROL, V30, P138, DOI 10.1159/000117330; Burgess RC, 2011, J CLIN NEUROPHYSIOL, V28, P355, DOI 10.1097/WNP.0b013e3182272ffe; Bussiere M, 2005, NEUROCRIT CARE, V2, P29, DOI 10.1385/NCC:2:1:029; Butler CR, 2008, BRAIN, V131, P2243, DOI 10.1093/brain/awn127; Buzea C E, 1995, J Neurosci Nurs, V27, P292; CALLAGHAN N, 1988, NEW ENGL J MED, V318, P942, DOI 10.1056/NEJM198804143181502; Cambier DM, 2001, ACTA NEUROL SCAND, V103, P231, DOI 10.1034/j.1600-0404.2001.d01-26.x; Camfield PR, 1996, EPILEPSIA, V37, pS60, DOI 10.1111/j.1528-1157.1996.tb06023.x; Campos C, 2012, INT J MED INFORM, V81, P404, DOI 10.1016/j.ijmedinf.2012.01.006; Cardinale F, 2013, NEUROSURGERY, V72, P353, DOI 10.1227/NEU.0b013e31827d1161; Carpay JA, 1997, EPILEPSIA, V38, P595, DOI 10.1111/j.1528-1157.1997.tb01145.x; Carrette E, 2011, SEIZURE-EUR J EPILEP, V20, P414, DOI 10.1016/j.seizure.2011.01.015; Cascino GD, 2002, EPILEPSIA, V43, P80, DOI 10.1046/j.1528-1157.43.s.3.14.x; Casetta I, 1999, ACTA NEUROL SCAND, V99, P329, DOI 10.1111/j.1600-0404.1999.tb07360.x; Catenoix H, 2008, NEUROLOGY, V71, P1719, DOI 10.1212/01.wnl.0000335166.20451.88; CAVAZZUTI GB, 1980, EPILEPSIA, V21, P43, DOI 10.1111/j.1528-1157.1980.tb04043.x; CHADWICK D, 1993, BRIT MED J, V306, P1374; Chan D, 2004, NEUROLOGY, V62, P1628, DOI 10.1212/01.WNL.0000123103.89419.B7; Chang BS, 2002, J CLIN NEUROPHYSIOL, V19, P152, DOI 10.1097/00004691-200203000-00006; Chassoux F, 2000, BRAIN, V123, P1733, DOI 10.1093/brain/123.8.1733; Chemmanam T, 2009, J CLIN NEUROPHYSIOL, V26, P123, DOI 10.1097/WNP.0b013e31819d8030; CHEN LS, 1995, PEDIATR NEUROL, V12, P220, DOI 10.1016/0887-8994(95)00021-7; Cheron G, 2004, ARCH PEDIATRIE, V11, P692, DOI 10.1016/j.arcped.2004.03.052; CILLESSEN JPM, 1994, STROKE, V25, P1968, DOI 10.1161/01.STR.25.10.1968; Claassen J, 2007, NEUROLOGY, V69, P1356, DOI 10.1212/01.wnl.0000281664.02615.6c; Claassen J, 2006, NEUROCRIT CARE, V4, P103, DOI 10.1385/NCC:4:2:103; Claassen J, 2005, J CLIN NEUROPHYSIOL, V22, P92, DOI 10.1097/01.WNP.0000145006.02048.3A; Claassen J, 2004, CLIN NEUROPHYSIOL, V115, P2699, DOI 10.1016/j.clinph.2004.06.017; Claassen J, 2004, NEUROLOGY, V62, P1743, DOI 10.1212/01.WNL.0000125184.88797.62; Claassen J, 2013, INTENS CARE MED, V39, P1337, DOI 10.1007/s00134-013-2938-4; Claus JJ, 1999, CLIN NEUROPHYSIOL, V110, P825, DOI 10.1016/S1388-2457(98)00076-5; CLELAND PG, 1981, BRIT MED J, V283, P1364, DOI 10.1136/bmj.283.6303.1364; Clinique Bdlsdn, 1989, NEUROPHYSIOL CLIN, V19, P339; Coates S, 2012, J TELEMED TELECARE, V18, P243, DOI 10.1258/jtt.2012.111003; COHEN D, 1968, SCIENCE, V161, P784, DOI 10.1126/science.161.3843.784; Cohen D, 1989, ELECTROENCEPHALOGRAM; Cokar O, 2004, SEIZURE-EUR J EPILEP, V13, P264, DOI 10.1016/S1059-1311(03)00155-9; Collins SJ, 2006, BRAIN, V129, P2278, DOI 10.1093/brain/awl159; COSELLI JS, 1988, ANN THORAC SURG, V45, P638, DOI 10.1016/S0003-4975(10)64766-2; Cossu M, 2005, NEUROSURGERY, V57, P706, DOI 10.1227/01.NEU.0000176656.33523.1e; Cossu M, 2014, J NEUROL NEUROSUR PS, V85, P611, DOI 10.1136/jnnp-2013-305514; Cottenceau V, 2008, ANESTH ANALG, V107, P1676, DOI 10.1213/ane.0b013e318184e9ab; COURJON J, 1970, EPILEPSIA, V11, P29, DOI 10.1111/j.1528-1157.1970.tb03863.x; Courjon JSE, 1972, HDB ELECTROENCEPHALO, V14B, P1; Crepeau AZ, 2014, RESUSCITATION, V85, P785, DOI 10.1016/j.resuscitation.2014.01.019; Crepeau AZ, 2013, NEUROLOGY, V80, P339, DOI 10.1212/WNL.0b013e31827f089d; Crespel A, 2004, EPILEPSIES, P121; Cross JH, 2006, EPILEPSIA, V47, P952, DOI 10.1111/j.1528-1167.2006.00569.x; Curzi-Dacalova L, 1996, MANUEL TECHNIQUES EN; da Conceicao PO, 2012, SEIZURE-EUR J EPILEP, V21, P583, DOI 10.1016/j.seizure.2012.06.002; da Silva A M, 1992, Acta Neurochir Suppl (Wien), V55, P56; Dalmagro CL, 2005, EPILEPSIA, V46, P1442, DOI 10.1111/j.1528-1167.2005.70904.x; Dalmau J, 2004, BRAIN, V127, P1831, DOI 10.1093/brain/awh203; Dalmau J, 2008, LANCET NEUROL, V7, P1091, DOI 10.1016/S1474-4422(08)70224-2; DANZL DF, 1994, NEW ENGL J MED, V331, P1756, DOI 10.1056/NEJM199412293312607; Das RR, 2009, NEUROCRIT CARE, V10, P368, DOI 10.1007/s12028-008-9142-3; Dash D, 2012, EPILEPTIC DISORD, V14, P290, DOI 10.1684/epd.2012.0529; DAVIS TL, 1990, ARCH INTERN MED, V150, P2027, DOI 10.1001/archinte.150.10.2027; de Almeida AN, 2006, J NEUROSURG, V104, P483, DOI 10.3171/jns.2006.104.4.483; De Deyne C, 1998, INTENS CARE MED, V24, P1294, DOI 10.1007/s001340050765; De Jonghe B, 2008, ANN FR ANESTH, V27, P641, DOI 10.1016/j.annfar.2008.05.003; De Jonghe B, 2005, CRIT CARE MED, V33, P120, DOI 10.1097/01.CCM.0000150268.04228.68; De Jonghe B, 2000, INTENS CARE MED, V26, P275, DOI 10.1007/s001340051150; de Toffol B, 1997, NEUROPHYSIOL CLIN, V27, P383, DOI 10.1016/S0987-7053(97)88804-1; DEGEN R, 1987, EUR NEUROL, V26, P51, DOI 10.1159/000116312; DEGEN R, 1991, EPILEPSIA, V32, P515, DOI 10.1111/j.1528-1157.1991.tb04686.x; Del Felice A, 2011, EPILEPSY RES, V96, P123, DOI 10.1016/j.eplepsyres.2011.05.015; DeLorenzo RJ, 1998, EPILEPSIA, V39, P833, DOI 10.1111/j.1528-1157.1998.tb01177.x; Derambure P, 2001, EVALUATION NEUROPHYS, P271; DeRoos ST, 2009, PEDIATRICS, V123, P703, DOI 10.1542/peds.2008-0357; Deuschl G, 2002, GUIDE PRATIQUE NEURO; Di Gennaro G, 2012, CLIN NEUROPHYSIOL, V123, P486, DOI 10.1016/j.clinph.2011.08.011; Dike GL, 1997, J NEUROL NEUROSUR PS, V62, P200, DOI 10.1136/jnnp.62.2.200; Dobesberger J, 2011, EPILEPSIA, V52, P443, DOI 10.1111/j.1528-1167.2010.02782.x; Doi M, 2005, INTENS CARE MED, V31, P41, DOI 10.1007/s00134-004-2516-x; DOPPELBAUER A, 1993, ACTA NEUROL SCAND, V87, P345; Dreyfus-Brissac C, 1979, PERINATAL MED, P379; DUCHOWNY M, 1992, J CHILD NEUROL, V7, P66, DOI 10.1177/088307389200700112; Dunand AC, 2002, NEUROPHYSIOL CLIN, V32, P2, DOI 10.1016/S0987-7053(01)00288-X; DUNCAN JS, 1987, EPILEPSIA, V28, P259, DOI 10.1111/j.1528-1157.1987.tb04216.x; Durand G, 1994, EPIDEMIOLOGIE ETIOLO; EBERSOLE JS, 1983, NEUROLOGY, V33, P853, DOI 10.1212/WNL.33.7.853; Eisenschenk S, 2001, CLIN NEUROPHYSIOL, V112, P836, DOI 10.1016/S1388-2457(01)00517-X; Eisermann M, 2010, NEUROPEDIATRICS, V41, P163, DOI 10.1055/s-0030-1267920; ELAD B, 1994, ELECTROEN CLIN NEURO, V90, P313, DOI 10.1016/0013-4694(94)90150-3; Eleftheriadis N, 2003, ACTA NEUROL SCAND, V107, P142, DOI 10.1034/j.1600-0404.2003.02092.x; Elgavish RA, 2011, J CLIN NEUROPHYSIOL, V28, P311, DOI 10.1097/WNP.0b013e31821c3aa9; Elger CE, 2000, EPILEPSIA, V41, pS9; Eliashiv DS, 2002, NEUROLOGY, V59, P1600, DOI 10.1212/01.WNL.0000032493.83875.0B; ELLINGSON RJ, 1984, J CLIN NEUROPHYSIOL, V1, P83, DOI 10.1097/00004691-198401000-00005; ENGEL J, 1993, ELECTROEN CLIN NEURO, V87, P437, DOI 10.1016/0013-4694(93)90158-R; FAGAN KJ, 1990, NEUROLOGY, V40, P1689, DOI 10.1212/WNL.40.11.1689; Falco C, 2005, CLIN NEUROPHYSIOL, V116, P1771, DOI 10.1016/j.clinph.2005.04.012; Farias ST, 2003, EPILEPSY BEHAV, V4, P424, DOI 10.1016/S1525-5050(03)00143-4; Fattouch J, 2012, EPILEPSY BEHAV, V25, P32, DOI 10.1016/j.yebeh.2012.07.001; Faulkner HJ, 2012, CLIN NEUROPHYSIOL, V123, P1732, DOI 10.1016/j.clinph.2012.01.023; Faulkner HJ, 2012, SEIZURE-EUR J EPILEP, V21, P491, DOI 10.1016/j.seizure.2012.04.015; Feyissa AM, 2014, J NEUROL SCI, V336, P109, DOI 10.1016/j.jns.2013.10.018; Ficker DM, 1997, J CLIN NEUROPHYSIOL, V14, P230, DOI 10.1097/00004691-199705000-00008; Finocchi C, 1996, ITAL J NEUROL SCI, V17, P341, DOI 10.1007/BF01999896; Fischer C, 1997, NEUROPHYSIOL CLIN, V27, P373, DOI 10.1016/S0987-7053(97)88803-X; Fisher RS, 2014, EPILEPSIA, V55, P475, DOI 10.1111/epi.12550; Fitch K, 2001, RANDUCLA APPROPRIATE; Fitzsimons M, 2000, J CLIN NEUROPHYSIOL, V17, P59, DOI 10.1097/00004691-200001000-00006; Flink R, 2002, ACTA NEUROL SCAND, V106, P1, DOI 10.1034/j.1600-0404.2002.01361.x; Fohlen M, 2008, NEUROCHIRURGIE, V54, P347, DOI 10.1016/j.neuchi.2008.02.050; Fohlen M, 2004, NEUROPEDIATRICS, V35, P336, DOI 10.1055/s-2004-830410; Foley CM, 2000, J CHILD NEUROL, V15, P49, DOI 10.1177/088307380001500111; Fountain NB, 2001, J CLIN NEUROPHYSIOL, V18, P345, DOI 10.1097/00004691-200107000-00006; Fountain NB, 1998, J CLIN NEUROPHYSIOL, V15, P69, DOI 10.1097/00004691-199801000-00009; Fountas KN, 2004, STEREOT FUNCT NEUROS, V82, P165, DOI 10.1159/000081881; Frenzel D, 2002, INTENS CARE MED, V28, P178, DOI 10.1007/s00134-001-1183-4; Freye Enno, 2005, J Clin Monit Comput, V19, P1, DOI 10.1007/s10877-005-0712-z; Friedman D, 2009, ANESTH ANALG, V109, P506, DOI 10.1213/ane.0b013e3181a9d8b5; Friedman DE, 2009, J CLIN NEUROPHYSIOL, V26, P213, DOI 10.1097/WNP.0b013e3181b2f2da; Gaetz M, 2001, J HEAD TRAUMA REHAB, V16, P386, DOI 10.1097/00001199-200108000-00008; Gambardella A, 1996, ELECTROEN CLIN NEURO, V98, P243, DOI 10.1016/0013-4694(95)00266-9; Gandelman-Marton R, 2011, ACTA NEUROL SCAND, V124, P202, DOI 10.1111/j.1600-0404.2010.01453.x; GANJI S, 1993, CLIN ELECTROENCEPHAL, V24, P44, DOI 10.1177/155005949302400110; Garcia-Larrea L., 1993, Neurophysiologie Clinique, V23, P141; GASTAUT HJ, 1954, ELECTROEN CLIN NEURO, V6, P433, DOI 10.1016/0013-4694(54)90058-9; Gavaret M, 2008, NEUROCHIRURGIE, V54, P185, DOI 10.1016/j.neuchi.2008.02.014; Gavaret M, 2004, J CLIN NEUROPHYSIOL, V21, P267, DOI 10.1097/01.WNP.0000139929.06455.82; Gavaret M, 2006, J CLIN NEUROPHYSIOL, V23, P358, DOI 10.1097/01.wnp.0000214588.94843.c2; Gawel M, 2007, J NEUROL SCI, V257, P11, DOI 10.1016/j.jns.2007.01.046; Geets W, 1983, Rev Electroencephalogr Neurophysiol Clin, V13, P253, DOI 10.1016/S0370-4475(83)80036-7; Genow A, 2004, NEUROIMAGE, V21, P444, DOI 10.1016/j.neuroimage.2003.08.029; Gerstner T, 2006, SEIZURE-EUR J EPILEP, V15, P443, DOI 10.1016/j.seizure.2006.05.007; Ghougassian DF, 2004, EPILEPSIA, V45, P928, DOI 10.1111/j.0013-9580.2004.51003.x; Giorgi FS, 2013, CLIN NEUROPHYSIOL, V124, P2101, DOI 10.1016/j.clinph.2013.04.342; Gitiaux C, 2013, CLIN NEUROPHYSIOL, V124, P2354, DOI 10.1016/j.clinph.2013.05.023; Gold JJ, 2014, PEDIATR NEUROL, V50, P318, DOI 10.1016/j.pediatrneurol.2013.12.014; Goldenholz DM, 2009, HUM BRAIN MAPP, V30, P1077, DOI 10.1002/hbm.20571; Gonzalez-Martinez J, 2013, EPILEPSIA, V54, P323, DOI 10.1111/j.1528-1167.2012.03672.x; Granerod J, 2010, LANCET INFECT DIS, V10, P835, DOI 10.1016/S1473-3099(10)70222-X; GREGORY RP, 1993, ELECTROEN CLIN NEURO, V86, P75, DOI 10.1016/0013-4694(93)90069-8; GRIGG MM, 1987, ARCH NEUROL-CHICAGO, V44, P948, DOI 10.1001/archneur.1987.00520210048018; GRONSETH GS, 1995, NEUROLOGY, V45, P1263, DOI 10.1212/WNL.45.7.1263; Gross J, 2013, NEUROIMAGE, V65, P349, DOI 10.1016/j.neuroimage.2012.10.001; Gueguen B, 1998, NEUROPHYSIOL CLIN, V28, P134, DOI 10.1016/S0987-7053(98)80024-5; Guellerin J, 2012, J CLIN NEUROPHYSIOL, V29, P160, DOI 10.1097/WNP.0b013e31824d949f; Guenot M, 2004, EPILEPSIA, V45, P1368, DOI 10.1111/j.0013-9580.2004.17704.x; Guenot M, 2011, ADV TECH STAND NEURO, V36, P61, DOI 10.1007/978-3-7091-0179-7_4; Guenot M, 2001, STEREOT FUNCT NEUROS, V77, P29, DOI 10.1159/000064595; Guerit JM, 2009, NEUROPHYSIOL CLIN, V39, P71, DOI 10.1016/j.neucli.2009.03.002; Guerit JM, 2009, LIVER INT, V29, P789, DOI 10.1111/j.1478-3231.2009.02030.x; Guerit JM, 2004, ANN FR ANESTH, V23, P99, DOI 10.1016/j.annfar.2004.01.002; Guerit JM, 2002, GUIDE PRATIQUE NEURO; Guerreiro CAM, 2002, J CLIN NEUROPHYSIOL, V19, P204, DOI 10.1097/00004691-200206000-00003; Hader WJ, 2013, EPILEPSIA, V54, P840, DOI 10.1111/epi.12161; HAMALAINEN MS, 1989, IEEE T BIO-MED ENG, V36, P165, DOI 10.1109/10.16463; Hamelin S, 2004, REV NEUROL S4, V18; Hamelin S, 2005, EPILEPSIES, V17, P64; Hasbani DM, 2013, PEDIATR CRIT CARE ME, V14, P709, DOI 10.1097/PCC.0b013e3182917b83; Haseeb A, 2007, EPILEPSY RES, V76, P131, DOI 10.1016/j.eplepsyres.2007.07.007; Haupt WF, 1999, J NEUROL, V246, P432, DOI 10.1007/s004150050378; Hauser WA, 1998, NEW ENGL J MED, V338, P429, DOI 10.1056/NEJM199802123380704; HAUSER WA, 1990, NEUROLOGY, V40, P1163, DOI 10.1212/WNL.40.8.1163; Haut SR, 2002, EPILEPSIA, V43, P711, DOI 10.1046/j.1528-1157.2002.26401.x; Heers M, 2010, SEIZURE-EUR J EPILEP, V19, P397, DOI 10.1016/j.seizure.2010.06.004; Hellstrom-Westas L, 2006, SEMIN FETAL NEONAT M, V11, P503, DOI 10.1016/j.siny.2006.07.011; HELLSTROMWESTAS L, 1995, ARCH DIS CHILD-FETAL, V72, pF97, DOI 10.1136/fn.72.2.F97; HELLSTROMWESTAS L, 1985, ACTA PAEDIATR SCAND, V74, P741, DOI 10.1111/j.1651-2227.1985.tb10024.x; HENCHEY R, 1995, NEUROLOGY, V45, P977, DOI 10.1212/WNL.45.5.977; Hessen E, 2009, BRAIN INJURY, V23, P234, DOI 10.1080/02699050902748349; HILL RA, 1994, CAN J NEUROL SCI, V21, pS12, DOI 10.1017/S0084255900007488; HILZ MJ, 1991, INTENS CARE MED, V17, P87, DOI 10.1007/BF01691429; Hirsch LJ, 2005, J CLIN NEUROPHYSIOL, V22, P128, DOI 10.1097/01.WNP.0000158701.89576.4C; Hirsch LJ, 2004, J CLIN NEUROPHYSIOL, V21, P332; Holmes GL, 1996, EPILEPSIA, V37, P14, DOI 10.1111/j.1528-1157.1996.tb01815.x; Holmes MD, 2004, EPILEPSIA, V45, P618, DOI 10.1111/j.0013-9580.2004.63803.x; HOPKINS A, 1988, LANCET, V1, P721; HORMES JT, 1988, ARCH NEUROL-CHICAGO, V45, P814, DOI 10.1001/archneur.1988.00520310132033; Huang LC, 2014, CLIN EEG NEUROSCI, V45, P126, DOI 10.1177/1550059413490930; HUGHES JR, 1980, ELECTROEN CLIN NEURO, V48, P583, DOI 10.1016/0013-4694(80)90293-X; HUGHES JR, 1980, NEUROLOGY, V30, P1148, DOI 10.1212/WNL.30.11.1148; Hui ACF, 2001, EPILEPSIA, V42, P94, DOI 10.1046/j.1528-1157.2001.99352.x; HUNTER J, 1949, ELECTROEN CLIN NEURO, V1, P113, DOI 10.1016/0013-4694(49)90167-4; Huppertz HJ, 2001, NEUROIMAGE, V13, P15, DOI 10.1006/nimg.2000.0680; Hussain E, 2014, J PEDIATR GASTR NUTR, V58, P449, DOI 10.1097/MPG.0000000000000271; Hyllienmark L, 2007, EUR J PAEDIATR NEURO, V11, P70, DOI 10.1016/j.ejpn.2006.11.005; Ikeda A, 2003, CURRENT PRACTICE CLI, P348; Irani SR, 2011, ANN NEUROL, V69, P892, DOI 10.1002/ana.22307; ITOH N, 1994, CLIN ELECTROENCEPHAL, V25, P164, DOI 10.1177/155005949402500411; JABBARI B, 1979, CLIN ELECTROENCEPHAL, V10, P190, DOI 10.1177/155005947901000403; JAYAKAR P, 1992, J CLIN NEUROPHYSIOL, V9, P288, DOI 10.1097/00004691-199204010-00009; Jelic V, 2009, CLIN EEG NEUROSCI, V40, P129, DOI 10.1177/155005940904000211; JENNETT B, 1975, EPILEPSIA, V16, P251, DOI 10.1111/j.1528-1157.1975.tb06055.x; JENNETT WB, 1969, LANCET, V1, P1023; Jerbi K, 2004, NEUROIMAGE, V22, P779, DOI 10.1016/j.neuroimage.2004.02.010; Jette N, 2006, ARCH NEUROL-CHICAGO, V63, P1750, DOI 10.1001/archneur.63.12.1750; Jirsch J, 2007, CLIN NEUROPHYSIOL, V118, P1660, DOI 10.1016/j.clinph.2006.11.312; Johnson N, 2010, NEUROLOGY, V75, P1480, DOI 10.1212/WNL.0b013e3181f8831a; Johnston JM, 2006, J NEUROSURG, V105, P343, DOI 10.3171/ped.2006.105.5.343; Jonas J, 2011, J NEUROL NEUROSUR PS, V82, P928, DOI 10.1136/jnnp.2009.200329; Jordan KG, 2004, J CLIN NEUROPHYSIOL, V21, P341; JORDAN KG, 1995, NEUROL CLIN, V13, P579, DOI 10.1016/S0733-8619(18)30035-5; JORDAN KG, 1993, J CLIN NEUROPHYSIOL, V10, P445, DOI 10.1097/00004691-199310000-00006; Jung J, 2013, BRAIN, V136, P3176, DOI 10.1093/brain/awt213; Kagan-Kushnir T, 2005, J CHILD NEUROL, V20, P197, DOI 10.1177/08830738050200030601; Kahn A, 2004, EUR J PEDIATR, V163, P108, DOI 10.1007/s00431-003-1365-x; Kalita J, 2006, Electromyogr Clin Neurophysiol, V46, P139; Kamel JT, 2010, EPILEPSY BEHAV, V19, P608, DOI 10.1016/j.yebeh.2010.09.026; Kanemura H, 2012, BRAIN DEV-JPN, V34, P302, DOI 10.1016/j.braindev.2011.07.007; KANNER AM, 1990, NEUROLOGY, V40, P1404, DOI 10.1212/WNL.40.9.1404; Kaplan PW, 2006, EPILEPSIA, V47, P2071, DOI 10.1111/j.1528-1167.2006.00849.x; Kaplan PW, 2012, EPILEPSY BEHAV, V24, P1, DOI 10.1016/j.yebeh.2011.11.029; Kaplan PW, 2004, J CLIN NEUROPHYSIOL, V21, P307; Kaplan PW, 1998, CLIN ELECTROENCEPHAL, V29, P120, DOI 10.1177/155005949802900302; Karakis I, 2010, J CLIN NEUROPHYSIOL, V27, P100, DOI 10.1097/WNP.0b013e3181d649e4; Kayser MS, 2010, AM J PSYCHIAT, V167, P1039, DOI 10.1176/appi.ajp.2010.09101547; KAYSERGATCHALIAN MC, 1980, ELECTROEN CLIN NEURO, V49, P608, DOI 10.1016/0013-4694(80)90401-0; Kelly JP, 1997, NEUROLOGY, V48, P575, DOI 10.1212/WNL.48.3.575; Keranen T, 2002, SEIZURE-EUR J EPILEP, V11, P269, DOI 10.1053/seiz.2001.0608; Kho LK, 2006, NEUROLOGY, V67, P1047, DOI 10.1212/01.wnl.0000237555.12146.66; Kifune A, 2000, EPILEPSIA, V41, P909, DOI 10.1111/j.1528-1157.2000.tb00263.x; Kim H, 2011, J NEUROSURG-PEDIATR, V8, P49, DOI 10.3171/2011.4.PEDS10519; Kim LG, 2006, LANCET NEUROL, V5, P317, DOI 10.1016/S1474-4422(06)70383-0; King MA, 1998, LANCET, V352, P1007, DOI 10.1016/S0140-6736(98)03543-0; King W A, 1994, Neurosurg Clin N Am, V5, P767; Kipervasser S, 2007, ACTA NEUROL SCAND, V116, P221, DOI 10.1111/j.1600-0404.2007.00888.x; Kirkham FJ, 2012, INTENS CARE MED, V38, P853, DOI 10.1007/s00134-012-2529-9; Kirkpatrick MP, 2011, EPILEPSY BEHAV, V20, P392, DOI 10.1016/j.yebeh.2010.11.020; Klinger D, 1991, EPILPSY SLEEP DEPRIV, P217; Knight WA, 2013, EPILEPSY RES, V106, P396, DOI 10.1016/j.eplepsyres.2013.06.018; Knowlton RC, 2006, ANN NEUROL, V59, P835, DOI 10.1002/ana.20857; Knowlton RC, 2008, ANN NEUROL, V64, P25, DOI 10.1002/ana.21389; Knowlton RC, 2009, ANN NEUROL, V65, P716, DOI 10.1002/ana.21660; Ko TS, 1999, CLIN NEUROPHYSIOL, V110, P1245, DOI 10.1016/S1388-2457(99)00068-1; Kobayashi K, 2005, EPILEPSIA, V46, P1098, DOI 10.1111/j.1528-1167.2005.63004.x; Koenig MA, 2006, NEUROL CLIN, V24, P89, DOI 10.1016/j.ncl.2005.11.003; Koessler L, 2008, NEUROIMAGE, V41, P914, DOI 10.1016/j.neuroimage.2008.02.039; Koessler L, 2007, NEUROPHYSIOL CLIN, V37, P97, DOI 10.1016/j.neucli.2007.03.002; Koessler L, 2011, ANN BIOMED ENG, V39, P983, DOI 10.1007/s10439-010-0230-0; Koessler L, 2010, NEUROIMAGE, V51, P642, DOI 10.1016/j.neuroimage.2010.02.067; Kovacs GG, 2005, HUM GENET, V118, P166, DOI 10.1007/s00439-005-0020-1; KRAMER U, 1994, BRAIN DEV-JPN, V16, P304, DOI 10.1016/0387-7604(94)90028-0; Krauss GL, 2005, NEUROLOGY, V64, P1879, DOI 10.1212/01.WNL.0000163991.97456.03; Krishnamurthy KB, 1999, EPILEPSIA, V40, P759, DOI 10.1111/j.1528-1157.1999.tb00775.x; Kubicki S, 1991, Epilepsy Res Suppl, V2, P217; Kull LL, 2005, J CLIN NEUROPHYSIOL, V22, P107, DOI 10.1097/01.WNP.0000158361.24544.2D; Kurtz P, 2009, CURR OPIN CRIT CARE, V15, P99, DOI 10.1097/MCC.0b013e3283294947; Kwan P, 2000, NEW ENGL J MED, V342, P314, DOI 10.1056/NEJM200002033420503; Kwong KL, 2003, PEDIATR NEUROL, V29, P46, DOI 10.1016/S0887-8994(03)00028-6; LABAR DR, 1991, ELECTROEN CLIN NEURO, V78, P325, DOI 10.1016/0013-4694(91)90094-K; Lamblin MD, 2011, NEUROPHYSIOL CLIN, V41, P1, DOI 10.1016/j.neucli.2010.12.001; Lamblin MD, 1999, NEUROPHYSIOL CLIN, V29, P123, DOI 10.1016/S0987-7053(99)80051-3; Lancman ME, 1996, J NEUROL SCI, V142, P54, DOI 10.1016/0022-510X(96)00092-5; Landre E, 2004, EPILEPSIES, V16, P213; Lantz G, 2003, CLIN NEUROPHYSIOL, V114, P63, DOI 10.1016/S1388-2457(02)00337-1; Larsson PG, 2010, EPILEPSY BEHAV, V19, P348, DOI 10.1016/j.yebeh.2010.07.021; Lasierra N, 2009, IEEE ENG MED BIO, P5211, DOI 10.1109/IEMBS.2009.5334076; LAURITZEN M, 1981, CEPHALALGIA, V1, P63, DOI 10.1111/j.1468-2982.1981.tb00010.x; Lawn ND, 2003, MAYO CLIN PROC, V78, P1363, DOI 10.4065/78.11.1363; Leach JP, 2006, J NEUROL NEUROSUR PS, V77, P1040, DOI 10.1136/jnnp.2005.084871; Leach JP, 2005, SEIZURE-EUR J EPILEP, V14, P514, DOI 10.1016/j.seizure.2005.08.008; Legriel S, 2009, NEUROCRIT CARE, V11, P338, DOI 10.1007/s12028-009-9246-4; Lewine JD, 2007, J HEAD TRAUMA REHAB, V22, P141, DOI 10.1097/01.HTR.0000271115.29954.27; Liedorp M, 2009, DEMENT GERIATR COGN, V27, P18, DOI 10.1159/000182422; Lindsten H, 2001, EPILEPSIA, V42, P1025, DOI 10.1046/j.1528-1157.2001.0420081025.x; Liporace J, 1998, EPILEPSY RES, V32, P357, DOI 10.1016/S0920-1211(98)00069-2; Lobello K, 2006, EPILEPSY BEHAV, V8, P261, DOI 10.1016/j.yebeh.2005.10.010; LOGAR C, 1994, EUR NEUROL, V34, P29, DOI 10.1159/000119506; Loiseau P, 1984, LES EPILEPSIES, P167; Lossius MI, 2008, EPILEPSIA, V49, P455, DOI 10.1111/j.1528-1167.2007.01323.x; Loula P, 1997, J Telemed Telecare, V3, P89, DOI 10.1258/1357633971930922; MADKOUR O, 1993, J NEUROL SCI, V119, P8, DOI 10.1016/0022-510X(93)90186-3; Maillard L, 2009, CLIN NEUROPHYSIOL, V120, P1628, DOI 10.1016/j.clinph.2009.06.022; Maillard L, 2011, J COGNITIVE NEUROSCI, V23, P782, DOI 10.1162/jocn.2010.21434; Malow BA, 2002, NEUROLOGY, V59, P1371, DOI 10.1212/01.WNL.0000031810.15811.9E; Mani R, 2012, RESUSCITATION, V83, P840, DOI 10.1016/j.resuscitation.2012.02.015; Pardal-Fernandez JM, 2012, EUR J PAEDIATR NEURO, V16, P749, DOI 10.1016/j.ejpn.2012.03.008; Marinig R, 2000, CLIN NEUROPHYSIOL, V111, pS47, DOI 10.1016/S1388-2457(00)00401-6; MARSAN CA, 1970, EPILEPSIA, V11, P361, DOI 10.1111/j.1528-1157.1970.tb03903.x; Martin RC, 1998, SEIZURE-EUR J EPILEP, V7, P385, DOI 10.1016/S1059-1311(05)80007-X; Martz GU, 2009, NEUROCRIT CARE, V11, P223, DOI 10.1007/s12028-009-9215-y; MASQUIN A, 1963, EPILEPSIA, V4, P285, DOI 10.1111/j.1528-1157.1963.tb05226.x; MATTSON RH, 1965, ARCH NEUROL-CHICAGO, V13, P310, DOI 10.1001/archneur.1965.00470030090009; McBride AE, 2002, EPILEPSIA, V43, P165, DOI 10.1046/j.1528-1157.2002.24401.x; McCabe PH, 2003, NEUROLOGY, V60, P975, DOI 10.1212/01.WNL.0000053748.83309.28; McCoy B, 2013, J CLIN NEUROPHYSIOL, V30, P106, DOI 10.1097/WNP.0b013e3182872919; McGonigal A, 2004, J NEUROL NEUROSUR PS, V75, P771, DOI 10.1136/jnnp.2003.024893; McGonigal A, 2002, J NEUROL NEUROSUR PS, V72, P549; McGonigal A, 2007, BRAIN, V130, P3169, DOI 10.1093/brain/awm218; McHugh JC, 2009, IRISH J MED SCI, V178, P263, DOI 10.1007/s11845-009-0317-5; Meinitzer A, 2008, CLIN CHEM LAB MED, V46, P1732, DOI 10.1515/CCLM.2008.335; MELLERIO F, 1970, ELECTROEN CLIN NEURO, V29, P101; Merlet I, 1998, ELECTROEN CLIN NEURO, V107, P206, DOI 10.1016/S0013-4694(98)00055-8; Merlet I, 1999, CLIN NEUROPHYSIOL, V110, P1013, DOI 10.1016/S1388-2457(98)00062-5; Meunier S, 2001, ANN NEUROL, V50, P521, DOI 10.1002/ana.1234; Michel CM, 2004, CLIN NEUROPHYSIOL, V115, P2195, DOI 10.1016/j.clinph.2004.06.001; Millichap JG, 2006, CLIN EEG NEUROSCI, V37, P190, DOI 10.1177/155005940603700305; Minahan R E, 1997, New Horiz, V5, P406; Minassian BA, 1999, ANN NEUROL, V46, P627, DOI 10.1002/1531-8249(199910)46:4<627::AID-ANA11>3.0.CO;2-C; Mirsattari SM, 2009, EPILEPSY RES, V84, P28, DOI 10.1016/j.eplepsyres.2008.12.002; Mohan KK, 1996, ACTA NEUROL SCAND, V94, P320, DOI 10.1111/j.1600-0404.1996.tb07073.x; Moien-Afshari F, 2009, CAN J NEUROL SCI, V36, P587, DOI 10.1017/S0317167100008088; Mondello Epifanio, 2002, J Clin Monit Comput, V17, P271, DOI 10.1023/A:1021250320103; Morenski John D, 2003, J Intensive Care Med, V18, P211, DOI 10.1177/0885066603254359; MORRIS GL, 1994, ELECTROEN CLIN NEURO, V91, P229, DOI 10.1016/0013-4694(94)90073-6; Morris GL, 1997, J MED ENG TECHNOL, V21, P47, DOI 10.3109/03091909709008404; Mosbah A, 2014, EPILEPSIA, V55, P699, DOI 10.1111/epi.12565; Mosher JC, 1999, J CLIN NEUROPHYSIOL, V16, P225, DOI 10.1097/00004691-199905000-00004; Muniz J, 2010, EPILEPSY BEHAV, V18, P472, DOI 10.1016/j.yebeh.2010.06.014; Murahara T, 2013, EPILEPTIC DISORD, V15, P197, DOI 10.1684/epd.2013.0567; Murri L, 1998, NEUROPHYSIOL CLIN, V28, P249, DOI 10.1016/S0987-7053(98)80115-9; Musialowicz T, 2010, EPILEPSIA, V51, P1580, DOI 10.1111/j.1528-1167.2009.02514.x; MUSICCO M, 1993, NEUROLOGY, V43, P478; Naeije G, 2012, EPILEPSY BEHAV, V23, P330, DOI 10.1016/j.yebeh.2012.01.023; Nair DR, 2008, CLIN NEUROPHYSIOL, V119, P11, DOI 10.1016/j.clinph.2007.09.117; Nakagawa TA, 2011, PEDIATRICS, V128, pE720, DOI 10.1542/peds.2011-1511; Navarro V, 2009, REANIMATION, V18, P26; Navarro V, 2009, REANIMATION, V18, P33; Navelet Y, 1998, NEUROPHYSIOL CLIN, V28, P435, DOI 10.1016/S0987-7053(99)80027-6; NAVELET Y, 1990, Neurophysiologie Clinique, V20, P237, DOI 10.1016/S0987-7053(05)80113-3; NEUFELD MY, 1992, NEUROLOGY, V42, P444, DOI 10.1212/WNL.42.2.444; NEUFELD MY, 1988, ACTA NEUROL SCAND, V78, P1, DOI 10.1111/j.1600-0404.1988.tb03609.x; Neufeld MY, 2000, EPILEPSY RES, V42, P197, DOI 10.1016/S0920-1211(00)00183-2; Ney JP, 2013, NEUROLOGY, V81, P2002, DOI 10.1212/01.wnl.0000436948.93399.2a; NICOLAIDES P, 1995, ARCH DIS CHILD, V72, P522, DOI 10.1136/adc.72.6.522; Niedermeyer E, 2000, ELECTROENCEPHALOGRAP; Nilsson D, 2009, EPILEPSIA, V50, P2085, DOI 10.1111/j.1528-1167.2009.02135.x; Nitzkin J L, 1997, Telemed J, V3, P141, DOI 10.1089/tmj.1.1997.3.141; Noachtar S, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P21; Noachtar S, 2009, EPILEPSY BEHAV, V15, P22, DOI 10.1016/j.yebeh.2009.02.035; Noe KH, 2011, EPILEPSY RES, V93, P84, DOI 10.1016/j.eplepsyres.2010.10.014; Noe KH, 2009, MAYO CLIN PROC, V84, P495, DOI 10.1016/S0025-6196(11)60580-6; Noone ML, 2007, EPILEPSIA, V48, P390, DOI 10.1111/j.1528-1167.2007.00921.x; Nordli DR, 2006, EPILEPSIA, V47, P26, DOI 10.1111/j.1528-1167.2006.00656.x; Nordli DR, 2012, NEUROLOGY, V79, P2180, DOI 10.1212/WNL.0b013e3182759766; NOUSIAINEN U, 1989, ARCH NEUROL-CHICAGO, V46, P1171, DOI 10.1001/archneur.1989.00520470025019; Nuwer M, 1997, NEUROLOGY, V49, P277, DOI 10.1212/WNL.49.1.277; Nuwer MR, 2005, CLIN NEUROPHYSIOL, V116, P2001, DOI 10.1016/j.clinph.2005.05.008; O'Sullivan SS, 2007, EPILEPSY BEHAV, V11, P77, DOI 10.1016/j.yebeh.2007.04.003; Ojemann SG, 2003, J NEUROSURG, V98, P465, DOI 10.3171/jns.2003.98.3.0465; Onal C, 2003, J NEUROSURG, V98, P1017, DOI 10.3171/jns.2003.98.5.1017; Ong C, 2012, NEUROCRIT CARE, V17, P39, DOI 10.1007/s12028-012-9728-7; Osredkar D, 2005, PEDIATRICS, V115, P327, DOI 10.1542/peds.2004-0863; Ossenblok P, 2007, EPILEPSIA, V48, P2139, DOI 10.1111/j.1528-1167.2007.01223.x; Oster I, 2010, J PAEDIATR CHILD H, V46, P373, DOI 10.1111/j.1440-1754.2010.01754.x; Outin H, 2009, REV NEUROL-FRANCE, V165, P297, DOI 10.1016/j.neurol.2009.01.048; PAILLAS JE, 1970, EPILEPSIA, V11, P5, DOI 10.1111/j.1528-1157.1970.tb03860.x; Pandian JD, 2004, ARCH NEUROL-CHICAGO, V61, P1090, DOI 10.1001/archneur.61.7.1090; Panzica F, 1999, CLIN NEUROPHYSIOL, V110, P593, DOI 10.1016/S1388-2457(98)00031-5; PAOLIN A, 1995, INTENS CARE MED, V21, P657, DOI 10.1007/BF01711544; Parisi P, 2013, SEIZURE-EUR J EPILEP, V22, P253, DOI 10.1016/j.seizure.2013.01.013; Park KI, 2009, SEIZURE-EUR J EPILEP, V18, P94, DOI 10.1016/j.seizure.2008.07.001; Parmeggiani A, 2010, BRAIN DEV-JPN, V32, P783, DOI 10.1016/j.braindev.2010.07.003; Passaro AD, 2011, BRAIN RES, V1416, P44, DOI 10.1016/j.brainres.2011.08.017; PASSIER PECA, 1994, HEADACHE, V34, P56, DOI 10.1111/j.1526-4610.1994.hed3401056.x; Peraita-Adrados R, 2001, NEUROPHYSIOL CLIN, V31, P34, DOI 10.1016/S0987-7053(00)00242-2; Perrin MW, 2010, EPILEPSY BEHAV, V19, P32, DOI 10.1016/j.yebeh.2010.06.006; PERRY TR, 1983, PUBLIC HEALTH REP, V98, P384; Piantino JA, 2013, PEDIATR CRIT CARE ME, V14, P601, DOI 10.1097/PCC.0b013e318291755a; Pires LA, 2001, ARCH INTERN MED, V161, P1889, DOI 10.1001/archinte.161.15.1889; Plouin P, 2005, LEEG EN PEDIAT; Pohlmann-Eden B, 2008, EPILEPSIA, V49, P19, DOI 10.1111/j.1528-1167.2008.01445.x; Ponten SC, 2010, SEIZURE-EUR J EPILEP, V19, P580, DOI 10.1016/j.seizure.2010.09.007; Poser S, 1999, BRAIN, V122, P2345, DOI 10.1093/brain/122.12.2345; POWNER DJ, 1976, JAMA-J AM MED ASSOC, V236, P1123, DOI 10.1001/jama.236.10.1123; Praline J, 2007, CLIN NEUROPHYSIOL, V118, P2149, DOI 10.1016/j.clinph.2007.07.003; PRATT KL, 1968, ELECTROEN CLIN NEURO, V24, P11, DOI 10.1016/0013-4694(68)90061-8; PRIVITERA M, 1994, EPILEPSY RES, V18, P155, DOI 10.1016/0920-1211(94)90008-6; Quigg M, 2002, EPILEPSY BEHAV, V3, P455, DOI 10.1016/S1525-5050(02)00524-3; Ramelli GP, 1998, ELECTROEN CLIN NEURO, V107, P374, DOI 10.1016/S0013-4694(98)00094-7; Reardon KA, 1999, J CLIN NEUROSCI, V6, P492, DOI 10.1016/S0967-5868(99)90007-3; REISNER T, 1979, J NEUROL, V221, P93, DOI 10.1007/BF00313106; REITE M, 1976, ELECTROEN CLIN NEURO, V40, P59, DOI 10.1016/0013-4694(76)90179-6; Reuber M, 2003, ANN NEUROL, V53, P305, DOI 10.1002/ana.3000; Riker RR, 2003, PHARMACOTHERAPY, V23, P1087, DOI 10.1592/phco.23.10.1087.32766; Rikir E, 2014, ADDED VALUE ELECT SO; Riquet A, 2011, SEIZURE-EUR J EPILEP, V20, P18, DOI 10.1016/j.seizure.2010.09.011; Riviello JJ, 2013, J CLIN NEUROPHYSIOL, V30, P143, DOI 10.1097/WNP.0b013e3182872b0e; RIVIEREZ M, 1991, ACTA NEUROCHIR, V110, P17, DOI 10.1007/BF01402042; Robinson AA, 2011, EPILEPSY BEHAV, V21, P76, DOI 10.1016/j.yebeh.2011.03.014; Rodin E, 1991, Epilepsy Res Suppl, V2, P265; Roger J, 2005, EPILEPTIC SYNDROMES; Roks G, 2008, J NEUROL NEUROSUR PS, V79, P377, DOI 10.1136/jnnp.2007.125385; Rosenow F, 2007, EPILEPSIA, V48, P82, DOI 10.1111/j.1528-1167.2007.01359.x; Rossetti AO, 2010, CRIT CARE, V14, DOI 10.1186/cc9276; Rossetti AO, 2005, ARCH NEUROL-CHICAGO, V62, P1698, DOI 10.1001/archneur.62.11.1698; Rossi G F, 1991, Epilepsy Res Suppl, V2, P23; Roustan JP, 2005, ANESTH ANALG, V101, P1141, DOI 10.1213/01.ane.0000167782.47957.e1; Rozza L, 1996, Telemed J, V2, P267, DOI 10.1089/tmj.1.1996.2.267; Rumpl E, 2005, ELECTROENCEPHALOGRAP, P415; Rundgren M, 2006, INTENS CARE MED, V32, P836, DOI 10.1007/s00134-006-0178-6; Saab ME, 2005, CLIN NEUROPHYSIOL, V116, P427, DOI 10.1016/j.clinph.2004.08.004; Sackellares JC, 2011, EPILEPSY BEHAV, V22, pS69, DOI 10.1016/j.yebeh.2011.08.028; SAINIO K, 1983, ELECTROEN CLIN NEURO, V56, P117, DOI 10.1016/0013-4694(83)90066-4; SALINSKY M, 1987, EPILEPSIA, V28, P331, DOI 10.1111/j.1528-1157.1987.tb03652.x; SAMMARITANO M, 1991, NEUROLOGY, V41, P290, DOI 10.1212/WNL.41.2_Part_1.290; Samson-Dollfus D, 1998, ELECTROENCEPHALOGRAP; Sanchez SM, 2013, EPILEPSIA, V54, P1419, DOI 10.1111/epi.12261; Sand T, 1991, Funct Neurol, V6, P7; Sander J, 2012, EUR J PEDIATR, V171, P675, DOI 10.1007/s00431-011-1640-1; Sanders P T, 1996, J Neurosci Nurs, V28, P305; SARVAS J, 1987, PHYS MED BIOL, V32, P11, DOI 10.1088/0031-9155/32/1/004; SAVAGE DD, 1985, STROKE, V16, P626, DOI 10.1161/01.STR.16.4.626; Schauble B, 2003, CLIN NEUROPHYSIOL, V114, P32, DOI 10.1016/S1388-2457(02)00343-7; Scheepers B, 1998, SEIZURE-EUR J EPILEP, V7, P403, DOI 10.1016/S1059-1311(05)80010-X; Scheltens-de Boer M, 2009, EPILEPSIA, V50, P13, DOI 10.1111/j.1528-1167.2009.02211.x; Scherg M, 1999, J CLIN NEUROPHYSIOL, V16, P214, DOI 10.1097/00004691-199905000-00003; SCHERZER E, 1978, EUR NEUROL, V17, P38, DOI 10.1159/000114919; Scheuer ML, 2004, J CLIN NEUROPHYSIOL, V21, P353; Scheuer ML, 2002, EPILEPSIA, V43, P114, DOI 10.1046/j.1528-1157.43.s.3.7.x; Schevon CA, 2007, EPILEPSIA, V48, P539, DOI 10.1111/j.1528-1167.2006.00962.x; Schlede N, 2011, J NEUROL SCI, V310, P75, DOI 10.1016/j.jns.2011.05.034; Schmitt SE, 2012, NEUROLOGY, V79, P1094, DOI 10.1212/WNL.0b013e3182698cd8; Schomer DL, 1999, J CLIN NEUROPHYSIOL, V16, P116, DOI 10.1097/00004691-199903000-00004; World Health Organisation, 1998, WKLY EPIDEMIOL REC; [Anonymous], 1995, Neurology, V45, P1012; Lv YD, 2013, INT J NEUROSCI, V123, P196, DOI 10.3109/00207454.2012.746334; Schreiber JM, 2012, NEUROCRIT CARE, V17, P31, DOI 10.1007/s12028-012-9715-z; Schreiner A, 2003, CLIN ELECTROENCEPHAL, V34, P140, DOI 10.1177/155005940303400307; Sediri H, 2007, REV NEUROL-FRANCE, V163, P248, DOI 10.1016/S0035-3787(07)90399-9; Seiler L, 2012, J NEUROSCI NURS, V44, pE1, DOI 10.1097/JNN.0b013e3182478c7c; Seneviratne U, 2012, EPILEPSIA, V53, P234, DOI 10.1111/j.1528-1167.2011.03344.x; Shafer PO, 2011, EPILEPSY BEHAV, V20, P502, DOI 10.1016/j.yebeh.2010.12.048; Shafer PO, 2012, EPILEPSY BEHAV, V25, P449, DOI 10.1016/j.yebeh.2012.07.014; SHAFER SQ, 1988, EPILEPSIA, V29, P590, DOI 10.1111/j.1528-1157.1988.tb03767.x; Shafi MM, 2012, NEUROLOGY, V79, P1796, DOI 10.1212/WNL.0b013e3182703fbc; Shahwan A, 2010, EPILEPSIA, V51, P1198, DOI 10.1111/j.1528-1167.2009.02517.x; Shevell M, 2003, NEUROLOGY, V60, P367, DOI 10.1212/01.WNL.0000031431.81555.16; Shinnar S, 2000, ANN NEUROL, V48, P140, DOI 10.1002/1531-8249(200008)48:2<140::AID-ANA2>3.3.CO;2-P; Shinnar S, 1996, PEDIATRICS, V98, P216; Shoar Z, 2013, J PEDIATR ENDOCR MET, V26, P561, DOI 10.1515/jpem-2012-0321; Sieradzan K, 2013, J NEUROL NEUROSUR PS, V84, DOI 10.1136/jnnp-2013-306573.104; SILLANPAA M, 1993, EPILEPSIA, V34, P930, DOI 10.1111/j.1528-1157.1993.tb02114.x; Singh RK, 2012, J PEDIATR-US, V160, P291, DOI 10.1016/j.jpeds.2011.07.048; Smith SJM, 2005, J NEUROL NEUROSUR PS, V76, P2, DOI 10.1136/jnnp.2005.069245; SOIKKELI R, 1991, ELECTROEN CLIN NEURO, V79, P159, DOI 10.1016/0013-4694(91)90134-P; Sorbi S, 2012, EUR J NEUROL, V19, P1159, DOI 10.1111/j.1468-1331.2012.03784.x; Soriani S, 1996, EUR J PEDIATR, V155, P126, DOI 10.1007/s004310050389; Sousa NAD, 2005, ARQ NEURO-PSIQUIAT, V63, P383, DOI 10.1590/S0004-282X2005000300003; Specchio LM, 2002, J NEUROL NEUROSUR PS, V72, P22, DOI 10.1136/jnnp.72.1.22; SPENCER SS, 1990, NEUROLOGY, V40, P74, DOI 10.1212/WNL.40.1.74; Sperli F, 2006, EPILEPSIA, V47, P981, DOI 10.1111/j.1528-1167.2006.00550.x; Spindler M, 2013, J CLIN NEUROPHYSIOL, V30, P339, DOI 10.1097/WNP.0b013e31829ddcdb; Stefan H, 2011, SEIZURE-EUR J EPILEP, V20, P97, DOI 10.1016/j.seizure.2010.10.035; Steiner I, 2010, EUR J NEUROL, V17, P999, DOI 10.1111/j.1468-1331.2010.02970.x; Steinhoff BJ, 2004, ANN NEUROL, V56, P702, DOI 10.1002/ana.20261; Stewart CP, 2010, NEUROLOGY, V75, P1501, DOI 10.1212/WNL.0b013e3181f9619e; Stockard JJBRG, 1975, HDB CLIN NEUROLOGY, V23, P217; Sullivan Joseph E 3rd, 2007, Am J Electroneurodiagnostic Technol, V47, P127; Sullivan R, 2012, CLIN TOXICOL, V50, P141, DOI 10.3109/15563650.2011.654209; SUNDARAM M, 1990, ELECTROEN CLIN NEURO, V75, P358, DOI 10.1016/0013-4694(90)90114-Y; Surbeck W, 2011, EPILEPSIA, V52, P458, DOI 10.1111/j.1528-1167.2010.02910.x; Sutter R, 2013, CLIN NEUROPHYSIOL, V124, P1952, DOI 10.1016/j.clinph.2013.03.031; Sutter R, 2013, CRIT CARE MED, V41, P1124, DOI 10.1097/CCM.0b013e318275882f; Sutter R, 2011, EPILEPSIA, V52, P453, DOI 10.1111/j.1528-1167.2010.02888.x; SVEINBJORNSDOTTIR S, 1993, EPILEPSIA, V34, P493, DOI 10.1111/j.1528-1157.1993.tb02590.x; Szurhaj W, 2004, REV NEUROL-FRANCE, V160, P1113, DOI 10.1016/S0035-3787(04)71153-4; Szurhaj W, 2001, REANIMATION, V10, P368; TAGHAVY A, 1992, INT J NEUROSCI, V66, P251; TALAIRACH J, 1974, NEUROCHIRURGIE, V20, P1; Talairach J., 1973, PROGR NEUROLOGICAL S, V5, P297, DOI [10.1159/000394343, DOI 10.1159/000394343]; Tao JX, 2005, EPILEPSIA, V46, P669, DOI 10.1111/j.1528-1167.2005.11404.x; Tatum WO, 2001, J CLIN NEUROPHYSIOL, V18, P14, DOI 10.1097/00004691-200101000-00004; Taussig D, 2012, STEREOTAXY EPILEPSY, P21; Taussig D, 2012, SEIZURE-EUR J EPILEP, V21, P631, DOI 10.1016/j.seizure.2012.07.004; THOMAS P, 1992, NEUROLOGY, V42, P104, DOI 10.1212/WNL.42.1.104; Tieder JS, 2013, J PEDIATR-US, V163, P94, DOI 10.1016/j.jpeds.2012.12.086; Tinuper P, 1996, NEUROLOGY, V47, P76, DOI 10.1212/WNL.47.1.76; TORRES F, 1961, ARCH NEUROL-CHICAGO, V5, P28, DOI 10.1001/archneur.1961.00450130030005; Towne AR, 2000, NEUROLOGY, V54, P340, DOI 10.1212/WNL.54.2.340; Trenite DGAKN, 1999, EPILEPSIA, V40, P75, DOI 10.1111/j.1528-1157.1999.tb00911.x; Trenite DKN, 2012, EPILEPSIA, V53, P16, DOI 10.1111/j.1528-1167.2011.03319.x; Trevathan Edwin, 2006, Am J Electroneurodiagnostic Technol, V46, P4; Trinh-Duc A, 2006, CRISES CONVULSIVES A; TROJABORG W, 1992, CLIN ELECTROENCEPHAL, V23, P72, DOI 10.1177/155005949202300206; Uldal SB, 2004, J TELEMED TELECARE, V10, P11, DOI 10.1258/135763304322764121; Van CA, 2003, CURRENT PRACTICE CLI, P463; Van Gompel JJ, 2010, J NEUROSURG, V113, P32, DOI 10.3171/2009.12.JNS091073; van Putten MJAM, 2004, STROKE, V35, P2489, DOI 10.1161/01.STR.0000144649.49861.1d; van Vliet J, 2012, CLIN EEG NEUROSCI, V43, P161, DOI 10.1177/1550059411433612; VANDONSELAAR CA, 1992, ARCH NEUROL-CHICAGO, V49, P231, DOI 10.1001/archneur.1992.00530270045017; VANDONSELAAR CA, 1991, LANCET, V337, P46, DOI 10.1016/0140-6736(91)93361-C; Varela HL, 2007, J CLIN NEUROPHYSIOL, V24, P390, DOI 10.1097/WNP.0b013e31812f6c11; VECCHIERINI-BLINEAU M F, 1992, Neurophysiologie Clinique, V22, P179, DOI 10.1016/S0987-7053(05)80214-X; Veggiotti P, 2012, EPILEPTIC DISORD, V14, P1, DOI 10.1684/epd.2012.0482; Velasco TR, 2006, EPILEPSIA, V47, P1300, DOI 10.1111/j.1528-1167.2006.00547.x; VELDHUIZEN R, 1983, ELECTROEN CLIN NEURO, V55, P505, DOI 10.1016/0013-4694(83)90161-X; Velis D, 2007, EPILEPSIA, V48, P379, DOI 10.1111/j.1528-1167.2007.00920.x; Velly L, 2012, Ann Fr Anesth Reanim, V31, pe145, DOI 10.1016/j.annfar.2012.04.019; Vendrame M, 2011, PEDIATR NEUROL, V44, P427, DOI 10.1016/j.pediatrneurol.2011.01.004; Veran O, 2010, EPILEPSIA, V51, P1030, DOI 10.1111/j.1528-1167.2009.02410.x; Vercueil L, 2013, EPILEPSY BEHAV, V27, P307, DOI 10.1016/j.yebeh.2013.02.007; Verrotti A, 2012, EPILEPTIC DISORD, V14, P349, DOI 10.1684/epd.2012.0539; Vespa P, 2005, J CLIN NEUROPHYSIOL, V22, P99, DOI 10.1097/01.WNP.0000154919.54202.E0; Vespa PM, 2007, CRIT CARE MED, V35, P2830, DOI 10.1097/01.CCM.0000295667.66853.BC; Vespa PM, 1999, J NEUROSURG, V91, P750, DOI 10.3171/jns.1999.91.5.0750; Vespa PM, 1997, ELECTROEN CLIN NEURO, V103, P607, DOI 10.1016/S0013-4694(97)00071-0; Vespa PM, 2003, NEUROLOGY, V60, P1441, DOI 10.1212/01.WNL.0000063316.47591.B4; Vespa PM, 1999, J CLIN NEUROPHYSIOL, V16, P1, DOI 10.1097/00004691-199901000-00001; Vignal JP, 2008, FUNCTIONAL LOCALIZAT; Villanueva V, 2011, NEUROLOGIA, V26, P6, DOI 10.1016/j.nrl.2010.09.029; Vivien B, 2003, ANESTHESIOLOGY, V99, P9, DOI 10.1097/00000542-200307000-00006; Vivien B, 2001, ANN FR ANESTH, V20, P370; Voller B, 1999, BRAIN INJURY, V13, P821, DOI 10.1080/026990599121214; Vrba J, 2001, METHODS, V25, P249, DOI 10.1006/meth.2001.1238; Wallois F, 2007, NEUROPHYSIOL CLIN, V37, P149, DOI 10.1016/j.neucli.2007.07.001; Wang LH, 2013, J NEUROL, V260, P498, DOI 10.1007/s00415-012-6664-6; Wang L, 2012, EPILEPSY RES, V98, P116, DOI 10.1016/j.eplepsyres.2011.06.008; Wang YH, 2007, P ANN INT IEEE EMBS, P553; Wassmer E, 2001, DEV MED CHILD NEUROL, V43, P136, DOI 10.1017/S0012162201210251; Welschehold S, 2012, DTSCH ARZTEBL INT, V109, P624, DOI 10.3238/arztebl.2012.0624; Wennberg R, 2011, CLIN NEUROPHYSIOL, V122, P1295, DOI 10.1016/j.clinph.2010.11.019; Wieser HG, 2006, CLIN NEUROPHYSIOL, V117, P935, DOI 10.1016/j.clinph.2005.12.007; WIESER HG, 1991, EPILEPSIA, V32, P838, DOI 10.1111/j.1528-1157.1991.tb05540.x; Wijdicks EFM, 2002, NEUROLOGY, V58, P20, DOI 10.1212/WNL.58.1.20; WIJDICKS EFM, 1995, NEUROLOGY, V45, P1003, DOI 10.1212/WNL.45.5.1003; WIKSWO JP, 1993, ELECTROEN CLIN NEURO, V87, P1, DOI 10.1016/0013-4694(93)90169-V; WILLIAMS GW, 1985, NEUROLOGY, V35, P1714, DOI 10.1212/WNL.35.12.1714; Williams K, 2011, EPILEPSIA, V52, P1130, DOI 10.1111/j.1528-1167.2011.03070.x; WINER JW, 1991, NEUROSURGERY, V29, P739, DOI 10.1227/00006123-199111000-00016; Wirrell EC, 1996, EPILEPSIA, V37, P459, DOI 10.1111/j.1528-1157.1996.tb00592.x; Woollacott IOC, 2010, EPILEPSY BEHAV, V17, P228, DOI 10.1016/j.yebeh.2009.12.002; Wright WL, 2007, J NEUROL SCI, V261, P10, DOI 10.1016/j.jns.2007.04.027; WYLLIE E, 1988, NEUROPEDIATRICS, V19, P80, DOI 10.1055/s-2008-1052406; Wyllie E, 1998, PEDIATR NEUROL, V19, P179, DOI 10.1016/S0887-8994(98)00062-9; YAMATANI M, 1994, EPILEPSIA, V35, P1199, DOI 10.1111/j.1528-1157.1994.tb01789.x; Yang LH, 2013, NEUROL MED-CHIR, V53, P12, DOI 10.2176/nmc.53.12; Yen DJ, 2001, EPILEPSIA, V42, P251, DOI 10.1046/j.1528-1157.2001.15100.x; Yogarajah M, 2009, J NEUROL NEUROSUR PS, V80, P305, DOI 10.1136/jnnp.2008.144634; Young GB, 2006, CLIN NEUROPHYSIOL, V117, P1376, DOI 10.1016/j.clinph.2006.02.006; Young GB, 2009, CAN J NEUROL SCI, V36, pS89; Young GB, 2006, ACTA NEUROL SCAND, V114, P67, DOI 10.1111/j.1600-0404.2006.00651.x; Young GB, 1996, NEUROLOGY, V47, P83; Young GB, 1999, J CLIN NEUROPHYSIOL, V16, P40, DOI 10.1097/00004691-199901000-00003; Zappella M, 2010, BRAIN DEV-JPN, V32, P739, DOI 10.1016/j.braindev.2010.05.004; Zerr I, 2000, NEUROLOGY, V55, P811, DOI 10.1212/WNL.55.6.811; Zerr I, 2009, BRAIN, V132, P2659, DOI 10.1093/brain/awp191; Zhang YC, 2009, EPILEPSY BEHAV, V15, P303, DOI 10.1016/j.yebeh.2009.04.008; ZIVIN L, 1968, BRAIN, V91, P751, DOI 10.1093/brain/91.4.751; Zumsteg D, 2005, CLIN NEUROPHYSIOL, V116, P2810, DOI 10.1016/j.clinph.2005.08.009; Zumsteg D, 2000, EPILEPSIA, V41, pS55, DOI 10.1111/j.1528-1157.2000.tb01535.x	626	17	17	0	25	ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER	ISSY-LES-MOULINEAUX	65 RUE CAMILLE DESMOULINS, CS50083, 92442 ISSY-LES-MOULINEAUX, FRANCE	0987-7053	1769-7131		NEUROPHYSIOL CLIN	Neurophysiol. Clin.-Clin. Neurophysiol.	DEC	2014	44	6					515	612		10.1016/j.neucli.2014.10.001			98	Clinical Neurology; Neurosciences; Physiology	Neurosciences & Neurology; Physiology	AZ1OH	WOS:000348007600001	25435392				2021-06-18	
J	Dvela-Levitt, M; Cohen-Ben Ami, H; Rosen, H; Shohami, E; Lichtstein, D				Dvela-Levitt, Moran; Cohen-Ben Ami, Hagit; Rosen, Haim; Shohami, Esther; Lichtstein, David			Ouabain Improves Functional Recovery following Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						cardiac steroids; cell viability; closed head injury; Na+, K+-ATPase	CLOSED-HEAD INJURY; ATPASE ACTIVITY; PATHOPHYSIOLOGY; DIGITALIS; ISCHEMIA; MICE; RAT; NEUROPROTECTION; NEUROGENESIS; PHARMACOLOGY	The cardiac steroid ouabain binds to Na+, K+-ATPase and inhibits its activity. Administration of the compound to animals and humans causes an increase in the force of contraction of heart muscle and stabilizes heart rate. In addition, this steroid promotes the growth of cardiac, vascular, and neuronal cells both in vitro and in vivo. We studied the effects of ouabain on mouse recovery following closed head injury (CHI), a model for traumatic brain injury. We show that chronic (three times a week), but not acute, intraperitoneal administration of a low dose (1 mu g/kg) of ouabain significantly improves mouse recovery and functional outcome. The improvement in mouse performance was accompanied by a decrease in lesion size, estimated 43 d following the trauma. In addition, mice that underwent CHI and were treated with ouabain showed an increase in the number of proliferating cells in the subventricular zone and in the area surrounding the site of injury. Determination of the identity of the proliferating cells in the area surrounding the trauma showed that whereas there was no change in the proliferation of endothelial cells or astrocytes, neuronal cell proliferation almost doubled in the ouabain-treated mice in comparison with that of the vehicle animals. These results point to a neuroprotective effects of low doses of ouabain and imply its involvement in brain recovery and neuronal regeneration. This suggests that ouabain and maybe other cardiac steroids may be used for the treatment of traumatic brain injury.	[Dvela-Levitt, Moran; Cohen-Ben Ami, Hagit; Lichtstein, David] Hebrew Univ Hadassah Med Sch, Dept Med Neurobiol, IL-91120 Jerusalem, Israel; [Rosen, Haim] Hebrew Univ Hadassah Med Sch, Dept Microbiol, IL-91120 Jerusalem, Israel; [Rosen, Haim] Hebrew Univ Hadassah Med Sch, Dept Mol Genet, IL-91120 Jerusalem, Israel; [Shohami, Esther] Hebrew Univ Hadassah Med Sch, Dept Pharmacol, IL-91120 Jerusalem, Israel	Lichtstein, D (corresponding author), Hebrew Univ Hadassah Med Sch, Inst Med Res Israel Canada, Dept Med Neurobiol, POB 12272, IL-91120 Jerusalem, Israel.	davidli@ekmd.huji.ac.il			Federico Foundation; Hoffman Leadership and Responsibility Fellowship Program	We would like to thank Mr. Yoni Levitt for his assistance in analyzing the immunostaining images. This work was supported in part by the Federico Foundation (D.L) and the Hoffman Leadership and Responsibility Fellowship Program (M.D.L).	Bagrov AY, 2009, PHARMACOL REV, V61, P9, DOI 10.1124/pr.108.000711; Bauman Jerry L, 2006, Am J Cardiovasc Drugs, V6, P77, DOI 10.2165/00129784-200606020-00002; Beauchamp K, 2008, MOL MED, V14, P731, DOI 10.2119/2008-00050.Beauchamp; Beni-Adani L, 2001, J PHARMACOL EXP THER, V296, P57; Blanco G, 1998, AM J PHYSIOL-RENAL, V275, pF633; Chen Y, 1996, J NEUROTRAUM, V13, P557, DOI 10.1089/neu.1996.13.557; Cohen-Yeshurun A, 2011, J CEREBR BLOOD F MET, V31, P1768, DOI 10.1038/jcbfm.2011.53; Compagnone NA, 2000, FRONT NEUROENDOCRIN, V21, P1, DOI 10.1006/frne.1999.0188; Correa GD, 2005, BRAIN RES, V1049, P89, DOI 10.1016/j.brainres.2005.04.082; Cuny GD, 2009, CURR PHARM DESIGN, V15, P3919, DOI 10.2174/138161209789649330; Dvela M, 2012, AM J PHYSIOL-CELL PH, V302, pC442, DOI 10.1152/ajpcell.00336.2011; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Furstenwerth H, 2010, INT J CLIN PRACT, V64, P1591, DOI 10.1111/j.1742-1241.2010.02395.x; Gao JY, 2002, J GEN PHYSIOL, V119, P297, DOI 10.1085/jgp.20028501; Greve MW, 2009, MT SINAI J MED, V76, P97, DOI 10.1002/msj.20104; Jin KL, 2001, P NATL ACAD SCI USA, V98, P4710, DOI 10.1073/pnas.081011098; Jin K, 2007, J NEUROIMMUNE PHARM, V2, P236, DOI 10.1007/s11481-007-9076-0; Kaplan JH, 2002, ANNU REV BIOCHEM, V71, P511, DOI 10.1146/annurev.biochem.71.102201.141218; LICHTSTEIN D, 1985, BRAIN RES, V325, P13, DOI 10.1016/0006-8993(85)90297-5; Lichtstein D, 2001, NEUROCHEM RES, V26, P971, DOI 10.1023/A:1012340702763; LICHTSTEIN D, 1985, NEUROCHEM INT, V7, P709, DOI 10.1016/0197-0186(85)90069-5; Lima FD, 2008, BEHAV BRAIN RES, V193, P306, DOI 10.1016/j.bbr.2008.05.013; Liu J., 1802, BIOCH BIOPHYS ACTA, P1237; Liu JA, 2010, BBA-MOL BASIS DIS, V1802, P1237, DOI 10.1016/j.bbadis.2010.01.013; Matsumoto S, 2008, NEUROSCI LETT, V439, P241, DOI 10.1016/j.neulet.2008.05.032; Murata Y, 1996, JPN J PHARMACOL, V72, P347, DOI 10.1254/jjp.72.347; Mustafa AG, 2013, NEUROSCIENCES, V18, P222; Nesher M, 2007, LIFE SCI, V80, P2093, DOI 10.1016/j.lfs.2007.03.013; Oselkin M, 2010, NEUROSCI LETT, V473, P67, DOI 10.1016/j.neulet.2009.10.021; Qiu J, 2007, BIOL PHARM BULL, V30, P247, DOI 10.1248/bpb.30.247; Shein NA, 2007, J NEUROCHEM, V103, P1523, DOI 10.1111/j.1471-4159.2007.04862.x; Shioda N, 2009, INT REV NEUROBIOL, V85, P375, DOI 10.1016/S0074-7742(09)85026-5; Sibarov DA, 2012, J PHARMACOL EXP THER, V343, P596, DOI 10.1124/jpet.112.198341; SWANSON RA, 1990, J CEREBR BLOOD F MET, V10, P290, DOI 10.1038/jcbfm.1990.47; Tsenter J, 2008, J NEUROTRAUM, V25, P324, DOI 10.1089/neu.2007.0452; Wang JKT, 2006, P NATL ACAD SCI USA, V103, P10461, DOI 10.1073/pnas.0600930103; Wasserstrom JA, 2005, AM J PHYSIOL-HEART C, V289, pH1781, DOI 10.1152/ajpheart.00707.2004; Xie ZJ, 2002, EUR J BIOCHEM, V269, P2434, DOI 10.1046/j.1432-1033.2002.02910.x	38	17	18	0	11	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	DEC 1	2014	31	23					1942	1947		10.1089/neu.2014.3544			6	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	AT6US	WOS:000345075500007	25007121	Green Published			2021-06-18	
J	Echlin, PS; Johnson, AM; Holmes, JD; Tichenoff, A; Gray, S; Gatavackas, H; Walsh, J; Middlebro, T; Blignaut, A; MacIntyre, M; Anderson, C; Fredman, E; Mayinger, M; Skopelja, EN; Sasaki, T; Bouix, S; Pasternak, O; Helmer, KG; Koerte, IK; Shenton, ME; Forwell, LA				Echlin, Paul S.; Johnson, Andrew M.; Holmes, Jeffrey D.; Tichenoff, Annalise; Gray, Sarah; Gatavackas, Heather; Walsh, Joanne; Middlebro, Tim; Blignaut, Angelique; MacIntyre, Martin; Anderson, Chris; Fredman, Eli; Mayinger, Michael; Skopelja, Elaine N.; Sasaki, Takeshi; Bouix, Sylvain; Pasternak, Ofer; Helmer, Karl G.; Koerte, Inga K.; Shenton, Martha E.; Forwell, Lorie A.			The Sport Concussion Education Project. A brief report on an educational initiative: from concept to curriculum	JOURNAL OF NEUROSURGERY			English	Article						concussion; mild traumatic brain injury; education; student; youth athlete	TRAUMATIC BRAIN-INJURY; FOR-DISEASE-CONTROL; RECURRENT CONCUSSION; KNOWLEDGE TRANSFER; PLAYERS; EPIDEMIOLOGY; TRENDS; HEADS	Current research on concussion is primarily focused on injury identification and treatment. Prevention initiatives are, however, important for reducing the incidence of brain injury. This report examines the development and implementation of an interactive electronic teaching program (an e-module) that is designed specifically for concussion education within an adolescent population. This learning tool and the accompanying consolidation rubric demonstrate that significant engagement occurs in addition to the knowledge gained among participants when it is used in a school curriculum setting.	[Echlin, Paul S.] Elliott Sports Med Clin, Burlington, ON L7N 2G3, Canada; [Gray, Sarah; Gatavackas, Heather; Walsh, Joanne; Middlebro, Tim; Blignaut, Angelique; MacIntyre, Martin; Anderson, Chris] Halton Dist Board Educ, Burlington, ON, Canada; [Johnson, Andrew M.; Tichenoff, Annalise] Univ Western Ontario, Sch Hlth Studies, London, ON, Canada; [Holmes, Jeffrey D.] Univ Western Ontario, Sch Occupat Therapy, London, ON, Canada; [Forwell, Lorie A.] Univ Western Ontario, Sch Phys Therapy, London, ON, Canada; [Forwell, Lorie A.] Univ Western Ontario, Fowler Kennedy Sports Med Clin, London, ON, Canada; [Fredman, Eli; Mayinger, Michael; Sasaki, Takeshi; Bouix, Sylvain; Pasternak, Ofer; Koerte, Inga K.; Shenton, Martha E.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Psychiat, Boston, MA 02115 USA; [Koerte, Inga K.; Shenton, Martha E.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Helmer, Karl G.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Shenton, Martha E.] VA Boston Healthcare Syst, Brockton, MA USA; [Skopelja, Elaine N.] Indiana Univ, Sch Med Lib, Indianapolis, IN 46204 USA; [Mayinger, Michael; Koerte, Inga K.] Univ Munich, Inst Clin Radiol, Munich, Germany	Echlin, PS (corresponding author), Elliott Sports Med Clin, 1100 Walkers Line,Ste 102, Burlington, ON L7N 2G3, Canada.	psechlin@gmail.com	Johnson, Andrew M/B-2048-2012; Shenton, Martha/V-8780-2019; Holmes, Jeffrey/M-6484-2015	Holmes, Jeffrey/0000-0002-5744-8338; Skopelja, Elaine/0000-0002-2847-8909; Johnson, Andrew M./0000-0002-7269-3016	Ontario Trillium Foundation; Dave Irwin Foundation for Brain Injury Recovery; Ontario Neurotrauma Foundation, Air Canada; Ontario Ministry of Health and Long-Term CareMinistry of Health and Long-Term Care, Ontario; Ontario Ministry of Tourism, Culture and Sport; Ontario Ministry of Education; National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [P41RR013218, P41EB015902, R01MH074794]; Department of DefenseUnited States Department of Defense [X81XWH-07-CC-CSDoD]; VA merit grant; Brain & Behavior Research FoundationNARSAD; Japan Society for the Promotion of ScienceMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science; Petraeic Legate Foundation; NIEI grant; Henry Jackson Foundation; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [P41RR013218] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [P41EB015902] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH074794] Funding Source: NIH RePORTER	This work is funded by the Ontario Trillium Foundation, the Dave Irwin Foundation for Brain Injury Recovery, the Ontario Neurotrauma Foundation, Air Canada, the Ontario Ministry of Health and Long-Term Care, the Ontario Ministry of Tourism, Culture and Sport, and the Ontario Ministry of Education. This work was partially funded by grants from the National Institutes of Health (NIH) (P41RR013218, P41EB015902, R01MH074794), the Department of Defense (X81XWH-07-CC-CSDoD), and a VA merit grant. Dr. Ofer Pasternak was partially supported by a NARSAD Young Investigator grant from the Brain & Behavior Research Foundation. Dr. Inga Koerte is supported by the Else Kroner-Fresenius Stiftung, Germany. Dr. Takeshi Sasaki is supported by the Strategic Young Researcher Overseas Visits Program for Accelerating Brain Circulation from the Japan Society for the Promotion of Science. Mr. Michael Mayinger is supported by the Petraeic Legate Foundation. Dr. Shenton is a consultant on an NIEI grant to SUNY on velocardiofascial syndrome and on a grant supported by the Henry Jackson Foundation.	Bonk C. J., 2006, DISTANCE EDUC, V27, P249, DOI DOI 10.1080/01587910600789670; Bramley H, 2012, CLIN PEDIATR, V51, P332, DOI 10.1177/0009922811425233; Burke MJ, 2012, CAN J NEUROL SCI, V39, P763, DOI 10.1017/S0317167100015584; Chrisman SP, 2013, J ADOLESCENT HEALTH, V52, P330, DOI 10.1016/j.jadohealth.2012.10.271; Ciavarro C, 2008, COMPUT HUM BEHAV, V24, P2862, DOI 10.1016/j.chb.2008.04.011; Cusimano MD, 2014, BRIT J SPORT MED, V48, P141, DOI 10.1136/bjsports-2012-091660; Cusimano MD, 2009, CAN J NEUROL SCI, V36, P315, DOI 10.1017/S0317167100007046; De Beaumont L, 2007, NEUROSURGERY, V61, P329, DOI 10.1227/01.NEU.0000280000.03578.B6; De Beaumont L, 2009, BRAIN, V132, P695, DOI 10.1093/brain/awn347; Delaney JS, 2000, CLIN J SPORT MED, V10, P9, DOI 10.1097/00042752-200001000-00003; Echlin PS, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.10.FOCUS12286; Echlin PS, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.9.FOCUS10186; Echlin PS, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.9.FOCUS10187; Echlin PS, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.10.FOCUS10222; Echlin PS, 2012, NEUROSURG FOCUS, V33, P1, DOI DOI 10.3171/2012.10.F0CUS12286; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Faure C, 2010, AM SECONDARY ED, V39, P5; Faure CE, 2011, SPORT J; Gioia GA, 2009, BRIT J SPORT MED, V43, pI13, DOI 10.1136/bjsm.2009.058255; Graham ID, 2006, J CONTIN EDUC HEALTH, V26, P13, DOI 10.1002/chp.47; Guerriero RM, 2012, CURR OPIN PEDIATR, V24, P696, DOI 10.1097/MOP.0b013e3283595175; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Kaut KP, 2003, CLIN J SPORT MED, V13, P213, DOI 10.1097/00042752-200307000-00004; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Mckinlay A, 2011, BRAIN INJURY, V25, P761, DOI 10.3109/02699052.2011.579935; Moser RS, 2005, NEUROSURGERY, V57, P300, DOI 10.1227/01.NEU.0000166663.98616.E4; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; Provvidenza CF, 2009, BRIT J SPORT MED, V43, pI68, DOI 10.1136/bjsm.2009.058180; Provvidenza C, 2013, BRIT J SPORT MED, V47, P332, DOI 10.1136/bjsports-2012-092099; Sarmiento K, 2010, J SCHOOL HEALTH, V80, P112, DOI 10.1111/j.1746-1561.2010.00491.x; Saunders EA, 2013, ATHLETIC TRAINING SP, V5, P175; Sawyer RJ, 2010, HEALTH PROMOT PRACT, V11, P34, DOI 10.1177/1524839907309377; Schwarzer R, 2011, REHABIL PSYCHOL, V56, P161, DOI 10.1037/a0024509	38	17	17	0	49	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	DEC	2014	121	6					1331	1336		10.3171/2014.8.JNS132804			6	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	AU3CP	WOS:000345490700005	25280091	Green Published, Green Accepted			2021-06-18	
J	Roach, JP; Acker, SN; Bensard, DD; Sirotnak, AP; Karrer, FM; Partrick, DA				Roach, Jonathan P.; Acker, Shannon N.; Bensard, Denis D.; Sirotnak, Andrew P.; Karrer, Frederick M.; Partrick, David A.			Head injury pattern in children can help differentiate accidental from non-accidental trauma	PEDIATRIC SURGERY INTERNATIONAL			English	Article						Child abuse; Abusive head trauma; Subdural hemorrhage; Diffuse axonal injury; Non-accidental trauma	BRAIN-INJURY; YOUNG-CHILDREN; ABUSE	Our aim was to define the radiographic findings that help differentiate abusive head trauma (AHT) from accidental head injury. Our trauma registry was queried for all children a parts per thousand currency sign5 years of age presenting with traumatic brain injury (TBI) from 1996-2011. Of 2,015 children with TBI, 71 % had accidental injury and 29 % had AHT. Children with AHT were more severely injured (ISS 22.1 vs 14.4; p < 0.0001) and had a higher mortality rate (15 vs 5 %; p < 0.0001). Patients with AHT had higher rates of diffuse axonal injury (14 vs 8 %; p < 0.0001) and subdural hemorrhage (76 vs 23 %; p < 0.0001). Children with accidental injury had higher rates of skull fractures (52 vs 21 %; p < 0.0001) and epidural hemorrhages (11 vs 3 %). AHT occurred in 29 % of children and resulted in increased mortality rates. These children had higher rates of subdural hemorrhages and diffuse axonal injury. Physicians initially evaluating injured children must maintain a high index of suspicion for abuse in those who present with subdural hematoma or diffuse axonal injury.	[Roach, Jonathan P.; Acker, Shannon N.; Karrer, Frederick M.; Partrick, David A.] Childrens Hosp Colorado, Dept Pediat Surg, Aurora, CO 80045 USA; [Bensard, Denis D.] Denver Hlth Med Ctr, Dept Surg, Denver, CO USA; [Sirotnak, Andrew P.] Childrens Hosp Colorado, Kempe Child Protect Team, Aurora, CO 80045 USA	Acker, SN (corresponding author), Childrens Hosp Colorado, Dept Pediat Surg, 13123 E 16th Ave,B323, Aurora, CO 80045 USA.	shannon.acker@ucdenver.edu					Acker SN, 2014, J PEDIATR SURG, V49, P338, DOI 10.1016/j.jpedsurg.2013.10.008; Arbogast KB, 2005, PEDIATRICS, V116, P180, DOI 10.1542/peds.2004-2671; Barsness KA, 2003, J TRAUMA, V54, P1107, DOI 10.1097/01.TA.0000068992.01030.A8; Bonnier C, 2007, J CHILD NEUROL, V22, P519, DOI 10.1177/0883073807302604; Chang DC, 2004, J TRAUMA, V57, P1189, DOI 10.1097/01.TA.0000145076.05111.E1; Chiesa A, 2009, PEDIATR CLIN N AM, V56, P317, DOI 10.1016/j.pcl.2009.02.001; Ewing-Cobbs L, 1998, PEDIATRICS, V102, P300, DOI 10.1542/peds.102.2.300; Ewing-Cobbs L, 2000, CHILD NERV SYST, V16, P25, DOI 10.1007/s003810050006; Flaherty EG, 2005, PEDIATR ANN, V34, P349, DOI 10.3928/0090-4481-20050501-08; Fujiwara T, 2008, PEDIATRICS, V122, pE841, DOI 10.1542/peds.2008-0387; HAHN YS, 1983, CHILD BRAIN, V10, P229; Keenan HT, 2003, JAMA-J AM MED ASSOC, V290, P621, DOI 10.1001/jama.290.5.621; KEMPE CH, 1962, JAMA-J AM MED ASSOC, V181, P17, DOI 10.1001/jama.1962.03050270019004; Oehmichen M, 2005, NEUROPEDIATRICS, V36, P240, DOI 10.1055/s-2005-872812; Roaten JB, 2006, J PEDIATR SURG, V41, P2013, DOI 10.1016/j.jpedsurg.2006.08.028; Tung GA, 2006, PEDIATRICS, V118, P626, DOI 10.1542/peds.2006-0130; Vinchon M, 2005, J NEUROSURG, V102, P380, DOI 10.3171/ped.2005.102.4.0380	17	17	18	1	7	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0179-0358	1437-9813		PEDIATR SURG INT	Pediatr. Surg. Int.	NOV	2014	30	11					1103	1106		10.1007/s00383-014-3598-3			4	Pediatrics; Surgery	Pediatrics; Surgery	AS5UX	WOS:000344335900003	25252922				2021-06-18	
J	Zhou, Y; Cui, ZM; Xia, XP; Liu, C; Zhu, XH; Cao, JH; Wu, YY; Zhou, L; Ben, ZY; Song, Y; Zhang, HY; Zhang, DM				Zhou, Ying; Cui, Zhiming; Xia, Xiaopeng; Liu, Chun; Zhu, Xinhui; Cao, Jianhua; Wu, Yuanyuan; Zhou, Li; Ben, Zhiyun; Song, Yan; Zhang, Haiyan; Zhang, Dongmei			Matrix Metalloproteinase-1 (MMP-1) Expression in Rat Spinal Cord Injury Model	CELLULAR AND MOLECULAR NEUROBIOLOGY			English	Article						Spinal cord injury (SCI); Matrix metalloproteinase-1 (MMP-1); Astrocyte proliferation; Neuronal apoptosis	CELL-DEATH; FUNCTIONAL RECOVERY; SIGNALING SYSTEM; APOPTOSIS; ACTIVATION; INHIBITION; SCAR; GENE; PAR1; NEURODEGENERATION	Matrix metalloproteinase-1 (MMP-1), a member of the matrix metalloproteinases family, plays an integral role in extracellular matrix degradation and has been reportedly involved in the regulation of the brain or spinal cord traumatic neurovascular remodeling. Although the critical involvement of MMP-1 in the metastasis of tumors has been extensively documented, the role of MMP-1 in the pathology of neurological diseases remains largely elusive. In the present study, we established an adult rat spinal cord injury (SCI) model and investigated a potential role of MMP-1 in the pathological process of SCI. Using Western blot analysis, we identified notable expression change of MMP-1 after SCI. Immunohistochemistry showed that MMP-1 was distributed widely in rat spinal cord. Double immunofluorescence staining revealed that MMP-1 immunoreactivity was predominantly increased in neurons and astrocytes following SCI. Moreover, after injury, colocalization of MMP-1/active caspase-3 in neurons (NeuN-positive), and colocalization of MMP-1/PCNA in astrocytes (GFAP-positive) were clearly observed. We also examined the protein expression of PCNA, active caspase-3, Bcl-2, and Bax and found that the expression of the proteins was closely correlated with that of MMP-1. Taken together, our findings indicate that MMP-1 might play an important role in the regulation of neuronal apoptosis and astrocyte proliferation after SCI.	[Zhou, Ying; Zhou, Li; Ben, Zhiyun; Song, Yan; Zhang, Haiyan] Nantong Univ, Dept Immunol, Coll Med, Jiangsu Prov Key Lab Inflammat & Mol Drug Target, Nantong 226001, Peoples R China; [Cui, Zhiming; Zhu, Xinhui; Cao, Jianhua] Nantong Univ, Dept Osteol, Affiliated Hosp 2, Nantong 226001, Peoples R China; [Xia, Xiaopeng] Nantong Tradit Chinese Med Hosp, Dept Osteol, Nantong 226001, Peoples R China; [Liu, Chun] Nantong Univ, Lab Anim Ctr, Nantong 226001, Peoples R China; [Wu, Yuanyuan; Zhang, Dongmei] Nantong Univ, Coll Med, Dept Pathogen Biol, Nantong 226001, Peoples R China	Zhang, DM (corresponding author), Nantong Univ, Coll Med, Dept Pathogen Biol, Nantong 226001, Peoples R China.	sidezuoyinyuan@126.com			National Basic Research Program of China (973 Program)National Basic Research Program of China [2012CB822104]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [31170766]; Natural Science Foundation of Jiangsu University and College [11KJA310002]; Nantong City Social Development Projects [HS2012032]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This work was supported by National Basic Research Program of China (973 Program, No. 2012CB822104); National Natural Science Foundation of China (31170766); Key Project Natural Science Foundation of Jiangsu University and College (No. 11KJA310002); Nantong City Social Development Projects funds (HS2012032); A Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD).	Agapova OA, 2003, BRAIN RES, V967, P132, DOI 10.1016/S0006-8993(02)04234-8; Agarwal A, 2008, MOL CANCER THER, V7, P2746, DOI 10.1158/1535-7163.MCT-08-0177; Agarwal A, 2010, CANCER RES, V70, P5880, DOI 10.1158/0008-5472.CAN-09-4341; Bao Y, 2012, J CEREBR BLOOD F MET, V32, P1567, DOI 10.1038/jcbfm.2012.52; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Boire A, 2005, CELL, V120, P303, DOI 10.1016/j.cell.2004.12.018; Bujor AM, 2008, J INVEST DERMATOL, V128, P1906, DOI 10.1038/jid.2008.39; Buss A, 2007, BMC NEUROL, V7, DOI 10.1186/1471-2377-7-17; Casha S, 2005, EXP NEUROL, V196, P390, DOI 10.1016/j.expneurol.2005.08.020; Chen DF, 1997, NATURE, V385, P434, DOI 10.1038/385434a0; Chen JJ, 2013, J MOL NEUROSCI, V51, P82, DOI 10.1007/s12031-013-0003-y; Choi DC, 2010, NEUROBIOL DIS, V39, P272, DOI 10.1016/j.nbd.2010.04.003; Dang ABC, 2008, SPINE, V33, pE576, DOI 10.1097/BRS.0b013e31817ecc87; DUCKER TB, 1971, J NEUROSURG, V35, P700, DOI 10.3171/jns.1971.35.6.0700; Dumont RJ, 2001, CLIN NEUROPHARMACOL, V24, P254, DOI 10.1097/00002826-200109000-00002; FAIRHOLM D, 1970, Surgical Forum (Chicago), V21, P453; Fawcett JW, 1999, BRAIN RES BULL, V49, P377, DOI 10.1016/S0361-9230(99)00072-6; Feng LX, 1999, J CELL BIOCHEM, V74, P576, DOI 10.1002/(SICI)1097-4644(19990915)74:4<576::AID-JCB7>3.0.CO;2-N; GOLDBERG GI, 1986, J BIOL CHEM, V261, P6600; GROSS J, 1962, P NATL ACAD SCI USA, V48, P1014, DOI 10.1073/pnas.48.6.1014; GRUNER JA, 1992, J NEUROTRAUM, V9, P123, DOI 10.1089/neu.1992.9.123; Gu ZZ, 2005, J NEUROSCI, V25, P6401, DOI 10.1523/JNEUROSCI.1563-05.2005; Hang QL, 2014, GLYCOBIOLOGY, V24, P292, DOI 10.1093/glycob/cwt110; Hermann GE, 2001, NEUROBIOL DIS, V8, P590, DOI 10.1006/nbdi.2001.0414; Jana A, 2009, J NEUROL SCI, V278, P5, DOI 10.1016/j.jns.2008.12.010; Kahari VM, 1997, EXP DERMATOL, V6, P199, DOI 10.1111/j.1600-0625.1997.tb00164.x; Khalatbary AR, 2012, IRAN RED CRESCENT ME, V14, P229; Kiaei M, 2007, EXP NEUROL, V205, P74, DOI 10.1016/j.expneurol.2007.01.036; Kunapuli P, 2004, J BIOL CHEM, V279, P23151, DOI 10.1074/jbc.M314192200; Lee SR, 2004, J NEUROSCI, V24, P671, DOI 10.1523/JNEUROSCI.4243-03.2004; Liu Y, 2010, NEUROBIOL DIS, V37, P384, DOI 10.1016/j.nbd.2009.10.018; Lopez-Vales R, 2010, J NEUROSCI, V30, P3220, DOI 10.1523/JNEUROSCI.5770-09.2010; Lu PF, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005058; Marani M, 2002, MOL CELL BIOL, V22, P3577, DOI 10.1128/MCB.22.11.3577-3589.2002; Marriott JB, 2003, CANCER RES, V63, P593; Martinou JC, 2011, DEV CELL, V21, P92, DOI 10.1016/j.devcel.2011.06.017; McCawley LJ, 2000, MOL MED TODAY, V6, P149, DOI 10.1016/S1357-4310(00)01686-5; Nagase H, 2006, CARDIOVASC RES, V69, P562, DOI 10.1016/j.cardiores.2005.12.002; Nguyen N, 2006, CANCER RES, V66, P2658, DOI 10.1158/0008-5472.CAN-05-2082; Noel A, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00140; Ola MS, 2011, MOL CELL BIOCHEM, V351, P41, DOI 10.1007/s11010-010-0709-x; Pallavi SK, 2012, EMBO J, V31, P2895, DOI 10.1038/emboj.2012.129; Popovich PG, 2002, J NEUROPATH EXP NEUR, V61, P623, DOI 10.1093/jnen/61.7.623; Raghupathi R, 2004, BRAIN PATHOL, V14, P215, DOI 10.1111/j.1750-3639.2004.tb00056.x; Rahman MA, 2012, MOL CELL BIOCHEM, V369, P95, DOI 10.1007/s11010-012-1372-1; Romanic AM, 1998, STROKE, V29, P1020, DOI 10.1161/01.STR.29.5.1020; Rosell A, 2008, CURR OPIN PHARMACOL, V8, P82, DOI 10.1016/j.coph.2007.12.001; Rosenberg GA, 2002, GLIA, V39, P279, DOI 10.1002/glia.10108; Ryu B, 2011, J INVEST DERMATOL, V131, P1579, DOI 10.1038/jid.2011.65; Saadoun S, 2008, BRAIN, V131, P1087, DOI 10.1093/brain/awn014; SENTER HJ, 1978, J NEUROSURG, V49, P569, DOI 10.3171/jns.1978.49.4.0569; Shang L, 2009, CLIN EXP PHARMACOL P, V36, P912, DOI 10.1111/j.1440-1681.2009.05171.x; Soell M, 2002, J DENT RES, V81, P174, DOI 10.1177/154405910208100306; Sternlicht MD, 2001, ANNU REV CELL DEV BI, V17, P463, DOI 10.1146/annurev.cellbio.17.1.463; Sunkaria A, 2012, CHEM RES TOXICOL, V25, P1762, DOI 10.1021/tx300234n; Tang MJ, 2007, J BIOL CHEM, V282, P34457, DOI 10.1074/jbc.M704459200; Trivedi V, 2009, CELL, V137, P332, DOI 10.1016/j.cell.2009.02.018; Uhlirova M, 2006, EMBO J, V25, P5294, DOI 10.1038/sj.emboj.7601401; Ullah N, 2011, NEUROPHARMACOLOGY, V61, P1248, DOI 10.1016/j.neuropharm.2011.06.031; Vos CMP, 2000, EXP NEUROL, V163, P324, DOI 10.1006/exnr.2000.7388; Vu TH, 2000, GENE DEV, V14, P2123, DOI 10.1101/gad.815400; Wang XY, 2000, J NEUROSCI, V20, P7037, DOI 10.1523/JNEUROSCI.20-18-07037.2000; Woessner JF, 1998, CONNECT TISSUE RES, V39, P69, DOI 10.3109/03008209809023913; Wu JF, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-169; Xiao XY, 2012, TUMOR BIOL, V33, P2385, DOI 10.1007/s13277-012-0502-4; Xu DW, 2011, J NEUROL SCI, V309, P141, DOI 10.1016/j.jns.2011.06.024; Yang E, 2009, CANCER RES, V69, P6223, DOI 10.1158/0008-5472.CAN-09-0187; Yin X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038381; Yong VW, 2005, NAT REV NEUROSCI, V6, P931, DOI 10.1038/nrn1807; Young Wise, 1993, Journal of Emergency Medicine, V11, P13; Zhang JL, 2013, J MOL NEUROSCI, V49, P417, DOI 10.1007/s12031-012-9914-2; Zhao BQ, 2006, NAT MED, V12, P441, DOI 10.1038/nm1387; ZIMMERMANN M, 1983, PAIN, V16, P109, DOI 10.1016/0304-3959(83)90201-4	73	17	18	2	17	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0272-4340	1573-6830		CELL MOL NEUROBIOL	Cell. Mol. Neurobiol.	NOV	2014	34	8					1151	1163		10.1007/s10571-014-0090-5			13	Cell Biology; Neurosciences	Cell Biology; Neurosciences & Neurology	AQ9XJ	WOS:000343211900009	25073870				2021-06-18	
J	Kim, H; Kim, GD; Yoon, BC; Kim, K; Kim, BJ; Choi, YH; Czosnyka, M; Oh, BM; Kim, DJ				Kim, Hakseung; Kim, Gwang-dong; Yoon, Byung C.; Kim, Keewon; Kim, Byung-Jo; Choi, Young Hun; Czosnyka, Marek; Oh, Byung-Mo; Kim, Dong-Joo			Quantitative analysis of computed tomography images and early detection of cerebral edema for pediatric traumatic brain injury patients: retrospective study	BMC MEDICINE			English	Article						Cerebral edema; Computed tomography; Densitometry; Traumatic brain injury; Pediatrics	HISTOGRAM ANALYSIS; VASOGENIC EDEMA; LUNG DENSITY; HEAD-INJURY; ARTERY OCCLUSION; CT DENSITOMETRY; CHILDREN; CLASSIFICATION; MYELINATION; PREDICTION	Background: The purpose of this study was to identify whether the distribution of Hounsfield Unit (HU) values across the intracranial area in computed tomography (CT) images can be used as an effective diagnostic tool for determining the severity of cerebral edema in pediatric traumatic brain injury (TBI) patients. Methods: CT images, medical records and radiology reports on 70 pediatric patients were collected. Based on radiology reports and the Marshall classification, the patients were grouped as mild edema patients (n = 37) or severe edema patients (n = 33). Automated quantitative analysis using unenhanced CT images was applied to eliminate artifacts and identify the difference in HU value distribution across the intracranial area between these groups. Results: The proportion of pixels with HU = 17 to 24 was highly correlated with the existence of severe cerebral edema (P < 0.01). This proportion was also able to differentiate patients who developed delayed cerebral edema from mild TBI patients. A significant difference between deceased patients and surviving patients in terms of the HU distribution came from the proportion of pixels with HU = 19 to HU = 23 (P < 0.01). Conclusions: The proportion of pixels with an HU value of 17 to 24 in the entire cerebral area of a non-enhanced CT image can be an effective basis for evaluating the severity of cerebral edema. Based on this result, we propose a novel approach for the early detection of severe cerebral edema.	[Kim, Hakseung; Kim, Dong-Joo] Korea Univ, Dept Brain & Cognit Engn, Seoul 136713, South Korea; [Kim, Gwang-dong; Kim, Keewon; Oh, Byung-Mo] Seoul Natl Univ, Coll Med, Dept Rehabil Med, Seoul, South Korea; [Yoon, Byung C.] Stanford Univ, Sch Med, Dept Neurosurg, Stanford, CA USA; [Kim, Byung-Jo] Korea Univ, Coll Med, Dept Neurol, Seoul 136705, South Korea; [Choi, Young Hun] Seoul Natl Univ, Childrens Hosp, Dept Radiol, Seoul, South Korea; [Czosnyka, Marek; Kim, Dong-Joo] Univ Cambridge, Sch Clin, Acad Neurosurg Unit, Cambridge, England	Kim, DJ (corresponding author), Korea Univ, Dept Brain & Cognit Engn, Seoul 136713, South Korea.	dongjookim@korea.ac.kr	Kim, Byung-Jo/A-5943-2012; Choi, Young Hun/O-3282-2015	Kim, Byung-Jo/0000-0002-0445-7185; Choi, Young Hun/0000-0002-1842-9062	National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning [2013R1A1A1004827]; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G9439390, G0600986] Funding Source: researchfish	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (2013R1A1A1004827).	Abe S, 2012, IFMBE PROC, V37, P555; Adelson PD, 1997, PEDIATR NEUROSURG, V26, P200; Adelson PD, 1998, J CHILD NEUROL, V13, P2, DOI 10.1177/088307389801300102; ALDRICH EF, 1992, J NEUROSURG, V76, P450, DOI 10.3171/jns.1992.76.3.0450; Barras CD, 2013, AM J NEURORADIOL, V34, P1139, DOI 10.3174/ajnr.A3375; Barzo P, 1997, J NEUROSURG, V87, P900, DOI 10.3171/jns.1997.87.6.0900; Bauer R, 1999, EXP TOXICOL PATHOL, V51, P143, DOI 10.1016/S0940-2993(99)80088-8; Bendszus M, 1997, NEURORADIOLOGY, V39, P127, DOI 10.1007/s002340050379; Biernacki W, 1997, EUR RESPIR J, V10, P2455, DOI 10.1183/09031936.97.10112455; BRUCE DA, 1981, J NEUROSURG, V54, P170, DOI 10.3171/jns.1981.54.2.0170; Camilla Lindan EG, 2012, FUNDAMENTALS DIAGNOS, P1420; Claassen J, 2002, STROKE, V33, P1225, DOI 10.1161/01.STR.0000015624.29071.1F; CLASEN RA, 1981, J COMPUT ASSIST TOMO, V5, P313, DOI 10.1097/00004728-198106000-00001; Creasy JL, 2011, DATING NEUROLOGICAL INJURY: A FORENSIC GUIDE FOR RADIOLOGISTS, OTHER EXPERT MEDICAL WITNESSES, AND ATTORNEYS, P119, DOI 10.1007/978-1-60761-250-6_9; Degos V, 2010, YB INTENSIVE CARE EM, V2010, P399, DOI [10.1007/978-3-642-10286-8_38, DOI 10.1007/978-3-642-10286-8_38]; DIETRICH RB, 1988, AM J ROENTGENOL, V150, P889, DOI 10.2214/ajr.150.4.889; Doelken M, 2007, DIAGN INTERV RADIOL, V13, P125; Donkin JJ, 2010, CURR OPIN NEUROL, V23, P293, DOI 10.1097/WCO.0b013e328337f451; Dzialowski I, 2004, J NEUROIMAGING, V14, P42, DOI 10.1177/1051228403258135; Dzialowski I, 2007, RADIOLOGY, V243, P720, DOI 10.1148/radiol.2432060137; GARDEUR D, 1977, J COMPUT ASSIST TOMO, V1, P231, DOI 10.1097/00004728-197704000-00014; Hagen T, 2007, NEURORADIOLOGY, V49, P921, DOI 10.1007/s00234-007-0272-7; HEREMANS A, 1992, CHEST, V102, P805, DOI 10.1378/chest.102.3.805; Hiler M, 2006, J NEUROSURG, V104, P731, DOI 10.3171/jns.2006.104.5.731; Huh Jimmy W, 2009, Anesthesiol Clin, V27, P213, DOI 10.1016/j.anclin.2009.05.006; IMANAGA H, 1983, Neurological Surgery, V11, P481; Jaffe TA, 2010, AM J ROENTGENOL, V195, P433, DOI 10.2214/AJR.09.3957; Kahle KT, 2009, PHYSIOLOGY, V24, P257, DOI 10.1152/physiol.00015.2009; Kalef-Ezra J, 1999, ACTA RADIOL, V40, P333, DOI 10.3109/02841859909175564; Kato S, 1996, CHEST, V109, P1439, DOI 10.1378/chest.109.6.1439; Kawata Y, 2012, MED PHYS, V39, P988, DOI 10.1118/1.3679017; Kemp AM, 2009, CLIN RADIOL, V64, P473, DOI 10.1016/j.crad.2008.11.011; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; KONDO T, 1982, ACTA NEUROCHIR, V64, P19, DOI 10.1007/BF01405616; Lee C, 2006, CURR OPIN ANESTHESIO, V19, P262, DOI 10.1097/01.aco.0000192787.93386.9c; Liang Danny, 2007, Neurosurg Focus, V22, pE2, DOI 10.3171/foc.2007.22.5.3; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Mangel L, 2002, NEOPLASMA, V49, P237; Manolakaki D, 2009, J TRAUMA, V66, P1008, DOI 10.1097/TA.0b013e31819adba2; Marmarou A, 2006, ACTA NEUROCHIR SUPPL, V96, P24; Marmarou A, 2000, ACT NEUR S, V76, P349; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Metter RB, 2011, RESUSCITATION, V82, P1180, DOI 10.1016/j.resuscitation.2011.04.001; Moppett IK, 2007, BRIT J ANAESTH, V99, P18, DOI 10.1093/bja/aem128; Murakami JW, 1999, AM J NEURORADIOL, V20, P1406; Nag S, 2009, ACTA NEUROPATHOL, V118, P197, DOI 10.1007/s00401-009-0541-0; Nakayama Y, 2005, RADIOLOGY, V237, P945, DOI 10.1148/radiol.2373041655; Nomori H, 2003, J THORAC CARDIOV SUR, V126, P1584, DOI 10.1016/S0022-5223(03)00885-7; Provenzale JM, 2010, AM J ROENTGENOL, V194, P16, DOI 10.2214/AJR.09.3687; Reithmeier T, 2005, CHILD NERV SYST, V21, P249, DOI 10.1007/s00381-004-1044-x; Rosand J, 2001, J INTENSIVE CARE MED, V16, P128, DOI 10.1046/j.1525-1489.2001.00128.x; ROZSA L, 1989, NEUROSURG REV, V12, P133, DOI 10.1007/BF01741486; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Schaefer PW, 2000, RADIOLOGY, V217, P331, DOI 10.1148/radiology.217.2.r00nv24331; Schneider W, 2000, PHYS MED BIOL, V45, P459, DOI 10.1088/0031-9155/45/2/314; Serafini G, 2008, CURR OPIN ANESTHESIO, V21, P499, DOI 10.1097/ACO.0b013e328304115b; STAUDT M, 1994, PEDIATR RADIOL, V24, P122, DOI 10.1007/BF02020169; Thalacker U, 1998, STRAHLENTHER ONKOL, V174, P14, DOI 10.1007/BF03038222; Udomphorn Y, 2008, PEDIATR NEUROL, V38, P225, DOI 10.1016/j.pediatrneurol.2007.09.012; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; WARD JD, 1994, PEDIATR NEUROSURG, V20, P183, DOI 10.1159/000120784; WARE AJ, 1971, GASTROENTEROLOGY, V61, P877; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Yamashiro T, 2011, COPD, V8, P13, DOI 10.3109/15412555.2010.541537; Yuan R, 2007, CHEST, V132, P617, DOI 10.1378/chest.06-2325; Yuh EL, 2012, J NEUROTRAUM, V29, P735, DOI 10.1089/neu.2011.2008; Zach JA, 2012, INVEST RADIOL, V47, P596, DOI 10.1097/RLI.0b013e318262292e; Zhu GW, 2009, J INT MED RES, V37, P983, DOI 10.1177/147323000903700402; Zimmerman RD, 2004, AM J NEURORADIOL, V25, P1304; Zwienenberg M, 1999, J NEUROTRAUM, V16, P937, DOI 10.1089/neu.1999.16.937	70	17	17	0	5	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1741-7015			BMC MED	BMC Med.	OCT 22	2014	12								186	10.1186/s12916-014-0186-2			16	Medicine, General & Internal	General & Internal Medicine	AT4ER	WOS:000344893100001	25339549	DOAJ Gold, Green Published			2021-06-18	
J	Vonder Haar, C; Maass, WR; Jacobs, EA; Hoane, MR				Vonder Haar, Cole; Maass, William R.; Jacobs, Eric A.; Hoane, Michael R.			Deficits in Discrimination after Experimental Frontal Brain Injury Are Mediated by Motivation and Can Be Improved by Nicotinamide Administration	JOURNAL OF NEUROTRAUMA			English	Article						animal models; controlled cortical impact; operant learning	CORTICAL CONTUSION INJURY; FUNCTIONAL RECOVERY; PREFRONTAL CORTEX; DECISION-MAKING; SELF-AWARENESS; LONG-TERM; RATS; BEHAVIOR; IMPACT; MOTOR	One of the largest challenges in experimental neurotrauma work is the development of models relevant to the human condition. This includes both creating similar pathophysiology as well as the generation of relevant behavioral deficits. Recent studies have shown that there is a large potential for the use of discrimination tasks in rats to detect injury-induced deficits. The literature on discrimination and TBI is still limited, however. The current study investigated motivational and motor factors that could potentially contribute to deficits in discrimination. In addition, the efficacy of a neuroprotective agent, nicotinamide, was assessed. Rats were trained on a discrimination task and motivation task, given a bilateral frontal controlled cortical impact TBI (+ 3.0 AP, 0.0 ML from bregma), and then reassessed. They were also assessed on motor ability and Morris water maze (MWM) performance. Experiment 1 showed that TBI resulted in large deficits in discrimination and motivation. No deficits were observed on gross motor measures; however, the vehicle group showed impairments in fine motor control. Both injured groups were impaired on the reference memory MWM, but only nicotinamide-treated rats were impaired on the working memory MWM. Nicotinamide administration improved performance on discrimination and motivation measures. Experiment 2 evaluated retraining on the discrimination task and suggested that motivation may be a large factor underlying discrimination deficits. Retrained rats improved considerably on the discrimination task. The tasks evaluated in this study demonstrate robust deficits and may improve the detection of pharmaceutical effects by being very sensitive to pervasive cognitive deficits that occur after frontal TBI.	[Vonder Haar, Cole; Maass, William R.; Jacobs, Eric A.; Hoane, Michael R.] So Illinois Univ, Dept Psychol, Restorat Neurosci Lab, Ctr Integrated Res Cognit & Neural Sci, Carbondale, IL 62901 USA	Hoane, MR (corresponding author), So Illinois Univ, Dept Psychol, Restorat Neurosci Lab, MC 6502, Carbondale, IL 62901 USA.	mhoane@siu.edu		Hoane, Michael/0000-0001-7779-2657; Vonder Haar, Cole/0000-0001-7949-2068	SIUC Graduate School; SIUC Department of Psychology; SIUC Graduate and Professional Student Council	The authors would like to thank Travis Smith and Charles Frye for their assistance in this research. This work was funded in part by the SIUC Graduate School, SIUC Department of Psychology and the SIUC Graduate and Professional Student Council.	Anderson GD, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00021; Andersson S, 2002, NEUROPSY NEUROPSY BE, V15, P184, DOI 10.1097/01.WNN.0000026596.88167.8E; [Anonymous], 2010, TRAUM BRAIN INJ US; Bauer DJ, 2011, NEUROBIOL LEARN MEM, V95, P166, DOI 10.1016/j.nlm.2010.12.009; Birrell JM, 2000, J NEUROSCI, V20, P4320; Bondi CO, 2014, J NEUROTRAUM, V31, P926, DOI 10.1089/neu.2013.3295; Bussey TJ, 1997, BEHAV NEUROSCI, V111, P908, DOI 10.1037/0735-7044.111.5.908; Bussey TJ, 1997, BEHAV NEUROSCI, V111, P920, DOI 10.1037/0735-7044.111.5.920; Clark L, 2004, BRAIN COGNITION, V55, P41, DOI 10.1016/s0278-2626(03)00284-7; COGGESHALL RE, 1992, TRENDS NEUROSCI, V15, P9, DOI 10.1016/0166-2236(92)90339-A; Cole JT, 2011, J NEUROTRAUM, V28, P359, DOI 10.1089/neu.2010.1427; Corso P, 2006, INJURY PREV, V12, P212, DOI 10.1136/ip.2005.010983; de Bruin JPC, 2001, NEUROBIOL LEARN MEM, V75, P164, DOI 10.1006/nlme.2000.3962; Ferster C.B., 1957, SCHEDULES REINFORCEM; Fleming JM, 1996, BRAIN INJURY, V10, P1; Goffus AM, 2010, OXID MED CELL LONGEV, V3, P145, DOI 10.4161/oxim.3.2.11315; GORMAN LK, 1993, BRAIN RES, V614, P29, DOI 10.1016/0006-8993(93)91014-J; Haar CV, 2011, BEHAV BRAIN RES, V224, P311, DOI 10.1016/j.bbr.2011.06.009; Hoane MR, 2008, NEUROSCIENCE, V154, P861, DOI 10.1016/j.neuroscience.2008.04.044; Hoane MR, 2006, J NEUROTRAUM, V23, P1535, DOI 10.1089/neu.2006.23.1535; Hoane MR, 2003, J NEUROTRAUM, V20, P1189, DOI 10.1089/089771503770802871; HOFFMAN SW, 1994, J NEUROTRAUM, V11, P417, DOI 10.1089/neu.1994.11.417; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Ikemoto S, 1999, BRAIN RES REV, V31, P6, DOI 10.1016/S0165-0173(99)00023-5; Jorge R, 2003, INT REV PSYCHIATR, V15, P317, DOI 10.1080/09540260310001606700; Klaidman L, 2003, PHARMACOLOGY, V69, P150, DOI 10.1159/000072668; KOLB B, 1984, BRAIN RES REV, V8, P65, DOI 10.1016/0165-0173(84)90018-3; Lindner MD, 1998, J NEUROTRAUM, V15, P199, DOI 10.1089/neu.1998.15.199; Maas AIR, 2007, J NEUROTRAUM, V24, P232, DOI 10.1089/neu.2006.0024; Maiese K, 2009, MOLECULES, V14, P3446, DOI 10.3390/molecules14093446; Martens KM, 2013, JOVE-J VIS EXP, DOI 10.3791/50033; Martens KM, 2012, J NEUROTRAUM, V29, P2505, DOI 10.1089/neu.2012.2388; McIntosh TK, 1989, J NEUROTRAUM, V6, P247, DOI 10.1089/neu.1989.6.247; MORGAN MA, 1993, NEUROSCI LETT, V163, P109, DOI 10.1016/0304-3940(93)90241-C; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Peterson TC, 2012, J NEUROTRAUM, V29, P2823, DOI 10.1089/neu.2012.2471; Port A, 2002, BRAIN INJURY, V16, P277, DOI 10.1080/02699050110103274; Powell JH, 1996, J NEUROL NEUROSUR PS, V60, P416, DOI 10.1136/jnnp.60.4.416; Richardson NR, 1996, J NEUROSCI METH, V66, P1, DOI 10.1016/0165-0270(95)00153-0; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Salamone JD, 2002, BEHAV BRAIN RES, V137, P3, DOI 10.1016/S0166-4328(02)00282-6; Stafford D, 1998, J EXP ANAL BEHAV, V70, P123, DOI 10.1901/jeab.1998.70-123; Swan AA, 2011, J NEUROTRAUM, V28, P431, DOI 10.1089/neu.2010.1519; Temel Y, 2005, EXP NEUROL, V193, P43, DOI 10.1016/j.expneurol.2004.12.025; Temel Y, 2006, NEUROSCI LETT, V406, P138, DOI 10.1016/j.neulet.2006.07.036; Uylings HBM, 2003, BEHAV BRAIN RES, V146, P3, DOI 10.1016/j.bbr.2003.09.028; Vonder Haar C, 2013, CLIN PHARM BIOPHAR S, VS1; Vonder Haar C, 2014, BRAIN INJURY, V28, P235, DOI 10.3109/02699052.2013.860473; Washington PM, 2012, J NEUROTRAUM, V29, P2283, DOI 10.1089/neu.2012.2456; Zhao ZR, 2012, J NEUROTRAUM, V29, P2475, DOI 10.1089/neu.2012.2511	50	17	17	0	8	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	OCT 15	2014	31	20					1711	1720		10.1089/neu.2014.3459			10	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	AP8BF	WOS:000342302200004	24934504	Green Published			2021-06-18	
J	Forward, KE; Seabrook, JA; Lynch, T; Lim, R; Poonai, N; Sangha, GS				Forward, Karen E.; Seabrook, Jamie A.; Lynch, Tim; Lim, Rodrick; Poonai, Naveen; Sangha, Gurinder S.			A comparison of the epidemiology of ice hockey injuries between male and female youth in Canada	PAEDIATRICS & CHILD HEALTH			English	Article						Epidemiology; Female; Hockey; Injury; Minor; Youth	RISK-FACTORS	BACKGROUND: Hockey is played by youth across Canada, and its popularity has increased dramatically among females in the past decade. Despite this, there has been little epidemiological research comparing the injury patterns of young female and male hockey players. OBJECTIVE: To describe and compare injuries sustained by female and male youth hockey players using the Canadian Hospitals Injury Reporting and Prevention Program database. METHODS: In the present cross-sectional, retrospective comparison study, the Canadian Hospitals Injury Reporting and Prevention Program database was used to identify all hockey-related injuries sustained by children seven to 17.5 years of age over a 15-year period (January 1995 to December 2009). Exclusion criteria included paid professional players and children with injuries sustained while playing road hockey. RESULTS: Inclusion criteria were met by 33,233 children (2637 [7.9%] females and 30,596 [92.1%] males). Compared with males, females reported proportionately more soft tissue injuries (39.8% versus 32.6%; P<0.01) and sprains/strains (21.1% versus 17.6%; P<0.01). Males experienced more fractures (27.1% versus 18.2%; P<0.01) and were most often injured through body checking (42.8% versus 25.7%; P<0.01). Females showed a trend toward increased concussion with age, and were most often injured through collisions (28.6% versus 24.6%; P<0.01). CONCLUSION: Compared with males, female hockey players sustained proportionately more soft tissue injures and sprains/strains, and showed a trend toward concussions in late adolecence. Males experienced more fractures, shoulder injuries and injuries due to body checking. Further research is required to identify risk factors for injury in female youth hockey players and to target injury prevention.	[Forward, Karen E.; Seabrook, Jamie A.; Lynch, Tim; Lim, Rodrick; Poonai, Naveen; Sangha, Gurinder S.] Western Univ, Dept Paediat, London, ON, Canada; [Seabrook, Jamie A.; Lynch, Tim; Lim, Rodrick] Childrens Hlth Inst, London, ON, Canada	Sangha, GS (corresponding author), Childrens Hosp, London Hlth Sci Ctr, Dept Emergency Med, Room E1-105,800 Commissioners Rd East, London, ON N6C 2V5, Canada.	gurinder.sangha@lhsc.on.ca					Agel J, 2007, J ATHL TRAINING, V42, P249; Agel J, 2010, CAN J SURG, V53, P319; Brainard LL, 2012, MED SCI SPORT EXER, V44, P297, DOI 10.1249/MSS.0b013e31822b0ab4; Canada Hockey, HOCK CAN 94 ANN GEN; Cusimano Michael D, 2011, Open Med, V5, pe57; Darling SR, 2011, BRIT J SPORT MED, V45, P492, DOI 10.1136/bjsm.2009.063693; Decloe MD, 2014, BRIT J SPORT MED, V48, P51, DOI 10.1136/bjsports-2012-091653; Deits J, 2010, J ATHL TRAINING, V45, P467, DOI 10.4085/1062-6050-45.5.467; Dryden D M, 2000, J Sci Med Sport, V3, P140, DOI 10.1016/S1440-2440(00)80076-6; Dryden DM, 2000, MED SCI SPORT EXER, V32, P1378, DOI 10.1097/00005768-200008000-00004; Emery CA, 2010, INJURY PREV, V16, P113, DOI 10.1136/ip.2009.022764; Hockey Canada, AG CHANG GEN INF; Hockey Canada, HOCK CAN BAS REG STA; Hockey Canada, FEM HOCK STAT HIST; Houghton KM, 2012, PAED CHILD HEALT-CAN, V17, P509, DOI 10.1093/pch/17.9.509; Keightley M, 2013, INT J SPORTS MED, V34, P756, DOI 10.1055/s-0032-1327574; Macpherson A, 2006, PEDIATRICS, V117, pE143, DOI 10.1542/peds.2005-1163; Public Health Agency of Canada, CHIRPP UN SOURC CHIL	18	17	17	0	9	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	1205-7088	1918-1485		PAED CHILD HEALT-CAN	Paediatr. Child Health	OCT	2014	19	8					418	422		10.1093/pch/19.8.418			5	Pediatrics	Pediatrics	AT0OP	WOS:000344635500009	25382998	Green Published			2021-06-18	
J	Lorente, L; Martin, MM; Gonzalez-Rivero, AF; Ramos, L; Argueso, M; Caceres, JJ; Sole-Violan, J; Serrano, N; Rodriguez, ST; Jimenez, A; Borreguero-Leon, JM				Lorente, Leonardo; Martin, Maria M.; Gonzalez-Rivero, Agustin F.; Ramos, Luis; Argueso, Monica; Caceres, Juan J.; Sole-Violan, Jordi; Serrano, Nicolas; Rodriguez, Sergio T.; Jimenez, Alejandro; Borreguero-Leon, Juan M.			Serum soluble CD40 Ligand levels are associated with severity and mortality of brain trauma injury patients	THROMBOSIS RESEARCH			English	Article						sCD40L; Brain trauma; Patients; Mortality; Injury	TISSUE FACTOR; ENDOTHELIAL-CELLS; INFLAMMATION; EXPRESSION; PLATELETS; INVOLVEMENT; THROMBOSIS; DISEASE; EVENTS	Background: Serum soluble CD40 Ligand (sCD40L) levels, which exhibit prothrombotic and proinflammatory properties, have not been studied in patients with traumatic brain injury (TBI). Thus, the objective of this study was to determine whether serum sCD40L levels are associated with severity and mortality in patients with severe TBI. Methods: This was a prospective, observational and multicenter study carried out in six Spanish Intensive Care Units. Patients with severe TBI defined as Glasgow Coma Scale (GCS) lower than 9 were included, while those with Injury Severity Score (ISS) in non-cranial aspects higher than 9 were excluded. Serum levels of sCD40L were measured on the day of TBI. Endpoint was established in 30-day mortality. Results: We found higher serum sCD40L levels (P < 0.001) in non-surviving TBI patients (N = 27) than in survivor ones (N = 73). Logistic regression analysis showed that serum sCD40L levels were associated with 30-day mortality (OR = 1.58; 95% CI = 1.12-2.21; P = 0.008) controlling for APACHE-II score and computer tomography findings. The area under the curve (AUC) for serum sCD40L levels as predictor of 30-day mortality was 0.79 (95% CI = 0.70-0.86; P < 0.001). Survival analysis showed that patients with serum sCD40L levels higher than 2.11 ng/mL presented increased 30-day mortality than patients with lower levels (Hazard ratio = 9.0; 95% CI = 4.25-19.27; P < 0.001). We found an association between serum sCD40L levels and APACHE-II (rho = 0.33; P = 0.001), and GCS score (rho = -0.21; P = 0.04). Conclusions: To our knowledge, this is the first study reporting data on serum sCD40L levels in patients with severe TBI. The most relevant and newer findings of our study are that serum sCD40L levels in non-surviving patients with severe TBI are higher than in surviving ones, and that there are an association between serum sCD40L levels and TBI severity and mortality. (C) 2014 Elsevier Ltd. All rights reserved.	[Lorente, Leonardo; Serrano, Nicolas] Hosp Univ Canarias, Intens Care Unit, San Cristobal la Laguna 38320, Santa Cruz De T, Spain; [Martin, Maria M.; Rodriguez, Sergio T.] Hosp Univ Nuestra Senora Candelaria, Intens Care Unit, Santa Cruz De Tenerife 38010, Spain; [Gonzalez-Rivero, Agustin F.; Borreguero-Leon, Juan M.] Hosp Univ Canarias, Lab Deparment, San Cristobal la Laguna 38320, Santa Cruz De T, Spain; [Ramos, Luis] Hosp Gen La Palma, Intens Care Unit, Brena Alta, La Palma, Spain; [Argueso, Monica] Hosp Clin Univ Valencia, Intens Care Unit, Valencia 46004, Spain; [Caceres, Juan J.] Hosp Insular, Intens Care Unit, Las Palmas Gran Canaria 35016, Spain; [Sole-Violan, Jordi] Hosp Univ Dr Negrin, Intens Care Unit, Las Palmas Gran Canaria 35010, Spain; [Jimenez, Alejandro] Hosp Univ Canarias, Res Unit, San Cristobal la Laguna 38320, Santa Cruz De T, Spain	Lorente, L (corresponding author), Hosp Univ Canarias, Intens Care Unit, Ofra S-N, San Cristobal la Laguna 38320, Santa Cruz De T, Spain.	lorentemartin@msn.com		Borreguero Leon, Juan Maria/0000-0001-7414-5278; Rodriguez Ramos, Sergio/0000-0003-1635-3604; Argueso, Monica/0000-0001-5917-1056	Instituto de Salud Carlos III (Madrid, Spain)Instituto de Salud Carlos III [I3SNS-INT-11-063, I3SNS-INT-12-087]; Fondo Europeo de Desarrollo Regional (FEDER)European Commission	This study was supported, in part, by grants from Instituto de Salud Carlos III (I3SNS-INT-11-063 and I3SNS-INT-12-087) (Madrid, Spain) and co-financed with Fondo Europeo de Desarrollo Regional (FEDER).	Anand SX, 2003, THROMB HAEMOSTASIS, V90, P377, DOI 10.1160/TH03-05-0268; Andre P, 2002, NAT MED, V8, P247, DOI 10.1038/nm0302-247; Antoniades C, 2009, J AM COLL CARDIOL, V54, P669, DOI 10.1016/j.jacc.2009.03.076; Aukrust P, 2004, J AM COLL CARDIOL, V43, P2326, DOI 10.1016/j.jacc.2004.03.023; Aukrust P, 1999, CIRCULATION, V100, P614, DOI 10.1161/01.CIR.100.6.614; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Chen YL, 2006, BIOCHEM BIOPH RES CO, V345, P106, DOI 10.1016/j.bbrc.2006.04.034; Davi G, 2009, J ATHEROSCLER THROMB, V16, P707; Dominguez-Rodriguez A, 2007, THROMB RES, V121, P293, DOI 10.1016/j.thromres.2007.04.007; Ferro D, 2007, ARTERIOSCL THROM VAS, V27, P2763, DOI 10.1161/ATVBAHA.107.152777; Ferroni P, 2007, CURR MED CHEM, V14, P2170; Garlichs CD, 2003, STROKE, V34, P1412, DOI 10.1161/01.STR.0000074032.64049.47; Hamdan Righab, 2011, J Med Liban, V59, P65; Han SH, 2007, ATHEROSCLEROSIS, V190, P205, DOI 10.1016/j.atherosclerosis.2006.01.021; Hezi-Yamit A, 2005, P NATL ACAD SCI USA, V102, P12077, DOI 10.1073/pnas.0504526102; Kleinbaum DG, 1998, APPL REGRESSION ANAL, P281; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Li J, 2004, CLIN CHEM, V50, P1696, DOI 10.1373/clinchem.2003.030940; Lorente L, 2011, CRIT CARE, V15, DOI 10.1186/cc10104; Lucas SM, 2006, BRIT J PHARMACOL, V147, pS232, DOI 10.1038/sj.bjp.0706400; Lukasik M, 2012, PLATELETS, V23, P132, DOI 10.3109/09537104.2011.597528; Mach F, 1997, P NATL ACAD SCI USA, V94, P1931, DOI 10.1073/pnas.94.5.1931; Mao De-Jun, 2011, Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi, V27, P177; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; de Lizarrondo SM, 2012, ARTERIOSCL THROM VAS, V32, P1477, DOI 10.1161/ATVBAHA.112.248773; Miller DL, 1998, J LEUKOCYTE BIOL, V63, P373; NOELLE RJ, 1992, P NATL ACAD SCI USA, V89, P6550, DOI 10.1073/pnas.89.14.6550; Prasad KSS, 2003, P NATL ACAD SCI USA, V100, P12367, DOI 10.1073/pnas.2032886100; Rovegno M, 2012, MED INTENSIVA, V36, P37, DOI 10.1016/j.medin.2011.06.008; Shantsila E, 2009, THROMB HAEMOSTASIS, V102, P916, DOI 10.1160/TH09-01-0023; Sivro A, 2013, IMMUN AGEING, V10, DOI 10.1186/1742-4933-10-42; Slupsky JR, 1998, THROMB HAEMOSTASIS, V80, P1008; TEASDALE G, 1974, LANCET, V2, P81; Varo N, 2003, CIRCULATION, V108, P1049, DOI 10.1161/01.CIR.0000088521.04017.13; Weber M, 2006, CLIN CHEM, V52, P888, DOI 10.1373/clinchem.2005.062083; Wible EF, 2010, NEUROTHERAPEUTICS, V7, P62, DOI 10.1016/j.nurt.2009.11.003; Zhao W, 2014, CHINESE MED J-PEKING, V127, P2218, DOI 10.3760/cma.j.issn.0366-6999.20133159; Zhou L, 1998, THROMB HAEMOSTASIS, V79, P1025	39	17	19	0	3	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0049-3848			THROMB RES	Thromb. Res.	OCT	2014	134	4					832	836		10.1016/j.thromres.2014.07.034			5	Hematology; Peripheral Vascular Disease	Hematology; Cardiovascular System & Cardiology	AP8WU	WOS:000342360900013	25123332				2021-06-18	
J	Talbott, JF; Gean, A; Yuh, EL; Stiver, SI				Talbott, J. F.; Gean, A.; Yuh, E. L.; Stiver, S. I.			Calvarial Fracture Patterns on CT Imaging Predict Risk of a Delayed Epidural Hematoma following Decompressive Craniectomy for Traumatic Brain Injury	AMERICAN JOURNAL OF NEURORADIOLOGY			English	Article							ACUTE SUBDURAL-HEMATOMA; CONTRALATERAL EXTRADURAL HEMATOMA; CLINICAL-FEATURES; SURGERY; COMPLICATIONS; EVACUATION; SECONDARY	BACKGROUND AND PURPOSE: The development of a delayed epidural hematoma as a result of decompressive craniectomy represents an urgent and potentially lethal complication in traumatic brain injury. The goal of this study was to determine the incidence of delayed epidural hematoma and whether patterns of skull fractures on the preoperative CT scan could predict risk of a delayed epidural hematoma. MATERIALS AND METHODS: We retrospectively evaluated medical records and imaging studies for patients with acute traumatic brain injury who underwent a decompressive craniectomy during a 9-year period. We compared patterns of skull fractures contralateral to the side of the craniectomy with the occurrence of a postoperative delayed epidural hematoma. RESULTS: In a series of 203 patients undergoing decompressive craniectomy for acute traumatic brain injury, the incidence of a delayed epidural hematoma complication was 6% (12 of 203). All 12 patients who developed a delayed epidural hematoma had a contralateral calvarial fracture on preoperative CT at the site where the delayed epidural hematoma subsequently formed. A contralateral calvarial fracture has perfect sensitivity (100%) for subsequent development of delayed epidural hematoma in our study population. Moreover, a contralateral calvarial fracture involving 2 or more bone plates had an especially high diagnostic odds ratio of 41 for delayed epidural hematoma. CONCLUSIONS: Recognition of skull fracture patterns associated with delayed epidural hematoma following decompressive craniectomy may reduce morbidity and mortality by prompting early postoperative intervention in high-risk situations.	[Talbott, J. F.; Gean, A.; Yuh, E. L.] San Francisco Gen Hosp, Dept Radiol & Biomed Imaging, San Francisco, CA 94110 USA; [Talbott, J. F.; Gean, A.; Yuh, E. L.] San Francisco Gen Hosp, Brain & Spine Injury Ctr, San Francisco, CA 94110 USA; [Gean, A.; Stiver, S. I.] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA USA	Talbott, JF (corresponding author), San Francisco Gen Hosp, Dept Radiol, 1001 Potrero Ave,Room 1X55F, San Francisco, CA 94110 USA.	Jason.talbott@ucsf.edu			Educational Symposia; Ceretom (Samsung)	Alisa Gean-UNRELATED: Board Membership: www.image32.com, Comments: no financial compensation yet; Consultancy: National Football League (NFL); Employment: www.hindsightwines.com (owner); Expert Testimony various legal firms (plaintiff and defense); Payment for Lectures and the Development of Educational Presentations: Educational Symposia (various courses and meetings, Tampa, Florida); Ceretom (Samsung); Royalties: Lippincott Williams & Wilkins, Comments: author, Brain Injury: Applications from War and Terrorism; Stock/Stock Options: GBLI (Global Indemnity), NASDAQ, and Ceretom (Samsung); Travel/Accommodations/Meeting Expenses Unrelated to Activities Listed: honoraria, University of California, San Francisco.	Bullock M Ross, 2006, Neurosurgery, V58, pS7; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Di Rienzo A, 2008, ACTA NEUROCHIR, V150, P1057, DOI 10.1007/s00701-008-0019-1; FEUERMAN T, 1988, NEUROSURGERY, V23, P480, DOI 10.1227/00006123-198810000-00013; Lasierra JLF, 2013, EUR J TRAUMA EMERG S, V39, P277, DOI 10.1007/s00068-013-0268-4; Hofmeijer J, 2009, LANCET NEUROL, V8, P326, DOI 10.1016/S1474-4422(09)70047-X; Honeybul S, 2010, J CLIN NEUROSCI, V17, P430, DOI 10.1016/j.jocn.2009.09.007; Hutchinson P J, 2004, Curr Opin Crit Care, V10, P101, DOI 10.1097/00075198-200404000-00004; Hutchinson P, 2011, CAN J NEUROL SCI, V38, P541, DOI 10.1017/S0317167100012051; JENNETT B, 1975, LANCET, V1, P480; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Marion DW, 2006, NEUROSURGERY, V58, P655; Matsuno A, 2003, SURG NEUROL, V60, P23, DOI 10.1016/S0090-3019(03)00023-5; MEGURO K, 1987, NEUROSURGERY, V20, P326, DOI 10.1227/00006123-198702000-00023; Mohindra S, 2005, BRIT J NEUROSURG, V19, P490, DOI 10.1080/02688690500495216; Moon KS, 2007, J CLIN NEUROSCI, V14, P283, DOI 10.1016/j.jocn.2005.11.016; PETERSEN OF, 1984, NEURORADIOLOGY, V26, P363, DOI 10.1007/BF00327488; Plesnila N, 2007, PROG BRAIN RES, V161, P393, DOI 10.1016/S0079-6123(06)61028-5; Romero CM, 2011, NEW ENGL J MED, V365, P373, DOI 10.1056/NEJMc1106421; Sahuquillo J, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003983.pub2; Stiver SI, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.4.FOCUS0965; Su TM, 2008, J TRAUMA, V65, P1298, DOI 10.1097/TA.0b013e31815885d9; Su TM, 2011, J TRAUMA, V71, P833, DOI 10.1097/TA.0b013e31821b092a; Takeuchi S, 2012, J TRAUMA ACUTE CARE, V73, P1254, DOI 10.1097/TA.0b013e318265cc14; Wen L, 2013, BRAIN INJURY, V27, P286, DOI 10.3109/02699052.2012.743180; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Yang XF, 2008, ACTA NEUROCHIR, V150, P1241, DOI 10.1007/s00701-008-0145-9	27	17	20	0	2	AMER SOC NEURORADIOLOGY	DENVILLE	PO BOX 3000, DENVILLE, NJ 07834-9349 USA	0195-6108	1936-959X		AM J NEURORADIOL	Am. J. Neuroradiol.	OCT	2014	35	10					1930	1935		10.3174/ajnr.A4001			6	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	AQ5YY	WOS:000342885700015	24948502	Other Gold, Green Published			2021-06-18	
J	Jabara, M; Bradley, J; Merrick, M				Jabara, Michael; Bradley, Jeffrey; Merrick, Michael			Is Stability of the Proximal Tibiofibular Joint Important in the Multiligament-injured Knee?	CLINICAL ORTHOPAEDICS AND RELATED RESEARCH			English	Article							POSTEROLATERAL CORNER; LIGAMENT INSTABILITIES; SURGICAL-MANAGEMENT; ACUTE DISLOCATION; RECONSTRUCTION; CLASSIFICATION; RELIABILITY; COMPARTMENT; VALIDITY; REPAIR	The incidence of proximal tibiofibular joint instability in the setting of the multiligament-injured knee has not been previously reported. The integrity of the proximal tibiofibular joint is required to perform a fibular-based, lateral-sided knee reconstruction. We report (1) the frequency of proximal tibiofibular joint instability in patients presenting with multiligament knee injuries and evaluate (2) our ability to restore stability to this joint, (3) patient-reported outcome scores, and (4) complications in patients surgically treated for proximal tibiofibular joint instability at the time of treatment of multiligament knee instability. From 2005 to 2013, 124 patients (129 knees) sustaining multiligament knee injuries with Grade 3 instability to at least two ligaments were treated at our institution. We defined proximal tibiofibular joint instability as a dislocated or dislocatable proximal tibiofibular joint at the time of surgery. These patients underwent surgery to restore proximal tibiofibular joint stability and ligament reconstruction or repair and were followed with routine clinical examination, radiographs, and subjective outcome measures, including Lysholm and IKDC scores. Minimum followup was 12 months (mean, 32 months; range, 12-61 months). Twelve knees (12 patients, 9% of 129 knees) showed proximal tibiofibular joint instability. Knee stability in 10 patients was restored to Grade 1 or less in all surgically treated ligaments. No proximal tibiofibular joint instability has recurred. No patients have complained of ankle stiffness or pain. In the ten patients with subjective scores, mean Lysholm score was 75 (range, 54-95) and mean IKDC score was 58 (range, 22-78). There were four complications: one failed posterolateral corner reconstruction, one proximal tibiofibular joint screw removal secondary to pain over the screw head, one deep infection treated with serial irrigation and d,bridements with graft retention, and one closed manipulation secondary to arthrofibrosis and loss of ROM. In the setting of multiligament-injured knees, our series demonstrated a 9% incidence of proximal tibiofibular joint instability. The technique we describe successfully restored stability to the proximal tibiofibular joint and resulted in satisfactory patient-reported outcomes with low complication rates.	[Jabara, Michael] Orthopaed Associates Michigan, Grand Rapids, MI 49503 USA; [Bradley, Jeffrey; Merrick, Michael] Grand Rapids Med Educ Partners, Orthoped Surg Residency Program, Grand Rapids, MI USA	Jabara, M (corresponding author), Orthopaed Associates Michigan, 230 Michigan,Suite 300, Grand Rapids, MI 49503 USA.	Michael.Jabara@oamichigan.com					Ahmad Riaz, 2008, J Med Case Rep, V2, P158, DOI 10.1186/1752-1947-2-158; Bicos J, 2006, SPORTS MED ARTHROSC, V14, P28, DOI 10.1097/00132585-200603000-00006; Briggs KK, 2006, J BONE JOINT SURG AM, V88A, P698, DOI 10.2106/JBJS.E.00339; Chhabra A, 2006, J BONE JOINT SURG AM, V88A, P2, DOI 10.2106/JBJS.F.00616; Engebretsen L, 2009, KNEE SURG SPORT TR A, V17, P1013, DOI 10.1007/s00167-009-0869-y; FALLON P, 1994, J ORTHOP TRAUMA, V8, P350, DOI 10.1097/00005131-199408000-00013; Fanelli GC, 2002, ARTHROSCOPY, V18, P703, DOI 10.1053/jars.2002.35142; Harvey GP, 1991, AM J KNEE SURG, V4, P151; Herscovici D Jr, 1992, J Orthop Trauma, V6, P116; Higgins LD, 2007, JOINT BONE SPINE, V74, P594, DOI 10.1016/j.jbspin.2007.01.036; Horst PK, 2010, KNEE SURG SPORT TR A, V18, P1452, DOI 10.1007/s00167-010-1049-9; HUGHSTON JC, 1976, J BONE JOINT SURG AM, V58, P173, DOI 10.2106/00004623-197658020-00002; HUGHSTON JC, 1976, J BONE JOINT SURG AM, V58, P159, DOI 10.2106/00004623-197658020-00001; Ibrahim SAR, 2008, ARTHROSCOPY, V24, P178, DOI 10.1016/j.arthro.2007.08.007; Ibrahim SAR, 2013, ARTHROSCOPY, V29, P733, DOI 10.1016/j.arthro.2012.11.021; Johnson Bryce A, 2007, Am J Orthop (Belle Mead NJ), V36, P439; LAMBERT KL, 1971, J BONE JOINT SURG AM, VA 53, P507, DOI 10.2106/00004623-197153030-00007; Levy BA, 2010, AM J SPORT MED, V38, P804, DOI 10.1177/0363546509352459; Levy BA, 2009, ARTHROSCOPY, V25, P430, DOI 10.1016/j.arthro.2009.01.008; Maffulli N, 2005, TECH KNEE SURG, V4, P126; Maffulli N, 2010, AM J SPORT MED, V38, P2294, DOI 10.1177/0363546510373472; Mariani P P, 1999, Am J Knee Surg, V12, P214; Miettinen H, 1999, ARCH ORTHOP TRAUM SU, V119, P358, DOI 10.1007/s004020050428; Nelaton A., 1874, ELEMENS PATHOLOGIE C, P292; OGDEN JA, 1974, CLIN ORTHOP RELAT R, P186; OGDEN JA, 1974, J BONE JOINT SURG AM, VA 56, P145, DOI 10.2106/00004623-197456010-00015; PARKES JC, 1973, J BONE JOINT SURG AM, VA 55, P177, DOI 10.2106/00004623-197355010-00019; Rajkumar P, 2002, INT J CLIN PRACT, V56, P556; Robinson Y, 2007, KNEE SURG SPORT TR A, V15, P199, DOI 10.1007/s00167-006-0147-1; Sekiya Jon K, 2003, J Am Acad Orthop Surg, V11, P120; Sreesobh K V, 2009, J Orthop Surg (Hong Kong), V17, P109; Stannard JP, 2005, AM J SPORT MED, V33, P881, DOI 10.1177/0363546504271208; Stannard JP, 2005, ARTHROSCOPY, V21, P1051, DOI 10.1016/j.arthro.2005.05.020; Tanner SM, 2007, CLIN J SPORT MED, V17, P75, DOI 10.1097/JSM.0b013e31802b4feb; van den Bekerom Michel P J, 2004, Acta Orthop Belg, V70, P604	35	17	17	0	8	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0009-921X	1528-1132		CLIN ORTHOP RELAT R	Clin. Orthop. Rel. Res.	SEP	2014	472	9					2691	2697		10.1007/s11999-014-3574-1			7	Orthopedics; Surgery	Orthopedics; Surgery	AM7LR	WOS:000340049200019	24664195	Green Published			2021-06-18	
J	Merzagora, ACR; Izzetoglu, M; Onaral, B; Schultheis, MT				Merzagora, Anna C. Rodriguez; Izzetoglu, Meltem; Onaral, Banu; Schultheis, Maria T.			Verbal working memory impairments following traumatic brain injury: an fNIRS investigation	BRAIN IMAGING AND BEHAVIOR			English	Article						Near-infrared specroscopy; Brain injuries; Working memory; Hemodynamics	NEAR-INFRARED SPECTROSCOPY; FRONTAL ACTIVATION; HEMOGLOBIN OXYGENATION; PREFRONTAL CORTEX; COGNITIVE-CONTROL; FUNCTIONAL MRI; FLUENCY TASK; PERFORMANCE; LOAD; FMRI	The construct of working memory and its reliance on dorsolateral prefrontal cortex (DLPFC) have been the focus of many studies in healthy subjects and in clinical populations. However, transfer of knowledge gained from cognitive science studies to clinical applications can be a challenging goal. This scarce cross-dissemination may be partially due to the use of 'tools' that are limited in their ability to generate meaningful information about impairments in clinical groups. To this end, this paper investigates the use of functional near-infrared spectroscopy (fNIRS), which offers unique opportunities for recording neuroactivation. Specifically, we examine measures of the DLPFC hemodynamic response during a working memory task in adults with traumatic brain injury (TBI) and healthy controls. Analysis of hemodynamic measures showed significant differences between the two groups, even without differences in behavioral performance. Additional subtle disparities were linked to levels of performance in TBI and healthy subjects. fNIRS hemodynamic measures may therefore provide novel information to existing theories and knowledge of the working memory construct. Future studies may further define these subtle differences captured by fNIRS to help identify which components affect inter-individual variations in performance and could play a contributing role in the choice and planning of neurorehabilitation interventions targeting working memory.	[Merzagora, Anna C. Rodriguez; Izzetoglu, Meltem; Onaral, Banu; Schultheis, Maria T.] Drexel Univ, Sch Biomed Engn Sci & Hlth Syst, Philadelphia, PA 19104 USA; [Schultheis, Maria T.] Drexel Univ, Dept Psychol, Philadelphia, PA 19104 USA	Merzagora, ACR (corresponding author), Drexel Univ, Sch Biomed Engn Sci & Hlth Syst, 3141 Chestnut St, Philadelphia, PA 19104 USA.	a.merzagora@drexel.edu		Schultheis, Maria/0000-0002-6558-548X			Allain P, 2001, BRAIN COGNITION, V45, P21, DOI 10.1006/brcg.2000.1249; Andreasen NC, 1995, NEUROIMAGE, V2, P284, DOI 10.1006/nimg.1995.1036; Arenth PM, 2007, CLIN NEUROPSYCHOL, V21, P38, DOI 10.1080/13854040600878785; Azechi M, 2010, SCHIZOPHR RES, V117, P52, DOI 10.1016/j.schres.2009.10.003; Baddeley A, 2000, TRENDS COGN SCI, V4, P417, DOI 10.1016/S1364-6613(00)01538-2; Baddeley A, 2010, CURR BIOL, V20, pR136, DOI 10.1016/j.cub.2009.12.014; Bakvis P, 2010, EPILEPSY BEHAV, V19, P448, DOI 10.1016/j.yebeh.2010.08.026; Beauchamp MH, 2003, NEUROIMAGE, V20, P1649, DOI 10.1016/j.neuroimage.2003.07.003; Beneventi H, 2010, SCAND J PSYCHOL, V51, P192, DOI 10.1111/j.1467-9450.2010.00808.x; BINDER LM, 1986, J CLIN EXP NEUROPSYC, V8, P323, DOI 10.1080/01688638608401325; Birbaumer N, 2006, PSYCHOPHYSIOLOGY, V43, P517, DOI 10.1111/j.1469-8986.2006.00456.x; Bozkurt A, 2005, BIOMED ENG ONLINE, V4, DOI 10.1186/1475-925X-4-29; BRITTAIN JL, 1991, CLIN NEUROPSYCHOL, V5, P163, DOI DOI 10.1080/13854049108403300; Bublak P, 2000, J CLIN EXP NEUROPSYC, V22, P176, DOI 10.1076/1380-3395(200004)22:2;1-1;FT176; Buxton RB, 2004, NEUROIMAGE, V23, pS220, DOI 10.1016/j.neuroimage.2004.07.013; Cabeza R, 2000, J COGNITIVE NEUROSCI, V12, P1, DOI 10.1162/08989290051137585; Chan RCK, 2010, PSYCHIAT RES, V179, P259, DOI 10.1016/j.psychres.2009.07.014; Chance B, 1998, OPT EXPRESS, V2, P411, DOI 10.1364/OE.2.000411; CHANCE B, 1993, P NATL ACAD SCI USA, V90, P3770, DOI 10.1073/pnas.90.8.3770; Christodoulou C, 2001, J NEUROL NEUROSUR PS, V71, P161, DOI 10.1136/jnnp.71.2.161; Ciaramelli E, 2006, BRAIN COGNITION, V60, P198; Cohen JD, 1997, NATURE, V386, P604, DOI 10.1038/386604a0; Conners C, 1999, ADHD ADULTS CHILDREN; Curtis CE, 2003, TRENDS COGN SCI, V7, P415, DOI 10.1016/S1364-6613(03)00197-9; Cutini S, 2008, NEUROIMAGE, V42, P945, DOI 10.1016/j.neuroimage.2008.05.013; D'Esposito M, 1999, BRAIN COGNITION, V41, P66, DOI 10.1006/brcg.1999.1096; D'Esposito M, 1998, COGNITIVE BRAIN RES, V7, P1, DOI 10.1016/S0926-6410(98)00004-4; DELPY DT, 1988, PHYS MED BIOL, V33, P1433, DOI 10.1088/0031-9155/33/12/008; Dumas JA, 2010, HORM BEHAV, V58, P929, DOI 10.1016/j.yhbeh.2010.09.003; Ehlis AC, 2007, PSYCHIAT RES-NEUROIM, V156, P1, DOI 10.1016/j.pscychresns.2006.11.007; Fallgatter AJ, 1997, NEUROSCI LETT, V223, P89, DOI 10.1016/S0304-3940(97)13416-4; Ferrari M, 2012, NEUROIMAGE, V63, P921, DOI 10.1016/j.neuroimage.2012.03.049; FUNAHASHI S, 1993, J NEUROSCI, V13, P1479; Genova HM, 2009, FRONT BIOSCI-LANDMRK, V14, P1730, DOI 10.2741/3336; Goldman-Rakic P. S., 1987, NERVOUS SYSTEM, P373, DOI DOI 10.1002/CPHY.CP010509; Gotlib IH, 2010, ANNU REV CLIN PSYCHO, V6, P285, DOI 10.1146/annurev.clinpsy.121208.131305; HAIER RJ, 1988, INTELLIGENCE, V12, P199, DOI 10.1016/0160-2896(88)90016-5; Hale JB, 2002, J PSYCHOEDUC ASSESS, V20, P128, DOI 10.1177/073428290202000202; HarrisonFelix C, 1996, J HEAD TRAUMA REHAB, V11, P1, DOI 10.1097/00001199-199610000-00002; Herrmann MJ, 2003, BRAIN RES BULL, V61, P51, DOI 10.1016/S0361-9230(03)00066-2; Hillary FG, 2008, J INT NEUROPSYCH SOC, V14, P526, DOI 10.1017/S1355617708080788; Hillary FG, 2006, HUM BRAIN MAPP, V27, P837, DOI 10.1002/hbm.20226; Hillary FG, 2011, BRAIN, V134, P1555, DOI 10.1093/brain/awr043; Hitch GJ, 2005, MEMORY, V13, P247, DOI 10.1080/09658210344000314; Hock C, 1997, BRAIN RES, V755, P293, DOI 10.1016/S0006-8993(97)00122-4; Hoffmann S, 2007, CURR OPIN NEUROL, V20, P275, DOI 10.1097/WCO.0b013e32810c8e87; Honma M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012923; Horovitz SG, 2004, HUM BRAIN MAPP, V22, P110, DOI 10.1002/hbm.20018; Hoshi Y, 2011, PHILOS T R SOC A, V369, P4425, DOI 10.1098/rsta.2011.0262; Howard MW, 1999, J EXP PSYCHOL LEARN, V25, P923, DOI 10.1037/0278-7393.25.4.923; Izzetoglu K, 2011, J INNOV OPT HEAL SCI, V4, P239, DOI 10.1142/S1793545811001587; Izzetoglu M, 2005, IEEE T NEUR SYS REH, V13, P153, DOI 10.1109/TNSRE.2005.847377; Izzetoglu M, 2007, IEEE ENG MED BIOL, V26, P38, DOI 10.1109/MEMB.2007.384094; Jaeggi SM, 2010, MEMORY, V18, P394, DOI 10.1080/09658211003702171; Kennan RP, 2002, NEUROIMAGE, V16, P587, DOI 10.1006/nimg.2002.1060; Krainik A, 2005, STROKE, V36, P1146, DOI 10.1161/01.STR.0000166178.40973.a7; Kubota Y, 2006, NEUROIMAGE, V31, P1783, DOI 10.1016/j.neuroimage.2006.02.003; LANGFITT TW, 1986, J NEUROSURG, V64, P760, DOI 10.3171/jns.1986.64.5.0760; Leon-Carrion J, 2006, NEUROSCI LETT, V403, P90, DOI 10.1016/j.neulet.2006.04.050; LEVIN HS, 1982, NEUROBEHAVIORAL CONS; Levy R, 2000, EXP BRAIN RES, V133, P23, DOI 10.1007/s002210000397; Lindauer Ute, 2010, Front Neuroenergetics, V2, DOI 10.3389/fnene.2010.00025; Logie RH, 1995, VISUOSPATIAL WORKING; Lovell M. R., 2007, NEUROSURGERY, V61, P359, DOI [10.1227/ 01. NEU. 0000279985.94168.7F, DOI 10.1227/01.NEU.0000279985.94168.7F.359-360]; Lovell MR, 2007, NEUROSURGERY, V61, P352, DOI 10.1227/01.NEU.0000279985.94168.7F; Matsuo K, 2000, J NEUROPSYCH CLIN N, V12, P465, DOI 10.1176/appi.neuropsych.12.4.465; McAllister TW, 2006, J NEUROTRAUM, V23, P1450, DOI 10.1089/neu.2006.23.1450; McAllister TW, 2001, NEUROIMAGE, V14, P1004, DOI 10.1006/nimg.2001.0899; McAllister TW, 1999, NEUROLOGY, V53, P1300, DOI 10.1212/WNL.53.6.1300; McDonald BC, 2002, NEUROREHABILITATION, V17, P333; Medaglia JD, 2012, HUM BRAIN MAPP, V33, P979, DOI 10.1002/hbm.21264; Mehta MA, 2000, J NEUROSCI, V20; Miyai I, 2003, STROKE, V34, P2866, DOI 10.1161/01.STR.0000100166.81077.8A; Negoro H, 2010, CHILD PSYCHIAT HUM D, V41, P193, DOI 10.1007/s10578-009-0160-y; Newsome MR, 2007, CORTEX, V43, P95, DOI 10.1016/S0010-9452(08)70448-9; Owen AM, 1996, CEREB CORTEX, V6, P31, DOI 10.1093/cercor/6.1.31; Owen AM, 2005, HUM BRAIN MAPP, V25, P46, DOI 10.1002/hbm.20131; Park DC, 2002, PSYCHOL AGING, V17, P299, DOI 10.1037//0882-7974.17.2.299; Perlstein WM, 2004, J INT NEUROPSYCH SOC, V10, P724, DOI 10.1017/S1355617704105110; Petrides Michael, 1994, Current Opinion in Neurobiology, V4, P207, DOI 10.1016/0959-4388(94)90074-4; Pfurtscheller G, 2010, INT J PSYCHOPHYSIOL, V76, P186, DOI 10.1016/j.ijpsycho.2010.03.013; Philipose LE, 2007, BEHAV NEUROL, V18, P37, DOI 10.1155/2007/396946; Postle BR, 1999, P NATL ACAD SCI USA, V96, P12959, DOI 10.1073/pnas.96.22.12959; Prat CS, 2007, J COGNITIVE NEUROSCI, V19, P1950, DOI 10.1162/jocn.2007.19.12.1950; Reichle ED, 2000, COGNITIVE PSYCHOL, V40, P261, DOI 10.1006/cogp.2000.0733; Ricker JH, 2001, J HEAD TRAUMA REHAB, V16, P191, DOI 10.1097/00001199-200104000-00007; Roussotte FF, 2011, NEUROIMAGE, V54, P3067, DOI 10.1016/j.neuroimage.2010.10.072; Ruocco AC, 2010, PSYCHIAT RES-NEUROIM, V182, P117, DOI 10.1016/j.pscychresns.2010.01.011; Rypma B, 2002, J COGNITIVE NEUROSCI, V14, P721, DOI 10.1162/08989290260138627; Rypma B, 1999, NEUROIMAGE, V9, P216, DOI 10.1006/nimg.1998.0404; Rypma B, 1999, P NATL ACAD SCI USA, V96, P6558, DOI 10.1073/pnas.96.11.6558; Sanchez-Carrion R, 2008, J NEUROTRAUM, V25, P479, DOI 10.1089/neu.2007.0417; Sanchez-Carrion R, 2008, NEUROIMAGE, V43, P421, DOI 10.1016/j.neuroimage.2008.08.003; Schecklmann M, 2008, J PSYCHIATR RES, V43, P98, DOI 10.1016/j.jpsychires.2008.02.005; Scheibel RS, 2009, J NEUROTRAUM, V26, P1447, DOI 10.1089/neu.2008.0736; Scheibel RS, 2007, NEUROREHAB NEURAL RE, V21, P36, DOI 10.1177/1545968306294730; Scheibel RS, 2003, BRAIN INJURY, V17, P919, DOI 10.1080/0269905031000110472; Schreppel T, 2008, NEUROPSYCHOBIOLOGY, V57, P188, DOI 10.1159/000147473; Schroeter ML, 2002, HUM BRAIN MAPP, V17, P61, DOI 10.1002/hbm.10052; Smith EE, 1999, SCIENCE, V283, P1657, DOI 10.1126/science.283.5408.1657; Smith EE, 1998, P NATL ACAD SCI USA, V95, P12061, DOI 10.1073/pnas.95.20.12061; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Tian FH, 2009, BRAIN RES, V1303, P120, DOI 10.1016/j.brainres.2009.09.085; Townsend J, 2010, PSYCHIAT RES-NEUROIM, V182, P22, DOI 10.1016/j.pscychresns.2009.11.010; Tuchin VV, 2002, HDB OPTICAL BIOMEDIC; Turner GR, 2008, NEUROLOGY, V71, P812, DOI 10.1212/01.wnl.0000325640.18235.1c; Van Snellenberg JX, 2009, PSYCHIAT RES-NEUROIM, V174, P89, DOI 10.1016/j.pscychresns.2009.04.001; Wechsler D, 1997, WAIS 3 ADM SCORING M; Weissman DH, 2002, COGNITIVE BRAIN RES, V15, P47, DOI 10.1016/S0926-6410(02)00215-X; Wright HH, 2005, AM J SPEECH-LANG PAT, V14, P107, DOI 10.1044/1058-0360(2005/012)	110	17	19	0	10	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	1931-7557	1931-7565		BRAIN IMAGING BEHAV	Brain Imaging Behav.	SEP	2014	8	3			SI		446	459		10.1007/s11682-013-9258-8			14	Neuroimaging	Neurosciences & Neurology	AP9ZR	WOS:000342441400013	24085609				2021-06-18	
J	Schatz, P; Kelley, T; Ott, SD; Solomon, GS; Elbin, RJ; Higgins, K; Moser, RS				Schatz, Philip; Kelley, Timothy; Ott, Summer D.; Solomon, Gary S.; Elbin, R. J.; Higgins, Kate; Moser, Rosemarie Scolaro			Utility of Repeated Assessment After Invalid Baseline Neurocognitive Test Performance	JOURNAL OF ATHLETIC TRAINING			English	Article						baseline testing; concussion testing; invalid baseline; neuropsychological testing; ImPACT; head injuries	HIGH-SCHOOL; NEUROPSYCHOLOGICAL ASSESSMENT; BRAIN-INJURY; CONCUSSION; SPORTS; SYMPTOMS; ACADEMY	Context: Although the prevalence of invalid baseline neurocognitive testing has been documented, and repeated administration after obtaining invalid results is recommended, no empirical data are available on the utility of repeated assessment after obtaining invalid baseline results. Objective: To document the utility of readministering neurocognitive testing after an invalid baseline test. Design: Case series. Setting: Schools, colleges, and universities. Patients or Other Participants: A total of 156 athletes who obtained invalid results on ImPACT baseline neurocognitive testing and were readministered the ImPACT baseline test within a 2-week period (mean = 4 days). Main Outcome Measure(s): Overall prevalence of invalid results on reassessment, specific invalidity indicators at initial and follow-up baseline, dependent-samples analysis of variance, with Bonferroni correction for multiple comparisons. Results: Reassessment resulted in valid test results for 87.2% of the sample. Poor performance on the Design Memory and Three-Letter subscales were the most common reasons for athletes obtaining an invalid baseline result, on both the initial assessment and the reassessment. Significant improvements were noted on all ImPACT composite scores except for Reaction Time on reassessment. Of note, 40% of athletes showed slower reaction time scores on reassessment, perhaps reflecting a more cautious approach taken the second time. Invalid results were more likely to be obtained by athletes with a self-reported history of attention-deficit disorder or learning disability on reassessments (35%) than on initial baseline assessments (10%). Conclusions: Repeat assessment after the initial invalid baseline performance yielded valid results in nearly 90% of cases. Invalid results on a follow-up assessment may be influenced by a history of attention-deficit disorder or learning disability, the skills and abilities of the individual, or a particular test-taking approach; in these cases, a third assessment may not be useful.	[Schatz, Philip; Kelley, Timothy] St Josephs Univ, Philadelphia, PA 19131 USA; [Ott, Summer D.] Mem Hermann Ironman Sports Med Inst, Houston, TX USA; [Solomon, Gary S.] Vanderbilt Univ, Med Ctr, Dept Neurol Surg, Nashville, TN USA; [Elbin, R. J.] Univ Arkansas, Dept Human Performance Hlth Promot & Recreat, Fayetteville, AR 72701 USA; [Higgins, Kate] Sch Profess Psychol, Forest Inst, Springfield, MO USA; [Moser, Rosemarie Scolaro] Sports Concuss Ctr New Jersey, Lawrenceville, NJ USA	Schatz, P (corresponding author), St Josephs Univ, 5600 City Ave,222 Post Hall, Philadelphia, PA 19131 USA.	pschatz@sju.edu	Solomon, Gary/K-9011-2019				Bakhos LL, 2010, PEDIATRICS, V126, pE550, DOI 10.1542/peds.2009-3101; Barth JT., 1989, MILD HEAD INJURY, P257; Bauer RM, 2012, ARCH CLIN NEUROPSYCH, V27, P362, DOI 10.1093/arclin/acs027; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Covassin T, 2012, CLIN J SPORT MED, V22, P98, DOI 10.1097/JSM.0b013e31823403d2; Echemendia RJ, 2003, APPL NEUROPSYCHOL, V10, P48, DOI 10.1207/S15324826AN1001_7; Elbin RJ, 2013, ARCH CLIN NEUROPSYCH, V28, P476, DOI 10.1093/arclin/act024; Erdal K, 2012, ARCH CLIN NEUROPSYCH, V27, P473, DOI 10.1093/arclin/acs050; Iverson GL, 2004, J INT NEUROPSYCH SOC, V10, P904, DOI 10.1017/S1355617704106139; Law R, 2012, ANXIETY STRESS COPIN, V25, P711, DOI 10.1080/10615806.2011.630070; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Lovell M. R., 2002, Medicine & Science in Sports & Exercise, V34, pS298, DOI 10.1097/00005768-200205001-01680; Lovell MR, 1998, J HEAD TRAUMA REHAB, V13, P9, DOI 10.1097/00001199-199804000-00004; Lovell MR, 2003, J NEUROSURG, V98, P296, DOI 10.3171/jns.2003.98.2.0296; Lovell MR., CLIN INTERPRETIVE MA; Marvez A., PLAYERS MAY TRY BEAT; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Moser RS, 2011, AM J SPORT MED, V39, P2325, DOI 10.1177/0363546511417114; Moser RS, 2013, APPL NEUROP IN PRESS; Neylan TC, 2010, CHRONOBIOL INT, V27, P1493, DOI 10.3109/07420528.2010.504992; Podell K, 2004, STUD NEUROPSYCHOL DE, P375; Reilly R., TALKING FOOTBALL ARC; Schatz P, 2013, ARCH CLIN NEUROPSYCH, V28, P236, DOI 10.1093/arclin/act009; Schatz P, 2012, J ATHL TRAINING, V47, P289, DOI 10.4085/1062-6050-47.3.14; Schatz P, 2010, ARCH CLIN NEUROPSYCH, V25, P285, DOI 10.1093/arclin/acq022	25	17	17	0	13	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	SEP-OCT	2014	49	5					659	664		10.4085/1062-6050-49.3.37			6	Sport Sciences	Sport Sciences	AY4NN	WOS:000347555600013	25162778	Green Published, Bronze			2021-06-18	
J	Solomon, GS; Sills, A				Solomon, Gary S.; Sills, Allen			Chronic Traumatic Encephalopathy and the Availability Cascade	PHYSICIAN AND SPORTSMEDICINE			English	Article						concussion; sports; chronic traumatic encephalopathy; mild traumatic brain injury	INTERNATIONAL-CONFERENCE; CONSENSUS STATEMENT; SPORTS CONCUSSION; FOOTBALL; TAU; DISEASE; RISK; AFTERMATH; SPECTRUM; POSITION	Chronic traumatic encephalopathy (CTE) in sports has been known for > 85 years, and has experienced a resurgence of interest over the past decade, both in the media and in the scientific community. However, there appears to be a disconnection between the public's perception of CTE and the currently available scientific data. The cognitive bias known as the "availability cascade" has been suggested as a reason to explain this rift in knowledge. This review summarizes and updates the history of CTE in sports, discusses recent epidemiological and autopsy studies, summarizes the evidence base related to CTE in sports, and offers recommendations for future directions.	[Solomon, Gary S.; Sills, Allen] Vanderbilt Univ, Sch Med, Vanderbilt Sports Concuss Ctr, Dept Neurol Surgery,Dept Orthoped Surg & Rehabil, Nashville, TN 37212 USA; [Solomon, Gary S.] Vanderbilt Univ, Sch Med, Dept Psychiat, Nashville, TN 37212 USA	Solomon, GS (corresponding author), Neurosurg Clin, 1500 21st Ave South,Suite 1506, Nashville, TN 37212 USA.	gary.solomon@vanderbilt.edu	Solomon, Gary/K-9011-2019		Rawlings; Nashville Predators and Tennessee Titans	Allen Sills, MD, receives funding (unrestricted educational grant) from Rawlings, the sports equipment manufacturing company. Gary Solomon, PhD, receives funding (unrestricted educational grant) from Rawlings; consulting fees from the Nashville Predators and Tennessee Titans; royalties from book sales; and is a member of the Professional Advisory Board of ImPACT, for which he receives expense reimbursement for attendance at board meetings.	Andrikopoulos J, 2014, JAMA NEUROL, V71, P654, DOI 10.1001/jamaneurol.2013.6408; [Anonymous], 2011, MED SCI SPORT EXER, V43, P2412, DOI 10.1249/MSS.0b013e3182342e64; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Baron SL, 2012, AM J CARDIOL, V109, P889, DOI 10.1016/j.amjcard.2011.10.050; Barr WB, 2013, NEUROPSYCHOL REV, V23, P271, DOI 10.1007/s11065-013-9244-3; Casson I, 2010, NEUROLOGY TODAY, V10, P6, DOI DOI 10.1097/01.NT.0000380917.17552.b7; CASSON IR, 1984, JAMA-J AM MED ASSOC, V251, P2663, DOI 10.1001/jama.251.20.2663; CORSELLIS JA, 1973, PSYCHOL MED, V3, P270, DOI 10.1017/S0033291700049588; COURVILLE CYRIL B., 1962, BULL LOS ANGELES NEUROL SOC, V27, P160; Critchley M, 1949, HOMMAGE C VINCENT; Duhaime AC, 2012, J NEUROSURG, V117, P1092, DOI 10.3171/2012.8.JNS112298; Gardner A, 2014, BRIT J SPORT MED, V48, P84, DOI 10.1136/bjsports-2013-092646; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Hazrati LN, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00222; Iverson GL, 2014, BRIT J SPORT MED, V48, P162, DOI 10.1136/bjsports-2013-092935; Jordan BD, 1997, JAMA-J AM MED ASSOC, V278, P136, DOI 10.1001/jama.278.2.136; Karantzoulis S, 2013, NEUROPSYCHOL REV, V23, P350, DOI 10.1007/s11065-013-9243-4; Kuran T, 1999, STANFORD LAW REV, V51, P683, DOI 10.2307/1229439; Lehman EJ, 2012, NEUROLOGY, V79, P1970, DOI 10.1212/WNL.0b013e31826daf50; Lesort M, 1999, J NEURAL TRANSM, V106, P1217, DOI 10.1007/s007020050235; Love S, 2014, AM J SPORTS MED; Martland HS, 1928, J AMER MED ASSOC, V91, P1103, DOI 10.1001/jama.1928.02700150029009; MAWDSLEY C, 1963, LANCET, V2, P795; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McCrory P, 2011, CLIN J SPORT MED, V21, P6, DOI 10.1097/JSM.0b013e318204db50; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; McKee AC, 2010, J NEUROPATH EXP NEUR, V69, P918, DOI 10.1097/NEN.0b013e3181ee7d85; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Mietelska-Porowska A, 2014, INT J MOL SCI, V15, P4671, DOI 10.3390/ijms15034671; MILLER H, 1966, P ROY SOC MED, V59, P257, DOI 10.1177/003591576605900327; Millspaugh J., 1937, US NAVAL MED B, V35, P297; Omalu B, 2011, NEUROSURGERY, V69, P173, DOI 10.1227/NEU.0b013e318212bc7b; Omalu BI, 2006, NEUROSURGERY, V59, P1086, DOI 10.1227/01.NEU.0000245601.69451.27; Omalu Bennet I, 2010, J Forensic Nurs, V6, P130, DOI 10.1111/j.1939-3938.2010.01078.x; Omalu BI, 2010, AM J FOREN MED PATH, V31, P130, DOI 10.1097/PAF.0b013e3181ca7f35; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Parker HL, 1934, J NEUROL PSYCHOPATHO, V15, P20; Ramage SN, 2005, NEUROPATH APPL NEURO, V31, P439, DOI 10.1111/j.1365-2990.2005.00670.x; Randolph C, 2014, CURR SPORT MED REP, V13, P33, DOI [10.1097/OPX.0000000000000170, 10.1249/JSR.0000000000000022]; ROBERTS GW, 1990, J NEUROL NEUROSUR PS, V53, P373, DOI 10.1136/jnnp.53.5.373; Savica R, 2012, MAYO CLIN PROC, V87, P335, DOI 10.1016/j.mayocp.2011.12.016; Schwenk TL, 2007, MED SCI SPORT EXER, V39, P599, DOI 10.1249/mss.0b013e31802fa679; Small GW, 2013, AM J GERIAT PSYCHIAT, V21, P138, DOI 10.1016/j.jagp.2012.11.019; Weir D. R., 2009, STUDY RETIRED NFL PL	48	17	17	0	10	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0091-3847	2326-3660		PHYSICIAN SPORTSMED	Physician Sportsmed.	SEP	2014	42	3					26	31		10.3810/psm.2014.09.2072			6	Primary Health Care; Orthopedics; Sport Sciences	General & Internal Medicine; Orthopedics; Sport Sciences	AR2FQ	WOS:000343399400003	25295763				2021-06-18	
J	Roach, EB; Bleiberg, J; Lathan, CE; Wolpert, L; Tsao, JW; Roach, RC				Roach, Emma B.; Bleiberg, Joseph; Lathan, Corinna E.; Wolpert, Lawrence; Tsao, Jack W.; Roach, Robert C.			AltitudeOmics: Decreased reaction time after high altitude cognitive testing is a sensitive metric of hypoxic impairment	NEUROREPORT			English	Article						brain hypoxia; cognitive reserve; mild cognitive impairment; military psychology; neuropsychological tests	SPORT-RELATED CONCUSSION; PERFORMANCE; EFFICIENCY; STAY	Humans experiencing hypoxic conditions exhibit multiple signs of cognitive impairment, and high altitude expeditions may be undermined by abrupt degradation in mental performance. Therefore, the development of psychometric tools to quickly and accurately assess cognitive impairment is of great importance in aiding medical decision-making in the field, particularly in situations where symptoms may not be readily recognized. The present study used the Defense Automated Neurobehavioral Assessment (DANA), a ruggedized and portable neurocognitive assessment tool, to examine cognitive function in healthy human volunteers at sea level, immediately after ascending to an elevation over 5000 m, and following 16 days of acclimatization to this high altitude. The DANA battery begins with a simple reaction time test (SRT1) which is followed by a 20-min series of complex cognitive tests and ends with a second test of simple reaction time (SRT2). Tabulating the performance scores from these two tests allows the calculation of an SRT change score (dSRT = SRT1-SRT2) that reflects the potential effect of mental effort spent during the 20-min testing session. We found that dSRT, but not direct SRT in comparison to sea-level baseline performance, is highly sensitive to acute altitude-related performance deficits and the remission of impairment following successful acclimatization. Our results suggest that dSRT is a potentially useful analytical method to enhance the sensitivity of neurocognitive assessment. (C) 2014 Wolters Kluwer Health vertical bar Lippincott Williams & Wilkins.	[Roach, Emma B.; Lathan, Corinna E.; Wolpert, Lawrence] AnthroTronix Inc, Silver Spring, MD USA; [Bleiberg, Joseph] Walter Reed Natl Mil Med Ctr, Natl Intrepid Ctr Excellence, Bethesda, MD USA; [Tsao, Jack W.] US Navy Bur Med & Surg, Wounded Ill & Injured Directorate, Falls Church, VA USA; [Roach, Robert C.] Univ Colorado, Altitude Res Ctr, Dept Emergency Med, Denver, CO 80202 USA	Roach, RC (corresponding author), 8737 Colesville Rd,Suite L203, Silver Spring, MD 20910 USA.	emma.roach@atinc.com	Roach, Robert/F-4729-2011	Roach, Robert/0000-0002-7998-8976; Bleiberg, Joseph/0000-0003-0867-5494	BUMED; US Department of DefenseUnited States Department of Defense [W81XWH-11-2-0040 TATRC]; NIH/NCATS Colorado CTSIUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1 TR000154]; Cardiopulmonary & Respiratory Physiology Laboratory, University of Oregon; Altitude Research Center; Charles S. Houston Endowed Professorship, Department of Emergency Medicine, School of Medicine, University of Colorado Denver; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000154] Funding Source: NIH RePORTER	This study was funded by BUMED; US Department of Defense (W81XWH-11-2-0040 TATRC); NIH/NCATS Colorado CTSI (UL1 TR000154); the Cardiopulmonary & Respiratory Physiology Laboratory, University of Oregon; and the Altitude Research Center and the Charles S. Houston Endowed Professorship, Department of Emergency Medicine, School of Medicine, University of Colorado Denver.	Bartholomew CJ, 1999, INT J AVIAT PSYCHOL, V9, P351, DOI 10.1207/s15327108ijap0904_3; Basnyat B, 2000, High Alt Med Biol, V1, P167; Bleiberg J, 2004, NEUROSURGERY, V54, P1073, DOI 10.1227/01.NEU.0000118820.33396.6A; Bolmont B, 2000, PHYSIOL BEHAV, V71, P469, DOI 10.1016/S0031-9384(00)00362-0; Bonnon M, 2000, AVIAT SPACE ENVIR MD, V71, P678; Campbell W, 2007, 132 ANN M AM NEUR AS; Echemendia RJ, 2013, BRIT J SPORT MED, V47, P294, DOI 10.1136/bjsports-2013-092186; Guskiewicz KM, 2004, J ATHL TRAINING, V39, P280; HORNBEIN TF, 1989, NEW ENGL J MED, V321, P1714, DOI 10.1056/NEJM198912213212505; Lathan C, 2013, MIL MED, V178, P365, DOI 10.7205/MILMED-D-12-00438; Petrassi FA, 2012, AVIAT SPACE ENVIR MD, V83, P975, DOI 10.3357/ASEM.3315.2012; SHARMA VM, 1975, ERGONOMICS, V18, P511, DOI 10.1080/00140137508931485; Stivalet P, 2000, ERGONOMICS, V43, P474, DOI 10.1080/001401300184350; Subudhi AW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092191; Virues-Ortega Javier, 2004, Neuropsychology Review, V14, P197	15	17	18	1	29	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0959-4965	1473-558X		NEUROREPORT	Neuroreport	AUG 6	2014	25	11					814	818		10.1097/WNR.0000000000000169			5	Neurosciences	Neurosciences & Neurology	AK9UH	WOS:000338772700002	24722229	Green Published			2021-06-18	
J	Borkar, SA; Garg, K; Garg, M; Sharma, BS				Borkar, Sachin Anil; Garg, Kanwaljeet; Garg, Mayank; Sharma, Bhawani Shankar			Transorbital penetrating cerebral injury caused by a wooden stick: surgical nuances for removal of a foreign body lodged in cavernous sinus	CHILDS NERVOUS SYSTEM			English	Article						Transorbital injury; Penetrating injury; Cavernous sinus	INTRAORBITAL WOODEN; INTRACRANIAL WOOD; BRAIN-ABSCESS; CT	Penetrating head injury (PHI) is rare in civilian population and is mostly caused by low-velocity modes. A transorbital penetrating intracranial injury is very rare and more severe than traumatic brain injury. We report a rare case of transorbital penetrating cranial injury caused by a wooden stick. The surgical strategy was planned as the wooden stick was lodged in the right cavernous sinus. The wooden stick was successfully removed. Patient made an uneventful recovery. Transorbital penetrating injuries are uncommon form of injury and require a multidisciplinary approach. No attempt should be made to remove the foreign body without the backup of an operating room because of the possibility that the object may be tamponading an injured vessel. A careful planning and a strict adherence to basic perioperative principles can lead to a satisfactory outcome.	[Borkar, Sachin Anil; Garg, Kanwaljeet; Garg, Mayank; Sharma, Bhawani Shankar] All India Inst Med Sci, Dept Neurosurg, New Delhi, India	Borkar, SA (corresponding author), All India Inst Med Sci, Dept Neurosurg, New Delhi, India.	sachin.aiims@gmail.com; kanwaljeet84@gmail.com					AMANO K, 1982, J COMPUT ASSIST TOMO, V6, P1163, DOI 10.1097/00004728-198212000-00018; BERT F, 1995, J CLIN MICROBIOL, V33, P1950, DOI 10.1128/JCM.33.7.1950-1953.1995; BRAUN J, 1987, J COMPUT ASSIST TOMO, V11, P525, DOI 10.1097/00004728-198705000-00030; Domenicucci M, 1999, J Neurosurg Sci, V43, P229; Faraji M, 2005, NEUROSURG QUART, V15, P160, DOI 10.1097/01.wnq.0000176390.07352.4d; HANSEN JE, 1988, J NEUROSURG, V68, P752, DOI 10.3171/jns.1988.68.5.0752; Ho VT, 1996, AM J NEURORADIOL, V17, P134; Jacob JT, 2005, J NEUROSURG, V102, P350, DOI 10.3171/ped.2005.102.3.0350; Kitakami A, 1999, NEUROL MED-CHIR, V39, P150, DOI 10.2176/nmc.39.150; Lasky JB, 1997, J TRAUMA, V42, P555, DOI 10.1097/00005373-199703000-00030; Lin Hung-Lin, 2007, J Chin Med Assoc, V70, P36; Maruya J, 2002, NEUROL MED-CHIR, V42, P143, DOI 10.2176/nmc.42.143; Matsumoto S, 1998, AM J NEURORADIOL, V19, P1163; Matsuyama T, 2001, NEUROL MED-CHIR, V41, P345, DOI 10.2176/nmc.41.345; Matsuyama T, 1997, J NEUROSURG, V86, P619, DOI 10.3171/jns.1997.86.4.0619; MILLER CF, 1977, SURG NEUROL, V7, P95; Santiago LA, 2012, BRAIN INJURY, V26, P107, DOI 10.3109/02699052.2011.635363; Satyarthee GD, 2009, NEUROL INDIA, V57, P331, DOI 10.4103/0028-3886.53285; Schreckinger M, 2011, J NEUROSURG, V114, P53, DOI 10.3171/2010.8.JNS10301; Turbin RE, 2006, SURV OPHTHALMOL, V51, P449, DOI 10.1016/j.survophthal.2006.06.008; Uchino A, 1997, NEURORADIOLOGY, V39, P213, DOI 10.1007/s002340050396	21	17	23	0	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0256-7040	1433-0350		CHILD NERV SYST	Childs Nerv. Syst.	AUG	2014	30	8					1441	1444		10.1007/s00381-014-2364-0			4	Clinical Neurology; Pediatrics; Surgery	Neurosciences & Neurology; Pediatrics; Surgery	AM3CY	WOS:000339730800016	24493367				2021-06-18	
J	Brickell, TA; Lange, RT; French, LM				Brickell, Tracey A.; Lange, Rael T.; French, Louis M.			Health-Related Quality of Life Within the First 5 Years Following Military-Related Concurrent Mild Traumatic Brain Injury and Polytrauma	MILITARY MEDICINE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; PERSISTENT POSTCONCUSSIVE SYMPTOMS; POST-CONCUSSION SYMPTOMS; MENTAL-HEALTH; SERVICE MEMBERS; PSYCHIATRIC DIAGNOSES; HEAD-INJURY; COMBAT; IRAQ; VETERANS	This study examined health-related quality of life within the first 5 years following concurrent mild traumatic brain injury (MTBI) and polytrauma. Participants were 167 U.S. service members who had sustained a MTBI who had completed a brief neurobehavioral evaluation within 3 months postinjury and at least one telephone follow-up interview at 6 (n = 46), 12 (n = 89), 24 (n = 54), 36 (n = 42), 48 (n = 30) or 60 months (n = 25) postinjury. Within the first 5years postinjury, service members reported ongoing headaches (67.4% to 92.0%), bodily pain (66.7% to 88.9%), medication use (71.7% to 92.0%), mental health treatment (28.3% to 60.0%), and the need for help with daily activities (18.5% to 40.0%). Problematic alcohol consumption was common within the first 24 months postinjury (23.9% to 29.2%). Many service members were working for pay (36.0% to 70.8%) though many reported a decline in work quality (16.0% to 30.4%). Despite ongoing symptom reporting, many service members reported that their medications were effective (43.3% to 80.0%), good/excellent health status (68.0% to 80.0%), and life satisfaction (79.6% to 90.5%). A minority reported suicidal or homicidal ideation (5.6% to 14.8%). Recovery from MTBI in a military setting is complex and multifaceted. Continued support and care for all service members who sustain a combat-related MTBI with polytrauma is recommended, regardless of the presence or absence of symptom reporting within the first few months postinjury.	[Brickell, Tracey A.; Lange, Rael T.; French, Louis M.] Def & Vet Brain Injury Ctr, Bethesda, MD 20889 USA; [Brickell, Tracey A.; Lange, Rael T.; French, Louis M.] Walter Reed Natl Mil Med Ctr, Bethesda, MD 20889 USA; [Brickell, Tracey A.; French, Louis M.] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20889 USA; [Brickell, Tracey A.; Lange, Rael T.; French, Louis M.] Ctr Neurosci & Regenerat Med, Bethesda, MD 20814 USA; [Lange, Rael T.] Univ British Columbia, Dept Psychiat, Vancouver, BC V6T 1Z4, Canada	Brickell, TA (corresponding author), Def & Vet Brain Injury Ctr, 8901 Wisconsin Ave, Bethesda, MD 20889 USA.		french, louis/AAB-2083-2020	french, louis/0000-0002-9451-0604			BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P194, DOI 10.1017/S1355617709990841; Belanger HG, 2009, J HEAD TRAUMA REHAB, V24, P4, DOI 10.1097/HTR.0b013e3181957032; Bradley CS, 2014, J UROLOGY, V191, P1327, DOI 10.1016/j.juro.2013.11.100; Brenner LA, 2010, J HEAD TRAUMA REHAB, V25, P307, DOI 10.1097/HTR.0b013e3181cada03; Brenner LA, 2009, REHABIL PSYCHOL, V54, P239, DOI 10.1037/a0016908; Carlozzi NE, 2011, ARCH PHYS MED REHAB, V92, pS52, DOI 10.1016/j.apmr.2010.12.046; Carlson KF, 2010, J TRAUMA STRESS, V23, P17, DOI 10.1002/jts.20483; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; CELLA DF, 1995, SEMIN ONCOL, V22, P73; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Cooper DB, 2011, BRAIN INJURY, V25, P1, DOI 10.3109/02699052.2010.531692; Defense and Veterans Brain Injury Center D, 2012, DOD NUMB TRAUM BRAIN; Department of Veterans Affairs and Department of Defense, 2009, VA DOD CLIN PRACT GU; Dikmen S, 2010, J INT NEUROPSYCH SOC, V16, P401, DOI 10.1017/S1355617710000196; Emanuelson I, 2003, ACTA NEUROL SCAND, V108, P332, DOI 10.1034/j.1600-0404.2003.00155.x; Eskridge SL, 2013, J NEUROTRAUM, V30, P1391, DOI 10.1089/neu.2012.2537; Findler M, 2001, BRAIN INJURY, V15, P715, DOI 10.1080/02699050010013941; French LM, 2012, J HEAD TRAUMA REHAB, V27, P63, DOI 10.1097/HTR.0b013e3182248344; Frenisy MC, 2006, J TRAUMA, V60, P1018, DOI 10.1097/01-ta.0000215977.00034.c2; Goodwin L, 2012, J NERV MENT DIS, V200, P429, DOI 10.1097/NMD.0b013e31825322fe; Heitger MH, 2007, J REHABIL MED, V39, P612, DOI 10.2340/16501977-0100; Hill JJ, 2009, AM J PHYS MED REHAB, V88, P605, DOI 10.1097/PHM.0b013e3181ae0f83; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2006, JAMA-J AM MED ASSOC, V295, P1023, DOI 10.1001/jama.295.9.1023; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Horesh D, 2013, PSYCHIAT RES, V208, P265, DOI 10.1016/j.psychres.2012.12.004; Iverson GL, 2007, BRAIN INJURY MED PRI, P333; Iverson GL, 2013, BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION, P470; Jakola AS, 2007, ACTA NEUROL SCAND, V115, P398, DOI 10.1111/j.1600-0404.2007.00827.x; Keane T., 1994, PTSD CHECKLIST CIVIL; Kennedy JE, 2010, NEUROREHABILITATION, V26, P191, DOI 10.3233/NRE-2010-0555; Kennedy JE, 2010, NEUROREHABILITATION, V26, P223, DOI 10.3233/NRE-2010-0558; Lange RT, 2013, J NEUROTRAUM, V30, P958, DOI 10.1089/neu.2012.2743; Lange RT, 2012, J CLIN EXP NEUROPSYC, V34, P453, DOI 10.1080/13803395.2011.648175; Lapierre CB, 2007, J TRAUMA STRESS, V20, P933, DOI 10.1002/jts.20278; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; MacGregor AJ, 2013, J HEAD TRAUMA REHAB, V28, P59, DOI 10.1097/HTR.0b013e3182596382; Marx BP, 2009, ARCH GEN PSYCHIAT, V66, P996, DOI 10.1001/archgenpsychiatry.2009.109; Meares S, 2011, NEUROPSYCHOLOGY, V25, P454, DOI 10.1037/a0022580; Milliken CS, 2007, JAMA-J AM MED ASSOC, V298, P2141, DOI 10.1001/jama.298.18.2141; Nestvold K, 2009, BRAIN INJ; Olson-Madden JH, 2010, J HEAD TRAUMA REHAB, V25, P470, DOI 10.1097/HTR.0b013e3181d717a7; Pagulayan KF, 2006, ARCH PHYS MED REHAB, V87, P611, DOI 10.1016/j.apmr.2006.01.018; Polusny MA, 2011, ARCH GEN PSYCHIAT, V68, P79, DOI 10.1001/archgenpsychiatry.2010.172; Roe C, 2009, DISABIL REHABIL, V31, P1235, DOI 10.1080/09638280802532720; Runnals JJ, 2013, PAIN MED, V14, P1529, DOI 10.1111/pme.12208; Sareen J, 2007, ARCH GEN PSYCHIAT, V64, P843, DOI 10.1001/archpsyc.64.7.843; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Schnurr PP, 2009, CLIN PSYCHOL REV, V29, P727, DOI 10.1016/j.cpr.2009.08.006; Seal KH, 2008, AM J PUBLIC HEALTH, V98, P714, DOI 10.2105/AJPH.2007.115519; Stevenson M, 2001, Inj Prev, V7, P10, DOI 10.1136/ip.7.1.10; Tanielian T, 2008, INVISIBLE WOUNDS WAR; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Tsai J, 2012, J CLIN PSYCHIAT, V73, P1110, DOI 10.4088/JCP.11m07587; Vanderploeg RD, 2012, ARCH PHYS MED REHAB, V93, P1887, DOI 10.1016/j.apmr.2012.05.024; Vasterling JJ, 2010, J TRAUMA STRESS, V23, P41, DOI 10.1002/jts.20487	57	17	17	0	12	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	AUG	2014	179	8					827	838		10.7205/MILMED-D-13-00506			12	Medicine, General & Internal	General & Internal Medicine	AN7UO	WOS:000340806700004	25102525	Bronze			2021-06-18	
J	Leong, DF; Master, CL; Messner, LV; Pang, Y; Smith, C; Starling, AJ				Leong, Danielle F.; Master, Christina L.; Messner, Leonard V.; Pang, Yi; Smith, Craig; Starling, Amaal J.			The Effect of Saccadic Training on Early Reading Fluency	CLINICAL PEDIATRICS			English	Article						eye movements; reading fluency; saccades; remediation	VISUAL SCREENING TOOL; KING-DEVICK TEST; EYE-MOVEMENT; SLEEP-DEPRIVATION; CONCUSSION; VISION; AREA	Background. Eye movements are necessary for the physical act of reading and have been shown to relate to underlying cognitive and visuoattentional processes during reading. The purpose of this study was to determine the effect of saccadic training using the King-Devick remediation software on reading fluency. Methods. In this prospective, single-blinded, randomized, crossover trial, a cohort of elementary students received standardized reading fluency testing pre- and posttreatment. Treatment consisted of in-school training 20 minutes per day, 3 days per week for 6 weeks. Results. The treatment group had significantly higher reading fluency scores after treatment (P < .001), and posttreatment scores were significantly higher than the control group (P < .005). Conclusion. Saccadic training can significantly improve reading fluency. We hypothesize that this improvement in reading fluency is a result of rigorous practice of eye movements and shifting visuospatial attention, which are vital to the act of reading.	[Leong, Danielle F.] King Devick Test LLC, Oak Brook Terrace, IL 60181 USA; [Master, Christina L.] Univ Penn, Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Messner, Leonard V.; Pang, Yi] Illinois Coll Optometry, Illinois Eye Inst, Chicago, IL USA; [Smith, Craig] Aegis Creat, Lakewood, CO USA; [Smith, Craig] Bill & Melinda Gates Fdn, Seattle, WA USA; [Starling, Amaal J.] Mayo Clin, Dept Neurol, Phoenix, AZ USA	Leong, DF (corresponding author), King Devick Test LLC, Two Mid America Plaza,Suite 110, Oak Brook Terrace, IL 60181 USA.	dleong@kingdevicktest.com		Master, Christina/0000-0002-6717-4270			*ALL EXC ED, 2007, HIGH COST HIGH SCH D; Allen M, 2012, M AM OPT ASS OPT JUN; Bucci MP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033458; Capo-Aponte JE, 2012, MIL MED, V177, P804, DOI 10.7205/MILMED-D-12-00061; CASS HD, 1994, ARCH DIS CHILD, V70, P192, DOI 10.1136/adc.70.3.192; Chetwood ASA, 2012, SURG ENDOSC, V26, P2003, DOI 10.1007/s00464-011-2143-x; Cymerman A, 2005, AVIAT SPACE ENVIR MD, V76, P627; Davies EC, 2012, NEUROLOGY, V78, pE103, DOI 10.1212/WNL.0b013e318251833d; Dore-Mazars K, 2004, PSYCHOL RES-PSYCH FO, V69, P67, DOI 10.1007/s00426-003-0166-1; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Fielding J, 2009, NEUROPSYCHOLOGIA, V47, P1647, DOI 10.1016/j.neuropsychologia.2009.01.040; FIORAVANTI F, 1995, VISION RES, V35, P3217, DOI 10.1016/0042-6989(95)00152-5; Galetta KM, 2011, NEUROLOGY, V76, P1456, DOI 10.1212/WNL.0b013e31821184c9; Galetta KM, 2011, J NEUROL SCI, V309, P34, DOI 10.1016/j.jns.2011.07.039; Galetta MS, 2013, J NEUROL SCI, V328, P28, DOI 10.1016/j.jns.2013.02.008; Gamlin PD, 2000, NATURE, V407, P1003, DOI 10.1038/35039506; Gold DR, 2012, CURR TREAT OPTION NE, V14, P73, DOI 10.1007/s11940-011-0160-7; Goldich Y, 2010, CURR EYE RES, V35, P1135, DOI 10.3109/02713683.2010.507902; Goldstand S, 2005, AM J OCCUP THER, V59, P377, DOI 10.5014/ajot.59.4.377; Jacquin-Courtois S, 2013, CORTEX, V49, P994, DOI 10.1016/j.cortex.2012.03.025; Kastner S, 2000, NEURON, V28, P314; King D, 2013, J NEUROL SCI, V326, P59, DOI 10.1016/j.jns.2013.01.012; King D, 2012, J NEUROL SCI, V320, P16, DOI 10.1016/j.jns.2012.05.049; Lin TP, 2014, PARKINSONISM RELAT D, V20, P226, DOI 10.1016/j.parkreldis.2013.10.009; Luna B, 2008, BRAIN COGNITION, V68, P293, DOI 10.1016/j.bandc.2008.08.019; Markowitz SN, 2006, CAN J OPHTHALMOL, V41, P289, DOI 10.1139/I06-027; Matsumoto H, 2011, MOVEMENT DISORD, V26, P1619, DOI 10.1002/mds.23683; National Institute of Child Health and Human Development, 2000, NIH PUBL; Prasad S, 2010, NEUROL CLIN, V28, P641, DOI 10.1016/j.ncl.2010.03.006; Puig SM, 2013, PLOS ONE, V8; Rayner K, 1998, PSYCHOL BULL, V124, P372, DOI 10.1037/0033-2909.124.3.372; Rayner K., 1985, REMEDIAL SPEC ED, V6, P53, DOI [10.1177/074193258500600609, DOI 10.1177/074193258500600609]; Roth T, 2009, NEUROLOGY, V72, P324, DOI 10.1212/01.wnl.0000341276.65721.f2; Rounds B B, 1991, J Am Optom Assoc, V62, P92; Rouse C, 2005, S SOC COSTS IN ED OC; SAMUELS SJ, 1988, READ TEACH, V41, P756; Schubert MC, 2010, RESTOR NEUROL NEUROS, V28, P9, DOI 10.3233/RNN-2010-0523; Seassau M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070261; Stepanek J, 2013, AVIAT SPACE ENVIR MD, V84, P1017, DOI 10.3357/ASEM.3616.2013; U.S. Department of Education Institute of Education Sciences, NAT ASS ED PROGR NAE	40	17	19	0	14	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0009-9228	1938-2707		CLIN PEDIATR	Clin. Pediatr.	AUG	2014	53	9					858	864		10.1177/0009922814532520			7	Pediatrics	Pediatrics	AM8LD	WOS:000340125700007	24790022				2021-06-18	
J	Cui, QJ; Wang, LY; Wei, ZX; Qu, WS				Cui, Qun-jian; Wang, Li-yi; Wei, Zhi-xuan; Qu, Wen-sheng			Continual Naringin Treatment Benefits the Recovery of Traumatic Brain Injury in Rats Through Reducing Oxidative and Inflammatory Alterations	NEUROCHEMICAL RESEARCH			English	Article						Traumatic brain injury; Naringin; Oxidative stress; Inflammation	NITRIC-OXIDE SYNTHASE; HEAD-INJURY; ANTIOXIDANT THERAPIES; INDUCED NEUROTOXICITY; SELECTIVE-INHIBITION; REPLACEMENT THERAPY; CLINICAL-TRIALS; FEMALE RATS; MODEL; NEUROPROTECTION	Naringin is neuroprotective in ischemia and other disease models. However, the effects of naringin are unknown after traumatic brain injury (TBI). The present study explored the role of naringin for neuroprotection in TBI rats. TBI was performed with the weight drop technique, and naringin was given orally at a dose of 100 mg/kg/day. The neurological scores, tissue edema, and oxidative stress/inflammation parameters [malondialdehyde (MDA), superoxide dismutase, nitric oxide, inducible nitric oxide synthase (iNOS), as well as interleukin-1 beta (IL-1 beta)] were measured. Compared to sham controls, TBI rats displayed obvious sensorimotor dysfunction, significant brain edema, and elevated oxidative and inflammatory molecules. Although a 7-day pre-treatment of naringin was unable to reverse these pathological changes, a 14-day continual treatment (7 days before and 7 days after the TBI) attenuated the increases in MDA and nitric oxide; enhanced the activation of superoxide dismutase; depressed the over-activation of iNOS; down-regulated the over-expression of IL-1 beta; and reduced the cortex edema. Additionally, the TBI-induced behavioral dysfunction was reduced. These results suggest that naringin treatment can attenuate cellular and histopathological alterations and improve the sensorimotor dysfunction of TBI rats, which may be partly due to the attenuation of oxidative and inflammatory damages.	[Cui, Qun-jian; Wang, Li-yi] Nanyang Med Collage, Dept Neurosurg, Affiliated Hosp 1, Nanyang 473000, Henan, Peoples R China; [Wei, Zhi-xuan] Nanyang Med Collage, Dept Gen Surg, Affiliated Hosp 1, Nanyang 473000, Henan, Peoples R China; [Qu, Wen-sheng] Huazhong Univ Sci & Technol, Dept Neurol, Tongji Hosp, Tongji Med Collage, Wuhan 430030, Hunan, Peoples R China	Qu, WS (corresponding author), Huazhong Univ Sci & Technol, Dept Neurol, Tongji Hosp, Tongji Med Collage, 1095 Rd Jiefang, Wuhan 430030, Hunan, Peoples R China.	qws0309@163.com					Allan SM, 2005, NAT REV IMMUNOL, V5, P629, DOI 10.1038/nri1664; Bains M, 2012, BBA-MOL BASIS DIS, V1822, P675, DOI 10.1016/j.bbadis.2011.10.017; Benavente-Garcia O, 2008, J AGR FOOD CHEM, V56, P6185, DOI 10.1021/jf8006568; Boto GR, 2005, NEUROCIRUGIA, V16, P39; Bramlett HM, 2001, J NEUROTRAUM, V18, P891, DOI 10.1089/089771501750451811; Chanet A, 2012, J NUTR BIOCHEM, V23, P469, DOI 10.1016/j.jnutbio.2011.02.001; Chen SF, 2007, LIFE SCI, V81, P288, DOI 10.1016/j.lfs.2007.05.023; Cherian L, 2004, BRAIN PATHOL, V14, P195, DOI 10.1111/j.1750-3639.2004.tb00053.x; Clark RSB, 1996, PEDIATR RES, V39, P784, DOI 10.1203/00006450-199605000-00007; Cornelius C, 2013, ANTIOXID REDOX SIGN, V19, P836, DOI 10.1089/ars.2012.4981; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Dajas F, 2003, BRAZ J MED BIOL RES, V36, P1613, DOI 10.1590/S0100-879X2003001200002; Das M, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-236; Ercan M, 2001, NEUROSURG REV, V24, P127, DOI 10.1007/PL00012396; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; FUHR U, 1995, CLIN PHARMACOL THER, V58, P365, DOI 10.1016/0009-9236(95)90048-9; Gahm C, 2006, J NEUROTRAUM, V23, P1343, DOI 10.1089/neu.2006.23.1343; Gaur V, 2009, EUR J PHARMACOL, V616, P147, DOI 10.1016/j.ejphar.2009.06.056; Golechha M, 2011, BIOL PHARM BULL, V34, P360, DOI 10.1248/bpb.34.360; Goodman JC, 2008, ACTA NEUROCHIR SUPPL, V102, P437, DOI 10.1007/978-3-211-85578-2_85; Gopinath K, 2012, NEUROSCIENCE, V227, P134, DOI 10.1016/j.neuroscience.2012.07.060; Haber M, 2013, EXP NEUROL, V249, P169, DOI 10.1016/j.expneurol.2013.09.002; Hall ED, 2010, NEUROTHERAPEUTICS, V7, P51, DOI 10.1016/j.nurt.2009.10.021; Helmy A, 2011, PROG NEUROBIOL, V95, P352, DOI 10.1016/j.pneurobio.2011.09.003; Heo HJ, 2004, J AGR FOOD CHEM, V52, P1520, DOI 10.1021/jf035079g; Hwang SL, 2012, J AGR FOOD CHEM, V60, P877, DOI 10.1021/jf204452y; Jafarian-Tehrani M, 2005, NITRIC OXIDE-BIOL CH, V12, P61, DOI 10.1016/j.niox.2004.12.001; Jagetia A, 2007, J APPL TOXICOL, V27, P122, DOI 10.1002/jat.1175; JUDD HL, 1983, ANN INTERN MED, V98, P195, DOI 10.7326/0003-4819-98-2-195; Kalayci M, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-75; Kinoshita K, 2002, NEUROSURGERY, V51, P195, DOI 10.1097/00006123-200207000-00027; Kumar A, 2010, FOOD CHEM TOXICOL, V48, P626, DOI 10.1016/j.fct.2009.11.043; Liu Y, 2012, MOL MED REP, V6, P1343, DOI 10.3892/mmr.2012.1072; Louin G, 2006, NEUROPHARMACOLOGY, V50, P182, DOI 10.1016/j.neuropharm.2005.08.020; Ma JP, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008409.pub3; Mazur W, 1998, BAILLIERE CLIN ENDOC, V12, P729, DOI 10.1016/S0950-351X(98)80013-X; Meffre D, 2007, ENDOCRINOLOGY, V148, P2505, DOI 10.1210/en.2006-1678; Menze ET, 2012, NEUROTOXICOLOGY, V33, P1265, DOI 10.1016/j.neuro.2012.07.007; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Nones J, 2011, NEUROCHEM RES, V36, P1776, DOI 10.1007/s11064-011-0493-3; O'Connor CA, 2003, J NEUROTRAUM, V20, P533, DOI 10.1089/089771503767168465; Orihara Y, 2001, FORENSIC SCI INT, V123, P142, DOI 10.1016/S0379-0738(01)00537-0; Potts Mathew B, 2006, NeuroRx, V3, P143; Prakash A, 2013, INT J NEUROSCI, V123, P636, DOI 10.3109/00207454.2013.785542; Raafat AM, 2001, AM J OBSTET GYNECOL, V184, P340, DOI 10.1067/mob.2001.110447; Rong W, 2012, NEUROCHEM RES, V37, P1615, DOI 10.1007/s11064-012-0756-7; Shahrokhi N, 2012, PAK J PHARM SCI, V25, P219; Simi A, 2007, BIOCHEM SOC T, V35, P1122, DOI 10.1042/BST0351122; Tehranian R, 2002, J NEUROTRAUM, V19, P939, DOI 10.1089/089771502320317096; Tsai TH, 2002, J AGR FOOD CHEM, V50, P6669, DOI 10.1021/jf020603p; Urso ML, 2003, TOXICOLOGY, V189, P41, DOI 10.1016/S0300-483X(03)00151-3; Utagawa A, 2008, EXP NEUROL, V211, P283, DOI 10.1016/j.expneurol.2008.02.001; Vavilala MS, 2001, ANESTH ANALG, V93, P351, DOI 10.1097/00000539-200108000-00023; Wagner AK, 2004, BRAIN RES, V998, P113, DOI 10.1016/j.brainres.2003.11.027; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; White TE, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-282; Wright DW, 2007, ANN EMERG MED, V49, P391, DOI 10.1016/j.annemergmed.2006.07.932; Youdim KA, 2002, BIOL CHEM, V383, P503, DOI 10.1515/BC.2002.052; Youdim KA, 2004, FREE RADICAL BIO MED, V36, P592, DOI 10.1016/j.freeradbiomed.2003.11.023; Zbarsky V, 2005, FREE RADICAL RES, V39, P1119, DOI 10.1080/10715760500233113	60	17	17	0	6	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-3190	1573-6903		NEUROCHEM RES	Neurochem. Res.	JUL	2014	39	7					1254	1262		10.1007/s11064-014-1306-2			9	Biochemistry & Molecular Biology; Neurosciences	Biochemistry & Molecular Biology; Neurosciences & Neurology	AM3BU	WOS:000339727300009	24728904				2021-06-18	
J	Naftel, KG; Yust, EM; Nichols, MH; King, WD; Davis, D				Naftel, Kimberly G.; Yust, Elizabeth M.; Nichols, Michele H.; King, William D.; Davis, Drew			Knowledge and Management of Sports Concussions among Coaches and Certified Athletic Trainers in Alabama	SOUTHERN MEDICAL JOURNAL			English	Article						athletes; concussion; head injuries; mild traumatic brain injury; return to play	HIGH-SCHOOL SPORTS; SIDELINE	Objectives: To identify modifiable barriers in resources, knowledge, and management that may improve the care of young athletes with concussions in the state of Alabama. Methods: An electronic survey was distributed to 2668 middle and high school coaches of contact sports in Alabama, and a paper survey was completed by 79 certified athletic trainers (ATCs) in 2010. Questions focused on their resource availability, knowledge of concussions based on the 2008 Consensus Statement on Concussion in Sport: the 3rd International Conference on Concussion in Sport (commonly known as the Zurich consensus statement), and management of concussions. Results: A total of 402 (16% response rate) coaches and 55 ATCs (70% response rate) responded to the survey. This study highlights that ATC coverage often is limited to the high school level, football, and competitions. Both coaches and ATCs primarily use physicians to make return-to-play decisions, although coaches (43.7%) usually refer to primary care physicians, whereas ATCs (43.6%) refer to orthopedic or sports medicine physicians. The study also revealed that coaches and ATCs desire education and could expand concussion awareness by providing education to parents and athletes. No overall difference was seen in the knowledge and management of concussions between coaches and ATCs; however, ATCs were more likely to identify symptoms that are positive for concussions (P = 0.04). Both groups had difficulty recognizing subtle symptoms such as trouble sleeping, personality changes, and dizziness; they also were unaware that strenuous mental activities could delay concussion recovery, although ATCs scored significantly better than coaches (P < 0.001). Neither coaches nor ATCs consistently use standardized measures such as the Sports Concussion Assessment Tool 2 (7.5% vs 56.4%) or neuropsychological testing (5.3% vs 14.5%). Conclusions: This study describes coaches' and ATCs' varying knowledge and management techniques and highlights areas in which targeted interventions and outreach could be useful. These areas include increased ATC availability, coach/ATC concussion education, improved parent/athlete education, increased "return to think'' awareness, and more consistent use of Sports Concussion Assessment Tool 2.	Monroe Carell Jr Childrens Hosp Vanderbilt, Div Pediat Emergency Med, Nashville, TN 37232 USA; Texas Childrens Hosp, Div Pediat Emergency Med, Houston, TX 77030 USA; Univ Alabama Birmingham, Div Pediat Emergency Med, Birmingham, AL USA; Univ Alabama Birmingham, Southeast Child Safety Inst, Childrens Alabama, Birmingham, AL USA; Univ Alabama Birmingham, Div Pediat Rehabil Med, Birmingham, AL USA	Naftel, KG (corresponding author), Monroe Carell Jr Childrens Hosp Vanderbilt, Dept Pediat, Div Emergency Med, 2200 Childrens Way,Suite 1014, Nashville, TN 37232 USA.	kimberly.gran@vanderbilt.edu			Alabama High School Athletic Association; Alabama Athletic Trainers' Association	The authors would like to acknowledge the Alabama High School Athletic Association and the Alabama Athletic Trainers' Association for their support. The authors also thank John Clifton Wellons III, MD and Joseph D. Ackerson, PhD, who assisted with survey development.	Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Bay E, 2011, ADV EMERG NURS J, V33, P71, DOI 10.1097/TME.0b013e318207e851; Cohen JS, 2009, CURR OPIN PEDIATR, V21, P288, DOI 10.1097/MOP.0b013e32832b1195; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Eckner JT, 2010, CURR SPORT MED REP, V9, P8, DOI 10.1249/JSR.0b013e3181caa778; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Kutcher JS, 2010, CURR SPORT MED REP, V9, P16, DOI 10.1249/JSR.0b013e3181caa89d; Likert R, 1932, ARCH PSYCHOL VOL, P136; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrea M, 2001, J ATHL TRAINING, V36, P274; McCrory Paul, 2005, Clin J Sport Med, V15, P48; McCrory Paul, 2009, J Athl Train, V44, P434, DOI 10.4085/1062-6050-44.4.434; Meehan WP, 2011, AM J SPORT MED, V39, P2304, DOI 10.1177/0363546511423503; Meehan WP, 2009, PEDIATRICS, V123, P114, DOI 10.1542/peds.2008-0309; Nesmith J Darrell, 2010, J Ark Med Soc, V107, P111; Patel DR, 2005, SPORTS MED, V35, P671, DOI 10.2165/00007256-200535080-00002; Rechel JA, 2008, J ATHL TRAINING, V43, P197, DOI 10.4085/1062-6050-43.2.197; Sarmiento K, 2010, J SCHOOL HEALTH, V80, P112, DOI 10.1111/j.1746-1561.2010.00491.x; Sawyer RJ, 2010, HEALTH PROMOT PRACT, V11, P34, DOI 10.1177/1524839907309377; Schulz MR, 2004, AM J EPIDEMIOL, V160, P937, DOI 10.1093/aje/kwh304; Stevens Penelope K, 2010, J Trauma Nurs, V17, P178, DOI 10.1097/JTN.0b013e3181ff2789; Williams Nolan, 2012, Front Neurol, V3, P130, DOI 10.3389/fneur.2012.00130	23	17	17	0	14	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0038-4348	1541-8243		SOUTH MED J	South.Med.J.	JUL	2014	107	7					418	423		10.14423/SMJ.0000000000000136			6	Medicine, General & Internal	General & Internal Medicine	AQ4ZZ	WOS:000342812700006	25010582				2021-06-18	
J	Spaite, DW; Bobrow, BJ; Stolz, U; Sherrill, D; Chikani, V; Barnhart, B; Sotelo, M; Gaither, JB; Viscusi, C; Adelson, PD; Denninghoff, KR				Spaite, Daniel W.; Bobrow, Bentley J.; Stolz, Uwe; Sherrill, Duane; Chikani, Vatsal; Barnhart, Bruce; Sotelo, Michael; Gaither, Joshua B.; Viscusi, Chad; Adelson, P. David; Denninghoff, Kurt R.			Evaluation of the Impact of Implementing the Emergency Medical Services Traumatic Brain Injury Guidelines in Arizona: The Excellence in Prehospital Injury Care (EPIC) Study Methodology	ACADEMIC EMERGENCY MEDICINE			English	Article							CEREBRAL-BLOOD-FLOW; RAPID-SEQUENCE INTUBATION; ADVANCED LIFE-SUPPORT; SEVERE HEAD-INJURY; HOSPITAL CARDIAC-ARREST; ENDOTRACHEAL INTUBATION; MAJOR TRAUMA; INTRAHOSPITAL TRANSPORT; PEDIATRIC-PATIENTS; EARLY VENTILATION	Traumatic brain injury (TBI) exacts a great toll on society. Fortunately, there is growing evidence that the management of TBI in the early minutes after injury may significantly reduce morbidity and mortality. In response, evidence-based prehospital and in-hospital TBI treatment guidelines have been established by authoritative bodies. However, no large studies have yet evaluated the effectiveness of implementing these guidelines in the prehospital setting. This article describes the background, design, implementation, emergency medical services (EMS) treatment protocols, and statistical analysis of a prospective, controlled (before/after), statewide study designed to evaluate the effect of implementing the EMS TBI guidelines-the Excellence in Prehospital Injury Care (EPIC) study (NIH/NINDS R01NS071049, "EPIC"; and 3R01NS071049-S1, "EPIC4Kids"). The specific aim of the study is to test the hypothesis that statewide implementation of the international adult and pediatric EMS TBI guidelines will significantly reduce mortality and improve nonmortality outcomes in patients with moderate or severe TBI. Furthermore, it will specifically evaluate the effect of guideline implementation on outcomes in the subgroup of patients who are intubated in the field. Over the course of the entire study (similar to 9 years), it is estimated that approximately 25,000 patients will be enrolled. (C) 2014 by the Society for Academic Emergency Medicine	[Spaite, Daniel W.; Bobrow, Bentley J.; Stolz, Uwe; Chikani, Vatsal; Barnhart, Bruce; Sotelo, Michael; Gaither, Joshua B.; Viscusi, Chad; Denninghoff, Kurt R.] Phoenix Childrens Hosp, Barrow Neurol Inst, Arizona Emergency Med Res Ctr, Tucson, AZ USA; [Spaite, Daniel W.; Stolz, Uwe; Barnhart, Bruce; Gaither, Joshua B.; Denninghoff, Kurt R.] Phoenix Childrens Hosp, Barrow Neurol Inst, Dept Emergency Med, Tucson, AZ USA; [Adelson, P. David] Univ Arizona, Coll Med, Dept Child Hlth Neurosurg, Tucson, AZ USA; [Bobrow, Bentley J.; Chikani, Vatsal] Arizona Dept Hlth Serv, Phoenix, AZ 85007 USA; [Bobrow, Bentley J.] Maricopa Integrated Hlth Syst, Phoenix, AZ USA; [Sherrill, Duane] Univ Arizona, Coll Publ Hlth, Tucson, AZ USA	Spaite, DW (corresponding author), Phoenix Childrens Hosp, Barrow Neurol Inst, Arizona Emergency Med Res Ctr, Tucson, AZ USA.	dan@aemrc.arizona.edu	Adelson, David/W-2083-2019	Spaite, Daniel/0000-0003-2601-6476; Chikani, Vatsal/0000-0003-0904-7887	National Institute of Neurological Disorders and Stroke of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS071049]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS071049] Funding Source: NIH RePORTER	Research reported in this publication was supported by the National Institute of Neurological Disorders and Stroke of the National Institutes of Health under Award R01NS071049. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adelson PD, 1997, PEDIATR NEUROSURG, V26, P200; American Heart Association, PED ADV LIF SUPP PAL; Armitage P., 1975, SEQUENTIAL MED TRIAL; Aufderheide Tom P, 2004, Crit Care Med, V32, pS345, DOI 10.1097/01.CCM.0000134335.46859.09; Ausina A, 1998, ACT NEUR S, V71, P1; Badjatia N, 2008, PREHOSP EMERG CARE, V12, pS1, DOI 10.1080/10903120701732052; Bao Yinghui, 2000, Chin J Traumatol, V3, P210; Barell V, 2002, INJ PREV, V8, P91, DOI 10.1136/ip.8.2.91; Barton CW, 2005, ACAD EMERG MED, V12, P1, DOI 10.1197/j.aem.2004.08.043; Bernard SA, 2010, ANN SURG, V252, P959, DOI 10.1097/SLA.0b013e3181efc15f; Bloomfield GL, 1997, CRIT CARE MED, V25, P496, DOI 10.1097/00003246-199703000-00020; Bobrow BJ, 2008, PREHOSP EMERG CARE, V12, P381, DOI 10.1080/10903120802100670; Bobrow BJ, 2008, JAMA-J AM MED ASSOC, V299, P1158, DOI 10.1001/jama.299.10.1158; Bobrow BJ, 2013, ANN EMERG MED, V62, P47, DOI 10.1016/j.annemergmed.2012.12.020; Bobrow BJ, 2010, JAMA-J AM MED ASSOC, V304, P1447, DOI 10.1001/jama.2010.1392; Bobrow BJ, 2009, ANN EMERG MED, V54, P656, DOI 10.1016/j.annemergmed.2009.06.011; BOUMA GJ, 1992, J NEUROSURG, V77, P360, DOI 10.3171/jns.1992.77.3.0360; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; BOYD CR, 1987, J TRAUMA, V27, P370, DOI 10.1097/00005373-198704000-00005; BRAMAN SS, 1987, ANN INTERN MED, V107, P469, DOI 10.7326/0003-4819-107-4-469; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; BRUCE DA, 1979, CHILD BRAIN, V5, P174; Bulger EM, 2005, J TRAUMA, V58, P718, DOI 10.1097/01.TA.0000159239.14181.BC; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Carney Nancy A, 2003, Pediatr Crit Care Med, V4, pS1; CARREL M, 1994, ANN FR ANESTH, V13, P326, DOI 10.1016/S0750-7658(94)80041-3; Champion H R, 2002, Scand J Surg, V91, P12; CHAMPION HR, 1995, J TRAUMA, V38, P94, DOI 10.1097/00005373-199501000-00024; CHAMPION HR, 1990, J TRAUMA, V30, P1356, DOI 10.1097/00005373-199011000-00008; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Chesnut RM, 2000, J NEUROTRAUM, V17, P555; Citerio G, 2001, CRIT CARE MED, V29, P1466, DOI 10.1097/00003246-200107000-00027; Clark DE, 2006, INJURY PREV, V12, P111, DOI 10.1136/ip.2005.010058; Coles JP, 2002, CRIT CARE MED, V30, P1950, DOI 10.1097/00003246-200209000-00002; Cudnik MT, 2010, J EMERG MED, V38, P175, DOI 10.1016/j.jemermed.2008.01.022; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; DARBY JM, 1988, NEUROSURGERY, V23, P84, DOI 10.1227/00006123-198807000-00014; Davis DP, 2008, RESUSCITATION, V76, P333, DOI 10.1016/j.resuscitation.2007.08.004; Davis DP, 2007, RESUSCITATION, V73, P354, DOI 10.1016/j.resuscitation.2006.09.015; Davis DP, 2007, PREHOSP EMERG CARE, V11, P1, DOI 10.1080/10903120601021093; Davis DP, 2006, CRIT CARE MED, V34, P1202, DOI 10.1097/01.CCM.0000208359.74623.1C; Davis DP, 2005, ANN EMERG MED, V46, P115, DOI 10.1016/j.annemergmed.2005.01.024; Davis DP, 2005, NEUROCRIT CARE, V2, P165, DOI 10.1385/NCC:2:2:165; Davis DP, 2004, J TRAUMA, V57, P1, DOI 10.1097/01.TA.0000135503.71684.C8; Davis DP, 2004, J TRAUMA, V56, P808, DOI 10.1097/01.TA.0000100217.05066.87; Denninghoff KR, 2008, WEST J EMERG MED, V9, P184; Dunford JV, 2003, ANN EMERG MED, V42, P721, DOI 10.1016/S0196-0644(03)00660-7; Eckstein M, 2000, J TRAUMA, V48, P643, DOI 10.1097/00005373-200004000-00010; Engdahl J, 2000, RESUSCITATION, V43, P201, DOI 10.1016/S0300-9572(99)00154-9; Erdfelder E, 1996, BEHAV RES METH INS C, V28, P1, DOI 10.3758/BF03203630; Fakhry SM, 2004, J TRAUMA, V56, P492, DOI 10.1097/01.TA.0000115650.07193.66; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Faul M, TRAUMATIC BRAIN INJU; Faul M, 2007, J TRAUMA, V63, P1271, DOI 10.1097/TA.0b013e3181493080; FEARNSIDE MR, 1993, BRIT J NEUROSURG, V7, P267, DOI 10.3109/02688699309023809; FIESCHI C, 1974, J NEUROL NEUROSUR PS, V37, P1378, DOI 10.1136/jnnp.37.12.1378; Fingerhut LA, 2002, INJ PREV, V8, P259, DOI 10.1136/ip.8.3.259; Finkelstein EA., 2006, INCIDENCE EC BURDEN; Forbes ML, 1998, J NEUROSURG, V88, P549, DOI 10.3171/jns.1998.88.3.0549; Fortune JB, 1995, J TRAUMA, V39, P1091, DOI 10.1097/00005373-199512000-00014; Garrison HG, 2002, ANN EMERG MED, V40, P81, DOI 10.1067/mem.2002.124758; Gausche M, 2000, JAMA-J AM MED ASSOC, V283, P783, DOI 10.1001/jama.283.6.783; GENTLEMAN D, 1992, INT SURG, V77, P297; GERVAIS HW, 1987, CRIT CARE MED, V15, P761, DOI 10.1097/00003246-198708000-00010; GORDON E, 1968, ACTA ANAESTH SCAND, V12, P51, DOI 10.1111/j.1399-6576.1968.tb00411.x; Helm M, 2002, BRIT J ANAESTH, V88, P345, DOI 10.1093/bja/88.3.345; Helmy A, 2007, BRIT J ANAESTH, V99, P32, DOI 10.1093/bja/aem139; HILL DA, 1993, AUST NZ J SURG, V63, P604, DOI 10.1111/j.1445-2197.1993.tb00466.x; Hsia RY, 2010, J TRAUMA, V68, P217, DOI 10.1097/TA.0b013e3181a0e66d; HURST JM, 1989, J TRAUMA, V29, P1637, DOI 10.1097/00005373-198912000-00008; Iezzoni L, 2003, RISK ADJUSTMENT MEAS; JAGGI JL, 1990, J NEUROSURG, V72, P176, DOI 10.3171/jns.1990.72.2.0176; Jankowitz BT, 2006, DEV NEUROSCI-BASEL, V28, P264, DOI 10.1159/000094153; JEFFREYS RV, 1981, LANCET, V2, P459; JONES PA, 1994, J NEUROSURG ANESTH, V6, P4; KARIM MR, 1992, BIOMETRICS, V48, P631, DOI 10.2307/2532317; KAUFMANN CR, 1991, J TRAUMA, V31, P691, DOI 10.1097/00005373-199105000-00014; Keim SM, 2004, ACAD EMERG MED, V11, P1067, DOI 10.1197/j.aem.2004.04.014; Kiening KL, 1997, NEUROL RES, V19, P233, DOI 10.1080/01616412.1997.11740805; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; KOHI YM, 1984, INJURY, V16, P25, DOI 10.1016/0020-1383(84)90110-4; Kokoska ER, 1998, J PEDIATR SURG, V33, P333, DOI 10.1016/S0022-3468(98)90457-2; Kreutzer JS, 2001, BRAIN INJURY, V15, P763, DOI 10.1080/02699050010025786; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lewis F., 2008, AM HEART ASS RES SCI; LUERSSEN TG, 1988, J NEUROSURG, V68, P409, DOI 10.3171/jns.1988.68.3.0409; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; MacKenzie EJ, 2006, NEW ENGL J MED, V354, P366, DOI 10.1056/NEJMsa052049; Manley G, 2001, ARCH SURG-CHICAGO, V136, P1118, DOI 10.1001/archsurg.136.10.1118; Manley GT, 2000, J TRAUMA, V48, P1025, DOI 10.1097/00005373-200006000-00005; Marcin JP, 2002, CRIT CARE MED, V30, pS457, DOI 10.1097/00003246-200211001-00011; MARION DW, 1991, J NEUROSURG, V74, P407, DOI 10.3171/jns.1991.74.3.0407; Marion DW, 2002, CRIT CARE MED, V30, P2619, DOI 10.1097/00003246-200212000-00001; MARMAROU A, 1991, J NEUROSURG, V75, pS59, DOI 10.3171/sup.1991.75.1s.0s59; MAYER TA, 1985, ANN EMERG MED, V14, P1178, DOI 10.1016/S0196-0644(85)81025-8; McCullagh P., 1989, GEN LINEAR MODELS; McCulloch C.E., 2001, GEN LINEAR MIXED MOD; McLean Samuel A, 2002, Prehosp Emerg Care, V6, pS52; MCPHERSON K, 1990, STAT MED, V9, P595, DOI 10.1002/sim.4780090605; Miller J D, 1982, J R Coll Surg Edinb, V27, P292; MUIZELAAR JP, 1989, J NEUROSURG, V71, P63, DOI 10.3171/jns.1989.71.1.0063; MUIZELAAR JP, 1991, J NEUROSURG, V75, P731, DOI 10.3171/jns.1991.75.5.0731; Nakamura Y, 2012, ANN EMERG MED, V60, P335, DOI 10.1016/j.annemergmed.2012.04.006; Newgard CD, 2004, ACAD EMERG MED, V11, P953, DOI 10.1197/j.aem.2004.02.530; Newgard CD, 2011, J AM COLL SURGEONS, V213, P709, DOI 10.1016/j.jamcollsurg.2011.09.012; OBRIEN PC, 1979, BIOMETRICS, V35, P549, DOI 10.2307/2530245; Obrist WD, 1987, CEREBRAL VASCULAR DI, V6, P241; Ong LC, 1996, PEDIATR NEUROSURG, V24, P285, DOI 10.1159/000121057; Ott R, 2000, J TRAUMA, V49, P729, DOI 10.1097/00005373-200010000-00023; Palmer S, 2001, J TRAUMA, V50, P657, DOI 10.1097/00005373-200104000-00010; Pepe Paul E, 2004, Crit Care Med, V32, pS414, DOI 10.1097/01.CCM.0000134264.88332.37; Pepe PE, 2005, CURR OPIN CRIT CARE, V11, P212, DOI 10.1097/01.ccx.0000163650.80601.24; PETO R, 1976, BRIT J CANCER, V34, P585, DOI 10.1038/bjc.1976.220; PIGULA FA, 1993, J PEDIATR SURG, V28, P310, DOI 10.1016/0022-3468(93)90223-8; POCOCK SJ, 1981, PERSPECTIVES MED STA; Poste Jennifer C, 2004, Air Med J, V23, P36, DOI 10.1016/j.amj.2004.04.006; Prause G, 1997, RESUSCITATION, V35, P145, DOI 10.1016/S0300-9572(97)00043-9; PRICE DJE, 1972, INJURY-BR J ACCIDENT, V3, P218, DOI 10.1016/0020-1383(72)90104-0; RAPHAELY RC, 1980, PEDIATR CLIN N AM, V27, P715; Robertson CS, 1999, CRIT CARE MED, V27, P2086, DOI 10.1097/00003246-199910000-00002; ROSE J, 1977, BRIT MED J, V2, P615, DOI 10.1136/bmj.2.6087.615; Rubin DB, 1997, ANN INTERN MED, V127, P757, DOI 10.7326/0003-4819-127-8_Part_2-199710151-00064; SEELIG JM, 1986, INTRACRANIAL PRESSUR, P675; Senkowski CK, 1999, J AM COLL SURGEONS, V189, P491, DOI 10.1016/S1072-7515(99)00190-8; SHARPLES PM, 1995, J NEUROL NEUROSUR PS, V58, P153, DOI 10.1136/jnnp.58.2.153; Shutter LA, 2008, ANN EMERG MED, V51, pS37, DOI 10.1016/j.annemergmed.2007.11.013; SILVERSTON P, 1989, BRIT MED J, V298, P711, DOI 10.1136/bmj.298.6675.711; SIOUTOS PJ, 1995, NEUROSURGERY, V36, P943, DOI 10.1227/00006123-199505000-00009; Skippen P, 1997, CRIT CARE MED, V25, P1402, DOI 10.1097/00003246-199708000-00031; Slutsky A S, 2000, Respir Res, V1, P73, DOI 10.1186/rr15; Spaite DW, 2008, RESUSCITATION, V79, P61, DOI 10.1016/j.resuscitation.2008.05.006; SPAITE DW, 1995, ANN EMERG MED, V26, P146, DOI 10.1016/S0196-0644(95)70144-3; SPAITE DW, 1993, ANN EMERG MED, V22, P638, DOI 10.1016/S0196-0644(05)81840-2; Spaite DW, 2001, ANN EMERG MED, V37, P657, DOI 10.1067/mem.2001.115215; Spaite DW, 2009, EMERGENCY MED SERVIC; Stiell IG, 2008, CAN MED ASSOC J, V178, P1141, DOI 10.1503/cmaj.071154; Stiell IG, 2007, NEW ENGL J MED, V356, P2156, DOI 10.1056/NEJMoa060334; Stiell IG, 2004, NEW ENGL J MED, V351, P647, DOI 10.1056/NEJMoa040325; Stiell IG, 1999, JAMA-J AM MED ASSOC, V281, P1175, DOI 10.1001/jama.281.13.1175; Stiell IG, 1999, ANN EMERG MED, V34, P256, DOI 10.1016/S0196-0644(99)70241-6; Stocchetti N, 1996, J TRAUMA, V40, P764, DOI 10.1097/00005373-199605000-00014; TEPAS JJ, 1990, J PEDIATR SURG, V25, P92, DOI 10.1016/S0022-3468(05)80170-8; Thomas SH, 2002, J TRAUMA, V52, P47, DOI 10.1097/00005373-200201000-00010; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Tobias JD, 1996, PEDIATR EMERG CARE, V12, P249, DOI 10.1097/00006565-199608000-00003; Uhlig S, 2002, AM J PHYSIOL-LUNG C, V282, pL892, DOI 10.1152/ajplung.00124.2001; Wang HE, 2004, ANN EMERG MED, V44, P439, DOI 10.1016/j.annemergmed.2004.04.008; Wang HE, 2006, PREHOSP EMERG CARE, V10, P261, DOI 10.1080/10903120500541506; Warner KJ, 2007, J TRAUMA, V62, P1330, DOI 10.1097/TA.0b013e31804a8032; Warner KJ, 2007, TRAUMA, V9, P283, DOI 10.1177/1460408607088317	150	17	18	0	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1069-6563	1553-2712		ACAD EMERG MED	Acad. Emerg. Med.	JUL	2014	21	7					818	830		10.1111/acem.12411			13	Emergency Medicine	Emergency Medicine	AN5AA	WOS:000340600200014	25112451	Green Accepted			2021-06-18	
J	Alsalaheen, BA; Whitney, SL; Marchetti, GF; Furman, JM; Kontos, AP; Collins, MW; Sparto, PJ				Alsalaheen, Bara A.; Whitney, Susan L.; Marchetti, Gregory F.; Furman, Joseph M.; Kontos, Anthony P.; Collins, Michael W.; Sparto, Patrick J.			Performance of High School Adolescents on Functional Gait and Balance Measures	PEDIATRIC PHYSICAL THERAPY			English	Article						activities of daily living; adolescence; gait; motor skills; postural balance; reproducibility of results; vestibular function tests/standards	SPORT-RELATED CONCUSSION; TO-STAND PERFORMANCE; MILD HEAD-INJURY; VESTIBULAR REHABILITATION; NORMATIVE DATA; OLDER-ADULTS; NEUROCOGNITIVE FUNCTION; POSTURAL STABILITY; ELDERLY PERSONS; BRAIN-INJURY	Purpose: To describe the performance of high school adolescents during common functional gait and balance measures used in vestibular physical therapy. Methods: A cross-sectional study of 91 participants determined their performance on the Activities-specific Balance Confidence (ABC) scale, Dynamic Gait Index, Functional Gait Assessment, Timed "Up and Go" (TUG), Five Times Sit to Stand (FTSTS) test, tests of gait speed (GS), and the Balance Error Scoring System. In a subset of this sample, GS, TUG, and the FTSTS were repeated twice to examine test-retest reliability. Results: The measures of GS, TUG, and FISTS were normally distributed. The Activities-specific Balance Confidence, Dynamic Gait Index, and Functional Gait Assessment exhibited a ceiling effect. The timed measures exhibited moderate to good reliability. Conclusions: These performance scores may provide end points for discharge from vestibular physical therapy. However, clinicians should be aware of the ceiling effect exhibited by some measures.	[Alsalaheen, Bara A.] Univ Michigan, Phys Therapy Dept, Flint, MI 48502 USA; [Whitney, Susan L.; Furman, Joseph M.; Sparto, Patrick J.] Univ Pittsburgh, Dept Phys Therapy, Pittsburgh, PA USA; [Whitney, Susan L.; Furman, Joseph M.; Sparto, Patrick J.] Univ Pittsburgh, Dept Otolaryngol, Pittsburgh, PA 15260 USA; [Kontos, Anthony P.; Collins, Michael W.] Univ Pittsburgh, Dept Orthoped Surg, Pittsburgh, PA USA; [Marchetti, Gregory F.] Duquesne Univ, Dept Phys Therapy, Pittsburgh, PA 15219 USA; [Whitney, Susan L.] King Saud Univ, Dept Rehabil Sci, Riyadh, Saudi Arabia	Alsalaheen, BA (corresponding author), Univ Michigan, Phys Therapy Dept, 2157 William S White Bldg,303 E Kearsley St, Flint, MI 48502 USA.	Alsalahe@umflint.edu		Sparto, Patrick/0000-0002-8351-3789; Kontos, Anthony/0000-0002-3749-4310	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [UL1 RR024153, UL1TR000005]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [UL1RR024153] Funding Source: NIH RePORTER	The National Institutes of Health through Grants Number UL1 RR024153 and UL1TR000005 supported the project described.	Alsalaheen BA, 2010, J NEUROL PHYS THER, V34, P87, DOI 10.1097/NPT.0b013e3181dde568; Bell DR, 2011, SPORTS HEALTH, V3, P287, DOI 10.1177/1941738111403122; Bohannon RW, 1997, AGE AGEING, V26, P15, DOI 10.1093/ageing/26.1.15; Bressel E, 2007, J ATHL TRAINING, V42, P42; Broglio SP, 2009, CLIN J SPORT MED, V19, P377, DOI 10.1097/JSM.0b013e3181b625fe; Brown KE, 2006, ARCH PHYS MED REHAB, V87, P76, DOI 10.1016/j.apmr.2005.08.003; Bruininks R. H., 1978, BRUININKS OSERETSKY; Cohen JS, 2009, CURR OPIN PEDIATR, V21, P288, DOI 10.1097/MOP.0b013e32832b1195; CSUKA M, 1985, AM J MED, V78, P77, DOI 10.1016/0002-9343(85)90465-6; Enticott JC, 2005, OTOL NEUROTOL, V26, P265, DOI 10.1097/00129492-200503000-00024; Evans MD, 1997, ARCH PHYS MED REHAB, V78, P725, DOI 10.1016/S0003-9993(97)90080-0; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Finnoff JT, 2009, PM&R, V1, P50, DOI 10.1016/j.pmrj.2008.06.002; Gill-Body KM, 2000, PHYS THER, V80, P748, DOI 10.1093/ptj/80.8.748; Gurr B, 2001, BRAIN INJURY, V15, P387, DOI 10.1080/02699050010005904; Guskiewicz KM, 2004, J ATHL TRAINING, V39, P280; Hall TD, 2004, OTOL NEUROTOL, V25, P746, DOI 10.1097/00129492-200409000-00017; HERDMAN SJ, 1995, OTOLARYNG HEAD NECK, V113, P77, DOI 10.1016/S0194-5998(95)70148-6; Herdman SJ, 2003, ARCH OTOLARYNGOL, V129, P819, DOI 10.1001/archotol.129.8.819; Hoffer ME, 2004, OTOL NEUROTOL, V25, P135, DOI 10.1097/00129492-200403000-00009; HORAK FB, 1992, OTOLARYNG HEAD NECK, V106, P175, DOI 10.1177/019459989210600220; Hunt TN, 2009, CLIN J SPORT MED, V19, P471, DOI 10.1097/JSM.0b013e3181c12c7b; Jette AM, 1999, J GERONTOL A-BIOL, V54, pM3, DOI 10.1093/gerona/54.1.M3; Kirkwood MW, 2006, PEDIATRICS, V117, P1359, DOI 10.1542/peds.2005-0994; Krebs DE, 2003, OTOLARYNG HEAD NECK, V128, P240, DOI 10.1067/mhn.2003.72; Lord SR, 2002, J GERONTOL A-BIOL, V57, pM539, DOI 10.1093/gerona/57.8.M539; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Maskell F, 2006, BRAIN INJURY, V20, P293, DOI 10.1080/02699050500488041; Masson F, 1996, BRAIN INJURY, V10, P487, DOI 10.1080/026990596124205; McClincy MP, 2006, BRAIN INJURY, V20, P33, DOI 10.1080/02699050500309817; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2004, BRIT J SPORT MED, V38, P516, DOI 10.1136/bjsm.2004.014811; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; McLeod TCV, 2009, J SPORT REHABIL, V18, P465, DOI 10.1123/jsr.18.4.465; Meretta BM, 2006, J VESTIBUL RES-EQUIL, V16, P233; Mong YQ, 2010, ARCH PHYS MED REHAB, V91, P407, DOI 10.1016/j.apmr.2009.10.030; OBERG T, 1993, J REHABIL RES DEV, V30, P210; Oliaro SM, 1998, J ATHL TRAINING, V33, P36; Ostchega Y, 2000, J AM GERIATR SOC, V48, P1136, DOI 10.1111/j.1532-5415.2000.tb04792.x; Patel DR, 2005, SPORTS MED, V35, P671, DOI 10.2165/00007256-200535080-00002; Peretz C, 2006, MOVEMENT DISORD, V21, P2101, DOI 10.1002/mds.21113; PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142, DOI 10.1111/j.1532-5415.1991.tb01616.x; POWELL LE, 1995, J GERONTOL A-BIOL, V50, pM28, DOI 10.1093/gerona/50A.1.M28; Reddy CC, 2009, CURR SPORT MED REP, V8, P10, DOI 10.1249/JSR.0b013e31819539ca; Reddy CC, 2008, PHYS MED REH CLIN N, V19, P247, DOI 10.1016/j.pmr.2007.12.002; Register-Mihalik J, 2007, CLIN J SPORT MED, V17, P282, DOI 10.1097/JSM.0b013e31804ca68a; Riemann BL, 1999, J SPORT REHABIL, V8, P71, DOI 10.1123/jsr.8.2.71; Riemann BL, 2000, J ATHL TRAINING, V35, P19; Rockwood K, 2000, J GERONTOL A-BIOL, V55, pM70; Rose DJ, 2006, ARCH PHYS MED REHAB, V87, P1478, DOI 10.1016/j.apmr.2006.07.263; Sabin MJ, 2011, CLIN J SPORT MED, V21, P411, DOI 10.1097/JSM.0b013e318223f3a4; Schaubert K, 2005, ISOKINET EXERC SCI, V13, P119, DOI 10.3233/IES-2005-0188; Schaubert KL, 2005, J STRENGTH COND RES, V19, P717, DOI 10.1519/R-15954.1; Schmidt JD, 2012, MED SCI SPORT EXER, V44, P1621, DOI 10.1249/MSS.0b013e318258a9fb; Shumway-Cook A., 1995, MOTOR CONTROL THEORY; ShumwayCook A, 1997, PHYS THER, V77, P812, DOI 10.1093/ptj/77.8.812; Steffen TM, 2002, PHYS THER, V82, P128, DOI 10.1093/ptj/82.2.128; Viccaro LJ, 2011, J AM GERIATR SOC, V59, P887, DOI 10.1111/j.1532-5415.2011.03336.x; Walker ML, 2007, PHYS THER, V87, P1468, DOI 10.2522/ptj.20060344; Whitney S. L., 2007, VESTIBULAR REHABILIT, P272; Whitney SL, 2005, PHYS THER, V85, P1034, DOI 10.1093/ptj/85.10.1034; Whitney SL, 2004, J VESTIBUL RES-EQUIL, V14, P397; Whitney Susan, 2003, Physiother Res Int, V8, P178, DOI 10.1002/pri.288; Whitney SL, 2007, ARCH PHYS MED REHAB, V88, P99, DOI 10.1016/j.apmr.2006.10.027; Wrisley DM, 2004, PHYS THER, V84, P906, DOI 10.1093/ptj/84.10.906; Wrisley DM, 2003, ARCH PHYS MED REHAB, V84, P1528, DOI 10.1016/S0003-9993(03)00274-0; Wrisley DM, 2002, OTOL NEUROTOL, V23, P483, DOI 10.1097/00129492-200207000-00016; Yardley L, 1998, BRIT J GEN PRACT, V48, P1136	68	17	17	0	22	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0898-5669	1538-005X		PEDIATR PHYS THER	Pediatr. Phys. Ther.	SUM	2014	26	2					191	199		10.1097/PEP.0000000000000037			9	Pediatrics; Rehabilitation	Pediatrics; Rehabilitation	AK8RF	WOS:000338695000007	24675118	Green Accepted			2021-06-18	
J	Gupte, AA; Hocevar, SN; Lea, AS; Kulkarni, RD; Schain, DC; Casey, MJ; Zendejas-Ruiz, IR; Chung, WK; Mbaeyi, C; Roy, SL; Visvesvara, GS; da Silva, AJ; Tallaj, J; Eckhoff, D; Baddley, JW				Gupte, A. A.; Hocevar, S. N.; Lea, A. S.; Kulkarni, R. D.; Schain, D. C.; Casey, M. J.; Zendejas-Ruiz, I. R.; Chung, W. K.; Mbaeyi, C.; Roy, S. L.; Visvesvara, G. S.; da Silva, A. J.; Tallaj, J.; Eckhoff, D.; Baddley, J. W.			Transmission of Balamuthia mandrillaris Through Solid Organ Transplantation: Utility of Organ Recipient Serology to Guide Clinical Management	AMERICAN JOURNAL OF TRANSPLANTATION			English	Article						Amebic encephalitis; Balamuthia mandrillaris; donor-derived infection; miltefosine	FREE-LIVING AMEBAS; ACANTHAMOEBA SPP.; MENINGOENCEPHALITIS; ENCEPHALITIS; INFECTION; PATIENT; AGENT; PCR	A liver, heart, iliac vessel and two kidneys were recovered from a 39-year-old man who died of traumatic head injury and were transplanted into five recipients. The liver recipient 18 days posttransplantation presented with headache, ataxia and fever, followed by rapid neurologic decline and death. Diagnosis of granulomatous amebic encephalitis was made on autopsy. Balamuthia mandrillaris infection was confirmed with immunohistochemical and polymerase chain reaction (PCR) assays. Donor and recipients' sera were tested for B. mandrillaris antibodies. Donor brain was negative for Balamuthia by immunohistochemistry and PCR; donor serum Balamuthia antibody titer was positive (1:64). Antibody titers in all recipients were positive (range, 1:64-1:512). Recipients received a four-to five-drug combination of miltefosine or pentamidine, azithromycin, albendazole, sulfadiazine and fluconazole. Nausea, vomiting, elevated liver transaminases and renal insufficiency were common. All other recipients survived and have remained asymptomatic 24 months posttransplant. This is the third donor-derived Balamuthia infection cluster described in solid organ transplant recipients in the United States. As Balamuthia serologic testing is only available through a national reference laboratory, it is not feasible for donor screening, but may be useful to determine exposure status in recipients and to help guide chemotherapy.	[Gupte, A. A.; Kulkarni, R. D.; Schain, D. C.; Casey, M. J.; Zendejas-Ruiz, I. R.] Univ Florida, Coll Med, Gainesville, FL USA; [Hocevar, S. N.; Mbaeyi, C.; Roy, S. L.; Visvesvara, G. S.; da Silva, A. J.] Ctr Dis Control & Prevent, Atlanta, GA USA; [Lea, A. S.; Chung, W. K.] Univ Texas Med Branch, Galveston, TX 77555 USA; [Tallaj, J.; Eckhoff, D.; Baddley, J. W.] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA	Baddley, JW (corresponding author), Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA.	jbaddley@uab.edu	Mbaeyi, Chukwuma/P-3984-2016	Mbaeyi, Chukwuma/0000-0002-4519-3075	Intramural CDC HHS [CC999999] Funding Source: Medline		Ahmad AF, 2011, J EUKARYOT MICROBIOL, V58, P269, DOI 10.1111/j.1550-7408.2011.00541.x; Bravo FG, 2012, CURR INFECT DIS REP, V14, P391, DOI 10.1007/s11908-012-0266-4; Bravo FG, 2011, CURR OPIN INFECT DIS, V24, P112, DOI 10.1097/QCO.0b013e3283428d1e; Cary LC, 2010, PEDIATRICS, V125, pE699, DOI 10.1542/peds.2009-1797; Centers for Disease Control and Prevention (CDC), 2010, MMWR Morb Mortal Wkly Rep, V59, P1165; Centers for Disease Control and Prevention (CDC), 2010, MMWR Morb Mortal Wkly Rep, V59, P1182; Deetz TR, 2003, CLIN INFECT DIS, V37, P1304, DOI 10.1086/379020; Doyle JS, 2011, J NEUROSURG, V114, P458, DOI 10.3171/2010.10.JNS10677; Dunnebacke TH, 2004, MICROBIOL-SGM, V150, P2837, DOI 10.1099/mic.0.27218-0; Jung SM, 2004, ARCH PATHOL LAB MED, V128, P466; Martinez DY, 2010, CLIN INFECT DIS, V51, pE7, DOI 10.1086/653609; Matin A, 2008, CLIN MICROBIOL REV, V21, P435, DOI 10.1128/CMR.00056-07; Niyyati M, 2009, PARASITOL RES, V106, P279, DOI 10.1007/s00436-009-1592-9; Qvarnstrom Y, 2006, J CLIN MICROBIOL, V44, P3589, DOI 10.1128/JCM.00875-06; Schuster FL, 2004, DRUG RESIST UPDATE, V7, P41, DOI 10.1016/j.drup.2004.01.002; Schuster FL, 2006, J EUKARYOT MICROBIOL, V53, P121, DOI 10.1111/j.1550-7408.2005.00082.x; Schuster FL, 2004, EMERG INFECT DIS, V10, P1510; Schuster FL, 2003, J CLIN MICROBIOL, V41, P3175, DOI 10.1128/JCM.41.7.3175-3180.2003; Schuster FL, 2003, J EUKARYOT MICROBIOL, V37, P1304; Schuster FL, 2008, J EUKARYOT MICROBIOL, V55, P313, DOI 10.1111/j.1550-7408.2008.00333.x; Schuster FL, 2009, CLIN INFECT DIS, V48, P879, DOI 10.1086/597260; Silva-Vergara ML, 2007, AM J TROP MED HYG, V77, P1096, DOI 10.4269/ajtmh.2007.77.1096; The Organ Procurement and Transplantation Network, 2012, GUID REP POT DEC LIV; Visvesvara GS, 2007, FEMS IMMUNOL MED MIC, V50, P1, DOI 10.1111/j.1574-695X.2007.00232.x; VISVESVARA GS, 1990, J CLIN MICROBIOL, V28, P2750, DOI 10.1128/JCM.28.12.2750-2756.1990	25	17	18	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1600-6135	1600-6143		AM J TRANSPLANT	Am. J. Transplant.	JUN	2014	14	6					1417	1424		10.1111/ajt.12726			8	Surgery; Transplantation	Surgery; Transplantation	AJ2UP	WOS:000337519500024	24840013	Green Accepted, Bronze			2021-06-18	
J	Sanchez, J; Centanaro, M; Solis, J; Delgado, F; Yepez, L				Sanchez, Javier; Centanaro, Mirella; Solis, Juanita; Delgado, Fabrizio; Yepez, Luis			Factors predicting the outcome following medical treatment of mesial temporal epilepsy with hippocampal sclerosis	SEIZURE-EUROPEAN JOURNAL OF EPILEPSY			English	Article						Prognostic factors; Mesial temporal sclerosis; Epilepsy surgery; Hippocampal sclerosis; Outcome	LOBE EPILEPSY; EARLY IDENTIFICATION; SEIZURES; PROGNOSIS; ABNORMALITIES; LOCALIZATION; REMISSION; ETIOLOGY; HISTORY; SURGERY	Purpose: There is a lack of information from South America regarding factors that predict the clinical outcomes of patients treated medically for mesial temporal lobe epilepsy with hippocampal sclerosis (MTLE-HS). This study was conducted to determine which of these factors are the most important. Methods: This study included 110 South American patients with MTLE-HS treated with antiepileptic drugs. The factors considered included age, gender, age of epilepsy onset, interval between the lesion and the first seizure, central nervous system infection, traumatic brain injury, perinatal asphyxia, febrile convulsion, history of status epilepticus, types of seizures, site of hippocampal sclerosis (HS), extrahippocampal pathology, and electroencephalogram (EEG) abnormalities. The patients were divided into two groups based on the response to treatment: Group I, seizure free for at least two years; and Group II, not seizure free. Results: On the multivariate analysis, the factors associated with a poor prognosis in terms of seizure frequency and control following treatment included the presence of an early onset of seizure, more than 10 seizures per month before treatment, and EEG abnormalities. Conclusion: The recognition of risk factors, such as early onset of seizures, more than 10 seizures per month before treatment, and EEG abnormalities, could lead to the identification of risk groups among patients with MTLE-HS and refractory epilepsy, possibly designating these individuals as candidates for early epilepsy surgery. (C) 2014 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.	[Sanchez, Javier; Centanaro, Mirella; Solis, Juanita; Delgado, Fabrizio; Yepez, Luis] Guayaquil Welf Board, Inst Neurosci, Brain Res Ctr, Guayaquil, Ecuador	Sanchez, J (corresponding author), Guayaquil Welf Board, Inst Neurosci, Brain Res Ctr, Guayaquil, Ecuador.	javiersanchez503@yahoo.com					Aguglia U, 2011, J NEUROL NEUROSUR PS, V82, P555, DOI 10.1136/jnnp.2010.217620; Arroyo S, 1997, EPILEPSIA, V38, P1098, DOI 10.1111/j.1528-1157.1997.tb01199.x; Auer T, 2008, EPILEPSIA, V49, P1562, DOI 10.1111/j.1528-1167.2008.01679.x; Babb T.L., 1987, SURGICAL TREATMENT E, P511; BEGHI E, 1992, EPILEPSIA, V33, P45; Berg AT, 1996, EPILEPSIA, V37, P126, DOI 10.1111/j.1528-1157.1996.tb00003.x; Berg AT, 2003, EPILEPSIA, V44, P1425, DOI 10.1046/j.1528-1157.2003.24203.x; Bernasconi Andrea, 2006, Adv Neurol, V97, P273; Cendes F, 1997, ANN NEUROL, V42, P737, DOI 10.1002/ana.410420510; Engel J, 2003, EPILEPSIA, V44, P741, DOI 10.1046/j.1528-1157.2003.48202.x; Engel J, 2012, JAMA-J AM MED ASSOC, V307, P922, DOI 10.1001/jama.2012.220; FOIS A, 1988, CLIN ELECTROENCEPHAL, V19, P68, DOI 10.1177/155005948801900207; Gasparini S, 2013, EPILEPSY RES, V107, P101, DOI 10.1016/j.eplepsyres.2013.07.004; Hitiris N, 2007, EPILEPSY RES, V75, P192, DOI 10.1016/j.eplepsyres.2007.06.003; Holmes MD, 2000, SEIZURE-EUR J EPILEP, V9, P407, DOI 10.1053/seiz.2000.0423; Kim WJ, 1999, EPILEPSIA, V40, P290, DOI 10.1111/j.1528-1157.1999.tb00706.x; Kumlien E, 2002, SEIZURE-EUR J EPILEP, V11, P413, DOI 10.1053/seiz.2001.0614; Kwan P, 2000, NEW ENGL J MED, V342, P314, DOI 10.1056/NEJM200002033420503; Kwan P, 2010, EPILEPSIA, V51, P1069, DOI 10.1111/j.1528-1167.2009.02397.x; Langfitt JT, 2008, CURR OPIN NEUROL, V21, P179, DOI 10.1097/WCO.0b013e3282f47931; Lee DH, 1998, AM J NEURORADIOL, V19, P19; MacDonald BK, 2000, ANN NEUROL, V48, P833, DOI 10.1002/1531-8249(200012)48:6<833::AID-ANA3>3.0.CO;2-U; MARGERISON JH, 1966, BRAIN, V89, P499, DOI 10.1093/brain/89.3.499; MARKS DA, 1995, NEUROLOGY, V45, P2051, DOI 10.1212/WNL.45.11.2051; MATHERN GW, 1995, J NEUROSURG, V82, P220, DOI 10.3171/jns.1995.82.2.0220; Ngugi AK, 2010, EPILEPSIA, V51, P883, DOI 10.1111/j.1528-1167.2009.02481.x; Pittau F, 2009, EPILEPSIA, V50, P41, DOI 10.1111/j.1528-1167.2008.01969.x; ROWAN AJ, 1980, EPILEPSIA, V21, P219, DOI 10.1111/j.1528-1157.1980.tb04066.x; Schomer DL, 2012, JAMA-J AM MED ASSOC, V307, P966, DOI 10.1001/jama.2012.251; Semah F, 2002, ARCH NEUROL-CHICAGO, V59, P1042, DOI 10.1001/archneur.59.6.1042-a; Semah F, 1998, NEUROLOGY, V51, P1256, DOI 10.1212/WNL.51.5.1256; SILLANPAA M, 1993, EPILEPSIA, V34, P930, DOI 10.1111/j.1528-1157.1993.tb02114.x; Stephen LJ, 2001, EPILEPSIA, V42, P357, DOI 10.1046/j.1528-1157.2001.29000.x; VanPaesschen W, 1997, NEUROLOGY, V49, P753, DOI 10.1212/WNL.49.3.753; Varoglu AO, 2009, EPILEPSY RES, V85, P206, DOI 10.1016/j.eplepsyres.2009.03.001; Wieser HG, 2004, EPILEPSIA, V45, P32; WILLIAMSON PD, 1993, ANN NEUROL, V34, P781, DOI 10.1002/ana.410340605	37	17	18	0	4	W B SAUNDERS CO LTD	LONDON	32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND	1059-1311	1532-2688		SEIZURE-EUR J EPILEP	Seizure	JUN	2014	23	6					448	453		10.1016/j.seizure.2014.03.003			6	Clinical Neurology; Neurosciences	Neurosciences & Neurology	AJ8ZT	WOS:000337997300008	24680551	Bronze			2021-06-18	
J	Walker, WC; Franke, LM; Cifu, DX; Hart, BB				Walker, William C.; Franke, Laura Manning; Cifu, David X.; Hart, Brett B.			Randomized, Sham-Controlled, Feasibility Trial of Hyperbaric Oxygen for Service Members With Postconcussion Syndrome: Cognitive and Psychomotor Outcomes 1 Week Postintervention	NEUROREHABILITATION AND NEURAL REPAIR			English	Article						postconcussion syndrome; traumatic brain injury; hyperbaric oxygenation; cognition disorders; psychomotor performance; randomized controlled trial	TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; POST-CONCUSSION SYNDROME; MEMORY MALINGERING TOMM; OIF/OEF VETERANS; NORMATIVE DATA; HEAD-INJURIES; CHRONIC PAIN; MILD TBI; SYMPTOMS	Background. Mild traumatic brain injury (mTBI) and residual postconcussion syndrome (PCS) are common among combatants of the recent military conflicts in Iraq and Afghanistan. Hyperbaric oxygen (HBO2) is a proposed treatment but has not been rigorously studied for this condition. Objectives. In a secondary analysis, examine for possible effects on psychomotor (balance and fine motor) and cognitive performance 1 week after an HBO2 intervention in service members with PCS after mTBI. Methods. A randomized, double-blind, sham control, feasibility trial comparing pretreatment and posttreatment was conducted in 60 male active-duty marines with combat-related mTBI and PCS persisting for 3 to 36 months. Participants were randomized to 1 of 3 preassigned oxygen fractions (10.5%, 75%, or 100%) at 2.0 atmospheres absolute (ATA), resulting in respective groups with an oxygen exposure equivalent to (1) breathing surface air (Sham Air), (2) 100% oxygen at 1.5 ATA (1.5 ATAO2), and (3) 100% oxygen at 2.0 ATA (2.0 ATAO2). Over a 10-week period, participants received 40 hyperbaric chamber sessions of 60 minutes each. Outcome measures, including computerized posturography (balance), grooved pegboard (fine motor speed/dexterity), and multiple neuropsychological tests of cognitive performance, were collected preintervention and 1-week postintervention. Results. Despite the multiple sensitive cognitive and psychomotor measures analyzed at an unadjusted 5% significance level, this study demonstrated no immediate postintervention beneficial effect of exposure to either 1.5 ATAO2 or 2.0 ATAO2 compared with the Sham Air intervention. Conclusions. These results do not support the use of HBO2 to treat cognitive, balance, or fine motor deficits associated with mTBI and PCS.	[Walker, William C.; Franke, Laura Manning; Cifu, David X.] Virginia Commonwealth Univ, Richmond, VA 23298 USA; [Walker, William C.; Franke, Laura Manning; Cifu, David X.] Hunter Holmes McGuire Vet Affairs Med Ctr, Richmond, VA USA; [Walker, William C.; Franke, Laura Manning] Richmond Def & Vet Brain Injury Ctr, Richmond, VA USA; [Cifu, David X.] Dept Vet Affairs, Washington, DC USA; [Hart, Brett B.] Navy Med Operat Training Ctr, Pensacola, FL USA	Walker, WC (corresponding author), Virginia Commonwealth Univ, Dept PM&R, 1223 East Marshall St, Richmond, VA 23298 USA.	wwalker@mcvh-vcu.edu	Walker, William C/N-3162-2014	Cifu, David/0000-0003-1600-9387	Defense Advanced Research Projects AgencyUnited States Department of DefenseDefense Advanced Research Projects Agency (DARPA) [N66001-09-2-206]; US Navy Bureau of Medicine and Surgery; US Army Medical Material Development Activity; Defense and Veterans Brain Injury CenterUS Department of Veterans Affairs	The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: Funding was provided for the primary study by a Defense Advanced Research Projects Agency grant (N66001-09-2-206), US Navy Bureau of Medicine and Surgery for contract funding temporary duty requirements, and the US Army Medical Material Development Activity for end-of-study contract funding. Drs Franke's and Walker's efforts were additionally supported, in part, through contracts from the Defense and Veterans Brain Injury Center. The funding sources had no role in the study design, analysis, interpretation of the data, the writing of the article, or the decision to submit the paper for publication.	Belanger HG, 2011, CLIN NEUROPSYCHOL, V25, P702, DOI 10.1080/13854046.2011.566892; BENTON A L, 1981, Journal of Clinical Neuropsychology, V3, P33, DOI 10.1080/01688638108403111; BOHNEN NI, 1995, BRAIN INJURY, V9, P27, DOI 10.3109/02699059509004568; Centers for Disease Control and Prevention, DOD VA COD PROP DOD; Cicerone KD, 1996, BRAIN INJURY, V10, P79, DOI 10.1080/026990596124566; Cifu DX, J HEAD TRAU IN PRESS; Clarke D, 2009, UNDERSEA HYPERBAR M, V36, P13; Conners C., 2000, CONNERS CONTINUOUS P; Cripps A, 2013, J SPORT REHABIL, V22, P67, DOI 10.1123/jsr.22.1.67; Curtis KL, 2009, ASSESSMENT, V16, P401, DOI 10.1177/1073191109338161; Defense and Veterans Brain Injury Center, 2013, DOD WORLDW NUMB TBI; Delis DC, 1991, J CONSULT CLIN PSYCH, V3, P19, DOI DOI 10.1037/1040-3590.3.1.19; DIKMEN S, 1986, J NEUROL NEUROSUR PS, V49, P1227, DOI 10.1136/jnnp.49.11.1227; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; Donders J, 2007, J INT NEUROPSYCH SOC, V13, P354, DOI 10.1017/S1355617707070439; Eyres S, 2005, CLIN REHABIL, V19, P878, DOI 10.1191/0269215505cr905oa; Gesell L.B., 2008, HYPERBARIC OXYGEN TH, V12th; GRONWALL DMA, 1977, PERCEPT MOTOR SKILL, V44, P367, DOI 10.2466/pms.1977.44.2.367; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Halbauer JD, 2009, J REHABIL RES DEV, V46, P757, DOI 10.1682/JRRD.2008.08.0119; Harch PG, 2012, J NEUROTRAUM, V29, P168, DOI 10.1089/neu.2011.1895; Harrison JE, 2000, BRIT J CLIN PSYCHOL, V39, P181, DOI 10.1348/014466500163202; Jacobs ML, 2007, ARCH CLIN NEUROPSYCH, V22, P143, DOI 10.1016/j.acn.2006.12.002; Kaufman KR, 2006, MED ENG PHYS, V28, P234, DOI 10.1016/j.medengphy.2005.05.005; KLOVE H, 1963, MED CLIN N AM, V47, P1647, DOI 10.1016/S0025-7125(16)33515-5; Lange RT, 2013, J NEUROTRAUM, V30, P958, DOI 10.1089/neu.2012.2743; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; Mathias JL, 2007, BRIT J CLIN PSYCHOL, V46, P457, DOI 10.1348/014466507X190197; Multiple A, 2012, J REHABIL RES DEV, V49, P971; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; National Institute of Neurologic Disorders (NINDS), TRAUMATIC BRAIN INJU; NEUBAUER RA, 1990, LANCET, V335, P542, DOI 10.1016/0140-6736(90)90777-3; Otis JD, 2011, J CLIN PSYCHOL MED S, V18, P145, DOI 10.1007/s10880-011-9239-2; Peterson CL, 2003, CLIN J SPORT MED, V13, P230, DOI 10.1097/00042752-200307000-00006; Pickett TC, 2007, J REHABIL RES DEV, V44, P983, DOI 10.1682/JRRD.2007.01.0001; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; Riccio CA, 2002, ARCH CLIN NEUROPSYCH, V17, P235, DOI 10.1016/S0887-6177(01)00111-1; Rockswold SB, 2013, J NEUROSURG, V118, P1317, DOI 10.3171/2013.2.JNS121468; Ruffolo LF, 2000, CLIN NEUROPSYCHOL, V14, P223, DOI 10.1076/1385-4046(200005)14:2;1-Z;FT223; Ruttan L, 2008, ARCH PHYS MED REHAB, V89, pS69, DOI 10.1016/j.apmr.2008.07.007; Scherer MR, 2011, EXP BRAIN RES, V208, P399, DOI 10.1007/s00221-010-2490-1; Spencer RJ, 2010, J REHABIL RES DEV, V47, P521, DOI 10.1682/JRRD.2009.11.0181; Sterr A, 2006, BMC NEUROL, V6, DOI 10.1186/1471-2377-6-7; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Taylor BC, 2012, MED CARE, V50, P342, DOI 10.1097/MLR.0b013e318245a558; Teichner G, 2004, ARCH CLIN NEUROPSYCH, V19, P455, DOI 10.1016/S0887-6177(03)00078-7; Tombaugh TN, 1997, PSYCHOL ASSESSMENT, V9, P260, DOI 10.1037/1040-3590.9.3.260; Vanderploeg RD, 2005, J INT NEUROPSYCH SOC, V11, P228, DOI 10.1017/S1355617705050289; Vanderploeg RD, 2007, J CLIN EXP NEUROPSYC, V29, P585, DOI 10.1080/13803390600826587; Vanderploeg RD, 2012, ARCH PHYS MED REHAB, V93, P1887, DOI 10.1016/j.apmr.2012.05.024; Walker WC, 2013, J HEAD TRAUMA REHAB, V28, P68, DOI 10.1097/HTR.0b013e318255dfd0; Weaver LK, 2012, UNDERSEA HYPERBAR M, V39, P807; Wechsler D., 2008, WECHSLER ADULT INTEL, V4th ed; Wolf G, 2012, J NEUROTRAUM, V29, P2606, DOI 10.1089/neu.2012.2549	54	17	18	0	4	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1545-9683	1552-6844		NEUROREHAB NEURAL RE	Neurorehabil. Neural Repair	JUN	2014	28	5					420	432		10.1177/1545968313516869			13	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	AN6SQ	WOS:000340727700004	24370568				2021-06-18	
J	Vonder Haar, C; Anderson, GD; Elmore, BE; Moore, LH; Wright, AM; Kantor, ED; Farin, FM; Bammler, TK; MacDonald, JW; Hoane, MR				Vonder Haar, Cole; Anderson, Gail D.; Elmore, Brandy E.; Moore, Lynn H.; Wright, Amanda M.; Kantor, Eric D.; Farin, Fred M.; Bammler, Theo K.; MacDonald, James W.; Hoane, Michael R.			Comparison of the Effect of Minocycline and Simvastatin on Functional Recovery and Gene Expression in a Rat Traumatic Brain Injury Model	JOURNAL OF NEUROTRAUMA			English	Article						simvastatin; gene expression; traumatic brain injury; cortical contusion injury model; minocycline	INTRAVENOUS MINOCYCLINE; MICROGLIAL ACTIVATION; INFLAMMATORY RESPONSE; REDUCTASE INHIBITOR; NEUROPROTECTION; PROGESTERONE; NICOTINAMIDE; BEHAVIOR; NEUROGENESIS; APOPTOSIS	The goal of this study was to compare the effects of minocycline and simvastatin on functional recovery and brain gene expression after a cortical contusion impact (CCI) injury. Dosage regimens were designed to provide serum concentrations in a rat model in the range obtained with clinically approved doses; minocycline 60 mg/kg q12h and simvastatin 10 mg/kg q12h for 72 h. Functional recovery was assessed using motor and spatial learning tasks and neuropathological measurements. Microarray-based transcriptional profiling was used to determine the effect on gene expression at 24 h, 72 h, and 7 days post-CCI. Gene Ontology analysis (GOA) was used to evaluate the effect on relevant biological pathways. Both minocycline and simvastatin improved fine motor function, but not gross motor or cognitive function. Minocycline modestly decreased lesion size with no effect of simvastatin. At 24 h post-CCI, GOA identified a significant effect of minocycline on chemotaxis, blood circulation, immune response, and cell to cell signaling pathways. Inflammatory pathways were affected by minocycline only at the 72 h time point. There was a minimal effect of simvastatin on gene expression 24 h after injury, with increasing effects at 72 h and 7 days. GOA identified a significant effect of simvastatin on inflammatory response at 72 h and 7 days. In conclusion, treatment with minocycline and simvastatin resulted in significant effects on gene expression in the brain reflecting adequate brain penetration without producing significant neurorestorative effects.	[Vonder Haar, Cole; Elmore, Brandy E.; Moore, Lynn H.; Wright, Amanda M.; Hoane, Michael R.] So Illinois Univ, Dept Psychol, Ctr Integrated Res Cognit & Neural Sci, Restorat Neurosci Lab, Carbondale, IL 62901 USA; [Anderson, Gail D.; Kantor, Eric D.] Univ Washington, Dept Pharm, Seattle, WA 98195 USA; [Farin, Fred M.; Bammler, Theo K.; MacDonald, James W.] Univ Washington, Dept Environm & Occupat Hlth Sci, Seattle, WA 98195 USA	Anderson, GD (corresponding author), Univ Washington, Dept Pharm, Box 357630, Seattle, WA 98195 USA.	gaila@washington.edu		Vonder Haar, Cole/0000-0001-7949-2068; Hoane, Michael/0000-0001-7779-2657	National Institutes of Health/National Institute of Child, Health and DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)NIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 HD061944-01]; NIEHS Center for Ecogenetics & Environmental Health [P30ES007033]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD061944] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS) [P30ES007033] Funding Source: NIH RePORTER	The research was supported by a grant from the National Institutes of Health/National Institute of Child, Health and Development (R01 HD061944-01) and by the NIEHS Center for Ecogenetics & Environmental Health (P30ES007033).	Anderson GD, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00021; Anderson GD, 2011, J NEUROTRAUM, V28, P1827, DOI 10.1089/neu.2011.1911; Atif F, 2009, MOL MED, V15, P328, DOI 10.2119/molmed.2009.00016; Baki SGA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012490; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bye N, 2007, EXP NEUROL, V204, P220, DOI 10.1016/j.expneurol.2006.10.013; Camon E, 2004, NUCLEIC ACIDS RES, V32, pD262, DOI 10.1093/nar/gkh021; Centers for Disease Control, 2010, INJ PREV CONTR TRAUM; Chen XR, 2008, J PHARMACOL EXP THER, V326, P966, DOI 10.1124/jpet.108.140368; Chiaretti A, 2008, J NEUROTRAUM, V25, P225, DOI 10.1089/neu.2007.0405; Correale J, 2004, J NEUROL, V251, P1304, DOI 10.1007/s00415-004-0649-z; Crack P, 2009, J NEURAL TRANSM, V116, P1, DOI 10.1007/s00702-008-0145-1; Croce K, 2009, CIRCULATION, V120, P427, DOI 10.1161/CIRCULATIONAHA.108.814582; Cutler SM, 2007, J NEUROTRAUM, V24, P1475, DOI 10.1089/neu.2007.0294; Fagan SC, 2004, EXP NEUROL, V186, P248, DOI 10.1016/j.expneurol.2003.12.006; Goss CW, 2003, PHARMACOL BIOCHEM BE, V76, P231, DOI 10.1016/j.pbb.2003.07.003; Haar CV, 2012, RESTOR NEUROL NEUROS, V30, P291, DOI 10.3233/RNN-2012-110196; Haar CV, 2011, BEHAV BRAIN RES, V224, P311, DOI 10.1016/j.bbr.2011.06.009; Hayashi T, 2009, BRAIN RES, V1280, P172, DOI 10.1016/j.brainres.2009.05.040; Hermann A, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00067; Hoane MR, 2008, OXID MED CELL LONGEV, V1, P46, DOI 10.4161/oxim.1.1.6694; Holmin S, 1999, NEUROREPORT, V10, P1889, DOI 10.1097/00001756-199906230-00017; Homsi S, 2010, J NEUROTRAUM, V27, P911, DOI 10.1089/neu.2009.1223; Homsi S, 2009, BRAIN RES, V1291, P122, DOI 10.1016/j.brainres.2009.07.031; Indraswari F, 2012, J NEUROTRAUM, V29, P1388, DOI 10.1089/neu.2011.2117; Jennings JS, 2008, MINI-REV MED CHEM, V8, P689, DOI 10.2174/138955708784567377; Kotani N, 1999, ANESTH ANALG, V89, P1250, DOI 10.1213/00000539-199911000-00032; Kovesdi Erzsebet, 2012, Front Neurol, V3, P111, DOI 10.3389/fneur.2012.00111; Kuhn H, 2006, PROG LIPID RES, V45, P334, DOI 10.1016/j.plipres.2006.02.003; Laufs U, 2012, J AM COLL CARDIOL, V59, P71, DOI 10.1016/j.jacc.2011.08.063; Lenzlinger PM, 2001, MOL NEUROBIOL, V24, P169; Li B, 2009, NEUROSURGERY, V65, P179, DOI 10.1227/01.NEU.0000346272.76537.DC; LIGHT RW, 1994, CHEST, V106, P577, DOI 10.1378/chest.106.2.577; Lu DY, 2007, J NEUROTRAUM, V24, P1132, DOI 10.1089/neu.2007.0288; Mahmood A, 2009, NEUROSURGERY, V65, P187, DOI 10.1227/01.NEU.0000343540.24780.D6; Martens KM, 2012, J NEUROTRAUM, V29, P2505, DOI 10.1089/neu.2012.2388; McConeghy KW, 2012, CNS DRUGS, V26, P613, DOI 10.2165/11634020-000000000-00000; Mejia ROS, 2001, NEUROSURGERY, V48, P1393; Mercier E, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1757; Ng SY, 2012, J NEUROTRAUM, V29, P1410, DOI 10.1089/neu.2011.2188; Peterson TC, 2012, J NEUROTRAUM, V29, P2823, DOI 10.1089/neu.2012.2471; Plane JM, 2010, ARCH NEUROL-CHICAGO, V67, P1442, DOI 10.1001/archneurol.2010.191; Rosenberg GA, 2002, GLIA, V39, P279, DOI 10.1002/glia.10108; Schouten JW, 2007, CURR OPIN CRIT CARE, V13, P134, DOI 10.1097/MCC.0b013e3280895d5c; SINGHVI SM, 1990, BRIT J CLIN PHARMACO, V29, P239, DOI 10.1111/j.1365-2125.1990.tb03626.x; Siopi E, 2012, NEUROSCI LETT, V511, P110, DOI 10.1016/j.neulet.2012.01.051; Siopi E, 2012, J NEUROTRAUM, V29, P354, DOI 10.1089/neu.2011.2055; Siopi E, 2011, J NEUROTRAUM, V28, P2135, DOI 10.1089/neu.2010.1738; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Switzer JA, 2011, STROKE, V42, P2633, DOI 10.1161/STROKEAHA.111.618215; Wang HC, 2007, EXP NEUROL, V206, P59, DOI 10.1016/j.expneurol.2007.03.031; Wang KKW, 2006, CURR OPIN NEUROL, V19, P514, DOI 10.1097/WCO.0b013e3280102b10; Wu HT, 2008, J NEUROSURG, V109, P691, DOI 10.3171/JNS/2008/109/10/0691; Wu HT, 2011, NEUROSURGERY, V68, P1363, DOI 10.1227/NEU.0b013e31820c06b9; Wu HT, 2012, BRAIN RES, V1486, P121, DOI 10.1016/j.brainres.2012.09.039; Xu L, 2004, BMC NEUROL, V4, DOI 10.1186/1471-2377-4-7	56	17	17	0	17	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAY 15	2014	31	10					961	975		10.1089/neu.2013.3119			15	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	AH1ES	WOS:000335863200008	24308531	Green Published			2021-06-18	
J	Crowe, LM; Anderson, V; Barton, S; Babl, FE; Catroppa, C				Crowe, Louise M.; Anderson, Vicki; Barton, Sarah; Babl, Franz E.; Catroppa, Cathy			Verbal Ability and Language Outcome Following Traumatic Brain Injury in Early Childhood	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						language; traumatic brain injury; children	CLOSED-HEAD-INJURY; YOUNG-CHILDREN; INFANTS; AGE; RECOVERY; SEQUELAE	Objective: To investigate language outcomes of TBI in preschool-aged children. Competent early language skills are pivotal for the future development of literacy skills. While previous research has reported that traumatic brain injury (TBI) places children at risk of language impairments, the majority of these studies have been conducted with school-aged children. Setting: Royal Children's Hospital, Melbourne, Australia. Participants: Children aged 4 to 6 years who had sustained a mild (N = 19) or moderate/severe (N = 16) TBI prior to 3 years of age and a control group (N = 20) of typically developing children matched for age, gender, and socioeconomic status. Main Measures: The Wechsler Preschool and Primary School Scale of Intelligence, Third Edition, measured Verbal IQ. The Clinical Evaluation of Language Fundamentals-Preschool version and the Bus Story Test measured language skills. Results: More severely injured children displayed greater impairments in verbal intellectual abilities and language skills compared with children with mild TBI and uninjured children. Children with mild TBI performed similarly to children in the control group. Conclusion: Language appears vulnerable to TBI and should be investigated as a matter of course in clinical assessments of TBI recovery.	[Crowe, Louise M.; Anderson, Vicki; Barton, Sarah; Babl, Franz E.; Catroppa, Cathy] Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Crowe, Louise M.; Anderson, Vicki; Babl, Franz E.; Catroppa, Cathy] Univ Melbourne, Melbourne, Vic, Australia; [Anderson, Vicki; Babl, Franz E.] Royal Childrens Hosp, Melbourne, Vic, Australia	Crowe, LM (corresponding author), Royal Childrens Hosp, Australian Ctr Child Neuropsychol Studies, Murdoch Childrens Res Inst, Flemington Rd, Parkville, Vic 3052, Australia.	louise.crowe@mcri.edu.au		Crowe, Louise/0000-0003-4619-9708; Barton, Sarah/0000-0001-7077-0906	Foundation for Children; Victorian Government's Operational Infrastructure Support Program	This work was supported by a grant from the Foundation for Children and by the Victorian Government's Operational Infrastructure Support Program.	Anderson VA, 2004, BRAIN, V127, P2608, DOI 10.1093/brain/awh320; Case ME, 2008, BRAIN PATHOL, V18, P562, DOI 10.1111/j.1750-3639.2008.00202.x; Catroppa C, 2004, BRAIN LANG, V88, P68, DOI 10.1016/S0093-934X(03)00159-7; Chapman SB, 2001, J HEAD TRAUMA REHAB, V16, P441, DOI 10.1097/00001199-200110000-00004; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd; Crowe L, 2009, J PAEDIATR CHILD H, V45, P346, DOI 10.1111/j.1440-1754.2009.01499.x; Crowe LM, 2012, PEDIATRICS, V129, pE262, DOI 10.1542/peds.2011-0438; Dehaene-Lambertz G, 2006, TRENDS NEUROSCI, V29, P367, DOI 10.1016/j.tins.2006.05.011; Dennis M., 1989, CLIN NEUROPSYCHOLOGY; Didus E, 1999, Pediatr Rehabil, V3, P177; Ewing-Cobbs L, 1998, BRAIN LANG, V61, P395, DOI 10.1006/brln.1997.1884; Ewing-Cobbs L, 1997, J Int Neuropsychol Soc, V3, P581; Ewing-Cobbs L, 2006, J NEUROSURG, V105, P287, DOI 10.3171/ped.2006.105.4.287; EWINGCOBBS L, 1989, J PEDIATR PSYCHOL, V14, P531, DOI 10.1093/jpepsy/14.4.531; HAHN YS, 1988, CHILD NERV SYST, V4, P34; Hanten G, 2009, TOP LANG DISORD, V29, P236, DOI 10.1097/TLD.0b013e3181b531f0; Keenan HT, 2007, PEDIATRICS, V119, pE616, DOI 10.1542/peds.2006-2313; Keenan HT, 2006, PEDIATRICS, V117, P317, DOI 10.1542/peds.2005-0979; KRIEL RL, 1989, PEDIATR NEUROL, V5, P296, DOI 10.1016/0887-8994(89)90021-0; Lalloo R, 2003, INJURY, V34, P261, DOI 10.1016/S0020-1383(02)00277-2; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Levin HS, 2001, NEUROPSYCHOLOGIA, V39, P122, DOI 10.1016/S0028-3932(00)00111-1; Margulies SS, 2000, J BIOMECH ENG-T ASME, V122, P364, DOI 10.1115/1.1287160; MEHLER J, 1978, PERCEPTION, V7, P491, DOI 10.1068/p070491; Morse S, 1999, Pediatr Rehabil, V3, P139; Pankratz ME, 2007, LANG SPEECH HEAR SER, V38, P390, DOI 10.1044/0161-1461(2007/040); Paul R., 2007, LANGUAGE DISORDERS I; Prasad MR, 1999, J CHILD NEUROL, V14, P496, DOI 10.1177/088307389901400803; REILLY PL, 1988, CHILD NERV SYST, V4, P30; Renfrew C, 1991, RENFREW BUS STORY MA; Schjolberg S, 2011, J DEV BEHAV PEDIATR, V32, P375, DOI 10.1097/DBP.0b013e31821bd1dd; Trewin D., 2006, AUSTR NZ STANDARD CL; Trudeau N, 2000, INT J LANG COMM DIS, V35, P227; van Kleeck A, 2011, J SPEECH LANG HEAR R, V54, P1546, DOI 10.1044/1092-4388(2011/10-0079); Wade SL, 2011, DEV PSYCHOL, V47, P119, DOI 10.1037/a0021028; Wechsler, 2002, WECHSLER PRESCHOOL P; Wiig E.H., 2006, CLIN EVALUATION LANG; Yeates KO, 2010, NEUROPSYCHOLOGY, V24, P345, DOI 10.1037/a0018387	38	17	17	1	22	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAY-JUN	2014	29	3					217	223		10.1097/HTR.0b013e31829babfd			7	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	AG9SE	WOS:000335759100009	23835877				2021-06-18	
J	D'Onofrio, F; Russo, A; Conte, F; Casucci, G; Tessitore, A; Tedeschi, G				D'Onofrio, F.; Russo, A.; Conte, F.; Casucci, G.; Tessitore, A.; Tedeschi, G.			Post-traumatic headaches: an epidemiological overview	NEUROLOGICAL SCIENCES			English	Article; Proceedings Paper	6th ANIRCEF National Congress on Headache and Social Context	MAY 29-31, 2014	Asti, ITALY	ANIRCEF		Post-traumatic headache; PTH; Epidemiological aspects; Epidemiology; Trauma	TRAUMATIC BRAIN-INJURY; MILD HEAD TRAUMA; STRESS-DISORDER; POSTCONCUSSION SYNDROME; CHRONIC PAIN; US SOLDIERS; PREVALENCE; CONCUSSION; CHILDREN	Post-traumatic headache (PTH) is the most common secondary headache disorder, corresponding to approximately 4 % of all symptomatic headaches. PTH, a cardinal feature of the post-concussive syndrome, usually shows a phenotype similar to migraine or tension-type headache. However, rare cases of PTH similar to trigeminal autonomic cephalalgias have been described. Many studies have investigated PTH prevalence and potential risk factors for its development and maintenance. In general population, the majority of PTH patients is female and has been involved in vehicle-related accidents. Generally, headache gradually disappears over few weeks or months; however, PTH could become persistent and very disabling in a minority of patients. This brief review will focus on PTH epidemiological aspects.	[D'Onofrio, F.] San G Moscati Hosp, Div Neurol, Avellino, Italy; [Russo, A.; Conte, F.; Tessitore, A.; Tedeschi, G.] Univ Naples 2, Dept Med Surg Neurol Metab & Aging Sci, Naples, Italy; [Russo, A.; Tedeschi, G.] IDC Hermitage Capodimonte, SUN FISM Ctr, Naples, Italy; [Casucci, G.] S Francesco Nursing Home, Telese Terme, Benevento, Italy	Tessitore, A (corresponding author), Univ Naples 2, Dept Med Surg Neurol Metab & Aging Sci, Naples, Italy.	alessandro.tessitore@unina2.it	Tessitore, Alessandro/K-3124-2018	Tessitore, Alessandro/0000-0003-1740-8566; Gerardo, Casucci/0000-0001-6137-117X			Bes A, 2013, CEPHALALGIA, V33, P629, DOI 10.1177/0333102413485658; Bettucci D, 1998, ITAL J NEUROL SCI, V19, P20, DOI 10.1007/BF03028807; Butler IJ, 2013, JAMA NEUROL, V70, P636, DOI 10.1001/jamaneurol.2013.2801; CHIBNALL JT, 1994, HEADACHE, V34, P357, DOI 10.1111/j.1526-4610.1994.hed3406357.x; de Gray LC, 2005, ANAESTHESIA, V60, P693, DOI 10.1111/j.1365-2044.2005.03997.x; Martins HAD, 2009, ARQ NEURO-PSIQUIAT, V67, P43; Donnell AJ, 2012, CLIN NEUROPSYCHOL, V26, P1092, DOI 10.1080/13854046.2012.713984; Erickson JC, 2011, HEADACHE, V51, P932, DOI 10.1111/j.1526-4610.2011.01909.x; Evans RW, 2010, HEADACHE, V50, P716, DOI 10.1111/j.1526-4610.2010.01645.x; Evans RW., 2006, NEUROLOGY TRAUMA, P95; Faux S, 2008, PAIN MED, V9, P1001, DOI 10.1111/j.1526-4637.2007.00404.x; HICKLING EJ, 1992, HEADACHE, V32, P147, DOI 10.1111/j.1526-4610.1992.hed3203147.x; Hoffman JM, 2011, J NEUROTRAUM, V28, P1719, DOI 10.1089/neu.2011.1914; Jennett B, 1990, HDB CLIN NEUROLOGY, V13; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Kjeldgaard D, 2014, CEPHALALGIA; Kolias Angelos G, 2013, Pract Neurol, V13, P228, DOI 10.1136/practneurol-2012-000268; Kuczynski A, 2013, DEV MED CHILD NEUROL, V55, P636, DOI 10.1111/dmcn.12152; Lay CL, 1999, HEADACHE, V39, P275, DOI 10.1046/j.1526-4610.1999.3904275.x; Lew HL, 2006, AM J PHYS MED REHAB, V85, P619, DOI 10.1097/01.phm.0000223235.09931.c0; Lucas S, 2014, CEPHALALGIA, V34, P93, DOI 10.1177/0333102413499645; Lucas S, 2012, CEPHALALGIA, V32, P600, DOI 10.1177/0333102412445224; Matharu MS, 2001, NEUROLOGY, V56, P273, DOI 10.1212/WNL.56.2.273; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Obermann M, 2009, EXPERT REV NEUROTHER, V9, P1361, DOI 10.1586/ERN.09.84; Peterlin BL, 2009, HEADACHE, V49, P541, DOI 10.1111/j.1526-4610.2009.01368.x; Piovesan EJ, 1996, ARQ NEURO-PSIQUIAT, V54, P494, DOI 10.1590/S0004-282X1996000300022; Schrader H, 1996, LANCET, V347, P1207, DOI 10.1016/S0140-6736(96)90733-3; Seifert TD, 2010, CURR PAIN HEADACHE R, V14, P292, DOI 10.1007/s11916-010-0117-7; Sullivan KA, 2013, BRAIN INJURY, V27, P19, DOI 10.3109/02699052.2012.698360; Theeler B, 2013, HEADACHE, V53, P881, DOI 10.1111/head.12123; Theeler BJ, 2010, HEADACHE, V50, P1262, DOI 10.1111/j.1526-4610.2010.01700.x; Theeler BJ, 2009, HEADACHE, V49, P529, DOI 10.1111/j.1526-4610.2009.01345.x; Walker Russell W, 2007, Curr Pain Headache Rep, V11, P137, DOI 10.1007/s11916-007-0011-0; WEISS HD, 1991, HEADACHE, V31, P451, DOI 10.1111/j.1526-4610.1991.hed3107451.x; World Health Organization, 1992, ICD 10 INT STAT CLAS	36	17	17	0	8	SPRINGER-VERLAG ITALIA SRL	MILAN	VIA DECEMBRIO, 28, MILAN, 20137, ITALY	1590-1874	1590-3478		NEUROL SCI	Neurol. Sci.	MAY	2014	35			1			S203	S206		10.1007/s10072-014-1771-z			4	Clinical Neurology; Neurosciences	Neurosciences & Neurology	AI3EZ	WOS:000336744400042	24867867				2021-06-18	
J	Lobel, DA; Lee, KH				Lobel, Darlene A.; Lee, Kendall H.			Brain Machine Interface and Limb Reanimation Technologies: Restoring Function After Spinal Cord Injury Through Development of a Bypass System	MAYO CLINIC PROCEEDINGS			English	Article							COMPUTER INTERFACE; INTRASPINAL MICROSTIMULATION; STIMULATION; MOVEMENT	Functional restoration of limb movement after traumatic spinal cord injury (SCI) remains the ultimate goal in SCI treatment and directs the focus of current research strategies. To date, most investigations in the treatment of SCI focus on repairing the injury site. Although offering some promise, these efforts have met with significant roadblocks because treatment measures that are successful in animal trials do not yield similar results in human trials. In contrast to biologic therapies, there are now emerging neural interface technologies, such as brain machine interface (BMI) and limb reanimation through electrical stimulators, to create a bypass around the site of the SCI. The BMI systems analyze brain signals to allow control of devices that are used to assist SCI patients. Such devices may include a computer, robotic arm, or exoskeleton. Limb reanimation technologies, which include functional electrical stimulation, epidural stimulation, and intraspinal microstimulation systems, activate neuronal pathways below the level of the SCI. We present a concise review of recent advances in the BMI and limb reanimation technologies that provides the foundation for the development of a bypass system to improve functional outcome after traumatic SCI. We also discuss challenges to the practical implementation of such a bypass system in both these developing fields. (C) 2014 Mayo Foundation for Medical Education and Research	[Lobel, Darlene A.] Cleveland Clin, Dept Neurosurg, Ctr Neurol Restorat, Cleveland, OH 44106 USA; [Lee, Kendall H.] Mayo Clin, Dept Neurol Surg, Rochester, MN USA	Lobel, DA (corresponding author), Cleveland Clin, Dept Neurosurg, Ctr Neurol Restorat, 9500 Euclid Ave,S31, Cleveland, OH 44106 USA.	lobeld@ccf.org			Grainger Foundation Grant	This work was supported by The Grainger Foundation Grant awarded to Dr Lee.	Bamford JA, 2011, PROG BRAIN RES, V194, P227, DOI 10.1016/B978-0-444-53815-4.00004-2; Birbaumer N, 2006, PROG BRAIN RES, V159, P369, DOI 10.1016/S0079-6123(06)59024-7; Chang SY, 2013, J NEUROSURG, V119, P1556, DOI 10.3171/2013.8.JNS122142; Charvet G, 2012, IEEE ENG MED BIO, P783, DOI 10.1109/EMBC.2012.6346048; Collinger JL, 2013, LANCET, V381, P557, DOI 10.1016/S0140-6736(12)61816-9; CRAGO PE, 1980, IEEE T BIO-MED ENG, V27, P679, DOI 10.1109/TBME.1980.326592; Eliseyev A, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/4/046012; Fatourechi M, 2008, J NEURAL ENG, V5, P9, DOI 10.1088/1741-2560/5/1/002; Filli L, 2012, ANN NEUROL, V72, P491, DOI 10.1002/ana.23630; Freund P, 2011, BRAIN, V134, P1610, DOI 10.1093/brain/awr093; Harkema S, 2011, LANCET, V377, P1938, DOI 10.1016/S0140-6736(11)60547-3; Holinski BJ, 2011, IEEE ENG MED BIO, P5798, DOI 10.1109/IEMBS.2011.6091435; Jackson A, 2012, NAT REV NEUROL, V8, P690, DOI 10.1038/nrneurol.2012.219; Leuthardt EC, 2004, J NEURAL ENG, V1, P63, DOI 10.1088/1741-2560/1/2/001; Loeb GE, 2005, IEEE ENG MED BIOL, V24, P45, DOI 10.1109/MEMB.2005.1511499; Muller-Putz GR, 2006, BIOMED TECH, V51, P57, DOI 10.1515/BMT.2006.011; Peckham PH, 2005, ANNU REV BIOMED ENG, V7, P327, DOI 10.1146/annurev.bioeng.6.040803.140103; Rath SA, 2008, J NEUROSURG-SPINE, V8, P237, DOI 10.3171/SPI/2008/8/3/237; Renard Y, 2010, PRESENCE-TELEOP VIRT, V19, P35, DOI 10.1162/pres.19.1.35; Royer AS, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/3/036012; Schalk G, 2004, IEEE T BIO-MED ENG, V51, P1034, DOI 10.1109/TBME.2004.827072; Shih JJ, 2012, MAYO CLIN PROC, V87, P268, DOI 10.1016/j.mayocp.2011.12.008; Troyk PR, 2012, IEEE ENG MED BIO, P900, DOI 10.1109/EMBC.2012.6346077; Troyk PR, 2001, NEUROMODULATION, V4, P196, DOI 10.1046/j.1525-1403.2001.00196.x; Wolpaw JR, 2004, P NATL ACAD SCI USA, V101, P17849, DOI 10.1073/pnas.0403504101	25	17	18	1	27	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0025-6196	1942-5546		MAYO CLIN PROC	Mayo Clin. Proc.	MAY	2014	89	5					708	714		10.1016/j.mayocp.2014.02.003			7	Medicine, General & Internal	General & Internal Medicine	AG6WU	WOS:000335560400019	24797649	Bronze			2021-06-18	
J	Schramm, A; Ndayisaba, JP; Brinke, MAD; Hecht, M; Herrmann, C; Huber, M; Lobsien, E; Mehnert, S; Reuter, I; Stenner, A; van der Ven, C; Winterholler, M; Kupsch, A; Wissel, J				Schramm, Axel; Ndayisaba, Jean-Pierre; Brinke, Matthias Auf Dem; Hecht, Martin; Herrmann, Christoph; Huber, Martin; Lobsien, Elmar; Mehnert, Sabine; Reuter, Iris; Stenner, Andrea; van der Ven, Christian; Winterholler, Martin; Kupsch, Andreas; Wissel, Joerg			Spasticity treatment with onabotulinumtoxin A: data from a prospective German real-life patient registry	JOURNAL OF NEURAL TRANSMISSION			English	Article						Botulinum toxin A; Onabotulinumtoxin; Spasticity; Stroke; Traumatic brain injury; Multiple sclerosis; Cerebral palsy	TOXIN TYPE-A	This study aimed at providing real-life baseline, injection and outcome data for the treatment of various forms of spasticity with onabotulinumtoxin A in Germany. Prospective data were collected in an open multicenter patient registry from 2005 until 2010, encompassing the experience of ten specialized German centers in the treatment of spasticity using onabotulinumtoxin A in 508 patients with a total of 2005 treatment sessions. Disease entities comprised spasticity following stroke (both ischemic and hemorrhagic), traumatic brain injury, multiple sclerosis, cerebral palsy, and anoxia. Sustained improvement was observed in a variety of outcome parameters including goal attainment and motor performance scores for up to five repeated injection sessions. No significant differences between disease entities or between upper and lower limb treatment were observed with regard to efficacy and safety following onabotulinumtoxin A treatment. Minor to moderate side effects were reported in < 1 % of the study population. We conclude that repetitive treatment of focal and multifocal spasticity with onabotulinumtoxin A provides a safe and efficacious therapeutic strategy for patients with different disease entities of the central nervous system.	[Schramm, Axel] Univ Erlangen Nurnberg, Dept Neurol, D-91054 Erlangen, Germany; [Ndayisaba, Jean-Pierre] Med Univ Innsbruck, Dept Neurol, A-6020 Innsbruck, Austria; [Brinke, Matthias Auf Dem] Asklepios Klin Fuerstenhof, Dept Neurol, Bad Wildungen, Germany; [Hecht, Martin] Bezirkskrankenhaus Kaufbeuren, Dept Neurol, Kaufbeuren, Germany; [Herrmann, Christoph] Asklepios Kliniken Schildautal, Dept Neurol Rehabil, Seesen, Germany; [Huber, Martin] Therapiezentrum Burgau, Dept Neurol Rehabil, Burgau, Germany; [Lobsien, Elmar] Univ Med Berlin, Charite, Dept Neurol, Berlin, Germany; [Mehnert, Sabine; Reuter, Iris] Univ Giessen, Dept Neurol, D-35390 Giessen, Germany; [Stenner, Andrea] Paracelsus Kliniken, Dept Movement Disorders, Zwickau, Germany; [van der Ven, Christian] Neurol Rehazentrum Godeshohe, Bonn, Germany; [Winterholler, Martin] Krankenhaus Rummelsberg, Dept Neurol, Nurnberg, Germany; [Kupsch, Andreas] Univ Magdeburg, Dept Neurol & Stereotact Neurosurg, D-39106 Magdeburg, Germany; [Wissel, Joerg] Vivantes Klinikum Spandau, Dept Neurol, Berlin, Germany	Schramm, A (corresponding author), Univ Erlangen Nurnberg, Dept Neurol, Schwabachanlage 6, D-91054 Erlangen, Germany.	axel.schramm@uk-erlangen.de			Allergan-Germany, Ettlingen	This study was in part supported by an unrestricted educational grant of Allergan-Germany, Ettlingen. The authors report no conflict of interest with regard to the content of this article.	Bohannon RW, 1997, AGE AGEING, V26, P15, DOI 10.1093/ageing/26.1.15; Collen F M, 1990, Int Disabil Stud, V12, P6; Ertzgaard P, 2011, J REHABIL MED, V43, P8, DOI 10.2340/16501977-0664; Esquenazi A, 2013, TOXICON, V67, P115, DOI 10.1016/j.toxicon.2012.11.025; Esquenazi A, 2012, AM J PHYS MED REHAB, V91, P729, DOI 10.1097/PHM.0b013e31824fa9ca; Kossmehl P, 2012, NEUROREHAB NEURAL RE, V26, P395; Lagalla G, 2000, AM J PHYS MED REHAB, V79, P377, DOI 10.1097/00002060-200007000-00010; Mehrholz J, 2007, ARCH PHYS MED REHAB, V88, P1314, DOI 10.1016/j.apmr.2007.06.764; Mohammadi B, 2010, NEUROL RES, V32, P309, DOI 10.1179/016164109X12478302362734; Wissel J, 2011, NERVENARZT, V82, P481, DOI 10.1007/s00115-010-3172-8; Wissel J, 2009, J REHABIL MED, V41, P13, DOI 10.2340/16501977-0303	11	17	18	0	1	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0300-9564	1435-1463		J NEURAL TRANSM	J. Neural Transm.	MAY	2014	121	5					521	530		10.1007/s00702-013-1145-3			10	Clinical Neurology; Neurosciences	Neurosciences & Neurology	AF7ZE	WOS:000334933500008	24407377				2021-06-18	
J	Turner, AP; Sloan, AP; Kivlahan, DR; Haselkorn, JK				Turner, Aaron P.; Sloan, Alicia P.; Kivlahan, Daniel R.; Haselkorn, Jodie K.			Telephone Counseling and Home Telehealth Monitoring to Improve Medication Adherence: Results of a Pilot Trial Among Individuals With Multiple Sclerosis	REHABILITATION PSYCHOLOGY			English	Article						multiple sclerosis; medication adherence; motivational interviewing; self-management; telehealth	DISEASE-MODIFYING THERAPIES; RANDOMIZED CONTROLLED-TRIAL; TRAUMATIC BRAIN-INJURY; QUALITY-OF-LIFE; INJECTION ANXIETY; CHRONIC ILLNESS; PRIMARY-CARE; SELF-INJECT; ALCOHOL-DEPENDENCE; DEPRESSION	Objective: To evaluate the impact upon medication adherence of brief telephone-based counseling using principles of motivational interviewing and telehealth home monitoring. Design: Randomized controlled pilot trial of 19 veterans with multiple sclerosis (MS) currently prescribed disease modifying therapy (DMT) who endorsed missing doses. Follow-up was conducted at 1, 3, and 6 months. Results: Participants in the intervention condition reported better adherence relative to controls at 6-month follow-up [M (SD) = 1.3 (2.1) vs. 8.2 (12.3) past month missed doses]. All participants in the intervention condition completed all 3 telephone counseling sessions and 90% or greater rated the program as highly successful. Conclusion: Brief telephone counseling represents a promising mechanism for improving medication adherence. The primary components, motivational interviewing and home telehealth monitoring, provided complementary mechanisms for initiating and sustaining behavior change over time. The intervention was well tolerated and provided an opportunity to extend access and reduce barriers to care by bringing it into the homes of participants.	[Turner, Aaron P.; Sloan, Alicia P.; Kivlahan, Daniel R.; Haselkorn, Jodie K.] VA Puget Sound Hlth Care Syst, Seattle, WA 98108 USA; [Turner, Aaron P.; Sloan, Alicia P.; Haselkorn, Jodie K.] VA MS Ctr Excellence West, Seattle, WA USA; [Turner, Aaron P.; Kivlahan, Daniel R.] VA Ctr Excellence Subst Abuse Treatment & Educ, Seattle, WA USA; [Turner, Aaron P.] Univ Washington, Dept Rehabil Med, Seattle, WA 98195 USA; [Kivlahan, Daniel R.] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; [Haselkorn, Jodie K.] Univ Washington, VA Puget Sound Hlth Care Syst, VA MS Ctr Excellence West, Dept Rehabil Med, Seattle, WA 98195 USA; [Haselkorn, Jodie K.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA	Turner, AP (corresponding author), VA Puget Sound Hlth Care Syst, Rehabil Care Serv, S-117-RCS,1660 S Columbian Way, Seattle, WA 98108 USA.	Aaron.Turner@med.va.gov	Turner, Aaron/A-7902-2009	Turner, Aaron/0000-0001-6897-8003; sloan, alicia/0000-0003-4891-3266			American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Aronson KJ, 1997, NEUROLOGY, V48, P74, DOI 10.1212/WNL.48.1.74; BEATTY WW, 1995, NEUROLOGY, V45, P718, DOI 10.1212/WNL.45.4.718; Bell KR, 2005, ARCH PHYS MED REHAB, V86, P851, DOI 10.1016/j.apmr.2004.09.015; Bell KR, 2003, J HEAD TRAUMA REHAB, V18, P504, DOI 10.1097/00001199-200311000-00004; Bodenheimer T, 2002, JAMA-J AM MED ASSOC, V288, P1775, DOI 10.1001/jama.288.14.1775; Bodenheimer T, 2002, JAMA-J AM MED ASSOC, V288, P1909, DOI 10.1001/jama.288.15.1909; Bombardier CH, 2008, ARCH PHYS MED REHAB, V89, P1849, DOI 10.1016/j.apmr.2008.03.021; Bombardier CH, 2013, J CONSULT CLIN PSYCH, V81, P89, DOI 10.1037/a0031242; Bombardier CH, 2009, J HEAD TRAUMA REHAB, V24, P230, DOI 10.1097/HTR.0b013e3181ad65f0; Bruce JM, 2010, ARCH CLIN NEUROPSYCH, V25, P39, DOI 10.1093/arclin/acp092; Bruce JM, 2010, MULT SCLER, V16, P112, DOI 10.1177/1352458509351897; Clark NM, 2000, BMJ-BRIT MED J, V320, P572, DOI 10.1136/bmj.320.7234.572; Cook PF, 2007, AM J MED QUAL, V22, P445, DOI 10.1177/1062860607307990; Cook PF, 2009, J ASSOC NURSE AIDS C, V20, P316, DOI 10.1016/j.jana.2009.02.008; Cook PF, 2008, AM J MANAG CARE, V14, P841; Debanne SM, 1997, J AM GERIATR SOC, V45, P1352, DOI 10.1111/j.1532-5415.1997.tb02935.x; DelliFraine JL, 2008, J TELEMED TELECARE, V14, P62, DOI 10.1258/jtt.2007.070709; Department of Veterans Affairs. (Producer), 2013, VHA TEL SERV; Devonshire V, 2011, EUR J NEUROL, V18, P69, DOI 10.1111/j.1468-1331.2010.03110.x; DiIorio C, 2008, AIDS CARE, V20, P273, DOI 10.1080/09540120701593489; Fan VS, 2002, J CLIN EPIDEMIOL, V55, P371, DOI 10.1016/S0895-4356(01)00493-0; Fischer JS, 1999, MULT SCLER J, V5, P251, DOI 10.1177/135245859900500410; Fraser Cira, 2003, J Neurosci Nurs, V35, P163; Goodkin D, 1992, NATURAL HIST MULTIPL; Gottberg K, 2006, MULT SCLER J, V12, P605, DOI 10.1177/1352458505070660; Hadjimichael O, 1999, NEUROLOGY, V52, pA549; Halterman JS, 2011, J ASTHMA, V48, P523, DOI 10.3109/02770903.2011.576741; Hatzakis M, 2003, J REHABIL RES DEV, V40, P265; Haynes R B, 2002, Cochrane Database Syst Rev, pCD000011; Haynes RB, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000011.pub3; Haynes RB, 2002, JAMA-J AM MED ASSOC, V288, P2880, DOI 10.1001/jama.288.22.2880; Haynes RB, 1996, LANCET, V348, P383; Heffner JL, 2010, J STUD ALCOHOL DRUGS, V71, P61, DOI 10.15288/jsad.2010.71.61; Holt C. S., 1990, BEHAV THERAPIST, V13, p[213, 222]; Ingersoll KS, 2011, DRUG ALCOHOL DEPEN, V116, P177, DOI 10.1016/j.drugalcdep.2010.12.016; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Miller W. R., 2002, MOTIVATIONAL INTERVI; Miller WR, 2009, BEHAV COGN PSYCHOTH, V37, P129, DOI 10.1017/S1352465809005128; Mohr D C, 1996, Mult Scler, V2, P222; Mohr DC, 1997, ARCH NEUROL-CHICAGO, V54, P531, DOI 10.1001/archneur.1997.00550170015009; Mohr DC, 2005, MULT SCLER J, V11, P182, DOI 10.1191/1352458505ms1146oa; Mohr DC, 2002, J BEHAV THER EXP PSY, V33, P39, DOI 10.1016/S0005-7916(02)00011-3; Mohr DC, 2001, ANN BEHAV MED, V23, P125, DOI 10.1207/S15324796ABM2302_7; Mohr DC, 2005, ARCH GEN PSYCHIAT, V62, P1007, DOI 10.1001/archpsyc.62.9.1007; Noseworthy JH, 2000, NEW ENGL J MED, V343, P938, DOI 10.1056/NEJM200009283431307; Ogedegbe G, 2008, AM J HYPERTENS, V21, P1137, DOI 10.1038/ajh.2008.240; Pare G, 2007, J AM MED INFORM ASSN, V14, P269, DOI 10.1197/jamia.M2270; Pare G, 2010, J MED INTERNET RES, V12, DOI 10.2196/jmir.1357; PROCHASKA JO, 1983, J CONSULT CLIN PSYCH, V51, P390, DOI 10.1037//0022-006X.51.3.390; RAO SM, 1991, NEUROLOGY, V41, P685, DOI 10.1212/WNL.41.5.685; Reid SC, 2005, J STUD ALCOHOL, V66, P833, DOI 10.15288/jsa.2005.66.833; Schwartz CE, 1999, NEUROLOGY, V52, P63, DOI 10.1212/WNL.52.1.63; Siegel SD, 2008, REHABIL PSYCHOL, V53, P73, DOI 10.1037/0090-5550.53.1.73; Solomon DH, 2012, ARCH INTERN MED, V172, P477, DOI 10.1001/archinternmed.2011.1977; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Steinberg SC, 2010, CLIN DRUG INVEST, V30, P89, DOI 10.2165/11533330-000000000-00000; Stockl KM, 2010, AM J MANAG CARE, V16, P139; Stone VE, 2001, CLIN INFECT DIS, V33, P865, DOI 10.1086/322698; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Tan H, 2011, ADV THER, V28, P51, DOI 10.1007/s12325-010-0093-7; Tremlett HL, 2003, NEUROLOGY, V61, P551, DOI 10.1212/01.WNL.0000078885.05053.7D; Turner AP, 2007, MULT SCLER, V13, P1146, DOI 10.1177/1352458507078911; Turner AP, 2009, REHABIL PSYCHOL, V54, P116, DOI 10.1037/a0014460; Unverzagt FW, 2007, J INT NEUROPSYCH SOC, V13, P799, DOI 10.1017/S1355617707071020; Vickers A J, 2001, BMC Med Res Methodol, V1, P6, DOI 10.1186/1471-2288-1-6; Vollmer TL, 2002, J REHABIL RES DEV, V39, P163; Von Korff M, 1997, ANN INTERN MED, V127, P1097, DOI 10.7326/0003-4819-127-12-199712150-00008; Wagner EH, 1996, MILBANK Q, V74, P511, DOI 10.2307/3350391; Wagner EH, 2000, BMJ-BRIT MED J, V320, P569, DOI 10.1136/bmj.320.7234.569; Wechsler D, 1997, WAIS 3 ADM SCORING M; Williams A, 2012, J ADV NURS, V68, P2515, DOI 10.1111/j.1365-2648.2012.05950.x; Williams RM, 2005, NEUROLOGY, V64, P75, DOI 10.1212/01.WNL.0000148480.31424.2A; World Health Organization, 2003, ADHERENCE LONG TERM	75	17	17	1	14	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550	1939-1544		REHABIL PSYCHOL	Rehabil. Psychol.	MAY	2014	59	2					136	146		10.1037/a0036322			11	Psychology, Clinical; Rehabilitation	Psychology; Rehabilitation	AJ7SQ	WOS:000337897800003	24708232				2021-06-18	
J	Ottens, AK; Stafflinger, JE; Griffin, HE; Kunz, RD; Cifu, DX; Niemeier, JP				Ottens, Andrew K.; Stafflinger, Jillian E.; Griffin, Hailey E.; Kunz, Richard D.; Cifu, David X.; Niemeier, Janet P.			Post-Acute Brain Injury Urinary Signature: A New Resource for Molecular Diagnostics	JOURNAL OF NEUROTRAUMA			English	Article						rehabilitation; brain injury, mass spectrometry; biomarker; metabolomics; urine	RANDOMIZED CONTROLLED-TRIAL; CEREBROSPINAL-FLUID; BIOMARKERS; REHABILITATION; REORGANIZATION; REHABILOMICS; PROTEINS; RECOVERY; TRAUMA; IMPACT	Heterogeneity within brain injury presents a challenge to the development of informative molecular diagnostics. Recent studies show progress, particularly in cerebrospinal fluid, with biomarker assays targeting one or a few structural proteins. Protein-based assays in peripheral fluids, however, have been more challenging to develop, in part because of restricted and intermittent barrier access. Further, a greater number of molecular variables may be required to inform on patient status given the multi-factorial nature of brain injury. Presented is an alternative approach profiling peripheral fluid for a class of small metabolic by-products rendered by ongoing brain pathobiology. Urine specimens were collected for head trauma subjects upon admission to acute brain injury rehabilitation and non-traumatized matched controls. An innovative data-independent mass spectrometry approach was employed for reproducible molecular quantification across osmolarity-normalized samples. The postacute human traumatic brain injury urinary signature encompassed 2476 discriminant variables reproducibly measured in specimens for subject classification. Multiple subprofiles were then discerned in correlation with injury severity per the Glasgow Comma Scale and behavioral and neurocognitive function per the Patient Competency Rating Scale and Frontal Systems Behavioral Scale. Identified peptide constituents were enriched for outgrowth and guidance, extracellular matrix, and post-synaptic density proteins, which were reflective of ongoing post-acute neuroplastic processes demonstrating pathobiological relevance. Taken together, these findings support further development of diagnostics based on brain injury urinary signatures using either combinatorial quantitative models or pattern-recognition methods. Particularly, these findings espouse assay development to address unmet diagnostic and theragnostic needs in brain injury rehabilitative medicine.	[Ottens, Andrew K.; Stafflinger, Jillian E.; Griffin, Hailey E.] Virginia Commonwealth Univ, Sch Med, Dept Anat & Neurobiol, Richmond, VA 23298 USA; [Kunz, Richard D.; Cifu, David X.; Niemeier, Janet P.] Virginia Commonwealth Univ, Sch Med, Dept Phys Med & Rehabil, Richmond, VA 23298 USA	Ottens, AK (corresponding author), Virginia Commonwealth Univ, Sch Med, Dept Anat & Neurobiol, POB 980709, Richmond, VA 23298 USA.	akottens@vcu.edu		Ottens, Andrew/0000-0002-2118-3796; Cifu, David/0000-0003-1600-9387	Virginia Commonwealth University School of Medicine; National Institutes of Health National Center for Medical Rehabilitation Research/National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [HD052922]; National Center for Advancing Translational SciencesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [TR000058]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD052922] Funding Source: NIH RePORTER	This research was supported in part by the Virginia Commonwealth University School of Medicine and the National Institutes of Health National Center for Medical Rehabilitation Research/National Institute of Child Health and Human Development (grant HD052922) and the National Center for Advancing Translational Sciences (grant TR000058). The authors thank William Korzun for assistance with osmolarity analysis. Many thanks to the nursing staff of the Brain Injury Rehabilitation Unit of Virginia Commonwealth University Health Systems for their crucial assistance on the unit. The authors are grateful to the participants and their families for their voluntary contribution to this research.	Adamczak S, 2012, J NEUROSURG, V117, P1119, DOI 10.3171/2012.9.JNS12815; Bajor M, 2013, NEUROCHEM RES, V38, P1113, DOI 10.1007/s11064-012-0919-6; Berger RP, 2006, J HEAD TRAUMA REHAB, V21, P315, DOI 10.1097/00001199-200607000-00004; Chen J, 2009, NUCLEIC ACIDS RES, V37, pW305, DOI 10.1093/nar/gkp427; Cicerone KD, 2008, ARCH PHYS MED REHAB, V89, P2239, DOI 10.1016/j.apmr.2008.06.017; Cifu DX, 2003, ARCH PHYS MED REHAB, V84, P1441, DOI 10.1016/S0003-9993(03)00272-7; Cortes DF, 2012, ELECTROPHORESIS, V33, P3712, DOI 10.1002/elps.201200341; Gabathuler R, 2010, NEUROBIOL DIS, V37, P48, DOI 10.1016/j.nbd.2009.07.028; Gordon WA, 2006, AM J PHYS MED REHAB, V85, P343, DOI 10.1097/01.phm.0000202106.01654.61; Griesbach GS, 2004, NEUROSCIENCE, V125, P129, DOI 10.1016/j.neuroscience.2004.01.030; Jeter CB, 2013, J NEUROTRAUM, V30, P657, DOI 10.1089/neu.2012.2439; Kall L, 2008, J PROTEOME RES, V7, P40, DOI 10.1021/pr700739d; Kobeissy FH, 2011, PM&R, V3, pS139, DOI 10.1016/j.pmrj.2011.02.012; Kochanek PM, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00040; Kusuhara Hiroyuki, 2005, NeuroRx, V2, P73, DOI 10.1007/BF03206644; Matter AM, 2011, NEUROREHAB NEURAL RE, V25, P558, DOI 10.1177/1545968310397206; Niemeier JP, 2011, BRAIN INJURY, V25, P680, DOI 10.3109/02699052.2011.573520; Nishibe M, 2010, J NEUROTRAUM, V27, P2221, DOI 10.1089/neu.2010.1456; Niyonkuru C, 2013, J NEUROTRAUM, V30, P938, DOI 10.1089/neu.2012.2578; Nudo RJ, 2011, J COMMUN DISORD, V44, P515, DOI 10.1016/j.jcomdis.2011.04.004; Papa L, 2013, J NEUROTRAUM, V30, P324, DOI 10.1089/neu.2012.2545; Berger RP, 2006, PEDIATR CRIT CARE ME, V7, P557, DOI 10.1097/01.PCC.0000244426.37793.23; Pelinka LE, 2005, SHOCK, V24, P119, DOI 10.1097/01.shk.0000168876.68154.43; Ragnarsson KT, 2006, J HEAD TRAUMA REHAB, V21, P379, DOI 10.1097/00001199-200609000-00002; Rajalahti T, 2011, INT J PHARMACEUT, V417, P280, DOI 10.1016/j.ijpharm.2011.02.019; Robin X, 2009, EXPERT REV PROTEOMIC, V6, P675, DOI 10.1586/EPR.09.83; Roozenbeek B, 2012, J NEUROTRAUM, V29, P1306, DOI 10.1089/neu.2011.1988; Ruttan L, 2008, ARCH PHYS MED REHAB, V89, pS69, DOI 10.1016/j.apmr.2008.07.007; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Salazar AM, 2000, JAMA-J AM MED ASSOC, V283, P3075, DOI 10.1001/jama.283.23.3075; Silva JC, 2005, ANAL CHEM, V77, P2187, DOI 10.1021/ac048455k; Siman R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028938; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Vanderploeg RD, 2008, ARCH PHYS MED REHAB, V89, P2227, DOI 10.1016/j.apmr.2008.06.015; Wagner AK, 2010, EUR J PHYS REHAB MED, V46, P549; Walder B, 2013, J NEUROTRAUM, V30, P1631, DOI 10.1089/neu.2012.2791; Warren KM, 2012, J NEUROTRAUM, V29, P1922, DOI 10.1089/neu.2012.2383; Witt KA, 2001, PEPTIDES, V22, P2329, DOI 10.1016/S0196-9781(01)00537-X; Yokobori S, 2013, CNS NEUROSCI THER, V19, P556, DOI 10.1111/cns.12127; Zetterberg H, 2013, NAT REV NEUROL, V9, P201, DOI 10.1038/nrneurol.2013.9; Zitnay GA, 2008, J NEUROTRAUM, V25, P1135, DOI 10.1089/neu.2008.0599	41	17	18	0	14	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR 15	2014	31	8					782	788		10.1089/neu.2013.3116			7	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	AD7PX	WOS:000333457200009	24372380	Green Published			2021-06-18	
J	Bilaniuk, JW; Adams, JM; DiFazio, LT; Siegel, BK; Allegra, JR; Lujan, JJ; Durling-Grover, R; Pawar, J; Rolandelli, RH; Nemeth, ZH				Bilaniuk, Jaroslaw W.; Adams, John M.; DiFazio, Louis T.; Siegel, Brian K.; Allegra, John R.; Lujan, Juan J.; Durling-Grover, Renay; Pawar, Joanne; Rolandelli, Rolando H.; Nemeth, Zoltan H.			Equestrian Trauma: Injury Patterns Vary among Age Groups	AMERICAN SURGEON			English	Article; Proceedings Paper	98th Annual Clinical Meeting of the American-College-of-Surgeons (ACS)	SEP 30-OCT 04, 2012	Chicago, IL	Amer Coll Surg			UNITED-STATES; PREVENTION; HORSES; RIDERS	Patients with equestrian injuries were identified in the trauma registry from 2004 to 2007. We a priori divided patients into three groups: 0 to 18 years, 19 to 49 years, and 50 years old or older. There were 284 patients identified with equestrian-related trauma. Injury Severity Score for the three major age categories 0 to 18 years, 19 to 49 years, and 50 years or older, were 3.47, 5.09, and 6.27, respectively. The most common body region injured among all patients was the head (26.1%). The most common injuries by age group were: 0 to 18 years, upper extremity fractures; 19 to 49 year olds, concussions; and 50 years or older, rib fractures. Significant differences were observed among the three age groups in terms of percent of patients with rib fractures: percent of patients with rib fractures was 2, 8, and 22 per cent in age groups 0 to 18, 19 to 49, and 50 years or older, respectively. We found different patterns of injuries associated with equestrian accidents by age. Head injuries were commonly seen among participants in equestrian activities and helmet use should be promoted to minimize the severity of closed head injuries. Injury patterns also seem to vary among the various age groups that ride horses. This information could be used to better target injury prevention efforts among these patients.	[Bilaniuk, Jaroslaw W.; Adams, John M.; DiFazio, Louis T.; Siegel, Brian K.; Lujan, Juan J.; Durling-Grover, Renay; Pawar, Joanne; Rolandelli, Rolando H.; Nemeth, Zoltan H.] Morristown Med Ctr, Dept Surg, Morristown, NJ 07962 USA; [Allegra, John R.] Morristown Med Ctr, Dept Emergency Med, Morristown, NJ 07962 USA; [Nemeth, Zoltan H.] Rutgers State Univ, New Jersey Med Sch, Dept Surg, Newark, NJ 07102 USA	Bilaniuk, JW (corresponding author), Morristown Med Ctr, Dept Surg, 100 Madison Ave, Morristown, NJ 07962 USA.	Jaroslaw.Bilaniuk@atlantichealth.org					American Horse Council, NAT EC IMP US HORS I; Ball CG, 2007, AM J SURG, V193, P636, DOI 10.1016/j.amjsurg.2007.01.016; BUSCH HM, 1986, J TRAUMA, V26, P559, DOI 10.1097/00005373-198606000-00013; Carrillo EH, 2007, SCAND J SURG, V96, P79, DOI 10.1177/145749690709600115; *CDCP, 1990, MMWR-MORBID MORTAL W, V39, P329; Chitnavis JP, 1996, INJURY, V27, P103, DOI 10.1016/0020-1383(95)00176-X; Frankel HL, 1998, AM SURGEON, V64, P151; Griffen M, 2002, SOUTHERN MED J, V95, P441, DOI 10.1097/00007611-200204000-00013; Hobbs Gregory D., 1994, Journal of Emergency Medicine, V12, P143, DOI 10.1016/0736-4679(94)90690-4; Ketai LH, 2000, INJURY, V31, P757, DOI 10.1016/S0020-1383(00)00108-X; Lim J, 2003, ANZ J SURG, V73, P567, DOI 10.1046/j.1445-2197.2003.02707.x; Loder RT, 2008, J TRAUMA, V65, P447, DOI 10.1097/TA.0b013e31817dac43; Mayberry JC, 2007, J TRAUMA, V62, P735, DOI 10.1097/ta.0b013e318031b5d4; Moss PS, 2002, EMERG MED J, V19, P412, DOI 10.1136/emj.19.5.412; Northey G., 2003, New Zealand Medical Journal, V116, P601; Norwood S, 2000, J TRAUMA, V48, P740, DOI 10.1097/00005373-200004000-00025; Petridou E, 2004, J TRAUMA, V56, P643, DOI 10.1097/01.TA.0000053470.38129.F4; Ronning R, 2001, AM J SPORT MED, V29, P581, DOI 10.1177/03635465010290051001; Sorli J M, 2000, Inj Prev, V6, P59, DOI 10.1136/ip.6.1.59; Thomas KE, 2006, BRIT J SPORT MED, V40, P619, DOI 10.1136/bjsm.2006.025858	20	17	17	0	5	SOUTHEASTERN SURGICAL CONGRESS	CUMMING	115 SAMARITAN DR, #200, CUMMING, GA 30040-2354 USA	0003-1348	1555-9823		AM SURGEON	Am. Surg.	APR	2014	80	4					396	402					7	Surgery	Surgery	AJ5RL	WOS:000337744400024	24887673				2021-06-18	
J	Billeter, AT; Miller, FB; Harbrecht, BG; Bowen, W; Stephens, MJ; Postel, GC; Smith, JW; Penta, M; Coleman, R; Franklin, GA; Trunkey, DD; Polk, HC				Billeter, Adrian T.; Miller, Frank B.; Harbrecht, Brian G.; Bowen, Wanda; Stephens, Matthew J.; Postel, Gregory C.; Smith, Jason W.; Penta, Matthew; Coleman, Royce; Franklin, Glen A.; Trunkey, Donald D.; Polk, Hiram C., Jr.			Interhospital transfer of blunt multiply injured patients to a level 1 trauma center does not adversely affect outcome	AMERICAN JOURNAL OF SURGERY			English	Article						Interhospital transfer; Trauma; Head injuries; Referral; Traumatic brain injury; Imaging	BRAIN-INJURY; COMPUTED-TOMOGRAPHY; FIELD TRIAGE; CARE; GUIDELINES; MANAGEMENT; MORTALITY; IMPACT; AGE	BACKGROUND: Stops at nontrauma centers for severely injured patients are thought to increase deaths and costs, potentially because of unnecessary imaging and indecisive/delayed care of traumatic brain injuries (TBIs). METHODS: We studied 754 consecutive blunt trauma patients with an Injury Severity Score greater than 20 with an emphasis on 212 patients who received care at other sites en route to our level 1 trauma center. RESULTS: Referred patients were older, more often women, and had more severe TBI (all P < .05). After correction for age, sex, and injury pattern, there was no difference in the type of TBI, Glasgow Coma Scale (GCS) upon arrival at the trauma center, or overall mortality between referred and directly admitted patients. GCS at the outside institution did not influence promptness of transfer. CONCLUSIONS: Interhospital transfer does not affect the outcome of blunt trauma patients. However, the unnecessarily prolonged stay of low GCS patients in hospitals lacking neurosurgical care is inappropriate. (C) 2014 Elsevier Inc. All rights reserved.	[Billeter, Adrian T.; Miller, Frank B.; Harbrecht, Brian G.; Bowen, Wanda; Smith, Jason W.; Penta, Matthew; Franklin, Glen A.; Polk, Hiram C., Jr.] Univ Louisville, Sch Med, Dept Surg, Louisville, KY 40292 USA; [Stephens, Matthew J.; Postel, Gregory C.] Univ Louisville, Sch Med, Dept Diagnost Radiol, Louisville, KY 40292 USA; [Coleman, Royce] Univ Louisville, Sch Med, Dept Emergency Med, Louisville, KY 40292 USA; [Trunkey, Donald D.] Oregon Hlth & Sci Univ, Dept Surg, Portland, OR USA	Polk, HC (corresponding author), Univ Louisville, Sch Med, Dept Surg, Louisville, KY 40292 USA.	hcpolk01@louisvill.edu	Billeter, Adrian/O-2185-2019	Billeter, Adrian/0000-0001-8724-4793	Price Trust Fund; Joint Royal College of Surgeons of Edinburgh/James; Emmeline Ferguson Research Fellowship Trust	Supported in part by the Price Trust Fund and by the Joint Royal College of Surgeons of Edinburgh/James and Emmeline Ferguson Research Fellowship Trust.	Ball CG, 2009, J TRAUMA, V67, P180, DOI 10.1097/TA.0b013e3181a595c3; Cudnik MT, 2009, J TRAUMA, V66, P1321, DOI 10.1097/TA.0b013e3181929e2b; Cuschieri J, 2012, ANN SURG, V255, P993, DOI 10.1097/SLA.0b013e31824f1ebc; Demetriades D, 2002, BRIT J SURG, V89, P1319, DOI 10.1046/j.1365-2168.2002.02210.x; Demetriades D, 2001, J TRAUMA, V51, P754, DOI 10.1097/00005373-200110000-00022; DuBose JJ, 2011, J TRAUMA, V70, P11, DOI 10.1097/TA.0b013e318207c563; Gabbe BJ, 2012, ANN SURG, V255, P1009, DOI 10.1097/SLA.0b013e31824c4b91; Goh KYC, 1997, CAN J NEUROL SCI, V24, P235, DOI 10.1017/S0317167100021867; Haley Theodore, 2009, Am J Surg, V198, P858, DOI 10.1016/j.amjsurg.2009.05.030; Hill AD, 2011, J TRAUMA, V71, P1885, DOI 10.1097/TA.0b013e31823ac642; Hsiao KY, 2012, EMERG MED J, V29, P156, DOI 10.1136/emj.2010.097295; Huber-Wagner S, 2009, LANCET, V373, P1455, DOI 10.1016/S0140-6736(09)60232-4; Janssens L, 2012, J TRAUMA ACUTE CARE, V73, P1284, DOI 10.1097/TA.0b013e318265d0ac; Kejriwal R, 2009, NEW ZEAL MED J, V122, P40; Laack TA, 2011, J TRAUMA, V70, P1362, DOI 10.1097/TA.0b013e3181e1707f; Lee CY, 2008, J TRAUMA, V65, P1359, DOI 10.1097/TA.0b013e31818c10fc; Liepert AE, 2011, J SURG RES, V170, P309, DOI 10.1016/j.jss.2011.06.018; Livingston DH, 2009, J TRAUMA, V67, P341, DOI 10.1097/TA.0b013e3181a5cc34; MacKenzie EJ, 2010, J TRAUMA, V69, P1, DOI 10.1097/TA.0b013e3181e03a21; Mohan D, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-103; Moore MM, 2012, J TRAUMA ACUTE CARE, V73, P126, DOI 10.1097/TA.0b013e31824b01af; Nirula R, 2010, J TRAUMA, V69, P595, DOI 10.1097/TA.0b013e3181ee6e32; Pearson WS, 2012, PREHOSP EMERG CARE, V16, P323, DOI 10.3109/10903127.2012.682701; Rivara FP, 2008, J TRAUMA, V64, P1594, DOI 10.1097/TA.0b013e3181493099; Salottolo K, 2009, CRIT CARE MED, V37, P1336, DOI 10.1097/CCM.0b013e31819d6739; Sasser Scott M, 2012, MMWR Recomm Rep, V61, P1; Sasser Scott M., 2009, Morbidity and Mortality Weekly Report, V58, P1; Scheetz Linda J, 2003, J Emerg Nurs, V29, P109, DOI 10.1067/men.2003.59; Scheetz LJ, 2011, PREHOSP EMERG CARE, V15, P83, DOI 10.3109/10903127.2010.514088; Schonenberger A, 2012, ARCH GERONTOL GERIAT, V55, P660, DOI 10.1016/j.archger.2012.02.013; Siman-Tov M, 2012, INJURY; Sugerman DE, 2012, J TRAUMA ACUTE CARE, V73, P1491, DOI 10.1097/TA.0b013e3182782675; Tauber M, 2009, J TRAUMA, V67, P521, DOI 10.1097/TA.0b013e3181a7c184; Tohira Hideo, 2011, Ann Adv Automot Med, V55, P255	34	17	17	0	3	EXCERPTA MEDICA INC-ELSEVIER SCIENCE INC	BRIDGEWATER	685 ROUTE 202-206 STE 3, BRIDGEWATER, NJ 08807 USA	0002-9610	1879-1883		AM J SURG	Am. J. Surg.	APR	2014	207	4					459	466		10.1016/j.amjsurg.2013.04.015			8	Surgery	Surgery	AD7BN	WOS:000333416100003	24674826				2021-06-18	
J	Murray, NG; Ambati, VNP; Contreras, MM; Salvatore, AP; Reed-Jones, RJ				Murray, Nicholas G.; Ambati, V. N. Pradeep; Contreras, Monica M.; Salvatore, Anthony P.; Reed-Jones, Rebecca J.			Assessment of oculomotor control and balance post-concussion: A preliminary study for a novel approach to concussion management	BRAIN INJURY			English	Article						Assessment; balance; concussion; eye tracking; post-concussion syndrome; vestibular; vision	STATES HIGH-SCHOOL; INTERNATIONAL-CONFERENCE; SPORT; ADAPTATION; RECOVERY; DEFICITS	Primary objective: Balance disturbances occur in similar to 30% of concussion injuries, with vestibular dysfunction reported as the main contributor. However, few have studied oculomotor control post-concussion to assess vestibular dysfunction. Research design: The current research measured the differences in oculomotor control between athletes post-concussion (PC) and athletes without concussion (NC) during an active balance control task. Methods: Nine PC and nine NC athletes wore a monocular eye tracking device, while balance tests were performed using the Nintendo WiiFit (R) soccer heading game. Average game scores, eye deviations from centre (Gaze Deviations) and gaze fixation (Percentage Time on Centre) were measured. Results: PC made significantly greater Gaze Deviations from centre compared to NC (p<0.001), however Percentage Time on Centre and game scores were not significantly different between groups. Correlations between gaze and balance within groups revealed a significant positive correlation in NC, while a significant negative correlation in PC. Conclusions: Results from this exploratory examination of oculomotor behaviour post-concussion revealed significant differences in gaze stability between athletes with a concussion and those without, suggesting vestibular involvement post-concussion. Assessment of oculomotor control during balance activities may provide further insight into dysfunction of the vestibular system following a concussion injury.	[Murray, Nicholas G.; Ambati, V. N. Pradeep] Univ Texas El Paso, Coll Hlth Sci, Interdisciplinary Hlth Sci PhD Program, El Paso, TX 79968 USA; [Contreras, Monica M.; Reed-Jones, Rebecca J.] Univ Texas El Paso, Coll Hlth Sci, Dept Kinesiol, El Paso, TX 79968 USA; [Salvatore, Anthony P.] Univ Texas El Paso, Coll Hlth Sci, Speech Language Pathol Program, El Paso, TX 79968 USA; [Reed-Jones, Rebecca J.] Univ Texas El Paso, Coll Hlth Sci, Phys Therapy Program, El Paso, TX 79968 USA	Reed-Jones, RJ (corresponding author), Univ Prince Edward Isl, Kinesiol Program, Dept Appl Human Sci, Fac Sci, 550 Univ Ave, Charlottetown, PE C1A 4P3, Canada.	rreedjones@upei.ca	Reed-Jones, Rebecca/L-2021-2019	Reed-Jones, Rebecca/0000-0002-2128-2671			Albright TD, 2000, CURR OPIN NEUROBIOL, V10, P612, DOI 10.1016/S0959-4388(00)00132-X; ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; [Anonymous], NCAA SPORTS MED HDB; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Baron IS, 2007, BRAIN INJURY MED; Bell DR, 2011, SPORTS HEALTH, V3, P287, DOI 10.1177/1941738111403122; Berger RP, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.2.e31; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Clark RA, 2010, GAIT POSTURE, V31, P307, DOI 10.1016/j.gaitpost.2009.11.012; Crisco JJ, 2010, J ATHL TRAINING, V45, P549, DOI 10.4085/1062-6050-45.6.549; DeLong M R, 1984, Hum Neurobiol, V2, P235; Fetsch CR, 2009, J NEUROSCI, V29, P15601, DOI 10.1523/JNEUROSCI.2574-09.2009; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Guskiewicz KM, 2007, NEUROSURGERY, V61, P1244, DOI 10.1227/01.neu.0000306103.68635.1a; Guskiewicz KM, 2011, CLIN SPORT MED, V30, P89, DOI 10.1016/j.csm.2010.09.004; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Heitger MH, 2009, BRAIN, V132, P2850, DOI 10.1093/brain/awp181; Holmes JD, 2013, CLIN REHABIL, V27, P361, DOI 10.1177/0269215512458684; Kandel ER, 2000, PRINCIPLES NEURAL SC, P810; Kraus MF, 2010, COGN BEHAV NEUROL, V23, P210, DOI 10.1097/WNN.0b013e3181cefe2e; Lanska DJ, 2000, NEUROLOGY, V55, P1201, DOI 10.1212/WNL.55.8.1201; Lovell M, 2006, SPORTS NEUROPSYCHOLO; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McCrea MA, 2008, MILD TRAUMATIC BRAIN; McCrory P, 2005, PHYSICIAN SPORTSMED, V33, P29, DOI 10.3810/psm.2005.04.76; McCrory P, 2013, CLIN J SPORT MED, V23, P89, DOI 10.1097/JSM.0b013e31828b67cf; McFadyen BJ, 2009, ARCH PHYS MED REHAB, V90, P1596, DOI 10.1016/j.apmr.2009.03.010; Mucha A, 2012, BRAIN INJURY PROFESS, V9, P12, DOI DOI 10.3109/02699052.2014.887144; NASHNER LM, 1982, J NEUROSCI, V2, P536; Peterson CL, 2003, CLIN J SPORT MED, V13, P230, DOI 10.1097/00042752-200307000-00006; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; Salvatore AP, 2011, J MED SPEECH-LANG PA, V19, P1; Shumway-Cook A., 2012, MOTOR CONTROL TRANSL; SHUMWAYCOOK A, 1986, PHYS THER, V66, P1548, DOI 10.1093/ptj/66.10.1548; Slobounov S, 2007, NEUROSURGERY, V61, P338, DOI 10.1227/01.NEU.0000280001.03578.FF; Vallee M, 2006, ARCH PHYS MED REHAB, V87, P806, DOI 10.1016/j.apmr.2006.02.031; Yamada M, 2011, GERIATR NURS, V32, P188, DOI 10.1016/j.gerinurse.2011.02.002	37	17	17	0	27	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	APR	2014	28	4					496	503		10.3109/02699052.2014.887144			8	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	AF5GL	WOS:000334741900014	24564740				2021-06-18	
J	Singh, D; Cronin, DS; Haladuick, TN				Singh, Dilaver; Cronin, Duane S.; Haladuick, Tyler N.			Head and brain response to blast using sagittal and transverse finite element models	INTERNATIONAL JOURNAL FOR NUMERICAL METHODS IN BIOMEDICAL ENGINEERING			English	Article						head and brain modeling; finite element modeling; mild traumatic brain injury; blast	INTRACRANIAL-PRESSURE; INJURY; DEFORMATION; THRESHOLD; IMPULSE	Mild traumatic brain injury caused by blast exposure from Improvised Explosive Devices has become increasingly prevalent in modern conflicts. To investigate head kinematics and brain tissue response in blast scenarios, two solid hexahedral blast-head models were developed in the sagittal and transverse planes. The models were coupled to an Arbitrary Lagrangian-Eulerian model of the surrounding air to model blast-head interaction, for three blast load cases (5 kg C4 at 3, 3.5 and 4 m). The models were validated using experimental kinematic data, where predicted accelerations were in good agreement with experimental tests, and intracranial pressure traces at four locations in the brain, where the models provided good predictions for frontal, temporal and parietal, but underpredicted pressures at the occipital location. Brain tissue response was investigated for the wide range of constitutive properties available. The models predicted relatively low peak principal brain tissue strains from 0.035 to 0.087; however, strain rates ranged from 225 to 571 s-1. Importantly, these models have allowed us to quantify expected strains and strain rates experienced in brain tissue, which can be used to guide future material characterization. These computationally efficient and predictive models can be used to evaluate protection and mitigation strategies in future analysis. Copyright (c) 2013 John Wiley & Sons, Ltd.	[Singh, Dilaver; Cronin, Duane S.; Haladuick, Tyler N.] Univ Waterloo, Waterloo, ON N2L 3G1, Canada	Singh, D (corresponding author), Univ Waterloo, Dept Mech Engn, 200 Univ Ave West, Waterloo, ON N2L 3G1, Canada.	d3singh@uwaterloo.ca	Lang, Steven/AAE-8102-2021	Lang, Steven/0000-0003-1669-9146; Cronin, Duane/0000-0001-7538-0560	Natural Sciences and Engineering Research CouncilNatural Sciences and Engineering Research Council of Canada (NSERC); Defence Research and Development Canada - Valcartier; Med-Eng Corporation	The authors would like to acknowledge the support of the Natural Sciences and Engineering Research Council, Defence Research and Development Canada - Valcartier, and Med-Eng Corporation.	Abolfathi N, 2009, COMPUT METHOD BIOMEC, V12, P249, DOI [10.1080/10255840802430587, 10.1080/10255840903097871]; [Anonymous], VIS HUM PROJ; Bayly PV, 2005, J NEUROTRAUM, V22, P845, DOI 10.1089/neu.2005.22.845; Belytschko T., 2000, NONLINEAR FINITE ELE; Bir C, 2011, W81XWH0910498 US ARM; Bolander R, 2011, ANN BIOMED ENG, V39, P2550, DOI 10.1007/s10439-011-0343-0; Bulson PS, 1997, EXPLOSIVE LOADING EN; Chafi MS, 2010, ANN BIOMED ENG, V38, P490, DOI 10.1007/s10439-009-9813-z; Chafi MS, 2011, INT J APPL MECH, V3, P803, DOI 10.1142/S175882511100124X; COLEMAN AJ, 1995, ULTRASOUND MED BIOL, V21, P405, DOI 10.1016/0301-5629(94)00116-U; Cronin D. S., 2008, P PERS ARM SYST S, P84; Danelson KA, 2008, STAPP CAR C, V52, P59; Deck C, 2008, INT J CRASHWORTHINES, V13, P667, DOI 10.1080/13588260802411523; Dionne JP, 2002, REDUCTION BLAST INDU; DuBois P, 2003, 4 EUR LS DYNA US C U, P31; Feng Y, 2010, J R SOC INTERFACE, V7, P1677, DOI 10.1098/rsif.2010.0210; Gehre C., 2009, ENHANCED SAFETY VEHI; Gennarelli TA, 2003, ANN P ASS ADV AUTOMO, V4, P624; Greer A, 2006, THESIS U WATERLOO WA; Grujicic M, 2010, MULTIDISCIP MODEL MA, V6, P335, DOI 10.1108/15736101011080097; Grujicic M, 2011, J MATER ENG PERFORM, V20, P877, DOI 10.1007/s11665-010-9724-z; Haladuick TN, 2011, MODELLING GLOBAL HEA; Hardy W N, 2001, Stapp Car Crash J, V45, P337; Herbert E, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.041603; Hutchinson J, 1998, APPL MATH COMPUT, V96, P1, DOI 10.1016/S0096-3003(97)10106-0; Ipek H., 2009, 21 INT TECH C ENH SA; Kingery C.N., 1984, ARBRLTR02555; Kleinberger M, 1993, P 37 STAPP CAR CRASH, V37, P261; Kleiven S., 2008, MTBI PREC S IBIA C L; Leonardi AD, 2011, J NEUROTRAUM, V28, P85, DOI 10.1089/neu.2010.1324; Lockhart P. A., 2012, P PASS NUR GERM; Lockhart PA, 2010, THESIS U WATERLOO WA; Lockhart P, 2011, J TRAUMA, V70, pE29, DOI 10.1097/TA.0b013e3181de3f4b; Makris A, 2000, REDUCTION BLAST INDU; Mao H., 2009, THESIS WAYNE STATE U; Mao HJ, 2011, J NEUROTRAUM, V28, P2263, DOI 10.1089/neu.2010.1600; Moore DF, 2009, NEUROIMAGE, V47, pT10, DOI 10.1016/j.neuroimage.2009.02.019; Moore DF, 2008, FUTUR NEUROL, V3, P243, DOI 10.2217/14796708.3.3.243; Nahum AM., 1977, P 21 STAPP CAR CRASH, P339, DOI [10.4271/770922., DOI 10.4271/770922]; Namani R, 2009, J BIOMECH, V42, P2047, DOI 10.1016/j.jbiomech.2009.06.007; Needham CE, 2010, SHOCK WAVE HIGH PRES, P1, DOI 10.1007/978-3-642-05288-0; Nelson TJ, 2006, J AM COLL SURGEONS, V202, P418, DOI 10.1016/j.jamcollsurg.2005.11.011; Newman J A, 2000, Stapp Car Crash J, V44, P215; Panzer MB, 2013, COMPUT METHOD BIOMEC, V16, P612, DOI 10.1080/10255842.2011.629615; Panzer MB, 2012, ANN BIOMED ENG, V40, P1530, DOI 10.1007/s10439-012-0519-2; Panzer MB, 2012, J TRAUMA ACUTE CARE, V72, P454, DOI 10.1097/TA.0b013e31821e8270; Puso MA, 2006, INT J NUMER METH ENG, V67, P841, DOI 10.1002/nme.1651; Rafaels K, 2011, J NEUROTRAUM, V28, P2319, DOI 10.1089/neu.2009.1207; Roberts JC, 2012, J BIOMECH, V45, P2899, DOI 10.1016/j.jbiomech.2012.07.027; Saljo A, 2009, J NEUROTRAUM, V26, P1345, DOI [10.1089/neu.2008.0856, 10.1089/neu.2008-0856]; Saljo A, 2008, J NEUROTRAUM, V25, P1397, DOI 10.1089/neu.2008.0602; Shafieian M, 2011, 37 ANN IEEE BIOENG C; Shridharani Jay K, 2012, Front Neurol, V3, P70, DOI 10.3389/fneur.2012.00070; Singh D, 2012, P PASS NUR GERM; Singh D, 2011, COMP DETAILED SAGITT; Sista B, 2011, OH STAT U INJ BIOM S; Takhounts EG, 2008, STAPP CAR C, V52, P1; Tan P, 2009, 18TH WORLD IMACS CONGRESS AND MODSIM09 INTERNATIONAL CONGRESS ON MODELLING AND SIMULATION, P1657; Taylor PA, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3118765; Thunert C, 2013, CORA RELEASE 3 6 USE; Trosseille X., 1992, P 36 STAPP CAR CRASH, DOI 10.4271/922527; Tsaklis P, 2010, HUMAN MOV SCI, V11, P91, DOI [DOI 10.2478/V10038-009-0025-Z, 10.2478/v10038-009-0025-z]; Van Sligtenhorst C, 2006, J BIOMECH, V39, P1852, DOI 10.1016/j.jbiomech.2005.05.015; Ward C., 1980, 801304 SAE, DOI [10.4271/801304, DOI 10.4271/801304]; Wittek A, 2003, JSME INT J C-MECH SY, V46, P1388, DOI 10.1299/jsmec.46.1388; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446; Zhang LY, 2001, J NEUROTRAUM, V18, P21, DOI 10.1089/089771501750055749; Zhu F, 2013, INT J NUMER METH BIO, V29, P392, DOI 10.1002/cnm.2518; Zhu Feng, 2010, Stapp Car Crash J, V54, P211; Zhu F, 2010, MATER DESIGN, V31, P4704, DOI 10.1016/j.matdes.2010.05.023	70	17	17	0	18	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2040-7939	2040-7947		INT J NUMER METH BIO	Int. J. Numer. Meth. Biomed.	APR	2014	30	4					470	489		10.1002/cnm.2612			20	Engineering, Biomedical; Mathematical & Computational Biology; Mathematics, Interdisciplinary Applications	Engineering; Mathematical & Computational Biology; Mathematics	AE0UB	WOS:000333680600002	24293124				2021-06-18	
J	Sun, WF; Liu, JF; Huan, Y; Zhang, CD				Sun, Weifeng; Liu, Jiafeng; Huan, Yu; Zhang, Chaodong			Intracranial injection of recombinant stromal-derived factor-1 alpha (SDF-1 alpha) attenuates traumatic brain injury in rats	INFLAMMATION RESEARCH			English	Article						TBI; SDF-1 alpha; Neuronal degradation and apoptosis; Inflammation; ERK pathway; NF-kappa B pathway	NF-KAPPA-B; ACTIVATED PROTEIN-KINASE; REGIONAL CEREBRAL EDEMA; BCL-2 FAMILY-MEMBERS; GLUTAMATE-RECEPTOR 5; NITRIC-OXIDE; CHEMOKINE RECEPTOR; NEURONAL APOPTOSIS; CELL-SURVIVAL; INHIBITION	This study was conducted to investigate the role of stromal-derived factor-1 alpha (SDF-1 alpha) in a secondary brain injury after traumatic brain injury (TBI) in rats, and to further elucidate its underlying regulatory mechanisms. Male Sprague-Dawley rats underwent TBI for 30 min, and then received intracranial injections of recombinant SDF-1 alpha, SDF-1 alpha antibody, or saline as a vehicle control. At 24 h after TBI, brain tissues from the experimental animals were subjected to histology, immunohistochemistry, quantitative real-time polymerase chain reaction (PCR), enzyme-linked immunosorbent assay (ELISA), and western blot analyses. TBI-induced brain edema and blood-brain barrier disruption were ameliorated by post-injury injections of SDF-1 alpha. TBI-induced neuronal degradation and apoptosis, accompanied by increased cleaved caspase-3, cleaved PARP and Bax, and decreased Bcl-2 were found to be attenuated by SDF-1 alpha injection. Nitric oxide (NO) and inducible nitric oxide synthase (iNOS) levels decreased in SDF-1 alpha treated animals after TBI. SDF-1 alpha repressed inflammatory responses by inhibiting the expression of pro-inflammatory cytokines, such as TNF-alpha, IL-1 beta, and IL-6. However, neutralizing the effect of SDF-1 alpha with its antibody abolished these therapeutic alterations in TBI animals. Importantly, SDF-1 alpha attenuated the brain lesion by affecting the ERK and NF-kappa B signaling pathways after mechanical head trauma in rats. SDF-1 alpha ameliorates mechanical trauma-induced pathological changes via its anti-apoptotic and anti-inflammatory action in the brain.	[Sun, Weifeng; Zhang, Chaodong] China Med Univ, Affiliated Hosp 1, Dept Neurol, Shenyang 110001, Peoples R China; [Sun, Weifeng; Liu, Jiafeng; Huan, Yu] Harbin First Hosp, Dept Neurol, Harbin 150010, Peoples R China	Zhang, CD (corresponding author), China Med Univ, Affiliated Hosp 1, Dept Neurol, 155 North Nanjing St, Shenyang 110001, Peoples R China.	cmu1hzhangchaodong@163.com					Bacon KB, 2000, J NEUROIMMUNOL, V104, P92, DOI 10.1016/S0165-5728(99)00266-0; Banisadr Ghazal, 2005, Current Drug Targets - Inflammation and Allergy, V4, P387, DOI 10.2174/1568010054022097; Burns JM, 2006, J EXP MED, V203, P2201, DOI 10.1084/jem.20052144; Calderon TM, 2006, J NEUROIMMUNOL, V177, P27, DOI 10.1016/j.jneuroim.2006.05.003; Chen CH, 2006, J CEREBR BLOOD F MET, V26, P951, DOI 10.1038/sj.jcbfm.9600248; Chen SF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045763; Clausen F, 2011, EUR J NEUROSCI, V34, P110, DOI 10.1111/j.1460-9568.2011.07723.x; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; Cullen SP, 2009, CELL DEATH DIFFER, V16, P935, DOI 10.1038/cdd.2009.59; D'Amelio M, 2010, CELL DEATH DIFFER, V17, P1104, DOI 10.1038/cdd.2009.180; Davis A E, 2000, Crit Care Nurs Q, V23, P1; Demir H, 2013, PEPTIDES, V43, P27, DOI 10.1016/j.peptides.2013.02.018; Eldadah BA, 2000, J NEUROTRAUM, V17, P811, DOI 10.1089/neu.2000.17.811; Esche C, 2005, J INVEST DERMATOL, V125, P615, DOI 10.1111/j.0022-202X.2005.23841.x; Gerard C, 2001, NAT IMMUNOL, V2, P108, DOI 10.1038/84209; Hayden MS, 2011, CELL RES, V21, P223, DOI 10.1038/cr.2011.13; Hilton GD, 2008, J CEREBR BLOOD F MET, V28, P1845, DOI 10.1038/jcbfm.2008.75; Huang CY, 2001, J CEREBR BLOOD F MET, V21, P163, DOI 10.1097/00004647-200102000-00008; Jeong SJ, 2005, ONCOGENE, V24, P6719, DOI 10.1038/sj.onc.1208825; Kanbak G, 2013, GENE, V512, P492, DOI 10.1016/j.gene.2012.10.012; Kremer KN, 2013, J BIOL CHEM, V288, P22899, DOI 10.1074/jbc.M113.449926; Kroncke KD, 1997, NITRIC OXIDE-BIOL CH, V1, P107, DOI 10.1006/niox.1997.0118; Lechner M, 2005, SEMIN CANCER BIOL, V15, P277, DOI 10.1016/j.semcancer.2005.04.004; Li SH, 2012, BRAIN RES, V1444, P76, DOI 10.1016/j.brainres.2011.12.055; Liu XL, 2011, PROTEIN CELL, V2, P845, DOI 10.1007/s13238-011-1097-z; Liu XQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054077; Lowenstein CJ, 2004, J CELL SCI, V117, P2865, DOI 10.1242/jcs.01166; Lu DY, 2009, EUR J PHARMACOL, V613, P146, DOI 10.1016/j.ejphar.2009.03.001; Lu J, 2003, NEUROPHARMACOLOGY, V44, P253, DOI 10.1016/S0028-3908(02)00380-5; Lu J, 2003, NEUROSCI LETT, V339, P147, DOI 10.1016/S0304-3940(03)00003-X; Lukacs NW, 2002, AM J PATHOL, V160, P1353, DOI 10.1016/S0002-9440(10)62562-X; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Mao WF, 2014, INT J NEUROSCI, V124, P281, DOI 10.3109/00207454.2013.838236; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Martinou JC, 2011, DEV CELL, V21, P92, DOI 10.1016/j.devcel.2011.06.017; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; McCandless EE, 2006, J IMMUNOL, V177, P8053, DOI 10.4049/jimmunol.177.11.8053; Mithal DS, 2012, J NEUROIMMUNE PHARM, V7, P820, DOI 10.1007/s11481-011-9336-x; Mori T, 2002, J NEUROTRAUM, V19, P1411, DOI 10.1089/089771502320914642; Mori T, 2002, J CEREBR BLOOD F MET, V22, P444, DOI 10.1097/00004647-200204000-00008; OKIYAMA K, 1995, J NEUROCHEM, V64, P802; Otani N, 2002, J CEREBR BLOOD F MET, V22, P327, DOI 10.1097/00004647-200203000-00010; Qiu RF, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-99; Robin AM, 2006, J CEREBR BLOOD F MET, V26, P125, DOI 10.1038/sj.jcbfm.9600172; Rostene W, 2007, NAT REV NEUROSCI, V8, P895, DOI 10.1038/nrn2255; Sanz O, 2002, J NEUROSCI RES, V67, P772, DOI 10.1002/jnr.10140; Savas HA, 2006, WORLD J BIOL PSYCHIA, V7, P51, DOI 10.1080/15622970510029993; Wang JW, 2013, BIOCHEM BIOPH RES CO, V430, P1016, DOI 10.1016/j.bbrc.2012.12.046; Wang JW, 2012, BRAIN RES, V1464, P73, DOI 10.1016/j.brainres.2012.05.014; Wang J, 2007, J CEREBR BLOOD F MET, V27, P894, DOI 10.1038/sj.jcbfm.9600403; Werner L, 2013, THERANOSTICS, V3, P40, DOI 10.7150/thno.5135; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yilmaz ER, 2013, ACTA NEUROCHIR, V155, P141, DOI 10.1007/s00701-012-1501-3; Yoo J, 2012, NEUROSCIENCE, V209, P171, DOI 10.1016/j.neuroscience.2012.02.031; Zhang D, 2013, NEUROSCIENCE, V238, P209, DOI 10.1016/j.neuroscience.2013.02.022; Zhao YB, 2012, EXP NEUROL, V237, P489, DOI 10.1016/j.expneurol.2012.07.004; Zheng H, 2008, ATHEROSCLEROSIS, V201, P36, DOI 10.1016/j.atherosclerosis.2008.02.011; Zhuang Z, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-47	58	17	20	0	11	SPRINGER BASEL AG	BASEL	PICASSOPLATZ 4, BASEL, 4052, SWITZERLAND	1023-3830	1420-908X		INFLAMM RES	Inflamm. Res.	APR	2014	63	4					287	297		10.1007/s00011-013-0699-8			11	Cell Biology; Immunology	Cell Biology; Immunology	AD0WD	WOS:000332954100005	24352531				2021-06-18	
J	Ustinova, KI; Perkins, J; Leonard, WA; Hausbeck, CJ				Ustinova, K. I.; Perkins, J.; Leonard, W. A.; Hausbeck, C. J.			Virtual reality game-based therapy for treatment of postural and co-ordination abnormalities secondary to TBI: A pilot study	BRAIN INJURY			English	Article						Brain injury; clinical trial; motor recovery; postural control; rehabilitation; virtual reality	TRAUMATIC BRAIN-INJURY; EXERCISE PROGRAMS; CHRONIC STROKE; REHABILITATION; BALANCE; TELEREHABILITATION; ENVIRONMENTS; RELIABILITY; RECOVERY; BENEFITS	Primary objective: The study objective was to test the efficacy of game-based virtual reality (VR) therapy as a mean of correcting postural and co-ordination abnormalities in individuals with traumatic brain injury (TBI). Therapy was done with interactive customized VR games and scenarios, utilizing an Xbox Kinect sensor. Research design: The study was a pilot project using the structure of a phase II clinical trial. Methods and procedures: Fifteen participants with mild-to-moderate chronic TBI-related balance and motor co-ordination impairments participated in 15 sessions, each lasting similar to 50-55 minutes, scheduled 2-3 times a week over 5-6 consecutive weeks. Participants were evaluated at baseline, immediately after the final session and in a 1-month follow-up with a battery of clinical tests (measuring postural stability, gait and co-ordination) and movement performance parameters. Movement parameters included arm-leg co-ordination, dynamic stability and arm precision, calculated from kinematic data recorded with Xbox Kinect sensor. Results: Following therapy, most participants improved their static and dynamic postural stability, gait and arm movements. These effects persisted over the retention interval. Conclusions: Results will be used to improve the VR program, with the goal of producing a cost-effective, accessible and easy to individualize therapeutic approach. The pilot data will be used for designing a larger scale clinical trial.	[Ustinova, K. I.; Perkins, J.; Leonard, W. A.] Cent Michigan Univ, Herbert H & Grace A Dow Coll Hlth Profess, Mt Pleasant, MI 48858 USA; [Hausbeck, C. J.] Hope Network Rehabil Serv, Phys Therapy Dept, Mt Pleasant, MI USA	Ustinova, KI (corresponding author), Cent Michigan Univ, Doctoral Program Phys Therapy, Mt Pleasant, MI 48858 USA.	ustin1k@cmich.edu	Ustinova, Ksenia I/M-8250-2016	Ustinova, Ksenia I/0000-0002-1531-7591	Blue Cross Blue Shield Foundation of Michigan; Association of Schools of Allied Health Professions; US Department of DefenseUnited States Department of Defense	The authors report no conflicts of interest. Supported by Blue Cross Blue Shield Foundation of Michigan and Association of Schools of Allied Health Professions. The VR therapy development was sponsored by the US Department of Defense.	Arce FI, 2004, HUM MOVEMENT SCI, V22, P749, DOI 10.1016/j.humov.2003.12.002; BERG K, 1989, Physiotherapy Canada, V41, P304; Bickerstaff ER, 1989, NEUROLOGICAL EXAMINA; Bobath K, 1972, PHYS THERAPY SERVICE, P37; Burdea GC, 2003, METHOD INFORM MED, V42, P519; Caeyenberghs K, 2010, HUM BRAIN MAPP, V31, P992, DOI 10.1002/hbm.20911; Carr JH, 1987, MOTOR RELEARNING STR; Christiansen C, 1998, ARCH PHYS MED REHAB, V79, P888, DOI 10.1016/S0003-9993(98)90083-1; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Danek A, 2004, NERVENARZT, V75, P411, DOI 10.1007/s00115-004-1717-4; Dault MC, 2002, BRAIN INJURY, V16, P231, DOI 10.1080/02699050110103300; Demiris G, 2005, J MED SYST, V29, P595, DOI 10.1007/s10916-005-6127-z; Deutsch JE, 2011, TOP STROKE REHABIL, V18, P701, DOI 10.1310/tsr1806-701; Donoghue D, 2009, J REHABIL MED, V41, P343, DOI 10.2340/16501977-0337; DUNCAN PW, 1990, J GERONTOL, V45, pM192, DOI 10.1093/geronj/45.6.M192; Fulk GD, 2007, PHYS REHABILITATION, P895; Gil-Gomez JA, 2011, J NEUROENG REHABIL, V8, DOI 10.1186/1743-0003-8-30; Grealy MA, 1999, ARCH PHYS MED REHAB, V80, P661, DOI 10.1016/S0003-9993(99)90169-7; Holden KM, 2002, NEUROL REP, V26, P62, DOI [DOI 10.1097/01253086-200226020-00003, 10.1097/01253086-200226020-00003]; Katz-Leurer M, 2009, DISABIL REHABIL, V31, P243, DOI 10.1080/09638280801927830; Keshner E.A., 2004, J NEUROENG REHABIL, V1, P8, DOI [10.1186/1743-0003-1-8, DOI 10.1186/1743-0003-1-8]; KLOCKGETHER T, 1990, J NEUROL NEUROSUR PS, V53, P297, DOI 10.1136/jnnp.53.4.297; Knott M., 1968, PROPRIOCEPTIVE NEURO; Kuhtz-Buschbeck JP, 2003, ARCH PHYS MED REHAB, V84, P424, DOI 10.1053/apmr.2003.50017; Lange B, 2009, EUR J PHYS REHAB MED, V45, P143; Levin MF, 2009, STUD HEALTH TECHNOL, V145, P94, DOI 10.3233/978-1-60750-018-6-94; Lin JH, 2010, STROKE, V41, P2021, DOI 10.1161/STROKEAHA.110.589739; Liston RAL, 1996, ARCH PHYS MED REHAB, V77, P425, DOI 10.1016/S0003-9993(96)90028-3; Mumford N, 2012, BRAIN INJURY, V26, P166, DOI 10.3109/02699052.2011.648706; Newstead Ann H, 2005, J Neurol Phys Ther, V29, P18; O'Neil RL, 2013, NEUROREHABILITATION, V33, P667, DOI 10.3233/NRE-130985; Paavola JM, 2013, J NOVEL PHYSIOTHERAP, V3, P129, DOI DOI 10.4172/2165-7025.1000129; Perkins J, 2013, J NOVEL PHYSIOTHERAP, V177, P112, DOI [10.4172/2165-7025.1000177, DOI 10.4172/2165-7025.1000177]; Potts MB, 2009, CEREBELLUM, V8, P211, DOI 10.1007/s12311-009-0114-8; Rogante M, 2010, NEUROREHABILITATION, V27, P287, DOI 10.3233/NRE-2010-0612; Saposnik G, 2010, STROKE, V41, P1477, DOI 10.1161/STROKEAHA.110.584979; Schafer AY, 2013, J NEUROENG REHABIL, V10, DOI 10.1186/1743-0003-10-76; Siegelbaum SA, 2013, PRINCIPLES NEURAL SC, P1487; Subramanian SK, 2013, NEUROREHAB NEURAL RE, V27, P13, DOI 10.1177/1545968312449695; Subramony SH, 2012, BRADLEYS NEUROLOGY C, P285; Sveistrup H, 2003, CYBERPSYCHOL BEHAV, V6, P245, DOI 10.1089/109493103322011524; Tariq SH, 2006, AM J GERIAT PSYCHIAT, V14, P900, DOI 10.1097/01.JGP.0000221510.33817.86; TAUB E, 1993, ARCH PHYS MED REHAB, V74, P347; The Management of Concussion/mTBI Working Group, 2009, VA DOD CLIN PRACT GU; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; Thornton M, 2005, BRAIN INJURY, V19, P989, DOI 10.1080/02699050500109944; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Ustinova K. I., 2013, 2013 International Conference on Virtual Rehabilitation (ICVR), P87, DOI 10.1109/ICVR.2013.6662109; Ustinova KI, 2011, J NEUROENG REHABIL, V8, DOI 10.1186/1743-0003-8-61; van der Steen MC, 2011, EXP BRAIN RES, V208, P411, DOI 10.1007/s00221-010-2493-y; Weiss PL, 2004, J NEUROENG REHABIL, V1, P1, DOI DOI 10.1186/1743-0003-1-12; WOLF SL, 1989, EXP NEUROL, V104, P125, DOI 10.1016/S0014-4886(89)80005-6; Wrisley DM, 2004, PHYS THER, V84, P906, DOI 10.1093/ptj/84.10.906; Yavuzer G, 2008, EUR J PHYS REHAB MED, V44, P237	54	17	19	2	55	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	APR	2014	28	4					486	495		10.3109/02699052.2014.888593			10	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	AF5GL	WOS:000334741900013	24702281				2021-06-18	
J	Parsons, TD; Courtney, CG				Parsons, Thomas D.; Courtney, Christopher G.			An initial validation of the Virtual Reality Paced Auditory Serial Addition Test in a college sample	JOURNAL OF NEUROSCIENCE METHODS			English	Article						Neuropsychological assessment; Ecological validity; Paced Auditory Serial Addition Test; Virtual environment	TRAUMATIC BRAIN-INJURY; INFORMATION-PROCESSING CAPACITY; CLOSED-HEAD-INJURY; RADIAL-ARM MAZE; MULTIPLE-SCLEROSIS; NEUROPSYCHOLOGICAL ASSESSMENT; EXECUTIVE FUNCTION; TEST PASAT; COGNITIVE IMPAIRMENT; CONSTRUCT-VALIDITY	Background: Numerous studies have demonstrated that the Paced Auditory Serial Addition Test (PASAT) has utility for the detection of cognitive processing deficits. While the PASAT has demonstrated high levels of internal consistency and test-retest reliability, administration of the PASAT has been known to create undue anxiety and frustration in participants. As a result, degradation of performance may be found on the PASAT. The difficult nature of the PASAT may subsequently decrease the probability of their return for follow up testing. New method: This study is a preliminary attempt at assessing the potential of a PASAT embedded in a virtual reality environment. The Virtual Reality PASAT (VR-PASAT) was compared with a paper-and-pencil version of the PASAT as well as other standardized neuropsychological measures. The two modalities of the PASAT were conducted with a sample of 50 healthy university students, between the ages of 19 and 34 years. Equivalent distributions were found for age, gender, education, and computer familiarity. Results: Moderate relationships were found between VR-PASAT and other putative attentional processing measures. The VR-PASAT was unrelated to indices of learning, memory, or visuospatial processing. Comparison with existing method(s): Comparison of the VR-PASAT with the traditional paper-and-pencil PASAT indicated that both versions require the examinee to sustain attention at an increasingly demanding, externally determined rate. Conclusions: Results offer preliminary support for the construct validity (in a college sample) of the VR-PASAT as an attentional processing measure and suggest that this task may provide some unique information not tapped by traditional attentional processing tasks. (C) 2013 Elsevier B.V. All rights reserved.	[Parsons, Thomas D.] Univ N Texas, Dept Psychol, Denton, TX 76203 USA; [Courtney, Christopher G.] Univ So Calif, Dept Psychol, Los Angeles, CA 90089 USA	Parsons, TD (corresponding author), Univ N Texas, Dept Psychol, Clin Neuropsychol & Simulat CNS Lab, 1155 Union Circle 311280, Denton, TX 76203 USA.	Thomas.Parsons@unt.edu		Parsons, Thomas/0000-0003-0331-5019			An KY, 2012, ARCH CLIN NEUROPSYCH, V27, P849, DOI 10.1093/arclin/acs085; [Anonymous], 2007, AUT NEUR ASS METR VE; Armstrong CM, 2013, J CLIN EXP NEUROPSYC, V35, P113, DOI 10.1080/13803395.2012.740002; Astur RS, 2004, BEHAV BRAIN RES, V151, P103, DOI 10.1016/j.bbr.2003.08.024; Aupperle RL, 2002, MULT SCLER J, V8, P382, DOI 10.1191/1352458502ms832oa; Bate AJ, 2001, CLIN NEUROPSYCHOL, V15, P405, DOI 10.1076/clin.15.3.405.10279; Beck L, 2010, CYBERPSYCH BEH SOC N, V13, P211, DOI 10.1089/cyber.2008.0343; Benedict RHB, 2002, CLIN NEUROPSYCHOL, V16, P381, DOI 10.1076/clin.16.3.381.13859; BRITTAIN JL, 1991, CLIN NEUROPSYCHOL, V5, P163, DOI DOI 10.1080/13854049108403300; Broadbent DE, 1958, PERCEPTION COMMUNICA; CAMPBELL DT, 1959, PSYCHOL BULL, V56, P81, DOI 10.1037/h0046016; Chronicle EP, 1998, NEUROPSYCHOL REHABIL, V8, P273; Cicerone KD, 1997, CLIN NEUROPSYCHOL, V11, P266, DOI 10.1080/13854049708400455; Dandeneau SD, 2007, J PERS SOC PSYCHOL, V93, P651, DOI 10.1037/0022-3514.93.4.651; DEARY IJ, 1994, BIOL PSYCHOL, V38, P1, DOI 10.1016/0301-0511(94)90046-9; Delis D, 1997, DELIS KAPLAN EXECUTI; Demaree HA, 1999, J NEUROL NEUROSUR PS, V67, P661, DOI 10.1136/jnnp.67.5.661; Diehr MC, 2003, J CLIN EXP NEUROPSYC, V25, P571, DOI 10.1076/jcen.25.4.571.13876; Diehr MC, 1998, ASSESSMENT, V5, P375, DOI 10.1177/107319119800500407; Dujardin K, 2007, CORTEX, V43, P601, DOI 10.1016/S0010-9452(08)70490-8; Goodrich-Hunsaker NJ, 2010, BEHAV NEUROSCI, V124, P405, DOI 10.1037/a0019193; GRONWALL D, 1981, J NEUROL NEUROSUR PS, V44, P889, DOI 10.1136/jnnp.44.10.889; Gronwall D.M., 1974, PSYCHOL EFFECTS CONC; GRONWALL DMA, 1977, PERCEPT MOTOR SKILL, V44, P367, DOI 10.2466/pms.1977.44.2.367; Heaton R K, 1995, J Int Neuropsychol Soc, V1, P231; Henry M, 2012, J NEUROSCI METH, V210, P125, DOI 10.1016/j.jneumeth.2012.07.025; Hiscock M, 1998, J CLIN EXP NEUROPSYC, V20, P463, DOI 10.1076/jcen.20.4.463.1466; Holdwick DJ, 1999, ARCH CLIN NEUROPSYCH, V14, P273, DOI 10.1016/S0887-6177(98)00021-3; HUGENHOLTZ H, 1988, NEUROSURGERY, V22, P853, DOI 10.1227/00006123-198805000-00006; Iverson GL, 2000, ARCH CLIN NEUROPSYCH, V15, P643, DOI 10.1016/S0887-6177(99)00048-7; JOHNSON DA, 1988, J CHILD PSYCHOL PSYC, V29, P199, DOI 10.1111/j.1469-7610.1988.tb00704.x; Johnson S K, 1997, Appl Neuropsychol, V4, P145, DOI 10.1207/s15324826an0403_1; Jovanovski D, 2012, APPL NEUROPSYCH-ADUL, V19, P171, DOI 10.1080/09084282.2011.643955; KENNEDY RS, 1992, AVIAT SPACE ENVIR MD, V63, P588; Kinsella GJ, 1998, NEUROPSYCHOL REHABIL, V8, P351, DOI 10.1080/713755576; Knight RG, 2009, BRAIN IMPAIR, V10, P3, DOI 10.1375/brim.10.1.3; KUJALA P, 1995, J NEUROL NEUROSUR PS, V59, P77, DOI 10.1136/jnnp.59.1.77; Law AS, 2006, ACTA PSYCHOL, V122, P27, DOI 10.1016/j.actpsy.2005.09.002; Lejuez C., 2003, BEHAV THER, V26, P290; Levin HS, 1982, LANCET, V2, P605; Madigan NK, 2000, J HEAD TRAUMA REHAB, V15, P943, DOI 10.1097/00001199-200006000-00007; McGeorge P, 2001, PRESENCE-TELEOP VIRT, V10, P375, DOI 10.1162/1054746011470235; Moffat SD, 2009, NEUROPSYCHOL REV, V19, P478, DOI 10.1007/s11065-009-9120-3; O'Jile JR, 2006, ARCH CLIN NEUROPSYCH, V21, P293, DOI 10.1016/j.acn.2006.03.003; Parsons TD, 2008, J BEHAV THER EXP PSY, V39, P250, DOI 10.1016/j.jbtep.2007.07.007; Parsons TD, 2008, CYBERPSYCHOL BEHAV, V11, P17, DOI 10.1089/cpb.2007.9934; Parsons TD, 2007, CHILD NEUROPSYCHOL, V13, P363, DOI 10.1080/13825580600943473; Parsons Thomas D, 2012, Stud Health Technol Inform, V173, P331; Plancher G, 2012, NEUROPSYCHOLOGIA, V50, P592, DOI 10.1016/j.neuropsychologia.2011.12.013; PONSFORD J, 1992, J CLIN EXP NEUROPSYC, V14, P822, DOI 10.1080/01688639208402865; Prevey ML, 1998, EPILEPSY RES, V30, P1, DOI 10.1016/S0920-1211(97)00091-0; Prins PJM, 2011, CYBERPSYCH BEH SOC N, V14, P115, DOI 10.1089/cyber.2009.0206; Rao S., 1990, MANUAL BRIEF REPEATA; Renison B, 2012, J INT NEUROPSYCH SOC, V18, P440, DOI 10.1017/S1355617711001883; Roman DD, 1991, CLIN NEUROPSYCHOL, V5, P33; Royan J, 2004, ARCH CLIN NEUROPSYCH, V19, P131, DOI 10.1016/S0887-6177(02)00216-0; Rudick R, 1997, ANN NEUROL, V42, P379, DOI 10.1002/ana.410420318; SAMPSON H, 1960, AUST J PSYCHOL, V12, P70, DOI 10.1080/00049536008255188; SAMPSON H, 1958, CAN J PSYCHOLOGY, V12, P179, DOI 10.1037/h0083750; Scarpetta F., 2008, J CYBERTHERAPY REHAB, V1, P127; Schultheis MT, 2002, J HEAD TRAUMA REHAB, V17, P378, DOI 10.1097/00001199-200210000-00002; Schweitzer JB, 2000, AM J PSYCHIAT, V157, P278, DOI 10.1176/appi.ajp.157.2.278; Sherman EMS, 1997, CLIN NEUROPSYCHOL, V11, P34, DOI 10.1080/13854049708407027; Shucard JL, 2004, J INT NEUROPSYCH SOC, V10, P35, DOI 10.1017/S1355617704101057; Spikman JM, 2001, BRAIN COGNITION, V47, P446, DOI 10.1006/brcg.2001.1320; STRAUSS E, 1994, ARCH CLIN NEUROPSYCH, V9, P483, DOI 10.1016/0887-6177(94)90039-6; Tombaugh TN, 2006, ARCH CLIN NEUROPSYCH, V21, P53, DOI 10.1016/j.acn.2005.07.006; Tombaugh TN, 2004, J CLIN EXP NEUROPSYC, V26, P257, DOI 10.1076/jcen.26.2.257.28080; Tombaugh TN, 1999, ADM MANUAL ADJUSTING; Vincent AS, 2012, MIL MED, V177, P256, DOI 10.7205/MILMED-D-11-00289; Wiens AN, 1997, J CLIN EXP NEUROPSYC, V19, P473, DOI 10.1080/01688639708403737; Wingenfeld SA, 1999, CLIN NEUROPSYCHOL, V13, P268, DOI 10.1076/clin.13.3.268.1736; Wu DR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056624; Wu DR, 2010, IEEE T AFFECT COMPUT, V1, P109, DOI 10.1109/T-AFFC.2010.12	74	17	17	1	33	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0165-0270	1872-678X		J NEUROSCI METH	J. Neurosci. Methods	JAN 30	2014	222						15	23		10.1016/j.jneumeth.2013.10.006			9	Biochemical Research Methods; Neurosciences	Biochemistry & Molecular Biology; Neurosciences & Neurology	AB3DR	WOS:000331672000002	24184058				2021-06-18	
J	Torrente, D; Mendes-Da-Silva, RF; Lopes, AAC; Gonzalez, J; Barreto, GE; Guedes, RCA				Torrente, Daniel; Mendes-da-Silva, Rosangela Figueiredo; Cunha Lopes, Andreia Albuquerque; Gonzalez, Janneth; Barreto, George E.; Araujo Guedes, Rubem Carlos			Increased calcium influx triggers and accelerates cortical spreading depression in vivo in male adult rats	NEUROSCIENCE LETTERS			English	Article						Ca2+ influx; Ionophore; Cortical spreading depression; Rat	BRAIN; CELLS; CHANNELS; A23187; CA2+	Cortical spreading depression (CSD) is a depolarization wave associated with neurological disorders such as migraine, cerebral ischemia and traumatic brain injury. The mechanism of action of this phenomenon still remains unclear. Although it is suggested that extracellular K+ accumulation contributes to CSD, other ions may play a relevant role in the mechanism of propagation of the wave. In this context, we hypothesize that Ca2+ may play an important function in the wave propagation. Our results demonstrate that enhancing Ca2+ influx into the cells by topical cortical application of the ionophore A23187 (10 mu M, 50 mu M and 100 mu M solutions) increases the velocity of CSD propagation in a dose-dependent manner, and a much higher dose of this compound (2 mM) triggers CSD. In conclusion, increased Ca2+ influx can be a key element in the induction mechanism of the CSD, and should be assessed in further experimental strategies targeting brain disorders related to CSD. (C) 2013 Elsevier Ireland Ltd. All rights reserved.	[Torrente, Daniel; Gonzalez, Janneth; Barreto, George E.] Pontificia Univ Javeriana, Fac Ciencias, Dept Nutr & Bioquim, Bogota, DC, Colombia; [Mendes-da-Silva, Rosangela Figueiredo; Cunha Lopes, Andreia Albuquerque; Araujo Guedes, Rubem Carlos] Univ Fed Pernambuco, Dept Nutr, Ctr Ciencias Saude, BR-50670901 Recife, PE, Brazil	Guedes, RCA (corresponding author), Univ Fed Pernambuco, Dept Nutr, Ctr Ciencias Saude, Rua Prof Moraes Rego,S-N Cidade Univ, BR-50670901 Recife, PE, Brazil.	guedes.rca@gmail.com	Janneth Gonzalez Santos, M.Sc./AAB-9948-2020; Guedes, Rubem C. A./A-3246-2008; Guedes, Rubem/AAF-3426-2020; Barreto, George E./B-5747-2014; Barreto, George E./AAD-7420-2020	Janneth Gonzalez Santos, M.Sc./0000-0003-2009-3374; Guedes, Rubem C. A./0000-0002-2396-4019; Guedes, Rubem/0000-0002-2396-4019; Barreto, George E./0000-0002-6644-1971; Barreto, George E./0000-0002-6644-1971; Morais, Andreia/0000-0002-9351-2552; Gonzalez, Janneth/0000-0003-4482-256X; Mendes da Silva, Rosangela/0000-0002-4659-1534	PUJ [5024, 4367]; PROLAB IBRO/LARC CNPq - Convenio Brazil/ColombiaConselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ); CNPq (INCT de Neurociencia Translacional) [573604/2008-8]; Edital MCT/CNPqConselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ) [477456/2010-3]; IBN-Net/FinepFinanciadora de Inovacao e Pesquisa (Finep) [4191]	This work was supported in part by PUJ grants IDs 5024 and 4367, and PROLAB IBRO/LARC CNPq - Convenio Brazil/Colombia to GEB, and by CNPq (INCT de Neurociencia Translacional; No. 573604/2008-8); Edital MCT/CNPq 14/2010 (No. 477456/2010-3) and IBN-Net/Finep (No. 4191) to RCAG.	Amancio-dos-Santos A, 2013, EUR J PHARMACOL, V706, P70, DOI 10.1016/j.ejphar.2013.02.047; AMEMORI T, 1987, NEUROSCIENCE, V22, P29, DOI 10.1016/0306-4522(87)90195-3; Brittain MK, 2012, NEUROBIOL DIS, V46, P109, DOI 10.1016/j.nbd.2011.12.051; COLQUHOUN D, 1981, NATURE, V294, P752, DOI 10.1038/294752a0; Erdahl WL, 1995, BIOPHYS J, V69, P2350, DOI 10.1016/S0006-3495(95)80104-9; HANSEN AJ, 1985, PHYSIOL REV, V65, P101; KRAIG RP, 1978, NEUROSCIENCE, V3, P1045, DOI 10.1016/0306-4522(78)90122-7; Kuge Y, 2000, J NEUROL SCI, V176, P114, DOI 10.1016/S0022-510X(00)00327-0; Lauritzen M, 2011, J CEREBR BLOOD F MET, V31, P17, DOI 10.1038/jcbfm.2010.191; Leao AAP, 1944, J NEUROPHYSIOL, V7, P359; MARTINA M, 1994, J MEMBRANE BIOL, V142, P209, DOI 10.1007/BF00234942; PARTRIDGE LD, 1988, TRENDS NEUROSCI, V11, P69, DOI 10.1016/0166-2236(88)90167-1; Racay P, 1996, GEN PHYSIOL BIOPHYS, V15, P273; Shi Y, 2007, BRIT J PHARMACOL, V150, P624, DOI 10.1038/sj.bjp.0706999; SIESJO BK, 1989, J CEREBR BLOOD F MET, V9, P127, DOI 10.1038/jcbfm.1989.20; Smith JM, 2006, BIOL REV, V81, P457, DOI 10.1017/S1464793106007081; Smith MI, 2000, CEPHALALGIA, V20, P546, DOI 10.1046/j.1468-2982.2000.00092.x; Van Harreveld A., 1970, BIBL PSYCHIAT, V143, P62; WANG XY, 1994, J BIOCHEM-TOKYO, V116, P858, DOI 10.1093/oxfordjournals.jbchem.a124607; YOUNG W, 1992, J NEUROTRAUM, V9, pS9	20	17	17	0	9	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	JAN 13	2014	558						87	90		10.1016/j.neulet.2013.11.004			4	Neurosciences	Neurosciences & Neurology	AK5QO	WOS:000338481300017	24246901				2021-06-18	
J	Zhao, GW; Wang, Y; Li, YC; Jiang, ZL; Sun, L; Xi, X; He, P; Wang, GH; Xu, SH; Ma, DM; Ke, KF				Zhao, Guang-Wei; Wang, Yong; Li, Yong -Cai; Jiang, Zheng-Lin; Sun, Li; Xi, Xin; He, Peng; Wang, Guo-Hua; Xu, Shi-Hui; Ma, Dong-Ming; Ke, Kai-Fu			The neuroprotective effect of modified "Shengyu" decoction is mediated through an anti-inflammatory mechanism in the rat after traumatic brain injury	JOURNAL OF ETHNOPHARMACOLOGY			English	Article						Modified "Shengyu" decoction; Rat; Traumatic brain injury; Neuroprotection; Inflammatory response	MOTOR-PERFORMANCE; TRANSGENIC MICE; INFLAMMATION; CYTOKINES; INTERLEUKIN-6; ASTROCYTES; ACTIVATION; MANAGEMENT; MICROGLIA; ISCHEMIA	Ethnopharmacological relevance: "Shengyu" decoction, a traditional Chinese medicine, has been used to treat diseases with deficit in "qi" and "blood" induced frequently by profound loss of blood or by long sores with heavy pus, in which a potential anti-inflammatory effect is implied. The modified "Shengyu" decoction (MSD) used in the present study was designed on the basis of the "Shengyu" decoction, additional four herbs were added in. Many ingredients in these herbs have been demonstrated to be anti-inflammatory and thus MSD may be used for the treatment of traumatic brain injury (TBI). To evaluate the neuroprotective effect and the underlying mechanisms of MSD on the rat brain after TBI. Materials and methods: TBI was induced in the right cerebral cortex of male adult rats using Feeney's weight-drop method. The rats were administered a gavage of MSD (0.5, 1.0 or 2.0 ml/200 g) 6 h after TBI. The neurological functions, brain water content, contusion volume, and neuron loss were determined. The levels of TNF-alpha, IL-1 beta, IL-6, and IL-10 and the number of GFAP- and Iba1-positive cells in the brain ipsilateral to TBI were also measured. Moreover, the influence of MSD on these variables was observed at the same time. Results: The neurological deficits, brain water content, and neuron loss were significantly reduced after 1.0 or 2.0 ml/200 g of MSD treatment but not after 0.5 ml/200 g. In addition, treatment with MSD (1.0 ml/200 g) significantly increased the level of IL-10 and reduced the level of TNF-a and IL-10 and the number of GFAP- and lba1-positive cells after TBI. However, the contusion volume of brain tissue and the expression of IL-6 were not significantly changed. Conclusion: MSD may be a potential therapeutic for the treatment of TBI because MSD alleviated secondary brain injury induced by TBI. In addition, MSD inhibited the inflammatory response through reducing the expression of inflammatory cytokines and the activation of microglial cells and astrocytes in the brain tissue of rats after TBI. Therefore, a potential anti-inflammatory mechanism of the "Shengyu" decoction was confirmed, which may be one of the main reasons of "Shengyu" decoction used to treat diseases with obvious inflammatory responses. (C) 2013 Elsevier Ireland Ltd. All rights reserved.	[Zhao, Guang-Wei; Jiang, Zheng-Lin; Sun, Li; Wang, Guo-Hua] Nantong Univ, Inst Naut Med, Dept Neuropharmacol, Nantong 226001, Jiangsu, Peoples R China; [Li, Yong -Cai; He, Peng; Xu, Shi-Hui; Ma, Dong-Ming] Peoples Hosp Ningxia, Dept Neurosurg, Yinchuan 750021, Ningxia, Peoples R China; [Wang, Yong; Xi, Xin] Peoples Hosp Nantong, Dept Neurosurg & Chinese Med, Nantong 226001, Jiangsu, Peoples R China; [Zhao, Guang-Wei; Jiang, Zheng-Lin; Ke, Kai-Fu] Nantong Univ, Affiliated Hosp, Dept Neurol, Nantong 226001, Jiangsu, Peoples R China; [Zhao, Guang-Wei] Peoples Hosp Gaocheng, Dept Neurol, Hebei 052160, Peoples R China	Li, YC (corresponding author), Nantong Univ, Inst Naut Med, Dept Neuropharmacol, 19 Qixiu Rd, Nantong 226001, Jiangsu, Peoples R China.	yclee7833@hotmail.com; jiangzl@ntu.edu.cn			Natural Science Foundation of Ningxia [NZ10178]	This work was supported by the Natural Science Foundation of Ningxia (Grant NZ10178).	Adamides AA, 2006, ANZ J SURG, V76, P163, DOI 10.1111/j.1445-2197.2006.03674.x; Aloisi F, 2001, GLIA, V36, P165, DOI 10.1002/glia.1106; Bareyre F, 1997, J NEUROTRAUM, V14, P839, DOI 10.1089/neu.1997.14.839; Bermpohl D, 2007, J CEREBR BLOOD F MET, V27, P1806, DOI 10.1038/sj.jcbfm.9600487; Buffo A, 2010, BIOCHEM PHARMACOL, V79, P77, DOI 10.1016/j.bcp.2009.09.014; CAMPBELL IL, 1993, P NATL ACAD SCI USA, V90, P10061, DOI 10.1073/pnas.90.21.10061; Chang H-M, 2001, PHARM APPL CHINESE M; Chao WW, 2010, J ETHNOPHARMACOL, V129, P244, DOI 10.1016/j.jep.2010.03.022; Chew E, 2009, J REHABIL RES DEV, V46, P851, DOI 10.1682/JRRD.2008.09.0120; Chio CC, 2010, J NEUROCHEM, V115, P921, DOI 10.1111/j.1471-4159.2010.06969.x; Chua KSG, 2007, ANN ACAD MED SINGAP, V36, P31; COMBS DJ, 1987, STROKE, V18, P503, DOI 10.1161/01.STR.18.2.503; DEGRABA TJ, 1994, J CEREBR BLOOD F MET, V14, P262, DOI 10.1038/jcbfm.1994.33; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Hanisch UK, 2002, GLIA, V40, P140, DOI 10.1002/glia.10161; Helmy A, 2011, PROG NEUROBIOL, V95, P352, DOI 10.1016/j.pneurobio.2011.09.003; Hernandez-Ontiveros DG, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00030; Heyser CJ, 1997, P NATL ACAD SCI USA, V94, P1500, DOI 10.1073/pnas.94.4.1500; Ji Y.B., 2005, PHARM APPL COMPOUND; Khuman J, 2011, J CEREBR BLOOD F MET, V31, P778, DOI 10.1038/jcbfm.2010.172; Lee HF, 2012, RESP PHYSIOL NEUROBI, V182, P1, DOI 10.1016/j.resp.2012.01.016; Lenzlinger PM, 2001, MOL NEUROBIOL, V24, P169; Liu G.S., 2004, SECRET BOOK ORCHID C, V3; Lucas SM, 2006, BRIT J PHARMACOL, V147, pS232, DOI 10.1038/sj.bjp.0706400; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Middeldorp J, 2011, PROG NEUROBIOL, V93, P421, DOI 10.1016/j.pneurobio.2011.01.005; Rubio-Perez JM, 2012, SCI WORLD J, DOI 10.1100/2012/756357; Morganti-Kossmann Maria Cristina, 2002, Curr Opin Crit Care, V8, P101; Morganti-Kossmann MC, 2001, SHOCK, V16, P165, DOI 10.1097/00024382-200116030-00001; Or TCT, 2011, NEUROPHARMACOLOGY, V60, P823, DOI 10.1016/j.neuropharm.2010.12.002; Raivich G, 1999, BRAIN RES REV, V30, P77, DOI 10.1016/S0165-0173(99)00007-7; Rao VLR, 2000, EXP NEUROL, V161, P102, DOI 10.1006/exnr.1999.7269; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Schneider G, 2002, MAGN RESON MATER PHY, V14, P233, DOI 10.1016/S1352-8661(02)00068-6; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Wang GH, 2011, J NEUROTRAUM, V28, P2123, DOI 10.1089/neu.2011.1939; Wang T, 2012, J NEUROIMMUNOL, V245, P79, DOI 10.1016/j.jneuroim.2012.02.008; Wu Q., 1957, CORRECTION DRUGS PRE, V3; Xia L, 2012, J NEUROSCI RES, V90, P1424, DOI 10.1002/jnr.22811; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	40	17	17	0	12	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0378-8741			J ETHNOPHARMACOL	J. Ethnopharmacol.	JAN 10	2014	151	1					694	703		10.1016/j.jep.2013.11.041			10	Plant Sciences; Chemistry, Medicinal; Integrative & Complementary Medicine; Pharmacology & Pharmacy	Plant Sciences; Pharmacology & Pharmacy; Integrative & Complementary Medicine	AA3TU	WOS:000331017200075	24296086				2021-06-18	
J	Chitsabesan, P; Lennox, C; Theodosiou, L; Law, H; Bailey, S; Shaw, J				Chitsabesan, Prathiba; Lennox, Charlotte; Theodosiou, Louise; Law, Heather; Bailey, Sue; Shaw, Jenny			The development of the comprehensive health assessment tool for young offenders within the secure estate	JOURNAL OF FORENSIC PSYCHIATRY & PSYCHOLOGY			English	Article						young offenders; screening; mental health; physical health; substance misuse and neurodisability	CONCUSSION SYMPTOMS QUESTIONNAIRE; PSYCHIATRIC-DISORDERS; PERSISTENT; NEEDS; YOUTH; BOYS	Health inequalities are high among offending groups. The comprehensive health assessment tool (CHAT) is a semi-structured assessment developed to provide a standardised approach to health screening for all young offenders admitted to the secure estate. The four sections of the CHAT (physical health, mental health, substance misuse and neurodisability) were evaluated within a two-phased study of male adolescents (aged 15-18years) within a young offenders institution in the north-west of England. Within Phase 1, a consecutive sample of 127 new receptions was assessed using the physical health, mental health and substance misuse sections of the CHAT against a range of reference standard assessments. Phase 2 of the study evaluated the neurodisability section on 93 male adolescents against reference standard tools. The four sections of the CHAT demonstrated fair to good convergent validity when compared against reference standard tools in male offenders. The diagnostic accuracy rate was 76% for mental health, 63% for physical health, 83% for substance misuse and 53% for neurodisability when compared against reference standard assessment tools. The introduction of the CHAT offers the opportunity to enhance existing reception screening practices and create an integrated approach to the assessment of health needs across the secure estate.	[Chitsabesan, Prathiba; Lennox, Charlotte; Theodosiou, Louise; Shaw, Jenny] Univ Manchester, Manchester Acad Hlth Sci Ctr, Manchester M13 9PL, Lancs, England; [Law, Heather] Greater Manchester West NHS Fdn Trust, Manchester, Lancs, England; [Bailey, Sue] Univ Cent Lancashire, Sch Social Work, London, England	Chitsabesan, P (corresponding author), Univ Manchester, Manchester Acad Hlth Sci Ctr, Manchester M13 9PL, Lancs, England.	pchitsabesan@nhs.net		Lennox, Charlotte/0000-0001-9014-9965; shaw, jennifer/0000-0003-2569-7687			American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Anastasi A, 1997, PSYCHOL TESTING, V7th; Berument SK, 1999, BRIT J PSYCHIAT, V175, P444, DOI 10.1192/bjp.175.5.444; British Psychological Society, 2001, LEARN DIS DEF CONT; Butcher J., 1992, MMPI A MINNESOTA MUL; Centre for Mental Health, 2010, YOU JUST GET DO IT H; Chitsabesan P, 2006, BRIT J PSYCHIAT, V188, P534, DOI 10.1192/bjp.bp.105.010116; Chitsabesan P, 2007, J CHILD SERV, V2, P4, DOI 10.1108/17466660200700032; Constantino J.N., 2002, SOCIAL RESPONSIVENES; De Meyrick J., 2003, HLTH ED, V103, P7, DOI DOI 10.1108/09654280310459112; Foxcroft C., 2004, PSYCHOL ASSESSMENT S; Golzari M, 2006, J ADOLESCENT HEALTH, V38, P776, DOI 10.1016/j.jadohealth.2005.06.008; Gregory J, 2011, INT J LANG COMM DIS, V46, P202, DOI 10.3109/13682822.2010.490573; Grisso T., 2001, MASSACHUSETTS YOUTH; Harrington R., 2005, MENTAL HLTH NEEDS EF; Hughes N., 2012, NOBODY CONNECTION PR; Johnson M., 1998, CANTERBURY THANET VE; Kaufman A.S., 1990, KAUFMAN BRIEF INTELL; Kaufman J., 1996, SCHEDULE AFFECTIVE D; King G., 2009, BRADLEY REPORT; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kroll L, 2002, LANCET, V359, P1975, DOI 10.1016/S0140-6736(02)08829-3; Lader D, 2000, PSYCHIAT MORBIDITY Y; Lennox C., CRIMINAL BE IN PRESS; Loeber R, 2000, DEV PSYCHOPATHOL, V12, P737, DOI 10.1017/S0954579400004107; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; Meltzer H., 2000, MENTAL HLTH CHILDREN; MOFFITT TE, 1993, PSYCHOL REV, V100, P674, DOI 10.1037/0033-295X.100.4.674; Offender Health Research Network, 2013, COMPR HLTH ASS TOOL; Office of the Children's Commissioner, 2011, I THINK I MUST HAV B; Paley L, 2011, ARCH INTERN MED, V171, P1394, DOI 10.1001/archinternmed.2011.340; Perron Brian E, 2008, Crim Behav Ment Health, V18, P243, DOI 10.1002/cbm.702; Potter S, 2006, J NEUROL, V253, P1603, DOI 10.1007/s00415-006-0275-z; Prison Reform Trust, 2012, FAT FLAW HAS STAT LE; Royal College of Paediatrics and Child Health, 2013, HEALTHC STAND CHILDR; Ryan M., 2012, HLTH WELL BEING NEED; Secord, 1989, TEST LANGUAGE COMPET; Teplin LA, 2002, ARCH GEN PSYCHIAT, V59, P1133, DOI 10.1001/archpsyc.59.12.1133; Vreugdenhil C, 2004, J AM ACAD CHILD PSY, V43, P97, DOI 10.1097/00004583-200401000-00019; Wechsler D., 1991, WECHSLER INTELLIGENC; Williams H, 2010, TLS-TIMES LIT SUPPL, P20; World Health Organization, 1992, ICD 10 CLASS MENT BE; Youth Justice Board, 2012, SUBST MIS INT YOUNG	43	17	17	1	9	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1478-9949	1478-9957		J FORENSIC PSYCHI PS	J. Forensic Psychiatry Psychol.	JAN 2	2014	25	1					1	25		10.1080/14789949.2014.882387			25	Criminology & Penology; Psychiatry	Criminology & Penology; Psychiatry	303QZ	WOS:000330690600001					2021-06-18	
J	Cifu, DX; Hoke, KW; Wetzel, PA; Wares, JR; Gitchel, G; Carne, W				Cifu, David X.; Hoke, Kathy W.; Wetzel, Paul A.; Wares, Joanna R.; Gitchel, George; Carne, William			Effects of hyperbaric oxygen on eye tracking abnormalities in males after mild traumatic brain injury	JOURNAL OF REHABILITATION RESEARCH AND DEVELOPMENT			English	Article						blast injury; blinded; concussion; eye tracking; hyperbaric oxygen; postconcussive syndrome; randomized; saccades; sham controlled; traumatic brain injury	POST-CONCUSSION SYNDROME; POSTTRAUMATIC-STRESS-DISORDER; NEURAL STEM-CELLS; POSTCONCUSSION SYMPTOMS; THERAPY; RATS; PERSISTENT; MOVEMENTS; MILITARY; RECOVERY	The effects of hyperbaric oxygen (HBO2) on eye movement abnormalities in 60 military servicemembers with at least one mild traumatic brain injury (mTBI) from combat were examined in a single-center, randomized, double-blind, sham-controlled, prospective study at the Naval Medicine Operational Training Center. During the 10 wk of the study, each subject was delivered a series of 40, once a day, hyperbaric chamber compressions at a pressure of 2.0 atmospheres absolute (ATA). At each session, subjects breathed one of three preassigned oxygen fractions (10.5%, 75%, or 100%) for 1 h, resulting in an oxygen exposure equivalent to breathing either surface air, 100% oxygen at 1.5 ATA, or 100% oxygen at 2.0 ATA, respectively. Using a standardized, validated, computerized eye tracking protocol, fixation, saccades, and smooth pursuit eye movements were measured just prior to intervention and immediately postintervention. Between-and within-groups testing of pre-and postintervention means revealed no significant differences on eye movement abnormalities and no significant main effect for HBO2 at either 1.5 ATA or 2.0 ATA equivalent compared with the sham-control. This study demonstrated that neither 1.5 nor 2.0 ATA equivalent HBO2 had an effect on postconcussive eye movement abnormalities after mTBI when compared with a sham-control.	[Cifu, David X.; Carne, William] Virginia Commonwealth Univ, Dept PM&R, Richmond, VA 23298 USA; [Cifu, David X.] US Dept Vet Affairs, Phys Med & Rehabil Program Off, Richmond, VA USA; [Hoke, Kathy W.; Wares, Joanna R.] Univ Richmond, Dept Math & Comp Sci, Richmond, VA 23173 USA; [Wetzel, Paul A.; Gitchel, George] Virginia Commonwealth Univ, Dept Biomed Engn, Richmond, VA 23298 USA	Carne, W (corresponding author), Virginia Commonwealth Univ, Dept PM&R, 1223 East Marshall St, Richmond, VA 23298 USA.	lasile@aol.com		Cifu, David/0000-0003-1600-9387	Air Force Medical Support Agency Medical Modernization Directorate; 711th Human Performance Wing; U.S. Navy Bureau of Medicine and Surgery; U.S. Army Medical Materiel Development Activity; Defense Advanced Research Projects AgencyUnited States Department of DefenseDefense Advanced Research Projects Agency (DARPA) [N66001-09-2-206]; Defense and Veterans Brain Injury CenterUS Department of Veterans Affairs; U.S. Army Medical Research Acquisition Activity [W81XWH-08-2-0178]; DoDUnited States Department of Defense; VA Chronic Effects of Neurotrauma Consortium [W81XWH-13-2-0095]	This material was based on work funded by the Air Force Medical Support Agency Medical Modernization Directorate and the 711th Human Performance Wing for the primary study, the U.S. Navy Bureau of Medicine and Surgery for contract funding temporary duty requirements, and the U.S. Army Medical Materiel Development Activity for end of study contract funding. Dr. Cifu's efforts were supported, in part, through a Defense Advanced Research Projects Agency grant (N66001-09-2-206) and a contract from the U.S. Army Medical Materiel Development Activity. Dr. Carne's efforts were supported, in part, through contracts from the U.S. Army Medical Materiel Development Activity and the Defense and Veterans Brain Injury Center. This work was funded primarily by the U.S. Army Medical Research Acquisition Activity (award W81XWH-08-2-0178) with support from the Defense and Veterans Brain Injury Center. Following completion of the study, additional support came from the DoD and VA Chronic Effects of Neurotrauma Consortium (grant W81XWH-13-2-0095).	Cifu D.X., 2009, CRIT REV PHYS REHABI, V21, P197, DOI DOI 10.1615/CRITREVPHYSREHABI1MED.V2113-4.10; Cifu DX, 2014, ANN NEUROL, V75, P277, DOI 10.1002/ana.24067; Cifu DX, 2014, J HEAD TRAUMA REHAB, V29, P11, DOI 10.1097/HTR.0b013e3182a6aaf0; Cifu DX, 2013, J REHABIL RES DEV, V50, P1169, DOI 10.1682/JRRD.2013.01.0006; Cifu DX, 2014, J HEAD TRAUMA REHABI; Cifu DX, 2011, OVERCOMING POSTDEVEL; Eyres S, 2005, CLIN REHABIL, V19, P878, DOI 10.1191/0269215505cr905oa; Gesell L.B., 2008, HYPERBARIC OXYGEN TH, V12th; Harch P.G., 2002, P 2 INT S HYP OXYG C; Harch PG, 2012, J NEUROTRAUM, V29, P168, DOI 10.1089/neu.2011.1895; Heitger MH, 2007, J REHABIL MED, V39, P612, DOI 10.2340/16501977-0100; Heitger MH, 2009, BRAIN, V132, P2850, DOI 10.1093/brain/awp181; HEITGER MH, 2008, C P IEEE ENG MED BIO, P3570; Kraus MF, 2007, COGN BEHAV NEUROL, V20, P170, DOI 10.1097/WNN.0b013e318142badb; Lange RT, 2013, J NEUROTRAUM, V30, P958, DOI 10.1089/neu.2012.2743; Leigh R. J., 2006, NEUROLOGY EYE MOVEME; Lew HL, 2007, J REHABIL RES DEV, V44, P1027, DOI 10.1682/JRRD.2007.05.0073; Palzur E, 2008, BRAIN RES, V1221, P126, DOI 10.1016/j.brainres.2008.04.078; Peng ZY, 2008, BRAIN RES, V1212, P71, DOI 10.1016/j.brainres.2008.03.027; Ramat S, 2007, BRAIN, V130, P10, DOI 10.1093/brain/awl309; Rockswold SB, 2007, NEUROL RES, V29, P162, DOI 10.1179/016164107X181798; Rockswold SB, 2010, J NEUROSURG, V112, P1080, DOI 10.3171/2009.7.JNS09363; Suh M, 2006, NEUROSCI LETT, V401, P108, DOI 10.1016/j.neulet.2006.02.074; Taylor BC, 2012, MED CARE, V50, P342, DOI 10.1097/MLR.0b013e318245a558; Walker RL, 2010, PSYCHOL SERV, V7, P136, DOI 10.1037/a0019684; Wang XL, 2008, BRAIN RES, V1222, P87, DOI 10.1016/j.brainres.2008.05.016; Wang XL, 2007, NEUROREPORT, V18, P1753, DOI 10.1097/WNR.0b013e3282f0ec09; Weaver LK, 2012, UNDERSEA HYPERBAR M, V39, P807; Wolf G, 2012, J NEUROTRAUM, V29, P2606, DOI 10.1089/neu.2012.2549; Yang YJ, 2008, UNDERSEA HYPERBAR M, V35, P113; Zhou ZW, 2007, J NEUROSURG, V106, P687, DOI 10.3171/jns.2007.106.4.687	31	17	17	0	7	JOURNAL REHAB RES & DEV	BALTIMORE	DEPT OF VETERANS AFFAIRS REHABIL RES & DEVELOP CTR 103 SOUTH GAY STREET, BALTIMORE, MD 21202-4051 USA	0748-7711	1938-1352		J REHABIL RES DEV	J. Rehabil. Res. Dev.		2014	51	7					1047	1055		10.1682/JRRD.2014.01.0013			9	Rehabilitation	Rehabilitation	AU8JB	WOS:000345841300004	25436771	Bronze			2021-06-18	
J	Cotrena, C; Branco, LD; Zimmermann, N; Cardoso, CO; Grassi-Oliveira, R; Fonseca, RP				Cotrena, Charles; Branco, Laura Damiani; Zimmermann, Nicolle; Cardoso, Caroline Oliveira; Grassi-Oliveira, Rodrigo; Fonseca, Rochele Paz			Impaired decision-making after traumatic brain injury: The Iowa Gambling Task	BRAIN INJURY			English	Article						Decision-making; executive functions; Iowa Gambling Task; traumatic brain injury	DIFFUSE AXONAL INJURY; PREFRONTAL CORTEX; NEUROPSYCHIATRIC COMPLICATIONS; FUTURE CONSEQUENCES; HEAD-INJURY; PERFORMANCE; DAMAGE; DIAGNOSIS; SEQUELAE; LESIONS	The Summary: The aim of the present study was to use the Iowa Gambling Task (IGT) to investigate differences in decision-making (DM) between patients who sustained TBI and healthy subjects, while controlling for age, education and gender. Methods: A hundred and ten participants, half of whom had severe or mild TBI, completed the IGT. Results: Differences between control participants and patients with TBI were found regarding total net score, block score, number of selections from each deck and classification of performance as impaired or unimpaired. No significant differences in IGT performance were found between patients with and without frontal lesions and between patients with mild and severe TBI. Conclusions: Results indicate poor DM on the IGT in patients with TBI, regardless of lesion location and severity. The instrument proved to be equally sensitive to both frontal and extrafrontal lesions and did not differentiate between patients with mild and severe TBI.	[Cotrena, Charles; Branco, Laura Damiani; Zimmermann, Nicolle; Cardoso, Caroline Oliveira; Grassi-Oliveira, Rodrigo; Fonseca, Rochele Paz] Pontificia Univ Catolica Rio Grande do Sul, Dept Psychol, Porto Alegre, RS, Brazil	Cotrena, C (corresponding author), Pontificia Univ Catolica Rio Grande do Sul, Dept Psychol, Clin & Expt Neuropsychol Res Grp, Av Ipiranga,6681 Predio 11-9 Andar,Sala 932, Porto Alegre, RS, Brazil.	c.cotrena@gmail.com	Branco, Laura Damiani/I-7438-2019; Grassi-Oliveira, R/G-2623-2012; Cotrena, Charles/J-7979-2014	Grassi-Oliveira, R/0000-0001-9911-5921; Cotrena, Charles/0000-0002-3573-7809; Cardoso, Caroline/0000-0002-3720-0845; Branco, Laura Damiani/0000-0001-7967-7142; ZIMMERMANN, NICOLLE/0000-0003-4771-4070			ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Anderson CV, 1995, J CLIN EXP NEUROPSYC, V17, P900, DOI 10.1080/01688639508402438; Bechara A, 2000, CEREB CORTEX, V10, P295, DOI 10.1093/cercor/10.3.295; Bechara A, 2002, NEUROPSYCHOLOGIA, V40, P1675, DOI 10.1016/S0028-3932(02)00015-5; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; Bechara A, 1996, CEREB CORTEX, V6, P215, DOI 10.1093/cercor/6.2.215; Bechara A., 2007, IOWA GAMBLING TASK P; Bonatti E, 2008, COGN BEHAV NEUROL, V21, P164, DOI 10.1097/WNN.0b013e318184e688; Bootes K, 2010, WORK, V36, P207, DOI [10.3233/WOR-2010-1021, 10.3233/WOR-2010-01021]; CHAVES MLF, 1992, ACTA NEUROL SCAND, V85, P378; Damasio A., 1996, ERRO DESCARTES EMOCA; Fellows LK, 2007, CEREB CORTEX, V17, P2669, DOI 10.1093/cercor/bhl176; Fonseca R. P., 2012, METODOS NEUROCIENCIA, P300; Fonseca Rochele Paz, 2012, Psychol. Neurosci., V5, P183, DOI 10.3922/j.psns.2012.2.08; Fonseca Rochele Paz, 2008, Psychol. Neurosci., V1, P55, DOI 10.1590/S1983-32882008000100009; Fork M, 2005, BRAIN INJURY, V19, P101, DOI 10.1080/02699050410001726086; Fujiwara E, 2008, NEUROPSYCHOLOGIA, V46, P461, DOI 10.1016/j.neuropsychologia.2007.08.027; Garcia-Molina A, 2007, NEUROLOGIA, V22, P206; Gould KR, 2011, PSYCHOL MED, V41, P2099, DOI 10.1017/S003329171100033X; Hanten G, 2006, NEUROCASE, V12, P247, DOI 10.1080/13554790600910490; Iverson GL, 2011, LITTLE BLACK BOOK OF NEUROPSYCHOLOGY: A SYNDROME-BASED APPROACH, P663, DOI 10.1007/978-0-387-76978-3_21; Kim E, 2007, J NEUROPSYCH CLIN N, V19, P106, DOI 10.1176/appi.neuropsych.19.2.106; Levin HS, 2010, J NEUROTRAUM, V27, P683, DOI 10.1089/neu.2009.1073; Levine B, 2005, COGN BEHAV NEUROL, V18, P45, DOI 10.1097/01.wnn.0000152227.13001.c3; LEZAK MD, 1998, NEUROPSYCHOLOGICAL A; Li XR, 2010, HUM BRAIN MAPP, V31, P410, DOI 10.1002/hbm.20875; MacPherson SE, 2009, CLIN NEUROPSYCHOL, V23, P510, DOI 10.1080/13854040802396586; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Reeves RR, 2011, J PSYCHOSOC NURS MEN, V49, P42, DOI 10.3928/02793695-20110201-03; Rogers JM, 2007, BRAIN INJURY, V21, P1321, DOI 10.1080/02699050701765700; Schneider Daniela Di Giorgio, 2006, Psicol. Reflex. Crit., V19, P442, DOI 10.1590/S0102-79722006000300013; Sigurdardottir S, 2010, NEUROPSYCHOLOGY, V24, P504, DOI 10.1037/a0018934; Stuss DT, 2002, ANNU REV PSYCHOL, V53, P401, DOI 10.1146/annurev.psych.53.100901.135220; TEASDALE G, 1974, LANCET, V2, P81; Temkin NR, 2009, J HEAD TRAUMA REHAB, V24, P460, DOI 10.1097/HTR.0b013e3181c13413; van Noordt S, 2011, BRAIN INJURY, V25, P707, DOI 10.3109/02699052.2011.580312; Wiederkehr S, 2005, REV NEUROL-FRANCE, V161, P201, DOI 10.1016/S0035-3787(05)85023-4; Xu J, 2007, J NEUROTRAUM, V24, P753, DOI 10.1089/neu.2006.0208; Yacubian J, 2007, NEUROIMAGE, V38, P557, DOI 10.1016/j.neuroimage.2007.08.007; Zgaljardic DJ, 2010, APPL NEUROPSYCHOL, V17, P283, DOI 10.1080/09084282.2010.525118	40	17	18	0	6	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2014	28	8					1070	1075		10.3109/02699052.2014.896943			6	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	AI6KP	WOS:000336983200007	24654680				2021-06-18	
J	Dyer, K; das Nair, R				Dyer, Kerry; das Nair, Roshan			Talking about sex after traumatic brain injury: perceptions and experiences of multidisciplinary rehabilitation professionals	DISABILITY AND REHABILITATION			English	Article						Rehabilitation; sexuality; traumatic brain injury	QUALITY-OF-LIFE; HEAD-INJURY; SEXUALITY; HEALTH; ISSUES; SATISFACTION; DYSFUNCTION; PREDICTORS; DISABILITY; ADJUSTMENT	Purpose: Research indicates that although 50-60% of people who have had a traumatic brain injury (TBI) experience changes in sexual functioning, sexuality issues remain largely unaddressed in rehabilitation. This study aimed to explore rehabilitation professionals' perceptions and experiences of discussing sexuality with service-users who have had a TBI. Method: Purposeful sampling was used to recruit 24 participants from two local National Health Service trusts and from a national charity. Four focus groups were conducted with pre-existing groups of professionals, using a semi-structured interview schedule. Focus group data were transcribed verbatim and analysed using thematic analysis. Results: Six main themes were derived from the analysis: (1) sexuality after TBI is a specialist issue; (2) sexuality is a sensitive subject; (3) practicalities of discussing sexuality; (4) roles and responsibilities; (5) dilemmas about risk and vulnerabilities; and (6) organisational and structural issues. Conclusions: Our findings suggest that a more proactive approach to addressing sexuality issues be taken by incorporating sexuality into assessments and by having sexuality information available for service-users. Support for professionals is also needed in the form of the development of policy, on-going training and supervision.	[Dyer, Kerry] Lincoln Univ, Inst Hlth Life & Social Sci, Lincoln, England; [das Nair, Roshan] Univ Nottingham, Div Psychiat & Appl Psychol, Nottingham NG7 2RD, England; [das Nair, Roshan] Univ Nottingham, Div Rehabil & Ageing, Nottingham NG7 2RD, England	Dyer, K (corresponding author), Lincoln Univ, Inst Hlth Life & Social Sci, Lincoln, England.	kerry_dyer@hotmail.co.uk		das Nair, Roshan/0000-0001-8143-7893			Annon JS., 1976, J SEX EDUC THER, V2, P1, DOI [10.1080/01614576.1976.11074483, DOI 10.1080/01614576.1976.11074483]; Arango-Lasprilla JC, 2008, BRAIN INJURY, V22, P565, DOI 10.1080/02699050802172004; Baker M., 2010, SOCIAL CARE NEURODIS, V1, P4, DOI [https://doi.org/10.5042/scn.2010.0597, DOI 10.5042/SCN.2010.0597]; Blackerby W, 1987, NATL HEAD INJURY FDN, V7, P8; Blackerby WF, 1990, J HEAD TRAUMA REHAB, V5, P73; Braun V., 2006, QUALITATIVE RES PSYC, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706qp063oa]; Cellek S, 2012, NAT REV UROL, V9, P537, DOI 10.1038/nrurol.2012.134; Cote-Arsenault D, 1999, NURS RES, V48, P280; Creswell JW, 2000, THEOR PRACT, V39, P124, DOI 10.1207/s15430421tip3903_2; Dattilo J, 2005, J HOLIST NURS, V23, P208, DOI 10.1177/0898010105275839; DAVIS DL, 1990, J HEAD TRAUMA REHAB, V5, P31, DOI DOI 10.1097/00001199-199005020-00006; Davis S, 2006, REHABILITATION USE T, V25; *DEP HLTH, 2001, NAT STRAT SEX HLTH; Department of Health, 2010, HLTH LIV HLTH PEOPL; Ducharme S, 1991, SEX UPDATE, V4, P8; DUCHARME S, 1990, J HEAD TRAUMA REHAB, V5, P38, DOI DOI 10.1097/00001199-199005020-00007; DUCHARME S, 1997, SEXUALITY SPINAL COR; Dyer K, 2013, J SEX MED, V10, P2658, DOI 10.1111/j.1743-6109.2012.02856.x; Earle S, 2001, J ADV NURS, V36, P433, DOI 10.1046/j.1365-2648.2001.01991.x; Gianotten W.L., 2006, SEX RELATSH THER, V21, P303, DOI [DOI 10.1080/14681990600754559, 10.1080/14681990600754559]; Glass CA, 1995, J MENT HEALTH, P251; Godwin EE, 2011, J HEAD TRAUMA REHAB, V26, P43, DOI 10.1097/HTR.0b013e3182048f54; Gott M, 2004, SOC SCI MED, V58, P2093, DOI 10.1016/j.socscimed.2003.08.025; Gott M, 2004, FAM PRACT, V21, P528, DOI 10.1093/fampra/cmh509; Guthrie C, 1999, J CLIN NURS, V8, P313, DOI 10.1046/j.1365-2702.1999.00253.x; Haboubi NHJ, 2003, DISABIL REHABIL, V25, P291, DOI 10.1080/0963828021000031188; Hall KM., 1993, J HEAD TRAUMA REHAB, V8, DOI [DOI 10.1097/00001199-199308020-00008, 10.1097/00001199-199308020-00008]; Harris AJR, 2004, J APPL RES INTELLECT, V17, P235, DOI 10.1111/j.1468-3148.2004.00211.x; Herson L, 1999, Rehabil Nurs, V24, P148; Hordern AJ, 2007, MED J AUSTRALIA, V186, P224, DOI 10.5694/j.1326-5377.2007.tb00877.x; HOUGH S, 1989, PSYCHOL REP, V65, P745, DOI 10.2466/pr0.1989.65.3.745; Jefferson G., 1984, STRUCTURES SOCIAL AC, pIX; Johnson CL, 2010, REHABIL PSYCHOL, V55, P180, DOI 10.1037/a0019480; Katz S, 1999, INT J REHABIL RES, V22, P45, DOI 10.1097/00004356-199903000-00006; KITZINGER J, 1995, BRIT MED J, V311, P299, DOI 10.1136/bmj.311.7000.299; KOSTELJANETZ M, 1981, ACTA NEUROL SCAND, V63, P169; Kreuter M, 1998, BRAIN INJURY, V12, P349, DOI 10.1080/026990598122494; Kreutzer J S, 1989, Brain Inj, V3, P177, DOI 10.3109/02699058909004550; Lincoln Y.S., 1985, NATURALISTIC INQUIRY, V75; Madriz E., 2000, HDB QUALITATIVE RES, P835; Magnan Morris A, 2005, Medsurg Nurs, V14, P282; Marwick C, 1999, JAMA-J AM MED ASSOC, V281, P2132; MATOCHA LK, 1993, RES NURS HEALTH, V16, P371, DOI 10.1002/nur.4770160508; McCabe MP, 2000, SEX DISABIL, V18, P115, DOI 10.1023/A:1005562813603; McLaughlin J, 2005, SEX DISABIL, V23, P213, DOI 10.1007/s11195-005-8929-9; MEDLAR T, 1990, J HEAD TRAUMA REHAB, V5, P46; MILLER BL, 1986, J NEUROL NEUROSUR PS, V49, P867, DOI 10.1136/jnnp.49.8.867; MILLER L, 1994, J COGNITIVE REHABILI, V12, P12; Nomejko A, 2011, POL J APP PSYCHOL, V9, P65; Northcott R, 2000, BR J OCCUP THER, V63, P412, DOI DOI 10.1177/030802260006300902; O'CARROLL R E, 1991, Brain Injury, V5, P303, DOI 10.3109/02699059109008100; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; Ponsford J, 2003, NEUROPSYCHOL REHABIL, V13, P275, DOI 10.1080/09602010244000363; Price B, 2010, CANC NURS PRACT, V9, P29; Rathus SA, 2005, HUMAN SEXUALITY WORL; Rubin Rona, 2005, Nurs Stand, V19, P33; SABHESAN S, 1989, ARCH SEX BEHAV, V18, P349, DOI 10.1007/BF01541953; Sim J, 1998, J ADV NURS, V28, P345, DOI 10.1046/j.1365-2648.1998.00692.x; Simpson G., 2001, BRAIN IMPAIR, V2, P97, DOI [https://doi.org/10.1375/brim.2.2.97, DOI 10.1375/BRIM.2.2.97]; Taleporos G, 2002, SEX DISABIL, V20, P177, DOI 10.1023/A:1021493615456; TATE RL, 1989, J NEUROL NEUROSUR PS, V52, P1128, DOI 10.1136/jnnp.52.10.1128; Taylor B, 2007, SEX DISABIL, V25, P135, DOI 10.1007/s11195-007-9044-x; Turner-Stokes L, 1999, CLIN REHABIL, V13, P277, DOI 10.1191/026921599676896799; WATERHOUSE J, 1991, J ADV NURS, V16, P1048, DOI 10.1111/j.1365-2648.1991.tb03365.x; Wedcliffe T, 2001, S Afr J Commun Disord, V48, P77; Westcott H., 1994, EQUAL TERMS WORKING, P190; Wilkinson S, 1998, HLTH PSYCHOL, V3, P329, DOI DOI 10.1177/135910539800300304; Wood RL, 1997, BRAIN INJURY, V11, P491, DOI 10.1080/713802183; World Health Organization, 2001, INT CLASS FUNCT DIS; World Health Organization, 2012, SEX DRAFT WORK DEF; Zinn W M, 1981, Int Rehabil Med, V3, P18	71	17	17	0	10	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.		2014	36	17					1431	1438		10.3109/09638288.2013.859747			8	Rehabilitation	Rehabilitation	AN8XG	WOS:000340888500006	24286234	Green Accepted			2021-06-18	
J	Ekici, MA; Uysal, O; Cikriklar, HI; Ozbek, Z; Cosan, DT; Baydemir, C; Kazanci, B; Hafizoglu, D				Ekici, M. A.; Uysal, O.; Cikriklar, H. I.; Ozbek, Z.; Cosan, D. Turgut; Baydemir, C.; Kazanci, B.; Hafizoglu, D.			Effect of etanercept and lithium chloride on preventing secondary tissue damage in rats with experimental diffuse severe brain injury	EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES			English	Article						Traumatic brain injury; Etanercept; Lithium chloride; TNF-alpha	NECROSIS-FACTOR-ALPHA; SPINAL-CORD-INJURY; FIBRILLARY ACIDIC PROTEIN; FOCAL CEREBRAL-ISCHEMIA; TAU-PROTEIN; RHEUMATOID-ARTHRITIS; NEURONAL DAMAGE; TNF-ALPHA; EXPRESSION; MODEL	OBJECTIVE: Studies in animals have provided key evidence that antagonizing TNF-alpha is a viable therapeutic strategy for diffuse severe brain injury. This study is planned to prevent post-traumatic secondary tissue damages in rat diffuse severe brain injury model, which is induced by alone or combined administration of Etanercept and lithium chloride (LiCl). MATERIALS AND METHODS: Male SpragueDawley rats were used in the current study. Rats were divided into 5 groups. Trauma was not induced and treatment was not applied to rats of Sham group. For rats of Trauma+Saline group, saline 0.9% was administered via intraperitoneal (i.p.) route at dose of 1 mg/100 g body weight 1 hour after trauma. For rats of Trauma+Etanercept group, Etanercept was administered via i.p. route at dose of 5 mg/kg body weight 1 hour after trauma. For rats of Trauma+LiCl group, LiCl was administered via i.p. route at dose of 50 mg/kg body weight 1 hour after trauma. For rats of Etanercept+LiCl group, Etanercept and LiCl were administered via i.p. route at dose of 5 mg/kg body weight and 50 mg/kg body weight, respectively, 1 hour after trauma. Serum glial fibrillary acidic protein (GFAP) and Tau levels were analyzed with ELISA. For analyses H&E, TUNEL, GFAP and TNF-alpha staining methods were used. RESULTS: We demonstrate that Etanercept treatment reduced the TBI-induced brain tissues alteration, reduced the expression of TNF-alpha and improve edema and axonal swelling. We observed a significant decrease in TNF-alpha and GFAP positivity after LiCl was administered. CONCLUSIONS: The findings obtained in this study suggest that the combination therapy with Etanercept and LiCl decreased neuronal degeneration and alleviated secondary tissue damage in post-traumatic period.	[Ekici, M. A.] Sevket Yilmaz Res & Training Hosp, Neurosurg Clin, Minist Hlth, Bursa, Turkey; [Uysal, O.] Eskisehir Osmangazi Univ, Vocat Sch Hlth Serv, Eskisehir, Turkey; [Cikriklar, H. I.] Sevket Yilmaz Res & Training Hosp, Emergency Clin, Minist Hlth, Bursa, Turkey; [Ozbek, Z.] Eskisehir Osmangazi Univ, Fac Med, Dept Neurosurg, Eskisehir, Turkey; [Cosan, D. Turgut] Eskisehir Osmangazi Univ, Fac Med, Dept Med Biol, Eskisehir, Turkey; [Baydemir, C.] Eskisehir Osmangazi Univ, Fac Med, Dept Biostat, Eskisehir, Turkey; [Kazanci, B.] Ufuk Univ, Fac Med, Dept Neurosurg, Ankara, Turkey; [Hafizoglu, D.] Uludag Univ, Fac Med, Dept Pediat Immunol, Bursa, Turkey	Uysal, O (corresponding author), Eskisehir Osmangazi Univ, Vocat Sch Hlth Serv, Eskisehir, Turkey.	ouysal1971@gmail.com	Cosan, Didem Turgut/ABC-1466-2020; Ekici, Mehmet Ali/ABE-1571-2020; UYSAL, ONUR/W-4144-2017; cikriklar, halil ibrahim/AAH-8714-2021	Cosan, Didem Turgut/0000-0002-8488-6405; UYSAL, ONUR/0000-0001-6800-5607; 			Albert-WeiSSenberger Christiane, 2012, Exp Transl Stroke Med, V4, P1, DOI 10.1186/2040-7378-4-1; Ananiadou Olga G, 2005, Interact Cardiovasc Thorac Surg, V4, P597; Campbell SJ, 2007, J NEUROCHEM, V103, P2245, DOI 10.1111/j.1471-4159.2007.04928.x; Chen G, 2008, MEDIAT INFLAMM, V2008, DOI 10.1155/2008/716458; Chen SF, 2007, LIFE SCI, V81, P288, DOI 10.1016/j.lfs.2007.05.023; Chen YM, 2003, J CEREBR BLOOD F MET, V23, P137, DOI 10.1097/01.WCB.0000044631.80210.3C; Chio CC, 2010, J NEUROCHEM, V115, P921, DOI 10.1111/j.1471-4159.2010.06969.x; Conroy BP, 2001, ANN THORAC SURG, V71, P1325, DOI 10.1016/S0003-4975(01)02401-8; Das M, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-236; Fix AS, 1996, TOXICOL PATHOL, V24, P291, DOI 10.1177/019262339602400305; Genovese T, 2007, NEUROSCIENCE, V150, P168, DOI 10.1016/j.neuroscience.2007.06.059; Genovese T, 2006, J PHARMACOL EXP THER, V316, P1006, DOI 10.1124/jpet.105.097188; Gong C, 1998, BRAIN RES, V801, P1, DOI 10.1016/S0006-8993(98)00489-2; Hang CH, 2004, BRAIN RES, V1026, P23, DOI 10.1016/j.brainres.2004.07.090; Hausmann R, 2000, INT J LEGAL MED, V113, P70, DOI 10.1007/PL00007711; Herrera DG, 1998, BRAIN RES, V784, P71, DOI 10.1016/S0006-8993(97)01162-1; Hortobagyi T, 2008, ACNR, V8, P16; Irazuzta JE, 2001, BRAIN RES, V913, P95, DOI 10.1016/S0006-8993(01)02764-0; Isaksson J, 2001, ACTA NEUROPATHOL, V102, P246; Kalayci M, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-75; Kato K, 2010, J NEUROSCI RES, V88, P360, DOI 10.1002/jnr.22202; Khan M, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-32; Kita T, 1997, INT J LEGAL MED, V110, P305, DOI 10.1007/s004140050093; Lafuente JV, 2007, NEUROSCI RES, V57, P354, DOI 10.1016/j.neures.2006.11.005; Lee EJ, 2010, ANN DERMATOL, V22, P138, DOI 10.5021/ad.2010.22.2.138; Li FH, 2002, AM J NEURORADIOL, V23, P180; Liliang PC, 2010, RESUSCITATION, V81, P1205, DOI 10.1016/j.resuscitation.2010.05.016; Lin HW, 2006, J NEUROINFLAMM, V3, DOI 10.1186/1742-2094-3-15; LIU T, 1994, STROKE, V25, P1481, DOI 10.1161/01.STR.25.7.1481; Lopez NE, 2012, J TRAUMA ACUTE CARE, V72, P1562, DOI 10.1097/TA.0b013e3182569875; Lopez NE, 2012, J NEUROTRAUM, V29, P385, DOI 10.1089/neu.2011.2053; Mao M, 2006, NEUROSCI LETT, V403, P227, DOI 10.1016/j.neulet.2006.03.078; Marchand F, 2009, EUR J PAIN, V13, P673, DOI 10.1016/j.ejpain.2008.08.001; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Moreland LW, 1997, NEW ENGL J MED, V337, P141, DOI 10.1056/NEJM199707173370301; Myer DJ, 2006, BRAIN, V129, P2761, DOI 10.1093/brain/awl165; Neher MD, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-90; Oshima T, 2009, BRAIN RES, V1290, P102, DOI 10.1016/j.brainres.2009.07.022; Park E, 2008, CAN MED ASSOC J, V178, P1163, DOI 10.1503/cmaj.080282; Pettigrew LC, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-47; Sairanen T, 2001, STROKE, V32, P1750, DOI 10.1161/01.STR.32.8.1750; Schmidt OI., 2004, EUR J TRAUMA, V30, P135, DOI [10.1007/s00068-004-1394-9, DOI 10.1007/S00068-004-1394-9]; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Shojo H, 2006, BRAIN RES, V1078, P198, DOI 10.1016/j.brainres.2006.01.063; Smith DH, 2000, NEUROSCIENTIST, V6, P483, DOI 10.1177/107385840000600611; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Sriram K, 2006, FASEB J, V20, P670, DOI 10.1096/fj.05-5106com; Su HX, 2009, J NEUROCHEM, V108, P1385, DOI 10.1111/j.1471-4159.2009.05902.x; Tweedie D, 2007, CURR ALZHEIMER RES, V4, P378, DOI 10.2174/156720507781788873; Umeda N, 2010, INTERNAL MED, V49, P187, DOI 10.2169/internalmedicine.49.2439; Williams AJ, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-17; Woiciechowsky C, 2004, MED SCI MONITOR, V10, pBR325; Wong YW, 2011, SPINAL CORD, V49, P94, DOI 10.1038/sc.2010.69; Wunderlich MT, 2006, CLIN NEUROL NEUROSUR, V108, P558, DOI 10.1016/j.clineuro.2005.12.006; Yang LQ, 2005, J CLIN NEUROSCI, V12, P276, DOI 10.1016/j.jocn.2004.06.011; Young W, 2009, CELL TRANSPLANT, V18, P951, DOI 10.3727/096368909X471251; Yu CH, 2011, J VET SCI, V12, P299, DOI 10.4142/jvs.2011.12.3.299; Yu HM, 2004, NEUROPATHOLOGY, V24, P136, DOI 10.1111/j.1440-1789.2003.00539.x; Zurek J, 2012, ACTA NEUROCHIR, V154, P93, DOI 10.1007/s00701-011-1175-2	59	17	17	0	8	VERDUCI PUBLISHER	ROME	VIA GREGORIO VII, ROME, 186-00165, ITALY	1128-3602			EUR REV MED PHARMACO	Eur. Rev. Med. Pharmacol. Sci.	JAN	2014	18	1					10	27					18	Pharmacology & Pharmacy	Pharmacology & Pharmacy	AA9TV	WOS:000331436700002	24452937				2021-06-18	
J	Norris, JN; Sams, R; Lundblad, P; Frantz, E; Harris, E				Norris, Jacob N.; Sams, Richard; Lundblad, Peter; Frantz, Earl; Harris, Erica			Blast-related mild traumatic brain injury in the acute phase: Acute stress reactions partially mediate the relationship between loss of consciousness and symptoms	BRAIN INJURY			English	Article						Acute stress; blast-injury; combat; loss of consciousness; mild traumatic brain injury	SPORT-RELATED CONCUSSION; NEUROPSYCHOLOGICAL ASSESSMENT METRICS; PERSISTENT POSTCONCUSSIVE SYMPTOMS; HEAD-INJURY; SERVICE MEMBERS; DISORDER; MILITARY; SOLDIERS; IRAQ; VETERANS	Primary objective: The objective was to compare symptoms in service members diagnosed with a blast-related mTBI (mild traumatic brain injury) with a loss of consciousness (LOC) to those without LOC. Research design: Clinicians saw US military personnel within 72 hours of sustaining a blast-related mTBI and at a follow-up visit 48-72 hours later (n = 210). Methods and procedures: Demographics, post-concussive symptoms, diagnosis of acute stress reaction (ASR) and simple reaction time data from the Automated Neuropsychological Assessment Metric (ANAM) were collected. Main outcomes and results: ASRs were significantly more likely in patients reporting LOC versus patients reporting no LOC. At the first post-injury visit, LOC was associated with difficulty sleeping, hearing loss, memory problems and reporting more symptoms. A follow-up analysis explored if symptomatic differences were influenced by ASR. Adjusting for ASR, the statistical relationships between LOC and symptoms were weaker (i.e. reduced Odds Ratios). At the follow-up visit, difficulty sleeping was associated with LOC before and after adjusting for ASR. Patients with both ASR and LOC had the slowest simple reaction times. Conclusions: Results suggest ASR may partially mediate symptom presentation and cognitive dysfunction in the acute phase following blast-related mTBI. Future research is warranted.	[Norris, Jacob N.] Naval Med Res Ctr, Neurotrauma Dept, Silver Spring, MD 20910 USA; [Sams, Richard] Branch Hlth Clin Kings Bay, Kings Bay, GA USA; [Lundblad, Peter] Naval Hosp Bremerton, Bremerton, WA USA; [Frantz, Earl] Naval Hosp Camp Lejeune, Camp Lejeune, NC USA; [Harris, Erica] Naval Hlth Res Ctr, San Diego, CA USA	Norris, JN (corresponding author), Naval Med Res Ctr, Silver Spring, MD 20910 USA.	jacob.norris@med.navy.mil		Sams, Richard/0000-0003-3264-9616	Navy Bureau of Medicine and Surgery [N24LB]	This report was supported by Navy Bureau of Medicine and Surgery, under Work Unit No. N24LB. The views expressed in this article are those of the authors and do not necessarily reflect the official policy or position of the Department of the Navy, Department of Defense, or the US Government. Approved for public release; distribution is unlimited. This research has been conducted in compliance with all applicable federal regulations governing the protection of human subjects in research (USAMRMC IRB Number M-10166 and NMRC.2013.0003).	APA, 2000, DIAGN STAT MAN MENT; Asplund CA, 2004, CLIN J SPORT MED, V14, P339, DOI 10.1097/00042752-200411000-00003; Associated Press, 2007, CARS STUD CARS STUD; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P194, DOI 10.1017/S1355617709990841; Belanger HG, 2009, J INT NEUROPSYCH SOC, V15, P1, DOI 10.1017/S1355617708090036; Benson BW, 2011, CAN MED ASSOC J, V183, P905, DOI 10.1503/cmaj.092190; Bleiberg J, 1998, J HEAD TRAUMA REHAB, V13, P36, DOI 10.1097/00001199-199804000-00006; Brenner LA, 2010, NEUROPSYCHOLOGY, V24, P160, DOI 10.1037/a0017966; Coldren RL, 2012, MIL MED, V177, P179, DOI 10.7205/MILMED-D-11-00278; Collins MW, 2003, CLIN J SPORT MED, V13, P222, DOI 10.1097/00042752-200307000-00005; Conaton E., 2012, 649011 DODI; Cooper DB, 2011, BRAIN INJURY, V25, P1, DOI 10.3109/02699052.2010.531692; Cunningham J, 2011, J EMERG MED, V40, P262, DOI 10.1016/j.jemermed.2008.08.017; Defense and Veterans Brain Injury Center, 2013, MIL AC CONC EV MACE; DePalma RG, 2005, NEW ENGL J MED, V352, P1335, DOI 10.1056/NEJMra042083; Drag LL, 2012, J INT NEUROPSYCH SOC, V18, P576, DOI 10.1017/S1355617712000203; Elder GA, 2010, PSYCHIAT CLIN N AM, V33, P757, DOI 10.1016/j.psc.2010.08.001; Eonta SE, 2011, AVIAT SPACE ENVIR MD, V82, P34, DOI 10.3357/ASEM.2799.2011; Erlanger D, 2003, J NEUROSURG, V98, P477, DOI 10.3171/jns.2003.98.3.0477; Eskridge SL, 2013, J NEUROTRAUM, V30, P1391, DOI 10.1089/neu.2012.2537; French LM, 2012, J HEAD TRAUMA REHAB, V27, P63, DOI 10.1097/HTR.0b013e3182248344; Gordon SN, 2011, CLIN NEUROPSYCHOL, V25, P337, DOI 10.1080/13854046.2010.550634; Gosselin N, 2010, J NEUROL NEUROSUR PS, V81, P1297, DOI 10.1136/jnnp.2010.222471; Hoffman JM, 2011, J NEUROTRAUM, V28, P1719, DOI 10.1089/neu.2011.1914; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Holmes S, 2011, BIOL RES NURS, V13, P97, DOI 10.1177/1099800410382290; Isserlin L, 2008, AM J ORTHOPSYCHIAT, V78, P423, DOI 10.1037/a0014304; Iverson GL, 2000, ARCH CLIN NEUROPSYCH, V15, P643, DOI 10.1016/S0887-6177(99)00048-7; Iverson G, 2007, CLIN J SPORT MED, V17, P31; Iverson GL, 2006, ARCH CLIN NEUROPSYCH, V21, P303, DOI 10.1016/j.acn.2005.12.008; Ivins BJ, 2009, J HEAD TRAUMA REHAB, V24, P24, DOI 10.1097/HTR.0b013e3181957042; Kelly JP, 1998, J HEAD TRAUMA REHAB, V13, P53, DOI 10.1097/00001199-199804000-00008; Kelly JP, 2001, J ATHL TRAINING, V36, P249; Kelly MP, 2012, ARCH CLIN NEUROPSYCH, V27, P375, DOI 10.1093/arclin/acs036; Kennedy CH, 2012, ARCH CLIN NEUROPSYCH, V27, P817, DOI 10.1093/arclin/acs092; Lau BC, 2011, AM J SPORT MED, V39, P2311, DOI 10.1177/0363546511410655; Lees-Haley PR, 2001, ARCH CLIN NEUROPSYCH, V16, P689, DOI 10.1016/S0887-6177(00)00092-5; Levinson D, 2005, ARCH CLIN NEUROPSYCH, V20, P403, DOI 10.1016/j.acn.2004.09.001; Luethcke CA, 2011, J INT NEUROPSYCH SOC, V17, P36, DOI 10.1017/S1355617710001207; Matthews S, 2011, PSYCHIAT RES-NEUROIM, V191, P76, DOI 10.1016/j.pscychresns.2010.09.013; McCrea M, 2010, J HEAD TRAUMA REHAB, V25, P283, DOI 10.1097/HTR.0b013e3181e67923; McLean SA, 2009, AM J EMERG MED, V27, P182, DOI 10.1016/j.ajem.2008.01.054; Norris JN, 2013, MIL MED, V178, P767, DOI 10.7205/MILMED-D-12-00493; Peskind ER, 2013, J CLIN PSYCHIAT, V74, P180, DOI 10.4088/JCP.12011co1c; Polusny MA, 2011, ARCH GEN PSYCHIAT, V68, P79, DOI 10.1001/archgenpsychiatry.2010.172; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; Sams R, 2012, MIL MED, V177, P48, DOI 10.7205/MILMED-D-11-00214; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Seifman MA, 2008, J CEREBR BLOOD F MET, V28, P684, DOI 10.1038/sj.jcbfm.9600603; Shekleton JA, 2010, NEUROLOGY, V74, P1732, DOI 10.1212/WNL.0b013e3181e0438b; Swick D, 2013, NEUROPSYCHOLOGIA, V51, P3033, DOI 10.1016/j.neuropsychologia.2013.10.008; Swick D, 2012, J INT NEUROPSYCH SOC, V18, P917, DOI 10.1017/S1355617712000458; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Torg JS, 1982, ATHLETIC INJURIES HE; Vaishnavi S, 2009, PSYCHOSOMATICS, V50, P198, DOI 10.1176/appi.psy.50.3.198; Vasterling JJ, 2009, J INT NEUROPSYCH SOC, V15, P826, DOI 10.1017/S1355617709990683; Vasterling JJ, 1998, NEUROPSYCHOLOGY, V12, P125, DOI 10.1037/0894-4105.12.1.125; Warden DL, 2001, NEUROLOGY, V57, P524, DOI 10.1212/WNL.57.3.524; Wilk JE, 2010, J HEAD TRAUMA REHAB, V25, P9, DOI 10.1097/HTR.0b013e3181bd090f; Xydakis MS, 2012, ANN NEUROL, V72, P673, DOI 10.1002/ana.23757; Zhang Jiangyue, 2009, Biomed Sci Instrum, V45, P119; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446	63	17	18	0	8	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2014	28	8					1052	1062		10.3109/02699052.2014.891761			11	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	AI6KP	WOS:000336983200005	24655334				2021-06-18	
J	Pieper, P; Garvan, C				Pieper, Pam; Garvan, Cynthia			Health-related quality-of-life in the first year following a childhood concussion	BRAIN INJURY			English	Article						Children; concussion; mild brain injury; paediatric; outcome; quality-of-life	TRAUMATIC BRAIN-INJURY; PEDIATRIC POPULATION; CHILDREN; ADOLESCENTS; PEDSQL(TM)-4.0; PERSPECTIVES; RELIABILITY; INVENTORY; VALIDITY; OUTCOMES	Objectives: (1) To compare pre-injury health-related quality-of-life (HRQoL) of children who have sustained mild traumatic brain injury (mTBI) to their HRQoL at 1, 3, 6 and 12 months post-injury and (2) to compare the HRQoL of children with mTBI, children with mild non-brain injuries and children who were uninjured at the same time points. Child and parent responses were obtained for both objectives. Patients and methods: This prospective cohort study involved a self-selected convenience sample to evaluate child and parent perspectives of the HRQoL of 5-17 year old children with mTBI using the PedsQL Generic Core Scales and Cognitive Functioning Scale. Total sample size was 120 child/parent dyads, with 40 dyads each in the study and two control groups. Children who required hospitalization greater than 24 hours were excluded from the study. Results: HRQoL of children with mTBI was not significantly different between pre- and post-injury at all-time points. However, children and parents in the mild non-brain injury group reported significantly lower physical HRQoL 1 month post-injury. Conclusions: Children with mTBI had similar pre- and post-injury HRQoL. Thus, children who sustain mTBI and have significantly lower HRQoL within the first year post-injury merit further evaluation.	[Pieper, Pam] Univ Florida, Coll Nursing, Jacksonville, FL 32209 USA; [Garvan, Cynthia] Univ Florida, Hlth Sci Ctr, Gainesville, FL USA	Pieper, P (corresponding author), Univ Florida, Coll Nursing, 653 W 8th St,L-4, Jacksonville, FL 32209 USA.	pam.pieper@jax.ufl.edu			American Pediatric Surgical Nurses Association; Florida Nurses Association	The authors would like to thank Mary Bear, PhD, RN for contributions to the conception and design of this study and Debra McDonald of the University of Florida College of Nursing Office of Research Support for editorial assistance. This research was supported by grants from the American Pediatric Surgical Nurses Association and the Florida Nurses Association. The Quality of Life study described in this paper was carried out using the PedsQL, developed by Dr. James W. Varni.	Aitken ME, 2009, PEDIATRICS, V123, P199, DOI 10.1542/peds.2008-0607; Anderson V, 2009, J HEAD TRAUMA REHAB, V24, P303, DOI 10.1097/HTR.0b013e3181ada830; Bland JM, 1997, BRIT MED J, V314, P572, DOI 10.1136/bmj.314.7080.572; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Ding R, 2006, J PEDIATR ORTHOPED, V26, P157, DOI 10.1097/01.bpo.0000218521.98244.7e; Erickson SJ, 2010, DEV NEUROREHABIL, V13, P175, DOI 10.3109/17518420903479867; FARMER MY, 1987, PEDIATR NEUROSCI, V13, P304, DOI 10.1159/000120348; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Gagnon I, 2005, J HEAD TRAUMA REHAB, V20, P436, DOI 10.1097/00001199-200509000-00005; Gagnon I, 2008, BRAIN INJURY, V22, P161, DOI 10.1080/02699050701867381; Gardner Helen, 2012, Nurse Res, V19, P6; Haas B K, 1999, Image J Nurs Sch, V31, P215, DOI 10.1111/j.1547-5069.1999.tb00483.x; Haverman L, 2011, BMC PEDIATR, V11, DOI 10.1186/1471-2431-11-3; Horneman G, 2005, INT J REHABIL RES, V28, P245, DOI 10.1097/00004356-200509000-00007; Kaye AJ, 2010, J TRAUMA, V68, P1396, DOI 10.1097/TA.0b013e3181cf7d1b; Limond J, 2009, BRAIN INJURY, V23, P617, DOI 10.1080/02699050902997870; McCarthy ML, 2007, J TRAUMA, V63, pS122, DOI 10.1097/TA.0b013e31815accdf; McCarthy ML, 2006, ARCH PEDIAT ADOL MED, V160, P252, DOI 10.1001/archpedi.160.3.252; McCarthy ML, 2005, ARCH PHYS MED REHAB, V86, P1901, DOI 10.1016/j.apmr.2005.03.026; Mitra B, 2007, J PAEDIATR CHILD H, V43, P154, DOI 10.1111/j.1440-1754.2007.01035.x; Nacajauskaite O, 2006, BRAIN DEV-JPN, V28, P507, DOI 10.1016/j.braindev.2006.02.010; Petersen C, 2008, BRAIN INJURY, V22, P215, DOI 10.1080/02699050801935245; Pieper P, 2011, J TRAUMA NURS, V18, P11; Ponsford J, 1999, J HEAD TRAUMA REHAB, V14, P360, DOI 10.1097/00001199-199908000-00005; Ravens-Sieberer U, 2002, RESTOR NEUROL NEUROS, V20, P151; Rivara FP, 2007, J TRAUMA, V63, pS155, DOI 10.1097/TA.0b013e31815acd92; Rivara FP, 2011, PEDIATRICS, V128, pE1129, DOI 10.1542/peds.2011-0840; Slomine BS, 2006, PEDIATRICS, V117, pE663, DOI 10.1542/peds.2005-1892; Souza Ligia Maria Do N, 2007, Dev Neurorehabil, V10, P35, DOI 10.1080/13638490600822239; Stancin T, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.2.e34; UNICEF Innocenti Research Center, 2007, REP CARD 7 CHILD POV; Varni JW, 2007, HEALTH QUAL LIFE OUT, V5, DOI 10.1186/1477-7525-5-1; Varni JW, 2003, AMBUL PEDIATR, V3, P329, DOI 10.1367/1539-4409(2003)003<0329:TPAAPP>2.0.CO;2; Winthrop AL, 2010, CURR OPIN PEDIATR, V22, P346, DOI 10.1097/MOP.0b013e3283394351; Young NL, 2009, J CLIN EPIDEMIOL, V62, P314, DOI 10.1016/j.jclinepi.2008.06.011	36	17	17	0	9	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JAN	2014	28	1					105	113		10.3109/02699052.2013.847208			9	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	274CC	WOS:000328581700013	24180478				2021-06-18	
J	Ripley, DL; Morey, CE; Gerber, D; Harrison-Felix, C; Brenner, LA; Pretz, CR; Cusick, C; Wesnes, K				Ripley, David L.; Morey, Clare E.; Gerber, Don; Harrison-Felix, Cynthia; Brenner, Lisa A.; Pretz, Christopher R.; Cusick, Chris; Wesnes, Keith			Atomoxetine for attention deficits following traumatic brain injury: Results from a randomized controlled trial	BRAIN INJURY			English	Article						Attention; atomoxetine; cognitive drug research; controlled trial; norepinephrine; traumatic brain injury	COMPUTERIZED ASSESSMENT SYSTEM; WORLD-HEALTH-ORGANIZATION; HYPERACTIVITY DISORDER; COGNITIVE FUNCTION; ADULTS; ADHD; ADOLESCENTS; DEMENTIA; CHILDREN; RIVASTIGMINE	Objective: To determine if atomoxetine would improve attention impairment following traumatic brain injury (TBI). Setting: Outpatients from a free-standing, private, not-for-profit rehabilitation hospital. Population: Fifty-five adult participants with a history of a single moderate-to-severe TBI, who were at least 1 year from injury and with self-reported complaints of attention difficulties. Intervention: Atomoxetine, a selective norepinephrine re-uptake inhibitor with a primary indication for attention dosed at 40 mg twice a day for 2 weeks, compared to placebo. Design: Randomized double-blind placebo controlled trial, with placebo run-in. Measures: Cognitive Drug Research (CDR), Computerized Cognitive Assessment System, Stroop Color and Word Test, Adult ADHD Self-Report Scale (ASRS-v1.1), Neurobehavioural Functioning Inventory (NFI). Results: Atomoxetine was well-tolerated by the subject sample. The use of atomoxetine by individuals with reported attention difficulty following TBI did not significantly improve scores on measures of attention, the CDR Power of Attention domain or the Stroop Interference score. In addition, no significant relationship was found between atomoxetine use and self-reported symptoms of attention or depression. Conclusion: Atomoxetine did not significantly improve performance on measures of attention among individuals post-TBI with difficulties with attention. This study follows a trend of other pharmacological studies not demonstrating significant results among those with a history of TBI. Various possibilities are discussed, including the need for a more sophisticated system of classification of TBI.	[Ripley, David L.] Northwestern Univ, Rehabil Inst Chicago, Feinberg Sch Med, Dept Phys Med & Rehabil, Chicago, IL 60611 USA; [Morey, Clare E.; Gerber, Don; Harrison-Felix, Cynthia; Brenner, Lisa A.; Pretz, Christopher R.; Cusick, Chris] Univ Colorado, Sch Med, Dept Phys Med & Rehabil, Aurora, CO USA; [Brenner, Lisa A.] Univ Colorado, Sch Med, Dept Psychiat, Aurora, CO USA; [Brenner, Lisa A.] Univ Colorado, Sch Med, Dept Neurol, Aurora, CO USA; [Brenner, Lisa A.] Univ Colorado, Sch Med, Dept Phys Med & Rehabil, Aurora, CO USA; [Wesnes, Keith] Bracket Global, Goring On Thames, England; [Wesnes, Keith] Swinburne Univ Technol, Ctr Human Psychopharmacol, Melbourne, Vic, Australia	Ripley, DL (corresponding author), Rehabil Inst Chicago, Chicago, IL 60611 USA.	dripley@ric.org	Wesnes, Keith A/D-7148-2018; Brenner, Lisa A./AAG-2442-2019	Wesnes, Keith/0000-0002-4498-8511; Ripley, David/0000-0002-5349-1830	Rocky Mountain Regional Brain Injury System - US Department of Education's National Institute on Disability and Rehabilitation Research [H133A070022]; Lilly Research LaboratoriesEli Lilly	This research was supported by the Rocky Mountain Regional Brain Injury System (Grant number H133A070022) which was funded by an award from the US Department of Education's National Institute on Disability and Rehabilitation Research. The contents of this publication are the opinions of the authors and do not necessarily reflect the views of the Department of Education. Additionally, this research received investigator-initiated support from Lilly Research Laboratories, who provided active drug and placebo for this project.	BROADBENT DE, 1982, BRIT J CLIN PSYCHOL, V21, P1, DOI 10.1111/j.2044-8260.1982.tb01421.x; Buitelaar JK, 2004, EUR CHILD ADOLES PSY, V13, P249, DOI 10.1007/s00787-004-0401-3; Christman AK, 2004, PHARMACOTHERAPY, V24, P1020, DOI 10.1592/phco.24.11.1020.36146; DACKIS C A, 1990, Advances in Alcohol and Substance Abuse, V9, P9; Golden CJ, 2002, STROOP COLOR WORD TE; Hart T, 2005, J HEAD TRAUMA REHAB, V20, P333, DOI 10.1097/00001199-200507000-00005; Hawley CA, 2004, BRAIN INJURY, V18, P645, DOI 10.1080/02699050310001646189; Hwang BH, 1999, NEUROSCI LETT, V265, P151, DOI 10.1016/S0304-3940(99)00241-4; James W., 1980, PRINCIPLES PSYCHOL; Keith MS, 1998, BRAIN INJURY, V12, P1037, DOI 10.1080/026990598121945; Kessler RC, 2005, PSYCHOL MED, V35, P245, DOI 10.1017/S0033291704002892; Kessler RC, 2004, INT J METH PSYCH RES, V13, P93, DOI 10.1002/mpr.168; Kreutzer JS, 1996, ARCH PHYS MED REHAB, V77, P116, DOI 10.1016/S0003-9993(96)90155-0; Lezak M.D., 2004, NEUROPSYCHOLOGICAL A, Vfourth; Mathias JL, 2007, NEUROPSYCHOLOGY, V21, P212, DOI 10.1037/0894-4105.21.2.212; Michelson D, 2003, BIOL PSYCHIAT, V53, P112, DOI 10.1016/S0006-3223(02)01671-2; PONSFORD JL, 1995, BRAIN INJURY, V9, P1, DOI 10.3109/02699059509004565; Preti Antonio, 2002, Curr Opin Investig Drugs, V3, P272; SAS Institute Inc, 2011, SAS 9 3 SOFTW; Sauer JM, 2004, J PHARMACOL EXP THER, V308, P410, DOI 10.1124/jpet.103.058727; Simpson D, 2004, CNS DRUGS, V18, P397, DOI 10.2165/00023210-200418060-00011; Spencer T, 2004, PSYCHIAT CLIN N AM, V27, P373, DOI 10.1016/j.psc.2003.12.001; Spreen O., 1998, COMPENDIUM NEUROPSYC; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Walker G., 2010, COMMON STAT METHODS; Wernicke JF, 2002, J CLIN PSYCHIAT, V63, P50; Wernicke JF, 2003, DRUG SAFETY, V26, P729, DOI 10.2165/00002018-200326100-00006; Wesnes KA, 2003, APPETITE, V41, P329, DOI 10.1016/j.appet.2003.08.009; Wesnes KA, 2005, NEUROLOGY, V65, P1654, DOI 10.1212/01.wnl.0000184517.69816.e9; Wesnes KA, 2002, DEMENT GERIATR COGN, V13, P183, DOI 10.1159/000048651; Wesnes KA, COGNITIVE DRUG RES C; Wesnes KA, 2008, NEURODEGENER DIS, V5, P261, DOI 10.1159/000113719; Whiteneck G, 2001, COLORADO TRAUMATIC B; ZERBE RL, 1985, J PHARMACOL EXP THER, V232, P139	34	17	17	0	8	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2014	28	12					1514	1522		10.3109/02699052.2014.919530			9	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	AR6UD	WOS:000343717700003	25180876				2021-06-18	
J	Russell, KL; Berman, NEJ; Gregg, PRA; Levant, B				Russell, K. L.; Berman, N. E. J.; Gregg, P. R. A.; Levant, B.			Fish oil improves motor function, limits blood-brain barrier disruption, and reduces Mmp9 gene expression in a rat model of juvenile traumatic brain injury	PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS			English	Article						Traumatic brain injury; Juvenile; Rat; Fish oil; Blood-brain barrier; Matrix metalloproteinase 9	POLYUNSATURATED FATTY-ACIDS; DOCOSAHEXAENOIC ACID; DIETARY SUPPLEMENTATION; CORTICAL IMPACT; KNOCK-OUT; MATRIX-METALLOPROTEINASE-9; OMEGA-3-FATTY-ACIDS; MECHANISMS; DAMAGE; HOMEOSTASIS	The effects of an oral fish oil treatment regimen on sensorimotor, blood-brain barrier, and biochemical outcomes of traumatic brain injury (TBI) were investigated in a juvenile rat model. Seventeen-day old Long-Evans rats were given a 15 mL/kg fish oil (2.01 g/kg EPA, 1.34 g/kg DHA) or soybean oil dose via oral gavage 30 min prior to being subjected to a controlled cortical impact injury or sham surgery, followed by daily doses for seven days. Fish oil treatment resulted in less severe hindlimb deficits after TBI as assessed with the beam walk test, decreased cerebral IgG infiltration, and decreased TBI-induced expression of the Mmp9 gene one day after injury. These results indicate that fish oil improved functional outcome after TBI resulting, at least in part from decreased disruption of the blood-brain barrier through a mechanism that includes attenuation of TBI-induced expression of Mmp9. (C) 2013 Elsevier Ltd. All rights reserved.	[Russell, K. L.; Gregg, P. R. A.; Levant, B.] Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, Kansas City, KS 66160 USA; [Berman, N. E. J.] Univ Kansas, Med Ctr, Dept Anat & Cell Biol, Kansas City, KS 66160 USA	Levant, B (corresponding author), Univ Kansas, Med Ctr, Dept Pharmacol, Mail Stop 1018,3901 Rainbow Blvd, Kansas City, KS 66160 USA.	kristinlrussell@gmail.com; nberman@kumc.edu; pragregg@gmail.com; blevant@kumc.edu			NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R03 HD059939, P30 HD02528, P20 RR016475, T32 ES007079, T32 HD007523]; University of Kansas Medical Center Biomedical Research Training Program; American Society for Pharmacology and Experimental Therapeutics (ASPET) Zannoni Summer Undergraduate Research Fellow (SURF) Program; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [P30HD002528] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [T32HD007523, R03HD059939] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [P20RR016475] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS) [T32ES007079] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [P20GM103418] Funding Source: NIH RePORTER	Supported by the NIH R03 HD059939 (BL), P30 HD02528 (BL, NEJB), P20 RR016475 (BL), T32 ES007079 (KLR), T32 HD007523 (KLR), the University of Kansas Medical Center Biomedical Research Training Program (KLR), and the American Society for Pharmacology and Experimental Therapeutics (ASPET) Zannoni Summer Undergraduate Research Fellow (SURF) Program (PRAG).	Abbott NJ, 2010, NEUROBIOL DIS, V37, P13, DOI 10.1016/j.nbd.2009.07.030; AIHARA N, 1994, J COMP NEUROL, V342, P481, DOI 10.1002/cne.903420402; Akbar M, 2005, P NATL ACAD SCI USA, V102, P10858, DOI 10.1073/pnas.0502903102; ALTMAN J, 1975, ANIM BEHAV, V23, P896, DOI 10.1016/0003-3472(75)90114-1; Asahi M, 2001, J NEUROSCI, V21, P7724; Bailes JE, 2010, J NEUROTRAUM, V27, P1617, DOI 10.1089/neu.2009.1239; Bazan NG, 2005, ANN NY ACAD SCI, V1053, P137, DOI 10.1196/annals.1344.011; Bazan NG, 2009, J LIPID RES, V50, pS400, DOI 10.1194/jlr.R800068-JLR200; Belayev L, 2009, STROKE, V40, P3121, DOI 10.1161/STROKEAHA.109.555979; CLANDININ MT, 1980, EARLY HUM DEV, V4, P131, DOI 10.1016/0378-3782(80)90016-X; CLANDININ MT, 1980, EARLY HUM DEV, V4, P121, DOI 10.1016/0378-3782(80)90015-8; Cole JT, 2011, J NEUROTRAUM, V28, P359, DOI 10.1089/neu.2010.1427; Conroy S, 2000, BRIT J CLIN PHARMACO, V49, P93, DOI 10.1046/j.1365-2125.2000.00125.x; Draper E, 2011, J NUTR BIOCHEM, V22, P784, DOI 10.1016/j.jnutbio.2010.06.009; Eady TN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046151; Edmond J, 2001, J MOL NEUROSCI, V16, P181, DOI 10.1385/JMN:16:2-3:181; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Florent S, 2006, J NEUROCHEM, V96, P385, DOI 10.1111/j.1471-4159.2005.03541.x; Gasche Y, 1999, J CEREBR BLOOD F MET, V19, P1020, DOI 10.1097/00004647-199909000-00010; Giza CC, 2006, DEV NEUROSCI-BASEL, V28, P364, DOI 10.1159/000094163; Green P, 1996, LIPIDS, V31, P859, DOI 10.1007/BF02522981; Hamm RJ, 2001, J NEUROTRAUM, V18, P1207, DOI 10.1089/089771501317095241; Harkness KA, 2000, BRAIN, V123, P698, DOI 10.1093/brain/123.4.698; Harris JL, 2009, J NEUROTRAUM, V26, P1669, DOI [10.1089/neu.2009.0875, 10.1089/neu.2009-0875]; Hogyes E, 2003, NEUROSCIENCE, V119, P999, DOI 10.1016/S0306-4522(03)00198-2; Homayoun P, 2000, NEUROCHEM RES, V25, P269, DOI 10.1023/A:1007583806138; Hossain S, 1998, NEUROSCI LETT, V244, P157, DOI 10.1016/S0304-3940(98)00147-5; Javierre C, 2006, J PHYSIOL BIOCHEM, V62, P271, DOI 10.1007/BF03165756; Kearns GL, 2003, NEW ENGL J MED, V349, P1157, DOI 10.1056/NEJMra035092; Khan SA, 2003, J NUTR BIOCHEM, V14, P554, DOI 10.1016/S0955-2863(03)00098-6; King VR, 2006, J NEUROSCI, V26, P4672, DOI 10.1523/JNEUROSCI.5539-05.2006; Laird MD, 2008, NEUROSIGNALS, V16, P154, DOI 10.1159/000111560; Levant B, 2006, LIPIDS, V41, P407, DOI 10.1007/s11745-006-5114-6; Lewis M, 2013, AM J EMERG MED, V31, DOI 10.1016/j.ajem.2012.05.014; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lohmann C, 2004, BRAIN RES, V995, P184, DOI 10.1016/j.brainres.2003.10.002; Mills JD, 2011, J NEUROSURG, V114, P77, DOI 10.3171/2010.5.JNS08914; Mills JD, 2011, NEUROSURGERY, V68, P474, DOI 10.1227/NEU.0b013e3181ff692b; Novak TE, 2003, AM J PHYSIOL-LUNG C, V284, pL84, DOI 10.1152/ajplung.00077.2002; Ogawa K, 2004, BIOCHEM J, V381, P413, DOI 10.1042/BJ20040058; Onyszchuk G, 2008, J NEUROTRAUM, V25, P153, DOI 10.1089/neu.2007.0430; Onyszchuk G, 2007, J NEUROSCI METH, V160, P187, DOI 10.1016/j.jneumeth.2006.09.007; Pan HC, 2009, J NUTR BIOCHEM, V20, P715, DOI 10.1016/j.jnutbio.2008.06.014; Prins ML, 2003, J NEUROTRAUM, V20, P123, DOI 10.1089/08977150360547053; Rasband W. S, 2012, IMAGEJ; Russell KL, 2013, PROSTAG LEUKOTR ESS, V89, P97, DOI 10.1016/j.plefa.2013.05.004; Russell KL, 2011, J NEUROSCI METH, V199, P214, DOI 10.1016/j.jneumeth.2011.05.008; Salem N, 2001, LIPIDS, V36, P945, DOI 10.1007/s11745-001-0805-6; Schumacher M.A., 2012, BASIC CLIN PHARM, P543; SEITZ RJ, 1985, ACTA NEUROPATHOL, V68, P15, DOI 10.1007/BF00688950; Semple BD, 2010, J CEREBR BLOOD F MET, V30, P769, DOI 10.1038/jcbfm.2009.262; Serhan CN, 2008, ANNU REV PATHOL-MECH, V3, P279, DOI 10.1146/annurev.pathmechdis.3.121806.151409; Serhan CN, 2009, J EXP MED, V206, P15, DOI 10.1084/jem.20081880; Shaikh SR, 2012, J NUTR BIOCHEM, V23, P101, DOI 10.1016/j.jnutbio.2011.07.001; Sherwood N.M., 1970, STEREOTAXIC ATLAS DE; Shigemori Y, 2006, ACTA NEUROCHIR SUPPL, V96, P130; Shin SS, 2011, NEUROSCI LETT, V496, P168, DOI 10.1016/j.neulet.2011.04.009; Shinto L, 2011, AUTOIMMUN DIS, V2011, DOI 10.4061/2011/134592; Sifringer M, 2007, NEUROBIOL DIS, V25, P526, DOI 10.1016/j.nbd.2006.10.019; Sinha RA, 2009, INT J DEV NEUROSCI, V27, P377, DOI 10.1016/j.ijdevneu.2009.02.003; Stokely ME, 2008, J NEUROTRAUM, V25, P52, DOI 10.1089/neu.2007.0397; Svedin P, 2007, J NEUROSCI, V27, P1511, DOI 10.1523/JNEUROSCI.4391-06.2007; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; WESTERGA J, 1990, DEV BRAIN RES, V57, P163, DOI 10.1016/0165-3806(90)90042-W; Wu A, 2004, J NEUROTRAUM, V21, P1457, DOI 10.1089/neu.2004.21.1457; Wu AG, 2007, J NEUROTRAUM, V24, P1587, DOI 10.1089/neu.2007.0313; Wu AG, 2011, J NEUROTRAUM, V28, P2113, DOI 10.1089/neu.2011.1872; Wu JCC, 2013, J SURG RES, V179, P138, DOI 10.1016/j.jss.2012.09.013; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134; Zuniga J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028502	71	17	17	0	12	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0952-3278	1532-2823		PROSTAG LEUKOTR ESS	Prostaglandins Leukot. Essent. Fatty Acids	JAN	2014	90	1					5	11		10.1016/j.plefa.2013.11.003			7	Biochemistry & Molecular Biology; Cell Biology; Endocrinology & Metabolism	Biochemistry & Molecular Biology; Cell Biology; Endocrinology & Metabolism	AA9LI	WOS:000331414600002	24342130	Green Accepted			2021-06-18	
J	Sharma, S; Gomez, D; deMestral, C; Hsiao, M; Rutka, J; Nathens, AB				Sharma, Sunjay; Gomez, David; deMestral, Charles; Hsiao, Marvin; Rutka, James; Nathens, Avery B.			Emergency Access to Neurosurgical Care for Patients with Traumatic Brain Injury	JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS			English	Article							OUTCOMES	BACKGROUND: Traumatic brain injury (TBI) is one of the most common causes of injury-related morbidity and mortality. Access to neurosurgical services is critical to optimal outcomes through reduction of secondary injury. We sought to evaluate variations in access to neurosurgical care across a regional trauma system. STUDY DESIGN: This is a population-based retrospective cohort study of patients who sustained isolated severe TBI from 2005 to 2009. Administrative datasets capturing all emergency department visits and hospitalizations were linked deterministically. Differences between access to a trauma center (TC), defined as direct transport from scene or transfer from a nontrauma center (NTC) as opposed to no access, were evaluated; this included patient level determinants of access to TC and delineation of mortality differences between TC and NTC care. Transfer patterns from NTC to TC were also evaluated. RESULTS: We identified 9,448 patients with isolated severe TBI. Almost two-thirds (60%, n = 5,701) received initial care at an NTC. Of these patients, 30% (n = 1,737) were subsequently transferred to a TC. Thirty-day mortality rates of patients treated at a TC vs NTC were 19% vs 18%, respectively (p = 0.19). Among patients younger than 65 years, 67% received TC care; only 41% of patients older than 65 were treated at a TC (p < 0.01). Mechanism, age, brain hemorrhage, and injury severity were associated with TC care. CONCLUSIONS: Considerable variation in delivery of initial care to TBI patients was identified. Factors such as age and injury characteristics were associated with TC access. Because early TC care in TBI confers survival benefits, the demonstrated variability necessitates improvements in access to care for patients with severe head injuries. (C) 2014 by the American College of Surgeons	[Sharma, Sunjay; Rutka, James] Univ Toronto, Dept Surg, Div Neurosurg, Toronto, ON, Canada; [Gomez, David; deMestral, Charles; Hsiao, Marvin; Nathens, Avery B.] Univ Toronto, Dept Surg, Div Gen Surg, Toronto, ON, Canada	Sharma, S (corresponding author), Toronto Western Hosp, Div Neurosurg, WW 4-427, Toronto, ON M5T 2S8, Canada.	sunjay.sharma@gmail.com	Sharma, Sunjay/AAR-7129-2021	Sharma, Sunjay/0000-0001-7826-9075; Gomez, David/0000-0002-0926-2547	Institute for Clinical Evaluative Sciences (ICES)University of Toronto; Ontario Ministry of Health and Long-Term Care (MOHLTC)Ministry of Health and Long-Term Care, Ontario	This study was supported by the Institute for Clinical Evaluative Sciences (ICES), which is funded by an annual grant from the Ontario Ministry of Health and Long-Term Care (MOHLTC). The opinions, results, and conclusions reported in this paper are those of the authors and are independent from the funding sources. No endorsement by ICES, the Ontario MOHLTC, or ROC Investigators is intended or should be inferred. The authors have no other financial disclosures or any conflict of interest to declare.	Caro D. H., 2011, GLOBAL J HLTH SCI, V3, P19, DOI DOI 10.5539/GJHS.V3N1P19; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Ergh TC, 2002, J HEAD TRAUMA REHAB, V17, P155, DOI 10.1097/00001199-200204000-00006; Fakhry SM, 2004, J TRAUMA, V56, P492, DOI 10.1097/01.TA.0000115650.07193.66; Faul M, 2007, J TRAUMA, V63, P1271, DOI 10.1097/TA.0b013e3181493080; Finkelstein EA., 2006, INCIDENCE EC BURDEN; Glazier RH, 2011, GEOGRAPHIC ACCESS PR; Haas B, 2012, CAN J SURG, V55, P21, DOI 10.1503/cjs.017510; Zygun DA, 2005, CAN J NEUROL SCI, V32, P87, DOI 10.1017/S0317167100016930	9	17	17	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1072-7515	1879-1190		J AM COLL SURGEONS	J. Am. Coll. Surg.	JAN	2014	218	1					51	57		10.1016/j.jamcollsurg.2013.10.005			7	Surgery	Surgery	276KM	WOS:000328749200011	24355876				2021-06-18	
J	Tator, CH				Tator, Charles H.			Chronic traumatic encephalopathy: How serious a sports problem is it?	BRITISH JOURNAL OF SPORTS MEDICINE			English	Article						Concussion; Head injuries; Contact sports	INTERNATIONAL-CONFERENCE; CONCUSSION; STATEMENT	It is now recognised that there is a spectrum of concussion disorders ranging from acute concussion at one end to various forms of brain degeneration at the other end. The spectrum includes acute concussion, second impact syndrome or acute cerebral swelling, postconcussion syndrome, depression or anxiety, chronic traumatic encephalopathy (CTE) and possibly other forms of central nervous system degeneration. It is essential to carefully evaluate the clinical and neuropathological correlations of CTE that have been published. This has been accomplished in an excellent paper on this subject by Gardner and colleagues in this issue. There have been significant advances in our knowledge of the clinical and neuropathological features of CTE in athletes in the past 10years. However, we are just at the beginning of our appreciation of this entity due to the paucity of research and the inability to diagnose CTE during life. At present, it is not possible to assess the validity of the proposed methods of classification and grading of the severity of the disease. Additional studies of large numbers of at-risk athletes are essential, especially prospective longitudinal studies. Obviously, such studies would be even more effective if reliable in vivo biomarkers were discovered, especially non-invasive ones such as advanced MRI or MR spectroscopy or invasive ones such as blood or cerebrospinal fluid tests. The major questions that remain unanswered include the frequency of CTE in various collision sports, the causal or otherwise relationship between concussions and CTE, the number of concussions that need to be involved and their management.	Univ Toronto, Div Neurosurg, Toronto Western Hosp, Toronto, ON M5T 2S8, Canada	Tator, CH (corresponding author), Univ Toronto, Div Neurosurg, Toronto Western Hosp, 399 Bathurst St,Room 4W-422, Toronto, ON M5T 2S8, Canada.	charles.tator@uhn.ca			Canadian Sports Concussion Project at the Toronto Western Hospital, Toronto, Ontario Canada	This work was supported by the Canadian Sports Concussion Project at the Toronto Western Hospital, Toronto, Ontario Canada.	American Congress of Rehabilitation Medicine, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Gardner A, 2014, BRIT J SPORT MED, V48, P84, DOI 10.1136/bjsports-2013-092646; Hazrati LN, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00222; Martland HS, 1928, J AMER MED ASSOC, V91, P1103, DOI 10.1001/jama.1928.02700150029009; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Omalu B, 2011, NEUROSURGERY, V69, P173, DOI 10.1227/NEU.0b013e318212bc7b; Omalu BI, 2006, NEUROSURGERY, V59, P1086, DOI 10.1227/01.NEU.0000245601.69451.27; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Ruff R, 2005, J HEAD TRAUMA REHAB, V20, P5, DOI 10.1097/00001199-200501000-00003; Tator CH, 2013, CAN MED ASSOC J, V185, P975, DOI 10.1503/cmaj.120039; Tator CH, 2009, CAN J NEUROL SCI, V36, P405, DOI 10.1017/S031716710000771X	16	17	18	0	21	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0306-3674	1473-0480		BRIT J SPORT MED	Br. J. Sports Med.	JAN	2014	48	2					81	83		10.1136/bjsports-2013-093040			3	Sport Sciences	Sport Sciences	276KK	WOS:000328749000006	24273309				2021-06-18	
J	Thelin, EP; Nelson, DW; Ghatan, PH; Bellander, BM				Thelin, Eric P.; Nelson, David W.; Ghatan, Per Hamid; Bellander, Bo-Michael			Microdialysis monitoring of CSF parameters in severe traumatic brain injury patients: a novel approach	FRONTIERS IN NEUROLOGY			English	Article						TBI; microdialysis; cerebrospinal fluid; lactate; pyruvate; outcome	CEREBROSPINAL-FLUID; CEREBRAL MICRODIALYSIS; INTRACEREBRAL MICRODIALYSIS; SUBARACHNOID HEMORRHAGE; INTRACRANIAL-PRESSURE; EXTRACELLULAR FLUID; LACTATE PYRUVATE; METABOLIC CRISIS; GLUCOSE; BLOOD	Background: Neuro-intensive care following traumatic brain injury (TBI) is focused on preventing secondary insults that may lead to irreversible brain damage. Microdialysis (MD) is used to detect deranged cerebral metabolism. The clinical usefulness of the MD is dependent on the regional localization of the MD catheter. The aim of this study was to analyze a new method of continuous cerebrospinal fluid (CSF) monitoring using the MD technique. The method was validated using conventional laboratory analysis of CSF samples. MD-CSF and regional MD-Brain samples were correlated to patient outcome. Materials and Methods: A total of 14 patients suffering from severe TBI were analyzed. They were monitored using (1) a MD catheter (CMA64-iView, n=7448 MD samples) located in a CSF-pump connected to the ventricular drain and (2) an intraparenchymal MD catheter (CMA70, n=8358 MD samples). CSF-lactate and CSF-glucose levels were monitored and were compared to MD-CSF samples. MD-CSF and MD-Brain parameters were correlated to favorable (Glasgow Outcome Score extended, GOSe 6-8) and unfavorable (GOSe 1-5) outcome. Results: Levels of glucose and lactate acquired with the CSF-MD technique could be correlated to conventional levels. The median MD recovery using the CMA64 catheter in CSF was 0.98 and 0.97 for glucose and lactate, respectively. Median MD-CSF (CMA 64) lactate (p=0.0057) and pyruvate (p=0.0011) levels were significantly lower in the favorable outcome group compared to the unfavorable group. No significant difference in outcome was found using the lactate:pyruvate ratio (LPR), or any of the regional MD-Brain monitoring in our analyzed cohort. Conclusion:This new technique of global MD-CSF monitoring correlates with conventional CSF levels of glucose and lactate, and the MD recovery is higher than previously described. Increase in lactate and pyruvate, without any effect on the LPR, correlates to unfavorable outcome, perhaps related to the presence of erythrocytes in the CSF.	[Thelin, Eric P.; Bellander, Bo-Michael] Karolinska Univ Hosp Solna, Karolinska Inst, Dept Clin Neurosci, Neurosurg Sect, Bldg R2 02, S-17176 Stockholm, Sweden; [Nelson, David W.] Karolinska Inst, Dept Physiol & Pharmacol, Sect Anesthesiol & Intens Care, Stockholm, Sweden; [Ghatan, Per Hamid] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden	Thelin, EP (corresponding author), Karolinska Univ Hosp Solna, Karolinska Inst, Dept Clin Neurosci, Neurosurg Sect, Bldg R2 02, S-17176 Stockholm, Sweden.	eric.thelin@ki.se	Viani, Rafael/V-1196-2018; Thelin, Eric Peter/K-2144-2012	Thelin, Eric Peter/0000-0002-2338-4364			Abi-Saab WM, 2002, J CEREBR BLOOD F MET, V22, P271, DOI 10.1097/00004647-200203000-00004; Armin SS, 2006, NEUROL RES, V28, P445, DOI 10.1179/016164106X115053; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bellander BM, 2004, INTENS CARE MED, V30, P2166, DOI 10.1007/s00134-004-2461-8; Benjamin RK, 2004, NEURO-ONCOLOGY, V6, P65, DOI 10.1215/S1152851703000103; BENVENISTE H, 1989, J NEUROCHEM, V52, P1741, DOI 10.1111/j.1471-4159.1989.tb07252.x; BLAND JM, 1995, BRIT MED J, V310, P170, DOI 10.1136/bmj.310.6973.170; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; BRONDSTED HE, 1970, J PHYSIOL-LONDON, V208, P187, DOI 10.1113/jphysiol.1970.sp009113; Chen Jeff W, 2012, Surg Neurol Int, V3, P57, DOI 10.4103/2152-7806.96868; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; COPES WS, 1988, J TRAUMA, V28, P69, DOI 10.1097/00005373-198801000-00010; CROCKARD HA, 1972, EUR NEUROL, V8, P151, DOI 10.1159/000114569; Dahlin AP, 2010, ANAL CHEM, V82, P4376, DOI 10.1021/ac1007706; DESALLES AAF, 1986, J NEUROSURG, V65, P615, DOI 10.3171/jns.1986.65.5.0615; Engstrom M, 2005, J NEUROSURG, V102, P460, DOI 10.3171/jns.2005.102.3.0460; Eymann R, 2012, ACTA NEUROCHIR SUPPL, V113, P181, DOI 10.1007/978-3-7091-0923-6_36; Foley N, 2008, J NEUROTRAUM, V25, P1415, DOI 10.1089/neu.2008.0628; Fox E, 2002, J PHARMACOL EXP THER, V301, P1003, DOI 10.1124/jpet.301.3.1003; Glimaker M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091976; GRANHOLM L, 1969, SCAND J CLIN LAB INV, V23, P361, DOI 10.3109/00365516909081702; GUERRAROMERO L, 1992, J INFECT DIS, V166, P546, DOI 10.1093/infdis/166.3.546; Gustavsson A, 2011, EUR NEUROPSYCHOPHARM, V21, P718, DOI 10.1016/j.euroneuro.2011.08.008; Hage C, 2010, DIABETES TECHNOL THE, V12, P291, DOI 10.1089/dia.2009.0150; Hillered L, 2005, J NEUROTRAUM, V22, P3, DOI 10.1089/neu.2005.22.3; Hillered L, 1998, J NEUROL NEUROSUR PS, V64, P486, DOI 10.1136/jnnp.64.4.486; Hlatky R, 2004, J NEUROTRAUM, V21, P894, DOI 10.1089/0897715041526195; HOCHWALD GM, 1983, NEUROSCIENCE, V10, P1035, DOI 10.1016/0306-4522(83)90241-5; HOCHWALD GM, 1985, J NEUROCHEM, V44, P1832, DOI 10.1111/j.1471-4159.1985.tb07176.x; Hutchinson PJ, 2000, J NEUROSURG, V93, P37, DOI 10.3171/jns.2000.93.1.0037; JACOBSON I, 1985, J NEUROSCI METH, V15, P263, DOI 10.1016/0165-0270(85)90107-4; Johnston Andrew J, 2002, Curr Opin Crit Care, V8, P121, DOI 10.1097/00075198-200204000-00006; Kerner A, 2007, NEUROL RES, V29, P647, DOI 10.1179/016164107X248983; Leib SL, 1999, CLIN INFECT DIS, V29, P69, DOI 10.1086/520184; Lew HL, 2003, AM J PHYS MED REHAB, V82, P53, DOI 10.1097/01.PHM.0000043771.90606.81; Linsler S, 2013, ACTA NEUROCHIR, V155, P1589, DOI 10.1007/s00701-012-1562-3; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; MORI K, 1993, ACTA NEUROCHIR, V125, P20, DOI 10.1007/BF01401823; Myles PS, 2007, BRIT J ANAESTH, V99, P309, DOI 10.1093/bja/aem214; NAROTAM PK, 1994, NEUROSURGERY, V34, P409, DOI 10.1227/00006123-199403000-00004; NAU R, 1992, EUR J CLIN PHARMACOL, V42, P181, DOI 10.1007/BF00278481; Nelson DW, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-21; Nelson DW, 2010, J NEUROTRAUM, V27, P51, DOI 10.1089/neu.2009.0986; Nelson DW, 2004, CRIT CARE MED, V32, P2428, DOI 10.1097/01.CCM.0000147688.08813.9C; Nielsen TH, 2013, ACTA ANAESTH SCAND, V57, P229, DOI 10.1111/j.1399-6576.2012.02783.x; PERSSON L, 1992, J NEUROSURG, V76, P72, DOI 10.3171/jns.1992.76.1.0072; POSNER JB, 1967, ARCH NEUROL-CHICAGO, V16, P492, DOI 10.1001/archneur.1967.00470230044005; Reinstrup P, 2000, NEUROSURGERY, V47, P701, DOI 10.1097/00006123-200009000-00035; Robertson CS, 1999, CRIT CARE MED, V27, P2086, DOI 10.1097/00003246-199910000-00002; Romner B, 2000, J NEUROTRAUM, V17, P641, DOI 10.1089/089771500415391; Rooyackers O, 2013, ACTA ANAESTH SCAND, V57, P214, DOI 10.1111/j.1399-6576.2012.02787.x; Rooyackers O, 2010, ACTA ANAESTH SCAND, V54, P841, DOI 10.1111/j.1399-6576.2010.02264.x; Rostami Elham, 2011, J Diabetes Sci Technol, V5, P596; Sanchez Jose J, 2013, Acta Neurochir Suppl, V118, P223, DOI 10.1007/978-3-7091-1434-6_42; Sasaki M, 1996, J NUCL MED, V37, P1174; Seifman MA, 2008, J CEREBR BLOOD F MET, V28, P684, DOI 10.1038/sj.jcbfm.9600603; Siesj_o B K, 1978, BRAIN ENERGY METABOL; Simpson IA, 1999, J NEUROCHEM, V72, P238, DOI 10.1046/j.1471-4159.1999.0720238.x; SKOGSEID IM, 1992, ACTA NEUROCHIR, V115, P106, DOI 10.1007/BF01406367; Stein NR, 2012, NEUROCRIT CARE, V17, P49, DOI 10.1007/s12028-012-9708-y; Stern P, 2007, TUMOR BIOL, V28, P84, DOI 10.1159/000098441; TEASDALE G, 1974, LANCET, V2, P81; Thelin EP, 2013, J NEUROTRAUM, V30, P519, DOI 10.1089/neu.2012.2553; Timofeev I, 2011, BRAIN, V134, P484, DOI 10.1093/brain/awq353; Toczylowska B, 2006, BRAIN RES, V1104, P183, DOI 10.1016/j.brainres.2006.05.057; Veening JG, 2010, FLUIDS BARRIERS CNS, V7, DOI 10.1186/1743-8454-7-1; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073; WATERHOUSE JM, 1970, J NEUROL SCI, V10, P305, DOI 10.1016/0022-510X(70)90157-7; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Zhang WM, 2013, CLIN BIOCHEM, V46, P694, DOI 10.1016/j.clinbiochem.2012.11.008	71	17	17	0	4	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.		2014	5								159	10.3389/fneur.2014.00159			12	Clinical Neurology; Neurosciences	Neurosciences & Neurology	V42QW	WOS:000209629300152	25228896	DOAJ Gold, Green Published			2021-06-18	
J	Vermetten, E; Greenberg, N; Boeschoten, MA; Delahaije, R; Jetly, R; Castro, CA; McFarlane, AC				Vermetten, Eric; Greenberg, Neil; Boeschoten, Manon A.; Delahaije, Roos; Jetly, Rakesh; Castro, Carl A.; McFarlane, Alexander C.			Deployment-related mental health support: comparative analysis of NATO and allied ISAF partners	EUROPEAN JOURNAL OF PSYCHOTRAUMATOLOGY			English	Article						Military; deployment; mental health; NATO; review	POSTTRAUMATIC-STRESS-DISORDER; TRAUMATIC BRAIN-INJURY; NATIONAL-GUARD SOLDIERS; UK ARMED-FORCES; RANDOMIZED CONTROLLED-TRIAL; MILITARY PERSONNEL; PEACEKEEPING OPERATIONS; IRAQ RANDOMIZATION; RISK-MANAGEMENT; COMBAT STRESS	Background: For years there has been a tremendous gap in our understanding of the mental health effects of deployment and the efforts by military forces at trying to minimize or mitigate these. Many military forces have recently systematized the mental support that is provided to support operational deployments. However, the rationale for doing so and the consequential allocation of resources are felt to vary considerably across North Atlantic Treaty Organisation (NATO) International Security Assistance (ISAF) partners. This review aims to compare the organization and practice of mental support by five partnering countries in the recent deployment in Afghanistan in order to identify and compare the key methods and structures for delivering mental health support, describe bottlenecks and illustrate new developments. Method: Information was collected through document analysis and semi-structured interviews with key military mental healthcare stakeholders. The review resulted from close collaboration between key military mental healthcare professionals within the Australian Defense Forces (ADF), Canadian Armed Forces (CAF), United Kingdom Armed Forces (UK), Netherlands Armed Forces (NLD), and the United States Army (US). Key stakeholders were interviewed about the mental health support provided during a serviceperson's military career. The main items discussed were training, prevention, early identification, intervention, and aftercare in the field of mental health. Results: All forces reported that much attention was paid to mental health during the individual's military career, including deployment. In doing so there was much overlap between the rationale and applied methods. The main method of providing support was through training and education. The educative focus was to strengthen the mental resilience of individual soldiers while providing a range of mental healthcare services. All forces had abandoned standard psychological debriefing after critical incidents. Instead, by default, mental healthcare professionals acted to support the leader and peer led "after action'' reviews. All countries provided professional mental support close to the front line, aimed at early detection and early return to normal activities within the unit. All countries deployed a mental health support team that consisted of a range of mental health staff including psychiatrists, psychologists, social workers, mental health nurses, and chaplains. There was no overall consensus in the allocation of mental health disciplines in theatre. All countries (except the US) provided troops with a third location decompression (TLD) stop after deployment, which aimed to recognize what the deployed units had been through and to prepare them for transition home. The US conducted in-garrison 'decompression', or 'reintegration training' in the US, with a similiar focus to TLD. All had a reasonably comparable infrastructure in the field of mental healthcare. Shared bottlenecks across countries included perceived stigma and barriers to care around mental health problems as well as the need for improving the awareness and recognition of mental health problems among service members. Conclusion: This analysis demonstrated that in all five partners state-of-the-art preventative mental healthcare was included in the last deployment in Afghanistan, including a positive approach towards strengthening the mental resilience, a focus on self-regulatory skills and self-empowerment, and several initiatives that were well-integrated in a military context. These initiatives were partly/completely implemented by the military/colleagues/supervisors and applicable during several phases of the deployment cycle. Important new developments in operational mental health support are recognition of the role of social leadership and enhancement of operational peer support. This requires awareness of mental problems that will contribute to reduction of the barriers to care in case of problems. Finally, comparing mental health support services across countries can contribute to optimal preparation for the challenges of military deployment.	[Vermetten, Eric] Mil Mental Hlth Res, Dept Def, NL-3500 EZ Utrecht, Netherlands; [Vermetten, Eric] Leiden Univ, Med Ctr, Dept Psychiat, Leiden, Netherlands; [Vermetten, Eric; Boeschoten, Manon A.] Arq Psychotrauma Res Grp, Diemen, Netherlands; [Greenberg, Neil] Kings Coll London, Weston Educ Ctr, Acad Ctr Def Mental Hlth, London, England; [Delahaije, Roos] Netherlands Org Appl Sci Res TNO, Def Safety & Secur, Soesterberg, Netherlands; [Jetly, Rakesh] Natl Def, Hlth Serv Grp, Directorate Mental Hlth, Ottawa, ON, Canada; [Castro, Carl A.] Univ So Calif, Sch Social Work, Los Angeles, CA 90089 USA; [McFarlane, Alexander C.] Univ Adelaide, Ctr Traumat Stress Studies, Adelaide, SA, Australia	Vermetten, E (corresponding author), Mil Mental Hlth Res, Lundlaan 1, NL-3500 EZ Utrecht, Netherlands.	hgjm.vermetten@mindef.nl	Vermetten, Eric/B-1335-2008	Vermetten, Eric/0000-0003-0579-4404; Boeschoten, Manon/0000-0001-5722-0731; greenberg, neil/0000-0003-4550-2971			Adler AB, 2008, MIL MED, V173, P10, DOI 10.7205/MILMED.173.1.10; Adler AB, 2013, MIL MED, V178, P760, DOI 10.7205/MILMED-D-12-00549; Adler AB, 2009, MIL MED, V174, P21, DOI 10.7205/MILMED-D-00-2208; Adler AB, 2009, J CONSULT CLIN PSYCH, V77, P928, DOI 10.1037/a0016877; Andrews B, 2007, AM J PSYCHIAT, V164, P1319, DOI 10.1176/appi.ajp.2007.06091491; Bartone PT, 1998, MIL MED, V163, P587; Britt T W, 2001, J Occup Health Psychol, V6, P53, DOI 10.1037/1076-8998.6.1.53; Britt TW, 2007, MIL MED, V172, P157, DOI 10.7205/MILMED.172.2.157; Britt TW, 2012, PSYCHOL SERV, V9, P26, DOI 10.1037/a0026412; Britt TW, 2004, MIL MED, V169, P541, DOI 10.7205/MILMED.169.7.541; Bryant RA, 2013, JAMA PSYCHIAT, V70, P839, DOI 10.1001/jamapsychiatry.2013.1137; Carty J, 2006, J AFFECT DISORDERS, V90, P257, DOI 10.1016/j.jad.2005.11.011; Castro CA, 2012, J TRAUMA STRESS, V25, P376, DOI 10.1002/jts.21721; Creamer M, 2005, BEHAV RES THER, V43, P1383, DOI 10.1016/j.brat.2004.11.001; Creamer M, 2001, PSYCHOL MED, V31, P1237, DOI 10.1017/S0033291701004287; Davidovitz R, 2007, J PERS SOC PSYCHOL, V93, P632, DOI 10.1037/0022-3514.93.4.632; Davis JJ, 2013, REHABIL PSYCHOL, V58, P36, DOI 10.1037/a0031525; Engelhard IM, 2007, BRIT J PSYCHIAT, V191, P140, DOI 10.1192/bjp.bp.106.034884; Fear NT, 2010, LANCET, V375, P1783, DOI 10.1016/S0140-6736(10)60672-1; Goodwin L, 2012, J NERV MENT DIS, V200, P429, DOI 10.1097/NMD.0b013e31825322fe; Gould M, 2010, J ROY SOC MED, V103, P148, DOI 10.1258/jrsm.2010.090426; Greenberg N, 2011, OCCUP MED-OXFORD, V61, P184, DOI 10.1093/occmed/kqr022; Greenberg N, 2008, J R Army Med Corps, V154, P124; Greenberg N, 2010, J TRAUMA STRESS, V23, P430, DOI 10.1002/jts.20538; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2006, JAMA-J AM MED ASSOC, V295, P1023, DOI 10.1001/jama.295.9.1023; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Horesh D, 2011, SOC PSYCH PSYCH EPID, V46, P863, DOI 10.1007/s00127-010-0255-6; Hunt E, 2013, OCCUP MED-OXFORD, V63, P549, DOI 10.1093/occmed/kqt113; Hyams KC, 2006, BMJ-BRIT MED J, V333, P979, DOI 10.1136/bmj.39023.648970.80; Institute of Medicine (IOM), 2014, PREV PSYCH DIS SERV; Iversen AC, 2008, PSYCHOL MED, V38, P511, DOI 10.1017/S0033291708002778; Iversen AC, 2009, BMC PSYCHIATRY, V9, DOI 10.1186/1471-244X-9-68; Johnson WB, 2010, MIL MED, V175, P548, DOI 10.7205/MILMED-D-09-00119; Jones E, 2003, J TRAUMA STRESS, V16, P411, DOI 10.1023/A:1024426321072; Jones N, 2013, OCCUP ENVIRON MED, V70, P439, DOI 10.1136/oemed-2012-101229; Jones N, 2012, PSYCHIATRY, V75, P49, DOI 10.1521/psyc.2012.75.1.49; Jones N, 2010, PSYCHIATRY, V73, P352, DOI 10.1521/psyc.2010.73.4.352; Keller RT, 2005, MIL MED, V170, P355, DOI 10.7205/MILMED.170.5.355; Kelsall HL, 2009, AM J EPIDEMIOL, V170, P1048, DOI 10.1093/aje/kwp238; Killgore WDS, 2008, J PSYCHIATR RES, V42, P1112, DOI 10.1016/j.jpsychires.2008.01.001; Kim PY, 2010, PSYCHIAT SERV, V61, P582, DOI 10.1176/ps.2010.61.6.582; Kok BC, 2012, J NERV MENT DIS, V200, P444, DOI 10.1097/NMD.0b013e3182532312; Luxton DD, 2011, SLEEP, V34, P1189, DOI 10.5665/SLEEP.1236; Mulligan K, 2011, PSYCHOL MED, V41, P673, DOI 10.1017/S003329171000125X; Mulligan K, 2012, J CONSULT CLIN PSYCH, V80, P331, DOI 10.1037/a0027664; Peterson C, 2011, AM PSYCHOL, V66, P10, DOI 10.1037/a0021658; Pfeiffer PN, 2012, MIL MED, V177, P1471, DOI 10.7205/MILMED-D-12-00115; Pietrzak Robert H, 2009, J Spec Oper Med, V9, P74; Rona RJ, 2006, BMJ-BRIT MED J, V333, P991, DOI 10.1136/BMJ.38985.610949.55; Ruff Robert L, 2010, F1000 Med Rep, V2, P64, DOI 10.3410/M2-64; Sareen J, 2007, ARCH GEN PSYCHIAT, V64, P843, DOI 10.1001/archpsyc.64.7.843; Seligman MEP, 2011, AM PSYCHOL, V66, P82, DOI 10.1037/a0021898; Smid GE, 2013, SOC PSYCH PSYCH EPID, V48, P1743, DOI 10.1007/s00127-013-0709-8; Smid GE, 2009, J CLIN PSYCHIAT, V70, P1572, DOI 10.4088/JCP.08r04484; Smith TC, 2009, PUBLIC HEALTH REP, V124, P90, DOI 10.1177/003335490912400112; Solomon Z, 2006, AM J PSYCHIAT, V163, P659, DOI 10.1176/appi.ajp.163.4.659; Solomon Z, 2005, AM J PSYCHIAT, V162, P2309, DOI 10.1176/appi.ajp.162.12.2309; SOLOMON Z, 1991, SOC PSYCH PSYCH EPID, V26, P8, DOI 10.1007/BF00783574; SOLOMON Z, 1991, SOC PSYCH PSYCH EPID, V26, P1, DOI 10.1007/BF00783573; Solomon Z, 2006, J NERV MENT DIS, V194, P935, DOI 10.1097/01.nmd.0000249060.48248.ba; Steenkamp MM, 2013, AM J PREV MED, V44, P507, DOI 10.1016/j.amepre.2013.01.013; Theeler BJ, 2008, HEADACHE, V48, P876, DOI 10.1111/j.1526-4610.2008.01159.x; Thomas JL, 2010, ARCH GEN PSYCHIAT, V67, P614, DOI 10.1001/archgenpsychiatry.2010.54; van Emmerik AAP, 2002, LANCET, V360, P766, DOI 10.1016/S0140-6736(02)09897-5; Vanderploeg RD, 2009, ARCH PHYS MED REHAB, V90, P1084, DOI 10.1016/j.apmr.2009.01.023; Vasterling JJ, 2010, J TRAUMA STRESS, V23, P41, DOI 10.1002/jts.20487; Wallace D, 2009, AUSTRALAS PSYCHIATRY, V17, P218, DOI 10.1080/10398560902878679; Wilk JE, 2012, PSYCHOSOM MED, V74, P249, DOI 10.1097/PSY.0b013e318244c604; Wittchen HU, 2012, INT J METH PSYCH RES, V21, P98, DOI 10.1002/mpr.1356	70	17	17	2	42	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	2000-8066			EUR J PSYCHOTRAUMATO	Eur. J. Psychotraumatol.		2014	5								23732	10.3402/ejpt.v5.23732			19	Psychology, Clinical; Psychiatry	Psychology; Psychiatry	AO2HD	WOS:000341138300001	25206953	DOAJ Gold, Green Published			2021-06-18	
J	Wortzel, HS; Arciniegas, DB				Wortzel, Hal S.; Arciniegas, David B.			The DSM-5 approach to the evaluation of traumatic brain injury and its neuropsychiatric sequelae	NEUROREHABILITATION			English	Article						Traumatic brain injury; cognition disorders; DSM-5	MONTREAL COGNITIVE ASSESSMENT; MINI-MENTAL-STATE; MILD HEAD-INJURY; COMPUTED-TOMOGRAPHY; POSTCONCUSSIONAL DISORDER; INTRACRANIAL INJURY; UNIFIED DEFINITION; IV CRITERIA; MANAGEMENT; RECOVERY	INTRODUCTION: The advent of the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) is accompanied by substantial changes in the approach taken in this manual to traumatic brain injury (TBI) and its neuropsychiatric sequelae. OBJECTIVE: This article reviews the issues pertaining to the treatment of TBI in the DSM-5, and changes relative to the outgoing DSM-IV-TR. The primary context for discussion of TBI in the DSM-5 is the section on Neurocognitive Disorders, where a basic framework is provided for the retrospective diagnosis of TBI and characterization of the clinical presentation as a Mild or Major Neurocognitive Disorder. The distinctions between these conditions rest not on the initial severity of TBI but instead on the severity of posttraumatic cognitive impairments and their effects on everyday function. The text succinctly reviews the epidemiology, phenomenology, and natural history of TBI and highlights the need to consider the differential diagnosis for persistent postconcussive symptoms. CONCLUSION: The approach taken to the diagnosis of TBI and its neuropsychiatric consequences in the DSM-5 is improved substantially over that of the DSM-IV-TR, and it is likely to improve the evaluations of persons with TBI by mental health professionals. However, challenges borne of this approach are likely to be revealed as it is implemented in everyday practice and will guide the development of this section of DSM-5.1.	[Wortzel, Hal S.] Denver Vet Affairs Med Ctr, Denver, CO USA; [Wortzel, Hal S.] Univ Colorado, Sch Med, Dept Psychiat, Div Forens Psychiat, Aurora, CO USA; [Wortzel, Hal S.; Arciniegas, David B.] Univ Colorado, Sch Med, Dept Psychiat, Neuropsychiat Serv, Aurora, CO USA; [Wortzel, Hal S.; Arciniegas, David B.] Baylor Coll Med, Menninger Dept Psychiat & Behav Sci, Beth K & Stuart C Yudofsky Div Neuropsychiat, Houston, TX 77030 USA; [Arciniegas, David B.] TIRR Mem Hermann, Brain Injury Res Ctr, Houston, TX USA	Wortzel, HS (corresponding author), Denver Vet Hosp, VISN 19 MIRECC,1055 Clermont St, Denver, CO 80220 USA.	hal.wortzel@ucdenver.edu			Veterans Health Administration's VISN-19 MIRECC; National Institute on Disability and Rehabilitation Research (NIDRR) [H133A120020, H133A130047]	Support for this work was provided by the Veterans Health Administration's VISN-19 MIRECC (HSW) and National Institute on Disability and Rehabilitation Research (NIDRR) grants H133A120020 and H133A130047 (DBA). The content is solely the responsibility of the authors and does not necessarily represent the official views of the Department of Veterans Affairs or NIDRR.	American Psychiatric Association, 2013, DIAGN STAT MAN MENT, V5, DOI [10.1176/appi.books.9780890425596., DOI 10.1176/APPI.BOOKS.9780890425596, 10.1176/appi.books.9780890425596]; American Psychiatric Association, 1987, DIAGN STAT MAN MENT; American Psychiatric Association, 1980, DIAGN STAT MAN MENT, V3rd; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Arciniegas D. B., 2013, MANAGEMENT ADULTS TR; Arciniegas D. B., 2013, MANAGEMENT ADULTS TR, P25; Arciniegas DB, 2008, CRIT CARE CLIN, V24, P737, DOI 10.1016/j.ccc.2008.06.001; Arciniegas David B, 2005, Neuropsychiatr Dis Treat, V1, P311; Arciniegas David B, 2011, Dialogues Clin Neurosci, V13, P325; Arciniegas DB, 2010, PSYCHIAT ANN, V40, P540, DOI 10.3928/00485713-20101022-05; Arciniegas DB, 2001, BRAIN INJURY, V15, P649, DOI 10.1080/02699050010019800; Arciniegas DB, 2013, BEHAV NEUROLOGY NEUR, P344; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Boake C, 2005, J NEUROPSYCH CLIN N, V17, P350, DOI 10.1176/appi.neuropsych.17.3.350; Boake C, 2004, J NEUROPSYCH CLIN N, V16, P493, DOI 10.1176/appi.neuropsych.16.4.493; BORCZUK P, 1995, ANN EMERG MED, V25, P731, DOI 10.1016/S0196-0644(95)70199-0; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; CRUM RM, 1993, JAMA-J AM MED ASSOC, V269, P2386, DOI 10.1001/jama.269.18.2386; Department of Veterans Affairs and Department of Defense, 2009, CLIN PRACT GUID MAN; DIKMEN S, 1986, J NEUROL NEUROSUR PS, V49, P1227, DOI 10.1136/jnnp.49.11.1227; Dikmen S S, 1995, J Int Neuropsychol Soc, V1, P67; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Frances A, 2010, J AM ACAD PSYCHIATRY, V38, P11; Frances A, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1168; HARAD FT, 1992, J TRAUMA, V32, P359, DOI 10.1097/00005373-199203000-00014; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Holm L, 2005, J REHABIL MED, V37, P137, DOI 10.1080/16501970510027321; Iverson GL, 2006, BRAIN INJURY, V20, P1335, DOI 10.1080/02699050601082156; Kashluba S, 2008, ARCH PHYS MED REHAB, V89, P904, DOI 10.1016/j.apmr.2007.12.029; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Larrabee GJ., 1997, SEMIN CLIN NEUROPSYC, V2, P196, DOI [10.1053/SCNP00200196, DOI 10.1053/SCNP00200196]; Leon-Carrion J, 2002, NEUROREHABILITATION, V17, P115; Malloy PF, 1997, J NEUROPSYCH CLIN N, V9, P189; Marr A., 2002, CTR NERVOUS SYSTEM I; McAllister TW, 2002, NEUROREHABILITATION, V17, P357; McCauley SR, 2005, J NERV MENT DIS, V193, P540, DOI 10.1097/01.nmd.0000172592.05801.71; McCauley SR, 2008, J CLIN EXP NEUROPSYC, V30, P360, DOI 10.1080/13803390701416635; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Miller Erik C., 1997, Journal of Emergency Medicine, V15, P453, DOI 10.1016/S0736-4679(97)00071-1; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; National Institute of Neurological Disorders and Stroke Common Data Elements Team, 2013, TRAUM BRAIN INJ COMM; Rossetti HC, 2011, NEUROLOGY, V77, P1272, DOI 10.1212/WNL.0b013e318230208a; Ruff RM, 1999, BRAIN INJURY, V13, P943; SCHYNOLL W, 1993, AM J EMERG MED, V11, P321, DOI 10.1016/0735-6757(93)90160-D; SHACKFORD SR, 1992, J TRAUMA, V33, P385, DOI 10.1097/00005373-199209000-00009; Silver JM., 2011, TXB TRAUMATIC BRAIN, V2nd ed.; Silver JM, 2009, AM J PSYCHIAT, V166, P653, DOI 10.1176/appi.ajp.2009.08111676; STEIN SC, 1992, J TRAUMA, V33, P11, DOI 10.1097/00005373-199207000-00003; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Stuss DT, 1999, J NEUROSURG, V90, P635, DOI 10.3171/jns.1999.90.4.0635; TEASDALE G, 1974, LANCET, V2, P81; van der Naalt J, 1999, ANN NEUROL, V46, P70, DOI 10.1002/1531-8249(199907)46:1<70::AID-ANA11>3.0.CO;2-L; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; Wortzel HS, 2013, BEHAV SCI LAW, V31, P721, DOI 10.1002/bsl.2079; Wortzel HS, 2013, J AM ACAD PSYCHIATRY, V41, P274; Wortzel HS, 2013, J PSYCHIATR PRACT, V19, P238, DOI 10.1097/01.pra.0000430508.44768.9d; Zasler ND, 2013, BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION, P1	60	17	17	0	21	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2014	34	4					613	623		10.3233/NRE-141086			11	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	AK5CY	WOS:000338443100003	24820171				2021-06-18	
J	Xu, FF; Sun, S; Ho, ASW; Lee, D; Kiang, KMY; Zhang, XQ; Wang, AM; Wu, EX; Lui, WM; Liu, BY; Leung, GKK				Xu, Fei-Fan; Sun, Stella; Ho, Amy S. W.; Lee, Derek; Kiang, Karrie M. Y.; Zhang, Xiao-Qin; Wang, Anna M.; Wu, Ed X.; Lui, Wai-Man; Liu, Bai-Yun; Leung, Gilberto K. K.			Effects of progesterone vs. dexamethasone on brain oedema and inflammatory responses following experimental brain resection	BRAIN INJURY			English	Article						Brain oedema; dexamethasone; inflammation; matrix metalloproteinase 9; progesterone; surgical brain injury	GENE KNOCK-OUT; MATRIX METALLOPROTEINASES; INJURY; BARRIER; EXPRESSION; RECOVERY; NEUROPROTECTION; MECHANISMS; ISCHEMIA; ABLATION	Background: Dexamethasone (DEXA) is commonly used to reduce brain swelling during neurosurgical procedures. DEXA, however, has many side-effects that can increase the risks of post-operative complications. In contrast, progesterone (PRO) has fewer side-effects and has been found to be neuroprotective on traumatic brain injury (TBI). Whether PRO may be used as an alternative to DEXA during routine procedures has not been fully explored. Object: To compare the effects of DEXA and PRO on surgical brain injury (SBI). Methods: Seventy-five adult male Sprague Dawley rats were randomized into five groups: (1) SBI + drug vehicle (peanut oil, 1ml kg(-1)); (2) SBI + DEXA (1 mg kg(-1)); (3) SBI + low-dose PRO (10 mg kg(-1)); (4) SBI + high-dose PRO (20 mg kg(-1)); and (5) sham SBI + drug vehicle. Magnetic resonance imaging study and assessments of brain water content (BWC), blood-brain barrier (BBB) permeability, cellular inflammatory responses and matrix metalloproteinase 9 (MMP-9) expression were conducted. Results: This model consistently resulted in increased BWC and BBB disruption. PRO reduced astrocyte and microglia responses and attenuated brain oedema with preservation of BBB. A significant down-regulation of MMP-9 expression occurred in the PRO 20 group. Conclusions: PRO is as effective as DEXA in reducing brain oedema and inflammation following SBI; 10 mg kg(-1) of PRO was demonstrated to be more effective in relieving acute cellular inflammatory responses.	[Xu, Fei-Fan; Sun, Stella; Ho, Amy S. W.; Lee, Derek; Kiang, Karrie M. Y.; Zhang, Xiao-Qin; Lui, Wai-Man; Liu, Bai-Yun; Leung, Gilberto K. K.] Univ Hong Kong, Queen Mary Hosp, Li Ka Shing Fac Med, Div Neurosurg,Dept Surg, Hong Kong, Hong Kong, Peoples R China; [Xu, Fei-Fan] Capital Med Univ, Beijing Tiantan Hosp, Dept Neurosurg, Beijing, Peoples R China; [Wang, Anna M.; Wu, Ed X.] Univ Hong Kong, Lab Biomed Imaging & Signal Proc, Hong Kong, Hong Kong, Peoples R China; [Wang, Anna M.; Wu, Ed X.] Univ Hong Kong, Dept Elect & Elect Engn, Hong Kong, Hong Kong, Peoples R China; [Liu, Bai-Yun] Beijing Neurosurg Inst, Beijing, Peoples R China; [Liu, Bai-Yun] Chinese Peoples Armed Police Force, Gen Hosp, Dept Neurotrauma, Beijing, Peoples R China	Leung, GKK (corresponding author), Univ Hong Kong, Queen Mary Hosp, Li Ka Shing Fac Med, Div Neurosurg,Dept Surg, Hong Kong, Hong Kong, Peoples R China.	gilberto@hku.hk	Kiang, Karrie Mei-Yee/ABI-2656-2020; Wu, Ed Xuekui/C-1579-2009; Leung, Gilberto Ka Kit/C-4337-2009	Wu, Ed Xuekui/0000-0001-5581-1546; Leung, Gilberto Ka Kit/0000-0003-3147-3057			Alderson P, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000196.pub2; Anderson GD, 2011, J NEUROTRAUM, V28, P1827, DOI 10.1089/neu.2011.1911; Asahi M, 2001, J NEUROSCI, V21, P7724; Asbury ET, 1998, BEHAV BRAIN RES, V97, P99, DOI 10.1016/S0166-4328(98)00031-X; ATTELLA MJ, 1987, BEHAV NEURAL BIOL, V48, P352, DOI 10.1016/S0163-1047(87)90918-6; Barnes PJ, 2005, IMMUNOL ALLERGY CLIN, V25, P451, DOI 10.1016/j.iac.2005.05.003; Barzo P, 1996, J NEUROSURG, V85, P1113, DOI 10.3171/jns.1996.85.6.1113; Barzo P, 1997, J NEUROSURG, V87, P900, DOI 10.3171/jns.1997.87.6.0900; Baughman Verna L, 2002, Anesthesiol Clin North Am, V20, P315, DOI 10.1016/S0889-8537(01)00004-9; Bebawy JF, 2012, J NEUROSURG ANESTH, V24, P173, DOI 10.1097/ANA.0b013e3182578bb5; Candelario-Jalil E, 2009, NEUROSCIENCE, V158, P983, DOI 10.1016/j.neuroscience.2008.06.025; Cutler SM, 2007, J NEUROTRAUM, V24, P1475, DOI 10.1089/neu.2007.0294; Das M, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-236; Deutsch ER, 2013, BRAIN RES, V1530, P82, DOI 10.1016/j.brainres.2013.07.014; Ding JY, 2009, BRAIN RES, V1268, P125, DOI 10.1016/j.brainres.2009.02.060; Donkin JJ, 2010, CURR OPIN NEUROL, V23, P293, DOI 10.1097/WCO.0b013e328337f451; Garay L, 2007, J STEROID BIOCHEM, V107, P228, DOI 10.1016/j.jsbmb.2007.03.040; Gibson CL, 2008, BRAIN, V131, P318, DOI 10.1093/brain/awm183; Goldstein LB, 1999, RESTOR NEUROL NEUROS, V15, P39; Goss CW, 2003, PHARMACOL BIOCHEM BE, V76, P231, DOI 10.1016/j.pbb.2003.07.003; Grossman KJ, 2004, BRAIN RES, V1008, P29, DOI 10.1016/j.brainres.2004.02.022; Guo QM, 2006, EXP NEUROL, V198, P469, DOI 10.1016/j.expneurol.2005.12.013; Habgood MD, 2007, EUR J NEUROSCI, V25, P231, DOI 10.1111/j.1460-9568.2006.05275.x; HANSTOCK CC, 1994, STROKE, V25, P843, DOI 10.1161/01.STR.25.4.843; Hayashi T, 2009, BRAIN RES, V1280, P172, DOI 10.1016/j.brainres.2009.05.040; Ishrat T, 2010, EXP NEUROL, V226, P183, DOI 10.1016/j.expneurol.2010.08.023; Jadhav V, 2007, SURG NEUROL, V67, P15, DOI 10.1016/j.surneu.2006.07.014; Jiang C, 2009, INFLAMM RES, V58, P619, DOI 10.1007/s00011-009-0032-8; Kilts JD, 2010, PAIN MED, V11, P1469, DOI 10.1111/j.1526-4637.2010.00927.x; Maghool F, 2013, BRAIN RES, V1497, P61, DOI 10.1016/j.brainres.2012.12.014; Marmarou A, 2000, J NEUROSURG, V93, P183, DOI 10.3171/jns.2000.93.2.0183; Marmarou A, 2003, ACT NEUR S, V86, P7; MILLER JD, 1975, J NEUROSURG, V42, P274, DOI 10.3171/jns.1975.42.3.0274; Roof RL, 1996, EXP NEUROL, V138, P246, DOI 10.1006/exnr.1996.0063; Rosenberg Gary A, 2007, Neurosurg Focus, V22, pE4; Rosenberg GA, 2009, LANCET NEUROL, V8, P205, DOI 10.1016/S1474-4422(09)70016-X; Sayeed I, 2009, PROG BRAIN RES, V175, P219, DOI 10.1016/S0079-6123(09)17515-5; Schumacher M, 1996, DEV NEUROSCI-BASEL, V18, P6, DOI 10.1159/000111391; Singh M, 2008, FRONT BIOSCI-LANDMRK, V13, P1083, DOI 10.2741/2746; Singh M, 2013, HORM BEHAV, V63, P284, DOI 10.1016/j.yhbeh.2012.06.003; Stein DG, 2008, BRAIN RES REV, V57, P386, DOI 10.1016/j.brainresrev.2007.06.012; Stein DG, 2008, ANN EMERG MED, V51, P164, DOI 10.1016/j.annemergmed.2007.05.001; Stein Donald G, 2011, Dialogues Clin Neurosci, V13, P352; Tang HL, 2013, HORM BEHAV, V64, P527, DOI 10.1016/j.yhbeh.2013.06.009; Un KC, 2013, J CLIN NEUROSCI, V20, P1329, DOI 10.1016/j.jocn.2012.10.032; VECHT CJ, 1994, NEUROLOGY, V44, P675, DOI 10.1212/WNL.44.4.675; Wang JP, 2009, BRAIN RES BULL, V79, P426, DOI 10.1016/j.brainresbull.2009.05.018; Wang XY, 2000, J NEUROSCI, V20, P7037, DOI 10.1523/JNEUROSCI.20-18-07037.2000; Wojtal K, 2006, PHARMACOL REP, V58, P335; Wright DW, 2007, ANN EMERG MED, V49, P391, DOI 10.1016/j.annemergmed.2006.07.932; Wright DW, 2001, J NEUROTRAUM, V18, P901, DOI 10.1089/089771501750451820; Xiao GM, 2008, CRIT CARE, V12, DOI 10.1186/cc6887; Yamaguchi M, 2007, NEUROSURGERY, V61, P1067, DOI 10.1227/01.neu.0000303203.07866.18	53	17	18	0	10	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2014	28	12					1594	1601		10.3109/02699052.2014.943289			8	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	AR6UD	WOS:000343717700011	25093611				2021-06-18	
J	Xue, FT; Stoica, BA; Hanscom, M; Kabadi, SV; Faden, AI				Xue, Fengtian; Stoica, Bogdan A.; Hanscom, Marie; Kabadi, Shruti V.; Faden, Alan I.			Positive Allosteric Modulators (PAMs) of Metabotropic Glutamate Receptor 5 (mGluR5) Attenuate Microglial Activation	CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS			English	Article						Metabotropic glutamate receptor 5; microglial activation; neuroinflammation; neuroprotection; positive allosteric modulator; traumatic brain injury	PROTEIN-COUPLED RECEPTORS; IN-VIVO; BRAIN-INJURY; DRUG DEVELOPMENT; CELL-DEATH; RAT; DISCOVERY; VITRO; SUBTYPE-5; APOPTOSIS	Traumatic brain injury causes progressive neurodegeneration associated with chronic microglial activation. Recent studies show that neurodegeneration and neuroinflammation after traumatic brain injury can be inhibited as late as one month in animals by the activation of the metabotropic glutamate receptor 5 in microglia using (RS)-2-chloro-5-hydroxy-phenylglycine. However, the therapeutic potential of this agonist is limited due to its relatively weak potency and brain permeability. To address such concerns, we evaluated the anti-inflammatory activities of several positive allosteric modulators using various in vitro assays, and found that 3,3'-difluorobenzaldazine, 3-cyano-N-(1,3-diphenyl-1H-pyrazol-5-yl) benzamide and 4-nitro-N-(1-(2-fluorophenyl)-3-phenyl-1H-pyrazol-5-yl) benzamide showed significantly improved potency which makes them potential lead compounds for further development of positive allosteric modulators for the treatment of traumatic brain injury.	[Xue, Fengtian; Stoica, Bogdan A.; Hanscom, Marie; Kabadi, Shruti V.; Faden, Alan I.] Univ Maryland, Sch Med, Dept Anesthesiol, Baltimore, MD 21201 USA; [Xue, Fengtian] Univ Maryland, Sch Pharm, Dept Pharmaceut Sci, Baltimore, MD 21201 USA	Xue, FT (corresponding author), Univ Maryland, Sch Pharm, Dept Pharmaceut Sci, 20 Penn St, Baltimore, MD 21201 USA.	fxue@rx.umaryland.edu	STOICA, BOGDAN/H-9782-2013	STOICA, BOGDAN/0000-0002-2501-6434; Faden, Alan I./0000-0003-0128-2348; Hanscom, Marie/0000-0001-8308-135X			Allen JW, 1999, NEUROPHARMACOLOGY, V38, P1243, DOI 10.1016/S0028-3908(99)00044-1; Allen JW, 2000, CELL DEATH DIFFER, V7, P470, DOI 10.1038/sj.cdd.4400678; Aloisi F, 2001, GLIA, V36, P165, DOI 10.1002/glia.1106; Arkhipov V. I., 2011, Eksperimental'naya i Klinicheskaya Farmakologiya, V74, P46; Ayala JE, 2009, NEUROPSYCHOPHARMACOL, V34, P2057, DOI 10.1038/npp.2009.30; Byrnes KR, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-43; Cleva RM, 2011, MOLECULES, V16, P2097, DOI 10.3390/molecules16032097; Conigrave AD, 2010, PHARMACOL THERAPEUT, V127, P252, DOI 10.1016/j.pharmthera.2010.04.007; de Paulis T, 2006, J MED CHEM, V49, P3332, DOI 10.1021/jm051252j; Doherty AJ, 1997, NEUROPHARMACOLOGY, V36, P265, DOI 10.1016/S0028-3908(97)00001-4; Engers DW, 2009, CHEMMEDCHEM, V4, P505, DOI 10.1002/cmdc.200800357; Enz R, 2012, CURR DRUG TARGETS, V13, P145, DOI 10.2174/138945012798868452; Fei Z, 2006, J CLIN NEUROSCI, V13, P1023, DOI 10.1016/j.jocn.2005.11.042; Gass JT, 2009, BIOL PSYCHIAT, V65, P717, DOI 10.1016/j.biopsych.2008.11.001; Gravius A, 2008, J NEURAL TRANSM, V115, P1609, DOI 10.1007/s00702-008-0098-4; Homayoun H, 2004, NEUROPSYCHOPHARMACOL, V29, P1259, DOI 10.1038/sj.npp.1300417; Homayoun H, 2010, EUR J PHARMACOL, V639, P33, DOI 10.1016/j.ejphar.2009.12.042; Kinney GG, 2005, J PHARMACOL EXP THER, V313, P199, DOI 10.1124/jpet.104.079244; Kinney GG, 2003, J PHARMACOL EXP THER, V306, P116, DOI 10.1124/jpet.103.048702; Kunishima N, 2000, NATURE, V407, P971, DOI 10.1038/35039564; Lamb JP, 2011, BIOORG MED CHEM LETT, V21, P2711, DOI 10.1016/j.bmcl.2010.11.119; Lecourtier L, 2007, BIOL PSYCHIAT, V62, P739, DOI 10.1016/j.biopsych.2006.12.003; Lindsley CW, 2004, J MED CHEM, V47, P5825, DOI 10.1021/jm049400d; Loane DJ, 2009, J BIOL CHEM, V284, P15629, DOI 10.1074/jbc.M806139200; Maeda J, 2007, BRAIN RES, V1157, P100, DOI 10.1016/j.brainres.2007.04.054; Molcanyi M, 2007, J NEUROTRAUM, V24, P625, DOI 10.1089/neu.2006.0180; Movsesyan VA, 2004, J NEUROCHEM, V89, P1528, DOI 10.1111/j.1471-4159.2004.02451.x; NAKANISHI S, 1992, SCIENCE, V258, P597, DOI 10.1126/science.1329206; O'Brien JA, 2004, J PHARMACOL EXP THER, V309, P568, DOI 10.1124/jpet.103.061747; O'Brien JA, 2003, MOL PHARMACOL, V64, P731, DOI 10.1124/mol.64.3.731; Olive MF, 2010, EUR J PHARMACOL, V639, P47, DOI 10.1016/j.ejphar.2010.01.029; Pierce JES, 1998, NEUROSCIENCE, V87, P359, DOI 10.1016/S0306-4522(98)00142-0; Piers TM, 2011, NEUROSCI LETT, V505, P140, DOI 10.1016/j.neulet.2011.10.007; Pin JP, 2003, PHARMACOL THERAPEUT, V98, P325, DOI 10.1016/S0163-7258(03)00038-X; PIN JP, 1995, NEUROPHARMACOLOGY, V34, P1, DOI 10.1016/0028-3908(94)00129-G; Recasens M, 2007, CURR DRUG TARGETS, V8, P651, DOI 10.2174/138945007780618544; Sharma S, 2009, J MED CHEM, V52, P4103, DOI 10.1021/jm900654c; Shindo T, 2006, J MED INVESTIG, V53, P42, DOI 10.2152/jmi.53.42; Smith DH, 1997, J NEUROTRAUM, V14, P715, DOI 10.1089/neu.1997.14.715; Stauffer SR, 2011, ACS CHEM NEUROSCI, V2, P450, DOI 10.1021/cn2000519; Szydlowska K, 2007, EUR J PHARMACOL, V554, P18, DOI 10.1016/j.ejphar.2006.09.061; Tharmalingam S, 2012, NEUROPHARMACOLOGY, V63, P667, DOI 10.1016/j.neuropharm.2012.05.029; Vilhardt F, 2005, INT J BIOCHEM CELL B, V37, P17, DOI 10.1016/j.biocel.2004.06.010; Wilms H, 2003, NEUROBIOL DIS, V14, P417, DOI 10.1016/j.nbd.2003.07.002; Yasuhara Akito, 2010, Open Med Chem J, V4, P20, DOI 10.2174/1874104501004020020; Zhao ZJ, 2007, BIOORG MED CHEM LETT, V17, P1386, DOI 10.1016/j.bmcl.2006.11.081; Zhou Y, 2010, ACS MED CHEM LETT, V1, P433, DOI 10.1021/ml100181a	47	17	17	0	1	BENTHAM SCIENCE PUBL	BUSUM	PO BOX 294, BUSUM, 1400 AG, NETHERLANDS	1871-5273	1996-3181		CNS NEUROL DISORD-DR	CNS Neurol. Disord.-Drug Targets		2014	13	4					558	566		10.2174/18715273113126660199			9	Neurosciences; Pharmacology & Pharmacy	Neurosciences & Neurology; Pharmacology & Pharmacy	AN8EO	WOS:000340836200004	24168364				2021-06-18	
J	Yang, B; Tse, KM; Chen, N; Tan, LB; Zheng, QQ; Yang, HM; Hu, M; Pan, G; Lee, HP				Yang, Bin; Tse, Kwong-Ming; Chen, Ning; Tan, Long-Bin; Zheng, Qing-Qian; Yang, Hui-Min; Hu, Min; Pan, Gang; Lee, Heow-Pueh			Development of a Finite Element Head Model for the Study of Impact Head Injury	BIOMED RESEARCH INTERNATIONAL			English	Article							TRAUMATIC BRAIN-INJURY; DEFORMATION; SEGMENTATION; BIOMECHANICS; VALIDATION; GENERATION; CARTILAGE; BEHAVIOR; TISSUE; MOTION	This study is aimed at developing a high quality, validated finite element (FE) human head model for traumatic brain injuries (TBI) prediction and prevention during vehicle collisions. The geometry of the FE model was based on computed tomography (CT) and magnetic resonance imaging (MRI) scans of a volunteer close to the anthropometry of a 50th percentile male. The material and structural properties were selected based on a synthesis of current knowledge of the constitutive models for each tissue. The cerebrospinal fluid (CSF) was simulated explicitly as a hydrostatic fluid by using a surface-based fluid modeling method. The model was validated in the loading condition observed in frontal impact vehicle collision. These validations include the intracranial pressure (ICP), brain motion, impact force and intracranial acceleration response, maximum von Mises stress in the brain, and maximum principal stress in the skull. Overall results obtained in the validation indicated improved biofidelity relative to previous FE models, and the change in the maximum von Mises in the brain is mainly caused by the improvement of the CSF simulation. The model may be used for improving the current injury criteria of the brain and anthropometric test devices.	[Yang, Bin; Chen, Ning; Zheng, Qing-Qian; Yang, Hui-Min; Hu, Min; Pan, Gang] Nanjing Forestry Univ, Coll Automobile & Traff Engn, Nanjing 210037, Jiangsu, Peoples R China; [Yang, Bin; Tse, Kwong-Ming; Tan, Long-Bin; Lee, Heow-Pueh] Natl Univ Singapore, Dept Mech Engn, Singapore 117576, Singapore	Yang, B (corresponding author), Nanjing Forestry Univ, Coll Automobile & Traff Engn, Nanjing 210037, Jiangsu, Peoples R China.	yangb123@126.com	Lee, Heow Pueh/I-7834-2014; Tse, Kwong Ming/D-8669-2011	Lee, Heow Pueh/0000-0002-4380-3888; Tse, Kwong Ming/0000-0002-8170-0775; Tan, Long Bin/0000-0002-3897-7365	National Natural Science FoundationNational Natural Science Foundation of China (NSFC) [11272159, 11172099]; Jiangsu Overseas Research & Training Program for University Prominent Young & Middle-Aged Teachers and Presidents of China	The financial supports from the National Natural Science Foundation (Grant nos. 11272159 and 11172099) and Jiangsu Overseas Research & Training Program for University Prominent Young & Middle-Aged Teachers and Presidents of China are acknowledged. This research was undertaken at the Department of Mechanical Engineering in National University of Singapore.	Al-Bsharat A. S., 2000, THESIS WAYNE STATE U; Allsop D. L., 1988, P 32 STAPP CAR CRASH, P139; Bilston LE, 2011, STUD MECHANOBIOL TIS, V3, P11, DOI 10.1007/8415_2010_36; Boltcheva D, 2009, LECT NOTES COMPUT SC, V5762, P283; Chatelin S, 2010, BIORHEOLOGY, V47, P255, DOI 10.3233/BIR-2010-0576; Claessans M., 1997, P 41 STAPP CAR CRASH, P315, DOI DOI 10.4271/973338; Cloots RJH, 2008, ANN BIOMED ENG, V36, P1203, DOI 10.1007/s10439-008-9510-3; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Farmanzad F, 2007, BIO-MED MATER ENG, V17, P119; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Grellmann W, 2006, J BIOMED MATER RES A, V78A, P168, DOI 10.1002/jbm.a.30625; Hardy WN, 2007, STAPP CAR CRASH JO, V51, P17; Hertz E, 1993, 37 ANN P ASS ADV AUT, P303; Horgan TJ, 2004, INT J CRASHWORTHINES, V9, P401, DOI 10.1533/ijcr.2004.0299; Horgan TJ, 2003, INT J CRASHWORTHINES, V8, P353, DOI 10.1533/cras.8.4.353.19278; Huang SC, 1999, BIO-MED MATER ENG, V9, P61; Kang HS, 1997, P STAPP CAR CRASH J, V41, P329; Kim YH, 2014, COMPUT METHOD BIOMEC, V17, P997, DOI 10.1080/10255842.2012.731594; Kleiven S, 2006, INT J CRASHWORTHINES, V11, P65, DOI 10.1533/ijcr.2005.0384; Kleiven S., 2001, P INT C BIOM IMP IRC, P161; Kleiven Svein, 2002, Stapp Car Crash J, V46, P123; Lin Q. F., 2006, J TRANSPORTATION SYS, V6, P73; Mao HJ, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4025101; Marjoux D, 2008, ACCIDENT ANAL PREV, V40, P1135, DOI 10.1016/j.aap.2007.12.006; MENDIS KK, 1995, J BIOMECH ENG-T ASME, V117, P279, DOI 10.1115/1.2794182; Meyer M, 2008, IEEE T VIS COMPUT GR, V14, P1539, DOI 10.1109/TVCG.2008.154; Monson K. L., 2001, THESIS U CALIFORNIA; Nahum AM., 1977, P 21 STAPP CAR CRASH, P339, DOI [10.4271/770922., DOI 10.4271/770922]; Netter F, 1997, ATLAS HUMAN ANATOMY; Nyquist G. W., 1986, P 30 STAPP CAR CRASH; Pons JP, 2007, LECT NOTES COMPUT SC, V4584, P198; Rooij L. V., 2003, P 17 INT C ENH SAF V; Ruan J. S., 1993, P 37 STAPP CAR CRASH, P69, DOI DOI 10.4271/933114; RUAN JS, 1994, J BIOMECH ENG-T ASME, V116, P44, DOI 10.1115/1.2895703; Sabet AA, 2008, J BIOMECH, V41, P307, DOI 10.1016/j.jbiomech.2007.09.016; SHUCK LZ, 1972, J BASIC ENG-T ASME, V94, P905, DOI 10.1115/1.3425588; Simms C, 2009, SOLID MECH APPL, V166, P75; Summers CR, 2009, MT SINAI J MED, V76, P105, DOI 10.1002/msj.20100; Takhounts EG, 2008, STAPP CAR C, V52, P1; Teasdale G. M., 1999, J NEUROL NEUROSUR PS, V558, P526; Tse KM, 2014, INT J NUMER METH BIO, V30, P397, DOI 10.1002/cnm.2609; Turquier F, 1996, STAPP CAR C, VP-30, P283; Ward C. C., 1980, P 24 STAPP CAR CRASH, P347; Westreich RW, 2007, ARCH FACIAL PLAST S, V9, P264, DOI 10.1001/archfaci.9.4.264; WILLINGER R, 1995, J NEUROTRAUM, V12, P743, DOI 10.1089/neu.1995.12.743; Willinger R, 1999, ANN BIOMED ENG, V27, P403, DOI 10.1114/1.165; Wu X, 2008, J TRAUMA, V64, P1313, DOI 10.1097/TA.0b013e318165c803; Yan WY, 2011, COMPUT METHOD BIOMEC, V14, P1049, DOI 10.1080/10255842.2010.506435; Yoganandan N, 2004, CLIN BIOMECH, V19, P225, DOI 10.1016/j.clinbiomech.2003.12.014; Yoganandan N, 2009, J BIOMECH, V42, P1177, DOI 10.1016/j.jbiomech.2009.03.029; Zhang LY, 2001, J NEUROTRAUM, V18, P21, DOI 10.1089/089771501750055749; Zhang YJ, 2010, COMPUT METHOD APPL M, V199, P405, DOI 10.1016/j.cma.2009.06.007; Zhou C., 1995, P 39 STAPP CAR CRASH, P121	53	17	17	0	27	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	2314-6133	2314-6141		BIOMED RES INT	Biomed Res. Int.		2014	2014								408278	10.1155/2014/408278			14	Biotechnology & Applied Microbiology; Medicine, Research & Experimental	Biotechnology & Applied Microbiology; Research & Experimental Medicine	AX5RK	WOS:000346984500001	25405201	DOAJ Gold, Green Published			2021-06-18	
J	Zhang, XP; Yan, XW; Gorman, J; Hoffman, SN; Zhang, L; Boscarino, JA				Zhang, Xiaopeng; Yan, Xiaowei; Gorman, Jennifer; Hoffman, Stuart N.; Zhang, Li; Boscarino, Joseph A.			Perioperative hyperglycemia is associated with postoperative neurocognitive disorders after cardiac surgery	NEUROPSYCHIATRIC DISEASE AND TREATMENT			English	Article						insulin resistance; neurocognitive disorders; intensive care; gender	CORONARY-ARTERY-BYPASS; TRAUMATIC BRAIN-INJURY; VENOUS OXYGEN-SATURATION; COGNITIVE DYSFUNCTION; INSULIN-RESISTANCE; CARDIOPULMONARY BYPASS; BLOOD-TRANSFUSION; DIABETES-MELLITUS; RANDOMIZED-TRIAL; GLUCOSE CONTROL	Objective: Neurocognitive disorders commonly occur following cardiac surgery. However, the underlying etiology of these disorders is not well understood. The current study examined the association between perioperative glucose levels and other risk factors and the onset of neurocognitive disorders in adult patients following coronary artery bypass and/or valvular surgery. Methods: Adult patients who underwent their first cardiac surgery at a large tertiary care medical center were identified and those with neurocognitive disorders prior to surgery were excluded. Demographic, perioperative, and postoperative neurocognitive outcome data were extracted from the Society for Thoracic Surgery database, and from electronic medical records, between January 2004 and June 2009. Multiple clinical risk factors and measures associated with insulin resistance, such as hyperglycemia, were assessed. Multivariable Cox competing risk survival models were used to assess hyperglycemia and postoperative neurocognitive disorders at follow up, adjusting for other risk factors and confounding variables. Results: Of the 855 patients included in the study, 271 (31.7%) had new onset neurocognitive disorders at follow-up. Age, sex, New York Heart Failure (NYHF) Class, length of postoperative intensive care unit stay, perioperative blood product transfusion, and other key factors were identified and assessed as potential risk factors (or confounders) for neurocognitive disorders at follow-up. Bivariate analyses suggested that new onset neurocognitive disorders were associated with NYHF Class, cardiopulmonary bypass, history of diabetes, intraoperative blood product use, and number of diseased coronary vessels, which are commonly-accepted risk factors in cardiac surgery. In addition, higher first glucose level (median=116 mg/dL) and higher peak glucose >169 mg/dL were identified as risk factors. Male sex and nonuse of intra-operative blood products appeared to be protective. Controlling for potential risk factors and confounders, multivariable Cox survival models suggested that increased perioperative first glucose measured in 20 unit increments, was significantly associated with the onset of postoperative neurocognitive disorders at follow-up (hazard ratio [HR]=1.16, P<0.001) and that women had an elevated risk for this outcome (HR=4.18, P=0.01). Conclusion: Our study suggests that perioperative hyperglycemia was associated with new onset of postoperative neurocognitive disorders in adult patients after cardiac surgery, and that men tended to be protected from these outcomes. These findings may suggest a need for the revision of clinical protocols for perioperative insulin therapy to prevent long-term neurocognitive complications.	[Zhang, Xiaopeng; Zhang, Li] Geisinger Med Ctr, Dept Anesthesiol, Danville, PA 17822 USA; [Yan, Xiaowei; Gorman, Jennifer; Boscarino, Joseph A.] Weis Ctr Res, Geisinger Clin, Ctr Hlth Res, Danville, PA 17822 USA; [Hoffman, Stuart N.] Geisinger Med Ctr, Dept Neurol, Danville, PA 17822 USA	Zhang, XP (corresponding author), Geisinger Med Ctr, Dept Anesthesiol, 100 North Acad Ave, Danville, PA 17822 USA.	xzhang1@geisinger.edu			Geisinger Clinic Research Fund	This work was funded by the Geisinger Clinic Research Fund. We would like to thank Ms Amanda Bengier and Ms Mary Ann Blosky, RN, for their assistance in data collection and project management, and Drs Alfred S Casale, Joel J Berberich, Xianren Wu and Thomas M Schieble for making this project possible.	Anastasiadis K, 2011, HEART, V97, P1082, DOI 10.1136/hrt.2010.218610; Anderson RE, 2005, EUR J CARDIO-THORAC, V28, P425, DOI 10.1016/j.ejcts.2005.05.025; Baker LD, 2011, ARCH NEUROL-CHICAGO, V68, P51, DOI 10.1001/archneurol.2010.225; Boodhwani M, 2007, J THORAC CARDIOV SUR, V134, P1453, DOI 10.1016/j.jtcvs.2007.08.025; Boodhwani M, 2007, J THORAC CARDIOV SUR, V134, P1443, DOI 10.1016/j.jtcvs.2007.08.016; Boodhwani M, 2006, CIRCULATION, V114, pI461, DOI 10.1161/CIRCULATIONAHA.105.001354; Brazinova A, 2010, J NEUROTRAUM, V27, P1549, DOI 10.1089/neu.2010.1315; Bruno A, 1999, NEUROLOGY, V52, P280, DOI 10.1212/WNL.52.2.280; Bucciarelli-Ducci C, 2006, AM J CARDIOL, V98, P1349, DOI 10.1016/j.amjcard.2006.06.025; Charlson ME, 2007, J CARDIAC SURG, V22, P465, DOI 10.1111/j.1540-8191.2007.00471.x; Cheng DCH, 1996, J THORAC CARDIOV SUR, V112, P755, DOI 10.1016/S0022-5223(96)70062-4; de la Monte SM, 2010, J ALZHEIMERS DIS, V21, P967, DOI 10.3233/JAD-2010-091726; Degroot A, 2003, BRAIN RES, V979, P71, DOI 10.1016/S0006-8993(03)02868-3; Dennis SH, 2011, J NEUROSCI, V31, P11941, DOI 10.1523/JNEUROSCI.1183-11.2011; Dungan K, 2011, DIABETES OBES METAB, V13, P1130, DOI 10.1111/j.1463-1326.2011.01474.x; Faivre E, 2011, J NEUROPHYSIOL, V105, P1574, DOI 10.1152/jn.00866.2010; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Finfer S, 2009, NEW ENGL J MED, V360, P1283, DOI 10.1056/NEJMoa0810625; Gerriets T, 2010, EUR HEART J, V31, P360, DOI 10.1093/eurheartj/ehp178; Gold JP, 2004, ANN THORAC SURG, V78, P1579, DOI 10.1016/j.athoracsur.2004.05.051; Gore DC, 2001, J TRAUMA, V51, P540, DOI 10.1097/00005373-200109000-00021; Grigore AM, 2002, ANESTH ANALG, V94, P4, DOI 10.1097/00000539-200201000-00002; Haljan G, 2009, STROKE, V40, P2769, DOI 10.1161/STROKEAHA.109.549436; Hammon JW, 2006, J THORAC CARDIOV SUR, V131, P114, DOI 10.1016/j.jtcvs.2005.08.057; Hannerz H, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000180; Heo K, 2003, CEREBROVASC DIS, V15, P230, DOI 10.1159/000068825; Hill J, 2010, J NEUROTRAUM, V27, P1439, DOI 10.1089/neu.2010.1328; Hogue CW, 2003, ANN THORAC SURG, V76, P1119, DOI 10.1016/S0003-4975(03)00817-8; Holinski S, 2011, ANN THORAC CARDIOVAS, V17, P137, DOI 10.5761/atcs.oa.10.01545; Howell NJ, 2011, CIRCULATION, V123, P170, DOI 10.1161/CIRCULATIONAHA.110.945170; Hudetz JA, 2009, ACTA ANAESTH SCAND, V53, P864, DOI 10.1111/j.1399-6576.2009.01978.x; Hui L, 2005, BRAIN RES, V1052, P1, DOI 10.1016/j.brainres.2005.05.043; Ingels C, 2006, EUR HEART J, V27, P2716, DOI 10.1093/eurheartj/ehi855; Iverson KM, 2011, WOMEN HEALTH ISS, V21, pS210, DOI 10.1016/j.whi.2011.04.019; Kadoi Y, 2005, J THORAC CARDIOV SUR, V129, P576, DOI 10.1016/j.jtcvs.2004.07.012; Kawahara F, 2003, ACTA ANAESTH SCAND, V47, P419, DOI 10.1034/j.1399-6576.2003.00063.x; Kozora E, 2010, ANN THORAC SURG, V90, P1134, DOI 10.1016/j.athoracsur.2010.05.076; Krebs-Kraft DL, 2008, NEUROBIOL LEARN MEM, V89, P142, DOI 10.1016/j.nlm.2007.07.008; Lang BT, 2009, BRAIN RES, V1258, P25, DOI 10.1016/j.brainres.2008.12.026; Leitgeb J, 2011, J TRAUMA, V71, P1620, DOI 10.1097/TA.0b013e318226ea0e; Lennmyr F, 2010, CRIT CARE MED, V38, P1726, DOI 10.1097/CCM.0b013e3181e7982e; Martin ED, 2012, CEREB CORTEX, V22, P1717, DOI 10.1093/cercor/bhr216; Mathew JP, 2009, STROKE, V40, P880, DOI 10.1161/STROKEAHA.108.531236; McNay EC, 2010, NEUROBIOL LEARN MEM, V93, P546, DOI 10.1016/j.nlm.2010.02.002; Meyer LE, 2006, J BIOL CHEM, V281, P37361, DOI 10.1074/jbc.M604123200; Moreira T, 2007, NEUROSCIENCE, V144, P1169, DOI 10.1016/j.neuroscience.2006.10.054; Nagasawa H, 2005, J NEUROL, V252, P1541, DOI 10.1007/s00415-005-0878-9; Notzold A, 2006, THORAC CARDIOV SURG, V54, P307, DOI 10.1055/s-2006-924089; Nuttall GA, 1998, CRIT CARE MED, V26, P1351, DOI 10.1097/00003246-199808000-00019; Pei D, 2003, J ENDOCRINOL INVEST, V26, P397, DOI 10.1007/BF03345193; Porizka M, 2011, EUR J CARDIO-THORAC, V39, P442, DOI 10.1016/j.ejcts.2010.11.054; Reger MA, 2008, NEUROLOGY, V70, P440, DOI 10.1212/01.WNL.0000265401.62434.36; Saczynski JS, 2008, AM J EPIDEMIOL, V168, P1132, DOI 10.1093/aje/kwn228; Sanderson TH, 2009, NEUROL RES, V31, P947, DOI 10.1179/174313209X382449; Siepe M, 2011, EUR J CARDIO-THORAC, V40, P200, DOI 10.1016/j.ejcts.2010.11.024; Silbert BS, 2006, ANESTHESIOLOGY, V104, P1137, DOI 10.1097/00000542-200606000-00007; Smith MJ, 2004, J NEUROSURG, V101, P1, DOI 10.3171/jns.2004.101.1.0001; Stanley TO, 2002, ANESTH ANALG, V94, P290, DOI 10.1097/00000539-200202000-00011; Suh SW, 2007, J CLIN INVEST, V117, P910, DOI 10.1172/JCI30077; Szalma I, 2006, ANN THORAC SURG, V82, P1430, DOI 10.1016/j.athoracsur.2006.05.005; Tong M, 2009, J ALZHEIMERS DIS, V17, P827, DOI 10.3233/JAD-2009-1115; van Dijk D, 2007, JAMA-J AM MED ASSOC, V297, P701, DOI 10.1001/jama.297.7.701; VENN GE, 1995, ANN THORAC SURG, V59, P1331, DOI 10.1016/0003-4975(95)00096-4; Verhoeven JJ, 2011, PEDIATR CARDIOL, V32, P131, DOI 10.1007/s00246-010-9829-z; VOLL CL, 1991, J CEREBR BLOOD F MET, V11, P1006, DOI 10.1038/jcbfm.1991.168; Williamson JD, 2007, AM J CARDIOL, V99, p112I, DOI 10.1016/j.amjcard.2007.03.029; Winocur G, 2005, BEHAV NEUROSCI, V119, P1389, DOI 10.1037/0735-7044.119.5.1389; Yamada S, 2005, CEREBROVASC DIS, V20, P164, DOI 10.1159/000087200; Yoshitani K, 2001, ANESTH ANALG, V92, P1370; Zhang XP, 2006, J CEREBR BLOOD F MET, V26, P915, DOI 10.1038/sj.jcbfm.9600238; Zhong J, 2009, NEUROL RES, V31, P483, DOI 10.1179/174313208X338133	71	17	19	0	6	DOVE MEDICAL PRESS LTD	ALBANY	PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND		1178-2021		NEUROPSYCH DIS TREAT	Neuropsychiatr. Dis. Treat.		2014	10						361	369		10.2147/NDT.S57761			9	Clinical Neurology; Psychiatry	Neurosciences & Neurology; Psychiatry	AB5ZD	WOS:000331866300001	24570589	DOAJ Gold, Green Published			2021-06-18	
J	Astur, N; Klimo, P; Sawyer, JR; Kelly, DM; Muhlbauer, MS; Warner, WC				Astur, Nelson; Klimo, Paul, Jr.; Sawyer, Jeffrey R.; Kelly, Derek M.; Muhlbauer, Michael S.; Warner, William C., Jr.			Traumatic Atlanto-Occipital Dislocation in Children Evaluation, Treatment, and Outcomes	JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME			English	Article								Background: Advancements in emergency care and diagnostic methods have increased the number of children who survive atlanto-occipital dislocation. We report our experience with one of the largest series of pediatric patients with atlanto-occipital dislocation. Methods: Patients ranging in age from newborn to sixteen years old who had a diagnosis of atlanto-occipital dislocation from 1991 through 2011 were identified. Inclusion criteria were complete radiographic and clinical records and duration of follow-up of at least six months. Basic patient characteristics, mechanism of injury, associated injuries, neurological impairment, surgical treatment and type of implant used for fixation, complications, and clinical and radiographic outcomes were recorded. Results: The fourteen patients who were included (seven male and seven female) had a mean age of 5.2 years at the time of injury. An automobile accident in which the victim was a passenger was the most common mechanism of injury. Twelve patients had associated injuries, with a brain injury in eleven of them, and nearly half sustained a spinal cord injury. According to the Traynelis classification system, eight patients had a type-II (longitudinal) atlanto-occipital dislocation, five had a typed (anterior) dislocation, and one had a type-Ill (posterior) dislocation. All patients had posterior occipitocervical fusion with internal fixation. The mean duration of follow-up was 75.4 months. The most common postoperative complication was hydrocephalus, which occurred in four patients. Spinal fusion occurred in all patients by four to six months postoperatively. At the time of the most recent follow-up evaluation, half of the patients had neurological impairment. Conclusions: More patients with atlanto-occipital dislocation now survive the initial trauma, although most have associated injuries and many have neurological impairment. Our preferred management is early occipitocervical fusion and stabilization. If there is neurological decline after spinal fixation, obstructive hydrocephalus should be suspected.	[Astur, Nelson; Klimo, Paul, Jr.; Sawyer, Jeffrey R.; Kelly, Derek M.; Muhlbauer, Michael S.; Warner, William C., Jr.] Le Bonheur Childrens Hosp, Memphis, TN USA	Astur, N (corresponding author), Le Bonheur Childrens Hosp, Memphis, TN USA.		Astur, Nelson/F-3267-2015	Astur, Nelson/0000-0002-2608-2118				0	17	18	0	3	JOURNAL BONE JOINT SURGERY INC	NEEDHAM	20 PICKERING ST, NEEDHAM, MA 02192 USA	0021-9355			J BONE JOINT SURG AM	J. Bone Joint Surg.-Am. Vol.	DEC 18	2013	95A	24					2213	2213		10.2106/JBJS.L.01295			1	Orthopedics; Surgery	Orthopedics; Surgery	273IG	WOS:000328527900010	24352780				2021-06-18	
J	Leng, DD; Han, WJ; Rui, Y; Dai, Y; Xia, YF				Leng, Dan-dan; Han, Wen-jing; Rui, Yao; Dai, Yue; Xia, Yu-feng			In vivo disposition and metabolism of madecassoside, a major bioactive constituent in Centella asiatica (L.) Urb.	JOURNAL OF ETHNOPHARMACOLOGY			English	Article						Madecassoside; Tissue distribution; Excretion; Metabolism; Enterohepatic circulation; Hepatobiliary transporter	COLLAGEN-INDUCED ARTHRITIS; TISSUE DISTRIBUTION; MASS-SPECTROMETRY; MICE; RAT; PHARMACOKINETICS; EXCRETION	Ethnopharmacological relevance: Centella asiatica (L.) Urb. herb is frequently used in traditional Chinese medicine for many indications, such as traumatic injuries, keloid and scar. Madecassoside is the main active ingredient of this herb drug with higher content than other triterpenoid constituents. Understandings of pharmacokinetic profiles of madecassoside should be beneficial for its development as a therapeutic agent. Materials and methods: Sprague-Dawley rats were intravenously and orally administered madecassoside (100 mg/kg), respectively. Plasma, heart, liver, spleen, lung, kidney, brain, bile, urine and feces were collected at the designed time points. Madecassoside concentrations in biological samples were determined by a sensitive and well-validated liquid chromatography-electrospray ionization-mass spectrometry (LC-ESI-MS) method. A liquid chromatography coupled with time-of-flight mass spectrometry (LC-TOF-MS) method was established to identify its major metabolites in feces. To further pursue the disposition characteristics of madecassoside in rats, the involvement of the hepatobiliary efflux transporters in biliary elimination were studied by combination with digoxin (P-glycoprotein inhibitor) or probenecid (multidrug resistance-associated protein inhibitor). A linked-rat model was also used to assess the role of enterohepatic circulation in the pharmacokinetics of madecassoside. Results: After a single oral dosing, madecassoside was widely distributed in heart, liver, spleen, lung and kidney of rats, and the levels of madecassoside in liver and kidney were relatively higher than other organs. The excretions of madecassoside in bile, urine and feces were 7.16% (0-12 h), 0.25% (0-72 h) and 24.68% (0-72 h), respectively. The findings suggested that madecassoside might excrete mainly by metabolites. The combination with either digoxin or probenecid significantly attenuated the excretion of madecassoside as parent from bile, indicating that P-glycoprotein and multidrug resistance-associated protein might contribute to the hepatobiliary elimination of madecassoside. The presence of enterohepatic circulation, as implied by double-humped profiles in plasma and tissue concentration-time curves, was confirmed by a linked-rat model. Furthermore, three metabolities of madecassoside were indentified in rat feces and the possible metabolic pathways were proposed. Conclusions: These findings provide valuable information regarding in vivo process of madecassoside, and help us to recognize the efficacy and safety of madecassoside itself, the relevant herbs or herbal preparations. (C) 2013 Elsevier Ireland Ltd. All rights reserved.	[Leng, Dan-dan; Han, Wen-jing; Dai, Yue; Xia, Yu-feng] China Pharmaceut Univ, State Key Lab Nat Med, Nanjing 210009, Peoples R China; [Leng, Dan-dan; Han, Wen-jing; Rui, Yao; Xia, Yu-feng] China Pharmaceut Univ, Dept Chinese Mat Med Anal, Nanjing 210009, Peoples R China; [Dai, Yue] China Pharmaceut Univ, Dept Pharmacol Chinese Mat Med, Nanjing 210009, Peoples R China	Xia, YF (corresponding author), China Pharmaceut Univ, Dept Chinese Mat Med Anal, 24 Tong Jia Xiang, Nanjing 210009, Peoples R China.	yfxiacpu@126.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81173631]; National Innovative Research Plan for Undergraduate Students of China [J0630858]; Qing lan Project of Jiangsu Province; Priority Academic Program Development of Jiangsu Higher Education Institutions	The research was financially supported by the National Natural Science Foundation of China (No. 81173631), National Innovative Research Plan for Undergraduate Students of China (No. J0630858), Qing lan Project of Jiangsu Province, and partially funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions.	BOITEAU P, 1956, Therapie, V11, P125; Cao W, 2010, INT IMMUNOPHARMACOL, V10, P723, DOI 10.1016/j.intimp.2010.03.015; Chen LH, 2013, J ETHNOPHARMACOL, V145, P77, DOI 10.1016/j.jep.2012.09.054; Fardel O, 2001, TOXICOLOGY, V167, P37, DOI 10.1016/S0300-483X(01)00456-5; Han WJ, 2012, BIOMED CHROMATOGR, V26, P26, DOI 10.1002/bmc.1620; Li Gui-gui, 2007, Yaoxue Xuebao, V42, P475; Li HZ, 2009, PHYTOMEDICINE, V16, P538, DOI 10.1016/j.phymed.2008.11.002; Liu M, 2008, INT IMMUNOPHARMACOL, V8, P1561, DOI 10.1016/j.intimp.2008.06.011; Liu M, 2008, PLANTA MED, V74, P809, DOI 10.1055/s-2008-1074533; Liu Mu-Rong, 2004, Zhong Xi Yi Jie He Xue Bao, V2, P440; Marier JF, 2002, J PHARMACOL EXP THER, V302, P369, DOI 10.1124/jpet.102.033340; Song J, 2012, BURNS, V38, P677, DOI 10.1016/j.burns.2011.12.017; Sun XH, 2009, J PHARMACEUT BIOMED, V50, P27, DOI 10.1016/j.jpba.2009.03.011; Thomas MT, 2010, IND CROP PROD, V32, P545, DOI 10.1016/j.indcrop.2010.07.003; Wang R, 2008, J PHOTOCH PHOTOBIO B, V90, P179, DOI 10.1016/j.jphotobiol.2008.01.003; 张蕾磊, 2007, [中草药, Chinese Traditional and Herbal Drugs], V38, P455	16	17	21	0	36	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0378-8741			J ETHNOPHARMACOL	J. Ethnopharmacol.	NOV 25	2013	150	2					601	608		10.1016/j.jep.2013.09.004			8	Plant Sciences; Chemistry, Medicinal; Integrative & Complementary Medicine; Pharmacology & Pharmacy	Plant Sciences; Pharmacology & Pharmacy; Integrative & Complementary Medicine	260AR	WOS:000327567900024	24091240				2021-06-18	
J	Greer, J; Riby, DM; Hamiliton, C; Riby, LM				Greer, Joanna; Riby, Deborah M.; Hamiliton, Colin; Riby, Leigh M.			Attentional lapse and inhibition control in adults with Williams Syndrome	RESEARCH IN DEVELOPMENTAL DISABILITIES			English	Article						Williams Syndrome; Ageing; Cognition; Inhibition; Executive function; Attentional lapse; Concentration	TRAUMATIC BRAIN-INJURY; SUSTAINED ATTENTION; EXECUTIVE FUNCTION; DEFICIT/HYPERACTIVITY DISORDER; AGE; FAILURES; DISSOCIATION; PERFORMANCE; COGNITION; ACCURACY	Research exploring cognitive processing associated with Williams Syndrome (WS) has suggested that executive functioning deficits exist across the developmental spectrum. Such executive functions include problem solving, planning, dividing attention and inhibiting responses. Within a framework of executive functions, the aim of the current study was to explore attentional lapse and inhibition skills in older adults with WS (n = 20; aged 36-61 yr) and consider the implications of deficits within this group. Participants with WS were compared to typical adults of the same chronological age and typical older adults (aged 65+ yr) to consider attentional changes seen in the ageing process. The study employed a sustained attention to response task known to assess inhibition and attentional lapse but which had not previously been used with this population. Compared to both groups of typical matches, the results indicated atypicalities of attention and inhibition in adults with WS. Specifically, compared to the typical matches, adults with WS failed to withhold a response (showing inhibition deficits), had problems re-engaging attentional control processes after making an error and showed a generalised deficit of concentration and task engagement. We conclude that further attention should be paid to the cognitive capacity of older individuals with WS in order to consider the everyday challenges faced by this group and to provide adequate intervention and support for daily living. (C) 2013 Elsevier Ltd. All rights reserved.	[Greer, Joanna; Hamiliton, Colin; Riby, Leigh M.] Northumbria Univ, Dept Psychol, Newcastle Upon Tyne NE1 8ST, Tyne & Wear, England; [Riby, Deborah M.] Univ Durham, Dept Psychol, Durham DH1 3HP, England	Riby, LM (corresponding author), Northumbria Univ, Dept Psychol, Northumberland Bldg, Newcastle Upon Tyne NE1 8ST, Tyne & Wear, England.	leigh.riby@northumbria.ac.uk	Riby, Deborah/G-8474-2013	Riby, Deborah/0000-0001-5747-8441			Alvarez JA, 2006, NEUROPSYCHOL REV, V16, P17, DOI 10.1007/s11065-006-9002-x; Bellugi U, 1999, TRENDS NEUROSCI, V22, P197, DOI 10.1016/S0166-2236(99)01397-1; Carriere JSA, 2010, PSYCHOL AGING, V25, P569, DOI 10.1037/a0019363; Costanzo F, 2013, RES DEV DISABIL, V34, P1770, DOI 10.1016/j.ridd.2013.01.024; Crosbie J, 2001, AM J PSYCHIAT, V158, P1884, DOI 10.1176/appi.ajp.158.11.1884; Dockree PM, 2004, COGNITIVE BRAIN RES, V20, P403, DOI 10.1016/j.cogbrainres.2004.03.019; Dykens EM, 2007, MENT RETARD DEV D R, V13, P272, DOI 10.1002/mrdd.20159; Greenwood PM, 2000, J INT NEUROPSYCH SOC, V6, P705, DOI 10.1017/S1355617700666092; Hasher L., 1988, PSYCHOL LEARNING MOT, V22, P193, DOI DOI 10.1016/S0079-7421(08)60041-9; Hocking DR, 2013, DEVELOPMENTAL SCI, V16, P428, DOI 10.1111/desc.12042; Johnson KA, 2007, NEUROPSYCHOLOGIA, V45, P2234, DOI 10.1016/j.neuropsychologia.2007.02.019; Jones W, 2000, J COGNITIVE NEUROSCI, V12, P30, DOI 10.1162/089892900561968; Krinsky-McHale SJ, 2005, AM J MENT RETARD, V110, P482, DOI 10.1352/0895-8017(2005)110[482:RPIAWW]2.0.CO;2; Leyfer OT, 2006, AM J MED GENET B, V141B, P615, DOI 10.1002/ajmg.b.30344; Little K, 2013, RES DEV DISABIL, V34, P959, DOI 10.1016/j.ridd.2012.11.020; McVay JC, 2013, ACTA PSYCHOL, V142, P136, DOI 10.1016/j.actpsy.2012.11.006; Meyer-Lindenberg A, 2005, NAT NEUROSCI, V8, P991, DOI 10.1038/nn1494; Mills DL, 2000, J COGNITIVE NEUROSCI, V12, P47, DOI 10.1162/089892900561977; Mobbs D, 2007, BIOL PSYCHIAT, V62, P256, DOI 10.1016/j.biopsych.2006.05.041; Nigg JT, 2001, PSYCHOL BULL, V127, P571, DOI 10.1037//0033-2909.127.5.571; Osborne Lucy R., 2007, Expert Reviews in Molecular Medicine, V9, P1, DOI 10.1017/S146239940700035X; Osorio A, 2012, RES DEV DISABIL, V33, P1169, DOI 10.1016/j.ridd.2012.02.003; Porter MA, 2005, DEV NEUROPSYCHOL, V27, P275, DOI 10.1207/s15326942dn2702_5; Rhodes SM, 2011, J CLIN EXP NEUROPSYC, V33, P147, DOI 10.1080/13803395.2010.495057; Rhodes SM, 2010, NEUROPSYCHOLOGIA, V48, P1216, DOI 10.1016/j.neuropsychologia.2009.12.021; Robertson IH, 1997, NEUROPSYCHOLOGIA, V35, P747, DOI 10.1016/S0028-3932(97)00015-8; Schmajuk M, 2006, NEUROPSYCHOLOGIA, V44, P384, DOI 10.1016/j.neuropsychologia.2005.06.005; Searcy YM, 2004, AM J MENT RETARD, V109, P231, DOI 10.1352/0895-8017(2004)109<231:TRBAAI>2.0.CO;2; Sinopoli KJ, 2012, INT J DEV NEUROSCI, V30, P207, DOI 10.1016/j.ijdevneu.2011.08.006; Slovarp L, 2012, BRAIN INJURY, V26, P48, DOI 10.3109/02699052.2011.635355; Smallwood J, 2006, CONSCIOUS COGN, V15, P218, DOI 10.1016/j.concog.2005.03.003; Smilek D, 2010, NEUROPSYCHOLOGIA, V48, P2564, DOI 10.1016/j.neuropsychologia.2010.05.002; Smith AD, 2009, PERCEPTION, V38, P694, DOI 10.1068/p6050; Starns JJ, 2010, PSYCHOL AGING, V25, P377, DOI 10.1037/a0018022; Stromme P, 2002, J CHILD NEUROL, V17, P269, DOI 10.1177/088307380201700406; Wang YK, 1997, HUM MOL GENET, V6, P465, DOI 10.1093/hmg/6.3.465; West R, 2010, CORTEX, V46, P550, DOI 10.1016/j.cortex.2009.08.001; Willcutt EG, 2005, BIOL PSYCHIAT, V57, P1336, DOI 10.1016/j.biopsych.2005.02.006; Williams LM, 2010, PEDIATR NEUROL, V42, P118, DOI 10.1016/j.pediatrneurol.2009.08.010	39	17	18	1	19	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0891-4222			RES DEV DISABIL	Res. Dev. Disabil.	NOV	2013	34	11					4170	4177		10.1016/j.ridd.2013.08.041			8	Education, Special; Rehabilitation	Education & Educational Research; Rehabilitation	251BD	WOS:000326901900056	24076981	Green Accepted			2021-06-18	
J	Roebuck-Spencer, TM; Vincent, AS; Gilliland, K; Johnson, DR; Cooper, DB				Roebuck-Spencer, Tresa M.; Vincent, Andrea S.; Gilliland, Kirby; Johnson, Dan R.; Cooper, Douglas B.			Initial Clinical Validation of an Embedded Performance Validity Measure within the Automated Neuropsychological Metrics (ANAM)	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Computer-based testing; Performance Validity Testing; ANAM; Simulators; Neuropsychology	TRAUMATIC BRAIN-INJURY; RESPONSE BIAS; MEMORY; TESTS; COMPONENTS; BATTERY; DYSFUNCTION; CONCUSSION; SIMULATION; INDICATORS	The measurement of effort and performance validity is essential for computerized testing where less direct supervision is needed. The clinical validation of an Automated Neuropsychological Metrics-Performance Validity Index (ANAM-PVI) was examined by converting ANAM test scores into a common metric based on their relative infrequency in an outpatient clinic sample with presumed good effort. Optimal ANAM-PVI cut-points were determined using receiver operator characteristic (ROC) curve analyses and an a priori specificity of 90. Sensitivity/specificity was examined in available validation samples (controls, simulators, and neurorehabilitation patients). ANAM-PVI scores differed between groups with simulators scoring the highest. ROC curve analysis indicated excellent discriminability of ANAM-PVI scores 5 to detect simulators versus controls (area under the curve 0.858; odds ratio for detecting suboptimal performance 15.6), but resulted in a 27 false-positive rate in the clinical sample. When specificity in the clinical sample was set at 90, sensitivity decreased (68), but was consistent with other embedded effort measures. Results support the ANAM-PVI as an embedded effort measure and demonstrate the value of sample-specific cut-points in groups with cognitive impairment. Examination of different cut-points indicates that clinicians should choose sample-specific cut-points based on sensitivity and specificity rates that are most appropriate for their patient population with higher cut-points for those expected to have severe cognitive impairment (e.g., dementia or severe acquired brain injury).	[Roebuck-Spencer, Tresa M.; Vincent, Andrea S.; Gilliland, Kirby] Univ Oklahoma, Cognit Sci Res Ctr, Norman, OK 73072 USA; [Johnson, Dan R.] Washington & Lee Univ, Lexington, VA 24450 USA; [Cooper, Douglas B.] SAMMC, Dept Neurol, Def & Vet Brain Injury Ctr, Ft Sam Houston, TX USA	Roebuck-Spencer, TM (corresponding author), Univ Oklahoma, Cognit Sci Res Ctr, 3200 Marshall Ave,Suite 260, Norman, OK 73072 USA.	tresa@ou.edu			U.S. Army Medical Research Acquisition Activity [W81XWH-09-1-0707]	This work was supported in part by the U.S. Army Medical Research Acquisition Activity, 1054 Patchel Street, Fort Detrick, MD 21702-5012, Project W81XWH-09-1-0707.	Allen L. M., 2006, CARB COMPUTERIZED AS; Bianchini KJ, 2001, CLIN NEUROPSYCHOL, V15, P19, DOI 10.1076/clin.15.1.19.1907; Bleiberg J, 2004, NEUROSURGERY, V54, P1073, DOI 10.1227/01.NEU.0000118820.33396.6A; Bleiberg J, 2000, CLIN NEUROPSYCHOL, V14, P287, DOI 10.1076/1385-4046(200008)14:3;1-P;FT287; Bolan B, 2002, J CLIN EXP NEUROPSYC, V24, P154, DOI 10.1076/jcen.24.2.154.1000; Boone KB, 2005, ARCH CLIN NEUROPSYCH, V20, P301, DOI 10.1016/j.acn.2004.08.001; Boone KB, 2009, CLIN NEUROPSYCHOL, V23, P729, DOI 10.1080/13854040802427803; Bryan C, 2012, J HEAD TRAUMA REHAB, V27, P45, DOI 10.1097/HTR.0b013e318238f146; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; Cercy S. P., 1997, CLIN ASSESSMENT MALI, P85; Cognitive Science Research Center (CSRC), 2012, ANAM4 COR ADM MAN; Coldren RL, 2012, MIL MED, V177, P179, DOI 10.7205/MILMED-D-11-00278; Dunn TM, 2003, ARCH CLIN NEUROPSYCH, V18, P121, DOI 10.1016/S0887-6177(01)00188-3; Friedl KE, 2007, ARCH CLIN NEUROPSYCH, V22, pS7, DOI 10.1016/j.acn.2006.10.002; Greve KW, 2004, ARCH CLIN NEUROPSYCH, V19, P533, DOI 10.1016/j.acn.2003.08.002; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; HODDES E, 1973, PSYCHOPHYSIOLOGY, V10, P431, DOI 10.1111/j.1469-8986.1973.tb00801.x; HOHLE RH, 1965, J EXP PSYCHOL, V69, P382, DOI 10.1037/h0021740; Johnson D. R., 2009, NAT AC NEUR NEW ORL; Kabat MH, 2001, CLIN NEUROPSYCHOL, V15, P498, DOI 10.1076/clin.15.4.498.1882; Kane RL, 2007, ARCH CLIN NEUROPSYCH, V22, pS115, DOI 10.1016/j.acn.2006.10.006; Kelly MP, 2012, ARCH CLIN NEUROPSYCH, V27, P375, DOI 10.1093/arclin/acs036; Kim N, 2010, ARCH CLIN NEUROPSYCH, V25, P420, DOI 10.1093/arclin/acq040; Larrabee G. J., 2007, ASSESSMENT MALINGERE, P80; Larrabee G.J., 2007, ASSESSMENT MALINGERE; Larrabee GJ, 2008, CLIN NEUROPSYCHOL, V22, P666, DOI 10.1080/13854040701494987; Lowe M, 2007, ARCH CLIN NEUROPSYCH, V22, pS89, DOI 10.1016/j.acn.2006.10.010; Luce R.D., 1986, RESPONSE TIMES THEIR; Luethcke CA, 2011, J INT NEUROPSYCH SOC, V17, P36, DOI 10.1017/S1355617710001207; Madden DJ, 1999, J COGNITIVE NEUROSCI, V11, P511, DOI 10.1162/089892999563571; McCaffrey RJ, 2007, ARCH CLIN NEUROPS S1, V22, P1; McDiarmid Melissa A, 2002, Mil Med, V167, P123; Rahill AA, 1996, AVIAT SPACE ENVIR MD, V67, P640; Reedy SD, 2013, ARCH CLIN NEUROPSYCH, V28, P30, DOI 10.1093/arclin/acs106; Rees LM, 1998, PSYCHOL ASSESSMENT, V10, P10, DOI 10.1037/1040-3590.10.1.10; Reicker LI, 2008, ARCH CLIN NEUROPSYCH, V23, P419, DOI 10.1016/j.acn.2008.02.003; ROSE FE, 1995, CLIN NEUROPSYCHOL, V9, P124, DOI 10.1080/13854049508401594; Schmiedek F, 2007, J EXP PSYCHOL GEN, V136, P414, DOI 10.1037/0096-3445.136.3.414; Silverberg ND, 2007, CLIN NEUROPSYCHOL, V21, P841, DOI 10.1080/13854040600850958; Sim A, 2008, J NEUROSURG, V108, P511, DOI 10.3171/JNS/2008/108/3/0511; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; Suhr J.A., 2007, ASSESSMENT MALINGERE, P287; Tan JE, 2002, CLIN NEUROPSYCHOL, V16, P495, DOI 10.1076/clin.16.4.495.13909; Thompson G. B., 2005, VSVT VICTORIA SYMPTO; van Gorp WG, 1999, J CLIN EXP NEUROPSYC, V21, P245; Vincent AS, 2008, MIL MED, V173, P836, DOI 10.7205/MILMED.173.9.836; Vincent AS, 2012, MIL MED, V177, P256, DOI 10.7205/MILMED-D-11-00289; Vincent AS, 2012, MIL MED, V177, P248, DOI 10.7205/MILMED-D-11-00156; Wilken JA, 2003, MULT SCLER, V9, P119, DOI 10.1191/1352458503ms893oa; Wilken JA, 2007, ARCH CLIN NEUROPSYCH, V22, pS127, DOI 10.1016/j.acn.2006.10.007; Willison J, 2006, ARCH CLIN NEUROPSYCH, V21, P41, DOI 10.1016/j.acn.2005.07.005; Woodhouse J, 2013, CLIN NEUROPSYCHOL, V27, P376, DOI 10.1080/13854046.2012.762427	52	17	17	0	12	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	NOV	2013	28	7					700	710		10.1093/arclin/act055			11	Psychology, Clinical; Psychology	Psychology	243AS	WOS:000326289300008	23887185	Bronze			2021-06-18	
J	Harman-Smith, YE; Mathias, JL; Bowden, SC; Rosenfeld, JV; Bigler, ED				Harman-Smith, Yasmin E.; Mathias, Jane L.; Bowden, Stephen C.; Rosenfeld, Jeffrey V.; Bigler, Erin D.			Wechsler Adult Intelligence Scale-Third Edition profiles and their relationship to self-reported outcome following traumatic brain injury	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						Cognitive tests; Cluster analysis; Cognitive symptoms; Functional recovery; Outcomes; Wechsler Adult Intelligence Scale-Third Edition	INDEX SCORE PATTERNS; NEUROPSYCHOLOGICAL OUTCOMES; HEAD-INJURY; EPIDEMIOLOGY; SYMPTOMS; MODERATE	Neuropsychological assessments of outcome after traumatic brain injury (TBI) are often unrelated to self-reported problems after TBI. The current study cluster-analyzed the Wechsler Adult Intelligence Scale-Third Edition (WAIS-III) subtest scores from mild, moderate, and severe TBI (n = 220) and orthopedic injury control (n = 95) groups, to determine whether specific cognitive profiles are related to people's perceived outcomes after TBI. A two-stage cluster analysis produced 4- and 6-cluster solutions, with the 6-cluster solution better capturing subtle variations in cognitive functioning. The 6 clusters differed in the levels and profiles of cognitive performance, self-reported recovery, and education and injury severity. The findings suggest that subtle cognitive impairments after TBI should be interpreted in conjunction with patient's self-reported problems.	[Harman-Smith, Yasmin E.; Mathias, Jane L.] Univ Adelaide, Sch Psychol, Adelaide, SA 5005, Australia; [Bowden, Stephen C.] Univ Melbourne, Sch Psychol Sci, Dept Psychol, Melbourne, Vic, Australia; [Rosenfeld, Jeffrey V.] Monash Univ, Dept Surg, Melbourne, Vic 3004, Australia; [Rosenfeld, Jeffrey V.] Alfred Hosp, Dept Neurosurg, Melbourne, Vic, Australia; [Bigler, Erin D.] Brigham Young Univ, Dept Psychol & Neurosci, Salt Lake City, UT USA	Mathias, JL (corresponding author), Univ Adelaide, Sch Psychol, Adelaide, SA 5005, Australia.	jane.mathias@adelaide.edu.au	Rosenfeld, Jeffrey V/B-7249-2011; Mathias, J L/L-6295-2013	Mathias, Jane/0000-0001-8957-8594; Harman-Smith, Yasmin/0000-0002-9227-8530			Aldenderfer M.S., 1984, CLUSTER ANAL; Allen DN, 2010, ARCH CLIN NEUROPSYCH, V25, P618, DOI 10.1093/arclin/acq051; Axelrod BN, 2001, CLIN NEUROPSYCHOL, V15, P516, DOI 10.1076/clin.15.4.516.1884; Babor T. F., 1989, AUDIT ALCOHOL DISORD; Bagiella E, 2010, J HEAD TRAUMA REHAB, V25, P375, DOI 10.1097/HTR.0b013e3181d27fe3; Bardenhagen FJ, 1999, NEUROCASE, V5, P325; Beck A. T., 1996, BECK DEPRESSION INVE, VII; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Boone KB, 2002, J CLIN EXP NEUROPSYC, V24, P561, DOI 10.1076/jcen.24.5.561.1004; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Callahan CD, 1997, ARCH CLIN NEUROPSYCH, V12, P133, DOI 10.1016/S0887-6177(96)00029-7; Castellanos NP, 2011, NEUROIMAGE, V55, P1189, DOI 10.1016/j.neuroimage.2010.12.046; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; Dikmen S, 2010, J INT NEUROPSYCH SOC, V16, P401, DOI 10.1017/S1355617710000196; Donders J, 2001, J INT NEUROPSYCH SOC, V7, P892, DOI 10.1017/S1355617701777132; Donders J, 2001, ASSESSMENT, V8, P193, DOI 10.1177/107319110100800207; Fisher D C, 2000, Appl Neuropsychol, V7, P126, DOI 10.1207/S15324826AN0703_2; Goldstein G, 2010, BRAIN INJURY, V24, P625, DOI 10.3109/02699051003670882; Hartikainen KM, 2010, J CLIN EXP NEUROPSYC, V32, P767, DOI 10.1080/13803390903521000; Hawkins KA, 1998, CLIN NEUROPSYCHOL, V12, P535, DOI 10.1076/clin.12.4.535.7236; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Iverson GL, 2010, BRAIN INJURY, V24, P1246, DOI 10.3109/02699052.2010.490513; JOHNSTONE B, 1995, BRAIN INJURY, V9, P377, DOI 10.3109/02699059509005777; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Lundqvist A, 2001, NEUROPSYCHOL REHABIL, V11, P171, DOI 10.1080/09602010042000240; Martin TA, 2000, REHABIL PSYCHOL, V45, P402, DOI 10.1037/0090-5550.45.4.402; Mathias JL, 2007, BRIT J CLIN PSYCHOL, V46, P457, DOI 10.1348/014466507X190197; Myburgh JA, 2008, J TRAUMA, V64, P854, DOI 10.1097/TA.0b013e3180340e77; Pertab JL, 2009, BRAIN INJURY, V23, P498, DOI 10.1080/02699050902927984; Rickels E, 2010, BRAIN INJURY, V24, P1491, DOI 10.3109/02699052.2010.498006; Schinka J A, 1997, J Int Neuropsychol Soc, V3, P120; Schroeder RW, 2012, ASSESSMENT, V19, P21, DOI 10.1177/1073191111428764; Shames J, 2007, DISABIL REHABIL, V29, P1387, DOI 10.1080/09638280701315011; Sigurdardottir S, 2009, J INT NEUROPSYCH SOC, V15, P740, DOI 10.1017/S1355617709990452; van der Heijden P, 2003, ASSESSMENT, V10, P115, DOI 10.1177/1073191103010002001; Wechsler D., 1997, WAIS 3 ADM SCORING M; Wechsler D., 2001, WECHSLER TEST ADULT; Willer B., 1993, J HEAD TRAUMA REHAB, V8, P75, DOI DOI 10.1097/00001199-199308020-00009; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Zakzanis K. K., 1999, STUD NEUROPSYCHOL DE	40	17	18	0	16	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	OCT 1	2013	35	8					785	798		10.1080/13803395.2013.824554			14	Psychology, Clinical; Clinical Neurology; Psychology	Psychology; Neurosciences & Neurology	226TQ	WOS:000325059300001	23947758				2021-06-18	
J	Olivier, J; Walter, SR				Olivier, Jake; Walter, Scott R.			Bicycle Helmet Wearing Is Not Associated with Close Motor Vehicle Passing: A Re-Analysis of Walker, 2007	PLOS ONE			English	Article							NEW-SOUTH-WALES; RISK COMPENSATION; HEAD; AUSTRALIA; SELECTION; TRIALS; INJURY; IMPACT; POWER	Objectives: To re-analyse bicycle overtaking data collected by Walker (2007) with a view to assess factors associated with close passing (<1 m), to adjust for other observed factors in a multivariable analysis, and to assess the extent to which the sample size in the original analysis may have contributed to spurious results. Method: A re-analysis of 2,355 motor vehicle passing events recorded by Walker that includes information on cyclist's distance to the kerb, vehicle size and colour, city of observation, time of day, whether the event occurred while in a bikelane and helmet wearing. Each variable was considered for a final, multivariable model using purposeful selection of variables. The analysis was repeated using multiple logistic regression with passing distance dichotomised by the one metre rule. Bootstrap p-values were computed using sample sizes computed from conventional values of power and effect size. Results: The previously observed significant association between passing distance and helmet wearing was not found when dichotomised by the one metre rule. Other factors were found to be significantly associated with close passing including cyclists' distance to the kerb, vehicle size and city of observation (Salisbury or Bristol, UK). P-values from bootstrap samples indicate the significance of helmet wearing resulted from an overly large sample size. Conclusions: After re-analysis of Walker's data, helmet wearing is not associated with close motor vehicle passing. The results, however, highlight other more important factors that may inform effective bicycle safety strategies.	[Olivier, Jake] Univ New S Wales, Sch Math & Stat, Sydney, NSW, Australia; [Walter, Scott R.] Univ New S Wales, Ctr Hlth Syst & Safety Res, Australian Inst Hlth Innovat, Sydney, NSW, Australia	Olivier, J (corresponding author), Univ New S Wales, Sch Math & Stat, Sydney, NSW, Australia.	j.olivier@unsw.edu.au	Olivier, Jake/D-2034-2012	Olivier, Jake/0000-0002-3144-4507			Amoros E, 2012, INJURY PREV, V18, P27, DOI 10.1136/ip.2011.031815; Amy Gillett Foundation, MET MATT; [Anonymous], 2011, ALBERTAS HELMET LAW; Attewell RG, 2001, ACCIDENT ANAL PREV, V33, P345, DOI 10.1016/S0001-4575(00)00048-8; Bambach MR, 2013, ACCIDENT ANAL PREV, V53, P78, DOI 10.1016/j.aap.2013.01.005; Basford L., 2002, TRL549; Bell ML, 2013, PSYCHO-ONCOLOGY, V22, P499, DOI 10.1002/pon.3046; Bursac Z, 2008, SOURCE CODE BIOL MED, V3, DOI 10.1186/1751-0473-3-17; CAMERON MH, 1994, ACCIDENT ANAL PREV, V26, P325, DOI 10.1016/0001-4575(94)90006-X; Case L. Douglas, 2007, V404, P377, DOI 10.1007/978-1-59745-530-5_19; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd; Ewald B, 2006, J CLIN EPIDEMIOL, V59, P798, DOI 10.1016/j.jclinepi.2005.11.025; Foot Rule, LIST US STAT HAV 3 F; Fox T, 2010, J AUSTRALAS COLL ROA, V21, P22; Hosmer DW, 2004, APPL LOGISTIC REGRES; Johnson M, 2011, ACCIDENT ANAL PREV, V43, P323, DOI 10.1016/j.aap.2010.08.030; Johnston MF, 2009, BMC COMPLEM ALTERN M, V9, DOI 10.1186/1472-6882-9-1; Julious SA, 2004, STAT MED, V23, P1921, DOI 10.1002/sim.1783; Khan A.M., 1995, TRANSP RES REC J TRA, V1502, P8; Lardelli-Claret P, 2003, INJURY PREV, V9, P128, DOI 10.1136/ip.9.2.128; Love DC, 2012, ACCIDENT ANAL PREV, V48, P451, DOI 10.1016/j.aap.2012.03.002; Lumley T, 2002, ANNU REV PUBL HEALTH, V23, P151, DOI 10.1146/annurev.publhealth.23.100901.140546; Macpherson A, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005401.pub2; Messiah A, 2012, AM J PUBLIC HEALTH, V102, pS204, DOI 10.2105/AJPH.2012.300711; MICKEY RM, 1989, AM J EPIDEMIOL, V129, P125, DOI 10.1093/oxfordjournals.aje.a115101; Nolan R, 2010, COMMUNICATION; Nova Scotia Government, FREQ ASK QUEST ON ME; O'Reilly M, 2012, SYDNEY MORNING HERAL; Olivier J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058777; Olivier J, 2013, ACCIDENT ANAL PREV, V50, P1128, DOI 10.1016/j.aap.2012.09.003; Phillips RO, 2011, RISK ANAL, V31, P1187, DOI 10.1111/j.1539-6924.2011.01589.x; Safe Cycling Australia, CAMP; Stone M, 2003, ACCIDENT ANAL PREV, V35, P549, DOI 10.1016/S0001-4575(02)00032-5; Thompson DC, 2000, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD001855; Tibshirani, 1994, INTRO BOOTSTRAP, DOI 10.1201/9780429246593; Walker I, BICYCLE OVERTAKING S; Walker I, 2007, ACCIDENT ANAL PREV, V39, P417, DOI 10.1016/j.aap.2006.08.010; Walter SR, 2011, ACCIDENT ANAL PREV, V43, P2064, DOI 10.1016/j.aap.2011.05.029; Wiltshire Council, CHILDC SUFF 2011 201	40	17	17	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e75424	10.1371/journal.pone.0075424			7	Multidisciplinary Sciences	Science & Technology - Other Topics	228VC	WOS:000325218700085	24086528	DOAJ Gold, Green Published			2021-06-18	
J	Holley, MAB; Petteys, S; Mitchell, JD; Holley, PR; Collen, JF				Holley, Maj (P) Aaron B.; Petteys, Sarah; Mitchell, Joshua D.; Holley, Paul R.; Collen, Jacob F.			Thromboprophylaxis and VTE Rates in Soldiers Wounded in Operation Enduring Freedom and Operation Iraqi Freedom	CHEST			English	Article							MOLECULAR-WEIGHT HEPARIN; DEEP VENOUS THROMBOSIS; TRAUMATIC BRAIN-INJURY; THROMBOEMBOLISM PROPHYLAXIS; PULMONARY-EMBOLISM; VEIN THROMBOSIS; MAJOR TRAUMA; PHARMACOLOGICAL PROPHYLAXIS; INTRACRANIAL HEMORRHAGE; UNFRACTIONATED HEPARIN	Objectives: US soldiers suffer catastrophic injuries during combat. We sought to define risk factors and rates for VTE in this population. Methods: We gathered data each hospital day on all patients injured in Afghanistan or Iraq who were admitted to the Walter Reed Army Medical Center (WRAMC). We analyzed prophylaxis rates and efficacy and identified risk factors for VTE. Results: We recorded data on 506 combat casualties directly admitted to WRAMC after medical air evacuation. The average injury severity score for the group was 18.4 +/- 11.7, and the most common reason for air evacuation was injury by improvised explosive device (65%). As part of the initial resuscitation, patients received 4.7 +/- 9.0 and 4.00 +/- 7.8 units of packed RBCs and fresh frozen plasma, respectively, and 42 patients received factor VIIa. Forty-six patients (9.1%) were given a diagnosis of VTE prior to discharge, 18 (3.6%) during air evacuation, and 28 (5.5%) during the hospital stay. In Cox regression analysis, administration of 1 unit of packed RBCs was associated with a hazard ratio (HR) of 1.04 (95% CI, 1.02-1.07; P = .002), and enoxaparin, 30 mg bid, administered subcutaneously for the majority of hospital days was associated with a HR of 0.31 (95% CI, 0.11-0.86; P = .02) for VTE during the hospitalization. Conclusions: Patients who suffer traumatic injuries in combat overseas are at high risk for VTE during evacuation and recovery. Those with large resuscitations are at particularly high risk, and low-molecular-weight heparin is associated with a decrease in VTE.	[Holley, Maj (P) Aaron B.; Collen, Jacob F.] Walter Reed Natl Mil Med Ctr, Dept Pulm Crit Care & Sleep Med, Bethesda, MD 20889 USA; [Petteys, Sarah; Mitchell, Joshua D.] Walter Reed Natl Mil Med Ctr, Dept Internal Med, Bethesda, MD 20889 USA; [Holley, Paul R.] US Army Med Res Inst Infect Dis, Dept Informat, Frederick, MD USA	Holley, MAB (corresponding author), Walter Reed Natl Mil Med Ctr, Dept Pulm Crit Care & Sleep Med, 8901 Rockville Pike, Bethesda, MD 20889 USA.	aholley9@gmail.com	Mitchell, Joshua/AAY-8104-2020	Mitchell, Joshua/0000-0001-7371-5742			Altman DG, 1999, BRIT MED J, V319, P1492, DOI 10.1136/bmj.319.7223.1492; [Anonymous], 2008, JTTS CLIN PRACT GUID; [Anonymous], 2010, JOINT THEAT TRAUM SY; [Anonymous], 2007, JOINT THEAT TRAUM SY; Arnold JD, 2010, AM SURGEON, V76, P563; Carrier M, 2010, J THROMB HAEMOST, V8, P1716, DOI 10.1111/j.1538-7836.2010.03938.x; Chung KK, 2008, J TRAUMA, V65, P19, DOI 10.1097/TA.0b013e3181271b8a; Cohn SM, 1999, VASCULAR SURG, V33, P219, DOI 10.1177/153857449903300219; Cook D, 2005, CRIT CARE MED, V33, P1565, DOI 10.1097/01.CCM.0000171207.95319.B2; Depew AJ, 2008, AM SURGEON, V74, P906; Geerts WH, 2004, CHEST, V126, p338S, DOI 10.1378/chest.126.3_suppl.338S; GEERTS WH, 1994, NEW ENGL J MED, V331, P1601, DOI 10.1056/NEJM199412153312401; Geerts WH, 1996, NEW ENGL J MED, V335, P701, DOI 10.1056/NEJM199609053351003; Geerts WH, 2008, CHEST, V133, p381S, DOI 10.1378/chest.08-0656; Gillern SM, 2011, J TRAUMA, V71, P607, DOI 10.1097/TA.0b013e3182282574; Ginzburg E, 2003, BRIT J SURG, V90, P1338, DOI 10.1002/bjs.4309; Gould MK, 2012, CHEST S, V141, pe227S; GREEN D, 1990, ANN INTERN MED, V113, P571, DOI 10.7326/0003-4819-113-8-571; Greenfield LJ, 1997, J TRAUMA, V42, P100, DOI 10.1097/00005373-199701000-00017; Horlocker TT, 2010, REGION ANESTH PAIN M, V35, P64, DOI 10.1097/AAP.0b013e3181c15c70; Horlocker TT, 2003, REGION ANESTH PAIN M, V28, P172, DOI 10.1053/rapm.2003.50046; Kim J, 2002, J TRAUMA, V53, P38, DOI 10.1097/00005373-200207000-00008; Knudson MM, 1996, J TRAUMA, V41, P446, DOI 10.1097/00005373-199609000-00010; KNUDSON MM, 1992, J TRAUMA, V32, P2, DOI 10.1097/00005373-199201000-00002; Koehler DM, 2011, J TRAUMA, V70, P324, DOI 10.1097/TA.0b013e31820b5d22; Malinoski D, 2010, J TRAUMA, V68, P874, DOI 10.1097/TA.0b013e3181d32271; Menaker J, 2009, J TRAUMA, V67, P1244, DOI 10.1097/TA.0b013e31818c173a; Murray CK, 2008, J TRAUMA, V64, pS232, DOI 10.1097/TA.0b013e318163c3f5; Nathens AB, 2007, J TRAUMA, V62, P557, DOI 10.1097/TA.0b013e318031b5f5; Netto FS, 2012, INJURY, V43, P1502, DOI 10.1016/j.injury.2010.12.028; Norwood SH, 2008, J TRAUMA, V65, P1021, DOI 10.1097/TA.0b013e31818a0e74; Reiff DA, 2009, J TRAUMA, V66, P1436, DOI 10.1097/TA.0b013e31817fdf1c; Rogers FB, 2002, J TRAUMA, V53, P142, DOI 10.1097/00005373-200207000-00032; Salottolo K, 2011, J TRAUMA, V70, P19, DOI 10.1097/TA.0b013e318207c54d; SEVITT S, 1961, BRIT J SURG, V48, P475, DOI 10.1002/bjs.18004821103; Shackford SR, 1988, J INTENSIVE CARE MED, V3, P87, DOI DOI 10.1177/088506668800300205; Stannard JP, 2006, J BONE JOINT SURG AM, V88A, P261, DOI 10.2106/JBJS.D.02932; Velmahos GC, 1998, J AM COLL SURGEONS, V187, P529, DOI 10.1016/S1072-7515(98)00223-3; Velmahos GC, 2006, AM SURGEON, V72, P757; Vittinghoff E, 2007, AM J EPIDEMIOL, V165, P710, DOI 10.1093/aje/kwk052; White RH, 2010, THROMB RES, V126, P61, DOI 10.1016/j.thromres.2010.03.009	41	17	19	0	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0012-3692			CHEST	Chest	SEP	2013	144	3					966	973		10.1378/chest.12-2879			8	Critical Care Medicine; Respiratory System	General & Internal Medicine; Respiratory System	241JC	WOS:000326161700035	23539197				2021-06-18	
J	Huang, YH; Lee, TC; Liao, CC; Deng, YH; Kwan, AL				Huang, Yu-Hua; Lee, Tao-Chen; Liao, Chen-Chieh; Deng, Yu-Han; Kwan, Aij-Lie			Tracheostomy in craniectomised survivors after traumatic brain injury: A cross-sectional analytical study	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Decompressive craniectomy; Traumatic brain injury; Tracheostomy; Glasgow coma scale; Age	DECOMPRESSIVE CRANIECTOMY	Background: Decompressive craniectomy (DC) is a life-saving measure for traumatic brain injury (TBI). However, survivors may remain in a vegetative or minimally conscious state and require tracheostomy to facilitate airway management. In this cross-sectional analytical study, we investigated the predictors for tracheostomy requirement and influence of tracheostomy timing on outcomes in craniectomised survivors after TBI. Methods: We enrolled 160 patients undergoing DC and surviving >7 days after TBI in this 3-year retrospective study. The patients were subdivided into 2 groups based on whether tracheostomy was (N = 38) or was not (N = 122) performed. We identified intergroup differences in early clinical parameters. Multivariable logistic regression was used to adjust for independent predictors of the need for tracheostomy. Early tracheostomy was defined as the performance of the procedure within the first 10 days after DC. Intensive care unit (ICU) stay, hospital stay, mortality, and Glasgow outcome scale (GOS) were analysed according to the timing of the tracheostomy procedure. Results: After TBI, 24% of craniectomised survivors required tracheostomy. In the multivariate logistic regression mode, the significant factors related to the need for tracheostomy were age (odds ratio = 1.041; p = 0.002), the Glasgow coma score (GCS) at admission (odds ratio = 0.733; p = 0.005), and normal status of basal cisterns (odds ratio = 0.000; p = 0.008). The ICU stay was shorter for patients with early tracheostomy than for those undergoing late tracheostomy (p = 0.004). The timing of tracheostomy had no influence on the hospital stay, mortality, or GOS. Conclusion: Age and admission GCS were independent predictors of the need for tracheostomy in craniectomised survivors after TBI. If tracheostomy is necessary, an earlier procedure may assist in patient care. (C) 2013 Elsevier Ltd. All rights reserved.	[Huang, Yu-Hua; Lee, Tao-Chen; Liao, Chen-Chieh; Deng, Yu-Han] Kaohsiung Chang Gung Mem Hosp, Dept Neurosurg, Kaohsiung, Taiwan; [Huang, Yu-Hua; Lee, Tao-Chen; Liao, Chen-Chieh; Deng, Yu-Han] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan; [Huang, Yu-Hua; Deng, Yu-Han] Kaohsiung Med Univ, Coll Med, Grad Inst Med, Kaohsiung, Taiwan; [Kwan, Aij-Lie] Kaohsiung Med Univ Hosp, Dept Neurosurg, Kaohsiung, Taiwan; [Kwan, Aij-Lie] Kaohsiung Med Univ, Dept Surg, Coll Med, Kaohsiung, Taiwan	Huang, YH (corresponding author), Kaohsiung Chang Gung Mem Hosp, Dept Neurosurg, 123 Ta Pei Rd, Kaohsiung, Taiwan.	newlupin2001@yahoo.com.tw					Aarabi B, 2006, J NEUROSURG, V104, P469, DOI 10.3171/jns.2006.104.4.469; Bouderka MA, 2004, J TRAUMA, V57, P251, DOI 10.1097/01.TA.0000087646.68382.9A; Chan ED, 1998, CHEST, V114, P1704, DOI 10.1378/chest.114.6.1704; Chintamani, 2005, BMC EMERG MED, V5, DOI 10.1186/1471-227X-5-8; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Goettler CE, 2006, J TRAUMA, V60, P991, DOI 10.1097/01.ta.0000217270.16860.32; Gurkin MA, 2002, AM SURGEON, V68, P324; Ho KM, 2011, CRIT CARE MED, V39, P2495, DOI 10.1097/CCM.0b013e318225764e; Horn EM, 1998, RESP PHYSIOL, V114, P201, DOI 10.1016/S0034-5687(98)00087-5; Jiang JY, 2005, J NEUROTRAUM, V22, P623, DOI 10.1089/neu.2005.22.623; Koh WY, 1997, ANAESTH INTENS CARE, V25, P365, DOI 10.1177/0310057X9702500407; MacIntyre NR, 2001, CHEST, V120, p375S, DOI 10.1378/chest.120.6_suppl.375S; Major KM, 2003, AM J SURG, V186, P615, DOI 10.1016/j.amjsurg.2003.08.012; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Morgalla MH, 2008, J NEUROSURG, V109, P685, DOI 10.3171/JNS/2008/109/10/0685; Munch E, 2000, NEUROSURGERY, V47, P315; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; PLUMMER AL, 1989, CHEST, V96, P178, DOI 10.1378/chest.96.1.178; Polin RS, 1997, NEUROSURGERY, V41, P84, DOI 10.1097/00006123-199707000-00018; Pompucci A, 2007, J NEUROTRAUM, V24, P1182, DOI 10.1089/neu.2006.0244; Sahuquillo J, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003983.pub2; Scales DC, 2008, CRIT CARE MED, V36, P2547, DOI 10.1097/CCM.0b013e31818444a5; Stocchetti N, 2004, J NEUROTRAUM, V21, P1131, DOI 10.1089/neu.2004.21.1131; Taylor A, 2001, CHILD NERV SYST, V17, P154, DOI 10.1007/s003810000410; Wang HK, 2012, INJURY, V43, P1432, DOI 10.1016/j.injury.2011.03.059	26	17	17	0	6	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	SEP	2013	44	9					1226	1231		10.1016/j.injury.2012.12.029			6	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	211VX	WOS:000323940600016	23347766				2021-06-18	
J	Korngold, C; Farrell, HM; Fozdar, M				Korngold, Caleb; Farrell, Helen M.; Fozdar, Manish			The National Football League and Chronic Traumatic Encephalopathy: Legal Implications	JOURNAL OF THE AMERICAN ACADEMY OF PSYCHIATRY AND THE LAW			English	Article							SELF-REPORTED CONCUSSIONS; PROFESSIONAL FOOTBALL; NEUROPSYCHOLOGICAL PERFORMANCE; RECURRENT CONCUSSION; PLAYERS; BRAIN; INJURIES; DEPRESSION; AFTERMATH; RISK	The growing awareness of chronic traumatic encephalopathy (CTE) has the potential to change the public perception and on-field rules of the National Football League (NFL). More than 3,000 ex-NFL players or their relatives are engaged in litigation alleging that the NFL failed to acknowledge and address the neuropsychiatric risks associated with brain injuries that result from playing in the NFL. This article explores the intersection between the medical and legal aspects of CTE in the NFL from a forensic psychiatry perspective.	[Korngold, Caleb; Farrell, Helen M.] Harvard Univ, Sch Med, Boston, MA USA; [Korngold, Caleb] Harvard Longwood Psychiat Residency Training Prog, Boston, MA USA; [Korngold, Caleb; Farrell, Helen M.] Beth Israel Deaconess Med Ctr, Boston, MA 02116 USA; [Fozdar, Manish] Triangle Forens Neuropsychiat, Raleigh, NC USA; [Fozdar, Manish] Duke Univ, Med Ctr, Durham, NC USA; [Fozdar, Manish] Univ N Carolina, Chapel Hill, NC USA	Farrell, HM (corresponding author), Beth Israel Deaconess Med Ctr, 173 Commonwealth Ave,5R, Boston, MA 02116 USA.	hfarrell@bidmc.harvard.edu					[Anonymous], 2012, NIELSENWIRE     0130; [Anonymous], 2012, ESPN COM NEWS S 0504; [Anonymous], 2011, BLOOMBERGBUSINE 0127; [Anonymous], 2012, USAFOOTBALL     0817; [Anonymous], 2012, ESPN COM NEWS S 0503; Associated Press, 2011, ASS PRESS; Ax Joseph, 2012, REUTERS; Badenhausen K, 2011, FORBES          0909; Barber P, 1996, FOOTBALL AM CELEBRAT; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P262, DOI 10.1017/S1355617709991287; Boren C, 2013, WASHINGTON POST 0829; Casson IR, 2008, NEUROL CLIN, V26, P217, DOI 10.1016/j.ncl.2007.11.005; Casson IR, 2010, SPORTS HEALTH, V2, P471, DOI 10.1177/1941738110383963; Clausen H, 2005, BRIT J SPORT MED, V39, P661, DOI 10.1136/bjsm.2004.017046; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Cook B, 2007, NBC SPORTS      0204; CORSELLIS JA, 1973, PSYCHOL MED, V3, P270, DOI 10.1017/S0033291700049588; CORSELLIS JAN, 1989, BRIT MED J, V298, P105, DOI 10.1136/bmj.298.6666.105; Dart T, 2012, TIMES; Fainaru S, 2012, ESPN            1116; Futterman Matthew, 2012, WALL STREET J; Gavett BE, 2011, CURR OPIN NEUROL, V24, P525, DOI 10.1097/WCO.0b013e32834cd477; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Granacher R, 2003, TRAUMATIC BRAIN INJU; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; GUTERMAN A, 1987, SPORTS MED, V4, P194, DOI 10.2165/00007256-198704030-00004; Jordan BD, 2000, SEMIN NEUROL, V20, P179, DOI 10.1055/s-2000-9826; Kerr ZY, 2012, AM J SPORT MED, V40, P2206, DOI 10.1177/0363546512456193; Lapchick R., 2011, 2011 RACIAL GENDER R; Lehman EJ, 2012, NEUROLOGY, V79, P1970, DOI 10.1212/WNL.0b013e31826daf50; Martland HS, 1928, J AMER MED ASSOC, V91, P1103, DOI 10.1001/jama.1928.02700150029009; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; McLuskey D, 2011, MULTIPLE CIT; National Football League, 2012, NFL DON 30 MILL NAT; Omalu B, 2011, NEUROSURGERY, V69, P173, DOI 10.1227/NEU.0b013e318212bc7b; Omalu BI, 2006, NEUROSURGERY, V59, P1086, DOI 10.1227/01.NEU.0000245601.69451.27; Omalu Bennet I, 2010, J Forensic Nurs, V6, P40, DOI 10.1111/j.1939-3938.2009.01064.x; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Ozanian M, 2012, FORBES          0905; Parlour R R, 1980, Bull Am Acad Psychiatry Law, V8, P445; Pellman E, 2004, NEUROSURGERY, V55, P860, DOI 10.1227/01.NEU.0000137657.00146.7D; Pellman EJ, 2005, NEUROSURGERY, V56, P79, DOI 10.1227/01.NEU.0000150180.16552.8D; Pellman EJ, 2004, NEUROSURGERY, V55, P1100, DOI 10.1227/01.NEU.0000147063.12873.F5; Pellman EJ, 2004, NEUROSURGERY, V54, P81, DOI 10.1227/01.NEU.0000097267.54786.54; Pellman Elliot J, 2006, Neurosurg Focus, V21, pE12; Porter MD, 2003, CLIN J SPORT MED, V13, P339, DOI 10.1097/00042752-200311000-00002; ROBERTS GW, 1990, J NEUROL NEUROSUR PS, V53, P373, DOI 10.1136/jnnp.53.5.373; Schuck PH, 1994, FACULTY SCHOLARSHIP; Schwarz A, 2011, NY TIMES; Searcy T, 2012, FORBES          0925; Small GW, 2013, AM J GERIAT PSYCHIAT, V21, P138, DOI 10.1016/j.jagp.2012.11.019; Spiotta AM, 2011, WORLD NEUROSURG, V75, P175, DOI 10.1016/j.wneu.2011.01.019; Stern RA, 2011, PM&R, V3, pS460, DOI 10.1016/j.pmrj.2011.08.008; The Nielsen Company, 2009, GUID SUP BOWL XLIII; Tierney M, 2012, NY TIMES; United States Army, 2012, NFL ARM BOTH WORK CO; Wall SE, 2006, J NEUROL NEUROSUR PS, V77, P518, DOI 10.1136/jnnp.2004.061044; Zazryn T, 2007, SPORTS MED, V37, P467	59	17	16	0	26	AMER ACAD PSYCHIATRY & LAW	BLOOMFIELD	ONE REGENCY DR, PO BOX 30, BLOOMFIELD, CT 06002 USA	1093-6793	1943-3662		J AM ACAD PSYCHIATRY	J. Am. Acad. Psychiatry Law	SEP 1	2013	41	3					430	436					7	Law; Psychiatry	Government & Law; Psychiatry	AN8LT	WOS:000340856400014	24051597				2021-06-18	
J	Kreuzer, PM; Landgrebe, M; Frank, E; Langguth, B				Kreuzer, Peter Michael; Landgrebe, Michael; Frank, Elmar; Langguth, Berthold			Repetitive Transcranial Magnetic Stimulation for the Treatment of Chronic Tinnitus After Traumatic Brain Injury: A Case Study	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						affective disorder; alcohol abuse; depression; repetitive transcranial magnetic stimulation; rTMS; TBI; tinnitus; traumatic brain injury	SEVERITY; INHIBIT; RETURN	Tinnitus is a frequent symptom of traumatic brain injury, which is difficult to treat. Repetitive transcranial magnetic stimulation has shown beneficial effects in some forms of tinnitus. However, traumatic brain injury in the past has been considered as a relative contraindication for repetitive transcranial magnetic stimulation because of the increased risk of seizures. Here we present the case of a 53-year-old male patient suffering from severe tinnitus after traumatic brain injury with comorbid depression and alcohol abuse, who received 5 treatment series of repetitive transcranial magnetic stimulation (1 Hz stimulation protocol over left primary auditory cortex, 10 sessions of 2000 stimuli each, stimulation intensity 110% resting motor threshold). Repetitive transcranial magnetic stimulation was tolerated without any side effects and tinnitus complaints (measured by a validated tinnitus questionnaire and numeric rating scales) were improved in a replicable way throughout 5 courses of transcranial magnetic stimulation up to now.	[Kreuzer, Peter Michael; Landgrebe, Michael; Frank, Elmar; Langguth, Berthold] Univ Regensburg, Dept Psychiat & Psychotherapy, D-93053 Regensburg, Germany	Kreuzer, PM (corresponding author), Univ Regensburg, Dept Psychiat & Psychotherapy, Univ Str 84, D-93053 Regensburg, Germany.	peter.kreuzer@medbo.de	Langguth, Berthold/AAP-2638-2021				Bayar N, 2001, J OTOLARYNGOL, V30, P300, DOI 10.2310/7070.2001.19597; Bernabeu M, 2004, CLIN NEUROPHYSIOL, V115, P1714, DOI 10.1016/j.clinph.2004.02.021; Cosentino G, 2010, NEUROCASE, V16, P267, DOI 10.1080/13554790903456191; Demirtas-Tatlidede A, 2012, J HEAD TRAUMA REHAB, V27, P274, DOI 10.1097/HTR.0b013e318217df55; Fagelson Marc A, 2007, Am J Audiol, V16, P107, DOI 10.1044/1059-0889(2007/015); Fausti SA, 2009, J REHABIL RES DEV, V46, P797, DOI 10.1682/JRRD.2008.09.0118; Fitzgerald PB, 2011, J ECT, V27, P38, DOI 10.1097/YCT.0b013e3181eb30c6; Folmer RL, 2003, LARYNGOSCOPE, V113, P821, DOI 10.1097/00005537-200305000-00010; Frank G, 2010, EUR J NEUROL, V17, P951, DOI 10.1111/j.1468-1331.2010.02956.x; GOEBEL G, 1994, HNO, V42, P166; Hinton DE, 2006, J TRAUMA STRESS, V19, P541, DOI 10.1002/jts.20138; Jury MA, 2001, NEW ZEAL MED J, V114, P286; Kreuzer PM, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00088; Langguth B, 2010, J PSYCHOPHARMACOL, V24, P1273, DOI 10.1177/0269881109106929; Langguth B, 2008, LARYNGOSCOPE, V118, P2264, DOI 10.1097/MLG.0b013e318182c325; Mennemeier M, 2008, LARYNGOSCOPE, V118, P1228, DOI 10.1097/MLG.0b013e318170f8ac; Moller A, 2011, TXB TINNITUS, P511; Rossi S, 2009, CLIN NEUROPHYSIOL, V120, P2008, DOI 10.1016/j.clinph.2009.08.016; Sindhusake Doungkamol, 2004, J Am Acad Audiol, V15, P269; Tergau F, 1999, LANCET, V353, P2209, DOI 10.1016/S0140-6736(99)01301-X; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004	24	17	20	0	15	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	SEP-OCT	2013	28	5					386	389		10.1097/HTR.0b013e318254736e			4	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	298ZU	WOS:000330364600085	22688213				2021-06-18	
J	Xiong, N; Yang, HC; Liu, L; Xiong, L; Zhang, ZW; Zhang, XW; Jia, M; Huang, JS; Zhang, ZT; Mohamed, AA; Lin, ZC; Wang, T				Xiong, Nian; Yang, Hecheng; Liu, Ling; Xiong, Ling; Zhang, Zhaowen; Zhang, Xiaowei; Jia, Min; Huang, Jinsha; Zhang, Zhentao; Mohamed, Asrah A.; Lin, Zhicheng; Wang, Tao			bFGF promotes the differentiation and effectiveness of human bone marrow mesenchymal stem cells in a rotenone model for Parkinson's disease	ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY			English	Article						Human bone marrow mesenchymal stem cells; Parkinson's disease; Basic fibroblast growth factor; Dopaminergic neurons; Multipotency; Rotenone	FIBROBLAST-GROWTH-FACTOR; TRAUMATIC BRAIN-INJURY; STROMAL CELLS; DOPAMINERGIC PHENOTYPE; IN-VITRO; TRANSPLANTATION; PROLIFERATION; RATS; NEUROGENESIS; EXPRESSION	Previous studies have shown that bone marrow mesenchymal stem cells (BMSCs) engraftment could alleviate motor dysfunction in parkinsonian animal models, but with limited efficacy and few engrafted cells surviving. On the other side, basic fibroblast growth factor (bFGF) reportedly displays many effects including neuroprotection and promoting multipotent cells to expand and differentiate. In this study, we assessed whether a combination of bFGF and human BMSCs (HBMSCs) therapy could enhance the treatment effectiveness in Parkinson's disease (PD) rat models. Specifically, bFGF promoted HBMSCs to transdifferentiate toward neural-like lineages in vitro. In addition, HBMSCs transplantation alleviated the motor functional asymmetry, as well as prevented dopaminergic neuron loss in a PD model, while bFGF administration enhances its neurodifferentiation capacity and therapeutic effect. In conclusion, optimizing culture condition like supplementation of bFGF could significantly improve the output of HBMSCs in vitro, and HBMSCs transplantation with bFGF might represent an improved transplantation approach for PD. (C) 2013 Elsevier B.V. All rights reserved.	[Xiong, Nian; Yang, Hecheng; Liu, Ling; Xiong, Ling; Zhang, Zhaowen; Zhang, Xiaowei; Jia, Min; Huang, Jinsha; Zhang, Zhentao; Mohamed, Asrah A.; Wang, Tao] Huazhong Univ Sci & Technol, Dept Neurol, Union Hosp, Tongji Med Coll, Wuhan 430022, Hubei, Peoples R China; [Zhang, Zhentao] Wuhan Univ, Renmin Hosp, Dept Neurol, Wuhan 430060, Peoples R China; [Lin, Zhicheng] Harvard Univ, Dept Psychiat, Sch Med, Cambridge, MA 02138 USA; [Lin, Zhicheng] McLean Hosp, Div Alcohol & Drug Abuse, Belmont, MA 02478 USA; [Lin, Zhicheng] McLean Hosp, Mailman Neurosci Res Ctr, Belmont, MA 02478 USA; [Lin, Zhicheng] Harvard NeuroDiscovery Ctr, Boston, MA 02114 USA	Wang, T (corresponding author), Huazhong Univ Sci & Technol, Dept Neurol, Union Hosp, Tongji Med Coll, 1277 Jiefang Rd, Wuhan 430022, Hubei, Peoples R China.	wangtaowh@yahoo.cn			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [30870866, 81071021, 31171211, 81200983, 81100958]; China Medical FoundationChina Medical University [2012B09]; Wuhan Science and Technology Bureau, China [20066002100]	This work was supported by grants 30870866, 81071021 and 31171211 from the National Natural Science Foundation of China (to TW), grant 81200983 from the National Natural Science Foundation of China (to NX), grant 81100958 from the National Natural Science Foundation of China (to ZTZ), grant 2012B09 from China Medical Foundation (to NX) and grant 20066002100 from the Wuhan Science and Technology Bureau, China (to TW).	Akino K, 2003, WOUND REPAIR REGEN, V11, P354, DOI 10.1046/j.1524-475X.2003.11507.x; Barzilay R, 2008, STEM CELLS DEV, V17, P547, DOI 10.1089/scd.2007.0172; Barzilay R, 2009, STEM CELLS DEV, V18, P591, DOI 10.1089/scd.2008.0138; Bhang SH, 2007, BIOCHEM BIOPH RES CO, V359, P40, DOI 10.1016/j.bbrc.2007.05.046; Deierborg T, 2008, PROG NEUROBIOL, V85, P407, DOI 10.1016/j.pneurobio.2008.05.001; Delcroix GJR, 2011, BIOMATERIALS, V32, P1560, DOI 10.1016/j.biomaterials.2010.10.041; Freed CR, 2001, NEW ENGL J MED, V344, P710, DOI 10.1056/NEJM200103083441002; Hori Y, 2004, TISSUE ENG, V10, P995, DOI 10.1089/1076327041887790; Jiang JJ, 2010, NEUROSCI RES, V66, P46, DOI 10.1016/j.neures.2009.09.1711; Jiang XW, 2010, BONE, V46, P1156, DOI 10.1016/j.bone.2009.12.017; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Jin GZ, 2008, CELL BIOL INT, V32, P1433, DOI 10.1016/j.cellbi.2008.08.014; Karp JM, 2009, CELL STEM CELL, V4, P206, DOI 10.1016/j.stem.2009.02.001; Laskowski A, 2005, BRAIN RES, V1037, P78, DOI 10.1016/j.brainres.2004.12.035; Lee ST, 2008, BRAIN, V131, P616, DOI 10.1093/brain/awm306; Li Y, 2001, NEUROSCI LETT, V316, P67, DOI 10.1016/S0304-3940(01)02384-9; Lindvall Olle, 2002, Neurosurg Focus, V13, pe2; Mezey E, 2003, P NATL ACAD SCI USA, V100, P1364, DOI 10.1073/pnas.0336479100; Neubauer M, 2004, FEBS LETT, V577, P277, DOI 10.1016/j.febslet.2004.10.020; Ramirez JJ, 1999, NEUROREPORT, V10, P1201, DOI 10.1097/00001756-199904260-00008; Sadan O, 2009, STEM CELLS DEV, V18, P1179, DOI 10.1089/scd.2008.0411; Tatard VM, 2004, CELL TRANSPLANT, V13, P573, DOI 10.3727/000000004783983675; Trzaska KA, 2007, STEM CELLS, V25, P2797, DOI 10.1634/stemcells.2007-0212; Wakabayashi K, 2010, J NEUROSCI RES, V88, P1017, DOI 10.1002/jnr.22279; Wang K, 2004, NEUROSCI LETT, V364, P154, DOI 10.1016/j.neulet.2004.04.086; Xiong N, 2011, GENE THER, V18, P394, DOI 10.1038/gt.2010.152; Xiong NA, 2010, BIOL BLOOD MARROW TR, V16, P1519, DOI 10.1016/j.bbmt.2010.06.004; Xiong NA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007878; Xue XJ, 2010, MOL CELL NEUROSCI, V45, P26, DOI 10.1016/j.mcn.2010.05.006; Ye M, 2007, PARKINSONISM RELAT D, V13, P44, DOI 10.1016/j.parkreldis.2006.07.013; Yedjou CG, 2008, J BIOCHEM MOL TOXIC, V22, P85, DOI 10.1002/jbt.20223; Yoshimura S, 2003, J CLIN INVEST, V112, P1202, DOI 10.1172/JCI200316618; Zanini C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028175	33	17	22	0	27	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1382-6689			ENVIRON TOXICOL PHAR	Environ. Toxicol. Pharmacol.	SEP	2013	36	2					411	422		10.1016/j.etap.2013.05.005			12	Environmental Sciences; Pharmacology & Pharmacy; Toxicology	Environmental Sciences & Ecology; Pharmacology & Pharmacy; Toxicology	213TK	WOS:000324082900020	23770451				2021-06-18	
J	Yim, J; Babbage, DR; Zupan, B; Neumann, D; Willer, B				Yim, Jackki; Babbage, Duncan R.; Zupan, Barbra; Neumann, Dawn; Willer, Barry			The relationship between facial affect recognition and cognitive functioning after traumatic brain injury	BRAIN INJURY			English	Article						Affect; cognitive functioning; emotion; facial affect; traumatic brain injury	EMOTION RECOGNITION; NONVERBAL-COMMUNICATION; SOCIAL COGNITION; IMPAIRMENT; EXPRESSION; DEFICITS; MIND; DISSOCIATION; PERCEPTION; BATTERY	Primary objective: There is considerable evidence suggesting facial affect recognition and cognitive functions are impaired in many people with moderate-to-severe traumatic brain injury (TBI). However, little is known about the relationship between these two domains in the TBI population. Research design: This study investigated the relationship between facial affect recognition and cognitive functioning in 75 adults with moderate-to-severe TBI. Methods and procedures: Participants were administered three facial affect recognition tests and a computerized cognitive test battery that assessed seven cognitive domains. Main outcomes and results: Deficits in facial affect recognition were significantly correlated with impairments in non-verbal memory, working memory, speed of processing, verbal memory and verbal delayed memory. No significant relationship was found between executive dysfunction and facial affect recognition impairments. Non-verbal memory, working memory and speed of processing significantly predicted overall facial affect recognition performance. Conclusions: It is concluded that impairment in several cognitive processes may contribute to facial affect recognition deficits in TBI, in particular non-verbal memory, working memory and speed of processing. Furthermore, executive functioning may not be a critical factor in facial affect recognition, but would most likely be important in deciding what to do once facial affect is perceived.	[Yim, Jackki] Massey Univ, Sch Psychol, Wellington, New Zealand; [Babbage, Duncan R.] Auckland Univ Technol, Hlth & Rehabil Res Inst, Auckland 1142, New Zealand; [Zupan, Barbra] Brock Univ, Dept Appl Linguist, St Catharines, ON L2S 3A1, Canada; [Neumann, Dawn] Indiana Univ Sch Med, Dept Psychiat, Indianapolis, IN 46202 USA; [Willer, Barry] SUNY Buffalo, Buffalo, NY 14260 USA	Babbage, DR (corresponding author), Auckland Univ Technol, Hlth & Rehabil Res Inst, Private Bag 92006, Auckland 1142, New Zealand.	duncan.babbage@aut.ac.nz		Babbage, Duncan/0000-0002-9259-9246; Barbra, Zupan/0000-0002-4603-333X	National Institute on Disability and Rehabilitation Research [H133G080043]	Supported by the National Institute on Disability and Rehabilitation Research (grant no. H133G080043). The data presented in this study was collected as part of a registered clinical trial-ClinicalTrials.gov identifier: NCT00283153.	Adolphs Ralph, 2002, Behav Cogn Neurosci Rev, V1, P21, DOI 10.1177/1534582302001001003; Allerdings MD, 2006, BRAIN COGNITION, V60, P193, DOI 10.1016/j.bandc.2004.09.018; Babbage DR, 2011, NEUROPSYCHOLOGY, V25, P277, DOI 10.1037/a0021908; Barrett LF, 2007, TRENDS COGN SCI, V11, P327, DOI 10.1016/j.tics.2007.06.003; Bowers D., 1991, FLORIDA AFFECT BATTE; Brookshire RH, 1993, DISCOURSE COMPREHENS; Cherniss C, 2010, IND ORGAN PSYCHOL-US, V3, P110, DOI 10.1111/j.1754-9434.2010.01231.x; Darby D, 2002, NEUROLOGY, V59, P1042, DOI 10.1212/WNL.59.7.1042; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; Driscoll DM, 2011, J NEUROTRAUM, V28, P319, DOI 10.1089/neu.2010.1523; Falleti MG, 2006, J CLIN EXP NEUROPSYC, V28, P1095, DOI 10.1080/13803390500205718; Gendron M, 2012, EMOTION, V12, P314, DOI 10.1037/a0026007; Henry JD, 2006, NEUROPSYCHOLOGIA, V44, P1623, DOI 10.1016/j.neuropsychologia.2006.03.020; Henry JD, 2009, J INT NEUROPSYCH SOC, V15, P277, DOI 10.1017/S1355617709090195; Knox L, 2009, BRAIN COGNITION, V69, P442, DOI 10.1016/j.bandc.2008.09.009; Lee SJ, 2009, PSYCHIAT INVEST, V6, P156, DOI 10.4306/pi.2009.6.3.156; Maruff P, 2009, ARCH CLIN NEUROPSYCH, V24, P165, DOI 10.1093/arclin/acp010; Mathersul D, 2009, J CLIN EXP NEUROPSYC, V31, P278, DOI 10.1080/13803390802043619; McDonald S, 2003, J HEAD TRAUMA REHAB, V18, P219, DOI 10.1097/00001199-200305000-00001; Middleton J.A., 2001, ADV PSYCHIAT TREATME, V7, P257, DOI [10.1192/apt.7.4.257, DOI 10.1192/APT.7.4.257]; NOWICKI S, 1994, J NONVERBAL BEHAV, V18, P9, DOI 10.1007/BF02169077; Nowicki S., 2004, DIAGNOSTIC ANAL NONV; Phillips LH, 2008, EMOTION, V8, P184, DOI 10.1037/1528-3542.8.2.184; Pinkham AE, 2003, AM J PSYCHIAT, V160, P815, DOI 10.1176/appi.ajp.160.5.815; Radice-Neumann D, 2007, BRAIN INJURY, V21, P807, DOI 10.1080/02699050701504281; Roebuck-Spencer T., 2008, TXB CLIN NEUROPSYCHO, P411; Sachs G, 2004, SCHIZOPHR RES, V68, P27, DOI 10.1016/S0920-9964(03)00131-2; Schafer JL, 1999, STAT METHODS MED RES, V8, P3, DOI 10.1191/096228099671525676; Shamay-Tsoory SG, 2007, PSYCHIAT RES, V149, P11, DOI 10.1016/j.psychres.2005.10.018; Spell LA, 2000, J NONVERBAL BEHAV, V24, P285, DOI 10.1023/A:1006675230193; Spikman JM, 2012, J NEUROTRAUM, V29, P101, DOI 10.1089/neu.2011.2084; Tonks J, 2008, BRAIN INJURY, V22, P325, DOI 10.1080/02699050801968303; Watts AJ, 2006, APHASIOLOGY, V20, P707, DOI 10.1080/02687030500489953; Williams C, 2010, J CLIN EXP NEUROPSYC, V32, P113, DOI 10.1080/13803390902806543	34	17	17	1	15	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	SEP	2013	27	10					1155	1161		10.3109/02699052.2013.804203			7	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	204KW	WOS:000323365200008	23895556				2021-06-18	
J	Hubel, KA; Yund, EW; Herron, TJ; Woods, DL				Hubel, Kerry A.; Yund, E. William; Herron, Timothy J.; Woods, David L.			Computerized measures of finger tapping: Reliability, malingering and traumatic brain injury	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						Finger oscillation; Symptom validity; Traumatic brain injury; Tapping rate; Motor speed; Tap failure; Index finger; Effort; Test-retest	HEAD-INJURY; PARKINSONS-DISEASE; MOTOR-PERFORMANCE; SEX-DIFFERENCES; PTSD CHECKLIST; TEST BATTERY; HANDEDNESS; TESTS; SPEED; HAND	We analyzed computerized finger tapping metrics in four experiments. Experiment 1 showed tapping-rate differences associated with hand dominance, digits, sex, and fatigue that replicated those seen in a previous, large-scale community sample. Experiment 2 revealed test-retest correlations (r = .91) that exceeded those reported in previous tapping studies. Experiment 3 investigated subjects simulating symptoms of traumatic brain injury (TBI); 62% of malingering subjects produced abnormally slow tapping rates. A tapping-rate malingering index, based on rate-independent tapping patterns, provided confirmatory evidence of malingering in 48% of the subjects with abnormal tapping rates. Experiment 4 compared tapping in 24 patients with mild TBI (mTBI) and a matched control group; mTBI patients showed slowed tapping without evidence of malingering. Computerized finger tapping measures are reliable measures of motor speed, useful in detecting subjects performing with suboptimal effort, and are sensitive to motor abnormalities following mTBI.	[Hubel, Kerry A.; Yund, E. William; Herron, Timothy J.; Woods, David L.] Martinez Clin, Human Cognit Neurophysiol Lab, Martinez, CA USA; [Woods, David L.] Univ Calif Davis, Dept Neurol, Sacramento, CA 95817 USA; [Woods, David L.] Univ Calif Davis, Ctr Neurosci, Davis, CA 95616 USA; [Woods, David L.] Univ Calif Davis, Ctr Mind & Brain, Davis, CA 95616 USA	Woods, DL (corresponding author), VANCHCS, Neurol Serv 127E, 150 Muir Rd, Martinez, CA 94553 USA.	dlwoods@ucdavis.edu		Herron, Timothy/0000-0002-4297-014X; Woods, David/0000-0002-8804-3587; Yund, E./0000-0002-6833-0052	VA Research Service Grant [6119R]	This research was supported by the VA Research Service Grant 6119R to D. L. W. The content is solely the responsibility of the authors and does not necessarily represent the official views of the agencies.	Aoki T, 2003, EXP BRAIN RES, V152, P270, DOI 10.1007/s00221-003-1552-z; Arnold G, 2005, CLIN NEUROPSYCHOL, V19, P105, DOI 10.1080/13854040490888567; Ashendorf L, 2009, APPL NEUROPSYCHOL, V16, P171, DOI 10.1080/09084280903098562; BARNSLEY RH, 1970, PERCEPT MOTOR SKILL, V30, P343, DOI 10.2466/pms.1970.30.2.343; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; BROWN MB, 1975, BIOMETRICS, V31, P987, DOI 10.2307/2529826; Cameron A, 1998, REGRESSION ANAL COUN; Christianson MK, 2004, NEW ZEAL J PSYCHOL, V33, P44; Commodari E, 2008, AGING CLIN EXP RES, V20, P578; CROSSLEY M, 1992, PSYCHOL AGING, V7, P499, DOI 10.1037/0882-7974.7.4.499; de Groot-Driessen D, 2006, ARCH PHYS MED REHAB, V87, P40, DOI 10.1016/j.apmr.2005.09.022; De Monte VE, 2005, J CLIN EXP NEUROPSYC, V27, P224, DOI 10.1080/13803390490515766; Dikmen SS, 1999, J INT NEUROPSYCH SOC, V5, P346, DOI 10.1017/S1355617799544056; DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80; Fan LZ, 2010, BRAIN RES, V1353, P60, DOI 10.1016/j.brainres.2010.07.031; Foo S. C., 1994, Annals Academy of Medicine Singapore, V23, P650; GARDNER W, 1995, PSYCHOL BULL, V118, P392, DOI 10.1037/0033-2909.118.3.392; GILL DM, 1986, PERCEPT MOTOR SKILL, V62, P675, DOI 10.2466/pms.1986.62.2.675; Greiffenstein MF, 2008, CLIN NEUROPSYCHOL, V22, P565, DOI 10.1080/13854040701377810; Gualtieri CT, 2006, ARCH CLIN NEUROPSYCH, V21, P623, DOI 10.1016/j.acn.2006.05.007; HAALAND KY, 1994, J CLIN EXP NEUROPSYC, V16, P448, DOI 10.1080/01688639408402655; Haaxma CA, 2010, MOVEMENT DISORD, V25, P1150, DOI 10.1002/mds.23100; Halstead WC, 1947, BRAIN INTELLIGENCE; HEATON RK, 1978, J CONSULT CLIN PSYCH, V46, P892, DOI 10.1037/0022-006X.46.5.892; Heaton RK, 2004, REVISED COMPREHENSIV; Herve PV, 2005, NEUROIMAGE, V25, P1133, DOI 10.1016/j.neuroimage.2004.12.062; Hinton SC, 2007, J INT NEUROPSYCH SOC, V13, P539, DOI 10.1017/S1355617707070671; Hubel K. A., 2013, PERCEPT MOTOR SKILL, V116, P1; Jarvis PE., 1994, HALSTEAD REITAN NEUR; Jimenez-Jimenez FJ, 2010, EUR J NEUROL, V17, P152, DOI 10.1111/j.1468-1331.2009.02784.x; Kang XJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045582; Koeneke S, 2009, J MOTOR BEHAV, V41, P347, DOI 10.3200/JMBR.41.4.347-356; Lang AJ, 2003, J TRAUMA STRESS, V16, P257, DOI 10.1023/A:1023796007788; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P410, DOI 10.1076/clin.17.3.410.18089; Lee MS, 2010, MOVEMENT DISORD, V25, P2531, DOI 10.1002/mds.23304; Massman PJ, 1996, J CLIN EXP NEUROPSYC, V18, P110, DOI 10.1080/01688639608408267; Mittenberg W, 1996, ARCH CLIN NEUROPSYCH, V11, P271, DOI 10.1016/0887-6177(95)00040-2; MORRISON MW, 1979, PERCEPT MOTOR SKILL, V48, P139, DOI 10.2466/pms.1979.48.1.139; MURELIUS O, 1991, ACTA NEUROL SCAND, V83, P9; Nalcaci E, 2001, CORTEX, V37, P493, DOI 10.1016/S0010-9452(08)70589-6; PALMER RD, 1974, J CLIN PSYCHOL, V30, P545, DOI 10.1002/1097-4679(197410)30:4<545::AID-JCLP2270300424>3.0.CO;2-I; PETERS M, 1980, CAN J PSYCHOL, V34, P62, DOI 10.1037/h0081014; Peters M, 1996, J EXP PSYCHOL HUMAN, V22, P1107; Prigatano GP, 2003, J INT NEUROPSYCH SOC, V9, P128, DOI 10.1017/S1355617703000134; Prigatano GP, 1997, ARCH PHYS MED REHAB, V78, P847, DOI 10.1016/S0003-9993(97)90198-2; PROVINS KA, 1972, NEUROPSYCHOLOGIA, V10, P199, DOI 10.1016/0028-3932(72)90060-7; REITAN RM, 1994, CLIN NEUROPSYCHOL, V8, P193, DOI 10.1080/13854049408401557; Reitan RM., 1985, HALSTEAD REITAN NEUR; ROBINSON LR, 1993, ARCH PHYS MED REHAB, V74, P1134; RUFF RM, 1993, PERCEPT MOTOR SKILL, V76, P1219, DOI 10.2466/pms.1993.76.3c.1219; Schmidt SL, 2000, NEUROPSYCHOLOGIA, V38, P529, DOI 10.1016/S0028-3932(99)00120-7; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Tanner BA, 2003, J CLIN PSYCHOL, V59, P123, DOI 10.1002/jclp.10122; TANNER BA, 1995, BEHAV RES METH INSTR, V27, P160, DOI 10.3758/BF03204722; Teixeira LA, 2008, CORTEX, V44, P707, DOI 10.1016/j.cortex.2006.10.002; Tobimatsu S, 1998, J NEUROL, V245, P256, DOI 10.1007/s004150050215; TODOR JI, 1987, ACTA PSYCHOL, V65, P65, DOI 10.1016/0001-6918(87)90047-3; Tsushima WT, 2009, BRAIN INJURY, V23, P809, DOI 10.1080/02699050903200530; Wells FL, 1908, AM J PSYCHOL, V19, P437, DOI 10.2307/1413393; Western Psychological Services, 1998, WPS ELECT TAPPING TE; Wolfson D., 1993, HALSTEAD REITAN NEUR; Woods DL, 2011, J CLIN EXP NEUROPSYC, V33, P101, DOI 10.1080/13803395.2010.493149; Zelaznik HN, 2010, J SPEECH LANG HEAR R, V53, P383, DOI 10.1044/1092-4388(2009/08-0204)	63	17	17	0	11	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	AUG 19	2013	35	7					745	758		10.1080/13803395.2013.824070			14	Psychology, Clinical; Clinical Neurology; Psychology	Psychology; Neurosciences & Neurology	219NG	WOS:000324513100007	23947782				2021-06-18	
J	Olson, DM; Lewis, LS; Bader, MK; Bautista, C; Malloy, R; Riemen, KE; McNett, MM				Olson, DaiWai M.; Lewis, Lisa S.; Bader, Mary Kay; Bautista, Cynthia; Malloy, Rachel; Riemen, Kristina E.; McNett, Molly M.			Significant Practice Pattern Variations Associated With Intracranial Pressure Monitoring	JOURNAL OF NEUROSCIENCE NURSING			English	Article						intracranial pressure; nursing; nursing interventions; nursing practice	TRAUMATIC BRAIN-INJURY; PATIENT; MEDICINE; SAFETY	Purpose: The purpose of this study was to describe nursing practice in the care of patients with intracranial pressure monitoring. Although standards for care of such patients have been established, there continue to be variations in the nursing practice. Methods: This was an observational study in which data were collected from 28 nurse-patient dyads at 16 different hospitals across the United States. Each dyad was observed for 2 hours; nursing actions and patient responses including intracranial pressure readings were documented. Results: Differences in the care of patients with intracranial pressure monitoring were prevalent. Variations in practice were prompted by healthcare provider prescriptions as well as nursing decisions. Prescriptions and interventions were often not supported by the available scientific evidence. Video Abstract: For more insights from the authors, see Supplemental Digital Content 1, at http://links.lww.com/JNN/A7.	[Olson, DaiWai M.] Univ Texas Southwestern, Dallas, TX USA; [Lewis, Lisa S.] Watts Sch Nursing, Durham, NC USA; [Bader, Mary Kay] Mission Hosp, Mission Viejo, CA USA; [Bautista, Cynthia] Yale New Haven Med Ctr, New Haven, CT 06504 USA; [Malloy, Rachel] Integra Lifesci, Plainsboro, NJ USA; [Riemen, Kristina E.] Duke Univ, Durham, NC USA; [McNett, Molly M.] Case Western Reserve Univ, Metrohlth Med Ctr, Cleveland, OH USA	Olson, DM (corresponding author), Univ Texas Southwestern, Dallas, TX USA.	DaiWai.Olson@UTsouthwestern.edu	Olson, DaiWai/I-5932-2019; Malloy, Rachel/J-5917-2019	Olson, DaiWai/0000-0002-9280-078X; 			ALLAN D, 1989, J ADV NURS, V14, P127, DOI 10.1111/j.1365-2648.1989.tb00910.x; *AM ASS NEUR NURS, 2004, AANN COR CURR NEUR N; Andrews PJD, 2008, INTENS CARE MED, V34, P1362, DOI 10.1007/s00134-008-1103-y; Bartels Jean E, 2005, Nurs Health Sci, V7, P221, DOI 10.1111/j.1442-2018.2005.00249.x; Benner P., 1984, NOVICE EXPERT EXCELL; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS55; Brain Trauma Foundation American Association of Neurological Surgeons Congress of Neurological Surgeons, 2007, J NEUROTRAUM, V24, pS45, DOI DOI 10.1089/NEU.2007.9989; Given B, 2009, CANCER NURS, V32, P89, DOI 10.1097/NCC.0b013e31819ac87f; Greenberg MS., 2010, HDB NEUROSURGERY, V7th; Grenvik A, 2009, CRIT CARE CLIN, V25, P239, DOI 10.1016/j.ccc.2008.11.001; Hickey JV, 2009, CLIN PRACTICE NEUROL, P270; Kerr ME, 1997, NURS RES, V46, P195, DOI 10.1097/00006199-199707000-00003; Leape LL, 2002, JAMA-J AM MED ASSOC, V288, P501, DOI 10.1001/jama.288.4.501; LUNDBERG N, 1965, J NEUROSURG, V22, P581, DOI 10.3171/jns.1965.22.6.0581; March K, 1990, J Neurosci Nurs, V22, P375; Marshall AP, 2011, WORLDV EVID-BASED NU, V8, P224, DOI 10.1111/j.1741-6787.2011.00221.x; Mauritz W, 2007, WIEN KLIN WOCHENSCHR, V119, P46, DOI 10.1007/s00508-006-0763-2; McIlvoy L., 2011, AANN CLIN PRACTICE G; McNett M, 2010, AM J CRIT CARE, V19, P250, DOI 10.4037/ajcc2009293; McNett MM, 2010, J NEUROSCI NURS, V42, P71, DOI 10.1097/JNN.0b013e3181ce5b8a; Miller CM, 2012, CURR NEUROL NEUROSCI, V12, P474, DOI 10.1007/s11910-012-0274-7; MITCHELL PH, 1981, NURS RES, V30, P212; MITCHELL PH, 1978, NURS RES, V27, P4; Olson DM, 2010, J NEUROSCI NURS, V42, P119, DOI 10.1097/JNN.0b013e3181d4a3aa; Olson DM, 2005, AACN ADV CRIT CARE, V16, P441, DOI 10.1097/00044067-200510000-00003; Palmer S, 2001, J TRAUMA, V50, P657, DOI 10.1097/00005373-200104000-00010; Rising C J, 1993, J Neurosci Nurs, V25, P302; SNYDER M, 1983, J ADV NURS, V8, P273; Wolfe TJ, 2009, CURR NEUROL NEUROSCI, V9, P477, DOI 10.1007/s11910-009-0070-1	29	17	18	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0888-0395	1945-2810		J NEUROSCI NURS	J. Neurosci. Nurs.	AUG	2013	45	4					186	193		10.1097/JNN.0b013e3182986400			8	Clinical Neurology; Nursing	Neurosciences & Neurology; Nursing	183XC	WOS:000321849600005	23812048				2021-06-18	
J	Sarsfield, MJ; Morley, EJ; Callahan, JM; Grant, WD; Wojcik, SM				Sarsfield, Matthew J.; Morley, Eric J.; Callahan, James M.; Grant, William D.; Wojcik, Susan M.			Evaluation of Emergency Medicine Discharge Instructions in Pediatric Head Injury	PEDIATRIC EMERGENCY CARE			English	Article						mild traumatic brain injury; discharge instructions; return to play; concussion; head injury	TRAUMATIC BRAIN-INJURY; INTERNATIONAL-CONFERENCE; CONCUSSION; MANAGEMENT; STATEMENT; SPORTS; CHILDREN	Objectives: Pediatric head trauma is a common occurrence. There is mounting evidence that even patients with minor head injury require limits on school activities and/or removal from sports and play to help speed recovery and limit morbidity. The objective of this study was to determine whether discharge instructions given to children who had sustained head injuries included information regarding activity restrictions, activity time constraints, and/or specifics of follow-up care. Methods: This was a retrospective chart review of patients aged 2 to 18 years evaluated and treated for head injury during a 4-month period at a level I trauma center (volume similar to 23,000 pediatric patients per year). Included were those children seen, evaluated, and diagnosed with any of the following: mild head injury, concussion, minor head trauma, or mild traumatic brain injury (mTBI). Subjects were excluded if there was a positive acute head injury computed tomography finding (other than findings of a simple linear skull fracture) or if the subject required admission. Results: Among the 204 patients meeting eligibility, 95.1% received instruction to follow up with a physician, 82.8% received anticipatory guidance regarding expected symptoms, 15.2% received specific restriction time from sports, and 21.5% were removed from sports. Of these patients, 113 patients were determined "likely" to have sustained an mTBI. Patients with sports-related mTBI received return-to-sports restrictions (chi(2) = 11.225, P < 0.008) and to remove the child from play (chi(2) = 9.781, P < 0.004) as discharge instructions significantly more than did patients with motor vehicle accident or other mechanisms of injury. Conclusions: Children sustaining head injury were inadequately instructed to restrict athletic activities upon discharge. This is particularly true for patients who sustain an mTBI from non-sports-related activity.	[Sarsfield, Matthew J.; Grant, William D.; Wojcik, Susan M.] SUNY Upstate Med Univ, Dept Emergency Med, Syracuse, NY 13202 USA; [Morley, Eric J.] SUNY Downstate Med Univ, Dept Emergency Med, Brooklyn, NY USA; [Callahan, James M.] Childrens Hosp Philadelphia, Dept Pediat, Philadelphia, PA 19104 USA	Sarsfield, MJ (corresponding author), SUNY Upstate Med Univ, Dept Emergency Med, 550 E Genesee St, Syracuse, NY 13202 USA.	sarsfiem@upstate.edu					Adams J, 2001, J PEDIATR SURG, V36, P119, DOI 10.1053/jpsu.2001.20026; Adirim TA, 2007, CLIN PEDIATR EMERG M, V8, P2, DOI 10.1016/j.cpem.2007.02.002; [Anonymous], TRAUMATIC BRAIN INJU; Bakhos LL, 2010, PEDIATRICS, V126, pE550, DOI 10.1542/peds.2009-3101; Barlas D, 1999, ANN EMERG MED, V34, P610, DOI 10.1016/S0196-0644(99)70163-0; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Bowen Anne Phelan, 2003, J Emerg Nurs, V29, P287, DOI 10.1067/men.2003.90; Fung M, 2006, BRAIN INJURY, V20, P889, DOI 10.1080/02699050600831934; GENUARDI FJ, 1995, PEDIATRICS, V95, P216; Harmon KG, 1999, AM FAM PHYSICIAN, V60, P887; Kamerling SN, 2003, PEDIATR EMERG CARE, V19, P431, DOI 10.1097/01.pec.0000092590.40174.1f; Kelly JP, 1997, NEUROLOGY, V48, P581; Kirkwood MW, 2006, PEDIATRICS, V117, P1359, DOI 10.1542/peds.2005-0994; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Langlois JA, 2006, TRAUMATIC BRAIN INJU; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; Poirier MP, 2000, PEDIATR EMERG CARE, V16, P278, DOI 10.1097/00006565-200008000-00018; POIRIER MP, 2003, CLIN PEDIAT EMERG ME, V4, P179, DOI DOI 10.1016/S1522-8401(03)00061-2; Scarfone RJ, 1996, ARCH PEDIAT ADOL MED, V150, P948, DOI 10.1001/archpedi.1996.02170340062012; Wang NE, 2003, ACAD EMERG MED, V10, P1278, DOI 10.1197/S1069-6563(03)00499-8	22	17	18	0	8	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0749-5161	1535-1815		PEDIATR EMERG CARE	Pediatr. Emerg. Care	AUG	2013	29	8					884	887		10.1097/PEC.0b013e31829ec0d9			4	Emergency Medicine; Pediatrics	Emergency Medicine; Pediatrics	300NL	WOS:000330470500002	23903674				2021-06-18	
J	Sillesen, M; Jin, G; Oklu, R; Albadawi, H; Imam, AM; Jepsen, CH; Hwabejire, JO; Ostrowski, SR; Johansson, PI; Rasmussen, LS; Alam, HB				Sillesen, Martin; Jin, Guang; Oklu, Rahmi; Albadawi, Hassan; Imam, Ayesha M.; Jepsen, Cecilie H.; Hwabejire, John O.; Ostrowski, Sisse R.; Johansson, Par I.; Rasmussen, Lars S.; Alam, Hasan B.			Fresh-frozen plasma resuscitation after traumatic brain injury and shock attenuates extracellular nucleosome levels and deoxyribonuclease 1 depletion	SURGERY			English	Article							ENDOTHELIAL GLYCOCALYX; DNA TRAPS; HISTONES; MARKER; PATHOGENESIS; INFLAMMATION; DEGRADATION; MORTALITY; DEATH; MODEL	Introduction. Traumatic brain injury and shock are among the leading causes of trauma-related mortality. We have previously shown that fresh-frozen plasma (FFP) resuscitation reduces the size of brain lesion and associated swelling compared with crystalloids. We hypothesized that this, effect would be associated with an attenuation of circulating nucleosome levels, a biomarker of injury with cytotoxic potential, through reconstitution of circulating deoxyribonuclease-1 (DNAse1), an enzyme identified as critical in nucleosome clearance from the circulation. Methods. Twelve swine underwent a protocol of traumatic brain injury followed by 40% volume-controlled hemorrhage. Animals were left in shock (mean arterial pressure of 35 mmHg) for 2 hours before they were resuscitated with normal saline (NS) or FFP Circulating levels of nucleosomes and DNAse1 were measured whereas extracellular nucleosomes were quantified on brain histology. Lesion size and brain swelling were also quantified. Results. Nucleosome levels were significantly greater in the NS group 6 hours after resuscitation (0.32 mU vs 0.15 mU, P = .030) whereas DNAse1 levels were substantially greater in the FFP group (9.82 ng/mL vs 4.54 ng/mL, P = .010). Circulating nucleosomes levels correlated with lesion size (rho = 0.79, P = .002) as well as brain swelling (rho = 0.89, P < .001) whereas DNAse1 levels correlated with brain swelling (rho = -0.61, P =.036) but not lesion size (rho = -0.47, P = .124). Brain staining revealed nucleosome extracellularization in both groups, but this appeared more frequent in the NS-resuscitated animals. Conclusion. Our results show that resuscitation with FFP attenuates circulating. nucleosome levels and prevents DNAse1 depletion. These factors may play a role in the neuroprotective effects observed during early resuscitation with FFP.	[Sillesen, Martin; Jin, Guang; Imam, Ayesha M.; Jepsen, Cecilie H.; Hwabejire, John O.; Alam, Hasan B.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Div Trauma Emergency Surg & Surg Crit Care,Dept S, Boston, MA USA; [Sillesen, Martin; Rasmussen, Lars S.] Copenhagen Univ Hosp, Dept Anesthesia, Ctr Head & Orthoped, Copenhagen, Denmark; [Jin, Guang; Alam, Hasan B.] Univ Ann Arbor Hosp, Dept Surg, Ann Arbor, MI USA; [Oklu, Rahmi] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Div Vasc Imaging & Intervent, Boston, MA USA; [Albadawi, Hassan] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Div Vasc & Endovasc Surg, Boston, MA USA; [Ostrowski, Sisse R.; Johansson, Par I.] Copenhagen Univ Hosp, Sect Transfus Med, Copenhagen, Denmark; [Johansson, Par I.] Univ Texas Hlth Sci Ctr Houston, Dept Surg, Houston, TX 77030 USA	Alam, HB (corresponding author), Univ Michigan Hosp, Taubman Ctr 5331 2920, 1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA.	alamh@med.umich.edu	Ostrowski, Sisse R/E-7423-2011; Johansson, Par I/P-9283-2015	Ostrowski, Sisse R/0000-0001-5288-3851; Johansson, Par I/0000-0001-9778-5964; Rasmussen, Lars/0000-0002-7480-3004; Sillesen, Martin/0000-0001-9494-5475	U.S. Army Medical Research Materiel CommandU.S. Army Medical Research & Materiel Command (USAMRMC) [GRANTT00521959]; Rigshospitalet (Copenhagen University Hospital, Denmark); Tryg Foundation (Denmark)	The study was funded by U.S. Army Medical Research Materiel Command (GRANTT00521959; to H.A.), a grant from Rigshospitalet (Copenhagen University Hospital, Denmark; to M.S.), and L.S.R. has received a grant from the Tryg Foundation (Denmark).	Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS7; Brill A, 2012, J THROMB HAEMOST, V10, P136, DOI 10.1111/j.1538-7836.2011.04544.x; Brown LM, 2011, J TRAUMA, V71, pS358, DOI 10.1097/TA.0b013e318227f152; Chappell D, 2008, ANESTHESIOLOGY, V109, P723, DOI 10.1097/ALN.0b013e3181863117; Clark SR, 2007, NAT MED, V13, P463, DOI 10.1038/nm1565; De Meyer SF, 2012, ARTERIOSCL THROM VAS, V32, P1884, DOI 10.1161/ATVBAHA.112.250993; Fuchs TA, 2007, J CELL BIOL, V176, P231, DOI 10.1083/jcb.200606027; Fuchs TA, 2011, BLOOD, V118, P3708, DOI 10.1182/blood-2011-01-332676; Fuchs TA, 2010, P NATL ACAD SCI USA, V107, P15880, DOI 10.1073/pnas.1005743107; Geiger S, 2007, J NEUROL, V254, P617, DOI 10.1007/s00415-006-0407-5; Hakkim A, 2010, P NATL ACAD SCI USA, V107, P9813, DOI 10.1073/pnas.0909927107; Helmy A, 2011, PROG NEUROBIOL, V95, P352, DOI 10.1016/j.pneurobio.2011.09.003; Jin G, 2012, SHOCK, V38, P49, DOI 10.1097/SHK.0b013e3182574778; Johansson PI, 2011, ANN SURG, V254, P194, DOI 10.1097/SLA.0b013e318226113d; Kawai Y, 2004, CIRCULATION, V109, P2398, DOI 10.1161/01.CIR.0000129232.61483.43; Kominato Y, 2007, BBA-GEN SUBJECTS, V1770, P1567, DOI 10.1016/j.bbagen.2007.08.012; Kozar RA, 2011, ANESTH ANALG, V112, P1289, DOI 10.1213/ANE.0b013e318210385c; Kutcher ME, 2012, J TRAUMA ACUTE CARE, V73, P1389, DOI 10.1097/TA.0b013e318270d595; Longstaff C, 2013, J BIOL CHEM, V288, P6946, DOI 10.1074/jbc.M112.404301; LOSMAN MJ, 1992, J IMMUNOL, V148, P1561; Mannherz H G, 1995, Curr Top Microbiol Immunol, V198, P161; Martinez-Valle F, 2009, LUPUS, V18, P418, DOI 10.1177/0961203308098189; Massberg S, 2010, NAT MED, V16, P887, DOI 10.1038/nm.2184; Meng W, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/149560; Oklu R, 2012, J VASC INTERV RADIOL, V23, P712, DOI 10.1016/j.jvir.2012.01.072; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Thomas GM, 2012, BLOOD, V119, P6335, DOI 10.1182/blood-2012-01-405183; Xu J, 2009, NAT MED, V15, P1318, DOI 10.1038/nm.2053	29	17	17	0	6	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0039-6060			SURGERY	Surgery	AUG	2013	154	2					197	205		10.1016/j.surg.2013.04.002			9	Surgery	Surgery	196UB	WOS:000322801800008	23889948				2021-06-18	
J	Liu, P; Li, YS; Quartermain, D; Boutajangout, A; Ji, Y				Liu, Ping; Li, Yong-Sheng; Quartermain, David; Boutajangout, Allal; Ji, Yong			Inhaled nitric oxide improves short term memory and reduces the inflammatory reaction in a mouse model of mild traumatic brain injury	BRAIN RESEARCH			English	Article						Inhaled nitric oxide (INO); Mild traumatic brain injury (mTBI); Short term memory (STM); Inflammatory reaction; Mouse	CLOSED-HEAD INJURY; CELL-DEATH; CONSEQUENCES; ASTROCYTES; EXPRESSION; LEVEL; RATS	Although the mechanisms underlying mild traumatic brain injury (mTBI) are becoming well understood, treatment options are still limited. In the present study, mTBI was induced by a weight drop model to produce a closed head injury to mice and the effect of inhaled nitric oxide (INO) was evaluated by a short term memory task (object recognition task) and immunohistochemical staining of glial fibrillary acidic protein (GFAP) and CD45 for the detection of reactive astrocytes and microglia. Results showed that mTBI model did not produce brain edema, skull fracture or sensorimotor coordination dysfunctions. Mice did however exhibit a significant deficit in short term memory (STM) and strong inflammatory reaction in the ipsilateral cortex and hippocampus compared to sham-injured controls 24 h after mTBI. Additional groups of untreated mice tested 3 and 7 days later, demonstrated that recognition memory had recovered to normal levels by Day 3. Mice treated with 10 ppm INO for 4 or 8 h, beginning immediately after TBI demonstrated significantly improved STM at 24 h when compared with room air controls (p < 0.05). Whereas mice treated with 10 ppm INO for 24 h showed no improvement in STM. Mice treated with INO 10 ppm for 8 h exhibited significantly reduced microglia and astrocyte activation compared with room air controls. These data demonstrate that mTBI produces a disruption of STM which is evident 24 h after injury and persists for 2-3 days. Treatment with low concentration or short durations of INO prevents this memory loss and also attenuates the inflammatory response. These findings may have relevance for the treatment of patients diagnosed with concussion. (c) 2013 Elsevier B.V. All rights reserved.	[Liu, Ping; Ji, Yong] Huanhu Hosp, Dept Neurol, Tianjin, Peoples R China; [Liu, Ping; Li, Yong-Sheng; Quartermain, David] NYU, Sch Med, Dept Neurol, Lab Behav Neurol, New York, NY 10003 USA; [Boutajangout, Allal] NYU, Sch Med, Dept Physiol & Neurosci & Psychiat, New York, NY 10003 USA	Liu, P (corresponding author), Huanhu Hosp, Dept Neurol, Tianjin, Peoples R China.	ping.liu@nyumc.org					Baldus S, 2001, AM J RESP CRIT CARE, V163, P308, DOI 10.1164/ajrccm.163.2.ed2000c; Beni-Adani L, 2001, J PHARMACOL EXP THER, V296, P57; Bloomfield GL, 1997, CRIT CARE MED, V25, P584, DOI 10.1097/00003246-199704000-00006; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Cernak I, 2010, J CEREBR BLOOD F MET, V30, P255, DOI 10.1038/jcbfm.2009.203; Creed JA, 2011, J NEUROTRAUM, V28, P547, DOI 10.1089/neu.2010.1729; Da JP, 2007, CRIT CARE MED, V35, P26, DOI 10.1097/01.CCM.0000250319.91575.BB; Dempsey RJ, 2000, NEUROSURGERY, V47, P399, DOI 10.1097/00006123-200008000-00024; Fawcett JW, 1999, BRAIN RES BULL, V49, P377, DOI 10.1016/S0361-9230(99)00072-6; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Gao XA, 2011, J NEUROPATH EXP NEUR, V70, P183, DOI 10.1097/NEN.0b013e31820c6878; GROSS SS, 1995, ANNU REV PHYSIOL, V57, P737, DOI 10.1146/annurev.ph.57.030195.003513; Ichinose F, 2004, CIRCULATION, V109, P3106, DOI 10.1161/01.CIR.0000134595.80170.62; Israelsson C, 2009, J NEUROTRAUM, V26, P1307, DOI [10.1089/neu.2008.0676, 10.1089/neu.2008-0676]; Laroux FS, 2001, ACTA PHYSIOL SCAND, V173, P113, DOI 10.1046/j.1365-201X.2001.00891.x; Laufs U, 1998, J BIOL CHEM, V273, P24266, DOI 10.1074/jbc.273.37.24266; Leinhase I, 2006, EXP NEUROL, V199, P454, DOI 10.1016/j.expneurol.2006.01.033; Li B, 2009, NEUROSURGERY, V65, P179, DOI 10.1227/01.NEU.0000346272.76537.DC; Lucas SM, 2006, BRIT J PHARMACOL, V147, pS232, DOI 10.1038/sj.bjp.0706400; Margulies S, 2009, J NEUROTRAUM, V26, P925, DOI [10.1089/neu.2008.0794, 10.1089/neu.2008-0794]; Marklund N, 2006, CURR PHARM DESIGN, V12, P1645, DOI 10.2174/138161206776843340; Mautes AEM, 1996, NEUROSCI LETT, V214, P95, DOI 10.1016/0304-3940(96)12916-5; McCrory P, 2009, PHYSICIAN SPORTSMED, V37, P141, DOI 10.3810/psm.2009.06.1721; Miguel-Hidalgo JJ, 2005, ALCOHOL CLIN EXP RES, V29, P766, DOI 10.1097/01.ALC.0000164378.92680.FA; MONCADA S, 1991, PHARMACOL REV, V43, P109; Morganti-Kossmann MC, 2001, SHOCK, V16, P165, DOI 10.1097/00024382-200116030-00001; Pan WH, 2003, EXP BRAIN RES, V149, P195, DOI 10.1007/s00221-002-1355-7; Papadimos TJ, 2009, SCAND J TRAUMA RESUS, V17, DOI 10.1186/1757-7241-17-5; Papadimos Thomas J, 2008, J Trauma Manag Outcomes, V2, P1, DOI 10.1186/1752-2897-2-1; Peillon D, 1999, ANN FR ANESTH, V18, P225, DOI 10.1016/S0750-7658(99)90186-7; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Raghupathi R, 2004, BRAIN PATHOL, V14, P215, DOI 10.1111/j.1750-3639.2004.tb00056.x; Rick A.B., 2006, NAT PROTOC, V3, P1306; Schmidt OI, 2005, BRAIN RES REV, V48, P388, DOI 10.1016/j.brainresrev.2004.12.028; Sehba FA, 2011, ACTA NEUROCHIR SUPPL, V110, P99, DOI 10.1007/978-3-7091-0353-1_18; Shay M., 2011, J NEUROL RES, V1, P1; Sironi L, 2003, ARTERIOSCL THROM VAS, V23, P322, DOI 10.1161/01.ATV.0000044458.23905.3B; Sittipunt C, 2001, AM J RESP CRIT CARE, V163, P503, DOI 10.1164/ajrccm.163.2.2004187; Spain A, 2010, J NEUROTRAUM, V27, P1429, DOI 10.1089/neu.2010.1288; Stahel PF, 2000, J CEREBR BLOOD F MET, V20, P369, DOI 10.1097/00004647-200002000-00019; STRUGAR J, 1993, J TRAUMA, V34, P555, DOI 10.1097/00005373-199304000-00012; Tapia-Perez JH, 2008, J NEUROTRAUM, V25, P1011, DOI 10.1089/neu.2008.0554; Vavilala MS, 2001, ANESTH ANALG, V93, P351, DOI 10.1097/00000539-200108000-00023; Wachtel M, 2001, J NEUROCHEM, V78, P155, DOI 10.1046/j.1471-4159.2001.00399.x; Zohar O, 2003, NEUROSCIENCE, V118, P949, DOI 10.1016/S0306-4522(03)00048-4; Zohar O, 2011, ACTA NEUROBIOL EXP, V71, P36; Zohar O, 2011, NEUROBIOL DIS, V41, P329, DOI 10.1016/j.nbd.2010.10.001	47	17	20	0	13	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	JUL 19	2013	1522						67	75		10.1016/j.brainres.2013.05.032			9	Neurosciences	Neurosciences & Neurology	198NU	WOS:000322930400007	23743262				2021-06-18	
J	Zhu, JM; Zhang, JF; Ji, M; Gu, HW; Xu, Y; Chen, C; Hu, N				Zhu, Juming; Zhang, Junfang; Ji, Min; Gu, Hongwei; Xu, Yue; Chen, Chen; Hu, Nan			The Role of Peroxisome Proliferator-Activated Receptor and Effects of Its Agonist, Pioglitazone, on a Rat Model of Optic Nerve Crush: PPAR gamma in Retinal Neuroprotection	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; GANGLION-CELL DAMAGE; MOUSE MODEL; ROSIGLITAZONE; GLAUCOMA; INHIBITION; MECHANISMS; EXPRESSION; PROTECTION; NEUROPATHY	It has been shown that peroxisome proliferators-activated receptor gamma (PPAR gamma) is beneficial for central nervous system injury. However its role on optic nerve injury remains unknown. In the present study, we examined the change of PPAR gamma expression in rat retina following optic nerve injury and investigated the effect of pioglitazone (Pio), a PPAR gamma agonist, on retinal ganglion cells (RGCs) neuroprotection using a rat optic nerve crush (ONC) model. Our results showed that PPAR gamma mRNA and protein levels were increased after ONC, and most of PPAR gamma-immunoreactive cells colocalized with Muller cells. Pio treatment significantly enhanced the number of surviving RGCs and inhibited RGCs apoptosis induced by ONC. However, when PPAR gamma antagonist GW9662 was used, these neuroprotective effects were abolished. In addition, pio attenuated Muller cell activation after ONC. These results indicate that PPAR gamma appears to protect RGCs from ONC possibly via the reduction of Muller glial activation. It provides evidence that activation of PPAR gamma may be a potential alternative treatment for RGCs neuroprotection.	[Zhu, Juming; Zhang, Junfang; Ji, Min; Gu, Hongwei; Xu, Yue; Chen, Chen; Hu, Nan] Nantong Univ, Inst Eye, Nantong, Peoples R China	Hu, N (corresponding author), Nantong Univ, Inst Eye, Nantong, Peoples R China.	hunaneye@hotmail.com			science and technology project of Nantong, China [BK2012070]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81200680]	This work was supported by a grant from the science and technology project of Nantong, China (No. BK2012070), the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD) and the National Natural Science Foundation of China (No: 81200680). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoun P, 2003, INVEST OPHTH VIS SCI, V44, P2999, DOI 10.1167/iovs.02-1060; Bernardo A, 2000, EUR J NEUROSCI, V12, P2215, DOI 10.1046/j.1460-9568.2000.00110.x; Bringmann A, 2006, PROG RETIN EYE RES, V25, P397, DOI 10.1016/j.preteyeres.2006.05.003; Bringmann A, 2012, OPHTHALMOLOGICA, V227, P1, DOI 10.1159/000328979; Carta AR, 2011, NEUROSCIENCE, V194, P250, DOI 10.1016/j.neuroscience.2011.07.046; Chidlow G, 2007, DRUGS, V67, P725, DOI 10.2165/00003495-200767050-00006; Escher P, 2000, MUTAT RES-FUND MOL M, V448, P121, DOI 10.1016/S0027-5107(99)00231-6; Escribano L, 2009, BIOCHEM BIOPH RES CO, V379, P406, DOI 10.1016/j.bbrc.2008.12.071; Esposito E, 2011, EXPERT OPIN THER TAR, V15, P943, DOI 10.1517/14728222.2011.581231; Fu QL, 2009, NEUROSCIENCE, V162, P375, DOI 10.1016/j.neuroscience.2009.04.075; Goldblum D, 2002, VISION RES, V42, P471, DOI 10.1016/S0042-6989(01)00194-8; Herzlich Alexandra A, 2009, Open Biol J, V2, P141; Kiaei M, 2005, EXP NEUROL, V191, P331, DOI 10.1016/j.expneurol.2004.10.007; Kisiswa L, 2010, OPHTHALMIC RES, V43, P61, DOI 10.1159/000247591; Kusari J, 2007, INVEST OPHTH VIS SCI, V48, P5152, DOI 10.1167/iovs.07-0427; Lee CH, 2011, J NEUROL SCI, V300, P120, DOI 10.1016/j.jns.2010.09.005; Lehrke M, 2005, CELL, V123, P993, DOI 10.1016/j.cell.2005.11.026; Leung CKS, 2008, INVEST OPHTH VIS SCI, V49, P4898, DOI 10.1167/iovs.07-1447; Mabuchi F, 2004, INVEST OPHTH VIS SCI, V45, P4352, DOI 10.1167/iovs.04-0355; Mackenzie P, 2008, SURV OPHTHALMOL, V53, pS39, DOI 10.1016/j.survophthal.2008.08.008; Michalik L, 2002, INT J DEV BIOL, V46, P105; Nakazawa T, 2006, MOL VIS, V12, P867; Neufeld AH, 2003, NEUROSCIENTIST, V9, P485, DOI 10.1177/1073858403253460; Pershadsingh HA, 2008, PPAR RES, V2008, DOI 10.1155/2008/164273; Qi L, 2010, INT J CLIN EXP MED, V3, P283; Quigley HA, 2000, INVEST OPHTH VIS SCI, V41, P3460; Rosen ED, 2001, J BIOL CHEM, V276, P37731, DOI 10.1074/jbc.R100034200; Sarayba MA, 2005, EXP EYE RES, V80, P435, DOI 10.1016/j.exer.2004.10.009; Schmidt KG, 2008, CURR NEUROPHARMACOL, V6, P164, DOI 10.2174/157015908784533851; Schwartz M, 2004, BRAIN RES BULL, V62, P467, DOI 10.1016/S0361-9230(03)00076-5; Sucher NJ, 1997, VISION RES, V37, P3483, DOI 10.1016/S0042-6989(97)00047-3; Tezel G, 2006, PROG RETIN EYE RES, V25, P490, DOI 10.1016/j.preteyeres.2006.07.003; Tura A, 2009, INVEST OPHTH VIS SCI, V50, P452, DOI 10.1167/iovs.08-1973; Victor NA, 2006, EUR J NEUROSCI, V24, P1653, DOI 10.1111/j.1460-9568.2006.05037.x; Vidal-Sanz M, 2000, NEUROTOX RES, V2, P215, DOI 10.1007/BF03033795; Vigneswara V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053473; Wilhelm B, 2006, GRAEF ARCH CLIN EXP, V244, P551, DOI 10.1007/s00417-005-0102-8; Yi JH, 2008, BRAIN RES, V1244, P164, DOI 10.1016/j.brainres.2008.09.074; Zhao Y, 2006, FASEB J, V20, P1162, DOI 10.1096/fj.05-5007com	39	17	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2013	8	7							e68935	10.1371/journal.pone.0068935			10	Multidisciplinary Sciences	Science & Technology - Other Topics	214PM	WOS:000324146200040	23874818	DOAJ Gold, Green Published			2021-06-18	
J	Steel, J; Ferguson, A; Spencer, E; Togher, L				Steel, Joanne; Ferguson, Alison; Spencer, Elizabeth; Togher, Leanne			Speech pathologists' current practice with cognitive-communication assessment during post-traumatic amnesia: A survey	BRAIN INJURY			English	Article						Acute; cognitive communication assessment; inpatient; PTA; rehabilitation; speech pathology; traumatic brain injury	TRAUMATIC BRAIN-INJURY; REHABILITATION; INTERVENTION; PERFORMANCE; EMERGENCE; CONFUSION; SEVERITY; BATTERY; ADULTS	Primary objective: To investigate speech pathologists' current practice with adults who are in post-traumatic amnesia (PTA). Method: Speech pathologists with experience of adults in PTA were invited to take part in an online survey through Australian professional email/internet-based interest groups. Results: Forty-five speech pathologists responded to the online survey. The majority of respondents (78%) reported using informal, observational assessment methods commencing at initial contact with people in PTA or when patients' level of alertness allowed and initiating formal assessment on emergence from PTA. Seven respondents (19%) reported undertaking no assessment during PTA. Clinicians described using a range of techniques to monitor cognitive-communication during PTA, including static, dynamic, functional and impairment-based methods. Conclusions: The study confirmed that speech pathologists have a key role in the multidisciplinary team caring for the person in PTA, especially with family education and facilitating interactions with the rehabilitation team and family. Decision-making around timing and means of assessment of cognitive-communication during PTA appeared primarily reliant on speech pathologists' professional experience and the culture of their workplace. The findings support the need for further research into the nature of cognitive-communication disorder and resolution over this period.	[Steel, Joanne; Ferguson, Alison; Spencer, Elizabeth] Univ Newcastle, Newcastle, NSW 2308, Australia; [Togher, Leanne] Univ Sydney, Sydney, NSW 2006, Australia	Steel, J (corresponding author), Univ Newcastle, Sch Humanities & Social Sci, Sch Off, 1st Floor,McMullin Bldg,Callaghan Campus, Newcastle, NSW 2308, Australia.	joanne.steel@uon.edu.au	Steel, Joanne/M-2585-2018; Togher, Leanne/AAC-7083-2019	Steel, Joanne/0000-0002-5478-5865; Togher, Leanne/0000-0002-4518-6748			Adamovich B. B., 1992, SCALES COGNITIVE ABI; Andelic N, 2012, J NEUROTRAUM, V29, P66, DOI 10.1089/neu.2011.1811; ANSELL BJ, 1989, ARCH PHYS MED REHAB, V70, P104; Armstrong E., 2003, ADV SPEECH LANGUAGE, V5, P137, DOI [10.1080/14417040510001669171, DOI 10.1080/14417040510001669171]; Babcock H, 1940, MEASUREMENT EFFICIEN; Bayles K. A., 1993, ARIZONA BATTERY COMM; Bittner RM, 2007, BRAIN INJURY, V21, P709, DOI 10.1080/02699050701468917; Bloomberg K., 2009, TRIPLE C CHECKLIST C; Blyth T, 2012, BRAIN INJURY, V26, P234, DOI 10.3109/02699052.2012.654587; Boake C, 2001, ARCH PHYS MED REHAB, V82, P761, DOI 10.1053/apmr.2001.23753; BODY R, 2006, BRAIN IMPAIR, V7, P212, DOI DOI 10.1375/BRIM.7.3.212; Bragge P, 2011, J NEUROTRAUM, V29, P1; Buchanan EA, 2009, J EMPIR RES HUM RES, V4, P37, DOI 10.1525/jer.2009.4.2.37; Burns MS, 1985, RIC EVALUATION COMMU; Butt P., 2004, BUTT NONVERBAL REASO; Christie J, 1986, MT WILGA HIGH LEVEL; Coelho Carl, 2005, Seminars in Speech and Language, V26, P223, DOI 10.1055/s-2005-922102; Couper MP, 2000, PUBLIC OPIN QUART, V64, P464, DOI 10.1086/318641; Cullen N, 2013, MODULE3 EFFICACY MOD; Douglas JM, 2010, J SPEECH LANG HEAR R, V53, P365, DOI 10.1044/1092-4388(2009/08-0205); Duff MC, 2002, BRAIN INJURY, V16, P773, DOI 10.1080/02699050210128870; Frank EM, 1996, J MED SPEECH-LANG PA, V4, P81; Giacino J, 2004, COMA RECOVERY SCALE; Hanks RA, 2008, ARCH PHYS MED REHAB, V89, P950, DOI 10.1016/j.apmr.2008.01.011; Harradine PG, 2004, MED J AUSTRALIA, V181, P130, DOI 10.5694/j.1326-5377.2004.tb06202.x; Hart T, 2009, NEUROPSYCHOL REHABIL, V19, P161, DOI 10.1080/09602010802188393; Hartley L. L., 1995, COGNITIVE COMMUNICAT; Helm-Estabrooks N, 1991, BRIEF TEST HEAD INJU; Henry JD, 2004, NEUROPSYCHOLOGY, V18, P621, DOI 10.1037/0894-4105.18.4.621; Holland A, 1980, COMMUNICATIVE ABILIT; Howard D., 1992, PYRAMIDS PALM TREES; Kalmar K, 2008, ARCH PHYS MED REHAB, V89, P942, DOI 10.1016/j.apmr.2008.01.008; Kaplan E., 1983, BOSTON NAMING TEST; Kertesz A., 1982, W APHASIA BATTERY; Langhorn L, 2010, J CLIN NURS, V19, P2959, DOI 10.1111/j.1365-2702.2010.03330.x; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Marsh NV, 1991, NEUROPSYCHOLOGY, V5, P107, DOI 10.1037/0894-4105.5.2.107; McDonald S., 2002, AWARENESS SOCIAL INF; McGhee H, 2006, BRAIN INJURY, V20, P1307, DOI 10.1080/02699050601081851; Menachemi N., 2010, EVALUATION RES ED, V24, P5; MORTON MV, 1995, BRAIN INJURY, V9, P81, DOI 10.3109/02699059509004574; Nakase-Richardson R, 2007, J NEUROL NEUROSUR PS, V78, P872, DOI 10.1136/jnnp.2006.104190; Niemeier JP, 2011, BRAIN INJURY, V25, P680, DOI 10.3109/02699052.2011.573520; Nott MT, 2008, BRAIN INJURY, V22, P669, DOI 10.1080/02699050802227170; O'Callaghan AM, 2010, INT J SPEECH-LANG PA, V12, P107, DOI 10.3109/17549500903431774; O'Halloran R, 2009, INT J SPEECH-LANG PA, V11, P438, DOI 10.3109/17549500902741363; Pastorek NJ, 2004, J INT NEUROPSYCH SOC, V10, P807, DOI 10.1017/S1355617704106012; Ponsford J, 2002, J NEUROL NEUROSUR PS, V73, P330, DOI 10.1136/jnnp.73.3.330; Prigatano GP, 2005, J HEAD TRAUMA REHAB, V20, P19, DOI 10.1097/00001199-200501000-00004; RUSSELL WR, 1961, ARCH NEUROL-CHICAGO, V5, P4, DOI 10.1001/archneur.1961.00450130006002; Secord, 1989, TEST LANGUAGE COMPET; Sherer M, 2008, ARCH PHYS MED REHAB, V89, P42, DOI 10.1016/j.apmr.2007.08.128; Smith VH, 2001, BRAIN IMPAIR, V2, P29, DOI DOI 10.1375/BRIM.2.1.29; Smyth J.D., 2011, SOCIAL BEHAV RES INT, P11; Snow P, 1998, BRAIN INJURY, V12, P911, DOI 10.1080/026990598121981; Snow P, 1995, TRAUMATIC BRAIN INJU, P33; Sue V.M., 2007, CONDUCTING ONLINE SU; Syder D., 1993, SHEFFIELD SCREENING; Tate RL., 2000, BRAIN IMPAIR, V1, P116; Taylor CM, 2007, ARCH PHYS MED REHAB, V88, P521, DOI 10.1016/j.apmr.2007.01.013; Teasell R., 2013, EVIDENCE BASED REV M; Togher L, 2009, BRAIN IMPAIR, V10, P188, DOI 10.1375/brim.10.2.188; Turkstra L, 2005, J MED SPEECH-LANG PA, V13, pIX; Turkstra Lyn S., 2005, Seminars in Speech and Language, V26, P215, DOI 10.1055/s-2005-922101; Weir N, 2006, BRAIN INJURY, V20, P927, DOI 10.1080/02699050600832684; Ylvisaker Mark, 1995, Seminars in Speech and Language, V16, P32, DOI 10.1055/s-2008-1064109	66	17	17	0	15	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUL	2013	27	7-8					819	830		10.3109/02699052.2013.775492			12	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	169UO	WOS:000320806200008	23758272	Green Accepted			2021-06-18	
J	Taylor, AN; Tio, DL; Sutton, RL				Taylor, Anna N.; Tio, Delia L.; Sutton, Richard L.			Restoration of Neuroendocrine Stress Response by Glucocorticoid Receptor or GABA(A) Receptor Antagonists after Experimental Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						bicuculline; corticosterone; glutamic acid decarboxylase 67; mifepristone; parvalbumin	CORTICOTROPIN-RELEASING HORMONE; PREFRONTAL CORTEX; EXPRESSION; RAT; DEXAMETHASONE; INVOLVEMENT; SECONDARY; VETERANS; NEURONS; AXIS	We previously reported that traumatic brain injury (TBI) produced by moderate controlled cortical impact (CCI) attenuates the stress response of the hypothalamic-pituitary-adrenal (HPA) axis between 21 and 70 days postinjury and enhances the sensitivity of the stress response to glucocorticoid negative feedback. In the current study, we investigated two possible mechanisms for the CCI-induced attenuation of the HPA stress response-i.e, glucocorticoid receptor (GR) and GABA-mediated inhibition of the HPA axis, with the GR antagonist, mifepristone (RU486), or the GABA(A)-receptor antagonist, bicuculline. In addition, we examined the effect of moderate CCI on GR and inhibitory neurons histologically in subfields of the hippocampus, medial prefrontal cortex, and amygdala. We show that at 30-min after onset of restraint stress, GR as well as GABA antagonism with MIFE or BIC, respectively, reversed the attenuating effects of moderate CCI on the stress-induced HPA response. Our histological results demonstrate that moderate CCI led to a loss of glutamic acid decarboxylase 67 or parvalbumin-positive inhibitory neurons within regions of the hippocampus and amygdala but did not lead to significant increases in GR in these regions. These findings indicate that suppression of the stress-induced HPA response after moderate CCI is mediated by the inhibitory actions of both GR and GABA, with a corresponding loss of inhibitory neurons within brain regions with neural pathways affecting limbic stress-integrative pathways.	[Taylor, Anna N.] Univ Calif Los Angeles, David Geffen Sch Med, Brain Res Inst, Dept Neurobiol, Los Angeles, CA 90095 USA; [Taylor, Anna N.; Sutton, Richard L.] Univ Calif Los Angeles, David Geffen Sch Med, Brain Injury Res Ctr, Dept Neurobiol, Los Angeles, CA 90095 USA; [Tio, Delia L.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurobiol, Los Angeles, CA 90095 USA	Taylor, AN (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurobiol, 10833 Le Conte Ave,Box 951763, Los Angeles, CA 90095 USA.	ataylor@mednet.ucla.edu			UCLA Brain Injury Research Center	We thank Tracy Papathakis, Yvonne Xuanhang Pham, and Amanda Dao for their excellent technical assistance and Sima Ghavim for her expert assistance with the histological preparations. This research was supported by the UCLA Brain Injury Research Center.	Agha A, 2007, BRIT J NEUROSURG, V21, P210, DOI 10.1080/02688690701253331; Akana SF, 2001, J NEUROENDOCRINOL, V13, P625, DOI 10.1046/j.1365-2826.2001.00676.x; Beleslin DB, 1997, ALCOHOL, V14, P167, DOI 10.1016/S0741-8329(96)00140-1; Benvenga S, 2000, J CLIN ENDOCR METAB, V85, P1353, DOI 10.1210/jc.85.4.1353; Carlson KF, 2010, J TRAUMA STRESS, V23, P17, DOI 10.1002/jts.20483; Cernak I, 1999, BRAIN INJURY, V13, P1005; Cohan P, 2005, CRIT CARE MED, V33, P2358, DOI 10.1097/01.CCM.0000181735.51183.A7; Cullinan WE, 2008, BRAIN STRUCT FUNCT, V213, P63, DOI 10.1007/s00429-008-0192-2; de Kloet CS, 2007, PSYCHONEUROENDOCRINO, V32, P215, DOI 10.1016/j.psyneuen.2006.12.009; de Kloet ER, 2000, EUR J PHARMACOL, V405, P187, DOI 10.1016/S0014-2999(00)00552-5; Di S, 2009, J NEUROSCI, V29, P393, DOI 10.1523/JNEUROSCI.4546-08.2009; DIORIO D, 1993, J NEUROSCI, V13, P3839; Furay AR, 2008, ENDOCRINOLOGY, V149, P5482, DOI 10.1210/en.2008-0642; Gibson CJ, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-38; Golarai G, 2001, J NEUROSCI, V21, P8523; Gottesfeld Z, 2002, J NEUROTRAUM, V19, P317, DOI 10.1089/089771502753594882; Grundy PL, 2001, J NEUROTRAUM, V18, P1373, DOI 10.1089/08977150152725669; Guo AL, 1996, J ENDOCRINOL INVEST, V19, P83, DOI 10.1007/BF03349841; Haller J, 2008, FRONT NEUROENDOCRIN, V29, P273, DOI 10.1016/j.yfrne.2007.10.004; Herman JP, 2005, PROG NEURO-PSYCHOPH, V29, P1201, DOI 10.1016/j.pnpbp.2005.08.006; HERMAN JP, 1993, CELL MOL NEUROBIOL, V13, P349, DOI 10.1007/BF00711577; Hoskison MM, 2009, NEUROSCIENCE, V159, P483, DOI 10.1016/j.neuroscience.2008.12.050; Kobori N, 2006, J NEUROSCI, V26, P4236, DOI 10.1523/JNEUROSCI.4687-05.2006; Kohda K, 2007, NEUROSCIENCE, V148, P22, DOI 10.1016/j.neuroscience.2007.05.041; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; McCullers DL, 2002, BRAIN RES, V947, P41, DOI 10.1016/S0006-8993(02)02904-9; Miklos IH, 2002, NEUROSCIENCE, V113, P581, DOI 10.1016/S0306-4522(02)00147-1; Moro N, 2010, EXP NEUROL, V225, P391, DOI 10.1016/j.expneurol.2010.07.013; Pavlov I, 2011, NEUROSCIENCE, V194, P208, DOI 10.1016/j.neuroscience.2011.07.074; Paxinos G., 2005, RAT BRAIN STEREOTAXI; Roe SY, 1998, EUR J NEUROSCI, V10, P553, DOI 10.1046/j.1460-9568.1998.00064.x; Shohami E, 1995, J NEUROTRAUM, V12, P1069, DOI 10.1089/neu.1995.12.1069; SUTTON RL, 1993, J NEUROTRAUM, V10, P135, DOI 10.1089/neu.1993.10.135; Tasker JG, 2006, ENDOCRINOLOGY, V147, P5549, DOI 10.1210/en.2006-0981; Taylor AN, 2002, J NEUROTRAUM, V19, P1597, DOI 10.1089/089771502762300256; Taylor AN, 2008, J NEUROTRAUM, V25, P311, DOI 10.1089/neu.2007.0486; Taylor AN, 2010, J NEUROTRAUM, V27, P1081, DOI 10.1089/neu.2009.1252; Taylor AN, 2006, J NEUROTRAUM, V23, P1802, DOI 10.1089/neu.2006.23.1802; Toth Z, 1997, J NEUROSCI, V17, P8106; Walilko T, 2009, J TRAUMA, V67, P1311, DOI 10.1097/TA.0b013e31819adc36; Wulsin AC, 2010, PSYCHONEUROENDOCRINO, V35, P1100, DOI 10.1016/j.psyneuen.2010.01.011; Yehuda R, 2009, ANN NY ACAD SCI, V1179, P56, DOI 10.1111/j.1749-6632.2009.04979.x	42	17	18	0	13	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL	2013	30	14					1250	1256		10.1089/neu.2012.2847			7	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	183MV	WOS:000321821100005	23384619	Green Published			2021-06-18	
J	Leitgeb, J; Mauritz, W; Brazinova, A; Majdan, M; Janciak, I; Wilbacher, I; Rusnak, M				Leitgeb, J.; Mauritz, W.; Brazinova, A.; Majdan, M.; Janciak, I.; Wilbacher, I.; Rusnak, M.			Glasgow Coma Scale score at intensive care unit discharge predicts the 1-year outcome of patients with severe traumatic brain injury	EUROPEAN JOURNAL OF TRAUMA AND EMERGENCY SURGERY			English	Article						Traumatic brain injury; Severe; Glasgow Coma Scale score; Glasgow Outcome Scale score; Long-term outcomes	ADMISSION CHARACTERISTICS; PROGNOSTIC VALUE; EPIDEMIOLOGY; MANAGEMENT; VALIDATION; IMPACT	To analyse the association between the Glasgow Coma Scale (GCS) score at intensive care unit (ICU) discharge and the 1-year outcome of patients with severe traumatic brain injury (TBI). Retrospective analysis of prospectively collected observational data. Between 01/2001 and 12/2005, 13 European centres enrolled 1,172 patients with severe TBI. Data on accident, treatment and outcomes were collected. According to the GCS score at ICU discharge, survivors were classified into four groups: GCS scores 3-6, 7-9, 10-12 and 13-15. Using the Glasgow Outcome Scale (GOS), 1-year outcomes were classified as "favourable" (scores 5, 4) or "unfavourable" (scores < 4). Factors that may have contributed to outcomes were compared between groups and for favourable versus unfavourable outcomes within each group. Of the 538 patients analysed, 308 (57 %) had GCS scores 13-15, 101 (19 %) had scores 10-12, 46 (9 %) had scores 7-9 and 83 (15 %) had scores 3-6 at ICU discharge. Factors significantly associated with these GCS scores included age, severity of trauma, neurological status (GCS, pupils) at admission and patency of the basal cisterns on the first computed tomography (CT) scan. Favourable outcome was achieved in 74 % of all patients; the rates were significantly different between GCS groups (93, 83, 37 and 10 %, respectively). Within each of the GCS groups, significant differences regarding age and trauma severity were found between patients with favourable versus unfavourable outcomes; neurological status at admission and CT findings were not relevant. The GCS score at ICU discharge is a good predictor of 1-year outcome. Patients with a GCS score < 10 at ICU discharge have a poor chance of favourable outcome.	[Leitgeb, J.] Med Univ Vienna, Dept Traumatol, A-1090 Vienna, Austria; [Mauritz, W.] Trauma Hosp Lorenz Boehler, Vienna, Austria; [Mauritz, W.; Brazinova, A.; Janciak, I.; Wilbacher, I.; Rusnak, M.] INRO, Vienna, Austria; [Brazinova, A.; Majdan, M.; Rusnak, M.] Trnava Univ, Fac Hlth & Social Serv, Dept Publ Hlth, Trnava, Slovakia	Leitgeb, J (corresponding author), Med Univ Vienna, Dept Traumatol, Wahringer Gurtel 18-20, A-1090 Vienna, Austria.	johannes.leitgeb@meduniwien.ac.at	Brazinova, Alexandra/C-4265-2016; Rusnak, Martin/K-9349-2016; Majdan, Marek/K-5017-2012	Brazinova, Alexandra/0000-0003-0625-256X; Rusnak, Martin/0000-0003-3321-1042; Majdan, Marek/0000-0001-8037-742X	European UnionEuropean Commission [ICA2-CT-2002-100]; Austrian Worker's Compensation Board (AUVA) [FK 33/2003]; Austrian National Bank [8987]	The data used for this study were collected for a project funded by a European Union grant (Project "Research-Treat-TBI''; 6th Framework Program: INCO-DEV: International Cooperation with Developing Countries 1998-2002; contract number: ICA2-CT-2002-100) and for another project funded by the Austrian Worker's Compensation Board (AUVA; contract number FK 33/2003) and by the "Jubilee Fund'' of the Austrian National Bank (project number 8987). The International Neurotrauma Research Organization (INRO) is supported by an annual grant from Mrs. Ala Auersperg-Isham and Mr. Ralph Isham, and by donations from various sources.	Berardino M, 2004, ACTA NEUROCHIR, V146, P453, DOI 10.1007/s00701-003-0176-1; BOYD CR, 1987, J TRAUMA, V27, P370, DOI 10.1097/00005373-198704000-00005; Bullock R, 1996, Eur J Emerg Med, V3, P109, DOI 10.1097/00063110-199606000-00010; Hukkelhoven CWPM, 2005, J NEUROTRAUM, V22, P1025, DOI 10.1089/neu.2005.22.1025; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; JENNETT B, 1975, LANCET, V1, P480; King JT, 2005, J NEUROTRAUM, V22, P947, DOI 10.1089/neu.2005.22.947; Leitgeb J, 2007, WIEN KLIN WOCHENSCHR, V119, P56, DOI 10.1007/s00508-006-0764-1; Lenartova L, 2007, WIEN KLIN WOCHENSCHR, V119, P35, DOI 10.1007/s00508-006-0762-3; Maas AIR, 2007, J NEUROTRAUM, V24, P303, DOI 10.1089/neu.2006.0033; Marmarou A, 2007, J NEUROTRAUM, V24, P270, DOI 10.1089/neu.2006.0029; MARSHALL LF, 1983, J NEUROSURG, V59, P276, DOI 10.3171/jns.1983.59.2.0276; Mauritz W, 2008, EUR J PUBLIC HEALTH, V18, P575, DOI 10.1093/eurpub/ckn079; Mauritz W, 2007, WIEN KLIN WOCHENSCHR, V119, P46, DOI 10.1007/s00508-006-0763-2; Rosso A, 2007, WIEN KLIN WOCHENSCHR, V119, P29, DOI 10.1007/s00508-006-0761-4; Rusnak M, 2007, WIEN KLIN WOCHENSCHR, V119, P64, DOI 10.1007/s00508-006-0765-0; Rusnak M, 2007, WIEN KLIN WOCHENSCHR, V119, P23, DOI 10.1007/s00508-006-0760-5; Signorini DF, 1999, J NEUROL NEUROSUR PS, V66, P20, DOI 10.1136/jnnp.66.1.20; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y	20	17	18	0	11	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1863-9933			EUR J TRAUMA EMERG S	Eur. J. Trauma Emerg. Surg.	JUN	2013	39	3					285	292		10.1007/s00068-013-0269-3			8	Emergency Medicine	Emergency Medicine	159MR	WOS:000320050000010	23762202	Green Published, Other Gold			2021-06-18	
J	Jang, SH; Kim, SH; Kim, OR; Byun, WM; Kim, MS; Seo, JP; Chang, MC				Jang, Sung Ho; Kim, Seong Ho; Kim, Oh Ryong; Byun, Woo Mok; Kim, Min-Su; Seo, Jeong Pyo; Chang, Min Cheol			Cingulum injury in patients with diffuse axonal injury: A diffusion tensor imaging study	NEUROSCIENCE LETTERS			English	Article						Diffusion tensor imaging; Diffusion tensor tractography; Diffuse axonal injury; Head trauma; Cingulum	TRAUMATIC BRAIN-INJURY; FORNIX INJURY; CORTEX	Accurate assessment of the cingulum is difficult, because it is a long neural tract that extends from the orbitofrontal cortex to the medial temporal lobe. We divided the cingulum into five parts and investigated changes caused by injury in these regions in patients with diffuse axonal injury (DAI) using diffusion tensor tractography (DTT). Twenty-one patients with DAI and 21 control subjects were recruited. The cingulum was divided into; the anterior, superior (the anterior and posterior portions), posterior, and inferior regions. Fractional anisotropy (FA), apparent diffusion coefficient (ADC), and tract number were measured in each region. FA values and tract numbers in the patient group were lower in the anterior superior cingulum than in controls (p<0.05); whereas the ADC values in the patient group were higher in the anterior and posterior superior cingulum than in controls (p<0.05). In the superior cingulum, increases in the ADC values of the anterior portion (Delta 8.1%) were higher than those of the posterior portion (Delta 5.5%). We found that the superior cingulum was injured in patients with DAI, and that the anterior portion of the superior cingulum was more injured than the posterior portion. Consequently, the superior cingulum appears to be a vulnerable area and the anterior superior cingulum appears more vulnerable than the posterior superior cingulum in DAI. (C) 2013 Elsevier Ireland Ltd. All rights reserved.	[Jang, Sung Ho; Seo, Jeong Pyo; Chang, Min Cheol] Yeungnam Univ, Coll Med, Dept Phys Med & Rehabil, Taegu 705717, South Korea; [Kim, Seong Ho; Kim, Oh Ryong; Kim, Min-Su] Yeungnam Univ, Coll Med, Dept Neurosurg, Taegu 705717, South Korea; [Byun, Woo Mok] Yeungnam Univ, Coll Med, Dept Radiol, Taegu 705717, South Korea	Chang, MC (corresponding author), Yeungnam Univ, Coll Med, Dept Phys Med & Rehabil, 317-1 Daemyungdong, Taegu 705717, South Korea.	wheel633@hanmail.net			Ministry of Education, Science and Technology of KoreaMinistry of Education, Science and Technology, Republic of Korea [13-BD-0401]	This research was supported by the DGIST R&D Program of the Ministry of Education, Science and Technology of Korea (13-BD-0401).	Afifi A.K., FUNCTIONAL NEUROANAT; Assaf Y, 2008, J MOL NEUROSCI, V34, P51, DOI 10.1007/s12031-007-0029-0; Bendlin BB, 2008, NEUROIMAGE, V42, P503, DOI 10.1016/j.neuroimage.2008.04.254; Chang MC, 2010, NEUROREHABILITATION, V26, P339, DOI 10.3233/NRE-2010-0571; Chang MC, 2010, NEUROREHABILITATION, V26, P347, DOI 10.3233/NRE-2010-0572; Concha L, 2005, AM J NEURORADIOL, V26, P2267; DEVINSKY O, 1995, BRAIN, V118, P279, DOI 10.1093/brain/118.1.279; GENTRY LR, 1988, AM J ROENTGENOL, V150, P673, DOI 10.2214/ajr.150.3.673; Hong JH, 2010, J REHABIL MED, V42, P979, DOI 10.2340/16501977-0603; Jang SH, 2009, ARCH NEUROL-CHICAGO, V66, P1424, DOI 10.1001/archneurol.2009.242; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Kwak SY, 2010, EUR NEUROL, V63, P149, DOI 10.1159/000281108; LONG CJ, 1978, J NEUROSURG, V49, P264, DOI 10.3171/jns.1978.49.2.0264; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; Neil JJ, 2008, J MAGN RESON IMAGING, V27, P1, DOI 10.1002/jmri.21087; Nielson KA, 2005, NEUROBIOL LEARN MEM, V84, P42, DOI 10.1016/j.nlm.2005.03.004; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; PAUS T, 1993, J NEUROPHYSIOL, V70, P453; PETERSEN SE, 1988, NATURE, V331, P585, DOI 10.1038/331585a0; Rutgers DR, 2008, AM J NEURORADIOL, V29, P514, DOI 10.3174/ajnr.A0856; Wakana S, 2004, RADIOLOGY, V230, P77, DOI 10.1148/radiol.2301021640; Wechsler D, 2008, WECHSLER ADULT INTEL, V4th; Wilde EA, 2011, INT J PSYCHOPHYSIOL, V82, P86, DOI 10.1016/j.ijpsycho.2011.04.006; Wilde EA, 2010, DEV NEUROPSYCHOL, V35, P333, DOI 10.1080/87565641003696940; Williams JM, 1991, MEMORY ASSESSMENT SC; Wu TC, 2010, J NEUROTRAUM, V27, P303, DOI 10.1089/neu.2009.1110	26	17	17	0	4	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	MAY 24	2013	543						47	51		10.1016/j.neulet.2013.02.058			5	Neurosciences	Neurosciences & Neurology	154BH	WOS:000319646000010	23562507				2021-06-18	
J	Wang, JY; Liou, AKF; Ren, ZH; Zhang, L; Brown, BN; Cui, XT; Badylak, SF; Cai, YN; Guan, YQ; Leak, RK; Chen, J; Ji, X; Chen, L				Wang, J. Y.; Liou, A. K. F.; Ren, Z. H.; Zhang, L.; Brown, B. N.; Cui, X. T.; Badylak, S. F.; Cai, Y. N.; Guan, Y. Q.; Leak, Rehana K.; Chen, J.; Ji, X.; Chen, L.			Neurorestorative Effect of Urinary Bladder Matrix-Mediated Neural Stem Cell Transplantation Following Traumatic Brain Injury in Rats	CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS			English	Article						TBI; UBM; stem cell transplantation; protection; neurodegeneration; neurobehavioral function	EXTRACELLULAR-MATRIX; SUBVENTRICULAR ZONE; COGNITIVE DEFICITS; COLLAGEN MATRIX; CHEMOKINES; SCAFFOLD; DAMAGE; MODEL; MOTOR; SITE	Traumatic brain injury (TBI) is a leading cause of cell death and disability among young adults and lacks a successful therapeutic strategy. The multiphasic injuries of TBI severely limit the success of conventional pharmacological approaches. Recent successes with transplantation of stem cells in bioactive scaffolds in other injury paradigms provide new hope for the treatment of TBI. In this study, we transplanted neural stem cells (0.5x10(5) cells/mu l) cultured in a bioactive scaffold derived from porcine urinary bladder matrix (UBM; 4 injection sites, 2.5 mu l each) into the rat brain following controlled cortical impact (CCI, velocity, 4.0 m/sec; duration, 0.5 sec; depth, 3.2mm). We evaluated the effectiveness of this strategy to combat the loss of motor, memory and cognitive faculties. Before transplantation, compatibility experiments showed that UBM was able to support extended proliferation and differentiation of neural stem cells. Together with its reported anti-inflammatory properties and rapid degradation characteristics in vivo, UBM emerged to be an ideal scaffold. The transplants reduced neuron/tissue loss and white matter injury, and also significantly ameliorated motor, memory, and cognitive impairments. Furthermore, exposure to UBM alone was sufficient to decrease the loss of sensorimotor skills from TBI (examined 3-28 days post-CCI). However, only UBMs that contained proliferating neural stem cells helped attenuate memory and cognitive impairments (examined 26-28 days post-CCI). In summary, these results demonstrate the therapeutic efficacy of stem cells in bioactive scaffolds against TBI and show promise for translation into future clinical use.	[Wang, J. Y.; Ren, Z. H.; Cai, Y. N.; Guan, Y. Q.; Chen, J.; Ji, X.; Chen, L.] Capital Med Univ, Dept Neurosurg, Xuanwu Hosp, Beijing 100053, Peoples R China; [Wang, J. Y.; Ren, Z. H.; Cai, Y. N.; Guan, Y. Q.; Chen, J.; Ji, X.; Chen, L.] Capital Med Univ, China Int Neurosci Inst, Xuanwu Hosp, Beijing 100053, Peoples R China; [Liou, A. K. F.; Chen, J.] Univ Pittsburgh, Sch Med, Ctr Cerebrovasc Dis Res, Pittsburgh, PA 15213 USA; [Zhang, L.; Cui, X. T.] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15261 USA; [Brown, B. N.; Cui, X. T.; Badylak, S. F.] Univ Pittsburgh, McGowan Inst Regenerat Med, Pittsburgh, PA 15261 USA; [Brown, B. N.; Badylak, S. F.] Univ Pittsburgh, Dept Surg, Sch Med, Pittsburgh, PA 15261 USA; [Leak, Rehana K.] Duquesne Univ, Mylan Sch Pharm, Div Pharmaceut Sci, Pittsburgh, PA 15282 USA; [Cui, X. T.] Univ Pittsburgh, Ctr Neural Basis Cognit, Pittsburgh, PA 15261 USA	Chen, L (corresponding author), Capital Med Univ, Dept Neurosurg, Xuanwu Hosp, 45 Changchun St, Beijing 100053, Peoples R China.	jixm@ccmu.edu.cn; chlyz34@163.com	Leak, Rehana K/I-2607-2019; Ji, Xunming/AAN-3370-2021	Leak, Rehana K/0000-0003-2817-7417; Cui, Xinyan/0000-0002-0470-2005; Badylak, Stephen/0000-0003-3555-0689	Department of Defense Concept grant; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS36736, NS43802, NS45048]; National Science FoundationNational Science Foundation (NSF) [DMR-0748001]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81272804, 30970939, 30870854, 81171241]; Key Project of Chinese Ministry of EducationMinistry of Education, China [210003]; National Basic Research Program of China (973 Program)National Basic Research Program of China [2011CB707804];  [2011-3-093]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS043802, R01NS045048, R01NS036736] Funding Source: NIH RePORTER	J.Y. Wang and A.K.F. Liou contributed equally to this work. This work was supported by the Department of Defense Concept grant (to J.C. and X.T.C,), the National Institutes of Health Grants (NS36736, NS43802, and NS45048 to J.C), and National Science Foundation (DMR-0748001 to X.T.C.). L.C. was supported by grants from the National Natural Science Foundation of China (Grant # 81272804 and 30970939), the Key Project of Chinese Ministry of Education (Grant # 210003), and the High Level Talent Fund from the Beijing Healthcare System (Grant # 2011-3-093). X.J. was supported by grants from the National Natural Science Foundation of China (Grant # 30870854 and 81171241) and the National Basic Research Program of China (973 Program) (Grant # 2011CB707804).	Badylak S, 2003, HEART SURG FORUM, V6, pE20; Boruch AV, 2010, J SURG RES, V161, P217, DOI 10.1016/j.jss.2009.02.014; Campos LS, 2006, J BIOL CHEM, V281, P5300, DOI 10.1074/jbc.M511886200; Campos LS, 2004, DEVELOPMENT, V131, P3433, DOI 10.1242/dev.01199; Cao T, 2012, NEUROSCIENCE, V225, P65, DOI 10.1016/j.neuroscience.2012.08.058; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Dai WD, 2009, REGEN MED, V4, P387, DOI 10.2217/RME.09.2; Davis NF, 2011, UROLOGY, V77, DOI 10.1016/j.urology.2010.11.036; De Feo D, 2012, CURR OPIN NEUROL, V25, P322, DOI 10.1097/WCO.0b013e328352ec45; Ding YC, 2001, NEUROL RES, V23, P193, DOI 10.1179/016164101101198334; Freytes DO, 2008, BIOMATERIALS, V29, P1630, DOI 10.1016/j.biomaterials.2007.12.014; Fujii D, 2012, J NEUROPSYCH CLIN N, V24, P278, DOI 10.1176/appi.neuropsych.11070176; Gilbert TW, 2008, J SURG RES, V147, P61, DOI 10.1016/j.jss.2007.04.035; Gilmer LK, 2009, J NEUROTRAUM, V26, P1271, DOI 10.1089/neu.2008.0857; Goldman S, 2005, NAT BIOTECHNOL, V23, P862, DOI 10.1038/nbt1119; Guerreiro DF, 2009, BRAIN INJURY, V23, P358, DOI 10.1080/02699050902800918; Han SH, 2000, ANN NY ACAD SCI, V903, P357, DOI 10.1111/j.1749-6632.2000.tb06387.x; Hodgetts S.I., 2012, CELL TRANSPLANT; Huh JW, 2008, EXP NEUROL, V213, P84, DOI 10.1016/j.expneurol.2008.05.009; Iosif RE, 2008, J CEREBR BLOOD F MET, V28, P1574, DOI 10.1038/jcbfm.2008.47; Ji JF, 2004, NEUROSCI LETT, V355, P236, DOI 10.1016/j.neulet.2003.11.024; Ji JF, 2004, STEM CELLS, V22, P415, DOI 10.1634/stemcells.22-3-415; Jin KL, 2010, J CEREBR BLOOD F MET, V30, P534, DOI 10.1038/jcbfm.2009.219; Kohen NT, 2009, BIOINTERPHASES, V4, P69, DOI 10.1116/1.3274061; Kouris NA, 2011, REGEN MED, V6, P569, DOI [10.2217/rme.11.48, 10.2217/RME.11.48]; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Larijani Bagher, 2012, Acta Med Iran, V50, P79; Lewis M., 2012, AM J EMERG MED; Liew A, 2012, STEM CELL RES THER, V3, DOI 10.1186/scrt119; Lifshitz J, 2012, BRAIN STRUCT FUNCT, V217, P49, DOI 10.1007/s00429-011-0323-z; Liu LB, 2012, INT UROGYNECOL J, V23, P1271, DOI 10.1007/s00192-012-1745-8; Martino G, 2006, NAT REV NEUROSCI, V7, P395, DOI 10.1038/nrn1908; Martino G, 2004, LANCET NEUROL, V3, P372, DOI 10.1016/S1474-4422(04)00771-9; Martino G, 2002, LANCET NEUROL, V1, P499, DOI 10.1016/S1474-4422(02)00223-5; Martino G, 2011, PHYSIOL REV, V91, P1281, DOI 10.1152/physrev.00032.2010; Mauney J, 2010, MATRIX BIOL, V29, P657, DOI 10.1016/j.matbio.2010.08.008; Metz GA, 2002, J NEUROSCI METH, V115, P169, DOI 10.1016/S0165-0270(02)00012-2; Penolazzi L, 2012, J CELL PHYSIOL, V227, P857, DOI 10.1002/jcp.22983; Piot-Grosjean O, 2001, NEUROBIOL DIS, V8, P1082, DOI 10.1006/nbdi.2001.0450; Pluchino S, 2005, NATURE, V436, P266, DOI 10.1038/nature03889; Pluchino S, 2003, NATURE, V422, P688, DOI 10.1038/nature01552; Reeves RR, 2011, J PSYCHOSOC NURS MEN, V49, P42, DOI 10.3928/02793695-20110201-03; Rosario DJ, 2008, REGEN MED, V3, P145, DOI 10.2217/17460751.3.2.145; Sawyer E, 2008, ANN PHARMACOTHER, V42, P247, DOI 10.1345/aph.1K284; Shah U, 2010, ACTA BIOMATER, V6, P3029, DOI 10.1016/j.actbio.2010.02.041; Shein NA, 2009, FASEB J, V23, P4266, DOI 10.1096/fj.09-134700; Snyder EY, 2012, NEW ENGL J MED, V366, P1940, DOI 10.1056/NEJMcibr1200138; Soares HD, 1995, J NEUROTRAUM, V12, P1059, DOI 10.1089/neu.1995.12.1059; Trovato M, 2006, BRAIN INJURY, V20, P339, DOI 10.1080/02699050500487811; Uemura M, 2010, J NEUROSCI RES, V88, P542, DOI 10.1002/jnr.22223; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Wang G., 2012, NEUROTHERAPEUTICS; Wang HC, 2007, EXP NEUROL, V206, P59, DOI 10.1016/j.expneurol.2007.03.031; Wheaton P, 2011, J CLIN PSYCHOPHARM, V31, P745, DOI 10.1097/JCP.0b013e318235f4ac; Zhao YH, 2012, J TRADIT CHIN MED, V32, P289, DOI 10.1016/S0254-6272(13)60027-8; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	56	17	17	0	14	BENTHAM SCIENCE PUBL	BUSUM	PO BOX 294, BUSUM, 1400 AG, NETHERLANDS	1871-5273	1996-3181		CNS NEUROL DISORD-DR	CNS Neurol. Disord.-Drug Targets	MAY	2013	12	3					413	425		10.2174/1871527311312030014			13	Neurosciences; Pharmacology & Pharmacy	Neurosciences & Neurology; Pharmacology & Pharmacy	145CE	WOS:000318990800014	23469853	Green Accepted			2021-06-18	
J	Zhuang, YF; Li, JE				Zhuang, Yan-Feng; Li, Jie			Serum EGF and NGF levels of patients with brain injury and limb fracture	ASIAN PACIFIC JOURNAL OF TROPICAL MEDICINE			English	Article						Fracture healing; Traumatic brain injury; EGF; NGF		OBJECTIVE: To explore the expression and significance of human epidermal growth factor (EGF) and nerve growth factor (NGF) in patients with knee osteoarthritis. METHODS: RT-PCR and enzyme-linked immunosorbent assay were used to measure the serum EGF and NGF expression levels of patients with limb fracture and brain trauma injurry after 1 d, 3 d, 7 d, 14 d and the relationship between them was analyzed. The level was compared among the simple fracture group, traumatic brain injury group and the normal control group, with 40 cases in each group. RESULTS: The serum NGF levels were significantly different among three groups. Serum NGF, EGF mRNA and protein levels gradually decreased with the increasing injury time in the limb fracture combined with brain injury group, traumatic brain injury group, the simple fracture group and the health control group (P<0.05). CONCLUSIONS: The serum of NGF, EGF levels significantly increased when limb fracture combined with brain injury, so EGF and NGF may be involved in the process of fracture healing.	[Zhuang, Yan-Feng; Li, Jie] Fuzhou Gen Hosp, Dept Orthoped, Fuzhou 350000, Fujian Province, Peoples R China	Li, JE (corresponding author), 156 North Rd West 2nd Ring, Fuzhou, Fujian Province, Peoples R China.	boban10@126.com					Boes M, 2006, J BONE JOINT SURG AM, V88A, P738, DOI 10.2106/JBJS.D.02648; Cadosch D, 2010, J BONE JOINT SURG AM, V92A, P645, DOI 10.2106/JBJS.I.00097; Cadosch D, 2009, J BONE JOINT SURG AM, V91A, P282, DOI 10.2106/JBJS.G.01613; Gautschi OP, 2009, ANZ J SURG, V79, P449, DOI 10.1111/j.1445-2197.2008.04803.x; Katsios C, 2013, EXPERT REV GASTROENT, V7, P5, DOI [10.1586/EGH.12.60, 10.1586/egh.12.60]; Kong QL, 2007, CHIN J TISSUE ENG, V11, P247; Morley J, 2005, INJURY, V36, P363, DOI 10.1016/j.injury.2004.08.028; Onodera S, 2004, HISTOCHEM CELL BIOL, V121, P209, DOI 10.1007/s00418-004-0624-x; Schnitzler AC, 2010, J NEUROSCI, V30, P8221, DOI 10.1523/JNEUROSCI.5611-09.2010; Tan Y, 2012, CYTOTECHNOLOGY, V64, P635, DOI 10.1007/s10616-012-9439-0; Yang HL, 2012, CHIN J MODERN MED, V22, P45	11	17	25	1	8	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	1995-7645	2352-4146		ASIAN PAC J TROP MED	Asian Pac. J. Trop. Med.	MAY	2013	6	5					383	386		10.1016/S1995-7645(13)60043-7			4	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	136AU	WOS:000318332600008	23608378	DOAJ Gold			2021-06-18	
J	Aboulafia-Brakha, T; Buschbeck, CG; Rochat, L; Annoni, JM				Aboulafia-Brakha, T.; Buschbeck, C. Greber; Rochat, L.; Annoni, J. -M.			Feasibility and initial efficacy of a cognitive-behavioural group programme for managing anger and aggressiveness after traumatic brain injury	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Traumatic brain injury; Cognitive behavioural therapy; Anger; Neurorehabilitation	HIGH-FUNCTIONING AUTISM; ASPERGER-SYNDROME; FOLLOW-UP; MANAGEMENT; PSYCHOTHERAPY; IMPULSIVITY; QUESTIONNAIRE; IRRITABILITY; DEPRESSION; PEOPLE	This study assesses the feasibility of a cognitive-behavioural group programme for treating anger and aggressiveness after a traumatic brain injury (TBI). Five feasibility criteria were considered: demand, implementation, practicality, acceptability and initial efficacy. A self-report questionnaire of aggressiveness (AQ-12) was administered before the intervention (T1), one week following the intervention (T2) and at a four months follow-up (T3). Ten patients with moderate to severe chronic TBI completed the programme through eight once-a-week sessions. The analysis of the feasibility outcomes suggests that: (1) The recruitment, the process of grouping participants and the characterisation of anger and aggressiveness at baseline need to be re-evaluated and improved for future designs. (2) The use of specific strategies for bypassing cognitive and other behavioural dysfunctions related to TBI is crucial for the success of this intervention and merits special attention. (3) The high retention rate, the convenient meeting schedule, cost advantages and the good acceptability by participants are positive arguments for the implementation of a larger trial. (4) The significant reduction of AQ-12 scores at T3 and the high effect size constitute a change in the expected direction and support the initial efficacy of the programme.	[Aboulafia-Brakha, T.; Annoni, J. -M.] Univ Hosp Geneva, Dept Clin Neurosci, Div Neurol, CH-1211 Geneva, Switzerland; [Aboulafia-Brakha, T.; Buschbeck, C. Greber] Univ Hosp Geneva, Dept Clin Neurosci, Div Neurorehabil, CH-1211 Geneva, Switzerland; [Aboulafia-Brakha, T.; Rochat, L.] Univ Geneva, Cognit Psychopathol & Neuropsychol Unit, CH-1211 Geneva 4, Switzerland; [Rochat, L.] Univ Geneva, Swiss Ctr Affect Sci, CH-1211 Geneva 4, Switzerland; [Aboulafia-Brakha, T.; Annoni, J. -M.] Univ Fribourg, Dept Med, Neurol Unit, CH-1700 Fribourg, Switzerland	Aboulafia-Brakha, T (corresponding author), Univ Hosp Geneva, Dept Neurol, Neuropsychol Unit, Rue Gabrielle Perret Gentil 4, CH-1211 Geneva, Switzerland.	Tatiana.Aboulafia@hcuge.ch		Rochat, Lucien/0000-0002-9992-2720	Swiss National Science FoundationSwiss National Science Foundation (SNSF)European Commission [32-138497]	The study was partly supported by the Swiss National Science Foundation (32-138497 to JMA). We would like to thank Blaise Christe and Ann Travis for their comments on the manuscript as well as the Clinical Research Centre of the Geneva University Hospitals for their statistical advices (T Perneger).	Adair JC, 1996, NEUROLOGY, V46, P842; Alderman N, 2003, NEUROPSYCHOL REHABIL, V13, P211, DOI 10.1080/09602010244000327; Anson K, 2006, BRAIN INJURY, V20, P167, DOI 10.1080/02699050500442956; Baguley IJ, 2006, J HEAD TRAUMA REHAB, V21, P45, DOI 10.1097/00001199-200601000-00005; Baron-Cohen S, 2001, J CHILD PSYCHOL PSYC, V42, P241, DOI 10.1017/S0021963001006643; Baron-Cohen S, 2004, J AUTISM DEV DISORD, V34, P163, DOI 10.1023/B:JADD.0000022607.19833.00; Bazin N, 2009, PSYCHIAT RES, V167, P28, DOI 10.1016/j.psychres.2007.12.010; Bowen DJ, 2009, AM J PREV MED, V36, P452, DOI 10.1016/j.amepre.2009.02.002; Bryant FB, 2001, J RES PERS, V35, P138, DOI 10.1006/jrpe.2000.2302; BUSS AH, 1992, J PERS SOC PSYCHOL, V63, P452, DOI 10.1037/0022-3514.63.3.452; CARROLL KM, 1994, ARCH GEN PSYCHIAT, V51, P989; Cattelani R, 2010, NEUROPSYCHOL REV, V20, P52, DOI 10.1007/s11065-009-9125-y; Ciurli P, 2010, J INT NEUROPSYCH SOC, V16, P360, DOI 10.1017/S135561770999141X; Coetzer R, 2009, CNS SPECTRUMS, V14, P632, DOI 10.1017/S1092852900023877; Couillet J, 2010, NEUROPSYCHOL REHABIL, V20, P321, DOI 10.1080/09602010903467746; Denson TF, 2009, SYD SYM SOC PSYCHOL, P233; Dikmen S, 2010, J INT NEUROPSYCH SOC, V16, P401, DOI 10.1017/S1355617710000196; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Genoud P. A., 2009, FRENCH VERSION 12 IT; Greenberger D., 1995, MIND MOOD COGNITIVE; Gross JJ, 2002, PSYCHOPHYSIOLOGY, V39, P281, DOI 10.1017/S0048577201393198; Hart T, 2008, NEUROPSYCHOL REHABIL, V18, P1, DOI 10.1080/09602010601082359; Hart T, 2012, J HEAD TRAUMA REHAB, V27, P113, DOI 10.1097/HTR.0b013e31820e686c; Huntley AL, 2012, BRIT J PSYCHIAT, V200, P184, DOI 10.1192/bjp.bp.111.092049; Johansson SH, 2008, BRAIN INJURY, V22, P999, DOI 10.1080/02699050802530573; KAGAN J, 1966, J ABNORM PSYCHOL, V71, P17, DOI 10.1037/h0022886; Kalechstein AD, 2003, J CLIN EXP NEUROPSYC, V25, P1186, DOI 10.1076/jcen.25.8.1186.16723; Kangas M, 2011, NEUROPSYCHOL REHABIL, V21, P250, DOI 10.1080/09602011.2010.540920; Kertzman S, 2010, EUR ADDICT RES, V16, P23, DOI 10.1159/000253861; Kim SH, 1999, J NERV MENT DIS, V187, P327, DOI 10.1097/00005053-199906000-00001; LEVIN HS, 1995, J NEUROTRAUM, V12, P913, DOI 10.1089/neu.1995.12.913; Malloy PF, 2001, FRONTAL SYSTEMS BEHA; Mayne TJ, 1999, J CLIN PSYCHOL, V55, P353, DOI 10.1002/(SICI)1097-4679(199903)55:3<353::AID-JCLP7>3.0.CO;2-B; Medd J, 2000, NEUROPSYCHOL REHABIL, V10, P185, DOI 10.1080/096020100389246; O'Connor C, 2005, PSYCHOL REP, V97, P169, DOI 10.2466/PR0.97.5.169-179; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; Padesky C. A., 1995, CLIN GUIDE MIND MOOD; Rochat L, 2010, NEUROPSYCHOL REHABIL, V20, P778, DOI 10.1080/09602011.2010.495245; Salmond CH, 2005, CURR OPIN CRIT CARE, V11, P111, DOI 10.1097/01.ccx.0000155358.31983.37; TEASDALE G, 1974, LANCET, V2, P81; Walker AJ, 2010, BRAIN INJURY, V24, P517, DOI 10.3109/02699051003601721; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Wechsler D., 1997, WMS 3 WECHSLER MEMOR; Whiteside SP, 2001, PERS INDIV DIFFER, V30, P669, DOI 10.1016/S0191-8869(00)00064-7; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x; Zimmermann P, 1995, TEST ATTENTIONAL PER	46	17	17	0	20	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.	APR 1	2013	23	2					216	233		10.1080/09602011.2012.747443			18	Neurosciences; Psychology	Neurosciences & Neurology; Psychology	105KU	WOS:000316068800004	23259694				2021-06-18	
J	Gardner, CJ; Javadpour, M; Stoneley, C; Purthuran, M; Biswas, S; Daousi, C; MacFarlane, IA; Cuthbertson, DJ				Gardner, Chris J.; Javadpour, Mohsen; Stoneley, Catherine; Purthuran, Mani; Biswas, Shubhabrata; Daousi, Christina; MacFarlane, Ian A.; Cuthbertson, Daniel J.			Low prevalence of hypopituitarism after subarachnoid haemorrhage using confirmatory testing and with BMI-specific GH cut-off levels	EUROPEAN JOURNAL OF ENDOCRINOLOGY			English	Article							HORMONE (GH)-RELEASING HORMONE; GLUCAGON STIMULATION TEST; TRAUMATIC BRAIN-INJURY; BODY-MASS INDEX; GROWTH-HORMONE; PITUITARY-FUNCTION; ENDOCRINE-SOCIETY; DEFICIENCY; DYSFUNCTION; DIAGNOSIS	Objective: Hypopituitarism following subarachnoid haemorrhage (SAH) has been reported to be a frequent occurrence. However, there is considerable heterogeneity between studies with differing patient populations and treatment modalities and most importantly employing differing endocrine protocols and (normal) reference ranges of GH. We aimed to examine prospectively a cohort of SAH survivors for development of hypopituitarism post-SAH using rigorous endocrine testing and compare GH response to glucagon stimulation with a cohort of healthy controls of a similar BMI. Design and methods: Sixty-four patients were investigated for evidence of hypopituitarism 3 months post-SAH with 50 patients tested again at 12 months. Glucagon stimulation testing (GST), with confirmation of deficiencies by GHRH/arginine testing for GH deficiency (GHD) and short synacthen testing for ACTH deficiency, was used. Basal testing of other hormonal axes was undertaken. Results: Mean age of patients was 53 +/- 11.7 years and mean BMI was 27.5 +/- 5.7 kg/m(2). After confirmatory testing, the prevalence of hypopituitarism was 12% (GHD 10%, asymptomatic hypocortisolaemia 2%). There was no association between hypopituitarism and post-SAH vasospasm, presence of cerebral infarction, Fisher grade, or clinical grading at presentation. There was a significant correlation between BMI and peak GH to glucagon stimulation in both patients and controls. Conclusions: Identification of 'true' GHD after SAH requires confirmatory testing with an alternative stimulation test and application of BMI-specific cut-offs. Using such stringent criteria, we found a prevalence of hypopituitarism of 12% in our population. European Journal of Endocrinology 168 473-481	[Gardner, Chris J.; Daousi, Christina; MacFarlane, Ian A.; Cuthbertson, Daniel J.] Aintree Univ Hosp NHS Fdn Trust, Aintree Univ Hosp NHS Fdn Trust, Univ Dept Obes & Endocrinol, Floor Clin Sci Ctr 3, Liverpool L9 7AL, Merseyside, England; [Javadpour, Mohsen; Stoneley, Catherine; Purthuran, Mani; Biswas, Shubhabrata] Walton Ctr Neurol & Neurosurg NHS Fdn Trust, Dept Neurosurg, Liverpool, Merseyside, England; [Javadpour, Mohsen; Stoneley, Catherine; Purthuran, Mani; Biswas, Shubhabrata] Walton Ctr Neurol & Neurosurg NHS Fdn Trust, Dept Radiol, Liverpool, Merseyside, England	Cuthbertson, DJ (corresponding author), Aintree Univ Hosp NHS Fdn Trust, Aintree Univ Hosp NHS Fdn Trust, Univ Dept Obes & Endocrinol, Floor Clin Sci Ctr 3, Longmoor Lane, Liverpool L9 7AL, Merseyside, England.	daniel.cuthbertson@liverpool.ac.uk	Javadpour, Mohsen/AAX-4657-2020	Javadpour, Mohsen/0000-0001-9836-1741; Cuthbertson, Daniel/0000-0002-6128-0822	PfizerPfizer; Weight Matters; medical research charity	The study was funded jointly by an investigator-initiated research award to D J Cuthbertson from Pfizer and by the medical research charity, Weight Matters.	Aimaretti G, 2005, J CLIN ENDOCR METAB, V90, P6085, DOI 10.1210/jc.2005-0504; Bellebaum C, 2004, J CLIN EXP NEUROPSYC, V26, P1081, DOI 10.1080/13803390490515342; BJERRE P, 1986, NEUROSURGERY, V19, P1012, DOI 10.1227/00006123-198612000-00018; Bonert VS, 2004, J CLIN ENDOCR METAB, V89, P3397, DOI 10.1210/jc.2003-032213; Conceicao FL, 2003, J ENDOCRINOL INVEST, V26, P1065, DOI 10.1007/BF03345251; Cordido F, 2003, EUR J ENDOCRINOL, V149, P117, DOI 10.1530/eje.0.1490117; Corneli G, 2005, EUR J ENDOCRINOL, V153, P257, DOI 10.1530/eje.1.01967; CROMPTON MR, 1963, BRAIN, V86, P301, DOI 10.1093/brain/86.2.301; Dimopoulou I, 2004, STROKE, V35, P2884, DOI 10.1161/01.STR.0000147716.45571.45; FISHER CM, 1980, NEUROSURGERY, V6, P1, DOI 10.1227/00006123-198001000-00001; Gardner CJ, 2011, BRIT J NEUROSURG, V25, P337, DOI 10.3109/02688697.2010.546900; Gomez JM, 2002, CLIN ENDOCRINOL, V56, P329, DOI 10.1046/j.1365-2265.2002.01472.x; Ho KKY, 2007, EUR J ENDOCRINOL, V157, P695, DOI 10.1530/EJE-07-0631; IRANMANESH A, 1991, J CLIN ENDOCR METAB, V73, P1081, DOI 10.1210/jcem-73-5-1081; Karaca Z, 2013, PITUITARY, V16, P76, DOI 10.1007/s11102-012-0377-9; Kelestimur F, 2006, CLIN ENDOCRINOL, V64, P667, DOI 10.1111/j.1365-2265.2006.02525.x; Kelly DF, 2000, J NEUROSURG, V93, P743, DOI 10.3171/jns.2000.93.5.0743; Klose M, 2010, CLIN ENDOCRINOL, V73, P95, DOI 10.1111/j.1365-2265.2010.03791.x; Kokshoorn NE, 2010, EUR J ENDOCRINOL, V162, P11, DOI 10.1530/EJE-09-0601; Kreitschmann-Andermahr I, 2004, J CLIN ENDOCR METAB, V89, P4986, DOI 10.1210/jc.2004-0146; Kreitschmann-Andermahr Ilonka, 2005, Pituitary, V8, P219, DOI 10.1007/s11102-006-6044-2; Lammert A, 2012, PITUITARY, V15, P505, DOI 10.1007/s11102-011-0357-5; Leong KS, 2001, CLIN ENDOCRINOL, V54, P463, DOI 10.1046/j.1365-2265.2001.01169.x; Lissett CA, 1999, CLIN ENDOCRINOL, V51, P551, DOI 10.1046/j.1365-2265.1999.00836.x; LITTLEY MD, 1989, CLIN ENDOCRINOL, V31, P527, DOI 10.1111/j.1365-2265.1989.tb01276.x; McKenna SP, 1999, QUAL LIFE RES, V8, P373, DOI 10.1023/A:1008987922774; Molitch ME, 2011, J CLIN ENDOCR METAB, V96, P1587, DOI 10.1210/jc.2011-0179; Orme SM, 1998, CLIN ENDOCRINOL, V49, P773, DOI 10.1046/j.1365-2265.1998.00610.x; OSTERMAN PO, 1975, ACTA NEUROL SCAND, V52, P56, DOI 10.1111/j.1600-0404.1975.tb02827.x; RAO RH, 1987, METABOLISM, V36, P658, DOI 10.1016/0026-0495(87)90150-8; Schneider HJ, 2007, JAMA-J AM MED ASSOC, V298, P1429, DOI 10.1001/jama.298.12.1429; Tanriverdi F, 2007, CLIN ENDOCRINOL, V67, P931, DOI 10.1111/j.1365-2265.2007.02989.x; TEASDALE GM, 1988, J NEUROL NEUROSUR PS, V51, P1457, DOI 10.1136/jnnp.51.11.1457; Toogood A, 2007, HORM RES, V68, P66, DOI 10.1159/000110479; Tzanela M, 2010, EUR J ENDOCRINOL, V162, P29, DOI 10.1530/EJE-09-0390; van der Schaaf I, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003085.pub2; Veldhuis JD, 2011, J CLIN ENDOCR METAB, V96, P2874, DOI 10.1210/jc.2011-0084; Yuen KCJ, 2009, J CLIN ENDOCR METAB, V94, P2702, DOI 10.1210/jc.2009-0299	38	17	18	0	3	BIOSCIENTIFICA LTD	BRISTOL	EURO HOUSE, 22 APEX COURT WOODLANDS, BRADLEY STOKE, BRISTOL BS32 4JT, ENGLAND	0804-4643	1479-683X		EUR J ENDOCRINOL	Eur. J. Endocrinol.	APR	2013	168	4					473	481		10.1530/EJE-12-0849			9	Endocrinology & Metabolism	Endocrinology & Metabolism	124PY	WOS:000317478700004	23258271	Bronze			2021-06-18	
J	Li, WC; Jiang, DM; Hu, N; Qi, XT; Qiao, B; Luo, XJ				Li, Wei-Chao; Jiang, Dian-Ming; Hu, Ning; Qi, Xiao-Tong; Qiao, Bo; Luo, Xiao-Ji			Lipopolysaccharide preconditioning attenuates neuroapoptosis and improves functional recovery through activation of Nrf2 in traumatic spinal cord injury rats	INTERNATIONAL JOURNAL OF NEUROSCIENCE			English	Article						lipopolysaccharide; Nrf2; apoptosis; function recovery; spinal cord injury	NF-KAPPA-B; CELL-DEATH; INFLAMMATORY RESPONSE; APOPTOSIS; ISCHEMIA; BRAIN; INDUCTION; TOLERANCE; PROTECTS; DAMAGE	The previous studies suggested that low-dose lipopolysaccharide (LPS) provides neuroprotection against subsequent challenge with ischemic/reperfusion injury in the brain. But there were few reports about the neuroprotective effects of low-dose LPS against spinal cord injury (SCI). In this study, we evaluated the effect of low-dose LPS preconditioning on neuroapoptosis status after traumatic SCI (TSCI), using a standardized contusion model (NYU, New York University, impactor). SCI-induced rats were randomly divided into three groups: sham operation, control (receiving only normal saline) and LPS preconditioning (0.2 mg/kg, ip; 72 hours before injury). Neurologic function was assessed by the Basso, Beattie and Bresnahan (BBB) score at 6, 12, 24, 48 and 72 hours after TSCI. Rats were sacrificed at 72 hours postinjury. Histological changes were studied using Nissl staining. Apoptotic neural cells were assessed using the TdT-mediated dUTP Nick End Labeling (TUNEL) assay. Nuclear factor erythroid 2-related factor 2 (Nrf2) and caspase-3 were detected with immunohistochemistry and Western blot. LPS preconditioning reduced neuron apoptosis, improved neurologic outcome and actived Nrf2 expression. Moreover, Histological changes and the number of apoptotic cells were correlated with Nrf2 expression after the rats suffered the SCI. Our results suggest that LPS preconditioning exerted a neuroprotective effect against TSCI in rats, and activation of Nrf2 was believed to be one of the contributing mechanisms.	[Li, Wei-Chao; Jiang, Dian-Ming; Hu, Ning; Qi, Xiao-Tong; Qiao, Bo; Luo, Xiao-Ji] Chongqing Med Univ, Affiliated Hosp 1, Dept Orthoped Surg, Chongqing 400016, Peoples R China	Jiang, DM (corresponding author), Chongqing Med Univ, Affiliated Hosp 1, Dept Orthoped Surg, 1 Youyi Rd, Chongqing 400016, Peoples R China.	jdm571026@vip.163.com			University Development Program, Chongqing	This study was supported by a scholarship from the University Development Program, Chongqing.	BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Bingham D, 2011, BRAIN RES BULL, V85, P403, DOI 10.1016/j.brainresbull.2011.04.007; Byrnes KR, 2007, BRAIN, V130, P2977, DOI 10.1093/brain/awm179; CHITTENDEN T, 1995, NATURE, V374, P733, DOI 10.1038/374733a0; Cittelly DM, 2008, EXP NEUROL, V210, P295, DOI 10.1016/j.expneurol.2007.03.001; Crowe MJ, 1997, NAT MED, V3, P73, DOI 10.1038/nm0197-73; Fansa I, 2009, J INT MED RES, V37, P520, DOI 10.1177/147323000903700228; Furuya K, 2005, J NEUROSURG, V103, P715, DOI 10.3171/jns.2005.103.4.0715; Gidday JM, 2006, NAT REV NEUROSCI, V7, P437, DOI 10.1038/nrn1927; Hirose K, 2004, THROMB HAEMOSTASIS, V91, P162, DOI 10.1160/TH03-06-0385; Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943; Jain AK, 2005, J BIOL CHEM, V280, P29158, DOI 10.1074/jbc.M502083200; Jalabi W, 2009, CLEV CLIN J MED, V76, P97; Jin W, 2008, ANN CLIN LAB SCI, V38, P221; Jin W, 2009, J NEUROTRAUM, V26, P131, DOI 10.1089/neu.2008.0655; Lastres-Becker I, 2006, J NEUROIMMUNOL, V173, P108, DOI 10.1016/j.jneuroim.2005.12.006; Lee SM, 2003, J NEUROTRAUM, V20, P1017, DOI 10.1089/089771503770195867; Liu XZ, 1997, J NEUROSCI, V17, P5395; Longhi L, 2011, J CEREBR BLOOD F MET, V31, P1919, DOI 10.1038/jcbfm.2011.42; Mallard C, 2007, SEMIN FETAL NEONAT M, V12, P280, DOI 10.1016/j.siny.2007.01.014; Mao L, 2012, J TRAUMA ACUTE CARE, V72, P189, DOI 10.1097/TA.0b013e31821bf541; Mao L, 2011, J SURG RES, V170, pE105, DOI 10.1016/j.jss.2011.05.049; Mattson MP, 2000, NAT REV MOL CELL BIO, V1, P120, DOI 10.1038/35040009; Naidu KA, 2003, ANESTH ANALG, V97, P857, DOI 10.1213/01.ANE.0000072800.66277.CC; Omata Y, 2008, FREE RADICAL BIO MED, V45, P1437, DOI 10.1016/j.freeradbiomed.2008.08.018; Orio M, 2007, STROKE, V38, P2812, DOI 10.1161/STROKEAHA.107.486837; Pereira JE, 2009, EXP NEUROL, V220, P71, DOI 10.1016/j.expneurol.2009.07.030; Pignataro G, 2009, FEBS J, V276, P46, DOI 10.1111/j.1742-4658.2008.06769.x; Porter AG, 1999, CELL DEATH DIFFER, V6, P99, DOI 10.1038/sj.cdd.4400476; Rosenzweig HL, 2004, STROKE, V35, P2576, DOI 10.1161/01.STR.0000143450.04438.ae; Rupinder SK, 2007, VASC PHARMACOL, V46, P383, DOI 10.1016/j.vph.2007.01.006; Shuman SL, 1997, J NEUROSCI RES, V50, P798, DOI 10.1002/(SICI)1097-4547(19971201)50:5<798::AID-JNR16>3.3.CO;2-#; Slee EA, 2001, J BIOL CHEM, V276, P7320, DOI 10.1074/jbc.M008363200; Springer JE, 1999, NAT MED, V5, P943, DOI 10.1038/11387; Surh YJ, 2008, GENES NUTR, V2, P313, DOI 10.1007/s12263-007-0063-0; Thimmulappa RK, 2006, J CLIN INVEST, V116, P984, DOI 10.1172/JCI25790; Yune TY, 2004, J NEUROTRAUM, V21, P293, DOI 10.1089/089771504322972086	37	17	20	0	23	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0020-7454			INT J NEUROSCI	Int. J. Neurosci.	APR	2013	123	4					240	247		10.3109/00207454.2012.755181			8	Neurosciences	Neurosciences & Neurology	107BS	WOS:000316190300005	23215850				2021-06-18	
J	Mojtahedi, S; Kordi, MR; Hosseini, SE; Omran, SF; Soleimani, M				Mojtahedi, Shima; Kordi, Mohammad Reza; Hosseini, Seyed Ebrahim; Omran, Simin Fallah; Soleimani, Masoud			Effect of treadmill running on the expression of genes that are involved in neuronal differentiation in the hippocampus of adult male rats	CELL BIOLOGY INTERNATIONAL			English	Article						BDNF; hippocampus; miR-124; NRSF/REST; treadmill running; TrkB	TRAUMATIC BRAIN-INJURY; MOUSE DENTATE GYRUS; NEURAL STEM-CELLS; NEUROTROPHIC FACTOR; MESSENGER-RNA; POSTSYNAPTIC DENSITIES; HUNTINGTONS-DISEASE; PHYSICAL-ACTIVITY; PROGENITOR CELLS; NERVOUS-SYSTEM	Gene expression in the rodent brain is dependent on exercise. However, our findings regarding this fact are inadequate. The aim of this study was to evaluate the effect of exercise intensity on changes in factors involved in neuronal differentiation and plasticity in the hippocampus of adult male rats. Thus, the effects of 2 weeks treadmill running at of low (11m/min) and high (25m/min) intensities, 30min/day for 14 consecutive days on the expression of two genes, microRNA-124 and neuron-restrictive silencer factor/RE1-silencing transcription factor (REST) as well as changes of two proteins of brain-derived neurotrophic factor (BDNF) and tyrosine kinase B (TrkB) were analysed. Using quantitative real-time PCR techniques have shown that both exercise intensities reduced the expression of REST (31% in low exercise intensity, 52% in high exercise intensity) and elevated the expression of miR-124 (3.8-fold in low exercise intensity, 11.9-fold in high exercise intensity) significantly (P0.05). This suggests that exercise probably through the changes in these genes is involved in neuronal differentiation in the hippocampus of rats. BDNF and TrkB levels were measured by ELISA. Exercise, at low intensity, increased TrkB (4.51ng/L vs. 3.73ng/L) and BDNF (11.97ng/L vs. 11.08ng/L) proteins significantly (P0.05), while at high intensity, the changes in comparison with the control group were not significant. Expression levels during the exercise programme with high intensity were dramatic for miR-124 and less dramatic for REST compared with low intensity exercise programme.	[Mojtahedi, Shima; Kordi, Mohammad Reza; Omran, Simin Fallah] Univ Tehran, Fac Phys Educ & Sport Sci, Dept Exercise Physiol, Tehran, Iran; [Hosseini, Seyed Ebrahim] Islamic Azad Univ, Sabzevar Branch, Sabzevar, Iran; [Soleimani, Masoud] Tarbiat Modares Univ, Dept Hematol, Tehran, Iran; [Soleimani, Masoud] Stem Cell Technol Res Ctr, Dept Stem Cell Biol, Tehran, Iran	Soleimani, M (corresponding author), Tarbiat Modares Univ, Dept Hematol, Tehran, Iran.	soleim_m@modares.ac.ir	Kordi, Mohammadreza/AAD-8148-2020; Hosseini, Seyed Ebrahim/AAC-9627-2020	Kordi, Mohammadreza/0000-0002-7999-4292; Hosseini, Seyed Ebrahim/0000-0002-8683-2590; mojtahedi, shima/0000-0003-3592-0010			Aoki C, 2000, J NEUROSCI RES, V59, P454, DOI 10.1002/(SICI)1097-4547(20000201)59:3<454::AID-JNR21>3.0.CO;2-H; Balkowiec A, 2002, J NEUROSCI, V22, P10399; Bequet F, 2001, ACTA PHYSIOL SCAND, V173, P223, DOI 10.1046/j.1365-201X.2001.00859.x; Briones Teresita L, 2005, Biol Res Nurs, V6, P167, DOI 10.1177/1099800404271328; Calderone A, 2003, J NEUROSCI, V23, P2112; Cao L, 2004, NAT GENET, V36, P827, DOI 10.1038/ng1395; Chandrasekar V, 2011, NEUROPSYCHOPHARMACOL, V36, P1149, DOI 10.1038/npp.2010.250; Chandrasekar V, 2009, MOL CELL NEUROSCI, V42, P350, DOI 10.1016/j.mcn.2009.08.009; Chen MJ, 2009, HIPPOCAMPUS, V19, P962, DOI 10.1002/hipo.20579; Cheng LC, 2009, NAT NEUROSCI, V12, P399, DOI 10.1038/nn.2294; CHONG JHA, 1995, CELL, V80, P949, DOI 10.1016/0092-8674(95)90298-8; Conaco C, 2006, P NATL ACAD SCI USA, V103, P2422, DOI 10.1073/pnas.0511041103; Cotman CW, 2007, TRENDS NEUROSCI, V30, P464, DOI 10.1016/j.tins.2007.06.011; Dash PK, 2001, J NEUROSCI RES, V63, P313, DOI 10.1002/1097-4547(20010215)63:4<313::AID-JNR1025>3.0.CO;2-4; Fabel K, 2003, EUR J NEUROSCI, V18, P2803, DOI 10.1111/j.1460-9568.2003.03041.x; Fabel K, 2009, FRONT NEUROGENESIS, V10, P30; Fayard B, 2005, J NEUROSCI RES, V80, P18, DOI 10.1002/jnr.20432; GAGE FH, 1995, P NATL ACAD SCI USA, V92, P11879, DOI 10.1073/pnas.92.25.11879; Gomez-Merino D, 2001, NEUROSCI LETT, V301, P143, DOI 10.1016/S0304-3940(01)01626-3; Greenway DJ, 2007, STEM CELLS, V25, P354, DOI 10.1634/stemcells.2006-0207; Grimes JA, 2000, J BIOL CHEM, V275, P9461, DOI 10.1074/jbc.275.13.9461; Hartmann M, 2001, EMBO J, V20, P5887, DOI 10.1093/emboj/20.21.5887; Hennigan A, 2007, BIOCHEM SOC T, V35, P424, DOI 10.1042/BST0350424; Huang AM, 2006, J NEURAL TRANSM, V113, P803, DOI 10.1007/s00702-005-0359-4; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Itoh T, 2011, J NEURAL TRANSM, V118, P1263, DOI 10.1007/s00702-011-0629-2; Kapsimali M, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r173; Ke Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016643; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Kernie SG, 2010, NEUROBIOL DIS, V37, P267, DOI 10.1016/j.nbd.2009.11.002; Khabour OF, 2010, HIPPOCAMPUS, V20, P637, DOI 10.1002/hipo.20657; Krichevsky AM, 2003, RNA, V9, P1274, DOI 10.1261/rna.5980303; Krichevsky AM, 2006, STEM CELLS, V24, P857, DOI 10.1634/stemcells.2005-0441; Kronenberg G, 2006, NEUROBIOL AGING, V27, P1505, DOI 10.1016/j.neurobiolaging.2005.09.016; Kuhn HG, 1996, J NEUROSCI, V16, P2027; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lin SY, 1998, MOL BRAIN RES, V55, P20, DOI 10.1016/S0169-328X(97)00349-5; Liu YF, 2009, J PHYSIOL-LONDON, V587, P3221, DOI 10.1113/jphysiol.2009.173088; Llorens-Martin M, 2006, HIPPOCAMPUS, V16, P480, DOI 10.1002/hipo.20175; Lou SJ, 2008, BRAIN RES, V1210, P48, DOI 10.1016/j.brainres.2008.02.080; Makeyev EV, 2007, MOL CELL, V27, P435, DOI 10.1016/j.molcel.2007.07.015; Mehler MF, 2008, PROG NEUROBIOL, V86, P305, DOI 10.1016/j.pneurobio.2008.10.001; Mulligan P, 2008, MOL CELL, V32, P718, DOI 10.1016/j.molcel.2008.10.025; Neeper SA, 1996, BRAIN RES, V726, P49, DOI 10.1016/0006-8993(96)00273-9; Packer AN, 2008, J NEUROSCI, V28, P14341, DOI 10.1523/JNEUROSCI.2390-08.2008; Ramsbottom R, 2010, J SPORT SCI, V28, P843, DOI 10.1080/02640411003702686; Sempere LF, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r13; Shimojo M, 2004, LIFE SCI, V74, P2213, DOI 10.1016/j.lfs.2003.08.045; Smirnova L, 2005, EUR J NEUROSCI, V21, P1469, DOI 10.1111/j.1460-9568.2005.03978.x; Soya H, 2007, BIOCHEM BIOPH RES CO, V358, P961, DOI 10.1016/j.bbrc.2007.04.173; Suen PC, 1997, P NATL ACAD SCI USA, V94, P8191, DOI 10.1073/pnas.94.15.8191; Uda M, 2006, BRAIN RES, V1104, P64, DOI 10.1016/j.brainres.2006.05.066; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; van Praag H, 2005, J NEUROSCI, V25, P8680, DOI 10.1523/JNEUROSCI.1731-05.2005; van Praag H, 1999, NAT NEUROSCI, V2, P266; Vaynman S, 2004, EUR J NEUROSCI, V20, P2580, DOI 10.1111/j.1460-9568.2004.03720.x; Vaynman SS, 2006, BRAIN RES, V1070, P124, DOI 10.1016/j.brainres.2005.11.062; Widenfalk J, 1999, NEUROSCI RES, V34, P125, DOI 10.1016/S0168-0102(99)00051-6; Wu CW, 2008, J APPL PHYSIOL, V105, P1585, DOI 10.1152/japplphysiol.90775.2008; Wu K, 1996, MOL BRAIN RES, V43, P286, DOI 10.1016/S0169-328X(96)00211-2; Yoon BC, 2009, NEUROREHABILITATION, V24, P291, DOI 10.3233/NRE-2009-0481; Zuccato C, 2003, NAT GENET, V35, P76, DOI 10.1038/ng1219; Zuccato C, 2007, J NEUROSCI, V27, P6972, DOI 10.1523/JNEUROSCI.4278-06.2007	64	17	18	0	17	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1065-6995	1095-8355		CELL BIOL INT	Cell Biol. Int.	APR	2013	37	4					276	283		10.1002/cbin.10022			8	Cell Biology	Cell Biology	107MP	WOS:000316222000002	23427087				2021-06-18	
J	Ramaiah, VK; Sharma, D; Ma, L; Prathep, S; Hoffman, NG; Vavilala, MS				Ramaiah, Vijay Kumar; Sharma, Deepak; Ma, Li; Prathep, Sumidtra; Hoffman, Noah G.; Vavilala, Monica S.			Admission oxygenation and ventilation parameters associated with discharge survival in severe pediatric traumatic brain injury	CHILDS NERVOUS SYSTEM			English	Article						Traumatic brain injury; Oxygenation; Ventilation	SEVERE HEAD-INJURY; CEREBRAL-BLOOD-FLOW; HYPEROXIA; CHILDREN; HYPERVENTILATION; PREDICTORS; TOXICITY	Current Brain Trauma Foundation guidelines recommend avoiding hypoxemia after severe pediatric traumatic brain injury (TBI). Yet, recent studies on optimum admission oxygenation and ventilation parameters associated with discharge survival in pediatric TBI are lacking. After IRB approval, a retrospective study involving pediatric patients ages a parts per thousand currency sign14 years with severe TBI (head Abbreviated Injury Scale (AIS) score of a parts per thousand yen3, Glasgow Coma Scale score of a parts per thousand currency sign8 on admission) admitted to Harborview Medical Center (level 1 pediatric trauma center), Seattle, WA, during 2003 to 2007 was performed. Admission demographics, clinical data, and laboratory characteristics were abstracted. Hypoxemia was defined as PaO2 < 60 mmHg, hypocarbia was defined as PaCO2 a parts per thousand currency signaEuro parts per thousand 35 mmHg, and hypercarbia was defined as PaCO2 a parts per thousand yenaEuro parts per thousand 46 mmHg. One hundred ninety-four patients met inclusion criteria of which 162 (83.5 %) patients survived. Admission hypoxemia occurred in nine (5.6 %) patients who survived and eight (25 %) patients who died (p < 0.001). Children with admission PaCO2 between 36 and 45 mmHg had greater discharge survival compared with those with both admission hypocarbia (PaCO2 a parts per thousand currency signaEuro parts per thousand 35 mmHg) and hypercarbia (PaCO2 a parts per thousand yenaEuro parts per thousand 46 mmHg). Admission PaO2 301-500 mmHg (adjusted odds ratio (AOR), 8.02 (95 % confidence interval (CI), 1.73-37.10); p = 0.008) and admission PaCO2 = 36-45 mmHg (AOR, 5.47 (95 % CI, 1.30-23.07); p = 0.02) were independently associated with discharge survival. Discharge survival after severe pediatric TBI was associated with admission PaO2 301-500 mmHg and PaCO2 = 36-45 mmHg. Admission hypocarbia and hypercarbia were each associated with increased discharge mortality.	[Ramaiah, Vijay Kumar; Sharma, Deepak; Ma, Li; Prathep, Sumidtra; Vavilala, Monica S.] Univ Washington, Harborview Med Ctr, Dept Anesthesiol & Pain Med, Seattle, WA 98104 USA; [Sharma, Deepak; Vavilala, Monica S.] Univ Washington, Dept Neurol Surg, Seattle, WA 98104 USA; [Hoffman, Noah G.] Univ Washington, Dept Lab Med, Seattle, WA 98104 USA; [Sharma, Deepak; Vavilala, Monica S.] Univ Washington, Harborview Med Ctr, Harborview Injury Prevent & Res Ctr, Seattle, WA 98104 USA	Vavilala, MS (corresponding author), Univ Washington, Harborview Med Ctr, Dept Anesthesiol & Pain Med, 325 9Th Ave,POB 359724, Seattle, WA 98104 USA.	vavilala@uw.edu			 [R01NS072308-03]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS072308] Funding Source: NIH RePORTER	R01NS072308-03	Adelson P David, 2003, Pediatr Crit Care Med, V4, pS12; Bitterman N, 2004, UNDERSEA HYPERBAR M, V31, P63; Bostek C C, 1989, AANA J, V57, P231; Davis DP, 2009, J NEUROTRAUM, V26, P2217, DOI 10.1089/neu.2009.0940; Demchenko IT, 2007, AM J PHYSIOL-LUNG C, V293, pL229, DOI 10.1152/ajplung.00450.2006; Diringer MN, 2008, CURR OPIN CRIT CARE, V14, P167, DOI 10.1097/MCC.0b013e3282f57552; Diringer MN, 2007, J NEUROSURG, V106, P526, DOI 10.3171/jns.2007.106.4.526; Feickert HJ, 1999, J TRAUMA, V47, P33, DOI 10.1097/00005373-199907000-00008; Floyd TF, 2003, J APPL PHYSIOL, V95, P2453, DOI 10.1152/japplphysiol.00303.2003; Jenkinson S G, 1993, New Horiz, V1, P504; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; MAYER TA, 1985, ANN EMERG MED, V14, P1178, DOI 10.1016/S0196-0644(85)81025-8; Menzel M, 1999, J NEUROSURG ANESTH, V11, P240, DOI 10.1097/00008506-199910000-00003; MICHAUD LJ, 1992, NEUROSURGERY, V31, P254, DOI 10.1227/00006123-199208000-00010; MILLER JD, 1978, JAMA-J AM MED ASSOC, V240, P439, DOI 10.1001/jama.240.5.439; MUIZELAAR JP, 1991, J NEUROSURG, V75, P731, DOI 10.3171/jns.1991.75.5.0731; PIGULA FA, 1993, J PEDIATR SURG, V28, P310, DOI 10.1016/0022-3468(93)90223-8; Rossi S, 2000, ACTA NEUROCHIR SUPPL, V76, P243; Skippen P, 1997, CRIT CARE MED, V25, P1402, DOI 10.1097/00003246-199708000-00031; Tasman W, 2006, AM J OPHTHALMOL, V141, P167, DOI 10.1016/j.ajo.2005.07.034; TEPAS JJ, 1990, J PEDIATR SURG, V25, P92, DOI 10.1016/S0022-3468(05)80170-8; Verweij BH, 2000, J NEUROSURG, V93, P815, DOI 10.3171/jns.2000.93.5.0815; White JRM, 2001, CRIT CARE MED, V29, P534, DOI 10.1097/00003246-200103000-00011	23	17	18	0	3	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0256-7040	1433-0350		CHILD NERV SYST	Childs Nerv. Syst.	APR	2013	29	4					629	634		10.1007/s00381-012-1984-5			6	Clinical Neurology; Pediatrics; Surgery	Neurosciences & Neurology; Pediatrics; Surgery	106FI	WOS:000316127800014	23207977	Green Accepted			2021-06-18	
J	Yuhasz, JE				Yuhasz, James E.			Misconceptions About Traumatic Brain Injury Among Correctional Health Care Professionals	JOURNAL OF CORRECTIONAL HEALTH CARE			English	Article						traumatic brain injury; inmates; correctional health care professionals	HEAD-INJURIES; EPIDEMIOLOGY	This study explored the prevalence of misconceptions of traumatic brain injury (TBI) among a sample of correctional health care professionals. Prior research has identified a high prevalence of TBI among criminal offenders, and misconceptions about TBI exist among laypersons and nonexpert professionals. Participants (N = 155) completed a 25-item survey about the sequelae of TBI. Results were compared with previous studies. This sample performed significantly better than laypersons and commensurable to other nonexpert professionals. Misconceptions were higher on items related to loss of consciousness, memory, and recovery. Gender, prior familiarity to someone with a history of TBI, and prior training in TBI accounted for statistically fewer misconceptions. The findings support the need for continued training and increased awareness about TBI among inmates.	[Yuhasz, James E.] Univ Med & Dent New Jersey, Annandale, NJ 08801 USA	Yuhasz, JE (corresponding author), Univ Med & Dent New Jersey, Dept Psychol, 31 Petticoat Lane, Annandale, NJ 08801 USA.	dryuhasz@hotmail.com					Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Farmer JE, 1997, REHABIL PSYCHOL, V42, P273; Finkelstein EA., 2006, INCIDENCE EC BURDEN; GLAZE LE, 2008, PROBATION PAROLE US; Gouvier D. W., 1988, ARCH CLIN NEUROPSYCH, V3, P331; Guilmette TJ, 2004, ARCH CLIN NEUROPSYCH, V19, P183, DOI 10.1016/S0887-6177(03)00025-8; Hooper S., 2006, EXCEPTIONALITY, V14, P171, DOI DOI 10.1207/s15327035ex1403_5; Hux K, 2006, BRAIN INJURY, V20, P547, DOI 10.1080/02699050600676784; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; O'Jile J. R., 1997, INT J REHABILITATION, V3, P61, DOI DOI 10.1007/BF02766798; Shah MN, 2004, BRAIN INJURY, V18, P765, DOI 10.1080/02699050410001671801; Shiroma E. J., 2009, J CORRECT HEALTH CAR, V16, P147; Silver JM, 2001, BRAIN INJURY, V15, P935, DOI 10.1080/02699050110065295; Swift TL, 2001, BRAIN INJURY, V15, P149, DOI 10.1080/026990501458380; WILLER B, 1993, ARCH CLIN NEUROPSYCH, V8, P461, DOI 10.1016/0887-6177(93)90009-P	15	17	17	0	10	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1078-3458	1940-5200		J CORRECT HEALTH CAR	J. Correct. Health Care	APR	2013	19	2					135	143		10.1177/1078345812474644			9	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	AK3QU	WOS:000338340600006	23446874				2021-06-18	
J	Nakajima, T; Barss, T; Klarner, T; Komiyama, T; Zehr, EP				Nakajima, Tsuyoshi; Barss, Trevor; Klarner, Taryn; Komiyama, Tomoyoshi; Zehr, E. Paul			Amplification of interlimb reflexes evoked by stimulating the hand simultaneously with conditioning from the foot during locomotion	BMC NEUROSCIENCE			English	Article						Reflex; Interlimb; Propriospinal; Central pattern generator; Afferent feedback; Rehabilitation; Walking; Cycling; Arm swing	RHYTHMIC ARM MOVEMENT; CUTANEOUS REFLEXES; SPINAL-CORD; ELECTRICAL-STIMULATION; LEG MOVEMENT; WALKING; COORDINATION; AFFERENTS; MUSCLES; PATHWAY	Background: Widespread interlimb reflexes evoked in leg muscles by cutaneous stimulation of the hand are phase-modulated and behaviorally relevant to produce functional changes in ankle trajectory during walking. These reflexes are complementary to the segmental responses evoked by stimulation at the ankle. Despite differences in the expression of reflex amplitude based upon site of nerve stimulation, there are some common features as well, suggesting the possibility of shared interneuronal pathways. Currently little is known about integration or shared reflex systems from interlimb cutaneous networks during human locomotion. Here we investigated convergent reflex effects following cutaneous stimulation of the hand and foot during arm and leg cycling (AL) by using spatial facilitation. Participants performed AL cycling and static activation of the target muscle knee extensor vastus lateralis (VL) in 3 different randomly ordered nerve stimulation conditions: 1) superficial radial nerve (SR; input from hand); 2) superficial peroneal nerve (SP; input from foot); and, 3) combined stimulation (SR + SP). Stimuli were applied around the onset of rhythmic EMG bursts in VL corresponding to the onset of the power or leg extension phase. Results: During AL cycling, small inhibitory (similar to 80 ms) and large facilitatory reflexes (similar to 100 similar to 150 ms) were seen in VL. The amplitudes of the facilitatory responses with SR + SP stimulation were significantly larger than those for SP or SR stimulation alone. The facilitation was also significantly larger than the simple mathematical summation of amplitudes from SP and SR trials. This indicates extra facilitation beyond what would be accounted for by serial neuronal processing and was not observed during static activation. Conclusions: We conclude that AL cycling activates shared interneurons in convergent reflex pathways from cutaneous inputs innervating the hand and leg. This enhanced activity has functional implications for corrective responses during locomotion and for translation to rehabilitation after neurotrauma.	[Nakajima, Tsuyoshi] Kyorin Univ, Sch Med, Dept Integrat Physiol, Mitaka, Tokyo 181, Japan; [Barss, Trevor; Klarner, Taryn; Zehr, E. Paul] Univ Victoria, Rehabil Neurosci Lab, Victoria, BC V8W 3P1, Canada; [Komiyama, Tomoyoshi] Chiba Univ, Fac Educ, Dept Hlth & Sports Sci, Chiba, Japan; [Zehr, E. Paul] Int Collaborat Repair Discoveries ICORD, Vancouver, BC, Canada; [Zehr, E. Paul] Univ Victoria, Ctr Biomed Res, Victoria, BC, Canada; [Zehr, E. Paul] Univ Victoria, Div Med Sci, Victoria, BC, Canada; [Zehr, E. Paul] Univ Victoria, Sch Exercise Sci Phys & Hlth Educ, Victoria, BC, Canada	Zehr, EP (corresponding author), Univ Victoria, Rehabil Neurosci Lab, POB 3010 STN CSC, Victoria, BC V8W 3P1, Canada.	pzehr@uvic.ca	Barss, Trevor/L-7045-2019	Barss, Trevor/0000-0003-3466-2750	Natural Sciences and Engineering Research Council (NSERC) of CanadaNatural Sciences and Engineering Research Council of Canada (NSERC); Japanese Society for the Promotion of ScienceMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science; Grants-in-Aid for Scientific ResearchMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI) [22500525] Funding Source: KAKEN	This work was supported by a Discovery grant from the Natural Sciences and Engineering Research Council (NSERC) of Canada to EPZ and a Research Fellowships for Young Scientists from the Japanese Society for the Promotion of Science to TN.	Baldiserra F, 1981, HDB PHYSL, P509; Balter JE, 2007, J NEUROPHYSIOL, V97, P1809, DOI 10.1152/jn.01038.2006; Borgmann A, 2009, J NEUROSCI, V29, P2972, DOI 10.1523/JNEUROSCI.3155-08.2009; Calancie B, 1996, ELECTROMYOGR MOTOR C, V101, P304, DOI 10.1016/0924-980X(96)95194-2; Christensen LOD, 1999, EXP BRAIN RES, V124, P59, DOI 10.1007/s002210050600; Dietz V, 2002, TRENDS NEUROSCI, V25, P462, DOI 10.1016/S0166-2236(02)02229-4; Dietz V, 2011, J NEUROL, V258, P1406, DOI 10.1007/s00415-011-6063-4; Falgairolle M, 2007, J PHYSL PAR IN PRESS; Falgairolle M, 2006, J PHYSIOL-PARIS, V100, P304, DOI 10.1016/j.jphysparis.2007.05.003; Frigon A, 2004, J NEUROPHYSIOL, V91, P1516, DOI 10.1152/jn.00695.2003; Haridas C, 2003, J NEUROPHYSIOL, V90, P2850, DOI 10.1152/jn.00531.2003; Juvin L, 2005, J NEUROSCI, V25, P6025, DOI 10.1523/JNEUROSCI.0696-05.2005; Kagamihara Y, 2003, EXP BRAIN RES, V151, P136, DOI 10.1007/s00221-003-1436-2; Kawashima N, 2008, J NEUROPHYSIOL, V99, P2946, DOI 10.1152/jn.00020.2008; LABELLA LA, 1990, J NEUROPHYSIOL, V64, P403; Lamont EV, 2007, J NEUROPHYSIOL, V98, P433, DOI 10.1152/jn.00002.2007; Lamont EV, 2006, EXP BRAIN RES, V173, P185, DOI 10.1007/s00221-006-0586-4; Lloyd DPC, 1942, J NEUROPHYSIOL, V5, P435; LUNDBERG A, 1975, BRAIN RES, V87, P81, DOI 10.1016/0006-8993(75)90783-0; Lundberg A, 1979, Prog Brain Res, V50, P11; Mezzarane RA, 2011, EXP BRAIN RES, V208, P157, DOI 10.1007/s00221-010-2467-0; Nakajima T, 2011, J NEUROPHYSIOL, V106, P1679, DOI 10.1152/jn.01049.2010; Sakamoto M, 2007, EXP BRAIN RES, V176, P188, DOI 10.1007/s00221-006-0742-x; Sakamoto M, 2006, CLIN NEUROPHYSIOL, V117, P1301, DOI 10.1016/j.clinph.2006.03.005; Sasada S, 2010, J NEUROPHYSIOL, V104, P210, DOI 10.1152/jn.00774.2009; Sherrington CS, 1903, J PHYSIOL-LONDON, V29, P58; Sherrington CS, 1910, J PHYSIOL-LONDON, V40, P28; Wannier T, 2001, EXP BRAIN RES, V141, P375, DOI 10.1007/s002210100875; Zehr EP, 2007, J NEUROPHYSIOL, V98, P1810, DOI 10.1152/jn.00562.2007; Zehr EP, 2007, J PHYSIOL-LONDON, V582, P209, DOI 10.1113/jphysiol.2007.133843; Zehr EP, 2012, CLIN NEUROPHYSIOL, V123, P796, DOI 10.1016/j.clinph.2011.07.049; Zehr EP, 2009, EXERC SPORT SCI REV, V37, P102, DOI 10.1097/JES.0b013e31819c2ed6; Zehr EP, 2004, EXP BRAIN RES, V159, P382, DOI 10.1007/s00221-004-2092-x; Zehr EP, 2004, NEUROSCIENTIST, V10, P347, DOI 10.1177/1073858404264680; Zehr EP, 2001, EXP BRAIN RES, V140, P495	35	17	18	0	12	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1471-2202			BMC NEUROSCI	BMC Neurosci.	MAR 13	2013	14								28	10.1186/1471-2202-14-28			8	Neurosciences	Neurosciences & Neurology	112AB	WOS:000316562500001	23497331	DOAJ Gold, Green Published			2021-06-18	
J	Uysal, N; Baykara, B; Kiray, M; Cetin, F; Aksu, I; Dayi, A; Gurpinar, T; Ozdemir, D; Arda, MN				Uysal, Nazan; Baykara, Basak; Kiray, Muge; Cetin, Ferihan; Aksu, Ilkay; Dayi, Ayfer; Gurpinar, Tugba; Ozdemir, Durgul; Arda, M. Nuri			Combined Treatment with Progesterone and Magnesium Sulfate Positively Affects Traumatic Brain Injury in Immature Rats	TURKISH NEUROSURGERY			English	Article						Traumatic brain injury; Immature rat; Spatial learning and memory; Apoptosis; VEGF; Magnesium sulfate; Progesterone	INDUCED HIPPOCAMPAL DAMAGE; METHYL-D-ASPARTATE; COGNITIVE DYSFUNCTION; NEUROTROPHIC FACTOR; HEAD TRAUMA; CELL-DEATH; MEMORY; CHILDREN; ANTAGONISTS; ACTIVATION	AIM: It is well known that head trauma results in damage in hippocampal and cortical areas of the brain and impairs cognitive functions. The aim of this study is to explore the neuroprotective effect of combination therapy with magnesium sulphate (MgSO4) and progesterone in the 7-days-old rat pups subjected to contusion injury. MATERIAL and METHODS: Progesterone (8 mg/kg) and MgSO4 (150 mg/kg) were injected intraperitoneally immediately after induction of traumatic brain injury. Half of groups were evaluated 24 hours later, the remaining animals 3 weeks after trauma or sham surgery. Anxiety levels were assessed with open field activity and elevated plus maze; learning and memory performance were evaluated with Morris Water maze in postnatal 27 days. RESULTS: Combined therapy with progesterone and magnesium sulfate significantly attenuated trauma-induced neuronal death, increased brain VEGF levels and improved spatial memory deficits that appear later in life. Brain VEGF levels were higher in rats that received combined therapy compared to rats that received either medication alone. Moreover, rats that received combined therapy had reduced hipocampus and prefrontal cortex apoptosis in the acute period. CONCLUSION: These results demonstrate that combination of drugs with different mechanisms of action may be preferred in the treatment of head trauma.	[Uysal, Nazan; Kiray, Muge; Cetin, Ferihan; Aksu, Ilkay; Dayi, Ayfer] Dokuz Eylul Univ, Fac Med, Dept Physiol, Izmir, Turkey; [Baykara, Basak] Dokuz Eylul Univ, High Sch Phys Therapy & Rehabil, Izmir, Turkey; [Gurpinar, Tugba] Celal Bayar Univ, Dept Pharmacol, Fac Med, Manisa, Turkey; [Ozdemir, Durgul] Dokuz Eylul Univ, Dept Pediat, Fac Med, Izmir, Turkey; [Arda, M. Nuri] Dokuz Eylul Univ, Dept Neurosurg, Fac Med, Izmir, Turkey	Uysal, N (corresponding author), Dokuz Eylul Univ, Fac Med, Dept Physiol, Izmir, Turkey.	nazan.uysal@deu.edu.tr	dayi, ayfer/O-9503-2019; Baykara, Basak/AAC-6504-2019	dayi, ayfer/0000-0002-4102-1399; Baykara, Basak/0000-0002-4178-2235; Uysal, Nazan/0000-0002-2348-7427			Adelson PD, 1998, J CHILD NEUROL, V13, P2, DOI 10.1177/088307389801300102; Altura BM, 2003, NEUROSCI LETT, V341, P189, DOI 10.1016/S0304-3940(03)00134-4; Bayir H, 2003, CRIT CARE CLIN, V19, P529, DOI 10.1016/S0749-0704(03)00014-9; BEERS SR, 1992, NEUROPSYCHOL REV, V3, P281, DOI 10.1007/BF01108414; Bittigau D, 1999, ANN NEUROL, V45, P724, DOI 10.1002/1531-8249(199906)45:6<724::AID-ANA6>3.0.CO;2-P; Bremner JD, 1997, BIOL PSYCHIAT, V41, P23, DOI 10.1016/S0006-3223(96)00162-X; CHOI DW, 1987, J NEUROSCI, V7, P369; Conte V., 2003, EUR J TRAUMA, V29, P335; Cook NL, 2009, MAGNESIUM RES, V22, P225, DOI 10.1684/mrh.2009.0189; Cutler SM, 2006, EXP NEUROL, V200, P378, DOI 10.1016/j.expneurol.2006.02.137; Dang J, 2011, BRAIN BEHAV IMMUN, V25, P715, DOI 10.1016/j.bbi.2011.01.013; DOBBING J, 1979, EARLY HUM DEV, V3, P79, DOI 10.1016/0378-3782(79)90022-7; Enomoto T, 2005, J NEUROTRAUM, V22, P783, DOI 10.1089/neu.2005.22.783; Frankland PW, 2004, SCIENCE, V304, P881, DOI 10.1126/science.1094804; GARFINKEL L, 1985, Magnesium, V4, P60; GENTILE NT, 1993, ANN EMERG MED, V22, P1028, DOI 10.1016/S0196-0644(05)82746-5; Guthrie E, 1999, CHILD ADOL PSYCH CL, V8, P807; Heath DL, 1999, J NEUROSURG, V90, P504, DOI 10.3171/jns.1999.90.3.0504; Heath DL, 1999, J CLIN NEUROSCI, V6, P505, DOI 10.1016/S0967-5868(99)90011-5; Heath DL, 2001, J NEUROTRAUM, V18, P465, DOI 10.1089/089771501750171074; Kahraman S, 2003, CLIN CHIM ACTA, V334, P211, DOI 10.1016/S0009-8981(03)00235-3; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Klur S, 2009, HIPPOCAMPUS, V19, P800, DOI 10.1002/hipo.20562; Laird MD, 2008, NEUROSIGNALS, V16, P154, DOI 10.1159/000111560; Lee I, 2003, J NEUROSCI, V23, P1517; Lu KT, 2011, J NEUROTRAUM, V28, P441, DOI 10.1089/neu.2010.1473; Luoma JI, 2011, STEROIDS, V76, P845, DOI 10.1016/j.steroids.2011.02.013; MCDONALD JW, 1988, BRAIN RES, V459, P200, DOI 10.1016/0006-8993(88)90306-X; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Osteen CL, 2001, J NEUROTRAUM, V18, P141, DOI 10.1089/08977150150502587; Ozdemir D, 2005, NEUROSCI LETT, V385, P234, DOI 10.1016/j.neulet.2005.05.055; Ozdemir D, 2012, NEUROSCI LETT, V507, P84, DOI 10.1016/j.neulet.2011.11.059; Pifarre P, 2010, J NEUROCHEM, V112, P807, DOI 10.1111/j.1471-4159.2009.06518.x; Pohl D, 1999, P NATL ACAD SCI USA, V96, P2508, DOI 10.1073/pnas.96.5.2508; Polderman KH, 2000, CRIT CARE MED, V28, P2022, DOI 10.1097/00003246-200006000-00057; Sen AP, 2010, NEUROTHERAPEUTICS, V7, P91, DOI 10.1016/j.nurt.2009.10.014; Slutsky I, 2010, NEURON, V65, P165, DOI 10.1016/j.neuron.2009.12.026; SMITH DH, 1994, NEUROSCI LETT, V168, P151, DOI 10.1016/0304-3940(94)90438-3; Sondell M, 2000, EUR J NEUROSCI, V12, P4243, DOI 10.1046/j.0953-816X.2000.01326.x; Stein DG, 2008, BRAIN RES REV, V57, P386, DOI 10.1016/j.brainresrev.2007.06.012; Temkin NR, 2007, LANCET NEUROL, V6, P29, DOI 10.1016/S1474-4422(06)70630-5; Tong W, 2002, EXP NEUROL, V176, P105, DOI 10.1006/exnr.2002.7941; VINK R, 1988, J BIOL CHEM, V263, P757; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Wright DW, 2007, ANN EMERG MED, V49, P391, DOI 10.1016/j.annemergmed.2006.07.932; Yang K, 1996, J NEUROSCI RES, V44, P157, DOI 10.1002/(SICI)1097-4547(19960415)44:2<157::AID-JNR8>3.0.CO;2-C	46	17	22	0	12	TURKISH NEUROSURGICAL SOC	BAHCELIEVLER	TASKENT CADDESI 13-4, BAHCELIEVLER, ANKARA 06500, TURKEY	1019-5149			TURK NEUROSURG	Turk. Neurosurg.	MAR	2013	23	2					129	137		10.5137/1019-5149.JTN.5582-11.1			9	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	123GH	WOS:000317375900001	23546895	Bronze			2021-06-18	
J	Park, HJ; Machado, AG; Cooperrider, J; Havan, TF; Johnson, M; Krishna, V; Chen, ZH; Gale, JT				Park, Hyun-Joo; Machado, Andre G.; Cooperrider, Jessica; Havan Truong-Furmaga; Johnson, Matthew; Krishna, Vibhuti; Chen, Zhihong; Gale, John T.			Semi-automated method for estimating lesion volumes	JOURNAL OF NEUROSCIENCE METHODS			English	Article						Lesion volume; Stroke; Traumatic brain injury; Cell death; Lesion estimation; Computational method	MOTOR CORTEX STIMULATION; FOCAL CEREBRAL-ISCHEMIA; ELECTRICAL-STIMULATION; MULTIPLE-SCLEROSIS; RECOVERY; STROKE; INJURY; RAT	Accurately measuring the volume of tissue damage in experimental lesion models is crucial to adequately control for the extent and location of the lesion, variables that can dramatically bias the outcome of preclinical studies. Many of the current commonly used techniques for this assessment, such as measuring the lesion volume with primitive software macros and plotting the lesion location manually using atlases, are time-consuming and offer limited precision. Here we present an easy to use semi-automated computational method for determining lesion volume and location, designed to increase precision and reduce the manual labor required. We compared this novel method to currently used methods and demonstrate that this tool is comparable or superior to current techniques in terms of precision and has distinct advantages with respect to user interface, labor intensiveness and quality of data presentation. (c) 2012 Elsevier B.V. All rights reserved.	[Park, Hyun-Joo; Machado, Andre G.; Cooperrider, Jessica; Havan Truong-Furmaga; Johnson, Matthew; Krishna, Vibhuti; Chen, Zhihong; Gale, John T.] Cleveland Clin, Dept Neurosci, Lerner Res Inst, Cleveland, OH 44195 USA; [Machado, Andre G.; Gale, John T.] Cleveland Clin, Neurol Inst, Ctr Neurol Restorat, Cleveland, OH 44195 USA	Gale, JT (corresponding author), Cleveland Clin, Dept Neurosci, 9500 Euclid Ave,NC30, Cleveland, OH 44195 USA.	galej@ccf.org	Machado, Andre GG/B-7572-2014	Machado, Andre GG/0000-0002-8132-5610; Chen, zhihong/0000-0001-7403-7015; Johnson, Matthew/0000-0002-0264-8498	NIH grantUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [5R01HD061363]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD061363] Funding Source: NIH RePORTER	The research was funded by an NIH grant: 5R01HD061363.	Adkins-Muir DL, 2003, NEUROL RES, V25, P780, DOI 10.1179/016164103771953853; Bagnato F, 2011, MULT SCLER J, V17, P1424, DOI 10.1177/1352458511414601; Baker KB, 2010, EXP NEUROL, V226, P259, DOI 10.1016/j.expneurol.2010.08.019; Brown JA, 2003, NEUROL RES, V25, P815, DOI 10.1179/016164103771953907; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; COOK LT, 1980, IEEE T BIO-MED ENG, V27, P493, DOI 10.1109/TBME.1980.326663; Criminisi A, 1999, IMAGE VISION COMPUT, V17, P625, DOI 10.1016/S0262-8856(98)00183-8; Darling WG, 2011, EXP NEUROL, V231, P56, DOI 10.1016/j.expneurol.2011.05.015; Di Stefano G, 2000, J NEUROL NEUROSUR PS, V69, P210, DOI 10.1136/jnnp.69.2.210; GOLDBERG SN, 1995, ACAD RADIOL, V2, P399; Kleim JA, 2003, NEUROL RES, V25, P789, DOI 10.1179/016164103771953862; Lee VM, 1996, STROKE, V27, P2110, DOI 10.1161/01.STR.27.11.2110; Machado AG, 2009, BRAIN RES, V1280, P107, DOI 10.1016/j.brainres.2009.05.007; Merino JG, 2007, STROKE, V38, P2919, DOI 10.1161/STROKEAHA.107.485995; MEYERS D, 1992, ACM T GRAPHIC, V11, P228, DOI 10.1145/130881.131213; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Rivers CS, 2006, STROKE, V37, P98, DOI 10.1161/01.STR.0000195197.66606.bb; Wieshmann UC, 1997, EPILEPSIA, V38, P1238, DOI 10.1111/j.1528-1157.1997.tb01222.x; Windle V, 2006, EXP NEUROL, V201, P324, DOI 10.1016/j.expneurol.2006.04.012; Wolf SL, 2006, JAMA-J AM MED ASSOC, V296, P2095, DOI 10.1001/jama.296.17.2095; Zivadinov R, 2012, NEUROIMAGE, V59, P331, DOI 10.1016/j.neuroimage.2011.07.045	21	17	17	0	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0165-0270	1872-678X		J NEUROSCI METH	J. Neurosci. Methods	FEB 15	2013	213	1					76	83		10.1016/j.jneumeth.2012.12.010			8	Biochemical Research Methods; Neurosciences	Biochemistry & Molecular Biology; Neurosciences & Neurology	098JC	WOS:000315544500010	23261655	Green Accepted			2021-06-18	
J	Dubendorfer, C; Billeter, AT; Seifert, B; Keel, M; Turina, M				Duebendorfer, C.; Billeter, A. T.; Seifert, B.; Keel, M.; Turina, M.			Serial lactate and admission SOFA scores in trauma: an analysis of predictive value in 724 patients with and without traumatic brain injury	EUROPEAN JOURNAL OF TRAUMA AND EMERGENCY SURGERY			English	Article						Trauma; Infection; Sepsis; Lactate; Base excess; SOFA score	GLASGOW COMA SCALE; ORGAN FAILURE; BASE DEFICIT; OCCULT HYPOPERFUSION; SERUM LACTATE; MORTALITY; SEPSIS; SURVIVAL; MULTICENTER; CLEARANCE	Objective Arterial lactate, base excess (BE), lactate clearance, and Sequential Organ Failure Assessment (SOFA) score have been shown to correlate with outcome in severely injured patients. The goal of the present study was to separately assess their predictive value in patients suffering from traumatic brain injury (TBI) as opposed to patients suffering from injuries not related to the brain. Materials and methods A total of 724 adult trauma patients with an Injury Severity Score (ISS) >= 16 were grouped into patients without TBI (non-TBI), patients with isolated TBI (isolated TBI), and patients with a combination of TBI and non-TBI injuries (combined injuries). The predictive value of the above parameters was then analyzed using both uni- and multivariate analyses. Results The mean age of the patients was 39 years (77 % males), with a mean ISS of 32 (range 16-75). Mortality ranged from 14 % (non-TBI) to 24 % (combined injuries). Admission and serial lactate/BE values were higher in non-survivors of all groups (all p < 0.01), but not in patients with isolated TBI. Admission SOFA scores were highest in non-survivors of all groups (p = 0.023); subsequently septic patients also showed elevated SOFA scores (p < 0.01), except those with isolated TBI. In this group, SOFA score was the only parameter which showed significant differences between survivors and non-survivors. Receiver operating characteristic (ROC) analysis revealed lactate to be the best overall predictor for increased mortality and further septic complications, irrespective of the leading injury. Conclusion Lactate showed the best performance in predicting sepsis or death in all trauma patients except those with isolated TBI, and the differences were greatest in patients with substantial bleeding. Following isolated TBI, SOFA score was the only parameter which could differentiate survivors from non-survivors on admission, although the SOFA score, too, was not an independent predictor of death following multivariate analysis.	[Duebendorfer, C.] Kantonsspital Winterthur, Dept Anesthesiol, CH-8401 Winterthur, Switzerland; [Duebendorfer, C.; Billeter, A. T.] Univ Zurich Hosp, Div Trauma Surg, Dept Surg, CH-8091 Zurich, Switzerland; [Billeter, A. T.] Univ Louisville, Price Inst Surg Res, Sch Med, Louisville, KY 40202 USA; [Seifert, B.] Univ Zurich, Biostat Unit, Inst Social & Prevent Med, CH-8001 Zurich, Switzerland; [Keel, M.] Inselspital Bern, Dept Orthopaed Surg, Univ Hosp Bern, CH-3002 Bern, Switzerland; [Turina, M.] Cleveland Clin Fdn, Dept Colorectal Surg, Cleveland, OH 44195 USA	Billeter, AT (corresponding author), Univ Zurich Hosp, Div Trauma Surg, Dept Surg, Ramistr 100, CH-8091 Zurich, Switzerland.	adrianbilleter@bluewin.ch	Billeter, Adrian/O-2185-2019				ABRAMSON D, 1993, J TRAUMA, V35, P584, DOI 10.1097/00005373-199310000-00014; Antonelli M, 1999, INTENS CARE MED, V25, P389, DOI 10.1007/s001340050863; Arnold RC, 2009, SHOCK, V32, P35, DOI 10.1097/SHK.0b013e3181971d47; Aslar AK, 2004, INJURY, V35, P746, DOI 10.1016/j.injury.2003.09.030; Bakker J, 1996, AM J SURG, V171, P221, DOI 10.1016/S0002-9610(97)89552-9; Billeter A, 2009, WORLD J SURG, V33, P558, DOI 10.1007/s00268-008-9896-y; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Bota DP, 2002, INTENS CARE MED, V28, P1619, DOI 10.1007/s00134-002-1491-3; Chamoun RB, 2009, J NEUROSURG, V111, P683, DOI 10.3171/2009.2.JNS08817; Claridge JA, 2000, J TRAUMA, V48, P8, DOI 10.1097/00005373-200001000-00003; Cureton EL, 2010, J SURG RES, V159, P468, DOI 10.1016/j.jss.2009.04.020; DAVIS JW, 1988, J TRAUMA, V28, P1464, DOI 10.1097/00005373-198810000-00010; Davis JW, 1996, J TRAUMA, V41, P769, DOI 10.1097/00005373-199611000-00001; DAVIS JW, 1991, SURG GYNECOL OBSTET, V173, P473; DAVIS JW, 1991, ANN EMERG MED, V20, P842, DOI 10.1016/S0196-0644(05)81423-4; Demetriades D, 2006, J TRAUMA, V61, P868, DOI 10.1097/01.ta.0000219135.33398.f3; Ikossi DG, 2006, J TRAUMA, V61, P780, DOI 10.1097/01.ta.0000239500.71419.58; Jackson EV, 1997, CRIT CARE MED, V25, P1840, DOI 10.1097/00003246-199711000-00022; Jansen TC, 2009, CRIT CARE MED, V37, P2827, DOI 10.1097/CCM.0b013e3181a98899; Jansen TC, 2009, CRIT CARE MED, V37, P2369, DOI 10.1097/CCM.0b013e3181a0f919; KENNEDY F, 1993, J TRAUMA, V35, P75, DOI 10.1097/00005373-199307000-00013; LANDOW L, 1994, J TRAUMA, V37, P869; Lee TT, 1997, ACTA NEUROCHIR, V139, P1042, DOI 10.1007/BF01411558; MANIKIS P, 1995, AM J EMERG MED, V13, P619, DOI 10.1016/0735-6757(95)90043-8; Meregalli A, 2004, CRIT CARE, V8, pR60, DOI 10.1186/cc2423; Mikkelsen ME, 2009, CRIT CARE MED, V37, P1670, DOI 10.1097/CCM.0b013e31819fcf68; Mikulaschek A, 1996, J TRAUMA, V40, P218, DOI 10.1097/00005373-199602000-00008; Namendys-Silva SA, 2009, AM J HOSP PALLIAT ME, V26, P341, DOI 10.1177/1049909109333041; Neumann F, 2008, ANN HEMATOL, V87, P299, DOI 10.1007/s00277-008-0440-9; RUTHERFORD EJ, 1992, J TRAUMA, V33, P417, DOI 10.1097/00005373-199209000-00014; Schulman AM, 2004, J TRAUMA, V57, P795, DOI 10.1097/01.TA.0000140835.65944.54; TEASDALE G, 1974, LANCET, V2, P81; Tien HC, 2006, J TRAUMA, V60, P274, DOI 10.1097/01.ta.0000197177.13379.f4; Udekwu P, 2004, J TRAUMA, V56, P1084, DOI 10.1097/01.TA.0000124283.02605.A5; Vincent JL, 1998, CRIT CARE MED, V26, P1793, DOI 10.1097/00003246-199811000-00016; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; Zehtabchi S, 2007, EMERG MED J, V24, P333, DOI 10.1136/emj.2006.044578	37	17	17	0	6	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1863-9933	1863-9941		EUR J TRAUMA EMERG S	Eur. J. Trauma Emerg. Surg.	FEB	2013	39	1					25	34		10.1007/s00068-012-0212-z			10	Emergency Medicine	Emergency Medicine	119FK	WOS:000317083000005	26814920	Green Accepted			2021-06-18	
J	Lai, WJ; Wu, J; Zou, X; Xie, J; Zhang, LW; Zhao, XY; Zhao, MZ; Wang, QS; Ji, JG				Lai, Wenjia; Wu, Jing; Zou, Xiao; Xie, Jian; Zhang, Liwei; Zhao, Xuyang; Zhao, Minzhi; Wang, Qingsong; Ji, Jianguo			Secretome Analyses of A beta(1-42) Stimulated Hippocampal Astrocytes Reveal that CXCL10 is Involved in Astrocyte Migration	JOURNAL OF PROTEOME RESEARCH			English	Article						cell migration; secreted protein; reactive astrocytes; Alzheimer's disease; amyloid-beta; LC-MS/MS	ONSET ALZHEIMERS-DISEASE; TRAUMATIC BRAIN-INJURY; SHOTGUN PROTEOMICS; MTT REDUCTION; CANCER-CELLS; A-BETA; EXPRESSION; PROTEIN; RAT; IDENTIFICATION	Amyloid-beta (A beta) aggregation plays an important role in the development of Alzheimer's disease (AD). In the AD brain, amyloid plaques are surrounded by reactive astrocytes, and many essential functions of astrocytes have been reported to be mediated by protein secretion. However, the roles of activated astrocytes in AD progression are under intense debate. To provide an in-depth view of the secretomes of activated astrocytes, we present in this study a quantitative profile of rat hippocampal astrocyte secretomes at multiple time points after both brief and sustained A beta(1-42) stimulation. Using SILAC labeling and LC-MS/MS analyses, we identified 19 up-regulated secreted proteins after A beta(1-42) treatment. These differentially expressed proteins have been suggested to be involved in key aspects of biological processes, such as cell recruitment, A beta clearance, and regulation of neurogenesis. Particularly, we validated the role played by CXCL10 in promoting astrocyte aggregation around amyloid plagues through in vitro cell migration analysis. This research provides global, quantitative profiling of astrocyte secretomes produced on A beta stimulation and hence provides a detailed molecular basis for the relationship between amyloid plaques and astrocyte aggregation; the findings thus have important implications for further investigations into AD development and therapy.	[Lai, Wenjia; Wu, Jing; Zou, Xiao; Zhao, Xuyang; Zhao, Minzhi; Wang, Qingsong; Ji, Jianguo] Peking Univ, Coll Life Sci, Natl Lab Prot Engn & Plant Genet Engn, Beijing 100871, Peoples R China; [Xie, Jian; Zhang, Liwei] Capital Med Univ, Beijing TianTan Hosp, Dept Neurosurg, Beijing 100875, Peoples R China	Ji, JG (corresponding author), Peking Univ, Coll Life Sci, Natl Lab Prot Engn & Plant Genet Engn, Beijing 100871, Peoples R China.	jijg@pku.edu.cn	wu, jing/C-4576-2015		National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [31270872, 30970652]; National Key Basic Research Program of ChinaNational Basic Research Program of China [2010CB912203, 2011CB915504]	This work was supported by grants from the National Natural Science Foundation of China (Nos. 31270872 and 30970652) and the National Key Basic Research Program of China (Nos. 2010CB912203 and 2011CB915504).	Abe K, 1998, NEUROSCI RES, V31, P295, DOI 10.1016/S0168-0102(98)00055-8; Ahlemeyer B, 2013, J NEUROSCI METH, V212, P156, DOI 10.1016/j.jneumeth.2012.09.016; Bendtsen JD, 2004, PROTEIN ENG DES SEL, V17, P349, DOI 10.1093/protein/gzh037; Bonneh-Barkay D, 2010, J NEUROTRAUM, V27, P1215, DOI 10.1089/neu.2010.1310; Boyle EI, 2004, BIOINFORMATICS, V20, P3710, DOI 10.1093/bioinformatics/bth456; Brazil MI, 2000, J BIOL CHEM, V275, P16941, DOI 10.1074/jbc.M000937200; Camon Evelyn, 2004, In Silico Biology, V4, P5; Chen YJ, 2005, NUCLEIC ACIDS RES, V33, pD169; Citron M, 2010, NAT REV DRUG DISCOV, V9, P387, DOI 10.1038/nrd2896; Cox J, 2009, NAT PROTOC, V4, P698, DOI 10.1038/nprot.2009.36; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Crespo-Biel Natalia, 2012, Int J Alzheimers Dis, V2012, P251426, DOI 10.1155/2012/251426; Di Fede G, 2012, PROG NEUROBIOL, V99, P281, DOI 10.1016/j.pneurobio.2012.06.004; Dowell JA, 2009, J PROTEOME RES, V8, P4135, DOI 10.1021/pr900248y; Du JL, 2012, PROTEIN ENG DES SEL, V25, P337, DOI 10.1093/protein/gzs026; Duan RS, 2008, NEUROCHEM RES, V33, P1085, DOI 10.1007/s11064-007-9554-z; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Enderlin M, 2009, CANCER GENE THER, V16, P149, DOI 10.1038/cgt.2008.62; Endo T, 2005, CURR DRUG TARGETS, V6, P427, DOI 10.2174/1389450054021909; Fotopoulou S, 2010, DEV BIOL, V339, P451, DOI 10.1016/j.ydbio.2010.01.007; Fu HJ, 2012, GLIA, V60, P993, DOI 10.1002/glia.22331; Gongidi V, 2004, NEURON, V41, P57, DOI 10.1016/S0896-6273(03)00818-3; Greco TM, 2010, J PROTEOME RES, V9, P2764, DOI 10.1021/pr100134n; Hamel MG, 2005, J NEUROCHEM, V93, P1533, DOI 10.1111/j.1471-4159.2005.03144.x; Han H, 2011, ARCH ORTHOP TRAUM SU, V131, P829, DOI 10.1007/s00402-010-1233-x; Han NK, 2012, PROTEOMICS, V12, P2822, DOI 10.1002/pmic.201100419; Hickman SE, 2013, ADV ALZH DIS, V3, P295, DOI 10.3233/978-1-61499-154-0-295; HOFFMANN MC, 1992, NEUROSCIENCE, V49, P397, DOI 10.1016/0306-4522(92)90105-B; Ishibashi S, 2007, EXP NEUROL, V207, P302, DOI 10.1016/j.expneurol.2007.06.024; Israelsson C, 2010, EUR J NEUROSCI, V31, P852, DOI 10.1111/j.1460-9568.2010.07105.x; Jia JX, 2010, MOL CELL BIOCHEM, V335, P127, DOI 10.1007/s11010-009-0249-4; Kanekiyo T, 2007, P NATL ACAD SCI USA, V104, P6412, DOI 10.1073/pnas.0701585104; Kang WF, 2011, MOL NEUROBIOL, V43, P147, DOI 10.1007/s12035-011-8163-7; Kanno M, 2005, J NEUROIMMUNOL, V167, P72, DOI 10.1016/j.jneuroim.2005.06.028; Keene SD, 2009, PROTEOMICS, V9, P768, DOI 10.1002/pmic.200800385; Lafon-Cazal M, 2003, J BIOL CHEM, V278, P24438, DOI 10.1074/jbc.M211980200; Lee JH, 2012, CANCER RES, V72, P3175, DOI 10.1158/0008-5472.CAN-12-0481; Lee S, 2011, J BIOL CHEM, V286, P43855, DOI 10.1074/jbc.M111.299248; Li XY, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-79; Liu YB, 1997, J NEUROCHEM, V69, P2285; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loeffler DA, 2001, FREE RADICAL RES, V35, P111, DOI 10.1080/10715760100300651; Luan KL, 2013, AGEING RES REV, V12, P174, DOI 10.1016/j.arr.2012.06.002; MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890; McKimmie CS, 2010, BIOCHEM BIOPH RES CO, V394, P1006, DOI 10.1016/j.bbrc.2010.03.111; Miura T, 2004, CELL DEATH DIFFER, V11, P1076, DOI 10.1038/sj.cdd.4401462; Moon LDF, 2003, J NEUROSCI RES, V71, P23, DOI 10.1002/jnr.10449; Moore NH, 2009, J NEUROCHEM, V108, P891, DOI 10.1111/j.1471-4159.2008.05836.x; Nelson PT, 2012, J NEUROPATH EXP NEUR, V71, P362, DOI 10.1097/NEN.0b013e31825018f7; Nielsen HM, 2010, GLIA, V58, P1235, DOI 10.1002/glia.21004; Nishitsuji K, 2011, J BIOL CHEM, V286, P6393, DOI 10.1074/jbc.M110.172106; Noda Mariko, 2012, Int J Alzheimers Dis, V2012, P891087, DOI 10.1155/2012/891087; Omari KM, 2005, BRAIN, V128, P1003, DOI 10.1093/brain/awh479; Parpura V, 2012, J NEUROCHEM, V121, P4, DOI 10.1111/j.1471-4159.2012.07664.x; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Piacentini S, 2012, J NEUROL SCI, V317, P137, DOI 10.1016/j.jns.2012.01.026; Pinhel MAS, 2008, CLIN CHEM LAB MED, V46, P439, DOI 10.1515/CCLM.2008.102; Pocernich CB, 2005, MOL BRAIN RES, V133, P307, DOI 10.1016/j.molbrainres.2004.10.023; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; Romagnani P, 2012, CLIN CHIM ACTA, V413, P1364, DOI 10.1016/j.cca.2012.02.009; Sasaki T, 2004, GLYCOBIOLOGY, V14, P357, DOI 10.1093/glycob/cwh043; Satoh K, 2005, BIOCHEM BIOPH RES CO, V335, P631, DOI 10.1016/j.bbrc.2005.07.117; Savaskan NE, 2007, CELL MOL LIFE SCI, V64, P230, DOI 10.1007/s00018-006-6412-0; Shwartsman A L, 2011, Tsitologiia, V53, P772; Sidahmed AME, 2012, CYTOKINE, V59, P433, DOI 10.1016/j.cyto.2012.05.002; Skalnikova H, 2011, PROTEOMICS, V11, P691, DOI 10.1002/pmic.201000402; Spisni E, 2009, NEUROTOXICOLOGY, V30, P605, DOI 10.1016/j.neuro.2009.03.005; Squitti Rosanna, 2009, Recent Pat CNS Drug Discov, V4, P209; Stroombergen MCMJ, 1999, HUM EXP TOXICOL, V18, P141, DOI 10.1191/096032799678839815; Sui YJ, 2006, EUR J NEUROSCI, V23, P957, DOI 10.1111/j.1460-9568.2006.04631.x; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Takanashi Masashi, 2012, Nihon Rinsho, V70, P94; Takata T, 2012, ONCOL REP, V28, P1968, DOI 10.3892/or.2012.2020; Thal DR, 2012, EXP NEUROL, V236, P1, DOI 10.1016/j.expneurol.2012.04.021; Thomas Saskia, 2012, Inflammopharmacology, V20, P1, DOI 10.1007/s10787-011-0104-6; Tirotta E, 2012, STEM CELL RES, V9, P208, DOI 10.1016/j.scr.2012.06.005; Umemura K, 2006, NEUROSCI LETT, V400, P97, DOI 10.1016/j.neulet.2006.02.008; Vafadar-Isfahani B, 2012, J ALZHEIMERS DIS, V28, P625, DOI 10.3233/JAD-2011-111505; von Mering C, 2005, NUCLEIC ACIDS RES, V33, pD433, DOI 10.1093/nar/gki005; Wyss-Coray T, 2003, NAT MED, V9, P453, DOI 10.1038/nm838; Yamamori H, 2012, NEUROSCI LETT, V513, P204, DOI 10.1016/j.neulet.2012.02.039; Yang LL, 2012, ONCOL LETT, V3, P383, DOI 10.3892/ol.2011.472; Yates-Binder CC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040812	83	17	20	0	18	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1535-3893	1535-3907		J PROTEOME RES	J. Proteome Res.	FEB	2013	12	2					832	843		10.1021/pr300895r			12	Biochemical Research Methods	Biochemistry & Molecular Biology	084SG	WOS:000314558800026	23270423				2021-06-18	
J	Shin, SS; Bales, JW; Yan, HQ; Kline, AE; Wagner, AK; Lyons-Weiler, J; Dixon, CE				Shin, Samuel S.; Bales, James W.; Yan, Hong Q.; Kline, Anthony E.; Wagner, Amy K.; Lyons-Weiler, James; Dixon, C. Edward			The Effect of Environmental Enrichment on Substantia Nigra Gene Expression after Traumatic Brain Injury in Rats	JOURNAL OF NEUROTRAUMA			English	Article						dopamine; EE; microarray; TBI	CLOSED HEAD-INJURY; MEDIATED FUNCTIONAL IMPROVEMENT; RANDOMIZED CONTROLLED-TRIAL; CONTROLLED CORTICAL IMPACT; WATER MAZE PERFORMANCE; LONG-TERM POTENTIATION; PARKINSONS-DISEASE; MESSENGER-RNA; AXONAL INJURY; NEUROBEHAVIORAL RECOVERY	Experimental investigations into the effects of traumatic brain injury (TBI) have demonstrated significant alterations in dopaminergic systems. Dopaminergic fibers originating within the substantia nigra and ventral tegmental area (VTA) are important for reward learning, addiction, movement, and behavior. However, little is known about the effect of TBI on substantia nigra and VTA function. Environmental enrichment (EE) has been shown to improve functional outcome after TBI, and a number of studies suggest that it may exert some benefits via dopaminergic signaling. To better understand the role of dopamine in chronic TBI pathophysiology and the effect of EE, we examined the mRNA expression profile within the substantia nigra and VTA at 4 weeks post-injury. Specifically, three comparisons were made: 1) TBI versus sham, 2) sham + EE versus sham + standard (STD) housing, and 3) TBI + EE versus TBI + STD. There were differential expressions of 25, 4, and 40 genes in these comparisons, respectively. Chronic alterations in genes post-injury within the substantia nigra and VTA included genes important for cellular membrane homeostasis and transcription. EE-induced gene alterations after TBI included genes important for signal transduction, in particular calcium signaling pathways, membrane homeostasis, and metabolism. Elucidation of these alterations in gene expression within the substantia nigra and VTA provides new insights into chronic changes in dopamine signaling post-TBI, and the potential role of EE in TBI rehabilitation.	[Shin, Samuel S.; Bales, James W.; Yan, Hong Q.; Dixon, C. Edward] Univ Pittsburgh, Brain Trauma Res Ctr, Pittsburgh, PA 15260 USA; [Shin, Samuel S.; Bales, James W.; Yan, Hong Q.; Kline, Anthony E.; Wagner, Amy K.; Dixon, C. Edward] Univ Pittsburgh, Ctr Neurosci, Pittsburgh, PA 15260 USA; [Shin, Samuel S.; Bales, James W.; Yan, Hong Q.; Dixon, C. Edward] Univ Pittsburgh, Dept Neurol Surg, Pittsburgh, PA 15260 USA; [Shin, Samuel S.; Bales, James W.; Yan, Hong Q.; Kline, Anthony E.; Wagner, Amy K.; Dixon, C. Edward] Univ Pittsburgh, Safar Ctr Resuscitat Res, Pittsburgh, PA 15260 USA; [Kline, Anthony E.] Univ Pittsburgh, Dept Psychol, Pittsburgh, PA 15260 USA; [Kline, Anthony E.; Wagner, Amy K.; Dixon, C. Edward] Univ Pittsburgh, Dept Phys Med & Rehabil, Pittsburgh, PA 15260 USA; [Lyons-Weiler, James] Univ Pittsburgh, Genom & Prote Core Labs Bioinformat Anal Core, Pittsburgh, PA 15260 USA; [Dixon, C. Edward] Vet Affairs Pittsburgh Healthcare Syst, Pittsburgh, PA USA	Dixon, CE (corresponding author), Univ Pittsburgh, 201 Hill Bldg,3434 Fifth Ave, Pittsburgh, PA 15260 USA.	dixonec@upmc.edu	Lyons-Weiler, James/Q-4948-2019	Lyons-Weiler, James/0000-0001-9343-7508	National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R21NS047919, P01NS030318, R01NS060672, 5F30NS067731-03]; Pittsburgh Copeland Foundation;  [R01NS060005]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS060005, R01NS060672, F30NS067731, R21NS047919, P01NS030318] Funding Source: NIH RePORTER	This research was supported by National Institutes of Health (NIH) grants R21NS047919, P01NS030318, R01NS060672, NIH F30 grant 5F30NS067731-03, and the Pittsburgh Copeland Foundation (CED), and R01NS060005 (AEK).	Alerte TNM, 2008, NEUROSCI LETT, V435, P24, DOI 10.1016/j.neulet.2008.02.014; Bales JW, 2011, EXP NEUROL, V229, P300, DOI 10.1016/j.expneurol.2011.02.013; Bales JW, 2009, NEUROSCI BIOBEHAV R, V33, P981, DOI 10.1016/j.neubiorev.2009.03.011; BARDO MT, 1995, PHARMACOL BIOCHEM BE, V51, P397, DOI 10.1016/0091-3057(94)00413-D; Barembaum M, 2000, NAT CELL BIOL, V2, P219; BINDER LM, 1986, J CLIN EXP NEUROPSYC, V8, P323, DOI 10.1080/01688638608401325; BINDER LM, 1987, J NEUROSURG, V67, P785; Bomze HM, 2001, NAT NEUROSCI, V4, P38; Burke WJ, 2003, BRAIN RES, V989, P205, DOI 10.1016/S0006-8993(03)03354-7; Burre J, 2010, SCIENCE, V329, P1663, DOI 10.1126/science.1195227; Caleo M, 2009, EXP NEUROL, V216, P515, DOI 10.1016/j.expneurol.2008.12.016; CAPRUSO DX, 1992, NEUROL CLIN, V10, P879; Chang PY, 2005, J NEUROSCI RES, V79, P788, DOI 10.1002/jnr.20409; Chao CCK, 2003, J NEUROSCI RES, V74, P248, DOI 10.1002/jnr.10763; Chen DY, 2011, NATURE, V469, P491, DOI 10.1038/nature09667; Chen SJ, 1997, BRAIN RES, V749, P181, DOI 10.1016/S0006-8993(96)01159-6; COULTER PM, 1993, J NEUROCHEM, V61, P756; Cramer SC, 2000, TRENDS NEUROSCI, V23, P265, DOI 10.1016/S0166-2236(00)01562-9; Dahlqvist P, 2004, EUR J NEUROSCI, V19, P2288, DOI 10.1111/j.0953-816X.2004.03248.x; de Castro IP, 2011, MOL NEUROBIOL, V43, P80, DOI 10.1007/s12035-010-8150-4; de Witt BW, 2011, NEUROREHAB NEURAL RE, V25, P343, DOI 10.1177/1545968310390520; Dixon CE, 1999, RESTOR NEUROL NEUROS, V14, P285; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Draghici S, 2007, GENOME RES, V17, P1537, DOI 10.1101/gr.6202607; During Matthew J., 2006, Current Alzheimer Research, V3, P29, DOI 10.2174/156720506775697133; Founds SA, 2009, PLACENTA, V30, P15, DOI 10.1016/j.placenta.2008.09.015; Frey D, 2000, J CELL BIOL, V149, P1443, DOI 10.1083/jcb.149.7.1443; Fujimoto ST, 2004, NEUROSCI BIOBEHAV R, V28, P365, DOI 10.1016/j.neubiorev.2004.06.002; Gelfo F, 2011, NEUROREHAB NEURAL RE, V25, P243, DOI 10.1177/1545968310380926; Giacino JT, 2012, NEW ENGL J MED, V366, P819, DOI 10.1056/NEJMoa1102609; Gualtieri C T, 1988, Brain Inj, V2, P273, DOI 10.3109/02699058809150898; Hall ED, 2005, J NEUROTRAUM, V22, P252, DOI 10.1089/neu.2005.22.252; Herb A, 1997, MOL CELL NEUROSCI, V8, P367, DOI 10.1006/mcne.1996.0594; Hicks RR, 2002, NEUROSCIENCE, V112, P631, DOI 10.1016/S0306-4522(02)00104-5; Hoffman AN, 2008, NEUROSCI LETT, V431, P226, DOI 10.1016/j.neulet.2007.11.042; Hoffmann LC, 2009, NEUROSCIENCE, V158, P1589, DOI 10.1016/j.neuroscience.2008.11.035; Hsu E, 2011, ARTHRITIS RHEUM-US, V63, P783, DOI 10.1002/art.30159; Ickes BR, 2000, EXP NEUROL, V164, P45, DOI 10.1006/exnr.2000.7415; Jadavji NM, 2006, NEUROSCIENCE, V140, P1127, DOI 10.1016/j.neuroscience.2006.03.027; Jankowsky JL, 2005, J NEUROSCI, V25, P5217, DOI 10.1523/JNEUROSCI.5080-04.2005; Diez-Guerra FJ, 2010, IUBMB LIFE, V62, P597, DOI 10.1002/iub.357; Johansson BB, 1996, STROKE, V27, P324, DOI 10.1161/01.STR.27.2.324; Jordan R, 2008, CANCER INFORM, V6, P389; Ju YT, 1998, P NATL ACAD SCI USA, V95, P11423, DOI 10.1073/pnas.95.19.11423; Kadenbach B, 2004, BBA-BIOENERGETICS, V1655, P400, DOI 10.1016/j.bbabio.2003.06.005; Khatri P, 2007, NUCLEIC ACIDS RES, V35, pW206, DOI 10.1093/nar/gkm327; Kim J, 2012, PSYCHOPHARMACOLOGY, V222, P47, DOI 10.1007/s00213-011-2622-8; Kline AE, 2000, NEUROSCI LETT, V280, P163, DOI 10.1016/S0304-3940(00)00797-7; Kline AE, 2004, J NEUROTRAUM, V21, P1712, DOI 10.1089/0897715042664849; Kline AE, 2007, BEHAV BRAIN RES, V177, P186, DOI 10.1016/j.bbr.2006.11.036; Kline AE, 2012, J NEUROTRAUM, V29, P1960, DOI 10.1089/neu.2012.2385; Kline AE, 2010, J NEUROTRAUM, V27, P2021, DOI 10.1089/neu.2010.1535; Kremerskothen J, 2006, J NEUROCHEM, V96, P1659, DOI 10.1111/j.1471-4159.2006.03679.x; Kuroda S, 1999, BIOCHEM BIOPH RES CO, V265, P79, DOI 10.1006/bbrc.1999.1638; Lee SW, 2003, NAT MED, V9, P900, DOI 10.1038/nm889; LEVIN HS, 1978, ARCH NEUROL-CHICAGO, V35, P720, DOI 10.1001/archneur.1978.00500350024005; LEVIN HS, 1988, SCAND J REHABIL MED, P33; LEVIN HS, 1988, BRAIN COGNITION, V7, P283, DOI 10.1016/0278-2626(88)90003-6; Li HH, 2004, J NEUROTRAUM, V21, P1141, DOI 10.1089/0897715041953777; Li SW, 2001, MOL BRAIN RES, V93, P1, DOI 10.1016/S0169-328X(01)00120-6; Lin XY, 1996, J BIOL CHEM, V271, P28430, DOI 10.1074/jbc.271.45.28430; Marciano PG, 2002, NEUROCHEM RES, V27, P1147, DOI 10.1023/A:1020973308941; Matter AM, 2011, NEUROREHAB NEURAL RE, V25, P558, DOI 10.1177/1545968310397206; Matzilevich DA, 2002, J NEUROSCI RES, V67, P646, DOI 10.1002/jnr.10157; Meythaler JM, 2002, J HEAD TRAUMA REHAB, V17, P300, DOI 10.1097/00001199-200208000-00004; Montecalvo A, 2012, BLOOD, V119, P756, DOI 10.1182/blood-2011-02-338004; Moreno TA, 2001, DEV BIOL, V240, P340, DOI 10.1006/dbio.2001.0472; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Okonkwo DO, 2003, NEUROREPORT, V14, P463, DOI 10.1097/01.wnr.0000058958.85541.d3; Okonkwo DO, 1999, NEUROREPORT, V10, P353, DOI 10.1097/00001756-199902050-00026; Overton PG, 1999, NEUROREPORT, V10, P221, DOI 10.1097/00001756-199902050-00004; Passineau MJ, 2001, EXP NEUROL, V168, P373, DOI 10.1006/exnr.2000.7623; Patel Satish, 2004, Appl Bioinformatics, V3, P49; Rall JM, 2003, NEUROPATH APPL NEURO, V29, P118, DOI 10.1046/j.1365-2990.2003.00439.x; Redell JB, 2009, J NEUROSCI RES, V87, P1435, DOI 10.1002/jnr.21945; SAARI MJ, 1990, NEUROTOXICOL TERATOL, V12, P29, DOI 10.1016/0892-0362(90)90109-P; Segovia G, 2010, J NEURAL TRANSM, V117, P1123, DOI 10.1007/s00702-010-0447-y; Shiel A, 2001, CLIN REHABIL, V15, P501, DOI 10.1191/026921501680425225; Shin SS, 2011, BRAIN RES, V1369, P208, DOI 10.1016/j.brainres.2010.10.096; Singleton RH, 2001, J NEUROTRAUM, V18, P607, DOI 10.1089/089771501750291846; Solinas M, 2009, NEUROPSYCHOPHARMACOL, V34, P1102, DOI 10.1038/npp.2008.51; Sozda CN, 2010, J NEUROTRAUM, V27, P1047, DOI 10.1089/neu.2010.1313; Tehranian R, 2006, J NEUROCHEM, V99, P1188, DOI 10.1111/j.1471-4159.2006.04146.x; Tomarev SI, 2009, MOL NEUROBIOL, V40, P122, DOI 10.1007/s12035-009-8076-x; Wagner AK, 2005, EXP NEUROL, V195, P475, DOI 10.1016/j.expneurol.2005.06.009; Wagner AK, 2002, NEUROSCI LETT, V334, P165, DOI 10.1016/S0304-3940(02)01103-5; Wanger AK, 2009, J NEUROCHEM, V110, P801, DOI 10.1111/j.1471-4159.2009.06155.x; Whyte J, 2004, AM J PHYS MED REHAB, V83, P401, DOI 10.1097/01.PHM.0000128789.75375.D3; Whyte J, 2008, AM J PHYS MED REHAB, V87, P85, DOI 10.1097/PHM.0b013e3181619609; Yan HQ, 2007, BRAIN RES, V1134, P171, DOI 10.1016/j.brainres.2006.11.087; Yan HQ, 2000, BRAIN RES, V887, P134, DOI 10.1016/S0006-8993(00)03002-X; Zhu XL, 2007, BRAIN INJURY, V21, P681, DOI 10.1080/02699050701468941	92	17	18	0	12	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	FEB	2013	30	4					259	270		10.1089/neu.2012.2462			12	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	093CM	WOS:000315169300003	23094804	Green Published			2021-06-18	
J	Alhabdan, S; Zamakhshary, M; AlNaimi, M; Mandora, H; Alhamdan, M; Al-Bedah, K; Al-Enazi, S; Al-Habib, A				Alhabdan, Sultan; Zamakhshary, Mohammed; AlNaimi, Manal; Mandora, Hala; Alhamdan, Manal; Al-Bedah, Khalid; Al-Enazi, Salem; Al-Habib, Amro			Epidemiology of traumatic head injury in children and adolescents in a major trauma center in Saudi Arabia: implications for injury prevention	ANNALS OF SAUDI MEDICINE			English	Article							SEVERITY SCORE; BLUNT TRAUMA; BRAIN-INJURY; CHILDHOOD; IMPACT; MANAGEMENT; PATTERNS; OBESITY	BACKGROUND AND OBJECTIVES: Injury to the head is the most common affected body part in pediatric trauma and could be associated with deleterious consequences. It presents a challenge for developing countries since many injuries are preventable and there are few epidemiological data to support injury prevention programs. The current study aimed to determine demographic characteristics, etiology and outcome of head injury in the pediatric population and compare findings to international figures. DESIGN AND SETINGS: Retrospective review of consecutive cases registered in major trauma center database, Riyadh, from 2001 to 2009. PATIENTS AND METHODS: The database registry was limited to hospitalized patients following injury. Any head injury in a patient <= 18 years was included. RESULTS: Of 3796 patients identified, 1219 patients (32.1%) suffered head injury (mean age 8.6 years; males 78.4%). Children under 12 years comprised 66.3%. Motor vehicle crash (MVC) was the commonest cause (34.2%), followed by pedestrian injury (30.3%) and falls (28.4%). When stratified by age, falls (45.6%) were the most common etiology under 6 years while MVC was the leading cause in high school students (74.4%). The latter group had the lowest mean (SD) Glascow coma scale scores (8.58 [4.7]), highest mean injury severity scale scores (23.4 [21]), highest rate of craniotomy (7%) and highest mortality (20%). CONCLUSION: One third of pediatric trauma requiring hospital admission suffered head injury. Preschoolers and elementary school students were mostly affected. The striking incidence of pedestrian and fall injuries call for organized national prevention programs. Additionally, more attention should be directed to reduce MVC among high school students given their comparative high rate of severe injuries and deaths following trauma.	[Alhabdan, Sultan; Zamakhshary, Mohammed] King Saud bin Abdulaziz Univ Hlth Sci, Riyadh, Saudi Arabia; [AlNaimi, Manal; Mandora, Hala] King Abdul Aziz Med City, Dept Surg, Riyadh, Saudi Arabia; [Alhamdan, Manal; Al-Bedah, Khalid; Al-Enazi, Salem] King Abdullah Int Med Ctr, Riyadh, Saudi Arabia; [Al-Habib, Amro] King Saud Univ, Dept Surg, Riyadh 11472, Saudi Arabia	Al-Habib, A (corresponding author), King Saud Univ, Coll Med, Surg Dept 37, Riyadh 11472, Saudi Arabia.	amro.alhabib@gmail.com	Alhabib, Amro F/F-1778-2018	Zamakhshary, Mohammed/0000-0001-8870-8684			Abantanga FA, 1998, PEDIATR SURG INT, V13, P515, DOI 10.1007/s003830050387; Adesunkanmi ARK, 2000, INJURY, V31, P225, DOI 10.1016/S0020-1383(99)00236-3; [Anonymous], 2007, CENTRAL DEP STAT INF; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; BOULANGER BR, 1992, J TRAUMA, V33, P228, DOI 10.1097/00005373-199208000-00011; Brown CVR, 2006, J PEDIATR SURG, V41, P88, DOI 10.1016/j.jpedsurg.2005.10.012; Brown CVR, 2005, J TRAUMA, V59, P1048, DOI 10.1097/01.ta.0000189047.65630.c5; Brudvik C, 2000, INJURY, V31, P761, DOI 10.1016/S0020-1383(00)00093-0; Central Department for Statistics and Information, 2007, ANN STAT BOOKS; CIASTKO AR, 1983, CAN MED ASSOC J, V129, P532; Crankson SJ, 2006, PEDIATR SURG INT, V22, P641, DOI 10.1007/s00383-006-1715-7; Demetriades D, 2004, J AM COLL SURGEONS, V199, P382, DOI 10.1016/j.jamcollsurg.2004.03.027; Emejulu JKC, 2010, NIGER J CLIN PRACT, V13, P276; Feickert HJ, 1999, J TRAUMA, V47, P33, DOI 10.1097/00005373-199907000-00008; Gofin R, 1999, J TRAUMA, V47, P15, DOI 10.1097/00005373-199907000-00004; Gresham L S, 2001, J Pediatr Nurs, V16, P79, DOI 10.1053/jpdn.2001.23148; IVAN LP, 1983, CAN MED ASSOC J, V128, P281; Lam WH, 1999, PAEDIATR ANAESTH, V9, P377; MacKenzie EJ, 2000, EPIDEMIOL REV, V22, P112, DOI 10.1093/oxfordjournals.epirev.a018006; MAZUREK AJ, 1994, J ACCID EMERG MED, V11, P9; Multiple Indicator Cluster Survey (MICS), STAT MON; Osmond MH, 2002, J TRAUMA, V52, P8, DOI 10.1097/00005373-200201000-00004; Parker S ZB, 2004, DEV BEHAV PEDIAT HDB; Pomerantz WJ, 2010, PEDIATRICS, V125, P681, DOI 10.1542/peds.2009-2367; Reid SR, 2001, ARCH PEDIAT ADOL MED, V155, P784, DOI 10.1001/archpedi.155.7.784; Rickels E, 2010, BRAIN INJURY, V24, P1491, DOI 10.3109/02699052.2010.498006; Rohana J, 1998, Med J Malaysia, V53, P217; Tabish A, 2006, INJURY, V37, P410, DOI 10.1016/j.injury.2006.01.039; Tamimi TM DM, 2003, LANCET, V7	29	17	17	0	3	K FAISAL SPEC HOSP RES CENTRE	RIYADH	PUBLICATIONS OFFICE PO BOX 3354, RIYADH 11211, SAUDI ARABIA	0256-4947	1319-9226		ANN SAUDI MED	Ann. Saudi Med.	JAN-FEB	2013	33	1					52	56		10.5144/0256-4947.2013.52			5	Medicine, General & Internal	General & Internal Medicine	AA3MW	WOS:000330997700012	23458942	DOAJ Gold, Green Published			2021-06-18	
J	Bali, N; Morgan, TE; Finch, CE				Bali, N.; Morgan, T. E.; Finch, C. E.			Pgrmc1: new roles in the microglial mediation of progesterone-antagonism of estradiol-dependent neurite sprouting and in microglial activation	FRONTIERS IN NEUROSCIENCE			English	Article						Prgmc1; microglia; progesterone; sprouting; S2R	MEMBRANE COMPONENT 1; TRAUMATIC BRAIN-INJURY; GENE-EXPRESSION; BINDING PROTEIN; RECEPTORS; RAT; INCREASES; OUTGROWTH; MOUSE; 25-DX	Pgrmc1 (progesterone receptor membrane component 1) is a multifunctional 22 kDa protein with heme-binding and P450-activating capacity which was recognized under different names for roles in cell motility during neural development and in cancer, and apoptosis. Pgrmc1 expression in microglia was recently shown by the present authors to mediate estrogen-progesterone interactions during axonal sprouting and to mediate microglial activation itself. We also discuss other functions of Pgramc1 in the nervous system and its possible relationship to the 18 kDa sigma-2 receptor (S2R).	[Bali, N.; Morgan, T. E.; Finch, C. E.] Univ So Calif, Davis Sch Gerontol, Los Angeles, CA 90089 USA; [Bali, N.; Morgan, T. E.; Finch, C. E.] Univ So Calif, Dornsife Coll Letters Arts & Sci, Los Angeles, CA 90089 USA	Finch, CE (corresponding author), Univ So Calif, Davis Sch Gerontol, 3715 McClintock Ave, Los Angeles, CA 90089 USA.	cefinch@usc.edu			NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [2P01 AG026572-06]; Project 2; Animal Core; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P01AG026572] Funding Source: NIH RePORTER	This work was supported by NIH grant 2P01 AG026572-06 to Roberta D. Brinton; Project 2 to C. E. Finch and T. E. Morgan; Animal Core to T. E. Morgan. We also thank John Peluso, Javier Cuevas, and Arnold E. Ruoho for helpful comments.	Aguzzi A, 2013, SCIENCE, V339, P156, DOI 10.1126/science.1227901; Ahmed IS, 2010, J PHARMACOL EXP THER, V333, P564, DOI 10.1124/jpet.109.164210; Bali N, 2013, ENDOCRINOLOGY, V154, P2468, DOI 10.1210/en.2012-2109; Bashour NM, 2012, ENDOCRINOLOGY, V153, P4457, DOI 10.1210/en.2012-1122; Braak H, 2006, ACTA NEUROPATHOL, V112, P389, DOI 10.1007/s00401-006-0127-z; Brinton RD, 2008, FRONT NEUROENDOCRIN, V29, P313, DOI 10.1016/j.yfrne.2008.02.001; Cahill MA, 2007, J STEROID BIOCHEM, V105, P16, DOI 10.1016/j.jsbmb.2007.02.002; Chen ZH, 2012, J NEUROSCI, V32, P11706, DOI 10.1523/JNEUROSCI.0730-12.2012; Cuevas J, 2011, J PHARMACOL EXP THER, V339, P161, DOI 10.1124/jpet.111.182816; Gatson JW, 2011, ENDOCRINOLOGY, V152, P207, DOI 10.1210/en.2010-0724; Intlekofer KA, 2011, NEUROSCIENCE, V172, P55, DOI 10.1016/j.neuroscience.2010.10.051; Johannessen M, 2011, AM J PHYSIOL-CELL PH, V300, pC328, DOI 10.1152/ajpcell.00383.2010; Kimura I, 2012, CURR PROTEIN PEPT SC, V13, P687, DOI 10.2174/138920312804142110; Krebs CJ, 2000, P NATL ACAD SCI USA, V97, P12816, DOI 10.1073/pnas.97.23.12816; Labombarda F, 2010, NEUROSCIENCE, V166, P94, DOI 10.1016/j.neuroscience.2009.12.012; Liu LF, 2009, ENDOCRINOLOGY, V150, P3186, DOI 10.1210/en.2008-1447; Meffre D, 2005, J NEUROCHEM, V93, P1314, DOI 10.1111/j.1471-4159.2005.03127.x; Meffre D, 2013, NEUROSCIENCE, V231, P111, DOI 10.1016/j.neuroscience.2012.11.039; Mir SUR, 2012, INT J CANCER, V131, pE1, DOI 10.1002/ijc.26432; Peluso JJ, 2010, MOL CELL ENDOCRINOL, V320, P153, DOI 10.1016/j.mce.2010.02.005; Peluso JJ, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00099; Ruoho A. E., 2013, SOC NEUR ABSTR, V631; RUOHO AE, 2013, SOC NEUR ABSTR, V631, P8; Sierra A, 2008, GLIA, V56, P659, DOI 10.1002/glia.20644; Stein DG, 2011, NEUROSCIENCE, V191, P101, DOI 10.1016/j.neuroscience.2011.04.013; Su C, 2012, ENDOCRINOLOGY, V153, P4389, DOI 10.1210/en.2011-2177; Wong AM, 2009, ENDOCRINOLOGY, V150, P324, DOI 10.1210/en.2008-0988; WOOLLEY CS, 1992, J NEUROSCI, V12, P2549; Xu JB, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1386	29	17	18	0	3	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1662-453X			FRONT NEUROSCI-SWITZ	Front. Neurosci.		2013	7								157	10.3389/fnins.2013.00157			5	Neurosciences	Neurosciences & Neurology	AW9HF	WOS:000346567300156	24027494	DOAJ Gold, Green Published			2021-06-18	
J	Barfield, JP; Malone, LA				Barfield, J. P.; Malone, Laurie A.			Perceived exercise benefits and barriers among power wheelchair soccer players	JOURNAL OF REHABILITATION RESEARCH AND DEVELOPMENT			English	Article						disability sport; environmental barriers; multiple sclerosis; physical disability; rehabilitation; social barriers; social cognitive theory; spinal cord injury; therapeutic exercise; traumatic brain injury	SPINAL-CORD-INJURY; QUALITY-OF-LIFE; PHYSICAL-ACTIVITY; DISABILITIES; PARTICIPATION; FACILITATORS; ADULTS; GAMES; BASKETBALL; VETERANS	Lack of exercise is a major risk factor for secondary conditions among persons dependent upon motorized wheelchairs. Power wheelchair soccer is a unique exercise opportunity for this population, and understanding factors that influence exercise decision-making is necessary for clinicians to help those in motorized chairs reduce their secondary risk. Therefore, this study examined differences in perceived benefits and barriers to exercise among power wheelchair soccer players using a mixed-methods analysis. The most common perceived benefit to exercise was "Exercising lets me have contact with friends and persons I enjoy." Post hoc comparisons of quantitative data indicated that persons with muscular dystrophy perceived exercise to be significantly less important than did other disability groups (p < 0.05). "Exercise is hard work for me," "Exercise tires me," and "There are too few places for me to exercise" were the most common perceived barriers. These findings can assist with development of exercise opportunities for power wheelchair users.	[Barfield, J. P.] Tennessee Technol Univ, Dept Exercise Sci Phys Educ & Wellness, Cookeville, TN USA; [Malone, Laurie A.] Lakeshore Fdn, Birmingham, AL USA	Barfield, JP (corresponding author), Endicott Coll, Sch Sport Sci, 376 Hale St, Beverly, MA 01945 USA.	barfield@endicott.edu		Barfield, J.P./0000-0003-1692-9650; Malone, Laurie/0000-0001-9426-6325			Abel T, 2008, SPINAL CORD, V46, P785, DOI 10.1038/sc.2008.54; Anneken V, 2010, SPINAL CORD, V48, P393, DOI 10.1038/sc.2009.137; Barfield JP, 2010, J SPORT SCI, V28, P389, DOI 10.1080/02640410903508839; Barfield JP, 2005, MED SCI SPORT EXER, V37, P718, DOI 10.1249/01.MSS.0000161807.77552.8B; Bodde AE, 2009, DISABIL HEALTH J, V2, P57, DOI 10.1016/j.dhjo.2008.11.004; Brown Debra J, 2005, Policy Polit Nurs Pract, V6, P331, DOI 10.1177/1527154405283380; Buffart LM, 2009, J REHABIL MED, V41, P881, DOI 10.2340/16501977-0420; Cardinal BJ, 2004, MED SCI SPORT EXER, V36, P868, DOI 10.1249/01.MSS.0000126568.63402.22; Croft L, 2010, INT J SPORT PHYSIOL, V5, P301, DOI 10.1123/ijspp.5.3.301; Di Russo F, 2010, J NEUROTRAUM, V27, P2309, DOI 10.1089/neu.2010.1501; Disability and Health-Healthy People 2020, 2012, DIS HLTH HLTH PEOPL; Driver S, 2005, BRAIN INJURY, V19, P1067, DOI 10.1080/02699050500149338; Furmaniuk L, 2010, J REHABIL MED, V42, P688, DOI 10.2340/16501977-0580; FURST DM, 1993, PSYCHOL REP, V72, P403, DOI 10.2466/pr0.1993.72.2.403; Giacobbi PR, 2008, ADAPT PHYS ACT Q, V25, P189, DOI 10.1123/apaq.25.3.189; Gil-Agudo Angel, 2010, Phys Med Rehabil Clin N Am, V21, P141, DOI 10.1016/j.pmr.2009.07.002; Ginis KAM, 2008, SPINAL CORD, V46, P216, DOI 10.1038/sj.sc.3102103; Goosey-Tolfrey V, 2006, BRIT J SPORT MED, V40, P684, DOI 10.1136/bjsm.2006.026815; Johnson CC, 2009, AM J HEALTH PROMOT, V23, P157, DOI 10.4278/ajhp.070930103; Karmarkar AM, 2009, J REHABIL RES DEV, V46, P567, DOI 10.1682/JRRD.2008.08.0102; Kehn M, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-168; Kerstin W, 2006, DISABIL REHABIL, V28, P481, DOI 10.1080/09638280500211932; Kinne S, 1999, DISABIL REHABIL, V21, P15, DOI 10.1080/096382899298052; Kumar A, 2012, J REHABIL RES DEV, V49, P75, DOI 10.1682/JRRD.2010.09.0191; Levins SM, 2004, PHYS THER, V84, P496, DOI 10.1093/ptj/84.6.496; Malone LA, 2012, DISABIL HEALTH J, V5, P254, DOI 10.1016/j.dhjo.2012.05.004; Martin JJ, 2008, ADAPT PHYS ACT Q, V25, P275, DOI 10.1123/apaq.25.4.275; McVeigh SA, 2009, J SPINAL CORD MED, V32, P115, DOI 10.1080/10790268.2009.11760762; MORGULEC N., 2006, RES YB STUDIES PHYS, V12, P195; National Disability Sports Alliance, 2009, PALAESTRA, V24, P17; Odette Fran, 2003, Health Care Women Int, V24, P125, DOI 10.1080/07399330304008; Rimmer J. H., 2007, Morbidity and Mortality Weekly Report, V56, P1021; Rimmer JH, 2010, AM J PHYS MED REHAB, V89, P249, DOI 10.1097/PHM.0b013e3181c9fa9d; Rimmer JH, 2004, AM J PREV MED, V26, P419, DOI 10.1016/j.amepre.2004.02.002; Rimmer JH, 2000, ARCH PHYS MED REHAB, V81, P182; Roy JLP, 2006, J STRENGTH COND RES, V20, P665; Scelza WM, 2005, AM J PHYS MED REHAB, V84, P576, DOI 10.1097/01.phm.0000171172.96290.67; SECHRIST KR, 1987, RES NURS HEALTH, V10, P357, DOI 10.1002/nur.4770100603; Shiba S, 2010, ARCH PHYS MED REHAB, V91, P1262, DOI 10.1016/j.apmr.2010.04.024; Sporner ML, 2009, PROSTHET ORTHOT INT, V33, P210, DOI 10.1080/03093640903051816; Sporner ML, 2009, DISABIL REHABIL, V31, P410, DOI 10.1080/09638280802030923; U.S. Department of Health and Human Services, 2010, HLTH PEOPL 2010 UND; van Langeveld SA, 2011, DISABIL REHABIL, V33, P412, DOI 10.3109/09638288.2010.498548; Vissers M, 2008, J REHABIL MED, V40, P461, DOI 10.2340/16501977-0191; Vlak T, 2009, CROAT MED J, V50, P527, DOI 10.3325/cmj.2009.50.527; Williams Bernadette R, 2006, J Geriatr Phys Ther, V29, P43	46	17	17	0	35	JOURNAL REHAB RES & DEV	BALTIMORE	DEPT OF VETERANS AFFAIRS REHABIL RES & DEVELOP CTR 103 SOUTH GAY STREET, BALTIMORE, MD 21202-4051 USA	0748-7711	1938-1352		J REHABIL RES DEV	J. Rehabil. Res. Dev.		2013	50	2					231	238		10.1682/JRRD.2011.12.0234			8	Rehabilitation	Rehabilitation	149FF	WOS:000319303700012	23761004	Bronze			2021-06-18	
J	Brenkert, TE; Estrada, CM; McMorrow, SP; Abramo, TJ				Brenkert, Timothy E.; Estrada, Cristina M.; McMorrow, Sheila P.; Abramo, Thomas J.			Intravenous Hypertonic Saline Use in the Pediatric Emergency Department	PEDIATRIC EMERGENCY CARE			English	Article						hypertonic saline; 3% saline; traumatic brain injury; TBI; diabetic ketoacidosis	TRAUMATIC BRAIN-INJURY; INTRACRANIAL-PRESSURE; CEREBRAL EDEMA; DIABETIC-KETOACIDOSIS; CHILDREN; HYPERTENSION; MANAGEMENT	Objectives: The objective of this study was to describe the use, dosing, and administration of intravenous hypertonic saline (IHS) use in a pediatric emergency department. Methods: This was a retrospective chart review of patients 0 to 18 years receiving IHS as part of their management in a pediatric ED with an annual volume of more than 50,000 visits. Results: Over 4 years, 56 patients received IHS as part of their management in the emergency department. Clinical scenarios for IHS administration included traumatic brain injury with concern for increased intracranial pressure in 19 patients (34%), diabetic ketoacidosis with altered mental status in 18 (32%), hyponatremia without seizure activity in 6 (10.7%), hyponatremic seizure in 3 (5.4%), and altered mental status secondary to a nontraumatic, non-diabetic ketoacidosis cause in 10 (17.9%). The median age of the patients was 11.3 years (interquartile range, 6-13.9 years) receiving a median dose of 4.1 mL/kg (interquartile range, 3.08-5 mL/kg) of IHS. The median time for administration of the IHS was 17 minutes, with 87% of doses given via peripheral intravenous catheters. Approximately one fourth (26.8%) of patients received their dose in 10 minutes or less, with 7.2% of patients receiving a bolus of IHS in 3 minutes or less. We found no evidence of adverse effects. Conclusions: Intravenous hypertonic saline use is increasing within the pediatric emergency department. Within this institution, it is most frequently used at a dosing range of 3 to 5 mL/kg and does not require central venous access for rapid infusion.	[Brenkert, Timothy E.] Cincinnati Childrens Hosp Med Ctr, Div Emergency Med, Cincinnati, OH 45229 USA; [Estrada, Cristina M.; McMorrow, Sheila P.; Abramo, Thomas J.] Monroe Carell Jr Childrens Hosp Vanderbilt, Dept Pediat, Div Emergency Med, Nashville, TN USA	Brenkert, TE (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Emergency Med, 3333 Burnet Ave,ML 2008, Cincinnati, OH 45229 USA.	timothy.brenkert@cchmc.org		Abramo MD, Thomas/0000-0003-2331-4582			Adelson P David, 2003, Pediatr Crit Care Med, V4, pS40; Banks CJ, 2008, EMERG MED AUSTRALAS, V20, P294, DOI 10.1111/j.1742-6723.2008.01086.x; Bohn D, 2002, CURR OPIN PEDIATR, V14, P287, DOI 10.1097/00008480-200206000-00001; Curtis J R, 2001, Pediatr Diabetes, V2, P191, DOI 10.1034/j.1399-5448.2001.20409.x; Doyle JA, 2001, J TRAUMA, V50, P367, DOI 10.1097/00005373-200102000-00030; Drobin D, 2002, ANESTHESIOLOGY, V96, P1371, DOI 10.1097/00000542-200206000-00016; Dunger DB, 2004, ARCH DIS CHILD, V89, P188, DOI 10.1136/adc.2003.044875; FISHER B, 1992, J NEUROSURG ANESTH, V4, P4, DOI 10.1097/00008506-199201000-00002; Forsyth LL, 2008, PHARMACOTHERAPY, V28, P469, DOI 10.1592/phco.28.4.469; Francony G, 2008, CRIT CARE MED, V36, P795, DOI 10.1097/CCM.0B013E3181643B41; Hinson HE, 2011, J INTENSIVE CARE MED, P1; HUANG PP, 1995, ANN SURG, V221, P543, DOI 10.1097/00000658-199505000-00012; Kamat Pradip, 2003, Pediatr Crit Care Med, V4, P239, DOI 10.1097/01.PCC.0000059340.19010.CE; Khanna S, 2000, CRIT CARE MED, V28, P1144, DOI 10.1097/00003246-200004000-00038; Peterson B, 2000, CRIT CARE MED, V28, P1136, DOI 10.1097/00003246-200004000-00037; REED RL, 1991, J TRAUMA, V31, P8, DOI 10.1097/00005373-199101000-00002; SARNAIK AP, 1991, CRIT CARE MED, V19, P758, DOI 10.1097/00003246-199106000-00005; Schimetta W, 2002, WIEN KLIN WOCHENSCHR, V114, P89; Yildizdas D, 2006, INDIAN PEDIATR, V43, P771; Zeng HK, 2010, NEUROSCIENCE, V166, P878, DOI 10.1016/j.neuroscience.2009.12.076	20	17	18	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0749-5161			PEDIATR EMERG CARE	Pediatr. Emerg. Care	JAN	2013	29	1					71	73		10.1097/PEC.0b013e31827b54c3			3	Emergency Medicine; Pediatrics	Emergency Medicine; Pediatrics	064FY	WOS:000313059600016	23283268				2021-06-18	
J	Chen, CY; Noble-Haeusslein, LJ; Ferriero, D; Semple, BD				Chen, Chien-Yi; Noble-Haeusslein, Linda J.; Ferriero, Donna; Semple, Bridgette D.			Traumatic Injury to the Immature Frontal Lobe: A New Murine Model of Long-Term Motor Impairment in the Absence of Psychosocial or Cognitive Deficits	DEVELOPMENTAL NEUROSCIENCE			English	Article						Traumatic brain injury; Frontal lobe; Behavior; Pathology; Development; Motor deficit	BRAIN-INJURY; SOCIAL-BEHAVIOR; CHILDREN; GAIT; RECOVERY; ANXIETY; LESIONS; SENSORIMOTOR; MAZE; RATS	Traumatic brain injury in children commonly involves the frontal lobes and is associated with distinct structural and behavioral changes. Despite the clinical significance of injuries localized to this region during brain development, the mechanisms underlying secondary damage and long-term recovery are poorly understood. Here, we have characterized the first model of unilateral focal traumatic injury to the developing frontal lobe. Male C57BI/6J mice at postnatal day (p)21, an age approximating a toddler-aged child, received a controlled cortical impact or sham surgery to the left frontal lobe and were euthanized 1 or 7 days later. A necrotic cavity and local inflammatory response were largely confined to the unilateral frontal lobe, dorsal corpus callosum and striatum anterior to the bregma. While cell death and accumulated B-amyloid precursor protein were characteristic features of the pericontusional motor cortex, corpus callosum, cingulum and dorsal striatum, underlying structures including the hippocampus showed no overt pathology. To determine the long-term functional consequences of injury at p21, two additional cohorts were subjected to a battery of behavioral tests in adolescence (p35-45) or adulthood (p70-80). In both cohorts, brain-injured mice showed normal levels of anxiety, sociability, spatial learning and memory. The signature phenotypic features were deficits in motor function and motor learning, coincident with a reduction in ipsilateral cortical brain volumes. Together, these findings demonstrate classic morphological features of a focal traumatic injury, including early cell death and axonal injury, and long-term volumetric loss of cortical volumes. The presence of deficits in sensorimotor function and coordination in the absence of abnormal findings related to anxiety, sociability and memory likely reflects several variables, including the unique location of the injury and the emergence of favorable compensatory mechanisms during subsequent brain development. (C) 2013 S. Karger AG, Basel	[Chen, Chien-Yi; Noble-Haeusslein, Linda J.; Semple, Bridgette D.] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA; [Noble-Haeusslein, Linda J.] Univ Calif San Francisco, Dept Phys Therapy & Rehabil Sci, San Francisco, CA 94143 USA; [Ferriero, Donna] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA; [Ferriero, Donna] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Noble-Haeusslein, Linda J.] Natl Taiwan Univ Hosp, Taipei, Taiwan; [Chen, Chien-Yi] Natl Taiwan Univ, Coll Med, Taipei 10764, Taiwan; [Chen, Chien-Yi] Grad Inst Clin Med, Taipei, Taiwan; [Semple, Bridgette D.] Univ Melbourne, Dept Med, Royal Melbourne Hosp, Melbourne Brain Ctr, Melbourne, Vic, Australia	Semple, BD (corresponding author), Univ Calif San Francisco, Dept Neurol Surg, 513 Parnassus Ave,Room HSE-722, San Francisco, CA 94143 USA.	Bridgette.Semple@ucsf.edu	Chen, Chien-Yi/A-9680-2015	Chen, Chien-Yi/0000-0002-6030-2655	National Institutes of Health/National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS050159, NS077767]; American Australian Association; National Health and Medical Research Council of AustraliaNational Health and Medical Research Council of AustraliaUK Research & Innovation (UKRI)Medical Research Council UK (MRC); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS077767, R01NS050159] Funding Source: NIH RePORTER	Funding was provided by National Institutes of Health/National Institute of Neurological Disorders and Stroke grants R01 NS050159 and NS077767 (L.J.N.-H.), a Sir Keith Murdoch Postdoctoral Fellowship from the American Australian Association (B.D.S.) and a CJ Martin Overseas Biomedical Postdoctoral Fellowship from the National Health and Medical Research Council of Australia (B.D.S.).	Adelson PD, 2013, CHILD NERV SYST, V29, P43, DOI 10.1007/s00381-012-1932-4; Adelson PD, 1997, J NEUROTRAUM, V14, P99, DOI 10.1089/neu.1997.14.99; Adelson PD, 2000, J NEUROTRAUM, V17, P273, DOI 10.1089/neu.2000.17.273; Ajao DO, 2012, J NEUROTRAUM, V29, P2060, DOI 10.1089/neu.2011.1883; Anderson V, 2005, J INT NEUROPSYCH SOC, V11, P817, DOI 10.1017/S1355617705051052; Anderson V, 2012, INT J DEV NEUROSCI, V30, P217, DOI 10.1016/j.ijdevneu.2011.09.008; Basford JR, 2003, ARCH PHYS MED REHAB, V84, P343, DOI 10.1053/apmr.2003.50034; Bravo TP, 2008, BRAIN RES, V1205, P100, DOI 10.1016/j.brainres.2008.01.102; Cestari V, 2007, CAN J EXP PSYCHOL, V61, P13, DOI 10.1037/cjep2007002; Claus CP, 2010, DEV NEUROSCI-BASEL, V32, P454, DOI 10.1159/000316805; Depino AM, 2007, BEHAV BRAIN RES, V177, P254, DOI 10.1016/j.bbr.2006.11.025; Duvoisin RM, 2011, BEHAV BRAIN RES, V221, P50, DOI 10.1016/j.bbr.2011.02.049; Eslinger PJ, 2000, DEV NEUROPSYCHOL, V18, P297, DOI 10.1207/S1532694203Eslinger; File SE, 2001, BEHAV BRAIN RES, V125, P151, DOI 10.1016/S0166-4328(01)00292-3; Gerlai R, 2001, BEHAV BRAIN RES, V125, P269, DOI 10.1016/S0166-4328(01)00296-0; Goldman P S, 1974, Neurosci Res Program Bull, V12, P217; Hoane MR, 2004, BEHAV BRAIN RES, V153, P189, DOI 10.1016/j.bbr.2003.11.012; Hu PP, 2013, NEUROSCI LETT, V534, P177, DOI 10.1016/j.neulet.2012.12.038; Jacobs R, 2007, CORTEX, V43, P792, DOI 10.1016/S0010-9452(08)70507-0; Jadhav V, 2007, J NEUROSURG, V106, P680, DOI 10.3171/jns.2007.106.4.680; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Karver CL, 2012, REHABIL PSYCHOL, V57, P256, DOI 10.1037/a0029522; Katz-Leurer M, 2008, BRAIN INJURY, V22, P153, DOI 10.1080/02699050801895399; Kilbourne M, 2009, J NEUROTRAUM, V26, P2233, DOI 10.1089/neu.2009.0968; Kolb B, 2000, DEV NEUROPSYCHOL, V18, P423, DOI 10.1207/S1532694208Kolb; KOLB B, 1985, BEHAV NEUROSCI, V99, P691, DOI 10.1037/0735-7044.99.4.691; KOLB B, 1987, BEHAV BRAIN RES, V26, P119, DOI 10.1016/0166-4328(87)90161-6; Kuhtz-Buschbeck JP, 2003, ARCH PHYS MED REHAB, V84, P424, DOI 10.1053/apmr.2003.50017; Kuhtz-Buschbeck JP, 2003, DEV MED CHILD NEUROL, V45, P821, DOI 10.1017/S001216220300152X; Lalonde R, 2008, J NEUROSCI METH, V171, P48, DOI 10.1016/j.jneumeth.2008.02.003; Langlois JA, 2000, TRAUMATIC BRAIN INJU; Laviola G, 2003, NEUROSCI BIOBEHAV R, V27, P19, DOI 10.1016/S0149-7634(03)00006-X; Lemon RN, 2005, MUSCLE NERVE, V32, P261, DOI 10.1002/mus.20333; Levin HS, 2005, PEDIATR NEUROL, V33, P79, DOI 10.1016/j.pediatrneurol.2005.02.002; Levin HS, 2004, J INT NEUROPSYCH SOC, V10, P305, DOI 10.1017/S1355617704102129; Lindner MD, 1998, J NEUROTRAUM, V15, P199, DOI 10.1089/neu.1998.15.199; Martens KM, 2012, J NEUROTRAUM, V29, P2505, DOI 10.1089/neu.2012.2388; Moy SS, 2004, GENES BRAIN BEHAV, V3, P287, DOI 10.1111/j.1601-1848.2004.00076.x; Oni MB, 2010, J CHILD NEUROL, V25, P976, DOI 10.1177/0883073809356034; Potts Mathew B, 2006, NeuroRx, V3, P143; Prins ML, 1998, J NEUROTRAUM, V15, P799, DOI 10.1089/neu.1998.15.799; Pullela R, 2006, DEV NEUROSCI-BASEL, V28, P396, DOI 10.1159/000094166; Rudebeck PH, 2006, SCIENCE, V313, P1310, DOI 10.1126/science.1128197; Rudebeck PH, 2007, EUR J NEUROSCI, V26, P2315, DOI 10.1111/j.1460-9568.2007.05844.x; Ryan BC, 2008, BEHAV BRAIN RES, V193, P235, DOI 10.1016/j.bbr.2008.06.002; Salchner P, 2004, BEHAV BRAIN RES, V151, P1, DOI 10.1016/j.bbr.2003.07.002; Semple BD, 2013, PROG NEUROBIOL, V106, P1, DOI 10.1016/j.pneurobio.2013.04.001; Semple BD, 2012, J NEUROTRAUM, V29, P2672, DOI 10.1089/neu.2012.2595; Spear L, 2000, ALCOHOL RES HEALTH, V24, P115; Spencer CM, 2005, GENES BRAIN BEHAV, V4, P420, DOI 10.1111/j.1601-183X.2005.00123.x; Spencer-Smith M, 2009, DEV NEUROREHABIL, V12, P279, DOI 10.3109/17518420903090701; Spreng M, 2002, BEHAV BRAIN RES, V128, P103, DOI 10.1016/S0166-4328(01)00266-2; Tong W, 2002, EXP NEUROL, V176, P105, DOI 10.1006/exnr.2002.7941; Tsuru-Aoyagi K, 2009, ANN NEUROL, V65, P540, DOI 10.1002/ana.21600; Walker WC, 2007, J REHABIL RES DEV, V44, P975, DOI 10.1682/JRRD.2006.12.0158; Wilde EA, 2005, J NEUROTRAUM, V22, P333, DOI 10.1089/neu.2005.22.333; Wilde EA, 2012, BRAIN IMAGING BEHAV, V6, P404, DOI 10.1007/s11682-012-9150-y; Wilde EA, 2012, INT J DEV NEUROSCI, V30, P267, DOI 10.1016/j.ijdevneu.2012.01.003; Williams G, 2010, J HEAD TRAUMA REHAB, V25, P366, DOI 10.1097/HTR.0b013e3181cd3600; Yang Mu, 2011, Curr Protoc Neurosci, VChapter 8, DOI 10.1002/0471142301.ns0826s56; Yang Mu, 2009, Curr Protoc Neurosci, VChapter 8, DOI 10.1002/0471142301.ns0824s48; Yoneyama-Sarnecky T, 2010, DEV NEUROSCI-BASEL, V32, P81, DOI 10.1159/000258700	62	17	18	0	17	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	0378-5866	1421-9859		DEV NEUROSCI-BASEL	Dev. Neurosci.		2013	35	6					474	490		10.1159/000355874			17	Developmental Biology; Neurosciences	Developmental Biology; Neurosciences & Neurology	268PW	WOS:000328184000004	24247103	Green Accepted, Bronze			2021-06-18	
J	Dukes, SF; Bridges, E; Johantgen, M				Dukes, Susan F.; Bridges, Elizabeth; Johantgen, Meg			Occurrence of Secondary Insults of Traumatic Brain Injury in Patients Transported by Critical Care Air Transport Teams From Iraq/Afghanistan: 2003-2006	MILITARY MEDICINE			English	Article							INTRACRANIAL-PRESSURE; IRAQI FREEDOM; HYPERGLYCEMIA; TEMPERATURE; HYPOTHERMIA; MORTALITY; IMPACT; HYPERTHERMIA; HYPOTENSION; HYPOXIA	Traumatic brain injury patients are susceptible to secondary insults to the injured brain. A retrospective cohort study was conducted to describe the occurrence of secondary insults in 63 combat casualties with severe isolated traumatic brain injury who were transported by the U.S. Air Force Critical Care Air Transport Teams (CCATT) from 2003 through 2006. Data were obtained from the Wartime Critical Care Air Transport Database, which describes the patient's physiological state and care as they are transported across the continuum of care from the area of responsibility (Iraq/Afghanistan) to Germany and the United States. Fifty-three percent of the patients had at least one documented episode of a secondary insult. Hyperthermia was the most common secondary insult and was associated with severity of injury. The hyperthermia rate increased across the continuum, which has implications for en route targeted temperature management. Hypoxia occurred most frequently within the area of responsibility, but was rare during CCATT flights, suggesting that concerns for altitude-induced hypoxia may not be a major factor in the decision when to move a patient. Similar research is needed for polytrauma casualties and analysis of the association between physiological status and care across the continuum and long-term outcomes.	[Dukes, Susan F.] US Air Force, Sch Aerosp Med, Wright Patterson AFB, OH 45433 USA; [Bridges, Elizabeth] Univ Washington, Seattle, WA 98195 USA; [Johantgen, Meg] Univ Maryland, Sch Nursing, Baltimore, MD 21201 USA	Dukes, SF (corresponding author), US Air Force, Sch Aerosp Med, 2510 5th St, Wright Patterson AFB, OH 45433 USA.						Armonda RA, 2006, NEUROSURGERY, V59, P1215, DOI 10.1227/01.NEU.0000249190.46033.94; Badjatia N, 2009, CRIT CARE MED, V37, pS250, DOI 10.1097/CCM.0b013e3181aa5e8d; Bell RS, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2010.2.FOCUS1025; Bell RS, 2009, J TRAUMA, V66, pS104, DOI 10.1097/TA.0b013e31819d88c8; Beninati W, 2008, CRIT CARE MED, V36, pS370, DOI 10.1097/CCM.0b013e31817e3143; Bridges E, 2009, MIL MED, V174, P370, DOI 10.7205/MILMED-D-03-9607; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Chi JH, 2006, J TRAUMA, V61, P1134, DOI 10.1097/01.ta.0000196644.64653.d8; Choi HA, 2012, NAT REV NEUROL, V8, P214, DOI 10.1038/nrneurol.2012.21; Clifton GL, 2011, LANCET NEUROL, V10, P131, DOI 10.1016/S1474-4422(10)70300-8; Diringer MN, 2004, CRIT CARE MED, V32, P1489, DOI 10.1097/01.CCM.0000129484.61912.84; Duckworth JL, 2012, PATHOPHYSIO IN PRESS; Elf K, 2008, NEUROL RES, V30, P1097, DOI 10.1179/174313208X319125; Fang R, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2010.2.FOCUS1043; Fox JL, 2010, CAN J EMERG MED, V12, P355; Franschman G, 2011, J TRAUMA, V71, P826, DOI 10.1097/TA.0b013e31820cebf0; Galarneau MR, 2008, J NEUROSURG, V108, P950, DOI 10.3171/JNS/2008/108/5/0950; Goodman MD, 2011, J SURG RES, V165, P30, DOI 10.1016/j.jss.2010.05.055; Goodman MD, 2010, J SURG RES, V164, P286, DOI 10.1016/j.jss.2009.07.040; Jeremitsky E, 2005, J TRAUMA, V58, P47, DOI 10.1097/01.TA.0000135158.42242.B1; Kim YJ, 2011, J CLIN NURS, V20, P1518, DOI 10.1111/j.1365-2702.2010.03618.x; Liu-DeRyke X, 2009, NEUROCRIT CARE, V11, P151, DOI 10.1007/s12028-009-9228-6; Mason PE, 2011, J EMERG MED, V41, P8, DOI 10.1016/j.jemermed.2008.06.032; McHugh GS, 2007, J NEUROTRAUM, V24, P287, DOI 10.1089/neu.2006.0031; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Prisco L, 2012, J NEUROSURG SCI, V56, P131; Puccio AM, 2009, NEUROCRIT CARE, V11, P82, DOI 10.1007/s12028-009-9213-0; Richardson MW, 2007, J TRAUMA, V62, pS64, DOI 10.1097/TA.0b013e318065adf3; Rossi S, 2001, J NEUROL NEUROSUR PS, V71, P448, DOI 10.1136/jnnp.71.4.448; Sadaka F, 2012, BRAIN INJURY, V26, P899, DOI 10.3109/02699052.2012.661120; Salim A, 2009, AM SURGEON, V75, P25; Shafi S, 2005, J TRAUMA, V59, P830, DOI 10.1097/01.ta.0000188147.36232.c0; Shafi S, 2005, J TRAUMA, V59, P1081, DOI 10.1097/01.ta.0000188647.03665.fd; Soukup J, 2002, J NEUROTRAUM, V19, P559, DOI 10.1089/089771502753754046; Stahel PF, 2008, INTENS CARE MED, V34, P402, DOI 10.1007/s00134-007-0889-3; Stocchetti N, 2002, INTENS CARE MED, V28, P1555, DOI 10.1007/s00134-002-1513-1; Thompson HJ, 2003, NEUROBIOL DIS, V12, P163, DOI 10.1016/S0969-9961(02)00030-X; Vespa P, 2012, CRIT CARE MED, V40, P1923, DOI 10.1097/CCM.0b013e31824e0fcc; Wang HE, 2005, CRIT CARE MED, V33, P1296, DOI 10.1097/01.CCM.0000165965.31895.80; Whitcomb BW, 2005, CRIT CARE MED, V33, P2772, DOI 10.1097/01.CCM.0000189741.44071.25	40	17	17	0	3	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	JAN	2013	178	1					11	17		10.7205/MILMED-D-12-00177			7	Medicine, General & Internal	General & Internal Medicine	AN7TV	WOS:000340804800007	23356112	Bronze			2021-06-18	
J	Galloway, RV; Granger, CV; Karmarkar, AM; Graham, JE; Deutsch, A; Niewczyk, P; DiVita, MA; Ottenbacher, KJ				Galloway, Rebecca V.; Granger, Carl V.; Karmarkar, Amol M.; Graham, James E.; Deutsch, Anne; Niewczyk, Paulette; DiVita, Margaret A.; Ottenbacher, Kenneth J.			The Uniform Data System for Medical Rehabilitation Report of Patients with Debility Discharged from Inpatient Rehabilitation Programs in 2000-2010	AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION			English	Article						Rehabilitation Outcome; Activities of Daily Living; Benchmarking; Muscle Weakness	FUNCTIONAL INDEPENDENCE MEASURE; TRAUMATIC BRAIN-INJURY; SPINAL-CORD-INJURY; OLDER-ADULTS; ASSESSMENT SCALES; HIP FRACTURE; OUTCOMES; RELIABILITY; PAYMENT; STROKE	Galloway RV, Granger CV, Karmarkar AM, Graham JE, Deutsch A, Niewczyk P, DiVita MA, Ottenbacher KJ: The Uniform Data System for Medical Rehabilitation: Report of patients with debility discharged from inpatient rehabilitation programs in 2000-2010. Am J Phys Med Rehabil 2013;92:14-27. Objective: Benchmark data are provided for a national sample of patients who received inpatient rehabilitation for debility. Design: Patients with debility from 830 inpatient rehabilitation facilities in the United States contributing to the Uniform Data System for Medical Rehabilitation from 2000 to 2010 were examined. Demographic information (age, marital status, sex, race/ethnicity, prehospital living setting, and discharge setting), hospital information (length of stay, program interruptions, payer, and codes for admitting diagnosis), and functional status (Functional Independence Measure [FIM] instrument ratings at admission and discharge, FIM change, and FIM efficiency) were analyzed. Results: Data from 2000 to 2010 (N = 260,373) revealed a decrease in mean (SD) FIM total admission ratings from 73.9 (16.2) to 62.5 (15.8). The FIM total discharge ratings decreased from 95.0 (19.7) to 88.2 (19.8). Mean (SD) length of stay decreased from 14.3 (9.1) to 12.1 (6.2) days. The FIM efficiency (change/day) increased from 1.9 (1.7) to 2.4 (1.9). Discharge to community decreased from 80% to 75%. Acute care discharges accounted for 12% of the cases. Policy changes affecting classification, reimbursement, and/or documentation processes may have influenced the results. Conclusions: National data indicate that the number of debility cases is increasing with diverse composition of etiologic diagnoses. A high proportion of these patients is discharged to acute care compared with other impairment groups.	[Karmarkar, Amol M.; Graham, James E.; Ottenbacher, Kenneth J.] Univ Texas Med Branch, Div Rehabil Sci, Galveston, TX 77555 USA; [Galloway, Rebecca V.] Univ Texas Med Branch, Dept Phys Therapy, Galveston, TX 77555 USA; [Granger, Carl V.; Niewczyk, Paulette; DiVita, Margaret A.] UB Fdn Act Inc, Uniform Data Syst Med Rehabil, Buffalo, NY USA; [Deutsch, Anne] Northwestern Univ, Rehabil Inst Chicago, Feinberg Sch Med, Chicago, IL 60611 USA; [Deutsch, Anne] Northwestern Univ, Dept Phys Med & Rehabil, Feinberg Sch Med, Chicago, IL 60611 USA; [Deutsch, Anne] Northwestern Univ, Inst Healthcare Studies, Feinberg Sch Med, Chicago, IL 60611 USA	Ottenbacher, KJ (corresponding author), Univ Texas Med Branch, Div Rehabil Sci, 301 Univ Blvd, Galveston, TX 77555 USA.		Karmarkar, Amol/E-6030-2011	Karmarkar, Amol/0000-0001-8355-1585; Galloway, Rebecca/0000-0002-8013-7781; DiVita, Margaret/0000-0002-4878-2959; Ottenbacher, Kenneth/0000-0001-5990-3982	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R24 HD065702]; National Institute on Disability and Rehabilitation Research [H133G080163]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R24HD065702] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P30AG024832] Funding Source: NIH RePORTER	Supported, in part, by grants from the National Institutes of Health (R24 HD065702) and the National Institute on Disability and Rehabilitation Research (H133G080163).	[Anonymous], 2010, INT CLASS DIS 9 REV; Carter GM, 2003, HEALTH CARE FINANC R, V24, P25; CARTER GM, 2002, EXECUTIVE SUMMARY AN; Corrigan JD, 1997, ARCH PHYS MED REHAB, V78, P828, DOI 10.1016/S0003-9993(97)90195-7; Deutsch A, 2002, AM J PHYS MED REHAB, V81, P133, DOI 10.1097/00002060-200202000-00010; Deutsch A, 2008, ARCH PHYS MED REHAB, V89, P2274, DOI 10.1016/j.apmr.2008.06.014; DISLER PB, 1993, ARCH PHYS MED REHAB, V74, P139; DODDS TA, 1993, ARCH PHYS MED REHAB, V74, P531, DOI 10.1016/0003-9993(93)90119-U; Federal Register, 2005, FED REG, V70, P47880; Granger CV, 2007, AM J PHYS MED REHAB, V86, P883, DOI 10.1097/PHM.0b013e318152058a; Granger CV, 2012, AM J PHYS MED REHAB, V91, P289, DOI 10.1097/PHM.0b013e31824ad2fd; Granger CV, 2011, AM J PHYS MED REHAB, V90, P177, DOI 10.1097/PHM.0b013e31820b18d7; Granger CV, 2010, AM J PHYS MED REHAB, V89, P781, DOI 10.1097/PHM.0b013e3181f1c83a; Granger CV, 2010, AM J PHYS MED REHAB, V89, P265, DOI 10.1097/PHM.0b013e3181d3eb20; Granger CV, 2009, AM J PHYS MED REHAB, V88, P961, DOI [10.1097/PHM.0b013e3181c1ec38, 10.1097/PHM.0b013e3181clec38]; GRANGER CV, 1993, ARCH PHYS MED REHAB, V74, P133; GRANGER CV, 1990, ARCH PHYS MED REHAB, V71, P870; Granger CV, 1998, ARCH PHYS MED REHAB, V79, P235, DOI 10.1016/S0003-9993(98)90000-4; Haley R, 2011, AM J PHYS MED REHAB, V90, P791, DOI 10.1097/PHM.0b013e31822deaf4; Hamilton BB, 1999, ARCH PHYS MED REHAB, V80, P385, DOI 10.1016/S0003-9993(99)90274-5; Kortebein P, 2008, AM J PHYS MED REHAB, V87, P118, DOI 10.1097/PHM.0b013e3181588429; Kortebein P, 2009, ARCH PHYS MED REHAB, V90, P934, DOI 10.1016/j.apmr.2008.12.010; Medicare Payment Advisory Commission, 2012, REPORT C MED PAYM PO; Ottenbacher KJ, 1996, ARCH PHYS MED REHAB, V77, P1226, DOI 10.1016/S0003-9993(96)90184-7; Stineman MG, 1996, ARCH PHYS MED REHAB, V77, P1101, DOI 10.1016/S0003-9993(96)90130-6; UB Foundation Activities, 2002, INP REH FAC PAT ASS; UB Foundation Activities, 2004, INP REH FAC PAT ASS; 2003, FED REG, V68, P45674	28	17	17	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0894-9115			AM J PHYS MED REHAB	Am. J. Phys. Med. Rehabil.	JAN	2013	92	1					14	27		10.1097/PHM.0b013e31827441bc			14	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	057DO	WOS:000312542500002	23117268	Green Accepted			2021-06-18	
J	Itoh, T; Imano, M; Nishida, S; Tsubaki, M; Mizuguchi, N; Hashimoto, S; Ito, A; Satou, T				Itoh, Tatsuki; Imano, Motohiro; Nishida, Shozo; Tsubaki, Masahiro; Mizuguchi, Nobuyuki; Hashimoto, Shigeo; Ito, Akihiko; Satou, Takao			Increased apoptotic neuronal cell death and cognitive impairment at early phase after traumatic brain injury in aged rats	BRAIN STRUCTURE & FUNCTION			English	Article						Cell death; Traumatic brain injury; Cerebral dysfunction; Apoptosis; Oxidative stress	CENTRAL-NERVOUS-SYSTEM; MITOCHONDRIAL DYSFUNCTION; CEREBRAL-CORTEX; OXYGEN RADICALS; HEAD-INJURY; ISCHEMIA; HIPPOCAMPUS; ACTIVATION; PROTECTS; DAMAGE	Progressive age-associated increases in cerebral dysfunction have been shown to occur following traumatic brain injury (TBI). Moreover, levels of neuronal mitochondrial antioxidant enzymes in the aged brain are reduced, resulting in free radical-induced cell death. It was hypothesized that cognitive impairment after TBI in the aged progresses to a greater degree than in younger individuals, and that damage involves neuronal degeneration and death by free radicals. In this study, we investigated the effects of free radicals on neuronal degeneration, cell death, and cognitive impairment in 10-week-old (young group) and 24-month-old rats (aged group) subjected to TBI. Young and aged rats received TBI with a pneumatic controlled injury device. At 1, 3 and 7 days after TBI, immunohistochemistry, lipid peroxidation and behavioral studies were performed. At 1, 3 and 7 days post-TBI, the number of 8-hydroxy-2'-deoxyguanosine-, 4-hydroxy-2-nonenal- and single-stranded DNA (ssDNA)-positive cells, and the levels of malondialdehyde around the damaged area after TBI significantly increased in the aged group when compared with the young group (P < 0.05). In addition, the majority of ssDNA-positive cells in both groups co-localized with neuronal cells around the damaged area. There was a significant decrease in the number of surviving neurons and an increase in cognitive impairment after TBI in the aged group when compared with the young group (P < 0.05). These results indicate that following TBI, high levels of free radicals are produced in the aged rat brain, which induces neuronal degeneration and apoptotic cell death around the damaged area, resulting in cognitive impairment.	[Itoh, Tatsuki; Ito, Akihiko; Satou, Takao] Kinki Univ, Dept Pathol, Fac Med, Osaka 5898511, Japan; [Imano, Motohiro] Kinki Univ, Dept Surg, Fac Med, Osaka 5898511, Japan; [Nishida, Shozo; Tsubaki, Masahiro] Kinki Univ, Fac Pharmaceut Sci, Higashiosaka, Osaka 577, Japan; [Mizuguchi, Nobuyuki] Kinki Univ, Life Sci Res Inst, Osaka 5898511, Japan; [Hashimoto, Shigeo] PL Hosp, Dept Pathol, Osaka, Japan; [Satou, Takao] Kinki Univ Hosp, Fac Med, Div Hosp Pathol, Osaka, Japan	Itoh, T (corresponding author), Kinki Univ, Dept Pathol, Fac Med, 377-2 Ohno Higashi, Osaka 5898511, Japan.	tatsuki@med.kindai.ac.jp			Grants-in-Aid for Scientific ResearchMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI) [23500629, 24501009, 21500803] Funding Source: KAKEN		Ates O, 2007, MOL CELL BIOCHEM, V294, P137, DOI 10.1007/s11010-006-9253-0; Azbill RD, 1997, BRAIN RES, V765, P283, DOI 10.1016/S0006-8993(97)00573-8; Buga AM, 2008, ROM J MORPHOL EMBRYO, V49, P279; CHAN PH, 1985, PROG BRAIN RES, V63, P227; Clausen F, 2004, J NEUROTRAUM, V21, P1168, DOI 10.1089/neu.2004.21.1168; DAS S, 2008, CURR AGING SCI, P1; Dorszewska J, 2004, RESP PHYSIOL NEUROBI, V139, P145, DOI 10.1016/j.resp.2003.10.009; Gilmer LK, 2010, MECH AGEING DEV, V131, P133, DOI 10.1016/j.mad.2009.12.011; HALL ED, 1989, FREE RADICAL BIO MED, V6, P303, DOI 10.1016/0891-5849(89)90057-9; HAMM RJ, 1991, J NEUROSURG, V75, P916, DOI 10.3171/jns.1991.75.6.0916; Hata R, 1999, METAB BRAIN DIS, V14, P117, DOI 10.1023/A:1020709814456; HOCKENBERY D, 1990, NATURE, V348, P334, DOI 10.1038/348334a0; Irving EA, 2002, J CEREBR BLOOD F MET, V22, P631, DOI 10.1097/00004647-200206000-00001; Itoh T, 2005, NEUROREPORT, V16, P1687, DOI 10.1097/01.wnr.0000183330.44112.ab; Itoh T, 2007, NEUROL RES, V29, P734, DOI 10.1179/016164107X208086; Itoh T, 2011, J NEURAL TRANSM, V118, P1263, DOI 10.1007/s00702-011-0629-2; Itoh T, 2010, NEUROCHEM RES, V35, P348, DOI 10.1007/s11064-009-0061-2; Itoh T, 2009, NEUROL RES, V31, P103, DOI 10.1179/016164108X323771; Itoh T, 2009, MOL CELL BIOCHEM, V324, P191, DOI 10.1007/s11010-008-0013-1; Jin Y, 2008, ACTA PHARMACOL SIN, V29, P1399, DOI 10.1111/j.1745-7254.2008.00848.x; KAWAMATA T, 1995, BRAIN RES, V674, P196, DOI 10.1016/0006-8993(94)01444-M; KONTOS HA, 1985, CIRC RES, V57, P508, DOI 10.1161/01.RES.57.4.508; Lee EJ, 2005, J PINEAL RES, V38, P42, DOI 10.1111/j.1600-079X.2004.00173.x; LUERSSEN TG, 1988, J NEUROSURG, V68, P409, DOI 10.3171/jns.1988.68.3.0409; Lynch AM, 2002, EUR J NEUROSCI, V15, P1779, DOI 10.1046/j.1460-9568.2002.02012.x; Martinez-Lara E, 2005, BRAIN RES, V1054, P88, DOI 10.1016/j.brainres.2005.06.060; MARTINOU JC, 1994, NEURON, V13, P1017, DOI 10.1016/0896-6273(94)90266-6; Ochoa JJ, 2011, FREE RADICAL BIO MED, V50, P1053, DOI 10.1016/j.freeradbiomed.2011.02.004; PENTLAND B, 1986, AGE AGEING, V15, P193, DOI 10.1093/ageing/15.4.193; Sauerbeck A, 2011, EXP NEUROL, V227, P128, DOI 10.1016/j.expneurol.2010.10.003; Shultz SR, 2012, J NEUROTRAUM, V29, P281, DOI 10.1089/neu.2011.2123; Smith DR, 2001, NEUROBIOL AGING, V22, P773, DOI 10.1016/S0197-4580(01)00240-8; Sugawara T, 2002, J NEUROSCI, V22, P209, DOI 10.1523/JNEUROSCI.22-01-00209.2002; Tsuji M, 2000, NEUROSCI LETT, V282, P41, DOI 10.1016/S0304-3940(00)00844-2; Wasserman JK, 2008, EXP NEUROL, V214, P266, DOI 10.1016/j.expneurol.2008.08.010; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Wilson J A, 1987, Brain Inj, V1, P183, DOI 10.3109/02699058709034456; Xiong Y, 1997, J NEUROTRAUM, V14, P23, DOI 10.1089/neu.1997.14.23; Xiong Y, 2008, BRAIN RES, V1230, P247, DOI 10.1016/j.brainres.2008.06.127; Xu K, 2008, ADV EXP MED BIOL, V614, P379, DOI 10.1007/978-0-387-74911-2_42	40	17	19	0	6	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1863-2653			BRAIN STRUCT FUNCT	Brain Struct. Funct.	JAN	2013	218	1					209	220		10.1007/s00429-012-0394-5			12	Anatomy & Morphology; Neurosciences	Anatomy & Morphology; Neurosciences & Neurology	063SB	WOS:000313019200016	22374222				2021-06-18	
J	Larson, EB; Kondiles, BR; Starr, CR; Zollman, FS				Larson, Eric B.; Kondiles, Bethany R.; Starr, Christine R.; Zollman, Felise S.			Postconcussive Complaints, Cognition, Symptom Attribution and Effort among Veterans	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						Postconcussion syndrome; Brain concussion - diagnosis; Brain concussion - complications; Neuropsychological tests methods; Diagnosis threat; Symptom attribution	TRAUMATIC BRAIN-INJURY; MILD HEAD-INJURY; POST-CONCUSSION SYNDROME; ILLNESS PERCEPTIONS; REPEATABLE BATTERY; IDENTIFICATION; PERFORMANCE; TBI	The etiology of postconcussive symptoms is not clearly understood. Development of etiological models of those symptoms will be helpful for accurate diagnosis and for planning effective treatment. Such a model should characterize the role of subject characteristics (education, premorbid intelligence), social psychological factors and symptom validity. Toward that end, the present study examined the association of postconcussive complaints and cognitive performance with symptom attribution and level of effort on testing. In a sample of 155 veterans, attribution to concussion was associated with endorsement of more severe postconcussive complaints, after controlling for the effects of other factors such as subject characteristics. Similarly, effort was associated with cognitive performance after controlling for the effects of these other factors. The present findings are consistent with previous reports that illness perception and effort on testing are associated with postconcussive complaints. This supports previous recommendations to routinely educate all concussion patients immediately after injury to reduce distorted perceptions and related persistent complaints. Finally, these findings highlight a need for routine assessment of patients' perception of their injury to identify cases that may require psychotherapy to address any misattributions that develop. (JINS, 2013, 19, 88-95)	[Larson, Eric B.; Kondiles, Bethany R.; Starr, Christine R.] Rehabil Inst Chicago, Brain Injury Med & Rehabil Program, Chicago, IL 60611 USA; [Larson, Eric B.] Northwestern Univ, Dept Phys Med & Rehabil, Feinberg Sch Med, Chicago, IL 60611 USA; [Zollman, Felise S.] NorthShore Univ Hlth Syst, Dept Neurol, Glenview, IL USA	Larson, EB (corresponding author), Rehabil Inst Chicago, Brain Injury Med & Rehabil Program, 345 E Super St, Chicago, IL 60611 USA.	elarson@ric.org	Larson, Eric/AAD-9567-2021	Starr, Christine/0000-0002-8662-0387	Robert M. McCormick Tribune Foundation; Julius N. Frankel Foundation; Joseph G. Nicholas Foundation; Barker Welfare Foundation	This study was funded by grants from the Robert M. McCormick Tribune Foundation, the Julius N. Frankel Foundation, the Joseph G. Nicholas Foundation and the Barker Welfare Foundation. All of the authors report they have no conflicts of interest.	American Psychiatric Association Task Force on DSM-IV, 1994, DIAGN STAT MAN MENT; Barker MD, 2010, CLIN NEUROPSYCHOL, V24, P1064, DOI 10.1080/13854046.2010.486009; Chan RCK, 2005, BRAIN INJURY, V19, P1117, DOI 10.1080/026990500150088; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P315, DOI 10.1097/01.HTR.0000300226.67748.3e; FENTON G, 1993, BRIT J PSYCHIAT, V162, P493, DOI 10.1192/bjp.162.4.493; Gunstad J, 2002, J INT NEUROPSYCH SOC, V8, P37, DOI 10.1017/S1355617701020045; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2009, NEW ENGL J MED, V360, P1588, DOI 10.1056/NEJMp0810606; Iverson G.L., 2007, BRAIN INJURY MED PRI; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Iverson GL, 2006, ARCH CLIN NEUROPSYCH, V21, P303, DOI 10.1016/j.acn.2005.12.008; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Lannsjo M, 2009, BRAIN INJURY, V23, P213, DOI 10.1080/02699050902748356; Larson E., 2011, MEMORY POSTCONCUSSIO; Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379; Mittenberg W, 2001, J CLIN EXP NEUROPSYC, V23, P829, DOI 10.1076/jcen.23.6.829.1022; MITTENBERG W, 1992, J NEUROL NEUROSUR PS, V55, P200, DOI 10.1136/jnnp.55.3.200; Moser RS, 2002, ARCH CLIN NEUROPSYCH, V17, P91, DOI 10.1016/S0887-6177(01)00108-1; Nelson NW, 2011, CLIN NEUROPSYCHOL, V25, P716, DOI 10.1080/13854046.2011.579174; Nelson NW, 2010, ARCH CLIN NEUROPSYCH, V25, P713, DOI 10.1093/arclin/acq075; Randolph C, 1998, REPEATABLE BATTERY A; Resnick PJ, 1997, CLIN ASSESSMENT MALI, P130; Rief W, 2007, CLIN PSYCHOL REV, V27, P821, DOI 10.1016/j.cpr.2007.07.005; Santa Maria MP, 2001, ARCH CLIN NEUROPSYCH, V16, P133; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Silverberg ND, 2007, CLIN NEUROPSYCHOL, V21, P841, DOI 10.1080/13854040600850958; Snell DL, 2011, BRAIN INJURY, V25, P1126, DOI 10.3109/02699052.2011.607786; Snell D, 2009, J CLIN EXP NEUROPSYC, V31, P20, DOI 10.1080/13803390801978849; Suhr JA, 2002, J CLIN EXP NEUROPSYC, V24, P448, DOI 10.1076/jcen.24.4.448.1039; Tanielian T, 2008, INVISIBLE WOUNDS WAR; Vanderploeg RD, 2005, J INT NEUROPSYCH SOC, V11, P228, DOI 10.1017/S1355617705050289; Wechsler D., 2001, WECHSLER TEST ADULT; Whittaker R, 2007, J NEUROL NEUROSUR PS, V78, P644, DOI 10.1136/jnnp.2006.101105; World Health Organization, 1992, ICD 10 CLASS MENT BE	36	17	17	0	14	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	JAN	2013	19	1					88	95		10.1017/S1355617712000999			8	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Neurosciences & Neurology; Psychiatry; Psychology	063NB	WOS:000313005400009	23146625				2021-06-18	
J	Taylor, MK				Taylor, Marcus K.			Dehydroepiandrosterone and Dehydroepiandrosterone Sulfate: Anabolic, Neuroprotective, and Neuroexcitatory Properties in Military Men	MILITARY MEDICINE			English	Article							SALIVARY ALPHA-AMYLASE; TRAUMATIC BRAIN-INJURY; ADRENERGIC ACTIVITY; STRESS; RECEPTOR; CORTICOSTERONE; DHEA; HIPPOCAMPAL; RAT; METABOLITES	Evidence links dehydroepiandrosterone (DHEA) and dehydroepiandrosterone sulfate (DHEAS) to crucial military health issues, including operational stress, resilience, and traumatic brain injury. This study evaluated the anabolic, neuroprotective, and neuroexcitatory properties of DHEA(S) in healthy military men. A salivary sample was obtained from 42 men and assayed for DHEA(S), testosterone, nerve growth factor (NGF; which supports nerve cell proliferation), and salivary alpha amylase (sAA; a proxy of sympathetic nervous system function). Separate regression analyses were conducted with DHEA and DHEAS as independent variables, and testosterone, NGF, and sAA as dependent variables, respectively. The models explained 23.4% of variance in testosterone (p < 0.01), 17.2% of variance in NGF (p < 0.01), and 7.4% of variance in sAA (p = 0.09). Standardized beta coefficients revealed that DHEA independently influenced testosterone (beta = 0.40, p < 0.01), whereas DHEAS independently influenced NGF (beta = 0.48, p < 0.01) and sAA (beta = 0.36, p < 0.05). DHEA demonstrated anabolic properties, whereas DHEAS demonstrated neuroprotective and neuroexcitatory properties in military men. This area of study has broad implications for stress inoculation, traumatic brain injury rehabilitation, and regenerative medicine in military personnel.	Naval Hlth Res Ctr, Dept Behav Sci & Epidemiol, Behav Sci Lab, San Diego, CA 92106 USA	Taylor, MK (corresponding author), Naval Hlth Res Ctr, Dept Behav Sci & Epidemiol, Behav Sci Lab, San Diego, CA 92106 USA.				Office of Naval ResearchOffice of Naval Research [PB401]	The author would like to thank Michelle LeWark for her editorial expertise. This work was supported by the Office of Naval Research, under Work Unit No. PB401.	Bastianetto S, 1999, MOL BRAIN RES, V66, P35, DOI 10.1016/S0169-328X(99)00002-9; Baulieu EE, 1998, P NATL ACAD SCI USA, V95, P4089, DOI 10.1073/pnas.95.8.4089; Charney DS, 2004, AM J PSYCHIAT, V161, P195, DOI 10.1176/appi.ajp.161.2.195; Compagnone NA, 1998, P NATL ACAD SCI USA, V95, P4678, DOI 10.1073/pnas.95.8.4678; Dazzi L, 2011, BRAIN RES, V1386, P41, DOI 10.1016/j.brainres.2011.02.065; Gartside SE, 2010, J PSYCHOPHARMACOL, V24, P1717, DOI 10.1177/0269881109105836; Giordano R, 2003, CLIN ENDOCRINOL, V59, P314, DOI 10.1046/j.1365-2265.2003.01847.x; Granger DA, 2007, PHYSIOL BEHAV, V92, P583, DOI 10.1016/j.physbeh.2007.05.004; Gubba EM, 2004, MOL BRAIN RES, V127, P48, DOI 10.1016/j.molbrainres.2004.05.004; Hoffman SW, 2003, J NEUROTRAUM, V20, P859, DOI 10.1089/089771503322385791; Hu Y, 2000, BIOCHEM PHARMACOL, V59, P753, DOI 10.1016/S0006-2952(99)00385-8; Hulin MW, ADV PHARM SCI, DOI [10.1155/2011/926361, DOI 10.1155/2011/926361]; Imamura M, 1998, BIOCHEM BIOPH RES CO, V243, P771, DOI 10.1006/bbrc.1998.8177; Karishma KK, 2002, EUR J NEUROSCI, V16, P445, DOI 10.1046/j.1460-9568.2002.02099.x; Kimonides VG, 1999, NEUROSCIENCE, V89, P429, DOI 10.1016/S0306-4522(98)00347-9; Lazaridis I, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001051; Malik AS, 2003, J NEUROTRAUM, V20, P463, DOI 10.1089/089771503765355531; MILLER WL, 1988, ENDOCR REV, V9, P295, DOI 10.1210/edrv-9-3-295; Morgan CA, 2009, BIOL PSYCHIAT, V66, P334, DOI 10.1016/j.biopsych.2009.04.004; Moriguchi S, 2011, J NEUROCHEM, V117, P879, DOI 10.1111/j.1471-4159.2011.07256.x; Nater UM, 2006, PSYCHONEUROENDOCRINO, V31, P49, DOI 10.1016/j.psyneuen.2005.05.010; Nater UM, 2007, PSYCHONEUROENDOCRINO, V32, P392, DOI 10.1016/j.psyneuen.2007.02.007; Newman AEM, 2010, J COMP NEUROL, V518, P3662, DOI 10.1002/cne.22395; Park-Chung M, 1999, BRAIN RES, V830, P72, DOI 10.1016/S0006-8993(99)01381-5; Payne AH, 2004, ENDOCR REV, V25, P947, DOI 10.1210/er.2003-0030; Schulte-Herbruggen O, 2007, J REPROD IMMUNOL, V74, P170, DOI 10.1016/j.jri.2006.10.003; Smith KS, 2012, NEUROPHARMACOLOGY, V62, P54, DOI 10.1016/j.neuropharm.2011.07.026; Steiner PM, 2010, PSYCHOL METHODS, V15, P250, DOI 10.1037/a0018719; Stuart-Hamilton I., 2007, DICT PSYCHOL TESTING; Tanaka M, 2012, NEUROPHARMACOLOGY, V62, P2373, DOI 10.1016/j.neuropharm.2012.02.007; Taylor MK, 2012, STRESS, V15, P85, DOI 10.3109/10253890.2011.585189; van Stegeren A, 2006, PSYCHONEUROENDOCRINO, V31, P137, DOI 10.1016/j.psyneuen.2005.05.012; Xu YX, 2012, HIPPOCAMPUS, V22, P707, DOI 10.1002/hipo.20932	33	17	18	0	4	ASSOC MILITARY SURG US	BETHESDA	9320 OLD GEORGETOWN RD, BETHESDA, MD 20814 USA	0026-4075	1930-613X		MIL MED	Milit. Med.	JAN	2013	178	1					100	106		10.7205/MILMED-D-12-00296			7	Medicine, General & Internal	General & Internal Medicine	AN7TV	WOS:000340804800022	23356127	Bronze			2021-06-18	
S	Yenari, MA; Han, HS		Naritomi, H; Krieger, DW		Yenari, M. A.; Han, H. S.			Influence of Therapeutic Hypothermia on Regeneration after Cerebral Ischemia	CLINICAL RECOVERY FROM CNS DAMAGE	Frontiers of Neurology and Neuroscience		English	Article; Book Chapter							TRAUMATIC BRAIN-INJURY; ENDOTHELIAL GROWTH-FACTOR; NEUROTROPHIC FACTOR; MILD HYPOTHERMIA; CARDIAC-ARREST; ADULT NEUROGENESIS; GLOBAL-ISCHEMIA; RAT HIPPOCAMPUS; ANGIOGENESIS; CELLS	The protective effect of therapeutic hypothermia in cerebral ischemia is well accepted in experimental models, and some clinical studies show that there is benefit in humans as well. Long-term observations in animal and clinical studies have documented recovery of neurological function following hypothermia treatment. Diminished damage by hypothermic protection should contribute to the recovery in many ways, but hypothermia appears to enhance regeneration of brain tissue as well. Since regeneration of the brain after damage initiates within hours and is active days and weeks after stroke, prolonged hypothermia might affect regenerative processes which have been documented to occur in these time frames. As there is a lack of data at the basic and clinical levels, the mechanism of neuroregeneration by hypothermia is unclear. Yet, we speculate that hypothermia enhances regeneration by positively influencing neurogenesis, angiogenesis, gliogenesis and synapse/circuit formation after stroke. In this chapter, we will provide up-to-date data from experimental studies and clinical reports on the effect of therapeutic hypothermia on neuroregeneration, with perspectives on future research. Copyright (C) 2013 S. Karger AG, Basel	[Yenari, M. A.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94121 USA; [Yenari, M. A.] San Francisco VA Med Ctr, San Francisco, CA 94121 USA; [Han, H. S.] Kyungpook Natl Univ, Sch Med, Dept Physiol, Taegu, South Korea	Yenari, MA (corresponding author), Univ Calif San Francisco, Dept Neurol, 4150 Clement St, San Francisco, CA 94121 USA.	yenari@alum.mit.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS040516] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS040516] Funding Source: Medline		Bennet L, 2007, J PHYSIOL-LONDON, V578, P491, DOI 10.1113/jphysiol.2006.119602; Boris-Moller F, 1998, MOL BRAIN RES, V63, P163, DOI 10.1016/S0169-328X(98)00286-1; Bregy A, 2012, EXP NEUROL, V233, P821, DOI 10.1016/j.expneurol.2011.12.008; Coassin M, 2010, BRIT J OPHTHALMOL, V94, P1678, DOI 10.1136/bjo.2009.168864; D'Cruz BJ, 2002, J CEREBR BLOOD F MET, V22, P843, DOI 10.1097/00004647-200207000-00009; Feng JF, 2010, NEUROSURGERY, V67, P730, DOI 10.1227/01.NEU.0000378023.81727.6E; Geocadin RG, 2012, NAT REV NEUROL, V8, P5, DOI 10.1038/nrneurol.2011.201; Hermann DM, 2012, LANCET NEUROL, V11, P369, DOI 10.1016/S1474-4422(12)70039-X; Imada S, 2010, J NEUROSCI RES, V88, P3457, DOI 10.1002/jnr.22520; Jinno S, 2011, J COMP NEUROL, V519, P451, DOI 10.1002/cne.22527; Kanagawa T, 2006, BRAIN RES, V1111, P36, DOI 10.1016/j.brainres.2006.06.112; Kao CH, 2011, J TRAUMA, V70, P885, DOI 10.1097/TA.0b013e3181e7456d; Kuo JR, 2010, J TRAUMA, V69, P1467, DOI 10.1097/TA.0b013e3181f31b06; Lasarzik I, 2009, ANESTH ANALG, V109, P1632, DOI 10.1213/ANE.0b013e3181bab451; Li L, 2010, GLIA, V58, P1610, DOI 10.1002/glia.21033; Lotocki G, 2011, NEUROSCI LETT, V499, P143, DOI 10.1016/j.neulet.2011.05.056; Manoonkitiwongsa PS, 2004, J CEREBR BLOOD F MET, V24, P693, DOI 10.1097/01.WCB.0000126236.54306.21; Navarro-Sobrino M, 2011, ATHEROSCLEROSIS, V216, P205, DOI 10.1016/j.atherosclerosis.2011.01.030; Oddo M, 2011, CURR OPIN CRIT CARE, V17, P254, DOI 10.1097/MCC.0b013e328344f2ae; Petcu EB, 2010, VASC CELL, V2, DOI 10.1186/2040-2384-2-26; Saito K, 2010, BRAIN RES, V1358, P20, DOI 10.1016/j.brainres.2010.08.048; Schmidt KM, 2004, NEUROSCI LETT, V368, P135, DOI 10.1016/j.neulet.2004.06.071; Schmitt KRL, 2007, NEUROSCI RES, V59, P68, DOI 10.1016/j.neures.2007.05.011; Schmitt KRL, 2010, BRAIN PATHOL, V20, P771, DOI 10.1111/j.1750-3639.2009.00358.x; Shruster A, 2010, APOPTOSIS, V15, P1415, DOI 10.1007/s10495-010-0491-y; Silasi G, 2012, J CEREBR BLOOD F MET, V32, P1525, DOI 10.1038/jcbfm.2012.38; Silasi G, 2011, J CEREBR BLOOD F MET, V31, P1725, DOI 10.1038/jcbfm.2011.25; Trendelenburg G, 2005, GLIA, V50, P307, DOI 10.1002/glia.20204; Vosler PS, 2005, MOL BRAIN RES, V135, P21, DOI 10.1016/j.molbrainres.2004.11.006; Xie YC, 2007, NEUROSCI LETT, V422, P87, DOI 10.1016/j.neulet.2007.03.072; Xiong M, 2011, NEUROCHEM INT, V58, P625, DOI 10.1016/j.neuint.2011.01.026; Yenari MA, 2012, NAT REV NEUROSCI, V13, P267, DOI 10.1038/nrn3174; Yoneyama M, 2011, J PHARMACOL SCI, V115, P425, DOI 10.1254/jphs.11R02CP	33	17	17	0	3	KARGER	BASEL	POSTFACH, CH-4009 BASEL, SWITZERLAND	1660-4431	1662-2804	978-3-318-02309-1; 978-3-318-02308-4	FRONT NEUROL NEUROSC	Front. Neurol. Neurosci.		2013	32						122	128		10.1159/000346428			7	Clinical Neurology	Neurosciences & Neurology	BGG55	WOS:000322844300015	23859971	Green Published, Green Accepted			2021-06-18	
J	Copin, JC; Rebetez, MML; Turck, N; Robin, X; Sanchez, JC; Schaller, K; Gasche, Y; Walder, B				Copin, Jean-Christophe; Rebetez, Marie My Lien; Turck, Natacha; Robin, Xavier; Sanchez, Jean-Charles; Schaller, Karl; Gasche, Yvan; Walder, Bernhard			Matrix metalloproteinase 9 and cellular fibronectin plasma concentrations are predictors of the composite endpoint of length of stay and death in the intensive care unit after severe traumatic brain injury	SCANDINAVIAN JOURNAL OF TRAUMA RESUSCITATION & EMERGENCY MEDICINE			English	Article						Head injury; Prediction; Outcome; Plasmatic biomarker	MATRIX METALLOPROTEINASES; BARRIER BREAKDOWN; PROTEIN-LEVELS; BLOOD; SERUM; MORTALITY; MODERATE; MODELS; S100B; EPIDEMIOLOGY	Background: The relationship between severe traumatic brain injury (TBI) and blood levels of matrix metalloproteinase-9 (MMP-9) or cellular fibronectin (c-Fn) has never been reported. In this study, we aimed to assess whether plasma concentrations of MMP-9 and c-Fn could have predictive values for the composite endpoint of intensive care unit (ICU) length of stay (LOS) of survivors and mortality after severe TBI. Secondary outcomes were the state of consciousness measured with the Glasgow Coma Scale (GCS) of survivors at 14 days and Glasgow Outcome Scale Extended (GOSE) at 3 months. Methods: Forty-nine patients with abbreviated injury scores of the head region >= 4 were included. Blood was sampled at 6, 12, 24 and 48 hours after injury. MMP-9 and c-Fn concentrations were measured by ELISA. The values of MMP-9 and c-Fn, and, for comparison, the value of the GCS on the field of the accident (fGCS), as predictors of the composite outcome of ICU LOS and death were assessed by logistic regression. Results: There was a linear relationship between maximal MMP-9 concentration, measured during the 6-12-hour period, and maximal c-Fn concentration, measured during the 24-48-hour period. The risk of staying longer than 9 days in the ICU or of dying was increased in patients with a maximal early MMP-9 concentration >= 21.6 ng/ml (OR = 5.0; 95% CI: 1.3 to 18.6; p = 0.02) or with a maximal late c-Fn concentration >= 7.7 mu g/ml (OR = 5.4; 95% CI: 1.4 to 20.8; p = 0.01). A similar risk association was observed with fGCS = 8 (OR, 4.4; 95% CI, 1.2-15.8; p = 0.02). No relationship was observed between MMP-9, c-Fn concentrations or fGCS and the GCS at 14 days of survivors and GOSE at 3 months. Conclusions: Plasma MMP-9 and c-Fn concentrations in the first 48 hours after injury are predictive for the composite endpoint of ICU LOS and death after severe TBI but not for consciousness at 14 days and outcome at 3 months.	[Copin, Jean-Christophe; Gasche, Yvan] Univ Geneva, Geneva Neurosci Ctr, Geneva, Switzerland; [Copin, Jean-Christophe; Gasche, Yvan] Univ Hosp Geneva, Div Intens Care, Geneva, Switzerland; [Copin, Jean-Christophe] Univ Hosp Geneva, Div Neurosurg, Geneva, Switzerland; [Rebetez, Marie My Lien; Walder, Bernhard] Univ Hosp Geneva, Div Anaesthesiol, Geneva, Switzerland; [Turck, Natacha; Robin, Xavier; Sanchez, Jean-Charles; Schaller, Karl] Univ Geneva, Med Ctr, Biomed Prote Res Grp, Dept Human Prot Sci, CH-1211 Geneva, Switzerland; [Copin, Jean-Christophe] Ctr Med Univ Geneva, CH-1211 Geneva 4, Switzerland	Copin, JC (corresponding author), Univ Geneva, Geneva Neurosci Ctr, Geneva, Switzerland.	jean-christophe.copin@unige.ch	Robin, Xavier/A-1680-2009	Robin, Xavier/0000-0002-6813-3200	SUVA Foundation; Bangerter-Rhyner Foundation; Geneva University Hospital Research & Development fund; Swiss National Science FoundationSwiss National Science Foundation (SNSF)European Commission [32003B-116774]	This study was supported by the SUVA Foundation (BW), the Bangerter-Rhyner Foundation (BW), the Geneva University Hospital Research & Development fund (YG) and the Swiss National Science Foundation grant #32003B-116774 (YG).	American Association for Automotive Medicine, 1998, ABBR INJ SCAL 1990 V; Andelic N, 2012, NEUROEPIDEMIOLOGY, V38, P259, DOI 10.1159/000338032; Andriessen TMJC, 2011, J NEUROTRAUM, V28, P2019, DOI 10.1089/neu.2011.2034; Arango-Lasprilla JC, 2010, ARCH PHYS MED REHAB, V91, P1495, DOI 10.1016/j.apmr.2010.07.010; Astrof S, 2009, ANGIOGENESIS, V12, P165, DOI 10.1007/s10456-009-9136-6; Bohmer AE, 2011, NEUROSURGERY, V68, P1624, DOI 10.1227/NEU.0b013e318214a81f; Bouillon B, 1999, RESTOR NEUROL NEUROS, V14, P85; Castellanos M, 2007, STROKE, V38, P1855, DOI 10.1161/STROKEAHA.106.481556; Copin JC, 2008, EXP NEUROL, V213, P196, DOI 10.1016/j.expneurol.2008.05.022; Dalla Libera AL, 2011, BRAIN INJURY, V25, P365, DOI 10.3109/02699052.2011.556107; Donkin JJ, 2010, CURR OPIN NEUROL, V23, P293, DOI 10.1097/WCO.0b013e328337f451; Gasche Y, 2006, FRONT BIOSCI-LANDMRK, V11, P1289, DOI 10.2741/1883; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Gidday JM, 2005, AM J PHYSIOL-HEART C, V289, pH558, DOI 10.1152/ajpheart.01275.2004; Grossetete M, 2009, NEUROSURGERY, V65, P702, DOI 10.1227/01.NEU.0000351768.11363.48; Hergenroeder GW, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-19; Hyam JA, 2006, CRIT CARE, V10, DOI 10.1186/cc5066; Jia F, 2010, J NEUROTRAUM, V27, P1059, DOI 10.1089/neu.2009.1067; Lescot T, 2010, J NEUROTRAUM, V27, P1069, DOI 10.1089/neu.2009.1188; Lin ZX, 2011, CLIN CHIM ACTA, V412, P1678, DOI 10.1016/j.cca.2011.05.031; Masson F, 2001, J TRAUMA, V51, P481, DOI 10.1097/00005373-200109000-00010; McKeating EG, 1998, ANESTH ANALG, V86, P759, DOI 10.1097/00000539-199804000-00016; Mondello S, 2012, BRAIN INJURY, V26, P1629, DOI 10.3109/02699052.2012.700083; Mondello S, 2012, NEUROSURGERY, V70, P666, DOI 10.1227/NEU.0b013e318236a809; Murray CJL, 1997, LANCET, V349, P1269, DOI 10.1016/S0140-6736(96)07493-4; Olesen J, 2012, EUR J NEUROL, V19, P155, DOI 10.1111/j.1468-1331.2011.03590.x; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Peters JH, 2003, J LAB CLIN MED, V141, P401, DOI 10.1016/S0022-2143(03)00042-8; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Rondina C, 2005, J HEAD TRAUMA REHAB, V20, P368, DOI 10.1097/00001199-200507000-00008; Roozenbeek B, 2012, J NEUROTRAUM, V29, P1306, DOI 10.1089/neu.2011.1988; Rosell A, 2008, STROKE, V39, P1121, DOI 10.1161/STROKEAHA.107.500868; Scholz M, 2007, MED RES REV, V27, P401, DOI 10.1002/med.20064; Sen J, 2007, J NEUROSCI RES, V85, P1373, DOI 10.1002/jnr.21211; Singh P, 2010, ANNU REV CELL DEV BI, V26, P397, DOI 10.1146/annurev-cellbio-100109-104020; Suehiro E, 2004, J NEUROTRAUM, V21, P1706, DOI 10.1089/0897715042664957; Tejima E, 2009, J NEUROTRAUM, V26, P1935, DOI 10.1089/neu.2009.0959; Truettner JS, 2005, J CEREBR BLOOD F MET, V25, P1505, DOI 10.1038/sj.jcbfm.9600150; van Velzen JM, 2009, BRAIN INJURY, V23, P473, DOI 10.1080/02699050902970737; Vecil GG, 2000, J NEUROSCI RES, V61, P212, DOI 10.1002/1097-4547(20000715)61:2<212::AID-JNR12>3.0.CO;2-9; Vilalta A, 2008, INTENS CARE MED, V34, P1384, DOI 10.1007/s00134-008-1056-1; von Elm E, 2008, SWISS MED WKLY, V138, P327, DOI 2008/23/smw-12025; Vos PE, 2010, NEUROLOGY, V75, P1786, DOI 10.1212/WNL.0b013e3181fd62d2; Wang XY, 2000, J NEUROSCI, V20, P7037, DOI 10.1523/JNEUROSCI.20-18-07037.2000; White ES, 2008, J PATHOL, V216, P1, DOI 10.1002/path.2388; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Zuercher M, 2009, BRAIN INJURY, V23, P371, DOI 10.1080/02699050902926267	47	17	19	0	15	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1757-7241			SCAND J TRAUMA RESUS	Scand. J. Trauma Resusc. Emerg. Med.	DEC 18	2012	20								83	10.1186/1757-7241-20-83			9	Emergency Medicine	Emergency Medicine	088KP	WOS:000314833400002	23249478	DOAJ Gold, Green Published			2021-06-18	
J	Choi, JS; Leem, JW; Lee, KH; Kim, SS; Suh-Kim, H; Jung, SJ; Kim, UJ; Lee, BH				Choi, Ji Soo; Leem, Joong Woo; Lee, Kyung Hee; Kim, Sung-Soo; Suh-Kim, Haeyoung; Jung, Se Jung; Kim, Un Jeng; Lee, Bae Hwan			Effects of Human Mesenchymal Stem Cell Transplantation Combined with Polymer on Functional Recovery Following Spinal Cord Hemisection in Rats	KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY			English	Article						Electrophysiology; Mesenchymal stem cells; Polymer; Spinal cord injury	MARROW STROMAL CELLS; TRAUMATIC BRAIN INJURY; BONE-MARROW; ADULT-RAT; GUIDANCE CHANNELS; NUCLEUS NEURONS; TISSUE-REPAIR; SCHWANN-CELLS; IN-VITRO; REGENERATION	The spontaneous axon regeneration of damaged neurons is limited after spinal cord injury (SCI). Recently, mesenchymal stem cell (MSC) transplantation was proposed as a potential approach for enhancing nerve regeneration that avoids the ethical issues associated with embryonic stem cell transplantation. As SCI is a complex pathological entity, the treatment of SCI requires a multipronged approach. The purpose of the present study was to investigate the functional recovery and therapeutic potential of human MSCs (hMSCs) and polymer in a spinal cord hemisection injury model. Rats were subjected to hemisection injuries and then divided into three groups. Two groups of rats underwent partial thoracic hemisection injury followed by implantation of either polymer only or polymer with hMSCs. Another hemisection-only group was used as a control. Behavioral, electrophysiological and immunohistochemical studies were performed on all rats. The functional recovery was significantly improved in the polymer with hMSC-transplanted group as compared with control at five weeks after transplantation. The results of electrophysiologic study demonstrated that the latency of somatosensory-evoked potentials (SSEPs) in the polymer with hMSC-transplanted group was significantly shorter than in the hemisection-only control group. In the results of immunohistochemical study, beta-gal-positive cells were observed in the injured and adjacent sites after hMSC transplantation. Surviving hMSCs differentiated into various cell types such as neurons, astrocytes and oligodendrocytes. These data suggest that hMSC transplantation with polymer may play an important role in functional recovery and axonal regeneration after SCI, and may be a potential therapeutic strategy for SCI.	[Choi, Ji Soo; Leem, Joong Woo; Jung, Se Jung; Kim, Un Jeng; Lee, Bae Hwan] Yonsei Univ, Dept Physiol, Coll Med, Brain Korea Project Med Sci 21, Seoul 120752, South Korea; [Choi, Ji Soo; Leem, Joong Woo; Jung, Se Jung; Kim, Un Jeng; Lee, Bae Hwan] Yonsei Univ, Brain Res Inst, Coll Med, Seoul 120752, South Korea; [Lee, Kyung Hee] Dongseo Univ, Dept Dent Hyg, Div Hlth Sci, Pusan 617716, South Korea; [Kim, Sung-Soo; Suh-Kim, Haeyoung] Ajou Univ, Sch Med, Dept Anat, Suwon 443721, South Korea; [Kim, Sung-Soo] Ajou Univ, Sch Med, Ctr Cell Death Regulating Biodrug, Suwon 443721, South Korea	Lee, BH (corresponding author), Yonsei Univ, Dept Physiol, Coll Med, Brain Korea Project Med Sci 21, CPO Box 8044, Seoul 120752, South Korea.	bhlee@yuhs.ac		Kim, Sung-Soo/0000-0003-3591-5932; Lee, Bae H./0000-0003-4719-9021; Suh-Kim, Haeyoung/0000-0001-8175-1209; Leem, Joong/0000-0002-1605-2230; Kim, Un Jeng/0000-0003-0968-0252	Stem Cell Research Center of the 21st Century Frontier Research ProgramMinistry of Education, Science and Technology, Republic of Korea [SC4140]; Basic Science Research Program through the National Research Foundation [2005-0049404, 20090076605]; Ministry of Education, Science and TechnologyMinistry of Education, Science and Technology, Republic of Korea	The research was supported by grants from the Stem Cell Research Center of the 21st Century Frontier Research Program (SC4140) and from Basic Science Research Program (No. 2005-0049404, 20090076605) through the National Research Foundation funded by the Ministry of Education, Science and Technology.	Akiyama Y, 2002, J NEUROSCI, V22, P6623; Ankeny DP, 2004, EXP NEUROL, V190, P17, DOI 10.1016/J.expneurol.2004.05.045; Azizi SA, 1998, P NATL ACAD SCI USA, V95, P3908, DOI 10.1073/pnas.95.7.3908; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Chen G, 2010, CHINESE MED J-PEKING, V123, P2424, DOI 10.3760/cma.j.issn.0366-6999.2010.17.025; Chopp M, 2002, LANCET NEUROL, V1, P92, DOI 10.1016/S1474-4422(02)00040-6; Chopp M, 2000, NEUROREPORT, V11, P3001, DOI 10.1097/00001756-200009110-00035; Fawcett JW, 1999, BRAIN RES BULL, V49, P377, DOI 10.1016/S0361-9230(99)00072-6; Himes BT, 2006, NEUROREHAB NEURAL RE, V20, P278, DOI 10.1177/1545968306286976; HIMES BT, 1994, J COMP NEUROL, V339, P117, DOI 10.1002/cne.903390111; Himes BT, 2001, J NEUROSCI RES, V65, P549, DOI 10.1002/jnr.1185; Hofstetter CP, 2002, P NATL ACAD SCI USA, V99, P2199, DOI 10.1073/pnas.042678299; HOULE JD, 1994, J NEURAL TRANSP PLAS, V5, P115, DOI 10.1155/NP.1994.115; Jendelova P, 2004, J NEUROSCI RES, V76, P232, DOI 10.1002/jnr.20041; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Kang CE, 2009, TISSUE ENG PT A, V15, P595, DOI 10.1089/ten.tea.2007.0349; Kopen GC, 1999, P NATL ACAD SCI USA, V96, P10711, DOI 10.1073/pnas.96.19.10711; Lee KH, 2007, ACTA NEUROBIOL EXP, V67, P13; Lesny P, 2002, J CHEM NEUROANAT, V23, P243, DOI 10.1016/S0891-0618(02)00011-X; Li Y, 2001, NEUROLOGY, V56, P1666, DOI 10.1212/WNL.56.12.1666; Liu WG, 2011, NEUROL RES, V33, P686, DOI 10.1179/1743132810Y.0000000031; Liu Y, 2002, EXP NEUROL, V178, P150, DOI 10.1006/exnr.2002.7977; Lu D, 2001, NEUROREPORT, V12, P559, DOI 10.1097/00001756-200103050-00025; Lu DY, 2001, J NEUROTRAUM, V18, P813, DOI 10.1089/089771501316919175; Lu P, 2005, EXP NEUROL, V191, P344, DOI 10.1016/j.expneurol.2004.09.018; Mahmood A, 2001, NEUROSURGERY, V49, P1196, DOI 10.1097/00006123-200111000-00031; Maquet V, 2001, BIOMATERIALS, V22, P1137, DOI 10.1016/S0142-9612(00)00357-4; Neuhuber B, 2005, BRAIN RES, V1035, P73, DOI 10.1016/j.brainres.2004.11.055; Oswald J, 2004, STEM CELLS, V22, P377, DOI 10.1634/stemcells.22-3-377; Oudega M, 2001, BIOMATERIALS, V22, P1125, DOI 10.1016/S0142-9612(00)00346-X; Piantino J, 2006, EXP NEUROL, V201, P359, DOI 10.1016/j.expneurol.2006.04.020; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Quertainmont R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039500; Sasaki M, 2001, GLIA, V35, P26, DOI 10.1002/glia.1067; Schwab ME, 2002, SCIENCE, V295, P1029, DOI 10.1126/science.1067840; Schwab ME, 1996, PHYSIOL REV, V76, P319; SIDDALL PJ, 2000, IASP NEWSLETTER, V3, P3; Tsai EC, 2004, J NEUROTRAUM, V21, P789, DOI 10.1089/0897715041269687; Woerly S, 2001, J NEUROSCI RES, V66, P1187; Woodbury D, 2000, J NEUROSCI RES, V61, P364, DOI 10.1002/1097-4547(20000815)61:4<364::AID-JNR2>3.0.CO;2-C; Wu SF, 2003, J NEUROSCI RES, V72, P343, DOI 10.1002/jnr.10587; Yazdani SO, 2012, TISSUE CELL, V44, P205, DOI 10.1016/j.tice.2012.03.003; Yoon YW, 2004, SOMATOSENS MOT RES, V21, P25, DOI 10.1080/0899022042000201272; Zhang YQ, 2012, CELLS TISSUES ORGANS, V195, P313, DOI 10.1159/000327724; Zurita M, 2004, NEUROREPORT, V15, P1105, DOI 10.1097/00001756-200405190-00004; Zurita M, 2006, NEUROSCI LETT, V402, P51, DOI 10.1016/j.neulet.2006.03.069	47	17	18	0	16	KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY	SEOUL	C/O EDITORIAL OFFICE, 448-13 SEOKYO-DONG, SEOUL, SOUTH KOREA	1226-4512			KOREAN J PHYSIOL PHA	KOREAN J. PHYSIOL. PHARMACOL.	DEC	2012	16	6					405	411		10.4196/kjpp.2012.16.6.405			7	Pharmacology & Pharmacy; Physiology	Pharmacology & Pharmacy; Physiology	060AZ	WOS:000312749300006	23269903	Green Published			2021-06-18	
J	Malec, JF; Kean, J; Altman, IM; Swick, S				Malec, James F.; Kean, Jacob; Altman, Irwin M.; Swick, Shannon			Mayo-Portland Adaptability Inventory: Comparing Psychometrics in Cerebrovascular Accident to Traumatic Brain Injury	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Outcome assessment (health care); Rehabilitation; Stroke	POSTACUTE REHABILITATION; SAMPLE	Malec JF, Kean J, Altman IM, Swick S. Mayo-Portland Adaptability Inventory: comparing psychometrics in cerebrovascular accident to traumatic brain injury. Arch Phys Med Rehabil 2012;93:2271-5. Objectives: (1) To evaluate the measurement reliability and construct validity of the Mayo-Portland Adaptability Inventory, 4th revision (MPAI-4) in a sample consisting exclusively of patients with cerebrovascular accident (CVA) using single parameter (Rasch) item-response methods; (2) to examine the differential item functioning (DIF) by sex within the CVA population; and (3) to examine DIF and differential test functioning (DTF) across traumatic brain injury (TB!) and CVA samples. Design: Retrospective psychometric analysis of rating scale data. Setting: Home- and community-based brain injury rehabilitation program. Participants: Individuals post-CVA (n=861) and individuals with TBI (n=603). Interventions: Not applicable. Main Outcome Measure: MPAI-4. Results: Item data on admission to community-based rehabilitation were submitted to Rasch, DIF, and DTF analyses. The final calibration in the CVA sample revealed satisfactory reliability/separation for persons (.91/3.16) and items (1.00/23.64). DIF showed that items for pain, anger, audition, and memory were associated with higher levels of disability for CVA than TBI patients; whereas, self-care, mobility, and use of hands indicated greater overall disability for TBI patients. DTF analyses showed a high degree of association between the 2 sets of items (R=.92; R-2=.85) and, at most, a 3.7 point difference in raw scores. Conclusions: The MPAI-4 demonstrates satisfactory psychometric properties for use with individuals with CVA applying for interdisciplinary posthospital rehabilitation. DIF reveals clinically meaningful differences between CVA and TBI groups that should be considered in results at the item and subscale level.	[Malec, James F.; Kean, Jacob] Indiana Univ Sch Med, Dept Phys Med & Rehabil, Indianapolis, IN 46254 USA; [Malec, James F.; Kean, Jacob] Rehabil Hosp Indiana, Indianapolis, IN 46254 USA; [Altman, Irwin M.] Rehab Walls, Phoenix, AZ USA; [Swick, Shannon] Rehab Walls, Marshall, AZ USA	Malec, JF (corresponding author), Indiana Univ Sch Med, Dept Phys Med & Rehabil, 4141 Shore Dr, Indianapolis, IN 46254 USA.	jmalec@rhin.com		Kean, Jacob/0000-0002-8577-0586	National Institute for Neurological Diseases and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [3R42NS059133-02]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R42NS059133] Funding Source: NIH RePORTER	Supported by the National Institute for Neurological Diseases and Stroke by a Small Business Technology Transfer Research grant (no. 3R42NS059133-02).	Altman IM, 2010, ARCH PHYS MED REHAB, V91, P1697, DOI 10.1016/j.apmr.2010.08.001; Bohac DL, 1997, BRAIN INJURY, V11, P469, DOI 10.1080/713802185; Bond T.G., 2007, APPL RASCH MODEL FUN; Constantinidou F, 2005, J HEAD TRAUMA REHAB, V20, P143, DOI 10.1097/00001199-200503000-00003; Kean J, 2011, J NEUROTRAUM, V28, P745, DOI 10.1089/neu.2010.1573; Linacre J.M., 2002, RASCH MEASUREMENT T, V16, P878; Linacre JM, 2002, RASCH MEASUREMENT T, V16, P889; Malec JF, 2003, J HEAD TRAUMA REHAB, V18, P479, DOI 10.1097/00001199-200311000-00002; Malec JF, 2000, J HEAD TRAUMA REHAB, V15, P670, DOI 10.1097/00001199-200002000-00006; Malec JF, 2001, ARCH PHYS MED REHAB, V82, P885, DOI 10.1053/apmr.2001.23895; Malec JF, 2000, ARCH PHYS MED REHAB, V81, P1007, DOI 10.1053/apmr.2000.6980; Malec JF., 1994, J HEAD TRAUMA REHAB, V9, P1, DOI [10. 1097/ 00001199- 199412000- 00003, DOI 10.1097/00001199-199412000-00003]; Malec JF, MANUAL MAYO PORTLAND; Smith AB, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-33; Wyse AE, 2011, APPL PSYCH MEAS, V35, P217, DOI 10.1177/0146621610377082	15	17	18	0	16	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993			ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	DEC	2012	93	12					2271	2275		10.1016/j.apmr.2012.06.013			5	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	051IX	WOS:000312121000020	22743410				2021-06-18	
J	Mattei, TA; Bond, BJ; Goulart, CR; Sloffer, CA; Morris, MJ; Lin, JJ				Mattei, Tobias A.; Bond, Brandon J.; Goulart, Carlos R.; Sloffer, Chris A.; Morris, Martin J.; Lin, Julian J.			Performance analysis of the protective effects of bicycle helmets during impact and crush tests in pediatric skull models Laboratory investigation	JOURNAL OF NEUROSURGERY-PEDIATRICS			English	Article						crushing traumatic brain injury; pediatric traumatic brain injury; cadaver skull; bicycle helmet; performance analysis; trauma	TRAUMATIC BRAIN-INJURY; HEAD-INJURIES; DECOMPRESSIVE CRANIECTOMY; UNITED-STATES; CHILDREN; FOOTBALL; LEGISLATION; SEVERITY; OUTCOMES	Object. Bicycle accidents are a very important cause of clinically important traumatic brain injury (TB!) in children. One factor that has been shown to mitigate the severity of lesions associated with TBI in such scenarios is the proper use of a helmet. The object of this study was to test and evaluate the protection afforded by a children's bicycle helmet to human cadaver skulls with a child's anthropometry in both "impact" and "crushing" situations. Methods. The authors tested human skulls with and without bicycle helmets in drop tests in a monorail-guided free-fall impact apparatus from heights of 6 to 48 in onto a flat steel anvil. Unhelmeted skulls were dropped at 6 in, with progressive height increases until failure (fracture). The maximum resultant acceleration rates experienced by helmeted and unhelmeted skulls on impact were recorded by an accelerometer attached to the skulls. In addition, compressive forces were applied to both helmeted and unhelmeted skulls in progressive amounts. The tolerance in each circumstance was recorded and compared between the two groups. Results. Helmets conferred up to an 87% reduction in so-called mean maximum resultant acceleration over unhelmeted skulls. In compression testing, helmeted skulls were unable to be crushed in the compression fixture up to 470 pound-force (approximately 230 kgf), whereas both skull and helmet alone failed in testing. Conclusions. Children's bicycle helmets provide measurable protection in terms of attenuating the acceleration experienced by a skull on the introduction of an impact force. Moreover, such helmets have the durability to mitigate the effects of a more rare but catastrophic direct compressive force. Therefore, the use of bicycle helmets is an important preventive tool to reduce the incidence of severe associated TBI in children as well as to minimize the morbidity of its neurological consequences. (http://thejns.org/doi/abs/10.3171/2012.8.PEDS12116)	[Mattei, Tobias A.; Lin, Julian J.] Univ Illinois, Dept Neurosurg, Coll Med, Illinois Neurol Inst, Peoria, IL 61637 USA; [Sloffer, Chris A.; Morris, Martin J.] Bradley Univ, Dept Mech Engn, Peoria, IL 61625 USA; [Goulart, Carlos R.] Evangel Univ Parana, Curitiba, Parana, Brazil	Mattei, TA (corresponding author), Univ Illinois, Dept Neurosurg, Coll Med, Illinois Neurol Inst, 530 NE Glen Oak,7430, Peoria, IL 61637 USA.	tobiasmattei@yahoo.com	Goulart, Carlos/AAB-3827-2019; Mattei, Tobias A./U-7166-2019				American National Standards Institute, 1984, AM NAT STAND PROT HE; American Society of Testing and Materials Committee on Standards, 1993, STAND SPEC PROT HEAD; Appelboom G, 2011, NEUROSURG FOCUS, V31, DOI 10.3171/2011.8.FOCUS11177; Asiminei AG, 2008, P 2008 FIN EL WORKSH, V1, P13; Bartsch A, 2012, J NEUROSURG, V116, P222, DOI 10.3171/2011.9.JNS111059; Bass CR, 2012, ANN BIOMED ENG, V40, P185, DOI 10.1007/s10439-011-0424-0; BENZ G, 1993, EUR J PEDIATR SURG, V3, P259, DOI 10.1055/s-2008-1063555; Chaze B, 2008, NEUROL CLIN, V26, P325, DOI 10.1016/j.ncl.2007.11.009; CODY BE, 2004, HEADED INJURY OBSERV; COTE TR, 1992, PEDIATRICS, V89, P1216; CPSC, 1998, FED REGISTER, V63, P11711; Davidsson Johan, 2011, Front Neurol, V2, P41, DOI 10.3389/fneur.2011.00041; DeRosia J, 2000, FRONTIERS WHIPLASH T, P265; DIGUISEPPI CG, 1989, JAMA-J AM MED ASSOC, V262, P2256, DOI 10.1001/jama.262.16.2256; DORSCH MM, 1987, ACCIDENT ANAL PREV, V19, P183, DOI 10.1016/0001-4575(87)90002-9; FRIEDE AM, 1985, PEDIATR CLIN N AM, V32, P141; Higgins M, 2007, J ATHL TRAINING, V42, P5; Hoshizaki B, 2012, J NEUROSURG-PEDIATR, V9, P133, DOI 10.3171/2011.11.PEDS11299; Kan P, 2006, J NEUROSURG, V105, P337, DOI 10.3171/ped.2006.105.5.337; KRAUS JF, 1987, AM J PUBLIC HEALTH, V77, P76, DOI 10.2105/AJPH.77.1.76; Levy S, 1999, NEUROSURGERY, V45, P696; MACPHERSON A, 2008, COCHRANE DB SYST REV, V16; Meaney DF, 1998, BIOM HLTH R, V21, P169; Mehan TJ, 2009, CLIN PEDIATR, V48, P166, DOI 10.1177/0009922808324952; Mills N J, 1990, Br J Sports Med, V24, P55; MORRIS BAP, 1991, CAN J PUBLIC HEALTH, V82, P92; Niess C, 2002, ACTA NEUROPATHOL, V104, P79, DOI 10.1007/s00401-002-0525-9; Nigrovic LE, 2012, ARCH PEDIAT ADOL MED, V166, P356, DOI 10.1001/archpediatrics.2011.1156; Ommaya AK, 1967, 11 STAPP CAR CRASH C, P73; PARKIN PC, 1993, PEDIATRICS, V91, P772; Pellman EJ, 2006, NEUROSURGERY, V58, P78, DOI 10.1227/01.NEU.0000196265.35238.7C; RIVARA FP, 1994, PEDIATRICS, V93, P567; RODGERS GB, 1995, ACCIDENT ANAL PREV, V27, P43, DOI 10.1016/0001-4575(94)00044-M; SACKS JJ, 1991, JAMA-J AM MED ASSOC, V266, P3016, DOI 10.1001/jama.266.21.3016; SELBST SM, 1987, AM J DIS CHILD, V141, P140, DOI 10.1001/archpedi.1987.04460020030021; Shafi S, 1998, J PEDIATR SURG, V33, P317, DOI 10.1016/S0022-3468(98)90454-7; SMITH TA, 1994, ACCIDENT ANAL PREV, V26, P795, DOI 10.1016/0001-4575(94)90055-8; Snell Memorial Foundation, 1990, 1990 STAND PROT HEAD; Taylor A, 2001, CHILD NERV SYST, V17, P154, DOI 10.1007/s003810000410; THOMPSON RS, 1989, NEW ENGL J MED, V320, P1361, DOI 10.1056/NEJM198905253202101; TORG JS, 1990, AM J SPORT MED, V18, P50, DOI 10.1177/036354659001800109; WASSERMAN RC, 1988, AM J PUBLIC HEALTH, V78, P1220, DOI 10.2105/AJPH.78.9.1220; WASSERMAN RC, 1990, AM J SPORT MED, V18, P96, DOI 10.1177/036354659001800116; WILLIAMS M, 1991, ACCIDENT ANAL PREV, V23, P119, DOI 10.1016/0001-4575(91)90043-5; Yoganandan N, 2004, CLIN BIOMECH, V19, P225, DOI 10.1016/j.clinbiomech.2003.12.014; YOGANANDAN N, 1987, CRIT REV BIOMED ENG, V15, P29	46	17	17	0	1	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1933-0707	1933-0715		J NEUROSURG-PEDIATR	J. Neurosurg.-Pediatr.	DEC	2012	10	6					490	497		10.3171/2012.8.PEDS12116			8	Clinical Neurology; Pediatrics; Surgery	Neurosciences & Neurology; Pediatrics; Surgery	042IE	WOS:000311464100008	23030382	Bronze			2021-06-18	
J	Kucherov, Y; Hubler, GK; DePalma, RG				Kucherov, Yan; Hubler, Graham K.; DePalma, Ralph G.			Blast induced mild traumatic brain injury/concussion: A physical analysis	JOURNAL OF APPLIED PHYSICS			English	Article							WATER; BRILLOUIN; SPECTRUM; INJURY	Currently, a consensus exists that low intensity non-impact blast wave exposure leads to mild traumatic brain injury (mTBI). Considerable interest in this "invisible injury" has developed in the past few years but a disconnect remains between the biomedical outcomes and possible physical mechanisms causing mTBI. Here, we show that a shock wave travelling through the brain excites a phonon continuum that decays into specific acoustic waves with intensity exceeding brain tissue strength. Damage may occur within the period of the phonon wave, measured in tens to hundreds of nanometers, which makes the damage difficult to detect using conventional modalities. [http://dx.doi.org/10.1063/1.4765727]	[Kucherov, Yan; Hubler, Graham K.] USN, Div Mat Sci & Technol, Res Lab, Washington, DC 20375 USA; [DePalma, Ralph G.] Dept Vet Affairs, Washington, DC 20420 USA	Hubler, GK (corresponding author), USN, Div Mat Sci & Technol, Res Lab, Code 6360,4555 Overlook Ave SW, Washington, DC 20375 USA.	graham.hubler@nrl.navy.mil			US Marine Corps Systems Command; PM Infantry Combat Equipment; US Veterans Administration ORD	We thank Jeffrey Byers for useful comments. This work was sponsored by the US Marine Corps Systems Command, PM Infantry Combat Equipment, and US Veterans Administration ORD. The authors report no conflicts of interest and no commercial sponsorships as they pertain to this topic. The opinions expressed herein are those of the authors. They do not and should not be interpreted as belonging to or being endorsed by the Department of Veterans Affairs, Department of Defense, or the Government of the United States.	Boteler JM, 2004, J APPL PHYS, V96, P6919, DOI 10.1063/1.1810635; Cernak I, 2010, J CEREBR BLOOD F MET, V30, P255, DOI 10.1038/jcbfm.2009.203; Courtney AC, 2009, MED HYPOTHESES, V72, P76, DOI 10.1016/j.mehy.2008.08.015; DePalma RG, 2005, NEW ENGL J MED, V352, P1335, DOI 10.1056/NEJMra042083; Elder GA, 2010, PSYCHIAT CLIN N AM, V33, P757, DOI 10.1016/j.psc.2010.08.001; Garai J., 2009, J FLUID PHASE EQUILI, V283, P89; Graham, 1997, MODERN SUPERABSORBEN; Granacher R. P., 2007, TRAUMATIC BRAIN INJU, P6; Hrapko M, 2008, BIORHEOLOGY, V45, P663, DOI 10.3233/BIR-2008-0512; Kucherov Y, 2012, J APPL PHYS, V111, DOI 10.1063/1.3675274; LEIRO JA, 1989, SURF SCI, V211, P350, DOI 10.1016/0039-6028(89)90789-9; Lin A. P., 2012, METAB IMAGING BEHAV, V6, P208; Ling GSF, 2011, CURR OPIN ANESTHESIO, V24, P124, DOI 10.1097/ACO.0b013e32834458da; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Mott D.R., 2008, P 20 INT S MIL ASP B; NOVIKOV AG, 1990, J STRUCT CHEM+, V31, P77, DOI 10.1007/BF00752017; Nyein MK, 2010, P NATL ACAD SCI USA, V107, P20703, DOI 10.1073/pnas.1014786107; Park E, 2011, J NEUROTRAUM, V28, P343, DOI 10.1089/neu.2009.1050; PRATESI G, 1995, MEAS SCI TECHNOL, V6, P41, DOI 10.1088/0957-0233/6/1/008; Saljo A, 2009, J NEUROTRAUM, V26, P1345, DOI [10.1089/neu.2008.0856, 10.1089/neu.2008-0856]; Scarcelli G, 2008, NAT PHOTONICS, V2, P39, DOI 10.1038/nphoton.2007.250; Shah NJ, 2011, METHODS MOL BIOL, V711, P29, DOI 10.1007/978-1-61737-992-5_3; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Taraskin SN, 2000, PHYS REV B, V61, P12031, DOI 10.1103/PhysRevB.61.12031; Topolovec-Vranic J, 2011, J TRAUMA, V71, pS478, DOI 10.1097/TA.0b013e318232fa70; WALRAFEN GE, 1990, J PHYS CHEM-US, V94, P2237, DOI 10.1021/j100369a008; Weinberger S, 2011, NATURE, V477, P390, DOI 10.1038/477390a; Zeldovich Y., 2002, PHYS SHOCK WAVES HIG, P705	28	17	17	0	17	AMER INST PHYSICS	MELVILLE	1305 WALT WHITMAN RD, STE 300, MELVILLE, NY 11747-4501 USA	0021-8979	1089-7550		J APPL PHYS	J. Appl. Phys.	NOV 15	2012	112	10							104701	10.1063/1.4765727			5	Physics, Applied	Physics	049GF	WOS:000311969800158					2021-06-18	
J	Bukur, M; Lustenberger, T; Cotton, B; Arbabi, S; Talving, P; Salim, A; Ley, EJ; Inaba, K				Bukur, Marko; Lustenberger, Thomas; Cotton, Bryan; Arbabi, Saman; Talving, Peep; Salim, Ali; Ley, Eric J.; Inaba, Kenji			Beta-blocker exposure in the absence of significant head injuries is associated with reduced mortality in critically ill patients	AMERICAN JOURNAL OF SURGERY			English	Article						Trauma; Critically ill; Beta-blocker; Inflammation; Mortality	TRAUMATIC BRAIN-INJURY; NONCARDIAC SURGERY; ADRENERGIC-BLOCKADE; SYSTEMIC INFLAMMATION; IMPROVED OUTCOMES; RISK PATIENTS; PROPRANOLOL; SEPSIS; CATECHOLAMINES; SURVIVAL	BACKGROUND: The effect of beta-blockade in trauma patients without significant head injuries is unknown. The purpose of this investigation was to determine the impact of beta-blocker exposure on mortality in critically injured trauma patients who did not sustain significant head injuries. METHODS: Critically ill trauma patients (Injury Severity Score >= 25) admitted to the surgical intensive care unit from January 2000 to December 2008 without severe traumatic brain injuries (head Abbreviated Injury Score >= 3) were included in this retrospective review. Patients who received beta-blockers within 30 days of intensive care unit admission were compared with those who did not. The primary outcome measure evaluated was in-hospital mortality. RESULTS: During the 9-year study period, 663 critically injured patients (Injury Severity Score >= 25) were admitted to the intensive care unit. Of these, 98 patients (14.8%) received beta-blockers. Patients exposed to beta-blockers had significantly lower in-hospital mortality (11.2% vs 19.3%, P = .006). Stepwise logistic regression identified beta-blocker use as an independent protective factor for mortality (adjusted odds ratio, .37; P = .007) in critically injured patients. CONCLUSIONS: Beta-blocker exposure was associated with reduced mortality in critically injured patients without head injuries. Prospective validation of this finding is warranted. (C) 2012 Elsevier Inc. All rights reserved.	[Bukur, Marko; Salim, Ali; Ley, Eric J.] Cedars Sinai Med Ctr, Dept Surg, Div Trauma & Surg Crit Care, Los Angeles, CA 90048 USA; [Lustenberger, Thomas; Talving, Peep; Inaba, Kenji] Los Angeles Cty Univ So Calif Med Ctr, Dept Surg, Div Acute Care Surg & Surg Crit Care, Los Angeles, CA USA; [Cotton, Bryan] Univ Texas Med Sch Houston, Dept Surg, Div Acute Care Surg, Houston, TX USA; [Arbabi, Saman] Univ Washington, Harborview Med Ctr, Dept Surg, Div Trauma & Crit Care, Seattle, WA 98104 USA	Bukur, M (corresponding author), Cedars Sinai Med Ctr, Dept Surg, Div Trauma & Surg Crit Care, Los Angeles, CA 90048 USA.	marko.bukur@cshs.org	Talving, Peep/G-8621-2015; INABA, KENJI/AAC-8532-2020; Talving, Peep/E-6015-2013	Talving, Peep/0000-0002-9741-2073; Bukur, Marko/0000-0002-1850-7147			Ackland GL, 2010, CRIT CARE MED, V38, P388, DOI 10.1097/CCM.0b013e3181c03dfa; Arbabi S, 2004, J TRAUMA, V56, P265, DOI 10.1097/01.TA.0000109859.91202.C8; Arbabi S, 2007, J TRAUMA, V62, P56, DOI 10.1097/TA.0b013e31802d972b; Barrow RE, 2006, ANN SURG, V243, P115, DOI 10.1097/01.sla.0000193834.07413.91; Benschop RJ, 1997, BRAIN BEHAV IMMUN, V11, P321, DOI 10.1006/brbi.1997.0499; Benschop RJ, 1996, FASEB J, V10, P517; Cioca DP, 2000, JPN HEART J, V41, P385; Cotton BA, 2007, J TRAUMA, V62, P26, DOI 10.1097/TA.0b013e31802d02d0; Devereaux PJ, 2008, LANCET, V371, P1839, DOI 10.1016/S0140-6736(08)60601-7; Devereaux PJ, 2005, BMJ-BRIT MED J, V331, P313, DOI 10.1136/bmj.38503.623646.8F; Devereaux PJ, 2005, CAN MED ASSOC J, V173, P627, DOI 10.1503/cmaj.050011; DOUGLAS RG, 1989, BRIT J SURG, V76, P115, DOI 10.1002/bjs.1800760205; FRAYN KN, 1985, CIRC SHOCK, V16, P229; Friese RS, 2008, J TRAUMA, V64, P1061, DOI 10.1097/TA.0b013e3181684cf0; Herndon DN, 2003, AM J PHYSIOL-ENDOC M, V285, pE783, DOI 10.1152/ajpendo.00508.2002; Herndon DN, 2001, NEW ENGL J MED, V345, P1223, DOI 10.1056/NEJMoa010342; HERNDON DN, 1988, ANN SURG, V208, P484, DOI 10.1097/00000658-198810000-00010; Inaba K, 2008, J AM COLL SURGEONS, V206, P432, DOI 10.1016/j.jamcollsurg.2007.10.005; Jacobs AK, 2009, J AM COLL CARDIOL, V54, P2102, DOI 10.1016/j.jacc.2009.07.004; Kohm AP, 2000, IMMUNOL TODAY, V21, P539, DOI 10.1016/S0167-5699(00)01747-3; Ley EJ, 2009, J TRAUMA, V66, P154, DOI 10.1097/TA.0b013e31819388be; LIU MY, 1995, J FORMOS MED ASSOC, V94, P386; Mangano DT, 1996, NEW ENGL J MED, V335, P1713, DOI 10.1056/NEJM199612053352301; Martin M, 2005, J TRAUMA, V59, P1086, DOI 10.1097/01.ta.0000190249.19668.37; MOORE FA, 1995, SURG CLIN N AM, V75, P257, DOI 10.1016/S0039-6109(16)46587-4; Neideen T, 2008, J TRAUMA, V65, P1016, DOI 10.1097/TA.0b013e3181897eac; Norbury WB, 2007, CRIT CARE MED, V35, pS616, DOI 10.1097/01.CCM.0000278599.30298.80; Oberbeck R, 2009, CURR MED CHEM, V16, P1082, DOI 10.2174/092986709787581770; Poldermans D, 1999, NEW ENGL J MED, V341, P1789, DOI 10.1056/NEJM199912093412402; Rough J, 2009, SURGERY, V145, P235, DOI 10.1016/j.surg.2008.09.013; Sametz W, 1999, EUR J CLIN INVEST, V29, P582; Schmitz D, 2007, RESUSCITATION, V72, P286, DOI 10.1016/j.resuscitation.2006.07.001; SHAW JHF, 1988, SURGERY, V103, P520; Shojania KG, 2001, AHRQ PUBLICATION; TRUNKEY DD, 1983, SCI AM, V249, P28, DOI 10.1038/scientificamerican0883-28; Wallace A, 1998, ANESTHESIOLOGY, V88, P7, DOI 10.1097/00000542-199801000-00005; WILMORE DW, 1974, ANN SURG, V180, P653, DOI 10.1097/00000658-197410000-00031; WOOLF PD, 1992, ARCH SURG-CHICAGO, V127, P899	38	17	17	0	2	EXCERPTA MEDICA INC-ELSEVIER SCIENCE INC	BRIDGEWATER	685 ROUTE 202-206 STE 3, BRIDGEWATER, NJ 08807 USA	0002-9610			AM J SURG	Am. J. Surg.	NOV	2012	204	5					697	703		10.1016/j.amjsurg.2012.02.007			7	Surgery	Surgery	045YZ	WOS:000311734000031	22578406				2021-06-18	
J	Burke, MJ; Chundamala, J; Tator, CH				Burke, Matthew J.; Chundamala, Josie; Tator, Charles H.			Deficiencies in Concussion Education in Canadian Medical Schools	CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES			English	Article							KNOWLEDGE	Background: Recent reports raise concern that physician knowledge of the identification and management of concussion may be deficient. There is little information known about the adequacy of concussion education provided to physicians or medical students. The present study assesses the concussion curriculum offered at medical schools in Canada. Methods: We asked all 17 Canadian medical schools to complete a questionnaire on their concussion curriculum, including the following: year of medical school offered; format/setting; and estimated teaching hours. The responses were organized into three categories: ( I) concussion-specific education; (2) head injury education incorporating a concussion component; and (3) no concussion education. Results: Replies were received from 14 (82%) of the 17 medical schools in Canada. Of the 14 responding schools, four (29%) provided concussion-specific education, six (43%) offered head injury education that incorporated a concussion component, and four (29%) reported no concussion teaching in their curriculum. Conclusion: We found deficiencies in the concussion education curriculum provided in the majority of Canadian medical schools. To address this issue, we recommend that all medical schools should, at a minimum, include a one-hour formal concussion-specific teaching session in an early year of their curriculum to be followed by clinical exposure to concussed patients in the later years of medical school. Future studies will be necessary to evaluate if these recommended curricular enhancements are effective in remedying the reported gaps in physicians' concussion knowledge and whether the improved curriculum translates into better care for patients suffering concussion.	Univ Toronto, Toronto, ON M5T 2S8, Canada; Toronto Western Hosp, Toronto, ON M5T 2S8, Canada	Tator, CH (corresponding author), Univ Toronto, ThinkFirst Canada Toronto Western Hosp, 399 Bathurst St,Ste 4W-433, Toronto, ON M5T 2S8, Canada.	charles.tator@uhn.ca			Ontario Neurotrauma Foundation	This research study was supported by funding from the Ontario Neurotrauma Foundation.	Boggild M, 2012, CAN J NEUROL SCI, V39, P361, DOI 10.1017/S0317167100013524; Colantonio A, 2010, CAN J NEUROL SCI, V37, P783, DOI 10.1017/S0317167100051441; Covassin T, 2009, J ATHL TRAINING, V44, P400, DOI 10.4085/1062-6050-44.4.400; Cusimano MD, 2009, CAN J NEUROL SCI, V36, P315, DOI 10.1017/S0317167100007046; Demorest RA, 2005, PEDIATRICS, V115, P28, DOI 10.1542/peds.2004-0266; Guilmette TJ, 2007, BRAIN INJURY, V21, P1039, DOI 10.1080/02699050701633080; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; Medical Council of Canada, OBJ QUAL EX; Provvidenza CF, 2009, BRIT J SPORT MED, V43, pI68, DOI 10.1136/bjsm.2009.058180	9	17	17	0	5	CANADIAN JOURNAL NEUROLOGICAL SCIENCES INC	CALGARY	709-7015 MACLEOD TRAIL SW, CALGARY, AB T2H 2K6, CANADA	0317-1671			CAN J NEUROL SCI	Can. J. Neurol. Sci.	NOV	2012	39	6					763	766		10.1017/S0317167100015584			4	Clinical Neurology	Neurosciences & Neurology	034FX	WOS:000310859000009	23230614	Bronze			2021-06-18	
J	Costine, BA; Quebeda-Clerkin, PB; Dodge, CP; Harris, BT; Hillier, SC; Duhaime, AC				Costine, Beth A.; Quebeda-Clerkin, Patricia B.; Dodge, Carter P.; Harris, Brent T.; Hillier, Simon C.; Duhaime, Ann-Christine			Neuron-Specific Enolase, but Not S100B or Myelin Basic Protein, Increases in Peripheral Blood Corresponding to Lesion Volume after Cortical Impact in Piglets	JOURNAL OF NEUROTRAUMA			English	Article						age; biomarkers; controlled cortical impact	TRAUMATIC BRAIN-INJURY; SERUM-LEVELS; CEREBROSPINAL-FLUID; INFANTS; MARKERS	A peripheral indicator of the presence and magnitude of brain injury has been a sought-after tool by clinicians. We measured neuron-specific enolase (NSE), myelin basic protein (MBP), and S100B, prior to and after scaled cortical impact in immature pigs, to determine if these purported markers increase after injury, correlate with the resulting lesion volume, and if these relationships vary with maturation. Scaled cortical impact resulted in increased lesion volume with increasing age. Concentrations of NSE, but not S100B or MBP, increased after injury in all age groups. The high variability of S100B concentrations prior to injury may have precluded detection of an increase due to injury. Total serum markers were estimated, accounting for the allometric growth of blood volume, and resulted in a positive correlation of both NSE and S100B with lesion volume. Even with allometric scaling of blood volume and a uniform mechanism of injury, NSE had only a fair to poor predictive value. In a clinical setting, where the types of injuries are varied, more investigation is required to yield a panel of serum markers that can reliably predict the extent of injury. Allometric scaling may improve estimation of serum marker release in pediatric populations.	[Costine, Beth A.; Duhaime, Ann-Christine] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Neurosurg, Boston, MA USA; [Quebeda-Clerkin, Patricia B.] Childrens Hosp Cent Calif, Dept Neurosurg, Madera, CA USA; [Dodge, Carter P.; Hillier, Simon C.] Dartmouth Hitchcock Med Ctr, Dept Anesthesiol, Dartmouth Med Sch, Lebanon, NH 03766 USA; [Harris, Brent T.] Georgetown Univ, Med Ctr, Dept Pathol, Washington, DC 20007 USA; [Harris, Brent T.] Georgetown Univ, Med Ctr, Dept Neurol, Washington, DC 20007 USA	Costine, BA (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Neurosurg, 149 13th St,Room 3-405, Charlestown, MA 02129 USA.	bcostine@partners.org			NIH's National Institute of Child Health and Human Development [R01 (HD45364-5)]; Pediatric Neurosurgery Research Fund from the Children's Hospital at Dartmouth; Nicolas T. Zervas Endowed Chair Fund of Massachusetts General Hospital Department of Neurosurgery; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD045364] Funding Source: NIH RePORTER	This study was supported by an R01 (HD45364-5) from the NIH's National Institute of Child Health and Human Development, the Pediatric Neurosurgery Research Fund from the Children's Hospital at Dartmouth, and the Nicolas T. Zervas Endowed Chair Fund of Massachusetts General Hospital Department of Neurosurgery.	Abraham H, 2010, INT J DEV NEUROSCI, V28, P401, DOI 10.1016/j.ijdevneu.2010.03.004; Bechtel K, 2009, PEDIATRICS, V124, pE697, DOI 10.1542/peds.2008-1493; Berger RP, 2006, PEDIATRICS, V117, P325, DOI 10.1542/peds.2005-0711; Berger RP, 2005, J NEUROSURG, V103, P61, DOI 10.3171/ped.2005.103.1.0061; Berger RP, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.2.e31; Blyth BJ, 2009, J NEUROTRAUM, V26, P1497, DOI [10.1089/neu.2008.0738, 10.1089/neu.2008-0738]; BUSH JA, 1955, AM J PHYSIOL, V181, P9; Cata JP, 2011, BRIT J ANAESTH, V107, P844, DOI 10.1093/bja/aer338; Costine B.A., 2011, ISOFLURANE SOLE ANES; Darrow DC, 1928, J CLIN INVEST, V5, P243, DOI 10.1172/JCI100156; Duhaime AC, 2000, J NEUROSURG, V93, P455, DOI 10.3171/jns.2000.93.3.0455; Geyer C, 2009, J NEUROS-PEDIATR, V4, P339, DOI 10.3171/2009.5.PEDS08481; Gyorgy A, 2011, J NEUROTRAUM, V28, P1121, DOI 10.1089/neu.2010.1561; HANSEN TWR, 1992, PEDIATR RES, V32, P524, DOI 10.1203/00006450-199211000-00005; Harauz G, 2009, BIOCHEMISTRY-US, V48, P8094, DOI 10.1021/bi901005f; HARDEMARK HG, 1988, STROKE, V19, P1140, DOI 10.1161/01.STR.19.9.1140; HULLIN DA, 1980, BIOCHIM BIOPHYS ACTA, V628, P98, DOI 10.1016/0304-4165(80)90355-4; Jevtovic-Todorovic V, 2003, J NEUROSCI, V23, P876, DOI 10.1523/jneurosci.23-03-00876.2003; Jonsson H, 2000, J CARDIOTHOR VASC AN, V14, P698, DOI 10.1053/jcan.2000.18444; Kleindienst A, 2005, J NEUROTRAUM, V22, P645, DOI 10.1089/neu.2005.22.645; Knibbe CAJ, 2005, BRIT J CLIN PHARMACO, V59, P705, DOI 10.1111/j.1365-2125.2005.02239.x; Missios S, 2009, J NEUROTRAUM, V26, P1943, DOI [10.1089/neu.2009.0956, 10.1089/neu.2009-0956]; Nemergut M, 2011, ANN M SOC PED AN SAN; Nylen K, 2008, ACTA NEUROCHIR, V150, P221, DOI 10.1007/s00701-007-1489-2; OLIVA D, 1989, GENE, V79, P355, DOI 10.1016/0378-1119(89)90217-5; Pelinka LE, 2005, SHOCK, V24, P119, DOI 10.1097/01.shk.0000168876.68154.43; Piazza O, 2007, PEDIATR NEUROSURG, V43, P258, DOI 10.1159/000103304; Portela LVC, 2002, CLIN CHEM, V48, P950; Rainey T, 2009, RESUSCITATION, V80, P341, DOI 10.1016/j.resuscitation.2008.11.021; Rizzi S, 2010, ANN NY ACAD SCI, V1199, P43, DOI 10.1111/j.1749-6632.2009.05173.x; Rothermundt M, 2003, MICROSC RES TECHNIQ, V60, P614, DOI 10.1002/jemt.10303; Rothoerl RD, 2000, ACTA NEUROCHIR, V142, P199, DOI 10.1007/s007010050024; Woertgen C, 2001, J NEUROTRAUM, V18, P569, DOI 10.1089/089771501300227378; YAMAZAKI Y, 1995, SURG NEUROL, V43, P267, DOI 10.1016/0090-3019(95)80012-6; Zhao H, 2012, RESUSCITATION, V83, P913, DOI 10.1016/j.resuscitation.2012.01.001	35	17	20	0	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	NOV	2012	29	17					2689	2695		10.1089/neu.2012.2428			7	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	047QU	WOS:000311856400010	22867012	Green Published			2021-06-18	
J	DiLeonardi, AM; Huh, JW; Raghupathi, R				DiLeonardi, Ann Mae; Huh, Jimmy W.; Raghupathi, Ramesh			Differential Effects of FK506 on Structural and Functional Axonal Deficits After Diffuse Brain Injury in the Immature Rat	JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY			English	Article						Axonal injury; Calcineurin; Compound action potential; FK506; Immature rat; Neurofilament; Traumatic brain injury	FLUID PERCUSSION INJURY; SPINAL-CORD-INJURY; CORPUS-CALLOSUM; STRETCH INJURY; CYCLOSPORINE-A; NEUROFILAMENT COMPACTION; UNMYELINATED AXONS; WHITE-MATTER; HEAD-INJURY; AXOLEMMAL PERMEABILITY	Diffuse axonal injury is a major component of traumatic brain injury in children and correlates with long-term cognitive impairment. Traumatic brain injury in adult rodents has been linked to a decrease in compound action potential (CAP) in the corpus callosum, but information on trauma-associated diffuse axonal injury in immature rodents is limited. We investigated the effects of closed head injury on CAP in the corpus callosum of 17-day-old rats. The injury resulted in CAP deficits of both myelinated and unmyelinated fibers in the corpus callosum between 1 and 14 days postinjury (dpi). These deficits were accompanied by intra-axonal dephosphorylation of the 200-kDa neurofilament subunit (NF200) at 1 and 3 dpi, a decrease in total NF200 at 3 dpi and axonal degeneration at 3 and 7 dpi. Although total phosphatase activity decreased at 1 dpi, calcineurin activity was unchanged. The calcineurin inhibitor, FK506, significantly attenuated the injury-induced NF200 dephosphorylation of NF200 at 3 dpi and axonal degeneration at 3 and 7 dpi but did not affect the decrease in NF200 protein levels or impaired axonal transport. FK506 had no effect on CAP deficits at 3 dpi but exacerbated the deficit in only the myelinated fibers at 7 dpi. Thus, in contrast to adult animals, FK506 treatment did not improve axonal function in brain-injured immature animals, suggesting that calcineurin may not contribute to impaired axonal function.	[Raghupathi, Ramesh] Drexel Univ, Coll Med, Dept Neurobiol & Anat, Philadelphia, PA 19129 USA; [DiLeonardi, Ann Mae; Raghupathi, Ramesh] Drexel Univ, Coll Med, Program Neurosci, Philadelphia, PA 19129 USA; [Huh, Jimmy W.] Childrens Hosp Philadelphia, Dept Anesthesiol & Crit Care, Philadelphia, PA 19104 USA	Raghupathi, R (corresponding author), Drexel Univ, Coll Med, Dept Neurobiol & Anat, 2900 Queen Lane, Philadelphia, PA 19129 USA.	rramesh@drexelmed.edu		DiLeonardi, Ann Mae/0000-0002-1476-7726	 [R01-HD061963];  [K08-NS053651]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD061963] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K08NS053651] Funding Source: NIH RePORTER	These studies are supported in part by R01-HD061963 and K08-NS053651.	Adelson PD, 2001, J NEUROTRAUM, V18, P967, DOI 10.1089/08977150152693674; Ai JL, 2007, J NEUROTRAUM, V24, P960, DOI 10.1089/neu.2006.0224; Ai JL, 2007, EXP BRAIN RES, V177, P95, DOI 10.1007/s00221-006-0654-9; Babikian T, 2005, PEDIATR NEUROL, V33, P184, DOI 10.1016/j.pediatrneurol.2005.03.015; Babikian T, 2009, PEDIATR NEUROL, V41, P406, DOI 10.1016/j.pediatrneurol.2009.06.002; Baker AJ, 2002, J NEUROTRAUM, V19, P587, DOI 10.1089/089771502753754064; Bales JW, 2010, BRAIN RES, V1358, P211, DOI 10.1016/j.brainres.2010.08.029; Bales JW, 2010, J NEUROTRAUM, V27, P109, DOI 10.1089/neu.2009.1072; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; Buki A, 1999, J NEUROTRAUM, V16, P511, DOI 10.1089/neu.1999.16.511; Buki A, 1999, J NEUROPATH EXP NEUR, V58, P365; Chung RS, 2005, J NEUROTRAUM, V22, P1081, DOI 10.1089/neu.2005.22.1081; Colley BS, 2010, EXP NEUROL, V224, P241, DOI 10.1016/j.expneurol.2010.03.026; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Creed JA, 2011, J NEUROTRAUM, V28, P547, DOI 10.1089/neu.2010.1729; DEWAEGH SM, 1992, CELL, V68, P451, DOI 10.1016/0092-8674(92)90183-D; DiLeonardi AM, 2009, BRAIN RES, V1263, P174, DOI 10.1016/j.brainres.2009.01.021; EYER J, 1988, BIOCHEM J, V252, P655, DOI 10.1042/bj2520655; FERN R, 1995, J NEUROPHYSIOL, V74, P369; Gennarelli TA, 1996, NEUROPATH APPL NEURO, V22, P509, DOI 10.1111/j.1365-2990.1996.tb01126.x; GUANDALINI P, 1989, EXP BRAIN RES, V74, P453; HALL GF, 1995, J COMP NEUROL, V353, P38, DOI 10.1002/cne.903530106; Huh JW, 2008, EXP NEUROL, V213, P84, DOI 10.1016/j.expneurol.2008.05.009; Iwata A, 2004, J NEUROSCI, V24, P4605, DOI 10.1523/JNEUROSCI.0515-03.2004; Jafari SS, 1998, J NEUROTRAUM, V15, P955, DOI 10.1089/neu.1998.15.955; Jafari SS, 1997, J NEUROCYTOL, V26, P207, DOI 10.1023/A:1018588114648; Kurz JE, 2005, BRAIN RES, V1048, P153, DOI 10.1016/j.brainres.2005.04.062; Kurz JE, 2005, J NEUROTRAUM, V22, P476, DOI 10.1089/neu.2005.22.476; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; Ma M, 2009, EXP NEUROL, V215, P119, DOI 10.1016/j.expneurol.2008.09.024; Marmarou CR, 2006, EXP NEUROL, V197, P353, DOI 10.1016/j.expneurol.2005.10.003; Maxwell WL, 1995, J NEUROCYTOL, V24, P925, DOI 10.1007/BF01215643; Maxwell WL, 1999, J NEUROTRAUM, V16, P273, DOI 10.1089/neu.1999.16.273; Maxwell WL, 1997, J NEUROTRAUM, V14, P419, DOI 10.1089/neu.1997.14.419; NIXON RA, 1994, J CELL BIOL, V126, P1031, DOI 10.1083/jcb.126.4.1031; Nottingham S, 2002, EXP NEUROL, V177, P242, DOI 10.1006/exnr.2002.7975; Okonkwo DO, 1998, BRAIN RES, V784, P1, DOI 10.1016/S0006-8993(97)01075-5; Okonkwo DO, 1999, NEUROREPORT, V10, P353, DOI 10.1097/00001756-199902050-00026; Pettus EH, 1996, BRAIN RES, V722, P1, DOI 10.1016/0006-8993(96)00113-8; POVLISHOCK JT, 1983, J NEUROPATH EXP NEUR, V42, P225, DOI 10.1097/00005072-198305000-00002; PRESTON RJ, 1983, EXP NEUROL, V79, P808, DOI 10.1016/0014-4886(83)90044-4; Raghupathi R, 2002, J NEUROTRAUM, V19, P843, DOI 10.1089/08977150260190438; Raghupathi R, 2007, J NEUROTRAUM, V24, P1596, DOI 10.1089/neu.2007.3790; Reeves TM, 2007, BRAIN RES, V1154, P225, DOI 10.1016/j.brainres.2007.04.002; Reeves TM, 2012, J NEUROPATH EXP NEUR, V71, P198, DOI 10.1097/NEN.0b013e3182482590; Reeves TM, 2005, EXP NEUROL, V196, P126, DOI 10.1016/j.expneurol.2005.07.014; Saatman KE, 2003, J CEREBR BLOOD F MET, V23, P34, DOI 10.1097/01.WCB.0000035040.10031.B0; Saatman KE, 1996, J NEUROPATH EXP NEUR, V55, P850, DOI 10.1097/00005072-199607000-00010; Saljo A, 2000, J NEUROTRAUM, V17, P719, DOI 10.1089/089771500415454; Schumacher PA, 1999, NEUROSCIENCE, V91, P733, DOI 10.1016/S0306-4522(98)00552-1; Setkowicz Z, 2004, EPILEPSY RES, V61, P63, DOI 10.1016/j.eplepsyres.2004.06.001; Singleton RH, 2001, J NEUROTRAUM, V18, P607, DOI 10.1089/089771501750291846; Staal JA, 2010, J NEUROCHEM, V112, P1147, DOI 10.1111/j.1471-4159.2009.06531.x; Stone JR, 2004, EXP NEUROL, V190, P59, DOI 10.1016/j.expneurol.2004.05.022; Stone JR, 1999, ACTA NEUROPATHOL, V97, P335, DOI 10.1007/s004010050996; Stone JR, 2001, EXP NEUROL, V172, P320, DOI 10.1006/exnr.2001.7818; STYS PK, 1990, P NATL ACAD SCI USA, V87, P4212, DOI 10.1073/pnas.87.11.4212; TANAKA T, 1993, METHOD FIND EXP CLIN, V15, P77; Tong KA, 2004, ANN NEUROL, V56, P36, DOI 10.1002/ana.20123; von Reyn CR, 2009, J NEUROSCI, V29, P10350, DOI 10.1523/JNEUROSCI.2339-09.2009; Wakita H, 1998, BRAIN RES, V792, P105, DOI 10.1016/S0006-8993(98)00126-7	61	17	17	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0022-3069			J NEUROPATH EXP NEUR	J. Neuropathol. Exp. Neurol.	NOV	2012	71	11					959	972		10.1097/NEN.0b013e31826f5876			14	Clinical Neurology; Neurosciences; Pathology	Neurosciences & Neurology; Pathology	030CF	WOS:000310544800003	23095847	Bronze, Green Accepted			2021-06-18	
J	Hu, HT; Xiao, F; Yan, YQ; Wen, SQ; Zhang, L				Hu, Hai-Tao; Xiao, Feng; Yan, Yu-Qing; Wen, Shu-Qun; Zhang, Liang			The prognostic value of serum tau in patients with intracerebral hemorrhage	CLINICAL BIOCHEMISTRY			English	Article						Intracerebral hemorrhage; Outcome; Stroke; Tau	TRAUMATIC BRAIN-INJURY; ACUTE ISCHEMIC-STROKE; CEREBROSPINAL-FLUID; NEUROFIBRILLARY TANGLES; ALZHEIMERS-DISEASE; PROTEIN; PREDICT; LOCALIZATION; MORTALITY; MARKER	Objectives: This study aimed to investigate the relationship between serum tau concentrations and 3-month clinical outcomes in patients with intracerebral hemorrhage. Design and methods: Serum tau concentrations of 176 patients were quantified by enzyme-linked immunosorbent assay. The end points were mortality and poor outcome (modified Rankin Scale score > 2) after 3 months. Results: 110 patients (62.5%) had a poor outcome at 3 months. The 3-month mortality rate was 36.4% (64/176). A forward stepwise logistic regression selected serum tau concentration as an independent predictor for 3-month mortality (P = 0.002) and poor outcomes (P = 0.009) of patients. A receiver operating characteristic curve analysis showed that serum tau concentration predicted 3-month mortality (P = 0.001) and poor outcomes (P = 0.001) statistically significantly. The area under curve of tau was similar to that of the National Institutes of Health Stroke Scale score for 3-month mortality (P = 0.715) and poor outcomes (P = 0.315). In a combined logistic-regression model, tau statistically significantly improved the area under curve of the National Institutes of Health Stroke Scale score for the prediction of 3-month poor outcome (P = 0.039), but not for the prediction of 3-month mortality (P = 0.106). Conclusions: Serum tau concentration represents a novel biomarker for predicting mortality and poor outcomes at 3 months in patients with intracerebral hemorrhage. (C) 2012 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.	[Hu, Hai-Tao; Yan, Yu-Qing; Wen, Shu-Qun; Zhang, Liang] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Neurol, Hangzhou 310000, Zhejiang, Peoples R China; [Xiao, Feng] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Neurosurg, Hangzhou 310000, Zhejiang, Peoples R China	Zhang, L (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Neurol, 88 Jiefang Rd, Hangzhou 310000, Zhejiang, Peoples R China.	haohaowangwan@126.com					Andersen KK, 2009, STROKE, V40, P2068, DOI 10.1161/STROKEAHA.108.540112; Ariesen MJ, 2005, J NEUROL NEUROSUR PS, V76, P839, DOI 10.1136/jnnp.2004.048223; Bielewicz J, 2011, J MOL NEUROSCI, V43, P241, DOI 10.1007/s12031-010-9403-4; Bitsch A, 2002, EUR NEUROL, V47, P45, DOI 10.1159/000047946; Brott T, 1997, STROKE, V28, P1, DOI 10.1161/01.STR.28.1.1; Cheung C. M., 2008, Hong Kong Medical Journal, V14, P367; Franz G, 2003, NEUROLOGY, V60, P1457, DOI 10.1212/01.WNL.0000063313.57292.00; GOEDERT M, 1989, NEURON, V3, P519, DOI 10.1016/0896-6273(89)90210-9; Hesse Camilla, 2000, Journal of Alzheimer's Disease, V2, P199; HIMMLER A, 1989, MOL CELL BIOL, V9, P1381, DOI 10.1128/MCB.9.4.1381; Kothari U, 1996, STROKE, V27, P1304, DOI 10.1161/01.STR.27.8.1304; Kurzepa J, 2010, J CLIN NEUROSCI, V17, P997, DOI 10.1016/j.jocn.2010.01.005; Liliang PC, 2010, J SURG RES, V160, P302, DOI 10.1016/j.jss.2008.12.022; Otto M, 2003, RESTOR NEUROL NEUROS, V21, P191; Shiiya N, 2004, ANN THORAC SURG, V77, P2034, DOI 10.1016/j.athoracsur.2003.12.057; Tapiola T, 1997, NEUROREPORT, V8, P3961, DOI 10.1097/00001756-199712220-00022; Tashiro K, 1997, NEUROREPORT, V8, P2797, DOI 10.1097/00001756-199708180-00029; WEINGARTEN MD, 1975, P NATL ACAD SCI USA, V72, P1858, DOI 10.1073/pnas.72.5.1858; Wunderlich MT, 2006, CLIN NEUROL NEUROSUR, V108, P558, DOI 10.1016/j.clineuro.2005.12.006; Zanier ER, 2008, ACTA NEUROCHIR SUPPL, V102, P339, DOI 10.1007/978-3-211-85578-2_65	20	17	17	0	7	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0009-9120	1873-2933		CLIN BIOCHEM	Clin. Biochem.	NOV	2012	45	16-17					1320	1324		10.1016/j.clinbiochem.2012.06.003			5	Medical Laboratory Technology	Medical Laboratory Technology	036WY	WOS:000311064200009	22705449				2021-06-18	
J	Kopterides, P; Theodorakopoulou, M; Nikitas, N; Ilias, I; Vassiliadi, DA; Orfanos, SE; Tsangaris, I; Maniatis, NA; Tsantes, AE; Travlou, A; Dimitriadis, G; Armaganidis, A; Ungerstedt, U; Dimopoulou, I				Kopterides, Petros; Theodorakopoulou, Maria; Nikitas, Nikitas; Ilias, Ioannis; Vassiliadi, Dimitra Argiro; Orfanos, Stylianos E.; Tsangaris, Iraklis; Maniatis, Nikolaos A.; Tsantes, Argirios E.; Travlou, Anthi; Dimitriadis, George; Armaganidis, Apostolos; Ungerstedt, Urban; Dimopoulou, Ioanna			Red blood cell transfusion affects microdialysis-assessed interstitial lactate/pyruvate ratio in critically ill patients with late sepsis	INTENSIVE CARE MEDICINE			English	Article						Transfusion; Sepsis; Lactate; Microdialysis; Microcirculation; Metabolism	TRAUMATIC BRAIN-INJURY; CARDIAC-SURGERY; ORGAN FAILURE; SEPTIC SHOCK; OXYGENATION; ANEMIA; MULTICENTER; METABOLISM; INFECTION; CARE	The aim of this study was to explore the effect of red blood cell (RBC) transfusion on microdialysis-assessed interstitial fluid metabolic parameters in septic patients. We conducted a retrospective study of 37 patients with severe sepsis/septic shock requiring transfusion of one to two RBC units. Interstitial fluid metabolic alterations were monitored by a microdialysis catheter inserted in the subcutaneous adipose tissue. Samples were collected before (T0) and after transfusion at two time-points: T1a and T1b; median post-transfusion times of 120 [interquartile range (IQR); 45-180] and 360 (IQR; 285-320) min. Lactate, pyruvate, glycerol and glucose concentrations were measured with a bedside analyzer, and the lactate/pyruvate (LP) ratio was calculated automatically. RBC transfusions decreased the LP ratio from (T0) 18.80 [interquartile range (IQR); 14.85-27.45] to (T1a) 17.80 (IQR; 14.35-25.20; P < 0.05) and (T1b) 17.90 (IQR; 14.45-22.75; P < 0.001), while there was also significant interindividual variation. Post-transfusion LP ratio changes at T1a [r = -0.42; 95 % confidence interval (CI), -0.66 to -0.098; P = 0.01] and T1b (r = -0.68; 95 % [CI], -0.82 to -0.44; P < 0.001) were significantly correlated with the pre-transfusion LP ratio, but not with baseline demographic characteristics, vital signs, severity scores, hemoglobin level and blood lactate. RBC storage time and leukocyte reduction had no influence on the tissue metabolic response to transfusion. Tissue oxygenation is affected by RBC transfusion in critically ill septic patients. Monitoring of tissue LP ratio by microdialysis may represent a useful method for individual clinical management.	[Kopterides, Petros; Theodorakopoulou, Maria; Nikitas, Nikitas; Orfanos, Stylianos E.; Tsangaris, Iraklis; Maniatis, Nikolaos A.; Armaganidis, Apostolos; Dimopoulou, Ioanna] Univ Athens, Attiko Univ Hosp, Dept Crit Care Med 2, Sch Med, Athens 12462, Greece; [Ilias, Ioannis] Elena Hosp, Dept Endocrinol, Athens, Greece; [Vassiliadi, Dimitra Argiro; Dimitriadis, George] Univ Athens, Attiko Univ Hosp, Dept Internal Med 2, Sch Med, Athens 12462, Greece; [Tsantes, Argirios E.; Travlou, Anthi] Univ Athens, Attiko Univ Hosp, Sch Med, Hematol Lab, Athens 12462, Greece; [Tsantes, Argirios E.; Travlou, Anthi] Univ Athens, Attiko Univ Hosp, Sch Med, Blood Bank Unit, Athens 12462, Greece; [Ungerstedt, Urban] Karolinska Inst, Dept Physiol & Pharmacol, Stockholm, Sweden	Kopterides, P (corresponding author), Univ Athens, Attiko Univ Hosp, Dept Crit Care Med 2, Sch Med, 1 Rimini St, Athens 12462, Greece.	petkop@ath.forthnet.gr	Ilias, Ioannis/AAA-2927-2020; Tsangaris, Iraklis/AAA-3627-2020; ILIAS, IOANNIS/AAI-4033-2020	Tsangaris, Iraklis/0000-0003-4395-0471; ILIAS, IOANNIS/0000-0001-5718-7441			Ba VN, 2003, CRIT CARE MED, V31, P406, DOI 10.1097/01.CCM.0000048623.00778.3F; Corwin HL, 2000, CRIT CARE MED, V28, P3098, DOI 10.1097/00003246-200008000-00079; Corwin HL, 2004, CRIT CARE MED, V32, P39, DOI 10.1097/01.CCM.0000104112.34142.79; Creteur J, 2009, CRIT CARE, V13, DOI 10.1186/cc8009; De Backer D, 2002, AM J RESP CRIT CARE, V166, P98, DOI 10.1164/rccm.200109-016OC; De Backer D, 2010, CURR OPIN CRIT CARE, V16, P250, DOI 10.1097/MCC.0b013e3283383621; Dellinger RP, 2008, CRIT CARE MED, V36, P296, DOI 10.1097/01.CCM.0000298158.12101.41; Dimopoulou I, 2011, SHOCK, V35, P343, DOI 10.1097/SHK.0b013e318206aafa; Doerschug KC, 2007, AM J PHYSIOL-HEART C, V293, pH1065, DOI 10.1152/ajpheart.01237.2006; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Gogos C, 2010, CRIT CARE, V14, DOI 10.1186/cc9031; Hebert PC, 1999, NEW ENGL J MED, V340, P409, DOI 10.1056/NEJM199902113400601; Hollenberg SM, 2010, INTENS CARE MED, V36, P1807, DOI 10.1007/s00134-010-1973-7; Jhanji S, 2009, INTENS CARE MED, V35, P671, DOI 10.1007/s00134-008-1325-z; Kopterides P, 2011, INTENS CARE MED, V37, P1756, DOI 10.1007/s00134-011-2336-8; Lelubre C, 2011, ANN INTENSIVE CARE, V1, DOI 10.1186/2110-5820-1-43; Levy MM, 2003, CRIT CARE MED, V31, P1250, DOI 10.1097/01.CCM.0000050454.01978.3B; MARIK PE, 1993, JAMA-J AM MED ASSOC, V269, P3024, DOI 10.1001/jama.269.23.3024; Mohnle P, 2011, INTENS CARE MED, V37, P97, DOI 10.1007/s00134-010-2017-z; Nichol AD, 2010, CRIT CARE, V14, DOI 10.1186/cc8888; Oliver E, 2009, INTENS CARE MED, V35, P1548, DOI 10.1007/s00134-009-1526-0; Orlov D, 2009, TRANSFUSION, V49, P682, DOI 10.1111/j.1537-2995.2008.02022.x; Ospina-Tascon G, 2010, INTENS CARE MED, V36, P949, DOI 10.1007/s00134-010-1843-3; Pojar M, 2008, EUR J CARDIO-THORAC, V33, P899, DOI 10.1016/j.ejcts.2008.01.039; Pottecher J, 2010, INTENS CARE MED, V36, P1867, DOI 10.1007/s00134-010-1966-6; Rivers E, 2001, NEW ENGL J MED, V345, P1368, DOI 10.1056/NEJMoa010307; Ruggieri AJ, 2010, CRIT CARE CLIN, V26, P567, DOI 10.1016/j.ccc.2010.04.007; Sakr Y, 2007, CRIT CARE MED, V35, P1639, DOI 10.1097/01.CCM.0000269936.73788.32; Timofeev I, 2011, BRAIN, V134, P484, DOI 10.1093/brain/awq353; Ungerstedt U, 2004, CURR PHARM DESIGN, V10, P2145, DOI 10.2174/1381612043384105; Vallet B, 2007, BEST PRACT RES-CLIN, V21, P173, DOI 10.1016/j.bpa.2007.02.003; Vallet B, 2010, CRIT CARE, V14, DOI 10.1186/cc8854; Vincent JL, 2002, JAMA-J AM MED ASSOC, V288, P1499, DOI 10.1001/jama.288.12.1499; Wang JK, 2010, VOX SANG, V98, P2, DOI 10.1111/j.1423-0410.2009.01223.x; Westbrook A, 2010, INTENS CARE MED, V36, P1138, DOI 10.1007/s00134-010-1867-8; Zallen G, 1999, AM J SURG, V178, P570, DOI 10.1016/S0002-9610(99)00239-1; Zygun DA, 2009, CRIT CARE MED, V37, P1074, DOI 10.1097/CCM.0b013e318194ad22	37	17	18	0	9	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0342-4642	1432-1238		INTENS CARE MED	Intensive Care Med.	NOV	2012	38	11					1843	1850		10.1007/s00134-012-2635-8			8	Critical Care Medicine	General & Internal Medicine	026CN	WOS:000310250500014	22777518				2021-06-18	
J	Li, L; Chopp, M; Ding, GL; Qu, CS; Li, QJ; Lu, M; Wang, SY; Nejad-Davarani, SP; Mahmood, A; Jiang, Q				Li, Lian; Chopp, Michael; Ding, Guang Liang; Qu, Chang Sheng; Li, Qing Jiang; Lu, Mei; Wang, Shiyang; Nejad-Davarani, Siamak P.; Mahmood, Asim; Jiang, Quan			MRI measurement of angiogenesis and the therapeutic effect of acute marrow stromal cell administration on traumatic brain injury	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						angiogenesis; marrow stromal cells; MRI; perfusion; ventricular dilation	CEREBRAL-BLOOD-FLOW; ENDOTHELIAL GROWTH-FACTOR; ISCHEMIC BOUNDARY ZONE; BONE-MARROW; ADULT RATS; STROKE; TRANSPLANTATION; NEUROGENESIS; EXPRESSION; PERFUSION	Using magnetic resonance imaging (MRI), the present study was undertaken to investigate the therapeutic effect of acute administration of human bone marrow stromal cells (hMSCs) on traumatic brain injury (TBI) and to measure the temporal profile of angiogenesis after the injury with or without cell intervention. Male Wistar rats (300 to 350 g, n=18) subjected to controlled cortical impact TBI were intravenously injected with 1 mL of saline (n=9) or hMSCs in suspension (n=9, 3x10(6) hMSCs) 6 hours after TBI. In-vivo MRI acquisitions of T2-weighted imaging, cerebral blood flow (CBF), three-dimensional (3D) gradient echo imaging, and blood-to-brain transfer constant (Ki) of contrast agent were performed on all animals 2 days after injury and weekly for 6 weeks. Sensorimotor function and spatial learning were evaluated. Volumetric changes in the trauma-induced brain lesion and the lateral ventricles were tracked and quantified using T2 maps, and hemodynamic alteration and blood-brain barrier permeability were monitored by CBF and Ki, respectively. Our data show that transplantation of hMSCs 6 hours after TBI leads to reduced cerebral atrophy, early and enhanced cerebral tissue perfusion and improved functional outcome compared with controls. The hMSC treatment increases angiogenesis in the injured brain, which may promote neurologic recovery after TBI. Journal of Cerebral Blood Flow & Metabolism (2012) 32, 2023-2032; doi:10.1038/jcbfm.2012.106; published online 11 July 2012	[Li, Lian; Chopp, Michael; Ding, Guang Liang; Li, Qing Jiang; Nejad-Davarani, Siamak P.; Jiang, Quan] Henry Ford Hosp, Dept Neurol, Detroit, MI 48202 USA; [Chopp, Michael; Wang, Shiyang; Jiang, Quan] Oakland Univ, Dept Phys, Rochester, MI USA; [Qu, Chang Sheng; Mahmood, Asim] Henry Ford Hosp, Dept Neurosurg, Detroit, MI 48202 USA; [Lu, Mei] Henry Ford Hosp, Dept Biostat & Res Epidemiol, Detroit, MI 48202 USA	Jiang, Q (corresponding author), Henry Ford Hosp, Dept Neurol, B126,Educ & Res Bldg,2799 W Grand Blvd, Detroit, MI 48202 USA.	qjiang1@hfhs.org	Wang, Shiyang/C-1729-2012; Nejad-Davarani, Siamak/AAH-8399-2021	Nejad-Davarani, Siamak/0000-0002-2415-6689; Ding, Guangliang/0000-0003-1286-5901	National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50 NS23393, RO1 NS064134, RO1 NS48349, RO1 NS43324, HL64766]; Mort and Brigitte Harris Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL064766] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS043324, R01NS064134, P50NS023393, R01NS048349] Funding Source: NIH RePORTER	This work was supported by National Institute of Neurological Disorders and Stroke grants, P50 NS23393, RO1 NS064134, RO1 NS48349, RO1 NS43324, HL64766, and the Mort and Brigitte Harris Foundation.	Bonne O, 2003, PSYCHIAT RES-NEUROIM, V124, P141, DOI 10.1016/S0925-4927(03)00109-4; Borlongan CV, 2004, BRAIN RES, V1009, P26, DOI 10.1016/j.brainres.2004.02.050; CHEN HH, 1994, STROKE, V25, P1651, DOI 10.1161/01.STR.25.8.1651; Chen JL, 2005, J CEREBR BLOOD F MET, V25, P281, DOI 10.1038/sj.jcbfm.9600034; Chen JL, 2003, CIRC RES, V92, P692, DOI 10.1161/01.RES.0000063425.51108.8D; Chen XG, 2002, J NEUROSCI RES, V69, P687, DOI 10.1002/jnr.10334; Chopp M, 2007, STROKE, V38, P827, DOI 10.1161/01.STR.0000250235.80253.e9; Chopp M, 2006, ADV EXP MED BIOL, V585, P49; Cunningham AS, 2005, BRAIN, V128, P1931, DOI 10.1093/brain/awh536; Ewing JR, 2003, MAGN RESON MED, V50, P283, DOI 10.1002/mrm.10524; Iihoshi S, 2004, BRAIN RES, V1007, P1, DOI 10.1016/j.brainres.2003.09.084; Jiang Q, 2005, NEUROIMAGE, V28, P698, DOI 10.1016/j.neuroimage.2005.06.063; Kochanek PM, 2002, J NEUROTRAUM, V19, P1029, DOI 10.1089/089771502760341947; Leventhal C, 1999, MOL CELL NEUROSCI, V13, P450, DOI 10.1006/mcne.1999.0762; Li L, 2006, J CEREBR BLOOD F MET, V26, P1366, DOI 10.1038/sj.jcbfm.9600288; Li LA, 2011, J NEUROTRAUM, V28, P535, DOI 10.1089/neu.2010.1619; Li L, 2010, J CEREBR BLOOD F MET, V30, P653, DOI 10.1038/jcbfm.2009.238; Li L, 2009, STROKE, V40, P936, DOI 10.1161/STROKEAHA.108.527713; Mahmood A, 2004, J NEUROTRAUM, V21, P33, DOI 10.1089/089771504772695922; Mahmood A, 2003, NEUROSURGERY, V53, P697, DOI 10.1227/01.NEU.0000079333.61863.AA; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Morgan R, 2007, NEUROL RES, V29, P375, DOI 10.1179/016164107X204693; Nag S, 1997, J NEUROPATH EXP NEUR, V56, P912, DOI 10.1097/00005072-199708000-00009; Opydo-Chanek M, 2007, ACTA NEUROBIOL EXP, V67, P187; Parr AM, 2007, BONE MARROW TRANSPL, V40, P609, DOI 10.1038/sj.bmt.1705757; Pasco A, 2007, J NEUROTRAUM, V24, P1321, DOI 10.1089/neu.2006.0136; Pettersson A, 2000, LAB INVEST, V80, P99, DOI 10.1038/labinvest.3780013; Plate KH, 1999, J NEUROPATH EXP NEUR, V58, P313, DOI 10.1097/00005072-199904000-00001; Qu CS, 2008, BRAIN RES, V1208, P234, DOI 10.1016/j.brainres.2008.02.042; Qu CS, 2011, BRAIN RES, V1371, P129, DOI 10.1016/j.brainres.2010.10.088; Rossignol J, 2009, J CELL MOL MED, V13, P2547, DOI 10.1111/j.1582-4934.2009.00657.x; Seevinck PR, 2010, ANGIOGENESIS, V13, P101, DOI 10.1007/s10456-010-9174-0; Shen LH, 2010, GLIA, V58, P1074, DOI 10.1002/glia.20988; Shen Q, 2004, J CEREBR BLOOD F MET, V24, P887, DOI 10.1097/01.WCB.0000124321.60992.87; Tha-Zuchman O, 2010, J CEREB BLOOD FLOW M, V30, P1008; Wu HT, 2011, NEUROSURGERY, V68, P1363, DOI 10.1227/NEU.0b013e31820c06b9; Xiong Y, 2010, CURR OPIN INVEST DR, V11, P298; Xiong Y, 2009, EXPERT OPIN EMERG DR, V14, P67, DOI [10.1517/14728210902769601, 10.1517/14728210902769601 ]; Xiong Y, 2009, BRAIN RES, V1263, P183, DOI 10.1016/j.brainres.2009.01.032; Zacharek A, 2007, J CEREBR BLOOD F MET, V27, P1684, DOI 10.1038/sj.jcbfm.9600475	40	17	18	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0271-678X			J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	NOV	2012	32	11					2023	2032		10.1038/jcbfm.2012.106			10	Endocrinology & Metabolism; Hematology; Neurosciences	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	033AV	WOS:000310765600007	22781331	Green Published, Bronze			2021-06-18	
J	O'Neil-Pirozzi, TM; Goldstein, R; Strangman, GE; Glenn, MB				O'Neil-Pirozzi, Therese M.; Goldstein, Richard; Strangman, Gary E.; Glenn, Mel B.			Test-re-test reliability of the Hopkins Verbal Learning Test-Revised in individuals with traumatic brain injury	BRAIN INJURY			English	Article						Test-re-test reliability; traumatic brain injury; memory	TEST-RETEST RELIABILITY; RELIABLE CHANGE INDEXES; VIRTUAL PLANNING TEST; CLOSED HEAD-INJURY; ALTERNATE FORMS; MEMORY TESTS; REHABILITATION; RECOGNITION; RIVASTIGMINE; DEVICES	Primary objective: To determine test-re-test reliability of the Hopkins Verbal Learning Test-Revised (HVLT-R) in a group of individuals with traumatic brain injury (TBI). Research design: Single-group repeated measures design. Methods and procedures: Seventy-five individuals with TBI were administered the HVLT-R twice, with 6-8 weeks between the two test sessions. Main outcomes and results: Test-re-test reliability on HVLT-R scoring parameters ranged from 0.537-0.818, with seven of the eight scoring parameters exhibiting r>0.6. At re-test, scores did not significantly change on any of the eight HVLT-R scoring parameters. Conclusions: HVLT-R use with individuals with TBI is supported. Test-re-test reliability of total recall and delayed recall sub-scores was particularly high.	[O'Neil-Pirozzi, Therese M.] Northeastern Univ, Speech Language Pathol & Audiol Dept, Boston, MA 02115 USA; [O'Neil-Pirozzi, Therese M.; Goldstein, Richard; Strangman, Gary E.; Glenn, Mel B.] Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, Boston, MA USA; [Goldstein, Richard; Glenn, Mel B.] Harvard Univ, Sch Med, Boston, MA USA; [Strangman, Gary E.] Harvard Univ, Sch Med, Dept Psychiat, Massachusetts Gen Hosp, Boston, MA 02115 USA	O'Neil-Pirozzi, TM (corresponding author), Northeastern Univ, Speech Language Pathol & Audiol Dept, 103 Forsyth Bldg, Boston, MA 02115 USA.	t.oneil-pirozzi@neu.edu		Strangman, Gary/0000-0001-8896-2164	National Institute on Disability and Rehabilitation Research, US Department of EducationUS Department of Education [H133A020513]	This work was supported in part by grant #H133A020513 from the National Institute on Disability and Rehabilitation Research, US Department of Education. The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper.	American Psychiatric Association, 1994, DIAGN STAT MAN MENT; BADDELEY A, 1987, NEUROBEHAVIORAL RECO, P295; Baddeley AD, 2001, J COGNITIVE NEUROSCI, V13, P357, DOI 10.1162/08989290151137403; Benedict RHB, 1998, CLIN NEUROPSYCHOL, V12, P43, DOI 10.1076/clin.12.1.43.1726; Benedict RHB, 1998, J CLIN EXP NEUROPSYC, V20, P339, DOI 10.1076/jcen.20.3.339.822; Benedict RHB, 2005, J INT NEUROPSYCH SOC, V11, P727, DOI 10.1017/S1355617705050782; Bird CM, 2003, BRIT J CLIN PSYCHOL, V42, P407, DOI 10.1348/014466503322528946; Brandt J., 2001, HOPKINS VERBAL LEARN; Brandt J., 1991, CLIN NEUROPSYCHOL, V5, P125, DOI 10.1080/13854049108403297.; BUTTERS N, 1986, CORTEX, V22, P11, DOI 10.1016/S0010-9452(86)80030-2; Chu BC, 2007, J CLIN EXP NEUROPSYC, V29, P617, DOI 10.1080/13803390600878893; Consensus conference, 1999, J AM MED ASS, V282, P974; Dawson B, 2004, BASIC CLIN BIOSTATIS; Delis DC, 2000, CALIFORNIA VERBAL LE; Delis DC, 1987, CALIFORNIA VERBAL LE; Hart T, 2003, BRAIN INJURY, V17, P401, DOI 10.1080/0269905021000038438; Johnson MK, 1990, BRAIN ORG MEMORY CEL, P106; Kennedy M, 2006, AHSA LEAD, V11, P34; Lengenfelder J, 2007, REHABIL PSYCHOL, V52, P290, DOI 10.1037/0090-5550.52.3.290; LEVIN HS, 1982, NEUROBEHAVIORAL CONS; Lowe C, 1998, NEUROPSYCHOLOGIA, V36, P915, DOI 10.1016/S0028-3932(98)00036-0; McKinlay W, 1999, REHABILITATION ADULT, V3, P74; Morey CE, 2003, BRAIN INJURY, V17, P809, DOI 10.1080/0269905031000088586; Moscovitch M, 2005, DYNAMIC COGNITIVE PROCESSES, P333, DOI 10.1007/4-431-27431-6_14; O'Neil-Pirozzi TM, 2010, BRAIN INJURY, V24, P509, DOI 10.3109/02699051003601697; O'Neil-Pirozzi TM, 2010, J HEAD TRAUMA REHAB, V25, P43, DOI 10.1097/HTR.0b013e3181bf24b1; O'Neil-Pirozzi TM, 2005, BRAIN INJURY, V19, P1191, DOI 10.1080/02699050500149916; O'Neil-Pirozzi TM, 2004, BRAIN INJURY, V18, P179, DOI 10.1080/0269905031000149560; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; Portney L., 2015, FDN CLIN RES APPL PR, V3rd ed.; RASMUSSON DX, 1995, ARCH CLIN NEUROPSYCH, V10, P21, DOI 10.1016/0887-6177(94)E0001-6; Rousson V, 2002, STAT MED, V21, P3431, DOI 10.1002/sim.1253; RYAN T V, 1992, Brain Injury, V6, P175, DOI 10.3109/02699059209029656; SCHACTER DL, 1977, CORTEX, V13, P150, DOI 10.1016/S0010-9452(77)80006-3; Silver JM, 2006, NEUROLOGY, V67, P748, DOI 10.1212/01.wnl.0000234062.98062.e9; Silver JM, 2009, BRAIN INJURY, V23, P123, DOI 10.1080/02699050802649696; Sohlberg M. M., 2001, COGNITIVE REHABILITA; Sohlberg M. M., 2005, REHABILITATION TRAUM, P47; Steinberg WJ, 2010, MENTAL MEASUREMENTS, P16; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Tulving E, 2000, OXFORD HDB MEMORY, P33; Wilson BA, 1998, NEUROPSYCHOL REHABIL, V8, P213, DOI 10.1080/713755570; Woods SP, 2005, ASSESSMENT, V12, P96, DOI 10.1177/1073191104270342; Woods SP, 2006, ARCH CLIN NEUROPSYCH, V21, P413, DOI 10.1016/j.acn.2006.06.002	44	17	17	0	13	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	NOV	2012	26	12					1425	1430		10.3109/02699052.2012.694561			6	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	022DL	WOS:000309935400003	22715921				2021-06-18	
J	Shafaroodi, H; Moezi, L; Fakhrzad, A; Hassanipour, M; Rezayat, M; Dehpour, AR				Shafaroodi, Hamed; Moezi, Leila; Fakhrzad, Ali; Hassanipour, Mahsa; Rezayat, Mehdi; Dehpour, Ahmad Reza			The involvement of nitric oxide in the anti-seizure effect of acute atorvastatin treatment in mice	NEUROLOGICAL RESEARCH			English	Article						Atorvastatin; Convulsion; Seizure; Nitric oxide; Mice	SMOOTH-MUSCLE-CELLS; A REDUCTASE INHIBITORS; PENTYLENETETRAZOL-INDUCED SEIZURES; TRAUMATIC BRAIN-INJURY; SYNTHASE EXPRESSION; ALZHEIMER-DISEASE; MESSENGER-RNA; BLOOD-FLOW; STATIN; SIMVASTATIN	Objectives: In addition to reducing the serum level of cholesterol, statins have various pleiotropic effects such as increasing nitric oxide and reducing oxidative stress, neuroinflammation, and neurotoxicity. Increasing evidence indicates that statins are neuroprotective in several conditions, including stroke, cerebral ischemia and traumatic brain injury. However, only a few studies have investigated whether statins modulate seizure activity. Methods: In the current study, we investigated whether acute treatment with atorvastatin alters the seizures induced by electroshock or pentylenetetrazole in mice. We also evaluated whether nitrergic system is involved in the effects of acute atorvastatin on seizure. Results: The results of the present study demonstrate that acute atorvastatin (10 and 20 mg/kg) treatment decreased the incidence of tonic seizure and death in electroshock-induced seizure model. We also showed that acute atorvastatin (10 mg/kg) treatment increased the clonic seizure threshold in pentylenetetrazole-seizure model. Acute L-NAME (5 mg/kg), a non-selective inhibitor of nitric oxide synthase, or aminoguanidine (100 mg/kg), a selective inhibitor of inducible nitric oxide synthase, administration prevented the anti-convulsant effect of atorvastatin in electroshock-induced seizure model. We also demonstrated that acute L-NAME (5 mg/kg) or aminoguanidine (100 mg/kg) administration decreased the enhanced clonic latency of clonic seizure threshold induced by atorvastatin in mice in pentylenetetrazole model. Discussion: In conclusion, anti-convulsant effect of atorvastatin was demonstrated in two seizure models of electroshock and intraperitoneal pentylenetetrazole. Nitric oxide release, probably through inducible nitric oxide synthase at least in part is responsible for this effect.	[Moezi, Leila; Fakhrzad, Ali] Shiraz Univ Med Sci, Sch Med, Dept Pharmacol, Shiraz, Iran; [Shafaroodi, Hamed; Hassanipour, Mahsa; Rezayat, Mehdi] Islamic Azad Univ, Dept Pharmacol & Toxicol, Pharmaceut Sci Branch, Tehran, Iran; [Shafaroodi, Hamed; Hassanipour, Mahsa; Rezayat, Mehdi] Islamic Azad Univ, Pharmaceut Sci Res Ctr, Tehran, Iran; [Dehpour, Ahmad Reza] Univ Tehran Med Sci, Sch Med, Dept Pharmacol, Tehran, Iran	Moezi, L (corresponding author), Shiraz Univ Med Sci, Sch Med, Dept Pharmacol, Shiraz, Iran.	moezile@yahoo.com	Hassanipour, Mahsa/H-1732-2017; Dehpour, Ahmad Reza/I-6422-2019; moezi, leila/D-5127-2012	Hassanipour, Mahsa/0000-0003-2350-0326; Dehpour, Ahmad Reza/0000-0002-8001-5565; moezi, leila/0000-0002-6990-9138			Angalakuditi M, 2011, NEUROPSYCH DIS TREAT, V7, P585, DOI 10.2147/NDT.S24966; BREDT DS, 1990, NATURE, V347, P768, DOI 10.1038/347768a0; BUISSON A, 1993, NEUROREPORT, V4, P444, DOI 10.1097/00001756-199304000-00027; Chen H, 2000, HYPERTENSION, V36, P923, DOI 10.1161/01.HYP.36.6.923; Chen SF, 2007, LIFE SCI, V81, P288, DOI 10.1016/j.lfs.2007.05.023; Endres M, 1998, P NATL ACAD SCI USA, V95, P8880, DOI 10.1073/pnas.95.15.8880; Funck VR, 2011, EPILEPSIA, V52, P2094, DOI 10.1111/j.1528-1167.2011.03261.x; Hattori Y, 2002, CARDIOVASC RES, V54, P649, DOI 10.1016/S0008-6363(02)00266-3; Hemandez-Romero MD, 2008, J NEUROCHEM, V105, P445, DOI 10.1111/j.1471-4159.2007.05148.x; Homayoun H, 2002, EPILEPSY RES, V48, P33, DOI 10.1016/S0920-1211(01)00316-3; John S, 2001, J AM COLL CARDIOL, V37, P1351, DOI 10.1016/S0735-1097(01)01128-7; Johnson-Anuna LN, 2007, J NEUROCHEM, V101, P77, DOI 10.1111/j.1471-4159.2006.04375.x; KARATINOS J, 1995, CLIN NEUROPHARMACOL, V18, P482, DOI 10.1097/00002826-199512000-00002; Khavandgar S, 2003, PHARMACOL BIOCHEM BE, V74, P795, DOI 10.1016/S0091-3057(02)01077-8; Kolyada AY, 2001, HYPERTENSION, V38, P1024, DOI 10.1161/hy1101.093103; Kotamraju S, 2007, CANCER RES, V67, P7386, DOI 10.1158/0008-5472.CAN-07-0993; Kupferberg H, 2001, EPILEPSIA, V42, P7, DOI 10.1046/j.1528-1157.2001.0420s4007.x; Laufs U, 1998, J BIOL CHEM, V273, P24266, DOI 10.1074/jbc.273.37.24266; Laufs U, 1997, J BIOL CHEM, V272, P31725, DOI 10.1074/jbc.272.50.31725; Laufs U, 1998, CIRCULATION, V97, P1129, DOI 10.1161/01.CIR.97.12.1129; Lee JK, 2008, NEUROSCI LETT, V440, P260, DOI 10.1016/j.neulet.2008.05.112; LOSCHER W, 1991, EPILEPSY RES, V8, P171, DOI 10.1016/0920-1211(91)90062-K; Macaulay RJB, 1999, J NEURO-ONCOL, V42, P1, DOI 10.1023/A:1006164406202; MONCADA S, 1993, NEW ENGL J MED, V329, P2002; MONCADA S, 1991, PHARMACOL REV, V43, P109; MULSCH A, 1994, NEUROREPORT, V5, P2325; Nidhi G, 1999, METHOD FIND EXP CLIN, V21, P609; Omori H, 2002, BRIT J CLIN PHARMACO, V54, P395, DOI 10.1046/j.1365-2125.2002.01677.x; Ortego M, 1999, ATHEROSCLEROSIS, V147, P253, DOI 10.1016/S0021-9150(99)00193-8; OSONOE K, 1994, BRAIN RES, V663, P338, DOI 10.1016/0006-8993(94)91283-1; Piermartiri TCB, 2009, NEUROTOX RES, V16, P106, DOI 10.1007/s12640-009-9057-6; Ramirez C, 2011, J ALZHEIMERS DIS, V24, P161, DOI 10.3233/JAD-2010-101653; Rangel P, 2005, ARQ NEURO-PSIQUIAT, V63, P972, DOI 10.1590/S0004-282X2005000600013; Rikitake Y, 2005, CIRC RES, V97, P1232, DOI 10.1161/01.RES.0000196564.18314.23; Selley ML, 2005, BRAIN RES, V1037, P1, DOI 10.1016/j.brainres.2004.02.083; Sparks DL, 2005, ARCH NEUROL-CHICAGO, V62, P753, DOI 10.1001/archneur.62.5.753; STARR MS, 1993, PHARMACOL BIOCHEM BE, V45, P321, DOI 10.1016/0091-3057(93)90246-P; Stepien KM, 2012, EUR J PHARMACOL, V674, P20, DOI 10.1016/j.ejphar.2011.10.030; Tannous M, 1999, THROMB HAEMOSTASIS, V82, P1390; THEARD MA, 1995, NEUROREPORT, V6, P921, DOI 10.1097/00001756-199504190-00024; Vaughan CJ, 2000, J AM COLL CARDIOL, V35, P1, DOI 10.1016/S0735-1097(99)00525-2; Wang HC, 2007, EXP NEUROL, V206, P59, DOI 10.1016/j.expneurol.2007.03.031; Wang J, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008386.pub2; Wolozin B, 2000, ARCH NEUROL-CHICAGO, V57, P1439, DOI 10.1001/archneur.57.10.1439; WOODBURY LA, 1952, AM J PHYSIOL, V170, P661; WOODBURY LA, 1952, ARCH INT PHARMACOD T, V92, P97; Zacco A, 2003, J NEUROSCI, V23, P11104	47	17	18	0	7	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0161-6412	1743-1328		NEUROL RES	Neurol. Res.	NOV	2012	34	9					847	853		10.1179/1743132812Y.0000000080			7	Clinical Neurology; Neurosciences	Neurosciences & Neurology	027NJ	WOS:000310359100003	22909758				2021-06-18	
J	Tsan, JY; Zeber, JE; Stock, EM; Sun, FF; Copeland, LA				Tsan, Jack Y.; Zeber, John E.; Stock, Eileen M.; Sun, Fangfang; Copeland, Laurel A.			Primary Care Mental Health Integration and Treatment Retention Among Iraq and Afghanistan War Veterans	PSYCHOLOGICAL SERVICES			English	Article						integrated care; mental health services; primary care; posttraumatic stress disorder; veterans	TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; PSYCHIATRIC-DIAGNOSES; RETURNING VETERANS; MEDICAL-CARE; SERVICES; AFFAIRS; PTSD; ACCESS; SYSTEM	Despite the high prevalence of posttraumatic stress disorder (PTSD) and medical comorbidity among veterans from Iraq/Afghanistan (OEF/OIF), keeping these patients engaged in health care is challenging. Primary Care Mental Health Integration (PC-MHI), an initiative in the Veterans Health Administration (VA), sought to improve access to mental health care from within primary care. This study examined the lag between first PC-MHI visit and next mental/medical care visit, if any, and the relationship of PC-MHI with short-term (subsequent year) and long-term (4 years later) use of VA. We identified 2,470 OEF/OIF veterans receiving care during fiscal year 2006 (FY06) in a regional VA health care system. Unconditional survival analysis modeled time to next mental/medical visit and logistic regression modeled short- and long-term care as a function of PC-MHI, demo-graphics, and clinical covariates. Of 181 patients in the PC-MHI program, 60%/ 18% returned for mental/medical care within 1 month, and 82%/74% within 1 year. Sixty-one percent (1,503) were still using the VA in FY09. Short-term mental care was related to prior-year PC-MHI. Consistent correlates of short- and long-term mental/medical care included physical comorbidity and Priority 1 status. Most patients attended mental health appointments subsequent to PC-MHI, and PC-MHI was correlated with mental health treatment retention in adjusted models for our cohort. Need for treatment, notably VA Priority 1 status and physical comorbidity, were the primary correlates of care-seeking. Developing innovative approaches to engaging new veterans in care remains imperative as multiple options will be necessary to meet the needs of these complex patients.	[Tsan, Jack Y.] US Dept Vet Affairs, VISN 17 Ctr Excellence Res Returning War Vet, Waco, TX 76711 USA; [Tsan, Jack Y.] Texas A&M Hlth Sci Ctr, Houston, TX USA	Tsan, JY (corresponding author), US Dept Vet Affairs, VISN 17 Ctr Excellence Res Returning War Vet, 4800 Mem Dr 151C, Waco, TX 76711 USA.	Jack.Tsan@va.gov	Copeland, Laurel A/C-3763-2017	Copeland, Laurel A/0000-0002-9478-0209			Atun R, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-780; Ayalon L, 2007, AM J GERIAT PSYCHIAT, V15, P906, DOI 10.1097/JGP.0b013e318135113e; Batten SV, 2008, J CLIN PSYCHOL, V64, P928, DOI 10.1002/jclp.20513; Blazina C, 2001, PSYCHOTHERAPY, V38, P297, DOI 10.1037/0033-3204.38.3.297; Block R, 2008, PSYCHIAT SERV, V59, P860, DOI 10.1176/ps.2008.59.8.860; Brawer PA, 2010, FAM SYST HEALTH, V28, P175, DOI 10.1037/a0020342; Brown MC, 2011, J NERV MENT DIS, V199, P797, DOI 10.1097/NMD.0b013e31822fc9bf; Butler M, 2011, J AMBUL CARE MANAG, V34, P113, DOI 10.1097/JAC.0b013e31820ef605; Carlson KF, 2010, J TRAUMA STRESS, V23, P17, DOI 10.1002/jts.20483; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Copeland Laurel A, 2011, Depress Res Treat, V2011, P370962, DOI 10.1155/2011/370962; Copeland LA, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-84; Copeland LA, 2011, J AFFECT DISORDERS, V130, P226, DOI 10.1016/j.jad.2010.10.017; Cully Jeffrey A, 2008, Psychol Serv, V5, P320, DOI 10.1037/a0013719; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Druss BG, 2001, ARCH GEN PSYCHIAT, V58, P861, DOI 10.1001/archpsyc.58.9.861; Frayne SM, 2011, J GEN INTERN MED, V26, P33, DOI 10.1007/s11606-010-1497-4; Gironda RJ, 2009, REHABIL PSYCHOL, V54, P247, DOI 10.1037/a0016906; Gravely AA, 2011, J REHABIL RES DEV, V48, P21, DOI 10.1682/JRRD.2009.08.0116; Harpaz-Rotem I, 2011, PSYCHIAT SERV, V62, P22, DOI 10.1176/ps.62.1.pss6201_0022; Jakupcak M, 2008, J NERV MENT DIS, V196, P425, DOI 10.1097/NMD.0b013e31817108ed; Kazis LE, 1998, ARCH INTERN MED, V158, P626, DOI 10.1001/archinte.158.6.626; Krahn DD, 2006, PSYCHIAT SERV, V57, P946, DOI 10.1176/appi.ps.57.7.946; Pfeiffer PN, 2011, PSYCHIAT SERV, V62, P422, DOI 10.1176/ps.62.4.pss6204_0422; Pomerantz A, 2008, GEN HOSP PSYCHIAT, V30, P546, DOI 10.1016/j.genhosppsych.2008.09.004; Pomerantz AS, 2010, FAM SYST HEALTH, V28, P78, DOI 10.1037/a0020341; Possemato K, 2010, PSYCHOL TRAUMA-US, V2, P218, DOI 10.1037/a0019236; Post EP, 2010, FAM SYST HEALTH, V28, P83, DOI 10.1037/a0020130; Pugh MJV, 2005, EPILEPSIA, V46, P1820, DOI 10.1111/j.1528-1167.2005.00291.x; Reger MA, 2009, J CLIN PSYCHIAT, V70, P1266, DOI 10.4088/JCP.08m04361; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Seal KH, 2010, J TRAUMA STRESS, V23, P5, DOI 10.1002/jts.20493; Selim Alfredo J, 2004, J Ambul Care Manage, V27, P281; Shiner B, 2009, MIL MED, V174, P1024, DOI 10.7205/MILMED-D-03-6608; Sigford BJ, 2008, ARCH PHYS MED REHAB, V89, P160, DOI 10.1016/j.apmr.2007.09.015; Spoont MR, 2010, PSYCHIAT SERV, V61, P58, DOI 10.1176/appi.ps.61.1.58; Summerall EL, 2010, PSYCHIAT ANN, V40, P563, DOI 10.3928/00485713-20101022-07; Wang PS, 2007, LANCET, V370, P841, DOI 10.1016/S0140-6736(07)61414-7; Watts BV, 2007, QUAL SAF HEALTH CARE, V16, P378, DOI 10.1136/qshc.2007.022418; WIERZBICKI M, 1993, PROF PSYCHOL-RES PR, V24, P190, DOI 10.1037/0735-7028.24.2.190; Worley MJ, 2010, J SUBST ABUSE TREAT, V39, P124, DOI 10.1016/j.jsat.2010.05.009; Yano EM, 2010, J GEN INTERN MED, V25, P56, DOI 10.1007/s11606-009-1116-4; Zeiss AM, 2008, J CLIN PSYCHOL MED S, V15, P73, DOI 10.1007/s10880-008-9100-4; Zivin K, 2010, MED CARE, V48, P843, DOI 10.1097/MLR.0b013e3181e5792b	44	17	17	0	11	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	1541-1559	1939-148X		PSYCHOL SERV	Psychol. Serv.	NOV	2012	9	4			SI		336	348		10.1037/a0028308			13	Psychology, Clinical	Psychology	036ZP	WOS:000311071100002	22545824				2021-06-18	
J	Garland, P; Broom, LJ; Quraishe, S; Dalton, PD; Skipp, P; Newman, TA; Perry, VH				Garland, Patrick; Broom, Lucy J.; Quraishe, Shmma; Dalton, Paul D.; Skipp, Paul; Newman, Tracey A.; Perry, V. Hugh			Soluble Axoplasm Enriched from Injured CNS Axons Reveals the Early Modulation of the Actin Cytoskeleton	PLOS ONE			English	Article							SPINAL-CORD-INJURY; RAT PERIPHERAL-NERVE; WALLERIAN DEGENERATION; OPTIC-NERVE; CELL-DEATH; NEURONS; TRANSPORT; REGENERATION; HIPPOCAMPAL; RETROGRADE	Axon injury and degeneration is a common consequence of diverse neurological conditions including multiple sclerosis, traumatic brain injury and spinal cord injury. The molecular events underlying axon degeneration are poorly understood. We have developed a novel method to enrich for axoplasm from rodent optic nerve and characterised the early events in Wallerian degeneration using an unbiased proteomics screen. Our detergent-free method draws axoplasm into a dehydrated hydrogel of the polymer poly(2-hydroxyethyl methacrylate), which is then recovered using centrifugation. This technique is able to recover axonal proteins and significantly deplete glial contamination as confirmed by immunoblotting. We have used iTRAQ to compare axoplasm-enriched samples from naive vs injured optic nerves, which has revealed a pronounced modulation of proteins associated with the actin cytoskeleton. To confirm the modulation of the actin cytoskeleton in injured axons we focused on the RhoA pathway. Western blotting revealed an augmentation of RhoA and phosphorylated cofilin in axoplasm-enriched samples from injured optic nerve. To investigate the localisation of these components of the RhoA pathway in injured axons we transected axons of primary hippocampal neurons in vitro. We observed an early modulation of filamentous actin with a concomitant redistribution of phosphorylated cofilin in injured axons. At later time-points, RhoA is found to accumulate in axonal swellings and also colocalises with filamentous actin. The actin cytoskeleton is a known sensor of cell viability across multiple eukaryotes, and our results suggest a similar role for the actin cytoskeleton following axon injury. In agreement with other reports, our data also highlights the role of the RhoA pathway in axon degeneration. These findings highlight a previously unexplored area of axon biology, which may open novel avenues to prevent axon degeneration. Our method for isolating CNS axoplasm also represents a new tool to study axon biology.	[Garland, Patrick; Broom, Lucy J.; Perry, V. Hugh] Univ Southampton, Southampton Gen Hosp, Ctr Biol Sci, Southampton, Hants, England; [Dalton, Paul D.] Shanghai Jiao Tong Univ, Med X Res Inst, Shanghai 200030, Peoples R China	Garland, P (corresponding author), Univ Southampton, Southampton Gen Hosp, Ctr Biol Sci, Southampton, Hants, England.	pg1p07@soton.ac.uk	Dalton, Paul/AAO-9805-2021; Perry, V. Hugh/Y-2935-2019; Newman, Tracey A/I-8884-2012	Dalton, Paul/0000-0001-9602-4151; Newman, Tracey A/0000-0002-3727-9258; Garland, Patrick/0000-0002-7679-6426	(EU) NeuroproMiSe [LSHM-CT-2005-018637]; Multiple Sclerosis Society (United Kingdom); Kerkut Trust (United Kingdom)	(EU) NeuroproMiSe: LSHM-CT-2005-018637. Multiple Sclerosis Society (United Kingdom). Kerkut Trust (United Kingdom). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin D, 2010, J NEUROTRAUM, V27, P349; Arundell M, 2011, LAB CHIP, V11, P3001, DOI 10.1039/c1lc20120d; Beirowski B, 2010, J NEUROPATH EXP NEUR, V69, P455, DOI 10.1097/NEN.0b013e3181da84db; Bishop AL, 2000, BIOCHEM J, V348, P241, DOI 10.1042/0264-6021:3480241; BRADY ST, 1982, SCIENCE, V218, P1129, DOI 10.1126/science.6183745; BUCKMASTER EA, 1995, EUR J NEUROSCI, V7, P1596, DOI 10.1111/j.1460-9568.1995.tb01155.x; CAMPENOT RB, 1994, J NEUROBIOL, V25, P599, DOI 10.1002/neu.480250603; Coleman MP, 2010, ANNU REV NEUROSCI, V33, P245, DOI 10.1146/annurev-neuro-060909-153248; Conrad S, 2005, J COMP NEUROL, V487, P166, DOI 10.1002/cne.20561; Fath T, 2009, NAT PROTOC, V4, P78, DOI 10.1038/nprot.2008.199; Franklin-Tong VE, 2008, BIOCHEM J, V413, P389, DOI 10.1042/BJ20080320; Hejcl A, 2008, PHYSIOL RES, V57, pS121; Hemphill MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022899; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; Kerschensteiner M, 2005, NAT MED, V11, P572, DOI 10.1038/nm1229; Larsen AK, 2008, BIOCHEM J, V411, P657, DOI 10.1042/BJ20070522; LAWSON LJ, 1994, J NEUROCYTOL, V23, P729, DOI 10.1007/BF01268086; LUNN ER, 1989, EUR J NEUROSCI, V1, P27, DOI 10.1111/j.1460-9568.1989.tb00771.x; Madura T, 2004, EMBO REP, V5, P412, DOI 10.1038/sj.embor.7400117; MARQUIS JK, 1974, J NEUROCHEM, V23, P1085, DOI 10.1111/j.1471-4159.1974.tb10763.x; Masiero L, 1999, J CELL SCI, V112, P3205; Michaelevski I, 2010, MOL CELL PROTEOMICS, V9, P976, DOI 10.1074/mcp.M900369-MCP200; Minamide LS, 2000, NAT CELL BIOL, V2, P628; Morley SC, 2003, J CELL BIOCHEM, V88, P1066, DOI 10.1002/jcb.10449; Paul C, 2002, MOL CELL BIOL, V22, P816, DOI 10.1128/MCB.22.3.816-834.2002; Perlson E, 2004, MOL CELL PROTEOMICS, V3, P510, DOI 10.1074/mcp.M400004-MCP200; PERRY VH, 1991, EUR J NEUROSCI, V3, P102, DOI 10.1111/j.1460-9568.1991.tb00815.x; Pollard TD, 2009, SCIENCE, V326, P1208, DOI 10.1126/science.1175862; Rishal I, 2010, DEV NEUROBIOL, V70, P126, DOI 10.1002/dneu.20755; Saxena S, 2007, PROG NEUROBIOL, V83, P174, DOI 10.1016/j.pneurobio.2007.07.007; SCHLAEPFER WW, 1979, BRAIN RES, V168, P299, DOI 10.1016/0006-8993(79)90171-9; SCHLAEPFER WW, 1974, BRAIN RES, V78, P71, DOI 10.1016/0006-8993(74)90354-0; SCHMIED R, 1993, J NEUROSCI, V13, P4064; Taylor AM, 2009, J NEUROSCI, V29, P4697, DOI 10.1523/JNEUROSCI.6130-08.2009; Thomas SG, 2006, J CELL BIOL, V174, P221, DOI 10.1083/jcb.200604011; VERONESI B, 1988, EXP NEUROL, V101, P176, DOI 10.1016/0014-4886(88)90002-7; Waller A, 1850, PHILOS T R SOC LOND, V140, P423, DOI [10.1098/rspl.1843.0224, DOI 10.1098/RSTL.1850.0021, 10.1098/rstl.1850.0021]; Wu CH, 2012, NATURE, V488, P499, DOI 10.1038/nature11280; Yamagishi S, 2005, J BIOL CHEM, V280, P20384, DOI 10.1074/jbc.M501945200	39	17	18	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2012	7	10							e47552	10.1371/journal.pone.0047552			8	Multidisciplinary Sciences	Science & Technology - Other Topics	026VC	WOS:000310310200049	23115653	DOAJ Gold, Green Published, Green Accepted			2021-06-18	
J	Silva, MA; Nakase-Richardson, R; Sherer, M; Barnett, SD; Evans, CC; Yablon, SA				Silva, Marc A.; Nakase-Richardson, Risa; Sherer, Mark; Barnett, Scott D.; Evans, Clea C.; Yablon, Stuart A.			Posttraumatic Confusion Predicts Patient Cooperation During Traumatic Brain Injury Rehabilitation	AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION			English	Article						Brain Injuries; Confusion; Neurobehavioral Manifestations; Patient Compliance; Rehabilitation	WORKING ALLIANCE; AWARENESS; SEVERITY; RECOVERY; AMNESIA	Silva MA, Nakase-Richardson R, Sherer M, Barnett SD, Evans CC, Yablon SA: Posttraumatic confusion predicts patient cooperation during traumatic brain injury rehabilitation. Am J Phys Med Rehabil 2012; 91: 890-893. Scant research has examined the relationship between posttraumatic confusion (PTC) and cooperation during rehabilitation from moderate to severe traumatic brain injury. In this study, PTC and cooperation were examined in a prospective cohort of 74 inpatients with traumatic brain injury. Confusion was measured using the Confusion Assessment Protocol. Cooperation was rated on a 0-100 scale by rehabilitation therapists. Using multiple regression analysis, PTC significantly predicted cooperation (R-2 = 0.33, P < 0.001). Age at injury, education, days since injury, and Glasgow Come Scale scores were not significant predictors. Bivariate analyses indicated that four PTC symptoms significantly predicted poorer cooperation: daytime hypersomnolence (rho = -0.42, P < 0.001), agitation (rho = -0.39, P = 0.001), psychosis (rho = -0.39, P = 0.001), and cognitive impairment (rho = -0.24, P = 0.04). Results provide empirical support that PTC is associated with poorer cooperation and empirical justification for interventions to manage confusion during early recovery from traumatic brain injury.	[Silva, Marc A.; Nakase-Richardson, Risa] James A Haley Vet Hosp, Mental Hlth & Behav Sci Serv, Tampa, FL 33612 USA; [Nakase-Richardson, Risa; Barnett, Scott D.] Res Ctr Excellence Maximizing Rehabil Outcomes, Tampa, FL USA; [Nakase-Richardson, Risa] Univ S Florida, Dept Psychol, Tampa, FL 33620 USA; [Sherer, Mark] TIRR Mem Hermann, Houston, TX USA; [Sherer, Mark] Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX 77030 USA; [Evans, Clea C.] Methodist Rehabil Ctr, Jackson, MS USA; [Evans, Clea C.] Univ Mississippi, Med Ctr, Jackson, MS 39216 USA; [Yablon, Stuart A.] Glenrose Rehabil Hosp, Edmonton, AB, Canada; [Yablon, Stuart A.] Univ Alberta, Div Phys Med & Rehabil, Edmonton, AB, Canada	Nakase-Richardson, R (corresponding author), James A Haley Vet Hosp, Mental Hlth & Behav Sci Serv, 13000 Bruce B Downs Blvd,116B, Tampa, FL 33612 USA.		Silva, Marc A./J-1874-2019	Silva, Marc A./0000-0002-3879-6054	National Institute on Disability and Rehabilitation Research, Department of Education [H133A060038, H133A070043, H133A070027]	Financial disclosure statements have been obtained, and no conflicts of interest have been reported by the authors or by any individuals in control of the content of this article. Supported by grants from the National Institute on Disability and Rehabilitation Research, Department of Education (H133A060038, [TBI Model System National Data and Statistical Center], H133A070043 [Texas TBI Model System of TIRR], H133A070027, [North Texas TBI Model System]). However, the contents of this article do not necessarily represent the policy of the National Institute on Disability and Rehabilitation Research, Department of Education, and endorsement by the Federal Government should not be assumed. Statistical support was provided by the HSR&D/RR&D Center of Excellence for Maximizing Rehabilitation Outcomes (COE-HFP 09-156). Presented, in part, in poster format at the annual meeting of the American Psychological Association, Washington, DC, August 2011.	Horn TS, 2010, ARCH PHYS MED REHAB, V91, P30, DOI 10.1016/j.apmr.2009.08.148; Nakase-Richardson R, 2007, J NEUROL NEUROSUR PS, V78, P872, DOI 10.1136/jnnp.2006.104190; Nakase-Thompson R, 2004, BRAIN INJURY, V18, P131, DOI 10.1080/0269905031000149542; Schonberger M, 2006, NEUROPSYCHOL REHABIL, V16, P561, DOI 10.1080/09602010500263084; Schonberger M, 2006, NEUROPSYCHOL REHABIL, V16, P298, DOI 10.1080/09602010500176476; Schonberger M, 2006, BRAIN INJURY, V20, P445, DOI 10.1080/02699050600664772; Sherer M, 2005, ARCH PHYS MED REHAB, V86, P896, DOI 10.1016/j.apmr.2004.09.029; SHERER M, 2004, CONFUSION ASSESSMENT; Sherer M, 2003, ARCH PHYS MED REHAB, V84, pA1; Sherer M, 2008, ARCH PHYS MED REHAB, V89, P42, DOI 10.1016/j.apmr.2007.08.128; Sherer M, 2009, ARCH PHYS MED REHAB, V90, P1749, DOI 10.1016/j.apmr.2009.05.011; Stuss DT, 1999, J NEUROSURG, V90, P635, DOI 10.3171/jns.1999.90.4.0635	12	17	18	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0894-9115	1537-7385		AM J PHYS MED REHAB	Am. J. Phys. Med. Rehabil.	OCT	2012	91	10					890	893		10.1097/PHM.0b013e31825a1648			4	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	012FU	WOS:000309222100009	22660372				2021-06-18	
J	Song, KS; Ramnani, K; Bae, KC; Cho, CH; Lee, KJ; Son, ES				Song, Kwang Soon; Ramnani, Kirti; Bae, Ki Cheor; Cho, Chul Hyun; Lee, Kyung Jae; Son, Eun Seok			Indirect Reduction of the Radial Head in Children With Chronic Monteggia Lesions	JOURNAL OF ORTHOPAEDIC TRAUMA			English	Article						chronic Monteggia lesion; ulna osteotomy; closed reduction; children	ANNULAR LIGAMENT RECONSTRUCTION; ANTERIOR DISLOCATION; FRACTURE-DISLOCATIONS; ULNAR OSTEOTOMY	Objective: The purpose of this study was to report the long-term follow-up results of chronic Monteggia fractures treated with angulation-translation osteotomy of ulna and closed reduction of the radial head. Design: Retrospective. Setting: Level 1 trauma center. Patients: We retrospectively reviewed 10 missed Monteggia fractures in children. The mean age of the patients was 7.5 years (range, 6-10 years), and there were 2 girls and 8 boys. The mean duration of time between initial injury and initial presentation was 1.7 years (range, 6 weeks to 5 years). Intervention: Closed reduction with ulna osteotomy or lengthening was performed in all 10 cases. Annular ligament reconstruction (ALR) was done in 2 cases. Final follow-up ranged from 3 to 20 years (mean 10 years). Main Outcome Measurement: We assessed preoperative and postoperative radiographs to evaluate the quality of the radial head reduction. Clinical results were assessed according to the functional elbow score devised by Kim et al. Results: Radial head reduction was achieved and maintained in 8 of 10 cases after primary or secondary surgery. The radial head was mildly subluxated in one case and dislocated in another case at final follow-up. ALR was performed in only 2 cases. Open reduction and ALR is not required in every case, and its need should depend on intraoperative stability of radial head.	[Song, Kwang Soon; Ramnani, Kirti; Bae, Ki Cheor; Cho, Chul Hyun; Lee, Kyung Jae; Son, Eun Seok] Keimyung Univ, Dept Orthoped Surg, Taegu 700712, South Korea	Song, KS (corresponding author), Keimyung Univ, Dept Orthoped Surg, 194 Dongsandong, Taegu 700712, South Korea.	skspos@dsmc.or.kr		Song, Kwang Soon/0000-0001-6029-1901; Cho, Chul-Hyun/0000-0003-0252-8741			Bell Tawse A J, 1965, J Bone Joint Surg Br, V47, P718; BEST TN, 1994, J PEDIATR ORTHOPED, V14, P193, DOI 10.1097/01241398-199403000-00012; Bhaskar A, 2010, J CHILD ORTHOP, V4, P479, DOI 10.1007/s11832-010-0286-2; Cappellino A, 1998, J PEDIATR ORTHOPED, V18, P410, DOI 10.1097/00004694-199805000-00026; De Boeck H, 2000, CLIN ORTHOP RELAT R, P215; Degreff I, 2004, J ORTHOP TRAUMA, V18, P375, DOI 10.1097/00005131-200407000-00008; Devnani AS, 1997, INJURY, V28, P131, DOI 10.1016/S0020-1383(96)00160-X; Exner GU, 2001, J BONE JOINT SURG BR, V83B, P547, DOI 10.1302/0301-620X.83B4.11103; FREEDMAN L, 1988, J BONE JOINT SURG BR, V70, P846; Gyr BM, 2004, J PEDIATR ORTHOP B, V13, P402, DOI 10.1097/01202412-200411000-00011; Hasler CC, 2005, J BONE JOINT SURG BR, V87B, P88; HIRAYAMA T, 1987, J BONE JOINT SURG BR, V69, P639; Hui JHP, 2005, J PEDIATR ORTHOPED, V25, P501, DOI 10.1097/01.bpo.0000158812.37225.b3; Kim HT, 2002, J PEDIATR ORTHOPED, V22, P583, DOI 10.1097/00004694-200209000-00004; Kim HT, 2002, J PEDIATR ORTHOPED, V22, P591, DOI 10.1097/01.BPO.0000023140.69745.72; LLOYDROBERTS GC, 1977, J BONE JOINT SURG BR, V59, P402; Nakamura K, 2009, J BONE JOINT SURG AM, V91A, P1394, DOI 10.2106/JBJS.H.00644; ONER FC, 1993, J BONE JOINT SURG BR, V75, P577; Rodgers WB, 1996, J BONE JOINT SURG AM, V78A, P1322, DOI 10.2106/00004623-199609000-00005; Slongo TF, 2008, OPER ORTHOPADE TRAUM, V20, P435, DOI 10.1007/s00064-008-1414-8; STOLL TM, 1992, J BONE JOINT SURG BR, V74, P436; Wang MN, 2006, J ORTHOP TRAUMA, V20, P1, DOI 10.1097/01.bot.0000189881.75421.92	22	17	21	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0890-5339	1531-2291		J ORTHOP TRAUMA	J. Orthop. Trauma	OCT	2012	26	10					597	601		10.1097/BOT.0b013e3182548981			5	Orthopedics; Sport Sciences	Orthopedics; Sport Sciences	022LV	WOS:000309961800016	22495527				2021-06-18	
J	Ding, J; Yuan, F; Guo, Y; Chen, SW; Gao, WW; Wang, G; Cao, HL; Ju, SM; Chen, H; Zhang, PQ; Tian, HL				Ding, Jun; Yuan, Fang; Guo, Yan; Chen, Shi-Wen; Gao, Wen -Wei; Wang, Gan; Cao, He-Li; Ju, Shi-Ming; Chen, Hao; Zhang, Peng-Qi; Tian, Heng-Li			A prospective clinical study of routine repeat computed tomography (CT) after traumatic brain injury (TBI)	BRAIN INJURY			English	Article						Traumatic brain injury; routine computed tomography; progressive haemorrhage	MINIMAL HEAD-INJURY; RISK-FACTORS; HEMORRHAGE; MODERATE	Purpose: To discuss the repeated CT scanning in patients with traumatic brain injury (TBI) and to identify the conditions under which this approach is necessary. Methods: One hundred and seventy-one patients who suffered TBI but were not surgically treated were divided into two groups: the routine-repeat CT group (n=89) and the non-routine-repeat CT group (n=82). The patients' clinical characteristics were compared. T-tests and stepwise logistic regression were used for analysis. Patients in the routine-repeat CT group were divided into three groups according to GCS scores to determine the need for routinely repeated CT scans. Results: The results revealed statistically significant differences between the two groups in terms of neuro-ICU-LOS and LOS (p<0.01). No significant differences emerged with respect to hospital charges and GCS scores at discharge (p>0.05). AGE, international normalized ratio (INR), D-dimer concentration (DD), GCS scores and number of hours between the first CT scan and the injury (HCT1) were influential factors of developing progressive haemorrhage. Conclusion: The routine-repeat CT group fared better than did the non-routine-repeat CT group. Routinely repeated CTs were minimally effective among those with mild TBI, whereas this procedure demonstrated a significant effect on patients with moderate and severe TBI.	[Ding, Jun; Yuan, Fang; Guo, Yan; Chen, Shi-Wen; Gao, Wen -Wei; Wang, Gan; Cao, He-Li; Ju, Shi-Ming; Chen, Hao; Zhang, Peng-Qi; Tian, Heng-Li] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 6, Dept Neurosurg, Shanghai 200233, Peoples R China	Tian, HL (corresponding author), Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 6, Dept Neurosurg, Shanghai 200233, Peoples R China.	tianhengli1964@yahoo.com.cn			Shanghai Science and Technology CommitteeShanghai Science & Technology Committee [10JC1412500]	This work was supported by a grant from the Shanghai Science and Technology Committee (No. 10JC1412500). The authors report no conflicts of interest.	Brown CVR, 2007, J TRAUMA, V62, P1339, DOI 10.1097/TA.0b013e318054e25a; Brown CVR, 2004, J TRAUMA, V57, P939, DOI 10.1097/01.TA.0000149492.92558.03; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Chao A, 2001, J TRAUMA, V51, P870, DOI 10.1097/00005373-200111000-00008; Falimirski ME, 2003, J TRAUMA, V55, P1, DOI 10.1097/01.TA.0000071295.67263.A2; Figg RE, 2003, J TRAUMA, V55, P1061, DOI 10.1097/01.TA.0000096712.90133.5C; Kaups KL, 2004, J TRAUMA, V56, P475, DOI 10.1097/01.TA.0000114304.56006.D4; Narayan RK, 2008, J NEUROTRAUM, V25, P629, DOI 10.1089/neu.2007.0385; Oertel M, 2002, J NEUROSURG, V96, P109, DOI 10.3171/jns.2002.96.1.0109; Patel NY, 2000, J TRAUMA, V48, P367, DOI 10.1097/00005373-200003000-00001; Sifri ZC, 2004, AM J SURG, V187, P338, DOI 10.1016/j.amjsurg.2003.12.015; Sifri ZC, 2006, J TRAUMA, V61, P862, DOI 10.1097/01.ta.0000224225.54982.90; STEIN SC, 1993, NEUROSURGERY, V32, P25, DOI 10.1227/00006123-199301000-00004; Stein SC, 2008, J TRAUMA, V65, P66, DOI 10.1097/TA.0b013e318068d75f; Tabori U, 2000, CRIT CARE MED, V28, P840, DOI 10.1097/00003246-200003000-00038; Tian HL, 2008, NEUROSURG REV, V31, P431, DOI 10.1007/s10143-008-0153-5; Tian HL, 2008, SURG NEUROL, V69, P241, DOI 10.1016/j.surneu.2007.02.032; VALADKA AB, 2000, TRAUMA, P377; Velmahos GC, 2006, J TRAUMA, V60, P494, DOI 10.1097/01.ta.0000203546.14824.0d	19	17	18	0	5	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	SEP	2012	26	10					1211	1216		10.3109/02699052.2012.667591			6	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	984GR	WOS:000307178600006	22571813				2021-06-18	
J	Hocomb, EM; Millis, SR; Hanks, RA				Hocomb, Erin M.; Millis, Scott R.; Hanks, Robin A.			Comorbid Disease in Persons With Traumatic Brain Injury: Descriptive Findings Using the Modified Cumulative Illness Rating Scale	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Brain injuries; Comorbidity; Rehabilitation	INPATIENT REHABILITATION; METHODOLOGIC CONSIDERATIONS; CO-MORBIDITY; RESOURCE USE; AGE; POPULATION; VALIDATION; LENGTH; STAY; HYPERTENSION	Holcomb EM, Millis SR, Hanks RA. Comorbid disease in persons with traumatic brain injury: descriptive findings using the Modified Cumulative Illness Rating Scale. Arch Phys Med Rehabil 2012;93:1338-42. Objective: To provide descriptive findings regarding the overall health status and prevalence of medical comorbidities experienced by traumatic brain injury (TBI) patients. Design: Inception cohort design with cross-sectional follow-up at 1 to 15 years. Setting: Rehabilitation hospital. Participants: Adults (N = 258) with moderate to severe TBI. Interventions: Not applicable. Main Outcome Measure: The Modified Cumulative Illness Rating Scale is a 14-item rating scale used to indicate health status by rating impairment across 14 different domains. Results: The TBI sample had lower rates of comorbidities compared with other rehabilitation populations, including stroke and orthopedic samples. The most commonly encountered medical conditions within our sample were eyes, ears, nose, and throat problems, psychiatric or behavioral disturbances, hypertension, and musculoskeletal injury at mild to moderate severity. Prevalence of conditions did not differ by sex, race, or cause of TBI. Conclusions: The current TBI sample was relatively healthy with few medical comorbidities. Further, the Modified Cumulative Illness Rating Scale may better be used as a standardized checklist to assess for the presence of co-occurring conditions, given the near absence of conditions in the higher range of severity.	[Hocomb, Erin M.] Wayne State Univ, Dept Psychol, Detroit, MI 48202 USA; [Millis, Scott R.; Hanks, Robin A.] Wayne State Univ, Sch Med, Dept Phys Med & Rehabil, Detroit, MI USA	Hocomb, EM (corresponding author), Wayne State Univ, Dept Psychol, 5057 Woodward Ave,7th Fl, Detroit, MI 48202 USA.	du0878@wayne.edu			U.S. Department of Education-National Institute of Disability Research and Rehabilitation-The Traumatic Brain Injury Model Systems Project [H133A020515]	Supported by the U.S. Department of Education-National Institute of Disability Research and Rehabilitation-The Traumatic Brain Injury Model Systems Project (grant no. H133A020515).	BOONE KB, 1993, DEMENTIA, V4, P232; Brady CB, 2001, J GERONTOL B-PSYCHOL, V56, pP340, DOI 10.1093/geronb/56.6.P340; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Coronado VG, 2005, J HEAD TRAUMA REHAB, V20, P215, DOI 10.1097/00001199-200505000-00005; Dahmer ER, 1993, J HEAD TRAUMA REHAB, V8, P13; de Groot V, 2003, J CLIN EPIDEMIOL, V56, P221, DOI 10.1016/S0895-4356(02)00585-1; Deb S, 1999, AM J PSYCHIAT, V156, P374; ELIAS MF, 1995, EXP AGING RES, V21, P369, DOI 10.1080/03610739508253991; Fahlander K, 2000, J GERONTOL B-PSYCHOL, V55, pP259, DOI 10.1093/geronb/55.5.P259; Giaquinto S, 2003, EUR J NEUROL, V10, P235, DOI 10.1046/j.1468-1331.2003.00563.x; Giaquinto S, 2001, DISABIL REHABIL, V23, P296; Golding EM, 2002, BRAIN RES REV, V38, P377, DOI 10.1016/S0165-0173(02)00141-8; HarrisonFelix C, 1996, J HEAD TRAUMA REHAB, V11, P1, DOI 10.1097/00001199-199610000-00002; Imamura K, 1997, J CLIN EPIDEMIOL, V50, P1011, DOI 10.1016/S0895-4356(97)00128-5; KAPLAN MH, 1974, J CHRON DIS, V27, P387, DOI 10.1016/0021-9681(74)90017-4; Koponen S, 2002, AM J PSYCHIAT, V159, P1315, DOI 10.1176/appi.ajp.159.8.1315; Lew HL, 2002, AM J PHYS MED REHAB, V81, P830, DOI 10.1097/00002060-200211000-00005; Ley EJ, 2011, J TRAUMA, V70, P1141, DOI 10.1097/TA.0b013e3182146d66; LINN BS, 1968, J AM GERIATR SOC, V16, P622, DOI 10.1111/j.1532-5415.1968.tb02103.x; Manolio TA, 2003, CURR HYPERTENS REP, V5, P255, DOI 10.1007/s11906-003-0029-6; MILLER MD, 1992, PSYCHIAT RES, V41, P237, DOI 10.1016/0165-1781(92)90005-N; Miller MD, 1991, MANUAL GUIDELINES SC; MORTON MV, 1995, BRAIN INJURY, V9, P81, DOI 10.3109/02699059509004574; Mosenthal AC, 2004, J TRAUMA, V56, P1042, DOI 10.1097/01.TA.0000127767.83267.33; PARMELEE PA, 1995, J AM GERIATR SOC, V43, P130, DOI 10.1111/j.1532-5415.1995.tb06377.x; Reistetter TA, 2011, DIABETES CARE, V34, P1375, DOI 10.2337/dc10-2220; Rochon PA, 1996, MED CARE, V34, P1093, DOI 10.1097/00005650-199611000-00004; Salvi F, 2008, J AM GERIATR SOC, V56, P1926, DOI 10.1111/j.1532-5415.2008.01935.x; Sondik EJ, 2010, SUMMARY HLTH STAT US; Stineman MG, 2000, ARCH PHYS MED REHAB, V81, P549, DOI 10.1053/mr.2000.5977; Tamari K, 2010, ARCH PHYS MED REHAB, V91, P1363, DOI 10.1016/j.apmr.2010.06.014; Tan WS, 2009, ARCH PHYS MED REHAB, V90, P1202, DOI 10.1016/j.apmr.2009.01.027; The Eastern Association for the Surgery of Trauma, 2005, EAST PRACT MAN GUID; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; van Dijk GM, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-95; WALDSTEIN SR, 1991, PSYCHOL BULL, V110, P451, DOI 10.1037/0033-2909.110.3.451; Weeks DL, 2009, ARCH PHYS MED REHAB, V90, P1937, DOI 10.1016/j.apmr.2009.06.008; WONG DT, 1991, CAN J ANAESTH, V38, P374, DOI 10.1007/BF03007629	38	17	17	0	8	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	AUG	2012	93	8					1338	1342		10.1016/j.apmr.2012.04.029			5	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	983XJ	WOS:000307151700007	22840832				2021-06-18	
J	Itoh, T; Imano, M; Nishida, S; Tsubaki, M; Mizuguchi, N; Hashimoto, S; Ito, A; Satou, T				Itoh, Tatsuki; Imano, Motohiro; Nishida, Shozo; Tsubaki, Masahiro; Mizuguchi, Nobuyuki; Hashimoto, Shigeo; Ito, Akihiko; Satou, Takao			(-)-Epigallocatechin-3-gallate increases the number of neural stem cells around the damaged area after rat traumatic brain injury	JOURNAL OF NEURAL TRANSMISSION			English	Article						Neural stem cell; Traumatic brain injury; Nestin; Neurosphere; Catechin	CENTRAL-NERVOUS-SYSTEM; GREEN TEA POLYPHENOL; EXPERIMENTAL-ISCHEMIA; OXIDATIVE STRESS; NEURONAL DAMAGE; CEREBRAL-CORTEX; OXYGEN RADICALS; DEATH; PROLIFERATION; PROTECTS	A major component of green tea is (-)-epigallocatechin gallate (EGCG), which has strong antioxidant properties. Here, we investigated the effect of EGCG on neural stem cell (NSC) proliferation around the damaged area following traumatic brain injury (TBI). In this study, male Wistar rats that had access to normal drinking water, or water containing 0.1% (w/v) EGCG, ad libitum received TBI at 10 weeks of age. Immunohistochemistry revealed that the number of nestin-positive cells around the damaged area after TBI in the EGCG treatment group increased significantly compared with the normal water group (P < 0.05). However, the number of 8-hydroxy-2'-deoxyguanosine-, 4-hydroxy-2-nonenal-, single-stranded DNA (ssDNA)-positive cells and the level of peroxidation around the damaged area after TBI significantly decreased in the EGCG treatment group when compared with the water group (P < 0.05). Furthermore, in contrast to the EGCG group, almost all ssDNA-positive cells in the water group co-localized with NeuN and nestin-staining. Ex vivo studies revealed that spheres could only be isolated from injured brain tissue in the water group at 3 days following TBI. However, in the EGCG group, spheres could be isolated at both 3 and 7 days following TBI. A greater number of spheres could be isolated from the EGCG group, which differentiated into neurons and glia in culture without basic fibroblast growth factor. These results indicate that consumption of water containing EGCG pre- and post-TBI inhibits free radical-induced degradation of NSCs, which have the potential to differentiate into neurons and glia around the area of damage following TBI.	[Itoh, Tatsuki; Ito, Akihiko; Satou, Takao] Kinki Univ, Fac Med, Dept Pathol, Osaka 5898511, Japan; [Imano, Motohiro] Kinki Univ, Sch Med, Dept Surg, Osaka 5898511, Japan; [Nishida, Shozo; Tsubaki, Masahiro] Kinki Univ, Fac Pharmaceut Sci, Osaka 5898511, Japan; [Mizuguchi, Nobuyuki] Kinki Univ, Life Sci Res Inst, Osaka 5898511, Japan; [Hashimoto, Shigeo] PL Hosp, Div Hosp, Osaka, Japan; [Satou, Takao] Kinki Univ Hosp, Div Hosp Pathol, Fac Med, Osaka, Japan	Itoh, T (corresponding author), Kinki Univ, Fac Med, Dept Pathol, 377-2 Ohno Higashi, Osaka 5898511, Japan.	tatsuki@med.kindai.ac.jp			 [21500803]; Grants-in-Aid for Scientific ResearchMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI) [23500629, 24501009, 21500803] Funding Source: KAKEN	This work was supported by the Grant-in-Aid for Scientific Research (21500803). The authors thank Mari Yachi for technical assistance.	Aktas O, 2004, J IMMUNOL, V173, P5794, DOI 10.4049/jimmunol.173.9.5794; Amemiya S, 2005, EUR J PHARMACOL, V516, P125, DOI 10.1016/j.ejphar.2005.04.036; Ates O, 2007, MOL CELL BIOCHEM, V294, P137, DOI 10.1007/s11010-006-9253-0; CHAN PH, 1985, PROG BRAIN RES, V63, P227; Chen S, 2003, EXP NEUROL, V182, P87, DOI 10.1016/S0014-4886(03)00002-5; Chirumamilla S, 2002, J NEUROTRAUM, V19, P693, DOI 10.1089/08977150260139084; Clausen F, 2004, J NEUROTRAUM, V21, P1168, DOI 10.1089/neu.2004.21.1168; Douen AG, 2004, BRAIN RES, V1008, P139, DOI 10.1016/j.brainres.2003.08.070; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; HALL ED, 1989, FREE RADICAL BIO MED, V6, P303, DOI 10.1016/0891-5849(89)90057-9; Hata R, 1999, METAB BRAIN DIS, V14, P117, DOI 10.1023/A:1020709814456; HOCKENBERY D, 1990, NATURE, V348, P334, DOI 10.1038/348334a0; Hong JT, 2000, BRAIN RES BULL, V53, P743, DOI 10.1016/S0361-9230(00)00348-8; Irving EA, 2002, J CEREBR BLOOD F MET, V22, P631, DOI 10.1097/00004647-200206000-00001; Itoh T, 2005, NEUROREPORT, V16, P1687, DOI 10.1097/01.wnr.0000183330.44112.ab; Itoh T, 2007, NEUROL RES, V29, P734, DOI 10.1179/016164107X208086; Itoh T, 2006, NEUROCHEM RES, V31, P1381, DOI 10.1007/s11064-006-9186-8; Itoh T, 2011, NEUROMOL MED, V13, P300, DOI 10.1007/s12017-011-8162-x; Itoh T, 2009, NEUROTOX RES, V16, P378, DOI 10.1007/s12640-009-9081-6; KAWAMATA T, 1995, BRAIN RES, V674, P196, DOI 10.1016/0006-8993(94)01444-M; Kim CY, 2009, ARCH PHARM RES, V32, P869, DOI 10.1007/s12272-009-1609-z; Koh SH, 2004, NEUROTOXICOLOGY, V25, P793, DOI 10.1016/j.neuro.2004.02.001; KONTOS HA, 1985, CIRC RES, V57, P508, DOI 10.1161/01.RES.57.4.508; Kuhn HG, 1996, J NEUROSCI, V16, P2027; Lee SR, 2000, NEUROSCI LETT, V287, P191, DOI 10.1016/S0304-3940(00)01159-9; Lee SY, 2003, BRAIN RES BULL, V61, P399, DOI 10.1016/S0361-9230(03)00139-4; Lin HJ, 2004, FEBS LETT, V570, P102, DOI 10.1016/j.febslet.2004.06.019; LOIS C, 1994, SCIENCE, V264, P1145, DOI 10.1126/science.8178174; Mandel S, 2004, J NEUROCHEM, V88, P1555, DOI 10.1046/j.1471-4159.2003.02291.x; Mandel SA, 2005, NEUROSIGNALS, V14, P46, DOI 10.1159/000085385; MARTINOU JC, 1994, NEURON, V13, P1017, DOI 10.1016/0896-6273(94)90266-6; Moon C, 2004, BRAIN RES, V1028, P238, DOI 10.1016/j.brainres.2004.09.022; Parent JM, 1997, J NEUROSCI, V17, P3727; Picard-Riera N, 2004, J NEUROSCI RES, V76, P223, DOI 10.1002/jnr.20040; Rice AC, 2003, EXP NEUROL, V183, P406, DOI 10.1016/S0014-4886(03)00241-3; Seri B, 2001, J NEUROSCI, V21, P7153, DOI 10.1523/JNEUROSCI.21-18-07153.2001; Sugawara T, 2002, J NEUROSCI, V22, P209, DOI 10.1523/JNEUROSCI.22-01-00209.2002; Suzuki M, 2004, MED SCI MONITOR, V10, pBR166; Tsuji M, 2000, NEUROSCI LETT, V282, P41, DOI 10.1016/S0304-3940(00)00844-2; Walton KM, 1998, J NEUROCHEM, V70, P1764; Weinreb O, 2009, GENES NUTR, V4, P283, DOI 10.1007/s12263-009-0143-4; Xiong Y, 1997, J NEUROTRAUM, V14, P23, DOI 10.1089/neu.1997.14.23; Yamamoto S, 2001, EXP NEUROL, V172, P115, DOI 10.1006/exnr.2001.7798; Yu JX, 2010, FEBS LETT, V584, P2921, DOI 10.1016/j.febslet.2010.05.011	44	17	23	0	15	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0300-9564			J NEURAL TRANSM	J. Neural Transm.	AUG	2012	119	8					877	890		10.1007/s00702-011-0764-9			14	Clinical Neurology; Neurosciences	Neurosciences & Neurology	977XR	WOS:000306698700001	22212485				2021-06-18	
J	Johnson, JE; Turkstra, LS				Johnson, Jacqueline E.; Turkstra, Lyn S.			Inference in conversation of adults with traumatic brain injury	BRAIN INJURY			English	Article						Inference; communication; implicature; language; pragmatics; brain injury	COMPREHENSION; LANGUAGE; ADOLESCENTS; ABILITY; SKILLS	Objective: To examine elaborative and automatic linguistic inferences in conversations between adults with and without traumatic brain injury (TBI) and their frequent communication partners. Design and methods: Participants with TBI were four female and three male adults and seven female communication partners. Comparison peers were two males and five females and one male and six female communication partners. Each participant completed 20-minute video-recorded conversation with his or her frequent communication partner. Conversations were transcribed, implicatures were identified and the percentage of correct inferences was determined. Inferences were categorized as automatic or elaborative and as missed or understood. Results: Participants in both groups made significantly more errors on elaborative inferences than automatic inferences and participants with TBI made significantly more elaborative inference errors than comparison peers. There was no significant between-groups difference in error rates for automatic inferences. Conclusions: Individuals with TBI may show impairments in social language skills not only on standardized tests but also in everyday conversations. This may contribute to everyday partners' perceptions of social communication problems in adults with TBI.	[Turkstra, Lyn S.] Univ Wisconsin, Dept Communicat Disorders, Madison, WI 53706 USA	Turkstra, LS (corresponding author), Univ Wisconsin, Dept Communicat Disorders, Madison, WI 53706 USA.	lsturkstra@wisc.edu					Angeleri R, 2008, BRAIN LANG, V107, P229, DOI 10.1016/j.bandl.2008.01.002; Bergemalm PO, 2005, INT J AUDIOL, V44, P39, DOI 10.1080/14992020400022546; Brownell H, 1998, RIGHT HEMISPHERE LANGUAGE COMPREHENSION, P309; Colvin C. Randall, 1997, EMPATHIC ACCURACY, P169; Dennis M, 2001, J AUTISM DEV DISORD, V31, P47, DOI 10.1023/A:1005661613288; Douglas JM, 2007, J HEAD TRAUMA REHAB, V22, P31, DOI 10.1097/00001199-200701000-00004; Ferstl EC, 2002, NEUROPSYCHOLOGY, V16, P292, DOI 10.1037//0894-4105.16.3.292; Grice HP, 1975, SPEECH ACTS, P17; Letts C, 2001, INT J LANG COMM DIS, V36, P307; MacWhinney B., 2008, CHILDES PROJECT TOOL; McDonald S, 2003, J HEAD TRAUMA REHAB, V18, P219, DOI 10.1097/00001199-200305000-00001; MCDONALD S, 1992, APPL PSYCHOLINGUIST, V13, P295, DOI 10.1017/S0142716400005658; McDonald S, 1999, BRAIN LANG, V68, P486, DOI 10.1006/brln.1999.2124; McDonald S, 2000, METAPHOR SYMBOL, V15, P85, DOI DOI 10.1080/10926488.2000.9678866; McDonald S, 2008, ARCH PHYS MED REHAB, V89, P1648, DOI 10.1016/j.apmr.2008.02.029; MCKOON G, 1992, PSYCHOL REV, V99, P440, DOI 10.1037/0033-295X.99.3.440; MILTON SB, 1984, CLIN APHASIOLOGY C P, P114; Moran C, 2005, BRAIN INJURY, V19, P743, DOI 10.1080/02699050500110199; Osterhout L., 1990, PSYCHOL LEARN MOTIV, V25, P17, DOI DOI 10.1016/S0079-7421(08)60246-7; STINSON L, 1992, J PERS SOC PSYCHOL, V62, P787, DOI 10.1037/0022-3514.62.5.787; Togher L, 1999, COMMUNICATION DISORD, P1; Tompkins CA, 2009, APHASIOLOGY, V23, P1016, DOI 10.1080/02687030802588858; Turkstra LS, 1996, BRAIN INJURY, V10, P329, DOI 10.1080/026990596124359; Virtue S, 2006, MEM COGNITION, V34, P1341, DOI 10.3758/BF03193276	24	17	17	0	8	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	AUG	2012	26	9					1118	1126		10.3109/02699052.2012.666370			9	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	971GI	WOS:000306191400009	22642382				2021-06-18	
J	Rivara, FP; Ennis, SK; Mangione-Smith, R; MacKenzie, EJ; Jaffe, KM				Rivara, Frederik P.; Ennis, Stephanie K.; Mangione-Smith, Rita; MacKenzie, Ellen J.; Jaffe, Kenneth M.			Variation in Adherence to New Quality-of-Care Indicators for the Acute Rehabilitation of Children With Traumatic Brain Injury	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Adolescent; Child; Quality of health care; Rehabilitation; Traumatic brain injuries	HEALTH-CARE; IMPROVEMENT	Objective: To determine variations in care provided by 9 inpatient rehabilitation units for children with traumatic brain injury (TBI) using newly developed quality indicators. Design Retrospective cohort study. Setting: Nine inpatient rehabilitation units. Participants: Children (N = 174; age range, 0-17y) admitted for the inpatient rehabilitation of moderate to severe TBI. Interventions: Not applicable. Main Outcome Measures: Adherence to 119 newly developed quality-of-care indicators in 7 different domains: general care, family-centered care, cognitive-communication, motor, neuropsychological, school, and community integration. Results: There was substantial variation both within and between institutions in the percentage of patients receiving recommended care in the 7 domains. The lowest scores were found for the school domain. Only 5 institutions scored above 50% for all quality indicators, and only 1 institution scored above 70% overall. Greater adherence to quality indicators was found for facilities with a higher proportion of therapists with pediatric training and for facilities that only admitted children. Patient volume was not associated with adherence to quality indicators. Conclusions: The results indicate a tremendous variability and opportunity for improvement in the care of children with TBI.	[Rivara, Frederik P.; Ennis, Stephanie K.; Jaffe, Kenneth M.] Harborview Injury Prevent & Res Ctr, Seattle, WA 98104 USA; [Rivara, Frederik P.; Mangione-Smith, Rita; Jaffe, Kenneth M.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Rivara, Frederik P.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Ennis, Stephanie K.; Jaffe, Kenneth M.] Univ Washington, Dept Rehabil Med, Seattle, WA 98195 USA; [Rivara, Frederik P.; Mangione-Smith, Rita] Seattle Childrens Res Inst, Ctr Child Hlth Behav & Dev, Seattle, WA USA; [MacKenzie, Ellen J.] Johns Hopkins B Oomberg Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD USA; [MacKenzie, Ellen J.] Johns Hopkins B Oomberg Sch Publ Hlth, Ctr Injury Res & Policy, Baltimore, MD USA	Rivara, FP (corresponding author), Harborview Injury Prevent & Res Ctr, Box 359960,325 9th Ave, Seattle, WA 98104 USA.	fpr@uw.edu			Eunice Kennedy Shriver National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R21 HD059049-01A1]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R21HD059049] Funding Source: NIH RePORTER	Supported by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (grant no. R21 HD059049-01A1).	Adelson P David, 2003, Pediatr Crit Care Med, V4, pS2, DOI 10.1097/01.CCM.0000066600.71233.01; Asch Steven M, 2005, BMC Cardiovasc Disord, V5, P1, DOI 10.1186/1471-2261-5-1; Brook RH, 1996, NEW ENGL J MED, V335, P966, DOI 10.1056/NEJM199609263351311; Brook RH, 2000, INT J QUAL HEALTH C, V12, P281, DOI 10.1093/intqhc/12.4.281; DONABEDIAN A, 1966, MILBANK FUND Q, V44, P166, DOI 10.2307/3348969; Fountain NB, 2011, NEUROLOGY, V76, P94, DOI 10.1212/WNL.0b013e318203e9d1; Mangione-Smith R, 2005, AMBUL PEDIATR, V5, P75, DOI 10.1367/A04-106R.1; Mangione-Smith R, 2007, NEW ENGL J MED, V357, P1515, DOI 10.1056/NEJMsa064637; O'Callaghan AM, 2010, INT J SPEECH-LANG PA, V12, P107, DOI 10.3109/17549500903431774; Rivara FP, 2012, ARCH PHYS MED REHAB, V93, P381, DOI 10.1016/j.apmr.2011.08.015; Slomine BS, 2006, PEDIATRICS, V117, pE663, DOI 10.1542/peds.2005-1892; Zumsteg JM, 2012, ARCH PHYS MED REHAB, V93, P386, DOI 10.1016/j.apmr.2011.08.018	12	17	17	0	5	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993			ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	AUG	2012	93	8					1371	1376		10.1016/j.apmr.2012.02.031			6	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	983XJ	WOS:000307151700012	22446294	Green Accepted			2021-06-18	
J	Tong, WS; Zheng, P; Zeng, JS; Guo, YJ; Yang, WJ; Li, GY; He, B; Yu, H; Li, YS; Tang, XF; Lin, TS; Xu, JF				Tong, Wu-Song; Zheng, Ping; Zeng, Jing-Song; Guo, Yi-Jun; Yang, Wen-Jin; Li, Gao-Yi; He, Bin; Yu, Hui; Li, Yong-Sheng; Tang, Xin-Fen; Lin, Tong-Shun; Xu, Jun-Fa			Prognosis analysis and risk factors related to progressive intracranial haemorrhage in patients with acute traumatic brain injury	BRAIN INJURY			English	Article						Traumatic brain injury (TBI); progressive intracranial haemorrhage (PIH); risk factor; prognosis	HEAD-INJURY; COAGULOPATHY; THROMBOCYTOPENIA; PREDICTORS; LESIONS	Background: Since progressive intracranial haemorrhage (PIH) was introduced in neurosurgical literatures, several studies have been performed. PIH has been shown to be associated with a high increase in the risk of clinical worsening and related to morbidity and mortality as well. So, early detection and prediction of PIH is practically important in a clinical situation. Objectves: To investigate the risk factors related to PIH in patients with acute traumatic brain injury (TBI) and analyse their clinical significances. Methods: PIH was confirmed by comparing the first and repeated CT scans. Data compared included gender, age, mechanism of injury, Glasgow Coma Score (GCS) at admission, timing from injury to the first CT, the signs of the initial CT scan, prothrombin time (PT), activated partial thromboplastin time (APTT), fibrinogen (Fg), thrombin time (TT), platelet (PLT) and D-dimer (D-D) values. Logistic regression analysis was used to show the risk factors related to PIH. Results: A cohort of 498 patients with TBI was evaluated, and there were 139 (27.91%) patients who suffered from PIH. The differences between PIHs and non-PIHs were significant in age, GCS at admission, the signs of the initial CT scan (fracture, subarachnoid haemorrhage, brain contusion and primary haematoma), PT, Fg and D-D values (p<0.001). Logistic regression analysis was used to identify that CT scans (subarachnoid haemorrhage, brain contusion and primary haematoma) and plasma D-D values as the most important predictors of PIH (p<0.001). Conclusions: For patients with the initial CT scan showing subarachnoid haemorrhage, brain contusion and primary haematoma with abnormal D-D levels, an earlier and dynamic CT scan should be performed, for the detection of PIH as early as possible and the medical intervention would be enforced in time.	[Tong, Wu-Song; Zheng, Ping; Zeng, Jing-Song; Guo, Yi-Jun; Yang, Wen-Jin; Li, Gao-Yi; He, Bin; Yu, Hui; Li, Yong-Sheng; Xu, Jun-Fa] Pudong New Area Peoples Hosp, Dept Neurosurg, Shanghai, Peoples R China; [Tang, Xin-Fen; Lin, Tong-Shun] Pudong New Area Peoples Hosp, Dept Lab Examine, Shanghai, Peoples R China	Tong, WS (corresponding author), Pudong New Area Peoples Hosp, Dept Neurosurg, 490 S Chuanhuan Rd, Shanghai, Peoples R China.	tongws001@yahoo.com.cn					BULLOCK R, 1990, J NEUROSURG, V72, P9, DOI 10.3171/jns.1990.72.1.0009; Carrick MM, 2005, J TRAUMA, V58, P725, DOI 10.1097/01.TA.0000159249.68363.78; Chang EF, 2006, NEUROSURGERY, V58, P647, DOI 10.1227/01.NEU.0000197101.68538.E6; Engstrom M, 2005, J NEUROTRAUM, V22, P291, DOI 10.1089/neu.2005.22.291; Halpern CH, 2008, J NEUROTRAUM, V25, P997, DOI 10.1089/neu.2008.0548; Jiang JY, 2008, CLIN GUIDELINES MANA; KLAUBER MR, 1985, J NEUROSURG, V62, P528, DOI 10.3171/jns.1985.62.4.0528; Narayan RK, 2008, J NEUROTRAUM, V25, P629, DOI 10.1089/neu.2007.0385; Oertel M, 2002, J NEUROSURG, V96, P109, DOI 10.3171/jns.2002.96.1.0109; Pahatouridis D, 2010, BRAIN INJURY, V24, P1189, DOI 10.3109/02699052.2010.490510; Patel NY, 2000, J TRAUMA, V48, P367, DOI 10.1097/00005373-200003000-00001; Perel P, 2009, BMC EMERG MED, V9, DOI 10.1186/1471-227X-9-15; ROOF RL, 1993, BRAIN RES, V607, P333, DOI 10.1016/0006-8993(93)91526-X; Roof RL, 2000, J NEUROTRAUM, V17, P367, DOI 10.1089/neu.2000.17.367; Sanus GZ, 2004, NEUROSURG QUART, V14, P97, DOI 10.1097/01.wnq.0000127718.06183.12; Selladurai BM, 1997, BRIT J NEUROSURG, V11, P398; SERVADEI F, 1995, NEUROSURGERY, V37, P899, DOI 10.1227/00006123-199511000-00008; SHACKFORD SR, 1987, ARCH SURG-CHICAGO, V122, P523; STEIN SC, 1993, NEUROSURGERY, V32, P25, DOI 10.1227/00006123-199301000-00004; Takahashi H, 1997, J NEUROSURG, V86, P768, DOI 10.3171/jns.1997.86.5.0768; Talving P, 2009, J TRAUMA, V66, P55, DOI 10.1097/TA.0b013e318190c3c0	21	17	25	1	4	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	AUG	2012	26	9					1136	1142		10.3109/02699052.2012.666437			7	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	971GI	WOS:000306191400011	22630115				2021-06-18	
J	Byard, RW; Gabrielian, L; Helps, SC; Thornton, E; Vink, R				Byard, Roger W.; Gabrielian, Levon; Helps, Stephen C.; Thornton, Emma; Vink, Robert			Further Investigations into the Speed of Cerebral Swelling Following Blunt Cranial Trauma	JOURNAL OF FORENSIC SCIENCES			English	Article						forensic science; traumatic brain injury; intracranial pressure; blunt craniocerebral trauma; lucid interval; impact; shaking	SHAKEN-BABY SYNDROME; BRAIN-INJURY; INTRACRANIAL-PRESSURE; HEAD-INJURY; MODEL; EDEMA; SHEEP; RATS	An anesthetized sheep model of traumatic brain injury (TBI) has been developed to assess early changes in intracranial pressure (ICP) following closed head injury. Immediately after TBI, a transient (<10 min) hypertensive response occurred, followed by significant and prolonged systemic hypotension. ICP demonstrated a biphasic response, being seven times baseline values of 8 +/- 2 mm Hg 10 min after injury, decreasing to 25 +/- 2 mm Hg by 30 min, and then increasing to values exceeding 30 mm Hg by 4 h postinjury. ICP was always significantly higher than baseline values, which combined with hypotension, reduced cerebral perfusion pressure to less than 60% of normal. This early and sustained increase in ICP after craniocerebral trauma acutely alters cerebral perfusion pressure and brain oxygenation and provides a potential pathophysiological explanation for immediate clinical manifestations in humans following significant TBI.	[Byard, Roger W.; Gabrielian, Levon; Helps, Stephen C.; Thornton, Emma; Vink, Robert] Univ Adelaide, Sch Med Sci, Adelaide Ctr Neurosci Res, Adelaide, SA 5005, Australia	Byard, RW (corresponding author), Univ Adelaide, Sch Med Sci, Adelaide Ctr Neurosci Res, Frome Rd, Adelaide, SA 5005, Australia.	roger.byard@adelaide.edu.au	AM, Robert Vink/S-5616-2019; Vink, Robert/J-7351-2012	AM, Robert Vink/0000-0002-4885-0667; Vink, Robert/0000-0002-4885-0667; Byard, Roger/0000-0002-0524-5942	Neurosurgical Research Foundation (Australia); National Health and Medical Research Council of AustraliaNational Health and Medical Research Council of AustraliaUK Research & Innovation (UKRI)Medical Research Council UK (MRC)	Funded, in part, by the Neurosurgical Research Foundation (Australia) and by a grant from the National Health and Medical Research Council of Australia.	Barzo P, 1997, J NEUROSURG, V87, P900, DOI 10.3171/jns.1997.87.6.0900; Bull JW, 1969, P ROY SOC MED, V12, P1301; Byard Roger W, 2009, Leg Med (Tokyo), V11 Suppl 1, pS128, DOI 10.1016/j.legalmed.2009.02.001; Byard RW, 2010, SUDDEN DEATH YOUNG; Chadwick DL, 1998, PEDIATRICS, V101, P321, DOI 10.1542/peds.101.2.321; Denton S, 2003, AM J FOREN MED PATH, V24, P371, DOI 10.1097/01.paf.0000097851.18478.16; Duhaime AC, 1998, NEW ENGL J MED, V338, P1822, DOI 10.1056/NEJM199806183382507; Engelborghs K, 1998, J NEUROSURG, V89, P796, DOI 10.3171/jns.1998.89.5.0796; HUMPHREYS RP, 1990, CHILD NERV SYST, V6, P139, DOI 10.1007/BF00308490; Krous Henry F, 2005, Forensic Sci Med Pathol, V1, P9, DOI 10.1385/FSMP:1:1:009; Lewis SB, 1996, J NEUROTRAUM, V13, P505, DOI 10.1089/neu.1996.13.505; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; O'Connor CA, 2006, ACTA NEUROCHIR SUPPL, V96, P121; PFENNINGER EG, 1989, J NEUROSURG, V70, P774, DOI 10.3171/jns.1989.70.5.0774; Plunkett J, 2001, AM J FOREN MED PATH, V22, P1, DOI 10.1097/00000433-200103000-00001; Treggiari MM, 2007, NEUROCRIT CARE, V6, P104, DOI 10.1007/s12028-007-0012-1; Van den Heuvel C, 2004, J NEUROTRAUM, V21, P1562, DOI 10.1089/0897715042441783; Vink R, 2008, ACTA NEUROCHIR SUPPL, V102, P189, DOI 10.1007/978-3-211-85578-2_37	19	17	17	0	6	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-1198			J FORENSIC SCI	J. Forensic Sci.	JUL	2012	57	4					973	975		10.1111/j.1556-4029.2012.02109.x			3	Medicine, Legal	Legal Medicine	967HE	WOS:000305896700016	22372694				2021-06-18	
J	Mulligan, I; Boland, M; Payette, J				Mulligan, Ivan; Boland, Mark; Payette, Justin			Prevalence of Neurocognitive and Balance Deficits in Collegiate Football Players Without Clinically Diagnosed Concussion	JOURNAL OF ORTHOPAEDIC & SPORTS PHYSICAL THERAPY			English	Article						BESS; ImPACT; test battery; traumatic brain injury	SPORT-RELATED CONCUSSION; HIGH-SCHOOL; NEUROPSYCHOLOGICAL ASSESSMENT; POSTURAL STABILITY; MANAGEMENT; PERFORMANCE; STATEMENT; IMPACT; INJURY; RECOMMENDATIONS	STUDY DESIGN: Prospective cohort. OBJECTIVES: To identify the prevalence of neurocognitive and balance deficits in collegiate football players 48 hours following competition. BACKGROUND: Neurocognitive testing, balance assessments, and subjective report of symptoms are a test battery commonly used to examine athletes suspected of having sustained a concussion. Previous literature suggests that many concussions go unreported. Little research exists examining the prevalence of neurocognitive or balance deficits in athletes who do not report concussion-like symptoms to a healthcare provider. METHODS: Forty-five Division IA collegiate football players participated in this study. Preseason baseline scores using the Balance Error Scoring System, the Immediate Post-Concussion Assessment and Cognitive Testing, and the Postconcussion Symptom Scale were compared to posttest results obtained 48 hours following a game. Prevalence of symptoms was analyzed and reported. RESULTS: Thirty-two (71%) of the 45 athletes tested demonstrated at least 1 deficit in either the Postconcussion Symptom Scale, Balance Error Scoring System, or at least 1 composite score of the Immediate Post-Concussion Assessment and Cognitive Testing. Nineteen of the 32 subjects demonstrated a change in 2 or more categories of neurocognitive and balance function. CONCLUSION: In a cohort of football players tested 48 hours following their last game of the season, who did not seek medical attention related to a concussion, a significant number demonstrated limitations in neurocognitive and balance performance, suggesting that further research may need to be performed to improve recognition of an athlete's deficits and to improve the ability to assess concussion.	[Mulligan, Ivan; Boland, Mark; Payette, Justin] St Francis Univ, DiSepio Inst Rural Hlth & Wellness, Loretto, PA 15940 USA; [Mulligan, Ivan] St Francis Univ, Phys Therapy Dept, Loretto, PA 15940 USA	Mulligan, I (corresponding author), St Francis Univ, DiSepio Inst Rural Hlth & Wellness, 108 Franciscan Way, Loretto, PA 15940 USA.	imulligan@francis.edu					Alsalaheen BA, 2010, J NEUROL PHYS THER, V34, P87, DOI 10.1097/NPT.0b013e3181dde568; Broglio SP, 2007, J ATHL TRAINING, V42, P504; Broglio SP, 2007, NEUROSURGERY, V60, P1050, DOI 10.1227/01.NEU.0000255479.90999.C0; Broglio SP, 2009, SPORTS HEALTH, V1, P361, DOI 10.1177/1941738109343158; Brown CN, 2007, J ATHL TRAINING, V42, P515; Centers for Disease Control and Prevention, 2009, HEADS FACTS PHYS MIL; Chen JK, 2007, J NEUROL NEUROSUR PS, V78, P1231, DOI 10.1136/jnnp.2006.110395; Collins Michael W, 2002, Curr Sports Med Rep, V1, P12; Collins MW, 2003, CLIN J SPORT MED, V13, P222, DOI 10.1097/00042752-200307000-00005; Collins MW, 2003, AM J SPORT MED, V31, P168, DOI 10.1177/03635465030310020301; Covassin T, 2007, BRIT J SPORT MED, V41, P370, DOI 10.1136/bjsm.2006.032334; Fazio VC, 2007, NEUROREHABILITATION, V22, P207; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Finnoff JT, 2009, PM&R, V1, P50, DOI 10.1016/j.pmrj.2008.06.002; Giza CC, 2001, J ATHL TRAINING, V36, P228; Grindel SH, 2001, CLIN J SPORT MED, V11, P134, DOI 10.1097/00042752-200107000-00003; Guskiewicz Kevin M, 2003, Curr Sports Med Rep, V2, P24; Guskiewicz KM, 2006, BRIT J SPORT MED, V40, P6, DOI 10.1136/bjsm.2005.021683; Guskiewicz KM, 2004, NEUROSURGERY, V55, P891, DOI 10.1227/01.NEU.0000143800.49798.19; Guskiewicz KM, 2004, J ATHL TRAINING, V39, P280; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Hutchison M, 2011, AM J SPORT MED, V39, P2331, DOI 10.1177/0363546511413375; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lovell MR, 2006, J ATHL TRAINING, V41, P137; Lovell MR, 2007, TECHNICAL MANUAL PSY; Lovell MR, 2006, J ATHL TRAINING, V41, P138; Makdissi M, 2010, AUST FAM PHYSICIAN, V39, P12; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; McLeod TCV, 2006, J ATHL TRAINING, V41, P399; Miller JR, 2007, AM J SPORT MED, V35, P1284, DOI 10.1177/0363546507300261; Randolph C, 2001, J ATHL TRAINING, V36, P288; Riemann BL, 2000, J ATHL TRAINING, V35, P19; Runkle D, 2010, CONCUSSION MANAGEMEN; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Shuttleworth-Edwards AB, 2008, ARCH CLIN NEUROPSYCH, V23, P479, DOI 10.1016/j.acn.2008.07.002; Talavage T, J NEUROTRAUMA; Theriault M, 2011, J CLIN EXP NEUROPSYC, V33, P30, DOI 10.1080/13803391003772873; Van Kampen DA, 2006, AM J SPORT MED, V34, P1630, DOI 10.1177/0363546506288677	42	17	17	0	23	J O S P T	ALEXANDRIA	1111 NORTH FAIRFAX ST, STE 100, ALEXANDRIA, VA 22314-1436 USA	0190-6011	1938-1344		J ORTHOP SPORT PHYS	J. Orthop. Sports Phys. Ther.	JUL	2012	42	7					625	632		10.2519/jospt.2012.3798			8	Orthopedics; Rehabilitation; Sport Sciences	Orthopedics; Rehabilitation; Sport Sciences	969YG	WOS:000306094700005	22531476				2021-06-18	
J	Peiniger, S; Nienaber, U; Lefering, R; Braun, M; Wafaisade, A; Borgman, MA; Spinella, PC; Maegele, M				Peiniger, Sigune; Nienaber, Ulrike; Lefering, Rolf; Braun, Maximilian; Wafaisade, Arasch; Borgman, Matthew A.; Spinella, Philip C.; Maegele, Marc		Trauma Registry Deutsch Gesell Unf	Glasgow Coma Scale as a predictor for hemocoagulative disorders after blunt pediatric traumatic brain injury	PEDIATRIC CRITICAL CARE MEDICINE			English	Article						children; Glasgow Coma Scale; hemocoagulative disorders; traumatic brain injury	SEVERE HEAD-INJURY; MASSIVE TRANSFUSION; RETROSPECTIVE ANALYSIS; PROGNOSTIC FACTORS; MULTIPLE INJURY; CHILDREN; COAGULOPATHY; COAGULATION; MODERATE; RESUSCITATION	Objective: Coagulopathy is a complication of traumatic brain injury and its presence after injury has been identified as a risk factor for prognosis. It was our aim to determine whether neurologic findings reflected by Glasgow Coma Scale at initial resuscitation can predict hemocoagulative disorders resulting from traumatic brain injury that may aggravate clinical sequelae and outcome in children. Design: A retrospective analysis of 200 datasets from children with blunt, isolated traumatic brain injury documented in the Trauma Registry of the Deutsche Gesellschaft fur Unfallchirurgie was conducted. Inclusion criteria were primary admission, age <14 yrs, and sustained isolated blunt traumatic brain injury. Setting: Trauma Registry of the Deutsche Gesellschaft fur Unfallchirurgie-affiliated trauma centers in Germany. Patients: Two hundred datasets of children (age <14 yrs) with blunt isolated traumatic brain injury were analyzed: children were subdivided into two groups according to Glasgow Coma Scale at the scene (Glasgow Coma Scale <= 8 vs. Glasgow Coma Scale >8) and reviewed for coagulation abnormalities upon emergency room admission and outcome. Measurement and Main Results: Fifty-one percent (n = 102 of 200) of children had Glasgow Coma Scale >8 and 49% (n = 98 of 200) had Glasgow Coma Scale <= 8 at the scene. The incidence of coagulopathy at admission was higher in children with Glasgow Coma Scale <= 8 compared to children with Glasgow Coma Scale >8: 44% (n = 31 of 71) vs. 14% (n = 11 of 79) (p < .001). Multivariate logistic regression revealed that Glasgow Coma Scale <= 8 at scene was associated with coagulopathy at admission (odds ratio 3.378, p = .009) and stepwise regression identified Glasgow Coma Scale <= 8 as an independent risk factor for coagulopathy. Mortality in children with Glasgow Coma Scale <= 8 at scene was substantially higher with the presence of coagulation abnormalities at admission compared to children in which coagulopathy was absent (51.6%, n = 16 of 31 vs. 5% n = 2 of 40). Conclusions: Glasgow Coma Scale <= 8 at scene in children with isolated traumatic brain injury is associated with increased risk for coagulopathy and mortality. These results may guide laboratory testing, management, and blood bank resources in acute pediatric trauma care. (Pediatr Crit Care Med 2012; 13:455-460)	[Peiniger, Sigune; Braun, Maximilian; Wafaisade, Arasch; Maegele, Marc] Univ Witten Herdecke, Cologne Merheim Med Ctr, Dept Trauma & Orthoped Surg, Cologne, Germany; [Peiniger, Sigune; Nienaber, Ulrike; Braun, Maximilian; Wafaisade, Arasch; Maegele, Marc] Univ Witten Herdecke, Cologne Merheim Med Ctr, Inst Res Operat Med, Cologne, Germany; [Borgman, Matthew A.] Brooke Army Med Ctr, Houston, TX USA; [Spinella, Philip C.] Washington Univ, Dept Pediat, St Louis, MO 63130 USA; [Spinella, Philip C.] USA, Inst Surg Res, Ft Sam Houston, TX 78234 USA	Maegele, M (corresponding author), Univ Witten Herdecke, Cologne Merheim Med Ctr, Dept Trauma & Orthoped Surg, Cologne, Germany.	Marc.Maegele@t.online.de	Borgman, Matthew A/L-9477-2015	Borgman, Matthew A/0000-0002-2008-7380			Affonseca CA, 2007, J PEDIAT-BRAZIL, V83, P274, DOI [10.1590/S0021-75572007000400014, 10.2223/JPED.1639]; Becker S, 1999, EUR J PEDIATR, V158, pS197, DOI 10.1007/PL00014355; Borgman MA, 2007, J TRAUMA, V63, P805, DOI 10.1097/TA.0b013e3181271ba3; Carrick MM, 2005, J TRAUMA, V58, P725, DOI 10.1097/01.TA.0000159249.68363.78; Chiaretti A, 2002, CHILD NERV SYST, V18, P54, DOI 10.1007/s00381-001-0533-4; Chiaretti A, 2002, CHILD NERV SYST, V18, P129, DOI 10.1007/s00381-002-0558-3; Chiaretti A, 2001, PEDIATR NEUROSURG, V34, P131, DOI 10.1159/000056008; Duchesne JC, 2009, BRIT J HOSP MED, V70, P22, DOI 10.12968/hmed.2009.70.1.37690; GOODNIGHT SH, 1974, ANN NY ACAD SCI, V230, P271, DOI 10.1111/j.1749-6632.1974.tb14459.x; Harhangi BS, 2008, ACTA NEUROCHIR, V150, P165, DOI 10.1007/s00701-007-1475-8; Hulka F, 1996, ARCH SURG-CHICAGO, V131, P923; Hymel KP, 1997, PEDIATRICS, V99, P371, DOI 10.1542/peds.99.3.371; Kapapa T, 2010, J CHILD NEUROL, V25, P409, DOI 10.1177/0883073809340697; Keller M S, 2001, Semin Pediatr Surg, V10, P12, DOI 10.1053/spsu.2001.19381; Maegele M, 2008, VOX SANG, V95, P112, DOI 10.1111/j.1423-0410.2008.01074.x; Maegele M, 2011, VOX SANG, V100, P231, DOI 10.1111/j.1423-0410.2010.01387.x; Maegele M, 2009, VOX SANG, V97, P39, DOI 10.1111/j.1423-0410.2009.01179.x; Maegele M, 2009, TRANSFUSION MED, V19, P117, DOI 10.1111/j.1365-3148.2009.00920.x; Marton E, 2007, CHILD NERV SYST, V23, P873, DOI 10.1007/s00381-007-0314-9; May AK, 1997, AM SURGEON, V63, P233; MINER ME, 1982, J PEDIATR-US, V100, P687, DOI 10.1016/S0022-3476(82)80565-9; Morenski JD, 2003, J NEUROSURG, V98, P611, DOI 10.3171/jns.2003.98.3.0611; Oertel M, 2002, J NEUROSURG, V96, P109, DOI 10.3171/jns.2002.96.1.0109; Pathak A, 2005, Neurol India, V53, P178; Peiniger S, 2011, CRIT CARE, V15, DOI 10.1186/cc10048; PFENNINGER J, 1982, Z KINDERCHIR, V37, P53; Pfenninger J, 2002, SWISS MED WKLY, V132, P116; PFENNINGER J, 1984, Z KINDERCHIR, V39, P223; PIEK J, 1992, J NEUROSURG, V77, P901, DOI 10.3171/jns.1992.77.6.0901; Pillai S, 2001, PEDIATR NEUROSURG, V34, P98, DOI 10.1159/000056002; SIMPSON DA, 1991, CHILD NERV SYST, V7, P183; Spinella PC, 2009, BLOOD REV, V23, P231, DOI 10.1016/j.blre.2009.07.003; Talving P, 2009, J TRAUMA, V66, P55, DOI 10.1097/TA.0b013e318190c3c0; TEASDALE G, 1974, LANCET, V2, P81; Thomas L, 2000, LABOR DIAGNOSE INDIK; Vavilala MS, 2001, J NEUROSURG ANESTH, V13, P13, DOI 10.1097/00008506-200101000-00003; Wafaisade A, 2010, NEUROCRIT CARE, V12, P211, DOI 10.1007/s12028-009-9281-1; WAGNER C, 2000, LABOR DIAGNOSE, P613; Zebrack M, 2009, PEDIATRICS, V124, P56, DOI 10.1542/peds.2008-1006; Zehtabchi S, 2008, RESUSCITATION, V76, P52, DOI 10.1016/j.resuscitation.2007.06.024; Zehtahchi S, 2008, J TRAUMA, V65, P1571, DOI 10.1097/TA.0b013e31818c9c33	41	17	21	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1529-7535	1947-3893		PEDIATR CRIT CARE ME	Pediatr. Crit. Care Med.	JUL	2012	13	4					455	460		10.1097/PCC.0b013e31823893c5			6	Critical Care Medicine; Pediatrics	General & Internal Medicine; Pediatrics	970FU	WOS:000306114300023	22422166				2021-06-18	
J	Bukur, M; Kurtovic, S; Berry, C; Tanios, M; Ley, EJ; Salim, A				Bukur, Marko; Kurtovic, Silvia; Berry, Cherisse; Tanios, Mina; Ley, Eric J.; Salim, Ali			Pre-Hospital Hypothermia is Not Associated with Increased Survival After Traumatic Brain Injury	JOURNAL OF SURGICAL RESEARCH			English	Article; Proceedings Paper	Annual Meeting of the Association-of-Academic-Surgery (AAS)/6th Annual Academic-Surgical Congress	FEB 01-03, 2011	Huntington Beach, CA	Assoc Acad Surg (AAS), Acad Surg		traumatic brain injury; pre-hospital hypothermia; mortality; outcomes	CEREBRAL BLOOD-FLOW; THERAPEUTIC HYPOTHERMIA; MODERATE HYPOTHERMIA; MILD HYPOTHERMIA; ADMISSION HYPOTHERMIA; EARLY COAGULOPATHY; ORGAN DYSFUNCTION; PROTEIN-LEVELS; HEAD-INJURY; EXPRESSION	Background. Conclusions from in vivo and in vitro studies suggest hypothermia may be protective in traumatic brain injury (TBI). Few studies evaluated the effect of admission temperature on outcomes. The purpose of this study is to examine the relationship between admission hypothermia and mortality in patients with isolated, blunt, moderate to severe TBI. Methods. The Los Angeles Trauma Database was queried for all patients >= 14 y of age with isolated, blunt, moderate to severe TBI (head abbreviated injury score (AIS) >= 3, all other < 3), admitted between 2005 and 2009. The study population was then stratified into two groups by admission temperature: hypothermic (<= 35 degrees C) and normothermic (> 35 degrees C). Demographic characteristics and outcomes were compared between groups. Logistic regression analysis was used to determine the relationship between admission hypothermia and mortality. Results. A total of 1834 patients were analyzed and then stratified into two groups: hypothermic (n = 44) and normothermic (n = 1790). There was a significant difference noted in overall mortality (25% versus 7%), with the hypothermic group being four times more likely to succumb to their injuries. After adjusting for confounding factors, admission hypothermia was independently associated with increased mortality (AOR 2.5; 95% CI 1.1-6.3; P = 0.04). Conclusions. Although in-vivo and in-vitro studies demonstrate induced hypothermia may be protective in TBI, our study demonstrates that admission hypothermia was associated with increased mortality in isolated, blunt, moderate to severe TBI. Further prospective research is needed to elucidate the role of thermoregulation in patients sustaining TBI. (C) 2012 Elsevier Inc. All rights reserved.	[Bukur, Marko; Kurtovic, Silvia; Berry, Cherisse; Tanios, Mina; Ley, Eric J.; Salim, Ali] Cedars Sinai Med Ctr, Dept Surg, Div Trauma & Crit Care, Los Angeles, CA 90048 USA	Salim, A (corresponding author), Cedars Sinai Med Ctr, Dept Surg, Div Trauma & Crit Care, 8700 Beverly Blvd,Suite 8215 N, Los Angeles, CA 90048 USA.	ali.salim@cshs.org	Berry, Cherisse/AAO-5701-2020	Bukur, Marko/0000-0002-1850-7147			Adelson PD, 2005, NEUROSURGERY, V56, P740, DOI 10.1227/01.NEU.0000156471.50726.26; ALDERSON P, 2000, COCHRANE DB SYST REV, V2; Arican N, 2006, INT J NEUROSCI, V116, P1249, DOI 10.1080/00207450600550303; Atkins CM, 2007, EUR J NEUROSCI, V26, P810, DOI 10.1111/j.1460-9568.2007.05720.x; Badjatia N, 2009, CRIT CARE MED, V37, pS250, DOI 10.1097/CCM.0b013e3181aa5e8d; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; Biswas AK, 2002, CRIT CARE MED, V30, P2742, DOI 10.1097/00003246-200212000-00020; Bratton SL, 2007, J NEUROTRAUMA S1, V24, pS7, DOI DOI 10.1089/NEU.2007.9995; Broessner G, 2009, STROKE, V40, pE657, DOI 10.1161/STROKEAHA.109.557652; Chatzipanteli K, 1999, J NEUROCHEM, V72, P2047, DOI 10.1046/j.1471-4159.1999.0722047.x; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; Cosgriff N, 1997, J TRAUMA, V42, P857, DOI 10.1097/00005373-199705000-00016; Demetriades D, 2006, J TRAUMA, V61, P868, DOI 10.1097/01.ta.0000219135.33398.f3; den Hartog AW, 2010, CRIT CARE, V14, DOI 10.1186/cc9077; Dietrich WD, 2010, NEUROTHERAPEUTICS, V7, P43, DOI 10.1016/j.nurt.2009.10.015; Eddy VA, 2000, SURG CLIN N AM, V80, P845, DOI 10.1016/S0039-6109(05)70099-2; Ehrlich MP, 2002, ANN THORAC SURG, V73, P191, DOI 10.1016/S0003-4975(01)03273-8; Enriquez P, 2004, CURR PHARM DESIGN, V10, P2131; Fildes J, 2008, ATLS ADV TRAUMA LIFE; Fukudome EY, 2009, CRIT CARE MED, V37, pS265, DOI 10.1097/CCM.0b013e3181aa60ac; GLOBUS MYT, 1995, J NEUROCHEM, V65, P1704; GOSS JR, 1995, J NEUROTRAUM, V12, P159, DOI 10.1089/neu.1995.12.159; Harris OA, 2002, ARCH NEUROL-CHICAGO, V59, P1077, DOI 10.1001/archneur.59.7.1077; Heffernan DS, 2010, J TRAUMA, V69, P1602, DOI 10.1097/TA.0b013e3181f2d3e8; Henderson WR, 2003, INTENS CARE MED, V29, P1637, DOI 10.1007/s00134-003-1848-2; Holzer M, 2002, NEW ENGL J MED, V346, P549; Hutchison JS, 2008, NEW ENGL J MED, V358, P2447, DOI 10.1056/NEJMoa0706930; Jiang JY, 2006, J NEUROTRAUM, V23, P1847, DOI 10.1089/neu.2006.23.1847; JIANG JY, 1992, ACTA NEUROPATHOL, V84, P495, DOI 10.1007/BF00304468; Jiang JY, 2004, NEUROSURGERY, V54, P713, DOI 10.1227/01.NEU.0000109535.58429.49; Kemp CD, 2008, AM SURGEON, V74, P866; Kinoshita K, 2002, J NEUROSURG, V97, P945, DOI 10.3171/jns.2002.97.4.0945; Kinoshita K, 2002, NEUROSURGERY, V51, P195, DOI 10.1097/00006123-200207000-00027; Koizumi H, 1997, BRAIN RES, V747, P304, DOI 10.1016/S0006-8993(96)01240-1; Lotocki G, 2006, EUR J NEUROSCI, V24, P2283, DOI 10.1111/j.1460-9568.2006.05123.x; Lustenberger T, 2010, J TRAUMA, V69, P1410, DOI 10.1097/TA.0b013e3181cdae81; LYETH BG, 1993, MOL CHEM NEUROPATHOL, V18, P247, DOI 10.1007/BF03160117; MacLeod JBA, 2003, J TRAUMA, V55, P39, DOI 10.1097/01.TA.0000075338.21177.EF; Maier CM, 2002, NEUROBIOL DIS, V11, P28, DOI 10.1006/nbdi.2002.0513; Maxwell WL, 1999, J NEUROTRAUM, V16, P1225, DOI 10.1089/neu.1999.16.1225; McHugh GS, 2007, J NEUROTRAUM, V24, P287, DOI 10.1089/neu.2006.0031; McIntyre LA, 2003, JAMA-J AM MED ASSOC, V289, P2992, DOI 10.1001/jama.289.22.2992; Ottochian M, 2009, J TRAUMA, V67, P81, DOI 10.1097/TA.0b013e318188b934; Polderman KH, 2008, LANCET, V371, P1955, DOI 10.1016/S0140-6736(08)60837-5; Polderman KH, 2009, CRIT CARE MED, V37, P1101, DOI 10.1097/CCM.0b013e3181962ad5; Polderman KH, 2005, CRIT CARE MED, V33, P2744, DOI 10.1097/01.CCM.0000190427.88735.19; Sambasivan CN, 2009, CURR OPIN CRIT CARE, V15, P560, DOI 10.1097/MCC.0b013e328331f57c; Selladurai BM, 1997, BRIT J NEUROSURG, V11, P398; Shaz BH, 2009, ANESTH ANALG, V108, P1760, DOI 10.1213/ane.0b013e3181a0b6c6; STEINEMANN S, 1990, J TRAUMA, V30, P200, DOI 10.1097/00005373-199002000-00011; TAFT WC, 1993, J CEREBR BLOOD F MET, V13, P796, DOI 10.1038/jcbfm.1993.101; Talving P, 2009, J TRAUMA, V66, P55, DOI 10.1097/TA.0b013e318190c3c0; Truettner JS, 2005, J CEREBR BLOOD F MET, V25, P1505, DOI 10.1038/sj.jcbfm.9600150; Vitarbo EA, 2004, NEUROSURGERY, V55, P416, DOI 10.1227/01.NEU.0000130036.52521.2C; Walters JH, 2011, RESUSCITATION, V82, P508, DOI 10.1016/j.resuscitation.2011.01.021; Wang GJ, 2002, NEUROSCIENCE, V114, P1081, DOI 10.1016/S0306-4522(02)00350-0; Wang HE, 2005, CRIT CARE MED, V33, P1296, DOI 10.1097/01.CCM.0000165965.31895.80; Zygun DA, 2005, CRIT CARE MED, V33, P654, DOI 10.1097/01.ccm.0000155911.01844.54	58	17	19	0	6	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	JUN 1	2012	175	1					24	29		10.1016/j.jss.2011.07.003			6	Surgery	Surgery	934UP	WOS:000303472500010	21872881				2021-06-18	
J	Donders, J; Levitt, T				Donders, Jacobus; Levitt, Terry			Criterion Validity of the Neuropsychological Assessment Battery after Traumatic Brain Injury	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Neuropsychological assessment; Executive functioning; Clinical utility	COGNITIVE IMPAIRMENT; SCREENING MODULE; UTILITY; SAMPLE	The performance of 54 patients with complicated mildsevere traumatic brain injury (TBI) was evaluated on the Attention, Executive Functions, and Memory modules of the Neuropsychological Assessment Battery (NAB) and compared with that of 54 demographically matched healthy controls. All three NAB indices demonstrated statistically significant group differences and negative covariances with the duration of coma, with large effect sizes. The Numbers and Letters and Mazes subtests had the most consistent evidence for sensitivity to brain injury. The findings provide preliminary support for the criterion validity of the NAB in the assessment of patients with complicated mildsevere TBI.	[Donders, Jacobus] Mary Free Bed Rehabil Hosp, Psychol Serv, Grand Rapids, MI 49503 USA	Donders, J (corresponding author), Mary Free Bed Rehabil Hosp, Psychol Serv, 235 Wealthy SE, Grand Rapids, MI 49503 USA.	jacobus.donders@maryfreebed.com					American Educational Research Association American Psychological Association and National Council on Measurement in Education, 1999, STAND ED PSYCH TESTS; Anderson TM, 2010, J CLIN EXP NEUROPSYC, V32, P1074, DOI 10.1080/13803391003733560; Banos J, 2010, PRINCIPLES PRACTICE, P329; DeJong J, 2010, J CLIN EXP NEUROPSYC, V32, P953, DOI 10.1080/13803391003645640; Donders J, 2001, J INT NEUROPSYCH SOC, V7, P892, DOI 10.1017/S1355617701777132; Draper K, 2008, NEUROPSYCHOLOGY, V22, P618, DOI 10.1037/0894-4105.22.5.618; Gavett BE, 2009, J INT NEUROPSYCH SOC, V15, P121, DOI 10.1017/S1355617708090176; Green P., 2003, GREENS WORD MEMORY T; Grohman K, 2004, EXP CLIN PSYCHOPHARM, V12, P200, DOI 10.1037/1064-1297.12.3.200; Hanks RA, 2004, DIFFERENTIAL DIAGNOSIS IN ADULT NEUROPSYCHOLOGICAL ASSESSMENT, P218; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Rios M, 2004, BRAIN INJURY, V18, P257, DOI 10.1080/02699050310001617442; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Stern RA, 2003, NEUROPSYCHOLOGICAL A; Stricker NH, 2010, J INT NEUROPSYCH SOC, V16, P813, DOI 10.1017/S1355617710000652; Strong CAH, 2008, J CLIN EXP NEUROPSYC, V30, P885, DOI 10.1080/13803390701858224; Strong CAH, 2011, J INT NEUROPSYCH SOC, V17, P230, DOI 10.1017/S1355617710001451; Willmott C, 2009, NEUROPSYCHOLOGY, V23, P424, DOI 10.1037/a0015058; Zgaljardic DJ, 2010, APPL NEUROPSYCHOL, V17, P27, DOI 10.1080/09084280903297909	19	17	18	0	11	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177			ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	JUN	2012	27	4					440	445		10.1093/arclin/acs043			6	Psychology, Clinical; Psychology	Psychology	944JX	WOS:000304198300007	22532153	Bronze			2021-06-18	
J	James, ML; Wang, HC; Cantillana, V; Lei, BL; Kernagis, DN; Dawson, HN; Klaman, LD; Laskowitz, DT				James, Michael L.; Wang, Haichen; Cantillana, Viviana; Lei, Beilei; Kernagis, Dawn N.; Dawson, Hana N.; Klaman, Lori D.; Laskowitz, Daniel T.			TT-301 Inhibits Microglial Activation and Improves Outcome after Central Nervous System Injury in Adult Mice	ANESTHESIOLOGY			English	Article							TRAUMATIC BRAIN-INJURY; INTRACEREBRAL HEMORRHAGE; APOLIPOPROTEIN-E; MOUSE MODEL; WATER-MAZE; PROINFLAMMATORY CYTOKINE; FUNCTIONAL RECOVERY; UP-REGULATION; CELL-DEATH; INFLAMMATION	Background: Microglial inhibition may reduce secondary tissue injury and improve functional outcome following acute brain injury. Utilizing clinically relevant murine models of traumatic brain injury and intracerebral hemorrhage, neuroinflammatory responses and functional outcome were examined in the presence of a potential microglial inhibitor, TT-301. Methods: TT-301 or saline was administered following traumatic brain injury or intracerebral hemorrhage, and then for four subsequent days. The effect of TT-301 on neuroinflammatory responses and neuronal viability was assessed, as well as short-term vestibulomotor deficit (Rotorod) and long-term neurocognitive impairment (Morris water maze). Finally differential gene expression profiles of mice treated with TT-301 were compared with those of vehicle. Results: Reduction in F4/80+ staining was demonstrated at 1 and 10 days, but not 28 days, after injury in mice treated with TT-301 (n = 6). These histologic findings were associated with improved neurologic function as assessed by Rotorod, which improved by 52.7% in the treated group by day 7, and Morris water maze latencies, which improved by 232.5% as a function of treatment (n = 12; P < 0.05). Similar benefit was demonstrated following intracerebral hemorrhage, in which treatment with TT-301 was associated with functional neurologic improvement of 39.6% improvement in Rotorod and a reduction in cerebral edema that was independent of hematoma volume (n = 12; P < 0.05). Differential gene expression was evaluated following treatment with TT-301, and hierarchical cluster analysis implicated involvement of the Janus kinase-Signal Transducer and Activator of Transcription pathway after administration of TT-301 (n = 3/group). Conclusions: Modulation of neuroinflammatory responses through TT-301 administration improved histologic and functional parameters in murine models of acute neurologic injury.	[James, Michael L.; Lei, Beilei; Laskowitz, Daniel T.] Duke Univ, Dept Anesthesiol, Durham, NC 27710 USA; [James, Michael L.; Wang, Haichen; Cantillana, Viviana; Dawson, Hana N.; Laskowitz, Daniel T.] Duke Univ, Dept Med Neurol, Durham, NC 27710 USA; [James, Michael L.; Wang, Haichen; Lei, Beilei; Laskowitz, Daniel T.] Duke Univ, Multidisciplinary Neuroprotect Labs, Med Ctr, Durham, NC 27710 USA; [Kernagis, Dawn N.] Duke Univ, Dept Pathol, Durham, NC 27710 USA; [Klaman, Lori D.] Transit Therapeut Inc, Preclin Res, Toronto, ON, Canada	James, ML (corresponding author), Duke Univ, Dept Anesthesiol, Box 3904, Durham, NC 27710 USA.	michael.james@duke.edu	James, Michael L./AAJ-5592-2020	James, Michael L./0000-0002-8715-5210	Transition Therapeutics	Received from the Departments of Anesthesiology and Medicine (Neurology), Duke University, Durham, North Carolina. Submitted for publication January 26, 2011. Accepted for publication February 3, 2012. Supported by a grant from Transition Therapeutics. Toronto, Ontario, Canada (to Dr. Laskowitz), the American Heart Association Scientist Development Grant, Dallas, Texas (to Dr. James), and the Foundation of Anesthesia Education and Research, Rochester, Minnesota (to Dr. James). TT-301 was provided by Transition Therapeutics. Dr. Laskowitz serves as consultant for Transition Therapeutics.	Allaman I, 2011, TRENDS NEUROSCI, V34, P76, DOI 10.1016/j.tins.2010.12.001; Bahniwal M, 2011, J NEUROIMMUNOL, V233, P65, DOI 10.1016/j.jneuroim.2010.11.016; Bessis A, 2007, GLIA, V55, P233, DOI 10.1002/glia.20459; Broderick J, 2007, STROKE, V38, P2001, DOI 10.1161/STROKEAHA.107.183689; Bulger EM, 2002, CRIT CARE MED, V30, P1870, DOI 10.1097/00003246-200208000-00033; Chen CJ, 2011, NEUROCHEM INT, V58, P234, DOI 10.1016/j.neuint.2010.12.009; Dawson HN, 2010, NEUROSCIENCE, V169, P516, DOI 10.1016/j.neuroscience.2010.04.037; Dawson HN, 2007, J NEUROSCI, V27, P9155, DOI 10.1523/JNEUROSCI.5492-06.2007; Feigin VL, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004583.pub2; Hamm RJ, 2001, J NEUROTRAUM, V18, P1207, DOI 10.1089/089771501317095241; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; Holscher C, 1999, BEHAV BRAIN RES, V100, P225, DOI 10.1016/S0166-4328(98)00134-X; Hoofien D, 2001, BRAIN INJURY, V15, P189; Hu WH, 2007, BIOORG MED CHEM LETT, V17, P414, DOI 10.1016/j.bmcl.2006.10.028; Huang CF, 2008, J NEUROIMMUNOL, V204, P118, DOI 10.1016/j.jneuroim.2008.07.004; James ML, 2010, J NEUROTRAUM, V27, P217, DOI 10.1089/neu.2009.1022; James ML, 2009, STROKE, V40, P632, DOI 10.1161/STROKEAHA.108.530402; James ML, 2008, NEUROCRIT CARE, V9, P139, DOI 10.1007/s12028-007-9030-2; Kellner CP, 2010, STROKE, V41, pS99, DOI 10.1161/STROKEAHA.110.597476; Kim HY, 2003, J IMMUNOL, V171, P6072, DOI 10.4049/jimmunol.171.11.6072; Laskowitz DT, 2007, J NEUROTRAUM, V24, P1093, DOI 10.1089/neu.2006.0192; Laskowitz DT, 2010, J NEUROTRAUM, V27, P1983, DOI 10.1089/neu.2010.1396; LEENEN PJM, 1994, J IMMUNOL METHODS, V174, P5, DOI 10.1016/0022-1759(94)90005-1; Leung Lai Yee, 2008, Molecular & Cellular Biomechanics, V5, P155; Lloyd E, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-28; Lynch JR, 2002, ANN NEUROL, V51, P113, DOI 10.1002/ana.10098; Madinier A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008101; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Park EJ, 2003, J BIOL CHEM, V278, P14747, DOI 10.1074/jbc.M210819200; RAMILO O, 1990, J EXP MED, V172, P497, DOI 10.1084/jem.172.2.497; Rao V, 2002, PSYCHIAT CLIN N AM, V25, P43, DOI 10.1016/S0193-953X(03)00052-2; ROSENBERG GA, 1990, ACT NEUR S, V51, P280; Saijo K, 2010, ADV IMMUNOL, V106, P21, DOI 10.1016/S0065-2776(10)06002-5; Satriotomo I, 2006, J NEUROCHEM, V98, P1353, DOI 10.1111/j.1471-4159.2006.04051.x; Skelton RW, 2006, BRAIN INJURY, V20, P189, DOI 10.1080/02699050500456410; Song EC, 2003, STROKE, V34, P2215, DOI 10.1161/01.STR.0000088060.83709.2C; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; Xue MZ, 2000, NEUROSCI LETT, V283, P230, DOI 10.1016/S0304-3940(00)00971-X; Zhu K, 2003, J BIOL CHEM, V278, P21869, DOI 10.1074/jbc.M213052200	39	17	18	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0003-3022	1528-1175		ANESTHESIOLOGY	Anesthesiology	JUN	2012	116	6					1299	1311		10.1097/ALN.0b013e318253a02a			13	Anesthesiology	Anesthesiology	946MR	WOS:000304356500020	22487803	Bronze			2021-06-18	
J	Armstead, WM; Riley, J; Vavilala, MS				Armstead, William M.; Riley, John; Vavilala, Monica S.			TBI Sex Dependently Upregulates ET-1 To Impair Autoregulation, which Is Aggravated by Phenylephrine in Males but Is Abrogated in Females	JOURNAL OF NEUROTRAUMA			English	Article						cerebral autoregulation; endothelin; K channels; signal transduction; TBI	TRAUMATIC BRAIN-INJURY; K+ CHANNEL FUNCTION; PROTEIN-KINASE-C; INTRACRANIAL-PRESSURE; ATP; AGE; HYPOTENSION; ACTIVATION; CHILDREN; NEWBORN	Traumatic brain injury (TBI) contributes to morbidity in children, and boys are disproportionately represented. Endothelin-1 (ET-1) contributes to impaired autoregulation via oxygen (O-2(-)) after TBI in piglets, but its relative role in males compared with females has not been previously investigated. Increased cerebral perfusion pressure (CPP) via phenylephrine (Phe) sex dependently improves impairment of autoregulation after TBI through modulation of extracellular signal-related kinase (ERK) mitogen-activated protein kinase (MAPK) upregulation, aggravated in males, but blocked in females. Activation of adenosine-5'-triphosphate (ATP) and Ca sensitive K channels produce vasodilation, contributing to autoregulation. We hypothesized that ET-1 upregulation is greater in males after TBI and that disturbed autoregulation will be prevented by Phe in a sex-dependent manner through modulation of ET-1, O-2(-), and ERK. Results show that ET-1 release was greater in males after fluid percussion injury (FPI), blunted by Phe in females, but aggravated in males. K channel vasodilation was impaired more in males than in females after TBI. Phe prevented reductions in K channel vasodilation in females, but further reduced dilation in males after TBI. Co-administration of BQ-123, U0126, or PEG-SOD (ET-1, ERK antagonist, and O-2(-) scavenger) with Phe restored dilation to K agonists and hypotension in males after TBI. ERK upregulation was blocked by BQ-123 and PEG-SOD. These data indicate that TBI upregulates ET-1 more in males than in females. Elevation of CPP with Phe sex dependently prevents impairment of cerebral autoregulation after TBI through modulation of ET-1, O-2(-), and ERK mediated impairment of K channel vasodilation. These observations advocate for the consideration of development of sex-based therapies for the treatment of hemodynamic sequelae of pediatric TBI.	[Armstead, William M.; Riley, John] Univ Penn, Dept Anesthesiol & Crit Care, Philadelphia, PA 19104 USA; [Armstead, William M.] Univ Penn, Dept Pharmacol, Philadelphia, PA 19104 USA; [Vavilala, Monica S.] Univ Washington, Dept Anesthesiol Pediat & Neurol Surg, Seattle, WA 98195 USA	Armstead, WM (corresponding author), Univ Penn, Dept Anesthesiol & Crit Care, 3620 Hamilton Walk,JM3, Philadelphia, PA 19104 USA.	armsteaw@uphs.upenn.edu		Riley, John/0000-0002-7932-8935	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [HD57355]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD057355] Funding Source: NIH RePORTER	This research was supported by grant HD57355 from the National Institutes of Health.	Adelson P David, 2003, Pediatr Crit Care Med, V4, pS12; Armstead WM, 2007, J CEREBR BLOOD F MET, V27, P1702, DOI 10.1038/sj.jcbfm.9600473; Armstead William M, 2005, Pathophysiology, V12, P5, DOI 10.1016/j.pathophys.2005.01.002; Armstead WM, 2011, NEUROL RES, V33, P127, DOI 10.1179/016164111X12881719352138; Armstead WM, 2011, J NEUROTRAUM, V28, P105, DOI 10.1089/neu.2010.1581; Armstead WM, 2010, CRIT CARE MED, V38, P1868, DOI 10.1097/CCM.0b013e3181e8ac1a; Armstead WM, 2010, J NEUROTRAUM, V27, P391, DOI 10.1089/neu.2009.1094; Armstead WM, 2009, J CEREBR BLOOD F MET, V29, P524, DOI 10.1038/jcbfm.2008.142; Armstead WM, 1999, STROKE, V30, P153, DOI 10.1161/01.STR.30.1.153; Armstead WM, 1999, AM J PHYSIOL-HEART C, V277, pH1884; Armstead WM, 1999, BRAIN RES, V816, P158, DOI 10.1016/S0006-8993(98)01146-9; Armstead WM, 1997, STROKE, V28, P2273, DOI 10.1161/01.STR.28.11.2273; Armstead WM, 2000, MICROCIRCULATION, V7, P225, DOI 10.1038/sj.mn.7300110; Bratton SL, 2007, J NEUROTRAUMA, V24, pS7; Catala-Temprano A, 2007, J NEUROSURG, V106, P463, DOI 10.3171/ped.2007.106.6.463; Coles JP, 2004, BRAIN, V127, P2479, DOI 10.1093/brain/awh268; Cremer OL, 2005, CRIT CARE MED, V33, P2207, DOI 10.1097/01.CCM.0000181300.99078.B5; Di Gennaro JL, 2010, DEV NEUROSCI-BASEL, V32, P420, DOI 10.1159/000322083; EDVINSSON L, 1987, J CEREBR BLOOD F MET, V7, P720, DOI 10.1038/jcbfm.1987.126; Faraci FM, 1998, PHYSIOL REV, V78, P53; Freeman SS, 2008, ANESTHESIOLOGY, V108, P588, DOI 10.1097/ALN.0b013e31816725d7; Ishikawa S, 2009, ANESTH ANALG, V108, P1631, DOI 10.1213/ane.0b013e31819d94e3; Keenan Heather T, 2005, Pediatr Crit Care Med, V6, P537, DOI 10.1097/01.PCC.0000164638.44600.67; Laher I, 2001, J CEREBR BLOOD F MET, V21, P887, DOI 10.1097/00004647-200108000-00001; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006	25	17	18	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAY	2012	29	7					1483	1490		10.1089/neu.2011.2248			8	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	933TC	WOS:000303384600020	22335188	Green Published			2021-06-18	
J	Chiba, Y; Kuroda, S; Osanai, T; Shichinohe, H; Houkin, K; Iwasaki, Y				Chiba, Yasuhiro; Kuroda, Satoshi; Osanai, Toshiya; Shichinohe, Hideo; Houkin, Kiyohiro; Iwasaki, Yoshinobu			Impact of ageing on biological features of bone marrow stromal cells (BMSC) in cell transplantation therapy for CNS disorders: Functional enhancement by granulocyte-colony stimulating factor (G-CSF)	NEUROPATHOLOGY			English	Article						ageing; bone marrow stromal cell (BMSC); brain freezing injury; G-CSF; transplantation	MESENCHYMAL STEM-CELLS; MICE CEREBRAL INFARCT; SPINAL-CORD; INJURY; DIFFERENTIATION; SENESCENCE; EXPRESSION; RECOVERY; CULTURE; YOUNG	This study was designed to clarify the effects of donor age on biological features of bone marrow stromal cells (BMSC), one of the candidates for cell transplantation therapy for CNS disorders, because many aged patients might require such therapy. This study was also aimed to test whether ex vivo treatments with granulocyte-colony stimulating factor (G-CSF) could modify biological properties of BMSC from aged donors and enhance its therapeutic effects in an animal model of traumatic brain injury. The BMSC were harvested from young (6-week-old) and aged (100-week-old) rats. The ageing significantly increased the senescence-associated beta-galactosidase (SA-beta-gal) activity of the cultured BMSC, and decreased their proliferative capacity and production of nerve growth factor (NGF) and brain-derived neurotrophic factor (BDNF). As the next step, the rats were subjected to brain freezing injury by applying liquid nitrogen onto the neocortex through the thinned skull. The 6-week BMSC, 100-week BMSC, G-CSF-treated 100-week BMSC or vehicle were stereotactically injected into the ipsilateral striatum at 7 days post-injury. Transplantation of the 6-week BMSC, but not 100-week BMSC, significantly improved locomotor function. However, treatment of the 100-week BMSC with 0.1 mu mol of G-CSF significantly improved their proliferation activity and growth factor production, and recovered therapeutic effects in the injured brain. In conclusion, donor age may largely determine biological aspects of BMSC. G-CSF may contribute to improve the outcome of BMSC transplantation therapy for CNS disorders in aged patients.	[Kuroda, Satoshi] Hokkaido Univ, Grad Sch Med, Dept Neurosurg, Kita Ku, Sapporo, Hokkaido 0608638, Japan	Kuroda, S (corresponding author), Hokkaido Univ, Grad Sch Med, Dept Neurosurg, Kita Ku, North 15 West 7, Sapporo, Hokkaido 0608638, Japan.	skuroda@med.hokudai.ac.jp	Shichinohe, Hideo/G-5367-2012; Osanai, Toshiya/AAF-3011-2020; Houkin, Kiyohiro/G-5364-2012		Ministry of Education, Science and Culture of JapanMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT) [19390371, 20591701, 20390377, 21390400, 23390342]; Grants-in-Aid for Scientific ResearchMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI) [23390342] Funding Source: KAKEN	This study was supported by Grant-in-aid from the Ministry of Education, Science and Culture of Japan (No.19390371, 20591701, 20390377, 21390400, and 23390342). The authors sincerely thank Yumiko Shinohe for her technical assistance with cell cultures and immunohistochemistry.	Beausejour C., 2007, V180, P67; Chiba Y, 2009, NEUROSURGERY, V64, P991, DOI 10.1227/01.NEU.0000341905.57162.1D; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Garcia R, 2004, BIOCHEM BIOPH RES CO, V316, P753, DOI 10.1016/j.bbrc.2004.02.111; Gu Y, 2010, J MOL NEUROSCI, V40, P332, DOI 10.1007/s12031-009-9304-6; Hokari M, 2008, J NEUROSCI RES, V86, P1024, DOI 10.1002/jnr.21572; Hokari M, 2009, CYTOKINE, V46, P260, DOI 10.1016/j.cyto.2009.02.008; Itosaka H, 2009, NEUROPATHOLOGY, V29, P248, DOI 10.1111/j.1440-1789.2008.00971.x; Jiang S, 2008, J MOL CELL CARDIOL, V44, P582, DOI 10.1016/j.yjmcc.2007.11.014; Kinnaird T, 2004, CIRC RES, V94, P678, DOI 10.1161/01.RES.0000118601.37875.AC; Kuroda S, 2011, J STEM CELLS REGEN, V7, P2; Lee BY, 2006, AGING CELL, V5, P187, DOI 10.1111/j.1474-9726.2006.00199.x; Lee JB, 2004, BRAIN RES PROTOC, V14, P37, DOI 10.1016/j.brainresprot.2004.09.004; Lu J, 2006, NEUROSCI LETT, V398, P12, DOI 10.1016/j.neulet.2005.12.053; Mahmood A, 2006, J NEUROSURG, V104, P272, DOI 10.3171/jns.2006.104.2.272; Maruichi K, 2009, NEUROPATHOLOGY, V29, P422, DOI 10.1111/j.1440-1789.2008.00995.x; Roobrouck VD, 2008, EXP CELL RES, V314, P1937, DOI 10.1016/j.yexcr.2008.03.006; Sethe S, 2006, AGEING RES REV, V5, P91, DOI 10.1016/j.arr.2005.10.001; Shichinohe H, 2004, BRAIN RES PROTOC, V13, P166, DOI 10.1016/j.brainresprot.2004.04.004; Shichinohe H, 2007, BRAIN RES, V1183, P138, DOI 10.1016/j.brainres.2007.08.091; Shichinohe H, 2006, J NUCL MED, V47, P486; Stenderup K, 2003, BONE, V33, P919, DOI 10.1016/j.bone.2003.07.005; von Aulock Sonja, 2004, Curr Opin Investig Drugs, V5, P1148; Wagner W, 2010, AGING-US, V2, P224, DOI 10.18632/aging.100136; Wagner W, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005846; Wang YQ, 2008, CHINESE MED J-PEKING, V121, P2290, DOI 10.1097/00029330-200811020-00015; Welte K, 1985, Haematol Blood Transfus, V29, P398; Wilkins A, 2009, STEM CELL RES; Wright KT, 2008, SPINAL CORD, V46, P811, DOI 10.1038/sc.2008.77; Yamaguchi S, 2006, BRAIN RES, V1087, P15, DOI 10.1016/j.brainres.2006.02.127; Yano S, 2005, BRAIN RES, V1065, P60, DOI 10.1016/j.brainres.2005.10.031; Yasuda H, 2010, J NEUROSURG, V112, P336, DOI 10.3171/2009.2.JNS08495; Zhou S, 2008, AGING CELL, V7, P335, DOI 10.1111/j.1474-9726.2008.00377.x; Zhuo YF, 2010, J THORAC CARDIOV SUR, V139, P1286, DOI 10.1016/j.jtcvs.2009.08.052	34	17	20	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0919-6544	1440-1789		NEUROPATHOLOGY	Neuropathology	APR	2012	32	2					139	148		10.1111/j.1440-1789.2011.01255.x			10	Clinical Neurology; Neurosciences; Pathology	Neurosciences & Neurology; Pathology	915DH	WOS:000302003500005	21981141				2021-06-18	
J	Holmes, J; Peng, J; Bair, A				Holmes, James; Peng, James; Bair, Aaron			ABNORMAL END-TIDAL CARBON DIOXIDE LEVELS ON EMERGENCY DEPARTMENT ARRIVAL IN ADULT AND PEDIATRIC INTUBATED PATIENTS	PREHOSPITAL EMERGENCY CARE			English	Article; Proceedings Paper	ACEP Scientific Assembly	OCT, 2010	Boston, MA			prehospital intubation; trauma; ETCO2	TRAUMATIC BRAIN-INJURY; ENDOTRACHEAL INTUBATION; PREHOSPITAL INTUBATION; VENTILATION; FIELD; SURVIVAL; IMPACT; TIME	Background. The utility of prehospital intubation is controversial, as uncontrolled studies in trauma patients suggest adverse outcomes with prehospital intubation, perhaps secondary to inappropriate ventilation once intubation is accomplished. Objectives. The objectives were 1) to establish, immediately upon arrival to the emergency department (ED), the prevalence of abnormal end-tidal carbon dioxide (ETCO2) levels in patients with prehospital intubation and 2) to describe the relationship between abnormal ETCO2 levels on ED arrival and mortality. Methods. This was a prospective, observational cohort study of patients with prehospital intubation. Patients were excluded if they underwent prehospital cardiopulmonary resuscitation (CPR). On ED arrival, the initial ETCO2 measurement from the patient's endotracheal tube was immediately obtained prior to purposeful intervention in the patient's ventilation by using an Oridion Surestream Sure VentLine H Set with a Welch Allyn Propaq CS monitor. For each patient, the treating physician documented the ETCO2 measurement, patient demographics, and details of the transport. The primary outcome was an abnormal ETCO2 value (<30 mmHg or >45 mmHg). The secondary outcome was mortality. Results. One hundred eligible patients were enrolled, with a median age of 30 years (interquartile range [IQR] 15, 48 years). Esophageal intubations were identified in four cases, and those cases were excluded from further analysis. Mechanisms included trauma, 74; medical, 12; and burn, 10. The median ETCO2 value was 32 mmHg (IQR 27, 38 mmHg), range 18-80 mmHg. Forty-six of 96 (48%, 95% confidence interval [CI] 38%, 58%) patients had abnormal ETCO2 values, including 37 (39%, 95% CI 29%, 49%) with low ETCO2 levels and nine (9%, 95% CI 4%, 17%) with high ETCO2 levels. Death was higher in those trauma patients with abnormal ETCO2 levels (10/33, 30%, 95% CI 16%, 49%) than in those with normal ETCO2 levels (2/41, 5%, 95% CI 0.6%, 17%), relative risk = 6.2 (95% CI 1.5, 26.4), p = 0.004. Conclusion. Nearly half of all patients transported by prehospital providers had abnormal ETCO2 measurements on initial ED presentation, suggesting an area for potential improvement. Trauma patients with abnormal initial ETCO2 levels were more likely to die.	[Holmes, James; Peng, James; Bair, Aaron] Univ Calif Davis, Sch Med, Dept Emergency Med, Sacramento, CA 95817 USA	Holmes, J (corresponding author), Univ Calif Davis, Sch Med, Dept Emergency Med, 2315 Stockton Blvd,PSSB 2100, Sacramento, CA 95817 USA.	jfholmes@ucdavis.edu					Bair AE, 2005, J EMERG MED, V28, P403, DOI 10.1016/j.jemermed.2004.12.008; Bochicchio GV, 2003, J TRAUMA, V54, P307, DOI 10.1097/01.TA.0000046252.97590.BE; Carr BG, 2008, PREHOSP EMERG CARE, V12, P327, DOI 10.1080/10903120802096928; Caulfield EV, 2009, J TRAUMA, V66, P1577, DOI 10.1097/TA.0b013e3181a3931d; Chi JH, 2006, J TRAUMA, V61, P1134, DOI 10.1097/01.ta.0000196644.64653.d8; Cobas MA, 2009, ANESTH ANALG, V109, P489, DOI 10.1213/ane.0b013e3181aa3063; Colwell CB, 2009, PREHOSP EMERG CARE, V13, P304, DOI 10.1080/10903120902935280; Cooper A, 2001, Semin Pediatr Surg, V10, P3, DOI 10.1053/spsu.2001.19379; Cudnik MT, 2007, PREHOSP EMERG CARE, V11, P224, DOI 10.1080/10903120701205208; Davis DP, 2005, J TRAUMA, V58, P933, DOI 10.1097/01.TA.0000162731.53812.58; Davis DP, 2005, NEUROCRIT CARE, V2, P165, DOI 10.1385/NCC:2:2:165; Davis DP, 2004, J TRAUMA, V56, P808, DOI 10.1097/01.TA.0000100217.05066.87; Davis DP, 2003, J TRAUMA, V54, P444, DOI 10.1097/01.TA.0000053396.02126.CD; Deakin CD, 2009, EMERG MED J, V26, P888, DOI 10.1136/emj.2008.064642; DiRusso SM, 2005, J TRAUMA, V59, P84, DOI 10.1097/01.TA.0000171462.28379.F3; Dumont TM, 2010, J NEUROTRAUM, V27, P1233, DOI 10.1089/neu.2009.1216; Gausche M, 2000, JAMA-J AM MED ASSOC, V283, P783, DOI 10.1001/jama.283.6.783; Kupas DF, 2010, PREHOSP EMERG CARE, V14, P26, DOI 10.3109/10903120903144932; Lecky F, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001429.pub2; Lyon RM, 2010, EMERG MED J, V27, P321, DOI 10.1136/emj.2009.076737; Murray JA, 2000, J TRAUMA, V49, P1065, DOI 10.1097/00005373-200012000-00015; Stiell IG, 2008, CAN MED ASSOC J, V178, P1141, DOI 10.1503/cmaj.071154; Wang HE, 2004, ANN EMERG MED, V44, P439, DOI 10.1016/j.annemergmed.2004.04.008; Wang HE, 2003, ACAD EMERG MED, V10, P717, DOI 10.1111/j.1553-2712.2003.tb00065.x; Wang HE, 2010, ANN EMERG MED, V55, P527, DOI 10.1016/j.annemergmed.2009.12.020; Warner KJ, 2008, J TRAUMA, V64, P341, DOI 10.1097/TA.0b013e318160dfb3; Warner KJ, 2010, PREHOSP EMERG CARE, V14, P103, DOI 10.3109/10903120903144858	27	17	17	0	4	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1090-3127	1545-0066		PREHOSP EMERG CARE	Prehosp. Emerg. Care	APR-JUN	2012	16	2					210	216		10.3109/10903127.2011.640416			7	Emergency Medicine; Public, Environmental & Occupational Health	Emergency Medicine; Public, Environmental & Occupational Health	899BU	WOS:000300788700004	22217189				2021-06-18	
J	Kim, HB; Kim, DK; Kwak, YH; Shin, SD; Song, KJ; Lee, SC; Park, JO; Jang, HY; Kim, SC				Kim, Hahn Bom; Kim, Do Kyun; Kwak, Young Ho; Shin, Sang Do; Song, Kyoung Jun; Lee, Seung Chul; Park, Ju Ok; Jang, Hye Young; Kim, Seong Chun			Epidemiology of Traumatic Head Injury in Korean Children	JOURNAL OF KOREAN MEDICAL SCIENCE			English	Article						Epidemiology; Head Trauma; Pediatrics	BRAIN-INJURY; UNITED-STATES; COMPUTED-TOMOGRAPHY; AGE	The aim of this study was to elucidate the epidemiology of traumatic head injury (THI) among Korean children. A prospective, in-depth trauma survey was conducted in five teaching hospitals. Data from all of the children who attended the emergency department (ED) were analyzed. From June 2008 to May 2009, 2,856 children with THI visited the 5 EDs. The average age of the subjects was 5.6 (SD +/- 4.9) yr old, and 1,585 (55.5%) were 0-4 yr old. The male-to-female ratio was 2.3 to 1 (1,979 vs 877). Consciousness levels of the subjects were classified according to the Glasgow Coma Scale (GCS), and 99.1%, 0.6%, and 0.4% were determined as mild, moderate, or severe injury, respectively, according to the GCS categorization. Most injuries occurred at home (51.3%), and the most common mechanism of injury was collision (43.2%). With regard to outcome, 2,682 (93.9%) patients were sent home, and 35 (1.2%) were transferred to another hospital. A total of 133 (4.7%) patients were hospitalized, and 38 (1.3%) underwent surgery. The incidence and characteristics of pediatric THI in Korea are affected by sex, location and injury mechanism.	[Kim, Do Kyun; Kwak, Young Ho; Shin, Sang Do] Seoul Natl Univ, Coll Med, Dept Emergency Med, Seoul 110744, South Korea; [Kim, Hahn Bom; Song, Kyoung Jun] Seoul Natl Univ, Boramae Med Ctr, Dept Emergency Med, Seoul 110744, South Korea; [Lee, Seung Chul] Dongguk Univ, Coll Med, Dept Emergency Med, Goyang, South Korea; [Park, Ju Ok] Cheju Natl Univ, Sch Med, Dept Emergency Med, Cheju, South Korea; [Jang, Hye Young] Soonchunhyang Univ, Seoul Hosp, Dept Emergency Med, Seoul, South Korea; [Kim, Seong Chun] Gyeongsang Natl Univ, Sch Med, Dept Emergency Med, Jinju, South Korea	Kim, DK (corresponding author), Seoul Natl Univ, Coll Med, Dept Emergency Med, 101 Daehak Ro, Seoul 110744, South Korea.	birdbeak@snuh.org	Kwak, Young Ho/J-5373-2012; Shin, Sang/J-5523-2012; KIM, KYUN/Q-3070-2018	KIM, KYUN/0000-0002-6144-302X; Kwak, Young Ho/0000-0003-2062-7575			Bayreuther J, 2009, ARCH DIS CHILDHOOD-E, V94, P37, DOI 10.1136/adc.2007.132787; BERNEY J, 1994, CHILD NERV SYST, V10, P509, DOI 10.1007/BF00335073; Berry JG, 2010, INJURY PREV, V16, P198, DOI 10.1136/ip.2009.022442; Blackwell CD, 2007, ANN EMERG MED, V49, P320, DOI 10.1016/j.annemergmed.2006.09.025; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; DUHAIME AC, 1992, PEDIATRICS, V90, P179; Dunning J, 2004, ARCH DIS CHILD, V89, P763, DOI 10.1136/adc.2003.042523; Hawkins ER, 2007, PEDIATR EMERG CARE, V23, P790, DOI 10.1097/PEC.0b013e318159ffd9; Kim JK, 1998, J KOREAN NEUROSURG S, V27, P625; Korean Statistical Information Service, 2009, ANN REP CAUS DEATH S; KRAUS JF, 1986, AM J DIS CHILD, V140, P687, DOI 10.1001/archpedi.1986.02140210085032; Krug EG, 2000, AM J PUBLIC HEALTH, V90, P523, DOI 10.2105/AJPH.90.4.523; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; Lee KW, 1999, J KOREAN NEUROSURG S, V28, P42; Nagaraja J, 2005, PEDIATRICS, V116, P454, DOI 10.1542/peds.2004-1415; National Center for Health Statistics; National Vital Statistics Reports, NAT VIT STAT REP; National Center for Injury Prevention and Control, TRAUM BRAIN INJ US E; National Center for Injury Prevention and Control, WEB BAS INJ STAT QUE; National Center for Injury Prevention and Control, TRAUM BRAIN INJ US A; Osmond MH, 2010, CAN MED ASSOC J, V182, P341, DOI 10.1503/cmaj.091421; Park HS, CONSTRUCTION NATL SY; Ryu MS, 2006, J KOREAN CHILD NEURO, V14, P87; Schneier AJ, 2006, PEDIATRICS, V118, P483, DOI 10.1542/peds.2005-2588; Schwartz L, 2003, J PEDIATR PSYCHOL, V28, P251, DOI 10.1093/jpepsy/jsg013; Shudy M, 2006, PEDIATRICS, V118, pS203, DOI 10.1542/peds.2006-0951B; SOSIN DM, 1995, JAMA-J AM MED ASSOC, V273, P1778, DOI 10.1001/jama.273.22.1778; UNICEF, LEAG TABL CHILD DEAT; WHO-ICECI Coordination and Maintenance Group, 2004, TEST ICECI REV FIL T; Youn S, 2004, KOREAN J PEDIAT, V47, P1198	30	17	18	0	2	KOREAN ACAD MEDICAL SCIENCES	SEOUL	302 75 DONG DU ICHON, DONG YONGSAN KU, SEOUL 140 031, SOUTH KOREA	1011-8934			J KOREAN MED SCI	J. Korean Med. Sci.	APR	2012	27	4					437	442		10.3346/jkms.2012.27.4.437			6	Medicine, General & Internal	General & Internal Medicine	922ZX	WOS:000302588800016	22468109	DOAJ Gold, Green Published			2021-06-18	
J	Matsushima, K; Peng, M; Velasco, C; Schaefer, E; Diaz-Arrastia, R; Frankel, H				Matsushima, Kazuhide; Peng, Monica; Velasco, Carlos; Schaefer, Eric; Diaz-Arrastia, Ramon; Frankel, Heidi			Glucose variability negatively impacts long-term functional outcome in patients with traumatic brain injury	JOURNAL OF CRITICAL CARE			English	Article						Glucose variability; Traumatic brain injury; Long-term functional outcome	INTENSIVE INSULIN THERAPY; CRITICALLY-ILL PATIENTS; FASTING PLASMA-GLUCOSE; BLOOD-GLUCOSE; INDEPENDENT PREDICTOR; INCREASED MORTALITY; CARE-UNIT; HYPERGLYCEMIA; MANAGEMENT	Purpose: Significant glycemic excursions (so-called glucose variability) affect the outcome of generic critically ill patients but has not been well studied in patients with traumatic brain injury (TBI). The purpose of this study was to evaluate the impact of glucose variability on long-term functional outcome of patients with TBI. Material and Methods: A noncomputerized tight glucose control protocol was used in our intensivist model surgical intensive care unit. The relationship between the glucose variability and long-term (a median of 6 months after injury) functional outcome defined by extended Glasgow Outcome Scale (GOSE) was analyzed using ordinal logistic regression models. Glucose variability was defined by SD and percentage of excursion (POE) from the preset range glucose level. Results: A total of 109 patients with TBI under tight glucose control had long-term GOSE evaluated. In univariable analysis, there was a significant association between lower GOSE score and higher mean glucose, higher SD, POE more than 60, POE 80 to 150, and single episode of glucose less than 60 mg/dL but not POE 80 to 110. After adjusting for possible confounding variables in multivariable ordinal logistic regression models, higher SD, POE more than 60, POE 80 to 150, and single episode of glucose less than 60 mg/dL were significantly associated with lower GOSE score. Conclusions: Glucose variability was significantly associated with poorer long-term functional outcome in patients with TBI as measured by the GOSE score. Well-designed protocols to minimize glucose variability may be key in improving long-term functional outcome. (C) 2012 Elsevier Inc. All rights reserved.	[Matsushima, Kazuhide] Penn State Milton S Hershey Med Ctr, Dept Surg, Div Trauma Acute Care & Crit Care Surg, Hershey, PA 17036 USA; [Peng, Monica; Velasco, Carlos] Univ Texas SW Med Ctr Dallas, Dept Surg, Dallas, TX 75390 USA; [Schaefer, Eric] Penn State Milton S Hershey Med Ctr, Dept Publ Hlth Sci, Hershey, PA 17036 USA; [Diaz-Arrastia, Ramon] Univ Texas SW Med Ctr Dallas, Dept Neurol, Dallas, TX 75390 USA; [Frankel, Heidi] R Adams CowleyUniv Maryland, Sch Med, Baltimore, MD 21201 USA	Matsushima, K (corresponding author), Penn State Milton S Hershey Med Ctr, Dept Surg, Div Trauma Acute Care & Crit Care Surg, Hershey, PA 17036 USA.	kmatsushima@hmc.psu.edu		Diaz-Arrastia, Ramon/0000-0001-6051-3594			Ali NA, 2008, CRIT CARE MED, V36, P2316, DOI 10.1097/CCM.0b013e3181810378; Arabi YM, 2008, CRIT CARE MED, V36, P3190, DOI 10.1097/CCM.0b013e31818f21aa; ATKINSON EJ, 1997, TECHNICAL REPORT SER, V61; Bartlett J, 1998, BRIT J NEUROSURG, V12, P349, DOI 10.1080/02688699844871; Bilotta F, 2008, NEUROCRIT CARE, V9, P159, DOI 10.1007/s12028-008-9084-9; Brunkhorst FM, 2008, NEW ENGL J MED, V358, P125, DOI 10.1056/NEJMoa070716; Bullock AR, 2006, NEUROSURGERY, V58, pVI; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Cavalcanti AB, 2009, J CRIT CARE, V24, P371, DOI 10.1016/j.jcrc.2009.05.005; Egi M, 2008, CRIT CARE MED, V36, P2249, DOI 10.1097/CCM.0b013e318181039a; Egi M, 2006, ANESTHESIOLOGY, V105, P244, DOI 10.1097/00000542-200608000-00006; Finfer S, 2009, NEW ENGL J MED, V360, P1283, DOI 10.1056/NEJMoa0810625; Gale SC, 2007, AM SURGEON, V73, P454; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Griesdale DEG, 2009, NEUROCRIT CARE, V11, P311, DOI 10.1007/s12028-009-9249-1; Helmy A, 2007, BRIT J ANAESTH, V99, P32, DOI 10.1093/bja/aem139; Hermanides J, 2010, CRIT CARE MED, V38, P838, DOI 10.1097/CCM.0b013e3181cc4be9; Hirshberg E, 2008, PEDIATR CRIT CARE ME, V9, P361, DOI 10.1097/PCC.0b013e318172d401; Holzinger U, 2010, DIABETES CARE, V33, P467, DOI 10.2337/dc09-1352; Jacka MJ, 2009, CAN J NEUROL SCI, V36, P436, DOI 10.1017/S0317167100007757; Kreutziger J, 2009, J TRAUMA, V67, P704, DOI 10.1097/TA.0b013e3181b22e37; Krinsley JS, 2008, CRIT CARE MED, V36, P3008, DOI 10.1097/CCM.0b013e31818b38d2; Langlois JA, 2006, TRAUMATIC BRAIN INJU; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Ling GSF, 2008, NEUROL CLIN, V26, P409, DOI 10.1016/j.ncl.2008.02.001; Marik PE, 2002, CHEST, V122, P699, DOI 10.1378/chest.122.2.699; Monnier Louis, 2008, J Diabetes Sci Technol, V2, P1094; Muggeo M, 2000, DIABETES CARE, V23, P45, DOI 10.2337/diacare.23.1.45; Muggeo M, 1997, CIRCULATION, V96, P1750, DOI 10.1161/01.CIR.96.6.1750; Paddle JJ, 2011, ANAESTHESIA, V66, P92, DOI 10.1111/j.1365-2044.2010.06603.x; PETERSON B, 1990, J R STAT SOC C-APPL, V39, P205; Preiser JC, 2009, INTENS CARE MED, V35, P1738, DOI 10.1007/s00134-009-1585-2; Salim A, 2009, AM SURGEON, V75, P25; Suarez JI, 2009, J NEUROSURG ANESTH, V21, P52, DOI 10.1097/01.ana.0000343199.62838.02; Van den Berghe G, 2005, NEUROLOGY, V64, P1348, DOI 10.1212/01.WNL.0000158442.08857.FC; Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300; Wahl WL, 2008, J TRAUMA, V65, P42, DOI 10.1097/TA.0b013e318176c54e; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Yoder J, 2009, J NEUROSURG ANESTH, V21, P55, DOI 10.1097/01.ana.0000343200.93263.a4	39	17	21	0	7	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0883-9441	1557-8615		J CRIT CARE	J. Crit. Care	APR	2012	27	2					125	131		10.1016/j.jcrc.2011.08.012			7	Critical Care Medicine	General & Internal Medicine	918ZV	WOS:000302291300004	22033047				2021-06-18	
J	Menuet, C; Borghgraef, P; Voituron, N; Gestreau, C; Gielis, L; Devijver, H; Dutschmann, M; Van Leuven, F; Hilaire, G				Menuet, Clement; Borghgraef, Peter; Voituron, Nicolas; Gestreau, Christian; Gielis, Lies; Devijver, Herman; Dutschmann, Mathias; Van Leuven, Fred; Hilaire, Gerard			Isoflurane anesthesia precipitates tauopathy and upper airways dysfunction in pre-symptomatic Tau.P301L mice: Possible implication for neurodegenerative diseases	NEUROBIOLOGY OF DISEASE			English	Article						Tauopathy; Anesthesia; Upper airways; Memantine; Isoflurane; NMDA receptors; Mice; Brainstem; Alzheimer's disease	TRAUMATIC BRAIN-INJURY; D-ASPARTATE RECEPTORS; ALZHEIMERS-DISEASE; TAU PHOSPHORYLATION; MEMORY IMPAIRMENT; PREMOTOR NEURONS; TRANSGENIC MICE; STEM NUCLEI; PROTEIN-TAU; C-FOS	The postoperative cognitive decline resulting from volatile anesthesia is gaining acceptance as a major health problem. The common anesthetic isoflurane is suspected to precipitate neurodegeneration in Alzheimer's disease by unknown mechanisms. We previously validated that 8 month old Tau.P301L mice suffer upper airways defects related to tauopathy within the Kolliker-Fuse nucleus that controls upper airways function. We now report that isoflurane anesthesia in young, pre-symptomatic Tau.P301L mice triggered precocious upper airways defects and tauopathy in several brainstem nuclei, including the nucleus ambiguus that contains upper airways motor neurons and the Kolliker-Fuse. The prescription drug memantine, identified as an NMDA receptor antagonist, prevented the post-anesthesia upper airways dysfunction and alleviated tauopathy in the nucleus ambiguus and Kolliker-Fuse. We further identified protocols of anesthesia in young Tau.P301L mice that mitigated adverse effects of isoflurane anesthesia. Thus, our experimental findings in a validated mouse model for tauopathy demonstrate the link between isoflurane anesthesia, earlier onset of tauopathy and earlier onset of functional deficits, highlight the implication of NMDA-receptors in the mechanisms mediating the adverse effects of isoflurane, and potentially identify safer protocols for anesthesia in patients with tauopathy. (C) 2012 Elsevier Inc. All rights reserved.	[Menuet, Clement; Voituron, Nicolas; Gestreau, Christian; Hilaire, Gerard] Fac Sci & Tech St Jerome, Resp Team MP3, Unite Mixte Rech 6231, Ctr Rech Neurobiol & Neurophysiol Marseille,Serv, F-13397 Marseille 20, France; [Borghgraef, Peter; Gielis, Lies; Devijver, Herman; Van Leuven, Fred] KULeuven, Expt Genet Grp, LEGTEGG, Dept Human Genet, B-3000 Louvain, Belgium; [Dutschmann, Mathias] Univ Leeds, Inst Membrane & Syst Biol, Leeds LS2 9JT, W Yorkshire, England	Hilaire, G (corresponding author), Fac Sci & Tech St Jerome, Resp Team MP3, Unite Mixte Rech 6231, Ctr Rech Neurobiol & Neurophysiol Marseille,Serv, F-13 Marseille, France.	gerard.hilaire@univ-cezanne.fr	Gestreau, Christian/K-5161-2017	Gestreau, Christian/0000-0001-5069-482X; Menuet, Clement/0000-0002-7419-6427; Dutschmann, Mathias/0000-0002-0692-746X	Unite Mixte de Recherche [6231]; Fonds Wetenschappelijk Onderzoek-Vlaanderen (FWO-Vlaanderen)FWO; Instituut voor Wetenschap en Techniek (IWT)Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT); KULeuven-Research Fund (BOF)KU Leuven; KULeuven-Research&Development and EEC Framework programs; NHLBIUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)	This work was supported by the Unite Mixte de Recherche 6231, the Fonds Wetenschappelijk Onderzoek-Vlaanderen (FWO-Vlaanderen), Instituut voor Wetenschap en Techniek (IWT), KULeuven-Research Fund (BOF), KULeuven-Research&Development and EEC Framework programs FP6 & FP7 and NHLBI. The authors thank Luc Quintin, MD, PhD, for his invaluable comments and advices about the translation of our data obtained in Tau.P301L mice to human anesthesia.	Alonso AD, 2004, J BIOL CHEM, V279, P34873, DOI 10.1074/jbc.M405131200; Arrich Jasmin, 2010, Anesth Analg, V110, P1239, DOI 10.1213/ANE.0b013e3181ce8d34; Baranov D, 2009, ANESTH ANALG, V108, P1627, DOI 10.1213/ane.0b013e318199dc72; Benumof J.L., 1986, ANESTHESIA, V2, P1115; Bhatnagar S, 1998, NEUROSCIENCE, V84, P1025, DOI 10.1016/S0306-4522(97)00577-0; Bilotta F, 2010, J ALZHEIMERS DIS, V22, pS81, DOI 10.3233/JAD-2010-100825; Bonis JM, 2011, RESP PHYSIOL NEUROBI, V175, P272, DOI 10.1016/j.resp.2010.12.002; BRAAK H, 1994, NEUROBIOL AGING, V15, P355, DOI 10.1016/0197-4580(94)90032-9; BRION JP, 1986, LANCET, V2, P1098, DOI 10.1016/S0140-6736(86)90495-2; CAILLE D, 1979, RESP PHYSIOL, V36, P201, DOI 10.1016/0034-5687(79)90025-2; Chen HSV, 2006, J NEUROCHEM, V97, P1611, DOI 10.1111/j.1471-4159.2006.03991.x; Chohan MO, 2006, FEBS LETT, V580, P3973, DOI 10.1016/j.febslet.2006.06.021; Cooke JR, 2009, J CLIN SLEEP MED, V5, P305; Daulatzai MA, 2010, J ALZHEIMERS DIS, V20, P355, DOI 10.3233/JAD-2010-1374; Dietrich WD, 2010, NEUROTHERAPEUTICS, V7, P43, DOI 10.1016/j.nurt.2009.10.015; Dutschmann M, 1998, BRAIN RES, V809, P221, DOI 10.1016/S0006-8993(98)00885-3; Dutschmann M, 1998, J PHYSIOL-LONDON, V510, P793, DOI 10.1111/j.1469-7793.1998.793bj.x; Dutschmann M, 2006, EUR J NEUROSCI, V24, P1071, DOI 10.1111/j.1460-9568.2006.04981.x; Dutschmann M, 2010, J NEUROSCI, V30, P1810, DOI 10.1523/JNEUROSCI.5261-09.2010; Froessler B, 2010, ANAESTHESIST, V59, P1003, DOI 10.1007/s00101-010-1764-0; FUNG ML, 1994, RESP PHYSIOL, V96, P177, DOI 10.1016/0034-5687(94)90125-2; Gestreau C, 2005, RESP PHYSIOL NEUROBI, V147, P159, DOI 10.1016/j.resp.2005.03.015; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V122, P1131, DOI 10.1016/0006-291X(84)91209-9; GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913; GRUNDKEIQBAL I, 1986, J BIOL CHEM, V261, P6084; Guo ZL, 2002, NEUROSCIENCE, V113, P435, DOI 10.1016/S0306-4522(02)00173-2; Guthman A, 1999, J COMP NEUROL, V415, P501; Hansen MLH, 2011, ALZ DIS ASSOC DIS, V25, P269, DOI 10.1097/WAD.0b013e3182096624; Harris MB, 2003, RESP PHYSIOL NEUROBI, V134, P191, DOI 10.1016/S1569-9048(02)00223-9; Horiuchi J, 1999, NEUROSCIENCE, V89, P1319, DOI 10.1016/S0306-4522(98)00399-6; HORNER J, 1994, ALZ DIS ASSOC DIS, V8, P177; Humbert IA, 2010, J ALZHEIMERS DIS, V19, P1185, DOI 10.3233/JAD-2010-1316; Kuna ST, 1999, RESP PHYSIOL, V117, P85, DOI 10.1016/S0034-5687(99)00058-4; Liang L, 2004, FEBS LETT, V566, P261, DOI 10.1016/j.febslet.2004.04.047; LING LM, 1994, J APPL PHYSIOL, V76, P1138; Lipton SA, 2006, NAT REV DRUG DISCOV, V5, P160, DOI 10.1038/nrd1958; Lipton SA, 2007, CURR DRUG TARGETS, V8, P621, DOI 10.2174/138945007780618472; Martinez-Coria H, 2010, AM J PATHOL, V176, P870, DOI 10.2353/ajpath.2010.090452; Menuet C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025770; Menuet C, 2011, RESP PHYSIOL NEUROBI, V178, P290, DOI 10.1016/j.resp.2011.06.030; NUNEZABADES PA, 1990, J ANAT, V172, P1; Pan CX, 2011, ANESTH ANALG, V113, P145, DOI 10.1213/ANE.0b013e3182185fee; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Planel E, 2007, J NEUROSCI, V27, P3090, DOI 10.1523/JNEUROSCI.4854-06.2007; Planel E, 2009, FASEB J, V23, P2595, DOI 10.1096/fj.08-122424; Priefer BA, 1997, DYSPHAGIA, V12, P212, DOI 10.1007/PL00009539; Rahman A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006344; Reisberg B, 2003, NEW ENGL J MED, V348, P1333, DOI 10.1056/NEJMoa013128; Roda F, 2004, J COMP NEUROL, V468, P571, DOI 10.1002/cne.10974; Rohrer JD, 2011, CURR ALZHEIMER RES, V8, P266; Run XQ, 2009, J ALZHEIMERS DIS, V16, P619, DOI 10.3233/JAD-2009-1003; Saab BJ, 2010, ANESTHESIOLOGY, V113, P1061, DOI 10.1097/ALN.0b013e3181f56228; Sakata DJ, 2007, ANESTH ANALG, V104, P587, DOI 10.1213/01.ane.0000255074.96657.39; Sinclair HL, 2010, CRIT CARE, V14, DOI 10.1186/cc8220; Song MS, 2008, EUR J NEUROSCI, V28, P1989, DOI 10.1111/j.1460-9568.2008.06498.x; Subramanian HH, 2008, J NEUROSCI, V28, P12274, DOI 10.1523/JNEUROSCI.4168-08.2008; Suh MK, 2009, ALZ DIS ASSOC DIS, V23, P178, DOI 10.1097/WAD.0b013e318192a539; Tang JXX, 2011, ANESTHESIOLOGY, V115, P727, DOI 10.1097/ALN.0b013e31822e9306; Teppema LJ, 1997, J COMP NEUROL, V388, P169, DOI 10.1002/(SICI)1096-9861(19971117)388:2<169::AID-CNE1>3.0.CO;2-#; Terwel D, 2005, J BIOL CHEM, V280, P3963, DOI 10.1074/jbc.M409876200; Terwel D, 2008, AM J PATHOL, V172, P786, DOI 10.2353/ajpath.2008.070904; Tokutomi T, 2009, J TRAUMA, V66, P166, DOI 10.1097/TA.0b013e318157dbec; Vanderweyde T, 2010, J ALZHEIMERS DIS, V22, pS91, DOI 10.3233/JAD-2010-100843; VILLARD MF, 1984, J PHYSIOL-PARIS, V79, P11; Wada H, 2001, GERONTOLOGY, V47, P271, DOI 10.1159/000052811; Yamazaki H, 2009, BIOL PHARM BULL, V32, P293, DOI 10.1248/bpb.32.293	66	17	17	0	8	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0969-9961	1095-953X		NEUROBIOL DIS	Neurobiol. Dis.	APR	2012	46	1					234	243		10.1016/j.nbd.2012.01.012			10	Neurosciences	Neurosciences & Neurology	913SQ	WOS:000301898100025	22316605				2021-06-18	
J	Murtha, L; McLeod, D; Spratt, N				Murtha, Lucy; McLeod, Damian; Spratt, Neil			Epidural Intracranial Pressure Measurement in Rats Using a Fiber-optic Pressure Transducer	JOVE-JOURNAL OF VISUALIZED EXPERIMENTS			English	Article						Medicine; Issue 62; Neuroscience; brain; rat; intracranial pressure; epidural; fibre-optic transducer; ischemic injury		Elevated intracranial pressure (ICP) is a significant problem in several forms of ischemic brain injury including stroke, traumatic brain injury and cardiac arrest. This elevation may result in further neurological injury, in the form of transtentorial herniation(1,2,3,4), midbrain compression, neurological deficit or increased cerebral infarct(2,4). Current therapies are often inadequate to control elevated ICP in the clinical setting(5,6,7). Thus there is a need for accurate methods of ICP measurement in animal models to further our understanding of the basic mechanisms and to develop new treatments for elevated ICP. In both the clinical and experimental setting ICP cannot be estimated without direct measurement. Several methods of ICP catheter insertion currently exist. Of these the intraventricular catheter has become the clinical 'gold standard' of ICP measurement in humans(8). This method involves the partial removal of skull and the instrumentation of the catheter through brain tissue. Consequently, intraventricular catheters have an infection rate of 6-11% (9). For this reason, subdural and epidural cannulations have become the preferred methods in animal models of ischemic injury. Various ICP measurement techniques have been adapted for animal models, and of these, fluid-filled telemetry catheters(10) and solid state catheters are the most frequently used(11,12,13,14,15). The fluid-filled systems are prone to developing air bubbles in the line, resulting in false ICP readings. Solid state probes avoid this problem (Figure 1). An additional problem is fitting catheters under the skull or into the ventricles without causing any brain injury that might alter the experimental outcomes. Therefore, we have developed a method that places an ICP catheter contiguous with the epidural space, but avoids the need to insert it between skull and brain. An optic fibre pressure catheter (420LP, SAMBA Sensors, Sweden) was used to measure ICP at the epidural location because the location of the pressure sensor (at the very tip of the catheter) was found to produce a high fidelity ICP signal in this model. There are other manufacturers of similar optic fibre technologies(13) that may be used with our methodology. Alternative solid state catheters, which have the pressure sensor located at the side of the catheter tip, would not be appropriate for this model as the signal would be dampened by the presence of the monitoring screw. Here, we present a relatively simple and accurate method to measure ICP. This method can be used across a wide range of ICP related animal models.	[Murtha, Lucy; McLeod, Damian; Spratt, Neil] Univ Newcastle, Callaghan, NSW 2308, Australia	Spratt, N (corresponding author), Univ Newcastle, Callaghan, NSW 2308, Australia.	Neil.Spratt@newcastle.edu.au	MCLEOD, DAMIAN/G-7704-2013; Spratt, Neil J/K-4208-2012	MCLEOD, DAMIAN/0000-0002-1297-8984; Spratt, Neil J/0000-0002-9023-6177	National Stroke Foundation; Hunter Medical Research Institute (HMRI); National Health and Medical Research Council (NHMRC), AustraliaNational Health and Medical Research Council of Australia	This project was funded by the National Stroke Foundation, Hunter Medical Research Institute (HMRI) and National Health and Medical Research Council (NH&MRC), Australia. Special thanks to the Faculty of Health Workshop staff at The University of Newcastle for their technical expertise.	Adams HP, 2003, STROKE, V34, P1056, DOI 10.1161/01.STR.0000064841.47697.22; AUCOIN PJ, 1986, AM J MED, V80, P369, DOI 10.1016/0002-9343(86)90708-4; Bolander R, 2011, ANN BIOMED ENG, V39, P2550, DOI 10.1007/s10439-011-0343-0; Chavko M, 2007, J NEUROSCI METH, V159, P277, DOI 10.1016/j.jneumeth.2006.07.018; Chavko M, 2011, J NEUROSCI METH, V195, P61, DOI 10.1016/j.jneumeth.2010.11.019; CRUTCHFIELD JS, 1990, J NEUROSURG, V72, P482, DOI 10.3171/jns.1990.72.3.0482; Geraci E B, 1996, J Neurosci Nurs, V28, P381; Hg LKY, 1970, STROKE, V1, P158, DOI 10.1161/01.STR.1.3.158; Leonardi AD, 2011, J NEUROTRAUM, V28, P85, DOI 10.1089/neu.2010.1324; Plum F, 1966, Res Publ Assoc Res Nerv Ment Dis, V41, P318; ROPPER AH, 1984, ARCH NEUROL-CHICAGO, V41, P26, DOI 10.1001/archneur.1984.04050130032017; Schwab S, 1996, NEUROLOGY, V47, P393, DOI 10.1212/WNL.47.2.393; Silasi G, 2009, CURR NEUROVASC RES, V6, P62, DOI 10.2174/156720209787466046; SILVER FL, 1984, STROKE, V15, P492, DOI 10.1161/01.STR.15.3.492; Zhong J, 2003, NEUROL RES, V25, P339, DOI 10.1179/016164103101201661	15	17	17	0	14	JOURNAL OF VISUALIZED EXPERIMENTS	CAMBRIDGE	1 ALEWIFE CENTER, STE 200, CAMBRIDGE, MA 02140 USA	1940-087X			JOVE-J VIS EXP	J. Vis. Exp.	APR	2012		62							e3689	10.3791/3689			7	Multidisciplinary Sciences	Science & Technology - Other Topics	V36PG	WOS:000209222900026	22565931	Green Published			2021-06-18	
J	Olivecrona, Z; Koskinen, LOD				Olivecrona, Zandra; Koskinen, Lars-Owe D.			The release of S-100B and NSE in severe traumatic head injury is associated with APOE epsilon 4	ACTA NEUROCHIRURGICA			English	Article						Severe traumatic brain injury; APOE epsilon 4; S-100B; NSE	APOLIPOPROTEIN-E POLYMORPHISM; CEREBRAL AMYLOID ANGIOPATHY; BRAIN-INJURY; ALZHEIMERS-DISEASE; E GENOTYPE; SUBARACHNOID HEMORRHAGE; S-100-BETA; PATHOLOGY; ALLELES	In this article we tested the hypothesis that the level of two biochemical markers of brain injury may be associated with the apolipoprotein E (APOE) epsilon 4 allele. In this prospective consecutive study patients with sTBI were included (n = 48). Inclusion criteria were Glasgow Coma Scale (GCS) score a parts per thousand currency signaEuro parts per thousand 8 at the time of intubation and sedation, patient age between 15 and 70 years, an initial cerebral perfusion pressure > 10 mmHg, and arrival to our level-one trauma university hospital within 24 h after trauma. Blood samples for neuron-specific enolase (NSE) and S-100B were collected as soon as possibly after arrival, and then twice daily (12-h intervals) for 5 consecutive days. Venous blood was used for APOE genotype determination. Clinical outcome at 3 months after injury was assessed with the Extended Glasgow Outcome Scale (GOSE). Significantly higher levels of the maximal S-100B (S-100B(max)) and area under the curve (S-100B(AUC)) were found in subjects with the APOE epsilon 4 allele compared to those with non-epsilon 4. A similar tendency was observed for NSEmax and NSEAUC, though not statistically significant. Our data indicate that there might be a gene-induced susceptibility to severe traumatic brain injury and that patients with the APOE epsilon 4 allele may be more predisposed to brain cellular damage measured as S-100B and NSE. Thus, it seems to be of importance to consider the APOE genotype in interpreting the levels of the biomarkers.	[Olivecrona, Zandra; Koskinen, Lars-Owe D.] Umea Univ, Dept Pharmacol & Clin Neurosci, Sect Neurosurg, SE-90185 Umea, Sweden	Olivecrona, Z (corresponding author), Umea Univ, Dept Pharmacol & Clin Neurosci, Sect Neurosurg, SE-90185 Umea, Sweden.	zandra.olivecrona@gmail.com; lars-owe.koskinen@neuro.umu.se	Koskinen, Lars-Owe/AAQ-8957-2020	Koskinen, Lars-Owe/0000-0003-3528-8502	Department of Pharmacology and Clinical Neuroscience, Umea University; Tore Nilsson Foundation; Kempe Foundation; Capio Research Foundation	We acknowledge the staff at the intensive care unit and neurosurgical department, our research nurses Kristin Nyman and Anna-Lena Ostlund, and our colleagues Drs. Magnus Olivecrona, Silvana Naredi and Marie Rodling-Wahlstrom. Special thanks to Ann-Margret Kallberg at Sangtech Medical for assistance with the analysis of the biomarkers. Financial support from the Department of Pharmacology and Clinical Neuroscience, Umea University, the Tore Nilsson Foundation, Kempe Foundation and Capio Research Foundation is acknowledged.	Alexander S, 2007, J NEUROTRAUM, V24, P790, DOI 10.1089/neu.2006.0133; Alfieri A, 2008, J NEUROSURG, V109, P1019, DOI 10.3171/JNS.2008.109.12.1019; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Dickstein DL, 2010, MT SINAI J MED, V77, P82, DOI 10.1002/msj.20155; Friedman G, 1999, NEUROLOGY, V52, P244, DOI 10.1212/WNL.52.2.244; GREENBERG SM, 1995, ANN NEUROL, V38, P254, DOI 10.1002/ana.410380219; Juvela S, 2009, J NEUROSURG, V110, P989, DOI 10.3171/2008.11.JNS081266; Kalaria RN, 1996, ANN NY ACAD SCI, V777, P266, DOI 10.1111/j.1749-6632.1996.tb34430.x; Kim S, 2011, NEUROLOGY, V76, P69, DOI 10.1212/WNL.0b013e318204a397; Kofke WA, 2004, ANESTH ANALG, V99, P1323, DOI 10.1213/01.ANE.0000135345.03635.6A; Leclercq PD, 2005, J NEUROL NEUROSUR PS, V76, P229, DOI 10.1136/jnnp.2003.025528; Lynch JR, 2002, ANN NEUROL, V51, P113, DOI 10.1002/ana.10098; Marshall, 1991, J NEUROSURG S, V75, pS14; McDonagh DL, 2010, ANESTHESIOLOGY, V112, P852, DOI 10.1097/ALN.0b013e3181d31fd7; Methia N, 2001, MOL MED, V7, P810, DOI 10.1007/BF03401973; Miller MA, 2010, BRAIN INJURY, V24, P1468, DOI 10.3109/02699052.2010.520299; Morris JC, 2010, ANN NEUROL, V67, P122, DOI 10.1002/ana.21843; Olivecrona M, 2010, J NEUROSURG, V112, P1113, DOI 10.3171/2009.8.JNS09636; Olivecrona M, 2009, J NEUROTRAUM, V26, P1251, DOI [10.1089/neu.2008.0605, 10.1089/neu.2008-0605]; Ost M, 2008, ACTA ANAESTH SCAND, V52, P1364, DOI 10.1111/j.1399-6576.2008.01675.x; Premkumar DRD, 1996, AM J PATHOL, V148, P2083; Pruthi N, 2010, NEUROL INDIA, V58, P264, DOI 10.4103/0028-3886.63810; Quinn TJ, 2004, NEUROPATH APPL NEURO, V30, P569, DOI 10.1111/j.1365-2990.2004.00581.x; Raabe A, 1999, BRIT J NEUROSURG, V13, P56, DOI 10.1080/02688699944195; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; Teasdale GM, 1997, LANCET, V350, P1069, DOI 10.1016/S0140-6736(97)04318-3; Waters RJ, 2005, CURR OPIN CRIT CARE, V11, P105, DOI 10.1097/01.ccx.0000155354.78617.91; Ytrebo LM, 2000, SCAND J GASTROENTERO, V35, P546	28	17	21	0	1	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268			ACTA NEUROCHIR	Acta Neurochir.	APR	2012	154	4					675	680		10.1007/s00701-012-1292-6			6	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	912IA	WOS:000301788900017	22322856				2021-06-18	
J	Sahni, T; Jain, M; Prasad, R; Sogani, SK; Singh, VP				Sahni, Tarun; Jain, Madhur; Prasad, Rajendra; Sogani, Shanti K.; Singh, Varindera. P.			Use of hyperbaric oxygen in traumatic brain injury: Retrospective analysis of data of 20 patients treated at a tertiary care centre	BRITISH JOURNAL OF NEUROSURGERY			English	Article						brain; cognitive function; brain ischemia; hyperbaric oxygen therapy; neurorehabilitation; traumatic brain injury	CEREBRAL-BLOOD-FLOW; SEVERE HEAD-INJURY; TECHNETIUM-99M-HMPAO SPECT; INTRACRANIAL-PRESSURE; CLINICAL-TRIALS; THERAPY; METABOLISM; DYSFUNCTION; IMPROVEMENT; MODERATE	Traumatic brain injury (TBI) related impact results in a permanent need for help in performing daily activities. Standard treatment consists of removing the cause, restore perfusion, support metabolic requirement and limit inflammatory and oxidative damage. Hyperbaric oxygen therapy (HBOT) is one such newer promising treatment that enhances neurological recovery to some extent. HBOT is intermittent inhalation of 100% oxygen at greater than normal atmospheric pressure and is internationally accepted for its role in well-defined indications. It is hypothesised that HBO has a role in reviving 'idling neurons', also called the ischemic penumbra defined as area of reduced cerebral blood flow, abolished synaptic activity but preserved structural integrity. We carried out a retrospective analysis of medical records of 20 patients of TBI who had been treated with HBOT in addition to standard management. These were placed in Group A (test group) and received at least 30 sessions of HBO along with standard treatment. The patients were assessed along the Disability Rating Scale (DRS), Glasgow coma scale (GCS) and Rancho Los Amigos Scale (RLAS). Another 20 patients of TBI, matched in age and severity of brain injury, who received standard treatment but not HBOT, were selected as the control group (Group B). Assessment on the DRS showed maximum improvement in patients with scores of 22-24 (vegetative state). The percentage of patients in the test group fell from 45% to 5% whereas only 20% patients in Group B had similar progress. After the treatment, a significantly higher proportion of HBOT treated subjects showed a good response in cognitive functions, as measured by RLA. In group A, 90% patients had a score of <= 3 and in Group B 95% had a similar score, which improved to >= 3 in 60% patients versus 30% patients respectively. In both groups maximum patients are in 1-6 months post-injury category and within the groups this category showed the greatest recovery, with a greater improvement in the test group as compared to control group.	[Sahni, Tarun; Jain, Madhur] Indraprastha Apollo Hosp, Dept Hyperbar Oxygen Therapy, New Delhi 110076, India; [Prasad, Rajendra; Sogani, Shanti K.; Singh, Varindera. P.] Indraprastha Apollo Hosp, Dept Neurosurg, New Delhi 110076, India	Sahni, T (corresponding author), Indraprastha Apollo Hosp, Dept Internal & Hyperbar Med, Delhi Mathura Rd, New Delhi 110076, India.	tarun.sahni@adventhcg.com					Adamides AA, 2006, ANZ J SURG, V76, P163, DOI 10.1111/j.1445-2197.2006.03674.x; Al-Waili NS, 2005, ADV THER, V22, P659, DOI 10.1007/BF02849960; Barrett KF, 2004, UNDERSEA HYPERBAR M, V31, P395; BOUMA GJ, 1992, J NEUROSURG, V77, P360, DOI 10.3171/jns.1992.77.3.0360; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Daugherty WP, 2004, J NEUROSURG, V101, P499, DOI 10.3171/jns.2004.101.3.0499; DEMOPOULOS HB, 1982, PATHOLOGY OXYGEN, P127; Diringer MN, 2002, J NEUROSURG, V96, P103, DOI 10.3171/jns.2002.96.1.0103; Doppenberg EMR, 2004, J NEUROSURG ANESTH, V16, P87, DOI 10.1097/00008506-200401000-00019; Fam SS, 2003, CURR MED CHEM, V10, P1723, DOI 10.2174/0929867033457115; Glenn TC, 2003, J CEREBR BLOOD F MET, V23, P1239, DOI 10.1097/01.WCB.0000089833.23606.7F; Golden Z, 2006, DISABIL REHABIL, V28, P1379, DOI 10.1080/09638280600638364; Golden ZL, 2002, INT J NEUROSCI, V112, P119, DOI 10.1080/00207450212027; GRAY BG, 1992, J NUCL MED, V33, P52; Harch PG, 2007, BRAIN RES, V1174, P120, DOI 10.1016/j.brainres.2007.06.105; Harch PG, TXB HYPERBARIC MED; Hardy P, 2007, J NEUROL SCI, V253, P94, DOI 10.1016/j.jns.2006.12.005; HOLBACH KH, 1974, ACTA NEUROCHIR, V30, P247, DOI 10.1007/BF01405583; Holbach KH, 1977, P 6 INT C HYP MED, VE, P104; HOLBACH KH, 1973, ADV NEUROSURG, V1, P158; ICHISE M, 1994, J NUCL MED, V35, P217; IKEDA Y, 1990, NEUROSURGERY, V27, P1; Juul N, 2000, J NEUROSURG, V92, P1, DOI 10.3171/jns.2000.92.1.0001; Lifshitz J, 2004, MITOCHONDRION, V4, P705, DOI 10.1016/j.mito.2004.07.021; Lin JW, 2008, ACTA NEUROCHIR SUPPL, V101, P145; Liu Zhan, 2006, Chin J Traumatol, V9, P168; Magnoni S, 2003, J NEUROSURG, V98, P952, DOI 10.3171/jns.2003.98.5.0952; McDonagh M, 2004, ARCH PHYS MED REHAB, V85, P1198, DOI 10.1016/j.apmr.2003.12.026; Menzel M, 1999, J NEUROSURG, V91, P1, DOI 10.3171/jns.1999.91.1.0001; MILLER JD, 1971, ARCH NEUROL-CHICAGO, V24, P210, DOI 10.1001/archneur.1971.00480330038003; MINK RB, 1995, STROKE, V26, P2307, DOI 10.1161/01.STR.26.12.2307; MOGAMI H, 1969, J NEUROSURG, V31, P636, DOI 10.3171/jns.1969.31.6.0636; Murr R, 1996, ACTA NEUROCHIR, V138, P928, DOI 10.1007/BF01411281; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Neubauer RA, 2005, J AM PHYS SURGEONS, V2; OBRIST WD, 1984, J NEUROSURG, V61, P241, DOI 10.3171/jns.1984.61.2.0241; Palzur E, 2008, BRAIN RES, V1221, P126, DOI 10.1016/j.brainres.2008.04.078; Puvanachandra P., 2009, PAK J NEUROL SCI, V4, P27; Rockswold SB, 2010, J NEUROSURG, V112, P1080, DOI 10.3171/2009.7.JNS09363	40	17	24	2	9	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0268-8697	1360-046X		BRIT J NEUROSURG	Br. J. Neurosurg.	APR	2012	26	2					202	207		10.3109/02688697.2011.626879			6	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	912XP	WOS:000301835000008	22085249				2021-06-18	
J	Hunt, RF; Haselhorst, LA; Schoch, KM; Bach, EC; Rios-Pilier, J; Scheff, SW; Saatman, KE; Smith, BN				Hunt, Robert F.; Haselhorst, Laura A.; Schoch, Kathleen M.; Bach, Eva C.; Rios-Pilier, Jennifer; Scheff, Stephen W.; Saatman, Kathryn E.; Smith, Bret N.			Posttraumatic mossy fiber sprouting is related to the degree of cortical damage in three mouse strains	EPILEPSY RESEARCH			English	Article						Contusion; Dentate gyrus; Epileptogenesis; Epilepsy model; Seizure; Traumatic brain injury	TRAUMATIC BRAIN-INJURY; DENTATE GYRUS; TREATED RATS; MODEL; EPILEPSY; MICE; IMPACT; REORGANIZATION; SUSCEPTIBILITY; SEIZURES	Controlled cortical impact injury was used to examine relationships between focal posttraumatic cortical damage and mossy fiber sprouting (MFS) in the dentate gyrus in three mouse strains. Posttraumatic MFS was more robust when cortical injury impinged upon the hippocampus, versus contusions restricted to neocortex, and was qualitatively similar among CD-1, C57BL/6, and FVB/N background strains. Impact parameters influencing injury severity may be critical in reproducing epilepsy-related changes in neurotrauma models. (C) 2011 Elsevier B.V. All rights reserved.	[Smith, Bret N.] Univ Kentucky, Coll Med, Dept Physiol, Chandler Med Ctr MS508, Lexington, KY 40536 USA; [Scheff, Stephen W.] Univ Kentucky, Dept Anat & Neurobiol, Lexington, KY 40536 USA; [Scheff, Stephen W.] Univ Kentucky, Sanders Brown Ctr Aging, Lexington, KY 40536 USA; [Schoch, Kathleen M.; Scheff, Stephen W.; Saatman, Kathryn E.; Smith, Bret N.] Univ Kentucky, Spinal Cord & Brain Injury Res Ctr, Lexington, KY 40536 USA	Smith, BN (corresponding author), Univ Kentucky, Coll Med, Dept Physiol, Chandler Med Ctr MS508, 800 Rose St, Lexington, KY 40536 USA.	bret.smith@uky.edu		Hunt, Robert/0000-0003-4490-8718	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS052302, AG21981, P01 NS058484]; USAMRMCU.S. Army Medical Research & Materiel Command (USAMRMC) [W81XWH-11-1-0502]; Epilepsy Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS058484] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG021981] Funding Source: NIH RePORTER	This research was supported by NIH NS052302 and USAMRMC W81XWH-11-1-0502 to B.N.S., NIH AG21981 to S.W.S., NIH P01 NS058484 to K.E.S., and an Epilepsy Foundation Training Fellowship to R.F.H.	Bolkvadze T., 2009, J NEUROTRAUMA; Buckmaster PS, 1997, J COMP NEUROL, V385, P385; Chrzaszcz M, 2010, J NEUROTRAUM, V27, P1283, DOI 10.1089/neu.2009.1227; Hanell A, 2010, J NEUROTRAUM, V27, P1297, DOI 10.1089/neu.2009.1255; Hunt RF, 2011, J NEUROSCI, V31, P6880, DOI 10.1523/JNEUROSCI.0032-11.2011; Hunt RF, 2010, J NEUROPHYSIOL, V103, P1490, DOI 10.1152/jn.00957.2009; Hunt RF, 2009, EXP NEUROL, V215, P243, DOI 10.1016/j.expneurol.2008.10.005; Kharatishvili I, 2006, NEUROSCIENCE, V140, P685, DOI 10.1016/j.neuroscience.2006.03.012; Kharatishvili I, 2007, BRAIN, V130, P3155, DOI 10.1093/brain/awm268; Kharatishvili I, 2009, EXP NEUROL, V217, P154, DOI 10.1016/j.expneurol.2009.01.026; Mao HJ, 2010, BIOMECH MODEL MECHAN, V9, P763, DOI 10.1007/s10237-010-0212-z; Onyszchuk G, 2007, J NEUROSCI METH, V160, P187, DOI 10.1016/j.jneumeth.2006.09.007; Pleasant JM, 2011, J NEUROTRAUM, V28, P2245, DOI 10.1089/neu.2010.1499; Santhakumar V, 2000, J PHYSIOL-LONDON, V524, P117, DOI 10.1111/j.1469-7793.2000.00117.x; Schauwecker PE, 1997, P NATL ACAD SCI USA, V94, P4103, DOI 10.1073/pnas.94.8.4103; Shibley H, 2002, EPILEPSY RES, V49, P109, DOI 10.1016/S0920-1211(02)00012-8; Statler KD, 2009, EPILEPSY RES, V86, P221, DOI 10.1016/j.eplepsyres.2009.05.006; Swartz BE, 2006, EPILEPSIA, V47, P1373, DOI 10.1111/j.1528-1167.2006.00602.x; TAUCK DL, 1985, J NEUROSCI, V5, P1016	19	17	18	0	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0920-1211			EPILEPSY RES	Epilepsy Res.	MAR	2012	99	1-2					167	170		10.1016/j.eplepsyres.2011.10.011			4	Clinical Neurology	Neurosciences & Neurology	920TV	WOS:000302431700021	22047981	Green Accepted			2021-06-18	
J	Kim, S; Scalzo, F; Bergsneider, M; Vespa, P; Martin, N; Hu, X				Kim, Sunghan; Scalzo, Fabien; Bergsneider, Marvin; Vespa, Paul; Martin, Neil; Hu, Xiao			Noninvasive Intracranial Pressure Assessment Based on a Data-Mining Approach Using a Nonlinear Mapping Function	IEEE TRANSACTIONS ON BIOMEDICAL ENGINEERING			English	Article						Data mining; kernel spectral regression (KSR); noninvasive ICP (NICP); nonlinear mapping function; ordinary least squares (OLS); quadratic programming (QP); recursive weighted least squares (RWL)	TRANSCRANIAL DOPPLER ULTRASONOGRAPHY; CEREBRAL PERFUSION-PRESSURE; FULMINANT HEPATIC-FAILURE; TRAUMATIC BRAIN-INJURY; TECHNICAL NOTE; CLASSIFICATION; AUTOREGULATION	The current gold standard to determine intracranial pressure (ICP) involves an invasive procedure for direct access to the intracranial compartment. The risks associated with this invasive procedure include intracerebral hemorrhage, infection, and discomfort. We previously proposed an innovative data-mining framework of noninvasive ICP (NICP) assessment. The performance of the proposed framework relies on designing a good mapping function. We attempt to achieve performance gain by adopting various linear and nonlinear mapping functions. Our results demonstrate that a nonlinear mapping function based on the kernel spectral regression technique significantly improves the performance of the proposed data-mining framework for NICP assessment in comparison to other linear mapping functions.	[Kim, Sunghan; Scalzo, Fabien; Hu, Xiao] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurosurg, Neural Syst & Dynam Lab, Los Angeles, CA 90095 USA; [Martin, Neil] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurosurg, UCLA Stroke Ctr, Los Angeles, CA 90095 USA; [Vespa, Paul] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurosurg, Neurocrit Care Program, Los Angeles, CA 90095 USA; [Bergsneider, Marvin] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurosurg, UCLA Adult Hydrocephalus Ctr, Los Angeles, CA 90095 USA	Hu, X (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurosurg, Neural Syst & Dynam Lab, Los Angeles, CA 90095 USA.	visionsk@gmail.com; fscalzo@mednet.ucla.edu; mbergsneider@mednet.ucla.edu; pvespa@mednet.ucla.edu; nmartin@mednet.ucla.edu; xhu@mednet.ucla.edu	Scalzo, Fabien/AAM-6328-2020	Scalzo, Fabien/0000-0001-9755-8104; Martin, Neil/0000-0002-6565-4131	NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS066008-03, R01 NS066008-02, R01 NS066008] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS066008] Funding Source: NIH RePORTER		Aaslid R., 1986, P 6 INT S INTR PRESS, P226; Aggarwal S, 2008, LIVER TRANSPLANT, V14, P1048, DOI 10.1002/lt.21499; Belfort MA, 2000, HYPERTENS PREGNANCY, V19, P331, DOI 10.1081/PRG-100101995; Cai D., 2007, UIUCDCSR20072888; Czosnyka M, 1998, J NEUROSURG, V88, P802, DOI 10.3171/jns.1998.88.5.0802; Detry O, 1999, TRANSPLANTATION, V67, P767, DOI 10.1097/00007890-199903150-00024; Detry O, 2006, WORLD J GASTROENTERO, V12, P7405, DOI 10.3748/wjg.v12.i46.7405; Hu X, 2004, CLIN NEUROPHYSIOL, V115, P1276, DOI 10.1016/j.clinph.2003.12.030; Hu X, 2010, J BIOMED INFORM, V43, P190, DOI 10.1016/j.jbi.2009.11.002; Hu X, 2006, BIOMED SIGNAL PROCES, V1, P64, DOI 10.1016/j.bspc.2006.05.003; Kim S, 2011, PHYSIOL MEAS, V32, P319, DOI 10.1088/0967-3334/32/3/004; Larsen FS, 2000, CRIT CARE MED, V28, P996, DOI 10.1097/00003246-200004000-00014; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Michaeli D, 2002, J NEUROSURG, V96, P1132, DOI 10.3171/jns.2002.96.6.1132; Nocedal J, 2006, SPRINGER SER OPER RE, P1, DOI 10.1007/978-0-387-40065-5; Panerai RB, 1999, AM J PHYSIOL-HEART C, V277, pH1089; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Scalzo F, 2010, BIOMED ENG ONLINE, V9, DOI 10.1186/1475-925X-9-61; Schmidt B, 2003, STROKE, V34, P84, DOI 10.1161/01.STR.0000047849.01376.AE; Schmidt B, 2000, J NEUROSURG, V92, P793, DOI 10.3171/jns.2000.92.5.0793; Sherman RW, 2002, BRIT J ANAESTH, V89, P687, DOI 10.1093/bja/aef247; Tibshirani, 1994, INTRO BOOTSTRAP, DOI 10.1201/9780429246593; Ueno T, 1998, ACT NEUR S, V71, P66; Ueno T, 2005, J NEUROSURG, V103, P361, DOI 10.3171/jns.2005.103.2.0361; Zhang F., 2000, P IEEE INT S CIRC SY, V5, P45	26	17	17	0	2	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9294			IEEE T BIO-MED ENG	IEEE Trans. Biomed. Eng.	MAR	2012	59	3					619	626		10.1109/TBME.2010.2093897			8	Engineering, Biomedical	Engineering	895PK	WOS:000300508400004	21097375	Green Accepted			2021-06-18	
J	Liu, H; Yang, M; Qiu, GP; Zhuo, F; Yu, WH; Sun, SQ; Xiu, Y				Liu, Hui; Yang, Mei; Qiu, Guo-ping; Zhuo, Fei; Yu, Wei-hua; Sun, Shan-quan; Xiu, Yun			Aquaporin 9 in rat brain after severe traumatic brain injury	ARQUIVOS DE NEURO-PSIQUIATRIA			English	Article						aquaporin-9; traumatic brain injury; brain edema	ENERGY-METABOLISM; CATECHOLAMINERGIC NEURONS; EXPRESSION; ROLES; CELLS; AQP9	Objective: To reveal the expression and possible roles of aquaporin 9 (AQP9) in rat brain, after severe traumatic brain injury (TBI). Methods: Brain water content (BWC), tetrazolium chloride staining, Evans blue staining, immunohistochemistry (IHC), immunofluorescence (IF), western blot, and real-time polymerase chain reaction were used. Results: The BWC reached the first and second (highest) peaks at 6 and 72 hours, and the blood brain barrier (BBB) was severely destroyed at six hours after the TBI. The worst brain ischemia occurred at 72 hours after TBI. Widespread AQP9-positive astrocytes and neurons in the hypothalamus were detected by means of IHC and IF after TBI. The abundance of AQP9 and its mRNA increased after TBI and reached two peaks at 6 and 72 hours, respectively, after TBI. Conclusions: Increased AQP9 might contribute to clearance of excess water and lactate in the early stage of TBI. Widespread AQP9-positive astrocytes might help lactate move into neurons and result in cellular brain edema in the later stage of TBI. AQP9-positive neurons suggest that AQP9 plays a role in energy balance after TBI.	[Liu, Hui; Yang, Mei; Qiu, Guo-ping; Zhuo, Fei; Yu, Wei-hua; Sun, Shan-quan] Chongqing Med Univ, Inst Neurosci, Chongqing 400016, Peoples R China; [Xiu, Yun] Chongqing Med Univ, Inst Life Sci, Chongqing 400016, Peoples R China	Sun, SQ (corresponding author), Chongqing Med Univ, Inst Neurosci, Chongqing 400016, Peoples R China.	19659179@qq.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [30470608, 81000566]; Ministry of Education of China for New Teacher [20105503120009]; Chongqing Natural Science FoundationNatural Science Foundation of Chongqing [cstc2011jjA10093]	This research was supported by the National Natural Science Foundation of China (No. 30470608 and 81000566), Ph.D. Programs Foundation of Ministry of Education of China for New Teacher (No. 20105503120009) and Chongqing Natural Science Foundation (cstc2011jjA10093).	Badaut J, 2008, BRAIN RES, V1188, P17, DOI 10.1016/j.brainres.2007.10.087; Badaut J, 2004, NEUROSCIENCE, V129, P971, DOI 10.1016/j.neuroscience.2004.06.035; Badaut J, 2004, NEUROSCIENCE, V128, P27, DOI 10.1016/j.neuroscience.2004.05.042; Badaut J, 2010, NEUROSCIENCE, V168, P1047, DOI 10.1016/j.neuroscience.2009.10.030; Dibas A, 2007, PHARMACOL RES, V55, P378, DOI 10.1016/j.phrs.2007.01.021; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Finnie JW, 2002, VET PATHOL, V39, P679, DOI 10.1354/vp.39-6-679; Hwang IK, 2007, J NEUROSCI RES, V85, P2470, DOI 10.1002/jnr.21381; Magistretti PJ, 1999, PHILOS T R SOC B, V354, P1155, DOI 10.1098/rstb.1999.0471; Marmarou A, 2007, NEUROSURG FOCUS, V22, pE1, DOI DOI 10.3171/F0C.2007.22.5.2; Ribeiro MD, 2006, J NEUROSCI RES, V83, P1231, DOI 10.1002/jnr.20819; Schurr A, 2002, INT J MOL MED, V10, P131, DOI 10.3892/ijmm.10.2.131; Tsukaguchi H, 1998, J BIOL CHEM, V273, P24737, DOI 10.1074/jbc.273.38.24737; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Verkman AS, 2005, J CELL SCI, V118, P3225, DOI 10.1242/jcs.02519; Verweij BH, 2007, PROG BRAIN RES, V161, P111, DOI 10.1016/S0079-6123(06)61008-X	16	17	18	0	1	ASSOC ARQUIVOS NEURO- PSIQUIATRIA	SAO PAULO SP	PR AMADEU AMARAL 47/33, 01327-010 SAO PAULO SP, BRAZIL	0004-282X			ARQ NEURO-PSIQUIAT	Arq. Neuro-Psiquiatr.	MAR	2012	70	3					214	220		10.1590/S0004-282X2012000300012			7	Neurosciences; Psychiatry	Neurosciences & Neurology; Psychiatry	902YO	WOS:000301080300012	22392116	DOAJ Gold			2021-06-18	
J	Liddle, J; Fleming, J; McKenna, K; Turpin, M; Whitelaw, P; Allen, S				Liddle, Jacki; Fleming, Jennifer; McKenna, Kryss; Turpin, Merrill; Whitelaw, Penny; Allen, Shelley			Adjustment to loss of the driving role following traumatic brain injury: A qualitative exploration with key stakeholders	AUSTRALIAN OCCUPATIONAL THERAPY JOURNAL			English	Article						automobile driving; community	OUTCOMES; DRIVERS; RETURN	Background/aims: Community mobility is affected by an interruption to or cessation of driving following traumatic brain injury (TBI). This study aimed to examine loss of the driving role and to explore the outcomes associated with driving cessation from the perspectives of key people involved within the process: people with TBI, their family members and involved health professionals. Methods: A qualitative methodology was used, employing semi-structured interviews with 15 individuals with TBI who had experienced driving cessation, 10 family members and 10 health professionals working with this population. Results: This article focuses on two themes, each with three subthemes. Being stuck: needs related to driving cessation had subthemes: (i) an emotional time, (ii) being normal and (iii) participation without driving. The second theme, A better way: suggestions to improve outcomes had subthemes: (i) information, (ii) support and trying it out and (iii) their family member's roles and needs. Conclusions: Driving cessation following TBI is associated with emotional, identity, transport and participation-related needs. An ongoing, individualised approach involving information, support and practical experiences may improve outcomes of driving cessation for people with TBI and their family members.	[Liddle, Jacki] Univ Queensland, Sch Hlth & Rehabil Sci, Div Occupat Therapy, Brisbane, Qld 4072, Australia; [Fleming, Jennifer] Princess Alexandra Hosp, Occupat Therapy Dept, Woolloongabba, Qld, Australia; [Fleming, Jennifer] Queensland Hlth, MetroS Hlth Serv Dist, Ctr Functioning & Hlth Res, Brisbane, Qld, Australia	Liddle, J (corresponding author), Univ Queensland, Sch Hlth & Rehabil Sci, Div Occupat Therapy, Brisbane, Qld 4072, Australia.	j.liddle@uq.edu.au	; Liddle, Jacki/F-6872-2010	Turpin, Merrill/0000-0001-7946-0883; Liddle, Jacki/0000-0002-6336-9898	School of Health and Rehabilitation Motor Accident Insurance Commission (MAIC)	This project was funded by a School of Health and Rehabilitation Motor Accident Insurance Commission (MAIC) Rehabilitation Research Grant. The authors would like to thank the staff, patients and families involved in the study for their assistance.	Austroads, 2003, ASS FITN DRIV; Coleman RD, 2002, ARCH PHYS MED REHAB, V83, P1415, DOI 10.1053/apmr.2002.35111; Doig E, 2009, AM J OCCUP THER, V63, P559, DOI 10.5014/ajot.63.5.559; EISENHANDLER SA, 1990, INT J AGING HUM DEV, V30, P1, DOI 10.2190/0MF5-HQ1L-7EBY-XNXV; Fleming JM, 2006, NEUROPSYCHOL REHABIL, V16, P474, DOI 10.1080/09602010500505518; Harradine PG, 2004, MED J AUSTRALIA, V181, P130, DOI 10.5694/j.1326-5377.2004.tb06202.x; Hawley CA, 2001, J NEUROL NEUROSUR PS, V70, P761, DOI 10.1136/jnnp.70.6.761; Hoffmann T, 2008, AUST OCCUP THER J, V55, P239, DOI 10.1111/j.1440-1630.2007.00693.x; Jensen M., 1999, TRANSPORT POLICY, V6, P19; Jumisko E, 2007, DISABIL REHABIL, V29, P1535, DOI 10.1080/09638280601055816; Langdridge D., 2007, PHENOMENOLOGICAL PSY; Liddle J., 2003, BRIT J OCCUP THER, V66, DOI [https://doi.org/10.1177/030802260306600307, DOI 10.1177/030802260306600307]; Liddle J, 2007, AUST OCCUP THER J, V54, P303, DOI 10.1111/j.1440-1630.2006-00614.x; Liddle J, 2011, DISABIL REHABIL, V33, P2574, DOI 10.3109/09638288.2011.582922; Lister R., 1999, BRIT J OCCUPATIONAL, V62, P514; Lundqvist A, 2008, BRAIN INJURY, V22, P295, DOI 10.1080/02699050801966133; Marottoli RA, 2000, J GERONTOL B-PSYCHOL, V55, pS334, DOI 10.1093/geronb/55.6.S334; MOLNAR LJ, 2008, PROMISING APPROACHES; Oxley J, 2008, TRAFFIC INJ PREV, V9, P367, DOI 10.1080/15389580801895285; Patton M.Q., 2002, QUALITATIVE RES EVAL; Pietrapiana P, 2005, BRAIN INJURY, V19, P197, DOI 10.1080/02699050400017197; Ponsford J., 1995, TRAUMATIC BRAIN INJU; Qualitative Solutions and Research, 1999, NVIVO REF GUID SOFTW; Ragland DR, 2005, J GERONTOL A-BIOL, V60, P399, DOI 10.1093/gerona/60.3.399; Rapport LJ, 2008, ARCH PHYS MED REHAB, V89, P922, DOI 10.1016/j.apmr.2008.01.009; Schanke AK, 2000, SCAND J PSYCHOL, V41, P113, DOI 10.1111/1467-9450.00179; Turner B, 2007, BRAIN INJURY, V21, P1119, DOI 10.1080/02699050701651678; Turner B, 2009, AM J OCCUP THER, V63, P609, DOI 10.5014/ajot.63.5.609	28	17	17	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0045-0766	1440-1630		AUST OCCUP THER J	Aust. Occup. Ther. J.	FEB	2012	59	1			SI		79	88		10.1111/j.1440-1630.2011.00978.x			10	Rehabilitation	Rehabilitation	880NY	WOS:000299415300011	22272886				2021-06-18	
J	Modig, F; Fransson, PA; Magnusson, M; Patel, M				Modig, Fredrik; Fransson, Per-Anders; Magnusson, Mans; Patel, Mitesh			Blood alcohol concentration at 0.06 and 0.10% causes a complex multifaceted deterioration of body movement control	ALCOHOL			English	Article						Postural control; Balance; Alcohol; Adaptation; Vision; Body movements	MOTOR COORDINATION; SUPPORT SURFACES; POSTURAL CONTROL; EYE-MOVEMENTS; ETHANOL; ADAPTATION; BALANCE; STIMULATION; INGESTION; INJURIES	Alcohol-related falls are recognized as a major contributor to the occurrence of traumatic brain injury. The control of upright standing balance is complex and composes of contributions from several partly independent mechanisms such as appropriate information from multiple sensory systems and correct feedback and feed forward movement control. Analysis of multisegmented body movement offers a rarely used option for detecting the fine motor problems associated with alcohol intoxication. The study aims were to investigate whether (1) alcohol intoxication at 0.06 and 0.10% blood alcohol concentration (BAC) affected the body movements under unperturbed and perturbed standing; and (2) alcohol affected the ability for sensorimotor adaptation. Body movements were recorded in 25 participants (13 women and 12 men, mean age 25.1 years) at five locations (ankle, knee, hip, shoulder, and head) during quiet standing and during balance perturbations from pseudorandom pulses of calf muscle vibration over 200 s with eyes closed or open. Tests were performed at 0.00, 0.06, and 0.10% BAC. The study revealed several significant findings: (1) an alcohol dose-specific effect; (2) a direction-specific stability decrease from alcohol intoxication; (3) a movement pattern change related to the level of alcohol intoxication during unperturbed standing and perturbed standing; (4) a sensorimotor adaptation deterioration with increased alcohol intoxication; and (5) that vision provided a weaker contribution to postural control during alcohol intoxication. Hence, alcohol intoxication at 0.06 and 0.10% BAC causes a complex multifaceted deterioration of human postural control. (C) 2012 Elsevier Inc. All rights reserved.	[Modig, Fredrik; Fransson, Per-Anders; Magnusson, Mans; Patel, Mitesh] Lund Univ, Dept Clin Sci, S-22185 Lund, Sweden	Fransson, PA (corresponding author), Lund Univ, Dept Clin Sci, S-22185 Lund, Sweden.	Per-Anders.Fransson@med.lu.se		Magnusson, Mans/0000-0002-4266-1996; Patel, Mitesh/0000-0002-3594-5448; Patel, Mitesh/0000-0001-6926-941X; Fransson, Per-Anders/0000-0002-9789-1748			Abroms BD, 2006, PSYCHOPHARMACOLOGY, V188, P324, DOI 10.1007/s00213-006-0524-y; Altman D, 1991, PRACTICAL STAT MED R; ASHBY P, 1977, ANN NEUROL, V1, P478, DOI 10.1002/ana.410010513; Bastian AJ, 2008, CURR OPIN NEUROL, V21, P628, DOI 10.1097/WCO.0b013e328315a293; Belmeguenai A, 2008, J NEUROPHYSIOL, V100, P3167, DOI 10.1152/jn.90384.2008; Blackburn JT, 2003, CLIN BIOMECH, V18, P655, DOI 10.1016/S0268-0033(03)00091-3; Boonstra TW, 2008, J NEUROPHYSIOL, V100, P2158, DOI 10.1152/jn.90474.2008; Connor J, 2004, EPIDEMIOLOGY, V15, P337, DOI 10.1097/01.ede.0000120045.58295.86; Corna S, 1999, EXP BRAIN RES, V124, P331, DOI 10.1007/s002210050630; DICK RB, 1989, BRIT J IND MED, V46, P111; DIENER HC, 1983, Z RECHTSMED, V90, P159, DOI 10.1007/BF02116226; Fransson M, 2005, MED SCI LAW, V45, P61, DOI 10.1258/rsmmsl.45.1.61; Fransson PA, 2007, EUR J APPL PHYSIOL, V101, P81, DOI 10.1007/s00421-007-0476-x; Fransson PA, 2007, J VESTIBUL RES-EQUIL, V17, P47; Fransson PA, 2010, CLIN NEUROPHYSIOL, V121, P2134, DOI 10.1016/j.clinph.2010.05.003; FUSTER JM, 1985, ALCOHOL, V2, P611, DOI 10.1016/0741-8329(85)90088-6; Gomez S, 2008, CLIN NEUROPHYSIOL, V119, P617, DOI 10.1016/j.clinph.2007.10.058; Gomez S, 2009, GAIT POSTURE, V30, P93, DOI 10.1016/j.gaitpost.2009.03.009; Granata KP, 2008, J ELECTROMYOGR KINES, V18, P172, DOI 10.1016/j.jelekin.2007.06.008; Hafstrom A, 2007, NEUROREPORT, V18, P391, DOI 10.1097/WNR.0b013e328013e3eb; HORAK FB, 1986, J NEUROPHYSIOL, V55, P1369; Johansson R, 1993, SYSTEM MODELING IDEN; Johnston JJE, 2004, EMERG MED J, V21, P185, DOI 10.1136/emj.2003.006130; Kool B, 2008, ALCOHOL, V42, P383, DOI 10.1016/j.alcohol.2008.04.004; KUBO T, 1990, AM J OTOLARYNG, V11, P416, DOI 10.1016/0196-0709(90)90121-B; Lockhart DB, 2007, NAT NEUROSCI, V10, P1329, DOI 10.1038/nn1986; Moser A, 1998, J NEUROL, V245, P542, DOI 10.1007/s004150050240; MULLIKINKILPATRICK D, 1994, EUR J PHARM-ENVIRON, V270, P17, DOI 10.1016/0926-6917(94)90076-0; Nieschalk M, 1999, INT J LEGAL MED, V112, P253, DOI 10.1007/s004140050245; Oie KS, 2002, COGNITIVE BRAIN RES, V14, P164, DOI 10.1016/S0926-6410(02)00071-X; Pai YC, 1999, J BIOMECH, V32, P779, DOI 10.1016/S0021-9290(99)00074-3; Patel M, 2010, EXP BRAIN RES, V202, P431, DOI 10.1007/s00221-009-2150-5; Patel M, 2009, CLIN NEUROPHYSIOL, V120, P601, DOI 10.1016/j.clinph.2008.11.026; Pavol MJ, 2002, EXP BRAIN RES, V145, P528, DOI 10.1007/s00221-002-1143-4; Servais L, 2005, BRAIN RES, V1055, P171, DOI 10.1016/j.brainres.2005.07.026; Talving P, 2010, J TRAUMA, V68, P357, DOI 10.1097/TA.0b013e3181bb80bf; Testa M, 2006, ALCOHOL CLIN EXP RES, V30, P339, DOI 10.1111/j.1530-0277.2006.00039.x; THYSSEN HH, 1981, Z RECHTSMED, V87, P257; TIANWU H, 1995, ACTA OTO-LARYNGOL, P127; Tjernstrom F, 2002, GAIT POSTURE, V15, P75, DOI 10.1016/S0966-6362(01)00175-8; Todorov E, 2002, NAT NEUROSCI, V5, P1226, DOI 10.1038/nn963; TREISTMAN SN, 1991, ANN NY ACAD SCI, V625, P249, DOI 10.1111/j.1749-6632.1991.tb33844.x; VOGELSPROTT MD, 1979, PSYCHOPHARMACOLOGY, V61, P287, DOI 10.1007/BF00432274; WANG MQ, 1992, PERCEPT MOTOR SKILL, V75, P1095, DOI 10.2466/PMS.75.8.1095-1106; WOOLLACOTT MH, 1983, EXP NEUROL, V80, P55, DOI 10.1016/0014-4886(83)90006-7	45	17	17	0	15	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0741-8329	1873-6823		ALCOHOL	Alcohol	FEB	2012	46	1					75	88		10.1016/j.alcohol.2011.06.001			14	Substance Abuse; Pharmacology & Pharmacy; Toxicology	Substance Abuse; Pharmacology & Pharmacy; Toxicology	885DC	WOS:000299757700009	21816558				2021-06-18	
J	Mumford, N; Duckworth, J; Thomas, PR; Shum, D; Williams, G; Wilson, PH				Mumford, Nick; Duckworth, Jonathan; Thomas, Patrick R.; Shum, David; Williams, Gavin; Wilson, Peter H.			Upper-limb virtual rehabilitation for traumatic brain injury: A preliminary within-group evaluation of the elements system	BRAIN INJURY			English	Article						Virtual rehabilitation; traumatic brain injury; augmented feedback; elements; movement rehabilitation; motor control; virtual reality; upper-limb; motor learning	COGNITIVE FUNCTION; MOTOR IMPAIRMENT; ARM FUNCTION; REALITY; SEVERITY; RECOVERY; EXERCISE; VALIDITY; ENVIRONMENTS; POSTSTROKE	Aim: The aim of this study was to assess the efficacy of the Elements virtual reality (VR) system for rehabilitation of upper-limb function in patients with traumatic brain injury (TBI). Methods: Using a within-group design, patients were tested three times, each 4 weeks apart: Pre-intervention 1 and 2 and Post-intervention. During intervention, participants received 12 1-hour training sessions over 4 weeks in addition to their usual care. Five males and four females aged 18-48 years with severe TBI were recruited. The Elements system consisted of a 100-cm tabletop LCD, camera tracking system, tangible user interfaces (i.e. graspable objects of basic shape) and software. The system provided two modes of interaction with augmented feedback: goal-directed and exploratory. Upper-limb performance was assessed using system-rated measures (movement speed, accuracy and efficiency) and standardized tests. Results: Planned comparisons revealed little change in performance over the pre-test period apart from an increase in movement speed. There were significant training effects, with large effect sizes on all measures except the nuts-and-bolts task. Conclusions: These preliminary findings support the results of an early case study of the Elements system, further demonstrating that VR training is a viable adjunct to conventional physical therapy in facilitating motor learning in patients with TBI.	[Wilson, Peter H.] Australian Catholic Univ, Sch Psychol, Melbourne, Vic 3065, Australia; [Mumford, Nick; Wilson, Peter H.] RMIT Univ, Discipline Psychol, Melbourne, Vic, Australia; [Duckworth, Jonathan] RMIT Univ, Sch Media & Commun, Melbourne, Vic, Australia; [Thomas, Patrick R.] Griffith Univ, Sch Educ & Profess Studies, Brisbane, Qld 4111, Australia; [Thomas, Patrick R.; Shum, David] Griffith Univ, Behav Basis Hlth Program, Brisbane, Qld 4111, Australia; [Shum, David] Griffith Univ, Griffith Hlth Inst, Sch Psychol, Brisbane, Qld 4111, Australia; [Williams, Gavin] Epworth Med Fdn, Melbourne, Vic, Australia	Wilson, PH (corresponding author), Australian Catholic Univ, Sch Psychol, 115 Victoria Parade, Melbourne, Vic 3065, Australia.	peterh.wilson@acu.edu.au	Shum, David/A-3914-2008; Wilson, Peter H./E-2881-2018	Shum, David/0000-0002-4810-9262; Wilson, Peter H./0000-0003-3747-0287; Williams, Gavin/0000-0003-2758-7473	Australian Research CouncilAustralian Research Council [LP0562622]; Australia Council for the Arts	We wish to acknowledge the invaluable contribution of another member of the broader Elements project, Mr Ross Eldridge from the School of Electrical and Computer Engineering, RMIT University. This research was supported under Australian Research Council's Linkage Projects funding scheme (Project Number LP0562622) and the Australia Council for the Arts under the Synapse Scheme.	Adamovich SV, 2004, P ANN INT IEEE EMBS, V26, P4936; Albensi BC, 2003, BRAIN INJURY, V17, P653, DOI 10.1080/0269905031000107142; Andelic N, 2009, ACTA NEUROL SCAND, V120, P16, DOI 10.1111/j.1600-0404.2008.01116.x; Bialocerkowski AE, 2003, HAND CLIN, V19, P449, DOI 10.1016/S0749-0712(02)00148-8; Boian R, 2002, VIRTUAL REALITY BASE, P64; Bordens K., 2008, RES DESIGN METHODS P; BRAVO G., 1997, CANADIAN J OCCUPATIO, V64, P270, DOI DOI 10.1177/000841749706400504; CASTANEDA MB, 1993, J MANAGE, V19, P707; Chua KSG, 2007, ANN ACAD MED SINGAP, V36, P31; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Cook Lysandra, 2005, Work, V25, P279; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; Draper K, 2008, NEUROPSYCHOLOGY, V22, P618, DOI 10.1037/0894-4105.22.5.618; Eastridge D, 2005, BEHAV INTERVENT, V20, P77, DOI 10.1002/bin.175; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Fleming Jennifer M, 2006, Can J Occup Ther, V73, P44; Goodwin C., 2005, RES PSYCHOL METHODS; Grealy MA, 1999, ARCH PHYS MED REHAB, V80, P661, DOI 10.1016/S0003-9993(99)90169-7; HEBERT R, 1988, AGE AGEING, V17, P293, DOI 10.1093/ageing/17.5.293; Henderson A, 2007, TOP STROKE REHABIL, V14, P52, DOI 10.1310/tsr1402-52; Holden KM, 2002, NEUROL REP, V26, P62, DOI [DOI 10.1097/01253086-200226020-00003, 10.1097/01253086-200226020-00003]; Holden M., 1999, NEUROLOGY REPORT, V23, P57; Holden MK, 2007, IEEE T NEUR SYS REH, V15, P36, DOI 10.1109/TNSRE.2007.891388; Holden MK, 2005, CYBERPSYCHOL BEHAV, V8, P187, DOI 10.1089/cpb.2005.8.187; Holden MK, 2001, ST HEAL T, V81, P192; HOLDEN MK, 2001, NEUROLOGY REPORT, V25, P129; Hoofien D, 2002, BRAIN INJURY, V16, P9, DOI 10.1080/02699050110088227; Jack D, 2001, IEEE T NEUR SYS REH, V9, P308, DOI 10.1109/7333.948460; Jane Cox SS, 2006, J HAND THER, V19, P444; Karnezis IA, 2002, J BONE JOINT SURG BR, V84B, P967, DOI 10.1302/0301-620X.84B7.12673; Katz DI, 1998, ARCH PHYS MED REHAB, V79, P488, DOI 10.1016/S0003-9993(98)90060-0; Kreutzer JS., 1999, NEUROBEHAVIORAL FUNC; Kuttuva M, 2006, CYBERPSYCHOL BEHAV, V9, P148, DOI 10.1089/cpb.2006.9.148; Lezak M.D., 2004, NEUROPSYCHOLOGICAL A, Vfourth; Linden A, 2005, ACTA NEUROL SCAND, V111, P48, DOI 10.1111/j.1600-0404.2004.00356.x; Marshall S, 2007, BRAIN INJURY, V21, P133, DOI 10.1080/02699050701201383; Matheis RJ, 2007, CLIN NEUROPSYCHOL, V21, P146, DOI 10.1080/13854040601100668; McCarron L., 1997, MCCARRON ASSESSMENT; McCrea PH, 2002, DISABIL REHABIL, V24, P534, DOI 10.1080/09638280110115393; McGeorge P, 2001, PRESENCE-TELEOP VIRT, V10, P375, DOI 10.1162/1054746011470235; Mitchell M. L., 2007, RES DESIGN EXPLAINED; Mumford N, 2008, P ANN C VIRT REH VAN; Mumford N, 2010, BRAIN INJURY, V24, P780, DOI 10.3109/02699051003652807; Nolan S, 2005, CRIT CARE NURS Q, V28, P188, DOI 10.1097/00002727-200504000-00010; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; Piron L, 2005, PRESENCE-TELEOP VIRT, V14, P732, DOI 10.1162/105474605775196580; Piron L, 2004, MED INFORM INTERNET, V29, P119, DOI 10.1080/14639230410001723428; Piron L, 2003, ST HEAL T, V94, P265; Piron L, 2007, P ANN C VIRT REH VEN; Platz T, 2005, CLIN REHABIL, V19, P404, DOI 10.1191/0269215505cr832oa; Platz T., 2005, ARM ARM REHABILITATI; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; Rizzo AA, 2004, NEUROPSYCHOL REHABIL, V14, P207, DOI 10.1080/09602010343000183; Schultheis MT, 2001, PRESENCE-TELEOP VIRT, V10, P431, DOI 10.1162/1054746011470271; Seidler RD, 2004, NEUROIMAGE, V22, P1775, DOI 10.1016/j.neuroimage.2004.05.003; Shaw SE, 2005, J REHABIL RES DEV, V42, P769, DOI 10.1682/JRRD.2005.06.0094; Shumway-Cook A, 2007, MOTOR CONTROL TRANSL; Sveistrup H, 2003, CYBERPSYCHOL BEHAV, V6, P245, DOI 10.1089/109493103322011524; Todorov E, 1997, J MOTOR BEHAV, V29, P147, DOI 10.1080/00222899709600829; Toschlog EA, 2003, AM SURGEON, V69, P491; Triffitt PD, 1998, J BONE JOINT SURG AM, V80A, P41, DOI 10.2106/00004623-199801000-00008; Wald JL, 2000, CYBERPSYCHOL BEHAV, V3, P643, DOI 10.1089/109493100420232; Walker AJ, 2005, BRAIN INJURY, V19, P1237, DOI 10.1080/02699050500309411; Walker WC, 2007, J REHABIL RES DEV, V44, P975, DOI 10.1682/JRRD.2006.12.0158; Waller SM, 2008, HUM MOVEMENT SCI, V27, P749, DOI 10.1016/j.humov.2008.03.006; Weigelt M, 2009, ACTA PSYCHOL, V132, P68, DOI 10.1016/j.actpsy.2009.06.005; Wiese H, 2004, CLIN NEUROPHYSIOL, V115, P2677, DOI 10.1016/j.clinph.2004.06.015; WILSON BA, 1998, COMPREHENSIVE CLIN P, P463; Wilson PH, 2006, P 5 INT WORKSH VIRT; Wulf G, 2001, PSYCHON B REV, V8, P648, DOI 10.3758/BF03196201; Zhang L, 2001, AM J PHYS MED REHAB, V80, P597, DOI 10.1097/00002060-200108000-00010	71	17	17	0	33	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	FEB	2012	26	2					166	176		10.3109/02699052.2011.648706			11	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	897NP	WOS:000300658200005	22360522				2021-06-18	
J	Qi, L; Cui, XX; Dong, WF; Barrera, R; Nicastro, J; Coppa, GF; Wang, P; Wu, RQ				Qi, Lei; Cui, Xiaoxuan; Dong, Weifeng; Barrera, Rafael; Nicastro, Jeffrey; Coppa, Gene F.; Wang, Ping; Wu, Rongqian			Ghrelin Attenuates Brain Injury after Traumatic Brain Injury and Uncontrolled Hemorrhagic Shock in Rats	MOLECULAR MEDICINE			English	Article							SECRETAGOGUE RECEPTOR; HEAD-INJURY; ACYLATED PEPTIDE; STIMULATES GH; HORMONE; APOPTOSIS; STOMACH; SEPSIS; CELLS; PATHOPHYSIOLOGY	Traumatic brain injury (TBI) and hemorrhagic shock often occur concomitantly due to multiple injuries. Gastrointestinal dysfunction occurs frequently in patients with TBI. However, whether alterations in the gastrointestinal system are involved in modulating neuronal damage and recovery after TBI is largely neglected. Ghrelin is a "gut-brain" hormone with multiple functions including antiinflammation and antiapoptosis. The purpose of this study was to determine whether ghrelin attenuates brain injury in a rat model of TBI and uncontrolled hemorrhage (UH). To study this, brain injury was induced by dropping a 450-g weight from 1.5 m onto a steel helmet attached to the skull of male adult rats. Immediately after TBI, a midline laparotomy was performed and both lumbar veins were isolated and severed at the junction with the vena cava. At 45 min after TBI/UH, ghrelin (4,8 or 16 nmol/rat) or 1 mL normal saline (vehicle) was intravenously administered. Brain levels of TNF-alpha and IL-6, and cleaved PARP-1 levels in the cortex were measured at 4 h after TBI/UH. Beam balance test, forelimb placing test and hindlimb placing test were used to assess sensorimotor and reflex function. In additional groups of animals, ghrelin (16 nmol/rat) or vehicle was subcutaneously (s.c.) administered daily for 10 d after TBI/UH. The animals were monitored for 28 d to record body weight changes, neurological severity scale and survival. Our results showed that ghrelin downregulated brain levels of TNF-a and IL-6, reduced cortical levels of cleaved PARP-1, improved sensorimotor and reflex functions, and decreased mortality after TBI/UH. Thus, ghrelin has a great potential to be further developed as an effective resuscitation approach for the trauma victims with brain injury and severe blood loss. Online address: http://www.molmed.org doi: 10.2119/molmed.2011.00390	[Wu, Rongqian] Feinstein Inst Med Res, Surg Res Lab, Manhasset, NY 11030 USA; [Qi, Lei; Cui, Xiaoxuan; Dong, Weifeng; Barrera, Rafael; Nicastro, Jeffrey; Coppa, Gene F.; Wang, Ping; Wu, Rongqian] N Shore Univ Hosp, Dept Surg, Manhasset, NY USA; [Qi, Lei; Cui, Xiaoxuan; Dong, Weifeng; Barrera, Rafael; Nicastro, Jeffrey; Coppa, Gene F.; Wang, Ping; Wu, Rongqian] Long Isl Jewish Med Ctr, Manhasset, NY USA; [Qi, Lei] Xi An Jiao Tong Univ, Sch Med, Affiliated Hosp 1, Dept Neurosurg, Xian 710049, Shaanxi, Peoples R China	Wu, RQ (corresponding author), Feinstein Inst Med Res, Surg Res Lab, 350 Community Dr, Manhasset, NY 11030 USA.	rwu@nshs.edu	Wu, Rongqian/I-3614-2012; Qi, Lei/A-2980-2009	Wu, Rongqian/0000-0003-0993-4531; Wang, Ping/0000-0002-1557-0394; Qi, Lei/0000-0002-9525-9132	DoD/DRMRP [DR080669]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R21 NS072608]	This study was supported by a DoD/DRMRP Grant DR080669 (R Wu) and an NIH grant R21 NS072608 (R Wu).	Ammori JB, 2008, SURGERY, V144, P159, DOI 10.1016/j.surg.2008.03.008; Andrews ZB, 2008, NATURE, V454, P846, DOI 10.1038/nature07181; Arvat E, 2000, J ENDOCRINOL INVEST, V23, P493, DOI 10.1007/BF03343763; Bansal V, 2012, INFLAMMATION, V35, P214, DOI 10.1007/s10753-011-9307-7; Bansal V, 2010, J NEUROTRAUM, V27, P2255, DOI 10.1089/neu.2010.1372; Bilotta F, 2009, J NEUROSURG ANESTH, V21, P2, DOI 10.1097/ANA.0b013e31818f8a5c; Boulanger L, 2007, AM SURGEON, V73, P1269; Cederberg D, 2010, CHILD NERV SYST, V26, P221, DOI 10.1007/s00381-009-1029-x; Chaitanya GV, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-31; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Cheyuo C, 2011, SHOCK, V35, P258, DOI 10.1097/SHK.0b013e3181f48a37; Chung H, 2007, ENDOCRINOLOGY, V148, P148, DOI 10.1210/en.2006-0991; Clark RSB, 1999, FASEB J, V13, P813; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Cowley MA, 2004, ENDOCRINOLOGY, V145, P2604, DOI 10.1210/en.2004-0346; Date Y, 2000, BIOCHEM BIOPH RES CO, V275, P477, DOI 10.1006/bbrc.2000.3342; Davis KL, 2007, J TRAUMA, V62, P622, DOI 10.1097/TA.0b013e318031afe3; DeWitt DS, 2009, J NEUROTRAUM, V26, P877, DOI 10.1089/neu.2007.0439; Dezaki K, 2008, PHARMACOL THERAPEUT, V118, P239, DOI 10.1016/j.pharmthera.2008.02.008; Dressler J, 2007, INT J LEGAL MED, V121, P365, DOI 10.1007/s00414-006-0126-6; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; Godoy DA, 2010, NEUROCRIT CARE, V13, P425, DOI 10.1007/s12028-010-9404-8; Hattori N, 2001, J CLIN ENDOCR METAB, V86, P4284, DOI 10.1210/jc.86.9.4284; Jacka MJ, 2009, CAN J NEUROL SCI, V36, P436, DOI 10.1017/S0317167100007757; Katsaragakis S, 2010, BRAIN INJURY, V24, P871, DOI 10.3109/02699051003789237; Kelly DF, 2006, J NEUROTRAUM, V23, P928, DOI 10.1089/neu.2006.23.928; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Kojima M, 2005, PHYSIOL REV, V85, P495, DOI 10.1152/physrev.00012.2004; Krakau K, 2006, BRAIN INJURY, V20, P345, DOI 10.1080/02699050500487571; Luo Chun, 2002, Chin J Traumatol, V5, P24; Manley G, 2001, ARCH SURG-CHICAGO, V136, P1118, DOI 10.1001/archsurg.136.10.1118; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Medana IM, 2003, BRAIN, V126, P515, DOI 10.1093/brain/awg061; Miao YY, 2007, BIOCHEM BIOPH RES CO, V359, P795, DOI 10.1016/j.bbrc.2007.05.192; Nass R, 2000, J NEUROENDOCRINOL, V12, P1194, DOI 10.1046/j.1365-2826.2000.00586.x; Papotti M, 2000, J CLIN ENDOCR METAB, V85, P3803, DOI 10.1210/jc.85.10.3803; Sakata I, 2003, NEUROSCI LETT, V342, P183, DOI 10.1016/S0304-3940(03)00294-5; Sangiao-Alvarellos S, 2010, INT J PEPT, V2010; Savitz SI, 1998, NEUROSURGERY, V42, P555, DOI 10.1097/00006123-199803000-00026; Shuto YJ, 2001, LIFE SCI, V68, P991, DOI 10.1016/S0024-3205(00)01001-8; van der Lely AJ, 2004, ENDOCR REV, V25, P426, DOI 10.1210/er.2002-0029; Wang GY, 2002, REGUL PEPTIDES, V105, P75, DOI 10.1016/S0167-0115(02)00012-5; Wong J, 2005, NEUROCRIT CARE, V3, P177, DOI 10.1385/NCC:3:2:177; Wu R, 2007, AM J PHYSIOL-ENDOC M, V293, pE1697, DOI 10.1152/ajpendo.00098.2007; Wu R, 2007, AM J RESP CRIT CARE, V176, P805, DOI 10.1164/rccm.200604-511OC; Wu RQ, 2007, CRIT CARE MED, V35, P912, DOI 10.1097/01.CCM.0000257327.61829.34; Wu RQ, 2007, ANN SURG, V245, P480, DOI 10.1097/01.sla.0000251614.42290.ed; Wu RQ, 2009, ANN SURG, V250, P126, DOI 10.1097/SLA.0b013e3181ad85d6; Wu RQ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002026; Wu RQ, 2005, CARDIOVASC RES, V68, P318, DOI 10.1016/j.cardiores.2005.06.011; Wu X, 2008, J TRAUMA, V64, P1313, DOI 10.1097/TA.0b013e318165c803; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	52	17	20	0	3	FEINSTEIN INST MED RES	MANHASSET	350 COMMUNITY DR, MANHASSET, NY 11030 USA	1076-1551			MOL MED	Mol. Med.	FEB	2012	18	2					186	193		10.2119/molmed.2011.00390			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	941KS	WOS:000303962700005	22160303	DOAJ Gold, Green Published			2021-06-18	
J	Lafuente, JV; Sharma, A; Patnaik, R; Muresanu, DF; Sharma, HS				Vicente Lafuente, Jose; Sharma, Aruna; Patnaik, Ranjana; Muresanu, Dafin Fior; Sharma, Hari Shanker			Diabetes Exacerbates Nanoparticles Induced Brain Pathology	CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS			English	Article						Nanoparticles; SiO2; Cu; Ag; Blood-brain barrier; brain edema; neuronal injury; myelin damage; diabetes; streptozotocine; electron microscopy; cerebral blood flow; neurotoxicity; sensory-motor function; cognitive disturbances; hyperglycemia	CEREBRAL-BLOOD-FLOW; ANTIOXIDANT COMPOUND H-290/51; SPINAL-CORD-INJURY; ACUTE METHAMPHETAMINE INTOXICATION; ACUTE HEAT EXPOSURE; BARRIER PERMEABILITY; EDEMA FORMATION; YOUNG-RATS; ENGINEERED NANOPARTICLES; POSSIBLE NEUROPROTECTION	Long term exposure of nanoparticles e.g., silica dust (SiO2) from desert environments, or engineered nanoparticles from metals viz., Cu, Al or Ag from industry, ammunition, military equipment and related products may lead to adverse effects on mental health. However, it is unclear whether these nanoparticles may further adversely affect human health in cardiovascular or metabolic diseases e.g., hypertension or diabetes. It is quite likely that in diabetes or hypertension where the body immune system is already compromised there will be greater adverse effects following nanoparticles exposure on human health as compared to their exposure to healthy individuals. Previous experiments from our laboratory showed that diabetic or hypertensive animals are more susceptible to heat stress-induced neurotoxicity. Furthermore, traumatic injury to the spinal cord in SiO2 exposed rats resulted in exacerbation of cord pathology. However, whether nanoparticles such as Cu, Ag or SiO2 exposure will lead to enhanced neurotoxicity in diabetic animals are still not well investigated. Previous data from our laboratory showed that Cu or Ag intoxication (50 mg/kg, i.p. per day for 7 days) in streptozotocine induced diabetic rats exhibited enhanced neurotoxicity and exacerbation of sensory, motor and cognitive function as compared to normal animals under identical conditions. Thus the diabetic animals showed exacerbation of regional blood-brain barrier (BBB) disruption, edema formation and cell injuries along with greater reduction in the local cerebral blood flow (CBF) as compared to normal rats. These observations suggest that diabetic animals are more vulnerable to nanoparticles induced brain damage than healthy rats. The possible mechanisms and functional significance of these findings are discussed in this review largely based on our own investigations.	[Sharma, Aruna; Sharma, Hari Shanker] Uppsala Univ, Univ Hosp, Dept Surg Sci Anesthesiol & Intens Care Med, Lab Cerebrovasc Res, SE-75185 Uppsala, Sweden; [Vicente Lafuente, Jose] Univ Basque Country, Dept Neurosci, Lab Clin & Expt Neurosci LaCEN, Bilbao 48080, Spain; [Patnaik, Ranjana] Banaras Hindu Univ, Inst Technol, Sch Biomed Engn, Deaprtment Biomat, Varanasi 221005, Uttar Pradesh, India; [Muresanu, Dafin Fior] Univ Med & Pharm Iuliu Hatieganu, Dept Neurosci, Cluj Napoca, Romania	Sharma, HS (corresponding author), Uppsala Univ, Univ Hosp, Dept Surg Sci Anesthesiol & Intens Care Med, Lab Cerebrovasc Res, SE-75185 Uppsala, Sweden.	Sharma@surgsci.uu.se	Patnaik, Ranjana/AAZ-4440-2020; Muresanu, Fior-Dafin/AAI-8120-2021; Lafuente, Jose-Vicente/O-6395-2014	Patnaik, Ranjana/0000-0002-8131-177X; Lafuente, Jose-Vicente/0000-0001-7246-0987	Air Force Office of Scientific Research (London), Air Force Material Command, USAFUnited States Department of DefenseAir Force Office of Scientific Research (AFOSR) [FA8655-05-1-3065]; EOARD, London office; Swedish Medical Research Council, SwedenSwedish Medical Research Council (SMRC) [2710]; Astra-Zeneca, Molndal, SwedenAstraZeneca; Alexander von Humboldt Foundation, GermanyAlexander von Humboldt Foundation; University Grants Commission, Govt. of India, New DelhiUniversity Grants Commission, India; Amity Science & Technology Foundation, New Delhi, India; Indian Medical Research Council, Govt. of India, New Delhi; Department of Science & Technology, Govt. of IndiaDepartment of Science & Technology (India); SAIOTEK; (Basque Gov.), Spain [IT491-10]	This investigation is partially supported by the Air Force Office of Scientific Research (London), Air Force Material Command, USAF, under grant number FA8655-05-1-3065. The U.S. Government is authorized to reproduce and distribute reprints for Government purpose notwithstanding any copyright notation thereon. The views and conclusions contained herein are those of the authors and should not be interpreted as necessarily representing the official policies or endorsements, either expressed or implied, of the Air Force Office of Scientific Research or the U.S. Government. We express sincere gratitude to Dr Robert N Kang, EOARD, London office for all necessary support and help during this investigation and several laboratories where a part of the work is done or some data is recorded and evaluated. Financial support from Swedish Medical Research Council (2710 HSS), Sweden; Astra-Zeneca (HSS). Molndal, Sweden; Alexander von Humboldt Foundation (HSS), Germany; University Grants Commission, Govt. of India, New Delhi (HSS/AS), Amity Science & Technology Foundation, New Delhi, India (AS/HSS), Indian Medical Research Council (HSS), Govt. of India, New Delhi, Department of Science & Technology, Govt. of India (HSS/AS); SAIOTEK and IT491-10 (Basque Gov.), Spain (JV) is gratefully acknowledged. Technical assistance of Mari-Anne Carlsson, Ingmarie Olsson, Karstin Flink, Margaretta Butler of Uppsala University is highly appreciated. The authors have no conflict of interest with any financial agencies mentioned above.	Berger M, 2006, MILITARY NANOTECHNOL; Beurskens-Comuth PAWV, 2011, ANN OCCUP HYG, V55, P937, DOI 10.1093/annhyg/mer060; Bi R, 2009, J BIOMED NANOTECHNOL, V5, P84, DOI 10.1166/jbn.2009.036; Chen X, 2008, TOXICOL LETT, V176, P1, DOI 10.1016/j.toxlet.2007.10.004; Chow JC, 2005, J AIR WASTE MANAGE, V55, P1411, DOI 10.1080/10473289.2005.10464743; Ding CN, 2005, J NEUROIMMUNOL, V161, P61, DOI 10.1016/j.jneuroim.2004.12.011; Drews G., 2010, PFLUGERS ARCH; Eisen EA, 2011, J OCCUP ENVIRON MED, V53, pS57, DOI 10.1097/JOM.0b013e31821bde98; Fenoglio I, 2006, FREE RADICAL BIO MED, V40, P1227, DOI 10.1016/j.freeradbiomed.2005.11.010; Glaser N, 2009, PEDIATR DIABETES, V10, P534, DOI 10.1111/j.1399-5448.2009.00511.x; Heng BC, 2011, ARCH TOXICOL, V85, P1517, DOI 10.1007/s00204-011-0722-1; Hillman KL, 2010, J NEUROSCI, V30, P7705, DOI 10.1523/JNEUROSCI.1273-10.2010; Hirano Seishiro, 2009, Environmental Health and Preventive Medicine, V14, P223, DOI 10.1007/s12199-008-0064-7; Hoffman WH, 2009, BRAIN RES, V1254, P138, DOI 10.1016/j.brainres.2008.11.100; Jachak A, 2011, NANOTOXICOLOGY; Jankord R, 2010, AM J PHYSIOL-REG I, V299, pR343, DOI 10.1152/ajpregu.00131.2010; Kelly E, 2010, EXPERT REV NEUROTHER, V10, P1045, DOI [10.1586/ern.10.79, 10.1586/ERN.10.81]; Kim JH, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/50/505101; Kiyatkin EA, 2009, NEUROSCIENCE, V161, P926, DOI 10.1016/j.neuroscience.2009.04.004; Kiyatkin EA, 2007, EUR J NEUROSCI, V26, P1242, DOI 10.1111/j.1460-9568.2007.05741.x; Kiyatkin EA, 2009, INT REV NEUROBIOL, V88, P65, DOI 10.1016/S0074-7742(09)88004-5; Konczol M, 2011, CHEM RES TOXICOL, V24, P1460, DOI 10.1021/tx200051s; Kreyling Wolfgang G, 2009, Inhal Toxicol, V21 Suppl 1, P55, DOI 10.1080/08958370902942517; Leppanen M., 2011, NANOTOXICOLOGY; Li N, 2011, J OCCUP ENVIRON MED, V53, pS74, DOI 10.1097/JOM.0b013e31821b1bf2; Li PA, 1998, BRAIN RES, V804, P36, DOI 10.1016/S0006-8993(98)00651-9; Long TC, 2006, ENVIRON SCI TECHNOL, V40, P4346, DOI 10.1021/es060589n; Lucchini RG, 2011, NEUROTOXICOLOGY; Manna SK, 2005, NANO LETT, V5, P1676, DOI 10.1021/nl0507966; Muresanu DF, 2007, ANN NY ACAD SCI, V1122, P1, DOI 10.1196/annals.1403.001; Muresanu DF, 2010, ANN NY ACAD SCI, V1199, P15, DOI 10.1111/j.1749-6632.2009.05328.x; Muresanu DF, 2010, ACTA NEUROCHIR SUPPL, V106, P327, DOI 10.1007/978-3-211-98811-4_61; Oberdorster G, 2009, J NANOSCI NANOTECHNO, V9, P4996, DOI 10.1166/jnn.2009.GR02; Oberdorster G, 2010, J INTERN MED, V267, P89, DOI 10.1111/j.1365-2796.2009.02187.x; OLSSON Y, 1990, ACTA NEUROPATHOL, V79, P595, DOI 10.1007/BF00294236; Peters A, 2011, J OCCUP ENVIRON MED, V53, pS8, DOI 10.1097/JOM.0b013e31821ad5c0; PETTERSSON CAV, 1990, ACTA NEUROPATHOL, V81, P148, DOI 10.1007/BF00334503; Powers CM, 2010, ENVIRON HEALTH PERSP, V118, P73, DOI 10.1289/ehp.0901149; Rahman MF, 2009, TOXICOL LETT, V187, P15, DOI 10.1016/j.toxlet.2009.01.020; Rushton EK, 2010, J TOXICOL ENV HEAL A, V73, P445, DOI 10.1080/15287390903489422; Schubauer-Berigan MK, 2011, J OCCUP ENVIRON MED, V53, pS62, DOI 10.1097/JOM.0b013e31821b1e2c; Sharma H. S., 2009, HDB NEUROCHEMISTRY M, P363, DOI DOI 10.1007/978-0-387-30375-8_17; Sharma HS, 2009, INT REV NEUROBIOL, V88, P297, DOI 10.1016/S0074-7742(09)88011-2; Sharma HS, 2009, J NANOSCI NANOTECHNO, V9, P5014, DOI 10.1166/jnn.2009.GR04; Sharma HS, 2009, J NANOSCI NANOTECHNO, V9, P5055, DOI 10.1166/jnn.2009.GR09; Sharma HS, 2009, J CHEM NEUROANAT, V37, P18, DOI 10.1016/j.jchemneu.2008.08.002; Sharma HS, 2007, ANN NY ACAD SCI, V1122, P197, DOI 10.1196/annals.1403.014; Sharma HS, 2007, NANOMEDICINE-UK, V2, P753, DOI 10.2217/17435889.2.6.753; Sharma HS, 2007, PROG BRAIN RES, V162, P245, DOI 10.1016/S0079-6123(06)62013-X; Sharma HS, 2007, CURR PHARM DESIGN, V13, P1903; Sharma HS, 2012, WIRES NANOMED NANOBI, V4, P184, DOI 10.1002/wnan.172; Sharma HS, 2011, J NANOSCI NANOTECHNO, V11, P7549, DOI 10.1166/jnn.2011.5114; Sharma HS, 2011, J NEURAL TRANSM, V118, P155, DOI 10.1007/s00702-010-0514-4; Sharma HS, 2010, J NANOSCI NANOTECHNO, V10, P7931, DOI 10.1166/jnn.2010.3616; Sharma HS, 2010, BRAIN PROTECTION IN SCHIZOPHRENIA, MOOD AND COGNITIVE DISORDERS, P243, DOI 10.1007/978-90-481-8553-5_9; Sharma HS, 2009, PROG BRAIN RES, V180, P155, DOI 10.1016/S0079-6123(08)80009-X; Sharma Hari Shanker, 2010, Nanomedicine (Lond), V5, P533, DOI 10.2217/nnm.10.25; Sharma HS, 2010, ACTA NEUROCHIR SUPPL, V106, P351, DOI 10.1007/978-3-211-98811-4_64; Sharma HS, 2010, ACTA NEUROCHIR SUPPL, V106, P359, DOI 10.1007/978-3-211-98811-4_65; Sharma HS, 2010, ACTA NEUROCHIR SUPPL, V106, P61, DOI 10.1007/978-3-211-98811-4_10; Sharma HS, 2009, J NANOSCI NANOTECHNO, V9, P5073, DOI 10.1166/jnn.2009.GR10; Sharma HS, 2009, J NANOSCI NANOTECHNO, V9, P4970, DOI 10.1166/jnn.2009.1717; Sharma HS, 2009, J NANOSCI NANOTECHNO, V9, P4992, DOI 10.1166/jnn.2009.GR01; Sharma HS, 2008, ANN NY ACAD SCI, V1139, P242, DOI 10.1196/annals.1432.052; SHARMA HS, 1990, BRAIN RES, V517, P215, DOI 10.1016/0006-8993(90)91029-G; Sharma HS, 2006, J NEURAL TRANSM, V113, P521, DOI 10.1007/s00702-005-0405-2; Sharma HS, 1998, PROG BRAIN RES, V115, P351; SHARMA HS, 1986, NEUROPHARMACOLOGY, V25, P161, DOI 10.1016/0028-3908(86)90037-7; SHARMA HS, 1987, NEUROPHARMACOLOGY, V26, P85, DOI 10.1016/0028-3908(87)90049-9; Sharma HS, 2009, PROG BRAIN RES, V180, P1; SHARMA HS, 1991, NEUROREPORT, V2, P155, DOI 10.1097/00001756-199103000-00012; Sharma HS, 2002, AMINO ACIDS, V23, P261, DOI 10.1007/s00726-001-0137-z; Sharma HS, 1997, ANN NY ACAD SCI, V813, P559, DOI 10.1111/j.1749-6632.1997.tb51747.x; SHARMA HS, 1990, ACT NEUR S, V51, P383; SHARMA HS, 1987, BRAIN RES, V424, P153, DOI 10.1016/0006-8993(87)91205-4; SHARMA HS, 1988, NEUROSCI RES, V5, P224, DOI 10.1016/0168-0102(88)90051-X; SHARMA HS, 1992, NEUROSCIENCE, V50, P445, DOI 10.1016/0306-4522(92)90436-6; SHARMA HS, 1990, ACTA NEUROPATHOL, V79, P604, DOI 10.1007/BF00294237; Sheikpranbabu S, 2010, BIOMATERIALS, V31, P2260, DOI 10.1016/j.biomaterials.2009.11.076; Shvedova AA, 2004, BIOCHEMISTRY-MOSCOW+, V69, P23, DOI 10.1023/B:BIRY.0000016347.35373.39; Sonaje K, 2010, BIOMATERIALS, V31, P3384, DOI 10.1016/j.biomaterials.2010.01.042; Song YG, 2011, THESCIENTIFICWORLDJO, V11, P1821, DOI 10.1100/2011/794801; Stone V, 2006, NAT NANOTECHNOL, V1, P23, DOI 10.1038/nnano.2006.69; Sun J, 2011, CELL BIOL TOXICOL, V27, P333, DOI 10.1007/s10565-011-9191-9; Sun SP, 2010, J MICROENCAPSUL, V27, P471, DOI 10.3109/02652040903515490; Ting JHY, 2006, CURR GENE THER, V6, P193, DOI 10.2174/156652306776359487; van Berlo D, 2010, ARCH TOXICOL, V84, P553, DOI 10.1007/s00204-010-0551-7; Vanwinkle BA, 2009, NANOTOXICOLOGY, V3, P307, DOI 10.3109/17435390903121949; Win-Shwe TT, 2009, INHAL TOXICOL, V21, P828, DOI 10.1080/08958370802538068; Yuen N, 2008, DIABETES, V57, P2588, DOI 10.2337/db07-1410; Zhang L, 2011, NANOTOXICOLOGY; Zhang R., 2011, J HAZARD MAT	92	17	19	0	17	BENTHAM SCIENCE PUBL	BUSUM	PO BOX 294, BUSUM, 1400 AG, NETHERLANDS	1871-5273	1996-3181		CNS NEUROL DISORD-DR	CNS Neurol. Disord.-Drug Targets	FEB	2012	11	1					26	39					14	Neurosciences; Pharmacology & Pharmacy	Neurosciences & Neurology; Pharmacology & Pharmacy	934MW	WOS:000303449400005	22229323				2021-06-18	
J	Yang, TY; Wang, TC; Tsai, YH; Huang, KC				Yang, T-Y.; Wang, T-C.; Tsai, Y-H.; Huang, K-C.			The effects of an injury to the brain on bone healing and callus formation in young adults with fractures of the femoral shaft	JOURNAL OF BONE AND JOINT SURGERY-BRITISH VOLUME			English	Article							HEAD-INJURY; SERUM	In patients with traumatic brain injury and fractures of long bones, it is often clinically observed that the rate of bone healing and extent of callus formation are increased. However, the evidence has been unconvincing and an association between such an injury and enhanced fracture healing remains unclear. We performed a retrospective cohort study of 74 young adult patients with a mean age of 24.2 years (16 to 40) who sustained a femoral shaft fracture (AO/OTA type 32A or 32B) with or without a brain injury. All the fractures were treated with closed intramedullary nailing. The main outcome measures included the time required for bridging callus formation (BCF) and the mean callus thickness (MCT) at the final follow-up. Comparative analyses were made between the 20 patients with a brain injury and the 54 without brain injury. Subgroup comparisons were performed among the patients with a brain injury in terms of the severity of head injury, the types of intracranial haemorrhage and gender. Patients with a brain injury had an earlier appearance of BCF (p < 0.001) and a greater final MCT value (p < 0.001) than those without. There were no significant differences with respect to the time required for BCF and final MCT values in terms of the severity of head injury (p = 0.521 and p = 0.153, respectively), the types of intracranial haemorrhage (p = 0.308 and p = 0.189, respectively) and gender (p = 0.383 and p = 0.662, respectively). These results confirm that an injury to the brain may be associated with accelerated fracture healing and enhanced callus formation. However, the severity of the injury to the brain, the type of intracranial haemorrhage and gender were not statistically significant factors in predicting the rate of bone healing and extent of final callus formation.	[Yang, T-Y.; Tsai, Y-H.; Huang, K-C.] Chang Gung Univ, Coll Med, Chang Gung Mem Hosp Chiayi, Dept Orthopaed, Pu Tz City 613, Chia Yi, Taiwan; [Wang, T-C.] Chang Gung Univ, Coll Med, Chang Gung Mem Hosp Chiayi, Dept Neurosurg, Pu Tz City 613, Chia Yi, Taiwan	Huang, KC (corresponding author), Chang Gung Univ, Coll Med, Chang Gung Mem Hosp Chiayi, Dept Orthopaed, 6 West Sec,Chia Pu Rd, Pu Tz City 613, Chia Yi, Taiwan.	kc2672@adm.cgmh.org.tw	HUANG, Kuo-Chin/S-7371-2019	HUANG, Kuo-Chin/0000-0002-3225-1504			Babhulkar S, 2005, CLIN ORTHOP RELAT R, P50, DOI 10.1097/01.blo.0000152369.99312.c5; Beil FT, 2010, J TRAUMA, V69, P1259, DOI 10.1097/TA.0b013e3181c4544d; BRUMBACK RJ, 1988, J BONE JOINT SURG AM, V70A, P1453, DOI 10.2106/00004623-198870100-00003; Cadosch D, 2010, J BONE JOINT SURG AM, V92A, P645, DOI 10.2106/JBJS.I.00097; Cadosch D, 2009, J BONE JOINT SURG AM, V91A, P282, DOI 10.2106/JBJS.G.01613; GARLAND DE, 1983, CLIN ORTHOP RELAT R, P190; GARLAND DE, 1982, CLIN ORTHOP RELAT R, P219; GARLAND DE, 1982, CLIN ORTHOP RELAT R, P38; GARLAND DE, 1980, CLIN ORTHOP RELAT R, P198; Giannoudis PV, 2006, INJURY, V37, pS18, DOI 10.1016/j.injury.2006.08.020; Helmy A, 2011, J CEREBR BLOOD F MET, V31, P658, DOI 10.1038/jcbfm.2010.142; Jones Kevin B, 2004, Iowa Orthop J, V24, P123; Kadhim Hazim J, 2008, J Intensive Care Med, V23, P236, DOI 10.1177/0885066608318458; Little DG, 2007, J BONE JOINT SURG BR, V89B, P425, DOI 10.1302/0301-620X.89B4.18301; Morley J, 2005, INJURY, V36, P363, DOI 10.1016/j.injury.2004.08.028; NEWMAN RJ, 1987, INJURY, V18, P241, DOI 10.1016/0020-1383(87)90006-4; PERKINS R, 1987, J BONE JOINT SURG BR, V69, P521; Rigaux P, 2005, JOINT BONE SPINE, V72, P146, DOI 10.1016/j.jbspin.2004.05.012; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; SMITH R, 1987, J BONE JOINT SURG BR, V69, P518; SPENCER RF, 1987, J BONE JOINT SURG BR, V69, P525; Weitzmann MN, 2006, J CLIN INVEST, V116, P1186, DOI 10.1172/JCI28550	22	17	22	0	6	BRITISH EDITORIAL SOC BONE JOINT SURGERY	LONDON	22 BUCKINGHAM STREET, LONDON WC2N 6ET, ENGLAND	0301-620X	2044-5377		J BONE JOINT SURG BR	J. Bone Joint Surg.-Br. Vol.	FEB	2012	94B	2					227	230		10.1302/0301-620X.94B2.28193			4	Orthopedics; Surgery	Orthopedics; Surgery	893WF	WOS:000300387700016	22323691				2021-06-18	
J	Wang, EY; Gao, JL; Yang, Q; Parsley, MO; Dunn, TJ; Zhang, L; DeWitt, DS; Denner, L; Prough, DS; Wu, P				Wang, Enyin; Gao, Junling; Yang, Qin; Parsley, Margaret O.; Dunn, Tiffany J.; Zhang, Lin; DeWitt, Douglas S.; Denner, Larry; Prough, Donald S.; Wu, Ping			Molecular Mechanisms Underlying Effects of Neural Stem Cells against Traumatic Axonal Injury	JOURNAL OF NEUROTRAUMA			English	Article						alpha-SMA; calcineurin; GDNF; human NSC; Rho; TBI; traumatic axonal injury	AMYLOID PRECURSOR PROTEIN; MARROW STROMAL CELLS; BRAIN-INJURY; NEUROTROPHIC FACTOR; DOPAMINERGIC-NEURONS; COGNITIVE FUNCTION; THERAPEUTIC STRATEGY; CALCINEURIN SUBUNIT; ISOFORM EXPRESSION; PROGENITOR CELLS	Transplantation of neural stem cells (NSCs) improves functional outcomes following traumatic brain injury (TBI). Previously we demonstrated that human NSCs (hNSCs) via releasing glial cell line-derived neurotrophic factor (GDNF), preserved cognitive function in rats following parasagittal fluid percussion. However, the underlying mechanisms remain elusive. In this study, we report that NSC grafts significantly reduce TBI-induced axonal injury in the fimbria and other brain regions by blocking abnormal accumulation of amyloid precursor protein (APP). A preliminary mass spectrometry proteomics study revealed the opposite effects of TBI and NSCs on many of the cytoskeletal proteins in the CA3 region of the hippocampus, including alpha-smooth muscle actin (alpha-SMA), the main stress fiber component. Further, Western blot and immunostaining studies confirmed that TBI significantly increased the expression of alpha-SMA in hippocampal neurons, whereas NSC grafts counteracted the effect of TBI. In an in vitro model, rapid stretch injury significantly shortened lengths of axons and dendrites, increased the expression of both APP and alpha-SMA, and induced actin aggregation, effects offset by GDNF treatment. These GDNF protective effects were reversed by a GDNF-neutralizing antibody or a specific calcineurin inhibitor, and were mimicked by a specific Rho inhibitor. In summary, we demonstrate for the first time that hNSC grafts and treatment with GDNF acutely reduce traumatic axonal injury and promote neurite outgrowth. Possible mechanisms underlying GDNF-mediated neurite protection include balancing the activity of calcineurin, whereas GDNF-induced neurite outgrowth may result from the reduction of the abnormal alpha-SMA expression and actin aggregation via blocking Rho signals. Our study also suggests the necessity of further exploring the roles of alpha-SMA in the central nervous system (CNS), which may lead to a new avenue to facilitate recovery after TBI and other injuries.	[Wang, Enyin; Gao, Junling; Dunn, Tiffany J.; Wu, Ping] Univ Texas Med Branch, Dept Neurosci & Cell Biol, Galveston, TX 77555 USA; [Parsley, Margaret O.; DeWitt, Douglas S.; Prough, Donald S.] Univ Texas Med Branch, Dept Anesthesiol, Galveston, TX 77555 USA; [Denner, Larry] Univ Texas Med Branch, Dept Internal Med, Galveston, TX 77555 USA; [Wang, Enyin; Zhang, Lin] Sichuan Univ, W China Sch Preclin & Forens Med, Dept Forens Biol, Chengdu 610064, Peoples R China; [Yang, Qin] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Neurol, Wuhan 430074, Peoples R China	Wu, P (corresponding author), Univ Texas Med Branch, Dept Neurosci & Cell Biol, Galveston, TX 77555 USA.	piwu@utmb.edu	Prough, Donald S/G-5793-2013; wu, Ping/G-8958-2011	Prough, Donald S/0000-0001-7994-532X; 	Department of the Army via the United States Army [W81XWH-08-2-0137]; Coalition for Brain Injury Research; Moody Center for Traumatic Brain & Spinal Cord Injury Research/Mission Connect; TIRR Foundation; China Scholarship CouncilChina Scholarship Council; John S. Dunn Research Foundation; Cullen Foundation	We thank Sigmund J. Haidacher, Yaping Zeng, Wenru Zhang, and Jason R. Thonhoff for technical support. This work was supported by the Department of the Army (W81XWH-08-2-0137 to P.W.) via the United States Army Medical Research Acquisition Activity, 820 Chandler Street, Fort Detrick, MD 21702-5014. The content of this work does not necessarily reflect the position or the policy of the government, and no official endorsement should be inferred. Other support for this study came from the Coalition for Brain Injury Research (P.W.), the Moody Center for Traumatic Brain & Spinal Cord Injury Research/Mission Connect (P.W.), the TIRR Foundation (P.W.), the China Scholarship Council (E.W.), the John S. Dunn Research Foundation (P.W.), and the Cullen Foundation (P.W.).	ADAMS JH, 1991, J NEUROL NEUROSUR PS, V54, P481, DOI 10.1136/jnnp.54.6.481; Akerud P, 1999, J NEUROCHEM, V73, P70, DOI 10.1046/j.1471-4159.1999.0730070.x; Al Nimer F, 2004, NEUROREPORT, V15, P1871, DOI 10.1097/00001756-200408260-00007; Back S, 2007, J NEUROSCI RES, V85, P2580, DOI 10.1002/jnr.21239; Bakshi A, 2006, EUR J NEUROSCI, V23, P2119, DOI 10.1111/j.1460-9568.2006.04743.x; Bales JW, 2010, BRAIN RES, V1358, P211, DOI 10.1016/j.brainres.2010.08.029; Bales JW, 2010, J NEUROTRAUM, V27, P109, DOI 10.1089/neu.2009.1072; Batchelor PE, 2002, MOL CELL NEUROSCI, V21, P436, DOI 10.1006/mcne.2002.1185; BECK KD, 1995, NATURE, V373, P339, DOI 10.1038/373339a0; Bonde C, 2000, NEUROREPORT, V11, P4069, DOI 10.1097/00001756-200012180-00032; Boockvar JA, 2005, NEUROSURGERY, V56, P163, DOI 10.1227/01.NEU.0000145866.25433.FF; Borisoff JF, 2003, MOL CELL NEUROSCI, V22, P405, DOI 10.1016/S1044-7431(02)00032-5; Bramlett HM, 1997, J NEUROPATH EXP NEUR, V56, P1132, DOI 10.1097/00005072-199710000-00007; Brodhun M, 2004, EXP TOXICOL PATHOL, V56, P103, DOI 10.1016/j.etp.2004.04.004; Buki A, 1999, J NEUROTRAUM, V16, P511, DOI 10.1089/neu.1999.16.511; Chaponnier C, 2004, J PATHOL, V204, P386, DOI 10.1002/path.1635; Ciallella JR, 2002, J NEUROTRAUM, V19, P1555, DOI 10.1089/089771502762300229; Consales C, 2007, BRAIN RES, V1159, P28, DOI 10.1016/j.brainres.2007.04.071; Coulpier M, 2004, MOL CELL NEUROSCI, V27, P132, DOI 10.1016/j.mcn.2004.06.001; ELLIS EF, 1995, J NEUROTRAUM, V12, P325, DOI 10.1089/neu.1995.12.325; ERB DE, 1991, EXP BRAIN RES, V83, P253; Gao JL, 2006, EXP NEUROL, V201, P281, DOI 10.1016/j.expneurol.2006.04.039; Geddes JF, 2000, NEUROPATH APPL NEURO, V26, P105, DOI 10.1046/j.1365-2990.2000.026002105.x; GENTLEMAN SM, 1993, NEUROSCI LETT, V160, P139, DOI 10.1016/0304-3940(93)90398-5; Gerlai R, 2001, EUR J NEUROSCI, V14, P1153, DOI 10.1046/j.0953-816x.2001.01724.x; Goffin JM, 2006, J CELL BIOL, V172, P259, DOI 10.1083/jcb.200506179; Graef IA, 2003, CELL, V113, P657, DOI 10.1016/S0092-8674(03)00390-8; Greer JE, 2011, J NEUROSCI, V31, P5089, DOI 10.1523/JNEUROSCI.5103-10.2011; Groth RD, 2003, BIOCHEM BIOPH RES CO, V311, P1159, DOI 10.1016/j.bbrc.2003.09.002; Hagan M, 2003, NEUROSCI LETT, V351, P149, DOI 10.1016/j.neulet.2003.07.021; Harting MT, 2009, J NEUROSURG, V110, P1189, DOI 10.3171/2008.9.JNS08158; Harting MT, 2009, J SURG RES, V153, P188, DOI 10.1016/j.jss.2008.03.037; Hausenloy DJ, 2009, BASIC RES CARDIOL, V104, P189, DOI 10.1007/s00395-009-0010-x; HENDERSON CE, 1994, SCIENCE, V266, P1062, DOI 10.1126/science.7973664; Herman IM, 1993, CURR OPIN CELL BIOL, V5, P48, DOI 10.1016/S0955-0674(05)80007-9; Hoane MR, 2004, J NEUROTRAUM, V21, P163, DOI 10.1089/089771504322778622; Hurley RA, 2004, J NEUROPSYCH CLIN N, V16, P1, DOI 10.1176/appi.neuropsych.16.1.1; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; Kilinc D, 2008, EXP NEUROL, V212, P422, DOI 10.1016/j.expneurol.2008.04.025; Kim BT, 2001, J NEUROSURG, V95, P674, DOI 10.3171/jns.2001.95.4.0674; Kim HJ, 2010, J NEUROTRAUM, V27, P131, DOI [10.1089/neu.2008.0818, 10.1089/neu.2008-0818]; Kitagawa H, 1999, J CEREBR BLOOD F MET, V19, P1336, DOI 10.1097/00004647-199912000-00007; KOO EH, 1990, P NATL ACAD SCI USA, V87, P1561, DOI 10.1073/pnas.87.4.1561; Kulbatski I, 2005, CURR DRUG TARGETS, V6, P111, DOI 10.2174/1389450053345037; Kurz JE, 2005, BRAIN RES, V1048, P153, DOI 10.1016/j.brainres.2005.04.062; Lanner JT, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003996; Lee JI, 2004, MOL CELLS, V17, P390; LIN LFH, 1993, SCIENCE, V260, P1130, DOI 10.1126/science.8493557; Longhi L, 2005, TRANSPL IMMUNOL, V15, P143, DOI 10.1016/j.trim.2005.09.003; Lu DY, 2001, J NEUROTRAUM, V18, P813, DOI 10.1089/089771501316919175; MACKAY DJG, 1995, TRENDS NEUROSCI, V18, P496, DOI 10.1016/0166-2236(95)92773-J; Mahmood A, 2001, J NEUROSURG, V94, P589, DOI 10.3171/jns.2001.94.4.0589; Mahmood A, 2007, NEUROSURGERY, V60, P546, DOI 10.1227/01.NEU.0000255346.25959.99; Mansuy IM, 2003, BIOCHEM BIOPH RES CO, V311, P1195, DOI 10.1016/j.bbrc.2003.10.046; Marmarou CR, 2006, EXP NEUROL, V197, P353, DOI 10.1016/j.expneurol.2005.10.003; Maxwell WL, 1997, J NEUROTRAUM, V14, P419, DOI 10.1089/neu.1997.14.419; McGee AW, 2003, TRENDS NEUROSCI, V26, P193, DOI 10.1016/S0166-2236(03)00062-6; Minnich JE, 2010, RESTOR NEUROL NEUROS, V28, P293, DOI 10.3233/RNN-2010-0528; Miyazaki H, 2001, BRAIN RES, V922, P165, DOI 10.1016/S0006-8993(01)03013-X; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Okonkwo DO, 1999, J CEREBR BLOOD F MET, V19, P443, DOI 10.1097/00004647-199904000-00010; OPPENHEIM RW, 1995, NATURE, V373, P344, DOI 10.1038/373344a0; Pertusa A, 2008, NEUROBIOL AGING, V29, P1366, DOI 10.1016/j.neurobiolaging.2007.02.026; Phillips LL, 2001, RESTOR NEUROL NEUROS, V19, P213; Pierce JES, 1996, J NEUROSCI, V16, P1083; POVLISHOCK JT, 1992, BRAIN PATHOL, V2, P1; Richardson RM, 2010, J NEUROSURG, V112, P1125, DOI 10.3171/2009.4.JNS081087; Riedel G, 1999, CELL MOL LIFE SCI, V55, P549, DOI 10.1007/s000180050313; Riess P, 2002, NEUROSURGERY, V51, P1043, DOI 10.1097/00006123-200210000-00035; Riess P, 2007, J NEUROTRAUM, V24, P216, DOI 10.1089/neu.2006.0141; Saatman KE, 1998, J NEUROTRAUM, V15, P1047, DOI 10.1089/neu.1998.15.1047; SAUER H, 1995, P NATL ACAD SCI USA, V92, P8935, DOI 10.1073/pnas.92.19.8935; SCHAAR DG, 1993, EXP NEUROL, V124, P368, DOI 10.1006/exnr.1993.1207; Schouten JW, 2004, J NEUROTRAUM, V21, P1501, DOI 10.1089/neu.2004.21.1501; Shear DA, 2004, BRAIN RES, V1026, P11, DOI 10.1016/j.brainres.2004.07.087; SHERRIFF FE, 1994, ACTA NEUROPATHOL, V88, P433; Shindo T, 2006, J MED INVESTIG, V53, P42, DOI 10.2152/jmi.53.42; Singleton RH, 2001, J NEUROTRAUM, V18, P607, DOI 10.1089/089771501750291846; Singleton RH, 2002, J NEUROSCI, V22, P791, DOI 10.1523/JNEUROSCI.22-03-00791.2002; Staal JA, 2010, J NEUROCHEM, V112, P1147, DOI 10.1111/j.1471-4159.2009.06531.x; Stone JR, 2000, BRAIN RES, V871, P288, DOI 10.1016/S0006-8993(00)02485-9; Svendsen CN, 1998, J NEUROSCI METH, V85, P141, DOI 10.1016/S0165-0270(98)00126-5; Tarasenko YI, 2004, J NEUROSCI RES, V78, P625, DOI 10.1002/jnr.20316; Tate MC, 2002, CELL TRANSPLANT, V11, P283; TOMAC A, 1995, NATURE, V373, P335, DOI 10.1038/373335a0; Walker PA, 2010, STEM CELLS DEV, V19, P867, DOI 10.1089/scd.2009.0188; Wang Y, 1997, J NEUROSCI, V17, P4341; Wennersten A, 2004, J NEUROSURG, V100, P88, DOI 10.3171/jns.2004.100.1.0088; Wu P, 2002, NAT NEUROSCI, V5, P1271, DOI 10.1038/nn974; Xiong Y, 2009, EXPERT OPIN EMERG DR, V14, P67, DOI [10.1517/14728210902769601, 10.1517/14728210902769601 ]; Yoong LF, 2009, MOL CELL NEUROSCI, V41, P464, DOI 10.1016/j.mcn.2009.05.002	91	17	19	0	10	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 20	2012	29	2					295	312		10.1089/neu.2011.2043			18	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	885SO	WOS:000299801300009	22077363				2021-06-18	
J	Abrishamkar, S; Safavi, M; Honarmand, A				Abrishamkar, Saeid; Safavi, Mohammadreza; Honarmand, Azim			Effect of erythropoietin on Glasgow Coma Scale and Glasgow Outcome Scale in patient with diffuse axonal injury	JOURNAL OF RESEARCH IN MEDICAL SCIENCES			English	Article						Erythropoietin; Outcome; Diffuse Axonal Injury	IN-VITRO; RECEPTOR; NEUROPROTECTION; APOPTOSIS; PROTECTS; INHIBITION; EXPRESSION; RECOVERY; CALCIUM; NEURONS	BACKGROUND: Erythropoietin (EPO) as a major stimulator of red blood cell (RBC) production play a key role on brain protection and have a caring effect on neurons from hypoxic or traumatic injury. The objective of this trial was to study the safety and efficacy of recombinant human EPO (rhEPO) on level of consciousness and other outcomes in patient with post traumatic diffuse axonal injury (PTDAI). METHODS: In a controlled double-blind randomized clinical trial, 54 patients aged 20-47 years were randomly allocated to 2 groups. Subjects in intervention group (n = 27) received 2000U open-label rhEPO (Erythropoietin-beta; Roche, Grenzach-Wyhlen, Germany) subcutaneously for six doses in two weeks (on days: 2, 4, 6, 8 and 10). The efficacies of the intervention were evaluated by GCS (Glasgow Coma Scale) and GOS (Glasgow Outcome Scale). RESULTS: The patients that were treated by rhEPO improved earlier with the difference between the treatment groups occurring on the day 10 (score differences of 9.6 for GCS and 1.9 for GOS). The better course of the rhEPO-treated patients continued throughout the remaining study period. The hematocrit and red blood cell counts did not increase to levels exceeding the normal range in rhEPO patients. CONCLUSIONS: Intravenous EPO was well tolerated in diffuse axonal injury and was associated with an improvement in patients' outcome in 2 weeks.	[Safavi, Mohammadreza; Honarmand, Azim] Isfahan Univ Med Sci, Anesthesiol & Crit Care Res Ctr, Esfahan, Iran; [Abrishamkar, Saeid] Isfahan Univ Med Sci, Dept Neurosurg, Esfahan, Iran	Safavi, M (corresponding author), Isfahan Univ Med Sci, Anesthesiol & Crit Care Res Ctr, Esfahan, Iran.	safavi@med.mui.ac.ir	honarmand, azim/E-7215-2012; Abrishamkar, Saeid/A-1437-2018	Abrishamkar, Saeid/0000-0001-8860-5204			Assandri R, 1999, J PHYSIOL-LONDON, V516, P343, DOI 10.1111/j.1469-7793.1999.0343v.x; Bao HF, 1999, BLOOD, V93, P3757, DOI 10.1182/blood.V93.11.3757.411a34_3757_3773; Bernaudin M, 1999, J CEREBR BLOOD F MET, V19, P643, DOI 10.1097/00004647-199906000-00007; Brines ML, 2000, P NATL ACAD SCI USA, V97, P10526, DOI 10.1073/pnas.97.19.10526; Calapai G, 2000, EUR J PHARMACOL, V401, P349, DOI 10.1016/S0014-2999(00)00466-0; Celik M, 2002, P NATL ACAD SCI USA, V99, P2258, DOI 10.1073/pnas.042693799; Digicaylioglu M, 2001, NATURE, V412, P641, DOI 10.1038/35088074; Dirnagl U, 1999, TRENDS NEUROSCI, V22, P391, DOI 10.1016/S0166-2236(99)01401-0; Feng Dongxia, 2000, Chin J Traumatol, V3, P85; Fisher M, 2000, ARCH INTERN MED, V160, P3196, DOI 10.1001/archinte.160.21.3196; Gorio A, 2002, P NATL ACAD SCI USA, V99, P9450, DOI 10.1073/pnas.142287899; Grasso G, 2004, NEUROSCIENTIST, V10, P93, DOI 10.1177/1073858403259187; Grasso G, 2001, J Neurosurg Sci, V45, P7; Groswasser Z, 1998, BRAIN INJURY, V12, P805, DOI 10.1080/026990598122197; Kawakami M, 2001, J BIOL CHEM, V276, P39469, DOI 10.1074/jbc.M105832200; Kirkness Catherine J, 2004, Biol Res Nurs, V5, P299, DOI 10.1177/1099800404263050; Marti HH, 1996, EUR J NEUROSCI, V8, P666, DOI 10.1111/j.1460-9568.1996.tb01252.x; Morishita E, 1997, NEUROSCIENCE, V76, P105, DOI 10.1016/s0306-4522(96)00306-5; Mostafa G, 2002, J TRAUMA, V53, P430, DOI 10.1097/00005373-200209000-00006; Ozturk E, 2005, PROG NEURO-PSYCHOPH, V29, P920, DOI 10.1016/j.pnpbp.2005.04.028; Roof RL, 1999, PHYSIOL BEHAV, V68, P81, DOI 10.1016/S0031-9384(99)00162-6; Sakanaka M, 1998, P NATL ACAD SCI USA, V95, P4635, DOI 10.1073/pnas.95.8.4635; Shein NA, 2005, J CEREBR BLOOD F MET, V25, P1456, DOI 10.1038/sj.jcbfm.9600142; Shingo T, 2001, J NEUROSCI, V21, P9733, DOI 10.1523/JNEUROSCI.21-24-09733.2001; Siren AL, 2006, BRAIN, V129, P480, DOI 10.1093/brain/awh703; Siren AL, 2001, ACTA NEUROPATHOL, V101, P271, DOI 10.1007/s004010000297; TAN CC, 1991, KIDNEY INT, V40, P69, DOI 10.1038/ki.1991.181; Verdonck O, 2007, J CEREBR BLOOD F MET, V27, P1369, DOI 10.1038/sj.jcbfm.9600443; Wolf JA, 2001, J NEUROSCI, V21, P1923, DOI 10.1523/JNEUROSCI.21-06-01923.2001; Yamamoto M, 2004, NEUROSCIENCE, V128, P163, DOI 10.1016/j.neuroscience.2004.06.026; Yatsiv I, 2005, FASEB J, V19, P1701, DOI 10.1096/fj.05-3907fje	31	17	18	0	2	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	1735-1995	1735-7136		J RES MED SCI	J. Res. Med. Sci.	JAN	2012	17	1					51	56					6	Medicine, General & Internal	General & Internal Medicine	997OY	WOS:000308176700008	23248657				2021-06-18	
J	Agbeko, RS; Pearson, S; Peters, MJ; McNames, J; Goldstein, B				Agbeko, Rachel S.; Pearson, Sean; Peters, Mark J.; McNames, James; Goldstein, Brahm			Intracranial pressure and cerebral perfusion pressure responses to head elevation changes in pediatric traumatic brain injury	PEDIATRIC CRITICAL CARE MEDICINE			English	Article						brain injury; intracranial pressure; cerebral perfusion pressure; child; head of bed elevation	BODY POSITION; HYPERTENSION; MANAGEMENT; CHILDREN; OUTFLOW; SYSTEM; CPP; ICP	Objectives: To determine the effect of and dynamic interaction between head elevation on intracranial pressure and cerebral perfusion pressure in severe pediatric traumatic head injury. Design: Prospective, randomized, interventional cohort study. Setting: Two tertiary pediatric critical care referral units. Patients: Ten children admitted with severe traumatic brain injury defined as Glasgow Coma Score <= 8 necessitating intracranial pressure monitoring (10 yrs +/- 5 SD; range 2-16 yrs). Interventions: Head elevation was randomly increased or decreased between 0 and 40 degrees from baseline level (30 degrees) in increments or decrements of 10 degrees. Measurements and Main Results: Intracranial pressure and arterial blood pressure were continuously recorded in combination with time-stamped clinical notations. Data were available for analysis in eight subjects (seven males and one female; mean age, 10 yrs +/- SD 5; range, 2-16 yrs) during 18 protocol sessions. This resulted in a total of 66 head-of-the-bed challenges. To compare results for a given change in head-of-the-bed elevation across age, we transformed head-of-the-bed angle to change in height (cm) at the level of Monro's foramen. An increase in head elevation of 10 cm resulted in an average change in intracranial pressure of -3.9 mm Hg (SD +/- 3.2 mm Hg; p < .001), whereas cerebral perfusion pressure remained unchanged (0.1 +/- 5.6 mm Hg; p = .957). Individual subjects showed marked variability in intracranial pressure change (range, -8.4 to +1.9 mm Hg/10 cm). The overall regression analysis for intracranial pressure response was change in intracranial pressure = -0.39/cm Delta h, r(2) = 0.42, and p < .001, where Delta h is the change in vertical height at the level of foramen of Monro attributable to a change in the head of the bed. Conclusions: In severe pediatric traumatic brain injury, the relationship between change in head of the bed and change in intracranial pressure was negative and linear. The lowest intracranial pressure was usually, but not always, achieved at highest head-of-the-bed angles. The effect size of a head-of-the-bed angle change depended, in part, on the subject's height. In contrast, cerebral perfusion pressure was mostly unaffected by head-of-the-bed changes. (Pediatr Crit Care Med 2012; 13:e39-e47)	[Goldstein, Brahm] Ikaria Inc, Clinton, NJ USA; [Agbeko, Rachel S.] Newcastle Hosp NHS Fdn Trust, Great N Childrens Hosp, Paediat Intens Care Unit, Newcastle Upon Tyne, Tyne & Wear, England; [Peters, Mark J.] UCL, Crit Care Grp 9RSA, Portex Unit, Inst Child Hlth, London, England; [Pearson, Sean; McNames, James] Portland State Univ, Dept Elect & Comp Engn, Portland, OR 97207 USA; [Peters, Mark J.] Great Ormond St Hosp NHS Trust, Paediat Intens Care Unit, London, England	Goldstein, B (corresponding author), Ikaria Inc, Clinton, NJ USA.	brahm.goldstein@ikaria.com	Peters, Mark/AAD-7518-2019	Peters, Mark/0000-0003-3653-4808	Thrasher Research Fund; Department of Health's NIHR Biomedical Research CentreNational Institute for Health Research (NIHR); Special Trustees Great Ormond Street Hospital	Supported, in part, by the Thrasher Research Fund.; This work was undertaken at Great Ormond Street Hospital/UCL Institute of Child Health, which received a proportion of funding from the Department of Health's NIHR Biomedical Research Centre's funding scheme.; Rachel S. Agbeko was supported by the Special Trustees Great Ormond Street Hospital. The remaining authors have not disclosed any potential conflicts of interest.	Adelson P David, 2003, Pediatr Crit Care Med, V4, pS31; Adelson P David, 2003, Pediatr Crit Care Med, V4, pS2, DOI 10.1097/01.CCM.0000066600.71233.01; Adelson P David, 2003, Pediatr Crit Care Med, V4, pS25; Brady KM, 2009, PEDIATRICS, V124, pE1205, DOI 10.1542/peds.2009-0550; Carter BG, 2008, CHILD NERV SYST, V24, P245, DOI 10.1007/s00381-007-0461-z; Chambers IR, 2005, CHILD NERV SYST, V21, P195, DOI 10.1007/s00381-004-1060-x; Cunitz G, 1994, INT S INTR PRESS NAG, P674; DURWARD QJ, 1983, J NEUROSURG, V59, P938, DOI 10.3171/jns.1983.59.6.0938; EMERY JR, 1983, J PEDIATR-US, V103, P950, DOI 10.1016/S0022-3476(83)80728-8; FELDMAN Z, 1992, J NEUROSURG, V76, P207, DOI 10.3171/jns.1992.76.2.0207; Huh JW, 2003, CRIT CARE MED, V31, pA91; Jones HA, 2009, NURS CRIT CARE, V14, P303, DOI 10.1111/j.1478-5153.2009.00352.x; KENNING JA, 1981, SURG NEUROL, V15, P148, DOI 10.1016/0090-3019(81)90037-9; Lovell AT, 2000, ANESTH ANALG, V90, P372, DOI 10.1097/00000539-200002000-00025; MAGNAES B, 1976, J NEUROSURG, V44, P687, DOI 10.3171/jns.1976.44.6.0687; MARMAROU A, 1975, J NEUROSURG, V43, P523, DOI 10.3171/jns.1975.43.5.0523; McCann YG, 2001, CHEST, V120, P1322, DOI 10.1378/chest.120.4.1322; Meixensberger J, 1997, NEUROL RES, V19, P249, DOI 10.1080/01616412.1997.11740808; Munis JR, 2000, J NEUROSURG ANESTH, V12, P290, DOI 10.1097/00008506-200007000-00029; Ng I, 2004, NEUROSURGERY, V54, P593, DOI 10.1227/01.NEU.0000108639.16783.39; ROPPER AH, 1982, NEUROLOGY, V32, P1288, DOI 10.1212/WNL.32.11.1288; ROSNER MJ, 1986, J NEUROSURG, V65, P636, DOI 10.3171/jns.1986.65.5.0636; ROSNER MJ, 1995, J NEUROSURG, V83, P949, DOI 10.3171/jns.1995.83.6.0949; SCHNEIDER GH, 1993, ACTA NEUROCHIR, P107; Schulz-Stubner S, 2006, EUR J ANAESTH, V23, P177, DOI 10.1017/S0265021505232118; Segui-Gomez M, 2003, EPIDEMIOL REV, V25, P3, DOI 10.1093/epirev/mxg007; Vinecore K, 2007, PEDIATR CRIT CARE ME, V8, P563, DOI 10.1097/01.PCC.0000288715.66726.64; White H, 2008, ANESTH ANALG, V107, P979, DOI 10.1213/ane.0b013e31817e7b1a; Winkelman C, 2000, Am J Crit Care, V9, P373; Winkelman C., 2000, AM J CRIT CARE, V9, P381; WOISCHNECK D, 1992, J NEUROSURG, V77, P651	31	17	18	0	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1529-7535	1947-3893		PEDIATR CRIT CARE ME	Pediatr. Crit. Care Med.	JAN	2012	13	1					E39	E47		10.1097/PCC.0b013e31820ac2ad			9	Critical Care Medicine; Pediatrics	General & Internal Medicine; Pediatrics	875YT	WOS:000299073000007	21242856				2021-06-18	
J	Alway, Y; McKay, A; Ponsford, J; Schonberger, M				Alway, Yvette; McKay, Adam; Ponsford, Jennie; Schoenberger, Michael			Expressed emotion and its relationship to anxiety and depression after traumatic brain injury	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Expressed emotion; Traumatic brain injury; Attributions	ILLNESS PERCEPTION QUESTIONNAIRE; PSYCHIATRIC-DISORDERS; 1ST-EPISODE PSYCHOSIS; CAUSAL ATTRIBUTIONS; OVER-INVOLVEMENT; EATING-DISORDERS; HOSPITAL ANXIETY; SELF-REPORT; IPQ-R; RELATIVES	Levels of expressed emotion (EE) within the family, particularly criticism and emotional over-involvement, are associated with a patient's psychological outcome in a range of psychiatric and medical conditions. This study aimed to examine the relationship between levels of family EE and anxiety and depression in patients who have sustained a traumatic brain injury (TBI). A further aim was to examine whether family members' levels of psychological distress and attributions of patient symptom controllability, were related to their levels of patient-directed EE. Participants were 43 patients who had sustained a complicated mild to severe TBI three months to five years previously, and their nominated family members. Results indicated that family members' criticism and emotional over-involvement were associated with patients' levels of anxiety and depression. Moreover, family members' levels of anxiety and depression were associated with their levels of patient-directed criticism and emotional over-involvement, whilst their attributions of patient symptom control were not. These findings suggest that levels of EE within the family are associated with psychological adjustment following TBI. Consequently, interventions targeting EE in family members may help to reduce psychiatric difficulties following TBI.	[Alway, Yvette; McKay, Adam; Ponsford, Jennie; Schoenberger, Michael] Monash Univ, Sch Psychol & Psychiat, Melbourne, Vic 3800, Australia; [Alway, Yvette; McKay, Adam; Ponsford, Jennie; Schoenberger, Michael] Epworth Med Fdn, Monash Epworth Rehabil Res Ctr, Melbourne, Vic, Australia; [Ponsford, Jennie] Natl Trauma Res Inst, Melbourne, Vic, Australia; [Schoenberger, Michael] Univ Freiburg, Inst Psychol, Dept Rehabil Psychol & Psychotherapy, Freiburg, Germany	Ponsford, J (corresponding author), Monash Univ, Sch Psychol & Psychiat, Clayton Campus,Wellington Rd,Bldg 17, Melbourne, Vic 3800, Australia.	jennie.ponsford@monash.edu	McKay, Adam JD/M-6003-2017	McKay, Adam JD/0000-0002-0479-7681			Alvarez-Jimenez M, 2010, PSYCHOL MED, V40, P63, DOI 10.1017/S0033291708004765; Barrowclough C, 2003, CLIN PSYCHOL REV, V23, P849, DOI 10.1016/S0272-7358(03)00075-8; Barrowclough C, 2001, BRIT J CLIN PSYCHOL, V40, P371, DOI 10.1348/014466501163869; Barrowclough C, 2008, BEHAV RES THER, V46, P207, DOI 10.1016/j.brat.2007.11.005; Bentsen H, 1996, BRIT J PSYCHIAT, V169, P622, DOI 10.1192/bjp.169.5.622; Breitborde NJK, 2009, SOC PSYCH PSYCH EPID, V44, P716, DOI 10.1007/s00127-008-0492-0; Bressi C, 2007, SEIZURE-EUR J EPILEP, V16, P417, DOI 10.1016/j.seizure.2007.02.015; Bressi C, 2009, J CARDIOVASC MED, V10, P752, DOI 10.2459/JCM.0b013e32832cae71; BREWIN CR, 1991, J ABNORM PSYCHOL, V100, P546, DOI 10.1037/0021-843X.100.4.546; BROWN GW, 1958, LANCET, V2, P685; Butzlaff RL, 1998, ARCH GEN PSYCHIAT, V55, P547, DOI 10.1001/archpsyc.55.6.547; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd; Cutting LP, 2006, SCHIZOPHRENIA BULL, V32, P743, DOI 10.1093/schbul/sbl001; DeVellis R., 2003, SCALE DEV THEORY APP; EPSTEIN NB, 1983, J MARITAL FAM THER, V9, P171, DOI 10.1111/j.1752-0606.1983.tb01497.x; Fichter MM, 1997, FAM PROCESS, V36, P203, DOI 10.1111/j.1545-5300.1997.00203.x; Flanagan DAJ, 1998, BRIT J CLIN PSYCHOL, V37, P431, DOI 10.1111/j.2044-8260.1998.tb01400.x; Fogler JM, 2007, BEHAV RES THER, V45, P235, DOI 10.1016/j.brat.2006.03.002; Gould KR, 2011, J HEAD TRAUMA REHAB, V26, P79, DOI 10.1097/HTR.0b013e3182036799; Grice SJ, 2009, BEHAV RES THER, V47, P783, DOI 10.1016/j.brat.2009.06.004; Hooley J. M, 1987, NATURE ORIGINS EXPRE; Hooley JM, 2007, ANNU REV CLIN PSYCHO, V3, P329, DOI 10.1146/annurev.clinpsy.2.022305.095236; HOOLEY JM, 1985, CLIN PSYCHOL REV, V5, P119, DOI 10.1016/0272-7358(85)90018-2; Hooley JM, 2002, PSYCHOL MED, V32, P1091, DOI 10.1017/S0033291702005779; Hooley JM, 1997, J ABNORM PSYCHOL, V106, P298, DOI 10.1037/0021-843X.106.2.298; Judd D, 2005, BRAIN INJURY, V19, P437, DOI 10.1080/02699050400010994; Kelly G, 2008, BRAIN INJURY, V22, P457, DOI 10.1080/02699050802060647; Koponen S, 2002, AM J PSYCHIAT, V159, P1315, DOI 10.1176/appi.ajp.159.8.1315; KUIPERS L, 1988, PSYCHOL MED, V18, P893, DOI 10.1017/S0033291700009831; Kyriacou O, 2008, INT J EAT DISORDER, V41, P37, DOI 10.1002/eat.20469; Max JE, 1997, J AM ACAD CHILD PSY, V36, P1278, DOI 10.1097/00004583-199709000-00021; Max JE, 1997, J AM ACAD CHILD PSY, V36, P94, DOI 10.1097/00004583-199701000-00022; Max JE, 1998, J NEUROPSYCH CLIN N, V10, P290, DOI 10.1176/jnp.10.3.290; Max JE, 1997, J NERV MENT DIS, V185, P394, DOI 10.1097/00005053-199706000-00006; McMurrich SL, 2009, BEHAV THER, V40, P315, DOI 10.1016/j.beth.2008.09.003; McNab C, 2007, PSYCHIAT RES, V151, P97, DOI 10.1016/j.psychres.2006.08.004; Miklowitz DJ, 2004, DEV PSYCHOPATHOL, V16, P667, DOI 10.1017/S0954579404004729; Moss-Morris R, 2002, PSYCHOL HEALTH, V17, P1, DOI 10.1080/08870440290001494; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; Pharoah F, 2006, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD000088.pub2, 10.1002/14651858.CD000088.pub3]; Ponsford J, 2010, J INT NEUROPSYCH SOC, V16, P306, DOI 10.1017/S1355617709991342; Renshaw KD, 2006, BEHAV THER, V37, P159, DOI 10.1016/j.beth.2005.11.001; Rogosch FA, 2004, DEV PSYCHOPATHOL, V16, P689, DOI 10.1017/S0954579404004730; Saltapidas H, 2007, J HEAD TRAUMA REHAB, V22, P132, DOI 10.1097/01.HTR.0000265101.75177.8d; Sander AM, 2002, BRAIN INJURY, V16, P649, DOI 10.1080/02699050210128889; Schonberger M, 2010, PSYCHIAT RES, V179, P342, DOI 10.1016/j.psychres.2009.07.003; Shah AJ., 2010, BR J MED PRACT, V3, P327; Sterba KR, 2009, PSYCHOL HEALTH, V24, P473, DOI 10.1080/08870440701867788; Tarrier N, 2002, J ABNORM PSYCHOL, V111, P340, DOI 10.1037//0021-843X.111.2.340; Testa JA, 2006, J HEAD TRAUMA REHAB, V21, P236, DOI 10.1097/00001199-200605000-00004; Wearden AJ, 2000, J PSYCHOSOM RES, V49, P125, DOI 10.1016/S0022-3999(00)00141-0; Wearden AJ, 2000, CLIN PSYCHOL REV, V20, P633, DOI 10.1016/S0272-7358(99)00008-2; WEDDELL RA, 1987, SCAND J REHABIL MED, V19, P93; Weddell RA, 2006, BRAIN INJURY, V20, P1221, DOI 10.1080/02699050601049783; Weddell RA, 2010, ARCH PHYS MED REHAB, V91, P897, DOI 10.1016/j.apmr.2010.01.020; Whelan-Goodinson R, 2010, J HEAD TRAUMA REHAB, V25, P320, DOI 10.1097/HTR.0b013e3181c8f8e7; Whelan-Goodinson R, 2009, J AFFECT DISORDERS, V114, P94, DOI 10.1016/j.jad.2008.06.007; Whelan-Goodinson R, 2008, J REHABIL MED, V40, P850, DOI 10.2340/16501977-0271; Wiedemann G, 2002, PSYCHIAT RES, V109, P265, DOI 10.1016/S0165-1781(02)00023-9; Zabala MJ, 2009, EUR EAT DISORD REV, V17, P338, DOI 10.1002/erv.925; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	61	17	17	0	8	PSYCHOLOGY PRESS	HOVE	27 CHURCH RD, HOVE BN3 2FA, EAST SUSSEX, ENGLAND	0960-2011			NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.		2012	22	3					374	390		10.1080/09602011.2011.648757			17	Neurosciences; Psychology	Neurosciences & Neurology; Psychology	936BV	WOS:000303566800003	22292905				2021-06-18	
J	Antonini, TN; Raj, SP; Oberjohn, KS; Wade, SL				Antonini, Tanya N.; Raj, Stacey P.; Oberjohn, Karen S.; Wade, Shari L.			An online positive parenting skills programme for paediatric traumatic brain injury: feasibility and parental satisfaction	JOURNAL OF TELEMEDICINE AND TELECARE			English	Article							CHILD INTERACTION THERAPY; YOUNG-CHILDREN; EFFICACY; BEHAVIOR; OUTCOMES	We examined the feasibility of and parental satisfaction with a training programme for parents with children who had suffered traumatic brain injury (TBI). Families who did not have a home computer and/or webcam were loaned the necessary equipment. Skype was used for videoconferencing. After the initial treatment session in the family's home, the remaining nine sessions were conducted online. Each session had two parts: (1) a self-guided web session with information about a particular skill; (2) a videoconference session with the therapist. Three of the 20 families (15%) dropped out prior to the final 6-month follow-up visit. Of the remaining 17 families, 13 (65% of those enrolled) completed 9-14 sessions. Almost all of the caregivers (87%) said that the Skype sessions were helpful compared to a conventional office visit. Almost all parents were satisfied with the programme and the technology that was used. Parental satisfaction with the programme was not influenced by prior computer ownership or comfort with technology. The programme appears to be feasible for a wide range of parents of children with TBI and provides an alternative to conventional office-based sessions that may not be accessible to all families.	[Antonini, Tanya N.; Raj, Stacey P.; Oberjohn, Karen S.; Wade, Shari L.] Childrens Hosp, Med Ctr, Cincinnati, OH 45229 USA; [Wade, Shari L.] Univ Cincinnati, Coll Med, Cincinnati, OH USA; [Antonini, Tanya N.] Univ Cincinnati, Dept Psychol, Cincinnati, OH 45221 USA; [Raj, Stacey P.] Miami Univ, Dept Psychol, Oxford, OH 45056 USA	Wade, SL (corresponding author), Childrens Hosp, Med Ctr, 3333 Burnet Ave,ML 4009, Cincinnati, OH 45229 USA.	shari.wade@cchmc.org			National Institute on Disability and Rehabilitation Research, Department of Education [H133G060167, H133B090010]	The work was supported by grants H133G060167 and H133B090010 from the National Institute on Disability and Rehabilitation Research, Department of Education. Part of this work was presented at the 2011 annual meeting of the Society for Computers in Psychology in Seattle, Washington and at the 2011 Federal Interagency Conference on Traumatic Brain Injury in Washington, DC.	Anderson V, 2012, INT J DEV NEUROSCI, V30, P217, DOI 10.1016/j.ijdevneu.2011.09.008; Bodenmann G, 2008, BEHAV RES THER, V46, P411, DOI 10.1016/j.brat.2008.01.001; Ewing-Cobbs L, 2006, J NEUROSURG, V105, P287, DOI 10.3171/ped.2006.105.4.287; Eyberg S., 1988, CHILD FAM BEHAV THER, V10, P33, DOI [DOI 10.1300/J019V10N01_04, 10.1300/J019v10n01_04]; Feeney T, 2006, BRAIN INJURY, V20, P629, DOI 10.1080/02699050600744194; JENNETT B, 1975, LANCET, V1, P480; Kaminski JW, 2008, J ABNORM CHILD PSYCH, V36, P567, DOI 10.1007/s10802-007-9201-9; Kurowski BG, 2011, PM&R, V3, P836, DOI 10.1016/j.pmrj.2011.05.016; Newman MG, 2004, J CLIN PSYCHOL, V60, P141, DOI 10.1002/jclp.10240; Ruskin PE, 2004, AM J PSYCHIAT, V161, P1471, DOI 10.1176/appi.ajp.161.8.1471; Schuhmann EM, 1998, J CLIN CHILD PSYCHOL, V27, P34, DOI 10.1207/s15374424jccp2701_4; Slomine BS, 2002, BRAIN INJURY, V16, P759, DOI 10.1080/02699050210127286; Wade SL, 2006, J CONSULT CLIN PSYCH, V74, P445, DOI 10.1037/0022-006X.74.3.445; Wade SL, 2011, DEV PSYCHOL, V47, P119, DOI 10.1037/a0021028; Wade SL, 2009, J HEAD TRAUMA REHAB, V24, P239, DOI 10.1097/HTR.0b013e3181ad6680; Wade SL, 1996, J LEARN DISABIL, V29, P652, DOI 10.1177/002221949602900609; Webster-Stratton C, 2008, J CHILD PSYCHOL PSYC, V49, P471, DOI 10.1111/j.1469-7610.2007.01861.x; Werba BE, 2006, BEHAV MODIF, V30, P618, DOI 10.1177/0145445504272977	18	17	17	0	14	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1357-633X	1758-1109		J TELEMED TELECARE	J. Telemed. Telecare		2012	18	6					333	338		10.1258/jtt.2012.120404			6	Health Care Sciences & Services	Health Care Sciences & Services	014KU	WOS:000309375400006	22941332				2021-06-18	
J	Bakar, AM; Park, SW; Kim, M; Lee, HT				Bakar, Adnan M.; Park, Sang Won; Kim, Mihwa; Lee, H. Thomas			Isoflurane Protects Against Human Endothelial Cell Apoptosis by Inducing Sphingosine Kinase-1 via ERK MAPK	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES			English	Article						EA.hy926; sphingosine kinase; extracellular signal-regulated kinase; necrosis; volatile anesthetic	ISCHEMIA-REPERFUSION INJURY; MYOCARDIAL INFARCT SIZE; TRAUMATIC BRAIN-INJURY; PROXIMAL TUBULE CELLS; SMOOTH-MUSCLE-CELLS; VOLATILE ANESTHETICS; 1-PHOSPHATE; RATS; PRETREATMENT; KIDNEY	Endothelial dysfunction is a major clinical problem affecting virtually every patient requiring critical care. Volatile anesthetics are frequently used during the perioperative period and protect the heart and kidney against ischemia and reperfusion injury. We aimed to determine whether isoflurane, the most commonly used volatile anesthetic in the USA, protects against endothelial apoptosis and necrosis and the mechanisms involved in this protection. Human endothelial EA.hy926 cells were pretreated with isoflurane or carrier gas (95% room air + 5% CO2) then subjected to apoptosis with tumor necrosis factor-alpha or to necrosis with hydrogen peroxide. DNA laddering and in situ Terminal Deoxynucleotidyl Transferase Biotin-dUTP Nick-End Labeling (TUNEL) staining determined EA.hy926 cell apoptosis and percent LDH released determined necrosis. We also determined whether isoflurane modulates the expression and activity of sphingosine kinase-1 (SK1) and induces the phosphorylation of extracellular signal regulated kinase (ERK MAPK) as both enzymes are known to protect against cell death. Isoflurane pretreatment significantly decreased apoptosis in EA. hy926 cells as evidenced by reduced TUNEL staining and DNA laddering without affecting necrosis. Mechanistically, isoflurane induces the phosphorylation of ERK MAPK and increased SK1 expression and activity in EA.hy926 cells. Finally, selective blockade of SK1 (with SKI-II) or S1P(1) receptor (with W146) abolished the anti-apoptotic effects of isoflurane. Taken together, we demonstrate that isoflurane, in addition to its potent analgesic and anesthetic properties, protects against endothelial apoptosis most likely via SK1 and ERK MAPK activation. Our findings have significant clinical implication for protection of endothelial cells during the perioperative period and patients requiring critical care.	[Bakar, Adnan M.; Park, Sang Won; Kim, Mihwa; Lee, H. Thomas] Columbia Univ, Coll Phys & Surg, Dept Anesthesiol, New York, NY 10032 USA; [Bakar, Adnan M.] Columbia Univ, Coll Phys & Surg, Dept Pediat, New York, NY 10032 USA	Lee, HT (corresponding author), Columbia Univ, Coll Phys & Surg, Dept Anesthesiol, P&S Box 46,PH 5,630 W 168th St, New York, NY 10032 USA.	amb9045@nyp.org; swp2109@columbia.edu; mk2767@columbia.edu; TL128@columbia.edu			National Institute of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 DK-058547, 01 GM-067081]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [R01DK058547] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM067081] Funding Source: NIH RePORTER	This work was supported by National Institute of Health Grants R01 DK-058547 and 01 GM-067081.	Ait-Oufella H, 2010, INTENS CARE MED, V36, P1286, DOI 10.1007/s00134-010-1893-6; Awad AS, 2006, AM J PHYSIOL-RENAL, V290, pF1516, DOI 10.1152/ajprenal.00311.2005; Carden DL, 2000, J PATHOL, V190, P255, DOI 10.1002/(SICI)1096-9896(200002)190:3<255::AID-PATH526>3.0.CO;2-6; Cason BA, 1997, ANESTHESIOLOGY, V87, P1182, DOI 10.1097/00000542-199711000-00023; Chi OZ, 2010, ANESTH ANALG, V110, P1412, DOI 10.1213/ANE.0b013e3181d6c0ae; de Klaver MJM, 2003, ANESTHESIOLOGY, V99, P896, DOI 10.1097/00000542-200310000-00023; de Klaver MJM, 2002, ANESTHESIOLOGY, V97, P24, DOI 10.1097/00000542-200207000-00005; EDGELL CJ, 1983, P NATL ACAD SCI-BIOL, V80, P3734, DOI 10.1073/pnas.80.12.3734; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Hait NC, 2006, BBA-BIOMEMBRANES, V1758, P2016, DOI 10.1016/j.bbamem.2006.08.007; Head BP, 2009, ANESTHESIOLOGY, V110, P813, DOI 10.1097/ALN.0b013e31819b602b; HERRMANN M, 1994, NUCLEIC ACIDS RES, V22, P5506, DOI 10.1093/nar/22.24.5506; Jevtovic-Todorovic V, 2003, J NEUROSCI, V23, P876, DOI 10.1523/jneurosci.23-03-00876.2003; Jo SK, 2008, KIDNEY INT, V73, P1220, DOI 10.1038/ki.2008.34; Johnson ME, 1996, ANESTHESIOLOGY, V84, P103, DOI 10.1097/00000542-199601000-00013; Kersten JR, 1997, ANESTHESIOLOGY, V87, P361, DOI 10.1097/00000542-199708000-00024; Kim M, 2011, ANN SURG IN PRESS; Kim M, 2010, AM J NEPHROL, V31, P353, DOI 10.1159/000298339; Kim M, 2007, AM J PHYSIOL-RENAL, V293, pF1827, DOI 10.1152/ajprenal.00290.2007; Kimura T, 2001, J BIOL CHEM, V276, P31780, DOI 10.1074/jbc.M104353200; Kolch W, 2000, BIOCHEM J, V351, P289, DOI 10.1042/0264-6021:3510289; Kon SP, 1997, ANESTHESIOLOGY, V86, P128, DOI 10.1097/00000542-199701000-00017; Lee HT, 2006, AM J PHYSIOL-RENAL, V291, pF67, DOI 10.1152/ajprenal.00412.2005; Lee HT, 2004, ANESTHESIOLOGY, V101, P1313; Lee HT, 2002, AM J PHYSIOL-RENAL, V282, pF844, DOI 10.1152/ajprenal.00195.2001; Lemkuil BP, 2011, ANESTHESIOLOGY, V114, P49, DOI 10.1097/ALN.0b013e318201dcb3; LEVIN ED, 1991, NEUROTOXICOL TERATOL, V13, P461, DOI 10.1016/0892-0362(91)90096-F; Li L, 2009, NEUROSCIENCE, V164, P497, DOI 10.1016/j.neuroscience.2009.08.011; Liu H, 2002, PROG NUCLEIC ACID RE, V71, P493, DOI 10.1016/S0079-6603(02)71049-0; Lochhead KM, 1998, KIDNEY INT, V54, P373, DOI 10.1046/j.1523-1755.1998.00022.x; Min JK, 2002, ANAL BIOCHEM, V303, P167, DOI 10.1006/abio.2002.5579; Moriue T, 2008, BIOCHEM BIOPH RES CO, V368, P852, DOI 10.1016/j.bbrc.2008.01.155; Olivera A, 1999, J CELL BIOL, V147, P545, DOI 10.1083/jcb.147.3.545; Preckel B, 2005, BEST PRACT RES-CLIN, V19, P331, DOI 10.1016/j.bpa.2005.01.003; SHAYEVITZ JR, 1995, SHOCK, V4, P61, DOI 10.1097/00024382-199507000-00010; Statler KD, 2006, BRAIN RES, V1076, P216, DOI 10.1016/j.brainres.2005.12.106; Statler KD, 2006, J NEUROTRAUM, V23, P97, DOI 10.1089/neu.2006.23.97; Stefanec T, 2000, CHEST, V117, P841, DOI 10.1378/chest.117.3.841; Stratmann G, 2009, ANESTHESIOLOGY, V110, P834, DOI 10.1097/ALN.0b013e31819c463d; Venkataraman K, 2008, CIRC RES, V102, P669, DOI 10.1161/CIRCRESAHA.107.165845; Vessey DA, 2005, ANAL BIOCHEM, V337, P136, DOI 10.1016/j.ab.2004.10.032; Vessey DA, 2006, MED SCI MONITOR, V12, pBR318; Weber NC, 2008, ANESTHESIOLOGY, V108, P199, DOI 10.1097/01.anes.0000299441.32091.ed; WU J, 1995, J BIOL CHEM, V270, P11484, DOI 10.1074/jbc.270.19.11484; Zhou YL, 2010, STROKE, V41, P1521, DOI 10.1161/STROKEAHA.110.583757	45	17	18	1	22	MDPI AG	BASEL	POSTFACH, CH-4005 BASEL, SWITZERLAND	1661-6596			INT J MOL SCI	Int. J. Mol. Sci.	JAN	2012	13	1					977	993		10.3390/ijms13010977			17	Biochemistry & Molecular Biology; Chemistry, Multidisciplinary	Biochemistry & Molecular Biology; Chemistry	890ZE	WOS:000300184800064	22312298	DOAJ Gold, Green Published			2021-06-18	
J	Carlson, KF; Meis, LA; Jensen, AC; Simon, AB; Gravely, AA; Taylor, BC; Bangerter, A; Schaaf, KW; Griffin, JM				Carlson, Kathleen F.; Meis, Laura A.; Jensen, Agnes C.; Simon, Alisha Baines; Gravely, Amy A.; Taylor, Brent C.; Bangerter, Ann; Schaaf, Katy Wilder; Griffin, Joan M.			Caregiver Reports of Subsequent Injuries Among Veterans With Traumatic Brain Injury After Discharge From Inpatient Polytrauma Rehabilitation Programs	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						caregivers; health services; rehabilitation; traumatic brain injury; trauma; injury	RISK; MORTALITY; BEHAVIOR; DEATH; INDIVIDUALS; CHILDREN; OUTCOMES; BURDEN; CARE	Objective: We examined prevalence of, and potential risk factors for, nonfatal injuries among Veterans with traumatic brain injury (TBI) postdischarge from Veterans Affairs inpatient polytrauma rehabilitation programs. Methods: We surveyed caregivers of patients who had military service anytime from 2001 to 2009, sustained polytrauma including TBI, received Veterans Affairs inpatient care from 2001 to 2009, were discharged at least 3 months before the study, and were alive when the study was fielded about caregiver and patient health, including patients' medically treated "accidents/new injuries" since discharge. We examined prevalence and source(s) of subsequent injuries and estimated patients' injury risk in reference to hypothesized risk factors. Odds ratios and 95% confidence intervals were calculated using multivariate logistic regression. Results: Caregivers reported that nearly one-third (32%) of patients incurred medically treated injuries after discharge; most were associated with falls (49%) and motor vehicles (37%). Odds of subsequent injury were associated with select demographics, initial injury characteristics, and postdischarge health and functioning. Characteristics of caregivers, including physical and mental health, were also associated with patients' odds of subsequent injury. Conclusions: A significant number of caregivers reported subsequent nonfatal injuries among patients treated for TBI/polytrauma in inpatient rehabilitation settings. Enhanced injury prevention efforts may be beneficial for this population.	[Carlson, Kathleen F.] Portland VA Med Ctr, Portland Ctr Study Chron Comorbid Mental & Phys D, Portland, OR USA; [Carlson, Kathleen F.] Oregon Hlth & Sci Univ, Dept Publ Hlth & Prevent Med, Portland, OR 97201 USA; [Meis, Laura A.; Jensen, Agnes C.; Simon, Alisha Baines; Gravely, Amy A.; Taylor, Brent C.; Bangerter, Ann; Griffin, Joan M.] Minneapolis VA Hlth Care Syst, Ctr Chron Dis Outcomes Res, Minneapolis, MN USA; [Taylor, Brent C.] Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN USA; [Meis, Laura A.; Taylor, Brent C.; Griffin, Joan M.] Univ Minnesota, Sch Med, Dept Med, Minneapolis, MN 55455 USA; [Schaaf, Katy Wilder] Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Sch Med, Neuropsychol & Rehabil Psychol Serv, Richmond, VA USA; [Schaaf, Katy Wilder] Hunter Holmes McGuire VA Med Ctr, Richmond, VA USA	Carlson, KF (corresponding author), Portland VA Med Ctr R&D 66, Portland Ctr Study Chron Comorbid Mental & Phys D, 3715 SW US Vet Hosp Rd, Portland, OR 97239 USA.	kathleen.carlson@va.gov	Taylor, Brent C/A-8069-2009	Taylor, Brent C/0000-0002-2140-8377	Veterans Health Administration Health Services Research and Development ServiceUS Department of Veterans Affairs [SDR 07-044, CDA 08-025]	This work was supported by grants from the Veterans Health Administration Health Services Research and Development Service (SDR 07-044; CDA 08-025). The opinions expressed in this article are those of the authors and do not necessarily reflect the position or policy of the Department of Veterans Affairs or the United States government.	Adams Patricia F, 2009, Vital Health Stat 10, P1; Anderson MI, 2009, BRAIN INJURY, V23, P931, DOI 10.3109/02699050903302336; Brophy M, 2008, EPIDEMIOLOGY, V19, P465, DOI 10.1097/EDE.0b013e31816932ba; Brotherton SS, 2007, SPINAL CORD, V45, P37, DOI 10.1038/sj.sc.3101909; Carlson KF, 2011, INJURY PREV, V17, P343, DOI 10.1136/ip.2010.030213; Carlson KF, 2005, AM J IND MED, V47, P254, DOI 10.1002/ajim.20135; Carruth A K, 2001, J Am Med Womens Assoc (1972), V56, P15; Centers for Disease Control and Prevention , 2008, BEH RISK FACT SURV S; Chen JR, 2007, PEDIATRICS, V119, pE958, DOI 10.1542/peds.2006-1605; Christoffel T, 2006, INJURY PREVENTION PU; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Dischinger PC, 2001, J TRAUMA, V51, P877, DOI 10.1097/00005373-200111000-00009; Friedemann-Sanchez G, 2008, REHABIL NURS, V33, P206, DOI 10.1002/j.2048-7940.2008.tb00229.x; Gentilello LM, 1999, ANN SURG, V230, P473, DOI 10.1097/00000658-199910000-00003; Greenland S, 1999, EPIDEMIOLOGY, V10, P37, DOI 10.1097/00001648-199901000-00008; Griffin JM, J HEAD TRAUMA REHABI; Hall C, 2010, J GEN INTERN MED, V25, P18, DOI 10.1007/s11606-009-1125-3; Harrison-Felix C, 2006, J HEAD TRAUMA REHAB, V21, P22, DOI 10.1097/00001199-200601000-00003; Harrison-Felix CL, 2009, ARCH PHYS MED REHAB, V90, P1506, DOI 10.1016/j.apmr.2009.03.015; Hernan MA, 2002, AM J EPIDEMIOL, V155, P176, DOI 10.1093/aje/155.2.176; Hoffer Michael E, 2007, Int Tinnitus J, V13, P69; Johnston BD, 2002, PEDIATRICS, V110, P267, DOI 10.1542/peds.110.2.267; KATZ S, 1963, JAMA-J AM MED ASSOC, V185, P914, DOI 10.1001/jama.1963.03060120024016; Kazis LE, 2006, VETERANS RAND 12 ITE; Krause JS, 2010, ARCH PHYS MED REHAB, V91, P1741, DOI 10.1016/j.apmr.2010.07.219; Krause JS, 2004, ARCH PHYS MED REHAB, V85, P1503, DOI 10.1016/j.apmr.2004.01.017; Krause JS, 2000, ARCH PHYS MED REHAB, V81, P924, DOI 10.1053/apmr.2000.5618; LAWTON MP, 1969, GERONTOLOGIST, V9, P9, DOI 10.1093/geront/9.1.9; Marsh NV, 1998, BRAIN INJURY, V12, P225, DOI 10.1080/026990598122700; National Alliance for Caregiving AARP, 2010, CAR US 2009; Pentland B, 2005, J NEUROL NEUROSUR PS, V76, P395, DOI 10.1136/jnnp.2004.037861; Preece MHW, 2011, J NEUROL NEUROSUR PS, V82, P447, DOI 10.1136/jnnp.2010.215228; Probst C, 2009, J TRAUMA, V66, P1212, DOI 10.1097/TA.0b013e318197b97c; Sayer NA, 2008, ARCH PHYS MED REHAB, V89, P163, DOI 10.1016/j.apmr.2007.05.025; Schanke AK, 2008, J REHABIL MED, V40, P733, DOI 10.2340/16501977-0256; Schwebel DC, 2010, J PEDIATR PSYCHOL, V35, P45, DOI 10.1093/jpepsy/jsp033; Shavelle RM, 2001, AM J PHYS MED REHAB, V80, P510, DOI 10.1097/00002060-200107000-00009; Sigford BJ, 2008, ARCH PHYS MED REHAB, V89, P160, DOI 10.1016/j.apmr.2007.09.015; Simpson G, 2002, PSYCHOL MED, V32, P687, DOI 10.1017/S0033291702005561; Sohn Min-Woong, 2006, Popul Health Metr, V4, P2, DOI 10.1186/1478-7954-4-2; Teasdale TW, 2001, J NEUROL NEUROSUR PS, V71, P436, DOI 10.1136/jnnp.71.4.436; van Ryn M, 2011, PSYCHO-ONCOLOGY, V20, P44, DOI 10.1002/pon.1703; Vangel SJ, 2011, J HEAD TRAUMA REHAB, V26, P20, DOI 10.1097/HTR.0b013e318204a70d; Ventura T, 2010, ARCH PHYS MED REHAB, V91, P20, DOI 10.1016/j.apmr.2009.08.151; Vladutiu CJ, 2008, INJURY PREV, V14, P302, DOI 10.1136/ip.2008.018838; WAXWEILER RJ, 1995, J NEUROTRAUM, V12, P509, DOI 10.1089/neu.1995.12.509; Weightman MM, 2010, J HEAD TRAUMA REHAB, V25, P206, DOI 10.1097/HTR.0b013e3181dc82d3; WEISBESKI D, 1989, J TRAUMA, V29, P940, DOI 10.1097/00005373-198907000-00006; Williams GP, 2010, J HEAD TRAUMA REHAB, V25, P164, DOI 10.1097/HTR.0b013e3181dc120b; Wright J, 2000, INTRO FIM TM	50	17	17	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JAN-FEB	2012	27	1					14	25		10.1097/HTR.0b013e318236bd86			12	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	879JV	WOS:000299326400002	22218200				2021-06-18	
J	Chiu, CD; Chen, TY; Chin, LT; Shen, CC; Huo, J; Ma, SY; Chen, HM; Chu, CH				Chiu, Cheng-Di; Chen, Tze-Yung; Chin, Li-Te; Shen, Chiung-Chyi; Huo, Jie; Ma, Shin-Yi; Chen, Han-Min; Chu, Chi-Hong			Investigation of the effect of hyperglycemia on intracerebral hemorrhage by proteomic approaches	PROTEOMICS			English	Article						Albumin; Animal proteomics; Hematoma; Intracerebral hemorrhage; Rats	TRAUMATIC BRAIN-INJURY; SERUM-ALBUMIN; ENDOTHELIAL-CELLS; EXPERIMENTAL STROKE; CEREBRAL-ISCHEMIA; HYPERBARIC-OXYGEN; GENE-EXPRESSION; IN-VITRO; APOPTOSIS; RAT	Intracerebral hemorrhage (ICH) is associated with high mortality and disability, and hyperglycemia worsens the clinical and neurological outcomes of patients with ICH. In this study, we utilized proteomic approaches to investigate the role of hyperglycemia in ICH. Hyperglycemia was induced by intraperitoneal injection of streptozotocin (STZ) in adult SpragueDawley male rats; ICH was induced by stereotaxic infusion of collagenase/heparin into the right striatum. It was observed that the size of induced hemorrhage was significantly larger in the hyperglycemic group (n=6 in each group). On the first day after ICH, an apparent decrease in the bilateral grasp was also observed for the lesioned hyperglycemic rats compared with normoglycemic ones. When employing 2-DE and MS to examine the proteomes of perihematomal and control regions in individual hyperglycemic and normoglycemic rats, eight differentially expressed protein targets were identified. Most noteworthy, in response to ICH significant increase of albumin was ubiquitously observed in the brains of normoglycemic rats but not in the brains of hyperglycemic rats. Coincidentally, more significant neuronal apoptosis were found in the perihematomal regions of hyperglycemic rats. These observations described suggest the protection role of albumin in acute stage of ICH, which may be dependent on different blood sugar levels.	[Huo, Jie; Chen, Han-Min] Catholic Fu Jen Univ, Dept Life Sci, Taipei, Taiwan; [Chiu, Cheng-Di; Chin, Li-Te; Ma, Shin-Yi; Chu, Chi-Hong] Natl Def Med Ctr, Grad Inst Med Sci, Taipei, Taiwan; [Chiu, Cheng-Di; Chen, Tze-Yung] Taichung Tzu Chi Gen Hosp, Dept Neurosurg, Taichung, Taiwan; [Chiu, Cheng-Di] Taichung Hosp, Dept Neurosurg, Taichung, Taiwan; [Chin, Li-Te] Natl Chiayi Univ, Dept Microbiol Immunol & Biopharmaceut, Chiayi, Taiwan; [Shen, Chiung-Chyi] Taichung Vet Gen Hosp, Dept Neurosurg, Taichung, Taiwan; [Ma, Shin-Yi] Tri Serv Gen Hosp, Natl Def Med Ctr, Dept Neurosurg, Taipei, Taiwan; [Chen, Han-Min] Catholic Fu Jen Univ, Biomed & Photon Interdisciplinary Res Ctr, Taipei, Taiwan; [Chu, Chi-Hong] Tri Serv Gen Hosp, Natl Def Med Ctr, Dept Surg, Taipei, Taiwan	Chen, HM (corresponding author), Catholic Fu Jen Univ, Dept Life Sci, 510 Zhongzheng Rd, New Taipei City 24205, Taiwan.	056489@mail.fju.edu.tw; hong18002@hotmail.com		Chiu, Cheng-Di/0000-0003-0369-0935			AbuLebdeh HS, 1996, BAILLIERE CLIN ENDOC, V10, P589, DOI 10.1016/S0950-351X(96)80741-5; Arboix A, 2002, ACTA NEUROL SCAND, V105, P282, DOI 10.1034/j.1600-0404.2002.1o170.x; Ardizzone TD, 2004, STROKE, V35, P2587, DOI 10.1161/01.STR.0000143451.14228.ff; Aronowski J, 2005, NEUROL RES, V27, P268, DOI 10.1179/016164105X25225; Bakris G, 2003, J HUM HYPERTENS, V17, P7, DOI 10.1038/sj.jhh.1001444; BANKEY PE, 1990, J TRAUMA, V30, P1181, DOI 10.1097/00005373-199010000-00001; Belayev L, 2005, STROKE, V36, P326, DOI 10.1161/01.STR.0000152949.31366.3d; Belayev L, 2002, STROKE, V33, P1077, DOI 10.1161/hs0402.105555; Belayev L, 2001, STROKE, V32, P553, DOI 10.1161/01.STR.32.2.553; Bellin C, 2006, HORM METAB RES, V38, P732, DOI 10.1055/s-2006-955084; Bernard F, 2008, J TRAUMA, V64, P872, DOI 10.1097/TA.0b013e31803428cc; Bruno A, 2010, CURR TREAT OPTION NE, V12, P492, DOI 10.1007/s11940-010-0093-6; Busik JV, 2008, DIABETES, V57, P1952, DOI 10.2337/db07-1520; Callaghan MJ, 2005, ANTIOXID REDOX SIGN, V7, P1476, DOI 10.1089/ars.2005.7.1476; Carmichael ST, 2008, J CEREBR BLOOD F MET, V28, P1860, DOI 10.1038/jcbfm.2008.77; Chin LT, 2010, J PROTEOME RES, V9, P3091, DOI 10.1021/pr100005u; Ciccone A, 2008, NEUROL SCI, V29, pS256, DOI 10.1007/s10072-008-0955-9; Cook NL, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-7; DelBigio MR, 1996, STROKE, V27, P2312, DOI 10.1161/01.STR.27.12.2312; Ergul A, 2009, VASC PHARMACOL, V51, P44, DOI 10.1016/j.vph.2009.02.004; Faraco G, 2007, J NEUROCHEM, V103, P590, DOI 10.1111/j.1471-4159.2007.04788.x; Ferro Jose M, 2006, Cerebrovasc Dis, V21 Suppl 2, P127, DOI 10.1159/000091712; FIORAVANTI M, 1987, RES CLIN LAB, V17, P171; Godoy DA, 2008, NEUROCRIT CARE, V9, P217, DOI 10.1007/s12028-008-9063-1; HALLIWELL B, 1988, BIOCHEM PHARMACOL, V37, P569, DOI 10.1016/0006-2952(88)90126-8; Hankins J, 2006, J INFUS MURS, V29, P260, DOI 10.1097/00129804-200609000-00004; Huang FP, 2002, J NEUROSURG, V96, P287, DOI 10.3171/jns.2002.96.2.0287; Keep RF, 2008, ACT NEUR S, V105, P73; Lee Loretta T, 2009, Crit Care Nurs Clin North Am, V21, P507, DOI 10.1016/j.ccell.2009.08.002; Levetan Claresa S, 2004, Endocr Pract, V10 Suppl 2, P34; Lin CY, 2009, PROTEOMICS, V9, P696, DOI 10.1002/pmic.200700470; Lundsgaard-Hansen P, 1986, Curr Stud Hematol Blood Transfus, P1; MacManus JP, 2000, J NEUROTRAUM, V17, P899, DOI 10.1089/neu.2000.17.899; NAHON JL, 1988, J BIOL CHEM, V263, P11436; Nakagami H, 2005, CURR DIABETES REV, V1, P59, DOI 10.2174/1573399052952550; Panagos PD, 2002, EMERG MED CLIN N AM, V20, P631, DOI 10.1016/S0733-8627(02)00015-9; Paolino Alison S, 2005, J Neurosci Nurs, V37, P130; Pasternak JJ, 2008, MAYO CLIN PROC, V83, P406, DOI 10.4065/83.4.406; Peeling J, 2001, EXP NEUROL, V167, P341, DOI 10.1006/exnr.2000.7564; Pineda JA, 2004, BRAIN PATHOL, V14, P202, DOI 10.1111/j.1750-3639.2004.tb00054.x; Power C, 2003, ANN NEUROL, V53, P731, DOI 10.1002/ana.10553; Qin Z, 2008, ACTA NEUROCHIR SUPPL, V105, P113; Qin ZY, 2007, STROKE, V38, P1362, DOI 10.1161/01.STR.0000259660.62865.eb; Roche M, 2008, FEBS LETT, V582, P1783, DOI 10.1016/j.febslet.2008.04.057; Schiller M, 2008, APOPTOSIS, V13, P319, DOI 10.1007/s10495-007-0168-3; Shamay A, 2005, J DAIRY SCI, V88, P569, DOI 10.3168/jds.S0022-0302(05)72719-3; Shen CC, 2010, CURR NEUROVASC RES, V7, P6, DOI 10.2174/156720210790820208; Simpson R. J., 2003, QUANTIFYING PROTEIN; Song EC, 2003, STROKE, V34, P2215, DOI 10.1161/01.STR.0000088060.83709.2C; Stead LG, 2010, NEUROCRIT CARE, V13, P67, DOI 10.1007/s12028-010-9355-0; Syroid DE, 2000, J NEUROSCI, V20, P5741; TUCKER VL, 1995, SHOCK, V3, P189, DOI 10.1097/00024382-199503000-00006; Tuvemo T, 1997, ACTA PAEDIATR, V86, P7; Vannucci SJ, 2001, J CEREBR BLOOD F MET, V21, P52, DOI 10.1097/00004647-200101000-00007; Wagner KR, 2003, J CEREBR BLOOD F MET, V23, P629, DOI 10.1097/01.WCB.0000073905.87928.6D; Wu JM, 2002, BRAIN RES, V953, P45, DOI 10.1016/S0006-8993(02)03268-7; Yano M, 2004, REDOX REP, V9, P111, DOI 10.1179/135100004225004779; Yao DC, 2010, DIABETES, V59, P249, DOI 10.2337/db09-0801; Zhang Y, 2008, J ZHEJIANG UNIV-SC B, V9, P871, DOI 10.1631/jzus.B0820130; Zoellner H, 1999, MICROVASC RES, V57, P162, DOI 10.1006/mvre.1998.2126; Zoellner H, 1996, J CELL SCI, V109, P2571	61	17	17	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1615-9853	1615-9861		PROTEOMICS	Proteomics	JAN	2012	12	1					113	123		10.1002/pmic.201100256			11	Biochemical Research Methods; Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	872WL	WOS:000298841000014	22065606				2021-06-18	
J	Davis, JJ; Millis, SR; Axelrod, BN				Davis, Jeremy J.; Millis, Scott R.; Axelrod, Bradley N.			Derivation of an Embedded Rey Auditory Verbal Learning Test Performance Validity Indicator	CLINICAL NEUROPSYCHOLOGIST			English	Article						Performance validity; Effort assessment; Forensic neuropsychology; Rey Auditory Verbal Learning Test	INCOMPLETE EFFORT; MODEL SELECTION; RESPONSE BIAS; HEAD-INJURY; DIGIT SPAN; SPECIFICITY; SENSITIVITY; SCORES; NEUROPSYCHOLOGISTS; NAN	This study derived an embedded performance validity indicator for the Rey Auditory Verbal Learning Test (AVLT) using an archival dataset. Participants aged 20 to 65 (N = 167) who reported traumatic brain injury and completed at least two performance validity tests were included. The group who passed all performance validity measures (n = 68) demonstrated higher scores on all AVLT trials than the group who failed two or more validity indicators (n = 62). Bayesian model averaging was used to identify the optimal combination of AVLT variables for group discrimination; Total Learning and Recognition raw scores were selected. Logistic regression using these variables showed excellent discrimination with an area under the curve of .85. The resulting AVLT performance validity index demonstrated sensitivity of .55 with specificity of .91. Further study of this index is warranted and cross-validation is recommended prior to clinical use.	[Davis, Jeremy J.] Univ Utah, Sch Med, Div Phys Med & Rehabil, Salt Lake City, UT 84132 USA; [Millis, Scott R.] Wayne State Univ, Sch Med, Detroit, MI USA; [Axelrod, Bradley N.] Dept Vet Affairs Med Ctr, Detroit, MI USA	Davis, JJ (corresponding author), Univ Utah, Sch Med, Div Phys Med & Rehabil, 30 North 1900 East,1R55, Salt Lake City, UT 84132 USA.	jeremy.davis@hsc.utah.edu					Arnold G, 2005, CLIN NEUROPSYCHOL, V19, P105, DOI 10.1080/13854040490888567; Axelrod BN, 2006, CLIN NEUROPSYCHOL, V20, P513, DOI 10.1080/13854040590967117; Babikian T, 2006, CLIN NEUROPSYCHOL, V20, P145, DOI 10.1080/13854040590947362; Barrash J, 2004, J CLIN EXP NEUROPSYC, V26, P125, DOI 10.1076/jcen.26.1.125.23928; BERNARD LC, 1993, J CLIN PSYCHOL, V49, P45, DOI 10.1002/1097-4679(199301)49:1<45::AID-JCLP2270490107>3.0.CO;2-7; Bernard LC, 1996, ARCH CLIN NEUROPSYCH, V11, P231, DOI 10.1016/0887-6177(95)00025-9; Binder LM, 2003, J CLIN EXP NEUROPSYC, V25, P420, DOI 10.1076/jcen.25.3.420.13806; Boone KB, 2005, ARCH CLIN NEUROPSYCH, V20, P301, DOI 10.1016/j.acn.2004.08.001; Boone KB, 2009, CLIN NEUROPSYCHOL, V23, P729, DOI 10.1080/13854040802427803; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; Curtis KL, 2006, ASSESSMENT, V13, P46, DOI 10.1177/1073191105285210; Green P., 2002, GREENS WORD MEMORY T; Greiffenstein M.F., 1994, PSYCHOL ASSESSMENT, V6, P218, DOI [https://doi.org/10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; Griffin GAE, 1997, J CLIN PSYCHOL, V53, P757, DOI 10.1002/(SICI)1097-4679(199711)53:7<757::AID-JCLP14>3.0.CO;2-K; Harrell Frank E., 2001, REGRESSION MODELING; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Hoeting JA, 1999, STAT SCI, V14, P382, DOI 10.1214/ss/1009212519; Hosmer D. W., 2000, APPL LOGISTIC REGRES; Iverson GL, 1998, BRAIN INJURY, V12, P275, DOI 10.1080/026990598122575; Iverson GL, 2002, CLIN NEUROPSYCHOL, V16, P398, DOI 10.1076/clin.16.3.398.13861; Kashluba S, 2008, ARCH PHYS MED REHAB, V89, P904, DOI 10.1016/j.apmr.2007.12.029; Kay T., 1993, J HEAD TRAUMA REHABI, V8, P86, DOI [10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P410, DOI 10.1076/clin.17.3.410.18089; Larrabee GJ, 2008, CLIN NEUROPSYCHOL, V22, P666, DOI 10.1080/13854040701494987; Lezak M.D., 1983, NEUROPSYCHOLOGICAL A; Lu P. H., 2007, ASSESSMENT FEIGNED C, P128; Lu PH, 2003, CLIN NEUROPSYCHOL, V17, P426, DOI 10.1076/clin.17.3.426.18083; MADIGAN D, 1994, J AM STAT ASSOC, V89, P1535, DOI 10.2307/2291017; Meyers J E, 2001, Appl Neuropsychol, V8, P234, DOI 10.1207/S15324826AN0804_6; Meyers JE, 2011, ARCH CLIN NEUROPSYCH, V26, P8, DOI 10.1093/arclin/acq083; Millis S. R., 2002, J FORENSIC NEUROPSYC, V2, P147; Millis SR, 1995, PSYCHOL ASSESSMENT, V7, P463; Millis SR, 2001, J CLIN EXP NEUROPSYC, V23, P809, DOI 10.1076/jcen.23.6.809.1017; MILLIS SR, 1992, CLIN NEUROPSYCHOL, V6, P406; R Development Core Team, 2012, R LANG ENV STAT COMP; Rabin LA, 2005, ARCH CLIN NEUROPSYCH, V20, P33, DOI 10.1016/j.acn.2004.02.005; Raftery A, 2012, BMA BAYESIAN MODEL A; Schutte C., 2012, MILD TRAUMATIC BRAIN; Sharland MJ, 2007, ARCH CLIN NEUROPSYCH, V22, P213, DOI 10.1016/j.acn.2006.12.004; Suhr J. A., 2007, ASSESSMENT MALINGERE; Viallefont V, 2001, STAT MED, V20, P3215, DOI 10.1002/sim.976.abs; Wang DL, 2004, STAT MED, V23, P3451, DOI 10.1002/sim.1930; Wasserman L, 2000, J MATH PSYCHOL, V44, P92, DOI 10.1006/jmps.1999.1278; Wolfe PL, 2010, CLIN NEUROPSYCHOL, V24, P153, DOI 10.1080/13854040903107791	44	17	17	0	4	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.		2012	26	8					1397	1408		10.1080/13854046.2012.728627			12	Psychology, Clinical; Clinical Neurology; Psychology	Psychology; Neurosciences & Neurology	045LG	WOS:000311696700009	23075400				2021-06-18	
J	Hawley, CA				Hawley, Carol A.			Self-esteem in children after traumatic brain injury: An exploratory study	NEUROREHABILITATION			English	Article						Self-esteem; paediatrics; brain injury; stress	ACADEMIC-ACHIEVEMENT; BEHAVIOR; SCHOOL; DEPRESSION	Children with a traumatic brain injury (TBI) often have difficulties in adjusting to their injury and altered abilities, and may be at risk of low self-esteem and loss of confidence. However, few studies have examined self-esteem in this client group. The current study measured the self-esteem of a group of children who were, on average, two years post-TBI and compared this to their performance on other psychometric measures. Participants were 96 children with TBI and 31 peer controls, their parents and teachers. Self-esteem was measured using the Coopersmith Self-esteem Inventory (CSEI). CSEI scores were compared with performance on Wechsler Intelligence Scales (WISC-III), Hospital Anxiety and Depression Scale (HADS); Children's Memory Scale (CMS), Vineland Adaptive Behaviour Scales (VABS) and Parental Stress Index (PSI). Self-esteem was highly correlated with IQ; HADS anxiety and depression; and parental stress (p < 0.001). Children with TBI had significantly lower self-esteem than controls and population norms (p = 0.015). Many children with TBI demonstrate low self-esteem and this is closely linked with anxiety and depression. This may hamper academic performance and could lead to further psychosocial problems. It is recommended that self-esteem is routinely assessed after brain injury and rehabilitation strategies implemented to promote a sense of self-worth.	Univ Warwick, Warwick Med Sch, Div Mental Hlth & Wellbeing, Coventry CV4 7AL, W Midlands, England	Hawley, CA (corresponding author), Univ Warwick, Warwick Med Sch, Div Mental Hlth & Wellbeing, Coventry CV4 7AL, W Midlands, England.	c.a.hawley@warwick.ac.uk	Hawley, Carol/AAG-3830-2019				Abidin RR., 1995, PARENTING STRESS IND; Anderson VA, 2001, PEDIATR NEUROSURG, V34, P138, DOI 10.1159/000056009; Anderson V, 2009, BRAIN, V132, P45, DOI 10.1093/brain/awn293; Andrews TK, 1998, BRAIN INJURY, V12, P133, DOI 10.1080/026990598122755; Appleton R, 1998, MANAGEMENT BRAIN INJ; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; *BRIT SOC REH MED, 1998, REH TRAUM BRAIN INJ; Cobb J. C., 1998, CHILD STUDY J, V28, P291; COHEN B, 1997, CHILDRENS MEMORY SCA; Coopersmith S., 1967, ANTECEDENTS SELF EST; Coopersmith S., 1981, SELF ESTEEM INVENTOR; Eccles JS, 1999, FUTURE CHILD, V9, P30, DOI 10.2307/1602703; FELSON RB, 1989, J MARRIAGE FAM, V51, P727, DOI 10.2307/352171; GECAS V, 1986, J MARRIAGE FAM, V48, P37, DOI 10.2307/352226; Gillett J, 2004, NEUROREHABILITATION, V19, P207; Glia F., 2010, J CHILD FAM STUD, V19, P738; Harter S., 1999, CONSTRUCTION SELF DE; Hawley CA, 2004, BRAIN INJURY, V18, P645, DOI 10.1080/02699050310001646189; Hawley CA, 2004, ARCH DIS CHILD, V89, P136, DOI 10.1136/adc.2002.025577; Hawley CA, 2003, BRAIN INJURY, V17, P1, DOI 10.1080/0269905021000010096; Marsh HW, 2008, PERS SOC PSYCHOL B, V34, P542, DOI 10.1177/0146167207312313; MARSH HW, 1988, J EDUC PSYCHOL, V80, P366, DOI 10.1037/0022-0663.80.3.366; Meyer A., 1983, TOPICS LEARNIGN LEAR, V3, P59; Miller P.H., 2002, THEORIES DEV PSYCHOL; Nilsson KK, 2010, BIPOLAR DISORD, V12, P585, DOI 10.1111/j.1399-5618.2010.00856.x; OPENSHAW DK, 1984, J EARLY ADOLESC, V4, P259; Orth U, 2008, J PERS SOC PSYCHOL, V95, P695, DOI 10.1037/0022-3514.95.3.695; Ross CE, 2000, SOCIOL EDUC, V73, P270, DOI 10.2307/2673234; Sigelman C., 2003, LIFE SPAN HUMAN DEV; Sparrow S., 1984, VINELAND ADAPTIVE BE; Stanley PD, 1997, J ADOLESCENCE, V20, P219, DOI 10.1006/jado.1996.0079; Taylor LM, 2010, EDUC PSYCHOL-UK, V30, P191, DOI 10.1080/01443410903494478; Townsend P, 1986, INEQUALITIES HLTH NO; TREMBLAY RE, 1992, J CONSULT CLIN PSYCH, V60, P64, DOI 10.1037/0022-006X.60.1.64; Wechsler D., 1991, MANUAL WECHSLER INTE; Ylvisaker M., 1998, TRAUMATIC BRAIN INJU; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	37	17	17	0	19	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135			NEUROREHABILITATION	Neurorehabilitation		2012	30	3					173	181		10.3233/NRE-2012-0742			9	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	948CD	WOS:000304480300003	22635121				2021-06-18	
J	Hayes, JP; Morey, RA; Tupler, LA				Hayes, Jasmeet Pannu; Morey, Rajendra A.; Tupler, Larry A.			A case of frontal neuropsychological and neuroimaging signs following multiple primary-blast exposure	NEUROCASE			English	Article						Blast-induced neurotrauma; Closed-head injury; Diffusion-tensor imaging; Executive control; Explosive Ordnance Disposal Service; Fractional anisotropy; Primary blast; Traumatic brain injury; White matter	TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; VERBAL-LEARNING TEST; AXONAL INJURY; HEAD-INJURY; PERFORMANCE; SOLDIERS; CONCUSSION; DEFICITS; RISK	Blast-related traumatic brain injury (TBI) from the Afghanistan and Iraq wars represents a significant medical concern for troops and veterans. To better understand the consequences of primary-blast injury in humans, we present a case of a Marine exposed to multiple primary blasts during his 14-year military career. The neuropsychological profile of this formerly high-functioning veteran suggested primarily executive dysfunction. Diffusion-tensor imaging revealed white-matter pathology in long fiber tracks compared with a composite fractional-anisotropy template derived from a veteran reference control group without TBI. This study supports the existence of primary blast-induced neurotrauma in humans and introduces a neuroimaging technique with potential to discriminate multiple-blast TBI.	[Hayes, Jasmeet Pannu] VA Boston Healthcare Syst, Natl Ctr PTSD, Boston, MA 02130 USA; [Hayes, Jasmeet Pannu] Boston Univ, Sch Med, Dept Psychiat, Boston, MA 02118 USA; [Hayes, Jasmeet Pannu; Morey, Rajendra A.] Duke Univ, Duke UNC Brain Imaging & Anal Ctr, Durham, NC USA; [Hayes, Jasmeet Pannu; Morey, Rajendra A.; Tupler, Larry A.] Durham VA Med Ctr, Mental Illness Res Educ & Clin Ctr Postdeployment, Durham, NC USA; [Hayes, Jasmeet Pannu; Morey, Rajendra A.; Tupler, Larry A.] Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, Durham, NC USA	Hayes, JP (corresponding author), VA Boston Healthcare Syst, Natl Ctr PTSD 116B 2, 150 S Huntington Ave, Boston, MA 02130 USA.	jphayes@bu.edu	Morey, Rajendra A/P-3079-2018; Hayes, Jasmeet/AAN-4150-2020	Morey, Rajendra A/0000-0002-6517-6969; Hayes, Jasmeet/0000-0002-5157-0666	 [NIMH K23 MH084013];  [K23 MH073091];  [VHA 101RX000389];  [VISN6 MIRECC]; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [K23MH084013, K23MH073091] Funding Source: NIH RePORTER; Veterans AffairsUS Department of Veterans Affairs [I01RX000389] Funding Source: NIH RePORTER	We would like to thank J.G. for sharing his story with us, Elizabeth Selgrade and Gregory McCarthy for helpful discussions regarding the project, and Christopher Lascola for providing a neuroradiology consult. We would also like to acknowledge the contributions of the Mid-Atlantic Mental Illness Research, Education, and Clinical Center workgroup (members include Jean C. Beckham, Patrick S. Calhoun, Rita M. Davison, A. Meade Eggleston, John A. Fairbank, Kimberly T. Green, Angela C. Kirby, Harold Kudler, Jeffrey M. Hoerle, Christine E. Marx, Scott D. Moore, Victoria Payne, Mary C. Pender, Jennifer L. Strauss, Kristy K. Straits-Troster, and Richard D. Weiner). This work was supported by grants NIMH K23 MH084013 and K23 MH073091, VHA 101RX000389, and the VISN6 MIRECC. The views expressed herein are those of the authors and do not necessarily reflect the views of the Department of Veterans Affairs.	Andrews-Hanna JR, 2007, NEURON, V56, P924, DOI 10.1016/j.neuron.2007.10.038; Armonda RA, 2006, NEUROSURGERY, V59, P1215, DOI 10.1227/01.NEU.0000249190.46033.94; Bauman RA, 2009, J NEUROTRAUM, V26, P841, DOI 10.1089/neu.2009-0898; Belanger HG, 2009, J INT NEUROPSYCH SOC, V15, P1, DOI 10.1017/S1355617708090036; Benzinger TLS, 2009, J NEUROTRAUM, V26, P2127, DOI 10.1089/neu.2009-0885; Bhattacharjee Y, 2008, SCIENCE, V319, P406, DOI 10.1126/science.319.5862.406; Bigler ED, 2010, NEUROLOGY, V74, P626, DOI 10.1212/WNL.0b013e3181d3e43a; Brenner LA, 2010, NEUROPSYCHOLOGY, V24, P160, DOI 10.1037/a0017966; Brewin CR, 2007, J ABNORM PSYCHOL, V116, P448, DOI 10.1037/0021-843X.116.3.448; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; Cernak I, 2001, BRAIN INJURY, V15, P593, DOI 10.1080/02699050010009559; Cernak I, 2010, J CEREBR BLOOD F MET, V30, P255, DOI 10.1038/jcbfm.2009.203; Champion HR, 2009, J TRAUMA, V66, P1468, DOI 10.1097/TA.0b013e3181a27e7f; Chappell MH, 2008, MAGN RESON IMAGING, V26, P1398, DOI 10.1016/j.mri.2008.04.004; Chen YC, 2009, J NEUROTRAUM, V26, P861, DOI 10.1089/neu.2008.0645; Clausen H, 2005, BRIT J SPORT MED, V39, P661, DOI 10.1136/bjsm.2004.017046; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; CROSSON B, 1988, J CLIN EXP NEUROPSYC, V10, P754, DOI 10.1080/01688638808402812; De Beaumont L, 2009, BRAIN, V132, P695, DOI 10.1093/brain/awn347; de la Plata CDM, 2011, ARCH NEUROL-CHICAGO, V68, P74, DOI 10.1001/archneurol.2010.342; Dedert EA, 2009, J PSYCHIATR RES, V43, P830, DOI 10.1016/j.jpsychires.2009.01.004; DeWitt DS, 2009, J NEUROTRAUM, V26, P877, DOI 10.1089/neu.2007.0439; Di Russo F, 2010, PSYCHOPHYSIOLOGY, V47, P425, DOI 10.1111/j.1469-8986.2009.00950.x; DREW RH, 1986, J CLIN PSYCHOL, V42, P520, DOI 10.1002/1097-4679(198605)42:3<520::AID-JCLP2270420319>3.0.CO;2-6; Elder GA, 2009, MT SINAI J MED, V76, P111, DOI 10.1002/msj.20098; Finkel MF, 2006, J NEUROL SCI, V249, P63, DOI 10.1016/j.jns.2006.06.005; Fleminger S, 2003, J NEUROL NEUROSUR PS, V74, P857, DOI 10.1136/jnnp.74.7.857; Gaylord KM, 2008, J TRAUMA, V64, pS200, DOI 10.1097/TA.0b013e318160ba42; Gondusky JS, 2005, MIL MED, V170, P546, DOI 10.7205/MILMED.170.6.546; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Hartikainen KM, 2010, J CLIN EXP NEUROPSYC, V32, P767, DOI 10.1080/13803390903521000; Hogan J., 1985, PSYCHOL PHYS PERFORM; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hurley RA, 2004, J NEUROPSYCH CLIN N, V16, P1, DOI 10.1176/appi.neuropsych.16.1.1; Kinnunen K., 2010, BRAIN; Kizilbash AH, 2002, ARCH CLIN NEUROPSYCH, V17, P57, DOI 10.1016/S0887-6177(00)00101-3; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Lew HL, 2005, AM J PHYS MED REHAB, V84, P393, DOI 10.1097/01.phm.0000163703.91647.a7; Ling G, 2009, J NEUROTRAUM, V26, P815, DOI 10.1089/neu.2007.0484; Lipton ML, 2009, RADIOLOGY, V252, P816, DOI 10.1148/radiol.2523081584; Madrid R., 1992, INN APPL ART INT SAN; Martin EM, 2008, AM J NURS, V108, P40, DOI 10.1097/01.NAJ.0000315260.92070.3f; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; MCLATCHIE G, 1987, J NEUROL NEUROSUR PS, V50, P96, DOI 10.1136/jnnp.50.1.96; Moss WC, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.108702; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Omalu Bennet I, 2010, J Forensic Nurs, V6, P40, DOI 10.1111/j.1939-3938.2009.01064.x; POLLOCK BE, 1995, NEUROSURGERY, V36, P215, DOI 10.1227/00006123-199501000-00036; Polusny MA, 2011, ARCH GEN PSYCHIAT, V68, P79, DOI 10.1001/archgenpsychiatry.2010.172; POVLISHOCK JT, 1993, ANN EMERG MED, V22, P980, DOI 10.1016/S0196-0644(05)82738-6; Power JD, 2010, NEURON, V67, P735, DOI 10.1016/j.neuron.2010.08.017; Rosso SM, 2003, J NEUROL NEUROSUR PS, V74, P1574, DOI 10.1136/jnnp.74.11.1574; Saljo A, 2000, J NEUROTRAUM, V17, P719, DOI 10.1089/089771500415454; Stuhmiller J, 1991, TXB MILITARY MED CON; Sweet JJ, 2000, ARCH CLIN NEUROPSYCH, V15, P105, DOI 10.1016/S0887-6177(98)00153-X; Taber KH, 2006, J NEUROPSYCH CLIN N, V18, P141, DOI 10.1176/appi.neuropsych.18.2.141; Tanielian T, 2008, INVISIBLE WOUNDS WAR; Vanden Brook T, 2009, US TODAY; Warden DL, 2009, NEUROIMAGE, V47, pT152, DOI 10.1016/j.neuroimage.2009.01.060; Wiegner S, 1999, J CLIN EXP NEUROPSYC, V21, P159, DOI 10.1076/jcen.21.2.159.925; Wightman JM, 2001, ANN EMERG MED, V37, P664, DOI 10.1067/mem.2001.114906; Yilmaz S, 2007, AM J EMERG MED, V25, P97, DOI 10.1016/j.ajem.2006.04.014; Yuen TJ, 2009, J NEUROSCI RES, V87, P3620, DOI 10.1002/jnr.22161; Zhang L, 2006, AM J NEURORADIOL, V27, P2000; Zoroya G, 2010, US TODAY	65	17	17	0	9	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1355-4794	1465-3656		NEUROCASE	Neurocase		2012	18	3					258	269		10.1080/13554794.2011.588181			12	Clinical Neurology; Psychiatry; Psychology	Neurosciences & Neurology; Psychiatry; Psychology	936BH	WOS:000303565400009	21879996	Green Accepted			2021-06-18	
J	Kenardy, J; Le Brocque, R; Hendrikz, J; Iselin, G; Anderson, V; McKinlay, L				Kenardy, Justin; Le Brocque, Robyne; Hendrikz, Joan; Iselin, Greg; Anderson, Vicki; McKinlay, Lynne			Impact of Posttraumatic Stress Disorder and Injury Severity on Recovery in Children with Traumatic Brain Injury	JOURNAL OF CLINICAL CHILD AND ADOLESCENT PSYCHOLOGY			English	Article							QUALITY-OF-LIFE; EXECUTIVE FUNCTION; HEALTH; ADOLESCENTS; HOSPITALIZATION; PERFORMANCE; ADMISSION; SYMPTOMS; MEDIATOR; YOUTH	The adverse impact on recovery of posttraumatic stress disorder (PTSD) in mild traumatic brain injury (TBI) has been demonstrated in returned veterans. The study assessed this effect in children's health outcomes following TBI and extended previous work by including a full range of TBI severity, and improved assessment of PTSD within a longitudinal design. There were 205 children and adolescents (6 to 15 years of age) who experienced a TBI that were assessed at 2, 3, 6, 12, and 18 months following the TBI. Severity of TBI was classified as mild, moderate, or severe. After controlling for the impact of the severity of TBI, premorbid behavioral and emotional problems and executive function, children with TBI and PTSD did not experience as much psychosocial recovery as those without PTSD. Furthermore the level of psychosocial function was no better than that experienced by children with a severe TBI. In contrast, severe TBI was predictive of a poorer physical recovery in the first 6 months, after which recovery was equivalent across all severity levels.	[Kenardy, Justin; Le Brocque, Robyne; Hendrikz, Joan; Iselin, Greg] Univ Queensland, Ctr Natl Res Disabil & Rehabil Med, Brisbane, Qld 4029, Australia; [McKinlay, Lynne] Royal Childrens Hosp, Queensland Paediat Rehabil Serv, Melbourne, Vic, Australia	Kenardy, J (corresponding author), Univ Queensland, Sch Med, Ctr Natl Res Disabil & Rehabil Med, Royal Brisbane & Womens Hosp, Edith Cavell Bldg, Brisbane, Qld 4029, Australia.	j.kenardy@uq.edu.au	Kenardy, Justin/F-2085-2010; Le Brocque, Robyne/F-4848-2010; Kenardy, Justin A/H-6603-2014	Le Brocque, Robyne/0000-0002-4574-1254; Kenardy, Justin A/0000-0001-9475-8450; McKinlay, Lynne/0000-0002-6677-0628			Aaron J, 1999, J PEDIATR PSYCHOL, V24, P335, DOI 10.1093/jpepsy/24.4.335; Achenbach TM, 2001, MANUAL ASEBA SCH AGE; Aitken ME, 2002, PEDIATRICS, V110, P337, DOI 10.1542/peds.110.2.337; Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Anderson V. A., DISABILITY IN PRESS; Anderson VA, 2005, J NEUROL NEUROSUR PS, V76, P401, DOI 10.1136/jnnp.2003.019174; Apa Pesidential Task Force, 2006, AM PSYCHOL, V61, P271, DOI 10.1037/0003-066X.61.4.271; Bryant RA, 2001, CLIN PSYCHOL REV, V21, P931; Carrion VG, 2007, PEDIATRICS, V119, P509, DOI 10.1542/peds.2006-2028; Carrion VG, 2010, J PEDIATR PSYCHOL, V35, P559, DOI 10.1093/jpepsy/jsp112; *CDCP, 2000, TRAUM BRAIN INJ US A; COSTER WJ, 1994, AM J OCCUP THER, V48, P211, DOI 10.5014/ajot.48.3.211; Daviss WB, 2000, J AM ACAD CHILD PSY, V39, P576, DOI 10.1097/00004583-200005000-00011; De Bellis MD, 1999, BIOL PSYCHIAT, V45, P1271, DOI 10.1016/S0006-3223(99)00045-1; De Young MC, 2007, J TRAUMA STRESS, V20, P751, DOI 10.1002/jts.20235; Erickson SJ, 2010, DEV NEUROREHABIL, V13, P175, DOI 10.3109/17518420903479867; FAY GC, 1994, ARCH PHYS MED REHAB, V75, P733; Fay TB, 2009, NEUROPSYCHOLOGY, V23, P271, DOI 10.1037/a0014936; Friedman Matthew J., 1995, P507; Ganesalingam K, 2007, J INT NEUROPSYCH SOC, V13, P298, DOI 10.1017/S1355617707070324; Gioia G. A., 2000, BRIEF BEHAV RATING I; Greenham M, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00022; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Horneman G, 2005, INT J REHABIL RES, V28, P245, DOI 10.1097/00004356-200509000-00007; Iselin G, 2010, J ANXIETY DISORD, V24, P774, DOI 10.1016/j.janxdis.2010.05.011; JAFFE KM, 1995, ARCH PHYS MED REHAB, V76, P17, DOI 10.1016/S0003-9993(95)80037-9; Kenardy J, 2010, BMC PSYCHIATRY, V10, DOI 10.1186/1471-244X-10-92; Kenardy JA, 2006, PEDIATRICS, V118, P1002, DOI 10.1542/peds.2006-0406; KRIEL RL, 1989, PEDIATR NEUROL, V5, P296, DOI 10.1016/0887-8994(89)90021-0; Landgraf JM, 1996, CHILD HLTH QUESTIONN, V1st; McCarthy ML, 2006, ARCH PEDIAT ADOL MED, V160, P252, DOI 10.1001/archpedi.160.3.252; MCEWEN BS, 1993, ARCH INTERN MED, V153, P2093, DOI 10.1001/archinte.153.18.2093; McEwen BS, 1998, NEW ENGL J MED, V338, P171, DOI 10.1056/NEJM199801153380307; Murray BL, 2008, J PEDIATR PSYCHOL, V33, P435, DOI 10.1093/jpepsy/jsm078; Muscara F, 2008, DEV NEUROPSYCHOL, V33, P623, DOI 10.1080/87565640802171162; Muscara F, 2008, J NEUROPSYCHOL, V2, P445, DOI 10.1348/174866407X250820; Nader K., 1996, CLIN ADMINISTERED PT; Olsson KA, 2008, J ANXIETY DISORD, V22, P1447, DOI 10.1016/j.janxdis.2008.02.007; Petersen C, 2008, BRAIN INJURY, V22, P215, DOI 10.1080/02699050801935245; Pietrzak RH, 2009, J NERV MENT DIS, V197, P748, DOI 10.1097/NMD.0b013e3181b97a75; SAPOLSKY RM, 1990, J NEUROSCI, V10, P2897, DOI 10.1523/jneurosci.10-09-02897.1990; Sapolsky RM, 2000, ARCH GEN PSYCHIAT, V57, P925, DOI 10.1001/archpsyc.57.10.925; Scheeringa MS, 2006, AM J PSYCHIAT, V163, P644, DOI 10.1176/appi.ajp.163.4.644; Schnurr P.P., 2005, TRAUMA HLTH PHYS HLT, P247, DOI [https://doi.org/10.1037/10723-010, DOI 10.1037/10723-010]; Slomine BS, 2002, BRAIN INJURY, V16, P759, DOI 10.1080/02699050210127286; Sparrow S., 1984, VINELAND ADAPTIVE BE; Stallard P, 1998, BRIT MED J, V317, P1619, DOI 10.1136/bmj.317.7173.1619; Stancin T, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.2.e34; Taylor HG, 1999, NEUROPSYCHOLOGY, V13, P76, DOI 10.1037/0894-4105.13.1.76; TEASDALE G, 1974, LANCET, V2, P81; Wassenberg R, 2004, BRAIN INJURY, V18, P751, DOI 10.1080/02699050410001671775; Wells R, 2009, DEV NEUROREHABIL, V12, P12, DOI 10.1080/17518420902773109; Winston FK, 2003, JAMA-J AM MED ASSOC, V290, P643, DOI 10.1001/jama.290.5.643; Yeates KO, 2000, SCI PRACT NEUROPSYCH, P92	54	17	17	0	6	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1537-4416	1537-4424		J CLIN CHILD ADOLESC	J. Clin. Child Adolesc. Psychol.		2012	41	1					5	14		10.1080/15374416.2012.632348			10	Psychology, Clinical; Psychology, Developmental	Psychology	915WN	WOS:000302058400002	22233241				2021-06-18	
J	Leibowitz, A; Klin, Y; Gruenbaum, BF; Gruenbaum, SE; Kuts, R; Dubilet, M; Ohayon, S; Boyko, M; Sheiner, E; Shapira, Y; Zlotnik, A				Leibowitz, Akiva; Klin, Yael; Gruenbaum, Benjamin F.; Gruenbaum, Shaun E.; Kuts, Ruslan; Dubilet, Michael; Ohayon, Sharon; Boyko, Matthew; Sheiner, Eyal; Shapira, Yoram; Zlotnik, Alexander			Effects of strong physical exercise on blood glutamate and its metabolite 2-ketoglutarate levels in healthy volunteers	ACTA NEUROBIOLOGIAE EXPERIMENTALIS			English	Article						exercise; glutamate; hyperthermia; muscle damage; neurotoxicity; stress	TRAUMATIC BRAIN-INJURY; HUMAN HEAD-INJURY; EXCITATORY AMINO-ACIDS; CEREBROSPINAL-FLUID; ISCHEMIC-STROKE; CREATINE-PHOSPHOKINASE; SCAVENGING ACTIVITY; RELEASE; STRESS; PLASMA	Excessive concentrations of L-glutamate (glutamate) have been found to posses neurotoxic properties. This study investigates how stress induced by strong physical exercise effects blood glutamate, 2-ketoglutarate, Alanine aminotransferase (ALT) and Aspartate Aminotransferase (AST) levels. The relationship between muscle damage caused by strong physical exercise and blood glutamate levels was also examined. Twenty-two healthy volunteers engaged in intense veloergometry ("spinning") for a duration of 60 minutes. Two 10 minute peaks of extremely intense exercise were performed at 10 minutes and 50 minutes after the start of exercise. After 60 minutes of exercise, volunteers were monitored for an additional 180 minutes in resting conditions. Blood samples for determination of glutamate and 2-ketoglutarate levels were collected prior to exercise and then every 30 min for entire experiment. Blood samples were also taken at those time points to measure glutamate, 2-ketoglutarate, AST, ALT, creatine phosphokinase (CPK), myoglobin, lactate and venous blood gas levels. Blood glutamate levels were significantly elevated throughout the exercise session (P<0.001) and then returned to baseline levels at the cessation of exercise. 2-ketoglutarate, a product of glutamate metabolism, reached significantly elevated levels at 30 minutes (P<0.01) from the start of exercise and remained elevated up to 240 minutes post exercise initiation (P<0.001). AST and ALT levels were elevated at 60 minutes when compared to baseline. AST levels remained elevated at 240 minutes, unlike ALT levels which returned to baseline values at 240 minutes. Strong physical exercise leads to a significant elevation in blood glutamate, most likely as a result of skeletal muscle damage. 2-ketoglutarate was also found to be elevated for long periods of time, reflecting an ongoing process of glutamate breakdown. Elevated concentrations of AST and ALT in plasma reflect the importance of these enzymes in the maintenance of stable blood glutamate concentrations.	[Leibowitz, Akiva; Gruenbaum, Benjamin F.; Kuts, Ruslan; Dubilet, Michael; Ohayon, Sharon; Boyko, Matthew; Shapira, Yoram; Zlotnik, Alexander] Ben Gurion Univ Negev, Soroka Univ, Dept Anesthesiol & Crit Care, Med Ctr, IL-84105 Beer Sheva, Israel; [Klin, Yael] Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel; [Gruenbaum, Shaun E.] Yale Univ, Sch Med, Dept Anesthesiol, New Haven, CT 06510 USA; [Sheiner, Eyal] Ben Gurion Univ Negev, Soroka Univ, Dept Obstet & Gynecol, Med Ctr, IL-84105 Beer Sheva, Israel	Leibowitz, A (corresponding author), Ben Gurion Univ Negev, Soroka Univ, Dept Anesthesiol & Crit Care, Med Ctr, IL-84105 Beer Sheva, Israel.	akival@bgu.ac.il	SHEINER, EYAL/F-1488-2012	Boyko, Matthew/0000-0003-3116-1643; Leibowitz, Akiva/0000-0003-4244-1915			APPLE JK, 1993, J ANIM SCI, V71, P71, DOI 10.2527/1993.71171x; Arakawa H, 1997, J PHARMACOL EXP THER, V280, P1296; BAKER AJ, 1993, J NEUROSURG, V79, P369, DOI 10.3171/jns.1993.79.3.0369; BERL S, 1961, J NEUROCHEM, V7, P186, DOI 10.1111/j.1471-4159.1961.tb13503.x; BLOMSTRAND E, 1988, ACTA PHYSIOL SCAND, V133, P115, DOI 10.1111/j.1748-1716.1988.tb08388.x; Blomstrand E, 2009, AMINO ACIDS, V37, P629, DOI 10.1007/s00726-008-0182-y; Boyko M, 2012, NEUROCHEM RES, V37, P2198, DOI 10.1007/s11064-012-0843-9; Bullock R, 1998, J NEUROSURG, V89, P507, DOI 10.3171/jns.1998.89.4.0507; Camacho A, 2006, ARCH MED RES, V37, P11, DOI 10.1016/j.arcmed.2005.05.014; Castillo J, 1997, LANCET, V349, P79, DOI 10.1016/S0140-6736(96)04453-4; Castillo J, 1996, STROKE, V27, P1060, DOI 10.1161/01.STR.27.6.1060; Castillo J, 2002, NEUROLOGY, V58, P624, DOI 10.1212/WNL.58.4.624; Chio A, 2009, AMYOTROPH LATERAL SC, V10, P205, DOI 10.1080/17482960902721634; Cohen-Kashi-Malina K, 2012, J CEREBR BLOOD F MET, V32, P177, DOI 10.1038/jcbfm.2011.121; Cotman CW, 2002, TRENDS NEUROSCI, V25, P295, DOI 10.1016/S0166-2236(02)02143-4; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; Davalos A, 1997, STROKE, V28, P708, DOI 10.1161/01.STR.28.4.708; Espey MG, 2002, NEUROLOGY, V58, P1439, DOI 10.1212/WNL.58.9.1439; Fu FH, 2002, PERCEPT MOTOR SKILL, V95, P1171, DOI 10.2466/PMS.95.8.1171-1178; Gottlieb M, 2003, J NEUROCHEM, V87, P119, DOI 10.1046/j.1471-4159.2003.01972.x; GRAHAM LT, 1966, ANAL BIOCHEM, V15, P487, DOI 10.1016/0003-2697(66)90110-2; Hammarqvist F, 2001, CLIN PHYSIOL, V21, P44, DOI 10.1046/j.1365-2281.2001.00291.x; Hediger MA, 1999, AM J PHYSIOL-RENAL, V277, pF477; Helms HC, 2012, GLIA, V60, P882, DOI 10.1002/glia.22321; Johnston MV, 2001, PEDIATR RES, V49, P735, DOI 10.1203/00006450-200106000-00003; KAYASHIMA S, 1995, EUR J APPL PHYSIOL O, V70, P413, DOI 10.1007/BF00618492; Klin Y, 2010, BIOCHEM BIOPH RES CO, V399, P694, DOI 10.1016/j.bbrc.2010.07.144; Koura SS, 1998, ACT NEUR S, V71, P244; Kratz A, 2002, AM J CLIN PATHOL, V118, P856, DOI 10.1092/BTWQ5YMYVQ67QK9L; Leibowitz A, 2012, INT J MOL SCI, V13, P10041, DOI 10.3390/ijms130810041; MARLISS EB, 1971, J CLIN INVEST, V50, P814, DOI 10.1172/JCI106552; MELTZER HY, 1971, AM J PHYSIOL, V221, P896; Mitani H, 2006, PROG NEURO-PSYCHOPH, V30, P1155, DOI 10.1016/j.pnpbp.2006.03.036; MUKHERJEE K, 1987, AVIAT SPACE ENVIR MD, V58, P18; Newsholme EA, 1996, EXPERIENTIA, V52, P413, DOI 10.1007/BF01919308; O'Callaghan RM, 2007, BEHAV BRAIN RES, V176, P362, DOI 10.1016/j.bbr.2006.10.018; O'Kane RL, 1999, J BIOL CHEM, V274, P31891, DOI 10.1074/jbc.274.45.31891; PALMER AM, 1993, J NEUROCHEM, V61, P2015, DOI 10.1111/j.1471-4159.1993.tb07437.x; Paul P, 2012, AMINO ACIDS, V43, P1823, DOI 10.1007/s00726-012-1385-9; Resende NM, 2011, OMICS, V15, P695, DOI 10.1089/omi.2011.0010; Richards DA, 2003, PHARMACOL RES, V48, P101, DOI 10.1016/S1043-6618(03)00081-1; Rose ME, 2002, BRAIN RES, V943, P15, DOI 10.1016/S0006-8993(02)02471-X; ROSS JH, 1983, Q J MED, V52, P268; ROTI S, 1981, J SPORT MED PHYS FIT, V21, P113; SEN CK, 1992, J APPL PHYSIOL, V73, P1265; Sen P., 1992, Indian Journal of Experimental Biology, V30, P1170; Serena J, 2001, STROKE, V32, P1154, DOI 10.1161/01.STR.32.5.1154; Stern RA, 2011, PM&R, V3, pS460, DOI 10.1016/j.pmrj.2011.08.008; Sutedja NA, 2009, AMYOTROPH LATERAL SC, V10, P295, DOI 10.3109/17482960802430799; Teichberg VI, 2009, NEUROSCIENCE, V158, P301, DOI 10.1016/j.neuroscience.2008.02.075; Tong LQ, 2001, NEUROBIOL DIS, V8, P1046, DOI 10.1006/nbdi.2001.0427; Tran TY, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E8; Vesce S, 2007, INT REV NEUROBIOL, V82, P57, DOI 10.1016/S0074-7742(07)82003-4; Wu CW, 2008, J APPL PHYSIOL, V105, P1585, DOI 10.1152/japplphysiol.90775.2008; Yamamoto T, 1999, ACT NEUR S, V75, P17; Yan B, 2009, J APPL PHYSIOL, V106, P531, DOI 10.1152/japplphysiol.90816.2008; Zauner A, 1996, ACT NEUR S, V67, P40; Zhang H, 2001, CLIN CHEM, V47, P1458; Zlotnik A, 2008, NEUROCHEM RES, V33, P1044, DOI 10.1007/s11064-007-9548-x; Zlotnik A, 2007, EXP NEUROL, V203, P213, DOI 10.1016/j.expneurol.2006.08.021; Zlotnik A, 2012, ANESTHESIOLOGY, V116, P73, DOI 10.1097/ALN.0b013e31823d7731; Zlotnik A, 2012, INTENS CARE MED, V38, P137, DOI 10.1007/s00134-011-2401-3; Zlotnik A, 2011, NEUROCHEM RES, V36, P732, DOI 10.1007/s11064-010-0388-8; Zlotnik A, 2010, ANESTH ANALG, V111, P1497, DOI 10.1213/ANE.0b013e3181fc0112; Zlotnik A, 2010, EXP NEUROL, V224, P465, DOI 10.1016/j.expneurol.2010.05.009; Zlotnik A, 2009, J NEUROSURG ANESTH, V21, P235, DOI 10.1097/ANA.0b013e3181a2bf0b	66	17	18	0	7	NENCKI INST EXPERIMENTAL BIOLOGY	WARSAW	UL PASTEURA 3, 02-093 WARSAW, POLAND	0065-1400			ACTA NEUROBIOL EXP	Acta Neurobiol. Exp.		2012	72	4					385	396					12	Neurosciences	Neurosciences & Neurology	087CI	WOS:000314738500007	23377269				2021-06-18	
J	Lewis, JD; Wassermann, EM; Chao, WD; Ramage, AE; Robin, DA; Clauw, DJ				Lewis, Jeffrey D.; Wassermann, Eric M.; Chao, Wendy; Ramage, Amy E.; Robin, Donald A.; Clauw, Daniel J.			Central sensitization as a component of post-deployment syndrome	NEUROREHABILITATION			English	Article						Chronic widespread pain; post-deployment; mild traumatic brain injury	CHRONIC-FATIGUE-SYNDROME; IRRITABLE-BOWEL-SYNDROME; PERSIAN-GULF-WAR; POSTINJURY PAIN HYPERSENSITIVITY; POSTTRAUMATIC-STRESS-DISORDER; CHRONIC WIDESPREAD PAIN; POSTCONCUSSIVE SYMPTOMS; FIBROMYALGIA SYNDROME; MUSCULOSKELETAL PAIN; SOMATIC SYMPTOMS	Many service members and veterans report chronic unexplained symptoms such as pain, fatigue and memory complaints, which have most recently been characterized as post-deployment syndrome (PDS). Chronic widespread pain is a component of this syndrome, producing significant disability and considerable health care costs. The similarity between the nature of these complaints and other medically unexplained illnesses such as fibromyalgia, irritable bowel syndrome, and chronic fatigue syndrome suggest that they may share a common mechanism. Here, we provide support for PDS as a consequence of pain and sensory amplification secondary to neuroplastic changes within the central nervous system, a phenomenon often termed central sensitization. We also discuss how factors such as stress and genetics may promote chronic widespread pain in veterans and service members who develop PDS.	[Lewis, Jeffrey D.; Wassermann, Eric M.] NINDS, Behav Neurol Unit, Bethesda, MD 20892 USA; [Lewis, Jeffrey D.] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA; [Chao, Wendy] Brooke Army Med Ctr, Dept Neurol, Ft Sam Houston, TX 78234 USA; [Ramage, Amy E.] Univ Texas Hlth Sci Ctr San Antonio, Dept Psychiat, San Antonio, TX 78229 USA; [Robin, Donald A.] Univ Texas Hlth Sci Ctr San Antonio, Res Imaging Inst, San Antonio, TX 78229 USA; [Clauw, Daniel J.] Univ Michigan, Chron Pain & Fatigue Ctr, Ann Arbor, MI 48109 USA	Wassermann, EM (corresponding author), Behav Neurol Univ, NINDS, 10 Ctr Dr,MSC 1440,Bldg 10,Room 7D43, Bethesda, MD 20892 USA.	Wassermanne@ninds.nih.gov	Wassermann, Eric M./AAC-9064-2020; Ramage, Amy/S-9227-2018	Wassermann, Eric M./0000-0003-0628-0210; Ramage, Amy/0000-0001-8554-555X	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [ZIANS002977] Funding Source: NIH RePORTER; Intramural NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [Z99 NS999999] Funding Source: Medline		Ablin JN, 2010, CLIN EXP RHEUMATOL, V28, pS15; Ablin K, 2009, RHEUM DIS CLIN N AM, V35, P233, DOI 10.1016/j.rdc.2009.06.006; Afari N, 2003, AM J PSYCHIAT, V160, P221, DOI 10.1176/appi.ajp.160.2.221; Association A. P, 1994, DIAGN STAT MAN MENT, V4; Azari P, 2012, CNS DRUGS, V26, P215, DOI 10.2165/11595200-000000000-00000; Benison AM, 2011, J NEUROSCI, V31, P6317, DOI 10.1523/JNEUROSCI.0076-11.2011; Bonds T., 2010, ARMY DEPLOYMENTS OIF; Brody AL, 2001, BIOL PSYCHIAT, V50, P171, DOI 10.1016/S0006-3223(01)01117-9; Buskila D, 2008, AUTOIMMUN REV, V8, P41, DOI 10.1016/j.autrev.2008.07.023; Choy E, 2011, SEMIN ARTHRITIS RHEU, V41, P335, DOI 10.1016/j.semarthrit.2011.06.003; Cifu D, 2011, OVERCOMING POSTDEPLO; Cifu D. X., 2011, COMMUNICATION; Clauw D, 2003, BMJ-BRIT MED J, V327, P1357, DOI 10.1136/bmj.327.7428.1357; Cook DB, 2010, J PAIN, V11, P764, DOI 10.1016/j.jpain.2009.11.010; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; Craig AD, 2002, NAT REV NEUROSCI, V3, P655, DOI 10.1038/nrn894; Dunphy RC, 2003, PAIN, V102, P79, DOI 10.1016/S0304-3959(02)00342-1; Fukuda K, 1998, JAMA-J AM MED ASSOC, V280, P981, DOI 10.1001/jama.280.11.981; Fulton J. F., 1942, NEW ENGL J MED, V226, P1; Gale JD, 2011, FRONT PHARMACOL, V2, DOI 10.3389/fphar.2011.00028; Garza Ivan, 2006, Neuropsychiatr Dis Treat, V2, P281, DOI 10.2147/nedt.2006.2.3.281; Geisser ME, 2008, J PAIN, V9, P417, DOI 10.1016/j.jpain.2007.12.006; Geisser ME, 2008, PSYCHOSOMATICS, V49, P235, DOI 10.1176/appi.psy.49.3.235; Gironda RJ, 2006, PAIN MED, V7, P339, DOI 10.1111/j.1526-4637.2006.00146.x; GOLDENBERG DL, 1987, JAMA-J AM MED ASSOC, V257, P2782, DOI 10.1001/jama.257.20.2782; Gracely RH, 2002, ARTHRITIS RHEUM-US, V46, P1333, DOI 10.1002/art.10225; Green PG, 2011, J PAIN, V12, P811, DOI 10.1016/j.jpain.2011.01.006; Hassett AL, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3024; Helmer DA, 2009, PAIN MED, V10, P1174, DOI 10.1111/j.1526-4637.2009.00723.x; Hickie I, 2006, BRIT MED J, V333, P575, DOI 10.1136/bmj.38933.585764.AE; Hollins M, 2009, PAIN, V141, P215, DOI 10.1016/j.pain.2008.10.003; HOLMES GP, 1988, ANN INTERN MED, V108, P387, DOI 10.7326/0003-4819-108-3-387; Ismail K, 2008, PSYCHOL MED, V38, P953, DOI 10.1017/S0033291707001560; Iverson G.L., 2007, BRAIN INJURY MED PRI, P373; Iverson GL, 1997, BRAIN INJURY, V11, P783, DOI 10.1080/026990597122990; Jason LA, 1999, ARCH INTERN MED, V159, P2129, DOI 10.1001/archinte.159.18.2129; Jones E, 2002, BMJ-BRIT MED J, V324, P321, DOI 10.1136/bmj.324.7333.321; Jones E, 2007, AM J PSYCHIAT, V164, P1641, DOI 10.1176/appi.ajp.2007.07071180; Jones G. T., 2011, ARTHRITIS CARE RES H; Kang HK, 2000, J OCCUP ENVIRON MED, V42, P491, DOI 10.1097/00043764-200005000-00006; Kehlet H, 2006, LANCET, V367, P1618, DOI 10.1016/S0140-6736(06)68700-X; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; Mailis A, 1997, PAIN, V70, P69, DOI 10.1016/S0304-3959(96)03300-3; Maixner W, 1995, PAIN, V63, P341, DOI 10.1016/0304-3959(95)00068-2; May A, 2008, PAIN, V137, P7, DOI 10.1016/j.pain.2008.02.034; McBeth J, 2001, RHEUMATOLOGY, V40, P95, DOI 10.1093/rheumatology/40.1.95; McFarlane AC, 2007, BEST PRACT RES CL RH, V21, P549, DOI 10.1016/j.berh.2007.03.008; McLean SA, 2005, PSYCHOSOM MED, V67, P783, DOI 10.1097/01.psy.0000181276.49204.bb; MERTZ H, 1995, GASTROENTEROLOGY, V109, P40, DOI 10.1016/0016-5085(95)90267-8; N-Hoffmant VLF, 2007, J PAIN, V8, P954, DOI 10.1016/j.jpain.2007.07.003; Naliboff BD, 2001, PSYCHOSOM MED, V63, P365, DOI 10.1097/00006842-200105000-00006; Obermann M, 2009, NEUROLOGY, V73, P978, DOI 10.1212/WNL.0b013e3181b8791a; Pae CU, 2009, EXPERT OPIN PHARMACO, V10, P1561, DOI 10.1517/14656560902988510; Rahimi R, 2009, WORLD J GASTROENTERO, V15, P1548, DOI 10.3748/wjg.15.1548; Raphael KG, 2002, PAIN, V100, P131, DOI 10.1016/S0304-3959(02)00273-7; Rau V, 2005, NEUROSCI BIOBEHAV R, V29, P1207, DOI 10.1016/j.neubiorev.2005.04.010; Ravindran MK, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-30; Reeser JC, 2011, PM&R, V3, P193, DOI 10.1016/j.pmrj.2010.12.009; Reid S, 2001, AM J EPIDEMIOL, V153, P604, DOI 10.1093/aje/153.6.604; Rodriguez-Raecke R, 2010, J NEUROSCI, V30, P11363, DOI 10.1523/JNEUROSCI.2197-10.2010; Soros P, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-48; Stimpson NJ, 2006, MIL MED, V171, P1181, DOI 10.7205/MILMED.171.12.1181; Turk DC, 2002, CLIN J PAIN, V18, P355, DOI 10.1097/00002508-200211000-00003; Unwin C, 1999, LANCET, V353, P169, DOI 10.1016/S0140-6736(98)11338-7; Valdes M, 2010, ARTHRITIS RHEUM-US, V62, P1829, DOI 10.1002/art.27430; Veterans Administration Office of Public Health and Environmental Hazards Briefing, 2010, AN VA HLTH CAR UT OP; Williams DA, 2003, JAMA-J AM MED ASSOC, V289, P1637, DOI 10.1001/jama.289.13.1637; Williams DA, 2003, BEST PRACT RES CL RH, V17, P649, DOI 10.1016/S1521-6942(03)00034-2; Williams DA, 2009, J PAIN, V10, P777, DOI 10.1016/j.jpain.2009.06.001; WOOLF CJ, 1983, NATURE, V306, P686, DOI 10.1038/306686a0; WOOLF CJ, 1991, PAIN, V44, P293, DOI 10.1016/0304-3959(91)90100-C; Woolf CJ, 2011, PAIN, V152, pS2, DOI 10.1016/j.pain.2010.09.030; Woolfolk RL, 2012, PAIN RES TREAT, V2012, DOI 10.1155/2012/937873; YUNUS M, 1981, SEMIN ARTHRITIS RHEU, V11, P151, DOI 10.1016/0049-0172(81)90096-2; Yunus M B, 1989, J Rheumatol Suppl, V19, P62; Yunus MB, 2007, SEMIN ARTHRITIS RHEU, V36, P339, DOI 10.1016/j.semarthrit.2006.12.009	76	17	17	0	10	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2012	31	4					367	372		10.3233/NRE-2012-00805			6	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	052GV	WOS:000312186600004	23232159	Green Accepted			2021-06-18	
J	Morris, CE; Boucher, PA; Joos, B				Morris, Catherine E.; Boucher, Pierre-Alexandre; Joos, Bela			Left-shifted Nav channels in injured bilayer: primary targets for neuroprotective Nav antagonists?	FRONTIERS IN PHARMACOLOGY			English	Article						traumatic brain injury; spinal; riluzole; ranolazine; simulation; modeling	GATED SODIUM-CHANNELS; LIPID-COMPOSITION; NEUROPATHIC PAIN; DRUG-BINDING; TETRODOTOXIN; CHOLESTEROL; MODULATION; MECHANOSENSITIVITY; CONDUCTANCE; INHIBITION	Mechanical, ischemic, and inflammatory injuries to voltage-gated sodium channel (Nav)-rich membranes of axon initial segments and nodes of Ranvier render Nav channels dangerously leaky. By what means? The behavior of recombinant Nav1.6 (Wang et al., 2009) leads us to postulate that, in neuropathologic conditions, structural degradation of axolemmal bilayer fosters chronically left-shifted Nay channel operation, resulting in E-Na rundown. This "sick excitable cell Nav-leak" would encompass left-shifted fast- and slow-mode based persistent /(Na) (i.e., /(window) and slow-inactivating /(Na)). Bilayer-damage-induced electrophysiological dysfunctions of native-Nay channels, and effects on inhibitors on those channels, should, we suggest, be studied in myelinated axons, exploiting /(Na)(V, t) hysteresis data from sawtooth ramp clamp. We hypothesize that (like dihydropyridines for Ca channels), protective lipophilic Nay antagonists would partition more avidly into disorderly bilayers than into the well-packed bilayers characteristic of undamaged, healthy plasma membrane. Whereas inhibitors using aqueous routes would access all Navs equally, differential partitioning into "sick bilayer" would co-localize lipophilic antagonists with "sick-Nav channels," allowing for more specific targeting of impaired cells. Molecular fine-tuning of Nav antagonists to favor more avid partitioning into damaged than into intact bilayers could reduce side effects. In potentially salvageable neurons of traumatic and/or ischemic penumbras, in inflammatory neuropathies, in muscular dystrophy, in myocytes of cardiac infarct borders, Nav-leak driven excitotoxicity overwhelms cellular repair mechanisms. Precision-tuning of a lipophilic Nav antagonist for greatest efficacy in mildly damaged membranes could render it suitable for the prolonged continuous administration needed to allow for the remodeling of the excitable membranes, and thus functional recovery.	[Morris, Catherine E.] Ottawa Hosp Res Inst, Ottawa, ON K1H 8M5, Canada; [Boucher, Pierre-Alexandre; Joos, Bela] Univ Ottawa, Inst Phys Ottawa Carleton, Ottawa, ON, Canada	Morris, CE (corresponding author), Ottawa Hosp Res Inst, 450 Smyth Rd, Ottawa, ON K1H 8M5, Canada.	cmorris@uottawa.ca		Joos, Bela/0000-0001-8576-5579; Morris, Catherine/0000-0002-7401-6545	NSERCNatural Sciences and Engineering Research Council of Canada (NSERC); CIHR, CanadaCanadian Institutes of Health Research (CIHR)	Support for this work is from NSERC and CIHR, Canada.	Ali MH, 2010, J PHARM PHARMACOL, V62, P1646, DOI 10.1111/j.2042-7158.2010.01090.x; Allen DG, 2011, INT J BIOCHEM CELL B, V43, P290, DOI 10.1016/j.biocel.2010.11.005; Antzelevitch C, 2011, HEART RHYTHM, V8, P1281, DOI 10.1016/j.hrthm.2011.03.045; Armstrong SC, 2001, J MOL CELL CARDIOL, V33, P1165, DOI 10.1006/jmcc.2001.1380; Ates O, 2007, J CLIN NEUROSCI, V14, P658, DOI 10.1016/j.jocn.2006.03.023; Baenziger JE, 2008, MOL PHARMACOL, V73, P880, DOI 10.1124/mol.107.039008; Banderali U, 2010, CHANNELS, V4, P12, DOI 10.4161/chan.4.1.10260; Benabdellah F, 2009, NEUROBIOL DIS, V36, P252, DOI 10.1016/j.nbd.2009.07.013; BENOIT E, 1991, PFLUG ARCH EUR J PHY, V419, P603, DOI 10.1007/BF00370302; Beyder A, 2010, J PHYSIOL-LONDON, V588, P4969, DOI 10.1113/jphysiol.2010.199034; Boucher P.-A., 2011, THESIS U OTTAWA OTTA; Boucher P. A., 2012, J COMPUT NE IN PRESS; Browne SE, 2006, NEUROBIOL DIS, V22, P599, DOI 10.1016/j.nbd.2006.01.001; Cadotte DW, 2011, CLIN ORTHOP RELAT R, V469, P732, DOI 10.1007/s11999-010-1674-0; Catterall WA, 2008, J NEUROSCI, V28, P11768, DOI 10.1523/JNEUROSCI.3901-08.2008; Charras GT, 2009, J CELL SCI, V122, P3233, DOI 10.1242/jcs.049262; Chatelier A., 2010, PFLUGERS ARCH, V460, P1; Chen SB, 2011, J NEUROSCI METH, V195, P222, DOI 10.1016/j.jneumeth.2010.12.018; Chisari M, 2009, J NEUROPHYSIOL, V102, P1254, DOI 10.1152/jn.00346.2009; Coggan JS, 2010, P NATL ACAD SCI USA, V107, P20602, DOI 10.1073/pnas.1013798107; CONTI F, 1976, J PHYSIOL-LONDON, V262, P729, DOI 10.1113/jphysiol.1976.sp011617; Dib-Hajj SD, 2010, NEUROSCI LETT, V486, P84, DOI 10.1016/j.neulet.2010.08.077; Dong CJ, 2005, DOC OPHTHALMOL, V110, P15, DOI 10.1007/s10633-005-7339-8; Douglas HA, 2011, J NEUROPHYSIOL, V105, P1482, DOI 10.1152/jn.00817.2010; Eckford PDW, 2008, BIOCHEMISTRY-US, V47, P13686, DOI 10.1021/bi801409r; Finol-Urdaneta RK, 2010, BIOPHYS J, V98, P762, DOI 10.1016/j.bpj.2009.10.053; Fu Y, 2011, J PHYSIOL-LONDON, V589, P525, DOI 10.1113/jphysiol.2010.199430; Haeseler G, 2008, CRIT CARE MED, V36, P1239, DOI 10.1097/CCM.0b013e31816a02cf; Henry MA, 2009, J PAIN, V10, P750, DOI 10.1016/j.jpain.2009.01.264; HERBETTE LG, 1989, J MOL CELL CARDIOL, V21, P187, DOI 10.1016/0022-2828(89)90861-4; Hirn C, 2008, J GEN PHYSIOL, V132, P199, DOI 10.1085/jgp.200810024; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Iwata A, 2004, J NEUROSCI, V24, P4605, DOI 10.1523/JNEUROSCI.0515-03.2004; Jastrzebska B, 2011, PROG LIPID RES, V50, P267, DOI 10.1016/j.plipres.2011.03.002; Jo S, 2011, MOL PHARMACOL, V80, P247, DOI 10.1124/mol.110.070276; Kaiser HJ, 2009, P NATL ACAD SCI USA, V106, P16645, DOI 10.1073/pnas.0908987106; Khanal G, 2011, ANALYST, V136, P3519, DOI 10.1039/c0an00845a; Kole MHP, 2008, NAT NEUROSCI, V11, P178, DOI 10.1038/nn2040; Kole MHP, 2011, NEURON, V71, P671, DOI 10.1016/j.neuron.2011.06.024; Krepkiy D, 2009, NATURE, V462, P473, DOI 10.1038/nature08542; Kuwabara S, 2006, CLIN NEUROPHYSIOL, V117, P810, DOI 10.1016/j.clinph.2005.11.018; Kuwabara Satoshi, 2008, Curr Mol Pharmacol, V1, P61; Lee SY, 2004, NATURE, V430, P232, DOI 10.1038/nature02632; Lenkey N, 2011, NEUROPHARMACOLOGY, V60, P191, DOI 10.1016/j.neuropharm.2010.08.005; Letienne R, 2009, EUR J PHARMACOL, V624, P16, DOI 10.1016/j.ejphar.2009.09.032; Levental I, 2011, P NATL ACAD SCI USA, V108, P11411, DOI 10.1073/pnas.1105996108; Lin W, 2007, BIOPHYS J, V92, P1559, DOI 10.1529/biophysj.106.092478; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Lombardi D, 2009, EUR J PHARM SCI, V38, P533, DOI 10.1016/j.ejps.2009.10.001; Lopez-Marques RL, 2011, BIOL CHEM, V392, P67, DOI 10.1515/BC.2011.015; Mantegazza M, 2010, LANCET NEUROL, V9, P413, DOI 10.1016/S1474-4422(10)70059-4; Martinez V, 2008, EUR J PAIN, V12, P934, DOI 10.1016/j.ejpain.2007.12.011; MASON RP, 1993, BIOCHEM PHARMACOL, V45, P2173, DOI 10.1016/0006-2952(93)90186-Z; MASON RP, 1992, MOL PHARMACOL, V41, P315; Maxwell WL, 1996, MICROSC RES TECHNIQ, V34, P522, DOI 10.1002/(SICI)1097-0029(19960815)34:6<522::AID-JEMT4>3.0.CO;2-L; McGinn MJ, 2009, J NEUROPATH EXP NEUR, V68, P241, DOI 10.1097/NEN.0b013e3181996bfe; Milescu M, 2009, NAT STRUCT MOL BIOL, V16, P1080, DOI 10.1038/nsmb.1679; MILTON RL, 1990, J NEUROSCI, V10, P885; Misawa S, 2009, J PERIPHER NERV SYST, V14, P279, DOI 10.1111/j.1529-8027.2009.00239.x; Morris C.E., 2011, CELL PHYSL SOURCE BO, P493; Morris C. E., 2011, CARDIAC MECHANOELECT, P43; Morris CE, 2007, BIOPHYS J, V93, P822, DOI 10.1529/biophysj.106.101246; Morris Catherine E., 2006, V322, P315; Morris CE, 2011, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00025; Morris CE, 2001, J MEMBRANE BIOL, V179, P79, DOI 10.1007/s002320010040; Muddana HS, 2012, BIOPHYS J, V102, P489, DOI 10.1016/j.bpj.2011.12.033; MUSTERS RJP, 1993, CIRC RES, V73, P514, DOI 10.1161/01.RES.73.3.514; Nesterenko VV, 2011, AM J PHYSIOL-HEART C, V301, pH1615, DOI 10.1152/ajpheart.00243.2011; Nikic I, 2011, NAT MED, V17, P495, DOI 10.1038/nm.2324; Novak KR, 2009, J CLIN INVEST, V119, P1150, DOI 10.1172/JCI36570; Phillips R, 2009, NATURE, V459, P379, DOI 10.1038/nature08147; Pieri M, 2009, EXP NEUROL, V215, P368, DOI 10.1016/j.expneurol.2008.11.002; Rajendran L, 2010, NAT REV DRUG DISCOV, V9, P29, DOI 10.1038/nrd2897; Ritter AM, 2009, NEUROSCI LETT, V452, P28, DOI 10.1016/j.neulet.2008.12.051; Rusinova R, 2011, J GEN PHYSIOL, V138, P249, DOI 10.1085/jgp.201010529; Schafer DP, 2009, J NEUROSCI, V29, P13242, DOI 10.1523/JNEUROSCI.3376-09.2009; Schlegel RA, 2001, CELL DEATH DIFFER, V8, P551, DOI 10.1038/sj.cdd.4400817; Schmidt D, 2008, P NATL ACAD SCI USA, V105, P19276, DOI 10.1073/pnas.0810187105; Schwarz JR, 2006, J PHYSIOL-LONDON, V573, P17, DOI 10.1113/jphysiol.2006.106815; SCHWARZ JR, 1995, PFLUG ARCH EUR J PHY, V430, P283, DOI 10.1007/BF00374660; Shcherbatko A, 1999, BIOPHYS J, V77, P1945, DOI 10.1016/S0006-3495(99)77036-0; Sheetz MP, 2006, ANNU REV BIOPH BIOM, V35, P417, DOI 10.1146/annurev.biophys.35.040405.102017; Shevchenko A, 2010, NAT REV MOL CELL BIO, V11, P593, DOI 10.1038/nrm2934; Song JH, 1997, J PHARMACOL EXP THER, V282, P707; STYS PK, 1993, P NATL ACAD SCI USA, V90, P6976, DOI 10.1073/pnas.90.15.6976; Sun GC, 2006, ACTA PHARMACOL SIN, V27, P1537, DOI 10.1111/j.1745-7254.2006.00452.x; Tabarean IV, 1999, BIOPHYS J, V77, P758, DOI 10.1016/S0006-3495(99)76930-4; Taddese A, 2002, NEURON, V33, P587, DOI 10.1016/S0896-6273(02)00574-3; Tejwani RW, 2011, J PHARM SCI-US, V100, P2136, DOI 10.1002/jps.22441; Underhill SM, 2007, NEUROBIOL DIS, V25, P284, DOI 10.1016/j.nbd.2006.09.011; van Genderen HO, 2008, BBA-MOL CELL RES, V1783, P953, DOI 10.1016/j.bbamcr.2008.01.030; Villalba-Galea CA, 2008, P NATL ACAD SCI USA, V105, P17600, DOI 10.1073/pnas.0807387105; Vucic S, 2010, J NEUROL NEUROSUR PS, V81, P222, DOI 10.1136/jnnp.2009.183079; Wang JA, 2009, AM J PHYSIOL-CELL PH, V297, pC823, DOI 10.1152/ajpcell.00505.2008; Waxman SG, 2008, NAT CLIN PRACT NEURO, V4, P159, DOI 10.1038/ncpneuro0735; Webb J, 2009, PFLUG ARCH EUR J PHY, V457, P1253, DOI 10.1007/s00424-008-0600-8; Weiss S, 2010, BRIT J PHARMACOL, V160, P1072, DOI 10.1111/j.1476-5381.2010.00766.x; Weston RM, 2009, NEUROCHEM RES, V34, P1816, DOI 10.1007/s11064-009-0012-y; Wolf JA, 2001, J NEUROSCI, V21, P1923, DOI 10.1523/JNEUROSCI.21-06-01923.2001; Yuen TJ, 2009, J NEUROSCI RES, V87, P3620, DOI 10.1002/jnr.22161; Zhang JZ, 2007, BIOPHYS J, V92, P3988, DOI 10.1529/biophysj.106.102434; Zuliani V, 2010, EXPERT OPIN THER PAT, V20, P755, DOI 10.1517/13543771003774118	102	17	17	0	1	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1663-9812			FRONT PHARMACOL	Front. Pharmacol.		2012	3								19	10.3389/fphar.2012.00019			13	Pharmacology & Pharmacy	Pharmacology & Pharmacy	V35XE	WOS:000209177700019	22375118	DOAJ Gold, Green Published			2021-06-18	
J	Pieracci, FM; Moore, EE; Beauchamp, K; Tebockhorst, S; Barnett, CC; Bensard, DD; Burlew, CC; Biffl, WL; Stoval, RT; Johnson, JL				Pieracci, Fredric M.; Moore, Ernest E.; Beauchamp, Kathryn; Tebockhorst, Seth; Barnett, Carlton C.; Bensard, Denis D.; Burlew, Clay C.; Biffl, Walter L.; Stoval, Robert T.; Johnson, Jeffrey L.			A cost-minimization analysis of phenytoin versus levetiracetam for early seizure pharmacoprophylaxis after traumatic brain injury	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Traumatic brain injury; seizures; pharmacoeconomics; cost-effectiveness; outcomes	UNITED-STATES; PROPHYLAXIS; PREVENTION; RISK	BACKGROUND: Recent data indicate comparable efficacy and safety for levetiracetam (LEV) when compared with phenytoin (PHT) for prophylaxis of early seizures after traumatic brain injury. The purpose of this study was to conduct a cost-minimization analysis, from the perspective of both the acute care institution (cost) and patient (charges), comparing these two strategies. METHODS: A decision tree was constructed to include baseline event probabilities obtained from detailed literature review, costs, and charges. Monte Carlo simulation was used to derive the mean costs and charges per patient treated with the LEV when compared with the PHT strategy. Adverse event probabilities, costs, charges, and frequency of laboratory determination for the PHT group were varied in sensitivity analyses. RESULTS: Literature review indicated equal efficacy of PHT versus LEV for early seizure prevention. The PHT strategy was superior to the LEV strategy from both the institutional (mean cost per patient $151.24 vs. $411.85, respectively) and patient (mean charge per patient $2,302.58 vs. $3,498.40, respectively) perspectives. Varying both baseline adverse event probabilities and frequency of laboratory testing did not alter the superiority of the PHT strategy. LEV replaced PHT as the dominant strategy only when the cost/charge of treating mental status deterioration was increased markedly above baseline. CONCLUSIONS: From both institutional and patient perspectives, PHT is less expensive than LEV for routine pharmacoprophylaxis of early seizures among traumatic brain injury patients. Pending compelling efficacy data, LEV should not replace PHT as a first-line agent for this indication. (J Trauma. 2012;72: 276-281. Copyright (C) 2012 by Lippincott Williams & Wilkins)	[Pieracci, Fredric M.; Moore, Ernest E.; Tebockhorst, Seth; Barnett, Carlton C.; Bensard, Denis D.; Burlew, Clay C.; Biffl, Walter L.; Stoval, Robert T.; Johnson, Jeffrey L.] Univ Colorado, Hlth Sci Ctr, Denver Hlth Med Ctr, Div Trauma & Acute Care Surg,Dept Surg, Denver, CO 80206 USA; [Beauchamp, Kathryn] Univ Colorado, Hlth Sci Ctr, Denver Hlth Med Ctr, Dept Neurosurg, Denver, CO 80206 USA	Pieracci, FM (corresponding author), Univ Colorado, Hlth Sci Ctr, Denver Hlth Med Ctr, Div Trauma & Acute Care Surg,Dept Surg, 777 Bannock St MC0206, Denver, CO 80206 USA.	fredric.pieracci@dhha.org	MUNOZ, ROSA ANA/H-3964-2018	MUNOZ, ROSA ANA/0000-0002-7504-2163			Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS83; Chang BS, 2003, NEUROLOGY, V60, P10, DOI 10.1212/01.WNL.0000031432.05543.14; Claassen J, 2007, NEUROLOGY, V69, P1356, DOI 10.1212/01.wnl.0000281664.02615.6c; Drummond MF., 1997, METHODS EC EVALUATIO, P305; Jones KE, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E3; KILPATRICK CJ, 1992, ARCH NEUROL-CHICAGO, V49, P509, DOI 10.1001/archneur.1992.00530290097017; Lim DA, 2009, J NEURO-ONCOL, V93, P349, DOI 10.1007/s11060-008-9781-4; Merrell RT, 2010, J NEUROSURG, V113, P1176, DOI 10.3171/2010.5.JNS091367; Mockenhaupt M, 2005, NEUROLOGY, V64, P1134, DOI 10.1212/01.WNL.0000156354.20227.F0; PECHADRE JC, 1991, PRESSE MED, V20, P841; Rekling JC, 2003, NEUROSCI LETT, V335, P167, DOI 10.1016/S0304-3940(02)01193-X; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Schierhout G, 2001, COCHRANE DB SYST REV, V4; Shah D, 2009, SEIZURE-EUR J EPILEP, V18, P676, DOI 10.1016/j.seizure.2009.09.003; So EL, 1996, NEUROLOGY, V46, P350, DOI 10.1212/WNL.46.2.350; Szaflarski JP, 2010, NEUROCRIT CARE, V12, P165, DOI 10.1007/s12028-009-9304-y; TEMKIN NR, 1990, NEW ENGL J MED, V323, P497, DOI 10.1056/NEJM199008233230801; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Vespa PM, 1999, J NEUROSURG, V91, P750, DOI 10.3171/jns.1999.91.5.0750; Wang HC, 2006, NEUROCRIT CARE, V5, P71, DOI 10.1385/NCC:5:1:71	20	17	19	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	JAN	2012	72	1					276	281		10.1097/TA.0b013e31823df31f			6	Critical Care Medicine; Surgery	General & Internal Medicine; Surgery	898IF	WOS:000300734800050	22310136				2021-06-18	
J	Webb, JW; Batchelor, J; Meares, S; Taylor, A; Marsh, NV				Webb, James W.; Batchelor, Jennifer; Meares, Susanne; Taylor, Alan; Marsh, Nigel V.			Effort Test Failure: Toward a Predictive Model	CLINICAL NEUROPSYCHOLOGIST			English	Article						Symptom validity testing; Malingering; Effort; Depression; Psychosis; Illness behavior	TRAUMATIC BRAIN-INJURY; SYMPTOM VALIDITY TESTS; NEUROPSYCHOLOGICAL TEST-PERFORMANCE; DISABILITY PENSION; CLASSIFICATION ACCURACY; MEMORY PERFORMANCE; CROSS-VALIDATION; POOR EFFORT; TEST-SCORES; SICK-LEAVE	Predictors of effort test failure were examined in an archival sample of 555 traumatically brain-injured (TBI) adults. Logistic regression models were used to examine whether compensation-seeking, injury-related, psychological, demographic, and cultural factors predicted effort test failure (ETF). ETF was significantly associated with compensation-seeking (OR = 3.51, 95% CI [1.25, 9.79]), low education (OR: .83 [. 74, .94]), self-reported mood disorder (OR: 5.53 [3.10, 9.85]), exaggerated displays of behavior (OR: 5.84 [2.15, 15.84]), psychotic illness (OR: 12.86 [3.21, 51.44]), being foreign-born (OR: 5.10 [2.35, 11.06]), having sustained a workplace accident (OR: 4.60 [2.40, 8.81]), and mild traumatic brain injury severity compared with very severe traumatic brain injury severity (OR: 0.37 [0.13, 0.995]). ETF was associated with a broader range of statistical predictors than has previously been identified and the relative importance of psychological and behavioral predictors of ETF was evident in the logistic regression model. Variables that might potentially extend the model of ETF are identified for future research efforts.	[Webb, James W.; Batchelor, Jennifer; Meares, Susanne; Taylor, Alan] Macquarie Univ, Dept Psychol, Sydney, NSW 2109, Australia; [Marsh, Nigel V.] James Cook Univ, Dept Psychol, Singapore, Singapore	Webb, JW (corresponding author), Macquarie Univ, Dept Psychol, Sydney, NSW 2109, Australia.	james.webb@xtra.co.nz	Marsh, Nigel V./F-5433-2019	Marsh, Nigel V./0000-0002-4060-6432; Meares, Susanne/0000-0002-3859-9974; Batchelor, Jennifer/0000-0003-4438-4993			American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Armistead-Jehle P, 2010, APPL NEUROPSYCHOL, V17, P52, DOI 10.1080/09084280903526182; Ashendorf L, 2004, ARCH CLIN NEUROPSYCH, V19, P125, DOI 10.1016/S0887-6177(02)00218-4; Babikian T, 2006, CLIN NEUROPSYCHOL, V20, P145, DOI 10.1080/13854040590947362; Baker R, 2000, Appl Neuropsychol, V7, P111, DOI 10.1207/S15324826AN0702_8; Belsley D, 1980, REGRESSION DIAGNOSTI; Bianchini KJ, 2006, CLIN NEUROPSYCHOL, V20, P831, DOI 10.1080/13854040600875203; Bierley RA, 2001, BRAIN INJURY, V15, P697, DOI 10.1080/02699050010013671; Boone KB, 1999, CLIN NEUROPSYCHOL, V13, P414; Boone KB, 2002, J CLIN EXP NEUROPSYC, V24, P561, DOI 10.1076/jcen.24.5.561.1004; Bruusgaard D, 2010, SCAND J PUBLIC HEALT, V38, P686, DOI 10.1177/1403494810378916; Carone DA, 2008, BRAIN INJURY, V22, P960, DOI 10.1080/02699050802491297; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Chafetz M, 2011, APPL NEUROPSYCHOL, V18, P143, DOI 10.1080/09084282.2011.570619; Dandachi-FitzGerald B, 2011, CLIN NEUROPSYCHOL, V25, P812, DOI 10.1080/13854046.2011.583280; Demakis GJ, 2008, CLIN NEUROPSYCHOL, V22, P879, DOI 10.1080/13854040701564482; Donders J, 2007, BRAIN INJURY, V21, P319, DOI 10.1080/02699050701253129; Dragano N, 2011, REHABILITATION, V50, P28, DOI 10.1055/s-0030-1270431; Ekman P, 2006, BEHAV SCI LAW, V24, P673, DOI 10.1002/bsl.729; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Flach PA, 2008, SCAND J PUBLIC HEALT, V36, P713, DOI 10.1177/1403494808092251; Goldberg H. E., 2007, ASSESSMENT FEIGNED C, P281; Gorissen M, 2005, SCHIZOPHR RES, V78, P199, DOI 10.1016/j.schres.2005.02.016; Green P, 2001, CLIN NEUROPSYCHOL, V15, P492, DOI 10.1076/clin.15.4.492.1887; Green P, 2001, BRAIN INJURY, V15, P1045, DOI 10.1080/02699050110088254; Green P, 1999, BRAIN INJURY, V13, P813, DOI 10.1080/026990599121205; Green P., 2003, GREENS WORD MEMORY T; Green P., 2009, NEUROPSYCHOLOGY MALI, P132; Greiffenstein M.F., 1994, PSYCHOL ASSESSMENT, V6, P218, DOI [https://doi.org/10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; Greiffenstein MF, 2006, LEGAL CRIMINOL PSYCH, V11, P131, DOI 10.1348/135532505X49828; Greve KW, 2006, J CLIN EXP NEUROPSYC, V28, P1176, DOI 10.1080/13803390500263550; Greve KW, 2009, CLIN NEUROPSYCHOL, V23, P1250, DOI 10.1080/13854040902828272; GRONWALL D, 1980, Journal of Clinical Neuropsychology, V2, P51, DOI 10.1080/01688638008403780; Grote CL, 2000, J CLIN EXP NEUROPSYC, V22, P709, DOI 10.1076/jcen.22.6.709.958; Hardin J. W., 1995, STATA TECHNICAL B; Harrell Frank E., 2001, REGRESSION MODELING; Henry GK, 2011, APPL NEUROPSYCHOL, V18, P47, DOI 10.1080/09084282.2010.523385; Hoffman E, 1996, AM ECON REV, V86, P653; Hosmer D. W., 2000, APPL LOGISTIC REGRES; Inman TH, 1998, PSYCHOL ASSESSMENT, V10, P128, DOI 10.1037/1040-3590.10.2.128; Jones A, 2012, CLIN NEUROPSYCHOL, V26, P790, DOI 10.1080/13854046.2012.693202; Jones A, 2011, CLIN NEUROPSYCHOL, V25, P1207, DOI 10.1080/13854046.2011.600726; Kashluba S, 2008, ARCH PHYS MED REHAB, V89, P904, DOI 10.1016/j.apmr.2007.12.029; Killeen PR, 2009, PSYCHOL REV, V116, P602, DOI 10.1037/a0016414; Krokstad S, 2002, INT J EPIDEMIOL, V31, P1183, DOI 10.1093/ije/31.6.1183; Kuoppala J, 2011, J OCCUP ENVIRON MED, V53, P633, DOI 10.1097/JOM.0b013e31821aa48c; Lange RT, 2010, J CLIN EXP NEUROPSYC, V32, P961, DOI 10.1080/13803391003645657; Larrabee G. J., 2007, ASSESSMENT MALINGERE, P3; Larrabee G.J., 2007, ASSESSMENT MALINGERE, P334; Larrabee GJ, 2003, ARCH CLIN NEUROPSYCH, V18, P673, DOI 10.1016/S0887-6177(02)00157-9; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P410, DOI 10.1076/clin.17.3.410.18089; Mahdavi ME, 2011, ARCH IRAN MED, V14, P58, DOI 011141/AIM.0013; Mason S, 2002, J TRAUMA, V53, P98, DOI 10.1097/00005373-200207000-00019; Meyers JE, 2011, ARCH CLIN NEUROPSYCH, V26, P8, DOI 10.1093/arclin/acq083; MILLER H, 1961, BRIT MED J, V1, P919, DOI 10.1136/bmj.1.5230.919; MILLER H, 1961, BRIT MED J, V1, P992, DOI 10.1136/bmj.1.5231.992; MILLER H, 1972, LANCET, V1, P580; Mooney G, 2005, BRAIN INJURY, V19, P975, DOI 10.1080/02699050500110264; Moore BA, 2004, BRAIN INJURY, V18, P975, DOI 10.1080/02699050410001672350; Nelson NW, 2007, J INT NEUROPSYCH SOC, V13, P440, DOI 10.1017/S1355617707070373; OLEARY A, 1985, BEHAV RES THER, V23, P437, DOI 10.1016/0005-7967(85)90172-X; Ord JS, 2010, J CLIN EXP NEUROPSYC, V32, P380, DOI 10.1080/13803390903066881; Paniak C, 2002, J CLIN EXP NEUROPSYC, V24, P187, DOI 10.1076/jcen.24.2.187.999; Rees LM, 2001, ARCH CLIN NEUROPSYCH, V16, P501, DOI 10.1016/S0887-6177(00)00064-0; Rey A, 1964, EXAMEN CLIN PSYCHOL; Rohling ML, 2002, ARCH CLIN NEUROPSYCH, V17, P205, DOI 10.1016/S0887-6177(01)00109-3; Ross SR, 2006, CLIN NEUROPSYCHOL, V20, P798, DOI 10.1080/13854040500328477; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Ruocco AC, 2005, ARCH CLIN NEUROPSYCH, V20, P883; Salazar X. F., 2007, ASSESSMENT FEIGNED C, P405; Schroeder RW, 2011, CLIN NEUROPSYCHOL, V25, P437, DOI 10.1080/13854046.2011.556668; Seligman MEP, 2000, AM PSYCHOL, V55, P5, DOI 10.1037/0003-066X.55.1.5; SHORES EA, 1986, MED J AUSTRALIA, V144, P569, DOI 10.5694/j.1326-5377.1986.tb112311.x; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; Statacorp, 2011, STAT REL 12 STAT SOF; Stulemeijer M, 2007, BRAIN INJURY, V21, P309, DOI 10.1080/02699050701209980; Suhr J, 1997, J CLIN EXP NEUROPSYC, V19, P500, DOI 10.1080/01688639708403740; Suhr J. A., 2007, ASSESSMENT MALINGERE, P334; Sullivan MJL, 1995, PSYCHOL ASSESSMENT, V7, P524, DOI 10.1037/1040-3590.7.4.524; Sumanti M, 2006, CLIN NEUROPSYCHOL, V20, P754, DOI 10.1080/13854040500428467; TEASDALE G, 1974, LANCET, V2, P81; TEASDALE GM, 1995, J NEUROL NEUROSUR PS, V58, P526, DOI 10.1136/jnnp.58.5.526; Tombaugh TN, 1997, PSYCHOL ASSESSMENT, V9, P260, DOI 10.1037/1040-3590.9.3.260; Tombaugh TN, 1996, TEST MEMORY MALINGER; Torres X, 2009, GEN HOSP PSYCHIAT, V31, P137, DOI 10.1016/j.genhosppsych.2008.12.001; Victor T, 2009, CLIN NEUROPSYCHOL, V23, P297, DOI 10.1080/13854040802232682; WADDELL G, 1993, PAIN, V52, P157, DOI 10.1016/0304-3959(93)90127-B; Wenzel M, 2004, J ECON PSYCHOL, V25, P213, DOI 10.1016/S0167-4870(02)00168-X; West LK, 2011, J NEUROPSYCHOL, V5, P114, DOI 10.1348/174866410X521434; White B, 2008, REHABIL PSYCHOL, V53, P9, DOI 10.1037/0090-5550.53.1.9; Whiteside DM, 2009, CLIN NEUROPSYCHOL, V23, P523, DOI 10.1080/13854040802389169; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014	92	17	17	0	12	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.		2012	26	8					1377	1396		10.1080/13854046.2012.728248			20	Psychology, Clinical; Clinical Neurology; Psychology	Psychology; Neurosciences & Neurology	045LG	WOS:000311696700008	23061431				2021-06-18	
J	Bottari, C; Gosselin, N; Guillemette, M; Lamoureux, J; Ptito, A				Bottari, Carolina; Gosselin, Nadia; Guillemette, M.; Lamoureux, J.; Ptito, Alain			Independence in managing one's finances after traumatic brain injury	BRAIN INJURY			English	Article						Problem-solving; planning; cognition; brain injuries; independent living; rehabilitation; executive functions	MILD COGNITIVE IMPAIRMENT; PATIENTS PERFORMING ACTIVITIES; FRONTAL-LOBE DAMAGE; EXECUTIVE DEFICITS; DYSFUNCTION; ABILITIES; AWARENESS; CAPACITY; VALIDITY; PROFILE	Primary objective: To establish whether the budgeting task of the Instrumental Activities of Daily Living (IADL) Profile discriminates individuals with a traumatic brain injury (TBI) from healthy controls and to identify the nature of the observed difficulties. Method: This study tested 27 adults with moderate or severe TBI and 27 controls matched for age, sex and education on the budgeting task of the IADL Profile. The budgeting task is a complex real-world problem involving the preparation of a yearly budget for an individual living on a fixed income with the goal of saving money to purchase a car. Main results: The results showed that TBI subjects, the majority of whom had documented frontal lesions and/or diffuse axonal injury based on CT scan reports, were more likely than control subjects to experience difficulties on all task-related operations (planning, carrying out and verifying attainment of goal), with planning being particularly affected. These deficits were shown to impact on financial abilities, an issue of particular concern for TBI individuals reporting full responsibility of their finances. Conclusions: The budgeting task of the IADL Profile discriminates TBI subjects from controls. Planning was shown to be the most significant difficulty underlying reduced independence in the task.	[Ptito, Alain] McGill Univ, Ctr Hlth, Dept Psychol, Montreal, PQ H3A 1A1, Canada; [Bottari, Carolina] Univ Montreal, Sch Rehabil, Occupat Therapy Program, Montreal, PQ, Canada; [Bottari, Carolina; Gosselin, Nadia; Ptito, Alain] McGill Univ, Montreal Neurol Inst, Cognit Neurosci Unit, Montreal, PQ, Canada; [Bottari, Carolina; Gosselin, Nadia; Ptito, Alain] McGill Univ, Dept Neurol & Neurosurg, Montreal, PQ H3A 1A1, Canada; [Bottari, Carolina; Lamoureux, J.] Ctr Interdisciplinary Res Rehabil Greater Montrea, Montreal, PQ, Canada; [Guillemette, M.] Hop Anna Laberge, Montreal, PQ, Canada	Ptito, A (corresponding author), McGill Univ, Ctr Hlth, Dept Psychol, 1025 Pine Ave W, Montreal, PQ H3A 1A1, Canada.	alain.ptito@mcgill.ca			Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR); Quebec Rehabilitation Research network; Fonds de la recherche en sante du QuebecFonds de la Recherche en Sante du Quebec [6623]; Centre for Interdisciplinary Research in Rehabilitation of Greater Montreal	This study was supported by the Canadian Institutes of Health Research (fellowships to Nadia Gosselin and Carolina Bottari), the Quebec Rehabilitation Research network (studentship to Melanie Guillemette), the Fonds de la recherche en sante du Quebec (grant to Elisabeth Dutil, Carolina Bottari and collaborators; Grant number 6623) and the Centre for Interdisciplinary Research in Rehabilitation of Greater Montreal.	Ameratunga S, 2006, LANCET, V367, P1533, DOI 10.1016/S0140-6736(06)68654-6; Bottari C, 2010, ARCH PHYS MED REHAB, V91, P734, DOI 10.1016/j.apmr.2009.12.023; Bottari C, 2009, NEUROPSYCHOL REHABIL, V19, P177, DOI 10.1080/09602010802188435; Bottari C, 2009, BRAIN INJURY, V23, P322, DOI 10.1080/02699050902788436; Bottari CL, 2010, CAN J OCCUP THER, V77, P90, DOI 10.2182/cjot.2010.77.2.5; Chevignard M, 2000, CORTEX, V36, P649, DOI 10.1016/S0010-9452(08)70543-4; DUNCAN J, 1986, COGNITIVE NEUROPSYCH, V3, P271, DOI 10.1080/02643298608253360; ESLINGER PJ, 1985, NEUROLOGY, V35, P1731, DOI 10.1212/WNL.35.12.1731; Fleming J, 1999, OCCUP THER J RES, V19, P3, DOI 10.1177/153944929901900101; Fortin S, 2002, BRAIN COGNITION, V48, P361, DOI 10.1006/brcg.2001.1378; Fortin S, 2003, CORTEX, V39, P273, DOI 10.1016/S0010-9452(08)70109-6; Gale SD, 2005, J NEUROL NEUROSUR PS, V76, P984, DOI 10.1136/jnnp.2004.036210; Godbout L, 2005, BRAIN INJURY, V19, P337, DOI 10.1080/02699050400005093; Goel V, 1997, BRAIN, V120, P1805, DOI 10.1093/brain/120.10.1805; Grafman J, 1999, LANCET, V354, P1921, DOI 10.1016/S0140-6736(99)90438-5; Griffith HR, 2003, NEUROLOGY, V60, P449, DOI 10.1212/WNL.60.3.449; Hoskin K. M., 2005, PSYCHIAT PSYCHOL LAW, V12, P56, DOI [http://dx.doi.org/10.1375/pplt.2005.12.1.56, DOI 10.1375/PPLT.2005.12.1.56]; Hoskin KM, 2005, REHABIL PSYCHOL, V50, P355, DOI 10.1037/0090-5550.50.4.355; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Lezak M. D., 1989, ASSESSMENT BEHAV CON, P113; Luria, 1973, WORKING BRAIN INTRO; Luria A. R., 1966, HIGHER CORTICAL FUNC; MARSON DC, 2000, ARCH CLIN NEUROPSYCH, V15, P638; Moye J, 2007, J GERONTOL B-PSYCHOL, V62, pP3, DOI 10.1093/geronb/62.1.P3; Okonkwo OC, 2008, AM J GERIAT PSYCHIAT, V16, P650, DOI 10.1097/JGP.0b013e31817e8a9d; SEARIGHT R, 1991, J MENT HEALTH ADMIN, V18, P128; SHALLICE T, 1991, BRAIN, V114, P727, DOI 10.1093/brain/114.2.727; SHALLICE T, 1982, PHILOS T ROY SOC B, V298, P199, DOI 10.1098/rstb.1982.0082; Slawik H, 2009, J NEUROTRAUM, V26, P1891, DOI 10.1089/neu.2009.0942; Triebel KL, 2009, NEUROLOGY, V73, P928, DOI 10.1212/WNL.0b013e3181b87971; Turken And U, 2009, BMC Med Imaging, V9, P20, DOI 10.1186/1471-2342-9-20; Wechsler D., 1997, WMS 3 WECHSLER MEMOR	32	17	17	0	10	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	DEC	2011	25	13-14					1306	1317		10.3109/02699052.2011.624570			12	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	847MI	WOS:000296976600006	22077536				2021-06-18	
J	Giebel, S; Kothari, R; Koestner, A; Mohney, G; Baker, R				Giebel, Stephen; Kothari, Rashmi; Koestner, Amy; Mohney, Gretchen; Baker, Robert			FACTORS INFLUENCING EMERGENCY MEDICINE PHYSICIANS' MANAGEMENT OF SPORTS-RELATED CONCUSSIONS: A COMMUNITY-WIDE STUDY	JOURNAL OF EMERGENCY MEDICINE			English	Article						sports medicine; concussion; management	HIGH-SCHOOL; INTERNATIONAL-CONFERENCE; STATEMENT; RECOVERY	Background: Numerous guidelines to grade and manage sports-related concussions have been published. However, little is known about how frequently they are implemented in the emergency department. This study evaluates the current practices of emergency physicians (EPs) in managing sports-related concussions. Objectives: To evaluate the current practice of EP evaluation and management of sports-related concussions. Methods: All EPs and emergency medicine residents in Kalamazoo County were surveyed regarding their management of sports-related concussions. The surveys obtained demographic data, participants' use of guidelines, and the importance of clinical and non-clinical factors in deciding when to allow a player to return to play. Results: Of the 73 EP respondents, only 23% used a nationally recognized guideline, with no significant difference between attending and resident EPs. The symptomatic complaints of loss of consciousness, amnesia of the event, and difficulty concentrating were ranked most important by EPs in assessing patients with sports-related concussions. Among non-clinical factors, residents were significantly more likely than attendings to report that medical-legal, parental, and players' concerns were more likely to influence their decision in allowing a patient to return to play. Conclusion: EPs take into consideration important clinical factors in assessing patients with sports-related concussion. However, almost 75% do not use any nationally recognized guideline in their evaluation. Residents are more likely than attendings to be influenced by non-clinical factors. (C) 2011 Elsevier Inc.	[Giebel, Stephen; Kothari, Rashmi] Michigan State Univ, Kalamazoo Ctr Med Studies, Dept Emergency Med, Kalamazoo, MI 49008 USA; [Kothari, Rashmi; Koestner, Amy] Borgess Med Ctr, Kalamazoo, MI USA; [Mohney, Gretchen] Kalamazoo Valley Orthoped, Kalamazoo, MI USA; [Baker, Robert] Michigan State Univ, Kalamazoo Ctr Med Studies, Dept Family Med, Kalamazoo, MI 49008 USA	Kothari, R (corresponding author), Michigan State Univ, Kalamazoo Ctr Med Studies, Dept Emergency Med, 1000 Oakland Dr, Kalamazoo, MI 49008 USA.			Mohney, Gretchen/0000-0001-8600-9070			CANTU RC, 1995, PHYSICIAN SPORTSMED, V23, P27, DOI 10.1080/00913847.1995.11947799; Cantu RC, 2001, J ATHL TRAINING, V36, P244; *CDCP, 2007, MORTALITY MORBIDITY, V0056; Centers for Disease Control and Prevention (CDC), 1997, MMWR Morb Mortal Wkly Rep, V46, P224; Collins Michael W, 2002, Curr Sports Med Rep, V1, P12; Collins MW, 2003, CLIN J SPORT MED, V13, P222, DOI 10.1097/00042752-200307000-00005; Covassin T, 2009, J ATHL TRAINING, V44, P400, DOI 10.4085/1062-6050-44.4.400; Erlanger D, 2003, J NEUROSURG, V98, P477, DOI 10.3171/jns.2003.98.3.0477; Ferrara MS, 2001, J ATHL TRAINING, V36, P145; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; KELLY JP, 1991, JAMA-J AM MED ASSOC, V266, P2867, DOI 10.1001/jama.266.20.2867; Kelly JP, 1997, NEUROLOGY, V48, P581; Lovell M, 2009, CLIN SPORT MED, V28, P95, DOI 10.1016/j.csm.2008.08.008; Lovell MR, 2004, AM J SPORT MED, V32, P47, DOI 10.1177/0363546503260723; Lovell MR, 2003, J NEUROSURG, V98, P296, DOI 10.3171/jns.2003.98.2.0296; McCrea M, 2001, J ATHL TRAINING, V36, P274; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2009, PHYSICIAN SPORTSMED, V37, P141, DOI 10.3810/psm.2009.06.1721; SAUNDERS RL, 1984, JAMA-J AM MED ASSOC, V252, P538, DOI 10.1001/jama.252.4.538	19	17	17	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0736-4679	1090-1280		J EMERG MED	J. Emerg. Med.	DEC	2011	41	6					649	654		10.1016/j.jemermed.2011.03.021			6	Emergency Medicine	Emergency Medicine	869BZ	WOS:000298572000013	21550754				2021-06-18	
J	Huang, APH; Lee, CW; Hsieh, HJ; Yang, CC; Tsai, YH; Tsuang, FY; Kuo, LT; Chen, YS; Tu, YK; Huang, SJ; Liu, HM; Tsai, JC				Huang, Abel Po-Hao; Lee, Chung-Wei; Hsieh, Hong-Jen; Yang, Chi-Cheng; Tsai, Yi-Hsin; Tsuang, Fon-Yih; Kuo, Lu-Ting; Chen, Yuan-Shen; Tu, Yong-Kwang; Huang, Sheng-Jean; Liu, Hon-Man; Tsai, Jui-Chang			Early Parenchymal Contrast Extravasation Predicts Subsequent Hemorrhage Progression, Clinical Deterioration, and Need for Surgery in Patients With Traumatic Cerebral Contusion	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						Head trauma; Contrast extravasation; Perfusion; Computed tomography; Contusion; Blood-brain barrier	ACUTE ISCHEMIC-STROKE; SPOT SIGN SCORE; INTRACEREBRAL HEMORRHAGE; BRAIN-INJURY; IDENTIFIES PATIENTS; HIGHEST RISK; HEAD TRAUMA; BLOOD-FLOW; TRANSFORMATION; PERMEABILITY	Background: This study aimed to identify early radiologic signs that are predictive of hemorrhage progression and clinical deterioration in patients with traumatic cerebral contusion. We hypothesized that contrast extravasation (CE) and blood-brain barrier disruption might be associated with hemorrhage progression, brain edema, and clinical deterioration in these patients. Methods: Twenty-two patients with traumatic cerebral contusion (diagnosed on initial noncontrast head computed tomography [CT]) who initially did not require surgical intervention were enrolled in this study. Contrast-enhanced and perfusion CT scans were performed within 6 hours of injury, and follow-up noncontrast CT scans were performed at 24 hours and 72 hours. Results: In each noncontrast CT scan, the volumes of the contusion hemorrhage and edema were calculated using computerized planimetric techniques. The initial Glasgow Coma Scale, hemorrhage progression, clinical deterioration, and the need for subsequent surgery were recorded. The early radiologic findings were compared with these parameters and functional outcome at 6 months to identify predictive radiologic signs. CE was present in 9 of 22 patients (41%) and was highly associated with hemorrhage progression (p < 0.05), clinical deterioration (p < 0.01), and need for subsequent surgery (p < 0.01). In addition, patients with CE had a greater volume of edema at 24 hours (p < 0.01) and 72 hours (p < 0.01) than those who did not have CE. However, CE was not found to be associated with poor outcome. Conclusions: Early parenchymal CE is associated with hemorrhage progression, cerebral edema, clinical deterioration, and need for subsequent surgery. These patients should be monitored closely, and early surgery may be needed if deterioration occurs. Further elucidation of the pathophysiology is needed to formulate effective treatment for these high-risk patients.	[Huang, Abel Po-Hao; Tsai, Yi-Hsin; Tsuang, Fon-Yih; Kuo, Lu-Ting; Chen, Yuan-Shen; Tu, Yong-Kwang; Huang, Sheng-Jean; Tsai, Jui-Chang] Natl Taiwan Univ Hosp, Dept Surg, Div Neurosurg, Taipei 100, Taiwan; [Tsai, Yi-Hsin; Huang, Sheng-Jean] Natl Taiwan Univ Hosp, Dept Traumatol, Taipei, Taiwan; [Lee, Chung-Wei; Liu, Hon-Man] Natl Taiwan Univ Hosp, Dept Radiol, Taipei, Taiwan; [Huang, Abel Po-Hao; Kuo, Lu-Ting; Chen, Yuan-Shen; Huang, Sheng-Jean] Natl Taiwan Univ Hosp, Dept Surg, Yun Lin Branch, Yunlin, Taiwan; [Hsieh, Hong-Jen] Natl Taiwan Univ Hosp, Dept Radiol, Yun Lin Branch, Yunlin, Taiwan; [Tsai, Jui-Chang] Natl Taiwan Univ, Coll Med, Ctr Optoelect Biomed, Taipei, Taiwan; [Yang, Chi-Cheng] Chang Gung Univ, Grad Inst Clin Behav Sci, Tao Yuan, Taiwan; [Yang, Chi-Cheng] Chang Gung Univ, Dept Occupat Therapy, Tao Yuan, Taiwan	Tsai, JC (corresponding author), 7 Chung Shan S Rd, Taipei 100, Taiwan.	jctsai@ntu.edu.tw	Liu, Hon-Man/B-1352-2012	LIU, HON-MAN/0000-0001-6715-6366; Tu, Yong-kwang/0000-0003-2113-1176; Kuo, Lu-Ting/0000-0002-1405-8700; HUANG, ABEL PO-HAO/0000-0002-5689-6761; LEE, CHUNG-WEI/0000-0002-3573-2506; TSAI, JUI-CHANG/0000-0003-2723-6841; Tsuang, Fon-Yih/0000-0001-5797-1885			Allard CB, 2009, J TRAUMA, V67, P959, DOI 10.1097/TA.0b013e3181ad5d37; Almandoz JED, 2010, STROKE, V41, P54, DOI 10.1161/STROKEAHA.109.565382; Almandoz JED, 2009, STROKE, V40, P2994, DOI 10.1161/STROKEAHA.109.554667; Chakraborty S, 2010, BRIT J RADIOL, V83, pE216, DOI 10.1259/bjr/74416385; Chang EF, 2006, NEUROSURGERY, V58, P647, DOI 10.1227/01.NEU.0000197101.68538.E6; Chieregato A, 2005, NEUROSURGERY, V56, P671, DOI 10.1227/01.NEU.0000156200.76331.7A; Chieregato A, 2004, J NEUROTRAUM, V21, P655, DOI 10.1089/0897715041269669; Cohan MJ, 2007, J TRAUMA, V63, P1254, DOI 10.1097/TA.0b013e318156ee4c; Hallevi H, 2010, CEREBROVASC DIS, V29, P217, DOI 10.1159/000267842; Hom J, 2011, AM J NEURORADIOL, V32, P41, DOI 10.3174/ajnr.A2244; Jander S, 2007, STROKE, V38, P642, DOI 10.1161/01.STR.0000250048.42916.ad; Lescot T, 2006, CRIT CARE MED, V34, P3029, DOI 10.1097/01.CCM.0000243797.42346.64; Narayan RK, 2008, J NEUROTRAUM, V25, P629, DOI 10.1089/neu.2007.0385; Oertel M, 2002, J NEUROSURG, V96, P109, DOI 10.3171/jns.2002.96.1.0109; Powers WJ, 2010, STROKE, V41, pS107, DOI 10.1161/STROKEAHA.110.595058; Rodriguez-Baeza A, 2003, ANAT REC PART A, V273A, P583, DOI 10.1002/ar.a.10069; Servadei F, 2000, NEUROSURGERY, V46, P70; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Stein SC, 2004, NEUROSURGERY, V54, P687, DOI 10.1227/01.NEU.0000108641.98845.88; Stein SC, 2002, J NEUROSURG, V97, P1373, DOI 10.3171/jns.2002.97.6.1373; Vo KD, 2003, AM J NEURORADIOL, V24, P674; von Oettingen G, 2002, NEUROSURGERY, V50, P781, DOI 10.1097/00006123-200204000-00019; Zaharchuk G, 2007, AM J NEURORADIOL, V28, P1850, DOI 10.3174/ajnr.A0831	23	17	19	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	DEC	2011	71	6					1593	1599		10.1097/TA.0b013e31822c8865			7	Critical Care Medicine; Surgery	General & Internal Medicine; Surgery	869RT	WOS:000298616400026	22182869				2021-06-18	
J	Saboori, P; Sadegh, A				Saboori, P.; Sadegh, A.			Material modeling of the head's subarachnoid space	SCIENTIA IRANICA			English	Article						Subarachnoid; Material modeling; Finite element; Head; Brain; Impact		The goal of this study is to investigate the mechanotransduction of an external load to the brain and the causation of concussion and Traumatic Brain Injury (TBI). However, as one step toward this goal, in this paper, the investigation of the material model selection and material properties of the subarachnoid space (SAS) are presented. As the interface between the skull and the brain, the material modeling of SAS plays an important role in the analysis of damping and movement of the brain within the skull, leading to TBI. Based on the histology and morphology of the SAS region, three material types, namely, soft solid, viscous fluid and porous media were proposed. To validate these material models, the relative displacement between the skull and the brain was compared with the experimental study. It was concluded that the optimum material properties of the three material models are for soft solid material, E = 1000 Pa, for viscous fluid, mu = 0.25 Pa.s, and for porous media, the permeability of 3.125 x 10(-10) m(2). The results indicated that the properties determined in this study for the three material models are appropriate and reliable for future investigations. That is, if one decides to use any of these materials to model the SAS, in local or global FE analyses, these values are suitable. (C) 2012 Sharif University of Technology. Production and hosting by Elsevier B.V. All rights reserved.	[Sadegh, A.] CUNY City Coll, Dept Mech Engn, New York, NY 10031 USA; [Saboori, P.] Manhattan Coll, Dept Mech Engn, Riverdale, NY USA; [Sadegh, A.] CUNY City Coll, Ctr Adv Engn Design & Dev, New York, NY USA	Sadegh, A (corresponding author), CUNY City Coll, Dept Mech Engn, New York, NY 10031 USA.	sadegh@ccny.cuny.edu					Al-Bsharat A., 1999, J STAPP CAR CRASH C, V43; Bayly PV, 2005, J NEUROTRAUM, V22, P845, DOI 10.1089/neu.2005.22.845; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Feng Y, 2010, J R SOC INTERFACE, V7, P1677, DOI 10.1098/rsif.2010.0210; Gupta S, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3005171; Jin X., 2006, J STAPP CAR CRASH, V50, P637; Kierszenbaum AL, 2007, HISTOLOGY CELL BIOL; Killer HE, 2006, BRAIN, V129, P1027, DOI 10.1093/brain/awl045; Kleiven S., 2002, J STAPP CAR CRASH, V46; Kleiven S, 2007, J STAPP CAR CRASH, V21, P81; Moss WC, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.108702; Ruan J.S., 1993, STAPP CAR CRASH C, P37; Saboori P., 2011, THESIS CITY U NEW YO; Saboori P., 2010, 16 US NAT C THEOR AP; Saboori P., 2010, JUN SCI C JSC VIENN; Saboori P., 2009, P INT MECH ENG C EXP; Saboori P., 2010, 26 SO BIOM ENG C SBE; Saboori P., 2010, P INT MECH ENG C EXP; Saboori P., 2011, SOC BIOM C FARM PENN; Saboori P., 2010, SUMM BIOENG C SBS; Saboori P., 2011, ARCHITECTURE HISTOLO; Saboori P., 2011, P INT MECH ENG C EXP; Saboori Parisa, 2011, MECHANOTRANSDUCTION; Takhounts EG, 2008, STAPP CAR C, V52, P1; Trosseille X., 1992, STAPP CAR CRASH C, V36; Van Der Rest M., 1991, 412 CNRSUPR U C BERN; Zhang L, 2001, Stapp Car Crash J, V45, P369; Zhang Liying, 2002, Stapp Car Crash J, V46, P145; Zhang LY, 2001, NEUROL RES, V23, P144, DOI 10.1179/016164101101198488; Zhang LY, 2001, J NEUROTRAUM, V18, P21, DOI 10.1089/089771501750055749; Zoghi M., 2009, INT J COMPUT METHODS, V12, P1; Zoghi-Moghadam M, 2008, COMPUT METHOD BIOMEC, V11, P397, DOI 10.1080/10255840701848806; Zoghi-Moghadam M, 2010, INT J BIOMED ENG TEC, V4, P195, DOI 10.1504/IJBET.2010.034939	33	17	17	0	1	SHARIF UNIV TECHNOLOGY	TEHRAN	PO BOX 11155-8639, TEHRAN, 00000, IRAN	1026-3098			SCI IRAN	Sci. Iran.	DEC	2011	18	6					1492	1499		10.1016/j.scient.2011.11.032			8	Engineering, Multidisciplinary	Engineering	890VR	WOS:000300174500045					2021-06-18	
J	Toglia, J; Goverover, Y; Johnston, MV; Dain, B				Toglia, Joan; Goverover, Yael; Johnston, Mark V.; Dain, Barry			Application of the Multicontextual Approach in Promoting Learning and Transfer of Strategy Use in an Individual With TBI and Executive Dysfunction	OTJR-OCCUPATION PARTICIPATION AND HEALTH			English	Article						metacognition; strategy use; cognitive rehabilitation	TRAUMATIC BRAIN-INJURY; COGNITIVE REHABILITATION; OCCUPATIONAL-THERAPY; SELF-REGULATION; AWARENESS; INTERVENTIONS; ADULTS; SKILLS	The multicontext approach addresses strategy use and self-monitoring skills within activities and contexts that are systematically varied to facilitate transfer of learning. This article illustrates the application of the multicontext approach by presenting a case study of an adult who is 5 years post-traumatic brain injury with executive dysfunction and limited awareness. A single case study design with repeated pre-post measures was used. Methods to monitor strategy generation and specific awareness within intervention are described. Findings suggest improved functional performance and generalization of use of an external strategy despite absence of changes in general self-awareness of deficits. This case describes the multicontext intervention process and provides clinical suggestions for working with individuals with serious deficits in awareness and executive dysfunction following traumatic brain injury.	[Toglia, Joan] Mercy Coll, Dobbs Ferry, NY 10522 USA; [Goverover, Yael] NYU, Dept Occupat Therapy, New York, NY USA; [Johnston, Mark V.] Univ Wisconsin, Coll Hlth Sci, Milwaukee, WI 53201 USA; [Dain, Barry] Helen Hayes Hosp, Post Acute TBI Serv, W Haverstraw, NY USA	Toglia, J (corresponding author), Mercy Coll, Dobbs Ferry, NY 10522 USA.	JToglio@mercy.edu	Toglia, Joan/AAN-6674-2021	Toglia, Joan/0000-0002-6902-6853			Alderman N, 2003, J INT NEUROPSYCH SOC, V9, P31, DOI 10.1017/S1355617703910046; American Occupational Therapy Association, 2008, AM J OCCUPATIONAL TH, V62, P625, DOI DOI 10.5014/AJOT.62.6.625; Baum CM, 2008, TEST MANUAL EXECUTIV; BURKE W H, 1991, Brain Injury, V5, P241, DOI 10.3109/02699059109008095; *CDCP, 2003, TBI REP C MILD TRAUM; Cicerone KD, 1992, NEUROREHABILITATION, V2, P12, DOI DOI 10.3233/NRE-1992-2304; Cicerone K, 2006, J COGNITIVE NEUROSCI, V18, P1212, DOI 10.1162/jocn.2006.18.7.1212; ESLINGER P, 2007, BRAIN INJURY MED PRI, P770; Giles GM, 2005, COGNITION OCCUPATION, P139; Goverover Y, 2007, BRAIN INJURY, V21, P913, DOI 10.1080/02699050701553205; Johnston MV, 2009, OTJR-OCCUP PART HEAL, V29, P4; Kennedy MRT, 2008, NEUROPSYCHOL REHABIL, V18, P257, DOI 10.1080/09602010701748644; Martelli MF, 2008, NEUROREHABILITATION, V23, P115; MAYER NH, 1986, CLIN NEUROPSYCHOLOGY, P205; McDonald BC, 2002, NEUROREHABILITATION, V17, P333; Nelson DL, 1996, AM J OCCUP THER, V50, P223, DOI 10.5014/ajot.50.3.223; Ownsworth T., 2009, NEUROPSYCHOL REHABIL, V20, P59, DOI 10.1080/09602010902949223; Ownsworth TL, 2000, CLIN NEUROPSYCHOL, V14, P76, DOI 10.1076/1385-4046(200002)14:1;1-8;FT076; Parish L, 2007, NEUROPSYCHOL REHABIL, V17, P230, DOI 10.1080/09602010600750675; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Roth R.M., 2005, BEHAV RATING INVENTO; SCHWARTZ SM, 1995, AM J OCCUP THER, V49, P655, DOI 10.5014/ajot.49.7.655; Sherer M, 1998, J INT NEUROPSYCH SOC, V4, P380, DOI 10.1017/S1355617798003804; Sherer M, 1998, BRAIN INJURY, V12, P63, DOI 10.1080/026990598122863; Sosin DM, 1996, BRAIN INJURY, V10, P47; Toglia J, 2010, BRAIN INJURY, V24, P664, DOI 10.3109/02699051003610474; Toglia JP, 1998, COGNITION AND OCCUPATION IN REHABILITATION, P5; TOGLIA JP, 1991, AM J OCCUP THER, V45, P505, DOI 10.5014/ajot.45.6.505; TOGLIA JP, 2003, WILLARD SPACKMANS OC, P264	29	17	17	0	13	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1539-4492	1938-2383		OTJR-OCCUP PART HEAL	OTJR-Occup. Particip. Health	WIN	2011	31	1		S	SI		S53	S60		10.3928/15394492-20101108-09			8	Rehabilitation	Rehabilitation	707ME	WOS:000286289900009	24650265				2021-06-18	
J	Wheaton, P; Mathias, JL; Vink, R				Wheaton, P.; Mathias, J. L.; Vink, R.			Impact of pharmacological treatments on outcome in adult rodents after traumatic brain injury: a meta-analysis	JOURNAL OF PSYCHOPHARMACOLOGY			English	Article						Adult rodents; meta-analysis; outcome; pharmacological treatments; traumatic brain injury	CLOSED-HEAD INJURY; IMPROVES FUNCTIONAL RECOVERY; REDUCES NEUROLOGICAL DEFICIT; REGIONAL CEREBRAL EDEMA; NITRIC-OXIDE SYNTHASE; ACETYLCHOLINESTERASE INHIBITOR; NEUROBEHAVIORAL DEFICITS; COGNITIVE DEFICITS; MAGNESIUM THERAPY; CONTUSION VOLUME	Pharmacological treatments have been widely investigated in pre-clinical animal trials to evaluate their usefulness in reducing cognitive, behavioural and motor problems after traumatic brain injury (TBI). However, the relative efficacy of these agents has yet to be evaluated, making it difficult to assess the strength of evidence for their use in a clinical population. A meta-analytic review of research (1980-2009) was therefore conducted to examine the impact of pharmacological treatments administered to adult male rodents after experimental TBI on cognitive, behavioural, and motor outcome. The PubMed and PsycInfo databases were searched using 35 terms. Weighted Cohen's d effect sizes, percent overlap, Fail-Safe N statistics and confidence intervals were calculated for each treatment. In total, 91 treatments were evaluated in 223 pre-clinical trials, comprising 5988 rodents. Treatments that were investigated by multiple studies and showed large and significant treatment effects were of greatest interest. Of the 16 treatments that were efficacious, six improved cognition, 10 improved motor function and no treatment improved behaviour (depression/anxiety, aggression, zoosociat behaviour). Treatment benefits were found across a range of TBI models. Drug dosage and treatment interval impacted on treatment effects.	[Wheaton, P.; Mathias, J. L.] Univ Adelaide, Sch Psychol, Adelaide, SA 5005, Australia; [Vink, R.] Univ Adelaide, Sch Med Sci, Adelaide, SA 5005, Australia	Mathias, JL (corresponding author), Univ Adelaide, Sch Psychol, Adelaide, SA 5005, Australia.	jane.mathias@adelaide.edu.au	AM, Robert Vink/S-5616-2019; Mathias, J L/L-6295-2013; Vink, Robert/J-7351-2012	AM, Robert Vink/0000-0002-4885-0667; Vink, Robert/0000-0002-4885-0667; Mathias, Jane/0000-0001-8957-8594	Neurosurgical Foundation of Australia; Faculty of Health Sciences of The University of Adelaide	This research was supported by the Neurosurgical Foundation of Australia and the Faculty of Health Sciences of The University of Adelaide.	Arlinghaus KA, 2005, TXB TRAUMATIC BRAIN; Ashley MJ, 2004, TRAUMATIC BRAIN INJU; Barbre AB, 2006, BRAIN RES BULL, V69, P639, DOI 10.1016/j.brainresbull.2006.03.009; Bareyre FM, 1999, J NEUROCHEM, V73, P271, DOI 10.1046/j.1471-4159.1999.0730271.x; Barone FC, 2000, J CARDIOVASC PHARM, V36, pS357, DOI 10.1097/00005344-200036001-00104; Belayev L, 1999, J NEUROTRAUM, V16, P445, DOI 10.1089/neu.1999.16.445; Berman RF, 2000, J NEUROSURG, V93, P821, DOI 10.3171/jns.2000.93.5.0821; Besson VC, 2005, NEUROSCI LETT, V388, P7, DOI 10.1016/j.neulet.2005.06.019; Brauze Damian, 2002, Journal of Applied Genetics, V43, P371; Browne KD, 2004, J NEUROSCI RES, V77, P878, DOI 10.1002/jnr.20215; Chen Y, 1998, BRAIN RES, V784, P18, DOI 10.1016/S0006-8993(97)00982-7; Chen Y, 1998, J NEUROTRAUM, V15, P231, DOI 10.1089/neu.1998.15.231; Cheng JP, 2007, NEUROSCI LETT, V416, P165, DOI 10.1016/j.neulet.2007.02.006; Clark RSB, 2007, J NEUROTRAUM, V24, P1399, DOI 10.1089/neu.2007.0305; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Cohen J., 1977, STAT POWER ANAL BEHA, P1; Cooper J. R., 2003, BIOCH BASIS NEUROPHA; DELATORRE JC, 1995, NEUROSURGERY, V37, P273, DOI 10.1227/00006123-199508000-00012; Dempsey RJ, 2003, J NEUROSURG, V98, P867, DOI 10.3171/jns.2003.98.4.0867; Dixon CE, 1997, EXP NEUROL, V146, P479, DOI 10.1006/exnr.1997.6557; Dixon CE, 1997, J NEUROTRAUM, V14, P161, DOI 10.1089/neu.1997.14.161; Faden AI, 1999, AM J PHYSIOL-REG I, V277, pR1196; Faden AI, 2003, J CEREBR BLOOD F MET, V23, P342, DOI 10.1097/01.WCB.0000046143.31247.FD; FADEN AI, 1993, J NEUROTRAUM, V10, P91, DOI 10.1089/neu.1993.10.91; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Feng Dong-fu, 2004, Chin J Traumatol, V7, P148; Finnie JW, 2002, VET PATHOL, V39, P679, DOI 10.1354/vp.39-6-679; Finnie JW, 2001, AUST VET J, V79, P628, DOI 10.1111/j.1751-0813.2001.tb10785.x; Fromm L, 2004, J AM COLL NUTR, V23, p529S, DOI 10.1080/07315724.2004.10719396; HAMM RJ, 1993, COGNITIVE BRAIN RES, V1, P223, DOI 10.1016/0926-6410(93)90006-Q; Hamm RJ, 1996, J NEUROTRAUM, V13, P325, DOI 10.1089/neu.1996.13.325; Heath DL, 1998, SCAND J CLIN LAB INV, V58, P161, DOI 10.1080/00365519850186751; Heath DL, 1998, J NEUROTRAUM, V15, P183, DOI 10.1089/neu.1998.15.183; Heath DL, 1999, J NEUROSURG, V90, P504, DOI 10.3171/jns.1999.90.3.0504; Hedges L.V., 1985, STAT METHODS META AN; Hinson J, 1996, BRAIN RES BULL, V39, P311, DOI 10.1016/0361-9230(96)00025-1; Hoane MR, 2006, J NEUROTRAUM, V23, P1535, DOI 10.1089/neu.2006.23.1535; Hoane MR, 2005, J NEUROTRAUM, V22, P1112, DOI 10.1089/neu.2005.22.1112; Hoane MR, 2005, RESTOR NEUROL NEUROS, V23, P67; Hoane MR, 2003, J NEUROTRAUM, V20, P1189, DOI 10.1089/089771503770802871; Hoane MR, 2003, BRAIN RES BULL, V60, P105, DOI 10.1016/S0361-9230(03)00022-4; Hoffman AN, 2008, LIFE SCI, V83, P602, DOI 10.1016/j.lfs.2008.08.007; Huang W, 1999, EUR J PHARMACOL, V366, P127, DOI 10.1016/S0014-2999(98)00929-7; Hunter, 1982, METAANALYSIS CUMULAT, V4; Hunter J.E., 2004, METHODS METAANALYSIS; Ji BA, 2000, J BIOL CHEM, V275, P19115, DOI 10.1074/jbc.M001685200; Ji YC, 2005, J KOREAN MED SCI, V20, P291, DOI 10.3346/jkms.2005.20.2.291; Kline AE, 2002, NEUROSCI LETT, V333, P179, DOI 10.1016/S0304-3940(02)01101-1; Kline AE, 2001, NEUROSCIENCE, V106, P547, DOI 10.1016/S0306-4522(01)00300-1; Kline AE, 2004, J NEUROTRAUM, V21, P1712, DOI 10.1089/0897715042664849; Kline AE, 2007, BEHAV BRAIN RES, V177, P186, DOI 10.1016/j.bbr.2006.11.036; Knoblach SM, 2002, J NEUROTRAUM, V19, P1039, DOI 10.1089/089771502760341956; Knoller N, 2002, CRIT CARE MED, V30, P548, DOI 10.1097/00003246-200203000-00009; Lee LL, 2004, EXP NEUROL, V190, P70, DOI 10.1016/j.expneurol.2004.07.003; Lipsey M.W., 2001, PRACTICAL METAANALYS, V49; Longhi L, 2009, CRIT CARE MED, V37, P659, DOI 10.1097/CCM.0b013e318195998a; Louin G, 2006, NEUROPHARMACOLOGY, V50, P182, DOI 10.1016/j.neuropharm.2005.08.020; Lu DY, 2007, J NEUROTRAUM, V24, P1132, DOI 10.1089/neu.2007.0288; Lu DY, 2005, J NEUROTRAUM, V22, P1011, DOI 10.1089/neu.2005.22.1011; Lu DY, 2004, J NEUROTRAUM, V21, P21, DOI 10.1089/089771504772695913; Lu DY, 2003, J NEUROSURG, V99, P351, DOI 10.3171/jns.2003.99.2.0351; Lu DY, 2004, J NEUROSURG, V101, P813, DOI 10.3171/jns.2004.101.5.0813; Marklund N, 2001, J NEUROTRAUM, V18, P821, DOI 10.1089/089771501316919184; Marklund N, 2007, J NEUROSURG, V107, P844, DOI 10.3171/JNS-07/10/0844; Mbye LH, 2009, J CEREBR BLOOD F MET, V29, P87, DOI 10.1038/jcbfm.2008.93; McIntosh TK, 1989, J NEUROTRAUM, V6, P247, DOI 10.1089/neu.1989.6.247; Morganti-Kossmann MC, 2007, INJURY, V38, P1392, DOI 10.1016/j.injury.2007.10.005; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; O'Connor CA, 2003, J NEUROTRAUM, V20, P533, DOI 10.1089/089771503767168465; O'Connor CA, 2007, EXP NEUROL, V205, P145, DOI 10.1016/j.expneurol.2007.01.034; Okiyama K, 1998, BRAIN RES, V792, P291, DOI 10.1016/S0006-8993(98)00158-9; Okiyama K, 1997, J NEUROTRAUM, V14, P211, DOI 10.1089/neu.1997.14.211; Okuyama S, 1997, NEUROL RES, V19, P300, DOI 10.1080/01616412.1997.11740816; Olga NK, 2006, BEHAV BRAIN RES, V170, P233, DOI 10.1016/j.bbr.2006.02.026; PAPPIUS HM, 1991, NEUROCHEM RES, V16, P941, DOI 10.1007/BF00965837; Pascual JM, 2007, J NEUROTRAUM, V24, P944, DOI 10.1089/neu.2006.0190; Pike BR, 1997, PHARMACOL BIOCHEM BE, V57, P785, DOI 10.1016/S0091-3057(96)00453-4; Pillay NS, 2007, BRAIN RES, V1153, P158, DOI 10.1016/j.brainres.2007.03.056; ROSENTHAL R, 1995, PSYCHOL BULL, V118, P183, DOI 10.1037/0033-2909.118.2.183; Rothstein HR, 2005, PUBLICATION BIAS IN META-ANALYSIS: PREVENTION, ASSESSMENT AND ADJUSTMENTS, P1, DOI 10.1002/0470870168; Schmanke T, 1997, J NEUROTRAUM, V14, P459, DOI 10.1089/neu.1997.14.459; SHAPIRA Y, 1995, J NEUROSURG ANESTH, V7, P17, DOI 10.1097/00008506-199501000-00004; Shohami E, 2003, J CEREBR BLOOD F MET, V23, P728, DOI 10.1097/01.WCB.0000067704.86573.83; SHOHAMI E, 1995, BRAIN RES, V674, P55, DOI 10.1016/0006-8993(94)01433-I; Silver JM, 2005, TXB TRAUMATIC BRAIN; Sindhu F, 1997, J ADV NURS, V25, P1262, DOI 10.1046/j.1365-2648.1997.19970251262.x; Sinson G, 1997, J NEUROSURG, V86, P511, DOI 10.3171/jns.1997.86.3.0511; Sinz EH, 1999, J CLIN INVEST, V104, P647, DOI 10.1172/JCI6670; Smith JM, 2007, BRAIN, V130, P915, DOI 10.1093/brain/awl393; Tan AA, 2009, J NEUROTRAUM, V26, P539, DOI 10.1089/neu.2008.0611; Temple MD, 1996, BRAIN RES, V741, P246, DOI 10.1016/S0006-8993(96)00940-7; Tilley A, 1996, INTRO PSYCHOL RES ST; Turner RJ, 2004, J AM COLL NUTR, V23, p534S, DOI 10.1080/07315724.2004.10719397; Vales K, 2006, NEUROSCI RES, V55, P383, DOI 10.1016/j.neures.2006.04.007; Wagner AK, 2007, BEHAV BRAIN RES, V181, P200, DOI 10.1016/j.bbr.2007.04.006; Wahl F, 1997, BRAIN RES, V756, P247, DOI 10.1016/S0006-8993(97)00144-3; Webster RA, 2003, NEUROTRANSMITTERS DR; Yaka R, 2007, FASEB J, V21, P2033, DOI 10.1096/fj.06-7856com; Yatsiv I, 2005, FASEB J, V19, P1701, DOI 10.1096/fj.05-3907fje; Yatsiv I, 2002, J CEREBR BLOOD F MET, V22, P971, DOI 10.1097/00004647-200208000-00008; Zakzanis K. K., 1999, STUD NEUROPSYCHOL DE; Zakzanis KK, 2001, ARCH CLIN NEUROPSYCH, V16, P653, DOI 10.1016/S0887-6177(00)00076-7; Zamudio S, 2005, BRAIN RES BULL, V65, P339, DOI 10.1016/j.brainresbull.2005.01.009; Zarubina IV, 2003, B EXP BIOL MED+, V136, P56, DOI 10.1023/A:1026040930146; Zhu J, 2000, EXP NEUROL, V166, P136, DOI 10.1006/exnr.2000.7484	105	17	17	0	5	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0269-8811	1461-7285		J PSYCHOPHARMACOL	J. Psychopharmacol.	DEC	2011	25	12					1581	1599		10.1177/0269881110388331			19	Clinical Neurology; Neurosciences; Pharmacology & Pharmacy; Psychiatry	Neurosciences & Neurology; Pharmacology & Pharmacy; Psychiatry	869AW	WOS:000298569000001	21300634				2021-06-18	
J	Yang, CJ; Hsiao, KY; Su, IC; Chen, IC				Yang, Chia-Jung; Hsiao, Kuang-Yu; Su, I-Chun; Chen, I-Chuan			The Association Between Anemia and the Mortality of Severe Traumatic Brain Injury in Emergency Department	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						Anemia; Traumatic brain injury; Transfusion; Emergency department	CRITICALLY-ILL PATIENTS; SEVERE HEAD-INJURY; HYPOTENSION INCREASES MORTALITY; BLOOD-CELL TRANSFUSION; PREHOSPITAL HYPOTENSION; CARDIOPULMONARY BYPASS; CEREBRAL OXYGENATION; VALID INDICATOR; TEAM ACTIVATION; BRIEF EPISODE	Background: Anemia is a common medical problem for critically ill patients. Blood transfusion to augment oxygen delivery for these patients has been a traditional therapy. However, few studies have identified the impact of anemia on individuals suffering from severe traumatic brain injury (TBI). Hence, this study aims to evaluate the effects of initial anemia on patients with severe TBI admitted to the Emergency Unit. Methods: We reviewed the medical records of patients with isolated severe TBI admitted to the Emergency Unit of a university hospital from July 2003 to June 2008. Patients were divided into two groups based on their initial anemia data taken while in the Emergency Unit. The anemia datum is defined as hemoglobin (Hb) <10 mg/dL. The t test was used to identify the differences between the two groups, while logistic regression was applied to determine any significant differences found in the statistical analysis. Results: A total of 234 patients were signed up in our study. Based on their initial hemoglobin at emergency department, 23 patients (9.8%) comprised the anemia group, 17 patients (7.3%) comprised the nonanemia group, whereas 112 patients (47.9%) belonging to the nonanemia group were deceased. There is no significant difference between the two groups (p = 0.076; odds ratio, 0.97; confidence interval, 0.78-1.05). Conclusion: This study shows that initial anemia is not a mortality risk factor for patients with isolated severe blunt TBI.	[Yang, Chia-Jung; Hsiao, Kuang-Yu; Su, I-Chun; Chen, I-Chuan] Chang Gung Mem Hosp, Dept Emergency Med, Puzih City 613, Chiayi County, Taiwan; [Yang, Chia-Jung; Hsiao, Kuang-Yu; Su, I-Chun; Chen, I-Chuan] Chang Gung Univ, Coll Med, Dept Med, Gueishan Township, Taoyuan County, Taiwan	Chen, IC (corresponding author), Chang Gung Mem Hosp, Dept Emergency Med, 6 W Sec,Jiapu Rd, Puzih City 613, Chiayi County, Taiwan.	giomacky@gmail.com					Bjerke HS, 2000, J TRAUMA, V48, P1037; Carlson AP, 2006, J TRAUMA, V61, P567, DOI 10.1097/01.ta.0000231768.44727.a2; Chesnut RM, 1997, J TRAUMA, V42, pS4, DOI 10.1097/00005373-199705001-00002; Diringer MN, 2000, J NEUROSURG, V92, P7, DOI 10.3171/jns.2000.92.1.0007; Dorsch N W, 1994, J Clin Neurosci, V1, P19, DOI 10.1016/0967-5868(94)90005-1; Duane TM, 2008, J SURG RES, V147, P163, DOI 10.1016/j.jss.2008.02.044; Ely EW, 1999, NEW ENGL J MED, V340, P467, DOI 10.1056/NEJM199902113400610; Franklin GA, 2000, J TRAUMA, V48, P1034, DOI 10.1097/00005373-200006000-00006; George ME, 2008, NEUROCRIT CARE, V8, P337, DOI 10.1007/s12028-008-9066-y; GOPINATH SP, 1994, J NEUROL NEUROSUR PS, V57, P717, DOI 10.1136/jnnp.57.6.717; Habib RH, 2003, J THORAC CARDIOV SUR, V125, P1438, DOI 10.1016/S0022-5223(02)73291-1; Hebert PC, 1999, NEW ENGL J MED, V340, P409, DOI 10.1056/NEJM199902113400601; Hebert PC, 1997, AM J RESP CRIT CARE, V155, P1618, DOI 10.1164/ajrccm.155.5.9154866; Jeremitsky E, 2003, J TRAUMA, V54, P312, DOI 10.1097/01.TA.0000037876.37236.D6; Jonas RA, 2003, J THORAC CARDIOV SUR, V126, P1765, DOI 10.1016/j.jtcvs.2003.04.003; KASSELL NF, 1990, J NEUROSURG, V73, P18, DOI 10.3171/jns.1990.73.1.0018; KRAUS JF, 1984, AM J EPIDEMIOL, V119, P186, DOI 10.1093/oxfordjournals.aje.a113737; KRAUS JF, 2005, TXB TRAUMATIC BRAIN, P3; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Malone DL, 2006, J TRAUMA, V60, pS91, DOI 10.1097/01.ta.0000199549.80731.e6; Masson F, 2001, J TRAUMA, V51, P481, DOI 10.1097/00005373-200109000-00010; McCrossan L, 2002, BRIT J ANAESTH, V88, P6, DOI 10.1093/bja/88.1.6; McIntyre LA, 2006, NEUROCRIT CARE, V5, P4, DOI 10.1385/NCC:5:1:4; Leal-Noval SR, 2008, CRIT CARE MED, V36, P1290, DOI 10.1097/CCM.0b013e3181692dfc; Robertson CS, 1999, CRIT CARE MED, V27, P2086, DOI 10.1097/00003246-199910000-00002; Salim A, 2008, J AM COLL SURGEONS, V207, P398, DOI 10.1016/j.jamcollsurg.2008.03.013; Sena MJ, 2009, INTENS CARE MED, V35, P480, DOI 10.1007/s00134-008-1289-z; Shapiro MB, 2002, J TRAUMA, V53, P236; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; TIRET L, 1990, INT J EPIDEMIOL, V19, P133, DOI 10.1093/ije/19.1.133; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073; Walsh TS, 2004, CRIT CARE MED, V32, P364, DOI 10.1097/01.CCM.0000108878.23703.E0; Zenati MS, 2002, J TRAUMA, V53, P232, DOI 10.1097/00005373-200208000-00007; Zygun DA, 2005, CAN J NEUROL SCI, V32, P87, DOI 10.1017/S0317167100016930; Zygun DA, 2009, CRIT CARE MED, V37, P1074, DOI 10.1097/CCM.0b013e318194ad22	35	17	18	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0022-5282			J TRAUMA	J. Trauma-Injury Infect. Crit. Care	DEC	2011	71	6					E132	E135		10.1097/TA.0b013e31820ea36b			4	Critical Care Medicine; Surgery	General & Internal Medicine; Surgery	869RT	WOS:000298616400003	21427611				2021-06-18	
J	Cullen, DK; Browne, KD; Xu, YA; Adeeb, S; Wolf, JA; McCarron, RM; Yang, S; Chavko, M; Smith, DH				Cullen, D. Kacy; Browne, Kevin D.; Xu, Yongan; Adeeb, Saleena; Wolf, John A.; McCarron, Richard M.; Yang, Shu; Chavko, Mikulas; Smith, Douglas H.			Blast-Induced Color Change in Photonic Crystals Corresponds with Brain Pathology	JOURNAL OF NEUROTRAUMA			English	Article						blast exposure; blast injury detection; blast injury dosimeter; blast neuropathology; blast sensor; mild traumatic brain injury; nanomaterial	DIFFUSE AXONAL INJURY; ADULT-RAT BRAIN; MULTIBEAM INTERFERENCE; INDUCED NEUROTRAUMA; OXIDATIVE STRESS; AMYLOID-BETA; EXPOSURE; OVERPRESSURE; ACCUMULATION; MECHANISMS	A high incidence of blast exposure is a 21st century reality in counter-insurgency warfare. However, thresholds for closed-head blast-induced traumatic brain injury (bTBI) remain unknown. Moreover, without objective information about relative blast exposure, warfighters with bTBI may not receive appropriate medical care and may remain in harm's way. Accordingly, we have engineered a blast injury dosimeter (BID) using a photonic crystalline material that changes color following blast exposure. The photonic crystals are fabricated using SU-8 via multi-beam interference laser lithography. The final BID is similar in appearance to an array of small colored stickers that may be affixed to uniforms or helmets in multiple locations. Although durable under normal conditions, the photonic crystalline micro- and nano-structure are precisely altered by blast to create a color change. These BIDs were evaluated using a rat model of bTBI, for which blast shockwave exposure was generated via a compressed air-driven shock tube. With prototype BID arrays affixed to the animals, we found that BID color changes corresponded with subtle brain pathologies, including neuronal degeneration and reactive astrocytosis. These subtle changes were most notable in the dentate gyrus of the hippocampus, cerebral cortex, and cerebellum. These data demonstrate the feasibility of using a materials-based, power-free colorimetric BID as the first self-contained blast sensor calibrated to correspond with brain pathology.	[Cullen, D. Kacy; Browne, Kevin D.; Wolf, John A.; Smith, Douglas H.] Univ Penn, Ctr Brain Injury & Repair, Dept Neurosurg, Philadelphia, PA 19104 USA; [Xu, Yongan; Yang, Shu] Univ Penn, Dept Mat Sci & Engn, Philadelphia, PA 19104 USA; [Adeeb, Saleena; McCarron, Richard M.; Chavko, Mikulas] USN, Trauma & Resuscitat Med Dept, Med Res Ctr, Silver Spring, MD USA	Smith, DH (corresponding author), Univ Penn, Ctr Brain Injury & Repair, Dept Neurosurg, 105 Hayden Hall,3320 Smith Walk, Philadelphia, PA 19104 USA.	smithdou@mail.med.upenn.edu	Wolf, John A/A-1034-2007; Xu, Yongan/A-7078-2011; Yang, Shu/D-9758-2011	Wolf, John A/0000-0002-6950-2303; Yang, Shu/0000-0001-8834-3320	Nanotechnology Institute of Philadelphia; Office of Naval Research (ONR)Office of Naval Research [N00014-05-0303]; Air Force Office of Scientific Research (AFOSR)United States Department of DefenseAir Force Office of Scientific Research (AFOSR) [FA9550-06-1-0228]; National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS038104, NS056202, NS043126]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS038104, P01NS056202, T32NS043126] Funding Source: NIH RePORTER	This work was supported by the Nanotechnology Institute of Philadelphia Proof-of-Concept (PoC) Fund, the Office of Naval Research (ONR) (grant # N00014-05-0303), the Air Force Office of Scientific Research (AFOSR) (grant # FA9550-06-1-0228), and the National Institutes of Health (NIH) (grants # NS038104, # NS056202, and # NS043126). The authors thank Constance J. Mietus and William Lane for technical contributions.	Agoston DV, 2009, J NEUROTRAUM, V26, P901, DOI 10.1089/neu.2008.0724; Campbell M, 2000, NATURE, V404, P53; Cernak I, 2001, J TRAUMA, V50, P695, DOI 10.1097/00005373-200104000-00017; Chavko M, 2008, J TRAUMA, V65, P1140, DOI 10.1097/TA.0b013e3181870a8c; Chavko M, 2007, J NEUROSCI METH, V159, P277, DOI 10.1016/j.jneumeth.2006.07.018; Chavko M, 2006, J TRAUMA, V61, P933, DOI 10.1097/01.ta.0000233742.75450.47; Chavko M, 2009, SHOCK, V32, P325, DOI 10.1097/SHK.0b013e31819c38f1; Chen XH, 1999, J NEUROPATH EXP NEUR, V58, P588, DOI 10.1097/00005072-199906000-00003; Cullen DK, 2011, NEUROIMAGE, V54, pS37, DOI 10.1016/j.neuroimage.2010.10.076; DeWitt DS, 2009, J NEUROTRAUM, V26, P877, DOI 10.1089/neu.2007.0439; Elder GA, 2009, MT SINAI J MED, V76, P111, DOI 10.1002/msj.20098; Elsayed NM, 2007, TOXICOL SCI, V95, P289, DOI 10.1093/toxsci/kfl138; Elsayed NM, 2003, TOXICOLOGY, V189, P63, DOI 10.1016/S0300-483X(03)00153-7; Elsayed NM, 1997, TOXICOLOGY, V121, P81, DOI 10.1016/S0300-483X(97)03657-3; Garman RH, 2011, J NEUROTRAUM, V28, P947, DOI 10.1089/neu.2010.1540; GHIRADELLA H, 1972, SCIENCE, V178, P1214, DOI 10.1126/science.178.4066.1214; Gorbunov NV, 1997, AM J PHYSIOL-LUNG C, V272, pL320; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2009, NEW ENGL J MED, V360, P1588, DOI 10.1056/NEJMp0810606; Kato K, 2007, J NEUROSURG, V106, P667, DOI 10.3171/jns.2007.106.4.667; Kaur C., 1997, Annals Academy of Medicine Singapore, V26, P27; KAUR C, 1995, NEUROPATH APPL NEURO, V21, P369, DOI 10.1111/j.1365-2990.1995.tb01073.x; Kinoshita S, 2005, CHEMPHYSCHEM, V6, P1442, DOI 10.1002/cphc.200500007; Koliatsos VE, 2011, J NEUROPATH EXP NEUR, V70, P399, DOI 10.1097/NEN.0b013e3182189f06; Leung Lai Yee, 2008, Molecular & Cellular Biomechanics, V5, P155; Levin HS, 2010, J NEUROTRAUM, V27, P683, DOI 10.1089/neu.2009.1073; Li YZ, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.010902; Long JB, 2009, J NEUROTRAUM, V26, P827, DOI 10.1089/neu.2008.0748; Martin E.M, 2008, J TRAUMA NURS, V15, P100; Martin Elisabeth Moy, 2008, J Trauma Nurs, V15, P94, DOI 10.1097/01.JTN.0000337149.29549.28; Matthews SC, 2011, NEUROIMAGE, V54, pS69, DOI 10.1016/j.neuroimage.2010.04.269; Meagher Sean, 2008, Mil Med, V173, pxx; Miklyaev YV, 2003, APPL PHYS LETT, V82, P1284, DOI 10.1063/1.1557328; MITTL RL, 1994, AM J NEURORADIOL, V15, P1583; Moochhala SM, 2004, J TRAUMA, V56, P393, DOI 10.1097/01.TA.0000066181.50879.7A; Moon JH, 2005, J MACROMOL SCI-POL R, VC45, P351, DOI 10.1080/15321790500304163; Noh H, 2010, OPT EXPRESS, V18, P11942, DOI 10.1364/OE.18.011942; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; PHILLIPS YY, 1991, CONVENTIONAL WARFARE, P221; Readnower RD, 2010, J NEUROSCI RES, V88, P3530, DOI 10.1002/jnr.22510; Risling M, 2011, NEUROIMAGE, V54, pS89, DOI 10.1016/j.neuroimage.2010.05.031; Saljo A, 2002, J NEUROTRAUM, V19, P985, DOI 10.1089/089771502320317131; Saljo A, 2000, J NEUROTRAUM, V17, P719, DOI 10.1089/089771500415454; Saljo Annette, 2001, Pathophysiology, V8, P105, DOI 10.1016/S0928-4680(01)00067-0; Saljo A, 2008, J NEUROTRAUM, V25, P1397, DOI 10.1089/neu.2008.0602; Smith DH, 1999, J NEUROPATH EXP NEUR, V58, P982, DOI 10.1097/00005072-199909000-00008; Smith DH, 2003, J NEUROSURG, V98, P1072, DOI 10.3171/jns.2003.98.5.1072; Svetlov SI, 2009, J NEUROTRAUM, V26, P913, DOI 10.1089/neu.2008.0609; Taber KH, 2006, J NEUROPSYCH CLIN N, V18, P141, DOI 10.1176/appi.neuropsych.18.2.141; Tanielian T, 2008, INVISIBLE WOUNDS WAR; Van Boven RW, 2009, J REHABIL RES DEV, V46, P717, DOI 10.1682/JRRD.2008.12.0161; Vukusic P, 2003, NATURE, V424, P852, DOI 10.1038/nature01941; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Wojcik BE, 2010, AM J PREV MED, V38, pS108, DOI 10.1016/j.amepre.2009.10.006; Xu Y, 2008, CHEM MATER, V20, P1816, DOI 10.1021/cm702511k; Yang S, 2002, CHEM MATER, V14, P2831, DOI 10.1021/cm0256007; Zi J, 2003, P NATL ACAD SCI USA, V100, P12576, DOI 10.1073/pnas.2133313100	57	17	17	0	19	MARY ANN LIEBERT INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	NOV	2011	28	11			SI		2307	2318		10.1089/neu.2010.1718			12	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	849VY	WOS:000297154600009	22082449	Green Published			2021-06-18	
J	Magou, GC; Guo, Y; Choudhury, M; Chen, L; Hususan, N; Masotti, S; Pfister, BJ				Magou, George C.; Guo, Yi; Choudhury, Mridusmita; Chen, Linda; Hususan, Nicholae; Masotti, Stephanie; Pfister, Bryan J.			Engineering a High Throughput Axon Injury System	JOURNAL OF NEUROTRAUMA			English	Article						diffuse axonal injury; high throughput; in vitro model; stretch injury; traumatic axonal injury	TRAUMATIC BRAIN-INJURY; IN-VITRO MODEL; SQUID GIANT-AXON; MECHANICAL INJURY; CORTICAL-NEURONS; HEAD-INJURY; DELAYED DEPOLARIZATION; HIPPOCAMPAL-NEURONS; CALCIUM RESPONSE; SODIUM-CHANNELS	Several key biological mechanisms of traumatic injury to axons have been elucidated using in vitro stretch injury models. These models, however, are based on the experimentation of single cultures keeping productivity slow. Indeed, low yield has hindered important and well-founded investigations requiring high throughput methods such as proteomic analyses. To meet this need, we engineered a multi-well high throughput injury device to accelerate and accommodate the next generation of traumatic brain injury research. This modular system stretch injures neuronal cultures in either a 24-well culture plate format or 6 individual wells simultaneously. Custom software control allows the user to accurately program the pressure pulse parameters to achieve the desired substrate deformation and injury parameters. Analysis of the pressure waveforms showed that peak pressure was linearly related to input pressure and valve open times and that the 6- and 24-well modules displayed rise times, peak pressures, and decays with extremely small standard deviations. Data also confirmed that the pressure pulse was distributed evenly throughout the pressure chambers and therefore to each injury well. Importantly, the relationship between substrate deformation and applied pressure was consistent among the multiple wells and displayed a predictable linear behavior in each module. These data confirm that this multi-well system performs as well as currently used stretch injury devices and can undertake high throughput studies that are needed across the field of neurotrauma research.	[Magou, George C.; Guo, Yi; Choudhury, Mridusmita; Chen, Linda; Hususan, Nicholae; Masotti, Stephanie; Pfister, Bryan J.] New Jersey Inst Technol, Dept Biomed Engn, Newark, NJ 07102 USA	Pfister, BJ (corresponding author), New Jersey Inst Technol, Dept Biomed Engn, Newark, NJ 07102 USA.	pfister@njit.edu		Guo, Yi/0000-0003-3103-6447	New Jersey Commission on Brain Injury Research [07-3204-BIR-E-0]; NSFNational Science Foundation (NSF) [CBET-0747615]	This work was supported by the New Jersey Commission on Brain Injury Research (07-3204-BIR-E-0) and the NSF CAREER (CBET-0747615). We thank Mr. John Hoinowski of the Biomedical Engineering Design Studio for his ingenuity and construction of the device components. Also we would like to express our gratitude to Drs. Douglas H. Smith and David F. Meaney for their continued mentorship and support.	ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; Cargill RS, 1996, J NEUROTRAUM, V13, P395, DOI 10.1089/neu.1996.13.395; Chen YC, 2009, J NEUROTRAUM, V26, P861, DOI 10.1089/neu.2008.0645; Cohen AS, 2007, PROG BRAIN RES, V161, P143, DOI 10.1016/S0079-6123(06)61010-8; ELLIS EF, 1995, J NEUROTRAUM, V12, P325, DOI 10.1089/neu.1995.12.325; GALBRAITH JA, 1993, J BIOMECH ENG-T ASME, V115, P13, DOI 10.1115/1.2895464; Gallant PE, 1997, J NEUROTRAUM, V14, P811, DOI 10.1089/neu.1997.14.811; Geddes DM, 2003, J NEUROTRAUM, V20, P1039, DOI 10.1089/089771503770195885; Geddes DM, 2003, EXP NEUROL, V184, P420, DOI 10.1016/S0014-4886(03)00254-1; Geddes DM, 2001, J BIOMECH ENG-T ASME, V123, P247, DOI 10.1115/1.1374201; Goforth PB, 2004, J NEUROTRAUM, V21, P719, DOI 10.1089/0897715041269704; Graham D I, 1988, Prog Clin Biol Res, V264, P159; Graham D.I., 1993, HEAD INJURY, P91; GRAHAM DI, 1988, J CLIN PATHOL, V41, P34, DOI 10.1136/jcp.41.1.34; HOLBOURN AHS, 1945, BRIT MED BULL, V3, P147, DOI 10.1093/oxfordjournals.bmb.a071895; Iwata A, 2004, J NEUROSCI, V24, P4605, DOI 10.1523/JNEUROSCI.0515-03.2004; Kao CQ, 2004, J NEUROTRAUM, V21, P259, DOI 10.1089/089771504322972059; Kraus JF, 1993, HEAD INJURY, P1; LaPlaca MC, 2005, J BIOMECH, V38, P1093, DOI 10.1016/j.jbiomech.2004.05.032; LaPlaca MC, 1997, ANN BIOMED ENG, V25, P665, DOI 10.1007/BF02684844; LaPlaca MC, 1998, J NEUROSCI RES, V52, P220, DOI 10.1002/(SICI)1097-4547(19980415)52:2<220::AID-JNR10>3.0.CO;2-B; Lea PM, 2003, J NEUROTRAUM, V20, P1233, DOI 10.1089/089771503770802907; Lee AA, 1996, AM J PHYSIOL-CELL PH, V271, pC1400; Levin HS, 1998, CURR OPIN NEUROL, V11, P643, DOI 10.1097/00019052-199812000-00006; LIGHTHALL J W, 1989, Journal of Neurotrauma, V6, P83, DOI 10.1089/neu.1989.6.83; LUCAS JH, 1992, J NEUROTRAUM, V9, P117, DOI 10.1089/neu.1992.9.117; Lusardi TA, 2004, ANN BIOMED ENG, V32, P1546, DOI 10.1114/B:ABME.0000049038.75368.75; Lusardi TA, 2004, J NEUROTRAUM, V21, P61, DOI 10.1089/089771504772695959; Lusardi TA, 2003, BIORHEOLOGY, V40, P401; MARGULIES SS, 1992, J BIOMECH, V25, P917, DOI 10.1016/0021-9290(92)90231-O; MARGULIES SS, 1990, J BIOMECH, V23, P823, DOI 10.1016/0021-9290(90)90029-3; MARGULIES SS, 1985, P INT RES COUNCIL BI, P223; Meaney D.F., 1998, FRONTIERS HEAD NECK; Meaney D.F., 1990, INT C BIOMECHANICS I; MEANEY DF, 1995, J NEUROTRAUM, V12, P689, DOI 10.1089/neu.1995.12.689; Meaney DF, 1993, ASME CRASHWORTHINESS, V25, P169; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; Miller WJ, 2009, J NEUROTRAUM, V26, P789, DOI [10.1089/neu.2008.0727, 10.1089/neu.2008-0727]; Morrison B, 1998, J NEUROTRAUM, V15, P911, DOI 10.1089/neu.1998.15.911; Morrison B, 2006, J NEUROSCI METH, V150, P192, DOI 10.1016/j.jneumeth.2005.06.014; Morrison B, 1998, ANN BIOMED ENG, V26, P381, DOI 10.1114/1.61; Pfister B.J., 2001, THESIS J HOPKINS U; Pfister BJ, 2003, ANN BIOMED ENG, V31, P589, DOI 10.1114/1.1566445; Pfister Bryan, 2004, Mech Chem Biosyst, V1, P233; POVLISHOCK JT, 1992, BRAIN PATHOL, V2, P1; Prado GR, 2005, J NEURAL ENG, V2, P148, DOI 10.1088/1741-2560/2/4/011; Rzigalinski BA, 1998, J NEUROCHEM, V70, P2377; Santhakumar V, 2001, ANN NEUROL, V50, P708, DOI 10.1002/ana.1230; Smith DH, 2000, NEUROSCIENTIST, V6, P483, DOI 10.1177/107385840000600611; Smith DH, 1999, J NEUROSCI, V19, P4263; Smith DH, 2003, J HEAD TRAUMA REHAB, V18, P307, DOI 10.1097/00001199-200307000-00003; Sosin DM, 1996, BRAIN INJURY, V10, P47; Sotoudeh M, 1998, ANN BIOMED ENG, V26, P181, DOI 10.1114/1.88; Spaethling JM, 2008, J NEUROTRAUM, V25, P1207, DOI 10.1089/neu.2008.0532; STRICH SJ, 1961, LANCET, V2, P443; Tavalin SJ, 1997, J NEUROPHYSIOL, V77, P632; Tavalin SJ, 1995, J NEUROPHYSIOL, V74, P2767; von Reyn CR, 2009, J NEUROSCI, V29, P10350, DOI 10.1523/JNEUROSCI.2339-09.2009; Wolf JA, 2001, J NEUROSCI, V21, P1923, DOI 10.1523/JNEUROSCI.21-06-01923.2001; Yuen TJ, 2009, J NEUROSCI RES, V87, P3620, DOI 10.1002/jnr.22161	61	17	17	0	9	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	NOV	2011	28	11			SI		2203	2218		10.1089/neu.2010.1596			16	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	849VY	WOS:000297154600002	21787172				2021-06-18	
J	Ogilvie, MP; Pereira, BMT; Ryan, ML; Gomez-Rodriguez, JC; Pierre, EJ; Livingstone, AS; Proctor, KG				Ogilvie, Michael P.; Pereira, Bruno M. T.; Ryan, Mark L.; Gomez-Rodriguez, Juan Carlos; Pierre, Edgar J.; Livingstone, Alan S.; Proctor, Kenneth G.			Bispectral Index to Monitor Propofol Sedation in Trauma Patients	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						Electroencephalography; Electromyography; Heart rate variability; Fentanyl; Midazolam	INTENSIVE-CARE-UNIT; CRITICALLY-ILL PATIENTS; DEXMEDETOMIDINE/REMIFENTANIL; MIDAZOLAM/REMIFENTANIL; ELECTROENCEPHALOGRAM; ISOFLURANE; POTENTIALS; MIDAZOLAM; DEPTH; EEG	Background: This study tested the hypothesis that the bispectral index (BIS) is reliable relative to clinical judgment for estimating sedation level during daily propofol spontaneous awakening trials (SATs) in trauma patients. Methods: This was a prospective observational trial with waiver of consent conducted in the intensive care unit of Level I trauma center in 94 mechanically ventilated trauma patients sedated with propofol alone or in combination with midazolam. BIS, Richmond Agitation Sedation Scale (RASS), electromyography, and heart rate variability, as a test of autonomic function, were measured for 45 minutes during daily SATs. Data were evaluated with analysis of variance, linear regression, and nonparametric tests. Results: The BIS wave form coincided almost exactly with propofol on/off. Steady-state BIS correlated with RASS (p < 0.0001) and with propofol dose (p < 0.0001), but the strengths of association were relatively low (all r(2) < 0.5). BIS wave form was not altered by age, heart rate, or heart rate variability and was similar with propofol alone or propofol plus midazolam, but the presence of brain injury or the use of paralytics shifted the curve downward (both p < 0.001). The overall test characteristics for BIS versus RASS without neuromuscular blockade were sensitivity: 90% versus 77% (p = 0.034); specificity: 90% versus 75% (p = 0.021); positive predictive value: 90% versus 76% (p = 0.021), and negative predictive value: 90% versus 76% (p = 0.021). Conclusions: In the first trial in trauma patients and largest trial in any surgical population, the (1) BIS was reliable and has advantages over RASS of being continuous and objective, at least during a propofol SAT; (2) BIS interpretation remains somewhat subjective in patients receiving paralytic agents or with traumatic brain injury.	Univ Miami, Miller Sch Med, Daughtry Family Dept Surg, Div Trauma, Miami, FL 33136 USA; Univ Miami, Miller Sch Med, Daughtry Family Dept Surg, Div Surg Crit Care, Miami, FL 33136 USA	Proctor, KG (corresponding author), Univ Miami, Miller Sch Med, Dept Surg & Anesthesiol, Ryder Trauma Ctr, 1800 NW 10th Ave, Miami, FL 33136 USA.	kproctor@miami.edu	Livingstone, Alan/AAA-4026-2019; Pereira, Bruno M/D-4542-2015	Pereira, Bruno M/0000-0003-3763-1749	Office of Naval ResearchOffice of Naval Research [N140610670]	Supported, in part, by Grant no. N140610670 from the Office of Naval Research.	Arbour R, 2009, HEART LUNG, V38, P336, DOI 10.1016/j.hrtlng.2008.10.010; Consales G, 2006, MINERVA ANESTESIOL, V72, P329; Consales G, 2007, MINERVA ANESTESIOL, V73, P609; Cooke SE, 2002, AM J HEALTH-SYST PH, V59, P150; Ely EW, 2004, INTENS CARE MED, V30, P1537, DOI 10.1007/s00134-004-2298-1; Glass PS, 1997, ANESTHESIOLOGY, V86, P836, DOI 10.1097/00000542-199704000-00014; Haenggi M, 2006, ANESTH ANALG, V103, P1163, DOI 10.1213/01.ane.0000237394.21087.85; Haenggi M, 2009, ANESTH ANALG, V109, P807, DOI 10.1213/ane.0b013e3181acc85d; Haenggi M, 2009, CRIT CARE, V13, DOI 10.1186/cc7723; Hernandez-Gancedo Carmen, 2007, J Clin Monit Comput, V21, P295, DOI 10.1007/s10877-007-9087-7; Jacobi J, 2002, CRIT CARE MED, V30, P119, DOI 10.1097/00003246-200201000-00020; King DR, 2009, J TRAUMA, V67, P436, DOI 10.1097/TA.0b013e3181ad67de; LeBlanc JM, 2006, ANN PHARMACOTHER, V40, P490, DOI 10.1345/aph.1E491; Lu CH, 2008, ANESTH ANALG, V107, P1290, DOI 10.1213/ane.0b013e31818061ae; MARINO PL, 2006, ICU BOOK; McKeage K, 2003, CNS DRUGS, V17, P235, DOI 10.2165/00023210-200317040-00003; Mondello Epifanio, 2002, J Clin Monit Comput, V17, P271, DOI 10.1023/A:1021250320103; Nasraway  SA, 2002, AM J HEALTH-SYST PH, V59, P147, DOI 10.1093/ajhp/59.2.147; Ostermann ME, 2000, JAMA-J AM MED ASSOC, V283, P1451, DOI 10.1001/jama.283.11.1451; Riker RR, 2003, PHARMACOTHERAPY, V23, P1087, DOI 10.1592/phco.23.10.1087.32766; Roustan JP, 2005, ANESTH ANALG, V101, P1141, DOI 10.1213/01.ane.0000167782.47957.e1; Sackey PV, 2007, ANAESTH INTENS CARE, V35, P348, DOI 10.1177/0310057X0703500305; Sackey PV, 2008, CRIT CARE, V12, DOI 10.1186/cc7029; Sessler CN, 2002, AM J RESP CRIT CARE, V166, P1338, DOI 10.1164/rccm.2107138; Tonner PH, 2005, CRIT CARE MED, V33, P580, DOI 10.1097/01.ccm.0000156291.04287.7F; Trope RM, 2005, CHEST, V128, P303, DOI 10.1378/chest.128.1.303; Tukenmez Baris, 2008, J Opioid Manag, V4, P34; Weatherburn C, 2007, ANAESTH INTENS CARE, V35, P204, DOI 10.1177/0310057X0703500208	28	17	18	0	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	NOV	2011	71	5					1415	1421		10.1097/TA.0b013e3182178b8b			7	Critical Care Medicine; Surgery	General & Internal Medicine; Surgery	849IG	WOS:000297118600062	21768900				2021-06-18	
J	Sundberg, J; Estrada, C; Jenkins, C; Ray, J; Abramo, T				Sundberg, Jennifer; Estrada, Cristina; Jenkins, Cathy; Ray, Jacqueline; Abramo, Thomas			Hypothermia is associated with poor outcome in pediatric trauma patients	AMERICAN JOURNAL OF EMERGENCY MEDICINE			English	Article							ADMISSION HYPOTHERMIA; VITAL-STATISTICS; MORTALITY; SEVERITY; MODELS	Objective: The objective of the study was to determine if hypothermia in pediatric trauma patients is associated with increased mortality. Methods: We reviewed the charts of level 1 trauma patients aged 3 months to 17 years who presented between September 2006 and March 2008. We analyzed data for patients with temperatures recorded within 30 minutes of arrival to the pediatric emergency department. Logistic regression models were used to test for associations of hypothermia with death while adjusting for mode of transport, season of year, and presence of intracranial pathology as documented by an abnormal head computed tomographic scan. Results: Of the 226 level 1 trauma patients presenting during the study period, 190 met inclusion criteria. Twenty-one patients (11%) died. The odds ratio (OR) of a hypothermic patient dying was 9.2 times that of a normothermic patient when adjusting for seasonal variation (95% confidence interval [CI], 3.2-26.2; P < 0.0001). The OR of a hypothermic patient dying was 8.7 times that of a normothermic patient when adjusting for mode of transport (ground vs air) (95% CI, 3.1-24.6; P < 0.0001). Although it did not reach statistical significance, there was a trend toward an association between hypothermia and the presence of traumatic brain injury as evidenced by an abnormal head computed tomographic scan (OR = 2.4; 95% CI, 0.9-6.0; P = .07). Conclusions: Hypothermia is a risk factor for increased mortality in pediatric trauma patients. This pilot study warrants a more detailed, multicenter analysis to assess the impact of hypothermia in the pediatric trauma patient. (C) 2011 Elsevier Inc. All rights reserved.	[Sundberg, Jennifer; Estrada, Cristina; Ray, Jacqueline; Abramo, Thomas] Vanderbilt Univ, Dept Pediat, Nashville, TN 37235 USA; [Jenkins, Cathy] Vanderbilt Univ, Dept Biostat, Nashville, TN USA	Sundberg, J (corresponding author), Vanderbilt Univ, Dept Pediat, Nashville, TN 37235 USA.	sundbergj@ema.net		Abramo MD, Thomas/0000-0003-2331-4582			Aitken LM, 2009, RESUSCITATION, V80, P217, DOI 10.1016/j.resuscitation.2008.10.021; Arias E, 2003, PEDIATRICS, V112, P1215, DOI 10.1542/peds.112.6.1215; Bernardo L M, 1999, Int J Trauma Nurs, V5, P101, DOI 10.1016/S1075-4210(99)90057-3; CORNELI HM, 1992, J PEDIATR-US, V120, P671, DOI 10.1016/S0022-3476(05)80226-4; Coule LWW, 2007, PEDIAT CRITICAL CARE, P1805; Danseco ER, 2000, PEDIATRICS, V105, DOI 10.1542/peds.105.2.e27; Dilley Anthony WD, 2006, PEDIAT TRAUMA PATHOP, P419; Dowd MD, 2002, CRIT CARE MED, V30, pS385, DOI 10.1097/00003246-200211001-00002; Eddy VA, 2000, SURG CLIN N AM, V80, P845, DOI 10.1016/S0039-6109(05)70099-2; Ewald MBC, 2006, TXB PEDIAT EMERGENCY; Fukudome EY, 2009, CRIT CARE MED, V37, pS265, DOI 10.1097/CCM.0b013e3181aa60ac; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; JURKOVICH GJ, 1987, J TRAUMA, V27, P1019, DOI 10.1097/00005373-198709000-00011; LUNA GK, 1987, J TRAUMA, V27, P1014, DOI 10.1097/00005373-198709000-00010; Marcin JP, 2002, CRIT CARE MED, V30, pS457, DOI 10.1097/00003246-200211001-00011; Martin JA, 2008, PEDIATRICS, V121, P788, DOI 10.1542/peds.2007-3753; Martin RS, 2005, SHOCK, V24, P114, DOI 10.1097/01.shk.0000169726.25189.b1; R Development Core Team, 2009, R LANG ENV STAT COMP; Rotondo MF, 1997, SURG CLIN N AM, V77, P761, DOI 10.1016/S0039-6109(05)70582-X; Sambasivan CN, 2009, CURR OPIN CRIT CARE, V15, P560, DOI 10.1097/MCC.0b013e328331f57c; Seekamp A, 1999, J TRAUMA, V47, P673, DOI 10.1097/00005373-199910000-00011; Shafi S, 2005, J TRAUMA, V59, P1081, DOI 10.1097/01.ta.0000188647.03665.fd; Shaz BH, 2009, ANESTH ANALG, V108, P1760, DOI 10.1213/ane.0b013e3181a0b6c6; STEINEMANN S, 1990, J TRAUMA, V30, P200, DOI 10.1097/00005373-199002000-00011; Waibel BH, PEDIAT CRIT CARE MED, V11, P199; Wang HE, 2005, CRIT CARE MED, V33, P1296, DOI 10.1097/01.CCM.0000165965.31895.80; Wetzel RC, 2002, CRIT CARE MED, V30, pS468, DOI 10.1097/00003246-200211001-00012; Willis RB, 2008, PEDIATRICS, V121, P849, DOI 10.1542/peds.2008-0094	28	17	19	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0735-6757	1532-8171		AM J EMERG MED	Am. J. Emerg. Med.	NOV	2011	29	9					1019	1022		10.1016/j.ajem.2010.06.002			4	Emergency Medicine	Emergency Medicine	851OP	WOS:000297280800009	20708896				2021-06-18	
J	Volman, V; Sejnowski, TJ; Bazhenov, M				Volman, Vladislav; Sejnowski, Terrence J.; Bazhenov, Maxim			Topological basis of epileptogenesis in a model of severe cortical trauma	JOURNAL OF NEUROPHYSIOLOGY			English	Article						homeostatic plasticity; paroxysmal discharge; seizure	NECROSIS-FACTOR-ALPHA; IN-VITRO; CORTEX; NETWORKS; EPILEPSY; DEAFFERENTATION; CONNECTIVITY; TRANSITION; NEOCORTEX; NEURONS	Volman V, Sejnowski TJ, Bazhenov M. Topological basis of epileptogenesis in a model of severe cortical trauma. J Neurophysiol 106:1933-1942, 2011. First published July 20, 2011; doi:10.1152/jn.00458.2011.-Epileptic activity often arises after a latent period following traumatic brain injury. Several factors contribute to the emergence of post-traumatic epilepsy, including disturbances to ionic homeostasis, pathological action of intrinsic and synaptic homeostatic plasticity, and remodeling of anatomical network synaptic connectivity. We simulated a large-scale, biophysically realistic computational model of cortical tissue to study the mechanisms underlying the genesis of post-traumatic paroxysmal epileptic-like activity in the deafferentation model of a severely traumatized cortical network. Post-traumatic generation of paroxysmal events did not require changes of the structural connectivity. Rather, network bursts were induced following the action of homeostatic synaptic plasticity, which selectively influenced functionally dominant groups of intact neurons with preserved inputs. This effect critically depended on the spatial density of intact neurons. Thus in the deafferentation model of post-traumatic epilepsy, a trauma-induced change in functional (rather than anatomical) connectivity might be sufficient for epileptogenesis.	[Bazhenov, Maxim] Univ Calif Riverside, Dept Cell Biol & Neurosci, Riverside, CA 92521 USA; [Volman, Vladislav; Sejnowski, Terrence J.; Bazhenov, Maxim] Salk Inst Biol Studies, Howard Hughes Med Inst, Computat Neurobiol Lab, La Jolla, CA 92037 USA; [Sejnowski, Terrence J.] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA; [Volman, Vladislav; Sejnowski, Terrence J.] Univ Calif San Diego, Ctr Theoret Biol Phys, La Jolla, CA 92093 USA	Bazhenov, M (corresponding author), Univ Calif Riverside, Dept Cell Biol & Neurosci, Riverside, CA 92521 USA.	Maksim.Bazhenov@ucr.edu			National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01-NS-059740, R01-NS-060870]; Howard Hughes Medical InstituteHoward Hughes Medical Institute; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS060870, R01NS059740] Funding Source: NIH RePORTER	This research was supported by the National Institute of Neurological Disorders and Stroke Grants R01-NS-059740 and R01-NS-060870 and the Howard Hughes Medical Institute.	Avramescu S, 2008, J NEUROSCI, V28, P6760, DOI 10.1523/JNEUROSCI.0643-08.2008; Bogaard A, 2009, J NEUROSCI, V29, P1677, DOI 10.1523/JNEUROSCI.5218-08.2009; Butz M, 2009, FRONT COMPUT NEUROSC, V3, DOI 10.3389/neuro.10.010.2009; de Curtis M, 2001, PROG NEUROBIOL, V63, P541, DOI 10.1016/S0301-0082(00)00026-5; Dorogovtsev S. N., 2003, EVOLUTION NETWORKS B; Dyhrfjeld-Johnsen J, 2007, J NEUROPHYSIOL, V97, P1566, DOI 10.1152/jn.00950.2006; Dzhala VI, 2003, J NEUROSCI, V23, P7873; Edelstein-Keshet L, 2002, J THEOR BIOL, V216, P301, DOI 10.1006/jtbi.2002.2540; Frohlich F, 2008, J NEUROSCI, V28, P1709, DOI 10.1523/JNEUROSCI.4263-07.2008; GRAFSTEIN B, 1957, ELECTROEN CLIN NEURO, V9, P723, DOI 10.1016/0013-4694(57)90096-2; Houweling AR, 2005, CEREB CORTEX, V15, P834, DOI 10.1093/cercor/bhh184; Jin XM, 2006, J NEUROSCI, V26, P4891, DOI 10.1523/JNEUROSCI.4361-05.2006; Keller CJ, 2010, BRAIN, V133, P1668, DOI 10.1093/brain/awq112; Lau LT, 2001, J NEUROTRAUM, V18, P351, DOI 10.1089/08977150151071035; Morgan RJ, 2008, P NATL ACAD SCI USA, V105, P6179, DOI 10.1073/pnas.0801372105; Netoff TI, 2004, J NEUROSCI, V24, P8075, DOI 10.1523/JNEUROSCI.1509-04.2004; Pitkanen A, 2006, MODELS OF SEIZURES AND EPILEPSY, P1; Prescott SA, 2006, J NEUROSCI, V26, P9084, DOI 10.1523/JNEUROSCI.1388-06.2006; PRINCE DA, 1993, J NEUROPHYSIOL, V69, P1276; Srinivas KV, 2007, EUR J NEUROSCI, V25, P3276, DOI 10.1111/j.1460-9568.2007.05559.x; Steinmetz CC, 2010, J NEUROSCI, V30, P14685, DOI 10.1523/JNEUROSCI.2210-10.2010; Stellwagen D, 2006, NATURE, V440, P1054, DOI 10.1038/nature04671; Timofeev I, 2010, NEUROSCIENTIST, V16, P19, DOI 10.1177/1073858409333545; Topolnik L, 2003, CEREB CORTEX, V13, P883, DOI 10.1093/cercor/13.8.883; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; Wendling F, 2005, J CLIN NEUROPHYSIOL, V22, P343	26	17	17	1	15	AMER PHYSIOLOGICAL SOC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0022-3077			J NEUROPHYSIOL	J. Neurophysiol.	OCT	2011	106	4					1933	1942		10.1152/jn.00458.2011			10	Neurosciences; Physiology	Neurosciences & Neurology; Physiology	836EJ	WOS:000296092000029	21775725	Green Published			2021-06-18	
J	Wu, DY; Cai, G; Zorowitz, RD; Yuan, Y; Wang, J; Song, WQ				Wu, Dong-yu; Cai, Gui; Zorowitz, Richard D.; Yuan, Ying; Wang, Jie; Song, Wei-qun			Measuring interconnection of the residual cortical functional islands in persistent vegetative state and minimal conscious state with EEG nonlinear analysis	CLINICAL NEUROPHYSIOLOGY			English	Article						Electroencephalography; Nonlinear dynamics; Unconsciousness; Traumatic brain injury; Stroke	PATIENTS OWN NAME; APPROXIMATE ENTROPY; MISMATCH NEGATIVITY; EVOKED-POTENTIALS; CHRONIC DISORDERS; BISPECTRAL INDEX; SPECTRAL ENTROPY; BRAIN; ACTIVATION; PROPOFOL	Objectives: The aim of the study is to investigate the cortical response to painful and auditory stimuli for subjects in persistent vegetative state (PVS) and minimal conscious state (MCS), and measure the interconnection of the residual cortical functional islands with electroencephalographic (EEG) nonlinear dynamic analysis (NDA). Methods: Thirty PVS subjects, 20 MCS subjects and 30 subjects in normal conscious state (NCS) were involved in the study. EEG was recorded under three conditions: eyes closed, auditory stimuli and painful stimuli. EEG nonlinear index of cross-approximate entropy (C-ApEn) was calculated for all subjects. Results: Interconnection of local and distant cortical networks of patients in PVS was generally suppressed, and painful or auditory stimulation could hardly cause any activation of associative cortices. Instead, interconnection of local cortical networks of patients in MCS improved significantly. The only significant difference with the NCS existed in the unaffected distant cortical networks. Conclusions: Interconnection of local and distant cortical networks in MCS is superior to that of PVS. NDA could measure interconnection of the residual cortical functional islands with associative cortices in the unconscious patients. Significance: NDA can characterise the interconnection of cortical networks for the unconscious state and provide some information of unconsciousness at the awareness level. (C) 2011 International Federation of Clinical Neurophysiology. Published by Elsevier Ireland Ltd. All rights reserved.	[Wu, Dong-yu; Yuan, Ying; Wang, Jie; Song, Wei-qun] Capital Med Univ, Xuanwu Hosp, Dept Rehabil, Beijing 100053, Peoples R China; [Cai, Gui] China Astronaut Res & Training Ctr, Beijing, Peoples R China; [Zorowitz, Richard D.] Johns Hopkins Univ, Sch Med, Dept Phys Med & Rehabil, Baltimore, MD USA	Wu, DY (corresponding author), Capital Med Univ, Xuanwu Hosp, Dept Rehabil, 45 Changchun St,POB 100053, Beijing 100053, Peoples R China.	wudongyu73@yahoo.com.cn	Wu, Dongyu/AAW-6037-2020	Zorowitz, Richard/0000-0001-8938-786X	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [30600186]; National Basic Research Program of ChinaNational Basic Research Program of China [2011CB711000]	This study was supported by the grants from National Natural Science Foundation of China (Grant No. 30600186) and National Basic Research Program of China (Grant No. 2011CB711000).	Anderson RE, 2004, ANAESTHESIA, V59, P52, DOI 10.1111/j.1365-2044.2004.03523.x; ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; Bernat JL, 2006, LANCET, V367, P1181, DOI 10.1016/S0140-6736(06)68508-5; Boly M, 2005, NEUROPSYCHOL REHABIL, V15, P283, DOI 10.1080/09602010443000371; Boly M, 2008, LANCET NEUROL, V7, P1013, DOI 10.1016/S1474-4422(08)70219-9; Bruhn J, 2003, ANESTHESIOLOGY, V98, P621, DOI 10.1097/00000542-200303000-00008; Coleman MR, 2007, BRAIN, V130, P2494, DOI 10.1093/brain/awm170; Di HB, 2007, NEUROLOGY, V68, P895, DOI 10.1212/01.wnl.0000258544.79024.d0; Fischer C, 2004, NEUROLOGY, V63, P669, DOI 10.1212/01.WNL.0000134670.10384.E2; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; GRILLON C, 1986, ELECTROEN CLIN NEURO, V63, P42, DOI 10.1016/0013-4694(86)90061-1; Hans P, 2005, BRIT J ANAESTH, V94, P336, DOI 10.1093/bja/aei047; Hudetz AG, 2002, BRAIN RES, V954, P123, DOI 10.1016/S0006-8993(02)03358-9; Jelles B, 1999, ACTA NEUROL SCAND, V100, P360; Kassubek J, 2003, J NEUROL SCI, V212, P85, DOI 10.1016/S0022-510X(03)00106-0; Kotchoubey B, 2005, CLIN NEUROPHYSIOL, V116, P2441, DOI 10.1016/j.clinph.2005.03.028; Laureys S, 2005, TRENDS COGN SCI, V9, P556, DOI 10.1016/j.tics.2005.10.010; Laureys S, 2004, NEUROREHABILITATION, V19, P335; Laureys S, 2002, NEUROIMAGE, V17, P732, DOI 10.1006/nimg.2002.1236; Laureys S, 2006, J CLIN INVEST, V116, P1823, DOI 10.1172/JCI29172; Leon-Carrion J, 2008, CLIN NEUROPHYSIOL, V119, P1506, DOI 10.1016/j.clinph.2008.03.030; Lew HL, 2003, AM J PHYS MED REHAB, V82, P53, DOI 10.1097/01.PHM.0000043771.90606.81; Melloni L, 2007, J NEUROSCI, V27, P2858, DOI 10.1523/JNEUROSCI.4623-06.2007; Niedermeyer E., 2004, ELECTROENCEPHALOGRAP; Owen AM, 2008, ANN NY ACAD SCI, V1129, P130, DOI 10.1196/annals.1417.018; Owen AM, 2007, ARCH NEUROL-CHICAGO, V64, P1098, DOI 10.1001/archneur.64.8.1098; Owen AM, 2007, CURR OPIN NEUROL, V20, P632, DOI 10.1097/WCO.0b013e3282f15669; Owen AM, 2005, NEUROPSYCHOL REHABIL, V15, P290, DOI 10.1080/09602010443000579; Perrin F, 2006, ARCH NEUROL-CHICAGO, V63, P562, DOI 10.1001/archneur.63.4.562; Pincus S, 1996, P NATL ACAD SCI USA, V93, P2083, DOI 10.1073/pnas.93.5.2083; Pincus SM, 2006, BIPOLAR DISORD, V8, P430, DOI 10.1111/j.1399-5618.2006.00375.x; PRITCHARD WS, 1995, BRAIN COGNITION, V27, P353, DOI 10.1006/brcg.1995.1027; Qin PM, 2008, NEUROSCI LETT, V448, P24, DOI 10.1016/j.neulet.2008.10.029; Richman JS, 2000, AM J PHYSIOL-HEART C, V278, pH2039; Schiff ND, 2005, NEUROLOGY, V64, P514, DOI 10.1212/01.WNL.0000150883.10285.44; Sleigh J.W., 2001, P 5 INT C MEM AW CON; Vakkuri A, 2004, ACTA ANAESTH SCAND, V48, P145, DOI 10.1111/j.0001-5172.2004.00323.x; Voss HU, 2006, J CLIN INVEST, V116, P2005, DOI 10.1172/JCI27021; Wijnen VJM, 2007, CLIN NEUROPHYSIOL, V118, P597, DOI 10.1016/j.clinph.2006.11.020; Wu DY, 2011, CLIN NEUROPHYSIOL, V122, P490, DOI 10.1016/j.clinph.2010.05.036; Zeman A, 2001, BRAIN, V124, P1263, DOI 10.1093/brain/124.7.1263	41	17	22	0	11	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	1388-2457	1872-8952		CLIN NEUROPHYSIOL	Clin. Neurophysiol.	OCT	2011	122	10					1956	1966		10.1016/j.clinph.2011.03.018			11	Clinical Neurology; Neurosciences	Neurosciences & Neurology	814WZ	WOS:000294489200009	21530389				2021-06-18	
J	Norazit, A; Nguyen, MN; Dickson, CGM; Tuxworth, G; Goss, B; Mackay-Sim, A; Meedeniya, ACB				Norazit, A.; Nguyen, M. N.; Dickson, C. G. M.; Tuxworth, G.; Goss, B.; Mackay-Sim, A.; Meedeniya, A. C. B.			VASCULAR ENDOTHELIAL GROWTH FACTOR AND PLATELET DERIVED GROWTH FACTOR MODULATES THE GLIAL RESPONSE TO A CORTICAL STAB INJURY	NEUROSCIENCE			English	Article						vascular endothelial growth factor; platelet derived growth factor; astrogliosis; microglial response; brain injury	TRAUMATIC BRAIN-INJURY; HIPPOCAMPAL SLICE CULTURES; RESTING MICROGLIAL CELLS; CENTRAL-NERVOUS-SYSTEM; SPINAL-CORD-INJURY; NEUROTROPHIC FACTOR; DOPAMINERGIC-NEURONS; REACTIVE ASTROCYTES; IN-VITRO; PARKINSONS-DISEASE	Traumatic injury to the brain initiates an increase in astrocyte and microglial infiltration as part of an inflammatory response to injury. Increased astrogliosis around the injury impedes regeneration of axons through the injury, while activated microglia release inflammatory mediators. The persistent inflammatory response can lead to local progressive cell death. Modulating the astrocyte and microglial response to traumatic injury therefore has potential therapeutic benefit in brain repair. We examine the modulatory effect of a single bolus of vascular endothelial growth factor (VEGF) and platelet derived growth factor (PDGF) in combination on astrocytes and microglia to acute cerebral injury. A combination of VEGF and PDGF (20 pg) was injected into the striatum of adult male Sprague-Dawley rats. The effects of treatment were assessed by quantitative immunofluorescence microscopy analyzing astrocytes and microglia across the stab injury over time. Treatment delayed the onset of astrogliosis in the centre and edge of the stab injury up to day 5; however, increased astrogliosis at areas remote to the stab injury up to day 5 was observed. A persistent astrocytic response was observed in the centre and edge of the stab injury up to day 60. Treatment altered microglia cell morphology and numbers across the stab injury, with a decrease in ramified microglia, but an increase in activated and phagocytic microglia up to day 5 after stab injury. The increased microglial response from 10 until day 60 was comprised of the ramified morphology. Thus, VEGF and PDGF applied at the same time as a stab injury to the brain initially delayed the inflammatory response up to day 5 but evoked a persistent astrogliosis and microglial response up to 60 days. (C) 2011 IBRO. Published by Elsevier Ltd. All rights reserved.	[Norazit, A.; Nguyen, M. N.; Dickson, C. G. M.; Tuxworth, G.; Mackay-Sim, A.; Meedeniya, A. C. B.] Griffith Univ, Natl Ctr Adult Stern Cell Res, Eskitis Inst Cell & Mol Therapies, Brisbane, Qld 4111, Australia; [Norazit, A.] Univ Malaya, Fac Med, Dept Mol Med, Kuala Lumpur 50603, Malaysia; [Tuxworth, G.] Griffith Univ, Sch Informat & Commun Technol, Gold Coast, Qld 4222, Australia; [Goss, B.] Queensland Univ Technol, Brisbane Spine Reference Ctr, Inst Hlth & Biomed Innovat, Brisbane, Qld 4059, Australia	Meedeniya, ACB (corresponding author), Griffith Univ, Natl Ctr Adult Stern Cell Res, Eskitis Inst Cell & Mol Therapies, Brisbane, Qld 4111, Australia.	A.Meedeniya@griffith.edu.au	Mackay-Sim, Alan/C-3431-2008; NORAZIT, ANWAR/B-5263-2010; Goss, Ben/F-1867-2010	Mackay-Sim, Alan/0000-0003-4446-5371; Tuxworth, Gervase/0000-0002-9278-4695; Goss, Ben/0000-0003-0518-1229	National Health and Medical Research CouncilNational Health and Medical Research Council of Australia; Australian Department of Health and AgeingAustralian GovernmentDepartment of Health & Ageing	We would like to thank Brenton Cavanagh, Joseph Kan, Will Young, and Cameron Lutton for their technical support. This work was funded by a grant from the National Health and Medical Research Council and the Australian Department of Health and Ageing to A.M.S.	BARRES BA, 1991, J NEUROSCI, V11, P3685; Batchelor PE, 1999, J NEUROSCI, V19, P1708; Batchelor PE, 2008, J NEUROTRAUM, V25, P1217, DOI 10.1089/neu.2007.0308; BOGLER O, 1990, P NATL ACAD SCI USA, V87, P6368, DOI 10.1073/pnas.87.16.6368; Chen YM, 2003, J CEREBR BLOOD F MET, V23, P137, DOI 10.1097/01.WCB.0000044631.80210.3C; Croll SD, 2004, EXP NEUROL, V187, P388, DOI 10.1016/j.expneurol.2004.02.010; Dougherty KD, 2000, NEUROBIOL DIS, V7, P574, DOI 10.1006/nbdi.2000.0318; Faden AI, 2002, CURR OPIN NEUROL, V15, P707, DOI 10.1097/00019052-200212000-00008; Fawcett JW, 1999, BRAIN RES BULL, V49, P377, DOI 10.1016/S0361-9230(99)00072-6; Fitch MT, 1999, J NEUROSCI, V19, P8182; Forstreuter F, 2002, J NEUROIMMUNOL, V132, P93, DOI 10.1016/S0165-5728(02)00315-6; GEHRMANN J, 1995, BRAIN RES REV, V20, P269, DOI 10.1016/0165-0173(94)00015-H; Hailer NP, 1997, EUR J NEUROSCI, V9, P863, DOI 10.1111/j.1460-9568.1997.tb01436.x; Hailer NP, 1996, GLIA, V18, P319, DOI 10.1002/(SICI)1098-1136(199612)18:4<319::AID-GLIA6>3.0.CO;2-S; Hampton DW, 2004, NEUROSCIENCE, V127, P813, DOI 10.1016/j.neuroscience.2004.05.028; Hausmann O, 2003, SPINAL CORD, V41, P369, DOI 10.1038/sj.sc.3101483; HUTCHINS JB, 1993, MOL CELL NEUROSCI, V4, P250, DOI 10.1006/mcne.1993.1032; Kanazawa H, 2002, J BIOL CHEM, V277, P20026, DOI 10.1074/jbc.M109218200; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; Kettenmann H, 2004, NEUROGLIA; King CE, 2001, NEUROPATH APPL NEURO, V27, P115, DOI 10.1046/j.1365-2990.2001.00317.x; Kolker S, 2001, EUR J NEUROSCI, V13, P2115, DOI 10.1046/j.0953-816x.2001.01595.x; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Krum JM, 2008, EXP NEUROL, V212, P108, DOI 10.1016/j.expneurol.2008.03.019; Krum JM, 2002, NEUROSCIENCE, V110, P589, DOI 10.1016/S0306-4522(01)00615-7; Krum JM, 2003, EXP NEUROL, V181, P241, DOI 10.1016/S0014-4886(03)00039-6; Laird MD, 2008, NEUROSIGNALS, V16, P154, DOI 10.1159/000111560; LEVINE JM, 1989, NEURON, V3, P103, DOI 10.1016/0896-6273(89)90119-0; Lutton C, 2012, J NEUROTRAUM, V29, P957, DOI 10.1089/neu.2010.1423; Mizuta I, 2001, NEUROSCI LETT, V310, P117, DOI 10.1016/S0304-3940(01)02098-5; Myer DJ, 2006, BRAIN, V129, P2761, DOI 10.1093/brain/awl165; NGUYEN MN, 2010, TISSUE PROCESSING EP; Nicholas RS, 2001, EUR J NEUROSCI, V13, P959, DOI 10.1046/j.0953-816x.2001.01470.x; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; NOBLE M, 1988, NATURE, V333, P560, DOI 10.1038/333560a0; Norazit A, 2010, BRAIN RES, V1360, P119, DOI 10.1016/j.brainres.2010.08.070; Petersen MA, 2004, GLIA, V46, P195, DOI 10.1002/glia.10362; Peterson DA, 1999, METHODS, V18, P493, DOI 10.1006/meth.1999.0818; Pietz K, 1996, NEUROSCI LETT, V204, P101, DOI 10.1016/0304-3940(96)12326-0; Pitzer MR, 2003, EXP NEUROL, V182, P435, DOI 10.1016/S0014-4886(03)00100-6; Popovich PG, 2002, J NEUROPATH EXP NEUR, V61, P623, DOI 10.1093/jnen/61.7.623; RAFF MC, 1988, NATURE, V333, P562, DOI 10.1038/333562a0; Rezaie P, 2002, EXP CELL RES, V274, P68, DOI 10.1006/excr.2001.5431; RICHARDSON WD, 1988, CELL, V53, P309, DOI 10.1016/0092-8674(88)90392-3; SCHWARTZ JP, 1994, BRAIN RES BULL, V35, P403, DOI 10.1016/0361-9230(94)90151-1; Shih AH, 2004, CANCER RES, V64, P4783, DOI 10.1158/0008-5472.CAN-03-3831; Sofroniew MV, 2001, ANNU REV NEUROSCI, V24, P1217, DOI 10.1146/annurev.neuro.24.1.1217; Stence N, 2001, GLIA, V33, P256, DOI 10.1002/1098-1136(200103)33:3<256::AID-GLIA1024>3.0.CO;2-J; Szczepanik AM, 1996, NEUROSCIENCE, V70, P57, DOI 10.1016/0306-4522(95)00296-U; Thiruchelvam M, 2000, J NEUROSCI, V20, P9207; Vilhardt F, 2005, INT J BIOCHEM CELL B, V37, P17, DOI 10.1016/j.biocel.2004.06.010; Wang K, 2004, BRAIN RES, V1024, P193, DOI 10.1016/j.brainres.2004.07.086; WOLSWIJK G, 1991, GLIA, V4, P495, DOI 10.1002/glia.440040509; Yasuhara T, 2005, BRAIN RES, V1038, P1, DOI 10.1016/j.brainres.2004.12.055	54	17	17	0	4	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522			NEUROSCIENCE	Neuroscience	SEP 29	2011	192						652	660		10.1016/j.neuroscience.2011.06.035			9	Neurosciences	Neurosciences & Neurology	829DB	WOS:000295555100062	21704679	Green Published			2021-06-18	
J	Hollis, SJ; Stevenson, MR; McIntosh, AS; Li, L; Heritier, S; Shores, EA; Collins, MW; Finch, CF				Hollis, Stephanie J.; Stevenson, Mark R.; McIntosh, Andrew S.; Li, Ling; Heritier, Stephane; Shores, E. Arthur; Collins, Michael W.; Finch, Caroline F.			Mild traumatic brain injury among a cohort of rugby union players: predictors of time to injury	BRITISH JOURNAL OF SPORTS MEDICINE			English	Article							RISK-FACTORS; HIGH-SCHOOL; CONCUSSION; FOOTBALL; EPIDEMIOLOGY; MATCH	This study reports the time to sustain a mild traumatic brain injury (mTBI) among a cohort of community rugby union players. Demographic and player characteristics were collected and players followed up for between one and three playing seasons. 7% of the cohort sustained an mTBI within 10 h of game time, increasing twofold to 14% within 20 h. The mean time to first mTBI was 8 h with an SD of 6.2 (median 6.8 h; IQR: 2.9-11.7 h). Players reporting a recent history of concussion were 20% more likely to sustain an mTBI after 20 h of game time compared with those with no recent history of concussion. Players were likely to sustain an mTBI in shorter time if they trained for <3 h/week (HR= 1.48, p=0.03) or had a body mass index <27 (HR=1.77, p=0.007). The findings highlight modifiable characteristics to reduce the likelihood of shortened time to mTBI.	[Hollis, Stephanie J.; Heritier, Stephane] George Inst Global Hlth, Sydney, NSW, Australia; [Hollis, Stephanie J.; Heritier, Stephane] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia; [Stevenson, Mark R.] Monash Univ, Monash Injury Res Inst, Accid Res Ctr, Melbourne, Vic 3004, Australia; [Stevenson, Mark R.] Monash Univ, Sch Publ Hlth & Prevent Med, Melbourne, Vic 3004, Australia; [McIntosh, Andrew S.] Univ New S Wales, Sch Risk & Safety Sci, Sydney, NSW, Australia; [Li, Ling] Univ New S Wales, Ctr Hlth Syst & Safety Res, Sydney, NSW, Australia; [Shores, E. Arthur] Macquarie Univ, Dept Psychol, Sydney, NSW 2109, Australia; [Collins, Michael W.] Univ Pittsburgh, UPMC Ctr Sports Med, Pittsburgh, PA USA; [Finch, Caroline F.] Monash Univ, Monash Injury Res Inst, Australian Ctr Res Injury Sport & Its Prevent, Melbourne, Vic 3004, Australia	Hollis, SJ (corresponding author), Univ Sydney, Sydney Med Sch, 25 Nichols Parade, Mt Riverview, NSW 2774, Australia.	shollis@georgeinstitute.org.au	Hollis, Stephanie J/B-5977-2011; stevenson, mark/AAE-9706-2019; Li, Ling/E-1222-2012	stevenson, mark/0000-0003-3166-5876; Shores, Edwin A/0000-0003-1553-5131; Li, Ling/0000-0002-1642-142X	Australian Government's National Health and Medical Research CouncilNational Health and Medical Research Council of Australia; NSW Sporting Injuries Committee; New South Wales Health Biostatistical Training Program; US Centers for Disease Control and PreventionUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [5R49CE323155]; NATIONAL CENTER FOR INJURY PREVENTION AND CONTROLUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [R49CE323155] Funding Source: NIH RePORTER	SJH was supported by postgraduate scholarship funding from the Australian Government's National Health and Medical Research Council, and scholarship funding from the NSW Sporting Injuries Committee. MRS was also supported by funding from the Australian Government's National Health and Medical Research Council. LL was funded by the New South Wales Health Biostatistical Training Program. This study was supported by the US Centers for Disease Control and Prevention grant 5R49CE323155 to the University of Pittsburgh Center for Injury Research and Control.	Brooks JHM, 2005, BRIT J SPORT MED, V39, P757, DOI 10.1136/bjsm.2005.018135; Brooks JHM, 2008, J SPORT SCI, V26, P863, DOI 10.1080/02640410701832209; Cantu RC, 2001, J ATHL TRAINING, V36, P244; Cantu RC, 2009, CURR SPORT MED REP, V8, P6, DOI 10.1249/JSR.0b013e31819677db; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Hollis SJ, 2009, AM J SPORT MED, V37, P2328, DOI 10.1177/0363546509341032; Kerr HA, 2008, BRIT J SPORT MED, V42, P595, DOI 10.1136/bjsm.2007.035881; Koh JO, 2003, BRAIN INJURY, V17, P901, DOI 10.1080/0269905031000088869; Lee AJ, 2001, BRIT J SPORT MED, V35, P412, DOI 10.1136/bjsm.35.6.412; MacQueen AE, 2010, CURR SPORT MED REP, V9, P139, DOI 10.1249/JSR.0b013e3181df124c; McIntosh AS, 2010, BRIT J SPORT MED, V44, P188, DOI 10.1136/bjsm.2007.041400; Quarrie KL, 2001, BRIT J SPORT MED, V35, P157, DOI 10.1136/bjsm.35.3.157; SAS Institute, 2009, SAS STAT SOFTW; Schneiders AG, 2009, PHYS THER SPORT, V10, P85, DOI 10.1016/j.ptsp.2009.05.001; Schulz MR, 2004, AM J EPIDEMIOL, V160, P937, DOI 10.1093/aje/kwh304; Shankar PR, 2007, AM J SPORT MED, V35, P1295, DOI 10.1177/0363546507299745; StataCorp LP, 2007, STAT STAT SOFTW; Takemura M, 2007, BRIT J SPORT MED, V41, DOI 10.1136/bjsm.2007.035568	18	17	18	0	14	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0306-3674			BRIT J SPORT MED	Br. J. Sports Med.	SEP	2011	45	12					997	999		10.1136/bjsm.2010.079707			3	Sport Sciences	Sport Sciences	816PM	WOS:000294614600015	21482546				2021-06-18	
J	Ryan, PB; Lee-Wilk, T; Kok, BC; Wilk, JE				Ryan, Patricia B.; Lee-Wilk, Terry; Kok, Brian C.; Wilk, Joshua E.			Interdisciplinary rehabilitation of mild TBI and PTSD: A case report	BRAIN INJURY			English	Article						Concussion; post-concussive symptoms; post-traumatic stress disorder; veterans; blast injuries; iatrogenic effects	TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; GOOD OLD DAYS; HEAD-INJURY; SYMPTOMS; VETERANS; EXPECTATION; PERFORMANCE; HEALTH; IRAQ	Background: Prevalence of mild traumatic brain injury (mTBI) or concussion on the battlefield in Iraq/Afghanistan has resulted in its designation as a 'signature injury'. Civilian studies have shown that negative expectations for recovery may lead to worse outcomes. While there is concern that concussion screening procedures in the Veteran's Affairs Healthcare System and the Department of Defence could fuel negative expectations, leading to negative iatrogenic effects, it has been difficult to document this in clinical settings. The aim of this report is to describe the case of a veteran with comorbid mTBI/PTSD with persistent symptoms of unknown aetiology and the effects of provider communications on the patient's recovery. Methods: Case report of a veteran with reported mTBI, including provider communications, neuropsychological test results and report of functioning after changes in provider messages. Results: Two-years post-mTBI, the patient attributed cognitive difficulties to his brain injury, but neuropsychological assessment found that his cognitive profile was consistent with psychological rather than neurological dysfunction. After providers systematically emphasized expectations of recovery, the patient's daily functioning improved. Conclusions: This case illustrates difficulties in mass screening for and treating mTBI. Recommendations for improvement include clinician training in effectively communicating positive expectations of recovery after concussion.	[Ryan, Patricia B.; Lee-Wilk, Terry] Baltimore VA Med Ctr, VA Maryland Hlth Care Syst, Baltimore, MD USA; [Kok, Brian C.; Wilk, Joshua E.] Walter Reed Army Inst Res, Silver Spring, MD USA	Wilk, JE (corresponding author), 503 Robert Grant Dr, Silver Spring, MD 20910 USA.	joshua.wilk@amedd.army.mil					BATTEN S, 2009, CONS C COGN REH MILD; *BATTL TRANS OFF, 2010, CONC MTBI INF US 1 M; Belanger HG, 2009, J HEAD TRAUMA REHAB, V24, P4, DOI 10.1097/HTR.0b013e3181957032; Cooper DB, 2010, NEUROREHABILITATION, V26, P233, DOI 10.3233/NRE-2010-0559; Delis DC, 2000, CALIFORNIA VERBAL LE; Ferguson RJ, 1999, NEUROPSYCHOLOGY, V13, P582, DOI 10.1037/0894-4105.13.4.582; Gioia GA, 2000, CHILD NEUROPSYCHOL, V6, P235, DOI 10.1076/chin.6.3.235.3152; Golden C., 1978, STROOP COLOR WORD TE; Greiffenstein M.F., 1994, PSYCHOL ASSESSMENT, V6, P218, DOI [https://doi.org/10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; Gunstad J, 2001, J INT NEUROPSYCH SOC, V7, P323, DOI 10.1017/S1355617701733061; Heaton R., 1993, WISCONSIN CARD SORTI; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2009, NEW ENGL J MED, V360, P1588, DOI 10.1056/NEJMp0810606; Howe LLS, 2009, CLIN NEUROPSYCHOL, V23, P1315, DOI 10.1080/13854040903266928; Iverson G.L., 2007, BRAIN INJURY MED PRI, P373; Iverson GL, 2010, CLIN NEUROPSYCHOL, V24, P17, DOI 10.1080/13854040903190797; Lange RT, 2010, J CLIN EXP NEUROPSYC, V32, P961, DOI 10.1080/13803391003645657; Lew HL, 2008, J REHABIL RES DEV, V45, pXI, DOI 10.1682/JRRD.2008.05.0064; Lew HL, 2007, J REHABIL RES DEV, V44, P1027, DOI 10.1682/JRRD.2007.05.0073; Malec JF., 2005, The Mayo-Portland Adaptability Inventory; Marx BP, 2009, J INT NEUROPSYCH SOC, V15, P840, DOI 10.1017/S1355617709990488; McCrea M, 2008, MILD TRAUMATIC BRAIN; McDermott LM, 2009, J AFFECT DISORDERS, V119, P1, DOI 10.1016/j.jad.2009.04.022; Meares S, 2008, J NEUROL NEUROSUR PS, V79, P300, DOI 10.1136/jnnp.2007.126565; Meyers J., 1995, MEYERS SCORING SYSTE; MITTENBERG W, 1992, J NEUROL NEUROSUR PS, V55, P200, DOI 10.1136/jnnp.55.3.200; Mittenberg W, 2008, TXB CLIN NEUROPSYCHO, P430; Nelson LA, 2009, J HEAD TRAUMA REHAB, V24, P32, DOI 10.1097/HTR.0b013e3181957016; Pietrzak RH, 2009, J NERV MENT DIS, V197, P748, DOI 10.1097/NMD.0b013e3181b97a75; Ponsford J, 2002, J NEUROL NEUROSUR PS, V73, P330, DOI 10.1136/jnnp.73.3.330; Schell T.L., 2008, INVISIBLE WOUNDS WAR, DOI [10.7249/mg720-1ccf.12, DOI 10.7249/MG720-1CCF.12]; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Smith A., 1973, SYMBOL DIGIT MODALIT; Suhr JA, 2002, J CLIN EXP NEUROPSYC, V24, P448, DOI 10.1076/jcen.24.4.448.1039; The Management of Concussion/mTBI Working Group, 2009, VA DOD CLIN PRACT GU; *US ARM PHYS DIS A, 2008, TEMP DIS RET LIST TD, P1; *US DEP DEF TASK F, 2009, ACH VIS REP DEP DEF; *US GOV ACC OFF, 2008, GAO08276; Vanderploeg RD, 2009, ARCH PHYS MED REHAB, V90, P1084, DOI 10.1016/j.apmr.2009.01.023; Wechsler D., 2001, WECHSLER TEST ADULT; Wechsler D, 1997, WAIS 3 ADM SCORING M; Whittaker R, 2007, J NEUROL NEUROSUR PS, V78, P644, DOI 10.1136/jnnp.2006.101105; Wilk JE, 2010, J HEAD TRAUMA REHAB, V25, P9, DOI 10.1097/HTR.0b013e3181bd090f	43	17	17	0	10	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	SEP	2011	25	10					1019	1025		10.3109/02699052.2011.597044			7	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	801TZ	WOS:000293464800013	21812588				2021-06-18	
J	Lingsma, HF; Roozenbeek, B; Perel, P; Roberts, I; Maas, AIR; Steyerberg, EW				Lingsma, Hester F.; Roozenbeek, Bob; Perel, Pablo; Roberts, Ian; Maas, Andrew I. R.; Steyerberg, Ewout W.			Between-centre differences and treatment effects in randomized controlled trials: A case study in traumatic brain injury	TRIALS			English	Article							HEAD-INJURY; CLINICAL-TRIAL; HYPOTHERMIA; QUALITY; ADULTS	Background: In Traumatic Brain Injury (TBI), large between-centre differences in outcome exist and many clinicians believe that such differences influence estimation of the treatment effect in randomized controlled trial (RCTs). The aim of this study was to assess the influence of between-centre differences in outcome on the estimated treatment effect in a large RCT in TBI. Methods: We used data from the MRC CRASH trial on the efficacy of corticosteroid infusion in patients with TBI. We analyzed the effect of the treatment on 14 day mortality with fixed effect logistic regression. Next we used random effects logistic regression with a random intercept to estimate the treatment effect taking into account between-centre differences in outcome. Between-centre differences in outcome were expressed with a 95% range of odds ratios (OR) for centres compared to the average, based on the variance of the random effects (tau(2)). A random effects logistic regression model with random slopes was used to allow the treatment effect to vary by centre. The variation in treatment effect between the centres was expressed in a 95% range of the estimated treatment ORs. Results: In 9978 patients from 237 centres, 14-day mortality was 19.5%. Mortality was higher in the treatment group (OR = 1.22, p = 0.00010). Using a random effects model showed large between-centre differences in outcome (95% range of centre effects: 0.27-3.71), but did not substantially change the estimated treatment effect (OR = 1.24, p = 0.00003). There was limited, although statistically significant, between-centre variation in the treatment effect (OR = 1.22, 95% treatment OR range: 1.17-1.26). Conclusion: Large between-centre differences in outcome do not necessarily affect the estimated treatment effect in RCTs, in contrast to current beliefs in the clinical area of TBI.	[Lingsma, Hester F.; Roozenbeek, Bob; Steyerberg, Ewout W.] Erasmus MC, Dept Publ Hlth, NL-3000 CA Rotterdam, Netherlands; [Roozenbeek, Bob; Maas, Andrew I. R.] Univ Antwerp Hosp, Dept Neurosurg, B-2650 Edegem, Belgium; [Perel, Pablo; Roberts, Ian] London Sch Hyg & Trop Med, Epidemiol & Populat Hlth Dept, London WC1E 7HT, England	Lingsma, HF (corresponding author), Erasmus MC, Dept Publ Hlth, POB 2040, NL-3000 CA Rotterdam, Netherlands.	h.lingsma@erasmusmc.nl	Maas, Andrew IR/C-5584-2013; Steyerberg, Ewout/C-1509-2018	Maas, Andrew IR/0000-0003-1612-1264; /0000-0002-2342-301X; Steyerberg, Ewout/0000-0002-7787-0122	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS-01923521]	This work was supported by the National Institutes of Health [NS-01923521]	Clifton GL, 2001, J NEUROSURG, V95, P751, DOI 10.3171/jns.2001.95.5.0751; Clifton GL, 2009, J NEUROTRAUM, V26, P393, DOI 10.1089/neu.2008.0556; Dickinson K, 2000, BMJ-BRIT MED J, V320, P1308, DOI 10.1136/bmj.320.7245.1308; Finkelstein EA., 2006, INCIDENCE EC BURDEN; Kirkpatrick PJ, 1997, J NEUROL NEUROSUR PS, V62, P109, DOI 10.1136/jnnp.62.2.109; Lingsma HF, 2011, NEUROSURGERY, V68, P601, DOI 10.1227/NEU.0b013e318209333b; Maas AIR, 2006, LANCET NEUROL, V5, P38, DOI 10.1016/S1474-4422(05)70253-2; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Maas AIR, 2007, J NEUROTRAUM, V24, P232, DOI 10.1089/neu.2006.0024; Muzha I, 2004, LANCET, V364, P1321, DOI 10.1016/s0140-6736(04)17188-2; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Rothwell PM, 2005, LANCET, V365, P256; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Timbie JW, 2008, STAT MED, V27, P1351, DOI 10.1002/sim.3082	14	17	18	0	4	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1745-6215			TRIALS	Trials	AUG 25	2011	12								201	10.1186/1745-6215-12-201			6	Medicine, Research & Experimental	Research & Experimental Medicine	817OY	WOS:000294684900001	21867540	DOAJ Gold, Green Published, Green Accepted			2021-06-18	
J	Kim, YJ				Kim, Young Ju			THE IMPACT OF TIME FROM ED ARRIVAL TO SURGERY ON MORTALITY AND HOSPITAL LENGTH OF STAY IN PATIENTS WITH TRAUMATIC BRAIN INJURY	JOURNAL OF EMERGENCY NURSING			English	Article						Time to surgery; Traumatic brain injury; Mortality; Length of stay	HEAD-INJURY; LEVEL-I; OUTCOMES; CENTERS; TRIAGE	Introduction: The previous studies examining the benefits of timely surgery in patients with traumatic brain injury (TBI) have yielded inconsistent conclusions. This study examined how time from ED arrival to surgery in patients with TBI influenced two patient outcomes: hospital mortality and length of hospital stay. Methods: Using a multivariate and cross-sectional research design, the study sample included 493 patients from the 17 level I and II trauma centers that met inclusion criteria in the National Trauma Data Bank 4.0. The patient characteristics (eg, age, Glasgow Coma Scale score, Injury Severity score, and ED arrival time) and trauma center characteristics (eg, ownership, designation type, and center level) were examined. Student t test, chi(2) test, analysis of variance, and multilevel regression models were used to analyze data. Results: Patients who underwent craniotomy or drainage of hematoma within 4 hours of arrival had half the likelihood of mortality when compared with those who underwent surgery more than 4 hours after ED arrival (odds ratio = .49; 95% confidence interval = .24 to .99). When patients had surgery within 4 hours of arrival, they had a significantly shorter length of hospital stay than did patients who had surgery more than 4 hours after arrival in the emergency department (Estimate = -.10, 95% confidence interval = -.19 to -.01). Discussion: Based on the results of this study using a large sample from multiple centers and advanced statistics, benefits of early clinical assessment and quick access to neurosurgical surgery are substantiated in patients with TBI.	Sungshin Womens Univ, Coll Nursing, Seoul 136742, South Korea	Kim, YJ (corresponding author), Sungshin Womens Univ, Coll Nursing, 249-1 Dongseon Dong 3 Ga, Seoul 136742, South Korea.	yjkim727@sungshin.ac.kr			Sungshin Women's University	This work was supported by the Sungshin Women's University Research Grant.	Aiken LH, 2002, JAMA-J AM MED ASSOC, V288, P1987, DOI 10.1001/jama.288.16.1987; Chibbaro S, 2007, SURG NEUROL, V68, P632, DOI 10.1016/j.surneu.2006.12.046; Clancy TV, 2001, J TRAUMA, V51, P346, DOI 10.1097/00005373-200108000-00021; *COMM TRAUM, 2006, RES OPT CAR INJ PAT; Cudnik MT, 2009, J TRAUMA, V66, P1321, DOI 10.1097/TA.0b013e3181929e2b; Gruen RL, 2006, ANN SURG, V244, P371, DOI 10.1097/01.sla.0000234655.83517.56; Harrington DT, 2005, ANN SURG, V241, P961, DOI 10.1097/01.sla.0000164178.62726.f1; Karni A, 2001, AM SURGEON, V67, P1098; Kim KH, 2009, J KOREAN NEUROSURG S, V45, P143, DOI 10.3340/jkns.2009.45.3.143; Lehmann R, 2009, AM J SURG, V197, P571, DOI 10.1016/j.amjsurg.2008.12.037; Massaro F, 1996, ACTA NEUROCHIR, V138, P185, DOI 10.1007/BF01411359; Meagher R J, 2000, Clin Neurosurg, V46, P127; Sawauchi S, 2002, ACT NEUR S, V81, P243; Wolf L, 2006, J EMERG NURS, V32, P357, DOI 10.1016/j.jen.2006.04.019	14	17	17	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0099-1767	1527-2966		J EMERG NURS	J. Emerg. Nurs.	JUL	2011	37	4					328	333		10.1016/j.jen.2010.04.017			6	Emergency Medicine; Nursing	Emergency Medicine; Nursing	795ZX	WOS:000293020200011	21741566				2021-06-18	
J	Liraz-Zaltsman, S; Alexandrovich, AG; Trembovler, V; Fishbein, I; Yaka, R; Shohami, E; Biegon, A				Liraz-Zaltsman, Sigal; Alexandrovich, Alexander G.; Trembovler, Victoria; Fishbein, Ianai; Yaka, Rami; Shohami, Esther; Biegon, Anat			Regional Sensitivity to Neuroinflammation: In Vivo and In Vitro Studies	SYNAPSE			English	Article						neuroinflammation; regional sensitivity; autoradiography; cognitive deficits; LPS; peripheral benzodiazepine receptors; translocator protein	PERIPHERAL BENZODIAZEPINE-RECEPTORS; TRAUMATIC BRAIN-INJURY; CLOSED-HEAD INJURY; PROTEIN 18 KDA; NMDA RECEPTORS; BINDING-SITES; COGNITIVE IMPAIRMENT; NEURONAL DEATH; RAT-BRAIN; MICROGLIA	Background: Neuroinflammation is involved in several acute-onset neuropathologies such as meningitis, encephalitis, stroke, and traumatic brain injury as well as in neurodegenerative diseases. All of these patholologies are associated with cognitive deficits. Using a model of pure neuroinflammation (intracisternal injection of endotoxin in mice), we tested the hypothesis that brain regions involved in cognition are the most vulnerable to inflammatory insults, and this vulnerability is an inherent property of neocortical neurons. Methods: Mice (n = 10/group) injected with endotoxin (LPS) or saline in the cisterna magna underwent neurobehavioral and cognitive testing followed by quantitative autoradiographic assessment of regional neuroinflammation with [3H]PK11195, an established marker of microgliosis. In parallel, cocultures of cortical and striatal neurons taken from embryonic day 19 rat embryos or postnatal day 1 mice expressing green fluorescent protein were exposed for 24 h to the proinflammatory cytokine TNFalpha, glutamate, or a combination of the two agents. Results: LPS-treated mice exhibited significant deficits in memory and significant increases in specific PK11195 binding in cortical and hippocampal regions, but not in striatum. Cultured neurons of cortical origin showed significantly lower survival rate relative to striatal neurons in response to TNFalpha, glutamate, or a combination of the two agents. Furthermore, TNFalpha exerted neuroprotective rather than neurotoxic effects in the striatal but not in the cortical neurons. Conclusions: These results suggest that the cortex is inherently more sensitive than the striatum to the deleterious effects of neuroinflammation, and may offer an explanation for the preponderance of cognitive deficits in neuropathologies with a neuroinflammatory component. Synapse 65: 634-642, 2011. (C) 2010 Wiley-Liss, Inc.	[Liraz-Zaltsman, Sigal; Biegon, Anat] Sheba Med Ctr, Joseph Sagol Neurosci Ctr, Ramat Gan, Israel; [Liraz-Zaltsman, Sigal; Alexandrovich, Alexander G.; Trembovler, Victoria; Yaka, Rami; Shohami, Esther] Hebrew Univ Jerusalem, Sch Pharm, Dept Pharmacol, IL-91120 Jerusalem, Israel; [Yaka, Rami] Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel; [Biegon, Anat] Brookhaven Natl Lab, Dept Med, Upton, NY 11973 USA	Biegon, A (corresponding author), Bldg 490 Med, Upton, NY 11973 USA.	biegon@bnl.gov			BSFUS-Israel Binational Science Foundation [2005-021-01]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS050285] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific ResearchMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI) [21683009, 22300267] Funding Source: KAKEN	Contract grant sponsor: BSF; Contract grant number: 2005-021-01	Anderson V, 1997, J Int Neuropsychol Soc, V3, P147; Arvin B, 1996, NEUROSCI BIOBEHAV R, V20, P445, DOI 10.1016/0149-7634(95)00026-7; Banati RB, 1997, J NEUROCYTOL, V26, P77, DOI 10.1023/A:1018567510105; Banati RB, 2000, BRAIN, V123, P2321, DOI 10.1093/brain/123.11.2321; Beni-Adani L, 2001, J PHARMACOL EXP THER, V296, P57; Betarbet R, 2000, J NEUROCHEM, V74, P1166; Biegon A, 2002, J NEUROCHEM, V82, P924, DOI 10.1046/j.1471-4159.2002.01050.x; BOJE KMK, 1995, J PHARMACOL EXP THER, V274, P1199; Carter JA, 2003, BRAIN RES REV, V43, P57, DOI 10.1016/S0165-0173(03)00192-9; Chauveau F, 2008, EUR J NUCL MED MOL I, V35, P2304, DOI 10.1007/s00259-008-0908-9; Chen MK, 2008, PHARMACOL THERAPEUT, V118, P1, DOI 10.1016/j.pharmthera.2007.12.004; DUBOIS A, 1988, BRAIN RES, V445, P77, DOI 10.1016/0006-8993(88)91076-1; ENNACEUR A, 1988, BEHAV BRAIN RES, V31, P47, DOI 10.1016/0166-4328(88)90157-X; Floyd RA, 2000, ADV RES NEURODEGENER, V8, P387; Ghoshal A, 2007, GLIA, V55, P483, DOI 10.1002/glia.20474; GIULIAN D, 1993, STROKE, V24, pI84; Grossman R, 2003, NEUROIMAGE, V20, P1971, DOI 10.1016/j.neuroimage.2003.06.003; Hauss-Wegrzyniak B, 2000, BRAIN RES, V859, P157, DOI 10.1016/S0006-8993(00)01999-5; Hoogman M, 2007, J NEUROL NEUROSUR PS, V78, P1092, DOI 10.1136/jnnp.2006.110023; Kim WG, 2000, J NEUROSCI, V20, P6309, DOI 10.1523/JNEUROSCI.20-16-06309.2000; Maeda J, 2007, BRAIN RES, V1157, P100, DOI 10.1016/j.brainres.2007.04.054; McGeer E G, 1988, Alzheimer Dis Assoc Disord, V2, P331, DOI 10.1097/00002093-198802040-00001; Miyazawa N, 1995, ACTA NEUROCHIR, V137, P207, DOI 10.1007/BF02187195; Noble F, 2007, NEUROSCI LETT, V424, P106, DOI 10.1016/j.neulet.2007.07.005; Pickering M, 2005, EXP PHYSIOL, V90, P663, DOI 10.1113/expphysiol.2005.030734; Pikis A, 1996, CLIN PEDIATR, V35, P72, DOI 10.1177/000992289603500204; Qin LY, 2007, GLIA, V55, P453, DOI 10.1002/glia.20467; Quintana A, 2005, J NEUROSCI RES, V82, P701, DOI 10.1002/jnr.20680; Rao VLR, 2000, EXP NEUROL, V161, P102, DOI 10.1006/exnr.1999.7269; Rosi S, 2005, J NEUROSCI, V25, P723, DOI 10.1523/JNEUROSCI.4469-04.2005; Sayyah M, 2003, EPILEPSY RES, V57, P175, DOI 10.1016/j.eplepsyres.2003.11.002; Segal M, 2003, EUR J NEUROSCI, V17, P2573, DOI 10.1046/j.1460-9568.2003.02696.x; Semmler A, 2007, EXP NEUROL, V204, P733, DOI 10.1016/j.expneurol.2007.01.003; Sparkman NL, 2005, PHYSIOL BEHAV, V86, P244, DOI 10.1016/j.physbeh.2005.07.016; Sparkman NL, 2005, PHYSIOL BEHAV, V85, P278, DOI 10.1016/j.physbeh.2005.04.015; STEPHENSON DT, 1995, J NEUROSCI, V15, P5263; Tsenter J, 2008, J NEUROTRAUM, V25, P324, DOI 10.1089/neu.2007.0452; Venneti S, 2006, PROG NEUROBIOL, V80, P308, DOI 10.1016/j.pneurobio.2006.10.002; Wenk GL, 2000, BRAIN RES, V885, P1, DOI 10.1016/S0006-8993(00)02792-X; Willard LB, 1999, NEUROSCIENCE, V88, P193	40	17	17	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0887-4476	1098-2396		SYNAPSE	Synapse	JUL	2011	65	7					634	642		10.1002/syn.20889			9	Neurosciences	Neurosciences & Neurology	748WY	WOS:000289424900010	21108236	Green Accepted			2021-06-18	
J	Richmond, R; Aldaghlas, TA; Burke, C; Rizzo, AG; Griffen, M; Pullarkat, R				Richmond, Robyn; Aldaghlas, Tayseer A.; Burke, Christine; Rizzo, Anne G.; Griffen, Margaret; Pullarkat, Ranjit			Age: Is It All in the Head? Factors Influencing Mortality in Elderly Patients With Head Injuries	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						Elderly; Traumatic brain injury; Motor vehicle crashes; Mortality; CIREN	TRAUMATIC BRAIN-INJURY; PROSPECTIVE MULTICENTER TRIAL	Background: Elderly patients, an increasing segment of the population, who sustain traumatic brain injury (TBI) are known to have worse outcomes, including higher mortality. This objective of this study was to examine the Crash Injury Research Engineering Network and to determine at what age motor vehicle crash fatalities from head injuries increased. Methods: The Crash Injury Research Engineering Network database was queried from 1996 to 2009. Study inclusion criteria were adult vehicle occupants with TBI, with an Abbreviated Injury Scale score >= 2. The age at which mortality increased was calculated. Patients younger and older than this cutoff age were compared to determine differences in crash characteristics. The determined cutoff age was compared with one found in a larger, population-based database. Results: There were 915 patients who met the study criteria. An increase in mortality was seen at age 60 years despite no difference in Injury Severity Score and a decrease in crash severity. Patients <= 60 years were more likely to have alcohol involved, to be in a rollover crash, and had higher crash speeds. Comparing the element of the crash attributed to the head injury, the patients >60 years were more likely to have struck the airbag, door, and seat. An analysis of the larger database revealed an increase in mortality at age 70 years. Conclusions: There was a higher mortality secondary to head injuries in those older than 60 years involved in motor vehicle crashes. Improved safety measures in vehicle design may decrease the number of head injuries seen in the older population.	[Richmond, Robyn; Aldaghlas, Tayseer A.; Burke, Christine; Rizzo, Anne G.; Griffen, Margaret; Pullarkat, Ranjit] Inova Fairfax Hosp, Inova Reg Trauma Ctr, Falls Church, VA 22042 USA	Richmond, R (corresponding author), Inova Fairfax Hosp, Inova Reg Trauma Ctr, 3000 Gallows Rd, Falls Church, VA 22042 USA.	robyn.richmond@inova.org					*DEP TRANSP, 2008, TRAFF SAF FACTS 2008; Harris C, 2003, J AM COLL SURGEONS, V197, P711, DOI 10.1016/S1072-7515(03)00729-4; Langlois JA, 2006, TRAUMATIC BRAIN INJU; Livingston DH, 2005, J TRAUMA, V59, P1298, DOI 10.1097/01.ta.0000196002.03681.18; Mosenthal AC, 2004, J TRAUMA, V56, P1042, DOI 10.1097/01.TA.0000127767.83267.33; Mosenthal AC, 2002, J TRAUMA, V52, P907, DOI 10.1097/00005373-200205000-00015; Stitzel Joel D, 2008, Ann Adv Automot Med, V52, P235; Susman M, 2002, J TRAUMA, V53, P219, DOI 10.1097/00005373-200208000-00004; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; U.S. Bureau of the Census, 2001, PROF GEN DEM CHAR 20	10	17	17	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0022-5282			J TRAUMA	J. Trauma-Injury Infect. Crit. Care	JUL	2011	71	1					E8	E11		10.1097/TA.0b013e3181fbaa46			4	Critical Care Medicine; Surgery	General & Internal Medicine; Surgery	790RR	WOS:000292607400002	21336200				2021-06-18	
J	Bryan, CJ; Hernandez, AM				Bryan, Craig J.; Hernandez, Ann M.			Predictors of Post-Traumatic Headache Severity Among Deployed Military Personnel	HEADACHE			English	Article						post-traumatic headache; traumatic brain injury; military population	TRAUMATIC BRAIN-INJURY; CHRONIC PAIN; SLEEP; PTSD; EPIDEMIOLOGY; VETERANS; STRESS	Objective.- The current study used a cross-sectional observational design to evaluate the relationship between psychological, physiological, and contextual factors and headache severity among 133 deployed military personnel and 4 civilian contractors diagnosed with mild traumatic brain injury (mTBI) referred to a combat support hospital in Iraq. Background.- Although TBI and headache sequelae have been documented for military combatants, little is known about factors associated with headache severity. Methods.- Military personnel (n = 157) and civilian (n = 4) contractors referred to a combat support hospital in Iraq underwent a standardized intake evaluation which included computerized neurocognitive testing, psychological and physical health questionnaires, a clinical interview, and a physical examination by a physician. Results.- Results of zero-inflated Poisson regression modeling suggest that insomnia is associated with increased likelihood for endorsement of any headache, but loss of consciousness, post-traumatic stress disorder symptoms, and slowed reaction time only are predictive of headache severity. Among the subset of patients presenting to the combat support hospital within 7 days of mTBI (n = 101), number of TBI symptoms demonstrated a non-significant trend toward increased likelihood of headache endorsement of any kind, with loss of consciousness, post-traumatic stress disorder, and slowed reaction time demonstrating significant relationships with headache severity. Conclusion.- Knowledge of predictors of post-concussive headache onset and severity may assist clinicians in making important decisions regarding treatment recommendations for veterans with mTBI.	[Bryan, Craig J.; Hernandez, Ann M.] Univ Texas Hlth Sci Ctr San Antonio, Dept Psychiat, San Antonio, TX 78229 USA	Hernandez, AM (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Psychiat, 7550 IH 10 W,Suite 1325, San Antonio, TX 78229 USA.			Bryan, Craig/0000-0002-9714-0733			Afari N, 2009, HEADACHE, V49, P1267, DOI 10.1111/j.1526-4610.2009.01517.x; [Anonymous], 2007, AUT NEUR ASS METR CO; Asmundson GJG, 2002, CAN J PSYCHIAT, V47, P930; Bastien CH, 2001, SLEEP MED, V2, P297, DOI 10.1016/S1389-9457(00)00065-4; Bazarian JJ, 1999, BRAIN INJURY, V13, P173, DOI 10.1080/026990599121692; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Chaput G, 2009, SLEEP MED, V10, P713, DOI 10.1016/j.sleep.2008.07.015; Collins MW, 2003, AM J SPORT MED, V31, P168, DOI 10.1177/03635465030310020301; Couch JR, 2001, HEADACHE, V41, P559, DOI 10.1046/j.1526-4610.2001.041006559.x; COUCH JR, 1995, NEUROREHAB NEURAL RE, V9, P83; De Benedittis G, 1983, J Neurosurg Sci, V27, P177; Evans RW., 2006, NEUROLOGY TRAUMA, P95; Foo H, 2003, SLEEP MED REV, V7, P145, DOI 10.1053/smrv.2002.0224; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; JACOBSON NS, 1991, J CONSULT CLIN PSYCH, V59, P12, DOI 10.1037/0022-006X.59.1.12; Jensen O K, 2001, Ugeskr Laeger, V163, P5029; Kopta SM, 2002, PSYCHOTHER RES, V12, P413, DOI 10.1093/ptr/12.4.413; Lautenbacher S, 2006, SLEEP MED REV, V10, P357, DOI 10.1016/j.smrv.2005.08.001; Luethcke CA, 2011, J INT NEUROPSYCH SOC, V17, P36, DOI 10.1017/S1355617710001207; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; Mihalik JP, 2005, J NEUROSURG, V102, P850, DOI 10.3171/jns.2005.102.5.0850; Nash JM, 2006, HEADACHE, V46, P1377, DOI 10.1111/j.1526-4610.2006.00580.x; Neely ET, 2009, HEADACHE, V49, P1089, DOI 10.1111/j.1526-4610.2009.001460.x; Ouellet MC, 2004, NEUROREHAB NEURAL RE, V18, P187, DOI 10.1177/1545968304271405; Ruff RL, 2008, J REHABIL RES DEV, V45, P941, DOI 10.1682/JRRD.2008.02.0028; Sharp TJ, 2001, CLIN PSYCHOL REV, V21, P857, DOI 10.1016/S0272-7358(00)00071-4; Smith MT, 2004, SLEEP MED REV, V8, P119, DOI 10.1016/S1087-0792(03)00044-3; Tanielian T, 2008, INVISIBLE WOUNDS WAR; Weathers F. W., 1993, ANN M INT SOC TRAUM	29	17	17	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0017-8748	1526-4610		HEADACHE	Headache	JUN	2011	51	6					945	953		10.1111/j.1526-4610.2011.01887.x			9	Clinical Neurology	Neurosciences & Neurology	772GH	WOS:000291221800012	21457255				2021-06-18	
J	Hoogerdijk, B; Runge, U; Haugboelle, J				Hoogerdijk, Barbara; Runge, Ulla; Haugboelle, Jette			The adaptation process after traumatic brain injury An individual and ongoing occupational struggle to gain a new identity	SCANDINAVIAN JOURNAL OF OCCUPATIONAL THERAPY			English	Article						Occupational therapy; situated learning process; occupation; re-identification; narrative	STROKE; EXPERIENCES; RECOVERY; ADULTS; LIFE	The aim of this study is to understand better how individuals with traumatic brain injury make sense of their adaptation process and their performance of occupations within this process. For this study, four participants were interviewed twice. Thereafter analyses following a narrative approach led to the construction of four individual narratives. The results indicate that the adaptation process following traumatic brain injury is (1) a necessary struggle to gain a new identity; (2) facilitated by engagement in familiar occupations in familiar environments; (3) a protracted learning process that continues long after rehabilitation ends; (4) individual and situated. The results suggest that healthcare professionals including occupational therapists should: allow individuals with traumatic brain injury to test and practise their abilities within their own home environments; provide them with the necessary space to practise on their own; guide them in using their own and new strategies in a way that is both efficient and personally satisfying. Finally, this study discusses whether rehabilitation services should be offered over a protracted period of time. Professional support following the rehabilitation period--precisely the period in which they are trying to establish a meaningful existence with their disabilities--could be a more useful path to follow.	[Hoogerdijk, Barbara] Rehabil Ctr Heliomare, Dept Occupat Therapy, NL-1949 EC Wijk Aan Zee, Netherlands; [Runge, Ulla] Runge Consult, Copenhagen, Denmark; [Haugboelle, Jette] Univ Coll Sjaelland, Fac Occupat Therapy, Naestved, Denmark	Hoogerdijk, B (corresponding author), Rehabil Ctr Heliomare, Dept Occupat Therapy, Relweg 51, NL-1949 EC Wijk Aan Zee, Netherlands.	b.hoogerdijk@heliomare.nl			Rehabilitation Centre Heliomare at Wijk aan Zee, the NetherlandsNetherlands Government	The authors would like to thank the four participants who were generously willing to share their time and stories with the first-named author. This study was part of the European Master of Science in Occupational Therapy programme and was supported by Rehabilitation Centre Heliomare at Wijk aan Zee, the Netherlands.	Bendz M, 2000, SOC SCI MED, V51, P713, DOI 10.1016/S0277-9536(99)00486-4; BLAIR S, 2000, BRIT J OCCUPATIONAL, V63, P231, DOI DOI 10.1177/030802260006300508; Bontje P, 2004, AM J OCCUP THER, V58, P140, DOI 10.5014/ajot.58.2.140; Brown D, 2006, BRAIN INJURY, V20, P937, DOI 10.1080/02699050600909821; Burton CR, 2000, J ADV NURS, V32, P301, DOI 10.1046/j.1365-2648.2000.01477.x; Christiansen CH, 1999, AM J OCCUP THER, V53, P547, DOI 10.5014/ajot.53.6.547; Daniels R, 2002, SCAND J OCCUP THER, V9, P167, DOI DOI 10.1080/110381202605; *DUTCH HEART ASS, 2001, REV BER; Easton KL, 1999, GERIATR NURS, V20, P70, DOI 10.1053/gn.1999.v20.97009; Fleming Jennifer M, 2006, Can J Occup Ther, V73, P44; FORTMEIER S, 2002, PATIENTS VIEW; Goodfellow J., 1998, WRITING QUALITATIVE, P175; Gracey F, 2008, NEUROPSYCHOL REHABIL, V18, P627, DOI 10.1080/09602010802041238; Gray JM, 1998, AM J OCCUP THER, V52, P354, DOI 10.5014/ajot.52.5.354; Hill H, 1999, BRAIN INJURY, V13, P839, DOI 10.1080/026990599121043; KIELHOFNER G, 2008, MODEL HUMAN OCCUPATI, P107; Kincheloe J. L., 1994, HDB QUALITATIVE RES, P138; Kirkevold M, 2002, DISABIL REHABIL, V24, P887, DOI 10.1080/09638280210142239; Klinger L, 2005, J OCCUP SCI, V12, P9, DOI 10.1080/14427591.2005.9686543; Mee J., 2004, BRIT J OCCUP THER, V67, P225; MOLINEUX M, 2003, J OCCUPATIONAL SCI, V10, P52, DOI DOI 10.1080/14427591.2003.9686511; Muenchberger H, 2008, BRAIN INJURY, V22, P979, DOI 10.1080/02699050802530532; Nelson DL, 1996, AM J OCCUP THER, V50, P775, DOI 10.5014/ajot.50.10.775; Polkinghorne DE, 1996, AM J OCCUP THER, V50, P299, DOI 10.5014/ajot.50.4.299; PriceLackey P, 1996, AM J OCCUP THER, V50, P306, DOI 10.5014/ajot.50.4.306; Sabari JS, 1998, AM J OCCUP THER, V52, P299, DOI 10.5014/ajot.52.4.299; SCHJERNING J, 2004, LIFE FAST LANE QUALI; SCHKADE JK, 1992, AM J OCCUP THER, V46, P829, DOI 10.5014/ajot.46.9.829; Seibert PS, 2002, BRAIN INJURY, V16, P837, DOI 10.1080/02699050210131939; Strandberg T, 2009, SOC WORK HEALTH CARE, V48, P276, DOI 10.1080/00981380802599240; Tham K, 2000, AM J OCCUP THER, V54, P398, DOI 10.5014/ajot.54.4.398; TOGLIA JP, 1991, AM J OCCUP THER, V45, P505, DOI 10.5014/ajot.45.6.505; White MA, 2000, DISABIL REHABIL, V22, P140	33	17	17	0	19	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	1103-8128			SCAND J OCCUP THER	Scand. J. Occup. Ther.	JUN	2011	18	2					122	132		10.3109/11038121003645985			11	Rehabilitation	Rehabilitation	763OV	WOS:000290570500006	20384550				2021-06-18	
J	Stoddard, SA; Zimmerman, MA				Stoddard, Sarah A.; Zimmerman, Marc A.			Association of Interpersonal Violence With Self-Reported History of Head Injury	PEDIATRICS			English	Article						head injury; traumatic brain injury; violent behavior; longitudinal; emerging adulthood	TRAUMATIC BRAIN-INJURY; UNITED-STATES; REHABILITATION; BEHAVIOR; DEATH	OBJECTIVE: The purpose of this study was to examine differences in interpersonal violence among individuals who reported a head injury compared with those who did not report a head injury. METHODS: We used data from an 8-year longitudinal study of youth selected by their grade point average to study those at-risk for high school dropout in 4 public high schools in a Midwestern city (N = 850). Participants were followed up from mid-adolescence to the transition into young adulthood. One-way analyses of variance were used to test for differences in levels of interpersonal violence, and repeated measures multivariate analyses of variance were used to assess differences in levels of violence over time among participants based on reports of head injury. A series of multivariate regression analyses examined whether head injury was associated with subsequent violent behavior. RESULTS: Participants who had ever experienced a head injury before young adulthood reported more interpersonal violence in young adulthood than participants who had never had a head injury. In multivariate analyses, respondents who had a head injury in the past year reported more subsequent interpersonal violence than respondents who had not had a head injury. CONCLUSION: Our findings support other studies that link history of head injury to later interpersonal violence. Pediatrics 2011; 127:1074-1079	[Stoddard, Sarah A.] Univ Michigan, Sch Nursing, Ann Arbor, MI 48109 USA; [Zimmerman, Marc A.] Univ Michigan, Sch Publ Hlth, Dept Hlth Behav & Hlth Educ, Ann Arbor, MI 48109 USA	Stoddard, SA (corresponding author), Univ Michigan, Sch Nursing, 400 N Ingalls,Suite 4320, Ann Arbor, MI 48109 USA.	sastodda@umich.edu			National Institute of Drug AbuseUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA) [R01-DA07484]; University of Michigan School of Nursing's Health Promotion/Risk Reduction Interventions [5T32NR007073-18]; National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; NATIONAL INSTITUTE OF NURSING RESEARCHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [T32NR007073] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [R01DA007484] Funding Source: NIH RePORTER	This research was supported by a National Institute of Drug Abuse grant (R01-DA07484; Principal Investigator, Dr Zimmerman). Dr Stoddard is a Research Fellow supported by the University of Michigan School of Nursing's Health Promotion/Risk Reduction Interventions with Vulnerable Populations Training Program (Project No. 5T32NR007073-18; Principal Investigator, Antonia M. Villarruel).; Funded by the National Institutes of Health (NIH)	*CDCP, FACTS TRAUM BRAIN IN; Centers for Disease Control and Prevention, 2003, C MILD TRAUM BRAIN I; Centers for Disease Control and Prevention, INJ PREV CONTR VIOL; Centers for Disease Control and Prevention (CDC), 2008, MMWR Morb Mortal Wkly Rep, V57, P33; Cohen R A, 1999, Violence Vict, V14, P397; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Grafman J, 1996, NEUROLOGY, V46, P1231, DOI 10.1212/WNL.46.5.1231; Graham J., 1995, YOUNG PEOPLE CRIME, V145; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; JOHNSTON LD, 2002, NIH PUBL, V1; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Leon-Carrion J, 2003, BRAIN INJURY, V17, P207, DOI 10.1080/0269905021000010249; LEWIS DO, 1988, AM J PSYCHIAT, V145, P584; LEWIS DO, 1986, AM J PSYCHIAT, V143, P838; National Institute of Neurological Disorders and Stroke, 2002, NIH PUBL; Perron Brian E, 2008, Crim Behav Ment Health, V18, P243, DOI 10.1002/cbm.702; Pontifex MB, 2009, NEUROPSYCHOLOGIA, V47, P3210, DOI 10.1016/j.neuropsychologia.2009.07.021; Prigatano GP, 2005, J HEAD TRAUMA REHAB, V20, P19, DOI 10.1097/00001199-200501000-00004; Raine A, 2002, J ABNORM CHILD PSYCH, V30, P311, DOI 10.1023/A:1015754122318; Raine A., 1993, PSYCHOPATHOLOGY CRIM; Stuss DT, 2002, ANNU REV PSYCHOL, V53, P401, DOI 10.1146/annurev.psych.53.100901.135220; Volkow ND, 1995, PSYCHIAT RES-NEUROIM, V61, P243, DOI 10.1016/0925-4927(95)02671-J	22	17	17	0	5	AMER ACAD PEDIATRICS	ELK GROVE VILLAGE	141 NORTH-WEST POINT BLVD,, ELK GROVE VILLAGE, IL 60007-1098 USA	0031-4005			PEDIATRICS	Pediatrics	JUN	2011	127	6					1074	1079		10.1542/peds.2010-2453			6	Pediatrics	Pediatrics	771GV	WOS:000291146100048	21624875	Green Published			2021-06-18	
J	Wu, N; Wang, WH; Tian, Y; Zou, XT; Maffeo, M; Niezrecki, C; Chen, JL; Wang, XW				Wu, Nan; Wang, Wenhui; Tian, Ye; Zou, Xiaotian; Maffeo, Michael; Niezrecki, Christopher; Chen, Julie; Wang, Xingwei			Low-cost rapid miniature optical pressure sensors for blast wave measurements	OPTICS EXPRESS			English	Article							TRAUMATIC BRAIN-INJURY; SHOCK	This paper presents an optical pressure sensor based on a Fabry-Perot (FP) interferometer formed by a 45 degrees angle polished single mode fiber and an external silicon nitride diaphragm. The sensor is comprised of two V-shape grooves with different widths on a silicon chip, a silicon nitride diaphragm released on the surface of the wider V-groove, and a 45 degrees angle polished single mode fiber. The sensor is especially suitable for blast wave measurements: its compact structure ensures a high spatial resolution; its thin diaphragm based design and the optical demodulation scheme allow a fast response to the rapid changing signals experienced during blast events. The sensor shows linearity with the correlation coefficient of 0.9999 as well as a hysteresis of less than 0.3%. The shock tube test demonstrated that the sensor has a rise time of less than 2 mu s from 0 kPa to 140 kPa. (C) 2011 Optical Society of America	[Wu, Nan; Wang, Wenhui; Tian, Ye; Zou, Xiaotian; Wang, Xingwei] Univ Massachusetts Lowell, Dept Elect & Comp Engn, Lowell, MA 01854 USA; [Maffeo, Michael] USA, Natick Soldier Res Dev & Engn Ctr, Natick, MA 01760 USA; [Niezrecki, Christopher; Chen, Julie] Univ Massachusetts Lowell, Dept Mech Engn, Lowell, MA 01854 USA	Wu, N (corresponding author), Univ Massachusetts Lowell, Dept Elect & Comp Engn, 1 Univ Ave, Lowell, MA 01854 USA.	xingwei_wang@uml.edu	Zou, Xiaotian/J-8657-2013; Tian, Ye/C-4662-2013; Tian, Ye/A-1090-2014	Tian, Ye/0000-0002-0785-1145; Tian, Ye/0000-0002-0785-1145	Army Research LaboratoryUnited States Department of DefenseUS Army Research Laboratory (ARL) [W911NF-07-2-0081]	The authors are grateful for the collaboration with Natick Soldier Research, Development, and Engineering Center for sharing the shock tube and the reference pressure sensors. The authors also appreciate the Army Research Laboratory for sponsoring this work (Nanomanufacturing of Multifunctional Sensors Ref. Award Number: W911NF-07-2-0081).	Chavko M, 2007, J NEUROSCI METH, V159, P277, DOI 10.1016/j.jneumeth.2006.07.018; DePalma RG, 2005, NEW ENGL J MED, V352, P1335, DOI 10.1056/NEJMra042083; Irwin RJ, 1999, J TRAUMA, V47, P105, DOI 10.1097/00005373-199907000-00023; MacPherson WN, 2000, MEAS SCI TECHNOL, V11, P95, DOI 10.1088/0957-0233/11/2/302; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Parkes W, 2007, J MICROMECH MICROENG, V17, P1334, DOI 10.1088/0960-1317/17/7/016; Taber KH, 2006, J NEUROPSYCH CLIN N, V18, P141, DOI 10.1176/appi.neuropsych.18.2.141; TOHYAMA O, 1997, SOLID STATE SENSORS, V1482, P1489; Wang WH, 2010, OPT EXPRESS, V18, P9006, DOI 10.1364/OE.18.009006; Wang WH, 2009, OPT EXPRESS, V17, P16613, DOI 10.1364/OE.17.016613; Watson S, 2006, MEAS SCI TECHNOL, V17, P1337, DOI 10.1088/0957-0233/17/6/008; Xu JC, 2005, IEEE PHOTONIC TECH L, V17, P870, DOI 10.1109/LPT.2005.844013	12	17	19	1	14	OPTICAL SOC AMER	WASHINGTON	2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA	1094-4087			OPT EXPRESS	Opt. Express	MAY 23	2011	19	11					10797	10804		10.1364/OE.19.010797			8	Optics	Optics	767JN	WOS:000290852800076	21643336	DOAJ Gold			2021-06-18	
J	Lo, BWY; Kyu, HH; Jichici, D; Upton, AM; Akl, EA; Meade, MO				Lo, Benjamin W. Y.; Kyu, Hmwe H.; Jichici, Draga; Upton, Adrian M.; Akl, Elie A.; Meade, Maureen O.			Meta-Analysis of Randomized Trials on First Line and Adjunctive Levetiracetam	CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES			English	Article							ADD-ON THERAPY; REFRACTORY PARTIAL SEIZURES; PLACEBO-CONTROLLED TRIAL; MULTICENTER DOUBLE-BLIND; CHINESE PATIENTS; EFFICACY; SAFETY; TOLERABILITY; PHENYTOIN; EPILEPSY	Context: New evidence suggests that levetiracetam may be as effective as traditional agents, with better safety profile. Objective: To synthesize evidence regarding efficacy and tolerability of levetiracetam as first line, adjunctive or prophylactic antiepileptic agent. Study Selection & Data Extraction: Eligible studies were randomized controlled trials (RCTs) of levetiracetam used in adults with epilepsy. MEDLINE, EMBASE, CENTRAL, CINHAL, PAPERSFIRST, PROCEEDINGSFIRST, PROQUEST and conference proceedings identified studies (to September 30, 2010). Two investigators independently selected, appraised studies, collected and analyzed data. Results: Of ten eligible randomized trials, eight investigated adjunctive levetiracetam for refractory seizures, one as monotherapy for newly diagnosed seizures, one as monotherapy for prophylaxis. Eight RCTs of adjunctive levetiracetam were of moderate quality (GRADE criteria), with two showing lack of allocation concealment. Meta-analyses showed adjunctive levetiracetam was more effective than placebo in achieving at least 50% reduction of seizure frequency, when added to baseline antiepileptic regimen (pooled RR 2.15 [1.65,2.82], I-2 = 45%, p value (heterogeneity) = 0.08, p value (overall effect) < 0.01). Likelihood of serious adverse events necessitating withdrawal from study was not significantly different between levetiracetam and control (pooled RR 1.37 [0.88,2.13], I-2 = 0%, p value (heterogeneity) = 0.84, p value (overall effect) = 0.17). Subgroup analyses suggested similar effects across different dosages. Sensitivity analysis of studies with adequate concealment showed similar effects. Conclusions: Levetiracetam is an effective adjunctive agent for refractory epilepsy. More studies are needed to establish whether it is effective as monotherapy for newly diagnosed seizures, and for prophylaxis in traumatic brain injury.	[Lo, Benjamin W. Y.] McMaster Univ, Fac Hlth Sci, Div Crit Care Med, Dept Clin Edpiemiol & Biostat, Hamilton, ON L8N 3Z5, Canada; [Lo, Benjamin W. Y.] Univ Toronto, Div Neurosurg, Toronto, ON, Canada; [Akl, Elie A.] SUNY Buffalo, Dept Med, Buffalo, NY 14260 USA	Lo, BWY (corresponding author), McMaster Univ, Fac Hlth Sci, Div Crit Care Med, Dept Clin Edpiemiol & Biostat, Room 2U,1200 Main St W, Hamilton, ON L8N 3Z5, Canada.		Akl, Elie A/R-2079-2016; Akl, Elie/K-5269-2019	Akl, Elie A/0000-0002-3444-8618; 			Ben-Menachem E, 2000, EPILEPSIA, V41, P1276, DOI 10.1111/j.1528-1157.2000.tb04605.x; Berkovic SF, 2007, NEUROLOGY, V69, P1751, DOI 10.1212/01.wnl.0000268699.34614.d3; Betts T, 2000, SEIZURE-EUR J EPILEP, V9, P80, DOI 10.1053/seiz.2000.0380; Brodie MJ, 2007, NEUROLOGY, V68, P402, DOI 10.1212/01.wnl.0000252941.50833.4a; Cereghino JJ, 2000, NEUROLOGY, V55, P236, DOI 10.1212/WNL.55.2.236; Cramer JA, 2003, EPILEPSY BEHAV, V4, P124, DOI 10.1016/S1525-5050(03)00005-2; DAYA S, 2006, EVIDENCE BASED OBSTE, V8, P71, DOI DOI 10.1016/J.EBOBGYN.2006.10.001; French J, 2001, EPILEPSY RES, V47, P77, DOI 10.1016/S0920-1211(01)00296-0; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Higgins JPT, COCHRANE HDB SYSTEMA; Jones KE, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E3; Leppik I, 2003, EPILEPSIA, V44, P1350, DOI 10.1046/j.1528-1157.2003.62802.x; Lim DA, 2009, J NEURO-ONCOL, V93, P349, DOI 10.1007/s11060-008-9781-4; Milligan TA, 2008, NEUROLOGY, V71, P665, DOI 10.1212/01.wnl.0000324624.52935.46; Noachtar S, 2008, NEUROLOGY, V70, P607, DOI 10.1212/01.wnl.0000297512.18364.40; Otoul C, 2005, CLIN NEUROPHARMACOL, V28, P72, DOI 10.1097/01.wnf.0000159956.87511.67; Peltola J, 2009, EPILEPSIA, V50, P406, DOI 10.1111/j.1528-1167.2008.01817.x; Schunemann HJ, 2006, AM J RESP CRIT CARE, V174, P605, DOI 10.1164/rccm.200602-197ST; Shorvon SD, 2000, EPILEPSIA, V41, P1179, DOI 10.1111/j.1528-1157.2000.tb00323.x; Steinhoff BJ, 2007, EPILEPSY RES, V76, P6, DOI 10.1016/j.eplepsyres.2007.06.002; Szaflarski JP, 2010, NEUROCRIT CARE, V12, P165, DOI 10.1007/s12028-009-9304-y; Tsai JJ, 2006, EPILEPSIA, V47, P72, DOI 10.1111/j.1528-1167.2006.00372.x; Wu XY, 2009, EPILEPSIA, V50, P398, DOI 10.1111/j.1528-1167.2008.01729.x; Xiao Z, 2009, EUR NEUROL, V61, P233, DOI 10.1159/000197109	24	17	17	0	6	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0317-1671	2057-0155		CAN J NEUROL SCI	Can. J. Neurol. Sci.	MAY	2011	38	3					475	486		10.1017/S0317167100011902			12	Clinical Neurology	Neurosciences & Neurology	774IQ	WOS:000291379300021	21515509	Bronze			2021-06-18	
J	Zhang, Y; Popovich, P				Zhang, Yi; Popovich, Phillip			Roles of Autoantibodies in Central Nervous System Injury	DISCOVERY MEDICINE			English	Article							SPINAL-CORD-INJURY; BLOOD-BRAIN-BARRIER; TOLL-LIKE RECEPTORS; GLUTAMATE-RECEPTOR; BASIC-PROTEIN; CELL-DEATH; ANTIBODIES; DISEASE; REPAIR; INFLAMMATION	Stroke, traumatic brain injury (TBI), and spinal cord injury (SCI) cause irreversible damage to the nervous system. Although these are neurological disorders, pathology and loss of function also occur outside the nervous system and are often not easily explained by paralysis or impaired neural function. Emerging data indicate that much of the pathological sequelae that accompanies CNS trauma has characteristics of a self-directed immunological disease. Here, we outline those data, describing basic mechanisms of B cell activation and autoantibody synthesis after CNS injury. A summary of the anti-CNS autoantibodies that have been identified in humans and animals is provided along with a discussion of how autoantibodies may affect survival of neuronal and non-neuronal tissues and whether autoimmune reactions are feasible therapeutic targets after CNS trauma. [Discovery Medicine 11(60):395-402, May 2011]	[Zhang, Yi; Popovich, Phillip] Ohio State Univ, Dept Neurosci, Columbus, OH 43210 USA	Popovich, P (corresponding author), Ohio State Univ, Dept Neurosci, 460 W 12th Ave, Columbus, OH 43210 USA.	phillip.popovich@osumc.edu			NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS047175, NS067260]; Ray W. Poppleton Endowment; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS067260, R01NS047175] Funding Source: NIH RePORTER	Supported in part by NIH NS047175 and NS067260 and the Ray W. Poppleton Endowment.	Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Ankeny DP, 2006, J NEUROCHEM, V99, P1073, DOI 10.1111/j.1471-4159.2006.04147.x; Ankeny DP, 2010, TRENDS IMMUNOL, V31, P332, DOI 10.1016/j.it.2010.06.006; Ankeny DP, 2009, J CLIN INVEST, V119, P2990, DOI 10.1172/JCI39780; Archelos JJ, 2000, TRENDS NEUROSCI, V23, P317, DOI 10.1016/S0166-2236(00)01575-7; Bansal V, 2009, J NEUROTRAUM, V26, P1353, DOI 10.1089/neu.2008-0858; Basten A, 2010, CURR OPIN IMMUNOL, V22, P566, DOI 10.1016/j.coi.2010.08.001; Baumgarth N, 2011, NAT REV IMMUNOL, V11, P34, DOI 10.1038/nri2901; Berger T, 2003, NEW ENGL J MED, V349, P139, DOI 10.1056/NEJMoa022328; Bornstein NM, 2001, NEUROLOGY, V56, P529, DOI 10.1212/WNL.56.4.529; Bronstein JM, 1999, NEUROLOGY, V53, P154, DOI 10.1212/WNL.53.1.154; Carrasco YR, 2006, CURR OPIN IMMUNOL, V18, P286, DOI 10.1016/j.coi.2006.03.013; Carvey PM, 2009, J NEUROCHEM, V111, P291, DOI 10.1111/j.1471-4159.2009.06319.x; Cesarman-Maus G, 2011, STROKE, V42, P501, DOI 10.1161/STROKEAHA.110.592121; CHAPMAN J, 1988, NEUROSCI LETT, V86, P235, DOI 10.1016/0304-3940(88)90577-0; Colasanti T, 2009, J NEUROIMMUNOL, V212, P3, DOI 10.1016/j.jneuroim.2009.05.003; Dambinova SA, 2003, CLIN CHEM, V49, P1752, DOI 10.1373/49.10.1752; Dambinova SA, 2002, STROKE, V33, P1181, DOI 10.1161/01.STR.0000014922.83673.86; DAVIDOFF GN, 1992, ARCH PHYS MED REHAB, V73, P275; Davies AL, 2007, ARCH PHYS MED REHAB, V88, P1384, DOI 10.1016/j.apmr.2007.08.004; Davydova TV, 2007, B EXP BIOL MED+, V143, P182, DOI 10.1007/s10517-007-0044-8; DeGiorgio LA, 2001, NAT MED, V7, P1189, DOI 10.1038/nm1101-1189; Diamond B, 2009, NAT REV IMMUNOL, V9, P449, DOI 10.1038/nri2529; Double KL, 2009, EXP NEUROL, V217, P297, DOI 10.1016/j.expneurol.2009.03.002; Duan B, 2006, AUTOIMMUN REV, V5, P403, DOI 10.1016/j.autrev.2005.10.007; Ehrenstein MR, 2010, NAT REV IMMUNOL, V10, P778, DOI 10.1038/nri2849; Ganor Y, 2005, EXP NEUROL, V195, P92, DOI 10.1016/j.expneurol.2005.04.002; Ghosn EEB, 2011, P NATL ACAD SCI USA, V108, P2879, DOI 10.1073/pnas.1019764108; Gruden MA, 2007, J NEUROIMMUNOL, V186, P181, DOI 10.1016/j.jneuroim.2007.03.023; Gruden MA, 2011, J NEUROIMMUNOL, V233, P221, DOI 10.1016/j.jneuroim.2010.12.001; Harwood NE, 2010, ANNU REV IMMUNOL, V28, P185, DOI 10.1146/annurev-immunol-030409-101216; Hayes KC, 2002, J NEUROTRAUM, V19, P753, DOI 10.1089/08977150260139129; Jones TB, 2005, CURR PHARM DESIGN, V11, P1223, DOI 10.2174/1381612053507468; Knopf PM, 1998, J IMMUNOL, V161, P692; Kobayashi T, 2008, INT IMMUNOL, V20, P881, DOI 10.1093/intimm/dxn049; Kowal C, 2004, IMMUNITY, V21, P179, DOI 10.1016/j.immuni.2004.07.011; Kurosaki T, 2010, ANNU REV IMMUNOL, V28, P21, DOI 10.1146/annurev.immunol.021908.132541; Leinhase I, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-55; Liu JW, 2004, SPINE, V29, P164, DOI 10.1097/01.BRS.0000107234.74249.CD; Lopez-Escribano H, 2002, ARTHRITIS RHEUM, V46, P3290, DOI 10.1002/art.10684; Mackay F, 2003, ANNU REV IMMUNOL, V21, P231, DOI 10.1146/annurev.immunol.21.120601.141152; Martin F, 2006, ANNU REV IMMUNOL, V24, P467, DOI 10.1146/annurev.immunol.24.021605.090517; McGonagle D, 2006, PLOS MED, V3, P1242, DOI 10.1371/journal.pmed.0030297; McKnight K, 2005, NEUROLOGY, V65, P1730, DOI 10.1212/01.wnl.0000187129.66353.13; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; Mocco J, 2006, CIRC RES, V99, P209, DOI 10.1161/01.RES.0000232544.90675.42; Nath A, 2003, NEUROMOL MED, V3, P29, DOI 10.1385/NMM:3:1:29; OLSSON T, 1990, ANN NEUROL, V27, P132, DOI 10.1002/ana.410270207; Peltola JT, 2000, AM J MED, V109, P712, DOI 10.1016/S0002-9343(00)00617-3; Perry VH, 2003, NAT REV NEUROSCI, V4, P103, DOI 10.1038/nrn1032; Popovich PG, 2001, J NEUROTRAUM, V18, P957, DOI 10.1089/089771501750451866; Popovich PG, 2008, NAT REV NEUROSCI, V9, P481, DOI 10.1038/nrn2398; Prochazka M, 1971, Int Surg, V55, P322; Qiao F, 2006, AM J PATHOL, V169, P1039, DOI 10.2353/ajpath.2006.060248; Rite I, 2007, J NEUROCHEM, V101, P1567, DOI 10.1111/j.1471-4159.2007.04567.x; Sewell DL, 2004, J NEUROIMMUNOL, V155, P55, DOI 10.1016/j.jneuroim.2004.06.003; Shoenfeld Y, 2007, ANN NY ACAD SCI, V1108, P227, DOI 10.1196/annals.1422.025; SINGH VK, 1993, BRAIN BEHAV IMMUN, V7, P97, DOI 10.1006/brbi.1993.1010; Singh VK, 1997, PEDIATR NEUROL, V17, P88, DOI 10.1016/S0887-8994(97)00045-3; Skoda D, 2006, BRAIN RES BULL, V68, P213, DOI 10.1016/j.brainresbull.2005.05.032; Stagg CJ, 2010, EPILEPSIA, V51, P1898, DOI 10.1111/j.1528-1167.2010.02644.x; Tanne D, 1998, STROKE, V29, P1755, DOI 10.1161/01.STR.29.9.1755; Teeling JL, 2009, NEUROSCIENCE, V158, P1062, DOI 10.1016/j.neuroscience.2008.07.031; Ten VS, 2010, J NEUROSCI, V30, P2077, DOI 10.1523/JNEUROSCI.5249-09.2010; Trivedi A, 2006, CLIN NEUROSCI RES, V6, P283, DOI 10.1016/j.cnr.2006.09.007; Urbanus RT, 2009, LANCET NEUROL, V8, P998, DOI 10.1016/S1474-4422(09)70239-X; Vaccari JPDR, 2008, J NEUROSCI, V28, P3404, DOI 10.1523/JNEUROSCI.0157-08.2008; Vargas ME, 2010, P NATL ACAD SCI USA, V107, P11993, DOI 10.1073/pnas.1001948107; Warrington AE, 2010, J CLIN IMMUNOL, V30, pS50, DOI 10.1007/s10875-010-9406-5; Watzlawik J, 2010, GLIA, V58, P1782, DOI 10.1002/glia.21048; Wilhelm KR, 2007, EUR J NEUROL, V14, P327, DOI 10.1111/j.1468-1331.2006.01667.x; Wright BR, 2009, ARCH NEUROL-CHICAGO, V66, P1456, DOI 10.1001/archneurol.2009.262; Zappia M, 2002, ACTA NEUROL SCAND, V106, P54, DOI 10.1034/j.1600-0404.2002.01240.x; Zhang M, 2004, P NATL ACAD SCI USA, V101, P3886, DOI 10.1073/pnas.0400347101	74	17	17	0	1	DISCOVERY MEDICINE	TIMONIUM	10 GERARD AVE, STE 201, TIMONIUM, MD 21093 USA	1539-6509	1944-7930		DISCOV MED	Discov. Med.	MAY	2011	11	60					395	402					8	Medicine, Research & Experimental	Research & Experimental Medicine	V27VA	WOS:000208639500002	21616038				2021-06-18	
J	Moro, N; Ghavim, SS; Hovda, DA; Sutton, RL				Moro, Nobuhiro; Ghavim, Sima S.; Hovda, David A.; Sutton, Richard L.			Delayed sodium pyruvate treatment improves working memory following experimental traumatic brain injury	NEUROSCIENCE LETTERS			English	Article						Cerebral metabolism; Cortical contusion injury; Plus-maze; Pyruvate; Rat; Spatial alternation	CEREBRAL GLUCOSE-UTILIZATION; HIPPOCAMPAL ACETYLCHOLINE-RELEASE; CYTOCHROME-OXIDASE HISTOCHEMISTRY; POSITRON-EMISSION-TOMOGRAPHY; FLUID-PERCUSSION INJURY; CORTICAL CONTUSION; VISUAL-CORTEX; WATER MAZE; FDG-PET; METABOLISM	Prior work indicates that cerebral glycolysis is impaired following traumatic brain injury (TBI) and that pyruvate treatment acutely after TBI can improve cerebral metabolism and is neuroprotective. Since extracellular levels of glucose decrease during periods of increased cognitive demand and exogenous glucose improves cognitive performance, we hypothesized that pyruvate treatment prior to testing could ameliorate cognitive deficits in rats with TBI. Based on pre-surgical spatial alternation performance in a 4-arm plus-maze, adult male rats were randomized to receive either sham injury or unilateral (left) cortical contusion injury (CCI). On days 4,9 and 14 after surgery animals received an intraperitoneal injection of either vehicle (Sham-Veh, n = 6; CCI-Veh, n = 7) or 1000 mg/kg of sodium pyruvate (CCI-SP, n = 7). One hour after each injection rats were retested for spatial alternation performance. Animals in the CCI-SP group showed no significant working memory deficits in the spatial alternation task compared to Sham-Veh controls. The percent four/five alternation scores for CCI-Veh rats were significantly decreased from Sham-Veh scores on days 4 and 9(p < 0.01) and from CCI-SP scores on days 4,9 and 14(p < 0.05). Measures of cortical contusion volume, regional cerebral metabolic rates of glucose and regional cytochrome oxidase activity at day 15 post-injury did not differ between CCI-SP and CCI-Veh groups. These results show that spatial alternation testing can reliably detect temporal deficits and recovery of working memory after TBI and that delayed pyruvate treatment can ameliorate TBI-induced cognitive impairments. (C) 2011 Elsevier Ireland Ltd. All rights reserved.	[Moro, Nobuhiro; Ghavim, Sima S.; Hovda, David A.; Sutton, Richard L.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurosurg, Los Angeles, CA 90095 USA; [Moro, Nobuhiro; Ghavim, Sima S.; Hovda, David A.; Sutton, Richard L.] Univ Calif Los Angeles, David Geffen Sch Med, Brain Injury Res Ctr, Los Angeles, CA 90095 USA; [Hovda, David A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA	Moro, N (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurosurg, Box 957039, Los Angeles, CA 90095 USA.	nmoro@mednet.ucla.edu; sghavim@mednet.ucla.edu; dhovda@mednet.ucla.edu; rsutton@mednet.ucla.edu			UCLA Brain Injury Research Center; National Institute of Neurological Disorders and Stroke (NINDS)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS058489]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS058489] Funding Source: NIH RePORTER	Supported by the UCLA Brain Injury Research Center and Award Number P01NS058489 from the National Institute of Neurological Disorders and Stroke (NINDS). The content is the sole responsibility of the authors and does not necessarily represent official views of the NINDS or the National Institutes of Health.	Bartnik BL, 2005, J NEUROTRAUM, V22, P1052, DOI 10.1089/neu.2005.22.1052; Bartnik BL, 2007, J NEUROTRAUM, V24, P1079, DOI 10.1089/neu.2006.0210; Bergsneider M, 1997, J NEUROSURG, V86, P241, DOI 10.3171/jns.1997.86.2.0241; Bergsneider M, 2001, J HEAD TRAUMA REHAB, V16, P135, DOI 10.1097/00001199-200104000-00004; Bontempi B, 1996, EUR J NEUROSCI, V8, P2348, DOI 10.1111/j.1460-9568.1996.tb01198.x; Chen SHA, 2003, J NEUROL NEUROSUR PS, V74, P326, DOI 10.1136/jnnp.74.3.326; Conejo NM, 2007, NEUROSCIENCE, V145, P403, DOI 10.1016/j.neuroscience.2006.11.057; Dai W, 2009, BRAIN RES, V1251, P287, DOI 10.1016/j.brainres.2008.11.034; DUNNMEYNELL AA, 1995, BRAIN RES, V675, P143, DOI 10.1016/0006-8993(95)00050-Z; Fukushima M, 2009, J NEUROTRAUM, V26, P1095, DOI 10.1089/neu.2008.0771; Harrison FE, 2009, BEHAV BRAIN RES, V198, P247, DOI 10.1016/j.bbr.2008.10.015; HOVDA DA, 1991, BRAIN RES, V567, P1, DOI 10.1016/0006-8993(91)91429-5; HOVDA DA, 1987, EXP NEUROL, V97, P391, DOI 10.1016/0014-4886(87)90099-9; HUMAYUN MS, 1989, NUCL MED COMMUN, V10, P335, DOI 10.1097/00006231-198905000-00004; Huttemann M, 2008, NEUROSCIENCE, V151, P148, DOI 10.1016/j.neuroscience.2007.09.029; Izumi Y, 2010, NEUROSCI LETT, V478, P131, DOI 10.1016/j.neulet.2010.04.078; Kokiko ON, 2007, BRAIN INJURY, V21, P259, DOI 10.1080/02699050701209964; Kokiko-Cochran ON, 2008, NEUROSCI LETT, V436, P27, DOI 10.1016/j.neulet.2008.02.046; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lee SM, 1999, ANN NY ACAD SCI, V893, P337, DOI 10.1111/j.1749-6632.1999.tb07849.x; Lin AL, 2010, P NATL ACAD SCI USA, V107, P8446, DOI 10.1073/pnas.0909711107; McNay EC, 2006, PHYSIOL BEHAV, V87, P298, DOI 10.1016/j.physbeh.2005.10.016; McNay EC, 2001, J GERONTOL A-BIOL, V56, pB66, DOI 10.1093/gerona/56.2.B66; McNay EC, 2001, NEUROBIOL LEARN MEM, V75, P325, DOI 10.1006/nlme.2000.3976; McNay EC, 2000, P NATL ACAD SCI USA, V97, P2881, DOI 10.1073/pnas.050583697; Messier C, 2004, EUR J PHARMACOL, V490, P33, DOI 10.1016/j.ejphar.2004.02.043; Moore AH, 2000, J CEREBR BLOOD F MET, V20, P1492, DOI 10.1097/00004647-200010000-00011; Moro N, 2010, EXP NEUROL, V225, P391, DOI 10.1016/j.expneurol.2010.07.013; Nakashima T, 2007, AM J NEURORADIOL, V28, P236; Nakayama N, 2006, J NEUROL NEUROSUR PS, V77, DOI 10.1136/jnnp.2005.080523; Prins ML, 2009, J NEUROTRAUM, V26, P1083, DOI [10.1089/neu.2008.0769, 10.1089/neu.2008-0769]; Prins ML, 2001, J NEUROTRAUM, V18, P31, DOI 10.1089/089771501750055758; Queen SA, 1996, BRAIN RES, V724, P246, DOI 10.1016/0006-8993(96)00308-3; RAGOZZINO ME, 1995, NEUROSCIENCE, V68, P981, DOI 10.1016/0306-4522(95)00204-V; Ragozzino ME, 1998, J NEUROSCI, V18, P1595; Ragozzino ME, 1996, P NATL ACAD SCI USA, V93, P4693, DOI 10.1073/pnas.93.10.4693; Ragozzino ME, 1995, BEHAV NEUROSCI, V109, P1074; Sanchez-Carrion R, 2008, J NEUROTRAUM, V25, P479, DOI 10.1089/neu.2007.0417; Sharma Pushpa, 2009, J Emerg Trauma Shock, V2, P67, DOI 10.4103/0974-2700.50739; Soane L, 2007, J NEUROSCI RES, V85, P3407, DOI 10.1002/jnr.21498; SOKOLOFF L, 1977, J NEUROCHEM, V28, P897, DOI 10.1111/j.1471-4159.1977.tb10649.x; Sutton RL, 2000, NEURAL PLAST, V7, P109, DOI 10.1155/NP.2000.109; SUTTON RL, 1994, ACTA NEUROCHIR, P446; Taylor AN, 2008, J NEUROTRAUM, V25, P311, DOI 10.1089/neu.2007.0486; Wrubel KM, 2007, PHARMACOL BIOCHEM BE, V86, P712, DOI 10.1016/j.pbb.2007.02.018; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K; Zeng JY, 2007, J CEREBR BLOOD F MET, V27, P304, DOI 10.1038/sj.jcbfm.9600335; Zlotnik A, 2008, NEUROCHEM RES, V33, P1044, DOI 10.1007/s11064-007-9548-x	48	17	18	0	4	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	MAR 17	2011	491	2					158	162		10.1016/j.neulet.2011.01.029			5	Neurosciences	Neurosciences & Neurology	739QF	WOS:000288732200014	21241774	Green Accepted			2021-06-18	
J	Kim, J; Woo, J; Park, YG; Chae, S; Jo, S; Choi, JW; Jun, HY; Young, YI; Park, SH; Kim, KH; Shin, HS; Kim, D				Kim, Jeongjin; Woo, Jeonghoon; Park, Young-Gyun; Chae, Sujin; Jo, Seonmi; Choi, Jeong Woo; Jun, Hong Young; Yeom, Young Il; Park, Seong Hoon; Kim, Kyung Hwan; Shin, Hee-Sup; Kim, Daesoo			Thalamic T-Type Ca2+ Channels Mediate Frontal Lobe Dysfunctions Caused by a Hypoxia-Like Damage in the Prefrontal Cortex	JOURNAL OF NEUROSCIENCE			English	Article							DEFICIT HYPERACTIVITY DISORDER; ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; CORTICALLY GENERATED SEIZURES; TRAUMATIC BRAIN INJURY; SPIKE-WAVE COMPLEXES; THALAMOCORTICAL RELAY; CALCIUM-CHANNELS; ABSENCE SEIZURES; FAST COMPONENTS; EARLY-CHILDHOOD	Hypoxic damage to the prefrontal cortex (PFC) has been implicated in the frontal lobe dysfunction found in various neuropsychiatric disorders. The underlying subcortical mechanisms, however, have not been well explored. In this study, we induced a PFC-specific hypoxia-like damage by cobalt-wire implantation to demonstrate that the role of the mediodorsal thalamus (MD) is critical for the development of frontal lobe dysfunction, including frontal lobe-specific seizures and abnormal hyperactivity. Before the onset of these abnormalities, the cross talk between the MD and PFC nuclei at theta frequencies was enhanced. During the theta frequency interactions, burst spikes, known to depend on T-type Ca2+ channels, were increased in MD neurons. In vivo knockout or knockdown of the T-type Ca2+ channel gene (Ca(V)3.1) in the MD substantially reduced the theta frequency MD-PFC cross talk, frontal lobe-specific seizures, and locomotor hyperactivity in this model. These results suggest a two-step model of prefrontal dysfunction in which the response to a hypoxic lesion in the PFC results in abnormal thalamocortical feedback driven by thalamic T-type Ca2+ channels, which, in turn, leads to the onset of neurological and behavioral abnormalities. This study provides valuable insights into preventing the development of neuropsychiatric disorders arising from irreversible PFC damage.	[Kim, Jeongjin; Woo, Jeonghoon; Park, Young-Gyun; Jo, Seonmi; Kim, Daesoo] Korea Adv Inst Sci & Technol, Taejon 305701, South Korea; [Chae, Sujin; Yeom, Young Il] Korea Res Inst Biosci & Biotechnol, Med Genom Res Ctr, Taejon 305806, South Korea; [Choi, Jeong Woo; Kim, Kyung Hwan] Yonsei Univ, Wonju 220710, South Korea; [Shin, Hee-Sup] Korea Inst Sci & Technol, Ctr Neural Sci, Seoul 136791, South Korea; [Jun, Hong Young; Park, Seong Hoon] Wonkwang Univ, Sch Med, Dept Radiol, Iksan 570749, Chonbuk, South Korea; [Jun, Hong Young; Park, Seong Hoon] Wonkwang Univ, Sch Med, Inst Radiol Imaging Sci, Iksan 570749, Chonbuk, South Korea	Kim, D (corresponding author), Korea Adv Inst Sci & Technol, Taejon 305701, South Korea.	daesoo@kaist.ac.kr	Kim, Daesoo/C-1625-2011	Kim, Daesoo/0000-0001-9915-1463; Choi, Jeong Woo/0000-0001-5824-8859; Kim, Kyung Hwan/0000-0001-9044-0437	Korea governmentKorean Government [2010000002, 20100000032]; Korea Ministry of Education, Science and TechnologyMinistry of Education, Science and Technology, Republic of Korea [2010k000814]	This work was supported by the National Honor Scientist Program of Korea (Grant 2010000002, to H.-S.S.), the Mid-Career Researcher Program of the National Research Foundation of Korea funded by the Korea government (Grant 20100000032, to D. K.), and by the 21st Century Frontier R&D Programs of the Korea Ministry of Education, Science and Technology (Grant 2010k000814, to D. K.). We thank H. S. Choi and S. B. Park for their useful comments and help with data analysis. We are grateful to S. Y. Bahk for her assistance with manuscript preparation.	Adachi N, 2000, SEIZURE-EUR J EPILEP, V9, P328, DOI 10.1053/seiz.2000.0413; Anderson SW, 2000, DEV NEUROPSYCHOL, V18, P281, DOI 10.1207/S1532694202Anderson; Armony JL, 2002, NEUROPSYCHOLOGIA, V40, P817, DOI 10.1016/S0028-3932(01)00178-6; Barry RJ, 2003, CLIN NEUROPHYSIOL, V114, P171, DOI 10.1016/S1388-2457(02)00362-0; Beleza P, 2009, EPILEPSIA, V50, P550, DOI 10.1111/j.1528-1167.2008.01780.x; BENSON DF, 1991, J CHILD NEUROL, V6, pS9, DOI 10.1177/0883073891006001S02; CHOI DW, 1990, J NEUROSCI, V10, P2493; Chua C. K, 2007, C P IEEE ENG MED BIO, P6496, DOI 10.1109/IEMBS.2007.4353847; COULTER DA, 1989, ANN NEUROL, V25, P582, DOI 10.1002/ana.410250610; Cox CL, 1997, P NATL ACAD SCI USA, V94, P8854, DOI 10.1073/pnas.94.16.8854; CRICK F, 1984, P NATL ACAD SCI-BIOL, V81, P4586, DOI 10.1073/pnas.81.14.4586; CRUNELLI V, 1991, TRENDS NEUROSCI, V14, P16, DOI 10.1016/0166-2236(91)90178-W; CRUNELLI V, 1989, J PHYSIOL-LONDON, V413, P543, DOI 10.1113/jphysiol.1989.sp017668; Crunelli V, 2002, NAT REV NEUROSCI, V3, P371, DOI 10.1038/nrn811; Daffner KR, 2000, J NEUROL NEUROSUR PS, V68, P18, DOI 10.1136/jnnp.68.1.18; DAMASIO AR, 1985, CLIN NEUROPSYCHOLOGY, P339; DAMASIO H, 1994, SCIENCE, V264, P1102, DOI 10.1126/science.8178168; Davids E, 2003, BRAIN RES REV, V42, P1, DOI 10.1016/S0165-0173(02)00274-6; Destexhe A, 1999, NEUROSCIENCE, V92, P427, DOI 10.1016/S0306-4522(99)00024-X; ELBERT T, 1992, BIOL PSYCHIAT, V32, P595, DOI 10.1016/0006-3223(92)90072-8; Englander J, 2003, ARCH PHYS MED REHAB, V84, P365, DOI 10.1053/apmr.2003.50022; Ernst WL, 2009, J NEUROSCI, V29, P1615, DOI 10.1523/JNEUROSCI.2081-08.2009; Frampton JE, 2005, CNS DRUGS, V19, P347, DOI 10.2165/00023210-200519040-00010; Gainetdinov RR, 2001, TRENDS NEUROSCI, V24, P527, DOI 10.1016/S0166-2236(00)01886-5; GEDYE A, 1991, MED HYPOTHESES, V34, P174, DOI 10.1016/0306-9877(91)90189-6; Gilby KL, 2008, EPILEPSIA, V49, P108, DOI 10.1111/j.1528-1167.2008.01851.x; Gonzalez-Heydrich J, 2007, EPILEPSY BEHAV, V10, P384, DOI 10.1016/j.yebeh.2007.01.010; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; GRATTAN LM, 1992, BRAIN COGNITION, V20, P185, DOI 10.1016/0278-2626(92)90068-W; GROENEWEGEN HJ, 1988, NEUROSCIENCE, V24, P379, DOI 10.1016/0306-4522(88)90339-9; Gucuyener K, 2003, J CHILD NEUROL, V18, P109, DOI 10.1177/08830738030180020601; GUIDO W, 1992, J NEUROPHYSIOL, V68, P2199; GUTNICK MJ, 1982, J NEUROPHYSIOL, V48, P1321; Han CJ, 2003, P NATL ACAD SCI USA, V100, P13087, DOI 10.1073/pnas.2132313100; Helmstaedter C, 2001, EPILEPSY BEHAV, V2, P384, DOI 10.1006/ebeh.2001.0259; Hermann B, 2007, BRAIN, V130, P3135, DOI 10.1093/brain/awm227; HERNANDEZ MT, 2001, ADV BEHAV BIOL, V50, P103; Hockel M, 2001, JNCI-J NATL CANCER I, V93, P266, DOI 10.1093/jnci/93.4.266; HUGUENARD JR, 1994, J NEUROSCI, V14, P5485; Huguenard JR, 1996, ANNU REV PHYSIOL, V58, P329, DOI 10.1146/annurev.ph.58.030196.001553; ISHIGE N, 1987, NEUROSURGERY, V20, P848, DOI 10.1227/00006123-198706000-00005; Ito U, 2006, STROKE, V37, P2134, DOI 10.1161/01.STR.0000231875.96714.b1; Jeanmonod D., 2001, Thalamus & Related Systems, V1, P245, DOI 10.1016/S1472-9288(01)00026-7; Jeanmonod D, 1996, BRAIN, V119, P363, DOI 10.1093/brain/119.2.363; Jensen FE, 1998, J NEUROPHYSIOL, V79, P73; Jobst BC, 2005, PSYCHIAT CLIN N AM, V28, P635, DOI 10.1016/j.psc.2005.05.012; Kates WR, 2005, PEDIATR NEUROL, V32, P109, DOI 10.1016/j.pediatrneurol.2004.09.005; Kellinghaus C, 2004, EPILEPTIC DISORD, V6, P223; Kim D, 2003, SCIENCE, V302, P117, DOI 10.1126/science.1088886; Kim D, 2001, NEURON, V31, P35, DOI 10.1016/S0896-6273(01)00343-9; KURODA M, 1993, BRAIN RES, V612, P339, DOI 10.1016/0006-8993(93)91683-J; Lee J, 2004, P NATL ACAD SCI USA, V101, P18195, DOI 10.1073/pnas.0408089101; LEVIN S, 1984, J PSYCHIAT RES, V18, P57, DOI 10.1016/0022-3956(84)90047-5; Lisman JE, 1997, TRENDS NEUROSCI, V20, P38, DOI 10.1016/S0166-2236(96)10070-9; Llinas RR, 1999, P NATL ACAD SCI USA, V96, P15222, DOI 10.1073/pnas.96.26.15222; LUHMANN HJ, 1992, J NEUROPHYSIOL, V67, P798; LURIA AR, 1964, NEUROPSYCHOLOGIA, V2, P257, DOI 10.1016/0028-3932(64)90034-X; Macmillan Malcolm, 2002, ODD KIND FAME STORIE; MATEER CA, 1991, DEV NEUROPSYCHOL, V7, P359, DOI 10.1080/87565649109540498; Max JE, 2005, J AM ACAD CHILD PSY, V44, P443, DOI 10.1097/01.chi.0000156661.38576.0f; MCALLISTER TW, 1987, COMPR PSYCHIAT, V28, P14, DOI 10.1016/0010-440X(87)90039-3; McCormick David A., 1994, Current Opinion in Neurobiology, V4, P550, DOI 10.1016/0959-4388(94)90056-6; MCGUIRE TL, 1987, J LEARN DISABIL, V20, P590, DOI 10.1177/002221948702001004; McKinlay A, 2002, J NEUROL NEUROSUR PS, V73, P281, DOI 10.1136/jnnp.73.3.281; Millichap JG, 2008, PEDIATRICS, V121, pE358, DOI 10.1542/peds.2007-1332; Neckelmann D, 1998, J NEUROPHYSIOL, V80, P1480; Niedermeyer E, 1998, CLIN ELECTROENCEPHAL, V29, P79, DOI 10.1177/155005949802900206; OWEN AM, 1990, NEUROPSYCHOLOGIA, V28, P1021, DOI 10.1016/0028-3932(90)90137-D; OWEN AM, 1993, BRAIN, V116, P1159, DOI 10.1093/brain/116.5.1159; Paradiso S, 1999, J NEUROL NEUROSUR PS, V67, P664, DOI 10.1136/jnnp.67.5.664; Patrikelis P, 2009, EPILEPSY BEHAV, V14, P19, DOI 10.1016/j.yebeh.2008.09.013; Pereda E, 2005, PROG NEUROBIOL, V77, P1, DOI 10.1016/j.pneurobio.2005.10.003; Perez-Reyes E, 2003, PHYSIOL REV, V83, P117, DOI 10.1152/physrev.00018.2002; Perez-Reyes E, 1998, NATURE, V391, P896, DOI 10.1038/36110; PIGULA FA, 1993, J PEDIATR SURG, V28, P310, DOI 10.1016/0022-3468(93)90223-8; Piret JP, 2002, ANN NY ACAD SCI, V973, P443, DOI 10.1111/j.1749-6632.2002.tb04680.x; ROLLS ET, 1994, J NEUROL NEUROSUR PS, V57, P1518, DOI 10.1136/jnnp.57.12.1518; SCHEFFER IE, 1995, BRAIN, V118, P61, DOI 10.1093/brain/118.1.61; SHALLICE T, 1991, BRAIN, V114, P727, DOI 10.1093/brain/114.2.727; Sharp FR, 2004, NAT REV NEUROSCI, V5, P437, DOI 10.1038/nrn1408; Sherman SM, 2001, TRENDS NEUROSCI, V24, P122, DOI 10.1016/S0166-2236(00)01714-8; SHUE KL, 1992, BRAIN COGNITION, V20, P104, DOI 10.1016/0278-2626(92)90064-S; Sitnikova E, 2008, J NEUROSCI METH, V170, P245, DOI 10.1016/j.jneumeth.2008.01.017; Steriade M, 2006, NEUROSCIENCE, V137, P1087, DOI 10.1016/j.neuroscience.2005.10.029; STERIADE M, 1995, J NEUROSCI, V15, P623; Steriade M, 1998, J NEUROPHYSIOL, V80, P1439; STERIADE M, 1993, SCIENCE, V262, P679, DOI 10.1126/science.8235588; STORES G, 1991, DEV MED CHILD NEUROL, V33, P998; Stuss DT, 1992, NEUROPSY NEUROPSY BE, V5; Tan M, 2005, ARCH DIS CHILD, V90, P57, DOI 10.1136/adc.2003.048504; WALTON NY, 1988, EPILEPSY RES, V2, P79, DOI 10.1016/0920-1211(88)90023-X; Wienbruch C, 2003, CLIN NEUROPHYSIOL, V114, P2052, DOI 10.1016/S1388-2457(03)00210-4; Yoon JH, 2008, AM J PSYCHIAT, V165, P1006, DOI 10.1176/appi.ajp.2008.07060945; Zikopoulos B, 2006, J NEUROSCI, V26, P7348, DOI 10.1523/JNEUROSCI.5511-05.2006	94	17	22	0	6	SOC NEUROSCIENCE	WASHINGTON	11 DUPONT CIRCLE, NW, STE 500, WASHINGTON, DC 20036 USA	0270-6474			J NEUROSCI	J. Neurosci.	MAR 16	2011	31	11					4063	4073		10.1523/JNEUROSCI.4493-10.2011			11	Neurosciences	Neurosciences & Neurology	735YC	WOS:000288455700015	21411648	Green Published, Bronze			2021-06-18	
J	Zhang, BL; Chen, X; Tan, T; Yang, Z; Carlos, D; Jiang, RC; Zhang, JN				Zhang Bao-liang; Chen Xin; Tan Tao; Yang Zhuo; Carlos, Dayao; Jiang Rong-cai; Zhang Jian-ning			Traumatic brain injury impairs synaptic plasticity in hippocampus in rats	CHINESE MEDICAL JOURNAL			English	Article						traumatic brain injury; long-term potentiation; hippocampus; dentate gyrus; cornu ammonis 3 area	SPATIAL MEMORY; DENTATE GYRUS; DEFICITS	Background Traumatic brain injury (TBI) often causes cognitive deficits and remote symptomatic epilepsy. Hippocampal regional excitability is associated with the cognitive function. However, little is known about injury-induced neuronal loss and subsequent alterations of hippocampal regional excitability. The present study was designed to determine whether TBI may impair the cellular circuit in the hippocampus. Methods Forty male Wistar rats were randomized into control (n=20) and TBI groups (n=20). Long-term potentiation, extracellular input/output curves, and hippocampal parvalbumin-immunoreactive and cholecystokinin-immunoreactive interneurons were compared between the two groups. Results TBI resulted in a significantly increased excitability in the dentate gyrus (DG), but a significantly decreased excitability in the cornu ammonis 1 (CA1) area. Using design-based stereological injury procedures, we induced interneuronal loss in the DG and CA3 subregions in the hippocampus, but not in the CA1 area. Conclusions TBI leads to the impairment of hippocampus synaptic plasticity due to the changing of interneuronal interaction. The injury-induced disruption of synaptic efficacy within the hippocampal circuit may underlie the observed cognitive deficits and symptomatic epilepsy. Chin Med J 2011;124(5):740-745	[Zhang Bao-liang; Chen Xin; Carlos, Dayao; Jiang Rong-cai; Zhang Jian-ning] Tianjin Med Univ, Gen Hosp, Dept Neurosurg, Tianjin 300052, Peoples R China; [Zhang Bao-liang; Chen Xin; Carlos, Dayao; Jiang Rong-cai; Zhang Jian-ning] Tianjin Neurol Inst, Tianjin 300052, Peoples R China; [Zhang Bao-liang; Chen Xin; Carlos, Dayao; Jiang Rong-cai; Zhang Jian-ning] Minist Educ, Key Lab Posttrauma Neurorepair & Regenerat Cent N, Tianjin 300052, Peoples R China; [Zhang Bao-liang; Chen Xin; Carlos, Dayao; Jiang Rong-cai; Zhang Jian-ning] Tianjin Key Lab Injuries Variat & Regenerat Nervo, Tianjin 300052, Peoples R China; [Tan Tao] Tianjin Med Univ, Sch Biomed Engn, Tianjin 300070, Peoples R China; [Yang Zhuo] Nankai Univ, Sch Med, Tianjin 300071, Peoples R China	Zhang, JN (corresponding author), Tianjin Med Univ, Gen Hosp, Dept Neurosurg, Tianjin 300052, Peoples R China.	jianningzhang@hotmail.com	Tan, Tao/F-5535-2010	Tan, Tao/0000-0002-4571-3296	National "973 Projects" of ChinaNational Basic Research Program of China [2005CB522605]; Tianjin Science and Technology Development Plan [05YFGDSF02500]; Tianjin Natural Science FoundationNatural Science Foundation of Tianjin [033611511]	This work was supported by grants from the National "973 Projects" of China (No. 2005CB522605), Tianjin Science and Technology Development Plan (No. 05YFGDSF02500) and Tianjin Natural Science Foundation (No. 033611511).	ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Altinbilek B, 2007, EUR J NEUROSCI, V26, P1166, DOI 10.1111/j.1460-9568.2007.05742.x; Chen JL, 2001, STROKE, V32, P2682, DOI 10.1161/hs1101.098367; Coulter DA, 1996, EPILEPSY RES, V26, P81, DOI 10.1016/S0920-1211(96)00044-7; DASH PK, 1995, J NEUROSCI, V15, P2030; FREUND TF, 1996, HIPPOCAMPUS, V6, P345; Grady MS, 2003, J NEUROTRAUM, V20, P929, DOI 10.1089/089771503770195786; GRAHAM DI, 1995, BRAIN PATHOL, V5, P397, DOI 10.1111/j.1750-3639.1995.tb00618.x; HALASY K, 1993, EUR J NEUROSCI, V5, P411, DOI 10.1111/j.1460-9568.1993.tb00508.x; HAN ZS, 1993, EUR J NEUROSCI, V5, P395, DOI 10.1111/j.1460-9568.1993.tb00507.x; LAURER HL, 2002, ENCY HUMAN BRAIN, P93; Mathias JL, 2004, J INT NEUROPSYCH SOC, V10, P286, DOI 10.1017/S1355617704102117; Pierce JES, 1998, NEUROSCIENCE, V87, P359, DOI 10.1016/S0306-4522(98)00142-0; RINK A, 1995, AM J PATHOL, V147, P1575; SMITH KR, 1994, ARCH NEUROL-CHICAGO, V51, P653, DOI 10.1001/archneur.1994.00540190029012; Su ZJ, 2009, J NEUROTRAUM, V26, P1695, DOI 10.1089/neu.2008.0519; Toth Z, 1997, J NEUROSCI, V17, P8106; Witgen BM, 2005, NEUROSCIENCE, V133, P1, DOI 10.1016/j.neuroscience.2005.01.052	18	17	17	0	10	CHINESE MEDICAL ASSOC	BEIJING	42 DONGSI XIDAJIE, BEIJING 100710, PEOPLES R CHINA	0366-6999			CHINESE MED J-PEKING	Chin. Med. J.	MAR 5	2011	124	5					740	745		10.3760/cma.j.issn.0366-6999.2011.05.020			6	Medicine, General & Internal	General & Internal Medicine	743TC	WOS:000289040600020	21518569	DOAJ Gold			2021-06-18	
J	Armstead, WM; Raghupathi, R				Armstead, William M.; Raghupathi, Ramesh			Endothelin and the neurovascular unit in pediatric traumatic brain injury	NEUROLOGICAL RESEARCH			English	Article						Cerebral hemodynamics; Pediatric traumatic brain injury; Endothelin; Histopathology	MICROTUBULE-ASSOCIATED PROTEIN-2; ERK MAPK; RAT; ISCHEMIA; INHIBITION; FOREBRAIN; RESPONSES; CHILDREN; SYSTEM; PIG	Objective: This study characterized the association between endothelin-1, cerebral hemodynamics, and histopathology after fluid percussion brain injury in the newborn pig. Methods: Lateral fluid percussion injury was induced in newborn pigs equipped with a closed cranial window. Cerebral blood flow was determined with radiolabeled microspheres and cerebrospinal fluid endothelin-1 was measured by radioimmunoassay. Results: Cerebrospinal fluid endothelin-1 was increased from 26 +/- 4 to 296 +/- 37 pg/ml (similar to 10(-10)M) at 8 hours following fluid percussion injury. Post-injury treatment (30 minutes) with the endothelin-1 antagonist BQ-123 (1 mg/kg, intravenous) blocked pial artery vasoconstriction to topical endothelin-1 (similar to 10(-10)M) and blunted fluid percussion injury-induced reductions in cerebral blood flow at 8 hours post-insult (56 +/- 6 and 26 +/- 4 ml/minute versus 57 +/- 6 and 40 +/- 4 ml/minute; 100 g for cerebral blood flow before injury and 8 hours post-fluid percussion injury in vehicle and BQ-123 post-treated animals, respectively). Fluid percussion injury resulted in neuronal cell loss and decreased microtubule associated protein 2 immunoreactivity in the parietal cortex, which were blunted by BQ-123. Discussion: These data indicate that fluid percussion injury-induced changes in cerebral hemodynamics are associated with neuronal damage and that endothelin-1 contributes to fluid percussion injury-induced histopathologic changes.	[Armstead, William M.] Univ Penn, Dept Anesthesiol & Crit Care, Philadelphia, PA 19104 USA; [Armstead, William M.] Univ Penn, Dept Pharmacol, Philadelphia, PA 19104 USA; [Raghupathi, Ramesh] Drexel Univ, Coll Med, Dept Neurobiol & Anat, Philadelphia, PA 19104 USA	Armstead, WM (corresponding author), Univ Penn, Dept Anesthesiol & Crit Care, 3620 Hamilton Walk,JM3, Philadelphia, PA 19104 USA.	armsteaw@uphs.upenn.edu			National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; University of Pennsylvania Research Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD057355] Funding Source: NIH RePORTER	This research was supported by grants from the National Institutes of Health and the University of Pennsylvania Research Foundation.	Adelson PD, 1997, PEDIATR NEUROSURG, V26, P200; Armstead WM, 2006, NAT NEUROSCI, V9, P1150, DOI 10.1038/nn1757; Armstead WM, 2010, J NEUROTRAUM, V27, P391, DOI 10.1089/neu.2009.1094; Armstead WM, 2009, J CEREBR BLOOD F MET, V29, P524, DOI 10.1038/jcbfm.2008.142; ARMSTEAD WM, 1994, J NEUROTRAUM, V11, P487, DOI 10.1089/neu.1994.11.487; Armstead WM, 1999, AM J PHYSIOL-HEART C, V277, pH1884; BRUCE DA, 1981, J NEUROSURG, V54, P170, DOI 10.3171/jns.1981.54.2.0170; DECAMILLI P, 1984, NEUROSCIENCE, V11, P819, DOI 10.1016/0306-4522(84)90194-5; FRIEDRICH P, 1991, FEBS LETT, V295, P5, DOI 10.1016/0014-5793(91)81371-E; GENNARELLI TA, 1994, J NEUROTRAUM, V11, P357, DOI 10.1089/neu.1994.11.357; HICKS RR, 1995, BRAIN RES, V678, P151, DOI 10.1016/0006-8993(95)00179-T; Lo EH, 2004, STROKE, V35, P354, DOI 10.1161/01.STR.0000115164.80010.8A; Markgraf CG, 1998, STROKE, V29, P152, DOI 10.1161/01.STR.29.1.152; MATESIC DF, 1994, J NEUROCHEM, V63, P1012; MIYAZAWA T, 1993, ACTA NEUROPATHOL, V85, P526; Rafols D, 2004, NEUROSCI LETT, V362, P154, DOI 10.1016/j.neulet.2004.03.021; Richards HK, 2001, J CEREBR BLOOD F MET, V21, P779, DOI 10.1097/00004647-200107000-00002; RODRIGUEZ JG, 1990, AM J DIS CHILD, V144, P625, DOI 10.1001/archpedi.1990.02150300019014; SIMONSON MS, 1990, FASEB J, V4, P2989; Smith DH, 1997, J NEUROPATH EXP NEUR, V56, P822; WEI EP, 1980, CIRC RES, V46, P37, DOI 10.1161/01.RES.46.1.37; YAMAURA I, 1993, J NEUROSURG, V79, P537, DOI 10.3171/jns.1993.79.4.0537; YANAGISAWA M, 1988, NATURE, V332, P411, DOI 10.1038/332411a0	23	17	20	0	2	MANEY PUBLISHING	LEEDS	STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND	0161-6412			NEUROL RES	Neurol. Res.	MAR	2011	33	2					127	132		10.1179/016164111X12881719352138			6	Clinical Neurology; Neurosciences	Neurosciences & Neurology	723OM	WOS:000287516600003	21801587	Green Accepted			2021-06-18	
J	Hakan, T; Toklu, HZ; Biber, N; Celik, H; Erzik, C; Ogunc, AV; Cetinel, S; Sener, G				Hakan, Tayfun; Toklu, Hale Zerrin; Biber, Necat; Celik, Hasan; Erzik, Can; Ogunc, Ayliz Velioglu; Cetinel, Sule; Sener, Goksel			Meloxicam Exerts Neuroprotection on Spinal Cord Trauma in Rats	INTERNATIONAL JOURNAL OF NEUROSCIENCE			English	Article						COX-2; glutathione; lipid peroxidation; meloxicam; neuroprotection; spinal cord injury	OXIDATIVE STRESS; BRAIN-INJURY; CYCLOOXYGENASE-2; GLUTATHIONE; METABOLISM; CONTUSION; DAMAGE; ACID	Traumatic injury to the central nervous system results in the delayed dysfunction and neuronal death. Impaired mitochondrial function, generation of reactive oxygen species (ROS), and lipid peroxidation occur soon after traumatic spinal cord injury (SCI), while the activation of compensatory molecules that neutralize ROS occurs at later time points. The aim of the current study was to investigate the putative neuroprotective effect of the COX2 inhibitor meloxicam in a rat model of SCI. In order to induce SCI, a standard weight-drop method that induced a moderately severe injury (100 g/cm force) at T10, was used. Injured animals were given either 2 mg/kg meloxicam or saline 30 min postinjury by intraperitoneal injection. At seven days postinjury, neurological examination was performed and rats were decapitated. Spinal cord samples were taken for histological examination or determination of malondialdehyde (MDA) and glutathione (GSH) levels, myeloperoxidase (MPO) activity and DNA fragmentation. Formation of ROS in spinal cord tissue samples was monitored by using a chemiluminescence (CL) technique. SCI caused a significant decrease in spinal cord GSH content, which was accompanied with significant increases in CL, MDA levels, MPO activity, and DNA damage. On the other hand, meloxicam treatment reversed all these biochemical parameters as well as SCI-induced histopathological alterations. Furthermore, impairment of the neurological functions due to SCI was improved by meloxicam treatment. The present study suggests that meloxicam, reduces SCI-induced oxidative stress and exerts neuroprotection by inhibiting lipid peroxidation, GSH depletion, and DNA fragmentation.	[Hakan, Tayfun; Biber, Necat; Celik, Hasan] Haydarpasa Numune EAH, Beyin & Sinir Cerrahisi Klin, TR-34668 Istanbul, Turkey; [Toklu, Hale Zerrin; Sener, Goksel] Marmara Univ, Sch Pharm, Istanbul, Turkey; [Erzik, Can; Cetinel, Sule] Marmara Univ, Sch Med, Istanbul, Turkey; [Ogunc, Ayliz Velioglu] Marmara Univ, Vocat Sch Hlth Related Profess 10, Istanbul, Turkey	Hakan, T (corresponding author), Haydarpasa Numune EAH, Beyin & Sinir Cerrahisi Klin, Tibbiye Caddesi, TR-34668 Istanbul, Turkey.	tayfunhakan@yahoo.com	Hakan, Tayfun/P-8626-2015; Hakan, Tayfun/O-9979-2019; Toklu, Hale/AAR-2330-2020; Sener, Goksel/AAN-4461-2021	Hakan, Tayfun/0000-0003-1444-7076; Hakan, Tayfun/0000-0003-1444-7076; Toklu, Hale/0000-0002-9797-3591; Sener, Goksel/0000-0001-7444-6193; Erzik, Can/0000-0002-7914-1169			Adachi K, 2005, NEUROSCI RES, V51, P73, DOI 10.1016/j.neures.2004.10.007; Agha AM, 1999, PHARMACOL RES, V40, P385, DOI 10.1006/phrs.1999.0522; Allen A.R., 1911, JAMA-J AM MED ASSOC, V57, P878, DOI DOI 10.1001/JAMA.1911.04260090100008; Arafa HMM, 2007, EUR J PHARMACOL, V564, P181, DOI 10.1016/j.ejphar.2007.02.065; Azbill RD, 1997, BRAIN RES, V765, P283, DOI 10.1016/S0006-8993(97)00573-8; BEUTLER E, 1963, J LAB CLIN MED, V61, P882; Buege J A, 1978, Methods Enzymol, V52, P302; Burton K., 1968, METHODS ENZYMOL, V12, P163; Cemil B, 2010, ACTA NEUROCHIR, V152, P1583, DOI 10.1007/s00701-010-0702-x; Emerit J, 2004, BIOMED PHARMACOTHER, V58, P39, DOI 10.1016/j.biopha.2003.11.004; Engelhardt G, 1996, BIOCHEM PHARMACOL, V51, P29, DOI 10.1016/0006-2952(95)02110-8; GALE K, 1985, EXP NEUROL, V88, P123, DOI 10.1016/0014-4886(85)90118-9; Hakan T, 2010, NEUROL RES, V32, P629, DOI 10.1179/016164109X12464612122731; Haklar G, 1998, MARMARA MED J, V11, P55; Hall Edward D, 2004, NeuroRx, V1, P80, DOI 10.1602/neurorx.1.1.80; HILLEGASS LM, 1990, J PHARMACOL METHOD, V24, P285, DOI 10.1016/0160-5402(90)90013-B; Kamencic H, 2001, FASEB J, V15, P243, DOI 10.1096/fj.00-0228com; Lapchak PA, 2001, STROKE, V32, P1220, DOI 10.1161/01.STR.32.5.1220; Lopez-Vales R, 2010, J NEUROSCI, V30, P3220, DOI 10.1523/JNEUROSCI.5770-09.2010; Matthias C, 2006, ANTICANCER RES, V26, P2003; Minghetti L, 1998, PROG NEUROBIOL, V54, P99, DOI 10.1016/S0301-0082(97)00052-X; Ogino K, 1997, PHARMACOLOGY, V55, P44, DOI 10.1159/000139511; Pompella A, 2003, BIOCHEM PHARMACOL, V66, P1499, DOI 10.1016/S0006-2952(03)00504-5; Resnick DK, 1998, J NEUROTRAUM, V15, P1005, DOI 10.1089/neu.1998.15.1005; Slemmer JE, 2008, CURR MED CHEM, V15, P404, DOI 10.2174/092986708783497337; Smith WL, 1996, ADV IMMUNOL, V62, P167, DOI 10.1016/S0065-2776(08)60430-7; Strauss KI, 2002, J NEUROTRAUM, V19, P627, DOI 10.1089/089771502753754091; Tilleux S, 2007, J NEUROSCI RES, V85, P2059, DOI 10.1002/jnr.21325; Toklu HZ, 2010, J SPINAL CORD MED, V33, P401, DOI 10.1080/10790268.2010.11689719; Wu GY, 2004, J NUTR, V134, P489	30	17	20	0	10	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0020-7454			INT J NEUROSCI	Int. J. Neurosci.	MAR	2011	121	3					142	148		10.3109/00207454.2010.537415			7	Neurosciences	Neurosciences & Neurology	739MG	WOS:000288721300005	21138398				2021-06-18	
J	Krpan, KM; Stuss, DT; Anderson, ND				Krpan, Katherine M.; Stuss, Donald T.; Anderson, Nicole D.			Planful versus Avoidant Coping: Behavior of Individuals With Moderate-to-Severe Traumatic Brain Injury During a Psychosocial Stress Test	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						Traumatic brain injury; Coping; Stress; Methods; Adjustment; Rehabilitation	EXECUTIVE FUNCTION; STRATEGIES; INTERVENTION; PREDICTORS; RECOVERY	Many people who sustain traumatic brain injuries (TBI) have poor psychosocial outcomes that have been related to the use of avoidant coping. A major obstacle to understanding the mechanisms of this relationship are the self-report measures by which coping has been traditionally evaluated. The purpose of the present study was to compare coping behavior during a simulated real-world stress test with self-reported coping. People with moderate-to-severe TBI and matched controls completed the Baycrest Psychosocial Stress Test (BPST) where coping behavior was evaluated, and also completed the Ways of Coping Questionnaire (WOC). While there were no group differences in self- or significant-other-reported behavior on the WOC, the TBI group engaged in more avoidant than planful behavior on the BPST, while the control group displayed the opposite pattern of behavior. Moreover, in the control group there were positive relations between behavior on the BPST and self-reported coping on the WOC, but no such relation within the TB I group. Secondary analyses allowed for TBI participants to be characterized as "planners" or "avoiders." This is the first study, to our knowledge, to report behavioral differences in coping post-TBI. Future work investigating the moderators of these differences may have significant implications for rehabilitative intervention. (JINS, 2011, 17, 248-255)	[Krpan, Katherine M.; Stuss, Donald T.; Anderson, Nicole D.] Univ Toronto, Dept Psychol, Toronto, ON M5S 1A1, Canada; [Stuss, Donald T.] Rotman Res Inst, Toronto, ON, Canada; [Stuss, Donald T.] Univ Toronto, Fac Med Neurol Rehabil Sci, Toronto, ON M5S 1A1, Canada; [Anderson, Nicole D.] Univ Toronto, Fac Med Psychiat, Toronto, ON M5S 1A1, Canada; [Krpan, Katherine M.; Anderson, Nicole D.] Kunin Lunenfeld Appl Res Unit, Toronto, ON, Canada	Anderson, ND (corresponding author), KLARU Baycrest, 3560 Bathurst St, Toronto, ON M6A 2E1, Canada.	nanderson@klaru-baycrest.on.ca	Anderson, Nicole D/E-9101-2011	Anderson, Nicole D/0000-0002-5979-2220	NSERCNatural Sciences and Engineering Research Council of Canada (NSERC); CIHRCanadian Institutes of Health Research (CIHR); Ontario Research Coalition; Toronto Rehabilitation InstituteUniversity of Toronto; Max and Ruth Wiseman Award; Mary Gertrude l'Anson Scholarship	We thank Dr. M. Binns for his statistical advice on this project, and S. Blackwood, A. Chaudhry, S. Gillingham, A. Maione, C. Nguyen, S. Priselac, and S. Waters-Schulte for all their help with the study. Funding: There are no financial or other relationships that could be interpreted as a conflict of interest affecting this manuscript. This work was supported by an NSERC grant to N.D. Anderson. K.M. Krpan was a doctoral student in the Department of Psychology at the University of Toronto during the project, and was funded by CIHR Doctoral Fellowship, Ontario Research Coalition, Toronto Rehabilitation Institute, Max and Ruth Wiseman Award and the Mary Gertrude l'Anson Scholarship.	Anson K, 2006, BRAIN INJURY, V20, P1, DOI 10.1080/02699050500309791; Anson K, 2006, BRAIN INJURY, V20, P167, DOI 10.1080/02699050500442956; Anson K, 2006, J HEAD TRAUMA REHAB, V21, P248, DOI 10.1097/00001199-200605000-00005; Cicerone K, 2006, J COGNITIVE NEUROSCI, V18, P1212, DOI 10.1162/jocn.2006.18.7.1212; Cicerone KD, 2007, J HEAD TRAUMA REHAB, V22, P257, DOI 10.1097/01.HTR.0000290970.56130.81; Curran CA, 2000, J HEAD TRAUMA REHAB, V15, P1256, DOI 10.1097/00001199-200012000-00006; Dawson DR, 2007, DISABIL REHABIL, V29, P301, DOI 10.1080/09638280600756687; Dawson DR, 2006, BRAIN COGNITION, V60, P214; Dawson DR, 2004, BRAIN INJURY, V18, P221, DOI 10.1080/02699050310001617406; Dawson M. E., 1990, PRINCIPLES PSYCHOPHY, P295; Dikmen S S, 1995, J Int Neuropsychol Soc, V1, P67; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; Finset A, 2000, BRAIN INJURY, V14, P887; FINSET A, 1995, BRAIN INJURY, V9, P141, DOI 10.3109/02699059509008187; Fleming AS, 1997, HORM BEHAV, V32, P85, DOI 10.1006/hbeh.1997.1407; Folkman S., 1988, WAYS COPING QUESTION; Green RE, 2008, ARCH PHYS MED REHAB, V89, pS16, DOI 10.1016/j.apmr.2008.09.551; KIRSCHBAUM C, 1993, NEUROPSYCHOBIOLOGY, V28, P76, DOI 10.1159/000119004; Krpan KM, 2007, J CLIN EXP NEUROPSYC, V29, P36, DOI 10.1080/13803390500376816; Krpan KM, 2005, HORM BEHAV, V47, P112, DOI 10.1016/j.yhbeh.2004.08.006; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Lazarus R.S., 1984, STRESS APPRAISAL COP; Levine B, 2008, COGNITIVE NEUROREHAB, P464; Mateer CA, 2006, NEUROREHABILITATION, V21, P315; O'Keeffe FM, 2004, COGNITIVE BRAIN RES, V22, P101, DOI 10.1016/j.cogbrainres.2004.07.012; PRIGATANO GP, 2005, AWARENESS DEFICIT BR, P111; Spielberger CD, 1983, STATE TRAIT ANXIETY; STUSS DT, 1985, NEUROSURGERY, V17, P41, DOI 10.1227/00006123-198507000-00007; Stuss DT, 1992, NEUROPSY NEUROPSY BE, V5; Stuss DT., 1991, AWARENESS DEFICIT BR, P63; Whelan-Goodinson R, 2009, J HEAD TRAUMA REHAB, V24, P324, DOI 10.1097/HTR.0b013e3181a712aa; Wood RLL, 2006, J INT NEUROPSYCH SOC, V12, P350, DOI 10.1017/S1355617706060498; ZACHARY RA, 1982, SHIPLEY I LIVING SCA	33	17	17	0	6	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	MAR	2011	17	2					248	255		10.1017/S1355617710001499			8	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Neurosciences & Neurology; Psychiatry; Psychology	738DY	WOS:000288620900005	21205331				2021-06-18	
J	Larson, EB; Ramaiya, M; Zollman, FS; Pacini, S; Hsu, N; Patton, JL; Dvorkin, AY				Larson, Eric B.; Ramaiya, Milan; Zollman, Felise S.; Pacini, Sonia; Hsu, Nancy; Patton, James L.; Dvorkin, Assaf Y.			Tolerance of a virtual reality intervention for attention remediation in persons with severe TBI	BRAIN INJURY			English	Article						Brain injury; attention; rehabilitation	TRAUMATIC BRAIN-INJURY; REHABILITATION; EFFICACY; DEFICITS; SCALE	Objective: To evaluate the feasibility of applying virtual reality and robotics technology to improve attention in patients with severe traumatic brain injury (TBI) in the early stages of recovery. Methods: A sample of TBI patients (n = 18, aged 19-73) who were receiving acute inpatient rehabilitation completed three-dimensional cancellation exercises over two consecutive days in an interactive virtual environment that minimized distractions and that integrated both visual and haptic (tactile) stimuli. Observations of behaviour during the intervention and of the instructions needed to encourage compliance were recorded. Performance data were compiled to assess improvement across three different treatment conditions. Outcomes: Fifteen of the 18 patients demonstrated tolerance of the virtual environment by completing the entire treatment protocol. Within-subjects comparisons of target acquisition time during treatment showed that a treatment condition that included haptic cues produced improved performance compared to a condition in which such cues were not provided. Separating out participants who were in post-traumatic amnesia showed that this group also demonstrated improvement in performance across trials despite their memory impairment. Conclusions: It is proposed that attention exercises using virtual environments are well-tolerated and engaging and that they could be beneficial for inpatients with severe TBI.	[Larson, Eric B.; Zollman, Felise S.; Pacini, Sonia; Hsu, Nancy] Rehabil Inst Chicago, Brain Injury Rehabil & Med Program, Chicago, IL 60611 USA; [Larson, Eric B.; Zollman, Felise S.; Dvorkin, Assaf Y.] Northwestern Univ, Dept Phys Med & Rehabil, Chicago, IL 60611 USA; [Ramaiya, Milan; Patton, James L.] Univ Illinois, Dept Biomed Engn, Chicago, IL USA; [Ramaiya, Milan; Patton, James L.; Dvorkin, Assaf Y.] Rehabil Inst Chicago, Sensory Motor Performance Program, Chicago, IL 60611 USA; [Patton, James L.] Northwestern Univ, Dept Biomed & Mech Engn, Chicago, IL 60611 USA	Larson, EB (corresponding author), Rehabil Inst Chicago, Brain Injury Rehabil & Med Program, 345 E Super St, Chicago, IL 60611 USA.	elarson@ric.org	Larson, Eric/AAD-9567-2021		US Department of Education, National Institute on Disability and Rehabilitation Research Midwest Regional Traumatic Brain Injury Model SystemUS Department of Education [H133A080045A]	Supported by the US Department of Education, National Institute on Disability and Rehabilitation Research (Grant # H133A080045A) through the Midwest Regional Traumatic Brain Injury Model System: Innovative Approaches to Improve Cognition, Function, and Community Living.	Chib VS, 2006, J NEUROPHYSIOL, V95, P1068, DOI 10.1152/jn.00610.2005; CORRIGAN JD, 1989, J CLIN EXP NEUROPSYC, V11, P261, DOI 10.1080/01688638908400888; Dvorkin Assaf Y, 2009, 2009 IEEE International Conference on Rehabilitation Robotics: Reaching Users & the Community (ICORR), P962, DOI 10.1109/ICORR.2009.5209629; Galbiati S, 2009, NEUROPSYCHOLOGY, V23, P40, DOI 10.1037/a0013409; Giles GM, 2006, J HEAD TRAUMA REHAB, V21, P168, DOI 10.1097/00001199-200603000-00009; Gray J M, 1989, Brain Inj, V3, P163, DOI 10.3109/02699058909004548; Hagen C, 1979, REHABILITATION HEAD; Hartley L. L., 1995, COGNITIVE COMMUNICAT; Huang FC, 2007, J MOTOR BEHAV, V39, P179, DOI 10.3200/JMBR.39.3.179-193; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Lloyd J, 2009, NEUROPSYCHOL REHABIL, V19, P98, DOI 10.1080/09602010802117392; Matheis RJ, 2007, CLIN NEUROPSYCHOL, V21, P146, DOI 10.1080/13854040601100668; Novack TA, 1996, J HEAD TRAUMA REHAB, V11, P52, DOI 10.1097/00001199-199606000-00008; Patton J, 2006, ASSIST TECHNOL, V18, P181, DOI 10.1080/10400435.2006.10131917; Rizzo AA, 2004, NEUROPSYCHOL REHABIL, V14, P207, DOI 10.1080/09602010343000183; ROZARIO SV, 2009, EMBC 2009 ANN INT C, P1151; RUFF R, 1994, BRAIN INJURY, V8, P3, DOI 10.3109/02699059409150954; SOHLBERG MM, 1986, ATTENTION PROCESS TR; Sweeney S, 2010, NEUROPSYCHOL REHABIL, V20, P239, DOI 10.1080/09602010903080531; TEASDALE G, 1974, LANCET, V2, P81; Vanderploeg RD, 2008, ARCH PHYS MED REHAB, V89, P2227, DOI 10.1016/j.apmr.2008.06.015; Whyte J, 2004, AM J PHYS MED REHAB, V83, P401, DOI 10.1097/01.PHM.0000128789.75375.D3; YOUNG JJ, 2003, P 11 S HAPT INT VIRT; Zhang L, 2003, ARCH PHYS MED REHAB, V84, P1118, DOI 10.1016/S0003-9993(03)00203-X	24	17	22	0	17	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	MAR	2011	25	3					274	281		10.3109/02699052.2010.551648			8	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	734UP	WOS:000288365400003	21299370				2021-06-18	
J	Dhar, R; Murphy-Human, T				Dhar, Rajat; Murphy-Human, Theresa			A Bolus of Conivaptan Lowers Intracranial Pressure in a Patient with Hyponatremia after Traumatic Brain Injury	NEUROCRITICAL CARE			English	Article						Traumatic brain injury; Hyponatremia; Vasopressin; Intracranial pressure	ARGININE-VASOPRESSIN V-1; HYPERTONIC SALINE; RECEPTOR ANTAGONIST; CEREBRAL EDEMA; ANTIDIURETIC-HORMONE; WATER-CONTENT; MANNITOL; VOLUME; STROKE; MODULATION	Hyponatremia may complicate brain injury and exacerbate cerebral edema and intracranial pressure (ICP). Vasopressin-receptor antagonists (such as conivaptan) are promising novel agents to treat hyponatremia that act by inducing aquaresis. It is unclear whether raising serum sodium in this way could also confer an acute osmotic benefit, reducing brain water and thereby ICP. We evaluated the effect of a bolus of conivaptan on ICP in a patient with hyponatremia after traumatic brain injury (TBI). A 22-year-old suffered severe TBI with occlusive left carotid dissection. Her course was complicated by left hemispheric infarcts with cerebral edema and intermittently elevated ICP. Conivaptan 20-mg IV was given as a bolus when serum sodium rapidly dropped to 128 mEq/l. This dose resulted in significant aquaresis, with over 1 l per hour of dilute urine peaking at 3-5 h after the dose. By 8 h, sodium had risen to 146 mEq/l. ICP had been stable at 11-15 mmHg for several hours prior to the dose, remained in this range for 2 h after, but then fell to 2 mmHg at 4 h, and remained reduced out to 8 h. Cerebral perfusion pressure, initially stable at 60-80 mmHg, rose to over 90 mmHg at 4 h. In this preliminary case report, a single dose of conivaptan not only resulted in rapid correction of acute hyponatremia, but also a significant fall in ICP temporally associated with peak aquaresis. Vasopressin-receptor antagonists, by reversing osmotic shifts, may be novel agents to control ICP and cerebral edema, especially in the setting of falling sodium.	[Dhar, Rajat] Washington Univ, Sch Med, Dept Neurol, Div Neurocrit Care, St Louis, MO 63110 USA; [Murphy-Human, Theresa] Barnes Jewish Hosp, Intens Care Unit, Dept Clin Pharm & Neurol Neurosurg, St Louis, MO 63110 USA	Dhar, R (corresponding author), Washington Univ, Sch Med, Dept Neurol, Div Neurocrit Care, Campus Box 8111,660 S Euclid Ave, St Louis, MO 63110 USA.	dharr@neuro.wustl.edu		Dhar, Rajat/0000-0002-5167-5097			*AST PHARM US INC, 2007, VAPR CON HYDR INJ PR; BORN JD, 1985, SURG NEUROL, V23, P383, DOI 10.1016/0090-3019(85)90212-5; Brimioulle S, 2008, INTENS CARE MED, V34, P125, DOI 10.1007/s00134-007-0905-7; Carpenter J, 2007, NEUROCRIT CARE, V6, P195, DOI 10.1007/s12028-007-0032-x; Decaux G, 2008, LANCET, V371, P1624, DOI 10.1016/S0140-6736(08)60695-9; Fernandez N, 2001, BRIT J PHARMACOL, V132, P1837, DOI 10.1038/sj.bjp.0704034; Francony G, 2008, CRIT CARE MED, V36, P795, DOI 10.1097/CCM.0B013E3181643B41; GULLANS SR, 1993, ANNU REV MED, V44, P289, DOI 10.1146/annurev.med.44.1.289; Kerwin AJ, 2009, J TRAUMA, V67, P277, DOI 10.1097/TA.0b013e3181acc726; Keyrouz SG, 2008, NEUROCRIT CARE, V9, P204, DOI 10.1007/s12028-008-9118-3; Kleindienst A, 2006, ACTA NEUROCHIR SUPPL, V96, P303; Koenig MA, 2008, NEUROLOGY, V70, P1023, DOI 10.1212/01.wnl.0000304042.05557.60; Larive LL, 2004, NEUROCRIT CARE, V1, P435, DOI 10.1385/NCC:1:4:435; Liu XQ, 2010, NEUROCRIT CARE, V12, P124, DOI 10.1007/s12028-009-9277-x; Manno EM, 1999, NEUROLOGY, V52, P583, DOI 10.1212/WNL.52.3.583; Molnar AH, 2008, PROG BRAIN RES, V170, P519, DOI 10.1016/S0079-6123(08)00439-1; Moro N, 2007, SURG NEUROL, V68, P387, DOI 10.1016/j.surneu.2006.11.052; Murphy T, 2009, NEUROCRIT CARE, V11, P14, DOI 10.1007/s12028-008-9179-3; Nathan BR, 2007, NEUROCRIT CARE, V6, P72, DOI 10.1385/NCC:6:1:72; Niermann H, 2001, J NEUROSCI, V21, P3045, DOI 10.1523/JNEUROSCI.21-09-03045.2001; Paczynski RP, 1997, STROKE, V28, P1437, DOI 10.1161/01.STR.28.7.1437; RAICHLE ME, 1978, BRAIN RES, V143, P191, DOI 10.1016/0006-8993(78)90766-7; Rosenberg G A, 1990, Adv Neurol, V52, P149; Sherlock M, 2009, POSTGRAD MED J, V85, P171, DOI 10.1136/pgmj.2008.072819; Shuaib A, 2002, STROKE, V33, P3033, DOI 10.1161/01.STR.0000039405.31526.06; Sterns RH, 2006, AM J MED, V119, pS12, DOI 10.1016/j.amjmed.2006.05.003; Taya K, 2008, ACTA NEUROCHIR SUPPL, V102, P425, DOI 10.1007/978-3-211-85578-2_83; Trabold R, 2008, J NEUROTRAUM, V25, P1459, DOI 10.1089/neu.2008.0597; Treggiari MM, 2007, NEUROCRIT CARE, V6, P104, DOI 10.1007/s12028-007-0012-1; Vakili A, 2005, J CEREBR BLOOD F MET, V25, P1012, DOI 10.1038/sj.jcbfm.9600097; Videen TO, 2001, NEUROLOGY, V57, P2120, DOI 10.1212/WNL.57.11.2120; Wakai A, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001049.pub4; Wright WL, 2009, NEUROCRIT CARE, V11, P6, DOI 10.1007/s12028-008-9152-1	33	17	20	0	4	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933			NEUROCRIT CARE	Neurocrit. Care	FEB	2011	14	1					97	102		10.1007/s12028-010-9366-x			6	Critical Care Medicine; Clinical Neurology	General & Internal Medicine; Neurosciences & Neurology	708WF	WOS:000286394300017	20440600				2021-06-18	
J	Lockhart, P; Cronin, D; Williams, K; Ouellet, S				Lockhart, Philip; Cronin, Duane; Williams, Kevin; Ouellet, Simon			Investigation of Head Response to Blast Loading	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						Blast; Explosive; Head; Injury; CONWEP; LS-Dyna	TRAUMATIC BRAIN-INJURY	Background: Head injury resulting from blast loading, specifically mild traumatic brain injury, has been identified as a possible and important blast-related injury for soldiers in modern conflict zones. A study was undertaken to evaluate head response to blast loading scenarios using an explicit finite element numerical model and to comment on the potential for head injury. Methods: The blast loading and simplified human body numerical models were validated using impulse, peak acceleration and the Head Injury Criterion from experimental blast test data. A study was then undertaken to evaluate head response at varying distances and orientations from the explosive. Results: The accelerations and injury metrics for the head increased with decreasing distance to the explosive, as expected, but were also significant at intermediate distances from the explosive for larger charge sizes and intermediate heights of burst. Varying lateral position with constant standoff did not have a significant effect on the head kinematic response. Conclusions: The head injury criteria considered were exceeded in close proximity to the explosive (< 35 charge radii) and depended on the height of burst for the range of charge sizes considered. The injury criteria were also exceeded at intermediate distances for larger charge sizes because of the influence of the mach stem. Although the injury criteria used in this study are typically applied to longer duration events, and may not be applicable for shorter duration blast loading, aggressive loading is predicted at small standoff distances and confirmed by the resulting head kinematics.	[Lockhart, Philip; Cronin, Duane] Univ Waterloo, Waterloo, ON N2L 3G1, Canada; [Williams, Kevin; Ouellet, Simon] Def R&D, Quebec City, PQ, Canada	Lockhart, P (corresponding author), 200 Univ Ave W, Waterloo, ON N2L 3G1, Canada.	plockhar@lagavulin.uwaterloo.ca		Cronin, Duane/0000-0001-7538-0560	Natural Sciences and Engineering Research Council of CanadaNatural Sciences and Engineering Research Council of Canada (NSERC)CGIAR; Defense R&D Canada, Valcartier; Med-Eng Systems Inc.; Martec	Supported by Natural Sciences and Engineering Research Council of Canada; Defense R&D Canada, Valcartier; Med-Eng Systems Inc.; and Martec.	AYVAZYAN H, 1986, STRUCTURES RESIST EF, V2; Bowen IG, 1968, DASA2113; Bulson PS, 1997, EXPLOSIVE LOADING EN; CHENG H, 1994, GENERATOR BODY MANUA; CLEMEDSON CJ, 1956, BLAST INJURY; Cronin D. S., 2008, P PERS ARM SYST S, P84; *DEP ARM, 1967, EXPLOSIVES DEMOLITIO; DHARANEEPATHY MV, 1995, COMPUT STRUCT, V54, P587, DOI 10.1016/0045-7949(94)00380-L; Dionne JP, 2002, REDUCTION BLAST INDU; Gennarelli TA, 2003, ANN P ASS ADV AUTOMO, P624; Gruss E, 2006, J TRAUMA, V60, P1284, DOI 10.1097/01.ta.0000220015.21948.ec; HALLQUIST JO, 2006, LSDYNA THEORY MANUAL; Hetherington J, 1994, BLAST BALLISTIC LOAD; Hutchinson J, 1998, APPL MATH COMPUT, V96, P1, DOI 10.1016/S0096-3003(97)10106-0; HYDE D, 1998, 58551 TM; *LIV SOFT TECHN CO, 2008, LOAD BLAST ENHANCED; *LIV SOFT TECHN CO, 2008, ENHANCED BLAST LOADI; Makris A, 2000, REDUCTION BLAST INDU; MANSEAU J, 2006, P 19 INT S MIL ASP B; NAHUM AM, 2001, ACCIDENTAL INJURY BI; Newman J, 2000, P 44 STAPP CAR CRASH; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; STUHMILLER JH, 2008, BIQPJHSCH10; Taber KH, 2006, J NEUROPSYCH CLIN N, V18, P141, DOI 10.1176/appi.neuropsych.18.2.141; WILLIAMS K, 2004, TEST PLAN MABIL DEV	25	17	18	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0022-5282			J TRAUMA	J. Trauma-Injury Infect. Crit. Care	FEB	2011	70	2					E29	E36		10.1097/TA.0b013e3181de3f4b			8	Critical Care Medicine; Surgery	General & Internal Medicine; Surgery	719FV	WOS:000287187700002	20664376				2021-06-18	
J	Nelson, NG; McKenzie, LB				Nelson, Nicolas G.; McKenzie, Lara B.			Mountain Biking-Related Injuries Treated in Emergency Departments in the United States, 1994-2007	AMERICAN JOURNAL OF SPORTS MEDICINE			English	Article						National Electronic Injury Surveillance System; injury; mountain bike; outdoor; emergency department	RACING INJURIES; BIKERS	Background: Injury research on mountain biking has been mostly limited to examining professional riders and off-road biking. Mountain bikes represent the largest segment of bike sales in the United States. Recreational mountain bike use is popular and understudied. Purpose: To describe the scope, distribution, and trends of mountain bike-related injuries treated in US emergency departments. Study Design: Descriptive epidemiologic study. Methods: A retrospective analysis was conducted with data from the National Electronic Injury Surveillance System of the US Consumer Product Safety Commission for patients aged >= 8 years from 1994 through 2007. Sample weights provided by the system were used to calculate national estimates of mountain bike-related injuries based on 4624 cases. Bivariate comparisons between categorical variables were assessed with injury proportion ratios and 95% confidence intervals. Results: Nationwide, an estimated 217 433 patients were treated for mountain bike-related injuries in US emergency departments from 1994 to 2007, an average of 15 531 injuries per year. The annual number of injuries decreased 56%, from a high of 23 177 in 1995 to 10 267 in 2007 (P<.001). The most common injuries were upper extremity fractures (10.6%) and shoulder fractures (8.3%). Patients aged 14 to 19 years sustained a greater proportion of traumatic brain injuries (8.4%) than did patients aged 8 to 13 years and >= 20 years combined (4.3%). A greater proportion of female riders (6.1%) than male riders (4.5%) were hospitalized. Conclusion: Mountain bike-related injuries decreased from 1994 to 2007. Upper extremity fractures were the most common injury. Girls and women may be more likely than boys and men to sustain more severe injuries requiring hospitalization. Despite the decline over the past decade, more can be done to improve safety and reduce injuries in this popular recreational activity.	[McKenzie, Lara B.] Nationwide Childrens Hosp, Ctr Injury Res & Policy, Res Inst, Columbus, OH 43205 USA	McKenzie, LB (corresponding author), Nationwide Childrens Hosp, Ctr Injury Res & Policy, Res Inst, 700 Childrens Dr, Columbus, OH 43205 USA.	Lara.McKenzie@nationwidechildrens.org	McKenzie, Lara/C-5122-2012	McKenzie, Lara/0000-0003-2889-0001			*AM SPORTS DAT INC, 2008, 2008 SUP SPORTS PART, V3; *AM SPORTS DAT INC, 2008, 2008 SUP SPORTS PART; Apsingi S, 2006, AM J SPORT MED, V34, P487, DOI 10.1177/0363546505279917; Carmont MR, 2008, BRIT MED BULL, V85, P101, DOI 10.1093/bmb/ldn009; CHOW TK, 1993, WESTERN J MED, V159, P145; Chow TK, 2002, WILD ENVIRON MED, V13, P27, DOI 10.1580/1080-6032(2002)013[0027:MOIICO]2.0.CO;2; Finnoff JT, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.1.e4; Frauscher F, 2001, RADIOLOGY, V219, P427, DOI 10.1148/radiology.219.2.r01ma42427; Gassner R, 1999, INT J ORAL MAX SURG, V28, P188; Gassner RJ, 1999, J TRAUMA, V47, P50, DOI 10.1097/00005373-199907000-00011; Gaulrapp H, 2001, KNEE SURG SPORT TR A, V9, P48, DOI 10.1007/s001670000145; *INT OL COMM, 2000, GAMES 38 OL MOUNT BI; Jeys LM, 2001, BRIT J SPORT MED, V35, P197, DOI 10.1136/bjsm.35.3.197; Kroneke EL, 2008, CLIN J SPORT MED, V18, P38, DOI 10.1097/JSM.0b013e318160c044; Kronisch RL, 1996, MED SCI SPORT EXER, V28, P1351, DOI 10.1097/00005768-199611000-00002; Kronisch RL, 1996, AM J SPORT MED, V24, P88, DOI 10.1177/036354659602400116; Kronisch RL, 2002, CLIN J SPORT MED, V12, P158, DOI 10.1097/00042752-200205000-00003; Kronisch RL, 2002, SPORTS MED, V32, P523, DOI 10.2165/00007256-200232080-00004; Mitterberger M, 2008, CLIN J SPORT MED, V18, P49, DOI 10.1097/JSM.0b013e31815c042f; Muller KE, 2008, DENT TRAUMATOL, V24, P522, DOI 10.1111/j.1600-9657.2008.00660.x; *NAT BIK DEAL ASS, 2008 NBDA STATP LOOK; Nehoda H, 2001, INJURY, V32, P285, DOI 10.1016/S0020-1383(00)00193-5; PFEIFFER RP, 1995, SPORTS MED, V19, P311, DOI 10.2165/00007256-199519050-00002; PFEIFFER RP, 1994, CLIN SPORT MED, V13, P207; Rajapaske BN, 1996, NEW ZEAL MED J, V109, P147; Rivara FP, 1997, J FAM PRACTICE, V44, P481; Schroeder T., 2001, NEISS SAMPLE DESIGN; *US BUR CENS, INT EST US POP AG SE; *US BUR CENS, NAT POP EST 2000S; US Consumer Product Safety Commission, 2000, NAT EL INJ SURV SYST; *US CYCL, MOUNT BIK; Xiang HY, 2007, BRAIN INJURY, V21, P293, DOI 10.1080/02699050701311034	32	17	17	0	6	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0363-5465	1552-3365		AM J SPORT MED	Am. J. Sports Med.	FEB	2011	39	2					404	409		10.1177/0363546510383478			6	Orthopedics; Sport Sciences	Orthopedics; Sport Sciences	717EI	WOS:000287025700027	21076012				2021-06-18	
J	Tong, M; Qualls-Creekmore, E; Browning, KN; Travagli, RA; Holmes, GM				Tong, M.; Qualls-Creekmore, E.; Browning, K. N.; Travagli, R. A.; Holmes, G. M.			Experimental spinal cord injury in rats diminishes vagally-mediated gastric responses to cholecystokinin-8s	NEUROGASTROENTEROLOGY AND MOTILITY			English	Article						brainstem; gastrointestinal motility; gas-trointestinal transit; vago-vagal reflexes	NUCLEUS-TRACTUS-SOLITARIUS; GASTROINTESTINAL SATIETY SIGNALS; BRAIN-STEM; AFFERENT NEURONS; FOOD-INTAKE; IN-VITRO; MYENTERIC PLEXUS; FOS EXPRESSION; LEPTIN ACTION; AWAKE RATS	Background We have shown recently that our model of experimental high-thoracic spinal cord injury (T3-SCI) mirrors the gastrointestinal clinical presentation of neurotrauma patients, whereby T3-SCI animals show diminished gastric emptying and dysmotility. In this study we used cholecystokinin as a model peptide to test the hypothesis that the T3-SCI induced gastroparesis is due, in part, to an impaired vagally-mediated response to gastrointestinal peptides. Methods We measured the responses to sulfated cholecystokinin (CCK-8s) in control and T3-SCI (3 or 21 days after injury) rats utilizing: (i) c-fos expression in the nucleus tractus solitarius (NTS) following peripherally administered CCK-8s; (ii) in vivo gastric tone and motility following unilateral microinjection of CCK-8s into the dorsal vagal complex (DVC); and (iii) whole cell recordings of glutamatergic synaptic inputs to NTS neurons. Key Results Our results show that: (i) medullary c-fos expression in response to peripheral CCK-8s was significantly lower in T3-SCI rats 3 days after the injury, but recovered to control values at 3 weeks post-SCI, (ii) Unilateral microinjection of CCK-8s in the DVC induced a profound gastric relaxation in control animals, but did not induce any response in T3-SCI rats at both 3 and 21 days after SCI, (iii) Perfusion with CCK-8s increased glutamatergic currents in 55% of NTS neurons from control rats, but failed to induce any response in NTS neurons from T3-SCI rats. Conclusions & Inferences Our data indicate alterations of vagal responses to CCK-8s in T3-SCI rats that may reflect a generalized impairment of gastric vagal neurocircuitry, leading to a reduction of gastric functions after SCI.	[Tong, M.; Qualls-Creekmore, E.; Holmes, G. M.] Louisiana State Univ, Pennington Biomed Res Ctr, Neurotrauma & Nutr Lab, Baton Rouge, LA 70808 USA; [Browning, K. N.; Travagli, R. A.] Penn State Univ, Coll Med, Dept Neural & Behav Sci, Hershey, PA USA	Holmes, GM (corresponding author), Louisiana State Univ, Pennington Biomed Res Ctr, Neurotrauma & Nutr Lab, 6400 Perkins Rd, Baton Rouge, LA 70808 USA.	holmesgm@pbrc.edu	Qualls-Creekmore, Emily/N-1983-2017	Browning, Kirsteen/0000-0002-5062-3703	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NINDS 49177, NIDDK 55530]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [R01DK055530, P30DK072476] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS049177] Funding Source: NIH RePORTER	This work was supported by National Institutes of Health Grants NINDS 49177 (G. M. Holmes) and NIDDK 55530 (R. A. Travagli).	Appleyard SM, 2005, J NEUROSCI, V25, P3578, DOI 10.1523/JNEUROSCI.4177-04.2005; Baptista V, 2007, AM J PHYSIOL-REG I, V292, pR1092, DOI 10.1152/ajpregu.00517.2006; Baptista V, 2005, J NEUROPHYSIOL, V94, P2763, DOI 10.1152/jn.00351.2005; Baptista V, 2005, BRAIN RES, V1052, P139, DOI 10.1016/j.brainres.2005.05.073; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; BERLLY MH, 1984, ARCH PHYS MED REHAB, V65, P687; BLACKSHAW LA, 1990, J AUTONOM NERV SYST, V31, P191, DOI 10.1016/0165-1838(90)90185-L; Blevins JE, 2010, FORUM NUTR, V63, P133, DOI 10.1159/000264401; Blevins JE, 2004, AM J PHYSIOL-REG I, V287, pR87, DOI 10.1152/ajpregu.00604.2003; Blevins JE, 2000, BRAIN RES, V860, P1, DOI 10.1016/S0006-8993(99)02477-4; BRANCHEREAU P, 1993, J NEUROPHYSIOL, V70, P2584; BRANCHEREAU P, 1992, J PHARMACOL EXP THER, V260, P1433; Broberger C, 2001, BRAIN RES, V903, P128, DOI 10.1016/S0006-8993(01)02468-4; Burdyga G, 2006, NEUROSCIENCE, V137, P1405, DOI 10.1016/j.neuroscience.2005.10.057; Burdyga G, 2004, J NEUROSCI, V24, P2708, DOI 10.1523/JNEUROSCI.5404-03.2004; Burdyga G, 2008, J NEUROSCI, V28, P11583, DOI 10.1523/JNEUROSCI.2493-08.2008; Cosman B C, 1991, J Am Paraplegia Soc, V14, P175; Date Y, 2005, ENDOCRINOLOGY, V146, P3518, DOI 10.1210/en.2004-1240; Dockray GJ, 2006, PHYSIOLOGY OF THE GASTROINTESTINAL TRACT, VOLS 1 AND 2, 4TH EDITION, P91; FEALEY RD, 1984, GASTROENTEROLOGY, V87, P69; FRASER KA, 1992, EXP PHYSIOL, V77, P225, DOI 10.1113/expphysiol.1992.sp003579; Gamboa-Esteves FO, 2001, BRAIN RES, V921, P195, DOI 10.1016/S0006-8993(01)03118-3; Gondim FAA, 1999, SPINAL CORD, V37, P793, DOI 10.1038/sj.sc.3100923; Gondim FDA, 2001, AUTON NEUROSCI-BASIC, V87, P52; Hatanaka S, 1997, JPN J PHARMACOL, V74, P105, DOI 10.1254/jjp.74.105; Holmes GM, 2009, GASTROENTEROLOGY, V136, pA577; Holmes GM, 2009, AM J PHYSIOL-GASTR L, V296, pG621, DOI 10.1152/ajpgi.90567.2008; Holzer P, 2002, NEUROGASTROENT MOTIL, V14, P459, DOI 10.1046/j.1365-2982.2002.00353.x; Kabatas S, 2008, NEUROSCIENCE, V154, P1627, DOI 10.1016/j.neuroscience.2008.04.071; Kirshblum SC, 2002, ARCH PHYS MED REHAB, V83, pS50, DOI 10.1053/apmr.2002.32156; LIBH, 1995, BRAIN RES B, V37, P589; MENETREY D, 1991, EUR J NEUROSCI, V3, P249, DOI 10.1111/j.1460-9568.1991.tb00087.x; MENETREY D, 1987, J COMP NEUROL, V255, P439, DOI 10.1002/cne.902550310; Moran TH, 2004, AM J PHYSIOL-GASTR L, V286, pG183, DOI 10.1152/ajpgi.00434.2003; Morton GJ, 2005, J CLIN INVEST, V115, P703, DOI 10.1172/JCI200522081; NINOMURCIA M, 1991, AM J ROENTGENOL, V158, P279; Peters JH, 2004, ENDOCRINOLOGY, V145, P3652, DOI 10.1210/en.2004-0221; Primeaux SD, 2007, AM J PHYSIOL-REG I, V293, pR1102, DOI 10.1152/ajpregu.00224.2007; Qualls-Creekmore E, 2010, NEUROGASTROENT MOTIL, V22, P62, DOI 10.1111/j.1365-2982.2009.01347.x; RAYBOULD HE, 1988, AM J PHYSIOL, V255, pG242; Raybould HE, 2007, CURR OPIN PHARMACOL, V7, P570, DOI 10.1016/j.coph.2007.09.006; RENEHAN WE, 1995, AM J PHYSIOL-GASTR L, V268, pG780; RINAMAN L, 1993, J COMP NEUROL, V338, P475, DOI 10.1002/cne.903380402; RITTER RC, 1994, ANN NY ACAD SCI, V713, P255, DOI 10.1111/j.1749-6632.1994.tb44073.x; Rodrigues CL, 2001, DIGEST DIS SCI, V46, P1604, DOI 10.1023/A:1010624730975; Sayegh AI, 2000, BRAIN RES, V878, P155, DOI 10.1016/S0006-8993(00)02731-1; Scheff SW, 2003, J NEUROTRAUM, V20, P179, DOI 10.1089/08977150360547099; SEGAL JL, 1995, AM J GASTROENTEROL, V90, P466; Simasko SM, 2003, AM J PHYSIOL-GASTR L, V285, pG1204, DOI 10.1152/ajpgi.00132.2003; STINNEFORD JG, 1993, PARAPLEGIA, V31, P384, DOI 10.1038/sc.1993.64; Sullivan CN, 2007, AM J PHYSIOL-REG I, V292, pR1071, DOI 10.1152/ajpregu.00490.2006; Takahashi T, 1999, J AUTONOM NERV SYST, V75, P123, DOI 10.1016/S0165-1838(98)00181-7; TALMAN WT, 1991, AM J PHYSIOL, V261, pR217; TAPIA R, 1985, NEUROSCI BIOBEHAV R, V9, P391, DOI 10.1016/0149-7634(85)90017-X; Tong M, 2009, NEUROGASTROENT MOTIL, V21, P197, DOI 10.1111/j.1365-2982.2008.01215.x; Travagli RA, 2006, ANNU REV PHYSIOL, V68, P279, DOI 10.1146/annurev.physiol.68.040504.094635; Viard E, 2007, AM J PHYSIOL-GASTR L, V293, pG493, DOI 10.1152/ajpgi.00118.2007; Wan S, 2008, J NEUROSCI, V28, P4957, DOI 10.1523/JNEUROSCI.5398-07.2008; Wan SX, 2007, AM J PHYSIOL-GASTR L, V293, pG484, DOI 10.1152/ajpgi.00116.2007; Wolf C, 2003, SPINAL CORD, V41, P347, DOI 10.1038/sj.sc.3101440; Woods SC, 2004, AM J PHYSIOL-GASTR L, V286, pG7, DOI 10.1152/ajpgi.00448.2003; Xue B, 2009, NEUROGASTROENT MOTIL, V21, P322, DOI 10.1111/j.1365-2982.2008.01225.x; Zheng ZL, 2005, AM J PHYSIOL-GASTR L, V288, pG1066, DOI 10.1152/ajpgi.00497.2004; Zittel TT, 1999, BRAIN RES, V846, P1, DOI 10.1016/S0006-8993(99)01842-9	64	17	17	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1350-1925	1365-2982		NEUROGASTROENT MOTIL	Neurogastroenterol. Motil.	FEB	2011	23	2					e69	e79		10.1111/j.1365-2982.2010.01616.x			11	Gastroenterology & Hepatology; Clinical Neurology; Neurosciences	Gastroenterology & Hepatology; Neurosciences & Neurology	706IM	WOS:000286211600004	20950355	Green Accepted			2021-06-18	
J	Tsirka, V; Simos, PG; Vakis, A; Kanatsouli, K; Vourkas, M; Erimaki, S; Pachou, E; Stam, CJ; Micheloyannis, S				Tsirka, Vasso; Simos, Panagiotis G.; Vakis, Antonios; Kanatsouli, Kassiani; Vourkas, Michael; Erimaki, Sofia; Pachou, Ellie; Stam, Cornelis Jan; Micheloyannis, Sifis			Mild traumatic brain injury: Graph-model characterization of brain networks for episodic memory	INTERNATIONAL JOURNAL OF PSYCHOPHYSIOLOGY			English	Article						Small-World Networks; Graph theory; Synchronization likelihood; Mild traumatic brain injury; Episodic memory; Declarative memory	SMALL-WORLD NETWORKS; HUMAN NEOCORTICAL OSCILLATIONS; HEAD TRAUMA; THEORETICAL ANALYSIS; THETA-OSCILLATIONS; EEG ALPHA; FUNCTIONAL CONNECTIVITY; PHASE SYNCHRONIZATION; RECOGNITION MEMORY; QUANTITATIVE EEG	Episodic memory is among the cognitive functions that can be affected in the acute phase following mild traumatic brain injury (MTBI). The present study used EEG recordings to evaluate global synchronization and network organization of rhythmic activity during the encoding and recognition phases of an episodic memory task varying in stimulus type (kaleidoscope images, pictures, words, and pseudowords). Synchronization of oscillatory activity was assessed using a linear and nonlinear connectivity estimator and network analyses were performed using algorithms derived from graph theory. Twenty five MTBI patients (tested within days post-injury) and healthy volunteers were closely matched on demographic variables, verbal ability, psychological status variables, as well as on overall task performance. Patients demonstrated sub-optimal network organization, as reflected by changes in graph parameters in the theta and alpha bands during both encoding and recognition. There were no group differences in spectral energy during task performance or on network parameters during a control condition (rest). Evidence of less optimally organized functional networks during memory tasks was more prominent for pictorial than for verbal stimuli. (C) 2010 Elsevier B.V. All rights reserved.	[Tsirka, Vasso; Vakis, Antonios; Kanatsouli, Kassiani; Erimaki, Sofia; Pachou, Ellie; Micheloyannis, Sifis] Univ Crete, Dept Med, Clin Res Lab Widen, GR-71409 Iraklion, Greece; [Simos, Panagiotis G.] Univ Crete, Dept Psychol, Rethimnon, Greece; [Vourkas, Michael] Inst Educ Technol, Iraklion, Greece; [Stam, Cornelis Jan] Vrije Univ Amsterdam Med Ctr, Dept Clin Neurophysiol, Amsterdam, Netherlands	Tsirka, V (corresponding author), Mitropolitou Kallidou 5, Thessaloniki 54655, Greece.	tsirkav@yahoo.com	SIMOS, PANAGIOTIS/L-2107-2019	SIMOS, PANAGIOTIS/0000-0002-0116-8564	BIOPATTERN EU	This research was supported in part by the BIOPATTERN EU program.	ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Alstott J, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000408; Babiloni C, 2006, BRAIN RES BULL, V68, P203, DOI 10.1016/j.brainresbull.2005.04.019; Babiloni C, 2009, HUM BRAIN MAPP, V30, P2077, DOI 10.1002/hbm.20648; Bassett DS, 2009, CURR OPIN NEUROL, V22, P340, DOI 10.1097/WCO.0b013e32832d93dd; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Burgess AP, 1997, NEUROREPORT, V8, P1039, DOI 10.1097/00001756-199703030-00044; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; Calmels C, 2010, PSYCHOPHYSIOLOGY, V47, P799, DOI 10.1111/j.1469-8986.2010.00985.x; Cao C, 2010, IEEE T NEUR SYS REH, V18, P11, DOI 10.1109/TNSRE.2009.2027704; Dash P.K., 2006, AMNESIAS CLIN TXB ME, P30; De Monte VE, 2006, BRAIN INJURY, V20, P1345, DOI 10.1080/02699050601082073; Doppelmayr M, 1998, NEUROSCI LETT, V257, P41, DOI 10.1016/S0304-3940(98)00805-2; Fingelkurts A, 2003, NEUROIMAGE, V20, P529, DOI 10.1016/S1053-8119(03)00305-7; Ford MR, 1996, J HEAD TRAUMA REHAB, V11, P1, DOI 10.1097/00001199-199606000-00004; Gaetz M, 2002, CLIN NEUROPHYSIOL, V113, P1665, DOI 10.1016/S1388-2457(02)00270-5; Gaetz M, 2001, J HEAD TRAUMA REHAB, V16, P386, DOI 10.1097/00001199-200108000-00008; Gaetz M, 2000, BRAIN INJURY, V14, P1077; GENTILINI M, 1989, MILD HEAD INJURY, P163; Gevins A, 1997, CEREB CORTEX, V7, P374, DOI 10.1093/cercor/7.4.374; Gronwall D, 1989, MILD HEAD INJURY, P153; Humphries MD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002051; Jensen O, 2002, EUR J NEUROSCI, V15, P1395, DOI 10.1046/j.1460-9568.2002.01975.x; Kay T., 1993, J HEAD TRAUMA REHABI, V8, P86, DOI [10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kirk IJ, 2003, CORTEX, V39, P993, DOI 10.1016/S0010-9452(08)70874-8; KLIMESCH W, 1994, ELECTROEN CLIN NEURO, V91, P428, DOI 10.1016/0013-4694(94)90164-3; Klimesch W, 1996, NEUROREPORT, V7, P1235, DOI 10.1097/00001756-199605170-00002; Klimesch W, 1999, BRAIN RES REV, V29, P169, DOI 10.1016/S0165-0173(98)00056-3; Klimesch W, 2001, COGNITIVE BRAIN RES, V12, P33, DOI 10.1016/S0926-6410(01)00024-6; Klimesch W, 2001, NEUROSCI LETT, V302, P49, DOI 10.1016/S0304-3940(01)01656-1; Klimesch W, 2008, BRAIN RES, V1235, P31, DOI 10.1016/j.brainres.2008.06.049; Klimesch W, 2007, BRAIN RES REV, V53, P63, DOI 10.1016/j.brainresrev.2006.06.003; Landre N, 2006, ARCH CLIN NEUROPSYCH, V21, P255, DOI 10.1016/j.acn.2005.12.007; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; Lewine JD, 1999, AM J NEURORADIOL, V20, P857; Micheloyannis S, 2006, SCHIZOPHR RES, V87, P60, DOI 10.1016/j.schres.2006.06.028; Micheloyannis S, 2006, NEUROSCI LETT, V402, P273, DOI 10.1016/j.neulet.2006.04.006; Micheloyannis S, 2009, HUM BRAIN MAPP, V30, P200, DOI 10.1002/hbm.20492; Montez T, 2006, NEUROIMAGE, V33, P1117, DOI 10.1016/j.neuroimage.2006.06.066; Nakamura T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008220; Nunez PL, 2001, HUM BRAIN MAPP, V13, P125, DOI 10.1002/hbm.1030; Nuwer M, 1997, NEUROLOGY, V49, P277, DOI 10.1212/WNL.49.1.277; Nuwer MR, 2005, CLIN NEUROPHYSIOL, V116, P2001, DOI 10.1016/j.clinph.2005.05.008; Osipova D, 2006, J NEUROSCI, V26, P7523, DOI 10.1523/JNEUROSCI.1948-06.2006; Pointinger H, 2002, BRAIN INJURY, V16, P799, DOI 10.1080/02699050210131911; Ponten SC, 2009, EXP NEUROL, V217, P197, DOI 10.1016/j.expneurol.2009.02.001; Raghavachari S, 2006, J NEUROPHYSIOL, V95, P1630, DOI 10.1152/jn.00409.2005; Raskin S. A., 2000, NEUROPSYCHOLOGICAL M, P93; Rizzuto DS, 2006, NEUROIMAGE, V31, P1352, DOI 10.1016/j.neuroimage.2006.01.009; Rizzuto DS, 2003, P NATL ACAD SCI USA, V100, P7931, DOI 10.1073/pnas.0732061100; Rubinov M, 2009, HUM BRAIN MAPP, V30, P403, DOI 10.1002/hbm.20517; Ruff R.M., 1989, MILD HEAD INJURY, P176; Sauseng P, 2008, NEUROSCI BIOBEHAV R, V32, P1001, DOI 10.1016/j.neubiorev.2008.03.014; Sauseng P, 2008, NEUROIMAGE, V40, P308, DOI 10.1016/j.neuroimage.2007.11.032; Sporns O, 2004, TRENDS COGN SCI, V8, P418, DOI 10.1016/j.tics.2004.07.008; Stam CJ, 2007, CEREB CORTEX, V17, P92, DOI 10.1093/cercor/bhj127; Stam CJ, 2009, BRAIN, V132, P213, DOI 10.1093/brain/awn262; Stam CJ, 2002, PHYSICA D, V163, P236, DOI 10.1016/S0167-2789(01)00386-4; Stam Cornelis J, 2007, Nonlinear Biomed Phys, V1, P3, DOI 10.1186/1753-4631-1-3; Strogatz SH, 2001, NATURE, V410, P268, DOI 10.1038/35065725; Summerfield C, 2005, NEUROREPORT, V16, P117, DOI 10.1097/00001756-200502080-00008; THATCHER RW, 1989, ELECTROEN CLIN NEURO, V73, P94, DOI 10.1016/0013-4694(89)90188-0; Tsirka V, 2010, INT J NEUROSCI, V120, P184, DOI 10.3109/00207450903585308; Vanderploeg RD, 2005, J INT NEUROPSYCH SOC, V11, P228, DOI 10.1017/S1355617705050289; Voller B, 1999, BRAIN INJURY, V13, P821, DOI 10.1080/026990599121214; Wallace BE, 2001, J HEAD TRAUMA REHAB, V16, P165, DOI 10.1097/00001199-200104000-00006; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wechsler D., 2011, WECHLSER ABBREVIATED; Whitham EM, 2008, CLIN NEUROPHYSIOL, V119, P1166, DOI 10.1016/j.clinph.2008.01.024	72	17	17	0	13	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-8760	1872-7697		INT J PSYCHOPHYSIOL	Int. J. Psychophysiol.	FEB	2011	79	2					89	96		10.1016/j.ijpsycho.2010.09.006			8	Psychology, Biological; Neurosciences; Physiology; Psychology; Psychology, Experimental	Psychology; Neurosciences & Neurology; Physiology	733WH	WOS:000288294700002	20863861				2021-06-18	
J	Cullen, DK; Xu, YA; Reneer, DV; Browne, KD; Geddes, JW; Yang, S; Smith, DH				Cullen, D. Kacy; Xu, Yongan; Reneer, Dexter V.; Browne, Kevin D.; Geddes, James W.; Yang, Shu; Smith, Douglas H.			Color changing photonic crystals detect blast exposure	NEUROIMAGE			English	Article							TRAUMATIC BRAIN-INJURY; HEAD-INJURY; MULTIBEAM INTERFERENCE; RECURRENT CONCUSSION; ALZHEIMERS-DISEASE; AFGHANISTAN; FABRICATION; FREQUENCY; DEMENTIA; ONSET	Blast-induced traumatic brain injury (bTBI) is the "signaturewound" of the current wars in Iraq and Afghanistan. However, with no objective information of relative blast exposure, warfighters with bTBI may not receive appropriate medical care and are at risk of being returned to the battlefield. Accordingly, we have created a colorimetric blast injury dosimeter (BID) that exploits material failure of photonic crystals to detect blast exposure. Appearing like a colored sticker, the BID is fabricated in photosensitive polymers via multi-beam interference lithography. Although very stable in the presence of heat, cold or physical impact, sculpted micro -and nano-structures of the BID are physically altered in a precise manner by blast exposure, resulting in color changes that correspond with blast intensity. This approach offers a lightweight, power-free sensor that can be readily interpreted by the naked eye. Importantly, with future refinement this technology may be deployed to identify soldiers exposed to blast at levels suggested to be supra-threshold for non-impact blast-induced mild TBI. (C) 2010 Elsevier Inc. All rights reserved.	[Cullen, D. Kacy; Browne, Kevin D.; Smith, Douglas H.] Univ Penn, Dept Neurosurg, Sch Med, Ctr Brain Injury & Repair, Philadelphia, PA 19104 USA; [Xu, Yongan; Yang, Shu] Univ Penn, Dept Mat Sci & Engn, Sch Engn & Appl Sci, Philadelphia, PA 19104 USA; [Reneer, Dexter V.; Geddes, James W.] Univ Kentucky, Coll Med,Dept Anat & Neurobiol, Albert B Chandler Med Ctr, Spinal Cord & Brain Injury Res Ctr, Lexington, KY 40536 USA	Smith, DH (corresponding author), Univ Penn, Dept Neurosurg, Sch Med, Ctr Brain Injury & Repair, 105 Hayden Hall,3320 Smith Walk, Philadelphia, PA 19104 USA.	shuyang@seas.upenn.edu; smithdou@mail.med.upenn.edu	Xu, Yongan/A-7078-2011; Yang, Shu/D-9758-2011	Yang, Shu/0000-0001-8834-3320	Nanotechnology Institute Proof-of-Concept (PoC) Fund; Office of Naval Research (ONR)Office of Naval Research [N00014-05-0303]; Air Force Office of Scientific Research (AFOSR)United States Department of DefenseAir Force Office of Scientific Research (AFOSR) [FA9550-06-1-0228]; National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS038104, NS048949, NS043126]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS038104, T32NS043126, R01NS048949] Funding Source: NIH RePORTER	This work was supported in part by the Nanotechnology Institute Proof-of-Concept (PoC) Fund, the Office of Naval Research (ONR) (grant #N00014-05-0303), the Air Force Office of Scientific Research (AFOSR) (grant # FA9550-06-1-0228), and the National Institutes of Health (NIH) (grant #NS038104, #NS048949, and #NS043126). The funding sources had no involvement in any aspects of this work or the decision to publish.	Bauman RA, 2009, J NEUROTRAUM, V26, P841, DOI 10.1089/neu.2009-0898; Campbell M, 2000, NATURE, V404, P53; Cantu RC, 2003, CLIN SPORT MED, V22, P593, DOI 10.1016/S0278-5919(02)00095-9; Cernak I, 2001, J TRAUMA, V50, P695, DOI 10.1097/00005373-200104000-00017; Erlanger DM, 1999, CLIN NEUROPSYCHOL, V13, P193, DOI 10.1076/clin.13.2.193.1963; Guo Z, 2000, NEUROLOGY, V54, P1316, DOI 10.1212/WNL.54.6.1316; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Jellinger KA, 2001, EUR J NEUROL, V8, P707, DOI 10.1046/j.1468-1331.2001.00322.x; Jordan BD, 2000, SEMIN NEUROL, V20, P179, DOI 10.1055/s-2000-9826; Kato K, 2007, J NEUROSURG, V106, P667, DOI 10.3171/jns.2007.106.4.667; LEE KY, 1994, J VAC SCI TECHNOL B, V12, P3425, DOI 10.1116/1.587525; LING G, 2008, 26 ANN NAT NEUR S OR; Lorenz H, 1997, J MICROMECH MICROENG, V7, P121, DOI 10.1088/0960-1317/7/3/010; Loubeau A, 2006, J ACOUST SOC AM, V120, pEL29, DOI 10.1121/1.2234518; Martin E.M, 2008, J TRAUMA NURS, V15, P100; Martin Elisabeth Moy, 2008, J Trauma Nurs, V15, P94, DOI 10.1097/01.JTN.0000337149.29549.28; McMurtray A, 2006, DEMENT GERIATR COGN, V21, P59, DOI 10.1159/000089546; Miklyaev YV, 2003, APPL PHYS LETT, V82, P1284, DOI 10.1063/1.1557328; Moochhala SM, 2004, J TRAUMA, V56, P393, DOI 10.1097/01.TA.0000066181.50879.7A; Moon JH, 2006, POLYM ADVAN TECHNOL, V17, P83, DOI 10.1002/pat.663; Moon JH, 2005, J MACROMOL SCI-POL R, VC45, P351, DOI 10.1080/15321790500304163; Mori T, 2006, ACTA NEUROCHIR SUPPL, V96, P40; Nemetz PN, 1999, AM J EPIDEMIOL, V149, P32; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Ribeiro JC, 2005, SENSOR ACTUAT A-PHYS, V123-24, P77, DOI 10.1016/j.sna.2005.03.032; Saljo A, 2009, J NEUROTRAUM, V26, P1345, DOI [10.1089/neu.2008.0856, 10.1089/neu.2008-0856]; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Smith DH, 2003, J NEUROSURG, V98, P1072, DOI 10.3171/jns.2003.98.5.1072; Taber KH, 2006, J NEUROPSYCH CLIN N, V18, P141, DOI 10.1176/appi.neuropsych.18.2.141; TOKUDA T, 1991, ACTA NEUROPATHOL, V82, P280, DOI 10.1007/BF00308813; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Warden DL, 2005, J NEUROTRAUM, V22, P1178; Xu Y, 2008, CHEM MATER, V20, P1816, DOI 10.1021/cm702511k; Yang S, 2002, CHEM MATER, V14, P2831, DOI 10.1021/cm0256007	37	17	18	0	24	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1053-8119	1095-9572		NEUROIMAGE	Neuroimage	JAN	2011	54			1			S37	S44		10.1016/j.neuroimage.2010.10.076			8	Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	813ZF	WOS:000294408600006	21040795	Green Accepted			2021-06-18	
J	Hynes, CA; Stone, VE; Kelso, LA				Hynes, Catherine A.; Stone, Valerie E.; Kelso, Louise A.			Social and emotional competence in traumatic brain injury: New and established assessment tools	SOCIAL NEUROSCIENCE			English	Article						Traumatic brain injury; Social skills; Emotions; Head injury	HEAD-INJURY; ASPERGER-SYNDROME; SELF-AWARENESS; MIND; DEFICITS; INDIVIDUALS; RECOGNITION; IMPAIRMENTS; PERCEPTION; INVENTORY	Chronic social/emotional deficits are common in moderate to severe traumatic brain injury (TBI), leading to significant functional difficulties. Objective, quantitative tools for assessing social/emotional competence are an important adjunct to cognitive assessments. We review existing social/emotional measures, conclude that theory of mind tests are not adequate for clinical assessments of social competence, and explain the development and piloting of novel measures in a small group of moderate to severe TBI patients (N = 16) and non-brain-damaged controls (N = 16). The novel measures are the Global Interpersonal Skills Test (GIST), a questionnaire measuring informant-rated social skills; the Assessment of Social Context (ASC), a video-based task examining understanding of others' emotions, attitudes, and intentions; the Social Interpretations Test, a social framing task based on Heider and Simmel (1944); and Awareness of Interoception, a heartbeat-detection paradigm related to physiological self-awareness. In a MANOVA, other-rated social skills (GIST), ASC, and Awareness of Interoception scores were significantly lower for TBI patients than controls. ASC, r(31)=.655, and Social Interpretations, r(31)=.460, scores were significantly correlated with informant-rated social skills (GIST). We encourage clinicians to add social/emotional measures to assessments of TBI patients.	[Stone, Valerie E.] Answers Brain Injury LLC, Golden, CO 80401 USA; [Hynes, Catherine A.; Stone, Valerie E.; Kelso, Louise A.] Univ Queensland, Sch Psychol, Brisbane, Qld, Australia; [Hynes, Catherine A.] Kent & Medway NHS & Social Care Partnership Trust, Rehabil Serv, Maidstone, Kent, England; [Kelso, Louise A.] Griffith Univ, Sch Psychol, Mt Gravatt, Qld 4122, Australia	Stone, VE (corresponding author), Answers Brain Injury LLC, 601-C 16th St 191, Golden, CO 80401 USA.	vestone@gmail.com	Stone, Valerie E/J-3388-2019		Uniquest Trailblazer Award; Commonwealth Government of AustraliaAustralian Government; University of Queensland (UQ)University of Queensland; UQ Social and Behavioral Sciences; UQ International Living Allowance Scholarship	Original studies reported here were the doctoral dissertation research of Catherine Hynes, PhD (awarded 2009, University of Queensland), and the Honours Thesis research (GIST validation) of Louise Kelso, BPSc Hons (awarded 2006, University of Queensland). This research was supported by a Uniquest Trailblazer Award, an Endeavour International Postgraduate Research Scholarship from the Commonwealth Government of Australia, a University of Queensland (UQ) Research Development Grant, a UQ Social and Behavioral Sciences Tuition Fee Waiver Scholarship, and a UQ International Living Allowance Scholarship. The authors would like to thank the following people for their contributions to this research: Dana Schneider, Katrina Van Der List, Tirta Susilo, and Trudy Sinnamon (data collection); Anna Yuen and James White (acting in video clips); Paul Jackson (programming help); Dr Ron Hazelton (help with recruitment); and Beth O'Brien (statistical assistance).	Arango-Lasprilla JC, 2008, BRAIN INJURY, V22, P565, DOI 10.1080/02699050802172004; Baldo JV, 2006, J INT NEUROPSYCH SOC, V12, P896, DOI 10.1017/S1355617706061078; Barrash J, 2000, DEV NEUROPSYCHOL, V18, P355, DOI 10.1207/S1532694205Barrash; Barrett LF, 2004, J PERS SOC PSYCHOL, V87, P684, DOI 10.1037/0022-3514.87.5.684; Bayly PV, 2005, J NEUROTRAUM, V22, P845, DOI 10.1089/neu.2005.22.845; Benton A, 1989, MULTILINGUAL APHASIA; Berlin HA, 2004, BRAIN, V127, P1108, DOI 10.1093/brain/awh135; Bibby H, 2005, NEUROPSYCHOLOGIA, V43, P99, DOI 10.1016/j.neuropsychologia.2004.04.027; Blais MC, 2007, BRAIN INJURY, V21, P357, DOI 10.1080/02699050701311075; Bond F, 1997, BRAIN INJURY, V11, P319, DOI 10.1080/026990597123476; Boone K. B., 2007, ASSESSMENT FEIGNED C, P29; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Castelli F, 2002, BRAIN, V125, P1839, DOI 10.1093/brain/awf189; Channon S, 2005, BRAIN LANG, V93, P123, DOI 10.1016/j.bandl.2004.09.002; Critchley HD, 2004, NAT NEUROSCI, V7, P189, DOI 10.1038/nn1176; CUMMINGS JL, 1994, NEUROLOGY, V44, P2308, DOI 10.1212/WNL.44.12.2308; Dahlberg CA, 2007, ARCH PHYS MED REHAB, V88, P1561, DOI 10.1016/j.apmr.2007.07.033; de Sousa A, 2011, CORTEX, V47, P526, DOI 10.1016/j.cortex.2010.02.004; de Sousa A, 2010, NEUROPSYCHOLOGIA, V48, P3585, DOI 10.1016/j.neuropsychologia.2010.08.008; Devinsky O., 2004, NEUROLOGY COGNITIVE, V68; Drummond SS, 2004, BRAIN INJURY, V18, P41, DOI 10.1080/0269905031000149461; Engberg AW, 2004, BRAIN INJURY, V18, P533, DOI 10.1080/02699050310001645829; Gallagher HL, 2000, NEUROPSYCHOLOGIA, V38, P11, DOI 10.1016/S0028-3932(99)00053-6; Garmoe W, 2005, J HEAD TRAUMA REHAB, V20, P348, DOI 10.1097/00001199-200507000-00006; Graham DP, 2008, ANN NY ACAD SCI, V1141, P148, DOI 10.1196/annals.1441.029; Gregory C, 2002, BRAIN, V125, P752, DOI 10.1093/brain/awf079; Gronwall D., 1998, HEAD INJURY FACTS; Hanks RA, 1999, ARCH PHYS MED REHAB, V80, P991, DOI 10.1016/S0003-9993(99)90049-7; Happe F, 1999, COGNITION, V70, P211, DOI 10.1016/S0010-0277(99)00005-0; HAPPE FGE, 1994, J AUTISM DEV DISORD, V24, P129, DOI 10.1007/BF02172093; Hart T, 2004, ARCH PHYS MED REHAB, V85, P1450, DOI 10.1016/j.apmr.2004.01.030; Hawley LA, 2010, BRAIN INJURY, V24, P1292, DOI 10.3109/02699052.2010.506866; Hawthorne G, 2009, J NEUROTRAUM, V26, P1623, DOI [10.1089/neu.2008.0735, 10.1089/neu.2008-0735]; Heberlein AS, 2004, P NATL ACAD SCI USA, V101, P7487, DOI 10.1073/pnas.0308220101; Heider F, 1944, AM J PSYCHOL, V57, P243, DOI 10.2307/1416950; Jorge RE, 2005, CURR OPIN PSYCHIATR, V18, P289, DOI 10.1097/01.yco.0000165600.90928.92; Kertesz A, 1997, CAN J NEUROL SCI, V24, P29, DOI 10.1017/S0317167100021053; Kim E, 2002, NEUROREHABILITATION, V17, P297; Klin A, 2000, J CHILD PSYCHOL PSYC, V41, P831, DOI 10.1111/1469-7610.00671; Knox L, 2009, BRAIN COGNITION, V69, P442, DOI 10.1016/j.bandc.2008.09.009; Kreutzer JS, 1996, ARCH PHYS MED REHAB, V77, P116, DOI 10.1016/S0003-9993(96)90155-0; Kringelbach ML, 2003, NEUROIMAGE, V20, P1371, DOI 10.1016/S1053-8119(03)00393-8; Lang P. J., 2005, A6 U FLOR CTR RES PS; Lee TMC, 2005, MOL PSYCHIATR, V10, P450, DOI 10.1038/sj.mp.4001595; LEVENSON RW, 1992, PSYCHOL SCI, V3, P23, DOI 10.1111/j.1467-9280.1992.tb00251.x; Levine B, 2008, NEUROLOGY, V70, P771, DOI 10.1212/01.wnl.0000304108.32283.aa; Linscott RJ, 1996, BRAIN INJURY, V10, P397, DOI 10.1080/026990596124269; LOWE MR, 1978, BEHAV THER, V9, P535, DOI 10.1016/S0005-7894(78)80126-9; Malloy PF, 2001, FRONTAL SYSTEMS BEHA; McDonald S, 2003, J HEAD TRAUMA REHAB, V18, P219, DOI 10.1097/00001199-200305000-00001; McDonald S, 2004, NEUROPSYCHOL REHABIL, V14, P285, DOI 10.1080/09602010343000237; McDonald S, 1996, BRAIN LANG, V53, P81, DOI 10.1006/brln.1996.0038; McDonald S., 2002, AWARENESS SOCIAL INF; McDonald S, 2009, NEUROPSYCHOL REHABIL, V19, P321, DOI 10.1080/09602010802193989; McGann W, 1997, BRAIN INJURY, V11, P621, DOI 10.1080/026990597123179; Milders M, 2003, J CLIN EXP NEUROPSYC, V25, P157, DOI 10.1076/jcen.25.2.157.13642; Milders M, 2008, J INT NEUROPSYCH SOC, V14, P318, DOI 10.1017/S1355617708080351; Milders M, 2006, NEUROPSYCHOLOGY, V20, P400, DOI 10.1037/0894-4105.20.4.400; Muller F, 2010, CORTEX, V46, P1088, DOI 10.1016/j.cortex.2009.08.014; Nelson LD, 1998, ARCH CLIN NEUROPSYCH, V13, P549, DOI 10.1016/S0887-6177(97)00052-8; NHMRC, 2009, AUSTR GUID RED HLTH; Nyhus E, 2009, BRAIN COGNITION, V71, P437, DOI 10.1016/j.bandc.2009.03.005; Ownsworth T, 2004, DISABIL REHABIL, V26, P765, DOI 10.1080/09638280410001696700; Pagulayan KF, 2008, ARCH PHYS MED REHAB, V89, P1887, DOI 10.1016/j.apmr.2008.03.019; Parry-Jones BL, 2006, NEUROPSYCHOL REHABIL, V16, P537, DOI 10.1080/09602010500231875; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; Ponsford J, 2007, BRAIN INJURY, V21, P1385, DOI 10.1080/02699050701796960; Prigatano GP, 2005, J HEAD TRAUMA REHAB, V20, P19, DOI 10.1097/00001199-200501000-00004; *PSYCH CORP, 1997, WECHSL AD INT SCAL; Psychological Corporation, 2001, WECHSL TEST AD READ; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Rochat L, 2009, J NEUROPSYCHOL, V3, P213, DOI 10.1348/174866408X397656; Saunders JC, 2006, NEUROPSYCHOLOGY, V20, P224, DOI 10.1037/0894-4105.20.2.224; Shamay-Tsoory SG, 2005, COGN BEHAV NEUROL, V18, P55, DOI 10.1097/01.wnn.0000152228.90129.99; Shamay-Tsoory SG, 2003, J COGNITIVE NEUROSCI, V15, P324, DOI 10.1162/089892903321593063; Shamay-Tsoory SG, 2007, NEUROPSYCHOLOGIA, V45, P3054, DOI 10.1016/j.neuropsychologia.2007.05.021; Spreen O., 1998, COMPENDIUM NEUROPSYC; SPSS/IBM, 2007, STAT PACK SOC SCI; Stone VE, 1998, J COGNITIVE NEUROSCI, V10, P640, DOI 10.1162/089892998562942; Stone VE, 2011, OXFORD HDB SOCIAL NE, P455; Struchen MA, 2008, NEUROREHABILITATION, V23, P185; Temkin NR, 2009, J HEAD TRAUMA REHAB, V24, P460, DOI 10.1097/HTR.0b013e3181c13413; Wang JY, 2008, ARCH NEUROL-CHICAGO, V65, P619, DOI 10.1001/archneur.65.5.619; Wiens S, 2000, COGNITION EMOTION, V14, P417, DOI 10.1080/026999300378905; Williams C, 2010, J CLIN EXP NEUROPSYC, V32, P259, DOI 10.1080/13803390902976940; Yamasato M, 2007, PSYCHIAT CLIN NEUROS, V61, P658, DOI 10.1111/j.1440-1819.2007.01720.x	86	17	17	0	20	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1747-0919	1747-0927		SOC NEUROSCI-UK	Soc. Neurosci.		2011	6	5-6			SI		599	614		10.1080/17470919.2011.584447			16	Neurosciences; Psychology	Neurosciences & Neurology; Psychology	882NL	WOS:000299570500014	21777158				2021-06-18	
J	Koskinen, S; Hokkinen, EM; Wilson, L; Sarajuuri, J; Von Steinbuchel, N; Truelle, JL				Koskinen, Sanna; Hokkinen, Eeva-Maija; Wilson, Lindsay; Sarajuuri, Jaana; Von Steinbuechel, Nicole; Truelle, Jean-Luc			Comparison of subjective and objective assessments of outcome after traumatic brain injury using the International Classification of Functioning, Disability and Health (ICF)	DISABILITY AND REHABILITATION			English	Article						Outcome; HRQoL; TBI; ICF; QOLIBRI; GOSE	QUALITY-OF-LIFE; HEAD-INJURY; PROSPECTIVE COHORT; YOUNG-PEOPLE; CORE SETS; FOLLOW-UP; REHABILITATION; SATISFACTION; QOLIBRI; ADULTS	Purpose. The aim is to examine two aspects of outcome after traumatic brain injury (TBI). Functional outcome was assessed by the Glasgow Outcome Scale - Extended (GOSE) and by clinician ratings, while health-related quality of life (HRQoL) was assessed by the Quality of Life after Brain Injury (QOLIBRI). Method. The GOSE and the QOLIBRI were linked to the International Classification of Functioning, Disability and Health (ICF) to analyse their content. Functional outcome on ICF categories was assessed by rehabilitation clinicians in 55 participants with TBI and was compared to the participants' own judgements of their HRQoL. Results. The QOLIBRI was linked to 42 and the GOSE to 57 two-level ICF categories covering 78% of the categories on the ICF brief core set for TBI. The closest agreement in the views of the professionals and the participants was found on the Physical Problems and Cognition scales of the QOLIBRI. Conclusions. The problems encountered after TBI are well covered by the QOLIBRI and the GOSE. They capture important domains that are not traditionally sufficiently documented, especially in the domains of interpersonal relationships, social and leisure activities, self and the environment. The findings indicate that they are useful and complementary outcome measures for TBI. In rehabilitation, they can serve as tools in assessment, setting meaningful goals and creating therapeutic alliance.	[Koskinen, Sanna; Hokkinen, Eeva-Maija; Sarajuuri, Jaana] Kapyla Rehabil Ctr, Helsinki 00251, Finland; [Wilson, Lindsay] Univ Stirling, Dept Psychol, Stirling FK9 4LA, Scotland; [Von Steinbuechel, Nicole] Univ Gottingen, Dept Med Psychol & Med Sociol, Gottingen, Germany; [Truelle, Jean-Luc] CHU Raymond Poincare, Serv Med Phys & Readapt, Garches, France	Koskinen, S (corresponding author), Kapyla Rehabil Ctr, POB 103, Helsinki 00251, Finland.	sannakos@gmail.com	Sarajuuri, Jaana/AAD-8665-2019; Wilson, Lindsay/A-3659-2009; Wilson, Lindsay/O-8883-2019	Sarajuuri, Jaana/0000-0002-6432-0295; Wilson, Lindsay/0000-0003-4113-2328; Wilson, Lindsay/0000-0003-4113-2328; Koskinen, Sanna/0000-0002-3453-5084	EVO of the Kapyla Rehabilitation Centre; Alfred Kordelin Foundation, Finland; Finnish Cultural FoundationFinnish Cultural Foundation	The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper. This study was funded by EVO funding of the Kapyla Rehabilitation Centre, and by grants from the Alfred Kordelin Foundation, Finland, and the Finnish Cultural Foundation.	Alachini B, 2010, EUR J PHYS REHAB MED, V46, P27; Andelic N, 2010, DISABIL REHABIL, V32, P1122, DOI 10.3109/09638280903410722; [Anonymous], 1999, JAMA, V282, P974; Baumann CR, 2007, BRAIN, V130, P1873, DOI 10.1093/brain/awm109; Bernabeu M, 2009, NEUROREHAB NEURAL RE, V23, P464, DOI 10.1177/1545968308328725; Branca B, 2004, J HEAD TRAUMA REHAB, V19, P40, DOI 10.1097/00001199-200401000-00005; Bullinger M, 2002, RESTOR NEUROL NEUROS, V20, P111; Cantor JB, 2008, J HEAD TRAUMA REHAB, V23, P41, DOI 10.1097/01.HTR.0000308720.70288.af; Cieza A, 2005, J REHABIL MED, V37, P212, DOI 10.1080/16501970510040263; Cieza A, 2005, QUAL LIFE RES, V14, P1225, DOI 10.1007/s11136-004-4773-0; Cieza A, 2004, J REHABIL MED, V36, P9, DOI 10.1080/16501960410015353; Cieza A, 2002, J REHABIL MED, V34, P205, DOI 10.1080/165019702760279189; Coons SJ, 2000, PHARMACOECONOMICS, V17, P13, DOI 10.2165/00019053-200017010-00002; Corrigan JD, 2004, J HEAD TRAUMA REHAB, V19, P445, DOI 10.1097/00001199-200411000-00003; Corrigan JD, 2001, J HEAD TRAUMA REHAB, V16, P543, DOI 10.1097/00001199-200112000-00003; Dahlberg C, 2006, BRAIN INJURY, V20, P425, DOI 10.1080/02699050600664574; Dijkers M, 1999, AM J PHYS MED REHAB, V78, P286, DOI 10.1097/00002060-199905000-00022; Dijkers MP, 2004, ARCH PHYS MED REHAB, V85, pS21, DOI 10.1016/j.apmr.2003.08.119; Fuhrer MJ, 2000, DISABIL REHABIL, V22, P481, DOI 10.1080/096382800413961; HERRMAN H, 1993, QUAL LIFE RES, V2, P153; Hibbard MR, 2004, ARCH PHYS MED REHAB, V85, pS43, DOI 10.1016/j.apmr.2003.08.116; Hoffman JM, 2007, AM J PHYS MED REHAB, V86, P962, DOI 10.1097/PHM.0b013e31815b5ee5; JENNETT B, 1975, LANCET, V1, P480; Jorge RE, 2005, CURR OPIN PSYCHIATR, V18, P289, DOI 10.1097/01.yco.0000165600.90928.92; JUDD T, 1999, NEUROPSYCHOTHERAPY C; Koskinen S, 1998, BRAIN INJURY, V12, P631, DOI 10.1080/026990598122205; Koskinen S, 2007, J REHABIL MED, V39, P467, DOI 10.2340/16501977-0077; Kozlowski O., 2002, Annales de Readaptation et de Medecine Physique, V45, P466, DOI 10.1016/S0168-6054(02)00297-0; Machamer J, 2002, J CLIN EXP NEUROPSYC, V24, P420, DOI 10.1076/jcen.24.4.420.1040; Mailhan L, 2005, BRAIN INJURY, V19, P227, DOI 10.1080/02699050410001720149; Mazaux JM, 2002, ACT NEUR S, V79, P49; Mazaux JM, 1998, DISABIL REHABIL, V20, P435, DOI 10.3109/09638289809166108; McCarthy ML, 2006, ARCH PHYS MED REHAB, V87, P953, DOI 10.1016/j.apmr.2006.03.007; Neugebauer E, 2002, RESTOR NEUROL NEUROS, V20, P161; Oppermann JD, 2004, BRAIN INJURY, V18, P941, DOI 10.1080/02699050410001671919; Pagulayan KF, 2006, ARCH PHYS MED REHAB, V87, P611, DOI 10.1016/j.apmr.2006.01.018; Pierce CA, 2006, AM J PHYS MED REHAB, V85, P889, DOI 10.1097/01.phm.0000242615.43129.ae; Scarponi F, 2009, DISABIL REHABIL, V31, pS134, DOI 10.3109/09638280903317906; Seibert PS, 2002, BRAIN INJURY, V16, P837, DOI 10.1080/02699050210131939; Stucki G, 2008, EUR J PHYS REHAB MED, V44, P315; Stucki G, 2003, DISABIL REHABIL, V25, P628, DOI 10.1080/09638280110070221; Stucki G, 2007, J REHABIL MED, V39, P279, DOI 10.2340/16501977-0041; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; Truelle JL, 2010, BRAIN INJURY, V24, P1272, DOI 10.3109/02699052.2010.506865; Ueda S, 2003, DISABIL REHABIL, V25, P596, DOI 10.1080/0963828031000137108; Underhill AT, 2003, BRAIN INJURY, V17, P973, DOI 10.1080/0269905031000110418; Van Baalen B, 2003, DISABIL REHABIL, V25, P9, DOI 10.1080/713813430; Vickery CD, 2005, BRAIN INJURY, V19, P657, DOI 10.1080/02699050400005218; von Steinbuechel N, 2005, ACTA NEUROCHIR SUPPL, V93, P43; von Steinbuchel N, 2010, J NEUROTRAUM, V27, P1167, DOI 10.1089/neu.2009.1076; von Steinbuchel N, 2010, J NEUROTRAUM, V27, P1157, DOI 10.1089/neu.2009.1077; Whitnall L, 2006, J NEUROL NEUROSUR PS, V77, P640, DOI 10.1136/jnnp.2005.078246; WHO, ICF CHECKL VERS 2 1A; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wilson JTL, 2000, J NEUROL NEUROSUR PS, V69, P204, DOI 10.1136/jnnp.69.2.204; Wood RL, 2006, J NEUROL NEUROSUR PS, V77, P71, DOI 10.1136/jnnp.2005.065540; World Health Organization, 2001, INT CLASS FUNCT DIS; Zitnay GA, 2008, J NEUROTRAUM, V25, P1135, DOI 10.1089/neu.2008.0599	58	17	17	0	21	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.		2011	33	25-26					2464	2478		10.3109/09638288.2011.574776			15	Rehabilitation	Rehabilitation	851RO	WOS:000297288800008	21534850				2021-06-18	
J	Leemann, B; Laganaro, M; Chetelat-Mabillard, D; Schnider, A				Leemann, Beatrice; Laganaro, Marina; Chetelat-Mabillard, Daphne; Schnider, Armin			Crossover Trial of Subacute Computerized Aphasia Therapy for Anomia With the Addition of Either Levodopa or Placebo	NEUROREHABILITATION AND NEURAL REPAIR			English	Article						aphasia; levodopa; stroke; traumatic brain injury; rehabilitation	OPEN-LABEL TRIAL; DOUBLE-BLIND; NONFLUENT APHASIA; COGNITIVE REHABILITATION; BROMOCRIPTINE; STROKE; PHARMACOTHERAPY; PIRACETAM; RECOVERY; MEMORY	Background. The effect of levodopa on recovery from aphasia is controversial. Objective. To determine whether levodopa enhances the effect of intensive computer-assisted therapy (CAT) of anomia in the postacute stage of aphasia. Methods. Double-blind multiple case study with intrasubject crossover design comparing the effect of levodopa (100 mg) versus placebo, each given for 2 weeks. Subjects. Twelve patients with onset of aphasia from 2 to 9 weeks after stroke or traumatic brain injury were compared on naming performance on items trained and not trained with CAT. Subjects were randomized to either levodopa or placebo first, separated by a 1-week washout, and then switched to the other drug intervention for the second 2-week CAT intervention. The subjects also received routine aphasia therapies during these periods. Results. All patients improved their naming performance for items trained by CAT in both periods (P = .001). No significant difference was found between the placebo and levodopa phases. Conclusion. Administration of levodopa for 2 weeks during the postacute stage of aphasia did not augment the positive effects of subacute intensive language treatment with CAT for a spoken naming task.	[Leemann, Beatrice] Hop Univ Geneve, Serv Neuroreeduc, CH-1211 Geneva 14, Switzerland; [Laganaro, Marina] Univ Neuchatel, CH-2000 Neuchatel, Switzerland	Leemann, B (corresponding author), Hop Univ Geneve, Serv Neuroreeduc, CH-1211 Geneva 14, Switzerland.	beatrice.leemann@hcuge.ch		Laganaro, Marina/0000-0002-4054-0939			ALBERT ML, 1988, NEUROLOGY, V38, P877, DOI 10.1212/WNL.38.6.877; Bragoni M, 2000, NEUROL SCI, V21, P19, DOI 10.1007/s100720070114; Cappa SF, 2003, EUR J NEUROL, V10, P11, DOI 10.1046/j.1468-1331.2003.00537.x; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; de Boissezon X, 2007, BRAIN LANG, V102, P114, DOI 10.1016/j.bandl.2006.07.004; ENDERBY P, 1994, CLIN NEUROPHARMACOL, V17, P320, DOI 10.1097/00002826-199408000-00003; Floel A, 2005, ANN NEUROL, V58, P121, DOI 10.1002/ana.20536; Gold M, 2000, BRAIN LANG, V74, P141, DOI 10.1006/brln.2000.2332; Gupta SR, 1995, NEUROLOGY, V45, P2170, DOI 10.1212/WNL.45.12.2170; Huber W, 1997, ARCH PHYS MED REHAB, V78, P245, DOI 10.1016/S0003-9993(97)90028-9; Jay TM, 2003, PROG NEUROBIOL, V69, P375, DOI 10.1016/S0301-0082(03)00085-6; Knecht S, 2004, ANN NEUROL, V56, P20, DOI 10.1002/ana.20125; Laganaro M, 2006, NEUROPSYCHOL REHABIL, V16, P630, DOI 10.1080/09602010543000064; Liepert J, 2008, CURR OPIN NEUROL, V21, P639, DOI 10.1097/WCO.0b013e32831897a3; Rioult-Pedotti MS, 2000, SCIENCE, V290, P533, DOI 10.1126/science.290.5491.533; Rosser N, 2008, ARCH PHYS MED REHAB, V89, P1633, DOI 10.1016/j.apmr.2008.02.030; Sabe L, 1995, NEUROLOGY, V45, P2272, DOI 10.1212/WNL.45.12.2272; SABE L, 1992, NEUROLOGY, V42, P1637, DOI 10.1212/WNL.42.8.1637; Scheidtmann K, 2001, LANCET, V358, P787, DOI 10.1016/S0140-6736(01)05966-9; Seniow J, 2009, J NEUROL SCI, V283, P214, DOI 10.1016/j.jns.2009.02.336; Vitali P, 2007, NEUROREHAB NEURAL RE, V21, P152, DOI 10.1177/1545968306294735; Walker-Batson D, 2001, STROKE, V32, P2093, DOI 10.1161/hs0901.095720; Wertz R, 2004, APHASIOLOGY, V18, P229, DOI 10.1080/02687030444000048; Whiting E, 2008, BRAIN LANG, V104, P254, DOI 10.1016/j.bandl.2007.03.003	24	17	17	0	8	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1545-9683			NEUROREHAB NEURAL RE	Neurorehabil. Neural Repair	JAN	2011	25	1					43	47		10.1177/1545968310376938			5	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	700MS	WOS:000285747800005	20834044	Green Accepted			2021-06-18	
J	McCauley, SR; Pedroza, C; Chapman, SB; Cook, LG; Vasquez, AC; Levin, HS				McCauley, Stephen R.; Pedroza, Claudia; Chapman, Sandra B.; Cook, Lori G.; Vasquez, Ana C.; Levin, Harvey S.			Monetary incentive effects on event-based prospective memory three months after traumatic brain injury in children	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						Event-based prospective memory; Traumatic brain injury; Monetary incentives; Motivation; Memory rehabilitation; Pediatrics	PATIENTS PERFORMING ACTIVITIES; CUE-DISTINCTIVENESS; TASK INTERRUPTION; POCKET MONEY; ADULTS; AGE; SENSITIVITY; IMPAIRMENT; INTENTIONS; ALLOWANCE	Information regarding the remediation of event-based prospective memory (EB-PM) impairments following pediatric traumatic brain injury (TBI) is scarce. Addressing this, two levels of monetary incentives were used to improve EB-PM in children ages 7 to 16 years with orthopedic injuries (OI, n = 51), or moderate (n = 25) and severe (n = 39) TBI at approximately 3 months postinjury. The EB-PM task consisted of the child giving a specific verbal response to a verbal cue from the examiner while performing a battery of neuropsychological measures (ongoing task). Significant effects were found for age-at-test, motivation condition, period, and group. Within-group analyses indicated that OI and moderate TBI groups performed significantly better under the high-than under the low-incentive condition, but the severe TBI group demonstrated no significant improvement. These results indicate that EB-PM can be significantly improved at 3 months postinjury in children with moderate, but not severe, TBI.	[McCauley, Stephen R.] Baylor Coll Med, Cognit Neurosci Lab, Dept Pediat, Houston, TX 77030 USA; [Pedroza, Claudia] Univ Texas Med Sch Houston, Ctr Clin Res & Evidence Based Med, Houston, TX USA; [McCauley, Stephen R.; Levin, Harvey S.] Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA; [McCauley, Stephen R.; Levin, Harvey S.] Michael E DeBakey VA Med Ctr, Houston, TX USA; [Chapman, Sandra B.; Cook, Lori G.] Univ Texas Dallas, Ctr Brain Hlth, Dallas, TX 75230 USA	McCauley, SR (corresponding author), Baylor Coll Med, Cognit Neurosci Lab, Dept Pediat, 1709 Dryden Rd,Ste 1200, Houston, TX 77030 USA.	mccauley@bcm.edu		Pedroza, Claudia/0000-0003-4235-1282	National Center for Medical Rehabilitation Research [K23 HD-40896]; National Institute Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS-21889]; General Clinical Research Center at Texas Children's Hospital, Houston; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K23HD040896] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS021889] Funding Source: NIH RePORTER	This work was supported by National Center for Medical Rehabilitation Research Grant K23 HD-40896 ("Prospective memory in normal and head-injured children," awarded to Stephen R. McCauley) and National Institute Neurological Disorders and Stroke Grant NS-21889 ("Neurobehavioral outcome of head injury in children," awarded to Harvey S. Levin). The information in this manuscript and the manuscript itself have never been published either electronically or in print. None of the authors have any financial or other relationship(s) that could be construed as a conflict of interest with respect to the content of this manuscript. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Center for Medical Rehabilitation Research or the National Institutes of Health. We thank the participants and their families for their interest and willingness to be part of this research. I would like to extend my personal appreciation to Mark A. McDaniel and Harvey S. Levin who graciously served as mentors on my K-23 mentored patient-oriented research career development award. We also acknowledge the support of the General Clinical Research Center at Texas Children's Hospital, Houston.	Baddeley AD., 1990, HUMAN MEMORY; Barnet-Verzat C, 2002, J ECON PSYCHOL, V23, P339, DOI 10.1016/S0167-4870(02)00080-6; Best D. L., 1992, MEMORY IMPROVEMENT I, P122; BRANDIMONTE MA, 1994, Q J EXP PSYCHOL-A, V47, P565, DOI 10.1080/14640749408401128; COCKBURN J, 1995, CORTEX, V31, P87, DOI 10.1016/S0010-9452(13)80107-4; Cohen J, 1988, POWER ANAL BEHAV SCI; *COMM INJ SCAL, 1990, ABBR INJ SCAL; Driscoll I, 2005, NEUROPSYCHOLOGY, V19, P28, DOI 10.1037/0894-4105.19.1.28; Einstein G., 1996, PROSPECTIVE MEMORY T, P115; EINSTEIN GO, 1990, J EXP PSYCHOL LEARN, V16, P717, DOI 10.1037/0278-7393.16.4.717; Fortin S, 2002, BRAIN COGNITION, V48, P361, DOI 10.1006/brcg.2001.1378; Fortin S, 2003, CORTEX, V39, P273, DOI 10.1016/S0010-9452(08)70109-6; Furnham A, 1999, BRIT J DEV PSYCHOL, V17, P585, DOI 10.1348/026151099165492; Furnham A, 2000, EUR PSYCHOL, V5, P202, DOI 10.1027//1016-9040.5.3.202; Furst C., 1986, COGNITIVE REHABILITA, V4, P24; GENTRY M, 1990, PERS SOC PSYCHOL B, V16, P241, DOI 10.1177/0146167290162005; Groot YCT, 2002, J INT NEUROPSYCH SOC, V8, P645, DOI 10.1017/S1355617702801321; Guajardo NR, 2000, COGNITIVE DEV, V15, P75, DOI 10.1016/S0885-2014(00)00016-2; Hannon R, 1995, REHABIL PSYCHOL, V40, P289, DOI 10.1037/0090-5550.40.4.289; Harris J. E., 1984, EVERYDAY MEMORY ACTI, P71; Hauser RM, 1997, SOCIOL METHODOL, V27, P177, DOI 10.1111/1467-9531.271028; Henry JD, 2007, J CLIN EXP NEUROPSYC, V29, P457, DOI 10.1080/13803390600762717; Hicks JL, 2005, AM J PSYCHOL, V118, P1; HUPPERT FA, 1993, J CLIN EXP NEUROPSYC, V15, P805, DOI 10.1080/01688639308402597; Kerns KA, 2001, CHILD NEUROPSYCHOL, V7, P162, DOI 10.1076/chin.7.3.162.8744; Kerns KA, 2000, J INT NEUROPSYCH SOC, V6, P62, DOI 10.1017/S1355617700611074; Kidder DP, 1997, AGING NEUROPSYCHOL C, V4, P93, DOI 10.1080/13825589708256639; Kinsella G, 1996, BRAIN INJURY, V10, P499, DOI 10.1080/026990596124214; Kliegel M, 2004, BRAIN COGNITION, V56, P43, DOI 10.1016/j.bandc.2004.05.005; Knight RG, 2006, J INT NEUROPSYCH SOC, V12, P8, DOI 10.1017/S1355617706060048; Knight RG, 2005, BRAIN INJURY, V19, P19, DOI 10.1080/02699050410001720022; KVAVILASHVILI L, 1992, APPL COGNITIVE PSYCH, V6, P507, DOI 10.1002/acp.2350060605; KVAVILASHVILI L, 1987, BRIT J PSYCHOL, V78, P507, DOI 10.1111/j.2044-8295.1987.tb02265.x; Kvavilashvili L, 2001, DEV PSYCHOL, V37, P418, DOI 10.1037//0012-1649.37.3.418; Larson MJ, 2007, J INT NEUROPSYCH SOC, V13, P615, DOI 10.1017/S1355617707070762; LOUDA J, 2007, Z NEUROPSYCHOL, V18, P91; Mathias JL, 2005, BRAIN INJURY, V19, P271, DOI 10.1080/02699050400005028; Maujean A., 2003, BRAIN IMPAIR, V4, P135, DOI DOI 10.1375/BRIM.4.2.135.27024; MAYLOR EA, 1990, Q J EXP PSYCHOL-A, V42, P471, DOI 10.1080/14640749008401233; McCauley SR, 2004, DEV NEUROPSYCHOL, V25, P5, DOI 10.1207/s15326942dn2501&2_2; McCauley SR, 2010, CHILD NEUROPSYCHOL, V16, P293, DOI 10.1080/09297041003601470; McCauley SR, 2010, J INT NEUROPSYCH SOC, V16, P335, DOI 10.1017/S135561770999138X; McCauley SR, 2009, NEUROPSYCHOLOGY, V23, P201, DOI 10.1037/a0014192; McDaniel M A, 1993, Memory, V1, P23, DOI 10.1080/09658219308258223; Meacham J. A., 1982, MEMORY OBSERVED REME, P327; MEACHAM JA, 1976, PROSPECTIVE REMEMBER; Neul SKT, 2001, CHILD FAM BEHAV THER, V23, P37, DOI 10.1300/J019v23n04_03; PASTORE DR, 1992, COMPREHENSIVE ADOLES; Raskin SA, 2009, BRAIN IMPAIR, V10, P76, DOI 10.1375/brim.10.1.76; Roche NL, 2007, NEUROPSYCHOL REHABIL, V17, P314, DOI 10.1080/09602010600831004; Roche NL, 2002, BRAIN INJURY, V16, P931, DOI 10.1080/02699050210138581; RUTHER NM, 1993, M SE PSYCH ASS; Salthouse TA, 2004, MEM COGNITION, V32, P1133, DOI 10.3758/BF03196887; Shum D, 1999, J CLIN EXP NEUROPSYC, V21, P49, DOI 10.1076/jcen.21.1.49.943; Taylor HG, 2004, DEV NEUROPSYCHOL, V25, P199, DOI 10.1207/s15326942dn2501&2_11; Taylor HG, 2002, NEUROPSYCHOLOGY, V16, P15, DOI 10.1037//0894-4105.16.1.15; Taylor HG, 1999, NEUROPSYCHOLOGY, V13, P76, DOI 10.1037/0894-4105.13.1.76; TEASDALE G, 1974, LANCET, V2, P81; Thone-Otto AIT, 2003, INT J PSYCHOL, V38, P236, DOI 10.1080/00207590344000169; Ward H, 2005, CHILD NEUROPSYCHOL, V11, P527, DOI 10.1080/09297040490920186; Ward H, 2004, BRAIN INJURY, V18, P471, DOI 10.1080/02699050310001646107; Ward H, 2007, CHILD NEUROPSYCHOL, V13, P219, DOI 10.1080/09297040600910003; WILKINS AJ, 1978, PRACTICAL ASPECTS ME; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; Wilson B.A, 1987, REHABILITATION MEMOR; Winograd E., 1988, PRACTICAL ASPECTS ME, V1, P348; Yeates K O, 1997, J Int Neuropsychol Soc, V3, P617	67	17	18	1	8	TAYLOR & FRANCIS INC	PHILADELPHIA	325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA	1380-3395			J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.		2011	33	6					639	646		10.1080/13803395.2010.547844			8	Psychology, Clinical; Clinical Neurology; Psychology	Psychology; Neurosciences & Neurology	882GA	WOS:000299550100004	21347945	Green Accepted			2021-06-18	
J	Ownsworth, T; Fleming, J; Haines, T; Cornwell, P; Kendall, M; Nalder, E; Gordon, C				Ownsworth, Tamara; Fleming, Jennifer; Haines, Terry; Cornwell, Petrea; Kendall, Melissa; Nalder, Emily; Gordon, Cassandra			Development of Depressive Symptoms During Early Community Reintegration After Traumatic Brain Injury	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						Traumatic brain injury; Depressive symptoms; Community reintegration; Perceived functioning; Transition events	PSYCHOSOCIAL ADJUSTMENT; EMOTIONAL STATUS; REHABILITATION; IMPAIRMENT; PREDICTORS; STRESS; MODEL	The early onset of depression following traumatic brain injury (TBI) is associated with poorer psychosocial outcomes; however, the direction of this relationship is unclear. This study investigated the relationship between progress in resuming preinjury lifestyle (transition events), change in perceived functioning and level of depressive symptoms at discharge and 3-months postdischarge. As part of a prospective longitudinal study of brain injury outcomes, 96 consecutively discharged patients with TBI completed measures of transition events (Sentinel Events Questionnaire) and perceived functioning (Mayo-Portland Adaptability Inventory-4 Ability and Adjustment indices) at discharge and 3-months follow-up. Level of depressive symptoms was assessed at discharge and 3-months follow-up using the Depression Anxiety Stress Scale 21. After controlling for age and discharge depressive symptoms, change in perceived functioning was found to mediate the relationship between total transition events and depressive symptoms at 3-months postdischarge (beta reduced from .21 to .14), with a significant indirect effect observed. The present findings indicate that lack of progress in resuming preinjury lifestyle contributes to postdischarge depressive symptoms through an influence on perceived functioning, thus providing an improved conceptualization of reactive depression in the context of brain injury. (JINS, 2011, 17, 112-119)	[Ownsworth, Tamara; Cornwell, Petrea; Gordon, Cassandra] Griffith Univ, Sch Psychol, Mt Gravatt, Qld 4122, Australia; [Ownsworth, Tamara; Cornwell, Petrea; Gordon, Cassandra] Griffith Univ, Griffith Inst Hlth & Med Res, Mt Gravatt, Qld 4122, Australia; [Fleming, Jennifer; Nalder, Emily] Univ Queensland, Sch Hlth & Rehabil Sci, St Lucia, Qld, Australia; [Haines, Terry] Monash Univ, Sch Physiotherapy, Clayton, Vic 3800, Australia; [Haines, Terry] Southern Hlth, Allied Hlth Clin Res Unit, Clayton, Vic 3168, Australia	Ownsworth, T (corresponding author), Griffith Univ, Sch Psychol, Mt Gravatt, Qld 4122, Australia.	t.own-sworth@griffith.edu.au	Fleming, Jennifer M/B-4436-2011; Haines, Terrence/E-9372-2015; Cornwell, Petrea/AAE-5547-2019	Haines, Terrence/0000-0003-3150-6154; Ownsworth, Tamara/0000-0003-1835-7094			BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Bombardier CH, 2009, J HEAD TRAUMA REHAB, V24, P230, DOI 10.1097/HTR.0b013e3181ad65f0; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Felmingham KL, 2001, ARCH PHYS MED REHAB, V82, P435, DOI 10.1053/apmr.2001.21985; GODFREY HPD, 1993, J CLIN EXP NEUROPSYC, V15, P503, DOI 10.1080/01688639308402574; GomezHernandez R, 1997, ARCH PHYS MED REHAB, V78, P1321, DOI 10.1016/S0003-9993(97)90304-X; Gracey F, 2009, NEUROPSYCHOL REHABIL, V19, P867, DOI 10.1080/09602010903027763; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; Kendall E, 2008, SOC SCI MED, V67, P1217, DOI 10.1016/j.socscimed.2008.05.033; Kolb B., 2003, FUNDAMENTALS HUMAN N; Kreutzer JS, 2001, BRAIN INJURY, V15, P563, DOI 10.1080/02699050010009108; Lovibond S.H., 1995, MANUAL DEPRESSION AN; MACKINNON DP, 1995, MULTIVAR BEHAV RES, V30, pR2; Malec JF, 2007, J HEAD TRAUMA REHAB, V22, P156, DOI 10.1097/01.HTR.0000271116.12028.af; Malec JF., 2005, The Mayo-Portland Adaptability Inventory; NALDER E, 2010, 8 WORLD C BRAIN INJ; Ownsworth T, 2005, J HEAD TRAUMA REHAB, V20, P315, DOI 10.1097/00001199-200507000-00004; Ownsworth T, 2008, BRAIN INJURY, V22, P858, DOI 10.1080/02699050802446697; Ownsworth TL, 1998, BRAIN INJURY, V12, P735, DOI 10.1080/026990598122133; OWNSWORTH TL, 2009, J INT NEUROPSYCH SOC, V15, P102; Riley GA, 2004, BRAIN INJURY, V18, P871, DOI 10.1080/02699050410001671829; Robertson IH, 1999, PSYCHOL BULL, V125, P544, DOI 10.1037/0033-2909.125.5.544; RUFF RM, 1993, BRAIN INJURY, V7, P101, DOI 10.3109/02699059309008164; Rutterford NA, 2006, J INT NEUROPSYCH SOC, V12, P359, DOI 10.1017/S1355617706060450; Seel RT, 2003, ARCH PHYS MED REHAB, V84, P177, DOI 10.1053/apmr.2003.50106; Tate RL, 1999, PSYCHOL MED, V29, P713, DOI 10.1017/S0033291799008466; Turner B, 2009, AM J OCCUP THER, V63, P609, DOI 10.5014/ajot.63.5.609; Williams WH, 2003, NEUROPSYCHOL REHABIL, V13, P1, DOI [10.1080/09602010244000444, 10.1016/S0960-9822(02)01374-X]	28	17	17	0	9	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177			J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	JAN	2011	17	1					112	119		10.1017/S1355617710001311			8	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Neurosciences & Neurology; Psychiatry; Psychology	702KX	WOS:000285894700013	21083964	Green Published			2021-06-18	
J	Schramm, P; Klein, KU; Pape, M; Berres, M; Werner, C; Kochs, E; Engelhard, K				Schramm, Patrick; Klein, Klaus Ulrich; Pape, Monika; Berres, Manfred; Werner, Christian; Kochs, Eberhard; Engelhard, Kristin			Serial Measurement of Static and Dynamic Cerebrovascular Autoregulation After Brain Injury	JOURNAL OF NEUROSURGICAL ANESTHESIOLOGY			English	Article						traumatic brain injury; intracranial hemorrhage; dynamic cerebrovascular autoregulation; static cerebrovascular autoregulation; transcranial Doppler sonography	CEREBRAL PERFUSION-PRESSURE; HEAD-INJURY; INTRACEREBRAL HEMORRHAGE; BLOOD-FLOW; MANAGEMENT; METABOLISM; PROPOFOL; THERAPY; HUMANS	Background: In patients with neuronal injury, the knowledge of the status of cerebrovascular autoregulation can help to optimize the management of the cerebral perfusion pressure. This study characterizes dynamic and static cerebrovascular autoregulation during the first 7 days after severe traumatic brain injury or intracranial hemorrhage. Methods: After approval from the IRB, 16 patients were studied. Cerebral blood flow velocity (CBFV) was measured daily for the assessment of dynamic (10 patients) and static (16 patients) cerebrovascular autoregulation in both the middle cerebral arteries using the transcranial Doppler sonography. Dynamic cerebrovascular autoregulation (dAR) was measured using the cuff-deflation method and was expressed by the index of the dAR. The index of the static cerebrovascular autoregulation (sAR) was calculated from changes in the CBFV in relation to drug-induced alterations of the arterial blood pressure. For statistical analyses, t test and mixed effect model were used. Results: Both dAR and sAR after brain injury were impaired in most of the patients. The chronologic sequence of the dAR at the ipsilateral injured hemisphere showed a significant decrease until day 4 followed by an incomplete recovery (P < 0.002). Changes in sAR were similar, however, they did not gain statistical significance. CBFV was lower at day 1-2 after injury in comparison with day 4 to 7 (P < 0.02). Conclusion: Daily measured dAR and sAR were impaired after brain injury with a nadir on day 4 and consecutive incomplete recovery over time.	[Schramm, Patrick; Klein, Klaus Ulrich; Pape, Monika; Werner, Christian; Engelhard, Kristin] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Anesthesiol, D-55131 Mainz, Germany; [Berres, Manfred] Johannes Gutenberg Univ Mainz, Univ Med Ctr, IMBEI, D-55131 Mainz, Germany; [Berres, Manfred] RheinAhrCampus Remagen, Remagen, Germany; [Kochs, Eberhard] Tech Univ Munich, Klinikum Rechts Isar, Dept Anesthesiol, D-8000 Munich, Germany	Schramm, P (corresponding author), Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Anesthesiol, Langenbeckstr 1, D-55131 Mainz, Germany.	schrammp@uni-mainz.de	Schramm, Patrick/AAM-1482-2020	Klein, Klaus Ulrich/0000-0001-7446-0542			Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS59, DOI 10.1089/neu.2007.9990; Broderick J, 2007, CIRCULATION, V116, pE391, DOI 10.1161/CIRCULATIONAHA.107.183689; Bullock R, 1996, Eur J Emerg Med, V3, P109, DOI 10.1097/00063110-199606000-00010; Czosnyka M, 2001, J NEUROSURG, V95, P756, DOI 10.3171/jns.2001.95.5.0756; Engelhard K, 2001, CAN J ANAESTH, V48, P1034, DOI 10.1007/BF03016597; Engelhard K, 2001, ACTA ANAESTH SCAND, V45, P971, DOI 10.1034/j.1399-6576.2001.450809.x; Grande PO, 2002, ACTA ANAESTH SCAND, V46, P929, DOI 10.1034/j.1399-6576.2002.460802.x; Hlatky R, 2002, J NEUROSURG, V97, P1054, DOI 10.3171/jns.2002.97.5.1054; Lagerkranser M, 1997, J NEUROSURG ANESTH, V9, P188, DOI 10.1097/00008506-199704000-00015; Lang EW, 2003, J NEUROTRAUM, V20, P69, DOI 10.1089/08977150360517191; Mahony PJ, 2000, STROKE, V31, P476, DOI 10.1161/01.STR.31.2.476; Mascia L, 2000, INTENS CARE MED, V26, P202, DOI 10.1007/s001340050046; Moppett IK, 2008, BRIT J ANAESTH, V100, P240, DOI 10.1093/bja/aem374; Naredi S, 2001, ACTA ANAESTH SCAND, V45, P402, DOI 10.1034/j.1399-6576.2001.045004402.x; Peterson E, 2009, J TRAUMA, V67, P944, DOI 10.1097/TA.0b013e3181ae6e6d; Reinhard M, 2010, INTENS CARE MED, V36, P264, DOI 10.1007/s00134-009-1698-7; ROSNER MJ, 1995, J NEUROSURG, V83, P949, DOI 10.3171/jns.1995.83.6.0949; Steiner LA, 2003, ANESTH ANALG, V97, P572, DOI 10.1213/01.ANE.0000070234.17226.B0; Steiner LA, 2002, CRIT CARE MED, V30, P733, DOI 10.1097/00003246-200204000-00002; Sviri GE, 2009, J NEUROSURG, V111, P695, DOI 10.3171/2008.10.17686; TIECKS FP, 1995, STROKE, V26, P1014, DOI 10.1161/01.STR.26.6.1014	21	17	18	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0898-4921			J NEUROSURG ANESTH	J. Neurosurg. Anesthesiol.	JAN	2011	23	1					41	44		10.1097/ANA.0b013e3181f35854			4	Anesthesiology; Clinical Neurology; Surgery	Anesthesiology; Neurosciences & Neurology; Surgery	692FC	WOS:000285137200008	21252706				2021-06-18	
J	Wortzel, HS; Kraus, MF; Filley, CM; Anderson, CA; Arciniegas, DB				Wortzel, Hal S.; Kraus, Marilyn F.; Filley, Christopher M.; Anderson, C. Alan; Arciniegas, David B.			Diffusion Tensor Imaging in Mild Traumatic Brain Injury Litigation	JOURNAL OF THE AMERICAN ACADEMY OF PSYCHIATRY AND THE LAW			English	Article							WHITE-MATTER INTEGRITY; INDUCED AXONAL INJURY; CORPUS-CALLOSUM; YOUNG-ADULTS; ABNORMALITIES; MODERATE; DYSFUNCTION; PREDICTORS; MEMORY; COMA	A growing body of literature addresses the application of diffusion tensor imaging (DTI) to traumatic brain injury (TBI). Most TBIs are of mild severity, and their diagnosis and prognosis are often challenging. These challenges may be exacerbated in medicolegal contexts, where plaintiffs seek to present objective evidence that supports a clinical diagnosis of mild (m)TBI. Because DTI permits quantification of white matter integrity and because TBI frequently involves white matter injury, DTI represents a conceptually appealing method of demonstrating white matter pathology attributable to mTBI. However, alterations in white matter integrity are not specific to TBI, and their presence does not necessarily confirm a diagnosis of mTBI. Guided by rules of evidence shaped by Daubert v. Merrell Dow Pharmaceuticals, Inc., we reviewed and analyzed the literature describing DTI findings in mTBI and related neuropsychiatric disorders. Based on this review, we suggest that expert testimony regarding DTI findings will seldom be appropriate in legal proceedings focused on mTBI.	[Wortzel, Hal S.] Univ Colorado, Sch Med, Denver VA Med Ctr, VISN 19,MIRECC, Denver, CO USA; [Wortzel, Hal S.] Univ Colorado, Sch Med, Dept Psychiat, Denver, CO USA; [Kraus, Marilyn F.] Walter Reed Natl Mil Med Ctr, Neurobehav Traumat Brain Injury Consult Serv, Bethesda, MD USA; [Filley, Christopher M.] Univ Colorado, Sch Med, Dept Neurol, Behav Neurol Sect, Denver, CO USA; [Anderson, C. Alan] Univ Colorado, Sch Med, Neurobehavioral Disorders Program, Dept Psychiat, Denver, CO USA; [Anderson, C. Alan] Denver VA Med Ctr, Neurol Serv, Denver, CO USA	Wortzel, HS (corresponding author), VISN 19 MIRECC, 1055 Clermont St, Denver, CO 80220 USA.	wortzel@ucdenver.edu					Adinoff B, 2010, AM J PSYCHIAT, V167, P598, DOI 10.1176/appi.ajp.2010.10020157; Amen D, 2010, AM J PSYCHIAT, V167, P1125, DOI 10.1176/appi.ajp.2010.10060814; [Anonymous], 2010, TRAUM BRAIN INJ SCI; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Ashtari M, 2008, J PSYCHIATR RES, V43, P189, DOI 10.1016/j.jpsychires.2008.12.002; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Benson RR, 2007, J NEUROTRAUM, V24, P446, DOI 10.1089/neu.2006.0153; Bigler ED, 2010, NEUROLOGY, V74, P626, DOI 10.1212/WNL.0b013e3181d3e43a; BLUMBERGS PC, 1989, J NEUROL NEUROSUR PS, V52, P838, DOI 10.1136/jnnp.52.7.838; BORCZUK P, 1995, ANN EMERG MED, V25, P731, DOI 10.1016/S0196-0644(95)70199-0; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; Choi J, 2009, BIOL PSYCHIAT, V65, P227, DOI 10.1016/j.biopsych.2008.06.022; Chu Z, 2010, AM J NEURORADIOL, V31, P340, DOI 10.3174/ajnr.A1806; Geary EK, 2010, J INT NEUROPSYCH SOC, V16, P506, DOI 10.1017/S135561771000010X; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Hashimoto K, 2007, J REHABIL MED, V39, P418, DOI 10.2340/16501977-0065; Hoge CW, 2009, NEW ENGL J MED, V360, P1588, DOI 10.1056/NEJMp0810606; Huang MX, 2009, J NEUROTRAUM, V26, P1213, DOI 10.1089/neu.2008.0672; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Kay T., 1993, J HEAD TRAUMA REHABI, V8, P86, DOI [10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Kumar R, 2009, BRAIN INJURY, V23, P675, DOI 10.1080/02699050903014915; Levin HS, 2010, J NEUROTRAUM, V27, P683, DOI 10.1089/neu.2009.1073; Lim KO, 2002, BIOL PSYCHIAT, V51, P890, DOI 10.1016/S0006-3223(01)01355-5; Lipton ML, 2009, RADIOLOGY, V252, P816, DOI 10.1148/radiol.2523081584; Lipton ML, 2008, J NEUROTRAUM, V25, P1335, DOI 10.1089/neu.2008.0547; Little DM, 2010, NEUROLOGY, V74, P558, DOI 10.1212/WNL.0b013e3181cff5d5; Lo C, 2009, J COMPUT ASSIST TOMO, V33, P293, DOI 10.1097/RCT.0b013e31817579d1; Macey PM, 2008, SLEEP, V31, P967; MAYBERG HS, 1996, SEMIN CLIN NEUROPSYC, V1, P195; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; McCrea M, 2008, MILD TRAUMATIC BRAIN; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; Miles L, 2008, BRAIN INJURY, V22, P115, DOI 10.1080/02699050801888816; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Niogi SN, 2008, BRAIN, V131, P3209, DOI 10.1093/brain/awn247; Paul Robert, 2008, Neuropsychiatr Dis Treat, V4, P193; Paul RH, 2008, NICOTINE TOB RES, V10, P137, DOI 10.1080/14622200701767829; POVLISHOCK JT, 1995, J NEUROTRAUM, V12, P555, DOI 10.1089/neu.1995.12.555; POVLISHOCK JT, 1992, BRAIN PATHOL, V2, P1; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Reeves D, 2003, J AM ACAD PSYCHIATRY, V31, P89; Rutgers DR, 2008, AM J NEURORADIOL, V29, P1730, DOI 10.3174/ajnr.A1213; Rutgers DR, 2008, AM J NEURORADIOL, V29, P514, DOI 10.3174/ajnr.A0856; Schmahmann JD, 2008, ANN NY ACAD SCI, V1142, P266, DOI 10.1196/annals.1444.017; Society of Nuclear Medicine (SNM), 1999, SOC NUCL MED PROC GU, P113; STEIN SC, 1993, ANN EMERG MED, V22, P1193, DOI 10.1016/S0196-0644(05)80989-8; Taber KH, 2002, J NEUROPSYCH CLIN N, V14, P1, DOI 10.1176/appi.neuropsych.14.1.1; TEASDALE G, 1974, LANCET, V2, P81; White Tonya, 2008, Top Magn Reson Imaging, V19, P97, DOI 10.1097/RMR.0b013e3181809f1e; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54; Wilson J, 1996, J NUCL MED, V37, P1256; Wortzel HS, 2008, J AM ACAD PSYCHIATRY, V36, P310; Wozniak JR, 2007, ARCH CLIN NEUROPSYCH, V22, P555, DOI 10.1016/j.acn.2007.03.004; Wu TC, 2010, J NEUROTRAUM, V27, P303, DOI 10.1089/neu.2009.1110; Yeh PH, 2009, PSYCHIAT RES-NEUROIM, V173, P22, DOI 10.1016/j.pscychresns.2008.07.012; Yudofsky SC, 2008, NEUROPSYCHIATRY BEHA, P245	57	17	18	0	6	AMER ACAD PSYCHIATRY & LAW	BLOOMFIELD	ONE REGENCY DR, PO BOX 30, BLOOMFIELD, CT 06002 USA	1093-6793	1943-3662		J AM ACAD PSYCHIATRY	J. Am. Acad. Psychiatry Law		2011	39	4					511	523					13	Law; Psychiatry	Government & Law; Psychiatry	881DV	WOS:000299461600008	22159979				2021-06-18	
J	Zakzanis, KK; McDonald, K; Troyer, AK				Zakzanis, Konstantine K.; McDonald, Krysta; Troyer, Angela K.			Component analysis of verbal fluency in patients with mild traumatic brain injury	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						Traumatic brain injury; Verbal fluency; Component analysis scores	HEAD-INJURY; POSTCONCUSSIVE SYMPTOMS; LONGITUDINAL ANALYSIS; WORKING-MEMORY; BASE RATES; MODERATE; PERFORMANCE; DYSFUNCTION; FATIGUE; MRI	We set out to examine the sensitivity of switching and clustering component scores of verbal fluency in patients with mild traumatic brain injury (mTBI). Clustering and switching scores were compared between patients with mTBI and healthy normal controls as well as those with moderate TBI and severe TBI. Fifty-four healthy controls along with 20 mild TBI, 8 moderate TBI, and 12 severe TBI patients were included in the study. Our findings demonstrate that component score effect sizes were larger than those of total words generated for both phonemic and semantic fluency. This pattern of finding held true regardless of comparison group. In addition, semantic fluency component scores were found to correspond to larger component score effect sizes than did phonemic fluency component scores. Our findings demonstrate that component scores derived from the Controlled Oral Word Association Test may be sufficient to reliably capture the effects of unremitting injury (i.e., more than 3 months post status) to the frontal and temporal brain as evinced in cases of unremitting mTBI. This differential pattern of performance provides preliminary evidence for the potential usefulness of switching and clustering in the assessment of mTBI. Given the small sample sizes employed in our study, however, future studies are needed to determine whether component measures of verbal fluency have discriminative ability.	[Zakzanis, Konstantine K.; McDonald, Krysta] Univ Toronto Scarborough, Dept Psychol, Toronto, ON M1C 1A4, Canada; [Troyer, Angela K.] Baycrest Ctr Geriatr Care, Dept Psychol, Toronto, ON, Canada	Zakzanis, KK (corresponding author), Univ Toronto Scarborough, Dept Psychol, 1265 Mil Trail, Toronto, ON M1C 1A4, Canada.	zakzanis@utsc.utoronto.ca		Troyer, Angela K./0000-0001-5660-4127			ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Alves W., 1998, J HEAD TRAUMA REHAB, V8, P48, DOI DOI 10.1097/00001199-199309000-00007; Anderson CV, 1995, J CLIN EXP NEUROPSYC, V17, P900, DOI 10.1080/01688639508402438; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Bigler ED, 2004, J INT NEUROPSYCH SOC, V10, P794, DOI 10.1017/S1355617704105146; Bigler ED, 2003, ARCH CLIN NEUROPSYCH, V18, P595; Bigler ED, 2001, ARCH CLIN NEUROPSYCH, V16, P95; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; Bryant RA, 2008, NEW ENGL J MED, V358, P525, DOI 10.1056/NEJMe078235; Chan RCK, 2005, CLIN REHABIL, V19, P188, DOI 10.1191/0269215505cr838oa; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd; Drake AI, 2000, J HEAD TRAUMA REHAB, V15, P1103, DOI 10.1097/00001199-200010000-00004; Garden N, 2010, APPL NEUROPSYCHOL, V17, P1, DOI 10.1080/09084280903297495; Gasquoine PG, 1997, NEUROPSYCHOL REV, V7, P77, DOI 10.1023/B:NERV.0000005945.58251.c0; Goldstein FC, 2001, J INT NEUROPSYCH SOC, V7, P373, DOI 10.1017/S1355617701733115; GOUVIER WD, 1992, ARCH CLIN NEUROPSYCH, V7, P193, DOI 10.1016/0887-6177(92)90162-G; Green P, 2001, BRAIN INJURY, V15, P1045, DOI 10.1080/02699050110088254; Hartikainen KM, 2010, J CLIN EXP NEUROPSYC, V32, P767, DOI 10.1080/13803390903521000; Henry JD, 2004, NEUROPSYCHOLOGY, V18, P621, DOI 10.1037/0894-4105.18.4.621; Henry JD, 2004, NEUROPSYCHOLOGY, V18, P284, DOI 10.1037/0894-4105.18.2.284; Ho AK, 2002, NEUROPSYCHOLOGIA, V40, P1277, DOI 10.1016/S0028-3932(01)00217-2; Iverson GL, 1997, BRAIN INJURY, V11, P783, DOI 10.1080/026990597122990; Johansson B, 2009, BRAIN INJURY, V23, P1027, DOI 10.3109/02699050903421099; Jurado MA, 2000, BRAIN INJURY, V14, P789; Kashluba S, 2008, ARCH PHYS MED REHAB, V89, P904, DOI 10.1016/j.apmr.2007.12.029; Landre N, 2006, ARCH CLIN NEUROPSYCH, V21, P255, DOI 10.1016/j.acn.2005.12.007; Lange R. T., 2010, J CLIN EXPT NEUROPSY, V30, P1; Lanting S, 2009, J INT NEUROPSYCH SOC, V15, P196, DOI 10.1017/S1355617709090237; Levin HS, 2004, NEUROPSYCHOLOGY, V18, P240, DOI 10.1037/0894-4105.18.2.240; LEVIN HS, 1992, J NEUROL NEUROSUR PS, V55, P255, DOI 10.1136/jnnp.55.4.255; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; Lezak M.D., 2004, NEUROPSYCHOLOGICAL A, Vfourth; Mathias JL, 1999, J CLIN EXP NEUROPSYC, V21, P200, DOI 10.1076/jcen.21.2.200.930; Mathias JL, 2004, APPL NEUROPSYCHOL, V11, P134, DOI 10.1207/s15324826an1103_2; McAllister TW, 2006, J NEUROTRAUM, V23, P1450, DOI 10.1089/neu.2006.23.1450; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379; Mittenberg W, 2000, J HEAD TRAUMA REHAB, V15, P783, DOI 10.1097/00001199-200004000-00003; Moore DJ, 2006, SCHIZOPHR RES, V87, P254, DOI 10.1016/j.schres.2006.06.005; Nolin P, 2006, J HEAD TRAUMA REHAB, V21, P68, DOI 10.1097/00001199-200601000-00007; Ord JS, 2010, J CLIN EXP NEUROPSYC, V32, P132, DOI 10.1080/13803390902858874; Raskin SA, 1996, NEUROPSYCHOLOGY, V10, P416, DOI 10.1037/0894-4105.10.3.416; Rey A, 1941, ARCH PSYCHOLOGIE, V28, P286; Rich JB, 1999, NEUROPSYCHOLOGY, V13, P525, DOI 10.1037/0894-4105.13.4.525; Robert PH, 1998, J INT NEUROPSYCH SOC, V4, P539, DOI 10.1017/S1355617798466025; Ruff R, 2009, J HEAD TRAUMA REHAB, V24, P131, DOI 10.1097/01.HTR.0000348755.42649.e9; Sawchyn JM, 2000, ARCH CLIN NEUROPSYCH, V15, P1, DOI 10.1016/S0887-6177(98)00041-9; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Slick D., 1997, VICTORIA SYMPTOM VAL; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Suhr JA, 2002, J CLIN EXP NEUROPSYC, V24, P981, DOI 10.1076/jcen.24.8.981.8372; Tombaugh TN, 1996, TEST MEMORY MALINGER; Trahan DE, 2001, ARCH CLIN NEUROPSYCH, V16, P435, DOI 10.1016/S0887-6177(00)00051-2; Troyer AK, 1998, J INT NEUROPSYCH SOC, V4, P137, DOI 10.1017/S1355617798001374; Troyer AK, 1997, NEUROPSYCHOLOGY, V11, P138, DOI 10.1037/0894-4105.11.1.138; Troyer AK, 1998, NEUROPSYCHOLOGIA, V36, P499, DOI 10.1016/S0028-3932(97)00152-8; Troyer AK, 2000, J CLIN EXP NEUROPSYC, V22, P370, DOI 10.1076/1380-3395(200006)22:3;1-V;FT370; Vanderploeg RD, 2005, J INT NEUROPSYCH SOC, V11, P228, DOI 10.1017/S1355617705050289; Wrightson P, 1999, MILD HEAD INJURY GUI; Zakzanis K. K., 1999, STUD NEUROPSYCHOL DE; Zakzanis KK, 1998, J CLIN EXP NEUROPSYC, V20, P419, DOI 10.1076/jcen.20.3.419.821; Zakzanis KK, 2000, NEUROPSY NEUROPSY BE, V13, P239; Zakzanis KK, 2001, ARCH CLIN NEUROPSYCH, V16, P653, DOI 10.1016/S0887-6177(00)00076-7; Ziino C, 2006, J INT NEUROPSYCH SOC, V12, P100, DOI 10.1017/S1355617706060139	64	17	18	0	16	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.		2011	33	7					785	792		10.1080/13803395.2011.558496			8	Psychology, Clinical; Clinical Neurology; Psychology	Psychology; Neurosciences & Neurology	882HE	WOS:000299553600006	21480023				2021-06-18	
J	Kraus, MF; Little, DM; Wojtowicz, SM; Sweeney, JA				Kraus, Marilyn F.; Little, Deborah M.; Wojtowicz, Sydney M.; Sweeney, John A.			Procedural Learning Impairments Identified via Predictive Saccades in Chronic Traumatic Brain Injury	COGNITIVE AND BEHAVIORAL NEUROLOGY			English	Article						traumatic brain injury; oculomotor function; predictive saccades; reflexive guided saccades	EXECUTIVE FUNCTION; WORKING-MEMORY; AXONAL INJURY; HEAD-INJURY; SCHIZOPHRENIA; MILD; NEUROANATOMY; REFLEXIVE; DEFICITS; TASK	Objective: To characterize integrity of fronto-striatal circuitry in chronic traumatic brain injury (TBI). Background: Due to both direct and indirect effects, TBI is hypothesized to affect frontal and striatal function. On the basis of elegant animal, lesion, and neuroimaging literatures, oculomotor testing can provide a useful tool for in vivo assessments of neurophysiologic function. The predictive saccade paradigm in oculomotor function is well established to provide assessment of this fronto-striatal circuit. Methods: Sixty patients with a history of chronic TBI completed 2 specific tests of oculomotor function, including a test of reflexive visually guided saccades to assess basic oculomotor function and a predictive saccade test to assess procedural learning. Results: TBI (mild and moderate/severe) was associated with a decrease in rates of procedural learning, with degree of impairment increasing with injury severity. This was observed as a decrease in the proportion of anticipatory saccades (primary measure of learning). Conclusions: This abnormal oculomotor performance supports the hypothesis that TBI results in chronic impairment of frontal-striatal functions proportionally to injury severity and demonstrate that oculomotor testing is sensitive to all severities of closed-head injury.	[Kraus, Marilyn F.; Sweeney, John A.] Univ Illinois, Ctr Cognit Med, Coll Med, Chicago, IL 60612 USA; [Kraus, Marilyn F.; Sweeney, John A.] Univ Illinois, Dept Psychiat, Coll Med, Chicago, IL 60612 USA; [Kraus, Marilyn F.; Sweeney, John A.] Univ Illinois, Dept Neurol, Coll Med, Chicago, IL 60612 USA; [Little, Deborah M.] Univ Illinois, Ctr Stroke Res, Chicago, IL 60612 USA; [Wojtowicz, Sydney M.] Univ Illinois, Dept Ophthalmol, Chicago, IL 60612 USA; [Wojtowicz, Sydney M.] Univ Illinois, Dept Psychol, Chicago, IL 60612 USA	Kraus, MF (corresponding author), Univ Illinois, Ctr Cognit Med, Coll Med, 912 S Wood St MC 913, Chicago, IL 60612 USA.	mkraus@psych.uic.edu			National Institute of Mental HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [K23 MH068787]; Marshall Goldberg Traumatic Brain Injury Research Fund; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [K23MH068787] Funding Source: NIH RePORTER	Supported by NIH grant K23 MH068787 from the National Institute of Mental Health, and The Marshall Goldberg Traumatic Brain Injury Research Fund.	ADAMS JH, 1980, J CLIN PATHOL, V33, P1132, DOI 10.1136/jcp.33.12.1132; Basso MR, 2003, J CLIN EXP NEUROPSYC, V25, P893, DOI 10.1076/jcen.25.7.893.16489; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Bearden CE, 2004, AM J PSYCHIAT, V161, P1700, DOI 10.1176/appi.ajp.161.9.1700; Benedict R., 1997, BRIEF VISUOSPATIAL M; Benton A, 1989, MULTILINGUAL APHASIA; Bozikas VP, 2004, COMPR PSYCHIAT, V45, P392, DOI 10.1016/j.comppsych.2004.03.006; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Chey J, 2002, PSYCHIAT RES, V110, P259, DOI 10.1016/S0165-1781(02)00105-1; CONNERS DK, 2000, CONNERS CONTINUOUS P; Crevits L, 2005, NEUROPSYCHOBIOLOGY, V51, P39, DOI 10.1159/000082854; Culbertson W. C., 2001, TOWER LONDON DREXEL; Delis DC, 2000, CALIFORNIA VERBAL LE; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Golden CJ, 2002, STROOP COLOR WORD TE; GRAHAM DI, 2002, GREENFIELDS NEUROPAT, V2; GRONWALL DMA, 1977, PERCEPT MOTOR SKILL, V44, P367, DOI 10.2466/pms.1977.44.2.367; Hubert V, 2007, HUM BRAIN MAPP, V28, P1415, DOI 10.1002/hbm.20354; Jefferson AL, 2006, ARCH CLIN NEUROPSYCH, V21, P311, DOI 10.1016/j.acn.2006.03.007; Kay T., 1993, J HEAD TRAUMA REHABI, V8, P86, DOI [10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kraus MF, 2007, COGN BEHAV NEUROL, V20, P170, DOI 10.1097/WNN.0b013e318142badb; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; LEVIN HS, 1992, J NEUROL NEUROSUR PS, V55, P255, DOI 10.1136/jnnp.55.4.255; Little DM, 2000, PSYCHOL AGING, V15, P9, DOI 10.1037//0882-7974.15.1.9; Matthews C, 1964, INSTRUCTION MANUAL A; McDowell JE, 2008, BRAIN COGNITION, V68, P255, DOI 10.1016/j.bandc.2008.08.016; Miranda MC, 2008, J ATTEN DISORD, V11, P588, DOI 10.1177/1087054707299412; Newman SD, 2003, NEUROPSYCHOLOGIA, V41, P1668, DOI 10.1016/S0028-3932(03)00091-5; POVLISHOCK JT, 1992, BRAIN PATHOL, V2, P1; REITAN RM, 1995, CLIN NEUROPSYCHOL, V9, P50, DOI 10.1080/13854049508402057; Ruff R. M., 1988, RUFF FIGURAL FLUENCY; Simo LS, 2005, CEREB CORTEX, V15, P1982, DOI 10.1093/cercor/bhi073; Snitz BE, 2006, SCHIZOPHRENIA BULL, V32, P179, DOI 10.1093/schbul/sbi048; Suh M, 2006, NEUROSCI LETT, V401, P108, DOI 10.1016/j.neulet.2006.02.074; Taber KH, 2006, J NEUROPSYCH CLIN N, V18, P141, DOI 10.1176/appi.neuropsych.18.2.141; Tombaugh TN, 1996, TEST MEMORY MALINGER; Van der Elst W, 2006, ASSESSMENT, V13, P62, DOI 10.1177/1073191105283427; Wechsler D., 2001, WECHSLER TEST ADULT; Wechsler D., 1997, WMS 3 WECHSLER MEMOR	39	17	18	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1543-3633	1543-3641		COGN BEHAV NEUROL	Cogn. Behav. Neurol.	DEC	2010	23	4					210	217		10.1097/WNN.0b013e3181cefe2e			8	Behavioral Sciences; Clinical Neurology	Behavioral Sciences; Neurosciences & Neurology	692OC	WOS:000285161100001	21150346	Green Accepted			2021-06-18	
J	Lo, TYM; Jones, PA; Minns, RA				Lo, Tsz-Yan M.; Jones, Patricia A.; Minns, Robert A.			Combining Coma Score and Serum Biomarker Levels To Predict Unfavorable Outcome following Childhood Brain Trauma	JOURNAL OF NEUROTRAUMA			English	Article						biomarkers; Glasgow Coma Scale (GCS); outcome prediction; pediatrics; traumatic brain injury	NEURON-SPECIFIC ENOLASE; SEVERE HEAD-INJURY; CEREBROSPINAL-FLUID; PROGNOSTIC-FACTORS; YOUNG-CHILDREN; MOTOR SCORE; SCALE SCORE; DAMAGE; PROTEIN; INTERLEUKIN-6	This study aims to determine if pairing the Glasgow Coma Scale (GCS) with serum biomarker levels may achieve higher outcome predictive values than using either the GCS or biomarker levels alone in childhood brain trauma. Twenty-eight critically ill children with isolated accidental brain trauma were studied in a prospective observational study. The GCS was recorded at various time points post injury. Enzyme-linked immunosorbent assay (ELISA) was used to quantify eight different serum biomarker levels (S100b, NSE, IL-6, IL-8, IL-10, L-selectin, SICAM, and endothelin) on day 1 post injury. The Glasgow Outcome Score (GOS) was used to assess global outcome at 6 months post injury. Outcome predictive values of the GCS, individual biomarker levels, and paired combinations of the GCS and biomarkers were compared using receiver operator characteristic (ROC) curve analysis and its multivariate extension, multivariate ROC curve (MultiROC). When using either the GCS or individual biomarker levels alone to predict unfavorable outcome, only the PICU discharge summated GCS achieved an area under the ROC curve (AUC) of more than 0.95. This high degree of outcome predictability was also achieved by pairing the GCS with a single biomarker level. The most pronounced improvement in outcome prediction was observed by pairing the post-resuscitation summated GCS with the day-1 serum IL-8 level, which increased the AUC from 0.78 to 0.98 and the sensitivity and specificity from 75% to 100% and 96% respectively. Paired combinations of the GCS and serum biomarker levels greatly enhanced the accuracy of post-traumatic unfavorable outcome prediction than may be achieved using either the GCS or individual biomarker levels alone.	[Lo, Tsz-Yan M.] Royal Hosp Sick Children, Dept Paediat Intens Care Med, Edinburgh EH9 1LF, Midlothian, Scotland; [Minns, Robert A.] Royal Hosp Sick Children, Dept Paediat Neurosci, Edinburgh EH9 1LF, Midlothian, Scotland; [Lo, Tsz-Yan M.; Jones, Patricia A.; Minns, Robert A.] Univ Edinburgh, Edinburgh, Midlothian, Scotland	Lo, TYM (corresponding author), Royal Hosp Sick Children, Dept Paediat Intens Care Med, Sciennes Rd, Edinburgh EH9 1LF, Midlothian, Scotland.	mils.lo@doctors.org.uk					Adelson PD, 1997, PEDIATR NEUROSURG, V26, P200; Bahloul M, 2009, INJURY, V40, P535, DOI 10.1016/j.injury.2008.04.018; Bell MJ, 1997, J NEUROTRAUM, V14, P451, DOI 10.1089/neu.1997.14.451; Berger RP, 2007, J NEUROTRAUM, V24, P1793, DOI 10.1089/neu.2007.0316; Buttram SDW, 2007, J NEUROTRAUM, V24, P1707, DOI 10.1089/neu.2007.0349; Cantais E, 2001, INTENS CARE MED, V27, P1511, DOI 10.1007/s001340101039; Cho DY, 1997, INTENS CARE MED, V23, P77, DOI 10.1007/s001340050294; Ergun R, 1998, NEUROL RES, V20, P418; Fandino J, 2000, J CLIN NEUROSCI, V7, P226, DOI 10.1054/jocn.1999.0202; Gill M, 2005, ANN EMERG MED, V45, P37, DOI 10.1016/j.annemergmed.2004.07.429; Gill MR, 2004, ANN EMERG MED, V43, P215, DOI 10.1016/S0196-0644(03)00814-X; Haukoos JS, 2007, ANN EMERG MED, V50, P18, DOI 10.1016/j.annemergmed.2006.10.004; Healey C, 2003, J TRAUMA, V54, P671, DOI 10.1097/01.TA.0000058130.30490.5D; Jacobs B, 2010, J NEUROTRAUM, V27, P655, DOI 10.1089/neu.2009.1059; Jacobs B, 2010, J NEUROTRAUM, V27, P331, DOI 10.1089/neu.2009.1105; Jagannathan J, 2008, J NEUROSURG-PEDIATR, V2, P240, DOI 10.3171/PED.2008.2.10.240; Joosse P, 2009, J CLIN NEUROSCI, V16, P925, DOI 10.1016/j.jocn.2008.06.014; Liliang PC, 2010, J SURG RES, V160, P302, DOI 10.1016/j.jss.2008.12.022; Lo T, 2009, J NEUROTRAUM, V26, pA46; MCCLAIN C, 1991, J LAB CLIN MED, V118, P225; McKeating EG, 1998, ANESTH ANALG, V86, P759, DOI 10.1097/00000539-199804000-00016; Meric E, 2010, J EMERG MED, V38, P297, DOI 10.1016/j.jemermed.2007.11.032; PERSSON L, 1987, STROKE, V18, P911, DOI 10.1161/01.STR.18.5.911; Pleines UE, 1998, J NEUROTRAUM, V15, P399, DOI 10.1089/neu.1998.15.399; Pollack MM, 1996, CRIT CARE MED, V24, P743, DOI 10.1097/00003246-199605000-00004; Raabe A, 1999, BRIT J NEUROSURG, V13, P56, DOI 10.1080/02688699944195; Raabe A, 1999, NEUROSURGERY, V45, P477, DOI 10.1097/00006123-199909000-00012; REILLY PL, 1988, CHILD NERV SYST, V4, P30; Ross SE, 1998, J TRAUMA, V45, P42, DOI 10.1097/00005373-199807000-00008; SKOGSEID IM, 1992, ACTA NEUROCHIR, V115, P106, DOI 10.1007/BF01406367; Suominen P, 1998, INJURY, V29, P425; Vos PE, 2004, NEUROLOGY, V62, P1303, DOI 10.1212/01.WNL.0000120550.00643.DC; WALKER PJ, 1987, AUST NZ J SURG, V57, P715, DOI 10.1111/j.1445-2197.1987.tb01249.x; Whalen MJ, 1998, J NEUROTRAUM, V15, P777, DOI 10.1089/neu.1998.15.777; White JRM, 2001, CRIT CARE MED, V29, P534, DOI 10.1097/00003246-200103000-00011; Wiesmann M, 2010, ACTA NEUROL SCAND, V121, P178, DOI 10.1111/j.1600-0404.2009.01196.x; Woertgen C, 1997, ACTA NEUROCHIR, V139, P1161, DOI 10.1007/BF01410977; YAMAURA A, 1981, Neurologia Medico-Chirurgica, V21, P685; YAMAZAKI Y, 1995, SURG NEUROL, V43, P267, DOI 10.1016/0090-3019(95)80012-6	39	17	17	0	0	MARY ANN LIEBERT INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	DEC	2010	27	12					2139	2145		10.1089/neu.2010.1387			7	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	691PN	WOS:000285093400003	20858121				2021-06-18	
J	Coomber, B; Gibson, CL				Coomber, Ben; Gibson, Claire L.			Sustained levels of progesterone prior to the onset of cerebral ischemia are not beneficial to female mice	BRAIN RESEARCH			English	Article						Aquaporins; Cerebral edema; Focal cerebral ischemia; Progesterone; Stroke	TRAUMATIC BRAIN-INJURY; ARTERY OCCLUSION; PLASMA PROGESTERONE; FOCAL ISCHEMIA; STROKE INJURY; NITRIC-OXIDE; ESTROGEN; EDEMA; MECHANISMS; EXPRESSION	Female gender, which is abolished following ovariectomy and reproductive senescence, is associated with improved outcome following cerebral stroke. Estrogen replacement partially restores this benefit of the female gender but the effect of progesterone in hormone-deficient animals is currently unknown. We evaluated various outcomes following middle cerebral artery occlusion (MCAO) in ovariectomised female mice, with a physiologically relevant restoration of progesterone levels. Ovariectomised female mice had significantly elevated plasma (P=<0.05) and brain progesterone levels (P=<0.01) following implantation of a 21-day release pellet (50 mg) compared with mice that received placebo implants 7 days prior to undergoing 60 min MCAO. Assessment of well-being (body weight recovery) and neurological score at 24 h and 48 h post-MCAO indicated that MCAO significantly worsened outcome compared with sham-operated mice but progesterone had no effect. MCAO resulted in a substantial lesion formation and a significant increase (P<0.05) in ipsilateral brain water content, both of which were not affected by progesterone treatment. Furthermore, there was no significant alteration in ipsilateral Aquaporin-4 (AQP4) expression following MCAO or progesterone treatment. The present study indicates that sustained physiologically relevant levels of progesterone prior to cerebral ischemia neither benefited nor worsened outcomes in previously ovariectomised female mice. (C) 2010 Elsevier B.V. All rights reserved.	[Coomber, Ben; Gibson, Claire L.] Univ Leicester, Sch Psychol, Leicester LE1 9HN, Leics, England	Gibson, CL (corresponding author), Univ Leicester, Sch Psychol, Henry Wellcome Bldg,Lancaster Rd, Leicester LE1 9HN, Leics, England.	cg95@le.ac.uk		Gibson, Claire/0000-0002-3358-7341	Research Into Ageing [317]	This work was funded by Research Into Ageing (317 to CLG).	Alkayed NJ, 1998, STROKE, V29, P159, DOI 10.1161/01.STR.29.1.159; Alkayed NJ, 2000, STROKE, V31, P161, DOI 10.1161/01.STR.31.1.161; BEDERSON JB, 1986, STROKE, V17, P1304, DOI 10.1161/01.STR.17.6.1304; BEDERSON JB, 1986, STROKE, V17, P472, DOI 10.1161/01.STR.17.3.472; Chen JL, 1999, J NEUROL SCI, V171, P24, DOI 10.1016/S0022-510X(99)00247-6; Danton GH, 2003, J NEUROPATH EXP NEUR, V62, P127, DOI 10.1093/jnen/62.2.127; Dubal DB, 1998, J CEREBR BLOOD F MET, V18, P1253, DOI 10.1097/00004647-199811000-00012; DUVDEVANI R, 1995, J NEUROTRAUM, V12, P65, DOI 10.1089/neu.1995.12.65; FARR SA, 1995, PHYSIOL BEHAV, V58, P715, DOI 10.1016/0031-9384(95)00124-2; Fox J, 2006, MOUSE BIOMEDICAL RES, V3; FRYDENLUND DS, 2006, P NATL ACAD SCI USA, V103, P1353; Frye CA, 1998, BRAIN RES, V808, P72, DOI 10.1016/S0006-8993(98)00764-1; Gebel JM, 2002, STROKE, V33, P2636, DOI 10.1161/01.STR.0000035283.34109.EA; Gibson CL, 2005, EXP NEUROL, V193, P522, DOI 10.1016/j.expneurol.2005.01.009; Gibson CL, 2004, J CEREBR BLOOD F MET, V24, P805, DOI 10.1097/01.WCB.0000125365.83980.00; Gibson CL, 2005, J NEUROPATH EXP NEUR, V64, P763, DOI 10.1097/01.jnen.0000179196.10032.dd; Gibson CL, 2008, BRAIN, V131, P318, DOI 10.1093/brain/awm183; Gibson CL, 2009, NEUROSCIENTIST, V15, P324, DOI 10.1177/1073858409333069; Gonzalez-Vidal MD, 1998, ARCH MED RES, V29, P117; Grossman KJ, 2000, BEHAV BRAIN RES, V116, P141, DOI 10.1016/S0166-4328(00)00275-8; Guo QM, 2006, EXP NEUROL, V198, P469, DOI 10.1016/j.expneurol.2005.12.013; Hayakawa K, 2008, NEUROPHARMACOLOGY, V55, P1280, DOI 10.1016/j.neuropharm.2008.06.040; He J, 2004, EXP NEUROL, V189, P404, DOI 10.1016/j.expneurol.2004.06.008; Hurn PD, 2000, J CEREBR BLOOD F MET, V20, P631, DOI 10.1097/00004647-200004000-00001; HURN PD, 2002, PHARM CEREBRAL ISCHE, P17; Jiang N, 1996, BRAIN RES, V735, P101, DOI 10.1016/0006-8993(96)00605-1; KOMEYEV A, 1993, J NEUROCHEM, V61, P2041; Kumon Y, 2000, J NEUROSURG, V92, P848, DOI 10.3171/jns.2000.92.5.0848; LIU Y, 2008, J CEREB BLOOD FLOW M, V28, P1898; Lo EH, 2003, NAT REV NEUROSCI, V4, P399, DOI 10.1038/nrn1106; Loihl AK, 1999, BRAIN RES, V830, P155, DOI 10.1016/S0006-8993(99)01388-8; Manley GT, 2000, NAT MED, V6, P159, DOI 10.1038/72256; Murphy SJ, 2000, STROKE, V31, P1173, DOI 10.1161/01.STR.31.5.1173; Murphy SJ, 2004, ILAR J, V45, P147, DOI 10.1093/ilar.45.2.147; Murphy SJ, 2002, J CEREBR BLOOD F MET, V22, P1181; MURR SM, 1974, ENDOCRINOLOGY, V94, P1209, DOI 10.1210/endo-94-4-1209; Rash JE, 1998, P NATL ACAD SCI USA, V95, P11981, DOI 10.1073/pnas.95.20.11981; Rogers DC, 1997, STROKE, V28, P2060, DOI 10.1161/01.STR.28.10.2060; ROOF RL, 1992, RESTOR NEUROL NEUROS, V4, P425, DOI 10.3233/RNN-1992-4608; Roof RL, 1997, MOL CHEM NEUROPATHOL, V31, P1, DOI 10.1007/BF02815156; Rusa R, 1999, STROKE, V30, P1665, DOI 10.1161/01.STR.30.8.1665; SAITO TR, 1982, JPN J VET SCI, V44, P125; Simpkins JW, 1997, J NEUROSURG, V87, P724, DOI 10.3171/jns.1997.87.5.0724; SMITH SS, 1994, PROG NEUROBIOL, V44, P55, DOI 10.1016/0301-0082(94)90057-4; Toung TK, 2000, STROKE, V31, P2701, DOI 10.1161/01.STR.31.11.2701; Turtzo LC, 2008, CEREBROVASC DIS, V26, P462, DOI 10.1159/000155983; WASSERTHEILSMOL.S, 2003, WOMENS HLTH, V289, P2673; Wise PM, 2001, BRAIN RES REV, V37, P313, DOI 10.1016/S0165-0173(01)00136-9; Wright DW, 2007, ANN EMERG MED, V49, P391, DOI 10.1016/j.annemergmed.2006.07.932; Xiao GM, 2008, CRIT CARE, V12, DOI 10.1186/cc6887; Yahata T, 1996, CELL IMMUNOL, V171, P269, DOI 10.1006/cimm.1996.9988	51	17	17	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	NOV 18	2010	1361						124	132		10.1016/j.brainres.2010.09.037			9	Neurosciences	Neurosciences & Neurology	679WQ	WOS:000284191900013	20850417				2021-06-18	
J	Arciniegas, DB; Frey, KL; Newman, J; Wortzel, HS				Arciniegas, David B.; Frey, Kimberly L.; Newman, Jody; Wortzel, Hal S.			Evaluation and Management of Posttraumatic Cognitive Impairments	PSYCHIATRIC ANNALS			English	Article							TRAUMATIC BRAIN-INJURY; RANDOMIZED CONTROLLED-TRIAL; FRONTAL ASSESSMENT BATTERY; MINI-MENTAL-STATE; EFNS TASK-FORCE; HEAD-INJURY; RATING-SCALE; SUSTAINED ATTENTION; CONFUSIONAL STATE; PRACTICAL SCALE		[Arciniegas, David B.; Frey, Kimberly L.; Newman, Jody; Wortzel, Hal S.] Univ Colorado, Sch Med, Dept Psychiat, Neurobehav Disorders Program, Aurora, CO 80045 USA; [Arciniegas, David B.] Univ Colorado, Sch Med, Dept Neurol, Behav Neurol Sect, Aurora, CO 80045 USA; [Wortzel, Hal S.] Denver Vet Affairs Med Center, VISN Mental Illness Res Educ & Clin Ctr MIRECC 19, Denver, CO USA	Arciniegas, DB (corresponding author), Univ Colorado, Sch Med, Dept Psychiat, Neurobehav Disorders Program, 13001 E 17th Pl,Campus Box F546, Aurora, CO 80045 USA.	David.Arciniegas@UCDenver.edu			NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01 HD047242-04S1, R01 HD047242-05, R01 HD047242] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD047242] Funding Source: NIH RePORTER		Anderson GD, 2009, EPILEPSY BEHAV, V16, P501, DOI 10.1016/j.yebeh.2009.08.025; Appollonio I, 2005, NEUROL SCI, V26, P108, DOI 10.1007/s10072-005-0443-4; Arciniegas DB, 2008, CRIT CARE CLIN, V24, P737, DOI 10.1016/j.ccc.2008.06.001; Arciniegas David B, 2005, Neuropsychiatr Dis Treat, V1, P311; Arciniegas DB, 2006, BEHAV NEUROL, V17, P25, DOI 10.1155/2006/460592; Arciniegas David B, 2004, Phys Med Rehabil Clin N Am, V15, P177, DOI 10.1016/S1047-9651(03)00104-9; Arciniegas DB, 2010, NEUROPSYCHIATRIC DISORDERS, P125, DOI 10.1007/978-4-431-53871-4_10; Bloomfield ILM, 2010, J INT NEUROPSYCH SOC, V16, P17, DOI 10.1017/S1355617709990798; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS59, DOI 10.1089/neu.2007.9990; Cappa SF, 2005, EUR J NEUROL, V12, P665; Cappa SF, 2003, EUR J NEUROL, V10, P11, DOI 10.1046/j.1468-1331.2003.00537.x; Chang BS, 2003, NEUROLOGY, V60, P10, DOI 10.1212/01.WNL.0000031432.05543.14; Chew E, 2009, J REHABIL RES DEV, V46, P851, DOI 10.1682/JRRD.2008.09.0120; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240; Cicerone KD, 2008, ARCH PHYS MED REHAB, V89, P2239, DOI 10.1016/j.apmr.2008.06.017; CRUM RM, 1993, JAMA-J AM MED ASSOC, V269, P2386, DOI 10.1001/jama.269.18.2386; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; Dubois B, 2000, NEUROLOGY, V55, P1621, DOI 10.1212/WNL.55.11.1621; Fann JR, 2001, PSYCHOSOMATICS, V42, P48, DOI 10.1176/appi.psy.42.1.48; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Frey KL, 2007, BRAIN INJURY, V21, P513, DOI 10.1080/02699050701311026; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Hanks RA, 1999, ARCH PHYS MED REHAB, V80, P1030, DOI 10.1016/S0003-9993(99)90056-4; Hanks RA, 2008, ARCH PHYS MED REHAB, V89, P950, DOI 10.1016/j.apmr.2008.01.011; Hoge CW, 2009, NEW ENGL J MED, V360, P1588, DOI 10.1056/NEJMp0810606; Jackson WT, 1998, ARCH PHYS MED REHAB, V79, P718, DOI 10.1016/S0003-9993(98)90051-X; Kashluba S, 2008, ARCH PHYS MED REHAB, V89, P904, DOI 10.1016/j.apmr.2007.12.029; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Kean J, 2010, BRAIN INJURY, V24, P1222, DOI 10.3109/02699052.2010.498008; Kim E, 2007, J NEUROPSYCH CLIN N, V19, P106, DOI 10.1176/appi.neuropsych.19.2.106; Kim YW, 2009, CLIN NEUROPHARMACOL, V32, P63, DOI 10.1097/WNF.0b013e31816f1bc1; Kreutzer JS, 1996, ARCH PHYS MED REHAB, V77, P116, DOI 10.1016/S0003-9993(96)90155-0; Larson EB, 2008, PERCEPT MOTOR SKILL, V106, P725, DOI 10.2466/PMS.106.3.725-736; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Marion Donald W, 2006, Prog Neurol Surg, V19, P171, DOI 10.1159/000095191; Marr A, 2002, CENTRAL NERVOUS SYST; McAllister TW, 2006, J NEUROTRAUM, V23, P1450, DOI 10.1089/neu.2006.23.1450; McCauley SR, 2001, J NEUROL NEUROSUR PS, V71, P643, DOI 10.1136/jnnp.71.5.643; McMillan TM, 1996, J NEUROL NEUROSUR PS, V60, P422, DOI 10.1136/jnnp.60.4.422; Meyer MJ, 2010, BRAIN INJURY, V24, P722, DOI 10.3109/02699051003692134; Nakase-Richardson R, 2009, ARCH PHYS MED REHAB, V90, P17, DOI 10.1016/j.apmr.2008.06.030; Ponsford J, 2003, BRAIN INJURY, V17, P453, DOI 10.1080/0269905031000070143; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Rohling ML, 2009, NEUROPSYCHOLOGY, V23, P20, DOI 10.1037/a0013659; Royall DR, 2007, J NEUROPSYCH CLIN N, V19, P249, DOI 10.1176/appi.neuropsych.19.3.249; Sherer M, 2009, ARCH PHYS MED REHAB, V90, P1749, DOI 10.1016/j.apmr.2009.05.011; Sigurdardottir S, 2009, J INT NEUROPSYCH SOC, V15, P740, DOI 10.1017/S1355617709990452; Silver JM, 2006, NEUROLOGY, V67, P748, DOI 10.1212/01.wnl.0000234062.98062.e9; Silver JM, 2009, AM J PSYCHIAT, V166, P653, DOI 10.1176/appi.ajp.2009.08111676; Silver JM, 2009, BRAIN INJURY, V23, P123, DOI 10.1080/02699050802649696; Stuss DT, 1999, J NEUROSURG, V90, P635, DOI 10.3171/jns.1999.90.4.0635; TEASDALE G, 1974, LANCET, V2, P81; Tenovuo O, 2005, PROG NEURO-PSYCHOPH, V29, P61, DOI 10.1016/j.pnpbp.2004.10.006; Tenovuo O, 2009, BRAIN INJURY, V23, P548, DOI 10.1080/02699050902926275; Trzepacz PT, 2001, J NEUROPSYCH CLIN N, V13, P229, DOI 10.1176/appi.neuropsych.13.2.229; van der Naalt J, 1999, ANN NEUROL, V46, P70, DOI 10.1002/1531-8249(199907)46:1<70::AID-ANA11>3.0.CO;2-L; Vanier M, 2000, ARCH PHYS MED REHAB, V81, P796, DOI 10.1053/apmr.2000.4436; Vespa P, 2005, J CLIN NEUROPHYSIOL, V22, P99, DOI 10.1097/01.WNP.0000154919.54202.E0; Warden DL, 2006, J NEUROTRAUM, V23, P1468, DOI 10.1089/neu.2006.23.1468; Wheaton P, 2009, J CLIN PSYCHOPHARM, V29, P468, DOI 10.1097/JCP.0b013e3181b66f04; Whyte J, 2005, ARCH PHYS MED REHAB, V86, P453, DOI 10.1016/j.apmr.2004.05.016; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; Willmott C, 2009, J REHABIL MED, V41, P585, DOI 10.2340/16501977-0369; Wood S, 2000, AM J GERIAT PSYCHIAT, V8, P75, DOI 10.1097/00019442-200002000-00010; WROBLEWSKI BA, 1992, J CLIN PSYCHIAT, V53, P86; Zafonte RD, 1997, ARCH PHYS MED REHAB, V78, P1103, DOI 10.1016/S0003-9993(97)90135-0; Zhang L, 2004, ARCH PHYS MED REHAB, V85, P1050, DOI 10.1016/j.apmr.2003.10.014	68	17	17	0	5	SLACK INC	THOROFARE	6900 GROVE RD, THOROFARE, NJ 08086 USA	0048-5713			PSYCHIAT ANN	Psychiatr. Ann.	NOV	2010	40	11					540	552		10.3928/00485713-20101022-05			13	Psychiatry	Psychiatry	736IX	WOS:000288488200005	21270968	Green Accepted			2021-06-18	
J	Lee, JHT; Roy, J; Sohn, HM; Cheong, MA; Liu, J; Stammers, AT; Tetzlaff, W; Kwon, BK				Lee, Jae H. T.; Roy, Josee; Sohn, Hong Moon; Cheong, Mi Ae; Liu, Jie; Stammers, Anthea T.; Tetzlaff, Wolfram; Kwon, Brian K.			Magnesium in a Polyethylene Glycol Formulation Provides Neuroprotection After Unilateral Cervical Spinal Cord Injury	SPINE			English	Article						cervical spinal cord injury; magnesium chloride; polyethylene glycol; neuroprotection	INTRACELLULAR FREE MAGNESIUM; RANDOMIZED CONTROLLED-TRIAL; TRAUMATIC BRAIN-INJURY; SULFATE TREATMENT; ACUTE STROKE; RAT; FORELIMB; RECOVERY; THERAPY; PLASTICITY	Study Design. Experimental animal study. Objective. To investigate the neuroprotective efficacy of this magnesium in polyethylene glycol (PEG) formulation in a contusive model of cervical spinal cord injury (SCI). Summary of Background Data. Intravenously administered magnesium has been extensively investigated as a neuroprotective agent in animal models of SCI, stroke, and traumatic brain injuries, and has been evaluated in large scale clinical trials for the latter 2 indications. We have developed a novel formulation of magnesium chloride (MgCl(2)) within PEG, and have previously demonstrated the neuroprotective benefit of this formulation in animal models of thoracic SCI. Methods. Twenty-two Sprague Dawley rats underwent a unilateral cervical hemicontusion at C4-C5 and were randomized 2 hours later to either the MgCl(2) in PEG formulation, or normal saline. Each treatment was administered in 5 intravenous infusions spaced 6 hours apart. Behavioral recovery was assessed over 6 weeks, after which the cord was analyzed to measure the extent of gray matter and white matter sparing through the injury site. Results. In the horizontal ladder test, the percentage of forelimb errors made by the animals treated with MgCl(2) in PEG formulation was significantly lower than the saline-treated controls. Histologic analysis also revealed a significantly higher cumulative white matter sparing through the injury site in the MgCl(2) in PEG group. Conclusion. MgCl(2) in a PEG formulation reduced secondary damage and improved behavioral recovery when administered 2 hours after a unilateral cervical hemicontusion injury. These findings are consistent with the neurologic benefit observed when administering this magnesium formulation in contusive and compressive models of thoracic SCI. Demonstrating the robustness of this neuroprotective effect in multiple injury models (and in the cervical injury model in particular) is important when considering the applicability of such a therapy for human SCIs.	[Lee, Jae H. T.; Liu, Jie; Stammers, Anthea T.; Tetzlaff, Wolfram; Kwon, Brian K.] Univ British Columbia, ICORD, Vancouver, BC V5Z 1M9, Canada; [Roy, Josee] Medtronic, Memphis, TN USA; [Sohn, Hong Moon] Chosun Univ, Chosun Univ Hosp, Dept Orthopaed, Kwangju, South Korea; [Cheong, Mi Ae] Hanyang Univ, Dept Anesthesiol, Seoul 133791, South Korea; [Kwon, Brian K.] Univ British Columbia, Dept Orthopaed, Vancouver, BC V5Z 1M9, Canada	Kwon, BK (corresponding author), VGH, Blusson Spinal Cord Ctr, 6th Floor,818 W 10th Ave, Vancouver, BC V5Z 1M9, Canada.	brian.kwon@vch.ca	Tetzlaff, Wolfram/AAY-4430-2020				Anderson KD, 2005, EXP NEUROL, V194, P161, DOI 10.1016/j.expneurol.2005.02.006; Aronow Wilbert S, 2007, Heart Fail Clin, V3, P465, DOI 10.1016/j.hfc.2007.07.010; Ditor DS, 2007, J NEUROSCI RES, V85, P1458, DOI 10.1002/jnr.21283; Dumont RJ, 2001, CLIN NEUROPHARMACOL, V24, P265, DOI 10.1097/00002826-200109000-00003; Dumont RJ, 2001, CLIN NEUROPHARMACOL, V24, P254, DOI 10.1097/00002826-200109000-00002; FEHLINGS MG, 1995, EXP NEUROL, V132, P220, DOI 10.1016/0014-4886(95)90027-6; Fu ES, 2005, CURR OPIN ANESTHESIO, V18, P181, DOI 10.1097/01.aco.0000162838.56344.88; Gensel JC, 2006, J NEUROTRAUM, V23, P36, DOI 10.1089/neu.2006.23.36; Ginsberg MD, 2008, NEUROPHARMACOLOGY, V55, P363, DOI 10.1016/j.neuropharm.2007.12.007; Girgis J, 2007, BRAIN, V130, P2993, DOI 10.1093/brain/awm245; Gok B, 2007, CHINESE J PHYSIOL, V50, P93; Hamers FPT, 2006, J NEUROTRAUM, V23, P537, DOI 10.1089/neu.2006.23.537; Hoane MR, 2007, MAGNESIUM RES, V20, P229; Jain A, 2008, CRIT REV THER DRUG, V25, P403, DOI 10.1615/CritRevTherDrugCarrierSyst.v25.i5.10; JONES TA, 1992, BRAIN RES, V581, P156, DOI 10.1016/0006-8993(92)90356-E; Kaptanoglu E, 2003, NEUROSURG REV, V26, P283, DOI 10.1007/s10143-003-0272-y; Kaptanoglu E, 2003, J CLIN NEUROSCI, V10, P329, DOI 10.1016/S0967-5868(03)00031-6; Kwon Brian K, 2004, Spine J, V4, P451, DOI 10.1016/j.spinee.2003.07.007; Kwon Brian K, 2002, Mol Interv, V2, P244, DOI 10.1124/mi.2.4.244; Kwon BK, 2009, J NEUROTRAUM, V26, P1379, DOI [10.1089/neu.2009.0884, 10.1089/neu.2009-0884]; Lees KR, 2004, LANCET, V363, P439; Liu Y, 1999, J NEUROSCI, V19, P4370; McKenna JE, 2000, J COMP NEUROL, V419, P286, DOI 10.1002/(SICI)1096-9861(20000410)419:3<286::AID-CNE2>3.0.CO;2-3; Metz GA, 2002, J NEUROSCI METH, V115, P169, DOI 10.1016/S0165-0270(02)00012-2; *NAT SPIN CORD INJ, 2008, J SPINAL CORD MED, V31, P357; NOBLE LJ, 1985, EXP NEUROL, V88, P135, DOI 10.1016/0014-4886(85)90119-0; NOBLE LJ, 1989, EXP NEUROL, V103, P34, DOI 10.1016/0014-4886(89)90182-9; Nurko S, 2008, J PEDIATR, V153, P254, DOI 10.1016/j.jpeds.2008.01.039; Ozdemir M, 2005, MAGNESIUM RES, V18, P170; PENCE S, 2002, BASIC CLIN PHYSL PHA, V13, P41; Poschel KA, 2000, KIDNEY INT, V58, P2478, DOI 10.1046/j.1523-1755.2000.00431.x; Rabchevsky AG, 2001, J NEUROTRAUM, V18, P513, DOI 10.1089/089771501300227314; Saver JL, 2004, STROKE, V35, pE106, DOI 10.1161/01.STR.0000124458.98123.52; Schallert T, 2000, NEUROPHARMACOLOGY, V39, P777, DOI 10.1016/S0028-3908(00)00005-8; Schouten JW, 2007, CURR OPIN CRIT CARE, V13, P134, DOI 10.1097/MCC.0b013e3280895d5c; Soblosky JS, 1997, J NEUROSCI METH, V78, P75, DOI 10.1016/S0165-0270(97)00131-3; Soblosky JS, 2001, BEHAV BRAIN RES, V119, P1, DOI 10.1016/S0166-4328(00)00328-4; Solaroglu I, 2005, SURG NEUROL, V64, P17, DOI 10.1016/j.surneu.2005.07.058; Stackhouse SK, 2008, J NEUROTRAUM, V25, P1039, DOI 10.1089/neu.2007.0419; Suzer T, 1999, SPINAL CORD, V37, P480, DOI 10.1038/sj.sc.3100874; Tang AC, 2002, BEHAV BRAIN RES, V131, P1, DOI 10.1016/S0166-4328(01)00330-8; Temkin NR, 2007, LANCET NEUROL, V6, P29, DOI 10.1016/S1474-4422(06)70630-5; VINK R, 1989, BRAIN RES, V490, P144, DOI 10.1016/0006-8993(89)90440-X; Vink R, 2000, FRONT BIOSCI, V5, pD656, DOI 10.2741/Vink; VINK R, 1988, J BIOL CHEM, V263, P757; WHISHAW IQ, 1990, BEHAV BRAIN RES, V41, P49, DOI 10.1016/0166-4328(90)90053-H; Zhang L, 1996, SCIENCE, V274, P1921, DOI 10.1126/science.274.5294.1921	47	17	17	1	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0362-2436			SPINE	SPINE	NOV 1	2010	35	23					2041	2048		10.1097/BRS.0b013e3181d2d6c5			8	Clinical Neurology; Orthopedics	Neurosciences & Neurology; Orthopedics	671GX	WOS:000283490100022	20938394				2021-06-18	
J	Middleton, K; Krabak, BJ; Coppel, DB				Middleton, Kim; Krabak, Brian J.; Coppel, David B.			The Influence of Pediatric Autonomic Dysfunction on Recovery After Concussion	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						concussion; post-concussive syndrome; autonomic dysfunction; pediatric; sport	INJURY		[Krabak, Brian J.] Univ Washington, Med Ctr, Seattle, WA 98105 USA; [Krabak, Brian J.] Seattle Childrens Sports Med, Seattle, WA USA; [Middleton, Kim] Univ Washington, Sch Med, Seattle, WA USA; [Krabak, Brian J.; Coppel, David B.] Univ Washington, Harborview Med Ctr, Seattle Sports Concuss Program, Dept Neurol Surg Neuropsychol Serv & Res, Seattle, WA 98104 USA	Krabak, BJ (corresponding author), Univ Washington, Med Ctr, 4245 Roosevelt Way NE,Box 356490, Seattle, WA 98105 USA.	bkrabak@u.washington.edu					Gall B, 2004, MED SCI SPORT EXER, V36, P1269, DOI 10.1249/01.MSS.0000135787.73757.4D; Gioia GA, 2009, BRIT J SPORT MED, V43, pI13, DOI 10.1136/bjsm.2009.058255; Junger EC, 1997, J NEUROSURG, V86, P425, DOI 10.3171/jns.1997.86.3.0425; La Fountaine MF, 2009, AUTON NEUROSCI-BASIC, V148, P101, DOI 10.1016/j.autneu.2009.03.001; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Leddy JJ, 2007, NEUROREHABILITATION, V22, P199; LOVELL M, CLIN SPORT MED, V23, P421; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db	8	17	17	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1050-642X			CLIN J SPORT MED	Clin. J. Sport Med.	NOV	2010	20	6					491	492		10.1097/JSM.0b013e3181fac088			2	Orthopedics; Physiology; Sport Sciences	Orthopedics; Physiology; Sport Sciences	682DC	WOS:000284379100018	21079448				2021-06-18	
J	Perheentupa, U; Kinnunen, I; Grenman, R; Aitasalo, K; Makitie, AA				Perheentupa, Ulla; Kinnunen, Ilpo; Grenman, Reidar; Aitasalo, Kalle; Makitie, Antti A.			Management and outcome of pediatric skull base fractures	INTERNATIONAL JOURNAL OF PEDIATRIC OTORHINOLARYNGOLOGY			English	Article						Complication; Meningitis; Frontobasal; Intensive care; Outcome; Head injury	CEREBROSPINAL-FLUID FISTULAS; TEMPORAL BONE-FRACTURES; TRAUMATIC BRAIN-INJURY; HEAD-INJURIES; CHILDREN; LEAKAGE	Objective: The management of skull base fractures in the pediatric age group continues to be a major challenge even for experienced multidisciplinary teams. This retrospective study was undertaken at a tertiary care academic hospital to evaluate the management and outcome of pediatric skull base fractures. Methods: Retrospective analysis covering a period of 13.5 years (from 1996 to 2009) and 63 patients (mean age 10.7 years; range 1-18 years) was performed. Results: A road traffic accident was the most frequent etiological factor (38%). The most common skull base fracture type was temporal bone fracture (64%). Longitudinal temporal fractures were observed in 45% and transversal in 23% of these patients; in 10 cases (25%) the fracture was comminuted or mixed type. A fracture involving the spheno-ethmoidal complex was the second most common type of basilar skull fracture (41%) followed by fracture through the orbital bone (35%). Forty-three percent of the patients had a concomitant intracranial injury. Early neurological deficits were diagnosed in 21 patients (33%) and 10 patients (16%) had permanent neurological deficits. One patient died after 1 week of intensive care treatment. Fifty-four patients (86%) were discharged home and 8 patients (13%) were discharged for further rehabilitation. Glasgow Coma Scale score of 8 or lower correlated with moderate to poor outcome. Conclusions: We conclude that skull base fracture is a rare injury in childhood. Mortality is uncommon, but this trauma is commonly associated with intracranial injury. Early neurological deficits are caused by traumatic brain injury and were observed in one-third of the patients. However, only less than one-sixth suffered from permanent neurological or neuropsychiatric disorders. (C) 2010 Elsevier Ireland Ltd. All rights reserved.	[Perheentupa, Ulla; Kinnunen, Ilpo; Grenman, Reidar; Aitasalo, Kalle] Turku Univ Hosp, Dept Otolaryngol Head & Neck Surg, FI-20521 Turku, Finland; [Perheentupa, Ulla; Kinnunen, Ilpo; Grenman, Reidar; Aitasalo, Kalle] Univ Turku, SF-20500 Turku, Finland; [Makitie, Antti A.] Helsinki Univ Hosp, Dept Otolaryngol Head & Neck Surg, Helsinki, Finland; [Makitie, Antti A.] Univ Helsinki, FIN-00014 Helsinki, Finland	Perheentupa, U (corresponding author), Turku Univ Hosp, Dept Otolaryngol Head & Neck Surg, POB 52, FI-20521 Turku, Finland.	ulla.perheentupa@utu.fi					Abdel-Dayem HM, 1998, CLIN NUCL MED, V23, P309, DOI 10.1097/00003072-199805000-00009; BALTAS I, 1994, NEUROSURGERY, V35, P422, DOI 10.1227/00006123-199409000-00009; BECKHARDT RN, 1991, OTOLARYNG HEAD NECK, V104, P425, DOI 10.1177/019459989110400402; Bell RB, 2004, J ORAL MAXIL SURG, V62, P676, DOI 10.1016/j.joms.2003.08.032; Bowman SM, 2008, PEDIATRICS, V122, P988, DOI 10.1542/peds.2007-3511; Choi D, 1996, BRIT J NEUROSURG, V10, P571, DOI 10.1080/02688699646880; Fishman G, 2009, CHILD NERV SYST, V25, P915, DOI 10.1007/s00381-009-0887-6; Friedman JA, 2001, WORLD J SURG, V25, P1062, DOI 10.1007/s00268-001-0059-7; HAHN YS, 1988, CHILD NERV SYST, V4, P34; Imahara SD, 2008, J AM COLL SURGEONS, V207, P710, DOI 10.1016/j.jamcollsurg.2008.06.333; Jagannathan J, 2008, J NEUROSURG-PEDIATR, V2, P240, DOI 10.3171/PED.2008.2.10.240; Jagannathan J, 2007, J NEUROSURG, V106, P268, DOI 10.3171/ped.2007.106.4.268; Johnson K, 2005, CLIN RADIOL, V60, P464, DOI 10.1016/j.crad.2004.09.013; Kelly DF, 2001, WORLD J SURG, V25, P1179; Kinnunen I, 2006, J CRANIO MAXILL SURG, V34, P405, DOI 10.1016/j.jcms.2006.04.007; KITCHENS JL, 1991, J PEDIATR SURG, V26, P992, DOI 10.1016/0022-3468(91)90849-O; KRAUS JF, 1996, NEUROTRAUMA, P13; Kumar R, 2009, CHILD NERV SYST, V25, P813, DOI 10.1007/s00381-009-0820-z; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Lanza DC, 1996, LARYNGOSCOPE, V106, P1119, DOI 10.1097/00005537-199609000-00015; LIUSHINDO M, 1989, INT J PEDIATR OTORHI, V17, P109, DOI 10.1016/0165-5876(89)90086-4; Lloyd KM, 2008, RADIOLOGY, V248, P725, DOI 10.1148/radiol.2483070362; LUNDAR T, 1985, CHILD NERV SYST, V1, P24, DOI 10.1007/BF00706726; MARENTETTE LJ, 1991, OTOLARYNG CLIN N AM, V24, P151; MCGUIRT WF, 1992, CLIN PEDIATR, V31, P12, DOI 10.1177/000992289203100103; MEALEY J, 1968, PEDIATRIC HEAD INJUR, P88; Mendizabal G R, 1992, Rev Laryngol Otol Rhinol (Bord), V113, P423; Ort S, 2004, OTOLARYNG HEAD NECK, V131, P433, DOI 10.1016/j.otohns.2004.04.006; Palchak MJ, 2003, ANN EMERG MED, V42, P492, DOI 10.1067/S0196-0644(03)00425-6; Ragnarsson KT, 1999, JAMA-J AM MED ASSOC, V282, P974; Rivara FP, 1999, PEDIATRICS, V103, P883; Scholsem M, 2008, NEUROSURGERY, V62, P463, DOI [10.1227/01.NEU.0000297037.51609.07, 10.1227/01.neu.0000316014.97926.82, 10.1227/01.neu.0000325884.05871.aa]; Sookplung P, 2009, CURR OPIN ANESTHESIO, V22, P572, DOI 10.1097/ACO.0b013e3283303884; Stone JA, 1999, AM J NEURORADIOL, V20, P706; THOMALE UW, 2010, CHILDS NERV SYST; van de Beek D, 2010, NEW ENGL J MED, V362, P146, DOI 10.1056/NEJMra0804573; Yilmazlar S, 2006, NEUROSURG REV, V29, P64, DOI 10.1007/s10143-005-0396-3	37	17	17	0	4	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0165-5876	1872-8464		INT J PEDIATR OTORHI	Int. J. Pediatr. Otorhinolaryngol.	NOV	2010	74	11					1245	1250		10.1016/j.ijporl.2010.07.023			6	Otorhinolaryngology; Pediatrics	Otorhinolaryngology; Pediatrics	679RK	WOS:000284178300008	20800299				2021-06-18	
J	Tan, IL; Ng, T; Vucic, S				Tan, Ik Lin; Ng, Thomas; Vucic, Steve			Severe Guillain-Barre syndrome following head trauma	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article						AMSAN; Guillain-Barre syndrome; Head trauma	T-CELL FUNCTION; IDIOPATHIC POLYNEURITIS; INJURY; PATHOGENESIS; IMPAIRMENT; PATHOLOGY; SURGERY; DEATH; CHINA	Fulminant forms of Guillain-Barre syndrome (GBS) present as acute onset tetraparesis and areflexia with absent brainstem reflexes, simulating brain death. Head trauma as an antecedent to fulminant GBS has been infrequently reported, and recognizing an association between GBS and head trauma may be crucial for patient management. Consequently, we report a patient with fulminant GBS with mixed demyelinating and axonal features preceded by a closed head injury, and discuss the possible pathophysiological mechanisms. (C) 2010 Elsevier Ltd. All rights reserved.	[Tan, Ik Lin; Vucic, Steve] Westmead Hosp, Dept Neurol, Westmead, NSW 2145, Australia; [Ng, Thomas] Westmead Hosp, Dept Anat Pathol, Westmead, NSW 2145, Australia; [Ng, Thomas; Vucic, Steve] Univ Sydney, Westmead Hosp, Western Clin Sch, Westmead, NSW 2145, Australia; [Vucic, Steve] Univ New S Wales, Prince Wales Med Res Inst, Sydney, NSW 2052, Australia	Vucic, S (corresponding author), Westmead Hosp, Dept Neurol, Corner Hawkesbury & Darcy Rd, Westmead, NSW 2145, Australia.	s.vucic@student.unsw.edu.au		Vucic, Steve/0000-0002-8323-873X	Brain Foundation Australia; Motor Neuron Disease Research Institute of Australia	Grant support from Brain Foundation Australia and the Motor Neuron Disease Research Institute of Australia is gratefully acknowledged.	ASBURY AK, 1969, MEDICINE, V48, P173, DOI 10.1097/00005792-196905000-00001; BALDWIN RT, 1992, J HEART LUNG TRANSPL, V11, P817; DeFreitas GR, 1997, ARQ NEURO-PSIQUIAT, V55, P315, DOI 10.1590/S0004-282X1997000200022; DUNCAN R, 1987, POSTGRAD MED J, V63, P479, DOI 10.1136/pgmj.63.740.479; Friedman Y, 2003, CAN J NEUROL SCI, V30, P397, DOI 10.1017/S0317167100003152; Griffin JW, 1996, ANN NEUROL, V39, P17, DOI 10.1002/ana.410390105; HaferMacko CE, 1996, ANN NEUROL, V39, P627, DOI 10.1002/ana.410390512; Hughes RAC, 2005, LANCET, V366, P1653, DOI 10.1016/S0140-6736(05)67665-9; Hughes RAC, 1999, J NEUROIMMUNOL, V100, P74, DOI 10.1016/S0165-5728(99)00195-2; Hughes RAC, 1997, J INFECT DIS, V176, pS92, DOI 10.1086/513793; Hughes RC, 1985, PERIPHERAL NERVE DIS, P175; Lin TM, 2006, J PLAST RECONSTR AES, V59, P543, DOI 10.1016/j.bjps.2005.10.017; MCKHANN GM, 1993, ANN NEUROL, V33, P333, DOI 10.1002/ana.410330402; MCKHANN GM, 1991, LANCET, V338, P593, DOI 10.1016/0140-6736(91)90606-P; MILLER C H, 1991, Neurological Research, V13, P117; PRINEAS JW, 1981, ANN NEUROL, V9, P6, DOI 10.1002/ana.410090704; PRINEAS JW, 1972, LAB INVEST, V26, P133; Pritchard J, 2007, J NEUROIMMUNOL, V183, P232, DOI 10.1016/j.jneuroim.2006.12.002; QUATTROCCHI KB, 1992, J NEUROTRAUM, V9, P1, DOI 10.1089/neu.1992.9.1; QUATTROCCHI KB, 1991, J NEUROSURG, V75, P766, DOI 10.3171/jns.1991.75.5.0766; QUATTROCCHI KB, 1992, J NEUROSURG, V77, P694, DOI 10.3171/jns.1992.77.5.0694; RENLUND DG, 1987, AM HEART J, V113, P844, DOI 10.1016/0002-8703(87)90736-8; Rivas S, 2008, J NEUROSURG, V108, P595, DOI 10.3171/JNS/2008/108/3/0595; ROPPER AH, 1992, NEW ENGL J MED, V326, P1130, DOI 10.1056/NEJM199204233261706; SHUERT GT, 1972, J ORAL SURG, V30, P913; Vargas F, 2000, INTENS CARE MED, V26, P623, DOI 10.1007/s001340051213; Vucic S, 2009, J CLIN NEUROSCI, V16, P733, DOI 10.1016/j.jocn.2008.08.033	27	17	17	0	2	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0967-5868	1532-2653		J CLIN NEUROSCI	J. Clin. Neurosci.	NOV	2010	17	11					1452	1454		10.1016/j.jocn.2009.11.037			3	Clinical Neurology; Neurosciences	Neurosciences & Neurology	705JF	WOS:000286124000027	20638848				2021-06-18	
J	Niemi, T; Armstrong, E				Niemi, Tomi; Armstrong, Elina			Thromboprophylactic management in the neurosurgical patient with high risk for both thrombosis and intracranial bleeding	CURRENT OPINION IN ANESTHESIOLOGY			English	Article						antithrombotic drugs; bridging therapy; neurosurgery; thromboembolism	TRAUMATIC BRAIN-INJURY; VENOUS THROMBOEMBOLISM; POSTOPERATIVE HEMATOMA; HEMORRHAGE; SURGERY; PROPHYLAXIS; STENT; ANTICOAGULANTS; ENOXAPARIN; PREVENTION	Purpose of review Pharmacologic thromboprophylaxis is indicated in neurosurgery patients having high risk for venous or arterial thrombosis. The pharmacologic thromboprophylaxis, as well as temporary interruption of antithrombotic drugs because of surgery, and possible use of substitutive medication ('bridging therapy') are reviewed. Recent findings Pharmacologic thromboprophylaxis is used for most neurosurgical patients, but clinical practices vary a lot. There are only few reports of the management of neurosurgery patients having mechanical prosthetic heart valves, atrial fibrillation with comorbidities, history of deep venous thrombosis, thrombophilia, or coronary artery stent. These patients present a high risk for both thrombosis and bleeding as temporary interruption of antithrombotic medication as well as a substitutive medication would be indicated. Generally, the bridging therapy with low-molecular-weight heparin (LMWH) is a feasible approach in patients needing interruption of vitamin K antagonists. Experiences in neurosurgery patients emphasize carefully secured hemostasis and tailored dose as well as timing of LMWH. In patients with a recent coronary artery stent scheduled for neurosurgery, an individualized plan is needed. Bridging therapy for antiplatelet agents or novel oral anticoagulants is not yet settled. Summary Pharmacologic thromboprophylaxis, or bridging therapy, should be tailored according to the individual risks and the type of neurosurgery. The bleeding risk is likely minimized by allowing coagulation capacity to normalize preoperatively and by using reduced doses of LMWH starting relatively late after neurosurgery.	[Niemi, Tomi] Univ Helsinki, Cent Hosp, Dept Anesthesiol & Intens Care Med, FI-00029 Helsinki, Finland; [Armstrong, Elina] Univ Helsinki, Cent Hosp, Dept Med Hematol, FI-00029 Helsinki, Finland	Niemi, T (corresponding author), Univ Helsinki, Cent Hosp, Dept Anesthesiol & Intens Care Med, POB 266, FI-00029 Helsinki, Finland.	tomi.niemi@hus.fi					Bratton SL, 2007, J NEUROTRAUMA S1, V24, P32; Broad L, 2007, BRIT J ANAESTH, V98, P19, DOI 10.1093/bja/ael318; Caird J, 2006, BRIT J NEUROSURG, V20, P40, DOI 10.1080/02688690600603719; Collen JF, 2008, CHEST, V134, P237, DOI 10.1378/chest.08-0023; Cutlip DE, 2001, CIRCULATION, V103, P1967; Datta Indraneel, 2010, J Trauma Manag Outcomes, V4, P1, DOI 10.1186/1752-2897-4-1; Depew AJ, 2008, AM SURGEON, V74, P906; Douketis JD, 2008, CHEST, V133, p299S, DOI 10.1378/chest.08-0675; Geerts WH, 2008, CHEST, V133, p381S, DOI 10.1378/chest.08-0656; Gerlach R, 2004, NEUROL RES, V26, P61, DOI 10.1179/016164104773026543; Gerlach R, 2002, STROKE, V33, P1618, DOI 10.1161/01.STR.0000017219.83330.FF; Gerlach R, 2009, ACTA NEUROCHIR, V151, P873, DOI 10.1007/s00701-009-0409-z; Glotzbecker MP, 2010, SPINE, V35, pE413, DOI 10.1097/BRS.0b013e3181d9bb77; Kim KS, 2009, NEUROCRIT CARE, V11, P28, DOI 10.1007/s12028-009-9201-4; Korinth MC, 2006, ACTA NEUROCHIR, V148, P1189, DOI 10.1007/s00701-006-0868-4; Levy AS, 2010, J TRAUMA, V68, P886, DOI 10.1097/TA.0b013e3181d27dd5; Muntz JE, 2010, AM J SURG, V199, pS11, DOI 10.1016/j.amjsurg.2009.10.007; Niemi T, 2009, ACTA NEUROCHIR, V151, P1289, DOI 10.1007/s00701-009-0419-x; Norwood SH, 2008, J TRAUMA, V65, P1021, DOI 10.1097/TA.0b013e31818a0e74; Oscarsson A, 2010, BRIT J ANAESTH, V104, P305, DOI 10.1093/bja/aeq003; PALMER JD, 1994, NEUROSURGERY, V35, P1061, DOI 10.1227/00006123-199412000-00007; Pengo V, 2009, CIRCULATION, V119, P2920, DOI 10.1161/CIRCULATIONAHA.108.823211; Powner DJ, 2005, NEUROSURGERY, V57, P823, DOI 10.1227/01.NEU.0000179915.74429.b2; Raslan AM, 2010, NEUROCRIT CARE, V12, P297, DOI 10.1007/s12028-009-9316-7; Ray WZ, 2009, J NEUROSURG, V110, P1010, DOI 10.3171/2008.9.JNS08107; Savonitto S, 2010, BRIT J ANAESTH, V104, P285, DOI 10.1093/bja/aep373; Scales DC, 2009, J CRIT CARE, V24, P176, DOI 10.1016/j.jcrc.2009.03.010; Senft C, 2009, NEUROL RES, V31, P1012, DOI 10.1179/174313209X409034; Taniguchi S, 2009, HEART VESSELS, V24, P425, DOI 10.1007/s00380-008-1135-9; Tetri S, 2008, THROMB RES, V123, P206, DOI 10.1016/j.thromres.2008.01.018	30	17	17	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0952-7907	1473-6500		CURR OPIN ANESTHESIO	Curr. Opin. Anesthesiol.	OCT	2010	23	5					558	563		10.1097/ACO.0b013e32833e1589			6	Anesthesiology	Anesthesiology	646RR	WOS:000281560500004	20717013				2021-06-18	
J	Vanhorebeek, I; Gielen, M; Boussemaere, M; Wouters, PJ; Grandas, FG; Mesotten, D; Van den Berghe, G				Vanhorebeek, Ilse; Gielen, Marijke; Boussemaere, Magaly; Wouters, Pieter J.; Grandas, Fabian Guiza; Mesotten, Dieter; Van den Berghe, Greet			Glucose Dysregulation and Neurological Injury Biomarkers in Critically Ill Children	JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM			English	Article							INTENSIVE INSULIN THERAPY; TRAUMATIC BRAIN-INJURY; SEVERE HYPOGLYCEMIA; COGNITIVE FUNCTION; SERUM BIOMARKERS; HYPERGLYCEMIA; MARKERS; DAMAGE; S-100-BETA; ASSOCIATION	Context: Targeting normoglycemia with intensive insulin therapy (IIT) improved short-term outcome of pediatric intensive care unit (PICU) patients but increased the incidence of hypoglycemia. Both hyperglycemia and hypoglycemia may adversely affect the developing brain. Objective: We studied the impact of targeting normoglycemia with IIT on brain injury markers. Design: This is a preplanned analysis of PICU patients included in a randomized controlled study. Setting: The study was conducted at a university hospital PICU. Patients: Seven hundred PICU patients participated. Interventions: Patients were assigned to IIT targeting normal-for-age fasting blood glucose levels or insulin infusion only to prevent excessive hyperglycemia. Main Outcome Measures: Serum S100B and neuron-specific enolase (NSE), biomarkers of astrocytic and neuronal damage, respectively, were measured on fixed days (n = 700) and in a nested case-control design before and after hypoglycemia (n = 126). Results: Admission levels of S100B and NSE differed according to diagnosis and illness severity (P < 0.0001). IIT did not affect the time course of these markers. Patients experiencing hypoglycemia in PICU had higher S100B and NSE from admission onward than those without hypoglycemia. In the nested case-control study, both markers decreased after hypoglycemia (P = 0.001 and P = 0.009), unlike in the controls on matched days. Conclusions: IIT in PICU did not evoke neurological damage detectable by circulating S100B and NSE, despite increased incidence of hypoglycemia. Elevated markers in patients with hypoglycemia were not caused by hypoglycemia itself but rather reflect an increased incidence of hypoglycemia in the most severely ill. This hypoglycemia risk appears difficult to capture by classical illness severity scores. (J Clin Endocrinol Metab 95: 4669-4679, 2010)	[Vanhorebeek, Ilse] Katholieke Univ Leuven, Dept Intens Care Med, B-3000 Louvain, Belgium; Katholieke Univ Leuven, Lab Intens Care Med, B-3000 Louvain, Belgium	Vanhorebeek, I (corresponding author), Katholieke Univ Leuven, Dept Intens Care Med, B-3000 Louvain, Belgium.	ilse.vanhorebeek@med.kuleuven.be	Van den Berghe, Greet/J-6788-2018; Mesotten, Dieter/ABE-4176-2020	Van den Berghe, Greet/0000-0002-5320-1362; Mesotten, Dieter/0000-0002-3258-4720; Vanhorebeek, Ilse/0000-0002-5261-5192; Guiza, Fabian/0000-0001-7026-0957	Institute for Science and Technology, Flanders, Belgium [IWT 070695]; Research Council of the Katholieke Universiteit LeuvenKU Leuven [GOA2007/14]; Research Foundation, Flanders (Fonds voor Wetenschappelijk Onderzoek Vlaanderen, FWO)FWO; Clinical Research Fund of the University Hospitals Leuven; Flemish GovernmentEuropean Commission	This work was supported by the TBM program (Toegepast Biomedisch onderzoek met een primair Maatschappelijke finaliteit) of the Institute for Science and Technology, Flanders, Belgium (IWT 070695), the Research Council of the Katholieke Universiteit Leuven (GOA2007/14), PhD Fellowship of the Research Foundation, Flanders (Fonds voor Wetenschappelijk Onderzoek Vlaanderen, FWO) (to M.G.) and postdoctoral fellowship of the Clinical Research Fund of the University Hospitals Leuven (to D.M.). G.V.d.B., by the University of Leuven, receives structural research financing via the Methusalem program, funded by the Flemish Government.	Beardsall K, 2008, NEW ENGL J MED, V359, P1873, DOI 10.1056/NEJMoa0803725; Beers SR, 2007, J NEUROTRAUM, V24, P97, DOI 10.1089/neu.2006.0055; Berger RP, 2006, J HEAD TRAUMA REHAB, V21, P315, DOI 10.1097/00001199-200607000-00004; Bjorgaas M, 1997, ACTA PAEDIATR, V86, P148, DOI 10.1111/j.1651-2227.1997.tb08856.x; Branco Ricardo G, 2005, Pediatr Crit Care Med, V6, P470, DOI 10.1097/01.PCC.0000161284.96739.3A; BROWN TCK, 1980, AUST PAEDIATR J, V16, P28; Brunkhorst FM, 2008, NEW ENGL J MED, V358, P125, DOI 10.1056/NEJMoa070716; Cochran A, 2003, J TRAUMA, V55, P1035, DOI 10.1097/01.TA.0000031175.96507.48; de Ferranti S, 2004, ANESTHESIOLOGY, V100, P1345, DOI 10.1097/00000542-200406000-00005; Duning T, 2010, DIABETES CARE, V33, P639, DOI 10.2337/dc09-1740; Erb MA, 2000, ANN THORAC SURG, V69, P1515, DOI 10.1016/S0003-4975(00)01141-3; Fassbender K, 1997, J NEUROL SCI, V148, P101, DOI 10.1016/S0022-510X(96)05351-8; Faustino EV, 2005, J PEDIATR-US, V146, P30, DOI 10.1016/j.jpeds.2004.08.076; Finfer S, 2009, NEW ENGL J MED, V360, P1283, DOI 10.1056/NEJMoa0810625; Fontella FU, 2005, BRAIN RES BULL, V65, P443, DOI 10.1016/j.brainresbull.2005.02.026; Georgiadis D, 2000, J THORAC CARDIOV SUR, V119, P138, DOI 10.1016/S0022-5223(00)70229-7; Gerlach R, 2006, NEUROSCIENCE, V141, P1697, DOI 10.1016/j.neuroscience.2006.05.008; Gursoy M, 2010, NEUROCHEM RES, V35, P429, DOI 10.1007/s11064-009-0075-9; Hall NJ, 2004, J PEDIATR SURG, V39, P898, DOI 10.1016/j.jpedsurg.2004.02.005; Hovsepyan MR, 2004, NEUROSCI LETT, V369, P224, DOI 10.1016/j.neulet.2004.07.071; Hsu AA, 2008, PEDIATR CRIT CARE ME, V9, P245, DOI 10.1097/PCC.0b013e3181727b22; JACOBSON AM, 2007, NEW ENGL J MED, V356, P1842; Jenkins KJ, 2002, J THORAC CARDIOV SUR, V123, P110, DOI 10.1067/mtc.2002.119064; Kapural M, 2002, BRAIN RES, V940, P102, DOI 10.1016/S0006-8993(02)02586-6; Kochanek PM, 2008, CURR OPIN CRIT CARE, V14, P135, DOI 10.1097/MCC.0b013e3282f57564; Kosiborod M, 2009, JAMA-J AM MED ASSOC, V301, P1556, DOI 10.1001/jama.2009.496; Leviton A, 2002, ACTA PAEDIATR, V91, P9, DOI 10.1080/080352502753457851; Malone JI, 2008, PEDIATR DIABETES, V9, P531, DOI 10.1111/j.1399-5448.2008.00431.x; Marchi N, 2004, CLIN CHIM ACTA, V342, P1, DOI 10.1016/j.cccn.2003.12.008; Meyfroidt G, 2010, CRIT CARE MED, V38, P1021, DOI 10.1097/CCM.0b013e3181cf710e; Northam EA, 2006, NAT CLIN PRACT NEURO, V2, P78, DOI 10.1038/ncpneuro0097; Preiser JC, 2009, INTENS CARE MED, V35, P1738, DOI 10.1007/s00134-009-1585-2; RYAN CM, 1990, J PEDIATR-US, V117, P32, DOI 10.1016/S0022-3476(05)82440-0; Spinella PC, 2003, CRIT CARE MED, V31, P939, DOI 10.1097/01.CCM.0000053644.16336.52; Strachan MWJ, 1999, DIABETES-METAB RES, V15, P5, DOI 10.1002/(SICI)1520-7560(199901/02)15:1<5::AID-DMRR2>3.0.CO;2-S; Suh SW, 2007, J CLIN INVEST, V117, P910, DOI 10.1172/JCI30077; Sulter G, 1998, NEUROSCI LETT, V253, P71, DOI 10.1016/S0304-3940(98)00595-3; Van den Berghe G, 2005, NEUROLOGY, V64, P1348, DOI 10.1212/01.WNL.0000158442.08857.FC; Van den Berghe G, 2006, NEW ENGL J MED, V354, P449, DOI 10.1056/NEJMoa052521; Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300; Van den Berghe G, 2006, DIABETES, V55, P3151, DOI 10.2337/db06-0855; Vlasselaers D, 2010, ANN THORAC SURG, V90, P22, DOI 10.1016/j.athoracsur.2010.03.093; Vlasselaers D, 2009, LANCET, V373, P547, DOI 10.1016/S0140-6736(09)60044-1; Vriesendorp TM, 2006, CRIT CARE MED, V34, P2714, DOI 10.1097/01.CCM.0000241155.36689.91; Wysocki T, 2003, DIABETES CARE, V26, P1100, DOI 10.2337/diacare.26.4.1100; Yates AR, 2006, PEDIATR CRIT CARE ME, V7, P351, DOI 10.1097/01.PCC.0000227755.96700.98	46	17	17	0	4	ENDOCRINE SOC	WASHINGTON	2055 L ST NW, SUITE 600, WASHINGTON, DC 20036 USA	0021-972X	1945-7197		J CLIN ENDOCR METAB	J. Clin. Endocrinol. Metab.	OCT	2010	95	10					4669	4679		10.1210/jc.2010-0805			11	Endocrinology & Metabolism	Endocrinology & Metabolism	659NK	WOS:000282573300025	20668035	Bronze			2021-06-18	
J	Engel, DC; Mikocka-Walus, A; Cameron, PA; Maegele, M				Engel, D. C.; Mikocka-Walus, A.; Cameron, P. A.; Maegele, M.			Pre-hospital and in-hospital parameters and outcomes in patients with traumatic brain injury: A comparison between German and Australian trauma registries	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Traumatic brain injury; Pre-hospital management; Emergency medical service system; DOC-ALS; Paramedic; Trauma registry	SEVERE HEAD-INJURIES; GLASGOW COMA SCALE; PROGNOSTIC VALUE; MORTALITY; CARE; HYPOTENSION; SYSTEMS; AGE	Introduction: In Germany, physician-operated emergency medical services (EMS) manage most pre-hospital trauma care. Australia uses a different EMS system, deploying highly trained paramedics for road and air transport of trauma patients. The effect of these different systems on secondary insults to traumatic brain injury (TBI) patients is unclear. There is conflicting evidence regarding which system is preferable. To add to the body of evidence, we compared the profile of injury, pre-hospital management and outcomes of TBI patients from both populations. Methods: Cases aged >= 16 years, with AIS head >= 3, AIS other body parts <= 3, recorded in the Victorian State Trauma Registry (VSTR) and Trauma Registry of the German Society of Trauma Surgery (TR-DGU) from 2002 to 2007 were compared. Results: 10,183 cases (5665 German, 4518 Australian) were included. No difference in sex or median age was observed. There were major between-registry differences in type of injury, trauma circumstance, intent and severity of injury. German cases sustained more serious injury and received more pre-hospital interventions. Mortality was significantly higher amongst German patients even when adjusted for demographics, injury severity and in-and pre-hospital parameters. German patients had a longer hospital and ICU stay. Conclusion: There were clear differences in injury characteristics and outcomes in TBI patients between Germany and Australia. As differences in coding, data collection and patient selection are evident, firm conclusions regarding the contribution of variations in pre-hospital care are not possible. The differences in outcome deserve further exploration in prospective studies. (C) 2010 Elsevier Ltd. All rights reserved.	[Engel, D. C.] Univ Heidelberg Hosp, Dept Neurosurg, Heidelberg, Germany; [Mikocka-Walus, A.; Cameron, P. A.] Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia; [Maegele, M.] Univ Witten Herdecke, Inst Res Operat Med IFOM, Cologne, Germany; [Maegele, M.] Univ Witten Herdecke, CMMC, Dept Traumatol & Orthoped Surg, Cologne, Germany	Engel, DC (corresponding author), Univ Heidelberg Hosp, Dept Neurosurg, Heidelberg, Germany.	doortjeengel@gmail.com	Mikocka-Walus, Antonina/R-2363-2017; Mikocka-Walus, Antonina/B-4160-2010	Cameron, Peter/0000-0002-1443-557X; Mikocka-Walus, Antonina/0000-0003-4864-3956	Department of Human Services; Victorian Trauma Foundation	Authors are unaware of any conflicts of interest. The Victorian State Trauma Registry is a Department of Human Services and Victorian Trauma Foundation funded and approved initiative. The Trauma Registry of the German Society of Trauma Surgery is an initiative of the German Society of Trauma Surgery - Polytrauma Section.	Bernard Stephen A, 2006, Emerg Med Australas, V18, P221, DOI 10.1111/j.1742-6723.2006.00850.x; *BTF, 2000, J NEUROTRAUM, V17, P457; Butcher I, 2007, J NEUROTRAUM, V24, P281, DOI 10.1089/neu.2006.0030; Cameron PA, 2004, ANZ J SURG, V74, P424, DOI 10.1111/j.1445-1433.2004.03029.x; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Nieva JLGD, 2009, J EMERG MED, V37, P189, DOI 10.1016/j.jemermed.2007.10.089; Demetriades D, 2004, J AM COLL SURGEONS, V199, P216, DOI 10.1016/j.jamcollsurg.2004.02.030; Evans, 1991, TRAFFIC SAFETY DRIVE; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Kannus P, 2001, JAMA-J AM MED ASSOC, V286, P673, DOI 10.1001/jama.286.6.673; KRAUS JF, 1993, ACCIDENT ANAL PREV, V25, P229, DOI 10.1016/0001-4575(93)90018-R; Luukinen H, 1999, J AM GERIATR SOC, V47, P1451, DOI 10.1111/j.1532-5415.1999.tb01566.x; Maegele M, 2007, EUR SURG RES, V39, P372, DOI 10.1159/000107097; Manley G, 2001, ARCH SURG-CHICAGO, V136, P1118, DOI 10.1001/archsurg.136.10.1118; Marmarou A, 2007, J NEUROTRAUM, V24, P270, DOI 10.1089/neu.2006.0029; McHugh GS, 2007, J NEUROTRAUM, V24, P287, DOI 10.1089/neu.2006.0031; RADY MY, 1994, ANN EMERG MED, V24, P685, DOI 10.1016/S0196-0644(94)70279-9; Roudsari BS, 2007, INJURY, V38, P993, DOI 10.1016/j.injury.2007.03.028; Roudsari BS, 2007, INJURY, V38, P1001, DOI 10.1016/j.injury.2007.04.008; Stocchetti N, 1996, J TRAUMA, V40, P764, DOI 10.1097/00005373-199605000-00014; Sundstrom T, 2007, J NEUROTRAUM, V24, P147, DOI 10.1089/neu.2006.0099; Suzuki T, 2008, WEST J EMERG MED, V9, P166; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Westhoff J, 2003, INJURY, V34, P674, DOI 10.1016/S0020-1383(03)00147-5	24	17	17	0	6	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	SEP	2010	41	9					901	906		10.1016/j.injury.2010.01.002			6	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	634SL	WOS:000280605500005	20097343				2021-06-18	
J	Phillips, J; Drummond, A; Radford, K; Tyerman, A				Phillips, Julie; Drummond, Avril; Radford, Kathryn; Tyerman, Andy			Return to work after traumatic brain injury: recording, measuring and describing occupational therapy intervention	BRITISH JOURNAL OF OCCUPATIONAL THERAPY			English	Article						Traumatic brain injury; vocational rehabilitation; occupational therapy	VOCATIONAL-REHABILITATION; TREATMENT DEFINITION; BLACK-BOX; COMMUNITY; PHYSIOTHERAPY; DELIVERY; PEOPLE; ABI	Low post-injury employment rates indicate that returning to work is difficult following traumatic brain injury (TBI). Occupational therapists assist people with TBI to return to work, but rarely is their intervention described. This has hindered research into vocational rehabilitation. As no existing tool was identified for recording intervention, a proforma was developed for this study. Using best practice guidelines and a consensus of expert opinion, 15 categories of the vocational rehabilitation process were identified. Time spent on each category was recorded in 10-minute units after each occupational therapy session. The records of 21 participants who received occupational therapy focused on vocational rehabilitation were analysed. The proforma was quick and simple to use. The analysis showed that assessment, work preparation, employer involvement, education and dealing with issues of immediate concern to participants accounted for almost 85% of face-to-face intervention. It also showed that for every 1 hour of face-to-face contact, an additional 2 hours was required for liaison and travel. This study showed that there is potential for using a proforma for quantifying and describing occupational therapy. This is the basis for further work to enable meaningful comparisons with other services and use in future studies.	[Phillips, Julie; Drummond, Avril] Univ Nottingham, Queens Med Ctr, Sch Med, Div Rehabil & Ageing,Sch Community Hlth Sci, Nottingham NG7 2UH, England; [Radford, Kathryn] Univ Cent Lancashire, Preston, Lancs, England; [Tyerman, Andy] Cambourne Ctr, Community Head Injury Serv, Aylesbury, Bucks, England	Phillips, J (corresponding author), Univ Nottingham, Queens Med Ctr, Sch Med, Div Rehabil & Ageing,Sch Community Hlth Sci, Derby Rd, Nottingham NG7 2UH, England.	julie.phillips@nottingham.ac.uk	Radford, Kate A/F-8571-2013	Radford, Kate A/0000-0001-6246-3180; Drummond, Avril/0000-0003-1220-8354	College of Occupational Therapists	This study was funded by the College of Occupational Therapists. The authors wish to acknowledge the members of the steering group for their invaluable help With this study: Dr Tracey Sach, Senior Lecturer in Health Economics, University of East Anglia; Professor Marion Walker, Professor in Stroke Rehabilitation, University of Nottingham; Dr Naseer Habuoubi, Consultant in Rehabilitation Medicine, University Hospitals Nottingham; and Mr Trevor Jones, patient representative.	[Anonymous], 2005, CLIN REHABIL, V19, P811, DOI 10.1191/0269215505cr923ed; Ballinger C, 1999, CLIN REHABIL, V13, P301, DOI 10.1191/026921599673198490; Barnes T., 2007, OCCUPATIONAL THERAPY; Barnes T, 2006, OCCUPATIONAL THERAPY; *BRIT SOC REH MED, 1998, REH TRAUM BRAIN INJ; British Society of Rehabilitation Medicine, 2003, VOC REH WAY FORW EX; British Society of Rehabilitation Medicine, 2000, VOC REH WAY FORW WOR; British Society of Rehabilitation Medicine Royal College of Physicians, 2003, REH FOLL ACQ BRAIN I; Catalano D, 2006, NEUROREHABILITATION, V21, P279; Coetzer R, 2008, NEUROPSYCHOL REHABIL, V18, P766, DOI 10.1080/09602010701860266; Creek J, 2005, BRIT J OCCUPATIONAL, V68, P281, DOI DOI 10.1177/030802260506800607; De Wit L, 2007, CLIN REHABIL, V21, P450, DOI 10.1177/0269215507074385; Department for Work & Pensions and Department of Health, 2008, IMPR HLTH WORK CHANG; Department of Health, 2005, NAT SERV FRAM LONG T; Deshpande P, 2004, VOCATIONAL ASSESSMEN; Evans CC, 2008, J HEAD TRAUMA REHAB, V23, P329, DOI 10.1097/01.HTR.0000336845.06704.bc; Frank AO, 2006, INT J THER REHABIL, V13, P126, DOI 10.12968/ijtr.2006.13.3.21364; Geurtsen GJ, 2010, J REHABIL MED, V42, P97, DOI 10.2340/16501977-0508; Groswasser Z, 1999, NEUROPSYCHOL REHABIL, V9, P493, DOI 10.1080/096020199389545; Hart T, 2006, J HEAD TRAUMA REHAB, V21, P467, DOI 10.1097/00001199-200611000-00002; Hart T, 2009, NEUROPSYCHOL REHABIL, V19, P824, DOI 10.1080/09602010902995945; Huang HC, 2009, J CHIN MED ASSOC, V72, P257, DOI 10.1016/S1726-4901(09)70066-8; Johansson U, 2001, DISABIL REHABIL, V23, P474; Kendall E, 2006, J VOCAT REHABIL, V25, P149; Kuipers P, 2003, DISABIL REHABIL, V25, P154, DOI 10.1080/0963828021000024898; Murphy L, 2006, BRAIN INJURY, V20, P1119, DOI 10.1080/02699050600664335; O'Brien L, 2007, BRAIN INJURY, V21, P465, DOI 10.1080/02699050701315134; *OFF NAT STAT, 2000, STAND OCC CLASS 2000; Ownsworth T, 2004, DISABIL REHABIL, V26, P765, DOI 10.1080/09638280410001696700; Son AHPWV, 2007, CLIN REHABIL, V21, P1024, DOI 10.1177/0269215507077603; Tyerman A, 2004, VOCATIONAL ASSESSMEN; van Velzen JM, 2009, BRAIN INJURY, V23, P473, DOI 10.1080/02699050902970737; Vocational Rehabilitation Association, 2007, VRA STAND PRACT REP; Wagner AK, 2002, ARCH PHYS MED REHAB, V83, P107, DOI 10.1053/apmr.2002.27470; Walker WC, 2006, ARCH PHYS MED REHAB, V87, P1576, DOI 10.1016/j.apmr.2006.08.335; Whyte J, 2003, AM J PHYS MED REHAB, V82, P639, DOI 10.1097/01.PHM.0000078200.61840.2D; Whyte J, 2009, NEUROPSYCHOL REHABIL, V19, P807, DOI 10.1080/09602010903031146	37	17	17	0	18	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0308-0226	1477-6006		BRIT J OCCUP THER	Br. J. Occup. Ther.	SEP	2010	73	9					422	430		10.4276/030802210X12839367526138			9	Rehabilitation	Rehabilitation	V26JZ	WOS:000208543200005					2021-06-18	
J	Edwards, D; Das, M; Molnar, P; Hickman, JJ				Edwards, Darin; Das, Mainak; Molnar, Peter; Hickman, James J.			Addition of glutamate to serum-free culture promotes recovery of electrical activity in adult hippocampal neurons in vitro	JOURNAL OF NEUROSCIENCE METHODS			English	Article						Adult; Neuron; Culture; Hippocampal; Electrophysiology	PYRAMIDAL NEURONS; GENE-EXPRESSION; DEFINED SYSTEM; CELL; EXCITABILITY; PROTEIN; SURFACE; PLASTICITY; MONOLAYERS; BIOSENSORS	A long-term cell culture system utilizing normal adult hippocampal neurons would represent an important tool that could be useful in research on the mature brain, neurological disorders and age-related neurological diseases. Historically, in vitro neuronal systems are derived from embryonic rather than mature brain tissue, a practice predicated upon difficulties in supporting regeneration, functional recovery and long-term survival of adult neurons in vitro. A few studies have shown that neurons derived from the hippocampal tissue of adult rats can survive and regenerate in vitro under serum-free conditions. However, while the adult neurons regenerated morphologically under these conditions, both the electrical activity characteristic of in vivo neurons as well as long-term neuronal survival was not consistently recovered in vitro. In this study, we report on the development of a defined culture system with the ability to support functional recovery and long-term survival of adult rat hippocampal neurons. In this system, the cell-adhesive substrate, N-1[3-(trimethoxysilyl) propyl]-diethylenetriamine, supported neuronal attachment, regeneration, and long-term survival of adult neurons for more than 80 days in vitro. Additionally, the excitatory neurotransmitter glutamate, applied at 25 mu M for 1-7 days after morphological neuronal regeneration in vitro, enabled full recovery of neuronal electrical activity. This low concentration of glutamate promoted the recovery of neuronal electrical activity but with minimal excitotoxicity. These improvements allowed electrically active adult neurons to survive in vitro for several months, providing a stable test-bed for the long-term study of regeneration in adult-derived neuronal systems, especially for traumatic brain injury (TBI). (C) 2010 Elsevier B.V. All rights reserved.	[Edwards, Darin; Das, Mainak; Molnar, Peter; Hickman, James J.] NanoSci Technol Ctr, Orlando, FL 32826 USA	Hickman, JJ (corresponding author), NanoSci Technol Ctr, 12424 Res Pkwy,Suite 400, Orlando, FL 32826 USA.	jhickman@mail.ucf.edu			Department of EnergyUnited States Department of Energy (DOE) [DE-FG-02-04ER 46171]; UCF internal funds; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [5R01EB005459]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [R01EB005459] Funding Source: NIH RePORTER	Department of Energy DE-FG-02-04ER 46171 and UCF internal funds and NIH grant number 5R01EB005459.; The authors would like to acknowledge funding support from the Department of Energy, grant number DE-FG-02-04ER 46171 and National Institute of Health, grant number 5R01EB005459.	AUDITORE JV, 1966, J NEUROCHEM, V13, P1149, DOI 10.1111/j.1471-4159.1966.tb04272.x; Balazs R, 2006, CURR TOP MED CHEM, V6, P961, DOI 10.2174/156802606777323700; Barone FC, 1998, STROKE, V29, P1937, DOI 10.1161/01.STR.29.9.1937; Bousse L, 1996, SENSOR ACTUAT B-CHEM, V34, P270, DOI 10.1016/S0925-4005(96)01906-5; Brewer GJ, 1997, J NEUROSCI METH, V71, P143, DOI 10.1016/S0165-0270(96)00136-7; Brewer GJ, 2005, EXP GERONTOL, V40, P426, DOI 10.1016/j.exger.2005.03.007; Brewer GJ, 1998, NEUROBIOL AGING, V19, P561, DOI 10.1016/S0197-4580(98)00091-8; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; COCERES A, 1984, BRAIN RES, V315, P314; Dalva MB, 2000, CELL, V103, P945, DOI 10.1016/S0092-8674(00)00197-5; Daoudal G, 2002, P NATL ACAD SCI USA, V99, P14512, DOI 10.1073/pnas.222546399; Das M, 2005, IN VITRO CELL DEV-AN, V41, P343; Das M, 2003, BIOTECHNOL PROGR, V19, P1756, DOI 10.1021/bp034076l; Das M, 2008, EXP NEUROL, V209, P171, DOI 10.1016/j.expneurol.2007.09.019; Evans MS, 1998, J NEUROSCI METH, V79, P37, DOI 10.1016/S0165-0270(97)00159-3; Ginsberg SD, 2005, AM J GERIAT PSYCHIAT, V13, P1052, DOI 10.1176/appi.ajgp.13.12.1052; Harms H, 2006, APPL MICROBIOL BIOT, V70, P273, DOI 10.1007/s00253-006-0319-4; Heiduschka P, 1998, PROG NEUROBIOL, V55, P433, DOI 10.1016/S0301-0082(98)00013-6; HICKMAN JJ, 1994, J VAC SCI TECHNOL A, V12, P607, DOI 10.1116/1.578844; Husi H, 2000, NAT NEUROSCI, V3, P661; Kornhauser JM, 2002, NEURON, V34, P221, DOI 10.1016/S0896-6273(02)00655-4; MATTSON MP, 1988, BRAIN RES REV, V13, P179, DOI 10.1016/0165-0173(88)90020-3; MATTSON MP, 1988, J NEUROSCI, V8, P2087; Nakagawa S, 2002, J NEUROSCI, V22, P9868; Ravenscroft MS, 1998, J AM CHEM SOC, V120, P12169, DOI 10.1021/ja973669n; Schaffner AE, 1995, J NEUROSCI METH, V62, P111, DOI 10.1016/0165-0270(95)00063-1; Simpson ML, 2001, TRENDS BIOTECHNOL, V19, P317, DOI 10.1016/S0167-7799(01)01691-2; Sjostrom PJ, 2008, PHYSIOL REV, V88, P769, DOI 10.1152/physrev.00016.2007; SPARGO BJ, 1994, P NATL ACAD SCI USA, V91, P11070, DOI 10.1073/pnas.91.23.11070; STEMPLE DL, 1992, CELL, V71, P973, DOI 10.1016/0092-8674(92)90393-Q; Stenger DA, 1998, J NEUROSCI METH, V82, P167, DOI 10.1016/S0165-0270(98)00047-8; STENGER DA, 1993, BRAIN RES, V630, P136, DOI 10.1016/0006-8993(93)90651-3; Tominaga-Yoshino K, 2008, HIPPOCAMPUS, V18, P281, DOI 10.1002/hipo.20391; Verderio C, 1999, CELL MOL LIFE SCI, V55, P1448, DOI 10.1007/s000180050384; Walmsley B, 2006, J PHYSIOL-LONDON, V572, P313, DOI 10.1113/jphysiol.2006.104851; West AE, 2001, P NATL ACAD SCI USA, V98, P11024, DOI 10.1073/pnas.191352298; Zhang W, 2003, NAT REV NEUROSCI, V4, P885, DOI 10.1038/nrn1248; Zhu DM, 2005, J NEUROSCI RES, V80, P104, DOI 10.1002/jnr.20422	38	17	21	0	10	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0165-0270	1872-678X		J NEUROSCI METH	J. Neurosci. Methods	JUL 15	2010	190	2					155	163		10.1016/j.jneumeth.2010.04.030			9	Biochemical Research Methods; Neurosciences	Biochemistry & Molecular Biology; Neurosciences & Neurology	630EV	WOS:000280256700001	20452373	Green Accepted			2021-06-18	
J	Colgan, NC; Cronin, MM; Gobbo, OL; O'Mara, SM; O'Connor, WT; Gilchrist, MD				Colgan, Niall C.; Cronin, Michelle M.; Gobbo, Oliviero L.; O'Mara, Shane M.; O'Connor, William T.; Gilchrist, Michael D.			Quantitative MRI Analysis of Brain Volume Changes due to Controlled Cortical Impact	JOURNAL OF NEUROTRAUMA			English	Article						animal studies; MRI; rat; traumatic brain injury	HEAD-INJURY; NEUROPSYCHIATRIC SEQUELAE; EARLY INTERVENTION; MILD; RATS; PRESSURE; DEATH; INFLAMMATION; EVOLUTION; ATROPHY	More than 85% of reported brain traumas are classified clinically as "mild'' using the Glasgow Coma Scale (GCS); qualitative MRI findings are scarce and provide little correspondence to clinical symptoms. Our goal, therefore, was to establish in vivo sequelae of traumatic brain injury (TBI) following lower and higher levels of impact to the frontal lobe using quantitative MRI analysis and a mechanical model of penetrating impact injury. To investigate time-based morphological and physiological changes of living tissue requires a surrogate for the human central nervous system. The present model for TBI was a systematically varied and controlled cortical impact on deeply-anaesthetized Sprague-Dawley rats, that was designed to mimic different injury severities. Whole-brain MRI scans were performed on each rat prior to either a lower- or a higher-level of impact, and then at hourly intervals for 5 h post-impact. Both brain volume and specific anatomical structures were segmented from MR images for inter-subject comparisons post-registration. Animals subjected to lower and higher impact levels exhibited elevated intracranial pressure (ICP) in the low compensatory reserve (i.e., nearly exhausted), and terminal disturbance (i.e., exhausted) ranges, respectively. There was a statistically significant drop in cerebrospinal fluid (CSF) of 35% in the lower impacts, and 65% in the higher impacts, at 5 h compared to sham controls. There was a corresponding increase in corpus callosum volume starting at 1 h, of 60-110% and 30-40% following the lower- and higher-impact levels, respectively. A statistically significant change in the abnormal tissue from 2 h to 5 h was observed for both impact levels, with greater significance for higher impacts. Furthermore, a statistically significant difference between the lower impacts and the sham controls occurred at 3 h. These results are statistically substantiated by a fluctuation in the physical size of the corpus callosum, a decrease in the volume of CSF, and elevated levels of atrophy in the cerebral cortex.	[Colgan, Niall C.; Gilchrist, Michael D.] Natl Univ Ireland Univ Coll Dublin, Sch Elect Elect & Mech Engn, Dublin 4, Ireland; [Cronin, Michelle M.; O'Connor, William T.] Natl Univ Ireland Univ Coll Dublin, Conway Inst, Dublin 4, Ireland; [Gobbo, Oliviero L.; O'Mara, Shane M.] Trinity Coll Dublin, Inst Neurosci, Dublin, Ireland; [O'Connor, William T.] Univ Limerick, Grad Entry Med Sch, Castletroy, County Limerick, Ireland; [Gilchrist, Michael D.] Univ Ottawa, Sch Human Kinet, Ottawa, ON K1N 6N5, Canada	Gilchrist, MD (corresponding author), Natl Univ Ireland Univ Coll Dublin, Sch Elect Elect & Mech Engn, Dublin 4, Ireland.	michael.gilchrist@ucd.ie	O'Connor, William T./I-7459-2015; Gobbo, Oliviero/R-1763-2016; Gobbo, Oliviero/S-2043-2019; Colgan, Niall C/R-8537-2016; Gilchrist, Michael D/B-6100-2017	Gobbo, Oliviero/0000-0003-4629-9485; Gobbo, Oliviero/0000-0003-4629-9485; Colgan, Niall C/0000-0002-6482-0601; Gilchrist, Michael D/0000-0003-1765-429X; O'Mara, Shane/0000-0001-8087-8531; O'Connor, William/0000-0003-0082-1119	Higher Education Authority and Science Foundation IrelandScience Foundation Ireland [SC/2003/029]	We thank Mr. Gregory Byrne (University College Dublin) for his assistance in building the CCI apparatus, and Dr. Christian Kerskens (Trinity College Dublin) for his assistance in computer-assisted image analysis. This work was funded under an Enterprise Ireland basic research grant (SC/2003/029), using MRI facilities that were funded by the Programme for Research in Third Level Institutions by the Higher Education Authority and Science Foundation Ireland.	Andrews PJD, 2004, INTENS CARE MED, V30, P1730, DOI 10.1007/s00134-004-2376-4; BARTH JT, 1983, NEUROSURGERY, V13, P529, DOI 10.1227/00006123-198311000-00008; Bigler ED, 2001, J HEAD TRAUMA REHAB, V16, P117, DOI 10.1097/00001199-200104000-00003; Bowen JM, 1997, DEV MED CHILD NEUROL, V39, P17; Bramlett HM, 2002, ACTA NEUROPATHOL, V103, P607, DOI 10.1007/s00401-001-0510-8; Breen N, 2000, J ACCID EMERG MED, V17, P392; Chaudhury S, 2005, INDIAN J NEUROTRAUM, V2, P13, DOI 10.1016/S0973-0508(05)80005-X; CHERIAN L, 1994, J NEUROTRAUM, V11, P573, DOI 10.1089/neu.1994.11.573; Cohen BA, 2007, AM J NEURORADIOL, V28, P907; COLGAN N, 2009, THESIS U COLL DUBLIN; Colicos MA, 1996, BRAIN RES, V739, P111, DOI 10.1016/S0006-8993(96)00819-0; Conti AC, 1998, J NEUROSCI, V18, P5663; COPE DN, 1982, ARCH PHYS MED REHAB, V63, P433; Cronin C, 2008, IRISH J MED SCI, V177, P171, DOI 10.1007/s11845-008-0148-9; Dixon CE, 1999, J NEUROTRAUM, V16, P109, DOI 10.1089/neu.1999.16.109; DIXON CE, 1991, J NEUROSCI METH, V39, P253; EEC, 1986, OFFICIAL J EUROPEAN; EVANS RW, 1996, MED COMPLICATIONS HE; Friston KJ, 1995, HUM BRAIN MAPP, V3, P165, DOI 10.1002/hbm.460030303; Gefen A, 2003, J NEUROTRAUM, V20, P1163, DOI 10.1089/089771503770802853; Gilchrist MD, 2004, STRAIN, V40, P180, DOI 10.1111/j.1475-1305.2004.00168.x; Graham DI, 2000, ACTA NEUROPATHOL, V99, P117, DOI 10.1007/PL00007414; Gutteridge S, 2002, MAGNET RESON MED, V47, P871, DOI 10.1002/mrm.10142; Hall ED, 2008, J NEUROTRAUM, V25, P235, DOI 10.1089/neu.2007.0383; Holmin S, 1998, NEUROSURGERY, V42, P291, DOI 10.1097/00006123-199802000-00047; Hurley RA, 2004, J NEUROPSYCH CLIN N, V16, P1, DOI 10.1176/appi.neuropsych.16.1.1; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; King JT, 2005, J NEUROTRAUM, V22, P947, DOI 10.1089/neu.2005.22.947; Kraus JF, 1996, NEUROL CLIN, V14, P435, DOI 10.1016/S0733-8619(05)70266-8; Kuroiwa Toshihiko, 2007, Neurosurg Focus, V22, pE11, DOI 10.3171/foc.2007.22.5.12; LANGLOIS JA, 2004, TRAUMATIC BRAIN INJU, P1; LOFGREN J, 1973, ACTA NEUROL SCAND, V49, P557; MACKAY LE, 1992, ARCH PHYS MED REHAB, V73, P635; MacKenzie JD, 2002, AM J NEURORADIOL, V23, P1509; MARMAROU A, 1975, J NEUROSURG, V43, P523, DOI 10.3171/jns.1975.43.5.0523; MARMAROU A, 1991, J NEUROSURG, V75, pS59, DOI 10.3171/sup.1991.75.1s.0s59; MCALLISTER TW, 1992, PSYCHIAT CLIN N AM, V15, P395; MUTHUPILLAI R, 1995, SCIENCE, V269, P1854, DOI 10.1126/science.7569924; NILSSON P, 1990, J CEREBR BLOOD F MET, V10, P631, DOI 10.1038/jcbfm.1990.115; Ponsford J, 2002, J NEUROL NEUROSUR PS, V73, P330, DOI 10.1136/jnnp.73.3.330; RYDER HW, 1953, J LAB CLIN MED, V41, P428; SALVADO O, 2004, IEEE ENG MED BIOL SO, P539; SKLAR FH, 1977, J NEUROSURG, V47, P670, DOI 10.3171/jns.1977.47.5.0670; Smith DH, 2000, NEUROSCIENTIST, V6, P483, DOI 10.1177/107385840000600611; Smith DH, 1997, J NEUROTRAUM, V14, P715, DOI 10.1089/neu.1997.14.715; SORENSON SB, 1991, J HEAD TRAUMA REHAB, V6, P1, DOI DOI 10.1097/00001199-199106000-00003; Steiner LA, 2006, BRIT J ANAESTH, V97, P26, DOI 10.1093/bja/ael110; SUTTON RL, 1993, J NEUROTRAUM, V10, P135, DOI 10.1089/neu.1993.10.135; SZEWCZYKOWSKI J, 1977, J NEUROSURG, V47, P19, DOI 10.3171/jns.1977.47.1.0019; TEASDALE G, 1976, ACTA NEUROCHIR, V34, P45, DOI 10.1007/BF01405862; Tofts P, 2003, QUANTITATIVE MRI OF THE BRAIN: MEASURING CHANGES CAUSED BY DISEASE, pXV; VANZOMEREN AH, 1985, J NEUROL NEUROSUR PS, V48, P21, DOI 10.1136/jnnp.48.1.21; WHITFIELD A, 1989, BRIT J ANAESTH, V62, P694, DOI 10.1093/bja/62.6.694; Whiting M. D., 2006, ANIMAL MODELS COGNIT; Williams AJ, 2006, J NEUROTRAUM, V23, P1828, DOI 10.1089/neu.2006.23.1828; Yu SJ, 2009, BRAIN RES, V1287, P157, DOI 10.1016/j.brainres.2009.06.067	56	17	17	0	6	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL	2010	27	7					1265	1274		10.1089/neu.2009.1267			10	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	631FD	WOS:000280331100011	20486804				2021-06-18	
J	Wetherington, CE; Hooper, SR; Keenan, HT; Nocera, M; Runyan, D				Wetherington, Crista E.; Hooper, Stephen R.; Keenan, Heather T.; Nocera, Maryalice; Runyan, Desmond			Parent Ratings of Behavioral Functioning After Traumatic Brain Injury in Very Young Children	JOURNAL OF PEDIATRIC PSYCHOLOGY			English	Article						Behavioral ratings post traumatic brain injury; preschool traumatic brain injury; traumatic brain injury	DIATHESIS-STRESS-MODEL; LONG-TERM OUTCOMES; CLOSED-HEAD-INJURY; DEPRESSIVE SYMPTOMS; CHRONIC ILLNESS; ADOLESCENTS; CHILDHOOD; FAMILY; PREVALENCE; PREDICTORS	Objective The behavioral ratings of preschoolers who sustained traumatic brain injury (TBI) prior to the age of 2 years and a typically developing group were compared; predictors of behavioral functioning were examined. Methods Eighty-two 3-year-olds comprised mild TBI (n = 31), moderate/severe TBI (n = 20), and typically developing (n = 31) groups, with Child Behavior Checklist (CBCL) as the primary outcome measure. Results Groups differed on the CBCL Withdrawal Scale. No differences emerged in the proportion of children demonstrating clinical elevations, with average mean scores for each group. Exploratory analyses yielded no differences between inflicted, non-inflicted, and typical groups. Glasgow Coma Scale and Self-Report Family Inventory Leadership predicted Externalizing Problems; developmental level predicted Internalizing Problems. Conclusions After early TBI, preschoolers did not differ from one another or a matched comparison group in behavioral ratings; however, it may be premature to infer that preschoolers do not evidence behavioral dysfunction after early TBI.	[Hooper, Stephen R.] Univ N Carolina, Sch Med, Clin Ctr Study Dev & Learning, Carolina Inst Dev Disabil, Chapel Hill, NC 27599 USA; [Wetherington, Crista E.] Univ Texas SW Med Ctr, Ctr Pediat Psychiat, Childrens Med Ctr Dallas, Dallas, TX USA; [Wetherington, Crista E.] Univ Texas SW Med Ctr, Dept Psychiat, Dallas, TX USA; [Hooper, Stephen R.] Univ N Carolina, Sch Med, Dept Psychiat, Chapel Hill, NC 27599 USA; [Hooper, Stephen R.; Runyan, Desmond] Univ N Carolina, Sch Med, Dept Pediat, Chapel Hill, NC 27599 USA; [Keenan, Heather T.] Univ Utah, Dept Pediat, Sch Med, Salt Lake City, UT 84112 USA; [Nocera, Maryalice; Runyan, Desmond] Univ N Carolina, Sch Med, Injury Prevent Res Ctr, Chapel Hill, NC 27599 USA; [Runyan, Desmond] Univ N Carolina, Sch Med, Dept Social Med, Chapel Hill, NC 27599 USA; [Runyan, Desmond] Univ N Carolina, Sch Med, Dept Pediat, Chapel Hill, NC 27599 USA	Hooper, SR (corresponding author), Univ N Carolina, Sch Med, Clin Ctr Study Dev & Learning, Carolina Inst Dev Disabil, CB 7255, Chapel Hill, NC 27599 USA.	stephen.hooper@cdl.unc.edu	Runyan, Desmond/S-3974-2016; Hooper, Stephen/X-8171-2019	Runyan, Desmond/0000-0001-5571-9029; 	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K23HD041040] Funding Source: NIH RePORTER; NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K23 HD041040-01A2, K23 HD041040] Funding Source: Medline		Achenbach T. M., 2000, CHILD BEHAV CHECKLIS; Anderson V, 2005, BRAIN INJURY, V19, P699, DOI 10.1080/02699050400025281; Anderson VA, 2001, PEDIATR NEUROSURG, V34, P138, DOI 10.1159/000056009; Beavers W. R., 1990, SELF REPORT FAMILY I; BEAVERS WR, 1985, FAM PROCESS, V24, P398, DOI 10.1111/j.1545-5300.1985.00398.x; BROWN G, 1981, PSYCHOL MED, V11, P63, DOI 10.1017/S0033291700053289; Burke P, 1999, PSYCHOSOMATICS, V40, P5, DOI 10.1016/S0033-3182(99)71266-1; Carpentier MY, 2007, CHILD HEALTH CARE, V36, P181, DOI 10.1080/02739610701335027; Dennis M, 2001, J INT NEUROPSYCH SOC, V7, P683, DOI 10.1017/S1355617701766040; Donders J, 1996, J HEAD TRAUMA REHAB, V11, P67, DOI 10.1097/00001199-199606000-00010; Ewing-Cobbs L, 1997, J Int Neuropsychol Soc, V3, P581; EWINGCOBBS L, 1995, J HEAD TRAUMA REHAB, V10, P13, DOI 10.1097/00001199-199510000-00004; FAY GC, 1994, ARCH PHYS MED REHAB, V75, P733; Fenwick T, 1999, CHILD NEUROPSYCHOL, V5, P213, DOI 10.1076/0929-7049(199912)05:04;1-R;FT213; FLETCHER JM, 1990, J CONSULT CLIN PSYCH, V58, P93, DOI 10.1037/0022-006X.58.1.93; Green ML, 1998, J PEDIATR PSYCHOL, V23, P289, DOI 10.1093/jpepsy/23.5.289; HAMPSON RB, 1991, J FAMILY PSYCHOL, V4, P326, DOI DOI 10.1037/0893-3200.4.3.326; Janusz JA, 2002, CHILD NEUROPSYCHOL, V8, P179, DOI 10.1076/chin.8.3.179.13499; Keenan HT, 2007, PEDIATRICS, V119, pE616, DOI 10.1542/peds.2006-2313; Keenan HT, 2003, JAMA-J AM MED ASSOC, V290, P621, DOI 10.1001/jama.290.5.621; Kesler SR, 2008, J PEDIATR-US, V152, P513, DOI 10.1016/j.jpeds.2007.08.009; Kinsella G, 1999, J CONSULT CLIN PSYCH, V67, P116, DOI 10.1037/0022-006X.67.1.116; Kirkwood M, 2000, CHILD NEUROPSYCHOL, V6, P195, DOI 10.1076/chin.6.3.195.3157; Max JE, 1998, ARCH PHYS MED REHAB, V79, P893, DOI 10.1016/S0003-9993(98)90084-3; Morris MC, 2008, J ABNORM PSYCHOL, V117, P719, DOI 10.1037/a0013741; Mullen E. M., 1995, MULLEN SCALES EARLY; QI CH, 1995, LANG SPEECH HEAR SER, V37, P5; Rescorla LA, 2005, MENT RETARD DEV D R, V11, P226, DOI 10.1002/mrdd.20071; Schwartz L, 2003, J PEDIATR PSYCHOL, V28, P251, DOI 10.1093/jpepsy/jsg013; Taylor HG, 2002, NEUROPSYCHOLOGY, V16, P15, DOI 10.1037//0894-4105.16.1.15; Wagner J, 2007, CHILD HEALTH CARE, V36, P45, DOI 10.1080/02739610701316878; Wagner JL, 2009, J PEDIATR PSYCHOL, V34, P89, DOI 10.1093/jpepsy/jsn052; Yeates KO, 2004, J INT NEUROPSYCH SOC, V10, P412, DOI 10.1017/S1355617704103093	33	17	17	0	7	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0146-8693	1465-735X		J PEDIATR PSYCHOL	J. Pediatr. Psychol.	JUL	2010	35	6					662	671		10.1093/jpepsy/jsp081			10	Psychology, Developmental	Psychology	616EN	WOS:000279191700010	19820170	Green Published, Bronze			2021-06-18	
J	Dai, SS; Li, W; An, JH; Wang, H; Yang, N; Chen, XY; Zhao, Y; Li, P; Liu, P; Chen, JF; Zhou, YG				Dai, Shuang-Shuang; Li, Wei; An, Jian-Hong; Wang, Hao; Yang, Nan; Chen, Xing-Yun; Zhao, Yan; Li, Ping; Liu, Ping; Chen, Jiang-Fan; Zhou, Yuan-Guo			Adenosine A2A receptors in both bone marrow cells and non-bone marrow cells contribute to traumatic brain injury	JOURNAL OF NEUROCHEMISTRY			English	Article						adenosine A2A receptor; bone marrow-derived cell; glutamate; knockout; neuroinflammation; traumatic brain injury	ISCHEMIA-REPERFUSION INJURY; EXCITATORY AMINO-ACIDS; A(2A) RECEPTOR; GLUTAMATE RELEASE; INDUCED EXCITOTOXICITY; CEREBRAL-ISCHEMIA; P38 MAPK; IN-VIVO; ACTIVATION; PROTECTION	P>Adenosine A2A receptors (A(2A)Rs) in bone marrow-derived cells (BMDCs) are involved in regulation of inflammation and outcome in several CNS injuries; however their relative contribution to traumatic brain injury (TBI) is unknown. In this study, we created a mouse cortical impact model, and BMDC A(2A)Rs were selectively inactivated in wild-type (WT) mice or reconstituted in global A(2A)R knockout (KO) mice (i.e. inactivation of non-BMDC A(2A)Rs) by bone marrow transplantation. When compared with WT mice, selective inactivation of BMDC A(2A)Rs significantly attenuated the neurological deficits, brain water content and cell apoptosis at 24 h post-TBI as global A(2A)R KO did. However, compared with the A(2A)R KO mice, selective reconstitution of BMDC A(2A)Rs failed to reinstate brain injury, indicating the contribution of the non-BMDC A(2A)R to TBI. Furthermore, the protective outcome by selective inactivation of BMDC A(2A)R or broad inactivation of non-BMDC A(2A)Rs was accompanied with reduced CSF glutamate level and suppression of the inflammatory cytokines interleukin-1, or interleukin-1 and tumor necrosis factor-alpha. These findings demonstrate that inactivation of A(2A)Rs in either BMDCs or non-BMDCs is sufficient to confer the protective effect as global A(2A)R KO against TBI, indicating the A(2A)R involvement in TBI by multiple cellular mechanisms of A(2A)R involvement including inhibition of glutamate release and inflammatory cytokine expressions.	[Chen, Jiang-Fan] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [Dai, Shuang-Shuang; Li, Wei; An, Jian-Hong; Wang, Hao; Yang, Nan; Chen, Xing-Yun; Zhao, Yan; Li, Ping; Liu, Ping; Zhou, Yuan-Guo] Third Mil Med Univ, Inst Surg Res, State Key Lab Trauma Burn & Combined Injury, Ctr Mol Biol, Chongqing, Peoples R China; [Dai, Shuang-Shuang; Li, Wei; An, Jian-Hong; Wang, Hao; Yang, Nan; Chen, Xing-Yun; Zhao, Yan; Li, Ping; Liu, Ping; Zhou, Yuan-Guo] Third Mil Med Univ, Daping Hosp, Chongqing, Peoples R China; [Dai, Shuang-Shuang] Third Mil Med Univ, Dept Biochem & Mol Biol, Chongqing, Peoples R China; [Li, Wei] Third Mil Med Univ, Inst Surg Res, Dept Neurol, Chongqing, Peoples R China	Chen, JF (corresponding author), Boston Univ, Sch Med, Dept Neurol, 715 Albany St,C329, Boston, MA 02118 USA.	chenjf@bu.eduYuan-Guo; ygzhou@cta.cq.cn	Li, ping/J-6507-2019	Chen, Xingyun/0000-0001-7699-4425	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [30328015, 30900587]	We gratefully acknowledge the technical and equipment support provided by Drs Minghui Xu and Guansong Wang. We thank Dr Xing Lei for irradiation and Mr Chun Hu for handling of the animals. This work was supported by grants from the National Natural Science Foundation of China (No 30328015 and No. 30900587).	An Jian-Hong, 2007, Zhonghua Xue Ye Xue Za Zhi, V28, P174; Blum D, 2003, J NEUROSCI, V23, P5361; BROWN J, 1996, GLUTAMATE CYTOKINE R, P3968; CARLTON JT, 1999, BIOL INVASIONS, V1, P1; Cassada DC, 2002, ANN THORAC SURG, V74, P846, DOI 10.1016/S0003-4975(02)03793-1; Cassinis G, 2002, MEMOIRE ASS GEOLOGUE, V2, P53; Chaparro-Huerta V, 2005, J NEUROIMMUNOL, V165, P53, DOI 10.1016/j.jneuroim.2005.04.025; Chen JF, 1999, J NEUROSCI, V19, P9192, DOI 10.1523/jneurosci.19-21-09192.1999; Chen JF, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-10-j0001.2001; Chen JF, 2007, PROG NEUROBIOL, V83, P310, DOI 10.1016/j.pneurobio.2007.09.002; Corsi C, 1999, NEUROREPORT, V10, P687, DOI 10.1097/00001756-199903170-00005; Corsi C, 2000, NEUROREPORT, V11, P2591, DOI 10.1097/00001756-200008030-00048; Dai Shuangshuang, 2008, Sheng Wu Gong Cheng Xue Bao, V24, P700; Day YJ, 2004, AM J PHYSIOL-GASTR L, V286, pG285, DOI 10.1152/ajpgi.00348.2003; Day YJ, 2005, J IMMUNOL, V174, P5040, DOI 10.4049/jimmunol.174.8.5040; Day YJ, 2005, AM J PHYSIOL-RENAL, V288, pF722, DOI 10.1152/ajprenal.00378.2004; Day YJ, 2003, J CLIN INVEST, V112, P883, DOI 10.1172/JCI200315483; de Mendonca A, 2000, BRAIN RES REV, V33, P258, DOI 10.1016/S0165-0173(00)00033-3; Dionisotti S, 1996, J PHARMACOL EXP THER, V278, P1209; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Fenster MS, 2000, MICROCIRCULATION, V7, P129, DOI 10.1038/sj.mn.7300101; Fink JS, 2004, J NEUROCHEM, V88, P538, DOI 10.1046/j.1471-4159.2003.02145.x; Fredholm BB, 2003, CURR TOP MED CHEM, V3, P413, DOI 10.2174/1568026033392200; Graham DI, 2000, J NEUROPATH EXP NEUR, V59, P641, DOI 10.1093/jnen/59.8.641; Hasko G, 2006, CRIT CARE MED, V34, P1119, DOI 10.1097/01.CCM.0000206467.19509.C6; Hasko G, 2008, J LEUKOCYTE BIOL, V83, P447, DOI 10.1189/jlb.0607359; Higashi H, 2002, J NEUROSURG, V96, P117, DOI 10.3171/jns.2002.96.1.0117; Huang QY, 2006, J NEUROSCI, V26, P11371, DOI 10.1523/JNEUROSCI.1907-06.2006; Huang S, 1997, BLOOD, V90, P1600, DOI 10.1182/blood.V90.4.1600.1600_1600_1610; Jones PA, 1998, BRAIN RES, V800, P328, DOI 10.1016/S0006-8993(98)00540-X; Jones PA, 1998, NEUROSCIENCE, V85, P229, DOI 10.1016/S0306-4522(97)00613-1; Koshiba M, 1999, FASEB J, V13, pA944; Lappas CM, 2005, J IMMUNOL, V174, P1073, DOI 10.4049/jimmunol.174.2.1073; Leker RR, 2002, BRAIN RES REV, V39, P55, DOI 10.1016/S0165-0173(02)00157-1; Li W, 2008, NEUROSCIENCE, V151, P1198, DOI 10.1016/j.neuroscience.2007.11.020; Li W, 2009, EXP NEUROL, V215, P69, DOI 10.1016/j.expneurol.2008.09.012; Li Y, 2006, NEUROSCIENCE, V141, P2029, DOI 10.1016/j.neuroscience.2006.05.014; Link AA, 2000, J IMMUNOL, V164, P436, DOI 10.4049/jimmunol.164.1.436; Liu HT, 2006, GLIA, V54, P343, DOI 10.1002/glia.20400; LOHSE MJ, 1987, N-S ARCH PHARMACOL, V335, P555; Marcoli M, 2003, NEUROPHARMACOLOGY, V45, P201, DOI 10.1016/S0028-3908(03)00156-4; Marshall LF, 2000, NEUROSURGERY, V47, P546, DOI 10.1097/00006123-200009000-00002; Mayne M, 2001, ANN NEUROL, V49, P727, DOI 10.1002/ana.1010; Melani A, 2006, BRAIN RES, V1073, P470, DOI 10.1016/j.brainres.2005.12.010; Monopoli A, 1998, NEUROREPORT, V9, P3955, DOI 10.1097/00001756-199812010-00034; NILSSON P, 1990, J CEREBR BLOOD F MET, V10, P631, DOI 10.1038/jcbfm.1990.115; NILSSON P, 1994, BRAIN RES, V637, P227, DOI 10.1016/0006-8993(94)91237-8; Ohta A, 2001, NATURE, V414, P916, DOI 10.1038/414916a; OKIYAMA K, 1995, J NEUROCHEM, V64, P802; Okusa MD, 1999, AM J PHYSIOL-RENAL, V277, pF404; OREGAN MH, 1992, NEUROSCI LETT, V138, P169, DOI 10.1016/0304-3940(92)90498-V; PALMER AM, 1994, NEUROREPORT, V6, P153, DOI 10.1097/00001756-199412300-00039; PANTER SS, 1992, NEUROSCI LETT, V136, P165, DOI 10.1016/0304-3940(92)90040-E; Pedata F, 2005, NEUROL RES, V27, P169, DOI 10.1179/016164105X21913; Pedata F, 2001, ANN NY ACAD SCI, V939, P74; Phillis JW, 1995, BRAIN RES, V705, P79, DOI 10.1016/0006-8993(95)01153-6; Popoli P, 2002, J NEUROSCI, V22, P1967, DOI 10.1523/JNEUROSCI.22-05-01967.2002; Popoli P, 1995, EUR J PHARMACOL, V287, P215, DOI 10.1016/0014-2999(95)00679-6; Reinert M, 2000, Neurosurg Focus, V8, pe10; SIMPSON RE, 1992, J NEUROCHEM, V58, P1683, DOI 10.1111/j.1471-4159.1992.tb10041.x; Sullivan GW, 1999, J INFECT DIS, V180, P1550, DOI 10.1086/315084; Takeuchi H, 2006, J BIOL CHEM, V281, P21362, DOI 10.1074/jbc.M600504200; Thiel M, 2005, PLOS BIOL, V3, P1088, DOI 10.1371/journal.pbio.0030174; Varani K, 1998, BRIT J PHARMACOL, V123, P1723, DOI 10.1038/sj.bjp.0701758; Walker BAM, 1997, J IMMUNOL, V158, P2926; Yu LQ, 2004, NAT MED, V10, P1081, DOI 10.1038/nm1103	66	17	18	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3042	1471-4159		J NEUROCHEM	J. Neurochem.	JUN	2010	113	6					1536	1544		10.1111/j.1471-4159.2010.06716.x			9	Biochemistry & Molecular Biology; Neurosciences	Biochemistry & Molecular Biology; Neurosciences & Neurology	604WT	WOS:000278309900016	20367749	Bronze			2021-06-18	
J	Macleod, AD				Macleod, A. D. (Sandy)			Post concussion syndrome: The attraction of the psychological by the organic	MEDICAL HYPOTHESES			English	Article							TRAUMATIC BRAIN-INJURY; SYMPTOMS; PHYSIOGENESIS; PSYCHOGENESIS; SEQUELAE	Post concussion symptoms following mild traumatic brain injury are a difficult clinical state to conceptualise. The constellation of symptoms include those with an organic signature (and presumed organic aetiology), and those with overt psychological features. A seemingly trivial head injury may result in enduring symptoms. The validity of post concussion syndrome (PCS) has been the focus of much medico-legal debate, as has its cause. Whether PCS is 'neurogenic' or 'psychogenic' in aetiology remains contestable. Babinski, in 1918, hypothesised that an organic factor initiated the symptoms of the disorder now known as PCS, and that this acted as a 'bait', or attractor, for pre-existing and post-injury psychological influences. This hypothesis, which has been neither proven nor disproven over the subsequent nearly one hundred years, deserves reconsideration for it is an appealing model of PCS. (C) 2010 Elsevier Ltd. All rights reserved.	Burwood Hosp, Brain Injury Rehabil Serv, Christchurch 8140, New Zealand	Macleod, AD (corresponding author), Burwood Hosp, Brain Injury Rehabil Serv, Mairehau Rd, Christchurch 8140, New Zealand.	ad.macleod@cdhb.govt.nz					Allilaire JF, 2007, B ACAD NAT MED PARIS, V191, P1329, DOI 10.1016/S0001-4079(19)32953-X; Anderson T, 2006, PRACT NEUROL, V6, P342, DOI DOI 10.1136/JNNP.2006.106583; Babinski J, 1918, HYSTERIA PITHIATISM; Dewhurst K., 1982, H JACKSON PSYCHIAT; Fear NT, 2009, PSYCHOL MED, V39, P1379, DOI 10.1017/S0033291708004595; GOETZ CG, 1995, CHARCOT CONSTRUCTING, P200; INGEBRIGSTEN T, 1998, ASPECTS MANAGEMENT M; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; JACOBSON RR, 1995, J PSYCHOSOM RES, V39, P675, DOI 10.1016/0022-3999(95)00006-5; Kashluba S, 2008, CLIN NEUROPSYCHOL, V22, P195, DOI 10.1080/13854040701263655; LEVIN M, 1965, JAMA-J AM MED ASSOC, V191, P119; LISHMAN WA, 1988, BRIT J PSYCHIAT, V153, P460, DOI 10.1192/bjp.153.4.460; Meares S, 2008, J NEUROL NEUROSUR PS, V79, P300, DOI 10.1136/jnnp.2007.126565; Micale Mark S., 2001, TRAUMATIC PASTS HIST, DOI 10.1017/CBO9780511529252.007; Moore EL, 2006, BRAIN INJURY, V20, P117, DOI 10.1080/02699050500443558; Nicholl J, 2009, SEMIN NEUROL, V29, P247, DOI 10.1055/s-0029-1223878; Rees PM, 2003, ARCH PHYS MED REHAB, V84, P1885, DOI 10.1016/j.apmr.2003.03.001; Simon GE, 1999, NEW ENGL J MED, V341, P1329, DOI 10.1056/NEJM199910283411801; Smith L. B., 2006, BIOL THEORY, V1, P87; Thelen E., 1994, DYNAMIC SYSTEMS APPR; Wessely S, 2003, BRIT J PSYCHIAT, V183, P314, DOI 10.1192/bjp.183.4.314; York GK, 2002, J ROY SOC MED, V95, P314, DOI 10.1258/jrsm.95.6.314	22	17	17	0	3	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0306-9877			MED HYPOTHESES	Med. Hypotheses	JUN	2010	74	6					1033	1035		10.1016/j.mehy.2010.01.002			3	Medicine, Research & Experimental	Research & Experimental Medicine	598UI	WOS:000277863900019	20129739				2021-06-18	
J	Wilde, EA; McCauley, SR; Kelly, TM; Levin, HS; Pedroza, C; Clifton, GL; Robertson, CS; Moretti, P				Wilde, Elisabeth A.; McCauley, Stephen R.; Kelly, Tara M.; Levin, Harvey S.; Pedroza, Claudia; Clifton, Guy L.; Robertson, Claudia S.; Moretti, Paolo			Feasibility of the Neurological Outcome Scale for Traumatic Brain Injury (NOS-TBI) in Adults	JOURNAL OF NEUROTRAUMA			English	Article						neurological functioning; Neurological Outcome Scale for Traumatic Brain Injury; outcome; traumatic brain injury	NIH STROKE SCALE; SEVERE HEAD-INJURY; ACUTE REHABILITATION; RELIABILITY; PREDICTORS; DISABILITY; SAMPLE	This article describes the design and initial implementation of the Neurological Outcome Scale for Traumatic Brain Injury (NOS-TBI) as an adaptation of the National Institutes of Health Stroke Scale (NIHSS), specifically for clinical and research use in patients with TBI, including (1) the addition of items specific to TBI, (2) adjustment to the scoring algorithm to allow quantification of deficits in patients who are comatose/vegetative or agitated, and (3) the reassignment of items (i.e., limb ataxia) that are problematic in TBI as supplemental items. The feasibility of using the NOS-TBI is discussed and limitations of the scale are highlighted. This scale offers (1) a cost-effective, brief, practicable, standardized, and quantifiable method of communicating and analyzing neurological deficits in a way that traditional neurological assessment alone cannot currently provide, and (2) a measure that non-physicians can administer. The NOS-TBI may serve a role in clinical practice in patients with TBI similar to the way the NIHSS has functioned for patients following stroke, by serving as a tool for initial stratification of injury severity, and as an outcome measure in clinical trials.	[Wilde, Elisabeth A.] Baylor Coll Med, Cognit Neurosci Lab, Houston, TX 77030 USA; [McCauley, Stephen R.; Moretti, Paolo] Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA; [McCauley, Stephen R.] Baylor Coll Med, Dept Radiol, Houston, TX 77030 USA; [McCauley, Stephen R.] Baylor Coll Med, Dept Phys Med & Rehabil Alliance, Houston, TX 77030 USA; [McCauley, Stephen R.] Univ Texas Houston Med Sch, Dept Neurol, Houston, TX USA; [McCauley, Stephen R.] Univ Texas Houston Med Sch, Dept Pediat, Houston, TX USA; [Pedroza, Claudia] Univ Texas Med Sch Houston, Ctr Clin Res & Evidence Based Med, Houston, TX USA; [Robertson, Claudia S.] Baylor Coll Med, Dept Neurosurg, Houston, TX 77030 USA; [Moretti, Paolo] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA	Wilde, EA (corresponding author), Baylor Coll Med, Cognit Neurosci Lab, 1709 Dryden Rd,Suite 1200, Houston, TX 77030 USA.	ewilde@bcm.edu		Pedroza, Claudia/0000-0003-4235-1282	National Institutes of Health/National Institute of Neurological Disease and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS 43353]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U01NS043353] Funding Source: NIH RePORTER	We would like to extend our gratitude to the participants and their families, whose cooperation and patience helped make this study possible. This study was supported in part by grant NS 43353 from the National Institutes of Health/National Institute of Neurological Disease and Stroke, to Guy L. Clifton, Principal Investigator. The information in this article and the article itself has never been published either electronically or in print. None of the authors have any financial or other relationship(s) that could be construed as a conflict of interest with respect to the content of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anastasi A, 1997, PSYCHOL TESTING, V7th; Annoni J M, 1992, Disabil Rehabil, V14, P23; Appelros P, 2004, CEREBROVASC DIS, V17, P21, DOI 10.1159/000073894; BROTT T, 1989, STROKE, V20, P864, DOI 10.1161/01.STR.20.7.864; Callahan CD, 2002, J HEAD TRAUMA REHAB, V17, P251, DOI 10.1097/00001199-200206000-00006; Costanzo RM, 1986, CLIN MEASUREMENTS TA, P565; Dimopoulou I, 2004, AM J PHYS MED REHAB, V83, P171, DOI 10.1097/01.PHM.0000107497.77487.C1; Dromerick AW, 2000, STROKE, V31, P2984, DOI 10.1161/01.STR.31.12.2984; GOLDSTEIN LB, 1994, STROKE, V25, P1700, DOI 10.1161/01.STR.25.8.1700; GOLDSTEIN LB, 1989, ARCH NEUROL-CHICAGO, V46, P660, DOI 10.1001/archneur.1989.00520420080026; Heinemann AW, 1997, STROKE, V28, P1174, DOI 10.1161/01.STR.28.6.1174; JENNETT B, 1975, LANCET, V1, P480; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Josephson SA, 2006, CEREBROVASC DIS, V22, P389, DOI 10.1159/000094857; Kasner SE, 2006, LANCET NEUROL, V5, P603, DOI 10.1016/S1474-4422(06)70495-1; KEANE JR, 1992, NEUROL CLIN, V10, P849; KEANE JR, 1982, NEUROLOGY, V32, P757, DOI 10.1212/WNL.32.7.757; Lannoo E, 2000, J NEUROTRAUM, V17, P403, DOI 10.1089/neu.2000.17.403; LEVIN HS, 1992, NEUROSURGERY, V31, P435, DOI 10.1227/00006123-199209000-00008; McCauley SR, 2010, J NEUROTRAUM, V27, P991, DOI 10.1089/neu.2009.1195; PODOSHIN L, 1975, ARCH OTOLARYNGOL, V101, P15; PULLICINO P, 1992, STROKE, V23, P919, DOI 10.1161/str.23.6.919a; Rovit R. L., 2000, HEAD INJURY, P201; Rundek T, 2000, NEUROLOGY, V55, P1180, DOI 10.1212/WNL.55.8.1180; SABATES NR, 1991, J CLIN NEURO-OPHTHAL, V11, P273; Schlegel D, 2003, STROKE, V34, P134, DOI 10.1161/01.STR.0000048217.44714.02; SUMNER D, 1962, LANCET, V2, P895; TOKUNO T, 1995, NEUROL SURG TOKYO, V23, P497; Wilde EA, 2010, J NEUROTRAUM, V27, P983, DOI 10.1089/neu.2009.1194; WITYK RJ, 1994, STROKE, V25, P362, DOI 10.1161/01.STR.25.2.362	30	17	17	0	6	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUN	2010	27	6					975	981		10.1089/neu.2009.1193			7	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	612VO	WOS:000278933300001	20210593	Green Published			2021-06-18	
J	Colantonio, A; Howse, D; Patel, J				Colantonio, Angela; Howse, Dana; Patel, Jigisha			Young Adults With Traumatic Brain Injury in Long-Term Care Homes: A Population-Based Study	BRAIN IMPAIRMENT			English	Article						traumatic brain injury; young adults; long-term care		The aim of this research was to identify the number and characteristics of adults under the age of 65 with a diagnosis of traumatic brain injury (TBI) living in long-term care homes (nursing homes, homes for the aged and charitable homes) in Ontario, Canada. Methods: The study used a cross-sectional design. Secondary data analysis of a comprehensive provincial database of long-term care homes was conducted. Results: Of the 399 residents coded as having a TBI, 154 were < 65 years of age. Virtually all residents were limited in personal care and required assistance for eating (94.2%), toileting (92.2%) and dressing (99.4%). A large percentage also required care for challenging behaviours, while care needs due to substance abuse was common among 12.3% of TBI residents. Conclusion: As similar research in Australia has found, young persons in long-term care homes in Ontario, Canada, have high level personal health needs, however the appropriateness of this environment is questionable.	[Colantonio, Angela; Howse, Dana; Patel, Jigisha] Univ Toronto, Toronto, ON M5S 1A1, Canada; [Colantonio, Angela] Toronto Rehabil Inst, Toronto, ON, Canada	Colantonio, A (corresponding author), Dept Occupat Sci & Occupat Therapy, 160-500 Univ Ave, Toronto, ON M5G 1V7, Canada.	angela.colantonio@utoronto.ca		Colantonio, Angela/0000-0003-2094-4765	Ontario Neurotrauma Foundation; Toronto Rehabilitation Institute Foundation; Toronto Rehabilitation Institute from the Ontario Ministry of Health and Long-Term Care; Ministry of Health and Long-Term Care (MOHLTC)Ministry of Health and Long-Term Care, Ontario	Grant support for this study was provided by the Ontario Neurotrauma Foundation, the Toronto Rehabilitation Institute Foundation, and a grant to the Toronto Rehabilitation Institute from the Ontario Ministry of Health and Long-Term Care. We wish to thank Sue Guinard and her staff for their assistance in obtaining the data for this study.; Residential care and support services for persons in Ontario with TBI living in community-based accommodations are typically funded by the Ministry of Health and Long-Term Care (MOHLTC); however, residents are generally responsible for their own rental costs, personal expenses, and possibly a percentage of their food costs. These funds may come from other subsidies, such as Ontario Disability Support Program (ODSP) or other types of social support. The definition of 'developmental disability' put forth by the Ministry of Community and Social Services (MCSS), which includes limited intellectual development resulting from an illness or accident before age 18, suggests that some young persons with TBI would be eligible for developmental disability-dedicated services. The updated developmental disability act - the Services and Supports to Promote the Social Inclusion of Persons with Developmental Disabilities Act, 2008 - promotes the provision of services to persons with developmental disability via community agencies rather than institutions, and the government has recently begun actively assisting consumers to access appropriate community based support (Ontario MCSS, 2008). At the time of this writing, the revised legislation is not yet fully in effect.	Buchanan R., 2005, BRAIN INJURY, V17, P507; Colantonio A., 2005, NATURE EXTENT INAPPR; Colantonio A., HEALTHCARE IN PRESS; Community Affairs References Committee Senate, 2005, QUAL EQ AG CAR, P79; Foster M., 2007, BRAIN IMPAIR, V8, P312, DOI [10.1375/brim.8.3.312, DOI 10.1375/brim.8.3.312]; KELLY G, 2007, BRAIN IMPAIR, V8, P262, DOI DOI 10.1375/BRIM.8.3.262; McMillan TM, 2004, CLIN REHABIL, V18, P132, DOI 10.1191/0269215504cr712oa; *ONT MIN HLTH LONG, 2001, REP STUD REV LEV SER; Ontario Ministry of Community and Social Services, 2008, DEV SERV; Ontario Ministry of Health and Long Term Care, 2010, SEN CAR LONG TERM CA; Pickett W., 2005, CHRONIC DIS CANADA, V25, P32; Strettles B, 2005, ACCOMMODATION NSW AD; Wilson JRF, 2009, EUR J TRAUMA EMERG S, V35, P176, DOI 10.1007/s00068-008-8095-8; Winkler D., 2007, YOUNGER PEOPLE RESID; Winkler Dianne, 2006, Aust Health Rev, V30, P100	15	17	17	1	11	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1443-9646	1839-5252		BRAIN IMPAIR	Brain Impair.	MAY	2010	11	1					31	36		10.1375/brim.11.1.31			6	Clinical Neurology; Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	V24IR	WOS:000208404600003					2021-06-18	
J	Fulkerson, DH; Voorhies, JM; McCanna, SP; Payner, TD; Leipzig, TJ; Scott, JA; DeNardo, AJ; Redelman, K; Horner, TG				Fulkerson, Daniel H.; Voorhies, Jason M.; McCanna, Shannon P.; Payner, Troy D.; Leipzig, Thomas J.; Scott, John A.; DeNardo, Andrew J.; Redelman, Kathleen; Horner, Terry G.			Endovascular treatment and radiographic follow-up of proximal traumatic intracranial aneurysms in adolescents: case series and review of the literature	CHILDS NERVOUS SYSTEM			English	Article						Pediatric neurosurgery; Pseudoaneurysm; Trauma; Endovascular; Skull base	ARTERY DISSECTING ANEURYSM; POSTERIOR CEREBRAL-ARTERY; INTRACAVERNOUS ANEURYSM; CHILDREN; MANAGEMENT; PSEUDOANEURYSMS; RECANALIZATION; CHILDHOOD; INJURIES; GUNSHOT	Traumatic intracranial aneurysms are rare lesions that are relatively more common in the pediatric population. Proximal traumatic aneurysms occur near the skull base. Direct surgical repair of these lesions is difficult due to the anatomically confined area, clinical status of a head injury patient, and the transmural nature of the injury. These lesions often lack a definable neck or wall suitable for clipping. While the indications and capabilities of endovascular treatment continue to expand, there are unanswered questions about the durability of treatment, especially in young patients. There are few reports examining the radiographic outcomes of endovascular treatment specifically for traumatic intracranial aneurysms. Therefore, we examined our experience treating these rare proximal lesions in an adolescent population. A retrospective review of prospectively collected data from 2000-2008 in a large, multidisciplinary neurovascular and trauma center was performed. Three pediatric patients received endovascular treatment for traumatic intracranial aneurysms near the skull base. All patients had successful obliteration of their lesion without vessel sacrifice; however, two patients required multiple procedures for coil compaction or refilling of the aneurysm. There were no complications or ischemic events related to treatment. Follow-up imaging ranged from 6 months to 3.5 years. Traumatic intracranial aneurysms at the skull base can be successfully treated with endovascular methods; however, close follow-up is necessary.	[Fulkerson, Daniel H.] Texas Childrens Hosp, Houston, TX 77030 USA; [Payner, Troy D.; Leipzig, Thomas J.; Scott, John A.; DeNardo, Andrew J.; Redelman, Kathleen; Horner, Terry G.] Indianapolis Neurosurg Grp, Indianapolis, IN USA; [Voorhies, Jason M.; McCanna, Shannon P.] Indiana Univ, Sch Med, Dept Neurosurg, Indianapolis, IN USA; [Fulkerson, Daniel H.] Texas Childrens Hosp, Baylor Coll Med, Div Pediat Neurosurg, Houston, TX 77030 USA	Fulkerson, DH (corresponding author), Texas Childrens Hosp, 6621 Fannin St,CCC 1230-01,12th Floor, Houston, TX 77030 USA.	d_fulkers@hotmail.com					AARABI B, 1988, NEUROSURGERY, V22, P1056, DOI 10.1227/00006123-198806010-00014; Baik SK, 2007, SURG NEUROL, V68, P108, DOI 10.1016/j.surneu.2006.07.023; Binning MJ, 2009, ACTA NEUROCHIR, V151, P1647, DOI 10.1007/s00701-009-0323-4; BUCKINGHAM MJ, 1988, NEUROSURGERY, V22, P398, DOI 10.1227/00006123-198802000-00022; CHOI DS, 2009, J NEUROSURG, P1; Cohen JE, 2005, J NEUROSURG, V102, P555, DOI 10.3171/jns.2005.102.3.0555; Cohen JE, 2008, NEUROSURGERY, V63, P476, DOI 10.1227/01.NEU.0000324995.57376.79; ELGINDI S, 1979, ACTA NEUROCHIR, V48, P237, DOI 10.1007/BF02056972; Feugier P, 2007, EUR J VASC ENDOVASC, V34, P663, DOI 10.1016/j.ejvs.2007.06.011; FLEISCHER A S, 1975, Surgical Neurology, V4, P233; GUTIERREZ FA, 1987, CONCEPTS PEDIATR NEU, V7, P153; Hachemi M, 2007, CHILD NERV SYST, V23, P283, DOI 10.1007/s00381-006-0269-2; HADDAD FS, 1991, NEUROSURGERY, V28, P1; HAHN YS, 1990, CHILD NERV SYST, V6, P360, DOI 10.1007/BF00298285; Hemphill JC, 1999, CRIT CARE CLIN, V15, P811, DOI 10.1016/S0749-0704(05)70089-0; Hetts SW, 2009, AM J NEURORADIOL, V30, P1315, DOI 10.3174/ajnr.A1587; HIGASHIDA RT, 1989, AM J ROENTGENOL, V153, P577, DOI 10.2214/ajr.153.3.577; Horie N, 2008, CLIN NEUROL NEUROSUR, V110, P411, DOI 10.1016/j.clineuro.2007.12.022; HUMPHREYS RP, 1985, CONCEPTS PEDIATR NEU, V6, P213; Kikuchi Y, 2007, NEUROL SURG TOKYO, V35, P813; Kneyber MCJ, 2005, NEUROLOGY, V65, P1663, DOI 10.1212/01.wnl.0000184515.35205.10; Larson P S, 2000, Neurosurg Focus, V8, pe4; Lasjaunias P, 2005, CHILD NERV SYST, V21, P437, DOI 10.1007/s00381-004-1125-x; Lempert TE, 1998, AM J NEURORADIOL, V19, P907; Liang G, 2009, NEUROL RES; LIN TK, 1995, NEUROSURGERY, V36, P407, DOI 10.1227/00006123-199502000-00025; Lv XL, 2009, NEURORADIOLOGY, V51, P749, DOI 10.1007/s00234-009-0553-4; Medel R, 2009, J NEUROSURG-PEDIATR, V4, P445, DOI 10.3171/2009.6.PEDS09104; Mitchell P, 2008, J NEUROSURG, V108, P437, DOI 10.3171/JNS/2008/108/3/0437; Molyneux A, 2002, LANCET, V360, P1267, DOI 10.1016/S0140-6736(02)11314-6; Molyneux AJ, 2009, LANCET NEUROL, V8, P427, DOI 10.1016/S1474-4422(09)70080-8; Moron F, 2005, AM J NEURORADIOL, V26, P58; O'Shaughnessy BA, 2005, J NEUROSURG, V102, P231, DOI 10.3171/jns.2005.102.2.0231; Wang X, 2008, NEUROL INDIA, V56, P47, DOI 10.4103/0028-3886.39312; Yang TC, 2007, EUR NEUROL, V58, P239, DOI 10.1159/000107970; YAZBAK PA, 1995, PEDIATR NEUROSURG, V22, P15, DOI 10.1159/000121294	36	17	20	0	4	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0256-7040			CHILD NERV SYST	Childs Nerv. Syst.	MAY	2010	26	5					613	620		10.1007/s00381-010-1104-3			8	Clinical Neurology; Pediatrics; Surgery	Neurosciences & Neurology; Pediatrics; Surgery	582NV	WOS:000276605600007	20177686				2021-06-18	
J	Li, WJ; Wu, SS; Ahmad, M; Jiang, JF; Liu, H; Nagayama, T; Rose, ME; Tyurin, VA; Tyurina, YY; Borisenko, GG; Belikova, N; Chen, J; Kagan, VE; Graham, SH				Li, Wenjin; Wu, Shasha; Ahmad, Muzamil; Jiang, Jianfei; Liu, Hao; Nagayama, Tetsuya; Rose, Marie E.; Tyurin, Vladimir A.; Tyurina, Yulia Y.; Borisenko, Grigory G.; Belikova, Natalia; Chen, Jun; Kagan, Valerian E.; Graham, Steven H.			The cyclooxygenase site, but not the peroxidase site of cyclooxygenase-2 is required for neurotoxicity in hypoxic and ischemic injury	JOURNAL OF NEUROCHEMISTRY			English	Article						cell death; cyclooxygenase-2; hypoxia; ischemia; prostaglandin	PROSTAGLANDIN-H-SYNTHASE; TRAUMATIC BRAIN-INJURY; CEREBRAL-ISCHEMIA; ASCORBIC-ACID; CELL-DEATH; ENDOPEROXIDE SYNTHASE; REACTION-MECHANISM; SUPEROXIDE ANION; GENE-EXPRESSION; MOUSE MODEL	P>Cyclooxygenase-2 (COX-2) activity has been implicated in the pathogenesis of ischemic injury, but the exact mechanisms responsible for its toxicity remain unclear. Infection of primary neurons with an adenovirus expressing wild type (WT) COX-2 increased the susceptibility of neurons to hypoxia. Infection with an adenoviral vector expressing COX-2 with a mutation at the cyclooxygenase site did not increase susceptibility to hypoxia, whereas over-expression of COX-2 with a mutation in the peroxidase site produced similar susceptibility to hypoxia as WT COX-2. Primary neuronal cultures obtained from transgenic mice bearing a mutation in the COX-2 cylooxygenase site were protected from hypoxia. Mice with a mutation in the cyclooxygenase site had smaller infarctions 24 h after 70 min of middle cerebral artery occlusion than WT control mice. COX-2 activity had no effect on the formation of protein carbonyls. Ascorbate radicals were detected by electron paramagnetic resonance as a product of recombinant COX-2 activity and were blocked by COX-2 inhibitors. Similarly, formation of ascorbate radicals was inhibited in the presence of COX-2 inhibitors and in homogenates obtained from COX-2 null mice. Taken together, these results indicate that the cyclooxygenase activity of COX-2 is necessary to exacerbate neuronal hypoxia/ischemia injury rather than the peroxidase activity of the enzyme.	[Li, Wenjin; Wu, Shasha; Ahmad, Muzamil; Liu, Hao; Nagayama, Tetsuya; Rose, Marie E.; Chen, Jun; Graham, Steven H.] Univ Pittsburgh, VA Pittsburgh Healthcare Syst, Geriatr Res Educ & Clin Ctr, Pittsburgh, PA USA; [Li, Wenjin; Wu, Shasha; Ahmad, Muzamil; Liu, Hao; Nagayama, Tetsuya; Rose, Marie E.; Chen, Jun; Graham, Steven H.] Univ Pittsburgh, Dept Neurol, Pittsburgh, PA 15260 USA; [Jiang, Jianfei; Tyurin, Vladimir A.; Tyurina, Yulia Y.; Borisenko, Grigory G.; Belikova, Natalia; Kagan, Valerian E.] Univ Pittsburgh, Dept Environm & Occupat Hlth, Pittsburgh, PA USA	Graham, SH (corresponding author), VA Pittsburgh Healthcare, Geriatr Res Educ & Clin Ctr 00GRH, Highland Dr, Pittsburgh, PA 15205 USA.	sgra@pitt.edu		Tyurin, Vladimir/0000-0002-3474-1697; Tyurina, Yulia/0000-0003-0287-2091; Kagan, Valerian E./0000-0002-7245-1885	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS37549, HL70755, R03TW007320]; VA Merit Review program (SHG)US Department of Veterans Affairs; Pennsylvania Department of Health [SAP 4100027294]; FOGARTY INTERNATIONAL CENTERUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC) [R03TW007320] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL070755] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50NS030318, R01NS037549, R01NS037459] Funding Source: NIH RePORTER	The authors thank Pat Strickler for secretarial support. The Y371F mouse model was provided by Dr. Colin Funk of Queen's University, Kingston, Ontario. WT COX-2, H374Y COX-2 and Y371F COX-2 cDNAs were a gift of Dr. L.J. Marnett (Vanderbilt University, Nashville, TN). SC58125 and recombinant COX-2 were a gift of Peter Isakson (Monsanto-Searle, Saint Louis, MO.). This work was supported by NIH NS37549 and the VA Merit Review program (SHG), and by NIH Grants HL70755, R03TW007320 and the Pennsylvania Department of Health SAP 4100027294 (VEK). The authors declare no conflict of interest.	Ahmad M, 2006, EUR J NEUROSCI, V23, P35, DOI 10.1111/j.1460-9568.2005.04540.x; Ahmad M, 2008, J NEUROSCI RES, V86, P3605, DOI 10.1002/jnr.21809; Armstead WM, 2003, ANESTHESIOLOGY, V98, P1378, DOI 10.1097/00000542-200306000-00012; ARMSTEAD WM, 1988, AM J PHYSIOL, V255, pH401; Beal MF, 2002, FREE RADICAL BIO MED, V32, P797, DOI 10.1016/S0891-5849(02)00780-3; Candelario-Jalil E, 2003, J NEUROCHEM, V86, P545, DOI 10.1046/j.1471-4159.2003.01812.x; Candelario-Jalil E, 2006, J NEUROIMMUNOL, V174, P39, DOI 10.1016/j.jneuroim.2006.01.003; Chan PH, 1996, STROKE, V27, P1124, DOI 10.1161/01.STR.27.6.1124; Chan PH, 2001, J CEREBR BLOOD F MET, V21, P2, DOI 10.1097/00004647-200101000-00002; CHEN J, 1995, J NEUROSURG, V83, P99, DOI 10.3171/jns.1995.83.1.0099; Drachman DB, 2002, ANN NEUROL, V52, P771, DOI 10.1002/ana.10374; Goodwin DC, 2000, BIOCHEMISTRY-US, V39, P5422, DOI 10.1021/bi992752f; GRUNEWALD RA, 1993, BRAIN RES REV, V18, P123, DOI 10.1016/0165-0173(93)90010-W; Han SS, 2004, J CELL BIOCHEM, V93, P257, DOI 10.1002/jcb.20116; HASTINGS TG, 1995, J NEUROCHEM, V64, P919; Ho L, 1998, J NEUROIMMUNOL, V89, P142, DOI 10.1016/S0165-5728(98)00132-5; Horakova L, 1997, NEUROPHARMACOLOGY, V36, P177, DOI 10.1016/S0028-3908(96)00165-7; Ichimura S, 2007, J BIOL CHEM, V282, P16681, DOI 10.1074/jbc.M610785200; Im JY, 2006, FREE RADICAL BIO MED, V41, P960, DOI 10.1016/j.freeradbiomed.2006.06.001; Jiang JF, 2004, J NEUROCHEM, V90, P1036, DOI 10.1111/j.1471-4159.2004.02577.x; KAGAN VE, 1994, BIOCHEMISTRY-US, V33, P9651, DOI 10.1021/bi00198a034; KARTHEIN R, 1988, EUR J BIOCHEM, V171, P313, DOI 10.1111/j.1432-1033.1988.tb13792.x; Kawano T, 2006, NAT MED, V12, P225, DOI 10.1038/nm1362; Kim SH, 2000, ARTHRITIS RES, V2, P293, DOI 10.1186/ar104; KUKREJA RC, 1986, CIRC RES, V59, P612, DOI 10.1161/01.RES.59.6.612; Kunz T, 2006, RESTOR NEUROL NEUROS, V24, P55; Landino LM, 1997, J BIOL CHEM, V272, P21565, DOI 10.1074/jbc.272.34.21565; Li WJ, 2008, NEUROCHEM RES, V33, P490, DOI 10.1007/s11064-007-9462-2; Lopez-Lluch G, 2005, ARCH BIOCHEM BIOPHYS, V436, P32, DOI 10.1016/j.abb.2004.12.031; Lu GQ, 1999, J BIOL CHEM, V274, P16162, DOI 10.1074/jbc.274.23.16162; Maeda K, 1999, J CEREBR BLOOD F MET, V19, P1092, DOI 10.1097/00004647-199910000-00005; Manabe Y, 2004, ANN NEUROL, V55, P668, DOI 10.1002/ana.20078; Marnett LJ, 2000, CURR OPIN CHEM BIOL, V4, P545, DOI 10.1016/S1367-5931(00)00130-7; Nakayama M, 1998, P NATL ACAD SCI USA, V95, P10954, DOI 10.1073/pnas.95.18.10954; NELSON CW, 1992, AM J PHYSIOL, V263, pH1356; Nogawa S, 1997, J NEUROSCI, V17, P2746; O'Brien PJ, 1978, BIOCHEM SOC T, V6, P1169, DOI 10.1042/bst0061169; Patel M, 1996, NEURON, V16, P345, DOI 10.1016/S0896-6273(00)80052-5; Pepicelli O, 2005, J NEUROCHEM, V93, P1561, DOI 10.1111/j.1471-4159.2005.03150.x; Rice ME, 2000, TRENDS NEUROSCI, V23, P209, DOI 10.1016/S0166-2236(99)01543-X; ROSE RC, 1993, FASEB J, V7, P1135; SHIMOKAWA T, 1990, J BIOL CHEM, V265, P20073; SMITH BJ, 1991, CHEM-BIOL INTERACT, V79, P245, DOI 10.1016/0009-2797(91)90108-J; Smith WL, 2002, PROSTAG OTH LIPID M, V68-9, P115, DOI 10.1016/S0090-6980(02)00025-4; Spektor G, 2005, NAT CLIN PRACT CARD, V2, P290, DOI 10.1038/ncpcardio0214; Teismann P, 2003, P NATL ACAD SCI USA, V100, P5473, DOI 10.1073/pnas.0837397100; Tyurin VA, 2000, J NEUROCHEM, V75, P2178, DOI 10.1046/j.1471-4159.2000.0752178.x; van der Donk WA, 2002, BIOCHEMISTRY-US, V41, P15451, DOI 10.1021/bi026938h; Xiang ZM, 2002, GENE EXPRESSION, V10, P271, DOI 10.3727/000000002783992352; YAMAGATA K, 1993, NEURON, V11, P371, DOI 10.1016/0896-6273(93)90192-T; Yin XM, 2002, J BIOL CHEM, V277, P42074, DOI 10.1074/jbc.M204991200; Yu Y, 2006, NAT MED, V12, P699, DOI 10.1038/nm1412	52	17	17	0	1	WILEY-BLACKWELL	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	0022-3042			J NEUROCHEM	J. Neurochem.	MAY	2010	113	4					965	977		10.1111/j.1471-4159.2010.06674.x			13	Biochemistry & Molecular Biology; Neurosciences	Biochemistry & Molecular Biology; Neurosciences & Neurology	583EM	WOS:000276656100015	20236388	Green Accepted, Bronze			2021-06-18	
J	Swanson, CA; Burns, JC; Peterson, BM				Swanson, Craig A.; Burns, Jane C.; Peterson, Brad M.			Low Plasma D-Dimer Concentration Predicts the Absence of Traumatic Brain Injury in Children	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						Head trauma; Biomarker; D-dimer; CT	MINOR HEAD-INJURY; SIGNIFICANT INTRACRANIAL INJURY; NEW-ORLEANS CRITERIA; COMPUTED-TOMOGRAPHY; HEMOSTATIC SYSTEM; CT; RULE; VALIDATION; S100B; METAANALYSIS	Background: Head Computerized Tomography (CT) has significant risks, especially in children. To reduce this burden, we sought to develop a biomarker panel that predicts the absence of traumatic brain injury (TBI) on head CT. Methods: We conducted a prospective cohort observational study followed by validation in a retrospective cohort at a regional pediatric trauma center. The prospective cohort included 57 consecutive children evaluated for TBI in the emergency department between September 2007 and March 2008. At the time of initial evaluation, blood was obtained to measure electrolytes, coagulation markers, complete blood count, and plasma levels of s100 beta, D-dimer, and matrix metalloproteinase-9. We conducted routine statistical analysis to determine which predicted TBI on head CT. The independent retrospective cohort included 57 consecutive patients evaluated for the same indication. Results: All patients generally met common clinical criteria (such as the CHALICE criteria 4) for head CT after trauma. Plasma levels of D-dimer were associated with TBI on head CT by univariate analysis (p < 0.001). Other markers including prothrombin time, partial thromboplastin time, and s100 beta were not. D-Dimer also had the strongest association in multivariate analysis (p = 0.02). This association was independent of and stronger than the baseline Glascow Coma Scale (p = 0.08). A D-dimer level cut-off of 500 pg/mu l had 94% negative predictive value (p < 0.001) for brain injury on head CT. The discriminatory capacity of this D-dimer level was confirmed in the independent retrospective cohort. Conclusions: In children who meet clinical criteria for a head CT scan after trauma, low plasma D-dimer suggests the absence of significant brain injury.	[Swanson, Craig A.; Burns, Jane C.; Peterson, Brad M.] Sutter Community Hosp, Sacramento, CA USA	Swanson, CA (corresponding author), Sutter Community Hosp, Sacramento, CA USA.	cswanson@stanfordalumni.org			NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [K24HL074864] Funding Source: NIH RePORTER; NHLBI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [K24 HL074864-05, K24 HL074864] Funding Source: Medline		ANDREW M, 1990, AM J PEDIAT HEMATOL, V12, P95; ANDREW M, 1992, BLOOD, V80, P1998, DOI 10.1182/blood.V80.8.1998.1998; Bakhtiari K, 2004, CRIT CARE MED, V32, P2416, DOI 10.1097/01.CCM.0000147769.07699.E3; Bayir A, 2006, NEUROL INDIA, V54, P363, DOI 10.4103/0028-3886.28106; Biberthaler P, 2006, SHOCK, V25, P446, DOI 10.1097/01.shk.0000209534.61058.35; Blackwell CD, 2007, ANN EMERG MED, V49, P320, DOI 10.1016/j.annemergmed.2006.09.025; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Delgado P, 2006, NEUROLOGY, V67, P94, DOI 10.1212/01.wnl.0000223349.97278.e0; Dunning J, 2006, ARCH DIS CHILD, V91, P885, DOI 10.1136/adc.2005.083980; Dunning J, 2004, J NEUROTRAUM, V21, P877, DOI 10.1089/0897715041526122; Dunning J, 2004, ARCH DIS CHILD, V89, P653, DOI 10.1136/adc.2003.027722; Harhangi BS, 2008, ACTA NEUROCHIR, V150, P165, DOI 10.1007/s00701-007-1475-8; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Haydel MJ, 2003, ANN EMERG MED, V42, P507, DOI 10.1067/S0196-0644(03)00512-2; Meythaler JM, 2003, ARCH PHYS MED REHAB, V84, P285, DOI 10.1053/apmr.2003.50116; Morel N, 2008, J TRAUMA, V64, P698, DOI 10.1097/TA.0b013e31816493ad; Muller K, 2007, J TRAUMA, V62, P1452, DOI 10.1097/TA.0b013e318047bfaa; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Piazza O, 2007, PEDIATR NEUROSURG, V43, P258, DOI 10.1159/000103304; Pickering A, 2008, EMERG MED J, V25, P88, DOI 10.1136/emj.2007.046631; Smits M, 2005, JAMA-J AM MED ASSOC, V294, P1519, DOI 10.1001/jama.294.12.1519; Smits M, 2007, RADIOLOGY, V245, P831, DOI 10.1148/radiol.2452061509; Sosothikul D, 2007, J PEDIAT HEMATOL ONC, V29, P19, DOI 10.1097/MPH.0b013e3180308749; Stein SC, 2006, J TRAUMA, V61, P558, DOI 10.1097/01.ta.0000233766.60315.5e; Stiell IG, 2005, JAMA-J AM MED ASSOC, V294, P1511, DOI 10.1001/jama.294.12.1511; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Wells PS, 2003, NEW ENGL J MED, V349, P1227, DOI 10.1056/NEJMoa023153; White JRM, 2001, CRIT CARE MED, V29, P534, DOI 10.1097/00003246-200103000-00011	28	17	19	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	MAY	2010	68	5					1072	1077		10.1097/TA.0b013e3181d7a6f2			6	Critical Care Medicine; Surgery	General & Internal Medicine; Surgery	595MQ	WOS:000277615200009	20453761	Green Accepted			2021-06-18	
J	Turner, JD; Mammis, A; Prestigiacomo, CJ				Turner, Jay D.; Mammis, Antonios; Prestigiacomo, Charles J.			Erythropoietin for the Treatment of Subarachnoid Hemorrhage: A Review	WORLD NEUROSURGERY			English	Article						Erythropoietin; Neuroprotection; Subarachnoid hemorrhage; Vasospasm	RECOMBINANT-HUMAN-ERYTHROPOIETIN; TRAUMATIC BRAIN-INJURY; CENTRAL-NERVOUS-SYSTEM; RECEPTOR MESSENGER-RNA; IN-VIVO EVIDENCE; CEREBRAL VASOSPASM; CARBAMYLATED ERYTHROPOIETIN; CEREBROSPINAL-FLUID; ENDOTHELIAL-CELLS; NEONATAL-RATS	OBJECTIVE: Subarachnoid hemorrhage (SAH) has a worldwide incidence of approximately 10.5 cases per 100,000 person-years and constitutes 3% of all strokes. Erythropoietin (EPO) has recently been proposed for the treatment of a variety of brain diseases, including SAH, because of its neuroprotective effects. Hence, the current evidence in the published literature was reviewed to determine the potential utility of EPO in the treatment of SAH. METHODS: A careful retrospective review of the literature was performed to determine the potential benefit of employing EPO in the treatment of SAH and its sequelae. RESULTS: Careful literature review revelaed that the use of EPO may not necessarily reduce the incidence of vasospasm after SAH, but it may reduce the severity and its eventual outcome. CONCLUSION: Given the recent trial results, a dose-escalation study and subsequent randomized trial should be considered.	[Turner, Jay D.; Mammis, Antonios; Prestigiacomo, Charles J.] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Neurol Surg, Newark, NJ 07103 USA; [Prestigiacomo, Charles J.] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Radiol, Newark, NJ 07103 USA; [Turner, Jay D.] St Josephs Hosp, Barrow Neurol Inst, Div Neurol Surg, Phoenix, AZ USA	Prestigiacomo, CJ (corresponding author), Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Neurol Surg, 185 S Orange Ave, Newark, NJ 07103 USA.	presticj@umdnj.edu	Prestigiacomo, Charles J/B-3911-2018	Prestigiacomo, Charles J/0000-0002-5979-2378; /0000-0001-6867-3568; Mammis, Antonios/0000-0003-0892-9888			Adembri C, 2008, CRIT CARE MED, V36, P975, DOI 10.1097/CCM.0B013E3181644343; Alafaci C, 2000, EUR J PHARMACOL, V406, P219, DOI 10.1016/S0014-2999(00)00691-9; Ammarguellat F, 1996, NEPHROL DIAL TRANSPL, V11, P687, DOI 10.1093/oxfordjournals.ndt.a027361; ANAGNOSTOU A, 1990, P NATL ACAD SCI USA, V87, P5978, DOI 10.1073/pnas.87.15.5978; ANAGNOSTOU A, 1994, P NATL ACAD SCI USA, V91, P3974, DOI 10.1073/pnas.91.9.3974; Arcasoy MO, 2008, BRIT J HAEMATOL, V141, P14, DOI 10.1111/j.1365-2141.2008.07014.x; Ayer RE, 2008, ACTA NEUROCHIR SUPPL, V104, P33; Belayev L, 2005, STROKE, V36, P1065, DOI 10.1161/01.STR.0000160753.36093.da; Beleslin-Cokic BB, 2004, BLOOD, V104, P2073, DOI 10.1182/blood-2004-02-0744; Bernaudin M, 2000, GLIA, V30, P271, DOI 10.1002/(SICI)1098-1136(200005)30:3<271::AID-GLIA6>3.3.CO;2-8; Bernaudin M, 1999, J CEREBR BLOOD F MET, V19, P643, DOI 10.1097/00004647-199906000-00007; Bouscary D, 2003, BLOOD, V101, P3436, DOI 10.1182/blood-2002-07-2332; Brines M, 2005, NAT REV NEUROSCI, V6, P484, DOI 10.1038/nrn1687; Brines ML, 2000, P NATL ACAD SCI USA, V97, P10526, DOI 10.1073/pnas.97.19.10526; BRODERICK JP, 1994, STROKE, V25, P1342, DOI 10.1161/01.STR.25.7.1342; Buemi M, 2000, EUR J PHARMACOL, V392, P31, DOI 10.1016/S0014-2999(00)00081-9; Buemi M, 2003, J NEUROPATH EXP NEUR, V62, P228, DOI 10.1093/jnen/62.3.228; Cahill WJ, 2006, J CEREBR BLOOD F MET, V26, P1341, DOI 10.1038/sj.jcbfm.9600283; Calapai G, 2000, EUR J PHARMACOL, V401, P349, DOI 10.1016/S0014-2999(00)00466-0; Celik M, 2002, P NATL ACAD SCI USA, V99, P2258, DOI 10.1073/pnas.042693799; Chandel NS, 2000, J BIOL CHEM, V275, P25130, DOI 10.1074/jbc.M001914200; Chang YS, 2005, PEDIATR RES, V58, P106, DOI 10.1203/01.PDR.0000163616.89767.69; Cheetham JC, 1998, NAT STRUCT BIOL, V5, P861, DOI 10.1038/2302; Chen G, 2009, CYTOKINE, V45, P162, DOI 10.1016/j.cyto.2008.11.015; Chikuma M, 2000, AM J PHYSIOL-ENDOC M, V279, pE1242; Chin K, 2000, MOL BRAIN RES, V81, P29, DOI 10.1016/S0169-328X(00)00157-1; Chong ZZ, 2003, J CEREBR BLOOD F MET, V23, P320, DOI 10.1097/01.WCB.0000050061.57184.AE; Chong ZZ, 2002, J HEMATOTH STEM CELL, V11, P863, DOI 10.1089/152581602321080529; Chong ZZ, 2002, CIRCULATION, V106, P2973, DOI 10.1161/01.CIR.0000039103.58920.1F; Clark JF, 2006, J CEREBR BLOOD F MET, V26, P1223, DOI 10.1038/sj.jcbfm.9600280; Coleman TR, 2006, P NATL ACAD SCI USA, V103, P5965, DOI 10.1073/pnas.0601377103; Conrad KP, 1996, FASEB J, V10, P760; Corwin HL, 2007, NEW ENGL J MED, V357, P965, DOI 10.1056/NEJMoa071533; Crowley RW, 2008, DRUG DISCOV TODAY, V13, P254, DOI 10.1016/j.drudis.2007.11.010; Diaz Z, 2005, J NEUROCHEM, V93, P392, DOI 10.1111/j.1471-4159.2005.03038.x; Digicaylioglu M, 2001, NATURE, V412, P641, DOI 10.1038/35088074; DIGICAYLIOGLU M, 1995, P NATL ACAD SCI USA, V92, P3717, DOI 10.1073/pnas.92.9.3717; Dorsch Nicholas W C, 2002, Curr Opin Crit Care, V8, P128; ECKER A, 1951, J NEUROSURG, V8, P660, DOI 10.3171/jns.1951.8.6.0660; Ehrenreich H, 2002, MOL MED, V8, P495, DOI 10.1007/BF03402029; Ehrenreich H, 2007, BRAIN, V130, P2577, DOI 10.1093/brain/awm203; Erbayraktar S, 2003, P NATL ACAD SCI USA, V100, P6741, DOI 10.1073/pnas.1031753100; Ferro JM, 2008, J NEUROL, V255, P465, DOI 10.1007/s00415-008-0606-3; FISHER CM, 1980, NEUROSURGERY, V6, P1, DOI 10.1227/00006123-198001000-00001; Fisher JW, 2003, EXP BIOL MED, V228, P1; Fujii Y, 1997, J NEUROSURG, V86, P594, DOI 10.3171/jns.1997.86.4.0594; FUJII Y, 1995, NEUROSURGERY, V37, P226, DOI 10.1227/00006123-199508000-00006; Genc S, 2002, NEUROSCI LETT, V321, P73, DOI 10.1016/S0304-3940(02)00041-1; Grasso G, 2002, J NEUROSURG, V96, P565, DOI 10.3171/jns.2002.96.3.0565; Grasso G, 2002, P NATL ACAD SCI USA, V99, P5627, DOI 10.1073/pnas.082097299; Grimm C, 2002, NAT MED, V8, P718, DOI 10.1038/nm723; GROTE E, 1988, NEUROSURGERY, V22, P654, DOI 10.1227/00006123-198804000-00006; Hansen-Schwartz J, 2007, TRENDS PHARMACOL SCI, V28, P252, DOI 10.1016/j.tips.2007.04.002; Hop JW, 1997, STROKE, V28, P660, DOI 10.1161/01.STR.28.3.660; JACKOWSKI A, 1990, J CEREBR BLOOD F MET, V10, P835, DOI 10.1038/jcbfm.1990.140; Jubinsky PT, 1997, BLOOD, V90, P1867, DOI 10.1182/blood.V90.5.1867; Juul SE, 2000, PEDIATR RES, V48, P660, DOI 10.1203/00006450-200011000-00018; Juul SE, 1999, PEDIATR RES, V46, P543, DOI 10.1203/00006450-199911000-00009; Juul SE, 2004, BIOL NEONATE, V85, P138, DOI 10.1159/000074970; Juul SE, 1998, PEDIATR RES, V43, P40, DOI 10.1203/00006450-199801000-00007; Juul SE, 1997, J PEDIATR-US, V130, P428, DOI 10.1016/S0022-3476(97)70205-1; Katavetin P, 2007, KIDNEY INT, V72, pS10, DOI 10.1038/sj.ki.5002482; Kawakami M, 2000, BIOCHEM BIOPH RES CO, V279, P293, DOI 10.1006/bbrc.2000.3926; Kawakami M, 2001, J BIOL CHEM, V276, P39469, DOI 10.1074/jbc.M105832200; Kellert BA, 2007, PEDIATR RES, V61, P451, DOI 10.1203/pdr.0b013e3180332cec; Kobayashi T, 2002, BIOCHEM BIOPH RES CO, V296, P145, DOI 10.1016/S0006-291X(02)00832-X; Komotar RJ, 2008, NEUROSURGERY, V62, P396, DOI 10.1227/01.neu.0000316006.26635.b0; Komotar RJ, 2008, NEUROSURGERY, V62, P905, DOI [10.1227/01.neu.0000318175.05591.c318496195, DOI 10.1227/01.neu.0000318175.05591.c318496195]; KONISHI Y, 1993, BRAIN RES, V609, P29, DOI 10.1016/0006-8993(93)90850-M; Kornotar RJ, 2008, NEUROSURGERY, V62, P897, DOI [10.1227/01.neu.0000318175.05591.c3, 10.1227/01.NEU.0000310706.61025.38]; Koshimura K, 1999, J NEUROCHEM, V72, P2565, DOI 10.1046/j.1471-4159.1999.0722565.x; Kumral A, 2005, BIOL NEONATE, V87, P15, DOI 10.1159/000080490; Kumral A, 2003, BIOL NEONATE, V83, P224, DOI 10.1159/000068926; Lapchak PA, 2008, EXPERT OPIN INV DRUG, V17, P1175, DOI [10.1517/13543784.17.8.1175, 10.1517/13543784.17.8.1175 ]; Lewczuk P, 2000, NEUROREPORT, V11, P3485, DOI 10.1097/00001756-200011090-00017; Li WP, 2004, ANN NEUROL, V56, P767, DOI 10.1002/ana.20274; Linn FHH, 1996, STROKE, V27, P625, DOI 10.1161/01.STR.27.4.625; Liu C, 1997, J BIOL CHEM, V272, P32395, DOI 10.1074/jbc.272.51.32395; Magnanti M, 2001, BLOOD, V98, P2872, DOI 10.1182/blood.V98.9.2872; Mahmood A, 2007, J NEUROSURG, V107, P392, DOI 10.3171/JNS-07/08/0392; Maiese K, 2008, CYTOKINE GROWTH F R, V19, P145, DOI 10.1016/j.cytogfr.2008.01.004; Mammis A, 2009, SURG NEUROL, V71, P527, DOI 10.1016/j.surneu.2008.02.040; Marti HH, 1996, EUR J NEUROSCI, V8, P666, DOI 10.1111/j.1460-9568.1996.tb01252.x; Martinez-Estrada OM, 2003, EUR J NEUROSCI, V18, P2538, DOI 10.1046/j.1460-9568.2003.02987.x; Masuda S, 2000, AM J PHYSIOL-ENDOC M, V278, pE1038; MASUDA S, 1994, J BIOL CHEM, V269, P19488; McPherson RJ, 2007, NEONATOLOGY, V91, P36, DOI 10.1159/000096969; Morishita E, 1997, NEUROSCIENCE, V76, P105, DOI 10.1016/s0306-4522(96)00306-5; Murphy AM, 2008, J NEUROSURG, V109, P1155, DOI 10.3171/JNS.2008.109.12.1155; Nagai A, 2001, J NEUROPATH EXP NEUR, V60, P386, DOI 10.1093/jnen/60.4.386; Noguchi CT, 2007, CRIT REV ONCOL HEMAT, V64, P159, DOI 10.1016/j.critrevonc.2007.03.001; Ogilvie M, 2000, J BIOL CHEM, V275, P39754, DOI 10.1074/jbc.M004999200; OHMAN J, 1991, J NEUROSURG, V74, P8, DOI 10.3171/jns.1991.74.1.0008; Ostrowski RP, 2006, NEUROL RES, V28, P399, DOI 10.1179/016164106X115008; Peltonen S, 1997, J NEUROSURG, V87, P207, DOI 10.3171/jns.1997.87.2.0207; Pluta RM, 2005, PHARMACOL THERAPEUT, V105, P23, DOI 10.1016/j.pharmthera.2004.10.002; Rajajee Venkatakrishna, 2004, J Stroke Cerebrovasc Dis, V13, P47, DOI 10.1016/j.jstrokecerebrovasdis.2004.01.002; Renzi MJ, 2002, MOL BRAIN RES, V104, P86, DOI 10.1016/S0169-328X(02)00323-6; Rosamond W, 2008, CIRCULATION, V117, pE25, DOI 10.1161/CIRCULATIONAHA.107.187998; Sabri M, 2008, BRAIN RES, V1238, P163, DOI 10.1016/j.brainres.2008.08.031; Sakanaka M, 1998, P NATL ACAD SCI USA, V95, P4635, DOI 10.1073/pnas.95.8.4635; Sakowitz OW, 2006, CURR OPIN CRIT CARE, V12, P103, DOI 10.1097/01.ccx.0000216575.03815.ee; Santhanam AVR, 2005, STROKE, V36, P2731, DOI 10.1161/01.STR.0000190021.85035.5b; Sasaki R, 2003, INTERNAL MED, V42, P142, DOI 10.2169/internalmedicine.42.142; Sehba FA, 2005, J NEUROSURG, V102, P1094, DOI 10.3171/jns.2005.102.6.1094; Silva M, 1999, J BIOL CHEM, V274, P22165, DOI 10.1074/jbc.274.32.22165; Sinor AD, 2000, NEUROSCI LETT, V290, P213, DOI 10.1016/S0304-3940(00)01361-6; Siren AL, 2001, P NATL ACAD SCI USA, V98, P4044, DOI 10.1073/pnas.051606598; Siren AL, 2001, ACTA NEUROPATHOL, V101, P271, DOI 10.1007/s004010000297; SONOBE M, 1978, ACTA NEUROCHIR, V44, P97, DOI 10.1007/BF01401633; Springborg JB, 2007, ACTA NEUROCHIR, V149, P1089, DOI 10.1007/s00701-007-1284-z; Springborg JB, 2002, BRIT J PHARMACOL, V135, P823, DOI 10.1038/sj.bjp.0704521; Starke RM, 2008, NEUROSURGERY, V62, P1405, DOI 10.1227/01.neu.0000333471.90507.f8; Statler PA, 2007, PEDIATR RES, V61, P671, DOI 10.1203/pdr.0b013e31805341dc; Suarez JI, 2006, NEW ENGL J MED, V354, P387, DOI 10.1056/NEJMra052732; Sugawa M, 2002, NEUROSCI RES, V44, P391, DOI 10.1016/S0168-0102(02)00161-X; Tseng MY, 2009, J NEUROSURG, V111, P171, DOI 10.3171/2009.3.JNS081332; Vajkoczy P, 2005, J NEUROSURG, V103, P9, DOI 10.3171/jns.2005.103.1.0009; Villa P, 2003, J EXP MED, V198, P971, DOI 10.1084/jem.20021067; Wang L, 2004, STROKE, V35, P1732, DOI 10.1161/01.STR.0000132196.49028.a4; Wojchowski DM, 2006, BLOOD CELL MOL DIS, V36, P232, DOI 10.1016/j.bcmd.2006.01.007; Wu H, 1999, DEVELOPMENT, V126, P3597; Yamaji R, 1996, EUR J BIOCHEM, V239, P494, DOI 10.1111/j.1432-1033.1996.0494u.x; Yoo JY, 2009, J NEUROSCI RES, V87, P150, DOI 10.1002/jnr.21832; Yu YP, 2005, NEUROSCI LETT, V387, P5, DOI 10.1016/j.neulet.2005.07.008; Zhou CM, 2005, J CEREBR BLOOD F MET, V25, P572, DOI 10.1038/sj.jcbfm.9600069	126	17	19	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	MAY	2010	73	5					500	507		10.1016/j.wneu.2010.02.026			8	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	792UL	WOS:000292775800026	20920933				2021-06-18	
J	Brown, CVR; Foulkrod, KH; Lopez, D; Stokes, J; Villareal, J; Foarde, K; Curry, E; Coopwood, B				Brown, Carlos V. R.; Foulkrod, Kelli H.; Lopez, Daniel; Stokes, John; Villareal, Jesus; Foarde, Katie; Curry, Eardie; Coopwood, Ben			Recombinant Factor VIIa for the Correction of Coagulopathy Before Emergent Craniotomy in Blunt Trauma Patients	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						Factor VIIa; Traumatic brain injury; Craniotomy; Coagulopathy	ACTIVATED FACTOR-VII; ACUTE INTRACEREBRAL HEMORRHAGE; BRAIN-INJURY; CLINICAL-TRIAL; REVERSAL; SAFETY; RFVIIA	Background: Recombinant activated factor VII (rFVIIa) has been associated with decreased blood transfusion requirements in trauma patients. Clinical use has recently been extended to the treatment of coagulopathic patients with traumatic brain injury, and results have been encouraging. However, the cost and possible thromboembolic complications of rFVIIa have been considered barriers to its widespread use. We hypothesize that rFVIIa would provide an effective and cost efficient means of correcting coagulopathy in patients with traumatic brain injury undergoing emergent craniotomy. Methods: We performed a 2-year (2005-2006) retrospective study of adult blunt trauma patients with traumatic brain injury who presented coagulpathic (international normalized ratio [INR] >1.3) and required emergent craniotomy. We compared patients who did (rFVIIa group) and did not (no-rFVIIa group) receive rFVIIa to correct coagulopathy before craniotomy. Results: There were 14 rFVIIa patients and 14 no-rFVIIa patients. The rFVIIa patients were older (59 years vs. 41 years, p = 0.04), but there was no difference in male gender (79% vs. 79%, p = 0.68), injury severity score (29 vs. 29, p = 1.0). or Glasgow Coma Scale score (10 vs. 7, p = 0.67). Although there was no difference in admission INR (2.6 vs. 1.9, p = 0. 1 0) the rFVIIa group was more often taking preinjury coumadin (57% vs. 14%, p = 0.05). The rFVIIa group had a preoperative INR (1.2 +/- 0.4 vs. 1.4 +/- 0.2, p = 0.05), but there was no difference in the time from admission to craniotomy (135 minutes vs. 182 minutes, P = 0.51). The rFVIIa group received fewer units of packed red blood cells (PRBCs) and plasma during the perioperative period. In addition, the rVIIa group consumed fewer costs of PRBC ($756 per patient vs. S2,916 per patient, p < 0.001) and plasma ($369 per patient vs. $927 per patient, p = 0.001). The rFVIIa group still consumed fewer total costs of transfused blood products when cost of rFVIIa was included (S2,557 per patient vs. $4,110 per patient, p = 0.04). There were no thromboembolic complications in either group. Conclusions: rFVIIa provides a cost-efficient option to effectively correct coagulopathy in patients with traumatic brain injury undergoing emergent craniotomy. In addition, the use of rFVIIa is associated with decreased transfusion of PRBC and plasma and decreased transfusion-related hospital costs in this population.	[Brown, Carlos V. R.; Foulkrod, Kelli H.; Lopez, Daniel; Villareal, Jesus; Foarde, Katie; Coopwood, Ben] Univ Texas SW Med Sch Austin, Trauma Serv, Univ Med Ctr Brackenridge, Dept Surg, Austin, TX 78701 USA; [Stokes, John] Univ Med Ctr Brackenridge, Dept Neurosurg, Austin, TX USA; [Curry, Eardie] Univ Med Ctr Brackenridge, Dept Pharm, Austin, TX USA	Brown, CVR (corresponding author), Univ Texas SW Med Sch Austin, Trauma Serv, Univ Med Ctr Brackenridge, Dept Surg, 601 East,15th St, Austin, TX 78701 USA.	cvrbrown@seton.org					Bartal C, 2007, J TRAUMA, V63, P725, DOI 10.1097/TA.0b013e318031ccca; Boffard KD, 2005, J TRAUMA, V59, P8, DOI 10.1097/01.TA.0000171453.37949.B7; Dutton RP, 2003, J CLIN ANESTH, V15, P184, DOI 10.1016/S0952-8180(03)00034-5; HEDNER U, 1983, J CLIN INVEST, V71, P1836, DOI 10.1172/JCI110939; Ityas C, 2008, J CLIN ANESTH, V20, P276, DOI 10.1016/j.jclinane.2007.12.012; Ivascu FA, 2005, J TRAUMA, V59, P1131, DOI 10.1097/01.ta.0000189067.16368.83; Kenet G, 1999, LANCET, V354, P1879, DOI 10.1016/S0140-6736(99)05155-7; Kluger Y, 2007, CRIT CARE, V11, DOI 10.1186/cc6092; Martinowitz U, 2002, CAN J ANAESTH, V49, pS15; Martinowitz U, 2001, J TRAUMA, V51, P431, DOI 10.1097/00005373-200109000-00002; Mayer SA, 2005, NEW ENGL J MED, V352, P777, DOI 10.1056/NEJMoa042991; Mayer SA, 2008, NEW ENGL J MED, V358, P2127, DOI 10.1056/NEJMoa0707534; Narayan RK, 2008, NEUROSURGERY, V62, P776, DOI 10.1227/01.NEU.0000297095.04013.C4; O'Connell KA, 2006, JAMA-J AM MED ASSOC, V295, P293, DOI 10.1001/jama.295.3.293; O'Neill PA, 2002, J TRAUMA, V52, P400, DOI 10.1097/00005373-200202000-00034; Stein DM, 2008, INJURY, V39, P1054, DOI 10.1016/j.injury.2008.03.032; Stein DM, 2008, J TRAUMA, V64, P620, DOI 10.1097/TA.0b013e3181650fc7; Stein DM, 2009, J TRAUMA, V66, P63, DOI 10.1097/TA.0b013e318191bc8a; Thomas GOR, 2007, J TRAUMA, V62, P564, DOI 10.1097/TA.0b013e318031afc2	19	17	19	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	FEB	2010	68	2					348	352		10.1097/TA.0b013e3181bbfb6b			5	Critical Care Medicine; Surgery	General & Internal Medicine; Surgery	555FC	WOS:000274492600025	20154547				2021-06-18	
J	Cazzato, V; Basso, D; Cutini, S; Bisiacchi, P				Cazzato, Valentina; Basso, Demis; Cutini, Simone; Bisiacchi, Patrizia			Gender differences in visuospatial planning: An eye movements study	BEHAVIOURAL BRAIN RESEARCH			English	Article						Gender differences; Visuospatial planning; Navigation; Strategy; Optimisation; Eye movements	CLOSED-HEAD INJURY; SEX-DIFFERENCES; SPATIAL ABILITY; STRATEGIES; KNOWLEDGE; TASKS	Gender studies report a male advantage in several visuospatial abilities. Only few studies however, have evaluated differences in visuospatial planning behaviour with regard to gender. This study was aimed at exploring whether gender may affect the choice of cognitive strategies in a visuospatial planning task and, if oculomotor measures could assist in disentangling the cognitive processes involved. A computerised task based on the travelling salesperson problem paradigm, the Maps test, was used to investigate these issues. Participants were required to optimise time and space of a path travelling among a set of sub-goals in a spatially constrained environment. Behavioural results suggest that there are no gender differences in the initial visual processing of the stimuli, but rather during the execution of the plan, with males showing a shorter execution time and a higher path length optimisation than females. Males often showed changes of heuristics during the execution while females seemed to prefer a constant strategy. Moreover, a better performance in behavioural and oculomotor measures seemed to suggest that males are more able than females in either the optimisation of spatial features or the realisation of the planned scheme. Despite inconclusive findings, the results support previous research and provide insight into the level of cognitive processing involved in navigation and planning tasks, with regard to the influence of gender. (C) 2009 Elsevier B.V. All rights reserved.	[Basso, Demis; Bisiacchi, Patrizia] Univ Padua, Dept Gen Psychol, I-35100 Padua, Italy; [Cazzato, Valentina] Univ Roma La Sapienza, Dept Psychol, Rome, Italy; [Cazzato, Valentina] Santa Lucia Fdn, Neuroimaging Lab, Rome, Italy; [Cutini, Simone] Univ Padua, Dept Dev Psychol, I-35100 Padua, Italy	Basso, D (corresponding author), Univ Padua, Dept Gen Psychol, I-35100 Padua, Italy.	demis.basso@unipd.it	BISIACCHI, PATRIZIA/B-8976-2008; Basso, Demis/Q-4782-2017	BISIACCHI, PATRIZIA/0000-0003-2760-8000; Basso, Demis/0000-0002-4595-3513	Italian PRIN2005Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)	This work was supported by the Italian PRIN2005 awarded to P.S.B. The authors wish to thank the two anonymous reviewers for the thoughtful suggestions which sensibly improved the initial manuscript, and Dr. Rita Younan for language revisions. Individual contribution: D.B. and P.S.B. conceived the study, D.B. and S.C. prepared the materials, V.C. collected the data, V.C., D.B. and S.C. analysed the data, V.C. and D.B. wrote the manuscript, which was revised by all authors.	Alderman N, 2003, J INT NEUROPSYCH SOC, V9, P31, DOI 10.1017/S1355617703910046; Barr Avron, 1981, HDB ARTIFICIAL INTEL, V1; Basso D, 2006, EXP BRAIN RES, V171, P411, DOI 10.1007/s00221-006-0457-z; Basso D, 2001, BRAIN COGNITION, V46, P38, DOI 10.1016/S0278-2626(01)80029-4; BASSO D, 2005, THESIS U ROME SAPIEN; BASSO D, 1999, AIP C NAZ SEZ PSIC S, P155; Basso Demis, 2006, Cogn Process, V7, P73, DOI 10.1007/s10339-006-0034-1; Beatty J., 2000, HDB PSYCHOPHYSIOLOGY, P142; Bisiacchi PS, 1998, BRAIN COGNITION, V37, P113; BISIACCHI PS, 2002, IAPS B PEOPLE ENV ST, V21, P1; BISIACCHI PS, 1999, NEUROPSICOLOGIA INVE, P185; Buss D., 2003, EVOLUTIONARY PSYCHOL; BYRNE R, 1977, COGNITION, V5, P287, DOI 10.1016/0010-0277(77)90019-1; Byrnes JP, 1999, PSYCHOL BULL, V125, P367, DOI 10.1037/0033-2909.125.3.367; Carpenter P., 1986, ADV PSYCHOL HUMAN IN, V3, P221; Chen CH, 2009, J ENVIRON PSYCHOL, V29, P220, DOI 10.1016/j.jenvp.2008.07.003; Choi J., 1996, EVOLUTION COGNITION, V2, P165, DOI DOI 10.1016/S0191-8869(02)00105-8; Coluccia E, 2004, J ENVIRON PSYCHOL, V24, P329, DOI 10.1016/j.jenvp.2004.08.006; d'Acremont M, 2006, INT J BEHAV DEV, V30, P352, DOI 10.1177/0165025406066740; Dabbs JM, 1998, EVOL HUM BEHAV, V19, P89, DOI 10.1016/S1090-5138(97)00107-4; DUNCAN J, 1986, COGNITIVE NEUROPSYCH, V3, P271, DOI 10.1080/02643298608253360; GALEA LAM, 1993, PERS INDIV DIFFER, V14, P53, DOI 10.1016/0191-8869(93)90174-2; Gigerenzer G., 1999, SIMPLE HEURISTICS MA; Gitelman DR, 2002, BEHAV RES METH INS C, V34, P605, DOI 10.3758/BF03195488; GOEL V, 1995, NEUROPSYCHOLOGIA, V33, P623, DOI 10.1016/0028-3932(95)90866-P; Graham SM, 2000, MEM COGNITION, V28, P1191, DOI 10.3758/BF03211820; Halpern DF, 2004, CURR DIR PSYCHOL SCI, V13, P135, DOI 10.1111/j.0963-7214.2004.00292.x; HAYES-ROTH B, 1979, Cognitive Science, V3, P275, DOI 10.1016/S0364-0213(79)80010-5; Helsgaun K, 2000, EUR J OPER RES, V126, P106, DOI 10.1016/S0377-2217(99)00284-2; HIRTLE SC, 1985, MEM COGNITION, V13, P208, DOI 10.3758/BF03197683; HIRTLE SC, 1992, GEOFORUM, V23, P227, DOI 10.1016/0016-7185(92)90019-Z; JONKER J, 2003, BRAIN COGNITION, V52, P231; KAHNEMAN D, 1966, SCIENCE, V154, P1583, DOI 10.1126/science.154.3756.1583; Kimura D, 1999, SEX COGNITION; Klatzky R. L., 1998, Spatial Cognition. An Interdisciplinary Approach to Representing and Processing Spatial Knowledge, P1; Klippel A, 2009, COGN PROCESS, V10, P175, DOI 10.1007/s10339-008-0251-x; Law AS, 2006, ACTA PSYCHOL, V122, P27, DOI 10.1016/j.actpsy.2005.09.002; Lawton CA, 2002, SEX ROLES, V47, P389, DOI 10.1023/A:1021668724970; LAWTON CA, 1994, SEX ROLES, V30, P765, DOI 10.1007/BF01544230; Lawton CA, 2001, SEX ROLES, V44, P321, DOI 10.1023/A:1010981616842; MacGregor JN, 1996, PERCEPT PSYCHOPHYS, V58, P527, DOI 10.3758/BF03213088; McManis MH, 2001, PSYCHOPHYSIOLOGY, V38, P222, DOI 10.1111/1469-8986.3820222; Mueller SC, 2008, BEHAV BRAIN RES, V193, P209, DOI 10.1016/j.bbr.2008.05.017; Murakoshi S, 2000, ENVIRON BEHAV, V32, P756, DOI 10.1177/00139160021972784; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Payne J.W., 1993, ADAPTIVE DECISION MA; Rilea SL, 2008, BRAIN COGNITION, V67, P168, DOI 10.1016/j.bandc.2008.01.001; Sandstrom NJ, 1998, COGNITIVE BRAIN RES, V6, P351, DOI 10.1016/S0926-6410(98)00002-0; Saucier DM, 2002, BEHAV NEUROSCI, V116, P403, DOI 10.1037//0735-7044.116.3.403; SHALLICE T, 1991, BRAIN, V114, P727, DOI 10.1093/brain/114.2.727; SHALLICE T, 1982, PHILOS T ROY SOC B, V298, P199, DOI 10.1098/rstb.1982.0082; SIMON HA, 1976, COGNITIVE PSYCHOL, V8, P86, DOI 10.1016/0010-0285(76)90005-0; TAKEDA M, 1976, HUMAN ENG, V12, P175; Tenbrink T, 2009, COGN PROCESS, V10, P143, DOI 10.1007/s10339-008-0225-z; Vogeley K, 2003, TRENDS COGN SCI, V7, P38, DOI 10.1016/S1364-6613(02)00003-7; VOYER D, 1995, PSYCHOL BULL, V117, P250, DOI 10.1037/0033-2909.117.2.250; Weiss EM, 2003, PERS INDIV DIFFER, V35, P863, DOI 10.1016/S0191-8869(02)00288-X; WITKIN HA, 1950, J PERS, V19, P1, DOI 10.1111/j.1467-6494.1950.tb01084.x	58	17	19	0	11	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0166-4328	1872-7549		BEHAV BRAIN RES	Behav. Brain Res.	JAN	2010	206	2					177	183		10.1016/j.bbr.2009.09.010			7	Behavioral Sciences; Neurosciences	Behavioral Sciences; Neurosciences & Neurology	523KD	WOS:000272071100003	19761799				2021-06-18	
J	Cooper, DB; Mercado-Couch, JM; Critchfield, E; Kennedy, J; Vanderploeg, RD; DeVillibis, C; Gaylord, KM				Cooper, Douglas B.; Mercado-Couch, Janyna M.; Critchfield, Edan; Kennedy, Jan; Vanderploeg, Rodney D.; DeVillibis, Carita; Gaylord, Kathryn M.			Factors influencing cognitive functioning following mild traumatic brain injury in OIF/OEF burn patients	NEUROREHABILITATION			English	Article						Mild traumatic brain injury; blast injury; cognitive dysfunction	POSTTRAUMATIC-STRESS-DISORDER; NEUROPSYCHOLOGICAL STATUS RBANS; REPEATABLE BATTERY; POSTCONCUSSIVE SYMPTOMS; BASE RATES; IRAQ; AFGHANISTAN; MECHANISMS; DIAGNOSIS; VALIDITY	Objective: To examine the relationship between mild traumatic brain injury (mTBI), psychiatric conditions, pain medications, and injury severity on cognitive functioning in service members admitted to a burn unit. We hypothesize that psychiatric co-morbidity and pain medications will have a stronger relationship with cognitive dysfunction than mTBI diagnosis in this population. Method: Retrospective review of clinical evaluations (n = 194) completed between September 2005-October 2007 on service members with burn injuries secondary to explosive munitions. Evaluations were completed during the acute stage of recovery (mean = 7.87 weeks). mTBI diagnosis (n = 50) was made through a clinical interview using ACRM criteria [1]. Exclusion criteria included duration of posttraumatic amnesia > 24 hours (n = 10); and inability to complete neurocognitive measures due to severe bimanual burns and/or amputations (n = 17). Cognitive functioning was evaluated using the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS). Results: Subjects who sustained mTBI demonstrated significantly greater difficulty on the RBANS visuospatial and attention/processing speed indices. A hierarchical linear regression, using mTBI diagnosis, psychiatric diagnosis, time since injury, presence of pain medications, and measures of trauma severity as predictive factors, found that mTBI diagnosis had a significant, but small unique effect on cognitive functioning. Contrary to our hypothesis, psychiatric co-morbidity was not shown to have a significant effect on this population of acutely injured service members. Conclusions: While the relationship between severe TBI and cognitive functioning is well established, the relationship between mTBI and its effects on cognitive and behavioral abilities is less clear. The current study demonstrates that mTBI and analgesic medications have a small effect neurocognitive functioning in this population. Continued examination of this relationship is warranted.	[Cooper, Douglas B.] Brooke Army Med Ctr, Dept Orthoped, Traumat Brain Injury Serv, Ft Sam Houston, TX 78234 USA; [Cooper, Douglas B.] Brooke Army Med Ctr, Dept Rehabil, Traumat Brain Injury Serv, Ft Sam Houston, TX 78234 USA; [Mercado-Couch, Janyna M.; Critchfield, Edan] Brooke Army Med Ctr, Dept Behav Med, Ft Sam Houston, TX 78234 USA; [Kennedy, Jan; Vanderploeg, Rodney D.] DVBIC, Washington, DC USA; [Vanderploeg, Rodney D.] James A Haley Vet Adm Med Ctr, Tampa, FL 33612 USA; [Vanderploeg, Rodney D.] Univ S Florida, Tampa, FL USA; [DeVillibis, Carita] USA, Res Lab, Adelphi, MD USA; [Gaylord, Kathryn M.] US Inst Surg Res USAISR, Ft Sam Houston, TX USA	Cooper, DB (corresponding author), MCHE DOR TBI, Dept Orthoped & Rehabil, Traumat Brain Injury Serv, 3851 Roger Brooke Dr, Ft Sam Houston, TX 78234 USA.	douglas.cooper2@amedd.army.mil			NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P30AG012300] Funding Source: NIH RePORTER; NIA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [AG P30-12300-10] Funding Source: Medline		American Congress of Rehabilitation Medicine, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Atiyeh BS, 2005, WORLD J SURG, V29, P131, DOI 10.1007/s00268-004-1082-2; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Beatty WW, 2004, ARCH CLIN NEUROPSYCH, V19, P825, DOI 10.1016/j.acn.2003.12.001; Belanger HG, 2009, J INT NEUROPSYCH SOC, V15, P1, DOI 10.1017/S1355617708090036; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Chamelian L, 2006, J NEUROPSYCH CLIN N, V18, P33, DOI 10.1176/appi.neuropsych.18.1.33; FOX DD, 1995, NEUROPSYCHOLOGY, V9, P606, DOI 10.1037/0894-4105.9.4.606; Freilich BM, 2007, PSYCHOL REP, V101, P119, DOI 10.2466/PR0.101.1.119-129; Gaylord KM, 2008, J TRAUMA, V64, pS200, DOI 10.1097/TA.0b013e318160ba42; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Kennedy JE, 2007, J REHABIL RES DEV, V44, P895, DOI 10.1682/JRRD.2006.12.0166; Kwok FY, 2008, BRAIN INJURY, V22, P740, DOI 10.1080/02699050802336989; Landre N, 2006, ARCH CLIN NEUROPSYCH, V21, P255, DOI 10.1016/j.acn.2005.12.007; Lange RT, 2008, CLIN NEUROPSYCHOL, V22, P209, DOI 10.1080/13854040701290062; Lovell M, 2008, NEUROL CLIN, V26, P45, DOI 10.1016/j.ncl.2007.12.001; McCauley SR, 2005, J NERV MENT DIS, V193, P540, DOI 10.1097/01.nmd.0000172592.05801.71; Mckay C, 2008, CLIN NEUROPSYCHOL, V22, P228, DOI 10.1080/13854040701260370; Meares S, 2008, J NEUROL NEUROSUR PS, V79, P300, DOI 10.1136/jnnp.2007.126565; Moser RS, 2007, ARCH CLIN NEUROPSYCH, V22, P909, DOI 10.1016/j.acn.2007.09.004; Powell GE, 2008, J NEUROL NEUROSUR PS, V79, P237, DOI 10.1136/jnnp.2007.131722; Randolph C, 1998, J CLIN EXP NEUROPSYC, V20, P310, DOI 10.1076/jcen.20.3.310.823; Randolph C, 1998, REPEATABLE BATTERY A; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Schrimsher GW, 2008, J PSYCHOPATHOL BEHAV, V30, P146, DOI 10.1007/s10862-007-9054-0; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Wilde MC, 2006, CLIN NEUROPSYCHOL, V20, P702, DOI 10.1080/13854040500246901; Wilk CM, 2004, SCHIZOPHR RES, V70, P175, DOI 10.1016/j.schres.2003.10.009	28	17	17	0	8	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2010	26	3					233	238		10.3233/NRE-2010-0559			6	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	603OQ	WOS:000278218300007	20448313				2021-06-18	
J	Hunt, T; Asplund, C				Hunt, Tamerah; Asplund, Chad			Concussion Assessment and Management	CLINICS IN SPORTS MEDICINE			English	Article						Concussion; Head injury; Athletic training; Assessment; Management	TRAUMATIC BRAIN-INJURY; COLLEGIATE FOOTBALL PLAYERS; MILD HEAD-INJURY; NEUROPSYCHOLOGICAL DEFICITS; RECOVERY; SPORT; PERFORMANCE; STATEMENT	Sport-related concussions are becoming common place in athletics and daily activity. Proper assessment and management of concussions are crucial, as repeat concussion can result in prolonged symptoms and catastrophic outcomes. New research is changing the way concussions are managed. The previously used systems have been abandoned in favor of individualized assessment and management using a multidisciplinary approach to include clinical signs, neuropsychological assessment, and postural stability. Transitioning the new evidence to clinical practice is the future of diagnosis, management, and safe return to play following sport-related concussions. This article aims to bridge this gap and provide a systematic, easy-to-use methodology in the management of sport-related concussions.	[Hunt, Tamerah] Ohio State Univ, Sch Allied Med Profess, Columbus, OH 43221 USA; [Asplund, Chad] Ohio State Univ, Dept Family Med, Div Sports Med, Columbus, OH 43221 USA	Hunt, T (corresponding author), Ohio State Univ, Sch Allied Med Profess, 2050 Kenny Rd,Suite 3100, Columbus, OH 43221 USA.	tamerah.hunt@osumc.edu	Hunt, Tamerah/E-3281-2011				ALBERSON P, 1997, BRIT MED J, V314, P1855; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Bazarian JJ, 2006, ACAD EMERG MED, V13, P199, DOI 10.1197/j.aem.2005.07.031; Bleiberg J, 2004, NEUROSURGERY, V54, P1073, DOI 10.1227/01.NEU.0000118820.33396.6A; Broglio SP, 2005, MED SCI SPORT EXER, V37, P689, DOI 10.1249/01.MSS.0000159019.14919.09; Broglio SP, 2007, NEUROSURGERY, V60, P1050, DOI 10.1227/01.NEU.0000255479.90999.C0; Collie A, 2006, J NEUROL NEUROSUR PS, V77, P241, DOI 10.1136/jnnp.2005.073155; Collins MW, 2003, CLIN J SPORT MED, V13, P222, DOI 10.1097/00042752-200307000-00005; Comper P, 2005, BRAIN INJURY, V19, P863, DOI 10.1080/02699050400025042; COMPTON J S, 1990, British Journal of Neurosurgery, V4, P9, DOI 10.3109/02688699009000676; Echemendia RJ, 2001, CLIN J SPORT MED, V11, P23, DOI 10.1097/00042752-200101000-00005; Erlanger D, 2003, ARCH CLIN NEUROPSYCH, V18, P293, DOI 10.1016/S0887-6177(02)00138-5; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Grindel SH, 2001, CLIN J SPORT MED, V11, P134, DOI 10.1097/00042752-200107000-00003; Guskiewicz KM, 1997, MED SCI SPORT EXER, V29, pS213; Guskiewicz KM, 2004, J ATHL TRAINING, V39, P280; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; HALLENBECK JM, 1983, J NEUROSURG, V58, P749, DOI 10.3171/jns.1983.58.5.0749; HERRING S, 2006, MED SCI SPORTS EXERC, V38, P395, DOI DOI 10.1249/01.MSS.0000202025.48774.31; Ho MR, 1997, ARCH CLIN NEUROPSYCH, V12, P1; Hoane MR, 2003, J NEUROTRAUM, V20, P1189, DOI 10.1089/089771503770802871; King NS, 1997, CLIN REHABIL, V11, P13, DOI 10.1177/026921559701100104; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Macciocchi SN, 1996, NEUROSURGERY, V39, P510, DOI 10.1097/00006123-199609000-00014; Maddocks D, 1996, BRAIN INJURY, V10, P99, DOI 10.1080/026990596124584; Maiese K, 2003, TRENDS PHARMACOL SCI, V24, P228, DOI 10.1016/S0165-6147(03)00078-6; Maroon J C, 1980, Clin Neurosurg, V27, P414; McAllister TW, 2001, J CLIN EXP NEUROPSYC, V23, P775, DOI 10.1076/jcen.23.6.775.1026; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 2001, CLIN J SPORT MED, V11, P176, DOI 10.1097/00042752-200107000-00008; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2002, BRIT J SPORT MED, V36, P3, DOI 10.1136/bjsm.36.1.3; McCrory P, 2009, J SCI MED SPORT, V12, P340, DOI 10.1016/j.jsams.2009.02.004; Mendez CV, 2005, J NEUROPSYCH CLIN N, V17, P297, DOI 10.1176/appi.neuropsych.17.3.297; Mittenberg W, 2001, J CLIN EXP NEUROPSYC, V23, P829, DOI 10.1076/jcen.23.6.829.1022; Notebaert AJ, 2005, J ATHL TRAINING, V40, P320; Piland SG, 2003, J ATHL TRAINING, V38, P104; Randolph C, 2005, J ATHL TRAINING, V40, P139; Rigg JL, 2005, J HEAD TRAUMA REHAB, V20, P389, DOI 10.1097/00001199-200507000-00010; ROCKSWOLD GL, 1992, J NEUROSURG, V76, P929, DOI 10.3171/jns.1992.76.6.0929; SARAN A, 1988, INT J PSYCHIAT MED, V18, P75, DOI 10.2190/15AH-JB7Q-U94T-JEAF; Solomon S, 2001, MED CLIN N AM, V85, P987, DOI 10.1016/S0025-7125(05)70355-2; TEASDALE G, 1992, J NEUROTRAUM, V9, pS545; Thompson J, 2005, NEUROSCI LETT, V377, P158, DOI 10.1016/j.neulet.2004.11.090; TYLER GS, 1980, HEADACHE, V20, P213, DOI 10.1111/j.1526-4610.1980.hed2004213.x; Wade DT, 1998, J NEUROL NEUROSUR PS, V65, P177, DOI 10.1136/jnnp.65.2.177; YARNELL PR, 1973, NEUROLOGY, V23, P196, DOI 10.1212/WNL.23.2.196	48	17	18	0	12	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0278-5919	1556-228X		CLIN SPORT MED	Clin. Sports Med.	JAN	2010	29	1					5	+		10.1016/j.csm.2009.09.002			14	Sport Sciences	Sport Sciences	617CE	WOS:000279257600004	19945584				2021-06-18	
J	Milleville-Pennel, I; Pothier, J; Hoc, JM; Mathe, JF				Milleville-Pennel, Isabelle; Pothier, Johanna; Hoc, Jean-Michel; Mathe, Jean-Francois			Consequences of cognitive impairments following traumatic brain injury: Pilot study on visual exploration while driving	BRAIN INJURY			English	Article						Visual exploration; neuropsychological evaluation; driving simulator; traumatic brain injury; attention; executive functions	WORKING-MEMORY; EYE-MOVEMENTS; PERFORMANCE; ATTENTION; FIXATIONS; SYSTEM; TESTS; AGE	Research design: This study compared an analysis of eyes movements while driving with data from neuropsychological tests. Methods and procedures: Five participants suffering from TBI and six control participants took part in this study. All had good driving experience. They were invited to drive on a fixed-base driving simulator. Eye fixations were recorded using an eye tracker. Neuropsychological tests were used to assess attention, working memory, rapidity of information processing and executive functions. Main outcomes and results: Participants with TBI showed a reduction in the variety of the visual zones explored and a reduction of the distance of exploration. Moreover, neuropsychological evaluation indicates that there were difficulties in terms of divided attention, anticipation and planning. Conclusions: There is a complementarity of the information obtained. Tests give information about cognitive deficiencies but not about their translation into a dynamic situation. Conversely, visual exploration provides information about the dynamic with which information is picked up in the environment but not about the cognitive processes involved.	[Milleville-Pennel, Isabelle; Hoc, Jean-Michel] IRCCyN, F-44321 Nantes 03, France; [Pothier, Johanna; Mathe, Jean-Francois] CHU Nantes, F-44035 Nantes 01, France	Milleville-Pennel, I (corresponding author), IRCCyN, 1 Rue Noe,BP 92101, F-44321 Nantes 03, France.	isabelle.milleville-pennel@irccyn.ec-nantes.fr			foundation for 'Gueules Cassees'	This work has been undertaken within the GDR Psychoergo and in collaboration with the CHU of Nantes and ARTA (Association pour la Reinsertion des Traumatise's craniens Atlantique). It has also received the support of the foundation for 'Gueules Cassees'. We are very grateful to Robert Boisliveau for his technical assistance, to all of the participants and to Susan Watts for proofreading this paper.	Allain P, 2005, BRAIN COGNITION, V57, P4, DOI 10.1016/j.bandc.2004.08.011; Anderson S. W., 2005, P 3 INT DRIV S HUM F, P286; Baddeley A, 1997, NEUROPSYCHOLOGY, V11, P187, DOI 10.1037/0894-4105.11.2.187; Baddeley A, 1996, PHILOS T ROY SOC B, V351, P1397, DOI 10.1098/rstb.1996.0123; Ball K.K., 2005, P 3 INT DRIV S HUM F, P51, DOI [10.17077/drivingassessment.1142, DOI 10.17077/DRIVINGASSESSMENT.1142]; Brickenkamp, 1998, TEST ATTENTION CONCE; BROWN J, 1958, Q J EXP PSYCHOL, V10, P12, DOI 10.1080/17470215808416249; Crundall DE, 1998, ERGONOMICS, V41, P448, DOI 10.1080/001401398186937; DAMASIO HC, 1995, SPECIAL ISSUE ANN NY, V769, P241; DUNCAN J, 1986, COGNITIVE NEUROPSYCH, V3, P271, DOI 10.1080/02643298608253360; Elkin-Frankston S, 2007, ARCH CLIN NEUROPSYCH, V22, P631, DOI 10.1016/j.acn.2007.04.004; FAGLIONI P, 1998, HDB CLIN EXPT NEUROP, P525; Falkmer T, 2005, OPTOMETRY VISION SCI, V82, P732, DOI 10.1097/01.opx.0000175560.45715.5b; FATTAL C, 2006, EVALUATION TROUBLES, P123; Haut M., 1992, NEUROPSYCHOLOGY, V6, P51; Hoc JM, 2007, J COGN ENG DECIS MAK, V1, P22, DOI 10.1177/155534340700100102; HOC JM, 2009, P EUR C COGN ERG 200; LAND MF, 1994, NATURE, V369, P742, DOI 10.1038/369742a0; Land MF, 2001, MOTION VISION, P227; LAND MF, 1998, VISION ACTION, P163; Land MF, 2006, PROG RETIN EYE RES, V25, P296, DOI 10.1016/j.preteyeres.2006.01.002; LECOUTRE B, REV MODULAD, V33; Lew HL, 2005, BRAIN INJURY, V19, P177, DOI 10.1080/02699050400017171; Livingstone SA, 2007, BEHAV BRAIN RES, V185, P21, DOI 10.1016/j.bbr.2007.07.015; Martens MH, 2007, TRANSPORT RES F-TRAF, V10, P33, DOI 10.1016/j.trf.2006.03.002; Martin M., 2005, MIDDLE ADULTHOOD LIF, P179, DOI DOI 10.4135/9781452225999.N6; MATTSON AJ, 1992, J NERV MENT DIS, V178, P282; McDowell S, 1997, NEUROPSYCHOLOGIA, V35, P1341, DOI 10.1016/S0028-3932(97)00082-1; Novack TA, 2006, BRAIN INJURY, V20, P455, DOI 10.1080/02699050600664541; Park NW, 1999, NEUROPSYCHOLOGIA, V37, P1119, DOI 10.1016/S0028-3932(99)00034-2; PATOMELLA AH, 2005, P 3 INT DRIV S HUM F, P104; Patomella AH, 2006, J REHABIL MED, V38, P273, DOI 10.1080/16501970600632594; PETERSON LR, 1959, J EXP PSYCHOL, V58, P193, DOI 10.1037/h0049234; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; PRADATDIEHL P, 2006, EVALUATION TROUBLES, P123; Pradhan AK, 2005, HUM FACTORS, V47, P840, DOI 10.1518/001872005775570961; Richardson JTE, 2007, CORTEX, V43, P635, DOI 10.1016/S0010-9452(08)70493-3; ROGE J, 2003, RECHERCHE TRANSPORTS, V81, P157; ROUANET H, 1983, BRIT J MATH STAT PSY, V36, P252; Rouanet H, 1996, PSYCHOL BULL, V119, P149; Serino A, 2006, BRAIN INJURY, V20, P23, DOI 10.1080/02699050500309627; SHALLICE T, 1982, PHILOS T ROY SOC B, V298, P199, DOI 10.1098/rstb.1982.0082; Spreen O., 1998, COMPENDIUM NEUROPSYC; Stav WB, 2008, J SAFETY RES, V39, P1, DOI 10.1016/j.jsr.2007.10.004; STERN EB, 2004, DRIVING SIMULATION P; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Tombaugh TN, 2004, ARCH CLIN NEUROPSYCH, V19, P203, DOI 10.1016/S0887-6177(03)00039-8; Underwood G, 2003, ERGONOMICS, V46, P629, DOI 10.1080/0014013031000090116; Underwood G., 2002, TRANSPORTATION RES F, V5, P87, DOI [10.1016/S1369-8478(02)00008-6, DOI 10.1016/S1369-8478(02)00008-6]; Van Zomeren AH., 1994, CLIN NEUROPSYCHOLOGY; Vuadens P, 2001, Rev Med Suisse Romande, V121, P453; Wang C, 2003, PHYS GUIDE ASSESSING; Wechsler D., 2000, WECHSLER ADULT INTEL; Wilson BA, 1998, NEUROPSYCHOL REHABIL, V8, P213, DOI 10.1080/713755570; Wilson BA, 1996, BEHAV ASSESSMENT DYS; YILMAZ E, 1995, OPHTHALMOLOGY VISUAL, V36, pS940; Zimmermann P, 2002, APPLIED NEUROPSYCHOLOGY OF ATTENTION: THEORY DIAGNOSIS AND REHABILITATION, P110; Zimmermann P, 2007, TEST ATTENTIONAL PER; ZIMMERMANN P, 1993, DEV ASSESSMENT REHAB; Zoccolotti P, 2000, CORTEX, V36, P93, DOI 10.1016/S0010-9452(08)70839-6	60	17	18	0	9	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2010	24	4					678	691		10.3109/02699051003692159			14	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	570ML	WOS:000275682300012	20235770				2021-06-18	
J	Rasquin, SMC; Bouwens, SFM; Dijcks, B; Winkens, I; Bakx, WGM; van Heugten, CM				Rasquin, S. M. C.; Bouwens, S. F. M.; Dijcks, B.; Winkens, I.; Bakx, W. G. M.; van Heugten, C. M.			Effectiveness of a low intensity outpatient cognitive rehabilitation programme for patients in the chronic phase after acquired brain injury	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Brain injury; Cognitive rehabilitation; Outpatient; Chronic; Goal attainment	COMMUNITY INTEGRATION; RANDOMIZED-TRIAL; STROKE; IMPACT; QUESTIONNAIRE; INDIVIDUALS; VALIDATION; ADJUSTMENT; FAMILIES; MODERATE	The aim of this prospective cohort study was to examine the effectiveness of a low intensity outpatient cognitive rehabilitation programme for patients with acquired brain injury in the chronic phase. Twenty-seven patients with acquired brain injury (i.e., stroke, traumatic brain injury, subarachnoid haemorrhage; 52% male) with a mean age of 49.5 (SD 9.2) years and 25 relatives with a mean age of 48.8 (SD 8.8) years were recruited to the study. Mean time since injury in the patient group was 1.9 years (SD 2.0). The group programme consisted of 15 weekly sessions of 2.5 hours and included cognitive strategy training, social skills training, and psycho-education. Patients also received homework. Relatives were invited to attend twice. Repeated measurements were taken: prior to treatment (baseline, T0); directly after treatment (T1, 21 weeks); and at follow-up (T2, 45 weeks). Primary outcome measures were individualised goals (GAS), cognitive failures (CFQ), and quality of life (SA-SIP). Patients did improve significantly on individual goals (p .05) between T0 and T1 and the level of attainment remained stable between T1 and T2. Goals were mostly set in the cognitive and behavioural domains. There were no significant differences between the measurements (T0-T1-T2) on the CFQ and the SA-SIP. The programme had a positive effect on the individual goals set by the patients. However, this did not result in a higher participation level or a better quality of life. This may be due to the low intensity and short duration of the programme.	[Rasquin, S. M. C.; Bakx, W. G. M.] Adelante Rehabil, Hoensbroek, Netherlands; [Rasquin, S. M. C.; Bouwens, S. F. M.; Winkens, I.; van Heugten, C. M.] Maastricht Univ, Sch Mental Hlth & Neurosci, Dept Psychiat & Neuropsychol, Maastricht, Netherlands; [Dijcks, B.; Winkens, I.] Vilans, Utrecht, Netherlands; [van Heugten, C. M.] Ctr Excellence Rehabil Med, Utrecht, Netherlands; [van Heugten, C. M.] Rudolf Magnus Inst Neurosci, NL-3508 TA Utrecht, Netherlands; [van Heugten, C. M.] Maastricht Univ, Dept Neuropsychol & Psychopharmacol, Fac Psychol & Neurosci, Maastricht, Netherlands	Rasquin, SMC (corresponding author), POB 88, NL-6430 AB Hoensbroek, Netherlands.	s.rasquin@adelante-zorggroep.nl					ARRINDELL WA, 2003, SYMPTOM CHECKLIST; Beutler LE, 2003, J CLIN PSYCHOL, V59, P1151, DOI 10.1002/jclp.10216; Boothroyd Roger A, 2004, Ment Health Serv Res, V6, P143, DOI 10.1023/B:MHSR.0000036488.12833.6e; Bouwens SFM, 2009, CLIN REHABIL, V23, P310, DOI 10.1177/0269215508101744; Brickenkamp R., 1998, D2 TEST ATTENTION, V1st US ed; Brickenkamp R., 1962, AUFMERKSAMKEITS BELA; BROADBENT DE, 1982, BRIT J CLIN PSYCHOL, V21, P1, DOI 10.1111/j.2044-8260.1982.tb01421.x; Carney N, 1999, J HEAD TRAUMA REHAB, V14, P277, DOI 10.1097/00001199-199906000-00008; Chua KSG, 2007, ANN ACAD MED SINGAP, V36, P31; Cicerone KD, 2004, ARCH PHYS MED REHAB, V85, P943, DOI 10.1016/j.apmr.2003.07.019; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; Dittmar C, 1997, Appl Neuropsychol, V4, P50, DOI 10.1207/s15324826an0401_6; Drake AI, 2000, J HEAD TRAUMA REHAB, V15, P1103, DOI 10.1097/00001199-200010000-00004; Fisher K, 2008, CLIN REHABIL, V22, P252, DOI 10.1177/0269215507081928; Fraas M, 2007, BRAIN INJURY, V21, P1267, DOI 10.1080/02699050701721794; Franulic A, 2004, BRAIN INJURY, V18, P119, DOI 10.1080/0269905031000149515; Frencham KAR, 2005, J CLIN EXP NEUROPSYC, V27, P334, DOI 10.1080/13803390490520328; Geurtsen GJ, 2008, BRAIN INJURY, V22, P545, DOI 10.1080/02699050802132479; Geusgens CAV, 2007, J REHABIL MED, V39, P425, DOI 10.2340/16501977-0092; Gordon JE, 1999, AGE AGEING, V28, P275, DOI 10.1093/ageing/28.3.275; Graetz P., 1992, AKENSE AFASIETEST NE; Hibbard MR, 2002, J HEAD TRAUMA REHAB, V17, P112, DOI 10.1097/00001199-200204000-00004; JORM AF, 1989, PSYCHOL MED, V19, P1015, DOI 10.1017/S0033291700005742; JOYCE BM, 1994, AM J PHYS MED REHAB, V73, P10, DOI 10.1097/00002060-199473010-00003; KIRESUK TJ, 1968, COMMUNITY MENT HLT J, V4, P443, DOI 10.1007/BF01530764; KRUPP LB, 1989, ARCH NEUROL-CHICAGO, V46, P1121, DOI 10.1001/archneur.1989.00520460115022; Liu C, 2004, CLIN REHABIL, V18, P398, DOI 10.1191/0269215504cr741oa; LUTEIJN F, 1983, MANUAL GRONINGER INT; Malec JF, 2001, ARCH PHYS MED REHAB, V82, P885, DOI 10.1053/apmr.2001.23895; McAllister TW, 1997, COMMUNITY MENT HLT J, V33, P341, DOI 10.1023/A:1025055426260; McColl MA, 2001, ARCH PHYS MED REHAB, V82, P429, DOI 10.1053/apmr.2001.22195; Miller L J, 1998, Appl Neuropsychol, V5, P172, DOI 10.1207/s15324826an0504_2; Mittenberg W, 1996, ARCH CLIN NEUROPSYCH, V11, P139, DOI 10.1016/0887-6177(95)00006-2; Osterrieth P. A, 1944, ARCH PSYCHOL, V30, P286; Paniak C, 2000, BRAIN INJURY, V14, P219; Ponds R., 2006, TIJDSCHRIFT NEUROPSY, V1, P37; Ponsford J, 2003, BRAIN INJURY, V17, P453, DOI 10.1080/0269905031000070143; Prigatano GP., 1999, PRINCIPLES NEUROPSYC; Rapoport MJ, 2000, BRAIN INJURY, V14, P749; Reitan RM, 1956, TRAIL MAKING TEST MA; Rey A., 1958, LEXAMEN CLINIQUE PSY; Rey A, 1941, ARCH PSYCHOLOGIE, V28, P286; ROBINSON BC, 1983, J GERONTOL, V38, P344, DOI 10.1093/geronj/38.3.344; Salazar AM, 2000, JAMA-J AM MED ASSOC, V283, P3075, DOI 10.1001/jama.283.23.3075; Sarajuuri JM, 2005, ARCH PHYS MED REHAB, V86, P2296, DOI 10.1016/j.apmr.2005.06.018; Schreurs P. J. G., 1993, UTRECHTSE COPING LIJ; SCHULING J, 1993, STROKE, V24, P1173, DOI 10.1161/01.STR.24.8.1173; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Tiersky LA, 2005, ARCH PHYS MED REHAB, V86, P1565, DOI 10.1016/j.apmr.2005.03.013; Turner-Stokes L, 2002, CLIN REHABIL, V16, P231, DOI 10.1191/0269215502cr487oa; van der Naalt J, 2001, J CLIN EXP NEUROPSYC, V23, P837, DOI 10.1076/jcen.23.6.837.1018; vanStraten A, 1997, STROKE, V28, P2155, DOI 10.1161/01.STR.28.11.2155; VISSERMEILY J, 2007, NEDERLANDS TIJDSCHRI, V15, P2753; Wechsler D., 1997, WECHSLER ADULT INTEL; Wilson BA, 2002, J HEAD TRAUMA REHAB, V17, P542, DOI 10.1097/00001199-200212000-00006; Wilson BA, 2000, NEUROPSYCHOL REV, V10, P233, DOI 10.1023/A:1026464827874; Wilson BA, 1996, BEHAV ASSESSMENT DYS; Wyller TB, 2003, CLIN REHABIL, V17, P410, DOI 10.1191/0269215503cr627oa; Ylvisaker M, 2002, J HEAD TRAUMA REHAB, V17, P191, DOI 10.1097/00001199-200206000-00002	60	17	17	0	14	PSYCHOLOGY PRESS	HOVE	27 CHURCH RD, HOVE BN3 2FA, EAST SUSSEX, ENGLAND	0960-2011			NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.		2010	20	5					760	777	PII 922908508	10.1080/09602011.2010.484645			18	Neurosciences; Psychology	Neurosciences & Neurology; Psychology	648YB	WOS:000281730300007	20544502				2021-06-18	
S	Samantaray, S; Matzelle, DD; Ray, SK; Banik, NL		Andrews, RJ; Slikker, W; Trembly, B; Patterson, TA		Samantaray, Supriti; Matzelle, Denise D.; Ray, Swapan K.; Banik, Naren L.			Physiological low dose of estrogen-protected neurons in experimental spinal cord injury	NEUROPROTECTIVE AGENTS	Annals of the New York Academy of Sciences		English	Article; Proceedings Paper	9th International Conference on Neuroprotective Agents	SEP 07-11, 2008	Marine Biol Lab, Woods Hole, MA		Marine Biol Lab	estrogen; neuroprotection; spinal cord injury	GLUTAMATE-INDUCED APOPTOSIS; METHYLPREDNISOLONE; CELLS; RATS	A protective role for estrogen against neurodegeneration and neurotrauma has received enormous attention in recent years, unraveling multiple facets and thus establishing this steroid as a multiactive neuroprotectant. The present study briefly reports our findings on the neuroprotective efficacy of physiologically relevant low doses of estrogen in experimental spinal cord injury (SCI) in rats. The current finding further corroborates our earlier results on efficacy of pharmacological/supraphysiological levels of estrogen in SCI and adds to the significance of conducting preclinical studies on estrogen efficacy in SCI.	[Samantaray, Supriti; Matzelle, Denise D.; Banik, Naren L.] Med Univ S Carolina, Dept Neurosci, Div Neurol, Charleston, SC 29425 USA; [Ray, Swapan K.] Univ S Carolina, Sch Med, Dept Pathol Microbiol & Immunol, Columbia, SC USA	Banik, NL (corresponding author), Med Univ S Carolina, Dept Neurosci Neurol, 96 Jonathan Lucas St,MSC606,Suite 309CSB, Charleston, SC 29425 USA.	baniknl@musc.edu			NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS045967, R01 NS045967-03] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS045967] Funding Source: NIH RePORTER		Miller SM, 2008, J NEUROSURG ANESTH, V20, P140, DOI 10.1097/01.ana.0000314442.40952.0d; Perot P L Jr, 1987, Cent Nerv Syst Trauma, V4, P149; Ray SK, 2000, BRAIN RES PROTOC, V5, P305, DOI 10.1016/S1385-299X(00)00027-1; Rozet I, 2008, J NEUROSURG ANESTH, V20, P137, DOI 10.1097/01.ana.0000314441.63823.b0; Samantaray S, 2008, J PINEAL RES, V44, P348, DOI 10.1111/j.1600-079X.2007.00534.x; Sribnick EA, 2007, J NEUROCHEM, V102, P203; Sribnick EA, 2006, NEUROSCIENCE, V137, P197, DOI 10.1016/j.neuroscience.2005.08.074; Sribnick EA, 2005, J NEUROSCI RES, V82, P283, DOI 10.1002/jnr.20622; Sribnick EA, 2004, J NEUROSCI RES, V76, P688, DOI 10.1002/jnr.20124; SRIBNICK EA, 2009, HDB NEUROCHEMISTRY M, P581; Sribnick EA, 2006, J NEUROSCI RES, V84, P1064, DOI 10.1002/jnr.21016; Sur P, 2003, BRAIN RES, V971, P178, DOI 10.1016/S0006-8993(03)02349-7	12	17	18	0	4	WILEY-BLACKWELL	MALDEN	COMMERCE PLACE, 350 MAIN STREET, MALDEN 02148, MA USA	0077-8923		978-1-57331-777-1	ANN NY ACAD SCI	Ann.NY Acad.Sci.		2010	1199						86	89		10.1111/j.1749-6632.2009.05360.x			4	Multidisciplinary Sciences; Neurosciences	Science & Technology - Other Topics; Neurosciences & Neurology	BRJ59	WOS:000282838900009	20633112	Green Accepted			2021-06-18	
J	Scales, DC; Riva-Cambrin, J; Wells, D; Athaide, V; Granton, JT; Detsky, AS				Scales, Damon C.; Riva-Cambrin, Jay; Wells, Dave; Athaide, Valerie; Granton, John T.; Detsky, Allan S.			Prophylactic anticoagulation to prevent venous thromboembolism in traumatic intracranial hemorrhage: a decision analysis	CRITICAL CARE			English	Article							DEEP-VEIN THROMBOSIS; MOLECULAR-WEIGHT HEPARIN; SPONTANEOUS INTRACEREBRAL HEMORRHAGE; PNEUMATIC COMPRESSION DEVICES; QUALITY-OF-LIFE; BRAIN-INJURY; MAJOR TRAUMA; PULMONARY-EMBOLISM; HEAD TRAUMA; NEUROSURGICAL PATIENTS	Introduction: Patients with intracranial hemorrhage due to traumatic brain injury are at high risk of developing venous thromboembolism including deep vein thrombosis (DVT) and pulmonary embolism (PE). Thus, there is a trade-off between the risks of progression of intracranial hemorrhage (ICH) versus reduction of DVT/PE with the use of prophylactic anticoagulation. Using decision analysis modeling techniques, we developed a model for examining this trade-off for trauma patients with documented ICH. Methods: The decision node involved the choice to administer or to withhold low molecular weight heparin (LMWH) anticoagulation prophylaxis at 24 hours. Advantages of withholding therapy were decreased risk of ICH progression (death, disabling neurologic deficit, non-disabling neurologic deficit), and decreased risk of systemic bleeding complications (death, massive bleed). The associated disadvantage was greater risk of developing DVT/PE or death. Probabilities for each outcome were derived from natural history studies and randomized controlled trials when available. Utilities were obtained from accepted databases and previous studies. Results: The expected value associated with withholding anticoagulation prophylaxis was similar (0.90) to that associated with the LMWH strategy (0.89). Only two threshold values were encountered in one-way sensitivity analyses. If the effectiveness of LMWH at preventing DVT exceeded 80% (range from literature 33% to 82%) our model favoured this therapy. Similarly, our model favoured use of LMWH if this therapy increased the risk of ICH progression by no more than 5% above the baseline risk. Conclusions: Our model showed no clear advantage to providing or withholding anticoagulant prophylaxis for DVT/PE prevention at 24 hours after traumatic brain injury associated with ICH. Therefore randomized controlled trials are justifiable and needed to guide clinicians.	[Scales, Damon C.; Wells, Dave; Granton, John T.] Sunnybrook Hlth Sci Ctr, Dept Crit Care Med, Toronto, ON M4N 3M5, Canada; [Scales, Damon C.] Inst Clin Evaluat Sci, Toronto, ON M4N 3M5, Canada; [Scales, Damon C.] Univ Toronto, Interdept Div Crit Care Med, Toronto, ON M5B 1W8, Canada; [Scales, Damon C.] Univ Toronto, Dept Med, Toronto, ON M5B 1W8, Canada; [Riva-Cambrin, Jay] Primary Childrens Med Ctr, Dept Neurosurg, Salt Lake City, UT 84113 USA; [Riva-Cambrin, Jay] Univ Utah, Dept Neurosurg, Salt Lake City, UT 84132 USA; [Athaide, Valerie] Univ British Columbia, Fac Med, Vancouver, BC V6T 1Z3, Canada; [Granton, John T.] Univ Hlth Network, Dept Med, Toronto, ON M5G 2C4, Canada; [Granton, John T.] Univ Hlth Network, Dept Crit Care, Toronto, ON M5G 2C4, Canada; [Detsky, Allan S.] Mt Sinai Hosp, Dept Med, Toronto, ON M5G 1X5, Canada; [Detsky, Allan S.] Univ Toronto, Dept Hlth Policy Management & Evaluat, Toronto, ON M5T 3M6, Canada	Scales, DC (corresponding author), Sunnybrook Hlth Sci Ctr, Dept Crit Care Med, 2075 Bayview Ave,Room D108, Toronto, ON M4N 3M5, Canada.	damon.scales@utoronto.ca			Canadian Institutes for Health ResearchCanadian Institutes of Health Research (CIHR)	DCS is supported by a New Investigator Award from the Canadian Institutes for Health Research.	Agnelli G, 1998, NEW ENGL J MED, V339, P80, DOI 10.1056/NEJM199807093390204; Brothers TE, 1997, J SURG RES, V67, P72, DOI 10.1006/jsre.1996.4962; Caroli M, 2001, SURG NEUROL, V56, P82, DOI 10.1016/S0090-3019(01)00540-7; Collen JF, 2008, CHEST, V134, P237, DOI 10.1378/chest.08-0023; COLLINS R, 1988, NEW ENGL J MED, V318, P1162, DOI 10.1056/NEJM198805053181805; Cook DJ, 2001, CRIT CARE, V5, P369; Cupitt JM, 2001, ANAESTHESIA, V56, P780; Danish SF, 2005, NEUROSURGERY, V56, P1286, DOI 10.1227/01.NEU.0000159882.11635.EA; DAVERAT P, 1991, STROKE, V22, P1, DOI 10.1161/01.STR.22.1.1; Dennis M, 2009, LANCET, V373, P1958, DOI 10.1016/S0140-6736(09)60941-7; Denson K, 2007, AM J SURG, V193, P380, DOI 10.1016/j.amjsurg.2006.12.004; Detsky AS, 1997, MED DECIS MAKING, V17, P126, DOI 10.1177/0272989X9701700202; Dickinson LD, 1998, NEUROSURGERY, V43, P1074, DOI 10.1097/00006123-199811000-00039; FRYBACK DG, 1993, MED DECIS MAKING, V13, P89, DOI 10.1177/0272989X9301300202; GAGE BF, 1995, JAMA-J AM MED ASSOC, V274, P1839, DOI 10.1001/jama.274.23.1839; GEERTS WH, 1994, NEW ENGL J MED, V331, P1601, DOI 10.1056/NEJM199412153312401; Geerts WH, 1996, NEW ENGL J MED, V335, P701, DOI 10.1056/NEJM199609053351003; Ginsberg JS, 1996, NEW ENGL J MED, V335, P1816, DOI 10.1056/NEJM199612123352407; Goldhaber SZ, 1999, LANCET, V353, P1386, DOI 10.1016/S0140-6736(98)07534-5; GUDEMAN SK, 1979, NEUROSURGERY, V5, P309, DOI 10.1227/00006123-197909000-00002; Hirsh J, 2008, CHEST, V133, p110S, DOI 10.1378/chest.08-0652; JOFFE SN, 1975, J NEUROSURG, V42, P201, DOI 10.3171/jns.1975.42.2.0201; KAPLAN RM, 1988, HEALTH SERV RES, V23, P203; KELLETT J, 1995, MED DECIS MAKING, V15, P297, DOI 10.1177/0272989X9501500401; KERRIDGE RK, 1995, ANAESTH INTENS CARE, V23, P322, DOI 10.1177/0310057X9502300309; Knudson MM, 2004, ANN SURG, V240, P490, DOI 10.1097/01.sla.0000137138.40116.6c; Krahn MD, 1997, MED DECIS MAKING, V17, P142, DOI 10.1177/0272989X9701700204; Kurtoglu M, 2004, WORLD J SURG, V28, P807, DOI 10.1007/s00268-004-7295-6; Last JM, 2001, DICT EPIDEMIOLOGY; Lee TT, 1997, ANN INTERN MED, V126, P337, DOI 10.7326/0003-4819-126-5-199703010-00001; LIPPER MH, 1979, RADIOLOGY, V133, P645, DOI 10.1148/133.3.645; Macdonald RL, 2003, SURG NEUROL, V59, P363, DOI 10.1016/S0090-3019(03)00111-3; McLeod RS, 2001, ANN SURG, V233, P438, DOI 10.1097/00000658-200103000-00020; MONREAL M, 1992, CHEST, V102, P677, DOI 10.1378/chest.102.3.677; Naglie G, 1997, MED DECIS MAKING, V17, P136, DOI 10.1177/0272989X9701700203; Nathens AB, 2007, J TRAUMA, V62, P557, DOI 10.1097/TA.0b013e318031b5f5; Norwood SH, 2002, ARCH SURG-CHICAGO, V137, P696, DOI 10.1001/archsurg.137.6.696; Oertel M, 2002, J NEUROSURG, V96, P109, DOI 10.3171/jns.2002.96.1.0109; Patel NY, 2000, J TRAUMA, V48, P367, DOI 10.1097/00005373-200003000-00001; RADBERG JA, 1991, STROKE, V22, P571, DOI 10.1161/01.STR.22.5.571; ROGERS FB, 1993, J TRAUMA, V35, P637, DOI 10.1097/00005373-199310000-00021; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; SARASIN FP, 1993, J GEN INTERN MED, V8, P476, DOI 10.1007/BF02600108; Scales DC, 2009, J CRIT CARE, V24, P176, DOI 10.1016/j.jcrc.2009.03.010; Servadei F, 2002, NEUROSURGERY, V50, P261, DOI 10.1097/00006123-200202000-00006; Shorr AF, 2001, CRIT CARE MED, V29, P1659, DOI 10.1097/00003246-200109000-00001; Siddique MS, 2002, J NEUROSURG, V96, P86, DOI 10.3171/jns.2002.96.1.0086; STEIN SC, 1993, NEUROSURGERY, V32, P25, DOI 10.1227/00006123-199301000-00004; SWASH M, 1991, CLIN NEUROLOGY; Tabori U, 2000, CRIT CARE MED, V28, P840, DOI 10.1097/00003246-200003000-00038; Tengs TO, 2001, STROKE, V32, P964, DOI 10.1161/01.STR.32.4.964; TORRANCE GW, 1987, J CHRON DIS, V40, P593, DOI 10.1016/0021-9681(87)90019-1; TORRANCE GW, 1986, J HEALTH ECON, V5, P1, DOI 10.1016/0167-6296(86)90020-2; VALLADARES JB, 1980, NEUROSURGERY, V6, P138, DOI 10.1227/00006123-198002000-00004; VANSWIETEN JC, 1988, STROKE, V19, P604, DOI 10.1161/01.STR.19.5.604; ZELIKOVSKI A, 1981, J NEUROSURG, V54, P652, DOI 10.3171/jns.1981.54.5.0652	56	17	18	0	0	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1466-609X	1364-8535		CRIT CARE	Crit. Care		2010	14	2							R72	10.1186/cc8980			10	Critical Care Medicine	General & Internal Medicine	611LO	WOS:000278816800047	20406444	DOAJ Gold, Green Published			2021-06-18	
J	Quigley, A; Tan, AA; Hoane, MR				Quigley, Andrea; Tan, Arlene A.; Hoane, Michael R.			The effects of hypertonic saline and nicotinamide on sensorimotor and cognitive function following cortical contusion injury in the rat	BRAIN RESEARCH			English	Article						Therapy; Hippocampus; Neurodegeneration; Retrograde amnesia; Traumatic brain injury; Controlled cortical impact	TRAUMATIC BRAIN-INJURY; FLUID PERCUSSION INJURY; ELEVATED INTRACRANIAL-PRESSURE; FOCAL CEREBRAL-ISCHEMIA; HEAD-INJURY; HEMORRHAGIC-SHOCK; UNITED-STATES; WISTAR RATS; RESUSCITATION; RECOVERY	Hypertonic saline (HTS) is an accepted treatment for traumatic brain injury (TBI). However, the behavioral and cognitive consequences following FITS administration have not thoroughly been examined. Recent preclinical evidence has suggested that nicotinamide (NAM) is beneficial for recovery of function following TBI. The current study compared the behavioral and cognitive consequences of HTS and NAM as competitive therapeutic agents for the treatment of TBI. Following controlled cortical impact (CCI), bolus administrations of NAM (500 mg/kg), 7.5% HTS, or 0.9% saline Vehicle (1.0 mL/kg) were given at 2, 24, and 48 h post-CCI. Behavioral results revealed that animals treated with NAM and HTS showed significant improvements in beam walk and locomotor placing compared to the Vehicle group. The Morris water maze (MWM) retrograde amnesia test was conducted on day 12 post-CCI and showed that all groups had significant retention of memory compared to injured, Vehicle-treated animals. Working memory was also assessed on days 8-20 using the MWM. The NAM and Vehicle groups quickly acquired the task; however, HTS animals showed no acquisition of this task. Histological examinations revealed that the HTS-treated animals lost significantly more cortical tissue than either the NAM or Vehicle-treated animals. HTS-treated animals showed a greater loss of hippocampal tissue compared to the other groups. In general, NAM showed a faster rate of recovery than HTS without this associated tissue loss. The results of this study reiterate the strengths of NAM following injury and show concerns with bolus administrations of HTS due to the differential effects on cognitive performance and apparent tissue loss. (C) 2009 Elsevier B.V. All rights reserved.	[Hoane, Michael R.] So Illinois Univ, Dept Psychol, Restorat Neurosci Lab, Carbondale, IL 62901 USA	Hoane, MR (corresponding author), So Illinois Univ, Dept Psychol, Restorat Neurosci Lab, Life Sci 2,MC 6502, Carbondale, IL 62901 USA.	mhoane@siu.edu		Hoane, Michael/0000-0001-7779-2657	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS045647]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R15NS045647] Funding Source: NIH RePORTER	We would like to thank Jason Beare for his help in image capturing and analysis. Funded by NIH grant NS045647 to MRH.	Anderson JT, 1997, J TRAUMA, V42, P592, DOI 10.1097/00005373-199704000-00003; Ayoub IA, 1999, NEUROSCI LETT, V259, P21, DOI 10.1016/S0304-3940(98)00881-7; Baker AJ, 2009, J NEUROTRAUM, V26, P1227, DOI 10.1089/neu.2008.0868; Barbre AB, 2006, BRAIN RES BULL, V69, P639, DOI 10.1016/j.brainresbull.2006.03.009; BARTH TM, 1990, BEHAV BRAIN RES, V39, P73, DOI 10.1016/0166-4328(90)90122-U; BATTISTELLA FD, 1991, J TRAUMA, V31, P182, DOI 10.1097/00005373-199131020-00005; Bliese PD, 2008, J CONSULT CLIN PSYCH, V76, P272, DOI 10.1037/0022-006X.76.2.272; *CDCP, TRAUM BRAIN INJ US; COGGESHALL RE, 1992, TRENDS NEUROSCI, V15, P9, DOI 10.1016/0166-2236(92)90339-A; Cooper DJ, 2004, JAMA-J AM MED ASSOC, V291, P1350, DOI 10.1001/jama.291.11.1350; DeWitt DS, 1996, CRIT CARE MED, V24, P109, DOI 10.1097/00003246-199601000-00019; Elliott MB, 2007, J NEUROTRAUM, V24, P195, DOI 10.1089/neu.2006.0094; FEENEY DM, 1982, SCIENCE, V217, P855, DOI 10.1126/science.7100929; Feng YZ, 2006, BRAIN RES BULL, V69, P117, DOI 10.1016/j.brainresbull.2005.11.011; FISHER B, 1992, J NEUROSURG ANESTH, V4, P4, DOI 10.1097/00008506-199201000-00002; Friedberg MH, 1999, J NEUROPHYSIOL, V81, P2243; Grover GJ, 2003, J CARDIOVASC PHARM, V42, P790, DOI 10.1097/00005344-200312000-00014; GUEDEL AE, 1920, INHALATION ANESTHESI; Haijima A, 2008, LEARN MEMORY, V15, P477, DOI 10.1101/lm.862308; Himmelseher S, 2001, J NEUROSURG ANESTH, V13, P120, DOI 10.1097/00008506-200104000-00009; Hoane MR, 2008, NEUROSCIENCE, V154, P861, DOI 10.1016/j.neuroscience.2008.04.044; Hoane MR, 2006, BRAIN RES, V1125, P185, DOI 10.1016/j.brainres.2006.10.019; Hoane MR, 2006, NEUROSCI LETT, V408, P35, DOI 10.1016/j.neulet.2006.07.011; Hoane MR, 2006, J NEUROTRAUM, V23, P1535, DOI 10.1089/neu.2006.23.1535; Hoane MR, 2008, OXID MED CELL LONGEV, V1, P46, DOI 10.4161/oxim.1.1.6694; Hoane MR, 2005, J NEUROTRAUM, V22, P1112, DOI 10.1089/neu.2005.22.1112; Hoane MR, 2004, J NEUROTRAUM, V21, P163, DOI 10.1089/089771504322778622; Hoane MR, 2003, J NEUROTRAUM, V20, P1189, DOI 10.1089/089771503770802871; Holland MA, 2008, J NEUROTRAUM, V25, P140, DOI 10.1089/neu.2007.0312; Hoover RC, 2004, J NEUROTRAUM, V21, P501, DOI 10.1089/089771504774129847; Horn P, 1999, NEUROL RES, V21, P758, DOI 10.1080/01616412.1999.11741010; Khanna S, 2000, CRIT CARE MED, V28, P1144, DOI 10.1097/00003246-200004000-00038; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Mokudai T, 2000, STROKE, V31, P1679, DOI 10.1161/01.STR.31.7.1679; Munar F, 2000, J NEUROTRAUM, V17, P41, DOI 10.1089/neu.2000.17.41; Paxinos G., 2005, RAT BRAIN STEREOTAXI; Qureshi AI, 1998, CRIT CARE MED, V26, P440, DOI 10.1097/00003246-199803000-00011; Rhee P, 2003, J TRAUMA, V54, pS52, DOI 10.1097/01.TA.0000064507.80390.10; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Schatzmann C, 1998, ACT NEUR S, V71, P31; SCHELLER MS, 1991, J NEUROSURG ANESTH, V3, P291, DOI 10.1097/00008506-199112000-00009; Schmanke TD, 1996, J NEUROTRAUM, V13, P293, DOI 10.1089/neu.1996.13.293; Sell SL, 2008, ANESTHESIOLOGY, V108, P873, DOI 10.1097/ALN.0b013e31816c8a15; Smith DC, 2005, J NEUROTRAUM, V22, P1485, DOI 10.1089/neu.2005.22.1485; Smith DC, 2006, J NEUROTRAUM, V23, P1549, DOI 10.1089/neu.2006.23.1549; Soustiel JF, 2006, BRAIN RES, V1101, P136, DOI 10.1016/j.brainres.2006.05.045; Suarez JI, 1998, CRIT CARE MED, V26, P1118, DOI 10.1097/00003246-199806000-00038; Taylor G, 1996, J PEDIATR SURG, V31, P65, DOI 10.1016/S0022-3468(96)90321-8; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Ware ML, 2005, NEUROSURGERY, V57, P727, DOI 10.1227/01.NEU.0000175726.08903.OA; Weed LH, 1919, AM J PHYSIOL, V48, P531; WISNER DH, 1990, J TRAUMA, V30, P75, DOI 10.1097/00005373-199001000-00011; WORTHLEY LIG, 1988, J NEUROSURG, V68, P478, DOI 10.3171/jns.1988.68.3.0478; Yang J, 2002, PHARMACOL BIOCHEM BE, V73, P901, DOI 10.1016/S0091-3057(02)00939-5; Zausinger S, 2004, NEUROSURGERY, V55, P679, DOI 10.1227/01.NEU.0000134558.28977.EE; ZORNOW MH, 1990, ACT NEUR S, V51, P324	58	17	18	0	7	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	DEC 4	2009	1304						138	148		10.1016/j.brainres.2009.09.062			11	Neurosciences	Neurosciences & Neurology	531HE	WOS:000272654400015	19781534	Green Accepted			2021-06-18	
J	Aminmansour, B; Ghorbani, A; Sharifi, D; Shemshaki, H; Ahmadi, A				Aminmansour, Bahram; Ghorbani, Abbas; Sharifi, Davood; Shemshaki, Hamidreza; Ahmadi, Amin			Cerebral vasospasm following traumatic subarachnoid hemorrhage	JOURNAL OF RESEARCH IN MEDICAL SCIENCES			English	Article						Cerebral Vasospasm; Subarachnoid Hemorrhage; Trauma; Traumatic Brain Injury	TRANSCRANIAL DOPPLER ULTRASOUND; SEVERE HEAD-INJURY; POSTTRAUMATIC VASOSPASM; BRAIN-INJURY; BLOOD-FLOW; IMPACT; ULTRASONOGRAPHY; NIMODIPINE; SPASM	BACKGROUND: Cerebral vasospasm is a preventable cause of death and disability in patients who experience aneurysmal subarachnoid hemorrhage (SAH). The aim of this study is to investigate the incidence of cerebral vasospasm following traumatic SAH and its relationship with different brain injuries and severity of trauma. METHODS: This cross-sectional study was conducted from October 2006 to March 2007 in department of Neurosurgery in Al-Zahra Hospital. Consecutive head-injured patients who had SAH on the basis of an admission CT scan were prospectively evaluated. The severity of the trauma was evaluated by determining Glasgow Coma Scale (GCS) score on admission. Transcranial Doppler ultrasonography evaluations were performed at least 48 hours after admission and one week thereafter. Vasospasm in the MCA and ACA was defined by mean flow velocity (FV) of more than 120 cm/sec with a Lindegaard index (MVA/ICA FV ratio) higher than 3. Basilar artery vasospasm was defined by FV higher than 85 cm/sec. RESULTS: Seventy seven patients with tSAH were enrolled from whom 13 were excluded. The remaining were 52 (81.2%) men and 12 (18.7%) women, with a mean age of 37.89 years. Trauma was severe in 11 (17.2%), moderate in 13 (20.3%), and mild in 40 (62.5%) patients. From all, 27 patients (42.1%) experienced at least one vasospasm during the study period and MCA vasospasm was the most common in the first and second weeks (55.5%). CONCLUSIONS: Traumatic SAH is associated with a high incidence of cerebral vasospasm with a higher probability in patients with severe TBI.	[Aminmansour, Bahram; Sharifi, Davood] Isfahan Univ Med Sci, Dept Neurosurg, Sch Med, Esfahan, Iran; [Ghorbani, Abbas] Isfahan Univ Med Sci, Dept Neurol, Sch Med, Esfahan, Iran; [Shemshaki, Hamidreza; Ahmadi, Amin] Isfahan Univ Med Sci, Med Students Res Comm, Esfahan, Iran	Sharifi, D (corresponding author), Isfahan Univ Med Sci, Dept Neurosurg, Sch Med, Esfahan, Iran.	d_sharifi@resident.mui.ac.ir	Aminmansour, Bahram/C-8048-2018; Sharifi, Davoud/E-6922-2019	Aminmansour, Bahram/0000-0002-2961-2815	Vice Chancellor for Research of Isfahan University of Medical Sciences	The authors would like to appreciate the kind assistance and financial support provided by the Vice Chancellor for Research of Isfahan University of Medical Sciences. Also, we are thankful to Dr. Ali Gholamrezaei (Isfahan University of Medical Sciences) who helped us in editing this report.	AASLID R, 1984, J NEUROSURG, V60, P37, DOI 10.3171/jns.1984.60.1.0037; AASLID R, 1982, J NEUROSURG, V57, P769, DOI 10.3171/jns.1982.57.6.0769; Abraszko R, 1996, J CLIN NEUROSCI, V3, P21, DOI 10.1016/S0967-5868(96)90078-8; Crowley RW, 2008, DRUG DISCOV TODAY, V13, P254, DOI 10.1016/j.drudis.2007.11.010; EISENBERG HM, 1990, J NEUROSURG, V73, P688, DOI 10.3171/jns.1990.73.5.0688; HALEY EC, 1992, STROKE, V23, P205, DOI 10.1161/01.STR.23.2.205; Harders A, 1996, J NEUROSURG, V85, P82, DOI 10.3171/jns.1996.85.1.0082; KAKARIEKA A, 1994, J NEURAL TRANSM-SUPP, P13; Lindegaard K F, 1988, Acta Neurochir Suppl (Wien), V42, P81; Maas AIR, 2007, J NEUROTRAUM, V24, P303, DOI 10.1089/neu.2006.0033; MARTIN NA, 1992, J NEUROSURG, V77, P575, DOI 10.3171/jns.1992.77.4.0575; Mattioli C, 2003, J NEUROSURG, V98, P37, DOI 10.3171/jns.2003.98.1.0037; MAYBERG MR, 1994, CIRCULATION, V90, P2592, DOI 10.1161/01.CIR.90.5.2592; Morris GF, 1999, J NEUROSURG, V91, P737, DOI 10.3171/jns.1999.91.5.0737; Oertel M, 2005, J NEUROSURG, V103, P812, DOI 10.3171/jns.2005.103.5.0812; SANDER D, 1993, J NEUROL SCI, V119, P1, DOI 10.1016/0022-510X(93)90185-2; Servadei F, 2002, NEUROSURGERY, V50, P261, DOI 10.1097/00006123-200202000-00006; Soustiel JF, 2002, ACTA NEUROCHIR, V144, P137, DOI 10.1007/s007010200016; Soustiel JF, 1998, NEUROSURGERY, V43, P282, DOI 10.1097/00006123-199808000-00061; Sviri GE, 2006, STROKE, V37, P2738, DOI 10.1161/01.STR.0000244765.29502.85; Taneda M, 1996, J NEUROSURG, V84, P762, DOI 10.3171/jns.1996.84.5.0762; Vajramani GV, 1999, BRIT J NEUROSURG, V13, P468, DOI 10.1080/02688699908540620; WEBER M, 1990, NEUROSURGERY, V27, P106, DOI 10.1227/00006123-199007000-00015; Zubkov ZY, 2000, SURG NEUROL, V53, P126; Zurynski YA, 1998, J CLIN NEUROSCI, V5, P146, DOI 10.1016/S0967-5868(98)90028-5	25	17	18	0	2	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	1735-1995	1735-7136		J RES MED SCI	J. Res. Med. Sci.	NOV-DEC	2009	14	6					343	348					6	Medicine, General & Internal	General & Internal Medicine	538SN	WOS:000273204400002	21772907				2021-06-18	
J	Galvin, J; Froude, EH; Imms, C				Galvin, Jane; Froude, Elspeth H.; Imms, Christine			Sensory Processing Abilities of Children Who Have Sustained Traumatic Brain Injuries	AMERICAN JOURNAL OF OCCUPATIONAL THERAPY			English	Article						brain injuries; child behavior; sensation; sensation disorders	HEAD-INJURY; NATIONAL SAMPLE; EVERYDAY LIFE; DISABILITIES; CHILDHOOD; ATTENTION; PROFILE; ADOLESCENTS; PERFORMANCE; RECOVERY	OBJECTIVE. This study describes the sensory processing abilities of children ages 3-10 who sustained a moderate or severe traumatic brain injury l METHOD. We used a prospective, descriptive study design with convenience sampling of 20 children who were admitted to a pediatric neurosurgical unit. Caregivers provided information regarding their child's sensory processing abilities using the Sensory Profile (Dunn, 1999). We also collected demographic information related to the mechanism and severity of injury. Data were analyzed descriptively, and summary statistics were used to describe the Sensory Profiles of the children in comparison to normative data. RESULTS. Proportionally more children with TBI than children in the normative sample demonstrated behaviors outside of the typical range in all sections of the Sensory Profile except for oral sensory processing. CONCLUSION. These findings strongly support the need to include evaluation of sensory processing in any clinical assessment of children who have sustained TBI.	[Galvin, Jane] Royal Childrens Hosp, Victorian Paediat Rehabil Serv, Parkville, Vic 3052, Australia; [Galvin, Jane; Froude, Elspeth H.; Imms, Christine] Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Galvin, Jane; Froude, Elspeth H.; Imms, Christine] La Trobe Univ, Sch Occupat Therapy, Melbourne, Vic, Australia; [Imms, Christine] Royal Childrens Hosp, Occupat Therapy Dept, Parkville, Vic 3052, Australia	Galvin, J (corresponding author), Royal Childrens Hosp, Victorian Paediat Rehabil Serv, Flemington Rd, Parkville, Vic 3052, Australia.	jane.galvin@rch.org.au	Imms, Christine/G-9537-2018	Imms, Christine/0000-0001-9055-3554; Froude, Elspeth/0000-0002-6863-2317			Aitken ME, 2004, ARCH PHYS MED REHAB, V85, P567, DOI 10.1016/j.apmr.2003.06.018; Anderson V, 1998, NEUROPSYCHOL REHABIL, V8, P283; Anderson V, 2005, BRAIN INJURY, V19, P699, DOI 10.1080/02699050400025281; Anderson V, 1995, CHILD NEUROPSYCHOL, V1, P187, DOI 10.1080/09297049508400224; Ayres A. J., 1972, SENSORY INTEGRATION; Baranek GT, 2002, AM J OCCUP THER, V56, P538, DOI 10.5014/ajot.56.5.538; Bloom DR, 2001, J AM ACAD CHILD PSY, V40, P572, DOI 10.1097/00004583-200105000-00017; CaseSmith J, 1997, AM J OCCUP THER, V51, P496, DOI 10.5014/ajot.51.7.496; DAVIES PM, 1994, STARTING AGAIN EARLY; DeGangi GAP, 1991, INFANTS YOUNG CHILDR, V3, P1; Dennis M, 2000, J COMMUN DISORD, V33, P321, DOI 10.1016/S0021-9924(00)00028-9; Dennis M, 2001, J INT NEUROPSYCH SOC, V7, P683, DOI 10.1017/S1355617701766040; Dunn W, 1997, INFANT YOUNG CHILD, V9, P23, DOI 10.1097/00001163-199704000-00005; Dunn W, 2002, OTJR-OCCUP PARTICI H, V22, P4, DOI 10.1177/153944920202200102; Dunn W, 2002, AM J OCCUP THER, V56, P97, DOI 10.5014/ajot.56.1.97; Dunn W, 2001, AM J OCCUP THER, V55, P608, DOI 10.5014/ajot.55.6.608; Dunn W, 1997, AM J OCCUP THER, V51, P490, DOI 10.5014/ajot.51.7.490; Dunn W., 1999, SENSORY PROFILE USER; Dunn W., 2002, FOCUS AUTISM DEV DIS, V17, P172, DOI [10.1177/10883576020170030701, DOI 10.1177/10883576020170030701, DOI 10.1177/108835760201700]; Dunn W, 2007, INFANT YOUNG CHILD, V20, P84, DOI 10.1097/01.IYC.0000264477.05076.5d; Edwards S., 2002, NEUROLOGICAL PHYSIOT, P89; Erhardt RP, 1990, DEV VISUAL DYSFUNCTI; Ermer J, 1998, AM J OCCUP THER, V52, P283, DOI 10.5014/ajot.52.4.283; Hawley CA, 2003, BRAIN INJURY, V17, P105, DOI 10.1080/0269905021000010131; Hayden ME, 2000, J HEAD TRAUMA REHAB, V15, P1000, DOI 10.1097/00001199-200008000-00004; HUBEL D, 1988, EYE BRAIN VISION; Jones P., 2005, BRIT J OCCUP THER, V68, P324, DOI [https://doi.org/10.1177/030802260506800707, DOI 10.1177/030802260506800707]; Kandel E.R., 2000, PRINCIPLES NEURAL SC; KEINTZ MA, 1997, AM J OCCUPATIONAL TH, V51, P530; Max JE, 2004, DEV NEUROPSYCHOL, V25, P159, DOI 10.1207/s15326942dn2501&2_9; MILLER C, 2000, GENOME BIOL, V1, P4; Moore J., 1996, J OCCUPATIONAL SCI A, V3, P16; MOORE J, 1995, CLOSED HEAD INJURY C; Muller SV, 2002, ARCH PHYS MED REHAB, V83, P115, DOI 10.1053/apmr.2002.27472; O'Flaherty SJ, 2000, ARCH PHYS MED REHAB, V81, P723, DOI 10.1053/apmr.2000.4428; Sarno S, 2003, BRAIN INJURY, V17, P413, DOI 10.1080/0269905031000070161; Sellars C., 2004, PEDIAT BRAIN INJURY; Shumway-Cook A., 1995, MOTOR CONTROL THEORY; Slomine BS, 2002, BRAIN INJURY, V16, P759, DOI 10.1080/02699050210127286; Spence C, 2002, BEHAV BRAIN RES, V135, P57, DOI 10.1016/S0166-4328(02)00155-9; Spence C, 2001, PERCEPT PSYCHOPHYS, V63, P330, DOI 10.3758/BF03194473; TEASDALE G, 1974, LANCET, V2, P81	42	17	18	0	6	AMER OCCUPATIONAL THERAPY ASSOC, INC	BETHESDA	4720 MONTGOMERY LANE, BETHESDA, MD 20814-3425 USA	0272-9490			AM J OCCUP THER	Am. J. Occup. Ther.	NOV-DEC	2009	63	6					701	709		10.5014/ajot.63.6.701			9	Rehabilitation	Rehabilitation	532EZ	WOS:000272729500005	20092106	Bronze			2021-06-18	
J	Philip, S; Chaiwat, O; Udomphorn, Y; Moore, A; Zimmerman, JJ; Armstead, W; Vavilala, MS				Philip, Shaji; Chaiwat, Onuma; Udomphorn, Yuthana; Moore, Anne; Zimmerman, Jerry J.; Armstead, William; Vavilala, Monica S.			Variation in cerebral blood flow velocity with cerebral perfusion pressure > 40 mm Hg in 42 children with severe traumatic brain injury	CRITICAL CARE MEDICINE			English	Article						cerebral blood flow velocity; cerebral perfusion pressure; pediatric trauma; brain injury; blood pressure; middle cerebral artery flow	TRANSCRANIAL DOPPLER; AUTOREGULATION; HYPOTENSION; STRATEGIES; SURVIVAL; MODERATE	Objective: To determine the prevalence of low, normal, and high mean middle cerebral artery flow velocity when cerebral perfusion pressure is >40 mm Hg in children with severe traumatic brain injury. There is no information regarding the relationship between middle cerebral artery flow velocity and cerebral perfusion pressure in pediatric traumatic brain injury. Design: Prospective, observational study. Setting: Level I pediatric trauma center. Patients: A total of 42 children <17 yrs of age with an admission diagnosis of severe traumatic brain injury (admission Glasgow Coma Scale score of <9), traumatic brain injury on computed-tomography scan, tracheal intubation/mechanical ventilation, and intracranial pressure monitoring. Interventions: None. Measurements and Main Results: Bilateral middle cerebral arteries were insonated using transcranial Doppler ultrasonography to calculate mean middle cerebral artery flow velocity after traumatic brain injury. Low mean middle cerebral artery flow velocity was defined as middle cerebral artery flow velocity <2 standard deviation and high was defined as mean middle cerebral artery flow velocity >2 standard deviation. Patients were grouped by age (0.8-2.9, 3-5.9, 6-9.9, and 10-16.9 yrs) and gender to examine the relationship between cerebral perfusion pressure and low, high, or normal mean middle cerebral artery flow velocity. Potential confounders of the relationship between cerebral perfusion pressure and mean middle cerebral artery flow velocity (intracranial pressure, PaCO2, hematocrit, sedation, fever,and impaired autoregulation were examined). Most children (n = 33; 79%) had normal mean middle cerebral artery flow velocity but four patients (9%) had low mean middle cerebral artery flow velocity and five children (12%) had high mean middle cerebral artery flow velocity despite cerebral perfusion pressure >40 mm Hg. There was no difference in potential confounders of the relationship between cerebral perfusion pressure and mean middle cerebral artery flow velocity except for hematocrit, which was lower (25 +/- 4%; range = 21-30%) in children with high mean middle cerebral artery flow velocity. An inverse relationship between mean middle cerebral artery flow velocity and hematocrit was also found in boys aged 10 to 16.9 yrs. Conclusions: Both low and/or high mean middle cerebral artery flow velocity occur with cerebral perfusion pressure >40 mm Hg in severe pediatric traumatic brain injury. Of the potential confounders considered, only lower hematocrit was associated with high mean middle cerebral artery flow velocity. (Crit Care Med 2009; 37:2973-2978)	[Philip, Shaji; Chaiwat, Onuma; Udomphorn, Yuthana] Harborview Anesthesiol Res Ctr, Seattle, WA USA; [Zimmerman, Jerry J.; Vavilala, Monica S.] Univ Washington, Dept Anesthesiol, Seattle, WA 98195 USA; [Zimmerman, Jerry J.; Vavilala, Monica S.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Moore, Anne] Univ Washington, Cerebrovasc Lab, Seattle, WA 98195 USA; [Armstead, William] Univ Penn, Dept Anesthesiol, Philadelphia, PA 19104 USA	Philip, S (corresponding author), Harborview Anesthesiol Res Ctr, Seattle, WA USA.	vavilala@u.washington.edu			Eunice Kennedy Shriver National Instftute of Child Health and Human Development (NICHD), National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K23]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K23HD044632] Funding Source: NIH RePORTER	This study was supported, in part, by the Eunice Kennedy Shriver National Instftute of Child Health and Human Development (NICHD), National Institutes of Health, K23.	AASLID R, 1982, J NEUROSURG, V57, P769, DOI 10.3171/jns.1982.57.6.0769; BODE H, 1988, APPL PEDIAT TRANSCRA; Carney Nancy A, 2003, Pediatr Crit Care Med, V4, pS1; CHAN KH, 1992, J NEUROSURG, V77, P55, DOI 10.3171/jns.1992.77.1.0055; CHAN KH, 2002, CHIN J TRAUMATOL, V5, P380; Coles JP, 2004, J CEREBR BLOOD F MET, V24, P202, DOI 10.1097/01.WCB.0000103022.98348.24; Czosnyka M, 1998, J NEUROSURG, V88, P802, DOI 10.3171/jns.1998.88.5.0802; Diringer MN, 2002, J NEUROSURG, V96, P103, DOI 10.3171/jns.2002.96.1.0103; Downard C, 2000, J TRAUMA, V49, P654, DOI 10.1097/00005373-200010000-00012; Fisher A. Q., 1999, TRANSCRANIAL DOPPLER, P355; Hackbarth RM, 2002, CRIT CARE MED, V30, P1630, DOI 10.1097/00003246-200207000-00038; Hebert PC, 2004, CRIT CARE CLIN, V20, P187, DOI 10.1016/j.ccc.2004.01.001; Jaffres P, 2005, INTENS CARE MED, V31, P785, DOI 10.1007/s00134-005-2630-4; Kokoska ER, 1998, J PEDIATR SURG, V33, P333, DOI 10.1016/S0022-3468(98)90457-2; Lacroix J, 2007, NEW ENGL J MED, V356, P1609, DOI 10.1056/NEJMoa066240; Langlois JA, 2001, TRAUMATIC BRAIN INJU; Mazumdar M, 2007, PEDIATRICS, V120, pe1107, DOI 10.1542/peds.2006-2002; MILLER JD, 1980, P 2 INT WORKSH AMST, P476; NEWELL DW, 1994, STROKE, V25, P793, DOI 10.1161/01.STR.25.4.793; OBRIST WD, 1979, J NEUROSURG, V51, P292, DOI 10.3171/jns.1979.51.3.0292; PIGULA FA, 1993, J PEDIATR SURG, V28, P310, DOI 10.1016/0022-3468(93)90223-8; Ract C, 2007, INTENS CARE MED, V33, P645, DOI 10.1007/s00134-007-0558-6; Sahuquillo J, 1998, ACT NEUR S, V71, P233; Samant UB, 2008, J NEUROTRAUM, V25, P495, DOI 10.1089/neu.2007.0491; STREBEL S, 1995, ANESTHESIOLOGY, V83, P66, DOI 10.1097/00000542-199507000-00008; Sviri GE, 2006, NEUROSURGERY, V59, P360, DOI 10.1227/01.NEU.0000223502.93013.6E; Tontisirin N, 2007, PEDIATRICS, V119, pE610, DOI 10.1542/peds.2006-2110; Trabold F, 2004, INTENS CARE MED, V30, P108, DOI 10.1007/s00134-003-2057-8; Vavilala Monica S, 2004, Pediatr Crit Care Med, V5, P257, DOI 10.1097/01.PCC.0000123545.69133.C3; Vavilala MS, 2005, PEDIATR RES, V58, P574, DOI 10.1203/01.PDR.0000179405.30737.0F; Vavilala MS, 2003, J TRAUMA, V55, P1039, DOI 10.1097/01.TA.0000101759.23607.57; WARD JD, 1995, MANAGEMENT PEDIAT TR, P177; White H, 2006, INTENS CARE MED, V32, P981, DOI 10.1007/s00134-006-0173-y; Wintermark M, 2004, PEDIATRICS, V113, P1642, DOI 10.1542/peds.113.6.1642	34	17	17	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0090-3493	1530-0293		CRIT CARE MED	Crit. Care Med.	NOV	2009	37	11					2973	2978		10.1097/CCM.0b013e3181a963f6			6	Critical Care Medicine	General & Internal Medicine	517IP	WOS:000271607000015	19770734	Green Accepted			2021-06-18	
J	Shields, BJ; Smith, GA				Shields, Brenda J.; Smith, Gary A.			Cheerleading-Related Injuries in the United States: A Prospective Surveillance Study	JOURNAL OF ATHLETIC TRAINING			English	Article						injury rates; injury epidemiology; trauma; accidents; athletes	WOMENS GYMNASTICS INJURIES; HIGH-SCHOOL; SPORTS INJURIES; YOUNG ATHLETE; EPIDEMIOLOGY; PREVENTION; ISSUES; RISKS; HEAD	Context: Cheerleading injuries are on the rise and are a significant source of injury to females. No published studies have described the epidemiology of cheerleading injuries by type of cheerleading team and event. Objective: To describe the epidemiology of cheerleading injuries and to calculate injury rates by type of cheerleading team and event. Design: Prospective injury surveillance study. Setting: Participant exposure and injury data were collected from US cheerleading teams via the Cheerleading RIO (Reporting Information Online) online surveillance tool. Patients or Other Participants: Athletes from enrolled cheerleading teams who participated in official, organized cheerleading practices, pep rallies, athletic events, or cheerleading competitions. Main Outcome Measure(s): The numbers and rates of cheerleading injuries during a 1-year period (2006-2007) are reported by team type and event type. Results: A cohort of 9022 cheerleaders on 412 US cheerleading teams participated in the study. During the 1-year period, 567 cheerleading injuries were reported; 83% (467/565) occurred during practice, 52% (296/565) occurred while the cheerleader was attempting a stunt, and 24% (132/563) occurred while the cheerleader was basing or spotting 1 or more cheerleaders. Lower extremity injuries (30%, 168/565) and strains and sprains (53%, 302/565) were most common. Collegiate cheerleaders were more likely to sustain a concussion (P = .01, rate ratio [RR] = 2.98, 95% confidence interval [CI] = 1.34, 6.59), and All Star cheerleaders were more likely to sustain a fracture or dislocation (P = .01, RR = 1.76, 95% CI = 1.16, 2.66) than were cheerleaders on other types of teams. Overall injury rates for practices, pep rallies, athletic events, and cheerleading competitions were 1.0, 0.6, 0.6, and 1.4 injuries per 1000 athlete-exposures, respectively. Conclusions: We are the first to report cheerleading injury rates based on actual exposure data by type of team and event. These injury rates are lower than those reported for other high school and collegiate sports; however, many cheerleading injuries are preventable.	[Shields, Brenda J.] Nationwide Childrens Hosp, Res Inst, Ctr Injury Res & Policy, Columbus, OH 43205 USA; [Smith, Gary A.] Ohio State Univ, Coll Med, Columbus, OH 43210 USA	Shields, BJ (corresponding author), Nationwide Childrens Hosp, Res Inst, Ctr Injury Res & Policy, 700 Childrens Dr, Columbus, OH 43205 USA.	brenda.shields@nationwidechildrens.org			Research Institute at Nationwide Children's HospitalOhio State University	Funding for this study was provided by The Research Institute at Nationwide Children's Hospital. We thank Jason Morrison for designing the Cheerleading RIO Web site, programming the exposure and injury report questionnaires, and maintaining the Web site and database throughout the study year. Terri Blecker used her outstanding artistic talent to design the certificates presented to study participants. Debbie Bracewell, Lisa Thompson, and Steve Wedge helped to categorize the cheerleading maneuvers. Gwen Holtsclaw provided the cheerleading photographs used on the Web site and on the certificates and was invaluable in offering advice, answering questions, and helping with issues that arose during the study year. We thank the cheerleading industry for assistance in identifying and contacting potential study participants and for donating incentives for the participants who completed the full study year.	Adirim TA, 2003, SPORTS MED, V33, P75, DOI 10.2165/00007256-200333010-00006; *AM ASS CHEERL COA, 2007 08 HIGH SCH SAF; *AM ASS CHEERL COA, 2007 2008 AACCA COLL; *AM SPORTS DAT INC, 2004, SUP SPORTS PART, V2, P14; Boden BP, 2003, AM J SPORT MED, V31, P881, DOI 10.1177/03635465030310062501; Buzzini SRR, 2006, CURR OPIN PEDIATR, V18, P376, DOI 10.1097/01.mop.0000236385.26284.ec; Cantu RC, 1998, CLIN SPORT MED, V17, P37, DOI 10.1016/S0278-5919(05)70059-4; Cantu RC, 2003, CLIN SPORT MED, V22, P593, DOI 10.1016/S0278-5919(02)00095-9; Comstock R. D., 2006, Morbidity and Mortality Weekly Report, V55, P1037; GARRICK JG, 1980, AM J SPORT MED, V8, P261, DOI 10.1177/036354658000800409; Giannone L., 2006, AM ASS CHEERLEADING, P1; Hootman JM, 2007, J ATHL TRAINING, V42, P311; Hutchinson MR, 1997, PHYSICIAN SPORTSMED, V25, P83, DOI 10.3810/psm.1997.09.1508; Jacobson BH, 2004, J ORTHOP SPORT PHYS, V34, P261, DOI 10.2519/jospt.2004.34.5.261; KINGSBURY K, CHEERLEADINGS RISKY; Knowles SB, 2006, J ATHL TRAINING, V41, P207; Knowles SB, 2006, AM J EPIDEMIOL, V164, P1209, DOI 10.1093/aje/kwj337; Lawrence JP, 2006, J AM ACAD ORTHOP SUR, V14, P726, DOI 10.5435/00124635-200612000-00004; Luckstead EF, 2002, PEDIATR CLIN N AM, V49, P753, DOI 10.1016/S0031-3955(02)00017-2; Luckstead EF, 2002, PEDIATR CLIN N AM, V49, P581, DOI 10.1016/S0031-3955(02)00006-8; Marshall SW, 2007, J ATHL TRAINING, V42, P234; Mueller FO, 1982, 25 NAT CTR CAT SPORT; Proctor MR, 2000, CLIN SPORT MED, V19, P693, DOI 10.1016/S0278-5919(05)70233-7; Rechel JA, 2008, J ATHL TRAINING, V43, P197, DOI 10.4085/1062-6050-43.2.197; Schulz MR, 2004, AM J SPORT MED, V32, P396, DOI 10.1177/0363546503261715; Shankar PR, 2007, AM J SPORT MED, V35, P1295, DOI 10.1177/0363546507299745; Shields BJ, 2006, PEDIATRICS, V117, P122, DOI 10.1542/peds.2005-1139; Thacker SB, 2004, MED SCI SPORT EXER, V36, P371, DOI 10.1249/01.MSS.0000117134.83018.F7; US Consumer Product Safety Commission, PUBL PLAYGR SAF HDB; Yardt EE, 2008, AM J SPORT MED, V36, P57, DOI 10.1177/0363546507307507	30	17	17	2	21	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050			J ATHL TRAINING	J. Athl. Train.	NOV-DEC	2009	44	6					567	577		10.4085/1062-6050-44.6.567			11	Sport Sciences	Sport Sciences	522OU	WOS:000272008400002	19911082	Green Published, Bronze			2021-06-18	
J	Shields, BJ; Smith, GA				Shields, Brenda J.; Smith, Gary A.			The Potential for Brain Injury on Selected Surfaces Used by Cheerleaders	JOURNAL OF ATHLETIC TRAINING			English	Article						surface impact attenuation; Triax; critical height; Head Injury Criterion	COLLEGIATE FOOTBALL PLAYERS; RISK-FACTORS; PROFESSIONAL FOOTBALL; PLAYGROUND EQUIPMENT; OUTSTRETCHED HAND; ARM FRACTURE; CONCUSSION; FALLS; HEAD; IMPACTS	Context: Although playground surfaces have been investigated for fall impact attenuation, the surfaces that cheerleaders use have received little attention. Objective: To determine (1) the critical height for selected surfaces used by cheerleaders at or below which a serious head impact injury from a fall is unlikely to occur, (2) the critical heights for non-impact-absorbing surfaces for comparison purposes, and (3) the effect of soil moisture and grass height on g(max) (which is defined as the multiple of g [acceleration due to gravity at the earth's surface at sea level: ie, 32.2 feet.s(-1).s(-1)] that represents the maximum deceleration experienced during an impact) and the Head Injury Criterion (HIC) at the critical height for a dry grass surface. Design: Observational study. Settings: A local cheerleading gym, indoor locations within the authors' institution, and various outdoor locations. Main Outcome Measure(s): g(max), HIC, and critical height. Results: Critical heights for the surfaces tested ranged from 0.5 ft (0.15 m) for concrete and vinyl tile installed over concrete to more than 11 ft (3.35 m) for a spring floor. Increases in grass height and soil moisture resulted in an increase in the critical height for grass surfaces. Only spring floors and 4-in (0.10-m)-thick landing mats placed on traditional foam floors had critical heights greater than 10.5 ft (3.20 m), thus providing enough impact-absorbing capacity for performance of 2-level stunts. Conclusions: The potential for serious head impact injuries can be minimized by increasing the shock-absorbing capacity of the surface, decreasing the height from which the person falls, or both. Cheerleaders and cheerleading coaches should use the critical heights reported in this study to compare the relative impact-absorbing capacities of the various surfaces tested, with critical height as an indicator of the impact-absorption capacity of the surface. The findings of this study can be used to select the most appropriate surface for the type of maneuver to be performed, based on the maximum height expected to be achieved by the cheerleader(s) during execution of the maneuver. Cheerleaders should not perform maneuvers at heights that exceed the critical height for the surface on which they are performing.	[Shields, Brenda J.] Nationwide Childrens Hosp, Res Inst, Ctr Injury Res & Policy, Columbus, OH 43205 USA; [Smith, Gary A.] Ohio State Univ, Coll Med, Columbus, OH 43210 USA	Shields, BJ (corresponding author), Nationwide Childrens Hosp, Res Inst, Ctr Injury Res & Policy, 700 Childrens Dr, Columbus, OH 43205 USA.	brenda.shields@nationwidechildrens.org			Research Institute at Nationwide Children's HospitalOhio State University	Funding for this Study was provided by the Research Institute at Nationwide Children's Hospital. Randall Davis, Mandy Lucas, Jean Powers, Liz Rossetti, and Ashley Swert assisted in performing the Triax drop tests. Marcie Rehmar located testing sites and obtained permission to perform testing at the sites. Terri Bleeker took the photographs of the Triax 2000 and created Figure 1.	*AM ASS CHEERL COA, 2007 08 HIGH SCH SAF; *AM ASS CHEERL COA, 2007 2008 AACCA COLL; *ASTM, 1999, F129299 ASTM; ASTM, 2004, F129204 ASTM; Brolinson P Gunnar, 2006, Curr Sports Med Rep, V5, P23; *CBS BROADC INC, 2006, CHEERL INJ FALL COUR; Chalmers D J, 1996, Inj Prev, V2, P98, DOI 10.1136/ip.2.2.98; Chiu J, 1998, J BIOMECH, V31, P1169, DOI 10.1016/S0021-9290(98)00137-7; CHRISTIANSEN ML, 1995, POINTS PLAYGROUNDS, P157; Delaney JS, 2006, CLIN J SPORT MED, V16, P162, DOI 10.1097/00042752-200603000-00013; Duma SM, 2005, CLIN J SPORT MED, V15, P3, DOI 10.1097/00042752-200501000-00002; Greenwald RM, 2008, NEUROSURGERY, V62, P789, DOI 10.1227/01.neu.0000318162.67472.ad; Gunatilaka AH, 2004, INJURY PREV, V10, P174, DOI 10.1136/ip.2003.004010; Guskiewicz KM, 2007, NEUROSURGERY, V61, P1244, DOI 10.1227/01.neu.0000306103.68635.1a; Hutchinson MR, 1997, PHYSICIAN SPORTSMED, V25, P83, DOI 10.3810/psm.1997.09.1508; King AI, 2003, INT RES COUNC BIOM I; Kleiven S, 2003, J NEUROTRAUM, V20, P365, DOI 10.1089/089771503765172327; Laforest S, 2001, Inj Prev, V7, P35, DOI 10.1136/ip.7.1.35; LEWIS LM, 1993, J TRAUMA, V35, P932, DOI 10.1097/00005373-199312000-00020; Macarthur C, 2000, ACCIDENT ANAL PREV, V32, P377, DOI 10.1016/S0001-4575(99)00079-2; Mchenry B.G., 2004, HEAD INJURY CRITERIO; Mott A, 1997, LANCET, V349, P1874, DOI 10.1016/S0140-6736(96)10343-3; Mowat D L, 1998, Inj Prev, V4, P39; MUELLER FO, 25 NAT CTR CAT SPORT; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Pellman Elliot J, 2006, Neurosurg Focus, V21, pE12; Robinovitch SN, 1998, J ORTHOPAED RES, V16, P309, DOI 10.1002/jor.1100160306; Schulz MR, 2004, AM J SPORT MED, V32, P396, DOI 10.1177/0363546503261715; Sherker S, 2005, INJURY PREV, V11, P120, DOI 10.1136/ip.2004.007310; Sherker S, 2004, MED J AUSTRALIA, V180, P562, DOI 10.5694/j.1326-5377.2004.tb06092.x; Sherker S, 2003, INJURY PREV, V9, P279, DOI 10.1136/ip.9.3.279; Shields BJ, 2006, PEDIATRICS, V117, P122, DOI 10.1542/peds.2005-1139; Shields BJ, 2009, J ATHL TRAINING, V44, P578, DOI 10.4085/1062-6050-44.6.578; Viano DC, 2007, NEUROSURGERY, V61, P313, DOI 10.1227/01.NEU.0000279969.02685.D0; Viano DC, 2005, NEUROSURGERY, V57, P891, DOI 10.1227/01.NEU.0000186950.54075.3B; Vidair Charles, 2007, Int J Inj Contr Saf Promot, V14, P225, DOI 10.1080/17457300701584290; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446; Zhang LY, 2001, J NEUROTRAUM, V18, P21, DOI 10.1089/089771501750055749	38	17	17	2	16	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050			J ATHL TRAINING	J. Athl. Train.	NOV-DEC	2009	44	6					595	602		10.4085/1062-6050-44.6.595			8	Sport Sciences	Sport Sciences	522OU	WOS:000272008400005	19911085	Green Published, Bronze			2021-06-18	
J	Singh, PK; Singh, VK; Tomar, J; Azam, A; Gupta, S; Kumar, S				Singh, Pankaj Kumar; Singh, Vinay K.; Tomar, Juhi; Azam, Amir; Gupta, Sanjeev; Kumar, Sushil			Spinal Glioblastoma Multiforme: Unusual Cause of Post-Traumatic Tetraparesis	JOURNAL OF SPINAL CORD MEDICINE			English	Article						Tetraparesis; Intramedullary tumor; Glioblastoma multiforme; Spinal cord, cervical; Spine; Whiplash injury	SURVIVAL	Background/Objective: Glioblastoma multiforme (GBM) is the most common glial cell tumor of the adult brain. However, primary GBM of the spinal cord is a rare condition. Methods: Case report. Results: A young man presented with acute onset quadriparesis after a whiplash injury. A magnetic resonance scan showed the typical appearance of a high-grade intramedullary tumor with fusiform expansion of the entire cervical cord. Subtotal decompression and biopsy was done by posterior laminectomy, followed by external beam radiotherapy. Signs and symptoms improved after the completion of radiotherapy but did not resolve completely. Death caused by respiratory failure occurred 3 months later. Conclusions: This presentation of GBM of the cervical cord is rare; an intramedullary tumor should be considered when minor cervical trauma results in disproportionate neurologic deficit. To the best of our knowledge, this is the first reported case of spinal GBM with extensive pan-cervical involvement.	[Singh, Pankaj Kumar; Singh, Vinay K.; Tomar, Juhi; Azam, Amir; Gupta, Sanjeev; Kumar, Sushil] Royal Hallamshire Hosp, Sheffield S10 2JF, S Yorkshire, England	Singh, PK (corresponding author), Royal Hallamshire Hosp, Glossop Rd, Sheffield S10 2JF, S Yorkshire, England.	we.publish@googlemail.com					ALMEFTY O, 1987, NEUROSURGERY, V20, P416, DOI 10.1227/00006123-198703000-00010; ANDREWS AA, 1978, ARCH NEUROL-CHICAGO, V35, P244, DOI 10.1001/archneur.1978.00500280062013; ASANO N, 1990, Neurologia Medico-Chirurgica, V30, P489, DOI 10.2176/nmc.30.489; Caroli E, 2005, SPINAL CORD, V43, P565, DOI 10.1038/sj.sc.3101749; Chida K, 1995, Rinsho Shinkeigaku, V35, P1235; Chigasaki H, 1978, SHINKEI SHINPO, V20, P90; KOPELSON G, 1982, CANCER, V50, P732, DOI 10.1002/1097-0142(19820815)50:4<732::AID-CNCR2820500418>3.0.CO;2-0; Marchan EM, 2007, J NEUROSURG-SPINE, V7, P656, DOI 10.3171/SPI-07/12/656; RAMAMUTHI B, 2001, TXB NEUROSURGERY, P708; RUSSEL DS, 1959, PATHOLOGY TUMORS NER; SAGERMAN RH, 1979, RADIOLOGY, V84, P401; TAKARA E, 1985, Neurological Surgery, V13, P301; YAMAZAKI M, 1992, Neurological Surgery, V20, P85; Yeung YF, 2006, ACTA ONCOL, V45, P87, DOI 10.1080/02841860500341124	14	17	18	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1079-0268	2045-7723		J SPINAL CORD MED	J. Spinal Cord. Med.	NOV	2009	32	5					583	586		10.1080/10790268.2009.11754565			4	Clinical Neurology	Neurosciences & Neurology	534JX	WOS:000272893500011	20025156	Green Published			2021-06-18	
J	Bay, E; Xie, Y				Bay, Esther; Xie, Yan			Psychological and Biological Correlates of Fatigue After Mild-to-Moderate Traumatic Brain Injury	WESTERN JOURNAL OF NURSING RESEARCH			English	Article						mental health; neurology; depression; anxiety/stress; fatigue; descriptive quantitative	PITUITARY-ADRENAL AXIS; CHRONIC STRESS; PERCEIVED STRESS; HEAD-INJURY; CORTISOL; REHABILITATION; ACTIVATION; DEPRESSION; PLASTICITY; COMPLAINTS	Relationships between chronic perceived stress, cortisol response (area under the curve) and posttraumatic brain injury fatigue were examined with persons from outpatient settings. Seventy-five injured persons with traumatic brain injury and their relatives/significant others participated in this cross-sectional study. Using interviews and self-reported data from the Neurofunctional Behavioral Inventory, the Perceived Stress Scale, the Profile of Mood States-Fatigue subscale, the McGill Pain Scale, as well as self-collection of salivary cortisol over a 12-hour period (N = 50), we found that perceived chronic stress explained 40% of the variance in fatigue until depressive symptoms and pain were in the model. Hypocortisolemia was evident. Somatic symptom frequency and perceived chronic stress represented 50% of the variability in post-TBI fatigue. Fatigue and stress management interventions, as suggested in the Centers for Disease Control Acute Concussion guidelines, may be beneficial in reducing this common symptom.	[Bay, Esther; Xie, Yan] Michigan State Univ, E Lansing, MI 48824 USA	Bay, E (corresponding author), Michigan State Univ, E Lansing, MI 48824 USA.	baye@msu.edu					American Congress of Rehabilitation Medicine, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; ARNDT M, 2008, NEUROFATIGUE T UNPUB; Ashman TA, 2008, J HEAD TRAUMA REHAB, V23, P33, DOI 10.1097/01.HTR.0000308719.70288.22; Bay E, 2002, J NURS SCHOLARSHIP, V34, P221, DOI 10.1111/j.1547-5069.2002.00221.x; Bay E., 2005, J NEUROSCIENCE NURSI, V36, P55; Bay Esther, 2006, Care Manag J, V7, P3, DOI 10.1891/cmaj.7.1.3; Bay E, 2008, BRAIN INJURY, V22, P233, DOI 10.1080/02699050801953073; Bay Esther, 2004, Res Theory Nurs Pract, V18, P213, DOI 10.1891/088971804780957108; Bay E, 2009, BIOL RES NURS, V10, P213, DOI 10.1177/1099800408326453; Bondanelli M, 2007, J NEUROTRAUM, V24, P1687, DOI 10.1089/neu.2007.0343; Bushnik T, 2008, J HEAD TRAUMA REHAB, V23, P25, DOI 10.1097/01.HTR.0000308718.88214.bb; Bushnik T, 2007, BRAIN INJURY, V21, P559, DOI 10.1080/02699050701426915; Cantor JB, 2008, J HEAD TRAUMA REHAB, V23, P41, DOI 10.1097/01.HTR.0000308720.70288.af; *CDCP, 2007, TRAUM BRAIN INJ FACT; *CDCP, 2007, HEADS TOOL KIT PHYS; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404; Cohen S., 1995, MEASURING STRESS GUI; COHEN S, 1986, AM PSYCHOL, V41, P717; Conrad CD, 2004, NEUROSCIENCE, V125, P759, DOI 10.1016/j.neuroscience.2004.01.049; CROFFORD LJ, 1994, ARTHRITIS RHEUM-US, V37, P1583, DOI 10.1002/art.1780371105; de Groot MH, 2003, ARCH PHYS MED REHAB, V84, P1714, DOI 10.1053/S0003-9993(03)00346-0; DEMITRACK MA, 1991, J CLIN ENDOCR METAB, V73, P1224, DOI 10.1210/jcem-73-6-1224; Dijkers MPJM, 2008, J HEAD TRAUMA REHAB, V23, P3, DOI 10.1097/01.HTR.0000308716.80590.6b; Fillion L, 2008, CANCER NURS, V31, P145, DOI 10.1097/01.NCC.0000305698.97625.95; Gaab J, 2005, PSYCHONEUROENDOCRINO, V30, P599, DOI 10.1016/j.psyneuen.2005.02.001; Giza CC, 2001, J ATHL TRAINING, V36, P228; Jha A, 2008, J HEAD TRAUMA REHAB, V23, P52, DOI 10.1097/01.HTR.0000308721.77911.ea; Kashluba S, 2008, ARCH PHYS MED REHAB, V89, P904, DOI 10.1016/j.apmr.2007.12.029; KIRSCHBAUM C, 1994, PSYCHONEUROENDOCRINO, V19, P313, DOI 10.1016/0306-4530(94)90013-2; Kraus J, 2005, J HEAD TRAUMA REHAB, V20, P239, DOI 10.1097/00001199-200505000-00007; Kreutzer JS., 1999, NEUROBEHAVIORAL FUNC; MCEWEN B, 2002, END STRESS WE KNOW I; McEwen BS, 2008, EUR J PHARMACOL, V583, P174, DOI 10.1016/j.ejphar.2007.11.071; McEwen BS, 1998, NEW ENGL J MED, V338, P171, DOI 10.1056/NEJM199801153380307; MCNAIR DM, 1964, J ABNORM SOC PSYCH, V69, P620, DOI 10.1037/h0040902; MCNAIR DM, 2002, PROFILE MOOD STATES; MELZACK R, 1987, PAIN, V30, P191, DOI 10.1016/0304-3959(87)91074-8; Miller MM, 2006, ANN NY ACAD SCI, V1071, P294, DOI 10.1196/annals.1364.023; NICOLSON N, 2000, J PSYCHOSOM RES, V49, P385; Ouellet MC, 2006, REHABIL PSYCHOL, V51, P140, DOI 10.1037/0090-5550.51.2.140; Phillips Kenneth D, 2004, Biol Res Nurs, V6, P59, DOI 10.1177/1099800404264846; Pruessner JC, 2003, PSYCHONEUROENDOCRINO, V28, P916, DOI 10.1016/S0306-4530(02)00108-7; Pruessner JC, 1999, PSYCHOSOM MED, V61, P197, DOI 10.1097/00006842-199903000-00012; Reeves TM, 2005, EXP NEUROL, V196, P126, DOI 10.1016/j.expneurol.2005.07.014; Sapolsky RM, 2003, NEUROCHEM RES, V28, P1735, DOI 10.1023/A:1026021307833; Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55; STULEMEIJER M, 2007, J NEUROLOGICAL NEURO, V10, P1; Sundstrom A, 2007, BRAIN INJURY, V21, P1049, DOI 10.1080/02699050701630367; TEASDALE G, 1974, LANCET, V2, P81; Tsigos C, 2002, J PSYCHOSOM RES, V53, P865, DOI 10.1016/S0022-3999(02)00429-4; van der Naalt J, 1999, J NEUROL NEUROSUR PS, V66, P207, DOI 10.1136/jnnp.66.2.207; van Kessel K, 2008, PSYCHOSOM MED, V70, P205, DOI 10.1097/PSY.0b013e3181643065; Vitaz TW, 2003, SURG NEUROL, V60, P285, DOI 10.1016/S0090-3019(03)00378-1; WHITEGBADEBO D, 1993, J NEUROTRAUM, V10, P297, DOI 10.1089/neu.1993.10.297; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; Williams RA, 2000, J PSYCHIAT RES, V34, P227, DOI 10.1016/S0022-3956(00)00012-1; Yang CH, 2004, J NEUROSCI, V24, P11029, DOI 10.1523/JNEUROSCI.3968-04.2004	58	17	17	0	14	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0193-9459			WESTERN J NURS RES	West. J. Nurs. Res.	OCT	2009	31	6					731	747		10.1177/0193945909334856			17	Nursing	Nursing	498OZ	WOS:000270152700004	19502473				2021-06-18	
J	Deschamps, C; Faideau, M; Jaber, M; Gaillard, A; Prestoz, L				Deschamps, C.; Faideau, M.; Jaber, M.; Gaillard, A.; Prestoz, L.			Expression of ephrinA5 during development and potential involvement in the guidance of the mesostriatal pathway	EXPERIMENTAL NEUROLOGY			English	Article						Ephrin; Midbrain; Axon guidance; Dopamine; Tyrosine hydroxylase	IMMUNO-CYTOCHEMICAL LOCALIZATION; MIDBRAIN DOPAMINERGIC PATHWAYS; CENTRAL-NERVOUS-SYSTEM; PRENATAL RAT-BRAIN; AXON GUIDANCE; VISUAL-SYSTEM; TYROSINE-HYDROXYLASE; MOLECULAR-MECHANISMS; RECEPTOR EXPRESSION; NEURAL DEVELOPMENT	Identifying guidance cues that direct axon growth to their final connections during development is of crucial interest if we aim to repair circuits damaged in adulthood following neurodegenerative disorders or common traumatic injuries. In this work, we set out to determine the ephrinA5 guidance molecule involvement in the establishment of the mouse mesostriatal pathway during development. We showed, in vitro and in vivo, that a proportion of mesencephalic dopaminergic cells express the ephrinA5 receptor, EphA5. Moreover, we observed, using stripe assays, that ephrinA5 purified protein has a repulsive effect on most of the mesencephalic dopaminergic projections. In vivo, we detected rostro-caudal and ventro-dorsal ephrinA5 protein expression gradients in the vicinity of the dopaminergic axons in the ventral telencephalon and in the striatum, during the embryonic and early postnatal development. In addition, other EphA5 ligands were also detected in the mesostriatal pathway. Together, these expression patterns suggest that, ephrinAs and more specifically ephrinA5, may be actors in the guidance of dopaminergic projections. Further studies will focus on identifying the molecular specificity of these guidance cues, taking into account the mesencephalic dopaminergic heterogeneous neuronal population. This may help increase the integration of neuronal transplants in the mature lesioned brain or provide tools to re-establish mesostriatal circuits in vivo. (C) 2009 Elsevier Inc. All rights reserved.	[Deschamps, C.; Faideau, M.; Jaber, M.; Gaillard, A.; Prestoz, L.] Univ Poitiers, Inst Physiol & Biol Cellulaires, CNRS, F-86022 Poitiers, France	Prestoz, L (corresponding author), Univ Poitiers, Inst Physiol & Biol Cellulaires, CNRS, 40 Ave Recteur Pineau, F-86022 Poitiers, France.	Laetitia.Prestoz@univ-poitiers.fr		prestoz, Laetitia/0000-0002-2407-195X; Jaber, Mohamed/0000-0003-2536-1913			Banisadr G, 2003, EUR J NEUROSCI, V18, P1593, DOI 10.1046/j.1460-9568.2003.02893.x; Baschong W, 2001, J HISTOCHEM CYTOCHEM, V49, P1565, DOI 10.1177/002215540104901210; Chilton JK, 2006, DEV BIOL, V292, P13, DOI 10.1016/j.ydbio.2005.12.048; Cooper MA, 2009, J COMP NEUROL, V514, P310, DOI 10.1002/cne.22030; Cooper MA, 2009, DEV NEUROBIOL, V69, P36, DOI 10.1002/dneu.20685; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; Dufour A, 2006, DEVELOPMENT, V133, P4415, DOI 10.1242/dev.02623; Egea J, 2007, TRENDS CELL BIOL, V17, P230, DOI 10.1016/j.tcb.2007.03.004; Feldheim DA, 1998, NEURON, V21, P1303, DOI 10.1016/S0896-6273(00)80650-9; Feldheim DA, 2000, NEURON, V25, P563, DOI 10.1016/S0896-6273(00)81060-0; Flanagan JG, 2006, CURR OPIN NEUROBIOL, V16, P59, DOI 10.1016/j.conb.2006.01.010; Frisen J, 1998, NEURON, V20, P235, DOI 10.1016/S0896-6273(00)80452-3; Gao PP, 2000, J NEUROSCI RES, V60, P427, DOI 10.1002/(SICI)1097-4547(20000515)60:4<427::AID-JNR1>3.3.CO;2-4; Gates MA, 2004, EUR J NEUROSCI, V19, P831, DOI 10.1111/j.1460-9568.2004.03213.x; Greferath U, 2002, MECH DEVELOP, V119, pS231, DOI 10.1016/S0925-4773(03)00122-9; Hamasaki T, 2001, J NEUROSCI, V21, P4272, DOI 10.1523/JNEUROSCI.21-12-04272.2001; Haupt C, 2008, FRONT BIOSCI-LANDMRK, V13, P3136, DOI 10.2741/2915; Hernandez-Montiel HL, 2008, J COMP NEUROL, V506, P387, DOI 10.1002/cne.21503; Himanen JP, 2003, TRENDS NEUROSCI, V26, P46, DOI 10.1016/S0166-2236(02)00005-X; Hu ZL, 2004, J COMP NEUROL, V476, P301, DOI 10.1002/cne.20230; Jacobowitz DM, 1998, CHEMOARCHITECTONIC A; Janis LS, 1999, J NEUROSCI, V19, P4962; Kaufman MH, 1992, ATLAS MOUSE DEV; Knoll B, 2007, NAT PROTOC, V2, P1216, DOI 10.1038/nprot.2007.157; Knoll B, 2002, TRENDS NEUROSCI, V25, P145, DOI 10.1016/S0166-2236(00)02093-2; Kudo C, 2005, J COMP NEUROL, V487, P255, DOI 10.1002/cne.20551; Lin L, 2006, STEM CELLS, V24, P2504, DOI 10.1634/stemcells.2006-0119; Livesey FJ, 1997, MOL CELL NEUROSCI, V8, P417, DOI 10.1006/mcne.1997.0598; Mace K, 2002, J NEUROSCI RES, V70, P46, DOI 10.1002/jnr.10381; Mann F, 1998, J NEUROSCI, V18, P9409; Maroof AM, 2006, NEURON, V50, P185, DOI 10.1016/j.neuron.2006.04.001; Milligan ED, 2001, J NEUROSCI, V21, P2808, DOI 10.1523/JNEUROSCI.21-08-02808.2001; Mueller BK, 2006, PHILOS T R SOC B, V361, P1513, DOI 10.1098/rstb.2006.1888; Nakamura S, 2000, J NEUROSCI, V20, P4112; Nomura T, 2006, DEVELOPMENT, V133, P1335, DOI 10.1242/dev.02290; O'Leary DDM, 1999, CURR OPIN NEUROBIOL, V9, P65, DOI 10.1016/S0959-4388(99)80008-7; OSBORN M, 1982, METHOD CELL BIOL, V24, P97; Passante L, 2008, DEVELOPMENT, V135, P3281, DOI 10.1242/dev.024778; Peng J, 2005, J BIOL CHEM, V280, P29194, DOI 10.1074/jbc.M500984200; Peuckert C, 2008, MOL CELL NEUROSCI, V39, P21, DOI 10.1016/j.mcn.2008.05.011; Pfeiffenberger C, 2006, J NEUROSCI, V26, P12873, DOI 10.1523/JNEUROSCI.3595-06.2006; Plachez C, 2005, CURR TOP DEV BIOL, V69, P267, DOI 10.1016/S0070-2153(05)69010-2; Prestoz L, 2004, NEURON GLIA BIOL, V1, P73, DOI [10.1017/S1740925X04000109, 10.1017/s1740925x04000109]; Richards AB, 2007, EUR J NEUROSCI, V25, P2619, DOI 10.1111/j.1460-9568.2007.05523.x; Rogers JH, 1999, MOL BRAIN RES, V74, P225, DOI 10.1016/S0169-328X(99)00284-3; Sieber BA, 2004, MOL CELL NEUROSCI, V26, P418, DOI 10.1016/j.mcn.2004.03.009; SPECHT LA, 1981, J COMP NEUROL, V199, P255, DOI 10.1002/cne.901990208; SPECHT LA, 1981, J COMP NEUROL, V199, P233, DOI 10.1002/cne.901990207; St John JA, 2002, DEV BRAIN RES, V138, P1, DOI 10.1016/S0165-3806(02)00454-6; Uziel D, 2006, ANAT REC PART A, V288A, P135, DOI 10.1002/ar.a.20286; Van den Heuvel DMA, 2008, PROG NEUROBIOL, V85, P75, DOI 10.1016/j.pneurobio.2008.01.003; Vanderhaeghen P, 2000, NAT NEUROSCI, V3, P358; Verney C, 1999, MICROSC RES TECHNIQ, V46, P24; VOORN P, 1988, NEUROSCIENCE, V25, P857, DOI 10.1016/0306-4522(88)90041-3; Washburn Christopher P, 2007, Neurosci Bull, V23, P249, DOI 10.1007/s12264-007-0037-7; Wilkinson DG, 2001, NAT REV NEUROSCI, V2, P155, DOI 10.1038/35058515; Willson CA, 2006, J MOL HISTOL, V37, P369, DOI 10.1007/s10735-006-9067-0; Yamamoto N, 2002, PROG NEUROBIOL, V68, P393, DOI 10.1016/S0301-0082(02)00129-6; Yue Y, 1999, J NEUROSCI, V19, P2090; Zimmer G, 2007, J NEUROSCI, V27, P5643, DOI 10.1523/JNEUROSCI.0954-07.2007	60	17	19	0	3	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	OCT	2009	219	2					466	480		10.1016/j.expneurol.2009.06.020			15	Neurosciences	Neurosciences & Neurology	498QN	WOS:000270157300012	19576892				2021-06-18	
J	McEvoy, CT; Cran, GW; Cooke, SR; Young, IS				McEvoy, Claire T.; Cran, Gordon W.; Cooke, Stephen R.; Young, Ian S.			Resting energy expenditure in non-ventilated, non-sedated patients recovering from serious traumatic brain injury: Comparison of prediction equations with indirect calorimetry values	CLINICAL NUTRITION			English	Article						Brain injury; Energy expenditure; Indirect calorimetry	METABOLIC-RATE; HEAD; REQUIREMENTS; NUTRITION; THERAPY	Background & aims: Little is known about energy requirements in brain injured (TBI) patients, despite evidence suggesting adequate nutritional support can improve clinical outcomes. The study aim was to compare predicted energy requirements with measured resting energy expenditure (REE) values, in patients recovering from TBI. Methods: Indirect calorimetry (IC) was used to measure REE in 45 patients with TBI. Predicted energy requirements were determined using FAO/WHO/UNU and Harris-Benedict (HB) equations. Bland-Altman and regression analysis were used for analysis. Results: One-hundred and sixty-seven successful measurements were recorded in patients with TBI. At an individual level, both equations predicted REE poorly. The mean of the differences of standardised areas of measured REE and FAO/WHO/UNU was near zero (-9 kcal) but the variation in both directions was substantial (range -591 to +573 kcal). Similarly, the differences of areas of measured REE and HB demonstrated a mean of 1.9 kcal and range -568 to +571 kcal. Glasgow coma score, patient status, weight and body temperature were significant predictors of measured REE (p < 0.001; R(2) = 0.47). Conclusions: Clinical equations are poor predictors of measured REE in patients with TBI. The variability in REE is substantial. Clinicians should be aware of the limitations of prediction equations when estimating energy requirements in TBI patients. Crown Copyright (C) 2009 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.	[McEvoy, Claire T.] Queens Univ Belfast, Dept Med, Ctr Publ Hlth, Belfast BT12 6BJ, Antrim, North Ireland; [Cooke, Stephen R.] Royal Victoria Hosp, Reg Neurosurg Unit, Belfast Hlth & Social Care Trust, Belfast BT12 6BA, Antrim, North Ireland	McEvoy, CT (corresponding author), Queens Univ Belfast, Dept Med, Ctr Publ Hlth, Lower Ground Floor,Pathol Bldg,Grosvenor Rd, Belfast BT12 6BJ, Antrim, North Ireland.	c.mcevoy@qub.ac.uk		Young, Ian/0000-0003-3890-3152; McEvoy, Claire/0000-0001-8512-3293	Research & Development Office, Northern Ireland; Economic and Social Research CouncilUK Research & Innovation (UKRI)Economic & Social Research Council (ESRC) [ES/G007438/1] Funding Source: researchfish	All named authors made significant contributions to the study design, recruiting of patients, data collection, data analysis and preparation of the manuscript for submission. This research was supported by a grant from the Research & Development Office, Northern Ireland. This research was conducted using funding from the Research & Development Office, Northern Ireland. Reprints will be available from the authors.	Bader N, 2005, BRIT J NUTR, V94, P843, DOI 10.1079/BJN20051551; Baumann CR, 2005, NEUROLOGY, V65, P147, DOI 10.1212/01.wnl.0000167605.02541.f2; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; *BRAIN TRAUM FDN, 2007, J NEUROTRAUMA S1, V24, pS77, DOI DOI 10.1089/NEU.2006.9984; BRUDER N, 1994, CRIT CARE MED, V22, P1114, DOI 10.1097/00003246-199407000-00011; BRUDER N, 1991, CRIT CARE MED, V19, P43, DOI 10.1097/00003246-199101000-00013; CLIFTON GL, 1986, J NEUROSURG, V64, P895, DOI 10.3171/jns.1986.64.6.0895; CUNNINGHAM JJ, 1985, AM J CLIN NUTR, V41, P371; da Rocha EEM, 2005, CURR OPIN CLIN NUTR, V8, P319, DOI 10.1097/01.mco.0000165012.77567.1e; DEMPSEY DT, 1985, SURG GYNECOL OBSTET, V160, P128; DEUTSCHMAN CS, 1987, J NEUROSURG, V66, P388, DOI 10.3171/jns.1987.66.3.0388; DuBois EF, 1948, FEVER REGULATION BOD; Elia M, 2003, P NUTR SOC, V62, P529, DOI 10.1079/PNS2003255; Evans BM, 2002, J ROY SOC MED, V95, P591, DOI 10.1258/jrsm.95.12.591; Frankenfield DC, 2003, J AM DIET ASSOC, V103, P1152, DOI 10.1016/S0002-8223(03)00982-9; Frankenfield DC, 1998, J AM DIET ASSOC, V98, P439, DOI 10.1016/S0002-8223(98)00100-X; GARBY L, 1984, HUM NUTR-CLIN NUTR, V38C, P395; Hartl R, 2008, J NEUROSURG, V109, P50, DOI 10.3171/JNS/2008/109/7/0050; HARRIS JA, 1919, PUBLICATION CARNEGIE, V279; McClave S A, 1992, Nutr Clin Pract, V7, P207, DOI 10.1177/0115426592007005207; McClave S A, 1994, New Horiz, V2, P139; McClave SA, 2001, J CLIN GASTROENTEROL, V33, P14, DOI 10.1097/00004836-200107000-00005; Miles JM, 2006, MAYO CLIN PROC, V81, P809, DOI 10.4065/81.6.809; OWEN OE, 1988, MAYO CLIN PROC, V63, P503, DOI 10.1016/S0025-6196(12)65649-3; Perel P, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001530.pub2; Schofield W N, 1985, Hum Nutr Clin Nutr, V39 Suppl 1, P5; Weekes Elizabeth, 1996, Journal of Parenteral and Enteral Nutrition, V20, P31, DOI 10.1177/014860719602000131; WEIR JBD, 1949, J PHYSIOL-LONDON, V109, P1, DOI 10.1113/jphysiol.1949.sp004363; WEISSMAN C, 1986, ANESTHESIOLOGY, V64, P673, DOI 10.1097/00000542-198606000-00001; Wilson RF, 1998, J HEAD TRAUMA REHAB, V13, P11, DOI 10.1097/00001199-199802000-00005	30	17	22	0	5	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0261-5614			CLIN NUTR	Clin. Nutr.	OCT	2009	28	5					526	532		10.1016/j.clnu.2009.04.009			7	Nutrition & Dietetics	Nutrition & Dietetics	518IQ	WOS:000271685100007	19423202	Green Published			2021-06-18	
J	Li, CY; Ahn, CH; Shutter, LA; Narayan, RK				Li, Chunyan; Ahn, Chong H.; Shutter, Lori A.; Narayan, Raj K.			Toward real-time continuous brain glucose and oxygen monitoring with a smart catheter	BIOSENSORS & BIOELECTRONICS			English	Article						Glucose sensor; Oxygen sensor; Traumatic brain injury; Lab-on-a-tube; Continuous monitoring	IN-VIVO; INJURY; BIOSENSORS; MICRODIALYSIS; CARE; FILM; NANOPARTICLES; PRESSURE; CHITOSAN	Oxygen and glucose biosensors have been designed, fabricated, characterized and optimized for real-time continuous monitoring on a new smart catheter for use in patients with traumatic brain injury (TBI). Oxygen sensors with three-electrode configuration were designed to achieve zero net oxygen consumption. Glucose sensors were based on the use of platinum nanoparticle-enhanced electrodes that were modified with polycation and glucose oxidase immobilized by chitosan matrix. An iridium oxide electrode was developed to work as a biocompatible reference electrode with enhanced durability and stability in the biological solutions. A study of the effect of temperature on oxygen sensor performance, and both temperature and oxygen effects on glucose sensor performance were accomplished to enhance their operative stability and provide useful information for in vivo applications. A new methodology for automatic correction of the temperature and oxygen dependence of biosensor outputs is demonstrated through programmed LabView (TM) software. In vitro experiments in both physiological and pathophysiological ranges (oxygen: 0-60 mmHg; glucose: 0.1-10 mM; temperature: 25-40 degrees C) with clinical samples of cerebrospinal fluid obtained from TBI patients have demonstrated stable measurements with enhanced accuracy, indicating the feasibility of the sensors for a real-time continuous in vivo monitoring. Published by Elsevier B.V.	[Li, Chunyan; Shutter, Lori A.; Narayan, Raj K.] Univ Cincinnati, Dept Neurosurg, Cincinnati, OH 45267 USA; [Li, Chunyan; Ahn, Chong H.] Univ Cincinnati, Dept Elect & Comp Engn, Cincinnati, OH 45221 USA	Li, CY (corresponding author), Univ Cincinnati, Dept Neurosurg, Cincinnati, OH 45267 USA.	lic2@ucmail.uc.edu	Shutter, Lori A/G-2957-2013	Shutter, Lori/0000-0002-1390-0628	Integra Lifesciences Foundation	The work was supported by the Integra Lifesciences Foundation. The authors wish to thank Mr. Ron Flenniken of the Nano/Micro Fabrication Engineering Research Center at the University of Cincinnati for his technical support with the e-beam deposition of Iridium, and also Mr. Michael Rust at the Microsystems and BioMEMS lab for his valuable discussions.	Anzai Y, 2004, AM J NEURORADIOL, V25, P274; Belli A, 2008, ACTA NEUROCHIR, V150, P461, DOI 10.1007/s00701-008-1580-3; Bott A., 1995, CURR SEP, V14, P64; De Georgia MA, 2005, NEUROLOGIST, V11, P45, DOI 10.1097/01.nrl.0000149993.99956.09; EVANS ML, 2003, ELLENBERG RIFKINS DI, P117; FISHMAN RA, 2003, LUMBAR PUNCTURE, P953; Ges IA, 2005, BIOSENS BIOELECTRON, V21, P248, DOI 10.1016/j.bios.2004.09.021; JANKOWSKA L, 1979, AM J PHYSIOL, V236, pF220; Kang XH, 2008, TALANTA, V74, P879, DOI 10.1016/j.talanta.2007.07.019; KARAGOUNIS V, 1986, IEEE T BIO-MED ENG, V33, P108, DOI 10.1109/TBME.1986.325884; Kim DH, 2006, NEUROCRIT CARE, V4, P83, DOI 10.1385/NCC:4:1:083; Koschwanez HE, 2007, BIOMATERIALS, V28, P3687, DOI 10.1016/j.biomaterials.2007.03.034; Krajewska B, 2004, ENZYME MICROB TECH, V35, P126, DOI 10.1016/j.enzmictec.2003.12.013; Lau C, 2007, BIOSENS BIOELECTRON, V22, P3014, DOI 10.1016/j.bios.2006.12.033; Laurinavicius V, 1999, ANAL LETT, V32, P299, DOI 10.1080/00032719908542822; Li CY, 2008, BIOMED MICRODEVICES, V10, P671, DOI 10.1007/s10544-008-9178-3; Li CY, 2009, LAB CHIP, V9, P1988, DOI 10.1039/b900651f; Li J, 2007, BIOSENS BIOELECTRON, V22, P2898, DOI 10.1016/j.bios.2006.12.004; Luo XL, 2006, ELECTROANAL, V18, P319, DOI 10.1002/elan.200503415; MEIXENSBERGER J, 1997, SEVERE HEAD INJURIES, P99; Miyashita M, 2009, BIOSENS BIOELECTRON, V24, P1336, DOI 10.1016/j.bios.2008.07.072; Mulvey JM, 2004, NEUROCRIT CARE, V1, P391, DOI 10.1385/NCC:1:3:391; Nortje J, 2006, BRIT J ANAESTH, V97, P95, DOI 10.1093/bja/ael137; Schlenk F, 2008, INTENS CARE MED, V34, P1200, DOI 10.1007/s00134-008-1044-5; Smith M, 2005, ANAESTHESIA, PAIN, INTENSIVE CARE AND EMERGENCY MEDICINE - APICE 19, P139, DOI 10.1007/88-470-0351-2_13; Stevens Wendy J, 2004, J Neurosci Nurs, V36, P332; SUELTER CH, 1990, EXPT ENZYMOLOGIE GRU; Tisdall MM, 2007, BRIT J ANAESTH, V99, P61, DOI 10.1093/bja/aem143; Tisdall MM, 2006, BRIT J ANAESTH, V97, P18, DOI 10.1093/bja/ael109; Vespa PM, 2003, J CEREBR BLOOD F MET, V23, P865, DOI 10.1097/01.WCB.0000076701.45782.EF; Wang J, 2008, TALANTA, V75, P636, DOI 10.1016/j.talanta.2007.10.023; Wang J, 2008, CHEM REV, V108, P814, DOI 10.1021/cr068123a; Wartenberg KE, 2007, CRIT CARE CLIN, V23, P507, DOI 10.1016/j.ccc.2007.06.002; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Wright WL, 2007, J NEUROL SCI, V261, P10, DOI 10.1016/j.jns.2007.04.027; Yang MH, 2004, SENSOR ACTUAT B-CHEM, V101, P269, DOI 10.1016/j.snb.2004.01.003; Yang YX, 2004, PROG COMPUT FLUID DY, V4, P46, DOI 10.1504/PCFD.2004.003785; YEAGER E, 1984, ELECTROCHIM ACTA, V29, P1527, DOI 10.1016/0013-4686(84)85006-9; Zaharchuk G, 2005, MAGNET RESON MED, V54, P113, DOI 10.1002/mrm.20546	39	17	17	4	26	ELSEVIER ADVANCED TECHNOLOGY	OXFORD	OXFORD FULFILLMENT CENTRE THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0956-5663			BIOSENS BIOELECTRON	Biosens. Bioelectron.	SEP 15	2009	25	1					173	178		10.1016/j.bios.2009.06.032			6	Biophysics; Biotechnology & Applied Microbiology; Chemistry, Analytical; Electrochemistry; Nanoscience & Nanotechnology	Biophysics; Biotechnology & Applied Microbiology; Chemistry; Electrochemistry; Science & Technology - Other Topics	503MM	WOS:000270538400028	19625179				2021-06-18	
J	Park, SJ; Hur, JW; Kwon, KY; Rhee, JJ; Lee, JW; Lee, HK				Park, Sung Jun; Hur, Jin Woo; Kwon, Ki Young; Rhee, Jong Joo; Lee, Jong Won; Lee, Hyun Koo			Time to Recover Consciousness in Patients with Diffuse Axonal Injury: Assessment with Reference to Magnetic Resonance Grading	JOURNAL OF KOREAN NEUROSURGICAL SOCIETY			English	Article						Brain stem; Consciousness; Diffuse axonal injury; MRI	SEVERE HEAD-INJURY; CEREBRAL WHITE MATTER; TRAUMATIC COMA; CT	Objective : This study was conducted to investigate the correlation between the degrees of injury on brain magnetic resonance imaging (MRI) and the time interval to recovery of consciousness in patients with diffuse axonal injury. Methods : From January 2004 to December 2008, 25 patients with diffuse axonal injury were treated at our hospital. We retrospectively investigated the patients' medical records and radiological findings. We divided the patients into three groups according to the grade of MRI finding : grade I, small scattered lesions on the white matter of the cerebral hemisphere; grade II, focal lesions on the corpus callosum; and grade III, additional focal lesions on the brain stem. Result : Seven patients belonged to the grade I group; 10 to the grade II group; and 8 to the grade III group. The mean Glasgow Coma Scale (GCS) score of all patients at the time of admission was 7.28. Recovery of consciousness was observed in 23 of the 25 patients; the remaining two patients never regained consciousness. The time interval to recovery of consciousness (awake status) ranged from 1 day to 125 days (mean 22.1 days) : grade I group patients, within approximately 1 week (mean 3.7 days); grade II group patients, within approximately 2 weeks (mean 12.5 days); and grade III group patients, within approximately 2 months (mean 59.5 days). Conclusion : Our study results suggest a correlation between the mean time interval to recovery of consciousness in patients with diffuse axonal injuries and the degrees of brain injuries seen on MRI. Patients with grade I and II diffuse axonal injuries recovered consciousness within 2 weeks, while patients with grade III injuries required approximately 2 months.	[Park, Sung Jun; Hur, Jin Woo; Kwon, Ki Young; Rhee, Jong Joo; Lee, Jong Won; Lee, Hyun Koo] Cheongju St Marys Hosp, Dept Neurosurg, Cheongju 360568, South Korea	Hur, JW (corresponding author), Cheongju St Marys Hosp, Dept Neurosurg, 589-5 Jujung Dong, Cheongju 360568, South Korea.	somalh@naver.com					ADAMS JH, 1977, BRAIN, V100, P489, DOI 10.1093/brain/100.3.489; ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; ALBERICO AM, 1987, J NEUROSURG, V67, P648, DOI 10.3171/jns.1987.67.5.0648; EISENBERG HM, 1990, J NEUROSURG, V73, P688, DOI 10.3171/jns.1990.73.5.0688; Eum SW, 1998, J KOREAN NEUROSURG S, V27, P1668; GENNARELLI TA, 1982, J NEUROSURG, V56, P26, DOI 10.3171/jns.1982.56.1.0026; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; KALFF R, 1989, CHILD NERV SYST, V5, P156, DOI 10.1007/BF00272118; Kim CH, 1997, J KOREAN NEUROSURG S, V26, P241; Kim HJ, 2001, J KOREAN NEUROSURG S, V30, P168; Lee H. S., 1990, J KOREAN NEUROSURG S, V19, P1101; LEVATI A, 1982, J NEUROSURG, V57, P779, DOI 10.3171/jns.1982.57.6.0779; LEVI L, 1990, NEUROSURGERY, V27, P429, DOI 10.1227/00006123-199009000-00015; MILLER JD, 1981, J NEUROSURG, V54, P289, DOI 10.3171/jns.1981.54.3.0289; Oh KS, 2001, J KOREAN NEUROSUR S1, V30, pS20; Park SW, 1991, J KOREAN NEUROSURG S, V20, P983; STRICH SJ, 1956, J NEUROL NEUROSUR PS, V19, P163, DOI 10.1136/jnnp.19.3.163; WILLIAMS JM, 1984, J NEUROSURG, V61, P581, DOI 10.3171/jns.1984.61.3.0581; ZIMMERMAN RA, 1978, RADIOLOGY, V127, P393, DOI 10.1148/127.2.393; ZIMMERMAN RA, 1986, AM J ROENTGENOL, V147, P1215, DOI 10.2214/ajr.147.6.1215	20	17	21	0	1	KOREAN NEUROSURGICAL SOC	SEOUL	#402 POSCO # OFFICE BUILDING 151 SUNHWA-DONG, JUNG-GU, SEOUL, 100-130, SOUTH KOREA	2005-3711	1598-7876		J KOREAN NEUROSURG S	J. Korean. Neurosurg. Soc.	SEP	2009	46	3					205	209		10.3340/jkns.2009.46.3.205			5	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	507GC	WOS:000270839100005	19844619	DOAJ Gold, Green Published			2021-06-18	
J	Maruichi, K; Kuroda, S; Chiba, Y; Hokari, M; Shichinohe, H; Hida, K; Iwasaki, Y				Maruichi, Katsuhiko; Kuroda, Satoshi; Chiba, Yasuhiro; Hokari, Masaaki; Shichinohe, Hideo; Hida, Kazutoshi; Iwasaki, Yoshinobu			Transplanted bone marrow stromal cells improves cognitive dysfunction due to diffuse axonal injury in rats	NEUROPATHOLOGY			English	Article						bone marrow stromal cell; cognitive function; differentiation; diffuse axonal injury; neuroprotection; transplantation	TRAUMATIC BRAIN-INJURY; NERVE GROWTH-FACTOR; MICE CEREBRAL INFARCT; CLOSED-HEAD INJURY; SPINAL-CORD-INJURY; GENE-EXPRESSION; IN-VIVO; FUNCTIONAL RECOVERY; EXPERIMENTAL-MODEL; ACID RECEPTOR	Diffuse axonal injury (DAI) often leads to persistent cognitive dysfunction in spite of the lack of gross lesions on MRI. Therefore, this study was aimed to evaluate whether transplanted bone marrow stromal cells (BMSC) can improve DAI-induced cognitive dysfunction or not. The rats were subjected to impact acceleration head injury, using a pneumatic high-velocity impactor. The BMSC were harvested from the mice and were cultured. The BMSC (4.0 x 10(5) cells) or vehicle were stereotactically transplanted into the right striatum at 10 days post-injury. Cognitive function analysis was repeated at 1, 2, and 4 weeks post-injury, using the Morris water maze test. Histological analysis was performed at 2, 8 and 20 weeks post-injury, using double fluorescence immunohistochemistry. Transplanted BMSC were widely distributed in the injured brain and gradually acquired the phenotypes of neurons and astrocytes over 20 weeks. In addition, they significantly improved DAI-induced cognitive dysfunction as early as 2 weeks post-injury, although their processes of neuronal differentiation were not completed at this time point. The findings suggest that the engrafted BMSC may exhibit this early beneficial effect on cognitive function by producing neuroprotective or neurotrophic factors. In conclusion, direct transplantation of BMSC may serve as a novel therapeutic strategy to enhance the recovery from DAI-induced cognitive impairment.	[Kuroda, Satoshi] Hokkaido Univ, Grad Sch Med, Dept Neurosurg, Kita Ku, Sapporo, Hokkaido 0608638, Japan	Kuroda, S (corresponding author), Hokkaido Univ, Grad Sch Med, Dept Neurosurg, Kita Ku, North 15,West 7, Sapporo, Hokkaido 0608638, Japan.	skuroda@med.hokudai.ac.jp	Hokari, Masaaki/G-5395-2012; Shichinohe, Hideo/G-5367-2012		Ministry of Education, Science and Culture of JapanMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT) [17390389, 18390387, 18659411, 19390371]; Grants-in-Aid for Scientific ResearchMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI) [20390377] Funding Source: KAKEN	This study was supported by Grant-in-aid from the Ministry of Education, Science and Culture of Japan (No.17390389, No.18390387, No.18659411 and No.19390371).	ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; Alvarez-Dolado M, 2003, NATURE, V425, P968, DOI 10.1038/nature02069; Azizi SA, 1998, P NATL ACAD SCI USA, V95, P3908, DOI 10.1073/pnas.95.7.3908; Bakshi A, 2006, EUR J NEUROSCI, V23, P2119, DOI 10.1111/j.1460-9568.2006.04743.x; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; Cernak I, 2004, NEUROBIOL DIS, V17, P29, DOI 10.1016/j.nbd.2004.05.011; Cernak Ibolja, 2005, NeuroRx, V2, P410, DOI 10.1602/neurorx.2.3.410; Chen XG, 2002, J NEUROSCI RES, V69, P687, DOI 10.1002/jnr.10334; Chen Y, 1996, J NEUROTRAUM, V13, P557, DOI 10.1089/neu.1996.13.557; Ding YC, 2001, NEUROL RES, V23, P193, DOI 10.1179/016164101101198334; Gao JL, 2006, EXP NEUROL, V201, P281, DOI 10.1016/j.expneurol.2006.04.039; Gao Q, 2005, NEUROSCIENCE, V136, P123, DOI 10.1016/j.neuroscience.2005.06.091; Garcia R, 2004, BIOCHEM BIOPH RES CO, V316, P753, DOI 10.1016/j.bbrc.2004.02.111; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Hokari M, 2008, J NEUROSCI RES, V86, P1024, DOI 10.1002/jnr.21572; Kopen GC, 1999, P NATL ACAD SCI USA, V96, P10711, DOI 10.1073/pnas.96.19.10711; Kortesidis A, 2005, BLOOD, V105, P3793, DOI 10.1182/blood-2004-11-4349; Lee JB, 2004, BRAIN RES PROTOC, V14, P37, DOI 10.1016/j.brainresprot.2004.09.004; Lee JB, 2003, NEUROPATHOLOGY, V23, P169, DOI 10.1046/j.1440-1789.2003.00496.x; Lu D, 2001, NEUROREPORT, V12, P559, DOI 10.1097/00001756-200103050-00025; Lu DY, 2007, NEUROSURGERY, V61, P596, DOI 10.1227/01.NEU.0000290908.38438.B2; Lu DY, 2002, J NEUROSURG, V97, P935, DOI 10.3171/jns.2002.97.4.0935; Lu DY, 2001, J NEUROTRAUM, V18, P813, DOI 10.1089/089771501316919175; Lu J, 2006, NEUROSCI LETT, V398, P12, DOI 10.1016/j.neulet.2005.12.053; Mahmood A, 2006, J NEUROSURG, V104, P272, DOI 10.3171/jns.2006.104.2.272; Mahmood A, 2005, NEUROSURGERY, V57, P1026, DOI 10.1227/01.NEU.0000181369.76323.50; Mahmood A, 2004, NEUROSURGERY, V55, P1185, DOI 10.1227/01.NEU.0000141042.14476.3C; Mahmood A, 2003, NEUROSURGERY, V53, P697, DOI 10.1227/01.NEU.0000079333.61863.AA; Mahmood A, 2001, NEUROSURGERY, V49, P1196, DOI 10.1097/00006123-200111000-00031; Mahmood A, 2002, J NEUROTRAUM, V19, P1609, DOI 10.1089/089771502762300265; Mahmood A, 2003, NEUROSURGERY, V53, P702; Mahmood A, 2007, NEUROSURGERY, V61, P206, DOI 10.1227/01.neu.0000279914.37559.de; Mahmood A, 2007, NEUROSURGERY, V60, P546, DOI 10.1227/01.NEU.0000255346.25959.99; MARUICHI K, 2009, NEUROPATHOL IN PRESS; Maxwell WL, 1995, J NEUROCYTOL, V24, P925, DOI 10.1007/BF01215643; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Neuhuber B, 2005, BRAIN RES, V1035, P73, DOI 10.1016/j.brainres.2004.11.055; Philips MF, 2001, J NEUROSURG, V94, P765, DOI 10.3171/jns.2001.94.5.0765; Pike BR, 2000, J NEUROTRAUM, V17, P283, DOI 10.1089/neu.2000.17.283; Pineda JA, 2001, J NEUROTRAUM, V18, P625, DOI 10.1089/089771501750291864; POVLISHOCK JT, 1993, ANN EMERG MED, V22, P980, DOI 10.1016/S0196-0644(05)82738-6; POVLISHOCK JT, 1992, BRAIN PATHOL, V2, P1; Sanchez-Ramos J, 2000, EXP NEUROL, V164, P247, DOI 10.1006/exnr.2000.7389; Seki T, 2003, NEUROSURGERY, V53, P192, DOI 10.1227/01.NEU.0000068988.28788.2C; Seki T, 2002, NEUROSURGERY, V50, P1075, DOI 10.1097/00006123-200205000-00024; Shichinohe H, 2004, BRAIN RES PROTOC, V13, P166, DOI 10.1016/j.brainresprot.2004.04.004; Shichinohe H, 2008, NEUROREHAB NEURAL RE, V22, P447, DOI 10.1177/1545968308315596; Shichinohe H, 2007, BRAIN RES, V1183, P138, DOI 10.1016/j.brainres.2007.08.091; Shichinohe H, 2006, J NUCL MED, V47, P486; Sinson G, 1996, J NEUROSURG, V84, P655, DOI 10.3171/jns.1996.84.4.0655; Terada N, 2002, NATURE, V416, P542, DOI 10.1038/nature730; Watson DJ, 2003, J NEUROPATH EXP NEUR, V62, P368, DOI 10.1093/jnen/62.4.368; Woodbury D, 2002, J NEUROSCI RES, V69, P908, DOI 10.1002/jnr.10365; Woodbury D, 2000, J NEUROSCI RES, V61, P364, DOI 10.1002/1097-4547(20000815)61:4<364::AID-JNR2>3.0.CO;2-C; Yamaguchi S, 2006, BRAIN RES, V1087, P15, DOI 10.1016/j.brainres.2006.02.127; Yano S, 2005, BRAIN RES, V1065, P60, DOI 10.1016/j.brainres.2005.10.031; Yano S, 2005, J NEUROTRAUM, V22, P907, DOI 10.1089/neu.2005.22.907; Yano S, 2006, J NEUROTRAUM, V23, P1682, DOI 10.1089/neu.2006.23.1682; Zhong C, 2003, NEUROSCI LETT, V342, P93, DOI 10.1016/S0304-3940(03)00255-6	60	17	18	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0919-6544	1440-1789		NEUROPATHOLOGY	Neuropathology	AUG	2009	29	4					422	432		10.1111/j.1440-1789.2008.00995.x			11	Clinical Neurology; Neurosciences; Pathology	Neurosciences & Neurology; Pathology	471LY	WOS:000268060400005	19170895				2021-06-18	
J	Vulliemoz, S; Perrig, S; Pellise, D; Vargas, MI; Gasche, Y; Ives, JR; Seeck, M				Vulliemoz, Serge; Perrig, Stephen; Pellise, Daniel; Vargas, Maria I.; Gasche, Yvan; Ives, John R.; Seeck, Margitta			Imaging Compatible Electrodes for Continuous Electroencephalogram Monitoring in the Intensive Care Unit	JOURNAL OF CLINICAL NEUROPHYSIOLOGY			English	Article	62nd Annual Meeting of the American-Epilepsy-Society	DEC 05-09, 2008	Seattle, WA	Amer Epilepsy Soc		Coma; Critical care; Continuous EEG; Long-term monitoring; Imaging; Electrodes	TRAUMATIC BRAIN-INJURY; CONTINUOUS EEG; SUBARACHNOID HEMORRHAGE; NONCONVULSIVE SEIZURES; INTRACEREBRAL HEMORRHAGE; ELECTROGRAPHIC SEIZURES; ICU; QUALITY; MRI	Continuous electroencephalogram in the intensive care unit is increasingly recognized as An important diagnostic and prognostic tool in critically ill patients. Metal disc electrodes or subdermal needle electrodes are neither computed tomography nor magnetic resonance imaging compatible. Their frequent replacement required for imaging purposes is time consuming and contributes to scalp breakdown. We have developed and report Oil two new types of imaging compatible electrodes. The subdermal wire electrode and the silver-epoxy-coated conductive plastic electrode are magnetic resonance imaging, Computed tomography, and angiogram compatible. Moreover, the subdermal wire electrode does not require my daily maintenance. The electrodes were used on a total of 24 intensive care unit patients (subdermal wire electrode = 20, conductive plastic electrodes = 4) who required continuous electroencephalogram. During all average of 62.2 +/- 44 hours of electroencephalogram recording, 54% of the patients underwent imaging procedures (nine magnetic resonance imagings, five computed tomographic scans, and two angiograms) of good quality without the need to remove/replace the electrodes. The continuous electronencephalogram revealed epileptogenic activity that was not detected oil standard 20-minute recordings in 28% of patients screened, with electrographic seizures in 11%. These two types of imaging compatible electrodes offer definite advantages in clinical practice. The combined diagnostic information of continuous electroencephalogram and easy-to-plan imaging yields important results and improves the clinical management and treatment of intensive care unit patients.	[Vulliemoz, Serge; Perrig, Stephen; Pellise, Daniel; Seeck, Margitta] Univ Hosp Geneva, Dept Clin Neurosci, CH-1211 Geneva 14, Switzerland; [Vargas, Maria I.] Univ Hosp Geneva, Dept Radiol, CH-1211 Geneva, Switzerland; [Gasche, Yvan] Univ Hosp Geneva, Dept Anaesthesiol Pharmacol & Intens Care, CH-1211 Geneva 14, Switzerland; Univ Geneva, Fac Med, Geneva, Switzerland; [Ives, John R.] Univ Western Ontario, Dept Clin Neurol Sci, London, ON, Canada	Vulliemoz, S (corresponding author), Univ Hosp Geneva, EEG & Epilepsy Unit, Dept Neurol, 24 Micheli Du Crest, CH-1211 Geneva 14, Switzerland.	serge.vulliemoz@hcuge.ch		Vargas, Maria Isabel/0000-0002-6571-5336			Claassen J, 2007, NEUROLOGY, V69, P1356, DOI 10.1212/01.wnl.0000281664.02615.6c; Claassen J, 2005, J CLIN NEUROPHYSIOL, V22, P92, DOI 10.1097/01.WNP.0000145006.02048.3A; Claassen J, 2004, CLIN NEUROPHYSIOL, V115, P2699, DOI 10.1016/j.clinph.2004.06.017; Claassen J, 2004, NEUROLOGY, V62, P1743, DOI 10.1212/01.WNL.0000125184.88797.62; Das RR, 2009, NEUROCRIT CARE, V10, P368, DOI 10.1007/s12028-008-9142-3; Hirsch LJ, 2004, J CLIN NEUROPHYSIOL, V21, P332; Ives JR, 2006, CLIN NEUROPHYSIOL, V117, P1870, DOI 10.1016/j.clinph.2006.04.010; Ives JR, 2005, J CLIN NEUROPHYSIOL, V22, P119, DOI 10.1097/01.WNP.0000152659.30753.47; IVES JR, 1993, ELECTROEN CLIN NEURO, V87, P417, DOI 10.1016/0013-4694(93)90156-P; Jette N, 2006, ARCH NEUROL-CHICAGO, V63, P1750, DOI 10.1001/archneur.63.12.1750; Jirsch J, 2007, CLIN NEUROPHYSIOL, V118, P1660, DOI 10.1016/j.clinph.2006.11.312; Krakow K, 2000, HUM BRAIN MAPP, V10, P10, DOI 10.1002/(SICI)1097-0193(200005)10:1<10::AID-HBM20>3.0.CO;2-T; Kull LL, 2005, J CLIN NEUROPHYSIOL, V22, P107, DOI 10.1097/01.WNP.0000158361.24544.2D; LABAR DR, 1991, ELECTROEN CLIN NEURO, V78, P325, DOI 10.1016/0013-4694(91)90094-K; LUFKIN R, 1988, AM J NEURORADIOL, V9, P953; Mirsattari SM, 2004, CLIN NEUROPHYSIOL, V115, P2175, DOI 10.1016/j.clinph.2004.04.011; Scheuer ML, 2002, EPILEPSIA, V43, P114, DOI 10.1046/j.1528-1157.43.s.3.7.x; Stevens TK, 2007, J MAGN RESON IMAGING, V25, P872, DOI 10.1002/jmri.20872; Tallgren P, 2005, CLIN NEUROPHYSIOL, V116, P799, DOI 10.1016/j.clinph.2004.10.001; Vespa P, 2005, J CLIN NEUROPHYSIOL, V22, P99, DOI 10.1097/01.WNP.0000154919.54202.E0; Vespa PM, 1997, ELECTROEN CLIN NEURO, V103, P607, DOI 10.1016/S0013-4694(97)00071-0; Vespa PM, 2002, J NEUROSURG, V97, P84, DOI 10.3171/jns.2002.97.1.0084; Wijdicks EFM, 2006, NEUROLOGY, V67, P203, DOI 10.1212/01.wnl.0000227183.21314.cd; Young GB, 2006, CLIN NEUROPHYSIOL, V117, P1376, DOI 10.1016/j.clinph.2006.02.006; Young GB, 2005, NEUROCRIT CARE, V2, P5, DOI 10.1385/NCC:2:1:005; Young GB, 1996, NEUROLOGY, V47, P83	26	17	17	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0736-0258			J CLIN NEUROPHYSIOL	J. Clin. Neurophysiol.	AUG	2009	26	4					236	243		10.1097/WNP.0b013e3181af1c95			8	Clinical Neurology; Neurosciences	Neurosciences & Neurology	480OQ	WOS:000268746000004	19584749				2021-06-18	
J	Chiang, HL; Lyu, RK; Tseng, MY; Chang, KH; Chang, HS; Hsu, WC; Kuo, HC; Chu, CC; Wu, YR; Ro, LS; Huang, CC; Chen, CM				Chiang, Han-Lin; Lyu, Rong-Kuo; Tseng, Mu-Yun; Chang, Kuo-Hsuan; Chang, Hong-Shiu; Hsu, Wen-Chuin; Kuo, Hung-Chou; Chu, Chun-Che; Wu, Yih-Ru; Ro, Long-Sun; Huang, Chin-Chang; Chen, Chiung-Mei			Analyses of transthyretin concentration in the cerebrospinal fluid of patients with Guillain-Barre syndrome and other neurological disorders	CLINICA CHIMICA ACTA			English	Article						Transthyretin; Cerebrospinal fluid; Guillain-Barre syndrome	INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY; TRAUMATIC BRAIN-INJURY; MULTIPLE-SCLEROSIS; ALZHEIMERS-DISEASE; PRE-ALBUMIN; IDIOPATHIC POLYNEURITIS; COMPARATIVE PROTEOMICS; DIAGNOSTIC-CRITERIA; APOLIPOPROTEIN-E; PROTEIN MARKERS	Background: Guillain-Barre syndrome (GBS) is an autoimmune inflammatory polyradiculoneuropathy that causes acute are flexic paralysis with a high risk of respiratory failure. Previously, using two-dimensional gel electrophoresis and mass spectrometry, we found that the transthyretin level was altered in the cerebrospinal fluid (CSF) of GBS patients when compared to that in CSF of control patients. Methods: We used enzyme-linked immunosorbent assay (ELISA) to measure the transthyretin levels in the CSF and serum from 22 GBS, 4 Miller-Fisher syndrome (MFS), 9 chronic inflammatory demyelinating polyradiculoneuropathy (CIDP), 22 multiple sclerosis (MS), 10 Alzheimer's disease (AD), and 6 viral meningitis (VM) patients, and 18 controls. Results: The results show that CSF transthyretin concentration of the GBS patients is significantly higher than that of the control, MS, AD and VM patients (p < 0.05), although not significantly different from that of MFS and CIDP patients. Conclusion: The increased CSF transthyretin level may be explained by barrier dysfunction or decreased CSF flow in the GBS patients along with increased intrathecal synthesis of transthyretin that might be a protective response to nerve damage. (c) 2009 Elsevier B.V. All rights reserved.	[Chiang, Han-Lin; Lyu, Rong-Kuo; Tseng, Mu-Yun; Chang, Kuo-Hsuan; Chang, Hong-Shiu; Hsu, Wen-Chuin; Kuo, Hung-Chou; Chu, Chun-Che; Wu, Yih-Ru; Ro, Long-Sun; Huang, Chin-Chang; Chen, Chiung-Mei] Chang Gung Univ, Chang Gung Mem Hosp, Coll Med, Dept Neurol, Taipei, Taiwan	Chen, CM (corresponding author), Chang Gung Univ, Chang Gung Mem Hosp, Coll Med, Dept Neurol, 199 Tung Hwa N Rd, Taipei, Taiwan.	cmchen@adm.cgmh.org.tw	Chen, Chiung-Mei/AAL-6260-2020		Chang Gung Memorial Hospital, Taipei, TaiwanChang Gung Memorial Hospital [CMRPG 37056]; National Science Council, Executive Yuan, TaiwanMinistry of Science and Technology, Taiwan [96-2314-B-182A107-MY2]	This work was supported by grant CMRPG 37056 from Chang Gung Memorial Hospital, Taipei, Taiwan, and grant NSC 96-2314-B-182A107-MY2 from the National Science Council, Executive Yuan, Taiwan.	Abdi F, 2006, J ALZHEIMERS DIS, V9, P293; ASBURY AK, 1990, ANN NEUROL, V27, pS21, DOI 10.1002/ana.410270707; ASBURY AK, 1969, MEDICINE, V48, P173, DOI 10.1097/00005792-196905000-00001; BERLIT P, 1992, J CLIN NEURO-OPHTHAL, V12, P57; Castano EM, 2006, NEUROL RES, V28, P155, DOI 10.1179/016164106X98035; Chang KH, 2007, PROTEOM CLIN APPL, V1, P467, DOI 10.1002/prca.200600949; Chio A, 2003, NEUROLOGY, V60, P1146, DOI 10.1212/01.WNL.0000055091.96905.D0; Cosi V, 2006, NEUROL SCI, V27, pS47, DOI 10.1007/s10072-006-0548-4; Davidsson P, 2002, NEUROREPORT, V13, P611, DOI 10.1097/00001756-200204160-00015; DICKSON PW, 1982, EUR J BIOCHEM, V129, P289, DOI 10.1111/j.1432-1033.1982.tb07051.x; FISHER M, 1956, NEW ENGL J MED, V255, P57, DOI 10.1056/NEJM195607122550201; HERBERT J, 1986, NEUROLOGY, V36, P900, DOI 10.1212/WNL.36.7.900; Huang YC, 2009, J NEUROIMMUNOL, V206, P100, DOI 10.1016/j.jneuroim.2008.10.011; Hughes RAC, 2006, J PERIPHER NERV SYST, V11, P30, DOI 10.1111/j.1085-9489.2006.00061.x; Hughes RAC, 2005, LANCET, V366, P1653, DOI 10.1016/S0140-6736(05)67665-9; INGENBLEEK Y, 1994, ANNU REV NUTR, V14, P495, DOI 10.1146/annurev.nu.14.070194.002431; Jin T, 2007, EUR J NEUROL, V14, P563, DOI 10.1111/j.1468-1331.2007.01761.x; Kassem NA, 2006, AM J PHYSIOL-REG I, V291, pR1310, DOI 10.1152/ajpregu.00789.2005; KRZALIC L, 1982, CLIN CHIM ACTA, V124, P339, DOI 10.1016/0009-8981(82)90427-2; Kunicki S, 1998, CLIN BIOCHEM, V31, P409, DOI 10.1016/S0009-9120(98)00027-7; LAMOUREUX G, 1975, NEUROLOGY, V25, P537, DOI 10.1212/WNL.25.6.537; LARSEN PD, 1987, NEUROLOGY, V37, P1262, DOI 10.1212/WNL.37.7.1262; Lehmensiek V, 2007, MULT SCLER, V13, P840, DOI 10.1177/1352458507076406; Lehmensiek V, 2007, J NEUROIMMUNOL, V185, P190, DOI 10.1016/j.jneuroim.2007.01.022; Long Y, 2003, J NEUROSCI RES, V71, P710, DOI 10.1002/jnr.10524; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Merched A, 1998, FEBS LETT, V425, P225, DOI 10.1016/S0014-5793(98)00234-8; Press R, 2003, J CLIN IMMUNOL, V23, P259, DOI 10.1023/A:1024532715775; Puchades M, 2003, MOL BRAIN RES, V118, P140, DOI 10.1016/j.molbrainres.2003.08.005; Reiber H, 1997, NEUROCHEMISTRY, P423; Reiber H, 1998, MULT SCLER, V4, P99, DOI 10.1177/135245859800400302; Reiber H, 2001, CLIN CHIM ACTA, V310, P173, DOI 10.1016/S0009-8981(01)00573-3; ROSTENBERG I, 1979, J NATL CANCER I, V62, P299; Serot JM, 1997, J NEUROL NEUROSUR PS, V63, P506, DOI 10.1136/jnnp.63.4.506; SMITH FR, 1973, AM J CLIN NUTR, V26, P973; Stein TD, 2004, J NEUROSCI, V24, P7707, DOI 10.1523/JNEUROSCI.2211-04.2004; Trojaborg W, 1998, ELECTROEN CLIN NEURO, V107, P303, DOI 10.1016/S0013-4694(98)00096-0; Van Den Bergh PYK, 2004, MUSCLE NERVE, V29, P565, DOI 10.1002/mus.20022; Yang YR, 2008, CELL MOL NEUROBIOL, V28, P737, DOI 10.1007/s10571-007-9257-7; Yu RK, 2006, INFECT IMMUN, V74, P6517, DOI 10.1128/IAI.00967-06; Zou LL, 1998, J NEUROCHEM, V71, P887	42	17	18	0	4	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0009-8981	1873-3492		CLIN CHIM ACTA	Clin. Chim. Acta	JUL	2009	405	1-2					143	147		10.1016/j.cca.2009.04.022			5	Medical Laboratory Technology	Medical Laboratory Technology	463RA	WOS:000267448300026	19410571				2021-06-18	
J	Goodrich-Hunsaker, NJ; Gilbert, PE; Hopkins, RO				Goodrich-Hunsaker, Naomi J.; Gilbert, Paul E.; Hopkins, Ramona O.			The Role of the Human Hippocampus in Odor-Place Associative Memory	CHEMICAL SENSES			English	Article						amnesia; associative memory; hippocampus; odor-place paired associate; recognition memory	MEDIAL TEMPORAL-LOBE; MILD COGNITIVE IMPAIRMENT; TRAUMATIC BRAIN INJURY; RECOGNITION MEMORY; ALZHEIMERS-DISEASE; ITEM RECOGNITION; SPATIAL MEMORY; OLFACTORY RECOGNITION; LESIONS; OBJECT	Hippocampal lesions in rodents impair both object-place and odor-place associative memory. Subjects with hippocampal damage have impaired associative memory such as object-place memory. Whereas studies have investigated some types of associative memory, no investigation has specifically examined odor-place associative memory in subjects with well-defined amnesia. It is unknown whether amnesic subjects with hippocampal damage would be impaired on an odor-place associative task. We investigated the effect of hippocampal damage in amnesic subjects with hippocampal atrophy on odor-place associative memory and recognition memory tasks. Amnesic and healthy comparison subjects matched for age and education were tested on an odor-place associative task, an odor recognition task, and a place recognition task. The odor-place associative task required subjects to associate 6 odors with 6 spatial locations on a board. The recognition tasks required subjects to identify the 6 odors and the 6 locations that were presented during the associative task. Amnesic subjects were impaired for odor-place memory and place recognition, but not odor recognition compared with comparison subjects. These results suggest that the human hippocampus is necessary for odor-place associative memory and spatial recognition memory. These data provide support for the idea that odor-place associative memory is mediated by the hippocampus in both humans and rodents, suggesting an evolutionary continuity in cognitive function assigned to the hippocampus.	[Goodrich-Hunsaker, Naomi J.; Hopkins, Ramona O.] Brigham Young Univ, Dept Psychol, Provo, UT 84602 USA; [Goodrich-Hunsaker, Naomi J.] Brigham Young Univ, Dept Physiol & Dev Biol, Provo, UT 84602 USA; [Gilbert, Paul E.] San Diego State Univ, Dept Psychol, San Diego, CA 92182 USA; [Gilbert, Paul E.] Univ Calif San Diego, San Diego State Univ, Joint Doctoral Program Clin Psychol, San Diego, CA 92120 USA; [Goodrich-Hunsaker, Naomi J.; Hopkins, Ramona O.] Brigham Young Univ, Ctr Neurosci, Provo, UT 84602 USA; [Hopkins, Ramona O.] Latter Day St Hosp, Dept Med, Div Pulm & Crit Care, Salt Lake City, UT 84143 USA; [Hopkins, Ramona O.] Intermt Med Ctr, Dept Med, Div Pulm & Crit Care, Murray, UT 84157 USA	Goodrich-Hunsaker, NJ (corresponding author), Brigham Young Univ, Dept Psychol, 1082 SWKT, Provo, UT 84602 USA.	naomihunsaker@mac.com					Barrash J, 1998, J CLIN EXP NEUROPSYC, V20, P807, DOI 10.1076/jcen.20.6.807.1114; Bigler ED, 2002, AM J NEURORADIOL, V23, P255; Bigler ED, 1997, AM J NEURORADIOL, V18, P11; BLATTER DD, 1995, AM J NEURORADIOL, V16, P241; Braak H, 1997, NEUROBIOL AGING, V18, P351, DOI 10.1016/S0197-4580(97)00056-0; Broadbent NJ, 2004, P NATL ACAD SCI USA, V101, P14515, DOI 10.1073/pnas.0406344101; Brown MW, 2001, NAT REV NEUROSCI, V2, P51, DOI 10.1038/35049064; Cerf-Ducastel B, 2006, NEUROIMAGE, V31, P386, DOI 10.1016/j.neuroimage.2005.11.009; Chua EF, 2007, HIPPOCAMPUS, V17, P1071, DOI 10.1002/hipo.20340; Crane J, 2005, HIPPOCAMPUS, V15, P216, DOI 10.1002/hipo.20043; Davachi L, 2002, J NEUROPHYSIOL, V88, P982, DOI 10.1152/jn.2002.88.2.982; Davachi L, 2003, P NATL ACAD SCI USA, V100, P2157, DOI 10.1073/pnas.0337195100; Devanand DP, 2000, AM J PSYCHIAT, V157, P1399, DOI 10.1176/appi.ajp.157.9.1399; Di Paola M, 2008, HIPPOCAMPUS, V18, P719, DOI 10.1002/hipo.20432; Djordjevic J, 2008, NEUROBIOL AGING, V29, P693, DOI 10.1016/j.neurobiolaging.2006.11.014; Dudchenko PA, 2000, J NEUROSCI, V20, P2964; Eichenbaum H, 2000, NAT REV NEUROSCI, V1, P41, DOI 10.1038/35036213; Eichenbaum H, 1998, ANN NY ACAD SCI, V855, P657, DOI 10.1111/j.1749-6632.1998.tb10642.x; Ergorul C, 2004, LEARN MEMORY, V11, P397, DOI 10.1101/lm.73304; ESIRI MM, 1984, J NEUROL NEUROSUR PS, V47, P56, DOI 10.1136/jnnp.47.1.56; Gadian DG, 2000, BRAIN, V123, P499, DOI 10.1093/brain/123.3.499; Gilbert PE, 2008, EXP AGING RES, V34, P437, DOI 10.1080/03610730802271914; Gilbert PE, 2004, J CLIN EXP NEUROPSYC, V26, P779, DOI 10.1080/13803390490509439; Gilbert PE, 2004, NEUROBIOL LEARN MEM, V81, P39, DOI 10.1016/S1074-7427(03)00069-8; Gilbert PE, 2002, BEHAV NEUROSCI, V116, P63, DOI 10.1037//0735-7044.116.1.63; Giovanello KS, 2004, HIPPOCAMPUS, V14, P5; Goh JOS, 2004, J NEUROSCI, V24, P10223, DOI 10.1523/JNEUROSCI.3373-04.2004; Gold JJ, 2005, HIPPOCAMPUS, V15, P79, DOI 10.1002/hipo.20032; Hamilton JM, 1999, J INT NEUROPSYCH SOC, V5, P609, DOI 10.1017/S1355617799577035; Holdstock JS, 2005, HIPPOCAMPUS, V15, P203, DOI 10.1002/hipo.20046; Hopkins R O, 1995, J Int Neuropsychol Soc, V1, P454; Hopkins RO, 2004, NEUROPSYCHOLOGIA, V42, P524, DOI 10.1016/j.neuropsychologia.2003.09.005; Kesner RP, 2000, CURR OPIN NEUROBIOL, V10, P260, DOI 10.1016/S0959-4388(00)00067-2; Kesner RP, 2001, NEUROPSYCHOLOGY, V15, P58, DOI 10.1037/0894-4105.15.1.58; Kessels RPC, 2001, BRAIN RES REV, V35, P295, DOI 10.1016/S0165-0173(01)00058-3; Levy DA, 2004, LEARN MEMORY, V11, P794, DOI 10.1101/lm.82504; Maguire EA, 1997, J NEUROSCI, V17, P7103; Manns JR, 2003, NEURON, V38, P127, DOI 10.1016/S0896-6273(03)00146-6; Manns JR, 2003, NEURON, V37, P171, DOI 10.1016/S0896-6273(02)01147-9; Mayes AR, 2002, HIPPOCAMPUS, V12, P325, DOI 10.1002/hipo.1111; Meltzer JA, 2005, NEUROIMAGE, V24, P384, DOI 10.1016/j.neuroimage.2004.09.001; Meyers J., 1995, REY COMPLEX FIGURE T; MOBERG PJ, 1987, J CLIN EXP NEUROPSYC, V9, P650, DOI 10.1080/01688638708405208; MURPHY C, 1991, AM J PSYCHOL, V104, P161, DOI 10.2307/1423153; Murphy C, 1997, NEUROPSYCHOLOGY, V11, P126; Murphy C, 2002, JAMA-J AM MED ASSOC, V288, P2307, DOI 10.1001/jama.288.18.2307; Murphy C, 2003, J INT NEUROPSYCH SOC, V9, P459, DOI 10.1017/S1355617703930116; Nordin S, 1998, ANN NY ACAD SCI, V855, P686, DOI 10.1111/j.1749-6632.1998.tb10646.x; Nunn JA, 1999, BRAIN, V122, P47, DOI 10.1093/brain/122.1.47; O'Keefe J, 1998, PHILOS T ROY SOC B, V353, P1333, DOI 10.1098/rstb.1998.0287; O'Reilly RC, 2001, PSYCHOL REV, V108, P311, DOI 10.1037//0033-295X.108.2.311; OTTO T, 1992, HIPPOCAMPUS, V2, P323, DOI 10.1002/hipo.450020310; PRICE JL, 1991, NEUROBIOL AGING, V12, P295, DOI 10.1016/0197-4580(91)90006-6; Rolls ET, 2005, J NEUROPHYSIOL, V94, P833, DOI 10.1152/jn.01063.2004; Squire LR, 2007, NAT REV NEUROSCI, V8, P872, DOI 10.1038/nrn2154; SQUIRE LR, 1991, SCIENCE, V253, P1380, DOI 10.1126/science.1896849; Stark CEL, 2002, LEARN MEMORY, V9, P238, DOI 10.1101/lm.51802; Turriziani P, 2004, NEUROPSYCHOLOGIA, V42, P426, DOI 10.1016/j.neuropsychologia.2003.10.003; Wechsler D., 2011, WECHLSER ABBREVIATED; Wechsler D., 1997, WMS 3 WECHSLER MEMOR; Wilson RS, 2007, ARCH GEN PSYCHIAT, V64, P802, DOI 10.1001/archpsyc.64.7.802	61	17	17	0	6	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0379-864X	1464-3553		CHEM SENSES	Chem. Senses	JUL	2009	34	6					513	521		10.1093/chemse/bjp026			9	Behavioral Sciences; Food Science & Technology; Neurosciences; Physiology	Behavioral Sciences; Food Science & Technology; Neurosciences & Neurology; Physiology	457TE	WOS:000266955500007	19477953	Bronze			2021-06-18	
J	Roozenbeek, B; Maas, AIR; Marmarou, A; Butcher, I; Lingsma, HF; Lu, J; McHugh, GS; Murray, GD; Steyerberg, EW				Roozenbeek, Bob; Maas, Andrew I. R.; Marmarou, Anthony; Butcher, Isabella; Lingsma, Hester F.; Lu, Juan; McHugh, Gillian S.; Murray, Gordon D.; Steyerberg, Ewout W.		IMPACT Study Grp	The Influence of Enrollment Criteria on Recruitment and Outcome Distribution in Traumatic Brain Injury Studies: Results from the Impact Study	JOURNAL OF NEUROTRAUMA			English	Article						enrollment criteria; heterogeneity; outcome distribution; randomized controlled trial; recruitment; traumatic brain injury	HEAD-INJURY; CLINICAL-TRIALS; NEUROPROTECTIVE AGENTS; DESIGN; EFFICACY	Substantial heterogeneity exists among patients who suffer from traumatic brain injury (TBI). Strict enrollment criteria may diminish heterogeneity in randomized controlled trials (RCTs), but will also decrease recruitment and may affect the outcome distribution. The aim of this study was to investigate the influences of commonly used enrollment criteria for RCTs in TBI on potential recruitment and on outcome distribution. We used individual patient data from the International Mission on Prognosis and Analysis of Clinical Trials in TBI (IMPACT) database, including six therapeutic phase III RCTs (n-5816) and three surveys (n-2217) in TBI. The primary outcome was the Glasgow Outcome Scale (GOS) at 6 months after injury, which we dichotomized as favorable/unfavorable. We investigated the influences of commonly used enrollment criteria on recruitment and outcome distribution: time window between injury and admission to study hospital <= 8 h; age at injury <= 65 years; >= 1 reactive pupil; motor score > 1; Glasgow Coma Scale <= 8. Application of all enrollment criteria resulted in a large reduction of recruitment in both the surveys (up to 65%) and the RCTs (up to 41%). Among the remaining patients, fewer had an unfavorable outcome in both the surveys (original, 60%; remaining, 44%) and the RCTs (original, 43%; remaining, 38%). Applying these enrollment criteria to patients from the surveys resulted in an outcome distribution that approximated the outcome observed in the RCTs. The use of strict enrollment criteria leads to substantial reductions in the recruitment of RCTs in TBI. The outcome in TBI studies depends strongly on the enrollment criteria.	[Maas, Andrew I. R.] Univ Antwerp Hosp, Dept Neurosurg, Antwerp, Belgium; [Roozenbeek, Bob; Lingsma, Hester F.; Steyerberg, Ewout W.] Erasmus MC, Ctr Med Decis Making, Dept Publ Hlth, Rotterdam, Netherlands; [Roozenbeek, Bob; Maas, Andrew I. R.] Erasmus MC, Dept Neurosurg, Rotterdam, Netherlands; [Marmarou, Anthony; Lu, Juan] Virginia Commonwealth Univ, Dept Neurosurg, Richmond, VA USA; [Butcher, Isabella; McHugh, Gillian S.; Murray, Gordon D.] Univ Edinburgh, Div Community Hlth Sci, Edinburgh, Midlothian, Scotland	Maas, AIR (corresponding author), Univ Antwerp Hosp, Dept Neurosurg, Wilrijkstr 10, B-2650 Edegem, Belgium.	andrew.maas@uza.be	Maas, Andrew IR/C-5584-2013; Steyerberg, Ewout/C-1509-2018	Maas, Andrew IR/0000-0003-1612-1264; Murray, Gordon/0000-0001-9866-4734; Steyerberg, Ewout/0000-0002-7787-0122; Lu, Juan/0000-0002-5389-7603	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS-42691]; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0800803] Funding Source: researchfish; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS042691] Funding Source: NIH RePORTER	Grant support was provided by NIH NS-42691.	BULLOCK MR, 2002, NEUROSURG FOCUS; Choi SC, 2001, NEUROL RES, V23, P190, DOI 10.1179/016164101101198325; Edwards P, 2005, LANCET, V365, P1957; Hernandez AV, 2006, J NEUROTRAUM, V23, P1295, DOI 10.1089/neu.2006.23.1295; Hukkelhoven CWPM, 2006, J CLIN EPIDEMIOL, V59, P132, DOI 10.1016/j.jclinepi.2005.06.009; Hukkelhoven CWPM, 2005, J NEUROTRAUM, V22, P1025, DOI 10.1089/neu.2005.22.1025; Kompanje EJO, 2005, ACTA NEUROCHIR, V147, P633, DOI 10.1007/s00701-005-0525-3; Maas AIR, 1999, NEUROSURGERY, V44, P1286, DOI 10.1097/00006123-199906000-00076; Maas AIR, 2007, J NEUROTRAUM, V24, P232, DOI 10.1089/neu.2006.0024; Machado SG, 1999, J NEUROTRAUM, V16, P1131, DOI 10.1089/neu.1999.16.1131; Marmarou A, 2007, J NEUROTRAUM, V24, P239, DOI 10.1089/neu.2006.0036; Marshall LF, 1998, J NEUROSURG, V89, P519, DOI 10.3171/jns.1998.89.4.0519; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Slieker FJA, 2008, NEUROSURGERY, V62, P1321, DOI 10.1227/01.neu.0000333304.79931.4d	14	17	17	0	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL	2009	26	7					1069	1075		10.1089/neu.2008.0569			7	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	470HJ	WOS:000267965500012	19594383	Green Published			2021-06-18	
J	Wu, KLH; Hsu, C; Chan, JYH				Wu, Kay L. H.; Hsu, Chin; Chan, Julie Y. H.			Nitric Oxide and Superoxide Anion Differentially Activate Poly(ADP-ribose) Polymerase-1 and Bax to Induce Nuclear Translocation of Apoptosis-Inducing Factor and Mitochondrial Release of Cytochrome c after Spinal Cord Injury	JOURNAL OF NEUROTRAUMA			English	Article						apoptosis; mitochondrial respiratory enzyme complex; nitric oxide; spinal cord injury; superoxide anion	ROSTRAL VENTROLATERAL MEDULLA; TRAUMATIC BRAIN-INJURY; 2 DISTINCT PATHWAYS; CELL-DEATH; OXIDATIVE STRESS; GLUTATHIONE-PEROXIDASE; PROTEIN NITRATION; RESPIRATORY-CHAIN; IN-VITRO; SYNTHASE	We reported previously that complete spinal cord transection (SCT) results in depression of mitochondrial respiratory chain enzyme activity that triggers apoptosis via sequential activations of apoptosis-inducing factor (AIF)- and caspase- dependent cascades in the injured spinal cord. This study tested the hypothesis that nitric oxide (NO) and superoxide anion (O-2(center dot-)) serve as the interposing signals between SCT and impaired mitochondrial respiratory functions. Adult Sprague-Dawley rats manifested a significant increase in NO or O-2(center dot-) level in the injured spinal cord during the first 3 days after SCT. The augmented O-2(center dot-) production, along with concomitant reduction in mitochondrial respiratory chain enzyme activity or ATP level, nuclear translocation of AIF, cytosolic release of cytochrome c, and DNA fragmentation were reversed by osmotic minipump infusion of a NO trapping agent, carboxy-PTIO, or a superoxide dismutase mimetic, tempol, into the epicenter of the transected spinal cord. Intriguingly, carboxy-PTIO significantly suppressed upregulation of poly(ADP-ribose) polymerase-1 (PARP-1) in the nucleus, attenuated nuclear translocation of AIF, inhibited mitochondrial translocation of Bax and antagonized mitochondrial release of cytochrome c; whereas tempol only inhibited the later two cellular events after SCT. We conclude that overproduction of NO and O-2(center dot-) in the injured spinal cord promulgates mitochondrial dysfunction and triggers AIF- and caspase- dependent apoptotic signaling cascades via differential upregulation of nuclear PARP-1 and mitochondrial translocation of Bax.	[Wu, Kay L. H.; Chan, Julie Y. H.] Kaohsiung Vet Gen Hosp, Dept Med Educ & Res, Kaohsiung 81346, Taiwan; [Wu, Kay L. H.; Hsu, Chin] Kaohsiung Med Univ, Grad Inst Med, Kaohsiung, Taiwan	Chan, JYH (corresponding author), Kaohsiung Vet Gen Hosp, Dept Med Educ & Res, Kaohsiung 81346, Taiwan.	yhwa@isca.vghks.gov.tw	Chan, Julie/X-5253-2019		National Science CouncilMinistry of Science and Technology, Taiwan [NSC96-2320-B075-B-001]; Kaohsiung Veterans General Hospital [VGHKS 96G-21]	This study was supported by the National Science Council ( research grant NSC96-2320-B075-B-001 to J.Y.H.C.) and the Kaohsiung Veterans General Hospital ( research grant VGHKS 96G-21 to J.Y.H.C.), Taiwan, Republic of China.	Abdelkarim GE, 2001, INT J MOL MED, V7, P255; Aulak KS, 2004, AM J PHYSIOL-HEART C, V286, pH30, DOI 10.1152/ajpheart.00743.2003; Austin JW, 2008, J NEUROTRAUM, V25, P411, DOI 10.1089/neu.2007.0436; Bao F, 2004, J NEUROCHEM, V88, P1335, DOI 10.1046/j.1471-4159.2003.02240.x; Beattie MS, 2002, PROG BRAIN RES, V137, P37; BECKMAN JS, 1990, P NATL ACAD SCI USA, V87, P1620, DOI 10.1073/pnas.87.4.1620; Besson VC, 2005, BRAIN RES, V1041, P149, DOI 10.1016/j.brainres.2005.01.096; BONFOCO E, 1995, EXP CELL RES, V218, P189, DOI 10.1006/excr.1995.1147; Brown GC, 1999, BBA-BIOENERGETICS, V1411, P351, DOI 10.1016/S0005-2728(99)00025-0; Brown GC, 1997, MOL CELL BIOCHEM, V174, P189, DOI 10.1023/A:1006800322719; Brown GC, 2007, CARDIOVASC RES, V75, P283, DOI 10.1016/j.cardiores.2007.03.022; Carlson Gregory D, 2002, Spine J, V2, P116, DOI 10.1016/S1529-9430(01)00029-8; Chan JYH, 2007, MOL PHARMACOL, V71, P1129, DOI 10.1124/mol.106.031161; Chan SHH, 2005, FREE RADICAL BIO MED, V39, P603, DOI 10.1016/j.freeradbiomed.2005.04.012; Chuang YC, 2002, J BIOMED SCI, V9, P542, DOI 10.1159/000064727; Clementi E, 1998, P NATL ACAD SCI USA, V95, P7631, DOI 10.1073/pnas.95.13.7631; Conti A, 2007, BRAIN RES REV, V54, P205, DOI 10.1016/j.brainresrev.2007.01.013; Crompton M, 1999, BIOCHEM J, V341, P233, DOI 10.1042/0264-6021:3410233; Dawson VL, 2004, J BIOENERG BIOMEMBR, V36, P287, DOI 10.1023/B:JOBB.0000041755.22613.8d; Galkin A, 2007, J BIOL CHEM, V282, P37448, DOI 10.1074/jbc.M707543200; Genovese T, 2005, J PHARMACOL EXP THER, V313, P529, DOI 10.1124/jpet.104.080705; Hoch FL, 1998, J BIOENERG BIOMEMBR, V30, P511, DOI 10.1023/A:1020576315771; HUIE RE, 1993, FREE RADICAL RES COM, V18, P195, DOI 10.3109/10715769309145868; Joseph Troy W, 2003, Methods Mol Biol, V234, P211; Kantrow SP, 1997, ARCH BIOCHEM BIOPHYS, V345, P278, DOI 10.1006/abbi.1997.0264; Keane RW, 2006, J NEUROTRAUM, V23, P335, DOI 10.1089/neu.2006.23.335; Kroemer G, 2005, NAT MED, V11, P725, DOI 10.1038/nm1263; Kwak EK, 2005, J KOREAN MED SCI, V20, P663, DOI 10.3346/jkms.2005.20.4.663; Latini A, 2003, J NEUROSCI RES, V74, P103, DOI 10.1002/jnr.10735; Maier C, 2007, INTENS CARE MED, V33, P845, DOI 10.1007/s00134-007-0585-3; Meany DL, 2006, FREE RADICAL BIO MED, V41, P950, DOI 10.1016/j.freeradbiomed.2006.06.003; Naithani S, 2003, MOL BIOL CELL, V14, P324, DOI 10.1091/mbc.E02-08-0490; Nakahara S, 2002, J NEUROTRAUM, V19, P1467, DOI 10.1089/089771502320914697; Nomura K, 2001, BIOL SIGNAL RECEPT, V10, P81; Opii WO, 2007, J NEUROTRAUM, V24, P772, DOI 10.1089/neu.2006.0229; Paradies G, 2001, MITOCHONDRION, V1, P151, DOI 10.1016/S1567-7249(01)00011-3; Sastre J, 2000, IUBMB LIFE, V49, P427; Satake K, 2000, MOL BRAIN RES, V85, P114, DOI 10.1016/S0169-328X(00)00253-9; Schreiber V, 2006, NAT REV MOL CELL BIO, V7, P517, DOI 10.1038/nrm1963; Sheeran FL, 2006, BBA-BIOENERGETICS, V1757, P543, DOI 10.1016/j.bbabio.2006.03.008; Sheh YL, 2007, FREE RADICAL BIO MED, V42, P1610, DOI 10.1016/j.freeradbiomed.2007.02.019; Stefanis L, 2005, NEUROSCIENTIST, V11, P50, DOI 10.1177/1073858404271087; Sugawara T, 2002, FASEB J, V16, P1997, DOI 10.1096/fj.02-0251fje; Susin SA, 2000, J EXP MED, V192, P571, DOI 10.1084/jem.192.4.571; Vaziri ND, 2004, BRAIN RES, V995, P76, DOI 10.1016/j.brainres.2003.09.056; Wingrave JM, 2003, J NEUROSCI RES, V73, P95, DOI 10.1002/jnr.10607; Wu KLH, 2007, J NEUROCHEM, V101, P1552, DOI 10.1111/j.1471-4159.2006.04445.x; Xu W, 2005, SPINAL CORD, V43, P204, DOI 10.1038/sj.sc.3101674; Xu Z, 2006, LIFE SCI, V79, P1895, DOI 10.1016/j.lfs.2006.06.023; Yakovlev AG, 2001, MOL NEUROBIOL, V24, P131; Yeo JE, 2008, CELL PHYSIOL BIOCHEM, V21, P225, DOI 10.1159/000113764; Yu FS, 2006, J NEUROTRAUM, V23, P595, DOI 10.1089/neu.2006.23.595; Yu SW, 2006, P NATL ACAD SCI USA, V103, P18314, DOI 10.1073/pnas.0606528103; Yu SW, 2002, SCIENCE, V297, P259, DOI 10.1126/science.1072221; Zhang XP, 2002, J NEUROCHEM, V82, P181, DOI 10.1046/j.1471-4159.2002.00975.x	55	17	17	1	8	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL	2009	26	7					965	977		10.1089/neu.2008.0692			13	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	470HJ	WOS:000267965500003	19473058				2021-06-18	
J	Potts, MB; Rola, R; Claus, CP; Ferriero, DM; Fike, JR; Noble-Haeusslein, LJ				Potts, Matthew B.; Rola, Radoslaw; Claus, Catherine P.; Ferriero, Donna M.; Fike, John R.; Noble-Haeusslein, Linda J.			Glutathione Peroxidase Overexpression Does Not Rescue Impaired Neurogenesis in the Injured Immature Brain	JOURNAL OF NEUROSCIENCE RESEARCH			English	Article						traumatic brain injury; dentate gyrus; hippocampus; glutathione peroxidase	CENTRAL-NERVOUS-SYSTEM; DENTATE GYRUS; TRAUMATIC INJURY; SELECTIVE VULNERABILITY; REGIONAL VULNERABILITY; ENHANCED NEUROGENESIS; SUPEROXIDE-DISMUTASE; TRANSGENIC MICE; HEAD TRAUMA; ADULT RATS	Traumatic brain injury (TBI) is a leading cause of disability among young children and is associated with long-term cognitive deficits. These clinical findings have prompted an investigation of the hippocampus in an experimental model of trauma to the developing brain at postnatal day (p21). Previous studies using this model have revealed a progressive loss of neurons in the hippocampus as brain-injured animals mature to young adulthood. Here we determined whether this hippocampal vulnerability is likewise reflected in altered neurogenesis and whether the antioxidant glutathione peroxidase (GPx) modulates neurogenesis during maturation of the injured immature brain. Male transgenic mice that overexpress GPx and wild-type littermates were subjected to controlled cortical impact or sham surgery on p21. At 2 weeks postinjury, the numbers of proliferating cells and immature neurons within the subgranular zone were measured by using Ki-67 and doublecortin, respectively. Bromodeoxyuricline (BrdU) was used to label dividing cells beginning 2 weeks postinjury. Survival (BrdU(+)) and neuronal differentiation (BrdU(+)/NeuN(+)) were then measured 4 weeks later via confocal microscopy. Two-way ANOVA revealed no significant interaction between genotype and injury. Subsequent analysis of the individual effects of injury and genotype, however, showed a significant reduction in subgranular zone proliferation (Ki-67) at 2 weeks postinjury (P = 0.0003) and precursor cell survival (BrdU(+)) at 6 weeks postinjury (P = 0.016) and a trend toward reduced neuronal differentiation (BrdU(+)/NeuN(+)) at 6 weeks postinjury (P = 0.087). Overall, these data demonstrate that traumatic injury to the injured immature brain impairs neurogenesis during maturation and suggest that GPx cannot rescue this reduced neurogenesis. (C) 2009 Wiley-Liss, Inc.	[Potts, Matthew B.; Rola, Radoslaw; Claus, Catherine P.; Fike, John R.; Noble-Haeusslein, Linda J.] Univ Calif San Francisco, Brain & Spinal Injury Ctr, San Francisco, CA 94143 USA; [Potts, Matthew B.; Rola, Radoslaw; Claus, Catherine P.; Fike, John R.; Noble-Haeusslein, Linda J.] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA; [Ferriero, Donna M.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Ferriero, Donna M.] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA; [Noble-Haeusslein, Linda J.] Univ Calif San Francisco, Dept Phys Therapy & Rehabil Sci, San Francisco, CA 94143 USA	Noble-Haeusslein, LJ (corresponding author), 521 Parnassus Ave,Room C-224,UCSF Box 0520, San Francisco, CA 94143 USA.	linda.noble@ucsf.edu	Rola, Radoslaw/AAQ-5587-2021; Rola, Radoslaw/V-6749-2018	Rola, Radoslaw/0000-0003-0613-6593; Rola, Radoslaw/0000-0003-0613-6593	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS050159]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS050159] Funding Source: NIH RePORTER	Contract grant sponsor: NIH; Contract grant number: NS050159	Adelson PD, 1997, J NEUROTRAUM, V14, P99, DOI 10.1089/neu.1997.14.99; Adelson PD, 1996, J NEUROSURG, V85, P877, DOI 10.3171/jns.1996.85.5.0877; Adelson PD, 2001, J NEUROTRAUM, V18, P967, DOI 10.1089/08977150152693674; Baldwin SA, 1997, J NEUROTRAUM, V14, P385, DOI 10.1089/neu.1997.14.385; Bauer R, 2004, EXP TOXICOL PATHOL, V56, P65, DOI 10.1016/j.etp.2004.04.002; Bayir H, 2002, PEDIATR RES, V51, P571, DOI 10.1203/00006450-200205000-00005; Benz B, 1999, RESTOR NEUROL NEUROS, V14, P135; Bittigau D, 1999, ANN NEUROL, V45, P724, DOI 10.1002/1531-8249(199906)45:6<724::AID-ANA6>3.0.CO;2-P; Bittigau P, 2004, EXP TOXICOL PATHOL, V56, P83, DOI 10.1016/j.etp.2004.04.006; Braun H, 2002, J NEUROTRAUM, V19, P975, DOI 10.1089/089771502320317122; Card JP, 2005, J NEUROTRAUM, V22, P989, DOI 10.1089/neu.2005.22.989; Chirumamilla S, 2002, J NEUROTRAUM, V19, P693, DOI 10.1089/08977150260139084; Cuppini R, 2002, INT J VITAM NUTR RES, V72, P170, DOI 10.1024/0300-9831.72.3.170; Dash PK, 2001, J NEUROSCI RES, V63, P313, DOI 10.1002/1097-4547(20010215)63:4<313::AID-JNR1025>3.0.CO;2-4; Ditelberg JS, 1996, PEDIATR RES, V39, P204, DOI 10.1203/00006450-199602000-00003; Emery DL, 2005, J NEUROTRAUM, V22, P978, DOI 10.1089/neu.2005.22.978; Englund U, 2002, DEV BRAIN RES, V134, P123, DOI 10.1016/S0165-3806(01)00330-3; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Fan P, 2003, J NEUROTRAUM, V20, P437, DOI 10.1089/089771503765355513; FLOHE L, 1984, METHOD ENZYMOL, V105, P114; Gaulke LJ, 2005, MOL BRAIN RES, V141, P138, DOI 10.1016/j.molbrainres.2005.08.011; Grady MS, 2003, J NEUROTRAUM, V20, P929, DOI 10.1089/089771503770195786; HALL ED, 1993, RES P ARNMD, V71, P81; Herrera DG, 2003, P NATL ACAD SCI USA, V100, P7919, DOI 10.1073/pnas.1230907100; Igarashi T, 2001, EXP NEUROL, V172, P332, DOI 10.1006/exnr.2001.7820; Kee N, 2002, J NEUROSCI METH, V115, P97, DOI 10.1016/S0165-0270(02)00007-9; Kernie SG, 2001, J NEUROSCI RES, V66, P317, DOI 10.1002/jnr.10013; KOSKINIEMI M, 1995, ARCH PEDIAT ADOL MED, V149, P249, DOI 10.1001/archpedi.1995.02170150029004; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Levin H S, 1997, J Int Neuropsychol Soc, V3, P598; LEVIN HS, 1992, NEUROSURGERY, V31, P435, DOI 10.1227/00006123-199209000-00008; Lewen A, 2000, J NEUROTRAUM, V17, P871, DOI 10.1089/neu.2000.17.871; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; Mazzola CA, 2002, CRIT CARE MED, V30, pS393, DOI 10.1097/00003246-200211001-00003; McIntosh TK, 1998, NEUROPATH APPL NEURO, V24, P251; MIROCHNITCHENKO O, 1995, P NATL ACAD SCI USA, V92, P8120, DOI 10.1073/pnas.92.18.8120; NAWASHIRO H, 1995, NEUROL RES, V17, P455, DOI 10.1080/01616412.1995.11740363; Nichols NR, 2005, BRAIN RES REV, V48, P287, DOI 10.1016/j.brainresrev.2004.12.019; Nybo T, 2005, ACTA NEUROL SCAND, V112, P338, DOI 10.1111/j.1600-0404.2005.00489.x; Parent JM, 1997, J NEUROSCI, V17, P3727; Picard-Riera N, 2004, J NEUROSCI RES, V76, P223, DOI 10.1002/jnr.20040; Potts Mathew B, 2006, NeuroRx, V3, P143; Pullela R, 2006, DEV NEUROSCI-BASEL, V28, P396, DOI 10.1159/000094166; Rice AC, 2003, EXP NEUROL, V183, P406, DOI 10.1016/S0014-4886(03)00241-3; Sato M, 2001, BRAIN RES, V917, P45, DOI 10.1016/S0006-8993(01)02905-5; Sheldon RA, 2004, PEDIATR RES, V56, P656, DOI 10.1203/01.PDR.0000139413.27864.50; Sun D, 2007, EXP NEUROL, V204, P264, DOI 10.1016/j.expneurol.2006.11.005; Tong W, 2002, EXP NEUROL, V176, P105, DOI 10.1006/exnr.2002.7941; TSUROAOYAGI K, 2006, SOC NEUR ABSTR; Yager JY, 1997, NEUROSCI BIOBEHAV R, V21, P167, DOI 10.1016/S0149-7634(96)00006-1; Yoshimura S, 2003, J CLIN INVEST, V112, P1202, DOI 10.1172/JCI200316618; Zhang Q, 2005, NEUROL RES, V27, P552, DOI 10.1179/016164105X25126	52	17	17	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0360-4012	1097-4547		J NEUROSCI RES	J. Neurosci. Res.	JUN	2009	87	8					1848	1857		10.1002/jnr.21996			10	Neurosciences	Neurosciences & Neurology	437CD	WOS:000265462800012	19170177	Green Accepted			2021-06-18	
J	Bartal, C; Yitzhak, A				Bartal, Carmi; Yitzhak, Avraham			The role of thromboelastometry and recombinant factor VIIa in trauma	CURRENT OPINION IN ANESTHESIOLOGY			English	Article						coagulopathy; damage control strategy; recombinant factor VIIa; thromboelastometry; trauma	ACTIVATED FACTOR-VII; COAGULATION-FACTOR-VII; COAGULOPATHIC PATIENTS; MASSIVE TRANSFUSION; CELL TRANSFUSION; DOUBLE-BLIND; BLOOD; RFVIIA; MORTALITY; EFFICACY	Purpose of review Recombinant factor VIIa (rFVIIa) and thromboelastography have acquired increasing importance in patients with severe bleeding and coagulopathy. This article reviews the current opinions regarding their use, with the purpose of clarifying the ambiguities that exist in dealing with trauma patients. Recent findings Recent evidence encourages the early use of rFVIIa and thromboelastography in the severe trauma patient with hemorrhagic shock, as a component of the damage control strategy. rFVIIa may decrease short-term mortality and the rate of required blood components during resuscitation, with no apparent increase in thromboembolic complications. Thromboelastometry enables better and earlier recognition of the coagulopathy accompanying such trauma patients. In patients with traumatic brain injury and coagulopathy, rFVIIa may delay or even halt the need for surgery, with no proven decrease in mortality. In those who needed urgent neurosurgical intervention, rFVIIa may rapidly correct the coagulopathy, enabling earlier and safer surgical intervention. Summary Thromboelastometry may guide the medical staff when and to whom rFVIIa could be administered. Evidence also encourages the use of rFVIIa in traumatic brain injury. More research is required to prove decreases in mortality using both thromboelastography and rFVIIa in trauma, with a focus on clear end points and goal-directed therapy.	[Bartal, Carmi] Soroka Univ, Med Surg Intens Care Unit, Crit Care Dept, Med Ctr, Beer Sheva, Israel; [Yitzhak, Avraham] Soroka Univ, Surg Dept A, Div Surg, Med Ctr, Beer Sheva, Israel; [Yitzhak, Avraham] Ben Gurion Univ Negev, Fac Hlth Sci, IL-84105 Beer Sheva, Israel	Bartal, C (corresponding author), Soroka Univ, Med Surg Intens Care Unit, Crit Care Dept, Med Ctr, Beer Sheva, Israel.	carmibt@zahav.net.il		bartal, carmi/0000-0003-0894-5466			Bartal C, 2007, J TRAUMA, V63, P725, DOI 10.1097/TA.0b013e318031ccca; BEELKLEY AC, 2008, CRIT CARE MED, V36, pS267; Boffard KD, 2005, J TRAUMA, V59, P8, DOI 10.1097/01.TA.0000171453.37949.B7; Borgman MA, 2007, J TRAUMA, V63, P805, DOI 10.1097/TA.0b013e3181271ba3; Brohi K, 2003, J TRAUMA, V54, P1127, DOI 10.1097/01.TA.0000069184.82147.06; Brohi K, 2008, J TRAUMA, V64, P1211, DOI 10.1097/TA.0b013e318169cd3c; BUGLER E, 2002, CRIT CARE MED, V30, P1870; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Coats TJ, 2004, RESUSCITATION, V60, P101, DOI 10.1016/j.resuscitation.2003.08.001; DeLoughery TG, 2004, CRIT CARE CLIN, V20, P13, DOI 10.1016/S0749-0704(03)00089-7; Dutton RP, 2004, J TRAUMA, V57, P709, DOI 10.1097/01.TA.0000140646.66852.AB; GANTER MT, 2007, YB INTENSIVE CARE EM, P835; Goodnough LT, 2002, INTENS CARE MED, V28, pS221, DOI 10.1007/s00134-002-1468-2; Hansen Mads Koch, 2006, Ugeskr Laeger, V168, P3535; Hawryluk GWJ, 2006, J NEUROSURG, V105, P859, DOI 10.3171/jns.2006.105.6.859; Ho CH, 1998, TRANSFUSION, V38, P1011, DOI 10.1046/j.1537-2995.1998.38111299056308.x; Horton JD, 2008, AM SURGEON, V74, P413; HOYT DB, 1994, J TRAUMA, V37, P426, DOI 10.1097/00005373-199409000-00016; James KMH, 2008, ANESTH ANALG, V107, P402, DOI 10.1213/ane.0b013e3181770b87; Karadimov D, 2003, J NEUROSURG ANESTH, V15, P330, DOI 10.1097/00008506-200310000-00008; Kaufmann CR, 1997, J TRAUMA, V42, P716, DOI 10.1097/00005373-199704000-00023; Kenet G, 1999, LANCET, V354, P1879, DOI 10.1016/S0140-6736(99)05155-7; Kheirabadi BS, 2007, J TRAUMA, V63, P1079, DOI 10.1097/TA.0b013e31815885f1; Kozek-Langenecker S, 2007, MINERVA ANESTESIOL, V73, P401; KOZEKLANGENECKE.S, 2007, YB INTENSIVE CARE EM, P848; Levrat A, 2008, BRIT J ANAESTH, V100, P792, DOI 10.1093/bja/aen083; Lu J, 2005, ACT NEUR S, V95, P281; MacLeod JBA, 2003, J TRAUMA, V55, P39, DOI 10.1097/01.TA.0000075338.21177.EF; Malone DL, 2006, J TRAUMA, V60, pS91, DOI 10.1097/01.ta.0000199549.80731.e6; Marik PE, 2008, CRIT CARE MED, V36, P2667, DOI 10.1097/CCM.0b013e3181844677; Martinowitz U, 2005, J THROMB HAEMOST, V3, P640, DOI 10.1111/j.1538-7836.2005.01203.x; Martinowitz U, 2001, J TRAUMA, V50, P721, DOI 10.1097/00005373-200104000-00021; MATHIESEN T, 1995, ACTA NEUROL SCAND, V91, P208; Mayer SA, 2005, NEW ENGL J MED, V352, P777, DOI 10.1056/NEJMoa042991; Mayer SA, 2005, STROKE, V36, P74, DOI 10.1161/01.STR.0000149628.80251.b8; Mayer SA, 2003, STROKE, V34, P224, DOI 10.1161/01.STR.0000046458.67968.E4; Mayer SA, 2008, NEW ENGL J MED, V358, P2127, DOI 10.1056/NEJMoa0707534; Meng ZH, 2003, J TRAUMA, V55, P886, DOI 10.1097/01.TA.0000066184.20808.A5; Narayan RK, 2008, NEUROSURGERY, V62, P776, DOI 10.1227/01.NEU.0000297095.04013.C4; Nekludov M, 2007, J NEUROTRAUM, V24, P1699, DOI 10.1089/neu.2007.0322; Park P, 2003, NEUROSURGERY, V53, P34, DOI 10.1227/01.NEU.0000068830.54968.A8; Perkins JG, 2007, J TRAUMA, V62, P1095, DOI 10.1097/TA.0b013e31804798a4; Raobaikady R, 2005, BRIT J ANAESTH, V94, P586, DOI 10.1093/bja/aei102; Rizoli SB, 2006, J TRAUMA, V61, P1419, DOI 10.1097/01.ta.0000243045.56579.74; Rizoli SB, 2006, EXPERT OPIN BIOL TH, V6, P73, DOI 10.1517/14712598.6.1.73; Rugeri L, 2007, J THROMB HAEMOST, V5, P289, DOI 10.1111/j.1538-7836.2007.02319.x; SAUAIA A, 1995, J TRAUMA, V38, P185, DOI 10.1097/00005373-199502000-00006; Schreiber MA, 2004, CRIT CARE CLIN, V20, P101, DOI 10.1016/S0749-0704(03)00095-2; Schreiber MA, 2007, J AM COLL SURGEONS, V205, P541, DOI 10.1016/j.jamcollsurg.2007.05.007; Schurr MJ, 2004, J TRAUMA, V57, P718; Siddique MS, 2002, J NEUROSURG, V96, P86, DOI 10.3171/jns.2002.96.1.0086; Spinella PC, 2008, J TRAUMA, V64, P286, DOI 10.1097/TA.0b013e318162759f; Stein DM, 2008, J TRAUMA, V64, P620, DOI 10.1097/TA.0b013e3181650fc7; Stein DM, 2005, J TRAUMA, V59, P609, DOI 10.1097/01.ta.0000177655.67763.df; Stein SC, 2004, NEUROCRIT CARE, V1, P479, DOI 10.1385/NCC:1:4:479; Valeri CR, 2001, TRANSFUSION, V41, P977, DOI 10.1046/j.1537-2995.2001.41080977.x; Veldman A, 2003, CURR MED CHEM, V10, P797, DOI 10.2174/0929867033457728; VESHCHEV I, 2002, MED SCI MONITOR, V8, P98; Viuff D, 2008, BRIT J ANAESTH, V101, P324, DOI 10.1093/bja/aen175; Watts DD, 1998, J TRAUMA, V44, P846, DOI 10.1097/00005373-199805000-00017; Yasuda CL, 2003, ARQ NEURO-PSIQUIAT, V61, P1011, DOI 10.1590/S0004-282X2003000600023; Young G, 2007, BLOOD COAGUL FIBRIN, V18, P547, DOI 10.1097/MBC.0b013e328201c9a9; Yusim Y, 2006, J CLIN ANESTH, V18, P545, DOI 10.1016/j.jclinane.2006.02.012; Zygun DA, 2005, CRIT CARE MED, V33, P654, DOI 10.1097/01.ccm.0000155911.01844.54	64	17	18	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0952-7907	1473-6500		CURR OPIN ANESTHESIO	Curr. Opin. Anesthesiol.	APR	2009	22	2					281	288		10.1097/ACO.0b013e328325a6be			8	Anesthesiology	Anesthesiology	435MY	WOS:000265349200022	19390255				2021-06-18	
J	Fujii, Y; Tasaki, O; Yoshiya, K; Shiozaki, T; Ogura, H; Kuwagata, Y; Sugimoto, H; Sumi, Y				Fujii, Yoshiyuki; Tasaki, Osamu; Yoshiya, Kazuhisa; Shiozaki, Tadahiko; Ogura, Hiroshi; Kuwagata, Yasuyuki; Sugimoto, Hisashi; Sumi, Yuka			Evaluation of Posttraumatic Venous Sinus Occlusion With CT Venography	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						Cerebral venous sinus occlusion; Head trauma; Acute brain swelling; Skull fracture; Intracranial hypertension; Talk and deteriorate	CLOSED-HEAD-INJURY; THROMBOSIS	Background: Although cerebral venous sinus occlusion (CVSO) is reported to be associated with intracranial hypertension, its incidence or significance in head trauma is not clear. This study investigated with CT venography the incidence of posttraumatic CVSO, its clinical course, and relation to intracranial hypertension. Patients: This study comprised 97 consecutive patients admitted to our Trauma Center from 2002 through 2008 with skull fracture of the petrous portion of the temporal bone or that crossed the dural sinus. Patients with CVSO were examined with CT venography and followed up with CT venography or magnetic resonance imaging. The relation of CVSO to patient outcome and incidence of "talk and deteriorate" was also investigated. Results: CVSO was observed in 22 of 97 patients (22.4%). Mortality was significantly higher in the CVSO group versus no-CVSO group (50.0% vs. 9.3%, p < 0.001). Incidence of lethal intracranial hypertension was higher in the CVSO versus no-CVSO group (40.9% vs. 5.3%, p < 0.001), although there was no difference in Glasgow Coma Scale score at admission between the two groups (CVSO group, 8 +/- 5 vs. no-CVSO group, 10 +/- 4). Recanalization without treatment for CVSO occurred by 6 months in 9 of the 11 survivors (81.8%) who could be followed up. Conclusion: CVSO incidence after head injury was much higher than ever thought. It was associated with mortality and lethal intracranial hypertension, indicating that CVSO may induce acute increase in intracranial pressure in some cases. Early recognition of CVSO may be important to predict deterioration after admission and for starting immediate treatment.	[Fujii, Yoshiyuki; Tasaki, Osamu; Yoshiya, Kazuhisa; Shiozaki, Tadahiko; Ogura, Hiroshi; Kuwagata, Yasuyuki; Sugimoto, Hisashi] Osaka Univ, Grad Sch Med, Dept Traumatol & Acute Crit Med, Osaka, Japan; [Sumi, Yuka] Juntendo Univ, Urayasu Hosp, Emergency & Crit Care Ctr, Tokyo, Japan	Fujii, Y (corresponding author), Osaka Univ, Sch Med, 2-15 Yamadaoka, Suita, Osaka 5650871, Japan.	jan@v101.vaio.ne.jp			Ministry of Education, Culture, Sports, and Technology in JapanMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT) [19390459]; Labor Science's Research [H19-Iryou-Ippan-006]; Grants-in-Aid for Scientific ResearchMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI) [19390459] Funding Source: KAKEN	Supported by a Grant-in-aid for scientific research from the Ministry of Education, Culture, Sports, and Technology in Japan (no. 19390459); by Labor Science's Research Grant (Research on Medical Safety and Health Technology Assessment, H19-Iryou-Ippan-006).	*AM COLL SURG, 1999, ADV TRAUM LIF SUPP P; Barbati G, 2003, Minerva Anestesiol, V69, P919; Ferrera PC, 1998, AM J EMERG MED, V16, P382, DOI 10.1016/S0735-6757(98)90134-6; Ferro JM, 2004, STROKE, V35, P664, DOI 10.1161/01.STR.0000117571.76197.26; Kosinski CM, 2004, STROKE, V35, P2820, DOI 10.1161/01.STR.0000147045.71923.18; Kuether TA, 1998, NEUROSURGERY, V42, P1163, DOI 10.1097/00006123-199805000-00129; MARSHALL LF, 1991, J NEUROSURG, V75, pS28, DOI 10.3171/sup.1991.75.1s.0s28; Ochagavia AR, 1996, LANCET, V347, P1564, DOI 10.1016/S0140-6736(96)90721-7; Shigemori Y, 2007, SURG NEUROL, V68, P660, DOI 10.1016/j.surneu.2006.11.037; Shiozaki T, 2005, SHOCK, V23, P406, DOI 10.1097/01.shk.0000161385.62758.24; Wetzel SG, 1999, AM J NEURORADIOL, V20, P249; Yokota H, 2006, J NEUROSURG, V104, P849, DOI 10.3171/jns.2006.104.5.849	12	17	19	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	APR	2009	66	4					1002	1006		10.1097/TA.0b013e31819a0277			5	Critical Care Medicine; Surgery	General & Internal Medicine; Surgery	431KI	WOS:000265059800009	19359906				2021-06-18	
J	Itoh, T; Satou, T; Nishida, S; Tsubaki, M; Hashimoto, S; Ito, H				Itoh, Tatsuki; Satou, Takao; Nishida, Shozo; Tsubaki, Masahiro; Hashimoto, Shigeo; Ito, Hiroyuki			Improvement of cerebral function by anti-amyloid precursor protein antibody infusion after traumatic brain injury in rats	MOLECULAR AND CELLULAR BIOCHEMISTRY			English	Article						Amyloid precursor protein; Anti-APP antibody; Brain function; Traumatic brain injury; Water maze	CENTRAL-NERVOUS-SYSTEM; ALZHEIMERS-DISEASE; HEAD-INJURY; AXONAL INJURY; GLIAL-CELLS; NEUROFIBRILLARY TANGLES; NEURITE OUTGROWTH; BETA-SECRETASE; DAMAGED AXONS; EXPRESSION	We previously demonstrated the increased amyloid precursor protein (APP) immunoreactivity around the site of damage after traumatic brain injury (TBI). However, the function of APP after TBI has not been evaluated. In this study, we investigated the effects of direct infusion of an anti-APP antibody into the damaged brain region on cerebral function and morphological changes following TBI in rats. Three days after TBI, there were many TUNEL-positive neurons and astrocytes around the damaged region and a significantly greater number of TUNEL-positive cells in the PBS group compared with the anti-APP group found. Seven days after TBI, there were significantly a greater number of large glial fibrillary acidic protein-positive cells, long elongated projections, and microtubule-associated protein-2-positive cells around the damaged region in the anti-APP group compared with the PBS group found. Seven days after TBI, the region of brain damage was significantly smaller and the time to arrival at a platform was significantly shorter in the anti-APP group compared with the PBS group. Furthermore, after TBI in the anti-APP group, the time to arrival at the platform recovered to that observed in uninjured sham operation group rats. These data suggest that the overproduction of APP after TBI inhibits astrocyte activity and reduces neural cell survival around the damaged brain region, which speculatively may be related to the induction of Alzheimer disease-type dementia after TBI.	[Itoh, Tatsuki; Satou, Takao; Ito, Hiroyuki] Kinki Univ, Sch Med, Dept Pathol, Osaka 5898511, Japan; [Satou, Takao] Kinki Univ Hosp, Div Hosp Pathol, Osaka, Japan; [Satou, Takao] Kinki Univ, Div Sports Med, Inst Life Sci, Osaka 5898511, Japan; [Nishida, Shozo; Tsubaki, Masahiro] Kinki Univ, Sch Pharmaceut Sci, Osaka 5898511, Japan; [Hashimoto, Shigeo] PL Hosp, Dept Pathol, Osaka, Japan	Itoh, T (corresponding author), Kinki Univ, Sch Med, Dept Pathol, 377-2 Ohno Higashi, Osaka 5898511, Japan.	tatsuki@med.kindai.ac.jp			Grants-in-Aid for Scientific ResearchMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI) [20500472] Funding Source: KAKEN		Bechmann I, 2000, ANN NY ACAD SCI, V911, P192; Blasko I, 2004, J NEURAL TRANSM, V111, P523, DOI 10.1007/s00702-003-0095-6; BLUMBERGS PC, 1995, J NEUROTRAUM, V12, P565, DOI 10.1089/neu.1995.12.565; Bouron A, 2004, EUR J NEUROSCI, V20, P2071, DOI 10.1111/j.1460-9568.2004.03680.x; Chen XH, 2004, AM J PATHOL, V165, P357, DOI 10.1016/S0002-9440(10)63303-2; Davies SJA, 1999, J NEUROSCI, V19, P5810, DOI 10.1523/JNEUROSCI.19-14-05810.1999; Deller T, 2000, ANN NY ACAD SCI, V911, P207; Elvander E, 2004, NEUROSCIENCE, V126, P541, DOI 10.1016/j.neuroscience.2004.03.058; Feng Z, 2004, J PINEAL RES, V37, P129, DOI 10.1111/j.1600-079X.2004.00144.x; Gallo V, 2001, SCIENCE, V292, P872, DOI 10.1126/science.1060854; GENTLEMAN SM, 1993, NEUROSCI LETT, V160, P139, DOI 10.1016/0304-3940(93)90398-5; GOLDE TE, 1992, SCIENCE, V255, P728, DOI 10.1126/science.1738847; GOLDGABER D, 1987, SCIENCE, V235, P877, DOI 10.1126/science.3810169; Green-Sadan T, 2003, EUR J NEUROSCI, V18, P2093, DOI 10.1046/j.1460-9568.2003.02943.x; Hardy J, 1997, TRENDS NEUROSCI, V20, P154, DOI 10.1016/S0166-2236(96)01030-2; Ikonomovic MD, 2004, EXP NEUROL, V190, P192, DOI 10.1016/j.expneurol.2004.06.011; Itoh T, 2005, NEUROREPORT, V16, P1687, DOI 10.1097/01.wnr.0000183330.44112.ab; ITOH T, 2009, NEUROL RES IN PRESS; Itoh T, 2007, NEUROL RES, V29, P734, DOI 10.1179/016164107X208086; Jurynec MJ, 2003, MOL CELL NEUROSCI, V23, P69, DOI 10.1016/S1044-7431(03)00019-8; MASTERS CL, 1985, EMBO J, V4, P2757, DOI 10.1002/j.1460-2075.1985.tb04000.x; Matrone C, 2008, J ALZHEIMERS DIS, V13, P81; MATTSON MP, 1993, NEURON, V10, P243, DOI 10.1016/0896-6273(93)90315-I; Mills J, 1999, J NEUROCHEM, V72, P443, DOI 10.1046/j.1471-4159.1999.0720443.x; Murakami N, 1998, J NEUROTRAUM, V15, P993, DOI 10.1089/neu.1998.15.993; Nakagawa K, 2006, J NEUROCHEM, V96, P924, DOI 10.1111/j.1471-4159.2005.03595.x; NICOLL JAR, 1995, NAT MED, V1, P135, DOI 10.1038/nm0295-135; OTSUKA N, 1991, BRAIN RES, V568, P335, DOI 10.1016/0006-8993(91)91422-W; Pekny M, 2005, GLIA, V50, P427, DOI 10.1002/glia.20207; Pierce JES, 1996, J NEUROSCI, V16, P1083; ROBAKIS NK, 1987, P NATL ACAD SCI USA, V84, P4190, DOI 10.1073/pnas.84.12.4190; ROBERTS GW, 1994, J NEUROL NEUROSUR PS, V57, P419, DOI 10.1136/jnnp.57.4.419; ROBERTS GW, 1990, J NEUROL NEUROSUR PS, V53, P373, DOI 10.1136/jnnp.53.5.373; ROBERTS GW, 1988, LANCET, V2, P1456; RUDGE JS, 1990, J NEUROSCI, V10, P3594; RUMBLE B, 1989, NEW ENGL J MED, V320, P1446, DOI 10.1056/NEJM198906013202203; Schofield PW, 1997, J NEUROL NEUROSUR PS, V62, P119, DOI 10.1136/jnnp.62.2.119; SELKOE DJ, 1986, J NEUROCHEM, V46, P1820; Silver IA, 1997, NEUROSCIENCE, V78, P589, DOI 10.1016/S0306-4522(96)00600-8; Smith DH, 2003, NEUROMOL MED, V4, P59, DOI 10.1385/NMM:4:1-2:59; Vigo FS, 2009, NEUROBIOL AGING, V30, P1379, DOI 10.1016/j.neurobiolaging.2007.11.017; STEPHENSON DT, 1992, BRAIN RES, V593, P128, DOI 10.1016/0006-8993(92)91274-I; Stone JR, 2002, J NEUROTRAUM, V19, P601, DOI 10.1089/089771502753754073; Suh YH, 2002, PHARMACOL REV, V54, P469, DOI 10.1124/pr.54.3.469; Sun KH, 2004, APOPTOSIS, V9, P833, DOI 10.1023/B:APPT.0000045793.44842.e7; Thornton E, 2006, BRAIN RES, V1094, P38, DOI 10.1016/j.brainres.2006.03.107; Van den Heuvel C, 1999, EXP NEUROL, V159, P441, DOI 10.1006/exnr.1999.7150; Van den Heuvel C, 2004, J NEUROTRAUM, V21, P1562, DOI 10.1089/0897715042441783; Xiong Y, 2008, BRAIN RES, V1230, P247, DOI 10.1016/j.brainres.2008.06.127	49	17	17	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0300-8177			MOL CELL BIOCHEM	Mol. Cell. Biochem.	APR	2009	324	1-2					191	199		10.1007/s11010-008-0013-1			9	Cell Biology	Cell Biology	413HB	WOS:000263782400020	19130181				2021-06-18	
J	Street, D; Burge, S; Quadagno, J				Street, Debra; Burge, Stephanie; Quadagno, Jill			The Effect of Licensure Type on the Policies, Practices, and Resident Composition of Florida Assisted Living Facilities	GERONTOLOGIST			English	Article; Proceedings Paper	59th Annual Meeting of the Gerontological-Society-of-America	NOV 16-20, 2006	Dallas, TX	Gerontol Soc Amer		Long-term care; Residential care; Aging in place; Mental illness; Racial and ethnic minorities	MENTAL-ILLNESS; NURSING-HOMES; QUALITY; DECLINE; APPLES	Purpose: Most assisted living facility (ALF) residents are White widows in their mid- to late 80s who need assistance with activities of daily living (ADLs) because of frailty or cognitive decline. Yet, ALFs also serve younger individuals with physical disabilities, traumatic brain injury, or serious mental illness. We compare Florida ALFs with different licensure profiles by admission-discharge policies and resident population characteristics. Design and Methods: We use state administrative data and facility survey data from the Florida Study of Assisted Living (FSAL) to classify ALFs by licensure type and to determine how licensure influences ALF policies, practices, and resident population profiles. Results: Standard-licensed traditional ALFs primarily serve elderly White women with physical care needs and typically retain residents when their physical health deteriorates. Some ALFs that hold specialty licenses (extended congregate care and limited nursing services) offer extra physical care services and serve an older, more physically frail population with greater physical and cognitive challenges. ALFs with limited mental health (LMH) licenses serve clientele who are more racially and ethnically diverse, younger, and more likely to be men and single. LMH facilities also have a significant proportion of frail elder residents who live alongside these younger residents, including some who exhibit behavioral problems. LMH facilities also employ discharge policies that make it more difficult for frail elderly residents to age in place. implications: These differences by facility type raise important quality of life issues for both the frail elderly individuals and assisted living residents who do not fit the conventional demographic profile.	[Street, Debra] SUNY Buffalo, Dept Sociol, Buffalo, NY 14260 USA; [Burge, Stephanie] Univ Oklahoma, Dept Sociol, Norman, OK 73019 USA; [Quadagno, Jill] Florida State Univ, Dept Sociol, Pepper Inst Aging & Publ Policy, Tallahassee, FL 32306 USA	Street, D (corresponding author), SUNY Buffalo, Dept Sociol, 430 Pk Hall, Buffalo, NY 14260 USA.	dastreet@buffalo.edu					Ball MM, 2004, J GERONTOL B-PSYCHOL, V59, pS202, DOI 10.1093/geronb/59.4.S202; Ball MM, 2000, J APPL GERONTOL, V19, P304; Bishop CE, 1999, HEALTH AFFAIR, V18, P146, DOI 10.1377/hlthaff.18.4.146; BURBY RJ, 1990, J AM PLANN ASSOC, V56, P324, DOI 10.1080/01944369008975776; Chapin R, 2001, GERONTOLOGIST, V41, P43, DOI 10.1093/geront/41.1.43; Chou SC, 2003, GERONTOLOGIST, V43, P459, DOI 10.1093/geront/43.4.459; COHEN F, 1987, RES AGING, V9, P79, DOI 10.1177/0164027587009001004; *CTR MED MED SERV, 2005, NURS HOM DATA COMP 2; CUMMINGS C, 2004, J MENTAL HLTH AGING, V10, P151; DeJong G, 2002, MILBANK Q, V80, P261, DOI 10.1111/1468-0009.t01-1-00004; Frank JB., 2002, PARADOX AGING PLACE; Golant SM, 2004, J GERONTOL B-PSYCHOL, V59, pS68, DOI 10.1093/geronb/59.2.S68; Hawes C, 2003, GERONTOLOGIST, V43, P875, DOI 10.1093/geront/43.6.875; Hawes C., 2000, HIGH SERVICE HIGH PR; HAWES C, 1999, NATL STUDY ASSISTED; Hawes C, 2007, GERONTOLOGIST, V47, P40, DOI 10.1093/geront/47.Supplement_1.40; Hedrick S, 2007, GERONTOLOGIST, V47, P365, DOI 10.1093/geront/47.3.365; Hernandez M, 2007, GERONTOLOGIST, V47, P110, DOI 10.1093/geront/47.Supplement_1.110; Heumann LF, 1996, HOUS POLICY DEBATE, V7, P447; Kane RA, 2007, GERONTOLOGIST, V47, P125, DOI 10.1093/geront/47.Supplement_1.125; KELLAM S, 1992, C Q WEEKLY REP, V50, P23; Mechanic D, 2000, PSYCHIATR SERV, V51, P354, DOI 10.1176/appi.ps.51.3.354; MEHDIZADEH S, 2006, WHO STAYS WHO PAYS; Miller N, 2007, SOC SCI MED, V64, P303, DOI 10.1016/j.socscimed.2006.08.036; Mollica R. L., 2005, STATE RESIDENTIAL CA; *NAT CTR ASS LIV, 2008, ASS LIV STAT REG REV; SALMON J, 2004, 30347 USF FLOR POL E; SMITH V, 2004, CONTINUING MED BUDGE; STREET D, 2005, FLORIDA ASSISTED LIV; STREET D, 2004, NURSING HOME ASSISTE; STREET D, 2006, A0507 RC SUNY U BUFF; Street D, 2007, J GERONTOL B-PSYCHOL, V62, pS129, DOI 10.1093/geronb/62.2.S129; Zimmerman S, 2003, GERONTOLOGIST, V43, P107, DOI 10.1093/geront/43.suppl_2.107	33	17	17	1	9	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0016-9013	1758-5341		GERONTOLOGIST	Gerontologist	APR	2009	49	2					211	223		10.1093/geront/gnp022			13	Gerontology	Geriatrics & Gerontology	436GI	WOS:000265400300007	19363016	Green Published, Bronze			2021-06-18	
J	Pfleger, CCH; Koch-Henriksen, N; Stenager, E; Flachs, EM; Johansen, C				Pfleger, C. C. H.; Koch-Henriksen, N.; Stenager, E.; Flachs, E. M.; Johansen, C.			Head injury is not a risk factor for multiple sclerosis: a prospective cohort study	MULTIPLE SCLEROSIS JOURNAL			English	Article						craniocerebral trauma; epidemiology; head injury; head trauma; multiple sclerosis; pathogenesis; trauma	TRAUMA; REGISTRY; DENMARK	Background The idea of physical trauma being involved in the causation of multiple sclerosis ( MS) had been discussed since the earliest description of the illness. Despite the ongoing debate, the proposed association between physical and especially head trauma and MS failed to be proved or to be refuted conclusively. Objective To determine whether head trauma is associated with an increased risk of developing MS. Method A cohort of 150,868 subjects, 95,111 men, and 55,757 women registered in the National Danish Patient Registry with hospital admission for cerebral concussion, contusion, or skull fracture between 1977 and 1992, aged under 55, was selected. This trauma cohort was linked with the Danish MS Registry and followed up to the end of 1999 to retrieve subjects who had onset of MS after the year of the head trauma. We calculated the expected number of subjects, who, under a null-hypothesis, would subsequently develop MS, by using population age-, year-, and sex-specific MS-incidence densities from the Danish MS Registry. Results For men and women combined, the observed to expected number of MS cases (possible cases included) with onset after the head injury was 182/193.6 (standardized incidence ratio [SIR], 0.94; 95% CI, 0.81-1.09) and for possible MS excluded, 171/164.7 (SIR, 1.04; 95% CI, 0.89-1.21). In an analysis of a sub-cohort of 16,425 subjects with severe trauma ( contusion, traumatic cerebral hemorrhage, and base or skull fracture), the observed to expected numbers, including possible MS, were 15/15.3 (SIR, 0.98; 95% CI, 0.55-1.62) and with possible MS excluded, 13/12.9 (SIR, 1.01; 95% CI, 0.53-1.73). As for the total group and for any of the subgroups and for men and women separately, none of the SIRs differed statistically significantly from unity. Neither were there any trends, which could be missed by type II errors. Conclusion Head injury of any severity does not affect the risk of acquiring MS later in life. Multiple Sclerosis 2009; 15: 294-298. http://msj.sagepub.com	[Pfleger, C. C. H.; Koch-Henriksen, N.] Arhus Univ Hosp, Dept Neurol, DK-9000 Aalborg, Denmark; [Koch-Henriksen, N.; Stenager, E.; Flachs, E. M.] Danish Multiple Sclerosis Registry, Copenhagen, Denmark; [Stenager, E.] Sonderborg Hosp, Dept Neurol, Sonderborg, Denmark; [Flachs, E. M.] Univ So Denmark, Natl Inst Publ Hlth, Copenhagen, Denmark; [Johansen, C.] Danish Canc Soc, Danish Inst Canc Epidemiol, Copenhagen, Denmark	Pfleger, CCH (corresponding author), Arhus Univ Hosp, Dept Neurol, Ladegaardsgade 5, DK-9000 Aalborg, Denmark.	ccp@rn.dk	Johansen, Christoffer/AAG-7916-2020; Stenager, Egon/O-2275-2017; Stenager, Egon/AAU-4463-2020	Johansen, Christoffer/0000-0002-4384-206X; stenager, egon/0000-0002-4877-5193	Danish Multiple Sclerosis Society; Danish Multiple Sclerosis Registry; Danish Cancer SocietyDanish Cancer Society	The study was indirectly supported by the Danish Multiple Sclerosis Society by funding the maintenance of the Danish Multiple Sclerosis Registry. CJ was supported by the Danish Cancer Society.	ALTER M, 1968, NEUROLOGY, V18, P109, DOI 10.1212/WNL.18.2.109; Goldacre MJ, 2006, J NEUROL NEUROSUR PS, V77, P351, DOI 10.1136/jnnp.2005.077693; Goodin DS, 1999, NEUROLOGY, V52, P1737, DOI 10.1212/WNL.52.9.1737; HOFFMANN J, 1902, DTSCH Z NERVENHEILK, V21, P1; HYLLESTED K, 1956, THESIS COPENHAGEN; Inskip PD, 1998, CANCER CAUSE CONTROL, V9, P109, DOI 10.1023/A:1008861722901; JELLINEK EH, 1994, LANCET, V343, P1053, DOI 10.1016/S0140-6736(94)90178-3; Koch-Henriksen N, 1999, MULT SCLER, V5, P293, DOI 10.1191/135245899678846258; KOCHHENRIKSEN N, 1988, ACTA NEUROL SCAND, V78, P369, DOI 10.1111/j.1600-0404.1988.tb03672.x; KURLAND LEONARD T., 1954, ANN NEW YORK ACAD SCI, V58, P682, DOI 10.1111/j.1749-6632.1954.tb54106.x; KURLAND LT, 1994, ANN NEUROL, V36, pS33, DOI 10.1002/ana.410360711; LAUER K, 1994, NEUROLOGY, V44, P1360, DOI 10.1212/WNL.44.7.1360-a; MCALPINE D, 1952, Q J MED, V21, P135; MENDEL K, 1897, DEUT MED WOCHENSCHR, V7, P97; MILLAR J H, 1954, Ulster Med J, V23, P29; POSER CM, 1994, CLIN NEUROL NEUROSUR, V96, P103, DOI 10.1016/0303-8467(94)90042-6; POSER CM, 1983, ANN NEUROL, V13, P227, DOI 10.1002/ana.410130302; SIVA A, 1993, NEUROLOGY, V43, P1878, DOI 10.1212/WNL.43.10.1878; VONHOESSLIN R, 1934, UEBER MULTIPLE SKLER, P68	19	17	19	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1352-4585	1477-0970		MULT SCLER J	Mult. Scler. J.	MAR	2009	15	3					294	298		10.1177/1352458508099475			5	Clinical Neurology; Neurosciences	Neurosciences & Neurology	423AF	WOS:000264468100003	19028828				2021-06-18	
J	Tang, ME; Lobel, DA				Tang, Mary E.; Lobel, Darlene A.			Severe Traumatic Brain Injury: Maximizing Outcomes	MOUNT SINAI JOURNAL OF MEDICINE			English	Article						brain injury; brain mass lesions; brain tissue oxygenation; cerebral perfusion pressures; computed tomography; injury sequelae; secondary injury; seizures; severe injury; traumatic injury	HEAD-INJURY; VENOUS THROMBOEMBOLISM; CEREBRAL EDEMA; UNITED-STATES; MANAGEMENT; PROPHYLAXIS; PRESSURE; INFUSION; PROTOCOL; COMPLICATIONS	Severe traumatic brain injury is one of the leading causes of death and disability in the United States. The initial management of traumatic brain injury involves early resuscitation, computed tomography scanning, and surgical evacuation of mass lesions, when indicated. Recent research suggests that the prevention and treatment of secondary brain injury decrease mortality and improve outcomes. Specifically, treatment should address not only cerebral protection but also prevention of injury to other organ system. To achieve the best outcomes, attention must be focused on optimizing blood pressure and brain tissue oxygenation, maintaining adequate cerebral perfusion pressures, and preventing seizures. In addition, maximizing good outcomes depends on proactively addressing the risk of common sequelae of brain injury, including infection, deep venous thrombosis, and inadequate nutrition. Guidelines developed for the management of severe traumatic brain injury have dramatically improved functional neurological outcomes. Mt Sinai J Med 76:119-128, 2009 (C) 2009 Mount Sinai School of Medicine	[Lobel, Darlene A.] Univ Florida, Dept Neurosurg, Jacksonville, FL USA; [Tang, Mary E.] Univ Florida, Dept Emergency Med, Jacksonville, FL USA	Lobel, DA (corresponding author), Univ Florida, Dept Neurosurg, Jacksonville, FL USA.	darlene.lobel@jax.ufl.edu	Lobel, Darlene/H-4923-2012				Agnelli G, 1998, NEW ENGL J MED, V339, P80, DOI 10.1056/NEJM199807093390204; Ahmed Nasim, 2007, Surg Infect (Larchmt), V8, P343, DOI 10.1089/sur.2006.065; BORZOTTA AP, 1994, J TRAUMA, V37, P459, DOI 10.1097/00005373-199409000-00022; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Carlile MC, 2006, J HEAD TRAUMA REHAB, V21, P483, DOI 10.1097/00001199-200611000-00003; Chang BS, 2003, NEUROLOGY, V60, P10, DOI 10.1212/01.WNL.0000031432.05543.14; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; CLIFTON GL, 1986, J NEUROSURG, V64, P895, DOI 10.3171/jns.1986.64.6.0895; Dasic D, 2006, BRIT J NEUROSURG, V20, P296, DOI 10.1080/02688690600999901; DEUTSCHMAN CS, 1986, J NEUROSURG, V64, P89, DOI 10.3171/jns.1986.64.1.0089; Fakhry SM, 2004, J TRAUMA, V56, P492, DOI 10.1097/01.TA.0000115650.07193.66; Faul M, 2007, J TRAUMA, V63, P1271, DOI 10.1097/TA.0b013e3181493080; French JA, 2004, EPILEPSIA, V45, P401, DOI 10.1111/j.0013-9580.2004.06204.x; GOODPASTURE HC, 1977, J NEUROSURG, V47, P228, DOI 10.3171/jns.1977.47.2.0228; HELLING TS, 1988, J TRAUMA, V28, P1575, DOI 10.1097/00005373-198811000-00009; Hesdorffer DC, 2007, J TRAUMA, V63, P841, DOI 10.1097/TA.0b013e318123fc21; Jones KE, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E3; JONES PA, 1994, J NEUROSURG ANESTH, V6, P4; Kakarla UK, 2008, NEUROSURGERY, V63, P162, DOI 10.1227/01.NEU.0000312390.83127.7F; Kang TM, 2002, ANN PHARMACOTHER, V36, P1453; KLEINSCHMIDTDEMASTERS BK, 1981, SCIENCE, V211, P1068, DOI 10.1126/science.7466381; Knudson MM, 2004, ANN SURG, V240, P490, DOI 10.1097/01.sla.0000137138.40116.6c; LAM AM, 1991, J NEUROSURG, V75, P545, DOI 10.3171/jns.1991.75.4.0545; Lee TT, 1997, ACTA NEUROCHIR, V139, P1042, DOI 10.1007/BF01411558; LOSSIUS MI, 2008, EPILEPSY CURR, V4, P90; Manley G, 2001, ARCH SURG-CHICAGO, V136, P1118, DOI 10.1001/archsurg.136.10.1118; MARMAROU A, 1991, J NEUROSURG, V75, pS59, DOI 10.3171/sup.1991.75.1s.0s59; Muzha I, 2004, LANCET, V364, P1321, DOI 10.1016/s0140-6736(04)17188-2; NARAYAN RK, 1982, J NEUROSURG, V56, P650, DOI 10.3171/jns.1982.56.5.0650; Norwood SH, 2002, ARCH SURG-CHICAGO, V137, P696, DOI 10.1001/archsurg.137.6.696; Page RB, 2004, NEUROSURGERY, V54, P143, DOI 10.1227/01.NEU.0000097514.60813.1B; PICKARD JD, 1993, J NEUROL NEUROSUR PS, V56, P845, DOI 10.1136/jnnp.56.8.845; PIEK J, 1992, J NEUROSURG, V77, P901, DOI 10.3171/jns.1992.77.6.0901; Qureshi AI, 1999, J TRAUMA, V47, P659, DOI 10.1097/00005373-199910000-00009; Qureshi AI, 1998, CRIT CARE MED, V26, P440, DOI 10.1097/00003246-199803000-00011; Qureshi AI, 2000, CRIT CARE MED, V28, P3301, DOI 10.1097/00003246-200009000-00032; RAPP RP, 1983, J NEUROSURG, V58, P906, DOI 10.3171/jns.1983.58.6.0906; ROSNER MJ, 1995, J NEUROSURG, V83, P949, DOI 10.3171/jns.1995.83.6.0949; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Sirvent JM, 1997, AM J RESP CRIT CARE, V155, P1729, DOI 10.1164/ajrccm.155.5.9154884; Stocchetti N, 1996, J TRAUMA, V40, P764, DOI 10.1097/00005373-199605000-00014; Sugerman HJ, 1997, J TRAUMA, V43, P741, DOI 10.1097/00005373-199711000-00002; Temkin N R, 1991, Neurosurg Clin N Am, V2, P425; Valadka AB, 2007, NEUROSURGERY, V61, P203, DOI 10.1227/01.NEU.0000255497.26440.01; Wang HC, 2008, J TRAUMA, V64, P883, DOI 10.1097/TA.0b013e31804a7fa4; WOSTER PS, 1990, CLIN PHARMACY, V9, P762; YOUNG B, 1987, J NEUROSURG, V67, P668, DOI 10.3171/jns.1987.67.5.0668; Zhong J, 2003, NEUROL RES, V25, P339, DOI 10.1179/016164103101201661	48	17	19	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0027-2507	1931-7581		MT SINAI J MED	Mt. Sinai J. Med.	MAR-APR	2009	76	2					119	128		10.1002/msj.20106			10	Medicine, General & Internal	General & Internal Medicine	427OE	WOS:000264787800005	19306369				2021-06-18	
J	Doorly, MC; Gilchrist, MD				Doorly, M. C.; Gilchrist, M. D.			Three-dimensional multibody dynamics analysis of accidental falls resulting in traumatic brain injury	INTERNATIONAL JOURNAL OF CRASHWORTHINESS			English	Article						brain injury; accident; fall; multibody dynamics modelling	HEAD; RECONSTRUCTION; BIOMECHANICS	Clinical, physical and mechanical details of one of a set of ten real-world accidental falls which resulted in non-fatal head impact injury in the form of various traumatic brain lesions are presented herein. These are analysed and described in depth in this paper, along with the accompanying time profiles of linear and angular velocities of all 10 accident cases, which were predicted using multibody dynamics modelling simulations. It is suggested that these cases could usefully constitute the basis of a database of documented head injury cases that may be of use to the wider research community. As such, these are freely available to those researchers who would wish to use this set of data upon direct request to the authors.	[Doorly, M. C.; Gilchrist, M. D.] Univ Coll Dublin, Sch Elect Elect & Mech Engn, Dublin 2, Ireland	Gilchrist, MD (corresponding author), Univ Coll Dublin, Sch Elect Elect & Mech Engn, Dublin 2, Ireland.	michael.gilchrist@ucd.ie	Gilchrist, Michael D/B-6100-2017	Gilchrist, Michael D/0000-0003-1765-429X			AUER C, 2001, P INT SOC BIOM 18 C; CANTON B, 2003, THESIS U COLL DUBLIN; COLGAN N, 2006, P 7 INT S BIOM BIOM; DOORLY M, 2004, INT C CRASHW SAN FRA; Doorly M. C., 2006, Computer Methods in Biomechanics and Biomedical Engineering, V9, P371, DOI 10.1080/10255840601003551; Doorly M.C., 2007, THESIS U COLL DUBLIN; Doorly MC, 2005, SOLID MECH APPL, V124, P431; GENNARELLI TA, 1982, J TRAUMA, V22, P680, DOI 10.1097/00005373-198208000-00005; Gilchrist MD, 2000, COMPUT MECH, V26, P229, DOI 10.1007/s004660000179; Gilchrist MD, 2004, STRAIN, V40, P180, DOI 10.1111/j.1475-1305.2004.00168.x; Gilchrist MD, 2003, KEY ENG MATER, V245-2, P417, DOI 10.4028/www.scientific.net/KEM.245-246.417; Gilchrist MD, 2001, INT J CRASHWORTHINES, V6, P253, DOI 10.1533/cras.2001.0176; GILCHRIST MD, 2005, IMPACT BIOMECHANICS; GILCHRIST MD, 2004, P 6 INT S BIOM BIOM; GILCHRIST MD, 2009, PATHOMECHANICS TISSU, P19; Horgan T, 2005, THESIS U COLL DUBLIN; Horgan TJ, 2004, INT J CRASHWORTHINES, V9, P401, DOI 10.1533/ijcr.2004.0299; Horgan TJ, 2003, INT J CRASHWORTHINES, V8, P353, DOI 10.1533/cras.8.4.353.19278; HORGAN TJ, 2003, P IRCOBI C BIOM IMP, P347; HORGAN TJ, 2004, P 6 INT S BIOM BIOM; HORGAN TJ, 2004, INT C CRASHW SAN FRA; Kleiven S, 2003, J NEUROTRAUM, V20, P365, DOI 10.1089/089771503765172327; Neal-Sturgess CE, 2002, P I MECH ENG D-J AUT, V216, P883, DOI 10.1243/095440702321031432; Newman J, 2000, P 44 STAPP CAR CRASH; O'Donoghue D, 1998, IRISH J MED SCI, V167, P263; O'Riordain K, 2003, CLIN BIOMECH, V18, P590, DOI 10.1016/S0268-0033(03)00111-6; ODONOGHUE D, 1999, THESIS U COLL DUBLIN; ORIORDAIN K, 2002, THESIS U COLL DUBLIN; Smyth A, 2005, SOLID MECH APPL, V124, P393; SMYTH A, 2006, P 11 INT INV MET CAG, P369; THOMAS PM, 2002, IRISH J MED SCI, V171, P73; THOMSON R, P 2001 INT RES COUNC; *TNO AUT, 2004, MADYMO 6 2 1; YOGANANDAN N, 1995, J NEUROTRAUM, V12, P659, DOI 10.1089/neu.1995.12.659; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446	35	17	17	0	3	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1358-8265	1754-2111		INT J CRASHWORTHINES	Int. J. Crashworthiness		2009	14	5					503	509	PII 915135264	10.1080/13588260902826554			7	Engineering, Manufacturing; Engineering, Mechanical	Engineering	497IM	WOS:000270052400011					2021-06-18	
S	Fins, JJ		Schiff, ND; Laureys, S		Fins, Joseph J.			Being Conscious of Their Burden Severe Brain Injury and the Two Cultures Challenge	DISORDERS OF CONSCIOUSNESS	Annals of the New York Academy of Sciences		English	Article; Proceedings Paper	87th Annual Conference of the Association-for-Reseach-in-Nervous-and-Mental-Disease	DEC 07-08, 2007	New York Acad Med, New York, NY	Assoc Res Nervous & Mental Dis	New York Acad Med	medical ethics; neuroethics; disorders of consciousness; persistent vegetative state; minimally conscious state; traumatic brain injury	VEGETATIVE STATE; LATE RECOVERY; LIFE; DISORDERS; DIAGNOSIS; END; STIMULATION; NEUROETHICS; CARE	Writing 50 years after the publication of C. R Snow's Two Cultures and The Scientific Revolution, this paper considers the many cultures that have to intersect to sustain and deepen the advances in the diagnosis and treatment of patients with disorders of consciousness. To bridge this "two-culture divide," the paper contextualizes scientific developments in this field within work in medical ethics and the humanities. The author asserts that this line of inquiry cannot go forward responsibly absent input from the humanities and an appreciation of the lived experiences of patients and families who confront the quotidian and existential challenges of severe brain injury.	Cornell Univ, Div Med Eth, New York Presbyterian Weill Cornell Med Ctr, Weill Med Coll, New York, NY 10021 USA	Fins, JJ (corresponding author), Cornell Univ, Div Med Eth, New York Presbyterian Weill Cornell Med Ctr, Weill Med Coll, 435 E 70th St,Suite 4-J, New York, NY 10021 USA.	jjfins@med.cornell.edu					Andrews K, 1996, BRIT MED J, V313, P13, DOI 10.1136/bmj.313.7048.13; Annas GJ, 2005, NEW ENGL J MED, V352, P1710, DOI 10.1056/NEJMlim050643; [Anonymous], 2007, BBC NEWS        1027; ARROYO J, 2002, GUARDIAN        0731; ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; Bauby J-D., 1997, DIVING BELL BUTTERFL; BERENSON A, 2007, ARMYS AGGRESSIVE SUR; BILMES L, 2006, 12054 NAT BUR EC RES; BLAKE R, 2007, DAY D HERBERT WOKE; Brody H, 1992, HEALERS POWER; Carey Benedict, 2005, N Y Times Web; CHILDS NL, 1993, NEUROLOGY, V43, P1465, DOI 10.1212/WNL.43.8.1465; Christakis N.A., 1999, DEATH FORETOLD PROPH; Drazen JM, 2005, NEW ENGL J MED, V352, P2121, DOI 10.1056/NEJMe048332; Fins JJ, 1999, J PAIN SYMPTOM MANAG, V17, P6, DOI 10.1016/S0885-3924(98)00109-2; Fins JJ, 2005, PROG BRAIN RES, V150, P565, DOI 10.1016/S0079-6123(05)50040-2; Fins JJ, 2005, NEW YORK REV BOOKS, V52, P63; Fins JJ, 2004, ARCH NEUROL-CHICAGO, V61, P1354, DOI 10.1001/archneur.61.9.1354; Fins JJ, 2003, NAT REV NEUROSCI, V4, P323, DOI 10.1038/nrn1079; Fins JJ, 2005, HASTINGS CENT REP, V35, P22, DOI 10.1353/hcr.2005.0020; Fins JJ, 2000, NEUROL RES, V22, P273; FINS JJ, 2008, JAMA-J AM MED ASSOC, V299, P959; Fins JJ, 2006, PALLIATIVE ETHIC CAR; Fins JJ., 2007, PLUM POSNERS DIAGNOS; Fins JJ, 2008, AM J BIOETHICS, V8, P46, DOI 10.1080/15265160802334490; Fins JJ, 2008, AM J BIOETHICS, V8, P3, DOI 10.1080/15265160802318113; Fins JJ, 2006, HASTINGS CENT REP, V36, P8, DOI 10.1353/hcr.2006.0094; Fins JJ, 2007, ARCH NEUROL-CHICAGO, V64, P1400, DOI 10.1001/archneur.64.10.1400; Fins JJ, 2007, AM J BIOETHICS, V7, P51, DOI 10.1080/15265160601064231; Fins Joseph J, 2006, Palliat Support Care, V4, P169; Fins JJ, 2007, NEUROLOGY, V68, P304, DOI 10.1212/01.wnl.0000252376.43779.96; Fins JJ, 2007, NEUROLOGY, V68, P79, DOI 10.1212/01.wnl.0000253019.00880.72; Freud Sigmund, 1965, INTERPRETATION DREAM; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; GLASSER R, 2007, SHOCK WAVE BRAIN INJ; GROOPMAN J, 2007, NEW YORKER      1015; HOLLAND NH, 1998, J PSYCHOL STUDY ARTS; Ivins BJ, 2006, NEUROEPIDEMIOLOGY, V27, P154, DOI 10.1159/000096127; Jones E, 1957, LIFE WORK SIGMUND FR; JONSEN A, 2002, NEUROETHICS MAPPING, P273; Kobylarz EJ, 2005, NEUROPSYCHOL REHABIL, V15, P323, DOI 10.1080/09602010443000605; Lammi MH, 2005, ARCH PHYS MED REHAB, V86, P746, DOI 10.1016/j.apmr.2004.11.004; Laureys S, 2000, BRAIN, V123, P1589, DOI 10.1093/brain/123.8.1589; Laureys S, 2008, NEUROLOGY, V70, pE14, DOI 10.1212/01.wnl.0000303264.66049.c1; Leon-Carrion J, 2002, BRAIN INJURY, V16, P571, DOI 10.1080/02699050110119781; *MULT TASK FORC PV, 1994, NEW ENGL J MED, P1572; Naccache L, 2006, SCIENCE, V313, P1395, DOI 10.1126/science.1132881; *NERVECENTER, 2006, ANN NEUROL, pA13; OCONNOR A, 2005, NY TIMES        0504; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; ORSZAG PR, 2007, SENATE REPORT, P110; Owen AM, 2006, SCIENCE, V313, P1402, DOI 10.1126/science.1130197; PASCRELL W, 2006, 2 FED INT C TRAUM BR; Posner J., 2007, PLUM POSNERS DIAGNOS, V4; Ragnarsson KT, 1999, JAMA-J AM MED ASSOC, V282, P974; Rees PM, 2007, LANCET, V369, P512, DOI 10.1016/S0140-6736(07)60238-4; Schiff ND, 2007, NATURE, V448, P600, DOI 10.1038/nature06041; Schiff ND, 2005, NEUROLOGY, V64, P514, DOI 10.1212/01.WNL.0000150883.10285.44; SCHIFF ND, 2003, CEREBRUM, V5, P7; Schwaber P, 1976, Psychoanal Study Child, V31, P515; Snow C.P., 1964, 2 CULTURES 2 LOOK; Snow C. P., 1959, 2 CULTURES SCI REVOL; SOLOMON MZ, 1993, AM J PUBLIC HEALTH, V83, P14, DOI 10.2105/AJPH.83.1.14; Tavalaro J, 1997, LOOK YES; TAYLOR M, 2007, GUARDIAN        1027; THOMAS L, 1983, YOUNGEST SCI; Voss HU, 2006, J CLIN INVEST, V116, P2005, DOI 10.1172/JCI27021; WALLIS A, 2007, COMMUNICATION   0904; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Wijdicks EFM, 2007, NEUROLOGY, V68, P1092, DOI 10.1212/01.wnl.0000259401.36220.1a; Wilson FC, 2002, NEUROREHABILITATION, V17, P231; Wolfson J, 2005, HASTINGS CENT REP, V35, P16, DOI 10.1353/hcr.2005.0071; 2007, J TRAUMD, V62, P103	73	17	18	0	7	WILEY-BLACKWELL	MALDEN	COMMERCE PLACE, 350 MAIN STREET, MALDEN 02148, MA USA	0077-8923		978-1-57331-743-6	ANN NY ACAD SCI	Ann.NY Acad.Sci.		2009	1157						131	147		10.1111/j.1749-6632.2009.04473.x			17	Multidisciplinary Sciences; Neurosciences	Science & Technology - Other Topics; Neurosciences & Neurology	BJH38	WOS:000265826300012	19351362				2021-06-18	
J	Janowski, M; Date, I				Janowski, Miroslaw; Date, Isao			Systemic Neurotransplantation - A Problem-Oriented Systematic Review	REVIEWS IN THE NEUROSCIENCES			English	Article						systemic; neurotransplantation; intravenous; stem cells; cell therapy; neurological disorders	MARROW STROMAL CELLS; CORD BLOOD-CELLS; TRAUMATIC BRAIN-INJURY; MESENCHYMAL STEM-CELLS; CEREBRAL-ISCHEMIA MODEL; ADULT-RAT BRAIN; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; AMYOTROPHIC-LATERAL-SCLEROSIS; COLONY-STIMULATING FACTOR; TRANSPLANTED BONE-MARROW	Systemic neurotransplantation (SNT) was introduced in the laboratory in 2000 and currently it is being widely examined in animal models of neurological disorders. The aim of this systematic review was to evaluate the current state of knowledge in the field of experimental SNT and the premise for the introduction of clinical trials. PubMed was searched and 60 articles utilizing an SNT approach were found and subjected to analysis. The time window for cell transplantation was addressed in only two studies, with contradictory results. Immunosuppression was applied in 25% of studies. No study addressed the justification for immunosuppression. Bone marrow was the most frequent source of grafted cells, followed by cord blood and then by cells of embryonic origin. Studies investigating dose-dependency revealed no satisfactory results with transplantation of less than 106 cells/animal; the efficient dose most frequently ranged from 10(6) - 10(7) cells/animal (mice and rats). The behavioral effects of cell transplantation were assessed in 75% of all studies; significant improvement was achieved in 95% of them. Morphological effect was evaluated in half of the studies; significant positive effect was achieved in 73% of them. Experimental attempts to elucidate the mechanisms mediating cell-dependent effect were not undertaken in half of the studies. In the other half, the most frequent mechanisms were growth factors, neurogenesis and immunomodulation. SNT still seems to be at the very initial stage of development. Many critical factors have not been sufficiently addressed in laboratory studies and they must be clarified before the introduction of clinical trials.	[Janowski, Miroslaw] Polish Acad Sci, Med Res Ctr, Dept NeuroRepair, PL-02106 Warsaw, Poland; [Janowski, Miroslaw] Med Univ Warsaw, Dept Neurosurg, Warsaw, Poland; [Date, Isao] Okayama Univ, Dept Neurol Surg, Grad Sch Med Dent & Pharmaceut Sci, Okayama, Japan	Janowski, M (corresponding author), Polish Acad Sci, Med Res Ctr, Dept NeuroRepair, Pawinskiego 5, PL-02106 Warsaw, Poland.	mjanowsk@amwaw.edu.pl			Polish Ministry of Scientific Research and Higher EducationMinistry of Science and Higher Education, Poland [2P05/A05430]	The authors express their appreciation to Prof Krystyna Domanska-Janik, Head of the Department of NeuroRepair. Medical Research Center, Warsaw, Poland, for critical review of the manuscript. This study was supported by the Polish Ministry of Scientific Research and Higher Education, grant no. 2P05/A05430.	Bang OY, 2005, ANN NEUROL, V57, P874, DOI 10.1002/ana.20501; BJORKLUND A, 1979, BRAIN RES, V177, P555, DOI 10.1016/0006-8993(79)90472-4; Borlongan CV, 2004, STROKE, V35, P2385, DOI 10.1161/01.STR.0000141680.49960.d7; Buzanska L, 2002, J CELL SCI, V115, P2131; Chen JL, 2001, STROKE, V32, P2682, DOI 10.1161/hs1101.098367; Chen JL, 2003, J NEUROSCI RES, V73, P778, DOI 10.1002/jnr.10691; Chen JL, 2003, CIRC RES, V92, P692, DOI 10.1161/01.RES.0000063425.51108.8D; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; Chen Ruifeng, 2000, Journal of Medicine (Westbury), V31, P21; Chen SH, 2006, EXP NEUROL, V199, P67, DOI 10.1016/j.expneurol.2005.11.015; Chen SH, 2005, CRIT CARE MED, V33, P1377, DOI 10.1097/01.CCM.0000165966.28936.89; Chu K, 2005, NEUROSCI RES, V53, P384, DOI 10.1016/j.neures.2005.08.010; Chu K, 2004, NEUROSCI RES, V50, P459, DOI 10.1016/j.neures.2004.08.015; Chu K, 2004, BRAIN RES, V1023, P213, DOI 10.1016/j.brainres.2004.07.045; Chu K, 2003, NEUROSCI LETT, V343, P129, DOI 10.1016/S0304-3940(03)00174-5; Chu K, 2004, BRAIN RES, V1016, P145, DOI 10.1016/j.brainres.2004.04.038; Conti L, 2006, BRAIN PATHOL, V16, P143, DOI 10.1111/j.1750-3639.2006.00009.x; Corti S, 2005, FASEB J, V19, P1860, DOI 10.1096/fj.05-4170fje; Corti S, 2004, BRAIN, V127, P2518, DOI 10.1093/brain/awh273; Coyne TM, 2006, STEM CELLS, V24, P2483, DOI 10.1634/stemcells.2006-0174; Eclancher F, 1996, BRAIN RES, V737, P201, DOI 10.1016/0006-8993(96)00732-9; Ekdahl CT, 2003, P NATL ACAD SCI USA, V100, P13632, DOI 10.1073/pnas.2234031100; Eliopoulos N, 2005, BLOOD, V106, P4057, DOI 10.1182/blood-2005-03-1004; Ende N, 2000, LIFE SCI, V67, P53, DOI 10.1016/S0024-3205(00)00602-0; Ende Norman, 2002, Journal of Medicine (Westbury), V33, P173; Ende Norman, 2001, Journal of Medicine (Westbury), V32, P231; Ende Norman, 2001, Journal of Medicine (Westbury), V32, P241; Fujiwara Y, 2004, NEUROSCI LETT, V366, P287, DOI 10.1016/j.neulet.2004.05.080; Garbuzova-Davis S, 2003, J HEMATOTH STEM CELL, V12, P255, DOI 10.1089/152581603322022990; Honma T, 2006, EXP NEUROL, V199, P56, DOI 10.1016/j.expneurol.2005.05.004; Horita Y, 2006, J NEUROSCI RES, V84, P1495, DOI 10.1002/jnr.21056; Iihoshi S, 2004, BRAIN RES, V1007, P1, DOI 10.1016/j.brainres.2003.09.084; Jendelova P, 2003, MAGNET RESON MED, V50, P767, DOI 10.1002/mrm.10585; Jendelova P, 2004, J NEUROSCI RES, V76, P232, DOI 10.1002/jnr.20041; Jeong SW, 2003, STROKE, V34, P2258, DOI 10.1161/01.STR.0000083698.20199.1F; Jin HK, 2003, MOL THER, V8, P876, DOI 10.1016/j.ymthe.2003.07.008; Jin KL, 2005, NEUROBIOL DIS, V18, P366, DOI 10.1016/j.nbd.2004.10.010; Kang SK, 2006, STEM CELLS DEV, V15, P583, DOI 10.1089/scd.2006.15.583; Lee RH, 2006, BLOOD, V107, P2153, DOI 10.1182/blood-2005-07-2701; Lee ST, 2006, J NEUROSCI METH, V152, P250, DOI 10.1016/j.jneumeth.2005.09.013; Lee ST, 2005, NEUROSCI RES, V52, P243, DOI 10.1016/j.neures.2005.03.016; Li Y, 2006, EXP NEUROL, V198, P313, DOI 10.1016/j.expneurol.2005.11.029; Li Y, 2002, NEUROLOGY, V59, P514, DOI 10.1212/WNL.59.4.514; Lichtenwalner RJ, 2006, J CEREBR BLOOD F MET, V26, P1, DOI 10.1038/sj.jcbfm.9600170; Lindvall O, 2005, KIDNEY INT, V68, P1937, DOI 10.1111/j.1523-1755.2005.00623.x; Lindvall O, 2006, NATURE, V441, P1094, DOI 10.1038/nature04960; Liu H, 2006, BRAIN, V129, P2734, DOI 10.1093/brain/awl207; Lu D, 2001, NEUROREPORT, V12, P559, DOI 10.1097/00001756-200103050-00025; Lu DY, 2001, J NEUROTRAUM, V18, P813, DOI 10.1089/089771501316919175; Mahmood A, 2006, J NEUROSURG, V104, P272, DOI 10.3171/jns.2006.104.2.272; Mahmood A, 2004, NEUROSURGERY, V55, P1185, DOI 10.1227/01.NEU.0000141042.14476.3C; Mahmood A, 2004, J NEUROTRAUM, V21, P33, DOI 10.1089/089771504772695922; Mahmood A, 2003, NEUROSURGERY, V53, P697, DOI 10.1227/01.NEU.0000079333.61863.AA; Mahmood A, 2001, NEUROSURGERY, V49, P1196, DOI 10.1097/00006123-200111000-00031; Mahmood A, 2003, NEUROSURGERY, V53, P702; Makinen S, 2006, BRAIN RES, V1123, P207, DOI 10.1016/j.brainres.2006.09.056; Moon LDF, 2001, EUR J NEUROSCI, V14, P1667, DOI 10.1046/j.0953-816x.2001.01795.x; Nakano K, 2001, TRANSPLANTATION, V71, P1735, DOI 10.1097/00007890-200106270-00006; Newcomb JD, 2006, CELL TRANSPLANT, V15, P213, DOI 10.3727/000000006783982043; Newman MB, 2005, STEM CELLS DEV, V14, P576, DOI 10.1089/scd.2005.14.576; Nomura T, 2005, NEUROSCIENCE, V136, P161, DOI 10.1016/j.neuroscience.2005.06.062; Offner H, 2006, J CEREBR BLOOD F MET, V26, P654, DOI 10.1038/sj.jcbfm.9600217; Offner H, 2006, J IMMUNOL, V176, P6523, DOI 10.4049/jimmunol.176.11.6523; Pan Y, 2005, EXP NEUROL, V192, P365, DOI 10.1016/j.expneurol.2004.11.011; Park KW, 2001, NEUROSCI RES, V40, P315, DOI 10.1016/S0168-0102(01)00242-5; PERLOW MJ, 1979, SCIENCE, V204, P643, DOI 10.1126/science.571147; Pluchino S, 2003, NATURE, V422, P688, DOI 10.1038/nature01552; Prass K, 2003, J EXP MED, V198, P725, DOI 10.1084/jem.20021098; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; Ruffini F, 2001, GENE THER, V8, P1207, DOI 10.1038/sj.gt.3301523; SALTHOUSE TN, 1964, STAIN TECHNOL, V39, P123; Saporta S, 2003, J HEMATOTH STEM CELL, V12, P271, DOI 10.1089/152581603322023007; Seyfried D, 2006, J NEUROSURG, V104, P313, DOI 10.3171/jns.2006.104.2.313; Shen LH, 2006, NEUROSCIENCE, V137, P393, DOI 10.1016/j.neuroscience.2005.08.092; Shen LH, 2007, J CEREBR BLOOD F MET, V27, P6, DOI 10.1038/sj.jcbfm.9600311; Sykova E, 2006, CELL MOL NEUROBIOL, V26, P1113, DOI 10.1007/s10571-006-9007-2; Taguchi A, 2004, J CLIN INVEST, V114, P330, DOI 10.1172/jci200420622; Taguchi A, 2007, EUR J NEUROSCI, V26, P126, DOI 10.1111/j.1460-9568.2007.05640.x; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Urdzikova L, 2006, J NEUROTRAUM, V23, P1379, DOI 10.1089/neu.2006.23.1379; Vendrame M, 2004, STROKE, V35, P2390, DOI 10.1161/01.STR.0000141681.06735.9b; Vendrame M, 2005, STEM CELLS DEV, V14, P595, DOI 10.1089/scd.2005.14.595; Vendrame M, 2006, EXP NEUROL, V199, P191, DOI 10.1016/j.expneurol.2006.03.017; Willing AE, 2003, J NEUROSCI RES, V73, P296, DOI 10.1002/jnr.10659; Willing AE, 2003, CELL TRANSPLANT, V12, P449, DOI 10.3727/000000003108746885; Xiao J, 2005, STEM CELLS DEV, V14, P722, DOI 10.1089/scd.2005.14.722; Yang G, 2006, TRANSPL IMMUNOL, V16, P166, DOI 10.1016/j.trim.2006.08.001; Young PP, 2004, EXP NEUROL, V188, P104, DOI 10.1016/j.expneurol.2004.03.007; Zhang J, 2006, J NEUROSCI RES, V84, P587, DOI 10.1002/jnr.20962; Zhang ZG, 2000, J CLIN INVEST, V106, P829, DOI 10.1172/JCI9369	90	17	17	0	11	WALTER DE GRUYTER GMBH	BERLIN	GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY	0334-1763	1607-8470		REV NEUROSCIENCE	Rev. Neurosci.		2009	20	1					39	60					22	Neurosciences	Neurosciences & Neurology	443IM	WOS:000265903400004	19526733				2021-06-18	
J	Kim, HJ; Craik, FIM; Luo, L; Ween, JE				Kim, Hyun Jung; Craik, Fergus I. M.; Luo, Lin; Ween, Jon Erik			Impairments in prospective and retrospective memory following stroke	NEUROCASE			English	Article						Stroke; Prospective memory; Cognition; Executive function; Retrospective memory	TRAUMATIC BRAIN-INJURY; VASCULAR COGNITIVE IMPAIRMENT; STRATEGY APPLICATION DISORDER; FRONTAL LOBES; AGE; PERFORMANCE; INTENTIONS; DEMENTIA; LESIONS; ADULTS	Prospective memory (PM) is the ability to carry out a planned intention at a future time. We studied PM deficits in a group of community-dwelling stroke survivors compared with normal controls. Twelve stroke patients and 12 matched controls performed a series of tests assessing executive function, prospective (PM) and retrospective memory (RM). Patients performed less well than controls on laboratory measures of PM and associative RM; they also showed deficits on standard tests of RM and executive control. The groups did not differ on more structured clinical measures of executive function, RM, PM or self-rated PM and RM. The results are discussed in terms of an impairment in the ability to 'self-initiate' effortful cognitive processes.	[Kim, Hyun Jung] Eulji Univ, Sch Med, Eulji Gen Hosp, Dept Rehabil Med, Seoul, South Korea; [Craik, Fergus I. M.; Luo, Lin] Univ Toronto, Rotman Res Inst, Baycrest & Dept Psychol, Toronto, ON, Canada; [Ween, Jon Erik] Posluns Ctr Stroke & Cognit, Kunin Lunenfeld Appl Res Unit, Toronto, ON, Canada	Ween, JE (corresponding author), Kimmel Family Bldg,6th Floor,Room 644,Baycrest,35, Toronto, ON M6A 2E1, Canada.	jween@klaru-baycrest.on.ca		Craik, Fergus/0000-0001-8073-3236	Korea Research FoundationKorea Research Foundation [KRF-2006-013-E00133]; Natural Sciences and Engineering Research Council of CanadaNatural Sciences and Engineering Research Council of Canada (NSERC)CGIAR	This work was supported by the Korea Research Foundation Grant (KRF-2006-013-E00133) to H. J. Kim and by a grant from the Natural Sciences and Engineering Research Council of Canada to F. I. M. Craik. We also wish to thank HeeSun Lim for research assistance.	Brooks BM, 2004, BRAIN INJURY, V18, P391, DOI 10.1080/02699050310001619855; Burgess PW, 2001, NEUROPSYCHOLOGIA, V39, P545, DOI 10.1016/S0028-3932(00)00149-4; Burgess PW, 1996, NEUROPSYCHOLOGIA, V34, P263, DOI 10.1016/0028-3932(95)00104-2; Burgess PW, 2000, PSYCHOL RES-PSYCH FO, V63, P279, DOI 10.1007/s004269900006; Cohen AL, 2001, AGING NEUROPSYCHOL C, V8, P1, DOI 10.1076/anec.8.1.1.845; COHEN G, 1996, MEMORY INTENTIONS AC, P25; Craik F.I.M., 1986, HUMAN MEMORY COGNITI, P409; CRAIK FIM, 1983, PHILOS T ROY SOC B, V302, P341, DOI 10.1098/rstb.1983.0059; Crawford JR, 2003, MEMORY, V11, P261, DOI 10.1080/09658210244000027; Crowder RG., 1996, PROSPECTIVE MEMORY T, P143; CUMMINGS JL, 1993, ARCH NEUROL-CHICAGO, V50, P873, DOI 10.1001/archneur.1993.00540080076020; Delis DC, 2000, CALIFORNIA VERBAL LE; EINSTEIN GO, 1995, J EXP PSYCHOL LEARN, V21, P996, DOI 10.1037/0278-7393.21.4.996; EINSTEIN GO, 1990, J EXP PSYCHOL LEARN, V16, P717, DOI 10.1037/0278-7393.16.4.717; FOLSTEIN MF, 1975, J PSYCHIATR RES, V12, P198; GOLDSTEIN LH, 1993, J NEUROL NEUROSUR PS, V56, P274, DOI 10.1136/jnnp.56.3.274; Grady CL, 2000, CURR OPIN NEUROBIOL, V10, P224, DOI 10.1016/S0959-4388(00)00073-8; Guynn MJ, 2003, INT J PSYCHOL, V38, P245, DOI 10.1080/00207590344000178; Hachinski V, 2007, STROKE, V38, P1396, DOI 10.1161/01.STR.0000260101.08944.e9; HAMILTON BL, 1977, EDUC PSYCHOL MEAS, V37, P701, DOI 10.1177/001316447703700313; Henry JD, 2004, PSYCHOL AGING, V19, P27, DOI 10.1037/0882-7974.19.1.27; Kliegel M, 2004, BRAIN COGNITION, V56, P43, DOI 10.1016/j.bandc.2004.05.005; Kliegel M, 2003, INT J PSYCHOL, V38, P193, DOI 10.1080/00207590344000114; Kvavilashvili L., 1996, PROSPECTIVE MEMORY T, P23; Levine B, 2000, NEUROPSYCHOLOGY, V14, P491, DOI 10.1037/0894-4105.14.4.491; Lezak MD, 1995, NEUROPSYCHOLOGICAL A; Martin M, 2003, INT J PSYCHOL, V38, P195, DOI 10.1080/00207590344000123; Mathias JL, 2005, BRAIN INJURY, V19, P271, DOI 10.1080/02699050400005028; McDaniel MA, 1999, NEUROPSYCHOLOGY, V13, P103, DOI 10.1037/0894-4105.13.1.103; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Okuda J, 1998, NEUROSCI LETT, V253, P127, DOI 10.1016/S0304-3940(98)00628-4; Reed BR, 2004, ARCH NEUROL-CHICAGO, V61, P1545, DOI 10.1001/archneur.61.10.1545; Reed BR, 2001, ARCH NEUROL-CHICAGO, V58, P493, DOI 10.1001/archneur.58.3.493; Reitan R, 1986, TRAIL MAKING TEST; Rendell PG, 2000, APPL COGNITIVE PSYCH, V14, pS43, DOI 10.1002/acp.770; Robertson IH, 1997, NEUROPSYCHOLOGIA, V35, P747, DOI 10.1016/S0028-3932(97)00015-8; Roediger H. L., 1996, PROSPECTIVE MEMORY T, P149; Roman GC, 2004, J NEUROL SCI, V226, P81, DOI 10.1016/j.jns.2004.09.016; Schmitter-Edgecombe M, 2004, NEUROPSYCHOLOGY, V18, P353, DOI 10.1037/0894-4105.18.2.353; SHALLICE T, 1991, BRAIN, V114, P727, DOI 10.1093/brain/114.2.727; Smith RE, 2003, J EXP PSYCHOL LEARN, V29, P347, DOI 10.1037/0278-7393.29.3.347; Stuss DT, 2002, ANNU REV PSYCHOL, V53, P401, DOI 10.1146/annurev.psych.53.100901.135220; Wahlund LO, 2001, STROKE, V32, P1318, DOI 10.1161/01.STR.32.6.1318; Wechsler D., 1997, WMS 3 WECHSLER MEMOR; West R, 2002, NEUROSCI BIOBEHAV R, V26, P827, DOI 10.1016/S0149-7634(02)00069-6; West R, 2001, NEUROREPORT, V12, P2855, DOI 10.1097/00001756-200109170-00020; West R, 2005, NEUROPSYCHOLOGIA, V43, P418, DOI 10.1016/j.neuropsychologia.2004.06.012; West R, 2007, NEUROCASE, V13, P115, DOI 10.1080/13554790701399247; Wilson B. A., 1985, RIVERMEAD BEHAV MEMO	49	17	18	0	5	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1355-4794	1465-3656		NEUROCASE	Neurocase		2009	15	2					145	156	PII 909674187	10.1080/13554790802709039			12	Clinical Neurology; Psychiatry; Psychology	Neurosciences & Neurology; Psychiatry; Psychology	425SD	WOS:000264656500009	19296397				2021-06-18	
J	Tippett, WJ; Lee, JH; Zakzanis, KK; Black, SE; Mraz, R; Graham, SJ				Tippett, William J.; Lee, Jang-Han; Zakzanis, Konstantine K.; Black, Sandra E.; Mraz, Richard; Graham, Simon J.			Visually navigating a virtual world with real-world impairments: A study of visually and spatially guided performance in individuals with mild cognitive impairments	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						Mild cognitive impairment; Virtual environment; Visually guided performance; Spatial navigation	TRAUMATIC BRAIN-INJURY; NEUROPSYCHOLOGICAL ASSESSMENT; MEMORY; TASK; REHABILITATION; ENVIRONMENTS; DYSFUNCTION; RESPONSES; DISEASE; MAZE	In recent years, computer technology has evolved such that highly realistic virtual environments (VEs) can be used within a lab setting. Such VEs provide controlled ability to examine behavioral performance across different populations. The primary goal of this investigation was to examine the ability of mild cognitive impaired (MCI) participants to navigate effectively through a realistic, fictional virtual city. A total of 26 healthy control participants (age: 69 7.7 years; Mini-Mental State Examination, MMSE 29) and 8 MCI patients (age: 72 7 years, MMSE 26) were recruited. Both groups exhibited similar spatial-navigation ability. However, the MCI groups' ability to use effective visually guided navigation to traverse the VE was significantly compromised compared to healthy controls; a similar performance reduction was also observed when selecting appropriate paths. Though initially groups appear practically indistinguishable in regard to spatially navigating their way through the VE, these data indicate that careful evaluations of behavior in VEs may provide novel ways to differentiate between populations that have historically displayed relatively subtle differences.	[Tippett, William J.] Sunnybrook Hlth Sci Ctr, Cognit Neurol Res Unit, Div Neurol, Dept Med, Toronto, ON M4N 3M5, Canada; [Tippett, William J.; Black, Sandra E.] LC Campbell Cognit Neurol Res Unit, Toronto, ON, Canada; [Lee, Jang-Han] Chung Ang Univ, Dept Psychol, Seoul 156756, South Korea; [Zakzanis, Konstantine K.] Univ Toronto, Dept Psychol, Scarborough, ON M1C 1A4, Canada; [Tippett, William J.; Black, Sandra E.; Graham, Simon J.] Heart & Stroke Fdn Ctr Stroke Recovery, Toronto, ON, Canada; [Black, Sandra E.; Mraz, Richard; Graham, Simon J.] Univ Toronto, Toronto, ON, Canada; [Zakzanis, Konstantine K.; Graham, Simon J.] Rotman Res Inst, Toronto, ON, Canada	Tippett, WJ (corresponding author), Sunnybrook Hlth Sci Ctr, Cognit Neurol Res Unit, Div Neurol, Dept Med, 2075 Bayview Ave,Roorinm A419, Toronto, ON M4N 3M5, Canada.	bj.tippett@sunnybrook.ca	Black, Sandra E./C-7294-2011	Black, Sandra/0000-0001-7093-8289			Astur RS, 1998, BEHAV BRAIN RES, V93, P185, DOI 10.1016/S0166-4328(98)00019-9; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Broeren J, 2002, CYBERPSYCHOL BEHAV, V5, P207, DOI 10.1089/109493102760147196; Buckwalter J G, 1997, Stud Health Technol Inform, V39, P17; Burgess N, 2006, REV NEUROSCIENCE, V17, P239; Christiansen C, 1998, ARCH PHYS MED REHAB, V79, P888, DOI 10.1016/S0003-9993(98)90083-1; Drzezga A, 2005, PLOS MED, V2, P986, DOI 10.1371/journal.pmed.0020288; GALEA LAM, 1993, PERS INDIV DIFFER, V14, P53, DOI 10.1016/0191-8869(93)90174-2; Gillner S, 1998, J COGNITIVE NEUROSCI, V10, P445, DOI 10.1162/089892998562861; Glantz K, 1997, PRESENCE-TELEOP VIRT, V6, P87, DOI 10.1162/pres.1997.6.1.87; Goude D, 2007, STUD HEALTH TECHNOL, V125, P146; Kahana MJ, 1999, NATURE, V399, P781, DOI 10.1038/21645; KENNEDY RS, 1993, AVIAT SPACE ENVIR MD, V64, P912; KIRASIC KC, 1991, PSYCHOL AGING, V6, P10, DOI 10.1037/0882-7974.6.1.10; Ku JH, 2003, CYBERPSYCHOL BEHAV, V6, P497, DOI 10.1089/109493103769710523; Loewenstein DA, 2004, AM J GERIAT PSYCHIAT, V12, P395, DOI 10.1176/appi.ajgp.12.4.395; Lundberg C, 1997, ALZ DIS ASSOC DIS, V11, P28, DOI 10.1097/00002093-199703000-00006; Maguire EA, 1999, CURR OPIN NEUROBIOL, V9, P171, DOI 10.1016/S0959-4388(99)80023-3; Maguire EA, 1998, J NEUROL NEUROSUR PS, V65, P903, DOI 10.1136/jnnp.65.6.903; McCarthy RA, 1996, J NEUROL NEUROSUR PS, V60, P318, DOI 10.1136/jnnp.60.3.318; Moffat SD, 2001, NEUROBIOL AGING, V22, P787, DOI 10.1016/S0197-4580(01)00251-2; Mraz R, 2003, CYBERPSYCHOL BEHAV, V6, P359, DOI 10.1089/109493103322278736; Nadolne MJ, 2001, J INT NEUROPSYCH SOC, V7, P675, DOI 10.1017/S1355617701766039; Nomura Y, 2005, COGNITIVE BRAIN RES, V25, P624, DOI 10.1016/j.cogbrainres.2005.08.012; Petersen RC, 1999, ARCH NEUROL-CHICAGO, V56, P303, DOI 10.1001/archneur.56.3.303; Rose FD, 2005, CYBERPSYCHOL BEHAV, V8, P241, DOI 10.1089/cpb.2005.8.241; Sandstrom NJ, 1998, COGNITIVE BRAIN RES, V6, P351, DOI 10.1016/S0926-6410(98)00002-0; Shechtman Oritz, 2007, Traffic Inj Prev, V8, P78, DOI 10.1080/15389580600994321; Slobounov S, 2006, NEUROSURGERY, V59, P134, DOI 10.1227/01.NEU.0000219197.33182.3F; Walshe D, 2005, CYBERPSYCHOL BEHAV, V8, P532, DOI 10.1089/cpb.2005.8.532; Whitney SL, 2006, CYBERPSYCHOL BEHAV, V9, P152, DOI 10.1089/cpb.2006.9.152; Yan JH, 2006, AGING NEUROPSYCHOL C, V13, P385, DOI 10.1080/138255890969609	32	17	17	0	7	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.		2009	31	4					447	454	PII 901418728	10.1080/13803390802251360			8	Psychology, Clinical; Clinical Neurology; Psychology	Psychology; Neurosciences & Neurology	435HH	WOS:000265334200007	18686114				2021-06-18	
J	Tortorici, MA; Mu, Y; Kochanek, PM; Xie, W; Poloyac, SM				Tortorici, Michael A.; Mu, Ying; Kochanek, Patrick M.; Xie, Wen; Poloyac, Samuel M.			Moderate hypothermia prevents cardiac arrest-mediated suppression of drug metabolism and induction of interleukin-6 in rats	CRITICAL CARE MEDICINE			English	Article						heart arrest; pharmacology; metabolism; interleukin-6; cytochrome P450; pregnane-X-receptor	PREGNANE-X-RECEPTOR; TRAUMATIC BRAIN-INJURY; MILD THERAPEUTIC HYPOTHERMIA; ACUTE-PHASE RESPONSE; NF-KAPPA-B; PHARMACOKINETIC ALTERATIONS; CYTOCHROME-P-450 ENZYMES; CYP2E1 EXPRESSION; MESSENGER-RNA; HEAD-INJURY	Objective: Therapeutic hypothermia is being clinically used to reduce neurologic deficits after cardiac arrest (CA). Patents receiving hypothermia after CA receive a wide-array of medications. During hypothermia, drug metabolism is markedly reduced. Little, however, is known about the impact of hypothermia on drug metabolism after rewarming. The objective of this study was to examine the effect of CA and hypothermia on the functional regulation of two major drug metabolizing cytochrome P450 (CYP) isoforms. Design: Laboratory investigation. Setting: University pharmacy school and animal research facility. Subjects: Thirty-six male Sprague-Dawley rats. Interventions: Hypothermia was induced via surface cooling in a rat CA model and maintained for 3 hrs. Animals were killed at 5 or 24 hrs and liver was analyzed for hepatic activity and mRNA expression of CYP3A2 and CYP2E1. Plasma interleukin-6 (IL-6) concentrations were determined. The effect of IL-6 on pregnane X receptor-mediated transcription of the rat CYP3A2 promoter was evaluated via luciferase reporter in HepG2 cells. Measurements and Main Results: At 24 hrs after CA a decrease in CYP3A2 and CYP2E1 activity was observed, 55.7% +/- 12.8% and 46.8% +/- 29.7% of control, respectively (p < 0.01). CA decreased CYP3A2 mRNA (p < 0.05), but not CYP2E1 mRNA. Expression of other pregnane X receptor target enzymes and transporter genes were similarly down-regulated. CA also produced an approximately ten-fold increase in plasma IL-6. CA-mediated inhibition of CYP3A2 and CYP2E1 was attenuated by hypothermia, as was the increase in IL-6. Furthermore, IL-6 attenuated pregnane X receptor-mediated transcription of the CYP3A2 promoter. Conclusions. CA produces CYP3A2 down-regulation at 24 hrs, potentially via IL-6 effects on pregnane X receptor-mediated transcription. Also, hypothermia attenuates the CA-mediated down - regulation, thereby normalizing drug metabolism after rewarming. (Crit Care Med 2009; 37:263-269)	[Tortorici, Michael A.; Mu, Ying; Xie, Wen; Poloyac, Samuel M.] Univ Pittsburgh, Sch Pharm, Dept Pharmaceut Sci, Pittsburgh, PA 15261 USA; [Kochanek, Patrick M.] Univ Pittsburgh, Sch Med, Dept Crit Care Med, Safar Ctr Resuscitat Res, Pittsburgh, PA 15261 USA; [Kochanek, Patrick M.] Univ Pittsburgh, Sch Med, Dept Pediat, Childrens Hosp Pittsburgh, Pittsburgh, PA 15261 USA	Tortorici, MA (corresponding author), Univ Pittsburgh, Sch Pharm, Dept Pharmaceut Sci, Pittsburgh, PA 15261 USA.	poloyac@pitt.edu	Xie, Wen/M-1768-2016; Kochanek, Patrick M/D-2371-2015	Kochanek, Patrick M/0000-0002-2627-913X	National Institute of General Medical Sciences (Primary)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [GM073031]; National Heart, Lung, and Blood Institute (Secondary)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [S10 RR023461]; National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS30318 and NS 38087]; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [S10RR023461] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM073031] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS030318, R01NS038087, P20NS030318, P50NS030318] Funding Source: NIH RePORTER	Supported, in part, by grant GM073031 from the National Institute of General Medical Sciences (Primary) and the National Heart, Lung, and Blood Institute (Secondary), grant S10 RR023461 from the National Center for Research Resources, grants NS30318 and NS 38087 from National Institute of Neurological Disorders and Stroke.	ABDELRAZZAK Z, 1993, MOL PHARMACOL, V44, P707; Adrie C, 2002, CIRCULATION, V106, P562, DOI 10.1161/01.CIR.0000023891.80661.AD; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; Boucher BA, 1998, CLIN PHARMACOKINET, V35, P209, DOI 10.2165/00003088-199835030-00004; Caron E, 2005, J BIOCHEM MOL TOXIC, V19, P368, DOI 10.1002/jbt.20103; Fink Ericka L, 2004, Pediatr Crit Care Med, V5, P139, DOI 10.1097/01.PCC.0000112376.29903.8F; Fukuoka N, 2004, RESUSCITATION, V60, P225, DOI 10.1016/j.resuscitation.2003.09.017; Gu XS, 2006, J BIOL CHEM, V281, P17882, DOI 10.1074/jbc.M601302200; Guluma KZ, 2008, NEUROCRIT CARE, V8, P42, DOI 10.1007/s12028-007-9009-z; Gundersen Y, 2001, ACTA ANAESTH SCAND, V45, P994, DOI 10.1034/j.1399-6576.2001.450812.x; Hakkola J, 2003, J PHARMACOL EXP THER, V304, P1048, DOI 10.1124/jpet.102.041582; Holzer M, 2002, NEW ENGL J MED, V346, P549; Iida Y, 2001, THER DRUG MONIT, V23, P192, DOI 10.1097/00007691-200106000-00002; Kalsotra A, 2003, J NEUROTRAUM, V20, P1339, DOI 10.1089/089771503322686139; KATZ L, 1995, J CEREBR BLOOD F MET, V15, P1032, DOI 10.1038/jcbfm.1995.129; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; MCALLISTER RG, 1980, PHARMACOLOGY, V20, P95; MIYATA M, 1995, ARCH BIOCHEM BIOPHYS, V318, P71, DOI 10.1006/abbi.1995.1206; Mu Y, 2005, MOL PHARMACOL, V68, P403, DOI 10.1124/mol.105.013292; Nishida K, 2007, BIOL PHARM BULL, V30, P1763, DOI 10.1248/bpb.30.1763; Oppert M, 1999, INTENS CARE MED, V25, P1386, DOI 10.1007/s001340051086; Pohjanvirta R, 2006, CHEM-BIOL INTERACT, V160, P134, DOI 10.1016/j.cbi.2006.01.001; Poloyac SM, 2004, DRUG METAB DISPOS, V32, P727, DOI 10.1124/dmd.32.7.727; Poloyac SM, 2001, DRUG METAB DISPOS, V29, P296; Rendic S, 2002, DRUG METAB REV, V34, P83, DOI 10.1081/DMR-120001392; Rockich K, 1999, DRUG METAB DISPOS, V27, P1074; Roe AL, 2001, J PHARM PHARMACOL, V53, P1365, DOI 10.1211/0022357011777864; Saini SPS, 2005, HEPATOLOGY, V41, P497, DOI 10.1002/hep.20570; Shankaran S, 2005, NEW ENGL J MED, V353, P1574, DOI 10.1056/NEJMcps050929; SONDERFAN AJ, 1987, ARCH BIOCHEM BIOPHYS, V255, P27, DOI 10.1016/0003-9861(87)90291-8; Tanaka E, 2000, J CLIN PHARM THER, V25, P165; Teng S, 2005, J PHARMACOL EXP THER, V312, P841, DOI 10.1124/jpet.104.076141; TOLER SM, 1993, DRUG METAB DISPOS, V21, P1064; Tortorici MA, 2006, CRIT CARE MED, V34, P785, DOI 10.1097/01.CCM.0000201899.52739.4F; Weisfeldt ML, 2002, JAMA-J AM MED ASSOC, V288, P3035, DOI 10.1001/jama.288.23.3035; Xie W, 2000, NATURE, V406, P435, DOI 10.1038/35019116; Zhao H, 2007, J CEREBR BLOOD F MET, V27, P1879, DOI 10.1038/sj.jcbfm.9600540; Zhou C, 2006, J CLIN INVEST, V116, P2280, DOI 10.1172/JCI26283; Zhou J, 2006, J BIOL CHEM, V281, P15013, DOI 10.1074/jbc.M511116200	40	17	17	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0090-3493			CRIT CARE MED	Crit. Care Med.	JAN	2009	37	1					263	269		10.1097/CCM.0b013e3181931ed3			7	Critical Care Medicine	General & Internal Medicine	391YK	WOS:000262269900036	19050605	Green Accepted			2021-06-18	
J	Wallenquist, U; Brannval, K; Clausen, F; Lewen, A; Hillered, L; Forsberg-Nilsson, K				Wallenquist, U.; Brannval, K.; Clausen, F.; Lewen, A.; Hillered, L.; Forsberg-Nilsson, K.			Grafted neural progenitors migrate and form neurons after experimental traumatic brain injury	RESTORATIVE NEUROLOGY AND NEUROSCIENCE			English	Article						TBI; EGFP transgenic mice; transplantation; migration; regeneration; neural stem cells; CNS	STEM-CELLS; STEM/PROGENITOR CELLS; CONTUSION TRAUMA; SPINAL-CORD; ADULT; DIFFERENTIATION; TRANSPLANTATION; NEUROGENESIS; ENGRAFTMENT; CNS	Purpose: Neural stem and progenitor cells (NSPC) generate neurons and glia, a feature that makes them attractive for cell replacement therapies. However, efforts to transplant neural progenitors in animal models of brain injury typically result in high cell mortality and poor neuronal differentiation. Methods: In an attempt to improve the outcome for grafted NSPC after controlled cortical impact we transplanted Enhanced Green Fluorescent Protein (EGFP)-positive NSPC into the contra lateral ventricle of mice one week after injury. Results: Grafted EGFP-NSPC readily migrated to the injured hemisphere where we analyzed the proportion of progenitors and differentiated progeny at different time points. Transplantation directly into the injured parenchyma, resulted in few brains with detectable EGFP-NSPC. On the contrary, in more than 90% of the mice that received a transplant into the lateral ventricle detectable EGFP-positive cells were found. The cells were integrated into the lateral ventricle wall of the un-injured hemisphere, throughout the corpus callosum, and in the cortical perilesional area. At one-week post transplantation, grafted cells that had migrated to the perilesion area mainly expressed markers of neural progenitors and neurons, while in the corpus callosum and the ventricular lining, grafted cells with a glial fate were more abundant. After 3 months, grafted cells in the perilesion area were less abundant whereas cells that had migrated to the walls of the third-and lateral-ventricle of the injured hemisphere were still detectable, suggesting that the injury site remained a hostile environment. Conclusion: Transplantation to the lateral ventricle, presumably for being a neurogenic region, provides a favorable environment improving the outcome for grafted NSPC both in term of their appearance at the cortical site of injury, and their acquisition of neural markers.	[Wallenquist, U.; Brannval, K.; Forsberg-Nilsson, K.] Uppsala Univ, Dept Med Biochem & Microbiol, Biomed Ctr, S-75123 Uppsala, Sweden; [Clausen, F.; Lewen, A.; Hillered, L.] Univ Uppsala Hosp, Dept Neurosci, Uppsala, Sweden	Forsberg-Nilsson, K (corresponding author), Uppsala Univ, Dept Med Biochem & Microbiol, Biomed Ctr, Box 582, S-75123 Uppsala, Sweden.	karin.nilsson@imbim.uu.se	Forsberg-Nilsson, Karin/D-9604-2019; Lewen, Anders/A-5156-2013	Forsberg-Nilsson, Karin/0000-0003-0692-6245; Lewen, Anders/0000-0003-4925-1348; Hillered, Lars/0000-0002-2808-9292; Clausen, Fredrik/0000-0003-3592-4417	Swedish Research Council MedicineSwedish Research Council; Uppsala University Hospital	This study was supported by grants from the Swedish Research Council Medicine (LH and KFN) and Uppsala University Hospital. The authors would like to thank the animal facility personnel for excellent assistance with animal care. Dr. J. Grawe, Cell Analysis Core Facility, Rudbeck laboratory, Uppsala University, is acknowledged for expert advice with confocal microscopy, and Drs T. Olofsson and H. Kalimu for advice on brain morphology.	Aboody KS, 2000, P NATL ACAD SCI USA, V97, P12846, DOI 10.1073/pnas.97.23.12846; Bakshi A, 2005, BRAIN RES, V1065, P8, DOI 10.1016/j.brainres.2005.09.059; Brannvall K, 2006, NEUROREPORT, V17, P623; Brustle O, 1995, NEURON, V15, P1275, DOI 10.1016/0896-6273(95)90007-1; Cao QL, 2001, EXP NEUROL, V167, P48, DOI 10.1006/exnr.2000.7536; Chow SY, 2000, BRAIN RES, V874, P87, DOI 10.1016/S0006-8993(00)02443-4; Clausen F, 2007, J NEUROTRAUM, V24, P1295, DOI 10.1089/neu.2006.0258; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Fricker RA, 1999, J NEUROSCI, V19, P5990, DOI 10.1523/JNEUROSCI.19-14-05990.1999; GAGE FH, 1995, P NATL ACAD SCI USA, V92, P11879, DOI 10.1073/pnas.92.25.11879; Gross RE, 1996, NEURON, V17, P595, DOI 10.1016/S0896-6273(00)80193-2; Habgood MD, 2007, EUR J NEUROSCI, V25, P231, DOI 10.1111/j.1460-9568.2006.05275.x; Herrera DG, 1999, ANN NEUROL, V46, P867, DOI 10.1002/1531-8249(199912)46:6<867::AID-ANA9>3.0.CO;2-Z; Hillered L, 2005, J NEUROTRAUM, V22, P3, DOI 10.1089/neu.2005.22.3; Hoane MR, 2004, J NEUROTRAUM, V21, P163, DOI 10.1089/089771504322778622; HOLMIN S, 1995, ACTA NEUROCHIR, V132, P110, DOI 10.1007/BF01404857; Imitola J, 2004, P NATL ACAD SCI USA, V101, P18117, DOI 10.1073/pnas.0408258102; Israelsson C, 2006, J NEUROSCI RES, V84, P47, DOI 10.1002/jnr.20856; Johe KK, 1996, GENE DEV, V10, P3129, DOI 10.1101/gad.10.24.3129; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; KIRSCHENBAUM B, 1994, CEREB CORTEX, V4, P576, DOI 10.1093/cercor/4.6.576; Kukekov VG, 1999, EXP NEUROL, V156, P333, DOI 10.1006/exnr.1999.7028; Laurer HL, 1999, CURR OPIN NEUROL, V12, P715, DOI 10.1097/00019052-199912000-00010; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; Lewen A, 1999, ACTA NEUROCHIR, V141, P193, DOI 10.1007/s007010050286; LOIS C, 1993, P NATL ACAD SCI USA, V90, P2074, DOI 10.1073/pnas.90.5.2074; Longhi L, 2004, J NEUROTRAUM, V21, P1723, DOI 10.1089/0897715042664876; Marklund N, 2006, CURR PHARM DESIGN, V12, P1645, DOI 10.2174/138161206776843340; McKay R, 1997, SCIENCE, V276, P66, DOI 10.1126/science.276.5309.66; Mehler Mark F, 2002, Results Probl Cell Differ, V39, P27; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; NILSSON P, 1993, J CEREBR BLOOD F MET, V13, P183, DOI 10.1038/jcbfm.1993.22; NILSSON P, 1990, J CEREBR BLOOD F MET, V10, P631, DOI 10.1038/jcbfm.1990.115; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Reynolds BA, 2005, NAT METHODS, V2, P333, DOI 10.1038/nmeth758; REYNOLDS BA, 1992, J NEUROSCI, V12, P4565, DOI 10.1523/jneurosci.12-11-04565.1992; Riess P, 2002, NEUROSURGERY, V51, P1043, DOI 10.1097/00006123-200210000-00035; Schouten JW, 2004, J NEUROTRAUM, V21, P1501, DOI 10.1089/neu.2004.21.1501; Shear DA, 2004, BRAIN RES, V1026, P11, DOI 10.1016/j.brainres.2004.07.087; Shihabuddin LS, 2000, J NEUROSCI, V20, P8727; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; Sommer L, 1996, MOL CELL NEUROSCI, V8, P221, DOI 10.1006/mcne.1996.0060; Sun Y, 2001, CELL, V104, P365, DOI 10.1016/S0092-8674(01)00224-0; Suslov ON, 2002, P NATL ACAD SCI USA, V99, P14506, DOI 10.1073/pnas.212525299; Sykova E, 2005, ANN NY ACAD SCI, V1049, P146, DOI 10.1196/annals.1334.014; Tamaki S, 2002, J NEUROSCI RES, V69, P976, DOI 10.1002/jnr.10412; Wang KKW, 2006, CURR OPIN NEUROL, V19, P514, DOI 10.1097/WCO.0b013e3280102b10; Wennersten A, 2004, J NEUROSURG, V100, P88, DOI 10.3171/jns.2004.100.1.0088	49	17	18	0	4	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	0922-6028	1878-3627		RESTOR NEUROL NEUROS	Restor. Neurol. Neurosci.		2009	27	4					323	334		10.3233/RNN-2009-0481			12	Neurosciences	Neurosciences & Neurology	492BS	WOS:000269629700007	19738325				2021-06-18	
J	Wen, J; Shi, YK; Li, YP; Wang, L; Cheng, L; Gao, Z; Li, L				Wen, Jin; Shi, Ying Kang; Li, You Ping; Wang, Li; Cheng, Lan; Gao, Zhan; Li, Ling			Risk factors of earthquake inpatient death: a case control study	CRITICAL CARE			English	Article							HANSHIN-AWAJI EARTHQUAKE; 1999 MARMARA EARTHQUAKE; INJURY; MORTALITY; POPULATION; MODERATE; FAILURE; TURKEY	Introduction At 2: 28 p. m. on 12 May, 2008, a devastating earthquake measuring 8.0 on the Richter scale hit Wenchuan County, Sichuan Province in southwest China, and resulted in the deaths of thousands of people. To date, few epidemiological studies have been conducted on the determinants of the mortality of patients hospitalised after an earthquake. This paper is aimed at identifying the contributing factors of mortality and providing a clinical reference for the management of those injured in earthquakes. Methods A hospital-based case-control study was conducted. Cases included all deaths (n = 36) due to earthquake injuries in the West China Hospital. Controls were the quake survivors from the same hospital by at a ratio of four survivors to one death matched for sex and age. Data sources included death certificates and medical records. A conditional logistic regression was performed to assess the odds ratio (OR) of variables used in the study. A chi-squared test for trend was performed to reveal the possible relations between risk factor (variable) number and case fatality. Results People with a severe traumatic brain injury (TBI) had the greatest risk of death (adjusted OR = 253.3, 95% confidence interval (CI) = 8.9 to 7208.6), followed by patients with multiple system organ failure (MSOF; adjusted OR = 87.8, 95% CI = 3.9 to 1928.3). Prior major disease and infection significantly increased the risk of earthquake-related death (adjusted OR = 14.9, 95% CI = 1.9 to 119.0; adjusted OR = 13.7, 95% CI = 1.8 to 103.7; respectively). The number of fatal cases increased as the risk factor numbers also increased. Conclusions Severe TBI, infection, MSOF and prior major disease are the significant determinants of earthquake- related inpatient death in the 2008 Wenchuan earthquake. Future research with a large sample size including macro- and micro-level factors is needed.	[Shi, Ying Kang] Sichuan Univ, W China Hosp, Dept Thorac & Cardiovasc Surg, Chengdu 610041, Peoples R China; [Wen, Jin; Li, You Ping; Wang, Li; Cheng, Lan; Gao, Zhan; Li, Ling] Sichuan Univ, W China Hosp, Chinese Evidence Based Med Ctr, Chengdu 610041, Peoples R China; [Wen, Jin; Li, You Ping; Wang, Li; Cheng, Lan; Gao, Zhan; Li, Ling] Sichuan Univ, W China Hosp, Dept Clin Epidemiol, Chengdu 610041, Peoples R China	Shi, YK (corresponding author), Sichuan Univ, W China Hosp, Dept Thorac & Cardiovasc Surg, Chengdu 610041, Peoples R China.	huaxiwenjin@163.com	Wang, Li/T-1407-2017	Wang, Li/0000-0003-1585-8846			Armenian HK, 1997, INT J EPIDEMIOL, V26, P806, DOI 10.1093/ije/26.4.806; Bellomo R, 2001, INTENS CARE MED, V27, P1685, DOI 10.1007/s00134-001-1120-6; Bouras T, 2007, J NEUROTRAUM, V24, P1355, DOI 10.1089/neu.2005.370; Bulut M, 2005, EMERG MED J, V22, P494, DOI 10.1136/emj.2004.016295; Bywaters EGL, 1998, J AM SOC NEPHROL, V9, P322; Chan CC, 2003, ANN EPIDEMIOL, V13, P502, DOI 10.1016/S1047-2797(03)00040-1; Chou YJ, 2004, AM J EPIDEMIOL, V160, P688, DOI 10.1093/aje/kwh270; Duman H, 2003, EMERG MED J, V20, P251, DOI 10.1136/emj.20.3.251; FRY DE, 1980, ARCH SURG-CHICAGO, V115, P136; JUAN X, 2008, J EVID BASED MED, V1, P20; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Mahue-Giangreco M, 2001, ANN EPIDEMIOL, V11, P347, DOI 10.1016/S1047-2797(01)00220-4; Oncul O, 2002, J HOSP INFECT, V51, P47, DOI 10.1053/jhin.2002.1205; Osaki Y, 2001, AM J EPIDEMIOL, V153, P153, DOI 10.1093/aje/153.2.153; Peek-Asa C, 2003, INJ PREV, V9, P62, DOI 10.1136/ip.9.1.62; Tanaka H, 1999, AM J EMERG MED, V17, P186, DOI 10.1016/S0735-6757(99)90059-1; Valadka A. B., 2004, TRAUMA, P385	17	17	17	3	9	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1466-609X	1364-8535		CRIT CARE	Crit. Care		2009	13	1							R24	10.1186/cc7729			6	Critical Care Medicine	General & Internal Medicine	421IC	WOS:000264351600024	19243616	DOAJ Gold, Green Published			2021-06-18	
J	Williams, GP; Morris, ME				Williams, Gavin P.; Morris, Meg E.			High-level mobility outcomes following acquired brain injury: A preliminary evaluation	BRAIN INJURY			English	Article						Balance; outcome; rehabilitation; therapy; traumatic brain injury	RANDOMIZED CONTROLLED-TRIAL; ASSESSMENT-TOOL HIMAT; CHRONIC STROKE; EXERCISE; GAIT; INDIVIDUALS; CAPACITY; RECOVERY; VALIDITY; PROGRAM	Primary objective: To evaluate the efficacy of a high-level mobility programme for people with acquired brain injury (ABI). Research design: A cohort study which evaluated the efficacy of a high-level mobility programme for people with ABI. Setting: A major rehabilitation hospital. Participants: Twenty-eight people with acquired brain injury. Experimental interventions: A 3 month high-level mobility programme conducted twice weekly consisting of strengthening exercises, pre-running and running drills and agility exercises supplemented with a gym or home exercise programme. Main outcomes and results: The primary outcome measure was the high-level mobility assessment tool (HiMAT). Participants were predominantly male and young (average age 33.2 years, range 16-72 years) with chronic ABI. HiMAT scores for the 28 participants who returned at the 3 month follow-up initially ranged from 6-44 points (mean 20.3). The 3 month follow-up scores ranged from 12-51 points (mean 29.2). The mean HiMAT score change ranged from 2-20 points (mean 8.9). Conclusions: Significant recovery in high-level mobility was achieved during a 3 month running programme. People with chronic ABI may also expect to benefit from retraining high-level mobility. Clinical trials are needed to assess the effectiveness of training programmes for high-level mobility.	[Williams, Gavin P.] Epworth Med Fdn, Melbourne, Vic, Australia; [Williams, Gavin P.] Univ Melbourne, Ctr Hlth Exercise & Sports Med, Melbourne, Vic, Australia; [Morris, Meg E.] Univ Melbourne, Sch Physiotherapy, Melbourne, Vic, Australia	Williams, GP (corresponding author), Epworth Med Fdn, Physiotherapy Dept, 89 Bridge Rd, Richmond, Vic 3121, Australia.	Gavin.Williams@epworth.org.au		Morris, Meg/0000-0002-0114-4175; Williams, Gavin/0000-0003-2758-7473			Basford JR, 2003, ARCH PHYS MED REHAB, V84, P343, DOI 10.1053/apmr.2003.50034; Bateman A, 2001, ARCH PHYS MED REHAB, V82, P174, DOI 10.1053/apmr.2001.19744; Brown TH, 2005, J HEAD TRAUMA REHAB, V20, P402, DOI 10.1097/00001199-200509000-00002; Collen F M, 1991, Int Disabil Stud, V13, P50; Curran CA, 2000, J HEAD TRAUMA REHAB, V15, P1256, DOI 10.1097/00001199-200012000-00006; Duncan P, 2003, STROKE, V34, P2173, DOI 10.1161/01.STR.0000083699.95351.F2; Gardner MB, 1998, PHYS THER, V78, P361, DOI 10.1093/ptj/78.4.361; Gordon WA, 1998, J HEAD TRAUMA REHAB, V13, P58, DOI 10.1097/00001199-199808000-00006; Hillier SL, 1997, BRAIN INJURY, V11, P661; HUNTER M, 1990, PHYS THER, V70, P363, DOI 10.1093/ptj/70.6.363; Jackson D, 2001, CLIN REHABIL, V15, P535, DOI 10.1191/026921501680425252; JANKOWSKI LW, 1990, ARCH PHYS MED REHAB, V71, P500; Katz DI, 2004, ARCH PHYS MED REHAB, V85, P865, DOI 10.1016/j.apmr.2003.11.020; Macko RF, 2005, STROKE, V36, P2206, DOI 10.1161/01.STR.0000181076.91805.89; Miller EW, 2008, PHYS THER, V88, P511, DOI 10.2522/ptj.20050240; Olney SJ, 2006, STROKE, V37, P476, DOI 10.1161/01.STR.0000199061.85897.b7; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; Pang MYC, 2006, CLIN REHABIL, V20, P97, DOI 10.1191/0269215506cr926oa; PONSFORD JL, 1995, BRAIN INJURY, V9, P1, DOI 10.3109/02699059509004565; Regensteiner JG., 1990, J VASC MED BIOL, V2, P142; SHORES EA, 1986, MED J AUSTRALIA, V144, P569, DOI 10.5694/j.1326-5377.1986.tb112311.x; SULLIVAN S J, 1990, Brain Injury, V4, P407, DOI 10.3109/02699059009026194; Swaine BR, 1996, BRAIN INJURY, V10, P347, DOI 10.1080/026990596124368; Williams G, 2006, ARCH PHYS MED REHAB, V87, P437, DOI 10.1016/j.apmr.2005.10.028; Williams G, 2005, BRAIN INJURY, V19, P925, DOI 10.1080/02699050500058687; Williams G, 2004, AM J PHYS MED REHAB, V83, P910, DOI 10.1097/01.PHM.0000146503.25221.1D; Williams GP, 2005, BRAIN INJURY, V19, P833, DOI 10.1080/02699050500058711; Wolman RL, 1994, CLIN REHABIL, V8, P253; Yang YR, 2007, ARCH PHYS MED REHAB, V88, P1236, DOI 10.1016/j.apmr.2007.06.762	29	17	17	0	10	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.		2009	23	4					307	312	PII 909973890	10.1080/02699050902774170			6	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	425MY	WOS:000264643000005	19330594				2021-06-18	
J	Wong, GK; Tang, BYH; Yeung, JHH; Collins, G; Rainer, T; Ng, SC; Poon, WS				Wong, G. K.; Tang, B. Y. H.; Yeung, J. H. H.; Collins, G.; Rainer, T.; Ng, S. C.; Poon, W. S.			Traumatic intracerebral haemorrhage: Is the CT pattern related to outcome?	BRITISH JOURNAL OF NEUROSURGERY			English	Article						Cerebral contusion; intracerebral haemorrhage; outcome; trauma	BRAIN-INJURY; PROGNOSTIC VALUE; HEAD-INJURY; COMA	It is believed by many neurosurgeons that in addition to age and neurological status, the CT patterns of traumatic intracerebral haemorrhages are related to outcome. The aim of this study was to find out whether this is the case. The study was conducted in a regional level I trauma centre in Hong Kong. We prospectively collected data of patients with traumatic intracerebral haematomas over a 4-year period. Of 464 patients with head injuries, traumatic intracerebral haematoma was significantly associated with inpatient mortality and one year unfavorable outcome after adjustment for age, sex, post-resuscitation GCS, and presence of acute subdural haematoma. One hundred-and-fourteen patients had traumatic intracerebral haematomas and were included for further analysis. The mean age was 49, the male to female ratio was 2 to 1, and the median Glasgow Coma Scale (GCS) score on admission was 12. Logistic regression analysis showed that age and GCS score/GCS motor component score were significant factors for inpatient mortality, one-year mortality and one-year outcome. There was an association between temporal haematomas and inpatient mortality, subdural haematomas and inpatient mortality, and bilateral haematomas and unfavourable one-year outcome. In patients with severe head injury, a traumatic haematoma of more than 50 ml was associated higher inpatient mortality. In addition to age and GCS score, the CT patterns of bilateral haematomas, temporal haematomas and associated subdural haematomas were suggestive of poor outcome or mortality.	[Wong, G. K.] Chinese Univ Hong Kong, Dept Surg, Div Neurosurg, Prince Wales Hosp, Shatin, Hong Kong, Peoples R China; [Yeung, J. H. H.; Collins, G.; Rainer, T.] Chinese Univ Hong Kong, Prince Wales Hosp, Accid & Emergency Med Acad Unit, Hong Kong, Hong Kong, Peoples R China	Wong, GK (corresponding author), Chinese Univ Hong Kong, Dept Surg, Div Neurosurg, Prince Wales Hosp, Shatin, Hong Kong, Peoples R China.	georgewong@surgery.cuhk.edu.hk	Rainer, Timothy H/I-2591-2013; Poon, Wai Sang/F-1558-2011; Tang, Yan Ho Bruce/X-4573-2019; Wong, George Kwok Chu/L-4344-2016; Wong, George KC/A-6378-2011; Graham, Colin/B-4535-2013	Rainer, Timothy H/0000-0003-3355-3237; Tang, Yan Ho Bruce/0000-0002-5374-8472; Wong, George KC/0000-0002-6078-2548; Graham, Colin/0000-0002-4381-7470			ANDREWS BT, 1988, J NEUROSURG, V69, P518, DOI 10.3171/jns.1988.69.4.0518; [Anonymous], 2008, BMJ-BRIT MED J, V336, P425, DOI DOI 10.1136/bmj.39461.643438.25; Caroli M, 2001, SURG NEUROL, V56, P82, DOI 10.1016/S0090-3019(01)00540-7; Fleminger S, 2005, BRIT MED J, V331, P1419, DOI 10.1136/bmj.331.7530.1419; JENNETT B, 1975, LANCET, V1, P480; KUMCHEV Y, 1998, FOLIO MED PLOVDIV, V4091, P52; LOBATO RD, 1983, J NEUROSURG, V59, P762, DOI 10.3171/jns.1983.59.5.0762; Maas AIR, 2007, J NEUROTRAUM, V24, P303, DOI 10.1089/neu.2006.0033; Marmarou A, 2007, J NEUROTRAUM, V24, P270, DOI 10.1089/neu.2006.0029; Mushkudiani NA, 2007, J NEUROTRAUM, V24, P259, DOI 10.1089/neu.2006.0028; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; TEASDALE G, 1974, LANCET, V2, P81	12	17	19	1	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0268-8697	1360-046X		BRIT J NEUROSURG	Br. J. Neurosurg.		2009	23	6					601	605		10.3109/02688690902948184			5	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	585TK	WOS:000276851900008	19922273				2021-06-18	
J	Yanagawa, Y; Sakamoto, T; Takasu, A; Okada, Y				Yanagawa, Youchi; Sakamoto, Toshihisa; Takasu, Akira; Okada, Yoshiaki			Relationship Between Maximum Intracranial Pressure and Traumatic Lesions Detected by T2*-Weighted Imaging in Diffuse Axonal Injury	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						Intracranial pressure; T2*-weighted image; diffuse axonal injury	BRAIN-INJURY; HEAD-INJURY; NEUROPATHOLOGY; BIOMECHANICS; MECHANISMS; CHILDREN; IMPACT; MODEL; STATE; COMA	Background., We prospectively investigated whether the number of traumatic lesions detected by magnetic resonance imaging correlated with the level of intracranial pressure (ICP) and outcome among patients with diffuse axonal injury (DAI). Materials: We prospectively studied 19 patients with closed head injuries who were admitted to the Critical Care and Trauma Services at our medical center and who fulfilled the following criteria: did not recover to a Glasgow Coma Scale score greater than 8 after impact, without fixed dilated pupils, and with initial computed tomography findings compatible with DAI. All subjects (n = 19) underwent ICP monitoring for at least 4 days, and T2*-gradient echo imaging was performed within 4 weeks of the impact. Results: A significantly positive correlation was found between the number of lesions detected by magnetic resonance imaging and maximum ICP. The average Glasgow Coma Scale in the good outcome group (Glasgow Outcome Scale IV and V, n = 8) was significantly greater than that in the poor outcome group (Glasgow Outcome Scale I-III, n = 11). The average maximum ICP and the number of lesions in the good outcome group were significantly less than those in the poor outcome group. Conclusion: The number of lesions detected by T2*-gradient echo imaging correlates with the degree of intracranial hypertension and outcome in DAI.	[Yanagawa, Youchi; Sakamoto, Toshihisa; Takasu, Akira; Okada, Yoshiaki] Natl Def Med Coll, Dept Traumatol & Crit Care Med, Tokorozawa, Saitama 3598513, Japan	Yanagawa, Y (corresponding author), Natl Def Med Coll, Dept Traumatol & Crit Care Med, 3-2 Tokorozawa, Tokorozawa, Saitama 3598513, Japan.	yangawa@me.ndmc.ac.jp		Takasu, Akira/0000-0003-3430-0119			Adams JH, 2000, BRAIN, V123, P1327, DOI 10.1093/brain/123.7.1327; Association for the Advancement of Automotive Medicine, 1990, ABBR INJ SCAL 1990 R; Balestreri M, 2006, NEUROCRIT CARE, V4, P8, DOI 10.1385/NCC:4:1:008; Beaumont A, 2006, ACTA NEUROCHIR SUPPL, V96, P171; Czosnyka M, 2006, ACTA NEUROCHIR SUPPL, V96, P114; Ezaki Y, 2006, ACTA RADIOL, V47, P733, DOI 10.1080/02841850600771486; Geddes-Klein DM, 2006, J NEUROTRAUM, V23, P193, DOI 10.1089/neu.2006.23.193; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Gerber DJ, 2004, BRAIN INJURY, V18, P1083, DOI 10.1080/02699050410001672341; Hadjigeorgiou GM, 2005, NEUROLOGY, V65, P1077, DOI 10.1212/01.wnl.0000178890.93795.0e; Hiler M, 2006, J NEUROSURG, V104, P731, DOI 10.3171/jns.2006.104.5.731; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Lee TT, 1998, ACTA NEUROCHIR, V140, P41, DOI 10.1007/s007010050055; Manley GT, 2006, J NEUROTRAUM, V23, P128, DOI 10.1089/neu.2006.23.128; Marmarou A, 1990, Adv Neurol, V52, P233; Matute C, 2006, GLIA, V53, P212, DOI 10.1002/glia.20275; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; Ommaya AK, 2002, BRIT J NEUROSURG, V16, P220, DOI 10.1080/02688690220148824; Reinert M, 2000, Neurosurg Focus, V8, pe10; Schafer PW, 2004, RADIOLOGY, V233, P58, DOI 10.1148/radiol.2323031173; Scheid R, 2006, ARCH NEUROL-CHICAGO, V63, P418, DOI 10.1001/archneur.63.3.418; Scheid R, 2003, AM J NEURORADIOL, V24, P1049; Stiefel MF, 2005, J NEUROSURG, V103, P707, DOI 10.3171/jns.2005.103.4.0707; SULLIVAN HG, 1976, J NEUROSURG, V45, P520, DOI 10.3171/jns.1976.45.5.0520; Tomei G, 1991, J Neurosurg Sci, V35, P61; Tong KA, 2004, ANN NEUROL, V56, P36, DOI 10.1002/ana.20123; Tong KA, 2003, RADIOLOGY, V227, P332, DOI 10.1148/radiol.2272020176; Uzzell B P, 1990, Adv Neurol, V52, P269; Vlodavsky E, 2006, NEUROPATH APPL NEURO, V32, P40, DOI 10.1111/j.1365-2990.2005.00698.x; Woiciechowsky C, 2005, ACT NEUR S, V95, P373; Yanagawa Y, 2000, J TRAUMA, V49, P272, DOI 10.1097/00005373-200008000-00013; Yang Shu-Yuan, 2004, Chin J Traumatol, V7, P159	32	17	17	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	JAN	2009	66	1					162	165		10.1097/TA.0b013e3181469857			4	Critical Care Medicine; Surgery	General & Internal Medicine; Surgery	395SJ	WOS:000262543500021	19131819				2021-06-18	
J	Maher, AD; Patki, P; Lindon, JC; Want, EJ; Holmes, E; Craggs, M; Nicholson, JK				Maher, Anthony D.; Patki, Prasad; Lindon, John C.; Want, Elizabeth J.; Holmes, Elaine; Craggs, Michael; Nicholson, Jeremy K.			Seminal Oligouridinosis: Low Uridine Secretion as a Biomarker for Infertility in Spinal Neurotrauma	CLINICAL CHEMISTRY			English	Article								BACKGROUND: Compromised sexual health is a major rehabilitative barrier for men with lower-spinal cord injury (SCI). Although studies have revealed decreased sperm motility, the quantitative biochemical changes that underlie the infertility mechanism remain poorly understood. METHODS: We employed a nontargeted approach combining 800 MHz hydrogen nuclear magnetic resonance (H-1 NMR) spectroscopy and ultra-performance liquid chromatography-mass spectrometry (UPLC-MS) with pattern recognition methods to analyze seminal fluid metabolite profiles in 10 men with and 8 without SCI above thoracic vertebra 10 (T10). RESULTS: The metabolic phenotype for SCI could be predicted from the H-1 NMR data. The median concentration of uridine in fertile controls was 1.55 mmol/L (range 1.0-5.0 mmol/L), but was undetectable by both NMR and MS in all but 2 individuals from the SCI group, one who later fathered a child without assisted fertility techniques. CONCLUSIONS: We hypothesize that uridine is likely to be an essential precursor to metabolites required for capacitation and is a potential marker for the prognosis of post-SCI functional fertility recovery. We derived the term "seminal oligouridinosis" to describe this newly identified condition.	[Patki, Prasad; Craggs, Michael] Royal Natl Orthopaed Hosp, Dept Neurol, Stanmore HA7 4LP, Middx, England; [Maher, Anthony D.; Lindon, John C.; Want, Elizabeth J.; Holmes, Elaine; Nicholson, Jeremy K.] Univ London Imperial Coll Sci Technol & Med, Dept Biomol Med, SORA Div, Fac Med, London, England; [Craggs, Michael] Univ Coll London, Div Surg & Intervent Sci, Stanmore, Middx, England; [Craggs, Michael] Royal Natl Orthopaed Hosp, Spinal Res Ctr, Stanmore HA7 4LP, Middx, England	Craggs, M (corresponding author), Royal Natl Orthopaed Hosp, Dept Neurol, Stanmore HA7 4LP, Middx, England.	michael.craggs@ucl.ac.uk; j.nicholson@imperial.ac.uk	Nicholson, Jeremy K/B-3395-2012; Holmes, Elaine/ABE-6606-2020	Nicholson, Jeremy K/0000-0002-8123-8349; Holmes, Elaine/0000-0002-0556-8389; Lindon, John/0000-0002-0916-6360	EUEuropean Commission [LSHG-512066]	Research Funding: A.D. Maher received funding from the EU FP6 MolPAGE project (LSHG-512066).	Brackett NL, 1999, HUM REPROD UPDATE, V5, P216, DOI 10.1093/humupd/5.3.216; Lindon JC, 2007, FEBS J, V274, P1140, DOI 10.1111/j.1742-4658.2007.05673.x; LYNCH MJ, 1994, J PHARMACEUT BIOMED, V12, P5, DOI 10.1016/0731-7085(94)80004-9; Nicholson JK, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100095; Niemeyer T, 2006, NUCLEOS NUCLEOT NUCL, V25, P1215, DOI 10.1080/15257770600894584; Patki P, 2008, J SPINAL CORD MED, V31, P27, DOI 10.1080/10790268.2008.11753977; Trygg J, 2002, J CHEMOMETR, V16, P283, DOI 10.1002/cem.724; World Health Organization, 1999, WHO LAB MAN EX HUM S	8	17	17	0	9	AMER ASSOC CLINICAL CHEMISTRY	WASHINGTON	2101 L STREET NW, SUITE 202, WASHINGTON, DC 20037-1526 USA	0009-9147	1530-8561		CLIN CHEM	Clin. Chem.	DEC	2008	54	12					2063	2066		10.1373/clinchem.2008.112219			4	Medical Laboratory Technology	Medical Laboratory Technology	377JZ	WOS:000261248800020	18832471				2021-06-18	
J	Noble, AJ; Schenk, T				Noble, Adam J.; Schenk, Thomas			Posttraumatic stress disorder in the family and friends of patients who have suffered spontaneous subarachnoid hemorrhage Clinical article	JOURNAL OF NEUROSURGERY			English	Article						caregiver; family; outcome; posttraumatic stress disorder; subarachnoid hemorrhage	TRAUMATIC BRAIN-INJURY; LIAISON NURSE SERVICE; QUALITY-OF-LIFE; PSYCHOSOCIAL OUTCOMES; COPING STYLE; PROGNOSTIC-FACTORS; DEPRESSION SCALE; HOSPITAL ANXIETY; ASAH PATIENTS; CARERS	Object. Significant others (SOS). Such as Spouses and life partners, of patients who have survived subarachnoid hemorrhage (SAH) can experience psychiatric symptoms and psychosocial disability. The cause of Such symptoms has not been established. Authors of the present Study analyzed whether posttraumatic stress disorder (PTSD) subsequent 10 it loved one's SAH is a plausible explanation for these symptoms. Methods. The authors examined a large representative sample of 86 patient/SO pairs 3.5 months postictus. All SOS were evaluated using a diagnostic PTSD Measure. and coping skills were assessed. The cognitive, physical. and emotional Status of patients was comprehensively examined. Results. Twenty-six percent of SOS met the diagnostic criteria for PTSD, which represents a 3-fold increase ill the rate expected within the general Population. To establish the cause of PTSD, a logistic regression was performed, and results of this test showed that the use of maladaptive coping strategies was the best predictor of the disorder. A patient's level of disability held no significant association with the development of PTSD in his or her SO. Conclusions. The elevated incidence of PTSD in SOS helps to explain why these persons report concerning levels of psychiatric symptomatology and psychosocial disability. Greater attention must be given to an SO's adjustment to the experience of having, it loved one stiffer an SAH. This need is all the inore pertinent ggiven that SOS often act,is informal caregivers and that PTSD Could interfere with their ability to effectively minister. Because bad coping skills seem to be the main cause of PTSD. teaching SOS better strategies might prevent the disorder and any resulting psychosocial disability. (DOI: 10.3171/JNS.2008.109.12.1027)	[Noble, Adam J.] Univ Durham, Wolfson Res Inst, Dept Psychol, Stockton On Tees TS17 6BH, England	Noble, AJ (corresponding author), Univ Durham, Wolfson Res Inst, Dept Psychol, Queens Campus, Stockton On Tees TS17 6BH, England.	a_j_noble@hotmail.com	Noble, Adam/A-2786-2013; Noble, Adam/F-2604-2013	Noble, Adam/0000-0002-8070-4352	Clarke Lister Brain Haemorrhage Foundation	We are most grateful to the patients and families who willingly participated in this research and to the Clarke Lister Brain Haemorrhage Foundation for their generous Support of this research.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Azoulay E, 2005, AM J RESP CRIT CARE, V171, P987, DOI 10.1164/rccm.200409-1295OC; Berry E, 1997, BRIT J NEUROSURG, V11, P378; Berry E, 1998, BRIT J CLIN PSYCHOL, V37, P365, DOI 10.1111/j.2044-8260.1998.tb01392.x; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1002/jts.2490080106; Bryant RA, 2000, BRAIN INJURY, V14, P175, DOI 10.1080/026990500120826; BRYANT RA, 1995, BEHAV RES THER, V33, P631, DOI 10.1016/0005-7967(94)00093-Y; Buchanan KM, 2000, NEUROSURGERY, V46, P831, DOI 10.1097/00006123-200004000-00012; Cadell S, 2003, AIDS CARE, V15, P639, DOI 10.1080/09540120310001595122; Carver CS, 1997, INT J BEHAV MED, V4, P92, DOI 10.1207/s15327558ijbm0401_6; Crawford JR, 2001, BRIT J CLIN PSYCHOL, V40, P429, DOI 10.1348/014466501163904; de Vries APJ, 1999, PEDIATRICS, V104, P1293, DOI 10.1542/peds.104.6.1293; DRAKE CG, 1988, J NEUROSURG, V68, P985; Eid J, 2003, PERS INDIV DIFFER, V35, P771, DOI 10.1016/S0191-8869(02)00282-9; Foa E.B., 1995, POSTTRAUMATIC STRESS; FOA EB, 1989, BEHAV THER, V20, P155, DOI 10.1016/S0005-7894(89)80067-X; Fuemmeler BF, 2005, CHILD HEALTH CARE, V34, P289, DOI 10.1207/s15326888chc3404_4; Fuemmeler BF, 2001, CHILD HEALTH CARE, V30, P169, DOI 10.1207/S15326888CHC3003_1; Gil S, 2005, ANXIETY STRESS COPIN, V18, P351, DOI 10.1080/10615800500392732; Hellawell DJ, 2001, DISABIL REHABIL, V23, P300, DOI 10.1080/769979114; Hellawell DJ, 1999, CLIN REHABIL, V13, P333, DOI 10.1191/026921599669500092; Hop JW, 1998, STROKE, V29, P798, DOI 10.1161/01.STR.29.4.798; Hop JW, 2001, J NEUROSURG, V95, P957, DOI 10.3171/jns.2001.95.6.0957; Hutter B, 2000, NEUROPSYCHOLOGICAL S; LEZAK MD, 1988, J CLIN EXP NEUROPSYC, V10, P111, DOI 10.1080/01688638808405098; Low JTS, 1999, SOC SCI MED, V49, P711, DOI 10.1016/S0277-9536(99)00194-X; MCKENNA P, 1989, BRIT MED J, V299, P485, DOI 10.1136/bmj.299.6697.485; Mezue W, 2004, BRIT J NEUROSURG, V18, P135, DOI 10.1080/02688690410001680984; ODER W, 1990, SCAND J REHABIL MED, V22, P85; ODER W, 1991, J NEUROSURG, V74, P601, DOI 10.3171/jns.1991.74.4.0601; Ogden JA, 1997, NEUROSURGERY, V41, P25, DOI 10.1097/00006123-199707000-00008; OYEBODE F, 1986, BRIT J HOSP MED, V36, P104; OYEBODE F, 1986, BR J HOSP MED, V36, P106; OYEBODE J, 2003, ADV PSYCHIAT TREATME, V9, P45; PARKER G, 1990, DUE CARE ATTENTION R; PONSTORD J, 1995, TRAUMATIC BRAIN INJU; Pritchard C, 2004, BRIT J NEUROSURG, V18, P347, DOI 10.1080/02688690400004993; Pritchard C, 2004, SURG NEUROL, V62, P7, DOI 10.1016/j.surneu.2004.01.018; Pritchard C, 2004, SURG NEUROL, V62, P17, DOI 10.1016/j.surneu.2004.01.019; Pritchard C, 2001, BRIT J NEUROSURG, V15, P456, DOI 10.1080/02688690120097679; ROBERTS AR, 1994, CRISIS INTERV TIME-L, V1, P1; *STAT U NEW YORK B, 1993, GUID US UN DAT SET M; Toomela A, 2004, J REHABIL MED, V36, P63, DOI 10.1080/16501970310017414; Turton P, 2006, BRIT J PSYCHIAT, V188, P165, DOI 10.1192/bjp.188.2.165; van Gijn J, 2007, LANCET, V369, P306, DOI 10.1016/S0140-6736(07)60153-6; Wermer MJH, 2007, NEUROSURGERY, V60, P91, DOI 10.1227/01.NEU.0000249215.19591.86; Wilson B., 1999, RIVERMEAD BEHAV MEMO; Wilson BA, 1996, BEHAV ASSESSMENT DYS; Younger P, 2003, MATER WORLD, V11, P25; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	51	17	19	0	13	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085			J NEUROSURG	J. Neurosurg.	DEC	2008	109	6					1027	1033		10.3171/JNS.2008.109.12.1027			7	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	376SY	WOS:000261204500011	19035715				2021-06-18	
J	Stola, A; Perlman, J				Stola, Anita; Perlman, Jeffrey			Post-resuscitation strategies to avoid ongoing injury following intrapartum hypoxia-ischemia	SEMINARS IN FETAL & NEONATAL MEDICINE			English	Article						Hypoglycemia; Hypotension; Modest hypothermia; Neuroprotection; Seizures; Ventilator management	SEVERE INTRAVENTRICULAR HEMORRHAGE; WHOLE-BODY HYPOTHERMIA; BRAIN-INJURY; PERINATAL ASPHYXIA; NEONATAL BRAIN; SELECTIVE HEAD; CONTROLLED TRIAL; NEWBORN-INFANTS; NEURONAL RESCUE; CEREBRAL-PALSY	The interruption of placental. blood flow during labor with redistribution of cardiac output resulting in increased flow to brain, heart, and adrenal glands at the expense of flow to kidney, gut, and skin can result in systemic organ as well as cerebral injury. Thus, post-resuscitation strategies should focus on both the management of potential systemic organ dysfunction and on methods of preventing ongoing brain injury in high-risk infants. General management strategies should include ventilator management to maintain pCO(2) values in the normal range, close attention to blood pressure to avoid hypotension, striving to avoid hypoglycemia, and control of seizures. Modest hypothermia administered within the first 6 hours has been shown to reduce neurodevelopmental deficits and death in those infants at highest-risk infants for developing hypoxic-ischemic brain injury. (C) 2008 Elsevier Ltd. All rights reserved.	[Stola, Anita; Perlman, Jeffrey] Weill Cornell Med Coll, New York, NY 10021 USA	Perlman, J (corresponding author), Weill Cornell Med Coll, New York, NY 10021 USA.	jmp2007@med.cornell.edu					Arvin KL, 2002, ANN NEUROL, V52, P54, DOI 10.1002/ana.10242; Aydin A, 2003, BRAIN DEV-JPN, V25, P494, DOI 10.1016/S0387-7604(03)00039-1; Azzopardi D, 2000, PEDIATRICS, V106, P684, DOI 10.1542/peds.106.4.684; AZZORPARDI D, TOBY TREATMENT PERIN; Benders MJNL, 2006, ARCH DIS CHILD-FETAL, V91, pF163, DOI 10.1136/adc.2005.086652; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; Bhat MA, 2006, J PEDIATR-US, V149, P180, DOI 10.1016/j.jpeds.2006.03.053; Blackmon LR, 2006, PEDIATRICS, V117, P942, DOI 10.1542/peds.2005-2950; Collins MP, 2001, PEDIATR RES, V50, P712, DOI 10.1203/00006450-200112000-00014; Dingley J, 2006, STROKE, V37, P501, DOI 10.1161/01.STR.0000198867.31134.ac; duPlessis AJ, 1997, CLIN PERINATOL, V24, P627; Dzhala V, 2000, ANN NEUROL, V48, P632, DOI 10.1002/1531-8249(200010)48:4<632::AID-ANA10>3.3.CO;2-V; Eicher DJ, 2005, PEDIATR NEUROL, V32, P11, DOI 10.1016/j.pediatrneurol.2004.06.014; Fabres J, 2007, PEDIATRICS, V119, P299, DOI 10.1542/peds.2006-2434; Ferriero DM, 2004, NEW ENGL J MED, V351, P1985, DOI 10.1056/NEJMra041996; Gluckman PD, 2005, LANCET, V365, P663, DOI 10.1016/S0140-6736(05)17946-X; GOLDBERG RN, 1986, J PEDIATR-US, V109, P851, DOI 10.1016/S0022-3476(86)80713-2; Grow J, 2002, CLIN PERINATOL, V29, P585, DOI 10.1016/S0095-5108(02)00059-3; Gunn AJ, 1997, J CLIN INVEST, V99, P248, DOI 10.1172/JCI119153; Gunn AJ, 1998, PEDIATRICS, V102, P1098, DOI 10.1542/peds.102.5.1098; Gunn AJ, 1998, PEDIATRICS, V102, P885, DOI 10.1542/peds.102.4.885; Halle JN, 1997, BRAIN RES, V759, P309, DOI 10.1016/S0006-8993(97)00364-8; HALLER DG, 1986, SEMIN ONCOL, V13, P2; Hankins GDV, 2002, OBSTET GYNECOL, V99, P688, DOI 10.1016/S0029-7844(02)01959-2; Higgins RD, 2006, J PEDIATR-US, V148, P170, DOI 10.1016/j.jpeds.2005.12.009; Holmes GL, 1998, ANN NEUROL, V44, P845, DOI 10.1002/ana.410440602; Holtzman DM, 1996, ANN NEUROL, V39, P114, DOI 10.1002/ana.410390117; Holzer M, 2002, NEW ENGL J MED, V346, P549; Ichiba H, 2002, PEDIATR INT, V44, P505, DOI 10.1046/j.1442-200X.2002.01610.x; Jenik AG, 2000, PEDIATRICS, V105, DOI 10.1542/peds.105.4.e45; Johnston BM, 1996, J CLIN INVEST, V97, P300, DOI 10.1172/JCI118416; Johnston MV, 2001, PEDIATR RES, V49, P735, DOI 10.1203/00006450-200106000-00003; Kaiser JR, 2006, J PERINATOL, V26, P279, DOI 10.1038/sj.jp.7211492; Kumral A, 2003, BIOL NEONATE, V83, P224, DOI 10.1159/000068926; Laptook AR, 2002, CLIN PERINATOL, V29, P623, DOI 10.1016/S0095-5108(02)00057-X; LAPTOOK AR, 1994, PEDIATR RES, V35, P436, DOI 10.1203/00006450-199404000-00010; Laptook AR, 2001, PEDIATRICS, V108, P1103, DOI 10.1542/peds.108.5.1103; LEVENE MI, 1983, ARCH DIS CHILD, V58, P1013, DOI 10.1136/adc.58.12.1013; LEVENE MI, 1987, DEV MED CHILD NEUROL, V29, P311; Liu XH, 1996, PEDIATR RES, V40, P797, DOI 10.1203/00006450-199612000-00004; LOREK A, 1994, PEDIATR RES, V36, P699, DOI 10.1203/00006450-199412000-00003; MARTINANCEL A, 1995, J PEDIATR-US, V127, P786, DOI 10.1016/S0022-3476(95)70174-5; MCINTOSH TK, 1989, BRAIN RES, V482, P252, DOI 10.1016/0006-8993(89)91188-8; Miller SL, 2005, DEV NEUROSCI-BASEL, V27, P200, DOI 10.1159/000085993; MIZRAHI EM, 1989, CLIN PERINATOL, V16, P485; NELSON KB, 1995, PEDIATRICS, V95, P263; PALMER C, 1995, CLIN PERINATOL, V22, P481; Peeters-Scholte C, 2003, PEDIATR RES, V54, P516, DOI 10.1203/01.PDR.0000081297.53793.C6; PERLMAN JM, 1989, AM J DIS CHILD, V143, P617, DOI 10.1001/archpedi.1989.02150170119037; RAJU TNK, 1982, MED INSTRUM, V16, P154; Salhab WA, 2004, PEDIATRICS, V114, P361, DOI 10.1542/peds.114.2.361; SCHER MS, 1993, PEDIATRICS, V91, P128; Shah PS, 2007, ARCH PEDIAT ADOL MED, V161, P951, DOI 10.1001/archpedi.161.10.951; Shalak L, 2004, EARLY HUM DEV, V80, P125, DOI 10.1016/j.earlhumdev.2004.06.003; Shankaran S, 2002, PEDIATRICS, V110, P377, DOI 10.1542/peds.110.2.377; Shankaran S, 2005, NEW ENGL J MED, V353, P1574, DOI 10.1056/NEJMcps050929; Shimizu K, 2003, NEUROSCI LETT, V346, P41, DOI 10.1016/S0304-3940(03)00558-5; Simbruner G, 1999, INTENS CARE MED, V25, P1111, DOI 10.1007/s001340051020; TAN WKM, 1994, AM J OBSTET GYNECOL, V170, P663, DOI 10.1016/S0002-9378(94)70245-4; Thoresen M, 1996, ARCH DIS CHILD-FETAL, V74, pF3, DOI 10.1136/fn.74.1.F3; Thoresen M, 2000, PEDIATRICS, V106, P92, DOI 10.1542/peds.106.1.92; TSANG RC, 1974, PEDIATRICS, V84, P428; Van Bel F, 1998, PEDIATRICS, V101, P185, DOI 10.1542/peds.101.2.185; Vannucci RC, 1997, PEDIATRICS, V100, P1004, DOI 10.1542/peds.100.6.1004; Volpe J., 2001, NEUROLOGY NEWBORN, V4th ed.; Wyatt JS, 2007, PEDIATRICS, V119, P912, DOI 10.1542/peds.2006-2839; Wyckoff MH, 2005, PEDIATRICS, V115, P950, DOI 10.1542/peds.2004-0913; Wyckoff M, 2007, PEDIATR RES, V61, P415, DOI 10.1203/pdr.0b013e3180332c45; YAGER J, 1993, PEDIATR RES, V34, P525, DOI 10.1203/00006450-199310000-00029; Yager JY, 2002, CLIN PERINATOL, V29, P651, DOI 10.1016/S0095-5108(02)00054-4	70	17	17	0	4	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1744-165X	1878-0946		SEMIN FETAL NEONAT M	Semin. Fetal Neonatal Med.	DEC	2008	13	6					424	431		10.1016/j.siny.2008.04.011			8	Pediatrics	Pediatrics	373KR	WOS:000260971000010	18501692				2021-06-18	
J	Prigatano, GP; Gray, J				Prigatano, George P.; Gray, Jennifer			Parental Perspectives on Recovery and Social Reintegration After Pediatric Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						children; memory; neuropsychological status; parental judgment; processing speed; recovery; severity of traumatic brain injury; social reintegration	HEAD-INJURY; CHILDREN; REHABILITATION; SCHOOL; OUTCOMES	To determine the validity of parental ratings of their child's overall recovery and social reintegration after pediatric traumatic brain injury (TBI). Setting: Primary care hospital/medical center. Participants: Ninety-nine children aged 6 to 16 years (80 with TBI and 19 orthopedic trauma controls) evaluated as outpatients. Main Outcome Measures: Parental ratings of overall recovery and social reintegration; neuropsychological test performance. Results: Severity of injury correlated with postacute parental ratings of the child's overall recovery (r = -0.498, N = 84, P =.001) and social reintegration (r = -0.507, N = 84, P =.001). A similar correlation was observed between TBI severity and a known "objective" market of recovery (Wechsler Intelligence Scale for Children-III Coding subtest; r = -0.503, N = 84, P =.001). Conclusions: The present findings support the concurrent validity of parental perspectives of a child's overall recovery and social reintegration after pediatric TBI. Incorporating these views may assist in the rehabilitation of children following brain injury. Parental reasons for Judging a child's recovery as may differ as a function of severity of injury.	[Prigatano, George P.; Gray, Jennifer] St Josephs Hosp, Barrow Neurol Inst, Div Neurol, Phoenix, AZ 85013 USA	Prigatano, GP (corresponding author), St Josephs Hosp, Barrow Neurol Inst, Div Neurol, 222 W Thomas Rd,St 315, Phoenix, AZ 85013 USA.	george.prigatano@chw.edu					Achenbach T. M., 1991, CHILD BEHAV CHECKLIS; Aitken ME, 2004, ARCH PHYS MED REHAB, V85, P567, DOI 10.1016/j.apmr.2003.06.018; Als H, 2004, PEDIATRICS, V113, P846, DOI 10.1542/peds.113.4.846; Anderson SW, 2000, DEV NEUROPSYCHOL, V18, P281, DOI 10.1207/S1532694202Anderson; Birch HG, 1964, BRAIN DAMAGE CHILDRE; Bloom DR, 2001, J AM ACAD CHILD PSY, V40, P572, DOI 10.1097/00004583-200105000-00017; Braga LW, 2005, BRAIN INJURY, V19, P819, DOI 10.1080/02699050500110165; Catroppa C, 2003, NEUROPSYCHOL REHABIL, V13, P517, DOI 10.1080/09602010343000084; Clark E, 1999, SCHOOL PSYCHOL REV, V28, P242; DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80; Donders J, 2004, J INT NEUROPSYCH SOC, V10, P482, DOI 10.1017/S1355617704104025; Ewing-Cobbs L, 2006, AM J NEURORADIOL, V27, P879; Ewing-Cobbs L, 2004, DEV NEUROPSYCHOL, V25, P107, DOI 10.1207/s15326942dn2501&2_7; Farmer JE, 1996, J LEARN DISABIL-US, V29, P532, DOI 10.1177/002221949602900508; Fuld P. A., 1981, FULD OBJECT MEMORY E; GLANG A, 1992, J HEAD TRAUMA REHAB, V7, P93; Hawley CA, 2003, BRAIN INJURY, V17, P1, DOI 10.1080/0269905021000010096; JAFFE KM, 1995, ARCH PHYS MED REHAB, V76, P17, DOI 10.1016/S0003-9993(95)80037-9; Jennett B, 1981, MANAGEMENT HEAD INJU; Johnson SC, 1994, NEUROPSYCHOLOGY, V8, P307, DOI DOI 10.1037/0894-4105.8.3.301; Klonoff PS, 2001, BRAIN INJURY, V15, P413, DOI 10.1080/02699050010005968; Laatsch L, 2007, J HEAD TRAUMA REHAB, V22, P248, DOI 10.1097/01.HTR.0000281841.92720.0a; Levin HS, 2000, NEUROLOGY, V54, P647, DOI 10.1212/WNL.54.3.647; Prigatano GP, 2008, CLIN NEUROPSYCHOL, V22, P603, DOI 10.1080/13854040701440501; Prigatano GP, 2007, DEV NEUROPSYCHOL, V32, P757, DOI 10.1080/87565640701539469; Prigatano GP, 2007, BRAIN INJURY, V21, P721, DOI 10.1080/02699050701481605; Prigatano GP, 2006, J HEAD TRAUMA REHAB, V21, P505, DOI 10.1097/00001199-200611000-00005; Prigatano GP, 2003, J INT NEUROPSYCH SOC, V9, P128, DOI 10.1017/S1355617703000134; Prigatano GP., 1999, PRINCIPLES NEUROPSYC; PRIGATANO GP, 2005, BNI SCREEN HIGHER CE; PRIGATANO GP, 1994, J HEAD TRAUMA REHAB, V9, P81; PRIGATANO GP, 2004, COMMUNITY SCH REINTE, P151; Reitan RM, 1955, MANUAL ADM NEUROPSYC; ROMANO MD, 1974, SCAND J REHABIL MED, V6, P1; Rutter M, 1983, DEV NEUROPSYCHIATRY, P83; *SPSS INC, 1998, SPSS BAS 8 0 WIND US; Strauss A.A, 1947, PSYCHOPATHOLOGY ED B; Wechsler D., 1991, WISC 3 WECHSLER INTE; Wozniak JR, 2007, ARCH CLIN NEUROPSYCH, V22, P555, DOI 10.1016/j.acn.2007.03.004; Yeates K O, 1997, J Int Neuropsychol Soc, V3, P617; Ylvisaker M, 2005, J HEAD TRAUMA REHAB, V20, P95, DOI 10.1097/00001199-200501000-00009	41	17	17	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	NOV-DEC	2008	23	6					378	387		10.1097/01.HTR.0000341433.67251.01			10	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	379WZ	WOS:000261428300003	19033830				2021-06-18	
J	Beaulieu, C; Wertheimer, JC; Pickett, L; Spierre, L; Schnorbus, T; Healy, W; Palmer, C; Jones, A				Beaulieu, Cynthia; Wertheimer, Jeffrey C.; Pickett, Lee; Spierre, Louise; Schnorbus, Tonya; Healy, Wendy; Palmer, Candace; Jones, Amy			Behavior management on an acute brain injury unit: Evaluating the effectiveness of an interdisciplinary training program	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						agitation; behavior management; crisis intervention; interdisciplinary; rehabilitation; restraints; traumatic brain injury	HEAD-INJURY; AGITATION; REHABILITATION; SCALE; THROMBOSIS; RESTRAINT; PATIENT	Objective: To measure the effect of behavior management training on restraint use and pm medication delivery on an acute inpatient brain injury unit. Setting/participants: Interdisciplinary staff and hospitalized brain injury patients on a 20-bed unit within a freestanding rehabilitation hospital. Intervention: Staff participated in the Nonviolent Crisis Intervention (R) (NCI) program from the Crisis Prevention Institute (R). Main outcome measures: Applied physical restraints and delivered pm medications. Results: Despite comparable patient levels of agitation severity across the duration of the study, the use of physical restraints initially declined and then increased after training. Data collected on pm medication delivery also indicated a trend for an increase in the delivery of select medication categories across time. Conclusion: NCI training resulted in a temporary, short-lived reduction in physical restraint use, but had an inverse effect oil pm medication delivery for select categories of medication. Medication delivery significantly increased over time and restraint use eventually exceeded baseline level. Ramifications of these results are discussed.	[Beaulieu, Cynthia; Pickett, Lee; Spierre, Louise; Schnorbus, Tonya; Palmer, Candace] Brooks Rehabil Hosp, Brain Injury Program, Jacksonville, FL 32216 USA; [Wertheimer, Jeffrey C.] Brooks Behavioral Med, Jacksonville, FL USA; [Healy, Wendy] Brooks Rehabil Fleming Isl, Orange Pk, FL USA	Beaulieu, C (corresponding author), Brooks Rehabil Hosp, Brain Injury Program, 3599 Univ Blvd, Jacksonville, FL 32216 USA.	cynthia.beaulieu@brookshealth.org					Allen MH, 2000, J CLIN PSYCHIAT, V61, P11; ARTIOLAIFORTUNY L, 1980, J NEUROL NEUROSUR PS, V43, P377, DOI 10.1136/jnnp.43.5.377; Beaulieu CL, 1997, ARCH CLIN NEUROPSYCH, V12, P285, DOI 10.1093/arclin/12.4.285a; Bogner JA, 1999, J HEAD TRAUMA REHAB, V14, P91, DOI 10.1097/00001199-199902000-00012; Bogner JA, 2001, AM J PHYS MED REHAB, V80, P636, DOI 10.1097/00002060-200109000-00002; BROOKE MM, 1992, ARCH PHYS MED REHAB, V73, P320, DOI 10.1016/0003-9993(92)90003-F; Calabro Karen, 2002, Issues Ment Health Nurs, V23, P3, DOI 10.1080/01612840252825446; CORRIGAN JD, 1994, J CLIN EXP NEUROPSYC, V16, P386, DOI 10.1080/01688639408402649; CORRIGAN JD, 1989, J CLIN EXP NEUROPSYC, V11, P261, DOI 10.1080/01688638908400888; DeYoung Sandra, 2002, J Gerontol Nurs, V28, P22; Fugate LP, 1997, ARCH PHYS MED REHAB, V78, P924, DOI 10.1016/S0003-9993(97)90051-4; Gilbert M, 1999, J NURS CARE QUAL, V13, P57, DOI 10.1097/00001786-199906000-00007; Goldstein LB, 2003, BRAIN INJURY, V17, P685, DOI 10.1080/0269905031000107179; GOLDSTEIN LB, 1995, J NEUROL NEUROSUR PS, V58, P753, DOI 10.1136/jnnp.58.6.753; Hem E, 2001, ACTA PSYCHIAT SCAND, V103, P73, DOI 10.1034/j.1600-0447.2001.00082.x; Inouye SK, 1996, JAMA-J AM MED ASSOC, V275, P852, DOI 10.1001/jama.275.11.852; JACOBS HE, 1993, BEHAV ANAL GUIDELINE; Laursen SB, 2005, ACTA PSYCHIAT SCAND, V111, P324, DOI 10.1111/j.1600-0447.2004.00456.x; Morrison EF, 2003, ARCH PSYCHIAT NURS, V17, P146, DOI 10.1016/S0883-9417(03)00085-2; MURPHY MC, 2002, J AM PSYCHIAT NURSES, V8, pS2; Mysiw WJ, 2006, BRAIN INJURY, V20, P905, DOI 10.1080/02699050600743972; MYSIW WJ, 1988, AM J PHYS MED REHAB, V67, P29, DOI 10.1097/00002060-198802000-00006; MYSIW WJ, 2007, BRAIN INJURY MED PRI, P283; Nott MT, 2006, BRAIN INJURY, V20, P1175, DOI 10.1080/02699050601049114; Petit JR, 2005, PSYCHIAT CLIN N AM, V28, P701, DOI 10.1016/j.psc.2005.05.011; POOLE J, 2005, INT J NURS PRACT, V11, P95; Roth DL, 2002, J GERONTOL B-PSYCHOL, V57, pP461, DOI 10.1093/geronb/57.5.P461; Sherer M, 2005, ARCH PHYS MED REHAB, V86, P896, DOI 10.1016/j.apmr.2004.09.029; Stanislav SW, 2000, BRAIN INJURY, V14, P261; Temple RO, 2007, REHABIL PSYCHOL, V52, P429, DOI 10.1037/0090-5550.52.4.429; Zafonte RD, 1997, ARCH PHYS MED REHAB, V78, P1103, DOI 10.1016/S0003-9993(97)90135-0; Zhu J, 2000, EXP NEUROL, V166, P136, DOI 10.1006/exnr.2000.7484	32	17	17	0	10	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	SEP-OCT	2008	23	5					304	311		10.1097/01.HTR.0000336843.60961.b7			8	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	357GN	WOS:000259834400005	18815507				2021-06-18	
J	Ellis, J; Del Castillot, E; Bayon, MM; Grimm, R; Clark, JF; Pyne-Geithman, G; Wilbur, S; Caruso, JA				Ellis, Jenny; Del Castillot, Estela; Montes Bayon, Maria; Grimm, Rudolf; Clark, Joseph F.; Pyne-Geithman, Gail; Wilbur, Steve; Caruso, Joseph A.			A preliminary study of metalloproteins in CSF by CapLC-ICPMS and nanoLC-CHIP/ITMS	JOURNAL OF PROTEOME RESEARCH			English	Article						metals; metalloproteins; ICPMS; nanoLC-CHIP/ITMS; stroke; vasospasm; cerebrospinal fluid; CSF	INTEGRATED MICROFLUIDIC DEVICE; PLASMA-MASS SPECTROMETRY; CEREBROSPINAL-FLUID; HUMAN SERUM; VASCULAR REACTIVITY; MAGNESIUM; LEAD; IRON; CHROMATOGRAPHY; MANGANESE	Cerebrospinal fluid (CSF) has frequently been studied to explore the total metal concentrations in patients with neurodegenerative diseases. Some examples of neurologic diseases include but are not limited to intracerebral hemorrhage, intraventricular hemorrhage, traumatic brain injury, subarachnoid hemorrhage and hydrocephalus. In this study, however, a comprehensive approach was begun using metallomics methods, First, two molecular weight cutoff filters were used to separate CSF constituents by molecular weight. The remaining CSF was then separated with capillary liquid chromatography/normal bore liquid chromatography and analyzed with inductively coupled mass spectrometry (ICPMS). With this ICPMS screening, a possible iron associated protein was suggested by nanoliquid chromatography-CHIP/ion trap mass spectrometry (nanoLC-CHIP/ITMS) identification in conjunction with a Spectrum Mill database search. In this preliminary study, three different types of pooled CSF were partially characterized by their metal (Pb, Mg, Zn, Fe and Cu) containing species with suggestions for fuller studies. Chemical 'differences' in the CSF and metal constituents suggests some utility in this analysis for understanding some of the complications observed following subarachnoid hemorrhage.	[Ellis, Jenny; Del Castillot, Estela; Caruso, Joseph A.] Univ Cincinnati, Dept Chem, Cincinnati, OH 45221 USA; [Ellis, Jenny; Grimm, Rudolf; Clark, Joseph F.; Pyne-Geithman, Gail; Wilbur, Steve; Caruso, Joseph A.] Univ Cincinnati, Agilent Technol Met Ctr Amer, Cincinnati, OH 45221 USA; [Grimm, Rudolf; Wilbur, Steve] Agilent Technol, Life Sci Sol Unit, Santa Clara, CA 95052 USA; [Clark, Joseph F.; Pyne-Geithman, Gail] Univ Cincinnati, Dept Neurol, Cincinnati, OH 45221 USA; [Del Castillot, Estela; Montes Bayon, Maria] Univ Oviedo, Fac Chem, Dept Phys & Analyt Chem, E-33006 Oviedo, Spain	Caruso, JA (corresponding author), Univ Cincinnati, Dept Chem, Cincinnati, OH 45221 USA.	joseph.caruso@uc.edu	Del Castillo Busto, M Estela/A-5868-2012	Del Castillo Busto, M.Estela/0000-0001-6595-5236	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS050569] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS050569-04] Funding Source: Medline		ALCOCK NW, 1969, CLIN SCI, V22, P185; BENEDICT CR, 1978, STROKE, V9, P237, DOI 10.1161/01.STR.9.3.237; Bergdahl IA, 1996, J ANAL ATOM SPECTROM, V11, P735, DOI 10.1039/ja9961100735; Bocca B, 2004, SPECTROCHIM ACTA B, V59, P559, DOI 10.1016/j.sab.2004.02.007; Busto MEDC, 2008, ANALYST, V133, P379, DOI 10.1039/b715311b; CARRIER O, 1976, BLOOD VESSELS, V13, P321; Durken M, 2000, FREE RADICAL BIO MED, V28, P887, DOI 10.1016/S0891-5849(00)00174-X; ELYAZIGI A, 1988, CLIN CHEM, V34, P1084; Fernandes KG, 2005, J ANAL ATOM SPECTROM, V20, P210, DOI 10.1039/b414185g; Fortier MH, 2005, ANAL CHEM, V77, P1631, DOI 10.1021/ac048506d; Fujioka M, 2000, STROKE, V31, P797; Fujiwara Y, 1999, TOXICOLOGY, V133, P147, DOI 10.1016/S0300-483X(99)00025-6; Godlewska-Zylkiewicz B, 1998, ANAL CHIM ACTA, V358, P185, DOI 10.1016/S0003-2670(97)00612-0; Gomez-Ariza JL, 2004, ANAL CHIM ACTA, V524, P15, DOI 10.1016/j.aca.2004.01.061; Hall GS, 1999, ANAL COMMUN, V36, P93, DOI 10.1039/a900478e; Hardouin J, 2007, J SEP SCI, V30, P1482, DOI 10.1002/jssc.200600444; Hardouin J, 2006, RAPID COMMUN MASS SP, V20, P3236, DOI 10.1002/rcm.2725; HORN E, 1906, MED REV, V32, P264; Idama TO, 1998, BRIT J OBSTET GYNAEC, V105, P260, DOI 10.1111/j.1471-0528.1998.tb10084.x; Inagaki K, 2000, ANALYST, V125, P197, DOI 10.1039/a907088e; IOSE I, 2006, NEW ENGL J MED, V354, P387; Jakubowski N, 2004, J ANAL ATOM SPECTROM, V19, P1, DOI 10.1039/b313299b; Kaltashov IA, 2006, ANAL BIOANAL CHEM, V386, P472, DOI 10.1007/s00216-006-0636-6; KASSELL NF, 1985, STROKE, V16, P562, DOI 10.1161/01.STR.16.4.562; Kessler H, 2006, J NEURAL TRANSM, V113, P1763, DOI 10.1007/s00702-006-0485-7; Kikumoto K, 1998, ANESTH ANALG, V87, P859, DOI 10.1097/00000539-199810000-00021; KIS B, 2007, PEPTIDE MEDIATORS BR; Lampl Y, 1998, J NEUROL, V245, P584, DOI 10.1007/s004150050249; Lazard EM, 1933, AM J OBSTET GYNECOL, V26, P647, DOI 10.1016/S0002-9378(33)90285-9; Loftspring MC, 2007, J NEUROCHEM, V102, P1990, DOI 10.1111/j.1471-4159.2007.04667.x; Mason MG, 2001, APPL ENVIRON MICROB, V67, P4512, DOI 10.1128/AEM.67.10.4512-4519.2001; McCord JM, 1998, SEMIN HEMATOL, V35, P5; Melo TM, 2003, BIOL TRACE ELEM RES, V93, P1, DOI 10.1385/BTER:93:1-3:1; Michalke B, 2007, ELECTROPHORESIS, V28, P1380, DOI 10.1002/elps.200600686; Michalke B, 2007, J ANAL ATOM SPECTROM, V22, P267, DOI 10.1039/b610639k; Molina JA, 1998, J NEURAL TRANSM, V105, P479, DOI 10.1007/s007020050071; MORELAND RS, 1981, ARCH BIOCHEM BIOPHYS, V208, P325, DOI 10.1016/0003-9861(81)90516-6; Muniz CS, 2001, J ANAL ATOM SPECTROM, V16, P587, DOI 10.1039/b100947h; Ni ZM, 2004, KIDNEY INT, V66, P2329, DOI 10.1111/j.1523-1755.2004.66032.x; Ninonuevo M, 2005, ELECTROPHORESIS, V26, P3641, DOI 10.1002/elps.200500246; Ninonuevo MR, 2006, J AGR FOOD CHEM, V54, P7471, DOI 10.1021/jf0615810; PALATY V, 1971, J PHYSIOL-LONDON, V218, P353, DOI 10.1113/jphysiol.1971.sp009622; Prange A, 2005, ANAL BIOANAL CHEM, V383, P372, DOI 10.1007/s00216-005-3420-0; PRASAD DMV, 1978, EUR J PHARMACOL, V52, P421, DOI 10.1016/0014-2999(78)90303-5; Purdy RE, 1997, AM J HYPERTENS, V10, P997, DOI 10.1016/S0895-7061(97)00108-8; PYNEGAITHMAN G, 2007, COMMUNICATION; RUSSELL WE, 1973, EUR J BIOCHEM, V33, P459, DOI 10.1111/j.1432-1033.1973.tb02703.x; SHULL S, 1991, J BIOL CHEM, V266, P24398; SPEICH M, 1989, CLIN CHEM, V35, P833; Srbek J, 2007, J SEP SCI, V30, P2046, DOI 10.1002/jssc.200700053; Stuerenburg HJ, 2000, J NEURAL TRANSM, V107, P321, DOI 10.1007/s007020050026; Suarez JI, 2006, NEW ENGL J MED, V354, P387, DOI 10.1056/NEJMra052732; Szpunar J., 2003, RSC CHROM M; Van Bergen P, 1999, FREE RADICAL RES, V31, P631, DOI 10.1080/10715769900301201; Venne K, 2005, ANAL CHEM, V77, P2176, DOI 10.1021/ac048410j; Vindlacheruvu Raghu R, 2002, Practitioner, V246, P608; Vollmer M, 2006, J SEP SCI, V29, P499, DOI 10.1002/jssc.200500334; Wagner KR, 2003, J CEREBR BLOOD F MET, V23, P629, DOI 10.1097/01.WCB.0000073905.87928.6D; WEBB RC, 1981, AM J PHYSIOL, V241, pH211; WEBER A, 1969, BIOCHEMISTRY-US, V8, P2266, DOI 10.1021/bi00834a005; Wijdicks EFM, 2001, J NEUROSURG, V94, P252, DOI 10.3171/jns.2001.94.2.0252; Yuan XL, 2005, J MASS SPECTROM, V40, P176, DOI 10.1002/jms.737; ZHENGYU L, 1995, NEUROSURGERY, V37, P1154	63	17	19	0	12	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1535-3893	1535-3907		J PROTEOME RES	J. Proteome Res.	SEP	2008	7	9					3747	3754		10.1021/pr800024k			8	Biochemical Research Methods	Biochemistry & Molecular Biology	345RZ	WOS:000259015500013	18662025	Green Accepted			2021-06-18	
J	Hartman, M; Watson, RS; Linde-Zwirble, W; Clermont, G; Lave, J; Weissfeld, L; Kochanek, P; Angus, D				Hartman, Mary; Watson, Robert Scott; Linde-Zwirble, Walter; Clermont, Gilles; Lave, Judith; Weissfeld, Lisa; Kochanek, Patrick; Angus, Derek			Pediatric traumatic brain injury is inconsistently regionalized in the United States	PEDIATRICS			English	Article						trauma; triage; brain injury; regionalization; pediatric	TRIAGE CRITERIA; BLUNT TRAUMA; SYSTEM; CARE; CHILDREN; CENTERS; MORTALITY; VOLUME; HOSPITALIZATION; MECHANISM	OBJECTIVES. Traumatic brain injury is a leading cause of death in children. On the basis of evidence of better outcomes, the American College of Surgery Committee on Trauma recommends that children with severe traumatic brain injury receive care at high-level trauma centers. We assessed rates of adherence to these recommendations and factors associated with adherence. METHODS. We studied population and hospital discharge data from 2001 from all of the health care referral regions (n = 68) in 6 US states (Florida, Massachusetts, New Jersey, New York, Texas, and Virginia). We identified children with severe traumatic brain injury by using International Classification of Diseases, Ninth Revision, Clinical Modification, codes and American College of Surgery Committee on Trauma criteria. We defined "high- level centers" as either level I or pediatric trauma centers. We considered an area to be well regionalized if >= 90% of severe traumatic brain injury hospitalizations were in high-level centers. We also explored how use of level II trauma centers affected rates of care at high-level centers. RESULTS. Of 2117 admissions for severe pediatric traumatic brain injury, 67.3% were in high-level centers, and 87.3% were in either high-level or level II centers. Among states, 56.4% to 93.6% of severe traumatic brain injury admissions were in high-level centers. Only 2 states, Massachusetts and Virginia, were well regionalized. Across health care referral regions, 0% to 100% of severe traumatic brain injury admissions were in high-level centers, and only 19.1% of health care referral regions were well regionalized. Only a weak relationship existed between the distance to the nearest high-level center and regionalization. The age of statewide trauma systems had no relationship to the extent of regionalization. CONCLUSIONS. Despite evidence for improved outcomes of severely injured children admitted to high-level trauma centers, we found that almost one third of the children with severe traumatic brain injury failed to receive care in such centers. Only 2 of 6 states and less than one fifth of 68 health care referral regions were well regionalized. This study highlights problems with current pediatric trauma care that can serve as a basis for additional research and health care policy.	[Hartman, Mary; Watson, Robert Scott; Linde-Zwirble, Walter; Clermont, Gilles; Lave, Judith; Weissfeld, Lisa; Angus, Derek] Univ Pittsburgh, Clin Res Investigat & Syst Modeling Acute Illness, Pittsburgh, PA 15261 USA; [Hartman, Mary] Duke Childrens Hosp, Div Pediat Crit Care Med, Durham, NC USA; [Kochanek, Patrick] Univ Pittsburgh, Dept Crit Care Med, Safar Ctr Resuscitat Res, Pittsburgh, PA 15261 USA; [Lave, Judith] Univ Pittsburgh, Dept Hlth Policy & Management, Pittsburgh, PA 15261 USA; [Weissfeld, Lisa] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Biostat, Pittsburgh, PA 15261 USA; [Linde-Zwirble, Walter] ZD Associates LLC, Perkasie, PA USA	Watson, RS (corresponding author), Univ Pittsburgh, Clin Res Investigat & Syst Modeling Acute Illness, 3550 Terrace St,Room 606C Scaife Hall, Pittsburgh, PA 15261 USA.	watsonrs@upmc.edu	Kochanek, Patrick M/D-2371-2015; Angus, Derek C/E-9671-2012	Kochanek, Patrick M/0000-0002-2627-913X; Watson, R. Scott/0000-0002-2581-7186	NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [T32 HD40686, K23 HD046489-04, K23 HD046489, T32 HD040686-08, T32 HD040686] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [T32HD040686] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K23HD046489] Funding Source: NIH RePORTER		*AG HEALTHC ADM, 2000, HOSP INP DAT FIL STA; *AM COLL SURG COMM, 1990, RES OPT CAR INJ PAT; American Hospital Association, 2000, AHA GUID HLTH CAR FI; Baez AA, 2003, J TRAUMA, V54, P344, DOI 10.1097/01.TA.0000046258.81127.E1; CALES RH, 1985, JAMA-J AM MED ASSOC, V254, P1059, DOI 10.1001/jama.254.8.1059; Champion HR, 1986, TRAUMA CARE SYSTEMS, P79; Demetriades D, 2005, ANN SURG, V242, P512, DOI 10.1097/01.sla.0000184169.73614.09; *DEP HLTH SEN SERV, 2000, DISCH DAT UB 92 YTD; *DEP PUBL HLTH, 2000, MASS HOSP INP DAT 19; Dudley RA, 2000, JAMA-J AM MED ASSOC, V283, P1159, DOI 10.1001/jama.283.9.1159; Hall JR, 1996, J PEDIATR SURG, V31, P72, DOI 10.1016/S0022-3468(96)90322-X; *HEALTHC INF COUNC, 2002, TEX HOSP INP DISCH P; Henry MC, 1996, AM J EMERG MED, V14, P124, DOI 10.1016/S0735-6757(96)90117-5; Hulka F, 1997, J TRAUMA, V42, P514, DOI 10.1097/00005373-199703000-00020; Iezzoni L I, 1990, Int J Technol Assess Health Care, V6, P272; Jager TE, 2000, ACAD EMERG MED, V7, P134, DOI 10.1111/j.1553-2712.2000.tb00515.x; Johnson DL, 1996, PEDIATR NEUROSURG, V25, P309, DOI 10.1159/000121145; KANE G, 1992, J TRAUMA, V32, P576, DOI 10.1097/00005373-199205000-00007; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Ma MHM, 1999, J TRAUMA, V46, P168; MacKenzie EJ, 2003, JAMA-J AM MED ASSOC, V289, P1515, DOI 10.1001/jama.289.12.1515; *MASS TRAUM CTR, 2002, MASS OFF EM MED SERV; Mullins RJ, 1998, J TRAUMA, V44, P609, DOI 10.1097/00005373-199804000-00009; Murray JA, 2000, AM SURGEON, V66, P863; NAKAYAMA DK, 1992, J PEDIATR SURG, V27, P427, DOI 10.1016/0022-3468(92)90328-5; Nathens AB, 2000, J TRAUMA, V48, P25, DOI 10.1097/00005373-200001000-00005; Nathens AB, 2000, JAMA-J AM MED ASSOC, V283, P1990, DOI 10.1001/jama.283.15.1990; Nathens AB, 2001, JAMA-J AM MED ASSOC, V285, P1164, DOI 10.1001/jama.285.9.1164; *NEW JERS DEP HLTH, 2002, NEW JERS TRAUM CTR; *NEW YORK STAT DEP, 2006, NEW YORK STAT TRAUM; *NEW YORK STAT DEP, 2000, NEW YORK STAT DEP HL; Ni H, 2002, INJURY PREV, V8, P60, DOI 10.1136/ip.8.1.60; Potoka DA, 2001, J TRAUMA, V51, P824, DOI 10.1097/00005373-200111000-00002; Potoka DA, 2000, J TRAUMA, V49, P237, DOI 10.1097/00005373-200008000-00009; Reid SR, 2001, ARCH PEDIAT ADOL MED, V155, P784, DOI 10.1001/archpedi.155.7.784; Rubenfeld GD, 1999, AM J RESP CRIT CARE, V160, P358, DOI 10.1164/ajrccm.160.1.9807118; Santaniello JM, 2003, SURGERY, V134, P698, DOI 10.1016/S0039-6060(03)00331-3; SHACKFORD SR, 1986, J TRAUMA, V26, P812, DOI 10.1097/00005373-198609000-00006; SHATNEY CH, 1994, J TRAUMA, V37, P275, DOI 10.1097/00005373-199408000-00021; *STAT DEP HLTH, 2002, STAT APPR TRAUM CTR; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; Trunkey DD, 2000, CLIN ORTHOP RELAT R, P36; Ventura S J, 2001, Natl Vital Stat Rep, V49, P1; *VIRG DEP HLTH OFF, 2006, TRAUM CTR; *VIRG HLTH INF, 2000, PUBL US FIL PUF1 PAT; *WASH STAT OFF EM, 2003, WASH STAT DES TRAUM	46	17	18	0	2	AMER ACAD PEDIATRICS	ELK GROVE VILLAGE	141 NORTH-WEST POINT BLVD,, ELK GROVE VILLAGE, IL 60007-1098 USA	0031-4005			PEDIATRICS	Pediatrics	JUL	2008	122	1					E172	E180		10.1542/peds.2007-3399			9	Pediatrics	Pediatrics	320YN	WOS:000257271200082	18595962	Green Accepted			2021-06-18	
J	Notturno, F; Caporale, CM; De Lauretis, A; Uncini, A				Notturno, Francesca; Caporale, Christina M.; De Lauretis, Angelo; Uncini, Antonino			Glial fibrillary acidic protein: A marker of axonal Guillain-Barre syndrome and outcome	MUSCLE & NERVE			English	Article						axonal GBS; glial fibrillary acidic protein; diagnostic marker; outcome	SCHWANN-CELL PROLIFERATION; INTERMEDIATE-FILAMENTS; MULTIPLE-SCLEROSIS; GFAP EXPRESSION; POLYNEUROPATHY; DEMYELINATION; NEUROPATHY; INJURY; ADULTS; ELISA	Glial fibrillary acid protein (GFAP) is increased in serum and cerebrospinal fluid of patients with dementia, traumatic brain injury, stroke, and multiple sclerosis. To determine whether GFAP is increased in Guillain-Barre syndrome (GBS) we evaluated serum GFAP in 30 controls, 20 patients with acute inflammatory demyelinating neuropathy (AIDP), and 17 with primary axonal GBS. Serum GFAP levels were increased in axonal GBS (median, 0.74) compared with controls (median, 0.41; P < 0.0001) and AIDP (median, 0.58; P = 0.0015). GFAP levels correlated with Hughes grades (serum r = 0.74; P < 0.0001) 6 months after neuropathy onset. Applying the cutoff value in serum of 0.63 to the diagnosis of axonal GBS, we obtained a sensitivity of 76.5% and a specificity of 86%. Thus, serum GFAP levels may be used in GBS as a diagnostic marker of the axonal variant and to predict outcome.	[Notturno, Francesca; Caporale, Christina M.; Uncini, Antonino] Univ G Dannunzio, Dept Human Motor Sci, I-66013 Chieti, Italy; [Notturno, Francesca; Caporale, Christina M.; Uncini, Antonino] Univ G Dannunzio, Neuromuscular Dis Unit, I-66013 Chieti, Italy; [Notturno, Francesca; Caporale, Christina M.; Uncini, Antonino] Fdn Univ G Dannunzio, Inst Aging, Neurol Clin, Osped SS Annunziata, I-66013 Chieti, Italy; [De Lauretis, Angelo] Catholic Univ, Dept Resp Dis, Rome, Italy	Uncini, A (corresponding author), Univ G Dannunzio, Dept Human Motor Sci, Via Dei Vestini, I-66013 Chieti, Italy.	uncini@unich.it		Notturno, Francesca/0000-0002-4191-6619			ASBURY AK, 1990, ANN NEUROL, V27, pS21, DOI 10.1002/ana.410270707; AUTILIOGAMBETTI L, 1982, J NEUROCHEM, V38, P774, DOI 10.1111/j.1471-4159.1982.tb08698.x; BIANCHINI D, 1992, BRAIN RES, V570, P209, DOI 10.1016/0006-8993(92)90583-U; Brisby H, 1999, SPINE, V24, P742, DOI 10.1097/00007632-199904150-00003; Cheng C, 2002, NEUROSCIENCE, V115, P321, DOI 10.1016/S0306-4522(02)00291-9; FEASBY TE, 1986, BRAIN, V109, P1115, DOI 10.1093/brain/109.6.1115; FIELDS KL, 1985, J NEUROIMMUNOL, V8, P311, DOI 10.1016/S0165-5728(85)80070-9; GRIFFIN JW, 1990, J NEUROCYTOL, V19, P367, DOI 10.1007/BF01188405; Hadden RDM, 1998, ANN NEUROL, V44, P780, DOI 10.1002/ana.410440512; Herrmann M, 2000, STROKE, V31, P2670, DOI 10.1161/01.STR.31.11.2670; Ho TW, 1997, NEUROLOGY, V48, P717, DOI 10.1212/WNL.48.3.717; Hughes RAC, 2005, LANCET, V366, P1653, DOI 10.1016/S0140-6736(05)67665-9; HUGHES RAC, 1978, LANCET, V2, P750, DOI 10.1016/s0140-6736(78)92644-2; JESSEN KR, 1984, J NEUROCYTOL, V13, P923, DOI 10.1007/BF01148594; JESSEN KR, 1990, DEVELOPMENT, V109, P91; Jessen KR, 1999, TRENDS NEUROSCI, V22, P402, DOI 10.1016/S0166-2236(98)01391-5; Malmestrom C, 2003, NEUROLOGY, V61, P1720, DOI 10.1212/01.WNL.0000098880.19793.B6; MANCARDI GL, 1991, J NEUROL SCI, V102, P177, DOI 10.1016/0022-510X(91)90066-G; MCKHANN GM, 1991, LANCET, V338, P593, DOI 10.1016/0140-6736(91)90606-P; Norgren N, 2004, NEUROLOGY, V63, P1586, DOI 10.1212/01.WNL.0000142988.49341.D1; OBRIEN MD, 2000, AIDS EXAMINATION PER; Petzold A, 2004, J IMMUNOL METHODS, V287, P169, DOI 10.1016/j.jim.2004.01.015; Petzold A, 2002, BRAIN, V125, P1462, DOI 10.1093/brain/awf165; Quattrini A, 1996, GLIA, V17, P294, DOI 10.1002/(SICI)1098-1136(199608)17:4<294::AID-GLIA4>3.0.CO;2-#; ROSENGREN LE, 1994, J NEUROSCI METH, V51, P197, DOI 10.1016/0165-0270(94)90011-6; TOEWS AD, 1992, J NEUROSCI, V12, P3676; Triolo D, 2006, J CELL SCI, V119, P3981, DOI 10.1242/jcs.03168; van Geel WJA, 2002, CLIN CHIM ACTA, V326, P151, DOI 10.1016/S0009-8981(02)00330-3; van Koningsveld R, 2007, LANCET NEUROL, V6, P589, DOI 10.1016/S1474-4422(07)70130-8; Vos PE, 2004, NEUROLOGY, V62, P1303, DOI 10.1212/01.WNL.0000120550.00643.DC	30	17	17	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0148-639X	1097-4598		MUSCLE NERVE	Muscle Nerve	JUL	2008	38	1					899	903		10.1002/mus.20983			5	Clinical Neurology; Neurosciences	Neurosciences & Neurology	319MP	WOS:000257168100010	18508349				2021-06-18	
J	Srivastava, N; Seth, K; Srivastava, N; Khanna, VK; Agrawal, AK				Srivastava, Nishi; Seth, Kavita; Srivastava, Nalini; Khanna, Vinay K.; Agrawal, Ashok Kumar			Functional restoration using basic fibroblast growth factor (bFGF) infusion in kainic acid induced cognitive dysfunction in rat: Neurobehavioural and neurochemical studies	NEUROCHEMICAL RESEARCH			English	Article						cognitive dysfunction; Kainic acid; bFGF; neurogenesis; dentate gyrus; BrdU; ChAT	HIPPOCAMPAL NEUROTROPHIN LEVELS; TRAUMATIC BRAIN-INJURY; TEMPORAL-LOBE EPILEPSY; LONG-TERM POTENTIATION; DENTATE GYRUS; ENHANCED NEUROGENESIS; ADULT HIPPOCAMPUS; KNOCKOUT MICE; KAINATE MODEL; PROLIFERATION	Neurogenesis occurs in dentate gyrus of adult hippocampus under the influence of various mitogenic factors. Growth factors besides instigating the proliferation of neuronal progenitor cells (NPCs) in dentate gyrus, also supports their differentiation to cholinergic neurons. In the present study, an attempt has been made to investigate the neurotrophic effect of bFGF in Kainic acid (KA) induced cognitive dysfunction in rats. Stereotaxic lesioning using (KA) was performed in hippocampal CA3 region of rat's brain. Four-weeks post lesioning rats were assessed for impairment in learning and memory using Y maze followed by bFGF infusion in dentate gyrus region. The recovery was evaluated after bFGF infusion using neurochemical, neurobehavioural and immunohistochemical approaches and compared with lesioned group. Significant impairment in learning and memory (P < 0.01) observed in lesioned animals, four weeks post lesioning exhibited significant restoration (P < 0.001) following bFGF infusion twice at one and four week post lesion. The bFGF infused animals exhibited recovery in hippocampus cholinergic (76%)/ dopaminergic (46%) receptor binding and enhanced Choline acetyltransferase (ChAT) immunoreactivity in CA3 region. The results suggest restorative potential of bFGF in cognitive dysfunctions, possibly due to mitogenic effect on dentate gyrus neurogenic area leading to generation and migration of newer cholinergic neurons.	[Srivastava, Nishi; Seth, Kavita; Khanna, Vinay K.; Agrawal, Ashok Kumar] Ind Toxicol Res Ctr, Div Dev Toxicol, Lucknow 226001, Uttar Pradesh, India; [Srivastava, Nalini] Jiwaji Univ, Sch Studies, Gwalior 474001, India	Agrawal, AK (corresponding author), Ind Toxicol Res Ctr, Div Dev Toxicol, Post Box 80,MG Marg, Lucknow 226001, Uttar Pradesh, India.	aka33@rediffmail.com	Singh, Nishi/A-1086-2009				Abrous DN, 2005, PHYSIOL REV, V85, P523, DOI 10.1152/physrev.00055.2003; Adhami VM, 1996, NEUROCHEM RES, V21, P915, DOI 10.1007/BF02532341; Agrawal AK, 2004, NEUROBIOL DIS, V16, P516, DOI 10.1016/j.nbd.2004.04.014; AGRAWAL AK, 1981, TOXICOL APPL PHARM, V58, P89, DOI 10.1016/0041-008X(81)90119-8; AULS DS, 2002, PROG NEUROBIOL, V68, P209; BARONE S, 1991, EXP NEUROL, V114, P351, DOI 10.1016/0014-4886(91)90161-5; Bauer S, 2006, J NEUROSCI, V26, P12089, DOI 10.1523/JNEUROSCI.3047-06.2006; Bellucci A, 2006, NEUROBIOL DIS, V23, P260, DOI 10.1016/j.nbd.2006.03.012; Broughton SK, 2007, J NEUROCHEM, V100, P628, DOI 10.1111/j.1471-4159.2006.04171.x; Chaturvedi RK, 2006, NEUROSCI LETT, V398, P44, DOI 10.1016/j.neulet.2005.12.042; Choi YS, 2003, MOL CELLS, V16, P232; Chun SK, 2006, NEUROBIOL LEARN MEM, V86, P322, DOI 10.1016/j.nlm.2006.05.005; Dinocourt C, 2006, EUR J NEUROSCI, V24, P1857, DOI 10.1111/j.1460-9568.2006.05067.x; Doetsch F, 2005, CURR OPIN NEUROBIOL, V15, P121, DOI 10.1016/j.conb.2005.01.018; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Fagan AM, 1997, J NEUROSCI, V17, P2499; Felling RJ, 2003, J NEUROSCI RES, V73, P277, DOI 10.1002/jnr.10670; Feng RB, 2001, NEURON, V32, P911, DOI 10.1016/S0896-6273(01)00523-2; Ford-Perriss M, 2001, CLIN EXP PHARMACOL P, V28, P493, DOI 10.1046/j.1440-1681.2001.03477.x; Gould E, 2002, J NEUROSCI, V22, P619, DOI 10.1523/JNEUROSCI.22-03-00619.2002; Gray WP, 1998, BRAIN RES, V790, P52, DOI 10.1016/S0006-8993(98)00030-4; Gross CG, 2000, NAT REV NEUROSCI, V1, P67, DOI 10.1038/35036235; Hagood SK, 2006, J NEUROTRAUM, V23, P205, DOI 10.1089/neu.2006.23.205; Ikeda T, 2002, INT J DEV NEUROSCI, V20, P555, DOI 10.1016/S0736-5748(02)00082-5; JIN K, 2005, P NATL ACAD SCI USA, V102, P17889; Kar S, 2004, J PSYCHIATR NEUROSCI, V29, P427; Kempermann G, 2004, CURR OPIN NEUROBIOL, V14, P186, DOI 10.1016/j.conb.2004.03.001; Laplante F, 2004, NEUROPSYCHOPHARMACOL, V29, P1620, DOI 10.1038/sj.npp.1300467; Leker RR, 2007, STROKE, V38, P153, DOI 10.1161/01.STR.0000252156.65953.a9; Lisman JE, 2001, HIPPOCAMPUS, V11, P551; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Machon O, 2005, MOL CELL NEUROSCI, V30, P388, DOI 10.1016/j.mcn.2005.08.003; MANFRED KRUG, 2001, HIPPOCAMPUS, V11, P157; Maric D, 2007, J NEUROSCI, V27, P1836, DOI 10.1523/JNEUROSCI.5141-06.2007; Monje ML, 2003, CURR OPIN NEUROL, V16, P129, DOI 10.1097/00019052-200304000-00002; Monje ML, 2003, SCIENCE, V302, P1760, DOI 10.1126/science.1088417; Monje ML, 2002, NAT MED, V8, P955, DOI 10.1038/nm749; Nakagawa E, 2000, EPILEPSIA, V41, P10, DOI 10.1111/j.1528-1157.2000.tb01498.x; Otmakhova NA, 1998, J NEUROSCI, V18, P1270; Otmakhova NA, 1996, J NEUROSCI, V16, P7478; Parent JM, 1997, J NEUROSCI, V17, P3727; PAXINOS G, 1997, RAT BRAIN STEREOTAXI; Ramirez JJ, 1999, NEUROREPORT, V10, P1201, DOI 10.1097/00001756-199904260-00008; Rola R, 2006, EXP NEUROL, V202, P189, DOI 10.1016/j.expneurol.2006.05.034; Rosato-Siri M, 2006, J PHYSIOL-LONDON, V576, P361, DOI 10.1113/jphysiol.2006.114587; Row BW, 2007, BEHAV BRAIN RES, V177, P308, DOI 10.1016/j.bbr.2006.11.028; Roy TS, 2002, J PHARMACOL EXP THER, V300, P124, DOI 10.1124/jpet.300.1.124; Shetty AK, 2004, J NEUROSCI RES, V78, P520, DOI 10.1002/jnr.20302; Shetty AK, 2003, J NEUROCHEM, V87, P147, DOI 10.1046/j.1471-4159.2003.01979.x; Shimazu K, 2006, LEARN MEMORY, V13, P307, DOI 10.1101/lm.76006; Smith C, 2001, EUR J NEUROSCI, V13, P443, DOI 10.1046/j.1460-9568.2001.01400.x; Spencer B, 2001, MOL THER, V3, P746, DOI 10.1006/mthe.2001.0307; Sun YJ, 2006, DEV BIOL, V289, P329, DOI 10.1016/j.ydbio.2005.10.016; Tureyen K, 2005, NEUROSURGERY, V57, P1254, DOI 10.1227/01.NEU.0000186040.96929.8A; Vorobyov V, 2005, BRAIN RES, V1051, P123, DOI 10.1016/j.brainres.2005.06.001; Yoshimura S, 2003, J CLIN INVEST, V112, P1202, DOI 10.1172/JCI200316618; Yoshimura S, 2001, P NATL ACAD SCI USA, V98, P5874, DOI 10.1073/pnas.101034998; Youssoufian M, 2007, EUR J NEUROSCI, V25, P1647, DOI 10.1111/j.1460-9568.2007.05428.x; Zaman V, 2001, NEUROBIOL DIS, V8, P942, DOI 10.1006/nbdi.2001.0440	59	17	21	0	0	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-3190	1573-6903		NEUROCHEM RES	Neurochem. Res.	JUL	2008	33	7					1169	1177		10.1007/s11064-007-9478-7			9	Biochemistry & Molecular Biology; Neurosciences	Biochemistry & Molecular Biology; Neurosciences & Neurology	307MF	WOS:000256322300001	17955369				2021-06-18	
J	Cotena, S; Piazza, O; Tufano, R				Cotena, S.; Piazza, O.; Tufano, R.			The use of erythtropoietin in cerebral diseases	PANMINERVA MEDICA			English	Article						erythropoietin; cerebral arterial diseases; neuroprotective agents	RECOMBINANT-HUMAN-ERYTHROPOIETIN; EXPERIMENTAL INTRACEREBRAL HEMORRHAGE; RECEPTOR MESSENGER-RNA; NECROSIS-FACTOR-ALPHA; BRAIN-INJURY; NEURONAL APOPTOSIS; FOCAL ISCHEMIA; NITRIC-OXIDE; WHOLE-BLOOD; CELL-DEATH	Global and focal cerebral ischemia is followed by a secondary damage characterized by oxidative stress, excitotoxicity, inflammation and apoptosis. Erythropoietin (EPO) exerts antiapoptotic, anti-inflammatory, antioxidative, angiogenetic and neurotrophic properties. Its potential therapeutic role has been demonstrated in several animal models of cerebral ischemia and also in a clinical trial of ischemic stroke, so it could be considered an ideal compound for neuroprotection in ischemic stroke and in cardiac arrest. Intracerebral hemorrhage (ICH) is the least treatable form of stroke; the mechanisms involved in the secondary brain injury include hematoma mass effect, neuronal apoptosis and necrosis, inflammation. It has been demonstrated in an experimental ICH that EPO intervenes in the inflammatory process, reduces brain water content, hemorrhage volume and hemispheric atrophy, promotes cell survival, preserves cerebral blood flow, has antiapoptotic protective function against oxidative stress and excitotoxic damage. EPO can attenuate acute vasoconstriction and prevent brain ischemic damage in subarachnoid hemorrhage. The neuroprotective function of EPO has been studied also in traumatic brain injury: it reduces the inflammation and improves cognitive and motor deficits. The authors review some of the physiological actions of EPO in the physiopathology of ischemic and hemorrhagic stroke, subarachnoid hemorrhage and brain trauma, and its potential usefulness in the brain injured patient management.	[Cotena, S.; Piazza, O.; Tufano, R.] Univ Naples Federico II, Dept Anesthesiol & Resuscitat, I-80131 Naples, Italy	Cotena, S (corresponding author), Univ Naples Federico II, Dept Anesthesiol & Resuscitat, Via Pansini 5 Ed 8, I-80131 Naples, Italy.	si_mi@inwind.it	Piazza, Ornella/Q-2716-2019; Piazza, Ornella/G-5339-2012	Piazza, Ornella/0000-0002-0316-5930			Adembri C, 2004, J NEUROTRAUM, V21, P1103, DOI 10.1089/0897715041651079; Agnello D, 2002, BRAIN RES, V952, P128, DOI 10.1016/S0006-8993(02)03239-0; Alafaci C, 2000, EUR J PHARMACOL, V406, P219, DOI 10.1016/S0014-2999(00)00691-9; Baron JC, 2005, CEREBROVASC DIS, V20, P154, DOI 10.1159/000087199; Bernaudin M, 1999, J CEREBR BLOOD F MET, V19, P643, DOI 10.1097/00004647-199906000-00007; Brines M, 2004, P NATL ACAD SCI USA, V101, P14907, DOI 10.1073/pnas.0406491101; Brines ML, 2000, P NATL ACAD SCI USA, V97, P10526, DOI 10.1073/pnas.97.19.10526; Bryl E, 1998, ARTIF ORGANS, V22, P177, DOI 10.1046/j.1525-1594.1998.06002.x; Calvillo L, 2003, P NATL ACAD SCI USA, V100, P4802, DOI 10.1073/pnas.0630444100; Castillo J, 2002, NEUROLOGY, V58, P624, DOI 10.1212/WNL.58.4.624; Chavez JC, 2006, J NEUROSCI, V26, P9471, DOI 10.1523/JNEUROSCI.2838-06.2006; Choi K, 1998, DEVELOPMENT, V125, P725; Citerio G, 2006, MINERVA ANESTESIOL, V72, P407; CLARK DA, 1986, J LAB CLIN MED, V108, P423; Coleman TR, 2006, P NATL ACAD SCI USA, V103, P5965, DOI 10.1073/pnas.0601377103; Coughlin SR, 2000, NATURE, V407, P258, DOI 10.1038/35025229; Coughlin SR, 1999, P NATL ACAD SCI USA, V96, P11023, DOI 10.1073/pnas.96.20.11023; Dery O, 1998, AM J PHYSIOL-CELL PH, V274, pC1429, DOI 10.1152/ajpcell.1998.274.6.C1429; Donovan FM, 1997, J NEUROSCI, V17, P5316; Ehrenreich H, 2002, MOL MED, V8, P495, DOI 10.1007/BF03402029; Ehrenreich H, 2004, MOL PSYCHIATR, V9, P42, DOI 10.1038/sj.mp.4001442; Ehrenreich H, 2001, EUR ARCH PSY CLIN N, V251, P149, DOI 10.1007/s004060170034; Ferriero DM, 2005, EPILEPSIA, V46, P45, DOI 10.1111/j.1528-1167.2005.00302.x; Gawel M, 2003, ANN NEUROL, V54, pS32; Gong C, 2000, BRAIN RES, V871, P57, DOI 10.1016/S0006-8993(00)02427-6; Grasso G, 2001, J Neurosurg Sci, V45, P7; Grasso G, 2002, P NATL ACAD SCI USA, V99, P5627, DOI 10.1073/pnas.082097299; Hamada R, 2000, STROKE, V31, P794, DOI 10.1161/01.STR.31.3.791-c; Hebert P C, 1999, Minerva Anestesiol, V65, P293; Henrich-Noack P, 2006, BRAIN RES, V1070, P232, DOI 10.1016/j.brainres.2005.10.100; Hua Y, 2003, J CEREBR BLOOD F MET, V23, P1448, DOI 10.1097/01.WCB.0000090621.86921.D5; Huang FP, 2002, J NEUROSURG, V96, P287, DOI 10.3171/jns.2002.96.2.0287; Iadecola C, 1997, TRENDS NEUROSCI, V20, P132, DOI 10.1016/S0166-2236(96)10074-6; JENKINS A, 1989, NEUROPATH APPL NEURO, V15, P477, DOI 10.1111/j.1365-2990.1989.tb01247.x; Juul SE, 1998, EARLY HUM DEV, V52, P235, DOI 10.1016/S0378-3782(98)00030-9; Keller M, 2006, NEUROBIOL DIS, V24, P357, DOI 10.1016/j.nbd.2006.07.007; Lee ST, 2006, J NEUROCHEM, V96, P1728, DOI 10.1111/j.1471-4159.2006.03697.x; Leist M, 2004, SCIENCE, V305, P239, DOI 10.1126/science.1098313; Li Y, 2007, J CEREBR BLOOD F MET, V27, P1043, DOI 10.1038/sj.jcbfm.9600417; Lu DY, 2005, J NEUROTRAUM, V22, P1011, DOI 10.1089/neu.2005.22.1011; Mayne M, 2001, ANN NEUROL, V49, P727, DOI 10.1002/ana.1010; Mayne M, 2001, STROKE, V32, P240, DOI 10.1161/01.STR.32.1.240; Morishita E, 1997, NEUROSCIENCE, V76, P105, DOI 10.1016/s0306-4522(96)00306-5; Nakamura T, 2004, J NEUROSURG, V100, P672, DOI 10.3171/jns.2004.100.4.0672; NICLOU S, 1994, CELL MOL BIOL, V40, P421; Noorbakhsh F, 2003, NAT REV NEUROSCI, V4, P981, DOI 10.1038/nrn1255; Peeling J, 2001, EXP NEUROL, V167, P341, DOI 10.1006/exnr.2000.7564; Power C, 2003, ANN NEUROL, V53, P731, DOI 10.1002/ana.10553; Qureshi AI, 2001, NEW ENGL J MED, V344, P1450, DOI 10.1056/NEJM200105103441907; Sakanaka M, 1998, P NATL ACAD SCI USA, V95, P4635, DOI 10.1073/pnas.95.8.4635; Santhanam AVR, 2006, AM J PHYSIOL-HEART C, V291, pH781, DOI 10.1152/ajpheart.00045.2006; Santhanam AVR, 2005, STROKE, V36, P2731, DOI 10.1161/01.STR.0000190021.85035.5b; Siren AL, 2001, P NATL ACAD SCI USA, V98, P4044, DOI 10.1073/pnas.051606598; Siren AL, 2001, EUR ARCH PSY CLIN N, V251, P179, DOI 10.1007/s004060170038; Siren AL, 2001, ACTA NEUROPATHOL, V101, P271, DOI 10.1007/s004010000297; Squadrito F, 1999, BRIT J PHARMACOL, V127, P482, DOI 10.1038/sj.bjp.0702521; Tsai PT, 2006, J NEUROSCI, V26, P1269, DOI 10.1523/JNEUROSCI.4480-05.2006; Villa P, 2003, J EXP MED, V198, P971, DOI 10.1084/jem.20021067; Villa P, 2007, J CEREBR BLOOD F MET, V27, P552, DOI 10.1038/sj.jcbfm.9600370; Wang HC, 2005, J MANUF SCI E-T ASME, V127, P33, DOI 10.1115/1.1830492; WEINSTEIN JR, 1995, J NEUROSCI, V15, P2906; Xi GH, 2006, LANCET NEUROL, V5, P53, DOI 10.1016/S1474-4422(05)70283-0; Xi GH, 2003, J NEUROCHEM, V84, P3, DOI 10.1046/j.1471-4159.2003.01268.x; Xue MZ, 2000, NEUROSCI LETT, V283, P230, DOI 10.1016/S0304-3940(00)00971-X; Yamaji R, 1996, EUR J BIOCHEM, V239, P494, DOI 10.1111/j.1432-1033.1996.0494u.x; Yatsiv I, 2005, FASEB J, V19, P1701, DOI 10.1096/fj.05-3907fje	66	17	21	0	3	EDIZIONI MINERVA MEDICA	TURIN	CORSO BRAMANTE 83-85 INT JOURNALS DEPT., 10126 TURIN, ITALY	0031-0808	1827-1898		PANMINERVA MED	Panminerva Medica	JUN	2008	50	2					185	192					8	Medicine, General & Internal	General & Internal Medicine	353LR	WOS:000259569800011	18607342				2021-06-18	
J	Dalen, K; Bruaroy, S; Wentzel-Larsen, T; Laegreid, LM				Dalen, K.; Bruaroy, S.; Wentzel-Larsen, T.; Laegreid, L. M.			Intelligence in Children with Hydrocephalus, Aged 4-15 Years: A Population-based, Controlled Study	NEUROPEDIATRICS			English	Article						hydrocephalus; psychology; non-verbal communication; neuropsychological tests		The aim of this population-based study is to investigate IQ and IQ-related factors in children with hydrocephalus (HC). Psychometric intelligence was assessed in subjects below the age of 7.3 years (N = 52, F = 18, M = 34) with the Wechsler Preschool and. Primary Scale of Intelligence - Revised (WPPSI-R) and for children above the age of 7.3 years (N = 29, F = 6, M = 23) with the Wechsler Intelligence Scale for Children - Revised (WISC-R). The controls were matched according to age, gender, and geographic variables. All children were living in western Norway. 57 children had infantile HC (IH) and 24 had childhood HC (CH). Children with myelomeningocele (MMC), traumatic brain injury (TBI), or intracranial tumours were excluded. IQ levels were found to be significantly higher in the control group than in the HC groups. The Kaufman factors showed a similar pattern, with lowest values in IH, and CH intermediate between IH and NC. The results demonstrate that HC affects IQ. More specific cognitive profiles, such as nonverbal learning disabilities, are not detectable when using the Wechsler tests. For this purpose, other tests and models for analyses may be recommended.	[Dalen, K.] Univ Bergen, Dept Biol & Med Psychol, N-5009 Bergen, Norway; [Bruaroy, S.; Laegreid, L. M.] Haukeland Hosp, Dept Child Neurol, N-5021 Bergen, Norway; [Wentzel-Larsen, T.] Haukeland Hosp, Clin Res Ctr, N-5021 Bergen, Norway	Dalen, K (corresponding author), Univ Bergen, Dept Biol & Med Psychol, Jonas Liesvei 91, N-5009 Bergen, Norway.	knut.dalen@psych.uib.no					Dalen K, 2006, NEUROPEDIATRICS, V37, P1, DOI 10.1055/s-2006-923839; DELBIGIO MR, 1993, ACTA NEUROPATHOL, V85, P573, DOI 10.1007/BF00334666; DENNIS M, 1981, ARCH NEUROL-CHICAGO, V38, P607, DOI 10.1001/archneur.1981.00510100035004; HEIJ CPMOO, 1985, CLIN NEUROL NEUROSUR, V87, P247, DOI 10.1016/0303-8467(85)90131-3; Kaufman A. S., 1979, INTELLIGENT TESTING; Korkman M, 1998, DEV NEUROPSYCHOLOGIC; *PSYCH CORP, 1989, WECHSL PRESCH PRIM S; RICHARDSON JTE, 1978, BRIT J SOC CLIN PSYC, V17, P261, DOI 10.1111/j.2044-8260.1978.tb00276.x; Rourke B. P, 1995, SYNDROME NONVERBAL L, P1; ROURKE BP, 1994, FRAMES REFERENCE ASS, P475; SHURTLEF.DB, 1973, AM J DIS CHILD, V125, P688, DOI 10.1001/archpedi.1973.04160050042008; YUDKIN PL, 1987, ARCH DIS CHILD, V62, P24, DOI 10.1136/adc.62.1.24; ISI WEB KNOWLEDGE; 2007, STATA SE 9 2 WINDOWS; 2005, SPSS WINDOWS REL 14	15	17	17	0	2	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0174-304X	1439-1899		NEUROPEDIATRICS	Neuropediatrics	JUN	2008	39	3					146	150		10.1055/s-0028-1085463			5	Clinical Neurology; Pediatrics	Neurosciences & Neurology; Pediatrics	375MJ	WOS:000261117700002	18991193				2021-06-18	
J	Slieker, FJA; Kompanje, EJO; Murray, GD; Ohman, J; Stocchetti, N; Teasdale, G; Maas, AIR				Slieker, Francois J. A.; Kompanje, Erwin J. O.; Murray, Gordon D.; Ohman, Juha; Stocchetti, Nino; Teasdale, Graham; Maas, Andrew I. R.		SAPHIR & Pharmos TBI Invest	Importance of screening logs in clinical trials for severe traumatic brain injury	NEUROSURGERY			English	Article						clinical trials; Consolidated Standards of Reporting Trials guidelines; dexanabinol; neuroprotection; N-methyl-D-aspartate glutamate antagonists; screening logs; traumatic brain injury	GLASGOW COMA SCALE; SEVERE HEAD-INJURIES; ADULTS; IMPACT	OBJECTIVE: The primary intent for obtaining screening logs in a randomized clinical trial is to assess selection bias in patient recruitment. This is particularly relevant to focused trials in heterogeneous populations such as traumatic brain injury (TBI) patients. We aimed to investigate the benefits of collecting screening logs in two randomized clinical trials conducted in TBI. METHODS: Screening logs were collected as part of the conduct of two multicenter trials of neuroprotective agents in TBI: the Salzburg Atherosclerosis Prevention Program in Subjects at High Individual Risk study (n = 924) and the clexanabinol study (n = 861). Centers were requested to submit monthly information on all patients with TBI admitted to the intensive care unit, including demographics, time of injury and admission, injury severity, and, if not recruited, the reason(s) for exclusion. RESULTS: In the Salzburg Atherosclerosis Prevention Program in Subjects at High Individual Risk study, 52 centers submitted admission data on 4166 patients. in the clexanabinol trial, 96 centers submitted data on 7052 patients. On average, only 20% of patients screened for the Salzburg Atherosclerosis Prevention Program in Subjects at High Individual Risk study and 10% for the clexanabinol trial were enrolled. The main reasons for exclusion were neurological status (29 and 26%, respectively), age (24 and 30%, respectively), and admission outside of the time window (17 and 21%, respectively). Differences in patient characteristics between screened and enrolled patients, with substantial country-specific variation, were observed. CONCLUSION: The collection of screening logs is necessary to report trial results according to the Consolidated Standards of Reporting Trials guidelines and to assess the generalizability of findings. Our experience shows the feasibility of collecting screening logs and illustrates how the potential for selection bias may creep into well-designed randomized clinical trials as a result of factors outside the control of investigators. Consistency and accuracy in screening log completion may further serve as an early indicator of center performance in a trial.	[Slieker, Francois J. A.; Kompanje, Erwin J. O.; Maas, Andrew I. R.] Erasmus MC, Dept Neurosurg, Rotterdam, Netherlands; [Kompanje, Erwin J. O.] Erasmus MC, Dept Intens Care, Rotterdam, Netherlands; [Murray, Gordon D.] Univ Edinburgh, Sch Med, Edinburgh, Midlothian, Scotland; [Ohman, Juha] Pirkanmaa Hosp Dist, Tampere, Finland; [Stocchetti, Nino] Univ Milan, Osped Policlin Ist Ricovero & Cura Carattere Sci, Milan, Italy; [Teasdale, Graham] Univ Glasgow, Glasgow, Lanark, Scotland; [Teasdale, Graham] Royal Coll Physicians & Surg, Glasgow, Lanark, Scotland	Maas, AIR (corresponding author), Univ Antwerp Hosp, Dept Neurosurg, Wilrijkstr 10, B-2650 Edegem, Belgium.	Andrew.Maas@uza.be	Maas, Andrew IR/C-5584-2013; Stocchetti, Nino/O-7444-2017	Maas, Andrew IR/0000-0003-1612-1264; Stocchetti, Nino/0000-0003-3250-6834; Murray, Gordon/0000-0001-9866-4734; Ohman, Juha/0000-0002-6592-1367			Balestreri M, 2004, J NEUROL NEUROSUR PS, V75, P161; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Buechler CM, 1998, J TRAUMA, V45, P429, DOI 10.1097/00005373-199809000-00001; Dimond K, 2002, J BIOLAW BUS, V5, P50; Edwards P, 2005, LANCET, V365, P1957; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Hernandez AV, 2006, J NEUROTRAUM, V23, P1295, DOI 10.1089/neu.2006.23.1295; Kannus P, 1999, AM J EPIDEMIOL, V149, P143; Kannus P, 1997, LANCET, V350, P1174, DOI 10.1016/S0140-6736(97)26042-3; KANNUS P, JAMA, V286, P673; Luukinen H, 1999, J AM GERIATR SOC, V47, P1451, DOI 10.1111/j.1532-5415.1999.tb01566.x; MAAS AI, 2004, ANN SURG, V239, P772; Maas AIR, 2006, LANCET NEUROL, V5, P38, DOI 10.1016/S1474-4422(05)70253-2; Marmarou A, 2007, J NEUROTRAUM, V24, P270, DOI 10.1089/neu.2006.0029; Moher D, 2001, LANCET, V357, P1191, DOI 10.1016/S0140-6736(00)04337-3; Moskopp D, 1995, NEUROSURG REV, V18, P253, DOI 10.1007/BF00383876; Muzha I, 2004, LANCET, V364, P1321, DOI 10.1016/s0140-6736(04)17188-2; Stocchetti N, 2004, J NEUROTRAUM, V21, P1131, DOI 10.1089/neu.2004.21.1131	18	17	17	0	4	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0148-396X	1524-4040		NEUROSURGERY	Neurosurgery	JUN	2008	62	6					1321	1328		10.1227/01.neu.0000333304.79931.4d			8	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	334MS	WOS:000258226500033	18824999				2021-06-18	
J	Asloun, S; Soury, S; Couillet, J; Giroire', JM; Joseph, PA; Mazaux, JM; Azouvi, P				Asloun, Sybille; Soury, Stephane; Couillet, Josette; Giroire', Jean-Michel; Joseph, Pierre-Alain; Mazaux, Jean-Michel; Azouvi, Philippe			Interactions between divided attention and working-memory load in patients with severe traumatic brain injury	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						traumatic brain injury; executive functions; working memory; divided attention	DUAL-TASK PERFORMANCE; NEURAL BASIS; PREFRONTAL CORTEX; HEAD-INJURY; IMPAIRMENTS; ACTIVATION; COMA	The aim of this study was to assess the relationships between divided-attention deficits and working-memory limitations after severe traumatic brain injury (TBI). Severe TBI patients (n = 43) and controls were given a n-back task of three different load levels, which was performed as a single and a dual task. Patients demonstrated, as expected, a difficulty in dual-task processing and an increased susceptibility to high working-memory load, but dual-task performance and working-memory load did not interact as expected. These results are in accordance with recent findings suggesting that dual-task performance and other working-memory functions represent dissociable although interrelated abilities.	[Asloun, Sybille; Couillet, Josette; Azouvi, Philippe] Hop Raymond Poincare, Dept Phys Med & Rehabil, INSERM, UPMC 731, F-92380 Garches, France; [Asloun, Sybille; Couillet, Josette; Azouvi, Philippe] Univ Versailles, Dept Phys Med & Rehabil, F-78000 Versailles, France; [Soury, Stephane; Giroire', Jean-Michel; Joseph, Pierre-Alain; Mazaux, Jean-Michel] CHU Pellegrin, Dept Phys Med & Rehabil, Bordeaux, France	Azouvi, P (corresponding author), Hop Raymond Poincare, Dept Phys Med & Rehabil, INSERM, UPMC 731, F-92380 Garches, France.	philippe.azouvi@rpc.aphp.fr					Adcock RA, 2000, P NATL ACAD SCI USA, V97, P3567, DOI 10.1073/pnas.060588897; Azouvi P, 2004, NEUROPSYCHOLOGIA, V42, P1260, DOI 10.1016/j.neuropsychologia.2004.01.001; Azouvi P, 1996, J CLIN EXP NEUROPSYC, V18, P317, DOI 10.1080/01688639608408990; Baddeley A, 1998, CURR OPIN NEUROBIOL, V8, P234, DOI 10.1016/S0959-4388(98)80145-1; Baddeley A, 1997, NEUROPSYCHOLOGY, V11, P187, DOI 10.1037/0894-4105.11.2.187; Baddeley A. D., 2002, PRINCIPLES FRONTAL L, P246, DOI DOI 10.1093/ACPROF:OSO/9780195134971.003.0016; Baddeley A. D., 1986, WORKING MEMORY; Bennett PC, 2005, J INT NEUROPSYCH SOC, V11, P376, DOI 10.1017/S1355617705050423; Braver TS, 1997, NEUROIMAGE, V5, P49, DOI 10.1006/nimg.1996.0247; BROUWER WH, 1989, CORTEX, V25, P219, DOI 10.1016/S0010-9452(89)80038-3; Bublak P, 2000, J CLIN EXP NEUROPSYC, V22, P176, DOI 10.1076/1380-3395(200004)22:2;1-1;FT176; Bunge SA, 2000, P NATL ACAD SCI USA, V97, P3573, DOI 10.1073/pnas.050583797; Burgess PW, 1998, J INT NEUROPSYCH SOC, V4, P547, DOI 10.1017/S1355617798466037; Christodoulou C, 2001, J NEUROL NEUROSUR PS, V71, P161, DOI 10.1136/jnnp.71.2.161; Cohen JD, 1997, NATURE, V386, P604, DOI 10.1038/386604a0; Collette F, 2002, NEUROSCI BIOBEHAV R, V26, P105, DOI 10.1016/S0149-7634(01)00063-X; DESPOSITO M, 1995, NATURE, V378, P279, DOI 10.1038/378279a0; GUM T, 1992, PSYCHLAB SOFTWARE; Hart T, 1993, J HEAD TRAUMA REHAB, V8, P1; Klingberg T, 1998, CEREB CORTEX, V8, P593, DOI 10.1093/cercor/8.7.593; Koechlin E, 1999, NATURE, V399, P148; Leclercq M, 2000, J CLIN EXP NEUROPSYC, V22, P339, DOI 10.1076/1380-3395(200006)22:3;1-V;FT339; Leclercq M, 2002, APPLIED NEUROPSYCHOLOGY OF ATTENTION: THEORY DIAGNOSIS AND REHABILITATION, P257; LEVIN HS, 1990, J NEUROSURG, V73, P699, DOI 10.3171/jns.1990.73.5.0699; McAllister TW, 2001, NEUROIMAGE, V14, P1004, DOI 10.1006/nimg.2001.0899; McAllister TW, 1999, NEUROLOGY, V53, P1300, DOI 10.1212/WNL.53.6.1300; McDowell S, 1997, NEUROPSYCHOLOGIA, V35, P1341, DOI 10.1016/S0028-3932(97)00082-1; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Park NW, 1999, NEUROPSYCHOLOGIA, V37, P1119, DOI 10.1016/S0028-3932(99)00034-2; PASHLER H, 1994, PSYCHOL BULL, V116, P220, DOI 10.1037/0033-2909.116.2.220; Perlstein WM, 2004, J INT NEUROPSYCH SOC, V10, P724, DOI 10.1017/S1355617704105110; PONSFORD J, 1991, NEUROPSYCHOL REHABIL, V1, P241, DOI DOI 10.1080/09602019108402257; PONSFORD JL, 1995, BRAIN INJURY, V9, P1, DOI 10.3109/02699059509004565; Shallice T., 1993, ATTENTION SELECTION; Smith EE, 2001, P NATL ACAD SCI USA, V98, P2095, DOI 10.1073/pnas.98.4.2095; Smith EE, 1998, P NATL ACAD SCI USA, V95, P12061, DOI 10.1073/pnas.95.20.12061; STABLUM F, 1994, CORTEX, V30, P603, DOI 10.1016/S0010-9452(13)80238-9; TEASDALE G, 1974, LANCET, V2, P81; Vallat-Azouvi C, 2007, J INT NEUROPSYCH SOC, V13, P770, DOI 10.1017/S1355617707070993; Van Zomeren A. H., 1984, CLOSED HEAD INJURY P, P74; Van Zomeren AH., 1994, CLIN NEUROPSYCHOLOGY; VANZOMEREN AH, 1985, J NEUROL NEUROSUR PS, V48, P21, DOI 10.1136/jnnp.48.1.21; Veltman JC, 1996, NEUROPSYCHOLOGY, V10, P357, DOI 10.1037/0894-4105.10.3.357; Vilkki J, 1996, NEUROPSYCHOLOGIA, V34, P1051, DOI 10.1016/0028-3932(96)00028-0; Wilson BA, 1998, NEUROPSYCHOL REHABIL, V8, P213, DOI 10.1080/713755570	45	17	17	0	12	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	MAY	2008	30	4					481	490		10.1080/13803390701550144			10	Psychology, Clinical; Clinical Neurology; Psychology	Psychology; Neurosciences & Neurology	303FM	WOS:000256026400009	18415888				2021-06-18	
J	Catroppa, C; Anderson, V; Ditchfield, M; Coleman, L				Catroppa, Cathy; Anderson, Vicki; Ditchfield, Michael; Coleman, Lee			Using magnetic resonance imaging to predict new learning outcome at 5 years after childhood traumatic brain injury	JOURNAL OF CHILD NEUROLOGY			English	Article						traumatic brain injury; memory; magnetic resonance imaging	CLOSED-HEAD INJURY; WORKING-MEMORY; PREFRONTAL CORTEX; CHILDREN; RECOVERY	Memory and learning entail the recruitment of a number of neural areas, including the medial temporal lobes, temporal association areas, and prefrontal cortices. This study examined the effects of injury severity on long-term memory function in 55 children who sustained traumatic brain injury 5 years earlier and compared this with 17 healthy controls. It also investigated cortical damage and diffuse axonal injury and their association to memory and learning outcomes 5 years after traumatic brain injury Children were administered memory tests of increasing complexity. Results indicated that injury severity affected aspects of complex memory, with no significant influence on working memory; that focal cortical damage was not predictive of working or complex memory, whereas diffuse axonal injury predicted outcome on complex memory tasks. Findings suggest that the implementation of diffuse axonal injury as an index of injury may assist in predicting memory outcome after childhood traumatic brain injury.	Royal Childrens Hosp, Dept Psychol, Parkville, Vic 3052, Australia; [Catroppa, Cathy; Anderson, Vicki] Australian Ctr Child Neurospychol Studies, Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Catroppa, Cathy; Anderson, Vicki] Univ Melbourne, Melbourne, Vic, Australia	Catroppa, C (corresponding author), Royal Childrens Hosp, Dept Psychol, Flemington Rd, Parkville, Vic 3052, Australia.	cathy.catroppa@mcri.edu.au					ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; Alloway TP., 1997, DEV MEMORY CHILDHOOD, P163; AMACHER AL, 1988, PEDIAT HEAD INJURIES; Anderson V, 1998, BRAIN INJURY, V12, P937, DOI 10.1080/026990598121990; Anderson V, 2001, BRAIN DAM B, P125; ANDERSON V, 1997, NEUROPSCHOLOGICAL AS; Anderson VA, 2000, BRAIN INJURY, V14, P679; ANDREWES D, 2001, NEUROPSYCHOLOGY FROM; Baddeley A., 1997, HUMAN MEMORY THEORY; BADDLEY A, 1990, HUIRTAN MEMORY THEOR; Bigler ED, 1999, J HEAD TRAUMA REHAB, V14, P406, DOI 10.1097/00001199-199908000-00009; BROADBENT NJ, 2002, NEUROPSYCHOLOGY MEMO, P3; Cabeza R, 2000, J COGNITIVE NEUROSCI, V12, P1, DOI 10.1162/08989290051137585; Catroppa C, 2002, BRAIN INJURY, V16, P369, DOI 10.1080/02699050110104444; CHAPLIN D, 1993, ARCH PHYS MED REHAB, V74, P161; COFFEY CE, 1991, AM PSYCHOP, P243; Cowan Nelson, 1995, ATTENTION MEMORY INT; D'Esposito M, 2000, EXP BRAIN RES, V133, P3, DOI 10.1007/s002210000395; DANIEL A, 1983, PRIVILEGE PRESTIGE O; Farmer JE, 1999, DEV NEUROPSYCHOL, V15, P269, DOI 10.1080/87565649909540749; Gale S D, 1995, J Int Neuropsychol Soc, V1, P17; Garth J, 1997, Pediatr Rehabil, V1, P99; Gennarelli T. A., 1998, SEM CLIN NEUR, V3, P160; Harris JR, 1996, J COMMUN DISORD, V29, P79, DOI 10.1016/0021-9924(94)00035-2; Johnson M. H., 1997, DEV COGNITIVE NEUROS; Johnson MH, 2003, BIOL PSYCHIAT, V54, P1312, DOI 10.1016/S0006-3223(03)00426-8; KOPLEMAN M, 2004, HDB MEMORY DISORDERS; KOTAPKA MJ, 1994, J NEUROTRAUM, V11, P317, DOI 10.1089/neu.1994.11.317; Levin HS, 2002, ANN NEUROL, V52, P82, DOI 10.1002/ana.10252; Levin HS, 1997, NEUROSURGERY, V40, P432, DOI 10.1097/00006123-199703000-00002; Levin HS, 2000, NEUROLOGY, V54, P647, DOI 10.1212/WNL.54.3.647; MENDELSOHN D, 1992, CHILD NERV SYST, V8, P445, DOI 10.1007/BF00274405; Miller EK, 1996, J NEUROSCI, V16, P5154; PETRIDES M, 1982, NEUROPSYCHOLOGIA, V20, P249, DOI 10.1016/0028-3932(82)90100-2; Petrides M, 2000, EXP BRAIN RES, V133, P44, DOI 10.1007/s002210000399; PETRIDES M, 1989, HDB NEUROPSYCHOLOGY, V3, P75; Postle BR, 1999, P NATL ACAD SCI USA, V96, P12959, DOI 10.1073/pnas.96.22.12959; RYAN TV, 1996, PEDIAT ALEUROPSYCHOL, P17; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; Sheslow D., 1990, WIDE RANGE ASSESSMEN; Sparrow S., 1984, VINELAND ADAPTIVE BE; Tabachnick B.G., 2000, USING MULTIVARIATE S, V4th; Takaoka M, 2002, J NEUROL NEUROSUR PS, V73, P289, DOI 10.1136/jnnp.73.3.289; TEASDALE G, 1974, LANCET, V2, P81; TEASEDALE G, 1984, CLOSED HEAD INJURY P; TRAVEL D, 2002, HDB MEMORY DISORDERS, P17; Tsujimoto S, 2004, CEREB CORTEX, V14, P703, DOI 10.1093/cercor/bhh030; Ward H, 2004, BRAIN INJURY, V18, P471, DOI 10.1080/02699050310001646107; Wechsler D., 1991, MANUAL WECHSLER INTE; Yeates K O, 1995, J Int Neuropsychol Soc, V1, P78; Yeates KO, 2000, SCI PRACT NEUROPSYCH, P92	51	17	17	0	4	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0883-0738	1708-8283		J CHILD NEUROL	J. Child Neurol.	MAY	2008	23	5					486	496		10.1177/0883073807309773			11	Clinical Neurology; Pediatrics	Neurosciences & Neurology; Pediatrics	292XO	WOS:000255299600003	18184933				2021-06-18	
J	Spiotta, AM; Stiefel, MR; Heuer, GG; Bloom, S; Maloney-Wilensky, E; Yang, W; Grady, MS; Le Roux, PD				Spiotta, Alejandro M.; Stiefel, Michael R.; Heuer, Gregory G.; Bloom, Stephanie; Maloney-Wilensky, Eileen; Yang, Wei; Grady, M. Sean; Le Roux, Peter D.			Brain hyperthermia after traumatic brain injury does not reduce brain oxygen	NEUROSURGERY			English	Article						brain oxygen; hyperthermia; temperature; traumatic brain injury	CEREBRAL PERFUSION-PRESSURE; SEVERE HEAD-INJURY; LENGTH-OF-STAY; INTRACRANIAL-PRESSURE; MODERATE HYPOTHERMIA; TISSUE OXYGENATION; BLOOD-FLOW; RECTAL TEMPERATURES; CARE; METABOLISM	OBJECTIVE: Hyperthermia can exacerbate outcome after traumatic brain injury (TBI). In this study, we examined the relationship between brain temperature (BT) and core body temperature and the relationship between BT and brain tissue oxygen (BtO(2)) to determine whether hyperthermia adversely affects BtO(2). METHODS: Seventy-two patients (mean age, 41 +/- 19 years) admitted to a Level I trauma center after TBI were retrospectively identified from a prospective observational database. Intracranial pressure (ICP), BT, and BtO(2) were recorded continuously. Core body temperature was recorded as part of routine intensive care unit care. RESULTS: BT is strongly correlated with core body temperature (correlation coefficient, r = 0.92) over a wide range. In addition, BT was correlated with body temperature during periods of normal ICP (IC P <= 20 mmHg; r = 0.87) and transiently elevated ICP (ICP range 21-63 mrnHg; r = 0.94). During periods of brain normothermia (BT < 38.1 degrees C), the average BtO(2) was 36.3 +/- 22.9 mmHg. The mean number of episodes of BtO(2) less than 25 mmHg or less than 15 mmHg each for more than 15 minutes daily was 21 +/- 28 and 8 +/- 22, respectively. The mean BtO(2) (37.2 +/- 16.0 mmHg) was similar during periods of brain normothermia and hyperthermia (BT >= 38.1 degrees C). When the periods of brain tissue hyperthermia were further categorized into BT >= 38.6 degrees C or BT >= 39.2 degrees C, mean daily BtO(2) was similar in all of the groups. When BT was 38.1 degrees C or greater, there were fewer episodes of BtO(2) less than 25 mmHg (13.5 +/- 24.6; P < 0.05) and of BtO(2) less than 15 mmHg (3.3 +/- 11.9; P < 0.05) than observed during brain normothermia. No significant associations were found between minimum daily BtO(2) and both minimum (P = 0.81) and maximum (P = 0.19) daily BT or between maximum daily BtO(2) and both minimum (P = 0.62) and maximum (P = 0.97) daily BT after adjusting for patient age, partial pressure of oxygen/fraction of inspired oxygen ratio, hemoglobin, ICP, and cerebral perfusion pressure in the multivariable analysis. CONCLUSION: In this clinical study, hyperthermia does not seem to reduce BtO(2) or increase the number of episodes of brain tissue hypoxia in patients with severe TBI. These results suggest that hyperthermia may worsen outcome after TBI through mechanisms that may be separate from compromised brain oxygen.	[Spiotta, Alejandro M.; Stiefel, Michael R.; Heuer, Gregory G.; Bloom, Stephanie; Maloney-Wilensky, Eileen; Yang, Wei; Grady, M. Sean; Le Roux, Peter D.] Univ Penn, Dept Neurosurg, Sch Med, Philadelphia, PA 19107 USA; [Yang, Wei] Univ Penn, Dept Biostat, Sch Med, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19107 USA	Le Roux, PD (corresponding author), Univ Penn, Dept Neurosurg, Sch Med, 330 S 9th St, Philadelphia, PA 19107 USA.	lerouxp@uphs.upenn.edu	Yang, Wei/A-9223-2009	Yang, Wei/0000-0001-8984-4389			Adelson PD, 2005, NEUROSURGERY, V56, P740, DOI 10.1227/01.NEU.0000156471.50726.26; Albrecht RF, 1998, MAYO CLIN PROC, V73, P629; Allan SM, 2001, NAT REV NEUROSCI, V2, P734, DOI 10.1038/35094583; Alyagari V, 2007, J NEUROL SCI, V261, P39, DOI 10.1016/j.jns.2007.04.030; [Anonymous], 2000, MAN PROGN SEV TRAUM, P47; Axelrod YK, 2006, CRIT CARE CLIN, V22, P767, DOI 10.1016/j.ccc.2006.06.001; Bardt TF, 1998, ACT NEUR S, V71, P153; Chatzipanteli K, 2000, J CEREBR BLOOD F MET, V20, P531, DOI 10.1097/00004647-200003000-00012; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Childs C, 2005, ANAESTHESIA, V60, P759, DOI 10.1111/j.1365-2044.2005.04193.x; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; Clinchot DM, 1997, AM J PHYS MED REHAB, V76, P323, DOI 10.1097/00002060-199707000-00012; CRUZ J, 1995, CRIT CARE MED, V23, P1412, DOI 10.1097/00003246-199508000-00016; Dietrich WD, 1996, NEUROSURGERY, V38, P533, DOI 10.1097/00006123-199603000-00023; DIETRICH WD, 1992, J NEUROTRAUM, V9, pS475; Dings J, 1998, NEUROL RES, V20, pS71; Diringer MN, 2004, CRIT CARE MED, V32, P1489, DOI 10.1097/01.CCM.0000129484.61912.84; Geffroy A, 2004, INTENS CARE MED, V30, P785, DOI 10.1007/s00134-004-2280-y; Gupta AK, 1999, ANESTH ANALG, V88, P549, DOI 10.1097/00000539-199903000-00016; Gupta AK, 2002, BRIT J ANAESTH, V88, P188, DOI 10.1093/bja/88.2.188; HAGERDAL M, 1975, J NEUROCHEM, V24, P311, DOI 10.1111/j.1471-4159.1975.tb11881.x; Hemphill JC, 2001, NEUROSURGERY, V48, P377, DOI 10.1097/00006123-200102000-00028; Henker RA, 1998, NEUROSURGERY, V42, P1071, DOI 10.1097/00006123-199805000-00071; Huang WT, 2001, NEUROPHARMACOLOGY, V41, P811, DOI 10.1016/S0028-3908(01)00120-4; Jia Jun, 2005, Chin J Traumatol, V8, P138; Jiang JY, 2002, J NEUROTRAUM, V19, P869, DOI 10.1089/08977150260190456; Johnston AJ, 2005, CRIT CARE MED, V33, P189, DOI 10.1097/01.CCM.0000149837.09225.BD; Kiening KL, 1997, NEUROL RES, V19, P233, DOI 10.1080/01616412.1997.11740805; Kilpatrick MM, 2000, NEUROSURGERY, V47, P850, DOI 10.1097/00006123-200010000-00011; Kinoshita K, 2003, ACTA NEUROCHIR SUPPL, V86, P377; MATTHEWS DSF, 1995, ARCH DIS CHILD, V72, P507, DOI 10.1136/adc.72.6.507; McIntyre LA, 2003, JAMA-J AM MED ASSOC, V289, P2992, DOI 10.1001/jama.289.22.2992; MELLERGARD P, 1991, NEUROSURGERY, V28, P709, DOI 10.1227/00006123-199105000-00012; Menon DK, 2004, CRIT CARE MED, V32, P1384, DOI 10.1097/01.CCM.0000127777.16609.08; Menzel M, 1999, J NEUROSURG, V91, P1, DOI 10.3171/jns.1999.91.1.0001; MICHENFELDER JD, 1968, ANESTHESIOLOGY, V29, P1107, DOI 10.1097/00000542-196811000-00005; Morganti-Kossmann MC, 2001, SHOCK, V16, P165, DOI 10.1097/00024382-200116030-00001; MURR R, 1995, NEUROL RES, V17, P329, DOI 10.1080/01616412.1995.11740338; Natale JE, 2000, CRIT CARE MED, V28, P2608, DOI 10.1097/00003246-200007000-00071; ORITA T, 1995, NEUROL RES, V17, P443, DOI 10.1080/01616412.1995.11740360; Otawara Y, 2003, SURG NEUROL, V60, P549, DOI 10.1016/S0090-3019(03)00293-3; Qiu Wu-si, 2005, Chin J Traumatol, V8, P27; ROBERTSON C, 2004, YOUMANS NEUROLOGICAL, P5103; Rossi S, 2001, J NEUROL NEUROSUR PS, V71, P448, DOI 10.1136/jnnp.71.4.448; Rovlias A, 2000, NEUROSURGERY, V46, P335, DOI 10.1097/00006123-200002000-00015; Rumana CS, 1998, CRIT CARE MED, V26, P562, DOI 10.1097/00003246-199803000-00032; Sahuquillo J, 2007, CURR PHARM DESIGN, V13, P2310; Sakurai A, 2003, ACTA NEUROCHIR SUPPL, V86, P251; Salci Kontsantin, 2006, J Clin Monit Comput, V20, P25, DOI 10.1007/s10877-006-2864-x; SAPER CB, 1994, NEW ENGL J MED, V330, P1880; SAZBON L, 1990, J NEUROSURG, V72, P75, DOI 10.3171/jns.1990.72.1.0075; Sharma HS, 2000, ACTA NEUROCHIR SUPPL, V76, P81; Shiozaki T, 2003, J NEUROSURG, V99, P47, DOI 10.3171/jns.2003.99.1.0047; Soukup J, 2002, NEUROL RES, V24, P161, DOI 10.1179/016164102101199710; Soukup J, 2002, J NEUROTRAUM, V19, P559, DOI 10.1089/089771502753754046; Stiefel MF, 2005, J NEUROSURG, V103, P805, DOI 10.3171/jns.2005.103.5.0805; Stiefel MF, 2006, J NEUROSURG, V105, P568, DOI 10.3171/jns.2006.105.4.568; Stocchetti N, 2005, J NEUROL NEUROSUR PS, V76, P1135, DOI 10.1136/jnnp.2004.041269; Stocchetti N, 2002, INTENS CARE MED, V28, P1555, DOI 10.1007/s00134-002-1513-1; Stubbe HD, 2004, J CEREBR BLOOD F MET, V24, P1400, DOI 10.1097/01.WCB.0000141516.61418.82; Suazo JAC, 2000, CRIT CARE MED, V28, P3268, DOI 10.1097/00003246-200009000-00024; Thompson HJ, 2003, NEUROBIOL DIS, V12, P163, DOI 10.1016/S0969-9961(02)00030-X; Thompson HJ, 2005, J CEREBR BLOOD F MET, V25, P163, DOI 10.1038/sj.jcbfm.9600008; Tokutomi T, 2003, NEUROSURGERY, V52, P102, DOI 10.1097/00006123-200301000-00013; Valadka AB, 1998, CRIT CARE MED, V26, P1576, DOI 10.1097/00003246-199809000-00029; van den Brink WA, 2000, NEUROSURGERY, V46, P868, DOI 10.1097/00006123-200004000-00018; van Santbrink H, 2003, ACTA NEUROCHIR, V145, P429, DOI 10.1007/s00701-003-0032-3; Vespa PM, 2007, CRIT CARE MED, V35, P1153, DOI 10.1097/01.CCM.0000259466.66310.4F; Whalen MJ, 1997, ACT NEUR S, V70, P260; Wilensky Eileen Maloney, 2005, J Neurosci Nurs, V37, P278; Yamaguchi S, 2000, NEUROL RES, V22, P657; YOUNG B, 1996, NEUROTRAUMA, P345; Zhang Sai, 2002, Chin J Traumatol, V5, P43	73	17	17	0	2	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0148-396X	1524-4040		NEUROSURGERY	Neurosurgery	APR	2008	62	4					864	872		10.1227/01.neu.0000316900.63124.ce			9	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	294TR	WOS:000255429300036	18414135				2021-06-18	
J	Zhang, J; Groff, RF; Chen, XH; Browne, KD; Huang, J; Schwartz, ED; Meaney, DF; Johnson, VE; Stein, SC; Rojkjaer, R; Smith, DH				Zhang, Jun; Groff, Robert F.; Chen, Xiao-Han; Browne, Kevin D.; Huang, Jason; Schwartz, Eric D.; Meaney, David F.; Johnson, Victoria E.; Stein, Sherman C.; Rojkjaer, Rasmus; Smith, Douglas H.			Hemostatic and neuroprotective effects of human recombinant activated factor VII therapy after traumatic brain injury in pigs	EXPERIMENTAL NEUROLOGY			English	Article						traumatic brain injury; TBI; rFVIIa; cerebral contusion; recombinant activated factor VII; hemostasis; diffuse axonal injury; neuroprotection	V LIVER-INJURIES; SPONTANEOUS INTRACEREBRAL HEMORRHAGE; DIFFUSE AXONAL INJURY; HEAD TRAUMA; COMPUTERIZED-TOMOGRAPHY; VENOUS THROMBOEMBOLISM; COAGULOPATHIC PIGS; RISK-FACTORS; THROMBIN; DAMAGE	Human recombinant activated factor-VII (rFVIIa) has been used successfully in the treatment of spontaneous intracerebral hemorrhage. In addition, there is increasing interest in its use to treat uncontrolled bleeding of other origins, including trauma. The aim of this study was to evaluate the safety and potential effectiveness of rFVIIa to mitigate bleeding using a clinically relevant model of traumatic brain injury (TBI) in the pig. A double injury model was chosen consisting of (1) an expanding cerebral contusion induced by the application of negative pressure to the exposed cortical surface and (2) a rapid rotational acceleration of the head to induce diffuse axonal injury (DA1). Injuries were performed on 10 anesthetized pigs. Five minutes after injury, 720 mu g/kg rFVIIa (n = 5) or vehicle control (n = 5) was administered intravenously. Magnetic resonance imaging (MRI) studies were performed within 30 min and at 3 days post-TB1 to determine the temporal expansion of the cerebral contusion. Euthanasia and histopathologic analysis were performed at day 3. This included observations for hippocampal neuronal degeneration, axonal pathology and microclot formation. The expansion of contusion volume over the 3 days post-injury period was reduced significantly in animals treated with rFVIIa compared to vehicle controls. Surprisingly, immunohistochemical analysis demonstrated that the number of dead/dying hippocampal neurons and axonal pathology was reduced substantially by rFVIIa treatment compared to vehicle. In addition, there was no difference in the extent of microthrombi between groups. rFVIIa treatment after TBI in the pig reduced expansion of hemorrhagic cerebral contusion volume without exacerbating the severity of microclot formation. Finally, rFVIIa treatment provided a Surprising neuroprotective effect by reducing hippocampal neuron degeneration as well as the extent of DAI. (C) 2008 Published by Elsevier Inc.	[Zhang, Jun; Groff, Robert F.; Chen, Xiao-Han; Browne, Kevin D.; Johnson, Victoria E.; Stein, Sherman C.; Smith, Douglas H.] Univ Penn, Dept Neurosurg, Sch Med, Philadelphia, PA 19104 USA; [Zhang, Jun; Groff, Robert F.; Chen, Xiao-Han; Browne, Kevin D.; Johnson, Victoria E.; Stein, Sherman C.; Smith, Douglas H.] Univ Penn, Penn Ctr Brain Injury & Repair, Sch Med, Philadelphia, PA 19104 USA; [Huang, Jason] Univ Rochester, Sch Med & Dent, Dept Neurol Surg, Rochester, NY 14642 USA; [Schwartz, Eric D.] Univ Pittsburgh, Med Ctr, Dept Radiol, Pittsburgh, PA 15213 USA; [Meaney, David F.] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA; [Rojkjaer, Rasmus] Novo Nordisk Res US, N Brunswick, NJ USA; [Zhang, Jun] Peoples Liberat Army Gen Hosp, Dept Neurosurg, Beijing, Peoples R China	Smith, DH (corresponding author), Univ Penn, Dept Neurosurg, Sch Med, 105 Hayden Hall,3320 Smith Walk, Philadelphia, PA 19104 USA.	smithdou@mail.med.upenn.edu	smith, douglas/A-1321-2007; Huang, Jason H/J-4739-2019	Huang, Jason H/0000-0002-4426-0168; Meaney, David/0000-0002-0954-4122	NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS035712-12, R01 NS038104, NS38104, P01 NS056202, R01 NS035712, P01 NS056202-020003] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS056202, R01NS038104, R01NS035712] Funding Source: NIH RePORTER		ADAMS JH, 1991, J NEUROL NEUROSUR PS, V54, P481, DOI 10.1136/jnnp.54.6.481; Aiyagari V, 2005, J CRIT CARE, V20, P176, DOI 10.1016/j.jcrc.2005.02.004; Aldouri M, 2002, PATHOPHYSIOL HAEMO T, V32, P41, DOI 10.1159/000057301; BANNINGER H, 1994, BIOCHEM J, V298, P157; BLOMBACK B, 1994, THROMB RES, V75, P521, DOI 10.1016/0049-3848(94)90227-5; Brott T, 1997, STROKE, V28, P1, DOI 10.1161/01.STR.28.1.1; Bullock R, 1996, Eur J Emerg Med, V3, P109, DOI 10.1097/00063110-199606000-00010; Chang EF, 2006, NEUROSURGERY, V58, P647, DOI 10.1227/01.NEU.0000197101.68538.E6; Chen XH, 2004, AM J PATHOL, V165, P357, DOI 10.1016/S0002-9440(10)63303-2; Chieregato A, 2005, NEUROSURGERY, V56, P671, DOI 10.1227/01.NEU.0000156200.76331.7A; Chuang CS, 2000, STAT SINICA, V10, P1; CLOYD JC, 1986, J PHARMACOL EXP THER, V236, P301; Dutton RP, 2004, J TRAUMA, V57, P709, DOI 10.1097/01.TA.0000140646.66852.AB; Felix B, 1999, STEREOTAXIC ATLAS PI; Figueroa BE, 1998, STROKE, V29, P1202, DOI 10.1161/01.STR.29.6.1202; Filsoufi F, 2006, ANN THORAC SURG, V82, P1779, DOI 10.1016/j.athoracsur.2006.05.076; Friederich PW, 2003, LANCET, V361, P201, DOI 10.1016/S0140-6736(03)12268-4; FUJII Y, 1994, J NEUROSURG, V80, P51, DOI 10.3171/jns.1994.80.1.0051; GEERTS WH, 1994, NEW ENGL J MED, V331, P1601, DOI 10.1056/NEJM199412153312401; Gerotziafas GT, 2004, THROMB HAEMOSTASIS, V91, P977, DOI 10.1160/THo3-10-0638; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Gingrich MB, 2000, TRENDS NEUROSCI, V23, P399, DOI 10.1016/S0166-2236(00)01617-9; Gorbacheva LR, 2006, BIOCHEMISTRY-MOSCOW+, V71, P1082, DOI 10.1134/S000629790610004X; Gustafsson O, 1999, ACTA RADIOL, V40, P360, DOI 10.3109/02841859909177748; He S, 2003, J THROMB HAEMOST, V1, P1215, DOI 10.1046/j.1538-7836.2003.00242.x; Hettmansperger T. P., 1991, STAT INFERENCE BASED; Hoffman M, 2003, BLOOD REV, V17, pS1, DOI 10.1016/S0268-960X(03)90000-2; Kamphusien PW, 2002, AM J MED, V112, P332, DOI 10.1016/S0002-9343(01)01116-0; KEIMOWITZ RM, 1973, J NEUROSURG, V39, P178, DOI 10.3171/jns.1973.39.2.0178; Kenet G, 1999, LANCET, V354, P1879, DOI 10.1016/S0140-6736(99)05155-7; Khan AZ, 2005, AM J SURG, V189, P331, DOI 10.1016/j.amjsurg.2004.11.021; Kjalke M, 2007, J THROMB HAEMOST, V5, P774, DOI 10.1111/j.1538-7836.2007.02389.x; Kurtoglu M, 2004, WORLD J SURG, V28, P807, DOI 10.1007/s00268-004-7295-6; Lisman T, 2002, BLOOD, V99, P175, DOI 10.1182/blood.V99.1.175; LOBATO RD, 1991, J NEUROSURG, V75, P256, DOI 10.3171/jns.1991.75.2.0256; Lobato RD, 1997, ACTA NEUROCHIR, V139, P385, DOI 10.1007/BF01808871; Martinowitz U, 2005, J THROMB HAEMOST, V3, P640, DOI 10.1111/j.1538-7836.2005.01203.x; Martinowitz U, 2002, CAN J ANAESTH, V49, pS15; Martinowitz U, 2001, J TRAUMA, V51, P431, DOI 10.1097/00005373-200109000-00002; Mayer SA, 2005, NEW ENGL J MED, V352, P777, DOI 10.1056/NEJMoa042991; Mayer SA, 2005, STROKE, V36, P74, DOI 10.1161/01.STR.0000149628.80251.b8; Mayo A, 2004, VOX SANG, V87, P34, DOI 10.1111/j.1423-0410.2004.00533.x; McArthur DL, 2004, BRAIN PATHOL, V14, P185, DOI 10.1111/j.1750-3639.2004.tb00052.x; Monroe DM, 1997, BRIT J HAEMATOL, V99, P542, DOI 10.1046/j.1365-2141.1997.4463256.x; O'Neill PA, 2002, J TRAUMA, V52, P400, DOI 10.1097/00005373-200202000-00034; Oertel M, 2002, J NEUROSURG, V96, P109, DOI 10.3171/jns.2002.96.1.0109; Pusateri AE, 2005, THROMB HAEMOSTASIS, V93, P275, DOI 10.1160/TH04-03-0200; Ripoll MA, 2004, NEURORADIOLOGY, V46, P435, DOI 10.1007/s00234-004-1191-5; Ripoll MA, 2002, ACTA RADIOL, V43, P2, DOI 10.1080/028418502127347538; Schreiber MA, 2005, CRIT CARE, V9, pS25, DOI 10.1186/cc3782; Schreiber MA, 2003, J AM COLL SURGEONS, V196, P691, DOI 10.1016/S1072-7515(02)01835-5; Schreiber MA, 2002, J TRAUMA, V53, P252, DOI 10.1097/00005373-200208000-00011; Schurr MJ, 2004, J TRAUMA, V57, P718; SERVADEI F, 1995, NEUROSURGERY, V37, P899, DOI 10.1227/00006123-199511000-00008; Shreiber DI, 1999, J NEUROPATH EXP NEUR, V58, P153, DOI 10.1097/00005072-199902000-00005; Smith DH, 2000, NEUROSCIENTIST, V6, P483, DOI 10.1177/107385840000600611; Smith DH, 2000, J NEUROSURG, V93, P315, DOI 10.3171/jns.2000.93.2.0315; Smith DH, 2003, J HEAD TRAUMA REHAB, V18, P307, DOI 10.1097/00001199-200307000-00003; Smith DH, 1997, J NEUROPATH EXP NEUR, V56, P822; Sondeen JL, 2004, SHOCK, V22, P163, DOI 10.1097/01.shk.0000129202.76706.bd; Sorensen BB, 2003, BLOOD, V102, P1708, DOI 10.1182/blood-2003-01-0157; Stein SC, 2004, NEUROCRIT CARE, V1, P479, DOI 10.1385/NCC:1:4:479; STEIN SC, 1992, NEUROSURGERY, V30, P160, DOI 10.1227/00006123-199202000-00002; STEIN SC, 1993, NEUROSURGERY, V32, P25, DOI 10.1227/00006123-199301000-00004; Steiner T, 2006, NEUROSURGERY, V59, P767, DOI 10.1227/01.NEU.0000232837.34992.32; TANNO H, 1992, J NEUROTRAUM, V9, P21, DOI 10.1089/neu.1992.9.21; TANNO H, 1992, J NEUROTRAUM, V9, P335, DOI 10.1089/neu.1992.9.335; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Vaslef SN, 2002, J TRAUMA, V53, P257; White Christopher E, 2006, Curr Surg, V63, P310, DOI 10.1016/j.cursur.2006.04.013; Zaaroor M, 2004, SEMIN HEMATOL, V41, P175, DOI 10.1053/j.seminhematol.2003.11.033	71	17	18	0	4	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	APR	2008	210	2					645	655		10.1016/j.expneurol.2007.12.019			11	Neurosciences	Neurosciences & Neurology	287CL	WOS:000254894200037	18291370	Green Accepted			2021-06-18	
J	Vickery, CD; Sherer, M; Evans, CC; Gontkovsky, ST; Lee, JE				Vickery, Chad D.; Sherer, Mark; Evans, Clea C.; Gontkovsky, Samuel T.; Lee, Jae Eun			The relationship between self-esteem and functional outcome in the acute stroke-rehabilitation setting	REHABILITATION PSYCHOLOGY			English	Article						stroke; depression; self-esteem; rehabilitation outcome	TRAUMATIC BRAIN-INJURY; DEPRESSIVE SYMPTOMS; ANTIDEPRESSANT TREATMENT; POSTSTROKE DEPRESSION; GERIATRIC DEPRESSION; SOCIAL SUPPORT; SCALE; VALIDATION; PERSISTENCE; RECOVERY	Objective: To explore the relationship between self-esteem and functional recovery in patients with acute stroke. Design: A nonconsecutive sample of stroke survivors received ratings of functional status and completed self-report measures of self-esteem and depressive symptoms. Bivariate correlational analyses and multivariate regression analyses explored the relationships of functional status and self-report of self-esteem and depressive symptoms. Setting: Acute inpatient rehabilitation hospital. Participants: A group of 176 right- or left-hemisphere stroke participants. Main Outcome Measures: Self-care and mobility domain scores (based on Functional Independence Measure ratings) at admission and discharge. Efficiency scores for each domain. Visual Analogue Self-Esteem Scale (S. M. Brumfitt & P. Sheeran, 1999) and Geriatric Depression Scale (J. A. Yesavage et al., 1983). Results: Regression analyses indicated that lower self-esteem ratings were related to poorer discharge self-care and mobility scores and poorer efficiency in these domains, whereas ratings of depressive symptoms were not. However, interactions between self-esteem ratings and ratings of depressive symptoms were noted. Exploratory analyses suggested that self-esteem ratings mediated the relationship between ratings of depressive symptoms and functional outcome indices. Conclusions: Self-esteem ratings may have a mediating/moderating role in the relationship between emotional functioning and functional outcome. This may have implications for research in this area and the type of mental health treatment available to stroke rehabilitation patients.	[Vickery, Chad D.; Evans, Clea C.] Methodist Rehabil Ctr, Neuropsychol Dept, Jackson, MS 39216 USA; [Sherer, Mark] Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX 77030 USA; [Gontkovsky, Samuel T.; Lee, Jae Eun] Methodist Rehabil Ctr, Dept Res, Jackson, MS 39216 USA	Vickery, CD (corresponding author), Methodist Rehabil Ctr, Neuropsychol Dept, 1350 E Woodrow Wilson, Jackson, MS 39216 USA.	chadvickery@hotmail.com					Anson K, 2006, J HEAD TRAUMA REHAB, V21, P248, DOI 10.1097/00001199-200605000-00005; Baumeister RF, 2003, HANDBOOK OF SELF AND IDENTITY, P197; BROWN JD, 1995, J PERS SOC PSYCHOL, V68, P712, DOI 10.1037/0022-3514.68.4.712; Brown JD, 1998, SELF; Brumfitt SM, 1999, BRIT J CLIN PSYCHOL, V38, P387, DOI 10.1348/014466599162980; Chang AM, 1999, J CLIN NURS, V8, P477, DOI 10.1046/j.1365-2702.1999.0196a.x; Conn VS., 1992, HLTH VALUES J HLTH B, V16, P25; Coopersmith S., 1967, ANTECEDENTS SELF EST; Cully JA, 2005, ARCH PHYS MED REHAB, V86, P2256, DOI 10.1016/j.apmr.2005.07.292; Curran CA, 2000, J HEAD TRAUMA REHAB, V15, P1256, DOI 10.1097/00001199-200012000-00006; Ellis-Hill CS, 2000, CLIN REHABIL, V14, P279, DOI 10.1191/026921500671231410; ESSEX MJ, 1989, J AGING HEALTH, V1, P327; Fitts W.H., 1996, TENNESSEE SELF CONCE, V2nd ed; Fung LCL, 2006, J CLIN NURS, V15, P505, DOI 10.1111/j.1365-2702.2006.01328.x; Gammon J, 1996, J ADV NURS, V24, P303, DOI 10.1046/j.1365-2648.1996.17911.x; Gillen R, 2001, ARCH PHYS MED REHAB, V82, P1645, DOI 10.1053/apmr.2001.26249; Hall KM, 1996, J HEAD TRAUMA REHAB, V11, P27, DOI 10.1097/00001199-199610000-00004; HEATHERTON TF, 1991, J PERS SOC PSYCHOL, V60, P895, DOI 10.1037/0022-3514.60.6.895; HOBFOLL SE, 1984, AM J COMMUN PSYCHOL, V12, P87, DOI 10.1007/BF00896930; Holmbeck GN, 1997, J CONSULT CLIN PSYCH, V65, P599, DOI 10.1037/0022-006X.65.4.599; Keppel CC, 2000, NEUROPSYCHOL REHABIL, V10, P15, DOI 10.1080/096020100389273; Koehler M L, 1989, Rehabil Nurs, V14, P9; Leary MR, 2003, HANDBOOK OF SELF AND IDENTITY, P401; Li L, 1998, J SOC PSYCHOL, V138, P13, DOI 10.1080/00224549809600349; May LA, 2002, SPINAL CORD, V40, P341, DOI 10.1038/sj.sc.3101311; MCFARLIN DB, 1984, J PERS, V52, P138, DOI 10.1111/j.1467-6494.1984.tb00349.x; Myers R., 1990, CLASSICAL MODERN REG; Narushima K, 2003, J NERV MENT DIS, V191, P645, DOI 10.1097/01.nmd.0000092197.97693.d2; Ng JYY, 2000, PERCEPT MOTOR SKILL, V91, P107; Paolucci S, 2001, CEREBROVASC DIS, V12, P264, DOI 10.1159/000047714; Ravaud JF, 1999, SCAND J REHABIL MED, V31, P31; Rosenberg M., 1979, CONCEIVING SELF; SANDELANDS LE, 1988, J APPL PSYCHOL, V73, P208, DOI 10.1037/0021-9010.73.2.208; Schroevers MJ, 2003, SOC SCI MED, V57, P375, DOI 10.1016/S0277-9536(02)00366-0; Tarlow EM, 1996, J RES PERS, V30, P120, DOI 10.1006/jrpe.1996.0008; Vickery CD, 2006, REHABIL PSYCHOL, V51, P30, DOI 10.1037/0090-5550.51.1.30; VICKERY CD, IN PRESS CLIN REHABI; VICKERY CD, 2006, PSYCHOMETRIC CHARACT; Vickery CD, 2006, CLIN REHABIL, V20, P1075, DOI 10.1177/0269215506071269; Waschull SB, 1996, PERS SOC PSYCHOL B, V22, P4, DOI 10.1177/0146167296221001; YESAVAGE JA, 1983, J PSYCHIATR RES, V17, P37, DOI 10.1016/0022-3956(82)90033-4; 1996, UNIFORM DATA SET MED	42	17	18	0	14	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550	1939-1544		REHABIL PSYCHOL	Rehabil. Psychol.	FEB	2008	53	1					101	109		10.1037/0090-5550.53.1.101			9	Psychology, Clinical; Rehabilitation	Psychology; Rehabilitation	266JR	WOS:000253431900013					2021-06-18	
J	Bilotta, F; Branca, G; Lam, A; Cuzzone, V; Doronzio, A; Rosa, G				Bilotta, Federico; Branca, Giovanna; Lam, Arthur; Cuzzone, Vincenzo; Doronzio, Andrea; Rosa, Giovanni			Endotracheal lidocaine in preventing endotracheal suctioning-induced changes in cerebral hemodynamics in patients with severe head trauma	NEUROCRITICAL CARE			English	Article						endotracheal suctioning; lidocaine instillation; intracranial pressure; severe head trauma	INTRACRANIAL-PRESSURE; BRAIN-INJURY; REMIFENTANIL; INCREASES; ISCHEMIA	Introduction In patients with severe head trauma, endotracheal suctioning can result in adverse reactions including cough, systemic hypertension, increased intracranial pressure, and reduced cerebral perfusion pressure. The aim of this prospective, blinded clinical trial in mechanically ventilated patients with severe head trauma whose cough reflexes were still intact was to assess the effectiveness of endotracheally instilled lidocaine in preventing endotracheal suctioning-induced changes in cerebral hemodynamics (increase in intracranial pressure and reduced cerebral perfusion pressure) after a single endotracheal suctioning. Methods and Results Ten minutes after lidocaine instillation into the endotracheal tube, secretions were suctioned for <30 s through a standard closed endotracheal suctioning circuit. Heart rate, arterial pressure, intracranial pressure, and cerebral perfusion pressure were continuously monitored. The first patient studied received an endotracheal lidocaine dose of 2.0 mg/kg. The dose for the next study patient was titrated upwards or downwards in 0.5 mg/kg steps according to, whether the intracranial pressure reached the predefined threshold of 20 mmHg. A total of 41 patients were studied. Lidocaine instillation into the endotracheal tube had no effect on hemodynamic and ventilatory variables. In 21 patients lidocaine dose instilled into the endotracheal tube effectively prevented the endotracheal suctioning-induced intracranial pressure increase behind the predefined threshold of :20 mmHg and cerebral perfusion pressure remained unchanged. In the remaining 20, although intracranial pressure rose significantly cerebral perfusion pressure remained constant. Conclusions In mechanically ventilated patients with severe head trauma endotracheal lidocaine instillation effectively and dose-dependently prevents the endotracheal suctioning-induced intracranial pressure increase and cerebral perfusion pressure reduction.	[Bilotta, Federico; Branca, Giovanna; Cuzzone, Vincenzo; Doronzio, Andrea; Rosa, Giovanni] Univ Roma La Sapienza, Dept Anesthesiol Intens Care & Pain Med, I-00199 Rome, Italy; [Lam, Arthur] Univ Washington, Dept Anesthesiol & Neurol Surg, Seattle, WA 98195 USA	Bilotta, F (corresponding author), Univ Roma La Sapienza, Dept Anesthesiol Intens Care & Pain Med, Viale Somalia 81, I-00199 Rome, Italy.	bilotta@tiscali.it					Balestreri M, 2006, NEUROCRIT CARE, V4, P8, DOI 10.1385/NCC:4:1:008; Carhuapoma JR, 1999, CRIT CARE MED, V27, P2843, DOI 10.1097/00003246-199912000-00049; Cremer OL, 2004, ANESTH ANALG, V99, P1211, DOI 10.1213/01.ANE.0000133917.67728.2A; DIXON WJ, 1991, NEUROSCI BIOBEHAV R, V15, P47, DOI 10.1016/S0149-7634(05)80090-9; FLETCHER S, 2000, ANAESTHESIOL, V13, P155; Gemma M, 2002, J NEUROSURG ANESTH, V14, P50, DOI 10.1097/00008506-200201000-00010; HSIANG JK, 1994, CRIT CARE MED, V22, P1471, DOI 10.1097/00003246-199409000-00019; Jee D, 2003, ANESTH ANALG, V96, P293, DOI 10.1097/00000539-200301000-00058; Kerr ME, 1997, NURS RES, V46, P195, DOI 10.1097/00006199-199707000-00003; Kerr ME, 1999, CRIT CARE MED, V27, P2776, DOI 10.1097/00003246-199912000-00028; Leone M, 2004, ANESTH ANALG, V99, P1193, DOI 10.1213/01.ANE.0000132546.79769.91; Menon DK, 2006, CURR OPIN CRIT CARE, V12, P85, DOI 10.1097/01.ccx.0000216572.19062.8f; MILLER JD, 1974, INJURY, V5, P265, DOI 10.1016/S0020-1383(74)80021-5; Orsi GB, 2006, J HOSP INFECT, V64, P23, DOI 10.1016/j.jhin.2006.02.022; RUDY EB, 1991, HEART LUNG, V20, P667; Stapelfeldt C, 2005, ANESTH ANALG, V100, P226, DOI 10.1213/01.ANE.0000142122.57201.6B; Tipps LB, 2000, NEUROSURGERY, V46, P596, DOI 10.1097/00006123-200003000-00015; Treggiari MM, 2007, NEUROCRIT CARE, V6, P104, DOI 10.1007/s12028-007-0012-1; Wang DX, 2002, ANESTH ANALG, V95, P1134, DOI 10.1097/00000539-200211000-00002; WHITE PF, 1982, ANESTHESIOLOGY, V57, P242, DOI 10.1097/00000542-198209000-00019; YANO M, 1986, ANESTHESIOLOGY, V64, P651, DOI 10.1097/00000542-198605000-00019; Young PJ, 1999, ANAESTHESIA, V54, P1183, DOI 10.1046/j.1365-2044.1999.01035.x; 1996, J NEUROOTRAUMA, V13, P641	23	17	25	0	1	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care		2008	8	2					241	246		10.1007/s12028-007-9012-4			6	Critical Care Medicine; Clinical Neurology	General & Internal Medicine; Neurosciences & Neurology	270KE	WOS:000253718900003	17928962				2021-06-18	
J	Chan, RCK; Bode, RK				Chan, R. C. K.; Bode, R. K.			Analysis of patient and proxy ratings on the Dysexecutive Questionnaire: an application of Rasch analysis	JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY			English	Article							ATTENTIONAL DEFICITS; COMPLAINTS; AWARENESS; SYMPTOMS	Background: We provide an alternate method of analysing self-report and proxy-report data on subjective complaints of dysexecutive symptoms among a group of patients with traumatic brain injury. Objective: The purpose of this study was to examine differences in the ratings of patients and proxies on a measure of the dysexecutive syndrome and further explore the insight impairment problem in patients with traumatic brain injury. Methods: Rasch analysis was conducted on the ratings of the Dysexecutive Questionnaire (DEX) by a sample of patients and their proxies. Results: While the average scores based on patient and proxy ratings were approximately the same (mean patient raw score = 30.12 and mean proxy raw score = 31.32), differential item functioning was found in five DEX items. As a result, the relationship between measures obtained from patient and proxy ratings was only in the moderate range (intraclass correlation = 0.46). Conclusions: Identification of differential item functioning in five of the 20 DEX items reflected the different perspectives of patients and their proxies in reporting the frequency of dysexecutive behaviour and suggests that these ratings are not interchangeable.	[Chan, R. C. K.] Chinese Acad Sci, Inst Psychol, Neuropsychol & Appl Cognit Neurosci Lab, Beijing 100101, Peoples R China; [Chan, R. C. K.] Chinese Acad Sci, Key Lab Mental Hlth, Inst Psychol, Beijing, Peoples R China; [Bode, R. K.] Rehabil Inst Chicago, Ctr Rehabil Outcomes Res, Chicago, IL 60611 USA	Chan, RCK (corresponding author), Chinese Acad Sci, Inst Psychol, Neuropsychol & Appl Cognit Neurosci Lab, Beijing 100101, Peoples R China.	rckchan@psych.ac.cn	Chan, Raymond CK/B-6717-2009	Chan, Raymond CK/0000-0002-3414-450X			Bennett PC, 2005, J INT NEUROPSYCH SOC, V11, P606, DOI 10.1017/S1355617705050721; Bogod NM, 2003, J INT NEUROPSYCH SOC, V9, P450, DOI 10.1017/S1355617703930104; Bond Trevor G., 2001, APPLYING RASCH MODEL; Burgess P. W., 2002, PRINCIPLES FRONTAL L, P557, DOI 10.1093/acprof:oso/9780195134971.003.0033; Chan RCK, 2002, J CLIN EXP NEUROPSYC, V24, P1081, DOI 10.1076/jcen.24.8.1081.8371; Chan RCK, 2002, J INT NEUROPSYCH SOC, V8, P771, DOI 10.1017/S1355617702860052; Chan RCK, 2001, BRAIN INJURY, V15, P71, DOI 10.1080/02699050118215; Chan RCK, 2001, BRIT J PSYCHOL, V92, P551, DOI 10.1348/000712601162338; Goldstein G, 1996, ECOLOGICAL VALIDITY, P75; LINACRE JM, 2000, USERS GUIDE WINSTEPS; Rasch G., 1980, PROBABLISTIC MODELS; Sbordone RJ, 1998, BRAIN INJURY, V12, P505, DOI 10.1080/026990598122467; Sherer M, 1998, J INT NEUROPSYCH SOC, V4, P380, DOI 10.1017/S1355617798003804; Wilson BA, 1996, BEHAV ASSESSMENT DYS; Wright BD., 1994, RASCH MEASUREMENT T, V8, P370, DOI DOI 10.1177/01461672012710004	15	17	17	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0022-3050	1468-330X		J NEUROL NEUROSUR PS	J. Neurol. Neurosurg. Psychiatry	JAN	2008	79	1					86	88		10.1136/jnnp.2007.117184			3	Clinical Neurology; Psychiatry; Surgery	Neurosciences & Neurology; Psychiatry; Surgery	240ZD	WOS:000251625800024	17635974				2021-06-18	
J	Dijkers, MPJM; Bushnik, T				Dijkers, Marcel P. J. M.; Bushnik, Tamara			Assessing fatigue after traumatic brain injury: An evaluation of the Barroso Fatigue Scale	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						brain injuries; fatigue; mental fatigue; psychometrics	MINOR HEAD-INJURY; WORK; DEPRESSION; PREVALENCE; RECOVERY; OUTCOMES; ADULTS; SLEEP	Objective: To assess the suitability of the Barroso Fatigue Scale (BFS) for assessment of posttraumatic brain injury (Post-TBI) fatigue. Design: Analysis of self-report data. Setting: Community. Participants: 183 individuals with TBI in California, and 233 individuals with TBI and a comparison group of 85 persons without brain injury in New York. Interventions: None. Results: Both individuals with TBI and comparison participants reported high levels of fatigue on the Fatigue Severity Scale and the Fatigue Assessment Instrument, which can be scored from the BFS. Factor analysis of 40 BFS items resulted in 5 factors; because factors appeared to be based on both substantive issues and the format and location of the items, a BFS scoring algorithm was not pursued. The other 16 BFS items provided useful information in understanding post-TBI fatigue. Conclusions: The BFS in its current format is not recommended for assessing fatigue as a multidimensional entity after TBI. It may have utility for the 3 widely known fatigue measures that can be derived from it, and it generates information on the circumstances of fatigue.	[Dijkers, Marcel P. J. M.] Mt Sinai Sch Med, Dept Rehabil Med, New York, NY 10029 USA; [Bushnik, Tamara] Santa Clara Valley Med Ctr, San Jose, CA 95128 USA	Dijkers, MPJM (corresponding author), Mt Sinai Sch Med, Dept Rehabil Med, Box 1240,1 Gustave Levy Pl, New York, NY 10029 USA.	marcel.dijkers@mssm.edu		Bushnik, Tamara/0000-0003-3328-257X; Dijkers, Marcel/0000-0002-8362-5596			Aaronson L S, 1999, Image J Nurs Sch, V31, P45; Barroso Julie, 2002, J Assoc Nurses AIDS Care, V13, P66, DOI 10.1016/S1055-3290(06)60242-2; Barroso Julie, 2003, Clin Nurs Res, V12, P49, DOI 10.1177/1054773802238740; Bateman A, 2001, ARCH PHYS MED REHAB, V82, P174, DOI 10.1053/apmr.2001.19744; Belmont A., 2006, Annales de Readaptation et de Medecine Physique, V49, P370, DOI 10.1016/j.annrmp.2006.04.018; BELZA BL, 1995, J RHEUMATOL, V22, P639; BELZA BL, 1993, NURS RES, V42, P93; Borgaro SR, 2004, BRAIN INJURY, V18, P685, DOI 10.1080/02699050310001646080; Borgaro SR, 2005, J HEAD TRAUMA REHAB, V20, P416, DOI 10.1097/00001199-200509000-00003; Bushnik T, 2007, BRAIN INJURY, V21, P559, DOI 10.1080/02699050701426915; Clinchot DM, 1998, AM J PHYS MED REHAB, V77, P291, DOI 10.1097/00002060-199807000-00006; Darko DF, 1998, NEUROENDOCRINOLOGY, V67, P317, DOI 10.1159/000054329; DAVID A, 1990, BMJ-BRIT MED J, V301, P1199, DOI 10.1136/bmj.301.6762.1199; DeLuca J, 2005, ISS CLIN COGN NEUROP, P319; DIKMEN S, 1986, J NEUROL NEUROSUR PS, V49, P1227, DOI 10.1136/jnnp.49.11.1227; Dittner AJ, 2004, J PSYCHOSOM RES, V56, P157, DOI 10.1016/S0022-3999(03)00371-4; ENGLANDER J, 1992, Brain Injury, V6, P161, DOI 10.3109/02699059209029654; Fellus J, 2007, BRAIN INJURY MED, P545; FISK JD, 1994, CLIN INFECT DIS, V18, pS79, DOI 10.1093/clinids/18.Supplement_1.S79; Hillier SL, 1997, BRAIN INJURY, V11, P661; KESHAVAN MS, 1981, BRIT J PSYCHIAT, V138, P157, DOI 10.1192/bjp.138.2.157; Kreutzer JS, 2001, BRAIN INJURY, V15, P563, DOI 10.1080/02699050010009108; KRUPP LB, 1990, J RHEUMATOL, V17, P1450; LaChapelle DL, 1998, BRAIN INJURY, V12, P649, DOI 10.1080/026990598122214; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; McCrimmon S, 2006, BRAIN INJURY, V20, P1037, DOI 10.1080/02699050600909656; Meek PM, 1997, ONCOL NURS FORUM, V24, P334; Michielsen HJ, 2003, J PSYCHOSOM RES, V54, P345, DOI 10.1016/S0022-3999(02)00392-6; MIDDELBOE T, 1992, ACTA NEUROL SCAND, V85, P5; Mota Dalete D C F, 2006, Res Theory Nurs Pract, V20, P49, DOI 10.1891/rtnp.20.1.49; NEUBERGER GB, 2003, ARTHRITIS RHEUM, V49, P175, DOI DOI 10.1002/ART.11405; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; Ouellet MC, 2006, REHABIL PSYCHOL, V51, P140, DOI 10.1037/0090-5550.51.2.140; Piper BF, 1989, KEY ASPECTS COMFORT, DOI 10.1007/978-1-349-13397-0_25; Reyes-Gibby CC, 2006, J PAIN SYMPTOM MANAG, V32, P118, DOI 10.1016/j.jpainsymman.2006.01.008; Ricci JA, 2007, J OCCUP ENVIRON MED, V49, P1, DOI 10.1097/01.jom.0000249782.60321.2a; Rimes KA, 2007, PEDIATRICS, V119, pE603, DOI 10.1542/peds.2006-2231; SCHWARTZ JE, 1993, J PSYCHOSOM RES, V37, P753, DOI 10.1016/0022-3999(93)90104-N; *STAT SOC CAN, OBST SLEEP APN CAS S; Stein KD, 2004, J PAIN SYMPTOM MANAG, V27, P14, DOI 10.1016/j.jpainsymman.2003.06.003; Stulemeijer M, 2006, J NEUROL, V253, P1041, DOI 10.1007/s00415-006-0156-5; VANZOMEREN AH, 1985, J NEUROL NEUROSUR PS, V48, P21, DOI 10.1136/jnnp.48.1.21; Wijeratne C, 2007, J PSYCHOSOM RES, V62, P153, DOI 10.1016/j.jpsychores.2006.09.011; WRIGHTSON P, 1981, INJURY, V12, P445, DOI 10.1016/0020-1383(81)90161-3; Ziino C, 2005, J INT NEUROPSYCH SOC, V11, P416, DOI 10.1017/S1355617705050472; Ziino C, 2006, NEUROPSYCHOLOGY, V20, P383, DOI 10.1037/0894-4105.20.3.383	47	17	17	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JAN-FEB	2008	23	1					3	16		10.1097/01.HTR.0000308716.80590.6b			14	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	256HS	WOS:000252719800004	18219230				2021-06-18	
J	Forsyth, RJ; Parslow, RC; Tasker, RC; Hawley, CA; Morris, KP				Forsyth, Rob J.; Parslow, Roger C.; Tasker, Robert C.; Hawley, Carol A.; Morris, Kevin P.		UK Paediatric Traumatic Brain Inju	Prediction of raised intracranial pressure complicating severe traumatic brain injury in children: Implications for trial design	PEDIATRIC CRITICAL CARE MEDICINE			English	Article						traumatic brain injury; children; intracranial pressure; randomized clinical trial; treatment; monitoring	CEREBRAL PERFUSION-PRESSURE; RANDOMIZED CONTROLLED-TRIALS; HEAD-INJURY; CARE MANAGEMENT; INTENSIVE-CARE; QUALITY	Objectives. To describe current patterns of management of raised intracranial pressure (ICP) in traumatic brain injury relevant to clinician buy-in to possible randomized controlled trials of treatments of raised ICP. To examine the feasibility of early identification of children at sufficient risk of developing raised ICP to permit a uniform approach between centers to the initiation of ICP monitoring. This would permit quantification of ICP elevation and enrollment as appropriate to randomized controlled trials of raised ICP interventions. Design: Logistic regression modeling of death before pediatric intensive care unit discharge and decision tree and logistic regression of development of raised ICP through analysis of a prospectively collected, standardized, national data set. Setting: Pediatric intensive care units in the United Kingdom and Eire. Patients: Patients were 501 children < 16 yrs of age primarily admitted to intensive care unit for management of traumatic brain injury in the United Kingdom and Eire between February 2001 and August 2003. Measurements and Main Results. The data analyzed included demographic, acute physiologic, and cranial imaging variables. Death was associated with both raised ICP and the nonmeasurement of ICP. In a subset of 199 patients, an empirically derived decision rule predicted the development of raised ICP at any point during ICU admission with sensitivity of 73% and specificity of 74% (positive predictive value 82% and negative predictive value 63%). Logistic regression modeling performed comparably. The decision rule also predicted raised ICP in 20% of children not undergoing ICP monitoring. Conclusions. Simple models based on early clinical data may predict the development of raised ICP sufficiently well to encourage a consistent approach between centers to initiation of ICP monitoring. We estimate studies designed to detect reductions in ICU mortality will require > 320 children per arm, although this figure may be higher if more conservative assumptions are made.	[Forsyth, Rob J.] Royal Victoria Infirm, Sir James Spence Inst Child Hlth, Sch Clin Med Sci Child Hlth, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England; [Parslow, Roger C.] Univ Leeds, LIGHT, Ctr Biostat & Epidemiol, Paediat Epidemiol Grp, Leeds, W Yorkshire, England; [Tasker, Robert C.] Univ Cambridge, Sch Clin, Addenbrookes Hosp, Cambridge, England; [Hawley, Carol A.] Univ Warwick, Warwick Med Sch, Div Hlth & Community, Coventry CV4 7AL, W Midlands, England; [Morris, Kevin P.] Prince Wales Childrens Hosp, Birmingham, W Midlands, England	Forsyth, RJ (corresponding author), Royal Victoria Infirm, Sir James Spence Inst Child Hlth, Sch Clin Med Sci Child Hlth, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England.	r.j.forsyth@newcastle.ac.uk	Parslow, Roger/AAV-1477-2020; Forsyth, Rob J/I-9226-2012; Tasker, Robert C/R-5837-2019; Forsyth, Rob/H-9193-2019; Hawley, Carol/AAG-3830-2019; Chater, Tim/Q-4355-2016	Forsyth, Rob J/0000-0002-5657-4180; Forsyth, Rob/0000-0002-5657-4180; Chater, Tim/0000-0002-1138-0147; Tasker, Robert/0000-0003-3647-8113; Parslow, Roger/0000-0002-3945-5294			ADELSON PD, 2003, PEDIAT CRIT CARE M S, V4, P19; Andrews PJD, 2002, J NEUROSURG, V97, P326, DOI 10.3171/jns.2002.97.2.0326; Chambers IR, 2005, CHILD NERV SYST, V21, P195, DOI 10.1007/s00381-004-1060-x; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; Cremer OL, 2005, CRIT CARE MED, V33, P2207, DOI 10.1097/01.CCM.0000181300.99078.B5; Dickinson K, 2000, BMJ-BRIT MED J, V320, P1308, DOI 10.1136/bmj.320.7245.1308; Downard C, 2000, J TRAUMA, V49, P654, DOI 10.1097/00005373-200010000-00012; Dunham CM, 2004, J TRAUMA, V56, P482, DOI 10.1097/01.TA.0000114537.52540.95; ESPARZA J, 1985, CHILD NERV SYST, V1, P109, DOI 10.1007/BF00706691; FORSYTH RJ, 2006, ROUTINE INTRACRANIAL; Graham DI, 2000, J NEUROPATH EXP NEUR, V59, P641, DOI 10.1093/jnen/59.8.641; Lannoo E, 1998, INTENS CARE MED, V24, P236, DOI 10.1007/s001340050556; Mazzola CA, 2002, CRIT CARE MED, V30, pS393, DOI 10.1097/00003246-200211001-00003; Miller MT, 2004, J TRAUMA, V56, P967, DOI 10.1097/01.TA.0000123699.16465.8B; Morris KP, 2006, INTENS CARE MED, V32, P1606, DOI 10.1007/s00134-006-0285-4; *MRC, 1998, NEUR AC BRAIN INJ TR; Murray GD, 2000, BRIT MED J, V321, P1223, DOI 10.1136/bmj.321.7270.1223; Murray GD, 2005, J NEUROTRAUM, V22, P511, DOI 10.1089/neu.2005.22.511; *OFF NAT STAT, 2004, SERIES DH3; Office for National Statistics, 2002, SERIES DH3, V35; Olshen RA, 1984, CLASSIFICATION REGRE; Parslow RC, 2005, ARCH DIS CHILD, V90, P1182, DOI 10.1136/adc.2005.072405; PFENNINGER J, 1983, INTENS CARE MED, V9, P13, DOI 10.1007/BF01693699; Reinert MM, 1999, NEUROL RES, V21, P330, DOI 10.1080/01616412.1999.11740940; Roberts I, 1998, J NEUROL NEUROSUR PS, V65, P729, DOI 10.1136/jnnp.65.5.729; Sackett DL, 2000, CAN MED ASSOC J, V162, P1311; Segal S, 2001, INTENS CARE MED, V27, P236, DOI 10.1007/s001340000717; Segui-Gomez M, 2003, EPIDEMIOL REV, V25, P3, DOI 10.1093/epirev/mxg007; Steinberg Dan, 1995, TREE STRUCTURED NONP	29	17	17	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1529-7535	1947-3893		PEDIATR CRIT CARE ME	Pediatr. Crit. Care Med.	JAN	2008	9	1					8	14		10.1097/01.PCC.0000298759.78616.3A			7	Critical Care Medicine; Pediatrics	General & Internal Medicine; Pediatrics	252QR	WOS:000252462200003	18477907				2021-06-18	
J	Goslar, PW; Crawford, NR; Petersen, SR; Wilson, JR; Harrington, T				Goslar, Pamela W.; Crawford, Neil R.; Petersen, Scott R.; Wilson, Jeffrey R.; Harrington, Timothy			Helmet use and associated spinal fractures in motorcycle crash victims	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						motorcycle; helmets; spine fractures; statistics	FATAL INJURIES; NECK INJURIES; HEAD; SEVERITY; PATTERNS; ALCOHOL; TRAUMA; DRIVER; RIDERS; IMPACT	Background: The effect of helmet use on the incidence of cervical and thoracic fractures sustained in motorcycle crashes remains controversial. Methods: We retrospectively reviewed the incidence of these fractures in helmeted and nonhelmeted crash victims at a single Level I trauma hospital with a well-defined system for evaluating spinal fractures. Results: Of 422 motorcycle crash victims treated during 3 years, 190 had a traumatic brain injury (TBI) and 75 sustained some form of spinal fracture. Conclusions: Based on the statistical analysis, there was no relationship between helmet use and cervical or thoracic fractures, after controlling for speed of crash. The protective effect of helmet use in TBI was verified. These findings re-emphasize the need for a well-defined radiologic protocol for spinal injury at centers that evaluate crash victims.	[Wilson, Jeffrey R.] Arizona State Univ, WP Carey Sch Business, Tempe, AZ USA; [Petersen, Scott R.; Harrington, Timothy] St Josephs Hosp, Div Neurol Surg, Barrow Neurol Inst, Phoenix, AZ USA	Harrington, T (corresponding author), Barrow Neurol Inst, 350 W Thomas Rd, Phoenix, AZ 85013 USA.	neuropub@chw.edu		Crawford, Neil/0000-0003-2919-2053			*AM COLL SURG, 2005, NAT TRAUM DAT BANK D; *AM COLL SURG, 2004, AM COLL SURG, V199, P260; Ankarath S, 2002, INJURY, V33, P473, DOI 10.1016/S0020-1383(02)00048-7; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; BISHOP PJ, 1990, AM J SPORT MED, V18, P201, DOI 10.1177/036354659001800215; Bradbury A., 1993, Health Bulletin (Edinburgh), V51, P86; Branas CC, 2001, ACCIDENT ANAL PREV, V33, P641, DOI 10.1016/S0001-4575(00)00078-6; Camacho DLA, 2001, J BIOMECH ENG-T ASME, V123, P432, DOI 10.1115/1.1389086; CHENIER TC, 1987, ACCIDENT ANAL PREV, V19, P133, DOI 10.1016/0001-4575(87)90032-7; COPES WS, 1990, J TRAUMA, V30, P1200, DOI 10.1097/00005373-199010000-00003; DAFFNER RH, 1987, SKELETAL RADIOL, V16, P280, DOI 10.1007/BF00361469; FANTUS RJ, 2005, B AM COL SURG, V90, P43; GOLDSTEIN JP, 1986, EVALUATION REV, V10, P355, DOI 10.1177/0193841X8601000306; GOLDSTEIN JP, 1988, REV HELMET HELMET LA; GOLDSTEIN SC, 1992, WESTERN J MED, V156, P210; *GOV OFF HIGHW SAF, 2005, TRANSP SAF PLAN STAT; Hitosugi M, 2004, AM J FOREN MED PATH, V25, P125, DOI 10.1097/01.paf.0000127397.67081.f5; Hitosugi M, 1999, AM J FOREN MED PATH, V20, P251, DOI 10.1097/00000433-199909000-00007; Hundley JC, 2004, J TRAUMA, V57, P944, DOI 10.1097/01.TA.0000149497.20065.F4; HUSTON RL, 1981, J BIOMECH ENG-T ASME, V103, P18, DOI 10.1115/1.3138238; IVERS RQ, 2004, EVIDENCE BASED HEALT, V8, P265; Kasantikul V, 2002, Annu Proc Assoc Adv Automot Med, V46, P125; KRANTZ KPG, 1985, INJURY, V16, P253; KUPFERSCHMID JP, 1989, J TRAUMA, V29, P593, DOI 10.1097/00005373-198905000-00009; Lin MR, 2004, NEUROEPIDEMIOLOGY, V23, P269, DOI 10.1159/000080091; Lin MR, 2003, ANN EMERG MED, V41, P783, DOI 10.1067/mem.2003.186; LIU B, 2004, COCHRANE DATABASE SY; Liu B., 2004, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD004333.pub2, DOI 10.1002/14651858.CD004333.PUB2]; Lowenstein S, 1996, ANN EMERG MED, V27, P389; NELSON D, 1992, ANN EMERG MED, V21, P279, DOI 10.1016/S0196-0644(05)80888-1; Nightingale RW, 1996, J BONE JOINT SURG AM, V78A, P412, DOI 10.2106/00004623-199603000-00013; Nightingale RW, 1997, SPINE, V22, P2380, DOI 10.1097/00007632-199710150-00012; OFFNER PJ, 1992, J TRAUMA, V32, P636, DOI 10.1097/00005373-199205000-00016; Ooi S S, 2004, Med J Malaysia, V59, P146; ORSAY E, 1995, ANN EMERG MED, V26, P455, DOI 10.1016/S0196-0644(95)70114-1; ORSAY EM, 1994, ANN EMERG MED, V23, P802, DOI 10.1016/S0196-0644(94)70317-5; ORSAY EM, 1994, ANN EMERG MED, V24, P51, DOI 10.1016/S0196-0644(94)70162-8; PeekAsa C, 1996, J TRAUMA, V41, P989, DOI 10.1097/00005373-199612000-00008; Robertson A, 2002, SPINE, V27, P2825, DOI 10.1097/00007632-200212150-00019; Robertson A, 2002, J TRAUMA, V53, P5, DOI 10.1097/00005373-200207000-00002; RUTLEDGE R, 1993, ACCIDENT ANAL PREV, V25, P347, DOI 10.1016/0001-4575(93)90028-U; SARKAR S, 1995, J TRAUMA, V38, P242, DOI 10.1097/00005373-199502000-00017; SHROSBREE RD, 1978, PARAPLEGIA, V16, P102, DOI 10.1038/sc.1978.16; SOSIN DM, 1990, JAMA-J AM MED ASSOC, V264, P2395, DOI 10.1001/jama.264.18.2395; Stanislas MJC, 1998, INJURY, V29, P15, DOI 10.1016/S0020-1383(97)00109-5; TEASDALE G, 1974, LANCET, V2, P81; Van Camp L A, 1998, Eur J Emerg Med, V5, P207	47	17	17	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	JAN	2008	64	1					190	196		10.1097/TA.0b013e3180f62eec			7	Critical Care Medicine; Surgery	General & Internal Medicine; Surgery	250UE	WOS:000252325700038	18188120				2021-06-18	
J	Izaute, M; Durozard, C; Eldigier, E; Teissedre, F; Perreve, A; Gerbaud, L				Izaute, Marie; Durozard, Carole; Eldigier, Emilie; Teissedre, Frederique; Perreve, Anne; Gerbaud, Laurent			Perceived social support and locus of control after a traumatic brain injury (TBI)	BRAIN INJURY			English	Article						locus of control; perceived social support; social rehabilitation; traumatic brain injury	CLOSED-HEAD-INJURY; PSYCHOSOCIAL ADJUSTMENT; COPING STRATEGIES; DEPRESSION; INDIVIDUALS; STRESS	Research design: The aim of the study was to investigate the social rehabilitation related to the perceived social support and the locus of control (LC) of patients with traumatic brain injury (TBI). Methods and procedures: A group of 46 patients 3-5 years after injury was evaluated. For the social rehabilitation, patients were categorized as 'high rehabilitation' or 'low rehabilitation' as regards vocational rehabilitation. Low rehabilitation patients should confirm the idea of an external locus of control more than high rehabilitation patients. Main outcomes and results: As far as perceived social support is concerned, both groups reported a poor level of social support, although the patients considered as high rehabilitation exhibited greater satisfaction in terms of social support. When one considers LC, patients with TBI were associated with a weaker internal LC than non-patients with TBI. In patients exhibiting a high level of rehabilitation, the LC was less frequently attributed to 'chance' or 'powerful others'. Patients with a low level of rehabilitation explained their difficulties in terms of external factors. Conclusions: It is therefore necessary to take rehabilitation, perceived high-quality social support and low external LC into account if one is to improve the rehabilitation of TBI patients.	[Izaute, Marie; Durozard, Carole; Eldigier, Emilie; Teissedre, Frederique] Univ Blaise Pascal, CNRS, UMR 6024, LAPSCO, F-63037 Clermont Ferrand, France; [Perreve, Anne; Gerbaud, Laurent] Univ Auvergne, SSIU, Clermont Ferrand, France	Izaute, M (corresponding author), Univ Blaise Pascal, CNRS, UMR 6024, LAPSCO, 34 Ave Carnot, F-63037 Clermont Ferrand, France.	marie.izaute@univ-bpclermont.fr					Bamdad MJ, 2003, BRAIN INJURY, V17, P1011, DOI 10.1080/0269905031000110553; Bechtold KT, 2000, ARCH CLIN NEUROPSYCH, V15, P810, DOI 10.1016/S0887-6177(00)80291-7; Bruchon-Schweitzer M., 2003, PSYCHOL FR, V48, P41; BRUCHONSCHWEITZ.M, 2002, PSYCHOL SANTE MODELE, P43; Charles N, 2007, NEUROREHABILITATION, V22, P61; Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240; DICKMEN S, 1993, ARCH PHYS MED REHAB, V84, P1449; Eisenberg, 1987, NEUROBEHAVIORAL RECO, P215; FINSET A, 1995, BRAIN INJURY, V9, P141, DOI 10.3109/02699059509008187; Franulic A, 2004, BRAIN INJURY, V18, P119, DOI 10.1080/0269905031000149515; Gollaher K, 1998, BRAIN INJURY, V12, P255, DOI 10.1080/026990598122557; Holosko M, 1989, CANADIAN J REHABILIT, V2, P145; Junque C, 1997, BRAIN INJURY, V11, P251, DOI 10.1080/026990597123557; KAPLAN SP, 1990, REHABILITATION COUNS, V34, P17; Kendall E, 1996, NEUROPSYCHOL REHABIL, V6, P101, DOI 10.1080/713755502; KENDALL E, 2003, J VOCAT REHABIL, V19, P31; KESSLER RC, 1992, SER CLIN C, P259; Kinsella GJ, 1998, NEUROPSYCHOL REHABIL, V8, P351, DOI 10.1080/713755576; Koponen S, 2002, AM J PSYCHIAT, V159, P1315, DOI 10.1176/appi.ajp.159.8.1315; Lazarus RS, 2000, AM PSYCHOL, V55, P665, DOI 10.1037//0003-066X.55.6.665; LEACH LR, 1994, BRAIN INJURY, V8, P599, DOI 10.3109/02699059409151012; LEVENSON H, 1972, 80TH P ANN CONV AM P, V7, P259; Mazaux JM, 1997, ARCH PHYS MED REHAB, V78, P1316, DOI 10.1016/S0003-9993(97)90303-8; Millet P, 2003, J VOCATIONAL REHABIL, V19, P59; MOORE A D, 1992, Brain Injury, V6, P89, DOI 10.3109/02699059209008129; MORTON MV, 1995, BRAIN INJURY, V9, P81, DOI 10.3109/02699059509004574; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; Ownsworth T, 2004, DISABIL REHABIL, V26, P765, DOI 10.1080/09638280410001696700; Pelletier PM, 2000, BRAIN COGNITION, V44, P45; Rutterford NA, 2006, J INT NEUROPSYCH SOC, V12, P359, DOI 10.1017/S1355617706060450; SARASON IG, 1987, J SOC PERS RELAT, V4, P497, DOI 10.1177/0265407587044007; Seligman M., 1975, HELPLESSNESS; Shaw L, 2002, DISABIL REHABIL, V24, P185, DOI 10.1080/09638280110066299; Sherer M, 2002, CLIN NEUROPSYCHOL, V16, P157, DOI 10.1076/clin.16.2.157.13238; SykesHorn W, 1997, ARCH PHYS MED REHAB, V78, P1327, DOI 10.1016/S0003-9993(97)90305-1; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; Tomberg T, 2007, BRAIN INJURY, V21, P479, DOI 10.1080/02699050701311737; Tomberg T, 2005, BRAIN INJURY, V19, P1181, DOI 10.1080/02699050500150153; Vogenthaler D R, 1989, Brain Inj, V3, P369, DOI 10.3109/02699058909004561; Wood RL, 2006, J NEUROL NEUROSUR PS, V77, P71, DOI 10.1136/jnnp.2005.065540; Ylvisaker Mark, 2005, Seminars in Speech and Language, V26, P256, DOI 10.1055/s-2005-922104	42	17	17	0	5	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2008	22	10					758	764		10.1080/02699050802366002			7	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	347MJ	WOS:000259145400005	18787985				2021-06-18	
J	Jha, A; Lammertse, DP; Coll, JR; Charlifue, S; Coughlin, CT; Whiteneck, GG; Worley, G				Jha, Amitabh; Lammertse, Daniel P.; Coll, Joseph R.; Charlifue, Susan; Coughlin, Christopher T.; Whiteneck, Gale G.; Worley, Gordon			Apolipoprotein E epsilon-4 allele and outcomes of traumatic spinal cord injury	JOURNAL OF SPINAL CORD MEDICINE			English	Article						apolipoprotein E; polymorphism; genotype; spinal cord injuries, cervical; tetraplegia; rehabilitation, physical	E POLYMORPHISM; BRAIN-INJURY; E GENOTYPE; CEREBROVASCULAR-DISEASE; APOE GENOTYPE; ASSOCIATION; EXPRESSION; RECOVERY; SURVIVAL	Background/Objective: To test the hypothesis that apolipoprotein E (APOE) polymorphisms are associated with outcomes after spinal cord injury (SCI). Methods: Retrospective cohort study, from rehabilitation admission to discharge. Participants: Convenience sample of 89 persons with cervical SCI (C3-C8) treated from 1995 through 2003. Median age was 30 years (range 14-70); 67 were male (75%) and 83 were white (93%). Main Outcome Measures: American Spinal Injury Association (ASIA) motor and sensory scores, ASIA Impairment Scale (AIS), time from injury to rehabilitation admission, and length of stay (LOS) in rehabilitation. Results: Subjects with an APOE epsilon 4 allele (n = 15; 17%) had significantly less motor recovery during rehabilitation than did individuals without an epsilon 4 allele (median 3.0 vs 5.5; P < 0.05) and a longer rehabilitation LOS (median 106 vs 89 days; P = 0.04), but better sensory-pin prick recovery (median 5.0 vs 2.0; P = 0.03). There were no significant differences by APOE epsilon 4 allele status in sensory-light touch recovery, likelihood of improving AIS Grade, or time from injury to rehabilitation admission. Conclusions: APOE epsilon 4 allele was associated with differences in neurological recovery and longer rehabilitation LOS. Genetic factors may be among the determinants of outcome after SCI and warrant further study.	[Jha, Amitabh] Univ Colorado, Craig Hosp, Res Dept, Englewood, CO 80113 USA; [Jha, Amitabh; Lammertse, Daniel P.; Coll, Joseph R.] Univ Colorado, Denver, CO 80202 USA; [Worley, Gordon] Duke Univ, Durham, NC USA	Jha, A (corresponding author), Univ Colorado, Craig Hosp, Res Dept, 3425 S Clarkson St, Englewood, CO 80113 USA.	ajha@craighospital.org	Coll, Joseph R/C-3165-2012				ALBERTS MJ, 1995, LANCET, V346, P575, DOI 10.1016/S0140-6736(95)91411-0; Blackman JA, 2005, DEV MED CHILD NEUROL, V47, P64, DOI 10.1017/S0012162205000113; Carmel JB, 2001, PHYSIOL GENOMICS, V7, P201, DOI 10.1152/physiolgenomics.00074.2001; Cravchik A, 2001, ARCH NEUROL-CHICAGO, V58, P1772, DOI 10.1001/archneur.58.11.1772; Eastwood EA, 1999, ARCH PHYS MED REHAB, V80, P1457, DOI 10.1016/S0003-9993(99)90258-7; Friedman G, 1999, NEUROLOGY, V52, P244, DOI 10.1212/WNL.52.2.244; HIXSON JE, 1990, J LIPID RES, V31, P545; Horsburgh K, 1999, J NEUROPATH EXP NEUR, V58, P227, DOI 10.1097/00005072-199903000-00002; Horsburgh K, 2000, NEUROBIOL AGING, V21, P245, DOI 10.1016/S0197-4580(00)00097-X; Jackson AB, 2004, ARCH PHYS MED REHAB, V85, P1740, DOI 10.1016/j.apmr.2004.04.035; Jordan BD, 1997, JAMA-J AM MED ASSOC, V278, P136, DOI 10.1001/jama.278.2.136; Kutner KC, 2000, NEUROSURGERY, V47, P651, DOI 10.1097/00006123-200009000-00026; Lichtman SW, 2000, NEUROLOGY, V55, P1536, DOI 10.1212/WNL.55.10.1536; Lynch JR, 2005, EXP NEUROL, V192, P109, DOI 10.1016/j.expneurol.2004.11.014; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; Marino RJ, 1999, ARCH PHYS MED REHAB, V80, P1391, DOI 10.1016/S0003-9993(99)90249-6; Marino RJ, 2002, J SPINAL CORD MED S1, V26, pS50; McCarron MO, 1999, NEUROLOGY, V53, P1308, DOI 10.1212/WNL.53.6.1308; McCarron MO, 2000, ARCH NEUROL-CHICAGO, V57, P1480, DOI 10.1001/archneur.57.10.1480; McCarron MO, 1999, NEUROLOGY, V53, P2176, DOI 10.1212/WNL.53.9.2176; MENZEL HJ, 1983, ARTERIOSCLEROSIS, V3, P310, DOI 10.1161/01.ATV.3.4.310; Moretti EW, 2005, CRIT CARE MED, V33, P2521, DOI 10.1097/01.CCM.0000186368.96146.FB; SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467; Schiefermeier M, 2000, STROKE, V31, P2068, DOI 10.1161/01.STR.31.9.2068; Seitz A, 2003, J NEUROSCI RES, V71, P417, DOI 10.1002/jnr.10482; SORBI S, 1995, NAT MED, V1, P852, DOI 10.1038/nm0995-852; Tardiff BE, 1997, ANN THORAC SURG, V64, P715, DOI 10.1016/S0003-4975(97)00757-1; Teasdale GM, 1997, LANCET, V350, P1069, DOI 10.1016/S0140-6736(97)04318-3	28	17	17	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1079-0268	2045-7723		J SPINAL CORD MED	J. Spinal Cord. Med.		2008	31	2					171	176		10.1080/10790268.2008.11760708			6	Clinical Neurology	Neurosciences & Neurology	315KA	WOS:000256876200006	18581664	Green Published			2021-06-18	
J	Li, G; Wen, L; Zhan, RY; Shen, F; Yang, XF; Fu, WM				Li, G.; Wen, L.; Zhan, R. Y.; Shen, F.; Yang, X. F.; Fu, W. M.			Cranioplasty for patients developing large cranial defects combined with post-traumatic hydrocephalus after head trauma	BRAIN INJURY			English	Article						cranioplasty; post-traumatic hydrocephalus; traumatic brain injury	SINKING SKIN FLAP; BRAIN-INJURY; DECOMPRESSIVE CRANIECTOMY; BLOOD-FLOW	Background: Large cranial defects combined with hydrocephalus after decompressive craniectomy are a common, harsh reality among patients with head trauma. Typically, a shunt is first used to relieve the hydrocephalus. However, subsequently the patients may develop a severe sinking scalp flap over the skull defect before cranioplasty, which would make the procedure difficult. Methods: This problem was overcome by temporarily adjusting the shunt pressure using a programmable ventriculoperitoneal shunt tube, which allowed expansion of the depressed scalp flap and facilitated the subsequent cranioplasty. This study describes two patients who were treated for this problem after severe head trauma. Results: When performing a titanium mesh cranioplasty after a shunt, this new method facilitated the separation of the scalp from the underlying muscle or dura and obliterated the dead space between the titanium mesh and the underlying tissue. Both patients had satisfactory outcomes without complications. Conclusions: This method is easy and safe and it facilitates the cranioplasty, reducing the potential complications, including intracranial haematoma, effusions and infection, and thereby improving the patient outcome.	[Li, G.; Wen, L.; Shen, F.; Yang, X. F.; Fu, W. M.] Zhejiang Univ, Coll Med, Affiliated Hosp 1, Dept Neurosurg, Hangzhou 310003, Zhejiang, Peoples R China; [Li, G.; Wen, L.; Zhan, R. Y.; Shen, F.; Yang, X. F.] Zhejiang Univ, Inst Brain Med, Hangzhou 310003, Zhejiang, Peoples R China	Yang, XF (corresponding author), Zhejiang Univ, Coll Med, Affiliated Hosp 1, Dept Neurosurg, 79 Qingchn Rd, Hangzhou 310003, Zhejiang, Peoples R China.	jediwen@163.com	shen, fang/G-8439-2011				Aarabi B, 2006, J NEUROSURG, V104, P469, DOI 10.3171/jns.2006.104.4.469; Adamides AA, 2006, ANZ J SURG, V76, P163, DOI 10.1111/j.1445-2197.2006.03674.x; CARDOSO ER, 1985, SURG NEUROL, V23, P261, DOI 10.1016/0090-3019(85)90092-8; CARVI Y, 2006, NEUROL RES, V28, P139, DOI DOI 10.1179/016164106X98008; Dujovny M, 1997, SURG NEUROL, V47, P238, DOI 10.1016/S0090-3019(96)00013-4; FODSTAD H, 1984, ACTA NEUROCHIR, V70, P21, DOI 10.1007/BF01406039; Fodstad H, 1979, Acta Neurochir Suppl (Wien), V28, P514; Guyot LL, 2000, NEUROL RES, V22, P25; HENRY H, 2000, OPERATIVE NEUROSURGI, P26; Isago T, 2004, ANN PLAS SURG, V53, P288, DOI 10.1097/01.sap.0000106433.89983.72; Jiao Qing-fang, 2007, Chin J Traumatol, V10, P159; Kan P, 2006, J NEUROSURG, V105, P337, DOI 10.3171/ped.2006.105.5.337; Miki T, 2006, J TRAUMA, V61, P985, DOI 10.1097/01.ta.0000239665.39237.8c; Piek Jurgen, 2002, Curr Opin Crit Care, V8, P134, DOI 10.1097/00075198-200204000-00008; Sakamoto S, 2006, CLIN NEUROL NEUROSUR, V108, P583, DOI 10.1016/j.clineuro.2005.03.012; Schaller B, 2003, BRAIN RES, V982, P31, DOI 10.1016/S0006-8993(03)02900-7; Timofeev I, 2006, INJURY, V37, P1125, DOI 10.1016/j.injury.2006.07.031; Winkler PA, 2000, J NEUROSURG, V93, P53, DOI 10.3171/jns.2000.93.1.0053; Yang Xue-Jun, 2003, Chin J Traumatol, V6, P99	19	17	22	1	3	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2008	22	4					333	337		10.1080/02699050801958353			5	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	279HS	WOS:000254346900006	18365847				2021-06-18	
J	Prins, M				Prins, Mayumi			Diet, ketones, and neurotrauma	EPILEPSIA			English	Article						Ketones; Brain substrate; Metabolism; Injury; Development	TRAUMATIC BRAIN-INJURY; HEAD-INJURY; KETOGENIC DIET; ADULT RATS; JUVENILE; METABOLISM; EXPRESSION; DAMAGE	The annual incidence of traumatic brain injury far exceeds the rates of any other disease in the United States, yet progress toward age-relevant therapies, attention to patients needs, and research funding have all been minimal. Cerebral metabolism of glucose has been shown to be altered after head injury, and increasing cerebral metabolism of alternative substrates (ketones) has been shown to be neuroprotective in several models of traumatic brain injury. This altered dietary approach may have tremendous therapeutic potential for both the pediatric and adult head-injured populations.	[Prins, Mayumi] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurosurg, Los Angeles, CA 90095 USA	Prins, M (corresponding author), Univ Calif Los Angeles, Sch Med, Div Neurosurg, Room NPI 18-228,Box 957039, Los Angeles, CA 90095 USA.	mprins@mednet.ucla.edu	Prins, Mayumi/J-9571-2015	Prins, Mayumi/0000-0001-7694-9739	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS052406] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS052406, R01 NS052406-03, R01 NS104311] Funding Source: Medline		Appelberg S, 2007, J NEUROTRAUM, V24, P1267; Bartnik BL, 2005, J NEUROTRAUM, V22, P1052, DOI 10.1089/neu.2005.22.1052; BERGER NA, 1985, RADIAT RES, V101, P4, DOI 10.2307/3576299; Davis LM, 2008, J NEUROSCI RES, V86, P1812, DOI 10.1002/jnr.21628; HALL ED, 1993, J NEUROCHEM, V60, P588, DOI 10.1111/j.1471-4159.1993.tb03189.x; McIntosh TK, 1988, J NEUROTRAUM, V5, P17, DOI 10.1089/neu.1988.5.17; Prins ML, 2006, DEV NEUROSCI-BASEL, V28, P447, DOI 10.1159/000094170; Prins M, 2007, J NEUROTRAUM, V24, P1267; Prins ML, 2005, J NEUROSCI RES, V82, P413, DOI 10.1002/jnr.20633; Ritter AM, 1996, J NEUROTRAUM, V13, P473, DOI 10.1089/neu.1996.13.473; ROBERTSON CS, 1991, J NEUROSURG, V74, P43, DOI 10.3171/jns.1991.74.1.0043; Sullivan PG, 2000, ANN NEUROL, V48, P723, DOI 10.1002/1531-8249(200011)48:5&lt;723::AID-ANA5&gt;3.0.CO;2-W; Thomas S, 2000, J NEUROTRAUM, V17, P649, DOI 10.1089/089771500415409; Veech RL, 2004, PROSTAG LEUKOTR ESS, V70, P309, DOI 10.1016/j.plefa.2003.09.007; Wu A, 2004, J NEUROTRAUM, V21, P1457, DOI 10.1089/neu.2004.21.1457; Wu A, 2003, NEUROSCIENCE, V119, P365, DOI 10.1016/S0306-4522(03)00154-4; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K	17	17	17	0	2	BLACKWELL PUBLISHING	OXFORD	9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND	0013-9580			EPILEPSIA	Epilepsia		2008	49			8			111	113		10.1111/j.1528-1167.2008.01852.x			3	Clinical Neurology	Neurosciences & Neurology	374QW	WOS:000261059800033	19049605	Bronze, Green Accepted			2021-06-18	
J	Riganello, F; Quintieri, M; Candelieri, A; Conforti, D; Dolce, G				Riganello, F.; Quintieri, M.; Candelieri, A.; Conforti, D.; Dolce, G.			Heart Rate Response to Music An Artificial Intelligence Study on Healthy and Traumatic Brain-Injured Subjects	JOURNAL OF PSYCHOPHYSIOLOGY			English	Article						heart rate variability; emotional response to music; data mining procedures; traumatic brain injured patients; healthy controls	POSTTRAUMATIC-STRESS-DISORDER; POWER SPECTRUM ANALYSIS; RATE-VARIABILITY; VEGETATIVE STATE; CONSCIOUSNESS; PREDICTION; TREE; HRV; CLASSIFICATION; SCHIZOPHRENIA	Background and rationale: Investigation of the brain's emotional response to music is limited by methodological problems mainly related to the characterization of the emotions and concomitant brain conditions. In this study, artificial intelligence procedures were applied to identify significant music-induced changes in heart rate variability and to classify autonomic reactions to stimuli requiring complex brain operations. Both healthy subjects and traumatic brain-injury (TBI) patients were studied in order to test the method's validity. Methods: 16 TBI patents and 26 healthy subjects were requested to listen to selected music samples while the heart beat was continuously recorded. The parametric and nonparametric frequency spectra were computed on the heart rate and the spectra descriptors were entered into a 1-R rules (very simple classification rules) data-mining procedure. Data-mining procedures independently classified the heart-rate spectral patterns and the emotions reported by subjects as positive, indifferent, or negative. Results and conclusions: The data-mining procedures sorted the nu_LF descriptor as the spectral parameter that allowed clustering the emotions reported by the subjects as positive and negative. Classification by nu_LF was comparable to that by self-reported emotions, with an overall correct classification by author in 76.0% of controls and 70% of patients. The identification of negative and positive emotions was correct in 81.3% and 68.9% of controls and in 65% and 74% of TBI patients, without significant differences between healthy subjects and TBI patients. This observation suggests that autonomic concomitants of emotions are detectable in response to complex emotional stimuli.	[Riganello, F.; Quintieri, M.; Dolce, G.] S Anna Inst, Intens Care Unit, I-88900 Crotone, Italy; [Riganello, F.; Quintieri, M.; Dolce, G.] RAN, Crotone, Italy; [Candelieri, A.; Conforti, D.] Univ Calabria, Lab Decis Making Clin Serv, Dept Elect Informat & Systemist, I-87036 Cosenza, Italy	Riganello, F (corresponding author), S Anna Inst, Intens Care Unit, Via Siris 11, I-88900 Crotone, Italy.	francescoriganello@alice.it; giulianodolce@libero.it	/AAI-7627-2021; Riganello, Francesco/N-2615-2014; Riganello, Francesco/AAC-3976-2020; Conforti, Domenico/D-2734-2011; Campailla, Jasmin/AAK-2420-2021	/0000-0003-1431-576X; Riganello, Francesco/0000-0003-0678-9252; Riganello, Francesco/0000-0003-0678-9252; Conforti, Domenico/0000-0002-4816-4333; 	University of Calabria; Italian Ministry of University and Research (2004-2007)Ministry of Education, Universities and Research (MIUR)	This research has been supported by the S. Anna Institute, Crotone, and the University of Calabria under the special project "MIMERICA," funded by the Italian Ministry of University and Research (2004-2007). Thanks are due to Professors Leon Sazbon, MD, (the University of Tel Aviv, Israel) and Walter G. Sannita, MD (University of Genova, Genova, Italy, and State University of New York, Stony Brook, NY, USA) for their continuing support and valuable advice.	ALBENTOSA M, 1994, AQUACULTURE, V126, P315, DOI 10.1016/0044-8486(94)90048-5; Allerdings MD, 2006, BRAIN COGNITION, V60, P193, DOI 10.1016/j.bandc.2004.09.018; Aoki K, 2001, AM J PHYSIOL-REG I, V281, pR591; APPELHANS BM, 2007, BIOL PSYCHOL, V12; Appelhans BM, 2006, REV GEN PSYCHOL, V10, P229, DOI 10.1037/1089-2680.10.3.229; AYSIN B, 2007, IEEE ENG MED BIOL SO, V22, P5047; Aysin Benhur, 2006, Conf Proc IEEE Eng Med Biol Soc, V2006, P1776; Barbieri R, 2002, AM J PHYSIOL-REG I, V283, pR1210, DOI 10.1152/ajpregu.00127.2002; Beda A, 2007, PSYCHOPHYSIOLOGY, V44, P767, DOI 10.1111/j.1469-8986.2007.00542.x; Braga ANG, 2002, AM J PHYSIOL-REG I, V282, pR1663, DOI 10.1152/ajpregu.00583.2001; Briswas A. K., 2000, CRITICAL CARE MED, V28, P3907; Brown AW, 2005, J NEUROTRAUM, V22, P1040, DOI 10.1089/neu.2005.22.1040; Brown S, 2004, NEUROREPORT, V15, P2033, DOI 10.1097/00001756-200409150-00008; Chambers AS, 2002, PSYCHOPHYSIOLOGY, V39, P861, DOI 10.1111/1469-8986.3960861; Cohen H, 1998, BIOL PSYCHIAT, V44, P1054, DOI 10.1016/S0006-3223(97)00475-7; Cohen H, 2000, PSYCHIAT RES, V96, P1, DOI 10.1016/S0165-1781(00)00195-5; Cohen H, 2006, AUTON NEUROSCI-BASIC, V128, P1, DOI 10.1016/j.autneu.2005.06.007; Coleman MR, 2007, BRAIN, V130, P2494, DOI 10.1093/brain/awm170; Critchley HD, 2005, NEUROIMAGE, V24, P751, DOI 10.1016/j.neuroimage.2004.10.013; CRITCHLEY R, 1977, MUSIC BRAIN; Dolce G, 2008, BRAIN INJURY, V22, P617, DOI 10.1080/02699050802132503; Draper K, 2007, J HEAD TRAUMA REHAB, V22, P278, DOI 10.1097/01.HTR.0000290972.63753.a7; Eibe F., 2004, MACHINE LEARNING WEK; Fitch WT, 2005, ANN NY ACAD SCI, V1060, P29, DOI 10.1196/annals.1360.004; Frazier TW, 2004, PSYCHOPHYSIOLOGY, V41, P75, DOI 10.1046/j.1469-8986.2003.00131.x; Gehi A, 2005, ARCH GEN PSYCHIAT, V62, P661, DOI 10.1001/archpsyc.62.6.661; Hagen C., 1972, LEVELS COGNITIVE FUN; Han J., 2006, DATA MINING CONCEPTS; Hansson-Sandsten M, 2007, IEEE T BIO-MED ENG, V54, P1770, DOI 10.1109/TBME.2007.904527; Hildebrandt H, 2007, J NEUROL SCI, V260, P150, DOI 10.1016/j.jns.2007.04.035; HOLTE RC, 1993, MACH LEARN, V11, P63, DOI 10.1023/A:1022631118932; Hukkelhoven CWPM, 2005, J NEUROTRAUM, V22, P1025, DOI 10.1089/neu.2005.22.1025; Imberty M., 1997, PERCEPTION COGNITION, P429; IMBERTY M, 1981, ECRITURES TEMPS SEMA, V2; IMBERTY M, 1979, ENTENDRE MUSIQUE SEM, V1; Imberty M., 1976, SIGNIFICATION MEANIN; Janata P, 2002, SCIENCE, V298, P2167, DOI 10.1126/science.1076262; Jentschke S, 2005, ANN NY ACAD SCI, V1060, P231, DOI 10.1196/annals.1360.016; JOHN ER, LANCET IN PRESS; Keren O, 2005, BRAIN INJURY, V19, P605, DOI 10.1080/02699050400024946; King ML, 1997, BRAIN INJURY, V11, P445; Koelsch S, 2006, HUM BRAIN MAPP, V27, P239, DOI 10.1002/hbm.20180; Kohavi R, 1995, IJCAI, V14, P1137; Kotani K, 2007, METHOD INFORM MED, V46, P376, DOI 10.1160/ME0352; LAFRANCHI PA, 2003, AM J PHYSIOL-REG I, V283, pR815; Laureys S, 2004, NEUROLOGY, V63, P916, DOI 10.1212/01.WNL.0000137421.30792.9B; Laureys S, 2007, CONSCIOUS COGN, V16, P722, DOI 10.1016/j.concog.2007.04.004; LeDoux J., 1996, EMOTIONAL BRAIN; Lehrer PM, 2003, PSYCHOSOM MED, V65, P796, DOI 10.1097/01.PSY.0000089200.81962.19; Lippert-Gruner M, 2006, BRAIN INJURY, V20, P569, DOI 10.1080/02699050600664467; Luecken LJ, 2005, PSYCHOSOM MED, V67, P514, DOI 10.1097/01.psy.0000160466.10397.18; Malpas SC, 2002, AM J PHYSIOL-HEART C, V282, pH6; Mandal MK, 1998, SCHIZOPHRENIA BULL, V24, P399, DOI 10.1093/oxfordjournals.schbul.a033335; Mashin VA, 2000, HUMAN PHYSL, V26, P420, DOI [10.1007/BF02760270, DOI 10.1007/BF02760270]; Morita I, 2007, ACTA NEUROCHIR SUPPL, V97, P455; Neuhaus C, 2008, NEUROSCI LETT, V441, P11, DOI 10.1016/j.neulet.2008.05.101; Nikki S.R., 2004, PSYCHOL MUSIC, V32, P371; Niskanen JP, 2004, COMPUT METH PROG BIO, V76, P73, DOI 10.1016/j.cmpb.2004.03.004; Owen AM, 2007, ARCH NEUROL-CHICAGO, V64, P1098, DOI 10.1001/archneur.64.8.1098; Pang BC, 2007, J NEUROTRAUM, V24, P136, DOI 10.1089/neu.2006.0113; Parker RS, 1996, BRAIN INJURY, V10, P287, DOI 10.1080/026990596124467; Parncutt R., 2006, CHILD MUSICIAN, P1, DOI [10.1093/acprof:oso/9780198530329.003.0001, DOI 10.1093/ACPROF:OSO/9780198530329.003.0001]; Peretz I, 1998, COGNITION, V68, P111, DOI 10.1016/S0010-0277(98)00043-2; Perrin F, 2006, ARCH NEUROL-CHICAGO, V63, P562, DOI 10.1001/archneur.63.4.562; Plutchik R., 1994, PSYCHOL BIOL EMOTION; Qiu J, 2007, LANCET NEUROL, V6, P946, DOI 10.1016/S1474-4422(07)70255-7; REITERO N, 2002, AM J PHYSIOL-REG I, V283, pR1327; Rovlias A, 2004, J NEUROTRAUM, V21, P886, DOI 10.1089/0897715041526249; RUIZ MH, 2008, HUMAN BRAIN MAPPING, V20; Sannita WG, 2006, CLIN NEUROPHYSIOL, V117, P2569, DOI 10.1016/j.clinph.2006.04.026; Scholten MRM, 2006, J PSYCHIAT RES, V40, P638, DOI 10.1016/j.jpsychires.2006.03.005; SUDA M, 2008, NEUROLOGICAL RES, V15; Tarasti Eero., 1994, THEORY MUSICAL SEMIO; Thaut MH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002312; Trainor L, 2008, NATURE, V453, P598, DOI 10.1038/453598a; Urakawa K, 2005, TOHOKU J EXP MED, V206, P213, DOI 10.1620/tjem.206.213; Valkonen-Korhonen M, 2003, PSYCHOPHYSIOLOGY, V40, P716, DOI 10.1111/1469-8986.00072; van Bemmel J.H., 1997, HDB MED INFORM; Wijnen VJM, 2006, CLIN NEUROPHYSIOL, V117, P1794, DOI 10.1016/j.clinph.2006.03.006; Witten IH, 2005, DATA MINING PRACTICA; Yap L, 2008, CLIN MED, V8, P229, DOI 10.7861/clinmedicine.8-2-229b; Yien HW, 1997, CRIT CARE MED, V25, P258, DOI 10.1097/00003246-199702000-00011	82	17	17	0	12	HOGREFE & HUBER PUBLISHERS	GOTTINGEN	MERKELSTR 3, D-37085 GOTTINGEN, GERMANY	0269-8803	2151-2124		J PSYCHOPHYSIOL	J. Psychophysiol.		2008	22	4					166	174		10.1027/0269-8803.22.4.166			9	Psychology, Biological; Neurosciences	Psychology; Neurosciences & Neurology	468TC	WOS:000267843500002					2021-06-18	
J	Vagnini, VL; Berry, DTR; Clark, JA; Jiang, Y				Vagnini, Victoria L.; Berry, David T. R.; Clark, Jessica A.; Jiang, Yang			New measures to detect malingered neurocognitive deficit: Applying reaction time and event-related potentials	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						electroencephalography; event-related potential; malingered neurocognitive deficit; memory malingering; traumatic brain injury	COGNITIVE DEFICIT; BRAIN POTENTIALS; NAME AGREEMENT; MEMORY; DECEPTION; FAMILIARITY; AMPLITUDE; AMNESIA; NORMS; TASK	The ability of the Test of Memory Malingering (TOMM), reaction times (RTs), and event-related potentials (ERPs) to detect malingered neurocognitive deficit (MNCD) was examined in 32 normal individuals answering under honest (HON; n = 16) or malingering (MAL; n = 16) instructions as well as in 15 patients with traumatic brain injury (TBI) who answered under honest instructions. Overall, the TOMM was the most effective at classifying groups. However, new accuracy, RT, and ERP measures reached promising hit rates in the range of 71-88%. In particular, the difference in frontal versus posterior ERP obtained during an old-new task was effective at classifying MAL versus TBI (hit rate = 87%).	[Jiang, Yang] Univ Kentucky, Coll Med, Dept Behav Sci, Lexington, KY 40536 USA	Jiang, Y (corresponding author), Univ Kentucky, Coll Med, Dept Behav Sci, Lexington, KY 40536 USA.	yjiang@uky.edu		JIANG, Yang/0000-0003-4589-0097	American Forensic Academy; University of Kentucky; National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [AG00986]; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [K01AG000986] Funding Source: NIH RePORTER	The paper is based on V. L. Vagnini's PhD dissertation in partial fulfillment of the requirements for a doctoral degree in clinical psychology from the University of Kentucky. This research was supported in part by the American Forensic Academy for dissertation award funds, the Pilot fund of Behavioral Science Department at the University of Kentucky to VLV, and National Institutes of Health (NIH) Grant AG00986 to YJ.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Cohen J, 1998, STAT POWER ANAL BEHA; Cycowicz YM, 1997, J EXP CHILD PSYCHOL, V65, P171, DOI 10.1006/jecp.1996.2356; Ellwanger J, 1996, INT J PSYCHOPHYSIOL, V23, P9, DOI 10.1016/0167-8760(96)00035-9; Ellwanger J, 1999, J CLIN EXP NEUROPSYC, V21, P866, DOI 10.1076/jcen.21.6.866.850; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Kok A, 2001, PSYCHOPHYSIOLOGY, V38, P557, DOI 10.1017/S0048577201990559; Kozel FA, 2005, BIOL PSYCHIAT, V58, P605, DOI 10.1016/j.biopsych.2005.07.040; Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379; Osimani A, 1997, J NEUROL NEUROSUR PS, V62, P617, DOI 10.1136/jnnp.62.6.617; PALLER KA, 1992, J COGNITIVE NEUROSCI, V4, P375, DOI 10.1162/jocn.1992.4.4.375; Polo MD, 2002, NEUROPSYCHOLOGIA, V40, P2350, DOI 10.1016/S0028-3932(02)00127-6; Rees LM, 1998, PSYCHOL ASSESSMENT, V10, P10, DOI 10.1037/1040-3590.10.1.10; Rogers R., 1997, CLIN ASSESSMENT MALI, V2nd; ROSE FE, 1995, CLIN NEUROPSYCHOL, V9, P124, DOI 10.1080/13854049508401594; Rosenfeld JP, 1999, INT J PSYCHOPHYSIOL, V33, P3, DOI 10.1016/S0167-8760(99)00021-5; Rosenfeld JP, 1996, CLIN NEUROPSYCHOL, V10, P163, DOI 10.1080/13854049608406678; Rosenfeld JP, 1998, INT J PSYCHOPHYSIOL, V28, P233; Rosenfeld JP, 1999, STUD NEUROPSYCHOL DE, P287; RUGG MD, 1993, NEUROPSYCHOLOGIA, V31, P373, DOI 10.1016/0028-3932(93)90161-R; RUGG MD, 1995, NEUROPSYCHOLOGIA, V33, P1131, DOI 10.1016/0028-3932(95)00053-6; SNODGRASS JG, 1980, J EXP PSYCHOL-HUM L, V6, P174, DOI 10.1037/0278-7393.6.2.174; STRAUSS E, 1994, ARCH CLIN NEUROPSYCH, V9, P483, DOI 10.1016/0887-6177(94)90039-6; SUHR JA, 2007, ASSESSMENT MALINGERE, P287; Tardif HP, 2000, INT J PSYCHOPHYSIOL, V36, P1, DOI 10.1016/S0167-8760(00)00083-0; Tardif HP, 2002, INT J PSYCHOPHYSIOL, V46, P147, DOI 10.1016/S0167-8760(02)00090-9; Tombaugh TN, 1997, PSYCHOL ASSESSMENT, V9, P260, DOI 10.1037/1040-3590.9.3.260; Tombaugh TN, 1996, TEST MEMORY MALINGER; van Gorp WG, 1999, J CLIN EXP NEUROPSYC, V21, P245; Vickery CD, 2001, ARCH CLIN NEUROPSYCH, V16, P45, DOI 10.1016/S0887-6177(99)00058-X	30	17	17	0	6	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.		2008	30	7					766	776		10.1080/13803390701754746			11	Psychology, Clinical; Clinical Neurology; Psychology	Psychology; Neurosciences & Neurology	345EH	WOS:000258978400004	18608662	Green Accepted			2021-06-18	
J	Ventsel, G; Kolk, A; Talvik, I; Vali, M; Vaikmaa, M; Talvik, T				Ventsel, Gerli; Kolk, Anneli; Talvik, Inga; Vaeli, Marika; Vaikmaa, Maarja; Talvik, Tiina			The incidence of childhood traumatic brain injury in Tartu and Tartu County in Estonia	NEUROEPIDEMIOLOGY			English	Article						traumatic brain injury, structure; traumatic brain injury, children; traumatic brain injury, incidence, etiology	MILD HEAD-INJURY; YOUNG-CHILDREN; RECOVERY; OUTCOMES	Background: Traumatic brain injury (TBI) is a major health problem in childhood. Estonia and other Baltic states have the highest trauma-related mortality in the European Union. There are no data on the incidence and causes of TBI for children in Estonia. The aim of this study was to estimate the incidence, structure and main causes of TBI in Tartu and Tartu County. Methods: The study was carried out at Tartu University Hospital, between January 1, 2001, and December 31, 2005. For inclusion in the study the following criteria had to be fulfilled: age 0-14 years, documented brain trauma and neurological symptoms and residency in Tartu or Tartu County. Over the study period the inclusion criteria were fulfilled in 478 cases [272 boys (57%) and 206 girls (43%)]. Results: The incidence of TBI in childhood in Tartu and Tartu County was 369: 100,000 (405: 100,000 for boys, 330: 100,000 for girls). The incidence was highest among children from 0 to 4 years of age - 566: 100,000. The main cause of TBI in all age groups was falling - 63.6%. According to severity, 82% of the cases were mild and 18% were moderate and severe. Conclusions: There is an urgent need for governmental prevention programs for TBI in children in Estonia. Copyright (c) 2008 S. Karger AG, Basel.	[Kolk, Anneli; Talvik, Inga; Talvik, Tiina] Univ Tartu Hosp, Childrens Clin, Dept Paediat Neurol, EE-51014 Tartu, Estonia; [Ventsel, Gerli; Kolk, Anneli; Talvik, Inga; Talvik, Tiina] Childrens Clin, Tartu, Estonia; [Vaeli, Marika] Dept Pathol Anat & Forens Med, Tartu, Estonia; [Vaikmaa, Maarja] Univ Tartu, EE-50090 Tartu, Estonia	Talvik, T (corresponding author), Univ Tartu Hosp, Childrens Clin, Dept Paediat Neurol, Lunini 6, EE-51014 Tartu, Estonia.	Tiina.Talvik@kliinikum.ee					Anderson VA, 2004, BRAIN, V127, P2608, DOI 10.1093/brain/awh320; BARKER RA, 2004, A Z NEUROLOGICAL PRA, P860; Barlow KM, 2000, LANCET, V356, P1571, DOI 10.1016/S0140-6736(00)03130-5; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Catroppa C, 2005, J INT NEUROPSYCH SOC, V11, P84, DOI 10.1017/S1355617705050101; Catroppa C, 2004, BRAIN LANG, V88, P68, DOI 10.1016/S0093-934X(03)00159-7; Ewing-Cobbs L, 1998, PEDIATRICS, V102, P300, DOI 10.1542/peds.102.2.300; Ganesalingam K, 2006, J INT NEUROPSYCH SOC, V12, P609, DOI 10.1017/S1355617706060796; Hanten G, 2004, ANN NEUROL, V56, P847, DOI 10.1002/ana.20298; Hawley CA, 2003, INJURY, V34, P256, DOI 10.1016/S0020-1383(02)00193-6; Korinthenberg R, 2004, BRAIN DEV-JPN, V26, P113, DOI 10.1016/S0387-7604(03)00110-4; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; Makaroff KL, 2003, DEV MED CHILD NEUROL, V45, P497, DOI 10.1017/S0012162203000926; McKinlay A, 2002, J NEUROL NEUROSUR PS, V73, P281, DOI 10.1136/jnnp.73.3.281; *MIN SOC AFF, 1995, INT CLASS DIS REL HL; Mittenberg W, 2000, J HEAD TRAUMA REHAB, V15, P783, DOI 10.1097/00001199-200004000-00003; Talvik I, 2006, ACTA PAEDIATR, V95, P799, DOI 10.1080/08035250500464923; VINCENTEN J, 2004, EUR CHILD SAFETY ALI	18	17	17	0	4	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	0251-5350	1423-0208		NEUROEPIDEMIOLOGY	Neuroepidemiology		2008	30	1					20	24		10.1159/000113302			5	Public, Environmental & Occupational Health; Clinical Neurology	Public, Environmental & Occupational Health; Neurosciences & Neurology	263WL	WOS:000253247100005	18204293				2021-06-18	
J	Lim, DH; Kim, TS; Jac, SP; Kim, SH				Lim, Dong-Ho; Kim, Tae-Sun; Jac, Sung-Pil; Kim, Soo Han			Intracerebral hematoma caused by ruptured traumatic pseudoaneurysm of the middle meningeal artery: A case report	JOURNAL OF KOREAN NEUROSURGICAL SOCIETY			English	Article						traumatic pseudoaneurysm; middle meningeal artery (MMA); intracerebral hematoma	FALSE ANEURYSM	Hematomas caused by ruptured traumatic pseudoaneurysms of the middle meningeal artery (MMA) usually present with extradural hematomas, whereas intradural intraparenchymal hematomas are extremely rare. We report a case of traumatic pseudoaneurysm of the MMA giving rise to an intracerebral hematoma after head trauma. A 70-year-old man suffered a massive intracerebral temporoparietal hemorrhage after a head injury. CT angiogram of the brain revealed a large hematoma in the right middle cranial fossa extending to the right sylvian fissure. Cerebral angiogram also revealed a pseudoaneurysm of the MMA, which was successfully treated surgically. Although traumatic MMA pseudoaneurysm producing intracerebral hematoma (ICH) is rare, it should be considered as a possible cause of intracerebral hematoma.	[Lim, Dong-Ho; Kim, Tae-Sun; Jac, Sung-Pil; Kim, Soo Han] Chonnam Natl Univ, Hosp & Med Sch, Dept Neurosurg, Kwangju 501757, South Korea	Kim, TS (corresponding author), Chonnam Natl Univ, Hosp & Med Sch, Dept Neurosurg, 8 Hak Dong, Kwangju 501757, South Korea.	toesun1963@yahoo.co.kr					BENOIT BG, 1973, J NEUROL NEUROSUR PS, V36, P127, DOI 10.1136/jnnp.36.1.127; Bruneau M, 2002, SURG NEUROL, V57, P174, DOI 10.1016/S0090-3019(01)00668-1; GARZAMERCADO R, 1979, NEUROSURGERY, V5, P200; HIGAZI I, 1969, J NEUROSURG, V30, P172, DOI 10.3171/jns.1969.30.2.0172; Kim JH, 2001, J KOREAN NEUROSURG S, V30, P307; KIMORA T, 1995, NO SHINKEI GEKA, V23, P1021; KUHN RA, 1964, J NEUROSURG, V21, P92, DOI 10.3171/jns.1964.21.2.0092; MEDER JF, 1992, J NEURORADIOLOGY, V19, P248; MORARD M, 1991, NEUROSURGERY, V29, P438, DOI 10.1227/00006123-199109000-00018; Okumura H, 1998, NEUROL SURG TOKYO, V26, P929; PARKINSON D, 1980, J NEUROSURG, V52, P11, DOI 10.3171/jns.1980.52.1.0011; RAMBAUGH CL, 1972, RADIOLOGY, V104, P81; TSUTOMU K, 2002, NEUROL MED CHIR TOKY, V42, P221	13	17	19	0	0	KOREAN NEUROSURGICAL SOC	SEOUL	#402 POSCO # OFFICE BUILDING 151 SUNHWA-DONG, JUNG-GU, SEOUL, 100-130, SOUTH KOREA	2005-3711	1598-7876		J KOREAN NEUROSURG S	J. Korean. Neurosurg. Soc.	NOV	2007	42	5					416	418		10.3340/jkns.2007.42.5.416			3	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	279VT	WOS:000254384000014	19096582	DOAJ Gold, Green Published			2021-06-18	
J	Czosnyka, M; Smielewski, P; Lavinio, A; Czosnyka, Z; Pickard, JD				Czosnyka, Marek; Smielewski, Peter; Lavinio, Andrea; Czosnyka, Zofia; Pickard, John D.			A synopsis of brain pressures: which? when? are they all useful?	NEUROLOGICAL RESEARCH			English	Article						brain; biomechanics; critical care; head injury; cerebral perfusion pressure; intracranial pressure; monitoring; autoregulation	CRITICAL CLOSING PRESSURE; SEVERE HEAD-INJURY; TRANSCRANIAL DOPPLER ULTRASONOGRAPHY; CEREBRAL PERFUSION-PRESSURE; INTRA-CRANICAL PRESSURE; INTRACRANIAL-PRESSURE; BLOOD-FLOW; PULSATILITY INDEX; CEREBROVASCULAR AUTOREGULATION; NONINVASIVE ASSESSMENT	Objective: In addition to intracranial pressure (ICP) and cerebral perfusion pressure (CPP), there are many more brain-related measures defined as 'pressures'. Cerebral intra-tissue pressure, critical closing pressure, 'optimal' CPP, non-invasive CPP (nCPP) and non-invasive ICP (nICP), interhemispherical pressure gradients are the modalities which currently attract more attention in the management of head injured patients. Methods: This review summarizes the most important points related to the 'brain pressures' applied in clinical practice, and it is based both on the literature and the authors' own experience. Results: While ICP and CPP monitoring remains the cornerstone of head injury management, derived pressures are gaining clinical significance. 'Optimization' of CPP provides a rational compromise between the 'Critical Closing Pressure-oriented protocol' and the 'Lund concept', and it allows individualized tailoring of cerebral hemodynamics. Non-invasive ICP and CPP are practical surrogates for invasive monitoring especially in the early stages of trauma management. CCP and pressure gradients are promising prognostication tools. Discussion: Most of the derived brain pressures cannot be assessed at the bedside without a dedicated computer tool. Some practical and theoretical aspects about the measurement, signal analysis, estimation process, accuracy and interpretation need further researching and refinement.	Univ Cambridge, Addenbrookes Hosp, Dept Neurosci, Acad Neurosurg Unit, Cambridge CB2 2QQ, England	Czosnyka, M (corresponding author), Univ Cambridge, Addenbrookes Hosp, Dept Neurosci, Acad Neurosurg Unit, Box 167, Cambridge CB2 2QQ, England.	MC141@medschl.cam.ac.uk	Lavinio, Andrea/M-1778-2016	Smielewski, Peter/0000-0001-5096-3938	Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G9439390, G0001237, G0600986] Funding Source: Medline		Aaslid R, 2003, STROKE, V34, P1645, DOI 10.1161/01.STR.0000077927.63758.B6; Aaslid R, 1986, INTRACRANIAL PRESSUR, P229; AVEZAAT CJJ, 1979, J NEUROL NEUROSUR PS, V42, P687, DOI 10.1136/jnnp.42.8.687; Balestreri M, 2004, ACTA NEUROCHIR, V146, P131, DOI 10.1007/s00701-003-0187-y; Balestreri M, 2003, J NEUROSURG, V99, P616; Bellner J, 2004, SURG NEUROL, V62, P45, DOI 10.1016/j.surneu.2003.12.007; BURTON AC, 1951, AM J PHYSIOL, V164, P319; Chambers IR, 1998, ACT NEUR S, V71, P42; CHAPMAN PH, 1990, NEUROSURGERY, V26, P181, DOI 10.1227/00006123-199002000-00001; Czosnyka M, 1999, J NEUROSURG, V90, P752, DOI 10.3171/jns.1999.90.4.0752; Czosnyka M, 1996, ACTA NEUROCHIR, V138, P531, DOI 10.1007/BF01411173; Czosnyka M, 1996, J NEUROSURG, V84, P79, DOI 10.3171/jns.1996.84.1.0079; Czosnyka M, 1999, J NEUROSURG, V91, P11, DOI 10.3171/jns.1999.91.1.0011; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; Czosnyka M, 1998, J NEUROSURG, V88, P802, DOI 10.3171/jns.1998.88.5.0802; Czosnyka M, 2001, J NEUROSURG, V95, P756, DOI 10.3171/jns.2001.95.5.0756; Czosnyka M, 1999, J NEUROL NEUROSUR PS, V66, P606, DOI 10.1136/jnnp.66.5.606; CZOSNYKA M, 2003, J CEREB BLOOD FLOW M, V23, pS65; DAVSON H, 1970, Brain Behavior and Evolution, V93, P665, DOI 10.1093/brain/93.4.665; DEWEY RC, 1974, J NEUROSURG, V41, P597, DOI 10.3171/jns.1974.41.5.0597; Eker C, 2000, BRAIN INJURY, V14, P605; EKSTEDT J, 1978, J NEUROL NEUROSUR PS, V41, P345, DOI 10.1136/jnnp.41.4.345; Gooskens I, 2003, ACTA NEUROCHIR, V145, P527, DOI 10.1007/s00701-003-0045-y; Higgins JNP, 2003, J NEUROL NEUROSUR PS, V74, P1662, DOI 10.1136/jnnp.74.12.1662; Jaeger M, 2006, CRIT CARE MED, V34, P1783, DOI 10.1097/01.CCM.0000218413.51546.9E; KLINGELHOFER J, 1988, J NEUROL, V235, P159, DOI 10.1007/BF00314307; Kumar A, 2005, J NEUROL NEUROSUR PS, V76, P1570, DOI 10.1136/jnnp.2004.059493; LASSEN NA, 1959, PHYSIOL REV, V39, P183; MARMAROU A, 1992, J NEUROTRAUM, V9, pS327; MARMAROU A, 1987, J NEUROSURG, V66, P883, DOI 10.3171/jns.1987.66.6.0883; Miller J D, 1972, Prog Brain Res, V35, P411; MILLER JD, 1977, J NEUROSURG, V47, P503, DOI 10.3171/jns.1977.47.4.0503; MUIZELAAR JP, 1989, J NEUROSURG, V71, P72, DOI 10.3171/jns.1989.71.1.0072; NARAYAN RK, 1982, J NEUROSURG, V56, P650, DOI 10.3171/jns.1982.56.5.0650; OVERGAARD J, 1974, J NEUROSURG, V41, P531, DOI 10.3171/jns.1974.41.5.0531; Petkus V, 2002, ULTRASONICS, V40, P829, DOI 10.1016/S0041-624X(02)00216-0; Piechnik S, 1998, ACT NEUR S, V71, P269; Piechnik SK, 2001, NEUROSURGERY, V49, P1214, DOI 10.1097/00006123-200111000-00034; REID A, 1989, J NEUROL NEUROSUR PS, V52, P610, DOI 10.1136/jnnp.52.5.610; Richards HK, 1999, ACTA NEUROCHIR, V141, P1221, DOI 10.1007/s007010050422; Richards HK, 1998, ACT NEUR S, V71, P229; ROSNER MJ, 1995, J NEUROSURG, V83, P949, DOI 10.3171/jns.1995.83.6.0949; ROSNER MJ, 1984, J NEUROSURG, V60, P312, DOI 10.3171/jns.1984.60.2.0312; SAUL TG, 1982, J NEUROSURG, V56, P498, DOI 10.3171/jns.1982.56.4.0498; Schmidt B, 2003, STROKE, V34, P84, DOI 10.1161/01.STR.0000047849.01376.AE; Schmidt B, 1997, STROKE, V28, P2465, DOI 10.1161/01.STR.28.12.2465; Schmidt EA, 2003, J NEUROSURG, V99, P991, DOI 10.3171/jns.2003.99.6.0991; Schmidt EA, 2001, J NEUROL NEUROSUR PS, V70, P198, DOI 10.1136/jnnp.70.2.198; Schoser BGH, 1999, J NEUROSURG, V91, P744, DOI 10.3171/jns.1999.91.5.0744; Silverberg GD, 2001, NEUROLOGY, V57, P1763, DOI 10.1212/WNL.57.10.1763; Smielewski P, 2005, ACT NEUR S, V95, P43; Soehle M, 2004, STROKE, V35, P1393, DOI 10.1161/01.STR.0000128411.07036.a9; Steiner LA, 2003, STROKE, V34, P2404, DOI 10.1161/01.STR.0000089014.59668.04; Steiner LA, 2003, J NEUROL NEUROSUR PS, V74, P765, DOI 10.1136/jnnp.74.6.765; Steiner LA, 2002, CRIT CARE MED, V30, P733, DOI 10.1097/00003246-200204000-00002; Stephensen H, 2002, NEUROSURGERY, V50, P763, DOI 10.1097/00006123-200204000-00016; Torikoshi S, 1995, J Gravit Physiol, V2, pP145; UZZELL BP, 1986, J NEUROSURG, V65, P630, DOI 10.3171/jns.1986.65.5.0630; Wolfla CE, 1997, J NEUROSURG, V86, P505, DOI 10.3171/jns.1997.86.3.0505; Zhong J, 2003, NEUROL RES, V25, P339, DOI 10.1179/016164103101201661	60	17	17	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0161-6412	1743-1328		NEUROL RES	Neurol. Res.	OCT	2007	29	7					672	679		10.1179/016164107X240053			8	Clinical Neurology; Neurosciences	Neurosciences & Neurology	234MJ	WOS:000251167900008	18173906				2021-06-18	
J	Adjan, VV; Hauser, KF; Bakalkin, G; Yakovleva, T; Gharibyan, A; Scheff, SW; Knapp, PE				Adjan, V. V.; Hauser, K. F.; Bakalkin, G.; Yakovleva, T.; Gharibyan, A.; Scheff, S. W.; Knapp, P. E.			Caspase-3 activity is reduced after spinal cord injury in mice lacking dynorphin: Differential effects on glia and neurons	NEUROSCIENCE			English	Article						apoptosis; astrocyte; excitotoxic cell death; oligodendrocyte; glutamate; traumatic injury	EXCITATORY AMINO-ACIDS; CENTRAL-NERVOUS-SYSTEM; NMDA RECEPTORS; MESSENGER-RNA; BRAIN-INJURY; MATURE OLIGODENDROCYTES; REGIONAL DISTRIBUTION; ANTAGONIST NALMEFENE; NONOPIOID MECHANISMS; CULTURED ASTROCYTES	Dynorphins are endogenous opioid peptide products of the prodynorphin gene. An extensive literature suggests that dynorphins have deleterious effects on CNS injury outcome. We thus examined whether a deficiency of dynorphin would protect against tissue damage after spinal cord injury (SCI), and if individual cell types would be specifically affected. Wild-type and prodynorphin(-/-) mice received a moderate contusion injury at 10th thoracic vertebrae (T10). Caspase-3 activity at the injury site was significantly decreased in tissue homogenates from prodynorphin(-/-) mice after 4 h. We examined frozen sections at 4 h post-injury by immunostaining for active caspase-3. At 3-4 mm rostral or caudal to the injury, > 90% of all neurons, astrocytes and oligodendrocytes expressed active caspase-3 in both wildtype and knockout mice. At 6-7 mm, there were fewer caspase-3(+) oligodendrocytes and astrocytes than at 3-4 mm. Importantly, caspase-3 activation was significantly lower in prodynorphin(-/-) oligodendrocytes and astrocytes, as compared with wild-type mice. In contrast, while caspase-3 expression in neurons also declined with further distance from the injury, there was no effect of genotype. Radioimmunoassay showed that dynorphin A(1-17) was regionally increased in wild-type injured versus sham-injured tissues, although levels of the prodynorphin processing product Arg(6)-Leu-enkephalin were unchanged. Our results indicate that dynorphin peptides affect the extent of post-injury caspase-3 activation, and that glia are especially sensitive to these effects. By promoting caspase-3 activation, dynorphin peptides likely increase the probability of glial apoptosis after SCI. While normally beneficial, our findings suggest that prodynorphin or its peptide products become maladaptive following SCI and contribute to secondary injury. (c) 2007 Published by Elsevier Ltd on behalf of IBRO.	Univ Kentucky, Dept Anat & Neurobiol, Lexington, KY 40536 USA; Univ Kentucky, Sanders Brown Ctr Aging, Lexington, KY 40536 USA; Univ Kentucky, Spinal Cord & Brain Injury Res Ctr, Lexington, KY 40536 USA; Karolinska Inst, Dept Clin Neurosci, Expt Alcohol & Drug Addict Res Sect, Stockholm, Sweden	Knapp, PE (corresponding author), Virginia Commonwealth Univ, Coll Med, Dept Anat & Neurobiol, 1217 E Marshall St,Herman A Kontos Med Sci Bldg, Richmond, VA 23298 USA.	peknapp@vcu.edu	Gharibyan, Anna L./B-3401-2010; Hauser, Kurt/AAX-8361-2020	Gharibyan, Anna L./0000-0001-9070-6215; Hauser, Kurt/0000-0001-7886-0332; Bakalkin, Georgy/0000-0002-8074-9833	NATIONAL INSTITUTE ON DRUG ABUSEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [R01DA015097] Funding Source: NIH RePORTER; NIDA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA) [DA15097] Funding Source: Medline		BAKSHI R, 1992, BRAIN RES, V580, P255, DOI 10.1016/0006-8993(92)90952-6; Beattie MS, 2002, NEURON, V36, P375, DOI 10.1016/S0896-6273(02)01005-X; BEHRMANN DL, 1993, EXP NEUROL, V119, P258, DOI 10.1006/exnr.1993.1028; Benjamins JA, 2003, NEUROCHEM RES, V28, P143, DOI 10.1023/A:1021612615554; BERMAN YL, 1994, BIOCHIMIE, V76, P245, DOI 10.1016/0300-9084(94)90153-8; Campbell DS, 2003, NEURON, V37, P939, DOI 10.1016/S0896-6273(03)00158-2; Caudle RM, 2000, PAIN, V87, P235, DOI 10.1016/S0304-3959(00)00360-2; CHEN L, 1995, J PHYSIOL-LONDON, V482, P575, DOI 10.1113/jphysiol.1995.sp020541; Chou JZ, 1996, PEPTIDES, V17, P983; CHRISTENSSONNYLANDER I, 1985, NEUROPEPTIDES, V6, P391, DOI 10.1016/0143-4179(85)90137-4; CHRISTENSSONNYLANDER I, 1985, REGUL PEPTIDES, V11, P65, DOI 10.1016/0167-0115(85)90032-1; Citron BA, 2000, EXP NEUROL, V166, P213, DOI 10.1006/exnr.2000.7523; CONE RI, 1983, J NEUROSCI, V3, P2146; EVANS CJ, 1988, OPIATE RECEPTORS, P23; Faden A I, 1988, Adv Neurol, V47, P531; Faden A I, 1987, Cent Nerv Syst Trauma, V4, P227; Faden A I, 1996, NIDA Res Monogr, V163, P318; FADEN AI, 1984, BRIT J PHARMACOL, V81, P271, DOI 10.1111/j.1476-5381.1984.tb10074.x; FADEN AI, 1992, J NEUROSCI, V12, P425; FADEN AI, 1990, ANN NEUROL, V27, P67, DOI 10.1002/ana.410270111; FADEN AI, 1985, ANN NEUROL, V17, P386, DOI 10.1002/ana.410170414; Feldblum S, 2000, J NEUROTRAUM, V17, P1079, DOI 10.1089/neu.2000.17.1079; Garrido C, 2004, CURR OPIN CELL BIOL, V16, P639, DOI 10.1016/j.ceb.2004.09.008; GENTILE NT, 1993, ANN EMERG MED, V22, P1028, DOI 10.1016/S0196-0644(05)82746-5; Goody RJ, 2003, NEUROSCIENCE, V116, P807, DOI 10.1016/S0306-4522(02)00563-8; Hauser KF, 1999, EXP NEUROL, V160, P361, DOI 10.1006/exnr.1999.7235; Hauser KF, 2005, FRONT BIOSCI-LANDMRK, V10, P216, DOI 10.2741/1522; Hauser KF, 2001, EXP NEUROL, V168, P78, DOI 10.1006/exnr.2000.7580; HEADRICK JP, 1995, NEUROCHEM INT, V26, P489, DOI 10.1016/0197-0186(94)00153-L; HEALY DJ, 1994, NEUROPEPTIDES, V27, P277, DOI 10.1016/0143-4179(94)90108-2; Hu WH, 1996, NEUROSCI LETT, V203, P13, DOI 10.1016/0304-3940(95)12246-X; Jarskog LF, 2007, NEUROPSYCHOPHARMACOL, V32, P95, DOI 10.1038/sj.npp.1301074; Knapp PE, 2001, GLIA, V35, P156, DOI 10.1002/glia.1080; KOLAJ M, 1995, BRAIN RES, V671, P227, DOI 10.1016/0006-8993(94)01333-D; Launay S, 2005, ONCOGENE, V24, P5137, DOI 10.1038/sj.onc.1208524; Leuchtmann EA, 2003, NEUROBIOL DIS, V14, P336, DOI 10.1016/j.nbd.2003.07.004; Long J B, 1986, Cent Nerv Syst Trauma, V3, P295; Long JB, 2005, EUR J PHARMACOL, V508, P115, DOI 10.1016/j.ejphar.2004.12.008; LONG JB, 1994, J PHARMACOL EXP THER, V269, P358; MASSARDIER D, 1989, EUR J PHARMACOL, V170, P125, DOI 10.1016/0014-2999(89)90149-0; McAdoo DJ, 1999, EXP NEUROL, V159, P538, DOI 10.1006/exnr.1999.7166; McDonald JW, 1998, NAT MED, V4, P291, DOI 10.1038/nm0398-291; McEwen ML, 2005, J HISTOCHEM CYTOCHEM, V53, P809, DOI 10.1369/jhc.4A6467.2005; MCINTOSH TK, 1987, AM J PHYSIOL, V253, pE565; MCINTOSH TK, 1994, AM J PHYSIOL, V267, pR665; Merg F, 2006, J NEUROCHEM, V97, P292, DOI 10.1111/j.1471-4159.2006.03732.x; Micu I, 2006, NATURE, V439, P988, DOI 10.1038/nature04474; Mu XJ, 2002, J NEUROTRAUM, V19, P917, DOI 10.1089/089771502320317078; Nottingham S, 2002, EXP NEUROL, V177, P242, DOI 10.1006/exnr.2002.7975; Nottingham SA, 2003, J COMP NEUROL, V464, P463, DOI 10.1002/cne.10806; NYBERG F, 1985, NEUROPEPTIDES, V5, P537, DOI 10.1016/0143-4179(85)90073-3; Oomman S, 2006, BRAIN RES, V1078, P19, DOI 10.1016/j.brainres.2006.01.041; Oomman S, 2005, DEV BRAIN RES, V160, P130, DOI 10.1016/j.devbrainres.2005.07.010; Park E, 2004, J NEUROTRAUM, V21, P754, DOI 10.1089/0897715041269641; Ploj K, 1999, NEUROPEPTIDES, V33, P468, DOI 10.1054/npep.1999.0764; PRZEWLOCKI R, 1988, MOL BRAIN RES, V4, P37, DOI 10.1016/0169-328X(88)90016-2; Reed B, 2003, J NEUROCHEM, V86, P815, DOI 10.1046/j.1471-4159.2003.01859.x; Salter MG, 2005, NATURE, V438, P1167, DOI 10.1038/nature04301; Sanchez-Gomez MV, 2003, J NEUROSCI, V23, P9519; SASEK CA, 1984, NEUROSCIENCE, V12, P855, DOI 10.1016/0306-4522(84)90175-1; Scheff SW, 2003, J NEUROTRAUM, V20, P179, DOI 10.1089/08977150360547099; Sharifi N, 2001, MOL BRAIN RES, V86, P70, DOI 10.1016/S0169-328X(00)00264-3; SHINODA H, 1989, SCIENCE, V245, P415, DOI 10.1126/science.2569236; Shukla VK, 1997, J PHARMACOL EXP THER, V283, P604; Shuman SL, 1997, J NEUROSCI RES, V50, P798, DOI 10.1002/(SICI)1097-4547(19971201)50:5<798::AID-JNR16>3.3.CO;2-#; SILBERRING J, 1992, LIFE SCI, V50, P839, DOI 10.1016/0024-3205(92)90202-Z; Singh IN, 2003, NEUROSCIENCE, V122, P1013, DOI 10.1016/j.neuroscience.2003.08.033; SKILLING SR, 1992, BRAIN RES, V575, P272, DOI 10.1016/0006-8993(92)90090-V; Springer JE, 1999, NAT MED, V5, P943, DOI 10.1038/11387; Sun BY, 2006, J NEUROIMMUNOL, V174, P52, DOI 10.1016/j.jneuroim.2006.01.006; SWEETNAM PM, 1986, NEUROSCIENCE, V18, P947, DOI 10.1016/0306-4522(86)90110-7; Tachibana T, 1998, J NEUROTRAUM, V15, P485, DOI 10.1089/neu.1998.15.485; Tan-No K, 2001, EXP CELL RES, V269, P54, DOI 10.1006/excr.2001.5309; Tang QB, 1999, J PHARMACOL EXP THER, V291, P760; TanNo K, 1997, NEUROCHEM INT, V31, P27, DOI 10.1016/S0197-0186(96)00137-4; THORNHILL JA, 1989, BRAIN RES, V490, P174, DOI 10.1016/0006-8993(89)90447-2; Vanderah TW, 1996, PAIN, V68, P275, DOI 10.1016/S0304-3959(96)03225-3; VILIJN MH, 1988, P NATL ACAD SCI USA, V85, P6551, DOI 10.1073/pnas.85.17.6551; VINK R, 1990, J NEUROSCI, V10, P3524; WALKER JM, 1982, SCIENCE, V218, P1136, DOI 10.1126/science.6128791; Winkler T, 2002, AMINO ACIDS, V23, P273, DOI 10.1007/s00726-001-0138-y; Woods AS, 2006, J PROTEOME RES, V5, P1017, DOI 10.1021/pr060016+; Xu GY, 2005, NEUROSCI LETT, V384, P271, DOI 10.1016/j.neulet.2005.04.100; YAKOVLEV AG, 1994, MOL CHEM NEUROPATHOL, V23, P179, DOI 10.1007/BF02815410; Yang JY, 2004, BIOCHEM PHARMACOL, V68, P1027, DOI 10.1016/j.bcp.2004.03.043; Yang JY, 2004, MOL CELL BIOL, V24, P10425, DOI 10.1128/MCB.24.23.10425-10436.2004; Yong C, 1998, J NEUROTRAUM, V15, P459, DOI 10.1089/neu.1998.15.459; YOUNG EA, 1987, PEPTIDES, V8, P701, DOI 10.1016/0196-9781(87)90046-5; YUM SW, 1990, ARCH NEUROL-CHICAGO, V47, P277, DOI 10.1001/archneur.1990.00530030043014; Zipfel GJ, 2000, J NEUROTRAUM, V17, P857, DOI 10.1089/neu.2000.17.857	90	17	26	0	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522	1873-7544		NEUROSCIENCE	Neuroscience	SEP 7	2007	148	3					724	736		10.1016/j.neuroscience.2007.05.053			13	Neurosciences	Neurosciences & Neurology	216LG	WOS:000249878900012	17698296				2021-06-18	
J	Markovchick, VJ; Moore, EE				Markovchick, Vincent J.; Moore, Ernest E.			Optimal trauma outcome: Trauma system design and the trauma team	EMERGENCY MEDICINE CLINICS OF NORTH AMERICA			English	Article							SURGEON PRESENCE	Trauma is the number one killer of Americans under age 34, and optimal care of trauma patients is best provided when there is a well-functioning, comprehensive system of trauma care. Results of a recent poll indicate that 61% of the American public is unaware that injury is the leading cause of death for those ages 1 to 34. Only eight states currently have fully functioning trauma systems [1]. A recent meta-analysis of 14 published articles evaluating the impact of implementing trauma systems found a 15% reduction in mortality in favor of the presence of a trauma system [2]. Trauma system development in the United States has evolved over the past 35 years, and the organization taking the lead on trauma system development, review, and verification has been the American College of Surgeons Committee on Trauma (ACS/COT). The ACS/COT trauma center classification scheme has assisted communities in trauma system development [3]. The goal of a mature trauma system is to match the needs of the injured patients to the capabilities of the trauma receiving facility, thus maximizing the chances for the best possible outcome. A national survey conducted in 2002 by the United States Department of Health Resources and Services Administration (HRSA) revealed that most the field do not need a surgeon present on the arrival in the ED [8]. In addition, the majority of trauma patients who have a GCS score of less than 8 have either an abnormal mental status secondary to isolated head trauma or metabolic or toxicologic reasons. Therefore, the authors have modified the criteria at Denver Health for trauma activation and have developed the following protocol (Box 1). These protocols are a dynamic document and will be revised in the future based on the critical evaluation of trauma outcome data from the authors' trauma registry and continuous quality improvement (CQI) processes. In summary, optimal trauma care is a team effort from roadside through rehabilitation. Close collegial collaboration between emergency medicine specialists and trauma surgeons is essential. All efforts and protocols for trauma care should be based on objective CQI outcome data. The ultimate goal should be to make the most efficient use of resources that result in the best possible outcome for the trauma patient.	Univ Colorado, Hlth Sci Ctr, Dept Surg, Div Emergency Med, Denver, CO 80204 USA; Surg & Trauma Serv, Denver, CO 80204 USA; Dept Surg, Denver, CO USA	Markovchick, VJ (corresponding author), 777 Bannock St,MC 0108, Denver, CO 80204 USA.	vince.markovchick@dhha.org					Celso B, 2006, J TRAUMA, V60, P371, DOI 10.1097/01.ta.0000197916.99629.eb; Champion HR, 2006, J AM COLL SURGEONS, V203, P951, DOI 10.1016/j.jamcollsurg.2006.08.019; Ciesla DJ, 2004, J TRAUMA, V56, P937, DOI 10.1097/01.TA.0000127768.21385.81; *COMM TRAUM, 2006, AM COLL RES OPT CAR, P19; Esposito TJ, 2006, J AM COLL SURGEONS, V202, P655, DOI 10.1016/j.jamcollsurg.2005.12.008; Green SM, 2006, ANN EMERG MED, V47, P405, DOI 10.1016/j.annemergmed.2005.11.032; Jurkovich GJ, 2005, J TRAUMA, V58, P614, DOI 10.1097/01.TA0000159347.03278.E1; Moore EE, 2006, ANN EMERG MED, V47, P413, DOI 10.1016/j.annemergmed.2006.01.017; Nathens AB, 2001, JAMA-J AM MED ASSOC, V285, P1164, DOI 10.1001/jama.285.9.1164; WEST JG, JAMA, V1099, P3597	10	17	18	0	4	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0733-8627	1558-0539		EMERG MED CLIN N AM	Emerg. Med. Clin. N. Am.	AUG	2007	25	3					643	+		10.1016/j.emc.2007.07.002			13	Emergency Medicine	Emergency Medicine	216OF	WOS:000249886900005	17826210				2021-06-18	
J	Slemmer, JE; Haasdijk, ED; Engel, DC; Plesnila, N; Weber, JT				Slemmer, Jennifer E.; Haasdijk, Elize D.; Engel, Doortje C.; Plesnila, Nikolaus; Weber, John T.			Aldolase C-positive cerebellar Purkinje cells are resistant to delayed death after cerebral trauma and AMPA-mediated excitotoxicity	EUROPEAN JOURNAL OF NEUROSCIENCE			English	Article						cerebellum; controlled cortical impact; EAAT4; mouse; traumatic brain injury; zebrin II	CONTROLLED CORTICAL IMPACT; BRAIN-INJURY; GLUTAMATE TRANSPORTER; HIPPOCAMPAL CELLS; ZEBRIN-II; RECEPTORS; VULNERABILITY; SYNAPSES; ISCHEMIA; DAMAGE	The cerebellum has been shown to be vulnerable to global ischemic damage in tightly controlled zones of Purkinje cells (PCs) that lack aldolase C, an enzyme critical for glycolysis. Here, we investigated whether aldolase C-negative PCs were more likely to die after cerebral trauma in vivo, and whether this death was mediated by excitotoxic [alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA)-mediated] means in vitro. Mice were subjected to controlled cortical impact, or remained uninjured, and were killed at 6 h, 24 h or 7 days after injury. Cerebellar sections (both ipsilateral and contralateral to the site of cerebral injury) were stained against aldolase C and calbindin (a marker of PCs). The number of viable, calbindin-positive PCs decreased significantly at 24 h and 7 days after injury, and the percentage of surviving, aldolase C-positive PCs significantly increased at those time-points. In addition, we subjected murine cerebellar cultures to AMPA (30 mu m, 20 min), which killed a significant number of PCs at 24 h post-treatment. A similar number of PCs was lost after transfection with aldolase C siRNA, and this effect was exacerbated in transfected cultures treated with AMPA. The results from the present study indicate that aldolase C provides marked neuroprotection to PCs after trauma and excitotoxicity.	Mem Univ Newfoundland, Sch Pharm, Hlth Sci Ctr, St John, NF A1B 3V6, Canada; Erasmus MC, Dept Neurosci, Rotterdam, Netherlands; Univ Munich, Med Ctr, Lab Expt Neurosurg, D-80539 Munich, Germany	Weber, JT (corresponding author), Univ Prince Edward Isl, Dept Biol, Charlottetown, PE C1A 4P3, Canada.	jweber@mun.ca	Plesnila, Nikolaus/T-7522-2019				AHN AH, 1994, DEVELOPMENT, V120, P2081; Ai JL, 2004, PHARMACOLOGY, V71, P192, DOI 10.1159/000078085; Ai JL, 2002, NEUROSCI LETT, V332, P155, DOI 10.1016/S0304-3940(02)00945-X; Allen GV, 2001, NEUROSCIENCE, V102, P603, DOI 10.1016/S0306-4522(00)00519-4; Amino Y, 2001, NEUROSCI LETT, V309, P29, DOI 10.1016/S0304-3940(01)02018-3; BRASNJO G, 2004, P NATL ACAD SCI USA, V20, P6273; BRORSON JR, 1994, J NEUROSCI, V14, P187; Buono P, 2001, J NEUROCYTOL, V30, P957, DOI 10.1023/A:1021828421792; BURKE D, 2000, REHABILITATION PEOPL, P19; Donohoe PH, 2001, BRAIN RES, V917, P158, DOI 10.1016/S0006-8993(01)02849-9; Engel DC, 2005, NEUROPHARMACOLOGY, V49, P985, DOI 10.1016/j.neuropharm.2005.05.021; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; FAROOQUI AA, 1994, J NEUROSCI RES, V38, P6, DOI 10.1002/jnr.490380103; Fujimoto ST, 2004, NEUROSCI BIOBEHAV R, V28, P365, DOI 10.1016/j.neubiorev.2004.06.002; Fukuda K, 1996, J NEUROTRAUM, V13, P255, DOI 10.1089/neu.1996.13.255; Gaetz M, 2004, CLIN NEUROPHYSIOL, V115, P4, DOI 10.1016/S1388-2457(03)00258-X; Hawkes R, 1995, J MOL NEUROSCI, V6, P147, DOI 10.1007/BF02736761; Lopez-Bayghen E, 2003, MOL BRAIN RES, V115, P1, DOI 10.1016/S0169-328X(03)00136-0; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; Nagao S, 1997, NEUROSCIENCE, V78, P929; PALMER AM, 1993, J NEUROCHEM, V61, P2015, DOI 10.1111/j.1471-4159.1993.tb07437.x; PALMER AM, 1994, NEUROREPORT, V6, P153, DOI 10.1097/00001756-199412300-00039; Park E, 2006, J NEUROPATH EXP NEUR, V65, P226, DOI 10.1097/01.jnen.0000202888.29705.93; Park JY, 2004, BRAIN RES, V1026, P295, DOI 10.1016/j.brainres.2004.08.039; Rogido M, 2003, DEV BRAIN RES, V140, P287, DOI 10.1016/S0165-3806(02)00615-6; Sarna J, 2001, EUR J NEUROSCI, V13, P1873, DOI 10.1046/j.0953-816x.2001.01564.x; Sarna JR, 2003, PROG NEUROBIOL, V70, P473, DOI 10.1016/S0301-0082(03)00114-X; SASAKI K, 1977, EXP BRAIN RES, V29, P419; Shaw NA, 2002, PROG NEUROBIOL, V67, P281, DOI 10.1016/S0301-0082(02)00018-7; Slemmer JE, 2005, PROG BRAIN RES, V148, P367, DOI 10.1016/S0079-6123(04)48029-7; Slemmer JE, 2005, NEUROBIOL DIS, V18, P421, DOI 10.1016/j.nbd.2004.09.022; Slemmer JE, 2004, NEUROBIOL DIS, V15, P563, DOI 10.1016/j.nbd.2003.11.027; Slemmer JE, 2002, BRAIN, V125, P2699, DOI 10.1093/brain/awf271; Stepanova T, 2003, J NEUROSCI, V23, P2655; Takayasu Y, 2005, J NEUROSCI, V25, P8788, DOI 10.1523/JNEUROSCI.1020-05.2005; Teasdale E, 2005, HEAD INJURY PATHOPHY, P169; Tong W, 2002, EXP NEUROL, V176, P105, DOI 10.1006/exnr.2002.7941; Vakil E, 2005, J CLIN EXP NEUROPSYC, V27, P977, DOI 10.1080/13803390490919245; Voogd J, 1997, PROG BRAIN RES, V114, P21; Weber JT, 2004, CURR NEUROVASC RES, V1, P151, DOI 10.2174/1567202043480134; Welsh JP, 2002, ADV NEUROL, V89, P331; Yamada K, 1996, NEUROREPORT, V7, P2013, DOI 10.1097/00001756-199608120-00032; Zweckberger K, 2003, J NEUROTRAUM, V20, P1307, DOI 10.1089/089771503322686102	43	17	18	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0953-816X	1460-9568		EUR J NEUROSCI	Eur. J. Neurosci.	AUG	2007	26	3					649	656		10.1111/j.1460-9568.2007.05708.x			8	Neurosciences	Neurosciences & Neurology	197ZZ	WOS:000248598100012	17686042				2021-06-18	
J	Hornero, R; Aboy, M; Abasolo, D				Hornero, Roberto; Aboy, Mateo; Abasolo, Daniel			Analysis of intracranial pressure during acute intracranial hypertension using Lempel-Ziv complexity: further evidence	MEDICAL & BIOLOGICAL ENGINEERING & COMPUTING			English	Article						Lempel-Ziv complexity; intracranial hypertension; intracranial pressure irregularity; approximate entropy; traumatic brain injury	WAVE-FORM; APPROXIMATE ENTROPY; HEAD-INJURY; INFORMATION	We analyzed intracranial pressure (ICP) signals during periods of acute intracranial hypertension (ICH) using the Lempel-Ziv (LZ) complexity measure. Our results indicate the LZ complexity of ICP decreases during periods of ICH. The mean LZ complexity before ICH was 0.20 +/- 0.04, while the mean LZ complexity during ICH was 0.16 +/- 0.03 (p < 0.05). The mean decrease of the LZ complexity values during the ICH episodes was 19.5%. Additionally, we present preliminary evidence suggesting that periods of ICH may be detectable from non-invasive signals coupled with ICP, such as pulse oximetry (SpO(2)).	Univ Valladolid, ETS Ingn Telecomun, Biomed Engn Grp, E-47011 Valladolid, Spain; Oregon Inst Technol, Elect Engn Technol Dept, Portland, OR USA	Hornero, R (corresponding author), Univ Valladolid, ETS Ingn Telecomun, Biomed Engn Grp, Camino Cementerio S-N, E-47011 Valladolid, Spain.	robhor@tel.uva.es	Hornero, Roberto/B-5398-2008; Aboy, Mateo/K-4060-2019; Abasolo, Daniel/B-7322-2009; Hornero, Roberto/M-5313-2019	Hornero, Roberto/0000-0001-9915-2570; Abasolo, Daniel/0000-0002-4268-2885; Hornero, Roberto/0000-0001-9915-2570; Aboy, Mateo/0000-0002-5168-4321			Aboy M, 2006, IEEE T BIO-MED ENG, V53, P2282, DOI 10.1109/TBME.2006.883696; Balestreri M, 2004, ACTA NEUROCHIR, V146, P131, DOI 10.1007/s00701-003-0187-y; CONTANT CF, 1995, J NEUROSCI METH, V57, P15, DOI 10.1016/0165-0270(94)00106-Q; Czosnyka M, 2004, J NEUROL NEUROSUR PS, V75, P813, DOI 10.1136/jnnp.2003.033126; Czosnyka M, 1996, ACTA NEUROCHIR, V138, P531, DOI 10.1007/BF01411173; GOLDSTEIN B, 2004, CURRENT CONCEPTS PED, P201; Hornero R, 2006, CRIT CARE MED, V34, P87, DOI 10.1097/01.CCM.0000190426.44782.F0; Hornero R, 2005, IEEE T BIO-MED ENG, V52, P1671, DOI 10.1109/TBME.2005.855722; LEMPEL A, 1976, IEEE T INFORM THEORY, V22, P75, DOI 10.1109/TIT.1976.1055501; Luerssen T G, 1997, Semin Pediatr Neurol, V4, P146, DOI 10.1016/S1071-9091(97)80033-2; Nagarajan R, 2002, IEEE T BIO-MED ENG, V49, P1371, DOI 10.1109/TBME.2002.804582; PORTNOY HD, 1982, J NEUROSURG, V56, P666, DOI 10.3171/jns.1982.56.5.0666; Radhakrishnan N, 1998, IEEE ENG MED BIOL, V17, P89, DOI 10.1109/51.677174; Wu X., 1991, ACTA BIOPHYS SINICA, V7, P103; Xu JH, 1997, PHYSICA D, V106, P363, DOI 10.1016/S0167-2789(97)00042-0; Zhang XS, 1999, IEEE T BIO-MED ENG, V46, P548, DOI 10.1109/10.759055; Zhang XS, 2001, IEEE T BIO-MED ENG, V48, P1424, DOI 10.1109/10.966601	17	17	18	0	4	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0140-0118	1741-0444		MED BIOL ENG COMPUT	Med. Biol. Eng. Comput.	JUN	2007	45	6					617	620		10.1007/s11517-007-0194-x			4	Computer Science, Interdisciplinary Applications; Engineering, Biomedical; Mathematical & Computational Biology; Medical Informatics	Computer Science; Engineering; Mathematical & Computational Biology; Medical Informatics	178HN	WOS:000247211900012	17541667				2021-06-18	
J	Rao, V; Spiro, JR; Schretlen, DJ; Cascella, NG				Rao, Vani; Spiro, Jennifer R.; Schretlen, David J.; Cascella, Nicola G.			Apathy syndrome after traumatic brain injury compared with deficits in schizophrenia	PSYCHOSOMATICS			English	Article							NEGATIVE SYMPTOMS; NONDEFICIT FORMS; HEAD-INJURY; SCALE; PSYCHOPATHOLOGY; DEPRESSION	The authors compared the severity and clinical profiles of patients with two etiologically different apathy syndromes: apathy after traumatic brain injury (TBI) and deficit schizophrenia (DSS). Patients from both groups were equally apathetic, but those with DSS had more severe anhedonia, blunted affect, and alogia, as measured by the Scale for Assessment of Negative Symptoms. These findings suggest that patients with DSS have a more complex presentation of apathy. Their differences may help to identify anatomical correlates of these apathy syndromes and aid in the design of more effective management strategies for both groups of patients.	Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA	Rao, V (corresponding author), Johns Hopkins Univ Hosp, Div Neuropsychiat & Geriatr Psychiat, 600 N Wolfe St, Baltimore, MD 21287 USA.	vrao@jhmi.edu					Andreasen NC, 1981, SCALE ASSESSMENT NEG; Arango C, 2004, EUR PSYCHIAT, V19, P21, DOI 10.1016/j.eurpsy.2003.10.004; Blair JR., 1989, CLIN NEUROPSYCHOL, V3, P129; BUCHANAN RW, 1994, ARCH GEN PSYCHIAT, V51, P804; BUCHANAN RW, 1990, AM J PSYCHIAT, V147, P290; Carpenter WT, 1999, BIOL PSYCHIAT, V46, P352, DOI 10.1016/S0006-3223(99)00088-8; CARPENTER WT, 1988, AM J PSYCHIAT, V145, P578; DOODY RS, 1995, J NEUROPSYCH CLIN N, V7, P54; FABREGA H, 1988, COMPR PSYCHIAT, V29, P285, DOI 10.1016/0010-440X(88)90051-X; Finset A, 2000, BRAIN INJURY, V14, P887; First MB., 1997, STRUCTURED CLIN INTE; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Galderisi S, 2002, AM J PSYCHIAT, V159, P983, DOI 10.1176/appi.ajp.159.6.983; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Kant R, 1998, BRAIN INJURY, V12, P87, DOI 10.1080/026990598122908; KIRKPATRICK B, 1989, PSYCHIAT RES, V30, P119, DOI 10.1016/0165-1781(89)90153-4; Kopelowicz A, 1997, AM J PSYCHIAT, V154, P424; Levy R, 2006, CEREB CORTEX, V16, P916, DOI 10.1093/cercor/bhj043; Lyketsos CG, 2004, PSYCHOSOMATICS, V45, P247, DOI 10.1176/appi.psy.45.3.247; Mann R. S., 1996, REV PSYCHIAT, V15, P205; MARIN RS, 1991, PSYCHIAT RES, V38, P143, DOI 10.1016/0165-1781(91)90040-V; Marit RS, 2005, J HEAD TRAUMA REHAB, V20, P377, DOI 10.1097/00001199-200507000-00009; Mueser KT, 2004, LANCET, V363, P2063, DOI 10.1016/S0140-6736(04)16458-1; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; Resnick B, 1998, Rehabil Nurs, V23, P141; STARKSTEIN SE, 1993, STROKE, V24, P1625, DOI 10.1161/01.STR.24.11.1625; Stuss DT., 2000, DIFFERENTIATION STAT, P340; Tattan TMG, 2001, SCHIZOPHRENIA BULL, V27, P149, DOI 10.1093/oxfordjournals.schbul.a006853; TEASDALE G, 1974, LANCET, V2, P81; van Reekum R, 2005, J NEUROPSYCH CLIN N, V17, P7, DOI 10.1176/appi.neuropsych.17.1.7; VANZOMERAN A, 1985, J NEUROL NEUROSURGER, V41, P21; Verstraeten E, 2004, SLEEP MED REV, V8, P257, DOI 10.1016/j.smrv.2004.01.001; Weisman AG, 2000, SCHIZOPHRENIA BULL, V26, P817, DOI 10.1093/oxfordjournals.schbul.a033496	33	17	17	0	4	AMER PSYCHIATRIC PUBLISHING, INC	ARLINGTON	1000 WILSON BOULEVARD, STE 1825, ARLINGTON, VA 22209-3901 USA	0033-3182			PSYCHOSOMATICS	Psychosomatics	JUN	2007	48	3					217	222		10.1176/appi.psy.48.3.217			6	Psychiatry; Psychology	Psychiatry; Psychology	164CN	WOS:000246210400005	17478590				2021-06-18	
J	Huang, SJ; Hong, WC; Han, YY; Chen, YS; Wen, CS; Tsan, YS; Tu, YK				Huang, Sheng-Jean; Hong, Wei-Chen; Han, Yin-Yi; Chen, Yuan-Sen; Wen, Chung-Shi; Tsan, Yi-Shin; Tu, Yong-Kwang			Clinical outcome of severe head injury in different protocol-driven therapies	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article						severe head injury; protocol-driven therapy; intracranial hypertension; cerebral perfusion pressure	TRAUMATIC BRAIN-INJURY; CEREBRAL PERFUSION-PRESSURE; RESPIRATORY-DISTRESS-SYNDROME; INTRACRANIAL-PRESSURE; TARGETED THERAPY; PILOT TRIAL; MANAGEMENT; CARE; MORTALITY; ISCHEMIA	In the past 5 years cerebral perfusion pressure (CPP) management has become mainstream in the treatment of severe head injuries. The American Association of Neurological Surgeons guidelines (2000) suggest that CPP should be maintained at least 70 mmHg; however, there is still debate about optimal CPP level. The purpose of this study is to evaluate the effectiveness of three widely used therapies: intracranial pressure (ICP)-targeted therapy, CPP-targeted therapy with CPP > 70 mmHg, and modified CPP-targeted therapy with CPP > 60 mmHg. The clinical procedures, complications, and patient outcomes are compared. Data including patient age, sex, initial Glasgow Coma Score (GCS), ICP, CPP, fluid status, amount of mannitol and vasopressor used, daily intake and output, complications, and clinical results were collected from 213 patients with severe head injuries over a 12-year period. Patients were categorized into three groups (ICP, CPP, modified CPP [mCPP]) according to treatment protocol used. Retrospective data collection was by chart review. The mortality rate was 28.6%, 14.3%, and 13.5% in groups ICP, CPP, and mCPP, respectively. Highest intake/output ratio, amount of vasopressor used, and pulmonary complication rates were seen in group CPP patients. Group mCPP patients showed the best clinical outcome and lowest complication rate. Though CPP-targeted therapy is the most recommended therapeutic protocol, our data showed that the outcome is as good in the mCPP-targeted group with CPP > 60 mmHg as in the CPP-targeted group, but complications are fewer in the mCPP group. (C) 2006 Elsevier Ltd. All rights reserved.	Natl Taiwan Univ, Div Neurosurg, Coll Med & Hosp, Taipei, Taiwan; Natl Taiwan Univ Hosp, Dept Traumatol, Taipei, Taiwan	Tu, YK (corresponding author), Natl Taiwan Univ, Div Neurosurg, Coll Med & Hosp, 7 Chung Shan S Rd, Taipei, Taiwan.	yktu@ha.mc.iitu.edu.tw		HAN, YIN-YI/0000-0001-8831-7835; Tu, Yong-kwang/0000-0003-2113-1176			*AM ASS NEUR SURG, 2000, J NEUROTRAUM, V17, P493; *AM ASS NEUR SURG, 2000, J NEUROTRAUM, V17, P559; BERNARD GR, 1994, J CRIT CARE, V9, P72, DOI 10.1016/0883-9441(94)90033-7; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; Bullock R, 1996, Eur J Emerg Med, V3, P109, DOI 10.1097/00063110-199606000-00010; Bullock RM, 2000, J NEUROTRAUM, V17, P449; Clayton TJ, 2004, BRIT J ANAESTH, V93, P761, DOI 10.1093/bja/aeh249; Contant CF, 2001, J NEUROSURG, V95, P560, DOI 10.3171/jns.2001.95.4.0560; Czosnyka M, 2001, J NEUROSURG, V95, P756, DOI 10.3171/jns.2001.95.5.0756; Dickinson K, 2000, BMJ-BRIT MED J, V320, P1308, DOI 10.1136/bmj.320.7245.1308; Elf K, 2002, CRIT CARE MED, V30, P2129, DOI 10.1097/00003246-200209000-00029; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; GRAHAM DI, 1978, J NEUROL SCI, V39, P213, DOI 10.1016/0022-510X(78)90124-7; Grande PO, 2002, ACTA ANAESTH SCAND, V46, P929, DOI 10.1034/j.1399-6576.2002.460802.x; JENNETT B, 1975, LANCET, V1, P480; Kelly DF, 1999, J NEUROSURG, V90, P1042, DOI 10.3171/jns.1999.90.6.1042; Kiening KL, 1997, NEUROL RES, V19, P233, DOI 10.1080/01616412.1997.11740805; Klein D G, 1999, Crit Care Nurs Clin North Am, V11, P209; Macmillan CSA, 2001, J NEUROL NEUROSUR PS, V70, P101, DOI 10.1136/jnnp.70.1.101; MAPSTONE TB, 1996, CONT NEUROSURG, V18, P1; Marion DW, 1997, CONT NEUROSURG, V19, P1; MARMAROU A, 1991, J NEUROSURG, V75, pS59, DOI 10.3171/sup.1991.75.1s.0s59; MARSHALL LF, 1991, J NEUROSURG, V75, pS28, DOI 10.3171/sup.1991.75.1s.0s28; MILLER JD, 1981, J NEUROSURG, V54, P289, DOI 10.3171/jns.1981.54.3.0289; MILLER JD, 1990, ADV BRAIN RESUSCITAT, P315; Naredi S, 2001, ACTA ANAESTH SCAND, V45, P402, DOI 10.1034/j.1399-6576.2001.045004402.x; Patel HC, 2002, INTENS CARE MED, V28, P547, DOI 10.1007/s00134-002-1235-4; Prabhakaran P, 2004, J NEUROSURG, V100, P454, DOI 10.3171/ped.2004.100.5.0454; Robertson CS, 1999, CRIT CARE MED, V27, P2086, DOI 10.1097/00003246-199910000-00002; ROSNER MJ, 1987, NEUROSURGERY, V21, P147, DOI 10.1227/00006123-198708000-00003; ROSNER MJ, 1995, J NEUROSURG, V83, P949, DOI 10.3171/jns.1995.83.6.0949; SAHUQUILLO J, 1993, ACTA NEUROCHIR, V122, P204, DOI 10.1007/BF01405530; SAUL TG, 1982, J NEUROSURG, V56, P498, DOI 10.3171/jns.1982.56.4.0498; TEASDALE G, 1974, LANCET, V2, P81; The Brain Trauma Foundation; The American Association of Neurological Surgeons, 2000, J NEUROTRAUM, V17, P479	35	17	17	0	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0967-5868	1532-2653		J CLIN NEUROSCI	J. Clin. Neurosci.	MAY	2007	14	5					449	454		10.1016/j.jocn.2005.12.012			6	Clinical Neurology; Neurosciences	Neurosciences & Neurology	165ZR	WOS:000246346900009	17336527				2021-06-18	
J	Llompart-Pou, JA; Perez-Barcena, I; Raurich, JM; Burguera, B; Ayestaran, JI; Abadal, JM; Homar, J; Ibanez, J				Llompart-Pou, J. A.; Perez-Barcena, I.; Raurich, Ji. M.; Burguera, B.; Ayestaran, J. I.; Abadal, J. M.; Homar, J.; Ibanez, J.			Effect of barbiturate coma on adrenal response in patients with traumatic brain injury	JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION			English	Article						traumatic brain injury; barbiturate coma; adrenal insufficiency; hypotension; corticosteroids	ADRENOCORTICOTROPIC HORMONE; INTENSIVE-CARE; HEAD-INJURY; HYPOPITUITARISM; CORTISOL; HYDROCORTISONE; INSUFFICIENCY	Introduction: Barbiturate coma is the second tier measure recommended by guidelines to treat post-traumatic refractory intracranial pressure. Systemic hypotension is its most important side effect. Recent evidence suggests that low-dose corticosteroid therapy may be used in a subset of patients with traumatic brain injury (TBI) to avoid hypotension. We evaluated adrenal function in TBI patients undergoing barbiturate coma, as treatment of their refractory intracranial hypertension. Materials and methods: We prospectively studied 40 patients with moderate to severe TBI. Group A (17 patients) were treated with barbiturate coma. Group B (23 patients) presented intracranial hypertension controlled with first tier measures, and acted as a control. Adrenal function was evaluated by using the high-dose corticotropin stimulation test within 24 h after brain injury and after barbiturate coma induction. Results: Within 24 h after TBI, adrenal function was similar in both groups. Once barbiturate coma was induced, patients in group A treated with barbiturate coma presented a higher incidence of adrenal insufficiency compared with the control group B (53% vs 22%, p=0.03). Patients treated with barbiturates, who developed adrenal impairment, required higher doses of norepinephrine to maintain cerebral perfusion pressure than patients treated with barbiturates without adrenal impairment (1.07 +/- 1.04 mu g/kg/min vs 0.31 +/- 0.32 mu g/kg/min, p=0.03). Conclusions: Patients with TBI treated with barbiturate coma are at higher risk of developing adrenal insufficiency. This subset of patients presented higher requirements of vasoactive support to avoid hypotension. In these patients corticosteroid therapy may have potential therapeutic implications to treat hemodynamic instability.	Hosp Univ Son Dureta, Serv Med Intens, Palma de Mallorca, Spain; Autonomous Univ Barcelona, Dept Surg, Barcelona, Spain; Hosp Univ Son Dureta, Serv Endocrinol, Palma de Mallorca, Spain	Llompart-Pou, JA (corresponding author), Hosp Univ Son Dureta, Serv Med Intens, Palma de Mallorca, Spain.	jallompart@hsd.es					Absalom A, 1999, ANAESTHESIA, V54, P861; Agha Amar, 2005, Am J Med, V118, P1416; Annane D, 2005, CRIT CARE MED, V33, P2688, DOI 10.1097/01.CCM.0000186887.21494.4A; Annane D, 2002, JAMA-J AM MED ASSOC, V288, P862, DOI 10.1001/jama.288.7.862; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bernard F, 2006, BRIT J ANAESTH, V96, P72, DOI 10.1093/bja/aei277; BESSE JC, 1966, J PHARMACOL EXP THER, V154, P224; Bondanelli M, 2005, EUR J ENDOCRINOL, V152, P679, DOI 10.1530/eje.1.01895; Brain Trauma Foundation The American Association of Neurological Surgeons, 2000, J NEUROTRAUM, V17, P527; Broadbear JH, 2005, PSYCHOPHARMACOLOGY, V178, P83, DOI 10.1007/s00213-004-1986-4; Casanueva FF, 2004, J ENDOCRINOL INVEST, V27, P793, DOI 10.1007/BF03347526; Cohan P, 2005, CRIT CARE MED, V33, P2358, DOI 10.1097/01.CCM.0000181735.51183.A7; DeLong WG, 2004, CLIN ORTHOP RELAT R, P57, DOI 10.1097/01.blo.0000130840.64528.1e; DICKSTEIN G, 1991, J CLIN ENDOCR METAB, V72, P773, DOI 10.1210/jcem-72-4-773; Dimopoulou I, 2004, INTENS CARE MED, V30, P1051, DOI 10.1007/s00134-004-2257-x; Dimopoulou L, 2004, CRIT CARE MED, V32, P404, DOI 10.1097/01.CCM.0000108885.37811.CA; Edwards P, 2005, LANCET, V365, P1957; EISENBERG HM, 1988, J NEUROSURG, V69, P15, DOI 10.3171/jns.1988.69.1.0015; GHAJAR J, 1995, CRIT CARE MED, V23, P560, DOI 10.1097/00003246-199503000-00023; Ghigo E, 2005, BRAIN INJURY, V19, P711, DOI 10.1080/02699050400025315; Illera JC, 2000, J PHYSIOL BIOCHEM, V56, P329, DOI 10.1007/BF03179801; Jeevaratnam DR, 1996, BRIT MED J, V312, P944; LLOMPARTPOU JA, IN PRESS J TRAUMA; Marsden J, 1991, NONLINEAR SCI TODAY, V1, P4; Perez-Barcena J, 2005, NEUROCIRUGIA, V16, P5; PEREZBARCENA J, 2002, MED INTENSIVA, V26, P407; Putignano P, 1998, HORM METAB RES, V30, P389, DOI 10.1055/s-2007-978903; Savaridas T, 2004, INTENS CARE MED, V30, P1479, DOI 10.1007/s00134-004-2306-5; TEASDALE G, 1974, LANCET, V2, P81; The Brain Trauma Foundation, 2000, J NEUROTRAUM, V17, P591; TOSO CFR, 1993, CAN J ANAESTH, V40, P1084, DOI 10.1007/BF03009482; WHITEHOUSE BJ, 1993, J ENDOCRINOL, V136, P75, DOI 10.1677/joe.0.1360075	32	17	17	0	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1720-8386			J ENDOCRINOL INVEST	J. Endocrinol. Invest.	MAY	2007	30	5					393	398		10.1007/BF03346316			6	Endocrinology & Metabolism	Endocrinology & Metabolism	190MT	WOS:000248063800008	17598971				2021-06-18	
J	Whelan, BM; Murdoch, BE; Bellamy, N				Whelan, Brooke-Mai; Murdoch, Bruce E.; Bellamy, Nicholas			Delineating communication impairments associated with mild traumatic brain injury: A case report	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						head injury; language deficits	CLOSED-HEAD-INJURY; DIFFUSE AXONAL INJURY; SUBCORTICAL PARTICIPATION; SUBTHALAMIC NUCLEUS; LANGUAGE FUNCTION; CHILDREN; MODELS; LONG; ADOLESCENTS; DOMINANT	Background: Mild traumatic brain injury (mTBI) without frank neurological disturbance has been linked to persistent physical, cognitive, and affective disturbances in some cases. The cognitive sequelae of this syndrome represent the most frequently studied symptoms, yet the legacy of such injuries on communicative functions remains largely undetermined. Methods: A detailed language profile of a 19-year-old woman, 1 year 10 months following mTBI is compared with a matched normative cohort of 10 participants with nonneurological impairment. Results: Deficits in attention, lexical access, complex lexical-semantic manipulation, response monitoring, and organization were revealed as a consequence of mTBI. Conclusions: This profile provides support for hypotheses pertaining to neuronal fallout mechanisms within the frontal lobes as a consequence of mild neurological insult.	Univ Queensland, Motor Speech & Neurogen Language Res Ctr, Div Speech Pathol, Sch Hlth & Rehabil Sci, Brisbane, Qld 4072, Australia; Univ Queensland, Ctr Natl Res Disabil & Rehabil Med, Brisbane, Qld 4072, Australia	Whelan, BM (corresponding author), Univ Queensland, Motor Speech & Neurogen Language Res Ctr, Div Speech Pathol, Sch Hlth & Rehabil Sci, Brisbane, Qld 4072, Australia.	bmw@uq.edu.au	Bellamy, Nicholas/G-3631-2010; Murdoch, Bruce E/C-1397-2012	Whelan, Brooke-Mai/0000-0002-7909-3160			Adamovich B. B., 1992, SCALES COGNITIVE ABI; ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; ADAMS JH, 1975, HDB CLINICAL NEUROLO, V23, P35; Anderson V, 2001, J CLIN EXP NEUROPSYC, V23, P705, DOI 10.1076/jcen.23.6.705.1015; Azuma T, 1997, J MEM LANG, V36, P484, DOI 10.1006/jmla.1997.2502; BEERS SR, 1992, NEUROPSYCHOL REV, V3, P281, DOI 10.1007/BF01108414; Bernstein DM, 1999, BRAIN INJURY, V13, P151, DOI 10.1080/026990599121683; Borgaro SR, 2003, BRAIN INJURY, V17, P189, DOI 10.1080/0269905021000013183; Copland DA, 2000, J MED SPEECH-LANG PA, V8, P1; CROSSON B, 1998, HDB NEUROLINGUISTICS, P431; Cudmore LJ, 2000, BRAIN COGNITION, V44, P86; Duff MC, 2002, BRAIN INJURY, V16, P773, DOI 10.1080/02699050210128870; Ferguson RJ, 1999, NEUROPSYCHOLOGY, V13, P582, DOI 10.1037/0894-4105.13.4.582; GENNARELLI TA, 1982, ANN NEUROL, V12, P212; Goldstein FC, 2001, J INT NEUROPSYCH SOC, V7, P373, DOI 10.1017/S1355617701733115; GRONWALL D, 1981, J NEUROL NEUROSUR PS, V44, P889, DOI 10.1136/jnnp.44.10.889; GRONWALL D, 1974, LANCET, V2, P605; Gronwall D, 1989, MILD HEAD INJURY, P153; Gross H, 1996, J NEUROPSYCH CLIN N, V8, P324; Hanten G, 2004, DEV NEUROPSYCHOL, V25, P85, DOI 10.1207/s15326942dn2501&2_6; Hinchliffe FJ, 1998, BRAIN INJURY, V12, P369, DOI 10.1080/026990598122502; Hinchliffe FJ, 1998, BRAIN INJURY, V12, P109, DOI 10.1080/026990598122746; HUGENHOLTZ H, 1988, NEUROSURGERY, V22, P853, DOI 10.1227/00006123-198805000-00006; Huisingh R, 1990, WORD TEST REVISED TE; HUMAYUN MS, 1989, NUCL MED COMMUN, V10, P335, DOI 10.1097/00006231-198905000-00004; Kaplan E., 1983, BOSTON NAMING TEST; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; MACFLYNN G, 1984, J NEUROL NEUROSUR PS, V47, P1326, DOI 10.1136/jnnp.47.12.1326; Parker RS, 1996, NEUROPSYCHOL REV, V6, P135, DOI 10.1007/BF01874895; Ponsford J L, 1990, Brain Inj, V4, P111, DOI 10.3109/02699059009026156; Ragnarsson KT, 1999, JAMA-J AM MED ASSOC, V282, P974; RUBENSTEIN H, 1970, VERBAL LEARNING VERB, V9, P484; Satz P, 1997, PSYCHOL BULL, V122, P107, DOI 10.1037/0033-2909.122.2.107; Secord, 1989, TEST LANGUAGE COMPET; Spreen O, 1969, NEUROSENSORY CTR COM; Turkstra L, 2005, J MED SPEECH-LANG PA, V13, pIX; Umile EM, 2002, ARCH PHYS MED REHAB, V83, P1506, DOI 10.1053/apmr.2002.35092; VANORDEN GC, 1994, J EXP PSYCHOL HUMAN, V20, P1269, DOI 10.1037/0096-1523.20.6.1269; vansZomeren AH, 1987, NEUROBEHAVIORAL RECO, P398; VARNEY NR, 1995, J HEAD TRAUMA REHAB, V10, P18; Wallesch CW, 2001, BRAIN INJURY, V15, P401, DOI 10.1080/02699050010005959; Whelan BM, 2005, J NEUROLINGUIST, V18, P361, DOI 10.1016/j.jneuroling.2004.05.002; Whelan BM, 2005, NEUROCASE, V11, P93, DOI 10.1080/13554790590925501; Whelan BM, 2004, NEUROCASE, V10, P345, DOI 10.1080/13554790490893742; Whelan BM, 2004, MOVEMENT DISORD, V19, P1267, DOI 10.1002/mds.20252; Whelan BM, 2003, J NEUROL NEUROSUR PS, V74, P1543, DOI 10.1136/jnnp.74.11.1543; Whelan BM, 2002, APHASIOLOGY, V16, P1213, DOI 10.1080/02687030244000446; WHELAN BM, 2000, ASIA PACIFIC J SPEEC, V5, P93; WIIG EH, 1974, PERCEPT MOTOR SKILL, V38, P171, DOI 10.2466/pms.1974.38.1.171; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; YLVASAKER M, 1994, ED DIMENSIONS ACQUIR, P69	51	17	17	1	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAY-JUN	2007	22	3					192	197		10.1097/01.HTR.0000271120.04405.db			6	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	174OH	WOS:000246951100006	17510595				2021-06-18	
J	Kapsalaki, EZ; Machinis, TG; Robinson, JS; Newman, B; Grigorian, AA; Fountas, KN				Kapsalaki, E. Z.; Machinis, T. G.; Robinson, J. S., III; Newman, B.; Grigorian, A. A.; Fountas, K. N.			Spontaneous resolution of acute cranial subdural hematomas	CLINICAL NEUROLOGY AND NEUROSURGERY			English	Article						acute; redistribution; spontaneous resolution; subdural hematoma; cranial; MRI	RAPID SPONTANEOUS RESOLUTION; HEAD-INJURY; SURGICAL-TREATMENT; REDISTRIBUTION; MINUTES; ADULTS	Acute cranial subdural hematoma (SDH) represents a common consequence of traumatic brain injury. The vast majority of acute SDHs larger than 10 mm in thickness require immediate surgical evacuation. In rare occasions, however, spontaneous resolution may occur. In our current communication, we present four cases of spontaneous resolution of acute cranial SDH. Further more, the proposed theories explaining spontaneous resolution of acute SDH, as well as, clinical parameters and imaging characteristics that might predict such phenomenon, are also reviewed. The possibility of spontaneous resolution of an acute SDH, although remote, may impact the decision making process regarding the management of these patients under certain conditions. (c) 2006 Elsevier B.V. All rights reserved.	Mercer Univ, Sch Med, Med Ctr Cent Georgia, Dept Neuroradiol, Macon, GA 31207 USA; Mercer Univ, Sch Med, Med Ctr Cent Georgia, Dept Neurosurg, Macon, GA 31207 USA	Fountas, KN (corresponding author), 840 Pine St,Suite 880, Macon, GA 31201 USA.	knfountasmd@excite.com					ABE T, 1999, NO SHINKEI GEKA J, V8, P675; Ahn ES, 2005, J NEUROSURG, V103, P175, DOI 10.3171/ped.2005.103.2.0175; ALDRICH EF, 1993, BRAIN SURG COMPLICAT, P1283; AOKI N, 1990, ACTA NEUROCHIR, V103, P76, DOI 10.1007/BF01420196; ARAI H, 1990, SHONI NO NO SHINKEI, V15, P155; Bortolotti C, 2004, J NEUROSURG, V100, P372, DOI 10.3171/spi.2004.100.4.0372; *BRAIN TRAUM FDN A, 2001, MANAGEMENT PROGNOSIS, P47; Cohen JE, 1998, SURG NEUROL, V50, P241, DOI 10.1016/S0090-3019(97)00026-8; Edwards RJ, 2002, BRIT J NEUROSURG, V16, P609; FUJIOKA S, 1990, Neurologia Medico-Chirurgica, V30, P827, DOI 10.2176/nmc.30.827; Gelabert-Gonzalez M, 2005, CLIN NEUROL NEUROSUR, V107, P223, DOI 10.1016/j.clineuro.2004.09.015; HORIMOTO C, 1993, NIHON KYUKYU IGOKUKO, V17, P854; Inamasu J, 2002, AM J EMERG MED, V20, P376, DOI 10.1053/ajem.2002.33955; Izumihara A, 1997, NEUROL SURG TOKYO, V25, P307; Joki Tatsuhiro, 1992, Neurological Surgery, V20, P915; Kato N, 2001, NEUROL MED-CHIR, V41, P140, DOI 10.2176/nmc.41.140; Kelly DF, 1996, NEUROLOGICAL SURG, P1618; KOBRINE AI, 1977, J NEUROSURG, V46, P256, DOI 10.3171/jns.1977.46.2.0256; Kundra SN, 2005, NEUROL INDIA, V53, P124, DOI 10.4103/0028-3886.15083; KUROIWA T, 1993, J NEUROSURG, V78, P126, DOI 10.3171/jns.1993.78.1.0126; KURTI X, 1982, ACTA NEUROCHIR, V62, P87, DOI 10.1007/BF01402213; LOU XH, 2000, CHIN J TRAUMATOL, V16, P526; Maas AIR, 1997, ACTA NEUROCHIR, V139, P286, DOI 10.1007/BF01808823; MAKIYAMA Y, 1985, Nihon University Journal of Medicine, V27, P123; MATSUYAMA T, 1997, SURG NEUROL, V50, P289; Miller JD, 1992, NEUROSURG QUART, V2, P28; Mirzai H, 2005, J NEUROL NEUROSUR PS, V76, P1738, DOI 10.1136/jnnp.2005.067579; NAGAO T, 1986, NEUROSURGERY, V19, P465, DOI 10.1227/00006123-198609000-00024; NICHOLAS DS, 1988, J NEUROSURG, V69, P276, DOI 10.3171/jns.1988.69.2.0276; Niikawa S, 1989, Neurol Med Chir (Tokyo), V29, P820, DOI 10.2176/nmc.29.820; POLMAN CH, 1986, NEUROSURGERY, V19, P446, DOI 10.1227/00006123-198609000-00019; Reina MA, 2002, ANESTH ANALG, V94, P991; ROCKSWOLD GL, 1993, ANN EMERG MED, V22, P1004, DOI 10.1016/S0196-0644(05)82742-8; SEELIG JM, 1981, NEW ENGL J MED, V304, P1511, DOI 10.1056/NEJM198106183042503; Suzuki Y, 1998, NEUROL SURG TOKYO, V26, P1025; Tsui EYK, 2000, EUR J RADIOL, V36, P53, DOI 10.1016/S0720-048X(99)00167-9; Voelker JL, 2000, NEUROSURG CLIN N AM, V11, P507, DOI 10.1016/S1042-3680(18)30115-3; WAGA S, 1979, SURG NEUROL, V11, P191; WHALLEY N, 1948, LANCET, V254, P213; Wu Ming-can, 2004, Chin J Traumatol, V7, P96; YOSHINO E, 1985, J NEUROSURG, V63, P830, DOI 10.3171/jns.1985.63.6.0830	41	17	19	0	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0303-8467	1872-6968		CLIN NEUROL NEUROSUR	Clin. Neurol. Neurosurg.	APR	2007	109	3					287	291		10.1016/j.clineuro.2006.11.005			5	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	146TG	WOS:000244957000013	17182174				2021-06-18	
J	Dickin, DC; Clark, S				Dickin, D. Clark; Clark, Sean			Generalizability of the sensory organization test in college-aged males: Obtaining a reliable performance measure	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						posture; reliability; sensory motor performance; sensory integration	POSTURAL CONTROL; BASKETBALL PLAYERS; FUNCTIONAL INSTABILITY; OLDER ADULTS; ANKLE JOINT; BALANCE; STABILITY; CONCUSSION; RELIABILITY; INJURY	Objective: This Study used generalizability theory to (1) determine the reliability of the six Sensory Organization Test (SOT) conditions, and (2) to determine the most effective testing schedule to obtain reliable posture measurements. Design: Generalizability theory was used to determine the most effecting testing protocol to obtain reliable assessments of postural sway in various sensory environments. Participants: Twenty-five recreationally active college-aged males. Setting: University research laboratory. Interventions: None. Main Outcome Measurements: Postural stability as measured by equilibrium score (a percentage measure indicating amount Of sway, with lower scores indicating a greater amount of postural sway). Scores were obtained for each of the six sensory conditions across multiple trials, tests, and days. Results: This study showed that performing the SOT twice on a single testing day was sufficient to achieve moderate to good reliability across the six conditions of the SOT. Extending SOT testing to twice on 2 days yielded good to excellent reliability estimates across all SOT conditions. Conclusions: Taken together, these results indicate that for the purpose of monitoring changes in the postural control system, an individual needs to experience the full complement of SOT testing conditions at least twice. However, if highly reliable baseline measures of SOT performance are necessary, multiple tests performed on multiple days are warranted.	Univ Idaho, Dept Hlth Phys Educ Recreat & Dance, Moscow, ID 83844 USA; Gordon Coll, Dept Kinesiol, Wenham, MA USA	Dickin, DC (corresponding author), Univ Idaho, Dept Hlth Phys Educ Recreat & Dance, Box 442401, Moscow, ID 83844 USA.	cdickin@uidaho.edu	Dickin, D. Clark/A-8303-2009	Dickin, D. Clark/0000-0002-3104-4167			Brennan R. L., 2001, GEN THEORY; Cavanaugh JT, 2005, SPORTS MED, V35, P935, DOI 10.2165/00007256-200535110-00002; Clark S, 1997, ARCH PHYS MED REHAB, V78, P1078, DOI 10.1016/S0003-9993(97)90131-3; Cohen H, 1996, AGE AGEING, V25, P39, DOI 10.1093/ageing/25.1.39; COOGLER CE, 1992, POSTURE GAIT CONTROL, P361; Cronbach L. J., 1972, DEPENDABILITY BEHAV; Emery CA, 2005, PHYS THER, V85, P502, DOI 10.1093/ptj/85.6.502; FORDSMITH CD, 1995, ARCH PHYS MED REHAB, V76, P77, DOI 10.1016/S0003-9993(95)80047-6; Fu ASN, 2005, AM J SPORT MED, V33, P1174, DOI 10.1177/0363546504271976; GAUFFIN H, 1988, INT J SPORTS MED, V9, P141, DOI 10.1055/s-2007-1024996; Guskiewicz Kevin M, 2003, Curr Sports Med Rep, V2, P24; Guskiewicz KM, 1997, MED SCI SPORT EXER, V29, pS213; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Henriksson M, 2001, AM J SPORT MED, V29, P359, DOI 10.1177/03635465010290031801; HOFFMAN M, 1995, J ORTHOP SPORT PHYS, V21, P90, DOI 10.2519/jospt.1995.21.2.90; KOLLEGGER H, 1992, EUR NEUROL, V32, P253, DOI 10.1159/000116836; Mangus Brent C, 2004, Sports Biomech, V3, P209, DOI 10.1080/14763140408522841; McGuine TA, 2000, CLIN J SPORT MED, V10, P239, DOI 10.1097/00042752-200010000-00003; Morrow J.R., 1989, MEASUREMENT CONCEPTS, P73; Mrazik M, 2000, BRAIN INJURY, V14, P921, DOI 10.1080/026990500445736; *NEUROCOM INT INC, 2001, SMART BAL MAST OP MA; Paterno MV, 2004, J ORTHOP SPORT PHYS, V34, P305, DOI 10.2519/jospt.2004.34.6.305; Perrin PP, 1997, INT J SPORTS MED, V18, P387, DOI 10.1055/s-2007-972651; Peterka R J, 1990, J Vestib Res, V1, P73; Peterson CL, 2003, CLIN J SPORT MED, V13, P230, DOI 10.1097/00042752-200307000-00006; Pintsaar A, 1996, BRIT J SPORT MED, V30, P151, DOI 10.1136/bjsm.30.2.151; Portney L., 2015, FDN CLIN RES APPL PR, V3rd ed.; ROEBROECK ME, 1993, PHYS THER, V73, P386, DOI 10.1093/ptj/73.6.386; Rozzi SL, 1999, J ORTHOP SPORT PHYS, V29, P478, DOI 10.2519/jospt.1999.29.8.478; Shavelson R., 1991, GEN THEORY PRIMER; Speers RA, 1998, J BIOMECH, V31, P883, DOI 10.1016/S0021-9290(98)00065-7; TROPP H, 1984, MED SCI SPORT EXER, V16, P64	32	17	18	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	MAR	2007	17	2					109	115		10.1097/JSM.0b013e31803bf647			7	Orthopedics; Physiology; Sport Sciences	Orthopedics; Physiology; Sport Sciences	147GU	WOS:000244992200004	17414478				2021-06-18	
J	Grosjean, MB; Lenzlinger, PM; Stahel, PF; Yatsiv, I; Shohami, E; Trentz, O; Kossmann, T; Morganti-Kossmann, MC				Grosjean, M. B.; Lenzlinger, P. M.; Stahel, P. F.; Yatsiv, I.; Shohami, E.; Trentz, O.; Kossmann, T.; Morganti-Kossmann, M. C.			Immunohistochemical characterization of Fas (CD95) and Fas Ligand (FasL/CD95L) expression in the injured brain: Relationship with neuronal cell death and inflammatory mediators	HISTOLOGY AND HISTOPATHOLOGY			English	Article						apoptosis; Fas; cytokines; closed head injury; TUNEL; neurodegeneration; traumatic brain injury	TUMOR-NECROSIS-FACTOR; CLOSED-HEAD-INJURY; CENTRAL-NERVOUS-SYSTEM; CORTICAL IMPACT INJURY; NF-KAPPA-B; RAT-BRAIN; MULTIPLE-SCLEROSIS; FACTOR-ALPHA; AUTOIMMUNE ENCEPHALOMYELITIS; CEREBROSPINAL-FLUID	Traumatic brain injury causes progressive tissue atrophy and consequent neurological dysfunction, resulting from neuronal cell death in both animal models and patients. Fas ( CD95) and Fas ligand ( FasL/ CD95L) are important mediators of apoptosis. However, little is known about the relationship between Fas and FasL and neuronal cell death in mice lacking the genes for inflammatory cytokines. In the present study, double tumor necrosis factor/ lymphotoxin-alpha knockout (-/-) and interleukin-6-/- mice were subjected to closed head injury ( CHI) and sacrificed at 24 hours or 7 days post-injury. Consecutive brain sections were evaluated for Fas and FasL expression, in situ DNA fragmentation ( terminal deoxynucleotidyl transferase- mediated dUTP-biotin nick end- labeling; TUNEL), morphologic characteristics of apoptotic cell death and leukocyte infiltration. A peak incidence of TUNEL positive cells was found in the injured cortex at 24 hours which remained slightly elevated at 7 days and coincided with maximum Fas expression. FasL was only moderately increased at 24 hours and showed maximum expression at 7 days. A few TUNEL positive cells were also found in the ipsilateral hippocampus at 24 hours. Apoptotic, TUNEL positive cells mostly co- localized with neurons and Fas and FasL immunoreactivity. The amount of accumulated polymorphonuclear leukocytes and CD11b positive cells was maximal in the injured hemispheres at 24 hours. We show strong evidence that Fas and FasL might be involved in neuronal apoptosis after CHI. Furthermore, Fas and FasL upregulation seems to be independent of neuroinflammation since no differences were found between cytokine(-/-) and wild- type mice.	Univ Zurich, Ctr Dent & Oral Med & Cranio Maxillofacial Surg, Zurich, Switzerland; Univ Hosp, Div Surg Res, Zurich, Switzerland; Univ Hosp, Div Trauma Surg, Zurich, Switzerland; Charite, Dept Trauma & Reconstruct Surg, Berlin, Germany; Hadassah Univ Hosp, Jerusalem, Israel; Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Pharmacol, IL-91010 Jerusalem, Israel; Monash Univ, Alfred Hosp, Natl Trauma Res Inst, Dept Trauma Surg, Melbourne, Vic 3181, Australia	Morganti-Kossmann, MC (corresponding author), Monash Univ, Alfred Hosp, Natl Trauma Res Inst, Dept Trauma Surg, Commercial Rd, Melbourne, Vic 3004, Australia.	cristina.morganti-kossmann@med.monash.edu.au	Lenzlinger, Philipp/A-3822-2008	Morganti-Kossmann, Cristina/0000-0002-0807-2063			ADERKA D, 1989, J IMMUNOL, V143, P3517; Baldwin SA, 1997, J NEUROTRAUM, V14, P385, DOI 10.1089/neu.1997.14.385; Becher B, 1998, TRENDS NEUROSCI, V21, P114, DOI 10.1016/S0166-2236(97)01180-6; Bechmann I, 1999, GLIA, V27, P62, DOI 10.1002/(SICI)1098-1136(199907)27:1<62::AID-GLIA7>3.0.CO;2-S; Beer R, 2001, J NEUROCHEM, V78, P862, DOI 10.1046/j.1471-4159.2001.00460.x; Beer R, 2000, J CEREBR BLOOD F MET, V20, P669, DOI 10.1097/00004647-200004000-00004; BIAGAS KV, 1992, J NEUROTRAUM, V9, P363, DOI 10.1089/neu.1992.9.363; Bonetti B, 1997, ANN NEUROL, V42, P74, DOI 10.1002/ana.410420113; CharriautMarlangue C, 1995, NEUROREPORT, V7, P61, DOI 10.1097/00001756-199512000-00014; Cheema ZF, 1999, J NEUROSCI, V19, P1754; Chen Y, 1996, J NEUROTRAUM, V13, P557, DOI 10.1089/neu.1996.13.557; CHENG JH, 1994, SCIENCE, V263, P1759, DOI 10.1126/science.7510905; Choi C, 1999, J IMMUNOL, V162, P1889; Clark RSB, 2000, J NEUROCHEM, V74, P740, DOI 10.1046/j.1471-4159.2000.740740.x; Clark RSB, 1997, J NEUROTRAUM, V14, P179, DOI 10.1089/neu.1997.14.179; CLARK RSB, 1994, J NEUROTRAUM, V11, P499, DOI 10.1089/neu.1994.11.499; Colicos MA, 1996, BRAIN RES, V739, P120, DOI 10.1016/S0006-8993(96)00824-4; Conti AC, 1998, J NEUROSCI, V18, P5663; Dowling P, 1996, J EXP MED, V184, P1513, DOI 10.1084/jem.184.4.1513; DSouza SD, 1996, J EXP MED, V184, P2361, DOI 10.1084/jem.184.6.2361; Ertel W, 1997, J NEUROIMMUNOL, V80, P93, DOI 10.1016/S0165-5728(97)00139-2; Eugster HP, 1996, INT IMMUNOL, V8, P23, DOI 10.1093/intimm/8.1.23; Fan L, 1996, MOL BRAIN RES, V36, P287, DOI 10.1016/0169-328X(95)00274-V; Felderhoff-Mueser U, 2000, BRAIN PATHOL, V10, P17; Feuerstein GZ, 1998, NEUROIMMUNOMODULAT, V5, P143, DOI 10.1159/000026331; Fox GB, 1998, J NEUROTRAUM, V15, P599, DOI 10.1089/neu.1998.15.599; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; Ghirnikar RS, 1998, NEUROCHEM RES, V23, P329, DOI 10.1023/A:1022453332560; GRASLKRAUPP B, 1995, HEPATOLOGY, V21, P1465, DOI 10.1016/0270-9139(95)90071-3; GROSJEAN MB, 2001, J NEUROTRAUM, V18, P1161; HAMA T, 1991, NEUROSCIENCE, V40, P445, DOI 10.1016/0306-4522(91)90132-8; HAMA T, 1989, NEUROSCI LETT, V104, P340, DOI 10.1016/0304-3940(89)90600-9; Holmin S, 1997, J NEUROSURG, V86, P493, DOI 10.3171/jns.1997.86.3.0493; Kato H, 1997, EXP NEUROL, V148, P464, DOI 10.1006/exnr.1997.6707; Kaya SS, 1999, BRAIN RES, V818, P23, DOI 10.1016/S0006-8993(98)01204-9; Keane RW, 2001, J CEREBR BLOOD F MET, V21, P1189, DOI 10.1097/00004647-200110000-00007; Kiener PA, 1997, J IMMUNOL, V159, P1594; Knoblach SM, 1999, J NEUROIMMUNOL, V95, P115, DOI 10.1016/S0165-5728(98)00273-2; Kohji T, 2000, J NEUROIMMUNOL, V106, P165, DOI 10.1016/S0165-5728(00)00238-1; KOPF M, 1994, NATURE, V368, P339, DOI 10.1038/368339a0; Kossmann T, 1996, BRAIN RES, V713, P143, DOI 10.1016/0006-8993(95)01501-9; LaPlaca MC, 1999, J NEUROCHEM, V73, P205, DOI 10.1046/j.1471-4159.1999.0730205.x; Lassmann H, 1997, J NEURAL TRANSM-SUPP, P183; Lenzlinger PM, 2002, J NEUROIMMUNOL, V122, P167, DOI 10.1016/S0165-5728(01)00466-0; Lenzlinger PM, 2001, J NEUROTRAUM, V18, P479, DOI 10.1089/089771501300227288; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Martin-Villalba A, 1999, J NEUROSCI, V19, P3809; MartinezLorenzo MJ, 1996, IMMUNOLOGY, V89, P511, DOI 10.1046/j.1365-2567.1996.d01-782.x; Morganti-Kossmann MC, 2001, SHOCK, V16, P165, DOI 10.1097/00024382-200116030-00001; MorgantiKossman MC, 1997, MOL PSYCHIATR, V2, P133, DOI 10.1038/sj.mp.4000227; MROGANTIKOSSMAN.MC, 2000, RECENT RES DEVEL NEU, V3, P257; MROGANTIKOSSMAN.MC, 2002, IMMUNE INFLAMMATORY, P106; NAGATA S, 1995, SCIENCE, V267, P1449, DOI 10.1126/science.7533326; Nagata S, 1999, ANNU REV GENET, V33, P29, DOI 10.1146/annurev.genet.33.1.29; NAGATA S, 2001, SHOCK, V16, P165; NISHIMURA T, 1995, BRAIN RES, V695, P137, DOI 10.1016/0006-8993(95)00699-Q; Ottonello L, 1999, J IMMUNOL, V162, P3601; Padosch SA, 2003, NEUROSCI LETT, V338, P247, DOI 10.1016/S0304-3940(02)01408-8; Park CH, 1998, BIOCHEM BIOPH RES CO, V252, P623, DOI 10.1006/bbrc.1998.9572; Pender MP, 2001, GLIA, V36, P137, DOI 10.1002/glia.1103; Penkowa M, 1999, GLIA, V25, P343; Phanithi PB, 2000, NEUROPATHOLOGY, V20, P273, DOI 10.1046/j.1440-1789.2000.00346.x; Pollack A, 1990, Methods Cell Biol, V33, P19; Pravdenkova SV, 1996, BRAIN RES, V729, P151, DOI 10.1016/0006-8993(96)00222-3; Qiu JH, 2002, J NEUROSCI, V22, P3504; Raghupathi R, 2002, NEUROSCIENCE, V110, P605, DOI 10.1016/S0306-4522(01)00461-4; Raghupathi R, 2000, J NEUROTRAUM, V17, P927, DOI 10.1089/neu.2000.17.927; RINK A, 1995, AM J PATHOL, V147, P1575; Rose S, 2000, AM J GASTROENTEROL, V95, P1; ROTHWELL NJ, 1995, TRENDS NEUROSCI, V18, P130, DOI 10.1016/0166-2236(95)93890-A; Saas P, 1997, J CLIN INVEST, V99, P1173, DOI 10.1172/JCI119273; Sabelko KA, 1997, J IMMUNOL, V159, P3096; Scherbel U, 1999, P NATL ACAD SCI USA, V96, P8721, DOI 10.1073/pnas.96.15.8721; Schoettle R J, 1990, J Neurotrauma, V7, P207, DOI 10.1089/neu.1990.7.207; SEI Y, 1995, NEUROIMMUNOMODULAT, V2, P121, DOI 10.1159/000096881; SHAPIRA Y, 1993, ANESTH ANALG, V77, P141; SHAPIRA Y, 1988, CRIT CARE MED, V16, P258, DOI 10.1097/00003246-198803000-00010; Sherwood ER, 2000, CRIT CARE MED, V28, P1221, DOI 10.1097/00003246-200004000-00054; Shohami E, 1999, CYTOKINE GROWTH F R, V10, P119, DOI 10.1016/S1359-6101(99)00008-8; Shohami E, 1996, J CEREBR BLOOD F MET, V16, P378, DOI 10.1097/00004647-199605000-00004; Smith DH, 1997, J NEUROTRAUM, V14, P715, DOI 10.1089/neu.1997.14.715; Stahel PF, 2000, J CEREBR BLOOD F MET, V20, P369, DOI 10.1097/00004647-200002000-00019; Stahel PF, 1998, BRAIN RES REV, V27, P243, DOI 10.1016/S0165-0173(98)00015-0; SUDA T, 1994, J EXP MED, V179, P873, DOI 10.1084/jem.179.3.873; Sullivan PG, 1999, J NEUROSCI, V19, P6248; Tang YP, 1997, J NEUROTRAUM, V14, P863, DOI 10.1089/neu.1997.14.863; TAUPIN V, 1993, MOL PHARMACOL, V43, P64; TAUPIN V, 1993, J NEUROIMMUNOL, V42, P177, DOI 10.1016/0165-5728(93)90008-M; TOMINAGA T, 1992, NEUROSCI LETT, V139, P265, DOI 10.1016/0304-3940(92)90568-R; Venters HD, 2000, TRENDS NEUROSCI, V23, P175, DOI 10.1016/S0166-2236(99)01533-7; Waldner H, 1997, J IMMUNOL, V159, P3100; White CA, 1998, INT IMMUNOL, V10, P935, DOI 10.1093/intimm/10.7.935; WOODROOFE MN, 1991, J NEUROIMMUNOL, V33, P227, DOI 10.1016/0165-5728(91)90110-S; Yakovlev AG, 1997, J NEUROSCI, V17, P7415; Zipp F, 1997, NERVENARZT, V68, P94, DOI 10.1007/s001150050103	95	17	19	0	1	F HERNANDEZ	MURCIA	PLAZA FUENSANTA 2-7 C, 30008 MURCIA, SPAIN	0213-3911	1699-5848		HISTOL HISTOPATHOL	Histol. Histopath.	MAR	2007	22	3					235	250					16	Cell Biology; Pathology	Cell Biology; Pathology	134NZ	WOS:000244091400002	17163398				2021-06-18	
J	Niemeier, J; Arango-Lasprilla, JC				Niemeier, Janet; Arango-Lasprilla, Juan Carlos			Toward improved rehabilitation services for ethnically diverse survivors of traumatic brain injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						disparities; minorities; rehabilitation; TBI	NEUROPSYCHOLOGICAL TEST-PERFORMANCE; MENTAL-HEALTH-SERVICES; AFRICAN-AMERICAN WOMEN; PRIMARY-CARE PATIENTS; MINORITY STATUS; RACE; DISPARITIES; DEPRESSION; ACCULTURATION; OUTCOMES	Traumatic brain injury is an important public health problem in the United States, especially for individuals from racial and ethnic minorities. The first part of this article provides a synthesis of findings and discussions of cultural issues in the rehabilitation, medical, and psychological scientific literature highlighting the needs and challenges of our diverse population of minority traumatic brain injury survivors in the United States. The second part offers practical recommendations for rehabilitation professionals who desire to improve the healthcare and health outcomes of these individuals. Through an examination of research, guidelines, and resources, we justify the importance of cultural sensitivity in everyday provider interactions with minority clients and their families.	Virginia Commonwealth Univ, Sch Med, Dept Phys Med & Rehabil & Psychiat, Richmond, VA 23298 USA; Univ Med & Dent New Jersey, Dept Phys Med & Rehabil, Newark, NJ 07103 USA; Kessler Med Rehabil Res & Educ Corp, W Orange, NJ USA	Niemeier, J (corresponding author), Virginia Commonwealth Univ, Sch Med, Dept Phys Med & Rehabil & Psychiat, POB 980661, Richmond, VA 23298 USA.	jniemeier@mcvh-vcu.edu					Alegria M, 2004, INT J METH PSYCH RES, V13, P208, DOI 10.1002/mpr.178; Alston RJ, 2003, INT J REHABIL RES, V26, P289, DOI 10.1097/00004356-200312000-00006; *AM MED ASS, 2004, RES CULT GEND AW INT, P77; American Psychological Association, 2002, ETHICAL PRINCIPLES P; Anderson JTL, 2000, J OCCUP ENVIRON MED, V42, P176, DOI 10.1097/00043764-200002000-00016; Arango JC, 2006, J HEAD TRAUMA REHAB, V21, P422; ARANGOLASPRILLA JC, 2005, ARCH PHYS MED REHAB, V86, P17; Baker DW, 1998, MED CARE, V36, P1461, DOI 10.1097/00005650-199810000-00004; Bazarian JJ, 2003, ACAD EMERG MED, V10, P1209, DOI 10.1197/S1069-6563(03)00491-3; Beckfield J, 2004, J HEALTH SOC BEHAV, V45, P231, DOI 10.1177/002214650404500301; Betancourt JR, 2006, ACAD MED, V81, P788, DOI 10.1097/00001888-200609000-00004; Bostick N, 2006, J NATL MED ASSOC, V98, P1329; Boulware LE, 2003, PUBLIC HEALTH REP, V118, P358, DOI 10.1016/S0033-3549(04)50262-5; Brown SA, 2004, APPL NEUROPSYCHOL, V11, P54, DOI 10.1207/s15324826an1101_7; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Burnett DM, 2003, ARCH PHYS MED REHAB, V84, P263, DOI 10.1053/apmr.2003.50091; BURNNET M, 2005, ETHN DIS S3, V15; Cardemil EV, 2003, PROF PSYCHOL-RES PR, V34, P278, DOI 10.1037/0735-7028.34.3.278; CARTER RT, 1999, INFLUENCE RACE RACIA; Centers for Disease Control and Prevention, 1999, TRAUM BRAIN INJ US R; Centers for Disease Control and Prevention, 2003, REP C MILD TRAUM BRA; COOPER KD, 1983, NEUROEPIDEMIOLOGY, V2, P70; Cooper-Patrick L, 1999, JAMA-J AM MED ASSOC, V282, P583, DOI 10.1001/jama.282.6.583; Cutrona CE, 2005, J ABNORM PSYCHOL, V114, P3, DOI 10.1037/0021-843X.114.1.3; DANA RH, 2000, HISP J BEHAV SCI, V18, P317; DANA RH, 2000, HDB CROSS CULTURAL M; DANA RH, 1998, MULTICULTURAL ASSESS; Evans GW, 2002, ANNU REV PUBL HEALTH, V23, P303, DOI 10.1146/annurev.publhealth.23.112001.112349; Flores G, 2006, NEW ENGL J MED, V355, P229, DOI 10.1056/NEJMp058316; Gasquoine PG, 2001, CLIN NEUROPSYCHOL, V15, P2, DOI 10.1076/clin.15.1.2.1915; Gerhart KA, 2003, J TRAUMA, V55, P1045, DOI 10.1097/01.TA.0000044353.69681.96; Gordon WA, 2006, AM J PHYS MED REHAB, V85, P343, DOI 10.1097/01.phm.0000202106.01654.61; Hart T, 2005, J HEAD TRAUMA REHAB, V20, P158, DOI 10.1097/00001199-200503000-00004; Jacobs EA, 2001, J GEN INTERN MED, V16, P468, DOI 10.1046/j.1525-1497.2001.016007468.x; JARGER TE, 2000, ACAD EMERG MED, P134; Johnson B L, 1993, Ann Epidemiol, V3, P175; Johnson RL, 2004, AM J PUBLIC HEALTH, V94, P2084, DOI 10.2105/AJPH.94.12.2084; JORGE RE, 1994, J NEUROSURG, V81, P726, DOI 10.3171/jns.1994.81.5.0726; Kaplan SA, 2006, J HEALTH CARE POOR U, V17, P116, DOI 10.1353/hpu.2006.0026; KATZ JH, 1985, COUNS PSYCHOL, V13, P615, DOI 10.1177/0011000085134005; Kennepohl S, 2004, J INT NEUROPSYCH SOC, V10, P566, DOI 10.1017/S1355617704104128; Kreutzer JS, 2003, J HEAD TRAUMA REHAB, V18, P128, DOI 10.1097/00001199-200303000-00004; Lee LJ, 2002, J GEN INTERN MED, V17, P640, DOI 10.1046/j.1525-1497.2002.10742.x; Lomay VT, 2006, REHABIL PSYCHOL, V51, P36, DOI 10.1037/0090-5550.51.1.36; Lopez Rebecca A, 2005, J Immigr Health, V7, P23, DOI 10.1007/s10903-005-1387-8; Manly JJ, 2004, APPL NEUROPSYCHOL, V11, P37, DOI 10.1207/s15324826an1101_5; MAX W, J HEAD TRAUMA REHABI, V6, P219; Miranda J, 2003, HEALTH SERV RES, V38, P613, DOI 10.1111/1475-6773.00136; Miranda J, 2004, J GEN INTERN MED, V19, P120, DOI 10.1111/j.1525-1497.2004.30272.x; Niemeier JP, 2003, ARCH PHYS MED REHAB, V84, P1240, DOI 10.1016/S0003-9993(03)00295-8; NIEMEIER JP, 2006, AM PSYCH ASS NAT CON; *NIH CONS DEV PAN, 1999, JAMA-J AM MED ASSOC, V282, P219; OKAZAKI S, 1998, METHODOLOGICAL ISSUE, P265; PONTEROTTO JG, 2001, HDB MULTICULTURAL CO; PONTEROTTO JG, 2006, PREVENTING PREJUDICE; Primm AB, 2005, COMMUNITY MENT HLT J, V41, P557, DOI 10.1007/s10597-005-6361-3; Primm AB, 2002, J NATL MED ASSOC, V94, P1007; RAMIREZ RR, 2002, CURRENT POPULATION R, P520; ROGLER LH, 1987, AM PSYCHOL, V42, P565, DOI 10.1037/0003-066X.42.6.565; Rosenthal M, 1996, J HEAD TRAUMA REHAB, V11, P40, DOI 10.1097/00001199-199610000-00005; Rosselli N, 2003, BRAIN COGNITION, V52, P326, DOI 10.1016/S0278-2626(03)00170-2; ROTH C, 1999, MONITORING ADHERENCE; *RW JOHNSON FDN, IMPR HLTH HEALTHC AL; SANDOVAL J, 1999, TEST INTERPRETATION, P31; Satcher D, 2001, MENTAL HLTH CULTURE; Scarinci IC, 2004, ETHNIC DIS, V14, P567; Selassie AW, 2004, AM J EMERG MED, V22, P465, DOI 10.1016/j.ajem.2004.07.024; Sherer M, 2003, J HEAD TRAUMA REHAB, V18, P408, DOI 10.1097/00001199-200309000-00003; Sleath B, 2005, J AM GERIATR SOC, V53, P397, DOI 10.1111/j.1532-5415.2005.53155.x; SMEDLEY BD, 2003, UNEQUAL TREATMENT CO; Strothers HS, 2005, J AM GERIATR SOC, V53, P456, DOI 10.1111/j.1532-5415.2005.53164.x; THOMPSON RH, 1996, ENCY SOCIAL CULTURAL, V1, P112; THURMAN DJ, 2001, HEAD TRAUMA BASIC PR; Tucker CM, 2003, MED CARE, V41, P859, DOI 10.1097/00005650-200307000-00010; Wagner AK, 2000, J TRAUMA, V49, P404, DOI 10.1097/00005373-200009000-00004; Wang M., 2003, HLTH INSURANCE COVER; Wang VO, 2005, AM PSYCHOL, V60, P37, DOI 10.1037/0003-066X.60.1.37; WELLS KB, 1989, HEALTH SERV RES, V24, P237; Winthrop RH., 1991, DICT CONCEPTS CULTUR; XY JT, 2006, SOC SCI MED, V63, P457; Zane N., 2003, ACCULTURATION ADV TH, P39, DOI DOI 10.1037/10472-005; ZEMBECK BS, 2000, J AGING HEALTH, V12, P229	82	17	17	0	10	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAR-APR	2007	22	2					75	84		10.1097/01.HTR.0000265095.06565.7b			10	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	152NU	WOS:000245369500002	17414309				2021-06-18	
J	Sifringer, M; Stefovska, V; Endesfelder, S; Stahel, PF; Genz, K; Dzietko, M; Ikonomidou, C; Felderhoff-Mueser, U				Sifringer, Marco; Stefovska, Vanya; Endesfelder, Stefanie; Stahel, Philip F.; Genz, Kerstin; Dzietko, Mark; Ikonomidou, Chrysanthy; Felderhoff-Mueser, Ursula			Activation of caspase-1 dependent interleukins in developmental brain trauma	NEUROBIOLOGY OF DISEASE			English	Article						apoptosis; infant brain trauma; interleukin-1 beta; interleukin-18; caspase-1	DEVELOPING RAT-BRAIN; CLOSED-HEAD INJURY; CONVERTING-ENZYME; RECEPTOR ANTAGONIST; CYTOKINE INDUCTION; HYPOXIA-ISCHEMIA; MICE DEFICIENT; NEONATAL-RATS; CELL-DEATH; DAMAGE	Focal mechanical cortical trauma triggers diffuse apoptotic neurodegeneration in the developing rat brain which is associated with invasion of brain tissue with inflammatory mediators. We hypothesized that caspase-1 and the two caspase-l-processed cytokines, interleukin (IL)-1 beta and IL-18, are involved in trauma-induced neuronal cell death in the developing brain. 7-day-old Wistar rats or C57/BL6 mice were subjected to head trauma using a weight drop device. Animals were sacrificed at defined time points following trauma and brains were processed for histology and molecular analyses. Neuronal cell death in the immature brain peaked at 12-24 h and was accompanied by a marked increase of mRNA and protein levels for caspase-1, IL-1 beta and IL-18 within 2 to 12 h following the injury. Caspase-1 levels were elevated for 72 h, whereas IL-1 beta decreased earlier at 48 h. IL-18 remained high over a period of 3 days and decreased to normal levels by day 7 after the injury. Intraperitoneal injection of recombinant human IL-18-binding protein (IL-18BP), a specific inhibitor of IL-18, attenuated traumatic brain injury. Mice deficient in IL-18 (IL-18-/-) were protected against trauma-induced brain damage. These findings indicate that IL-18 is involved in trauma-induced neuronal cell death in the immature rodent brain and might serve as a potential therapeutic target. (c) 2006 Elsevier Inc. All rights reserved.	Univ Med Berlin, Dept Neonatol, Charite, D-13353 Berlin, Germany; Univ Colorado, Sch Med, Dept Orthopaed Surg, Denver Hlth Med Ctr, Denver, CO 80204 USA; Tech Univ Dresden, Med Fac Carl Gustav Carus, Dept Pediat Neurol, Childrens Hosp, D-01307 Dresden, Germany	Felderhoff-Mueser, U (corresponding author), Univ Med Berlin, Dept Neonatol, Charite, Campus Virchow Klinikum,Augustenburger Pl 1, D-13353 Berlin, Germany.	ursula.felderhoff@charite.de	Dzietko, Mark/AAH-5996-2019; Felderhoff-Muser, Ursula/AAU-9682-2020	Dzietko, Mark/0000-0002-3035-4841; Endesfelder, Stefanie/0000-0002-4030-7969			Adelson PD, 1998, J CHILD NEUROL, V13, P2, DOI 10.1177/088307389801300102; Bittigau D, 1999, ANN NEUROL, V45, P724, DOI 10.1002/1531-8249(199906)45:6<724::AID-ANA6>3.0.CO;2-P; Cai ZW, 2000, PEDIATR RES, V47, P64, DOI 10.1203/00006450-200001000-00013; DEOLMOS JS, 1971, BRAIN RES, V33, P523, DOI 10.1016/0006-8993(71)90130-2; Dinarello CA, 2006, AM J CLIN NUTR, V83, p447S; DOBBING J, 1979, EARLY HUM DEV, V3, P79, DOI 10.1016/0378-3782(79)90022-7; Fantuzzi G, 1999, J CLIN IMMUNOL, V19, P1, DOI 10.1023/A:1020506300324; Felderhoff-Mueser U, 2005, TRENDS NEUROSCI, V28, P487, DOI 10.1016/j.tins.2005.06.008; Felderhoff-Mueser U, 2005, ANN NEUROL, V57, P50, DOI 10.1002/ana.20322; Felderhoff-Mueser U, 2002, NEUROBIOL DIS, V11, P231, DOI 10.1006/nbdi.2002.0521; Firsching R, 2001, WORLD J SURG, V25, P1221; GOLDSTEIN M, 1990, ANN NEUROL, V27, P327, DOI 10.1002/ana.410270315; Hagberg H, 1996, PEDIATR RES, V40, P603, DOI 10.1203/00006450-199610000-00015; Hara H, 1997, P NATL ACAD SCI USA, V94, P2007, DOI 10.1073/pnas.94.5.2007; Hedtjarn M, 2002, J NEUROSCI, V22, P5910; Holmin S, 1997, J NEUROSURG, V86, P493, DOI 10.3171/jns.1997.86.3.0493; Jander S, 2002, J CEREBR BLOOD F MET, V22, P62, DOI 10.1097/00004647-200201000-00008; KOSKINIEMI M, 1995, ARCH PEDIAT ADOL MED, V149, P249, DOI 10.1001/archpedi.1995.02170150029004; KUIDA K, 1995, SCIENCE, V267, P2000, DOI 10.1126/science.7535475; Lebel-Binay S, 2000, EUR CYTOKINE NETW, V11, P15; Liu XH, 1999, J CEREBR BLOOD F MET, V19, P1099, DOI 10.1097/00004647-199910000-00006; MAHLY WJ, 1983, PEDIATRICS, V71, P756; MARTIN D, 1994, EXP NEUROL, V130, P362, DOI 10.1006/exnr.1994.1215; Masson F, 2001, J TRAUMA, V51, P481, DOI 10.1097/00005373-200109000-00010; Menge T, 2001, J NEUROSCI RES, V65, P332, DOI 10.1002/jnr.1158; Mori T, 2001, NEUROREPORT, V12, P4117, DOI 10.1097/00001756-200112210-00051; OKAMURA H, 1995, NATURE, V378, P88, DOI 10.1038/378088a0; Pohl D, 1999, P NATL ACAD SCI USA, V96, P2508, DOI 10.1073/pnas.96.5.2508; Rabuffetti M, 2000, J NEUROSCI, V20, P4398, DOI 10.1523/JNEUROSCI.20-12-04398.2000; Schmidt OI, 2004, J NEUROINFLAMM, V1, DOI 10.1186/1742-2094-1-13; Schmued LC, 1997, BRAIN RES, V751, P37, DOI 10.1016/S0006-8993(96)01387-X; Silverstein FS, 1997, NEUROCHEM INT, V30, P375, DOI 10.1016/S0197-0186(96)00072-1; SOSIN DM, 1995, JAMA-J AM MED ASSOC, V273, P1778, DOI 10.1001/jama.273.22.1778; Stahel Philip F, 2006, Expert Rev Clin Immunol, V2, P445, DOI 10.1586/1744666X.2.3.445; Stroemer RP, 1998, J CEREBR BLOOD F MET, V18, P833, DOI 10.1097/00004647-199808000-00003; STROOCK D, 1997, ASIAN J MATH, V1, P17; Tehranian R, 2002, J NEUROTRAUM, V19, P939, DOI 10.1089/089771502320317096; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; WEST MJ, 1990, J COMP NEUROL, V296, P1, DOI 10.1002/cne.902960102; Wheeler RD, 2003, J CEREBR BLOOD F MET, V23, P531, DOI 10.1097/01.WCB.0000059587.71206.BA; Xu RY, 2001, MOL BRAIN RES, V90, P57; YAMASAKI Y, 1995, STROKE, V26, P676, DOI 10.1161/01.STR.26.4.676; Yatsiv I, 2002, J CEREBR BLOOD F MET, V22, P971, DOI 10.1097/00004647-200208000-00008	43	17	19	0	3	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0969-9961	1095-953X		NEUROBIOL DIS	Neurobiol. Dis.	MAR	2007	25	3					614	622		10.1016/j.nbd.2006.11.003			9	Neurosciences	Neurosciences & Neurology	145NQ	WOS:000244872200017	17188500				2021-06-18	
J	Earle, SA; de Moya, MA; Zuccarelli, JE; Norenberg, MD; Proctor, KG				Earle, Steven A.; de Moya, Marc A.; Zuccarelli, Jennifer E.; Norenberg, Michael D.; Proctor, Kenneth G.			Cerebrovascular resuscitation after polytrauma and fluid restriction	JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS			English	Article; Proceedings Paper	92nd Annual Clinical Congress of the American-College-of-Surgeons	OCT 08-12, 2006	Chicago, IL	Amer Coll Surg			TRAUMATIC BRAIN-INJURY; OPERATION-IRAQI-FREEDOM; CEREBRAL PERFUSION-PRESSURE; HYDROXYETHYL STARCH; PULMONARY CONTUSION; BISPECTRAL INDEX; BLAST INJURIES; CHEST TRAUMA; CASUALTIES; EXPERIENCE	BACKGROUND: There are few reproducible models of blast injury, so it is difficult to evaluate new or existing therapies. We developed a clinically relevant polytrauma model to test the hypothesis that cerebrovascular resuscitation is optimized when intravenous fluid is restricted. STUDY DESIGN: Anesthetized swine (42 +/- 5 kg, n = 35) received blasts to the head and bilateral chests with captive bolt guns, followed by hypoventilation (4 breaths/min; FiO(2) = 0.21). After 30 minutes, resuscitation was divided into phases to simulate typical prehospital, emergency room, and ICU care. For 30 to 45 minutes, group 1, the control group (n = 5), received 1 L of normal saline (NS). For 45 to 120 minutes additional NS was titrated to mean arterial pressure (MAP) > 60 mmHg. After 120 minutes, mannitol (1g/kg) and phenylephrine were administered to manage cerebral perfusion pressure (CPP) > 70 mmHg, plus additional NS was given to maintain central venous pressure (CVP) > 12 mmHg. In group 2 (n = 5), MAP and CPP targets were the same, but the CVP target was > 8 mmHg. Group 3 (n = 5) received 1 L of NS followed only by CPP management. Group 4 (n = 5) received Hextend (Abbott Laboratories), instead of NS, to the same MAP and CPP targets as group 2. RESULTS: Polytrauma caused 13 deaths in the 35 animals. In survivors, at 30 minutes, MAP was 60 to 65 mmHg, heart rate was > 100 beats/min, PaO2 was < 50 mmHg, and lactate was > 5 mmol/L. In two experiments, no fluid or pressor was administered; the tachycardia and hypotension persisted. The first liter of intravenous fluid partially corrected these variables, and also partially corrected mixed venous O-2, gastric and portal venous O-2, cardiac output, renal blood flow, and urine output. Additional NS (total of 36 +/- 1 mL/kg/h and 17 6 mL/kg/h, in groups 1 and 2, respectively) correlated with increased intracranial pressure to 38 4 mmHg (group 1) and 26 +/- 4 mmHg (group 2) versus 22 +/- 4 mmHg in group 3 (who received 5 +/- 1 mL/kg/h). CPP was maintained only after mannitol and phenylephrine. By 5 hours, brain tissue PO2 was > 20 mmHg in groups 1 and 2, but only 6 +/- 1 mmHg in group 3. In contrast, minimal Hextend (6 3 mL/kg/h) was needed; the corrections in MAP and CPP were immediate and sustained, intracranial pressure was lower (14 +/- 2 mmHg), and brain tissue PO2 was > 20 mmHg. Neuropathologic changes were consistent with traumatic brain injury, but there were no statistically significant differences between groups. CONCLUSIONS: After polytrauma and resuscitation to standard MAP and CPP targets with mannitol and pressor therapy, we concluded that intracranial hypertension was attenuated and brain oxygenation was maintained with intravenous fluid restriction; cerebrovascular resuscitation was optimized with Hextend versus NS; and longer term studies are needed to determine neuropathologic consequences.	Univ Miami, Miller Sch Med, Dewitt Daughtry Family Dept Surg, Div Trauma & Surg Crit Care,Ryder Trauma Ctr, Miami, FL 33136 USA; Univ Miami, Miller Sch Med, Dept Pathol, Miami, FL USA	Proctor, KG (corresponding author), Univ Miami, Miller Sch Med, Dewitt Daughtry Family Dept Surg, Div Trauma & Surg Crit Care,Ryder Trauma Ctr, 1800 NW 10th Ave, Miami, FL 33136 USA.						BICKELL WH, 1994, NEW ENGL J MED, V331, P1105, DOI 10.1056/NEJM199410273311701; Bilski TR, 2003, J TRAUMA, V54, P814, DOI 10.1097/01.TA.0000046627.87250.1D; BOWEN TE, 1988, NATO HDB, pCH5; *BRAIN TRAUM FDN A, MAN PROGN SEV TRAUM; Butler FK, 2000, MIL MED, V165, P1; Chambers LW, 2005, ARCH SURG-CHICAGO, V140, P26, DOI 10.1001/archsurg.140.1.26; Champion HR, 2003, J TRAUMA, V54, pS13, DOI 10.1097/01.TA.0000057151.02906.27; Crookes BA, 2004, J TRAUMA, V57, P547, DOI 10.1097/01.TA.0000135162.85859.4C; DePalma RG, 2005, NEW ENGL J MED, V352, P1335, DOI 10.1056/NEJMra042083; Desselle WJ, 2001, J TRAUMA, V51, P239, DOI 10.1097/00005373-200108000-00005; Dubick MA, 2003, J TRAUMA, V54, pS43, DOI 10.1097/01.TA.0000064514.42470.3B; Feinstein AJ, 2005, J TRAUMA, V59, P876, DOI 10.1097/01.ta.0000187654.24146.22; Feinstein AJ, 2005, J AM COLL SURGEONS, V201, P536, DOI 10.1016/j.jamcollsurg.2005.05.031; Gan TJ, 1999, ANESTH ANALG, V88, P992, DOI 10.1097/00000539-199905000-00005; Gawande A, 2004, NEW ENGL J MED, V351, P2471, DOI 10.1056/NEJMp048317; Gutierrez de Ceballos J Peral, 2005, Crit Care Med, V33, pS107; Hayashida M, 2003, BRIT J ANAESTH, V90, P694, DOI 10.1093/bja/aeg107; Holcomb JB, 2003, J TRAUMA, V54, pS46, DOI 10.1097/01.TA.0000051936.91915.A2; Kelly ME, 2003, J TRAUMA, V55, P94, DOI 10.1097/01.TA.0000029042.37577.A6; King DR, 2006, J TRAUMA, V61, P943, DOI 10.1097/01.ta.0000233670.97515.3a; King DR, 2004, SURGERY, V136, P355, DOI 10.1016/j.surg.2004.05.011; Klein Yoram, 2002, Curr Opin Anaesthesiol, V15, P65; Kluger Y, 2004, J AM COLL SURGEONS, V199, P875, DOI 10.1016/j.jamcollsurg.2004.09.003; Krausz MM, 2003, J TRAUMA, V54, pS39, DOI 10.1097/01.TA.0000064506.47688.51; Ling GSF, 2005, NEUROCRIT CARE, V2, P75, DOI 10.1385/NCC:2:1:075; Majde JA, 2003, J TRAUMA, V54, pS100, DOI 10.1097/01.TA.0000064503.24416.F4; Mallonee S, 1996, JAMA-J AM MED ASSOC, V276, P382, DOI 10.1001/jama.276.5.382; Montgomery SP, 2005, J AM COLL SURGEONS, V201, P7, DOI 10.1016/j.jamcollsurg.2005.03.038; Myles PS, 2004, ANESTH ANALG, V98, P706; Nelson TJ, 2006, J AM COLL SURGEONS, V202, P418, DOI 10.1016/j.jamcollsurg.2005.11.011; Nielsen VG, 1997, CRIT CARE MED, V25, P1565, DOI 10.1097/00003246-199709000-00026; NORENBERG MD, 1994, J NEUROPATH EXP NEUR, V53, P213, DOI 10.1097/00005072-199405000-00001; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Panickar KS, 2005, GLIA, V50, P287, DOI 10.1002/glia.20181; Patel TH, 2004, J TRAUMA, V57, P201, DOI 10.1097/01.TA.0000133638.30269.38; Rafie AD, 2004, SHOCK, V22, P262, DOI 10.1097/01.shk.0000135255.59817.8c; Robertson CS, 1999, CRIT CARE MED, V27, P2086, DOI 10.1097/00003246-199910000-00002; Roche AM, 2004, BRIT J ANAESTH, V92, pA154, DOI 10.1093/bja/aeh502; Rodoplu Ulkumen, 2004, Prehosp Disaster Med, V19, P133; ROSNER MJ, 1995, J NEUROSURG, V83, P949, DOI 10.3171/jns.1995.83.6.0949; Ryan J, 2005, NEW ENGL J MED, V353, P543, DOI 10.1056/NEJMp058177; Sanui M, 2006, CRIT CARE MED, V34, P433, DOI 10.1097/01.CCM.0000196206.83534.39; Sondeen JL, 2003, J TRAUMA, V54, pS110, DOI 10.1097/01.TA.0000047220.81795.3D; Wiedermann CJ, 2004, WIEN KLIN WOCHENSCHR, V116, P583, DOI 10.1007/s00508-004-0237-3; Wilkes NJ, 2002, ANESTH ANALG, V94, P538, DOI 10.1097/00000539-200203000-00011; COALITION CASULTIES	46	17	17	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1072-7515	1879-1190		J AM COLL SURGEONS	J. Am. Coll. Surg.	FEB	2007	204	2					261	275		10.1016/j.jamcollsurg.2006.11.014			15	Surgery	Surgery	135DF	WOS:000244133600009	17254930				2021-06-18	
J	Irdesel, J; Aydiner, SB; Akgoz, S				Irdesel, J.; Aydiner, S. B.; Akgoz, S.			Rehabilitation outcome after traumatic brain injury	NEUROCIRUGIA			English	Article						traumatic brain injury; rehabilitation; complication	INTENSIVE-CARE-UNIT; FUNCTIONAL INDEPENDENCE; HEAD-INJURY; HETEROTOPIC OSSIFICATION; COMA; COMPLICATIONS; SCALE; RECOVERY; LENGTH; STAY	Rehabilitation goals after traumatic brain injury are improving function, increasing the level of independence as high as possible, preventing complications and providing an acceptable environment to the patient. Several complications can be encountered during the rehabilitation period which lead to physical, cognitive and neurobehavioral impairments that cause major delay in functional improvement. This prospective study was designed in order to investigate the complications and their relations with functional recovery in patients that were included in the acute phase of a rehabilitation program. Thirty traumatic brain injured patients admitted to the Intensive Care Units of Uludag University School of Medicine were included in the study. Rehabilitation program consisted in appropriate positioning, range of motion exercises, postural drainage and respiratory exercises. Complications that were encountered during intensive care rehabilitation program were recorded. All patients were evaluated by Functional Independence Measure, Disability Rating Scale and Ranchos Los Amigos Levels of Cognitive Function Scale at admission and discharge. Improvement was observed in patients in terms of functional outcome and disability levels. Pneumonia, athelectasis, anemia and meningitis were the most frequent complications. Deterioration in functional outcome and disability levels was noted as the number of these complications increased. In conclusion, rehabilitation has an important role in the management of traumatic brain injured patients. Reduction of frequency of complications and improvement in functional outcome and disability levels can be achieved through rehabilitation programs. Long-term controlled studies with large number of patients are needed in order to obtain accurate data on factors associated with rehabilitation outcomes.	Uludag Univ, Sch Med, Dept Phys Med & Rehabil, TR-16059 Bursa, Turkey; Uludag Univ, Sch Med, Dept Biostat, TR-16059 Bursa, Turkey	Irdesel, J (corresponding author), Uludag Univ, Sch Med, Dept Phys Med & Rehabil, TR-16059 Bursa, Turkey.						ALDRICH EF, 1992, SURG NEUROL, V38, P418, DOI 10.1016/0090-3019(92)90109-Z; Aras MD, 2004, INT J REHABIL RES, V27, P257, DOI 10.1097/00004356-200412000-00001; Boake C, 2000, PHYS MED REHABILITAT, P1073; BOHANNON RW, 1987, PHYS THER, V67, P206, DOI 10.1093/ptj/67.2.206; Bush BA, 2003, ARCH PHYS MED REHAB, V84, P1803, DOI 10.1016/S0003-9993(03)00367-8; Bushnik T, 2003, ARCH PHYS MED REHAB, V84, P255, DOI 10.1053/apmr.2003.50092; Bushnik T, 2003, ARCH PHYS MED REHAB, V84, P151, DOI 10.1053/apmr.2003.50123; Chesnut RM, 1999, J HEAD TRAUMA REHAB, V14, P176, DOI 10.1097/00001199-199904000-00007; Ciesla ND, 1996, PHYS THER, V76, P609, DOI 10.1093/ptj/76.6.609; CITTAPIETROLUNGO TJ, 1992, ARCH PHYS MED REHAB, V73, P258; COWEN TD, 1995, ARCH PHYS MED REHAB, V76, P797, DOI 10.1016/S0003-9993(95)80542-7; Davis CH, 1997, AM J PHYS MED REHAB, V76, P213, DOI 10.1097/00002060-199705000-00011; DEMIR SO, 2001, TURK FIZ TIP REHAB D, V47, P15; Deshpande AA, 1997, ARCH PHYS MED REHAB, V78, P350, DOI 10.1016/S0003-9993(97)90224-0; Edlich Richard F, 2004, J Long Term Eff Med Implants, V14, P285, DOI 10.1615/JLongTermEffMedImplants.v14.i4.20; Fuhrer MJ, 1987, REHABILITATION OUTCO, P137; GARLAND DE, 1980, J BONE JOINT SURG AM, V62, P1143, DOI 10.2106/00004623-198062070-00012; Gray DS, 2000, ARCH PHYS MED REHAB, V81, P1447, DOI 10.1053/apmr.2000.16343; Hagen C., 1972, LEVELS COGNITIVE FUN; HARRISONFELIX C, 1996, J HEAD TRAUMA REHAB, V11, P11; Hoffmann B, 2002, ACTA NEUROCHIR SUPPL, V79, P25; JOHN R, 1999, ARCH PHYS MED REHAB, V80, P1133; KALISKY Z, 1985, ARCH PHYS MED REHAB, V66, P25; KAPLAN CP, 1994, ARCH PHYS MED REHAB, V75, P643, DOI 10.1016/0003-9993(94)90186-4; KATZ DI, 1994, ARCH NEUROL-CHICAGO, V51, P661, DOI 10.1001/archneur.1994.00540190041013; KAUFMAN HH, 1993, MED CLIN N AM, V77, P43, DOI 10.1016/S0025-7125(16)30271-1; Kaya A, 2001, TURK FIZ TIP REHAB D, V47, P7; Lau AFC, 2003, INT J REHABIL RES, V26, P251, DOI 10.1097/00004356-200312000-00001; Lew HL, 2002, AM J PHYS MED REHAB, V81, P830, DOI 10.1097/00002060-200211000-00005; Lippert-Gruner M, 2003, BRAIN INJURY, V17, P49, DOI 10.1080/0269905021000010230; Mayer NH, 2003, ARCH PHYS MED REHAB, V84, P242, DOI 10.1053/apmr.2003.50101; MERAY J, 2000, FIZIKSEL TIP REHABIL, P1951; Nava S, 1998, ARCH PHYS MED REHAB, V79, P849, DOI 10.1016/S0003-9993(98)90369-0; Novack TA, 2001, ARCH PHYS MED REHAB, V82, P300, DOI 10.1053/apmr.2001.18222; Prigatano GP, 1997, ARCH PHYS MED REHAB, V78, P621, DOI 10.1016/S0003-9993(97)90428-7; Ragnarsson KT, 1999, JAMA-J AM MED ASSOC, V282, P974; RANKA V, 1999, ARCH PHYS MED REHAB, V80, P1131; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Schatz P, 2002, J HEAD TRAUMA REHAB, V17, P510, DOI 10.1097/00001199-200212000-00003; Semlyen JK, 1998, ARCH PHYS MED REHAB, V79, P678, DOI 10.1016/S0003-9993(98)90044-2; SIEGLER EL, 1994, ARCH INTERN MED, V154, P2185, DOI 10.1001/archinte.154.19.2185; TAN J, 2000, NOROREHABILITASYON, P83; TEASDALE G, 1974, LANCET, V2, P81; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; WHYTE J, 1998, REHABILITATION MED P, P997; Zafonte RD, 1996, AM J PHYS MED REHAB, V75, P364, DOI 10.1097/00002060-199609000-00012; Zafonte RD, 2001, ARCH PHYS MED REHAB, V82, P306, DOI 10.1053/apmr.2001.18226	47	17	20	0	6	SOCIEDAD ESPANOLA NEUROCIRUGIA	MURCIA	C/O  DR POZA, GRAN VIA SALZILLO 42, 30005 MURCIA, SPAIN	1130-1473			NEUROCIRUGIA	Neurocirugia	FEB	2007	18	1					5	15					11	Neurosciences; Surgery	Neurosciences & Neurology; Surgery	170MG	WOS:000246666900001	17393041				2021-06-18	
J	Veronesi, MC; Yard, M; Jackson, J; Lahiri, DK; Kubek, MJ				Veronesi, Michael C.; Yard, Michael; Jackson, James; Lahiri, Debomoy K.; Kubek, Michael J.			An analog of thyrotropin-releasing hormone (TRH) is neuroprotective against glutamate-induced toxicity in fetal rat hippocampal neurons in vitro	BRAIN RESEARCH			English	Article						neuroprotection; thyrotropin-releasing hormone; TRH analog; glutamate; hippocampus	PROTEIN-KINASE-C; POTASSIUM-STIMULATED GLUTAMATE; KAINATE-INDUCED SEIZURES; TEMPORAL-LOBE EPILEPSY; SPINAL-CORD INJURY; BRAIN-INJURY; CELL-DEATH; RAPID DESENSITIZATION; RECEPTOR AGONIST; NERVOUS-SYSTEM	TRH has been found to be efficacious in treating certain neurodegenerative disorders such as epilepsy, Alzheimer's disease, neurotrauma and depression, however, its mechanism of action is poorly understood. Since glutamate (Glu) toxicity has been implicated in these disorders, we utilized primary enriched cultures of rat fetal (E 17) hippocampal neurons to test the hypothesis that an analog of TRH, 3-Methyl-Histidine TRH (3Me-H TRH), given concurrently with Glu would protect such neurons against cell damage and cell death. Cell viability was assessed via Trypan Blue exclusion cell counts, and neuronal damage was determined by assaying lactic acid dehydrogenase (LDH) released in the conditioned media. Fetal hippocampal neurons were cultured in neurobasal media for 7 days. On day 7, neurons (10(6)/well) were treated with: control media, 10 mu M 3Me-H TRH, 500 mu M Glu or 500 mu M Glu with either 10, 1, 0.1, 0.01 or 0.001 mu M 3Me-H TRH. Both media and neurons were harvested 16 h after treatment. Prolonged exposure to 10 mu M 3Me-H TRH was not toxic to the cells, whereas neurons exposed to 500 mu M Glu resulted in maximal cell death. Notably, 10, 1 and 0.1 mu M We-H TRH, when co-treated with 500 mu M Glu, protected fetal neurons against cell death in a concentration-dependent manner. These results provide support for an important neuroprotective effect of TRH/analogs against glutamate toxicity in primary hippocampal neuronal culture and implicate a potentially beneficial role of TRH/analogs in neurodegenerative diseases. (c) 2006 Elsevier B.V. All rights reserved.	Indiana Univ, Sch Med, Dept Anat & Cell Biol, Indianapolis, IN 46202 USA; Indiana Univ, Sch Med, Dept Psychiat, Indianapolis, IN 46202 USA; Indiana Univ, Sch Med, Dept Pharmacol & Toxicol, Indianapolis, IN 46202 USA; Indiana Univ, Sch Med, Program Med Neurobiol, Indianapolis, IN 46202 USA	Kubek, MJ (corresponding author), Indiana Univ, Sch Med, Dept Anat & Cell Biol, 635 Barnhill Dr,Room MSS035, Indianapolis, IN 46202 USA.	mjkubek@iupui.edu			NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG018379, R01AG018884] Funding Source: NIH RePORTER; NIA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01 AG018379, R01 AG018884, AG18379, AG18884] Funding Source: Medline		BLANCHARD L, 1986, DEV BRAIN RES, V24, P85, DOI 10.1016/0165-3806(86)90175-6; Brecht S, 2001, MOL BRAIN RES, V94, P25, DOI 10.1016/S0006-8993(01)02767-6; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; BRUNO V, 1995, NEUROPHARMACOLOGY, V34, P1089, DOI 10.1016/0028-3908(95)00077-J; Chen QX, 1997, J NEUROSCI, V17, P4032; Conn PJ, 1997, ANNU REV PHARMACOL, V37, P205, DOI 10.1146/annurev.pharmtox.37.1.205; Dale LB, 2000, J BIOL CHEM, V275, P38213, DOI 10.1074/jbc.M006075200; Faden AI, 1999, AM J PHYSIOL-REG I, V277, pR1196; Faden AI, 2005, NEUROPHARMACOLOGY, V49, P410, DOI 10.1016/j.neuropharm.2005.04.001; FADEN AI, 1981, NEW ENGL J MED, V305, P1063, DOI 10.1056/NEJM198110293051806; Faden AI, 2004, J ALZHEIMERS DIS, V6, pS93; FADEN AI, 1993, J NEUROTRAUM, V10, P91, DOI 10.1089/neu.1993.10.91; FADEN AI, 1988, BRAIN RES, V448, P287, DOI 10.1016/0006-8993(88)91265-6; FADEN AI, 1989, BRAIN RES, V486, P228, DOI 10.1016/0006-8993(89)90509-X; Francesconi A, 2000, P NATL ACAD SCI USA, V97, P6185, DOI 10.1073/pnas.97.11.6185; Gary KA, 2003, J PHARMACOL EXP THER, V305, P410, DOI 10.1124/jpet.102.044040; Gereau RW, 1998, NEURON, V20, P143, DOI 10.1016/S0896-6273(00)80442-0; Gershengorn MC, 1996, PHYSIOL REV, V76, P175; GREBER S, 1994, BRIT J PHARMACOL, V113, P737, DOI 10.1111/j.1476-5381.1994.tb17055.x; GRIFFITHS EC, 1989, ANN NY ACAD SCI, V553, P217; HERRERO I, 1994, EUR J NEUROSCI, V6, P115, DOI 10.1111/j.1460-9568.1994.tb00253.x; Heuer H, 2000, J COMP NEUROL, V428, P319; HINKLE PM, 1989, ANN NY ACAD SCI, V553, P176; Hrabovszky E, 2005, ENDOCRINOLOGY, V146, P341, DOI 10.1210/en.2004-0856; IWASAKI Y, 1989, NEUROSCI LETT, V101, P316, DOI 10.1016/0304-3940(89)90552-1; Jaworska-Feil L, 1999, J NEURAL TRANSM, V106, P395, DOI 10.1007/s007020050167; Jaworska-Feil L, 2001, EPILEPSY RES, V43, P67, DOI 10.1016/S0920-1211(00)00178-9; Johansen PW, 2001, CELL SIGNAL, V13, P251, DOI 10.1016/S0898-6568(01)00144-9; JOHNSON WA, 1989, ANN NY ACAD SCI, V553, P137; KIM GD, 1994, J BIOL CHEM, V269, P19933; Knoblach SM, 1999, J NEUROCHEM, V72, pS8; Knoblach SM, 1997, NEUROSCIENCE, V76, P97; Knoblach SM, 1997, NEUROSCIENCE, V76, P85; Koenig ML, 1996, BRAIN RES, V730, P143; KOH JY, 1987, J NEUROSCI METH, V20, P83, DOI 10.1016/0165-0270(87)90041-0; KUBEK MJ, 1989, ANN NY ACAD SCI, V553, P286; Kubek MJ, 2002, PEDIATR NEUROL, V26, P9, DOI 10.1016/S0887-8994(01)00321-6; KUBEK MJ, 1977, BRAIN RES, V126, P196, DOI 10.1016/0006-8993(77)90230-X; LUO G, 2006, ABSTR SOC NEUR; Luo LG, 2001, ENDOCRINE, V15, P79, DOI 10.1385/ENDO:15:1:079; Luo LG, 2002, J ALZHEIMERS DIS, V4, P97, DOI 10.3233/JAD-2002-4204; MCDONALD JW, 1992, EUR J PHARMACOL, V215, P353, DOI 10.1016/0014-2999(92)90058-C; MCDONALD JW, 1993, J NEUROSCI, V13, P4445; MILLIGAN G, 1994, REGULATION CELLULAR; Mundell SJ, 2004, BIOCHEMISTRY-US, V43, P7541, DOI 10.1021/bi0359022; NAKANISHI S, 1994, NEURON, V13, P1031, DOI 10.1016/0896-6273(94)90043-4; NELSON EJ, 1994, J BIOL CHEM, V269, P30854; Nicoletti F, 1999, NEUROPHARMACOLOGY, V38, P1477, DOI 10.1016/S0028-3908(99)00102-1; Nie Y, 2005, BRAIN RES, V1054, P45, DOI 10.1016/j.brainres.2005.06.077; Nillni EA, 1999, ENDOCR REV, V20, P599, DOI 10.1210/er.20.5.599; PIN JP, 1995, NEUROPHARMACOLOGY, V34, P1, DOI 10.1016/0028-3908(94)00129-G; PITTS LH, 1995, J NEUROTRAUM, V12, P235, DOI 10.1089/neu.1995.12.235; Pizzi M, 1999, EUR J PHARMACOL, V370, P133, DOI 10.1016/S0014-2999(99)00139-9; REGAN RF, 1994, BRAIN RES, V633, P236, DOI 10.1016/0006-8993(94)91544-X; Reisberg B, 2003, NEW ENGL J MED, V348, P1333, DOI 10.1056/NEJMoa013128; RENAUD LP, 1979, SCIENCE, V205, P1275, DOI 10.1126/science.224461; RIVIER J, 1972, J MED CHEM, V15, P479, DOI 10.1021/jm00275a010; Schoepp DD, 1999, NEUROPHARMACOLOGY, V38, P1431, DOI 10.1016/S0028-3908(99)00092-1; SHARIF NA, 1991, NEUROCHEM RES, V16, P95, DOI 10.1007/BF00965695; Skeberdis VA, 2001, NEUROPHARMACOLOGY, V40, P856, DOI 10.1016/S0028-3908(01)00005-3; Svoboda P, 1996, MOL PHARMACOL, V49, P646; Takeuchi Y, 2001, BRAIN DEV-JPN, V23, P662, DOI 10.1016/S0387-7604(01)00303-5; Urayama A, 2002, LIFE SCI, V72, P601, DOI 10.1016/S0024-3205(02)02268-3; Wan RQ, 1998, NEUROREPORT, V9, P677, DOI 10.1097/00001756-199803090-00021; YARD M, 2002, ABSTR SOC NEUR, V552; YARD M, 2002, ABSTR END SOC, V28	66	17	18	0	5	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	JAN 12	2007	1128	1					79	85		10.1016/j.brainres.2006.10.047			7	Neurosciences	Neurosciences & Neurology	135CC	WOS:000244130400009	17125753	Green Accepted			2021-06-18	
J	Acerini, CL; Tasker, RC				Acerini, Carlo L.; Tasker, Robert C.			Endocrine sequelae of traumatic brain injury in childhood	HORMONE RESEARCH			English	Article; Proceedings Paper	39th International Symposium on Growth Hormone and Growth Factors in Endocrinology and Metabolism	MAY 11-12, 2007	Berlin, GERMANY	Pfizer		traumatic brain injury; hypopituitarism; pituitary dysfunction; rehabilitation; endocrine assessment; children and adolescents	ANTERIOR-PITUITARY DYSFUNCTION; GROWTH-FACTOR-I; HEAD TRAUMA; POSTTRAUMATIC HYPOPITUITARISM; NEUROENDOCRINE DYSFUNCTION; CHILDREN; ABNORMALITIES	Background: Anterior pituitary hormone dysfunction may be an important feature of long-term morbidity in survivors of traumatic brain injury (TBI). The hypothalamic-pituitary structures are vulnerable to damage following head injury. Therefore, pituitary dysfunction, which may be detected months or years after injury, is now well recognised as a long-term consequence of TBI in adults. In contrast, little is known about this potential complication in children and adolescents. This article reviews the available paediatric data, which show that hypopituitarism may occur after both mild and severe TBI, although there is little published data on its incidence or prevalence within this age group. A recent analysis of the KIGS (Pfizer International Growth Study database) highlights very few registered cases of TBI-related growth hormone deficiency, suggesting that this may be either an uncommon or an overlooked phenomenon. Prospective studies will be needed to determine the incidence, natural history and response to hormone replacement of post-TBI-induced hypopituitarism in children. Conclusions: Given the critical role of anterior pituitary hormones in the regulation of growth and pubertal and neurocognitive development in childhood, early detection of hormone abnormalities is vital. A multidisciplinary approach to follow-up and endocrine assessment is required for the long-term management and rehabilitation of children and adolescents who survive moderate to severe head injury. Copyright (c) 2007 S. Karger AG, Basel.	[Acerini, Carlo L.; Tasker, Robert C.] Univ Cambridge, Dept Paediat, Cambridge, England	Acerini, CL (corresponding author), Univ Cambridge, Addenbrookes Hosp, Level 8,Box 116, Cambridge CB2 2QQ, England.	cla22@cam.ac.uk	Tasker, Robert C/R-5837-2019	Tasker, Robert/0000-0003-3647-8113; Acerini, Carlo/0000-0003-2121-5871			Acerini CL, 2006, EUR J ENDOCRINOL, V155, P663, DOI 10.1530/eje.1.02284; Agha A, 2006, CLIN ENDOCRINOL, V64, P481, DOI 10.1111/j.1365-2265.2006.02517.x; Agha A, 2005, EUR J ENDOCRINOL, V152, P371, DOI 10.1530/eje.1.01861; Agha A, 2004, J CLIN ENDOCR METAB, V89, P5987, DOI 10.1210/jc.2004-1058; Agha A, 2004, CLIN ENDOCRINOL, V60, P584, DOI 10.1111/j.1365-2265.2004.02023.x; Agha A, 2004, J CLIN ENDOCR METAB, V89, P4929, DOI 10.1210/jc.2004-0511; Aimaretti G, 2004, CLIN ENDOCRINOL, V61, P320, DOI 10.1111/j.1365-2265.2004.02094.x; BARZILAY Z, 1988, J MED, V19, P47; Benvenga S, 2004, AM J MED, V116, P767, DOI 10.1016/j.amjmed.2003.12.038; Benvenga S, 2000, J CLIN ENDOCR METAB, V85, P1353, DOI 10.1210/jc.85.4.1353; CROMPTON MR, 1971, BRAIN, V94, P165, DOI 10.1093/brain/94.1.165; Cyran E, 1918, DEUT MED WOCHENSCHR, V44, P1261; Della Corte F, 1998, CRIT CARE MED, V26, P1419; EDWARDS OM, 1986, MEDICINE, V65, P281; Einaudi S, 2006, J PEDIATR ENDOCR MET, V19, P691; Escamilla RF, 1942, J CLIN ENDOCRINOL, V2, P65, DOI 10.1210/jcem-2-2-65; GROSSMAN WF, 1994, J REPROD MED, V39, P738; HARPER CG, 1986, J CLIN PATHOL, V39, P769, DOI 10.1136/jcp.39.7.769; Lieberman SA, 2001, J CLIN ENDOCR METAB, V86, P2752, DOI 10.1210/jc.86.6.2752; Mariani R, 1996, ARCH PEDIATRIE, V3, P796, DOI 10.1016/0929-693X(96)82164-6; Niederland T, 2007, J NEUROTRAUM, V24, P119, DOI 10.1089/neu.2005.369ER; Parslow RC, 2005, ARCH DIS CHILD, V90, P1182, DOI 10.1136/adc.2005.072405; SHINAR Y, 1995, J NEUROSCI RES, V42, P516, DOI 10.1002/jnr.490420410; SOCKALOSKY JJ, 1987, J PEDIATR-US, V110, P373, DOI 10.1016/S0022-3476(87)80497-3; Van den Berghe G, 2000, EUR J ENDOCRINOL, V143, P1, DOI 10.1530/eje.0.1430001; WOOLF PD, 1992, CRIT CARE MED, V20, P216, DOI 10.1097/00003246-199202000-00011; YAMANAKA C, 1993, EUR J PEDIATR, V152, P99, DOI 10.1007/BF02072482; Ye P, 2004, J NEUROSCI RES, V78, P472, DOI 10.1002/jnr.20288	28	17	17	0	1	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	0301-0163	1663-2826		HORM RES	Horm. Res.		2007	68			5			14	17		10.1159/000110465			4	Endocrinology & Metabolism	Endocrinology & Metabolism	247OE	WOS:000252088400006	18174697				2021-06-18	
J	Brown, AW; Malec, JF; Diehl, NN; Englander, J; Cifu, DX				Brown, Allen W.; Malec, James F.; Diehl, Nancy N.; Englander, Jeffrey; Cifu, David X.			Impairment at rehabilitation admission and 1 year after moderate-to-severe traumatic brain injury: A prospective multi-centre analysis	BRAIN INJURY			English	Article						closed head injury; recovery of function; physical examination	LENGTH-OF-STAY; FUNCTIONAL OUTCOMES; TBI PATIENTS; BALANCE; RECOVERY; AMBULATION; DEFICITS; IMPACT; 1-YEAR; STATES	Primary objective: Describe physical impairment at rehabilitation admission and 1- year after moderate- to- severe traumatic brain injury. Research design: Prospective longitudinal multi- centre descriptive analysis. Methods and procedures: Physical examination variables were analysed for all subjects in the Traumatic Brain Injury Model Systems database from 1988 - 2002 that had data both at rehabilitation admission and at 1 year. Main results: Standing balance was more commonly and severely impaired at admission ( 82% of sample impaired) and 1 year ( 24% impaired) compared to other examination variables. Sitting balance was impaired in 52% of the sample at admission, largely resolving ( 5% abnormal) by 1 year. The profile of impaired strength, coordination and tone was similar among the four limbs. Impaired limb strength was most common and persistent over the study period compared to coordination and tone, but strength was normal in greater than 80% of subjects at 1 year. Dysphagia present at admission ( 40% of sample) largely resolved by 1 year ( 0.4% unable to swallow). Impairment in audition and vision was uncommon and changed little during the study period. Conclusions: Acute impairment was present in all variables. A minority of the sample had detectable impairment at 1 year. Standing balance was most severely and persistently impaired.	Mayo Clin, Dept Phys Med & Rehabil, Rochester, MN 55905 USA; Mayo Clin, Dept Psychiat & Psychol, Rochester, MN 55905 USA; Mayo Clin, Coll Med, Rochester, MN USA; Mayo Clin, Dept Hlth Sci Res, Jacksonville, FL USA; Santa Clara Valley Med Ctr, Dept Phys Med & Rehabil, San Jose, CA 95128 USA; Virginia Commonwealth Univ, Med Coll Virginia, Dept Phys Med & Rehabil, Richmond, VA 23298 USA	Brown, AW (corresponding author), Mayo Clin, Dept Phys Med & Rehabil, Rochester, MN 55905 USA.	brown.allen@mayo.edu		Cifu, David/0000-0003-1600-9387; Brown, Allen W./0000-0001-7228-3351			Black K, 2000, BRAIN INJURY, V14, P141, DOI 10.1080/026990500120808; BOHANNON RW, 1995, ARCH PHYS MED REHAB, V76, P994, DOI 10.1016/S0003-9993(95)81035-8; Brown AW, 2005, J NEUROTRAUM, V22, P1503; Brown AW, 2005, J NEUROTRAUM, V22, P1040, DOI 10.1089/neu.2005.22.1040; Bushnik T, 2003, ARCH PHYS MED REHAB, V84, P255, DOI 10.1053/apmr.2003.50092; Chou LS, 2004, GAIT POSTURE, V20, P245, DOI 10.1016/j.gaitpost.2003.09.007; Cifu DX, 1996, ARCH PHYS MED REHAB, V77, P883, DOI 10.1016/S0003-9993(96)90274-9; Corrigan JD, 2003, ARCH PHYS MED REHAB, V84, P153, DOI 10.1053/apmr.2003.50093; Duong TT, 2004, ARCH PHYS MED REHAB, V85, P1291, DOI 10.1016/j.apmr.2003.11.032; Englander J, 2003, ARCH PHYS MED REHAB, V84, P214, DOI 10.1053/apmr.2003.50094; Greenwald BD, 2001, J HEAD TRAUMA REHAB, V16, P238, DOI 10.1097/00001199-200106000-00003; Hanks RA, 2003, ARCH PHYS MED REHAB, V84, P249, DOI 10.1053/apmr.2003.50096; Hawkins ML, 2005, AM SURGEON, V71, P920; Hillier SL, 1997, BRAIN INJURY, V11, P661; Katz DI, 1998, ARCH PHYS MED REHAB, V79, P488, DOI 10.1016/S0003-9993(98)90060-0; Katz DI, 2004, ARCH PHYS MED REHAB, V85, P865, DOI 10.1016/j.apmr.2003.11.020; Kaufman KR, 2006, MED ENG PHYS, V28, P234, DOI 10.1016/j.medengphy.2005.05.005; Langlois Jean A, 2003, MMWR Surveill Summ, V52, P1; Maynard FM, 1997, SPINAL CORD, V35, P266, DOI 10.1038/sj.sc.3100432; McNaughton HK, 2005, ARCH PHYS MED REHAB, V86, P2184, DOI 10.1016/j.apmr.2005.06.010; Mellick D, 2003, BRAIN INJURY, V17, P55, DOI 10.1080/0269905021000010159; Powell JM, 2001, ARCH PHYS MED REHAB, V82, P1025, DOI 10.1053/apmr.2001.25082; Saffle JR, 2005, AM SURGEON, V71, P929; Sorbo A, 2005, BRAIN INJURY, V19, P493, DOI 10.1080/02699050400013709; *TBIMS, 2002, TRAUM BRAIN INJ MOD; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; van der Naalt J, 1999, J NEUROL NEUROSUR PS, V66, P207, DOI 10.1136/jnnp.66.2.207; WITYK RJ, 1994, STROKE, V25, P362, DOI 10.1161/01.STR.25.2.362; World Health Organization, 2001, INT CLASS FUNCT DIS; Zafonte RD, 1997, BRAIN INJURY, V11, P403	30	17	17	0	6	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.		2007	21	7					673	680		10.1080/02699050701468925			8	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	192LX	WOS:000248204400003	17653941				2021-06-18	
J	DeHaan, A; Halterman, C; Langan, J; Drew, AS; Osternig, LR; Chou, LS; van Donkelaar, P				DeHaan, Alex; Halterman, Charlene; Langan, Jeanne; Drew, Anthony S.; Osternig, Louis R.; Chou, Li-Shan; van Donkelaar, Paul			Cancelling planned actions following mild traumatic brain injury	NEUROPSYCHOLOGIA			English	Article						mild traumatic brain injury; countermanding saccades; decision-making; executive function	INHIBITORY CONTROL; DEFICITS; ATTENTION; BEHAVIOR; SACCADES; ABILITY	Mild traumatic brain injury (mTBI) leads to a variety of attentional, cognitive, and sensorimotor deficits. An important aspect of behavior that intersects each of these functions is the ability to cancel a planned action. Thus, the purpose of this study was to determine the effects of mTBI on the ability to perform a countermanding saccade task. In this task, participants were asked to generate a saccade to a target appearing in peripheral vision, but to inhibit saccade execution if an auditory stop signal was presented. The delay between the appearance of the peripheral target and the presentation of the auditory stop signal was varied between 0 and 125 ms. We found that the change in the probability of cancelling the saccade as a function of this delay was no different between participants with mTBI tested within 2 days of their injury and matched controls. However, saccadic reaction times and the stop signal reaction time were unexpectedly faster in the participants with mTBI and, furthermore, they inaccurately inhibited saccades during 15% of the trials with no stop signal. Taken together, this data suggests that the ability to cancel planned actions is subtly yet adversely affected by mTBI. (c) 2006 Elsevier Ltd. All rights reserved.	Univ Oregon, Dept Human Physiol, Eugene, OR 97403 USA; Univ Oregon, Inst Neurosci, Eugene, OR 97403 USA	van Donkelaar, P (corresponding author), Univ Oregon, Dept Human Physiol, 122C Esslinger Hall, Eugene, OR 97403 USA.	paulvd@uoregon.edu		Langan, Jeanne/0000-0003-1417-2180			Armstrong IT, 2003, EXP BRAIN RES, V152, P444, DOI 10.1007/s00221-003-1569-3; Aron AR, 2006, J NEUROSCI, V26, P2424, DOI 10.1523/JNEUROSCI.4682-05.2006; Aron AR, 2003, NAT NEUROSCI, V6, P115, DOI 10.1038/nn1003; Aron AR, 2004, TRENDS COGN SCI, V8, P170, DOI 10.1016/j.tics.2004.02.010; Badcock JC, 2002, PSYCHOL MED, V32, P287, DOI 10.1017/S0033291701005128; Band GPH, 2003, ACTA PSYCHOL, V112, P105, DOI 10.1016/S0001-6918(02)00079-3; Cabel DWJ, 2000, EXP BRAIN RES, V133, P431, DOI 10.1007/s002210000440; CHIKAZOE J, 2005, SOC NEUR ABSTR; Crevits L, 2000, J NEUROL, V247, P179, DOI 10.1007/s004150050559; Curtis CE, 2005, CEREB CORTEX, V15, P1281, DOI 10.1093/cercor/bhi011; DEBEAUMONT L, 2006, UNPUB IMPAIRED CORTI; Fillmore MT, 2002, DRUG ALCOHOL DEPEN, V67, P157, DOI 10.1016/S0376-8716(02)00062-5; Gaetz M, 2004, CLIN NEUROPHYSIOL, V115, P4, DOI 10.1016/S1388-2457(03)00258-X; Halterman CI, 2006, BRAIN, V129, P747, DOI 10.1093/brain/awh705; Hanes DP, 1999, VISION RES, V39, P2777, DOI 10.1016/S0042-6989(99)00011-5; Hanisch C, 2006, J NEURAL TRANSM, V113, P671, DOI 10.1007/s00702-005-0344-y; Heitger MH, 2004, BRAIN, V127, P575, DOI 10.1093/brain/awh066; Kelly JP, 1997, NEUROLOGY, V48, P581; LOGAN GD, 1984, PSYCHOL REV, V91, P295, DOI 10.1037/0033-295X.91.3.295; McIntire A, 2006, EXP BRAIN RES, V174, P361, DOI 10.1007/s00221-006-0469-8; Mulvihill LE, 1997, J STUD ALCOHOL, V58, P600, DOI 10.15288/jsa.1997.58.600; Parker TM, 2005, CLIN BIOMECH, V20, P389, DOI 10.1016/j.clinbiomech.2004.12.004; Parker TM, 2006, MED SCI SPORT EXER, V38, P1032, DOI 10.1249/01.mss.0000222828.56982.a4; Reddi BAJ, 2000, NAT NEUROSCI, V3, P827; Schall JD, 2002, NEURON, V36, P309, DOI 10.1016/S0896-6273(02)00964-9; Schall JD, 2001, NAT REV NEUROSCI, V2, P33, DOI 10.1038/35049054; Schall JD, 2000, PSYCHOL RES-PSYCH FO, V63, P299, DOI 10.1007/s004269900008; van Donkelaar P, 2006, EXERC SPORT SCI REV, V34, P77, DOI 10.1249/00003677-200604000-00007; van Donkelaar P, 2005, BRAIN INJURY, V19, P1031, DOI 10.1080/02699050500110363; Werhahn KJ, 1999, J PHYSIOL-LONDON, V517, P591, DOI 10.1111/j.1469-7793.1999.0591t.x	30	17	17	0	7	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0028-3932	1873-3514		NEUROPSYCHOLOGIA	Neuropsychologia		2007	45	2					406	411		10.1016/j.neuropsychologia.2006.06.008			6	Behavioral Sciences; Neurosciences; Psychology, Experimental	Behavioral Sciences; Neurosciences & Neurology; Psychology	130XR	WOS:000243832800022	16876828				2021-06-18	
J	O'Brien, L				O'Brien, Lisa			Achieving a successful and sustainable return to the workforce after ABI: A client-centred approach	BRAIN INJURY			English	Article						acquired brain injury; stroke; vocational rehabilitation; employment; client-centred practice; work	TRAUMATIC BRAIN-INJURY; QUALITY-OF-LIFE; COMMUNITY INTEGRATION; PRODUCTIVE WORK; HEAD-INJURY; EMPLOYMENT; REHABILITATION; PREDICTION; WORKPLACE; MODERATE	Primary objective: This paper describes the approach used by the Victorian Acquired Brain Injury ( ABI) specialist team of CRS Australia ( formerly Commonwealth Rehabilitation Service) to facilitate participation in the workforce for its clients. The approach and results achieved are compared and contrasted with other models nationally and internationally. Method and procedures: This two part study involves a survey of the specialist team members regarding use and efficacy of assessment and intervention strategies and data mining of closed case files to identify predictors of sustainable employment outcomes for people with ABI. Main outcomes and results: CRS Australia's results compare favourably with other published results ( 50% achieved a minimum of 13 weeks open employment compared to population estimates of 38-46.5%). Results were achieved with people with mild, moderate and severe injury. Assessments and interventions that correlate with successful employment outcome are described. Conclusions: A client-centred approach, combining specialist ABI expertise, skilled assessment and practical workplace-based interventions results in favourable employment outcome rates.	Monash Univ, Dept Occupat Therapy, Fac Med Nursing & Hlth Sci, Frankston, Vic 3199, Australia	O'Brien, L (corresponding author), Monash Univ, Dept Occupat Therapy, Fac Med Nursing & Hlth Sci, POB 527, Frankston, Vic 3199, Australia.	lisa.obrien@med.monash.edu.au		O'Brien, Lisa/0000-0002-4149-6669			Abreu BC, 1996, AM J OCCUP THER, V50, P417, DOI 10.5014/ajot.50.6.417; BLACKSCHAFFER RM, 1990, ARCH PHYS MED REHAB, V71, P285; Boake C, 2005, NEUROSURGERY, V56, P994, DOI 10.1227/01.NEU.0000158319.38230.C3; Brooks N., 1987, J HEAD TRAUMA REHABI, V2, P1, DOI [10.1097/00001199-198709000-00003, DOI 10.1097/00001199-198709000-00003]; CHAPMAN B, 1994, SOCIAL SECURITY J, P19; Chapparo C, 1997, OCCUPATIONAL PERFORM, P189; Colantonio A, 2004, DISABIL REHABIL, V26, P253, DOI 10.1080/09638280310001639722; *DEP WORK PENS UK, 2004, FRAM VOC REH; Doig E, 2001, BRAIN INJURY, V15, P747, DOI 10.1080/02699050110034343; Engberg AW, 2004, BRAIN INJURY, V18, P533, DOI 10.1080/02699050310001645829; Ezzy D., 2001, NARRATING UNEMPLOYME; FEARING V, 2000, INDIVIDUALS CONTEXT; Fleming J, 1999, BRAIN INJURY, V13, P417; Heinemann AW, 2000, REHABIL COUNS BULL, V43, P165, DOI 10.1177/003435520004300307; Hodgkinson A, 2000, J HEAD TRAUMA REHAB, V15, P1208, DOI 10.1097/00001199-200012000-00003; Johansson U, 2006, AM J OCCUP THER, V60, P60, DOI 10.5014/ajot.60.1.60; Johnson R, 1998, NEUROPSYCHOL REHABIL, V8, P61, DOI 10.1080/713755552; Johnston MV, 2005, ARCH PHYS MED REHAB, V86, P735, DOI 10.1016/j.apmr.2004.10.031; Johnstone B, 2003, ARCH PHYS MED REHAB, V84, P238, DOI 10.1053/apmr.2003.50097; JUNANKAR PN, 1991, 249 AUSTR NAT U CTR; Keyser-Marcus LA, 2002, ARCH PHYS MED REHAB, V83, P635, DOI 10.1053/apmr.2002.31605; Kowalske K, 2000, J HEAD TRAUMA REHAB, V15, P989, DOI 10.1097/00001199-200008000-00003; Kreutzer JS, 2003, J HEAD TRAUMA REHAB, V18, P128, DOI 10.1097/00001199-200303000-00004; KREUTZER JS, 1990, J HEAD TRAUMA REHAB, V5, P9, DOI DOI 10.1097/00001199-199009000-00005; Law M, 1995, Can J Occup Ther, V62, P250; Leung K L, 2005, Work, V25, P333; Levack W, 2004, DISABIL REHABIL, V26, P290, DOI 10.1080/09638280310001647615; MCCOLL MAH, 2005, 6 WORLD C BRAIN INJ; MCLAUGHLIN E, 2002, EARLY INTERVENTIONS; MCMORDIE W R, 1990, Brain Injury, V4, P57, DOI 10.3109/02699059009026149; Morse P, 1992, CLIN SYNDROMES ADULT, P85; NAIR A, 2006, COCHRANE DB SYST REV, P2, DOI DOI 10.1002/14651858; O'Neill J, 1998, J HEAD TRAUMA REHAB, V13, P68, DOI 10.1097/00001199-199808000-00007; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; Partridge T M, 1996, Work, V7, P63, DOI 10.3233/WOR-1996-7108; PONSFORD JL, 1995, BRAIN INJURY, V9, P1, DOI 10.3109/02699059509004565; PONSFORD JL, 1995, BRAIN INJURY, V9, P11, DOI 10.3109/02699059509004566; Powell J, 2002, J NEUROL NEUROSUR PS, V72, P193, DOI 10.1136/jnnp.72.2.193; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; SANDERSON I, 1999, BACK WORK LOCAL ACTI; SHORES EA, 1986, MED J AUSTRALIA, V144, P569, DOI 10.5694/j.1326-5377.1986.tb112311.x; Sloan S., 2004, BRAIN IMPAIR, V5, P12, DOI DOI 10.1375/BRIM.5.1.12.35399; TATE RL, 1989, J NEUROL NEUROSUR PS, V52, P1128, DOI 10.1136/jnnp.52.10.1128; Tate RL, 2004, BRAIN IMPAIR, V5, P81, DOI [10.1375/brim.5.1.81.35408, DOI 10.1375/brim.5.1.81.35408, DOI 10.1375/BRIM.5.1.81.35408]; TEASDALE G, 1974, LANCET, V2, P81; Tomberg T, 2005, BRAIN INJURY, V19, P1181, DOI 10.1080/02699050500150153; TYERMAN R, 1986, CHESSINGTON OCCUPATI; Vandiver VL, 2003, J HEAD TRAUMA REHAB, V18, P457, DOI 10.1097/00001199-200309000-00007; Vestling M, 2003, J REHABIL MED, V35, P127, DOI 10.1080/16501970310010475; Vogenthaler D R, 1989, Brain Inj, V3, P369, DOI 10.3109/02699058909004561; Wehman P, 2005, J HEAD TRAUMA REHAB, V20, P115, DOI 10.1097/00001199-200503000-00001; Wehman P, 2003, ARCH PHYS MED REHAB, V84, P192, DOI 10.1053/apmr.2003.50027; WEHMAN PH, 1995, J HEAD TRAUMA REHAB, V10, P27; WEST MD, 1995, BRAIN INJURY, V9, P301, DOI 10.3109/02699059509008200; West MD, 1996, J VOCATIONAL REHABIL, V7, P143; Whiteneck G, 2004, ARCH PHYS MED REHAB, V85, pS73, DOI 10.1016/j.apmr.2003.08.107; Wilson B. A., 1991, RIVERMEAD BEHAV MEMO	57	17	17	0	17	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2007	21	5					465	478		10.1080/02699050701315134			14	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	175FI	WOS:000246998000003	17522986				2021-06-18	
J	LeBlanc, J; de Guise, E; Feyz, M; Lamoureux, J				LeBlanc, Joanne; de Guise, Elaine; Feyz, Mitra; Lamoureux, Julie			Early prediction of language impairment following traumatic brain injury	BRAIN INJURY			English	Article						language impairment; communication; traumatic brain injury; prediction	CLOSED-HEAD INJURY; COGNITIVE RESERVE; ELDERLY-PATIENTS; WORKING-MEMORY; VERBAL FLUENCY; ACUTE-CARE; COMA; LEVEL; INTEGRATION; MORTALITY	Primary objective: This study investigated which factors collected early in the acute care setting (age, education, cerebral imaging, Glasgow Coma Scale score) would predict initial impairments of language comprehension and expression in patients with traumatic brain injury (TBI) of all severity. Methods and procedures: Results of language tests carried out during the patients' stay in an acute tertiary trauma centre were obtained. These tests measured performance in the areas of confrontation naming, auditory comprehension, semantic and letter category naming and comprehension of verbal absurdities. Data for the predictive variables were gathered by retrospective chart review. Stepwise multiple linear regressions were carried out on the predictive variables. Main outcomes and results: Education and TBI severity as measured with the GCS score were the most significant factors predicting language deficits in the acute care setting. Conclusions: These findings will serve to guide health care professionals in predicting prognosis for cognitive-communication deficits post-TBI and in planning for appropriate resources in speech-language pathology to meet these patients' needs.	McGill Univ, Montreal Gen Hosp, Hlth Ctr, Traumat Brain Injury Program, Quebec City, PQ H3G 1A4, Canada; Univ Montreal, Social & Prevent Med Dept, Montreal, PQ, Canada	LeBlanc, J (corresponding author), McGill Univ, Montreal Gen Hosp, Hlth Ctr, Traumat Brain Injury Program, Local D13-124,1650 Av Cedar, Quebec City, PQ H3G 1A4, Canada.	joanne.leblanc@mcgill.ca		Lamoureux, Julie/0000-0002-4986-2504			ADAMOVICH BB, 1985, COGNITIVE REHABILITA, P98; *AM SPEECH LANG HE, 1988, ASHA, V30, P29; Andrews PJD, 2002, J NEUROSURG, V97, P326, DOI 10.3171/jns.2002.97.2.0326; Baker H. J., 1965, DETROIT TEST LEARNIN; Balestreri M, 2004, J NEUROL NEUROSUR PS, V75, P161; BAULES KA, 1991, ARIZONA BATTERY COMM; BAYLES KA, 1983, CLIN APHASIOLOGY C P, P304; Bombardier CH, 1998, BRAIN INJURY, V12, P725, DOI 10.1080/026990598122124; Bopp KL, 2005, J GERONTOL B-PSYCHOL, V60, pP223, DOI 10.1093/geronb/60.5.P223; Brickman AM, 2005, ARCH CLIN NEUROPSYCH, V20, P561, DOI 10.1016/j.acn.2004.12.006; Brooks N, 1987, Brain Inj, V1, P5, DOI 10.3109/02699058709034439; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cattelani R, 2002, BRAIN INJURY, V16, P51, DOI 10.1080/02699050110088821; Cifu DX, 1997, ARCH PHYS MED REHAB, V78, P125, DOI 10.1016/S0003-9993(97)90252-5; Coelho CA, 2002, J SPEECH LANG HEAR R, V45, P1232, DOI 10.1044/1092-4388(2002/099); COOKE DL, 1995, J CLIN EXP NEUROPSYC, V17, P90, DOI 10.1080/13803399508406585; De Guise E, 2005, BRAIN INJURY, V19, P1087, DOI 10.1080/02699050500149882; DEGUISE E, UNPUB PEDICTION BEHA; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; Duff MC, 2002, BRAIN INJURY, V16, P773, DOI 10.1080/02699050210128870; EISENBERG HM, 1990, J NEUROSURG, V73, P688, DOI 10.3171/jns.1990.73.5.0688; Frank EM, 1996, J MED SPEECH-LANG PA, V4, P81; Galski T, 1998, BRAIN INJURY, V12, P769, DOI 10.1080/026990598122160; Goodglass H., 1983, BOSTON DIAGNOSTIC AP; Goodglass H., 2001, BOSTON DIAGNOSTIC AP; GRUEN AK, 1990, J COMMUN DISORD, V23, P163, DOI 10.1016/0021-9924(90)90020-Y; Hagen C, 1981, TOP LANG DIS, V1, P73; Hammond FM, 2004, J HEAD TRAUMA REHAB, V19, P314, DOI 10.1097/00001199-200407000-00006; Harris OA, 2000, J TRAUMA, V49, P1076, DOI 10.1097/00005373-200012000-00017; HARTLEY L L, 1991, Brain Injury, V5, P267, DOI 10.3109/02699059109008097; Hartley Leila L., 1992, Seminars in Speech and Language, V13, P264, DOI 10.1055/s-2008-1064202; Henderson LW, 1998, APHASIOLOGY, V12, P901, DOI 10.1080/02687039808249458; Hinchliffe FJ, 1998, BRAIN INJURY, V12, P369, DOI 10.1080/026990598122502; Hinchliffe FJ, 1998, BRAIN INJURY, V12, P109, DOI 10.1080/026990598122746; HUX K, 1997, J MED SPEECH-LANG PA, V5, P181; Jiang JY, 2002, J NEUROTRAUM, V19, P869, DOI 10.1089/08977150260190456; KAKARIEKA A, 1994, ACTA NEUROCHIR, V129, P1, DOI 10.1007/BF01400864; Kaplan E., 1983, BOSTON NAMING TEST; KATZ DI, 1994, ARCH NEUROL-CHICAGO, V51, P661, DOI 10.1001/archneur.1994.00540190041013; Kelly MP, 1997, BRAIN INJURY, V11, P391, DOI 10.1080/026990597123386; KERR C, 1995, BRAIN INJURY, V9, P777, DOI 10.3109/02699059509008234; Kesler SR, 2003, APPL NEUROPSYCHOL, V10, P153, DOI 10.1207/S15324826AN1003_04; Kilaru S, 1996, J TRAUMA, V41, P957, DOI 10.1097/00005373-199612000-00003; Lannoo E, 1998, INTENS CARE MED, V24, P236, DOI 10.1007/s001340050556; Lannoo E, 2000, J NEUROTRAUM, V17, P403, DOI 10.1089/neu.2000.17.403; Leblanc J, 2006, BRAIN INJURY, V20, P779, DOI 10.1080/02699050600831835; Lehtonen S, 2005, BRAIN INJURY, V19, P239, DOI 10.1080/0269905040004310; LEVIN HS, 1990, J NEUROSURG, V73, P699, DOI 10.3171/jns.1990.73.5.0699; LEVIN HS, 1976, J NEUROL NEUROSUR PS, V39, P1062, DOI 10.1136/jnnp.39.11.1062; LIVINGSTON M, 1988, J HEAD TRAUMA REHAB, V3, P6, DOI DOI 10.1097/00001199-198812000-00004; MCDONALD S, 1999, BRAIN DAM B, P19; McDowell S, 1997, NEUROPSYCHOLOGIA, V35, P1341, DOI 10.1016/S0028-3932(97)00082-1; Raskin SA, 1996, NEUROPSYCHOLOGY, V10, P416, DOI 10.1037/0894-4105.10.3.416; RIMEL RW, 1982, NEUROSURGERY, V11, P344, DOI 10.1227/00006123-198209000-00002; SARNO MT, 1986, ARCH PHYS MED REHAB, V67, P400; SARNO MT, 1980, J NERV MENT DIS, V168, P685, DOI 10.1097/00005053-198011000-00008; Servadei F, 2000, NEUROSURGERY, V46, P70; SHATZ RS, 1998, MED SPEECH LANGUAGE, P243; Snow P, 1997, BRAIN INJURY, V11, P409; SOLOMON DA, 1992, NEUROPSYCHOL REV, V3, P249, DOI 10.1007/BF01109050; Spreen O, 1969, NEUROSENSORY CTR COM; Stern Y, 2002, J INT NEUROPSYCH SOC, V8, P448, DOI 10.1017/S1355617702813248; Stout CE, 2000, J MED SPEECH-LANG PA, V8, P15; Sullivan A, 2001, SOCIOLOGY, V35, P893, DOI 10.1177/0038038501035004006; Susman M, 2002, J TRAUMA, V53, P219, DOI 10.1097/00005373-200208000-00004; Turkstra L, 2005, J MED SPEECH-LANG PA, V13, pIX; VOLLMER DG, 1991, J NEUROSURG, V75, pS37, DOI 10.3171/sup.1991.75.1s.0s37; Wallesch CW, 2001, J NEUROTRAUM, V18, P11, DOI 10.1089/089771501750055730; Wecker NS, 2005, NEUROPSYCHOLOGY, V19, P345, DOI 10.1037/0894-4105.19.3.345; Wehman Paul, 1993, Brain Injury, V7, P31, DOI 10.3109/02699059309008154; Ylvisaker M, 2000, LANGUAGE INTERVENTIO, P745; Ylvisaker Mark, 1992, Seminars in Speech and Language, V13, P239, DOI 10.1055/s-2008-1064200; Youse KM, 2005, BRAIN INJURY, V19, P1001, DOI 10.1080/02699050500109951	73	17	17	0	16	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	DEC	2006	20	13-14					1391	1401		10.1080/02699050601081927			11	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	130GF	WOS:000243787100009	17378231				2021-06-18	
J	Deja, M; Wolf, S; Weber-Carstens, S; Lehmann, TN; Adler, A; Ruhnke, M; Tintelnot, K				Deja, Maria; Wolf, Steffen; Weber-Carstens, Steffen; Lehmann, Thomas-Nicolas; Adler, Andreas; Ruhnke, Markus; Tintelnot, Kathrin			Gastrointestinal zygomycosis caused by Mucor indicus in a patient with acute traumatic brain injury	MEDICAL MYCOLOGY			English	Article						zygomycosis; gastrointestinal; Mucor indicus; liposomal amphotericin B; trauma	TRANSPLANT RECIPIENT; MUCORMYCOSIS	We report a gastrointestinal infection caused by Mucor indicus in a patient with severe head injuries. Monotherapy with high-dose liposomal amphotericin B successfully eradicated the mucormycosis. Nevertheless, subsequently a hemicolectomy was necessary due to recurrent bleeding from a deep ulcer. Mucor indicus is an uncommon fungal pathogen, typically found in starters used for food fermentation. Reviewing other reports on Mucor indicus infections, primary gastrointestinal manifestations seem to be typical and indicate an oral route of infection.	Robert Koch Inst, D-13353 Berlin, Germany; Univ Med, Dept Anesthesiol & Intens Care Med, Charite, Berlin, Germany; Univ Med, Dept Neurosurg, Charite, Berlin, Germany; Univ Med, Div Hepatol Gastroenterol Endocrinol & Metab, Charite, Berlin, Germany; Univ Med, Dept Med, Div Oncol Hematol, Charite Mitte, Berlin, Germany	Tintelnot, K (corresponding author), Robert Koch Inst, D-13353 Berlin, Germany.	tintelnotk@rki.de	Weber-Carstens, Steffen/A-6401-2009	Weber-Carstens, Steffen/0000-0001-7405-0172			Aboltins CA, 2006, CLIN INFECT DIS, V42, P154, DOI 10.1086/498751; Azadeh B, 2004, HISTOPATHOLOGY, V44, P298, DOI 10.1111/j.1365-2559.2004.01761.x; de Hoog GS, 2000, ATLAS CLIN FUNGI; Frater JL, 2001, ARCH PATHOL LAB MED, V125, P375; Gil-Lamaignere C, 2005, J INFECT DIS, V191, P1180, DOI 10.1086/428503; JENSEN HE, 1994, VET PATHOL, V31, P28, DOI 10.1177/030098589403100104; Lee AC, 1999, WORLD J MICROB BIOT, V15, P57, DOI 10.1023/A:1008818511497; Martinez EJ, 1997, SOUTH MED J, V90, P341, DOI 10.1097/00007611-199703000-00017; Mata-Essayag S, 2001, INT J DERMATOL, V40, P406, DOI 10.1046/j.1365-4362.2001.01246-3.x; Oliver MR, 1996, CLIN INFECT DIS, V22, P521, DOI 10.1093/clinids/22.3.521; Prabhu RM, 2004, CLIN MICROBIOL INFEC, V10, P31, DOI 10.1111/j.1470-9465.2004.00843.x; Roden MM, 2005, CLIN INFECT DIS, V41, P634, DOI 10.1086/432579; SAMSON RA, 1989, SOC APPL BACTERIOL S, V18; Spellberg B, 2005, CLIN MICROBIOL REV, V18, P556, DOI 10.1128/CMR.18.3.556-569.2005; Stamm B, 2005, HISTOPATHOLOGY, V47, P222, DOI 10.1111/j.1365-2559.2005.02080.x; Sues A, 2005, FEMS YEAST RES, V5, P669, DOI 10.1016/j.femsyr.2004.10.013; TERBORG F, 1990, SCAND J INFECT DIS, V22, P499; White T.J., 1990, PCR PROTOCOLS GUIDE, V18, P315, DOI DOI 10.1016/B978-0-12-372180-8.50042-1; Wolach B, 2001, J NEUROSURG, V94, P706, DOI 10.3171/jns.2001.94.5.0706; Yousef OM, 1999, AM J CLIN PATHOL, V112, P610	20	17	18	0	2	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1369-3786			MED MYCOL	Med. Mycol.	NOV	2006	44	7					683	687		10.1080/13693780600803888			5	Infectious Diseases; Mycology; Veterinary Sciences	Infectious Diseases; Mycology; Veterinary Sciences	112UE	WOS:000242552000016	17071566	Bronze			2021-06-18	
J	Saniova, B; Drobny, M; Lehotsky, J; Sulaj, M; Schudichova, J				Saniova, B.; Drobny, M.; Lehotsky, J.; Sulaj, M.; Schudichova, J.			Biochemical and clinical improvement of cytotoxic state by amantadine sulphate	CELLULAR AND MOLECULAR NEUROBIOLOGY			English	Article						brain injury; antioxidative state; free oxygen radicals; income and outcome Glasgow Coma Scale; beta-caroten; malondialdehyde		The main idea of the open clinical trial was to compare the income and outcome clinical picture and the evolution of the biochemical markers in the defined intervals in closed head injury group patients. In the group of 32 patients, mean age 40.78 +/- 15.36 years suffering from closed traumatic brain injury the following markers were measured: glycaemia, malondialdehyde (MDA) as marker of lipid peroxidation, beta-caroten, total SH groups as marker of protein oxidation in the following intervals: between the 1st and the 3rd, between the 3rd and the 7th, between the 1st and the 7th day respectively. Glycaemia significantly decreased since the 1st day till the 3rd day (p < 0.05) and since the 1st day till the 7th day (p < 0.05) but it was not significantly changed since the 3rd day till the 7th day (p > 0.05). MDA 1st x MDA 3rd p > 0.05 insignificant change, MDA 1st x MDA 7th p < 0.001-high significant decrease, MDA 3rd x MDA 7th-p < 0.0001-very high significant decrease. Beta-caroten the 1st x beta-caroten the 3rd day was insignificantly changed-p > 0.05, the 3rd x the 7th day beta-caroten increased significantly-p < 0.0002, the 1st day x 7th day beta-caroten significantly increased-p < 0.0001. We examined the SH groups only in nine patients, due to technical problems and SH groups decrease on the 3rd day (p < 0.005). In 18 amantadine sulphate subgroups (randomly selected), there was 5.5% lethality and mean outcome GCS (outGCS) 9.83 +/- 3.8, while lethality of the control subgroup (n=14) was 42.9%, mean outGCS 6.28 +/- 3.5.	Fac Hosp, Jessenius Fac Med, Clin Anaesthesiol & Intens Med, Martin, Slovakia; Fac Hosp, Jessenius Fac Med, Neurol Clin, Martin, Slovakia; Fac Hosp, Jessenius Fac Med, Inst Med Biochem, Martin, Slovakia; Fac Hosp, Jessenius Fac Med, Inst Clin Biochem, Martin, Slovakia	Saniova, B (corresponding author), Fac Hosp, Jessenius Fac Med, Clin Anaesthesiol & Intens Med, Martin, Slovakia.	saniova@lefa.sk	Lehotsky, Jan/X-5951-2018; Lehotsky, Jan/AAE-3686-2019	Lehotsky, Jan/0000-0002-2408-5745			DROBNY M, 2002, AMANTADIN SULFAT PK, P1; FRYKHOLM P, 2002, CEREBRAL ISCHEMIA ST, P8; Jorg J, 2000, NERVENHEILKUNDE, V19, P521; SCHMIDT WJ, 1996, NERVENHEILKUNDE, V8, P1; STEUBE, 2000, NEUROL REHABIL, V6, P307; Tesoriere L, 2002, FREE RADICAL RES, V36, P89, DOI 10.1080/10715760210163; WALLNOFER H, 1974, MED WELT, V25, P703; Warner DS, 2004, J EXP BIOL, V207, P3221, DOI 10.1242/jeb.01022	8	17	20	0	1	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0272-4340			CELL MOL NEUROBIOL	Cell. Mol. Neurobiol.	NOV	2006	26	7-8					1475	1482		10.1007/s10571-006-9033-0			8	Cell Biology; Neurosciences	Cell Biology; Neurosciences & Neurology	114HO	WOS:000242657500030	16710757				2021-06-18	
J	Koob, AO; Cirillo, J; Babbs, CF				Koob, Andrew O.; Cirillo, John; Babbs, Charles F.			A novel open field activity detector to determine spatial and temporal movement of laboratory animals after injury and disease	JOURNAL OF NEUROSCIENCE METHODS			English	Article						brain injury; neurological disease; neurodegeneration; head injury; behavior; laboratory animal; open field; exploratory behavior	TRAUMATIC BRAIN-INJURY; RATS; HIPPOCAMPAL; NAVIGATION; BEHAVIOR; SYSTEM; MODEL	The wide range of tests for laboratory animal behavior after neurological injury or disease each have their benefits and detriments. The varied behavior an animal exhibits makes it difficult to decide which test to use. However, a fundamental instinct for the laboratory animal is to explore when placed in a new environment. A way to test exploratory behavior is in the open field. Here, we introduce a simple activity box without the use of video equipment to determine the exploratory movement of a rat after traumatic brain injury. The activity box is an open field and the rat explores its surroundings when placed inside. Four infrared beams were placed in both the X and Y-axis inside the box. Using a novel system to determine which beam the rat breaks, we describe where the rat is in space and time while in the activity box. Other models can show the number of beams broken, but here we elucidate the methods to additionally determine the amount of area explored, the total distance traveled by the rat and percent time exploring. (c) 2006 Elsevier B.V. All rights reserved.	Dartmouth Coll, Hitchcock Med Ctr, Dept Pediat Neurosurg, Lebanon, NH 03756 USA; Purdue Univ, Dept Basic Med Sci, Ctr Paralysis Res, W Lafayette, IN 47907 USA	Koob, AO (corresponding author), Dartmouth Coll, Hitchcock Med Ctr, Dept Pediat Neurosurg, 1 Med Ctr Dr, Lebanon, NH 03756 USA.	Andrew.O.Koob@Dartmouth.EDU					BARR GA, 1983, LIFE SCI, V33, P1341, DOI 10.1016/0024-3205(83)90817-2; Devan BD, 1996, NEUROBIOL LEARN MEM, V66, P305, DOI 10.1006/nlme.1996.0072; DUTRIEUX G, 1978, PHYSIOL BEHAV, V21, P721, DOI 10.1016/0031-9384(78)90010-0; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; GIULIAN D, 1975, PHYSIOL BEHAV, V14, P109, DOI 10.1016/0031-9384(75)90150-X; Koob AO, 2005, J NEUROTRAUM, V22, P1092, DOI 10.1089/neu.2005.22.1092; Marino MJ, 2003, P NATL ACAD SCI USA, V100, P13668, DOI 10.1073/pnas.1835724100; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; O'Connor C, 2003, J NEUROTRAUM, V20, P985, DOI 10.1089/089771503770195830; OLTON DS, 1976, J EXP PSYCHOL-ANIM B, V2, P97, DOI 10.1037/0097-7403.2.2.97; Pickens R., 1971, STIMULUS PROPERTIES, P39, DOI 10.1007/978-1-4757-0788-5_3; ROTH KA, 1979, NEUROSCI BIOBEHAV R, V3, P247, DOI 10.1016/0149-7634(79)90012-5; SCHWARTING RKW, 1993, J NEUROSCI METH, V49, P199, DOI 10.1016/0165-0270(93)90125-B; Tilson H.A., 1973, PHARM BIO B, V1, P149; TOMKINS PT, 1981, PHYSIOL BEHAV, V26, P741, DOI 10.1016/0031-9384(81)90154-2; Vicens P, 2003, PSICOTHEMA, V15, P539; Vink R, 2003, NEUROSCI LETT, V336, P41, DOI 10.1016/S0304-3940(02)01244-2; Whishaw IQ, 1999, MODERN TECHNIQUES NE, P1243; WILLIAMS T, 2004, GNUPLOT 4 0 INTERACT	20	17	18	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0165-0270	1872-678X		J NEUROSCI METH	J. Neurosci. Methods	OCT 30	2006	157	2					330	336		10.1016/j.jneumeth.2006.04.020			7	Biochemical Research Methods; Neurosciences	Biochemistry & Molecular Biology; Neurosciences & Neurology	101PU	WOS:000241753600017	16735064				2021-06-18	
J	Netto, KJ; Burnett, AF				Netto, Kevin J.; Burnett, Angus F.			Neck muscle activation and head postures in common high performance aerial combat maneuvers	AVIATION SPACE AND ENVIRONMENTAL MEDICINE			English	Article						electromyography; neck; cervical; hypergravity; injury	ISOMETRIC CERVICAL STRENGTH; FIGHTER PILOTS; SPINE; MOTION; KINEMATICS; INJURIES; STRAIN; FORCES; RANGE; LOADS	Introduction: Neck injuries are common in high performance combat pilots and have been attributed to high gravitational forces and the non-neutral head postures adopted during aerial combat maneuvers. There is still little known about the pathomechanics of these injuries. Methods: Six Royal Australian Air Force Hawk pilots flew a sortie that included combinations of three +Gz levels (1, 3, and 5) and four head postures (Neutral, Turn, Extension, and Check-6). Surface electromyography from neck and shoulder muscles was recorded in flight. Three-dimensional measures of head postures adopted in flight were estimated postflight with respect to end-range of the cervical spine using an electromagnetic tracking device. Results: Mean muscle activation increased significantly with both increasing +Gz and non-neutral head postures. Check-6 at +5 Gz (mean activation of all muscles = 51% MVIC) elicited significantly greater muscle activation in most muscles when compared with Neutral, Extension, and Turn head postures. High levels of muscle co-contraction were evident in high acceleration and non-neutral head postures. Head kinematics showed Check-6 was closest to end-range in any movement plane (86% ROM in rotation) and produced the greatest magnitude of rotation in other planes. Turn and Extension showed a large magnitude of rotation with reference to end-range in the primary plane of motion but displayed smaller rotations in other planes. Discussion: High levels of neck muscle activation and co-contraction due to high +Gz and head postures close to end range were evident in this study, suggesting the major influence of these factors on the pathomechanics of neck injuries in high performance combat pilots.	Charles Darwin Univ, Sch Sci & Primary Ind, Darwin, NT 0909, Australia; Edith Cowan Univ, Sch Exercise Biomed & Hlth Sci, Joondalup, WA, Australia; Curtin Univ Technol, Sch Phys, Bentley, WA 6102, Australia	Netto, KJ (corresponding author), Charles Darwin Univ, Sch Sci & Primary Ind, Casuarina Campus,Bldg 42-1-65,Ellengowan Dr, Darwin, NT 0909, Australia.	kevin.netto@cdu.edu.au	Netto, Kevin/ABE-1340-2020	Netto, Kevin/0000-0002-3680-3548			Alricsson M, 2004, AVIAT SPACE ENVIR MD, V75, P23; ANDERSEN HT, 1988, AVIAT SPACE ENVIR MD, V59, P356; Ang B, 2005, AVIAT SPACE ENVIR MD, V76, P375; Ariens GAM, 2001, AM J IND MED, V39, P180, DOI 10.1002/1097-0274(200102)39:2<180::AID-AJIM1005>3.0.CO;2-#; Aultman CD, 2004, SPINE, V29, pE304, DOI 10.1097/01.BRS.0000132515.21703.38; Bergman GJD, 2005, SPINE, V30, P650, DOI 10.1097/01.brs.0000155414.03723.3d; Burnett AF, 1998, CLIN BIOMECH, V13, P574, DOI 10.1016/S0268-0033(98)00026-6; Choi H, 2003, MED ENG PHYS, V25, P133, DOI 10.1016/S1350-4533(02)00151-0; Falla D, 2004, MANUAL THER, V9, P125, DOI 10.1016/j.math.2004.05.003; Finsen L, 1998, CLIN BIOMECH, V13, P272, DOI 10.1016/S0268-0033(98)00096-5; Garces GL, 2002, MED SCI SPORT EXER, V34, P464, DOI 10.1097/00005768-200203000-00013; Green NDC, 2004, AVIAT SPACE ENVIR MD, V75, P676; HAMALAINEN O, 1992, AVIAT SPACE ENVIR MD, V63, P709; Hamalainen O, 1999, AVIAT SPACE ENVIR MD, V70, P330; Hendriksen IJM, 1999, AVIAT SPACE ENVIR MD, V70, P1057; Hof AL, 2001, CLIN BIOMECH, V16, P455, DOI 10.1016/S0268-0033(01)00012-2; Jones JA, 2000, MIL MED, V165, P6; Kumar S, 2002, SPINE, V27, P1044, DOI 10.1097/00007632-200205150-00009; Linton SJ, 2001, SPINE, V26, P778, DOI 10.1097/00007632-200104010-00019; Netto Kevin J, 2006, Work, V26, P123; Newman DG, 1997, AVIAT SPACE ENVIR MD, V68, P732; Oksa J, 1996, AVIAT SPACE ENVIR MD, V67, P1138; PANJABI MM, 1992, J SPINAL DISORD, V5, P383, DOI 10.1097/00002517-199212000-00001; Rugulies R, 2005, SOC SCI MED, V61, P27, DOI 10.1016/j.socscimed.2004.11.042; Seng KY, 2003, AVIAT SPACE ENVIR MD, V74, P164; Sforza C, 2002, CLIN BIOMECH, V17, P611, DOI 10.1016/S0268-0033(02)00071-2; Siegmund GP, 2003, J BIOMECH, V36, P473, DOI 10.1016/S0021-9290(02)00458-X; Sommerich CM, 2000, J ELECTROMYOGR KINES, V10, P377, DOI 10.1016/S1050-6411(00)00033-X; Suryanarayana L, 2005, CLIN BIOMECH, V20, P138, DOI 10.1016/j.clinbiomech.2004.10.003; VANDIJKE GAH, 1993, J BIOMECH, V26, P1017, DOI 10.1016/S0021-9290(05)80001-6	30	17	23	0	1	AEROSPACE MEDICAL ASSOC	ALEXANDRIA	320 S HENRY ST, ALEXANDRIA, VA 22314-3579 USA	0095-6562	1943-4448		AVIAT SPACE ENVIR MD	Aviat. Space Environ. Med.	OCT	2006	77	10					1049	1055					7	Public, Environmental & Occupational Health; Medicine, General & Internal; Sport Sciences	Public, Environmental & Occupational Health; General & Internal Medicine; Sport Sciences	091SQ	WOS:000241049000008	17042250				2021-06-18	
J	Prigozen, JM; Horswell, BB; Flaherty, SK; Henderson, JM; Graham, DA; Armistead, LM; Habib, JH; Lukowski, DE				Prigozen, Jason M.; Horswell, Bruce B.; Flaherty, Sarah K.; Henderson, James M.; Graham, David A.; Armistead, Lauren M.; Habib, Joseph H.; Lukowski, David E.			All-terrain vehicle-related maxillofacial trauma in the pediatric population	JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY			English	Article							INJURIES; CHILDREN; COLLISIONS; ACCIDENTS	Purpose: Nearly 40% of ati-terrain vehicle (ATV) crash-related fatalities involve pediatric patients, with many of these patients dying from head and neck injuries. West Virginia is in a unique position to examine these injuries because of its high rate of ATV use. This study examines craniofacial ATV-related trauma in children. Patients and Methods: We conducted a single-center, retrospective, descriptive study of 26 children presenting with a craniofacial injury(ies) resulting from an ATV crash from January 2001 to December 2004. Results: Twenty-six children (65% boys) with a mean age of 13.1 years presented with craniofacial injuries during the study period. Two patients were helmeted. Mortality was 3.8% (n = 1, head injury related, postinjury day 3). Patients were most often drivers of the ATV (65%), although girls were more likely to be passengers (P = .03). Facial contusions, lacerations, and abrasions were highly prevalent (62%, 69%, 65%, respectively), as were fractures of the facial bones and skull (77%). Thirty-five percent sustained closed head injuries, which were significantly associated with mandible fractures (odds ratio 12.8%; 95% CI, 1.15-143). Mean length of hospital stay was 4.6 +/- 5 days, and 36% required an ICU stay (mean, 5.1 +/- 3 days). Twenty-four percent required ventilator support (mean, 107 +/- 43 hours; range, 48 to 168 hours). Operative intervention was required in 72% of patients (n = 18). Conclusion: Maxillofacial injury patterns from ATV-related crashes in children suggest a high percentage of significant facial injuries and closed head injuries. As new ATV legislation that addresses operator use is enacted, a decrease in the number and severity of craniofacial injuries may be seen. (c) 2006 American Association of Oral and Maxillofacial Surgeons.	CAMC Inst, Charleston, WV 25304 USA; W Virginia Univ, Sch Med, Charleston Div, Dept Surg, Charleston, WV 25304 USA; Charleston Area Med Ctr, Dept Surg, Sect Maxillofacial Surg, Charleston, WV 25304 USA; Charleston Area Med Ctr, Hlth Educ & Res Inst, Charleston, WV 25304 USA; Charleston Area Med Ctr, Dept Surg, Sect Maxillofacial Surg, Charleston, WV USA	Flaherty, SK (corresponding author), CAMC Inst, 3211 MacCorkle Ave SE, Charleston, WV 25304 USA.	sarah.flaherty@camc.org					Bhutta ST, 2004, PEDIATR RADIOL, V34, P130, DOI 10.1007/s00247-003-1085-4; Brown RL, 2002, J PEDIATR SURG, V37, P375, DOI 10.1053/jpsu.2002.30826; Carlin C B, 1998, J Craniomaxillofac Trauma, V4, P44; DEMAS PN, 1992, J ORAL MAXIL SURG, V50, P1280, DOI 10.1016/0278-2391(92)90227-Q; Fischer K, 2001, PLAST RECONSTR SURG, V108, P328, DOI 10.1097/00006534-200108000-00006; FRIEDMAN R, 1988, LARYNGOSCOPE, V98, P1251; Gassner R, 2004, J ORAL MAXIL SURG, V62, P399, DOI 10.1016/j.joms.2003.05.013; HAUG HZ, 1992, J ORAL MAXIL SURG, V50, P218, DOI 10.1016/0278-2391(92)90315-Q; Helmkamp JC, 2001, AM J PUBLIC HEALTH, V91, P1792, DOI 10.2105/AJPH.91.11.1792; Holmes PJ, 2004, J ORAL MAXIL SURG, V62, P697, DOI 10.1016/j.joms.2003.12.011; Keenan HT, 2004, PEDIATRICS, V113, pE330, DOI 10.1542/peds.113.4.e330; Marciani RD, 1999, J ORAL MAXIL SURG, V57, P119, DOI 10.1016/S0278-2391(99)90221-5; MCCORMICK G, 2004, PRIVATE PROPERTY CON; Moore EE, 2003, TRAUMA; *NSKC, 2004, INJ FACTS CHILDR RIS; Rodgers GB, 2002, INJ PREV, V8, P42, DOI 10.1136/ip.8.1.42; Touma BJ, 1999, OTOLARYNG HEAD NECK, V121, P736, DOI 10.1053/hn.1999.v121.a98198; U.S. Consumer Product Safety Commission, 1998, ALL TERR VEH EXP INJ; *W VIRG U CTR RUR, 2003, CURR ATV FACTS W VIR; 2003, ALL TERRAIN VEHICLE; 2002, ALL TERRAIN VEHICLE	21	17	19	0	1	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0278-2391	1531-5053		J ORAL MAXIL SURG	J. Oral Maxillofac. Surg.	SEP	2006	64	9					1333	1337		10.1016/j.joms.2006.05.014			5	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	078OW	WOS:000240114100002	16916665				2021-06-18	
J	Bittner, RM; Crowe, SF				Bittner, Robyn M.; Crowe, Simon F.			The relationship between naming difficulty and FAS performance following traumatic brain injury	BRAIN INJURY			English	Article						verbal fluency; word fluency; naming difficulty; FAS language; TBI	CLOSED-HEAD-INJURY; VERBAL FLUENCY; WORD-FLUENCY; FRONTAL-LOBE; DISSOCIATION; IMPAIRMENT; APHASIA; LESIONS; MEMORY; ADULTS	Primary objective: To investigate the relationship between naming difficulty (ND) and FAS performance in traumatic brain injury (TBI). Methods and procedure: Sixty-three patients with a TBI were divided into two groups based on the presence of a ND and were compared with a control group on FAS performance. Results: Whilst the group with a TBI performed more poorly than the control group on the FAS task, there was no difference between those participants who featured a ND and those who did not. The TBIs produced fewer words than the control group in the first time slice of the task, but there was no difference between the group with a ND and the non-ND group on this measure. Conclusion: The results indicate that the effect of word finding deficits is not the principal cause of the diminution of phonemic verbal fluency performance in TBI, which is probably more likely due to compromise in speed of information processing associated with the injury.	La Trobe Univ, Fac Sci Technol & Engn, Sch Psychol Sci, Bundoora, Vic 3086, Australia	Crowe, SF (corresponding author), La Trobe Univ, Fac Sci Technol & Engn, Sch Psychol Sci, Bundoora, Vic 3086, Australia.	s.crowe@latrobe.edu.au		Crowe, Simon/0000-0002-4407-8542			Au R, 1995, AGING COGNITION, V2, P300, DOI 10.1080/13825589508256605; BITTNER RM, 1998, THESIS U SO QUEENSLA; BORKOWSKI JG, 1967, NEUROPSYCHOLOGIA, V5, P135, DOI 10.1016/0028-3932(67)90015-2; BUNN T, 1995, ED CHILD PSYCHOL, V12, P46; Capitani E, 1998, CORTEX, V34, P779, DOI 10.1016/S0010-9452(08)70781-0; CROWE SF, 1992, J CLIN EXP NEUROPSYC, V14, P327, DOI 10.1080/01688639208402832; Crowe SF, 1998, J CLIN EXP NEUROPSYC, V20, P391, DOI 10.1076/jcen.20.3.391.810; CROWE SF, 1996, PSYCHIAT PSYCHOL LAW, V3, P39, DOI DOI 10.1080/13218719609524873; DENNIS M, 1992, TOP LANG DISORD, V13, P66, DOI 10.1097/00011363-199211000-00008; Fernaeus SE, 1998, J CLIN EXP NEUROPSYC, V20, P137, DOI 10.1076/jcen.20.2.137.1170; Fernaeus SE, 2001, DEMENT GERIATR COGN, V12, P52, DOI 10.1159/000051235; GROHER M, 1977, J SPEECH HEAR RES, V20, P212, DOI 10.1044/jshr.2002.212; HEILMAN KM, 1971, J NEUROL NEUROSUR PS, V34, P265, DOI 10.1136/jnnp.34.3.265; HOLLAND AL, 1982, P C CLIN APH JUN 6 1, P345; Jurado MA, 2000, BRAIN INJURY, V14, P789; Kaplan E., 1983, BOSTON NAMING TEST; KERR C, 1995, BRAIN INJURY, V9, P777, DOI 10.3109/02699059509008234; Killgore WDS, 1999, PERCEPT MOTOR SKILL, V89, P327, DOI 10.2466/PMS.89.5.327-337; Killgore WDS, 2000, J CLIN EXP NEUROPSYC, V22, P761; LEVIN HS, 1979, J NEUROSURG, V50, P412, DOI 10.3171/jns.1979.50.4.0412; LEVIN HS, 1981, BRAIN LANG, V12, P360, DOI 10.1016/0093-934X(81)90025-0; LEVIN HS, 1976, J NEUROL NEUROSUR PS, V39, P1062, DOI 10.1136/jnnp.39.11.1062; Morse P, 1992, CLIN SYNDROMES ADULT, P85; PERRET E, 1974, NEUROPSYCHOLOGIA, V12, P323, DOI 10.1016/0028-3932(74)90047-5; Randolph C, 1999, ARCH CLIN NEUROPSYCH, V14, P489, DOI 10.1016/S0887-6177(98)00023-7; Raskin SA, 1996, NEUROPSYCHOLOGY, V10, P416, DOI 10.1037/0894-4105.10.3.416; Rey A, 1964, EXAMEN CLIN PSYCHOL; Ruff RM, 1997, BRAIN LANG, V57, P394, DOI 10.1006/brln.1997.1755; RUSSELL WR, 1961, ARCH NEUROL-CHICAGO, V5, P16, DOI DOI 10.1001/ARCHNEUR.1961.00450130006002; SARNO MT, 1986, ARCH PHYS MED REHAB, V67, P400; SARNO MT, 1980, J NERV MENT DIS, V168, P685, DOI 10.1097/00005053-198011000-00008; Thompson L. L., 1989, CLIN NEUROPSYCHOL, V3, P184, DOI [DOI 10.1080/13854048908403291, 10.1080/13854048908403291]; THOMSEN IV, 1975, J NEUROL NEUROSUR PS, V38, P713, DOI 10.1136/jnnp.38.7.713; Timmerman ME, 1999, NEUROPSYCHOLOGIA, V37, P467, DOI 10.1016/S0028-3932(98)00085-2; Tombaugh TN, 1997, J CLIN EXP NEUROPSYC, V19, P922, DOI 10.1080/01688639708403773; Tombaugh TN, 1996, TEST MEMORY MALINGER; Troyer AK, 1997, NEUROPSYCHOLOGY, V11, P138, DOI 10.1037/0894-4105.11.1.138; Wechsler D., 1997, WECHSLER INTELLIGENC	38	17	17	0	4	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	AUG	2006	20	9					971	980		10.1080/02699050600909763			10	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	094ZN	WOS:000241278100009	17062428				2021-06-18	
J	Javouhey, E; Guerin, AC; Amoros, E; Haddak, M; Ndiaye, A; Floret, D; Chiron, M				Javouhey, Etienne; Guerin, Anne-Celine; Amoros, Emmanuele; Haddak, Mouloud; Ndiaye, Amina; Floret, Daniel; Chiron, Mireille			Severe outcome of children following trauma resulting from road accidents	EUROPEAN JOURNAL OF PEDIATRICS			English	Article						outcome prediction; paediatric; registry; road accident; traumatic brain injury	SEVERE HEAD-INJURY; BRAIN-INJURY; EARLY INTERVENTION; MULTIPLE INJURIES; PEDIATRIC TRAUMA; EPIDEMIOLOGY; ADOLESCENTS; DISABILITY; SURVIVAL; CARE	Objective: The aim of the study was to determine the risk factors of a severe outcome for children severely injured [killed or with an Injury Severity Score (ISS) >= N16] in a road accident. Materials and methods: Casualties that occurred between 1996 and 2001 which involved children under 14 years of age were assessed in a population-based study based on data included in a French road trauma Registry. A severe traumatic brain injury (TBI) was defined as a head injury with an Abbreviated Injury Scale (AIS) severity score >= 3. A multivariate logistic regression was performed to quantify the risk of a "severe outcome" defined as death or an expected serious impairment 1 year later. Results: The annual incidence of an ISS of 16+ was 7.7 per 100,000 children. Among the 126 severely injured children included in this study, 40 died (including 16 immediate deaths), and a severe outcome was expected for 54 of the 86 survivors. Children with an "isolated severe TBI" and those with "multiple injuries including TBI" were more likely to have a severe outcome than those who had an "isolated severe injury without TBI" (OR: 7.91; 95%CI: 1.43-43.77 and OR: 8.37; 95%CI: 1.52-46.13, respectively). Age was inversely linked to a severe outcome. The unprotected motor vehicle occupants (MVO) had an odds ratio of 7.56 (95%CI: 1.07-53.56) compared to the protected MVO. Only 30% of children who survived a severe TBI were admitted to rehabilitation. Conclusions: The mechanism of the injury, an injury pattern involving the head and a young age were associated with a severe outcome following a road accident. A majority of children severely injured were not referred to inpatient rehabilitation.	Hosp Civils Lyon, Hop Edouard Herriot, Pediat Intens Care Unit, F-69437 Lyon 03, France; Univ Lyon 1, UMRESTTE, Joint Unit Inrets, French Natl Inst Transport & Safety Res, Bron, France; Natl Inst Publ Hlth Surveillance, InVS, Bron, France	Javouhey, E (corresponding author), Hosp Civils Lyon, Hop Edouard Herriot, Pediat Intens Care Unit, Pl Arsonval, F-69437 Lyon 03, France.	etienne.javouhey@chu-lyon.fr	Javouhey, Etienne/G-3651-2013; Amoros, Emmanuelle/G-4334-2013; Haddak, Mouloud/AAC-4942-2019	Haddak, Mouloud/0000-0003-0633-3167			Adelson P David, 2003, Pediatr Crit Care Med, V4, pS56; Anderson V A, 1997, J Int Neuropsychol Soc, V3, P568; [Anonymous], 1990, ABBR INJ SCAL; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bayir H, 2003, CRIT CARE MED, V31, pS112, DOI 10.1097/01.CCM.0000042464.46603.0E; BOYER MG, 1991, INJURY, V22, P315, DOI 10.1016/0020-1383(91)90014-6; Calkins CM, 2002, J TRAUMA, V53, P1058, DOI 10.1097/00005373-200212000-00005; Cantais E, 2001, INTENS CARE MED, V27, P1511, DOI 10.1007/s001340101039; Emanuelson I, 1997, ACTA PAEDIATR, V86, P730, DOI 10.1111/j.1651-2227.1997.tb08576.x; Ewing-Cobbs L, 1997, J Int Neuropsychol Soc, V3, P581; FAY GC, 1994, ARCH PHYS MED REHAB, V75, P733; Fletcher JM, 1996, J CHILD NEUROL, V11, P283, DOI 10.1177/088307389601100404; GREENSPAN AI, 1994, PEDIATRICS, V94, P425; Hackbarth RM, 2002, CRIT CARE MED, V30, P1630, DOI 10.1097/00003246-200207000-00038; HU XH, 1994, J TRAUMA, V37, P209, DOI 10.1097/00005373-199408000-00010; HUSSAIN LM, 1994, BRIT MED J, V308, P1077, DOI 10.1136/bmj.308.6936.1077; Javouhey E, 2006, ACCIDENT ANAL PREV, V38, P225, DOI 10.1016/j.aap.2005.08.001; Laumon B, 2002, REV EPIDEMIOL SANTE, V50, P277; Laumon B, 1997, 41 ANN P ASS ADV AUT, P127; Levin HS, 1998, CURR OPIN NEUROL, V11, P643, DOI 10.1097/00019052-199812000-00006; MACKAY LE, 1992, ARCH PHYS MED REHAB, V73, P635; Macpherson AK, 2003, J TRAUMA, V55, P454, DOI 10.1097/01.TA.0000042158.79688.51; Masson F, 1996, ARCH PEDIATRIE, V3, P651, DOI 10.1016/0929-693X(96)87085-0; MAZUREK AJ, 1994, J ACCID EMERG MED, V11, P9; MICHAUD LJ, 1992, NEUROSURGERY, V31, P254, DOI 10.1227/00006123-199208000-00010; Nybo T, 1999, BRAIN INJURY, V13, P759; OSBERG JS, 1990, AM J PHYS MED REHAB, V69, P67, DOI 10.1097/00002060-199004000-00004; Ponsford J, 2001, PEDIATRICS, V108, P1297, DOI 10.1542/peds.108.6.1297; Robertson Charlene M T, 2002, Pediatr Crit Care Med, V3, P345, DOI 10.1097/00130478-200210000-00003; Stancin T, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.2.e34; Suominen P, 1998, INJURY, V29, P425; TEPAS JJ, 1990, J PEDIATR SURG, V25, P92, DOI 10.1016/S0022-3468(05)80170-8; Thakker JC, 1997, CRIT CARE MED, V25, P1396, DOI 10.1097/00003246-199708000-00030; Tilford JM, 2001, CRIT CARE MED, V29, P1056, DOI 10.1097/00003246-200105000-00037; Tomlin P, 2002, DEV MED CHILD NEUROL, V44, P828; Valadka S, 2000, J PEDIATR SURG, V35, P684, DOI 10.1053/jpsu.2000.5943; VANDERSLUIS CK, 1995, J TRAUMA, V38, P681, DOI 10.1097/00005373-199505000-00001; WALLER JA, 1995, J TRAUMA, V39, P949, DOI 10.1097/00005373-199511000-00021; WESSON DE, 1992, J TRAUMA, V33, P252, DOI 10.1097/00005373-199208000-00015	39	17	17	0	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0340-6199	1432-1076		EUR J PEDIATR	Eur. J. Pediatr.	AUG	2006	165	8					519	525		10.1007/s00431-006-0118-z			7	Pediatrics	Pediatrics	058SH	WOS:000238684400003	16649025				2021-06-18	
J	Tecco, S; Salini, V; Calvisi, V; Colucci, C; Orso, CA; Festa, F; D'Attilio, M				Tecco, S.; Salini, V.; Calvisi, V.; Colucci, C.; Orso, C. A.; Festa, F.; D'Attilio, M.			Effects of anterior cruciate ligament (ACL) injury on postural control and muscle activity of head, neck and trunk muscles	JOURNAL OF ORAL REHABILITATION			English	Article						anterior cruciate ligament (ACL) of the knee; body posture; head; neck and trunk muscles; stabilometry; surface electromyography	BODY POSTURE; PROPRIOCEPTION; POSITION; RUPTURE	The aim of the study was to evaluate the effects that an anterior cruciate ligament injury of the knee has on postural control and activity of neck, head and trunk muscles to investigate the existence of connections between the masticatory system and body posture. Surface electromyographic activity of the muscles at mandibular rest position, and during maximal voluntary clenching and posturometric and stabilometric measurements of 25 adult patients having pathology on the left knee were compared with a control non-pathological group. At rest, the patients showed a higher muscular activity of anterior temporalis, masseter, sternocleidomastoid and lower trapezius, compared with the control subjects (P < 0.05). At maximal voluntary clenching, the patients showed a lower muscular activity of the right anterior temporalis and masseter and a higher muscular activity of the lower trapezius, compared with the control subjects. For the stabilometric measurements, all the subjects showed a significant reduction in the postural centre of pressure path length during the test with eyes open and cotton rolls, compared with the test with eyes closed and mandibular rest position (P < 0.05). In addition, the patients showed a significant displacement of the postural centre of pressure in a forward direction (P < 0.05) and into the right side (P < 0.05), compared with the control subjects. Anterior cruciate ligament injury appears to be associated to a change in the activity of head, neck and trunk muscles and to a change in the position of the postural centre of pressure. Cotton rolls seem to improve the stability of the subject.	Univ G DAnnunzio, Dept Oral Sci, Chieti, Italy; Univ G DAnnunzio, Dept Orthopaedy & Traumatol, Chieti, Italy; Univ Aquila, Dept Orthopaedy & Traumatol, I-67100 Laquila, Italy	Tecco, S (corresponding author), Via Mainarde 26, I-65121 Pescara, Italy.	simtecc@tin.it	Tecco, Simona/AAZ-2264-2020; D'ATTILIO, MICHELE/AAF-7920-2020	Tecco, Simona/0000-0003-2986-1114; D'ATTILIO, MICHELE/0000-0003-1614-4204; Calvisi, Vittorio/0000-0002-8288-2291; Salini, Vincenzo/0000-0002-8166-3062; FESTA, Felice/0000-0002-5004-7945			BEARD DJ, 1993, J BONE JOINT SURG BR, V75, P311; Beynnon BD, 1999, AM J SPORT MED, V27, P150, DOI 10.1177/03635465990270020601; Bracco P, 1998, CRANIO, V16, P252, DOI 10.1080/08869634.1998.11746065; CRAM JR, 1997, INTRO SURFACE ELECTR; DALY P, 1982, AM J ORTHOD DENTOFAC, V82, P157, DOI 10.1016/0002-9416(82)90494-8; Darnell M W, 1983, J Craniomandibular Pract, V1, P49; Donaldson S, 1990, CLIN EMG SURFACE REC, P143; DRENMAN HS, 1963, DENT PROG, V4, P43; FERR FWL, 1961, EXP NEUROL, V4, P134; Gandevia SC, 1996, HDB PHYSIOL 12, P128; GAUFFIN H, 1990, INT J SPORTS MED, V11, P73, DOI 10.1055/s-2007-1024766; GOLDIE PA, 1992, ARCH PHYS MED REHAB, V73, P348, DOI 10.1016/0003-9993(92)90008-K; GOLDSTEIN DF, 1984, J PROSTHET DENT, V52, P421, DOI 10.1016/0022-3913(84)90460-8; HAIRSTON LE, 1983, J PROSTHET DENT, V49, P271, DOI 10.1016/0022-3913(83)90514-0; Hefti F, 1993, Knee Surg Sports Traumatol Arthrosc, V1, P226; HUGGARE JA, 1992, CRANIO, V10, P173, DOI 10.1080/08869634.1992.11677908; INGLIS JT, 1994, EXP BRAIN RES, V101, P159; Jerosch J, 1996, ARCH ORTHOP TRAUM SU, V115, P162, DOI 10.1007/BF00434546; JOHANSSON H, 1991, J ELECTROMYOGR KINES, V1, P158, DOI 10.1016/1050-6411(91)90032-Z; KILIARIDIS S, 1995, EUR J ORAL SCI, V103, P127, DOI 10.1111/j.1600-0722.1995.tb00013.x; KRAUS S, 1988, TMJ DISORDERS MANAGE, P380; Kuster MS, 1999, MED SCI SPORT EXER, V31, P368, DOI 10.1097/00005768-199903000-00003; Lephart S. M., 1992, J SPORT REHABIL, V1, P188; Lund P, 1970, Scand J Dent Res, V78, P417; Lysholm M, 1998, SCAND J MED SCI SPOR, V8, P432; MacDonald PB, 1996, AM J SPORT MED, V24, P774, DOI 10.1177/036354659602400612; MARFURT CF, 1991, J COMP NEUROL, V303, P489, DOI 10.1002/cne.903030313; MCLEAN LF, 1973, J DENT RES, V52, P1041, DOI 10.1177/00220345730520050701; MINTZ VW, 1977, DIS TEMPOROMANDIBULA, P198; MINUTA H, 1992, CLIN J SPORT MED, V2, P235; ROCABADO M, 1984, ABNORMAL JAW MECH DI; Ruf S, 1997, ACTA ODONTOL SCAND, V55, P44, DOI 10.3109/00016359709091940; SHIAU YY, 1990, CRANIO, V8, P244, DOI 10.1080/08869634.1990.11678318; Shiraishi M, 1996, CLIN J SPORT MED, V6, P32, DOI 10.1097/00042752-199601000-00008; TREVOR B, 2001, MED SCI SPORTS EXERC, V33, P1253; TRIPODAKIS AP, 1995, J PROSTHET DENT, V73, P190, DOI 10.1016/S0022-3913(05)80161-1; URBANOWICZ M, 1991, CRANIO, V9, P174, DOI 10.1080/08869634.1991.11678365; van der Bilt A, 2001, EUR J ORAL SCI, V109, P160, DOI 10.1034/j.1600-0722.2001.00030.x; WINTER D, 1996, BIOMECHANICS CONTROL, P5	39	17	18	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0305-182X	1365-2842		J ORAL REHABIL	J. Oral Rehabil.	AUG	2006	33	8					576	587		10.1111/j.1365-2842.2005.01592.x			12	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	059UO	WOS:000238757900004	16856955				2021-06-18	
J	Korfias, S; Stranjalis, G; Psachoulia, C; Vasiliadis, C; Pitaridis, M; Boviatsis, E; Sakas, DE				Korfias, Stefanos; Stranjalis, George; Psachoulia, Christina; Vasiliadis, Constantinos; Pitaridis, Marinos; Boviatsis, Efstathios; Sakas, Damianos E.			Slight and short-lasting increase of serum S-100B protein in extra-cranial trauma	BRAIN INJURY			English	Article						extra-cranial trauma; multi-trauma; S-100B protein; surgical trauma; traumatic brain injury	MINOR HEAD-INJURY; CARDIOPULMONARY BYPASS; BRAIN-INJURY; S100B LEVELS; CARDIAC-SURGERY; CEREBRAL INJURY; MARKER; RELEASE; S100-BETA; EMERGENCY	Objective: Serum S-100B protein is an established biochemical marker of traumatic brain injury. At the same time, the question of extra-cranial S-100B release has been raised. This study evaluates the post-traumatic and post-operative release kinetics of S-100B in 45 trauma victims without head injury. Method: Serum S-100B protein was measured on admission and every 24 hours for 4 consecutive days. Results: Initial S-100B was slightly increased (median: 0.54 mu g L-1) and correlated with the severity of extra-cranial trauma (p=0.0004, Mann-Whitney test). Both severely (abdominal or chest trauma with or without bone fractures) and mildly (long bone fractures) injured showed a rapid decline of S-100B (< 0.2 mu g L-1) around 72 hours post-trauma. Extra-cranial surgery caused a secondary increase of S-100B, especially in the mildly injured group (p=0.004, Wilcoxon signed rank test). Conclusions: Extra-cranial injury results in a mild elevation of serum S-100B protein that declines rapidly (1-3 days after injury).	Univ Athens, Evangelismos Hosp, Dept Neurosurg, Athens, Greece; Univ Athens, Evangelismos Hosp, Dept Biochem, Athens, Greece; Univ Athens, Evangelismos Hosp, Dept Intens Care Med, Athens, Greece	Korfias, S (corresponding author), Grove Hotel,134 Brighton Grove Rd, Newcastle Upon Tyne NE4 5NT, Tyne & Wear, England.	skorfias@mail.gr					Anderson RE, 2000, ANN THORAC SURG, V69, P847, DOI 10.1016/S0003-4975(99)01526-X; Anderson RE, 1999, ANN THORAC SURG, V67, P1721, DOI 10.1016/S0003-4975(99)00318-5; Anderson RE, 2001, NEUROSURGERY, V48, P1255, DOI 10.1097/00006123-200106000-00012; Anderson RE, 2001, ANN THORAC SURG, V71, P1512, DOI 10.1016/S0003-4975(01)02399-2; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Blomquist S, 1997, J CARDIOTHOR VASC AN, V11, P699, DOI 10.1016/S1053-0770(97)90160-9; Dimopoulou I, 2003, NEUROLOGY, V60, P947, DOI 10.1212/01.WNL.0000049931.77887.7F; EVANS RW, 1994, SEMIN NEUROL, V14, P32, DOI 10.1055/s-2008-1041056; Herrmann M, 2000, J NEUROTRAUM, V17, P113, DOI 10.1089/neu.2000.17.113; INGEBRIGTSEN T, 1995, J NEUROL NEUROSUR PS, V59, P103, DOI 10.1136/jnnp.59.1.103-a; Ingebrigtsen T, 1999, NEUROSURGERY, V45, P468, DOI 10.1097/00006123-199909000-00010; Ingebrigtsen T, 2002, J TRAUMA, V52, P798, DOI 10.1097/00005373-200204000-00038; Johnsson P, 1996, J CARDIOTHOR VASC AN, V10, P120, DOI 10.1016/S1053-0770(96)80187-X; Jonsson H, 1999, ANN THORAC SURG, V68, P2202, DOI 10.1016/S0003-4975(99)00851-6; Raabe A, 1999, NEUROSURGERY, V45, P477, DOI 10.1097/00006123-199909000-00012; Savola O, 2004, J TRAUMA, V56, P1229, DOI 10.1097/01.TA.0000096644.08735.72; Schafer BW, 1996, TRENDS BIOCHEM SCI, V21, P134, DOI 10.1016/S0968-0004(96)80167-8; SCHAFER BW, 1995, GENOMICS, V25, P638, DOI 10.1016/0888-7543(95)80005-7; SHAABANALI M, 2000, BRIT J ANAESTH, V85, P287; Stranjalis G, 2004, J NEUROTRAUM, V21, P1070, DOI 10.1089/0897715041651088; TEASDALE G, 1975, LANCET, V1, P480; Townend WJ, 2002, J NEUROL NEUROSUR PS, V73, P542, DOI 10.1136/jnnp.73.5.542; Unden J, 2005, J TRAUMA, V58, P59, DOI 10.1097/01.TA.0000130613.35877.75; Westaby S, 1996, ANN THORAC SURG, V61, P88, DOI 10.1016/0003-4975(95)00904-3; Wiesmann M, 1997, ACTA NEUROCHIR, V139, P1155, DOI 10.1007/BF01410976	25	17	17	0	0	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	JUL	2006	20	8					867	872		10.1080/02699050600832395			6	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	081ZO	WOS:000240356300009	17060153				2021-06-18	
J	Pasco, A; Ter Minassian, A; Chapon, C; Lemaire, L; Franconi, F; Darabi, D; Caron, C; Benoit, JP; Le Jeune, JJ				Pasco, A; Ter Minassian, A; Chapon, C; Lemaire, L; Franconi, F; Darabi, D; Caron, C; Benoit, JP; Le Jeune, JJ			Dynamics of cerebral edema and the apparent diffusion coefficient of water changes in patients with severe traumatic brain injury. A prospective MRI study	EUROPEAN RADIOLOGY			English	Article						traumatic brain injury; edema; magnetic resonance imaging; diffusion; apparent diffusion coefficient	INTRACEREBRAL HEMORRHAGE; TIME-COURSE; ISCHEMIA; STROKE; BARRIER; MECHANISMS; MODELS; RATS	The distinction between intracellular (ICE) and extracellular edema (ECE) has a crucial prognostic and therapeutic importance in patients with severe traumatic brain injury (STBI). Indeed, ICE usually leads to cellular death, and maintenance of a cerebral perfusion pressure (CPP) above 70 mmHg is still under debate since this practice may increase ECE. The purpose of this study was to describe the ECE and ICE kinetics associated with STBI using quantitative diffusion MRI. Twelve patients were prospectively studied. The initial ADC in ICE measured on day 1.3 +/- 0.7 is significantly reduced compared to normal-appearing parenchyma (0.51 +/- 0.12 * 10(-3) mm(2)/s vs. 0.76 +/- 0.03 * 10(-3) mm(2)/s, n=12, P < 0.0001) and reaches normality on MRI 3 performed on day 14.2 +/- 3.3. In patients presenting an extension of ICE on MRI 2 performed on day 6.7 +/- 1.4 (ADC(MRI2)=0.40 +/- 0.11 * 10(-3) mm(2)/s), ADC values in the extension area at the first MRI were slightly, but not significantly reduced compared to normal parenchyma (0.69 +/- 0.05 * 10(-3) mm(2)/s, P=0.29). Normalization occurred equally by day 14. ADC in ECE (1.34 +/- 0.22 * 10(-3) mm(2)/s) was elevated and stable with time under CPP therapy. Therefore, ECE is not worsened by CCP therapy, and ICE appears more relevant than ECE in STBI.	Univ Angers, Larrey Hosp, Dept Radiol, F-49033 Angers, France; Univ Angers, Larrey Hosp, Dept Anaesthesiol, F-49033 Angers, France; INSERM, U646, F-49100 Angers, France; Univ Angers, F-49100 Angers, France; Univ Angers, SCAS, F-49045 Angers, France	Pasco, A (corresponding author), Univ Angers, Larrey Hosp, Dept Radiol, F-49033 Angers, France.	anpasco@chu-angers.fr	FRANCONI, Florence/K-4258-2015; Benoit, Jean-Pierre/K-4387-2015; LEMAIRE, Laurent/A-3100-2011	FRANCONI, Florence/0000-0001-6725-0803; LEMAIRE, Laurent/0000-0002-1308-9345; BENOIT, Jean-Pierre/0000-0002-6178-7199			Albensi BC, 2000, EXP NEUROL, V162, P61, DOI 10.1006/exnr.2000.7256; Baird AE, 1997, ANN NEUROL, V41, P581, DOI 10.1002/ana.410410506; Barzo P, 1996, J NEUROSURG, V85, P1113, DOI 10.3171/jns.1996.85.6.1113; Barzo P, 1997, J NEUROSURG, V87, P900, DOI 10.3171/jns.1997.87.6.0900; Baskaya MK, 1997, NEUROSCI LETT, V226, P33; Beaumont A, 2000, ACT NEUR S, V76, P147; Beaumont A, 2000, ACTA NEUROCHIR SUPPL, V76, P125; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; Bullock R, 1996, Eur J Emerg Med, V3, P109, DOI 10.1097/00063110-199606000-00010; Carhuapoma JR, 2002, AM J NEURORADIOL, V23, P1322; Dirnagl U, 1999, TRENDS NEUROSCI, V22, P391, DOI 10.1016/S0166-2236(99)01401-0; GRAHAM DI, 1978, J NEUROL SCI, V39, P213, DOI 10.1016/0022-510X(78)90124-7; Hergan K, 2002, EUR RADIOL, V12, P2536, DOI 10.1007/s00330-002-1333-2; Huisman TAGM, 2003, EUR RADIOL, V13, P2283, DOI 10.1007/s00330-003-1843-6; Ito J, 1996, J NEUROSURG, V84, P97, DOI 10.3171/jns.1996.84.1.0097; KLATZO I, 1967, J NEUROPATH EXP NEUR, V26, P1, DOI 10.1097/00005072-196701000-00001; Laurer HL, 2000, EUR J TRAUMA, V26, P95, DOI DOI 10.1007/S000680050007; Lee KR, 1997, J NEUROSURG, V86, P272, DOI 10.3171/jns.1997.86.2.0272; Leker RR, 2002, BRAIN RES REV, V39, P55, DOI 10.1016/S0165-0173(02)00157-1; Marmarou A, 2000, J NEUROSURG, V93, P183, DOI 10.3171/jns.2000.93.2.0183; Marmarou A, 2000, ACT NEUR S, V76, P349; MILLER JD, 1994, INTENS CARE MED, V20, P249, DOI 10.1007/BF01708957; Parizel PM, 2005, EUR RADIOL, V15, P569, DOI 10.1007/s00330-004-2558-z; Portella G, 2000, ACT NEUR S, V76, P273; ROSNER MJ, 1995, J NEUROSURG, V83, P949, DOI 10.3171/jns.1995.83.6.0949; Sahuquillo J, 2001, CURR PHARM DESIGN, V7, P1475, DOI 10.2174/1381612013397311; Sansing LH, 2003, J NEUROSURG, V98, P985, DOI 10.3171/jns.2003.98.5.0985; Schneider G, 2002, MAGN RESON MATER PHY, V14, P233, DOI 10.1016/S1352-8661(02)00068-6; Schwamm LH, 1998, STROKE, V29, P2268, DOI 10.1161/01.STR.29.11.2268; Sharp FR, 2000, J CEREBR BLOOD F MET, V20, P1011, DOI 10.1097/00004647-200007000-00001; Sorensen AG, 2002, AM J NEURORADIOL, V23, P177; STEJSKAL EO, 1965, J CHEM PHYS, V42, P288, DOI 10.1063/1.1695690; Warach S, 1996, STROKE, V27, P1254; Witte OW, 2000, J CEREBR BLOOD F MET, V20, P1149, DOI 10.1097/00004647-200008000-00001; Zazulia AR, 2001, J CEREBR BLOOD F MET, V21, P804, DOI 10.1097/00004647-200107000-00005	35	17	19	0	2	SPRINGER	NEW YORK	233 SPRING STREET, NEW YORK, NY 10013 USA	0938-7994			EUR RADIOL	Eur. Radiol.	JUL	2006	16	7					1501	1508		10.1007/s00330-005-0086-0			8	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	052YP	WOS:000238270300012	16485132				2021-06-18	
J	Salmond, CH; Menon, DK; Chatfield, DA; Pickard, JD; Sahakian, BJ				Salmond, Claire H.; Menon, David K.; Chatfield, Doris A.; Pickard, John D.; Sahakian, Barbara J.			Cognitive reserve as a resilience factor against depression after moderate/severe head injury	JOURNAL OF NEUROTRAUMA			English	Article						cognitive reserve; depression; head injury	TRAUMATIC BRAIN-INJURY; MAJOR DEPRESSION; MOOD DISORDERS; HIPPOCAMPAL VOLUME; SYMPTOMS; ADULTS; LIFE; CLASSIFICATION; INTELLIGENCE; OUTPATIENTS	Depression is one of the most frequently reported and distressing residual complaints in survivors of head injury. Studies investigating the pattern of neuropathology associated with depression post head injury have found little consistency. One explanation for this is that cognitive reserve "protects" against depression either through more efficient processing or more effective compensation. An alternative explanation is that previous studies have used relatively gross measures of lesion location, and variable inclusion criteria and times between scan and injury. This study explored these possibilities in a cohort of survivors of moderate-severe head injury at least 6 months post-injury. Volunteers completed neuropsychological assessments and structural magnetic resonance imaging (MRI) scans. A significant difference between depressed and non-depressed survivors was found, with higher intelligence associated with lower rates of depression. No significant anatomical differences were found between depressed and non-depressed survivors. These results suggest that premorbid intelligence may provide a resilience factor against depression in head injury survivors.	Univ Cambridge, Addenbrookes Hosp, Sch Clin Med, Wolfson Brain Imaging Ctr,Univ Dept Anaesthet, Cambridge CB2 2QQ, England; Univ Cambridge, Addenbrookes Hosp, Sch Clin Med, Wolfson Brain Imaging Ctr,Univ Dept Neurosurg, Cambridge CB2 2QQ, England; Univ Cambridge, Addenbrookes Hosp, Sch Clin Med, Wolfson Brain Imaging Ctr,Univ Dept Psychiat, Cambridge CB2 2QQ, England	Salmond, CH (corresponding author), Univ Cambridge, Addenbrookes Hosp, Sch Clin Med, Wolfson Brain Imaging Ctr,Univ Dept Anaesthet, Cambridge CB2 2QQ, England.	Claire.Salmond@iop.kcl.ac.uk	Sahakian, Barbara/AAW-1198-2020	Sahakian, Barbara/0000-0001-7352-1745	Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0001354B] Funding Source: researchfish; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0600986, G9439390, G0001237, G0001354] Funding Source: Medline		ALOIA MS, 1995, BRAIN INJURY, V9, P575, DOI 10.3109/02699059509008216; Andersson S, 1999, PSYCHOL MED, V29, P447, DOI 10.1017/S0033291798008046; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Ashburner J, 1997, NEUROIMAGE, V6, P344, DOI 10.1006/nimg.1997.0299; Babin PR, 2003, BRAIN INJURY, V17, P889, DOI 10.1080/0269905031000088595; BARONA A, 1984, J CONSULT CLIN PSYCH, V52, P885, DOI 10.1037/0022-006X.52.5.885; Beck A.T., 1987, BECK DEPRESSION INVE; Beck AT., 1970, DEPRESSION CAUSES TR; BORNSTEIN RA, 1989, J NEUROSURG, V70, P509, DOI 10.3171/jns.1989.70.4.0509; Bowen A, 1999, BRAIN INJURY, V13, P547; Campbell S, 2004, AM J PSYCHIAT, V161, P598, DOI 10.1176/appi.ajp.161.4.598; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; Crawford J. R., 1992, HDB NEUROPSYCHOLOGIC, P21; CRAWFORD JR, 1987, BRIT J CLIN PSYCHOL, V26, P313, DOI 10.1111/j.2044-8260.1987.tb01366.x; Deb S, 1999, AM J PSYCHIAT, V156, P374; Drevets WC, 2000, BIOL PSYCHIAT, V48, P813, DOI 10.1016/S0006-3223(00)01020-9; Duncan J, 2000, SCIENCE, V289, P457, DOI 10.1126/science.289.5478.457; FANN JR, 1995, AM J PSYCHIAT, V152, P1493; FEDOROFF JP, 1992, AM J PSYCHIAT, V149, P918; Fleming JM, 1998, J HEAD TRAUMA REHAB, V13, P39, DOI 10.1097/00001199-199810000-00006; FORDYCE DJ, 1983, J NEUROL NEUROSUR PS, V46, P620, DOI 10.1136/jnnp.46.7.620; FRISTON KJ, 1995, HUM BRAIN MAPP, V0003, P00165, DOI DOI 10.1002/HBM.460030303; Glenn MB, 2001, BRAIN INJURY, V15, P811, DOI 10.1080/02699050010025777; GomezHernandez R, 1997, ARCH PHYS MED REHAB, V78, P1321, DOI 10.1016/S0003-9993(97)90304-X; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; GREENSPAN L, 1985, J TRAUMA, V25, P60, DOI 10.1097/00005373-198501000-00010; Groom KN, 1998, ARCH CLIN NEUROPSYCH, V13, P695, DOI 10.1016/S0887-6177(98)00005-5; Hibbard MR, 2004, ARCH PHYS MED REHAB, V85, pS43, DOI 10.1016/j.apmr.2003.08.116; Holsinger T, 2002, ARCH GEN PSYCHIAT, V59, P17, DOI 10.1001/archpsyc.59.1.17; Isacson D, 2005, EUR PSYCHIAT, V20, P205, DOI 10.1016/j.eurpsy.2004.12.011; JENKINSON C, 1993, AUDITORIUM, V2, P7; JENNETT B, 1981, MANAGEMENT HEAD INJU, P77; JORGE RE, 1993, J NERV MENT DIS, V181, P91, DOI 10.1097/00005053-199302000-00004; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; JORGE RE, 1993, J AFFECT DISORDERS, V27, P233, DOI 10.1016/0165-0327(93)90047-N; JORGE RE, 1994, J NEUROSURG, V81, P726, DOI 10.3171/jns.1994.81.5.0726; Lawrence NS, 2004, BIOL PSYCHIAT, V55, P578, DOI 10.1016/j.biopsych.2003.11.017; LISHMAN WA, 1987, ORGANIC PSYCHIATRY, P137; MACNIVEN E, 1993, BRAIN INJURY, V7, P241, DOI 10.3109/02699059309029676; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Mayberg HS, 1997, J NEUROPSYCH CLIN N, V9, P471; Mayberg HS, 1999, AM J PSYCHIAT, V156, P675; Mayes S D, 1989, Brain Inj, V3, P301, DOI 10.3109/02699058909029643; McCleary C, 1998, J CLIN EXP NEUROPSYC, V20, P270, DOI 10.1076/jcen.20.2.270.1172; Nelson HE, 1982, NATL ADULT READING T; OCarroll R, 1995, NEUROCASE, V1, P83, DOI 10.1080/13554799508402350; Ownsworth TL, 1998, BRAIN INJURY, V12, P735, DOI 10.1080/026990598122133; Powell BD, 2003, ARCH CLIN NEUROPSYCH, V18, P277, DOI 10.1016/S0887-6177(02)00135-X; Pukrop R, 2003, PSYCHIAT RES, V119, P63, DOI 10.1016/S0165-1781(03)00110-0; Richter P, 1998, PSYCHOPATHOLOGY, V31, P160, DOI 10.1159/000066239; Rose D, 2001, EUROPEAN SOCIOECONOM; Rosenberg M., 1989, SOC ADOLESCENT SELF; Rosenthal M, 1998, ARCH PHYS MED REHAB, V79, P90, DOI 10.1016/S0003-9993(98)90215-5; RUTHERFORD WH, 1979, LANCET, V1, P1; Salmond CH, 2005, BRAIN, V128, P189, DOI 10.1093/brain/awh352; Satz P, 1998, BRAIN INJURY, V12, P537, DOI 10.1080/026990598122313; Seel RT, 2003, ARCH PHYS MED REHAB, V84, P1621, DOI 10.1053/S0003-9993(03)00270-3; Sherman EMS, 2000, BRAIN INJURY, V14, P621; Sliwinski M, 1998, J HEAD TRAUMA REHAB, V13, P40, DOI 10.1097/00001199-199808000-00004; STARKSTEIN SE, 1988, ARCH GEN PSYCHIAT, V45, P247; STARKSTEIN SE, 1987, BRAIN, V110, P1045, DOI 10.1093/brain/110.4.1045; Stern Y, 2002, J INT NEUROPSYCH SOC, V8, P448, DOI 10.1017/S1355617702813248; Tavares JVT, 2003, PSYCHOL MED, V33, P959, DOI 10.1017/S0033291703008432; Trahan DE, 2001, ARCH CLIN NEUROPSYCH, V16, P435, DOI 10.1016/S0887-6177(00)00051-2; Underhill AT, 2003, BRAIN INJURY, V17, P973, DOI 10.1080/0269905031000110418; Vargha-Khadem F, 2003, P NATL ACAD SCI USA, V100, P10055, DOI 10.1073/pnas.1233756100; Varney NR, 1987, NEUROPSYCHOLOGY, V1, P7, DOI 10.1037//0894-4105.1.1.7; Vythilingam M, 2004, BIOL PSYCHIAT, V56, P101, DOI 10.1016/j.biopsych.2004.04.002; Watt KJ, 1999, J NEUROL NEUROSUR PS, V66, P474, DOI 10.1136/jnnp.66.4.474; Zasler ND, 1997, ARCH PHYS MED REHAB, V78, pS12, DOI 10.1016/S0003-9993(97)90150-7	70	17	19	0	9	MARY ANN LIEBERT INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	JUL	2006	23	7					1049	1058		10.1089/neu.2006.23.1049			10	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	069UG	WOS:000239473200001	16866618				2021-06-18	
J	Segal, ME; Goodman, PH; Goldstein, R; Hauck, W; Whyte, J; Graham, JW; Polansky, M; Hammond, FM				Segal, Mary E.; Goodman, Philip H.; Goldstein, Richard; Hauck, Walter; Whyte, John; Graham, John W.; Polansky, Marcia; Hammond, Flora M.			The accuracy of artificial neural networks in predicting long-term outcome after traumatic brain injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						classification and regression trees; multiple regression; neural networks; outcomes; traumatic brain injury	LOGISTIC-REGRESSION; COMMUNITY INTEGRATION; MISSING-DATA; REHABILITATION; TREE; CLASSIFICATION; DISABILITY; VARIABLES; RECOVERY	Objective: This study compared the accuracy of artificial neural networks to multiple regression and classification and regression trees in predicting outcomes of 1644 patients in the Traumatic Brain Injury Model Systems database 1 year after injury. Methods: Data from rehabilitation admission were used to predict discharge scores on the Functional Independence Measure, the Disability Rating Scale, and the Community Integration Questionnaire. Results: Artificial neural networks did not demonstrate greater accuracy in predicting outcomes than did the more widely used method of multiple regression. Both of these methods outperformed classification and regression trees. Conclusion: Because of the sophisticated form of multiple regression with splines that was used, firm conclusions are limited about the relative accuracy of artificial neural networks compared to more widely used forms of multiple regression.	Res Ctr Hlth Care Decis Making Inc, Wyndmoor, PA 19038 USA; Univ Nevada, Reno, NV 89557 USA; Harvard Univ, Sch Med, Boston, MA USA; Thomas Jefferson Univ, Philadelphia, PA 19107 USA; MossRehab Hosp, Moss Rehabil Res Inst, Philadelphia, PA USA; Penn State Univ, University Pk, PA 16802 USA; Drexel Sch Publ Hlth, Philadelphia, PA USA; Carolinas Rehabil, Charlotte, NC USA	Segal, ME (corresponding author), Res Ctr Hlth Care Decis Making Inc, 8200 Flourtown Ave,Suite 1-C, Wyndmoor, PA 19038 USA.	msegal@healthcaredecisions.org		Whyte, John/0000-0002-4381-1474			Andrews PJD, 2002, J NEUROSURG, V97, P326, DOI 10.3171/jns.2002.97.2.0326; Breiman L, 2001, STAT SCI, V16, P199, DOI 10.1214/ss/1009213726; Brown AW, 2005, J NEUROTRAUM, V22, P1040, DOI 10.1089/neu.2005.22.1040; Burke HB, 1997, CANCER, V79, P857, DOI 10.1002/(SICI)1097-0142(19970215)79:4<857::AID-CNCR24>3.0.CO;2-Y; CHOI SC, 1991, J NEUROSURG, V75, P251, DOI 10.3171/jns.1991.75.2.0251; CHOI SC, 1996, NEUROTRAUMA, P779; CODE C, 1994, CORTEX, V30, P527, DOI 10.1016/S0010-9452(13)80348-6; Corrigan JD, 2003, ARCH PHYS MED REHAB, V84, P153, DOI 10.1053/apmr.2003.50093; Dreiseitl S, 2002, J BIOMED INFORM, V35, P352, DOI 10.1016/S1532-0464(03)00034-0; EFTEKHAR B, 2005, BMC MED INFORM DECIS, P1; El-Solh AA, 2000, ARCH PHYS MED REHAB, V81, P1388, DOI 10.1053/apmr.2000.16348; Fleming J, 1999, BRAIN INJURY, V13, P417; GOODMAN P, 1999, P BIOM SECT JOINT ST; Graham J. W., 2003, HDB PSYCHOL RES METH, V2, P87, DOI DOI 10.1002/0471264385.WEI0204; GRIGSBY J, 1994, ARCH PHYS MED REHAB, V75, P1077, DOI 10.1016/0003-9993(94)90081-7; Harrell Frank E., 2001, REGRESSION MODELING; HART A, 1990, MED INFORM, V15, P229, DOI 10.3109/14639239009025270; Iezzoni LI, 2004, AM J PHYS MED REHAB, V83, P316, DOI 10.1097/01.PHM.0000118041.17739.BB; Lang EW, 1997, NEUROL RES, V19, P274, DOI 10.1080/01616412.1997.11740813; Oczkowski WJ, 1997, ARCH PHYS MED REHAB, V78, P340, DOI 10.1016/S0003-9993(97)90222-7; Ohno-Machado L, 1999, AM J PHYS MED REHAB, V78, P392, DOI 10.1097/00002060-199907000-00022; Olshen RA, 1984, CLASSIFICATION REGRE; Ottenbacher KJ, 2001, J CLIN EPIDEMIOL, V54, P1159, DOI 10.1016/S0895-4356(01)00395-X; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Reker DM, 1998, ARCH PHYS MED REHAB, V79, P751, DOI 10.1016/S0003-9993(98)90351-3; Rubin DB., 1987, MULTIPLE IMPUTATION; Schafer JL, 2002, PSYCHOL METHODS, V7, P147, DOI 10.1037//1082-989X.7.2.147; Schafer JL, 1998, MULTIVAR BEHAV RES, V33, P545, DOI 10.1207/s15327906mbr3304_5; Schafer JL., 1997, ANAL INCOMPLETE MULT; TEMKIN NR, 1995, J NEUROSURG, V82, P764, DOI 10.3171/jns.1995.82.5.0764; Tu JV, 1996, J CLIN EPIDEMIOL, V49, P1225, DOI 10.1016/S0895-4356(96)00002-9; *UDS, 1997, GUID UN DAT SET MED; Wagner AK, 2000, J TRAUMA, V49, P411, DOI 10.1097/00005373-200009000-00005; WILLER B, 1994, AM J PHYS MED REHAB, V73, P103; Willer B., 1993, J HEAD TRAUMA REHAB, V8, P75, DOI DOI 10.1097/00001199-199308020-00009	35	17	17	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JUL-AUG	2006	21	4					298	314		10.1097/00001199-200607000-00003			17	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	064SJ	WOS:000239109100003	16915007				2021-06-18	
J	Kreipke, CW; Morgan, NC; Petrov, T; Rafols, JA				Kreipke, Christian W.; Morgan, Noah C.; Petrov, Theodor; Rafols, Jose A.			RETRACTED: Calponin and caldesmon cellular domains in reacting microvessels following traumatic brain injury(Retracted article. See vol. 110, pg. 64, 2017)	MICROVASCULAR RESEARCH			English	Article; Retracted Publication						microvascular tone; neurotrauma; contractile proteins	VASCULAR SMOOTH-MUSCLE; ENDOTHELIAL GROWTH-FACTOR; PORCINE CORONARY-ARTERY; NITRIC-OXIDE SYNTHASE; PROTEIN-KINASE-C; CONTRACTILE PROTEINS; MESSENGER-RNA; EXPRESSION; PHOSPHORYLATION; MYOSIN	Calponin (Cp) and caldesmon (Cd) are actin-binding proteins involved in the regulation of smooth muscle (SM) tone during blood vessel contraction. While in vitro studies have reported modifications of these proteins during vessel contractility, their role in vivo remains unclear. Traumatic brain injury (TBI) causes disruption of cerebral microvascular tone, leading to sustained contractility in reacting microvessels and cerebral hypoperfusion. This study aimed to determine the spatial and temporal expressions of Cp and Cd in rat cerebral cortical and hippocampal microvessels post-TBI. Reacting microvessels were analyzed in control, 4, 24, and 48 h post-injury. Single and double immunocytochemical techniques together with semiquantitative analyses revealed a Cp upregulation in SM at all time frames post-TBI; with the protein migrating from SM cytosol to the vicinity of the cell membrane. Similarly, Cd immunoreactivity significantly increased in both SM and endothelial cells (En). However, while Cp and Cd in SM remained elevated, their levels in En returned to normal at 48 h post-TBI. The results suggest that Cp and Cd levels increase while compartmentalizing to specific subcellular domains. These changes are temporally associated with modifications in the cytoskeleton and contractile apparatus of SM and En during blood vessel contractility. Furthermore, these changes may underlie the state of sustained contractility and hypoperfusion observed in reacting microvessels after TBI. (c) 2006 Elsevier Inc. All rights reserved.	Wayne State Univ, Sch Med, Dept Anat & Cell Biol, Detroit, MI 48201 USA	Rafols, JA (corresponding author), Wayne State Univ, Sch Med, Dept Anat & Cell Biol, 540 E Cranfield, Detroit, MI 48201 USA.	jrafols@med.wayne.edu			NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS039860] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS039860] Funding Source: NIH RePORTER		Abu-Judeh HH, 1999, NUCL MED COMMUN, V20, P505, DOI 10.1097/00006231-199906000-00003; Ahn MJ, 2004, J NEUROTRAUM, V21, P1431, DOI 10.1089/neu.2004.21.1431; ARBUSTINI E, 1993, AM J CARDIOL, V71, P1382, DOI 10.1016/0002-9149(93)90597-6; Armstead WM, 2004, J NEUROTRAUM, V21, P1204, DOI 10.1089/0897715041953849; Bandopadhyay R, 2001, J NEUROCYTOL, V30, P35, DOI 10.1023/A:1011965307612; BARANY K, 1992, BIOCHEM BIOPH RES CO, V187, P847, DOI 10.1016/0006-291X(92)91274-T; BIRUKOV KG, 1991, CELL TISSUE RES, V266, P579, DOI 10.1007/BF00318599; Borovikov YS, 1999, INT REV CYTOL, V189, P267, DOI 10.1016/S0074-7696(08)61389-3; CHALOVICH JM, 1990, ANN NY ACAD SCI, V599, P85; Fee DB, 2004, BRAIN RES, V1012, P52, DOI 10.1016/j.brainres.2004.03.028; Folkerts MM, 1998, J NEUROTRAUM, V15, P349, DOI 10.1089/neu.1998.15.349; Foster DB, 2004, J BIOL CHEM, V279, P53387, DOI 10.1074/jbc.M410109200; FURST DO, 1986, EMBO J, V5, P251, DOI 10.1002/j.1460-2075.1986.tb04206.x; Gimona M, 1996, BIOCH SMOOTH MUSCLE, P91; Graceffa P, 1996, J BIOL CHEM, V271, P30336, DOI 10.1074/jbc.271.48.30336; KAMM KE, 1985, AM J PHYSIOL, V249, pC238; KATSUYAMA H, 1992, J BIOL CHEM, V267, P14555; Lee YH, 2000, J BIOL CHEM, V275, P3213, DOI 10.1074/jbc.275.5.3213; LEHMAN W, 1987, BIOCHIM BIOPHYS ACTA, V914, P35, DOI 10.1016/0167-4838(87)90158-0; LIN Y, 1993, J BIOCHEM-TOKYO, V113, P643, DOI 10.1093/oxfordjournals.jbchem.a124096; Mabuchi K, 1996, J MUSCLE RES CELL M, V17, P243, DOI 10.1007/BF00124246; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; MARSTON SB, 1991, BIOCHEM J, V279, P1; McBeth BD, 2005, ACAD EMERG MED, V12, P483, DOI 10.1197/j.aem.2004.11.028; MINO T, 1995, BIOCHEM BIOPH RES CO, V208, P397, DOI 10.1006/bbrc.1995.1351; Mirzapoiazova T, 2005, J CELL PHYSIOL, V203, P520, DOI 10.1002/jcp.20244; Nag S, 2002, J NEUROPATH EXP NEUR, V61, P778, DOI 10.1093/jnen/61.9.778; NORTH AJ, 1994, J CELL SCI, V107, P437; Petrov T, 2002, NEUROSCIENCE, V115, P275, DOI 10.1016/S0306-4522(02)00345-7; Petrov T, 2001, NEUROL RES, V23, P139, DOI 10.1179/016164101101198479; Petrov T, 2000, ACTA NEUROPATHOL, V100, P196, DOI 10.1007/s004019900167; Rafols D, 2004, NEUROSCI LETT, V362, P154, DOI 10.1016/j.neulet.2004.03.021; Sakihara C, 1996, BIOCHEM BIOPH RES CO, V222, P195, DOI 10.1006/bbrc.1996.0721; Skold MK, 2005, J NEUROTRAUM, V22, P353, DOI 10.1089/neu.2005.22.353; Small JV, 1998, ACTA PHYSIOL SCAND, V164, P341; SOBUE K, 1991, J BIOL CHEM, V266, P12115; Steiner J, 2004, NITRIC OXIDE-BIOL CH, V10, P162, DOI 10.1016/j.niox.2004.03.005; Suzuki R, 2003, ACTA NEUROCHIR SUPPL, V86, P277; Szmydynger-Chodobska J, 2004, J NEUROTRAUM, V21, P1090, DOI 10.1089/0897715041651033; Walsh MP, 1996, BIOCHEM CELL BIOL, V74, P485, DOI 10.1139/o96-053; Worth NF, 2001, CELL MOTIL CYTOSKEL, V49, P130, DOI 10.1002/cm.1027; Yang JX, 2004, ACTA BIOCH BIOPH SIN, V36, P529, DOI 10.1093/abbs/36.8.529; Yuasa U, 1999, J MOL CELL CARDIOL, V31, P1281, DOI 10.1006/jmcc.1999.0960	43	17	18	0	8	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0026-2862	1095-9319		MICROVASC RES	Microvasc. Res.	MAY	2006	71	3					197	204		10.1016/j.mvr.2006.02.002			8	Peripheral Vascular Disease	Cardiovascular System & Cardiology	056FP	WOS:000238507300006	16635497				2021-06-18	
J	Holmes, JF; Hendey, GW; Oman, JA; Norton, VC; Lazarenko, G; Ross, SE; Hoffman, JR; Mower, WR				Holmes, JF; Hendey, GW; Oman, JA; Norton, VC; Lazarenko, G; Ross, SE; Hoffman, JR; Mower, WR		NEXUS Grp	Epidemiology of blunt head injury victims undergoing ED cranial computed tomographic scanning	AMERICAN JOURNAL OF EMERGENCY MEDICINE			English	Article							TRAUMATIC BRAIN-INJURY; UNITED-STATES; PREINJURY WARFARIN; POPULATION; FALLS; MILD; SURVEILLANCE; PREDICTOR; MECHANISM; SEVERITY	Study Objective: We sought to describe the epidemiology of emergency department (ED) patients with blunt head injury undergoing cranial computed tomography (CT) scanning for the evaluation of possible traumatic brain injury (TBI). Methods: Prospective, multicenter, observational Study of ED patients undergoing cranial CT after blunt head injury. Patient's date of birth, sex, and race/ethnicity were documented before CT scanning, Individual patients were considered to have "significant" TBI if the official radiographic interpretation at the end of all imaging studies associated with the trauma was consistent with any of a set of predefined diagnoses. The relative prevalence of TBI among various prespecified groups from those undergoing cranial CT scanning was also calculated. Results: Of 13 728 patients who were enrolled, 8988 (65%) were men and 1193 (8.7%) had a significant acute TBI. Demographic findings associated with increased risk of TBI, among patients selected for scanning, included the following: age below 10 years (relative risk [RR] = 1.44, 95% confidence interval [CI], 1.19-1.77); age above 65 years (RR = 1.59; 95% Cl, 1.40-1.80), and male sex (RR = 1.27; 95% Cl, 1.30-1.43). Conclusion: Among patients selected for cranial CT scanning after blunt head injury, men, patients younger than 10 years, and those older than 65 years have an increased likelihood of significant TBI. (c) 2006 Elsevier Inc. All rights reserved.	Univ Calif Davis, Med Ctr, Div Emergency Med, Sacramento, CA 95817 USA; Univ Calif San Francisco, Fresno Med Educ Program, Dept Emergency Med, Fresno, CA 93702 USA; Univ Calif Irvine, Coll Med, Dept Emergency Med, Irvine, CA 92868 USA; Vanderbilt Univ, Sch Med, Dept Emergency Med, Nashville, TN 37232 USA; Univ Calgary, Foothills Med Ctr, Dept Emergency Med, Calgary, AB T2N 2T9, Canada; Cooper Hlth Syst, Dept Surg, Div Trauma, Camden, NJ 08103 USA; Univ Calif Los Angeles, Sch Med, Div Emergency Med, Los Angeles, CA 90024 USA	Holmes, JF (corresponding author), Univ Calif Davis, Med Ctr, Div Emergency Med, PSSB 2100, Sacramento, CA 95817 USA.	jfholmes@ucdavis.edu		Hendey, Gregory/0000-0002-0170-8743	PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [1 R01] Funding Source: Medline		Adekoya N, 2004, PUBLIC HEALTH REP, V119, P486, DOI 10.1016/j.phr.2004.07.006; AMACHER AL, 1987, NEUROSURGERY, V20, P954; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Coronado VG, 2005, J HEAD TRAUMA REHAB, V20, P215, DOI 10.1097/00001199-200505000-00005; de Guise E, 2005, CAN J NEUROL SCI, V32, P186, DOI 10.1017/S0317167100003954; DEMAREST GB, 1990, GERIATRICS, V45, P36; Garra G, 1999, ACAD EMERG MED, V6, P121, DOI 10.1111/j.1553-2712.1999.tb01048.x; GENNARELLI TA, 1982, J TRAUMA, V22, P680, DOI 10.1097/00005373-198208000-00005; Guerrero JL, 2000, BRAIN INJURY, V14, P181, DOI 10.1080/026990500120827; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Helling TS, 1999, J TRAUMA, V46, P453, DOI 10.1097/00005373-199903000-00019; Jager TE, 2000, ACAD EMERG MED, V7, P134, DOI 10.1111/j.1553-2712.2000.tb00515.x; Jindal A, 2002, WORLD J SURG, V26, P13; Kennedy DM, 2000, J TRAUMA, V48, P451, DOI 10.1097/00005373-200003000-00012; KRAUS JF, 1987, PEDIATRICS, V79, P501; KRAUS JF, 1986, AM J DIS CHILD, V140, P687, DOI 10.1001/archpedi.1986.02140210085032; KRAUS JF, 1988, J TRAUMA, V28, P1637, DOI 10.1097/00005373-198812000-00004; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; Langlois Jean A, 2003, MMWR Surveill Summ, V52, P1; Lowery DW, 2001, ANN EMERG MED, V38, P12, DOI 10.1067/mem.2001.116149; Mack LR, 2003, J EMERG MED, V24, P157, DOI 10.1016/S0736-4679(02)00714-X; Masson F, 2003, BRAIN INJURY, V17, P279, DOI 10.1080/0269905021000030805; Masson F, 2001, J TRAUMA, V51, P481, DOI 10.1097/00005373-200109000-00010; Mina AA, 2002, J TRAUMA, V53, P668, DOI 10.1097/00005373-200210000-00008; Mosenthal AC, 2002, J TRAUMA, V52, P907, DOI 10.1097/00005373-200205000-00015; Mower WR, 2002, ANN EMERG MED, V40, P505, DOI 10.1067/mem.2002.129245; Murray JA, 2000, AM SURGEON, V66, P863; Pickett W, 2001, CAN MED ASSOC J, V165, P288; Quigley MR, 1997, J TRAUMA, V42, P7, DOI 10.1097/00005373-199701000-00003; Reid SR, 2001, ARCH PEDIAT ADOL MED, V155, P784, DOI 10.1001/archpedi.155.7.784; ROZYCKI GS, 1991, ARCH EMERG MED, V8, P245; Sallee D, 2000, Alaska Med, V42, P37; Simon B, 2001, J TRAUMA, V51, P231, DOI 10.1097/00005373-200108000-00004; STEIN J, 1995, ARCH PHYS MED REHAB, V76, P840, DOI 10.1016/S0003-9993(95)80549-4; Sterling DA, 2001, J TRAUMA, V50, P116, DOI 10.1097/00005373-200101000-00021; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; Thurman DJ, 1996, WESTERN J MED, V165, P192; Velmahos GC, 2001, J AM COLL SURGEONS, V192, P147, DOI 10.1016/S1072-7515(00)00790-0; Wang MY, 2001, J PEDIATR SURG, V36, P1528, DOI 10.1053/jpsu.2001.27037; Wojcik R, 2001, J TRAUMA, V51, P1147, DOI 10.1097/00005373-200112000-00021	41	17	17	0	1	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0735-6757	1532-8171		AM J EMERG MED	Am. J. Emerg. Med.	MAR	2006	24	2					167	173		10.1016/j.ajem.2005.08.009			7	Emergency Medicine	Emergency Medicine	021FJ	WOS:000235968800006	16490645				2021-06-18	
B	Dennis, M		Risberg, J; Grafman, J		Dennis, Maureen			Prefrontal cortex: typical and atypical development	FRONTAL LOBES: DEVELOPMENT, FUNCTION, AND PATHOLOGY	Series for the International Neuropsychological Society		English	Article; Book Chapter							TRAUMATIC BRAIN-INJURY; CLOSED-HEAD-INJURY; DEFICIT HYPERACTIVITY DISORDER; HUMAN FRONTAL-CORTEX; AGE-RELATED-CHANGES; WORKING-MEMORY; COGNITIVE-DEVELOPMENT; INHIBITORY CONTROL; CEREBELLUM CONTRIBUTES; INTERFERENCE CONTROL		Hosp Sick Children, Dept Psychol, Toronto, ON M5G 1X8, Canada	Dennis, M (corresponding author), Hosp Sick Children, Dept Psychol, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.						ACKERLY SS, 1947, RES PUBL ASSOC RES N, V27, P479; Ackerly SS, 1964, FRONTAL GRANULAR COR, P192; Allen G, 1997, SCIENCE, V275, P1940, DOI 10.1126/science.275.5308.1940; Alloway TP., 1997, DEV MEMORY CHILDHOOD, P163; APPOLLONIO IM, 1993, NEUROLOGY, V43, P1536, DOI 10.1212/WNL.43.8.1536; Band GPH, 2000, J EXP CHILD PSYCHOL, V75, P263, DOI 10.1006/jecp.1999.2538; Barnes MA, 2001, BRAIN LANG, V76, P253, DOI 10.1006/brln.2000.2385; Bechara A, 2004, BRAIN COGNITION, V55, P30, DOI 10.1016/j.bandc.2003.04.001; Bibby H, 2005, NEUROPSYCHOLOGIA, V43, P99, DOI 10.1016/j.neuropsychologia.2004.04.027; Bird CM, 2004, BRAIN, V127, P914, DOI 10.1093/brain/awh108; BJORKLUND DF, 1990, DEV REV, V10, P48, DOI 10.1016/0273-2297(90)90004-N; Blair RJR, 2004, BRAIN COGNITION, V55, P198, DOI 10.1016/s0278-2626(03)00276-8; Broca P., 1877, SOC ANTHR PARIS, V2, P217; BUCK R, 1994, BIOL PSYCHOL, V38, P95, DOI 10.1016/0301-0511(94)90032-9; BUCK R, 1994, J PRAGMATICS, V22, P265, DOI 10.1016/0378-2166(94)90112-0; Bunge SA, 2001, BRAIN, V124, P2074, DOI 10.1093/brain/124.10.2074; Cabeza R, 2000, J COGNITIVE NEUROSCI, V12, P1, DOI 10.1162/08989290051137585; CECI SJ, 1985, CHILD DEV, V56, P152, DOI 10.2307/1130182; CHAPMAN SB, 1992, BRAIN LANG, V43, P42, DOI 10.1016/0093-934X(92)90020-F; CRICK NR, 1994, PSYCHOL BULL, V115, P74, DOI 10.1037/0033-2909.115.1.74; Crone EA, 2004, DEV NEUROPSYCHOL, V25, P251, DOI 10.1207/s15326942dn2503_2; Culhane-Shelburne K., 2002, J INT NEUROPSYCH SOC, V8, P623; D'Esposito M, 1999, BRAIN COGNITION, V41, P66, DOI 10.1006/brcg.1999.1096; DAMASIO H, 1994, SCIENCE, V264, P1102, DOI 10.1126/science.8178168; DAVIDSON D, 1991, COGNITIVE DEV, V6, P77, DOI 10.1016/0885-2014(91)90007-Z; DEMETRE JD, 1992, BRIT J PSYCHOL, V83, P189, DOI 10.1111/j.2044-8295.1992.tb02434.x; DEMOREST A, 1984, CHILD DEV, V55, P1527, DOI 10.2307/1130022; Dempster F.N., 1993, EMERGING THEMES COGN, P3, DOI DOI 10.1007/978-1-4613-9220-0_1; Dennis M, 1998, BRAIN LANG, V61, P450, DOI 10.1006/brln.1997.1886; DENNIS M, 1991, DEV NEUROPSYCHOL, V7, P327, DOI 10.1080/87565649109540497; Dennis M, 1996, DEV NEUROPSYCHOL, V12, P77, DOI 10.1080/87565649609540641; Dennis M, 2005, NEUROPSYCHOLOGIA, V43, P976, DOI 10.1016/j.neuropsychologia.2004.08.012; DENNIS M, 1990, BRAIN LANG, V39, P428, DOI 10.1016/0093-934X(90)90149-B; Dennis M, 2001, BRAIN LANG, V78, P1, DOI 10.1006/brln.2000.2431; Dennis M, 2004, BRAIN, V127, P1292, DOI 10.1093/brain/awh154; Dennis M, 1999, CHANGING NERVOUS SYSTEM, P172; Dennis M, 2000, SCI PRACT NEUROPSYCH, P3; Dennis M, 2000, APHASIOLOGY, V14, P391, DOI 10.1080/026870300401423; Dennis M., 1977, LANGUAGE DEV NEUROLO, P93; Dennis M., 2003, BEHAV NEUROLOGY NEUR, P783; Dennis M., 1988, CLIN NEUROPSYCHOLOGY, P85; Dennis M., 1995, TRAUMATIC HEAD INJUR, P165; Dennis M., 2006, THEORY MIND DE UNPUB; DENNIS M, 2004, BRAIN SPINAL TUMORS, P213; Derrfuss J, 2004, NEUROIMAGE, V23, P604, DOI 10.1016/j.neuroimage.2004.06.007; Diamond A, 1996, PHILOS T R SOC B, V351, P1483, DOI 10.1098/rstb.1996.0134; Diamond A, 1996, DEV PSYCHOBIOL, V29, P315, DOI 10.1002/(SICI)1098-2302(199605)29:4<315::AID-DEV2>3.0.CO;2-T; Diamond A, 2000, CHILD DEV, V71, P44, DOI 10.1111/1467-8624.00117; Diamond A, 2004, AM J PSYCHIAT, V161, P125, DOI 10.1176/appi.ajp.161.1.125; Dowsett SM, 2000, DEV PSYCHOBIOL, V36, P161, DOI 10.1002/(SICI)1098-2302(200003)36:2<161::AID-DEV7>3.0.CO;2-0; DUFRESNE A, 1989, J EXP CHILD PSYCHOL, V47, P274, DOI 10.1016/0022-0965(89)90033-7; Dum RP, 2003, J NEUROPHYSIOL, V89, P634, DOI 10.1152/jn.00626.2002; Durston S, 2002, DEVELOPMENTAL SCI, V5, pF9, DOI 10.1111/1467-7687.00235; Ekman P., 1978, FACIAL ACTION CODING; ENGLE RW, 1995, PSYCHOL SCI, V6, P122, DOI 10.1111/j.1467-9280.1995.tb00318.x; Eslinger PJ, 2004, BRAIN COGNITION, V55, P84, DOI 10.1016/s0278-2626(03)00281-1; ESLINGER PJ, 1992, ARCH NEUROL-CHICAGO, V49, P764, DOI 10.1001/archneur.1992.00530310112021; FIEZ JA, 1992, BRAIN, V115, P155, DOI 10.1093/brain/115.1.155; Fine C, 2001, BRAIN, V124, P287, DOI 10.1093/brain/124.2.287; Fivush R., 1990, KNOWING REMEMBERING, P223; FLAVELL JH, 1985, DEV PSYCHOL, V21, P207, DOI 10.1037/0012-1649.21.2.207; Fletcher JM, 2005, J NEUROSURG, V102, P268, DOI 10.3171/ped.2005.102.3.0268; Fletcher PC, 2001, BRAIN, V124, P849, DOI 10.1093/brain/124.5.849; FLETCHER PC, 1995, COGNITION, V57, P109, DOI 10.1016/0010-0277(95)00692-R; Fodor J. A., 1983, MODULARITY MIND; Friedman NP, 2004, J EXP PSYCHOL GEN, V133, P101, DOI 10.1037/0096-3445.133.1.101; Frye D, 1995, COGNITIVE DEV, V10, P483, DOI 10.1016/0885-2014(95)90024-1; Fuster JM, 2000, PSYCHOBIOLOGY, V28, P125; GARRITY LI, 1975, DEV PSYCHOL, V11, P274, DOI 10.1037/h0076563; Gazzaley A, 2005, J COGNITIVE NEUROSCI, V17, P507, DOI 10.1162/0898929053279522; GERSTADT CL, 1994, COGNITION, V53, P129, DOI 10.1016/0010-0277(94)90068-X; Gogtay N, 2004, P NATL ACAD SCI USA, V101, P8174, DOI 10.1073/pnas.0402680101; Goldman-Rakic P. S., 2002, PRINCIPLES FRONTAL L, P31; Goldman-Rakic PS, 1997, DEV PREFRONTAL CORTE, P27; GRAFMAN J, 1992, NEUROLOGY, V42, P1493, DOI 10.1212/WNL.42.8.1493; Grafman J., 2002, PRINCIPLES FRONTAL L, P209; Grafman J., 1989, INTEGRATING THEORY P, P93; GRATTAN LM, 1992, BRAIN COGNITION, V20, P185, DOI 10.1016/0278-2626(92)90068-W; Hall W. S., 1986, MODELS MODULES STUDI, P26; Hanten G, 2004, DEV NEUROPSYCHOL, V25, P85, DOI 10.1207/s15326942dn2501&2_6; Hanten G, 1999, DEV NEUROPSYCHOL, V16, P393, DOI 10.1207/S15326942DN1603_23; Happaney K, 2003, DEVELOPMENTAL SCI, V6, P468, DOI 10.1111/1467-7687.00301; Happe F, 2001, NEUROPSYCHOLOGIA, V39, P83, DOI 10.1016/S0028-3932(00)00093-2; Harlow J. M., 1993, HIST PSYCHIATR, V4, P274, DOI [10.1177/0957154X9300401407, DOI 10.1177/0957154X9300401407]; Harnishfeger K. K., 1993, EMERGING THEMES COGN, DOI DOI 10.1007/978-1-4613-9220-0_; Harnishfeger KK, 1996, J EXP CHILD PSYCHOL, V62, P292, DOI 10.1006/jecp.1996.0032; HAVERKATE H, 1990, J PRAGMATICS, V14, P77, DOI 10.1016/0378-2166(90)90065-L; HAYES-ROTH B, 1979, Cognitive Science, V3, P275, DOI 10.1016/S0364-0213(79)80010-5; HEBB D. O., 1942, PROC AMER PHIL SOC, V85, P275; Houghton George, 1994, P53; Hughes C, 2002, INFANT CHILD DEV, V11, P69, DOI 10.1002/icd.296; HULME C, 1995, J CHILD PSYCHOL PSYC, V36, P373, DOI 10.1111/j.1469-7610.1995.tb01297.x; HUTTENLOCHER PR, 1979, BRAIN RES, V163, P195; Ivry R B, 1989, J Cogn Neurosci, V1, P136, DOI 10.1162/jocn.1989.1.2.136; Janusz JA, 2002, CHILD NEUROPSYCHOL, V8, P179, DOI 10.1076/chin.8.3.179.13499; KARTTUNEN L, 1971, LANGUAGE, V47, P340, DOI 10.2307/412084; Kates WR, 2002, PSYCHIAT RES-NEUROIM, V116, P63, DOI 10.1016/S0925-4927(02)00066-5; Kennard MA, 1940, ARCH NEURO PSYCHIATR, V44, P377, DOI 10.1001/archneurpsyc.1940.02280080137008; Kennard MA, 1941, J NEUROPHYSIOL, V4, P512; Kennard MA, 1938, J NEUROPHYSIOL, V1, P477; Kennard MA, 1942, MT SINAI J MED, V9, P594; Kerr A, 2004, BRAIN COGNITION, V55, P148, DOI 10.1016/s0278-2626(03)00275-6; KIM SG, 1994, SCIENCE, V265, P949, DOI 10.1126/science.8052851; Kiparsky Paul, 1970, PROGR LINGUISTICS, P143; Kirkham NZ, 2003, DEVELOPMENTAL SCI, V6, P474, DOI 10.1111/1467-7687.00303; Kochanska G, 1996, CHILD DEV, V67, P490, DOI 10.2307/1131828; Kolb B, 2004, BRAIN COGNITION, V55, P104, DOI 10.1016/s0278-2626(03)00278-1; Konrad K, 2000, CHILD NEUROPSYCHOL, V6, P286, DOI 10.1076/chin.6.4.286.3145; Kreutzer M. A., 1975, MEMORY OBSERVED REME, P343; Kvavilashvili L, 2001, DEV PSYCHOL, V37, P418, DOI 10.1037//0012-1649.37.3.418; Kvavilashvili L., 1996, PROSPECTIVE MEMORY T, P23; Lee ZI, 2003, AM J PHYS MED REHAB, V82, P556, DOI 10.1097/01.PHM.0000073830.15643.6A; Levin HS, 1996, CORTEX, V32, P461, DOI 10.1016/S0010-9452(96)80004-9; Levin HS, 2004, J INT NEUROPSYCH SOC, V10, P305, DOI 10.1017/S1355617704102129; LEVIN HS, 1991, DEV NEUROPSYCHOL, V7, P377, DOI 10.1080/87565649109540499; LEVIN HS, 1993, ARCH NEUROL-CHICAGO, V50, P897, DOI 10.1001/archneur.1993.00540090008004; Levin HS, 2001, NEUROPSYCHOLOGY, V15, P557, DOI 10.1037//0894-4105.15.4.557; Levin HS, 2000, NEUROLOGY, V54, P647, DOI 10.1212/WNL.54.3.647; LEVIN HS, 1994, NEUROPSYCHOLOGY, V8, P171, DOI DOI 10.1037/0894-4105.8.2.171; Levine B, 2004, BRAIN COGNITION, V55, P54, DOI 10.1016/s0278-2626(03)00280-x; Levisohn L, 2000, BRAIN, V123, P1041, DOI 10.1093/brain/123.5.1041; LIVESEY DJ, 1991, AUST J PSYCHOL, V43, P133, DOI 10.1080/00049539108260137; Lough S, 2001, NEUROCASE, V7, P123, DOI 10.1093/neucas/7.2.123; MACMILLAN M, 2000, ODD KIND FAME STORIE; Manly T., 1999, TEST EVERYDAY ATTENT; MARLOWE WB, 1992, BRAIN COGNITION, V20, P205, DOI 10.1016/0278-2626(92)90070-3; Matsuzawa J, 2001, CEREB CORTEX, V11, P335, DOI 10.1093/cercor/11.4.335; Max J. E., 2005, J AM ACAD CHILD ADOL, V44, P435; Max JE, 2006, J NEUROPSYCH CLIN N, V18, P21, DOI 10.1176/appi.neuropsych.18.1.21; Mazzoni G, 1998, METACOGNITION AND COGNITIVE NEUROPSYCHOLOGY, pIX; McCabe, 1997, PROBLEM MEANING BEHA, P377, DOI DOI 10.1016/S0166-4115(97)80142-2; McCauley S. R., 2000, ANN M COGN NEUR SOC; McCauley S. R., 2001, 3 INT C MEM ICOM 3 V; McCauley SR, 2004, DEV NEUROPSYCHOL, V25, P5, DOI 10.1207/s15326942dn2501&2_2; MENDELSOHN D, 1992, CHILD NERV SYST, V8, P445, DOI 10.1007/BF00274405; Middleton FA, 2001, J NEUROSCI, V21, P700, DOI 10.1523/JNEUROSCI.21-02-00700.2001; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Miller EK, 2000, NAT REV NEUROSCI, V1, P59, DOI 10.1038/35036228; MIZE J, 1988, DEV PSYCHOL, V24, P782, DOI 10.1037/0012-1649.24.6.782; Montgomery J. W., 1995, J SPEECH HEAR RES, V33, P187; Moses LJ, 2001, CHILD DEV, V72, P688, DOI 10.1111/1467-8624.00306; O'Donnell S, 2005, NEUROIMAGE, V24, P948, DOI 10.1016/j.neuroimage.2004.10.014; Oberauer K, 2000, PSYCHON B REV, V7, P727, DOI 10.3758/BF03213013; Pascual-Leone J, 2001, BEHAV BRAIN SCI, V24, P136, DOI 10.1017/S0140525X01453921; Passolunghi MC, 1995, INT J BEHAV DEV, V18, P631, DOI 10.1177/016502549501800404; Paus T, 2005, TRENDS COGN SCI, V9, P60, DOI 10.1016/j.tics.2004.12.008; Perner J, 2002, CHILD DEV, V73, P752, DOI 10.1111/1467-8624.00436; PETRIDES M, 1993, P NATL ACAD SCI USA, V90, P878, DOI 10.1073/pnas.90.3.878; Petrides M, 2002, PRINCIPLES FRONTAL L, V1, P31, DOI DOI 10.1093/ACPROF:OSO/9780195134971.003.0003; PFEFFERBAUM A, 1994, ARCH NEUROL-CHICAGO, V51, P874, DOI 10.1001/archneur.1994.00540210046012; Porteus S. D., 1959, PORTEUS MAZE TEST 50; Purvis K., 2001, J INT NEUROPSYCH SOC, V7, P165; RABINOWICZ T, 1979, HUMAN GROWTH, V3, P97; Rattermann MJ, 2001, COGNITIVE SCI, V25, P941, DOI 10.1016/S0364-0213(01)00060-X; REIMAN EM, 1989, ARCH GEN PSYCHIAT, V46, P493; Reiss AL, 1996, BRAIN, V119, P1763, DOI 10.1093/brain/119.5.1763; Richards J. E., 2003, COGNITIVE NEUROSCIEN, P73; Riva D, 2000, BRAIN, V123, P1051, DOI 10.1093/brain/123.5.1051; Roberts WA, 2002, PSYCHOL BULL, V128, P473, DOI 10.1037//0033-2909.128.3.473; Rogoff B., 1974, CHILD DEV, V44, P238; Roncadin C, 2004, DEV NEUROPSYCHOL, V25, P21; Roncadin C., 2003, J INT NEUROPSYCH SOC, V9, P141; Rudolph KD, 1997, J APPL DEV PSYCHOL, V18, P107, DOI 10.1016/S0193-3973(97)90017-4; Rypma B, 2000, NAT NEUROSCI, V3, P509, DOI 10.1038/74889; Saarni C., 1999, DEV EMOTIONAL COMPET; Sadeh M, 2001, PEDIATR HEMAT ONCOL, V18, P423, DOI 10.1080/088800101750476005; Schachar R, 2004, DEV NEUROPSYCHOL, V25, P179, DOI 10.1207/s15326942dn2501&2_10; SCHEIBEL RS, 1997, DEV PREFRONTAL CORTE, P241; SCHMAHMANN JD, 1995, NEUROSCI LETT, V199, P175, DOI 10.1016/0304-3940(95)12056-A; Schmahmann JD, 1998, BRAIN, V121, P561, DOI 10.1093/brain/121.4.561; Schmahmann JD, 1997, J NEUROSCI, V17, P438; Schneider W, 1998, METACOGNITION AND COGNITIVE NEUROPSYCHOLOGY, P1; Segalowitz SJ, 2004, BRAIN COGNITION, V55, P116, DOI 10.1016/s0278-2626(03)00283-5; Seguin JR, 2004, BRAIN COGNITION, V55, P185, DOI 10.1016/s0278-2626(03)00273-2; Shammi P, 1999, BRAIN, V122, P657, DOI 10.1093/brain/122.4.657; SHIMAMURA AP, 1986, J EXP PSYCHOL LEARN, V12, P452, DOI 10.1037/0278-7393.12.3.452; Shum D., 2005, JOINT MID YEAR M INT; SILVERI MC, 1994, NEUROLOGY, V44, P2047, DOI 10.1212/WNL.44.11.2047; SOMERVILLE SC, 1983, J GENET PSYCHOL, V143, P87, DOI 10.1080/00221325.1983.10533537; Sowell ER, 1999, NEUROIMAGE, V9, P587, DOI 10.1006/nimg.1999.0436; Sowell ER, 1998, DEV NEUROPSYCHOL, V14, P599, DOI 10.1080/87565649809540731; Sowell ER, 2002, DEV MED CHILD NEUROL, V44, P4, DOI 10.1017/S0012162201001591; Sowell ER, 2001, J INT NEUROPSYCH SOC, V7, P312, DOI 10.1017/S135561770173305X; Steinberg L, 2005, TRENDS COGN SCI, V9, P69, DOI 10.1016/j.tics.2004.12.005; Stuss DT, 2001, BRAIN, V124, P279, DOI 10.1093/brain/124.2.279; Stuss DT, 2004, BRAIN COGNITION, V55, P69, DOI 10.1016/s0278-2626(03)00271-9; Tatcher R.W, 1997, DEV PREFRONTAL CORTE, P85; TRANEL D, 2002, PRINCIPLES FRONTAL L, P338, DOI DOI 10.1093/ACPROF:OSO/9780195134971.001.0001; Tulving E., 2002, PRINCIPLES FRONTAL L, P311, DOI DOI 10.1093/ACPROF:OSO/9780195134971.003.0020; Turkstra LS, 2001, J HEAD TRAUMA REHAB, V16, P469, DOI 10.1097/00001199-200110000-00006; Warschausky S, 1997, Pediatr Rehabil, V1, P77; WICHMAN H, 1983, HUM FACTORS, V25, P583; Wilde EA, 2005, J NEUROTRAUM, V22, P333, DOI 10.1089/neu.2005.22.333; Williams BR, 1999, DEV PSYCHOL, V35, P205, DOI 10.1037/0012-1649.35.1.205; Winner E., 1988, POINT WORDS CHILDREN; Wood JN, 2003, NAT REV NEUROSCI, V4, P139, DOI 10.1038/nrn1033; Yakovlev P.I., 1967, RETIONAL DEV BRAIN E, P3; Yeates KO, 2004, J INT NEUROPSYCH SOC, V10, P412, DOI 10.1017/S1355617704103093; YEATES KO, 1990, CLIN PSYCHOL REV, V10, P567, DOI 10.1016/0272-7358(90)90097-T	199	17	17	0	1	CAMBRIDGE UNIV PRESS	CAMBRIDGE	THE PITT BUILDING, TRUMPINGTON ST, CAMBRIDGE CB2 1RP, CAMBS, ENGLAND			978-0-521-67225-2	SER INT NEUROPSYCHOL			2006							128	162		10.1017/CBO9780511545917.007	10.1017/CBO9780511545917		35	Clinical Neurology; Psychology	Neurosciences & Neurology; Psychology	BXN05	WOS:000296459600007					2021-06-18	
J	Gamboa, AM; Holland, GH; Tierney, JP; Gibson, DS				Gamboa, A. M., Jr.; Holland, Gwendolyn H.; Tierney, John P.; Gibson, David S.			American Community Survey: Earnings and employment for persons with traumatic brain injury	NEUROREHABILITATION			English	Article; Proceedings Paper	1st International Conference on Vocational Outcomes in Traumatic Brain Injury	APR 14-16, 2005	Vancouver, CANADA			disability; brain injury; earnings; employment; American Community Survey		In 2000, the United States Census Bureau began the annual American Community Survey (ACS), which collects data on earnings and employment for persons with various types of impairment. One of the impairments is cognitive disability, defined as existing when a person has a condition lasting six months or more that results in difficulty learning, remembering, or concentrating. Individuals with such limitations are often defined as having mild traumatic brain injury (TBI). Persons with mild TBI often retain the ability to work competitively. Such individuals, however, typically earn less when employed year-round, full-time than do persons without disability and have lower levels of employment, resulting in reduced worklife expectancy. This article focuses on the effects of cognitive disability on earnings and employment. The ACS data are reported by gender and education level for those without disability or with cognitive disability. Employment levels are translated into worklife expectancies and the method of conversion through use of a joint probability of life, participation, and employment is examined.	Vocat Econ Inc, Louisville, KY 40243 USA	Holland, GH (corresponding author), Vocat Econ Inc, 11933 Brinley Ave, Louisville, KY 40243 USA.	gwenh@vocecon.com					ARIAS E, 2004, US LIFE LIFE TABLES; BRODWIN MG, 2002, MED PSYCHOSOCIAL VOC; BROOKSHIRE ML, 2006, TRIAL; BROOKSHIRE ML, 1983, DEFENSE, P20; *CORN U, 2005, REH RES TRAIN CTR DI; GAMBOA AM, 2006, NEW WORKLIFE EXPECTA; STAPLETON DC, 1997, EXPLORATORY STUDY HL; *US CTR DIS CONTR, TRAUM BRAIN INJ FACT; VOGENTHALER DR, 1987, BRAIN INJURY, P113	9	17	17	0	3	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2006	21	4					327	333					7	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	145VU	WOS:000244894700007	17361049				2021-06-18	
J	Rooker, S; Jander, S; Van Reempts, J; Stoll, G; Jorens, PG; Borgers, M; Verlooy, J				Rooker, Servan; Jander, Sebastian; Van Reempts, Jos; Stoll, Guido; Jorens, Philippe G.; Borgers, Marcel; Verlooy, Jan			Spatiotemporal pattern of neuroinflammation after impact-acceleration closed head injury in the rat	MEDIATORS OF INFLAMMATION			English	Article							MODIFIED EXPERIMENTAL-MODEL; INTRACRANIAL-PRESSURE; MESSENGER-RNA; GENE-EXPRESSION; TNF-ALPHA; BRAIN; CYTOKINES; IL-6; INTERLEUKIN-18; INDUCTION	Inflammatory processes have been implicated in the pathogenesis of traumatic brain damage. We analyzed the spatiotemporal expression pattern of the proinflammatory key molecules: interleukin-1 beta, interleukin-6, tumor necrosis factor-alpha, and inducible nitric oxide synthase in a rat closed head injury ( CHI) paradigm. 51 rats were used for RT- PCR analysis after CHI, and 18 for immunocytochemistry. We found an early upregulation of IL-1 beta, IL-6, and TNF-alpha mRNA between 1 h and 7 h after injury; the expression of iNOS mRNA only revealed a significant increase at 4 h. After 24 h, the expression decreased towards baseline levels, and remained low until 7 d after injury. Immunocytochemically, IL-1 beta induction was localized to ramified microglia in areas surrounding the primary impact place as well as deeper brain structures. Our study shows rapid induction of inflammatory gene expression that exceeds by far the primary impact site and might therefore contribute to tissue damage at remote sites. Copyright (c) 2006 Servan Rooker et al.	Univ Antwerp Hosp, Dept Neurosurg, B-2650 Edegem, Belgium; Univ Dusseldorf, Dept Neurol, D-40225 Dusseldorf, Germany; Janssen Res Fdn, Dept Life Sci, B-2340 Beerse, Belgium; Univ Wurzburg, Dept Neurol, D-97080 Wurzburg, Germany; Univ Antwerp Hosp, Dept Intens Care Med, B-2650 Edegem, Belgium	Rooker, S (corresponding author), Univ Antwerp Hosp, Dept Neurosurg, B-2650 Edegem, Belgium.		Rooker, Servan/AAD-4316-2020				ARAI K, 1990, ANNU REV BIOCHEM, V59, P783, DOI 10.1146/annurev.biochem.59.1.783; Barone FC, 1999, J CEREBR BLOOD F MET, V19, P819, DOI 10.1097/00004647-199908000-00001; BULLOCK R, 2000, EUROPEAN J EMERGENCY, V3, P109; Davies CA, 1999, J CEREBR BLOOD F MET, V19, P87, DOI 10.1097/00004647-199901000-00010; De Mulder G, 2000, ACT NEUR S, V76, P409; Engelborghs K, 2000, J NEUROTRAUM, V17, P667, DOI 10.1089/089771500415418; Engelborghs K, 1997, ACT NEUR S, V70, P123; Engelborghs K, 1998, J NEUROSURG, V89, P796, DOI 10.3171/jns.1998.89.5.0796; FAN L, 1995, MOL BRAIN RES, V30, P125; Fan L, 1996, MOL BRAIN RES, V36, P287, DOI 10.1016/0169-328X(95)00274-V; Gillen C, 1998, J NEUROSCI RES, V51, P489, DOI 10.1002/(SICI)1097-4547(19980215)51:4<489::AID-JNR8>3.3.CO;2-5; HARIRI RJ, 1994, BRAIN RES, V636, P139, DOI 10.1016/0006-8993(94)90188-0; HEWETT SJ, 1994, NEURON, V13, P487, DOI 10.1016/0896-6273(94)90362-X; Jander S, 2000, J NEUROIMMUNOL, V109, P181, DOI 10.1016/S0165-5728(00)00317-9; Jander S, 1998, J NEUROIMMUNOL, V91, P93, DOI 10.1016/S0165-5728(98)00162-3; Jander S, 2002, J CEREBR BLOOD F MET, V22, P62, DOI 10.1097/00004647-200201000-00008; Jander S, 2001, J CEREBR BLOOD F MET, V21, P218, DOI 10.1097/00004647-200103000-00005; Merrill JE, 1996, TRENDS NEUROSCI, V19, P331, DOI 10.1016/0166-2236(96)10047-3; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Rooker S, 2002, J NEUROSCI METH, V119, P83, DOI 10.1016/S0165-0270(02)00183-8; SHOHAMI E, 1994, J CEREBR BLOOD F MET, V14, P615, DOI 10.1038/jcbfm.1994.76; Shohami E, 1996, J CEREBR BLOOD F MET, V16, P378, DOI 10.1097/00004647-199605000-00004; Stoll G, 1998, PROG NEUROBIOL, V56, P149, DOI 10.1016/S0301-0082(98)00034-3; TAUPIN V, 1993, J NEUROIMMUNOL, V42, P177, DOI 10.1016/0165-5728(93)90008-M; TOULMOND S, 1995, BRAIN RES, V671, P261, DOI 10.1016/0006-8993(94)01343-G; van Rossem K, 1999, ADV EXP MED BIOL, V471, P209; VANROSSEM K, 1999, J CEREB BLOOD FLOW M, V19, pS391; WOODROOFE MN, 1991, J NEUROIMMUNOL, V33, P227, DOI 10.1016/0165-5728(91)90110-S; YAN HQ, 1992, EUR J IMMUNOL, V22, P2963, DOI 10.1002/eji.1830221131	29	17	17	0	1	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	0962-9351	1466-1861		MEDIAT INFLAMM	Mediat. Inflamm.		2006	2006								90123	10.1155/MI/2006/90123			6	Cell Biology; Immunology	Cell Biology; Immunology	080DN	WOS:000240227300001	16864909	DOAJ Gold, Green Published			2021-06-18	
J	Wachtel, LE; Hagopian, LP				Wachtel, Lee E.; Hagopian, Louis P.			Psychopharmacology and applied behavioral analysis: Tandem treatment of severe problem behaviors in intellectual disability and a case series	ISRAEL JOURNAL OF PSYCHIATRY AND RELATED SCIENCES			English	Article							MENTALLY-RETARDED PERSONS; SELF-INJURIOUS-BEHAVIOR; FUNCTIONAL-ANALYSIS; YOUNG-ADULTS; RETARDATION; PSYCHOPATHOLOGY; CHILDREN; PEOPLE; REINFORCEMENT; ADOLESCENTS	Many individuals with intellectual disability will at some time in their lives engage in problem behaviors that may place them and others at risk, and reduce their opportunities for healthy psychosocial functioning. These behaviors may reach severe proportions in both intensity and frequency, necessitating intervention. Both psychiatrists and behaviorists are often approached regarding negative behaviors in intellectual disability, and each discipline offers key tools in behavioral assessment and resolution. We believe that the coordinated effort of these two disciplines affords the most comprehensive and efficacious method of assessing, understanding and treating a wide range of problem behaviors and associated psychiatric pathology in individuals with various forms of intellectual disability. This paper briefly reviews the background of problem behaviors in intellectual disability and treatment of such disturbances through separate psychiatric and applied behavioral modalities, followed by the proposed coordinated neurobehavioral model. A case series ensues, describing the successful application of the neurobehavioral model to the severe problem behaviors demonstrated by three individuals with intellectual disability related to autism, Cornelia de Lange syndrome and traumatic brain injury.	Kennedy Krieger Inst, Neurobehav Unit, Dept Child & Adolescent Psychiat, Baltimore, MD 21205 USA; Kennedy Krieger Inst, Neurobehav Unit, Dept Behav Psychol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA	Wachtel, LE (corresponding author), Kennedy Krieger Inst, Neurobehav Unit, Dept Child & Adolescent Psychiat, 707 N Broadway St, Baltimore, MD 21205 USA.	wachtel@kennedykrieger.org					*AM ASS MENT RET, 2000, TREATM PSYCH BEH PRO, V105, P165; Aman MG, 2000, EUR CHILD ADOLES PSY, V9, P98; American Psychiatric Association, 2000, DIAGN CRIT DSM IV TR; BAUMEISTER AA, 1990, NEUROSCI BIOBEHAV R, V14, P253, DOI 10.1016/S0149-7634(05)80036-3; BorthwickDuffy SA, 1997, RES DEV DISABIL, V18, P415, DOI 10.1016/S0891-4222(97)00020-6; BORTHWICKDUFFY SA, 1994, J CONSULT CLIN PSYCH, V62, P17, DOI 10.1037/0022-006X.62.1.17; Buitelaar JK, 2000, EUR CHILD ADOLES PSY, V9, P85; DeLeon IG, 2000, J APPL BEHAV ANAL, V33, P73, DOI 10.1901/jaba.2000.33-73; EYMAN RK, 1981, AM J MENT DEF, V85, P473; FISHER W, 1992, J APPL BEHAV ANAL, V25, P491, DOI 10.1901/jaba.1992.25-491; Friedlander R, 2001, CAN J PSYCHIAT, V46, P741; Hagopian LP, 2001, J APPL BEHAV ANAL, V34, P527, DOI 10.1901/jaba.2001.34-527; Hagopian LP, 1998, J APPL BEHAV ANAL, V31, P211, DOI 10.1901/jaba.1998.31-211; Hagopian LP, 2000, J APPL BEHAV ANAL, V33, P433, DOI 10.1901/jaba.2000.33-433; Hanley GP, 2003, J APPL BEHAV ANAL, V36, P147, DOI 10.1901/jaba.2003.36-147; HARRIS JC, 1998, DEVELOPMENTAL NEUROP, V3; IWATA BA, 1994, J APPL BEHAV ANAL, V27, P215, DOI 10.1901/jaba.1994.27-215; IWATA BA, 1994, J APPL BEHAV ANAL, V27, P197, DOI 10.1901/jaba.1994.27-197; Janowsky DS, 2005, INT J NEUROPSYCHOPH, V8, P37, DOI 10.1017/S146114570400481X; Janowsky DS, 2005, J CLIN PSYCHOPHARM, V25, P19, DOI 10.1097/01.jcp.0000150218.51433.7b; Kahng S, 2002, AM J MENT RETARD, V107, P212, DOI 10.1352/0895-8017(2002)107<0212:BTOSIT>2.0.CO;2; Kodak T, 2003, J APPL BEHAV ANAL, V36, P379, DOI 10.1901/jaba.2003.36-379; Kowatch RA, 1998, PEDIATR CLIN N AM, V45, P1173, DOI 10.1016/S0031-3955(05)70068-7; Kraus MF, 1997, J NEUROPSYCH CLIN N, V9, P222; La Malfa G, 2006, HUM PSYCHOPHARM CLIN, V21, P73, DOI 10.1002/hup.748; MacIntyre D, 2003, MOL PSYCHIATR, V8, P275, DOI 10.1038/sj.mp.4001232; MACLEAN WE, 1993, PSYCHOPATHOLOGY MENT; Masi G, 2004, CNS DRUGS, V18, P1031, DOI 10.2165/00023210-200418140-00006; MATSON JL, 1994, J CONSULT CLIN PSYCH, V62, P6, DOI 10.1037/0022-006X.62.1.6; Matson JL, 2000, RES DEV DISABIL, V21, P263, DOI 10.1016/S0891-4222(00)00042-1; MATSON JL, 1984, APPL RES MENT RETARD, V5, P81, DOI 10.1016/S0270-3092(84)80021-1; McClintock K, 2003, J INTELL DISABIL RES, V47, P405, DOI 10.1046/j.1365-2788.2003.00517.x; McDougle CJ, 2005, AM J PSYCHIAT, V162, P1142, DOI 10.1176/appi.ajp.162.6.1142; McIntyre LL, 2002, J INTELL DISABIL RES, V46, P239, DOI 10.1046/j.1365-2788.2002.00371.x; Paclawskyj TR, 2004, BEHAV MODIF, V28, P649, DOI 10.1177/0145445503259834; REISS S, 1994, J CONSULT CLIN PSYCH, V62, P28, DOI 10.1037/0022-006X.62.1.28; RUEDRICH SL, 1990, AM J MENT RETARD, V95, P110; RUTTER M, 1976, PSYCHOL MED, V6, P313, DOI 10.1017/S003329170001388X; Schroeder SR, 2001, MENT RETARD DEV D R, V7, P3, DOI 10.1002/1098-2779(200102)7:1<3::AID-MRDD1002>3.0.CO;2-#; Shore BA, 1997, J APPL BEHAV ANAL, V30, P21, DOI 10.1901/jaba.1997.30-21; Sloman KN, 2005, J APPL BEHAV ANAL, V38, P373, DOI 10.1901/jaba.2005.118-04; Symons FJ, 2004, MENT RETARD DEV D R, V10, P193, DOI 10.1002/mrdd.20031; TUINIER S, 1993, J INTELL DISABIL RES, V37, P16; Wong DF, 1996, P NATL ACAD SCI USA, V93, P5539, DOI 10.1073/pnas.93.11.5539	44	17	17	0	19	MEDIAFARM GROUP	TEL-AVIV	23 ZAMENHOFF ST, TEL-AVIV, 64373, ISRAEL	0333-7308			ISR J PSYCHIATR REL	Isr. J. Psychiatr. Relat. Sci.		2006	43	4					265	274					10	Psychiatry	Psychiatry	133DE	WOS:000243991000006	17338446				2021-06-18	
J	Donnelly, JP; Donnelly, K; Grohman, KK				Donnelly, JP; Donnelly, K; Grohman, KK			A multi-perspective concept mapping study of problems associated with traumatic brain injury	BRAIN INJURY			English	Article						traumatic brain injury; concept mapping; quality of life	QUALITY-OF-LIFE; PROBLEM-SOLVING THERAPY; SELF-AWARENESS; HEAD-INJURY; REHABILITATION; DYSFUNCTION; DEPRESSION; BEHAVIOR; ADULTS; MODEL	Objective: To develop a model of the problems of persons with traumatic brain injury that includes multiple perspectives as well as the multi-dimensional nature of the phenomena. Design: Concept mapping, a multi-variate modelling strategy, was employed to produce an exhaustive inventory and concept map of TBI-related problems based on input from patients, family caregivers and professional providers. Results: The eight-cluster concept map included the following dimensions: social competence, intimacy, behavioural, maturity/ independence, neurophysiological, mood, executive functions and non-executive functions. Conclusions: An underlying two-dimensional conceptual model of TBI problems is proposed with relevance for theory, practice and further research.	SUNY Buffalo, Sch & Educ Psychol, Dept Counseling, Buffalo, NY 14260 USA; SUNY Buffalo, Res Inst Addict, Amherst, NY USA	Donnelly, JP (corresponding author), SUNY Buffalo, Sch & Educ Psychol, Dept Counseling, 401 Baldy Hall, Buffalo, NY 14260 USA.	jpd1@buffalo.edu	Donnelly, James/AAI-4840-2020				Alexopoulos GS, 2003, AM J GERIAT PSYCHIAT, V11, P46, DOI 10.1176/appi.ajgp.11.1.46; Bezeau SC, 2004, BRAIN INJURY, V18, P299, DOI 10.1080/02699050310001617398; Borgaro SR, 2003, BRAIN INJURY, V17, P189, DOI 10.1080/0269905021000013183; Bullinger M, 2002, RESTOR NEUROL NEUROS, V20, P111; Christ SE, 2003, NEUROPSYCHOLOGY, V17, P171, DOI 10.1037/0894-4105.17.1.171; Cock J, 2003, BRAIN INJURY, V17, P561, DOI 10.1080/0269905031000088306; Day SX, 1998, AM PSYCHOL, V53, P728, DOI 10.1037/0003-066X.53.7.728; Emanuelson I, 2003, ACTA NEUROL SCAND, V108, P332, DOI 10.1034/j.1600-0404.2003.00155.x; Everitt B. S., 1980, CLUSTER ANAL; Felmingham KL, 2004, NEUROPSYCHOLOGY, V18, P564, DOI 10.1037/0894-4105.18.3.564; Florio G A, 1998, J Occup Health Psychol, V3, P227; GATI I, 1991, PSYCHOL BULL, V109, P309, DOI 10.1037/0033-2909.109.2.309; Godfrey HPD, 2003, BRAIN INJURY, V17, P427, DOI 10.1080/0269905031000066201; Golden Z, 2003, INT J NEUROSCI, V113, P733, DOI 10.1080/00207450390200044; Gotay CC, 2002, PSYCHOL ASSESSMENT, V14, P439, DOI 10.1037//1040-3590.14.4.439; Heinemann AW, 2004, REHABIL PSYCHOL, V49, P156, DOI 10.1037/0090-5550.49.2.156; HINKELDEY N S, 1990, Brain Injury, V4, P115, DOI 10.3109/02699059009026157; Hoofien D, 2004, J CLIN EXP NEUROPSYC, V26, P278, DOI 10.1076/jcen.26.2.278.28084; KENDALL E, 2003, J VOCAT REHABIL, V19, P31; Malec JF, 2000, REHABIL PSYCHOL, V45, P227, DOI 10.1037/0090-5550.45.3.227; Man DWK, 2003, BRAIN INJURY, V17, P775, DOI 10.1080/0269905031000088577; Man DWK, 2003, BRAIN INJURY, V17, P437, DOI 10.1080/0269905031000070152; Marshall RC, 2003, AM J SPEECH-LANG PAT, V12, P333, DOI 10.1044/1058-0360(2003/079); McCrae RR, 1997, AM PSYCHOL, V52, P509, DOI 10.1037/0003-066X.52.5.509; McDonald S, 2004, NEUROPSYCHOLOGY, V18, P572, DOI 10.1037/0894-4105.18.3.572; Nezu AM, 1999, J PSYCHOSOC ONCOL, V16, P5, DOI 10.1300/J077v16n03_02; Ponsford J, 2003, NEUROPSYCHOL REHABIL, V13, P275, DOI 10.1080/09602010244000363; Power PW, 2003, BRAIN INJURY, V17, P1021, DOI 10.1080/0269905031000110526; PREDIGER DJ, 1982, J VOCAT BEHAV, V21, P259, DOI 10.1016/0001-8791(82)90036-7; Prigatano GP, 1997, NEUROPSY NEUROPSY BE, V10, P135; Rios M, 2004, BRAIN INJURY, V18, P257, DOI 10.1080/02699050310001617442; Ruttan LA, 2003, J CLIN EXP NEUROPSYC, V25, P407, DOI 10.1076/jcen.25.3.407.13812; Sahler OJZ, 2002, J DEV BEHAV PEDIATR, V23, P77, DOI 10.1097/00004703-200204000-00003; Simpson G, 2003, J HEAD TRAUMA REHAB, V18, P445, DOI 10.1097/00001199-200309000-00006; Simpson G, 2003, BRAIN INJURY, V17, P723, DOI 10.1080/0269905031000110481; TASKER SL, 2003, ILLNESS CRISIS LOSS, V11, P337, DOI DOI 10.1177/1054137303256585; Tateno A, 2003, J NEUROPSYCH CLIN N, V15, P155, DOI 10.1176/appi.neuropsych.15.2.155; Trochim WMK, 2003, TOB CONTROL, V12, P140, DOI 10.1136/tc.12.2.140; TROCHIM WMK, 1989, EVAL PROGRAM PLANN, V12, P1, DOI 10.1016/0149-7189(89)90016-5; Turkstra L, 2003, BRAIN INJURY, V17, P39, DOI 10.1080/0269905021000010122; Underhill AT, 2003, BRAIN INJURY, V17, P973, DOI 10.1080/0269905031000110418; Vandiver VL, 2003, J HEAD TRAUMA REHAB, V18, P457, DOI 10.1097/00001199-200309000-00007; VANZOMEREN AH, 1985, J NEUROL NEUROSUR PS, V48, P21, DOI 10.1136/jnnp.48.1.21; Wilson BA, 2002, NEUROPSYCHOL REHABIL, V12, P97, DOI 10.1080/09602010244000020; Zasler ND, 2003, NEUROPSYCHOL REHABIL, V13, P31, DOI 10.1080/09602010	45	17	17	0	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	DEC	2005	19	13					1077	1085		10.1080/02699050500110728			9	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	983ZD	WOS:000233270000002	16286321				2021-06-18	
J	Shafi, S; Gentilello, L				Shafi, S; Gentilello, L			Hypotension does not increase mortality in brain-injured patients more than it does in non-brain-injured patients	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article; Proceedings Paper	18th Annual Meeting of the Eastern-Association-for-the-Surgery-of-Trauma	JAN 11-15, 2005	Ft Lauderdale, FL	Eastern Assoc Surg Trauma		hypotension; brain injury; mortality; risk factor; traumatic brain injury	UNCONTROLLED HEMORRHAGIC-SHOCK; DELAYED FLUID RESUSCITATION; MULTIPLE ORGAN FAILURE; HEAD-INJURY; HYPOXIA; IMMEDIATE; DURATION; TRAUMA; MODEL; RATS	Objectives: Hypotension increases mortality after all types of injuries. Prior studies comparing mortality of hypotensive traumatic brain injury (TBI) patients to normotensive TBI patients have implied that hypotension is particularly detrimental after TBI. It is unknown whether hypotension affects TBI patients more severely than it affects other types of patients. We hypothesized that hypotension does not increase mortality in TBI patients more than it does in non-TBI patients. Methods: National Trauma Data Bank (1994-2002) patients aged 18 to 45 years with blunt mechanisms of injury treated at Level I and Level II centers were included. Deaths occurring before 24 hours were excluded. Logistic regression was used to measure the association between hypotension (<= 90 mm Hg) and death after adjusting for confounding variables of age, gender, comorbidities, complications, Glasgow Coma Scale score, and severity of associated injuries. Odds ratios (95% confidence interval) indicate the risk of death in hypotensive patients in each group compared with normotensive patients in the same group. Results: The study population consisted of 79,478 patients (TBI, 30,742; no TBI, 48,736). Hypotension independently quadrupled the risk of death after adjusting for confounding variables (odds ratio [OR], 4.8; 95% confidence interval [CI], 4.1-5.6). However, increase in this risk associated with hypotension was the same in TBI (OR, 4.1; 95% CI, 3.5-4.9) and non-TBI patients (OR, 4.6; 95% CI, 3.4-6.0). Furthermore, the relationship between hypotension and TBI did not change with increasing head Abbreviated Injury Scale score severity. Conclusion: Hypotension is an independent risk factor for mortality. However, it does not increase mortality in TBI patients more than it does for non-TBI patients.	Univ Texas, SW Med Ctr, Div Burn Trauma & Surg Crit Care, Dept Surg, Dallas, TX 75390 USA	Shafi, S (corresponding author), Univ Texas, SW Med Ctr, Div Burn Trauma & Surg Crit Care, Dept Surg, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	shahid.shafi@utsouthwestern.edu		holcomb, john/0000-0001-8312-9157			Beaumont A, 2002, ACT NEUR S, V81, P217; BICKELL WH, 1994, NEW ENGL J MED, V331, P1105, DOI 10.1056/NEJM199410273311701; Bourguignon PR, 1998, ARCH SURG-CHICAGO, V133, P390, DOI 10.1001/archsurg.133.4.390; *BRAIN TRAUM FDN, 2000, J NEUROTRAUM, V17, P471; Cairns C B, 2001, Curr Opin Crit Care, V7, P437, DOI 10.1097/00075198-200112000-00011; CHAMPION HR, 1990, J TRAUMA, V30, P1356, DOI 10.1097/00005373-199011000-00008; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Glass TF, 1999, J NEUROTRAUM, V16, P771, DOI 10.1089/neu.1999.16.771; Holtzer S, 2001, CRIT CARE MED, V29, P1609, DOI 10.1097/00003246-200108000-00018; ISHIGE N, 1988, J NEUROSURG, V68, P129, DOI 10.3171/jns.1988.68.1.0129; Jeremitsky E, 2003, J TRAUMA, V54, P312, DOI 10.1097/01.TA.0000037876.37236.D6; Manley G, 2001, ARCH SURG-CHICAGO, V136, P1118, DOI 10.1001/archsurg.136.10.1118; Matsushita Y, 2001, J CEREBR BLOOD F MET, V21, P847, DOI 10.1097/00004647-200107000-00010; Moore FA, 1996, J TRAUMA, V40, P501, DOI 10.1097/00005373-199604000-00001; Sakles JC, 1997, ANN EMERG MED, V29, P392, DOI 10.1016/S0196-0644(97)70352-4; Sauaia A, 1996, WORLD J SURG, V20, P392, DOI 10.1007/s002689900062; SCHMOKER JD, 1992, J TRAUMA, V32, P714, DOI 10.1097/00005373-199206000-00007; Solomonov E, 2000, CRIT CARE MED, V28, P749, DOI 10.1097/00003246-200003000-00024; Stern SA, 2000, J NEUROSURG, V93, P305, DOI 10.3171/jns.2000.93.2.0305; The Brain Trauma Foundation, 2000, J NEUROTRAUM, V17, P591; Winchell RJ, 1996, ARCH SURG-CHICAGO, V131, P533	21	17	17	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3261 USA	1079-6061			J TRAUMA	J. Trauma-Injury Infect. Crit. Care	OCT	2005	59	4					830	834		10.1097/01.ta.0000188147.36232.c0			5	Critical Care Medicine; Surgery	General & Internal Medicine; Surgery	001DN	WOS:000234513900006	16374269				2021-06-18	
J	Stoller, KP				Stoller, KP			Quantification of neurocognitive changes before, during, and after hyperbaric oxygen therapy in a case of fetal alcohol syndrome	PEDIATRICS			English	Article						hyperbaric oxygen therapy; fetal alcohol syndrome	DELAYED-ONSET DYSTONIA; BRAIN-INJURED PATIENTS; ACUTE ISCHEMIC STROKE; CEREBRAL-PALSY; CONCUSSION; HYPOXIA; HYPEROXIA; CHILDREN; TRIAL	Fetal alcohol syndrome (FAS) is the most common nonhereditary cause of mental retardation, with deficits in general intellectual functioning, learning, memory, attention, and problem-solving. Presented here is the first case in which measured neurocognitive abilities were determined before, during, and after hyperbaric oxygen therapy in a case of FAS involving a teenage male patient. Memory, reaction time, and visual motor speed assessments were compared. After 40 hyperbaric treatments with 100% oxygen at 1.5 atmospheres absolute, the patient's performance in 6 of 6 categories of the computer-administered test battery improved. Word composite (verbal) scores improved from 55% to 73%, memory composite (visual) scores improved from 38% to 55%, reaction time composites improved from 1.03 to 0.53 seconds, impulse control composite scores improved from 8 to 5, and visual motor speed scores improved from 18.6 to 19.03. The patient's subjective symptoms diminished 94%. Six months after these treatments, the patient's verbal memory was maintained at 73% without any other interventions; impulsivity continued to improve, whereas other indices did not. Thirty-three additional treatments continued to improve test performance, with verbal memory at 95%, visual memory at 57%, and a 100% reduction of subjective symptoms. This patient, with 15-year-matured FAS, benefited from a short course of low-pressure hyperbaric oxygen therapy, sustained durable cognitive improvements, and continued to exhibit improvement with another short course of treatments.	Univ New Mexico, Sch Med, Dept Pediat, Albuquerque, NM 87131 USA	Stoller, KP (corresponding author), 404 Brunn Sch Rd D, Santa Fe, NM 87505 USA.	hbotnm@netzero.net					BURKE RE, 1980, J NEUROL NEUROSUR PS, V43, P789, DOI 10.1136/jnnp.43.9.789; Calvert JW, 2004, EXP NEUROL, V189, P150, DOI 10.1016/j.expneurol.2004.05.030; Calvert JW, 2002, BRAIN RES, V951, P1, DOI 10.1016/S0006-8993(02)03094-9; Collet JP, 2001, LANCET, V357, P582, DOI 10.1016/S0140-6736(00)04054-X; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P2283, DOI 10.1001/jama.282.24.2283; Ersanli D, 2004, SWISS MED WKLY, V134, P650; Harch PG, 1994, UNDERSEA HYPERB ME S, V21, P22; HARCH PG, 1994, UNDERSEA HYPERB ME S, V21, P15; Harch PG, 1994, UNDERSEA HYPERB ME S, V21, P30; Hardy P, 2002, DEV MED CHILD NEUROL, V44, P436; HARIK SI, 1994, J APPL PHYSIOL, V77, P896; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Marois P, 2003, DEV MED CHILD NEUROL, V45, P646, DOI 10.1017/S001216220321191; May PA, 2001, ALCOHOL RES HEALTH, V25, P159; Montgomery D, 1999, UNDERSEA HYPERBAR M, V26, P235; Nakajima M, 1994, Rinsho Shinkeigaku, V34, P48; NEUBAUER RA, 1992, CLIN NUCL MED, V17, P477, DOI 10.1097/00003072-199206000-00010; NEUBAUER RA, 1990, LANCET, V335, P542, DOI 10.1016/0140-6736(90)90777-3; NEUBAUER RA, 1990, P 15 INT C NEUR OCC, P10; NIGHOGHOSSIAN N, 1995, STROKE, V26, P1369, DOI 10.1161/01.STR.26.8.1369; Nighoghossian N, 1997, J NEUROL SCI, V150, P27, DOI 10.1016/S0022-510X(97)05398-7; Pugh CW, 2003, NAT MED, V9, P677, DOI 10.1038/nm0603-677; ROCKSWOLD GL, 1992, J NEUROSURG, V76, P929, DOI 10.3171/jns.1992.76.6.0929; Rockswold SB, 2001, J NEUROSURG, V94, P403, DOI 10.3171/jns.2001.94.3.0403; SAINTHILAIRE MH, 1991, NEUROLOGY, V41, P216; Singhal AB, 2002, NEUROLOGY, V58, P945, DOI 10.1212/WNL.58.6.945; Stamler JS, 1997, SCIENCE, V276, P2034, DOI 10.1126/science.276.5321.2034; Steindler DA, 2002, LANCET, V359, P1047, DOI 10.1016/S0140-6736(02)08096-0; STOLLER KP, 2004, UND HYP MED SOC GULF; ZISER A, 1984, BRIT MED J, V289, P960, DOI 10.1136/bmj.289.6450.960	31	17	17	0	6	AMER ACAD PEDIATRICS	ELK GROVE VILLAGE	141 NORTH-WEST POINT BLVD,, ELK GROVE VILLAGE, IL 60007-1098 USA	0031-4005	1098-4275		PEDIATRICS	Pediatrics	OCT	2005	116	4					E586	E591		10.1542/peds.2004-2851			6	Pediatrics	Pediatrics	970FD	WOS:000232289700070	16166387	Bronze			2021-06-18	
J	Giles, GM; Wager, J; Fong, L; Waraich, BS				Giles, GM; Wager, J; Fong, L; Waraich, BS			Twenty-month effectiveness of a non-aversive, long-term, low-cost programme for persons with persisting neurobehavioural disability	BRAIN INJURY			English	Article						brain injury; aggression; non-aversive treatment; outcome	TRAUMATIC BRAIN-INJURY; CLOSED HEAD-INJURY; AGGRESSIVE-BEHAVIOR; PSYCHIATRIC-DISORDERS; PAST BEHAVIOR; MEMORY; STAFF; REHABILITATION; ADOLESCENTS; MANAGEMENT	Primary objective: To examine the effectiveness of a programme developed for persons with persisting neurobehavioural/ neuropsychiatric disorders. Research design: Descriptive study of a programme that has a philosophy of normalization, respect, non-confrontation, positive engagement, support and functional and behavioural skill development. Methods and procedures: Participants were the 40 clients admitted during the initial 20 months of operation. Prior to admission clients had recurrent placement failures secondary to behavioural disregulation and typically were housed at County or State Hospitals. An expanded version of the Overt Aggression Scale Modified for Neurorehabilitation was used to provide detailed descriptions of assaults. Main outcomes and results: Over the 20-month period, 49 incidents of client-to-client aggression occurred representing a rate of 0.11 incidents per client month. Thirty-five of 40 clients remained at the end of 20 months, with only three discharges due to behaviour. Conclusions: A long-term, stable living environment has been provided for individuals who had been intractable management problems elsewhere.	Samuel Merritt Coll, Oakland, CA 94609 USA; Crestwood Treatment Ctr, Fremont, CA USA; Univ Calif Davis, Dept Psychiat, Davis, CA 95616 USA	Giles, GM (corresponding author), Samuel Merritt Coll, 450 30th St, Oakland, CA 94609 USA.	ggiles@samuelmerritt.edu					Ackerman SJ, 2003, CLIN PSYCHOL REV, V23, P1, DOI 10.1016/s0272-7358(02)00146-0; Albarracin D, 2000, J PERS SOC PSYCHOL, V79, P5, DOI 10.1037//0022-3514.79.1.5; Alderman N, 1997, BRAIN INJURY, V11, P503, DOI 10.1080/713802182; Alderman N, 1999, BRAIN INJURY, V13, P669; ANDREWES D, 1989, J BEHAV THER EXP PSY, V20, P261, DOI 10.1016/0005-7916(89)90032-3; Bardenhagen FJ, 1999, NEUROCASE, V5, P325; Bargh JA, 1999, AM PSYCHOL, V54, P462, DOI 10.1037/0003-066x.54.7.462; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; Bordin E. S., 1979, PSYCHOTHER-THEOR RES, V16, P252, DOI DOI 10.1037/H0085885; BRAILSFORD DS, 1973, FACTORS RELATED VIOL, P9; BROOKE MM, 1992, ARCH PHYS MED REHAB, V73, P320, DOI 10.1016/0003-9993(92)90003-F; CHEUNG P, 1997, AUSTR NZ J PSYCHIAT, P31; Deb S, 1999, AM J PSYCHIAT, V156, P374; Eames P, 1996, BRAIN INJURY, V10, P631, DOI 10.1080/026990596124061; Evans JJ, 2000, NEUROPSYCHOL REHABIL, V10, P67, DOI 10.1080/096020100389309; FANN JR, 1995, AM J PSYCHIAT, V152, P1493; FEENEY TJ, 1995, J HEAD TRAUMA REHAB, V10, P67; FLEMINGER S, 2003, COCHRANE LIB; Fluharty G, 2001, BRAIN INJURY, V15, P995, DOI 10.1080/02699050010025795; Giles G. M., 1999, REHABILITATION SEVER, P81; Giles GM, 1997, AM J OCCUP THER, V51, P256, DOI 10.5014/ajot.51.4.256; Giles GM, 2001, BRAIN DAM B, P231; GILES GM, 1988, AM J OCCUP THER, V42, P658, DOI 10.5014/ajot.42.10.658; GILES GM, 1993, BRAIN INJURY REHABIL; GILES GM, 1999, REHABILITATION SEVER; Greve KW, 2001, BRAIN INJURY, V15, P255; HALLER RM, 1988, BRIT J PSYCHIAT, V152, P174, DOI 10.1192/bjp.152.2.174; Hayes SC, 1997, PSYCHOL SCI, V8, P170, DOI 10.1111/j.1467-9280.1997.tb00405.x; Heflin L. J., 2001, FOCUS AUTISM OTHER D, V16, P93, DOI DOI 10.1177/108835760101600205; HODGKINSON PE, 1985, MED SCI LAW, V25, P288, DOI 10.1177/002580248502500411; Johnson R., 1996, CLIN REHABIL, V10, P173, DOI [DOI 10.1177/026921559601000215, 10.1177/026921559601000215]; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; KELLY JP, 1997, PATIENT CARE, V31, P48; KELLY JP, 1997, PATIENT CARE, V31; KELLY JP, 1997, PATIENT CARE, V31, P46; Kelly MP, 1997, BRAIN INJURY, V11, P391, DOI 10.1080/026990597123386; Kim E, 2002, NEUROREHABILITATION, V17, P297; Klonoff PS, 1998, ARCH PHYS MED REHAB, V79, P684, DOI 10.1016/S0003-9993(98)90045-4; Koponen S, 2002, AM J PSYCHIAT, V159, P1315, DOI 10.1176/appi.ajp.159.8.1315; LEVIN HS, 1978, ARCH NEUROL-CHICAGO, V35, P720, DOI 10.1001/archneur.1978.00500350024005; LISHMAN WA, 1998, ORGANIC PSYCHIAT PSY; Luiselli J, 2003, BRAIN INJURY, V17, P255, DOI 10.1080/0269905021000030832; Manchester D, 1997, BRAIN INJURY, V11, P271; Manchester D, 2001, BRAIN DAM B, P157; Martin DJ, 2000, J CONSULT CLIN PSYCH, V68, P438, DOI 10.1037//0022-006X.68.3.438; MCDOWELL JJ, 1982, AM PSYCHOL, V37, P771, DOI 10.1037/0003-066X.37.7.771; McMillan TM, 2001, BRAIN DAM B, P257; MONAHAN J, 1992, AM PSYCHOL, V47, P511, DOI 10.1037/0003-066X.47.4.511; Murre JMJ, 1997, MEMORY, V5, P213, DOI 10.1080/741941155; Ouellette JA, 1998, PSYCHOL BULL, V124, P54, DOI 10.1037/0033-2909.124.1.54; PETERS M D, 1992, Brain Injury, V6, P299, DOI 10.3109/02699059209034944; Rabinowitz J, 1999, ACTA PSYCHIAT SCAND, V99, P341, DOI 10.1111/j.1600-0447.1999.tb07239.x; RUBEN I, 1980, J NERV MENT DIS, V168, P243, DOI 10.1097/00005053-198004000-00010; Safran JD, 2000, NEGOTIATING THERAPEU; SATEL SL, 1991, AM J PSYCHIAT, V148, P1708; SILVER JM, 1991, J NEUROPSYCHIAT, V3, P22; Smith RG, 1997, J APPL BEHAV ANAL, V30, P343, DOI 10.1901/jaba.1997.30-343; SOLOFF PH, 1985, HOSP COMMUNITY PSYCH, V36, P652; Tailby R, 2003, NEUROPSYCHOLOGIA, V41, P1230, DOI 10.1016/S0028-3932(03)00036-8; TANKE ED, 1985, AM J PSYCHIAT, V142, P1409; Tateno A, 2003, J NEUROPSYCH CLIN N, V15, P155, DOI 10.1176/appi.neuropsych.15.2.155; TEMPLER DI, 1992, PERCEPT MOTOR SKILL, V75, P195, DOI 10.2466/PMS.75.4.195-202; TERRACE HS, 1963, J EXP ANAL BEHAV, V6, P1, DOI 10.1901/jeab.1963.6-1; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; Triandis H. C., 1977, INTERPERSONAL BEHAV; VOLLMER TR, 1993, J APPL BEHAV ANAL, V26, P9, DOI 10.1901/jaba.1993.26-9; Waddington L, 2002, BEHAV COGN PSYCHOTH, V30, P179, DOI 10.1017/S1352465802002059; Watson C, 2001, BRAIN INJURY, V15, P1003, DOI 10.1080/02699050010022662; Whittington R, 1996, BRIT J CLIN PSYCHOL, V35, P11, DOI 10.1111/j.2044-8260.1996.tb01158.x; Zencius A H, 1989, Brain Inj, V3, P199, DOI 10.3109/02699058909004553	70	17	17	0	4	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	SEP	2005	19	10					753	764		10.1080/02699050500110108			12	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	945EI	WOS:000230484800002	16175836				2021-06-18	
J	Stephenson, S; Langley, J; Cryer, C				Stephenson, S; Langley, J; Cryer, C			Effects of service delivery versus changes in incidence on trends in injury: A demonstration using hospitalised traumatic brain injury	ACCIDENT ANALYSIS AND PREVENTION			English	Article						severity; inpatients; TBI; ICISS; ICD; AIS; trends	SEVERITY; MORTALITY	Though injury incidence and hospitalisations are likely to be correlated, a range of factors other than incidence of injury in a population may influence trends in hospitalised injuries. These include technical changes in the hospital data's coverage, and real changes in the incidence of hospitalisations independent of the population incidence. This paper addresses the latter using the example of traumatic brain injury (TBI) hospitalisations in New Zealand. Data were New Zealand public hospitals inpatient discharges. Five measures of TBI severity were used. The relative rate of minor to serious TBI hospitalisations declined by approximately 2-6% per year from 1988 to 1998. This decline is observed across different mechanisms and the two severity measures used in the detailed analysis. The relative decline in minor to serious TBI is likely to be related to a change in the probability of admission rather than a change in the population TBI incidence. As most TBI hospitalisations are minor this suggests the trend in TBI hospitalisations was significantly influenced by factors other than changes in population incidence. Any analysis of routinely collected secondary injury data needs to consider case selection carefully, especially if trends are being examined. Applying a severity threshold should give more reliable trends. (c) 2005 Elsevier Ltd. All rights reserved.	Univ Otago, Dunedin Sch Med, Injury Prevent Res Unit, Dunedin 9001, Otago, New Zealand	Langley, J (corresponding author), Univ Otago, Dunedin Sch Med, Injury Prevent Res Unit, POB 913, Dunedin 9001, Otago, New Zealand.	shaun.stephenson@ipru.otago.ac.nz; john.langley@ipru.otago.ac.nz; colin.cryer@ipru.otago.ac.nz					Association for the Advancement of Automotive Medicine, 1990, ABBR INJ SCAL 1990 R; Barell V, 2002, INJ PREV, V8, P91, DOI 10.1136/ip.8.2.91; *CDCP NAT CTR INJ, 1999, TRAUM BRAIN INJ US R, P1; Cryer PC, 1999, INT J CONS PROD SAFE, V6, P183; Engberg AW, 2001, EUR J EPIDEMIOL, V17, P437, DOI 10.1023/A:1013733107520; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Langley J, 2002, INJ PREV, V8, P332, DOI 10.1136/ip.8.4.332; Langley J, 2000, AUSTR EPIDEMIOLOGIST, V7, P5; MACKENZIE E, 1997, ICDMAP 90 SOFTWARE U; MACKENZIE EJ, 1989, MED CARE, V27, P412, DOI 10.1097/00005650-198904000-00008; McCarthy ML, 2002, ACAD EMERG MED, V9, P684; Meredith JW, 2002, J TRAUMA, V53, P621, DOI 10.1097/00005373-200210000-00001; *NAT COD CTR, 1996, AUSTR COD STAND ICD; OCONNOR P, 2001, HOSPITALISATION DUE, P1; Osler T, 1996, J TRAUMA, V41, P380, DOI 10.1097/00005373-199609000-00002; Stephenson SCR, 2002, J TRAUMA, V53, P326, DOI 10.1097/00005373-200208000-00023; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; *US NAT CTR HLTH S, 1979, INT CLASS DIS ICD 9, V1; WALSH SS, 1992, J EPIDEMIOL COMMUN H, V46, P26, DOI 10.1136/jech.46.1.26; WHO, 1977, MAN INT STAT CLASS D; Zee CS, 1998, NEUROIMAG CLIN N AM, V8, P525	21	17	17	0	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0001-4575			ACCIDENT ANAL PREV	Accid. Anal. Prev.	SEP	2005	37	5					825	832		10.1016/j.aap.2005.03.024			8	Ergonomics; Public, Environmental & Occupational Health; Social Sciences, Interdisciplinary; Transportation	Engineering; Public, Environmental & Occupational Health; Social Sciences - Other Topics; Transportation	961HP	WOS:000231652900003	15916746				2021-06-18	
J	Wedekind, C; Lippert-Gruner, M				Wedekind, C; Lippert-Gruner, M			Long-term outcome in severe traumatic brain injury is significantly influenced by brainstem involvement	BRAIN INJURY			English	Article						traumatic brain injury; long-term outcome; brainstem lesions	HEAD; LESIONS	Primary objective: To study the 1-year-outcome of 32 survivors of severe traumatic brain injury with respect to the impact of brainstem injury. Research design: Retrospective clinical study performed in a university hospital. Methods and procedures: Thirty-two 1-year-survivors ( 15 with brainstem injury present) of severe traumatic brain injury were investigated for neurological function, activities of daily living, need for care and professional ability. Main outcomes and results: Visual impairment, spasticity, co-ordination deficits and organic psychosis were more frequent in the group harbouring brainstem lesions. Professional ability was worse among these patients. Conclusion: Brainstem involvement in survivors of severe traumatic brain injury conveys a negative impact on long-term outcome.	Univ Cologne, Dept Neurosurg, D-50924 Cologne, Germany	Wedekind, C (corresponding author), Univ Cologne, Dept Neurosurg, D-50924 Cologne, Germany.	drchrwedekind@web.de					Cifu DX, 1997, ARCH PHYS MED REHAB, V78, P125, DOI 10.1016/S0003-9993(97)90252-5; CONSTANT C, 1996, NEUROLOGICAL SURG, P1792; Firsching R, 1998, J NEUROSURG, V89, P707, DOI 10.3171/jns.1998.89.5.0707; Gruner ML, 2000, BRAIN INJURY, V14, P585; HASHIMOTO T, 1993, NEUROSURG REV, V16, P291, DOI 10.1007/BF00383839; Hawkins ML, 1996, J TRAUMA, V41, P257, DOI 10.1097/00005373-199608000-00010; Keith R A, 1987, Adv Clin Rehabil, V1, P6; LEVIN HS, 1988, J NEUROSURG, V69, P861, DOI 10.3171/jns.1988.69.6.0861; Levin HS, 1997, NEUROSURGERY, V40, P432, DOI 10.1097/00006123-199703000-00002; MAHONEY F I, 1965, Md State Med J, V14, P61; Mazaux JM, 1998, DISABIL REHABIL, V20, P435, DOI 10.3109/09638289809166108; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; RHODES M, 1988, J TRAUMA, V28, P931, DOI 10.1097/00005373-198807000-00005; Wedekind C, 1999, J TRAUMA, V47, P44, DOI 10.1097/00005373-199907000-00010; Wedekind C, 2002, BRIT J NEUROSURG, V16, P256, DOI 10.1080/02688690220148842	16	17	19	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	AUG	2005	19	9					681	684		10.1080/02699050400025182			4	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	945EH	WOS:000230484600005	16195181				2021-06-18	
J	Maeda, T; Lee, SM; Hovda, DA				Maeda, T; Lee, SM; Hovda, DA			Restoration of cerebral vasoreactivity by an L-type calcium channel blocker following fluid percussion brain injury	JOURNAL OF NEUROTRAUMA			English	Article						hemodynamic depression; traumatic brain injury; vasoreactivity; verapamil	CORTICAL IMPACT INJURY; SMOOTH-MUSCLE-CELLS; BLOOD-FLOW; GLUCOSE-UTILIZATION; SUBARACHNOID HEMORRHAGE; INTRAVASCULAR PRESSURE; HEMODYNAMIC DEPRESSION; PIAL ARTERY; RAT; MICROCIRCULATION	Traumatic brain injury (TBI) results in significant acute reductions in regional cerebral blood flow (rCBF). However, the mechanisms by which TBI impairs CBF and cerebral vascular reactivity have remained elusive. In the present study, the effect of verapamil, an L-type calcium (Ca2+) channel blocker, on post-traumatic vascular reactivity was evaluated following a lateral fluid percussion injury (FPI) in rats. rCBF was measured by [C-14]-iodoantipyrine autoradiography 1 h after FPI. Following FPI, significant rCBF reductions were documented in all examined cortical areas. These reductions were the most prominent (72.0%) at the primary injury site. Intravenous infusion of verapamil (VE; 200 mu g/kg/min), and norepinephrine (NE; 20 mu g/mL/min) to maintain normal blood pressure, increased rCBF by 141.5% at the primary injury site when compared to untreated, FP-injured animals. Under stimulated conditions, both the ipsilateral and contralateral hemispheres failed to show any increases in rCBF at I h following FPI. In direct contrast, following VE+NE treatment all cortical areas measured showed near normal vascular reactivity to direct cortical stimulation (normal reactivity = 45% increase in rCBF vs. 47% increase in FPI+VE+NE cases). These findings suggest that the majority of post-traumatic hemodynamic depressions are closely related to mechanisms involving vasoconstriction. Furthermore, Ca2+ may play a causative role in this vasoconstriction and the loss of vasoreactivity.	Univ Calif Los Angeles, David Geffen Sch Med, Brain Injury Res Ctr, Div Neurosurg, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, David Geffen Sch Med, Dept Surg Neurosurg, Los Angeles, CA USA	Hovda, DA (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Brain Injury Res Ctr, Div Neurosurg, 10833 Le Conte Ave,Box 957039, Los Angeles, CA 90095 USA.	dhovda@mednet.ucla.edu			NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS37363, NS30308, NS27544] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS037363, R01NS027544, P50NS030308] Funding Source: NIH RePORTER		Alagarsamy S, 1998, J NEUROTRAUM, V15, P627, DOI 10.1089/neu.1998.15.627; Alder VA, 1996, EXP EYE RES, V63, P557, DOI 10.1006/exer.1996.0146; ANDERSEN BJ, 1992, BRAIN RES, V585, P184, DOI 10.1016/0006-8993(92)91205-S; ARMSTEAD WM, 1994, J NEUROTRAUM, V11, P487, DOI 10.1089/neu.1994.11.487; Armstead WM, 1996, J NEUROSURG, V85, P901, DOI 10.3171/jns.1996.85.5.0901; Bergsneider M, 1997, J NEUROSURG, V86, P241, DOI 10.3171/jns.1997.86.2.0241; BOUMA GJ, 1992, J NEUROTRAUM, V9, pS333; BRAYDEN JE, 1989, J CEREBR BLOOD F MET, V9, P256, DOI 10.1038/jcbfm.1989.42; Bryan RM, 2001, AM J PHYSIOL-HEART C, V280, pH2011; Bukoski RD, 1997, AM J PHYSIOL-HEART C, V272, pH1406; BULLOCK R, 1991, J NEUROL NEUROSUR PS, V54, P427, DOI 10.1136/jnnp.54.5.427; Busto R, 1997, J NEUROTRAUM, V14, P35, DOI 10.1089/neu.1997.14.35; Cherian L, 2000, J NEUROPHYSIOL, V83, P2171; CORTEZ SC, 1989, BRAIN RES, V482, P271, DOI 10.1016/0006-8993(89)91190-6; DAVIS MJ, 1992, AM J PHYSIOL, V262, pC1083; DEWITT DS, 1986, J NEUROSURG, V64, P787, DOI 10.3171/jns.1986.64.5.0787; Dietrich WD, 1996, J CEREBR BLOOD F MET, V16, P481, DOI 10.1097/00004647-199605000-00015; Dietrich WD, 1998, NEUROSURGERY, V43, P585, DOI 10.1097/00006123-199809000-00105; DIETRICH WD, 1994, J NEUROTRAUM, V11, P289, DOI 10.1089/neu.1994.11.289; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; ELLIS EF, 1988, AM J PHYSIOL, V255, pH397; FINEMAN I, 1993, BRAIN RES, V624, P94, DOI 10.1016/0006-8993(93)90064-T; Friedberg MH, 1999, J NEUROPHYSIOL, V81, P2243; Ginsberg MD, 1997, AM J PHYSIOL-HEART C, V272, pH2859; Golding EA, 2003, J CEREBR BLOOD F MET, V23, P210, DOI 10.1097/01.WCB.0000044739.64940.B5; HAGBERG H, 1984, J CEREBR BLOOD F MET, V4, P297, DOI 10.1038/jcbfm.1984.41; HARDER DR, 1987, AM J PHYSIOL, V269, pF778; Hong KW, 2001, AM J PHYSIOL-HEART C, V281, pH308; IIJIMA T, 1992, J CEREBR BLOOD F MET, V12, P727, DOI 10.1038/jcbfm.1992.103; Jiang XB, 2000, NEUROL MED-CHIR, V40, P16, DOI 10.2176/nmc.40.16; KAWAMATA T, 1992, J CEREBR BLOOD F MET, V12, P12, DOI 10.1038/jcbfm.1992.3; Kawanabe Y, 2003, J NEUROSURG, V98, P561, DOI 10.3171/jns.2003.98.3.0561; Kelly DF, 1997, J NEUROSURG, V86, P633, DOI 10.3171/jns.1997.86.4.0633; Kelly DF, 2000, J NEUROTRAUM, V17, P261, DOI 10.1089/neu.2000.17.261; Knot HJ, 1998, J PHYSIOL-LONDON, V508, P199, DOI 10.1111/j.1469-7793.1998.199br.x; KONTOS HA, 1986, J NEUROSURG, V64, P803, DOI 10.3171/jns.1986.64.5.0803; LO EH, 1991, NEUROSCI LETT, V131, P17, DOI 10.1016/0304-3940(91)90327-P; LO EH, 1991, J CEREBR BLOOD F MET, V11, P803, DOI 10.1038/jcbfm.1991.138; Maeda T, 1997, ACT NEUR S, V70, P102; MARTIN NA, 1992, J NEUROSURG, V77, P575, DOI 10.3171/jns.1992.77.4.0575; MAXWELL WL, 1988, J PATHOL, V155, P327, DOI 10.1002/path.1711550408; MCINTOSH TK, 1992, J CEREBR BLOOD F MET, V12, P697, DOI 10.1038/jcbfm.1992.95; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; MUIR JK, 1992, J NEUROTRAUM, V9, P355, DOI 10.1089/neu.1992.9.355; Mulligan SJ, 2004, NATURE, V431, P195, DOI 10.1038/nature02827; NEDERGAARD M, 1986, J CEREBR BLOOD F MET, V6, P607, DOI 10.1038/jcbfm.1986.108; OKIYAMA K, 1994, J NEUROTRAUM, V11, P83, DOI 10.1089/neu.1994.11.83; Osteen CL, 2001, J NEUROTRAUM, V18, P141, DOI 10.1089/08977150150502587; Prins ML, 1996, DEV BRAIN RES, V95, P272, DOI 10.1016/0165-3806(96)00098-3; ROBERTSON CS, 1992, J NEUROL NEUROSUR PS, V55, P594, DOI 10.1136/jnnp.55.7.594; SAKURADA O, 1978, AM J PHYSIOL, V234, pH59; Sato M, 1998, BRAIN RES, V809, P39, DOI 10.1016/S0006-8993(98)00817-8; Schmoker JD, 1996, J NEUROTRAUM, V13, P67, DOI 10.1089/neu.1996.13.67; Setoguchi M, 1997, J PHYSIOL-LONDON, V501, P343, DOI 10.1111/j.1469-7793.1997.343bn.x; SHAH KR, 1983, NEUROSCI LETT, V40, P287, DOI 10.1016/0304-3940(83)90053-8; SHIBATA M, 1993, J NEUROSURG, V79, P696, DOI 10.3171/jns.1993.79.5.0696; Suehiro E, 2003, J NEUROTRAUM, V20, P381, DOI 10.1089/089771503765172336; SUNAMI K, 1989, Neurosurgical Review, V12, P400, DOI 10.1007/BF01790682; Taneda M, 1996, J NEUROSURG, V84, P762, DOI 10.3171/jns.1996.84.5.0762; Thomale UW, 2001, J NEUROSCI METH, V108, P85, DOI 10.1016/S0165-0270(01)00375-2; WALSH MP, 1994, CAN J PHYSIOL PHARM, V72, P919, DOI 10.1139/y94-130; WEI EP, 1980, CIRC RES, V46, P37, DOI 10.1161/01.RES.46.1.37; WEI EP, 1981, CIRC RES, V48, P95, DOI 10.1161/01.RES.48.1.95; Welsh DG, 2000, J PHYSIOL-LONDON, V527, P139, DOI 10.1111/j.1469-7793.2000.t01-1-00139.x; Xiong Y, 1997, J NEUROTRAUM, V14, P23, DOI 10.1089/neu.1997.14.23; YAMAKAMI I, 1991, J CEREBR BLOOD F MET, V11, P655, DOI 10.1038/jcbfm.1991.117; YAMAKAMI I, 1989, J CEREBR BLOOD F MET, V9, P117, DOI 10.1038/jcbfm.1989.16; Yang J, 2003, MED ENG PHYS, V25, P691, DOI 10.1016/S1350-4533(03)00100-0; YOSHINO A, 1992, J CEREBR BLOOD F MET, V12, P996, DOI 10.1038/jcbfm.1992.137; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K; Yuan XQ, 1988, J NEUROTRAUM, V5, P289, DOI 10.1089/neu.1988.5.289; Zou H, 2000, J VASC RES, V37, P556, DOI 10.1159/000054089	72	17	17	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL	2005	22	7					763	771		10.1089/neu.2005.22.763			9	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	945VQ	WOS:000230530800004	16004579				2021-06-18	
J	Hukkelhoven, CWPM; Steyerberg, EW; Habbema, JDF; Maas, AIR				Hukkelhoven, CWPM; Steyerberg, EW; Habbema, JDF; Maas, AIR			Admission of patients with severe and moderate traumatic brain injury to specialized ICU facilities: a search for triage criteria	INTENSIVE CARE MEDICINE			English	Article						traumatic brain injury; intensive care; patient admission; hematoma; intracranial hypertension; prognosis	HEAD; PREDICTION; EXPERIENCE; MANAGEMENT; REGRESSION; VARIABLES; MORTALITY; SELECTION; REVISION; TREE	Objective: To investigate whether triage for direct admission of patients with traumatic brain injury to a trauma center is facilitated by predicting the risk of potentially removable lesions or raised intracranial pressure (ICP). Design and setting: Cohort study in a level I university trauma center. Patients and participants: A prospective cohort of primarily ( n= 200) and secondarily ( n= 75) referred patients with moderate or severe traumatic brain injury. Measurements and results: Predictive characteristics for the risk of surgically removable lesions and the risk of raised ICP ( repeatedly >= 20 mmHg) were identified and included in prognostic models. These models were validated internally with bootstrapping techniques and externally on a historic sample ( n= 205) regarding discriminative ability (AUC). Among the cohort patients, 67% had raised ICP and 54% had surgically removable lesions. Both outcomes occurred more frequently in patients secondarily referred, but the incidence in patients primarily referred was also high (62% and 33% respectively). No strong predictors of raised ICP were identified. Age and pupillary reactivity were significant predictors of surgically removable lesions. The models discriminated reasonably for surgically removable lesions ( AUC = 0.78 at development and AUC= 0.67 at external validation) but not for raised ICP ( AUC= 0.59 at development and AUC= 0.50 at external validation). Conclusions: It is difficult accurately to identify patients in need of specialized intensive care using baseline characteristics. The high incidence of both outcomes in patients primarily referred support direct admission of more and particularly older patients with severe or moderate brain trauma to level I trauma centers.	Erasmus MC, Dept Neurol Surg, NL-3000 CA Rotterdam, Netherlands; Erasmus MC, Dept Intens Care Med, NL-3000 CA Rotterdam, Netherlands; Erasmus MC, Dept Publ Hlth, Ctr Clin Decis Sci, Rotterdam, Netherlands	Maas, AIR (corresponding author), Erasmus MC, Dept Neurol Surg, POB 2040, NL-3000 CA Rotterdam, Netherlands.	airmaas@erasmusmc.nl	Maas, Andrew IR/C-5584-2013; Steyerberg, Ewout/C-1509-2018	Maas, Andrew IR/0000-0003-1612-1264; Steyerberg, Ewout/0000-0002-7787-0122; Hukkelhoven, Chantal/0000-0002-0015-1883			Altman DG, 2000, STAT MED, V19, P453, DOI 10.1002/(SICI)1097-0258(20000229)19:4<453::AID-SIM350>3.0.CO;2-5; Andrews PJD, 2002, J NEUROSURG, V97, P326, DOI 10.3171/jns.2002.97.2.0326; ANDREWS PJD, 1990, LANCET, V335, P327, DOI 10.1016/0140-6736(90)90614-B; Bleeker J K, 1993, Ned Tijdschr Geneeskd, V137, P1091; BRAAKMAN R, 1980, NEUROSURGERY, V6, P362, DOI 10.1227/00006123-198004000-00002; Bullock RM, 2000, J NEUROTRAUM, V17, P449; CHAMPION HR, 1989, J TRAUMA, V29, P623, DOI 10.1097/00005373-198905000-00017; CHOI SC, 1991, J NEUROSURG, V75, P251, DOI 10.3171/jns.1991.75.2.0251; Combes P, 1996, INTENS CARE MED, V22, P1391, DOI 10.1007/s001340050269; GENTLEMAN D, 1992, INT SURG, V77, P297; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Harrell Frank E., 2001, REGRESSION MODELING; HUKKELHOVEN C, IN PRESS J NEUROTRAU; Hukkelhoven CWPM, 2002, J NEUROSURG, V97, P549, DOI 10.3171/jns.2002.97.3.0549; LITTLE RJA, 1992, J AM STAT ASSOC, V87, P1227, DOI 10.2307/2290664; MARSHALL LF, 1991, J NEUROSURG, V75, pS28, DOI 10.3171/sup.1991.75.1s.0s28; Murray GD, 1999, ACTA NEUROCHIR, V141, P223, DOI 10.1007/s007010050292; NARAYAN RK, 1982, J NEUROSURG, V56, P650, DOI 10.3171/jns.1982.56.5.0650; Sakellaropoulos GC, 1999, METHOD INFORM MED, V38, P37; Schaan M, 2002, J TRAUMA, V52, P667, DOI 10.1097/00005373-200204000-00009; Schreiber MA, 2002, ARCH SURG-CHICAGO, V137, P285, DOI 10.1001/archsurg.137.3.285; SEELIG JM, 1981, NEW ENGL J MED, V304, P1511, DOI 10.1056/NEJM198106183042503; Signorini DF, 1999, J NEUROL NEUROSUR PS, V66, P20, DOI 10.1136/jnnp.66.1.20; SMITH JS, 1990, J TRAUMA, V30, P1533, DOI 10.1097/00005373-199012000-00017; *SPOED HULPV, 2004, HAAST SPOED NIET OV; Steyerberg EW, 2000, STAT MED, V19, P1059, DOI 10.1002/(SICI)1097-0258(20000430)19:8<1059::AID-SIM412>3.0.CO;2-0; Tibshirani, 1994, INTRO BOOTSTRAP, DOI 10.1201/9780429246593; van Houwelingen HC, 2000, STAT MED, V19, P3401, DOI 10.1002/1097-0258(20001230)19:24<3401::AID-SIM554>3.0.CO;2-2	29	17	17	0	1	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0342-4642	1432-1238		INTENS CARE MED	Intensive Care Med.	JUN	2005	31	6					799	806		10.1007/s00134-005-2628-y			8	Critical Care Medicine	General & Internal Medicine	932UC	WOS:000229578000008	15834705				2021-06-18	
J	Mottram, L; Donders, J				Mottram, L; Donders, J			Construct validity of the California Verbal Learning Test - Children's Version (CVLT-C) after pediatric traumatic brain injury	PSYCHOLOGICAL ASSESSMENT			English	Article						brain injury; memory; children; CVLT-C	STRUCTURAL EQUATION ANALYSIS; WIDE-RANGE ASSESSMENT; HEAD-INJURY; MEMORY; PERFORMANCE	The purpose of this study was to determine the latent structure of the California Verbal Learning Test-Children's Version (CVLT-C; D. Delis, J. Kramer, E. Kaplan, & B. Ober, 1994) in a sample of 175 children with traumatic brain injury (TBI). Maximum-likelihood confirmatory factor analyses were performed to test 6 competing hypothetical models for fit and parsimony. A 4-factor model consisting of Attention Span, Learning Efficiency, Delayed Recall, and Inaccurate Recall provided the best fit to the data. The results support the construct validity of the CVLT-C in children with TBI and suggest that a multifactorial interpretation of quantitative indexes from this instrument is appropriate for clinical practice.	Mary Free Bed Rehabil Hosp, Psychol Serv, Grand Rapids, MI 49503 USA	Donders, J (corresponding author), Mary Free Bed Rehabil Hosp, Psychol Serv, 235 Wealthy SE, Grand Rapids, MI 49503 USA.	jacobus.donders@maryfreebed.com					*AM ED RES ASS AM, 1999, STAND ED PSYCH TESTS; Arnau RC, 2000, ASSESSMENT, V7, P237, DOI 10.1177/107319110000700304; Browne M.W., 1993, TESTING STRUCTURAL E, P136, DOI DOI 10.1177/0049124192021002005; Burton DB, 1999, CHILD NEUROPSYCHOL, V5, P34, DOI 10.1076/chin.5.1.34.7077; Burton DB, 1996, CHILD NEUROPSYCHOL, V2, P39, DOI 10.1080/09297049608401349; Catroppa C, 2002, BRAIN INJURY, V16, P369, DOI 10.1080/02699050110104444; Delis D, 1994, CALIFORNIA VERBAL LE; Donders J, 1999, DEV NEUROPSYCHOL, V15, P395, DOI 10.1080/87565649909540757; Donders J, 1999, DEV NEUROPSYCHOL, V16, P163, DOI 10.1207/S15326942DN1602_2; Donders J, 2004, J INT NEUROPSYCH SOC, V10, P482, DOI 10.1017/S1355617704104025; DONDERS J, 1998, HDB PEDIAT PSYCHOL P, V2, P166; EWINGCOBBS L, 1998, TRAUMATIC BRAIN INJU, P11; Farmer JE, 1999, DEV NEUROPSYCHOL, V15, P269, DOI 10.1080/87565649909540749; Hatcher L., 1994, STEP BY STEP APPROAC; Hoffman N, 2000, ARCH CLIN NEUROPSYCH, V15, P47, DOI 10.1016/S0887-6177(98)00156-5; Levin HS, 2000, J CLIN EXP NEUROPSYC, V22, P1, DOI 10.1076/1380-3395(200002)22:1;1-8;FT001; Lowther JL, 2004, ARCH CLIN NEUROPSYCH, V19, P105, DOI 10.1016/S0887-6177(02)00222-6; Miller LJ, 2003, REHABIL PSYCHOL, V48, P237, DOI 10.1037/0090-5550.48.4.237; NETEMEYER RG, 1990, J APPL PSYCHOL, V75, P148, DOI 10.1037/0021-9010.75.2.148; Precourt S, 2002, DEV NEUROPSYCHOL, V21, P173, DOI 10.1207/S15326942DN2102_4; Roman MJ, 1998, J CLIN EXP NEUROPSYC, V20, P245, DOI 10.1076/jcen.20.2.245.1168; SAS Institute Inc, 1990, SAS STAT US GUID VER, V4th; Stevens J.P., 2002, APPL MULTIVARIATE ST, V4th ed; White DA, 2001, NEUROPSYCHOLOGY, V15, P221, DOI 10.1037/0894-4105.15.2.221; Wiegner S, 1999, J CLIN EXP NEUROPSYC, V21, P159, DOI 10.1076/jcen.21.2.159.925; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; Williams J, 2001, CHILD NEUROPSYCHOL, V7, P15, DOI 10.1076/chin.7.1.15.3148; Woodward H, 1998, APPL NEUROPSYCHOL, V5, P113, DOI 10.1207/s15324826an0503_1; Yeates K O, 1995, J Int Neuropsychol Soc, V1, P78; Yeates KO, 2000, SCI PRACT NEUROPSYCH, P92; Yeates KO, 2002, NEUROPSYCHOLOGY, V16, P514, DOI 10.1037//0894-4105.16.4.514	31	17	17	0	5	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	1040-3590	1939-134X		PSYCHOL ASSESSMENT	Psychol. Assess.	JUN	2005	17	2					212	217		10.1037/1040-3590.17.2.212			6	Psychology, Clinical	Psychology	948TE	WOS:000230737800010	16029108				2021-06-18	
J	de Guise, E; Feyz, M; LeBlanc, J; Richard, SL; Lamoureux, J				de Guise, E; Feyz, M; LeBlanc, J; Richard, SL; Lamoureux, J			Overview of traumatic brain injury patients at a tertiary trauma centre	CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES			English	Article							SEVERE HEAD-INJURY; COGNITIVE STATUS; CLASSIFICATION; RECOVERY; SCALE; REHABILITATION; HETEROGENEITY; PREDICTION; SPECTRUM; DEFICITS	Objective: The goal of this study was to provide a general descriptive and cognitive portrait of a population with traumatic brain injury (TBI) at the time of their acute care stay. Material and methods: Three hundred and forty-eight TBI patients were assessed. The following data were collected for each patient: age, level of education, duration of post-traumatic amnesia, Galveston Orientation Amnesia Test score, Glasgow Coma Scale score, results of cerebral imaging, Neurobehavioral Rating Scale score, the Functional Independence Measure cognitive score and the Glasgow Outcome Scale score. Results: The clinical profile of the population revealed a mean age of 40.2 (18.7) and a mean of 11.5 (+/- 3.6) years of education. Most patients presented with frontal (57.6%) and temporal (40%) lesions. Sixty-two percent had post-traumatic amnesia of less than 24 hours. Seventy percent presented with mild TBI, 14% with moderate and 15% with severe TBI. The cognitive deficits most frequently observed on the Neurobehavioral Rating Scale were in the areas of attention, memory and mental flexibility as well as slowness and mental fatigability. Most patients had good cognitive outcome on the Functional Independence Measure and scores of 2 and 3 were frequent on the GOS. Forty-five percent of the patients returned home after discharge, 51.7% were referred to in or out patient rehabilitation and 3.2% were transferred to long-term care facilities. Conclusion: Because of the specialized mandate of acute care institutions, the information provided here concerning characteristics of our TBI population is essential for more efficient decision-making and planning/programming with regards to care and service delivery.	McGill Univ, Ctr Hlth, Montreal Gen Hosp, Traumat Brain Injury Program, Montreal, PQ H3G 1A4, Canada	de Guise, E (corresponding author), McGill Univ, Ctr Hlth, Montreal Gen Hosp, Traumat Brain Injury Program, Local D13-124,1650 Ave Cedar, Montreal, PQ H3G 1A4, Canada.						ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; ALVES WM, 1985, CENTRAL NERVOUS SYST, P255; Asikainen I, 1998, BRAIN INJURY, V12, P95, DOI 10.1080/026990598122737; Azouvi P, 2000, CURR OPIN NEUROL, V13, P665, DOI 10.1097/00019052-200012000-00009; BERROL S, 1989, TRAUMATIC BRAIN INJU, P31; Blostein PA, 1997, J NEUROTRAUM, V14, P171, DOI 10.1089/neu.1997.14.171; Bombardier CH, 1998, BRAIN INJURY, V12, P725, DOI 10.1080/026990598122124; Caille S, 2000, BRAIN COGNITION, V44, P30; Culotta VP, 1996, NEUROSURGERY, V38, P245, DOI 10.1097/00006123-199602000-00002; DIKMEN S, 1987, J NEUROL NEUROSUR PS, V50, P1613, DOI 10.1136/jnnp.50.12.1613; ESSELMAN PC, 1995, BRAIN INJURY, V9, P417, DOI 10.3109/02699059509005782; GENTILINI M, 1985, J NEUROL NEUROSUR PS, V48, P137, DOI 10.1136/jnnp.48.2.137; GERVAIS M, 1999, PUBLICATION U LAVAL; GRAHAM DI, 1997, GREENFIELDS NEUROPAT, P197; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; KATZ DI, 1994, ARCH NEUROL-CHICAGO, V51, P661, DOI 10.1001/archneur.1994.00540190041013; Kelly MP, 1997, BRAIN INJURY, V11, P391, DOI 10.1080/026990597123386; Khan S, 2002, BRAIN INJURY, V16, P537, DOI 10.1080/02699050110119862; King NS, 1996, J NEUROL NEUROSUR PS, V61, P75, DOI 10.1136/jnnp.61.1.75; KRAUS JF, 1984, AM J EPIDEMIOL, V119, P186, DOI 10.1093/oxfordjournals.aje.a113737; LEVIN HS, 1990, J NEUROSURG, V73, P699, DOI 10.3171/jns.1990.73.5.0699; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; LEVIN HS, 1987, J NEUROL NEUROSUR PS, V50, P183, DOI 10.1136/jnnp.50.2.183; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; LONG CJ, 1988, NEUROPSYCHOLOGICAL S, P132; Mazaux JM, 1997, ARCH PHYS MED REHAB, V78, P1316, DOI 10.1016/S0003-9993(97)90303-8; *MED DIS SOC, 1988, MAN TRAUM BRAIN INJ; Milner B, 1975, Adv Neurol, V8, P299; PARKINSON D, 1985, CAN J SURG, V28, P79; Pierallini A, 2000, NEURORADIOLOGY, V42, P860, DOI 10.1007/s002340000447; RILEY E, 1999, REGIONNALISATION SER, P1; RIMEL RW, 1982, NEUROSURGERY, V11, P344, DOI 10.1227/00006123-198209000-00002; RUFF RM, 1991, J NEUROSURG, V75, pS50, DOI 10.3171/sup.1991.75.1s.0s50; RUFF RM, 1994, BRAIN INJURY, V8, P297, DOI 10.3109/02699059409150981; RUSSELL WR, 1961, ARCH NEUROL-CHICAGO, V5, P4, DOI 10.1001/archneur.1961.00450130006002; SOLOMON DA, 1992, NEUROPSYCHOL REV, V3, P249, DOI 10.1007/BF01109050; STUSS DT, 1984, PSYCHOL BULL, V95, P3, DOI 10.1037/0033-2909.95.1.3; TEASDALE G, 1976, ACTA NEUROCHIR, V34, P45, DOI 10.1007/BF01405862; *U NEW YORK RES FD, 1990, GUID US UN SET MED R; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; WILSON B, 1992, J NEUROL NEUROSUR PS, V55, P177, DOI 10.1136/jnnp.55.3.177	41	17	17	0	4	CANADIAN J NEUROL SCI INC	CALGARY	PO BOX 4220, STATION C EDITORIAL & SUBSCRIPTION SERV, CALGARY, AB T2T 5N1, CANADA	0317-1671			CAN J NEUROL SCI	Can. J. Neurol. Sci.	MAY	2005	32	2					186	193		10.1017/S0317167100003954			8	Clinical Neurology	Neurosciences & Neurology	930GF	WOS:000229403100007	16018153	Bronze			2021-06-18	
J	Bianco, A; Trani, F; Santoro, G; Angelillo, IF				Bianco, A; Trani, F; Santoro, G; Angelillo, IF			Adolescents' attitudes and behaviour towards motorcycle helmet use in Italy	EUROPEAN JOURNAL OF PEDIATRICS			English	Article; Proceedings Paper	3rd International Conference on Traffic and Transport Psychology	SEP 05-09, 2004	Nottingham, ENGLAND			adolescents; attitudes; behaviour; helmet use; motorcycle	INJURIES; RIDERS; SEVERITY	The study investigated the use of, attitudes towards, and adherence to motorcycle helmets in a group of adolescents. A random sample of 412 adolescents (14-19 years old) attending randomly selected public secondary classes in Catanzaro (Italy) received a questionnaire consisting of questions on socio-demographics, patterns of motorcycle use, frequency of helmet use, helmet use by adult family members and close friends who are motorcyclists, attitudes towards helmet use and number of traffic-related motorcycle accidents in the last year. A total of 387 adolescents participated. The frequency of self-reported helmet use as a driver of the motorcycle or as the passenger was 34.7% and 33.7% respectively. Routine helmet use was greater for adolescents from households in which at least one family member wore a helmet, for youths who agreed that helmet use should be mandatory, and for those who did not experience an accident in the past year. Regression analysis of the attitude models indicated that the younger the age, the more willing an adolescent would be to believe that helmet use reduced the risk of head injuries and the positive attitude that helmet use should be mandatory was higher in younger adolescents and in those who bad no road accident within the past year. A total of 17% reported that they had an accident during the last 12 months of the study period and 30 of them presented motorcycle-related injuries. Conclusion: The development of programmes on helmet use starting as early as primary school is strongly needed.	Univ Catanzaro Magna Graecia, Sch Med, Chair Hyg, I-88100 Catanzaro, Italy	Angelillo, IF (corresponding author), Univ Catanzaro Magna Graecia, Sch Med, Chair Hyg, Via Tommaso Campanella, I-88100 Catanzaro, Italy.	angelillo@unicz.it	Angelillo, Italo Francesco/AAK-1301-2021; Bianco, Aida/R-6612-2016	Angelillo, Italo Francesco/0000-0003-1213-6602; BIANCO, Aida/0000-0003-4674-0306			Brandt MM, 2002, J TRAUMA, V53, P469, DOI 10.1097/00005373-200209000-00012; Chapman S, 2001, J PAEDIATR CHILD H, V37, P567, DOI 10.1046/j.1440-1754.2001.00763.x; Chiu WT, 2000, AM J PUBLIC HEALTH, V90, P793, DOI 10.2105/AJPH.90.5.793; GRIMA FG, 1995, EUR J EPIDEMIOL, V11, P87, DOI 10.1007/BF01719951; Hennekens CH, 1987, EPIDEMIOLOGY MED, P101; *ISTAT, 2001, STAT INC STRAD ANN 2; Kraus JF, 2003, ANN EMERG MED, V41, P18, DOI 10.1067/mem.2003.1; LaTorre G, 2002, EUR J PUBLIC HEALTH, V12, P99, DOI 10.1093/eurpub/12.2.99; *LEGGE, 1999, 22016121999 CASC OBB; Lin MR, 2003, ANN EMERG MED, V41, P783, DOI 10.1067/mem.2003.186; Lin MR, 2001, J TRAUMA, V50, P24, DOI 10.1097/00005373-200101000-00004; Rothman KJ., 2002, EPIDEMIOLOGY INTRO, P57; Rowland J, 1996, AM J PUBLIC HEALTH, V86, P41, DOI 10.2105/AJPH.86.1.41; *STAT CORP, 2003, STAT REF MAN REL 8 1; Waller PF, 2002, ANNU REV PUBL HEALTH, V23, P93, DOI 10.1146/annurev.publhealth.23.100901.140522	15	17	18	0	3	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0340-6199	1432-1076		EUR J PEDIATR	Eur. J. Pediatr.	APR	2005	164	4					207	211		10.1007/s00431-004-1604-9			5	Pediatrics	Pediatrics	918EN	WOS:000228525200003	15633049				2021-06-18	
J	Hanlon, RE; Demery, JA; Kuczen, C; Kelly, JP				Hanlon, RE; Demery, JA; Kuczen, C; Kelly, JP			Effect of traumatic subarachnoid haemorrhage on neuropsychological profiles and vocational outcome following moderate or severe traumatic brain injury	BRAIN INJURY			English	Article						traumatic brain injury; outcome; subarachnoid haemorrhage	SEVERE HEAD-INJURY; IMPACT; SCAN	Objective: Traumatic subarachnoid haemorrhage (tSAH) frequently occurs in moderate or severe traumatic brain injury (TBI) and is related to worse outcome at time of discharge from the acute hospitalization. The current study compared neuropsychological impairment and vocational outcome at 1-year post-injury in patients with and without tSAH. Design: Acute injury, neuroradiological, neuropsychological and vocational data were collected for 100 patients admitted for neurorehabilitation following TBI. Results: Patients with tSAH had significantly worse vocational outcome than patients without tSAH. On neuropsychological measures, patients with tSAH generally performed worse than patients without tSAH across most neurocognitive domains. However, differences in neuropsychological test performance between patients with and without tSAH reached statistical significance on measures of visuospatial processing, verbal reasoning and mood only. Conclusion: The presence of tSAH appears to be associated with worse vocational outcome in survivors of moderate or severe TBI. As such, the presence of tSAH appears to have predictive value with respect to outcome following TBI.	Northwestern Univ, Sch Med, Dept Psychiat & Behav Sci, Chicago, IL 60611 USA; Univ Florida, Gainesville, FL USA; Univ Colorado, Sch Med, Boulder, CO 80309 USA	Hanlon, RE (corresponding author), Northwestern Univ, Sch Med, Dept Psychiat & Behav Sci, 446 E Ontario St,Ste 7-100, Chicago, IL 60611 USA.	r-hanlon@northwestern.edu					BRAAKMAN R, 1994, J NEUROSURG, V80, P797; BRUCE DA, 1981, J NEUROSURG, V54, P170, DOI 10.3171/jns.1981.54.2.0170; EISENBERG HM, 1990, J NEUROSURG, V73, P688, DOI 10.3171/jns.1990.73.5.0688; Fukuda T, 1998, NEUROSURGERY, V43, P1040, DOI 10.1097/00006123-199811000-00022; GREENE KA, 1995, J NEUROSURG, V83, P445, DOI 10.3171/jns.1995.83.3.0445; Greene KA, 1996, J TRAUMA, V41, P964, DOI 10.1097/00005373-199612000-00004; GROLIMUND P, 1988, LANCET, V1, P1173; Hanlon RE, 1999, BRAIN INJURY, V13, P873; Kakarieka A, 1997, NEUROL RES, V19, P230, DOI 10.1080/01616412.1997.11740804; KAKARIEKA A, 1994, ACTA NEUROCHIR, V129, P1, DOI 10.1007/BF01400864; KELLY JP, 1991, JAMA-J AM MED ASSOC, V266, P2867, DOI 10.1001/jama.266.20.2867; Mattioli C, 2003, J NEUROSURG, V98, P37, DOI 10.3171/jns.2003.98.1.0037; Servadei F, 2002, NEUROSURGERY, V50, P261, DOI 10.1097/00006123-200202000-00006	13	17	21	0	6	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	APR	2005	19	4					257	262		10.1080/02699050400004955			6	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	917MN	WOS:000228466400003	15832871				2021-06-18	
J	Mortensen, L				Mortensen, L			Written discourse and acquired brain impairment: Evaluation of structural and semantic features of personal letters from a Systemic Functional Linguistic perspective	CLINICAL LINGUISTICS & PHONETICS			English	Article						acquired brain impairment; aphasia; cognitive-language disorder; written discourse; sociolinguistics		This qualitative study investigated written discourse in the form of personal letters written by ten people with aphasia following stroke and ten people with cognitive-language disorder as a consequence of traumatic brain injury, and compared their performance with 15 non brain-damaged writers. Personal letters perform the dual function of providing information and maintaining social relationships. Using the Systemic Functional Linguistics framework for investigation, letters were examined in terms of their dual functions, and at two different strata of language-generic structure and semantic organisation. A small quantum of research suggests that the dissociation between different strata of language (i.e., macro and micro linguistic abilities), identified in the spoken discourse of people with aphasia and people with cognitive-language disorder is mirrored in written discourse. Aphasic writers largely maintain coherent text structure while writers with cognitive-language impairment demonstrate problems with global text coherence and the episodic structure of texts. Results of the generic structure analysis did not support the hypothesis. However, the semantic Move analysis revealed how diminished linguistic resources, most evident in the letters written by the subjects with aphasia, impacted upon the semantic diversity of the text, as well as the interpersonal function of the personal letter. Variable performance as a feature pathology and normality is highlighted and clinical implications discussed.	Macquarie Univ, Dept Linguist, Sydney, NSW 2109, Australia	Mortensen, L (corresponding author), Macquarie Univ, Dept Linguist, Sydney, NSW 2109, Australia.	lmortensen@ozemail.com.au					Barton D., 1999, LETT WRITING SOCIAL; BARTON D, 1991, WRITING COMMUNITY, P59; BEUKELMAN DR, 1991, COMMUNICATION DISORD; BIBER D., 1988, VARIATION SPEECH WRI; BLOOM RL, 1993, J SPEECH HEAR RES, V36, P1227, DOI 10.1044/jshr.3606.1227; BUTT DG, 2000, UNPUB MEANING POTENT, P228; CHAPMAN SB, 1997, M TEX SPEECH LANG HE; CHAPMAN SB, 1999, BRAIN DAM B, P235; COELHO CA, 1995, APHASIOLOGY, V9, P409, DOI 10.1080/02687039508248707; COELHO CA, 1994, CLIN APHASIOLOGY, V21, P183; DAVIS GA, 2000, APHASIOLOGY DISORDER; FREEDMANSTERN R, 1984, BRAIN LANG, V22, P181, DOI 10.1016/0093-934X(84)90089-0; GOODGLASS H, 1983, BOSTON DIAGNOSTIC EX; Hagen C, 1984, LANGUAGE DISORDERS A, P245; Halliday M., 1994, INTRO FUNCTIONAL GRA, V3rd; Halliday M.A.K., 1996, Functional Descriptions: Theory and Practice, P1; Halliday M. A. K., 1985, SPOKEN WRITTEN LANGU; Halliday M. A. K., 1999, CONSTRUING EXPERIENC; Halliday M. A. K., 1978, LANGUAGE SOCIAL SEMI; Halliday MAK, 1985, LANGUAGE CONTEXT TEX; Hartley L. L., 1995, COGNITIVE COMMUNICAT; HASAN R, 1994, PERSPECTIVES PEDAGOG; Hasan Ruqaiya, 1978, CURRENT TRENDS TEXT, P228; Holland A., 1982, CLIN APH P C, P345; IVASK I, 1990, WORLD LITERATURE TOD, V64, P213, DOI 10.2307/40146397; Matthiessen C. M. I. M., 1997, SYSTEMIC FUNCTIONAL; MORTENSEN L, 2003, THESIS MACQUARIE U S; PARR S, 1995, APHASIOLOGY, V9, P223, DOI 10.1080/02687039508248197; Prigatano G. P., 1985, LANG SCI, V7, P217, DOI [10.1016/S0388-0001(85)80020-6, DOI 10.1016/S0388-0001(85)80020-6]; Searle John, 1969, SPEECH ACTS; Simmons-Mackie N, 2002, APHASIOLOGY, V16, P837, DOI 10.1080/02687030244000185; ULATOWSKA H, 1988, J NEUROLINGUIST, V3, P77; Ulatowska H.K., 1978, CLIN APHASIOLOGY, P223; ULATOWSKA HK, 1981, BRAIN LANG, V13, P345, DOI 10.1016/0093-934X(81)90100-0; ULATOWSKA HK, 1983, BRAIN LANG, V19, P317, DOI 10.1016/0093-934X(83)90074-3; ULATOWSKA HK, 1979, STUDIES NEUROLINGUIS, P241; Williams, 1996, WAYS SAYING WAYS MEA, P51; Wilson BM, 2002, BRAIN INJURY, V16, P1011, DOI 10.1080/02699050210147248	38	17	17	0	13	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9206	1464-5076		CLIN LINGUIST PHONET	Clin. Linguist. Phon.	APR-MAY	2005	19	3					227	247		10.1080/02699200410001698652			21	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	913VC	WOS:000228182300008	15823958				2021-06-18	
J	Yang, JT; Lee, TH; Weng, HH; Chang, CN; Chen, WC; Cheng, WC; Wu, JH				Yang, JT; Lee, TH; Weng, HH; Chang, CN; Chen, WC; Cheng, WC; Wu, JH			Dexamethasone enhances NT-3 expression in rat hippocampus after traumatic brain injury	EXPERIMENTAL NEUROLOGY			English	Article						dexamethasone; hippocampus; in situ hybridization; immunohistochemistry; neurotrophin-3; traumatic brain injury	MESSENGER-RNA EXPRESSION; SPINAL-CORD INJURY; NEUROTROPHIC FACTOR; HEAD-INJURY; GLUCOCORTICOIDS MODULATE; FOREBRAIN ISCHEMIA; NEURONS; RECEPTOR; BDNF; CA1	The cellular events in traumatic brain injury (TBI) are complicated, and the factors mediating neurotrophins to protect and repair the injured brain cells are only beginning to be identified. This study examined the effect of dexamethasone (DEX) on neurotrophin-3 (NT-3) expression following TBI. Levels of NT-3 mRNA and protein in rat hippocampus were measured using in situ hybridization and immunohistochemistry, respectively. After TBI, the NT-3 mRNA expression was down-regulated during the first 24 h. DEX reversed the post-traumatic reduction of NT-3 mRNA expression at 2, 4, 6, and 12 h in the hippocampus, and also decreased the cell death in hippocampal hilum and supraventricular cerebral cortex after 7 days. The NT-3 protein levels generally corresponded to the mRNA levels in the hippocampal region. DEX enhanced the NT-3 expression after TBI, indicating that post-traumatic neuroprotection in the hippocampus is at least partially mediated by NT-3 and thus can be modulated by DEX treatment. (c) 2005 Elsevier Inc. All rights reserved.	Chang Gung Univ, Coll Med, Mol Genet Lab 3, Tao Yuan 333, Taiwan; Chang Gung Mem Hosp, Dept Neurosurg, Chiayi, Taiwan; Chang Gung Mem Hosp, Dept Neurol, Taipei 10591, Taiwan; Chang Gung Mem Hosp, Dept Radiol, Chiayi, Taiwan; Chang Gung Mem Hosp, Dept Neurosurg, Taipei 10591, Taiwan; Chang Gung Mem Hosp, Dept Radiat Oncol, Chiayi, Taiwan; Tsu Ai Gen Hosp, Dept Neurosurg, Shi Luo, Taiwan	Wu, JH (corresponding author), Chang Gung Univ, Coll Med, Mol Genet Lab 3, 259 Wen Haw 1 Rd, Tao Yuan 333, Taiwan.	jhwu@mail.cgu.edu.tw	Yang, Jen-Tsung/C-3187-2011; Lee, Tsong Hai/C-1235-2011; Weng, Hsu-Huei/N-8329-2014	Weng, Hsu-Huei/0000-0002-2020-8912			BARBANY G, 1992, EUR J NEUROSCI, V4, P396, DOI 10.1111/j.1460-9568.1992.tb00888.x; BRACKEN MB, 1990, NEW ENGL J MED, V322, P1405, DOI 10.1056/NEJM199005173222001; CHENG B, 1994, BRAIN RES, V640, P56, DOI 10.1016/0006-8993(94)91857-0; COLLAZO D, 1992, NEURON, V9, P643, DOI 10.1016/0896-6273(92)90028-C; DOI N, 1991, NEUROSCI LETT, V123, P99, DOI 10.1016/0304-3940(91)90167-R; DUPLESSIS JJ, 1992, BRIT J NEUROSURG, V6, P145, DOI 10.3109/02688699209002917; FANCONI S, 1988, INTENS CARE MED, V14, P163; Gaab M R, 1994, Zentralbl Neurochir, V55, P135; GOULD E, 1990, NEUROSCIENCE, V37, P367, DOI 10.1016/0306-4522(90)90407-U; Grundy PL, 2000, NEUROREPORT, V11, P3381, DOI 10.1097/00001756-200010200-00023; Grundy PL, 2004, MOL BRAIN RES, V120, P188, DOI 10.1016/j.molbrainres.2003.09.018; Grundy PL, 2001, BRAIN RES, V892, P386, DOI 10.1016/S0006-8993(00)03258-3; HALL ED, 1982, SURG NEUROL, V18, P320, DOI 10.1016/0090-3019(82)90140-9; Hansson AC, 2000, EUR J NEUROSCI, V12, P2918, DOI 10.1046/j.1460-9568.2000.00185.x; Hicks RR, 1999, EXP NEUROL, V160, P469, DOI 10.1006/exnr.1999.7216; Hicks RR, 1997, MOL BRAIN RES, V48, P401, DOI 10.1016/S0169-328X(97)00158-7; Kostron H, 1990, Adv Neurol, V52, P289; Kraus JF, 1996, OCCUP MED, V11, P201; Lee TH, 2004, J NEUROSCI RES, V76, P705, DOI 10.1002/jnr.20097; LEE TH, 1995, J NEUROSCI RES, V41, P684, DOI 10.1002/jnr.490410515; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; MEINIG G, 1990, ACT NEUR S, V51, P100; Otani N, 2002, J CEREBR BLOOD F MET, V22, P327, DOI 10.1097/00004647-200203000-00010; SHAPIRA Y, 1988, J CEREBR BLOOD F MET, V8, P395, DOI 10.1038/jcbfm.1988.75; SIMMONS DM, 1989, J HISTOTECHNOL, V12, P169; SMITH A, 1977, COLOUR ATLAS HISTOLO; Yang JT, 2002, CRIT CARE MED, V30, P913, DOI 10.1097/00003246-200204000-00034; Yang JT, 1998, NEUROREPORT, V9, P3477, DOI 10.1097/00001756-199810260-00026	29	17	19	1	4	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	APR	2005	192	2					437	443		10.1016/j.expneurol.2004.12.023			7	Neurosciences	Neurosciences & Neurology	908ZH	WOS:000227828200020	15755560				2021-06-18	
J	Brooks, N; Hawley, CA				Brooks, N; Hawley, CA			Return to driving after traumatic brain injury: a British perspective	BRAIN INJURY			English	Article						brain injury; driving; rehabilitation; mobility; community; assessment	SEVERE HEAD-INJURY; FITNESS; KNOWLEDGE; DAMAGE	Primary objective: To identify the current legal situation and professional practice in assisting persons with traumatic brain injury ( TBI) to return to safe driving after injury. Methods and procedures: A brief review of relevant literature, a description of the current statutory and quasi- statutory authorities regulating return to driving after TBI in the UK and a description of the nature and resolution of clinical and practical dilemmas facing professionals helping return to safe driving after TBI. Each of the 15 UK mobility centres was contacted and literature requested; in addition a representative of each centre responded to a structured telephone survey. Main outcome and results: The current situation in the UK is described, with a brief analysis of the strengths and weaknesses both of the current statutory situation, and also the practical situation ( driving centres), with suggestions for improvements in practice. Conclusion: Although brain injury may cause serious limitations in driving ability, previous drivers are not routinely assessed or advised regarding return to driving after TBI.	Univ Warwick, Ctr Hlth Serv Studies, Coventry CV4 7AL, W Midlands, England; Rehab Walls, Milton Keynes, Bucks, England	Hawley, CA (corresponding author), Univ Warwick, Ctr Hlth Serv Studies, Coventry CV4 7AL, W Midlands, England.	c.a.hawley@warwick.ac.uk	Hawley, Carol/AAG-3830-2019				Akinwuntan AE, 2002, ARCH PHYS MED REHAB, V83, P334, DOI 10.1053/apmr.2002.29662; British Psychological Society, 2001, FITN DRIV COGN; BROOKS N, 2002, EUROPA MEDICOPHYSICA, V38, P25; Brouwer WH, 2002, J HEAD TRAUMA REHAB, V17, P1, DOI 10.1097/00001199-200202000-00003; CAMPBELL GH, 2003, DRIVING NEUROLOGICAL; Daigneault G, 2002, J CLIN EXP NEUROPSYC, V24, P221, DOI 10.1076/jcen.24.2.221.993; DEBELLEIX X, 2001, EUROPA MEDICOPHYSICA, V37, P201; *DRIV MED GROUP DR, 2003, MED PRACT GLANC GUID; Galski T, 2000, J HEAD TRAUMA REHAB, V15, P895, DOI 10.1097/00001199-200006000-00004; Hall KM., 1993, J HEAD TRAUMA REHAB, V8, DOI [DOI 10.1097/00001199-199308020-00008, 10.1097/00001199-199308020-00008]; Hawley CA, 2001, J NEUROL NEUROSUR PS, V70, P761, DOI 10.1136/jnnp.70.6.761; HAWLEY CA, 2000, BRIT J THERAPY REHAB, V7, P116; KING D, 1992, POSTGRAD MED J, V68, P624, DOI 10.1136/pgmj.68.802.624; Kivioja A, 2003, PREDICTION IN FORENSIC AND NEUROPSYCHOLOGY, P209; LUNDQUIST A, 2001, EUROPA MEDICOPHYSICA, V37, P235; Marshall SC, 1999, CAN MED ASSOC J, V161, P687; Morgan JF, 1998, MED SCI LAW, V38, P28, DOI 10.1177/002580249803800105; NEUWIRTH W, 2001, EUROPA MEDICOPHYSICA, V37, P209; Newby G, 1999, BRIT J GEN PRACT, V49, P301; PRIDDY D A, 1990, Brain Injury, V4, P267, DOI 10.3109/02699059009026176; Schultheis MT, 2002, J HEAD TRAUMA REHAB, V17, P38, DOI 10.1097/00001199-200202000-00006; SIVAK M, 1981, ARCH PHYS MED REHAB, V62, P476; VANZOMEREN AH, 1988, ARCH PHYS MED REHAB, V69, P90; VANZOMEREN AH, 1987, ARCH PHYS MED REHAB, V68, P697; 2002, EUROPA MEDICOPHYSICA, V38; 2001, EUROPA MEDICOPHYSICA, V37	26	17	18	0	3	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	MAR	2005	19	3					165	175		10.1080/02699050410001720004			11	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	906WJ	WOS:000227675000003	15832891				2021-06-18	
J	Narozny, W; Sicko, Z; Kot, J; Stankiewicz, C; Przewozny, T; Kuczkowski, J				Narozny, W; Sicko, Z; Kot, J; Stankiewicz, C; Przewozny, T; Kuczkowski, J			Hyperbaric oxygen therapy in the treatment of complications of irradiation in head and neck area	UNDERSEA AND HYPERBARIC MEDICINE			English	Article							RADIATION; OSTEORADIONECROSIS; RADIONECROSIS; NECROSIS	Background and purpose: We have investigated the treatment results of hyperbaric oxygen (HBO2) to patients with radiation-induced tissue complications. Material and methods: Eight patients (1.4%) from 548 with head and neck cancers treated surgically with post- or preoperative radiotherapy or radiotherapy alone in standard doses who developed postradiation complications (6 patients with laryngeal chondroradionecrosis, 1 patient with osteoradionecrosis of the temporal bone, and 1 patient with soft tissue radionecrosis) are presented. To evaluate radiation reactions occuring in the head and neck region, we used the Chandler grading system for classification of postradiation larynx injuries and SOMA/LENT score for classification of postradiation injuries of mucosa of upper aerodigestive tract. Grades I and II in those grading systems are expected side effects of radiation therapy, thus our cases were all in grades III and IV The HBO2 was performed after failure of the conventional treatment (antibiotics, steroids, topical therapy). The number of HBO2 expositions was from 8 to 39 and the delay to therapy from 2 to 22 months. Results: Symptoms resolved in all treated patients. Six patients with laryngeal chondroradionecrosis had no symptoms after therapy and in three of them after partial laryngectomy the decannulation was performed. In one patient with mucosal radionecrosis after total laryngectomy, the esophageal fistula was closed and in one patient with osteoradionecrosis of the temporal bone, wound debridement followed. Conclusion: The authors' experience supports the increasing clinical evidence that HBO2 is an effective adjunct therapy for treatment of complications of irradiation in head and neck area.	Med Univ Gdansk, ENT Dept, Gdansk, Poland; Med Univ Gdansk, Inst Maritime & Trop Med Gdynia, Natl Ctr Hyperbar Med, Gdansk, Poland	Narozny, W (corresponding author), Med Univ Gdansk, ENT Dept, Gdansk, Poland.		Sicko, Zdzislaw/C-2877-2013; Narozny, Waldemar/T-7531-2018; Kot, Jacek/I-5284-2012	Narozny, Waldemar/0000-0001-5780-1923; Kot, Jacek/0000-0001-5604-8407; Przewozny, Tomasz/0000-0002-4719-9411			BARTON S, 2001, CLIN EVIDENCE; CHANDLER JR, 1979, ANN OTO RHINOL LARYN, V88, P509, DOI 10.1177/000348947908800410; Cox JD, 2003, RAD ONCOLOGY RATIONA; Cummins RO, 1998, CIRCULATION, V97, P1654, DOI 10.1161/01.CIR.97.16.1654; DISCHE S, 1986, INT J RADIAT ONCOL, V12, P1335, DOI 10.1016/0360-3016(86)90166-5; Feldmeier JJ, 2002, UNDERSEA HYPERBAR M, V29, P4; FELDMEIER JJ, 1993, UNDERSEA HYPERBAR M, V20, P329; FERGUSON BJ, 1987, ANN OTO RHINOL LARYN, V96, P1; Filntisis GA, 2000, ANN OTO RHINOL LARYN, V109, P554, DOI 10.1177/000348940010900605; FITZGERALD PJ, 1979, ANN OTO RHINOL LARYN, V98, P509; GREENWOOD TW, 1973, BRIT J SURG, V60, P394, DOI 10.1002/bjs.1800600522; Hampson NB, 1999, HYPERBARIC OXYGEN TH; HORSMAN MR, 1997, BASIC CLIN RADIOBIOL; Hunter Shannon E, 2003, Curr Opin Otolaryngol Head Neck Surg, V11, P103, DOI 10.1097/00020840-200304000-00007; JAIN KK, 1999, TXB HYPERBARIC MED; KEENE M, 1982, LARYNGOSCOPE, V92, P173; London SD, 1998, LARYNGOSCOPE, V108, P1291, DOI 10.1097/00005537-199809000-00005; MAINOUS EG, 1975, ARCH OTOLARYNGOL, V101, P173; MARRONI A, 2001, P ESTRO ECHM CONS C, P147; MARX RE, 1983, J ORAL MAXIL SURG, V41, P283, DOI 10.1016/0278-2391(83)90294-X; MARX RE, 1987, PROBLEM WOUNDS ROLE, P65; MARX RE, 1999, HYPERBARIC MED PRACT, P665; MAUCH PM, 1994, RAD ONCOLOGY RATIONA; MICHAELS L, 1984, PATHOLOGY LARYNX; Narozny W, 2001, Otolaryngol Pol, V55, P57; Neovius EB, 1997, HEAD NECK-J SCI SPEC, V19, P315, DOI 10.1002/(SICI)1097-0347(199707)19:4<315::AID-HED10>3.0.CO;2-8; PARK MK, 1994, HYPERBARIC MED PRACT, P141; PASQUIER D, 2001, P ESTRO ECHM CONS C, P21; PAVY JJ, 1995, RADIOTHER ONCOL, V35, P11, DOI 10.1016/0167-8140(95)97448-M; PEREZ CA, 1993, PRINICPLES PRACTICE; ROWLEY H, 1995, J LARYNGOL OTOL, V109, P218, DOI 10.1017/S0022215100129731; Tibbles PM, 1996, NEW ENGL J MED, V334, P1642, DOI 10.1056/NEJM199606203342506; VANKMERKSTEYN JPR, 1996, HDB HYPERBARIC MED, P387	33	17	19	0	1	UNDERSEA & HYPERBARIC MEDICAL SOC INC	DURHAM	21 WEST COLONY PLACE, STE 280, DURHAM, NC 27705 USA	1066-2936			UNDERSEA HYPERBAR M	Undersea Hyperb. Med.	MAR-APR	2005	32	2					103	110					8	Marine & Freshwater Biology; Medicine, Research & Experimental	Marine & Freshwater Biology; Research & Experimental Medicine	921KC	WOS:000228762100005	15926302				2021-06-18	
J	Bell, DA; Strong, AJ				Bell, DA; Strong, AJ			Glucose/insulin infusions in the treatment of subarachnoid haemorrhage: a feasibility study	BRITISH JOURNAL OF NEUROSURGERY			English	Article						glucose; hyperglycaemia; insulin; subarachnoid haemorrhage	INTENSIVE INSULIN THERAPY; FOCAL CEREBRAL-ISCHEMIA; TRAUMATIC BRAIN-INJURY; PERIINFARCT DEPOLARIZATIONS; MODERATE HYPERGLYCEMIA; SPREADING DEPRESSION; CRITICALLY-ILL; BLOOD-GLUCOSE; ACUTE STROKE; MICRODIALYSIS	Hyperglycaemia following subarachnoid haemorrhage (SAH) is well recognized and has been shown to be associated with a worse prognosis. It is currently unclear whether this is a secondary phenomenon reflecting the magnitude of the stress response or whether it contributes directly to the pathophysiological disturbances within the brain. There is significant experimental work on ischaemic stroke to suggest that hyperglycaemia increases infarct volume. The authors propose that controlling blood glucose following SAH is safe and that it might improve outcome. All patients admitted with SAH were treated with insulin to control plasma glucose with a target range of 5.0 - 7.0 mmol/l. Episodes of hypoglycaemia were recorded. Outcome was assessed at 3 months using the Glasgow Outcome Scale. Fifty-five patients were recruited. 32/3389 (0.94%) of glucose readings fell below 3.5 mmol/l. All were treated with i.v. glucose without evidence of clinical deterioration. Insulin treatment for hyperglycaemia following SAH is feasible and safe. A randomised trial is required to assess any effect on outcome.	Kings Coll Hosp London, Dept Neurosurg, London SE5 9RS, England	Strong, AJ (corresponding author), Kings Coll Hosp London, Dept Neurosurg, Denmark Hill, London SE5 9RS, England.	anthony.strong@kcl.ac.uk		Strong, Anthony/0000-0003-2432-5945			Alberti O, 2000, CLIN NEUROL NEUROSUR, V102, P78, DOI 10.1016/S0303-8467(00)00067-6; Back T, 1996, J CEREBR BLOOD F MET, V16, P202, DOI 10.1097/00004647-199603000-00004; BEREK K, 1991, LANCET, V338, P964; Bernard C, 1858, LECONS PHYSL PATHOLO, VI; BESSEY PQ, 1984, ANN SURG, V200, P264, DOI 10.1097/00000658-198409000-00004; BUCKELL M, 1966, J NEUROL NEUROSUR PS, V4, P293; Busch E, 1996, J CEREBR BLOOD F MET, V16, P1090, DOI 10.1097/00004647-199611000-00002; CRUICKSHANK JM, 1974, BRIT HEART J, V36, P697; DECOURTENMYERS G, 1988, STROKE, V19, P623, DOI 10.1161/01.STR.19.5.623; Dreier JP, 2000, J NEUROSURG, V93, P658, DOI 10.3171/jns.2000.93.4.0658; GINSBERG MD, 1980, STROKE, V11, P347, DOI 10.1161/01.STR.11.4.347; GRAY CS, 1987, DIABETIC MED, V4, P237, DOI 10.1111/j.1464-5491.1987.tb00870.x; HAMILTON MG, 1995, J NEUROSURG, V82, P262, DOI 10.3171/jns.1995.82.2.0262; Hopwood SE, 2005, J CEREBR BLOOD F MET, V25, P391, DOI 10.1038/sj.jcbfm.9600050; LANIER WL, 1987, ANESTHESIOLOGY, V66, P39, DOI 10.1097/00000542-198701000-00008; LANZINO G, 1993, J NEUROSURG, V79, P885, DOI 10.3171/jns.1993.79.6.0885; LONGSTRETH WT, 1993, NEUROLOGY, V43, P712, DOI 10.1212/WNL.43.4.712; MALMBERG K, 1995, J AM COLL CARDIOL, V26, P57, DOI 10.1016/0735-1097(95)00126-K; MARSH WR, 1986, J NEUROSURG, V65, P693, DOI 10.3171/jns.1986.65.5.0693; MYERS GMD, 1994, J CEREB BLOOD FLOW M, V14, P227; MYERS RE, 1977, ARCH NEUROL-CHICAGO, V34, P65, DOI 10.1001/archneur.1977.00500140019003; MYERS RE, 1976, J NEUROPATH EXP NEUR, V35, P301, DOI 10.1097/00005072-197605000-00011; MYERS RE, 1976, NEUROLOGY, V26, P345; NEILDWYER G, 1974, J NEUROL SCI, V22, P375, DOI 10.1016/0022-510X(74)90008-2; OPPENHEIMER SM, 1985, BRIT MED J, V291, P1014, DOI 10.1136/bmj.291.6501.1014-a; Parkin MC, 2005, J CEREBR BLOOD F MET, V25, P402, DOI 10.1038/sj.jcbfm.9600051; PEEK KE, 1989, METAB BRAIN DIS, V4, P261, DOI 10.1007/BF00999772; PICKARD JD, 1989, BRIT MED J, V298, P636, DOI 10.1136/bmj.298.6674.636; PULSINELLI WA, 1982, NEUROLOGY, V32, P1239, DOI 10.1212/WNL.32.11.1239; Scott JF, 1999, STROKE, V30, P793, DOI 10.1161/01.STR.30.4.793; SHIMAZU T, 1966, NATURE, V210, P1178, DOI 10.1038/2101178a0; Strong AJ, 2000, STROKE, V31, P214, DOI 10.1161/01.STR.31.1.214; Takano K, 1996, ANN NEUROL, V39, P308, DOI 10.1002/ana.410390307; Van den Berghe G, 2003, CRIT CARE MED, V31, P359, DOI 10.1097/01.CCM.0000045568.12881.10; Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300; Vespa PM, 2003, J CEREBR BLOOD F MET, V23, P865, DOI 10.1097/01.WCB.0000076701.45782.EF; VOLL CL, 1989, STROKE, V20, P646, DOI 10.1161/01.STR.20.5.646; VOLL CL, 1991, J CEREBR BLOOD F MET, V11, P1006, DOI 10.1038/jcbfm.1991.168; Zygun DA, 2004, NEUROSURGERY, V55, P877, DOI 10.1227/01.NEU.0000137658.14906.E4	39	17	18	0	1	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0268-8697			BRIT J NEUROSURG	Br. J. Neurosurg.	FEB	2005	19	1					21	24		10.1080/02688690500089423			4	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	933IO	WOS:000229622300003	16147578				2021-06-18	
J	Perez-Barcena, J; Barcelo, B; Homar, J; Abadal, JM; Molina, FJ; de la Pena, A; Sahuquillo, J; Ibanez, J				Perez-Barcena, J; Barcelo, B; Homar, J; Abadal, JM; Molina, FJ; de la Pena, A; Sahuquillo, J; Ibanez, J			Comparison of the effectiveness of pentobarbital and thiopental in patients with refractory intracranial hypertension. Preliminary report of 20 patients	NEUROCIRUGIA			Spanish	Article						head injury; intracranial hypertension; pentobarbital; thiopental	HEAD-INJURED PATIENTS; CEREBRAL PROTECTION; BARBITURATE THERAPY; LIPID-PEROXIDATION; PRESSURE; SODIUM; CARE	Objective. To assess the effectiveness of pentobarbital and thiopental to control raised intracranial pressure (ICP), refractory to first level measures, in patients with severe traumatic brain injury. Material and methods. Prospective, randomized study to compare the effectiveness between two treatments: pentobarbital and thiopental. The patients will be selected from those admitted to the Intensive Care Unit with a severe traumatic brain injury (postresuscitation Glasgow Coma Scale equal or less than 8 points) and raised ICP (ICP > 20 mmHg) refractory to first level measures according to the Brain Trauma Foundation guidelines. The adverse effects of both treatments were also collected. Results. We present the results of the first 20 patients included. Ten received pentobarbital and the other ten thiopental. There were no statistically significance differences in patients' characteristics (age, sex, severity of the trauma at admission and comorbilities). There were no differences between both groups neither in the Glasgow Coma Scale at admission (thiopental six points; pentobarbital seven points; P = 0,26) nor in the admission Cranial Tomography, according to the Traumatic Coma Data Bank classification. Thiopental treatment controlled raised ICP in five cases and pentobarbital in two cases (P = 0,16). Five patients in the thiopental group died and eight in the pentobarbital group (P = 0,16). There were no statistically differences between both groups regarding to the presence of hypotension (P = 1) or infectious complications. Conclusions. These preliminary results indicate that thiopental could be more effective than pentobarbital in patients with refractory intracranial hypertension. These results support previous experimental findings that show that both treatments are not equal and justify to continue this study.	Univ Autonoma Barcelona, Serv Med Intens, Hosp Dureta, Dept Cirurgia, E-08193 Barcelona, Spain; Hosp Son Dureta, Serv Anal Clin, Palma de Mallorca, Spain; Hosp Son Dureta, Serv Neurol, Palma de Mallorca, Spain; Hosp Son LLatzer, Med Interna Serv, Palma de Mallorca, Spain; Hosp Gen Valle Hebron, Serv Neurocirugia, Barcelona, Spain; Univ Autonoma Barcelona, Dept Cirurgia, E-08193 Barcelona, Spain	Perez-Barcena, J (corresponding author), Univ Autonoma Barcelona, Serv Med Intens, Hosp Dureta, Dept Cirurgia, E-08193 Barcelona, Spain.		Poca, Maria A./B-8475-2008; Sahuquillo, Juan/B-3577-2008; Barcelo Martin, Bernardino/H-2806-2017	Poca, Maria A./0000-0002-3831-0536; Sahuquillo, Juan/0000-0003-0713-5875; Barcelo Martin, Bernardino/0000-0002-6952-5994; Ibanez, Javier/0000-0003-3735-8332			Almaas R, 2000, ANESTHESIOLOGY, V92, P764, DOI 10.1097/00000542-200003000-00020; *BRAIN TRAUM FDN, 2000, J NEUROTRAUM, V17, P537; Brain Trauma Foundation The American Association of Neurological Surgeons, 2000, J NEUROTRAUM, V17, P527; Cole DJ, 2001, CAN J ANAESTH, V48, P807, DOI 10.1007/BF03016699; DEMOPOULOS HB, 1980, ACTA PHYSIOL SCAND, P91; Drummond JC, 1996, ANESTHESIOLOGY, V85, P1504, DOI 10.1097/00000542-199612000-00050; EISENBERG HM, 1988, J NEUROSURG, V69, P15, DOI 10.3171/jns.1988.69.1.0015; GHAJAR J, 1995, CRIT CARE MED, V23, P560, DOI 10.1097/00003246-199503000-00023; HATANO Y, 1989, ANESTHESIOLOGY, V71, P80, DOI 10.1097/00000542-198907000-00015; Horsley JS, 1937, LANCET, V1, P141; Jeevaratnam DR, 1996, BRIT MED J, V312, P944; KASSELL NF, 1980, NEUROSURGERY, V7, P598, DOI 10.1227/00006123-198012000-00011; MARSHALL LF, 1977, J NEUROSURG, V47, P481; MARSHALL LF, 1979, J NEUROSURG, V50, P20, DOI 10.3171/jns.1979.50.1.0020; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; MARSHALL LF, 1977, ACTA NEUROL SCAND, V56, P156; Perez-Barcena J, 2005, NEUROCIRUGIA, V16, P5; ROCKOFF MA, 1979, ANN NEUROL, V6, P194, DOI 10.1002/ana.410060303; Shibuta S, 1998, BRIT J PHARMACOL, V124, P804, DOI 10.1038/sj.bjp.0701884; SMITH DS, 1980, ANESTHESIOLOGY, V53, P186, DOI 10.1097/00000542-198009000-00002; STEEN PA, 1978, STROKE, V9, P140, DOI 10.1161/01.STR.9.2.140; STEEN PA, 1980, ANESTHESIOLOGY, V53, P183	22	17	17	0	4	ELSEVIER DOYMA SL	BARCELONA	TRAVESERA DE GARCIA, 17-21, BARCELONA, 08021, SPAIN	1130-1473			NEUROCIRUGIA	Neurocirugia	FEB	2005	16	1					5	12					8	Neurosciences; Surgery	Neurosciences & Neurology; Surgery	917JJ	WOS:000228456700001	15756405				2021-06-18	
J	Diamond, AL; Callison, RC; Shokri, J; Cruz-Flores, S; Kinsella, LJ				Diamond, AL; Callison, RC; Shokri, J; Cruz-Flores, S; Kinsella, LJ			Paroxysmal sympathetic storm	NEUROCRITICAL CARE			English	Article						diencephalic seizures; sympathetic storm; autonomic instability; cardiac arrest; hyperthermia	DIENCEPHALIC SEIZURES; EPILEPSY	Introduction: Paroxysmal sympathetic storm (PSS) is a rare syndrome characterized by episodic hypertension, hyperhydrosis, hyperthermia, tachycardia, tachypnea, and extensor posturing. Case reports: This article describes two cases of PSS: one following traumatic brain injury and the other following cardiac arrest. Discussion: The first responded to labetalol, morphine, and codeine, whereas the second responded to labetalol. Conclusion: These observations underscore the importance of central opioid receptors and nonselective P-adrenergic antagonists in modulating catecholamine pathways.	St Louis Univ, Sch Med, Dept Neurol, St Louis, MO 63103 USA; Forest Pk Hosp, Souers Stroke Inst, St Louis, MO 63139 USA; Forest Pk Hosp, Dept Internal Med, St Louis, MO 63139 USA; Forest Pk Hosp, Dept Neurol, Inst Neurosci, St Louis, MO 63139 USA	Kinsella, LJ (corresponding author), Forest Pk Hosp, Dept Neurol, Inst Neurosci, 6125 Clayton Ave,Suite 430, St Louis, MO 63139 USA.	laurence.Kinsella@FPHSTL.com	Cruz-Flores, Salvador/AAR-1233-2020	Cruz-Flores, Salvador/0000-0003-4998-1471			BHIGJEE AI, 1985, J NEUROL SCI, V71, P77, DOI 10.1016/0022-510X(85)90038-3; Boeve BF, 1998, MAYO CLIN PROC, V73, P148; BULLARD DE, 1987, ANN NEUROL, V21, P609, DOI 10.1002/ana.410210617; CARMEL PW, 1985, ACTA NEUROCHIR, V75, P113, DOI 10.1007/BF01406331; DARNELL RB, 1993, NEUROLOGY, V43, P579, DOI 10.1212/WNL.43.3_Part_1.579; Do D, 2000, J NEUROL NEUROSUR PS, V69, P832, DOI 10.1136/jnnp.69.6.832; Graham LN, 2002, CIRCULATION, V106, P793, DOI 10.1161/01.CIR.0000025610.14665.21; Penfield W, 1929, ARCH NEURO PSYCHIATR, V22, P358, DOI 10.1001/archneurpsyc.1929.02220020174010; Penfield W, 1954, EPILEPSY FUNCTIONAL; Ryan JB, 2003, J HEART LUNG TRANSPL, V22, P922, DOI 10.1016/S1053-2498(02)00558-2; SHAPIRO WR, 1969, BRAIN, V92, P423, DOI 10.1093/brain/92.2.423; SOLOMON GE, 1973, J PEDIATR-US, V83, P277, DOI 10.1016/S0022-3476(73)80492-5	12	17	19	0	2	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care		2005	2	3					288	291		10.1385/NCC:2:3:288			4	Critical Care Medicine; Clinical Neurology	General & Internal Medicine; Neurosciences & Neurology	955DD	WOS:000231204500008	16159077				2021-06-18	
J	Schneider, JJ; Gouvier, WD				Schneider, JJ; Gouvier, WD			Utility of the UFOV test with mild traumatic brain injury	APPLIED NEUROPSYCHOLOGY			English	Article						UFOV; driving; mild head injury; rehabilitation	MOTOR-VEHICLE CRASH; DRIVING PERFORMANCE; SELF-REPORT; FITNESS; INVOLVEMENT; IMPAIRMENT; CHALLENGE; DRIVER; DAMAGE	Driving skills are socially important, easily disrupted by brain injury, and potentially risky and difficult to evaluate afterward. The Useful Field of View test has seen successful use with severe traumatic brain injury (TBI), but its use with mild TBI victims has not been examined. This study shows its ecological insensitivity among persons with mild TBI or no impairment and suggests its use be limited to more severely impaired persons.	Louisiana State Univ, Dept Psychol, Baton Rouge, LA 70803 USA	Gouvier, WD (corresponding author), Louisiana State Univ, Dept Psychol, 236 Audubon Hall, Baton Rouge, LA 70803 USA.	wgouvie@lsu.edu					Arthur W, 2001, HUM FACTORS, V43, P1, DOI 10.1518/001872001775992507; BALL KK, 1998, UFOV USEFUL FIELD VI; Brouwer WH, 1997, NEUROPSYCHOL REHABIL, V7, P177, DOI 10.1080/713755536; De Raedt R, 2001, CLIN NEUROPSYCHOL, V15, P329, DOI 10.1076/clin.15.3.329.10277; Fisk GD, 1998, BRAIN INJURY, V12, P683; Fox GK, 1998, ARCH PHYS MED REHAB, V79, P1288, DOI 10.1016/S0003-9993(98)90277-5; GOUVIER WD, 1989, ARCH PHYS MED REHAB, V70, P745; Hanna-Pladdy B, 2001, CLIN NEUROPSYCHOL, V15, P289, DOI 10.1076/clin.15.3.289.10272; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Korteling JE, 1996, ARCH PHYS MED REHAB, V77, P138, DOI 10.1016/S0003-9993(96)90158-6; Lezak MD, 1995, NEUROPSYCHOLOGICAL A; LUCAS JA, 1998, CLIN NEUROPSYCHOLOGY, P243; NOVACK T, 2003, J INT NEUROPSYCH SOC, V9, P235; NOVACK TA, 2005, UFOV RISK LEVEL DRIV; OJILE J, 1998, UNPUB PREDICTING DRI; Owsley C, 1998, JAMA-J AM MED ASSOC, V279, P1083, DOI 10.1001/jama.279.14.1083; PIDIKITI RD, 1991, ARCH PHYS MED REHAB, V72, P109; Reitan R, 1974, CLIN NEUROPSYCHOLOGY; RUSSELL WR, 1946, BRAIN, V69, P280, DOI 10.1093/brain/69.4.280; Schanke AK, 2000, SCAND J PSYCHOL, V41, P113, DOI 10.1111/1467-9450.00179; Schultheis MT, 2002, J HEAD TRAUMA REHAB, V17, P38, DOI 10.1097/00001199-200202000-00006; SCHULTHEIS MT, 2000, M NAT AC NEUR ORL FL; SIVAK M, 1981, ARCH PHYS MED REHAB, V62, P476; SMITH A, 1961, DIS NERV SYST, V22, P69; Smith A., 1982, SYMBOL DIGIT MODALIT; STOKX LC, 1986, J CLIN EXP NEUROPSYC, V8, P421, DOI 10.1080/01688638608401332; VANZOMEREN AH, 1988, ARCH PHYS MED REHAB, V69, P90; VANZOMEREN AH, 1987, ARCH PHYS MED REHAB, V68, P697; Wechsler D, 1997, WAIS 3 ADM SCORING M; WEST R, 1993, ERGONOMICS, V36, P557, DOI 10.1080/00140139308967912	30	17	18	0	5	PSYCHOLOGY PRESS	HOVE	27 CHURCH RD, HOVE BN3 2FA, EAST SUSSEX, ENGLAND	0908-4282	1532-4826		APPL NEUROPSYCHOL	Appl. Neuropsychol.		2005	12	3					138	142		10.1207/S15324826AN1203_3			5	Clinical Neurology; Psychology	Neurosciences & Neurology; Psychology	965OR	WOS:000231960500003	16131340				2021-06-18	
J	Wongvatunyu, S; Porter, EJ				Wongvatunyu, S; Porter, EJ			Mothers' experience of helping young adults with traumatic brain injury	JOURNAL OF NURSING SCHOLARSHIP			English	Article						traumatic brain injury; maternal caregiving; phenomenology	HEAD-INJURY; FAMILY	Purpose: To describe mothers' experience of helping young adults with traumatic brain injury (TBI). Design: Descriptive. Methods: A convenience sample of participants from support groups for parents of young adults with TBI met the criteria of engaging in regular interaction or helping their children (aged 20 to 36 years). These young adults had suffered moderate or severe TBI from a motor vehicle collisions, sports-related injuries, or recreation-related injuries more than 6 months earlier. A descriptive phenomenological method was used. Three in-depth interviews were done with each mother over a 2-month period. Data were the mothers' perceptions, actions, and intentions pertaining to their experiences of helping the young adults. Findings: Five phenomena that were structures of the experience were discerned, discussed with participants to obtain their feedback, and compared to the relevant literature. The five phenomena of the mothers' experiences were: reconnecting my child's brain, considering my child's safety, making our lives as normal as possible, dealing with our biggest problem, and advocating for my child. Conclusions: The mothers continued rehabilitation efforts with the young adults, even when only minimal services were available to support their efforts. Mothers needed interventions to enhance their knowledge, and they and the young adults with TBI needed expanded community services.	Univ Missouri, Sinclair Sch Nursing, Columbia, MO 65211 USA; Mahidol Univ, Ramathibodi Hosp, Fac Med, Ramathibodi Sch Nursing, Bangkok 10700, Thailand	Porter, EJ (corresponding author), Univ Missouri, Sinclair Sch Nursing, Columbia, MO 65211 USA.	porterej@missouri.edu					*BRAIN INJ ASS MIS, 2000, BRAIN INJ BRIEF REV; BROOKS DN, 1991, J CLIN EXP NEUROPSYC, V13, P155, DOI 10.1080/01688639108407214; Carson P, 1993, J Neurosci Nurs, V25, P165; Centers for Disease Control and Prevention (CDC), 1997, MMWR Morb Mortal Wkly Rep, V46, P8; CRAFT MJ, 1992, NURS CLIN N AM, V27, P517; DEBOSKEY DS, 1991, ED FAMILIES HEAD INJ; *FAM CAR ALL, 1998, FACT SHEET TRAUM BRA; Florian V, 1989, Brain Inj, V3, P219, DOI 10.3109/02699058909029637; HAASE JE, 1987, ADV NURS SCI, V9, P64, DOI 10.1097/00012272-198701000-00010; Husserl E., 1913, Ideas: General introduction to pure phenomenology; Johnson B P, 1995, J Neurosci Nurs, V27, P113; KAITARO T, 1995, BRAIN INJURY, V9, P713, DOI 10.3109/02699059509008227; KARPMAN T, 1985, J APPL REHABILITATIO, V17, P28; KOHAK E, 1978, IDEAS EXPERIENCE; Kosciulek J. F., 1994, REHABILITATION COUNS, V37, P245; KOSCIULEK JF, 1995, J APPL REHABILITATIO, V26, P13; KOSCIULEK JF, 1996, J APPL REHABILITATIO, V27, P8; Kramer BJ, 1997, GERONTOLOGIST, V37, P218, DOI 10.1093/geront/37.2.218; Kraus J, 2000, HEAD INJURY, P1; KREUTZER JS, 1992, ARCH PHYS MED REHAB, V73, P771; McCubin M. A., 1991, FAMILY ASSESSMENT IN, P3; Morse J., 1989, QUALITATIVE NURSING, P117; *NAT HEAD INJ FDN, 1984, NIH PUBL; Porter EJ, 1998, ADV NURS SCI, V21, P16, DOI 10.1097/00012272-199809000-00003; Raskin S. A., 2000, NEUROPSYCHOLOGICAL M, P93; Russell WR, 1932, BRAIN, V55, P549, DOI 10.1093/brain/55.4.549; Smith J E, 2000, Care Manag J, V2, P27; Spiegelberg H, 1994, PHENOMENOLOGICAL MOV; TEASDALE G, 1976, ACTA NEUROCHIR, V34, P45, DOI 10.1007/BF01405862; Willer B., 1990, CANADIAN J REHABILIT, V3, P167	30	17	17	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1527-6546	1547-5069		J NURS SCHOLARSHIP	J. Nurs. Scholarsh.		2005	37	1					48	55		10.1111/j.1547-5069.2005.00015.x			8	Nursing	Nursing	900YM	WOS:000227250200012	15813587				2021-06-18	
J	Bergeson, AG; Lundin, R; Parkinson, RB; Tate, DF; Victoroff, J; Hopkins, RO; Bigler, ED				Bergeson, AG; Lundin, R; Parkinson, RB; Tate, DF; Victoroff, J; Hopkins, RO; Bigler, ED			Clinical rating of cortical atrophy and cognitive correlates following traumatic brain injury	CLINICAL NEUROPSYCHOLOGIST			English	Article; Proceedings Paper	14th Annual Meeting of the American-Neuropsychiatric-Association	FEB 01-04, 2003	Honolulu, HI	Amer Neuropsychopharmacol Assoc			HEAD-INJURY; MEMORY; DEMENTIA; SEQUELAE; LESIONS; MR	We report on the utility of using a rapid, easy-to-use, visually based semi-quantitative neuroimaging atrophy rating scale in individuals with traumatic brain injury (TBI) and normal control subjects. Magnetic resonance (MR) scans were rated using a standardized semi-quantitative MR rating method. A four-point scale was used to rate each scan for atrophy in frontal, temporal, and parietal areas. Seventy-five TBI subjects (50 males, 25 females) and 75 age- and gender-matched control subjects were compared for atrophy ratings. Clinical atrophy ratings were also compared to a quantitative measure of atrophy, the ventricle-to-brain ratio, and with the TBI subjects' scores on standard neuropsychological tests. TBI patients had significantly higher clinical atrophy ratings in frontal and temporal lobe areas compared to controls. The clinical atrophy ratings significantly correlated with the ventricle-to-brain ratio, a quantitative measure of atrophy in the same TBI subjects. Higher clinical ratings of frontal and temporal atrophy correlated with deficits in memory and executive function. These findings indicate that clinical ratings of trauma-induced atrophy can be reliably performed and are associated with neuropsychological outcome and quantitative measures of cerebral atrophy.	Brigham Young Univ, Dept Psychol, Provo, UT 84602 USA; Wake Forest Univ, Dept Biol, Winston Salem, NC 27109 USA; Brigham Young Univ, Ctr Neurosci, Provo, UT 84602 USA; Univ So Calif, Keck Sch Med, Dept Neurol, Los Angeles, CA 90089 USA; LDS Hosp, Dept Med, Div Pulm, Salt Lake City, UT USA; LDS Hosp, Dept Med, Crit Care Div, Salt Lake City, UT USA; Univ Utah, Dept Radiol, Salt Lake City, UT 84112 USA; Univ Utah, Dept Psychiat, Salt Lake City, UT 84112 USA	Bigler, ED (corresponding author), Brigham Young Univ, Dept Psychol, 1082 SWKT, Provo, UT 84602 USA.	erin_bigler@byu.edu	Tate, David/G-5166-2011	Tate, David/0000-0003-0213-1920; Lundin, Rebecca/0000-0002-8380-4834			Beck A.T., 1987, BECK DEPRESSION INVE; Beck AT., 1990, BECK ANXIETY INVENTO; Bigler ED, 1996, NEUROPSYCHOLOGY, V10, P333, DOI 10.1037/0894-4105.10.3.333; Bigler ED, 2002, AM J NEURORADIOL, V23, P255; Bigler ED, 2002, ALZ DIS ASSOC DIS, V16, P161, DOI 10.1097/00002093-200207000-00006; Bigler ED, 2001, J HEAD TRAUMA REHAB, V16, P117, DOI 10.1097/00001199-200104000-00003; BIGLER ED, 2004, NEUROREHABILITATION; Blatter DD, 1997, AM J NEURORADIOL, V18, P1; BLATTER DD, 1995, AM J NEURORADIOL, V16, P241; Dahmer E., 1993, J HEAD TRAUMA REHAB, V8, P12, DOI [10.1097/00001199-199308020-00004, DOI 10.1097/00001199-199308020-00004]; Delis DC, 1987, CALIFORNIA VERBAL LE; Heaton R.K., 1991, COMPREHENSIVE NORMS; Hofman PAM, 2002, J NEUROPSYCH CLIN N, V14, P176, DOI 10.1176/appi.neuropsych.14.2.176; Kounios J, 2001, NEURON, V29, P297, DOI 10.1016/S0896-6273(01)00199-4; LEVIN HS, 1995, J NEUROTRAUM, V12, P601, DOI 10.1089/neu.1995.12.601; Mann K, 2001, ALCOHOL CLIN EXP RES, V25, p104S, DOI 10.1097/00000374-200105051-00019; McAllister TW, 2001, J CLIN EXP NEUROPSYC, V23, P775, DOI 10.1076/jcen.23.6.775.1026; McDonald BC, 2002, NEUROREHABILITATION, V17, P333; Osterrieth PA, 1944, ARCH PSYCHOLOGIE, V30, P206; Primus EA, 1997, BRAIN INJURY, V11, P577; Ranganath C, 2003, NEUROPSYCHOLOGIA, V41, P378, DOI 10.1016/S0028-3932(02)00169-0; REIDERGROSWASSER I, 1993, AM J ROENTGENOL, V160, P147, DOI 10.2214/ajr.160.1.8416613; Rey A, 1964, EXAMEN CLIN PSYCHOL; Rey A, 1941, ARCH PSYCHOLOGIE, V28, P286; ROBB R, 1995, ANALYZE 3 DIMENSIONA; Robb RA, 2001, IEEE T MED IMAGING, V20, P854, DOI 10.1109/42.952724; Scheid R, 2003, AM J NEURORADIOL, V24, P1049; Umile EM, 2002, ARCH PHYS MED REHAB, V83, P1506, DOI 10.1053/apmr.2002.35092; van der Naalt J, 1999, ANN NEUROL, V46, P70, DOI 10.1002/1531-8249(199907)46:1<70::AID-ANA11>3.0.CO;2-L; VICTOROFF J, 1994, NEUROLOGY, V44, P2267, DOI 10.1212/WNL.44.12.2267; Warrington EK., 1984, RECOGNITION MEMORY T; Wechsler D., 1987, WECHSLER MEMORY SCAL; Wechsler D, 2008, WECHSLER ADULT INTEL, V4th; Wilde EA, 2004, J NEUROTRAUM, V21, P137, DOI 10.1089/089771504322778604; Wolfson D., 1993, HALSTEAD REITAN NEUR; Yoneoka Y, 2002, J NEUROIMAGING, V12, P231, DOI 10.1177/10528402012003004	36	17	18	0	7	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.	DEC	2004	18	4					509	520		10.1080/1385404049052414			12	Psychology, Clinical; Clinical Neurology; Psychology	Psychology; Neurosciences & Neurology	895BH	WOS:000226835400003	15841954				2021-06-18	
J	Montour-Proulx, I; Braun, CMJ; Daigneault, S; Rouleau, I; Kuehn, S; Begin, J				Montour-Proulx, I; Braun, CMJ; Daigneault, S; Rouleau, I; Kuehn, S; Begin, J			Predictors of intellectual function after a unilateral cortical lesion: Study of 635 patients from infancy to adulthood	JOURNAL OF CHILD NEUROLOGY			English	Article							TRAUMATIC BRAIN-INJURY; PATHOLOGICAL LEFT-HANDEDNESS; FRONTAL-LOBE LESIONS; SEX-DIFFERENCES; HEMIPLEGIC CHILDREN; CEREBRAL ORGANIZATION; LEFT HEMISPHERECTOMY; CHILDHOOD APHASIA; AGE ONE; INTELLIGENCE	This study investigated potential predictors of intellectual outcome in 417 children and 218 adults who had sustained a unilateral cortical lesion. Of these, 295 cases were collected from the scientific literature and 340 from medical records at seven hospitals in Canada. Different sets of predictors emerged for the Wechsler Verbal and Performance IQ values, accounting for differing variances (ie, 12.4% and 20.1%, respectively). The volume of the lesion was the factor that explained the most variance (ie, 4.95% and 11.7%, respectively). Age at lesion onset was significantly and positively correlated with verbal intelligence scores. This variable, considered independently or in interaction with other predictors, did not account for a large portion of the variance explained in intelligence. This refutes the commonly held notion that early onset of the insults results in a better prognosis.	Childrens Hosp Eastern Ontario, Oncol Patient Serv Unit, Ottawa, ON K1H 8L1, Canada; Childrens Hosp Eastern Ontario, Mental Hlth Patient Serv Unit, Ottawa, ON K1H 8L1, Canada; Univ Quebec, Dept Psychol, Montreal, PQ H3C 3P8, Canada; Hop Montreal Enfants, Psychol Serv, Montreal, PQ, Canada	Montour-Proulx, I (corresponding author), Childrens Hosp Eastern Ontario, Oncol Patient Serv Unit, 401 Smyth Rd, Ottawa, ON K1H 8L1, Canada.	montour@cheo.on.ca					Anderson V, 1995, CHILD NEUROPSYCHOL, V1, P187, DOI 10.1080/09297049508400224; Anderson V, 2000, PEDIATR NEUROSURG, V32, P282, DOI 10.1159/000028956; ARAM D, CHANGING NERVOUS SYS, P254; ARAM DM, 1988, NEUROPSYCHOLOGIA, V26, P903, DOI 10.1016/0028-3932(88)90058-9; ARAM DM, 1994, NEUROPSYCHOLOGIA, V32, P85, DOI 10.1016/0028-3932(94)90071-X; Aram DM, 1986, DEV NEUROPSYCHOL, V2, P155, DOI 10.1080/87565648609540339; BALLANTYNE AO, 1994, DEV NEUROPSYCHOL, V10, P39, DOI 10.1080/87565649409540565; BANICH MT, 1990, NEUROPSYCHOLOGIA, V28, P35, DOI 10.1016/0028-3932(90)90084-2; BATES E, CHANGING NERVOUS SYS, P214; BESAG FMC, EPILEPSY BEHAV COGNI, P113; BORNSTEIN RA, 1984, J NERV MENT DIS, V172, P707, DOI 10.1097/00005053-198412000-00002; BORNSTEIN RA, 1984, J CONSULT CLIN PSYCH, V52, P604; Braun CMJ, 2002, BEHAV NEUROL, V13, P105, DOI 10.1155/2002/634764; BREEDLOVE SM, 1994, ANNU REV PSYCHOL, V45, P389, DOI 10.1146/annurev.psych.45.1.389; CHAGNON M, 1953, MANUAL NORMES ECHELL; Cohen J., 1983, APPL MULTIPLE REGRES; DENNIS M, 1985, J CLIN EXP NEUROPSYC, V7, P526, DOI 10.1080/01688638508401283; DENNIS M, CLIN NEUROPSYCHOLOGY, P89; ESLINGER PJ, 1991, DEV NEUROPSYCHOL, V7, P257, DOI 10.1080/87565649109540493; Filley CM, 1999, NEUROPSY NEUROPSY BE, V12, P156; Gadian DG, 1996, NEUROLOGY, V46, P974, DOI 10.1212/WNL.46.4.974; GOLDENBERG G, 1994, BRAIN LANG, V47, P684, DOI 10.1006/brln.1994.1063; Goodman R, 1996, DEV MED CHILD NEUROL, V38, P881, DOI 10.1111/j.1469-8749.1996.tb15045.x; GRATTAN LM, 1991, DEV NEUROPSYCHOL, V7, P283, DOI 10.1080/87565649109540496; INGLIS J, 1981, SCIENCE, V212, P693, DOI 10.1126/science.7221560; INGLIS J, 1982, CAN J PSYCHOL, V36, P670, DOI 10.1037/h0080670; JAFFE KM, 1995, ARCH PHYS MED REHAB, V76, P17, DOI 10.1016/S0003-9993(95)80037-9; JONESGOTMAN M, 1977, NEUROPSYCHOLOGIA, V15, P653, DOI 10.1016/0028-3932(77)90070-7; Kennard MA, 1938, J NEUROPHYSIOL, V1, P477; KIMURA D, 1983, CAN J PSYCHOL, V37, P19, DOI 10.1037/h0080696; Kleihues P, 1997, PATHOLOGY GENETICS T; Klein B, 2000, NEUROLOGY, V55, P230, DOI 10.1212/WNL.55.2.230; Kuehn SM, 2002, CHILD NERV SYST, V18, P306, DOI 10.1007/s00381-002-0599-7; LANSDELL H, 1969, J COMP PHYSIOL PSYCH, V69, P734, DOI 10.1037/h0028306; LEHR E, PSYCHOLOGICAL MANAGE, P41; LEVINE SC, 1987, DEV MED CHILD NEUROL, V29, P27; LEVY J, HDB BEHAV NEUROBIOLO, V11, P245; LOONEN MCB, 1990, ARCH NEUROL-CHICAGO, V47, P1324, DOI 10.1001/archneur.1990.00530120068012; Mariotti P, 1998, NEUROPSYCHOLOGIA, V36, P1303, DOI 10.1016/S0028-3932(98)00031-1; MCGLONE J, 1977, BRAIN, V100, P775, DOI 10.1093/brain/100.4.775; MCGLONE J, 1978, CORTEX, V14, P122, DOI 10.1016/S0010-9452(78)80015-X; MILNER B, 1982, PHILOS T R SOC B, V298, P211, DOI 10.1098/rstb.1982.0083; MILNER B, ADV NEUROLOGY, V8, P299; Muter V, 1997, NEUROPSYCHOLOGIA, V35, P289, DOI 10.1016/S0028-3932(96)00079-6; NASS R, 1989, BRAIN COGNITION, V9, P258, DOI 10.1016/0278-2626(89)90035-3; NASS RD, 1985, ANN NEUROL, V18, P393; NOVELLY RA, 1986, INT NEUR SOC DENV CO; OGDEN JA, 1988, NEUROPSYCHOLOGIA, V26, P645, DOI 10.1016/0028-3932(88)90001-2; ORSINI DL, 1986, ARCH NEUROL-CHICAGO, V43, P333, DOI 10.1001/archneur.1986.00520040021012; RIS MD, 1994, J CLIN EXP NEUROPSYC, V16, P21, DOI 10.1080/01688639408402615; Riva D, 1997, J NEUROSURG, V86, P207, DOI 10.3171/jns.1997.86.2.0207; RIVA D, 1986, NEUROPSYCHOLOGIA, V24, P423, DOI 10.1016/0028-3932(86)90029-1; SATZ P, 1985, BRAIN COGNITION, V4, P27, DOI 10.1016/0278-2626(85)90052-1; Satz P., 1994, NEUROPSYCHOLOGY, V8, P255, DOI DOI 10.1037/0894-4105.8.2.255; Schretlen D., 1994, PSYCHOL ASSESSMENT, V6, P188; SEGALOWITZ SJ, 1992, DEV NEUROPSYCHOL, V8, P279, DOI 10.1080/87565649209540528; SPAYCAR M, 1995, STEDMANS MED DICT; STJAMESROBERTS I, 1981, BRAIN LANG, V13, P31; STRAUSS E, 1990, NEUROPSYCHOLOGIA, V28, P1221, DOI 10.1016/0028-3932(90)90057-U; Tabachnik BG, 1996, USING MULTIVARIATE S; TEUBER HL, NEUROSCIENCES THIRD, P71; VarghaKhadem F, 1997, BRAIN, V120, P159, DOI 10.1093/brain/120.1.159; VARGHAKHADEM F, 1992, BRAIN, V115, P315, DOI 10.1093/brain/115.1.315; VARGHAKHADEM K, 1994, CHILD NEUROL S, V9, pS67; Verger K, 2000, BRAIN INJURY, V14, P495; WARRINGTON EK, 1986, NEUROPSYCHOLOGIA, V24, P223, DOI 10.1016/0028-3932(86)90055-2; Wechsler D., 1991, MANUAL WECHSLER INTE, VIII; Wechsler D., 1974, MANUAL WECHSLER INTE; Wechsler D., 1967, MANUAL WECHSLER PRES; Wechsler D., 1989, MANUAL WECHSLER PRES; WECHSLER D, 1996, MANUAL CANADIAN SUPP; Wechsler D., 1949, MANUAL WECHSLER INTE; Wechsler D., 1981, WAIS R MANUAL WECHSL; Wechsler D., 1955, MANUAL WECHSLER ADUL; WELSH MC, 1991, DEV NEUROPSYCHOL, V7, P131, DOI 10.1080/87565649109540483; Woods B T, 1973, Trans Am Neurol Assoc, V98, P113; WOODS BT, 1978, ANN NEUROL, V3, P273, DOI 10.1002/ana.410030315; WOODS BT, 1980, NEUROPSYCHOLOGIA, V18, P65, DOI 10.1016/0028-3932(80)90084-6	78	17	19	0	1	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0883-0738	1708-8283		J CHILD NEUROL	J. Child Neurol.	DEC	2004	19	12					935	943		10.1177/08830738040190120501			9	Clinical Neurology; Pediatrics	Neurosciences & Neurology; Pediatrics	914LJ	WOS:000228228800005	15704866				2021-06-18	
J	Bell, KR; Hoffman, JM; Doctor, JN; Powell, JM; Esselman, P; Bombardier, C; Fraser, R; Dikmen, S				Bell, KR; Hoffman, JM; Doctor, JN; Powell, JM; Esselman, P; Bombardier, C; Fraser, R; Dikmen, S			Development of a telephone follow-up program for individuals following traumatic brain injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						rehabilitation; traumatic brain injury	CONTROLLED-TRIAL; NEEDS; EDUCATION; FAMILIES; SUPPORT	Objective: To describe the development of a telephone follow-up program that addresses the needs of survivors of traumatic brain injury (TBI) and their families in the year following injury. The process of developing the program is reviewed from the initial steps of identifying needs through final implementation of the program. Participants: Eighty-four TBI survivors with moderate to severe injuries and their families. Results: Descriptive statistics are presented including number of contacts, areas of concern for participants, and the types of interventions conducted. Case examples are provided to illustrate the impact of the telephone follow-up program. Conclusion: This project demonstrated the feasibility of using the telephone as a means of providing information and support during the first year after moderate to severe traumatic brain injury. Telephone follow-up may enhance service provision for persons with TBI, especially those with a lack of transportation or geographic isolation.	Univ Washington, Dept Rehabil Med, Seattle, WA 98195 USA; Univ Washington, Dept Med Educ & Biomed Informat, Seattle, WA 98195 USA; Univ Washington, Dept Hlth Serv, Seattle, WA 98195 USA; Univ Washington, Dept Neurosurg, Seattle, WA 98195 USA; Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA	Bell, KR (corresponding author), Univ Washington, Dept Rehabil Med, Box 356490, Seattle, WA 98195 USA.	krbell@u.washington.edu		Bell, Kathleen/0000-0002-0928-2046			*AM EL ASS, 2003, WASH TECH JOB GROWTH; Austin JS, 1996, ARTHRIT CARE RES, V9, P391, DOI 10.1002/1529-0131(199610)9:5<391::AID-ANR1790090508>3.0.CO;2-V; BANDURA A, 1986, SOCIAL FDN THOUGHT A; Bell KR, 2003, J HEAD TRAUMA REHAB, V18, P504, DOI 10.1097/00001199-200311000-00004; Bostrom J, 1996, APPL NURS RES, V9, P47, DOI 10.1016/S0897-1897(96)80402-2; Broadstock MJ, 1997, PATIENT EDUC COUNS, V32, P141, DOI 10.1016/S0738-3991(97)00036-0; Brown R, 1999, J HEAD TRAUMA REHAB, V14, P257, DOI 10.1097/00001199-199906000-00006; Campbell C H, 1988, Rehabil Nurs, V13, P320; Engli M, 1993, J Neurosci Nurs, V25, P78; Holland D, 1998, BRAIN INJURY, V12, P993, DOI 10.1080/026990598121918; Karlik B A, 1990, J Cardiovasc Nurs, V4, P70; McPherson KM, 2000, INT J REHABIL RES, V23, P295, DOI 10.1097/00004356-200023040-00005; Miller WR, 1991, MOTIVATIONAL INTERVI; Newton K M, 1988, Prog Cardiovasc Nurs, V3, P62; O'Connell JM, 2002, MED DECIS MAKING, V22, P309, DOI 10.1177/027298902400448876; Paterson B, 2001, Rehabil Nurs, V26, P48; PROCHASKA JO, 1992, AM PSYCHOL, V47, P1102, DOI 10.1037/0003-066X.47.9.1102; Serio CD, 1997, BRAIN INJURY, V11, P1, DOI 10.1080/026990597123764; *US CENS BUR, 2001, SEL HOUS CHAR; *US DEP COMM, 2002, NAT ONL AM EXP THEIR; VANELDERENVANKEMENADE T, 1994, BRIT J CLIN PSYCHOL, V33, P367, DOI 10.1111/j.2044-8260.1994.tb01133.x; vanVeenendaal H, 1996, PATIENT EDUC COUNS, V28, P265, DOI 10.1016/0738-3991(95)00853-5; Wade DT, 1998, J NEUROL NEUROSUR PS, V65, P177, DOI 10.1136/jnnp.65.2.177; WEINBERGER M, 1993, ARTHRITIS RHEUM, V36, P243, DOI 10.1002/art.1780360216	24	17	17	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	NOV-DEC	2004	19	6					502	512		10.1097/00001199-200411000-00007			11	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	873LZ	WOS:000225283100007	15602312				2021-06-18	
J	Castejon, OJ; De Castejon, HV				Castejon, OJ; De Castejon, HV			Structural patterns of injured mitochondnia in human oedematous cerebral cortex	BRAIN INJURY			English	Article							CYTOCHROME-C; BRAIN; ISCHEMIA; ANOXIA; NEURONS; DEATH	Primary objective: Cerebral cortical biopsies of 37 patients with clinical diagnosis of congenital malformations, brain trauma and tumours were studied to establish mitochondrial morphological alterations. Methods and procedures: Cortical biopsies obtained in the surgical room were immediately processed by conventional technique for transmission electron microscopy. Results: Three injured mitochondrial morphological patterns were found: swollen clear, (SCM), swollen dense (SDM) and dark degenerated (DDM) mitochondria. SCM were predominantly found in traumatic brain oedema. SDM and DDM were frequently observed in sustained permanent ischaemia induced by brain tumours, vascular anomaly and congenital hydrocephalus. SCM exhibited low electron dense mitochondrial matrix, enlarged intracristal space and continuity of outer and inner mitochondrial membranes. SDM showed high electron dense matrix and swollen intact or fragmented cristae. DDM displayed overall high electron density of matrix and mitochondrial membranes. Conclusion: The injured mitochondrial patterns are related with nerve cell death and considered markers of lethal nerve cell injury.	Univ Zulia, Fac Med, Inst Invest Biol, Maracaibo 4003A, Venezuela	Castejon, OJ (corresponding author), Univ Zulia, Fac Med, Inst Invest Biol, Apartado 526, Maracaibo 4003A, Venezuela.	ocastejo@cantv.net					Anderson MF, 1999, J NEUROCHEM, V73, P1189, DOI 10.1046/j.1471-4159.1999.0731189.x; ANKARCRONA M, 1995, NEURON, V15, P961, DOI 10.1016/0896-6273(95)90186-8; BONDY SC, 1996, PARADIGMS NERVE INJU, P243; BROWN AW, 1973, ACTA NEUROPATHOL, V23, P9, DOI 10.1007/BF00689000; Brown GC, 1999, BIOCHEM SOC SYMP, V66, P17, DOI 10.1042/bss0660017; Castejon O J, 1995, J Neurosurg Sci, V39, P47; CASTEJON OJ, 1980, J NEUROPATH EXP NEUR, V39, P296, DOI 10.1097/00005072-198005000-00006; CASTEJON OJ, 1988, J SUBMICR CYTOL PATH, V20, P519; Castejon OJ, 1999, J SUBMICR CYTOL PATH, V31, P203; CASTEJON OJ, 1994, J SUBMICR CYTOL PATH, V26, P29; Castejon OJ, 1997, BRAIN INJURY, V11, P363, DOI 10.1080/026990597123520; CASTEJON OJ, 1985, J SUBMICR CYTOL PATH, V17, P703; Castejon OJ, 2000, BRAIN INJURY, V14, P303; CASTEJON OJ, BRAIN INJURY, V4, P291; Chen DX, 2003, J CEREBR BLOOD F MET, V23, P88, DOI 10.1097/01.WCB.0000039286.37737.19; Chen H, 2001, STROKE, V32, P2382, DOI 10.1161/hs1001.097099; CLENDENON NR, 1979, SEMINAR NEUROLOGICAL, P115; Du G, 1998, FREE RADICAL BIO MED, V25, P1066, DOI 10.1016/S0891-5849(98)00148-8; Dubinsky JM, 1999, BIOCHEM SOC SYMP, V66, P75, DOI 10.1042/bss0660075; DZHAFAROV AI, 1989, EKSPERIMENTALNOI BIO, V107, P305; GINSBERG MD, 1988, NEUROCHEM PATHOL, V9, P171; GNAIGER E, 2000, TRANSPLANT INT S, V1, pS555; GUTIERREZDIAZ JA, 1985, SURG NEUROL, V24, P67, DOI 10.1016/0090-3019(85)90067-9; HAYES RL, 1996, CATASTROPHIC BRAIN I, P183; HILLERED L, 1989, J NEUROSCI RES, V24, P247, DOI 10.1002/jnr.490240216; HOSSMANN KA, 1985, ACTA NEUROPATHOL, V68, P230, DOI 10.1007/BF00690200; Ikrenyi K, 1976, Adv Exp Med Biol, V75, P159; KOIZUMI J, 1970, Archivum Histologicum Japonicum, V32, P241; KRISTIAN T, J NEUROCHEMISTRY, V83, P1297; KYKENS JA, 1994, J NEUROCHEM, V63, P584; LEHNINGER AL, 1971, BIOENERGETICS, P73; Lemasters JJ, 1997, MOL CELL BIOCHEM, V174, P159, DOI 10.1023/A:1006827601337; Martin LJ, 2000, NEUROBIOL DIS, V7, P169, DOI 10.1006/nbdi.2000.0282; MAYEVSKY A, 1991, Neurological Research, V13, P39; MCCLURE MJ, 1996, PARADIGMS NERVE INJU, P178; Morley P, 1999, CONT NEUROS, P69; Muizelaar JP, 1996, CATASTROPHIC BRAIN I, P233; Newcomb R, 1998, BRAIN RES, V813, P103, DOI 10.1016/S0006-8993(98)01006-3; Nicholls DG, 1999, BIOCHEM SOC SYMP, V66, P55, DOI 10.1042/bss0660055; NOVIKOF VE, FARMAKOLOGIIA TOKSIK, V54, P44; Novikov V. E., 1994, Eksperimental'naya i Klinicheskaya Farmakologiya, V57, P13; Perez-Pinzon MA, 1999, J CEREBR BLOOD F MET, V19, P39, DOI 10.1097/00004647-199901000-00004; ROMANSKY K, 1995, ZBL NEUROCHIR, V56, P111; Rosenthal M, 1997, ADV EXP MED BIOL, V428, P189; Solenski NJ, 2002, STROKE, V33, P816, DOI 10.1161/hs0302.104541; WAGNER KR, 1990, J NEUROL SCI, V100, P142, DOI 10.1016/0022-510X(90)90025-I; Wullner U, 1999, BRAIN RES, V826, P53, DOI 10.1016/S0006-8993(99)01228-7	47	17	18	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	NOV	2004	18	11					1107	1126		10.1080/02699050410001672332			20	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	863JW	WOS:000224558900004	15545208				2021-06-18	
J	Engberg, AW; Teasdale, TW				Engberg, AW; Teasdale, TW			A population-based study of survival and discharge status for survivors after head injury	ACTA NEUROLOGICA SCANDINAVICA			English	Article						traumatic brain injury; head injury; epidemiology; survival; sequelae; rehabilitation planning	TRAUMATIC BRAIN-INJURY; EPIDEMIOLOGY; DISABILITY	Objectives - Creation of a basis for the planning of rehabilitation after head injury in Denmark. Materials and methods - Patients with cranial fractures or traumatic cerebral lesions occurring in Denmark in 1979-93 were identified by computerized searches in the national hospital register. Kaplan-Meier survival functions were calculated for these two categories. Hospital records for a random sample of 389 survivors in 1997 after cranial fracture, acute brain lesion or chronical subdural haematoma, which occurred in 1982, 1987 and 1992 in patients aged 15 years or more at injury, were reviewed. Survivors were characterized by age, gender, place and severity of injury, as well as neurophysical, speech and mental deficits at discharge from hospital. Results - Acute/subacute mortality of hospitalized patients was 27% for cerebral lesions and 4% after cranial fracture. As attrition by death outweighed the decreasing incidence with time, the point prevalence of survivors in 1997 after brain lesions occurring in 1982, 1987 or 1992 was nearly the same, averaging 8.4 per 100 000 of the population above age 14. Half of them were severe, as defined by initial Glasgow Coma Score <9 for more than 6 h. There was no tendency with time of injury with regard to percentage occurrence of neurophysical, speech or mental deficits at discharge. The calculated number of candidates for rehabilitation of personal activities of daily life briefly after injury was 9.8 per 100 000 with cerebral lesion and 1.2 per 100 000 with cranial fracture. The severest 1.5 per 100 000 per year were candidates for early intensive centralized rehabilitation in special centres. Five years after injury, <0.13 per 100 000 population survived in the vegetative state. Conclusion - In this population-based study, survival after cranial fracture and cerebral lesion was described quantitatively through Kaplan-Meier survival distributions. Besides, patterns of severity, neurophysical and mental sequelae among survivors 5, 10 and 15 years post-injury were described. It was shown by examples how the study has been useful already for the planning of rehabilitation according to a national strategy from 1997 in Denmark. Besides, the results may serve as a reference for comparison with future studies.	Copenhagen Univ Hosp, Hvidovre Hosp, Dept Neurol Rehabil, DK-2650 Hvidovre, Denmark; Univ Copenhagen, Dept Psychol, Copenhagen, Denmark	Engberg, AW (corresponding author), Copenhagen Univ Hosp, Hvidovre Hosp, Dept Neurol Rehabil, DK-2650 Hvidovre, Denmark.	aase.engberg@hh.hosp.dk					Andersen TF, 1999, DAN MED BULL, V46, P263; ANNEGERS JF, 1980, NEUROLOGY, V30, P912, DOI 10.1212/WNL.30.9.912; Baguley I, 2000, BRAIN INJURY, V14, P505; Engberg A, 1995, Acta Neurol Scand Suppl, V164, P1; Engberg AW, 2004, BRAIN INJURY, V18, P533, DOI 10.1080/02699050310001645829; Engberg AW, 2001, EUR J EPIDEMIOL, V17, P437, DOI 10.1023/A:1013733107520; Frank L, 2000, SCIENCE, V287, P2398, DOI 10.1126/science.287.5462.2398; Hillier SL, 1997, BRAIN INJURY, V11, P661; JENNETT B, 1977, J NEUROL NEUROSUR PS, V40, P291, DOI 10.1136/jnnp.40.3.291; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; KRAUS JF, 1984, AM J EPIDEMIOL, V119, P186, DOI 10.1093/oxfordjournals.aje.a113737; LEE KF, 1987, J NEUROSURG, V66, P542, DOI 10.3171/jns.1987.66.4.0542; LEWIN W, 1979, BRIT MED J, V2, P1533, DOI 10.1136/bmj.2.6204.1533; Linn Shai, 1995, Annals of Epidemiology, V5, P440, DOI 10.1016/1047-2797(95)00059-3; Masson F, 1997, J CLIN EPIDEMIOL, V50, P595, DOI 10.1016/S0895-4356(97)00012-7; MCKENZIE EJ, 1989, MARYLAND MED J, V38, P725; Murray GD, 1999, ACTA NEUROCHIR, V141, P223, DOI 10.1007/s007010050292; *OECD, 1994, INT ROAD TRAFF ACC D; ROBERTS AH, 1979, SEVERE ACCIDENTAL HE; *SUNDH DAN NAT BOA, 1997, BEH TRAUM HJ TILGR L; TIRET L, 1990, INT J EPIDEMIOL, V19, P133, DOI 10.1093/ije/19.1.133	21	17	18	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0001-6314	1600-0404		ACTA NEUROL SCAND	Acta Neurol. Scand.	NOV	2004	110	5					281	290		10.1111/j.1600-0404.2004.00323.x			10	Clinical Neurology	Neurosciences & Neurology	861RC	WOS:000224434900002	15476456				2021-06-18	
J	Louin, G; Besson, VC; Royo, NC; Bonnefont-Rousselot, D; Marchand-Verrecchia, C; Plotkine, M; Jafarian-Tehrani, M				Louin, G; Besson, VC; Royo, NC; Bonnefont-Rousselot, D; Marchand-Verrecchia, C; Plotkine, M; Jafarian-Tehrani, M			Cortical calcium increase following traumatic brain injury represents a pitfall in the evaluation of Ca2+-independent NOS activity	JOURNAL OF NEUROSCIENCE METHODS			English	Article						nitric oxide synthases; inducible nitric oxide inhibitor; 1400W; calcium; traumatic brain injury; rat	NITRIC-OXIDE SYNTHASE; FOCAL CEREBRAL-ISCHEMIA; RATS; ACTIVATION; PHOSPHORYLATION; EXPRESSION; INDUCTION; BINDING; MICE; NEUROPROTECTION	In this report, our findings highlighted the presence of a high level of calcium in the cortex following traumatic brain injury (TBI) in a rat model of fluid percussion-induced brain injury. This calcium increase represents a pitfall in the assessment of Ca2+-independent nitric oxide synthase (NOS) activity supposed to play a role in the secondary brain lesion following TBI. The so-called Ca2+-independent NOS activity measured in the injured cortex 72 h after TBI had the pharmacological profile of a Ca2+-dependent NOS and was therefore inhibited with a supplement of calcium chelator. The remaining activity was very low and iNOS protein was hardly immumodetected on the same sample used for NOS activity assay. The concentration of calcium chelator used in the assay should be revised and adjusted consequently to make sure that the calcium-free condition is achieved for the assay. Otherwise, the findings tend towards an overestimation of Ca2+-independent and underestimation of Ca2+-dependent NOS activities. The revised Ca2+-independent NOS activity assay was then tested, in relation with the amount of iNOS protein, in a model of LPS-induced neuroinflammation. Taken together, precautions should be taken when assessing the Ca2+-independent enzymatic activity in cerebral tissue after a brain insult. (C) 2004 Elsevier B.V. All rights reserved.	Univ Paris 05, UPRES, EA 2510, Pharmacol Lab, F-75270 Paris 06, France; Univ Paris 05, UPRES, EA 3617, Lab Biochim Metab & Clin, F-75270 Paris 06, France	Jafarian-Tehrani, M (corresponding author), Univ Paris 05, UPRES, EA 2510, Pharmacol Lab, 4 Ave Observ, F-75270 Paris 06, France.	mehmaz.jafarian@univ-paris5.fr	MARCHAND-LEROUX, Catherine/L-7453-2017; BESSON, VALERIE/AAZ-9989-2020; Rousselot, Bonnefont/U-7434-2019; besson, valerie C/L-7388-2017	MARCHAND-LEROUX, Catherine/0000-0003-0113-5348; BESSON, VALERIE/0000-0002-1491-2380; besson, valerie C/0000-0002-1491-2380; Jafarian-Tehrani, Mehrnaz/0000-0001-6895-5856; Bonnefont-Rousselot, Dominique/0000-0003-4689-9202			Alderton WK, 2001, BIOCHEM J, V357, P593, DOI 10.1042/0264-6021:3570593; Besson VC, 2003, BRAIN RES, V989, P58, DOI 10.1016/S0006-8993(03)03362-6; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BREDT DS, 1989, P NATL ACAD SCI USA, V86, P9030, DOI 10.1073/pnas.86.22.9030; Butt E, 2000, J BIOL CHEM, V275, P5179, DOI 10.1074/jbc.275.7.5179; CaulinGlaser T, 1997, CIRC RES, V81, P885; Chatzipanteli K, 1999, J NEUROCHEM, V72, P2047, DOI 10.1046/j.1471-4159.1999.0722047.x; Colasanti M, 2000, TRENDS PHARMACOL SCI, V21, P249, DOI 10.1016/S0165-6147(00)01499-1; Corson MA, 1996, CIRC RES, V79, P984, DOI 10.1161/01.RES.79.5.984; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; Fleming I, 1999, P NATL ACAD SCI USA, V96, P1123, DOI 10.1073/pnas.96.3.1123; Gahm C, 2000, NEUROSURGERY, V46, P169; Garvey EP, 1997, J BIOL CHEM, V272, P4959, DOI 10.1074/jbc.272.8.4959; Grandati M, 1997, BRIT J PHARMACOL, V122, P625, DOI 10.1038/sj.bjp.0701427; IADECOLA C, 1995, J CEREBR BLOOD F MET, V15, P52, DOI 10.1038/jcbfm.1995.6; Igarashi J, 1999, P NATL ACAD SCI USA, V96, P12583, DOI 10.1073/pnas.96.22.12583; KNOWLES RG, 1990, BIOCHEM J, V270, P833, DOI 10.1042/bj2700833; Kristof AS, 1998, AM J RESP CRIT CARE, V158, P1883, DOI 10.1164/ajrccm.158.6.9802100; Lu J, 2003, NEUROPHARMACOLOGY, V44, P253, DOI 10.1016/S0028-3908(02)00380-5; Lu YC, 1997, MOL CHEM NEUROPATHOL, V30, P125, DOI 10.1007/BF02815154; Mesenge C, 1996, J NEUROTRAUM, V13, P209, DOI 10.1089/neu.1996.13.209; Osteen CL, 2001, J NEUROTRAUM, V18, P141, DOI 10.1089/08977150150502587; Parmentier S, 1999, BRIT J PHARMACOL, V127, P546, DOI 10.1038/sj.bjp.0702549; Petrov T, 2000, ACTA NEUROPATHOL, V100, P196, DOI 10.1007/s004019900167; Rao VLR, 1999, J NEUROTRAUM, V16, P865, DOI 10.1089/neu.1999.16.865; Sinz EH, 1999, J CLIN INVEST, V104, P647, DOI 10.1172/JCI6670; SMITH FS, 1998, DETECTION NOS ISOFOR, P171; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; Wada K, 1998, NEUROSURGERY, V43, P1427, DOI 10.1097/00006123-199812000-00096; Wada K, 1998, J NEUROSURG, V89, P807, DOI 10.3171/jns.1998.89.5.0807; Yamada K, 1999, NEUROSCIENCE, V88, P281, DOI 10.1016/S0306-4522(98)00237-1; Zamora R, 2000, MOL MED, V6, P347, DOI 10.1007/BF03401781	32	17	18	0	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0165-0270	1872-678X		J NEUROSCI METH	J. Neurosci. Methods	SEP 30	2004	138	1-2					73	79		10.1016/j.jneumeth.2004.03.010			7	Biochemical Research Methods; Neurosciences	Biochemistry & Molecular Biology; Neurosciences & Neurology	853CT	WOS:000223804600010	15325114				2021-06-18	
J	Brener, I; Harman, JS; Kelleher, KJ; Yeates, KO				Brener, I; Harman, JS; Kelleher, KJ; Yeates, KO			Medical costs of mild to moderate traumatic brain injury in children	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						healthcare expenditures; financial burden; traumatic brain injury	ECONOMIC BURDEN; CARE; ASTHMA	Objective: To estimate healthcare expenditures of children with mild to moderate traumatic brain injury (TBI) outside of acute care settings. Design: Data from the 1997-2000 Medical Expenditure Panel Survey were used to produce estimates of expenditures for a natural sample of 196 children with TBI. Results: Expenditures for TBI-related services in children averaged $77.9 million per year. Average per capita expenditure was $1044, of which $166 was for TBI-related services and $878 was for all other health services. Conclusion: Although total costs of TBI in children are high, the average costs are much lower than those previous reports because youth with minor trauma were not included in prior samples.	Columbus Childrens Res Inst, Columbus, OH 43205 USA; Denison Univ, Granville, OH 43023 USA; Univ Florida, Dept Hlth Serv Adm, Gainesville, FL 32611 USA; Ohio State Univ, Dept Pediat, Columbus, OH USA	Kelleher, KJ (corresponding author), Columbus Childrens Res Inst, 700 Childrens Dr, Columbus, OH 43205 USA.	kellebek@pediatrics.obio-state.edu	Yeates, Keith/AAJ-4223-2020; Kelleher, Kelly/E-3361-2011	Yeates, Keith/0000-0001-7680-2892			BROOKS CA, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199508000-00002; Bryant ET, 1993, J HEAD TRAUMA REHAB, V8, P15; Centers for Disease Control and Prevention, NATL CTR INJ PREV CO; Chambers J. G., 2003, TOTAL EXPENDITURES S; Chan E, 2002, ARCH PEDIAT ADOL MED, V156, P504, DOI 10.1001/archpedi.156.5.504; COHEN JW, 1997, HLTH AFF MILLWOOD, V22, P129; Edelstein Burton L, 2002, Pediatr Dent, V24, P11; Gergen PJ, 2001, J ALLERGY CLIN IMMUN, V107, pS445, DOI 10.1067/mai.2001.114992; Hwang W, 2001, HEALTH AFFAIR, V20, P267, DOI 10.1377/hlthaff.20.6.267; JAFFE KM, 1993, ARCH PHYS MED REHAB, V74, P681, DOI 10.1016/0003-9993(93)90024-5; LANGLOIS JA, 2003, CDCP MORB MORBTAL WK, V52, P1; Lehmkuhl L, 1993, J HEAD TRAUMA REHAB, V8, P88; Lozano P, 1999, J ALLERGY CLIN IMMUN, V104, P957, DOI 10.1016/S0091-6749(99)70075-8; MacKenzie E., 1991, J HEAD TRAUMA REHAB, V6, P76, DOI [10.1097/00001199-199106000-00010, DOI 10.1097/00001199-199106000-00010]; McGarry LJ, 2002, J TRAUMA, V53, P1152, DOI 10.1097/00005373-200212000-00020; MILLS RJ, 2001, HLTH INSURANCE COVER, P60; Osberg JS, 1997, BRAIN INJURY, V11, P11; *STAT CORP, 2002, STATACORP STAT STAT; Swigonski N, 2001, CHILD HEALTH CARE, V30, P219, DOI 10.1207/S15326888CHC3003_4; Thompson K, 2001, N C Med J, V62, P376; Yelin E, 2002, EUR RESPIR J, V19, P414, DOI 10.1183/09031936.02.00522001; FAMILY CAREGIVE ALLI	22	17	17	0	12	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	SEP-OCT	2004	19	5					405	412		10.1097/00001199-200409000-00005			8	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	858UB	WOS:000224216300005	15597031				2021-06-18	
J	De Monte, VE; Geffen, GM; May, CR; McFarland, K				De Monte, VE; Geffen, GM; May, CR; McFarland, K			RETRACTED: Double cross-validation and improved sensitivity of the rapid screen of mild traumatic brain injury (Retracted Article. See vol 29, pg 904, 2007)	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article; Retracted Publication							MINOR HEAD-INJURY; NEUROPSYCHOLOGICAL SEQUELAE; STANDARDIZED ASSESSMENT; POSTTRAUMATIC AMNESIA; AUSTRALIAN RULES; FOOTBALL PLAYERS; CONCUSSION; RECOVERY	This study aimed to replicate and cross-validate the Rapid Screen of Concussion (RSC) for diagnosing mild TBI (mTBI). One hundred (81 male, 19 female) cases of mTBI and 35 (23 male and 12 female) cases of orthopaedic injuries were tested within 24 hr of injury. Double cross-validation was used to examine whether total RSC scores obtained in the cur-rent sample, generalised to one previously reported. In the new sample, mTBI patients answered fewer orientation questions, recalled fewer words on the learning trial and after a delay, judged fewer sentences in 2 min, and completed fewer symbols in the Digit Symbol Substitution Test than orthopaedic controls. The formulae and cut-offs developed on the original and new samples produced similar sensitivity and overall correct classification rates. Inclusion of the Digit Symbol Substitution Test performance of the new sample improved the sensitivity (80.2%) and specificity (82.6%) in males. It did not improve the correct classification rate in females, which was 89.5% sensitivity and 91.7% specificity before the inclusion of the Digit Symbol Substitution Test. Taken together, these results indicate that a combined score on this 12-min screen yields a measure of level of brain impairment up to 24 hr after mTBI.	Univ Queensland, Cognit Psychophysiol Lab, St Lucia, Qld 4067, Australia; Royal Brisbane Hosp, Dept Emergency Med, Brisbane, Qld 4029, Australia; Univ Queensland, Sch Psychol, Brisbane, Qld, Australia	De Monte, VE (corresponding author), Sch Med, Cognit Psychophysiol Lab, Edith Cavell Bldg,Herston Rd, Brisbane, Qld 4006, Australia.	comerf@psy.uq.edu.au					ANNEGERS JF, 1980, NEUROLOGY, V30, P912, DOI 10.1212/WNL.30.9.912; Baddeley A.D., 1992, SPEED CAPACITY LANGU; BARTH JT, 1983, NEUROSURGERY, V13, P529, DOI 10.1227/00006123-198311000-00008; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Comerford VE, 2002, J CLIN EXP NEUROPSYC, V24, P409, DOI 10.1076/jcen.24.4.409.1044; FORRESTER G, 1994, BRAIN INJURY, V8, P175, DOI 10.3109/02699059409150969; FORRESTER G, 1995, J FARR SERVICES POST; GRONWALL DMA, 1977, PERCEPT MOTOR SKILL, V44, P367, DOI 10.2466/pms.1977.44.2.367; Hillier SL, 1997, BRAIN INJURY, V11, P649; Hinton-Bayre AD, 1999, J CLIN EXP NEUROPSYC, V21, P70, DOI 10.1076/jcen.21.1.70.945; HintonBayre AD, 1997, J CLIN EXP NEUROPSYC, V19, P275, DOI 10.1080/01688639708403857; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; KRAUS JF, 1989, MILD HEAD INJURY, P8; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; Maddocks D, 1996, BRAIN INJURY, V10, P99, DOI 10.1080/026990596124584; MADDOCKS DL, 1991, J CLIN EXP NEUROPSYC, V13, P439; McCrea M, 1997, NEUROLOGY, V48, P586, DOI 10.1212/WNL.48.3.586; McCrea M, 1998, J HEAD TRAUMA REHAB, V13, P27, DOI 10.1097/00001199-199804000-00005; McCrory PR, 1997, BRIT MED J, V314, P171, DOI 10.1136/bmj.314.7075.171; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; SHORES EA, 1986, MED J AUSTRALIA, V144, P569, DOI 10.5694/j.1326-5377.1986.tb112311.x; Tate RL, 1998, AUST NZ J PUBL HEAL, V22, P419, DOI 10.1111/j.1467-842X.1998.tb01406.x; Trenerry M.R., 1989, STROOP NEUROPSYCHOLO; Wechsler D, 2008, WECHSLER ADULT INTEL, V4th; WHITMAN S, 1984, AM J EPIDEMIOL, V119, P570, DOI 10.1093/oxfordjournals.aje.a113774	25	17	17	0	15	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	AUG	2004	26	5					628	644		10.1080/13803390490504443			17	Psychology, Clinical; Clinical Neurology; Psychology	Psychology; Neurosciences & Neurology	862HE	WOS:000224480800005	15370385				2021-06-18	
J	Harmsen, M; Geurts, ACH; Fasotti, L; Bevaart, BJW				Harmsen, M; Geurts, ACH; Fasotti, L; Bevaart, BJW			Positive behavioural disturbances in the rehabilitation phase after severe traumatic brain injury: an historic cohort study	BRAIN INJURY			English	Article							CLOSED-HEAD-INJURY; DIFFUSE AXONAL INJURY; AGITATION; HALOPERIDOL; RESTLESSNESS; COGNITION; RECOVERY; AMNESIA; AGENTS	Primary objective: To investigate the association of post-traumatic amnesia (PTA) with positive behavioural disturbances (PBD) in an historic cohort of patients with severe traumatic brain injury (TBI) and to evaluate the use and effects of neuroleptic drugs in this cohort. Research design: Historic cohort study. Methods: The medical files of 60 patients with severe TBI, selected for inpatient rehabilitation during a period of 5.5 years, were independently examined for the presence of PTA and PBD at admission in the rehabilitation centre as well as for the concomitant use of neuroleptic drugs. All TBI patients with PBD at admission were subjected to special nursing measures consisting of a structured and safe environment, a minimum number of caregivers and provision of simple and consistent feedback. As a basic policy, the use of neuroleptic medication was minimized or stopped. Results: Of the 28 patients suffering from PTA at admission, 16 demonstrated PBD (positive predictive value 0.57 (95% CI 0.45-0.70)). In contrast, all the 32 patients without PTA but one did not show PBD (negative predictive value 0.97 (95% CI 0.93-1.00)). Seven of the 17 patients with PBD (41%) had been prescribed neuroleptic medication, of whom five patients (81%) experienced undesired side effects. Because of the special nursing measures, these drugs could be stopped or substituted by non-neuroleptic behaviour-modifying drugs in all patients within 3 weeks, without aggravation of their PBD. Conclusions: These results suggest that impaired attention and memory may play a critical role in the development of PBD in patients with severe TBI. From this perspective, maximum effort must be made to improve TBI patients' level of attention, memory and orientation instead of using mechanical or chemical restraints.	St Maartens Clin, Dept Rehabil Med, NL-6500 GM Nijmegen, Netherlands; Rehabil Ctr Tolbrug, Shertogenbosch, Netherlands	Geurts, ACH (corresponding author), St Maartens Clin, Dept Rehabil Med, POB 9011, NL-6500 GM Nijmegen, Netherlands.	a.geurts@maartenskliniek.nl	Geurts, Alexander/H-8032-2014	Geurts, Alexander/0000-0001-7478-1119			Ahmed S, 2000, BRAIN INJURY, V14, P765; ARTIOLAIFORTUNY L, 1980, J NEUROL NEUROSUR PS, V43, P377, DOI 10.1136/jnnp.43.5.377; BROOKE MM, 1992, ARCH PHYS MED REHAB, V73, P320, DOI 10.1016/0003-9993(92)90003-F; Byerly MJ, 2001, DRUG AGING, V18, P45, DOI 10.2165/00002512-200118010-00004; CORRIGAN J D, 1992, Brain Injury, V6, P155, DOI 10.3109/02699059209029653; CORRIGAN JD, 1988, ARCH PHYS MED REHAB, V69, P487; Ducharme JM, 1999, BRAIN INJURY, V13, P645, DOI 10.1080/026990599121232; Fasotti L., 2003, HDB NEUROPSYCHOLOGY, V9, P67; Fugate LP, 1997, ARCH PHYS MED REHAB, V78, P924, DOI 10.1016/S0003-9993(97)90051-4; GOLDSTEIN LB, 1993, J NEURAL TRANSP PLAS, V4, P175, DOI 10.1155/NP.1993.175; Granon S, 2000, J NEUROSCI, V20, P1208, DOI 10.1523/JNEUROSCI.20-03-01208.2000; HAMM RJ, 1994, J NEUROSURG, V81, P267, DOI 10.3171/jns.1994.81.2.0267; JENNET B, 1981, MANAGEMENT HEAD INJU; Legangneux E, 2000, J PSYCHOPHARMACOL, V14, P164, DOI 10.1177/026988110001400206; LEVIN HS, 1978, ARCH NEUROL-CHICAGO, V35, P720, DOI 10.1001/archneur.1978.00500350024005; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Maryniak O, 2001, BRAIN INJURY, V15, P167, DOI 10.1080/026990501458399; McLean A. J., 1997, HEAD INJURY, P25; Meythaler JM, 2002, J HEAD TRAUMA REHAB, V17, P300, DOI 10.1097/00001199-200208000-00004; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; Mysiw WJ, 1997, ARCH PHYS MED REHAB, V78, P213, DOI 10.1016/S0003-9993(97)90266-5; Pike BR, 1997, PHARMACOL BIOCHEM BE, V57, P785, DOI 10.1016/S0091-3057(96)00453-4; POLING A, 1990, J PHARMACOL EXP THER, V255, P1240; RAO N, 1985, ARCH PHYS MED REHAB, V66, P30; REYES RL, 1981, ARCH PHYS MED REHAB, V62, P20; RUSSELL WR, 1971, TRAUMATIC AMNESIAS; SHALLICE T, 1982, PHILOS T ROY SOC B, V298, P199, DOI 10.1098/rstb.1982.0082; Shallice T., 1988, NEUROPSYCHOLOGY MENT; Stanislav SW, 1997, BRAIN INJURY, V11, P335, DOI 10.1080/026990597123494; Stanislav SW, 2000, BRAIN INJURY, V14, P261; Teng CJ, 2001, BRAIN INJURY, V15, P463, DOI 10.1080/02699050010005931; van der Naalt J, 2000, BRAIN INJURY, V14, P781; Whyte J, 2002, J HEAD TRAUMA REHAB, V17, P284, DOI 10.1097/00001199-200208000-00003; Wilkinson R, 1999, BRAIN INJURY, V13, P1025	34	17	17	0	5	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	AUG	2004	18	8					787	796		10.1080/02699050410001671757			10	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	826AN	WOS:000221801300005	15204319				2021-06-18	
J	Walter, B; Brust, P; Fuchtner, F; Muller, M; Hinz, R; Kuwabara, H; Fritz, H; Zwiener, U; Bauer, R				Walter, B; Brust, P; Fuchtner, F; Muller, M; Hinz, R; Kuwabara, H; Fritz, H; Zwiener, U; Bauer, R			Age-dependent effects of severe traumatic brain injury on cerebral dopaminergic activity in newborn and juvenile pigs	JOURNAL OF NEUROTRAUMA			English	Article						colored microspheres; dopamine metabolism; fluid-percussion; juvenile pig; newborn piglets; pediatric brain injury; positron emission tomography	AMINO-ACID DECARBOXYLASE; DEFICIT HYPERACTIVITY DISORDER; COLORED MICROSPHERE TECHNIQUE; PEDIATRIC HEAD-INJURY; MONOAMINE OXIDASE-B; BLOOD-FLOW; STRIATAL DOPAMINE; RAT-BRAIN; TYROSINE-HYDROXYLASE; CHILDREN	There is evidence that the dopaminergic system is sensitive to traumatic brain injury (TBI). However, the age-dependency of this sensitivity has not been studied together with brain oxidative metabolism. We postulate that the acute effects of severe TBI on brain dopamine turnover are age-dependent. Therefore F-18-labelled 6-fuoro-L-3,4-dihydroxyphenylalanine (FDOPA) together with Positron-Emission-Tomography (PET) was used to estimate the activity of the aromatic amino acid decarboxylase (AADC) in the brain of Ill newborn piglets (7-10 days old) and nine juvenile pigs (6-7 weeks old). Six newborn and five juvenile animals were subjected to a severe fluid-percussion (FP) induced TBI. The remaining animals were used as sham operated untreated control groups. Simultaneously, the regional cerebral blood flow (CBF) was measured with colored microspheres and the cerebral metabolic rates of oxygen and glucose were determined. At 1 h after FP-TBI, [F-18]FDOPA was infused and PET scanning was performed for 2 h. At 2 h after FP-TBI administration, a second series of measurements of physiological values including CBF and brain oxidative metabolism data had been obtained. Severe FP-TBI elicited a marked increase in the rate constant for fluorodopamine production (k(3)(FDOPA)) in all brain regions of newborn piglets studied by between 97% (mesencephalon) and 143% (frontal cortex) (p < 0.05). In contrast, brain hemodynamics and cerebral oxidative metabolism remained unaltered after TBI. Furthermore, the permeability-surface area product of FDOPA (PSFDOPA) was unchanged. In addition, regional blood flow differences between corresponding ipsi- and contralateral brain regions did not occur after TBI. Thus, it is suggested that severe FP-TBI induces an upregulation off AADC activity of newborn piglets that is not related to alterations in brain oxidative metabolism.	Univ Jena, Univ Klinikum Jena, Inst Pathophysiol, D-07740 Jena, Germany; Univ Jena, Inst Pathophysiol & Pathobiochem, D-6900 Jena, Germany; Univ Jena, Dept Neurosurg, D-6900 Jena, Germany; Univ Jena, Dept Anesthesiol & Intens Care, D-6900 Jena, Germany; Inst Interdisciplinary Isotope Res, Leipzig, Germany; Res Ctr Rossendorf, Inst Bioinorgan & Radiopharmaceut Chem, Dresden, Germany; Johns Hopkins Univ, Dept Radiol & Radiol Sci, Baltimore, MD USA	Bauer, R (corresponding author), Univ Jena, Univ Klinikum Jena, Inst Pathophysiol, D-07740 Jena, Germany.	Reinhard.Bauer@mti.uni-jena.de		, Peter/0000-0001-5555-7058; Hinz, Rainer/0000-0002-7808-9207			Adelson PD, 1998, J CHILD NEUROL, V13, P2, DOI 10.1177/088307389801300102; ARMSTEAD WM, 1994, J NEUROTRAUM, V11, P487, DOI 10.1089/neu.1994.11.487; Armstead WM, 2000, MICROCIRCULATION, V7, P225, DOI 10.1038/sj.mn.7300110; Bauer R, 1999, PEDIATR NEUROSURG, V30, P62, DOI 10.1159/000028765; Bauer R, 2002, BRAIN RES, V934, P23, DOI 10.1016/S0006-8993(02)02315-6; Bauer R, 1996, EXP TOXICOL PATHOL, V48, P415; Berry MD, 1996, NEUROCHEM RES, V21, P1075, DOI 10.1007/BF02532418; BERRY MD, 1994, BRIT J PHARMACOL, V113, P1159, DOI 10.1111/j.1476-5381.1994.tb17119.x; Brix G, 1997, J NUCL MED, V38, P1614; Brust P, 1998, INT J DEV NEUROSCI, V16, P353, DOI 10.1016/S0736-5748(98)00017-3; Brust P, 2003, SYNAPSE, V47, P143, DOI 10.1002/syn.10163; BRUST P, 2003, 5 INT C CER VASC BIO; Cho S, 1997, EUR J PHARMACOL, V323, P149, DOI 10.1016/S0014-2999(97)00037-X; COYLE MG, 1993, AM J PHYSIOL, V264, pH141; CUMMING P, 1995, J NEUROCHEM, V65, P1381; Cumming P, 1998, SYNAPSE, V29, P37, DOI 10.1002/(SICI)1098-2396(199805)29:1<37::AID-SYN4>3.0.CO;2-C; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Dougherty DD, 1999, LANCET, V354, P2132, DOI 10.1016/S0140-6736(99)04030-1; Ernst M, 1999, AM J PSYCHIAT, V156, P1209; Fisher A, 2000, NEUROSCIENCE, V95, P97; Fisher A, 1998, BRAIN RES, V792, P126, DOI 10.1016/S0006-8993(98)00129-2; GLOBUS MYT, 1988, J NEUROCHEM, V51, P1455, DOI 10.1111/j.1471-4159.1988.tb01111.x; Graham DI, 2001, BRAIN, V124, P1261, DOI 10.1093/brain/124.7.1261; HADJICONSTANTINOU M, 1995, EUR J PHARM-MOLEC PH, V289, P97, DOI 10.1016/0922-4106(95)90173-6; Hayes R L, 1987, Brain Inj, V1, P93, DOI 10.3109/02699058709034449; Henry JM, 1997, J INVEST SURG, V10, P281, DOI 10.3109/08941939709032167; HUANG CC, 1994, NEUROCHEM RES, V19, P649, DOI 10.1007/BF00967702; HUANG SC, 1991, J CEREBR BLOOD F MET, V11, P898, DOI 10.1038/jcbfm.1991.155; JOCHUM T, 2000, PFLUG ARCH EUR J P S, V439, pR287; Kline AE, 2000, NEUROSCI LETT, V280, P163, DOI 10.1016/S0304-3940(00)00797-7; Kline AE, 2002, J NEUROTRAUM, V19, P415, DOI 10.1089/08977150252932370; Konrad KN, 2000, BRAIN INJURY, V14, P859; Krause KH, 2000, NEUROSCI LETT, V285, P107, DOI 10.1016/S0304-3940(00)01040-5; LINDGREN S, 1969, ACTA PHYSIOL SCAND, V76, P340, DOI 10.1111/j.1748-1716.1969.tb04477.x; LUERSSEN TG, 1988, J NEUROSURG, V68, P409, DOI 10.3171/jns.1988.68.3.0409; MAKER HS, 1981, J NEUROCHEM, V36, P589, DOI 10.1111/j.1471-4159.1981.tb01631.x; MAKOWSKI EL, 1968, CIRC RES, V23, P623, DOI 10.1161/01.RES.23.5.623; McDowell S, 1998, BRAIN, V121, P1155, DOI 10.1093/brain/121.6.1155; MCINTOSH TK, 1994, J NEUROCHEM, V63, P1426; NAMAVARI M, 1992, APPL RADIAT ISOTOPES, V43, P989; PATERSON IA, 1991, J PHARMACOL EXP THER, V258, P1019; Pohl D, 1999, P NATL ACAD SCI USA, V96, P2508, DOI 10.1073/pnas.96.5.2508; Prins ML, 1998, J NEUROTRAUM, V15, P799, DOI 10.1089/neu.1998.15.799; Prins ML, 2003, J NEUROTRAUM, V20, P123, DOI 10.1089/08977150360547053; Prins ML, 1996, DEV BRAIN RES, V95, P272, DOI 10.1016/0165-3806(96)00098-3; ROSENBERG PA, 1988, J NEUROSCI, V8, P2887, DOI 10.1523/jneurosci.08-08-02887.1988; SHIBATA M, 1993, J NEUROSURG, V79, P696, DOI 10.3171/jns.1993.79.5.0696; SLIVKA A, 1985, J BIOL CHEM, V260, P5466; SULLIVAN HG, 1976, J NEUROSURG, V45, P520, DOI 10.3171/jns.1976.45.5.0520; Tang YP, 1997, EUR J NEUROSCI, V9, P1720, DOI 10.1111/j.1460-9568.1997.tb01529.x; Thibault KL, 1998, J BIOMECH, V31, P1119, DOI 10.1016/S0021-9290(98)00122-5; THOMPSON RF, 2000, EYEBLINK CLASSICAL C, V2, P17; Vargo JM, 1999, J TRAUMA, V47, P265, DOI 10.1097/00005373-199908000-00008; Vles JSH, 2003, NEUROPEDIATRICS, V34, P77; Vorwieger G, 1998, QUANTITATIVE FUNCTIONAL BRAIN IMAGING WITH POSITRON EMISSION TOMOGRAPHY, P285, DOI 10.1016/B978-012161340-2/50045-7; Walter B, 1997, BASIC RES CARDIOL, V92, P191, DOI 10.1007/s003950050037; Whyte J, 1996, J Int Neuropsychol Soc, V2, P274; Whyte J, 2002, J HEAD TRAUMA REHAB, V17, P284, DOI 10.1097/00001199-200208000-00003; ZHU MY, 1995, GEN PHARMACOL-VASC S, V26, P681, DOI 10.1016/0306-3623(94)00223-A; ZHU MY, 1992, J NEUROCHEM, V58, P636, DOI 10.1111/j.1471-4159.1992.tb09765.x; ZHU MY, 1994, BRIT J PHARMACOL, V112, P23, DOI 10.1111/j.1476-5381.1994.tb13023.x; ZINK BJ, 1995, J NEUROSURG, V82, P822, DOI 10.3171/jns.1995.82.5.0822	62	17	17	0	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	AUG	2004	21	8					1076	1089		10.1089/0897715041651024			14	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	846AK	WOS:000223286800010	15319007				2021-06-18	
J	Butterworth, P; Anstey, K; Jorm, AF; Rodgers, B				Butterworth, P; Anstey, K; Jorm, AF; Rodgers, B			A community survey demonstrated cohort differences in the lifetime prevalence of self-reported head injury	JOURNAL OF CLINICAL EPIDEMIOLOGY			English	Article						head injury; brain injury; lifetime prevalence; community survey; cohort effect	TRAUMATIC BRAIN-INJURY; CONSECUTIVE SERIES; DIMINISHED RECALL; COLLEGE-STUDENTS; SECULAR TRENDS; BIRTH-COHORT; DEPRESSION; SYMPTOMS; RISK; EPIDEMIOLOGY	Objective: The objective of the study was to assess the lifetime prevalence and validity of self-reported head injury. Study Design and Setting: Analysis of a cross-sectional community survey, stratified by birth cohort. Seven thousand four hundred eighty-eight residents of Canberra and Queanbeyan, 3,678 males and 3,810 females, representing three cohorts aged in their 20s, 40s and 60s at the time of the survey, were randomly selected from the Australian Electoral Roll. Results: The lifetime prevalence of head injury with at least 15 min loss of consciousness ranged from 5.6 to 6.0% across the three cohorts. Self-reported head injury was associated with symptoms of traumatic brain injury or postconcussion syndrome. Reported head injury did not differ across the birth cohorts, contrary to expectations that prevalence rates would increase with age. Analysis of age at first head injury showed significant differences between cohorts in the reported prevalence at age 20, with estimates considerably higher for the youngest cohort. Conclusion: Although the data may reflect real increases in the risk of head injury, it may be that self-reported measures of lifetime prevalence of head injury underestimate prevalence in older cohorts. (C) 2004 Elsevier Inc. All rights reserved.	Australian Natl Univ, Mental Hlth Res Ctr, Canberra, ACT 0200, Australia	Butterworth, P (corresponding author), Australian Natl Univ, Mental Hlth Res Ctr, Canberra, ACT 0200, Australia.	Peter.Butterworth@anu.edu.au	Jorm, Anthony F/B-5555-2009; Anstey, Kaarin/AAB-4870-2020; Anstey, Kaarin J/A-3852-2008; Rodgers, Bryan/B-2090-2013	Jorm, Anthony F/0000-0002-1424-4116; Rodgers, Bryan/0000-0002-2863-3737; Butterworth, Peter/0000-0002-1531-3881; Anstey, Kaarin/0000-0002-9706-9316			ALEXANDRE A, 1983, J NEUROSURG, V59, P751, DOI 10.3171/jns.1983.59.5.0751; ANNEGERS JF, 1980, NEUROLOGY, V30, P912, DOI 10.1212/WNL.30.9.912; Annoni J M, 1992, Disabil Rehabil, V14, P23; [Anonymous], 2000, Bull World Health Organ, V78, P413; *AUSTR BUR STAT, 1991, 1989 90 NAT HLTH SUR; Baguley I, 2000, BRAIN INJURY, V14, P505; Barnfield TV, 1998, BRAIN INJURY, V12, P455, DOI 10.1080/026990598122421; BOHNEN N, 1992, J NERV MENT DIS, V180, P683, DOI 10.1097/00005053-199211000-00002; Cattelani R, 1996, BRAIN INJURY, V10, P187, DOI 10.1080/026990596124502; Couch JR, 2001, HEADACHE, V41, P559, DOI 10.1046/j.1526-4610.2001.041006559.x; Deb S, 1998, J NEUROL NEUROSUR PS, V65, P899, DOI 10.1136/jnnp.65.6.899; Deb S, 1999, BRIT J PSYCHIAT, V174, P360, DOI 10.1192/bjp.174.4.360; EVANS RW, 1992, NEUROL CLIN, V10, P815; Fenton GW, 1996, CLIN ELECTROENCEPHAL, V27, P174; FORTUNE N, 1999, DEFINITIION INCIDENC; GIUFFRA LA, 1994, PSYCHOL MED, V24, P375, DOI 10.1017/S0033291700027355; GOLDBERG D, 1988, BRIT MED J, V297, P897, DOI 10.1136/bmj.297.6653.897; Gronwall D, 1991, NEUROPSYCHOLOGY, V5, P253, DOI DOI 10.1037/0894-4105.5.4.253; HOLMES CB, 1991, PERCEPT MOTOR SKILL, V73, P497, DOI 10.2466/PMS.73.5.497-498; Jennett B, 1996, J NEUROL NEUROSUR PS, V60, P362, DOI 10.1136/jnnp.60.4.362; Jennett B, 1998, ARCH DIS CHILD, V78, P403, DOI 10.1136/adc.78.5.403; Jennett B, 1989, MILD HEAD INJURY, P23; JOHANSSON E, 1991, SCAND J REHABIL MED, V23, P179; Kaufman Y, 2001, PEDIATR NEUROL, V24, P129, DOI 10.1016/S0887-8994(00)00254-X; Laforce R, 2001, PERCEPT MOTOR SKILL, V93, P281, DOI 10.2466/PMS.93.5.281-288; LASCH K, 1990, PSYCHIAT RES, V33, P31, DOI 10.1016/0165-1781(90)90146-V; LEWIN W, 1979, BRIT MED J, V2, P1533, DOI 10.1136/bmj.2.6204.1533; Masson F, 1997, J CLIN EPIDEMIOL, V50, P595, DOI 10.1016/S0895-4356(97)00012-7; McKinlay A, 2002, J NEUROL NEUROSUR PS, V73, P281, DOI 10.1136/jnnp.73.3.281; MOSCATO BS, 1994, J NEUROPSYCH CLIN N, V6, P134; OTTMAN R, 1995, AM J EPIDEMIOL, V141, P235, DOI 10.1093/oxfordjournals.aje.a117425; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; POWELL BD, 1995, PERCEPT MOTOR SKILL, V81, P227, DOI 10.2466/pms.1995.81.1.227; RICE JP, 1992, ARCH GEN PSYCHIAT, V49, P824; RISH BL, 1983, J NEUROSURG, V59, P775, DOI 10.3171/jns.1983.59.5.0775; Ryan L M, 1996, Appl Neuropsychol, V3, P49, DOI 10.1207/s15324826an0302_1; SALCIDO R, 1992, Brain Injury, V6, P293, DOI 10.3109/02699059209029671; Santa Maria MP, 2001, ARCH CLIN NEUROPSYCH, V16, P133; SEGALOWITZ SJ, 1993, J CLIN EXP NEUROPSYC, V15, P104; Shavelle RM, 2001, AM J PHYS MED REHAB, V80, P510, DOI 10.1097/00002060-200107000-00009; Silver JM, 2001, BRAIN INJURY, V15, P935, DOI 10.1080/02699050110065295; SIMON GE, 1995, J CLIN EPIDEMIOL, V48, P1109, DOI 10.1016/0895-4356(95)00010-2; SIMON GE, 1992, AM J EPIDEMIOL, V135, P1411, DOI 10.1093/oxfordjournals.aje.a116252; SIMON GE, 1995, EPIDEMIOL REV, V17, P221, DOI 10.1093/oxfordjournals.epirev.a036180; Strauss DJ, 1998, ARCH PHYS MED REHAB, V79, P1095, DOI 10.1016/S0003-9993(98)90177-0; Tate RL, 1998, AUST NZ J PUBL HEAL, V22, P419, DOI 10.1111/j.1467-842X.1998.tb01406.x; TATE RL, 1989, J NEUROL NEUROSUR PS, V52, P1128, DOI 10.1136/jnnp.52.10.1128; TATE RL, 1989, ACTA NEUROL SCAND, V79, P97, DOI 10.1111/j.1600-0404.1989.tb03719.x; TEMPLER DI, 1992, PERCEPT MOTOR SKILL, V75, P195, DOI 10.2466/PMS.75.4.195-202; Triplett G, 1996, PERCEPT MOTOR SKILL, V83, P1344, DOI 10.2466/pms.1996.83.3f.1344; Vastag B, 2002, JAMA-J AM MED ASSOC, V287, P437, DOI 10.1001/jama.287.4.437; Walker A E, 1971, Zentralbl Neurochir, V32, P3; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; WEISSMAN MM, 1991, PSYCHIAT DISORDERS A; Willer B, 1996, NEUROREHABILITATION, V6, P219, DOI 10.3233/NRE-1996-6308; Yoshihama M, 2002, J FAM VIOLENCE, V17, P199, DOI 10.1023/A:1016001211182	56	17	17	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0895-4356	1878-5921		J CLIN EPIDEMIOL	J. Clin. Epidemiol.	JUL	2004	57	7					742	748		10.1016/j.jclinepi.2003.10.015			7	Health Care Sciences & Services; Public, Environmental & Occupational Health	Health Care Sciences & Services; Public, Environmental & Occupational Health	856VB	WOS:000224072200011	15358403				2021-06-18	
J	Stover, JF; Sakowitz, OW; Kroppenstedt, SN; Thomale, UW; Kempski, OS; Flugge, G; Unterberg, AW				Stover, JF; Sakowitz, OW; Kroppenstedt, SN; Thomale, UW; Kempski, OS; Flugge, G; Unterberg, AW			Differential effects of prolonged isoflurane anesthesia on plasma, extracellular, and CSF glutamate, neuronal activity, I-125-Mk801 NMDA receptor binding, and brain edema in traumatic brain-injured rats	ACTA NEUROCHIRURGICA			English	Article						electroencephalography; excitotoxicity; in vitro receptor autoradiography; microdialysis; traumatic brain injury	EXCITATORY SYNAPTIC-TRANSMISSION; DEPOLARIZATION-EVOKED GLUTAMATE; CEREBRAL-BLOOD-FLOW; AMINO-ACID RELEASE; VOLATILE ANESTHETICS; CORTICAL PERFUSION; GATED CURRENTS; EEG ACTIVITY; METABOLISM; TRANSPORTERS	Background. Volatile anesthetics reduce neuronal excitation and cerebral metabolism but can also increase intracellular water accumulation in normal and injured brains. While attenuation of neuronal excitation and glutamate release are beneficial under pathological conditions, any increase in edema formation should be avoided. In the present study we investigated duration-dependent effects of the commonly used isoflurane/nitrous oxide (N2O) anesthesia on EEG activity, specific NMDA receptor binding, extracellular, CSF, and plasma glutamate, and cerebral water content in brain-injured rats subjected to short (30 minutes) or prolonged (4 hours) anesthesia. Methods. Before controlled cortical impact injury (CCI), during prolonged (4-8 hours) or short anesthesia (7.5-8 hours after CCI), and before brain removal, changes in neuronal activity were determined by quantitative EEG analysis and glutamate was measured in arterial plasma. Brains were processed to determine acute and persisting changes in cerebral water content and I-125-Mk801 NMDA receptor binding at 8 and 32 hours after CCI, i.e., immediately or 24 hours after short or prolonged anesthesia. During prolonged anesthesia glutamate was measured via microdialysis within the cortical contusion. CSF was sampled before brain removal. Findings. Prolonged isoflurane (1.8 vol%) anesthesia significantly increased EEG activity, plasma, cortical extracellular, and CSF glutamate, cortical and hippocampal I-125-Mk801 NMDA receptor binding, and cerebral water content in brain-injured rats. These changes were partially reversible within 24 hours after prolonged anesthesia. At 24 hours, CSF glutamate was significantly reduced following long isoflurane anesthesia compared to rats previously subjected to short anesthesia despite an earlier significant increase. Conclusions. The partially reversible increases in EEG activity, I-125-Mk801 NMDA receptor binding, cerebral water content, plasma and CSF glutamate appear important for physiological, pathophysiological, and pharmacological studies requiring prolonged anesthesia with isoflurane. Increases in extracellular cortical and plasma glutamate could contribute to acute aggravation of underlying tissue damage.	Univ Zurich Hosp, Div Surg Intens Care Med, CH-8006 Zurich, Switzerland; Charite Dept Neurosurg, Berlin, Germany; Inst Neurosurg Pathophysiol, Mainz, Germany; German Primate Ctr, Gottingen, Germany; Heidelberg Univ, Dept Neurosurg, Heidelberg, Germany	Stover, JF (corresponding author), Univ Zurich Hosp, Div Surg Intens Care Med, Turnerstr 12, CH-8006 Zurich, Switzerland.	stoverfam@bluewin.ch					Ali DW, 2001, CURR OPIN NEUROBIOL, V11, P336, DOI 10.1016/S0959-4388(00)00216-6; Baskaya MK, 1997, NEUROSCI LETT, V226, P33; Belelli D, 1999, TRENDS PHARMACOL SCI, V20, P496, DOI 10.1016/S0165-6147(99)01405-4; BERGJOHNSEN J, 1992, ACTA ANAESTH SCAND, V36, P350, DOI 10.1111/j.1399-6576.1992.tb03480.x; CARLI F, 1993, ACTA ANAESTH SCAND, V37, P672, DOI 10.1111/j.1399-6576.1993.tb03787.x; Carroll RC, 2002, TRENDS NEUROSCI, V25, P571, DOI 10.1016/S0166-2236(02)02272-5; Detsch O, 2002, NEUROSCI LETT, V317, P9, DOI 10.1016/S0304-3940(01)02419-3; Do SH, 2002, ANESTHESIOLOGY, V96, P1492, DOI 10.1097/00000542-200206000-00032; Duch DS, 1998, TOXICOL LETT, V101, P255, DOI 10.1016/S0378-4274(98)00193-3; Eilers H, 1999, ANESTH ANALG, V88, P1168, DOI 10.1097/00000539-199905000-00037; Harada H, 1999, ANESTH ANALG, V89, P1442, DOI 10.1097/00000539-199912000-00022; Hendrich KS, 2001, MAGNET RESON MED, V46, P202, DOI 10.1002/mrm.1178; HORBER FF, 1988, ANESTHESIOLOGY, V69, P319, DOI 10.1097/00000542-198809000-00006; Hudetz AG, 2002, BRAIN RES, V954, P123, DOI 10.1016/S0006-8993(02)03358-9; Kapinya KJ, 2002, STROKE, V33, P1889, DOI 10.1161/01.STR.0000020092.41820.58; Kindler CH, 1999, ANESTHESIOLOGY, V90, P1137, DOI 10.1097/00000542-199904000-00029; KOCHS E, 1993, ANESTH ANALG, V76, P1222, DOI 10.1213/00000539-199376060-00007; Kroppenstedt SN, 2002, J NEUROTRAUM, V19, P1421, DOI 10.1089/089771502320914651; KURODA Y, 1993, ANESTH ANALG, V77, P795; Larsen M, 1998, J NEUROSURG ANESTH, V10, P166, DOI 10.1097/00008506-199807000-00007; Larsen M, 1998, EUR J ANAESTH, V15, P224; Lenz C, 1999, ANESTHESIOLOGY, V91, P1720, DOI 10.1097/00000542-199912000-00025; Liachenko S, 1999, BRIT J PHARMACOL, V127, P131, DOI 10.1038/sj.bjp.0702543; Lu XW, 1997, NEUROCHEM RES, V22, P705, DOI 10.1023/A:1027354110563; MacIver MB, 1996, ANESTHESIOLOGY, V85, P823, DOI 10.1097/00000542-199610000-00018; MARTIN DC, 1995, BIOCHEM PHARMACOL, V49, P809, DOI 10.1016/0006-2952(94)00519-R; MCDONALD JW, 1990, NEUROSCIENCE, V38, P103, DOI 10.1016/0306-4522(90)90377-G; MILLER LP, 1990, BRAIN RES, V526, P103, DOI 10.1016/0006-8993(90)90254-9; Mills CD, 1997, J NEUROTRAUM, V14, P943, DOI 10.1089/neu.1997.14.943; Ming Z, 2002, ANESTHESIOLOGY, V97, P856, DOI 10.1097/00000542-200210000-00017; Ming Z, 2001, BRAIN RES, V920, P117, DOI 10.1016/S0006-8993(01)03044-X; Miyazaki H, 1997, ANESTHESIOLOGY, V86, P1359, DOI 10.1097/00000542-199706000-00018; Nakashima K, 1996, ANESTHESIOLOGY, V85, P161, DOI 10.1097/00000542-199607000-00022; Nishikawa K, 2000, ANESTHESIOLOGY, V92, P228, DOI 10.1097/00000542-200001000-00035; Nishimaki H, 2002, RESUSCITATION, V54, P207, DOI 10.1016/S0300-9572(02)00120-X; Oh S, 1997, NEUROCHEM RES, V22, P767, DOI 10.1023/A:1022019423197; Paas Y, 1998, TRENDS NEUROSCI, V21, P117, DOI 10.1016/S0166-2236(97)01184-3; PALMER AM, 1993, J NEUROCHEM, V61, P2015, DOI 10.1111/j.1471-4159.1993.tb07437.x; PATEL PM, 1995, ANESTHESIOLOGY, V82, P996, DOI 10.1097/00000542-199504000-00024; RAMPIL IJ, 1992, ANESTHESIOLOGY, V77, P920, DOI 10.1097/00000542-199211000-00014; SCHETTINI A, 1979, BRIT J ANAESTH, V51, P1117, DOI 10.1093/bja/51.12.1117; Shapira Y, 1997, J NEUROSURG ANESTH, V9, P51, DOI 10.1097/00008506-199701000-00012; Sihver S, 2001, J NEUROCHEM, V78, P417, DOI 10.1046/j.1471-4159.2001.00428.x; SMITH AL, 1976, ANESTHESIOLOGY, V45, P64, DOI 10.1097/00000542-197607000-00012; Statler KD, 2000, J NEUROTRAUM, V17, P1179, DOI 10.1089/neu.2000.17.1179; Stover JF, 2003, J NEUROTRAUM, V20, P315, DOI 10.1089/089771503765172273; Stover JF, 2000, ACT NEUR S, V76, P375; Stover JF, 1997, EUR J CLIN INVEST, V27, P1038, DOI 10.1046/j.1365-2362.1997.2250774.x; Takahashi M, 1997, J EXP BIOL, V200, P401; Van Landeghem FKH, 2001, GLIA, V35, P167, DOI 10.1002/glia.1082; Weiss HR, 1996, BRAIN RES, V730, P193; WENTHOLD RJ, 2003, ANN REV PHARM TOXICO, V143, P335; Wilson MA, 1998, DEV BRAIN RES, V109, P211, DOI 10.1016/S0165-3806(98)00084-4; Yu XM, 1999, P NATL ACAD SCI USA, V96, P7697, DOI 10.1073/pnas.96.14.7697; Zuo ZY, 2001, NEUROREPORT, V12, P1077, DOI 10.1097/00001756-200104170-00042	55	17	17	0	3	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.	JUL	2004	146	8					819	830		10.1007/s00701-004-0281-9			12	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	837NT	WOS:000222642900020	15254804				2021-06-18	
J	Ucar, T; Baykal, A; Akyuz, M; Dosemeci, L; Toptas, B				Ucar, T; Baykal, A; Akyuz, M; Dosemeci, L; Toptas, B			Comparison of serum and cerebrospinal fluid protein S-100b levels after severe head injury and their prognostic importance	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						severe head injury; S-100b; outcome	NEURON-SPECIFIC ENOLASE; TRAUMATIC BRAIN-DAMAGE; SERIAL S-100; MARKERS; PREDICTION	Background. This study aimed to compare serum and cerebrospinal fluid (CSF) S-100b protein levels after a severe head injury. The changes in serum S-100b and CSF S-100b concentrations were investigated as indicators of brain damage for patients suffering from severe head injuries. Methods. The sample included 48 patients with Glasgow Coma Scale scores of 8 or below who had been admitted to the authors' emergency service soon after their severe head injury occurred. Both blood and CSF samples were taken within 1 to 11 hours after admission, then 24, 48, and 72 hours after the injury. Samples of CSF were taken using a ventricular catheter. The outcome was evaluated 6 to 9 months after hospital discharge using the Glasgow Outcome Scale. Results. The overall mean serum S-100b concentration was 3.5 +/- 6.4 among the patients with unfavorable outcomes and 1.3 +/- 2.5 among those with favorable outcomes. These results were not statistically significant (p > 0.05). The overall mean CSF S-100b concentration was 62.2 +/- 21.8 among the patients with unfavorable outcomes and 21.8 +/- 17.7 among those with favorable outcomes. These results, however, were statistically significant (p < 0.05). Conclusion. The results show that CSF S-100b levels clearly are superior to serum S-100b levels for predicting outcome after severe head injury.	Univ Akdeniz, Sch Med, Dept Neurosurg, TR-07070 Antalya, Turkey; Univ Akdeniz, Sch Med, Dept Biochem, Antalya, Turkey; Univ Akdeniz, Sch Med, Dept Anesthesiol & Reanimat, Antalya, Turkey	Ucar, T (corresponding author), Univ Akdeniz, Sch Med, Dept Neurosurg, TR-07070 Antalya, Turkey.	tucar@superonline.com	BAYKAL, ASLI/G-1304-2016	baykal, asli/0000-0002-3935-1591			Ali MS, 2000, BRIT J ANAESTH, V85, P287, DOI 10.1093/bja/85.2.287; Anderson RE, 2001, NEUROSURGERY, V48, P1255, DOI 10.1097/00006123-200106000-00012; Beaudeux JL, 1999, ANN BIOL CLIN-PARIS, V57, P261; Connolly ES, 2001, NEUROSURGERY, V49, P1076, DOI 10.1097/00006123-200111000-00010; Elting JW, 2000, J NEUROL SCI, V181, P104, DOI 10.1016/S0022-510X(00)00442-1; HARDEMARK HG, 1989, J NEUROSURG, V71, P727, DOI 10.3171/jns.1989.71.5.0727; Herrmann M, 2001, J NEUROL NEUROSUR PS, V70, P95, DOI 10.1136/jnnp.70.1.95; INGEBRIGTSEN T, 1995, J NEUROL NEUROSUR PS, V59, P103, DOI 10.1136/jnnp.59.1.103-a; Ingebrigtsen T, 1999, NEUROSURGERY, V45, P468, DOI 10.1097/00006123-199909000-00010; Ingebrigtsen T, 1996, J NEUROSURG, V85, P945, DOI 10.3171/jns.1996.85.5.0945; Ingebrigtsen T, 2000, BRAIN INJURY, V14, P1047; Jackson RGM, 2000, CLIN CHEM LAB MED, V38, P1165, DOI 10.1515/CCLM.2000.179; Martens P, 1998, STROKE, V29, P2363, DOI 10.1161/01.STR.29.11.2363; PERSSON L, 1987, STROKE, V18, P911, DOI 10.1161/01.STR.18.5.911; Pleines UE, 2001, J NEUROTRAUM, V18, P491, DOI 10.1089/089771501300227297; Raabe A, 1998, J NEUROL NEUROSUR PS, V65, P930, DOI 10.1136/jnnp.65.6.930; Raabe A, 2000, NEUROSURG REV, V23, P136, DOI 10.1007/PL00011944; Raabe A, 1999, BRIT J NEUROSURG, V13, P56, DOI 10.1080/02688699944195; Raabe A, 1998, ACTA NEUROCHIR, V140, P787, DOI 10.1007/s007010050180; Raabe A, 1999, J NEUROSURG, V91, P875, DOI 10.3171/jns.1999.91.5.0875; Raabe A, 1999, NEUROSURGERY, V45, P477, DOI 10.1097/00006123-199909000-00012; Romner B, 2000, J NEUROTRAUM, V17, P641, DOI 10.1089/089771500415391; Rothoerl RD, 1999, BRAIN INJURY, V13, P387; Rothoerl RD, 1998, J TRAUMA, V45, P765, DOI 10.1097/00005373-199810000-00025; Waterloo K, 1997, ACTA NEUROCHIR, V139, P26, DOI 10.1007/BF01850864; Wiesmann M, 1997, ACTA NEUROCHIR, V139, P1155, DOI 10.1007/BF01410976; Woertgen C, 1997, ACTA NEUROCHIR, V139, P1161, DOI 10.1007/BF01410977; Woertgen C, 1999, J TRAUMA, V47, P1126, DOI 10.1097/00005373-199912000-00026	28	17	17	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	JUL	2004	57	1					95	98		10.1097/01.TA.0000071352.95491.75			4	Critical Care Medicine; Surgery	General & Internal Medicine; Surgery	844TR	WOS:000223183800021	15284555				2021-06-18	
J	Sanus, GZ; Tanriverdi, T; Alver, I; Aydin, S; Uzan, M				Sanus, GZ; Tanriverdi, T; Alver, I; Aydin, S; Uzan, M			Evolving traumatic brain lesions - Predictors and results of ninety-eight head-injured patients	NEUROSURGERY QUARTERLY			English	Article						predictors; progressive hemorrhagic injury; traumatic brain injury	INTRAVASCULAR COAGULATION; COMPUTERIZED-TOMOGRAPHY; INTRACEREBRAL HEMATOMA; HEMORRHAGE; FIBRINOLYSIS; PROGESTERONE; MANAGEMENT; FAILURE; COMA	Progression in intracranial lesion(s) caused by traumatic brain injuries may be determined by a serial computerized tomography (CT) scan in the early period, but its significance is still controversial. In this study, the records of 98 head-injured patients in whom 2 consecutive CT scans were performed within 48 hours of injury were analyzed, and the predictors and clinical significance of progressive hemorrhagic injury (PHI) were determined. From June 1, 1998 through July 13, 2002, a cohort of 98 head-injured patients (65 male and 33 female, mean age of 34.8 years, and median Glasgow Come Scale [GCS] score of 11) was evaluated in this retrospective clinical study. The patients were divided into 2 groups: groups 1 and 2 included 51 and 47 patients without and with PHI, respectively. Progression in traumatic lesion(s) was determined by comparing the initial and repeated CT scans. Logistic regression analysis was used to identify physiologic parameters (P = 0.02), Injury Severity Score (P = 0.01), increased intracranial pressure (P = 0.005), and initial diagnosis (P = 0.01) as the best predictors of PHI. The 6-month postinjury outcome was favorable in group 1. PHI occurs mostly in intracerebral hematomas, which are associated with an increase in ICP. Age, increase in ICP, type of initial lesion(s), ISS, anemia, hypoxia, hyperglycemia, coagulopathy, and timing of the first CT scan relative to injury seem to be predictors of PHI.	Univ Istanbul, Cerrahpasa Med Fac, Dept Neurosurg, Istanbul, Turkey	Uzan, M (corresponding author), POB 5,Cerrahpasa, TR-34301 Istanbul, Turkey.	tanerato2000@yahoo.com	Tanriverdi, Taner/C-9003-2019; Sanus, Galip Zihni/D-6715-2019; Uzan, Mustafa/D-6571-2019				*ASS ADV AUT MED, 1990, ABBR INJ SCAL 1990 R, P15; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bullock R, 1996, Eur J Emerg Med, V3, P109, DOI 10.1097/00063110-199606000-00010; BULLOCK R, 1989, SURG NEUROL, V32, P181, DOI 10.1016/0090-3019(89)90176-6; BULLOCK R, 1990, J NEUROSURG, V72, P9, DOI 10.3171/jns.1990.72.1.0009; CRONE KR, 1987, NEUROSURGERY, V21, P532, DOI 10.1227/00006123-198710000-00015; DIAZ FG, 1979, J NEUROSURG, V50, P217, DOI 10.3171/jns.1979.50.2.0217; Firsching R, 1997, NEUROL RES, V19, P257, DOI 10.1080/01616412.1997.11740810; FRENCH BN, 1977, SURG NEUROL, V7, P171; FROWEIN R A, 1989, Neurosurgical Review, V12, P184, DOI 10.1007/BF01790644; GALBRAITH S, 1981, J NEUROSURG, V55, P75, DOI 10.3171/jns.1981.55.1.0075; GUDEMAN SK, 1979, NEUROSURGERY, V5, P309, DOI 10.1227/00006123-197909000-00002; Huttunen P, 1998, ALCOHOL, V15, P315, DOI 10.1016/S0741-8329(97)00136-5; IKEDA Y, 1990, NEUROSURGERY, V27, P1; Jenkins LW, 1988, J NEUROTRAUM, V5, P275, DOI 10.1089/neu.1988.5.275; JENNETT B, 1975, LANCET, V1, P480; KAUFMAN HH, 1980, NEUROSURGERY, V7, P445, DOI 10.1227/00006123-198011000-00003; Kazui S, 1996, STROKE, V27, P1783, DOI 10.1161/01.STR.27.10.1783; KOBAYASHI S, 1983, SURG NEUROL, V20, P25, DOI 10.1016/0090-3019(83)90101-5; KUMURA E, 1987, ACTA NEUROCHIR, V85, P23, DOI 10.1007/BF01402365; LINDENBAUM J, 1969, NEW ENGL J MED, V281, P228; LOBATO RD, 1991, J NEUROSURG, V75, P256, DOI 10.3171/jns.1991.75.2.0256; MARSHALL LF, 1983, J NEUROSURG, V59, P276, DOI 10.3171/jns.1983.59.2.0276; MILLER JD, 1987, ACTA NEUROCHIR, V85, P80, DOI 10.1007/BF01456102; Oertel M, 2002, J NEUROSURG, V96, P109, DOI 10.3171/jns.2002.96.1.0109; Patel NY, 2000, J TRAUMA, V48, P367, DOI 10.1097/00005373-200003000-00001; PONDAAG W, 1978, ADV NEUROSURG, V6, P159; ROOF RL, 1993, BRAIN RES, V607, P333, DOI 10.1016/0006-8993(93)91526-X; Roof RL, 2000, J NEUROTRAUM, V17, P367, DOI 10.1089/neu.2000.17.367; ROSES AD, 1995, NAT MED, V1, P603, DOI 10.1038/nm0795-603; SAWADA Y, 1984, J NEUROL NEUROSUR PS, V47, P1125, DOI 10.1136/jnnp.47.10.1125; SERVADEI F, 1995, NEUROSURGERY, V37, P899, DOI 10.1227/00006123-199511000-00008; STEIN SC, 1992, NEUROSURGERY, V30, P160, DOI 10.1227/00006123-199202000-00002; STEIN SC, 1993, NEUROSURGERY, V32, P25, DOI 10.1227/00006123-199301000-00004; TOUHO H, 1986, NEUROSURGERY, V19, P523, DOI 10.1227/00006123-198610000-00005; VANDERSANDE JJ, 1981, J NEUROSURG, V54, P21, DOI 10.3171/jns.1981.54.1.0021	36	17	30	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-6438	1534-4916		NEUROSURG QUART	Neurosurg. Q.	JUN	2004	14	2					97	104		10.1097/01.wnq.0000127718.06183.12			8	Neurosciences; Surgery	Neurosciences & Neurology; Surgery	843UZ	WOS:000223113400005					2021-06-18	
J	Vega, RS; Adams, VI				Vega, RS; Adams, VI			Suffocation in motor vehicle crashes	AMERICAN JOURNAL OF FORENSIC MEDICINE AND PATHOLOGY			English	Article						accidents; traffic; suffocation; asphyxia; autopsy	ACCIDENTAL STRANGULATION; ASPHYXIA; WINDOW; DEATHS	Because death from suffocation in traffic fatalities has not been well described, we delineated the clinical, circumstantial, and autopsy findings associated with suffocation in a series of motor vehicle crashes. Medical examiner case files from a 5-year period were reviewed. Scene investigation, autopsy, toxicology, and first-responder reports were examined. Crash descriptions were reviewed, including vehicle type, mechanism of crash, response time, restraint use, occupant ejection, and victim position in cabins of vehicles. Mechanisms of suffocation, including torso compression, inversion, neck flexion, facial occlusion, and blood aspiration, were determined for each case. The files were searched for factors relevant to the diagnosis of suffocation, namely, cerebral concussion, alcohol intoxication, obesity, petechiae, lung weights as a proxy for livor, natural disease, and impact wounds. Twenty-nine traffic fatality cases were identified in which suffocation caused death. In 26, suffocation mechanisms were solely responsible for death. In 3, death was caused by suffocation in combination with other mechanisms. Twenty-five subjects were occupants of vehicles with cabins and 4 were motorcycle riders. The most common mechanism of suffocation was torso compression. Most subjects had either multiple mechanisms of suffocation or a single mechanism acting in concert with concussion or alcohol intoxication. Concussion and intoxication were common, with one or both present in 20 subjects, including all of those with blood aspiration. Petechiae were frequent but were found consistently only among those with inversion. Cutaneous c est petechiae were associated with inversion and torso compression. Lung weights were highest among those with blood aspiration and lowest among those with inversion. Body mass index was highest among those with inversion, suggesting that obesity could be a risk factor for this mechanism.	Univ S Florida, Dept Pathol, Tampa, FL USA	Vega, RS (corresponding author), James A Haley VA Hosp, Pathol & Lab Med Serv, 13000 Bruce B Downs Blvd, Tampa, FL 33612 USA.	russell.vega@med.va.gov					Aggarwal NK, 1998, MED SCI LAW, V38, P263, DOI 10.1177/002580249803800315; BELL MD, 1992, AM J FOREN MED PATH, V13, P101, DOI 10.1097/00000433-199206000-00004; CALVET R, 1992, J FORENSIC SCI, V37, P1697; DURSO S, 1995, AM J FOREN MED PATH, V16, P352, DOI 10.1097/00000433-199512000-00012; FLIER JS, 2001, HARRISONS PRINCIPLES, P479; FLOBECKER P, 1993, AM J FOREN MED PATH, V14, P74; HABAL MB, 1972, JAMA-J AM MED ASSOC, V22, P1269; Hossack D W, 1972, Med J Aust, V2, P193; KHOLI A, 1996, FORENSIC SCI INT, V78, P7; KOHR RM, 1992, J FORENSIC SCI, V37, P1693; MOORE L, 1993, AM J FOREN MED PATH, V14, P296, DOI 10.1097/00000433-199312000-00005; REAY DT, 1992, AM J FOREN MED PATH, V13, P90, DOI 10.1097/00000433-199206000-00002; SEVITT S, 1968, BRIT J SURG, V55, P481, DOI 10.1002/bjs.1800550702; SIMMONS GT, 1992, AM J FOREN MED PATH, V13, P112, DOI 10.1097/00000433-199206000-00006; SKLAR DP, 1988, AM J EMERG MED, V6, P219; SPITZ WU, 1993, MEDICOLEGAL INVESTIG, P529; Strauss RH, 1997, PEDIATR EMERG CARE, V13, P345, DOI 10.1097/00006565-199710000-00013; TAFF ML, 1991, AM J FOREN MED PATH, V12, P359, DOI 10.1097/00000433-199112000-00058	18	17	18	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0195-7910			AM J FOREN MED PATH	Am. J. Forensic Med. Pathol.	JUN	2004	25	2					101	107		10.1097/01.paf.0000114136.84700.f5			7	Medicine, Legal; Pathology	Legal Medicine; Pathology	824IW	WOS:000221681000002	15166758				2021-06-18	
J	Tsai, YJ; Leong, SM; Day, AS; Wen, CY; Shieh, JY; Lue, JH				Tsai, YJ; Leong, SM; Day, AS; Wen, CY; Shieh, JY; Lue, JH			A time course analysis of the changes in neuropeptide Y immunoreactivity in the rat cuneate nucleus following median nerve transection	NEUROSCIENCE RESEARCH			English	Article						calcitonin gene-related peptide; galanin; median nerve transection injury; neuropeptide Y; substance P; vasoactive intestinal peptide	C-FOS EXPRESSION; CHRONIC CONSTRICTION INJURY; PRIMARY SENSORY NEURONS; SPINAL-CORD NEURONS; SCIATIC-NERVE; GRACILE NUCLEUS; DORSAL-HORN; ELECTRICAL-STIMULATION; TRANSSYNAPTIC DEGENERATION; TRANSGANGLIONIC TRANSPORT	Using median nerve injury and immunocytochemical methods, we examined the temporal changes in neuropeptide Y (NPY) expression in the cuneate nucleus (CN) in rats following median nerve transection. Under normal circumstances, neuropeptide Y-immunoreactive (NPY-IR) fibers was not detectable in the CN. A few NPY-IR fibers were observed in the ipsilateral CN 5 days after the median nerve transection, and peaked at 4 weeks. Thereafter, they were gradually returned to nearly control level after 16 weeks. Quantitative evaluation showed that the mean percentage of area occupied by NPY-IR fibers in entire and three subregions of the CN at 4 weeks were significantly higher than that at other post-operated time points, respectively. The present ultrastructural observations in the middle region of CN showed that the significantly increased NPY immunoreactivity was confined only in the myelinated axons and terminals but not detected in the dendrites, somata, and glial cells. The NPY-IR terminals made axodendritic synaptic contacts with unlabeled elements. The present results indicate that the time course of the increase of NPY immunoreactivity is similar to c-Fos expression as described in a previous study [J. Neurotrauma 19 (2002) 897]. It is speculated that the increased NPY in the CN after axotomy may affect the excitability of postsynaptic cuneate neurons, however, the functional interaction between NPY and c-Fos-IR neurons needs to be further studied. (C) 2003 Elsevier Ireland Ltd and The Japan Neuroscience Society. All rights reserved.	Natl Taiwan Univ, Coll Med, Dept Anat & Cell Biol, 1-1,Jen Ai Rd, Taipei 10018, Taiwan; Kiang Wu Nursing, Coll Med, Macau, Peoples R China; Natl Taiwan Univ Hosp, Dept Otolaryngol, Taipei, Taiwan	Lue, JH (corresponding author), Natl Taiwan Univ, Coll Med, Dept Anat & Cell Biol, 1-1,Jen Ai Rd, Taipei 10018, Taiwan.	thomas@ha.mc.ntu.edu.tw		LUE, JUNE-HORNG/0000-0002-1087-1382			Abdulla FA, 1999, NEUROSCIENCE, V89, P43, DOI 10.1016/S0306-4522(98)00443-6; ANDERSEN P, 1963, NATURE, V199, P655, DOI 10.1038/199655a0; CODERRE TJ, 1986, PAIN, V26, P61, DOI 10.1016/0304-3959(86)90174-0; Day AS, 2001, BRAIN RES, V895, P194, DOI 10.1016/S0006-8993(01)02095-9; DEVOR M, 1978, NATURE, V276, P75, DOI 10.1038/276075a0; HOEFLINGER BF, 1993, J COMP NEUROL, V332, P378, DOI 10.1002/cne.903320309; HUNT SP, 1987, NATURE, V328, P632, DOI 10.1038/328632a0; LAMOTTE CC, 1991, J COMP NEUROL, V311, P546, DOI 10.1002/cne.903110409; Lue JH, 2000, SYNAPSE, V37, P222, DOI 10.1002/1098-2396(20000901)37:3<222::AID-SYN6>3.3.CO;2-2; Lue JH, 2002, J NEUROTRAUM, V19, P897, DOI 10.1089/08977150260190483; Ma W, 1999, NEUROSCIENCE, V93, P335, DOI 10.1016/S0306-4522(99)00145-1; Ma W, 1998, NEUROSCIENCE, V86, P1217, DOI 10.1016/S0306-4522(98)00068-2; Ma W, 1997, NEUROSCIENCE, V79, P1183, DOI 10.1016/S0306-4522(97)00088-2; Ma WY, 2000, J NEUROSCI RES, V60, P520, DOI 10.1002/(SICI)1097-4547(20000515)60:4<520::AID-JNR11>3.0.CO;2-D; MASLANY S, 1992, NEUROSCI LETT, V139, P130, DOI 10.1016/0304-3940(92)90874-7; Miki K, 1998, NEUROSCIENCE, V82, P1243; MOLANDER C, 1994, BRAIN RES, V644, P74, DOI 10.1016/0006-8993(94)90349-2; MOLANDER C, 1992, NEUROSCIENCE, V50, P223, DOI 10.1016/0306-4522(92)90394-H; NOGUCHI K, 1995, J NEUROSCI, V15, P7633; NYBERG G, 1982, BRAIN RES, V248, P209, DOI 10.1016/0006-8993(82)90579-0; OHARA S, 1994, J NEUROPATH EXP NEUR, V53, P646, DOI 10.1097/00005072-199411000-00012; PERSSON JKE, 1995, EXP BRAIN RES, V105, P331; PERSSON JKE, 1993, SOMATOSENS MOT RES, V10, P475, DOI 10.3109/08990229309028852; Shortland P, 1998, BRAIN RES, V810, P288, DOI 10.1016/S0006-8993(98)00940-8; SUGIMOTO T, 1986, PAIN, V27, P91, DOI 10.1016/0304-3959(86)90226-5; SUGIMOTO T, 1990, PAIN, V42, P205, DOI 10.1016/0304-3959(90)91164-E; TAMATANI M, 1989, BRAIN RES, V495, P122, DOI 10.1016/0006-8993(89)91225-0; TRACEY DJ, 1995, BRAIN RES, V669, P245, DOI 10.1016/0006-8993(94)01265-J; UCHIZONO K, 1965, NATURE, V207, P642, DOI 10.1038/207642a0; XU XJ, 1994, NEUROSCIENCE, V63, P817, DOI 10.1016/0306-4522(94)90526-6; YANG SN, 1995, NEUROREPORT, V6, P384, DOI 10.1097/00001756-199501000-00038; ZHANG X, 1993, EUR J NEUROSCI, V5, P1510, DOI 10.1111/j.1460-9568.1993.tb00219.x	32	17	17	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0168-0102	1872-8111		NEUROSCI RES	Neurosci. Res.	APR	2004	48	4					369	377		10.1016/j.neures.2003.12.003			9	Neurosciences	Neurosciences & Neurology	808OW	WOS:000220579400003	15041190				2021-06-18	
J	Burger, R; Bendszus, M; Vince, GH; Solymosi, L; Roosen, K				Burger, R; Bendszus, M; Vince, GH; Solymosi, L; Roosen, K			Neurophysiological monitoring, magnetic resonance imaging, and histological assays confirm the beneficial effects of moderate hypothermia after epidural focal mass lesion development in rodents	NEUROSURGERY			English	Article						hypothermia; ischemia-reperfusion; magnetic resonance imaging; mass lesion; neuromonitoring; trauma	CEREBRAL-BLOOD-FLOW; TRAUMATIC BRAIN-INJURY; MILD INTRAISCHEMIC HYPOTHERMIA; LASER-DOPPLER FLOWMETRY; FOREBRAIN ISCHEMIA; ARTERY OCCLUSION; TISSUE OXYGEN; POSTTRAUMATIC HYPOTHERMIA; REPRODUCIBLE MODEL; BARRIER DISRUPTION	OBJECTIVE: To assess the effects of moderate intraischemic hypothermia on neurophysiological parameters in an epidural balloon compression model in rats and to correlate the results with magnetic resonance imaging and histological findings. METHODS: Neurophysiological monitoring included laser Doppler flow, tissue partial oxygen pressure, and intracranial pressure measurements and electroencephalographic assessments during balloon expansion, sustained inflation, and reperfusion. Moderate intraischemic cooling of animals was extended throughout the reperfusion period, and results were compared with those for normothermic animals. Moreover, histological morphometric and magnetic resonance imaging volumetric analyses of the lesions were performed. RESULTS: Laser Doppler flow decreased slightly during ischemia (P < 0.05) in animals treated with hypothermia, and flow values demonstrated complete reperfusion, compared with incomplete flow restoration in untreated animals (P < 0.05). During ischemia, the tissue partial oxygen pressure was less than 4.3 mm Hg in both groups. After reperfusion, values returned to the normal range in both groups, but the tissue partial oxygen pressure in hypothermic animals was significantly higher (P = 0.042) and demonstrated 19% higher values, compared with normothermic animals, before rewarming. Moderate hypothermia attenuated a secondary increase in intracranial pressure (P < 0.05), and electroencephalographic findings indicated a trend toward faster recovery (P > 0.05) after reperfusion. Lesion size was reduced by 35% in magnetic resonance imaging volumetric evaluations and by 24.5% in histological morphometric analyses. CONCLUSION: Intraischemic hypothermia improves cerebral microcirculation, attenuates a secondary increase in intracranial pressure, facilitates electroencephalographic recovery, and reduces the lesion size.	Univ Regensburg, Dept Neurosurg, D-93053 Regensburg, Germany; Univ Wurzburg, Dept Neuroradiol, D-97070 Wurzburg, Germany; Univ Wurzburg, Dept Neurosurg, D-97070 Wurzburg, Germany	Burger, R (corresponding author), Univ Regensburg, Dept Neurosurg, Franz Josef Strauss Allee 11, D-93053 Regensburg, Germany.	RBurger@t-online.de	Solymosi, Laszlo/E-6449-2018	Solymosi, Laszlo/0000-0001-9647-8647; Vince, Giles/0000-0002-0222-8733			ASTRUP J, 1981, ANESTHESIOLOGY, V55, P263, DOI 10.1097/00000542-198109000-00013; BAKER CJ, 1992, J NEUROSURG, V77, P438, DOI 10.3171/jns.1992.77.3.0438; BAKER CJ, 1995, NEUROSURGERY, V36, P994, DOI 10.1227/00006123-199505000-00016; BALDWIN WA, 1991, AM J PHYSIOL, V261, pH774; Bendszus M, 2002, J NEUROSURG, V97, P1419, DOI 10.3171/jns.2002.97.6.1419; BENVENISTE H, 1991, STROKE, V22, P259, DOI 10.1161/01.STR.22.2.259; BONNER R, 1981, APPL OPTICS, V20, P2097, DOI 10.1364/AO.20.002097; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; Burger R, 2003, J NEUROTRAUM, V20, P543, DOI 10.1089/089771503767168474; Burger R, 2002, J NEUROSURG, V97, P1410, DOI 10.3171/jns.2002.97.6.1410; Burger R, 1999, J NEUROTRAUM, V16, P1149, DOI 10.1089/neu.1999.16.1149; BUSTO R, 1989, STROKE, V20, P1113, DOI 10.1161/01.STR.20.8.1113; BUSTO R, 1989, NEUROSCI LETT, V101, P299, DOI 10.1016/0304-3940(89)90549-1; Chatzipanteli K, 2000, J CEREBR BLOOD F MET, V20, P531, DOI 10.1097/00004647-200003000-00012; CHOPP M, 1989, J CEREBR BLOOD F MET, V9, P141, DOI 10.1038/jcbfm.1989.21; CHOPP M, 1991, STROKE, V22, P37, DOI 10.1161/01.STR.22.1.37; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; CLIFTON GL, 1991, J CEREBR BLOOD F MET, V11, P114, DOI 10.1038/jcbfm.1991.13; Colbourne F, 1999, J CEREBR BLOOD F MET, V19, P742, DOI 10.1097/00004647-199907000-00003; DEWITT DS, 1992, J NEUROSURG, V76, P812, DOI 10.3171/jns.1992.76.5.0812; DIETRICH WD, 1990, J NEUROPATH EXP NEUR, V49, P486, DOI 10.1097/00005072-199009000-00004; DIETRICH WD, 1992, J NEUROTRAUM, V9, pS475; DIETRICH WD, 1993, J CEREBR BLOOD F MET, V13, P541, DOI 10.1038/jcbfm.1993.71; Dings J, 1998, NEUROSURGERY, V43, P1082, DOI 10.1097/00006123-199811000-00045; DIRNAGL U, 1989, J CEREBR BLOOD F MET, V9, P589, DOI 10.1038/jcbfm.1989.84; Ebmeyer U, 1998, J NEUROTRAUM, V15, P323, DOI 10.1089/neu.1998.15.323; EYRE JA, 1988, CLIN PHYS PHYSIOL M, V9, P65, DOI 10.1088/0143-0815/9/1/006; FITCH W, 1977, J NEUROL NEUROSUR PS, V40, P843, DOI 10.1136/jnnp.40.9.843; GOTO Y, 1993, NEUROSURGERY, V32, P980, DOI 10.1227/00006123-199306000-00017; HABERL RL, 1989, AM J PHYSIOL, V256, pH1247; Herguido MJ, 1999, NEUROSCIENCE, V93, P71, DOI 10.1016/S0306-4522(99)00163-3; Hoffman WE, 1996, NEUROL RES, V18, P185; JAKOBSSON A, 1993, MED BIOL ENG COMPUT, V31, P301, DOI 10.1007/BF02458050; JAKOBSSON K E, 1990, Neurological Research, V12, P153; JIANG JY, 1992, ACTA NEUROPATHOL, V84, P495, DOI 10.1007/BF00304468; JIANG JY, 1991, J NEUROSURG, V74, P492, DOI 10.3171/jns.1991.74.3.0492; KARIBE H, 1994, J CEREBR BLOOD F MET, V14, P620, DOI 10.1038/jcbfm.1994.77; KARIBE H, 1995, J NEUROSURG, V83, P93, DOI 10.3171/jns.1995.83.1.0093; KIRINO T, 1984, ACTA NEUROPATHOL, V64, P139, DOI 10.1007/BF00695577; KUDAY C, 1994, ACTA NEUROCHIR, V131, P203, DOI 10.1007/BF01808613; KUROIWA T, 1990, J CEREB BLOOD FLOW M, V10, P365; Lee EJ, 1998, J TRAUMA, V45, P946, DOI 10.1097/00005373-199811000-00017; LO EH, 1992, STROKE, V23, P889, DOI 10.1161/01.STR.23.6.889; LOBATO RD, 1991, J NEUROSURG, V75, P256, DOI 10.3171/jns.1991.75.2.0256; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; MARION DW, 1993, J NEUROSURG, V79, P354, DOI 10.3171/jns.1993.79.3.0354; Markarian GZ, 1996, NEUROSURGERY, V38, P542; Markgraf CG, 2001, J NEUROSURG, V95, P979, DOI 10.3171/jns.2001.95.6.0979; MARSHALL LF, 1991, J NEUROSURG, V75, pS28, DOI 10.3171/sup.1991.75.1s.0s28; MELLERGARD P, 1991, NEUROSURGERY, V28, P709, DOI 10.1227/00006123-199105000-00012; Metz C, 1996, J NEUROSURG, V85, P533, DOI 10.3171/jns.1996.85.4.0533; MILLER JD, 1990, NEUROSURGERY, V27, P433, DOI 10.1227/00006123-199009000-00016; MINAMISAWA H, 1990, ANN NEUROL, V28, P26, DOI 10.1002/ana.410280107; MIYAZAWA T, 1993, ACTA NEUROPATHOL, V85, P488; MORIKAWA E, 1992, J CEREBR BLOOD F MET, V12, P380, DOI 10.1038/jcbfm.1992.55; Nagai S, 1999, NEUROL RES, V21, P204, DOI 10.1080/01616412.1999.11740919; Nakamura T, 1999, J NEUROSURG, V91, P114, DOI 10.3171/jns.1999.91.1.0114; PALMER C, 1989, ANESTHESIOLOGY, V71, P730, DOI 10.1097/00000542-198911000-00017; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; POMERANZ S, 1993, J NEUROSURG, V79, P241, DOI 10.3171/jns.1993.79.2.0241; ROSOMOFF HL, 1954, AM J PHYSIOL, V179, P85; Shiozaki T, 1998, J NEUROSURG, V89, P206, DOI 10.3171/jns.1998.89.2.0206; SHIOZAKI T, 1993, J NEUROSURG, V79, P363, DOI 10.3171/jns.1993.79.3.0363; SKARPHEDINSSON JO, 1988, ACTA PHYSIOL SCAND, V134, P133, DOI 10.1111/j.1748-1716.1988.tb08469.x; Toyoda T, 1996, NEUROSURGERY, V39, P1200, DOI 10.1097/00006123-199612000-00024; Uranishi R, 1999, J VASC RES, V36, P100, DOI 10.1159/000025631; vanSantbrink H, 1996, NEUROSURGERY, V38, P21, DOI 10.1097/00006123-199601000-00007; WEINSTEI.JD, 1968, J NEUROSURG, V28, P513, DOI 10.3171/jns.1968.28.6.0513; WELSH FA, 1991, J CEREBR BLOOD F MET, V11, P617, DOI 10.1038/jcbfm.1991.112; WIDMANN R, 1993, J NEUROCHEM, V61, P200, DOI 10.1111/j.1471-4159.1993.tb03556.x; XU BN, 1993, NEUROSURGERY, V32, P289, DOI 10.1227/00006123-199302000-00019; Zhao WZ, 1999, J NEUROSURG, V90, P510, DOI 10.3171/jns.1999.90.3.0510	72	17	18	0	1	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0148-396X	1524-4040		NEUROSURGERY	Neurosurgery	MAR	2004	54	3					701	711		10.1227/01.NEU.0000108784.80585.EE			11	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	802FN	WOS:000220149500051	15028147				2021-06-18	
J	Chen, T; Willoughby, KA; Ellis, EF				Chen, T; Willoughby, KA; Ellis, EF			Group I metabotropic receptor antagonism blocks depletion of calcium stores and reduces potentiated capacitative calcium entry in strain-injured neurons and astrocytes	JOURNAL OF NEUROTRAUMA			English	Article						AIDA; mGluR; tissue culture; traumatic brain injury	STRETCH-INDUCED INJURY; TRAUMATIC INJURY; GLUTAMATE RECEPTORS; CORTICAL-NEURONS; ARACHIDONIC-ACID; INFLUX; ACTIVATION; RELEASE; VITRO; CELLS	Antagonism of the group I metabotropic receptor subtype I (mGluR(1)) with (RS)-1-aminoindan-1,5-dicarboxylic acid (AIDA) has been shown to reduce deficits after in vivo or in vitro traumatic brain injury. We have previously demonstrated that AIDA prevents elevation of astrocyte IP3 subsequent to injury-induced activation of mGluRs and phospholipase C. Since IP3 can cause release of intracellular Ca2+ stores we tested the hypothesis that pre- or post-injury treatment with AIDA can affect (1) the depletion of Ca2+ stores which occurs soon after strain injury of cultured neurons and astrocytes and (2) the delayed potentiation of capacitative calcium entry in strain-injured neurons. Astrocyte or neuronal plus glial cultures were grown on Silastic membranes that were subjected to a 50-msec pulse of compressed gas, which caused membrane displacement and biaxial strain (stretch) injury of the adhering cells. Cells were treated 10 min before or immediately after injury with 100 muM AIDA and the intracellular free Ca2+ ([Ca2+](i)) response to thapsigargin, which inhibits the ability of the stores to sequester Ca2+, was measured at 15 min or 3 h after injury. AIDA pre- or post-injury treatment prevented the depletion of intracellular calcium stores at 15 min post-injury in astrocytes and neurons and reduced the potentiated neuronal capacitative calcium influx 3 h after injury. Since Ca2+ and Ca2+ stores influence many factors, including neuronal excitability, plasticity, protein synthesis, and neuronal-glial interactions, prevention of Ca2+ store depletion and subsequent exaggerated capacitative calcium entry may be an important subcellular mechanism by which antagonism of mGluR1 receptors exert an injury-reducing effect. More globally, the results further emphasize the importance of altered signaling and calcium regulatory mechanisms in the immediate and delayed sequelae of traumatic brain injury.	Virginia Commonwealth Univ, Dept Pharmacol & Toxicol, Richmond, VA 23298 USA	Ellis, EF (corresponding author), Virginia Commonwealth Univ, Dept Pharmacol & Toxicol, POB 980613, Richmond, VA 23298 USA.	eellis@mail2.vcu.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL057869] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS027214] Funding Source: NIH RePORTER; NHLBI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [HL 57869] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS 07288, NS 27214] Funding Source: Medline		Allen JW, 2001, EXP NEUROL, V169, P449, DOI 10.1006/exnr.2001.7672; AMRUTHESH SC, 1993, J NEUROCHEM, V61, P150, DOI 10.1111/j.1471-4159.1993.tb03550.x; BRORSON JR, 1991, J NEUROSCI, V11, P4024; Chen T, 2003, J NEUROTRAUM, V20, P1126; ELLIS EF, 1995, J NEUROTRAUM, V12, P325, DOI 10.1089/neu.1995.12.325; Faden AI, 2001, EXP NEUROL, V167, P435, DOI 10.1006/exnr.2000.7577; Floyd CL, 2001, GLIA, V33, P12, DOI 10.1002/1098-1136(20010101)33:1<12::AID-GLIA1002>3.0.CO;2-V; FLOYD CL, 2004, IN PRESS J NEUROTRAU; FLOYD CL, 1999, C J NEUROTRAUMA, V16, P961; Garaschuk O, 1997, J PHYSIOL-LONDON, V502, P13, DOI 10.1111/j.1469-7793.1997.013bl.x; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Lyeth BG, 2001, EXP NEUROL, V169, P191, DOI 10.1006/exnr.2001.7643; McKinney JS, 1996, STROKE, V27, P934, DOI 10.1161/01.STR.27.5.934; Mukhin A, 1996, J NEUROSCI, V16, P6012; POENIE M, 1990, CELL CALCIUM, V2, P85; PUTNEY JW, 1997, CAPACITATIVE CALCIUM; ROE MW, 1990, CELL CALCIUM, V11, P63, DOI 10.1016/0143-4160(90)90060-8; Rzigalinski BA, 1997, J NEUROCHEM, V68, P289; Rzigalinski BA, 1999, J BIOL CHEM, V274, P175, DOI 10.1074/jbc.274.1.175; Rzigalinski BA, 1998, J NEUROCHEM, V70, P2377; Sakaki Y, 1997, J NEUROBIOL, V32, P62, DOI 10.1002/(SICI)1097-4695(199701)32:1<62::AID-NEU6>3.0.CO;2-C; Schoepp DD, 1999, NEUROPHARMACOLOGY, V38, P1431, DOI 10.1016/S0028-3908(99)00092-1; Schreiber D., 1995, P 1995 INT RES C BIO, P233; Verkhratsky A, 2002, EUR J PHARMACOL, V447, P141, DOI 10.1016/S0014-2999(02)01838-1; Weber JT, 2001, J BIOL CHEM, V276, P1800, DOI 10.1074/jbc.M009209200; Weber JT, 1999, CELL CALCIUM, V26, P289, DOI 10.1054/ceca.1999.0082; WILLAN RL, 1990, MULTIPURPOSE TREE SP, V2, P11; Zhang L, 1996, SCIENCE, V274, P1921, DOI 10.1126/science.274.5294.1921	28	17	20	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAR	2004	21	3					271	281		10.1089/089771504322972068			11	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	806CI	WOS:000220411600005	15115602				2021-06-18	
J	Keenan, MAE; Mehta, S				Keenan, MAE; Mehta, S			Neuro-orthopedic management of shoulder deformity and dysfunction in brain-injured patients - A novel approach	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						adhesive capsulitis; brain injury; heterotopic ossification; inferior shoulder subluxation; shoulder contracture; shoulder surgery; spasticity; spastic shoulder	HETEROTOPIC OSSIFICATION; ADULTS; STROKE; PAIN; SPASTICITY; HEMIPLEGIA	Shoulder problems are common in patients with traumatic brain injury. Very little has been written about the evaluation and neuro-orthopedic management of these problems. This is largely because there have not been surgical treatments available other than release of contracted, nonfunctional shoulders. Shoulder problems can be classified and evaluated using several different strategies: bony versus soft tissue restrictions; static versus dynamic deformities; traumatic injuries versus impairments secondary to weakness and spasticity; or problems of active function versus problems of passive function. Regardless of the classification system employed a systematic approach to evaluation and treatment is essential. Shoulder impairments can be corrected leading to significant improvement in functional outcomes. In this paper we report on the novel evaluation and surgical management options developed in our program for the most common shoulder problems encountered in patients with traumatic brain injury.	Univ Penn, Dept Orthopaed Surg, Neuoorthopaed Program, Philadelphia, PA 19104 USA	Keenan, MAE (corresponding author), Univ Penn, Dept Orthopaed Surg, Neuoorthopaed Program, 3400 Spruce St,2 Silverstein, Philadelphia, PA 19104 USA.	maryann.keenan@uphs.upenn.edu	Keenan, Mary Ann/ABB-1551-2020				Aldwell C B, 1969, Clin Orthop Relat Res, V63, P69; Bhakta BB, 1996, J NEUROL NEUROSUR PS, V61, P30, DOI 10.1136/jnnp.61.1.30; BRAUN RM, 1971, J BONE JOINT SURG AM, VA 53, P1307, DOI 10.2106/00004623-197153070-00006; Braun RM, 1999, CLIN ORTHOP RELAT R, P54; Fuller DA, 2002, FOOT ANKLE INT, V23, P738, DOI 10.1177/107110070202300810; GARLAND DE, 1978, CLIN ORTHOP RELAT R, P111; GARLAND DE, 1980, J BONE JOINT SURG AM, V62, P1143, DOI 10.2106/00004623-198062070-00012; GARLAND DE, 1988, CLIN ORTHOP RELAT R, V233, P86; GARLAND DE, 1981, CLIN ORTHOP RELAT R, V155, P162; Ikai T, 1998, AM J PHYS MED REHAB, V77, P421, DOI 10.1097/00002060-199809000-00012; Keenan MA, 2003, ARCH PHYS MED REHAB, V84, P291, DOI 10.1053/apmr.2003.50099; Kolessar DJ, 1996, J HEAD TRAUMA REHAB, V11, P78, DOI 10.1097/00001199-199608000-00010; MCDAID P, 2001, CHAPMANS ORTHOPAEDIC, P1809; OGILVIEHARRIS DJ, 1995, CLIN ORTHOP RELAT R, P238; Turner-Stokes L, 2002, CLIN REHABIL, V16, P276, DOI 10.1191/0269215502cr491oa; Vuagnat H, 2003, J REHABIL MED, V35, P49, DOI 10.1080/16501970306111	16	17	19	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAR-APR	2004	19	2					143	154		10.1097/00001199-200403000-00006			12	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	809NR	WOS:000220643900006	15247824				2021-06-18	
J	Mayer, NH				Mayer, NH			Choosing upper limb muscles for focal intervention after traumatic brain injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						arms; chemodenervation; dynamic EMG; upper motoneuron	UPPER MOTONEURON DYSFUNCTION; BOTULINUM TOXIN; SPASTICITY; ELBOW; PATIENT; REFLEX	The upper motoneuron syndrome (UMNS) resulting from lesions of corticospinal pathways is an important source of disability after traumatic brain injury (TBI). Classic expressions of motor behavior in UMNS are of 2 kinds: (1) manifestation of muscle underactivity, termed negative signs, and (2) manifestation of a variety of forms of muscle overactivity, termed positive signs. Combinations of negative and positive signs give rise to clinical patterns of movement dysfunction such as the flexed elbow, the clenched fist, and the thumb-in-palm deformity. These clinical patterns can be viewed as reflecting a net balance of muscle forces acting across the joints of a limb. Individual muscles are amenable to a variety of focal interventions such as neurolysis, chemodenervation, or surgery. Since more than one muscle acts across most joints, choices among muscles for focal intervention are many. This article will focus on focal interventions of upper limb muscles of patients with TBI who have UMNS and will explore the theme of choosing upper limb muscles for focal interventions after TBI.	Drucker Brain Injury Ctr, Philadelphia, PA 19141 USA; Temple Univ, Hlth Sci Ctr, Dept Phys Med & Rehabil, Philadelphia, PA 19141 USA; Albert Einstein Healthcare Network, Motor Control Anal Lab, Jefferson Hlth Syst, Philadelphia, PA 19141 USA	Mayer, NH (corresponding author), Drucker Brain Injury Ctr, 1200 W Tabor Rd, Philadelphia, PA 19141 USA.	nmayer@einstein.edu					Ada L, 1996, HUM MOVEMENT SCI, V15, P671, DOI 10.1016/0167-9457(96)00015-2; BODINEFOWLER SC, 1992, ORTHOPAEDIC REHABILI; Damiano Diane L., 1993, Physical and Occupational Therapy in Pediatrics, V12, P3, DOI 10.1080/J006v12n04_02; DELWAIDE PJ, 1987, MOTOR DISTURBANCES, V1; DIETZ V, 1991, ANN NEUROL, V30, P767, DOI 10.1002/ana.410300605; FELLOWS SJ, 1994, ELECTROEN CLIN NEURO, V93, P106, DOI 10.1016/0168-5597(94)90073-6; Francisco GE, 2002, AM J PHYS MED REHAB, V81, P355, DOI 10.1097/00002060-200205000-00007; Gracies JM, 1997, ANN NEUROL, V42, pT183; HERMAN R, 1970, BRAIN, V93, P273, DOI 10.1093/brain/93.2.273; HUMPHREY DR, 1983, MOTOR CONTROL MECH H; Keenan MA, 1996, J HEAD TRAUMA REHAB, V11, P57, DOI 10.1097/00001199-199608000-00008; Keenan MA, 2003, ARCH PHYS MED REHAB, V84, P291, DOI 10.1053/apmr.2003.50099; Keenan MA, 1999, NEUROREHABILITATION, V12, P119; KEENAN MAE, 1990, J HAND SURG-AM, V15A, P607, DOI 10.1016/S0363-5023(09)90023-5; KEENAN MAE, 1990, J HEAD TRAUMA REHAB, V5, P13; Mayer NH, 1996, J HEAD TRAUMA REHAB, V11, P37, DOI 10.1097/00001199-199608000-00007; Mayer NH, 1997, MUSCLE NERVE, pS21; Mayer NH, 1997, MUSCLE NERVE, pS1; MAYER NH, 1996, MED REHABILITATION T; MEALS RA, 1988, J BONE JOINT SURG AM, V70A, P1081, DOI 10.2106/00004623-198870070-00017; Okuma Y, 1996, CAN J NEUROL SCI, V23, P15, DOI 10.1017/S0317167100039135; Pierson SH, 1996, ARCH PHYS MED REHAB, V77, P717, DOI 10.1016/S0003-9993(96)90015-5	22	17	17	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAR-APR	2004	19	2					119	142		10.1097/00001199-200403000-00005			24	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	809NR	WOS:000220643900005	15247823				2021-06-18	
J	Zuckerbraun, BS; Morrison, K; Gaines, B; Ford, HR; Hackam, DJ				Zuckerbraun, BS; Morrison, K; Gaines, B; Ford, HR; Hackam, DJ			Effect of age on cervical spine injuries in children after motor vehicle collisions: Effectiveness of restraint devices	JOURNAL OF PEDIATRIC SURGERY			English	Article; Proceedings Paper	34th Annual Meeting of the American-Pediatric-Surgical-Association	MAY 25-30, 2003	Ft Lauderdale, FL	Amer Pediat Surg Assoc		cervical spine; trauma; motor vehicle crash; car safety seats; child restraint devices		Purpose: Despite the devastating consequences of cervical spine (C-spine) injury in children after motor vehicle collisions (MVC), the factors leading to the injury and the appropriateness of protective restraints remain undefined. The authors hypothesized that age-related anatomic factors contribute to inadequate restraints and therefore increase injury severity after MVC. Methods: Data on children (<18 years, 1997 to 2002) admitted to a level 1 pediatric trauma center were prospectively collected and retrospectively reviewed. Those with C-spine injuries caused by MVC were extracted and divided into 2 groups: young (0 to 8 years) and old (9 to 18 years). Statistical comparison was by Student's t test or Z-test, with P less than .05 accepted as significant. Results: Of 5,117 trauma admissions, 94 had C-spine injuries with a mean age of 11 +/- 5 years, 66% of which were boys. Among 1,124 patients who had sustained MVC there were 27 C-spine injuries (2.4% incidence), of which, 12 were less than 8 and 15 were older than 8 years. Restraint devices were utilized at least as frequently in younger children (young, 58% v. old, 43%; not significant). However, younger children had an increased incidence of permanent cord deficit (young, 57% v. old, 13%; P < .05) and closed head injury (young, 50% v. old, 7%; P < .05) even while wearing restraint devices, suggesting that restraint devices are inadequate or improperly used in younger patients. This is supported by the increased injury severity scores of the younger group (young, 37.7 +/- 8.5 v. old, 16.5 +/- 4.6; P < .05). Conclusions: Younger children suffer more sever cervical spine injuries after motor vehicle collisions than their older counterparts, in part because of the inadequacy of currently existing restraint devices. Design modifications to current restraints, including the use of head straps, might improve outcome after MVC in younger patients.	Childrens Hosp Pittsburgh, Dept Surg, Div Pediat Surg, Pittsburgh, PA 15213 USA	Hackam, DJ (corresponding author), Childrens Hosp Pittsburgh, Dept Surg, Div Pediat Surg, 4A 486 Desoto,3705 5th Ave, Pittsburgh, PA 15213 USA.			Hackam, David/0000-0001-5195-8807			Baker C, 1999, AM J EMERG MED, V17, P230, DOI 10.1016/S0735-6757(99)90111-0; BOHN D, 1990, J TRAUMA, V30, P463, DOI 10.1097/00005373-199030040-00017; Brown RL, 2001, J PEDIATR SURG, V36, P1107, DOI 10.1053/jpsu.2001.25665; Bull MJ, 2002, PEDIATRICS, V109, P550; Durbin DR, 2001, PEDIATRICS, V108, part. no., DOI 10.1542/peds.108.6.e109; Eleraky MA, 2000, J NEUROSURG, V92, P12, DOI 10.3171/spi.2000.92.1.0012; Givens TG, 1996, J TRAUMA, V41, P310, DOI 10.1097/00005373-199608000-00019; HILL SA, 1984, J NEUROSURG, V60, P700, DOI 10.3171/jns.1984.60.4.0700; Kokoska ER, 2001, J PEDIATR SURG, V36, P100, DOI 10.1053/jpsu.2001.20022; ORENSTEIN JB, 1994, PEDIATR EMERG CARE, V10, P132, DOI 10.1097/00006565-199406000-00003; Patel JC, 2001, J PEDIATR SURG, V36, P373, DOI 10.1053/jpsu.2001.20720; RUGE JR, 1988, J NEUROSURG, V68, P25, DOI 10.3171/jns.1988.68.1.0025; Winston F K, 2000, LDI Issue Brief, V5, P1	13	17	17	0	1	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0022-3468	1531-5037		J PEDIATR SURG	J. Pediatr. Surg.	MAR	2004	39	3					483	486		10.1016/j.jpedsurg.2003.11.046			4	Pediatrics; Surgery	Pediatrics; Surgery	807ZN	WOS:000220539500073	15017574				2021-06-18	
J	Drummond, SS; Boss, MR				Drummond, SS; Boss, MR			Functional communication screening in individuals with traumatic brain injury	BRAIN INJURY			English	Article							DISCOURSE; ADULTS	The feasibility of a novel instrument, the Functional Communication Scale (FCS), was determined for individuals with moderate-to-mild cognitive-communication deficits secondary to traumatic brain injury (TBI). A group design including 30 adults with confirmed diagnosis and communication problems was utilized. Conversational samples with each participant were videotaped and rated for 13 FCS items. Three raters with diverse clinical experiences rated the elicited samples. Results identified significant and positive relationships between the cognitive-communication severities and the total FCS scores. Significant inter- and intra-rater reliability scores were found for the three raters. The FCS also determined significant differences between individuals with and without concurrent aphasia or dysarthria. No obvious differences were found between males and females nor between individuals with the primary diagnosis of TBI vs other neurological aetiologies. These findings have implications for assessing the adequacy of functional communication of individuals who are candidates for community re-entry.	SE Missouri State Univ, Dept Commun Disorders, Cape Girardeau, MO 63701 USA	Drummond, SS (corresponding author), SE Missouri State Univ, Dept Commun Disorders, MS 2600,1 Univ Plaza, Cape Girardeau, MO 63701 USA.						Adamovich Brenda B., 1998, Seminars in Speech and Language, V19, P281, DOI 10.1055/s-2008-1064050; [Anonymous], 1988, ASHA, V30, P79; COELHO CA, 1991, ARCH PHYS MED REHAB, V72, P465; Coelho CA, 1991, J HEAD TRAUMA REHAB, V6, P92, DOI DOI 10.1097/00001199-199106000-00011; ELLIOTHOLLAND L, 1999, ANN M AM SPEECH LANG; ENRLICH J, 1989, BRAIN INJURY, V3, P193; Frank EM, 1996, J MED SPEECH-LANG PA, V4, P81; Freund J, 1994, COGNITIVE COMMUNICAT; Hagen C, 1979, REHABILITATION HEAD; HARTLAGE LC, 1992, PREVENTABLE BRAIN DA, P3; Hartley Leila L., 1992, Seminars in Speech and Language, V13, P264, DOI 10.1055/s-2008-1064202; Linscott RJ, 1996, BRAIN INJURY, V10, P397, DOI 10.1080/026990596124269; MENTIS M, 1987, J SPEECH HEAR RES, V30, P88, DOI 10.1044/jshr.3001.88; ROSS D, 1986, ROSS INFORMATION PRO; Schwartz R, 1989, ASHA, V31, P91; SNOW P, 1995, APHASIOLOGY, V9, P365, DOI 10.1080/02687039508248210; Snow P, 1997, BRAIN INJURY, V11, P409; WILLER B, 1992, COMMUNITY INTEGRATIO, V2; Ylvisaker Mark, 1992, Seminars in Speech and Language, V13, P239, DOI 10.1055/s-2008-1064200; Ylvisaker Mark, 1992, Seminars in Speech and Language, V13, P308, DOI 10.1055/s-2008-1064205	20	17	17	0	5	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	JAN	2004	18	1					41	56		10.1080/0269905031000149461			16	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	749PB	WOS:000186928200003	14660235				2021-06-18	
J	Schmitter-Edgecombe, M; Marks, W; Wright, MJ; Ventura, M				Schmitter-Edgecombe, M; Marks, W; Wright, MJ; Ventura, M			Retrieval inhibition in directed forgetting following severe closed-head injury	NEUROPSYCHOLOGY			English	Article							TRAUMATIC BRAIN INJURY; POSTHYPNOTIC AMNESIA; SELECTIVE ATTENTION; STIMULUS MODALITY; DIVIDED ATTENTION; EXPLICIT MEMORY; LIST METHODS; PERFORMANCE; IMPLICIT; TASKS	A variant of the list method directed forgetting procedure was used to examine the role of inhibition in memory performance following severe closed-head injury (CHI). Twenty-four participants with severe CHI and 24 controls studied picture and word stimuli in both forget and remember conditions. Memory testing for the to-be-forgotten and to-be-remembered items consisted of a free-recall test followed by a source-monitoring task. Despite poorer recall performance, the participants with CHI exhibited a directed forgetting effect similar to that in controls. Item recognition scores indicated that the inhibited items were not forgotten but rather were items whose accessibility had been lowered. These findings suggest that residual memory deficits in patients with severe CHI are unlikely to reflect inefficient retrieval inhibition.	Washington State Univ, Dept Psychol, Pullman, WA 99164 USA; Univ Memphis, Dept Psychol, Memphis, TN 38152 USA	Schmitter-Edgecombe, M (corresponding author), Washington State Univ, Dept Psychol, POB 644820, Pullman, WA 99164 USA.	schmitter-e@wsu.edu			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R03HD035838] Funding Source: NIH RePORTER; NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R03 HD35838] Funding Source: Medline		Anderson Michael C., 1994, P265; [Anonymous], 1999, SUP PRO BET VERS EXP; Basden BH, 1996, MEMORY, V4, P633, DOI 10.1080/741941000; BASDEN BH, 1993, J EXP PSYCHOL LEARN, V19, P603, DOI 10.1037/0278-7393.19.3.603; Basden BH, 1998, INTENTIONAL FORGETTING: INTERDISCIPLINARY APPROACHES, P139; BATCHELDER WH, 1990, PSYCHOL REV, V97, P548, DOI 10.1037/0033-295X.97.4.548; Bjork EL, 1996, CONSCIOUS COGN, V5, P176, DOI 10.1006/ccog.1996.0011; Bjork EL, 1998, INTENTIONAL FORGETTING: INTERDISCIPLINARY APPROACHES, P103; Bjork R. A., 1989, VARIETIES MEMORY CON, P309; BJORK RA, 1978, J EXP PSYCHOL-HUM L, V4, P347; BJORKLUND DF, 1990, DEV REV, V10, P48, DOI 10.1016/0273-2297(90)90004-N; Blair JR., 1989, CLIN NEUROPSYCHOL, V3, P129; BROOKS D N, 1975, Cortex, V11, P329; BROOKS DN, 1976, J NEUROL NEUROSUR PS, V39, P593, DOI 10.1136/jnnp.39.6.593; Constantinidou F, 1999, J MED SPEECH-LANG PA, V7, P283; Constantinidou F, 1996, J GEN PSYCHOL, V123, P173, DOI 10.1080/00221309.1996.9921270; CONSTANTINIDOU F, 1995, J HEAD TRAUMA REHAB, V10, P90, DOI 10.1097/00001199-199508000-00009; Conway MA, 2000, J MEM LANG, V43, P409, DOI 10.1006/jmla.2000.2706; CROSSON B, 1988, J CLIN EXP NEUROPSYC, V10, P754, DOI 10.1080/01688638808402812; DANEMAN M, 1980, J VERB LEARN VERB BE, V19, P450, DOI 10.1016/S0022-5371(80)90312-6; David D, 2000, INT J CLIN EXP HYP, V48, P267, DOI 10.1080/00207140008415246; DELIS D, 1987, CALIFORNIA VERBAL LE; DYWAN J, 1993, BRAIN COGNITION, V21, P20, DOI 10.1006/brcg.1993.1002; Fleck DE, 2001, PSYCHOL REC, V51, P207, DOI 10.1007/BF03395395; GEISELMAN RE, 1983, J EXP PSYCHOL GEN, V112, P58, DOI 10.1037/0096-3445.112.1.58; GEISELMAN RE, 1985, MEM COGNITION, V13, P57, DOI 10.3758/BF03198444; Golden J. C., 1978, STROOP COLOR WORD TE; Golding JM, 1996, Q J EXP PSYCHOL-A, V49, P326, DOI 10.1080/027249896392667; Harnishfeger KK, 1996, J EXP CHILD PSYCHOL, V62, P292, DOI 10.1006/jecp.1996.0032; Heaton R., 1981, MANUAL WISCONSIN CAR; JOHNSON HM, 1994, PSYCHOL BULL, V116, P274, DOI 10.1037/0033-2909.116.2.274; Kucera H, 1967, COMPUTATIONAL ANAL P; Levin H. S., 1989, J CLIN EXP NEUROPSYC, V12, P129; LEVIN HS, 1986, J CLIN EXP NEUROPSYC, V8, P643, DOI 10.1080/01688638608405185; MacLeod CM, 1999, PSYCHON B REV, V6, P123, DOI 10.3758/BF03210819; Marks W, 2001, J EXP PSYCHOL LEARN, V27, P1464, DOI 10.1037//0278-7393.27.6.1464; Mattis S, 1988, DEMENTIA RATING SCAL; Murnane K, 1996, MEM COGNITION, V24, P417, DOI 10.3758/BF03200931; PANIAK CE, 1989, J CLIN EXP NEUROPSYC, V11, P631, DOI 10.1080/01688638908400921; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; RIEFER DM, 1994, J EXP PSYCHOL LEARN, V20, P680, DOI 10.1037/0278-7393.20.3.680; Sattler JM, 1988, ASSESSMENT CHILDREN; Schmitter-Edgecombe M, 2001, J INT NEUROPSYCH SOC, V7, P615, DOI 10.1017/S1355617701755099; Schmitter-Edgecombe M, 2000, NEUROPSYCHOLOGY, V14, P559; Schmitter-Edgecombe M, 1998, J INT NEUROPSYCH SOC, V4, P144, DOI 10.1017/S1355617798001441; Schmitter-Edgecombe M., 1993, NEUROPSYCHOLOGY, V7, P136, DOI DOI 10.1037/0894-4105.7.2.136; SchmitterEdgecombe M, 1997, NEUROPSYCHOLOGY, V11, P296, DOI 10.1037/0894-4105.11.2.296; Simpson A, 2000, NEUROPSYCHOLOGY, V14, P310, DOI 10.1037//0894-4105.14.2.310; Smith A., 1982, SYMBOL DIGIT MODALIT; SNODGRASS JG, 1980, J EXP PSYCHOL-HUM L, V6, P174, DOI 10.1037/0278-7393.6.2.174; STUSS DT, 1989, J NEUROL NEUROSUR PS, V52, P742, DOI 10.1136/jnnp.52.6.742; TEASDALE G, 1974, LANCET, V2, P81; Vakil E, 1996, NEUROPSY NEUROPSY BE, V9, P176; Vakil E, 1997, NEUROPSYCHOLOGY, V11, P545, DOI 10.1037/0894-4105.11.4.545; VAKIL E, 1995, J CLIN EXP NEUROPSYC, V17, P335, DOI 10.1080/01688639508405127; VAKIL E, 1991, J CLIN EXP NEUROPSYC, V13, P291, DOI 10.1080/01688639108401044; Van Zomeren A. H., 1981, REACTION TIME ATTENT; Van Zomeren A. H., 1984, CLOSED HEAD INJURY P, P74; Vanderploeg RD, 2001, J CLIN EXP NEUROPSYC, V23, P185, DOI 10.1076/jcen.23.2.185.1210; Veltman JC, 1996, NEUROPSYCHOLOGY, V10, P357, DOI 10.1037/0894-4105.10.3.357; Wechsler D., 1987, WECHSLER MEMORY SCAL; Wechsler D., 1981, WAIS R MANUAL WECHSL; Whetstone T, 1996, CONSCIOUS COGN, V5, P395, DOI 10.1006/ccog.1996.0025; Wilson SP, 1998, DEV REV, V18, P86, DOI 10.1006/drev.1997.0445; Zacks RT, 1996, J EXP PSYCHOL LEARN, V22, P143, DOI 10.1037/0278-7393.22.1.143	65	17	17	0	3	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0894-4105			NEUROPSYCHOLOGY	Neuropsychology	JAN	2004	18	1					104	114		10.1037/0894-4105.18.1.104			11	Psychology, Clinical; Neurosciences; Psychology	Psychology; Neurosciences & Neurology	766WJ	WOS:000188398100011	14744193				2021-06-18	
S	Toth, A; Arz, G; Fazekas, G; Bratanov, D; Zlatov, N		Bien, ZZ; Stefanov, D		Toth, A; Arz, G; Fazekas, G; Bratanov, D; Zlatov, N			Post stroke shoulder-elbow physiotherapy with industrial robots	ADVANCES IN REHABILITATION ROBOTICS: HUMAN-FRIENDLY TECHNOLOGIES ON MOVEMENT ASSISTANCE AND RESTORATION FOR PEOPLE WITH DISABILITIES	Lecture Notes in Control and Information Sciences		English	Article; Proceedings Paper	8th International Conference on Rehabilitation Robotics (ICORR 2003)	APR 22-25, 2003	Korea Adv Inst Sci & Technol, Daejeon, SOUTH KOREA		Korea Adv Inst Sci & Technol			Robotic motor rehabilitation is a promising approach to rehabilitation of post stroke, traumatic brain injury, and spinal cord injury neuromotor impairments. We have observed that manual physiotherapy of spastic hemiparetic patients include 45 different types of three-dimensional repetitive shoulder-elbow motion exercises. The physical capabilities as well as the availability of the physiotherapist limit the realization of effective physiotherapy in daily routine. The paper describes the REHAROB Therapeutic System that uses two industrial robot arms for exercising the patient's upper limb. Special devices and measures make the system safe both for the patient and for the physiotherapist. The current REHAROB system performs individual, three-dimensional, anti-spastic passive motion therapy in the full range of concerted shoulder girdle (5) and elbow (2) motions but due to its versatility it is going to be expanded towards active assisted and active against resistance therapy, and for the physiotherapy of spastic hemiparetic lower limbs. The REHAROB Therapeutic System was designed to integrate commercially available robot, safety, control, and sensor components.	Budapest Unit Technol & Econ, Dept Mfg Engn, H-1111 Budapest, Hungary; Natl Inst Med Rehabil, H-1528 Budapest, Hungary; Univ Rousse, Dept Mfg Engn, Automat & Robot Lab, Rousse 7017, Bulgaria; Cardiff Univ, Mfg Engn Ctr, Cardiff CF24 0YF, S Glam, Wales	Toth, A (corresponding author), Budapest Unit Technol & Econ, Dept Mfg Engn, Egry J 1, H-1111 Budapest, Hungary.	toth@manuf.bme.hu; arz@manuf.bme.hu; kassai@alarmix.net; dany@manuf.ru.acad.bg; zlatovnb@cf.ac.uk					AMIRABDOLLAHIAN F, 2001, INTEGRATION ASSIVE T, P109; ARZ G, 2003, P 8 INT C REH ROB IC, P215; Burgar CG, 2000, J REHABIL RES DEV, V37, P663; *EN, 1993, 540 EN; FAZEKAS G, 2002, CLIN NEUROSCI IDEGGY, V55, P268; FEHER M, 1999, NEUROREHABILITAITON; JOHNSON GR, 1998, P 9 WORLD C INT SOC, P639; KOVACS LL, 2001, ADV MANUFACTURING TE, V15, P479; Krebs H I, 2002, Top Stroke Rehabil, V8, P54; Lum Peter, 2002, Top Stroke Rehabil, V8, P40; MLADENOV M, 2002, P 4 INT C TECHN AUT, P173; ROTH A, 2001, INTEGRATION ASSISTIV, P109; TAUB E, 1993, ARCH PHYS MED REHAB, V74, P347; TOTH A, 2003, P 8 INT C INT C REH, P68	14	17	17	0	13	SPRINGER-VERLAG BERLIN	BERLIN	HEIDELBERGER PLATZ 3, D-14197 BERLIN, GERMANY	0170-8643		3-540-21986-2	LECT NOTES CONTR INF			2004	306						391	411					21	Automation & Control Systems; Computer Science, Artificial Intelligence; Computer Science, Information Systems; Robotics; Rehabilitation	Automation & Control Systems; Computer Science; Robotics; Rehabilitation	BAN10	WOS:000222920300025					2021-06-18	
J	Kennedy, MRT; Carney, E; Peters, SM				Kennedy, MRT; Carney, E; Peters, SM			Predictions of recall and study strategy decisions after diffuse brain injury	BRAIN INJURY			English	Article							CLOSED-HEAD-INJURY; SELF-AWARENESS; LEARNING JOLS; VERBAL MEMORY; FRONTAL LOBES; JUDGMENTS; METAMEMORY; ACCURACY; DEFICITS; LESIONS	Objective: To investigate relationships between self-monitoring operationalized by predicting recall and study strategy decisions made by adults with diffuse, acquired brain injury (ABI) and adults without ABI. Research design and methods: Eighteen adults with ABI and 16 without ABI studied two lists of unrelated noun-pairs, made item-by-item immediate and delayed recall predictions and selected items ( after predictions) to restudy again. The computer selected items for restudy based on the lowest prediction rating (i.e. unlikely to recall). A mixed list design was used to balance item selection ( self or computer, within-lists) by type of prediction ( immediate or delayed, between-lists). Recall was tested prior to and after restudying. Hypotheses: Delayed recall predictions would be more accurate than immediate recall predictions; participants would select items for restudy that corresponded with 'lower' delayed predictions (i.e. less likely to recall) and 'higher' immediate predictions (i.e. more likely to recall); for adults with ABI, recall would improve the most from restudying items selected after delayed predictions; and that recall predictive accuracy and study selection decisions are independent processes. Results: Delayed recall predictions were more accurate than immediate recall predictions, though adults with ABI tended to be less accurate than controls. Both groups selected items for restudy that had relatively low prediction ratings irrespective of prediction timing. Of adults with ABI, those with low recall prior to restudy selected items that had 'high' immediate predictions (i.e. likely to recall). However, there was no greater benefit to recall using this strategy. For adults with ABI, recall improved the most from restudying items that were self-selected after delayed predictions, whereas controls' recall improved, irrespective of prediction and selection timing. Between-person correlations revealed no relationship between recall predictive accuracy and study selection strategies. Conclusions: These findings imply that adults with ABI should base strategy decisions on delayed predictions rather than on ` in the moment' immediate ones, selecting items that they have predicted will be difficult to recall. Continued efforts to disambiguate self-monitoring from strategy decisions are required before direct clinical applications can be made.	Univ Minnesota, Dept Commun Disorders, Ctr Cognit Sci, Minneapolis, MN 55455 USA	Kennedy, MRT (corresponding author), Univ Minnesota, Dept Commun Disorders, Ctr Cognit Sci, 115 Shevlin Hall,164 Pillsbury Dr SE, Minneapolis, MN 55455 USA.			Carney, Edward/0000-0003-4518-3560			ALLEN C C, 1990, Brain Injury, V4, P7, DOI 10.3109/02699059009026143; American Congress of Rehabilitation Medicine, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; AMMONS RB, 1979, PSYCHOL REP, V45, P943, DOI 10.2466/pr0.1979.45.3.943; BARONA A, 1984, J CONSULT CLIN PSYCH, V52, P885, DOI 10.1037/0022-006X.52.5.885; Beardmore S, 1999, NEUROPSYCHOL REHABIL, V9, P45, DOI 10.1080/713755588; Bechara A, 2000, BRAIN, V123, P2189, DOI 10.1093/brain/123.11.2189; BLACHSTEIN H, 1993, NEUROPSYCHOLOGY, V7, P530, DOI DOI 10.1037/0894-4105.7.4.530; Burgess PW, 2000, PSYCHOL RES-PSYCH FO, V63, P279, DOI 10.1007/s004269900006; Carter CS, 1998, SCIENCE, V280, P747, DOI 10.1126/science.280.5364.747; Cicerone KD, 1992, NEUROREHABILITATION, V2, P12, DOI DOI 10.3233/NRE-1992-2304; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd; COURVILLE CB, 1937, PATHOLOGY CENTRAL NE; CROSSON B, 1993, NEUROPSYCHOLOGY, V7, P193, DOI DOI 10.1037/0894-4105.7.2.193; DUNLOSKY J, 1994, J MEM LANG, V33, P545, DOI 10.1006/jmla.1994.1026; Dunlosky J, 2001, J EXP PSYCHOL LEARN, V27, P1180, DOI 10.1037//0278-7393.27.5.1180; Dunlosky J, 1998, ACTA PSYCHOL, V98, P37, DOI 10.1016/S0001-6918(97)00051-6; DUNLOSKY J, 1997, J GERONTOL B-PSYCHOL, V552, pP178; Fernandez-Duque D, 2000, CONSCIOUS COGN, V9, P288, DOI 10.1006/ccog.2000.0447; FLAVELL JH, 1979, AM PSYCHOL, V34, P906, DOI 10.1037/0003-066X.34.10.906; Giacino JT, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199810000-00003; Gonzalez R, 1996, PSYCHOL BULL, V119, P159, DOI 10.1037/0033-2909.119.1.159; GOODMAN LA, 1954, J AM STAT ASSOC, V49, P732, DOI 10.2307/2281536; HACKER D, 1998, METACOGNITION ED THE; Hanten G, 2000, DEV NEUROPSYCHOL, V18, P383, DOI 10.1207/S1532694206Hanten; Hart T, 1998, J HEAD TRAUMA REHAB, V13, P16, DOI 10.1097/00001199-199810000-00004; Haut M., 1992, NEUROPSYCHOLOGY, V6, P51; JANOWSKY JS, 1989, PSYCHOBIOLOGY, V17, P3; Kennedy MRT, 2001, BRAIN INJURY, V15, P469, DOI 10.1080/02699050120517; Kennedy MRT, 2000, J SPEECH LANG HEAR R, V43, P1072, DOI 10.1044/jslhr.4305.1072; Kertesz A., 1982, W APHASIA BATTERY; LAWSON MJ, 1989, J CLIN EXP NEUROPSYC, V11, P842, DOI 10.1080/01688638908400939; LEVIN HS, 1986, J CLIN EXP NEUROPSYC, V8, P643, DOI 10.1080/01688638608405185; Levine B, 1998, J INT NEUROPSYCH SOC, V4, P247, DOI 10.1017/S1355617798002471; LEZAK MD, 1995, NEUROPSYCHOLOGICAL A; MCGLYNN SM, 1989, J CLIN EXP NEUROPSYC, V11, P143, DOI 10.1080/01688638908400882; MILLIS SR, 1994, J CLIN EXP NEUROPSYC, V16, P498, DOI 10.1080/01688639408402661; Nelson T. O., 1990, PSYCHOL LEARN MOTIV, V26, P125, DOI DOI 10.1016/S0079-7421(08)60053-5; NELSON TO, 1991, PSYCHOL SCI, V2, P267, DOI 10.1111/j.1467-9280.1991.tb00147.x; NELSON TO, 1994, PSYCHOL SCI, V5, P207, DOI 10.1111/j.1467-9280.1994.tb00502.x; NELSON TO, 1984, PSYCHOL BULL, V95, P109, DOI 10.1037/0033-2909.95.1.109; Newman AC, 2000, BRAIN INJURY, V14, P333; PAIVIO A, 1968, J EXP PSYCHOL, V76, P1, DOI 10.1037/h0025327; PARKER SA, 1976, ACTA NEUROCHIR, V34, P71, DOI 10.1007/BF01405864; Port A, 2002, BRAIN INJURY, V16, P277, DOI 10.1080/02699050110103274; PRIGATANO GP, 1990, ARCH PHYS MED REHAB, V71, P1058; Reder L. M., 1996, IMPLICIT MEMORY META, P45, DOI DOI 10.1037/A0034030; REITAN RM, 1985, HALSTAD REITAN NEURO; Schlund MW, 2002, BRAIN INJURY, V16, P347, DOI 10.1080/02699050110103977; Schlund MW, 1999, BRAIN INJURY, V13, P375, DOI 10.1080/026990599121566; Selznick L, 2000, BEHAV INTERVENT, V15, P243, DOI 10.1002/1099-078X(200007/09)15:3<243::AID-BIN59>3.0.CO;2-1; Shum D, 1999, J CLIN EXP NEUROPSYC, V21, P49, DOI 10.1076/jcen.21.1.49.943; Sohlberg M. M., 2001, COGNITIVE REHABILITA; Son LK, 2000, J EXP PSYCHOL LEARN, V26, P204, DOI 10.1037/0278-7393.26.1.204; STUSS DT, 1991, SELF : INTERDISCIPLINARY APPROACHES, P255; Stuss DT, 2000, PSYCHOL RES-PSYCH FO, V63, P289, DOI 10.1007/s004269900007; Stuss DT, 1992, NEUROPSY NEUROPSY BE, V5; TEASDALE G, 1974, LANCET, V2, P81; Thiede KW, 1999, J EXP PSYCHOL LEARN, V25, P1024, DOI 10.1037/0278-7393.25.4.1024; WEAVER CA, 1995, MEM COGNITION, V23, P12, DOI 10.3758/BF03210553; Wechsler D., 1997, WMS 3 WECHSLER MEMOR	60	17	17	0	2	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	DEC	2003	17	12					1043	1064		10.1080/0269905031000110436			22	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	731WR	WOS:000185909900004	14555364				2021-06-18	
J	Gillon, RS; Cui, Q; Dunlop, SA; Harvey, AR				Gillon, RS; Cui, Q; Dunlop, SA; Harvey, AR			Effects of immunosuppression on regrowth of adult rat retinal ganglion cell axons into peripheral nerve allografts	JOURNAL OF NEUROSCIENCE RESEARCH			English	Article						axonal regeneration; cyclosporin-A; FK506; optic nerve, neurotrauma	SPINAL-CORD-INJURY; CYCLOSPORINE-A; NEURONAL SURVIVAL; FK506 INCREASES; MONOCLONAL-ANTIBODY; SCHWANN-CELLS; REGENERATION; GRAFTS; EXPRESSION; TRANSPLANTATION	Analysis of the effectiveness of allografts and immunosuppression in the repair of nerve defects in the adult peripheral nervous system (PNS) has a long experimental and clinical history. There is little information, however, on the use of allografts in peripheral nerve (PN) transplantation into the injured central nervous system (CNS). We assessed the ability of PN allografts (from Dark-Agouti rats) to support regeneration of adult rat retinal ganglion cell (RGC) axons in immunosuppressed host Lewis rats. PN allografts were sutured onto intraorbitally transected optic nerves. Three weeks after grafting, regenerating RGC axon numbers were determined using retrograde fluorescent labelling, and total axons within PN grafts were assessed using pan-neurofilament immunohistochemistry. In the absence of immunosuppression, PN allografts contained few axons and there were very few labelled RGC. These degenerate grafts contained many T cells and macrophages. Systemic (intraperitoneal) application of the immunosuppressants cyclosporin-A or FK506 reduced cellular infiltration into allografts and resulted in extensive axonal regrowth from surviving RGCs. The average number of RGCs regenerating axons into immunosuppressed allografts was not significantly different from that seen in PN autografts in rats sham-injected with saline. Many pan-neurofilament-positive axons, a proportion of which were myelinated, were seen in immunosuppressed allografts, particularly in proximal regions of the grafts toward the optic nerve-PN interface. This study demonstrates that PN allografts can support axonal regrowth in immunosuppressed adult hosts, and points to possible clinical use in CNS repair. (C) 2003 Wiley-Liss, Inc.	Univ Western Australia, Sch Anat & Human Biol, Inst Med Res, Perth, WA 6009, Australia; Univ Western Australia, Sch Anim Biol, Inst Med Res, Perth, WA 6009, Australia	Harvey, AR (corresponding author), Univ Western Australia, Sch Anat & Human Biol, Inst Med Res, 35 Stirling Highway, Perth, WA 6009, Australia.	arharvey@anhb.uwa.edu.au	Harvey, Alan/A-4911-2008; Dunlop, Sarah A/G-9357-2013	Dunlop, Sarah/0000-0002-1306-3962; , Alan/0000-0002-2590-831X			ANTHONY JP, 1999, TIS ENGN INTELL UNIT, V2, P239; BAHR M, 1992, EXP NEUROL, V116, P13, DOI 10.1016/0014-4886(92)90172-M; Bain JR, 1998, TRANSPL P, V30, P2762, DOI 10.1016/S0041-1345(98)00804-5; Bavetta S, 1999, EXP NEUROL, V158, P382, DOI 10.1006/exnr.1999.7119; Bradbury EJ, 1999, EUR J NEUROSCI, V11, P3873, DOI 10.1046/j.1460-9568.1999.00809.x; BRAY GM, 1987, J EXP BIOL, V132, P5; Bregman BS, 1998, CURR OPIN NEUROBIOL, V8, P800, DOI 10.1016/S0959-4388(98)80124-4; Buki A, 1999, J NEUROTRAUM, V16, P511, DOI 10.1089/neu.1999.16.511; Campbell G, 1999, NEUROREPORT, V10, P3955, DOI 10.1097/00001756-199912160-00042; Chen MS, 2000, NATURE, V403, P434, DOI 10.1038/35000219; Cheng H, 1996, SCIENCE, V273, P510, DOI 10.1126/science.273.5274.510; CHO EYP, 1987, BRAIN RES, V419, P369, DOI 10.1016/0006-8993(87)90610-X; Cui Q, 2003, MOL CELL NEUROSCI, V22, P49, DOI 10.1016/S1044-7431(02)00037-4; Cui Q, 1999, INVEST OPHTH VIS SCI, V40, P760; DAVID S, 1981, SCIENCE, V214, P931, DOI 10.1126/science.6171034; Dezawa M, 2000, PROG RETIN EYE RES, V19, P171, DOI 10.1016/S1350-9462(99)00010-5; Freeman EE, 2000, INVEST OPHTH VIS SCI, V41, P1111; Fu SY, 1997, MOL NEUROBIOL, V14, P67, DOI 10.1007/BF02740621; Gold BG, 1999, DRUG METAB REV, V31, P649, DOI 10.1081/DMR-100101940; Gold BG, 1998, NEUROSCI LETT, V241, P25, DOI 10.1016/S0304-3940(97)00960-9; GOLD BG, 1995, J NEUROSCI, V15, P7509; Goldberg JL, 2000, ANNU REV NEUROSCI, V23, P579, DOI 10.1146/annurev.neuro.23.1.579; Golka B, 2001, EXP NEUROL, V167, P118, DOI 10.1006/exnr.2000.7540; Guo X, 2001, EUR J NEUROSCI, V13, P1683, DOI 10.1046/j.0953-816x.2001.01542.x; HARVEY AR, 1995, CLIN EXP PHARMACOL P, V22, P569, DOI 10.1111/j.1440-1681.1995.tb02068.x; HUNIG T, 1989, J EXP MED, V169, P73, DOI 10.1084/jem.169.1.73; Ide C, 1996, NEUROSCI RES, V25, P101; Inoue T, 2002, J NEUROSCI, V22, P4468, DOI 10.1523/JNEUROSCI.22-11-04468.2002; Jost SC, 2000, RESTOR NEUROL NEUROS, V17, P39; Keirstead HS, 1999, EXP NEUROL, V159, P225, DOI 10.1006/exnr.1999.7100; Klettner A, 2003, BRIT J PHARMACOL, V138, P1004, DOI 10.1038/sj.bjp.0705132; Klettner A, 2001, MOL BRAIN RES, V97, P21, DOI 10.1016/S0169-328X(01)00286-8; Loh NK, 2001, EXP NEUROL, V170, P72, DOI 10.1006/exnr.2001.7692; LYONS WE, 1995, J NEUROSCI, V15, P2985; Madsen JR, 1998, EXP NEUROL, V154, P673, DOI 10.1006/exnr.1998.6974; Marks AR, 1996, PHYSIOL REV, V76, P631; Midha R, 1997, J NEUROPATH EXP NEUR, V56, P421, DOI 10.1097/00005072-199704000-00011; Mirsky R, 1999, BRAIN PATHOL, V9, P293; Moon LDF, 2001, NAT NEUROSCI, V4, P465; MURAMATSU K, 1995, MICROSURG, V16, P496, DOI 10.1002/micr.1920160712; NG TF, 1995, J NEUROCYTOL, V24, P487, DOI 10.1007/BF01179974; Okonkwo DO, 1999, NEUROREPORT, V10, P353, DOI 10.1097/00001756-199902050-00026; Sauve Y, 2001, J NEUROSCI, V21, P951; SCHWAB ME, 1993, ANNU REV NEUROSCI, V16, P565, DOI 10.1146/annurev.ne.16.030193.003025; Sensenbrenner M, 1997, J MOL MED-JMM, V75, P653, DOI 10.1007/s001090050149; SNOW DM, 1990, EXP NEUROL, V109, P111, DOI 10.1016/S0014-4886(05)80013-5; SO KF, 1985, BRAIN RES, V328, P349, DOI 10.1016/0006-8993(85)91047-9; Steiner JP, 1997, NAT MED, V3, P421, DOI 10.1038/nm0497-421; Sugawara T, 1999, NEUROREPORT, V10, P3949, DOI 10.1097/00001756-199912160-00041; Sullivan PG, 2000, EXP NEUROL, V161, P631, DOI 10.1006/exnr.1999.7282; Symons NA, 2001, EUR J NEUROSCI, V14, P522, DOI 10.1046/j.0953-816x.2001.01681.x; Uchino H, 2002, NEUROBIOL DIS, V10, P219, DOI 10.1006/nbdi.2002.0514; VILLEGASPEREZ MP, 1988, J NEUROSCI, V8, P265; Wang HG, 1999, SCIENCE, V284, P339, DOI 10.1126/science.284.5412.339; Wang M S, 1999, J Spinal Cord Med, V22, P287; Wang MS, 1997, J PHARMACOL EXP THER, V282, P1084; Winter C, 2000, NEUROSCIENCE, V95, P753; Xu XM, 1999, EUR J NEUROSCI, V11, P1723, DOI 10.1046/j.1460-9568.1999.00591.x; XU XM, 1995, EXP NEUROL, V134, P261, DOI 10.1006/exnr.1995.1056; Ye JH, 1997, EXP NEUROL, V143, P70, DOI 10.1006/exnr.1996.6353; Yin YQ, 2003, J NEUROSCI, V23, P2284	61	17	18	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0360-4012	1097-4547		J NEUROSCI RES	J. Neurosci. Res.	NOV 15	2003	74	4					524	532		10.1002/jnr.10788			9	Neurosciences	Neurosciences & Neurology	739LW	WOS:000186348900006	14598296				2021-06-18	
J	Greiffenstein, MF; Baker, WJ				Greiffenstein, MF; Baker, WJ			Premorbid clues? Preinjury scholastic performance and present neuropsychological functioning in late postconcussion syndrome	CLINICAL NEUROPSYCHOLOGIST			English	Article							MILD HEAD-INJURY; RELIABLE DIGITS; CATEGORY TEST; TEST BATTERY; EDUCATION; REITAN; AGE; DYSFUNCTION; VALIDATION; GENDER	Neuropsychologists rely on demographic variables to form assumptions about premorbid status, and most use years of education as the main variable. School records are a more objective basis for such estimation, particularly in litigated cases. In the present study, final cumulative grade point average (GPA) was regressed on to Halstead-Reitan Battery (HRB), IQ and other neuropsychological test scores in 60 nonmalingering postconcussive litigants and 17 litigants with moderate-severe closed head injury. Results indicated significant correlations between GPA, HRB core tests, commonly used neuropsychological measures, and intelligence. A regression formula indicated litigants with poor grade point average were likely to perform in the impaired range. The present findings suggest the quality of premorbid academic performance also provides an important context in which to view present neuropsychological performance. Marginal premorbid achievement may be a risk factor for late developing postconcussion syndrome and litigation.	Psychol Syst Inc, Royal Oak, MI USA	Greiffenstein, MF (corresponding author), ABPP CN, 26862 Woodward,Suite 103, Royal Oak, MI 48067 USA.	mfgreiff@comcast.net					ADAMS KM, 1975, J PSYCHEDEL DRUG, V7, P151, DOI 10.1080/02791072.1975.10471994; ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; *AM PSYCH ASS, 2002, PSYCHINFO; Arnold B. R., 1994, ASSESSMENT, V1, P239, DOI [10.1177/107319119400100303., DOI 10.1177/107319119400100303]; BINDER LM, 1991, J CLIN CONSULTING PS, V3, P171; Bohnen N, 1992, Clin Neuropsychol, V6, P178, DOI 10.1080/13854049208401854; BRADFORD DT, 1992, INTERPRETIVE REASONI; Choca JP, 1997, NEUROPSYCHOL REV, V7, P61, DOI 10.1023/B:NERV.0000005944.98635.16; CUTLAN SL, 2000, DISS ABSTR INT B, V60, P4213; Dikmen S, 2001, J CLIN EXP NEUROPSYC, V23, P729, DOI 10.1076/jcen.23.6.729.1019; DIKMEN SS, 1993, J HEAD TRAUMA REHAB, V8, P30, DOI DOI 10.1097/00001199-199309000-00005; Dixon CE, 1993, J HEAD TRAUMA REHAB, V8, P1, DOI [10.1097/00001199-199309000-00003, DOI 10.1097/00001199-199309000-00003]; Dodrill CB, 1997, CLIN NEUROPSYCHOL, V11, P1, DOI 10.1080/13854049708407025; Duncan SA, 2002, ASSESSMENT, V9, P56, DOI 10.1177/1073191102009001007; Elias MF, 1997, EXP AGING RES, V23, P201, DOI 10.1080/03610739708254281; FAUST G, 1991, BRAIN DAMAGE CLAIM C; GFELLER JD, 1994, HEADACHE, V34, P503, DOI 10.1111/j.1526-4610.1994.hed3409503.x; GOETHE KE, 1984, PSYCHIAT ANN, V14, P540, DOI 10.3928/0048-5713-19840701-11; Green P, 2001, CLIN NEUROPSYCHOL, V15, P492, DOI 10.1076/clin.15.4.492.1887; Green P, 2001, NEUROREHABILITATION, V16, P237; Greiffenstein M.F., 1994, PSYCHOL ASSESSMENT, V6, P218, DOI [https://doi.org/10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; Greiffenstein M. F., 2000, BRAIN INJ SOURCE, V4, P26; Greiffenstein MF, 1996, ARCH CLIN NEUROPSYCH, V11, P283, DOI 10.1016/0887-6177(95)00038-0; Greiffenstein MF, 2002, PSYCHOL ASSESSMENT, V14, P202, DOI 10.1037//1040-3590.14.2.202; Halstead WC., 1947, BRAIN INTELLIGENCE Q; Heaton R.K., 1991, COMPREHENSIVE NORMS; Heaton R. K, 1981, WISCONSIN CARD SORTI; HEATON RK, 1978, J NERV MENT DIS, V166, P408, DOI 10.1097/00005053-197806000-00004; HEATON RK, 1994, PSYCHOSOM MED, V56, P8, DOI 10.1097/00006842-199401000-00001; HEATON RK, 1996, NEUROPSYCHOLOGICAL A; JARVIS PE, 1984, HALSTEAD REITAN BATT; Kaufman A. S., 1990, ASSESSING ADOLESCENT; KUPKE T, 1979, J CONSULT CLIN PSYCH, V47, P1128, DOI 10.1037/0022-006X.47.6.1128; LECKLITER IN, 1989, J CLIN PSYCHOL, V45, P484, DOI 10.1002/1097-4679(198907)45:4<484::AID-JCLP2270450402>3.0.CO;2-L; Leckliter Ingrid N, 1992, Clin Neuropsychol, V6, P201, DOI 10.1080/13854049208401856; LISHMAN WA, 1988, BRIT J PSYCHIAT, V153, P460, DOI 10.1192/bjp.153.4.460; Manly JJ, 2002, J INT NEUROPSYCH SOC, V8, P341, DOI 10.1017/S1355617702813157; Matarazzo JD, 1972, WECHSLERS MEASUREMEN; Mathias CW, 2002, ASSESSMENT, V9, P301, DOI 10.1177/1073191102009003009; Megargee EI, 1999, PSYCHOL ASSESSMENT, V11, P177, DOI 10.1037/1040-3590.11.2.177; Meyers JE, 1998, ASSESSMENT, V5, P303, DOI 10.1177/107319119800500309; Millis SR, 2001, J CLIN EXP NEUROPSYC, V23, P809, DOI 10.1076/jcen.23.6.809.1017; MILTON SB, 1988, J HEAD TRAUMA REHAB, V3, P1; Mitrushina M., 1999, HDB NORMATIVE DATA N; MITTENBERG W, 1993, PSYCHOL ASSESSMENT, V5, P34, DOI DOI 10.1037/1040-3590.5.1.34; NEWNAN OS, 1978, PERCEPT MOTOR SKILL, V46, P635, DOI 10.2466/pms.1978.46.2.635; Putnam SH, 1999, STUD NEUROPSYCHOL DE, P39; Rankin EJ, 1999, STUD NEUROPSYCHOL DE, P85; Reis A, 2001, BRAIN COGNITION, V47, P397, DOI 10.1006/brcg.2001.1316; Reitan R M, 1990, Arch Clin Neuropsychol, V5, P265; REITAN RM, 1995, CLIN NEUROPSYCHOL, V9, P151, DOI 10.1080/13854049508401597; Reitan RM, 1999, ARCH CLIN NEUROPSYCH, V14, P191, DOI 10.1016/S0887-6177(98)00012-2; Reitan RM., 1985, HALSTEAD REITAN NEUR; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; Ruff R.M., 1989, MILD HEAD INJURY, P176; Ruff RM, 1999, STUD NEUROPSYCHOL DE, P315; Rutter M, 1996, J DEV BEHAV PEDIATR, V17, P183; RYAN CM, 1987, J CLIN EXP NEUROPSYC, V9, P665, DOI 10.1080/01688638708405209; SCHMIDT M, 1994, ARCH CLIN NEUROPSYCH, V9, P383, DOI 10.1016/0887-6177(94)90002-7; Segalowitz SJ, 2001, BRAIN COGNITION, V45, P342, DOI 10.1006/brcg.2000.1263; SHERER M, 1991, J CLIN EXP NEUROPSYC, V13, P741, DOI 10.1080/01688639108401087; Sherrill-Pattison S, 2000, CLIN NEUROPSYCHOL, V14, P496, DOI 10.1076/clin.14.4.496.7196; Spreen O., 1998, COMPENDIUM NEUROPSYC; Sternberg RJ, 1997, AM PSYCHOL, V52, P1144; STERNBERG RJ, 1986, AM SCI, V74, P137; Strauss E, 2002, ARCH CLIN NEUROPSYCH, V17, P423, DOI 10.1016/S0887-6177(01)00126-3; Suhr J, 1997, J CLIN EXP NEUROPSYC, V19, P500, DOI 10.1080/01688639708403740; Sweet JJ, 1996, CLIN NEUROPSYCHOL, V10, P202, DOI 10.1080/13854049608406681; Tenhula WN, 1996, CLIN NEUROPSYCHOL, V10, P104, DOI 10.1080/13854049608406669; Vanderploeg RD, 1997, CLIN NEUROPSYCHOL, V11, P210, DOI 10.1080/13854049708407054; Wechsler D., 1987, MANUAL WECHSLER MEMO; Wechsler D., 1981, WAIS R MANUAL WECHSL; WILLIS L, 1988, DEV NEUROPSYCHOL, V4, P23, DOI 10.1080/87565648809540387	73	17	17	0	1	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.	NOV	2003	17	4					561	573		10.1076/clin.17.4.561.27937			13	Psychology, Clinical; Clinical Neurology; Psychology	Psychology; Neurosciences & Neurology	776XV	WOS:000189145400012	15168920				2021-06-18	
J	Bergemalm, PO				Bergemalm, PO			Progressive hearing loss after closed head injury: A predictable outcome?	ACTA OTO-LARYNGOLOGICA			English	Article						audiometry; closed head injury; contusion; fracture; progression; Swedish Reaction Level Scale; tinnitus	TEMPORAL BONE-FRACTURES; TRAUMA; CHILDREN	Objectives-To evaluate the prevalence of progression of closed head injury (CHI)-induced hearing impairment, defined as greater than or equal to 15 dB HL deterioration at 1 or more frequencies, and to identify risk factors in patient history and initial status that could predict progression. Material and Methods-A total of 600 patients with major CHI were admitted to 2 Swedish medical centres during a 14-year period. The type of injury was established by means of CT and the severity of head injury was measured using the Swedish Reaction Level Scale (RLS). In 62 of these patients, pure-tone audiometry was performed soon after the injury. Forty-three patients agreed to participate in the present investigation, which was carried out 2-13 years after the injury. Each participant was evaluated using pure-tone audiometry and an itemized anamnesis was obtained. Results-There was a higher prevalence of hearing impairments in the study group compared to a control group. Thirty-two subjects (74%) showed a progression of greater than or equal to 15 dB, which was significantly greater than the spontaneous progression in the control group. Age and temporal bone fracture were risk factors for progression but not brain contusion only or RLS. There was an association between early pure-tone average (PTA) and progression as well as regression, i.e. the poorer the initial PTA the greater the progression as well as regression, indicating increased instability in the auditory system. Examination of patient histories did not reveal any single risk factors for progression. A serendipitous finding was a higher prevalence of reported memory shortcomings among those with post-traumatic tinnitus. Conclusion-Especially for those with fracture of the temporal bone the present results stress the importance of audiometric evaluation and follow-up, from both rehabilitation and medicolegal perspectives.	Orebro Univ Hosp, Ahlsen Res Inst, SE-70185 Orebro, Sweden; Lindesberg Cty Hosp, ENT Dept, Lindesberg, Sweden	Bergemalm, PO (corresponding author), Orebro Univ Hosp, Ahlsen Res Inst, SE-70185 Orebro, Sweden.	per-olof.bergemalm@orebroll.se					Bergemalm PO, 2001, ACTA OTO-LARYNGOL, V121, P724, DOI 10.1080/00016480152583674; Berrettini S, 1998, SEMIN ARTHRITIS RHEU, V27, P301, DOI 10.1016/S0049-0172(98)80051-6; BROWNSON RJ, 1986, LARYNGOSCOPE, V96, P166; Dahiya R, 1999, J TRAUMA, V47, P1079, DOI 10.1097/00005373-199912000-00014; FELDMANN H, 1987, ACTA OTO-LARYNGOL, V103, P379; Fitzgerald DC, 1996, J TRAUMA, V40, P488, DOI 10.1097/00005373-199603000-00034; FUKUDA S, 1994, ACTA OTO-LARYNGOL, P108; GRIFFITHS MV, 1979, J LARYNGOL OTOL, V93, P253, DOI 10.1017/S0022215100086990; ILBERG CV, 1977, LARYNG RHINOL OTOL V, V56, P323; JACOBSON CA, 1989, EAR HEARING, V10, P178, DOI 10.1097/00003446-198906000-00007; LYOS AT, 1995, ARCH OTOLARYNGOL, V121, P795; MAKISHIMA K, 1975, ARCH OTOLARYNGOL, V101, P426; MCGUIRT WF, 1992, CLIN PEDIATR, V31, P12, DOI 10.1177/000992289203100103; NEUBERGER M, 1992, AUDIOLOGY, V31, P45; Niklasson M, 1998, SCAND AUDIOL, V27, P131, DOI 10.1080/010503998422629; PAULSEN K, 1971, Z LARYNGOL RHINO, V5, P297; PODOSHIN L, 1975, ARCH OTOLARYNGOL, V101, P15; Roizen NJ, 1999, PEDIATR CLIN N AM, V46, P49, DOI 10.1016/S0031-3955(05)70080-8; Scholer W, 1990, Z Unfallchir Versicherungsmed, V83, P237; SCHUKNECHT HF, 1969, ANN OTO RHINOL LARYN, V78, P253, DOI 10.1177/000348946907800205; SCHUKNECHT HF, 1991, ADV OTO-RHINO-LARYNG, V46, P50; Segal S, 2002, OTOL NEUROTOL, V23, P312, DOI 10.1097/00129492-200205000-00014; STARMARK JE, 1988, ACTA NEUROCHIR, V91, P12, DOI 10.1007/BF01400521; TONKIN JP, 1975, J LARYNGOL OTOL, V89, P733, DOI 10.1017/S0022215100080944; ZIMMERMAN WD, 1993, LARYNGOSCOPE, V103, P87	25	17	19	0	3	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0001-6489	1651-2251		ACTA OTO-LARYNGOL	Acta Oto-Laryngol.	OCT	2003	123	7					836	845		10.1080/00016480310002474			10	Otorhinolaryngology	Otorhinolaryngology	718GR	WOS:000185137200008	14575399				2021-06-18	
J	Kim, CW; Smith, JM; Lee, A; Hoyt, DB; Kennedy, F; Newton, PO; Meyer, RS				Kim, CW; Smith, JM; Lee, A; Hoyt, DB; Kennedy, F; Newton, PO; Meyer, RS			Personal watercraft injuries: 62 patients admitted to the San Diego County trauma services	JOURNAL OF ORTHOPAEDIC TRAUMA			English	Article						Jet Ski; waverunner; personal watercraft; boating; fractures; blunt trauma	HEALTH; JET	Objective: To determine the types and patterns of injuries seen in personal watercraft (PWC) accidents. Design: A retrospective review of medical records and imaging studies. Setting: Level 1 and 2 trauma centers in San Diego County, California. Patients/Participants: Trauma patients treated for PWC-related injuries between 1984 and 1997. Main Outcome Measurements: Evaluation of injury patterns via chart review and imaging studies. Intervention: None. Results: A total of 62 patients were identified. The average age was 23 years (range 2-59 years). There were 41 males and 21 females. A total of 35 injuries (56%) involved another PWC. Of patients, 24 had loss of consciousness, with 8 closed head injuries. There were 17 chest injuries, with 10 pneumothoraces, and 16 lower extremity fractures (9 femur, 3 hip, 3 tibia-fibula, and 1 patella). Conclusions: injuries related to PWC have increased dramatically over the past several years, becoming one of the leading causes of recreational water-sport injuries. This study supports a high level of awareness for significant blunt trauma to the chest and lower extremities in patients involved in PWC accidents.	Univ Calif San Diego, Med Ctr, Dept Orthopaed Surg, San Diego, CA 92103 USA; Univ Calif San Diego, Med Ctr, Div Trauma, San Diego, CA 92103 USA; Sharp Mem Hosp & Rehabil Ctr, Div Trauma, San Diego, CA 90034 USA; Childrens Hosp, San Diego, CA USA; Scripps Mem Hosp, San Diego, CA USA	Kim, CW (corresponding author), Univ Calif San Diego, Med Ctr, Dept Orthopaed, 350 Dickinson St, San Diego, CA 92103 USA.						Barach P, 1998, JAMA-J AM MED ASSOC, V279, P433, DOI 10.1001/jama.279.6.433-a; Bell W, 1998, CAN FAM PHYSICIAN, V44, P1775; Branche CM, 1997, JAMA-J AM MED ASSOC, V278, P663, DOI 10.1001/jama.278.8.663; DELPRINCIPE RF, 1997, CALIFORNIA BOATING A; Francis R A, 1994, Mo Med, V91, P241; Garri JI, 1999, PLAST RECONSTR SURG, V104, P922, DOI 10.1097/00006534-199909040-00005; HAMMAN BL, 1993, J PEDIATR SURG, V28, P920, DOI 10.1016/0022-3468(93)90697-J; Jeffery R S, 1991, Br J Sports Med, V25, P232; Jones C S, 1998, Inj Prev, V4, P61; Jones C S, 1999, J Ark Med Soc, V96, P97; Jones C S, 1997, J Ark Med Soc, V94, P111; Jones CS, 2000, ACCIDENT ANAL PREV, V32, P373, DOI 10.1016/S0001-4575(99)00091-3; Laraque D, 2000, PEDIATRICS, V105, P452; National Transportation Safety Board, 1998, PERS WAT SAF; Parsons DP, 1999, DIS COLON RECTUM, V42, P959, DOI 10.1007/BF02237110; Philpott JM, 1999, J TRAUMA, V47, P385, DOI 10.1097/00005373-199908000-00031; Shatz DV, 1998, J TRAUMA, V44, P198, DOI 10.1097/00005373-199801000-00029; Swinburn EEL, 1996, MED J AUSTRALIA, V165, P606, DOI 10.5694/j.1326-5377.1996.tb138662.x; Tyler B C, 1997, N C Med J, V58, P284; VERNBERG D, 1989, JAMA-J AM MED ASSOC, V261, P1883, DOI 10.1001/jama.1989.03420130045021; White MW, 1999, AM SURGEON, V65, P865	21	17	17	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0890-5339			J ORTHOP TRAUMA	J. Orthop. Trauma	SEP	2003	17	8					571	573		10.1097/00005131-200309000-00005			3	Orthopedics; Sport Sciences	Orthopedics; Sport Sciences	724PL	WOS:000185495900005	14504578				2021-06-18	
J	Dimopoulou, I; Anthi, A; Lignos, M; Boukouvalas, E; Evangelou, E; Routsi, C; Mandragos, K; Roussos, C				Dimopoulou, I; Anthi, A; Lignos, M; Boukouvalas, E; Evangelou, E; Routsi, C; Mandragos, K; Roussos, C			Prediction of prolonged ventilatory support in blunt thoracic trauma patients	INTENSIVE CARE MEDICINE			English	Article						thoracic trauma; mechanical ventilation; duration; prediction; bilateral chest injuries; severe head trauma; aging	INJURY SEVERITY SCORE; INTENSIVE-CARE UNIT; MECHANICAL VENTILATION; CHEST TRAUMA; PULMONARY CONTUSION; CONSENSUS CONFERENCE; EARLY TRACHEOSTOMY; STAY; INTUBATION; MORTALITY	Objective. To identify predictors of prolonged (>7 days) mechanical ventilation (MV) in patients with blunt thoracic trauma. Design. Prospective analysis of consecutive patients. Setting. Adult intensive care unit (ICU) in a teaching, tertiary-care hospital. Patients and participants. Sixty-nine patients (53 men, 16 women) with thoracic trauma having a median age of 35 (range 17-85) years and a median injury severity score (ISS) of 29 (range 14-41) were enrolled in the present study. Associated injuries included head-neck (77%), extremities (72%), external (67%), abdomen-pelvis (67%), and face (55%). Interventions. Patient surveillance and data collection. Measurements and results. Thirty-three (48%) of the 69 patients required prolonged ventilatory support, ranging in duration from 8 to 38 (median 18) days. Logistic regression analysis revealed that advancing age (odds ratio=1.04, p=0.04), severity of head injury (odds ratio=1.92, p=0.008), and bilateral thoracic injuries (odds ratio=12.80, p<0.0001) were significant and independent predictors of long-lasting MV. In contrast, gender, injuries affecting the other body regions (face, abdomen-pelvis, extremities, and external), laparotomy in patients with abdominal injury, or PaO2/FIO2 on admission in the ICU, were unrelated to prolonged MV. Conclusions. In thoracic trauma patients admitted in the ICU, prolonged mechanical ventilation was primarily determined by presence of bilateral chest injuries, age, and degree of neurotrauma. This information may help in planning the long-term care of such patients.	Evangelismos Med Ctr, Dept Crit Care Med, Athens, Greece; Natl & Kapodistrian Univ, Intens Care Unit, Hellen Red Cross Hosp, Sch Med, Athens, Greece	Dimopoulou, I (corresponding author), 2 Pesmazoglou St, Athens 14561, Greece.		Evangelou, Evangelos/C-3033-2013	Evangelou, Evangelos/0000-0002-5488-2999			Artigas A, 1998, INTENS CARE MED, V24, P378, DOI 10.1007/s001340050585; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; CLARK GC, 1988, J TRAUMA, V28, P298, DOI 10.1097/00005373-198803000-00004; GAILLARD M, 1990, J TRAUMA, V30, P93, DOI 10.1097/00005373-199001000-00015; GAYNOR EB, 1985, LARYNGOSCOPE, V95, P1461; GREENSPAN L, 1985, J TRAUMA, V25, P60, DOI 10.1097/00005373-198501000-00010; Guerrero-Lopez F, 2000, CRIT CARE MED, V28, P1370, DOI 10.1097/00003246-200005000-00018; JOHNSON JA, 1986, J TRAUMA, V26, P695, DOI 10.1097/00005373-198608000-00002; JOHNSON SB, 1992, J TRAUMA, V33, P95, DOI 10.1097/00005373-199207000-00018; LESNIK I, 1992, AM SURGEON, V58, P346; LEWIS FR, 1982, SURG CLIN N AM, V62, P97; Lipsett PA, 2000, ANN SURG, V231, P262, DOI 10.1097/00000658-200002000-00016; MACKENZIE EJ, 1989, J TRAUMA, V29, P757, DOI 10.1097/00005373-198906000-00011; Miller RS, 2000, J TRAUMA, V48, P229, DOI 10.1097/00005373-200002000-00006; Pape HC, 2000, J TRAUMA, V49, P496, DOI 10.1097/00005373-200009000-00018; PINILLA JC, 1982, J TRAUMA, V22, P221, DOI 10.1097/00005373-198203000-00008; PLUMMER AL, 1989, CHEST, V96, P178, DOI 10.1378/chest.96.1.178; Rashid MA, 2000, EUR J SURG, V166, P22; RODRIGUEZ JL, 1990, SURGERY, V108, P655; Ross BJ, 1996, AM SURGEON, V62, P19; SCHULPEN TMJ, 1986, INJURY, V17, P305, DOI 10.1016/0020-1383(86)90151-8; SPICHER JE, 1987, ARCH INTERN MED, V147, P421, DOI 10.1001/archinte.147.3.421; STELLIN G, 1991, AM SURGEON, V57, P780; Troche G, 1997, CHEST, V112, P745, DOI 10.1378/chest.112.3.745; Velmahos GC, 1997, AM SURGEON, V63, P811; WHITED RE, 1984, LARYNGOSCOPE, V94, P367; WISNER DH, 1990, J TRAUMA, V30, P799, DOI 10.1097/00005373-199007000-00006	27	17	18	0	3	SPRINGER-VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010 USA	0342-4642			INTENS CARE MED	Intensive Care Med.	JUL	2003	29	7					1101	1105		10.1007/s00134-003-1813-0			5	Critical Care Medicine	General & Internal Medicine	698ZD	WOS:000184030000012	12802485				2021-06-18	
J	Coughlan, MD; Fieggen, AG; Semple, PL; Peter, JC				Coughlan, MD; Fieggen, AG; Semple, PL; Peter, JC			Craniocerebral gunshot injuries in children	CHILDS NERVOUS SYSTEM			English	Article						penetrating head injury; missile injuries; traumatic brain injury	WOUNDS; MANAGEMENT; BRAIN; ADOLESCENTS; HEAD	Introduction. Despite the worldwide increase in the incidence of gunshot injuries, there are few large published series on craniocerebral gunshot injuries in children. Materials and methods. The records of 30 consecutive children who were treated for craniocerebral gunshot injuries at the Red Cross War Memorial Children's Hospital from 1989 to 2002 were reviewed retrospectively. The circumstances of the injury, clinical status, CT findings, complications, and outcome were assessed. Results. The median age was 7 years. Seventy-seven percent of the victims were boys. The majority of the children were injured in the crossfire of civilian violence. The initial management consisted of debridement under local anesthesia in 16 children and neurosurgical procedures under general anesthesia were performed in 14. Sixteen children sustained transhemispheric injuries, 5 bihemispheric injuries, 5 tangential injuries, and 4 transventricular injuries. All 3 children with a GCS <4 died within 72 h of admission. Three of the 7 children with GCS 4-7 died but there were no deaths in those children whose GCS was >7 post-resuscitation. Motor deficits, cranial nerve palsies, and visual field defects were very common. Early post-traumatic seizures were the commonest complication (18%). Conclusion. Children with higher post-resuscitation GCSs fared better than adults in terms of mortality but not necessarily morbidity. As in the case with adults, the GCS after resuscitation is a very good prognostic indicator of mortality.	Univ Cape Town, Sch Child & Adolescent Hlth, Div Pediat Neurosurg, ZA-7700 Rondebosch, South Africa; Red Cross War Mem Childrens Hosp, Inst Child Hlth, ZA-7700 Rondebosch, South Africa	Fieggen, AG (corresponding author), Univ Cape Town, Sch Child & Adolescent Hlth, Div Pediat Neurosurg, Klipfontein Rd, ZA-7700 Rondebosch, South Africa.			Fieggen, Graham/0000-0001-6541-8377			BARLOW B, 1982, J PEDIATR SURG, V17, P927, DOI 10.1016/S0022-3468(82)80469-7; BRANDVOLD B, 1990, J NEUROSURG, V72, P15, DOI 10.3171/jns.1990.72.1.0015; Bull MJ, 2000, PEDIATRICS, V105, P888; EWINGCOBBS L, 1994, NEUROSURGERY, V35, P225, DOI 10.1227/00006123-199408000-00007; GRAHM TW, 1990, NEUROSURGERY, V27, P696, DOI 10.1227/00006123-199011000-00005; HADDAD FS, 1991, NEUROSURGERY, V28, P1; KAUFMAN HH, 1985, NEUROSURGERY, V16, P754, DOI 10.1227/00006123-198506000-00002; KENNEDY F, 1993, J TRAUMA, V35, P72; LEVY ML, 1993, NEUROSURGERY, V33, P1018; MINER ME, 1990, NEUROSURGERY, V26, P20, DOI 10.1227/00006123-199001000-00002; NAGIB MG, 1986, NEUROSURGERY, V18, P533, DOI 10.1227/00006123-198605000-00003; Semple PL, 2001, S AFR MED J, V91, P141	12	17	18	0	2	SPRINGER-VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010 USA	0256-7040			CHILD NERV SYST	Childs Nerv. Syst.	JUN	2003	19	5-6					348	352		10.1007/s00381-003-0736-y			5	Clinical Neurology; Pediatrics; Surgery	Neurosciences & Neurology; Pediatrics; Surgery	699ZW	WOS:000184089000016	12768317				2021-06-18	
J	Glassmire, DM; Bierley, RA; Wisniewski, AM; Greene, RL; Kennedy, JE; Date, E				Glassmire, DM; Bierley, RA; Wisniewski, AM; Greene, RL; Kennedy, JE; Date, E			Using the WMS-III faces subtest to detect malingered memory impairment	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article							MIXED GROUP VALIDATION; BELIEVABLE DEFICITS; VALIDITY; PERFORMANCE; MMPI-2; TESTS; DYSFUNCTION; PROSPECTS; SYMPTOMS; CAPACITY	The current study evaluated the utility of the WMS-III Faces I subtest (Faces) for the assessment of malingering. Thirty nonlitigating traumatic brain injury patients and 30 control participants were administered Faces under standard administration and instructed malingering conditions. Although the two groups obtained similar scores when taking the test under standard instructions, both groups produced significantly lower performances when instructed to malinger, indicating that Faces is sensitive to malingering, but less sensitive to traumatic brain injury. The total raw score provided stronger classification accuracy than an empirically weighted combination of the five easiest items (i.e., floor effect items). A raw score cutoff of 31 yielded the maximum classification accuracy with 93.3% sensitivity and 80.0% specificity.	Pacific Grad Sch Psychol, Palo Alto, CA USA; Permanente Med Grp Inc, Redwood City, CA USA; Wilford Hall USAF Med Ctr, Def & Vet Head Injury Program, Lackland AFB, TX 78236 USA; Wilford Hall USAF Med Ctr, Dept Neurol, Lackland AFB, TX 78236 USA; VA Palo Alto Healthcare Syst, Palo Alto, CA USA; Def & Vet Head Injury Program, Palo Alto, CA USA	Glassmire, DM (corresponding author), Patton State Hosp, Dept Psychol, AX-234,31202 E Highland Ave, Patton, CA 92369 USA.	davidglassmire@hotmail.com	Glassmire, David/AAX-9268-2020; Glassmire, David/AAO-7344-2021				American Psychiatric Association, 1994, DIAGN STAT MAN MENT; BALDESSARINI RJ, 1983, ARCH GEN PSYCHIAT, V40, P569; BERNARD LC, 1993, ARCH CLIN NEUROPSYCH, V8, P539, DOI 10.1016/0887-6177(93)90054-5; BERNARD LC, 1990, J CLIN EXP NEUROPSYC, V12, P715, DOI 10.1080/01688639008401014; BERNARD LC, 1993, J CLIN PSYCHOL, V49, P45, DOI 10.1002/1097-4679(199301)49:1<45::AID-JCLP2270490107>3.0.CO;2-7; Bierley RA, 2001, BRAIN INJURY, V15, P697, DOI 10.1080/02699050010013671; Binder Laurence M, 1990, Clin Neuropsychol, V4, P25, DOI 10.1080/13854049008401494; Binder LM, 1996, AM J PSYCHIAT, V153, P7; BINDER LM, 1996, ASSESSMENT, V3, P403, DOI DOI 10.1177/107319119600300405; BORUM R, 1995, PROF PSYCHOL-RES PR, V26, P465, DOI 10.1037/0735-7028.26.5.465; BRANDT J, 1991, CLIN ASSESSMENT MALI, P65; Butcher J. N., 1989, MMPI 2 MANUAL ADM SC; Butcher JN, 1995, PSYCHOL ASSESSMENT, V7, P320, DOI 10.1037/1040-3590.7.3.320; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Cullum C, 1991, FORENSIC NEUROPSYCHO, P141; DAWES RM, 1966, PSYCHOL BULL, V66, P63, DOI 10.1037/h0023584; FAUST D, 1988, J CONSULT CLIN PSYCH, V56, P578, DOI 10.1037/0022-006X.56.4.578; Faust D, 1998, CRIT ISS NE, P1; FAUST D, 1988, PROF PSYCHOL-RES PR, V19, P508, DOI 10.1037/0735-7028.19.5.508; FRANZEN M D, 1990, Neuropsychology Review, V1, P247, DOI 10.1007/BF01112573; FREDERICK RI, 1995, B AM ACAD PSYCH LAW, V23, P231; Frederick RI, 2000, ARCH CLIN NEUROPSYCH, V15, P281, DOI 10.1016/S0887-6177(99)00002-5; Frederick RI, 2000, BEHAV SCI LAW, V18, P693, DOI 10.1002/bsl.432; FREED DM, 1989, NEUROPSYCHOLOGIA, V27, P325, DOI 10.1016/0028-3932(89)90022-5; GLASS LS, 1991, FORENSIC NEUROPSYCHO, P3; Gouvier WD, 1998, CRIT ISS NE, P55; Greiffenstein M.F., 1994, PSYCHOL ASSESSMENT, V6, P218, DOI [https://doi.org/10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; GREIFFENSTEIN MF, 1995, CLIN NEUROPSYCHOL, V9, P230, DOI 10.1080/13854049508400485; Griffin GAE, 1996, PSYCHOL ASSESSMENT, V8, P383; Griffin GAE, 1996, J CONSULT CLIN PSYCH, V64, P1425, DOI 10.1037/0022-006X.64.6.1425; Griffin GAE, 1997, J CLIN PSYCHOL, V53, P757, DOI 10.1002/(SICI)1097-4679(199711)53:7<757::AID-JCLP14>3.0.CO;2-K; Grote CL, 2000, J CLIN EXP NEUROPSYC, V22, P709, DOI 10.1076/jcen.22.6.709.958; Hagen C, 1979, REHABILITATION HEAD; HART RP, 1993, J CLIN EXP NEUROPSYC, V15, P245, DOI 10.1080/01688639308402561; HAYS JR, 1993, PERCEPT MOTOR SKILL, V76, P1331, DOI 10.2466/pms.1993.76.3c.1331; HEATON RK, 1978, J CONSULT CLIN PSYCH, V46, P892, DOI 10.1037/0022-006X.46.5.892; HISCOCK M, 1989, J CLIN EXP NEUROPSYC, V11, P967, DOI 10.1080/01688638908400949; Kaplan E, 1991, WAIS R NI USE WAIS R; Killgore WDS, 2000, J CLIN EXP NEUROPSYC, V22, P761; LEESHALEY PR, 1991, PSYCHOL REP, V68, P203, DOI 10.2466/PR0.68.1.203-210; Lezak MD, 1995, NEUROPSYCHOLOGICAL A; MEEHL PE, 1955, PSYCHOL BULL, V52, P194, DOI 10.1037/h0048070; Meyers JE, 1998, ASSESSMENT, V5, P303, DOI 10.1177/107319119800500309; MILLIS SR, 1994, J CLIN PSYCHOL, V50, P601, DOI 10.1002/1097-4679(199407)50:4<601::AID-JCLP2270500417>3.0.CO;2-9; MILLIS SR, 1992, CLIN NEUROPSYCHOL, V6, P406; MITTENBERG W, 1993, PSYCHOL ASSESSMENT, V5, P34, DOI DOI 10.1037/1040-3590.5.1.34; Orey SA, 2000, ARCH CLIN NEUROPSYCH, V15, P335, DOI 10.1016/S0887-6177(99)00024-4; Pankratz, 1997, CLIN ASSESSMENT MALI, P223; Pankratz L., 1988, CLIN ASSESSMENT MALI, P169; PRIGATANO GP, 1993, J CLIN EXP NEUROPSYC, V15, P537, DOI 10.1080/01688639308402577; Psychological Corporation, 1997, WAIS 3 WMS 3 TECHN M; Rees LM, 1998, PSYCHOL ASSESSMENT, V10, P10, DOI 10.1037/1040-3590.10.1.10; REY A, 1964, XAMEN CLIN PSYCHOL; Rogers R, 1990, Bull Am Acad Psychiatry Law, V18, P323; Rogers R, 1998, LAW HUMAN BEHAV, V22, P353, DOI 10.1023/A:1025714808591; ROGERS R, 1994, LAW HUMAN BEHAV, V18, P543, DOI 10.1007/BF01499173; ROGERS R, 1993, CLIN PSYCHOL REV, V13, P255, DOI 10.1016/0272-7358(93)90023-F; Rogers R., 1997, CLIN ASSESSMENT MALI, P398; Rosenfeld B, 2000, ARCH CLIN NEUROPSYCH, V15, P349, DOI 10.1016/S0887-6177(99)00025-6; Schretlen D., 1991, PSYCHOL ASSESSMENT J, V3, P667, DOI [10.1037/1040-3590.3.4.667, DOI 10.1037/1040-3590.3.4.667]; Slick D., 1997, VICTORIA SYMPTOM VAL; SLICK D, 1996, THESIS U VICTORIA; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; Strauss E, 2002, ARCH CLIN NEUROPSYCH, V17, P423, DOI 10.1016/S0887-6177(01)00126-3; Tombaugh TN, 1997, PSYCHOL ASSESSMENT, V9, P260, DOI 10.1037/1040-3590.9.3.260; Tombaugh TN, 1996, TEST MEMORY MALINGER; Vickery CD, 2001, ARCH CLIN NEUROPSYCH, V16, P45, DOI 10.1016/S0887-6177(99)00058-X; Wechsler D., 1987, WECHSLER MEMORY SCAL; Williams JM, 1998, CRIT ISS NE, P105; Willis SC., 1991, PSYCHOL ASSESSMENT J, V3, P175, DOI [10.1037/1040-3590.3.2.175, DOI 10.1037/1040-3590.3.2.175]; Youngjohn JR, 1999, ARCH CLIN NEUROPSYCH, V14, P511, DOI 10.1016/S0887-6177(98)00049-3	71	17	17	0	2	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	JUN	2003	25	4					465	481		10.1076/jcen.25.4.465.13875			17	Psychology, Clinical; Clinical Neurology; Psychology	Psychology; Neurosciences & Neurology	683GY	WOS:000183141300003	12911101				2021-06-18	
J	Lee, IK; Yun, BS; Kim, JP; Kim, WG; Ryoo, IJ; Oh, S; Kim, YH; Yoo, ID				Lee, IK; Yun, BS; Kim, JP; Kim, WG; Ryoo, IJ; Oh, S; Kim, YH; Yoo, ID			p-terphenyl curtisians protect cultured neuronal cells against glutamate neurotoxicity via iron chelation	PLANTA MEDICA			English	Article						Paxillus curtisii; Paxillaceae; mushroom; curtisians; glutamate neurotoxicity; iron chelator	HYDROXYL RADICALS; SUPEROXIDE	The hyperactivity of ionotropic glutamate receptors has been implicated in the development of the neuronal cell death seen in many neurodegenerative processes including ischemic stroke, traumatic brain injury, and epilepsy. Thus neuronal protection against glutamate-induced neurotoxicity is considered as an appropriate therapeutic strategy for preventing and treating neurodegenerative diseases. Whilst searching for blockers of glutamate-induced toxicity in mouse cortical cells, we isolated p-terphenyl curtisians A - D from the mushroom Paxillus curtisii. Curtisians protected cortical neurons from glutamate-induced toxicity in a dose-dependent manner. Among the glutamate receptor subtypes, curtisians were found to block NMDA receptor-mediated but not AMPA/kainate-mediated cell death. In addition, we found that curtisians exhibited potent antioxidative activity against iron-mediated oxidative damage which was generated by H2O2 neurotoxocity and lipid peroxidation, but no activity was detected in the superoxide, DPPH and ABTS radical scavenging systems, and in protection of N-18-RE-105 cells subjected to glutamate-induced glutathione depletion. This effect was likely due to the iron chelating properties of curtisians. The iron chelation ability of curtisians was then further investigated on DNA single strand breakage (SSB) induced by the addition of iron and H2O2, and curtisians prevented DNA SSB like the iron chelator desferrioxamine. These results suggest that the neuroprotective action of curtisians is dependent on their ability to chelate iron as well as to block the NMDA receptor, and that in this context curtisians may be useful as neuroprotective agents against neurological disorders which result in neuronal cell death.	Korea Res Inst Biosci & Biotechnol, Lab Antioxidants, Taejon 305600, South Korea; Ewha Womans Univ, Coll Med, Seoul, South Korea; Chungnam Natl Univ, Coll Pharm, Taejon, South Korea	Yoo, ID (corresponding author), Korea Res Inst Biosci & Biotechnol, Lab Antioxidants, POB 115, Taejon 305600, South Korea.	idyoo@kribb.re.kr					CHOI DW, 1985, NEUROSCI LETT, V58, P293, DOI 10.1016/0304-3940(85)90069-2; CHOI DW, 1988, J NEUROSCI, V8, P185; CHOI DW, 1990, ANNU REV NEUROSCI, V13, P171, DOI 10.1146/annurev.neuro.13.1.171; DUGAN LL, 1994, ANN NEUROL, V35, pS17, DOI 10.1002/ana.410350707; GUTTERIDGE JMC, 1979, BIOCHEM J, V184, P469, DOI 10.1042/bj1840469; Kim SR, 2002, BRIT J PHARMACOL, V135, P1281, DOI 10.1038/sj.bjp.0704576; LAFONCAZAL M, 1993, NATURE, V364, P535, DOI 10.1038/364535a0; Lee JM, 1999, NATURE, V399, pA7, DOI 10.1038/399a007; MIYAMOTO M, 1989, J PHARMACOL EXP THER, V250, P1132; NEILANDS JB, 1995, J BIOL CHEM, V270, P26723, DOI 10.1074/jbc.270.45.26723; Palmer C, 1999, J NEUROSCI RES, V56, P60, DOI 10.1002/(SICI)1097-4547(19990401)56:1<60::AID-JNR8>3.0.CO;2-A; Re R, 1999, FREE RADICAL BIO MED, V26, P1231, DOI 10.1016/S0891-5849(98)00315-3; RISHER M, 2000, ARCH INTERN MED, V160, P3196; Sarco DP, 2000, NEUROSCI LETT, V282, P113, DOI 10.1016/S0304-3940(00)00878-8; Seo SY, 2001, J PHARMACOL EXP THER, V299, P377; STARKE PE, 1985, J BIOL CHEM, V260, P99; Tan SL, 1998, J CELL BIOL, V141, P1423, DOI 10.1083/jcb.141.6.1423; TOYOKUNI S, 1992, J INORG BIOCHEM, V47, P241, DOI 10.1016/0162-0134(92)84069-Y; Xie CS, 2000, FREE RADICAL BIO MED, V28, P665, DOI 10.1016/S0891-5849(99)00268-3; Yun BS, 2000, J ANTIBIOT, V53, P114, DOI 10.7164/antibiotics.53.114	20	17	18	0	5	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0032-0943	1439-0221		PLANTA MED	Planta Med.	JUN	2003	69	6					513	517					5	Plant Sciences; Chemistry, Medicinal; Integrative & Complementary Medicine; Pharmacology & Pharmacy	Plant Sciences; Pharmacology & Pharmacy; Integrative & Complementary Medicine	701BA	WOS:000184144600006	12865968				2021-06-18	
J	Durmaz, R; Kanbak, G; Akyuz, F; Isiksoy, S; Yucel, F; Inal, M; Tel, E				Durmaz, R; Kanbak, G; Akyuz, F; Isiksoy, S; Yucel, F; Inal, M; Tel, E			Lazaroid attenuates edema by stabilizing ATPase in the traumatized rat brain	CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES			English	Article							CEREBRAL-ARTERY OCCLUSION; NERVOUS-SYSTEM TRAUMA; LIPID-PEROXIDATION; BARRIER PERMEABILITY; VASCULAR DISRUPTION; INDUCED INHIBITION; INJURY; ISCHEMIA; METHYLPREDNISOLONE; CELLS	Objective: The aim of the present study was to determine the potential therapeutic value of the lazaroid U-83836E on blood brain barrier (BBB) breakdown and edema with respect to the changes in the synaptosomal Na+/K+ and Mg2+/Ca2+- adenosinetriphosphatase (ATPase) activities, tissue malondialdehyde levels and the neuronal viability in the rat brain subjected to cerebral trauma. Methods: Traumatic brain injury (TBI) was introduced by applying a 75 gm. cm force to the right parietal cortex using the weight-drop method. The first set of animals was used for determining time course changes of the synaptosomal Na+/K+ and Mg2+/Ca2+-ATPase and the malondialdehyde levels and were sacrificed 2, 6 and 24h after lesion production. A group of the animals was treated with U-83836E proir to TBI and sacrificed 24h after cerebral injury. A second set of animals was used for evaluating the alterations in BBB disruption and tissue water content and were sacrificed 2, 6 and 24h after lesion production. Two groups of animals were treated with U-83836E and sacrificed after 2 and 24h following TBI. U-83836E was given intraperitoneally thirty minutes before trauma at a dose of 10 mg/kg. Neuronal necrosis was also evaluated in the groups of U-83836E and physiological saline-treated animals. Results: Extravasation of Evans blue into the traumatized hemisphere was maximum at 2h (p<0.001) and returned close to the control levels at 24h after TBI (p>0.05). Edema had developed progressively over time and reached the maximum degree of 2.1 % (p<0.001) at 24 h. U-83836E showed no effect on the BBB breakdown and the tissue water content at 2h and still had no effect on the BBB breakdown after 24h following the trauma (p>0.05), although it reduced edema after 24h (p<0.01). The losses of Na+/K+ and Mg2+/Ca2+-ATPase activities were found as 39.5 % (p<0.00 1) and 29.4 % (p<0.01) of the control value, respectively, and remained at the decreased levels throughout the experiment. Malondialdehyde level continued to increase over time reaching up to 209 % (p<0.001) of the control value 24h after TBI. Both ATPase activities were improved to near control values (p>0.05) by the effect of U-83836E. U-83836E inhibited the increase of lipid peroxidation (p<0.001) and also salvaged neuronal necrosis (p<0.05). Conclusion: U-83836E given prophylactically after cerebral trauma appears to reduce edema, possibly by inhibiting increases in lipid peroxidation and by stabilizing ATPase. Further studies are recommended to verify the similar effects of the brain penetrating lazaroids when they are given after trauma.	Osmangazi Univ, Dept Neurosurg, Fac Med, TR-26480 Eskisehir, Turkey; Osmangazi Univ, Dept Biochem, Fac Med, TR-26480 Eskisehir, Turkey; Osmangazi Univ, Dept Pathol, Fac Med, TR-26480 Eskisehir, Turkey; Osmangazi Univ, Dept Anat, Fac Med, TR-26480 Eskisehir, Turkey	Durmaz, R (corresponding author), Osmangazi Univ, Dept Neurosurg, Fac Med, TR-26480 Eskisehir, Turkey.						Adelson PD, 1998, ACT NEUR S, V71, P104; AUDUS KL, 1991, FREE RADICAL BIO MED, V11, P361, DOI 10.1016/0891-5849(91)90152-S; AUER RN, 1988, ANN NEUROL, V24, P699, DOI 10.1002/ana.410240602; Barzo P, 1996, J NEUROSURG, V85, P1113, DOI 10.3171/jns.1996.85.6.1113; Barzo P, 1997, ACT NEUR S, V70, P119; Boldyrev AA, 1997, ANN NY ACAD SCI, V834, P666, DOI 10.1111/j.1749-6632.1997.tb52345.x; BRAUGHLER JM, 1989, FREE RADICAL BIO MED, V7, P125, DOI 10.1016/0891-5849(89)90003-8; BRAUGHLER JM, 1989, FREE RADICAL BIO MED, V6, P289, DOI 10.1016/0891-5849(89)90056-7; BRAUGHLER JM, 1981, BRAIN RES, V219, P464; CHAN PH, 1985, PROG BRAIN RES, V63, P227; CORTEZ SC, 1989, BRAIN RES, V482, P271, DOI 10.1016/0006-8993(89)91190-6; Demediuk P, 1990, Adv Neurol, V52, P225; Durmaz R, 1999, ACTA NEUROBIOL EXP, V59, P99; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; FUKUDA K, 1995, J NEUROTRAUM, V12, P315, DOI 10.1089/neu.1995.12.315; Hall E D, 1994, Adv Pharmacol, V28, P221, DOI 10.1016/S1054-3589(08)60497-4; Hall ED, 1996, ACT NEUR S, V66, P107; HALL ED, 1988, BRAIN RES, V451, P350, DOI 10.1016/0006-8993(88)90782-2; HALL ED, 1990, STROKE, V21, P83; HALL ED, 1991, J PHARMACOL EXP THER, V258, P688; Ildan F, 1996, ACTA NEUROCHIR, V138, P338, DOI 10.1007/BF01411746; Jamme I, 1997, BRAIN RES, V774, P123, DOI 10.1016/S0006-8993(97)81695-2; Kaplan P, 1997, NEUROCHEM RES, V22, P1523, DOI 10.1023/A:1021918931780; Kimelberg Harold K., 1995, P919; KLATZO I, 1967, J NEUROPATH EXP NEUR, V26, P1, DOI 10.1097/00005072-196701000-00001; KLATZO I, 1994, ACTA NEUROCHIR, P3; LIN SCC, 1982, BRAIN RES, V235, P387, DOI 10.1016/0006-8993(82)91018-6; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MATTEUCCI E, 1994, ENZYME PROTEIN, V48, P105, DOI 10.1159/000474976; Mayhew TM, 1996, J ANAT, V188, P1; MCINTOSH TK, 1990, ACT NEUR S, V51, P329; MOTULSKY HG, 1994, GRAPHPAD; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; OURY TD, 1993, J BIOL CHEM, V268, P15394; PALKOVIT.M, 1971, BRAIN RES, V32, P15, DOI 10.1016/0006-8993(71)90152-1; Parsons JT, 1997, J NEUROCHEM, V68, P1124; SCHNEIDER GH, 1994, ACTA NEUROCHIR, P516; Schoettle R J, 1990, J Neurotrauma, V7, P207, DOI 10.1089/neu.1990.7.207; SHAPIRA Y, 1993, ANESTH ANALG, V77, P141; SUN AY, 1971, J NEUROCHEM, V18, P1711, DOI 10.1111/j.1471-4159.1971.tb03745.x; SUTTON RL, 1993, J NEUROTRAUM, V10, P135, DOI 10.1089/neu.1993.10.135; Whalen MJ, 1998, ACT NEUR S, V71, P212; YOUNG W, 1988, STROKE, V19, P1013, DOI 10.1161/01.STR.19.8.1013	44	17	17	0	4	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0317-1671	2057-0155		CAN J NEUROL SCI	Can. J. Neurol. Sci.	MAY	2003	30	2					143	149		10.1017/S0317167100053415			7	Clinical Neurology	Neurosciences & Neurology	679CU	WOS:000182903900010	12774954	Bronze			2021-06-18	
J	Pemberton, PL; Dinsmore, J				Pemberton, PL; Dinsmore, J			The use of hypothermia as a method of neuroprotection during neurosurgical procedures and after traumatic brain injury: A survey of clinical practice in Great Britain and Ireland	ANAESTHESIA			English	Article						hypothermia, induced; craniocerebral trauma; neurosurgery; anaesthesia	LOW INTRACRANIAL-PRESSURE; MILD HYPOTHERMIA; TRIAL; THERAPY	Hypothermia has been employed as a method of neuroprotection for many decades. The evidence base for its use is limited, and the balance between benefit and risk is unclear. We felt that in light of this confusion it would be interesting to canvas the opinion of the members of The Neuroanaesthesia Society of Great Britain and Ireland. A questionnaire was sent to all 274 members enquiring into their use of hypothermia during a variety of different neurosurgical procedures and in the management of the head-injured patient. A 75% response rate was achieved. The results showed that over half (58%) of those who replied attempted to cool the patient during cerebral aneurysm surgery. Forty-one per cent of respondents attempt to induce hypothermia in the head-injured patient. However, for other neurosurgical procedures most felt that the disadvantages of cooling the patient outweigh the advantages. The use of hypothermia remains a contentious issue, and as yet there is no clear answer as to whether it should be employed as a method of neuroprotection.	Atkinson Morleys Hosp, London SW20 0NE, England	Pemberton, PL (corresponding author), Atkinson Morleys Hosp, Copse Hill, London SW20 0NE, England.						Berti M, 1998, ANAESTHESIA, V53, P46; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; Frank SM, 1997, JAMA-J AM MED ASSOC, V277, P1127, DOI 10.1001/jama.277.14.1127; GADKARY CS, 2002, COCHRANE LIB; Hindman BJ, 1999, NEUROSURGERY, V44, P23, DOI 10.1097/00006123-199901000-00009; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; Sessler DI, 1997, NEW ENGL J MED, V336, P1730, DOI 10.1056/NEJM199706123362407; Shiozaki T, 1999, J NEUROSURG, V91, P185, DOI 10.3171/jns.1999.91.2.0185; Shiozaki T, 2001, J NEUROSURG, V94, P50, DOI 10.3171/jns.2001.94.1.0050; TODD MM, 1992, ANESTHESIOLOGY, V76, P161	10	17	18	0	2	BLACKWELL PUBLISHING LTD	OXFORD	9600 GARSINGTON RD, OXFORD OX4 2DG, OXON, ENGLAND	0003-2409			ANAESTHESIA	Anaesthesia	APR	2003	58	4					370	373					4	Anesthesiology	Anesthesiology	656WR	WOS:000181634500012	12688273				2021-06-18	
J	Statler, KD; Alexander, HL; Vagni, VA; Nemoto, EM; Tofovic, SP; Dixon, CE; Jenkins, LW; Marion, DW; Kochanek, PM				Statler, KD; Alexander, HL; Vagni, VA; Nemoto, EM; Tofovic, SP; Dixon, CE; Jenkins, LW; Marion, DW; Kochanek, PM			Moderate hypothermia may be detrimental after traumatic brain injury in fentanyl-anesthetized rats	CRITICAL CARE MEDICINE			English	Article						brain injury; sedation; analgesia; narcotics; excitotoxicity	CONTROLLED CORTICAL IMPACT; CEREBRAL BLOOD-FLOW; LOW INTRACRANIAL-PRESSURE; TOXICITY IN-VIVO; SPIN-LABELED MRI; MILD HYPOTHERMIA; POSTTRAUMATIC HYPOTHERMIA; GLUCOSE-METABOLISM; GLUTAMATE RELEASE; GLOBAL-ISCHEMIA	Objectives: To determine whether transient, moderate hypothermia is beneficial after traumatic brain injury in fentanyl-anesthetized rats. Design: Prospective, randomized study. Setting: University-based animal research facility. Subjects: Adult male Sprague-Dawley rats. Interventions: All rats were intubated, mechanically ventilated, and anesthetized with fentanyl (10 mug/kg intravenous bolus and then 50 mug.kg(-1).hr(-1) infusion). Controlled cortical impact was performed to the left parietal cortex, followed immediately by 1 hr of either normothermia (brain temperature 37+/-0.5degreesC) or hypothermia (brain temperature 32+/-0.5degreesC). Hypothermic rats were rewarmed gradually over 1 hr. Fentanyl anesthesia and mechanical ventilation were continued in both groups until the end of rewarming (2 hrs after traumatic brain injury). Measurements and Main Results: Histologic assessment performed 72 hrs after traumatic brain injury was the primary outcome variable. Secondary outcome variables were physiologic variables monitored during the first 2 hrs after traumatic brain injury and plasma catecholamine and serum fentanyl concentrations measured at the end of both hypothermia and rewarming (1 and 2 hrs after traumatic brain injury). Contusion volume was larger in hypothermic vs. normothermic rats (44.3+/-4.2 vs. 28.6+/-4.0 mm, p<.05), but hippocampal neuronal survival did not differ between groups. Physiologic variables did not differ between groups. Plasma dopamine and norepinephrine concentrations were increased at the end of hypothermia in hypothermic (vs. normothermic) rats (p<.05), indicating that hypothermia augmented the systemic stress response. Similarly, serum fentanyl concentrations were higher in hypothermic (vs. normothermic) rats at the end of both hypothermia and rewarming (p<.05), demonstrating that hypothermia reduced the clearance and/or metabolism of fentanyl. Conclusions: Moderate hypothermia was detrimental after experimental traumatic brain injury in fentanyl-anesthetized rats. Since treatment with hypothermia has provided reliable benefit in experimental traumatic brain injury with inhalational anesthetics, these results indicate that the choice of anesthesia/analgesia after traumatic brain injury may dramatically influence response to other therapeutic interventions, such as hypothermia. Given that narcotics commonly are administered to patients after severe traumatic brain injury, this study may have clinical implications.	Univ Pittsburgh, Sch Med, Safar Ctr Resuscitat Res, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Sch Med, Dept Crit Care Med, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Sch Med, Dept Med, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Sch Med, Dept Pediat, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Sch Med, Dept Pharmacol, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Sch Med, Dept Neurosurg, Pittsburgh, PA 15260 USA	Kochanek, PM (corresponding author), Univ Pittsburgh, Sch Med, Safar Ctr Resuscitat Res, 3434 5th Ave,Suite 201, Pittsburgh, PA 15260 USA.		Kochanek, Patrick M/D-2371-2015; Marion, Donald/AAR-5749-2021	Kochanek, Patrick M/0000-0002-2627-913X; 	NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [HD40686] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [T32HD040686] Funding Source: NIH RePORTER		ALCARAZ C, 1989, CLIN EXP PHARMACOL P, V16, P367, DOI 10.1111/j.1440-1681.1989.tb01573.x; Beaumont A, 2001, J NEUROTRAUM, V18, P1359, DOI 10.1089/08977150152725650; Beaumont A, 2000, ACT NEUR S, V76, P147; BICKLER PE, 1994, ANESTHESIOLOGY, V81, P1461, DOI 10.1097/00000542-199412000-00022; BOUMA GJ, 1992, J NEUROTRAUM, V9, pS333; BOYESON MG, 1990, PHARMACOL BIOCHEM BE, V35, P497, DOI 10.1016/0091-3057(90)90279-Q; Bramlett HM, 1997, ACTA NEUROPATHOL, V93, P190, DOI 10.1007/s004010050602; BRYAN RM, 1995, ANESTH ANALG, V80, P687, DOI 10.1097/00000539-199504000-00007; Clark RSB, 2000, J NEUROCHEM, V74, P740, DOI 10.1046/j.1471-4159.2000.740740.x; Clark RSB, 1996, J CEREBR BLOOD F MET, V16, P253, DOI 10.1097/00004647-199603000-00010; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; CLIFTON GL, 1981, NEUROSURGERY, V8, P10, DOI 10.1227/00006123-198101000-00003; CLIFTON GL, 1991, J CEREBR BLOOD F MET, V11, P114, DOI 10.1038/jcbfm.1991.13; Dixon CE, 1998, J NEUROTRAUM, V15, P95, DOI 10.1089/neu.1998.15.95; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Doppenberg EMR, 1997, J NEUROTRAUM, V14, P71, DOI 10.1089/neu.1997.14.71; Dunn-Meynell AA, 1998, BRAIN RES, V800, P245, DOI 10.1016/S0006-8993(98)00524-1; Eilers H, 1996, ANESTHESIOLOGY, V85, P600, DOI 10.1097/00000542-199609000-00020; Frank SM, 1997, AM J PHYSIOL-REG I, V272, pR557; Fujisawa H, 1999, J NEUROTRAUM, V16, P1083, DOI 10.1089/neu.1999.16.1083; GLOBUS MYT, 1995, J NEUROCHEM, V65, P1704; GREEN EJ, 1995, BRAIN RES, V702, P145, DOI 10.1016/0006-8993(95)01034-1; HANSEN TD, 1989, BRIT J ANAESTH, V63, P290, DOI 10.1093/bja/63.3.290; Harada H, 1999, ANESTH ANALG, V89, P1442, DOI 10.1097/00000539-199912000-00022; Hendrich KS, 2001, MAGNET RESON MED, V46, P202, DOI 10.1002/mrm.1178; Hendrich KS, 1999, MAGN RESON MED, V42, P673, DOI 10.1002/(SICI)1522-2594(199910)42:4<673::AID-MRM8>3.0.CO;2-B; Jiang JY, 2000, J NEUROSURG, V93, P546, DOI 10.3171/jns.2000.93.4.0546; KEARSE LA, 1993, ELECTROEN CLIN NEURO, V87, P374, DOI 10.1016/0013-4694(93)90150-T; Kimbro JR, 2000, ANESTHESIOLOGY, V92, P806, DOI 10.1097/00000542-200003000-00024; KISSIN I, 1983, CAN ANAESTH SOC J, V30, P623, DOI 10.1007/BF03015233; KOREN G, 1987, EUR J CLIN PHARMACOL, V32, P373, DOI 10.1007/BF00543972; Lenz C, 1999, ANESTHESIOLOGY, V91, P1720, DOI 10.1097/00000542-199912000-00025; MACHENSEN GB, 1999, ANESTHESIOLOGY, V90, P1; Mansfield RT, 1996, J CEREBR BLOOD F MET, V16, P244, DOI 10.1097/00004647-199603000-00009; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; Markgraf CG, 2001, J NEUROTRAUM, V18, P175, DOI 10.1089/08977150150502604; MCINTOSH TK, 1994, J NEUROCHEM, V63, P1426; Miura Y, 1999, ANESTH ANALG, V88, P787, DOI 10.1097/00000539-199904000-00020; Miura Y, 1998, ANESTHESIOLOGY, V89, P391, DOI 10.1097/00000542-199808000-00016; Mori K, 1999, NEUROL RES, V21, P585, DOI 10.1080/01616412.1999.11740981; Mueller E, 2000, ACTA NEUROCHIR SUPPL, V76, P551; Nakashima K, 1996, STROKE, V27, P913, DOI 10.1161/01.STR.27.5.913; Nemoto EM, 1996, ANESTH ANALG, V83, P1262, DOI 10.1097/00000539-199612000-00023; PALMER AM, 1993, J NEUROCHEM, V61, P2015, DOI 10.1111/j.1471-4159.1993.tb07437.x; PALMER AM, 1993, J NEUROTRAUM, V10, P363, DOI 10.1089/neu.1993.10.363; Popovic R, 2000, ANESTHESIOLOGY, V92, P1343, DOI 10.1097/00000542-200005000-00024; ROSNER MJ, 1984, J NEUROSURG, V61, P76, DOI 10.3171/jns.1984.61.1.0076; SAFO Y, 1985, ACTA ANAESTH SCAND, V29, P594, DOI 10.1111/j.1399-6576.1985.tb02261.x; Schmid-Elsaesser R, 1999, STROKE, V30, P1891, DOI 10.1161/01.STR.30.9.1891; Shiozaki T, 1999, J NEUROSURG, V91, P185, DOI 10.3171/jns.1999.91.2.0185; Shiozaki T, 2001, J NEUROSURG, V94, P50, DOI 10.3171/jns.2001.94.1.0050; Soonthon-Brant V, 1999, ANESTH ANALG, V88, P49, DOI 10.1097/00000539-199901000-00010; Statler KD, 2000, CRIT CARE MED, V28, pA210; Statler KD, 2000, CRIT CARE MED, V28, pA53; Statler KD, 2001, J NEUROTRAUM, V18, P1195, DOI 10.1089/089771501317095232; Statler KD, 2000, J NEUROTRAUM, V17, P1179, DOI 10.1089/neu.2000.17.1179; Suehiro E, 1999, J NEUROTRAUM, V16, P285, DOI 10.1089/neu.1999.16.285; TEMPELHOFF R, 1992, J NEUROSURG, V77, P201, DOI 10.3171/jns.1992.77.2.0201; Tofovic SP, 1996, J CARDIOVASC PHARM, V28, P302, DOI 10.1097/00005344-199608000-00018; WOOLF PD, 1987, J NEUROSURG, V66, P875, DOI 10.3171/jns.1987.66.6.0875; Yamamoto M, 1999, J NEUROTRAUM, V16, P487, DOI 10.1089/neu.1999.16.487; Zhao WZ, 1999, J NEUROSURG, V90, P510, DOI 10.3171/jns.1999.90.3.0510	62	17	17	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0090-3493	1530-0293		CRIT CARE MED	Crit. Care Med.	APR	2003	31	4					1134	1139		10.1097/01.CCM.0000054864.43122.52			6	Critical Care Medicine	General & Internal Medicine	670MF	WOS:000182411900022	12682484				2021-06-18	
J	Stover, JF; Sakowitz, OW; Beyer, TF; Dohse, NK; Kroppenstedt, SN; Thomale, UW; Schaser, KD; Unterberg, AW				Stover, JF; Sakowitz, OW; Beyer, TF; Dohse, NK; Kroppenstedt, SN; Thomale, UW; Schaser, KD; Unterberg, AW			Effects of LY379268, a selective group II metabotropic glutamate receptor agonist on EEG activity, cortical perfusion, tissue damage, and cortical glutamate, glucose, and lactate levels in brain-injured rats	JOURNAL OF NEUROTRAUMA			English	Article						brain edema; contusion; cortical impact; excitotoxicity; microdialysis; neuroprotection	CEREBROSPINAL-FLUID GLUTAMATE; CEREBRAL BLOOD-FLOW; LASER-DOPPLER FLOWMETRY; EXCITATORY AMINO-ACIDS; IMPACT INJURY; EXTRACELLULAR GLUTAMATE; TRANSPORTER GLT-1; TRAUMATIC INJURY; TEMPORAL PROFILE; IN-VIVO	Activating presynaptic group II metabotropic glutamate (mGlu II) receptors reduces synaptic glutamate release. Attenuating glutamatergic transmission without blocking ionotropic glutamate receptors, thus avoiding unfavorable psychomimetic side effects, makes mGlu II receptor agonists a promising target in treating brain-injured patients. Neuroprotective effects of LY379268 were investigated in rats following controlled cortical impact injury (CCI). At 30 min after CCI, rats received a single intraperitoneal injection of LY379268 (10 mg/kg/body weight) or NaCl. Changes in EEG activity and pericontusional cortical perfusion were determined before trauma, at 4, 24, and 48 h, and 7 days after CCI. Brain edema and contusion volume were determined at 24 h and 7 days after CCI, respectively. Before brain removal pericontusional cortical glutamate, glucose, and lactate were measured via microdialysis. During the early period following CCI, EEG activity and cortical perfusion were significantly reduced in rats receiving LY379268. At 7 days, cortical perfusion was significantly increased in rats treated with LY379268, while EEG activity was depressed as in control rats. While brain edema remained unchanged at 24 h, cortical contusion was significantly decreased by 56% at 7 days after CCI. Cortical glutamate, glucose, and lactate were not influenced. Significant reductions in EEG activity and contusion volume by LY379268 do not appear mediated by attenuated excitotoxicity and energetic impairment. Overall, an additional decrease in cortical perfusion seems to interfere with the anti-edematous potential of LY379268 during the early period following CCI, while an increase in perfusion in LY379268-treated rats at 7 days might contribute to tissue protection.	Humboldt Univ, Charite, Virchow Med Ctr, Dept Neurosurg, D-13353 Berlin, Germany; Humboldt Univ, Charite, Virchow Med Ctr, Dept Trauma & Reconstruct Surg, D-13353 Berlin, Germany	Stover, JF (corresponding author), Humboldt Univ, Charite, Virchow Med Ctr, Dept Neurosurg, Augustenburger Pl 1, D-13353 Berlin, Germany.						Allen JW, 1999, J PHARMACOL EXP THER, V290, P112; Battaglia G, 1997, NEUROSCI LETT, V229, P161, DOI 10.1016/S0304-3940(97)00442-4; Bell MJ, 1998, J NEUROTRAUM, V15, P163, DOI 10.1089/neu.1998.15.163; BENVENISTE H, 1990, PROG NEUROBIOL, V35, P195, DOI 10.1016/0301-0082(90)90027-E; Bond A, 2000, J PHARMACOL EXP THER, V294, P800; Bruno V, 2001, J CEREBR BLOOD F MET, V21, P1013, DOI 10.1097/00004647-200109000-00001; Bruno V, 1998, J NEUROSCI, V18, P9594; BRYAN RM, 1995, ANESTH ANALG, V80, P687, DOI 10.1097/00000539-199504000-00007; BUISSON A, 1995, NEUROPHARMACOLOGY, V34, P1081, DOI 10.1016/0028-3908(95)00073-F; Cai ZW, 1999, NEUROREPORT, V10, P3927, DOI 10.1097/00001756-199912160-00037; Cartmell J, 2000, J NEUROCHEM, V75, P889, DOI 10.1046/j.1471-4159.2000.0750889.x; CHAVIS P, 1995, J NEUROSCI, V15, P135; Colwell CS, 1999, BRAIN RES, V833, P234, DOI 10.1016/S0006-8993(99)01545-0; Dempsey RJ, 2000, NEUROSURGERY, V47, P399, DOI 10.1097/00006123-200008000-00024; DIRNAGL U, 1989, J CEREBR BLOOD F MET, V9, P589, DOI 10.1038/jcbfm.1989.84; FADEN AI, 1989, SCIENCE, V4, P800; Feinberg I, 2002, PHARMACOL BIOCHEM BE, V73, P467, DOI 10.1016/S0091-3057(02)00843-2; Ginsberg MD, 1997, AM J PHYSIOL-HEART C, V272, pH2859; Gu WG, 1999, J NEUROSCI METH, V90, P23, DOI 10.1016/S0165-0270(99)00041-2; Helton DR, 1997, NEUROPHARMACOLOGY, V36, P1511, DOI 10.1016/S0028-3908(97)00170-6; Helton DR, 1998, J PHARMACOL EXP THER, V284, P651; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; Kelly DF, 2000, J NEUROTRAUM, V17, P261, DOI 10.1089/neu.2000.17.261; Kilbride J, 1998, EUR J PHARMACOL, V356, P149, DOI 10.1016/S0014-2999(98)00526-3; Kingston AE, 1999, EUR J PHARMACOL, V377, P155, DOI 10.1016/S0014-2999(99)00397-0; Krishnappa IK, 1999, J NEUROTRAUM, V16, P213, DOI 10.1089/neu.1999.16.213; Kroppenstedt SN, 2000, CRIT CARE MED, V28, P3792, DOI 10.1097/00003246-200012000-00004; Kroppenstedt SN, 1998, J NEUROTRAUM, V15, P191, DOI 10.1089/neu.1998.15.191; LOVINGER DM, 1995, J NEUROPHYSIOL, V73, P1076; Lu XCM, 2001, NEUROPATH APPL NEURO, V27, P481, DOI 10.1046/j.1365-2990.2001.00357.x; McIntosh TK, 1996, LAB INVEST, V74, P315; Meir A, 1999, PHYSIOL REV, V79, P1019; Monn JA, 1997, J MED CHEM, V40, P528, DOI 10.1021/jm9606756; Morioka M, 1999, PROG NEUROBIOL, V58, P1, DOI 10.1016/S0301-0082(98)00073-2; Murray TK, 2002, PHARMACOL BIOCHEM BE, V73, P455, DOI 10.1016/S0091-3057(02)00842-0; NAKANISHI S, 1994, NEURON, V13, P1031, DOI 10.1016/0896-6273(94)90043-4; NILLSON P, 1990, J CEREB BLOOD FLOW M, V10, P631; Nilsson P, 1996, J NEUROTRAUM, V13, P201, DOI 10.1089/neu.1996.13.201; NILSSON P, 1994, BRAIN RES, V637, P227, DOI 10.1016/0006-8993(94)91237-8; Obrenovitch TP, 1997, PROG NEUROBIOL, V51, P39, DOI 10.1016/S0301-0082(96)00049-4; PALMER AM, 1993, J NEUROCHEM, V61, P2015, DOI 10.1111/j.1471-4159.1993.tb07437.x; Rao VLR, 1998, J NEUROCHEM, V70, P2020; Rao VLR, 2001, EUR J NEUROSCI, V13, P119, DOI 10.1046/j.1460-9568.2001.01367.x; Stoffel M, 2002, J NEUROTRAUM, V19, P467, DOI 10.1089/08977150252932415; Stover JF, 2000, J NEUROSURG, V92, P853, DOI 10.3171/jns.2000.92.5.0853; Stover JF, 2000, NEUROSCI LETT, V288, P25, DOI 10.1016/S0304-3940(00)01187-3; Stover JF, 2002, INTENS CARE MED, V28, P1491, DOI 10.1007/s00134-002-1431-2; Stover JF, 2000, J NEUROTRAUM, V17, P1171, DOI 10.1089/neu.2000.17.1171; Stover JF, 2000, BRAIN RES, V875, P51, DOI 10.1016/S0006-8993(00)02597-X; Thomale UW, 2002, J NEUROTRAUM, V19, P403, DOI 10.1089/08977150252932361; Thomas JM, 2001, TOP CATAL, V15, P85, DOI 10.1023/A:1016697525123; Unterberg AW, 1997, ACT NEUR S, V70, P106; Van Landeghem FKH, 2001, GLIA, V35, P167, DOI 10.1002/glia.1082; Xi ZX, 2002, J PHARMACOL EXP THER, V300, P162, DOI 10.1124/jpet.300.1.162	54	17	17	0	2	MARY ANN LIEBERT INC PUBL	LARCHMONT	2 MADISON AVENUE, LARCHMONT, NY 10538 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	APR	2003	20	4					315	326		10.1089/089771503765172273			12	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	673YY	WOS:000182609900001	12866811				2021-06-18	
J	Kennedy, MRT; Nawrocki, MD				Kennedy, MRT; Nawrocki, MD			Delayed predictive accuracy of narrative recall after traumatic brain injury: Salience and explicitness	JOURNAL OF SPEECH LANGUAGE AND HEARING RESEARCH			English	Article						narrative; brain injury; memory; learning; metamemory; self-monitoring; metacognition; metacomprehension	LEARNING JOLS; JUDGMENTS; MEMORY; METAMEMORY; COMPREHENSION; PERFORMANCE; AWARENESS; TEXT; CUE; ADOLESCENTS	Fifteen adults with traumatic brain injury (TBI) and 15 adults without brain injury listened to narratives, made delayed predictions of recall, and took a delayed recall test. Narrative questions differed by salience (main ideas, details) and explicitness (implied, stated) (R. H. Brookshire & L. E. Nicholas, 1993). TBI survivors recalled less than control participants regardless of question type. All participants recalled main ideas and implied information with greater accuracy than details and stated information. Predictive accuracy for recalling stated information was strong regardless of group. Participants were unable to predict recall for implied information. The materials-appropriate-processing (MAP) hypothesis proposes that predictive accuracy is biased by text type (i.e., predictive accuracy for recalling main ideas should be higher than for details when learning narratives). However, there were no differences in predictive accuracy for recalling main ideas and details, with both groups predicting recall modestly well. Controlling for explicitness appears to be an important variable for future metamemory text studies.	Univ Minnesota, Dept Commun Disorders, Minneapolis, MN 55455 USA	Kennedy, MRT (corresponding author), Univ Minnesota, Dept Commun Disorders, 115 Shevlin Hall,164 Pillbury Dr SE, Minneapolis, MN 55455 USA.	kenne047@tc.umn.edu					AGRESTI AA, 1989, J CLIN PSYCHOL, V45, P270, DOI 10.1002/1097-4679(198903)45:2<270::AID-JCLP2270450215>3.0.CO;2-9; ALLEN C C, 1990, Brain Injury, V4, P7, DOI 10.3109/02699059009026143; AMMONS RB, 1979, PSYCHOL REP, V45, P943, DOI 10.2466/pr0.1979.45.3.943; BARONA A, 1984, J CONSULT CLIN PSYCH, V52, P885, DOI 10.1037/0022-006X.52.5.885; BLACHSTEIN H, 1993, NEUROPSYCHOLOGY, V7, P530, DOI DOI 10.1037/0894-4105.7.4.530; BOAKE C, 1995, BRAIN INJURY, V9, P273, DOI 10.3109/02699059509008198; Brookshire RH, 1993, DISCOURSE COMPREHENS; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd; CROSSON B, 1988, J CLIN EXP NEUROPSYC, V10, P754, DOI 10.1080/01688638808402812; Darley F., 1978, DIAGNOSTIC METHODS S; Docking K, 2000, BRAIN INJURY, V14, P89, DOI 10.1080/026990500120952; DUNLOSKY J, 1992, MEM COGNITION, V20, P374, DOI 10.3758/BF03210921; DUNLOSKY J, 1994, J MEM LANG, V33, P545, DOI 10.1006/jmla.1994.1026; Dunlosky J, 1997, J MEM LANG, V36, P34, DOI 10.1006/jmla.1996.2476; Dunlosky J, 2000, PSYCHOL AGING, V15, P462, DOI 10.1037//0882-7974.15.3.462; GLENBERG AM, 1987, J EXP PSYCHOL GEN, V116, P119, DOI 10.1037/0096-3445.116.2.119; Gonzalez R, 1996, PSYCHOL BULL, V119, P159, DOI 10.1037/0033-2909.119.1.159; GOODMAN LA, 1954, J AM STAT ASSOC, V49, P732, DOI 10.2307/2281536; Hanten G, 2000, DEV NEUROPSYCHOL, V18, P383, DOI 10.1207/S1532694206Hanten; Haut M., 1992, NEUROPSYCHOLOGY, V6, P51; HAUT M W, 1990, Brain Injury, V4, P281, DOI 10.3109/02699059009026178; JOHNSON RE, 1970, J VERB LEARN VERB BE, V9, P12, DOI 10.1016/S0022-5371(70)80003-2; JOHNSONALIRD PN, 1983, MENTAL MODELS; JOHNSONALIRD PN, 1991, DEDUCTION; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Kennedy MRT, 2001, BRAIN INJURY, V15, P469, DOI 10.1080/02699050120517; Kennedy MRT, 2000, J SPEECH LANG HEAR R, V43, P1072, DOI 10.1044/jslhr.4305.1072; KENNEDY MRT, 2002, UNPUB SELF MONITORIN; Kertesz A., 1982, W APHASIA BATTERY; KINTSCH W, 1978, PSYCHOL REV, V85, P363, DOI 10.1037/0033-295X.85.5.363; LEVIN HS, 1986, J CLIN EXP NEUROPSYC, V8, P643, DOI 10.1080/01688638608405185; Luria A.R., 1980, HIGHER CORTICAL FUNC, V2nd; MAKI RH, 1987, MEM COGNITION, V15, P72, DOI 10.3758/BF03197713; Maki RH, 1998, MEM COGNITION, V26, P959, DOI 10.3758/BF03201176; MAKI RH, 1995, AM J PSYCHOL, V108, P327, DOI 10.2307/1422893; Maki RH, 1998, EDUC PSYCHO, P117; MCDANIEL MA, 1986, J MEM LANG, V25, P645, DOI 10.1016/0749-596X(86)90041-0; McDonald S, 1996, BRAIN LANG, V53, P81, DOI 10.1006/brln.1996.0038; McGuire MJ, 2001, J EXP PSYCHOL LEARN, V27, P1172, DOI 10.1037//0278-7393.27.5.1172; McNeil M.R., 1986, SEM SPEECH LANG, V7, P123, DOI DOI 10.1055/s-0028-1085226; METCALFE J, 1994, METACOGNITION KNOWIN, P137; MILLIS SR, 1994, J CLIN EXP NEUROPSYC, V16, P498, DOI 10.1080/01688639408402661; NELSON TO, 1991, PSYCHOL SCI, V2, P267, DOI 10.1111/j.1467-9280.1991.tb00147.x; NELSON TO, 1994, PSYCHOL SCI, V5, P207, DOI 10.1111/j.1467-9280.1994.tb00502.x; NELSON TO, 1984, PSYCHOL BULL, V95, P109, DOI 10.1037/0033-2909.95.1.109; Newman AC, 2000, BRAIN INJURY, V14, P333; Nicholas L.E., 1995, AM J SPEECH LANGUAGE, V4, P69, DOI [10.1044/1058-0360.0403.69, DOI 10.1044/1058-0360.0403.69]; Pearce S, 1998, BRAIN COGNITION, V38, P150, DOI 10.1006/brcg.1998.1018; PRIGATANO GP, 1990, ARCH PHYS MED REHAB, V71, P1058; REID DB, 1993, J CLIN PSYCHOL, V49, P245, DOI 10.1002/1097-4679(199303)49:2<245::AID-JCLP2270490219>3.0.CO;2-1; REITAN RM, 1985, HALSTADREITAN NEUROS; Schreiber TA, 1998, MEM COGNITION, V26, P553, DOI 10.3758/BF03201162; Shum D, 1999, J CLIN EXP NEUROPSYC, V21, P49, DOI 10.1076/jcen.21.1.49.943; SQUIRE LR, 1992, J COGNITIVE NEUROSCI, V4, P232, DOI 10.1162/jocn.1992.4.3.232; Stuss DT, 1992, NEUROPSY NEUROPSY BE, V5; Stuss DT., 1991, AWARENESS DEFICIT BR, P63; TEASDALE G, 1974, LANCET, V2, P81; Turkstra LS, 1996, BRAIN INJURY, V10, P329, DOI 10.1080/026990596124359; VAKIL E, 1992, J CONSULT CLIN PSYCH, V60, P802, DOI 10.1037/0022-006X.60.5.802; Wallsten TS, 1996, ORGAN BEHAV HUM DEC, V65, P220, DOI 10.1006/obhd.1996.0022; Weaver CA, 1997, PSYCHOL SCI, V8, P318, DOI 10.1111/j.1467-9280.1997.tb00445.x; WEAVER CA, 1995, MEM COGNITION, V23, P12, DOI 10.3758/BF03210553; Wechsler D., 1987, WECHSLER MEMORY SCAL; Wechsler D., 1997, WMS 3 WECHSLER MEMOR	64	17	17	0	1	AMER SPEECH-LANGUAGE-HEARING ASSOC	ROCKVILLE	2200 RESEARCH BLVD, #271, ROCKVILLE, MD 20850-3289 USA	1092-4388	1558-9102		J SPEECH LANG HEAR R	J. Speech Lang. Hear. Res.	FEB	2003	46	1					98	112		10.1044/1092-4388(2003/008)			15	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	651ZQ	WOS:000181354300008	12647891				2021-06-18	
J	Man, DWK; Lam, CS; Bard, CC				Man, DWK; Lam, CS; Bard, CC			Development and application of the Family Empowerment Questionnaire in brain injury	BRAIN INJURY			English	Article							SOCIAL SUPPORT; CAREGIVER; REHABILITATION; DISTRESS; MEMBER; BURDEN; NEEDS	Background: The present study was an ongoing development of a previous study of the Family Empowerment Questionnaire, which had already indicated a four-factor solution ( Skill, Knowledge, Support and Aspiration) empowerment process among family caretakers for their family members with traumatic brain injury (TBI). Objective: The Family Empowerment Questionnaire was used to further explore its applicability to rehabilitation professionals through investigating differences between rehabilitation professionals' and family members' perceptions of empowerment in the rehabilitation process of persons with TBI. Method and procedures: The present study compared the 52-item Family Empowerment Questionnaire scores between 65 rehabilitation professionals with the results obtained from 211 family caretakers. Main outcome: Statistical analyses using the factor-based scores of the four sub-scales revealed that professionals and family members differ significantly in their perceptions regarding family empowerment in TBI rehabilitation in any of the four empowerment factors and within individual items of each factor. Conclusions: Specific activities in which families and professionals' perceptions differed significantly should be explored further and clinical implications of the study are discussed.	Hong Kong Polytech Univ, Dept Rehabil Sci, Hong Kong, Hong Kong, Peoples R China; IIT, Chicago, IL 60616 USA	Man, DWK (corresponding author), Hong Kong Polytech Univ, Dept Rehabil Sci, Hong Kong, Hong Kong, Peoples R China.						ALLAN K, 1994, REHABIL PSYCHOL, V39, P29; BRUCE BW, 1988, FAMILY RELATIONS J A, V37, P12; DELEHANTY R, 1998, J COGNITIVE REHABILI, V16, P14; DURGIN CJ, 1993, STAFF DEV CLIN INTER, P3; Ergh TC, 2002, J HEAD TRAUMA REHAB, V17, P155, DOI 10.1097/00001199-200204000-00006; Jones TM, 1996, REDEFINING FAMILY SU, P87; Junque C, 1997, BRAIN INJURY, V11, P251, DOI 10.1080/026990597123557; Knight RG, 1998, BRAIN INJURY, V12, P467, DOI 10.1080/026990598122430; Kosciulek JF, 1999, INT J REHABIL RES, V22, P269, DOI 10.1097/00004356-199912000-00003; KREUTZER JS, 1994, J HEAD TRAUMA REHAB, V9, P104, DOI 10.1097/00001199-199409000-00009; KREUTZER JS, 1994, BRAIN INJURY, V8, P211, DOI 10.3109/02699059409150974; LARK CS, 2001, DISS ABSTR INT A, V61, P3785; Leathem J, 1996, BRAIN INJURY, V10, P27; Machamer J, 2002, J CLIN EXP NEUROPSYC, V24, P420, DOI 10.1076/jcen.24.4.420.1040; Man D, 1999, BRAIN INJURY, V13, P433, DOI 10.1080/026990599121485; Man DWK, 1998, BRAIN INJURY, V12, P245, DOI 10.1080/026990598122728; Marsh NV, 1998, BRAIN INJURY, V12, P225, DOI 10.1080/026990598122700; MAZZUCCHI A, 2000, INT HDB NEUROPSYCHOL, P299; Pelletier PM, 2000, BRAIN COGNITION, V44, P45; Shaw LR, 1997, BRAIN INJURY, V11, P219; Simpson G, 2000, BRAIN INJURY, V14, P125, DOI 10.1080/026990500120790; Smith J E, 2000, Care Manag J, V2, P27; Sohlberg MM, 2001, J HEAD TRAUMA REHAB, V16, P498, DOI 10.1097/00001199-200110000-00008; Struchen MA, 2002, J HEAD TRAUMA REHAB, V17, P132, DOI 10.1097/00001199-200204000-00005; WATANABE Y, 1996, JAPANESE J REHABILIT, V36, P180	25	17	18	1	6	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.		2003	17	5					437	450		10.1080/0269905031000070152			14	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	660MQ	WOS:000181837300007	12745715				2021-06-18	
J	Murdoch, BE; Goozee, JV				Murdoch, BE; Goozee, JV			EMA analysis of tongue function in children with dysarthria following traumatic brain injury	BRAIN INJURY			English	Article							CLOSED-HEAD INJURY; ELECTROMAGNETIC ARTICULOGRAPHY; SPEECH DISORDERS; MOVEMENTS	Primary objective : To investigate the speed and accuracy of tongue movements exhibited by a sample of children with dysarthria following severe traumatic brain injury (TBI) during speech using electromagnetic articulography (EMA). Methods and procedures : Four children, aged between 12.75-17.17 years with dysarthria following TBI, were assessed using the AG-100 electromagnetic articulography system (Carstens Medizinelektronik). The movement trajectories of receiver coils affixed to each child's tongue were examined during consonant productions, together with a range of quantitative kinematic parameters. The children's results were individually compared against the mean values obtained by a group of eight control children (mean age of 14.67 years, SD 1.60). Main outcomes and results : All four TBI children were perceived to exhibit reduced rates of speech and increased word durations. Objective EMA analysis revealed that two of the TBI children exhibited significantly longer consonant durations compared to the control group, resulting from different underlying mechanisms relating to speed generation capabilities and distances travelled. The other two TBI children did not exhibit increased initial consonant movement durations, suggesting that the vowels and/or final consonants may have been contributing to the increased word durations. Conclusions and clinical implications : The finding of different underlying articulatory kinematic profiles has important implications for the treatment of speech rate disturbances in children with dysarthria following TBI.	Univ Queensland, Dept Speech Pathol & Audiol, Motor Speech Res Unit, Brisbane, Qld, Australia	Murdoch, BE (corresponding author), Univ Queensland, Dept Speech Pathol & Audiol, St Lucia, Qld 4072, Australia.		Murdoch, Bruce E/C-1397-2012				CAHILL LM, 2001, TRAUMATIC BRAIN INJU, P121; Darley F., 1975, MOTOR SPEECH DISORDE; FISHER HB, 1971, FISHER LONGEMANN TES; Goozee JV, 2000, BRAIN INJURY, V14, P153, DOI 10.1080/026990500120817; HARDCASTLE W, 1976, PHYSL SPEECH PRODUCT; HARDCASTLE WJ, 1991, BRIT J DISORD COMMUN, V26, P41; HIROSE H, 1986, FOLIA PHONIATR, V38, P61, DOI 10.1159/000265824; Kuehn D. P., 1976, J PHONETICS, V4, P303; Murdoch B. E., 1990, ACQUIRED SPEECH LANG; Murdoch B. E., 1987, AUSTR J HUMAN COMMUN, V15, P15; MURDOCH BE, 1998, DYSARTHRIA PHYSL APP, P373; PERKELL JS, 1992, J ACOUST SOC AM, V92, P3078, DOI 10.1121/1.404204; Rosenbek JC, 1985, CLIN MANAGEMENT NEUR, P97; SCHONLE PW, 1987, BRAIN LANG, V31, P26, DOI 10.1016/0093-934X(87)90058-7; THEODOROS DG, 1994, BRAIN INJURY, V8, P101, DOI 10.3109/02699059409150963; THEODOROS DG, 1995, BRAIN INJURY, V9, P237, DOI 10.3109/02699059509008196; TULLER B, 1990, J ACOUST SOC AM, V88, P674, DOI 10.1121/1.399771; Yorkston K.M., 1981, ASSESSMENT INTELLIGI	18	17	17	0	6	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.		2003	17	1					79	93		10.1080/0269905021000010203			15	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	633LK	WOS:000180284600007	12519650				2021-06-18	
J	Yang, KH; King, AI				Yang, KH; King, AI			A limited review of finite element models developed for brain injury biomechanics research	INTERNATIONAL JOURNAL OF VEHICLE DESIGN			English	Article; Proceedings Paper	Impact Biomechanics Australia Conference	2001	SYDNEY, AUSTRALIA	Ctr Dis Control & Prevent, Natl Ctr Injury Prevent & Control		finite element model; injury tolerance; intracranial pressure; traumatic brain injury	ACUTE SUBDURAL-HEMATOMA; DIFFUSE AXONAL INJURY; HUMAN HEAD; DYNAMIC-RESPONSE; IMPACT; CONTUSION; TISSUE	In this paper, finite element models developed at Wayne State University to study impact injury biomechanics of the human brain were reviewed. The complexity of these models has been augmented significantly over the years in order to allow each new version of the model to address additional clinical phenomena or to make site-specific correlation between the computer model and biological data. Even though all available data have been used for validation of the latest model, it can only be considered partially validated because there is a lack of quantitative data for a complete validation. Nevertheless, useful information has been derived from model predictions. New and higher quality experimental or real world data are needed for making continued improvement to computer models so that they can accurately predict the risk of brain injury in a given impact.	Wayne State Univ, Ctr Bioengn, Detroit, MI 48202 USA	Yang, KH (corresponding author), Wayne State Univ, Ctr Bioengn, Detroit, MI 48202 USA.	king.yang@wayne.edu					Al-Bsharat A. S., 2000, THESIS WAYNE STATE U; ALBSHARAT AS, 1999, P 43 STAPP CRASH C; Allsop D, 1988, P 32 STAPP CAR CRASH; Anderson RWG, 1999, P INT IRCOBI C BIOM, P107; BAE J, 2001, P 6 US NAT C COMP ME; BANDAK FA, 2001, P 17 ESV C AMST TH N; Bradshaw DRS, 2001, J BIOMECH, V34, P85, DOI 10.1016/S0021-9290(00)00135-4; CHU CS, 1994, J BIOMECH, V27, P187, DOI 10.1016/0021-9290(94)90208-9; DIMASI FP, 1995, P 39 STAPP CRASH C; GENNARELLI TA, 1982, J TRAUMA, V22, P680, DOI 10.1097/00005373-198208000-00005; HARDY WN, 2001, STAPP CAR CRASH J, P45; HARDY WN, 1997, P CRASHW OCC PROT BI, V225, P241; Huang HM, 1999, J TRAUMA, V47, P538, DOI 10.1097/00005373-199909000-00019; Huang HM, 2000, MED BIOL ENG COMPUT, V38, P253, DOI 10.1007/BF02347044; KING AI, 1999, P 1999 BIOENG C ASME, P269; Kraus JF, 1996, NEUROL CLIN, V14, P435, DOI 10.1016/S0733-8619(05)70266-8; MCGRATH P, 1984, ATLAS SECTIONAL ANAT; MCLEAN AJ, 1995, J NEUROTRAUM, V12, P621, DOI 10.1089/neu.1995.12.621; MENDIS KK, 1995, J BIOMECH ENG-T ASME, V117, P279, DOI 10.1115/1.2794182; MILLER RT, 1998, P 42 STAPP CRASH C; NAGASHIMA T, 1990, Neurologia Medico-Chirurgica, V30, P1, DOI 10.2176/nmc.30.1; Nahum AM, 1977, P 21 STAPP CRASH C; Newman J. A., 1999, P INT RESEAR C BIOME, P17; Nishimoto T, 1998, J BIOMECH ENG-T ASME, V120, P140, DOI 10.1115/1.2834294; NUSHOLTZ GS, 1984, P 28 STAPP CAR CRASH; Nyquist G. W., 1986, P 30 STAPP CAR CRASH; OMORI K, 2000, P 9 ASME S CRASHW OC, V46, P167; ROSS DT, 1994, EXP NEUROL, V126, P291, DOI 10.1006/exnr.1994.1067; RUAN JS, 1995, J NEUROTRAUM, V12, P725, DOI 10.1089/neu.1995.12.725; RUAN JS, 1994, J BIOMECH ENG-T ASME, V116, P44, DOI 10.1115/1.2895703; RUAN JS, 1991, J BIOMECH ENG-T ASME, V113, P276, DOI 10.1115/1.2894885; RUAN JS, 1993, P 37 STAPP CAR C; Shreiber D. I., 1997, P 41 STAPP CAR CRASH; SHUGAR TA, 1975, P 19 STAPP CAR CRASH; TONG P, 1989, P 12 INT TECHN C EXP, P617; Trosseille X., 1992, P 36 STAPP CAR CRASH; TURQUIER F, 1996, P 40 STAPP CAR CRASH; UENO K, 1995, J NEUROTRAUM, V12, P695, DOI 10.1089/neu.1995.12.695; UENO K, 1996, AGARD AMP HEAD INJ S; VOO K, 1989, MED BIOL ENG COMPUT, V34, P375; Williams T. G., 1995, J CONSUMER MARKETING, V12, P4, DOI DOI 10.1108/07363769510147218; Willinger R, 1999, ANN BIOMED ENG, V27, P403, DOI 10.1114/1.165; Zhang L, 2001, STAPP CAR CRASH J; Zhang L.Y., 2001, THESIS WAYNE STATE U; Zhang LY, 2001, NEUROL RES, V23, P144, DOI 10.1179/016164101101198488; Zhang LY, 2001, J NEUROTRAUM, V18, P21, DOI 10.1089/089771501750055749; Zhou C, 1995, P 39 STAPP CAR CRASH; ZHOU C, 1994, P 38 STAPP CAR CRASH	48	17	17	0	8	INDERSCIENCE ENTERPRISES LTD	GENEVA	WORLD TRADE CENTER BLDG, 29 ROUTE DE PRE-BOIS, CASE POSTALE 856, CH-1215 GENEVA, SWITZERLAND	0143-3369	1741-5314		INT J VEHICLE DES	Int. J. Veh. Des.		2003	32	1-2					116	129		10.1504/IJVD.2003.003240			14	Engineering, Mechanical; Transportation Science & Technology	Engineering; Transportation	691PK	WOS:000183614500009					2021-06-18	
J	Krautstrunk, M; Scholtes, F; Martin, D; Schoenen, J; Schmitt, AB; Plate, D; Nacimiento, W; Noth, J; Brook, GA				Krautstrunk, M; Scholtes, F; Martin, D; Schoenen, J; Schmitt, AB; Plate, D; Nacimiento, W; Noth, J; Brook, GA			Increased expression of the putative axon growth-repulsive extracellular matrix molecule, keratan sulphate proteoglycan, following traumatic injury of the adult rat spinal cord	ACTA NEUROPATHOLOGICA			English	Article						spinal cord injury; regeneration; proteoglycan; keratan sulphate proteoglycan; extracellular matrix molecules	CENTRAL-NERVOUS-SYSTEM; CHONDROITIN-SULFATE PROTEOGLYCAN; NEURITE OUTGROWTH; INHIBITORY MOLECULES; RAMIFIED MICROGLIA; CELL-ADHESION; BRAIN INJURY; CNS INJURY; REGENERATION; ASTROCYTES	Keratan sulphate proteoglycan (KSPG) is a developmentally regulated barrier molecule, directing axonal growth during central nervous system (CNS) formation. The possible re-expression and functional significance of KSPG in preventing axon regeneration following spinal cord injury (SCI) is poorly understood. In the present investigation, the spatio-temporal expression of KSPG was studied following experimental SCI. There was no indication of sparing of axons at the lesion epicentre following severe compression injury. By 7 days post operation (p.o.) a diffuse increase of KSPG immunoreactivity (KSPG-IR) was observed in the parenchyma surrounding the lesion. This was followed by a delayed (21-28 days p.o.) and largely heterogeneous increase of KSPG-IR in the lesion epicentre, which revealed both cellular and extracellular matrix-like distribution patterns. Although no re-growth of anterogradely labelled corticospinal axons was observed, many 200-kDa neurofilament (NF)-positive axon could be detected growing into the connective tissue scar. This phase of spontaneous axonal re-growth was closely associated with a framework of glial cells (including Schwann cells from damaged local spinal nerve roots) that had migrated into the lesion site. The spontaneous nerve fibre re-growth could be detected in both KSPG-rich and KSPG-poor territories. The present data suggest that the lesion-induced up-regulation of KSPG-IR may have contributed to the lack of corticospinal axon re-growth. However, the lack of any direct spatio-temporal correlation between the distribution of raised KSPG-IR and spontaneous NF-positive axonal regeneration suggests that at least some populations of axons can resist the putative inhibitory effects of this extracellular matrix molecule.	Rhein Westfal TH Aachen, Sch Med, Dept Neurol, D-52057 Aachen, Germany; Univ Liege, Dept Neuroanat, Liege, Belgium; Univ Liege, CHU Sart Tilman, Dept Neurosurg, Liege, Belgium	Brook, GA (corresponding author), Rhein Westfal TH Aachen, Sch Med, Dept Neurol, Pauwelsstr 30, D-52057 Aachen, Germany.	Gary.Brook@RWTH-Aachen.de		MARTIN, Didier/0000-0001-7325-4958			Asher R A, 2001, Prog Brain Res, V132, P611; Asher RA, 2000, J NEUROSCI, V20, P2427; BERTOLOTTO A, 1995, DEV BRAIN RES, V86, P233, DOI 10.1016/0165-3806(95)00030-H; Bertolotto A, 1998, J NEUROIMMUNOL, V85, P69, DOI 10.1016/S0165-5728(97)00251-8; Brook GA, 2000, EUR J NEUROSCI, V12, P3224, DOI 10.1046/j.1460-9568.2000.00228.x; Brook GA, 1998, J NEUROSCI RES, V53, P51, DOI 10.1002/(SICI)1097-4547(19980701)53:1<51::AID-JNR6>3.0.CO;2-I; BROOK GA, 2000, RESTORATIVE NEUROL N, V16, P361; Bunge R P, 1997, Adv Neurol, V72, P305; Calingasan NY, 1996, J NEUROL SCI, V144, P21, DOI 10.1016/S0022-510X(96)00189-X; COLE GJ, 1991, NEURON, V7, P1007, DOI 10.1016/0896-6273(91)90345-Z; Davies SJA, 1997, NATURE, V390, P680; Davies SJA, 1999, J NEUROSCI, V19, P5810, DOI 10.1523/JNEUROSCI.19-14-05810.1999; DIETZ V, 1995, ANN NEUROL, V37, P574, DOI 10.1002/ana.410370506; Dou CL, 1995, J NEUROSCI, V15, P8053; Fernaud-Espinosa I, 1998, J NEUROBIOL, V36, P16, DOI 10.1002/(SICI)1097-4695(199807)36:1<16::AID-NEU2>3.0.CO;2-D; Fitch MT, 1997, EXP NEUROL, V148, P587, DOI 10.1006/exnr.1997.6701; FRISEN J, 1992, P NATL ACAD SCI USA, V89, P11282, DOI 10.1073/pnas.89.23.11282; GIORDANA MT, 1994, NEUROPATH APPL NEURO, V20, P163, DOI 10.1111/j.1365-2990.1994.tb01175.x; Hirsch S, 1999, GLIA, V26, P36, DOI 10.1002/(SICI)1098-1136(199903)26:1<36::AID-GLIA4>3.0.CO;2-C; Jander S, 2000, GLIA, V30, P401, DOI 10.1002/(SICI)1098-1136(200006)30:4<401::AID-GLIA90>3.0.CO;2-6; Jander S, 1996, GLIA, V18, P255, DOI 10.1002/(SICI)1098-1136(199611)18:3<255::AID-GLIA9>3.0.CO;2-Y; Jander S, 1996, AM J PATHOL, V148, P71; Johansson CB, 1999, CELL, V96, P25, DOI 10.1016/S0092-8674(00)80956-3; Kakulas B A, 1984, Cent Nerv Syst Trauma, V1, P117; Lander A D, 1993, Curr Opin Neurobiol, V3, P716, DOI 10.1016/0959-4388(93)90143-M; LAYWELL ED, 1991, ANN NY ACAD SCI, V633, P122; LAYWELL ED, 1992, P NATL ACAD SCI USA, V89, P2634, DOI 10.1073/pnas.89.7.2634; Lemons ML, 1999, EXP NEUROL, V160, P51, DOI 10.1006/exnr.1999.7184; LEVINE JM, 1994, J NEUROSCI, V14, P4716; MARGOLIS RK, 1993, EXPERIENTIA, V49, P429, DOI 10.1007/BF01923587; MARTIN D, 1992, J NEUROSCI RES, V32, P539, DOI 10.1002/jnr.490320409; MCKEON RJ, 1991, J NEUROSCI, V11, P3398; MCKEON RJ, 1995, EXP NEUROL, V136, P32, DOI 10.1006/exnr.1995.1081; Moon LDF, 2001, NAT NEUROSCI, V4, P465; PALLINI R, 1988, J NEUROSURG, V68, P124, DOI 10.3171/jns.1988.68.1.0124; Pasterkamp RJ, 1999, MOL CELL NEUROSCI, V13, P143, DOI 10.1006/mcne.1999.0738; Schnell L, 1999, EUR J NEUROSCI, V11, P3648, DOI 10.1046/j.1460-9568.1999.00792.x; Schwab ME, 1996, PHYSIOL REV, V76, P319; SMITHTHOMAS LC, 1995, J CELL SCI, V108, P1307; SNOW DM, 1990, DEV BIOL, V138, P359, DOI 10.1016/0012-1606(90)90203-U; SNOW DM, 1990, EXP NEUROL, V109, P111, DOI 10.1016/S0014-4886(05)80013-5; Stichel CC, 1999, EUR J NEUROSCI, V11, P632, DOI 10.1046/j.1460-9568.1999.00466.x; Stichel CC, 1999, NEUROSCIENCE, V93, P321, DOI 10.1016/S0306-4522(99)00112-8	43	17	18	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0001-6322	1432-0533		ACTA NEUROPATHOL	Acta Neuropathol.	DEC	2002	104	6					592	600		10.1007/s00401-002-0589-6			9	Clinical Neurology; Neurosciences; Pathology	Neurosciences & Neurology; Pathology	621EA	WOS:000179574500002	12410380				2021-06-18	
J	Simpson, A; Schmitter-Edgecombe, M				Simpson, A; Schmitter-Edgecombe, M			Prediction of employment status following traumatic brain injury using a behavioural measure of frontal lobe functioning	BRAIN INJURY			English	Article							ECOLOGICAL VALIDITY; REHABILITATION; ACTIVATION; RETURN; WORK	Objective: To examine whether a behavioural measure of frontal lobe functioning, the Brock Adaptive Functioning Questionnaire (BAFQ), could predict employment status following traumatic brain injury (TBI). Design: A discriminant function analysis was conducted to determine the ability of the BAFQ, along with other factors, to predict occupational status post-injury. Methods: Sixty-one TBI survivors completed a background information questionnaire, the BAFQ, and an employment status rating scale. Results: A factor analysis of the BAFQ sub-scales revealed two factors, one related to functioning in the orbitofrontal area, and one related to dorsolateral frontal lobe functioning. These two factors, along with background information, were entered into a discriminant function analysis, revealing a 77.4% accuracy rate in predicting occupational status post-injury. Conclusions: Demographic variables were found to differentiate employed from unemployed survivors. The BAFQ appeared useful in differentiating survivors who may return to their pre-injury employment level from those who may require modified employment.	Washington State Univ, Dept Psychol, Pullman, WA 99164 USA	Simpson, A (corresponding author), Oregon Hlth & Sci Univ, Child Dev & Rehabil Ctr, POB 574, Portland, OR 97207 USA.	simpso-na@ohsu.edu			NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R03HD35838] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R03HD035838] Funding Source: NIH RePORTER		Bowman ML, 1996, CLIN NEUROPSYCHOL, V10, P382, DOI 10.1080/13854049608406699; BUTLER RW, 1989, CLIN NEUROPSYCHOL, V3, P235; Casey BJ, 1997, J COGNITIVE NEUROSCI, V9, P835, DOI 10.1162/jocn.1997.9.6.835; CHANG SW, 1999, DISS ABSTR INT B, V59, P3684; Cifu DX, 1997, ARCH PHYS MED REHAB, V78, P125, DOI 10.1016/S0003-9993(97)90252-5; Cornette L, 2001, CEREB CORTEX, V11, P59, DOI 10.1093/cercor/11.1.59; DIKMEN SS, 1994, ARCH NEUROL-CHICAGO, V51, P177, DOI 10.1001/archneur.1994.00540140087018; Drake AI, 2000, J HEAD TRAUMA REHAB, V15, P1103, DOI 10.1097/00001199-200010000-00004; Dywan J, 1996, J HEAD TRAUMA REHAB, V11, P79, DOI 10.1097/00001199-199604000-00008; DYWAN J, 1995, J INT NEUROPSYCH SOC, V1, P121; FABIANO RJ, 1995, REHABIL PSYCHOL, V40, P223, DOI 10.1037/0090-5550.40.3.223; FISHBEIN D, 2000, SCI TREATMENT PREVEN; Fleming J, 1999, BRAIN INJURY, V13, P417; Greenspan AI, 1996, BRAIN INJURY, V10, P207, DOI 10.1080/026990596124520; Groom KN, 1998, ARCH CLIN NEUROPSYCH, V13, P695, DOI 10.1016/S0887-6177(98)00005-5; Johnson SC, 2001, J INT NEUROPSYCH SOC, V7, P55, DOI 10.1017/S135561770171106X; Kaplan S. P., 1988, J APPLIED REHABILITA, V19, P3; Kibby MY, 1998, ARCH CLIN NEUROPSYCH, V13, P523, DOI 10.1016/S0887-6177(97)00038-3; Kolb B., 1996, FUNDAMENTALS HUMAN N; LAM CS, 1991, REHABIL COUNS BULL, V35, P68; Leahy BJ, 1998, BRAIN INJURY, V12, P1025, DOI 10.1080/026990598121936; Lezak MD, 1995, NEUROPSYCHOLOGICAL A; NEWNAN OS, 1978, PERCEPT MOTOR SKILL, V46, P635, DOI 10.2466/pms.1978.46.2.635; Nunnally J. C., 1994, PSYCHOMETRIC THEORY; Pietrini P, 2000, AM J PSYCHIAT, V157, P1772, DOI 10.1176/appi.ajp.157.11.1772; Possl O, 2001, BRAIN INJURY, V15, P15; RAY JJ, 1987, PERS INDIV DIFFER, V8, P571, DOI 10.1016/0191-8869(87)90220-0; ROSS P, 2000, DISS ABSTR INT B, V61, P3319; RUFF RM, 1993, BRAIN INJURY, V7, P101, DOI 10.3109/02699059309008164; Sarazin M, 1998, NEUROLOGY, V51, P142, DOI 10.1212/WNL.51.1.142; SEIDMAN LJ, 1995, NEUROPSYCHOLOGY, V9, P481; SQUIRE LR, 1986, SCIENCE, V232, P1612, DOI 10.1126/science.3086978; STUSS DT, 1987, FRONTAL LOBES REVIS; Thomas DF, 1997, J HEAD TRAUMA REHAB, V12, P72, DOI 10.1097/00001199-199710000-00007; Wechsler D, 2008, WECHSLER ADULT INTEL, V4th; Wechsler D., 1955, MANUAL WECHSLER ADUL; Wong Pauline P., 1993, Brain Injury, V7, P283, DOI 10.3109/02699059309034955	37	17	17	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	DEC	2002	16	12					1075	1091		10.1080/02699050210155249			17	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	617KK	WOS:000179360700006	12487722				2021-06-18	
J	Eng, N; Obler, LK				Eng, N; Obler, LK			Acquired dyslexia in a biscript reader following traumatic brain injury: A second case	TOPICS IN LANGUAGE DISORDERS			English	Article						alexia; biscriptal; character; logographic; orthographic	CHINESE; PERCEPTION; TONE	This case study examines the reading disruptions in a bilingual/biscriptal (Cantonese/English) reader following traumatic brain injury. Reading disruptions following brain injury are termed acquired dyslexia and alexia. Because of their unique ability to read in two different scripts, biscript readers with acquired dyslexia pose unique questions to neurolinguists and psychologists. These readers possess two orthographic systems and thus allow the opportunity to explore the biscriptal lexicon. Additionally, when particular readers' two scripts are marked differently, as in the case of an alphabetic script and a logographic script, questions regarding word-recognition processes can be explored.	St Johns Univ, Dept Speech Commun Sci & Theatre, Jamaica, NY 11439 USA; CUNY, Grad Sch & Univ Ctr, New York, NY 10021 USA	Eng, N (corresponding author), St Johns Univ, Dept Speech Commun Sci & Theatre, Jamaica, NY 11439 USA.						Albert M.L., 1978, BILINGUAL BRAIN NEUR; Chao YuenRen., 1968, GRAMMAR SPOKEN CHINE; COLTHEART M, 1984, ORTHOGRAPHIES READIN; Coltheart M., 1980, DEEP DYSLEXIA; EHRLICH J, 1988, AM SPEECH HEAR ASS A; Eng N, 1996, APHASIOLOGY, V10, P649, DOI 10.1080/02687039608248441; ENG N, 1998, ADV STUD I NEUR COGN; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Francis W. N., 1982, FREQUENCY ANAL ENGLI; GANDOUR J, 1988, BRAIN LANG, V35, P201, DOI 10.1016/0093-934X(88)90109-5; GORAL M, 2001, J NEUROLINGUIST, V14, P321; Kaplan E., 1983, BOSTON NAMING TEST; KARANTH P, 1992, READ WRIT, V4, P87; Kroll JF., 2001, ONE MIND, P49; LIM V, 1998, 1 AS PAC COMM DIS C; LYMAN R. S., 1938, CHINESE MED JOUR, V54, P491; McNeil M. R., 1978, REVISED TOKEN TEST; OBLER LK, 1984, NEUROPSYCHOLOGIA, V22, P235, DOI 10.1016/0028-3932(84)90066-6; Perfetti CA, 1998, J EXP PSYCHOL LEARN, V24, P101, DOI 10.1037/0278-7393.24.1.101; Sasanuma S, 1972, Cortex, V8, P265; Sasanuma S., 1980, DEEP DYSLEXIA, P48; SUEN YS, 1986, MOST FREQUENT CHINES; Tzeng OJL, 1992, LANGUAGE PROCESSING, P3, DOI 10.1016/s0166-4115(08)61885-3; Weekes BS, 1998, APHASIOLOGY, V12, P77, DOI 10.1080/02687039808249445; Weekes BS, 1997, NEUROCASE, V3, P51, DOI 10.1080/13554799708404034; YIN WG, 1992, LANGUAGE PROCESSING, P349	26	17	17	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0271-8294			TOP LANG DISORD	Top. Lang. Disord.	NOV	2002	22	5					5	19		10.1097/00011363-200211000-00005			15	Linguistics; Rehabilitation	Linguistics; Rehabilitation	612HR	WOS:000179068800005					2021-06-18	
J	Steinmeier, R; Hofmann, RP; Bauhuf, C; Hubner, U; Fahlbusch, R				Steinmeier, R; Hofmann, RP; Bauhuf, C; Hubner, U; Fahlbusch, R			Continuous cerebral autoregulation monitoring by cross-correlation analysis	JOURNAL OF NEUROTRAUMA			English	Article						cerebral autoregulation; computer algorithm; continuous neuromonitoring; cross-correlation; traumatic brain injury	HEAD-INJURED PATIENTS; BLOOD-FLOW AUTOREGULATION; EXPERIMENTAL SUBARACHNOID HEMORRHAGE; LASER-DOPPLER FLOWMETRY; INTRACRANIAL-PRESSURE; CEREBROVASCULAR RESISTANCE; PHASE RELATIONSHIP; OXYGEN-SATURATION; VELOCITY; DYNAMICS	In order to validate cross-correlation analysis between spontaneous slow oscillations of arterial blood pressure (aBP) and intracranial pressure (ICP) or flow velocity as a means to assess the status of cerebral autoregulation continuously, we compared its results with different autoregulation bedside tests. The second aim was to check the method's stability over longer time periods. aBP, ICP, and flow velocity in the middle cerebral artery (FVMCA) was measured continuously in 13 critically ill comatose patients. Cross-correlation analysis was performed online and offline between aBP and ICP (CC [aBP --> ICP]) and aBP/FVMCA (CC [aBP --> FVMCA]). Three different-autoregulation bedside tests (cuff deflation, transient hyperemic response, orthostatic hypotension) were performed immediately before a 29-min cross-correlation test period. In addition, continuous cross-correlation autoregulation monitoring was performed over multiple hours (in order to analyze for stability and to assess the influence of other factors). Cluster analysis revealed two main clusters. Cluster 1 (indicative for disturbed autoregulation) showed a centroid at t = -0.21 +/- 3.32 sec, r = 0.43 +/- 0.18 for CC [aBP --> ICP], and t = 0 +/- 3.14 sec, r = 0.44 +/- 0.18 for CC [aBP --> FVMCA]. Cluster 2 (indicative for normal autoregulation) revealed a centroid at t = 4.94 +/- 3.74 sec, r = -0.4 +/- 0.16 for CC [aBP --> ICP], and t = 3.38 +/- 4.44 sec, r = -0.38 +/- 0.18 for CC [aBP --> FVMCA]. Comparison between the cross-correlation test results and the bedside tests showed a sensitivity of 44-73% for CC [aBP --> FVMCA], whereas CC [aBP --> ICP] was more specific (60-80%). Long-term monitoring revealed stable cross-correlation tests in about 45% of the measurement time. It is concluded that cross-correlation between aBP, ICP, and FVMCA is a valid means to monitor the autoregulation status continuously, although further improvement of sensitivity and specificity is needed to make it reliable for clinical decision making.	Univ Erlangen Nurnberg, Dept Neurosurg, Erlangen, Germany	Steinmeier, R (corresponding author), Tech Univ Dresden, Univ Klinikum Carl Gustav Carus, Neurochirurg Klin, Fetscherstr 74, D-01307 Dresden, Germany.						AASLID R, 1989, STROKE, V20, P45, DOI 10.1161/01.STR.20.1.45; BAUHUF C, 1998, ZENTRALBL NEUROCHI S, V59, P118; BIRCH AA, 1995, STROKE, V26, P834, DOI 10.1161/01.STR.26.5.834; BOUMA GJ, 1992, J NEUROSURG, V77, P15, DOI 10.3171/jns.1992.77.1.0015; BOUMA GJ, 1992, J NEUROTRAUMA S1, V9, P333; CZOSNYKA M, 1994, ACTA NEUROCHIR, V126, P113, DOI 10.1007/BF01476419; Czosnyka M, 1996, ACTA NEUROCHIR, V138, P531, DOI 10.1007/BF01411173; Czosnyka M, 1996, STROKE, V27, P1829, DOI 10.1161/01.STR.27.10.1829; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; Czosnyka M, 1998, ACT NEUR S, V71, P74; DAFFERTSHOFER M, 1995, J CLIN ULTRASOUND, V23, P125, DOI 10.1002/jcu.1870230207; DAFFERTSHOFER M, 1991, J NEUROL SCI, V104, P32, DOI 10.1016/0022-510X(91)90212-P; DALEY ML, 1995, IEEE T BIO-MED ENG, V42, P420, DOI 10.1109/10.376137; DIEHL RR, 1995, STROKE, V26, P1801, DOI 10.1161/01.STR.26.10.1801; Diehl RR, 1998, CLIN AUTON RES, V8, P7, DOI 10.1007/BF02267598; DIEHL RR, 1997, NEW TRENDS CEREBRAL, P605; FLORENCE G, 1992, J CEREBR BLOOD F MET, V12, P674, DOI 10.1038/jcbfm.1992.92; FORTUNE JB, 1994, J NEUROSURG, V80, P461, DOI 10.3171/jns.1994.80.3.0461; Giller CA, 1997, NEUROL RES, V19, P634; GILLER CA, 1991, ACTA NEUROCHIR, V108, P7, DOI 10.1007/BF01407660; GILLER CA, 1990, NEUROSURGERY, V27, P362, DOI 10.1227/00006123-199009000-00004; HAUERBERG J, 1993, J NEUROSURG ANESTH, V5, P258; Jorgensen L G, 1995, Acta Physiol Scand Suppl, V625, P1; Junger EC, 1997, J NEUROSURG, V86, P425, DOI 10.3171/jns.1997.86.3.0425; Kiening KL, 1996, J NEUROSURG, V85, P751, DOI 10.3171/jns.1996.85.5.0751; KONTOS HA, 1978, AM J PHYSIOL, V234, P371; Lam JMK, 1997, J NEUROSURG, V86, P438, DOI 10.3171/jns.1997.86.3.0438; Lang E W, 1995, New Horiz, V3, P400; Lang EW, 2001, CRIT CARE MED, V29, P158, DOI 10.1097/00003246-200101000-00031; MARION DW, 1991, J NEUROSURG, V74, P407, DOI 10.3171/jns.1991.74.3.0407; McLaughlin MR, 1996, J NEUROSURG, V85, P871, DOI 10.3171/jns.1996.85.5.0871; NEWELL DW, 1994, STROKE, V25, P793, DOI 10.1161/01.STR.25.4.793; Newell DW, 1996, NEUROSURGERY, V39, P35, DOI 10.1097/00006123-199607000-00008; Nichols JS, 1996, J NEUROTRAUM, V13, P439, DOI 10.1089/neu.1996.13.439; Panerai RB, 1996, IEEE T BIO-MED ENG, V43, P779, DOI 10.1109/10.508541; PIPER IR, 1993, NEUROSURGERY, V32, P805, DOI 10.1227/00006123-199305000-00014; PIPER IR, 1990, J NEUROSURG, V73, P871, DOI 10.3171/jns.1990.73.6.0871; PORTNOY HD, 1982, J NEUROSURG, V56, P666, DOI 10.3171/jns.1982.56.5.0666; RASMUSSEN G, 1992, ACTA NEUROCHIR, V119, P128, DOI 10.1007/BF01541796; Sahuquillo J, 1996, ACTA NEUROCHIR, V138, P435, DOI 10.1007/BF01420306; SHARPLES PM, 1995, J NEUROL NEUROSUR PS, V58, P153, DOI 10.1136/jnnp.58.2.153; Smielewski P, 1997, J NEUROSURG, V86, P773, DOI 10.3171/jns.1997.86.5.0773; Smielewski P, 1996, STROKE, V27, P2197, DOI 10.1161/01.STR.27.12.2197; STEIGER HJ, 1994, NEUROSURGERY, V34, P79; Steinmeier R, 1996, STROKE, V27, P2236, DOI 10.1161/01.STR.27.12.2236; Steinmeier R, 2002, CRIT CARE MED, V30, P1969, DOI 10.1097/00003246-200209000-00004; Strebel S, 1997, SURG NEUROL, V47, P128, DOI 10.1016/S0090-3019(96)00459-4; TIECKS FP, 1995, STROKE, V26, P1014, DOI 10.1161/01.STR.26.6.1014; Zunker P., 1997, NEW TRENDS CEREBRAL, P718	49	17	17	0	2	MARY ANN LIEBERT INC PUBL	LARCHMONT	2 MADISON AVENUE, LARCHMONT, NY 10538 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	OCT	2002	19	10					1127	1138		10.1089/08977150260337949			12	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	605MJ	WOS:000178681400003	12427323				2021-06-18	
J	Brewer, TL; Metzger, BL; Therrien, B				Brewer, TL; Metzger, BL; Therrien, B			Trajectories of cognitive recovery following a minor brain injury	RESEARCH IN NURSING & HEALTH			English	Article						attention; minor brain injury; healing	CLOSED-HEAD INJURY; INTEGRATIVE SPATIAL ABILITY; PORTEUS MAZE TEST; PERFORMANCE; ATTENTION; SEQUELAE	Minor brain injury (MBI) is the most frequently diagnosed head trauma in the United States, with treatment costing more than $1.5 billion annually and many patients incapacitated for months following injury. The purpose of this study was to characterize the brain function disruptions associated with MBI and to determine the time trajectory of recovery, using a theoretical model of attention. Distractibility, impulsivity, irritability, and impaired executive functioning were demonstrated in all participants during the 24 hr after injury. Twenty percent of participants continued to complain of distractibility, impulsivity, and/or irritability throughout the 30-day study. Loss of consciousness was shown to confound participants' healing trajectories. These results suggest that standard emergency room treatment following MBI is inadequate and should include discharge directives to reduce cognitive demands for at least 48 hr at a minimum, for 30 days or longer for those with loss of consciousness. (C) 2002 Wiley Periodicals, Inc.	Univ Connecticut, Sch Nursing, Storrs, CT 06269 USA; Univ Michigan, Sch Nursing, Ann Arbor, MI 48109 USA	Brewer, TL (corresponding author), Univ Connecticut, Sch Nursing, 231 Glenbrook Rd,U-26, Storrs, CT 06269 USA.				NATIONAL INSTITUTE OF NURSING RESEARCHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [T32NR007074] Funding Source: NIH RePORTER; NINR NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [T32 NR07074] Funding Source: Medline		ARCIA E, 1994, BRAIN INJURY, V8, P395, DOI 10.3109/02699059409150991; BERNDT DJ, 1981, J CLIN PSYCHOL, V37, P564, DOI 10.1002/1097-4679(198107)37:3<564::AID-JCLP2270370319>3.0.CO;2-2; BERNDT DJ, 1990, MULTISCORE DEPRESSIO; BOHNEN N, 1992, J NERV MENT DIS, V180, P683, DOI 10.1097/00005053-199211000-00002; Bornstein R. A., 1993, NEUROPSYCHOLOGY, V7, P228, DOI DOI 10.1037/0894-4105.7.2.228; BORNSTEIN RA, 1986, INT J CLIN NEUROPSYC, V8, P18; BREWER T, 1998, THESIS U MICHIGAN AN; CIMPRICH B, 1993, CANCER NURS, V16, P83; Cimprich B, 1990, THESIS U MICHIGAN AN; Conners C. K., 1995, CPT CONNERS CONTINUO; CURRY LM, 1997, PHILADELPHIA HEAD IN; Deb S, 1998, J NEUROL NEUROSUR PS, V65, P899, DOI 10.1136/jnnp.65.6.899; DIKMEN SS, 1993, J HEAD TRAUMA REHAB, V8, P30, DOI DOI 10.1097/00001199-199309000-00005; GOW L, 1982, PERCEPT MOTOR SKILL, V54, P1043, DOI 10.2466/pms.1982.54.3c.1043; James W., 1985, PSYCHOL BRIEFER COUR; KAPLAN S, 1995, J ENVIRON PSYCHOL, V15, P169, DOI 10.1016/0272-4944(95)90001-2; Kolb B., 1990, FUNDAMENTALS HUMAN N; KOZIOL LF, 1992, PERCEPT MOTOR SKILL, V75, P1187, DOI 10.2466/PMS.75.8.1187-1192; Levin HS, 1989, MILD HEAD INJURY; Lewine JD, 1999, AM J NEURORADIOL, V20, P857; Lezak M.D., 1983, NEUROPSYCHOLOGICAL A; LEZAK MD, 1982, INT J PSYCHOL, V17, P281, DOI 10.1080/00207598208247445; MALCOLM CD, 1993, THESIS BOSTON U BOST; Norusis M.J., 1993, SPSS WINDOWS BASE SY; OSHAUGHNESSY EJ, 1984, J FAM PRACTICE, V18, P391; PENDLETON MG, 1982, J CLIN NEUROPSYCHOL, V4, P307, DOI 10.1080/01688638208401139; PONSFORD J, 1992, J CLIN EXP NEUROPSYC, V14, P822, DOI 10.1080/01688639208402865; Porteus S.D., 1965, PORTEUS MAZE TEST 50; ROBERTS AH, 1968, J ABNORM PSYCHOL, V73, P449, DOI 10.1037/h0026211; Salthouse T. A., 1996, J GERONTOL B-PSYCHOL, V51B, P317; SALTHOUSE TA, 1995, J GERONTOL B-PSYCHOL, V50, pP297, DOI 10.1093/geronb/50B.6.P297; SALTHOUSE TA, 1989, PSYCHOL AGING, V4, P18, DOI 10.1037/0882-7974.4.1.18; SALTHOUSE TA, 1987, PSYCHOL AGING, V2, P254, DOI 10.1037/0882-7974.2.3.254; SHUM DHK, 1990, J CLIN EXP NEUROPSYC, V12, P247, DOI 10.1080/01688639008400971; Spreen O., 1991, COMPENDIUM NEUROPSYC; Stuss D.T., 1986, FRONTAL LOBES; TUPPER D, 1984, J CLIN PSYCHOL, V6, P411; UZZELL BP, 1988, ARCH NEUROL-CHICAGO, V45, P420, DOI 10.1001/archneur.1988.00520280066017; Wolfson D., 1993, HALSTEAD REITAN NEUR	39	17	17	0	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0160-6891	1098-240X		RES NURS HEALTH	Res. Nurs. Health	AUG	2002	25	4					269	281		10.1002/nur.10045			13	Nursing	Nursing	580CU	WOS:000177217700004	12124721				2021-06-18	
J	Fraisse, A; Piechaud, JF; Avierinos, JF; Aubert, F; Colavolpe, C; Habib, G; Bonnet, JL				Fraisse, A; Piechaud, JF; Avierinos, JF; Aubert, F; Colavolpe, C; Habib, G; Bonnet, JL			Transcatheter closure of traumatic ventricular septal defect: An alternative to surgical repair?	ANNALS OF THORACIC SURGERY			English	Article								A 19-year-old-man with multiple-system injuries including a serious head injury and two poorly tolerated traumatic ventricular septal defects, was admitted to our hospital. Transcatheter closure of the cardiac defects was attempted instead of surgical repair because the required anticoagulation for cardiopulmonary bypass could precipitate intracranial bleeding. The two ventricular septal defects were successfully closed with Amplatzer devices, but the patient remained in hemodynamically unstable condition and subsequently died. Transcatheter closure of traumatic ventricular septal defect is an alternative to surgical repair, although it remains a hazardous procedure and requires experienced anesthesia management.	Hop Enfants La Timone, Serv Cardiol A, F-13005 Marseille, France; Hop Enfants La Timone, Serv Reanimat Polyvalente, F-13005 Marseille, France; Hop Enfants La Timone, Serv Chirurg Thorac & Cardiovasc, Marseille, France; Inst Hosp Jacques Cartier, Massy, France	Fraisse, A (corresponding author), Hop Enfants La Timone, Serv Cardiol A, 264 Rue St Pierre, F-13005 Marseille, France.	afraisse@mail.ap-hm.fr	miaoyue, chen/A-6575-2012				LAUSSEN PC, 1995, ANESTH ANALG, V80, P1076, DOI 10.1097/00000539-199506000-00002; LOCK JE, 1988, CIRCULATION, V78, P361, DOI 10.1161/01.CIR.78.2.361; Pretre R, 1997, NEW ENGL J MED, V336, P626, DOI 10.1056/NEJM199702273360906; Schaffer RB, 1999, ANN THORAC SURG, V67, P843, DOI 10.1016/S0003-4975(99)00044-2; Thanopoulos BD, 1999, J AM COLL CARDIOL, V33, P1395, DOI 10.1016/S0735-1097(99)00011-X	5	17	18	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0003-4975	1552-6259		ANN THORAC SURG	Ann. Thorac. Surg.	AUG	2002	74	2					582	584	PII S0003-4975(02)03607-X	10.1016/S0003-4975(02)03607-X			3	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Cardiovascular System & Cardiology; Respiratory System; Surgery	581XR	WOS:000177320600071	12173854				2021-06-18	
J	Greiffenstein, MF; Baker, WJ; Johnson-Greene, D				Greiffenstein, MF; Baker, WJ; Johnson-Greene, D			Actual versus self-reported scholastic achievement of litigating postconcussion and severe closed head injury claimants	PSYCHOLOGICAL ASSESSMENT			English	Article							RESPONSE BIAS; MMPI-2; RECALL; SCALE; INDEX	Psychologists typically rely on patients' self-report of premorbid status in litigated settings, The authors examined the fidelity between self-reported and actual scholastic performance in litigating head injury claimants. The data indicated late postconcussion syndrome (LPCS) and severe closed head injury litigants retrospectively inflated scholastic performance to a greater degree than nonlitigating control groups. The LPCS group showed the highest magnitude of grade inflation, but discrepancy scores did not significantly correlate with a battery of malingering measures or with objective cerebral dysfunction. These findings support previous studies, which showed self-report is not a reliable basis for estimation of preinjury cognitive status. Retrospective inflation may represent a response shift bias shaped by an adversarial context rather than a form of malingering.	Psychol Syst Inc, Royal Oak, MI 48067 USA; Johns Hopkins Univ, Sch Med, Dept Phys Med & Rehabil, Baltimore, MD 21218 USA	Greiffenstein, MF (corresponding author), Psychol Syst Inc, 26862 Woodward,Suite 103, Royal Oak, MI 48067 USA.	mfg@neuro-psychology.com					Arbisi PA, 1997, PSYCHOL ASSESSMENT, V9, P102, DOI 10.1037/1040-3590.9.2.102; BARONA A, 1984, J CONSULT CLIN PSYCH, V52, P885, DOI 10.1037/0022-006X.52.5.885; BREWIN CR, 1993, PSYCHOL BULL, V113, P82, DOI 10.1037/0033-2909.113.1.82; BUTCHER JN, 1992, ESSENTIALS MMPI2 MMP; BUTCHER JN, 1989, MMPI2 MANUAL ADM SCO; COLLINS LM, 1985, APPL PSYCH MEAS, V9, P301, DOI 10.1177/014662168500900308; DALTON JE, 1989, PSYCHOL ASSESSMENT, V1, P56, DOI DOI 10.1037/1040-3590.1.1.56; Gosling SD, 1998, J PERS SOC PSYCHOL, V74, P1337, DOI 10.1037/0022-3514.74.5.1337; GREENE R, 1991, MMPI MMPI2 INTERPRET; Greiffenstein M F, 1996, J Int Neuropsychol Soc, V2, P477; Greiffenstein M.F., 1994, PSYCHOL ASSESSMENT, V6, P218, DOI [https://doi.org/10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; GREIFFENSTEIN MF, 1995, CLIN NEUROPSYCHOL, V9, P230, DOI 10.1080/13854049508400485; Greiffenstein MF, 2001, CLIN NEUROPSYCHOL, V15, P162, DOI 10.1076/clin.15.2.162.1895; GREIFFENSTEIN MF, 2001, J INT NEUROPSYCH SOC, V7, P181; HARRISON DA, 1994, J APPL PSYCHOL, V79, P240, DOI 10.1037/0021-9010.79.2.240; Haynes R, 1997, J EPIDEMIOL COMMUN H, V51, P283, DOI 10.1136/jech.51.3.283; Heaton R.K., 1991, COMPREHENSIVE NORMS; Henry B., 1994, PSYCHOL ASSESSMENT, V6, P92, DOI [DOI 10.1037/1040-3590.6.2.92, 10.1037/1040-3590.6.2.92]; Hilsabeck RC, 1998, J CLIN EXP NEUROPSYC, V20, P328, DOI 10.1076/jcen.20.3.328.813; HOFFMAN BF, 1986, AM J PSYCHIAT, V143, P1488; HYER L, 1989, J CLIN PSYCHOL, V45, P250, DOI 10.1002/1097-4679(198903)45:2<250::AID-JCLP2270450211>3.0.CO;2-N; JOHNSONGREENE D, 1995, ARCH CLIN NEUROPSYCH, V10, P251, DOI 10.1016/0887-6177(94)00043-P; JohnsonGreene D, 1997, ARCH CLIN NEUROPSYCH, V12, P635, DOI 10.1016/S0887-6177(96)00046-7; Kruger J, 1999, J PERS SOC PSYCHOL, V77, P1121, DOI 10.1037/0022-3514.77.6.1121; Kruger J, 1999, J PERS SOC PSYCHOL, V77, P221, DOI 10.1037/0022-3514.77.2.221; Larrabee GJ, 1998, CLIN NEUROPSYCHOL, V12, P179, DOI 10.1076/clin.12.2.179.2008; LEESHALEY PR, 1991, PSYCHOL REP, V68, P203, DOI 10.2466/PR0.68.1.203-210; LeesHaley PR, 1996, PSYCHOL REP, V79, P811, DOI 10.2466/pr0.1996.79.3.811; LeesHaley PR, 1997, BRAIN INJURY, V11, P791; Lezak MD, 1995, NEUROPSYCHOLOGICAL A; Meyers JE, 1998, ASSESSMENT, V5, P303, DOI 10.1177/107319119800500309; MITTENBERG W, 1992, J NEUROL NEUROSUR PS, V55, P200, DOI 10.1136/jnnp.55.3.200; *NAT CTR ED STAT, 2001, COMM COR DAT INF PUB; Rogers R, 1998, LAW HUMAN BEHAV, V22, P273, DOI 10.1023/A:1025702405865; ROGERS R, 1990, PROF PSYCHOL-RES PR, V21, P182; Rogers R., 1997, CLIN ASSESSMENT MALI, V2nd; SHEPPARD BH, 1980, J PERS SOC PSYCHOL, V39, P320; SPREEN O, 1998, COMPENDIUM NEUORPSYC; Tombaugh TN, 1997, PSYCHOL ASSESSMENT, V9, P260, DOI 10.1037/1040-3590.9.3.260; van den Brink M, 2001, HEADACHE, V41, P11, DOI 10.1046/j.1526-4610.2001.111006011.x; WELTE JW, 1993, ALCOHOL CLIN EXP RES, V17, P758, DOI 10.1111/j.1530-0277.1993.tb00836.x; Youngjohn JR, 1997, PSYCHOL ASSESSMENT, V9, P177, DOI 10.1037/1040-3590.9.3.177	42	17	17	1	4	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	1040-3590	1939-134X		PSYCHOL ASSESSMENT	Psychol. Assess.	JUN	2002	14	2					202	208		10.1037//1040-3590.14.2.202			7	Psychology, Clinical	Psychology	555JL	WOS:000175790900009	12056082				2021-06-18	
J	Hertel, M; Braun, S; Durka, S; Alzheimer, C; Werner, S				Hertel, M; Braun, S; Durka, S; Alzheimer, C; Werner, S			Upregulation and activation of the Nrf-1 transcription factor in the lesioned hippocampus	EUROPEAN JOURNAL OF NEUROSCIENCE			English	Article						brain; heme oxygenase; kainic acid; reactive oxygen species	ANTIOXIDANT RESPONSIVE ELEMENTS; KAINATE-MEDIATED EXCITOTOXICITY; NMDA RECEPTOR ACTIVATION; HEME OXYGENASE-1; CELL-DEATH; IN-VIVO; EXPRESSION; INDUCTION; PROTEINS; BINDING	The Nrf-1 and Nrf-2 transcription factors play a pivotal role in the cellular defence against the toxic effects of reactive oxygen species (ROS). Although ROS are key effectors of neuronal death after ischaemic and traumatic brain injury, it is not known whether Nrf-1 and Nrf-2 are involved in neuroprotective signalling. Here, we analysed the temporal and spatial expression pattern of Nrf-1 and Nrf-2 after unilateral excitotoxic lesion of mouse hippocampus. In marked contrast to previous in vitro studies, where upregulation of these transcription factors on the mRNA level was never detected, we found a strong induction of Nrf-1 mRNA and protein expression in neurons of the lesioned hippocampus, accompanied by a weak elevation of Nrf-2 mRNA levels. Nrf-1 predominantly localized to the nucleus in the injured hippocampus. Furthermore, expression of the cytoprotective enzyme, heme oxygenase-1, a major target of Nrf-1 and Nrf-2 action, was coregulated with Nrf-1 in the same hippocampal neurons, suggesting that Nrf-1 is functionally active. Because Nrf-1 and Nrf-2 are potent inducers of various cytoprotective proteins, our data suggest a role of Nrf-1 and Nrf-2 in neuronal survival after acute brain injury.	Swiss Fed Inst Technol, Inst Cell Biol, Dept Biol, CH-8093 Zurich, Switzerland; Univ Munich, Inst Physiol, D-80539 Munich, Germany	Werner, S (corresponding author), Swiss Fed Inst Technol, Inst Cell Biol, Dept Biol, CH-8093 Zurich, Switzerland.	Sabine.werner@cell.biol.ethz.ch		Werner, Sabine/0000-0001-7397-8710			ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; Bast A, 1997, NEUROPROTECTION CNS, P147; Ben-Ari Y, 2000, TRENDS NEUROSCI, V23, P580, DOI 10.1016/S0166-2236(00)01659-3; Boldyrev A, 2000, CELL MOL NEUROBIOL, V20, P433, DOI 10.1023/A:1007066913756; Chan JY, 1998, EMBO J, V17, P1779, DOI 10.1093/emboj/17.6.1779; Chan KM, 1999, P NATL ACAD SCI USA, V96, P12731, DOI 10.1073/pnas.96.22.12731; Dong Z, 2000, AM J PATHOL, V156, P1485, DOI 10.1016/S0002-9440(10)65019-5; Elbirt KK, 1999, P ASSOC AM PHYSICIAN, V111, P438; GORSKI K, 1986, CELL, V47, P767, DOI 10.1016/0092-8674(86)90519-2; GUNASEKAR PG, 1995, J NEUROCHEM, V65, P2016; Hanselmann C, 2001, BIOCHEM J, V353, P459, DOI 10.1042/0264-6021:3530459; Ishii T, 2000, J BIOL CHEM, V275, P16023, DOI 10.1074/jbc.275.21.16023; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Kwong M, 1999, J BIOL CHEM, V274, P37491, DOI 10.1074/jbc.274.52.37491; Matsuoka Y, 1998, NEUROSCIENCE, V85, P1223, DOI 10.1016/S0306-4522(97)00678-7; Nakaso K, 1999, BIOCHEM BIOPH RES CO, V259, P91, DOI 10.1006/bbrc.1999.0724; Nakaso K, 1999, MOL BRAIN RES, V69, P155, DOI 10.1016/S0169-328X(99)00093-5; Nakaso K, 2000, NEUROSCI LETT, V282, P57, DOI 10.1016/S0304-3940(00)00836-3; PRESKORN SH, 1995, PRINCIPLES PRACTICE, V1, P1; REYNOLDS IJ, 1995, J NEUROSCI, V15, P3318, DOI 10.1523/jneurosci.15-05-03318.1995; Tretter YP, 2000, NAT MED, V6, P812, DOI 10.1038/77548; Tretter YP, 1996, NEUROREPORT, V7, P1819, DOI 10.1097/00001756-199607290-00026; Venugopal R, 1998, ONCOGENE, V17, P3145, DOI 10.1038/sj.onc.1202237; Wasserman WW, 1997, P NATL ACAD SCI USA, V94, P5361, DOI 10.1073/pnas.94.10.5361; WERNER S, 1992, P NATL ACAD SCI USA, V89, P6896, DOI 10.1073/pnas.89.15.6896	25	17	18	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0953-816X	1460-9568		EUR J NEUROSCI	Eur. J. Neurosci.	MAY	2002	15	10					1707	1711		10.1046/j.1460-9568.2002.01992.x			5	Neurosciences	Neurosciences & Neurology	561FB	WOS:000176128600015	12059978				2021-06-18	
J	Young, RJ; Destian, S				Young, RJ; Destian, S			Imaging of traumatic intracranial hemorrhage	NEUROIMAGING CLINICS OF NORTH AMERICA			English	Article							ACUTE EPIDURAL HEMATOMA; DIFFUSE AXONAL INJURY; SEVERE HEAD-INJURY; INTRAVENTRICULAR HEMORRHAGE; BRAIN INJURY; SUBARACHNOID HEMORRHAGE; EXTRADURAL HEMATOMAS; COMPUTED-TOMOGRAPHY; FIELD MR; CT	Traumatic intracranial hemorrhage is a leading cause of morbidity and mortality in the United States. CT remains the primary imaging modality for initial evaluation of patients who have sustained head trauma. MR imaging, which has always been important for the evaluation of subacute and chronic head trauma, has been gaining popularity and recognition as an alternative primary imaging modality.	St Lukes Roosevelt Hosp, Dept Radiol, New York, NY 10019 USA; St Vincent Catholic Med Ctr, Dept Radiol, Manhattan Div, New York, NY 10011 USA	Young, RJ (corresponding author), St Lukes Roosevelt Hosp, Dept Radiol, 1000 10th Ave, New York, NY 10019 USA.						Abraszko RA, 1995, BRIT J NEUROSURG, V9, P769, DOI 10.1080/02688699550040747; Atlas SW, 1998, AM J NEURORADIOL, V19, P1471; Bakshi R, 1999, AM J NEURORADIOL, V20, P629; BARKOVICH AJ, 1988, RADIOL CLIN N AM, V26, P801; Blankenberg FG, 1996, RADIOLOGY, V199, P253, DOI 10.1148/radiology.199.1.8633155; *CDCP, 2000, EP TRAUM BRAIN INJ U, P1; CORDOBES F, 1983, J NEUROSURG, V58, P217, DOI 10.3171/jns.1983.58.2.0217; EBISU T, 1989, RADIOLOGY, V171, P449, DOI 10.1148/radiology.171.2.2704810; FUJITSU K, 1988, NEUROSURGERY, V23, P423, DOI 10.1227/00006123-198810000-00003; GENTRY LR, 1988, AM J ROENTGENOL, V150, P673, DOI 10.2214/ajr.150.3.673; GENTRY LR, 1988, AM J NEURORADIOL, V9, P1129; GENTRY LR, 1988, AM J ROENTGENOL, V150, P663, DOI 10.2214/ajr.150.3.663; GENTRY LR, 1994, RADIOLOGY, V191, P1; GOMORI JM, 1985, RADIOLOGY, V157, P87, DOI 10.1148/radiology.157.1.4034983; GREENE KA, 1995, J NEUROSURG, V83, P445, DOI 10.3171/jns.1995.83.3.0445; GURDJIAN ES, 1976, J TRAUMA, V16, P35, DOI 10.1097/00005373-197601000-00005; GUTMAN MB, 1992, J NEUROSURG, V77, P9, DOI 10.3171/jns.1992.77.1.0009; GUTMAN MB, 1991, J TRAUMA, V31, P974, DOI 10.1097/00005373-199107000-00016; HAMILTON M, 1992, AM J NEURORADIOL, V13, P853; HAYMAN LA, 1989, AM J ROENTGENOL, V153, P135, DOI 10.2214/ajr.153.1.135; Hofman PAM, 2001, AM J NEURORADIOL, V22, P441; ICHISE M, 1994, J NUCL MED, V35, P217; Jones TR, 2001, RADIOLOGY, V219, P750, DOI 10.1148/radiology.219.3.r01jn47750; LEE JP, 1991, J TRAUMA, V31, P376, DOI 10.1097/00005373-199103000-00011; LEROUX PD, 1992, NEUROSURGERY, V31, P678, DOI 10.1227/00006123-199210000-00010; Li J, 2001, LANCET, V357, P771, DOI 10.1016/S0140-6736(00)04163-5; Liang LX, 1999, AM J NEURORADIOL, V20, P1527; Liu AY, 1999, AM J NEURORADIOL, V20, P1636; MARTIN NA, 1995, J NEUROTRAUM, V12, P897, DOI 10.1089/neu.1995.12.897; MITTL RL, 1994, AM J NEURORADIOL, V15, P1583; NEW PFJ, 1976, RADIOLOGY, V121, P635, DOI 10.1148/121.3.635; OSBORN AG, 1994, DIAGNOSTIC NEURORADI, P199; Patel R, 2000, METH MOLEC MED, V48, P3; Paterakis K, 2000, J TRAUMA, V49, P1071, DOI 10.1097/00005373-200012000-00016; PETERSEN OF, 1984, NEURORADIOLOGY, V26, P285; POZZATI E, 1986, NEUROSURGERY, V18, P696, DOI 10.1227/00006123-198606000-00003; SAKAI H, 1988, J NEUROSURG, V68, P566, DOI 10.3171/jns.1988.68.4.0566; Singer MB, 1998, RADIOLOGY, V208, P417, DOI 10.1148/radiology.208.2.9680570; SMITH HK, 1991, NEUROSURGERY, V29, P258, DOI 10.1227/00006123-199108000-00016; Sullivan TP, 1999, AM J NEURORADIOL, V20, P107; Thurman DA, 1999, TRAUMATIC BRAIN INJU, P1; *US BUR CENS, 2000, VIT STAT, V63; WILBERGER JE, 1990, NEUROSURGERY, V27, P208, DOI 10.1227/00006123-199008000-00006; ZIMMERMAN RA, 1982, RADIOLOGY, V144, P809, DOI 10.1148/radiology.144.4.7111729; ZIMMERMAN RA, 1999, CRANIAL MRI CT, P435; Zwimpfer TJ, 1997, J NEUROSURG, V86, P433, DOI 10.3171/jns.1997.86.3.0433	46	17	17	1	1	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399 USA	1052-5149			NEUROIMAG CLIN N AM	Neuroimaging Clin. N. Am.	MAY	2002	12	2					189	+	PII S1052-5149(02)00003-5	10.1016/S1052-5149(02)00003-5			17	Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	609GA	WOS:000178894200004	12391631				2021-06-18	
J	Erdogan, E; Gonul, E; Seber, N				Erdogan, E; Gonul, E; Seber, N			Craniocerebral gunshot wounds	NEUROSURGERY QUARTERLY			English	Article						craniocerebral injury; prognostic factor; gunshot wound	INTRACRANIAL BONE FRAGMENTS; MISSILE HEAD WOUNDS; RETROSPECTIVE ANALYSIS; PENETRATING WOUNDS; FOREIGN-BODIES; BRAIN; INJURIES; MANAGEMENT; VIETNAM; TRAUMA	Cranial gunshot wounds frequently produce devastating injuries to central nervous system (CNS) structures. Surgical therapy and primary and secondary debridement, including repair of dural defects and removal of retained intracranial bone and metal fragments, were applied to 374 cranial gunshot wound victims at Gulhane Military Medical School in Turkey from 1992 to 1999. Dural defects were closed primarily or with temporalis fascia, pericranium, and cadaver grafts. Central nervous system infections were mostly observed in cases with cerebrospinal fluid (CSF) fistulas. All patients underwent computed tomography (CT) scans periodically. In 119 of 374 (32%) patients, bone and metal fragments were determined on control CT scans. We also performed angiography in some patients to reveal traumatic vascular pathologic findings. Most of the deaths in this group of patients were attributed to the direct effects of brain injury and occurred within the first month after injury. Fragments retained after the first debridement were followed periodically by CT scan. Surgery was not performed until infection developed. Retained fragments did not increase the infection risk, but high rates of infection did occur in cases with CSF fistulas. The presence of diffuse brain damage, brainstem. injury, CNS infection, or ventricular injury was associated with a poor outcome.	Gulhane Mil Med Acad, Dept Neurosurg, TR-06018 Ankara, Turkey		ersinerdogan@usa.net					AARABI B, 1987, NEUROSURGERY, V20, P610, DOI 10.1227/00006123-198704000-00018; AARABI B, 1989, NEUROSURGERY, V25, P923, DOI 10.1227/00006123-198912000-00011; AARABI B, 1988, NEUROSURGERY, V22, P1056, DOI 10.1227/00006123-198806010-00014; ABE T, 1986, EUR NEUROL, V25, P233, DOI 10.1159/000116013; ACHRAM M, 1980, BRIT J RADIOL, V53, P1144, DOI 10.1259/0007-1285-53-636-1144; ALLEN MB, 1995, ESSENTIALS NEUROSURG, P285; AMATO JJ, 1972, J CARDIOVASC SURG, V13, P147; BARNETT JC, 1955, J NEUROSURG, V12, P34, DOI 10.3171/jns.1955.12.1.0034; Bayston R, 2000, LANCET, V355, P1813, DOI 10.1016/S0140-6736(00)02275-3; BECKER DP, 1977, J NEUROSURG, V47, P491, DOI 10.3171/jns.1977.47.4.0491; BECKER DP, 1990, NEUROLOGICAL SURG, P2017; BRADLEY WG, 1986, MAGNETIC RESONANCE A; BRANDVOLD B, 1990, J NEUROSURG, V72, P15, DOI 10.3171/jns.1990.72.1.0015; BUTLER EG, 1945, J NEUROSURG, V2, P358, DOI 10.3171/jns.1945.2.4.0358; CAREY ME, 1971, J NEUROSURG, V34, P145, DOI 10.3171/jns.1971.34.2part1.0145; CAREY ME, 1974, J NEUROSURG, V41, P542, DOI 10.3171/jns.1974.41.5.0542; CAVENESS WF, 1979, J NEUROSURG, V50, P545, DOI 10.3171/jns.1979.50.5.0545; CLARK WC, 1986, J NEUROSURG, V65, P9, DOI 10.3171/jns.1986.65.1.0009; COOPER PR, 1979, NEUROSURGERY, V4, P373, DOI 10.1227/00006123-197905000-00001; COPLEY I B, 1991, British Journal of Neurosurgery, V5, P43, DOI 10.3109/02688699108998446; CROCKARD HA, 1977, J NEUROSURG, V46, P776, DOI 10.3171/jns.1977.46.6.0776; CRONE KR, 1986, SURG NEUROL, V25, P276, DOI 10.1016/0090-3019(86)90239-9; Cushing H, 1918, BRIT J SURG, V5, P558; DODGE PR, 1952, J NEUROSURG, V9, P472, DOI 10.3171/jns.1952.9.5.0472; ECKER AD, 1946, J NEUROSURG, V3, P1, DOI 10.3171/jns.1946.3.1.0001; EISENBERG HM, 1990, J NEUROSURG, V73, P688, DOI 10.3171/jns.1990.73.5.0688; ENZMANN DR, 1981, J NEUROSURG, V54, P304, DOI 10.3171/jns.1981.54.3.0304; FREYTAG E, 1963, ARCH PATHOL, V76, P215; FREYTAG E, 1971, PATHOL ANNU, V6, P321; Gean A, 1994, IMAGING HEAD TRAUMA; Gonul E, 1997, NEUROSURG REV, V20, P177, DOI 10.1007/BF01105561; Gonul E, 1998, OTOLARYNG HEAD NECK, V118, P559, DOI 10.1177/019459989811800421; Gonul E, 1999, MINIM INVAS NEUROSUR, V42, P207, DOI 10.1055/s-2008-1053401; GOODNIGHT SH, 1974, NEW ENGL J MED, V290, P1043, DOI 10.1056/NEJM197405092901903; GURDJIAN ES, 1950, J NEUROSURG, V7, P106, DOI 10.3171/jns.1950.7.2.0106; HADDAD FS, 1978, CAN J SURG, V21, P233; HADDAD FS, 1991, NEUROSURGERY, V28, P1; HAGAN RE, 1971, J NEUROSURG, V34, P132, DOI 10.3171/jns.1971.34.2part1.0132; HAMMON WM, 1971, J NEUROSURG, V34, P142, DOI 10.3171/jns.1971.34.2part1.0142; HAMMON WM, 1971, J NEUROSURG, V34, P127, DOI 10.3171/jns.1971.34.2part1.0127; HANIEH A, 1971, J NEUROSURG, V34, P222, DOI 10.3171/jns.1971.34.2part1.0222; HARDAWAY RM, 1978, J TRAUMA, V18, P635, DOI 10.1097/00005373-197809000-00004; HARSH GR, 1985, NEUROSURGERY, P1670; HAYNES WG, 1945, J NEUROSURG, V2, P365, DOI 10.3171/jns.1945.2.5.0365; HOPKINSON DA, 1967, BRIT J SURG, V54, P344, DOI 10.1002/bjs.1800540507; Horowitz MB, 1999, SURG NEUROL, V51, P31, DOI 10.1016/S0090-3019(98)00029-9; JACOBS GB, 1970, J NEUROSURG, V32, P642, DOI 10.3171/jns.1970.32.6.0642; JENNETT B, 1975, LANCET, V1, P480; Kaufman H H, 1991, Neurosurg Clin N Am, V2, P387; KAUFMAN HH, 1980, NEUROSURGERY, V7, P445, DOI 10.1227/00006123-198011000-00003; KAUFMAN HH, 1986, NEUROSURGERY, V18, P689, DOI 10.1227/00006123-198606000-00002; KIM PE, 1995, NEUROSURG CLIN N AM, V6, P669; KIRKPATRICK JB, 1978, J NEUROSURG, V49, P185, DOI 10.3171/jns.1978.49.2.0185; Kordestani RK, 1997, NEUROSURGERY, V41, P351, DOI 10.1097/00006123-199708000-00003; LEVY ML, 1993, NEUROSURGERY, V32, P532, DOI 10.1227/00006123-199304000-00007; LEVY ML, 1993, NEUROSURGERY, V33, P1018; MATSON DD, 1981, J NEUROSURG, V54, P44; Meirowsky A., 1965, NEUROLOGICAL SURGERY, P103; MEIROWSKY AM, 1982, J NEUROSURG, V57, P617, DOI 10.3171/jns.1982.57.5.0617; MEIROWSKY AM, 1981, J NEUROSURG, V54, P44, DOI 10.3171/jns.1981.54.1.0044; MINER ME, 1986, NEUROSURGERY, V19, P952, DOI 10.1227/00006123-198612000-00009; NINCHOJI T, 1984, ACTA NEUROCHIR, V71, P69, DOI 10.1007/BF01401152; PITLYK PJ, 1970, J NEUROSURG, V33, P19, DOI 10.3171/jns.1970.33.1.0019; RENGACHARY SS, 1994, PRINCIPLES NEUROSURG, P1; RISH BL, 1983, J NEUROSURG, V59, P775, DOI 10.3171/jns.1983.59.5.0775; RISH BL, 1981, NEUROSURGERY, V9, P535, DOI 10.1227/00006123-198111000-00008; RISH BL, 1976, MIL MED, V141, P448; ROSENWASSER RH, 1991, SURG CLIN N AM, V71, P305; SELDEN BS, 1988, ANN EMERG MED, V17, P247, DOI 10.1016/S0196-0644(88)80117-3; SHERMAN WD, 1980, WESTERN J MED, V132, P99; SHOUNG HM, 1985, ACTA NEUROCHIR, V74, P27, DOI 10.1007/BF01413272; SICCARDI D, 1991, SURG NEUROL, V35, P455, DOI 10.1016/0090-3019(91)90179-D; STRICH SJ, 1961, LANCET, V2, P443; SYKES LN, 1988, J TRAUMA, V28, P618, DOI 10.1097/00005373-198805000-00010; TANAKA T, 1988, J NEUROSURG, V69, P203, DOI 10.3171/jns.1988.69.2.0203; TSAI FY, 1978, J COMPUT ASSIST TOMO, V2, P323, DOI 10.1097/00004728-197807000-00018; TSAI FY, 1984, NEURORADIOLOGY HEAD; UNGER JM, 1990, RADIOLOGY, V175, P175, DOI 10.1148/radiology.175.1.2315477; WALKER AE, 1969, HEAD INJURED MEN 15, P10; WEISS GH, 1982, ARCH NEUROL-CHICAGO, V39, P741, DOI 10.1001/archneur.1982.00510240003001; Woodburne RT., 1978, ESSENTIALS HUMAN ANA; ZIMMERMAN RA, 1978, RADIOLOGY, V127, P393, DOI 10.1148/127.2.393	82	17	18	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-6438	1534-4916		NEUROSURG QUART	Neurosurg. Q.	MAR	2002	12	1					1	18		10.1097/00013414-200203000-00001			18	Neurosciences; Surgery	Neurosciences & Neurology; Surgery	523CX	WOS:000173935500001					2021-06-18	
J	Subramanian, SK; Roszler, MH; Gaudy, B; Michael, DB				Subramanian, SK; Roszler, MH; Gaudy, B; Michael, DB			Significance of computed tomography mixed density in traumatic extra-axial hemorrhage	NEUROLOGICAL RESEARCH			English	Article						computed tomography; extra-axial hemorrhage; traumatic brain injury	HEMATOMAS; CT	Computed tomography (CT) mixed density of traumatic extra-axial hemorrhages (TEN) or the 'swirl sign' has been reported to correlate with active bleeding found at craniotomy and poor outcome. This study was done to test the hypothesis that mixed density of TEH detected by third or fourth generation CT correlated with the type of bleeding or clinical outcome. All cases of TEH operated at Detroit Receiving Hospital from 1991-1997 were reviewed for type of bleeding (active vs. not active; arterial vs. venous); Glasgow Coma Scale (severe 1-8, not severe 9-15); and Glasgow Outcome Score (1-3 poor; 4,5 good). CT density (CTD) of 51 cases with specific written documentation of bleeding type were then independently reviewed (SKS and MHR) and classified into TEH with mixed or high density. Data was analyzed using corrected Chi Square analysis, Fischer's Exact Test and Pearson's Correlation (SPSS 6.0). The Pearson Chi Square probability for correlation follows: CTD vs. active bleeding, 0.21; CTD vs. arterial, 0.41; CTD vs. severity, 0.57; and CTD vs. outcome, 0.81. No other statistical analysis identified a significant correlation, thus the null hypothesis could not be rejected. CT mixed density was not found to be correlated by more than chance with bleeding type, injury severity or outcome. Surgeon inaccuracy in documentation of bleeding type and use of later generation CT may account for the discrepancy between this and previous studies. Nevertheless, we conclude clinical exam and other published CT criteria are better indicators of injury severity and outcome.	Detroit Receiving Hosp & Univ Hlth Ctr, Dept Neurol Surg, Detroit, MI 48201 USA; Wayne State Univ, Sch Med, Dept Radiol, Detroit, MI 48202 USA; Wayne State Univ, Sch Med, Dept Neurol Surg, Detroit, MI 48202 USA; Wayne State Univ, Sch Med, Dept Anat & Cell Biol, Detroit, MI 48202 USA	Michael, DB (corresponding author), Detroit Receiving Hosp & Univ Hlth Ctr, Dept Neurol Surg, 4201 St Antoine, Detroit, MI 48201 USA.						BERGSTROM M, 1977, J COMPUT ASSIST TOMO, V1, P449, DOI 10.1097/00004728-197710000-00011; CHEE CP, 1991, NEURORADIOLOGY, V33, P152, DOI 10.1007/BF00588255; GREENBERG J, 1985, NEUROSURGERY, V17, P48, DOI 10.1227/00006123-198507000-00008; GREENBERG MS, 1997, HDB NEUROSURGERY, V1, P426; GREENBERG MS, 1997, HDB NEUROSURGERY, V2, P553; HAMILTON M, 1992, AM J NEURORADIOL, V13, P853; HELMER FA, 1968, J NEUROSURG, V29, P652, DOI 10.3171/jns.1968.29.6.0652; KAUFMAN HH, 1980, J COMPUT ASSIST TOMO, V4, P557, DOI 10.1097/00004728-198008000-00034; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; REED D, 1986, AM J NEURORADIOL, V7, P417; SMITH WP, 1981, AM J ROENTGENOL, V136, P543, DOI 10.2214/ajr.136.3.543; ZIMMERMAN RA, 1982, RADIOLOGY, V144, P809, DOI 10.1148/radiology.144.4.7111729	12	17	17	0	1	FOREFRONT PUBL GROUP	WILTON	C/O MARY J RAWLINS, 5 RIVER RD, STE 113, WILTON, CT 06897 USA	0161-6412			NEUROL RES	Neurol. Res.	MAR	2002	24	2			SI		125	128	UNSP 0161-6412/02/020125-04	10.1179/016164102101199657			4	Clinical Neurology; Neurosciences	Neurosciences & Neurology	521YR	WOS:000173869400002	11877894				2021-06-18	
J	Choy, NL; Kuys, S; Richards, M; Isles, R				Choy, NL; Kuys, S; Richards, M; Isles, R			Measurement of functional ability following traumatic brain injury using the Clinical Outcomes Variable Scale: A reliability study	AUSTRALIAN JOURNAL OF PHYSIOTHERAPY			English	Article						brain injuries; outcome assessment (health care); rehabilitation; reproducibility of results	DISABILITY RATING-SCALE; MOTOR-ASSESSMENT SCALE; STROKE PATIENTS; INTERRATER RELIABILITY; REHABILITATION; COMMUNITY; VALIDITY	This study determined the inter-tester and intra-tester reliability of physiotherapists measuring functional motor ability of traumatic brain injury clients using the Clinical Outcomes Variable Scale (COVS). To test inter-tester reliability, 14 physiotherapists scored the ability of 16 videotaped patients to execute the items that comprise the COVS. Intra-tester reliability was determined by four physiotherapists repeating their assessments after one week, and three months later. The intra-class correlation coefficients (ICC) were very high for both inter-tester reliability (ICC > 0.97 for total COVS scores, ICC > 0.93 for individual COVS items) and intra-tester reliability (ICC > 0.97). This study demonstrates that physiotherapists are reliable in the administration of the COVS.	Univ Queensland, Dept Physiotherapy, Brisbane, Qld 4072, Australia	Choy, NL (corresponding author), Univ Queensland, Dept Physiotherapy, Brisbane, Qld 4072, Australia.		Kuys, Suzanne/S-8180-2019; Kuys, Suzanne S/J-5530-2017	Kuys, Suzanne/0000-0002-6263-4223; Kuys, Suzanne S/0000-0002-6263-4223			Ashley MJ, 1997, BRAIN INJURY, V11, P677; CARR JH, 1985, PHYS THER, V65, P175, DOI 10.1093/ptj/65.2.175; Collen F M, 1990, Int Disabil Stud, V12, P6; COLLIN C, 1990, J NEUROL NEUROSUR PS, V53, P576, DOI 10.1136/jnnp.53.7.576; Corrigan JD, 1997, ARCH PHYS MED REHAB, V78, P828, DOI 10.1016/S0003-9993(97)90195-7; Dean C, 1992, Aust J Physiother, V38, P31, DOI 10.1016/S0004-9514(14)60548-1; DODDS TA, 1993, ARCH PHYS MED REHAB, V74, P531, DOI 10.1016/0003-9993(93)90119-U; Donaghy S, 1998, ARCH PHYS MED REHAB, V79, P1231, DOI 10.1016/S0003-9993(98)90267-2; Fleming J, 1999, BRAIN INJURY, V13, P417; FLEMING JM, 1994, ARCH PHYS MED REHAB, V75, P156; Hajek VE, 1997, ARCH PHYS MED REHAB, V78, P1331, DOI 10.1016/S0003-9993(97)90306-3; HUIJBREGTS M, 1996, PHYSIOTHER CAN, V48, P285; LENNON S, 1996, PHYSIOTHERAPY, V82, P655; Lincoln N, 1979, Physiotherapy, V65, P48; MAHER C, 1909, AUSTR J PHYSIOTHERAP, V39, P5; McGraw KO, 1996, PSYCHOL METHODS, V1, P30, DOI 10.1037/1082-989X.1.4.390; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; Patrick L, 1996, AGING-CLIN EXP RES, V8, P328, DOI 10.1007/BF03339589; POOLE JL, 1988, ARCH PHYS MED REHAB, V69, P195; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; SEABY L, 1989, Physiotherapy Canada, V41, P264; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420	22	17	19	1	3	AUSTRALIAN PHYSIOTHERAPY ASSOC	ST KILDA	LEVEL 3, 201  FITZROY ST, ST KILDA, 3182, AUSTRALIA	0004-9514			AUST J PHYSIOTHER	Aust. J. Physiother.		2002	48	1					35	39		10.1016/S0004-9514(14)60280-4			5	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	532AX	WOS:000174450400005	11869163				2021-06-18	
J	Suhr, JA				Suhr, JA			Malingering, coaching, and the serial position effect	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						malingering; head injury; memory	ALZHEIMERS-DISEASE; HEAD-INJURY; FREE RECALL; MEMORY; TESTS; PERFORMANCE; DEMENTIA	The normal pattern of performance on list-learning tasks is to recall more words from the beginning (primacy) and end (recency) of the list. This pattern is also seen in patients with closed head injury, but malingerers tend to recall less words from the beginning of word lists, leading to a suppressed primacy effect. The present study examined this pattern on both learning trials and delayed recall of the Auditory Verbal Learning Test (AVLT) in 34 persons performing with normal effort, 38 naive malingerers, 33 warned malingerers, and 29 head-injured patients. Both malingering groups had lower scores on the primacy portion of the list during learning trials, while normals and head-injured patients had normal serial position curves. During delayed recall, normals and head-injured patients did better than the two malingering groups on middle and recency portions of the list. Findings suggest that the serial position effect during learning trials may be a useful pattern of performance to watch for when suspicious of malingering. (C) 2001 National Academy of Neuropsychology. Published by Elsevier Science Ltd.	Ohio Univ, Dept Psychol, Athens, OH 45701 USA	Suhr, JA (corresponding author), Ohio Univ, Dept Psychol, Porter Hall 200, Athens, OH 45701 USA.						BADDELEY AD, 1970, J VERB LEARN VERB BE, V9, P176, DOI 10.1016/S0022-5371(70)80048-2; Bernard L C, 1991, Arch Clin Neuropsychol, V6, P81, DOI 10.1016/0887-6177(91)90024-4; BERNARD LC, 1993, J CLIN PSYCHOL, V49, P45, DOI 10.1002/1097-4679(199301)49:1<45::AID-JCLP2270490107>3.0.CO;2-7; BIGLER ED, 1989, J CLIN PSYCHOL, V45, P277, DOI 10.1002/1097-4679(198903)45:2<277::AID-JCLP2270450216>3.0.CO;2-M; Burkart M, 1998, DEMENT GERIATR COGN, V9, P130, DOI 10.1159/000017036; Carlesimo GA, 1997, CORTEX, V33, P155, DOI 10.1016/S0010-9452(97)80011-1; Carlesimo GA, 1995, CORTEX, V31, P735, DOI 10.1016/S0010-9452(13)80024-X; CRAIK FIM, 1970, J VERB LEARN VERB BE, V9, P143, DOI 10.1016/S0022-5371(70)80042-1; GIBSON AJ, 1981, BRIT J CLIN PSYCHOL, V20, P179, DOI 10.1111/j.2044-8260.1981.tb00516.x; Hermann BP, 1996, CORTEX, V32, P323, DOI 10.1016/S0010-9452(96)80054-2; Martin RC, 1996, J CLIN EXP NEUROPSYC, V18, P265, DOI 10.1080/01688639608408281; MARTIN RC, 1993, J CLIN EXP NEUROPSYC, V15, P867, DOI 10.1080/01688639308402604; MARTIN RC, 1992, FORENSIC REPORTS, V5, P393; MASSMAN PJ, 1993, DEV NEUROPSYCHOL, V9, P1, DOI 10.1080/87565649309540540; Rose FE, 1998, ARCH CLIN NEUROPSYCH, V13, P349, DOI 10.1016/S0887-6177(97)00025-5; RUNDUS D, 1971, J EXP PSYCHOL, V89, P63, DOI 10.1037/h0031185; RUNDUS D, 1970, J VERB LEARN VERB BE, V9, P684, DOI 10.1016/S0022-5371(70)80033-0; SUHR J, 1997, J CLIN EXPT NEUROPSY, V19, P495; Suhr JA, 2000, ARCH CLIN NEUROPSYCH, V15, P415, DOI 10.1016/S0887-6177(99)00033-5; Youngjohn JR, 1999, ARCH CLIN NEUROPSYCH, V14, P511, DOI 10.1016/S0887-6177(98)00049-3	20	17	18	0	4	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0887-6177			ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	JAN	2002	17	1					69	77		10.1016/S0887-6177(00)00102-5			9	Psychology, Clinical; Psychology	Psychology	504XD	WOS:000172880700006	14589754	Bronze			2021-06-18	
J	Kishi, Y; Robinson, RG; Kosier, JT				Kishi, Y; Robinson, RG; Kosier, JT			Suicidal ideation among patients during the rehabilitation period after life-threatening physical illness	JOURNAL OF NERVOUS AND MENTAL DISEASE			English	Article							HEALTH-SERVICE NEEDS; PRIMARY-CARE; DEPRESSION; CONSULTATION; CANCER; STROKE	A total of 496 patients were examined for suicidal ideation during the acute hospital period and at 3, 6, 12, and 24 months' follow-up after suffering either stroke, traumatic brain injury, myocardial infarction, or spinal cord injury. A total of 7.3% of patients had suicidal ideation during the in-hospital evaluation (acute-onset suicidal ideation), and 11.3% developed it during the chronic 3 to 24 month rehabilitation period (delayed-onset suicidal ideation). Compared with delayed-onset suicidal patients, acute-onset suicidal patients had more predisposing risk factors (i.e., personal psychiatric history and alcohol abuse/dependence) and less social support (i.e., lower frequency of being married). Both acute and delayed-onset suicidal ideation, however, were strongly associated with the existence of major depression and impaired social functioning. These findings suggest that the detection and appropriate treatment of depressive disorders and social isolation may be the most important factor in preventing suicide both during the acute and chronic period following life-threatening physical illnesses.	Univ Iowa, Coll Med, Dept Psychiat, Iowa City, IA 52242 USA; Chiba Hokusoh Hosp, Nippon Med Sch, Dept Psychiat, Chiba, Japan	Robinson, RG (corresponding author), Univ Iowa, Coll Med, Dept Psychiat, Iowa City, IA 52242 USA.		Kishi, Yasuhiro/T-4047-2019; Robinson, Robert/AAF-6191-2021		NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH053592, R01MH052879] Funding Source: NIH RePORTER; NIMH NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [MH53592, MH52879] Funding Source: Medline		Akechi T, 1999, PSYCHIAT CLIN NEUROS, V53, P569, DOI 10.1046/j.1440-1819.1999.00607.x; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Breitbart W, 2000, JAMA-J AM MED ASSOC, V284, P2907, DOI 10.1001/jama.284.22.2907; CONOVER WJ, 1981, AM STAT, V35, P124, DOI 10.2307/2683975; Conwell Y, 2000, J AM GERIATR SOC, V48, P23, DOI 10.1111/j.1532-5415.2000.tb03024.x; FEDOROFF JP, 1991, J AFFECT DISORDERS, V22, P83, DOI 10.1016/0165-0327(91)90088-A; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; GUZE SB, 1970, BRIT J PSYCHIAT, V117, P437, DOI 10.1192/bjp.117.539.437; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Haste F, 1998, BRIT J GEN PRACT, V48, P1759; Huyse FJ, 1997, J PSYCHOSOM RES, V43, P233, DOI 10.1016/S0022-3999(97)00011-1; Huyse FJ, 1999, GEN HOSP PSYCHIAT, V21, P39, DOI 10.1016/S0163-8343(98)00057-7; Huyse FJ, 2001, PSYCHOSOMATICS, V42, P5, DOI 10.1176/appi.psy.42.1.5; KATON W, 1994, PSYCHOSOMATICS, V35, P268, DOI 10.1016/S0033-3182(94)71775-8; KATON W, 1995, JAMA-J AM MED ASSOC, V273, P1026, DOI 10.1001/jama.273.13.1026; Kelly B, 1998, PSYCHOSOMATICS, V39, P405, DOI 10.1016/S0033-3182(98)71299-X; KISHI Y, IN PRESS PSYCHOSOMAT; MACKENZIE TB, 1987, INT J PSYCHIAT MED, V17, P3; MILES CP, 1977, J NERV MENT DIS, V164, P231, DOI 10.1097/00005053-197704000-00002; MISSEL JL, 1978, ARCH PHYS MED REHAB, V59, P371; MURPHY GE, 1983, ARCH GEN PSYCHIAT, V40, P342; RABINS PV, 1982, BRIT J PSYCHIAT, V140, P149, DOI 10.1192/bjp.140.2.149; ROBINS E, 1959, AM J PUBLIC HEALTH N, V49, P888, DOI 10.2105/AJPH.49.7.888; ROBINSON RG, 1981, BRAIN LANG, V14, P282, DOI 10.1016/0093-934X(81)90080-8; ROBINSON RG, 1983, COMPR PSYCHIAT, V24, P555, DOI 10.1016/0010-440X(83)90024-X; Sartorius N, 1974, MEASUREMENT CLASSIFI; Starr L B, 1982, Soc Work Res Abstr, V18, P28; Stiefel FC, 1999, GEN HOSP PSYCHIAT, V21, P49, DOI 10.1016/S0163-8343(98)00061-9	28	17	17	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0022-3018			J NERV MENT DIS	J. Nerv. Ment. Dis.	SEP	2001	189	9					623	628		10.1097/00005053-200109000-00009			6	Clinical Neurology; Psychiatry	Neurosciences & Neurology; Psychiatry	475BH	WOS:000171141400009	11580007				2021-06-18	
J	Robertson, CL; Minamino, N; Ruppel, RA; Kangawa, K; Wisniewski, SR; Tsuji, T; Janesko, KL; Ohta, H; Adelson, PD; Marion, DW; Kochanek, PM				Robertson, CL; Minamino, N; Ruppel, RA; Kangawa, K; Wisniewski, SR; Tsuji, T; Janesko, KL; Ohta, H; Adelson, PD; Marion, DW; Kochanek, PM			Increased adrenomedullin in cerebrospinal fluid after traumatic brain injury in infants and children	JOURNAL OF NEUROTRAUMA			English	Article						cerebral blood flow; head injury; pediatrics	CEREBRAL BLOOD-FLOW; PLASMA ADRENOMEDULLIN; HYPOTENSIVE PEPTIDE; HEAD-INJURIES; HYPERTENSION; METABOLISM; CELLS; RAT; CORRELATE; SECRETION	Adrenomedullin is a recently discovered 52-amino acid peptide that is a potent vasodilator and is produced in the brain in experimental models of cerebral ischemia. Infusion of adrenomedullin increases regional cerebral blood flow and reduces infarct volume after vascular occlusion in rats, and thus may represent an endogenous neuroprotectant. Disturbances in cerebral blood flow (CBF), including hypoperfusion and hyperemia, frequently occur after severe traumatic brain injury (TBI) in infants and children. We hypothesized that cerebrospinal fluid (CSF) adrenomedullin concentration would be increased after severe TBI in infants and children, and that increases in adrenomedullin would be associated with alterations in CBF. We also investigated whether posttraumatic CSF adrenomedullin concentration was associated with relevant clinical variables (CBF, age, Glasgow Coma Scale [GCS] score, mechanism of injury, and outcome). Total adrenomedullin concentration was measured using a radioimmunometric assay. Sixty-six samples of ventricular CSF from 21 pediatric patients were collected during the first 10 days after severe TBI (GCS score < 8). Control CSF was obtained from children (n = 10) undergoing lumbar puncture without TBI or meningitis. Patients received standard neurointensive care, including CSF drainage. CBF was measured using Xenon computed tomography (CT) in 11 of 21 patients. Adrenomedullin concentration was markedly increased in CSF of infants and children after severe TBI vs control (median 4.5 versus 1.0 fmol/mL, p < 0.05). Sixty-two of 66 CSF samples (93.9%) from head-injured infants and children had a total adrenomedullin concentration that was greater than the median value for controls. Increases in CSF adrenomedullin were most commonly observed early after TBI. CBF was positively correlated with CSF adrenomedullin concentration (p < 0.001), but this relationship was not significant when controlling for the effect of time. CSF adrenomedullin was not significantly associated with other selected clinical variables. We conclude adrenomedullin is markedly increased in the CSF of infants and children early after severe TBI. We speculate that adrenomedullin participates in the regulation of CBF after severe TBI.	Univ Pittsburgh, Safar Ctr Resuscitat Res, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Dept Anesthesiol & Crit Care Med, Pittsburgh, PA 15261 USA; Univ Pittsburgh, Dept Pediat, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Dept Neurol Surg, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Sch Publ Hlth, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Ctr Injury Control & Res, Pittsburgh, PA USA; Univ Maryland, Dept Pediat, Baltimore, MD 21201 USA; Shionogi & Co Ltd, Diagnost Sci Div, Osaka, Japan; Natl Cardiovasc Ctr, Res Inst, Osaka, Japan	Kochanek, PM (corresponding author), Univ Pittsburgh, Safar Ctr Resuscitat Res, 3434 5th Ave, Pittsburgh, PA 15260 USA.	kochanekpm@anes.upmce.edu	Adelson, David/W-2083-2019; Kochanek, Patrick M/D-2371-2015; Marion, Donald/AAR-5749-2021	Kochanek, Patrick M/0000-0002-2627-913X; Wisniewski, Stephen/0000-0002-3877-9860	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS030318, K08NS001809, P50NS030318, P20NS030318] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS38081, NS30318, NS01809] Funding Source: Medline		Adelson PD, 1997, PEDIATR NEUROSURG, V26, P200; BASKAYA MK, 1995, J CEREBR BLOOD F MET, V15, P827, DOI 10.1038/jcbfm.1995.103; Biagas KV, 1996, J NEUROTRAUM, V13, P189, DOI 10.1089/neu.1996.13.189; BOUMA GJ, 1992, J NEUROTRAUM, V9, pS333; BRUCE DA, 1981, J NEUROSURG, V54, P170, DOI 10.3171/jns.1981.54.2.0170; Diringer MN, 2000, J NEUROSURG, V92, P7, DOI 10.3171/jns.2000.92.1.0007; Dogan A, 1997, J CEREBR BLOOD F MET, V17, P19, DOI 10.1097/00004647-199701000-00004; GUR D, 1989, Cerebrovascular and Brain Metabolism Reviews, V1, P68; Hinson JP, 2000, ENDOCR REV, V21, P138, DOI 10.1210/er.21.2.138; Inoue S, 1999, ANESTH ANALG, V88, P1030, DOI 10.1097/00000539-199905000-00011; ISHIMITSU T, 1994, J CLIN INVEST, V94, P2158, DOI 10.1172/JCI117573; JOUGASAKI M, 1995, CIRCULATION, V92, P286, DOI 10.1161/01.CIR.92.3.286; Kikumoto K, 1998, ANESTH ANALG, V87, P859, DOI 10.1097/00000539-199810000-00021; KITAMURA K, 1993, BIOCHEM BIOPH RES CO, V192, P553, DOI 10.1006/bbrc.1993.1451; KITAMURA K, 1993, BIOCHEM BIOPH RES CO, V194, P720, DOI 10.1006/bbrc.1993.1881; Kochanek Patrick M., 2000, Pediatr Crit Care Med, V1, P4, DOI 10.1097/00130478-200007000-00003; Kuwasako K, 1997, INT ANGIOL, V16, P272; Lang MG, 1997, STROKE, V28, P181, DOI 10.1161/01.STR.28.1.181; MARION DW, 1991, J NEUROSURG, V74, P407, DOI 10.3171/jns.1991.74.3.0407; Miyao Y, 1998, HEART, V79, P39, DOI 10.1136/hrt.79.1.39; MUIZELAAR JP, 1989, J NEUROSURG, V71, P63, DOI 10.3171/jns.1989.71.1.0063; Nagata N, 1998, EUR J ENDOCRINOL, V139, P611, DOI 10.1530/eje.0.1390611; Nishikimi T, 1997, HEART, V78, P390, DOI 10.1136/hrt.78.4.390; Nishio K, 1997, CRIT CARE MED, V25, P953, DOI 10.1097/00003246-199706000-00010; OBRIST WD, 1984, J NEUROSURG, V61, P241, DOI 10.3171/jns.1984.61.2.0241; Ohta H, 1999, CLIN CHIM ACTA, V287, P131, DOI 10.1016/S0009-8981(99)00128-X; Serrano J, 2000, BRAIN RES, V853, P245, DOI 10.1016/S0006-8993(99)02273-8; Shindo T, 2000, CIRCULATION, V101, P2309, DOI 10.1161/01.CIR.101.19.2309; Sone M, 1997, PEPTIDES, V18, P1125, DOI 10.1016/S0196-9781(97)00143-5; SUGO S, 1994, BIOCHEM BIOPH RES CO, V201, P1160, DOI 10.1006/bbrc.1994.1827; SUGO S, 1994, BIOCHEM BIOPH RES CO, V203, P719, DOI 10.1006/bbrc.1994.2241; Takahashi K, 1997, PEPTIDES, V18, P1051, DOI 10.1016/S0196-9781(97)00038-7; Takahashi K, 1997, J NEUROCHEM, V68, P726; Ueda S, 1999, AM J RESP CRIT CARE, V160, P132, DOI 10.1164/ajrccm.160.1.9810006; WANG XK, 1995, P NATL ACAD SCI USA, V92, P11480, DOI 10.1073/pnas.92.25.11480; WASHIMINE H, 1995, HISTOCHEM CELL BIOL, V103, P251, DOI 10.1007/BF01457408	36	17	17	0	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	SEP	2001	18	9					861	868		10.1089/089771501750451785			8	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	471TP	WOS:000170945000002	11565598				2021-06-18	
J	Schmitter-Edgecombe, M; Beglinger, L				Schmitter-Edgecombe, M; Beglinger, L			Acquisition of skilled visual search performance following severe closed-head injury	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						visual search; skill learning; automaticity; closed-head injury; traumatic brain injury	CONNECTIONIST CONTROL ARCHITECTURE; AUTOMATIC PROCESS-DEVELOPMENT; DIVIDED ATTENTION; MEMORY; CONSISTENT; RETENTION; CATEGORY; COMPONENTS; CAPACITY; IMPLICIT	This study used a semantic-category visual search task to investigate skill acquisition and automatic process development in a severe closed-head injured (CHI) population. Eighteen severe CHI participants (> 1 year post injury) and 18 matched controls completed over 3600 trials of training in both consistent mapping (CM) and varied mapping (VM) training situations. Transfer conditions were also used to test for development of an automatic attention response (AAR) that was independent of general, task-related learning. For both the severe CHI and control group, CM training, where individuals always responded in the same way to a specific class of stimuli, resulted in dramatic performance improvements and the development of an AAR. In the VM training condition, where individuals could not respond in the same way to a class of stimuli from one stimulus exposure to the next, there was little performance improvement and continued reliance on controlled processes. The visual search rates of the CHI participants also remained slower than those of controls following extended VM but not extended CM practice. These results indicate that skill acquisition training guidelines can be used to teach severe CHI patients to develop a new automatic skill.	Washington State Univ, Dept Psychol, Pullman, WA 99164 USA	Schmitter-Edgecombe, M (corresponding author), Washington State Univ, Dept Psychol, POB 644820, Pullman, WA 99164 USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R03HD035838] Funding Source: NIH RePORTER; NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R03 HD35838] Funding Source: Medline		ADAMS JH, 1977, BRAIN, V100, P489, DOI 10.1093/brain/100.3.489; ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; ANDERSON JR, 1982, PSYCHOL REV, V89, P369, DOI 10.1037/0033-295X.89.4.369; BATTIG WF, 1969, J EXP PSYCHOL, V80, P1, DOI 10.1037/h0027577; Blair JR., 1989, CLIN NEUROPSYCHOL, V3, P129; BOND MR, 1983, REHABILITATION HEAD, P185; COLLEN A, 1975, J EXP PSYCHOL-HUM L, V1, P629; Craik F.I.M., 1986, HUMAN MEMORY COGNITI, P409; CZERWINSKI M, 1992, AM J PSYCHOL, V105, P271, DOI 10.2307/1423030; DUNCAN J, 1989, PSYCHOL REV, V96, P433, DOI 10.1037/0033-295X.96.3.433; ERIKSEN CW, 1985, J EXP PSYCHOL HUMAN, V11, P583, DOI 10.1037/0096-1523.11.5.583; FISHER DL, 1984, COGNITIVE PSYCHOL, V16, P449, DOI 10.1016/0010-0285(84)90017-3; FISHER DL, 1988, J EXP PSYCHOL HUMAN, V14, P253, DOI 10.1037/0096-1523.14.2.253; FISHER DL, 1982, PSYCHOL REV, V89, P662, DOI 10.1037/0033-295X.89.6.662; Fisk A. D., 1991, MULTIPLE TASK PERFOR, P415; FISK AD, 1994, PSYCHOL AGING, V9, P206, DOI 10.1037/0882-7974.9.2.206; FISK AD, 1992, COGNITIVE APPROACHES TO AUTOMATED INSTRUCTION, P171; FISK AD, 1992, HUM FACTORS, V34, P147; FISK AD, 1992, HUM FACTORS, V34, P693, DOI 10.1177/001872089203400604; FISK AD, 1991, HUM FACTORS, V33, P267; FISK AD, 1988, HUM FACTORS, V30, P703, DOI 10.1177/001872088803000606; FISK AD, 1995, PSYCHOL AGING, V10, P255, DOI 10.1037/0882-7974.10.2.255; FISK AD, 1983, J EXP PSYCHOL LEARN, V9, P177, DOI 10.1037/0278-7393.9.2.177; HASHER L, 1979, J EXP PSYCHOL GEN, V108, P356, DOI 10.1037/0096-3445.108.3.356; Hays W. L., 1988, STATISTICS; Jennett B, 1981, MANAGEMENT HEAD INJU; JONIDES J, 1980, CAN J PSYCHOL, V34, P103, DOI 10.1037/h0081031; Kaplan E., 1987, MANUAL CALIFORNIA VE; KRAMER AF, 1990, J EXP PSYCHOL HUMAN, V16, P505; KRAMER AF, 1991, PSYCHOPHYSIOLOGY, V28, P425, DOI 10.1111/j.1469-8986.1991.tb00726.x; LOGAN GD, 1985, CAN J PSYCHOL, V39, P367, DOI 10.1037/h0080066; Mattis S, 1988, DEMENTIA RATING SCAL; MILLER E, 1981, BRIT J CLIN PSYCHOL, V20, P69, DOI 10.1111/j.2044-8260.1981.tb00498.x; PLUDE DJ, 1981, J GERONTOL, V36, P588; PRINZ W, 1979, PERCEPT PSYCHOPHYS, V25, P137, DOI 10.3758/BF03198800; ROGERS WA, 1994, J EXP PSYCHOL LEARN, V20, P710, DOI 10.1037/0278-7393.20.3.710; RUSSELL WR, 1961, ARCH NEUROL-CHICAGO, V5, P16, DOI DOI 10.1001/ARCHNEUR.1961.00450130006002; SALTHOUSE TA, 1978, J GERONTOL, V33, P232, DOI 10.1093/geronj/33.2.232; Sattler JM, 1988, ASSESSMENT CHILDREN; Schmitter-Edgecombe M, 2000, NEUROPSYCHOLOGY, V14, P559; Schmitter-Edgecombe M, 1998, J INT NEUROPSYCH SOC, V4, P144, DOI 10.1017/S1355617798001441; Schmitter-Edgecombe M., 1993, NEUROPSYCHOLOGY, V7, P136, DOI DOI 10.1037/0894-4105.7.2.136; SchmitterEdgecombe M, 1996, NEUROPSYCHOLOGY, V10, P155; SchmitterEdgecombe M, 1997, NEUROPSYCHOLOGY, V11, P296, DOI 10.1037/0894-4105.11.2.296; SCHNEIDER W, 1988, HUM FACTORS, V30, P539; SCHNEIDER W, 1987, PSYCHOL LEARN MOTIV, V21, P53; SCHNEIDER W, 1977, PSYCHOL REV, V84, P1, DOI 10.1037/0033-295X.84.1.1; SCHNEIDER W, 1988, BEHAV RES METH INSTR, V20, P206, DOI 10.3758/BF03203833; SCHNEIDER W, 1984, J EXP PSYCHOL LEARN, V10, P1; SCHNEIDER W, 1982, PERCEPT PSYCHOPHYS, V31, P160, DOI 10.3758/BF03206216; Schneider W., 1985, ATTENTION PERFORM, P475; SCHNEIDER W, 1980, 8004 U ILL HUM ATT R; SHIFFRIN RM, 1988, J EXP PSYCHOL LEARN, V14, P562, DOI 10.1037/0278-7393.14.3.562; SHIFFRIN RM, 1977, PSYCHOL REV, V84, P127, DOI 10.1037/0033-295X.84.2.127; SHIFFRIN RM, 1981, COGNITIVE SKILLS THE, P11; SHIFFRIN RM, 1988, STEVENS HDB EXPT PSY, V1, P739; Smith A., 1991, SYMBOL DIGIT MODALIT; STRAYER DL, 1994, PSYCHOL AGING, V9, P589, DOI 10.1037/0882-7974.9.4.589; TEASDALE G, 1974, LANCET, V2, P81; VAKIL E, 1994, J CLIN EXP NEUROPSYC, V16, P539, DOI 10.1080/01688639408402665; VAKIL E, 1991, J CLIN EXP NEUROPSYC, V13, P291, DOI 10.1080/01688639108401044; Van Zomeren A. H., 1981, REACTION TIME ATTENT; Wechsler D., 1987, WECHSLER MEMORY SCAL; Wechsler D., 1981, WAIS R MANUAL WECHSL; WHALEY CJ, 1993, HUM FACTORS, V35, P639	65	17	17	0	7	CAMBRIDGE UNIV PRESS	PORT CHESTER	110 MIDLAND AVE, PORT CHESTER, NY 10573-9863 USA	1355-6177			J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	JUL	2001	7	5					615	630		10.1017/S1355617701755099			16	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Neurosciences & Neurology; Psychiatry; Psychology	451XM	WOS:000169827900009	11459113				2021-06-18	
J	Sekiya, T; Tanaka, M; Shimamura, N; Suzuki, S				Sekiya, T; Tanaka, M; Shimamura, N; Suzuki, S			Macrophage invasion into injured cochlear nerve and its modification by methylprednisolone	BRAIN RESEARCH			English	Article						cochlear nerve; macrophage; methylprednisolone; nerve degeneration; nerve regeneration	MYELIN-ASSOCIATED GLYCOPROTEIN; RAT OPTIC-NERVE; SPINAL-CORD; WALLERIAN DEGENERATION; NEURITE GROWTH; MONONUCLEAR PHAGOCYTES; CEREBELLOPONTINE ANGLE; AXONAL REGENERATION; BRAIN MACROPHAGES; MICROGLIA	Post-traumatic invasion of macrophages into the cochlear nerve of the rat and measurement of how their invasion was modified by the administration of methylprednisolone were investigated for the first time by using a reproducible and quantifiable experimental model of cochlear nerve injury. Two weeks after precise cochlear nerve compression, a massive invasion of EDI immunostained macrophages was observed at the compressed portion of the cochlear nerve, and this invasion of macrophages was markedly reduced in the rats to which methylprednisolone had been administered during the pre- and post-compression period. Concomitantly, the residual number of spiral ganglion cells was found to be greater in the compression+methylprednisolone group than in the control compression group. The tissue loss observed in the lesion epicenter was also significantly less in the compression+methylprednisolone group than in the control compression group. The results of our present study demonstrated the effectiveness of methylprednisolone treatment to ameliorate trauma induced cochlear nerve degeneration in the acute phase. However, these results may reflect the sum effects of methylprednisolone on macrophages, including both its beneficial effect by inhibiting the negative aspects of macrophages through attenuating macrophage recruitment to the lesion site, and at the same time an undesirable effect by sacrificing the positive aspects of macrophage function. Moreover, one reservation should be added that the protective effects of steroid to injured cochlear nerve may have operated via a pathway not related to macrophage function. Besides macrophages, various cells and factors participate in the process of CNS injury, and their effects may potentially work either positively or negatively with respect to CNS protection and regeneration at each particular time during the on-going process of CNS injury. Therefore, future investigation in CNS injury should be directed toward understanding such complex mechanisms involved in this process. (C) 2001 Elsevier Science B.V, All rights reserved.	Hirosaki Univ, Sch Med, Dept Neurosurg, Hirosaki, Aomori 0368216, Japan	Sekiya, T (corresponding author), Hirosaki Univ, Sch Med, Dept Neurosurg, 5 Zaifu Cho, Hirosaki, Aomori 0368216, Japan.	seky@cc.hirosaki-u.ac.jp					BAMA BPJ, 1994, J NEUROIMMUNOL, V50, P101; BANATI RB, 1993, GLIA, V7, P111, DOI 10.1002/glia.440070117; BARTHOLDI D, 1995, BRAIN RES, V672, P177, DOI 10.1016/0006-8993(94)01410-J; BENVENISTE EN, 1992, AM J PHYSIOL, V263, pC1; BIGNAMI A, 1969, BRAIN RES, V13, P444, DOI 10.1016/0006-8993(69)90259-5; Carlson SL, 1998, EXP NEUROL, V151, P77, DOI 10.1006/exnr.1998.6785; CARONI P, 1988, J CELL BIOL, V106, P1281, DOI 10.1083/jcb.106.4.1281; CHAMAK B, 1994, J NEUROSCI RES, V38, P221, DOI 10.1002/jnr.490380213; Chen MS, 2000, NATURE, V403, P434, DOI 10.1038/35000219; COLTON CA, 1987, FEBS LETT, V223, P284, DOI 10.1016/0014-5793(87)80305-8; DIJKSTRA CD, 1985, IMMUNOLOGY, V54, P589; DINARELLO CA, 1989, ADV IMMUNOL, V44, P153, DOI 10.1016/S0065-2776(08)60642-2; Elkabes S, 1996, J NEUROSCI, V16, P2508; Flavin MP, 1997, EXP NEUROL, V145, P462, DOI 10.1006/exnr.1997.6474; GIULIAN D, 1993, ADV NEUROL, V59, P315; GIULIAN D, 1994, NEUROCHEM INT, V25, P227, DOI 10.1016/0197-0186(94)90066-3; GIULIAN D, 1990, ANN NEUROL, V27, P33, DOI 10.1002/ana.410270107; GUYRE PM, 1988, J STEROID BIOCHEM, V30, P89, DOI 10.1016/0022-4731(88)90080-5; Hayashi Mito, 1997, Acta Anatomica Nipponica, V72, P209; Klusman I, 1997, BRAIN RES, V762, P173, DOI 10.1016/S0006-8993(97)00381-8; LAWSON LJ, 1994, J NEUROCYTOL, V23, P729, DOI 10.1007/BF01268086; LazarovSpiegler O, 1996, FASEB J, V10, P1296; LING EA, 1978, J ANAT, V126, P111; Marchant A, 1996, CLIN EXP IMMUNOL, V106, P91, DOI 10.1046/j.1365-2249.1996.d01-799.x; MCKERRACHER L, 1994, NEURON, V13, P805, DOI 10.1016/0896-6273(94)90247-X; NATHAN CF, 1987, J CLIN INVEST, V79, P319, DOI 10.1172/JCI112815; Oudega M, 1999, EUR J NEUROSCI, V11, P2453, DOI 10.1046/j.1460-9568.1999.00666.x; Pavelko KD, 1998, J NEUROSCI, V18, P2498; PESHEVA P, 1989, J CELL BIOL, V109, P1765, DOI 10.1083/jcb.109.4.1765; SCHNELL L, 1990, NATURE, V343, P269, DOI 10.1038/343269a0; SEKIYA T, 1987, NEUROSURGERY, V21, P631, DOI 10.1227/00006123-198711000-00005; SEKIYA T, 1985, J NEUROSURG, V63, P598, DOI 10.3171/jns.1985.63.4.0598; Sekiya T, 2001, HEARING RES, V151, P125, DOI 10.1016/S0378-5955(00)00219-7; Sekiya T, 2000, EXP NEUROL, V161, P490, DOI 10.1006/exnr.1999.7280; STOLL G, 1989, J NEUROSCI, V9, P2327; Streit WJ, 1996, NEUROTOXICOLOGY, V17, P671; Tang S, 1997, MOL CELL NEUROSCI, V9, P333, DOI 10.1006/mcne.1997.0633; THERY C, 1991, EUR J NEUROSCI, V3, P1155, DOI 10.1111/j.1460-9568.1991.tb00050.x	38	17	17	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	JUN 29	2001	905	1-2					152	160		10.1016/S0006-8993(01)02523-9			9	Neurosciences	Neurosciences & Neurology	452RY	WOS:000169873600018	11423090				2021-06-18	
J	Diamond, PT; Gale, SD; Denkhaus, HK				Diamond, PT; Gale, SD; Denkhaus, HK			Head injuries in skiers: an analysis of injury severity and outcome	BRAIN INJURY			English	Article							SKIING INJURIES	To examine the incidence, injury severity, and outcomes of persons hospitalized as a result of ski-related head trauma, a cross-sectional survey was carried out from the Colorado traumatic brain injury database. This database is an ongoing population-based statewise surveillance system, compiled by the Department of Public Health and Environment. Participants were Colorado residents who sustained a head injury while skiing at Colorado ski resorts and hospitalized over three full ski seasons (1994-1997). Injury severity measures included GCS, ISS, AIS, and presence/absence of intracranial lesion, skull fracture and amnesia. Outcome measures included GOS and hospital length of stay. Mean injury severity scores were as follows: GCS 14.51 (SD = 0.99), AIS 2.98 (0.99) and ISS 13.17 (6.71). Twenty-four per cent sustained skull fracture, 39% had intracranial lesions, and 79% demonstrated amnesia. Mean length of stay was 4.31 days (10.58). Head injury incidence was 0.77 per 100 000 ski visits (age-specific range = 0.17-1.91). Males were more likely to have a skull fracture and evidence of intracranial lesion. Finally, children and older adults were at increased risk of ski-related head trauma, suggesting head injury prevention programmes geared toward these age groups should be emphasized.	Univ Virginia Hlth Syst, Dept Phys Med & Rehabil, Charlottesville, VA 22908 USA	Diamond, PT (corresponding author), Univ Virginia Hlth Syst, Dept Phys Med & Rehabil, 545 Ray C Hunt Dr,Suite 240,POB 801004, Charlottesville, VA 22908 USA.		Gale, Shawn/M-3144-2013	Gale, Shawn/0000-0002-8989-0964	PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [U17/CCU811909] Funding Source: Medline		*ASS ADV AUT MED, 1990, ABBR INJ SCAL; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Chissell HR, 1996, SPORTS MED, V22, P141, DOI 10.2165/00007256-199622030-00001; FURRER M, 1995, J TRAUMA, V39, P737, DOI 10.1097/00005373-199510000-00024; Hunter RE, 1999, AM J SPORT MED, V27, P381, DOI 10.1177/03635465990270032101; JENNETT B, 1975, LANCET, V1, P480; MORROW PL, 1988, J TRAUMA, V28, P95, DOI 10.1097/00005373-198801000-00014; Sacco DE, 1998, J TRAUMA, V44, P654, DOI 10.1097/00005373-199804000-00016; Sahlin Y, 1989, Br J Sports Med, V23, P241; Shealy J, 1985, SKIING TRAUMA SAFETY, P349; Shorter NA, 1996, J TRAUMA, V40, P997, DOI 10.1097/00005373-199606000-00024; TEASDALE G, 1974, LANCET, V2, P81; Thurman DJ., 1995, GUIDELINES SURVEILLA; US Consumer Product Safety Commission, 1999, SKIING HELM EV POT R	14	17	17	0	2	TAYLOR & FRANCIS LTD	LONDON	11 NEW FETTER LANE, LONDON EC4P 4EE, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	MAY	2001	15	5					429	434		10.1080/02699050010005922			6	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	431TW	WOS:000168648700005	11350656				2021-06-18	
J	McFarland, K; Jackson, L; Geffen, G				McFarland, K; Jackson, L; Geffen, G			Post-traumatic amnesia: Consistency-of-recovery and duration-to-recovery following traumatic brain impairment	CLINICAL NEUROPSYCHOLOGIST			English	Article							CLOSED-HEAD-INJURY; POSTTRAUMATIC AMNESIA; MEMORY; DISORIENTATION	The aim of this research was to examine the nature and order of recovery of orientation and memory functioning during Post-Traumatic Amnesia (PTA) in relation to injury severity and PTA duration. The Westmead PTA Scale was used across consecutive testing days to assess the recovery of orientation and memory during PTA in 113 patients. Two new indices were examined: a Consistency-of-Recovery and a Duration-to-Recovery index. a predictable order of recovery was observed during PTA: orientation-to-person recovered sooner and more consistently than the following cluster; orientation-to-time, orientation-to-place, and the ability to remember a face and name. However, the type of memory functioning required for the recall face and name task recovered more consistently than that required for memorizing three pictures. An important overall finding was that the "order-of-recovery'' of orientation and memory functioning was dependent upon both the elapsed days since injury, and the consistency of recovery. The newly developed indices were shown to be a valuable means of accounting for differences between groups in the elapsed days to recovery of orientation and memory. These indices also clearly increase the clinical utility of the Westmead PTA Scale and supply an objective means of charting (and potentially predicting) patients' recovery on the different components of orientation and memory throughout their period of hospitalization.	Univ Queensland, Sch Psychol, Brisbane, Qld 4072, Australia; Univ Queensland, Cognit Psychophysiol Lab, Herston, Qld, Australia	McFarland, K (corresponding author), Univ Queensland, Sch Psychol, Brisbane, Qld 4072, Australia.						DANIEL WF, 1987, CORTEX, V23, P169, DOI 10.1016/S0010-9452(87)80030-8; DAVIDOFF G, 1985, ARCH PHYS MED REHAB, V66, P41; FORRESTER G, 1994, J FARR CTR POST TRAU; FORRESTER G, 1994, BRAIN INJURY, V8, P15; GEFFEN GM, 1991, NEUROREPORT, V2, P105, DOI 10.1097/00001756-199102000-00010; GIACINO JT, 1991, ARCH PHYS MED REHAB, V72, P897, DOI 10.1016/0003-9993(91)90008-7; GRONWALL D, 1980, Journal of Clinical Neuropsychology, V2, P51, DOI 10.1080/01688638008403780; HIGH WM, 1990, J CLIN EXP NEUROPSYC, V12, P703, DOI 10.1080/01688639008401013; KREUTZER J, 1988, ARCH PHYS MED REHAB, V69, P768; LEVIN HS, 1985, J NEUROL NEUROSUR PS, V48, P556, DOI 10.1136/jnnp.48.6.556; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; LEVIN HS, 1990, J CLIN EXPT NEUROPSY, V21, P129; RICHARDSON JTE, 1984, COGN NEUROPSYCHOL, V1, P217, DOI 10.1080/02643298408252023; RICHARDSON JTE, 1990, CLIN NEUROPSYCHOLOGI; RUSSELL WR, 1946, BRAIN, V69, P280, DOI 10.1093/brain/69.4.280; RUSSELL WR, 1971, TRAUMATIC AMNESIAS; SHORES EA, 1986, MED J AUSTRALIA, V144, P569, DOI 10.5694/j.1326-5377.1986.tb112311.x; STERN JM, 1985, SCANDINAVIAN J REHAB, V4, P55; Tate RL, 2000, J NEUROL NEUROSUR PS, V68, P178, DOI 10.1136/jnnp.68.2.178; WITTY CWM, 1977, AMNESIA, P118	20	17	17	0	0	SWETS ZEITLINGER PUBLISHERS	LISSE	P O BOX 825, 2160 SZ LISSE, NETHERLANDS	0920-1637			CLIN NEUROPSYCHOL	Clin. Neuropsychol.	FEB	2001	15	1					59	68		10.1076/clin.15.1.59.1916			10	Psychology, Clinical; Clinical Neurology; Psychology	Psychology; Neurosciences & Neurology	439AH	WOS:000169086300005	11778579				2021-06-18	
J	Allen, GV; Chase, T				Allen, GV; Chase, T			Induction of heat shock proteins and motor function deficits after focal cerebellar injury	NEUROSCIENCE			English	Article						cerebellum; heat shock protein; motor function; beam walking test; traumatic brain injury; Purkinje cell	TRAUMATIC BRAIN INJURY; SENSORIMOTOR CORTEX INJURY; ALPHA-B-CRYSTALLIN; GLUCOSE-REGULATED PROTEINS; RAT-BRAIN; HUMAN HSP27; MOLECULAR CHAPERONES; CEREBRAL-ISCHEMIA; RABBIT CEREBELLUM; DROSOPHILA HSP27	A weight drop model of focal cerebellar injury was used to identify heat shock protein induction and motor function deficits in the anesthetized, adult male, Sprague-Dawley rat. All animals were trained on a beam walking test prior to surgery. Groups of animals received severe, mild or sham weight drop injury to the lateral/paravermal region of the cerebellum. The mild and sham-injured animals showed no motor deficits in the beam walking test, whereas animals with severe cerebellar injury showed significant motor deficits in the beam walking test that approached recovery of motor function 20 days after injury. Following severe injury, induction of hear shock protein of 27 kDa was observed in Purkinje cells and in neurons of the deep cerebellar nuclei, as well as Bergmann glial cells, glial cells located in the granule cell layer and the underlying white matter. Following mild injury, hear shook protein of 27 kDa induction was observed in Purkinje cells and gli;ll cells, but not in neurons of the deep cerebellar nuclei. The labeled Purkinje cells were widely distributed in the ipsilateral cerebellar cortex. Many of the glial cells that were immunostained with heat shock protein of 27 kDa co-localized with tells immunoreactive for glial fibrillary acidic protein. After severe injury, heat shock protein of 72 kDa was localized mainly in granule cells at the site of the trauma and in the ipsilateral deep cerebellar nuclei whereas, after mild injury, light labeling was observed only in the granule cell layer. The results demonstrate that focal cerebellar injury has profound effects on motor behavior and induces different families of heat shock proteins in specific groups of neurons and glial cells in the cerebellum. (C) 2001 IBRO. Published by Elsevier Science Ltd. All rights reserved.	Dalhousie Univ, Fac Med, Dept Neurobiol & Anat, Halifax, NS B3H 4H7, Canada	Allen, GV (corresponding author), Dalhousie Univ, Fac Med, Dept Neurobiol & Anat, Halifax, NS B3H 4H7, Canada.						ALBUS J S, 1971, Mathematical Biosciences, V10, P25, DOI 10.1016/0025-5564(71)90051-4; Allen GV, 2000, NEUROSCIENCE, V99, P93, DOI 10.1016/S0306-4522(00)00185-8; Armstrong CL, 2000, J COMP NEUROL, V416, P383, DOI 10.1002/(SICI)1096-9861(20000117)416:3<383::AID-CNE9>3.0.CO;2-M; Barr CS, 1999, BRAIN RES, V847, P9, DOI 10.1016/S0006-8993(99)01988-5; Beasley TC, 1998, DEV BRAIN RES, V105, P125, DOI 10.1016/S0165-3806(97)00179-X; Bechtold DA, 2000, MOL BRAIN RES, V75, P309, DOI 10.1016/S0169-328X(99)00323-X; BOTEZ MI, 1989, REHABILITATION PATH, P179; BOYESON MG, 1993, AM J PHYS MED REHAB, V72, P286, DOI 10.1097/00002060-199310000-00007; BOYESON MG, 1992, BRAIN RES BULL, V29, P435, DOI 10.1016/0361-9230(92)90080-H; BOYESON MG, 1994, AM J PHYS MED REHAB, V73, P76, DOI 10.1097/00002060-199404000-00002; BOYESON MG, 1991, RESTOR NEUROL NEUROS, V3, P227, DOI 10.3233/RNN-1991-3501; BOYESON MG, 1992, BEHAV NEUROSCI, V106, P964, DOI 10.1037/0735-7044.106.6.964; BROCHU G, 1990, J COMP NEUROL, V291, P538, DOI 10.1002/cne.902910405; BROWN IR, 1983, J NEUROCHEM, V40, P1490, DOI 10.1111/j.1471-4159.1983.tb13596.x; CHAMBERS WW, 1955, ARCH NEURO PSYCHIATR, V74, P653, DOI 10.1001/archneurpsyc.1955.02330180071008; Chen J, 1996, J CEREBR BLOOD F MET, V16, P566, DOI 10.1097/00004647-199607000-00006; CURRIE RW, 1981, SCIENCE, V214, P72, DOI 10.1126/science.7280681; D'Souza CA, 1998, J NEUROSCI RES, V52, P538, DOI 10.1002/(SICI)1097-4547(19980601)52:5<538::AID-JNR6>3.0.CO;2-D; DunnMeynell AA, 1997, J NEUROTRAUM, V14, P43, DOI 10.1089/neu.1997.14.43; Dutcher SA, 1998, J NEUROTRAUM, V15, P411, DOI 10.1089/neu.1998.15.411; EISENMAN LM, 1993, J COMP NEUROL, V335, P586, DOI 10.1002/cne.903350410; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; FEENEY DM, 1982, SCIENCE, V217, P855, DOI 10.1126/science.7100929; FEENEY DM, 1987, CRIT REV NEUROBIOL, V3, P135; Feeney DM, 1997, ADV NEUROL, V73, P383; FEENEY DM, 1985, PHYSIOL PSYCHOL, V13, P197; Fukuda K, 1996, J NEUROTRAUM, V13, P255, DOI 10.1089/neu.1996.13.255; Gao JH, 1996, SCIENCE, V272, P545, DOI 10.1126/science.272.5261.545; Glickstein M, 1990, J Cogn Neurosci, V2, P69, DOI 10.1162/jocn.1990.2.2.69; GOLDSTEIN LB, 1991, RESTOR NEUROL NEUROS, V3, P41, DOI 10.3233/RNN-1991-3105; GOODMAN DC, 1963, J COMP NEUROL, V121, P51, DOI 10.1002/cne.901210106; Hartl FU, 1996, NATURE, V381, P571, DOI 10.1038/381571a0; HAWKES R, 1987, J COMP NEUROL, V256, P29, DOI 10.1002/cne.902560104; HAYES RL, 1995, J NEUROTRAUM, V12, P779, DOI 10.1089/neu.1995.12.779; Hill SJ, 1996, J NEUROPATH EXP NEUR, V55, P1221, DOI 10.1097/00005072-199612000-00005; Hillier SL, 1997, BRAIN INJURY, V11, P661; JAKOB U, 1993, J BIOL CHEM, V268, P1517; Kanayama G, 1997, PSYCHIAT CLIN NEUROS, V51, P157, DOI 10.1111/j.1440-1819.1997.tb02379.x; KATO H, 1991, BRAIN RES, V553, P238, DOI 10.1016/0006-8993(91)90831-F; Kato K, 1999, J NEUROCHEM, V73, P229, DOI 10.1046/j.1471-4159.1999.0730229.x; KENNEDY PR, 1990, TRENDS NEUROSCI, V13, P475; Kikuchi K, 2000, BRAIN RES, V860, P130, DOI 10.1016/S0006-8993(00)02034-5; KITAGAWA K, 1991, J CEREBR BLOOD F MET, V11, P449, DOI 10.1038/jcbfm.1991.86; LANDRY J, 1991, J CELL PHYSIOL, V147, P93, DOI 10.1002/jcp.1041470113; LANDRY J, 1989, J CELL BIOL, V109, P7, DOI 10.1083/jcb.109.1.7; LAVOIE JN, 1993, J BIOL CHEM, V268, P24210; LEVIN HS, 1990, J NEUROSURG, V73, P699, DOI 10.3171/jns.1990.73.5.0699; LOWENSTEIN DH, 1994, MOL BRAIN RES, V22, P299, DOI 10.1016/0169-328X(94)90058-2; MANZERRA P, 1993, J NEUROSCI RES, V36, P480, DOI 10.1002/jnr.490360414; MARR D, 1969, J PHYSIOL-LONDON, V202, P437, DOI 10.1113/jphysiol.1969.sp008820; McIntosh TK, 1996, LAB INVEST, V74, P315; MEHLEN P, 1995, J IMMUNOL, V154, P363; Mehlen P, 1996, EMBO J, V15, P2695, DOI 10.1002/j.1460-2075.1996.tb00630.x; MEHLEN P, 1996, J BIOL CHEM, V271, P1610; MERCK KB, 1993, J BIOL CHEM, V268, P1046; MOSSER DD, 1997, MOL CELL BIOL, V17, P5217; NEEDELS DL, 1986, NEUROSCIENCE, V18, P517, DOI 10.1016/0306-4522(86)90055-2; NOWAK TS, 1985, J NEUROCHEM, V45, P1635, DOI 10.1111/j.1471-4159.1985.tb07236.x; Parsons LM, 1997, INT REV NEUROBIOL, V41, P255, DOI 10.1016/S0074-7742(08)60355-4; Paxinos G, 1986, RAT BRAIN STEREOTAXI; PELHAM HRB, 1990, TRENDS BIOCHEM SCI, V15, P483, DOI 10.1016/0968-0004(90)90303-S; PELHAM HRB, 1986, CELL, V46, P959, DOI 10.1016/0092-8674(86)90693-8; Plumier JCL, 1997, J CEREBR BLOOD F MET, V17, P781; Plumier JCL, 1997, MOL BRAIN RES, V45, P239, DOI 10.1016/S0169-328X(96)00255-0; Plumier JCL, 1996, NEUROSCIENCE, V75, P849, DOI 10.1016/0306-4522(96)00317-X; RAGHUPATHI R, 1995, BLOOD FOW METAB, V15, P467; Sato M, 1998, BRAIN RES, V809, P39, DOI 10.1016/S0006-8993(98)00817-8; Schmued LC, 1997, BRAIN RES, V751, P37, DOI 10.1016/S0006-8993(96)01387-X; TANNO H, 1993, J CEREBR BLOOD F MET, V13, P116, DOI 10.1038/jcbfm.1993.14; THOMPSON RF, 1994, ANNU REV NEUROSCI, V17, P519, DOI 10.1146/annurev.neuro.17.1.519; Turner CP, 1999, MOL BRAIN RES, V65, P87, DOI 10.1016/S0169-328X(98)00340-4; Wagstaff MJD, 1999, J BIOL CHEM, V274, P5061, DOI 10.1074/jbc.274.8.5061	72	17	20	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522			NEUROSCIENCE	Neuroscience		2001	102	3					603	614		10.1016/S0306-4522(00)00519-4			12	Neurosciences	Neurosciences & Neurology	400UM	WOS:000166890100010	11226697				2021-06-18	
J	Bieman-Copland, S; Dywan, J				Bieman-Copland, S; Dywan, J			Achieving rehabilitative gains in anosognosia after TBI	BRAIN AND COGNITION			English	Article								Impaired self-awareness can be a serious consequence of traumatic brain injury (TBI) and has been associated with poor therapeutic compliance and poor functional recovery. Traditional rehabilitation approaches which make use of direct feedback and education are often ineffective because they elicit more elaborated and entrenched confabulatory beliefs as individuals are forced to defend their position. Empirical case data is presented from a woman with profound anosognosia following a TBI with right frontal involvement. Targeted behaviors were decreased through behavioral interventions, bur the emphasis of treatment was on the formation of trusting, nonconfrontational therapeutic relationships. Marked reductions in inappropriate behaviors were achieved along with a return to supportive community living. (C) 2000 Academic Press.	Brock Univ, St Catharines, ON L2S 3A1, Canada	Bieman-Copland, S (corresponding author), Brock Univ, St Catharines, ON L2S 3A1, Canada.						Barco P.P., 1991, COGNITIVE REHABILITA, P129; Dywan J, 1996, J HEAD TRAUMA REHAB, V11, P79, DOI 10.1097/00001199-199604000-00008	2	17	17	0	4	ACADEMIC PRESS INC	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0278-2626			BRAIN COGNITION	Brain Cogn.	OCT	2000	44	1					1	5					5	Neurosciences; Psychology, Experimental	Neurosciences & Neurology; Psychology	358FJ	WOS:000089547300001					2021-06-18	
J	McHenry, M				McHenry, M			Acoustic characteristics of voice after severe traumatic brain injury	LARYNGOSCOPE			English	Article						voice disorders; traumatic brain injury; intelligibility	DYSARTHRIA; DISEASE	Objectives/Hypothesis: To describe the acoustic characteristics of voice in individuals with motor speech disorders after traumatic brain injury (TBI), Study Design: Prospective study of 100 individuals with TBI based on consecutive referrals for motor speech evaluations. Methods: Subjects were audio tape-recorded while producing sustained vowels and single word and sentence intelligibility tests. Laryngeal airway resistance was estimated, and voice quality was rated perceptually. Results: None of the subjects evidenced vocal parameters within normal limits. The most frequently occurring abnormal parameter across subjects was amplitude perturbation, followed by voice turbulence index. Twenty-three percent of subjects evidenced deviation in all five parameters measured. The perceptual ratings of breathiness were significantly correlated with both the amplitude perturbation quotient and the noise-to-harmonics ratio. Conclusions: Vocal quality deviation is common in motor speech disorders after TBI and mag impact intelligibility.	Transit Learning Ctr, Galveston, TX 77553 USA	McHenry, M (corresponding author), Transit Learning Ctr, 1528 PO St, Galveston, TX 77553 USA.						BARLOW S M, 1989, Journal of Voice, V3, P283, DOI 10.1016/S0892-1997(89)80050-5; BARLOW SM, 1991, J COMPUTER USERS SPE, V7, P211; COHEN J, 1993, APPL MULTIPLE REGRES; DARLEY FL, 1969, J SPEECH HEAR RES, V12, P462, DOI 10.1044/jshr.1203.462; DARLEY FL, 1969, J SPEECH HEAR RES, V12, P246, DOI 10.1044/jshr.1202.246; De Bodt M, 1996, Acta Otorhinolaryngol Belg, V50, P325; Dejonckere P H, 1998, Rev Laryngol Otol Rhinol (Bord), V119, P265; Dromey C, 1998, J SPEECH LANG HEAR R, V41, P1003, DOI 10.1044/jslhr.4105.1003; DROMEY C, 1995, J SPEECH HEAR RES, V38, P751, DOI 10.1044/jshr.3804.751; Duffy J. R., 2020, MOTOR SPEECH DISORDE; Hanson HM, 1997, J ACOUST SOC AM, V101, P466, DOI 10.1121/1.417991; Kent RD, 1999, AM J SPEECH-LANG PAT, V8, P129, DOI 10.1044/1058-0360.0802.129; Kent RD, 1997, FOLIA PHONIATR LOGO, V49, P63, DOI 10.1159/000266440; KENT RD, 1989, J SPEECH HEAR DISORD, V54, P482, DOI 10.1044/jshd.5404.482; McHenry MA, 1996, DISORDERS MOTOR SPEE, P229; MCHENRY MA, 1997, AM J SPEECH-LANG PAT, V6, P56; NETSELL R, 1991, J VOICE, V5, P1, DOI 10.1016/S0892-1997(05)80157-2; Ramig L. O., 1992, INTELLIGIBILITY SPEE, DOI [10.1075/sspcl.1.05ram, DOI 10.1075/SSPCL.1.05RAM]; RAMIG LA, 1988, ANN OTO RHINOL LARYN, V97, P164, DOI 10.1177/000348948809700214; RAMIG LO, 1992, DISORDERS LARYNX, P163; Theodoros DG, 1996, DISORDERS MOTOR SPEE, P205; TITZE IR, 1991, J SPEECH HEAR RES, V34, P460, DOI 10.1044/jshr.3403.460; Van Lierde K, 1996, Acta Otorhinolaryngol Belg, V50, P345; Yorkston K., 1984, COMPUTERIZED ASSESSM; ZWIRNER P, 1991, J COMMUN DISORD, V24, P287, DOI 10.1016/0021-9924(91)90004-3; ZYSKI BJ, 1987, J COMMUN DISORD, V20, P367, DOI 10.1016/0021-9924(87)90025-6	26	17	17	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0023-852X	1531-4995		LARYNGOSCOPE	Laryngoscope	JUL	2000	110	7					1157	1161		10.1097/00005537-200007000-00017			5	Medicine, Research & Experimental; Otorhinolaryngology	Research & Experimental Medicine; Otorhinolaryngology	330NZ	WOS:000087969300017	10892688	Bronze			2021-06-18	
J	Fujimura, M; Morita-Fujimura, Y; Noshita, N; Yoshimoto, T; Chan, PH				Fujimura, M; Morita-Fujimura, Y; Noshita, N; Yoshimoto, T; Chan, PH			Reduction of the DNA base excision repair protein, XRCC1, may contribute to DNA fragmentation after cold injury-induced brain trauma in mice	BRAIN RESEARCH			English	Article						DNA base excision repair; XRCC1; apoptosis; cold injury; traumatic brain injury	FOCAL CEREBRAL-ISCHEMIA; MITOCHONDRIAL CYTOCHROME-C; STRAND BREAK REPAIR; POLY(ADP-RIBOSE) POLYMERASE; SUPEROXIDE-DISMUTASE; NEURONAL APOPTOSIS; EARLY DECREASE; LIGASE-III; GENE XRCC1; APURINIC/APYRIMIDINIC ENDONUCLEASE	The X-ray repair cross-complementing group 1 (XRCC1) protein plays a central role in the DNA base excision repair pathway by interacting with DNA ligase III and DNA polymerase beta. The present study examined the protein expression of XRCC1 and DNA fragmentation before and after cold injury-induced brain trauma (CIBT) in mice, in which apoptosis is assumed to participate. Immunohistochemistry showed the nuclear expression of XRCC1 in the entire region of the control brains. Fifteen minutes after CIBT, nuclear immunoreactivity was predominantly decreased in the inner boundary of the lesion, followed by a significant reduction of XRCC1 in the entire lesion 4 h after CIBT. A characteristic 70-kDa band was detected in the non-traumatic area, and was markedly decreased after CIBT as shown by Western blot analysis. DNA fragmentation was also observed after CIBT, and double staining with XRCC1 immunohistochemistry and terminal deoxynucleotidyl transferase-mediated uridine 5'-triphosphate-biotin nick end labeling showed a spatial relationship between XRCC1 loss and DNA fragmentation 24 h after CIBT. These data indicate that early decrease of XRCC1 and failure of the DNA repair mechanism may contribute to DNA-damaged neuronal cell death after CIBT. (C) 2000 Elsevier Science B.V. All rights reserved.	Stanford Univ, Neurosurg Labs, Sch Med, Dept Neurosurg, Palo Alto, CA 94304 USA; Stanford Univ, Sch Med, Dept Neurol & Neurosurg Sci, Palo Alto, CA 94304 USA; Stanford Univ, Sch Med, Neurosci Program, Palo Alto, CA 94304 USA; Tohoku Univ, Sch Med, Dept Neurosurg, Sendai, Miyagi 980, Japan	Chan, PH (corresponding author), Stanford Univ, Neurosurg Labs, Sch Med, Dept Neurosurg, 701B Welch Rd,148, Palo Alto, CA 94304 USA.		fujimura, yuiko/M-7393-2013; Morita-fujimura, Yuiko/N-4804-2014		NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS014543, R01NS025372, P50NS014543, R01NS036147] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS25372, NS36147, NS14543] Funding Source: Medline		Caldecott KW, 1996, NUCLEIC ACIDS RES, V24, P4387, DOI 10.1093/nar/24.22.4387; Cappelli E, 1997, J BIOL CHEM, V272, P23970, DOI 10.1074/jbc.272.38.23970; CHAN PH, 1991, ANN NEUROL, V29, P482, DOI 10.1002/ana.410290506; Chopp M, 1996, STROKE, V27, P363, DOI 10.1161/01.STR.27.3.363; Conti AC, 1998, J NEUROSCI, V18, P5663; Eliasson MJL, 1997, NAT MED, V3, P1089, DOI 10.1038/nm1097-1089; Fujimura M, 1998, J CEREBR BLOOD F MET, V18, P1239, DOI 10.1097/00004647-199811000-00010; Fujimura M, 1999, STROKE, V30, P2456, DOI 10.1161/01.STR.30.11.2456; Fujimura M, 1999, J CEREBR BLOOD F MET, V19, P495, DOI 10.1097/00004647-199905000-00003; Fujimura M, 1999, STROKE, V30, P2408, DOI 10.1161/01.STR.30.11.2408; Fujimura M, 1999, J NEUROSCI, V19, P3414; Kawase M, 1999, STROKE, V30, P441, DOI 10.1161/01.STR.30.2.441; Kubota Y, 1996, EMBO J, V15, P6662, DOI 10.1002/j.1460-2075.1996.tb01056.x; Liu PK, 1996, J NEUROSCI, V16, P6795; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Masson M, 1998, MOL CELL BIOL, V18, P3563, DOI 10.1128/MCB.18.6.3563; Morita-Fujimura Y, 1999, NEUROSCI LETT, V267, P201, DOI 10.1016/S0304-3940(99)00327-4; Morita-Fujimura Y, 1999, J CEREBR BLOOD F MET, V19, P634, DOI 10.1097/00004647-199906000-00006; Morita-Fujimura Y, 1999, NEUROSCIENCE, V93, P1465, DOI 10.1016/S0306-4522(99)00231-6; Murakami K, 1997, NEUROSCIENCE, V81, P231, DOI 10.1016/S0306-4522(97)00197-8; Nash RA, 1997, BIOCHEMISTRY-US, V36, P5207, DOI 10.1021/bi962281m; Shen NR, 1998, NUCLEIC ACIDS RES, V26, P1032, DOI 10.1093/nar/26.4.1032; THOMPSON LH, 1990, MOL CELL BIOL, V10, P6160, DOI 10.1128/MCB.10.12.6160; TOMINAGA T, 1992, NEUROSCI LETT, V139, P265, DOI 10.1016/0304-3940(92)90568-R; Whalen MJ, 1999, J CEREBR BLOOD F MET, V19, P835, DOI 10.1097/00004647-199908000-00002; Yakovlev AG, 1997, J NEUROSCI, V17, P7415; YOO HY, 1992, BIOCHEM BIOPH RES CO, V186, P900, DOI 10.1016/0006-291X(92)90831-5; ZHANG J, 1994, SCIENCE, V263, P687, DOI 10.1126/science.8080500; ZHOU ZQ, 1995, MUTAT RES LETT, V348, P111, DOI 10.1016/0165-7992(95)00053-4	29	17	17	0	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993			BRAIN RES	Brain Res.	JUN 30	2000	869	1-2					105	111		10.1016/S0006-8993(00)02375-1			7	Neurosciences	Neurosciences & Neurology	330YY	WOS:000087990300013	10865064				2021-06-18	
J	Dean, S; Colantonio, A; Ratcliff, G; Chase, S				Dean, S; Colantonio, A; Ratcliff, G; Chase, S			Clients' perspectives on problems many years after traumatic brain injury	PSYCHOLOGICAL REPORTS			English	Article							CLOSED HEAD-INJURY; FOLLOW-UP	This study investigated the types of self-reported main problems that persons report many years following a traumatic brain injury. This preliminary study is part of a large ongoing study of disability and handicap in adults following traumatic brain injury. As part of an extensive interview, subjects were asked an open-ended question regarding their current main problems which they thought resulted from their traumatic brain injury. Responses were obtained from 166 adult subjects (119 men and 47 women) whose lime postinjury ranged from 9 to 24 pears. Categories for responses were subsequently developed. The most commonly reported categories of problems were those relating to movement (39%), cognition (36%), and sensory impairment (31%). Findings suggest that subjects' long-term concerns were related to specific impairments more than to psychosocial, emotional, or behavioral issues. Methodological issues concerning this research are discussed in relation to findings.	Univ Toronto, Grad Dept Rehabil Sci, Dept Occupat Therapy, Toronto, ON M5T 1W5, Canada; HealthS Harmarville Rehabil Hosp, Pittsburgh, PA USA	Colantonio, A (corresponding author), Univ Toronto, Grad Dept Rehabil Sci, Dept Occupat Therapy, 256 McCaul St, Toronto, ON M5T 1W5, Canada.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS034740] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS34740-02] Funding Source: Medline		*COUNC CLIN CLASS, 1980, INT CLASS DIS; HARRICK L, 1994, BRAIN INJURY, V8, P439, DOI 10.3109/02699059409150995; KLONOFF PS, 1986, NEUROSURGERY, V19, P735, DOI 10.1227/00006123-198611000-00004; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; PONSFORD JL, 1995, BRAIN INJURY, V9, P1, DOI 10.3109/02699059509004565; RAPPAPORT M, 1989, ARCH PHYS MED REHAB, V70, P885	6	17	17	0	2	PSYCHOLOGICAL REPORTS	MISSOULA	P O BOX 9229, MISSOULA, MT 59807 USA	0033-2941			PSYCHOL REP	Psychol. Rep.	APR	2000	86	2					653	658		10.2466/pr0.2000.86.2.653			6	Psychology, Multidisciplinary	Psychology	316AX	WOS:000087146100046	10840924				2021-06-18	
J	Stuss, DT; Binns, MA; Carruth, FG; Levine, B; Brandys, CF; Moulton, RJ; Snow, WG; Schwartz, ML				Stuss, DT; Binns, MA; Carruth, FG; Levine, B; Brandys, CF; Moulton, RJ; Snow, WG; Schwartz, ML			Prediction of recovery of continuous memory after traumatic brain injury	NEUROLOGY			English	Article						traumatic brain injury; post-traumatic amnesia; recovery; severity; confusion; prediction of recovery	SEVERE HEAD-INJURY; ALZHEIMERS-DISEASE; POSTTRAUMATIC AMNESIA; AGE; EDUCATION; IMPACT	Objective: To evaluate the ability of measures of initial severity, tests of attention, and demographic characteristics to predict recovery of continuous memory for words over a 24-hour period in patients with acute traumatic brain injury. Methods: Recovery of continuous memory was assessed prospectively in 94 patients with nonpenetrating traumatic brain injury. A classification and regression tree analysis identified a hierarchical subset of variables that may be used as a simple guideline for predicting recovery of continuous memory. Weibull regression models evaluated and compared the predictive ability of multiple variables. Results: Four groups of patients were identified based on measures of severity of injury and demographic characteristics. These four groups had recovery profiles that were more precise than could be obtained by using the Glasgow Coma Scale alone: mild, about 1 week to recovery of continuous memory; moderate, 1 to 4 weeks; severe, 2 to 6 weeks; and extremely severe, 4 to 8 weeks. Regression analysis confirmed that measures of capacity (inherent resources such as indicated by age) and compromise (general functional brain state measured neuropsychologically) improved prediction over models based only on injury severity measures, such as the Glasgow Coma Scale. Conclusions: Approaches to predicting recovery of continuous memory in the acute period after traumatic brain injury that take into account multiple measures provide a more sensitive predictive index.	Baycrest Ctr Geriatr Care, Rotman Res Inst, Toronto, ON M6A 2E1, Canada; Univ Toronto, Dept Med Neurol Rehabil Sci, Toronto, ON, Canada; Univ Toronto, Dept Psychol, Toronto, ON M5S 1A1, Canada; Univ Toronto, Dept Surg, Toronto, ON, Canada; Sunnybrook Hlth Sci Ctr, Toronto, ON M4N 3M5, Canada; St Michaels Hosp, Toronto, ON M5B 1W8, Canada	Stuss, DT (corresponding author), Baycrest Ctr Geriatr Care, Rotman Res Inst, 3560 Bathurst St, Toronto, ON M6A 2E1, Canada.		Binns, Malcolm/AAQ-9195-2020; Levine, Brian/O-2725-2019; Levine, Brian/G-4328-2010	Binns, Malcolm/0000-0001-9998-6612; Levine, Brian/0000-0003-4343-811X; Levine, Brian/0000-0003-4343-811X			Anderson V, 1995, CHILD NEUROPSYCHOL, V1, P187, DOI 10.1080/09297049508400224; Anderson V A, 1997, J Int Neuropsychol Soc, V3, P568; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; BROOKS D N, 1974, Cortex, V10, P224; DACEY R, 1991, J TRAUMA, V31, P217, DOI 10.1097/00005373-199131020-00011; DAVIS CS, 1988, J AM GERIATR SOC, V36, P225, DOI 10.1111/j.1532-5415.1988.tb01805.x; Evans D A, 1993, Ann Epidemiol, V3, P71; GOLDSTEIN FC, 1994, J NEUROL NEUROSUR PS, V57, P961, DOI 10.1136/jnnp.57.8.961; KATZ D, 1999, REHABILITATION ADULT, P89; KATZ DI, 1994, ARCH NEUROL-CHICAGO, V51, P661, DOI 10.1001/archneur.1994.00540190041013; KATZ DI, 1994, HDB NEUROREHABILITAT, P493; Kidron D, 1997, NEUROLOGY, V49, P1504, DOI 10.1212/WNL.49.6.1504; Lawless J.F., 1982, STAT MODELS METHODS; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; MCLEAN A, 1983, J CLIN NEUROPSYCHOL, V5, P361, DOI 10.1080/01688638308401185; MORTIMER JA, 1993, NEUROLOGY, V43, P39; ODDY M, 1980, J NEUROL NEUROSUR PS, V43, P798, DOI 10.1136/jnnp.43.9.798; Olshen RA, 1984, CLASSIFICATION REGRE; PENNINGS JL, 1993, ARCH SURG-CHICAGO, V128, P787; Reeder KP, 1996, J HEAD TRAUMA REHAB, V11, P22, DOI 10.1097/00001199-199606000-00006; RICHARDSON JTE, 1984, COGN NEUROPSYCHOL, V3, P217; SANEDA D L, 1992, Brain Injury, V6, P167, DOI 10.3109/02699059209029655; Schwartz ML, 1998, CAN J NEUROL SCI, V25, P108, DOI 10.1017/S0317167100033709; STERN Y, 1994, JAMA-J AM MED ASSOC, V271, P1004, DOI 10.1001/jama.271.13.1004; Stuss DT, 1999, J NEUROSURG, V90, P635, DOI 10.3171/jns.1999.90.4.0635; SUNDERLAND A, 1984, J CLIN NEUROPSYCHOL, V6, P127, DOI 10.1080/01688638408401204; Teasdale G, 1979, Acta Neurochir Suppl (Wien), V28, P140; TEMKIN NR, 1995, J NEUROSURG, V82, P764, DOI 10.3171/jns.1995.82.5.0764; VOLLMER DG, 1991, J NEUROSURG, V75, pS37, DOI 10.3171/sup.1991.75.1s.0s37; WILSON J T L, 1992, Brain Injury, V6, P391, DOI 10.3109/02699059209008135; WILSON JTL, 1994, J NEUROL NEUROSUR PS, V57, P198, DOI 10.1136/jnnp.57.2.198; WINOCUR G, 1990, CAN J PSYCHOL, V44, P435, DOI 10.1037/h0084270; Winocur G, 1992, HDB AGING COGNITION, P315; WONG PP, 1994, BRAIN INJURY, V8, P509, DOI 10.3109/02699059409151003; ZHANG MY, 1990, ANN NEUROL, V27, P428, DOI 10.1002/ana.410270412	35	17	17	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0028-3878			NEUROLOGY	Neurology	MAR 28	2000	54	6					1337	1344		10.1212/WNL.54.6.1337			8	Clinical Neurology	Neurosciences & Neurology	297XY	WOS:000086109300024	10746607				2021-06-18	
J	Whitfield, PC; Pickard, JD				Whitfield, PC; Pickard, JD			Expression of the immediate early genes c-Fos and c-Jun after head injury in man	NEUROLOGICAL RESEARCH			English	Article						immediate early gene; c-Fos; c-Jun; brain injury; contusion; human	PROGRAMMED CELL-DEATH; ISCHEMIC BRAIN-DAMAGE; PROTEIN; INDUCTION; NEURONS; APOPTOSIS; SEQUENCE; ENCODES; TRAUMA; NERVE	Immediate early genes (IEG) are expressed in a variety of experimental paradigms including cerebral ischemia and trauma. There is a paucity of information on whether the results of laboratory experiments can be extrapolated from animals into man. To examine this further we hypothesised that expression of c-Fos and c-Jun occurs after contusional head injury in man. We also sought to identify whether there was an association between the level of immediate early gene expression and 1. the outcome one year after head injury, 2. the timing of surgery after head injury. IEG expression was examined using in situ hybridisation and immunocytochemistry in brain tissue therapeutically removed in 14 patients with head injury 6 h to 6 days after contusional injury IEG expression was also examined in tissue removed during elective non-traumatic neurosurgery for comparative purposes. Expression of c-fos and c-jun mRNA was observed in 50% and 64% of head-injured patients respectively Protein immunoreactivity for these IEGs was evident in 67% of head injured patients. The expression of c-Fos and c-lun was associated with final outcome. Patients with poorer outcomes had higher levels of gene expression (p = 0.08 for c-Fos and p = 0.006 for c-jun). No correlation between the timing of surgery and the intensity of gene expression was evident in the trauma patients (r(2) = 0.09 and 0.10 for c-Fos and c-lun respectively). In the non-trauma patients 36% expressed c-fos and 73% expressed c-jun mRNA, with all patients studied expressing c-Fos and c-lun proteins. We conclude that differential expression of c-Fos and c-lun occurs in the patients with cerebral contusions. The difference in expression rates between mRNA and protein emphasises the need for analysis of gene products when investigating gene expression. These results support the hypothesis that IEGs may be involved in the pathogenetic mechanisms of contusional head injury. Observations of IEG expression in human brain injury are important in steering animal experimental programmes towards studies that may yield information directly applicable to human brain injury.	Addenbrookes NHS Trust, Whitfield Acad Neurosurg Unit, Dept Acad Neurosurg, MRC,Ctr Brain Repair, Cambridge CB2 2QQ, England	Whitfield, PC (corresponding author), Addenbrookes NHS Trust, Whitfield Acad Neurosurg Unit, Dept Acad Neurosurg, MRC,Ctr Brain Repair, Box 166,Hills Rd, Cambridge CB2 2QQ, England.				Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G9439390] Funding Source: Medline		Akins PT, 1996, STROKE, V27, P1682, DOI 10.1161/01.STR.27.9.1682; ANGEL P, 1988, NATURE, V332, P166, DOI 10.1038/332166a0; BOHMANN D, 1987, SCIENCE, V238, P1386, DOI 10.1126/science.2825349; Bullock R, 1998, J NEUROSURG, V89, P507, DOI 10.3171/jns.1998.89.4.0507; DRAGUNOW M, 1988, BRAIN RES, V455, P295, DOI 10.1016/0006-8993(88)90088-1; DRAGUNOW M, 1990, BRAIN RES, V527, P41, DOI 10.1016/0006-8993(90)91058-O; DRAGUNOW M, 1993, MOL BRAIN RES, V18, P347, DOI 10.1016/0169-328X(93)90101-T; DRAGUNOW M, 1990, EXP NEUROL, V107, P236, DOI 10.1016/0014-4886(90)90141-E; Dutcher SA, 1999, NEUROL RES, V21, P234, DOI 10.1080/01616412.1999.11740924; ESTUS S, 1994, J CELL BIOL, V127, P1717, DOI 10.1083/jcb.127.6.1717; GALBRAITH S, 1981, J NEUROSURG, V55, P75, DOI 10.3171/jns.1981.55.1.0075; GRAHAM DI, 1989, J NEUROL NEUROSUR PS, V52, P346, DOI 10.1136/jnnp.52.3.346; GRAHAM DI, 1978, J NEUROL SCI, V39, P213, DOI 10.1016/0022-510X(78)90124-7; Katano H, 1998, BRAIN RES, V800, P69, DOI 10.1016/S0006-8993(98)00493-4; LUCIBELLO FC, 1989, CELL, V59, P999, DOI 10.1016/0092-8674(89)90756-3; MacManus JP, 1997, J CEREBR BLOOD F MET, V17, P815, DOI 10.1038/aj.jcbfm.9590266; MORGAN JI, 1987, SCIENCE, V237, P192, DOI 10.1126/science.3037702; NILSSON P, 1993, J CEREBR BLOOD F MET, V13, P183, DOI 10.1038/jcbfm.1993.22; NOWAK TS, 1993, PROG BRAIN RES, V96, P195; RAGHUPATHI R, 1995, J CEREBR BLOOD F MET, V15, P467, DOI 10.1038/jcbfm.1995.58; SASSONECORSI P, 1988, NATURE, V334, P314, DOI 10.1038/334314a0; SCHLINGENSIEPEN KH, 1994, CELL MOL NEUROBIOL, V14, P487, DOI 10.1007/BF02088833; SMEYNE RJ, 1993, NATURE, V363, P166, DOI 10.1038/363166a0; SOMMER C, 1995, BRAIN PATHOL, V5, P135, DOI 10.1111/j.1750-3639.1995.tb00587.x; Soriano MA, 1996, NEUROREPORT, V7, P425, DOI 10.1097/00001756-199601310-00012; TEASDALE GM, 1995, J NEUROL NEUROSUR PS, V58, P526, DOI 10.1136/jnnp.58.5.526; VANSTRAATEN F, 1983, P NATL ACAD SCI-BIOL, V80, P3183; Whitfield P. C., 1997, Clinical Science (London), V93, p25P; Whitfield PC, 1999, BRAIN RES, V818, P450, DOI 10.1016/S0006-8993(98)01342-0; WHITFIELD PC, 1996, J NEUROL NEUROSUR PS, V61, P550	30	17	25	0	1	FOREFRONT PUBL GROUP	WILTON	C/O MARY J RAWLINS, 5 RIVER RD, STE 113, WILTON, CT 06897 USA	0161-6412			NEUROL RES	Neurol. Res.	MAR	2000	22	2					138	144		10.1080/01616412.2000.11741050			7	Clinical Neurology; Neurosciences	Neurosciences & Neurology	302VD	WOS:000086385600001	10763499				2021-06-18	
J	Henry, PT; Rajshekhar, V				Henry, PT; Rajshekhar, V			Post-traumatic malignant glioma: case report and review of the literature	BRITISH JOURNAL OF NEUROSURGERY			English	Article						brain tumour; head injury	LOS-ANGELES COUNTY; MENINGIOMAS	Posttraumatic gliomas have been described, but in none of these has there been documented evidence of absence of tumour at the time of the injury. We report a case of post-traumatic malignant glioma with radiological evidence of only a contusion prior to the development of the tumour.	Christian Med Coll & Hosp, Dept Neurol Sci, Vellore 632004, Tamil Nadu, India	Rajshekhar, V (corresponding author), Christian Med Coll & Hosp, Dept Neurol Sci, Vellore 632004, Tamil Nadu, India.	vraj@neuro.cmc.ernet.in					ANNEGERS JF, 1979, NEUROSURGERY, V4, P203, DOI 10.1227/00006123-197903000-00001; BEHREND RC, 1974, HDB CLIN NEUROLOGY, V16, P78; CHOI NW, 1968, NEUROLOGY, V18, P306; DIEZEL P, 1949, Frankf Z Pathol, V60, P316; FINKEMEYER H, 1956, Zentralbl Neurochir, V16, P318; HEYCK H, MONATS SCHR PSYCHIAT, V128, P180; LUDWIN SK, 1984, NATURE, V308, P274, DOI 10.1038/308274a0; MANUELIDIS EE, 1972, PATHOLOGY NERVOUS SY, V3, P2917; Manuelidis EE., 1972, PATHOLOGY NERVOUS SY, V2, P2237; MORANTZ RA, 1978, NEUROSURGERY, V3, P181, DOI 10.1227/00006123-197809000-00009; Parker HL, 1931, J AMER MED ASSOC, V97, P0535, DOI 10.1001/jama.1931.02730080027008; PEREZDIAZ C, 1985, SURG NEUROL, V24, P581, DOI 10.1016/0090-3019(85)90278-2; PRESTONMARTIN S, 1980, JNCI-J NATL CANCER I, V65, P67; PRESTONMARTIN S, 1983, J NATL CANCER I, V70, P863; SCHEID P, 1938, FRANKFURT Z PATHOL, V51, P446; WINGREN JE, 1948, NORD MED, V37, P163; Zulch KJ, 1974, HDB CLIN NEUROLOGY, V16, P31	17	17	18	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0268-8697	1360-046X		BRIT J NEUROSURG	Br. J. Neurosurg.	FEB	2000	14	1					64	67					4	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	298KT	WOS:000086138700016	10884891				2021-06-18	
J	Hermann, DM; Mies, G; Hata, R; Hossmann, KA				Hermann, DM; Mies, G; Hata, R; Hossmann, KA			Microglial and astrocytic reactions prior to onset of thalamic cell death after traumatic lesion of the rat sensorimotor cortex	ACTA NEUROPATHOLOGICA			English	Article						complement receptor type 3b; glial fibrillary acidic protein; major histocompatibility complex class II retrograde degeneration; terminal transferase-mediated biotinylated dUTP nick end labeling (TUNEL)	EXCITOTOXIC LESION; RETROGRADE DEGENERATION; BRAIN; EXPRESSION; COMPLEX; CNS; MACROPHAGES; ISCHEMIA; AXOTOMY; NEURONS	The temporospatial relationship between microglial and astrocytic reactions and delayed thalamic cell death was examined 1-7 days following a traumatic cold lesion of the rat sensorimotor cortex using immunocytochemistry in combination with terminal deoxynucleo-tidyltransferase-mediated biotinylated dUTP nick end labeling (TUNEL) of nuclear DNA fragmentation. No or only occasional TUNEL-positive cells were found in the thalamic relay nuclei up to 3 days after trauma. After 7 days, on the other hand, a considerable number of TUNEL-positive cells were seen in the ventrobasal, the ventrolateral and posterior thalamic nuclei. Already 3 days after trauma, i.e., before cell injury was detectable, many protoplasmic astrocytes, which were reactive for glial fibrillary acidic protein, and ramified microglia, which were positive for complement receptor type 3b (CR3b) but negative for major histocompatibility complex (MHC) class II antigen, were noticed in the thalamus. The number of labeled astro- and microglia further increased after 7 days, when DNA fragmentation became evident. At this time, the morphology of microglia shifted towards bushy and rod-like cells, and microglia became also reactive for MHC class LI antigen. Clusters of CR3b- and MHC class II-positive microglia were found in the ventrobasal thalamus. The present findings demonstrate that trauma-induced microglial and astrocytic reactions appear in the thalamus prior the onset of cell damage.	Max Planck Inst Neurol Res, Dept Expt Neurol, D-50931 Cologne, Germany	Hermann, DM (corresponding author), Max Planck Inst Neurol Res, Dept Expt Neurol, Gleueler Str 50, D-50931 Cologne, Germany.		Hermann, Dirk M/AAP-5538-2020				Acarin L, 1997, EXP NEUROL, V147, P410, DOI 10.1006/exnr.1997.6593; BANATI RB, 1993, GLIA, V7, P11; BARRON KD, 1967, J NEUROPATH EXP NEUR, V26, P300, DOI 10.1097/00005072-196704000-00007; BLINZING.K, 1968, Z ZELLFORSCH MIK ANA, V85, P145, DOI 10.1007/BF00325030; CHMIELOWSKA J, 1989, J COMP NEUROL, V285, P325, DOI 10.1002/cne.902850304; deBilbao F, 1996, NEUROREPORT, V7, P3051, DOI 10.1097/00001756-199611250-00051; DONOGHUE JP, 1977, BRAIN RES, V125, P351, DOI 10.1016/0006-8993(77)90629-1; DUSART I, 1991, NEUROSCIENCE, V45, P541, DOI 10.1016/0306-4522(91)90269-T; FERRER I, 1994, BRAIN PATHOL, V4, P115, DOI 10.1111/j.1750-3639.1994.tb00821.x; GRAEBER MB, 1988, J NEUROSCI RES, V21, P18, DOI 10.1002/jnr.490210104; Hermann DM, 1999, NEUROREPORT, V10, P759, DOI 10.1097/00001756-199903170-00018; Hermann DM, 1998, NEUROREPORT, V9, P1917, DOI 10.1097/00001756-199806010-00046; HERRERA DG, 1992, NEUROSCIENCE, V49, P781, DOI 10.1016/0306-4522(92)90356-7; Kermer P, 1998, J NEUROSCI, V18, P4656; KERNS JM, 1973, J COMP NEUROL, V151, P255, DOI 10.1002/cne.901510304; KOLB B, 1983, EXP NEUROL, V79, P223, DOI 10.1016/0014-4886(83)90393-X; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; MAEHLEN J, 1989, J NEUROIMMUNOL, V23, P125, DOI 10.1016/0165-5728(89)90031-3; MARTY S, 1991, NEUROSCIENCE, V45, P529, DOI 10.1016/0306-4522(91)90268-S; MATTHEWS MA, 1973, J NEUROCYTOL, V151, P255; MILLIGAN CE, 1991, J COMP NEUROL, V314, P136, DOI 10.1002/cne.903140113; PESCHANSKI M, 1987, J COMP NEUROL, V258, P185, DOI 10.1002/cne.902580203; RINK A, 1995, AM J PATHOL, V147, P1575; ROSS DT, 1990, NEUROSCIENCE, V35, P525, DOI 10.1016/0306-4522(90)90327-Z; Sorensen JC, 1996, EXP BRAIN RES, V112, P203; STREIT WJ, 1989, J NEUROIMMUNOL, V21, P117, DOI 10.1016/0165-5728(89)90167-7; Watanabe H, 1998, J CEREBR BLOOD F MET, V18, P686, DOI 10.1097/00004647-199806000-00011	27	17	18	0	0	SPRINGER VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010 USA	0001-6322			ACTA NEUROPATHOL	Acta Neuropathol.	FEB	2000	99	2					147	153		10.1007/PL00007418			7	Clinical Neurology; Neurosciences; Pathology	Neurosciences & Neurology; Pathology	275TA	WOS:000084835200009	10672321				2021-06-18	
J	Vajragupta, O; Toasaksiri, S; Boonyarat, C; Wongkrajang, Y; Peungvicha, P; Watanabe, H; Boonchoong, P				Vajragupta, O; Toasaksiri, S; Boonyarat, C; Wongkrajang, Y; Peungvicha, P; Watanabe, H; Boonchoong, P			Chroman amide and nicotinyl amide derivatives: Inhibition of lipid peroxidation and protection against head trauma	FREE RADICAL RESEARCH			English	Article						antioxidant; trolox; cerebroprotective radical scavenger; brain trauma; anoxia; antioxidative vitamins; QSAR; ESR	NERVOUS-SYSTEM TRAUMA; FREE-RADICALS; REPERFUSION INJURY; CEREBRAL-ISCHEMIA; ATHEROSCLEROSIS; DOPAMINE; AGENTS; BRAIN; METHAMPHETAMINE; ACIDS	A series of chroman amide and nicotinyl amide derivatives was designed and synthesized for the treatment of traumatic and ischemic CNS injury. Five compounds were significantly more potent inhibitors of lipid peroxidation in vitro than the reference antioxidant, trolox (p < 0.01). Quantitative structure activity studies demonstrated that the inhibitory action was related to the ability to donate electrons, charge on hydroxy group and E-LUMO, to scavenging radicals and to the lipophilicity log P, which determines penetration of membrane lipids. ESR study indicated the ability of 12 to scavenge the hydroxyl radicals. The most promising compound, [(3,4-dihydro-6-hydroxy2,5,7,8-tetramethyl-2H-1-benzopyran-2yl) carbonyl](aminoethyl) indole (12), inhibited ex vivo lipid peroxidation in a head injury model and showed potent in vivo neuroprotective efficacy. Improvement of neurological recovery within 1 h of injury (grip test score) by as much as 200% was observed together with significant anti-anoxia activity. Compound 12 was a potent antagonist of methamphetamine-induced hypermotility resulting from dopamine release in the mouse brain. These results support the importance of cerebroprotective radical-scavenging agents for the treatment of traumatic injury and anoxia as well as provide additional evidence for the role of oxygen radicals and dopamine in brain damage.	Mahidol Univ, Dept Pharmaceut Chem, Bangkok 10400, Thailand; Mahidol Univ, Fac Pharm, Dept Physiol, Bangkok 10400, Thailand; Toyama Med & Pharmaceut Univ, Res Inst Oriental Med, Sugitani, Toyama 93001, Japan	Vajragupta, O (corresponding author), Mahidol Univ, Dept Pharmaceut Chem, 447 Sri Ayudhya Rd, Bangkok 10400, Thailand.		vajragupta, opa/R-6616-2019	Boonyarat, Chantana/0000-0003-4065-6090; Vajragupta, Opa/0000-0003-3313-0621			AMES BN, 1993, P NATL ACAD SCI USA, V90, P7915, DOI 10.1073/pnas.90.17.7915; BOLLI R, 1991, CARDIOVASC DRUG THER, V5, P249, DOI 10.1007/BF00054747; BRAUGHLER JM, 1989, FREE RADICAL BIO MED, V6, P289, DOI 10.1016/0891-5849(89)90056-7; CADET JL, 1994, J NEUROCHEM, V62, P380; CLEMENS JA, 1988, LIFE SCI, V42, P707, DOI 10.1016/0024-3205(88)90463-8; FRAISSE L, 1993, J MED CHEM, V36, P1465, DOI 10.1021/jm00062a020; GRISAR JM, 1995, J MED CHEM, V38, P453, DOI 10.1021/jm00003a008; GROSS H, 1968, TETRAHEDRON, V24, P6935, DOI 10.1016/S0040-4020(01)96807-3; GUTTERIDGE J M C, 1990, Analytical Proceedings, V27, P219; Hall E D, 1986, Cent Nerv Syst Trauma, V3, P281; HALL ED, 1989, FREE RADICAL BIO MED, V6, P303, DOI 10.1016/0891-5849(89)90057-9; HALLIWELL B, 1989, BRIT J EXP PATHOL, V70, P737; JACOBSEN EJ, 1990, J MED CHEM, V33, P1145, DOI 10.1021/jm00166a010; JACOBSEN EJ, 1992, J MED CHEM, V35, P4465; KATO K, 1988, J MED CHEM, V31, P793, DOI 10.1021/jm00399a019; KONTOS HA, 1986, J NEUROSURG, V64, P803, DOI 10.3171/jns.1986.64.5.0803; KuehmCaubere C, 1997, J MED CHEM, V40, P1201, DOI 10.1021/jm960542k; NIHRO Y, 1991, J MED CHEM, V34, P2152, DOI 10.1021/jm00111a034; Ohkawa S, 1997, J MED CHEM, V40, P559, DOI 10.1021/jm960411j; OHKUBO M, 1995, CHEM PHARM BULL, V43, P947; OLIVER CN, 1990, P NATL ACAD SCI USA, V87, P5144, DOI 10.1073/pnas.87.13.5144; OSHIRO Y, 1991, J MED CHEM, V34, P2014, DOI 10.1021/jm00111a014; PANETTA JA, 1994, ANN NY ACAD SCI, V723, P239, DOI 10.1111/j.1749-6632.1994.tb36730.x; PIOTROWSKI JJ, 1990, LIFE SCI, V46, P715, DOI 10.1016/0024-3205(90)90077-5; ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0; ROUSSEAU EJ, 1992, FREE RADICAL BIO MED, V13, P407, DOI 10.1016/0891-5849(92)90183-H; SCHMIDT CJ, 1985, J PHARMACOL EXP THER, V233, P539; STOCKS J, 1974, CLIN SCI MOL MED, V47, P215, DOI 10.1042/cs0470215; VAJRAGUPTA O, 1988, J SCI SOC THAILAND, V14, P51; YAMAMOTO M, 1993, RES COMMUN CHEM PATH, V81, P221	30	17	18	0	3	HARWOOD ACAD PUBL GMBH	READING	C/O STBS LTD, PO BOX 90, READING, BERKS, ENGLAND RG1 8JL	1071-5762			FREE RADICAL RES	Free Radic. Res.		2000	32	2					145	155		10.1080/10715760000300151			11	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	276HG	WOS:000084871500005	10653485				2021-06-18	
J	Irazuzta, JE; Olson, J; Kiefaber, MP; Wong, H				Irazuzta, JE; Olson, J; Kiefaber, MP; Wong, H			Hypothermia decreases excitatory neurotransmitter release in bacterial meningitis in rabbits	BRAIN RESEARCH			English	Article						hypothermia; meningitis; glutamate; aspartate; neurotransmitter; heat shock protein	EXPERIMENTAL PNEUMOCOCCAL MENINGITIS; HEAT-SHOCK-PROTEIN; TRAUMATIC BRAIN INJURY; CENTRAL-NERVOUS-SYSTEM; CEREBROSPINAL-FLUID; RAT-BRAIN; MODERATE HYPOTHERMIA; NEURONAL INJURY; NITRIC-OXIDE; AMINO-ACIDS	The excitatory neurotransmitters glutamate (GLU) and aspartate (ASP) are involved in the pathogenesis of neuronal injury in meningitis. Based on past findings that the induction of moderate hypothermia (32-34 degrees C) attenuates the release of GLU in ischemic brain injury, this study was designed to detect if the application of moderate hypothermia decreases the release of excitatory amino acids (EAA) from brain tissue of animals with bacterial meningitis. Also examined was whether meningitis induces the expression of 72-kDa heat shock protein (HSP 70) in the cerebellum and how hypothermia affects it, for induction of HSP 70 has been used as a sensitive marker of neuronal stress in other forms of brain injury. Meningitis was induced by injecting Group B Streptococcus (GBS) into the cisterna magnae of rabbits. Antibiotic treatment began 16 h later. At this time the animals were anesthetized, instrumented, and randomized to normothermic (Nor) or hypothermic (Hy) conditions. Temperatures were strictly regimented for the following 10 h while maintaining stable cardiorespiratory parameters. Cerebrospinal fluid (CSF) samples were then withdrawn to measure concentrations of bacteria, protein, and amino acids. Meningitis causes CSF contents of GLU and ASP to increase significantly. Hypothermia treated animals demonstrated a 40-50% reduction in CSF GLU and ASP. Meningitis induced the expression of HSP 70 in the cerebellum while hypothermic animals experienced a significant decrease HSP 70 induction. These data demonstrate that hypothermia produces an attenuation of the release of excitatory neurotransmitters in meningitis and suggest that this treatment may attenuate neuronal stress. (C) 1999 Published by Elsevier Science B.V. All rights reserved.	Childrens Hosp, Med Ctr, Div Crit Care, Cincinnati, OH 45229 USA; Childrens Med Ctr, Dayton, OH 45404 USA; Wright State Univ, Dept Emergency Med, Dayton, OH 45435 USA; MSI Ohio State Univ, Columbus, OH USA	Irazuzta, JE (corresponding author), Childrens Hosp, Med Ctr, Div Crit Care, Cincinnati, OH 45229 USA.			Wong, Hector/0000-0001-7989-1173	NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [K08HL003725] Funding Source: NIH RePORTER; NHLBI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [K08HL03725] Funding Source: Medline		Arditi M, 1998, PEDIATRICS, V102, P1087, DOI 10.1542/peds.102.5.1087; BARAFF LJ, 1993, PEDIATR INFECT DIS J, V12, P389, DOI 10.1097/00006454-199305000-00008; BARONE FC, 1995, MOL CHEM NEUROPATHOL, V24, P13, DOI 10.1007/BF03160109; BARSARSKY TA, 1999, J NEUROSCI, V19, P6439; BENVENISTE H, 1984, J NEUROCHEM, V43, P1369, DOI 10.1111/j.1471-4159.1984.tb05396.x; BERING EA, 1961, AM J PHYSIOL, V200, P417; BROWN IR, 1989, NEURON, V2, P1559, DOI 10.1016/0896-6273(89)90044-5; Bullock R, 1998, J NEUROSURG, V89, P507, DOI 10.3171/jns.1998.89.4.0507; BURYAKOVA AV, 1975, ARCH NEUROL-CHICAGO, V32, P28, DOI 10.1001/archneur.1975.00490430050007; BUSTO R, 1989, STROKE, V20, P904, DOI 10.1161/01.STR.20.7.904; BUSTO R, 1987, J CEREBR BLOOD F MET, V7, P729, DOI 10.1038/jcbfm.1987.127; Clark RSB, 1996, J NEUROTRAUM, V13, P333, DOI 10.1089/neu.1996.13.333; CLIFTON GL, 1991, J CEREBR BLOOD F MET, V11, P114, DOI 10.1038/jcbfm.1991.13; Darakchiev BJ, 1997, ACT NEUR S, V70, P98; DIETRICH WD, 1994, ACTA NEUROPATHOL, V87, P250, DOI 10.1007/BF00296740; GUERRAROMERO L, 1993, PEDIATR RES, V33, P510, DOI 10.1203/00006450-199305000-00018; HILGIER W, 1994, J NEUROCHEM, V62, P197; KIM YS, 1995, J NEUROPATH EXP NEUR, V54, P531, DOI 10.1097/00005072-199507000-00007; KIMELBERG HK, 1990, J NEUROSCI, V10, P1583; KOEDEL U, 1995, ANN NEUROL, V37, P313, DOI 10.1002/ana.410370307; Lahrtz F, 1998, J NEUROIMMUNOL, V85, P33, DOI 10.1016/S0165-5728(97)00267-1; Leib SL, 1996, J INFECT DIS, V173, P166, DOI 10.1093/infdis/173.1.166; LOCKWOOD AH, 1980, BRAIN RES, V200, P216, DOI 10.1016/0006-8993(80)91112-9; LOWENSTEIN DH, 1990, BRAIN RES, V531, P173, DOI 10.1016/0006-8993(90)90771-3; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; MCALLISTER CK, 1975, J INFECT DIS, V132, P355, DOI 10.1093/infdis/132.4.355; MINAMISAWA H, 1990, J CEREBR BLOOD F MET, V10, P365, DOI 10.1038/jcbfm.1990.66; OLDENDORF WH, 1976, AM J PHYSIOL, V230, P940; Olney J W, 1986, Adv Neurol, V44, P857; Planas AM, 1997, PROG NEUROBIOL, V51, P607, DOI 10.1016/S0301-0082(97)00004-X; Qureshi GA, 1998, NEUROCHEM INT, V32, P197, DOI 10.1016/S0197-0186(97)00061-2; RAGHUPATHI R, 1995, BRAIN PATHOL, V5, P437, DOI 10.1111/j.1750-3639.1995.tb00622.x; ROSOMOFF HL, 1959, J NEUROSURG, V16, P177, DOI 10.3171/jns.1959.16.2.0177; ROTHMAN SM, 1987, TRENDS NEUROSCI, V10, P299, DOI 10.1016/0166-2236(87)90177-9; Rumana CS, 1998, CRIT CARE MED, V26, P562, DOI 10.1097/00003246-199803000-00032; SAEZLLORENS X, 1990, J PEDIATR-US, V116, P671, DOI 10.1016/S0022-3476(05)82647-2; Schuchat A, 1997, NEW ENGL J MED, V337, P970, DOI 10.1056/NEJM199710023371404; SHAVER EG, 1995, STROKE, V26, P1273, DOI 10.1161/01.STR.26.7.1273; SHIMADA N, 1993, J NEUROCHEM, V60, P66, DOI 10.1111/j.1471-4159.1993.tb05823.x; SIMON RP, 1991, J NEUROSCI, V11, P881; SLOVITER RS, 1992, J NEUROSCI, V12, P3004; Spranger M, 1996, J NEUROL SCI, V143, P126, DOI 10.1016/S0022-510X(96)00197-9; STERNS RH, 1993, AM J PHYSIOL, V264, P833; Stringaris AK, 1997, ACTA NEUROPATHOL, V93, P215, DOI 10.1007/s004010050606; Suehiro E, 1999, J NEUROTRAUM, V16, P285, DOI 10.1089/neu.1999.16.285; Szabo C, 1996, BRAIN RES BULL, V41, P131, DOI 10.1016/S0361-9230(96)00159-1; Tanaka K, 1996, BRAIN RES, V737, P59, DOI 10.1016/0006-8993(96)00658-0; TAUBER MG, 1992, AM J PATHOL, V141, P53; TUCCI S, 1998, CLIN BIOCHEM, P31; TUOMANEN EI, 1989, J EXP MED, V170, P959, DOI 10.1084/jem.170.3.959; Yu ACH, 1995, PROG BRAIN RES, V105, P245	51	17	17	0	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993			BRAIN RES	Brain Res.	NOV 13	1999	847	1					143	148		10.1016/S0006-8993(99)02120-4			6	Neurosciences	Neurosciences & Neurology	256UU	WOS:000083745500020	10564748				2021-06-18	
J	Wissel, J; Muller, J; Heinen, F; Mall, V; Sojer, M; Ebersbach, G; Poewe, W				Wissel, J; Muller, J; Heinen, F; Mall, V; Sojer, M; Ebersbach, G; Poewe, W			Safety and tolerance of a single dose of botulinum toxin type A in patients with local spasticity-associated problems: A prospective open multicenter study comprising 204 patients	WIENER KLINISCHE WOCHENSCHRIFT			German	Article						spasticity; botulinum toxin type A; rehabilitation; pain	PLACEBO-CONTROLLED TRIAL; DOUBLE-BLIND; MUSCLE; PARALLEL	High dose oral anti-spastic medication is effective in the treatment of spasticity but has the disadvantage of frequent systemic side effects such as drowsiness and general weakness. Therefore, neurolytic and chemodenervation procedures are further therapeutic options, especially in cases of local spasticity. Apart from phenol blocks with the risk of persisting painful dysesthesia, botulinum toxin type A (BtxA) appears to be a safe and effective treatment. In 204 patients (mean age, 41.5 years [range 3-91 years]) with acute (n = 29, mean duration of disease 2.9 months [range, 1-6 months]) and chronic (n = 175, mean duration of disease 111 months [range, 7-500 months]) spasticity due to stroke, traumatic brain and spinal injury and other lesions of the upper motor neuron, the effects of single-dose BtxA treatment were studied. An overall dose of 181.2 units [range, 15-600 units] of BtxA (Botox(R)) was injected in a mean of 3.3 [1-14] muscles per patient. Results were assessed using a modified Rating of Response to BtxA (RRB, Brin et al. 1995). The RRB includes a pre- and post BtxA assessment of the severity of spasticity-associated problems (patient's self-assessment), a rating of the current percentage of normal function in the region of the body selected for BtxA and a global rating of changes induced by BtxA. 191 (93.6%) patients demonstrated improvement over a mean of 7.7 weeks [1-36]; no deterioration was observed. Mean overall severity and function improved significantly (p < 0.001). No systemic or severe side effects were registered. Only in 5.9% of the patients were mild (n = 10) or moderate (n = 2) reversible adverse events reported. We conclude that BtxA injections are safe and effective in the treatment of local spasticity.	Univ Innsbruck, Neurol Klin, A-6020 Innsbruck, Austria; Univ Freiburg, Kinderklin, Abt Neuropadiat & Muskelerkrankungen, D-7800 Freiburg, Germany	Wissel, J (corresponding author), Univ Innsbruck, Neurol Klin, Anichstr 35, A-6020 Innsbruck, Austria.	Joerg.Wissel@uibk.ac.at	Heinen, Florian/B-6594-2015	Heinen, Florian/0000-0002-3872-6136; Ebersbach, Georg/0000-0003-3403-6987			BERGER W, 1984, J NEUROL NEUROSUR PS, V47, P1029, DOI 10.1136/jnnp.47.9.1029; BOHANNON RW, 1987, PHYS THER, V67, P659, DOI 10.1093/ptj/67.5.659; Brin MF, 1995, TREATMENT MOVEMENT D, P183; Emre M., 1993, SPASTICITY MECH MANA, P372; GRAZKO MA, 1995, NEUROLOGY, V45, P712, DOI 10.1212/WNL.45.4.712; Heinen F, 1997, NEUROPEDIATRICS, V28, P307, DOI 10.1055/s-2007-973721; Hesse S, 1998, CLIN REHABIL, V12, P381, DOI 10.1191/026921598668275996; HESSE S, 1994, J NEUROL NEUROSUR PS, V57, P1321, DOI 10.1136/jnnp.57.11.1321; HUFSCHMIDT A, 1985, J NEUROL NEUROSUR PS, V48, P676, DOI 10.1136/jnnp.48.7.676; JANKOVIC J, 1991, NEW ENGL J MED, V324, P1186, DOI 10.1056/nejm199104253241707; Lance J. W., 1980, SPASTICITY DISORDERE, P485; MEMIN B, 1992, REV NEUROL, V148, P212; Odergren T, 1998, J NEUROL NEUROSUR PS, V64, P6, DOI 10.1136/jnnp.64.1.6; Reiter F, 1996, J NEUROL REHABIL, V10, P47; Rosales RL, 1996, MUSCLE NERVE, V19, P488, DOI 10.1002/(SICI)1097-4598(199604)19:4<488::AID-MUS9>3.0.CO;2-8; Sampaio C, 1997, MOVEMENT DISORD, V12, P1013, DOI 10.1002/mds.870120627; Schnider P, 1999, WIEN KLIN WOCHENSCHR, V111, P59; Simpson DM, 1996, NEUROLOGY, V46, P1306, DOI 10.1212/WNL.46.5.1306; SNOW BJ, 1990, ANN NEUROL, V28, P512, DOI 10.1002/ana.410280407; *SPAST STUD GROUP, 1997, MUSCLE NERVE       S, V6, P208; Wissel J, 1999, NEUROPEDIATRICS, V30, P120, DOI 10.1055/s-2007-973475	21	17	18	0	0	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0043-5325	1613-7671		WIEN KLIN WOCHENSCHR	Wien. Klin. Wochen.	OCT 29	1999	111	20					837	842					6	Medicine, General & Internal	General & Internal Medicine	261EP	WOS:000083996300003	10586488				2021-06-18	
J	Lubillo, S; Bolanos, J; Carreira, L; Cardenosa, J; Arroyo, J; Manzano, J				Lubillo, S; Bolanos, J; Carreira, L; Cardenosa, J; Arroyo, J; Manzano, J			Prognostic value of early computerized tomography scanning following craniotomy for traumatic hematoma	JOURNAL OF NEUROSURGERY			English	Article						head injury; intracranial hematoma; computerized tomography scanning; intracranial pressure; cerebral perfusion pressure; outcome	SEVERE HEAD-INJURY; INTRA-CRANICAL PRESSURE; COMA DATA-BANK; CT SCAN; SUBARACHNOID HEMORRHAGE; PREDICTION; EXPERIENCE	Object. Patients with head injuries traditionally were categorized on the basis of whether their lesions appeared to be diffuse, focal, or mass lesions on admission computerized tomography (CT) scanning. In the classification of Marshall, et al., the presence of a hematoma (evacuated or not evacuated) is more significant than any diffuse injury (DI). The CT scan appearance after evacuation of a mass lesion has not been analyzed previously in relation to outcome. The authors have investigated the importance of: 1) neurological assessment at hospital admission; 2) the status of the basal cisterns and associated intracranial lesions on the admission CT scan; and 3) the degree of DI on the early CT scan obtained after craniotomy to identify patients at risk for development of raised intracranial pressure (ICP) and lowered cerebral perfusion pressure (CPP) and to discover the influence of the postoperative CT appearance of the lesion on patient outcome. Methods. The authors prospectively studied 82 patients with isolated, severe closed head injury (Glasgow Coma Scale [GCS] score < 8), all of whom had intracranial hematoma. Both ICP and CPP were continuously monitored, and a CT scan was obtained within 2 to 12 hours after craniotomy. The CT images were categorized according to the classification of Marshall, et al. The mortality rate during the hospital stay was 37%, and 50% of the patients achieved a favorable outcome. Compression of the basal cistern on the admission (preoperative) CT scan was associated with raised ICP and a CPP of less than 70 mm Hg but not with any other features or with poor patient outcome. In 53 patients the postoperative CT scan revealed DIs III or IV and 29 patients had DIs I or II. The percentages of time during the hospital stay in which ICP was higher than 20 mm Hg and CPP was lower than 70 mm Hg as well as unfavorable outcome were higher in the group of patients in whom DI III or IV was present (p < 0.001). Raised ICP, CPP lower than 70 mm Hg, DI III or IV, and unfavorable outcome were more frequently observed in patients who presented with a motor (m)GCS score of 3 or less, bilateral unreactive pupils: associated intracranial injuries, and hypotension (p < 0.001). When logistic regression analysis was performed, an mGCS score of 3 or less (p = 0.0013, odds ratio [OR] 10.8), bilateral unreactive pupils (p = 0.0047, OR 31.8), and DI In or IV observed on CT scanning after surgery (p = 0.015, OR 8.9) were independently associated with poor outcome. Conclusions. Features on CT scans obtained shortly after craniotomy constitute an independent predictor of outcome in patients with traumatic hematoma. Patients in whom DI III or IV appears on postoperative CT scanning, who often present with an mGCS score of 3 or less and nonreactive pupils, are at high risk for the development of raised ICP and lowered CPP.	Hosp Univ Pino, Intens Care Unit, Las Palmas Gran Canaria, Canary Isl, Spain; Hosp Univ Pino, Dept Neurosurg, Las Palmas Gran Canaria, Canary Isl, Spain	Lubillo, S (corresponding author), Care of Olivares C, 26-17A2, Las Palmas Gran Canaria 350011, Canary Isl, Spain.	cendrero@idecnet.com					BULLOCK R, 1989, SURG NEUROL, V32, P181, DOI 10.1016/0090-3019(89)90176-6; CHESNUT RM, 1993, ACTA NEUROCHIR, P121; CHOI SC, 1991, J NEUROSURG, V75, P251, DOI 10.3171/jns.1991.75.2.0251; DENT DL, 1995, J TRAUMA, V39, P36, DOI 10.1097/00005373-199507000-00005; EISENBERG HM, 1990, J NEUROSURG, V73, P688, DOI 10.3171/jns.1990.73.5.0688; FEARNSIDE MR, 1993, BRIT J NEUROSURG, V7, P267, DOI 10.3109/02688699309023809; GAETANI P, 1995, J NEUROL NEUROSUR PS, V59, P635, DOI 10.1136/jnnp.59.6.635; GENNARELLI TA, 1982, J NEUROSURG, V56, P26, DOI 10.3171/jns.1982.56.1.0026; GENTLEMAN D, 1990, LANCET, V335, P330, DOI 10.1016/0140-6736(90)90615-C; GENTLEMAN D, 1981, LANCET, V2, P853; GOPINATH SP, 1994, J NEUROL NEUROSUR PS, V57, P717, DOI 10.1136/jnnp.57.6.717; GREENE KA, 1995, J NEUROSURG, V83, P445, DOI 10.3171/jns.1995.83.3.0445; JENNETT B, 1975, LANCET, V1, P480; JENNETT B, 1976, LANCET, V1, P1031; KOHI YM, 1984, INJURY, V16, P25, DOI 10.1016/0020-1383(84)90110-4; LEVIN HS, 1990, J NEUROSURG, V73, P699, DOI 10.3171/jns.1990.73.5.0699; LUERSSEN TG, 1988, J NEUROSURG, V68, P409, DOI 10.3171/jns.1988.68.3.0409; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; MARSHALL LF, 1991, J NEUROSURG, V75, pS28, DOI 10.3171/sup.1991.75.1s.0s28; MILLER JD, 1981, J NEUROSURG, V54, P289, DOI 10.3171/jns.1981.54.3.0289; MILLER JD, 1985, BRIT J ANAESTH, V57, P120, DOI 10.1093/bja/57.1.120; MURPHY A, 1983, INTRACRANIAL PRESSUR, V5, P562; MURRAY LS, 1993, J NEUROTRAUMA, V10, pS101; NARAYAN RK, 1982, J NEUROSURG, V56, P650, DOI 10.3171/jns.1982.56.5.0650; NARAYAN RK, 1981, J NEUROSURG, V54, P751, DOI 10.3171/jns.1981.54.6.0751; OSULLIVAN MG, 1994, J NEUROSURG, V80, P46, DOI 10.3171/jns.1994.80.1.0046; SAKAS DE, 1995, J NEUROSURG, V82, P961, DOI 10.3171/jns.1995.82.6.0961; SWEET RC, 1978, NEUROSURGERY, V3, P16, DOI 10.1227/00006123-197807000-00003; TEASDALE G, 1974, LANCET, V2, P81; TEASDALE GM, 1995, J NEUROL NEUROSUR PS, V58, P526, DOI 10.1136/jnnp.58.5.526; TOUTANT SM, 1984, J NEUROSURG, V61, P691, DOI 10.3171/jns.1984.61.4.0691; WAXMAN K, 1991, ARCH SURG-CHICAGO, V126, P1237	32	17	19	0	2	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	OCT	1999	91	4					581	587		10.3171/jns.1999.91.4.0581			7	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	239HV	WOS:000082763400008	10507378				2021-06-18	
J	Hawkins, KA				Hawkins, KA			Memory deficits in patients with schizophrenia: preliminary data from the Wechsler Memory Scale Third Edition support earlier findings	JOURNAL OF PSYCHIATRY & NEUROSCIENCE			English	Article						Alzheimer disease; intelligence; intelligence tests; Korsakoff syndrome; learning; memory; schizophrenia; Wechsler Scales		Objective: To determine whether memory data presented for a schizophrenia sample in the Technical Manual of the Wechsler Memory Scale-Third Edition support trends identified in a previously published review of studies employing an earlier version of the instrument, the Wechsler Memory Scale-Revised. Design: Archival: reformulation of published data. Patients: Patients with schizophrenia, Alzheimer's disease, Korsakoffs syndrome or traumatic brain injury (TBI) for whom intelligence and memory data were reported in the Technical Manual of the Wechsler Adult Intelligence Scale-Third Edition Wechsler Memory Scale-Third Edition (WAIS-III WMS-III). Outcome measures: Mean Full Scale, Verbal, and Performance Intelligence Quotients of the WAIS-III and mean WMS-III Immediate and General Memory Indexes. Single-trial learning and learning slope data were also culled from the WAIS-III WMS-III Technical Manual. Results: Memory indexes for patients with Alzheimer's disease or Korsakoffs syndrome were substantially lower than those for patients with schizophrenia or TBI. In tests of learning processes, patients with schizophrenia had an inferior ability to repeat material presented just once, in comparison with the standardization sample. However, they did relatively better with repeated presentations than patients with Alzheimer's disease or Korsakoffs syndrome. The learning slope for patients with schizophrenia demonstrated an ability to absorb and consolidate increasing amounts of material with repeated exposure that is inconsistent with pronounced memory impairment. Conclusions: Although patients with schizophrenia exhibit new learning deficiencies, their memory capabilities are-not substantially weaker than their general intellectual abilities, and do not approach the memory impairment exhibited by patients with Alzheimer's disease or Korsakoffs syndrome.	Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06519 USA	Hawkins, KA (corresponding author), Yale Univ, Sch Med, Dept Psychiat, 34 Pk St, New Haven, CT 06519 USA.	Keith.Hawkins@Yale.edu		Hawkins, Keith/0000-0003-3494-2103			American Psychiatric Association, 1994, DIAGN STAT MAN MENT; GOLDBERG TE, 1991, REV PSYCHIATRY, V10, P60; Hawkins KA, 1997, J PSYCHIATR NEUROSCI, V22, P169; Hawkins KA, 1998, CLIN NEUROPSYCHOL, V12, P535, DOI 10.1076/clin.12.4.535.7236; Hawkins KA, 1997, J NEUROPSYCH CLIN N, V9, P81; LEVIN S, 1989, J ABNORM PSYCHOL, V98, P341, DOI 10.1037/0021-843X.98.4.341; NESTOR PG, 1993, AM J PSYCHIAT, V150, P1849; Psychological Corporation, 1997, WAIS 3 WMS 3 TECHN M; SAYKIN AJ, 1994, ARCH GEN PSYCHIAT, V51, P124; SEIDMAN LJ, 1994, BIOL PSYCHIAT, V35, P235, DOI 10.1016/0006-3223(94)91254-8; Sharma T, 1998, J CLIN PSYCHOPHARM, V18, p12S, DOI 10.1097/00004714-199804001-00004; SQUIRE LR, 1987, MEMORY BRAIN; Wechsler D., 1987, MANUAL WECHSLER MEMO; Wechsler D., 1981, WAIS R MANUAL WECHSL	14	17	18	0	3	CMA-CANADIAN MEDICAL ASSOC	OTTAWA	1867 ALTA VISTA DR, OTTAWA, ONTARIO K1G 5W8, CANADA	1180-4882	1488-2434		J PSYCHIATR NEUROSCI	J. Psychiatry Neurosci.	SEP	1999	24	4					341	347					7	Neurosciences; Psychiatry	Neurosciences & Neurology; Psychiatry	241KH	WOS:000082881800008	10516802				2021-06-18	
J	Katano, H; Fujita, K; Kato, T; Asai, K; Kawamura, Y; Masago, A; Yamada, K				Katano, H; Fujita, K; Kato, T; Asai, K; Kawamura, Y; Masago, A; Yamada, K			Traumatic injury in vitro induces IEG mRNAs in cultured glial cells, suppressed by co-culture with neurons	NEUROREPORT			English	Article						c-fos; c-jun; glia; immediate early gene; in situ hybridization; mechanical injury; mRNA; neuron; zif/268	MESSENGER-RNA EXPRESSION; IMMEDIATE EARLY GENES; REACTIVE ASTROCYTES; NERVOUS-SYSTEM; GROWTH-FACTOR; BRAIN INJURY; INVITRO; FOS; MODEL; RAT	GLIAL changes following traumatic injury to glial monolayers as well as to neuronal-glial co-culture systems in vitro were examined with a focus on the expression of mRNAs coding for the immediate early genes (IEG) c-fos, c-jun and zif/268, demonstrated using in situ hybridization. Glial cells along scratch wound lines extended cytoplasmic processes as early as 10 min post-injury and the whole wound was covered with gliosis by 24 h. For complete restoration in the case of glial cells co-cultured with neurons, this required 48h. Induction of the three IEG mRNAs was eminent along the edges of scratch wound, peaking at 30-60 min postinjury and subsiding by 3 h. The peak expression of IEG mRNAs was delayed to 1-3h post-injury and became undetectable at 6h in neuronal-glial co-cultures. The data suggest that mechanical injury to glial cells causes gliosis and the expression of IEG mRNAs, which are suppressed by co culture with neurons, indicating some influence of neuronal-glial interactions. NeuroReport 10:2439-2448 (C) 1999 Lippincott Williams & Wilkins.	Nagoya City Univ, Sch Med, Dept Neurosurg, Mizuho Ku, Nagoya, Aichi 4678601, Japan; Nagoya City Univ, Sch Med, Dept Bioregulat Res, Mizuho Ku, Nagoya, Aichi 4678601, Japan	Katano, H (corresponding author), Nagoya City Univ, Sch Med, Dept Neurosurg, Mizuho Ku, 1 Kawasumi,Mizuho Cho, Nagoya, Aichi 4678601, Japan.		Asai, Kiyofumi/H-2356-2014	Asai, Kiyofumi/0000-0001-7015-2251			Akins PT, 1996, STROKE, V27, P1682, DOI 10.1161/01.STR.27.9.1682; ANGEL P, 1988, NATURE, V332, P166, DOI 10.1038/332166a0; CONDORELLI DF, 1993, J NEUROCHEM, V60, P877, DOI 10.1111/j.1471-4159.1993.tb03232.x; CURRAN T, 1987, ONCOGENE, V2, P79; GASSER UE, 1990, J NEUROSCI, V10, P1276; Harada S, 1997, NEUROREPORT, V8, P3399, DOI 10.1097/00001756-199710200-00041; HATTEN ME, 1985, J CELL BIOL, V100, P384, DOI 10.1083/jcb.100.2.384; HAYES RL, 1995, J NEUROTRAUM, V12, P779, DOI 10.1089/neu.1995.12.779; Iwata A, 1997, J NEUROTRAUM, V14, P201, DOI 10.1089/neu.1997.14.201; Katano H, 1998, BRAIN RES, V800, P69, DOI 10.1016/S0006-8993(98)00493-4; MacFarlane SN, 1997, J NEUROSCI, V17, P7316; Masago A, 1996, NEUROREPORT, V7, P2565, DOI 10.1097/00001756-199611040-00032; MCKEON RJ, 1991, J NEUROSCI, V11, P3398; MCMILLIAN MK, 1994, TRENDS NEUROSCI, V17, P138, DOI 10.1016/0166-2236(94)90086-8; MORGAN JI, 1991, ANNU REV NEUROSCI, V14, P421, DOI 10.1146/annurev.ne.14.030191.002225; NAKANISHI K, 1994, BRAIN RES, V659, P169, DOI 10.1016/0006-8993(94)90876-1; PENDE M, 1994, P NATL ACAD SCI USA, V91, P3215, DOI 10.1073/pnas.91.8.3215; Pennypacker KR, 1996, MOL BRAIN RES, V37, P224, DOI 10.1016/0169-328X(95)00318-M; Ridet JL, 1997, TRENDS NEUROSCI, V20, P570, DOI 10.1016/S0166-2236(97)01139-9; SHENG M, 1990, NEURON, V4, P477, DOI 10.1016/0896-6273(90)90106-P; TECOMA ES, 1989, NEURON, V2, P1541, DOI 10.1016/0896-6273(89)90042-1; VIGE X, 1992, BRAIN RES, V591, P345, DOI 10.1016/0006-8993(92)91718-T; WISDEN W, 1990, NEURON, V4, P603, DOI 10.1016/0896-6273(90)90118-Y; YU ACH, 1993, J NEUROSCI RES, V34, P295, DOI 10.1002/jnr.490340306	24	17	17	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0959-4965			NEUROREPORT	Neuroreport	AUG 20	1999	10	12					2439	2448		10.1097/00001756-199908200-00002			10	Neurosciences	Neurosciences & Neurology	228BN	WOS:000082116100003	10574349				2021-06-18	
J	Brown, M; Gordon, WA				Brown, M; Gordon, WA			Quality of life as a construct in health and disability research	MOUNT SINAI JOURNAL OF MEDICINE			English	Article						quality of life; disability; chronic illness; research methodology	TRAUMATIC BRAIN INJURY; COMMUNITY INTEGRATION QUESTIONNAIRE; CLOSED-HEAD-INJURY; OF-LIFE; REHABILITATION OUTCOMES; FUNCTIONAL ASSESSMENT; MULTIPLE-SCLEROSIS; IMPACT PROFILE; SATISFACTION; HANDICAP	Definitional issues that affect the measurement of quality of life (QOL) in health care research are discussed. In reviewing a broad sample of health- and disability-related QOL studies, the authors note several characteristics in which respective approaches to measurement differ: (a) In various measurement tools, QOL has been located either within the insider's (i.e., the person being measured) judgment of the "goodness" of his or her life or outside this judgment. (b) The insider's and/or outsider's values may hold sway in deciding the elements of life that are relevant to QOL within the measurement process, and in rating the degree of "goodness" of these life domains. (c) QOL models incorporate domains of items varying in breadth and specificity; and they take either a negative or neutral view of functioning. (d) QOL models vary in their complexity, type of linkage between components, and inclusion (or not) of both the insider's judgment and external predictors of QOL. These distinctions are used by the authors in recommending approaches to QOL measurement suitable for health care research aimed at outcome assessment and description of populations.	Mt Sinai Sch Med, Dept Rehabil Med, New York, NY 10029 USA	Gordon, WA (corresponding author), Mt Sinai Sch Med, Dept Rehabil Med, Box 1240,1 E 100th St, New York, NY 10029 USA.						ALEXANDER JL, 1981, ARCH PHYS MED REHAB, V62, P261; Aller L J, 1995, J Gerontol Nurs, V21, P20; Allison PJ, 1997, SOC SCI MED, V45, P221, DOI 10.1016/S0277-9536(96)00339-5; Andrews F. M., 1976, SOCIAL INDICATORS WE; Aronson KJ, 1997, NEUROLOGY, V48, P74, DOI 10.1212/WNL.48.1.74; Bach C A, 1993, Rehabil Nurs, V18, P364; BADLEY EM, 1995, DISABIL REHABIL, V17, P53, DOI 10.3109/09638289509166628; Batterham RW, 1996, ARCH PHYS MED REHAB, V77, P1219, DOI 10.1016/S0003-9993(96)90183-5; Bauer R., 1966, SOCIAL INDICATORS; BERGNER M, 1976, MED CARE, V14, P57, DOI 10.1097/00005650-197601000-00006; Berzon RA, 1995, QUAL LIFE RES, V4, P547, DOI 10.1007/BF00634750; BOWLING A, 1995, SOC SCI MED, V41, P1447, DOI 10.1016/0277-9536(95)00113-L; Brazil L, 1997, J NEURO-ONCOL, V34, P187, DOI 10.1023/A:1005710729748; Brown M, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199808000-00002; Brown M, 1980, REHABILITATION CLIEN, P102; BURCKHARDT CS, 1989, RES NURS HEALTH, V12, P347, DOI 10.1002/nur.4770120604; Campbell A., 1976, QUALITY AM LIFE PERC; Carr AJ, 1996, BRIT J RHEUMATOL, V35, P275; Carr AJ, 1996, BRIT J RHEUMATOL, V35, P921; CHUBON RA, 1987, EVAL HEALTH PROF, V10, P186, DOI 10.1177/016327878701000203; CLAYTON KS, 1994, ARCH PHYS MED REHAB, V75, P633, DOI 10.1016/0003-9993(94)90184-8; CONDELUCI A, 1992, Brain Injury, V6, P543, DOI 10.3109/02699059209008151; DECKER SD, 1985, AM J OCCUP THER, V39, P740, DOI 10.5014/ajot.39.11.740; DENNIS RE, 1993, EXCEPT CHILDREN, V59, P499, DOI 10.1177/001440299305900603; DUNCAN OD, 1969, SOCIAL REPORTING NEX; EBRAHIM S, 1995, SOC SCI MED, V41, P1383, DOI 10.1016/0277-9536(95)00116-O; EDGERTON RB, 1990, QUALITY LIFE PERSPEC, P149; FADEN R, 1992, MED CARE, V30, pMS166, DOI 10.1097/00005650-199205001-00014; FARQUHAR M, 1995, SOC SCI MED, V41, P1439, DOI 10.1016/0277-9536(95)00117-P; Felce D, 1997, J INTELL DISABIL RES, V41, P126, DOI 10.1111/j.1365-2788.1997.tb00689.x; FLANAGAN JC, 1978, AM PSYCHOL, V33, P138, DOI 10.1037/0003-066X.33.2.138; FLANAGAN JC, 1982, ARCH PHYS MED REHAB, V63, P56; FUHRER MJ, 1992, ARCH PHYS MED REHAB, V73, P552; FUHRER MJ, 1994, AM J PHYS MED REHAB, V73, P358, DOI 10.1097/00002060-199409000-00010; FUHRER MJ, 1997, ASSESSING MED REHABI; Gill TM, 1995, J ROY SOC MED, V88, P680; GILL TM, 1994, JAMA-J AM MED ASSOC, V272, P619, DOI 10.1001/jama.272.8.619; GORDON WA, 1999, REHABILITATION ADULT, P372; GRANGER CV, 1995, AM J PHYS MED REHAB, V74, P107; HALPERN AS, 1984, FUNCTIONAL ASSESSMEN; HEINEMANN AW, 1995, J HEAD TRAUMA REHAB, V10, P54, DOI 10.1097/00001199-199508000-00006; Hobart JC, 1996, CURR OPIN NEUROL, V9, P441, DOI 10.1097/00019052-199612000-00008; HORLEY J, 1984, GERONTOLOGIST, V24, P124, DOI 10.1093/geront/24.2.124; IRWIN PH, 1982, SOC INDIC RES, V10, P187, DOI 10.1007/BF00302510; KLONOFF PS, 1986, NEUROSURGERY, V19, P735, DOI 10.1227/00006123-198611000-00004; KLONOFF PS, 1986, J CLIN EXP NEUROPSYC, V8, P469, DOI 10.1080/01688638608405171; LAMAN H, 1994, DISABIL REHABIL, V16, P198, DOI 10.3109/09638289409166613; Lankhorst GJ, 1996, J NEUROL, V243, P469, DOI 10.1007/BF00900502; LEHMAN AF, 1995, HEALTH AFFAIR, V14, P90, DOI 10.1377/hlthaff.14.3.90; Leplege A, 1997, JAMA-J AM MED ASSOC, V278, P47, DOI 10.1001/jama.278.1.47; LINDSTROM B, 1991, Pediatrician, V18, P121; MCGEE HM, 1991, PSYCHOL MED, V21, P749, DOI 10.1017/S0033291700022388; MINAIRE P, 1993, VITAL HLTH STAT, V5, P9; Montgomery H, 1996, SCAND J REHABIL MED, V28, P233; Ormel J, 1997, SOC SCI MED, V45, P1051, DOI 10.1016/S0277-9536(97)00032-4; PETERSON RA, 1995, J COUNTRY MUSIC, V17, P3; Raphael D, 1997, INT J NURS STUD, V34, P231, DOI 10.1016/S0020-7489(97)00010-2; ROBINSON JP, 1977, AM USE TIME SOCIAL P; ROGERSON RJ, 1995, SOC SCI MED, V41, P1373, DOI 10.1016/0277-9536(95)00122-N; ROWE JW, 1987, SCIENCE, V237, P143, DOI 10.1126/science.3299702; Sander AM, 1997, ARCH PHYS MED REHAB, V78, P353, DOI 10.1016/S0003-9993(97)90225-2; SIOSTEEN A, 1990, PARAPLEGIA, V28, P476, DOI 10.1038/sc.1990.64; SPILKER B, 1990, QUALITY LIFE PHARMAC; STENSMAN R, 1985, SCAND J REHABIL MED, V17, P87; SZALAI A, 1972, USE TIME; TENNANT A, 1995, ANN RHEUM DIS, V54, P439, DOI 10.1136/ard.54.6.439; Testa MA, 1996, NEW ENGL J MED, V334, P835, DOI 10.1056/NEJM199603283341306; VERBRUGGE LM, 1994, SOC SCI MED, V38, P1, DOI 10.1016/0277-9536(94)90294-1; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; WEBB CR, 1995, ARCH PHYS MED REHAB, V76, P1113, DOI 10.1016/S0003-9993(95)80118-9; WHITENECK GG, 1994, ARCH PHYS MED REHAB, V75, P1073, DOI 10.1016/0003-9993(94)90080-9; *WHO, 1997, ICIDH 2 INT CLASS IM; WILLER B, 1994, AM J PHYS MED REHAB, V73, P103; Willer B, 1993, J HEAD TRAUMA REHAB, V3, P75, DOI DOI 10.1097/00001199-199308020-00009; WILSON IB, 1995, JAMA-J AM MED ASSOC, V273, P59, DOI 10.1001/jama.273.1.59; WOODDAUPHINEE SL, 1988, ARCH PHYS MED REHAB, V69, P583; World Health Organization, 1980, INT CLASS IMP DIS HA; WRIGHT BA, 1960, PHYSICAL DISABILITY; ZIEBLAND S, 1993, SOC SCI MED, V37, P69, DOI 10.1016/0277-9536(93)90319-Y; 1995, MMWR MORB MORTAL WKL, V44, P195	80	17	18	0	4	MOUNT SINAI HOSPITAL	NEW YORK	BOX 1094 ONE GUSTAVE L LEVY PLACE ATTN: CIRCULATION ASST, NEW YORK, NY 10029-6574 USA	0027-2507			MT SINAI J MED	Mt. Sinai J. Med.	MAY	1999	66	3					160	169					10	Medicine, General & Internal	General & Internal Medicine	199UN	WOS:000080502600005	10377547				2021-06-18	
J	Adelson, PD				Adelson, PD			Animal models of traumatic brain injury in the immature: A review	EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY			English	Article; Proceedings Paper	IIIrd International Congress of Pathophysiology	JUN 28-JUL 03, 1998	LAHTI, FINLAND			brain injury; traumatic; Immature; brain injury; traumatic brain injury	CEREBRAL BLOOD-FLOW; FREELY MOVING RATS; SEVERE HEAD-INJURY; INTRACRANIAL-PRESSURE; CHILDREN; RESPONSES; METABOLISM; NEWBORN; PIGLETS; EDEMA		Childrens Hosp Pittsburgh, Pittsburgh, PA 15213 USA	Adelson, PD (corresponding author), Childrens Hosp Pittsburgh, 3705 5th Ave, Pittsburgh, PA 15213 USA.	david_adelson@poplar.chp.edu	Adelson, David/W-2083-2019				ADAMS JH, 1984, RECENT ADV HISTOPATH, P241; Adelson PD, 1997, PEDIATR NEUROSURG, V26, P200; Adelson PD, 1997, J NEUROTRAUM, V14, P99, DOI 10.1089/neu.1997.14.99; Adelson PD, 1996, J NEUROSURG, V85, P877, DOI 10.3171/jns.1996.85.5.0877; Adelson PD, 1996, J NEUROSURG, V84, P804; ADELSON PD, 1997, J NEUROTRAUM, V14, P787; ADELSON PD, 1995, J NEUROTRAUM, V12, P984; ADELSON PD, 1997, J NEUROTRAUM, V14, P781; ADELSON PD, 1998, IN PRESS J NEUROTRAU, V15; ADELSON PD, 1998, IN PRESS ACTA NEUR S, V71; ARMSTEAD WM, 1994, J NEUROTRAUM, V11, P487, DOI 10.1089/neu.1994.11.487; Armstead WM, 1996, J NEUROSURG, V85, P901, DOI 10.3171/jns.1996.85.5.0901; BERGER MS, 1985, J NEUROSURG, V62, P194, DOI 10.3171/jns.1985.62.2.0194; BOKSA P, 1995, PEDIATR RES, V37, P489, DOI 10.1203/00006450-199504000-00018; BRUCE DA, 1981, J NEUROSURG, V54, P170, DOI 10.3171/jns.1981.54.2.0170; DIXON CE, 1991, J NEUROSCI METH, V39, P253; DUHAIME AC, 1997, J NEUROTRAUM, V14, P777; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; Frankowski RF, 1985, CENTRAL NERVOUS SYST, P33; FRITZ H, 1998, PATHOPHYSIOLOGY S1, V5, P237; GRAHAM DI, 1989, J CLIN PATHOL, V42, P18, DOI 10.1136/jcp.42.1.18; GRAHAM DI, 1978, J NEUROL SCI, V39, P213, DOI 10.1016/0022-510X(78)90124-7; GRUNDL PD, 1994, J NEUROTRAUM, V11, P135, DOI 10.1089/neu.1994.11.135; Ito J, 1996, J NEUROSURG, V84, P97, DOI 10.3171/jns.1996.84.1.0097; KRAUS JF, 1987, PEDIATRICS, V79, P501; LEVIN HS, 1982, NEUROSURGERY, V11, P668, DOI 10.1227/00006123-198211000-00009; Lighthall JW, 1988, J NEUROTRAUM, V5, P1, DOI 10.1089/neu.1988.5.1; LINDENBERG R, 1969, ARCH PATHOL, V87, P298; Mansfield RT, 1996, J CEREBR BLOOD F MET, V16, P244, DOI 10.1097/00004647-199603000-00009; Marmarou A, 1997, ACT NEUR S, V70, P68; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; MCDONALD JW, 1990, BRAIN RES REV, V15, P41, DOI 10.1016/0165-0173(90)90011-C; MUIZELAAR JP, 1989, J NEUROSURG, V71, P63, DOI 10.3171/jns.1989.71.1.0063; Mukhin AG, 1997, J NEUROTRAUM, V14, P651, DOI 10.1089/neu.1997.14.651; NEHLIG A, 1989, J CEREBR BLOOD F MET, V9, P579, DOI 10.1038/jcbfm.1989.83; NEHLIG A, 1988, J NEUROSCI, V8, P2321; OI YO, 1995, NEUR ABSTR, V21; PRINS MI, 1997, J NEUROTRAUM, V14, P780; Prins ML, 1996, DEV BRAIN RES, V95, P272, DOI 10.1016/0165-3806(96)00098-3; SHARPLES PM, 1995, J NEUROL NEUROSUR PS, V58, P145, DOI 10.1136/jnnp.58.2.145; Shaver EG, 1996, PEDIATR NEUROSURG, V25, P123, DOI 10.1159/000121109; SMITH ML, 1995, J NEUROTRAUM, V12, P143; Walter B, 1997, BASIC RES CARDIOL, V92, P191, DOI 10.1007/s003950050037	44	17	17	0	0	ELSEVIER GMBH, URBAN & FISCHER VERLAG	JENA	OFFICE JENA, P O BOX 100537, 07705 JENA, GERMANY	0940-2993	1618-1433		EXP TOXICOL PATHOL	Exp. Toxicol. Pathol.	FEB	1999	51	2					130	136					7	Pathology; Toxicology	Pathology; Toxicology	177NZ	WOS:000079218000004	10192581				2021-06-18	
J	Sweet, JJ; Suchy, Y; Leahy, B; Abramowitz, C; Nowinski, CJ				Sweet, JJ; Suchy, Y; Leahy, B; Abramowitz, C; Nowinski, CJ			Normative clinical relationships between orientation and memory: Age as an important moderator variable	CLINICAL NEUROPSYCHOLOGIST			English	Article							MINI-MENTAL-STATE; CONFIRMATORY FACTOR-ANALYSIS; CLOSED-HEAD-INJURY; ALZHEIMERS-DISEASE; SCALE; DISORIENTATION; PERFORMANCE; DIAGNOSIS; DEMENTIA; ADULTS	The present study examined the relationship between memory and orientation to time, place, and personal and general information, as moderated by age, education, and simple attentional ability. A heterogeneous sample of 312 clinical referrals was divided into four groups, according to delayed memory functioning. Patients with globally good, globally poor, poor visual, and poor auditory memory were at differential risk of being disoriented, with the globally poor memory patients having the greatest risk. Overall, poorly oriented patients were older and less educated, with worse recall of digits backward. Discriminant Function Analysis selected visual and auditory memory and age as predictors of orientation. Normative tables stratified by age and memory performance are presented.	Northwestern Univ, Evanston Hosp, Sch Med, Evanston, IL 60201 USA; IIT, Chicago, IL 60616 USA; Finch Univ Hlth Sci Chicago Med Sch, N Chicago, IL 60064 USA; Northwestern Univ, Sch Med, Evanston, IL 60208 USA	Sweet, JJ (corresponding author), Evanston NW Healthcare, Neuropsychol Serv, 2650 Ridge Ave, Evanston, IL 60201 USA.	j-sweet@nwu.edu		Suchy, Yana/0000-0001-6513-565X			BACHRACH H, 1974, J CLIN PSYCHOL, V30, P58, DOI 10.1002/1097-4679(197401)30:1<58::AID-JCLP2270300115>3.0.CO;2-4; BENTON A L, 1981, Journal of Clinical Neuropsychology, V3, P33, DOI 10.1080/01688638108403111; BENTON AL, 1964, J NERV MENT DIS, V139, P110, DOI 10.1097/00005053-196408000-00003; BORNSTEIN RA, 1988, CLIN NEUROPSYCHOL, V2, P107, DOI DOI 10.1080/13854048808520093; Brooker AE, 1997, PERCEPT MOTOR SKILL, V84, P131; BROOKS DN, 1976, J NEUROL NEUROSUR PS, V39, P593, DOI 10.1136/jnnp.39.6.593; BROTCHIE J, 1985, BRIT J PSYCHIAT, V147, P692, DOI 10.1192/bjp.147.6.692; DANIEL WF, 1987, CORTEX, V23, P169, DOI 10.1016/S0010-9452(87)80030-8; DESMOND DW, 1994, J NEUROL, V241, P585, DOI 10.1007/BF00920621; ELWOOD RW, 1991, CLIN NEUROPSYCHOL, V5, P329; FEINSTEIN AR, 1970, CLIN EPIDEMIOLOGY AR; Ferrario E, 1998, ARCH GERONTOL GERIAT, P175; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; GUILMETTE TJ, 1995, NEUROPSY NEUROPSY BE, V8, P20; HIGH WM, 1990, J CLIN EXP NEUROPSYC, V12, P703, DOI 10.1080/01688639008401013; Hopp GA, 1997, J CLIN PSYCHOL, V53, P673, DOI 10.1002/(SICI)1097-4679(199711)53:7<673::AID-JCLP5>3.3.CO;2-8; Ishizaki J, 1998, J GERONTOL B-PSYCHOL, V53, pP359, DOI 10.1093/geronb/53B.6.P359; KEARCOLWELL JJ, 1973, BRIT J SOC CLIN PSYC, V12, P384, DOI 10.1111/j.2044-8260.1973.tb00085.x; LARRABEE GJ, 1983, J CLIN NEUROPSYCHOL, V5, P159, DOI 10.1080/01688638308401162; Leonberger FT, 1991, CLIN NEUROPSYCHOL, V5, P83, DOI DOI 10.1080/13854049108401845; MARGOLIS RB, 1984, J CLIN PSYCHOL, V40, P1442, DOI 10.1002/1097-4679(198411)40:6<1442::AID-JCLP2270400630>3.0.CO;2-Y; Mattis S, 1988, DEMENTIA RATING SCAL; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Meiran N, 1996, ARCH NEUROL-CHICAGO, V53, P1043, DOI 10.1001/archneur.1996.00550100129022; NATELSON BH, 1979, ARCH NEUROL-CHICAGO, V36, P444, DOI 10.1001/archneur.1979.00500430074014; PRIGATANO GP, 1977, J CLIN PSYCHOL, V33, P772, DOI 10.1002/1097-4679(197707)33:3<772::AID-JCLP2270330337>3.0.CO;2-Q; ROTH DL, 1990, J CLIN EXP NEUROPSYC, V12, P834; Schnider A, 1996, BRAIN, V119, P1627, DOI 10.1093/brain/119.5.1627; SKILBECK C E, 1980, Journal of Clinical Neuropsychology, V2, P293, DOI 10.1080/01688638008403801; Small BJ, 1997, J GERONTOL A-BIOL, V52, pM299, DOI 10.1093/gerona/52A.5.M299; VARNEY NR, 1991, NEUROPSYCHOLOGY, V5, P13; WANG PL, 1975, ARCH PHYS MED REHAB, V56, P517; Wechsler D., 1987, WECHSLER MEMORY SCAL; Wechsler D., 1997, WMS 3 WECHSLER MEMOR; WOODARD JL, 1993, J CLIN EXP NEUROPSYC, V15, P968, DOI 10.1080/01688639308402611; ZAGAR R, 1984, J CLIN PSYCHOL, V40, P1466, DOI 10.1002/1097-4679(198411)40:6<1466::AID-JCLP2270400635>3.0.CO;2-5	36	17	17	0	0	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.		1999	13	4					495	508		10.1076/1385-4046(199911)13:04;1-Y;FT495			14	Psychology, Clinical; Clinical Neurology; Psychology	Psychology; Neurosciences & Neurology	310PP	WOS:000086836800014	10806463				2021-06-18	
J	Fiser, SM; Johnson, SB; Fortun, JB				Fiser, SM; Johnson, SB; Fortun, JB			Resource utilization in traumatic brain injury: The Role of magnetic resonance imaging	AMERICAN SURGEON			English	Article; Proceedings Paper	Annual Meeting of the Southeastern-Surgical-Congress	FEB 01-05, 1997	NASHVILLE, TENNESSEE	SE Surg Congress			CLOSED-HEAD-INJURY; MR; CHILDREN; CT	Cerebral CT scanning is routine in the acute evaluation of traumatic brain injury (TBI) patients. MRI has been reported to identify cerebral lesions better than CT scan. The purpose of this study was to determine whether MRI influenced the acute diagnosis and management of TBI patients. A retrospective medical records review was performed on all TBI patients undergoing cerebral CT scan and MRI admitted to a regional trauma center during a 2-year period. Patient data collected included demography, extent of TBI, CT scan and MRT use, and therapeutic interventions. Forty TBI patients (initial Glascow Coma Scale, 8.8 +/- 0.7) underwent 79 CT scans and 40 MRIs. Time to initial CT scan was 6.3 +/- 4.3 hours and time to MRI was 2.9 +/- 3.1 days. Nine patients (22.5%) had injuries on CT scan but not on MRI, most commonly skull fractures or small subarachnoid hemorrhages. Twenty-four patients (60%) had injuries on MRI but not on CT scan, most commonly corpus callosum shear injuries. There were two cases of child abuse and both had injuries of varying ages identified by MRI, but not CT. All injuries requiring a therapeutic intervention or change in management were identified by CT scan. Magnetic resonance angiography identified one patient with a traumatic internal carotid artery thrombosis. The performance of MRI resulted in additional charges of $75,640 or $3,152/patient identified with a new lesion. Although MRI identifies lesions not evident on CT scan, MRI does not alter management plans and is of limited value in the acute management: of TBI, MRI may be of medicolegal benefit in cases of child abuse.	Univ Arizona, Hlth Sci Ctr, Dept Surg, Sect Gen Surg & Trauma, Tucson, AZ 85724 USA	Johnson, SB (corresponding author), Univ Arizona, Hlth Sci Ctr, Dept Surg, Sect Gen Surg & Trauma, 1501 N Campbell Ave, Tucson, AZ 85724 USA.		Fortun, Jesus/H-1816-2017	Fortun, Jesus/0000-0002-6959-5263			AICHNER F, 1992, ANN NEUROL, V32, P507, DOI 10.1002/ana.410320405; ANDERSON CV, 1995, J NEUROPSYCH CLIN N, V7, P42; GENTRY LR, 1988, AM J ROENTGENOL, V150, P673, DOI 10.2214/ajr.150.3.673; GENTRY LR, 1988, AM J ROENTGENOL, V150, P663, DOI 10.2214/ajr.150.3.663; GENTRY LR, 1994, RADIOLOGY, V191, P1; GODERSKY JC, 1990, ACT NEUR S, V51, P311; HADLEY DM, 1988, CLIN RADIOL, V39, P131; KELLY AB, 1988, AM J NEURORADIOL, V9, P699; LEVIN HS, 1989, NEUROSURGERY, V24, P223, DOI 10.1227/00006123-198902000-00011; LEVIN HS, 1993, ARCH NEUROL-CHICAGO, V50, P897, DOI 10.1001/archneur.1993.00540090008004; National Board of Health and Welfare, 1996, ANN PLAN FISC YEAR 1, P2; Ogawa T, 1992, Acta Neurochir Suppl (Wien), V55, P8; Olshaker Jonathan S., 1993, Emergency Medicine Clinics of North America, V11, P165; Romano Valerie A., 1994, Journal of Emergency Medicine, V12, P369, DOI 10.1016/0736-4679(94)90280-1; SKLAR EML, 1992, RADIOL CLIN N AM, V30, P353; WHITE RJ, 1992, NEW ENGL J MED, V327, P1507; WILSON JTL, 1988, J NEUROL NEUROSUR PS, V51, P391, DOI 10.1136/jnnp.51.3.391; YEALY D M, 1991, Emergency Medicine Clinics of North America, V9, P707; YOKATA H, 1991, J TRAUMA, V31, P351	19	17	17	0	6	SOUTHEASTERN SURGICAL CONGRESS	ATLANTA	141 WEST WIEUCA RD, STE B100, ATLANTA, GA 30342 USA	0003-1348			AM SURGEON	Am. Surg.	NOV	1998	64	11					1088	1093					6	Surgery	Surgery	131XU	WOS:000076601200017	9798776				2021-06-18	
J	Adams, VI; Carrubba, C				Adams, VI; Carrubba, C			The Abbreviated Injury Scale - Application to autopsy data	AMERICAN JOURNAL OF FORENSIC MEDICINE AND PATHOLOGY			English	Article						Abbreviated Injury Scale; AIS; autopsy, statistics and numerical data; injury scaling; Injury Severity Scale; ISS; trauma severity indices	SEVERITY SCORE; TRAUMA; CARE	Twenty autopsy reports, comprising 1 fall, 1 cutting, 1 burn, 1 drowning, 1 strangulation, 3 gunshot wound, and 13 traffic fatalities, were scored by the Abbreviated Injury Scale (AIS) and the Injury Severity Score (ISS). The codes were adequate for wounds of skin and long bones, and for most wounds of viscera. The autopsy descriptions were more detailed than the coding criteria for craniocerebral, cervicovertebral and muscular trauma, and less detailed for thoracoabdominal visceral, and long bone trauma. Lung contusions and rib fractures received scores that seemed unduly high, possibly reflecting the greater sensitivity of autopsy diagnosis over clinical diagnosis for these lesions. Complete hinge fractures of the skull base scored 4 (severe), which does not reflect the almost universally lethal nature of the accompanying cerebral concussion, which was itself not codeable. AIS scores were low and did not seem to reflect the lethal outcome when the lethal mechanism was purely physiologic and without a striking morphologic derangement, as in instances of cerebral or cardiac concussion, compression of the neck, occlusive airway hemorrhage, and visceral herniation into an adjacent body cavity. The scores were similarly low when therapy was delayed or adverse. Low AIS and ISS scores ina fatality from blunt or penetrating trauma may be useful retrospective clues to the presence of purely physiologic death mechanisms or therapeutic problems.	Univ S Florida, Hillsborough Cty Med Examiner Dept, Tampa, FL USA	Adams, VI (corresponding author), 401 S Morgan St, Tampa, FL 33602 USA.						*ASS ADV AUT MED, 1990, ABBR INJ SCAL; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; CHAMPION HR, 1995, J TRAUMA, V38, P94, DOI 10.1097/00005373-199501000-00024; CHAMPION HR, 1990, J TRAUMA, V30, P1356, DOI 10.1097/00005373-199011000-00008; Friedman Z, 1996, AM J FOREN MED PATH, V17, P233, DOI 10.1097/00000433-199609000-00011; Garber BG, 1996, J TRAUMA, V40, P733, DOI 10.1097/00005373-199605000-00008; Linn Shai, 1995, Annals of Epidemiology, V5, P440, DOI 10.1016/1047-2797(95)00059-3; LONG WB, 1994, J TRAUMA, V36, P499, DOI 10.1097/00005373-199404000-00007; PRUITT RD, 1974, MAYO CLIN PROC, V49, P627; Stewart TC, 1995, J TRAUMA, V39, P1036, DOI 10.1097/00005373-199512000-00003	10	17	18	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	227 EAST WASHINGTON SQ, PHILADELPHIA, PA 19106 USA	0195-7910			AM J FOREN MED PATH	Am. J. Forensic Med. Pathol.	SEP	1998	19	3					246	251		10.1097/00000433-199809000-00009			6	Medicine, Legal; Pathology	Legal Medicine; Pathology	120UM	WOS:000075975800009	9760090				2021-06-18	
J	Constantoyannis, C; Tzortzidis, F; Papadakis, N				Constantoyannis, C; Tzortzidis, F; Papadakis, N			Internuclear ophthalmoplegia following minor head injury: a case report	BRITISH JOURNAL OF NEUROSURGERY			English	Article						head injury; internuclear opthalmoplegia; multiple sclerosis		Internuclear ophthalmoplegia (INO) is a common sign of multiple sclerosis in young patients and of vascular diseases in older people. Traumatic bilateral internuclear ophthalmoplegia following severe head injuries may occur. We present the unusual case of a young patient suffered from bilateral INO as an isolated finding after a minor head injury, without other signs of brain stem or cortical injury. The ophthalmoplegia has persisted for 22 months.	Univ Hosp Patras, Sch Med, Dept Neurosurg, Patras, Greece	Constantoyannis, C (corresponding author), Univ Patras, Sch Med, Dept Neurosurg, Rion Patras 26500, Greece.			Constantoyannis, Constantine/0000-0003-3030-8439			BAKER RS, 1979, J NEUROSURG, V51, P552, DOI 10.3171/jns.1979.51.4.0552; BIELSCHOWSKY A, 1903, BER DTSCH OPHTHALMOL, V30, P164; COGAN DG, 1970, ARCH OPHTHALMOL-CHIC, V84, P583; Cooper PR, 1993, HEAD INJURY; DEVEREAUX MW, 1979, NEUROLOGY, V29, P251, DOI 10.1212/WNL.29.2.251; JAENSCH PA, 1924, KLIN MONATSBL AUGENH, V73, P471; MCALPINE D, 1972, MULTIPLE SCLEROSIS R, P101; RICH JR, 1974, ARCH OPHTHALMOL-CHIC, V92, P66; SATO O, 1974, NEUROCHIRURGIA, V17, P141; SMITH JL, 1959, ARCH OPHTHALMOL-CHIC, V61, P687, DOI 10.1001/archopht.1959.00940090689003; TANAKA R, 1973, CLIN NEUROL, V13, P518; VANVLIET AGM, 1976, HDB CLIN NEUROLOGY, V24, P75; WALSH FB, 1969, CLIN NEUROOPHTHALMOL, V1, P985; ZAUEL D, 1979, ANN NEUROL, V1, P308	14	17	17	0	1	CARFAX PUBL CO	ABINGDON	PO BOX 25, ABINGDON, OXFORDSHIRE, ENGLAND OX14 3UE	0268-8697			BRIT J NEUROSURG	Br. J. Neurosurg.	AUG	1998	12	4					377	379		10.1080/02688699844943			3	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	115AC	WOS:000075640500017	10070436				2021-06-18	
J	Katano, H; Masago, A; Harada, S; Iwata, A; Yamada, K				Katano, H; Masago, A; Harada, S; Iwata, A; Yamada, K			Differential induction of immediate early gene mRNAs following cryogenic and impact trauma with/without craniotomy in rats	BRAIN RESEARCH			English	Article						Immediate early gene; c-fos; c-jun; traumatic brain injury; messenger RNA; in situ hybridization	FOS MESSENGER-RNA; NERVE-CELL DEATH; C-FOS; BRAIN INJURY; TRANSCRIPTION FACTORS; INCREASED EXPRESSION; NMDA RECEPTOR; JUN; FOREBRAIN; CORTEX	Expression of immediate early gene (IEG) mRNAs following traumatic brain injury in 3 different models-cryogenic injury, impact injury with craniotomy and impact injury without craniotomy-was investigated using in situ hybridization. Cryogenic brain injury resulted in c-fos and c-jun mRNA expression throughout the ipsilateral cortex, piriform cortex and dentate gyrus on the injured side, with peak at 30 min to 1 h post-injury. Impact injury with craniotomy was associated with hybridization signals in the same areas and also in the subcortical white matter or ependyma underlying the impact site at 30 min post-injury. The expression was rather more prolonged than with cryogenic injury. Impact injury without craniotomy induced the expression of both mRNAs throughout the ipsilateral cortex, piriform cortex and dentate gyrus at 30 min post-injury, but this was promptly attenuated by 1 h post-injury, except for bilateral elevation in the dentate gyrus. The present study, thus, demonstrated that regional and temporal expression of IEG mRNAs is influenced by the intensity, quality and manner of application of the insult. Differences in the expression of IEGs may alter the late response gene expression and affect the succeeding events. (C) 1998 Elsevier Science B.V. All rights reserved.	Nagoya City Univ, Sch Med, Dept Neurosurg, Mizuho Ku, Nagoya, Aichi 467, Japan	Katano, H (corresponding author), Nagoya City Univ, Sch Med, Dept Neurosurg, Mizuho Ku, 1 Kawasumi,Mizuho Cho, Nagoya, Aichi 467, Japan.						Akins PT, 1996, STROKE, V27, P1682, DOI 10.1161/01.STR.27.9.1682; Amaral D.G., 1994, RAT NERVOUS SYSTEM, P443; ANGEL P, 1988, NATURE, V332, P166, DOI 10.1038/332166a0; BELLUARDO N, 1995, NEUROCHEM INT, V26, P443, DOI 10.1016/0197-0186(94)00155-N; Campeau S, 1997, NEUROSCIENCE, V78, P1087, DOI 10.1016/S0306-4522(96)00632-X; CURRAN T, 1987, ONCOGENE, V2, P79; DRAGUNOW M, 1995, BRAIN RES REV, V21, P1, DOI 10.1016/0165-0173(95)00003-L; DRAGUNOW M, 1988, BRAIN RES, V455, P295, DOI 10.1016/0006-8993(88)90088-1; DRAGUNOW M, 1993, MOL BRAIN RES, V18, P347, DOI 10.1016/0169-328X(93)90101-T; ESTUS S, 1994, J CELL BIOL, V127, P1717, DOI 10.1083/jcb.127.6.1717; FUKUHARA T, 1995, NEUROSCI LETT, V193, P133, DOI 10.1016/0304-3940(95)11687-R; Gass P, 1997, MOL BRAIN RES, V46, P177, DOI 10.1016/S0169-328X(96)00300-2; Hama H, 1997, J NEUROSCI RES, V47, P590, DOI 10.1002/(SICI)1097-4547(19970315)47:6<590::AID-JNR4>3.0.CO;2-8; HAYES RL, 1995, J NEUROTRAUM, V12, P779, DOI 10.1089/neu.1995.12.779; Herdegen T, 1997, TRENDS NEUROSCI, V20, P227, DOI 10.1016/S0166-2236(96)01000-4; Honkaniemi J, 1997, J CEREBR BLOOD F MET, V17, P636; Iwata A, 1997, J NEUROTRAUM, V14, P201, DOI 10.1089/neu.1997.14.201; Katano H, 1997, RESTOR NEUROL NEUROS, V11, P153, DOI 10.3233/RNN-1997-11305; KINOUCHI H, 1994, J CEREBR BLOOD F MET, V14, P808, DOI 10.1038/jcbfm.1994.101; KOHMURA E, 1995, MOL BRAIN RES, V28, P117, DOI 10.1016/0169-328X(94)00198-N; Lindsberg PJ, 1996, J CEREBR BLOOD F MET, V16, P82, DOI 10.1097/00004647-199601000-00010; Masago A, 1996, NEUROREPORT, V7, P2565, DOI 10.1097/00001756-199611040-00032; MORGAN JI, 1991, TRENDS PHARMACOL SCI, V12, P343, DOI 10.1016/0165-6147(91)90594-I; MORGAN JI, 1991, ANNU REV NEUROSCI, V14, P421, DOI 10.1146/annurev.ne.14.030191.002225; MUDO G, 1993, NEUROSCIENCE, V57, P901, DOI 10.1016/0306-4522(93)90036-F; Nag S, 1996, J NEUROPATH EXP NEUR, V55, P880, DOI 10.1097/00005072-199608000-00003; Paxinos G, 1986, RAT BRAIN STEREOTAXI; Posmantur RM, 1996, J NEUROTRAUM, V13, P125, DOI 10.1089/neu.1996.13.125; Raghupathi R, 1996, MOL BRAIN RES, V37, P134, DOI 10.1016/0169-328X(95)00289-5; Scheff SW, 1997, J NEUROTRAUM, V14, P615, DOI 10.1089/neu.1997.14.615; Schoettle R J, 1990, J Neurotrauma, V7, P207, DOI 10.1089/neu.1990.7.207; SHAPIRA Y, 1988, CRIT CARE MED, V16, P258, DOI 10.1097/00003246-198803000-00010; SHARP FR, 1989, NEUROSCI LETT, V100, P117, DOI 10.1016/0304-3940(89)90670-8; SHENG M, 1990, NEURON, V4, P477, DOI 10.1016/0896-6273(90)90106-P; Smith DH, 1997, J NEUROTRAUM, V14, P715, DOI 10.1089/neu.1997.14.715; Yang K, 1996, J NEUROSCI RES, V44, P157, DOI 10.1002/(SICI)1097-4547(19960415)44:2<157::AID-JNR8>3.0.CO;2-C; YANG K, 1994, BRAIN RES, V664, P141, DOI 10.1016/0006-8993(94)91964-X	37	17	19	0	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993			BRAIN RES	Brain Res.	JUL 27	1998	800	1					69	77		10.1016/S0006-8993(98)00493-4			9	Neurosciences	Neurosciences & Neurology	107YE	WOS:000075237900008	9685588				2021-06-18	
J	Oberg, L; Turkstra, LS				Oberg, L; Turkstra, LS			Use of elaborative encoding to facilitate verbal learning after adolescent traumatic brain injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article							CLOSED-HEAD-INJURY; MEMORY; CHILDREN; PERFORMANCE	Objective: To investigate the effectiveness of elaborative encoding in learning and remembering word definitions after traumatic brain injury (TBI). Design: Two case studies. Setting: University outpatient clinic. Participants: Two adolescents with severe memory impairments after TBI who needed specific vocabulary for school. Interventions: A series of individual speech-language therapy sessions incorperating clinician-and subject-generated strategies to facilitate elaborative encoding. Target words were based on school requirements and pretreatment test results and were assigned randomly to treatment or control groups. Main Outcome Measure: Accuracy of free recalled definitions at the conclusion of therapy and after 1 month with no therapy. Results: Significant improvement in expressed word knowledge at the conclusion of therapy, with improvement on treated words maintained at 1 month for both subjects. Conclusions: Elaborative encoding was an effective tool for teaching specific information required for school. Patterns of response differed substantially from those of normally developing children. Generalization to classroom use was planned for and should be measured in future research.	Univ Arizona, Dept Speech & Hearing Sci, Tucson, AZ 85721 USA; Univ Arizona, Dept Neurol, Tucson, AZ 85721 USA	Turkstra, LS (corresponding author), Case Western Reserve Univ, Dept Commun Sci, 11206 Euclid Ave,LC 7154, Cleveland, OH 44106 USA.				NIDCD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [DC-01409] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [P60DC001409] Funding Source: NIH RePORTER		ANSHEL J, 1990, HEALTHY EYES BETTER; BLOSSER J, 1994, PEDIAT TRAUMATIC BRA; CHORAZY AJL, 1985, HEAD INJURY REHABILI; CORDES AK, 1994, J SPEECH HEAR RES, V37, P264, DOI 10.1044/jshr.3702.264; CROSSON B, 1993, CLIN NEUROPSYCHOL, V7, P250, DOI 10.1080/13854049308401897; CURTIS ME, 1987, NATURE VOCABULARY AC; DELIS D, 1987, CALIFORNIA VERBAL LE; DEMPSTER FN, 1987, J EDUC PSYCHOL, V79, P162, DOI 10.1037/0022-0663.79.2.162; DILLER L, 1987, NEUROBEHAVIORAL RECO; DONDERS J, 1993, BRAIN INJURY, V7, P431, DOI 10.3109/02699059309029686; GOLDSTEIN FC, 1989, CORTEX, V25, P541, DOI 10.1016/S0010-9452(89)80016-4; GOLDSTEIN FC, 1990, J CLIN EXP NEUROPSYC, V12, P286, DOI 10.1080/01688639008400975; GOLDSTEIN G, 1988, CLIN NEUROPSYCHOL, V2, P251; GOODGLASS H, 1993, CORTEX, V29, P377, DOI 10.1016/S0010-9452(13)80250-X; HAMMILL D, 1991, DETROIT TESTS LEARNI; HAMMILL DD, 1994, TEST ADOLESCENT ADUL; HOBBS DJ, 1987, PROGRAM LEARN EDUC T, V24, P145; JOHNSON CJ, 1995, J SPEECH HEAR RES, V38, P612, DOI 10.1044/jshr.3803.612; LEE CP, 1994, J LEARN DISABIL, V27, P454, DOI 10.1177/002221949402700705; Levin H. S., 1989, J CLIN EXP NEUROPSYC, V12, P129; LEVIN HS, 1986, J CLIN EXP NEUROPSYC, V8, P643, DOI 10.1080/01688638608405185; LLOYD LF, 1994, BRAIN INJURY, V8, P529, DOI 10.3109/02699059409151005; MALEC EA, 1991, NEUROPSYCHOLOGY, V5, P29, DOI DOI 10.1037/0894-4105.5.1.29; Mateer Catherine A., 1992, Seminars in Speech and Language, V13, P280, DOI 10.1055/s-2008-1064203; MCKEOWN MG, 1987, NATURE VOCABULARY AC; MEHTA CR, 1983, J AM STAT ASSOC, V78, P427, DOI 10.2307/2288652; Nippold M. A., 1988, LATER LANGUAGE DEV; PRESSLEY M, 1984, J VERB LEARN VERB BE, V23, P270, DOI 10.1016/S0022-5371(84)90181-6; Raven J. C., 1938, PROGR MATRICES PERCE; Savage RC, 1987, J HEAD TRAUMA REHAB, V2, P1; SEMEL W, 1995, CLIN EVALUATION LANG; Sohlberg M. M., 1989, INTRO COGNITIVE REHA; SWANSON HL, 1989, J EXP CHILD PSYCHOL, V47, P370, DOI 10.1016/0022-0965(89)90020-9; TURKSTRA LS, 1995, BRAIN INJURY, V9, P61, DOI 10.3109/02699059509004573; Wechsler D., 1991, WECHSLER INTELLIGENC; WESSELLS MG, 1982, COGNITIVE PSYCHOL; WIIG EH, 1988, TEST LANGUAGE COMPET; ZACHMAN I, 1989, ADOLESCENT WORD TEST; ZURIF E, 1994, J PSYCHOLINGUIST RES, V23, P487, DOI 10.1007/BF02146687	39	17	18	0	10	ASPEN PUBL INC	FREDERICK	7201 MCKINNEY CIRCLE, FREDERICK, MD 21704 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JUN	1998	13	3					44	62		10.1097/00001199-199806000-00005			19	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	ZT046	WOS:000074042200005	9582178				2021-06-18	
J	Zhao, SR; Pang, Y; Beuerman, RW; Thompson, HW; Kline, DG				Zhao, SR; Pang, Y; Beuerman, RW; Thompson, HW; Kline, DG			Expression of c-fos protein in the spinal cord after brachial plexus injury: Comparison of root avulsion and distal nerve transection	NEUROSURGERY			English	Article						brachial plexus injury; c-fos; immediate-early gene; nerve root avulsion; nerve transection; spinal cord injury	PROGRAMMED CELL-DEATH; PERSISTENT EXPRESSION; RAT-BRAIN; INDUCTION; NEURONS; IMMUNOREACTIVITY; STIMULATION; APOPTOSIS; NOCICEPTION; PATTERNS	OBJECTIVE: Clinical reports indicate poor outcomes for avulsion injuries, compared with more peripheral nerve damage. These two different injuries may both affect gene expression in spinal neurons, and the changes in gene expression may be related to the types of injuries. METHODS: The brachial plexus of 48 adult male rats was lesioned by either root avulsion close to the spinal cord or distal nerve transection. The rats were quickly revived and remained awake until death at 30, 60, or 120 min after surgery. In rats with avulsive injuries, traumatic sites on the dorsal and ventral horns of the spinal cord were microscopically detected. Immunocytochemical analysis of the c-fos product was performed for the two experimental groups and for sham-treated control animals at the same survival times. RESULTS: An increase in Fos-like immunoreactivity (FLI) in cells of the spinal cord, at levels C4-T1, was detected at 30 min after nerve transection or root avulsion. The number of FLI-positive cells continued to increase at 60 and 120 min after the nerve injury (P = 0.001). FLI-positive cells were compared at the C7 level, in laminae 1 and 2, 3 and 4, and 5 to 10, after the two injuries and were found to be more abundant after the avulsive injury (P = 0.0001); furthermore, the number of FLI-positive cells increased with time (P = 0.001). In a comparison of ail levels, both experimental groups demonstrated significantly greater numbers of FLI-positive cells than did controls, and the group with nerve root avulsion showed significantly (P = 0.0001) more FLI-positive cells than did the group with distal nerve transection. CONCLUSION: These results suggest that nerve root avulsion from the spinal cord leads to increased and prolonged expression of c-fos and, potentially, greatly increased transcription of new messages for recovery, survival, or cell death.	Louisiana State Univ, Med Ctr, Dept Neurosurg, Ctr Eye, New Orleans, LA 70112 USA; Louisiana State Univ, Ctr Eye, Dept Neurol, New Orleans, LA 70112 USA; Louisiana State Univ, Sch Med, Lions Eye Res Ctr, New Orleans, LA 70112 USA	Kline, DG (corresponding author), Louisiana State Univ, Med Ctr, Dept Neurosurg, Ctr Eye, 1542 Tulane Ave, New Orleans, LA 70112 USA.				NATIONAL EYE INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [R01EY004074, P30EY002377] Funding Source: NIH RePORTER; NEI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [EY02377, EY04074] Funding Source: Medline		ABBADIE C, 1992, BRAIN RES, V578, P17, DOI 10.1016/0006-8993(92)90224-W; BERKELAAR M, 1994, J NEUROSCI, V14, P4368, DOI 10.1523/jneurosci.14-07-04368.1994; BULLITT E, 1992, BRAIN RES, V580, P172, DOI 10.1016/0006-8993(92)90941-2; BULLITT E, 1989, BRAIN RES, V493, P391, DOI 10.1016/0006-8993(89)91177-3; CHI SI, 1993, BRAIN RES, V617, P225, DOI 10.1016/0006-8993(93)91090-F; CHI SI, 1993, BRAIN RES, V617, P220, DOI 10.1016/0006-8993(93)91089-B; COLOTTA F, 1992, J BIOL CHEM, V267, P18278; DELEO JA, 1991, MOL BRAIN RES, V11, P167, DOI 10.1016/0169-328X(91)90118-H; DRAGUNOW M, 1990, BRAIN RES, V533, P324, DOI 10.1016/0006-8993(90)91357-M; DRAISCI G, 1989, MOL BRAIN RES, V6, P31, DOI 10.1016/0169-328X(89)90025-9; Ducker T B, 1977, Clin Neurosurg, V24, P406; EDSTROM JE, 1959, J NEUROCHEM, V5, P43, DOI 10.1111/j.1471-4159.1959.tb13331.x; EMERY DG, 1987, EXP BRAIN RES, V67, P41, DOI 10.1007/BF00269451; EVAN GI, 1992, CELL, V69, P119, DOI 10.1016/0092-8674(92)90123-T; GEHRMANN J, 1995, J NEUROPATH EXP NEUR, V54, P680, DOI 10.1097/00005072-199509000-00010; Grafstein B, 1978, NEURONAL PLASTICITY, P155; Gu ZZ, 1997, NEUROCHEM INT, V30, P417, DOI 10.1016/S0197-0186(96)00077-0; HUNT SP, 1987, NATURE, V328, P632, DOI 10.1038/328632a0; JONSE KJ, 1991, J NEUROSCI RES, V28, P291; KLINE DG, 1995, NERVE INJURIES OPERA, P397; LEE JH, 1992, BRAIN RES, V577, P80, DOI 10.1016/0006-8993(92)90540-P; LO AC, 1995, EXP NEUROL, V134, P49, DOI 10.1006/exnr.1995.1035; LUCAS J H, 1990, Journal of Neurotrauma, V7, P169, DOI 10.1089/neu.1990.7.169; LUCAS JH, 1992, J NEUROTRAUM, V9, P117, DOI 10.1089/neu.1992.9.117; MENETREY D, 1989, J COMP NEUROL, V285, P177, DOI 10.1002/cne.902850203; MORGAN JI, 1987, SCIENCE, V237, P192, DOI 10.1126/science.3037702; MORGAN JI, 1991, ANNU REV NEUROSCI, V14, P421, DOI 10.1146/annurev.ne.14.030191.002225; MUNGLANI R, 1995, BRIT J ANAESTH, V75, P186, DOI 10.1093/bja/75.2.186; PANG Y, 1993, MOL BRAIN RES, V20, P162, DOI 10.1016/0169-328X(93)90122-6; PHILLIPS LL, 1992, J NEUROTRAUM, V9, P323, DOI 10.1089/neu.1992.9.323; PLANTINGA LC, 1994, INT J DEV NEUROSCI, V12, P117, DOI 10.1016/0736-5748(94)90004-3; PRESLEY RW, 1990, J NEUROSCI, V10, P323; Preston GA, 1996, MOL CELL BIOL, V16, P211; Sandkuhler J, 1996, NEUROSCIENCE, V73, P657, DOI 10.1016/0306-4522(96)00073-5; SEARLE J, 1982, PATHOL ANNU, V17, P229; SHENG M, 1990, NEURON, V4, P477, DOI 10.1016/0896-6273(90)90106-P; SMEYNE RJ, 1993, NATURE, V363, P166, DOI 10.1038/363166a0; SMITH MA, 1992, BRAIN RES, V578, P135, DOI 10.1016/0006-8993(92)90240-A; SZENTAGOTHAI J, 1949, ARCH NEURO PSYCHIATR, V62, P734, DOI 10.1001/archneurpsyc.1949.02310180035005; WILLIAMS S, 1990, NEUROSCIENCE, V36, P73, DOI 10.1016/0306-4522(90)90352-5; YAKOVLEV AG, 1995, J NEUROTRAUM, V12, P767, DOI 10.1089/neu.1995.12.767; ZORUB DS, 1974, SURG NEUROL, V2, P347	42	17	18	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	227 EAST WASHINGTON SQ, PHILADELPHIA, PA 19106 USA	0148-396X			NEUROSURGERY	Neurosurgery	JUN	1998	42	6					1357	1362		10.1097/00006123-199806000-00099			6	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	ZR050	WOS:000073930700091	9632196				2021-06-18	
J	Coplin, WM; O'Keefe, GE; Grady, MS; Grant, GA; March, KS; Winn, HR; Lam, AM				Coplin, WM; O'Keefe, GE; Grady, MS; Grant, GA; March, KS; Winn, HR; Lam, AM			Accuracy of continuous jugular bulb oximetry in the intensive care unit	NEUROSURGERY			English	Article						arteriovenous difference of oxygen; continuous in vivo oximetry; head injury; intensive care unit; jugular bulb oxygen saturation; monitoring	HEAD-INJURED PATIENTS; VENOUS OXYGEN-SATURATION; CEREBRAL BLOOD-FLOW; CONTINUOUS MONITOR; SURGERY	OBJECTIVE: To address the accuracy of a bedside jugular bulb oxygen saturation (SjO2) catheter monitor (Baxter-Edwards, Santa Ana, CA) versus in vitro co-oximetry measurements in the intensive care unit (ICU). METHODS: By prospective protocol, we compared blood gas measurements with simultaneously recorded continuous bedside oximetric monitor values for 31 ICU patients with traumatic brain injury undergoing jugular bulb catheter monitoring. For suboptimal fiberoptic light signal quality indices, the catheter was repositioned, flushed, or both before drawing the sample for in vitro measurement. Laboratory and bedside monitor data were examined for association using the chi(2) and paired t tests and a linear regression model. RESULTS: We assessed 195 samples (median, 5 per patient; range, 1-14) who were monitored an average of 3.4 (range, 1-6) days. The in vivo monitor (range, 32-94%) and in vitro co-oximetry (range, 38-93%) values had acceptable correlation (y = 0.94x + 4.4, r(2) = 0.80). For bedside monitor detection of jugular bulb desaturation (SjO2 < 50% for 10 min), the kappa statistic was 0.35, the sensitivity was 45 to 50%, and the specificity was 98 to 100%. CONCLUSION: Continuous ICU SjO2 monitoring correlates significantly with in vitro values, but less so than previously described during intracranial surgery. Although sensitivity of the bedside monitor to detect confirmed desaturations remains an issue, the high specificity indicates that it is less of a concern that patients may be misdiagnosed as having desaturations resulting in unnecessary interventions. Nonetheless, suspected jugular bulb desaturation should be verified before taking therapeutic actions.	Univ Washington, Harborview Med Ctr, Dept Neurol Surg, Seattle, WA 98104 USA; Univ Washington, Harborview Med Ctr, Dept Neurol, Seattle, WA 98104 USA; Univ Washington, Harborview Med Ctr, Dept Anesthesiol, Seattle, WA 98104 USA; Univ Washington, Harborview Med Ctr, Dept Surg, Seattle, WA 98104 USA; Univ Washington, Harborview Med Ctr, Dept Nursing Educ, Seattle, WA 98104 USA; Univ Washington, Harborview Med Ctr, Div Pulm & Crit Care Med, Seattle, WA 98104 USA	Grady, MS (corresponding author), Univ Washington, Harborview Med Ctr, Dept Neurol Surg, 325 9Th Ave,Box 359766, Seattle, WA 98104 USA.				NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS 30305] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50NS030305] Funding Source: NIH RePORTER		ANDREWS PJD, 1991, BRIT J ANAESTH, V67, P553, DOI 10.1093/bja/67.5.553; Cruz J, 1988, Acta Neurochir Suppl (Wien), V42, P35; CRUZ J, 1993, J NEUROSURG, V79, P228, DOI 10.3171/jns.1993.79.2.0228; Fortune JB, 1995, J TRAUMA, V39, P1091, DOI 10.1097/00005373-199512000-00014; FORTUNE JB, 1994, J NEUROSURG, V80, P461, DOI 10.3171/jns.1994.80.3.0461; GARLICK R, 1987, SCAND J CLIN LAB INV, V47, P47; GIBBS EL, 1945, AM J PSYCHIAT, V102, P184, DOI 10.1176/ajp.102.2.184; GOPINATH SP, 1994, J NEUROL NEUROSUR PS, V57, P717, DOI 10.1136/jnnp.57.6.717; GUNN HC, 1995, J NEUROSURG ANESTH, V7, P174, DOI 10.1097/00008506-199507000-00003; JAKOBSEN M, 1989, J CEREBR BLOOD F MET, V9, P717, DOI 10.1038/jcbfm.1989.101; MATTA BF, 1994, ANESTH ANALG, V79, P745; NAKAJIMA T, 1992, ANESTH ANALG, V74, P630; NAKAJIMA T, 1993, ANESTH ANALG, V77, P1111; REICH DL, 1993, 15 ANN M SOC CARD AN; Ritter AM, 1996, J CLIN MONITOR, V12, P285, DOI 10.1007/BF02221748; ROBERTSON CS, 1992, J NEUROL NEUROSUR PS, V55, P594, DOI 10.1136/jnnp.55.7.594; ROBERTSON CS, 1992, J NEUROSURG, V77, P163; SHEINBERG M, 1992, J NEUROSURG, V76, P212, DOI 10.3171/jns.1992.76.2.0212; TEASDALE G, 1974, LANCET, V2, P81; Trubiano P, 1996, ANESTH ANALG, V82, P964, DOI 10.1097/00000539-199605000-00013	20	17	17	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	227 EAST WASHINGTON SQ, PHILADELPHIA, PA 19106 USA	0148-396X			NEUROSURGERY	Neurosurgery	MAR	1998	42	3					533	539		10.1097/00006123-199803000-00020			7	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	ZC008	WOS:000072530300069	9526988				2021-06-18	
J	Hollander, JE; Singer, AJ; Valentine, S				Hollander, JE; Singer, AJ; Valentine, S			Comparison of wound care practices in pediatric and adult lacerations repaired in the emergency department	PEDIATRIC EMERGENCY CARE			English	Article						laceration; wound; irrigation; infection; cleansing	TERM COSMETIC APPEARANCE; URBAN CHILDREN; IRRIGATION; RATES; LEVEL	Objective: We compared emergency physician's wound care practices in young children (less than or equal to 5 years) and adults (greater than or equal to 18 years) and the effect of these different practices on infection rate and cosmetic appearance, Design: Cross sectional study, Setting: University hospital emergency department that rarely uses conscious sedation, Participants: Consecutive patients who presented with lacerations over a four-year period, Methods: Structured closed question data sheets that assessed 26 separate wound characteristics were prospectively completed at initial presentation and at suture removal, Infection and cosmetic appearance were assessed with previously validated scales, chi(2) tests were used for categorical variables, t tests for continuous variables, Results: We evaluated 3624 patients: 853 children and 2771 adults, Wounds in children were more likely to be on the head (86 vs 38%, P < 0.01); linear (88 vs 77%, P < 0.01); shorter (1.9 vs 3.0 cm, P < 0.01); less often contaminated (4 vs 11%, P < 0.01); and more commonly caused by blunt injury (69 vs 37%, P < 0.01), With respect to treatment, lacerations in children were less likely to receive irrigation (53 vs 77%; P < 0.001) but slightly more likely to be scrubbed (50 vs 45%, P = 0.01), The two groups received similar numbers of sutures per centimeter (2.6 vs 2.3), Using logistic regression, the differences in irrigation were not explained by the differences in laceration characteristics, Despite less frequent irrigation, children had lower wound infection rates (2.1 vs 4.1%; P = 0.004) and better cosmetic appearances (optimal score, 75 vs 64%, P = 0.0003), Conclusions: Emergency physicians at our institution are less likely to irrigate lacerations in children than adults; however, children had a lower infection rate and more favorable cosmetic outcome.	SUNY Stony Brook, Med Ctr, Dept Emergency Med, Stony Brook, NY 11794 USA	Singer, AJ (corresponding author), SUNY Stony Brook, Med Ctr, Dept Emergency Med, Stony Brook, NY 11794 USA.			Hollander, Judd/0000-0002-1318-2785			BAKER MD, 1990, ANN EMERG MED, V19, P1001; BAKER MD, 1990, AM J DIS CHILD, V144, P87, DOI 10.1001/archpedi.1990.02150250097042; BROWN LL, 1978, ANN SURG, V187, P170, DOI 10.1097/00000658-197802000-00013; CHENOWITH A, 1973, MATERNAL CHILD HLTH, P651; DIRE DJ, 1990, ANN EMERG MED, V19, P704, DOI 10.1016/S0196-0644(05)82484-9; DIRE DJ, 1995, ACAD EMERG MED, V2, P4, DOI 10.1111/j.1553-2712.1995.tb03070.x; EDLICH RF, 1969, AM J SURG, V118, P21, DOI 10.1016/0002-9610(69)90089-0; GOSNOLD JK, 1977, PRACTITIONER, V218, P584; GROSS A, 1972, AM J SURG, V124, P373, DOI 10.1016/0002-9610(72)90044-X; GROSS AG, 1971, J ORAL SURG, V29, P187; HOLLANDER JE, 1995, ACAD EMERG MED, V2, P983, DOI 10.1111/j.1553-2712.1995.tb03126.x; HOLLANDER JE, 1995, ANN EMERG MED, V25, P675, DOI 10.1016/S0196-0644(95)70183-4; IZANT RJ, 1966, J TRAUM, V6, P65, DOI 10.1097/00005373-196601000-00008; MANHEIMER DI, 1966, PUBLIC HLTH REP, V81, P529; Quinn JV, 1996, ACAD EMERG MED, V3, P298, DOI 10.1111/j.1553-2712.1996.tb03440.x; RIVARA FP, 1982, AM J DIS CHILD, V136, P502, DOI 10.1001/archpedi.1982.03970420026004; ROBSON MC, 1973, J SURG RES, V14, P426, DOI 10.1016/0022-4804(73)90049-8; RODEHEAVER GT, 1975, SURG GYNECOL OBSTET, V141, P357; Rosenberg N M, 1987, Pediatr Emerg Care, V3, P239, DOI 10.1097/00006565-198712000-00005; SINGER AJ, 1995, AM J EMERG MED, V13, P265, DOI 10.1016/0735-6757(95)90197-3; Singer AJ, 1997, ACAD EMERG MED, V4, P133, DOI 10.1111/j.1553-2712.1997.tb03720.x; Singer AJ, 1996, ACAD EMERG MED, V3, P378, DOI 10.1111/j.1553-2712.1996.tb03454.x; SINGER AJ, IN PRESS ACAD EMERG; Stevenson T R, 1976, JACEP, V5, P17, DOI 10.1016/S0361-1124(76)80160-8; SUSSMAN BJ, 1996, ADV DATA VIT HLTH ST, V275	25	17	18	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	227 EAST WASHINGTON SQ, PHILADELPHIA, PA 19106 USA	0749-5161			PEDIATR EMERG CARE	Pediatr. Emerg. Care	FEB	1998	14	1					15	18		10.1097/00006565-199802000-00004			4	Emergency Medicine; Pediatrics	Emergency Medicine; Pediatrics	YY491	WOS:000072151900004	9516624				2021-06-18	
J	Papagno, C				Papagno, C			Transient retrograde amnesia associated with impaired naming of living categories	CORTEX			English	Article						retrograde amnesia; living/non-living dissociation	CLOSED-HEAD-INJURY; MEMORY; ENCEPHALITIS; CORTEX	A ease of pure retrograde amnesia following mild head injury is reported. The patient, who also showed a deficit in verbal fluency and a living/non-living dissociation in naming during the amnesic period, recovered progressively in about ten days post-trauma. Both a psychogenic and an organic origin could be taken into account. A mechanism (no matter if psychogenic or organic) can be hypothesized, which produces a functional inhibition also involving performances that are unlikely to be affected by psychological factors.	Univ Milan, Osped San Paolo, Clin Neurol 3, I-20142 Milan, Italy	Papagno, C (corresponding author), Univ Milan, Osped San Paolo, Clin Neurol 3, Via Rudini 8, I-20142 Milan, Italy.	costanza.p@iol.it	papagno, costanza/K-8460-2012	papagno, costanza/0000-0002-3659-6294			Barbarotto R, 1996, NEUROPSYCHOLOGIA, V34, P575, DOI 10.1016/0028-3932(95)00141-7; Barbarotto R, 1996, ACTA NEUROL SCAND, V93, P272; Benton A.L., 1983, CONTRIBUTIONS NEUROP; BORRINI G, 1989, PSYCHOL MED, V19, P215, DOI 10.1017/S0033291700011181; Calabrese P, 1996, J NEUROL NEUROSUR PS, V61, P304, DOI 10.1136/jnnp.61.3.304; Campodonico J R, 1996, J Int Neuropsychol Soc, V2, P146; CAPITANI E, 1991, ITAL J NEUROL SCI, V12, P461, DOI 10.1007/BF02335507; CAPITANI E, 1994, NEUROPSYCHOLOGIA, V16, P491; Capitani Erminio, 1993, Archivio di Psicologia Neurologia e Psichiatria, V54, P457; DeRenzi E, 1997, NEUROPSYCHOLOGIA, V35, P781, DOI 10.1016/S0028-3932(97)00018-3; DERENZI E, 1995, CORTEX, V31, P531, DOI 10.1016/S0010-9452(13)80064-0; DERENZI E, 1978, CORTEX, V14, P41, DOI 10.1016/S0010-9452(78)80006-9; FAGLIONI P, 1991, Archivio di Psicologia Neurologia e Psichiatria, V52, P339; GLOOR P, 1990, BRAIN, V113, P1673, DOI 10.1093/brain/113.6.1673; HODGES JR, 1994, J NEUROL NEUROSUR PS, V57, P605, DOI 10.1136/jnnp.57.5.605; HOKKANEN L, 1995, PSYCHOL MED, V25, P203, DOI 10.1017/S0033291700028245; HUNKIN NM, 1995, NEUROPSYCHOLOGIA, V33, P509, DOI 10.1016/0028-3932(94)00136-D; Kapur N, 1996, Cogn Neuropsychiatry, V1, P247, DOI 10.1080/135468096396541; KAPUR N, 1991, BRIT J PSYCHIAT, V159, P872, DOI 10.1192/bjp.159.6.872; KAPUR N, 1993, CORTEX, V29, P217, DOI 10.1016/S0010-9452(13)80177-3; KOPELMAN MD, 1994, NEUROPSYCHOLOGIA, V32, P675, DOI 10.1016/0028-3932(94)90028-0; KOPELMAN MD, 1992, NATO ADV SCI INST SE, V65, P427; KOPELMAN MD, 1987, BRIT J PSYCHIAT, V150, P428, DOI 10.1192/bjp.150.4.428; LUCCHELLI F, 1995, BRAIN, V118, P167, DOI 10.1093/brain/118.1.167; MALLOY P, 1994, HANDB NEUR, V9, P203; Markowitsch HJ, 1996, NEUROCASE, V2, P357; MARKOWITSCH HJ, 1993, J NEUROL NEUROSUR PS, V56, P988, DOI 10.1136/jnnp.56.9.988; NOVELLI C, 1986, ARCH NEUROLOGIA PSIC, V47, P278; NOVELLI G, 1986, Archivio di Psicologia Neurologia e Psichiatria, V47, P477; ORSINI A, 1987, ITAL J NEUROL SCI, V8, P539; PAPAGNO C, 1990, MOLTE FACCE MEMORIA, P107; SCHACTER DL, 1977, CORTEX, V13, P150, DOI 10.1016/S0010-9452(77)80006-3; SCHACTER DL, 1989, HDB NEUROPSYCHOLOGY, V3, P209; Spinnler H, 1996, BRAIN, V119, P1403, DOI 10.1093/brain/119.4.1403; SPINNLER H, 1987, ITALIAN J NEUROLOG S, V8	35	17	18	0	2	ELSEVIER MASSON, CORPORATION OFFICE	PARIS	65 CAMILLE DESMOULINS CS50083 ISSY-LES-MOULINEAUX, 92442 PARIS, FRANCE	0010-9452	1973-8102		CORTEX	Cortex	FEB	1998	34	1					111	121		10.1016/S0010-9452(08)70740-8			11	Behavioral Sciences; Neurosciences; Psychology, Experimental	Behavioral Sciences; Neurosciences & Neurology; Psychology	ZA672	WOS:000072389500007	9533997				2021-06-18	
J	Vaz, R; Sarmento, A; Borges, N; Cruz, C; Azevedo, T				Vaz, R; Sarmento, A; Borges, N; Cruz, C; Azevedo, T			Experimental traumatic cerebral contusion: Morphological study of brain microvessels and characterization of the oedema	ACTA NEUROCHIRURGICA			English	Article						brain oedema; head injury; blood-brain barrier; morphology	FLUID-PERCUSSION MODEL; DIFFUSE AXONAL INJURY; CLOSED-HEAD-INJURY; RAT; EDEMA; CONCUSSION	Several experimental brain oedema models are currently available, but most of them are very different from what happens in clinical practice. As it is simple and seems to replicate the range of injuries seen in man we decided to evaluate Marmarou's model of head injury in order to test physiopathogenic and therapeutic hypotheses. Three groups of Wistar rats weighting 360-400 gr, anaesthetized with sodium pentobarbitone and breathing spontaneously, without tracheal intubation, were studied. In the first group six animals were killed two hours after injury and the brain's water content compared with that of nine controls. In another group Evans blue (100 mg/kg) was injected one hour before trauma and dye's extraction ratio determined at various times after injury: five animals at 15 minutes, six at 30 minutes, five at 60 minutes and nine at 120 minutes. A total of twenty-eight animals served as controls. In the last group morphological studies with light and electron microscopy were performed in the traumatized brain tissue from rats killed 5 and 120 minutes after injury and in brain tissue from control rats. Results showed that Marmarou's brain trauma model induced perivascular brain oedema, already visible at the ultrastructural level 5 minutes after the injury. Endothelial cells themselves were "oedematiated", rich in pinocytotic vesicles and membrane blebs, and presented intact tight junctions. Two hours after trauma the perivascular oedema was more marked. At this time the brain water content was significantly higher than that in controls. Evans blue extraction ratio increased linearly with time, being significantly higher than in controls 120 minutes after injury. We conclude that Marmarou's model is a suitable model for the study of brain oedema induced by trauma, and that this oedema, assessed by three different methodologies, was statistically significant two hours after injury.	Hosp Sao Joao, Dept Neurosurg, Mes Fac, P-4200 Porto, Portugal; Hosp Sao Joao, Inst Pharmacol & Therapeut, Porto, Portugal	Vaz, R (corresponding author), Hosp Sao Joao, Dept Neurosurg, Mes Fac, Alameda Prof Hernani Monteiro, P-4200 Porto, Portugal.		Sarmento, Antonio/M-5235-2013; Borges, Nuno/K-7051-2013	Sarmento, Antonio/0000-0001-5269-7231; Vaz, Rui/0000-0001-7527-8187; Borges, Nuno/0000-0001-6357-0615			ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; BAKAY L, 1977, J NEUROSURG, V47, P525, DOI 10.3171/jns.1977.47.4.0525; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; Friedman A, 1996, NAT MED, V2, P1382, DOI 10.1038/nm1296-1382; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; HUGER F, 1979, J NEUROCHEM, V33, P89, DOI 10.1111/j.1471-4159.1979.tb11710.x; KARNOVSKY MJ, 1965, J CELL BIOL, V27, pA137; KIMELBERG HK, 1992, J NEUROTRAUM, V9, pS71; KIMELBERG HK, 1995, J NEUROSURG, V83, P1051, DOI 10.3171/jns.1995.83.6.1051; KITA H, 1994, ACTA NEUROCHIR, P452; KLATZO I, 1967, J NEUROPATH EXP NEUR, V26, P1, DOI 10.1097/00005072-196701000-00001; KLATZO I, 1944, ACTA NEUROCHIR WIE S, V60, P3; LANG DA, 1994, J NEUROSURG, V80, P675, DOI 10.3171/jns.1994.80.4.0675; LEVIN HS, 1981, ARCH NEUROL-CHICAGO, V38, P623, DOI 10.1001/archneur.1981.00510100051007; MARMAROU A, 1994, ACTA NEUROCHIR, P421; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; MILLER JD, 1977, J NEUROSURG, V47, P503, DOI 10.3171/jns.1977.47.4.0503; MILLER JD, 1990, NEUROSURGERY, V27, P433, DOI 10.1227/00006123-199009000-00016; NARAYAN RK, 1981, J NEUROSURG, V54, P751, DOI 10.3171/jns.1981.54.6.0751; NAVARRO JC, 1991, J NEUROL SCI, V103, pS3; PENN RD, 1982, HEAD INJURY, P233; SHAPIRA Y, 1988, CRIT CARE MED, V16, P258, DOI 10.1097/00003246-198803000-00010; STEWART PA, 1987, J NEUROSURG, V67, P697, DOI 10.3171/jns.1987.67.5.0697; SULLIVAN HG, 1976, J NEUROSURG, V45, P520, DOI 10.3171/jns.1976.45.5.0520; TORNHEIM PA, 1983, J NEUROSURG, V59, P431, DOI 10.3171/jns.1983.59.3.0431; UYAMA O, 1988, J CEREBR BLOOD F MET, V8, P282, DOI 10.1038/jcbfm.1988.59; VANDENBRINK WA, 1994, ACTA NEUROCHIR WIE S, V60, P455; Vaz R, 1997, ACTA NEUROCHIR, V139, P215, DOI 10.1007/BF01844754; WEST M, 1982, ELECTROEN CLIN NEURO, V53, P192, DOI 10.1016/0013-4694(82)90023-2	31	17	17	0	2	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.		1998	140	1					76	81		10.1007/s007010050061			6	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	YV305	WOS:000071809900026	9522912				2021-06-18	
J	Krauss, JK; Jankovic, J				Krauss, JK; Jankovic, J			Tics secondary to craniocerebral trauma	MOVEMENT DISORDERS			English	Article						head injury; movement disorder; tics; Tourette's syndrome	POSTTRAUMATIC MOVEMENT-DISORDERS; TOURETTE SYNDROME; HEAD TRAUMA; DYSTONIA; GILLES	We describe three adult patients who presented with multifocal motor and vocal tics secondary to craniocerebral trauma. In one case, the tics were accompanied by marked obsessive-compulsive behavior. All patients were involved in motor vehicle accidents resulting in closed craniocerebral trauma, The latency of onset between head trauma and the movement disorder varied between 1 day and a few months. Magnetic resonance imaging, which was performed in all three patients, did not detect any structural lesions of the basal ganglia or the brainstem. Extensive bifrontal leukoencephalopathy was found in one patient who suffered severe head trauma.	BAYLOR COLL MED, DEPT NEUROL, HOUSTON, TX 77030 USA; BAYLOR COLL MED, DEPT NEUROSURG, HOUSTON, TX 77030 USA							COMINGS DE, 1990, J CLIN PSYCHIAT, V51, P463; CURRAN TG, 1995, HDB TREMOR DISORDERS, P411; ERIKSSON B, 1969, BRIT J PSYCHIAT, V115, P351, DOI 10.1192/bjp.115.520.351; Fahn S, 1982, Adv Neurol, V35, P349; GAUL JJ, 1994, MOVEMENT DISORD, V9, P121; GOETZ CG, 1992, NEUROL CLIN, V10, P907; JANKOVIC J, 1994, MOVEMENT DISORD, V9, P347, DOI 10.1002/mds.870090315; Jankovic J, 1997, NEUROL CLIN, V15, P267, DOI 10.1016/S0733-8619(05)70311-X; Jankovic J, 1997, NEUROLOGY, V48, P358, DOI 10.1212/WNL.48.2.358; JANKOVIC J, 1994, NEUROLOGY, V44, P2006, DOI 10.1212/WNL.44.11.2006; JANKOVIC J, 1993, HDB TOURETTES SYNDRO, P167; JANKOVIC J, 1987, MOVEMENT DISORD, V2, P383; JANKOVIC J, 1993, CURR NEUROL, V13, P209; KLEMPEL K, 1974, S AFR MED J, V48, P1379; KOLLER WC, 1989, MOVEMENT DISORD, V4, P20, DOI 10.1002/mds.870040106; KRAUS JF, 1996, NEUROTRAUMA, P13; KRAUSS JK, 1992, MOVEMENT DISORD, V7, P263, DOI 10.1002/mds.870070313; KRAUSS JK, 1995, NEUROL RES, V17, P409, DOI 10.1080/01616412.1995.11740353; KRAUSS JK, 1997, IN PRESS MOV DISORD; KRAUSS JK, 1997, IN PRESS NEUROLOGY; Kumar R, 1997, NEUROL CLIN, V15, P309, DOI 10.1016/S0733-8619(05)70315-7; LANG AE, 1992, ADV NEUROL, V58, P25; LECKMAN JF, 1992, ADV NEUROL, V58, P15; LEE MS, 1994, NEUROLOGY, V44, P1374, DOI 10.1212/WNL.44.8.1374; RICHARDSON EP, 1982, G DELATOURETTE SYNDR, P83; ROBERTSON M, 1990, J NEUROL NEUROSUR PS, V53, P691, DOI 10.1136/jnnp.53.8.691; SACKS OW, 1982, GILLES TOURETTE SYND, P89; Siemers E, 1990, Mov Disord, V5, P183; SINGER C, 1989, MOVEMENT DISORD, V4, P342, DOI 10.1002/mds.870040409; Singer HS, 1997, NEUROL CLIN, V15, P357, DOI 10.1016/S0733-8619(05)70318-2; SINGER HS, 1991, ANN NEUROL, V30, P558, DOI 10.1002/ana.410300408; TALAIRAC.J, 1973, ELECTROEN CLIN NEURO, V34, P45, DOI 10.1016/0013-4694(73)90149-1; TRIMBLE MR, 1987, MOVEMENT DISORD, V2, P106	33	17	18	0	1	WILEY-BLACKWELL	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	0885-3185			MOVEMENT DISORD	Mov. Disord.	SEP	1997	12	5					776	782		10.1002/mds.870120527			7	Clinical Neurology	Neurosciences & Neurology	XX028	WOS:A1997XX02800026	9380066				2021-06-18	
J	OBrien, D; ODell, MW; Eversol, A				OBrien, D; ODell, MW; Eversol, A			Delayed traumatic cerebral aneurysm after brain injury	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article							INTRACRANIAL ANEURYSMS; CHILDHOOD	Traumatic aneurysms (TAs) are an unusual etiology for late neurological deterioration after traumatic brain injury (TBI) and represent less than 1% of all cerebral aneurysms. TAs most often are diagnosed acutely but may be delayed in presentation. To increase awareness of this serious but treatable condition when diagnosed early, we report a delayed TA after a motor vehicle accident. The patient experienced a seizure on day 46 postinjury while in rehabilitation and demonstrated persistent lethargy and hemiparesis. Neuroimaging revealed a large, ruptured left pericallosal artery TA, which was surgically clipped. The patient completed his rehabilitation course and was eventually discharged home with family. Among TBIs, TAs are associated with penetrating injuries and skull base or anterior cranial fossa fractures. Associated mortality is high, especially if rupture has occurred. Although TAs are rare, the clinician should be vigilant in the at-risk patient. (C) 1997 by the American Congress of Rehabilitation Medicine and the American Academy of Physical Medicine and Rehabilitation.	UNIV CINCINNATI,COLL MED,DEPT PHYS MED & REHABIL,CINCINNATI,OH; DRAKECTR INC,BRAIN INJURY REHABIL PROGRAMS,CINCINNATI,OH							ALMEIDA GM, 1977, CHILD BRAIN, V3, P193; ASARI S, 1977, J NEUROSURG, V46, P795, DOI 10.3171/jns.1977.46.6.0795; BECKER DP, 1990, NEUROLOGICAL SURG, P2105; BENOIT BG, 1973, J NEUROL NEUROSUR PS, V36, P127, DOI 10.1136/jnnp.36.1.127; BUCKINGHAM MJ, 1988, NEUROSURGERY, V22, P398, DOI 10.1227/00006123-198802000-00022; BURTON C, 1968, J NEUROSURG, V28, P468, DOI 10.3171/jns.1968.28.5.0468; FLEISHER AS, 1975, SURG NEUROL, V4, P223; FOX JL, 1983, INTRACRANIAL ANEURYS; FOX JL, 1983, INTRACRANIAL ANEURYS, V3; HADDAD FS, 1991, NEUROSURGERY, V28, P1; JUNGUEIRA LC, 1986, BASIC HISTOLOGY; LAUN A, 1979, CEREBRAL ANEURYSMS A, P364; LAURENT JP, 1981, NEUROSURGERY, V9, P303, DOI 10.1227/00006123-198109000-00015; MAURER JJ, 1961, J NEUROSURG, V18, P837, DOI 10.3171/jns.1961.18.6.0837; PATEL AN, 1971, J NEUROSURG, V35, P571, DOI 10.3171/jns.1971.35.5.0571; SMITH KR, 1968, J NEUROSURG, V29, P551, DOI 10.3171/jns.1968.29.5.0551; STEINMETZ H, 1988, SURG NEUROL, V30, P305, DOI 10.1016/0090-3019(88)90304-7; Takakura K, 1990, NEUROLOGICAL SURG, P1864; YOKOTA H, 1983, Neurological Surgery, V11, P521	19	17	18	0	0	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399	0003-9993			ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	AUG	1997	78	8					883	885		10.1016/S0003-9993(97)90205-7			3	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	XQ791	WOS:A1997XQ79100018	9344311				2021-06-18	
J	Cummings, RS; Shurland, AT; Prodoehl, JA; Moody, K; Sherk, HH				Cummings, RS; Shurland, AT; Prodoehl, JA; Moody, K; Sherk, HH			Injuries in the sport of luge - Epidemiology and analysis	AMERICAN JOURNAL OF SPORTS MEDICINE			English	Article							SKI	We undertook this study to determine the types and frequency of injuries sustained in the sport of luge. Before this study, no data were available in the medical literature on luge injuries. We performed a retrospective analysis between the years 1985 and 1992 using data obtained from the athlete injury and illness report forms at the US Training Center Sports Medicine Clinic in Lake Placid, New York. During the 7 years examined, 1043 athletes took 57, 244 track runs and sustained 407 injuries. The risk of sustaining an injury was 0.39 per person per year, and the risk of an injury causing the loss of more than 1 day of practice was 0.04 per person per year. Contusions were the major injury (51%), followed by strains (27%). Strains of the neck muscles and contusions of extremities, especially the hands, were characteristic injuries sustained by athletes. The most serious injuries were concussions (2%) and fractures (3%). Crashes were responsible for 64% of injuries. Luge appears to be a relatively safe sport with injury rates comparable with recreational alpine skiing.	UNIV PENN, SCH MED, PHILADELPHIA, PA 19104 USA; US OLYMP COMM, SPORTS MED CLIN, LAKE PLACID, NY USA	Cummings, RS (corresponding author), MED COLL PENN & HAHNEMANN UNIV, DEPT ORTHOPAED SURG, 3300 HENRY AVE, PHILADELPHIA, PA 19118 USA.						BACKX FJG, 1991, AM J SPORT MED, V19, P124, DOI 10.1177/036354659101900206; BJORNSTIG U, 1986, SCAND J SOC MED, V14, P83; BOYLE JJ, 1985, SKIING TRAUMA SAFETY, P411; ELMQUIST LG, 1994, SPORTS INJURIES MECH, P481; Garrick J G, 1979, Am J Sports Med, V7, P245, DOI 10.1177/036354657900700408; HERKOWITZ HN, 1978, J TRAUMA, V18, P806, DOI 10.1097/00005373-197812000-00004; REID DC, 1989, SPORTS MED, V7, P393, DOI 10.2165/00007256-198907060-00004; Rogowski P, 1978, SPORT LUGE; Shealy JE, 1989, SKIING TRAUMA SAFETY, P75; THOMPSON N, 1987, AM J SPORTS MED, V15, pS97; WARME WJ, 1995, AM J SPORT MED, V23, P597, DOI 10.1177/036354659502300514; WEBSTER K, 1985, AM J SPORTS MED, V13, P124; WRIGHT JR, 1991, AM J SPORT MED, V19, P615, DOI 10.1177/036354659101900611; YOUNG LR, 1991, AM SOC TEST MATER, P125, DOI 10.1520/STP17637S	14	17	17	0	8	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0363-5465			AM J SPORT MED	Am. J. Sports Med.	JUL-AUG	1997	25	4					508	513		10.1177/036354659702500414			6	Orthopedics; Sport Sciences	Orthopedics; Sport Sciences	XM181	WOS:A1997XM18100014	9240985				2021-06-18	
J	Armstrong, C				Armstrong, C			Selective versus sustained attention: A continuous performance test revisited	CLINICAL NEUROPSYCHOLOGIST			English	Article							EVENT-RELATED POTENTIALS; CLOSED-HEAD-INJURY; MULTIPLE-SCLEROSIS; ALZHEIMERS-DISEASE; DEMENTIA; CHILDREN; TASK; AGE; DEFICITS; BRAIN	The selective-set paradigm has dominated the measurement of visual selective attention in cognitive neuroscience. Previous auditory selective attention tests, the continuous performance tests (CPT), actually measure sustained attention, while auditory filtering paradigms require ''bottom-up'' perceptual processing. The development of the Auditory Selective Attention Test (ASAT) was based on selective-set theory. An age effect was found in subjects between 19-94 years of age who were over age 60. The probability foils were effective in discriminating impairment in four adult neurological groups (dementia, mild head injury, multiple sclerosis, learning disability). Impairment in discrimination (omission errors) but not response bias suggests that the ASAT requires cognitive search as defined by selective-set theory, which differentiates it from CPT and filtering paradigms. Associations with cognitive complexity and working memory are posited.		Armstrong, C (corresponding author), UNIV PENN,SCH MED,DEPT NEUROL,3 GATES,3400 SPRUCE ST,PHILADELPHIA,PA 19104, USA.						ALBERT MS, 1988, GERIATRIC NEUROPSYCH, P33; ALEXANDER DA, 1973, PSYCHOL REP, V32, P229, DOI 10.2466/pr0.1973.32.1.229; Armstrong C, 1996, NEUROPSYCHOLOGIA, V34, P853, DOI 10.1016/0028-3932(95)00171-9; Baddeley A. D., 1986, WORKING MEMORY; Benton AL., 1974, REVISED VISUAL RETEN; Broadbent D. E., 1970, ATTENTION CONT THEOR, P51; BROUWER WH, 1985, CORTEX, V21, P111, DOI 10.1016/S0010-9452(85)80019-8; COYLE S, 1991, EXP AGING RES, V17, P103, DOI 10.1080/03610739108253889; DIXON WJ, 1988, BMDP STATISTICAL SOF; DONALD MW, 1981, CAN J PSYCHOL, V35, P175, DOI 10.1037/h0081153; ESPOSITO RU, 1984, MEMORY CONSOLIDATION, P15; FISCHER P, 1990, NEUROLOGY, V40, P387; GAUTHIER L, 1989, INT J CLIN NEUROPSYC, V11, P49; GIESSER BS, 1992, ELECTROEN CLIN NEURO, V82, P320, DOI 10.1016/0013-4694(92)90002-Y; GRADY CL, 1989, ARCH NEUROL-CHICAGO, V46, P317, DOI 10.1001/archneur.1989.00520390083021; GRIMSLEY G, 1956, EMPLOYEE APTITUDE SU; GRONWALL DMA, 1977, PERCEPT MOTOR SKILL, V44, P367, DOI 10.2466/pms.1977.44.2.367; HALPERIN JM, 1991, INT J NEUROSCI, V58, P171, DOI 10.3109/00207459108985433; HALPERIN JM, 1988, J AM ACAD CHILD PSY, V27, P326, DOI 10.1097/00004583-198805000-00010; HALPERIN JM, 1990, J ABNORM CHILD PSYCH, V18, P437, DOI 10.1007/BF00917645; Halperin JM., 1991, PSYCHOL ASSESS A, V3, P603, DOI [10.1037/1040-3590.3.4.603, DOI 10.1037/1040-3590.3.4.603]; HEATON R, 1985, J CONSULT CLIN PSYCH, V53, P101; Heaton R. K, 1981, WISCONSIN CARD SORTI; JAMES L, 1989, INT J PSYCHOPHYSIOL, V8, P61, DOI 10.1016/0167-8760(89)90020-2; KACHIGAN SK, 1986, STAT ANAL; Kirby J. R., 1984, J PSYCHOEDUCATIONAL, V2, P9; KREMEN WS, 1992, J NERV MENT DIS, V180, P89, DOI 10.1097/00005053-199202000-00004; KUTAS M, 1984, HDB COGNITIVE NEUROS, P387; LAIDLAW TM, 1993, INT J CLIN EXPT HYPN, V16, P97; LEZAK MD, 1995, NEUROPSYCHOLOGICAL A; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; MIRSKY AF, 1987, ENVIRON HEALTH PERSP, V74, P191, DOI 10.2307/3430449; MIRSKY AF, 1965, ELECTROEN CLIN NEURO, V18, P334, DOI 10.1016/0013-4694(65)90053-2; MIRSKY AF, 1962, ELECTROEN CLIN NEURO, V14, P1, DOI 10.1016/0013-4694(62)90002-0; Money J., 1976, STANDARDIZED ROAD MA; NAATANEN R, 1990, BEHAV BRAIN SCI, V13, P201, DOI 10.1017/S0140525X00078407; Newcombe F., 1969, MISSILE WOUNDS BRAIN; NISSEU MJ, 1981, ANN C AM AG ASS CHIC; Osterrieth PA, 1944, ARCH PSYCHOLOGIE, V30, P206; PARASURAMAN R, 1991, HUM FACTORS, V33, P539; PARASURAMAN R, 1992, BRAIN, V115, P711, DOI 10.1093/brain/115.3.711; PARASURAMAN R, 1991, J CLIN EXP NEUROPSYC, V13, P789, DOI 10.1080/01688639108401090; Parasuraman R., 1993, NEUROPSYCHOLOGY, V7, P242, DOI DOI 10.1037/0894-4105.7.3.242; POLICH J, 1990, ELECTROEN CLIN NEURO, V77, P179, DOI 10.1016/0168-5597(90)90036-D; PONSFORD J, 1992, J CLIN EXP NEUROPSYC, V14, P822, DOI 10.1080/01688639208402865; POSER CM, 1983, ANN NEUROL, V13, P227, DOI 10.1002/ana.410130302; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; PRIOR M, 1985, J CHILD PSYCHOL PSYC, V26, P289, DOI 10.1111/j.1469-7610.1985.tb02267.x; Rey A, 1964, EXAMEN CLIN PSYCHOL; RITTER W, 1968, ELECTROEN CLIN NEURO, V25, P550, DOI 10.1016/0013-4694(68)90234-4; ROSVOLD HE, 1956, J CONSULT PSYCHOL, V20, P343, DOI 10.1037/h0043220; RUCH FR, 1963, EMPLOYEE APTITUDE SU; RUSSELL EW, 1970, ASSESSMENT BRAIN DAM; SAHAKIAN BJ, 1990, NEUROPSYCHOLOGIA, V28, P1197, DOI 10.1016/0028-3932(90)90055-S; SANDRONI P, 1992, ARCH NEUROL-CHICAGO, V49, P517, DOI 10.1001/archneur.1992.00530290105019; SCHNEIDER W, 1977, PSYCHOL REV, V84, P1, DOI 10.1037/0033-295X.84.1.1; SHIFFRIN RM, 1977, PSYCHOL REV, V84, P127, DOI 10.1037/0033-295X.84.2.127; Smith A., 1982, SYMBOL DIGIT MODALIT; SNODGRASS JG, 1988, J EXP PSYCHOL GEN, V117, P34, DOI 10.1037/0096-3445.117.1.34; Spreen O., 1977, NEUROSENSORY CTR COM; STEINSCHNEIDER M, 1992, HDB NEUROPSYCHOLOGY, V6, P239; SUNDERLAND T, 1987, ARCH GEN PSYCHIAT, V44, P418; TARNOWSKI KJ, 1986, J ABNORM PSYCHOL, V95, P341, DOI 10.1037/0021-843X.95.4.341; Treisman A., 1984, VARIETIES ATTENTION, P29; VANDERMEERE J, 1989, J ABNORM CHILD PSYCH, V17, P409, DOI 10.1007/BF00915035; Vanier M, 1990, NEUROPSYCHOLOGY, V4, P87, DOI 10.1037/0894-4105.4.2.87; Wechsler D., 1987, WECHSLER MEMORY SCAL; Weintraub S., 1985, PRINCIPLES BEHAV NEU, P71; WICKENS CD, 1987, PSYCHOL AGING, V2, P70, DOI 10.1037/0882-7974.2.1.70; WOODS DL, 1986, NEUROLOGY, V36, P212, DOI 10.1212/WNL.36.2.212	70	17	17	0	6	SWETS ZEITLINGER PUBLISHERS	LISSE	P O BOX 825, 2160 SZ LISSE, NETHERLANDS	0920-1637			CLIN NEUROPSYCHOL	Clin. Neuropsychol.	FEB	1997	11	1					18	33		10.1080/13854049708407026			16	Psychology, Clinical; Clinical Neurology; Psychology	Psychology; Neurosciences & Neurology	WK256	WOS:A1997WK25600002					2021-06-18	
J	DellaCorte, F; Giordano, A; Pennisi, MA; Barelli, A; Caricato, A; Campioni, P; Galli, G				DellaCorte, F; Giordano, A; Pennisi, MA; Barelli, A; Caricato, A; Campioni, P; Galli, G			Quantitative cerebral blood flow and metabolism determination in the first 48 hours after severe head injury with a new dynamic SPECT device	ACTA NEUROCHIRURGICA			English	Article						head trauma; cerebral blood flow; cerebral metabolism; jugular vein oxygen saturation; intracranial pressure	EMISSION COMPUTED-TOMOGRAPHY; INERT-GAS CONCENTRATIONS; INTRACRANIAL HYPERTENSION; BRAIN-FUNCTION; CIRCULATION; RECOVERY; COMA; ICP	Objective: To determine cerebral blood flow (CBF) and metabolism in the acute phase after severe head injury by a new dynamic SPECT device using (133)Xenon and to evaluate a possible role of CBF and metabolism in the determination of prognosis. Design: Prospective study Setting: General intensive carl unit in a universitary teaching hospital Subjects: 23 severely head injured patients having CT scan and CBF determination. intracranial pressure (ICP) and jugular bulb oxygen saturation monitoring in the first 35 hours. Measurements and main results: CBF varied from 18.0 to 60.0 ml/100 g/min. No correlation was found between early CBF and severity of trauma evaluated with the Glasgow Coma Score (GCS) (F = 2.151, p = 0.142) and between CBF and prognosis at 6 months evaluated with Glasgow outcome score (GOS) (F = 0.491, p = 0.622; r(s) = 0.251, p = 0.246). CMRO2 was depressed in relation to the severity of injury, specifically ranging from 0.9 +/- 0.5 ml 100 g/min in patients with GCS 3 to 1.7 +/- 0.8 ml/100 g/min in patients with GCS 6-7. In no patient with a CMRO2 less than 0.8 ml/100 g/min was a good outcome observed. PI significant cor; relation was found between GCS and GOS (r(s) = 0.699, p = 0.0002). between CMRO2 and GOS (F = 4.303, p = 0.031: r(s) = 0.525, p = 0.013) and between AJDO(2) and GOS (F = 3.602, p=0.046; r(s) = 0.491, p = 0.017. Fronto-occipital ratio (F/O) of CBF distribution was significantly lower than normal values (chi(2) = 18.658, p = 0.001) but did not correlate either with prognosis (chi(2) = 1.626. p = 0.443) of with severity (chi(2) = 1.913, p = 0.384). Conclusions: CBF ill the First 48 hours after trauma varies within a large range of values and is nor correlated with severity and prognosis. Clinical evaluation with GCS and CMRO2 are much more reliable indicators of severity of head trauma and have a sig nificant role in the determination of prognosis. F/O ration is significantly altered from normal values confirming ''post-traumatic hypofrontalism'' but does not correlate with severly sind prognosis.	UNIV CATTOLICA SACRO CUORE, DEPT NUCL MED, I-00168 ROME, ITALY; UNIV CATTOLICA SACRO CUORE, DEPT RADIOL, I-00168 ROME, ITALY	DellaCorte, F (corresponding author), UNIV CATTOLICA SACRO CUORE, IST ANESTESIOL & RIANIMAZ, DEPT ANAESTHESIOL & INTENS CARE, I-00168 ROME, ITALY.		Corte, Francesco Della/ABI-7646-2020; Campioni, Paolo/AAI-3729-2020; Campioni, Paolo/ABB-5437-2020	Corte, Francesco Della/0000-0003-1736-2318; Campioni, Paolo/0000-0002-7275-7358; PENNISI, Mariano Alberto/0000-0001-8761-5144			BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; CELSIS P, 1981, J COMPUT ASSIST TOMO, V5, P641, DOI 10.1097/00004728-198110000-00006; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; CLIFTON GL, 1981, CIRCULATING CATECHOL, P228; Cold G E, 1990, Acta Neurochir Suppl (Wien), V49, P1; DAJEM HMA, 1987, RADIOLOGY, V165, P221; DEROSSI G, 1992, RADIOL DIAGN, V33, P236; DEUTSCH G, 1987, J CEREBR BLOOD F MET, V7, P29, DOI 10.1038/jcbfm.1987.5; EISENBERG HM, 1983, INTRACRANIAL PRESSUR, V5, P549; FELDMAN Z, 1992, Contemporary Neurosurgery, V14, P1; GIORDANO A, 1991, NUCLEAR MED NUCLEAR, P6; HEMMER M, 1988, UPDATE INTENSIVE CAR, V5, P537; JAGGI JL, 1990, J NEUROSURG, V72, P176, DOI 10.3171/jns.1990.72.2.0176; JENNETT B, 1975, LANCET, V1, P480; KANNO I, 1979, J COMPUT ASSIST TOMO, V3, P71, DOI 10.1097/00004728-197902000-00012; Langfitt T W, 1981, Prog Neurol Surg, V10, P14, DOI 10.1159/000384767; LASSEN NA, 1978, SCI AM, V239, P62, DOI 10.1038/scientificamerican1078-62; MESSETER K, 1986, J NEUROSURG, V64, P231, DOI 10.3171/jns.1986.64.2.0231; MILLER JD, 1977, J NEUROSURG, V47, P503, DOI 10.3171/jns.1977.47.4.0503; MILLER JD, 1975, J NEUROL NEUROSUR PS, V38, P657, DOI 10.1136/jnnp.38.7.657; MILLER JD, 1978, JAMA-J AM MED ASSOC, V240, P439, DOI 10.1001/jama.240.5.439; MILLER JD, 1985, BRIT J ANAESTH, V57, P120, DOI 10.1093/bja/57.1.120; MUIZELAAR JP, 1989, J NEUROSURG, V71, P63, DOI 10.3171/jns.1989.71.1.0063; MUIZELAAR JP, 1989, TXB HEAD INJURY; OBRIST WD, 1984, J NEUROSURG, V61, P241, DOI 10.3171/jns.1984.61.2.0241; OBRIST WD, 1979, J NEUROSURG, V51, P292, DOI 10.3171/jns.1979.51.3.0292; ODER W, 1991, INTENS CARE MED, V17, P149, DOI 10.1007/BF01704718; OMMAYA AK, 1975, P 2 CHIC S NEUR TRAU; OVERGAARD J, 1981, J NEUROSURG, V55, P63, DOI 10.3171/jns.1981.55.1.0063; OVERGAARD J, 1974, J NEUROSURG, V41, P531, DOI 10.3171/jns.1974.41.5.0531; PFENNINGER EG, 1991, ACTA ANAESTH SCAND, V35, P148, DOI 10.1111/j.1399-6576.1991.tb03263.x; ROBERTSON CS, 1983, J NEUROSURG, V59, P455, DOI 10.3171/jns.1983.59.3.0455; ROINE RO, 1991, ARCH NEUROL-CHICAGO, V48, P625, DOI 10.1001/archneur.1991.00530180081021; ROPER SN, 1991, J NUCL MED, V32, P1684; Sato M, 1989, Neurol Med Chir (Tokyo), V29, P389, DOI 10.2176/nmc.29.389; TEASDALE G, 1974, LANCET, V2, P81; UZZELL BP, 1986, J NEUROSURG, V65, P630, DOI 10.3171/jns.1986.65.5.0630; YOSHINO E, 1985, J NEUROSURG, V63, P830, DOI 10.3171/jns.1985.63.6.0830	38	17	17	0	1	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.		1997	139	7					636	642					7	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	XL118	WOS:A1997XL11800013	9265957				2021-06-18	
J	Hoots, WK				Hoots, WK			Experience with antithrombin concentrates in neurotrauma patients	SEMINARS IN THROMBOSIS AND HEMOSTASIS			English	Article						antithrombin (AT); neurotrauma; disseminated intravascular coagulation (DIC); inflammation; clinical trial	DISSEMINATED INTRAVASCULAR COAGULATION; INJURY; BRAIN	Plasma coagulation results from 2,100 injured patients were sequentially and systematically evaluated in a large natural history study of neurotrauma. A significant correlation became apparent between the severity of and morbidity from head injury and the degree of abnormality in coagulation results, especially for young injured victims. Subsequent studies in the United States, Europe, and Japan have supported the significant correlation between final clinical outcome and these measurements of plasma coagulation, as well as inflammatory proteins, performed soon after injury. This discussion reviews the data from many published reports that support this conclusion, especially data that corroborate the strong clinical association between head trauma and disseminated intravascular coagulation (DIC), The data that demonstrate a high predisposition for head-injured individuals to develop DIC serve as a the rationale for therapeutic intervention with coagulation protease inhibitors, especially antithrombin (AT), A large, double-blind, placebo-controlled trial that evaluates the therapeutic use of AT concentrate for DIC in such patients has yet to be completed. Described here is the design for such a clinical trial that examined the impact of mortality as an outcome, However, this trial was terminated for nonscientific reasons soon after it began. Very truncated data collected from this aborted study support both the scientific rationale for and the feasibility of such a study in the future. Data from such a clinical trial are needed to support the use of AT concentrate to treat DIC in this and other morbid diseases.	Gulf States Hemophilia Diagnost & Treatment Ctr, Houston, TX 77030 USA; Univ Texas, Hlth Sci Ctr, MD Anderson Cancer Ctr, Houston, TX USA	Hoots, WK (corresponding author), Gulf States Hemophilia Diagnost & Treatment Ctr, 6410 Fannin,Suite 416 PHB, Houston, TX 77030 USA.						BLAUHUT B, 1985, THROMB RES, V39, P81, DOI 10.1016/0049-3848(85)90123-9; BREDBACKA S, 1992, J NEUROSURG ANESTH, V4, P128, DOI 10.1097/00008506-199204000-00008; CUNNINGHAM DD, 1993, THROMB HAEMOSTASIS, V70, P168; EDWARDS RL, 1992, SEMIN HEMATOL, V29, P202; FAULK WP, 1994, SEMIN HEMATOL, V31, P26; HOOTS K, 1996, NEUROTRAUMA, P673; HOOTS WK, 1983, BLOOD S1, V652, pA275; HOOTS WK, 1985, PEDIAT RES 2 S, V19, pA142; KAUFMAN HH, 1985, CENTRAL NERVOUS SYST, P187; MARBET GA, 1986, THROM HEMOSTAS, V55, P28; MARSHALL LF, 1983, J NEUROSURG, V59, P276, DOI 10.3171/jns.1983.59.2.0276; MARSHALL LF, 1983, J NEUROSURG, V59, P283; OLSON JD, 1989, NEUROSURGERY, V24, P825, DOI 10.1227/00006123-198906000-00007; Owings JT, 1996, J TRAUMA, V41, P396, DOI 10.1097/00005373-199609000-00004; ROSENZWEIG SM, 1989, COMMENTARY, V87, P2; STEIN SC, 1993, NEUROSURGERY, V32, P25, DOI 10.1227/00006123-199301000-00004; WADA H, 1993, AM J HEMATOL, V43, P190, DOI 10.1002/ajh.2830430306	17	17	17	0	2	THIEME MEDICAL PUBL INC	NEW YORK	333 SEVENTH AVE, NEW YORK, NY 10001 USA	0094-6176			SEMIN THROMB HEMOST	Semin. Thromb. Hemost.		1997	23			1			3	16					14	Hematology; Peripheral Vascular Disease	Hematology; Cardiovascular System & Cardiology	172RN	WOS:000078938200002	9156417				2021-06-18	
J	Markowitsch, HJ; Ewald, K				Markowitsch, HJ; Ewald, K			Right-hemispheric fronto-temporal injury leading to severe autobiographical retrograde and moderate anterograde episodic amnesia - implications for the anatomy of memory	NEUROLOGY PSYCHIATRY AND BRAIN RESEARCH			English	Article						prefrontal cortex; temporal cortex; amnesia; memory; hemispheric specialization; head trauma; ecphory	RETRIEVAL; CORTEX; DEFICITS; RECALL; PET	Neuropsychological and neuroradiological data are reported for a 56 year old patient, DD, with traumatic brain injury. Prior to injury the patient had been a top specialist in his professional field and had obtained a doctor's degree. Hit by a bus. DD received major right sided damage to his frontal skull. resulting in loss of right eye vision, and extensive right prefrontal and anterior temporal damage. In addition the anterior right basal ganglia and the inferior anterior left frontal lobe were damaged together with the genu of the corpus callosum. The patient was repeatedly tested neuropsychologically 2 to 3 years post-injury. He was depressed and manifested moderate anterograde and severe autobiographical retrograde amnesia. His anterograde memory problems seem to be a consequence of reduced cognitive flexibility and inefficient structuring and active self-organization abilities, caused by his prefrontal damage. His retrograde amnesia is interpreted as related to the combined temporo-frontal damage in the right hemisphere which has been shown to result in precisely this deficit pattern in other patients with the same pattern of brain damage. It is concluded that fronto-temporal brain damage, largely restricted to the right hemisphere, results in an inability to retrieve or ecphorize autobiographical old memories.	Univ Bielefeld, D-33501 Bielefeld, Germany							Calabrese P, 1996, J NEUROL NEUROSUR PS, V61, P304, DOI 10.1136/jnnp.61.3.304; Damasio A., 1994, DESCARTESERROR EMOTI; DAMASIO AR, 1989, COGNITION, V33, P25, DOI 10.1016/0010-0277(89)90005-X; DEROGATIS LR, 1983, PSYCHOL MED, V13, P595, DOI 10.1017/S0033291700048017; Fink GR, 1996, J NEUROSCI, V16, P4275; Fletcher PC, 1997, TRENDS NEUROSCI, V20, P213, DOI 10.1016/S0166-2236(96)01013-2; Fuster J, 1989, PREFRONTAL CORTEX; GRAFMAN J, 1988, BRAIN, V111, P169, DOI 10.1093/brain/111.1.169; HODGES JR, 1993, BRAIN, V116, P921, DOI 10.1093/brain/116.4.921; JOKEIT H, 1997, IN PRESS BRAIN; Kapur N, 1997, MEMORY, V5, P115, DOI 10.1080/741941152; KAPUR N, 1993, CORTEX, V29, P217, DOI 10.1016/S0010-9452(13)80177-3; Kapur N, 1996, J COGNITIVE NEUROSCI, V8, P416, DOI 10.1162/jocn.1996.8.5.416; KAPUR N, 1992, BRAIN, V115, P73, DOI 10.1093/brain/115.1.73; Kopelman M. D., 1990, AUTOBIOGRAPHICAL MEM; KOPELMAN MD, 1993, HDB NEUROPSYCHOLOGY, V8, P215; Kroll NEA, 1997, BRAIN, V120, P1377, DOI 10.1093/brain/120.8.1377; LEZAK MD, 1995, NEUROPSYCHOLOGICAL A; Markowitsch H J, 1997, Cogn Neuropsychiatry, V2, P135, DOI 10.1080/135468097396379; Markowitsch H. J., 1995, COGNITIVE NEUROSCIEN, P665; Markowitsch HJ, 1997, EUR J NEUROL, V4, P178, DOI 10.1111/j.1468-1331.1997.tb00324.x; MARKOWITSCH HJ, 1993, J CLIN EXP NEUROPSYC, V15, P627, DOI 10.1080/01688639308402586; Markowitsch HJ, 1996, NEUROCASE, V2, P357; MARKOWITSCH HJ, 1993, J NEUROL NEUROSUR PS, V56, P988, DOI 10.1136/jnnp.56.9.988; Markowitsch HJ, 1995, BRAIN RES REV, V21, P117, DOI 10.1016/0165-0173(95)00007-0; MARKOWITSCH HJ, 1993, J CLIN EXP NEUROPSYC, V15, P947, DOI 10.1080/01688639308402610; Markowitsch HJ, 1996, BEHAV NEUROL, V9, P45, DOI 10.3233/BEN-1996-9201; Markowitsch HJ, 1997, PSYCHIAT RES-NEUROIM, V74, P119, DOI 10.1016/S0925-4927(97)03041-2; MARKOWITSCH HJ, IN PRESS TRENDS NEUR; Mayes AR, 1997, CORTEX, V33, P197, DOI 10.1016/S0010-9452(08)70001-7; Nadel L, 1997, CURR OPIN NEUROBIOL, V7, P217, DOI 10.1016/S0959-4388(97)80010-4; PRIBRAM KH, 1967, SCIENCE, V156, P1765, DOI 10.1126/science.156.3783.1765; RempelClower NL, 1996, J NEUROSCI, V16, P5233; RUSSELL WR, 1971, TRAUMATIC AMNESIAS; Schmidtke K, 1997, NEUROPSYCHOLOGIA, V35, P505, DOI 10.1016/S0028-3932(96)00109-1; SHALLICE T, 1992, ATTENTION SELECTION, P195; Swick D, 1996, NEUROPSYCHOLOGIA, V34, P1019, DOI 10.1016/0028-3932(96)00011-5; Tulving E, 1997, CURR OPIN NEUROBIOL, V7, P209, DOI 10.1016/S0959-4388(97)80009-8; Tulving E, 1983, ELEMENTS EPISODIC ME; Tulving Endel, 1995, P839	40	17	17	1	5	UNIVERSITATSVERLAG ULM GMBH	ULM	BAHNHOFSTRASSE 20, D-89073 ULM, GERMANY	0941-9500			NEUROL PSYCHIAT BR	Neurol. Psychiatr. Brain Res.		1997	5	2					71	78					8	Neurosciences; Psychiatry	Neurosciences & Neurology; Psychiatry	117PF	WOS:000075790400002					2021-06-18	
J	LordMaes, J; Obrzut, JE				LordMaes, J; Obrzut, JE			Neuropsychological consequences of traumatic brain injury in children and adolescents	JOURNAL OF LEARNING DISABILITIES			English	Article							CLOSED-HEAD-INJURY; LEARNING-DISABLED CHILDREN; DAMAGE PATTERN; WISC-R; DISABILITIES; ATTENTION; DISORDERS; SEQUELAE; HYPERACTIVITY; COLLABORATION	The study of the relationship between neuroscientific information and cognitive function and dysfunction is clearly a widely expanding field. In particular, there has been a growing body of research on traumatic brain injury (TBI) in children and adolescents. This article conveys recent findings concerning cognitive outcomes, with a particular focus on age differences with TBI, suggests a relationship between specific learning disorders and brain dysfunction, addresses differential hemisphere functioning with TBI, and alludes to recent developments in assessment of TBI.		LordMaes, J (corresponding author), UNIV ARIZONA,COLL EDUC,DEPT SPECIAL EDUC & REHABIL,SCH PSYCHOL DOCTORAL PROGRAM,TUCSON,AZ 85721, USA.						ARAM DM, 1994, NEUROPSYCHOLOGIA, V32, P85, DOI 10.1016/0028-3932(94)90071-X; ARFFA S, 1989, J LEARN DISABIL, V22, P635, DOI 10.1177/002221948902201009; BANICH MT, 1990, NEUROPSYCHOLOGIA, V28, P35, DOI 10.1016/0028-3932(90)90084-2; BIGLER ED, 1992, J LEARN DISABIL, V25, P488, DOI 10.1177/002221949202500803; BIGLER ED, 1988, J LEARN DISABIL, V21, P476, DOI 10.1177/002221948802100805; BRADSHAW JL, 1981, BEHAV BRAIN SCI, V4, P51, DOI 10.1017/S0140525X00007548; BRAZZELLI M, 1994, CORTEX, V30, P27, DOI 10.1016/S0010-9452(13)80323-1; CHAPMAN SB, 1992, BRAIN LANG, V43, P42, DOI 10.1016/0093-934X(92)90020-F; CONNERS CK, 1973, PSYCHOPHARMACOLOGY B, P24; DALBY PR, 1991, DEV NEUROPSYCHOL, V7, P35, DOI 10.1080/87565649109540476; DOBBINS C, 1990, J CLIN PSYCHOL, V46, P863, DOI 10.1002/1097-4679(199011)46:6<863::AID-JCLP2270460628>3.0.CO;2-M; DONDERS J, 1993, J CLIN PSYCHOL, V49, P255, DOI 10.1002/1097-4679(199303)49:2<255::AID-JCLP2270490220>3.0.CO;2-Q; EISELE JA, 1993, APHASIOLOGY, V7, P513, DOI 10.1080/02687039308248627; Ewing-Cobbs L, 1990, TRAUMATIC BRAIN INJU, P107; EWINGCOBBS L, 1987, J CLIN EXP NEUROPSYC, V9, P575, DOI 10.1080/01688638708410770; EWINGCOBBS L, 1989, J PEDIATR PSYCHOL, V14, P531, DOI 10.1093/jpepsy/14.4.531; EWINGCOBBS L, 1986, J HEAD TRAUMA REHAB, V1, P57; FARMER JE, 1995, SCHOOL PSYCHOL REV, V24, P230; FLETCHER JM, 1988, HDB PEDIATRIC PSYCHO, P258; FUERST DR, 1989, J CONSULT CLIN PSYCH, V57, P275, DOI 10.1037/0022-006X.57.2.275; Gaddes W.H., 1994, LEARNING DISABILITIE; GESCHWIND N, 1979, SCI AM, V24, P180; GOLDSTEIN FC, 1991, BRAIN COGNITION, V17, P23, DOI 10.1016/0278-2626(91)90063-E; GOODYEAR P, 1992, J CLIN CHILD PSYCHOL, V21, P273, DOI 10.1207/s15374424jccp2103_9; Halstead WC, 1985, HALSTEAD REITAN NEUR; HEBB DO, 1949, ORG BEHAVIOR; HOM J, 1982, Journal of Clinical Neuropsychology, V4, P249, DOI 10.1080/01688638208401133; HOOPER SR, 1993, PSYCHOL REP, V72, P371, DOI 10.2466/pr0.1993.72.2.371; HUTTENLOCHER PR, 1990, NEUROPSYCHOLOGIA, V28, P517, DOI 10.1016/0028-3932(90)90031-I; JAFFE CC, 1982, AM SCI, V70, P576; JOHN ER, 1983, PROG NEUROBIOL, V21, P239, DOI 10.1016/0301-0082(83)90014-X; JOHN ER, 1986, INTERNAL MED SPECIAL, V7, P155; JOHNSON DA, 1992, BRIT J EDUC PSYCHOL, V62, P404, DOI 10.1111/j.2044-8279.1992.tb01033.x; KARZMARK P, 1992, Brain Injury, V6, P213, DOI 10.3109/02699059209029662; KATZ L, 1993, J LEARN DISABIL, V26, P65, DOI 10.1177/002221949302600108; KAUFMANN PM, 1993, J CHILD NEUROL, V8, P348, DOI 10.1177/088307389300800410; KELLY MS, 1989, BRAIN COGNITION, V11, P275, DOI 10.1016/0278-2626(89)90022-5; KUPFERMANN I, 1985, PRINCIPLES NEURAL SC, P806; Lehr E, 1990, PSYCHOL MANAGEMENT T; LEVIN HS, 1993, ARCH NEUROL-CHICAGO, V50, P897, DOI 10.1001/archneur.1993.00540090008004; LEVIN HS, 1989, J NEUROL NEUROSUR PS, V52, P1162, DOI 10.1136/jnnp.52.10.1162; LEVIN HS, 1991, J CLIN EXP NEUROPSYC, V13, P133, DOI 10.1080/01688639108407213; LEVIN HS, 1994, NEUROPSYCHOLOGY, V8, P171, DOI DOI 10.1037/0894-4105.8.2.171; LEVIN HS, 1994, J CHILD NEUROL, V9, P811; LEWIN W, 1968, BRIT MED J, V1, P5; LEZAK MD, 1988, J CLIN EXP NEUROPSYC, V10, P351, DOI 10.1080/01688638808400871; MARTIN DA, 1988, J LEARN DISABIL, V21, P464, DOI 10.1177/002221948802100803; MARTIN JH, 1985, PRINCIPLES NEURAL SC, P260; MATTSON AJ, 1990, J NERV MENT DIS, V178, P282, DOI 10.1097/00005053-199005000-00002; MATTSON AJ, 1994, J NEUROL NEUROSUR PS, V57, P818, DOI 10.1136/jnnp.57.7.818; MEYERS CA, 1992, NEUROPSY NEUROPSY BE, V5, P28; MURRAY R, 1992, BRAIN COGNITION, V18, P99, DOI 10.1016/0278-2626(92)90072-T; NASS R, 1987, DEV NEUROPSYCHOL, V3, P93, DOI 10.1080/87565648709540367; OBRZUT JE, 1987, J LEARN DISABIL, V20, P596, DOI 10.1177/002221948702001005; OBRZUT JE, 1981, DEV PSYCHOL, V17, P118, DOI 10.1037/0012-1649.17.1.118; OBRZUT JE, 1987, J LEARN DISABIL, V20, P170; OBRZUT JE, 1983, J LEARN DISABIL, V16, P532, DOI 10.1177/002221948301600907; PAPANICOLAOU AC, 1990, ARCH NEUROL-CHICAGO, V47, P562, DOI 10.1001/archneur.1990.00530050086016; REEDER KP, 1994, ARCH CLIN NEUROPSYCH, V9, P491, DOI 10.1016/0887-6177(94)90040-X; REID DB, 1993, J CLIN PSYCHOL, V49, P245, DOI 10.1002/1097-4679(199303)49:2<245::AID-JCLP2270490219>3.0.CO;2-1; REITAN RM, 1992, J CLIN PSYCHOL, V48, P760, DOI 10.1002/1097-4679(199211)48:6<760::AID-JCLP2270480610>3.0.CO;2-8; ROURKE BP, 1987, CLIN NEUROPSYCHOL, V1, P209, DOI DOI 10.1080/13854048708520056; RUSSELL EW, 1993, J CLIN PSYCHOL, V49, P241, DOI 10.1002/1097-4679(199303)49:2<241::AID-JCLP2270490218>3.0.CO;2-G; SEGALOWITZ SJ, 1991, J LEARN DISABIL, V24, P551, DOI 10.1177/002221949102400907; SELZ M, 1979, J NERV MENT DIS, V167, P298, DOI 10.1097/00005053-197905000-00006; SHERER M, 1994, ARCH CLIN NEUROPSYCH, V9, P427, DOI 10.1016/0887-6177(94)90005-1; SHERER M, 1991, J CLIN EXP NEUROPSYC, V13, P741, DOI 10.1080/01688639108401087; SHUE KL, 1992, BRAIN COGNITION, V20, P104, DOI 10.1016/0278-2626(92)90064-S; SPREEN O, 1989, J CLIN EXP NEUROPSYC, V11, P117, DOI 10.1080/01688638908400880; STILES J, 1991, BRAIN COGNITION, V15, P201, DOI 10.1016/0278-2626(91)90026-5; SZEKERES SF, 1994, TOP LANG DISORD, V15, P21, DOI 10.1097/00011363-199411000-00004; THAL DJ, 1991, BRAIN LANG, V40, P491, DOI 10.1016/0093-934X(91)90145-Q; THOMPSON NM, 1994, NEUROPSYCHOLOGY, V8, P333, DOI DOI 10.1037/0894-4105.8.3.333; VERDUYN W H, 1992, Brain Injury, V6, P245, DOI 10.3109/02699059209029666; VIKKI J, 1989, CORTEX, V25, P363; VILLA G, 1990, CORTEX, V26, P399, DOI 10.1016/S0010-9452(13)80089-5; Wechsler D., 1987, WECHSLER MEMORY SCAL; Wechsler D., 1974, MANUAL WECHSLER INTE; Wechsler D, 2008, WECHSLER ADULT INTEL, V4th; Wechsler D., 1981, WECHSLER INTELLIGENC, V3rd; WILLIAMS DL, 1992, J LEARN DISABIL, V25, P290, DOI 10.1177/002221949202500504; WILSON JTL, 1994, J NEUROL NEUROSUR PS, V57, P198, DOI 10.1136/jnnp.57.2.198; WOOD RL, 1989, J LEARN DISABIL, V21, P327; YLVISAKER M, 1994, TOP LANG DISORD, V15, P1, DOI 10.1097/00011363-199411000-00003; YLVISAKER M, 1994, TOP LANG DISORD, V15, P37, DOI 10.1097/00011363-199411000-00005	85	17	17	0	4	PRO-ED INC	AUSTIN	8700 SHOAL CREEK BLVD, AUSTIN, TX 78757-6897	0022-2194			J LEARN DISABIL	J. Learn. Disabil.	NOV	1996	29	6					609	617		10.1177/002221949602900605			9	Education, Special; Rehabilitation	Education & Educational Research; Rehabilitation	VU234	WOS:A1996VU23400005	8942305				2021-06-18	
